PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Wang, SH; Chang, JS; Hsiao, JR; Yen, YC; Jiang, SS; Liu, SH; Chen, YL; Shen, YY; Chang, JY; Chen, YW				Wang, S-H; Chang, J. S.; Hsiao, J-R; Yen, Y-C; Jiang, S. S.; Liu, S-H; Chen, Y-L; Shen, Y-Y; Chang, J-Y; Chen, Y-W			Tumour cell-derived WNT5B modulates in vitro lymphangiogenesis via induction of partial endothelial-mesenchymal transition of lymphatic endothelial cells	ONCOGENE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; SIGNALING PATHWAY; NODE METASTASIS; BINDING-PROTEIN; BREAST-CANCER; PROLIFERATION; EXPRESSION; PROMOTES; ANGIOGENESIS; VASCULATURE	Metastasis of the cervical lymph nodes frequently leads to poor survival of patients with oral squamous cell carcinoma (OSCC). The underlying mechanisms of lymph node metastasis are unclear. Wingless-type MMTV integration site family, member 5B (WNT5B), one component of the WNT signal pathway, was markedly up-regulated in OSCC sublines with high potential of lymphatic metastasis compared to that in OSCC cells with low nodal metastasis. Increased WNT5B mRNA was demonstrated in human OSCC tissues in comparison with adjacent non-tumorous tissues. Interestingly, the high level of WNT5B protein in serum was associated with lymph node metastasis in OSCC patients. Knockdown of WNT5B expression in OSCC sublines did not affect tumour growth but impaired lymph node metastasis and tumour lymphangiogenesis of orthotopic transplantation. Conditioned medium from WNT5B knockdown cells reduced the tube formation of lymphatic endothelial cells (LECs). In contrast, recombinant WNT5B enhanced the tube formation, permeability and migration of LECs. In LECs stained with phalloidin, the morphology of those treated with recombinant WNT5B changed from flat to spindle-like. Recombinant WNT5B also increased alpha-smooth muscle actin and inhibited the expression of vascular endothelial-cadherin but retained characteristics of endothelial cells. The results suggest that WNT5B functions in the partial endothelial-mesenchymal transition (EndoMT). Furthermore, WNT5B-induced tube formation was impaired in the LECs following the knockdown of EndoMT-related transcription factor, SNAIL or SLUG. The WNT5B-induced expression of Snail or Slug was abolished by IWR-1-endo and Rac1 inhibitors, which are involved in the WNT/beta-catenin and planar cell polarity pathways, respectively. Collectively, the data suggest that WNT5B induces tube formation by regulating the expression of Snail and Slug proteins through activation of canonical and non-canonical WNT signalling pathways.	[Wang, S-H; Yen, Y-C; Jiang, S. S.; Liu, S-H; Chen, Y-L; Chen, Y-W] Natl Hlth Res Inst, Natl Inst Canc Res, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan; [Chang, J. S.] Natl Hlth Res Inst, Natl Inst Canc Res, Tainan, Taiwan; [Hsiao, J-R] Natl Cheng Kung Univ, Natl Cheng Kung Univ Hosp, Dept Otolaryngol, Coll Med, Tainan, Taiwan; [Shen, Y-Y] Natl Hlth Res Inst, Pathol Core Lab, Miaoli, Taiwan; [Chang, J-Y] Natl Cheng Kung Univ, Coll Med, Natl Cheng Kung Univ Hosp, Dept Internal Med, Tainan, Taiwan; [Chen, Y-W] China Med Univ, Grad Inst Basic Med Sci, PhD Program Aging, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; National Health Research Institutes - Taiwan; National Cheng Kung University; National Cheng Kung University Hospital; China Medical University Taiwan	Chen, YW (corresponding author), Natl Hlth Res Inst, Natl Inst Canc Res, 35 Keyan Rd, Zhunan Town 35053, Miaoli County, Taiwan.	ywc@nhri.org.tw	Chen, Ya-Wen/AAG-7549-2019; Chang, Jeffrey Shu-Ming/AAR-4161-2020; Jiang, Shih Sheng/J-9671-2019	Chen, Ya-Wen/0000-0002-6080-8859; Chang, Jeffrey Shu-Ming/0000-0002-3236-6205; Jiang, Shih Sheng/0000-0003-1909-437X	NSC [NSC 97-3112-B-001-016]; Ministry of Science and Technology [MOST 104-2314-B-400-014, NHRI CA-104-PP-04, MOHW105-TDU-B-212-112015]; National Health Research Institutes; Ministry of Health and Welfare, Taiwan	NSC(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); National Health Research Institutes(National Health Research Institutes, Japan); Ministry of Health and Welfare, Taiwan	The authors thank Dr Wen-Chun Hung (National Institute of Cancer Research, National Health Research Institutes, Tainan, Taiwan) for providing technical support and reagents and Pathology Core Laboratory (National Health Research Institutes, Miaoli, Taiwan) for the scoring of immunohistochemistry staining. RNAi reagents were obtained from the National RNAi Core Facility located at the Institute of Molecular Biology/Genomic Research Center, Academia Sinica, supported by the National Research Program for Genomic Medicine Grants of NSC (NSC 97-3112-B-001-016). We are also grateful to the Tissue Bank, Research Center of Clinical Medicine, National Cheng Kung University Hospital for providing clinical samples. This study was supported by grants MOST 104-2314-B-400-014, NHRI CA-104-PP- 04 and MOHW105-TDU-B-212-112015 from Ministry of Science and Technology, National Health Research Institutes and Ministry of Health and Welfare, Taiwan, respectively.	Achen MG, 2008, ANN NY ACAD SCI, V1131, P225, DOI 10.1196/annals.1413.020; Andre P, 2012, J BIOL CHEM, V287, P44518, DOI 10.1074/jbc.M112.414441; Buttler K, 2013, DEV BIOL, V381, P365, DOI 10.1016/j.ydbio.2013.06.028; Chen YW, 2008, CANCER RES, V68, P476, DOI 10.1158/0008-5472.CAN-07-1960; Chen YW, 2007, CANCER RES, V67, P7589, DOI 10.1158/0008-5472.CAN-07-0381; Cheng CW, 2008, BIOCHEM BIOPH RES CO, V365, P285, DOI 10.1016/j.bbrc.2007.10.166; Cooley BC, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3006927; Dale TC, 1998, BIOCHEM J, V329, P209; Dejana E, 2010, CIRC RES, V107, P943, DOI 10.1161/CIRCRESAHA.110.223750; Deraz EM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025438; Dieterich LC, 2016, ADV DRUG DELIVER REV, V99, P148, DOI 10.1016/j.addr.2015.12.011; Festing Michael F W, 2002, ILAR J, V43, P244; Ghiabi P, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0386-3; Goodwin AM, 2007, GROWTH FACTORS, V25, P25, DOI 10.1080/08977190701272933; Green JL, 2008, TRENDS CELL BIOL, V18, P536, DOI 10.1016/j.tcb.2008.08.006; Hong YK, 2003, CELL TISSUE RES, V314, P85, DOI 10.1007/s00441-003-0747-8; Kanazawa A, 2005, BIOCHEM BIOPH RES CO, V330, P505, DOI 10.1016/j.bbrc.2005.03.007; Kato S, 2014, CANCER SCI, V105, P281, DOI 10.1111/cas.12336; Kestler HA, 2008, PHILOS T R SOC B, V363, P1333, DOI 10.1098/rstb.2007.2251; Kokudo T, 2008, J CELL SCI, V121, P3317, DOI 10.1242/jcs.028282; Lee CH, 2013, J PATHOL, V230, P298, DOI 10.1002/path.4173; Liao CT, 2009, INT J RADIAT ONCOL, V73, P764, DOI 10.1016/j.ijrobp.2008.05.004; Lin F, 2012, IUBMB LIFE, V64, P717, DOI 10.1002/iub.1059; Lin ZS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043593; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Macheda ML, 2012, J BIOL CHEM, V287, P29312, DOI 10.1074/jbc.M112.362681; Mangioni S, 2005, J CLIN ENDOCR METAB, V90, P5349, DOI 10.1210/jc.2005-0272; Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320; Miyahara M, 2007, CANCER-AM CANCER SOC, V110, P1287, DOI 10.1002/cncr.22900; Nicenboim J, 2015, NATURE, V522, P56, DOI 10.1038/nature14425; NUSSE R, 1992, CELL, V69, P1073, DOI 10.1016/0092-8674(92)90630-U; Pan MR, 2009, J CELL SCI, V122, P3358, DOI 10.1242/jcs.050005; Polakis P, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008052; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Sleeman JP, 2009, INT J CANCER, V125, P2747, DOI 10.1002/ijc.24702; Stacker SA, 2014, NAT REV CANCER, V14, P159, DOI 10.1038/nrc3677; Takeshita A, 2014, INT J ONCOL, V44, P59, DOI 10.3892/ijo.2013.2172; Tobler NE, 2006, J LEUKOCYTE BIOL, V80, P691, DOI 10.1189/jlb.1105653; Welch-Reardon KM, 2015, ARTERIOSCL THROM VAS, V35, P303, DOI 10.1161/ATVBAHA.114.303220; Welch-Reardon KM, 2014, J CELL SCI, V127, P2017, DOI 10.1242/jcs.143420; Xu XB, 2015, J BIOL CHEM, V290, P16653, DOI 10.1074/jbc.M115.636944; Yang LX, 2014, BMC CANCER, V14, DOI [10.1186/1471-2407-14-228, 10.1186/1471-2407-14-124]; Yang YZ, 2003, DEVELOPMENT, V130, P1003, DOI 10.1242/dev.00324; Yen YC, 2015, ONCOTARGET, V6, P41837, DOI 10.18632/oncotarget.5995; Yen YC, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-6; Zeisberg EM, 2007, CANCER RES, V67, P10123, DOI 10.1158/0008-5472.CAN-07-3127; Zeisberg EM, 2007, NAT MED, V13, P952, DOI 10.1038/nm1613	47	48	50	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1503	1515		10.1038/onc.2016.317	http://dx.doi.org/10.1038/onc.2016.317			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27593938				2022-12-26	WOS:000397458100005
J	Goetzl, EJ; Kapogiannis, D; Schwartz, JB; Lobach, IV; Goetzl, L; Abner, EL; Jicha, GA; Karydas, AM; Boxer, A; Miller, BL				Goetzl, Edward J.; Kapogiannis, Dimitrios; Schwartz, Janice B.; Lobach, Iryna V.; Goetzl, Laura; Abner, Erin L.; Jicha, Gregory A.; Karydas, Anna M.; Boxer, Adam; Miller, Bruce L.			Decreased synaptic proteins in neuronal exosomes of frontotemporal dementia and Alzheimer's disease	FASEB JOURNAL			English	Article						cognition; proteinopathy; neurotransmission; biomarkers	CEREBROSPINAL-FLUID BIOMARKER; CLINICAL-TRIALS; BLOOD EXOSOMES; SYNAPSIN-I; ADAS-COG; SYNAPTOPHYSIN; NEUROGRANIN; IDENTIFICATION; PLASTICITY; CRITERIA	Synaptic dysfunction occurs early in senile dementias, presumably as a result of decreased levels of functional synaptic proteins as found in autopsied brains of patients with Alzheimer's disease (AD) or frontotemporal dementia (FTD). Plasma neuronal-derived exosomes (NDEs) were recovered by precipitation and immunoabsorption from 12 patients with AD, 16 with FTD, and 28 controls in a cross-sectional study, and from 9 patients with AD, 10 with FTD, and 19 controls in a longitudinal study. Six synaptic proteins in NDE extracts were quantified by ELISAs and normalized for exosome amounts. NDE levels of synaptophysin, synaptopodin, synaptotagmin-2, and neurogranin were significantly lower in patients with FTD and AD than in controls, but those of growth-associated protein 43 and synapsin 1 were reduced only in patients with AD. Functionally relevant phosphorylation of synapsin 1 serine 9 was reduced in patients with FTD and AD, although total synapsin 1 protein was higher in FTD than in controls. NDE levels of synaptotagmin, synaptophysin, and neurogranin were decreased years before dementia inpatients with FTD and AD. NDE levels of synaptopodin, synaptotagmin, and synaptophysin, but not of amyloid beta-peptide 42 or P-T181-tau, were correlated significantly with cognition assessed by mini-mental state examination or AD assessment scale-cognitive subscale. NDE synaptic proteins may be useful preclinical indices and progression measures in senile dementias.	[Goetzl, Edward J.; Schwartz, Janice B.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Schwartz, Janice B.] Univ Calif San Francisco, Dept Bioengn, San Francisco, CA 94143 USA; [Lobach, Iryna V.] Univ Calif San Francisco, Clin Translat Sci Inst, San Francisco, CA 94143 USA; [Karydas, Anna M.; Boxer, Adam; Miller, Bruce L.] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, San Francisco, CA USA; [Goetzl, Edward J.; Schwartz, Janice B.] Jewish Home San Francisco, San Francisco, CA USA; [Kapogiannis, Dimitrios] NIA, Lab Neurosci, Baltimore, MD 21224 USA; [Goetzl, Laura] Temple Univ, Dept Obstet Gynecol & Reprod Sci, Philadelphia, PA 19122 USA; [Abner, Erin L.; Jicha, Gregory A.] Univ Kentucky, Sanders Brown Ctr Aging, Lexington, KY 40536 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; University of Kentucky	Goetzl, EJ (corresponding author), Univ Calif San Francisco, Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu	Kapogiannis, Dimitrios/AAW-4934-2020; Schwartz, Janice/K-6354-2019	Kapogiannis, Dimitrios/0000-0003-2181-3118; Goetzl, Laura/0000-0003-4130-2809	BAND2 Program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association; Weston Brain Institute (Toronto, ON, Canada); Nanosomix; Intramural Program of the U.S. National Institutes of Health, National Institute on Aging (NIA); NIA [P30 AG028383]; Acetylon; iPierian; Archer Biosciences; Alzheimer's Research UK; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS092089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG038791, P30AG028383, ZIAAG000975] Funding Source: NIH RePORTER	BAND2 Program of the Michael J. Fox Foundation for Parkinson's Research; Alzheimer's Association(Alzheimer's Association); Weston Brain Institute (Toronto, ON, Canada); Nanosomix; Intramural Program of the U.S. National Institutes of Health, National Institute on Aging (NIA); NIA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); Acetylon; iPierian; Archer Biosciences; Alzheimer's Research UK(Alzheimer's Research UK (ARUK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Sonya Anderson (University of Kentucky Alzheimer's Disease Center) for organizing and distributing biospecimens and Judith H. Goetzl (Jewish Home of San Francisco) for expert production of graphic illustrations. This work was supported by a grant from the BAND2 Program of the Michael J. Fox Foundation for Parkinson's Research, the Alzheimer's Association, Alzheimer's Research UK, and the Weston Brain Institute (Toronto, ON, Canada), by a grant for methodological development from Nanosomix (to E.J.G.), the Intramural Program of the U.S. National Institutes of Health, National Institute on Aging (NIA; to D.K.), and NIA Grant P30 AG028383 (to E.L.A.). E.J.G. has filed an application with the U.S. Patent Office for the platform and methodologies described in this report; he is a founder of Nanosomix, but now receives no salary or consulting fees, but only support for laboratory supplies. E.L.A. received travel support from Nanosomix for the 2015 annual meeting of the American Association for the Advancement of Science. A.B. declares that outside the submitted studies, he has grants from the NIA, Tau Research Consortium, Allon Therapeutics, Genentech, Bristol-Myers Squibb, TauRx, Alzheimer's Association, Bluefield Project to Cure FTD, the Association for Frontotemporal Degeneration, Alzheimer's Drug Discovery Foundation, EnVivo, C2N Diagnostics, Pfizer, Eli Lilly, and Corticobasal Degeneration Solutions; grants, personal fees, and nonfinancial support from Archer Biosciences; personal fees from Acetylon; and personal fees from iPierian. The remaining authors declare no conflicts of interest.	Bacaj T, 2015, PLOS BIOL, V13, DOI 10.1371/journal.pbio.1002267; Baker K, 2015, J CLIN INVEST, V125, P1670, DOI 10.1172/JCI79765; Cano SJ, 2010, J NEUROL NEUROSUR PS, V81, P1363, DOI 10.1136/jnnp.2009.204008; Clare R, 2010, J NEUROSCI RES, V88, P2083, DOI 10.1002/jnr.22392; Daly C, 2002, J BIOL CHEM, V277, P9010, DOI 10.1074/jbc.M110815200; Davidsson P, 1998, Int Psychogeriatr, V10, P11, DOI 10.1017/S1041610298005110; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Glavan G, 2009, ANAT REC, V292, P1849, DOI 10.1002/ar.21026; Goetzl EJ, 2015, ANN CLIN TRANSL NEUR, V2, P769, DOI 10.1002/acn3.211; Goetzl EJ, 2015, NEUROLOGY, V85, P40, DOI 10.1212/WNL.0000000000001702; Gordon SL, 2013, J NEUROSCI, V33, P13695, DOI 10.1523/JNEUROSCI.0636-13.2013; Gorno-Tempini ML, 2011, NEUROLOGY, V76, P1006, DOI 10.1212/WNL.0b013e31821103e6; Haruta T, 1997, BIOCHEM J, V325, P455, DOI 10.1042/bj3250455; Irizarry MC, 2008, J ALZHEIMERS DIS, V14, P301; Jackman SL, 2016, NATURE, V529, P88, DOI 10.1038/nature16507; Kalia M, 2008, METABOLISM, V57, pS2, DOI 10.1016/j.metabol.2008.07.009; Kapogiannis D, 2015, FASEB J, V29, P589, DOI 10.1096/fj.14-262048; Kester MI, 2015, JAMA NEUROL, V72, P1275, DOI 10.1001/jamaneurol.2015.1867; Kvartsberg H, 2015, ALZHEIMERS DEMENT, V11, P1180, DOI 10.1016/j.jalz.2014.10.009; MASLIAH E, 1991, AM J PATHOL, V138, P235; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Miyakawa T, 2001, HIPPOCAMPUS, V11, P763, DOI 10.1002/hipo.1092; PARKS KM, 1991, MOL BRAIN RES, V9, P125, DOI 10.1016/0169-328X(91)90137-M; Petersen RC, 2004, J INTERN MED, V256, P183, DOI 10.1111/j.1365-2796.2004.01388.x; Rascovsky K, 2011, BRAIN, V134, P2456, DOI 10.1093/brain/awr179; Reddy PH, 2005, J ALZHEIMERS DIS, V7, P103, DOI 10.3233/jad-2005-7203; Regan P, 2017, NEUROSCIENTIST, V23, P137, DOI 10.1177/1073858416633439; ROSAHL TW, 1993, CELL, V75, P661, DOI 10.1016/0092-8674(93)90487-B; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shaw LM, 2009, ANN NEUROL, V65, P403, DOI 10.1002/ana.21610; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Tau GZ, 2010, NEUROPSYCHOPHARMACOL, V35, P147, DOI 10.1038/npp.2009.115; Valtorta F, 2004, BIOESSAYS, V26, P445, DOI 10.1002/bies.20012	36	217	226	7	49	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4141	4148		10.1096/fj.201600816R	http://dx.doi.org/10.1096/fj.201600816R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601437	Green Published			2022-12-26	WOS:000388201500020
J	Zhu, S; Lu, YC; Sinno, T; Diamond, SL				Zhu, Shu; Lu, Yichen; Sinno, Talid; Diamond, Scott L.			Dynamics of Thrombin Generation and Flux from Clots during Whole Human Blood Flow over Collagen/Tissue Factor Surfaces	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VON-WILLEBRAND-FACTOR; PROTHROMBINASE COMPLEX; PLATELET DEPOSITION; TISSUE FACTOR; FACTOR-XI; SYSTEMS-APPROACH; COMPUTATIONAL SIMULATION; HEALTHY-INDIVIDUALS; MICROFLUIDIC ASSAY; FIBRIN DEPOSITION	Coagulation kinetics are well established for purified blood proteases or human plasma clotting isotropically. However, less is known about thrombin generation kinetics and transport within blood clots formed under hemodynamic flow. Using microfluidic perfusion (wall shear rate, 200 s(-1)) of corn trypsin inhibitor-treated whole blood over a 250-mu m long patch of type I fibrillar collagen/lipidated tissue factor (TF; similar to 1 TF molecule/mu m(2)), we measured thrombin released from clots using thrombin-antithrombin immunoassay. The majority (>85%) of generated thrombin was captured by intrathrombus fibrin as thrombin-antithrombin was largely undetectable in the effluent unless Gly-Pro-Arg-Pro (GPRP) was added to block fibrin polymerization. With GPRP present, the flux of thrombin increased to similar to 0.5 x 10(-12) nmol/mu m(2)-s over the first 500 s of perfusion and then further increased by similar to 2-3-fold over the next 300 s. The increased thrombin flux after 500 s was blocked by anti-FXIa antibody (O1A6), consistent with thrombin-feedback activation of FXI. Over the first 500 s, similar to 92,000 molecules of thrombin were generated per surface TF molecule for the 250-mu m-long coating. A single layer of platelets (obtained with alpha(IIb)beta(3) antagonism preventing continued platelet deposition) was largely sufficient for thrombin production. Also, the overall thrombin-generating potential of a 1000-mu m-long coating became less efficient on a per mu m(2) basis, likely due to distal boundary layer depletion of platelets. Overall, thrombin is robustly generated within clots by the extrinsic pathway followed by late-stage FXIa contributions, with fibrin localizing thrombin via its antithrombin-I activity as a potentially self-limiting hemostatic mechanism.	[Zhu, Shu; Lu, Yichen; Sinno, Talid; Diamond, Scott L.] Univ Penn, Inst Med & Engn, Dept Chem & Biomol Engn, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine	Diamond, SL (corresponding author), Univ Penn, Inst Med & Engn, Vagelos Res Labs 1024, 3340 Smith Walk, Philadelphia, PA 19104 USA.	sld@seas.upenn.edu			National Institutes of Health [R01 HL103419, U01-HL131053]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL131053, R01HL103419] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants R01 HL103419 and U01-HL131053 (to S. L. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bird R. B., 2006, TRANSPORT PHENOMENA, P543; Brummel-Ziedins K, 2005, J THROMB HAEMOST, V3, P1472, DOI 10.1111/j.1538-7836.2005.01249.x; Brummel-Ziedins KE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029178; Bungay SD, 2003, MATH MED BIOL, V20, P105, DOI 10.1093/imammb20.1.105; Butenas S, 2004, J BIOL CHEM, V279, P22875, DOI 10.1074/jbc.M400531200; Chandler WL, 2003, BLOOD, V101, P4355, DOI 10.1182/blood-2002-08-2400; Chatterjee MS, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000950; Choi SH, 2015, THROMB HAEMOSTASIS, V113, P599, DOI 10.1160/TH14-06-0515; Choi SH, 2011, BLOOD, V118, P6963, DOI 10.1182/blood-2011-07-368811; Colace TV, 2014, J THROMB HAEMOST, V12, P147, DOI 10.1111/jth.12457; Colace TV, 2013, ARTERIOSCL THROM VAS, V33, P105, DOI 10.1161/ATVBAHA.112.300522; Colace TV, 2012, ARTERIOSCL THROM VAS, V32, P1466, DOI 10.1161/ATVBAHA.112.249789; Colace TV, 2011, BIOCONJUGATE CHEM, V22, P2104, DOI 10.1021/bc200326v; Coughlin SR, 2000, NATURE, V407, P258, DOI 10.1038/35025229; DOWNING MR, 1978, BIOCHEMISTRY-US, V17, P2649, DOI 10.1021/bi00606a030; Duckers C, 2010, BLOOD, V115, P879, DOI 10.1182/blood-2009-08-237719; Fogelson AL, 2012, BIOPHYS J, V102, P10, DOI 10.1016/j.bpj.2011.10.048; FOLIE BJ, 1989, BIOPHYS J, V56, P1121, DOI 10.1016/S0006-3495(89)82760-2; Fredenburgh JC, 2004, BIOPHYS CHEM, V112, P277, DOI 10.1016/j.bpc.2004.07.031; Hemker HC, 2002, PATHOPHYSIOL HAEMO T, V32, P249, DOI 10.1159/000073575; Hockin MF, 2002, J BIOL CHEM, V277, P18322, DOI 10.1074/jbc.M201173200; Hoffman M, 2003, DM-DIS MON, V49, P14, DOI 10.1053/shem.2001.29504; HORNYAK TJ, 1989, BIOCHEMISTRY-US, V28, P7326, DOI 10.1021/bi00444a027; Kim OV, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003095; Kravtsov DV, 2009, BLOOD, V114, P452, DOI 10.1182/blood-2009-02-203604; KRISHNASWAMY S, 1988, J BIOL CHEM, V263, P3823; KRISHNASWAMY S, 1987, J BIOL CHEM, V262, P3291; Kuharsky AL, 2001, BIOPHYS J, V80, P1050, DOI 10.1016/S0006-3495(01)76085-7; Leiderman K, 2013, B MATH BIOL, V75, P1255, DOI 10.1007/s11538-012-9784-3; Li R, 2015, HAEMOPHILIA, V21, P266, DOI 10.1111/hae.12558; Lovely RS, 2003, J THROMB HAEMOST, V1, P124, DOI 10.1046/j.1538-7836.2003.00027.x; Maloney SF, 2010, INTEGR BIOL-UK, V2, P183, DOI 10.1039/b919728a; Meh DA, 1996, J BIOL CHEM, V271, P23121, DOI 10.1074/jbc.271.38.23121; Muthard RW, 2015, ARTERIOSCL THROM VAS, V35, P645, DOI 10.1161/ATVBAHA.114.305054; Neeves KB, 2008, J THROMB HAEMOST, V6, P2193, DOI 10.1111/j.1538-7836.2008.03188.x; Neeves KB, 2010, BIOPHYS J, V98, P1344, DOI 10.1016/j.bpj.2009.12.4275; NESHEIM ME, 1984, J BIOL CHEM, V259, P1447; Okorie UM, 2008, BLOOD, V111, P3507, DOI 10.1182/blood-2007-08-106229; Rivard GE, 2005, J THROMB HAEMOST, V3, P2039, DOI 10.1111/j.1538-7836.2005.01513.x; Ruhl H, 2012, THROMB HAEMOSTASIS, V107, P848, DOI 10.1160/TH11-10-0719; Ruiz FA, 2004, J BIOL CHEM, V279, P44250, DOI 10.1074/jbc.M406261200; SCHWARTZ ML, 1973, J BIOL CHEM, V248, P1395; Smith SA, 2010, BLOOD, V116, P4353, DOI 10.1182/blood-2010-01-266791; Sorensen EN, 1999, ANN BIOMED ENG, V27, P436, DOI 10.1114/1.200; Sorensen EN, 1999, ANN BIOMED ENG, V27, P449, DOI 10.1114/1.201; Stalker TJ, 2014, BLOOD, V124, P1824, DOI 10.1182/blood-2014-01-550319; Stalker TJ, 2013, BLOOD, V121, P1875, DOI 10.1182/blood-2012-09-457739; SWORDS NA, 1993, ARTERIOSCLER THROMB, V13, P1602, DOI 10.1161/01.ATV.13.11.1602; Tomaiuolo M, 2014, BLOOD, V124, P1816, DOI 10.1182/blood-2014-01-550343; TRACY PB, 1983, P NATL ACAD SCI-BIOL, V80, P2380, DOI 10.1073/pnas.80.8.2380; Voronov RS, 2013, ANN BIOMED ENG, V41, P1297, DOI 10.1007/s10439-013-0764-z; WALKER RK, 1994, J BIOL CHEM, V269, P27441; Welsh JD, 2012, J THROMB HAEMOST, V10, P2344, DOI 10.1111/j.1538-7836.2012.04928.x; Welsh JD, 2014, BLOOD, V124, P1808, DOI 10.1182/blood-2014-01-550335; WILLEMS GM, 1991, HAEMOSTASIS, V21, P197; Wolberg AS, 2007, BLOOD REV, V21, P131, DOI 10.1016/j.blre.2006.11.001; Xu ZL, 2010, BIOPHYS J, V98, P1723, DOI 10.1016/j.bpj.2009.12.4331; Yeh CH, 2012, CIRC RES, V111, P1069, DOI 10.1161/CIRCRESAHA.112.276741; Zhu S, 2016, J THROMB HAEMOST, V14, P1070, DOI 10.1111/jth.13245; Zhu S, 2016, INTEGR BIOL-UK, V8, P813, DOI 10.1039/c6ib00077k; Zhu S, 2015, BLOOD, V126, P1494, DOI 10.1182/blood-2015-04-641472; Zhu S, 2014, THROMB RES, V134, P1335, DOI 10.1016/j.thromres.2014.09.030; Zilberman-Rudenko J, 2016, ARTERIOSCL THROM VAS, V36, P510, DOI 10.1161/ATVBAHA.115.307034	63	25	25	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23027	23035		10.1074/jbc.M116.754671	http://dx.doi.org/10.1074/jbc.M116.754671			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27605669	Green Published, hybrid			2022-12-26	WOS:000387224800015
J	Kaur, S; Coulombe, Y; Ramdzan, ZM; Leduy, L; Masson, JY; Nepveu, A				Kaur, Simran; Coulombe, Yan; Ramdzan, Zubaidah M.; Leduy, Lam; Masson, Jean-Yves; Nepveu, Alain			Special AT-rich Sequence-binding Protein 1 (SATB1) Functions as an Accessory Factor in Base Excision Repair	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						8-oxoguanine (8-oxoG); 8-oxoguanine glycosylase (OGG1); base excision repair (BER); DNA damage; oxidative stress; Cut domains; Cut repeats; SATB1	MATRIX ATTACHMENT REGION; DOMAIN-MEDIATED DIMERIZATION; TRANSCRIPTION FACTOR SATB1; DNA GLYCOSYLASE ACTIVITY; AP-ENDONUCLEASE; GASTRIC-CANCER; DAMAGE REPAIR; CUT REPEATS; STIMULATION; HOMEODOMAIN	Base excision repair is initiated by DNA glycosylases that recognize specific altered bases. DNA glycosylases for oxidized bases carry both a glycosylase activity that removes the faulty base and an apyrimidinic/apurinic lyase activity that introduces a single-strand DNA incision. In particular, the CUT domains within the CUX1 and CUX2 proteins were recently shown to interact with the 8-oxoguanine (8-oxoG) DNA glycosylase and stimulate its enzymatic activities. SATB1, which contains two CUT domains, was originally characterized as a T cell-specific genome organizer whose aberrant overexpression in breast cancer can promote tumor progression. Here we investigated the involvement of SATB1 in DNA repair. SATB1 knockdown caused a delay in DNA repair following exposure to H2O2, an increase in OGG1-sensitive oxidized bases within genomic DNA, and a decrease in 8-oxoG cleavage activity in cell extracts. In parallel, we observed an increase in phospho-CHK1 and -H2AX levels and a decrease in DNA synthesis. Conversely, ectopic expression of SATB1 accelerated DNA repair and reduced the levels of oxidized bases in genomic DNA. Moreover, an enhanced GFP-SATB1 fusion protein was rapidly recruited to laser microirradiation-induced DNA damage. Using purified proteins, we showed that SATB1 interacts directly with OGG1, increases its binding to 8-oxoG-containing DNA, promotes Schiff base formation, and stimulates its glycosylase and apyrimidinic/apurinic lyase enzymatic activities. Structure/function analysis demonstrated that CUT domains, but not the homeodomain, are responsible for the stimulation of OGG1. Together, these results identify another CUT domain protein that functions both as a transcription factor and an accessory factor in base excision repair.	[Kaur, Simran; Ramdzan, Zubaidah M.; Leduy, Lam; Nepveu, Alain] Goodman Canc Res Ctr, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada; [Kaur, Simran; Nepveu, Alain] McGill Univ, Dept Biochem, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Oncol, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada; [Nepveu, Alain] McGill Univ, Dept Med, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada; [Coulombe, Yan; Masson, Jean-Yves] CHU Quebec Res Ctr, Genome Stabil Lab, Quebec City, PQ G1R 2J6, Canada; [Coulombe, Yan; Masson, Jean-Yves] Univ Laval, Canc Res Ctr, Dept Mol Biol Med Biochem & Pathol, Quebec City, PQ G1V 0A6, Canada	McGill University; McGill University; McGill University; Laval University	Nepveu, A (corresponding author), Goodman Canc Res Ctr, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada.; Nepveu, A (corresponding author), McGill Univ, Dept Biochem, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada.; Nepveu, A (corresponding author), McGill Univ, Dept Oncol, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada.; Nepveu, A (corresponding author), McGill Univ, Dept Med, 1160 Pine Ave W,Rm 414, Montreal, PQ H3A 1A3, Canada.	alain.nepveu@mcgill.ca	/AAB-8315-2020	Masson, Jean Yves/0000-0002-4403-7169; Kaur, Simran/0000-0003-1510-928X	Canadian Institutes of Health Research [MOP-130524, MOP-326694]; National Science and Engineering Council [RGPIN-2016-05155]; Maysie MacSporran graduate studentship; CIHR/Fonds de la recherche du Quebec en sante (FRQS) Training Grant in Cancer Research of the McGill Integrated Cancer Research Training Program [FRN53888]; FRQS	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Science and Engineering Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Maysie MacSporran graduate studentship; CIHR/Fonds de la recherche du Quebec en sante (FRQS) Training Grant in Cancer Research of the McGill Integrated Cancer Research Training Program; FRQS	This research was supported by Canadian Institutes of Health Research Grants MOP-130524 (to J.-Y.M.) and MOP-326694 (to A. N.) and National Science and Engineering Council Grant RGPIN-2016-05155 (to A. N.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a Maysie MacSporran graduate studentship and CIHR/Fonds de la recherche du Quebec en sante (FRQS) Training Grant in Cancer Research FRN53888 of the McGill Integrated Cancer Research Training Program.r Supported by a fellowship from the FRQS.	Akbari M, 2010, DNA REPAIR, V9, P785, DOI 10.1016/j.dnarep.2010.04.002; Allinson SL, 2001, EMBO J, V20, P6919, DOI 10.1093/emboj/20.23.6919; Alvarez JD, 2000, GENE DEV, V14, P521; ANDRES V, 1994, GENE DEV, V8, P245, DOI 10.1101/gad.8.2.245; Asagoshi K, 2010, DNA REPAIR, V9, P109, DOI 10.1016/j.dnarep.2009.11.002; AUFIERO B, 1994, P NATL ACAD SCI USA, V91, P7757, DOI 10.1073/pnas.91.16.7757; Banath JP, 1999, RADIAT RES, V151, P550, DOI 10.2307/3580031; Cai ST, 2006, NAT GENET, V38, P1278, DOI 10.1038/ng1913; Cai ST, 2003, NAT GENET, V34, P42, DOI 10.1038/ng1146; Campalans A, 2005, DNA REPAIR, V4, P826, DOI 10.1016/j.dnarep.2005.04.014; Campalans A, 2007, J CELL SCI, V120, P23, DOI 10.1242/jcs.03312; Campalans A, 2015, MOL CELL BIOL, V35, P1648, DOI 10.1128/MCB.00134-15; CHEN DS, 1991, NUCLEIC ACIDS RES, V19, P5907, DOI 10.1093/nar/19.21.5907; Chen HX, 2011, J DERMATOL SCI, V64, P39, DOI 10.1016/j.jdermsci.2011.06.007; Cheng C, 2010, APMIS, V118, P855, DOI 10.1111/j.1600-0463.2010.02673.x; Das S, 2007, J BIOL CHEM, V282, P28474, DOI 10.1074/jbc.M704672200; de Belle I, 1998, J CELL BIOL, V141, P335, DOI 10.1083/jcb.141.2.335; Demple B, 2005, DNA REPAIR, V4, P1442, DOI 10.1016/j.dnarep.2005.09.004; Dianov GL, 2013, NUCLEIC ACIDS RES, V41, P3483, DOI 10.1093/nar/gkt076; Dickinson LA, 1997, J BIOL CHEM, V272, P11463; DICKINSON LA, 1992, CELL, V70, P631, DOI 10.1016/0092-8674(92)90432-C; Egecioglu D, 2011, CURR OPIN CELL BIOL, V23, P338, DOI 10.1016/j.ceb.2011.01.001; Fessing MY, 2011, J CELL BIOL, V194, P825, DOI 10.1083/jcb.201101148; FRIEDBERG EC, 2006, DNA REPAIR MUTAGENES, P169; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Gingras N, 2005, GENE, V344, P273, DOI 10.1016/j.gene.2004.11.008; Han HJ, 2008, NATURE, V452, P187, DOI 10.1038/nature06781; HARADA R, 1995, MOL CELL BIOL, V15, P129, DOI 10.1128/MCB.15.1.129; Hegde ML, 2008, CELL RES, V18, P27, DOI 10.1038/cr.2008.8; Hill JW, 2001, NUCLEIC ACIDS RES, V29, P430, DOI 10.1093/nar/29.2.430; Hu JP, 2005, J BIOL CHEM, V280, P40544, DOI 10.1074/jbc.M508772200; Kohwi-Shigematsu T, 2013, SEMIN CANCER BIOL, V23, P72, DOI 10.1016/j.semcancer.2012.06.009; Kondo M, 2016, J IMMUNOL, V196, P563, DOI 10.4049/jimmunol.1501429; LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4; Li Z, 2015, NUCLEIC ACIDS RES, V43, P3986, DOI 10.1093/nar/gkv283; Liu JQ, 1999, MOL CELL BIOL, V19, P4918; Lu XM, 2010, ONCOL REP, V24, P981, DOI 10.3892/or_00000945; Luo J, 2009, CELL, V137, P835, DOI 10.1016/j.cell.2009.05.006; Marcotte R, 2012, CANCER DISCOV, V2, P172, DOI 10.1158/2159-8290.CD-11-0224; Marenstein DR, 2001, J BIOL CHEM, V276, P21242, DOI 10.1074/jbc.M101594200; Marsin S, 2003, J BIOL CHEM, V278, P44068, DOI 10.1074/jbc.M306160200; Mir R, 2016, ONCOGENE, V35, P1679, DOI 10.1038/onc.2015.232; Mokkapati SK, 2004, BIOCHEMISTRY-US, V43, P11596, DOI 10.1021/bi049097i; Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001; Noren Hooten N, 2012, AGING-US, V4, P674, DOI 10.18632/aging.100492; Noren Hooten N, 2011, J BIOL CHEM, V286, P44679, DOI 10.1074/jbc.M111.255869; Pal R, 2015, J BIOL CHEM, V290, P22520, DOI 10.1074/jbc.M115.651042; Paz-Elizur T, 2007, DNA REPAIR, V6, P45, DOI 10.1016/j.dnarep.2006.08.003; Prasad R, 2007, MOL CELL, V27, P829, DOI 10.1016/j.molcel.2007.06.029; Purbey PK, 2008, NUCLEIC ACIDS RES, V36, P2107, DOI 10.1093/nar/gkm1151; Radicella JP, 1997, P NATL ACAD SCI USA, V94, P8010, DOI 10.1073/pnas.94.15.8010; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Ramdzan ZM, 2015, ONCOTARGET, V6, P3613, DOI 10.18632/oncotarget.2919; Ramdzan ZM, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001807; Robertson AB, 2009, CELL MOL LIFE SCI, V66, P981, DOI 10.1007/s00018-009-8736-z; Serrano M, 1997, CELL, V88, P593, DOI 10.1016/S0092-8674(00)81902-9; Shen WF, 1996, NUCLEIC ACIDS RES, V24, P898, DOI 10.1093/nar/24.5.898; Svilar D, 2012, JOVE-J VIS EXP, DOI 10.3791/4168; Vadnais C, 2012, NUCLEIC ACIDS RES, V40, P4483, DOI 10.1093/nar/gks041; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Vidal AE, 2001, NUCLEIC ACIDS RES, V29, P1285, DOI 10.1093/nar/29.6.1285; WANG BC, 1995, J BIOL CHEM, V270, P23239, DOI 10.1074/jbc.270.40.23239; Wang FF, 2015, P NATL ACAD SCI USA, V112, pE4995, DOI 10.1073/pnas.1513780112; Weinfeld M, 2011, TRENDS BIOCHEM SCI, V36, P262, DOI 10.1016/j.tibs.2011.01.006; Wiederhold L, 2004, MOL CELL, V15, P209, DOI 10.1016/j.molcel.2004.06.003; Wilson DM, 2007, DNA REPAIR, V6, P544, DOI 10.1016/j.dnarep.2006.10.017; Yamaguchi H, 2006, J BIOL CHEM, V281, P5319, DOI 10.1074/jbc.M510933200; Yamasaki K, 2007, NUCLEIC ACIDS RES, V35, P5073, DOI 10.1093/nar/gkm504; Yasui D, 2002, NATURE, V419, P641, DOI 10.1038/nature01084	69	13	14	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22769	22780		10.1074/jbc.M116.735696	http://dx.doi.org/10.1074/jbc.M116.735696			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27590341	Green Published, hybrid			2022-12-26	WOS:000386760600034
J	Luu, HM; Klink, C; Niessen, W; Moelker, A; van Walsum, T				Ha Manh Luu; Klink, Camiel; Niessen, Wiro; Moelker, Adriaan; van Walsum, Theo			Non-Rigid Registration of Liver CT Images for CT-Guided Ablation of Liver Tumors	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION	CT-guided percutaneous ablation for liver cancer treatment is a relevant technique for patients not eligible for surgery and with tumors that are inconspicuous on US imaging. The lack of real-time imaging and the use of a limited amount of CT contrast agent make targeting the tumor with the needle challenging. In this study, we evaluate a registration framework that allows the integration of diagnostic pre-operative contrast enhanced CT images and intra-operative non-contrast enhanced CT images to improve image guidance in the intervention. The liver and tumor are segmented in the pre-operative contrast enhanced CT images. Next, the contrast enhanced image is registered to the intra-operative CT images in a two-stage approach. First, the contrast-enhanced diagnostic image is non-rigidly registered to a non-contrast enhanced image that is conventionally acquired at the start of the intervention. In case the initial registration is not sufficiently accurate, a refinement step is applied using non-rigid registration method with a local rigidity term. In the second stage, the intra-operative CT-images that are used to check the needle position, which often consist of only a few slices, are registered rigidly to the intra-operative image that was acquired at the start of the intervention. Subsequently, the diagnostic image is registered to the current intra-operative image, using both transformations, this allows the visualization of the tumor region extracted from pre-operative data in the intra-operative CT images containing needle. The method is evaluated on imaging data of 19 patients at the Erasmus MC. Quantitative evaluation is performed using the Dice metric, mean surface distance of the liver border and corresponding landmarks in the diagnostic and the intra-operative images. The registration of the diagnostic CT image to the initial intra-operative CT image did not require a refinement step in 13 cases. For those cases, the resulting registration had a Dice coefficient for the livers of 91.4%, a mean surface distance of 4.4 mm and a mean distance between corresponding landmarks of 4.7 mm. For the three cases with a refinement step, the registration result significantly improved (p < 0.05) compared to the result of the initial non rigid registration method (DICE of 90.3% vs 71.3% and mean surface distance of 5.1 mm vs 11.3 mm and mean distance between corresponding landmark of 6.4 mm vs 10.2 mm). The registration of the preoperative data with the needle image in 16 cases yielded a DICE of 90.1% and a mean surface distance of 5.2 mm. The remaining three cases with DICE smaller than 80% were classified as unsuccessful registration. The results show that this is promising tool for liver image registration in interventional radiology.	[Ha Manh Luu; Niessen, Wiro; van Walsum, Theo] Erasmus MC, Dept Radiol, Biomed Imaging Grp Rotterdam, Dr Molewaterpl 50-60, Rotterdam, Netherlands; [Ha Manh Luu; Niessen, Wiro; van Walsum, Theo] Erasmus MC, Dept Med Informat, Dr Molewaterpl 50-60, Rotterdam, Netherlands; [Klink, Camiel; Moelker, Adriaan] Erasmus MC, Dept Radiol, Dr Molewaterpl 50-60, Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Luu, HM (corresponding author), Erasmus MC, Dept Radiol, Biomed Imaging Grp Rotterdam, Dr Molewaterpl 50-60, Rotterdam, Netherlands.; Luu, HM (corresponding author), Erasmus MC, Dept Med Informat, Dr Molewaterpl 50-60, Rotterdam, Netherlands.	l.manhha@erasmusmc.nl		Niessen, Wiro/0000-0002-5822-1995; van Walsum, Theo/0000-0001-8257-7759	ITEA project, Benefit [13031]	ITEA project, Benefit	The work was supported by ITEA project 13031, Benefit (https://itea3.org/project/benefit.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank Stefan Klein for his kind introduction in Elastix software required for this study. This work was supported by ITEA project 13031, Benefit.	Altekruse SF, 2009, J CLIN ONCOL, V27, P1485, DOI 10.1200/JCO.2008.20.7753; Archip N, 2007, LECT NOTES COMPUT SC, V4792, P969; Elhawary H, 2010, ACAD RADIOL, V17, P1334, DOI 10.1016/j.acra.2010.06.004; Garrean S, 2008, AM J SURG, V195, P508, DOI 10.1016/j.amjsurg.2007.06.024; Heimann T, 2009, IEEE T MED IMAGING, V28, P1251, DOI 10.1109/TMI.2009.2013851; Kim KW, 2011, AM J ROENTGENOL, V196, pW565, DOI 10.2214/AJR.10.5122; Klein S, 2007, IEEE T IMAGE PROCESS, V16, P2879, DOI 10.1109/TIP.2007.909412; Klein S, 2010, IEEE T MED IMAGING, V29, P196, DOI 10.1109/TMI.2009.2035616; Lange T, 2009, EXPT COMP LANDMARK B; Llovet JM, 2005, J GASTROENTEROL, V40, P225, DOI 10.1007/s00535-005-1566-3; Luu HM, 2015, MED PHYS, V42, P5559, DOI 10.1118/1.4927790; Maes F, 2003, P IEEE, V91, P1699, DOI 10.1109/JPROC.2003.817864; Pereira PL, 2007, EUR RADIOL, V17, P2062, DOI 10.1007/s00330-007-0587-0; Pons Fernando, 2005, HPB (Oxford), V7, P35, DOI 10.1080/13651820410024058; Rieder C, 2012, AUTOMATIC ALIGNMENT, V8316; Rieder C, 2010, COMPUT GRAPH FORUM, V29, P1093, DOI 10.1111/j.1467-8659.2009.01665.x; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Staring M, 2007, MED PHYS, V34, P4098, DOI 10.1118/1.2776236; Weihusen A, 2007, PROC SPIE, V6509, DOI 10.1117/12.709503; Xie YQ, 2011, MED PHYS, V38, P5351, DOI 10.1118/1.3633902	20	18	18	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161600	10.1371/journal.pone.0161600	http://dx.doi.org/10.1371/journal.pone.0161600			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611780	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900023
J	Honda, H; Fujimoto, M; Miyamoto, S; Ishikawa, N; Serada, S; Hattori, N; Nomura, S; Kohno, N; Yokoyama, A; Naka, T				Honda, Hiromi; Fujimoto, Minoru; Miyamoto, Shintaro; Ishikawa, Nobuhisa; Serada, Satoshi; Hattori, Noboru; Nomura, Shintaro; Kohno, Nobuoki; Yokoyama, Akihito; Naka, Tetsuji			Sputum Leucine-Rich Alpha-2 Glycoprotein as a Marker of Airway Inflammation in Asthma	PLOS ONE			English	Article							EPITHELIAL-CELLS; HUMAN-SERUM; PERIOSTIN; ALPHA-2-GLYCOPROTEIN; DIFFERENTIATION; EXPRESSION; BIOMARKER; ALPHA(2)-GLYCOPROTEIN; ROLES; IL-13	Background Asthma is a chronic inflammatory disease of airways, but an ideal biomarker that accurately reflects ongoing airway inflammation has not yet been established. The aim of this study was to examine the potential of sputum leucine-rich alpha-2 glycoprotein (LRG) as a new biomarker for airway inflammation in asthma. Methods We obtained induced sputum samples from patients with asthma (N = 64) and healthy volunteers (N = 22) and measured LRG concentration by sandwich enzyme-linked immunosorbent assay (ELISA). Ovalbumin (OVA)-induced asthma model mice were used to investigate the mechanism of LRG production during airway inflammation. The LRG concentrations in the bronchoalveolar lavage fluid (BALF) obtained from mice were determined by ELISA and mouse lung sections were stained with anti-LRG antibody and periodic acid-Schiff (PAS) reagent. Results Sputum LRG concentrations were significantly higher in patients with asthma than in healthy volunteers (p = 0.00686). Consistent with patients' data, BALF LRG levels in asthma model mice were significantly higher than in control mice (p = 0.00013). Immunohistochemistry of lung sections from asthma model mice revealed that LRG was intensely expressed in a subpopulation of bronchial epithelial cells, which corresponded with PAS-positive mucus producing cells. Conclusion These findings suggest that sputum LRG is a promising biomarker of local inflammation in asthma.	[Honda, Hiromi; Fujimoto, Minoru; Serada, Satoshi; Naka, Tetsuji] Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Signal, Ibaraki, Osaka, Japan; [Miyamoto, Shintaro; Yokoyama, Akihito] Kochi Univ, Dept Haematol & Resp Med, Nankoku, Kochi, Japan; [Ishikawa, Nobuhisa] Hiroshima Prefectural Hosp, Dept Resp Med, Minami Ku, Hiroshima, Japan; [Hattori, Noboru; Kohno, Nobuoki] Hiroshima Univ, Grad Sch Biomed Sci, Dept Mol & Internal Med, Minami Ku, Hiroshima, Japan; [Nomura, Shintaro] Nagahama Inst Biosci & Technol, Dept Anim Biosci, Nagahama, Shiga, Japan; [Naka, Tetsuji] Kochi Univ, Kochi Med Sch, Integrated Ctr Adv Med Technol ICAM Tech, Div Translat Res, Nankoku, Kochi, Japan	Kochi University; Hiroshima University; Kochi University	Fujimoto, M; Naka, T (corresponding author), Natl Inst Biomed Innovat Hlth & Nutr, Lab Immune Signal, Ibaraki, Osaka, Japan.; Naka, T (corresponding author), Kochi Univ, Kochi Med Sch, Integrated Ctr Adv Med Technol ICAM Tech, Div Translat Res, Nankoku, Kochi, Japan.	mfujimoto@nibiohn.go.jp; tnaka@nibiohn.go.jp	Hiyama, Eiso/A-2013-2019	Hiyama, Eiso/0000-0001-9179-5037; Serada, Satoshi/0000-0001-6948-9009; Naka, Tetsuji/0000-0002-1269-3997; FUJIMOTO, MINORU/0000-0002-6390-8863	Japanese Ministry of Education, Culture, Sports, Science and Technology [22591101]; Ministry of Health, Labour and Welfare of Japan [H24-bio-ippan-002]; Japan Agency for Medical Research and Development [15ek0109045h0002]	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Agency for Medical Research and Development(Japan Agency for Medical Research and Development (AMED))	This study was partly supported by the Grant-in-Aid for Scientific Research (C) (22591101) from the Japanese Ministry of Education, Culture, Sports, Science and Technology, the Grant-in-Aid for Scientist from the Ministry of Health, Labour and Welfare of Japan (H24-bio-ippan-002) and the Practical Research Project for Rare/Intractable Diseases from Japan Agency for Medical Research and Development (15ek0109045h0002).	Atsuta J, 1999, AM J RESP CELL MOL, V20, P643, DOI 10.1165/ajrcmb.20.4.3265; Bobolea I, 2015, ALLERGY, V70, P540, DOI 10.1111/all.12580; Boero S, 2010, J ASTHMA, V47, P381, DOI 10.3109/02770901003759410; Dweik RA, 2011, AM J RESP CRIT CARE, V184, P602, DOI 10.1164/rccm.9120-11ST; Erle DJ, 2014, J CELL BIOL, V205, P621, DOI 10.1083/jcb.201401050; Fahy JV, 2010, NEW ENGL J MED, V363, P2233, DOI 10.1056/NEJMra0910061; Fujimoto M, 2015, ARTHRITIS RHEUMATOL, V67, P2056, DOI 10.1002/art.39164; HAUPT H, 1977, H-S Z PHYSIOL CHEM, V358, P639, DOI 10.1515/bchm2.1977.358.1.639; Ishikawa N, 2011, RESPIRATION, V82, P10, DOI 10.1159/000324539; Kanehara M, 2008, PULM PHARMACOL THER, V21, P874, DOI 10.1016/j.pupt.2008.09.003; Kanoh S, 2011, CLIN EXP ALLERGY, V41, P1747, DOI 10.1111/j.1365-2222.2011.03852.x; Kuperman DA, 2002, NAT MED, V8, P885, DOI 10.1038/nm734; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; Laoukili J, 2001, J CLIN INVEST, V108, P1817, DOI 10.1172/JCI13557; Li W, 2015, RESP RES, V16, DOI 10.1186/s12931-015-0218-2; O'Donnell LC, 2002, J LEUKOCYTE BIOL, V72, P478; Paggiaro PL, 2002, EUR RESPIR J, V20, p3S, DOI 10.1183/09031936.02.00000302; Seeber S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086184; Serada S, 2012, INFLAMM BOWEL DIS, V18, P2169, DOI 10.1002/ibd.22936; Serada S, 2010, ANN RHEUM DIS, V69, P770, DOI 10.1136/ard.2009.118919; Shirai R, 2009, BIOCHEM BIOPH RES CO, V382, P776, DOI 10.1016/j.bbrc.2009.03.104; Sidhu SS, 2010, P NATL ACAD SCI USA, V107, P14170, DOI 10.1073/pnas.1009426107; Simpson JL, 2016, BMC PULM MED, V16, DOI 10.1186/s12890-016-0230-4; TAKAHASHI N, 1985, P NATL ACAD SCI USA, V82, P1906, DOI 10.1073/pnas.82.7.1906; Takemoto N, 2015, ONCOTARGET, V6, P11009, DOI 10.18632/oncotarget.3557; Wadsworth SJ, 2011, J ASTHMA ALLERGY, V4, P77, DOI 10.2147/JAA.S15081; Wang XM, 2013, NATURE, V499, P306, DOI 10.1038/nature12345; Woodruff PG, 2009, AM J RESP CRIT CARE, V180, P388, DOI 10.1164/rccm.200903-0392OC; Zhen GH, 2007, AM J RESP CELL MOL, V36, P244, DOI 10.1165/rcmb.2006-0180OC; ZUHDI AM, 2000, AM J RESP CELL MOL B, V22, P253	30	35	35	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162672	10.1371/journal.pone.0162672	http://dx.doi.org/10.1371/journal.pone.0162672			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611322	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255900149
J	Mehta, S; Das, M; Laxmeshwar, C; Jonckheere, S; Thi, SS; Isaakidis, P				Mehta, Salil; Das, Mrinalini; Laxmeshwar, Chinmay; Jonckheere, Sylvie; Thi, Sein Sein; Isaakidis, Petros			Linezolid-Associated Optic Neuropathy in Drug-Resistant Tuberculosis Patients in Mumbai, India	PLOS ONE			English	Article							ACUTE LYMPHOCYTIC-LEUKEMIA; MULTIDRUG-RESISTANT; XDR-TB; EFFICACY; SAFETY; TOLERABILITY; METAANALYSIS; REGIMENS	Background Patients on linezolid-containing drug-resistant TB (DR-TB) regimen often develop adverse-events, particularly peripheral and optic neuropathy. Programmatic data and experiences of linezolid-associated optic neuropathy from high DR-TB burden settings are lacking. The study aimed to determine the frequency of and risk-factors associated with linezolid-associated optic neuropathy and document the experiences related to treatment/care of DR-TB patients on linezolid-containing regimens. Methods This was a retrospective cohort study using routine clinical and laboratory data in Medecins Sans Frontieres (MSF) HIV/DR-TB clinic in collaboration with Lilavati Hospital & Research Center, Mumbai, India. All DR-TB patients on linezolid-containing treatment regimens were included in the study and underwent routine evaluations for systemic and/or ocular complaints. Ophthalmological evaluation by a consultant ophthalmologist included visual-acuity screening, slit-lamp examination and dilated fundus examination. Results During January 2013-April 2016, 86 of 136 patients (with/without HIV co-infection) initiated linezolid-containing DR-TB treatment. The median age of these 86 patients was 25 (20-35) years and 47% were males. 20 percent of them had HIV co-infection. Of 86, 24 (27.9%) had at least one episode of ocular complaints (the majority blurred-vision) and among them, five (5.8%) had optic neuropathy. Patients received appropriate treatment and improvements were observed. None of the demographic/clinical factors were associated with optic neuropathy in Poissons ormultivariate binary logistic-regression models. Discussion This is the first report focusing on optic neuropathy in a cohort of complex DR-TB patients, including patients co-infected with HIV, receiving linezolid-containing regimens. In our study, one out of four patients on linezolid had at least one episode of ocular complaints; therefore, systematic monitoring of patients by primary physicians/nurses, and access to specialized diagnostic-services by specialists are needed. As linezolid will be increasingly added to treatment regimens of DR-TB patients, programmes should allocate adequate resources for early diagnosis, prevention and management of this disabling adverse event.	[Mehta, Salil] Lilavati Hosp & Res Ctr, Dept Ophthalmol, Bombay, Maharashtra, India; [Das, Mrinalini; Laxmeshwar, Chinmay; Jonckheere, Sylvie; Thi, Sein Sein; Isaakidis, Petros] Med Sans Frontieres, Bombay, Maharashtra, India; [Isaakidis, Petros] Med Sans Frontieres, Operat Res Unit, Luxembourg, Luxembourg	Doctors Without Borders	Das, M (corresponding author), Med Sans Frontieres, Bombay, Maharashtra, India.	msfocb-delhi-epi@brussels.msf.org	Mehta, Salil/ABG-1687-2020	Mehta, Salil/0000-0003-4175-459X; Laxmeshwar, Chinmay/0000-0003-1561-3857; Isaakidis, Petros/0000-0002-7881-1554				Agrawal R, 2015, OCUL IMMUNOL INFLAMM, V23, P90, DOI 10.3109/09273948.2013.874447; Alcala L, 2003, ANTIMICROB AGENTS CH, V47, P416, DOI 10.1128/AAC.47.1.416-417.2003; Cleveland KO, 2009, CLIN INFECT DIS, V49, P645, DOI 10.1086/603592; Han J, 2013, J NEURO-OPHTHALMOL, V33, P316, DOI 10.1097/WNO.0b013e31829b4265; Hughes J, 2015, EUR RESPIR J, V46, P271, DOI 10.1183/09031936.00188114; Isaakidis P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040781; Isaakidis P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028066; Javaheri M, 2007, BRIT J OPHTHALMOL, V91, P111, DOI 10.1136/bjo.2006.102541; Joshi L, 2009, CLIN INFECT DIS, V48, pe73, DOI 10.1086/597298; Karuppannasamy D, 2014, INDIAN J OPHTHALMOL, V62, P497, DOI 10.4103/0301-4738.118451; Kho RC, 2011, J NEURO-OPHTHALMOL, V31, P121, DOI 10.1097/WNO.0b013e318205a148; Kiuchi K, 2009, JPN J OPHTHALMOL, V53, P420, DOI 10.1007/s10384-009-0678-3; Kulkarni K, 2005, BRIT J OPHTHALMOL, V89, P1664, DOI 10.1136/bjo.2005.074237; Lee E, 2003, CLIN INFECT DIS, V37, P1389, DOI 10.1086/379012; Lee M, 2012, NEW ENGL J MED, V367, P1508, DOI 10.1056/NEJMoa1201964; McKinley SH, 2005, J NEURO-OPHTHALMOL, V25, P18, DOI 10.1097/00041327-200503000-00005; Rucker JC, 2006, NEUROLOGY, V66, P595, DOI 10.1212/01.wnl.0000201313.24970.b8; Saijo T, 2005, AM J OPHTHALMOL, V139, P1114, DOI 10.1016/j.ajo.2004.11.047; Schecter GF, 2010, CLIN INFECT DIS, V50, P49, DOI 10.1086/648675; Sotgiu G, 2012, EUR RESPIR J, V40, P1430, DOI 10.1183/09031936.00022912; Tang SJ, 2015, EUR RESPIR J, V45, P161, DOI 10.1183/09031936.00035114; Udwadia ZF, 2010, EUR RESPIR J, V35, P936, DOI 10.1183/09031936.00132009; Zhang X, 2015, J THORAC DIS, V7, P603, DOI 10.3978/j.issn.2072-1439.2015.03.10	23	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162138	10.1371/journal.pone.0162138	http://dx.doi.org/10.1371/journal.pone.0162138			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611434	Green Published, gold			2022-12-26	WOS:000383255900046
J	Sauter, A; Koehler, T; Fingerle, AA; Brendel, B; Richter, V; Rasper, M; Rummeny, EJ; Noel, PB; Munzel, D				Sauter, Andreas; Koehler, Thomas; Fingerle, Alexander A.; Brendel, Bernhard; Richter, Vivien; Rasper, Michael; Rummeny, Ernst J.; Noel, Peter B.; Muenzel, Daniela			Ultra Low Dose CT Pulmonary Angiography with Iterative Reconstruction	PLOS ONE			English	Article							LOW-TUBE-VOLTAGE; IMAGE QUALITY; COMPUTED-TOMOGRAPHY; ABDOMINAL CT; RADIATION; REDUCTION; EMBOLISM; ALGORITHM; CHEST; IMPACT	Objective Evaluation of a new iterative reconstruction algorithm (IMR) for detection/rule-out of pulmonary embolism (PE) in ultra-low dose computed tomography pulmonary angiography (CTPA). Methods Lower dose CT data sets were simulated based on CTPA examinations of 16 patients with pulmonary embolism (PE) with dose levels (DL) of 50%, 25%, 12.5%, 6.3% or 3.1% of the original tube current setting. Original CT data sets and simulated low-dose data sets were reconstructed with three reconstruction algorithms: the standard reconstruction algorithm "filtered back projection" (FBP), the first generation iterative reconstruction algorithm iDose and the next generation iterative reconstruction algorithm "Iterative Model Reconstruction" (IMR). In total, 288 CTPA data sets (16 patients, 6 tube current levels, 3 different algorithms) were evaluated by two blinded radiologists regarding image quality, diagnostic confidence, detectability of PE and contrast-to-noise ratio (CNR). Results iDose and IMR showed better detectability of PE than FBP. With IMR, sensitivity for detection of PE was 100% down to a dose level of 12.5%. iDose and IMR showed superiority to FBP regarding all characteristics of subjective (diagnostic confidence in detection of PE, image quality, image noise, artefacts) and objective image quality. The minimum DL providing acceptable diagnostic performance was 12.5% (= 0.45 mSv) for IMR, 25% (= 0.89 mSv) for iDose and 100% (= 3.57 mSv) for FBP. CNR was significantly (p < 0.001) improved by IMR compared to FBP and iDose at all dose levels. Conclusion By using IMR for detection of PE, dose reduction for CTPA of up to 75% is possible while maintaining full diagnostic confidence. This would result in a mean effective dose of approximately 0.9 mSv for CTPA.	[Sauter, Andreas; Fingerle, Alexander A.; Rasper, Michael; Rummeny, Ernst J.; Noel, Peter B.; Muenzel, Daniela] Tech Univ Munich, Dept Diagnost & Intervent Radiol, Munich, Germany; [Koehler, Thomas; Brendel, Bernhard] Philips GmbH, Innovat Technol, Res Labs, Hamburg, Germany; [Richter, Vivien] Univ Klinikum Tubingen, Dept Diagnost & Intervent Radiol, Tubingen, Germany; [Noel, Peter B.] Tech Univ Munich, Lehrstuhl Biomed Phys, Dept Phys, Garching, Germany; [Noel, Peter B.] Tech Univ Munich, Inst Med Tech, Garching, Germany	Technical University of Munich; Philips; Philips Research; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Technical University of Munich; Technical University of Munich	Sauter, A (corresponding author), Tech Univ Munich, Dept Diagnost & Intervent Radiol, Munich, Germany.	andreas.sauter@tum.de	Sauter, Andreas/AAM-6986-2020	Sauter, Andreas/0000-0003-4394-862X; Noel, Peter/0000-0002-9671-6171				Astani SA, 2014, NUCL MED COMMUN, V35, P704, DOI 10.1097/MNM.0000000000000114; Brenner DJ, 2007, NEW ENGL J MED, V357, P2277, DOI 10.1056/NEJMra072149; Chen MY, 2013, INT J CARDIOVAS IMAG, V29, P1167, DOI 10.1007/s10554-013-0190-1; de Gonzalez AB, 2009, ARCH INTERN MED, V169, P2071, DOI 10.1001/archinternmed.2009.440; EVANS SH, 1989, CLIN RADIOL, V40, P45, DOI 10.1016/S0009-9260(89)80021-2; Henes FOG, 2012, J THORAC IMAG, V27, P113, DOI 10.1097/RTI.0b013e31820b8696; Huda W, 1997, RADIOLOGY, V203, P417, DOI 10.1148/radiology.203.2.9114097; Itatani R, 2013, CLIN RADIOL, V68, pE128, DOI 10.1016/j.crad.2012.10.014; Kalra MK, 2005, RADIOLOGY, V237, P303, DOI 10.1148/radiol.2371041227; Kligerman S, 2013, J THORAC IMAG, V28, P49, DOI 10.1097/RTI.0b013e31825412b2; Lambert L, 2015, ACTA RADIOL, V56, P517, DOI 10.1177/0284185114533683; Laqmani A, 2013, ROFO-FORTSCHR RONTG, V185, P749, DOI 10.1055/s-0033-1335577; MacKenzie JD, 2007, AM J ROENTGENOL, V189, P1371, DOI 10.2214/AJR.07.2686; Marin D, 2010, RADIOLOGY, V254, P145, DOI 10.1148/radiol.09090094; Marin D, 2009, RADIOLOGY, V251, P771, DOI 10.1148/radiol.2513081330; Mayo J, 2013, AM J ROENTGENOL, V200, P522, DOI 10.2214/AJR.12.9928; Mehta DB B., 2011, EFFECT ITERATIVE REC; Muenzel D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107843; Nakayama Y, 2005, RADIOLOGY, V237, P945, DOI 10.1148/radiol.2373041655; Noel PB, 2014, J MED IMAGING, V1, DOI 10.1117/1.JMI.1.3.033501; Noel PB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081141; Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907; Oda S, 2011, ACAD RADIOL, V18, P991, DOI 10.1016/j.acra.2011.03.007; Parker Louise, 2013, Arch Dis Child Educ Pract Ed, V98, P239, DOI 10.1136/archdischild-2013-305274; Remy-Jardin M, 2007, RADIOLOGY, V245, P315, DOI 10.1148/radiol.2452070397; Schoepf UJ, 2004, RADIOLOGY, V230, P329, DOI 10.1148/radiol.2302021489; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Szucs-Farkas Z, 2014, EUR RADIOL, V24, P1868, DOI 10.1007/s00330-014-3208-8; Takahashi EA, 2013, RADIOL RES PRACT, V2013, DOI 10.1155/2013/482403; Waaijer A, 2007, RADIOLOGY, V242, P832, DOI 10.1148/radiol.2423051191; Willemink MJ, 2014, J COMPUT ASSIST TOMO, V38, P815, DOI 10.1097/RCT.0000000000000128; Zabic S, 2013, MED PHYS, V40, DOI 10.1118/1.4789628	32	34	38	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162716	10.1371/journal.pone.0162716	http://dx.doi.org/10.1371/journal.pone.0162716			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611830	Green Published, gold			2022-12-26	WOS:000383255900154
J	Su, Q; Gu, YQ; Yu, B; Yu, F; He, HY; Zhang, Q; Meng, G; Wu, HM; Du, HM; Liu, L; Shi, HB; Xia, Y; Guo, XY; Liu, X; Li, CL; Bao, X; Liu, FF; Fang, LY; Yang, HJ; Sun, SM; Wang, X; Zhou, M; Jia, QY; Zhao, HL; Song, K; Niu, KJ				Su, Qian; Gu, Yeqing; Yu, Bin; Yu, Fei; He, Haiyan; Zhang, Qing; Meng, Ge; Wu, Hongmei; Du, Huanmin; Liu, Li; Shi, Hongbin; Xia, Yang; Guo, Xiaoyan; Liu, Xing; Li, Chunlei; Bao, Xue; Liu, Fangfang; Fang, Liyun; Yang, Huijun; Sun, Shaomei; Wang, Xing; Zhou, Ming; Jia, Qiyu; Zhao, Honglin; Song, Kun; Niu, Kaijun			Association between Serum Ferritin Concentrations and Depressive Symptoms among Chinese Adults: A Population Study from the Tianjin Chronic Low-Grade Systemic Inflammation and Health (TCLSIHealth) Cohort Study	PLOS ONE			English	Article							MAJOR DEPRESSION; IRON STATUS; METABOLIC SYNDROME; DISORDERS; RISK; PREVALENCE; GENDER; AXIS	Depressive symptoms have become the most important global public health issue. Iron plays an important role in brain function, cognition, and behavior, and its impacts on depressive symptoms may be multifactorial with both positive and negative effects. Previous observational studies focusing on the association between iron status and depressive symptoms showed inconsistent results. Ferritin is a ubiquitous intracellular protein that can store and release iron and is widely used as a clinical biomarker to evaluate iron status. We performed a cross-sectional study to examine the relationship between serum ferritin and depressive symptoms among 3,839 subjects who were from the Tianjin Chronic Low-grade Systemic Inflammation and Health (TCLSIHealth) cohort. Depressive symptoms were assessed using the Chinese version of 20-item self-rating Depression Scale (SDS) with 4 cutoffs (40, 45, 48 and 50) to indicate elevated depressive symptoms (40 was the primary cut-off). The prevalence of depressive symptoms was 36.5%, 17.6%, 11.0% and 7.0% for SDS >= 40, >= 45, >= 48 and >= 50, respectively. With the primary cut-off point of 40, multiple potential confounding factors were adjusted and the odds ratios (95% confidence interval) of having elevated depressive symptoms by quartiles of serum ferritin concentrations were 1.00 (reference), 1.10 (0.91, 1.34), 0.81 (0.66, 1.01) and 1.02 (0.81, 1.28) for the first, second, third and fourth quartile, respectively (P for trend = 0.76). Similar relations were observed with the use of other cut-offs as a definition of depressive symptoms. In conclusion, there is no significant relationship between serum ferritin concentrations and depressive symptoms among Chinese adults.	[Su, Qian; Gu, Yeqing; Yu, Bin; Yu, Fei; He, Haiyan; Meng, Ge; Wu, Hongmei; Du, Huanmin; Xia, Yang; Guo, Xiaoyan; Liu, Xing; Li, Chunlei; Bao, Xue; Liu, Fangfang; Fang, Liyun; Yang, Huijun; Niu, Kaijun] Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China; [Su, Qian; Gu, Yeqing; Yu, Bin; Yu, Fei; He, Haiyan; Meng, Ge; Wu, Hongmei; Du, Huanmin; Xia, Yang; Guo, Xiaoyan; Liu, Xing; Li, Chunlei; Bao, Xue; Liu, Fangfang; Fang, Liyun; Yang, Huijun; Niu, Kaijun] Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China; [Zhang, Qing; Liu, Li; Shi, Hongbin; Sun, Shaomei; Wang, Xing; Zhou, Ming; Jia, Qiyu; Zhao, Honglin; Song, Kun; Niu, Kaijun] Tianjin Med Univ, Gen Hosp, Hlth Management Ctr, Tianjin, Peoples R China; [Yu, Bin] Tianjin Med Univ, Inst Psychol, Tianjin, Peoples R China; [Niu, Kaijun] Tianjin Med Univ, Collaborat Innovat Ctr Noncommunicable Dis, Tianjin, Peoples R China	Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University; Tianjin Medical University	Niu, KJ (corresponding author), Tianjin Med Univ, Nutr Epidemiol Inst, Tianjin, Peoples R China.; Niu, KJ (corresponding author), Tianjin Med Univ, Sch Publ Hlth, Tianjin, Peoples R China.; Niu, KJ (corresponding author), Tianjin Med Univ, Gen Hosp, Hlth Management Ctr, Tianjin, Peoples R China.; Niu, KJ (corresponding author), Tianjin Med Univ, Collaborat Innovat Ctr Noncommunicable Dis, Tianjin, Peoples R China.	niukaijun@tmu.edu.cn	Xia, Yang/AAW-9116-2021; Gu, Yeqing/S-3103-2017; Yu, Bin/AAV-1606-2020	Xia, Yang/0000-0001-8783-1592; Yu, Bin/0000-0002-8978-5144; Niu, Kaijun/0000-0002-8772-2481	National Natural Science Foundation of China [81673166, 81372118, 81372467, 81302422]; key technologies R&D program of Tianjin [11ZCGYSY05700, 12ZCZDSY20400, 13ZCZDSY20200]; National Science and Technology Support Program [2012BAI02B02]; Chinese Nutrition Society (CNS) Nutrition Research Foundation-DSM Research Fund [2014-071]; Technologies development program of Beichen District of Tianjin [bcws2013-21, bcws2014-05]; technologies project of Tianjin Binhai New Area [2013-02-04, 2013-02-06]; Science Foundation of Tianjin Medical University [2010KY28, 2013KYQ24]; Ministry of Education [GW2014-5]; National Training Programs of Innovation and Entrepreneurship for Undergraduates, China [201510062013]; Key Laboratory of Public Health Safety (Fudan University)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key technologies R&D program of Tianjin; National Science and Technology Support Program; Chinese Nutrition Society (CNS) Nutrition Research Foundation-DSM Research Fund; Technologies development program of Beichen District of Tianjin; technologies project of Tianjin Binhai New Area; Science Foundation of Tianjin Medical University; Ministry of Education; National Training Programs of Innovation and Entrepreneurship for Undergraduates, China; Key Laboratory of Public Health Safety (Fudan University)	This study was supported by grants from the National Natural Science Foundation of China (No. 81673166, 81372118, 81372467 and 81302422), the key technologies R&D program of Tianjin (Key Project: No. 11ZCGYSY05700, 12ZCZDSY20400, and 13ZCZDSY20200), the National Science and Technology Support Program (No. 2012BAI02B02), 2012 Chinese Nutrition Society (CNS) Nutrition Research Foundation-DSM Research Fund (No. 2014-071), the Technologies development program of Beichen District of Tianjin (No. bcws2013-21 and bcws2014-05), the technologies project of Tianjin Binhai New Area (No. 2013-02-04 and 2013-02-06), the Science Foundation of Tianjin Medical University (No. 2010KY28 and 2013KYQ24), the Key Laboratory of Public Health Safety (Fudan University), Ministry of Education (No. GW2014-5), and the National Training Programs of Innovation and Entrepreneurship for Undergraduates (No. 201510062013), China.	ACHTE K, 1986, PSYCHOPATHOLOGY, V19, P210, DOI 10.1159/000285157; Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Armony-Sivan R, 2012, J PREGNANCY, V2012, DOI 10.1155/2012/521431; BARTFAY WJ, 1995, CAN J CARDIOL, V11, P305; Baune BT, 2006, INT PSYCHOGERIATR, V18, P437, DOI 10.1017/S1041610205002759; Baune BT, 2010, ACTA PSYCHIAT SCAND, V121, P135, DOI 10.1111/j.1600-0447.2009.01435.x; Beard J, 2003, J NUTR, V133, p1468S, DOI 10.1093/jn/133.5.1468S; Beard JL, 2005, J NEUROSCI RES, V79, P254, DOI 10.1002/jnr.20324; Bhattacharya R, 2014, BMC PSYCHIATRY, V14, DOI 10.1186/1471-244X-14-10; Bland RC, 1997, CAN J PSYCHIAT, V42, P367, DOI 10.1177/070674379704200403; Bradvik L, 2008, ACTA PSYCHIAT SCAND, V117, P185, DOI 10.1111/j.1600-0447.2007.01136.x; Ferrari AJ, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001547; Han LL, 2014, MOL NUTR FOOD RES, V58, P2189, DOI 10.1002/mnfr.201400088; Huang TL, 2007, PSYCHIAT RES, V152, P277, DOI 10.1016/j.psychres.2005.07.038; Hunt JR, 1999, BEHAV MED, V25, P62, DOI 10.1080/08964289909595738; Kim J, 2014, J NUTR BIOCHEM, V25, P1101, DOI 10.1016/j.jnutbio.2014.07.003; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074168; Liu XL, 2015, ROUT ADV RISK MANAGE, V4, P1; Looker AC, 1997, JAMA-J AM MED ASSOC, V277, P973, DOI 10.1001/jama.277.12.973; Lozoff B, 1988, Adv Pediatr, V35, P331; MAES M, 1993, PSYCHIAT RES, V49, P11, DOI 10.1016/0165-1781(93)90027-E; Maes M, 1995, J AFFECT DISORDERS, V36, P29, DOI 10.1016/0165-0327(95)00049-6; MAES M, 1993, BIOL PSYCHIAT, V34, P690, DOI 10.1016/0006-3223(93)90042-C; MAES M, 1993, AM J PSYCHIAT, V150, P1189; Maes M, 1996, J AFFECT DISORDERS, V40, P23, DOI 10.1016/0165-0327(96)00038-9; MAES M, 1993, PSYCHIAT RES, V49, P151, DOI 10.1016/0165-1781(93)90102-M; McLean E, 2009, PUBLIC HEALTH NUTR, V12, P444, DOI 10.1017/S1368980008002401; Miller AH, 2016, NAT REV IMMUNOL, V16, P22, DOI 10.1038/nri.2015.5; Murakami K, 2008, NUTRITION, V24, P140, DOI 10.1016/j.nut.2007.10.013; Murray-Kolb LE, 2011, J NUTR, V141, p747S, DOI 10.3945/jn.110.130658; Pan A, 2012, DIABETES CARE, V35, P1171, DOI 10.2337/dc11-2055; Phillips MR, 2009, LANCET, V373, P2041, DOI 10.1016/S0140-6736(09)60660-7; Popa T A, 2012, J Med Life, V5, P414; Qu Ning-ning, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P265; Rangan AM, 1998, J AM COLL NUTR, V17, P351, DOI 10.1080/07315724.1998.10718774; Shariatpanaahi MV, 2007, EUR J CLIN NUTR, V61, P532, DOI 10.1038/sj.ejcn.1602542; Shiotani I, 2002, J CARDIOVASC RISK, V9, P153, DOI 10.1097/00043798-200206000-00004; Stoltzfus RJ, 2001, J NUTR, V131, p565S, DOI 10.1093/jn/131.2.565S; Sun SM, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/412386; Ustun TB, 2004, BRIT J PSYCHIAT, V184, P386, DOI 10.1192/bjp.184.5.386; van West Dirk, 1999, Neuro Endocrinol Lett, V20, P11; Xu L, 2004, ARCH MED RES, V35, P301, DOI 10.1016/j.arcmed.2004.04.006; Yi S, 2011, PSYCHIAT RES, V189, P368, DOI 10.1016/j.psychres.2011.03.009; Yip R, 2002, J NUTR, V132, p802S, DOI 10.1093/jn/132.4.802S; Zhu L, 2016, J AFFECT DISORDERS, V190, P98, DOI 10.1016/j.jad.2015.09.074; ZUNG WWK, 1965, ARCH GEN PSYCHIAT, V12, P63, DOI 10.1001/archpsyc.1965.01720310065008	47	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162682	10.1371/journal.pone.0162682	http://dx.doi.org/10.1371/journal.pone.0162682			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611581	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900151
J	Xia, K; Li, YD; Sun, J; Liang, XL				Xia, Kai; Li, Yudong; Sun, Jing; Liang, Xinle			Comparative Genomics of Acetobacterpasteurianus Ab3, an Acetic Acid Producing Strain Isolated from Chinese Traditional Rice Vinegar Meiguichu	PLOS ONE			English	Article							TOXIN-ANTITOXIN SYSTEMS; ACETOBACTER-PASTEURIANUS; BACTERIAL; GENES; RESISTANCE; DIVERSITY; PROTEOME; PROGRAM; SEARCH; SENSOR	Acetobacter pasteurianus, an acetic acid resistant bacterium belonging to alpha-proteobacteria, has been widely used to produce vinegar in the food industry. To understand the mechanism of its high tolerance to acetic acid and robust ability of oxidizing ethanol to acetic acid (> 12%, w/v), we described the 3.1 Mb complete genome sequence (including 0.28M plasmid sequence) with a G+ C content of 52.4% of A. pasteurianus Ab3, which was isolated from the traditional Chinese rice vinegar (Meiguichu) fermentation process. Automatic annotation of the complete genome revealed 2,786 protein-coding genes and 73 RNA genes. The comparative genome analysis among A. pasteurianus strains revealed that A. pasteurianus Ab3 possesses many unique genes potentially involved in acetic acid resistance mechanisms. In particular, two-component systems or toxin-antitoxin systems may be the signal pathway and modulatory network in A. pasteurianus to cope with acid stress. In addition, the large numbers of unique transport systems may also be related to its acid resistance capacity and cell fitness. Our results provide new clues to understanding the underlying mechanisms of acetic acid resistance in Acetobacter species and guiding industrial strain breeding for vinegar fermentation processes.	[Xia, Kai; Li, Yudong; Sun, Jing; Liang, Xinle] Zhejiang Gongshang Univ, Coll Food Sci & Biotechnol, Hangzhou 310018, Peoples R China	Zhejiang Gongshang University	Liang, XL (corresponding author), Zhejiang Gongshang Univ, Coll Food Sci & Biotechnol, Hangzhou 310018, Peoples R China.	dbiot@mail.zjgsu.edu.cn	li, yu/HGL-9518-2022; Li, Yudong/GSN-4036-2022; li, Yu/HCI-9086-2022		National Nature and Science Foundation of China [3117175]; Nature and Science Foundation of Zhejiang Province [LY15C200006, LY14C060001]; Youth Foundation of Zhejiang Gongshang University	National Nature and Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature and Science Foundation of Zhejiang Province; Youth Foundation of Zhejiang Gongshang University	The work was financially supported by National Nature and Science Foundation of China (3117175) and Nature and Science Foundation of Zhejiang Province (LY15C200006) to XL, and Youth Foundation of Zhejiang Gongshang University to YL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The work was financially supported by grants from the National Nature and Science Foundation of China (31171745 to X. Liang) and the Nature and Science Foundation of the Zhejiang Province (LY15C200006 to X. Liang, and LY14C060001 to Y. Li).	Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; Andres-Barrao C, 2012, J PROTEOMICS, V75, P1701, DOI 10.1016/j.jprot.2011.11.027; Azuma Y, 2009, NUCLEIC ACIDS RES, V37, P5768, DOI 10.1093/nar/gkp612; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Benson G, 1999, NUCLEIC ACIDS RES, V27, P573, DOI 10.1093/nar/27.2.573; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Brito PH, 2013, GENOME BIOL EVOL, V5, P16, DOI 10.1093/gbe/evs122; Bustamante P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112226; Darling ACE, 2004, GENOME RES, V14, P1394, DOI 10.1101/gr.2289704; Freeman ZN, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003201; Gao R, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003927; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Gullo M, 2008, INT J FOOD MICROBIOL, V125, P46, DOI 10.1016/j.ijfoodmicro.2007.11.076; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Haruta S, 2006, INT J FOOD MICROBIOL, V109, P79, DOI 10.1016/j.ijfoodmicro.2006.01.015; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Iida A, 2009, MICROBIOL-SGM, V155, P3021, DOI 10.1099/mic.0.028613-0; Illeghems K, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-526; Ishikawa M, 2010, J BIOSCI BIOENG, V110, P69, DOI 10.1016/j.jbiosc.2009.12.012; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Laermann V, 2013, MOL MICROBIOL, V88, P1194, DOI 10.1111/mmi.12251; Lagesen K, 2007, NUCLEIC ACIDS RES, V35, P3100, DOI 10.1093/nar/gkm160; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Li LP, 2002, P NATL ACAD SCI USA, V99, P12369, DOI 10.1073/pnas.192439499; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Luo RB, 2012, GIGASCIENCE, V1, DOI 10.1186/2047-217X-1-18; Maisonneuve E, 2013, CELL, V154, P1140, DOI 10.1016/j.cell.2013.07.048; Marcus EA, 2013, HELICOBACTER, V18, P363, DOI 10.1111/hel.12055; Mulder Nicola J, 2002, Brief Bioinform, V3, P225; Nakano S, 2006, APPL ENVIRON MICROB, V72, P497, DOI 10.1128/AEM.72.1.497-505.2006; Nakano S, 2008, INT J FOOD MICROBIOL, V125, P54, DOI 10.1016/j.ijfoodmicro.2007.05.015; Norton JP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002954; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Page R, 2016, NAT CHEM BIOL, V12, P208, DOI [10.1038/NCHEMBIO.2044, 10.1038/nchembio.2044]; Sakurai K, 2013, J BIOSCI BIOENG, V115, P32, DOI 10.1016/j.jbiosc.2012.07.017; Shi JY, 2014, LECT NOTES ELECTR EN, V249, P417, DOI 10.1007/978-3-642-37916-1_43; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Trcek J, 2006, APPL MICROBIOL BIOT, V70, P366, DOI 10.1007/s00253-005-0073-z; Trcek J, 2015, ANN MICROBIOL, V65, P1287, DOI 10.1007/s13213-014-0966-0; Trcek J, 2015, APPL MICROBIOL BIOT, V99, P6215, DOI 10.1007/s00253-015-6762-3; Wang Z, 2015, APPL BIOCHEM BIOTECH, V177, P1573, DOI 10.1007/s12010-015-1838-1; Wu CF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002938; Yamada Y, 2008, INT J FOOD MICROBIOL, V125, P15, DOI 10.1016/j.ijfoodmicro.2007.11.077; Yamada Y, 2012, J GEN APPL MICROBIOL, V58, P397, DOI 10.2323/jgam.58.397; Zeng XM, 2013, FEMS MICROBIOL LETT, V347, P83, DOI 10.1111/1574-6968.12221; Zhou Y, 2011, NUCLEIC ACIDS RES, V39, pW347, DOI 10.1093/nar/gkr485	47	11	12	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162172	10.1371/journal.pone.0162172	http://dx.doi.org/10.1371/journal.pone.0162172			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611790	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900050
J	Eng, GP; Bouchelouche, P; Bartels, EM; Bliddal, H; Bendtzen, K; Stoltenberg, M				Eng, Grith Petersen; Bouchelouche, Pierre; Bartels, Else Marie; Bliddal, Henning; Bendtzen, Klaus; Stoltenberg, Michael			Anti-Drug Antibodies, Drug Levels, Interleukin-6 and Soluble TNF Receptors in Rheumatoid Arthritis Patients during the First 6 Months of Treatment with Adalimumab or Infliximab: A Descriptive Cohort Study	PLOS ONE			English	Article							ANTITUMOR NECROSIS FACTOR; DISEASE-ACTIVITY; INFLAMMATORY DISEASES; MONOCLONAL-ANTIBODY; ALPHA THERAPY; IMMUNOGENICITY; EFFICACY; PREDICT; METHOTREXATE; ETANERCEPT	Objectives With the present study we wanted to explore the impact of treatment with a tumor necrosis factor-alpha -inhibitor (TNFi) on levels of soluble biomarkers in rheumatoid arthritis (RA) patients and to identify predictors of impaired drug levels and development of anti-TNFi antibodies (anti-TNFi Abs). Methods Blood samples from 26 patients with established RA were taken at baseline and following 6 months of treatment with adalimumab or infliximab. Samples were analyzed for levels of TNFi, interleukin (IL)-6, and soluble TNF-receptors 1 and -2 (sTNF-R1 and -2) and for presence of anti-TNFi Abs. Clinical and demographic data were recorded as well. Results During the initial 6 months treatment, DAS28(CRP) (Disease activity score in 28 joints using C-reactive protein) and levels of IL-6 and sTNF-R2 decreased significantly in patients without anti-TNFi Abs and in patients retaining detectable drug levels. The levels of other tested cytokines (TNF-alpha, TNF-beta, IL-1ra, IL-1b, IL-8, IL-10, IL-12(p70), IL-13, IL-17A, IL-17F, and IL-33) were generally below detection limits. Higher baseline levels of IL-6 associated with undetectable levels of TNFi at follow-up. Anti-TNFi Abs were associated with decreased drug levels, but no predictors for anti-TNFi Ab development could be found. Conclusion The effect of treatment with TNFi on RA disease activity depends on levels of active drug, and by presence of anti-TNFi Abs. In patients who retain detectable drug levels, and in the absence of anti-TNFi Abs, clinical outcome is improved during treatment, and circulating levels of IL-6 and sTNF-R2 decrease. Baseline levels of IL-6 may predict depletion of TNFi and may identify patients at risk of treatment failure.	[Eng, Grith Petersen; Bouchelouche, Pierre] Zealand Universityhosp Koge, Dept Clin Biochem, Koge, Denmark; [Eng, Grith Petersen; Stoltenberg, Michael] Zealand Universityhosp Koge, Dept Rheumatol, Koge, Denmark; [Eng, Grith Petersen; Bartels, Else Marie; Bliddal, Henning] Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Bispebjerg, Denmark; [Eng, Grith Petersen; Bartels, Else Marie; Bliddal, Henning] Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Frederiksberg, Denmark; [Bendtzen, Klaus] Rigshosp, Copenhagen Univ Hosp, Inst Inflammat Res, Copenhagen, Denmark	University of Copenhagen; University of Copenhagen; Rigshospitalet; University of Copenhagen	Eng, GP (corresponding author), Zealand Universityhosp Koge, Dept Clin Biochem, Koge, Denmark.; Eng, GP (corresponding author), Zealand Universityhosp Koge, Dept Rheumatol, Koge, Denmark.; Eng, GP (corresponding author), Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Bispebjerg, Denmark.; Eng, GP (corresponding author), Copenhagen Univ Hosp, Dept Rheumatol, Parker Inst, Frederiksberg, Denmark.	eng@dadlnet.dk	Bliddal, Henning/AAB-3168-2019	Bliddal, Henning/0000-0002-7951-1668; Bouchelouche, Pierre/0000-0002-0441-8194; Stoltenberg, Michael Bo/0000-0001-7982-0105; Petersen Eng, Grith/0000-0002-2587-8421	Research Foundation of Region Zealand	Research Foundation of Region Zealand	The study was supported by the Research Foundation of Region Zealand. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Bartelds GM, 2007, ANN RHEUM DIS, V66, P921, DOI 10.1136/ard.2006.065615; Bartelds GM, 2011, JAMA-J AM MED ASSOC, V305, P1460, DOI 10.1001/jama.2011.406; Bendtzen K, 2006, ARTHRITIS RHEUM-US, V54, P3782, DOI 10.1002/art.22214; Bendtzen K, 2011, ARTHRITIS RHEUM-US, V63, P867, DOI 10.1002/art.30207; Charles P, 1999, J IMMUNOL, V163, P1521; Choy E, 2012, RHEUMATOLOGY, V51, pV3, DOI 10.1093/rheumatology/kes113; Ducourau E, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3386; Ebert EC, 2009, AM J PHYSIOL-GASTR L, V296, pG612, DOI 10.1152/ajpgi.90576.2008; Ellegaard K, 2011, RHEUMATOLOGY, V50, P506, DOI 10.1093/rheumatology/keq336; Garces S, 2013, ANN RHEUM DIS, V72, P1947, DOI 10.1136/annrheumdis-2012-202220; Gottenberg JE, 2012, ANN RHEUM DIS, V71, P1243, DOI 10.1136/annrheumdis-2011-200975; Hayashi S, 2016, RHEUMATOL THER, V3, P155, DOI 10.1007/s40744-015-0022-y; Hueber W, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2706; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Krieckaert CL, 2012, ARTHRITIS RHEUM-US, V64, P3850, DOI 10.1002/art.34680; Krintel S. B., 2013, RHEUMATOLOGY OXFORD; Lallemand C, 2011, J IMMUNOL METHODS, V373, P229, DOI 10.1016/j.jim.2011.08.022; Lipsky PE, 2000, NEW ENGL J MED, V343, P1594, DOI 10.1056/NEJM200011303432202; Maini Ravinder N, 2002, Arthritis Res, V4 Suppl 2, pS22, DOI 10.1186/ar549; Mitoma H, 2008, ARTHRITIS RHEUM-US, V58, P1248, DOI 10.1002/art.23447; Mok CC, 2013, CLIN RHEUMATOL, V32, P1429, DOI 10.1007/s10067-013-2336-x; Ongaro A, 2008, RHEUMATOL INT, V28, P901, DOI 10.1007/s00296-008-0552-5; Pascual-Salcedo D, 2011, RHEUMATOLOGY, V50, P1445, DOI 10.1093/rheumatology/ker124; Pouw M. F., 2013, ANN RHEUM DIS; Radstake TRDJ, 2009, ANN RHEUM DIS, V68, P1739, DOI 10.1136/ard.2008.092833; SCALLON BJ, 1995, CYTOKINE, V7, P251, DOI 10.1006/cyto.1995.0029; Schulz M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/675108; Spoettl T, 2007, INFLAMM BOWEL DIS, V13, P727, DOI 10.1002/ibd.20107; Valle Y, 2009, SCAND J RHEUMATOL, V38, P332, DOI 10.1080/03009740902865456; van den Broek M, 2013, CURR OPIN PHARMACOL, V13, P463, DOI 10.1016/j.coph.2013.03.006; van der Maas A, 2012, BMC MUSCULOSKEL DIS, V13, DOI 10.1186/1471-2474-13-184; Vincent FB, 2013, ANN RHEUM DIS, V72, P165, DOI 10.1136/annrheumdis-2012-202545; Weinblatt ME, 1999, NEW ENGL J MED, V340, P253, DOI 10.1056/NEJM199901283400401; Weinblatt ME, 2003, ARTHRITIS RHEUM-US, V48, P35, DOI 10.1002/art.10697	35	22	24	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162316	10.1371/journal.pone.0162316	http://dx.doi.org/10.1371/journal.pone.0162316			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606615	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255600038
J	Zhou, WW; Wu, LM; Xie, J; Su, TW; Jiang, L; Jiang, YR; Cao, YA; Liu, JM; Ning, G; Wang, WQ				Zhou, Weiwei; Wu, Luming; Xie, Jing; Su, Tingwei; Jiang, Lei; Jiang, Yiran; Cao, Yanan; Liu, Jianmin; Ning, Guang; Wang, Weiqing			Steroidogenic Acute Regulatory Protein Overexpression Correlates with Protein Kinase A Activation in Adrenocortical Adenoma	PLOS ONE			English	Article							ADRENAL CUSHINGS-SYNDROME; CATALYTIC SUBUNIT; SOMATIC MUTATIONS; GENE-EXPRESSION; TUMORS; PRKACA; HYPERPLASIA	The association of pathological features of cortisol-producing adrenocortical adenomas (ACAs) with somatic driver mutations and their molecular classification remain unclear. In this study, we explored the association between steroidogenic acute regulatory protein ( StAR) expression and the driver mutations activating cyclic adenosine monophosphate (cAMP)/protein kinase A (PKA) signaling to identify the pathological markers of ACAs. Immunohistochemical staining for StAR and mutations in the protein kinase cAMP-activated catalytic subunit alpha (PRKACA), protein kinase cAMP-dependent type I regulatory subunit alpha (PRKAR1A) and guanine nucleotide binding protein, alpha stimulating (GNAS) genes were examined in 97 ACAs. The association of StAR expression with the clinical and mutational features of the ACAs was analyzed. ACAs with mutations in PRKACA, GNAS, and PRKAR1A showed strong immunopositive staining for StAR. The concordance between high StAR expression and mutations activating cAMP/PKA signaling in the ACAs was 99.0%. ACAs with high expression of StAR had significantly smaller tumor volume (P < 0.001) and higher urinary cortisol per tumor volume (P = 0.032) than those with low expression of StAR. Our findings suggest that immunohistochemical staining for StAR is a reliable pathological approach for the diagnosis and classification of ACAs with cAMP/PKA signaling-activating mutations.	[Zhou, Weiwei; Wu, Luming; Su, Tingwei; Jiang, Lei; Jiang, Yiran; Cao, Yanan; Liu, Jianmin; Ning, Guang; Wang, Weiqing] Shanghai Jiao Tong Univ, Shanghai Key Lab Endocrine Tumors, Dept Endocrine & Metab Dis,Rui Jin Hosp, Shanghai Natl Clin Ctr Endocrine & Metab Dis,Sch, Shanghai, Peoples R China; [Xie, Jing] Shanghai Jiao Tong Univ, Rui Jin Hosp, Dept Pathol, Sch Med, Shanghai, Peoples R China; [Ning, Guang] Chinese Acad Sci, Shanghai Inst Biol Sci, Inst Hlth Sci, Lab Endocrinol & Metab, Shanghai, Peoples R China	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Wang, WQ (corresponding author), Shanghai Jiao Tong Univ, Shanghai Key Lab Endocrine Tumors, Dept Endocrine & Metab Dis,Rui Jin Hosp, Shanghai Natl Clin Ctr Endocrine & Metab Dis,Sch, Shanghai, Peoples R China.	wqingw61@163.com		Cao, Yanan/0000-0002-3848-7040	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health [1994DP131044]; Natural Science Foundation of China grants [81400779, 81130016, 81522032]; Chinese Society of Endocrinology [13050890474]; Shanghai Municipal commission of Health and Family Planning [2013SY016]	Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health; Natural Science Foundation of China grants(National Natural Science Foundation of China (NSFC)); Chinese Society of Endocrinology; Shanghai Municipal commission of Health and Family Planning	This study was supported by the grants from the Key Laboratory for Endocrine and Metabolic Diseases of Ministry of Health (1994DP131044), Natural Science Foundation of China grants (No. 81400779, 81130016 and 81522032), Chinese Society of Endocrinology (13050890474), Shanghai Municipal commission of Health and Family Planning (2013SY016).	Almeida MQ, 2011, MOL CELL ENDOCRINOL, V336, P162, DOI 10.1016/j.mce.2010.11.018; Bertherat J, 2003, CANCER RES, V63, P5308; Beuschlein F, 2014, NEW ENGL J MED, V370, P1019, DOI 10.1056/NEJMoa1310359; Calebiro D, 2015, EUR J ENDOCRINOL, V173, pM99, DOI 10.1530/EJE-15-0353; Cao YN, 2014, SCIENCE, V344, P913, DOI 10.1126/science.1249480; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; De Venanzi A, 2014, CURR OPIN ENDOCRINOL, V21, P177, DOI 10.1097/MED.0000000000000061; Di Dalmazi G, 2014, J CLIN ENDOCR METAB, V99, pE2093, DOI 10.1210/jc.2014-2152; Duan K, 2015, J CLIN PATHOL, V68, P175, DOI 10.1136/jclinpath-2014-202612; Espiard S, 2014, HORM METAB RES, V46, P869, DOI 10.1055/s-0034-1385908; Goh G, 2014, NAT GENET, V46, P613, DOI 10.1038/ng.2956; Horvath A, 2006, J CLIN ENDOCR METAB, V91, P584, DOI 10.1210/jc.2005-1301; Jiang XL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6809; Lacroix A, 2015, LANCET, V386, P913, DOI 10.1016/S0140-6736(14)61375-1; Lefrancois-Martinez AM, 2011, J BIOL CHEM, V286, P32976, DOI 10.1074/jbc.M111.218016; LIN D, 1995, SCIENCE, V267, P1828, DOI 10.1126/science.7892608; Manna PR, 2009, MOL HUM REPROD, V15, P321, DOI 10.1093/molehr/gap025; Nieman LK, 2008, J CLIN ENDOCR METAB, V93, P1526, DOI 10.1210/jc.2008-0125; Sato Y, 2014, SCIENCE, V344, P917, DOI 10.1126/science.1252328; Stratakis CA, 2007, NAT CLIN PRACT ENDOC, V3, P748, DOI 10.1038/ncpendmet0648; Stratakis CA, 2014, J CLIN ENDOCR METAB, V99, P3629, DOI 10.1210/jc.2014-3295; Thiel A, 2015, EUR J ENDOCRINOL, V172, P677, DOI 10.1530/EJE-14-1113; Zeiger MA, 2009, ENDOCR PRACT, V15, P450, DOI 10.4158/EP.15.5.450	23	5	5	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162606	10.1371/journal.pone.0162606	http://dx.doi.org/10.1371/journal.pone.0162606			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606678	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600069
J	Bidkar, M; Vassallo, R; Luckey, D; Smart, M; Mouapi, K; Taneja, V				Bidkar, Mitali; Vassallo, Robert; Luckey, David; Smart, Michele; Mouapi, Kelly; Taneja, Veena			Cigarette Smoke Induces Immune Responses to Vimentin in both, Arthritis-Susceptible and -Resistant Humanized Mice	PLOS ONE			English	Article							REGULATORY T-CELLS; ANTI-CCP ANTIBODY; RHEUMATOID-ARTHRITIS; SHARED EPITOPE; CITRULLINATED VIMENTIN; PROTEIN ANTIBODIES; TRANSGENIC MICE; SYNOVIAL-FLUID; MACROPHAGES; INTERLEUKIN-13	Rheumatoid arthritis (RA) is an autoimmune disease marked by chronic synovial inflammation and both, genetic and environmental factors are involved in its pathogenesis. Human leukocyte antigen (HLA) DRB1*0401 is associated with susceptibility to develop RA, while cigarette smoke (CS) exposure promotes seropositive disease with increased severity in DRB1*0401+ individuals. Smokers have higher levels of antibodies against citrullinated peptides. In this study, we determined whether the response to a known autoantigen, Vimentin (Vim) is shared epitope specific and how CS influences this response using transgenic-mice carrying RA-susceptible,*0401, and -resistant, *0402, genes. Following relatively brief exposure to CS, peptidyl arginine deiminase (PAD) enzyme expression was increased in murine lungs. Cigarette smoking led to production of Interferon (IFN)-gamma with reduced levels of Interleukin (IL)-10 by splenocytes of *0401 mice. In contrast, CS augmented Th2 cytokines along with T-regulatory cells in *0402 mice. An increase in levels of antibodies to native and citrullinated Vim was observed in naive mice of both strains following CS exposure. Our data showed that both arthritis-susceptible and -resistant mice can generate cellular and humoral immunity to Vim; however CS-induced modulation of host immunity is dependent on the interaction with the host HLA genes.	[Bidkar, Mitali; Luckey, David; Smart, Michele; Mouapi, Kelly; Taneja, Veena] Mayo Clin, Dept Immunol, Rochester, MN 55902 USA; [Vassallo, Robert] Mayo Clin, Div Pulm & Crit Care Med, Dept Internal Med, Rochester, MN USA; [Taneja, Veena] Mayo Clin, Div Rheumatol, Rochester, MN 55902 USA; [Bidkar, Mitali] Ipca Labs Ltd, Clin Res & Dev, Bombay, Maharashtra, India	Mayo Clinic; Mayo Clinic; Mayo Clinic	Taneja, V (corresponding author), Mayo Clin, Dept Immunol, Rochester, MN 55902 USA.; Taneja, V (corresponding author), Mayo Clin, Div Rheumatol, Rochester, MN 55902 USA.	taneja.veena@mayo.edu	Vassallo, Robert/R-7752-2019	Vassallo, Robert/0000-0003-2328-0255; Taneja, Veena/0000-0003-2401-694X	National Institutes of Health (NIH) [AR30752, AR060077]; Flight Attendant Medical Research Institute (FAMRI) grant; FAMRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR060077, R01AR030752, R56AR030752] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Flight Attendant Medical Research Institute (FAMRI) grant; FAMRI; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This study was supported by National Institutes of Health (NIH) grants AR30752 and AR060077 to VT, and Flight Attendant Medical Research Institute (FAMRI) grant to RV. VT received some salary from AR30752 and AR060077. MS and DL received some salary from AR30752. RV received some salary from FAMRI. Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr Chella David for providing the transgenic mice and Julie Hanson and her staff for breeding and maintaining the mice. This study was supported by National Institute of Health (NIH) grants AR30752 and AR060077 to VT and Flight Attendant Medical Research Institute (FAMRI) grant to RV. VT received some salary from AR30752 and AR060077. MS and DL received some salary from AR30752. RV received some salary from FAMRI. Funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baka Z, 2011, INT IMMUNOL, V23, P405, DOI 10.1093/intimm/dxr026; Behrens M, 2010, J AUTOIMMUN, V35, P1, DOI 10.1016/j.jaut.2009.12.007; Chang K, 2014, INT J MOL SCI, V15, P22279, DOI 10.3390/ijms151222279; Chen WJ, 2010, J MOL CELL BIOL, V2, P30, DOI 10.1093/jmcb/mjp004; Claudia M, 2003, J EXP MED, V197, P489; Damgaard D, 2015, CLIN EXP RHEUMATOL, V33, P405; Damgaard D, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/s13075-014-0498-9; El-Gabalawy HS, 2004, ARTHRITIS RES THER, V6, P86, DOI 10.1186/ar1171; Esensten JH, 2009, NAT REV RHEUMATOL, V5, P560, DOI 10.1038/nrrheum.2009.183; Feitsma AL, 2010, ARTHRITIS RHEUM-US, V62, P117, DOI 10.1002/art.25059; Gonzalo-Gil E, 2014, REUMATOL CLIN, V10, P174, DOI 10.1016/j.reuma.2014.01.009; GREGERSEN PK, 1987, ARTHRITIS RHEUM, V30, P1205, DOI 10.1002/art.1780301102; Hensvold AH, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0760-9; Hsu PC, 2014, MOL CELLS, V37, P426, DOI 10.14348/molcells.2014.2359; Isomaki P, 1997, ANN MED, V29, P499, DOI 10.3109/07853899709007474; Karlson EW, 2012, RHEUM DIS CLIN N AM, V38, P405, DOI 10.1016/j.rdc.2012.04.002; Kinne RW, 2000, ARTHRITIS RES, V2, P189, DOI 10.1186/ar86; Klareskog L, 2006, ARTHRITIS RHEUM-US, V54, P38, DOI 10.1002/art.21575; Klareskog L, 2011, SEMIN IMMUNOL, V23, P92, DOI 10.1016/j.smim.2011.01.014; Lee J, 2012, J DENT RES, V91, P142, DOI 10.1177/0022034511421200; Lundstrom E, 2009, ARTHRITIS RHEUM, V60, P1597, DOI 10.1002/art.24572; Ma B, 2005, J CLIN INVEST, V115, P3460, DOI 10.1172/JCI24858; McInnes IB, 2011, NEW ENGL J MED, V365, P2205, DOI 10.1056/NEJMra1004965; Nashleanas M, 2000, INFECT IMMUN, V68, P1428, DOI 10.1128/IAI.68.3.1428-1434.2000; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Scally SW, 2013, J EXP MED, V210, P2569, DOI 10.1084/jem.20131241; Snir O, 2011, ARTHRITIS RHEUM-US, V63, P2873, DOI 10.1002/art.30445; Song YW, 2010, QJM-INT J MED, V103, P139, DOI 10.1093/qjmed/hcp165; Spadaro A, 2002, ANN RHEUM DIS, V61, P174, DOI 10.1136/ard.61.2.174; Taneja V, 2003, J IMMUNOL, V171, P4431, DOI 10.4049/jimmunol.171.8.4431; Taneja V, 2008, J IMMUNOL, V181, P2869, DOI 10.4049/jimmunol.181.4.2869; Taneja V, 2007, ARTHRITIS RHEUM-US, V56, P69, DOI 10.1002/art.22213; Taneja V, 2014, FEBS LETT, V588, P4244, DOI 10.1016/j.febslet.2014.05.034; Taneja V, 2010, IMMUNOL REV, V233, P62, DOI 10.1111/j.0105-2896.2009.00858.x; Tokayer A, 2002, J RHEUMATOL, V29, P454; van Venrooij WJ, 2008, ANN NY ACAD SCI, V1143, P268, DOI 10.1196/annals.1443.013; Vassallo R, 2014, CLIN IMMUNOL, V152, P25, DOI 10.1016/j.clim.2014.02.002; Vossenaar ER, 2004, ANN RHEUM DIS, V63, P373, DOI 10.1136/ard.2003.012211; Zanelli E, 1996, P NATL ACAD SCI USA, V93, P1814, DOI 10.1073/pnas.93.5.1814	39	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162341	10.1371/journal.pone.0162341	http://dx.doi.org/10.1371/journal.pone.0162341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602574	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200058
J	Du, H; Lv, P; Ayouz, M; Besserer, A; Perre, P				Du, Huan; Lv, Pin; Ayouz, Mehdi; Besserer, Arnaud; Perre, Patrick			Morphological Characterization and Quantification of the Mycelial Growth of the Brown-Rot Fungus Postia placenta for Modeling Purposes	PLOS ONE			English	Article							SCANNING CONFOCAL MICROSCOPY; HYPHAL GROWTH; PHYSISPORINUS-VITREUS; VESICLE TRAFFICKING; NEUROSPORA-CRASSA; FILAMENTOUS FUNGI; FLUORESCENT DYES; WOOD-DECAY; VISUALIZATION; DYNAMICS	Continuous observation was performed using confocal laser scanning microscopy to visualize the three-dimensional microscopic growth of the brown-rot fungus, Postia placenta, for seventeen days. The morphological characterization of Postia placenta was quantitatively determined, including the tip extension rate, branch angle and branching length, (hyphal length between two adjacent branch sites). A voxel method has been developed to measure the growth of the biomass. Additionally, the tip extension rate distribution, the branch angle distribution and the branching length distribution, which quantified the hyphal growth characteristics, were evaluated. Statistical analysis revealed that the extension rate of tips was randomly distributed in space. The branch angle distribution did not change with the development of the colony, however, the branching length distribution did vary with the development of the colony. The experimental data will be incorporated into a lattice-based model simulating the growth of Postia placenta.	[Du, Huan; Lv, Pin; Ayouz, Mehdi; Perre, Patrick] Univ Paris Saclay, Cent Supelec, LGPM, F-92290 Chatenay Malabry, France; [Besserer, Arnaud] Univ Lorraine, ENSTIB LERMAB, F-88000 Epinal, France	UDICE-French Research Universities; Universite Paris Saclay; Universite de Lorraine	Perre, P (corresponding author), Univ Paris Saclay, Cent Supelec, LGPM, F-92290 Chatenay Malabry, France.	patrick.perre@centralesupelec.fr	LV, PIN/AAT-7107-2020; Perre, Patrick/F-6150-2011; Perré, Patrick/AAC-6354-2020	Perre, Patrick/0000-0003-0419-4810; Perré, Patrick/0000-0003-0419-4810; DU, HUAN/0000-0002-0020-149X	LabeX LaSIPS [ANR-10-LABX-0040-LaSIPS]; French National Research Agency under the "Investissements d'avenir" program [ANR-11-IDEX-0003-02]; China Scholarship Council (CSC)	LabeX LaSIPS; French National Research Agency under the "Investissements d'avenir" program(French National Research Agency (ANR)); China Scholarship Council (CSC)(China Scholarship Council)	This work was financially supported by the LabeX LaSIPS (ANR-10-LABX-0040-LaSIPS), managed by the French National Research Agency (ANR - http://www.agence-nationale-recherche.fr/) under the "Investissements d'avenir" program (no ANR-11-IDEX-0003-02). Grant holder was PP. This work was also financially supported by the China Scholarship Council (CSC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x; Boswell Graeme P., 2012, Fungal Biology Reviews, V26, P30, DOI 10.1016/j.fbr.2012.02.002; de Ulzurrun GVD, 2015, FUNGAL GENET BIOL, V84, P12, DOI 10.1016/j.fgb.2015.09.004; Dickson S, 1999, MYCORRHIZA, V9, P205, DOI 10.1007/s005720050268; Dijksterhuis J, 2003, PROTOPLASMA, V222, P53, DOI 10.1007/s00709-003-0006-6; Eriksson K.-E., 1990, MICROBIAL ENZYMATIC; Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Fuhr MJ, 2011, FUNGAL BIOL-UK, V115, P919, DOI 10.1016/j.funbio.2011.06.017; Gonzalez JM, 2012, WOOD FIBER SCI, V44, P343; Goodell B, 1997, J BIOTECHNOL, V53, P133, DOI 10.1016/S0168-1656(97)01681-7; Harris SD, 2008, MYCOLOGIA, V100, P823, DOI 10.3852/08-177; Heaton LLM, 2010, P ROY SOC B-BIOL SCI, V277, P3265, DOI 10.1098/rspb.2010.0735; Hickey PC, 2005, METHOD MICROBIOL, V34, P63, DOI 10.1016/S0580-8517(04)3403-1; Hickey PC, 2002, FUNGAL GENET BIOL, V37, P109, DOI 10.1016/S1087-1845(02)00035-X; Hoch HC, 2005, MYCOLOGIA, V97, P580, DOI 10.3852/mycologia.97.3.580; HUTCHINSON SA, 1980, T BRIT MYCOL SOC, V75, P177, DOI 10.1016/S0007-1536(80)80078-7; Jacobs H, 2002, FEMS MICROBIOL ECOL, V40, P65, DOI 10.1111/j.1574-6941.2002.tb00937.x; JIN L, 1990, HOLZFORSCHUNG, V44, P133, DOI 10.1515/hfsg.1990.44.2.133; JONES CL, 1993, APPL MICROBIOL BIOT, V39, P242; Kim KW, 2009, MICRON, V40, P519, DOI 10.1016/j.micron.2009.04.006; Koch AP, 1985, WOOD DECAY DANISH BU; Meletiadis J, 2001, J CLIN MICROBIOL, V39, P478, DOI 10.1128/JCM.39.2.478-484.2001; Refshauge S, 2006, NEW PHYTOL, V172, P369, DOI 10.1111/j.1469-8137.2006.01825.x; RITZ K, 1990, MYCOL RES, V94, P1138, DOI 10.1016/S0953-7562(09)81346-4; Sampson KN, 2003, MICROBIOL-SGM, V149, P3111, DOI 10.1099/mic.0.26509-0; Schmidt O, 2005, WOOD AND TREE FUNGI; Schubert M, 2014, HOLZFORSCHUNG, V68, P727, DOI 10.1515/hf-2013-0183; Schweiger PF, 2002, MYCOL RES, V106, P349, DOI 10.1017/S0953756202005579; Vierheilig H, 2001, CAN J BOT, V79, P231, DOI 10.1139/cjb-79-2-231; Viitanen H., 1991, BROWN ROT DECAY WOOD; Villena GK, 2010, BIORESOURCE TECHNOL, V101, P1920, DOI 10.1016/j.biortech.2009.10.036; Wadso L, 2013, ENG LIFE SCI, V13, P536, DOI 10.1002/elsc.201200096; WALLIS JW, 1990, J NUCL MED, V31, P1421; Wilcox WW, 1997, WOOD FIBER SCI, V29, P291; Xie Y, 1997, HOLZFORSCHUNG, V51, P201, DOI 10.1515/hfsg.1997.51.3.201; Yelle DJ, 2011, ENVIRON MICROBIOL, V13, P1091, DOI 10.1111/j.1462-2920.2010.02417.x	37	10	10	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162469	10.1371/journal.pone.0162469	http://dx.doi.org/10.1371/journal.pone.0162469			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602575	Green Published, gold			2022-12-26	WOS:000383255200068
J	Lorenzo, D; Duarte, A; Mundiano, J; Berguer, P; Nepomnaschy, I; Piazzon, I				Lorenzo, Daniela; Duarte, Alejandra; Mundiano, Juliana; Berguer, Paula; Nepomnaschy, Irene; Piazzon, Isabel			A B-Cell Superantigen Induces the Apoptosis of Murine and Human Malignant B Cells	PLOS ONE			English	Article							STAPHYLOCOCCAL-ENTEROTOXIN-B; IN-VIVO; PROTEIN-L; CUTTING EDGE; T-CELLS; BIM; ACTIVATION; BCL-2; BAX; DELETION	B-cell superantigens (Sags) bind to conserved sites of the VH or VL regions of immunoglobulin molecules outside their complementarity-determining regions causing the apoptosis of normal cognate B cells. No attempts to investigate whether B-cell Sags are able to induce the apoptosis of cognate malignant B cells were reported. In the present study we show that protein L (PpL), secreted by Finegoldia magna, a B-cell Sag which interacts with kappa+ bearing cells, induces the apoptosis of murine and human kappa+ lymphoma B cells both in vitro and in vivo. Apoptosis was not altered by caspase-8 inhibitor. No alterations in the levels of Bid, Fas and Fas-L were found suggesting that PpL does not activate the extrinsic pathway of apoptosis. The involvement of the intrinsic pathway was clearly indicated by: i) alterations in mitochondrial membrane potential (Iota psi m) both in murine and human lymphoma cells exposed to PpL; ii) decreased levels of apoptosis in the presence of caspase-9 inhibitor; iii) significant increases of Bim and Bax protein levels and downregulation of Bcl-2; iv) the translocation from the cytoplasm to the mitochondria of Bax and Bim pro-apoptotic proteins and its inhibition by caspase-9 inhibitor but not by caspase-8 inhibitor and v) the translocation of Bcl-2 protein from the mitochondria to the cytosol and its inhibition by caspase-9 inhibitor but not by caspase-8 inhibitor. The possibility of a therapeutic use of Sags in lymphoma/leukemia B cell malignancies is discussed.	[Lorenzo, Daniela; Duarte, Alejandra; Mundiano, Juliana; Nepomnaschy, Irene; Piazzon, Isabel] Acad Nacl Med Buenos Aires, IMEX CONICET, Caba, Argentina; [Berguer, Paula] Consejo Nacl Invest Cient & Tecn, IIBBA, Fdn Inst Leloir, Buenos Aires, DF, Argentina	Buenos Aires National Academy of Medicine; IMEX - Instituto de Medicina Experimental; Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); Leloir Institute	Piazzon, I (corresponding author), Acad Nacl Med Buenos Aires, IMEX CONICET, Caba, Argentina.	ipiazzon@yahoo.com	Berguer, Paula/AAI-6353-2020		Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET) [PIP 2494, PIP 0614]; Fundacion para la Lucha contra la Leucemia (FUNDALEU)	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Fundacion para la Lucha contra la Leucemia (FUNDALEU)	This work was supported by grants from Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET), www.conicet.gov.ar, PIP 2494 to IP, PIP 0614 to IP, and Fundacion para la Lucha contra la Leucemia (FUNDALEU), www.fundaleu.org, to IP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERBERIAN L, 1993, SCIENCE, V261, P1588, DOI 10.1126/science.7690497; Biswas SC, 2002, J BIOL CHEM, V277, P49511, DOI 10.1074/jbc.M208086200; BJORCK L, 1988, J IMMUNOL, V140, P1194; Bomben R, 2010, CLIN CANCER RES, V16, P620, DOI 10.1158/1078-0432.CCR-09-1638; Bouillet P, 2002, NATURE, V415, P922, DOI 10.1038/415922a; Brown JM, 2005, NAT REV CANCER, V5, P231, DOI 10.1038/nrc1560; Cartron PF, 2003, MOL CELL BIOL, V23, P4701, DOI 10.1128/MCB.23.13.4701-4712.2003; Danial NN, 2007, CLIN CANCER RES, V13, P7254, DOI 10.1158/1078-0432.CCR-07-1598; Dimmeler S, 1999, J EXP MED, V189, P1815, DOI 10.1084/jem.189.11.1815; DomiatiSaad R, 1996, J IMMUNOL, V156, P3608; ENGEL P, 1994, BLOOD, V84, P1402, DOI 10.1182/blood.V84.5.1402.bloodjournal8451402; Genovese A, 2003, J IMMUNOL, V170, P1854, DOI 10.4049/jimmunol.170.4.1854; Gidlof C, 1997, BLOOD, V89, P2089, DOI 10.1182/blood.V89.6.2089; Goodyear CS, 2007, J IMMUNOL, V178, P2636, DOI 10.4049/jimmunol.178.5.2636; Goodyear CS, 2004, J IMMUNOL, V172, P2870, DOI 10.4049/jimmunol.172.5.2870; Goodyear CS, 2003, J EXP MED, V197, P1125, DOI 10.1084/jem.20020552; Hockings C, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.105; Housden NG, 2003, BIOCHEM SOC T, V31, P716, DOI 10.1042/BST0310716; Ingulli Elizabeth, 2007, Methods Mol Biol, V380, P365; Johnstone RW, 2002, CELL, V108, P153, DOI 10.1016/S0092-8674(02)00625-6; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; KIM KJ, 1979, J IMMUNOL, V122, P549; KIM KJ, 1978, J IMMUNOL, V121, P339; KLEIN E, 1968, CANCER RES, V28, P1300; Kostareli E, 2009, LEUKEMIA, V23, P919, DOI 10.1038/leu.2008.379; Kozlowski LM, 1996, J IMMUNOL, V157, P1200; LEVINSON AI, 1995, J CLIN IMMUNOL, V15, pS26, DOI 10.1007/BF01540891; MARRACK P, 1990, J EXP MED, V171, P455, DOI 10.1084/jem.171.2.455; Mundinano J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015694; NEWELL KA, 1991, P NATL ACAD SCI USA, V88, P1074, DOI 10.1073/pnas.88.3.1074; Badano MN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061347; Perabo FG, 2005, INT J CANCER, V115, P591, DOI 10.1002/ijc.20941; Renno T, 1999, J IMMUNOL, V162, P6312; Sarosiek KA, 2013, MOL CELL, V51, P751, DOI 10.1016/j.molcel.2013.08.048; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; SILVERMAN GJ, 1995, J CLIN INVEST, V96, P417, DOI 10.1172/JCI118051; Silverman GJ, 1997, IMMUNOL TODAY, V18, P379, DOI 10.1016/S0167-5699(97)01101-8; Sundstedt A, 2009, INT IMMUNOPHARMACOL, V9, P1063, DOI 10.1016/j.intimp.2009.04.013; Viau M, 2004, IMMUNOL LETT, V92, P91, DOI 10.1016/j.imlet.2003.10.016; Viau M, 2004, INFECT IMMUN, V72, P3515, DOI 10.1128/IAI.72.6.3515-3523.2004	40	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162456	10.1371/journal.pone.0162456	http://dx.doi.org/10.1371/journal.pone.0162456			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603942	Green Published, gold			2022-12-26	WOS:000383255200067
J	Marques, LM; Rezende, IS; Barbosa, MS; Guimaraes, AMS; Martins, HB; Campos, GB; do Nascimento, NC; dos Santos, AP; Amorim, AT; Santos, VM; Farias, ST; Barrence, FAC; de Souza, LM; Buzinhani, M; Arana-Chavez, VE; Zenteno, ME; Amarante-Mendes, GP; Messick, JB; Timenetsky, J				Marques, Lucas M.; Rezende, Izadora S.; Barbosa, Maysa S.; Guimaraes, Ana M. S.; Martins, Hellen B.; Campos, Guilherme B.; do Nascimento, Naila C.; dos Santos, Andrea P.; Amorim, Aline T.; Santos, Verena M.; Farias, Savio T.; Barrence, Fernanda A. C.; de Souza, Lauro M.; Buzinhani, Melissa; Arana-Chavez, Victor E.; Zenteno, Maria E.; Amarante-Mendes, Gustavo P.; Messick, Joanne B.; Timenetsky, Jorge			Ureaplasma diversum Genome Provides New Insights about the Interaction of the Surface Molecules of This Bacterium with the Host	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; MYCOPLASMA-GALLISEPTICUM; EXPERIMENTAL-INFECTION; PHYLOGENETIC ANALYSIS; NUCLEASE ACTIVITIES; CYTOTOXIC NUCLEASE; SIGNAL PEPTIDES; UREALYTICUM; VIRULENCE; LIPOPROTEINS	Whole genome sequencing and analyses of Ureaplasma diversum ATCC 49782 was undertaken as a step towards understanding U. diversum biology and pathogenicity. The complete genome showed 973,501 bp in a single circular chromosome, with 28.2% of G+C content. A total of 782 coding DNA sequences (CDSs), and 6 rRNA and 32 tRNA genes were predicted and annotated. The metabolic pathways are identical to other human urea-plasmas, including the production of ATP via hydrolysis of the urea. Genes related to pathogenicity, such as urease, phospholipase, hemolysin, and a Mycoplasma Ig binding protein (MIB)-Mycoplasma Ig protease (MIP) system were identified. More interestingly, a large number of genes (n = 40) encoding surface molecules were annotated in the genome (lipoproteins, multiple-banded antigen like protein, membrane nuclease lipoprotein and variable surface antigens lipoprotein). In addition, a gene encoding glycosyltransferase was also found. This enzyme has been associated with the production of capsule in mycoplasmas and ureaplasma. We then sought to detect the presence of a capsule in this organism. A polysaccharide capsule from 11 to 17 nm of U. diversum was observed trough electron microscopy and using specific dyes. This structure contained arabinose, xylose, mannose, galactose and glucose. In order to understand the inflammatory response against these surface molecules, we evaluated the response of murine macrophages J774 against viable and non-viable U. diversum. As with viable bacteria, non-viable bacteria were capable of promoting a significant inflammatory response by activation of Toll like receptor 2 (TLR2), indicating that surface molecules are important for the activation of inflammatory response. Furthermore, a cascade of genes related to the inflammasome pathway of macrophages was also up-regulated during infection with viable organisms when compared to noninfected cells. In conclusion, U. diversum has a typical ureaplasma genome and metabolism, and its surface molecules, including the identified capsular material, represent major components of the organism immunopathogenesis.	[Marques, Lucas M.; Rezende, Izadora S.; Barbosa, Maysa S.; Campos, Guilherme B.; Amorim, Aline T.; Santos, Verena M.; Buzinhani, Melissa; Timenetsky, Jorge] Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil; [Marques, Lucas M.; Rezende, Izadora S.; Barbosa, Maysa S.; Martins, Hellen B.] Univ Fed Bahia, Multidisciplinary Inst Hlth, Vitoria Da Conquista, Brazil; [Marques, Lucas M.; Martins, Hellen B.] Univ Santa Cruz UESC, Campus Soane Nazare de Andrade, Iheus, Brazil; [Guimaraes, Ana M. S.] Univ Sao Paulo, Coll Vet Med & Anim Sci, Dept Anim Hlth & Prevent Vet Med, Sao Paulo, Brazil; [Guimaraes, Ana M. S.; do Nascimento, Naila C.; dos Santos, Andrea P.; Messick, Joanne B.] Purdue Univ, Dept Comparat Pathobiol, W Lafayette, IN 47907 USA; [Farias, Savio T.] Univ Fed Paraiba, Evolutionary Genet Lab, Dept Mol Biol, Joao Pessoa, Paraiba, Brazil; [Barrence, Fernanda A. C.; Arana-Chavez, Victor E.] Univ Sao Paulo, Lab Biol Mineralized Tissues, Inst Biomed Sci, Sao Paulo, Brazil; [de Souza, Lauro M.] Inst Pesquisa Pele Pequeno Principe, Fac Pequeno Principe, Curitiba, Parana, Brazil; [Arana-Chavez, Victor E.] Univ Sao Paulo, Dept Dent Mat, Sch Dent, Sao Paulo, Brazil; [Zenteno, Maria E.; Amarante-Mendes, Gustavo P.] Univ Sao Paulo, Lab Cellular & Mol Biol, Inst Biomed Sci, Sao Paulo, Brazil	Universidade de Sao Paulo; Universidade Federal da Bahia; Universidade de Sao Paulo; Purdue University System; Purdue University; Purdue University West Lafayette Campus; Universidade Federal da Paraiba; Universidade de Sao Paulo; Hospital Pequeno Principe; Universidade de Sao Paulo; Universidade de Sao Paulo	Marques, LM (corresponding author), Univ Sao Paulo, Inst Biomed Sci, Dept Microbiol, Sao Paulo, Brazil.; Marques, LM (corresponding author), Univ Fed Bahia, Multidisciplinary Inst Hlth, Vitoria Da Conquista, Brazil.; Marques, LM (corresponding author), Univ Santa Cruz UESC, Campus Soane Nazare de Andrade, Iheus, Brazil.	lucasm@ufba.br	Mendes, Gustavo P Amarante/C-8187-2012; Souza, Lauro/AAE-3273-2019; Marques, Lucas M/L-2507-2018; dos Santos, Andrea Pires/O-5371-2019; Silva, Lucas/GQH-8201-2022; Guimaraes, Ana M. S./N-5603-2016; AMORIM, ALINE TEIXEIRA/H-3026-2016	Mendes, Gustavo P Amarante/0000-0002-7851-6205; Souza, Lauro/0000-0001-9166-2146; Marques, Lucas M/0000-0002-8276-8149; dos Santos, Andrea Pires/0000-0002-1037-970X; AMORIM, ALINE TEIXEIRA/0000-0003-2597-8665; Cannes do Nascimento, Naila/0000-0001-6233-2447	FAPESB [APP0097/2009]; FAPESP [2012/00719-2]; PROPI/UFBA [01/2013]	FAPESB(Fundacao de Amparo a Pesquisa do Estado da Bahia (FAPESB)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); PROPI/UFBA	This study was supported by FAPESB (No APP0097/2009) (Lucas Miranda Marques), FAPESP (2012/00719-2) (Jorge Timenetsky) and PROPI/UFBA (01/2013) (Lucas Miranda Marques). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMEIDA RA, 1992, INFECT IMMUN, V60, P2914, DOI 10.1128/IAI.60.7.2914-2919.1992; ALMEIDA RA, 1991, INFECT IMMUN, V59, P3119, DOI 10.1128/IAI.59.9.3119-3125.1991; Amorim AT, 2014, BIOL RES, V47, DOI 10.1186/0717-6287-47-38; Arfi Y, 2016, P NATL ACAD SCI USA, V113, P5406, DOI 10.1073/pnas.1600546113; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Bertin C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068373; BLANCHARD A, 1988, J BACTERIOL, V170, P2692, DOI 10.1128/jb.170.6.2692-2697.1988; BRITTON AP, 1987, CAN J VET RES, V51, P198; BRITTON AP, 1989, CAN J VET RES, V53, P172; Browning GF, 2011, VET MICROBIOL, V153, P44, DOI 10.1016/j.vetmic.2011.05.031; Buchenau I, 2010, RES VET SCI, V89, P223, DOI 10.1016/j.rvsc.2010.03.014; Buzinhani M, 2007, VET J, V173, P688, DOI 10.1016/j.tvjl.2006.02.001; Buzinhani Melissa, 2011, BMC Res Notes, V4, P455, DOI 10.1186/1756-0500-4-455; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Chambaud I, 1999, TRENDS MICROBIOL, V7, P493, DOI 10.1016/S0966-842X(99)01641-8; Chambaud I, 2001, NUCLEIC ACIDS RES, V29, P2145, DOI 10.1093/nar/29.10.2145; Chelmonska-Soyta A, 1994, CAN J VET RES, V58, P275; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; Crabtree Jonathan, 2007, V408, P93, DOI 10.1007/978-1-59745-547-3_6; Dando SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029856; DeSilva NS, 1999, MOL CELL BIOCHEM, V201, P159, DOI 10.1023/A:1007082507407; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; DOIG PA, 1980, CAN J COMP MED, V44, P252; Galens K, 2011, STAND GENOMIC SCI, V4, P244, DOI 10.4056/sigs.1223234; Garcia J, MYCOPLASMA FERMENTAN, P34391; Glass JI, 2001, TRENDS MICROBIOL, V9, P163, DOI 10.1016/S0966-842X(01)01951-5; Glass JI, 2000, NATURE, V407, P757, DOI 10.1038/35037619; GOEBEL W, 1988, A VAN LEEUW J MICROB, V54, P453, DOI 10.1007/BF00461864; Guimaraes AMS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091445; Guimaraes AMS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019574; Harasawa R, 1996, INT J SYST BACTERIOL, V46, P827, DOI 10.1099/00207713-46-3-827; Harasawa R, 1996, J VET MED SCI, V58, P191, DOI 10.1292/jvms.58.191; Harris JK, 2003, GENOME RES, V13, P407, DOI 10.1101/gr.652803; Hobson N, 2013, AUST VET J, V91, P469, DOI 10.1111/avj.12113; HOWARD CJ, 1973, J HYG-CAMBRIDGE, V71, P163, DOI 10.1017/S0022172400046337; Hyatt D, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-119; Inoue R, 2011, FEMS IMMUNOL MED MIC, V61, P94, DOI 10.1111/j.1574-695X.2010.00752.x; Juncker AS, 2003, PROTEIN SCI, V12, P1652, DOI 10.1110/ps.0303703; Kacerovsky M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060399; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; KIM JJ, 1994, INFECT IMMUN, V62, P1528, DOI 10.1128/IAI.62.5.1528-1533.1994; Klement MLR, 2007, MOL MICROBIOL, V65, P1444, DOI 10.1111/j.1365-2958.2007.05865.x; Kokkayil P, 2015, INDIAN J MED MICROBI, V33, P205, DOI 10.4103/0255-0857.154850; KREPLIN CMA, 1987, CAN J VET RES, V51, P440; LI Y, 2011, EURASIP J WIREL COMM, V2011, P1, DOI DOI 10.1093/ECAM/NEQ044; Li YH, 2000, INFECT IMMUN, V68, P7087, DOI 10.1128/IAI.68.12.7087-7093.2000; Li YH, 2000, PEDIATR RES, V48, P114, DOI 10.1203/00006450-200007000-00020; Lien E, 1999, J BIOL CHEM, V274, P33419, DOI 10.1074/jbc.274.47.33419; LIGON JV, 1991, INFECT IMMUN, V59, P1170, DOI 10.1128/IAI.59.3.1170-1171.1991; LLOYD LC, 1971, J MED MICROBIOL, V4, P425, DOI 10.1099/00222615-4-4-425; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; MANILOFF J, 1972, BACTERIOL REV, V36, P263, DOI 10.1128/MMBR.36.3.263-290.1972; Marques LM, 2011, VET MICROBIOL, V152, P205, DOI 10.1016/j.vetmic.2011.04.007; Marques LM, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-83; Masukagami Y, 2013, INFECT IMMUN, V81, P3220, DOI 10.1128/IAI.00365-13; MILLER RB, 1983, THERIOGENOLOGY, V20, P367, DOI 10.1016/0093-691X(83)90071-7; MINION FC, 1986, INFECT IMMUN, V51, P352, DOI 10.1128/IAI.51.1.352-354.1986; MINION FC, 1993, J BACTERIOL, V175, P7842, DOI 10.1128/JB.175.24.7842-7847.1993; Neyrolles O, 1996, J BACTERIOL, V178, P2725, DOI 10.1128/jb.178.9.2725-2725.1996; Noormohammadi AH, 2000, MOL MICROBIOL, V35, P911, DOI 10.1046/j.1365-2958.2000.01766.x; Paralanov V, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-88; Peltier MR, 2007, AM J REPROD IMMUNOL, V57, P186, DOI 10.1111/j.1600-0897.2006.00460.x; Pollack JD, 2001, TRENDS MICROBIOL, V9, P169, DOI 10.1016/S0966-842X(01)01950-3; Rao Xiayu, 2013, Biostat Bioinforma Biomath, V3, P71; Rawadi G, 2000, MICROBES INFECT, V2, P955, DOI 10.1016/S1286-4579(00)00395-6; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Robinson JW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062746; ROMANO N, 1976, J BACTERIOL, V128, P170, DOI 10.1128/JB.128.1.170-173.1976; Rottem S, 2003, PHYSIOL REV, V83, P417, DOI 10.1152/physrev.00030.2002; RUHNKE HL, 1978, CAN J COMP MED, V42, P151; RUHNKE HL, 1984, THERIOGENOLOGY, V21, P295, DOI 10.1016/0093-691X(84)90415-1; Sachs G, 2006, J MEMBRANE BIOL, V212, P71, DOI 10.1007/s00232-006-0867-7; Sacht G, 1998, EUR J IMMUNOL, V28, P4207, DOI 10.1002/(SICI)1521-4141(199812)28:12<4207::AID-IMMU4207>3.0.CO;2-R; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Santos AP, 2011, VET RES, V42, DOI 10.1186/1297-9716-42-102; Silva JR, 2016, AN ACAD BRAS CIENC, V88, P643, DOI 10.1590/0001-3765201620150244; SMITH DGE, 1993, J BACTERIOL, V175, P3253, DOI 10.1128/jb.175.11.3253-3258.1993; Somarajan SR, 2010, CELL MICROBIOL, V12, P1821, DOI 10.1111/j.1462-5822.2010.01513.x; Sugiyama M, 2016, MOL ORAL MICROBIOL, V31, P259, DOI 10.1111/omi.12117; TAJIMA M, 1982, INFECT IMMUN, V36, P830, DOI 10.1128/IAI.36.2.830-833.1982; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Viscardi RM, 2014, ARCH DIS CHILD-FETAL, V99, pF87, DOI 10.1136/archdischild-2012-303351; Waite ER, 2002, J COMP PATHOL, V126, P171, DOI 10.1053/jcpa.2001.0540; Xu J, 2015, APPL MICROBIOL BIOT, V99, P1859, DOI 10.1007/s00253-014-6185-6; Xu YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077955; You Xiao-xing, 2006, J Zhejiang Univ Sci B, V7, P342, DOI 10.1631/jzus.2006.B0342; Yus E, 2009, SCIENCE, V326, P1263, DOI 10.1126/science.1177263; ZHENG XT, 1995, INFECT IMMUN, V63, P891, DOI 10.1128/IAI.63.3.891-898.1995; Zuo LL, 2009, J ZHEJIANG UNIV-SC B, V10, P67, DOI 10.1631/jzus.B0820256	89	18	18	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161926	10.1371/journal.pone.0161926	http://dx.doi.org/10.1371/journal.pone.0161926			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603136	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200030
J	Kim, J; Wang, J; Wedell, DH; Shinkareva, SV				Kim, Jongwan; Wang, Jing; Wedell, Douglas H.; Shinkareva, Svetlana V.			Identifying Core Affect in Individuals from fMRI Responses to Dynamic Naturalistic Audiovisual Stimuli	PLOS ONE			English	Article							MULTISENSORY INTEGRATION; NEURAL REPRESENTATIONS; PATTERN-CLASSIFICATION; FACIAL EXPRESSIONS; EMOTIONAL AROUSAL; MUSICAL EMOTIONS; VALENCE; ACTIVATION; BRAIN; PERCEPTION	Recent research has demonstrated that affective states elicited by viewing pictures varying in valence and arousal are identifiable from whole brain activation patterns observed with functional magnetic resonance imaging (fMRI). Identification of affective states from more naturalistic stimuli has clinical relevance, but the feasibility of identifying these states on an individual trial basis from fMRI data elicited by dynamic multimodal stimuli is unclear. The goal of this study was to determine whether affective states can be similarly identified when participants view dynamic naturalistic audiovisual stimuli. Eleven participants viewed 5s audiovisual clips in a passive viewing task in the scanner. Valence and arousal for individual trials were identified both within and across participants based on distributed patterns of activity in areas selectively responsive to audiovisual naturalistic stimuli while controlling for lower level features of the stimuli. In addition, the brain regions identified by searchlight analyses to represent valence and arousal were consistent with previously identified regions associated with emotion processing. These findings extend previous results on the distributed representation of affect to multimodal dynamic stimuli.	[Kim, Jongwan; Wedell, Douglas H.; Shinkareva, Svetlana V.] Univ South Carolina, Dept Psychol, Columbia, SC 29208 USA; [Wang, Jing] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA	University of South Carolina System; University of South Carolina Columbia; Carnegie Mellon University	Shinkareva, SV (corresponding author), Univ South Carolina, Dept Psychol, Columbia, SC 29208 USA.	shinkareva@sc.edu		Kim, Jongwan/0000-0003-1316-1041; Shinkareva, Svetlana/0000-0001-5112-4829	Social Sciences Grant Program, Office of the Provost, University of South Carolina	Social Sciences Grant Program, Office of the Provost, University of South Carolina	This work was funded in part by the Social Sciences Grant Program, Office of the Provost, University of South Carolina, awarded to SVS and DHW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdi H, 2012, WILEY INTERDISCIPLIN, DOI DOI 10.1016/J.NEUROIMAGE.2010.10.011; Ambadar Z, 2005, PSYCHOL SCI, V16, P403, DOI 10.1111/j.0956-7976.2005.01548.x; Anders S, 2008, SOC COGN AFFECT NEUR, V3, P233, DOI 10.1093/scan/nsn017; Anderson AK, 2003, NAT NEUROSCI, V6, P196, DOI 10.1038/nn1001; Atkinson AP, 2004, PERCEPTION, V33, P717, DOI 10.1068/p5096; Barrett LF, 2011, CURR DIR PSYCHOL SCI, V20, P286, DOI 10.1177/0963721411422522; Baucom LB, 2012, NEUROIMAGE, V59, P718, DOI 10.1016/j.neuroimage.2011.07.037; Beauchamp MS, 2004, NEURON, V41, P809, DOI 10.1016/S0896-6273(04)00070-4; Bertelson P, 2004, CROSSMODAL SPACE CRO, P141, DOI DOI 10.1093/ACPROF:OSO/9780198524861.003.0007; Bishop C. M, 2006, PATTERN RECOGNITION; Bradley M., 1999, INT AFFECTIVE DIGITI; Bradley MM, 2000, PSYCHOPHYSIOLOGY, V37, P204, DOI 10.1111/1469-8986.3720204; Brosnan M, 2015, J AUTISM DEV DISORD, V45, P1785, DOI 10.1007/s10803-014-2338-9; Cacioppo J.T., 2000, HDB EMOTIONS, P173, DOI DOI 10.1017/CBO9780511546396.025; CARROLL JD, 1970, PSYCHOMETRIKA, V35, P283, DOI 10.1007/BF02310791; Chikazoe J, 2014, NAT NEUROSCI, V17, P1114, DOI 10.1038/nn.3749; Coutinho E, 2011, EMOTION, V11, P921, DOI 10.1037/a0024700; Daselaar SM, 2008, CEREB CORTEX, V18, P217, DOI 10.1093/cercor/bhm048; De Gelder B, 2003, TRENDS COGN SCI, V7, P460, DOI 10.1016/j.tics.2003.08.014; de Gelder B, 2005, SCHIZOPHR RES, V72, P195, DOI 10.1016/j.schres.2004.02.013; de Gelder B, 1999, NEUROREPORT, V10, P3759, DOI 10.1097/00001756-199912160-00007; de Jong JJ, 2010, SCHIZOPHR RES, V122, P136, DOI 10.1016/j.schres.2010.04.010; Erez J, 2015, CEREB CORTEX; Ethofer T, 2009, CURR BIOL, V19, P1028, DOI 10.1016/j.cub.2009.04.054; Etzel JA, 2013, NEUROIMAGE, V78, P261, DOI 10.1016/j.neuroimage.2013.03.041; Fossati P, 2003, AM J PSYCHIAT, V160, P1938, DOI 10.1176/appi.ajp.160.11.1938; FOX PT, 1985, ANN NEUROL, V17, P303, DOI 10.1002/ana.410170315; Gabrielsson A., 2001, MUSIC EMOTION THEORY, P223, DOI DOI 10.1525/MP.2004.21.4.561; Garrido-Vasquez P, 2011, SOC NEUROSCI-UK, V6, P515, DOI 10.1080/17470919.2011.620771; GERRARDSHESSE A, 1994, BRIT J PSYCHOL, V85, P55, DOI 10.1111/j.2044-8295.1994.tb02508.x; Gomez P, 2004, INT J PSYCHOPHYSIOL, V53, P91, DOI 10.1016/j.ijpsycho.2004.02.002; GROSS JJ, 1995, COGNITION EMOTION, V9, P87, DOI 10.1080/02699939508408966; Habes I, 2013, NEUROIMAGE-CLIN, V2, P675, DOI 10.1016/j.nicl.2013.05.001; Hahn T, 2011, ARCH GEN PSYCHIAT, V68, P361, DOI 10.1001/archgenpsychiatry.2010.178; Haller S, 2006, EUR J NEUROSCI, V24, P2672, DOI 10.1111/j.1460-9568.2006.05147.x; Harry B, 2013, EMOTIONAL EXPRESSION; Hasson U, 2010, TRENDS COGN SCI, V14, P40, DOI 10.1016/j.tics.2009.10.011; Henriksson L, 2015, NEUROIMAGE, V114, P275, DOI 10.1016/j.neuroimage.2015.04.026; HUBERT W, 1990, BIOL PSYCHOL, V31, P73, DOI 10.1016/0301-0511(90)90079-C; HUBERT W, 1991, INT J PSYCHOPHYSIOL, V11, P131, DOI 10.1016/0167-8760(91)90005-I; Juslin PN, 2004, J NEW MUSIC RES, V33, P217, DOI 10.1080/0929821042000317813; Kay KN, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00247; Kilts CD, 2003, NEUROIMAGE, V18, P156, DOI 10.1006/nimg.2002.1323; Kim J, 2015, J NEUROSCI, V35, P5655, DOI 10.1523/JNEUROSCI.4059-14.2015; Klasen M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00822; Klasen M, 2011, J NEUROSCI, V31, P13635, DOI 10.1523/JNEUROSCI.2833-11.2011; Kotz SA, 2013, HUM BRAIN MAPP, V34, P1971, DOI 10.1002/hbm.22041; Kragel PA, 2015, SOC COGN AFFECT NEUR, V10, P1437, DOI 10.1093/scan/nsv032; Kreifelts B, 2007, NEUROIMAGE, V37, P1445, DOI 10.1016/j.neuroimage.2007.06.020; Kriegeskorte N, 2006, P NATL ACAD SCI USA, V103, P3863, DOI 10.1073/pnas.0600244103; Lakens D, 2013, COGNITION EMOTION, V27, P1225, DOI 10.1080/02699931.2013.781501; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Lang PJ, 2008, INT AFFECTIVE PICTUR; Lewis PA, 2007, CEREB CORTEX, V17, P742, DOI 10.1093/cercor/bhk024; LINDQUIST KA, 2016, CEREB CORTEX, V26, P1910, DOI [DOI 10.1093/CERCOR/BHV001, 10.1093/cercor/bhv001]; Maddock RJ, 1997, PSYCHIAT RES-NEUROIM, V75, P1, DOI 10.1016/S0925-4927(97)00018-8; Maddock RJ, 2003, HUM BRAIN MAPP, V18, P30, DOI 10.1002/hbm.10075; Magnee MJCM, 2009, NEUROPSYCHOLOGIA, V47, P1728, DOI 10.1016/j.neuropsychologia.2009.02.012; Maurage P, 2013, EXPT CLIN USEFULNESS; Mourao-Miranda J, 2003, NEUROIMAGE, V20, P1955, DOI 10.1016/j.neuroimage.2003.08.011; Mourao-Miranda J, 2012, BIPOLAR DISORD, V14, P451, DOI 10.1111/j.1399-5618.2012.01019.x; Mourao-Miranda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029482; Park JY, 2010, CORTEX, V46, P161, DOI 10.1016/j.cortex.2008.06.008; Peelen MV, 2010, J NEUROSCI, V30, P10127, DOI 10.1523/JNEUROSCI.2161-10.2010; Pereira F, 2009, NEUROIMAGE, V45, pS199, DOI 10.1016/j.neuroimage.2008.11.007; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Pourtois G, 2000, NEUROREPORT, V11, P1329, DOI 10.1097/00001756-200004270-00036; Robins DL, 2009, BRAIN COGNITION, V69, P269, DOI 10.1016/j.bandc.2008.08.007; Rottenberg J., 2007, HDB EMOTION ELICITAT; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Russell JA, 1999, J PERS SOC PSYCHOL, V76, P805, DOI 10.1037/0022-3514.76.5.805; Russell JA, 2003, PSYCHOL REV, V110, P145, DOI 10.1037/0033-295X.110.1.145; RUSSELL JA, 1985, J PERS SOC PSYCHOL, V48, P1290, DOI 10.1037/0022-3514.48.5.1290; Sabatinelli D, 2011, NEUROIMAGE, V54, P2524, DOI 10.1016/j.neuroimage.2010.10.011; Sato W, 2004, COGNITIVE BRAIN RES, V20, P81, DOI 10.1016/j.cogbrainres.2004.01.008; Satpute A. B., 2015, BRAIN MAPPING ENCY R, P65; Shinkareva SV, 2014, HUM BRAIN MAPP, V35, P3558, DOI 10.1002/hbm.22421; Shinkareva SV, 2011, NEUROIMAGE, V54, P2418, DOI 10.1016/j.neuroimage.2010.10.042; Stelzer J, 2013, NEUROIMAGE, V65, P69, DOI 10.1016/j.neuroimage.2012.09.063; Tseng A, 2016, HUM BRAIN MAPP, V37, P443, DOI 10.1002/hbm.23041; Viinikainen M, 2012, HUM BRAIN MAPP, V33, P2295, DOI 10.1002/hbm.21362; Viinikainen M, 2010, HUM BRAIN MAPP, V31, P1030, DOI 10.1002/hbm.20915; Weisberg J, 2014, CEREB CORTEX, V24, P37, DOI 10.1093/cercor/bhs276; Wilson-Mendenhall CD, 2013, PSYCHOL SCI, V24, P947, DOI 10.1177/0956797612464242; Yuen KSL, 2012, TRANSL NEUROSCI, V3, P278, DOI 10.2478/s13380-012-0029-6; Zupan B, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829dded6	86	19	19	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161589	10.1371/journal.pone.0161589	http://dx.doi.org/10.1371/journal.pone.0161589			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598534	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800011
J	Estevinho, LM; Chambo, ED; Pereira, APR; de Carvalho, CAL; de Toledo, VDA				Estevinho, Leticia M.; Chambo, Emerson Dechechi; Rodrigues Pereira, Ana Paula; Lopes de Carvalho, Carlos Alfredo; Arnaut de Toledo, Vagner de Alencar			Characterization of Lavandula spp. Honey Using Multivariate Techniques	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; FLORAL ORIGIN MARKERS; PHYSICOCHEMICAL CHARACTERISTICS; ANTIOXIDANT CAPACITY; ORGANIC HONEY; POLLEN; LAVENDER; EUCALYPTUS; REGION; THYME	Traditionally, melissopalynological and physicochemical analyses have been the most used to determine the botanical origin of honey. However, when performed individually, these analyses may provide less unambiguous results, making it difficult to discriminate between mono and multifloral honeys. In this context, with the aim of better characterizing this beehive product, a selection of 112 Lavandula spp. monofloral honey samples from several regions were evaluated by association of multivariate statistical techniques with physicochemical, melissopalynological and phenolic compounds analysis. All honey samples fulfilled the quality standards recommended by international legislation, except regarding sucrose content and diastase activity. The content of sucrose and the percentage of Lavandula spp. pollen have a strong positive association. In fact, it was found that higher amounts of sucrose in honey are related with highest percentage of pollen of Lavandula spp.. The samples were very similar for most of the physicochemical parameters, except for proline, flavonoids and phenols (bioactive factors). Concerning the pollen spectrum, the variation of Lavandula spp. pollen percentage in honey had little contribution to the formation of samples groups. The formation of two groups regarding the physicochemical parameters suggests that the presence of other pollen types in small percentages influences the factor termed as "bioactive", which has been linked to diverse beneficial health effects.	[Estevinho, Leticia M.; Rodrigues Pereira, Ana Paula] Escola Super Agr, Inst Politecn Braganca, Dept Biol & Biotecnol, Braganca, Portugal; [Chambo, Emerson Dechechi; Lopes de Carvalho, Carlos Alfredo] Univ Fed Reconcavo Bahia, Ctr Ciencias Agr Ambientais & Biol, Cruz Das Almas, BA, Brazil; [Arnaut de Toledo, Vagner de Alencar] Univ Estadual Maringa, Dept Zootecnia, Maringa, Parana, Brazil	Instituto Politecnico de Braganca; Universidade Federal do Reconcavo da Bahia; Universidade Estadual de Maringa	Chambo, ED (corresponding author), Univ Fed Reconcavo Bahia, Ctr Ciencias Agr Ambientais & Biol, Cruz Das Almas, BA, Brazil.	chamboed@gmail.com	Estevinho, Leticia M./L-2656-2017; Pereira, Ana Paula/AAK-4584-2020; de Carvalho, Carlos Alfredo Lopes/N-6717-2019; Carvalho, Carlos A L/N-3321-2016; Arnaut de Toledo, Vagner De Alencar/I-8195-2012	Estevinho, Leticia M./0000-0002-9249-1948; de Carvalho, Carlos Alfredo Lopes/0000-0002-3306-3003; Carvalho, Carlos A L/0000-0002-3306-3003; Arnaut de Toledo, Vagner De Alencar/0000-0003-1814-9703; Pereira, Ana Paula/0000-0003-1489-5207	CAPES [88887.116238/2016-00]	CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	Funding for the present study was provided by CAPES (http://www.capes.gov.br/), process number 88887.116238/2016-00. The authors declare that this entity had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Anklam E, 2001, AM LAB, V33, P60; [Anonymous], 2014, R LANG ENV STAT COMP; Aoac, 1997, OFFICIAL METHODS ANA, DOI DOI 10.1016/0165-9936(90)87098-7; Baroni MV, 2006, J AGR FOOD CHEM, V54, P7235, DOI 10.1021/jf061080e; Finco FDBA, 2010, CIENCIA TECNOL ALIME, V30, P706, DOI 10.1590/S0101-20612010000300022; Bianchi F, 2005, FOOD CHEM, V89, P527, DOI 10.1016/j.foodchem.2004.03.009; Bocard D., 2011, NUMERICAL ECOLOGY R; Bogdanov S., 1997, APIDOLOGIE, P1, DOI DOI 10.1007/S13398-014-0173-7.2; Borcard D, 2011, USE R, P1, DOI 10.1007/978-1-4419-7976-6; Bouseta A, 1996, J FOOD SCI, V61, P683, DOI 10.1111/j.1365-2621.1996.tb12181.x; Castro-Vazquez L, 2009, FOOD CHEM, V112, P1022, DOI 10.1016/j.foodchem.2008.06.036; Castro-Vazquez L, 2014, FOOD CONTROL, V37, P362, DOI 10.1016/j.foodcont.2013.09.003; Ciappini MC, 2014, J APIC SCI, V58, P103, DOI 10.2478/JAS-2014-0010; Cordella CBY, 2003, J AGR FOOD CHEM, V51, P3234, DOI 10.1021/jf021100m; de la Fuente E, 2005, J SEP SCI, V28, P1093, DOI 10.1002/jssc.200500018; de la Fuente E, 2011, FOOD CHEM, V129, P1483, DOI 10.1016/j.foodchem.2011.05.121; ERDTMAN G., 1966, Pollen morphology and plant taxonomy. Angiosperms. An introduction to palynology I.; Estevinho LM, 2012, FOOD CHEM TOXICOL, V50, P258, DOI 10.1016/j.fct.2011.10.034; Goldberg Loretta, 2009, Rev. biol. trop, V57, P161; Gomes S, 2010, FOOD CHEM TOXICOL, V48, P544, DOI 10.1016/j.fct.2009.11.029; Gomes T, 2011, MOLECULES, V16, P5374, DOI 10.3390/molecules16075374; Guyot C, 1998, J AGR FOOD CHEM, V46, P625, DOI 10.1021/jf970510l; Hair J., 2010, MULTIVARIATE DATA AN, V7; Jaworska N, 2009, TUTOR QUANT METHODS, V5, P1, DOI 10.20982/tqmp.05.1.p001; Khoudja NK, 2014, IND CROP PROD, V52, P177, DOI 10.1016/j.indcrop.2013.10.004; Kim DO, 2003, FOOD CHEM, V81, P321, DOI 10.1016/S0308-8146(02)00423-5; Lachman J, 2010, LWT-FOOD SCI TECHNOL, V43, P52, DOI 10.1016/j.lwt.2009.06.008; LOUVEAUX J, 1978, BEE WORLD, V59, P139, DOI 10.1080/0005772X.1978.11097714; Marchini Luís Carlos, 2005, Food Sci. Technol (Campinas), V25, P8, DOI 10.1590/S0101-20612005000100003; Marghitas LA, 2009, FOOD CHEM, V112, P863, DOI 10.1016/j.foodchem.2008.06.055; Meda A, 2005, FOOD CHEM, V91, P571, DOI 10.1016/j.foodchem.2004.10.006; Moreira L, 2008, FOOD CHEM TOXICOL, V46, P3482, DOI 10.1016/j.fct.2008.08.025; Nogueira C, 2012, INT J MOL SCI, V13, P11173, DOI 10.3390/ijms130911173; Oddo L., 2004, APIDOLOGIE, V35, pS38, DOI [10.1051/apido:2004049, DOI 10.1051/APIDO:2004049]; PALFI G, 1984, BIOCHEM PHYSIOL PFL, V179, P237, DOI 10.1016/S0015-3796(84)80082-7; Persano Oddo L., 2004, APIDOLOGIE, V35, P82, DOI [10.1051/apido:2004045, DOI 10.1051/APIDO:2004045]; Silici S, 2010, FOOD CHEM, V121, P238, DOI 10.1016/j.foodchem.2009.11.078; SNEATH P H, 1973, P573; Sodre GD, 2011, REV BRAS ZOOTECN, V40, P1837; Sousa MEBC, 2014, TALANTA, V128, P284, DOI 10.1016/j.talanta.2014.05.004; Szczesna T, 2011, J APIC SCI, V55, P111; Tanzadehpanah H, 2012, FOOD RES INT, V49, P105, DOI 10.1016/j.foodres.2012.08.022; Terrab A, 2004, FOOD CHEM, V88, P537, DOI 10.1016/j.foodchem.2004.01.068; Truchado P, 2009, J CHROMATOGR A, V1216, P7241, DOI 10.1016/j.chroma.2009.07.057; Von Der Ohe W., 2004, APIDOLOGIE, V35, P18, DOI [10.1051/apido:2004050, DOI 10.1051/APIDO]; Ziyarat FP, 2014, J BIOMOL STRUCT DYN, V32, P613, DOI 10.1080/07391102.2013.785919	46	18	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162206	10.1371/journal.pone.0162206	http://dx.doi.org/10.1371/journal.pone.0162206			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588420	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800034
J	Hu, L; Li, X; Liu, Q; Xu, J; Ge, H; Wang, Z; Wang, H; Wang, Z; Shi, C; Xu, X; Huang, J; Lin, Z; Pieper, RO; Weng, C				Hu, L.; Li, X.; Liu, Q.; Xu, J.; Ge, H.; Wang, Z.; Wang, H.; Wang, Z.; Shi, C.; Xu, X.; Huang, J.; Lin, Z.; Pieper, R. O.; Weng, C.			UBE2S, a novel substrate of Akt1, associates with Ku70 and regulates DNA repair and glioblastoma multiforme resistance to chemotherapy	ONCOGENE			English	Article							STRAND BREAK REPAIR; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; CONJUGATING ENZYME E2-EPF; UBIQUITIN CARRIER PROTEIN; TUMOR-GROWTH; CELL-CYCLE; LIGASE-IV; CANCER; INHIBITION; PHOSPHORYLATION	Glioblastoma multiforme (GBM) is the most common primary malignant brain cancer in adults. However, the molecular events underlying carcinogenesis and their interplay remain elusive. Here, we report that the stability of Ubiquitin-conjugating enzyme E2S (UBE2S) is regulated by the PTEN/Akt pathway and that its degradation depends on the ubiquitin-proteasome system. Mechanistically, Akt1 physically interacted with and phosphorylated UBE2S at Thr 152, enhancing its stability by inhibiting proteasomal degradation. Additionally, accumulated UBE2S was found to be associated with the components of the nonhomologous end-joining (NHEJ) complex and participated in the NHEJ-mediated DNA repair process. The association of Ku70 with UBE2S was enhanced, and the complex was recruited to double-stranded break (DSB) sites in response to etoposide treatment. Furthermore, knockdown of UBE2S expression inhibited NHEJ-mediated DSB repair and rendered glioblastoma cells more sensitive to chemotherapy. Overall, our findings provide a novel drug target that may serve as the rationale for the development of a new therapeutic approach.	[Hu, L.; Ge, H.; Lin, Z.] Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin 150001, Heilongjiang Pr, Peoples R China; [Hu, L.; Liu, Q.; Weng, C.] Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Heilongjiang Pe, Peoples R China; [Li, X.] Shandong Univ, Liaocheng Peoples Hosp, Dept Neurosurg, Liaocheng, Peoples R China; [Xu, J.] Harbin Med Univ, Coll Bioinformat Sci & Technol, Harbin, Peoples R China; [Wang, Z.] Harbin Med Univ, Dept Epidemiol & Biostatist, Harbin, Peoples R China; [Wang, H.] Harbin Med Univ, Affiliated Hosp 1, Dept Pathol, Harbin, Peoples R China; [Wang, Z.] Univ Paris 06, St Antoine Res Ctr, CURIE, Paris, France; [Shi, C.] Univ Texas Dallas, Southwestern Med Ctr, Dept Neurosurg, Dallas, TX 75390 USA; [Xu, X.] Capital Normal Univ, DNA Damage Response & Coll Life Sci, Beijing Key Lab, Beijing, Peoples R China; [Huang, J.] Univ Florida, Dept Neurosurg, Gainesville, FL USA; [Pieper, R. O.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA	Harbin Medical University; Chinese Academy of Agricultural Sciences; Harbin Veterinary Research Institute, CAAS; Shandong University; Harbin Medical University; Harbin Medical University; Harbin Medical University; UDICE-French Research Universities; Sorbonne Universite; University of Texas System; University of Texas Dallas; University of Texas Southwestern Medical Center Dallas; Capital Normal University; State University System of Florida; University of Florida; University of California System; University of California San Francisco	Lin, Z (corresponding author), Harbin Med Univ, Affiliated Hosp 1, Dept Neurosurg, Harbin 150001, Heilongjiang Pr, Peoples R China.; Weng, C (corresponding author), Chinese Acad Agr Sci, Harbin Vet Res Inst, State Key Lab Vet Biotechnol, Harbin 150001, Heilongjiang Pe, Peoples R China.; Pieper, RO (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA.	linzhgu@sina.com; rpieper@cc.ucsf.edu; wengchji@163.com	Liu, Qinfang/ABC-9159-2021; weng, changjiang/HHR-8479-2022	Liu, Qinfang/0000-0003-2930-3892	National Natural Science Foundation of China [81372721]; International Science & Technology Cooperation Program of China [2014DFA31630]; Specialized Research Fund for the Doctoral Program of Higher Education [20132307110029]; National Cancer Institute [R01 CA171610T]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); International Science & Technology Cooperation Program of China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We are grateful to Dr Vera Gorbunova for providing the pEGFP-Pem1-Ad2 system. We thank Jane Gordon and Qimeng Tao for technical support. We thank Dr Lei Pan, Dr Changbin Shi for their critical review of the article. This work was supported by the National Natural Science Foundation of China (81372721); International Science & Technology Cooperation Program of China (2014DFA31630); Specialized Research Fund for the Doctoral Program of Higher Education (20132307110029) and National Cancer Institute (R01 CA171610T).	Ahnesorg P, 2006, CELL, V124, P301, DOI 10.1016/j.cell.2005.12.031; Brunet A, 1999, CELL, V96, P857, DOI 10.1016/S0092-8674(00)80595-4; Buck D, 2006, CELL, V124, P287, DOI 10.1016/j.cell.2005.12.030; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chen MF, 2009, J MOL MED-JMM, V87, P307, DOI 10.1007/s00109-008-0430-3; Chen YC, 2008, J MOL MED, V86, P401, DOI 10.1007/s00109-008-0302-x; Dang DT, 2006, CANCER RES, V66, P1684, DOI 10.1158/0008-5472.CAN-05-2887; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Davis AJ, 2014, DNA REPAIR, V17, P21, DOI 10.1016/j.dnarep.2014.02.020; Davis AJ, 2013, TRANSL CANCER RES, V2, P130, DOI 10.3978/j.issn.2218-676X.2013.04.02; Elson DA, 2001, GENE DEV, V15, P2520, DOI 10.1101/gad.914801; Fang LH, 2007, CELL RES, V17, P572, DOI 10.1038/cr.2007.50; Frank KM, 1998, NATURE, V396, P173, DOI 10.1038/24172; Gan WJ, 2015, NUCLEUS-PHILA, V6, P261, DOI 10.1080/19491034.2015.1074365; Gao DM, 2009, MOL BIOL CELL, V20, P3305, DOI 10.1091/mbc.E09-01-0092; Golding SE, 2009, CANCER BIOL THER, V8, P730, DOI 10.4161/cbt.8.8.7927; Hardee ME, 2012, CANCER RES, V72, P4119, DOI 10.1158/0008-5472.CAN-12-0546; Idogawa M, 2007, CANCER RES, V67, P911, DOI 10.1158/0008-5472.CAN-06-2360; Jung CR, 2006, NAT MED, V12, P809, DOI 10.1038/nm1440; Kao GD, 2007, J BIOL CHEM, V282, P21206, DOI 10.1074/jbc.M703042200; Khanna KK, 2001, NAT GENET, V27, P247, DOI 10.1038/85798; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; Liang J, 2012, ONCOL REP, V28, P1519, DOI 10.3892/or.2012.1949; Liu PD, 2015, MOL CELL, V57, P648, DOI 10.1016/j.molcel.2015.01.005; Liu Z, 1996, J BIOL CHEM, V271, P2817, DOI 10.1074/jbc.271.5.2817; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Plo I, 2008, CANCER RES, V68, P9404, DOI 10.1158/0008-5472.CAN-08-0861; Purow B, 2009, NAT REV NEUROL, V5, P419, DOI 10.1038/nrneurol.2009.96; Roos FC, 2011, AM J PATHOL, V178, P853, DOI 10.1016/j.ajpath.2010.10.033; Sancar A, 2004, ANNU REV BIOCHEM, V73, P39, DOI 10.1146/annurev.biochem.73.011303.073723; Sawada M, 2003, NAT CELL BIOL, V5, P320, DOI 10.1038/ncb950; Seluanov A, 2004, P NATL ACAD SCI USA, V101, P7624, DOI 10.1073/pnas.0400726101; Smith JS, 2001, JNCI-J NATL CANCER I, V93, P1246, DOI 10.1093/jnci/93.16.1246; Squatrito M, 2011, CANCER RES, V71, P5945, DOI 10.1158/0008-5472.CAN-11-1245; Tedesco D, 2007, NEOPLASIA, V9, P601, DOI 10.1593/neo.07385; Tonic I, 2010, J BIOL CHEM, V285, P23790, DOI 10.1074/jbc.M110.104372; Toulany M, 2008, MOL CANCER THER, V7, P1772, DOI 10.1158/1535-7163.MCT-07-2200; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Weng CJ, 2005, J BIOL CHEM, V280, P10491, DOI 10.1074/jbc.M412819200; Williams GJ, 2014, DNA REPAIR, V17, P110, DOI 10.1016/j.dnarep.2014.02.009; Woodbine L, 2014, DNA REPAIR, V16, P84, DOI 10.1016/j.dnarep.2014.02.011; Woodgett JR, 2005, CURR OPIN CELL BIOL, V17, P150, DOI 10.1016/j.ceb.2005.02.010; Yang J, 2002, NAT STRUCT BIOL, V9, P940, DOI 10.1038/nsb870; Zagzag D, 2000, CANCER-AM CANCER SOC, V88, P2606, DOI 10.1002/1097-0142(20000601)88:11<2606::AID-CNCR25>3.0.CO;2-W; Zhang H, 2002, J BIOL CHEM, V277, P39379, DOI 10.1074/jbc.M206399200	47	32	35	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1145	1156		10.1038/onc.2016.281	http://dx.doi.org/10.1038/onc.2016.281			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27593939				2022-12-26	WOS:000395371500012
J	Ban, HS; Xu, X; Jang, K; Kim, I; Kim, BK; Lee, K; Won, M				Ban, Hyun Seung; Xu, Xuezhen; Jang, Kusik; Kim, Inhyub; Kim, Bo-Kyung; Lee, Kyeong; Won, Misun			A Novel Malate Dehydrogenase 2 Inhibitor Suppresses Hypoxia-Inducible Factor-1 by Regulating Mitochondrial Respiration	PLOS ONE			English	Article							ACTIVATED PROTEIN-KINASE; CANCER-CELL METABOLISM; HIF-1 INHIBITOR; EXPRESSION; PATHWAY; TARGET; PROBES; LW6	We previously reported that hypoxia-inducible factor (HIF)-1 inhibitor LW6, an aryloxyacety-lamino benzoic acid derivative, inhibits malate dehydrogenase 2 (MDH2) activity during the mitochondrial tricarboxylic acid (TCA) cycle. In this study, we present a novel MDH2 inhibitor compound 7 containing benzohydrazide moiety, which was identified through structure-based virtual screening of chemical library. Similar to LW6, compound 7 inhibited MDH2 activity in a competitive fashion, thereby reducing NADH level. Consequently, compound 7 reduced oxygen consumption and ATP production during the mitochondrial respiration cycle, resulting in increased intracellular oxygen concentration. Therefore, compound 7 suppressed the accumulation of HIF-1 alpha and expression of its target genes, vascular endothelial growth factor (VEGF) and glucose transporter 1 (GLUT1). Moreover, reduction in ATP content activated AMPK, thereby inactivating ACC and mTOR the downstream pathways. As expected, compound 7 exhibited significant growth inhibition of human colorectal cancer HCT116 cells. Compound 7 demonstrated substantial anti-tumor efficacy in an in vivo xenograft assay using HCT116 mouse model. Taken together, a novel MDH2 inhibitor, compound 7, suppressed HIF-1 alpha accumulation via reduction of oxygen consumption and ATP production, integrating metabolism into anti-cancer efficacy in cancer cells.	[Ban, Hyun Seung] Korea Res Inst Biosci & Biotechnol, Metab Regulat Res Ctr, Daejeon, South Korea; [Ban, Hyun Seung] Univ Sci & Technol, Biomol Sci, Daejeon, South Korea; [Xu, Xuezhen; Jang, Kusik; Lee, Kyeong] Dongguk Univ Seoul, Coll Pharm, Goyang, South Korea; [Kim, Inhyub; Kim, Bo-Kyung; Won, Misun] Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea; [Kim, Inhyub; Won, Misun] Univ Sci & Technol, Funct Genom, Daejeon, South Korea	Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST); Dongguk University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); University of Science & Technology (UST)	Lee, K (corresponding author), Dongguk Univ Seoul, Coll Pharm, Goyang, South Korea.; Won, M (corresponding author), Korea Res Inst Biosci & Biotechnol, Personalized Genom Med Res Ctr, Daejeon, South Korea.; Won, M (corresponding author), Univ Sci & Technol, Funct Genom, Daejeon, South Korea.	kaylee@donggkuk.edu; misun@kribb.re.kr	Ban, Hyun Seung/F-9526-2014	Ban, Hyun Seung/0000-0002-2698-6037	Korea National Research Foundation (NRF) [2015M3A9A8032460]; National Research Foundation (NRF) [2015M3A9A8032460, 2014R1A2A2A01005455]; Health Technology RD [HI13C2162]; KRIBB Initiative of the Korea Research Council of Fundamental Science and Technology [KGM4751612]	Korea National Research Foundation (NRF); National Research Foundation (NRF); Health Technology RD; KRIBB Initiative of the Korea Research Council of Fundamental Science and Technology	This work was supported by grant 2015M3A9A8032460 by Korea National Research Foundation (NRF) (https://ernd.nrf.re.kr) to MW, grant 2014R1A2A2A01005455 by National Research Foundation (NRF) (https://ernd.nrf.re.kr) to KL, grant HI13C2162 by Health Technology R&D (https://www.htdream.kr) to MW, and grant KGM4751612 by KRIBB Initiative of the Korea Research Council of Fundamental Science and Technology (https://www.kribb.re.kr) to MW. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Research Foundation (NRF) grants (2014R1A2A2A01005455, 2015M3A9A8032460), Health Technology R&D grant (HI13C2162) and KRIBB Initiative of the Korea Research Council of Fundamental Science and Technology.	Akbay EA, 2014, GENE DEV, V28, P479, DOI 10.1101/gad.231233.113; Ban HS, 2016, EXPERT OPIN THER PAT, V26, P309, DOI 10.1517/13543776.2016.1146252; Cantor JR, 2012, CANCER DISCOV, V2, P881, DOI 10.1158/2159-8290.CD-12-0345; Gatenby RA, 2007, INT J BIOCHEM CELL B, V39, P1358, DOI 10.1016/j.biocel.2007.03.021; Gaude E, 2014, CANCER METAB, V2, DOI 10.1186/2049-3002-2-10; GOWARD CR, 1994, PROTEIN SCI, V3, P1883, DOI 10.1002/pro.5560031027; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hardie DG, 2003, FEBS LETT, V546, P113, DOI 10.1016/S0014-5793(03)00560-X; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hicklin DJ, 2005, J CLIN ONCOL, V23, P1011, DOI 10.1200/JCO.2005.06.081; Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021; Israel M, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-70; Jung EJ, 2011, J LIPID RES, V52, P1617, DOI 10.1194/jlr.M015263; Kim S, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-299; Lee K, 2007, J MED CHEM, V50, P1675, DOI 10.1021/jm0610292; Lee K, 2013, ANGEW CHEM INT EDIT, V52, P10286, DOI 10.1002/anie.201304987; Lee K, 2010, BIOCHEM PHARMACOL, V80, P982, DOI 10.1016/j.bcp.2010.06.018; Liu Q, 2013, PROSTATE, V73, P1028, DOI 10.1002/pros.22650; Lo YW, 2015, J CELL MOL MED, V19, P744, DOI 10.1111/jcmm.12388; Naik R, 2014, J MED CHEM, V57, P9522, DOI 10.1021/jm501241g; Naik R, 2012, J MED CHEM, V55, P10564, DOI 10.1021/jm301419d; Piao W, 2013, ANGEW CHEM INT EDIT, V52, P13028, DOI 10.1002/anie.201305784; Quintero M, 2004, EJSO-EUR J SURG ONC, V30, P465, DOI 10.1016/j.ejso.2004.03.008; Ren JG, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012520; Schlichtholz B, 2005, PANCREAS, V30, P99, DOI 10.1097/01.mpa.0000153326.69816.7d; Semenza GL, 2003, NAT REV CANCER, V3, P721, DOI 10.1038/nrc1187; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Tsui KH, 2013, J MOL ENDOCRINOL, V51, P131, DOI 10.1530/JME-13-0090; Xia Y, 2012, EUR J MED CHEM, V49, P24, DOI 10.1016/j.ejmech.2012.01.033; Yang M, 2013, J CLIN INVEST, V123, P3652, DOI 10.1172/JCI67228; Zhao Y, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.60	31	26	29	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162568	10.1371/journal.pone.0162568	http://dx.doi.org/10.1371/journal.pone.0162568			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611801	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900127
J	Chebon, LJ; Ngalah, BS; Ingasia, LA; Juma, DW; Muiruri, P; Cheruiyot, J; Opot, B; Mbuba, E; Imbuga, M; Akala, HM; Bulimo, W; Andagalu, B; Kamau, E				Chebon, Lorna J.; Ngalah, Bidii S.; Ingasia, Luicer A.; Juma, Dennis W.; Muiruri, Peninah; Cheruiyot, Jelagat; Opot, Benjamin; Mbuba, Emmanuel; Imbuga, Mabel; Akala, Hoseah M.; Bulimo, Wallace; Andagalu, Ben; Kamau, Edwin			Genetically Determined Response to Artemisinin Treatment in Western Kenyan Plasmodium falciparum Parasites	PLOS ONE			English	Article							IN-VIVO SELECTION; ARTEMETHER-LUMEFANTRINE; DRUG-RESISTANCE; LINKAGE DISEQUILIBRIUM; MALARIA TRANSMISSION; TEMPORAL TRENDS; POPULATION; CLEARANCE; DIVERSITY; CHILDREN	Genetically determined artemisinin resistance in Plasmodium falciparum has been described in Southeast Asia. The relevance of recently described Kelch 13-propellermutations for artemisinin resistance in Sub-Saharan Africa parasites is still unknown. Southeast Asia parasites have low genetic diversity compared to Sub-Saharan Africa, where parasites are highly genetically diverse. This study attempted to elucidate whether genetics provides a basis for discovering molecular markers in response to artemisinin drug treatment in P. falciparum in Kenya. The genetic diversity of parasites collected pre- and post-introduction of artemisinin combination therapy (ACT) in western Kenya was determined. A panel of 12 microsatellites and 91 single nucleotide polymorphisms (SNPs) distributed across the P. falciparum genome were genotyped. Parasite clearance rates were obtained for the post-ACT parasites. The 12 microsatellites were highly polymorphic with post-ACT parasites being significantly more diverse compared to pre- ACT (p < 0.0001). The median clearance half-life was 2.55 hours for the post-ACT parasites. Based on SNP analysis, 15 of 90 post-ACT parasites were single-clone infections. Analysis revealed 3 SNPs that might have some causal association with parasite clearance rates. Further, genetic analysis using Bayesian tree revealed parasites with similar clearance phenotypes were more closely genetically related. With further studies, SNPs described here and genetically determined response to artemisinin treatment might be useful in tracking artemisinin resistance in Kenya.	[Chebon, Lorna J.; Ngalah, Bidii S.; Ingasia, Luicer A.; Juma, Dennis W.; Muiruri, Peninah; Cheruiyot, Jelagat; Opot, Benjamin; Akala, Hoseah M.; Bulimo, Wallace; Andagalu, Ben; Kamau, Edwin] Kenya Med Res Inst KEMRI, Walter Reed Project, US Army Med Res Directorate Kenya, Dept Emerging & Infect Dis, Kisumu, Kenya; [Chebon, Lorna J.; Ngalah, Bidii S.; Muiruri, Peninah; Imbuga, Mabel] Jomo Kenyatta Univ Agr & Technol, Coll Hlth Sci, Inst Trop Med & Infect Dis, Nairobi, Kenya; [Mbuba, Emmanuel] Ifakara Hlth Inst, Bagamoyo, Tanzania	Kenya Medical Research Institute; Walter Reed Army Institute of Research (WRAIR); US Army Medical Research Directorate Kenya (USAMRU-K); Jomo Kenyatta University of Agriculture & Technology; Ifakara Health Institute	Kamau, E (corresponding author), Kenya Med Res Inst KEMRI, Walter Reed Project, US Army Med Res Directorate Kenya, Dept Emerging & Infect Dis, Kisumu, Kenya.	edwin.kamau.mil@mail.mil	Bulimo, Wallace/B-1982-2014; Mbuba, Emmanuel/ABQ-7945-2022	Bulimo, Wallace/0000-0001-8475-0586; Mbuba, Emmanuel/0000-0003-0157-1780; Akala, Hoseah/0000-0001-8584-2706; Chebon, Lorna/0000-0001-7236-8750	Armed Forces Health Surveillance Center, Division of Global Emerging Infections Surveillance and Response System Operations	Armed Forces Health Surveillance Center, Division of Global Emerging Infections Surveillance and Response System Operations	This work was supported by the Armed Forces Health Surveillance Center, Division of Global Emerging Infections Surveillance and Response System Operations. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal A, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-254; Alam MT, 2011, J INFECT DIS, V203, P220, DOI 10.1093/infdis/jiq038; Amin AA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-72; Anderson TJC, 2010, P ROY SOC B-BIOL SCI, V277, P2531, DOI 10.1098/rspb.2010.0196; Anderson TJC, 2010, J INFECT DIS, V201, P1326, DOI 10.1086/651562; Anderson TJC, 2000, MOL BIOL EVOL, V17, P1467, DOI 10.1093/oxfordjournals.molbev.a026247; [Anonymous], 2009, WORLD MAL REP 2009; Ariey F, 2014, NATURE, V505, P50, DOI 10.1038/nature12876; Ashley EA, 2014, NEW ENGL J MED, V371, P411, DOI 10.1056/NEJMoa1314981; Balloux F, 2002, MOL ECOL, V11, P155, DOI 10.1046/j.0962-1083.2001.01436.x; Bloland PB, 1999, AM J TROP MED HYG, V60, P641, DOI 10.4269/ajtmh.1999.60.641; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Bogreau H, 2006, AM J TROP MED HYG, V74, P953; Borrmann S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026005; Conrad MD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105690; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; Durand P, 2003, AM J TROP MED HYG, V68, P345, DOI 10.4269/ajtmh.2003.68.345; Dye C, 1997, P ROY SOC B-BIOL SCI, V264, P61, DOI 10.1098/rspb.1997.0009; Gatei W, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-353; Hamed K, 2012, EXPERT REV ANTI-INFE, V10, P645, DOI [10.1586/eri.12.51, 10.1586/ERI.12.51]; Hamel MJ, 2011, AM J TROP MED HYG, V85, P597, DOI 10.4269/ajtmh.2011.10-0678; Haubold B, 1998, GENETICS, V150, P1341; Haubold B, 2000, BIOINFORMATICS, V16, P847, DOI 10.1093/bioinformatics/16.9.847; HUDSON RR, 1994, J EVOLUTION BIOL, V7, P535, DOI 10.1046/j.1420-9101.1994.7050535.x; Iwagami M, 2009, MALAR J; Kamau E, 2014, JOURNAL OF INFECTIOU; Kublin JG, 2003, J INFECT DIS, V187, P1870, DOI 10.1086/375419; Maiga AW, 2012, AM J TROP MED HYG, V87, P23, DOI 10.4269/ajtmh.2012.12-0058; Malmberg M, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-103; Malmberg M, 2013, J INFECT DIS, V207, P842, DOI 10.1093/infdis/jis747; Mbogo GW, 2014, AM J TROP MED HYG, V91, P54, DOI 10.4269/ajtmh.13-0647; Miotto O, 2013, NAT GENET, V45, P648, DOI 10.1038/ng.2624; Muhindo MK, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-32; Ndenga B, 2006, J MED ENTOMOL, V43, P200, DOI 10.1603/0022-2585(2006)043[0200:PDOMVI]2.0.CO;2; Noedl H, 2008, NEW ENGL J MED, V359, P2619, DOI 10.1056/NEJMc0805011; Nwakanma DC, 2014, J INFECT DIS, V209, P1126, DOI 10.1093/infdis/jit618; O'Meara WP, 2008, LANCET, V372, P1555, DOI 10.1016/S0140-6736(08)61655-4; O'Meara WP, 2010, LANCET INFECT DIS, V10, P545, DOI 10.1016/S1473-3099(10)70096-7; Ogutu BR, 2005, TROP MED INT HEALTH, V10, P484, DOI 10.1111/j.1365-3156.2005.01415.x; Okiro EA, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-285; Okombo J, 2014, INT J PARASITOL-DRUG, V4, P152, DOI 10.1016/j.ijpddr.2014.07.003; Pandey R, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1024; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Phyo AP, 2012, LANCET, V379, P1960, DOI 10.1016/S0140-6736(12)60484-X; Pollitt LC, 2015, EVOL APPL, V8, P296, DOI 10.1111/eva.12194; Rambaut A., 2014, FIGTREE V 1 4 2 MOL; Rapuoda B, 2003, TROP MED INT HEALTH, V8, P860, DOI 10.1046/j.1360-2276.2003.01114.x; Ronquist F, 2012, SYST BIOL, V61, P539, DOI 10.1093/sysbio/sys029; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Schultz L, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-336; Shretta R, 2000, TROP MED INT HEALTH, V5, P755, DOI 10.1046/j.1365-3156.2000.00643.x; Sisowath C, 2005, J INFECT DIS, V191, P1014, DOI 10.1086/427997; Sisowath C, 2007, TROP MED INT HEALTH, V12, P736, DOI 10.1111/j.1365-3156.2007.01843.x; Sisowath C, 2009, J INFECT DIS, V199, P750, DOI 10.1086/596738; SOUZA V, 1992, P NATL ACAD SCI USA, V89, P8389, DOI 10.1073/pnas.89.17.8389; Stepniewska K, 2010, J INFECT DIS, V201, P570, DOI 10.1086/650301; Su XZ, 2007, NAT REV GENET, V8, P497, DOI 10.1038/nrg2126; Takala-Harrison S, 2013, P NATL ACAD SCI USA, V110, P240, DOI 10.1073/pnas.1211205110; Tanner M, 1999, Trans R Soc Trop Med Hyg, V93 Suppl 1, P1, DOI 10.1016/S0035-9203(99)90319-X; Taylor SM, 2015, J INFECT DIS, V211, P680, DOI 10.1093/infdis/jiu467; Vafa M, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-17; Vardo-Zalik AM, 2013, AM J TROP MED HYG, V88, P29, DOI 10.4269/ajtmh.2012.12-0308; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165; White NJ, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-297; White NJ, 2010, LANCET, V376, P2051, DOI 10.1016/S0140-6736(10)61963-0; White NJ, 2004, J CLIN INVEST, V113, P1084, DOI [10.1172/JCI21682, 10.1172/JCI200421682]; White NJ, 2003, P ROY SOC B-BIOL SCI, V270, P545, DOI 10.1098/rspb.2002.2241; WHO, 2015, N ENGL J MED; Zhong D, 2007, AM J TROP MED HYG, V77, P1043, DOI 10.4269/ajtmh.2007.77.1043; Zwang J, 2014, MALARIA J, V13, DOI 10.1186/1475-2875-13-114	71	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162524	10.1371/journal.pone.0162524	http://dx.doi.org/10.1371/journal.pone.0162524			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611315	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900123
J	Cheng, WJ; Ma, LY; Yang, TJ; Liang, JL; Zhang, Y				Cheng, Wenjun; Ma, Luyao; Yang, Tiejun; Liang, Jiali; Zhang, Yan			Joint Lung CT Image Segmentation: A Hierarchical Bayesian Approach	PLOS ONE			English	Article								Accurate lung CT image segmentation is of great clinical value, especially when it comes to delineate pathological regions including lung tumor. In this paper, we present a novel framework that jointly segments multiple lung computed tomography (CT) images via hierarchical Dirichlet process (HDP). In specifics, based on the assumption that lung CT images from different patients share similar image structure (organ sets and relative positioning), we derive a mathematical model to segment them simultaneously so that shared information across patients could be utilized to regularize each individual segmentation. Moreover, compared to many conventional models, the algorithm requires little manual involvement due to the nonparametric nature of Dirichlet process (DP). We validated proposed model upon clinical data consisting of healthy and abnormal (lung cancer) patients. We demonstrate that, because of the joint segmentation fashion, more accurate and consistent segmentations could be obtained.	[Cheng, Wenjun; Ma, Luyao; Yang, Tiejun] Taizhou Municipal Hosp, Dept Med Imaging, 381 East Zhongshan Rd, Taizhou 318000, Peoples R China; [Liang, Jiali; Zhang, Yan] China Jiliang Univ, Coll Opt & Elect Technol, Xueyuan St 258, Hangzhou 310018, Peoples R China	Taizhou University; China Jiliang University	Zhang, Y (corresponding author), China Jiliang Univ, Coll Opt & Elect Technol, Xueyuan St 258, Hangzhou 310018, Peoples R China.	05A0402032@cjlu.edu.cn						Farahani FV, 2015, 2015 IEEE CONFERENCE ON COMPUTATIONAL INTELLIGENCE IN BIOINFORMATICS AND COMPUTATIONAL BIOLOGY (CIBCB), P47; FERGUSON TS, 1973, THE ANNALS OF STATIS, P209, DOI DOI 10.1214/A0S/1176342360; HOFFMAN EA, 1983, J APPL PHYSIOL, V55, P935, DOI 10.1152/jappl.1983.55.3.935; Jbabdi S, 2009, NEUROIMAGE, V44, P373, DOI 10.1016/j.neuroimage.2008.08.044; MacEachern SN, 1998, J COMPUT GRAPH STAT, V7, P223, DOI 10.2307/1390815; Mesanovic N., 2011, 18 INT C SYSTEMS SIG, P395, DOI 1016/j.compmedimag.2008.04.005; ONOMA DP, 2012, BIOM IM ISBI 2012 9, P1260; Orbanz P, 2008, INT J COMPUT VISION, V77, P25, DOI 10.1007/s11263-007-0061-0; Pu J, 2008, COMPUT MED IMAG GRAP, V32, P452, DOI 10.1016/j.compmedimag.2008.04.005; Sun SH, 2012, IEEE T MED IMAGING, V31, P449, DOI 10.1109/TMI.2011.2171357; Sun Shanhui, 2011, 4 INT WORKSH PULM IM; Tan YQ, 2013, MED PHYS, V40, DOI 10.1118/1.4793409; Teh YW, 2006, J AM STAT ASSOC, V101, P1566, DOI 10.1198/016214506000000302; van Ginneken B, 2002, IEEE T MED IMAGING, V21, P924, DOI 10.1109/TMI.2002.803121; Wang XG, 2011, NEUROIMAGE, V54, P290, DOI 10.1016/j.neuroimage.2010.07.050	15	5	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162211	10.1371/journal.pone.0162211	http://dx.doi.org/10.1371/journal.pone.0162211			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611188	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900057
J	Gallo, S; Gili, M; Lombardo, G; Rossetti, A; Rosso, A; Dentelli, P; Togliatto, G; Deregibus, MC; Taverna, D; Camussi, G; Brizzi, MF				Gallo, Sara; Gili, Maddalena; Lombardo, Giusy; Rossetti, Alberto; Rosso, Arturo; Dentelli, Patrizia; Togliatto, Gabriele; Deregibus, Maria Chiara; Taverna, Daniela; Camussi, Giovanni; Brizzi, Maria Felice			Stem Cell-Derived, microRNA-Carrying Extracellular Vesicles: A Novel Approach to Interfering with Mesangial Cell Collagen Production in a Hyperglycaemic Setting	PLOS ONE			English	Article							DIABETIC-NEPHROPATHY; TGF-BETA; RENAL FIBROSIS; HORIZONTAL TRANSFER; MICROVESICLES; MIR-21; COMPLICATIONS; DISEASE; INJURY; CLASSIFICATION	Extracellular vesicles (EVs) that are derived from stem cells are proving to be promising therapeutic options. We herein investigate the therapeutic potential of EVs that have been derived from different stem cell sources, bone-marrow (MSC) and human liver (HLSC), on mesangial cells (MCs) exposed to hyperglycaemia. By expressing a dominant negative STAT5 construct (Delta NSTAT5) in HG-cultured MCs, we have demonstrated that miR-21 expression is under the control of STAT5, which translates into Transforming Growth Factor beta (TGF beta) expression and collagen production. A number of approaches have been used to show that both MSC-and HLSC-derived EVs protect MCs from HG-induced damage via the transfer of miR-222. This resulted in STAT5 down-regulation and a decrease in miR-21 content, TGF beta expression and matrix protein synthesis within MCs. Moreover, we demonstrate that changes in the balance between miR-21 and miR-100 in the recipient cell, which are caused by the transfer of EV cargo, further contribute to providing beneficial effects. Interestingly, these effects were only detected in HG-cultured cells. Finally, it was found that HG reduced the expression of the nuclear encoded mitochondrial electron transport chain (ETC) components, CoxIV. It is worth noting that EV administration can rescue CoxIV expression in HG-cultured MCs. These results thus demonstrate that both MSC-and HLSC-derived EVs transfer the machinery needed to preserve MCs from HG-mediated damage. This occurs via the horizontal transfer of functional miR-222 which directly interferes with damaging cues. Moreover, our data indicate that the release of EV cargo into recipient cells provides additional therapeutic advantages against harmful mitochondrial signals.	[Gallo, Sara; Gili, Maddalena; Lombardo, Giusy; Rossetti, Alberto; Rosso, Arturo; Dentelli, Patrizia; Togliatto, Gabriele; Deregibus, Maria Chiara; Camussi, Giovanni; Brizzi, Maria Felice] Univ Turin, Dept Med Sci, Turin, Italy; [Taverna, Daniela] Univ Turin, Dept Mol Biotechnol & Hlth Sci, Turin, Italy	University of Turin; University of Turin	Camussi, G; Brizzi, MF (corresponding author), Univ Turin, Dept Med Sci, Turin, Italy.	giovanni.camussi@unito.it; mariafelice.brizzi@unito.it	Brizzi, Maria Felice/J-7882-2016; Camussi, Giovanni/J-7624-2016; Togliatto, Gabriele/K-5668-2016	Camussi, Giovanni/0000-0003-2795-232X; Togliatto, Gabriele/0000-0002-3123-7823	Associazione Italiana per la Ricerca sul Cancro (AIRC) [IG 12890, IG 17630]; Ministero dell'Istruzione, Universita e Ricerca (MIUR)	Associazione Italiana per la Ricerca sul Cancro (AIRC)(Fondazione AIRC per la ricerca sul cancro); Ministero dell'Istruzione, Universita e Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This work has been supported by grants obtained by GC and MFB from the Associazione Italiana per la Ricerca sul Cancro (AIRC) projects IG 12890 and IG 17630 and by grants obtained by MFB from Ministero dell'Istruzione, Universita e Ricerca (MIUR) ex 60%.	Ahmadi M, 2015, CELL MOL BIOL, V61, P100; Blake R, 2014, BBA-GEN SUBJECTS, V1840, P1404, DOI 10.1016/j.bbagen.2013.11.007; Brizzi MF, 2004, FASEB J, V18, P1249, DOI 10.1096/fj.03-1053fje; Bruno S, 2009, J AM SOC NEPHROL, V20, P1053, DOI 10.1681/ASN.2008070798; Bussolati B, 1999, AM J PATHOL, V154, P623, DOI 10.1016/S0002-9440(10)65307-2; Camussi G, 2010, KIDNEY INT, V78, P838, DOI 10.1038/ki.2010.278; Collino F, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011803; Dentelli P, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28758; Dentelli P, 2010, ARTERIOSCL THROM VAS, V30, P1562, DOI 10.1161/ATVBAHA.110.206201; Deregibus MC, 2007, BLOOD, V110, P2440, DOI 10.1182/blood-2007-03-078709; Dey N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042316; Feuermann Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085123; Forbes JM, 2013, PHYSIOL REV, V93, P137, DOI 10.1152/physrev.00045.2011; Gili M, 2013, ENDOCRINE, V44, P557, DOI 10.1007/s12020-013-9936-8; Gnecchi M, 2012, VASC PHARMACOL, V57, P48, DOI 10.1016/j.vph.2012.04.002; Gomez IG, 2015, J CLIN INVEST, V125, P141, DOI 10.1172/JCI75852; Granata A, 2016, EUR J INTERN MED, V30, P1, DOI 10.1016/j.ejim.2016.02.019; Haneda M, 2015, CLIN EXP NEPHROL, V19, P1, DOI 10.1007/s10157-014-1057-z; Hayward RA, 2015, NEW ENGL J MED, V372, P2197, DOI 10.1056/NEJMoa1414266; Herrera MB, 2006, STEM CELLS, V24, P2840, DOI 10.1634/stemcells.2006-0114; Iavello A, 2016, INT J MOL MED, V37, P958, DOI 10.3892/ijmm.2016.2488; Iliopoulos D, 2011, EUR J IMMUNOL, V41, P1754, DOI 10.1002/eji.201040646; Kholia S, 2016, VASCUL PHARM; Lai JY, 2015, J AM SOC NEPHROL, V26, P805, DOI 10.1681/ASN.2013121274; Lombardo G, 2016, SCI REP-UK, V6, DOI 10.1038/srep25689; Maezawa Y, 2015, J DIABETES INVEST, V6, P3, DOI 10.1111/jdi.12255; McClelland AD, 2015, CLIN SCI, V129, P1237, DOI 10.1042/CS20150427; Meng XM, 2015, FRONT PHYSIOL, V6, DOI 10.3389/fphys.2015.00082; Ning L, 2014, AM J PATHOL, V184, P1683, DOI 10.1016/j.ajpath.2014.02.006; Osipova J, 2014, J CLIN ENDOCR METAB, V99, pE1661, DOI 10.1210/jc.2013-3868; Pinatel EM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084859; Pugliese G, 2014, CARDIOVASC DIABETOL, V13, DOI 10.1186/1475-2840-13-59; Qi R, 2014, RENAL FAILURE, V36, P589, DOI 10.3109/0886022X.2014.882713; Quesenberry PJ, 2014, STEM CELLS DEV, V23, P1429, DOI 10.1089/scd.2013.0594; Ratajczak MZ, 2016, CLIN TRANSL MED, V5, DOI 10.1186/s40169-016-0087-4; Ritz E, 1999, NEW ENGL J MED, V341, P1127, DOI 10.1056/NEJM199910073411506; Srinivasan S, 2012, FREE RADICAL BIO MED, V53, P1252, DOI 10.1016/j.freeradbiomed.2012.07.021; Sun X, 2013, CELL SIGNAL, V25, P1870, DOI 10.1016/j.cellsig.2013.05.013; Tetta C, 2013, ENDOCRINE, V44, P11, DOI 10.1007/s12020-012-9839-0; Togliatto G, 2016, INT J OBESITY, V40, P102, DOI 10.1038/ijo.2015.123; Togliatto G, 2010, DIABETES, V59, P1016, DOI 10.2337/db09-0858; Wang JY, 2013, CELL BIOCHEM BIOPHYS, V67, P537, DOI 10.1007/s12013-013-9539-2; Wang XD, 2002, DIABETES, V51, P3505, DOI 10.2337/diabetes.51.12.3505; Yuan A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004722; Zeoli A, 2008, BLOOD, V112, P350, DOI 10.1182/blood-2007-12-128215; Zhang L, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-014-0103-3; Zhang NJ, 2014, ONCOL REP, V32, P1409, DOI 10.3892/or.2014.3389; Zhang N, 2015, ONCOL REP, V33, P1493, DOI 10.3892/or.2015.3710; Zhong X, 2013, DIABETOLOGIA, V56, P663, DOI 10.1007/s00125-012-2804-x; Zhu HL, 2013, J CLIN IMMUNOL, V33, P1100, DOI 10.1007/s10875-013-9896-z	50	27	30	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162417	10.1371/journal.pone.0162417	http://dx.doi.org/10.1371/journal.pone.0162417			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611075	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255900095
J	Martin, OMF; Etheve, L; Launay, G; Martin, J				Martin, Olivier M. F.; Etheve, Loic; Launay, Guillaume; Martin, Juliette			Implication of Terminal Residues at Protein-Protein and Protein-DNA Interfaces	PLOS ONE			English	Article							CRYSTAL-STRUCTURE; RECOGNITION; COMPLEXES; PRINCIPLES; PREDICTION; REGIONS; CHAINS; DOMAIN	Terminal residues of protein chains are charged and more flexible than other residues since they are constrained only on one side. Do they play a particular role in protein-protein and protein-DNA interfaces? To answer this question, we considered large sets of non-redundant protein-protein and protein-DNA complexes and analyzed the status of terminal residues and their involvement in interfaces. In protein-protein complexes, we found that more than half of terminal residues (62%) are either modified by attachment of a tag peptide (10%) or have missing coordinates in the analyzed structures (52%). Terminal residues are almost exclusively located at the surface of proteins (94%). Contrary to charged residues, they are not over or under-represented in protein-protein interfaces, but strongly prefer the peripheral region of interfaces when present at the interface (83% of terminal residues). The almost exclusive location of terminal residues at the surface of the proteins or in the rim regions of interfaces explains that experimental methods relying on tail hybridization can be successfully applied without disrupting the complexes under study. Concerning conformational rearrangement in protein-protein complexes, despite their expected flexibility, terminal residues adopt similar locations between the free and bound forms of the docking benchmark. In protein-DNA complexes, N-terminal residues are twice more frequent than C-terminal residues at interfaces. Both N-terminal and C-terminal residues are under-represented in interfaces, in contrast to positively charged residues, which are strongly favored. When located in protein-DNA interfaces, terminal residues prefer the periphery. N-terminal and C-terminal residues thus have particular properties with regard to interfaces, which cannot be reduced to their charged nature.	[Martin, Olivier M. F.; Etheve, Loic; Launay, Guillaume; Martin, Juliette] Univ Lyon, CNRS, UMR 5086, MMSB, 7 Passage Vercors, F-69367 Lyon, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Martin, J (corresponding author), Univ Lyon, CNRS, UMR 5086, MMSB, 7 Passage Vercors, F-69367 Lyon, France.	juliette.martin@ibcp.fr	Martin, Juliette/T-9457-2019; Martin, Juliette/N-5545-2016; Martin, Olivier M. F./P-8253-2019	Martin, Juliette/0000-0002-4787-0885; Martin, Juliette/0000-0002-4787-0885; Martin, Olivier M. F./0000-0003-3661-7208; Etheve, Loic/0000-0003-4896-0791; Launay, Guillaume/0000-0003-0177-8706	Agence Nationale de la Recherche (projet MAPPING, Investissement d'avenir) [ANR-11-BINF-003]	Agence Nationale de la Recherche (projet MAPPING, Investissement d'avenir)(French National Research Agency (ANR))	This work was funded by Agence Nationale de la Recherche (projet MAPPING, Investissement d'avenir) (grant numbers: ANR-11-BINF-003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Agence Nationale de la Recherche (projet MAPPING, Investissement d'avenir); Grant numbers: ANR-11-BINF-003. We thank Raphael Guerois for providing data regarding the InterEvol dataset.	Bahadur RP, 2008, CELL MOL LIFE SCI, V65, P1059, DOI 10.1007/s00018-007-7451-x; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Block P, 2006, PROTEINS, V65, P607, DOI 10.1002/prot.21104; Chakrabarti P, 2002, PROTEINS, V47, P334, DOI 10.1002/prot.10085; Chatr-aryamontri A, 2015, NUCLEIC ACIDS RES, V43, pD470, DOI 10.1093/nar/gku1204; CHOTHIA C, 1975, NATURE, V256, P705, DOI 10.1038/256705a0; Christopher JA, 1996, J MOL BIOL, V257, P175, DOI 10.1006/jmbi.1996.0154; Coulocheri SA, 2007, BIOCHIMIE, V89, P1291, DOI 10.1016/j.biochi.2007.07.020; Crowley PB, 2005, PROTEINS, V59, P231, DOI 10.1002/prot.20417; De la Pena M, 2007, EMBO J, V26, P4913, DOI 10.1038/sj.emboj.7601912; Faure G, 2012, NUCLEIC ACIDS RES, V40, pD847, DOI 10.1093/nar/gkr845; Horton JR, 2006, NUCLEIC ACIDS RES, V34, P939, DOI 10.1093/nar/gkj484; Hubbard SJ, NACCESS COMPUTER PRO; Hwang H, 2010, PROTEINS, V78, P3111, DOI 10.1002/prot.22830; Jacob E, 2007, BIOINFORMATICS, V23, pE225, DOI 10.1093/bioinformatics/btl318; Jones S, 1997, J MOL BIOL, V272, P121, DOI 10.1006/jmbi.1997.1234; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024; Kodandapani R, 1996, NATURE, V380, P456, DOI 10.1038/380456a0; Krishna MMG, 2005, P NATL ACAD SCI USA, V102, P1053, DOI 10.1073/pnas.0409114102; Kuttner YY, 2012, J MOL BIOL, V415, P419, DOI 10.1016/j.jmb.2011.11.009; Laio A, 2006, PROTEINS, V62, P17, DOI 10.1002/prot.20712; Lejeune D, 2005, PROTEINS, V61, P258, DOI 10.1002/prot.20607; Levy ED, 2010, J MOL BIOL, V403, P660, DOI 10.1016/j.jmb.2010.09.028; Martin ACR, 2005, BIOINFORMATICS, V21, P4297, DOI 10.1093/bioinformatics/bti694; Martin J, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-7; Mezei M, 2015, ALGORITHMS, V8, P92, DOI 10.3390/a8020092; Orchard S, 2014, NUCLEIC ACIDS RES, V42, pD358, DOI 10.1093/nar/gkt1115; Pal D, 2000, BIOPOLYMERS, V53, P467, DOI 10.1002/(SICI)1097-0282(200005)53:6<467::AID-BIP3>3.0.CO;2-9; Perkins JR, 2010, STRUCTURE, V18, P1233, DOI 10.1016/j.str.2010.08.007; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Qin HX, 1999, NATURE, V399, P549, DOI 10.1038/21124; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Reverter D, 2000, NAT STRUCT BIOL, V7, P322, DOI 10.1038/74092; Santelli E, 2000, J MOL BIOL, V297, P437, DOI 10.1006/jmbi.2000.3568; Schneider B, 2014, NUCLEIC ACIDS RES, V42, P3381, DOI 10.1093/nar/gkt1273; Talavera D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021053; THORNTON JM, 1983, J MOL BIOL, V167, P443, DOI 10.1016/S0022-2836(83)80344-1; Toth-Petroczy A, 2009, J AM CHEM SOC, V131, P15084, DOI 10.1021/ja9052784; Uversky VN, 2013, FEBS LETT, V587, P1891, DOI 10.1016/j.febslet.2013.04.042; vanPouderoyen G, 1997, EMBO J, V16, P6044, DOI 10.1093/emboj/16.19.6044; Vreven T, 2015, J MOL BIOL, V427, P3031, DOI 10.1016/j.jmb.2015.07.016; Wang GL, 2003, BIOINFORMATICS, V19, P1589, DOI 10.1093/bioinformatics/btg224; Yan C, 2008, PROTEIN J, V27, P59, DOI 10.1007/s10930-007-9108-x; Zhu HB, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-27	45	0	0	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162143	10.1371/journal.pone.0162143	http://dx.doi.org/10.1371/journal.pone.0162143			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611671	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900048
J	Selby, MJ; Engelhardt, JJ; Johnston, RJ; Lu, LS; Han, MH; Thudium, K; Yao, DP; Quigley, M; Valle, J; Wang, CY; Chen, B; Cardarelli, PM; Blanset, D; Korman, AJ				Selby, Mark J.; Engelhardt, John J.; Johnston, Robert J.; Lu, Li-Sheng; Han, Minhua; Thudium, Kent; Yao, Dapeng; Quigley, Michael; Valle, Jose; Wang, Changyu; Chen, Bing; Cardarelli, Pina M.; Blanset, Diann; Korman, Alan J.			Preclinical Development of Ipilimumab and Nivolumab Combination Immunotherapy: Mouse Tumor Models, In Vitro Functional Studies, and Cynomolgus Macaque Toxicology	PLOS ONE			English	Article							FC-GAMMA RECEPTORS; REGULATORY T; PD-1 BLOCKADE; PROGRAMMED DEATH-1; ANTITUMOR-ACTIVITY; CTLA-4; CELLS; CANCER; ANTIBODY; STIMULATION	The monoclonal antibodies ipilimumab (anti-CTLA-4) and nivolumab (anti-PD-1) have shown remarkable antitumor activity in an increasing number of cancers. When combined, ipilimumab and nivolumab have demonstrated superior activity in patients with metastatic melanoma (CHECKMATE-067). Here we describe the preclinical development strategy that predicted these clinical results. Synergistic antitumor activity in mouse MC38 and CT26 colorectal tumor models was observed with concurrent, but not sequential CTLA-4 and PD1 blockade. Significant antitumor activity was maintained using a fixed dose of anti-CTLA-4 antibody with decreasing doses of anti-PD-1 antibody in the MC38 model. Immunohistochemical and flow cytometric analyses confirmedthat CD3(+) T cells accumulated at the tumor margin and infiltrated the tumor mass in response to the combination therapy, resulting in favorable effector and regulatory T-cell ratios, increased pro-inflammatory cytokine secretion, and activation of tumor-specific T cells. Similarly, in vitro studies with combined ipilimumab and nivolumab showed enhanced cytokine secretion in superantigen stimulation of human peripheral blood lymphocytes and in mixed lymphocyte response assays. In a cynomolgus macaque toxicology study, dose-dependent immune-related gastrointestinal inflammation was observed with the combination therapy; this response had not been observed in previous single agent cynomolgus studies. Together, these in vitro assays and in vivo models comprise a preclinical strategy for the identification and development of highly effective antitumor combination immunotherapies.	[Selby, Mark J.; Engelhardt, John J.; Johnston, Robert J.; Lu, Li-Sheng; Han, Minhua; Thudium, Kent; Yao, Dapeng; Quigley, Michael; Valle, Jose; Wang, Changyu; Chen, Bing; Cardarelli, Pina M.; Blanset, Diann; Korman, Alan J.] Bristol Myers Squibb, Redwood City, CA 94063 USA	Bristol-Myers Squibb	Korman, AJ (corresponding author), Bristol Myers Squibb, Redwood City, CA 94063 USA.	alan.korman@bms.com			Bristol-Myers Squibb	Bristol-Myers Squibb(Bristol-Myers Squibb)	The studies described in this manuscript were sponsored by Bristol-Myers Squibb. The funder provided support in the form of salaries for all authors (MJS JJE RJJ LL MH KT DY MQ JV CW BC PMC DB AJK) and was involved in study design, data collection and analysis, decision to publish, and preparation of the manuscript. The specific roles of these authors are articulated in the Authors' Contributions section. In addition, the funder provided support in the form of salaries to individuals listed in the Acknowledgements section (LW MS IC CB).	Ahmadzadeh M, 2009, BLOOD, V114, P1537, DOI 10.1182/blood-2008-12-195792; Antonia S., 2016, LANCET ONCOL; Brahmer JR, 2015, FUTURE ONCOL, V11, P1307, DOI 10.2217/fon.15.52; Bulliard Y, 2013, J EXP MED, V210, P1685, DOI 10.1084/jem.20130573; Chemnitz JM, 2004, J IMMUNOL, V173, P945, DOI 10.4049/jimmunol.173.2.945; Chen LP, 2013, NAT REV IMMUNOL, V13, P227, DOI 10.1038/nri3405; Corse E, 2012, J IMMUNOL, V189, P1123, DOI 10.4049/jimmunol.1200695; Curran MA, 2010, P NATL ACAD SCI USA, V107, P4275, DOI 10.1073/pnas.0915174107; Dahan R, 2015, CANCER CELL, V28, P285, DOI 10.1016/j.ccell.2015.08.004; Dasari A, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_suppl.3563; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Duraiswamy J, 2013, CANCER RES, V73, P3591, DOI 10.1158/0008-5472.CAN-12-4100; Francisco LM, 2010, IMMUNOL REV, V236, P219, DOI 10.1111/j.1600-065X.2010.00923.x; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Grosso Joseph F, 2013, Cancer Immun, V13, P5; Gubin MM, 2014, NATURE, V515, P577, DOI 10.1038/nature13988; Hellman MD, 2016, J CLIN ONCOL S, V34; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Keler T, 2003, J IMMUNOL, V171, P6251, DOI 10.4049/jimmunol.171.11.6251; Le DT, 2015, NEW ENGL J MED, V372, P2509, DOI 10.1056/NEJMoa1500596; LEBELBINAY S, 1995, EUR J IMMUNOL, V25, P2340, DOI 10.1002/eji.1830250833; Li B, 2009, CLIN CANCER RES, V15, P1623, DOI 10.1158/1078-0432.CCR-08-1825; Llosa NJ, 2015, CANCER DISCOV, V5, P43, DOI 10.1158/2159-8290.CD-14-0863; Melero I, 2015, NAT REV CANCER, V15, P457, DOI 10.1038/nrc3973; Mumm JB, 2011, CANCER CELL, V20, P781, DOI 10.1016/j.ccr.2011.11.003; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Ngiow SF, 2015, CANCER RES, V75, P3800, DOI 10.1158/0008-5472.CAN-15-1082; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Parry RV, 2005, MOL CELL BIOL, V25, P9543, DOI 10.1128/MCB.25.21.9543-9553.2005; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Peggs KS, 2008, IMMUNOL REV, V224, P141, DOI 10.1111/j.1600-065X.2008.00649.x; Peng WY, 2012, CANCER RES, V72, P5209, DOI 10.1158/0008-5472.CAN-12-1187; Postow MA, 2015, NEW ENGL J MED, V372, P2006, DOI 10.1056/NEJMoa1414428; Quezada SA, 2006, J CLIN INVEST, V116, P1935, DOI 10.1172/JCI27745; Qureshi OS, 2011, SCIENCE, V332, P600, DOI 10.1126/science.1202947; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Selby MJ, 2013, CANCER IMMUNOL RES, V1, P32, DOI 10.1158/2326-6066.CIR-13-0013; Simpson TR, 2013, J EXP MED, V210, P1695, DOI 10.1084/jem.20130579; Sivan A, 2015, SCIENCE, V350, P1084, DOI 10.1126/science.aac4255; Spranger S, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006504; Taube JM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003689; Tumeh PC, 2014, NATURE, V515, P568, DOI 10.1038/nature13954; Ueha S, 2015, CANCER IMMUNOL RES, V3, P631, DOI 10.1158/2326-6066.CIR-14-0190; Valsecchi ME, 2015, NEW ENGL J MED, V373, P1270, DOI [10.1056/NEJMoa1504030, 10.1056/NEJMc1509660]; Vetizou M, 2015, SCIENCE, V350, P1079, DOI 10.1126/science.aad1329; Walker LSK, 2015, TRENDS IMMUNOL, V36, P63, DOI 10.1016/j.it.2014.12.001; Wang CY, 2014, CANCER IMMUNOL RES, V2, P846, DOI 10.1158/2326-6066.CIR-14-0040; Wang CJ, 2012, J IMMUNOL, V189, P1118, DOI 10.4049/jimmunol.1200972; Wherry EJ, 2015, NAT REV IMMUNOL, V15, P486, DOI 10.1038/nri3862; Wing K, 2008, SCIENCE, V322, P271, DOI 10.1126/science.1160062; Wolchok JD, 2016, J CLIN ONCOL, V34, DOI 10.1200/JCO.2016.34.15_supll.9505; Wolchok JD, 2013, ANN NY ACAD SCI, V1291, P1, DOI 10.1111/nyas.12180; Wolchok JD, 2013, NEW ENGL J MED, V369, P122, DOI 10.1056/NEJMoa1302369; Zou WP, 2008, NAT REV IMMUNOL, V8, P467, DOI 10.1038/nri2326	56	145	156	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161779	10.1371/journal.pone.0161779	http://dx.doi.org/10.1371/journal.pone.0161779			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610613	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255900029
J	Shin, MH; Lee, SR; Kim, MK; Shin, CY; Lee, DH; Chung, JH				Shin, Mi Hee; Lee, Se-Rah; Kim, Min-Kyoung; Shin, Chang-Yup; Lee, Dong Hun; Chung, Jin Ho			Activation of Peroxisome Proliferator-Activated Receptor Alpha Improves Aged and UV-Irradiated Skin by Catalase Induction	PLOS ONE			English	Article							MESSENGER-RNA EXPRESSION; HUMAN DERMAL FIBROBLASTS; SUPEROXIDE-DISMUTASE; OXIDATIVE STRESS; ULTRAVIOLET; INFLAMMATION; MECHANISMS; MODULATION; RESPONSES; EPIDERMIS	Peroxisome proliferator-activated receptor alpha (PPAR alpha) is a nuclear hormone receptor involved in the transcriptional regulation of lipid metabolism, fatty acid oxidation, and glucose homeostasis. Its activation stimulates antioxidant enzymes such as catalase, whose expression is decreased in aged human skin. Here we investigated the expression of PPAR alpha in aged and ultraviolet (UV)-irradiated skin, and whether PPAR alpha activation can modulate expressions of matrix metalloproteinase (MMP)-1 and procollagen through catalase regulation. We found that PPAR alpha mRNA level was significantly decreased in intrinsically aged and photoaged human skin as well as in UV-irradiated skin. A PPAR alpha activator, Wy14643, inhibited UV-induced increase of MMP-1 and decrease of procollagen expression and caused marked increase in catalase expression. Furthermore, production of reactive oxygen species (ROS) was suppressed by Wy14643 in UV-irradiated and aged dermal fibroblasts, suggesting that the PPAR alpha activation-induced upregulation of catalase leads to scavenging of ROS produced due to UV irradiation or aging. PPAR alpha knockdown decreased catalase expression and abolished the beneficial effects of Wy14643. Topical application of Wy14643 on hairless mice restored catalase activity and prevented MMP-13 and inflammatory responses in skin. Our findings indicate that PPAR alpha activation triggers catalase expression and ROS scavenging, thereby protecting skin from UV-induced damage and intrinsic aging.	[Shin, Mi Hee; Lee, Se-Rah; Kim, Min-Kyoung; Shin, Chang-Yup; Lee, Dong Hun; Chung, Jin Ho] Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea; [Shin, Mi Hee; Lee, Se-Rah; Kim, Min-Kyoung; Shin, Chang-Yup; Lee, Dong Hun; Chung, Jin Ho] Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea; [Shin, Mi Hee; Lee, Se-Rah; Kim, Min-Kyoung; Shin, Chang-Yup; Lee, Dong Hun; Chung, Jin Ho] Seoul Natl Univ, Med Res Ctr, Inst Human Environm Interface Biol, Seoul, South Korea; [Chung, Jin Ho] Seoul Natl Univ, Inst Aging, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU); Seoul National University (SNU)	Lee, DH; Chung, JH (corresponding author), Seoul Natl Univ, Coll Med, Dept Dermatol, Seoul, South Korea.; Lee, DH; Chung, JH (corresponding author), Seoul Natl Univ Hosp, Biomed Res Inst, Seoul, South Korea.; Lee, DH; Chung, JH (corresponding author), Seoul Natl Univ, Med Res Ctr, Inst Human Environm Interface Biol, Seoul, South Korea.; Chung, JH (corresponding author), Seoul Natl Univ, Inst Aging, Seoul, South Korea.	ivymed27@snu.ac.kr; jhchung@snu.ac.kr	Lee, Dong Hun/AAS-6021-2021		Korea Research Foundation; Basic Science Research program through the National Research Foundation (NRF) of Korea [2009-2-E00032]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C0089]	Korea Research Foundation(National Research Foundation of Korea); Basic Science Research program through the National Research Foundation (NRF) of Korea; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea	This research was supported by a grant of Korea Research Foundation and Basic Science Research program through the National Research Foundation (NRF) of Korea (2009-2-E00032) and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C0089).	Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Briganti S, 2013, EXP DERMATOL, V22, P41, DOI 10.1111/exd.12066; Burri L, 2010, PPAR RES, V2010, DOI 10.1155/2010/542359; Chung JH, 2001, J INVEST DERMATOL, V117, P1218, DOI 10.1046/j.0022-202x.2001.01544.x; El-Abaseri TB, 2005, CANCER RES, V65, P3958, DOI 10.1158/0008-5472.CAN-04-2204; Fisher GJ, 2002, ARCH DERMATOL, V138, P1462, DOI 10.1001/archderm.138.11.1462; Fisher GJ, 1997, NEW ENGL J MED, V337, P1419, DOI 10.1056/NEJM199711133372003; Ghosh AK, 2004, ARTHRITIS RHEUM-US, V50, P1305, DOI 10.1002/art.20104; Girnun GD, 2002, MOL ENDOCRINOL, V16, P2793, DOI 10.1210/me.2002-0020; Gupta M, 2015, ARCH DERMATOL RES, V307, P767, DOI 10.1007/s00403-015-1571-1; Hatano Y, 2010, J ALLERGY CLIN IMMUN, V125, P160, DOI 10.1016/j.jaci.2009.06.049; Howroyd P, 2004, TOXICOL PATHOL, V32, P591, DOI 10.1080/01926230490515283; Ichihashi M, 2003, TOXICOLOGY, V189, P21, DOI 10.1016/S0300-483X(03)00150-1; Iemitsu M, 2002, AM J PHYSIOL-HEART C, V283, pH1750, DOI 10.1152/ajpheart.01051.2001; Inoue I, 1998, LIFE SCI, V63, P135, DOI 10.1016/S0024-3205(98)00249-5; ISSEMANN I, 1990, NATURE, V347, P645, DOI 10.1038/347645a0; Jeon Y, 2014, BIOCHEM BIOPH RES CO, V450, P1553, DOI 10.1016/j.bbrc.2014.07.026; Kawaguchi Y, 1996, ARCH DERMATOL RES, V288, P39, DOI 10.1007/BF02505041; Kim JK, 2012, EXP DERMATOL, V21, P211, DOI 10.1111/j.1600-0625.2011.01435.x; Kippenberger S, 2001, J INVEST DERMATOL, V117, P1430, DOI 10.1046/j.0022-202x.2001.01537.x; Kwok HH, 2012, BIOCHEM PHARMACOL, V84, P532, DOI 10.1016/j.bcp.2012.05.023; Lavrovsky Y, 2000, EXP GERONTOL, V35, P521, DOI 10.1016/S0531-5565(00)00118-2; Lee YM, 2011, ARCH DERMATOL RES, V303, P727, DOI 10.1007/s00403-011-1153-9; Li JL, 2012, J BIOMED SCI, V19, DOI 10.1186/1423-0127-19-32; Meissner M, 2011, CLIN EXP DERMATOL, V36, P911, DOI 10.1111/j.1365-2230.2011.04125.x; Michalik L, 2001, J CELL BIOL, V154, P799, DOI 10.1083/jcb.200011148; Michalik L, 2007, BBA-MOL CELL BIOL L, V1771, P991, DOI 10.1016/j.bbalip.2007.02.004; Naderi-Hachtroudi L, 2002, ARCH DERMATOL, V138, P1473, DOI 10.1001/archderm.138.11.1473; Park MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076820; Portilla D, 2000, AM J PHYSIOL-RENAL, V278, pF667, DOI 10.1152/ajprenal.2000.278.4.F667; Poynter ME, 1998, J BIOL CHEM, V273, P32833, DOI 10.1074/jbc.273.49.32833; Rhie GE, 2001, J INVEST DERMATOL, V117, P1212, DOI 10.1046/j.0022-202x.2001.01469.x; Rhie GE, 2001, MOL CELLS, V11, P399; Sarkar D, 2006, CANCER LETT, V236, P13, DOI 10.1016/j.canlet.2005.04.009; Seo JY, 2001, J INVEST DERMATOL, V116, P915, DOI 10.1046/j.1523-1747.2001.01358.x; Sheu MY, 2002, J INVEST DERMATOL, V118, P94, DOI 10.1046/j.0022-202x.2001.01626.x; Shin MH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061696; Shin MH, 2012, MECH AGEING DEV, V133, P92, DOI 10.1016/j.mad.2012.01.006; Skobowiat C, 2013, BRIT J DERMATOL, V168, P595, DOI 10.1111/bjd.12096; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; SLOMINSKI A, 2013, J STEROID BIOCHEM, V137, P107, DOI [10.1016/.jsbmb.2013.02.006, DOI 10.1016/J.JSBMB.2013.02.006]; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; SMITH WL, 1994, ANN NY ACAD SCI, V714, P136, DOI 10.1111/j.1749-6632.1994.tb12037.x; Staumont-Salle D, 2008, J ALLERGY CLIN IMMUN, V121, P962, DOI 10.1016/j.jaci.2007.12.1165; Wenk J, 2001, CURR PROBL DERMATOL, V29, P83; Youssef J, 1999, ENVIRON HEALTH PERSP, V107, P791, DOI 10.2307/3454575; Zhang GY, 2010, J PLAST RECONSTR AES, V63, P1209, DOI 10.1016/j.bjps.2009.06.032	47	19	21	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162628	10.1371/journal.pone.0162628	http://dx.doi.org/10.1371/journal.pone.0162628			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611371	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900137
J	Sistla, SA; Roddy, AB; Williams, NE; Kramer, DB; Stevens, K; Allison, SD				Sistla, Seeta A.; Roddy, Adam B.; Williams, Nicholas E.; Kramer, Daniel B.; Stevens, Kara; Allison, Steven D.			Agroforestry Practices Promote Biodiversity and Natural Resource Diversity in Atlantic Nicaragua	PLOS ONE			English	Article							SOIL CARBON SEQUESTRATION; LAND-USE CHANGE; PHYLOGENETIC DIVERSITY; FUNCTIONAL DIVERSITY; FOREST MANAGEMENT; TROPICAL FORESTS; CONSERVATION; PASTURE; CLIMATE; AGRICULTURE	Tropical forest conversion to pasture, which drives greenhouse gas emissions, soil degradation, and biodiversity loss, remains a pressing socio-ecological challenge. This problem has spurred increased interest in the potential of small-scale agroforestry systems to couple sustainable agriculture with biodiversity conservation, particularly in rapidly developing areas of the tropics. In addition to providing natural resources (i.e. food, medicine, lumber), agroforestry systems have the potential to maintain higher levels of biodiversity and greater biomass than lower diversity crop or pasture systems. Greater plant diversity may also enhance soil quality, further supporting agricultural productivity in nutrient-limited tropical systems. Yet, the nature of these relationships remains equivocal. To better understand how different land use strategies impact ecosystem services, we characterized the relationships between plant diversity (including species richness, phylogenetic diversity, and natural resource diversity), and soil quality within pasture, agroforests, and secondary forests, three common land use types maintained by small-scale farmers in the Pearl Lagoon Basin, Nicaragua. The area is undergoing accelerated globalization following the 2007 completion of the region's first major road; a change which is expected to increase forest conversion for agriculture. However, farmer agrobiodiversity maintenance in the Basin was previously found to be positively correlated with affiliation to local agricultural NGOs through the maintenance of agroforestry systems, despite these farmers residing in the communities closest to the new road, highlighting the potential for maintaining diverse agroforestry agricultural strategies despite heightened globalization pressures. We found that agroforestry sites tended to have higher surface soil % C, % N, and pH relative to neighboring to secondary forest, while maintaining comparable plant diversity. In contrast, pasture reduced species richness, phylogenetic diversity, and natural resource diversity. No significant relationships were found between plant diversity and the soil properties assessed; however higher species richness and phylodiversity was positively correlated with natural resource diversity. These finding suggest that small, diversified agroforestry systems may be a viable strategy for promoting both social and ecological functions in eastern Nicaragua and other rapidly developing areas of the tropics.	[Sistla, Seeta A.] Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA; [Sistla, Seeta A.; Allison, Steven D.] Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA; [Roddy, Adam B.] Yale Univ, Sch Forestry & Environm Studies, New Haven, CT 06511 USA; [Williams, Nicholas E.] Univ Calif Santa Barbara, Dept Anthropol, Santa Barbara, CA 93106 USA; [Williams, Nicholas E.] Univ Colorado, Dept Environm Studies, Boulder, CO USA; [Kramer, Daniel B.; Stevens, Kara] Michigan State Univ, Dept Fisheries & Wildlife, E Lansing, MI 48824 USA; [Allison, Steven D.] Univ Calif Irvine, Dept Earth Syst Sci, Irvine, CA 92697 USA	University of California System; University of California Irvine; Yale University; University of California System; University of California Santa Barbara; University of Colorado System; University of Colorado Boulder; Michigan State University; University of California System; University of California Irvine	Sistla, SA (corresponding author), Hampshire Coll, Sch Nat Sci, Amherst, MA 01002 USA.; Sistla, SA (corresponding author), Univ Calif Irvine, Dept Ecol & Evolutionary Biol, Irvine, CA 92697 USA.	ssistla@hampshire.edu	Roddy, Adam/M-4523-2013; Allison, Steven D./E-2978-2010	Roddy, Adam/0000-0002-4423-8729; Allison, Steven D./0000-0003-4629-7842	U.S. National Socio-Environmental Synthesis Center (SESYNC); Helmholtz Centre for Environmental Research (UFZ); German Center for Integrative Biodiversity Research (iDIV) Biodiversity and Ecosystem Services working group; National Oceanic and Atmospheric Agency Climate and Global Change Postdoctoral Fellowship; NOAA Climate and Global Change Postdoctoral Fellowship; Direct For Biological Sciences [1639145] Funding Source: National Science Foundation; Div Of Biological Infrastructure [1052875] Funding Source: National Science Foundation	U.S. National Socio-Environmental Synthesis Center (SESYNC)(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Helmholtz Centre for Environmental Research (UFZ)(Helmholtz Association); German Center for Integrative Biodiversity Research (iDIV) Biodiversity and Ecosystem Services working group; National Oceanic and Atmospheric Agency Climate and Global Change Postdoctoral Fellowship; NOAA Climate and Global Change Postdoctoral Fellowship(National Oceanic Atmospheric Admin (NOAA) - USA); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); Div Of Biological Infrastructure(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This work was supported by the U.S. National Socio-Environmental Synthesis Center (SESYNC), the Helmholtz Centre for Environmental Research (UFZ), and the German Center for Integrative Biodiversity Research (iDIV) Biodiversity and Ecosystem Services working group. SS was supported by the National Oceanic and Atmospheric Agency Climate and Global Change Postdoctoral Fellowship Program, administered by the University Corporation for Atmospheric Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Vanny Brown for expert field assistance, the Foundation for the Autonomy and Development of the Atlantic Coast of Nicaragua (FADCANIC) for field support, Inigo Granzo de la Cerda for help with plant identification, and Anna Schurkmann for GIS support. This work was supported by the U.S. National Socio-Environmental Synthesis Center (SESYNC), the Helmholtz Centre for Environmental Research (UFZ), and the German Center for Integrative Biodiversity Research (iDIV) Biodiversity and Ecosystem Services working group. SS was supported by the NOAA Climate and Global Change Postdoctoral Fellowship Program, administered by the University Corporation for Atmospheric Research.	Albrecht A, 2003, AGR ECOSYST ENVIRON, V99, P15, DOI 10.1016/S0167-8809(03)00138-5; Alfaia SS, 2004, AGR ECOSYST ENVIRON, V102, P409, DOI 10.1016/j.agee.2003.08.011; BARRETT B, 1994, ECON BOT, V48, P8, DOI 10.1007/BF02901375; Bond WJ, 2010, BIOL CONSERV, V143, P2395, DOI 10.1016/j.biocon.2009.12.012; BOUCHER DH, 1990, ECOLOGY, V71, P2022, DOI 10.2307/1937611; BRAY RH, 1945, SOIL SCI, V59, P39, DOI 10.1097/00010694-194501000-00006; Cadotte MW, 2015, FUNCT ECOL, V29, P718, DOI 10.1111/1365-2435.12429; Cadotte MW, 2011, J APPL ECOL, V48, P1079, DOI 10.1111/j.1365-2664.2011.02048.x; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; Coe FG, 2008, J ETHNOPHARMACOL, V117, P136, DOI 10.1016/j.jep.2008.01.027; Coe Felix G., 1997, Journal of Ethnobiology, V17, P171; Coe FG, 1996, ECON BOT, V50, P71, DOI 10.1007/BF02862114; Coe FG, 2005, J ETHNOPHARMACOL, V96, P303, DOI 10.1016/j.jep.2004.09.026; Coe FG, 1999, ECON BOT, V53, P363, DOI 10.1007/BF02866715; DENNIS PA, 1988, ECON BOT, V42, P16, DOI 10.1007/BF02859024; Flynn DFB, 2011, ECOLOGY, V92, P1573, DOI 10.1890/10-1245.1; Foley JA, 2005, SCIENCE, V309, P570, DOI 10.1126/science.1111772; Garcia-Oliva F, 2004, CLIMATIC CHANGE, V65, P347, DOI 10.1023/B:CLIM.0000038211.84327.d9; Giardina CP, 2000, SOIL SCI SOC AM J, V64, P399, DOI 10.2136/sssaj2000.641399x; Glaser B, 2002, BIOL FERT SOILS, V35, P219, DOI 10.1007/s00374-002-0466-4; GRAFEN A, 1989, PHILOS T R SOC B, V326, P119, DOI 10.1098/rstb.1989.0106; Guariguata MR, 2001, FOREST ECOL MANAG, V148, P185, DOI 10.1016/S0378-1127(00)00535-1; Gullison RE, 2007, SCIENCE, V316, P985, DOI 10.1126/science.1136163; Guo LB, 2002, GLOBAL CHANGE BIOL, V8, P345, DOI 10.1046/j.1354-1013.2002.00486.x; Harvey CA, 2008, CONSERV BIOL, V22, P8, DOI 10.1111/j.1523-1739.2007.00863.x; HilleRisLambers J, 2004, ECOL LETT, V7, P661, DOI 10.1111/j.1461-0248.2004.00623.x; Jandl R, 2007, GEODERMA, V137, P253, DOI 10.1016/j.geoderma.2006.09.003; JOHNSON DW, 1992, WATER AIR SOIL POLL, V64, P83, DOI 10.1007/BF00477097; Jose S, 2009, AGROFOREST SYST, V76, P1, DOI 10.1007/s10457-009-9229-7; Katovai E, 2012, BIOL CONSERV, V145, P214, DOI 10.1016/j.biocon.2011.11.008; Kembel SW, 2010, BIOINFORMATICS, V26, P1463, DOI 10.1093/bioinformatics/btq166; Kirby KR, 2007, FOREST ECOL MANAG, V246, P208, DOI 10.1016/j.foreco.2007.03.072; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lamb D, 2005, SCIENCE, V310, P1628, DOI 10.1126/science.1111773; Lawrence D, 2015, NAT CLIM CHANGE, V5, P27, DOI [10.1038/nclimate2430, 10.1038/NCLIMATE2430]; Mayfield MM, 2005, ECOL APPL, V15, P423, DOI 10.1890/03-5369; McCloskey TA, 2012, QUATERNARY RES, V78, P454, DOI 10.1016/j.yqres.2012.07.003; McNeely JA, 2006, BIODIVERS CONSERV, V15, P549, DOI 10.1007/s10531-005-2087-3; Milcu A, 2013, ECOLOGY, V94, P1878, DOI 10.1890/12-1936.1; Montagnini F, 2004, AGROFOREST SYST, V61-2, P281, DOI 10.1023/B:AGFO.0000029005.92691.79; Nair PKR, 2009, ENVIRON SCI POLICY, V12, P1099, DOI 10.1016/j.envsci.2009.01.010; Norris K, 2008, CONSERV LETT, V1, P2, DOI 10.1111/j.1755-263X.2008.00007.x; Paul KI, 2002, FOREST ECOL MANAG, V168, P241, DOI 10.1016/S0378-1127(01)00740-X; Perfecto I, 2010, P NATL ACAD SCI USA, V107, P5786, DOI 10.1073/pnas.0905455107; R Core Team, 2021, R LANGUAGE ENV STAT; REINERS WA, 1994, ECOL APPL, V4, P363, DOI 10.2307/1941940; Scales BR, 2008, ENVIRON CONSERV, V35, P160, DOI 10.1017/S0376892908004840; Schelhas J, 2009, CONSERV LETT, V2, P278, DOI 10.1111/j.1755-263X.2009.00079.x; Schmitt KM, 2009, ENVIRON CONSERV, V36, P289, DOI 10.1017/S0376892910000159; Schoenholtz SH, 2000, FOREST ECOL MANAG, V138, P335, DOI 10.1016/S0378-1127(00)00423-0; Stevens K, 2011, BIODIVERS CONSERV, V20, P2597, DOI 10.1007/s10531-011-0093-1; Tilman D, 2001, SCIENCE, V292, P281, DOI 10.1126/science.1057544; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Townsend AR, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000650; Tscharntke T, 2012, BIOL CONSERV, V151, P53, DOI 10.1016/j.biocon.2012.01.068; Tubiello FN, 2015, GLOBAL CHANGE BIOL, V21, P2655, DOI 10.1111/gcb.12865; van Ruijven J, 2005, P NATL ACAD SCI USA, V102, P695, DOI 10.1073/pnas.0407524102; Vandermeer J, 2007, CONSERV BIOL, V21, P274, DOI 10.1111/j.1523-1739.2006.00582.x; Wara M, 2007, NATURE, V445, P595, DOI 10.1038/445595a; Wassenaar T, 2007, GLOBAL ENVIRON CHANG, V17, P86, DOI 10.1016/j.gloenvcha.2006.03.007; Webb CO, 2005, MOL ECOL NOTES, V5, P181, DOI 10.1111/j.1471-8286.2004.00829.x; Williams NE, 2016, J POLIT ECOL, V23, P223, DOI 10.2458/v23i1.20210; Wright HL, 2012, CONSERV LETT, V5, P11, DOI 10.1111/j.1755-263X.2011.00208.x; Zimmerer KS, 2015, RESILIENCE, V3, P183, DOI 10.1080/21693293.2015.1072311	65	23	23	1	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162529	10.1371/journal.pone.0162529	http://dx.doi.org/10.1371/journal.pone.0162529			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606619	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255600058
J	Whitfield, CA; Hawkins, RJ				Whitfield, Carl A.; Hawkins, Rhoda J.			Immersed Boundary Simulations of Active Fluid Droplets	PLOS ONE			English	Article							INTERFACIAL FLOWS; CONTRACTILITY; DEFORMATION; SURFACTANTS; DYNAMICS; CORTEX; GELS	We present numerical simulations of active fluid droplets immersed in an external fluid in 2-dimensions using an Immersed Boundary method to simulate the fluid droplet interface as a Lagrangian mesh. We present results from two example systems, firstly an active isotropic fluid boundary consisting of particles that can bind and unbind from the interface and generate surface tension gradients through active contractility. Secondly, a droplet filled with an active polar fluid with homeotropic anchoring at the droplet interface. These two systems demonstrate spontaneous symmetry breaking and steady state dynamics resembling cell motility and division and show complex feedback mechanisms with minimal degrees of freedom. The simulations outlined here will be useful for quantifying the wide range of dynamics observable in these active systems and modelling the effects of confinement in a consistent and adaptable way.	[Whitfield, Carl A.; Hawkins, Rhoda J.] Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England; [Whitfield, Carl A.] Univ Warwick, Dept Phys, Coventry CV3 7AL, W Midlands, England	University of Sheffield; University of Warwick	Whitfield, CA (corresponding author), Univ Sheffield, Dept Phys & Astron, Sheffield S3 7RH, S Yorkshire, England.; Whitfield, CA (corresponding author), Univ Warwick, Dept Phys, Coventry CV3 7AL, W Midlands, England.	carl.whitfield@physics.org	Whitfield, Carl/J-5751-2019; Hawkins, Rhoda/G-5053-2011	Whitfield, Carl/0000-0001-5913-735X; Hawkins, Rhoda/0000-0002-9027-7622	EPSRC [EP-K503149-1]; Engineering and Physical Sciences Research Council [1294939] Funding Source: researchfish	EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by EPSRC https://www.epsrc.ac.uk, grant no. EP-K503149-1. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We acknowledge the EPSRC for funding this work, grant reference EP-K503149-1. We also thank Suzanne Fielding for useful discussion and insight, and Davide Marenduzzo and Elsen Tjhung for sharing the simulation source code used in [14].	[Anonymous], NAG LIB; Bendix PM, 2008, BIOPHYS J, V94, P3126, DOI 10.1529/biophysj.107.117960; Bois JS, 2011, PHYS REV LETT, V106, DOI 10.1103/PhysRevLett.106.028103; Chen KY, 2014, J COMPUT PHYS, V257, P1, DOI 10.1016/j.jcp.2013.10.003; Conn JJA, 2016, PHYS REV E, V93, DOI 10.1103/PhysRevE.93.043121; De Gennes P.-G., 1993, PHYS LIQUID CRYSTALS; Dombrowski C, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.098103; Furthauer S, 2012, NEW J PHYS, V14, DOI 10.1088/1367-2630/14/2/023001; GINZBURG VL, 1958, SOV PHYS JETP-USSR, V7, P78; Giomi L, 2012, NONLINEARITY, V25, P2245, DOI 10.1088/0951-7715/25/8/2245; Giomi L, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.147802; Giomi L, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.228101; Hawkins RJ, 2011, BIOPHYS J, V101, P1041, DOI 10.1016/j.bpj.2011.07.038; Herminghaus S, 2014, SOFT MATTER, V10, P7008, DOI 10.1039/c4sm00550c; James AJ, 2004, J COMPUT PHYS, V201, P685, DOI 10.1016/j.jcp.2004.06.013; Joanny JF, 2013, EUR PHYS J E, V36, DOI 10.1140/epje/i2013-13052-9; Joanny JF, 2009, HFSP J, V3, P94, DOI 10.2976/1.3054712; Keber FC, 2014, SCIENCE, V345, P1135, DOI 10.1126/science.1254784; Khoromskaia D, 2015, PHYS REV E, V92, DOI 10.1103/PhysRevE.92.062311; Kruse K, 2006, PHYS BIOL, V3, P130, DOI 10.1088/1478-3975/3/2/005; Kruse K, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.078101; Kruse K, 2005, EUR PHYS J E, V16, P5, DOI 10.1140/epje/e2005-00002-5; Lai MC, 2008, J COMPUT PHYS, V227, P7279, DOI 10.1016/j.jcp.2008.04.014; Lee J, 2006, COMPUT FLUIDS, V35, P43, DOI 10.1016/j.compfluid.2004.11.004; LEVEQUE RJ, 1994, SIAM J NUMER ANAL, V31, P1019, DOI 10.1137/0731054; Marchetti MC, 2013, REV MOD PHYS, V85, DOI 10.1103/RevModPhys.85.1143; Masoud H, 2014, PHYS REV LETT, V112, DOI 10.1103/PhysRevLett.112.128304; Pawar Y, 1996, PHYS FLUIDS, V8, P1738, DOI 10.1063/1.868958; Peskin CS, 2002, ACT NUMERIC, V11, P479, DOI 10.1017/S0962492902000077; PESKIN CS, 1982, ANNU REV FLUID MECH, V14, P235, DOI 10.1146/annurev.fl.14.010182.001315; Ramaswamy S, 2010, ANNU REV CONDEN MA P, V1, P323, DOI 10.1146/annurev-conmatphys-070909-104101; Sanchez T, 2012, NATURE, V491, P431, DOI 10.1038/nature11591; SMALL JV, 1978, NATURE, V272, P638, DOI 10.1038/272638a0; Teigen KE, 2009, COMMUN MATH SCI, V7, P1009; Tjhung E, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6420; Tjhung E, 2012, P NATL ACAD SCI USA, V109, P12381, DOI 10.1073/pnas.1200843109; Tjhung E, 2011, SOFT MATTER, V7, P7453, DOI 10.1039/c1sm05396e; Tsai FC, 2011, LANGMUIR, V27, P10061, DOI 10.1021/la201604z; UNVERDI SO, 1992, J COMPUT PHYS, V100, P25, DOI 10.1016/0021-9991(92)90307-K; Vladescu ID, 2014, PHYS REV LETT, V113, DOI 10.1103/PhysRevLett.113.268101; Whitfield CA, 2016, 1605018642016 ARXIV; Whitfield CA, 2015, THESIS; Wottawah F, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.098103; Xu JJ, 2014, COMMUN COMPUT PHYS, V15, P451, DOI 10.4208/cicp.241012.310513a; Yon S, 1998, COMPUT FLUIDS, V27, P879, DOI 10.1016/S0045-7930(98)00013-9; Yue PT, 2004, J FLUID MECH, V515, P293, DOI 10.1017/S0022112004000370; Ziebert F, 2012, J R SOC INTERFACE, V9, P1084, DOI 10.1098/rsif.2011.0433; Zumdieck A, 2005, PHYS REV LETT, V95, DOI [10.1103/PhysRevLett.95.258103, 10.1103/PhysREvLett.95.258103]	48	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162474	10.1371/journal.pone.0162474	http://dx.doi.org/10.1371/journal.pone.0162474			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606609	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000383255600048
J	Magnan, C; Yu, J; Chang, I; Jahn, E; Kanomata, Y; Wu, J; Zeller, M; Oakes, M; Baldi, P; Sandmeyer, S				Magnan, Christophe; Yu, James; Chang, Ivan; Jahn, Ethan; Kanomata, Yuzo; Wu, Jenny; Zeller, Michael; Oakes, Melanie; Baldi, Pierre; Sandmeyer, Suzanne			Sequence Assembly of Yarrowia lipolytica Strain W29/CLIB89 Shows Transposable Element Diversity	PLOS ONE			English	Article							RIBOSOMAL-RNA GENES; MUTATOR-LIKE ELEMENT; HEMIASCOMYCETOUS YEASTS; GENOMIC EXPLORATION; DIMORPHIC YEAST; RETROTRANSPOSON; EVOLUTION; EXPRESSION; PREDICTION; HOMOLOGY	Yarrowia lipolytica, an oleaginous yeast, is capable of accumulating significant cellular mass in lipid making it an important source of biosustainable hydrocarbon-based chemicals. In spite of a similar number of protein-coding genes to that in other Hemiascomycetes, the Y. lipolytica genome is almost double that of model yeasts. Despite its economic importance and several distinct strains in common use, an independent genome assembly exists for only one strain. We report here a de novo annotated assembly of the chromosomal genome of an industrially-relevant strain, W29/CLIB89, determined by hybrid next-generation sequencing. For the first time, each Y. lipolytica chromosome is represented by a single contig. The telomeric rDNA repeats were localized by Irys long-range genome mapping and one complete copy of the rDNA sequence is reported. Two large structural variants and retroelement differences with reference strain CLIB122 including a full-length, novel Ty3/Gypsy long terminal repeat (LTR) retrotransposon and multiple LTR-like sequences are described. Strikingly, several of these are adjacent to RNA polymerase III-transcribed genes, which are almost double in number in Y. lipolytica compared to other Hemiascomycetes. In addition to previously-reported dimeric RNA polymerase III-transcribed genes, tRNA pseudogenes were identified. Multiple full-length and truncated LINE elements are also present. Therefore, although identified transposons do not constitute a significant fraction of the Y. lipolytica genome, they could have played an active role in its evolution. Differences between the sequence of this strain and of the existing reference strain underscore the utility of an additional independent genome assembly for this economically important organism.	[Magnan, Christophe; Kanomata, Yuzo; Zeller, Michael; Baldi, Pierre] Univ Calif Irvine, Dept Comp Sci, Sch Comp Sci, Irvine, CA USA; [Magnan, Christophe; Kanomata, Yuzo; Baldi, Pierre; Sandmeyer, Suzanne] Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA; [Yu, James; Chang, Ivan; Jahn, Ethan; Wu, Jenny; Oakes, Melanie; Baldi, Pierre; Sandmeyer, Suzanne] Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA; [Jahn, Ethan] Rice Univ, Houston, TX USA	University of California System; University of California Irvine; University of California System; University of California Irvine; University of California System; University of California Irvine; Rice University	Sandmeyer, S (corresponding author), Univ Calif Irvine, Inst Genom & Bioinformat, Irvine, CA 92697 USA.; Sandmeyer, S (corresponding author), Univ Calif Irvine, Sch Med, Dept Biol Chem, Irvine, CA 92697 USA.	sbsandme@uci.edu			National Science Foundation through the Engineering Research Center for Biorenewable Chemicals, CBiRC [EEC-0813570]; National Institutes of Health [LM010235]; NIH-National Library of Medicine [07443]; NSF [IIS-1321053]; Genomic High Throughput Facility Shared Resource of the National Cancer Institute Cancer Center Support Grant at the University of California, Irvine [CA-62203]; NIH [1S10RR025496-01, 1S10OD010794-01]	National Science Foundation through the Engineering Research Center for Biorenewable Chemicals, CBiRC; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH-National Library of Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM)); NSF(National Science Foundation (NSF)); Genomic High Throughput Facility Shared Resource of the National Cancer Institute Cancer Center Support Grant at the University of California, Irvine; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This research was supported by the National Science Foundation (Grant no. EEC-0813570, B.Shanks, PI; subcontract SS) through the Engineering Research Center for Biorenewable Chemicals, CBiRC), and National Institutes of Health LM010235, NIH-National Library of Medicine 07443, and NSF IIS-1321053 to PB. This work was made possible, in part, through access to the Genomic High Throughput Facility Shared Resource of the National Cancer Institute Cancer Center Support Grant (CA-62203, R. Van Etten, PI) at the University of California, Irvine and NIH shared instrumentation grants 1S10RR025496-01 and 1S10OD010794-01 to SS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acker J, 2008, NUCLEIC ACIDS RES, V36, P5832, DOI 10.1093/nar/gkn549; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; AUSUBEL FM, 2007, CURRENT PROTOCOLS MO; Barth G, 1996, NONCONVENTIONAL YEAS, P313, DOI [DOI 10.1007/978-3-642-79856-6_10, 10.1007/978-3-642-79856-6_10]; Bateman A, 2015, NUCLEIC ACIDS RES, V43, pD204, DOI 10.1093/nar/gku989; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Beopoulos A, 2014, APPL MICROBIOL BIOT, V98, P251, DOI 10.1007/s00253-013-5295-x; Beopoulos A, 2011, APPL MICROBIOL BIOT, V90, P1193, DOI 10.1007/s00253-011-3212-8; Blazeck J, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4131; Burge CB, 1998, N COMP BIOC, V32, P129; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Casaregola S, 1997, CHROMOSOMA, V106, P380, DOI 10.1007/s004120050259; Casaregola S, 2002, MOL BIOL EVOL, V19, P664, DOI 10.1093/oxfordjournals.molbev.a004125; Casaregola S, 2000, FEBS LETT, V487, P95, DOI 10.1016/S0014-5793(00)02288-2; Casaregola S, 2013, TRANSPOSABLE ELEMENT; Chalvet F, 2003, MOL BIOL EVOL, V20, P1362, DOI 10.1093/molbev/msg155; CLARE JJ, 1986, CURR GENET, V10, P449, DOI 10.1007/BF00419872; Craig NL, 2015, MOBILE DNA 3, P3, DOI [10.1128/9781555819217.ch1, DOI 10.1128/MICROBIOLSPEC.MDNA3-0062-2014Z]; Curcio MJ, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0053-2014; DABOUSSI MJ, 1992, MOL GEN GENET, V232, P12, DOI 10.1007/BF00299131; Daboussi MJ, 2003, ANNU REV MICROBIOL, V57, P275, DOI 10.1146/annurev.micro.57.030502.091029; Dewannieux M, 2003, NAT GENET, V35, P41, DOI 10.1038/ng1223; Dujon B, 2004, NATURE, V430, P35, DOI 10.1038/nature02579; Durrens P, 2005, YEAST, V22, P337, DOI 10.1002/yea.1214; Duvick J, 2016, PLANT CELL, V28, P840, DOI 10.1105/tpc.15.00933; Forbes EM, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-94; Gabus C, 1998, EMBO J, V17, P4873, DOI 10.1093/emboj/17.16.4873; Gaillardin C, 2013, COMP GENOMICS YARROW; Gaillardin C, 2012, FEMS YEAST RES, V12, P317, DOI 10.1111/j.1567-1364.2011.00782.x; Goodwin TJD, 2001, CURR GENET, V39, P83, DOI 10.1007/s002940000181; HANSEN LJ, 1988, MOL CELL BIOL, V8, P5245, DOI 10.1128/MCB.8.12.5245; Holton NJ, 2001, NUCLEIC ACIDS RES, V29, P4014, DOI 10.1093/nar/29.19.4014; Hong JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079288; Kerkhoven EJ, 2016, NPJ SYST BIOL APPL, V2, DOI 10.1038/npjsba.2016.5; Kerscher S, 2001, COMPAR FUNCT GENOM, V2, P80, DOI 10.1002/cfg.72; Kovalchuk A, 2005, YEAST, V22, P979, DOI 10.1002/yea.1287; Kramerov DA, 2011, HEREDITY, V107, P487, DOI 10.1038/hdy.2011.43; Kretzschmar A, 2013, CURR GENET, V59, P63, DOI 10.1007/s00294-013-0389-7; Kurtz S, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-2-r12; Lang F, RNAWEASEL MFANNOT PR; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lisch D, 2002, TRENDS PLANT SCI, V7, P498, DOI 10.1016/S1360-1385(02)02347-6; Liu LQ, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00652-14; Lomsadze A, 2005, NUCLEIC ACIDS RES, V33, P6494, DOI 10.1093/nar/gki937; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Malik HS, 1999, J VIROL, V73, P5186, DOI 10.1128/JVI.73.6.5186-5190.1999; Marck C, 2006, NUCLEIC ACIDS RES, V34, P1816, DOI 10.1093/nar/gkl085; Neuveglise C, 2005, EUKARYOT CELL, V4, P615, DOI 10.1128/EC.4.3.615-624.2005; Neuveglise C, 2002, GENOME RES, V12, P930, DOI 10.1101/gr.219202; Neuveglise C, 2013, NONCODING RNA GENES; Nicaud JM, 2012, YEAST, V29, P409, DOI 10.1002/yea.2921; NICAUD JM, 1989, CURR GENET, V16, P253, DOI 10.1007/BF00422111; Nicaud JM, 2002, FEMS YEAST RES, V2, P371, DOI 10.1111/j.1567-1364.2002.tb00106.x; Pomraning KR, 2015, GENOME ANNOUNCEMENTS, V3, DOI 10.1128/genomeA.01211-15; Pomraning KR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123188; Proux-Wera E, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-237; Reid I, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-229; Richardson SR, 2015, MICROBIOL SPECTR, V3, DOI 10.1128/microbiolspec.MDNA3-0061-2014; ROBERTSON DS, 1978, MUTAT RES, V51, P21, DOI 10.1016/0027-5107(78)90004-0; SANDMEYER S, 2015, MICROBIOL SPECTR, V3, DOI DOI 10.1128/MICROBILSPEC.MDNA3-0057-2014; SCHMIDBERGER N, 1994, J BACTERIOL, V176, P2477, DOI 10.1128/JB.176.9.2477-2482.1994; Sherman F, 2002, METHOD ENZYMOL, V350, P3, DOI 10.1016/S0076-6879(02)50954-X; Slater GS, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-31; Souciet JL, 2000, FEBS LETT, V487, P3, DOI 10.1016/S0014-5793(00)02272-9; Standage DS, 2010, AEGEAN INT TOOLK AN; Stanke M, 2005, NUCLEIC ACIDS RES, V33, pW465, DOI 10.1093/nar/gki458; Sun J, 2015, J IND MICROBIOL BIOT, V42, P423, DOI 10.1007/s10295-014-1539-8; Symer DE, 2010, RETROVIRUSES: MOLECULAR BIOLOGY, GENOMICS AND PATHOGENESIS, P1; Tai M, 2013, METAB ENG, V15, P1, DOI 10.1016/j.ymben.2012.08.007; Ter-Hovhannisyan V, 2008, GENOME RES, V18, P1979, DOI 10.1101/gr.081612.108; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; VANHEERIKHUIZEN H, 1985, GENE, V39, P213, DOI 10.1016/0378-1119(85)90315-4; Vassetzky NS, 2013, NUCLEIC ACIDS RES, V41, pD83, DOI 10.1093/nar/gks1263; Walsh D, 2011, NAT REV MICROBIOL, V9, P860, DOI 10.1038/nrmicro2655; WEBER H, 1989, YEAST, V5, P279; Wolf K., 1996, NONCONVENTIONAL YEAS; Yu SF, 1996, SCIENCE, V271, P1579, DOI 10.1126/science.271.5255.1579; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhu Q, 2015, CURR OPIN BIOTECH, V36, P65, DOI 10.1016/j.copbio.2015.08.010	79	41	41	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162363	10.1371/journal.pone.0162363	http://dx.doi.org/10.1371/journal.pone.0162363			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603307	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200062
J	Wang, JB; Lin, NT; Tseng, YH; Weng, SF				Wang, Jian-Bin; Lin, Nien-Tsung; Tseng, Yi-Hsiung; Weng, Shu-Fen			Genomic Characterization of the Novel Aeromonas hydrophila Phage Ahp1 Suggests the Derivation of a New Subgroup from phiKMV-Like Family	PLOS ONE			English	Article							BACTERIOPHAGE-T7 RNA-POLYMERASE; CONTAINING BACTERIAL-VIRUS; SOLUBLE LYTIC TRANSGLYCOSYLASE; ESCHERICHIA-COLI; ACTIVE-SITE; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; DNA-POLYMERASE; GENE; INFECTIONS	Aeromonas hydrophila is an opportunistic pathogenic bacterium causing diseases in human and fish. The emergence of multidrug-resistant A. hydrophila isolates has been increasing in recent years. In this study, we have isolated a novel virulent podophage of A. hydrophila, designated as Ahp1, from waste water. Ahp1 has a rapid adsorption (96% adsorbed in 2 min), a latent period of 15 min, and a burst size of 112 PFU per infected cell. At least eighteen Ahp1 virion proteins were visualized in SDS-polyacrylamide gel electrophoresis, with a 36-kDa protein being the predicted major capsid protein. Genome analysis of Ahp1 revealed a linear doubled-stranded DNA genome of 42,167 bp with a G + C content of 58.8%. The genome encodes 46 putative open reading frames, 5 putative phage promoters, and 3 transcriptional terminators. Based on high degrees of similarity in overall genome organization and among most of the corresponding ORFs, as well as phylogenetic relatedness among their DNAP, RNAP and major capsid proteins, we propose a new subgroup, designated Ahp1-like subgroup. This subgroup contains Ahp1 and members previously belonging to phiKMV-like subgroup, phiAS7, phi80-18, GAP227, phiR8-01, and ISAO8. Since Ahp1 has a narrow host range, for effective phage therapy, different phages are needed for preparation of cocktails that are capable of killing the heterogeneous A. hydrophila strains.	[Wang, Jian-Bin; Lin, Nien-Tsung; Tseng, Yi-Hsiung] Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan; [Lin, Nien-Tsung] Tzu Chi Univ, Sch Med, Master Program Microbiol & Immunol, Hualien 970, Taiwan; [Tseng, Yi-Hsiung; Weng, Shu-Fen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan	Tzu Chi University; Tzu Chi University; National Chung Hsing University	Tseng, YH (corresponding author), Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan.; Tseng, YH; Weng, SF (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan.	yhtseng@dragon.nchu.edu.tw; sfweng@dragon.nchu.edu.tw		Weng, Shu Fen/0000-0001-8300-8929	Tzu Chi University [TCIRP98003-01]	Tzu Chi University	This work was supported by grant TCIRP98003-01 from Tzu Chi University.	Adriaenssens EM, 2011, APPL ENVIRON MICROB, V77, P3443, DOI 10.1128/AEM.00128-11; Alavandi SV, 1999, INDIAN J MED RES, V110, P50; Anand T, 2016, J BASIC MICROB, V56, P432, DOI 10.1002/jobm.201500318; Besemer J, 2001, NUCLEIC ACIDS RES, V29, P2607, DOI 10.1093/nar/29.12.2607; BONNER G, 1992, EMBO J, V11, P3767, DOI 10.1002/j.1460-2075.1992.tb05462.x; BOWMAN BU, 1973, AM REV RESPIR DIS, V107, P42; Chang HC, 2005, APPL ENVIRON MICROB, V71, P1387, DOI 10.1128/AEM.71.3.1387-1393.2005; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P1069, DOI 10.1007/s10096-013-1852-6; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P543, DOI 10.1007/s10096-012-1771-y; Chao CM, 2013, EUR J CLIN MICROBIOL, V32, P245, DOI 10.1007/s10096-012-1736-1; Chao CM, 2012, AM J TROP MED HYG, V87, P933, DOI 10.4269/ajtmh.2012.12-0275; Chauret C, 2001, CAN J MICROBIOL, V47, P782, DOI 10.1139/cjm-47-8-782; Cheetham GMT, 1999, NATURE, V399, P80, DOI 10.1038/19999; Chen PL, 2012, J MICROBIOL IMMUNOL, V45, P398, DOI 10.1016/j.jmii.2012.08.008; CHOW MS, 1983, APPL ENVIRON MICROB, V45, P1670, DOI 10.1128/AEM.45.5.1670-1676.1983; COTAROBLES E, 1968, J VIROL, V2, P56, DOI 10.1128/JVI.2.1.56-68.1968; Danaher PJ, 2011, MIL MED, V176, P1444, DOI 10.7205/MILMED-D-11-00211; DIJKSTRA BW, 1994, CURR OPIN STRUC BIOL, V4, P810, DOI 10.1016/0959-440X(94)90261-5; Doherty AJ, 2000, J MOL BIOL, V296, P43, DOI 10.1006/jmbi.1999.3423; Gibb EA, 2007, J BACTERIOL, V189, P4648, DOI 10.1128/JB.00321-07; Giltner CL, 2013, J CLIN MICROBIOL, V51, P1324, DOI 10.1128/JCM.03217-12; GUTMAN PD, 1993, NUCLEIC ACIDS RES, V21, P4406, DOI 10.1093/nar/21.18.4406; Hall BG, 2013, MOL BIOL EVOL, V30, P1229, DOI 10.1093/molbev/mst012; HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8; HANYCH B, 1993, GENE, V129, P1, DOI 10.1016/0378-1119(93)90689-Z; Igbinosa IH, 2012, THESCIENTIFICWORLDJO, V2012, DOI [10.1100/2012/764563, DOI 10.1100/2012/764563]; Iyer LM, 2004, J STRUCT BIOL, V146, P11, DOI 10.1016/j.jsb.2003.10.010; JONES WD, 1970, AM REV RESPIR DIS, V102, P814; Joseph Sam W., 1994, Annual Review of Fish Diseases, V4, P315, DOI 10.1016/0959-8030(94)90033-7; Jun JW, 2015, ARCH VIROL, V160, P561, DOI 10.1007/s00705-014-2221-1; Jun JW, 2013, AQUACULTURE, V416, P289, DOI 10.1016/j.aquaculture.2013.09.045; Kedzierska S, 1996, GENE, V168, P1, DOI 10.1016/0378-1119(95)00712-1; KIM Y, 1995, NATURE, V376, P612, DOI 10.1038/376612a0; Kivela HM, 1999, VIROLOGY, V262, P364, DOI 10.1006/viro.1999.9838; Lai CC, 2007, BURNS, V33, P255, DOI 10.1016/j.burns.2006.06.003; Lavigne R, 2004, BIOINFORMATICS, V20, P629, DOI 10.1093/bioinformatics/btg456; Lavigne R, 2008, RES MICROBIOL, V159, P406, DOI 10.1016/j.resmic.2008.03.005; Liakopoulos V, 2011, CLIN NEPHROL, V75, pS65, DOI 10.2379/CNP75065; Lin WT, 2013, INTERNAL MED, V52, P2517, DOI 10.2169/internalmedicine.52.0180; MAKSIMOVA TG, 1991, EUR J BIOCHEM, V195, P841, DOI 10.1111/j.1432-1033.1991.tb15773.x; Mann NH, 2005, PLOS BIOL, V3, P753, DOI 10.1371/journal.pbio.0030182; Mannisto RH, 1999, VIROLOGY, V262, P355, DOI 10.1006/viro.1999.9837; MCALLISTER WT, 1993, MOL MICROBIOL, V10, P1, DOI 10.1111/j.1365-2958.1993.tb00897.x; MERINO S, 1990, FEMS MICROBIOL LETT, V68, P239, DOI 10.1016/S0378-1097(05)80047-3; MERINO S, 1990, FEMS MICROBIOL LETT, V69, P277; Nielsen H, 1997, PROTEIN ENG, V10, P1, DOI 10.1093/protein/10.1.1; OLSEN RH, 1974, J VIROL, V14, P689, DOI 10.1128/JVI.14.3.689-699.1974; Pablos M, 2010, EUR J CLIN MICROBIOL, V29, P1163, DOI 10.1007/s10096-010-0982-3; RASKIN CA, 1992, J MOL BIOL, V228, P506, DOI 10.1016/0022-2836(92)90838-B; Roucourt B, 2009, VIROLOGY, V387, P50, DOI 10.1016/j.virol.2009.01.033; Sau Keya, 2007, Journal of Microbiology Immunology and Infection, V40, P24; Shen CJ, 2012, J VIROL, V86, P10900, DOI 10.1128/JVI.01882-12; Skwor T, 2014, APPL ENVIRON MICROB, V80, P841, DOI 10.1128/AEM.03645-13; SOUSA R, 1993, NATURE, V364, P593, DOI 10.1038/364593a0; THUNNISSEN AMWH, 1995, BIOCHEMISTRY-US, V34, P12729, DOI 10.1021/bi00039a032; Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712; TOMKINSON AE, 1991, P NATL ACAD SCI USA, V88, P400, DOI 10.1073/pnas.88.2.400; Tseng YH, 1999, J BACTERIOL, V181, P117, DOI 10.1128/JB.181.1.117-125.1999; WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x; Wang IN, 2000, ANNU REV MICROBIOL, V54, P799, DOI 10.1146/annurev.micro.54.1.799; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991	61	18	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162060	10.1371/journal.pone.0162060	http://dx.doi.org/10.1371/journal.pone.0162060			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603936	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200037
J	Fan, JJ; Zareyan, S; Zhao, W; Shimizu, Y; Pfeifer, TA; Tak, JH; Isman, MB; Van den Hoven, B; Duggan, ME; Wood, MW; Wellington, CL; Kulic, I				Fan, Jianjia; Zareyan, Shahab; Zhao, Wenchen; Shimizu, Yoko; Pfeifer, Tom A.; Tak, Jun-Hyung; Isman, Murray B.; Van den Hoven, Bernard; Duggan, Mark E.; Wood, Michael W.; Wellington, Cheryl L.; Kulic, Iva			Identification of a Chrysanthemic Ester as an Apolipoprotein E Inducer in Astrocytes	PLOS ONE			English	Article							TRANSGENIC MOUSE MODEL; BETA-AMYLOID LEVELS; LIVER-X-RECEPTORS; ALZHEIMERS-DISEASE; APOE LEVELS; E GENOTYPE; A-BETA; PYRETHROID INSECTICIDES; CEREBROSPINAL-FLUID; LIPID-METABOLISM	The apolipoprotein E (APOE) gene is the most highly associated susceptibility locus for late onset Alzheimer's Disease (AD), and augmenting the beneficial physiological functions of apoE is a proposed therapeutic strategy. In a high throughput phenotypic screen for small molecules that enhance apoE secretion from human CCF-STTG1 astrocytoma cells, we show the chrysanthemic ester 82879 robustly increases expressed apoE up to 9.4-fold and secreted apoE up to 6-fold and is associated with increased total cholesterol in conditioned media. Compound 82879 is unique as structural analogues, including pyrethroid esters, show no effect on apoE expression or secretion. 82879 also stimulates liver x receptor (LXR) target genes including ATP binding cassette A1 (ABCA1), LXR alpha and inducible degrader of low density lipoprotein receptor (IDOL) at both mRNA and protein levels. In particular, the lipid transporter ABCA1 was increased by up to 10.6-fold upon 82879 treatment. The findings from CCF-STTG1 cells were confirmed in primary human astrocytes from three donors, where increased apoE and ABCA1 was observed along with elevated secretion of high-density lipoprotein (HDL)-like apoE particles. Nuclear receptor transactivation assays revealed modest direct LXR agonism by compound 82879, yet 10 mu M of 82879 significantly upregulated apoE mRNA in mouse embryonic fibroblasts (MEFs) depleted of both LXRa and LXR beta, demonstrating that 82879 can also induce apoE expression independent of LXR transactivation. By contrast, deletion of LXRs in MEFs completely blocked mRNA changes in ABCA1 even at 10 mu M of 82879, indicating the ability of 82879 to stimulate ABCA1 expression is entirely dependent on LXR transactivation. Taken together, compound 82879 is a novel chrysanthemic ester capable of modulating apoE secretion as well as apoE-associated lipid metabolic pathways in astrocytes, which is structurally and mechanistically distinct from known LXR agonists.	[Fan, Jianjia; Zareyan, Shahab; Zhao, Wenchen; Wellington, Cheryl L.; Kulic, Iva] Univ British Columbia, Dept Pathol & Lab Med, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada; [Shimizu, Yoko; Pfeifer, Tom A.] Ctr Drug Res & Dev, Vancouver, BC, Canada; [Tak, Jun-Hyung; Isman, Murray B.] Univ British Columbia, Fac Land & Food Syst, Vancouver, BC, Canada; [Van den Hoven, Bernard] TC Sci Inc, Edmonton, AB, Canada; [Duggan, Mark E.; Wood, Michael W.] AstraZeneca, Cambridge, MA USA	University of British Columbia; University of British Columbia; AstraZeneca	Wellington, CL (corresponding author), Univ British Columbia, Dept Pathol & Lab Med, Djavad Mowafaghian Ctr Brain Hlth, Vancouver, BC, Canada.	wcheryl@mail.ubc.ca			Alzheimer Drug Discovery Foundation [209102.01]; Centre for Drug Research and Development; AstraZeneca; Robert and Kazuko Barker Award; J. Fred Muir Memorial Scholarship in Science; Canadian Institutes of Health Research [MOP 106706]	Alzheimer Drug Discovery Foundation; Centre for Drug Research and Development; AstraZeneca(AstraZeneca); Robert and Kazuko Barker Award; J. Fred Muir Memorial Scholarship in Science; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	Initial screening efforts were funded in part by grant 209102.01 from the Alzheimer Drug Discovery Foundation (https://www.alzdiscovery.org) and Centre for Drug Research and Development with subsequent operating support from the Canadian Institutes of Health Research (MOP 106706, http://www.cihr-irsc.gc.ca) to CLW. ADDF and CIHR had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. AstraZeneca provided support in the form of salaries for MED, MWW, indirect salary support for JF and IK, and support with data collection and analysis for the following techniques, independent of overall study design: analytical chemistry and nuclear receptor agonist assays. The specific roles of these authors are articulated in the 'author contributions' section. SZ was supported by a Robert and Kazuko Barker Award and a J. Fred Muir Memorial Scholarship in Science.	ABERNATHY CO, 1973, SCIENCE, V179, P1235, DOI 10.1126/science.179.4079.1235; Bales KR, 2009, J NEUROSCI, V29, P6771, DOI 10.1523/JNEUROSCI.0887-09.2009; Beaven SW, 2006, ANNU REV MED, V57, P313, DOI 10.1146/annurev.med.57.121304.131428; Beffert U, 1999, BRAIN RES, V843, P87, DOI 10.1016/S0006-8993(99)01894-6; BERTRAND P, 1995, MOL BRAIN RES, V33, P174, DOI 10.1016/0169-328X(95)00097-C; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Coccaro EF, 2015, CNS SPECTRUMS, V20, P295, DOI 10.1017/S1092852915000310; CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443; Corona AW, 2016, J NEUROIMMUNE PHARM, V11, P61, DOI 10.1007/s11481-015-9627-8; Covassin T, 2013, TRANSL STROKE RES, V4, P420, DOI 10.1007/s12975-012-0228-z; Cruchaga C, 2012, HUM MOL GENET, V21, P4558, DOI 10.1093/hmg/dds296; Davies TGE, 2007, IUBMB LIFE, V59, P151, DOI 10.1080/15216540701352042; de Boer SF, 2005, EUR J PHARMACOL, V526, P125, DOI 10.1016/j.ejphar.2005.09.065; DeMattos RB, 2001, NEUROCHEM INT, V39, P415, DOI 10.1016/S0197-0186(01)00049-3; Donkin JJ, 2010, J BIOL CHEM, V285, P34144, DOI 10.1074/jbc.M110.108100; Donover PS, 2013, COMB CHEM HIGH T SCR, V16, P180; Duke AA, 2013, PSYCHOL BULL, V139, P1148, DOI 10.1037/a0031544; ELSHOURBAGY NA, 1985, P NATL ACAD SCI USA, V82, P203, DOI 10.1073/pnas.82.1.203; Evans NA, 2004, AM J SPORT MED, V32, P534, DOI 10.1177/0363546503262202; Fagan AM, 1999, J BIOL CHEM, V274, P30001, DOI 10.1074/jbc.274.42.30001; Fan JJ, 2013, J LIPID RES, V54, P3139, DOI 10.1194/jlr.M042473; Fan JJ, 2011, J LIPID RES, V52, P1605, DOI 10.1194/jlr.M014365; Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.1997.03550160069041; Fitz NF, 2012, J NEUROSCI, V32, P13125, DOI 10.1523/JNEUROSCI.1937-12.2012; Grimes JM, 2002, PHARMACOL BIOCHEM BE, V73, P713, DOI 10.1016/S0091-3057(02)00880-8; Groot PHE, 2005, J LIPID RES, V46, P2182, DOI 10.1194/jlr.M500116-JLR200; Harrewijn P, 2000, NATURAL TERPENOIDS M, P297; Hirsch-Reinshagen V, 2005, J BIOL CHEM, V280, P43243, DOI 10.1074/jbc.M508781200; Hirsch-Reinshagen V, 2004, J BIOL CHEM, V279, P41197, DOI 10.1074/jbc.M407962200; Holtzman DM, 2000, P NATL ACAD SCI USA, V97, P2892, DOI 10.1073/pnas.050004797; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Jahn Holger, 2013, Dialogues Clin Neurosci, V15, P445; Jiang Q, 2008, NEURON, V58, P681, DOI 10.1016/j.neuron.2008.04.010; Kainu T, 1996, J MOL NEUROSCI, V7, P29, DOI 10.1007/BF02736846; Karasinska JM, 2009, J NEUROSCI, V29, P3579, DOI 10.1523/JNEUROSCI.4741-08.2009; Keene CD, 2011, CURR OPIN NEUROBIOL, V21, P920, DOI 10.1016/j.conb.2011.08.002; Kim J, 2015, J NEUROSCI, V35, P14717, DOI 10.1523/JNEUROSCI.2053-15.2015; Kim WK, 2009, MOL ENDOCRINOL, V23, P1532, DOI 10.1210/me.2008-0453; Koldamova R, 2005, J BIOL CHEM, V280, P43224, DOI 10.1074/jbc.M504513200; Koldamova R, 2014, NEUROBIOL DIS, V72, P13, DOI 10.1016/j.nbd.2014.05.007; Liu CC, 2013, NAT REV NEUROL, V9, P106, DOI 10.1038/nrneurol.2012.263; Lowe M N, 2000, Am J Clin Dermatol, V1, P245, DOI 10.2165/00128071-200001040-00006; Mahley RW, 2000, ANNU REV GENOM HUM G, V1, P507, DOI 10.1146/annurev.genom.1.1.507; Mayeux R, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006239; McMillan P, 2008, J COMP NEUROL, V511, P788, DOI 10.1002/cne.21867; Morris JC, 1997, NEUROLOGY, V49, pS7, DOI 10.1212/WNL.49.3_Suppl_3.S7; Nelson RJ, 2001, TRENDS NEUROSCI, V24, P713, DOI 10.1016/S0166-2236(00)01996-2; Nguyen U., 2011, NAT METHODS, V8, P11; Nishitsuji K, 2011, J BIOL CHEM, V286, P17536, DOI 10.1074/jbc.M111.225532; Nordestgaard LT, 2015, ALZHEIMERS DEMENT, V11, P1430, DOI 10.1016/j.jalz.2015.04.006; O'Neill RA, 2006, P NATL ACAD SCI USA, V103, P16153, DOI 10.1073/pnas.0607973103; PERICAKVANCE MA, 1991, AM J HUM GENET, V48, P1034; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Riddell DR, 2008, J NEUROSCI, V28, P11445, DOI 10.1523/JNEUROSCI.1972-08.2008; Riddell DR, 2007, MOL CELL NEUROSCI, V34, P621, DOI 10.1016/j.mcn.2007.01.011; Robinson S, 2012, HORM BEHAV, V61, P67, DOI 10.1016/j.yhbeh.2011.10.004; Saad F, 2011, EUR J ENDOCRINOL, V165, P675, DOI 10.1530/EJE-11-0221; SANCHEZ C, 1993, PSYCHOPHARMACOLOGY, V110, P53, DOI 10.1007/BF02246950; Soderlund DM, 2002, TOXICOLOGY, V171, P3, DOI 10.1016/S0300-483X(01)00569-8; Sullivan PM, 2011, NEUROBIOL AGING, V32, P791, DOI 10.1016/j.neurobiolaging.2009.05.011; Tai LM, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-2; Tak JH, 2016, PEST MANAG SCI, V72, P474, DOI 10.1002/ps.4010; Thomas L, 1997, CONSERV BIOL, V11, P276, DOI 10.1046/j.1523-1739.1997.96102.x; Toledo JB, 2014, ACTA NEUROPATHOL, V127, P621, DOI 10.1007/s00401-013-1236-0; Vanmierlo T, 2011, NEUROBIOL AGING, V32, P1262, DOI 10.1016/j.neurobiolaging.2009.07.005; VIRKKUNEN M, 1995, J PSYCHIATR NEUROSCI, V20, P271; Wahrle SE, 2005, J BIOL CHEM, V280, P43236, DOI 10.1074/jbc.M508780200; Wahrle SE, 2004, J BIOL CHEM, V279, P40987, DOI 10.1074/jbc.M407963200; Wahrle SE, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-7; Wahrle SE, 2008, J CLIN INVEST, V118, P671, DOI 10.1172/JCI33622; Wang N, 2003, ARTERIOSCL THROM VAS, V23, P1178, DOI 10.1161/01.ATV.0000075912.83860.26; Ward A, 2012, NEUROEPIDEMIOLOGY, V38, P1, DOI 10.1159/000334607; Wesson DW, 2011, J NEUROSCI, V31, P15962, DOI 10.1523/JNEUROSCI.2085-11.2011; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Wojcicka Grazyna, 2007, Postepy Hig Med Dosw (Online), V61, P736; Wolansky MJ, 2008, NEUROTOXICOL TERATOL, V30, P55, DOI 10.1016/j.ntt.2007.10.005; Youmans KL, 2012, J BIOL CHEM, V287, P41774, DOI 10.1074/jbc.M112.407957; ZANNIS VI, 1982, J LIPID RES, V23, P911; Zelcer N, 2007, P NATL ACAD SCI USA, V104, P10601, DOI 10.1073/pnas.0701096104	79	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162384	10.1371/journal.pone.0162384	http://dx.doi.org/10.1371/journal.pone.0162384			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598782	gold, Green Published, Green Submitted			2022-12-26	WOS:000383254800062
J	Guo, BJ; Wei, YF; Xu, RB; Lin, S; Luan, HY; Lv, C; Zhang, XZ; Song, XY; Xu, RG				Guo, Baojian; Wei, Yafeng; Xu, Ruibin; Lin, Shen; Luan, Haiye; Lv, Chao; Zhang, Xinzhong; Song, Xiyun; Xu, Rugen			Genome-Wide Analysis of APETALA2/Ethylene-Responsive Factor (AP2/ERF) Gene Family in Barley (Hordeum vulgare L.)	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION; SALT STRESS; TRANSCRIPTION FACTORS; EXPRESSION; ARABIDOPSIS; TOLERANCE; DROUGHT; RICE; DEHYDRATION; RESPONSES	APETALA2/Ethylene-Responsive Factor (AP2/ERF) gene family is plant specific transcription factor. It plays critical roles in development process, tolerance to biotic and abiotic stresses, and responses to plant hormones. However, limited data are available on the contributions of AP2/ERF gene family in barley (Hordeum vulgare L.). In the present study, 121 HvAP2/ERF genes in barley were identified by using bioinformatics methods. A total of 118 HvAP2/ERF (97.5%) genes were located on seven chromosomes. According to phylogenetic classification of AP2/ERF family in Arabidopsis, HvAP2/ERF proteins were divided into AP2 (APETALA2), RAV ( Related to ABI3/VP), DREB (dehydration responsive element binding), ERF (ethylene responsive factors) and soloist sub families. The analysis of duplication events indicated that tandem repeat and segmental duplication contributed to the expansion of the AP2/ERF family in barley. HvDREB1s/2s genes displayed various expression patterns under abiotic stress and phytohormone. Taken together, the data generated in this study will be useful for genome-wide analysis to determine the precise role of the HvAP2/ERF gene during barley development, abiotic stress and phytohormone responses with the ultimate goal of improving crop production.	[Guo, Baojian; Lin, Shen; Luan, Haiye; Lv, Chao; Zhang, Xinzhong; Xu, Rugen] Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Jiangsu Key Lab Crop Genet & Physiol, Key Lab Plant Funct Genom,Minist Educ,Barley Res, Yangzhou, Jiangsu, Peoples R China; [Wei, Yafeng] JiangSu Yanjiang Inst Agr Sci, Nantong, Peoples R China; [Xu, Ruibin; Song, Xiyun] Qingdao Agr Univ, Coll Agron & Plant Protect, Qingdao, Peoples R China	Yangzhou University; Jiangsu Academy of Agricultural Sciences; Qingdao Agricultural University	Xu, RG (corresponding author), Yangzhou Univ, Coinnovat Ctr Modern Prod Technol Grain Crops, Jiangsu Key Lab Crop Genet & Physiol, Key Lab Plant Funct Genom,Minist Educ,Barley Res, Yangzhou, Jiangsu, Peoples R China.	rgxu@yzu.edu.cn			National Natural Science Foundation of China [31401370, 31571648]; National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China [CARS-05]; Jiangsu Agriculture Science and Technology Innovation Fund [CX(14)2123]; Priority Academic Program Development of Jiangsu Higher Education Institutions	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China; Jiangsu Agriculture Science and Technology Innovation Fund; Priority Academic Program Development of Jiangsu Higher Education Institutions	This research was supported from the National Natural Science Foundation of China (31401370 and 31571648), National Barley and Highland Barley Industrial Technology Specially Constructive Foundation of China (CARS-05), Jiangsu Agriculture Science and Technology Innovation Fund (CX(14)2123) and a Project Funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Bailey T L, 1994, Proc Int Conf Intell Syst Mol Biol, V2, P28; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Chen JH, 2009, BIOCHEM BIOPH RES CO, V378, P483, DOI 10.1016/j.bbrc.2008.11.071; Chen Z, 2005, PLANT CELL ENVIRON, V28, P1230, DOI 10.1111/j.1365-3040.2005.01364.x; Chen Z, 2007, J EXP BOT, V58, P4245, DOI 10.1093/jxb/erm284; Dubouzet JG, 2003, PLANT J, V33, P751, DOI 10.1046/j.1365-313X.2003.01661.x; Ferdous J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118503; Golldack D, 2014, FRONT PLANT SCI, V5, DOI 10.3389/fpls.2014.00151; Gupta K, 2010, PLANT CELL REP, V29, P1131, DOI 10.1007/s00299-010-0896-7; Hattori Y, 2009, NATURE, V460, P1026, DOI 10.1038/nature08258; Houston K, 2013, P NATL ACAD SCI USA, V110, P16675, DOI 10.1073/pnas.1311681110; Hu B, 2015, BIOINFORMATICS, V31, P1296, DOI 10.1093/bioinformatics/btu817; International Barley Genome Sequencing Consortium, 2012, Nature, V491, P711, DOI 10.1038/nature11543; Jin JP, 2014, NUCLEIC ACIDS RES, V42, pD1182, DOI 10.1093/nar/gkt1016; Jofuku KD, 2005, P NATL ACAD SCI USA, V102, P3117, DOI 10.1073/pnas.0409893102; Klucher KM, 1996, PLANT CELL, V8, P137, DOI 10.1105/tpc.8.2.137; Lata C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113092; Lata C, 2011, J EXP BOT, V62, P4731, DOI 10.1093/jxb/err210; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr931, 10.1093/nar/gkr201]; Liu LQ, 2008, J PLANT RES, V121, P215, DOI 10.1007/s10265-007-0140-x; Liu Q, 1998, PLANT CELL, V10, P1391, DOI 10.1105/tpc.10.8.1391; Liu Ren-Hu, 2003, Yichuan, V25, P317; Liu SX, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003790; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maher C, 2006, GENOME RES, V16, P510, DOI 10.1101/gr.4680506; Mallikarjuna G, 2011, BIOTECHNOL LETT, V33, P1689, DOI 10.1007/s10529-011-0620-x; Mao DH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047275; Matsukura S, 2010, MOL GENET GENOMICS, V283, P185, DOI 10.1007/s00438-009-0506-y; Moose SP, 1996, GENE DEV, V10, P3018, DOI 10.1101/gad.10.23.3018; Nair SK, 2010, P NATL ACAD SCI USA, V107, P490, DOI 10.1073/pnas.0909097107; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Novillo F, 2004, P NATL ACAD SCI USA, V101, P3985, DOI 10.1073/pnas.0303029101; Ohto MA, 2009, SEX PLANT REPROD, V22, P277, DOI 10.1007/s00497-009-0116-1; Sakuma Y, 2002, BIOCHEM BIOPH RES CO, V290, P998, DOI 10.1006/bbrc.2001.6299; Schmidt R, 2013, PLANT CELL, V25, P2115, DOI 10.1105/tpc.113.113068; Sharma MK, 2010, MOL GENET GENOMICS, V284, P455, DOI 10.1007/s00438-010-0580-1; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shiu SH, 2003, PLANT PHYSIOL, V132, P530, DOI 10.1104/pp.103.021964; Sun ZM, 2014, FUNCT INTEGR GENOMIC, V14, P453, DOI 10.1007/s10142-014-0372-5; Suyama M, 2006, NUCLEIC ACIDS RES, V34, pW609, DOI 10.1093/nar/gkl315; Taketa S, 2008, P NATL ACAD SCI USA, V105, P4062, DOI 10.1073/pnas.0711034105; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thamilarasan SK, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-422; Wang A, 2007, J EXP BOT, V58, P3743, DOI 10.1093/jxb/erm224; Wang QY, 2008, PLANT MOL BIOL, V67, P589, DOI 10.1007/s11103-008-9340-6; Wessler SR, 2005, TRENDS PLANT SCI, V10, P54, DOI 10.1016/j.tplants.2004.12.007; Witzel K, 2009, J EXP BOT, V60, P3545, DOI 10.1093/jxb/erp198; Woo HR, 2010, J EXP BOT, V61, P3947, DOI 10.1093/jxb/erq206; WU DD, 2011, PLOS GENET, V7, P9390, DOI DOI 10.1371/JOURNAL.PONE.0022938; Yan HW, 2013, GENET MOL RES, V12, P2038, DOI 10.4238/2013.May.13.1; Yang CY, 2011, PLANT PHYSIOL, V156, P202, DOI 10.1104/pp.111.172486; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu XL, 2014, PLANT PHYSIOL, V164, P1499, DOI 10.1104/pp.113.229575	58	60	66	10	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161322	10.1371/journal.pone.0161322	http://dx.doi.org/10.1371/journal.pone.0161322			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598245	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800006
J	Spencer, NG; Schilling, T; Miralles, F; Eder, C				Spencer, Nicholas G.; Schilling, Tom; Miralles, Francesc; Eder, Claudia			Mechanisms Underlying Interferon-gamma-Induced Priming of Microglial Reactive Oxygen Species Production	PLOS ONE			English	Article							MEDIATED NEUROTOXICITY; SUPEROXIDE-PRODUCTION; ION CHANNELS; K+ CHANNEL; PROTEIN; ACTIVATION; CELLS; NOX2; PHOSPHORYLATION; PROLIFERATION	Microglial priming and enhanced reactivity to secondary insults cause substantial neuronal damage and are hallmarks of brain aging, traumatic brain injury and neurodegenerative diseases. It is, thus, of particular interest to identify mechanisms involved in microglial priming. Here, we demonstrate that priming of microglia with interferon-gamma(IFN gamma) substantially enhanced production of reactive oxygen species (ROS) following stimulation of microglia with ATP. Priming of microglial ROS production was substantially reduced by inhibition of p38 MAPK activity with SB203580, by increases in intracellular glutathione levels with N-Acetyl-L-cysteine, by blockade of NADPH oxidase subunit NOX2 activity with gp91ds-tat or by inhibition of nitric oxide production with L-NAME. Together, our data indicate that priming of microglial ROS production involves reduction of intracellular glutathione levels, upregulation of NADPH oxidase subunit NOX2 and increases in nitric oxide production, and suggest that these simultaneously occurring processes result in enhanced production of neurotoxic peroxynitrite. Furthermore, IFN gamma-induced priming of microglial ROS production was reduced upon blockade of Kir2.1 inward rectifier K+ channels with ML133. Inhibitory effects of ML133 on microglial priming were mediated via regulation of intracellular glutathione levels and nitric oxide production. These data suggest that microglial Kir2.1 channels may represent novel therapeutic targets to inhibit excessive ROS production by primed microglia in brain pathology.	[Spencer, Nicholas G.; Schilling, Tom; Eder, Claudia] St Georges Univ London, Infect & Immun Res Inst, London, England; [Miralles, Francesc] St Georges Univ London, Mol & Clin Sci Res Inst, London, England; [Miralles, Francesc] St Georges Univ London, Inst Med & Biomed Educ, London, England	St Georges University London; St Georges University London; St Georges University London	Eder, C (corresponding author), St Georges Univ London, Infect & Immun Res Inst, London, England.	ceder@sgul.ac.uk		Miralles, Francesc/0000-0003-3069-2725; Schilling, Tom/0000-0002-0274-5482	European Union FP7 grant "TargetBraIn" [279017]	European Union FP7 grant "TargetBraIn"	This work was supported by European Union FP7 grant "TargetBraIn" (#279017) to CE.	Ansari MA, 2015, J NEUROL SCI, V357, P41, DOI 10.1016/j.jns.2015.06.062; BEIS I, 1975, BIOCHEM J, V152, P23, DOI 10.1042/bj1520023; Bhattacharya A, 2016, GLIA, V64, P1772, DOI 10.1002/glia.23001; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; Block ML, 2007, NAT REV NEUROSCI, V8, P57, DOI 10.1038/nrn2038; CHAO CC, 1995, J LEUKOCYTE BIOL, V58, P65, DOI 10.1002/jlb.58.1.65; Dale E, 2016, GLIA, V64, P1733, DOI 10.1002/glia.22992; Diebold BA, 2015, ANTIOXID REDOX SIGN, V23, P375, DOI 10.1089/ars.2014.5862; Eder C, 2010, J NEUROIMMUNOL, V224, P51, DOI 10.1016/j.jneuroim.2010.05.008; El-Benna J, 2008, SEMIN IMMUNOPATHOL, V30, P279, DOI 10.1007/s00281-008-0118-3; Franciosi S, 2002, J NEUROSCI RES, V69, P607, DOI 10.1002/jnr.10331; HALLETT MB, 1995, IMMUNOL TODAY, V16, P264, DOI 10.1016/0167-5699(95)80178-2; Haslund-Vinding J, 2017, BRIT J PHARMACOL, V174, P1733, DOI 10.1111/bph.13425; HU SX, 1995, GLIA, V13, P45, DOI 10.1002/glia.440130106; KETTENMANN H, 1990, J NEUROSCI RES, V26, P278, DOI 10.1002/jnr.490260303; Khanna R, 2001, AM J PHYSIOL-CELL PH, V280, pC796, DOI 10.1152/ajpcell.2001.280.4.C796; Klegeris A, 1997, J NEUROSCI RES, V49, P229, DOI 10.1002/(SICI)1097-4547(19970715)49:2<229::AID-JNR11>3.0.CO;2-W; Lam D, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00185; LOWRY OH, 1964, J BIOL CHEM, V239, P18; Mangano EN, 2012, NEUROBIOL AGING, V33, P1411, DOI 10.1016/j.neurobiolaging.2011.02.016; McLarnon JG, 1997, NEUROSCIENCE, V78, P1217, DOI 10.1016/S0306-4522(96)00680-X; McManus RM, 2014, NEUROBIOL AGING, V35, P109, DOI 10.1016/j.neurobiolaging.2013.07.025; Milton RH, 2008, J NEUROSCI, V28, P11488, DOI 10.1523/JNEUROSCI.2431-08.2008; Minogue AM, 2014, NEUROBIOL AGING, V35, P1442, DOI 10.1016/j.neurobiolaging.2013.12.026; Nair JS, 2002, P NATL ACAD SCI USA, V99, P5971, DOI 10.1073/pnas.052159099; Nayernia Z, 2014, ANTIOXID REDOX SIGN, V20, P2815, DOI 10.1089/ars.2013.5703; Njie EG, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2010.05.008; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Park YC, 1996, IMMUNOLOGY, V87, P296, DOI 10.1046/j.1365-2567.1996.456544.x; Parvathenani LK, 2003, J BIOL CHEM, V278, P13309, DOI 10.1074/jbc.M209478200; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Purisai MG, 2007, NEUROBIOL DIS, V25, P392, DOI 10.1016/j.nbd.2006.10.008; Rojo AI, 2014, ANTIOXID REDOX SIGN, V21, P1766, DOI 10.1089/ars.2013.5745; Schilling T, 2015, GLIA, V63, P664, DOI 10.1002/glia.22776; Schilling T, 2014, J CELL SCI, V127, P4561, DOI 10.1242/jcs.151068; Schilling T, 2011, J CELL PHYSIOL, V226, P3295, DOI 10.1002/jcp.22675; Schilling T, 2010, J NEUROIMMUNOL, V225, P190, DOI 10.1016/j.jneuroim.2010.05.024; Schilling T, 2009, J NEUROIMMUNOL, V216, P118, DOI 10.1016/j.jneuroim.2009.07.008; Schmitz M, 2015, NEUROBIOL AGING, V36, P2597, DOI 10.1016/j.neurobiolaging.2015.05.013; Steinert JR, 2010, NEUROSCIENTIST, V16, P435, DOI 10.1177/1073858410366481; Surace MJ, 2012, CELL MOL LIFE SCI, V69, P2409, DOI 10.1007/s00018-012-1015-4; Thomas MP, 2007, J NEUROCHEM, V100, P503, DOI 10.1111/j.1471-4159.2006.04315.x; vanMuiswinkel FL, 1996, J NEUROCHEM, V66, P2468; Vilhardt F, 2002, J BIOL CHEM, V277, P42136, DOI 10.1074/jbc.M200862200; Wu LJ, 2012, NAT NEUROSCI, V15, P565, DOI 10.1038/nn.3059; Zhang JX, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/4350965	46	33	33	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162497	10.1371/journal.pone.0162497	http://dx.doi.org/10.1371/journal.pone.0162497			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598576	Green Accepted, gold, Green Published, Green Submitted			2022-12-26	WOS:000383254800071
J	Jacob, G; Prevot, AC; Baudry, E				Jacob, Gwenael; Prevot, Anne-Caroline; Baudry, Emmanuelle			Feral Pigeons (Columba livia) Prefer Genetically Similar Mates despite Inbreeding Depression	PLOS ONE			English	Article							GREAT REED WARBLER; NO EVIDENCE; AVOIDANCE; RELATEDNESS; POPULATION; DISPERSAL; CHOICE; SPARROWS; ANIMALS; RECOGNITION	Avoidance of mating between related individuals is usually considered adaptive because it decreases the probability of inbreeding depression in offspring. However, mating between related partners can be adaptive if outbreeding depression is stronger than inbreeding depression or if females gain inclusive fitness benefits by mating with close kin. In the present study, we used microsatellite data to infer the parentage of juveniles born in a French colony of feral pigeons, which allowed us to deduce parent pairs. Despite detectable inbreeding depression, we found that pairwise relatedness between mates was significantly higher than between nonmates, with a mean coefficient of relatedness between mates of 0.065, approximately half the theoretical value for first cousins. This higher relatedness between mates cannot be explained by spatial genetic structure in this colonial bird; it therefore probably results from an active choice. As inbreeding but not outbreeding depression is observed in the study population, this finding accords with the idea that mating with genetically similar mates can confer a benefit in terms of inclusive fitness. Our results and published evidence suggest that preference for related individuals as mates might be relatively frequent in birds.	[Jacob, Gwenael; Prevot, Anne-Caroline; Baudry, Emmanuelle] Univ Paris 11, Univ Paris Saclay, AgroParisTech, CNRS,Ecol Systemat Evolut, F-91400 Orsay, France; [Jacob, Gwenael] Univ Fribourg, Dept Biol, Fribourg, Switzerland; [Prevot, Anne-Caroline] Museum Natl Hist Nat, CNRS MNHN UPMC, Ctr Sci Conservat CESCO, UMR7204, CP 51,55 Rue Buffon, Paris 5, France	AgroParisTech; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; University of Fribourg; Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Sorbonne Universite	Baudry, E (corresponding author), Univ Paris 11, Univ Paris Saclay, AgroParisTech, CNRS,Ecol Systemat Evolut, F-91400 Orsay, France.	emmanuelle.baudry@u-psud.fr	Baudry, Emmanuelle/G-4005-2010; Jacob, Gwenaël/I-3644-2014	Jacob, Gwenaël/0000-0003-3064-9954	ANRJC - Agence Nationale de la Recherche, programme Jeune Chercheur [ANR-05-JCJC-0098-01]; Region Ile-de-France [06 - 1064 MN 07]	ANRJC - Agence Nationale de la Recherche, programme Jeune Chercheur(French National Research Agency (ANR)); Region Ile-de-France(Region Ile-de-France)	This study is a part of a general research program that was supported by grants from the ANRJC - Agence Nationale de la Recherche, programme Jeune Chercheur (ANR-05-JCJC-0098-01) and the Region Ile-de-France (no 06 - 1064 MN 07).	Amos W, 2001, P ROY SOC B-BIOL SCI, V268, P2021, DOI 10.1098/rspb.2001.1751; Arct A, 2015, BEHAV ECOL, V26, P959, DOI 10.1093/beheco/arv004; BATESON P, 1982, NATURE, V295, P236, DOI 10.1038/295236a0; BATESON P, 1978, NATURE, V273, P659, DOI 10.1038/273659a0; Bateson P., 1983, P257; BENGTSSON BO, 1978, J THEOR BIOL, V73, P439, DOI 10.1016/0022-5193(78)90151-0; BENSCH S, 1994, EVOLUTION, V48, P317, DOI 10.1111/j.1558-5646.1994.tb01314.x; Bichet C, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-47; Blouin MS, 1996, MOL ECOL, V5, P393, DOI 10.1111/j.1365-294X.1996.tb00329.x; Bohonak AJ, 1999, Q REV BIOL, V74, P21, DOI 10.1086/392950; Bonneaud C, 2006, P ROY SOC B-BIOL SCI, V273, P1111, DOI 10.1098/rspb.2005.3325; BROOKER MG, 1990, BEHAV ECOL SOCIOBIOL, V26, P191; Charlesworth D, 2009, NAT REV GENET, V10, P783, DOI 10.1038/nrg2664; Cherry JL, 2013, TRENDS ECOL EVOL, V28, P683, DOI 10.1016/j.tree.2013.08.001; Cohen LB, 2004, ANIM BEHAV, V68, P1229, DOI 10.1016/j.anbehav.2003.12.021; Edly-Wright C, 2007, ANIM BEHAV, V73, P367, DOI 10.1016/j.anbehav.2006.08.008; Foerster K, 2006, MOL ECOL, V15, P4555, DOI 10.1111/j.1365-294X.2006.03091.x; Frankham R, 2011, CONSERV BIOL, V25, P465, DOI 10.1111/j.1523-1739.2011.01662.x; Freeman-Gallant CR, 2006, BEHAV ECOL, V17, P952, DOI 10.1093/beheco/arl031; Giunchi D, 2012, INTEGRATED PEST MANAGEMENT AND PEST CONTROL - CURRENT AND FUTURE TACTICS, P215; GREENWOOD PJ, 1978, NATURE, V271, P52, DOI 10.1038/271052a0; Griffiths R, 1998, MOL ECOL, V7, P1071, DOI 10.1046/j.1365-294x.1998.00389.x; Hansson B, 2007, BEHAV ECOL, V18, P157, DOI 10.1093/beheco/arl062; Hoffman JI, 2005, MOL ECOL, V14, P599, DOI 10.1111/j.1365-294X.2004.02419.x; Jacob G, 2015, BIOL INVASIONS, V17, P23, DOI 10.1007/s10530-014-0713-2; Jamieson IG, 2009, BEHAV ECOL, V20, P575, DOI 10.1093/beheco/arp034; Johnston RF, 1995, FERAL PIGEONS; Kalinowski ST, 2007, MOL ECOL, V16, P1099, DOI 10.1111/j.1365-294X.2007.03089.x; Keller LF, 1998, AM NAT, V152, P380, DOI 10.1086/286176; Keller LF, 2002, TRENDS ECOL EVOL, V17, P230, DOI 10.1016/S0169-5347(02)02489-8; Kempenaers B, 2007, ADV STUD BEHAV, V37, P189, DOI 10.1016/S0065-3454(07)37005-8; Kimura M, 1991, RES B FACULTY AGR, V56, P7; Kleven O, 2005, BIOL LETT-UK, V1, P389, DOI 10.1098/rsbl.2005.0376; Kokko H, 2006, EVOLUTION, V60, P467, DOI 10.1554/05-613.1; Krause ET, 2012, BIOL LETTERS, V8, P327, DOI 10.1098/rsbl.2011.1093; Krokene C, 2000, BEHAVIOUR, V137, P1317, DOI 10.1163/156853900501944; Marshall T, 2001, CERVUS VERSION 2 0; Mulard H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-147; Nakagawa S, 2004, BIOL REV, V79, P101, DOI 10.1017/S1464793103006249; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Pinheiro JC, 2008, NLME LINEAR NONLINEA, P1; Pusey A, 1996, TRENDS ECOL EVOL, V11, P201, DOI 10.1016/0169-5347(96)10028-8; Puurtinen M, 2011, EVOLUTION, V65, P1501, DOI 10.1111/j.1558-5646.2010.01217.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Reynolds SM, 2014, BEHAV ECOL; Schjorring S, 2007, EVOLUTION, V61, P423, DOI 10.1111/j.1558-5646.2007.00028.x; Soulaymani A, 1999, J ANIM BREED GENET, V116, P139, DOI 10.1046/j.1439-0388.1999.00182.x; Szulkin M, 2013, TRENDS ECOL EVOL, V28, P205, DOI 10.1016/j.tree.2012.10.016; Szulkin M, 2009, J ANIM ECOL, V78, P778, DOI 10.1111/j.1365-2656.2009.01544.x; Traxler B, 2000, MOL ECOL, V9, P366, DOI 10.1046/j.1365-294x.2000.00874-2.x; Van de Casteele T, 2006, MOL ECOL, V15, P2557, DOI 10.1111/j.1365-294X.2006.02946.x; WASER PM, 1986, AM NAT, V128, P529, DOI 10.1086/284585; WOLFF JO, 1992, NATURE, V359, P409, DOI 10.1038/359409a0	53	8	9	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162451	10.1371/journal.pone.0162451	http://dx.doi.org/10.1371/journal.pone.0162451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588754	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800063
J	Neaves, LE; Frankham, GJ; Dennison, S; FitzGibbon, S; Flannagan, C; Gillett, A; Hynes, E; Handasyde, K; Helgen, KM; Tsangaras, K; Greenwood, AD; Eldridge, MDB; Johnson, RN				Neaves, Linda E.; Frankham, Greta J.; Dennison, Siobhan; FitzGibbon, Sean; Flannagan, Cheyne; Gillett, Amber; Hynes, Emily; Handasyde, Kathrine; Helgen, Kristofer M.; Tsangaras, Kyriakos; Greenwood, Alex D.; Eldridge, Mark D. B.; Johnson, Rebecca N.			Phylogeography of the Koala, (Phascolarctos cinereus), and Harmonising Data to Inform Conservation	PLOS ONE			English	Article							HISTORICAL BIOGEOGRAPHY; GENETIC DIVERSITY; CONTROL REGION; POPULATION; PATTERNS; QUEENSLAND; SEQUENCE; IMPACT; ISLAND; DIFFERENTIATION	The Australian continent exhibits complex biogeographic patterns but studies of the impacts of Pleistocene climatic oscillation on the mesic environments of the Southern Hemisphere are limited. The koala (Phascolarctos cinereus), one of Australia's most iconic species, was historically widely distributed throughout much of eastern Australia but currently represents a complex conservation challenge. To better understand the challenges to koala genetic health, we assessed the phylogeographic history of the koala. Variation in the maternally inherited mitochondrial DNA (mtDNA) Control Region (CR) was examined in 662 koalas sampled throughout their distribution. In addition, koala CR haplotypes accessioned to Gen-bank were evaluated and consolidated. A total of 53 unique CR haplotypes have been isolated from koalas to date (including 15 haplotypes novel to this study). The relationships among koala CR haplotypes were indicative of a single Evolutionary Significant Unit and do not support the recognition of subspecies, but were separated into four weakly differentiated lineages which correspond to three geographic clusters: a central lineage, a southern lineage and two northern lineages co-occurring north of Brisbane. The three geographic clusters were separated by known Pleistocene biogeographic barriers: the Brisbane River Valley and Clarence River Valley, although there was evidence of mixing amongst clusters. While there is evidence for historical connectivity, current koala populations exhibit greater structure, suggesting habitat fragmentation may have restricted female-mediated gene flow. Since mtDNA data informs conservation planning, we provide a summary of existing CR haplotypes, standardise nomenclature and make recommendations for future studies to harmonise existing datasets. This holistic approach is critical to ensuring management is effective and small scale local population studies can be integrated into a wider species context.	[Neaves, Linda E.; Frankham, Greta J.; Dennison, Siobhan; Eldridge, Mark D. B.; Johnson, Rebecca N.] Australian Museum Res Inst, Australian Ctr Wildlife Genom, 1 William St, Sydney, NSW 2010, Australia; [Neaves, Linda E.] Royal Bot Garden Edinburgh, 20A Inverleith Row, Edinburgh EH3 5LR, Midlothian, Scotland; [FitzGibbon, Sean] Univ Queensland, Sch Agr & Food Sci, Brisbane, Qld 4072, Australia; [Flannagan, Cheyne] Koala Hosp Port Macquarie, POB 236, Port Macquarie, NSW 2444, Australia; [Gillett, Amber] Australia Zoo Wildlife Hosp, Beerwah, Qld 4519, Australia; [Hynes, Emily] Ecoplan Australia Pty Ltd, POB 968, Torquay, Vic 3228, Australia; [Handasyde, Kathrine] Univ Melbourne, Sch BioSci, Melbourne, Vic 3010, Australia; [Helgen, Kristofer M.] Natl Museum Nat Hist, Smithsonian Inst, Washington, DC 20560 USA; [Tsangaras, Kyriakos] Cyprus Inst Neurol & Genet, Dept Translat Genet, 6 Int Airport Ave, CY-2370 Nicosia, Cyprus; [Greenwood, Alex D.] Leibniz Inst Zoo & Wildlife Res, D-10315 Berlin, Germany; [Greenwood, Alex D.] Free Univ Berlin, Dept Vet Med, D-14163 Berlin, Germany	Australian Museum; University of Queensland; University of Melbourne; Smithsonian Institution; Smithsonian National Museum of Natural History; Leibniz Institut fur Zoo und Wildtierforschung; Free University of Berlin	Neaves, LE (corresponding author), Australian Museum Res Inst, Australian Ctr Wildlife Genom, 1 William St, Sydney, NSW 2010, Australia.; Neaves, LE (corresponding author), Royal Bot Garden Edinburgh, 20A Inverleith Row, Edinburgh EH3 5LR, Midlothian, Scotland.	lneaves@gmail.com	Greenwood, Alex/GWU-8292-2022; Helgen, Kristofer M./AAB-8348-2019; Hynes, Emily/ABC-5591-2020; Johnson, Rebecca N/U-6514-2017; Neaves, Linda/AAY-6886-2020	Helgen, Kristofer M./0000-0002-8776-4040; Neaves, Linda/0000-0002-5626-1029; Johnson, Rebecca/0000-0003-3035-2827; Eldridge, Mark/0000-0002-7109-0600; Dennison, Siobhan/0000-0002-3308-2810	New South Wales Environmental Trust [2014/RD/0015]; New South Wales National Parks Foundation; Australian Museum Foundation; Australian Bluegum Plantations; PF Olsen Australia, New Forests; Ecoplan Australia Pty Ltd.; National Institute of General Medical Sciences (NIGMS) [R01 GM092706]; New South Wales National Parks; Parks Victoria	New South Wales Environmental Trust; New South Wales National Parks Foundation; Australian Museum Foundation; Australian Bluegum Plantations; PF Olsen Australia, New Forests; Ecoplan Australia Pty Ltd.; National Institute of General Medical Sciences (NIGMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); New South Wales National Parks; Parks Victoria	This work was supported by the New South Wales Environmental Trust (2014/RD/0015), New South Wales National Parks Foundation and the Australian Museum Foundation. EH was supported by the Australian Bluegum Plantations and PF Olsen Australia, New Forests. Ecoplan Australia Pty Ltd. provided support in the form of salary for EH. Sequencing of historical samples was supported by the National Institute of General Medical Sciences to ADG (NIGMS; grant number R01 GM092706). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Yasuko Ishida, Alfred Roca, Kyle Ewart, Zhoamin Zhou and Andrew King for assistance with generating sequence data and Sandy Ingleby, Anja Divljan, Scott Ginn, Bill Sherwin and Martin Taube for assistance with sample collection. We also wish to thank the New South Wales Environmental Trust, New South Wales National Parks and the Australian Museum Foundation, Australian Bluegum Plantations, PF Olsen Australia, New Forests and the National Institute of General Medical Sciences and Parks Victoria for support.	Adams-Hosking C, 2012, DIVERS DISTRIB, V18, P847, DOI 10.1111/j.1472-4642.2012.00881.x; Adams-Hosking Christine, 2011, Australian Zoologist, V35, P983; Andrews RM, 1999, NAT GENET, V23, P147, DOI 10.1038/13779; Armstrong K.N., 2008, MAMMALS AUSTR, P470; Bazinet AL, 2014, SYST BIOL, V63, P812, DOI 10.1093/sysbio/syu031; Briscoe NJ, 2015, J BIOGEOGR, V42, P791, DOI 10.1111/jbi.12445; Bryant LM, 2016, BIOL J LINN SOC, V119, P238, DOI 10.1111/bij.12821; Bryant LM, 2014, J BIOGEOGR, V41, P1923, DOI 10.1111/jbi.12341; Burbidge A.A., 2014, P15; Byrne M, 2008, MOL ECOL, V17, P4398, DOI 10.1111/j.1365-294X.2008.03899.x; Byrne M, 2008, QUATERNARY SCI REV, V27, P2576, DOI 10.1016/j.quascirev.2008.08.032; Byrne M, 2011, J BIOGEOGR, V38, P1635, DOI 10.1111/j.1365-2699.2011.02535.x; Chapple DG, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-191; Clement M., 2002, P 16 INT PARALLEL DI, P7; Colgan DJ, 2009, AUST J ZOOL, V57, P317, DOI 10.1071/ZO08088; Cristescu R, 2010, CONSERV GENET, V11, P1043, DOI 10.1007/s10592-009-9949-2; Cristescu R, 2009, WILDLIFE RES, V36, P299, DOI 10.1071/WR08010; De Groot GA, 2016, MAMMAL REV, V46, P44, DOI 10.1111/mam.12052; Dennison S, AUST J ZOOL UNPUB; Department of the Environment, 2016, PHASC CIN COMB POP Q; Dique DS, 2003, WILDLIFE RES, V30, P419, DOI 10.1071/WR02029; Dique DS, 2003, WILDLIFE RES, V30, P281, DOI 10.1071/WR02043; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Dupanloup I, 2002, MOL ECOL, V11, P2571, DOI 10.1046/j.1365-294X.2002.01650.x; Edwards DL, 2010, J BIOGEOGR, V37, P1543, DOI 10.1111/j.1365-2699.2010.02293.x; Ellis WAH, 2002, WILDLIFE RES, V29, P303, DOI 10.1071/WR00111; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fowler EV, 2000, MOL ECOL, V9, P155, DOI 10.1046/j.1365-294x.2000.00844.x; Frankham GJ, 2016, J BIOGEOGR, V43, P653, DOI 10.1111/jbi.12659; Fu YX, 1997, GENETICS, V147, P915; Fumagalli L, 1997, MOL ECOL, V6, P1199, DOI 10.1046/j.1365-294X.1997.00298.x; GORDON G, 1988, AUST J ECOL, V13, P451, DOI 10.1111/j.1442-9993.1988.tb00993.x; Grant WS, 2012, MOL PHYLOGENET EVOL, V65, P203, DOI 10.1016/j.ympev.2012.06.006; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Handasyde, 1999, KOALA NATURAL HIST C; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Hazlitt SL, 2014, ECOL EVOL, V4, P1102, DOI 10.1002/ece3.1009; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Houlden BA, 1996, J HERED, V87, P149, DOI 10.1093/oxfordjournals.jhered.a022972; Houlden BA, 1996, MOL ECOL, V5, P269, DOI 10.1111/j.1365-294X.1996.tb00314.x; Houlden BA, 1999, MOL ECOL, V8, P999, DOI 10.1046/j.1365-294x.1999.00656.x; Hynes EF, 2010, REPROD FERT DEVELOP, V22, P913, DOI 10.1071/RD09253; Jensen JL, 2005, BMC GENET, V6, DOI 10.1186/1471-2156-6-13; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Keogh SJ, 2003, CONSERV GENET, V4, P57, DOI 10.1023/A:1021823423944; Kershaw J.A., 1934, VICTORIAN NAT, V51, P76; Kjeldsen SR, 2016, CONSERV GENET, V17, P337, DOI 10.1007/s10592-015-0784-3; Lee KE, 2012, AUST J ZOOL, V60, P303, DOI 10.1071/ZO12075; Lee KE, 2010, CONSERV GENET, V11, P2091, DOI 10.1007/s10592-009-9987-9; Lee T, 2012, AUST MAMMAL, V34, P68, DOI 10.1071/AM10035; Lee T, 2010, WILDLIFE RES, V37, P156, DOI 10.1071/WR09134; lindsay HA, 1950, WILD LIFE, V12, P257; Lunney Daniel, 2007, Pacific Conservation Biology, V13, P189; Martin RW, 2008, MAMMALS AUSTR, P112; Masters P, 2004, WILDLIFE RES, V31, P267, DOI 10.1071/WR03007; McAlpine C, 2015, BIOL CONSERV, V192, P226, DOI 10.1016/j.biocon.2015.09.020; McGuigan K, 1998, MOL ECOL, V7, P175, DOI 10.1046/j.1365-294x.1998.00329.x; McInnes LM, 2011, PARASITOLOGY, V138, P873, DOI 10.1017/S0031182011000369; Melzer A, 2000, CONSERV BIOL, V14, P619, DOI 10.1046/j.1523-1739.2000.99383.x; Menkhorst P, 2008, TOO CLOSE FOR COMFORT : CONTENTIOUS ISSUES IN HUMAN-WILDLIFE ENCOUNTERS, P73; Middleton DR, 2003, WILDLIFE RES, V30, P207, DOI 10.1071/WR02052; MORITZ C, 1994, TRENDS ECOL EVOL, V9, P373, DOI 10.1016/0169-5347(94)90057-4; Neaves LE, 2012, J BIOGEOGR, V39, P1545, DOI 10.1111/j.1365-2699.2012.02702.x; Patterson JLS, 2015, J WILDLIFE DIS, V51, P309, DOI 10.7589/2014-07-176; Pereira L, 2004, FORENSIC SCI INT, V141, P99, DOI 10.1016/j.forsciint.2003.12.014; PHILLIPS B, 1990, KOALAS LITTLE AUSTR; Polkinghorne A, 2013, VET MICROBIOL, V165, P214, DOI 10.1016/j.vetmic.2013.02.026; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Ramirez-Soriano A, 2008, GENETICS, V179, P555, DOI 10.1534/genetics.107.083006; Rix MG, 2012, MOL PHYLOGENET EVOL, V62, P375, DOI 10.1016/j.ympev.2011.10.009; Robinson A.C., 1978, P132; Rousset F, 1997, GENETICS, V145, P1219; Rowe KMC, 2011, AUST J ZOOL, V59, P186, DOI 10.1071/ZO11046; Ruiz-Rodriguez CT, 2014, CONSERV GENET RESOUR, V6, P429, DOI 10.1007/s12686-013-0115-2; Schneider S, 1999, GENETICS, V152, P1079; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; Seddon JM, 2014, WILDLIFE RES, V41, P277, DOI 10.1071/WR13103; Seymour AM, 2001, ANIM CONSERV, V4, P211, DOI 10.1017/S1367943001001251; Sherwin WB, 2000, CONSERV BIOL, V14, P639, DOI 10.1046/j.1523-1739.2000.99384.x; Simmons GS, 2012, AUST VET J, V90, P404, DOI 10.1111/j.1751-0813.2012.00964.x; Sunnucks P, 1996, MOL BIOL EVOL, V13, P510, DOI 10.1093/oxfordjournals.molbev.a025612; TAJIMA F, 1989, GENETICS, V123, P585; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; TAYLOR AC, 1991, BIOCHEM GENET, V29, P355, DOI 10.1007/BF00554143; Taylor AC, 1997, GENET RES, V69, P25, DOI 10.1017/S0016672397002607; TEMPLETON AR, 1992, GENETICS, V132, P619; Tsangaras K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109101; Tsangaras K, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-92; Whisson DA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144348	90	19	21	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162207	10.1371/journal.pone.0162207	http://dx.doi.org/10.1371/journal.pone.0162207			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588685	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877800035
J	Carrell, EM; Coppola, AR; McBride, HJ; Dirksen, RT				Carrell, Ellie M.; Coppola, Aundrea R.; McBride, Helen J.; Dirksen, Robert T.			Orai1 enhances muscle endurance by promoting fatigue-resistant type I fiber content but not through acute store-operated Ca2+ entry	FASEB JOURNAL			English	Article						development; exercise; myosin; skeletal muscle	SKELETAL-MUSCLE; FREQUENCY FATIGUE; CALCIUM-CHANNELS; GENE-EXPRESSION; MICE LACKING; CRAC CHANNEL; T-CELL; STIM1; MOUSE; RELEASE	Orai1 is a transmembrane protein that forms homomeric, calcium-selective channels activated by stromal interaction molecule 1 (STIM1) after depletion of intracellular calcium stores. In adult skeletal muscle, depletion of sarcoplasmic reticulum calcium activates STIM1/Orai1-dependent store-operated calcium entry. Here, we used constitutive and inducible muscle-specific Orai1-knockout (KO) mice to determine the acute and long-term developmental effects of Orai1 ablation on muscle structure and function. Skeletal muscles from constitutive, muscle specific Orai-KO mice exhibited normal postnatal growth and fiber type differentiation. However, a significant reduction in fiber cross-sectional area occurred by 3 mo of age, with the most profound reduction observed in oxidative, fatigue-resistant fiber types. Soleus muscles of constitutive Orai-KO mice exhibited a reduction in unique type I fibers, concomitant with an increase in hybrid fibers expressing both type I and type IIA myosins. Additionally, ex vivo force measurements showed reduced maximal specific force and in vivo exercise assays revealed reduced endurance in constitutive muscle-specific Orai-KO mice. Using tamoxifen-inducible, muscle specific Orai-KO mice, these functional deficits were found to be the result of the delayed fiber changes resulting from an early developmental loss of Orai1 and not the result of an acute loss of Orai1-dependent store-operated calcium entry.	[Carrell, Ellie M.; Dirksen, Robert T.] Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA; [Coppola, Aundrea R.; McBride, Helen J.] Amgen Inc, Dept Inflammat Res, Thousand Oaks, CA 91320 USA	University of Rochester; Amgen	Dirksen, RT (corresponding author), Univ Rochester, Dept Physiol & Pharmacol, 601 Elmwood Ave, Rochester, NY 14642 USA.	robert_dirksen@urmc.rochester.edu		McBride, Helen/0000-0003-3428-2846	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases [AR059646]; M. D. Anderson Cancer Center [MDA275574]; National Science Foundation Graduate Research Fellowship Award [DGE-1419118]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059646] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); M. D. Anderson Cancer Center; National Science Foundation Graduate Research Fellowship Award(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by a U.S. National Institutes of Health, National Institute of Arthritis and Musculoskeletal and Skin Diseases grant (AR059646 to R.T.D.), an M. D. Anderson Cancer Center grant (MDA275574 to R.T.D.), and a National Science Foundation Graduate Research Fellowship Award (DGE-1419118 to E.M.C.).	Beard NA, 2004, PROG BIOPHYS MOL BIO, V85, P33, DOI 10.1016/j.pbiomolbio.2003.07.001; Brandman O, 2007, CELL, V131, P1327, DOI 10.1016/j.cell.2007.11.039; BUTLERBROWNE GS, 1984, DEV BIOL, V102, P324, DOI 10.1016/0012-1606(84)90197-0; Chin ER, 1996, J PHYSIOL-LONDON, V491, P813, DOI 10.1113/jphysiol.1996.sp021259; Chin ER, 1998, GENE DEV, V12, P2499, DOI 10.1101/gad.12.16.2499; Cully TR, 2013, CLIN EXP PHARMACOL P, V40, P338, DOI 10.1111/1440-1681.12078; Darbellay B, 2009, J BIOL CHEM, V284, P5370, DOI 10.1074/jbc.M806726200; Dirksen RT, 2009, J PHYSIOL-LONDON, V587, P3139, DOI 10.1113/jphysiol.2009.172148; Dolmetsch RE, 1997, NATURE, V386, P855, DOI 10.1038/386855a0; Dutka TL, 2005, AM J PHYSIOL-CELL PH, V289, pC1502, DOI 10.1152/ajpcell.00273.2005; Feske S, 2006, NATURE, V441, P179, DOI 10.1038/nature04702; Germinario E, 2008, EUR J APPL PHYSIOL, V104, P445, DOI 10.1007/s00421-008-0796-5; Gupta Anu, 2013, Indian J Endocrinol Metab, V17, P913, DOI 10.4103/2230-8210.117215; Guzman R, 2014, J HISTOCHEM CYTOCHEM, V62, P864, DOI 10.1369/0022155414554926; Gwack Y, 2008, MOL CELL BIOL, V28, P5209, DOI 10.1128/MCB.00360-08; Hakim CH, 2011, METHODS MOL BIOL, V709, P75, DOI 10.1007/978-1-61737-982-6_5; Hooper R, 2013, PFLUG ARCH EUR J PHY, V465, P1383, DOI 10.1007/s00424-013-1270-8; HOTH M, 1992, NATURE, V355, P353, DOI 10.1038/355353a0; Lacruz RS, 2015, ANN NY ACAD SCI, V1356, P45, DOI 10.1111/nyas.12938; Launikonis BS, 2010, PFLUG ARCH EUR J PHY, V460, P813, DOI 10.1007/s00424-010-0856-7; Li HL, 2010, J BIOL CHEM, V285, P39171, DOI 10.1074/jbc.M110.149690; Li TY, 2012, MOL CELL BIOL, V32, P3009, DOI 10.1128/MCB.06599-11; Liao Y, 2008, P NATL ACAD SCI USA, V105, P2895, DOI 10.1073/pnas.0712288105; Lyfenko AD, 2008, J PHYSIOL-LONDON, V586, P4815, DOI 10.1113/jphysiol.2008.160481; LYONS GE, 1991, DEVELOPMENT, V113, P1017; McCarl CA, 2009, J ALLERGY CLIN IMMUN, V124, P1311, DOI 10.1016/j.jaci.2009.10.007; McCarthy JJ, 2012, SKELET MUSCLE, V2, DOI 10.1186/2044-5040-2-8; McCullagh KJA, 2004, P NATL ACAD SCI USA, V101, P10590, DOI 10.1073/pnas.0308035101; Miniou P, 1999, NUCLEIC ACIDS RES, V27, DOI 10.1093/nar/27.19.e27; Prakriya M, 2015, PHYSIOL REV, V95, P1383, DOI 10.1152/physrev.00020.2014; Schiaffino S, 2011, PHYSIOL REV, V91, P1447, DOI 10.1152/physrev.00031.2010; Somasundaram A, 2014, J NEUROSCI, V34, P9107, DOI 10.1523/JNEUROSCI.0263-14.2014; Srikanth S, 2013, MOL CELLS, V35, P182, DOI 10.1007/s10059-013-0073-2; Stathopulos PB, 2006, J BIOL CHEM, V281, P35855, DOI 10.1074/jbc.M608247200; Stiber J, 2008, NAT CELL BIOL, V10, P688, DOI 10.1038/ncb1731; TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337, DOI 10.1152/jappl.1993.75.5.2337; Vig M, 2008, NAT IMMUNOL, V9, P89, DOI 10.1038/ni1550; Wei-LaPierre L, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3805; Yarotskyy V, 2012, BIOPHYS J, V103, P202, DOI 10.1016/j.bpj.2012.06.001; Zanou N, 2010, AM J PHYSIOL-CELL PH, V298, pC149, DOI 10.1152/ajpcell.00241.2009; Zhang WenJun, 2011, Proceedings of the International Academy of Ecology and Environmental Sciences, V1, P1	41	30	31	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4109	4119		10.1096/fj.201600621R	http://dx.doi.org/10.1096/fj.201600621R			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27587568	Green Published			2022-12-26	WOS:000388201500017
J	Chadi, S; Polyte, J; Lefevre, L; Castille, J; Ehanno, A; Laubier, J; Jaffrezic, F; Le Provost, F				Chadi, Sead; Polyte, Jacqueline; Lefevre, Lucas; Castille, Johan; Ehanno, Aude; Laubier, Johann; Jaffrezic, Florence; Le Provost, Fabienne			Phenotypic and Molecular Alterations in the Mammary Tissue of R-Spondin1 Knock-Out Mice during Pregnancy	PLOS ONE			English	Article							WNT/BETA-CATENIN; WNT RECEPTORS; LGR5; DIFFERENTIATION; MORPHOGENESIS; ENDOCYTOSIS; ACTIVATION; PROTEINS; ADULT; CELLS	R-spondin1 (Rspo1) is a member of a secreted protein family which has pleiotropic functions in development and stem cell growth. Rspo1 knock-out mice are sex-reversed, but some remain sub-fertile, so they fail to nurse their pups. A lack of Rspo1 expression in the mammary gland results in an absence of duct side-branching development and defective alveolar formation. The aim of this study was to characterize the phenotypic and molecular alterations of mammary gland due to Rspo1 knock-out. Using the transcriptional profiling of mammary tissues, we identified misregulated genes in the mammary gland of Rspo1 knock-out mice during pregnancy. A stronger expression of mesenchymal markers was observed, without modifications to the structure of mammary epithelial tissue. Mammary epithelial cell immunohistochemical analysis revealed a persistence of virgin markers, which signify a delay in cell differentiation. Moreover, serial transplantation experiments showed that Rspo1 is associated with a regenerative potential of mammary epithelial cell control. Our finding also highlights the negatively regulated expression of Rspo1's partners, Lgr4 and RNF43, in the mammary gland during pregnancy. Moreover, we offer evidence that Tgf-beta signalling is modified in the absence of Rspo1. Taken together, our results show an abrupt halt or delay to mammary development during pregnancy due to the loss of a further differentiated function.	[Chadi, Sead; Polyte, Jacqueline; Lefevre, Lucas; Castille, Johan; Ehanno, Aude; Laubier, Johann; Jaffrezic, Florence; Le Provost, Fabienne] Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France	AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay	Le Provost, F (corresponding author), Univ Paris Saclay, AgroParisTech, INRA, GABI, Jouy En Josas, France.	Fabienne.LeProvost@jouy.inra.fr		Lefevre, Lucas/0000-0003-0925-7411	INRA Animal Genetic Division [ANR-09-GENM-009-Genidov]	INRA Animal Genetic Division	Support was provided by ANR-09-GENM-009-Genidov, INRA Animal Genetic Division.	Affolter M, 2009, NAT REV MOL CELL BIO, V10, P831, DOI 10.1038/nrm2797; Baljinnyam B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029455; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brisken C, 2000, GENE DEV, V14, P650; Brisken C, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a003178; Cai CG, 2014, GENE DEV, V28, P2205, DOI 10.1101/gad.245142.114; Carmon KS, 2014, P NATL ACAD SCI USA, V111, pE1221, DOI 10.1073/pnas.1323106111; Carmon KS, 2012, MOL CELL BIOL, V32, P2054, DOI 10.1128/MCB.00272-12; Carmon KS, 2011, P NATL ACAD SCI USA, V108, P11452, DOI 10.1073/pnas.1106083108; Chadi S, 2009, BIOCHEM BIOPH RES CO, V390, P1040, DOI 10.1016/j.bbrc.2009.10.104; Chakrabarti R, 2012, STEM CELLS, V30, P1496, DOI 10.1002/stem.1112; Chassot AA, 2008, HUM MOL GENET, V17, P1264, DOI 10.1093/hmg/ddn016; DANIEL CW, 1973, EXPERIENTIA, V29, P1420, DOI 10.1007/BF01922854; de Lau W, 2011, NATURE, V476, P293, DOI 10.1038/nature10337; de Lau WBM, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-242; DEOME KB, 1959, CANCER RES, V19, P515; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gjorevski N, 2011, NAT REV MOL CELL BIO, V12, P581, DOI 10.1038/nrm3168; Glinka A, 2011, EMBO REP, V12, P1055, DOI 10.1038/embor.2011.175; Hao HX, 2012, NATURE, V485, P195, DOI 10.1038/nature11019; Harburg G, 2014, STEM CELL REP, V3, P385, DOI 10.1016/j.stemcr.2014.07.007; Hardy KM, 2010, J MAMMARY GLAND BIOL, V15, P191, DOI 10.1007/s10911-010-9172-2; Hennighausen L, 2005, NAT REV MOL CELL BIO, V6, P715, DOI 10.1038/nrm1714; Jin YR, 2012, INT J BIOCHEM CELL B, V44, P2278, DOI 10.1016/j.biocel.2012.09.006; Kim KA, 2006, CELL CYCLE, V5, P23, DOI 10.4161/cc.5.1.2305; Kim YC, 2009, BMC DEV BIOL, V9, DOI 10.1186/1471-213X-9-55; Koo BK, 2012, NATURE, V488, P665, DOI 10.1038/nature11308; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Locke D, 2007, CELL TISSUE RES, V328, P97, DOI 10.1007/s00441-006-0301-6; Macias H, 2011, DEV CELL, V20, P827, DOI 10.1016/j.devcel.2011.05.012; Ohkawara B, 2011, DEV CELL, V20, P303, DOI 10.1016/j.devcel.2011.01.006; Parma P, 2006, NAT GENET, V38, P1304, DOI 10.1038/ng1907; Polyak K, 2009, NAT REV CANCER, V9, P265, DOI 10.1038/nrc2620; Richert MM, 2000, J MAMMARY GLAND BIOL, V5, P227, DOI 10.1023/A:1026499523505; Ruffner H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040976; Shillingford JM, 2003, J HISTOCHEM CYTOCHEM, V51, P555, DOI 10.1177/002215540305100501; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stelwagen K, 2014, J MAMMARY GLAND BIOL, V19, P131, DOI 10.1007/s10911-013-9309-1; Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x; Team RDC, 2012, R LANG ENV STAT COMP; Teuliere J, 2005, DEVELOPMENT, V132, P267, DOI 10.1242/dev.01583; Tomaselli S, 2008, HUM MUTAT, V29, P220, DOI 10.1002/humu.20665; Tomizuka K, 2008, HUM MOL GENET, V17, P1278, DOI 10.1093/hmg/ddn036; Visvader JE, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004879; Wang DL, 2013, GENE DEV, V27, P1339, DOI 10.1101/gad.219360.113; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Yoon JK, 2012, CELL SIGNAL, V24, P369, DOI 10.1016/j.cellsig.2011.09.023; Zhou WJ, 2013, NATURE, V501, P107, DOI 10.1038/nature12416; Zhu WT, 2012, BIOSYSTEMS, V109, P403, DOI 10.1016/j.biosystems.2012.04.004	49	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162566	10.1371/journal.pone.0162566	http://dx.doi.org/10.1371/journal.pone.0162566			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611670	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900126
J	Hernandez-Montilla, MC; Martinez-Morales, MA; Vanegas, GP; de Jong, BHJ				Hernandez-Montilla, Mariana C.; Angel Martinez-Morales, Miguel; Posada Vanegas, Gregorio; de Jong, Bernardus H. J.			Assessment of Hammocks (Petenes) Resilience to Sea Level Rise Due to Climate Change in Mexico	PLOS ONE			English	Article							TROPICAL-FOREST; VULNERABILITY; STABILITY	There is a pressing need to assess resilience of coastal ecosystems against sea level rise. To develop appropriate response strategies against future climate disturbances, it is important to estimate the magnitude of disturbances that these ecosystems can absorb and to better understand their underlying processes. Hammocks (petenes) coastal ecosystems are highly vulnerable to sea level rise linked to climate change; their vulnerability is mainly due to its close relation with the sea through underground drainage in predominantly karstic soils. Hammocks are biologically importantbecause of their high diversity and restricted distribution. This study proposes a strategy to assess resilience of this coastal ecosystem when high-precision data are scarce. Approaches and methods used to derive ecological resilience maps of hammocks are described and assessed. Resilience models were built by incorporating and weighting appropriate indicators of persistence to assess hammocks resilience against flooding due to climate change at "Los Petenes Biosphere Reserve", in the Yucatan Peninsula, Mexico. According to the analysis, 25% of the study area is highly resilient (hot spots), whereas 51% has low resilience (cold spots). The most significant hot spot clusters of resilience were located in areas distant to the coastal zone, with indirect tidal influence, and consisted mostly of hammocks surrounded by basin mangrove and floodplain forest. This study revealed thatmulti-criteria analysis and the use of GIS for qualitative, semi-quantitative and statistical spatial analyses constitute a powerful tool to develop ecological resilience maps of coastal ecosystems that are highly vulnerable to sea level rise, even when high-precision data are not available. This method can be applied in other sites to help develop resilience analyses and decision-making processes for management and conservation of coastal areas worldwide.	[Hernandez-Montilla, Mariana C.; Angel Martinez-Morales, Miguel] El Colegio Frontera Sur, Dept Conservac Biodiversidad, Campeche, Campeche, Mexico; [Posada Vanegas, Gregorio] Univ Autonoma Campeche, Inst Ecol Pesquerias & Oceanog Golfo Mexico, Campeche, Campeche, Mexico; [de Jong, Bernardus H. J.] El Colegio Frontera Sur, Dept Ciencias Sustentabilidad, Campeche, Campeche, Mexico	El Colegio de la Frontera Sur (ECOSUR); El Colegio de la Frontera Sur (ECOSUR)	Martinez-Morales, MA (corresponding author), El Colegio Frontera Sur, Dept Conservac Biodiversidad, Campeche, Campeche, Mexico.	mmartinez@ecosur.mx	de Jong, Ben HJ/GYV-3632-2022		Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) [481804]; CONACYT	Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	MCHM received funding from Consejo Nacional de Ciencia y Tecnologia de Mexico (CONACYT) for this work. Register number 481804. The scholarship and the grant allowed the study design, data analysis, and the preparation of the manuscript. Information about the CONACYT Scholarship and Grant Program is available on the Web at: http://www.conacyt.mx/index.php/becas-y-posgrados and http://www.conacyt.mx/index.php/becas-mixtas.	Acosta Lugo E. D, 2010, PLAN CONSERVACION EC; Anderson KE, 2009, COASTAL SENSITIVITY; AOML/NOAA, 2006, ESC SAFF SIMPS HUR; Borrini-Feyerabend G., 2013, GOVERNANCE PROTECTED; Brand F, 2005, 09489452 LEIPZ HALLE; Brand FS, 2007, ECOL SOC, V12; Brown K, 2012, CLIMATE CHANGE CRISI, P37, DOI DOI 10.4324/9780203146118; Carpenter S, 2001, ECOSYSTEMS, V4, P765, DOI 10.1007/s10021-001-0045-9; Church J.A., 2013, CLIMATE CHANGE 2013, P1137, DOI [10.1017/CBO9781107415324.026, DOI 10.1017/CBO9781107415324.026, DOI 10.1017/CB09781107415324.026]; Cintron G, 1984, METHODS STUDYING MAN; CONANP, 2006, PROGR CONS MAN RES B; CONNELL JH, 1983, AM NAT, V121, P789, DOI 10.1086/284105; Diggle PJ, 2007, SPRINGER SER STAT, P1, DOI 10.1007/978-0-387-48536-2; Eakin H, 2006, ANNU REV ENV RESOUR, V31, P365, DOI 10.1146/annurev.energy.30.050504.144352; Eastman JR, 2009, IDRISI KILIMANJARO G; Espadas C, 2009, ATLAS ESCENARIOS CAM; Folke C, 2006, GLOBAL ENVIRON CHANG, V16, P253, DOI 10.1016/j.gloenvcha.2006.04.002; Koyoc-Ramirez LG, 2015, ACTA BOT MEX, V110, P89; Gallopin GC, 2006, GLOBAL ENVIRON CHANG, V16, P293, DOI 10.1016/j.gloenvcha.2006.02.004; Gunderson L. H., 2002, Panarchy: understanding transformations in human and natural systems; Gunderson LH, 2000, ANNU REV ECOL SYST, V31, P425, DOI 10.1146/annurev.ecolsys.31.1.425; Herrera-Silveira J, 2010, MANUAL PRACTICO REHA; Hodgson D, 2015, TRENDS ECOL EVOL, V30, P503, DOI 10.1016/j.tree.2015.06.010; Holling C.S., 1973, Annual Rev Ecol Syst, V4, P1, DOI 10.1146/annurev.es.04.110173.000245; Homogeneous A, 2012, NEXTMAP WORLD 30 MET; INEGI, 2013, CART US SUEL VEG 5; Karl TR., 2008, SYNTH ASSESS PROD, P164; Kates RW., 1985, CLIMATE IMPACT ASSES; Lehner B, 2006, HYDROSHEDS TECHNICAL; Torres-Castro IL, 2009, REV BIOL TROP, V57, P141; Lopez R, 2003, LANDSCAPE ATLAS ECOL; Ludwig D., 1997, CONSERV ECOL, V1, P1; March IJ, 2011, SERIE ESTRATEGIAS AD; Masson-Delmotte V., 2018, GLOBAL WARMING 15 C; McGarigal K., 1994, SPATIAL PATTERN ANAL; Michener WK, 1997, ECOL APPL, V7, P770, DOI 10.1890/1051-0761(1997)007[0770:CCHATS]2.0.CO;2; Nerheim S., 2008, 6 US EU BALT INT S O, DOI [10.1109/BALTIC.2008.4625543, DOI 10.1109/BALTIC.2008.4625543]; Nimmo DG, 2015, TRENDS ECOL EVOL, V30, P516, DOI 10.1016/j.tree.2015.07.008; NOAA, 2013, HIST HURR TRACKS V4; Order JK, 1995, GEOGR ANAL, V27, P286, DOI [10.1111/j.1538-4632.1995.tb00912.x, DOI 10.1111/J.1538-4632.1995.TB00912.X]; Ortiz-Perez M. A., 1999, INVESTIGACIONES GEOG, V39, P68; PIMM SL, 1984, NATURE, V307, P321, DOI 10.1038/307321a0; Posada G, 2010, INT C COAST ENG SHAN, P2156; Posada G, 2010, 16 C NAC OC ENS BAJ; Ramieri E., 2011, ETC CCA TECH PAP, V1, P1; SAATY TL, 1977, J MATH PSYCHOL, V15, P234, DOI 10.1016/0022-2496(77)90033-5; Sanchez OS, 1999, GLOBAL ECOL BIOGEOGR, V8, P29, DOI 10.1046/j.1365-2699.1999.00317.x; Schott T., 2012, SAFFIR SIMPSON HURRI; SEMARNAT-INECC, 2012, QUINT COM NAC ANT CO; Seneviratne SI, 2012, MANAGING THE RISKS OF EXTREME EVENTS AND DISASTERS TO ADVANCE CLIMATE CHANGE ADAPTATION, P109; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; The Nature Conservancy (TNC), 2011, GUIA EL PROGR AD CAM; Tighe ML, 2012, VALIDATION NEW 30 ME; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Yanez-Arancibia A., 1996, CARACTERIZACION ECOL	55	6	6	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162637	10.1371/journal.pone.0162637	http://dx.doi.org/10.1371/journal.pone.0162637			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611802	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900141
J	Kim, MN; Kim, JO; Lee, SM; Park, H; Lee, J; Rim, KS; Hwang, SG; Kim, NK				Kim, Mi Na; Kim, Jung Oh; Lee, Seung Min; Park, Hana; Lee, Juho; Rim, Kyu Sung; Hwang, Seong Gyu; Kim, Nam Keun			Variation in the Dicer and RAN Genes Are Associated with Survival in Patients with Hepatocellular Carcinoma	PLOS ONE			English	Article							MICRORNA-RELATED GENES; BLADDER-CANCER; POOR-PROGNOSIS; OVARIAN-CANCER; RISK-FACTORS; BIOGENESIS; EXPRESSION; DROSHA; ADENOCARCINOMA; POLYMORPHISMS	Single-nucleotide polymorphisms (SNPs) in microRNA machinery genes might affect microRNA processing and subsequently impact tumorigenesis. The aim of this study was to investigate the associations between SNPs in microRNA machinery genes and hepatocellular carcinoma (HCC) in a Korean population. Genotyping of six SNPs in microRNA machinery genes was performed using blood samples from 147 patients with HCC and 209 healthy control subjects. None of the six SNPs in microRNA machinery genes were significantly associated with HCC development. However, among the models for six polymorphic loci-DICER (rs3742330 and rs13078), DROSHA (rs10719 and rs6877842), RAN (rs14035) and XPO5 (rs11077)-one allele combination (A-A-T-C-C-C) showed synergistic effects in terms of an increased risk of HCC development (odds ratio = 8.881, 95% confidence interval [CI] = 1.889-41.750; P = 0.002). Multivariate Cox proportional hazard regression analysis showed a significant survival benefit for the DICER rs3742330 GG compared with the AA type (hazard ratio [HR], 0.314; 95% CI, 0.135-0.730; P = 0.007) and for the RAN rs14035 CT compared with the CC genotype (HR, 0.587; 95% CI, 0.349-0.987; P = 0.044). Although we found no direct association between DICER (rs3742330 and rs13078), DROSHA (rs10719 and rs6877842), RAN (rs14035) or XPO5 (rs11077) polymorphisms and HCC risk, we demonstrated that DICER (rs3742330) and RAN (rs14035) were associated with the survival of HCC patients. Future studies with larger samples are needed to determine associations of SNPs in microRNA machinery genes with HCC risk and prognosis.	[Kim, Mi Na; Park, Hana; Lee, Juho; Rim, Kyu Sung; Hwang, Seong Gyu] CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Songnam, South Korea; [Kim, Jung Oh; Lee, Seung Min; Kim, Nam Keun] CHA Univ, CHA Bundang Med Ctr, Inst Clin Res, Songnam, South Korea; [Kim, Jung Oh; Kim, Nam Keun] CHA Univ, Coll Life Sci, Dept Biomed Sci, Songnam, South Korea	Pochon Cha University; Pochon Cha University; Pochon Cha University	Hwang, SG (corresponding author), CHA Univ, CHA Bundang Med Ctr, Dept Internal Med, Songnam, South Korea.; Kim, NK (corresponding author), CHA Univ, CHA Bundang Med Ctr, Inst Clin Res, Songnam, South Korea.; Kim, NK (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, Songnam, South Korea.	sghwang@cha.ac.kr; nkkim@cha.ac.k		Kim, Jung Oh/0000-0002-4171-2034	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [2015R1D1A1A01058653]; Ministry of Education [2015R1D1A1A09057432]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education; Ministry of Education	This study was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (2015R1D1A1A01058653), and by the Ministry of Education 2015R1D1A1A09057432). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chiosea S, 2007, CANCER RES, V67, P2345, DOI 10.1158/0008-5472.CAN-06-3533; Chiosea S, 2006, AM J PATHOL, V169, P1812, DOI 10.2353/ajpath.2006.060480; Cho SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131125; Faber C, 2011, EUR J CANCER, V47, P1414, DOI 10.1016/j.ejca.2011.01.006; Gomaa AI, 2008, WORLD J GASTROENTERO, V14, P4300, DOI 10.3748/wjg.14.4300; Grelier G, 2009, BRIT J CANCER, V101, P673, DOI 10.1038/sj.bjc.6605193; Gu J, 2005, PHARMACOGENOMICS, V6, P575, DOI 10.2217/14622416.6.6.575; Guo XF, 2012, J CANCER RES CLIN, V138, P49, DOI 10.1007/s00432-011-1058-1; Honma K, 2009, INT J GEN MED, V2, P243; Karube Y, 2005, CANCER SCI, V96, P111, DOI 10.1111/j.1349-7006.2005.00015.x; Kim JS, 2010, MOL CARCINOGEN, V49, P913, DOI 10.1002/mc.20672; Kitagawa N, 2013, CANCER SCI, V104, P543, DOI 10.1111/cas.12126; Leaderer D, 2011, INT J MOL EPIDEMIOL, V2, P9; Liang D, 2010, CANCER RES, V70, P9765, DOI 10.1158/0008-5472.CAN-10-0130; Lin J, 2010, CARCINOGENESIS, V31, P1805, DOI 10.1093/carcin/bgq168; Martello G, 2010, CELL, V141, P1195, DOI 10.1016/j.cell.2010.05.017; McCormack VA, 2011, ANN ONCOL, V22, P2349, DOI 10.1093/annonc/mdq763; Merritt WM, 2008, NEW ENGL J MED, V359, P2641, DOI 10.1056/NEJMoa0803785; Murphy D, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-92; Papachristou DJ, 2012, HISTOPATHOLOGY, V60, pE28, DOI 10.1111/j.1365-2559.2012.04192.x; Papachristou DJ, 2012, CANCER INVEST, V30, P172, DOI 10.3109/07357907.2011.633293; Su XH, 2010, NATURE, V467, P986, DOI 10.1038/nature09459; Sugito N, 2006, CLIN CANCER RES, V12, P7322, DOI 10.1158/1078-0432.CCR-06-0515; Valencak J, 2011, J DERMATOL SCI, V64, P185, DOI 10.1016/j.jdermsci.2011.08.011; Wang JB, 2012, MUTAGENESIS, V27, P779, DOI 10.1093/mutage/ges052; Woo IS, 2008, APOPTOSIS, V13, P1223, DOI 10.1007/s10495-008-0247-0; Wu JF, 2011, MED ONCOL, V28, P804, DOI 10.1007/s12032-010-9520-5; Wu XF, 2006, AM J HUM GENET, V78, P464, DOI 10.1086/500848; Xie Y, 2015, ONCOTARGETS THER, V8, P567, DOI 10.2147/OTT.S79150; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Yang PW, 2014, ANN SURG ONCOL, V21, pS601, DOI 10.1245/s10434-014-3709-3	33	14	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162279	10.1371/journal.pone.0162279	http://dx.doi.org/10.1371/journal.pone.0162279			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611467	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900072
J	Chang, YF; Chang, CS; Wang, MW; Wu, CF; Chen, CY; Chang, HJ; Kuo, PH; Wu, CH				Chang, Yin-Fan; Chang, Chin-Sung; Wang, Mei-Wen; Wu, Chun-Feng; Chen, Chuan-Yu; Chang, Hsuan-Jui; Kuo, Po-Hsiu; Wu, Chih-Hsing			Effects of Age and Body Mass Index on Thoracolumbar Spine X-Ray for Diagnosing Osteoporosis in Elderly Women: Tianliao Old People (TOP) Study 07	PLOS ONE			English	Article							VERTEBRAL FRACTURE ASSESSMENT; BONE-MINERAL DENSITY; RISK; HIP; POPULATION; PREVALENCE; NUTRITION; OBESITY; WEIGHT; BURDEN	Purpose The aim of this study was to determine the effects of diagnostic discordance with or without a thoracolumbar spine lateral view X-ray in patients with osteoporosis. Methods We randomly enrolled 368 women over 65 years old (74.3 +/- 6.0 years) from Tianliao Township in 2009 (response rate: 75.7%). A diagnosis of osteoporosis was confirmed using one of these criteria: (1) a history of non-traumatic fracture, (2) vertebral fractures based on a thoracolumbar spine lateral view X-ray, or (3) a bone mineral density T-score <=-2.5 for the total hip, the femoral neck, the lumbar spine, or all 3 sites. The prevalence of osteoporosis in three groups was compared based on Model I (criteria 1+2) vs. Model II (criteria 1+3) vs. Model III (criteria 1+2+3). The role of thoracolumbar X-ray reflected by the diagnostic discordance of osteoporosis between Models II and III was evaluated. Results The overall prevalence of osteoporosis was 78.3%(Model III, age-standardized 78.1%). The diagnostic discordance was 17.4% in the 368 participants. A logistic regression model showed that age was negatively associated with diagnostic discordance (odds ratio [OR] = 0.93, 95% confidence interval [CI]: 0.88-0.98, p < 0.05), but body mass index was positively associated (OR = 1.07, 95% CI: 1.00-1.15, p < 0.05). Conclusions A thoracolumbar spine lateral view X-ray should be added for women >= 65 years old or with a body mass index >= 25 kg/m(2) to minimize the diagnostic discordance in osteoporosis, especially in highly endemic regions.	[Chang, Yin-Fan; Chang, Chin-Sung; Wu, Chih-Hsing] Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan, Taiwan; [Wang, Mei-Wen] Tainan Hosp, Dept Radiol, Dept Hlth, Xinhua Branch, Tainan, Taiwan; [Wu, Chun-Feng] Kuo Gen Hosp, Dept Family Med, Tainan, Taiwan; [Chen, Chuan-Yu] Dynasty clin, Tainan, Taiwan; [Chang, Hsuan-Jui] Changhua Christian Hosp, Dept Family Med, Changhua, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Dept Publ Hlth, Taipei, Taiwan; [Kuo, Po-Hsiu] Natl Taiwan Univ, Coll Publ Hlth, Inst Epidemiol, Taipei, Taiwan	National Cheng Kung University; National Cheng Kung University Hospital; Changhua Christian Hospital; National Taiwan University; National Taiwan University	Wu, CH (corresponding author), Natl Cheng Kung Univ Hosp, Dept Family Med, Tainan, Taiwan.	paulo@mail.ncku.edu.tw		Kuo, Po-Hsiu/0000-0003-0365-3587	National Cheng Kung University Hospital [NCKUH-9901020]	National Cheng Kung University Hospital	Financial support for this study was partially provided by grant NCKUH-9901020 from National Cheng Kung University Hospital. The funders had a role in data collection and reagents.	Bow CH, 2012, OSTEOPOROSIS INT, V23, P879, DOI 10.1007/s00198-011-1627-9; Chang CS, 2013, J CLIN DENSITOM, V16, P204, DOI 10.1016/j.jocd.2012.03.008; Choi YJ, 2012, J BONE MINER RES, V27, P1879, DOI 10.1002/jbmr.1635; Edwards BJ, 2007, CLIN ORTHOP RELAT R, P226, DOI 10.1097/BLO.0b013e3180534269; El Maghraoui A, 2013, BONE, V52, P176, DOI 10.1016/j.bone.2012.09.023; Fink HA, 2005, J BONE MINER RES, V20, P1216, DOI 10.1359/JBMR.050314; Gallacher SJ, 2007, OSTEOPOROSIS INT, V18, P185, DOI 10.1007/s00198-006-0211-1; GENANT HK, 1993, J BONE MINER RES, V8, P1137, DOI 10.1002/jbmr.5650080915; Howat I, 2007, CLIN ENDOCRINOL, V67, P923, DOI 10.1111/j.1365-2265.2007.02988.x; Iki M, 2001, OSTEOPOROSIS INT, V12, P529, DOI 10.1007/s001980170073; International Osteoporosis Foundation, FRACT AR WARN SIGNS; International Osteoporosis Foundation, POSTFR CAR GAP; Jager PL, 2010, CAN ASSOC RADIOL J, V61, P194, DOI 10.1016/j.carj.2009.12.012; Kanis JA, 2012, OSTEOPOROSIS INT, V23, P2239, DOI 10.1007/s00198-012-1964-3; Kanis JA, 2010, OSTEOPOROSIS INT, V21, P407, DOI 10.1007/s00198-010-1253-y; Kanis JA, 2002, LANCET, V359, P1929, DOI 10.1016/S0140-6736(02)08761-5; Kanis JA, 2004, OSTEOPOROSIS INT, V15, P20, DOI 10.1007/s00198-003-1463-7; Klibanski A, 2001, JAMA-J AM MED ASSOC, V285, P785; Lin YC, 2011, ASIA PAC J CLIN NUTR, V20, P283; Mpalaris V, 2015, OBES REV, V16, P225, DOI 10.1111/obr.12244; National Osteoporosis Foundation, 2008, CLIN GUID PREV TREAT; National Osteoporosis Foundation, 2014, CLIN GUID PREV TREAT; Nelson HD, 2010, ANN INTERN MED, V153, P99, DOI 10.7326/0003-4819-153-2-201007200-00262; Orimo Hajime, 2012, Arch Osteoporos, V7, P3; Papaioannou A, 2010, CAN MED ASSOC J, V182, P1864, DOI 10.1503/cmaj.100771; Port L, 2003, OSTEOPOROSIS INT, V14, P780, DOI 10.1007/s00198-003-1452-x; Schousboe JT, 2008, J CLIN DENSITOM, V11, P92, DOI 10.1016/j.jocd.2007.12.008; Setting Committee of the WHO Western Pacific Region IASO & IOTF, 2000, AS PAC PERSP RED OB; Shao CJ, 2009, BONE, V44, P125, DOI 10.1016/j.bone.2008.09.004; Stenholm S, 2008, CURR OPIN CLIN NUTR, V11, P693, DOI 10.1097/MCO.0b013e328312c37d; Strom O, 2011, Arch Osteoporos, V6, P59, DOI 10.1007/s11657-011-0060-1; TROISI RJ, 1991, AM J CLIN NUTR, V53, P1104, DOI 10.1093/ajcn/53.5.1104; Tzotzas T, 2010, J CLIN ENDOCR METAB, V95, P4251, DOI 10.1210/jc.2010-0757; van den Berg M, 2011, MATURITAS, V70, P74, DOI 10.1016/j.maturitas.2011.06.006; Woolf AD, 2003, B WORLD HEALTH ORGAN, V81, P646; Wortsman J, 2000, AM J CLIN NUTR, V72, P690, DOI 10.1093/ajcn/72.3.690; Writing Group for the ISCD Position Development Conference, 2004, J Clin Densitom, V7, P7; Wu CH, 2014, J CLIN DENSITOM, V17, P150, DOI 10.1016/j.jocd.2013.06.002; Yang YC, 2004, ARCH INTERN MED, V164, P1534, DOI 10.1001/archinte.164.14.1534	39	65	66	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161773	10.1371/journal.pone.0161773	http://dx.doi.org/10.1371/journal.pone.0161773			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606706	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600010
J	Diaz, SA; Martin, SR; Howell, SA; Grainger, M; Moon, RW; Green, JL; Holder, AA				Diaz, Suraya A.; Martin, Stephen R.; Howell, Steven A.; Grainger, Munira; Moon, Robert W.; Green, Judith L.; Holder, Anthony A.			The Binding of Plasmodium falciparum Adhesins and Erythrocyte Invasion Proteins to Aldolase Is Enhanced by Phosphorylation	PLOS ONE			English	Article							HOST-CELL INVASION; MALARIA PARASITE INVASION; TOXOPLASMA-GONDII; ANONYMOUS PROTEIN; CYTOPLASMIC DOMAIN; MEROZOITE PROTEINS; APICOMPLEXAN PARASITES; ACTIN POLYMERIZATION; GLIDING MOTILITY; MOTOR COMPLEX	Aldolase has been implicated as a protein coupling the actomyosin motor and cell surface adhesins involved in motility and host cell invasion in the human malaria parasite Plasmodium falciparum. It binds to the cytoplasmic domain (CTD) of type 1 membrane proteins of the thrombospondin-related anonymous protein (TRAP) family. Other type 1 membrane proteins located in the apical organelles of merozoites, the form of the parasite that invades red blood cells, including apical membrane antigen 1 (AMA1) and members of the erythrocyte binding ligand (EBL) and reticulocyte binding homologue (RH) protein families have been implicated in host cell binding and invasion. Using a direct binding method we confirm that TRAP and merozoite TRAP (MTRAP) bind aldolase and show that the interaction is mediated by more than just the C-terminal six amino acid residues identified previously. Single amino acid substitutions in the MTRAP CTD abolished binding to aldolase. The CTDs of AMA1 and members of the EBL and RH protein families also bound to aldolase. MTRAP competed with AMA1 and RH4 for binding to aldolase, indicating overlapping binding sites. MTRAP CTD was phosphorylated in vitro by both calcium dependent kinase 1 (CDPK1) and protein kinase A, and this modification increased the affinity of binding to aldolase by ten-fold. Phosphorylation of the CTD of members of the EBL and RH protein families also increased their affinity for aldolase in some cases. To examine whether or not MTRAP expressed in asexual blood stage parasites is phosphorylated, it was tagged with GFP, purified and analysed, however no phosphorylation was detected. We propose that CTD binding to aldolase may be dynamically modulated by phosphorylation, and there may be competition for aldolase binding between different CTDs. The use and efficiency of alternate invasion pathways may be determined by the affinity of adhesins and cell invasion proteins for aldolase, in addition to their host ligand specificity.	[Diaz, Suraya A.; Grainger, Munira; Moon, Robert W.; Green, Judith L.; Holder, Anthony A.] Francis Crick Inst, Mill Hill Lab, Malaria Parasitol Lab, Mill Hill, London NW7 1AA, England; [Martin, Stephen R.] Francis Crick Inst, Mill Hill Lab, Struct Biol Sci Technol Platform, Mill Hill, London NW7 1AA, England; [Howell, Steven A.] Francis Crick Inst, Mill Hill Lab, Mass Spectrometry Sci Technol Platform, Mill Hill, London NW7 1AA, England; [Diaz, Suraya A.] Natl Univ Ireland, Ctr Chromosome Biol, Biosci Res Bldg, Galway, Ireland; [Moon, Robert W.] London Sch Hyg & Trop Med, Dept Immunol & Infect, Fac Infect & Trop Dis, London, England	Ollscoil na Gaillimhe-University of Galway; University of London; London School of Hygiene & Tropical Medicine	Holder, AA (corresponding author), Francis Crick Inst, Mill Hill Lab, Malaria Parasitol Lab, Mill Hill, London NW7 1AA, England.	tony.holder@crick.ac.uk	Moon, Robert/AAF-9808-2019; Holder, Anthony A/A-7554-2013	Holder, Anthony A/0000-0002-8490-6058; Moon, Robert/0000-0002-9070-4292; Green, Judith/0000-0001-6825-9404	Francis Crick Institute from Cancer Research UK; UK Medical Research Council [U117532067]; Wellcome Trust; European Community [242095]; Portuguese FCT; MRC [MR/M021157/1, MC_U117532067] Funding Source: UKRI; Medical Research Council [MR/M021157/1, MC_U117532067] Funding Source: researchfish; The Francis Crick Institute [10097, 10015] Funding Source: researchfish	Francis Crick Institute from Cancer Research UK; UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Community(European Commission); Portuguese FCT(Portuguese Foundation for Science and Technology); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); The Francis Crick Institute	This work was supported by the Francis Crick Institute (https://www.crick.ac.uk/) which receives its core funding from Cancer Research UK (http://www.cancerresearchuk.org), the UK Medical Research Council (http://www.mrc.ac.uk/), and the Wellcome Trust (http://www.wellcome.ac.uk). In addition, this research was supported by the UK Medical Research Council (U117532067 to AAH) and the European Community's FP7 grant agreement 242095 to AAH (EviMalar; http://www.evimalar.org). SAD was in receipt of a Portuguese FCT Studentship (http://www.fct.pt). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS JH, 1992, P NATL ACAD SCI USA, V89, P7085, DOI 10.1073/pnas.89.15.7085; AIKAWA M, 1981, J CELL BIOL, V91, P55, DOI 10.1083/jcb.91.1.55; Akhouri RR, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-63; Alexander DL, 2006, EUKARYOT CELL, V5, P1169, DOI 10.1128/EC.00040-06; Andenmatten N, 2013, NAT METHODS, V10, P125, DOI 10.1038/NMETH.2301; ARNOLD H, 1970, EUR J BIOCHEM, V15, P360, DOI 10.1111/j.1432-1033.1970.tb01016.x; Bartholdson SJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003031; Baum J, 2006, J BIOL CHEM, V281, P5197, DOI 10.1074/jbc.M509807200; Baum J, 2006, NAT REV MICROBIOL, V4, P621, DOI 10.1038/nrmicro1465; Bosch J, 2007, P NATL ACAD SCI USA, V104, P7015, DOI 10.1073/pnas.0605301104; Buscaglia CA, 2003, MOL BIOL CELL, V14, P4947, DOI 10.1091/mbc.E03-06-0355; Buscaglia CA, 2007, PROTEINS, V66, P528, DOI 10.1002/prot.21266; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Chattopadhyay R, 2003, J BIOL CHEM, V278, P25977, DOI 10.1074/jbc.M300865200; Dawn A, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004520; Dessens JT, 1999, EMBO J, V18, P6221, DOI 10.1093/emboj/18.22.6221; Diaz SA, 2014, MOL BIOCHEM PARASIT, V197, P9, DOI 10.1016/j.molbiopara.2014.09.006; Douse CH, 2012, J BIOL CHEM, V287, P36968, DOI 10.1074/jbc.M112.379842; Dubremetz JF, 1998, INT J PARASITOL, V28, P1007, DOI 10.1016/S0020-7519(98)00076-9; Dvorin JD, 2010, MOL MICROBIOL, V75, P990, DOI 10.1111/j.1365-2958.2009.07040.x; Egarter S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091819; Engelberg K, 2013, BIOCHEM J, V452, P457, DOI 10.1042/BJ20121694; Gilberger TW, 2003, J CELL BIOL, V162, P317, DOI 10.1083/jcb.200301046; Goo YK, 2013, EXP PARASITOL, V135, P42, DOI 10.1016/j.exppara.2013.06.002; Green JL, 2008, J BIOL CHEM, V283, P30980, DOI 10.1074/jbc.M803129200; Jacot D, 2014, CELL MICROBIOL, V16, P1518, DOI 10.1111/cmi.12307; Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8; Kaneko O, 2002, MOL BIOCHEM PARASIT, V121, P275, DOI 10.1016/S0166-6851(02)00042-7; Lasonder E, 2015, PROTEOMICS, V15, P2716, DOI 10.1002/pmic.201400508; Lasonder E, 2012, MICROBES INFECT, V14, P811, DOI 10.1016/j.micinf.2012.04.008; Maier AG, 2003, NAT MED, V9, P87, DOI 10.1038/nm807; Maier AG, 2009, INFECT IMMUN, V77, P1689, DOI 10.1128/IAI.01331-08; Mayer DCG, 2001, P NATL ACAD SCI USA, V98, P5222, DOI 10.1073/pnas.081075398; Menard R, 1997, NATURE, V385, P336, DOI 10.1038/385336a0; MILLER LH, 1979, J EXP MED, V149, P172, DOI 10.1084/jem.149.1.172; Morahan BJ, 2009, TRENDS PARASITOL, V25, P77, DOI 10.1016/j.pt.2008.11.004; Nemetski SM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0834-9; Pal-Bhowmick I, 2012, MBIO, V3, DOI 10.1128/mBio.00292-12; Rayner JC, 2001, J EXP MED, V194, P1571, DOI 10.1084/jem.194.11.1571; Rayner JC, 2000, P NATL ACAD SCI USA, V97, P9648, DOI 10.1073/pnas.160469097; Riglar DT, 2016, J CELL SCI, V129, P228, DOI 10.1242/jcs.177741; Riglar DT, 2011, CELL HOST MICROBE, V9, P9, DOI 10.1016/j.chom.2010.12.003; RUSSELL DG, 1983, PARASITOLOGY, V87, P199, DOI 10.1017/S0031182000052562; Shen B, 2014, P NATL ACAD SCI USA, V111, P3567, DOI 10.1073/pnas.1315156111; Solyakov L, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1558; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Srinivasan P, 2011, P NATL ACAD SCI USA, V108, P13275, DOI 10.1073/pnas.1110303108; Sultan AA, 1997, CELL, V90, P511, DOI 10.1016/S0092-8674(00)80511-5; Tham WH, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005343; Thompson J, 2004, MOL BIOCHEM PARASIT, V134, P225, DOI 10.1016/j.molbiopara.2003.12.003; Treeck M, 2011, CELL HOST MICROBE, V10, P410, DOI 10.1016/j.chom.2011.09.004; Treeck M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000322; Uchime O, 2012, EUKARYOT CELL, V11, P615, DOI 10.1128/EC.00039-12; WALSH TP, 1977, BIOCHEM J, V165, P165, DOI 10.1042/bj1650165; Wang JA, 1996, J BIOL CHEM, V271, P6861, DOI 10.1074/jbc.271.12.6861; Yusuf NA, 2015, J BIOL CHEM, V290, P12147, DOI 10.1074/jbc.M115.637694	56	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161850	10.1371/journal.pone.0161850	http://dx.doi.org/10.1371/journal.pone.0161850			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607074	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600013
J	Hung, WC; Wan, TW; Kuo, YC; Yamamoto, T; Tsai, JC; Lin, YT; Hsueh, PR; Teng, LJ				Hung, Wei-Chun; Wan, Tsai-Wen; Kuo, Yu-Chia; Yamamoto, Tatsuo; Tsai, Jui-Chang; Lin, Yu-Tzu; Hsueh, Po-Ren; Teng, Lee-Jene			Molecular Evolutionary Pathways toward Two Successful Community-Associated but Multidrug-Resistant ST59 Methicillin-Resistant Staphylococcus aureus Lineages in Taiwan: Dynamic Modes of Mobile Genetic Element Salvages	PLOS ONE			English	Article							EPIDEMIOLOGY; EMERGENCE; INFECTION; CHILDREN; HOST; MRSA; COLONIZATION; VIRULENCE; STRAINS; IV	Clonal complex 59 (CC59) Staphylococcus aureus in Taiwan includes both methicillin-susceptible S. aureus (MSSA) and methicillin-resistant S. aureus (MRSA). As the most prominent community-associated MRSA (CA-MRSA) in Taiwan, CC59 has two major clones characterized as PVL-negative SCCmec IV (carrying the staphylococcal cassette chromosome mec IV but Panton-Valentine leukocidin-negative) and PVL-positive SCCmec V (5C2&5). We investigated the drug resistance, phylogeny and the distribution and sequence variation of SCCmec, staphylococcal bacteriophage phi SA3, genomic island nu Sa beta and MES (an enterococcal mobile genetic element conferring multidrug resistance) in 195 CC59 S. aureus. Sequencing and PCR mapping revealed that all of the CC59/SCCmec V (5C2&5) MRSA strains had acquired MESPM1 or its segregants, and obtained a phi SA3-related fragment in nu Sa beta. In contrast, MES6272-2 and MES4578, which showed gentamicin resistance that was not encoded by MESPM1, were dominant in SCCmec IVg MRSA. Translocation of a whole fSA3 into nu Sa beta instead of only a fSA3-related fragment was common in SCCmec IVg MRSA. However, the non-subtype-g SCCmec IV MRSA (SCCmec IVa is the major) still carried MES and nu Sa beta structures similar to those in SCCmec V (5C2&5) MRSA. A minimum spanning tree constructed by multiple-locus variable-number tandem repeat analysis revealed that SCCmec IVg MRSA and SCCmec V (5C2&5) MRSA grouped respectively in two major clades. The CC59 MSSA was equally distributed among the two clades, while the non-subtype-g SCCmec IV MRSA mostly clustered with SCCmec V (5C2&5) MRSA. Our	[Hung, Wei-Chun] Kaohsiung Med Univ, Dept Microbiol & Immunol, Kaohsiung, Taiwan; [Wan, Tsai-Wen; Kuo, Yu-Chia; Lin, Yu-Tzu; Teng, Lee-Jene] Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan; [Yamamoto, Tatsuo] Int Med Educ & Res Ctr, Dept Epidemiol Genom & Evolut, Niigata, Japan; [Tsai, Jui-Chang] Natl Taiwan Univ, Coll Med, Inst Med Device & Imaging, Taipei, Taiwan; [Tsai, Jui-Chang] Natl Taiwan Univ Hosp, Div Neurosurg, Dept Surg, Taipei, Taiwan; [Hsueh, Po-Ren; Teng, Lee-Jene] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	Kaohsiung Medical University; National Taiwan University; National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital	Teng, LJ (corresponding author), Natl Taiwan Univ, Dept Clin Lab Sci & Med Biotechnol, Coll Med, Taipei, Taiwan.; Teng, LJ (corresponding author), Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan.	ljteng@ntu.edu.tw	Hsueh, Po-Ren/ABE-1594-2021	TSAI, JUI-CHANG/0000-0003-2723-6841; Lin, Yu-Tzu/0000-0002-3815-6305; TENG, LEE-JENE/0000-0003-0104-741X; HSUEH, PO-REN/0000-0002-7502-9225	Ministry of Science and Technology of Taiwan [MOST 103-2320-B-002-056-MY3]; Kaohsiung Medical University Research Foundation [KMU-Q104012, KMU-Q105006]	Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Kaohsiung Medical University Research Foundation	This work was supported by grants from the Ministry of Science and Technology of Taiwan (MOST 103-2320-B-002-056-MY3) and from the Kaohsiung Medical University Research Foundation (KMU-Q104012 and KMU-Q105006).	Boyle-Vavra S, 2005, J CLIN MICROBIOL, V43, P4719, DOI 10.1128/JCM.43.9.4719-4730.2005; Chen CJ, 2014, CLIN MICROBIOL INFEC, V20, P605, DOI 10.1111/1469-0691.12705; Chen CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063210; Chen CJ, 2013, J CLIN MICROBIOL, V51, P2508, DOI 10.1128/JCM.00572-13; Chen CJ, 2011, J CLIN MICROBIOL, V49, P131, DOI 10.1128/JCM.01774-10; Chen FJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-343; Chen FJ, 2009, DIAGN MICR INFEC DIS, V65, P351, DOI 10.1016/j.diagmicrobio.2009.07.024; Chua K, 2011, CLIN INFECT DIS, V52, P99, DOI 10.1093/cid/ciq067; Chuang YY, 2013, LANCET INFECT DIS, V13, P698, DOI 10.1016/S1473-3099(13)70136-1; Coombs GW, 2010, ANTIMICROB AGENTS CH, V54, P1914, DOI 10.1128/AAC.01287-09; David MZ, 2010, CLIN MICROBIOL REV, V23, P616, DOI 10.1128/CMR.00081-09; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Diep BA, 2008, ANN INTERN MED, V148, P249, DOI 10.7326/0003-4819-148-4-200802190-00204; Enright MC, 2000, J CLIN MICROBIOL, V38, P1008, DOI 10.1128/JCM.38.3.1008-1015.2000; Geng WJ, 2010, FEMS IMMUNOL MED MIC, V58, P356, DOI [10.1111/j.1574-695X.2009.00648.x, 10.1111/j.1574-695X.2010.00648.x]; Glasner C, 2015, CLIN MICROBIOL INFEC, V21, DOI 10.1016/j.cmi.2014.09.010; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Gomez JAL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016720; Grundmann H, 2006, LANCET, V368, P874, DOI 10.1016/S0140-6736(06)68853-3; Higuchi W, 2010, J INFECT CHEMOTHER, V16, P144, DOI 10.1007/s10156-010-0029-9; Higuchi W, 2008, BIOCHEM BIOPH RES CO, V377, P752, DOI 10.1016/j.bbrc.2008.10.009; Ho CM, J MICROBIOL IMMUNOL; Ho PL, 2007, DIAGN MICR INFEC DIS, V57, P145, DOI 10.1016/j.diagmicrobio.2006.08.003; Hsu LY, 2005, EMERG INFECT DIS, V11, P341, DOI 10.3201/eid1102.040782; Huang YC, 2008, CLIN MICROBIOL INFEC, V14, P1167, DOI 10.1111/j.1469-0691.2008.02115.x; Huang YH, 2007, CLIN MICROBIOL INFEC, V13, P717, DOI 10.1111/j.1469-0691.2007.01718.x; Huang YC, 2011, INT J ANTIMICROB AG, V38, P2, DOI 10.1016/j.ijantimicag.2011.01.011; Hung WC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143106; Hung WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046987; Ito T, 2009, ANTIMICROB AGENTS CH, V53, P4961, DOI 10.1128/AAC.00579-09; Katayama Y, 2013, J BACTERIOL, V195, P1194, DOI 10.1128/JB.01786-12; Koreen L, 2004, J CLIN MICROBIOL, V42, P792, DOI 10.1128/JCM.42.2.792-799.2004; Li J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070602; McDougal LK, 2003, J CLIN MICROBIOL, V41, P5113, DOI 10.1128/JCM.41.11.5113-5120.2003; Mediavilla JR, 2012, CURR OPIN MICROBIOL, V15, P588, DOI 10.1016/j.mib.2012.08.003; Milheirico C, 2007, J ANTIMICROB CHEMOTH, V60, P42, DOI 10.1093/jac/dkm112; Monecke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017936; Patel JB, 2015, 25 INFORMATIONAL SUP; Pourcel C, 2009, J CLIN MICROBIOL, V47, P3121, DOI 10.1128/JCM.00267-09; Qu TT, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089235; Rooijakkers SHM, 2005, TRENDS MICROBIOL, V13, P596, DOI 10.1016/j.tim.2005.10.002; Salgado-Pabon W, 2014, J INFECT DIS, V210, P784, DOI 10.1093/infdis/jiu146; Sawanobori E, 2015, J MICROBIOL IMMUNOL, V48, P565, DOI 10.1016/j.jmii.2014.04.015; Sobral D, 2013, PLOS ONE, V7; Sung JML, 2008, MICROBIOL-SGM, V154, P1949, DOI 10.1099/mic.0.2007/015289-0; Takano T, 2008, ANTIMICROB AGENTS CH, V52, P837, DOI 10.1128/AAC.01001-07; Thammavongsa V, 2015, NAT REV MICROBIOL, V13, P529, DOI 10.1038/nrmicro3521; Uhlemann AC, 2014, INFECT GENET EVOL, V21, P563, DOI 10.1016/j.meegid.2013.04.030; van Wamel WJB, 2006, J BACTERIOL, V188, P1310, DOI 10.1128/JB.188.4.1310-1315.2006; Waldron DE, 2006, J BACTERIOL, V188, P5578, DOI 10.1128/JB.00418-06; Wang CC, 2004, CLIN INFECT DIS, V39, P481, DOI 10.1086/422642; Wang JT, 2009, J CLIN MICROBIOL, V47, P2957, DOI 10.1128/JCM.00853-09; Wang JL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009489; Yamamoto T, 2013, BIOMEDICINE-TAIWAN, V3, P2, DOI 10.1016/j.biomed.2012.12.001; Yamamoto T, 2010, J INFECT CHEMOTHER, V16, P225, DOI 10.1007/s10156-010-0045-9; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	56	6	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162526	10.1371/journal.pone.0162526	http://dx.doi.org/10.1371/journal.pone.0162526			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606427	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600056
J	Nakazono, H; Ogata, K; Kuroda, T; Tobimatsu, S				Nakazono, Hisato; Ogata, Katsuya; Kuroda, Tsuyoshi; Tobimatsu, Shozo			Phase and Frequency-Dependent Effects of Transcranial Alternating Current Stimulation on Motor Cortical Excitability	PLOS ONE			English	Article							OSCILLATORY ACTIVITY; CORTICOMUSCULAR COHERENCE; NEURONAL POPULATIONS; SENSORIMOTOR CORTEX; BRAIN OSCILLATIONS; ALPHA; SYNCHRONIZATION; PERFORMANCE; POTENTIALS; NETWORK	Transcranial alternating current stimulation (tACS) can entrain ongoing brain oscillations and modulate the motor system in a frequency-dependent manner. Recent animal studies have demonstrated that the phase of a sinusoidal current also has an important role in modulation of neuronal activity. However, the phase effects of tACS on the human motor system are largely unknown. Here, we systematically investigated the effects of tACS phase and frequency on the primary motor cortex (M1) by using motor evoked potentials (MEPs) with transcranial magnetic stimulation (TMS). First, we compared the phase effects (90 degrees, 180 degrees, 270 degrees or 360 degrees) of 10 and 20 Hz tACS on MEPs. The 20 Hz tACS significantly increased M1 excitability compared with the 10 Hz tACS at 90 degrees phase only. Second, we studied the 90 degrees phase effect on MEPs at different tACS frequencies (5, 10, 20 or 40 Hz). The 20 vs. 10 Hz difference was again observed, but the 90 degrees phase in 5 and 40 Hz tACS did not influence M1 excitability. Third, the 90 degrees phase effects of 10 and 20 Hz tACS were compared with sham stimulation. The 90 degrees phase of 20 Hz tACS enhanced MEP amplitudes compared with sham stimulation, but there was no significant effect of 10 Hz tACS. Taken together, we assume that the differential 90 degrees phase effects on 20 Hz and 10 Hz tACS can be attributed to the neural synchronization modulated by tACS. Our results further underline that phase and frequency are the important factors in the effects of tACS on M1 excitability.	[Nakazono, Hisato; Ogata, Katsuya; Tobimatsu, Shozo] Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Clin Neurophysiol, Fukuoka, Japan; [Kuroda, Tsuyoshi] Shizuoka Univ, Fac Informat, Shizuoka, Japan	Kyushu University; Shizuoka University	Nakazono, H (corresponding author), Kyushu Univ, Neurol Inst, Grad Sch Med Sci, Dept Clin Neurophysiol, Fukuoka, Japan.	nakazono@med.kyushu-u.ac.jp	Kuroda, Tsuyoshi/H-8369-2019; l_l, CuteBlock/L-4348-2018	l_l, CuteBlock/0000-0002-7559-9615; Nakazono, Hisato/0000-0002-5076-8953	 [15J03164];  [15K21195];  [15H05875]; Grants-in-Aid for Scientific Research [15H05871] Funding Source: KAKEN	; ; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by a Grant-in-Aid for JSPS KAKENHI 15J03164 to HN, and a Grant-in-Aid for JSPS KAKENHI 15K21195 to TK, and a Grant-in-Aid for Scientific Research on Innovative Areas MEXT KAKENHI 15H05875 to ST.	Ali MM, 2013, J NEUROSCI, V33, P11262, DOI 10.1523/JNEUROSCI.5867-12.2013; Antal A, 2008, BRAIN STIMUL, V1, P97, DOI 10.1016/j.brs.2007.10.001; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cancelli A, 2015, BRAIN STIMUL, V8, P555, DOI 10.1016/j.brs.2015.01.398; Cecere R, 2015, CURR BIOL, V25, P231, DOI 10.1016/j.cub.2014.11.034; Chen DF, 2005, J NEUROPHYSIOL, V94, P2713, DOI 10.1152/jn.00024.2005; Conway BA, 1995, J PHYSIOL-LONDON, V489, P917, DOI 10.1113/jphysiol.1995.sp021104; Datta Abhishek, 2012, Front Psychiatry, V3, P91, DOI 10.3389/fpsyt.2012.00091; Feurra M, 2013, J NEUROSCI, V33, P17483, DOI 10.1523/JNEUROSCI.1414-13.2013; Feurra M, 2011, J NEUROSCI, V31, P12165, DOI 10.1523/JNEUROSCI.0978-11.2011; Frohlich F, 2010, NEURON, V67, P129, DOI 10.1016/j.neuron.2010.06.005; Gross J, 2002, P NATL ACAD SCI USA, V99, P2299, DOI 10.1073/pnas.032682099; Haegens S, 2011, P NATL ACAD SCI USA, V108, P19377, DOI 10.1073/pnas.1117190108; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Helfrich RF, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1002031; Helfrich RF, 2014, CURR BIOL, V24, P333, DOI 10.1016/j.cub.2013.12.041; Herrmann CS, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00279; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; Joundi RA, 2012, CURR BIOL, V22, P403, DOI 10.1016/j.cub.2012.01.024; Keil J, 2014, J NEUROPHYSIOL, V111, P513, DOI 10.1152/jn.00387.2013; Krause V, 2016, FRONT BEHAV NEUROSCI, V10, DOI 10.3389/fnbeh.2016.00004; Kristeva R, 2007, NEUROIMAGE, V36, P785, DOI 10.1016/j.neuroimage.2007.03.025; Kutchko KM, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1003304; Lepage JF, 2008, J NEUROSCI METH, V175, P17, DOI 10.1016/j.jneumeth.2008.07.021; Maki H, 2010, CLIN NEUROPHYSIOL, V121, P492, DOI 10.1016/j.clinph.2009.11.078; Mitchell WK, 2007, J PHYSIOL-LONDON, V583, P567, DOI 10.1113/jphysiol.2007.134031; Muller NG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143533; MURTHY VN, 1992, P NATL ACAD SCI USA, V89, P5670, DOI 10.1073/pnas.89.12.5670; Neuling T, 2012, NEUROIMAGE, V63, P771, DOI 10.1016/j.neuroimage.2012.07.024; Neuling T, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00161; Neuling Toralf, 2012, Front Psychiatry, V3, P83; Nielsen J. F., 1996, CLIN NEUROPHYSIOL, V101, P404; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Ozen S, 2010, J NEUROSCI, V30, P11476, DOI 10.1523/JNEUROSCI.5252-09.2010; Pfurtscheller G, 1999, CLIN NEUROPHYSIOL, V110, P1842, DOI 10.1016/S1388-2457(99)00141-8; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Pollok B, 2015, BEHAV BRAIN RES, V293, P234, DOI 10.1016/j.bbr.2015.07.049; Raco V, 2014, BRAIN STIMUL, V7, P823, DOI 10.1016/j.brs.2014.08.005; Reato D, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00687; Reato D, 2010, J NEUROSCI, V30, P15067, DOI 10.1523/JNEUROSCI.2059-10.2010; Reimer J, 2010, J NEUROSCI, V30, P11506, DOI 10.1523/JNEUROSCI.5947-09.2010; Riecke L, 2015, BRAIN STIMUL, V8, P777, DOI 10.1016/j.brs.2015.04.004; Salenius S, 2003, CURR OPIN NEUROBIOL, V13, P678, DOI 10.1016/j.conb.2003.10.008; SALMELIN R, 1994, NEUROSCIENCE, V60, P537, DOI 10.1016/0306-4522(94)90263-1; Salmelin R, 1995, NEUROIMAGE, V2, P237, DOI 10.1006/nimg.1995.1031; Sauseng P, 2009, NEUROPSYCHOLOGIA, V47, P284, DOI 10.1016/j.neuropsychologia.2008.07.021; Schnitzler A, 1997, NEUROIMAGE, V6, P201, DOI 10.1006/nimg.1997.0286; Schulz H, 2014, CEREB CORTEX, V24, P1708, DOI 10.1093/cercor/bht024; Schutter DJLG, 2011, BRAIN STIMUL, V4, P97, DOI 10.1016/j.brs.2010.07.002; Schutter DJLG, 2010, CLIN NEUROPHYSIOL, V121, P1080, DOI 10.1016/j.clinph.2009.10.038; Tamura Y, 2005, EUR J NEUROSCI, V21, P2555, DOI 10.1111/j.1460-9568.2005.04096.x; Thut G, 2011, FRONT PSYCHOL, V2, DOI 10.3389/fpsyg.2011.00170; Thut G, 2009, TRENDS COGN SCI, V13, P182, DOI 10.1016/j.tics.2009.01.004; Turi Z, 2013, RESTOR NEUROL NEUROS, V31, P275, DOI 10.3233/RNN-120297; van Elswijk G, 2010, J NEUROSCI, V30, P4481, DOI 10.1523/JNEUROSCI.2794-09.2010; Voss U, 2014, NAT NEUROSCI, V17, P810, DOI 10.1038/nn.3719; Vossen A, 2015, BRAIN STIMUL, V8, P499, DOI 10.1016/j.brs.2014.12.004; Wach C, 2013, BEHAV BRAIN RES, V241, P1, DOI 10.1016/j.bbr.2012.11.038; Wetmore DZ, 2004, J PHYSIOL-LONDON, V555, P831, DOI 10.1113/jphysiol.2003.048918; Zaehle T, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013766; Zarkowski P, 2006, CLIN EEG NEUROSCI, V37, P247, DOI 10.1177/155005940603700316	61	37	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162521	10.1371/journal.pone.0162521	http://dx.doi.org/10.1371/journal.pone.0162521			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607431	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255600055
J	Rawal, R; Vijay, S; Kadian, K; Singh, J; Pande, V; Sharma, A				Rawal, Ritu; Vijay, Sonam; Kadian, Kavita; Singh, Jagbir; Pande, Veena; Sharma, Arun			Towards a Proteomic Catalogue and Differential Annotation of Salivary Gland Proteins in Blood Fed Malaria Vector Anopheles culicifacies by Mass Spectrometry	PLOS ONE			English	Article							AEDES-AEGYPTI; JUVENILE-HORMONE; FEMALE MOSQUITO; BOMBYX-MORI; DAP-KINASE; CELL-DEATH; GAMBIAE; GENE; TRANSCRIPTOME; AUTOPHAGY	In order to understand the importance of functional proteins in mosquito behavior, following blood meal, a baseline proteomic dataset is essential for providing insights into the physiology of blood feeding. Therefore, in this study as first step, in solution and 1-D electrophoresis digestion approach combined with tandem mass spectrometry (nano LC-MS/MS) and computational bioinformatics for data mining was used to prepare a baseline proteomic catalogue of salivary gland proteins of sugar fed An. culicifacies mosquitoes. A total of 106 proteins were identified and analyzed by SEQUEST algorithm against mosquito protein database from Uniprot/NCBI. Importantly, D7r1, D7r2, D7r4, salivary apyrase, anti-platelet protein, calreticulin, antigen 5 family proteins were identified and grouped on the basis of biological and functional roles. Secondly, differential protein expression and annotations between salivary glands of sugar fed vs blood fed mosquitoes was analyzed using 2-Delectrophoresis combined with MALDI-TOF mass spectrometry. The alterations in the differential expression of total 38 proteins was observed out of which 29 proteins like beclin-1, phosphorylating proteins, heme oxygenase 1, ferritin, apoptotic proteins, coagulation and immunity like, serine proteases, serpins, c-type lectin and protein in regulation of blood feeding behavior were found to be up regulated while 9 proteins related to blood feeding, juvenile hormone epoxide hydrolase ii, odorant binding proteins and energy metabolic enzymes were found to be down regulated. To our knowledge, this study provides a first time baseline proteomic dataset and functional annotations of An. culicifacies salivary gland proteins that may be involved during the blood feeding. Identification of differential salivary proteins between sugar fed and blood fed mosquitoes and their plausible role may provide insights into the physiological processes associated with feeding behavior and sporozoite transmission during the process of blood feeding.	[Rawal, Ritu; Vijay, Sonam; Kadian, Kavita; Singh, Jagbir; Sharma, Arun] Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol, Sect 8, New Delhi, India; [Pande, Veena] Kumaun Univ, Dept Biotechnol, Naini Tal, Uttarakhand, India	Indian Council of Medical Research (ICMR); ICMR - National Institute of Malaria Research (NIMR); Kumaun University	Sharma, A (corresponding author), Natl Inst Malaria Res ICMR, Prot Biochem & Struct Biol, Sect 8, New Delhi, India.	arushar@gmail.com		Pande, Veena/0000-0002-4839-7276	Department of Science and Technology, Government of India [SR/WOS-A/LS-590/2012]; Department of Biotechnology, New Delhi, Government of India [BT/PR8221/MED/12/617/2013]	Department of Science and Technology, Government of India(Department of Science & Technology (India)); Department of Biotechnology, New Delhi, Government of India(Department of Biotechnology (DBT) India)	This work has been financially supported by the grant from Department of Science and Technology, Government of India (Ritu Rawal, SR/WOS-A/LS-590/2012 and Department of Biotechnology, New Delhi, Government of India (Dr. Arun Sharma, BT/PR8221/MED/12/617/2013).	Adak T, 1999, T ROY SOC TROP MED H, V93, P573, DOI 10.1016/S0035-9203(99)90052-4; Almeras L, 2010, VECTOR-BORNE ZOONOT, V10, P391, DOI 10.1089/vbz.2009.0042; Amsalem E, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-45; Caljon G, 2009, INSECT BIOCHEM MOLEC, V39, P332, DOI 10.1016/j.ibmb.2009.01.010; Calvo E, 2006, J BIOL CHEM, V281, P1935, DOI 10.1074/jbc.M510359200; Calvo E, 2007, J BIOL CHEM, V282, P26928, DOI 10.1074/jbc.M705669200; Calvo E, 2007, INSECT BIOCHEM MOLEC, V37, P164, DOI 10.1016/j.ibmb.2006.11.005; Calvo E, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-57; CHAMPAGNE DE, 1995, P NATL ACAD SCI USA, V92, P694, DOI 10.1073/pnas.92.3.694; Choumet V, 2007, PROTEOMICS, V7, P3384, DOI 10.1002/pmic.200700334; Cooper DM, 2009, APOPTOSIS, V14, P247, DOI 10.1007/s10495-009-0322-1; Das S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-566; Das Suchismita, 2008, BMC Physiology, V8, P23, DOI 10.1186/1472-6793-8-23; deLeon AAP, 1996, VET PARASITOL, V61, P327, DOI 10.1016/0304-4017(95)00828-4; Dixit R, 2009, INT J INFECT DIS, V13, P636, DOI 10.1016/j.ijid.2008.07.027; Fu Q, 2011, INSECT MOL BIOL, V20, P541, DOI 10.1111/j.1365-2583.2011.01087.x; Gorman MJ, 2001, INSECT BIOCHEM MOLEC, V31, P257, DOI 10.1016/S0965-1748(00)00145-4; Goswami G, 2006, AM J TROP MED HYG, V75, P454, DOI 10.4269/ajtmh.2006.75.454; Gulley MM, 2013, J INSECT PHYSIOL, V59, P138, DOI 10.1016/j.jinsphys.2012.08.015; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; JAMES AA, 1991, MOL BIOCHEM PARASIT, V44, P245, DOI 10.1016/0166-6851(91)90010-4; JAMES AA, 1989, GENE, V75, P73, DOI 10.1016/0378-1119(89)90384-3; Jariyapan N, 2012, PARASITOL RES, V111, P1239, DOI 10.1007/s00436-012-2958-y; Kalume DE, 2005, PROTEOMICS, V5, P3765, DOI 10.1002/pmic.200401210; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Levine B, 2005, J CLIN INVEST, V115, P2679, DOI 10.1172/JCI26390; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lv ZB, 2012, GENE, V502, P118, DOI 10.1016/j.gene.2012.03.035; Olkkonen VM, 2006, BIOCHEM SOC T, V34, P389, DOI 10.1042/BST0340389; Paaijmans KP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055777; Pham DQD, 2010, BBA-GEN SUBJECTS, V1800, P824, DOI 10.1016/j.bbagen.2010.03.004; Ribeiro JMC, 2004, INSECT BIOCHEM MOLEC, V34, P543, DOI 10.1016/j.ibmb.2004.02.008; Ribeiro JMC, 2003, ANNU REV ENTOMOL, V48, P73, DOI 10.1146/annurev.ento.48.060402.102812; Ribeiro JMC, 2010, INSECT BIOCHEM MOLEC, V40, P767, DOI 10.1016/j.ibmb.2010.08.002; Ribeiro JMC, 2009, ADV INSECT PHYSIOL, V37, P59, DOI 10.1016/S0065-2806(09)37002-2; Rinker DC, 2013, P NATL ACAD SCI USA, V110, P8260, DOI 10.1073/pnas.1302562110; Rivera-Perez C, 2013, INSECT BIOCHEM MOLEC, V43, P675, DOI 10.1016/j.ibmb.2013.04.002; Rodriguez MH, 2004, INSECT BIOCHEM MOLEC, V34, P615, DOI 10.1016/j.ibmb.2004.03.014; Rost-Roszkowska MM, 2015, PROTOPLASMA, V252, P1387, DOI 10.1007/s00709-015-0774-9; Rund SSC, 2013, SCI REP-UK, V3, DOI 10.1038/srep02494; Scarlatti F, 2004, J BIOL CHEM, V279, P18384, DOI 10.1074/jbc.M313561200; Schnitger AKD, 2009, J BIOL CHEM, V284, P17616, DOI 10.1074/jbc.M808298200; Seino A, 2010, BIOSCI BIOTECH BIOCH, V74, P1421, DOI 10.1271/bbb.100104; Sharma AK, 2014, J ARTHROPOD-BORNE DI, V8, P186; Sharma P, 2015, BIOL OPEN, V4, P1002, DOI 10.1242/bio.012294; Shravage BV, 2013, DEVELOPMENT, V140, P1321, DOI 10.1242/dev.089490; So WV, 2000, MOL CELL BIOL, V20, P6935, DOI 10.1128/MCB.20.18.6935-6944.2000; Sor-suwan S, 2013, PARASITOL RES, V112, P1065, DOI 10.1007/s00436-012-3233-y; TITUS RG, 1988, SCIENCE, V239, P1306, DOI 10.1126/science.3344436; Valenzuela JG, 2003, INSECT BIOCHEM MOLEC, V33, P717, DOI 10.1016/S0965-1748(03)00067-5; Vijay S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119666; Vijay S, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/686319; Vizcaino JA, 2014, NAT BIOTECHNOL, V32, P223, DOI 10.1038/nbt.2839; Wasinpiyamongkol A, 2010, PROTEOMICS, V10, P1; Yu CS, 2006, PROTEINS, V64, P643, DOI 10.1002/prot.21018; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhou GL, 2007, J INSECT PHYSIOL, V53, P1169, DOI 10.1016/j.jinsphys.2007.06.009; Zhu JS, 2010, INSECT BIOCHEM MOLEC, V40, P23, DOI 10.1016/j.ibmb.2009.12.004	59	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161870	10.1371/journal.pone.0161870	http://dx.doi.org/10.1371/journal.pone.0161870			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602567	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200028
J	Gonzalez-Wevar, CA; Rosenfeld, S; Segovia, NI; Hune, M; Gerard, K; Ojeda, J; Mansilla, A; Brickle, P; Diaz, A; Poulin, E				Gonzalez-Wevar, Claudio A.; Rosenfeld, Sebastian; Segovia, Nicolas I.; Hune, Mathias; Gerard, Karin; Ojeda, Jaime; Mansilla, Andres; Brickle, Paul; Diaz, Angie; Poulin, Elie			Genetics, Gene Flow, and Glaciation: The Case of the South American Limpet Nacella mytilina	PLOS ONE			English	Article							FISH ELEGINOPS-MACLOVINUS; LONG-DISTANCE DISPERSAL; TIERRA-DEL-FUEGO; COMPARATIVE PHYLOGEOGRAPHY; POPULATION-STRUCTURE; FALKLAND-ISLANDS; CLIMATE-CHANGE; HISTORICAL BIOGEOGRAPHY; GIGARTINA-SKOTTSBERGII; EVOLUTIONARY HISTORY	Glacial episodes of the Quaternary, and particularly the Last Glacial Maximum (LGM) drastically altered the distribution of the Southern-Hemisphere biota, principally at higher latitudes. The irregular coastline of Patagonia expanding for more than 84.000 km constitutes a remarkable area to evaluate the effect of Quaternary landscape and seascape shifts over the demography of near-shore marine benthic organisms. Few studies describing the bio-geographic responses of marine species to the LGM have been conducted in Patagonia, but existing data from coastal marine species have demonstrated marked genetic signatures of post-LGM recolonization and expansion. The kelp-dweller limpet Nacella mytilina is broadly distributed along the southern tip of South America and at the Falkland/Malvinas Islands. Considering its distribution, abundance, and narrow bathymetry, N. mytilina represents an appropriate model to infer how historical and contemporary processes affected the distribution of intraspecific genetic diversity and structure along the southern tip of South America. At the same time, it will be possible to determine how life history traits and the ecology of the species are responsible for the current pattern of gene flow and connectivity across the study area. We conducted phylogeographic and demographic inference analyses in N. mytilina from 12 localities along Pacific Patagonia (PP) and one population from the Falkland/Malvinas Islands (FI). Analyses of the mitochondrial gene COI in 300 individuals of N. mytilina revealed low levels of genetic polymorphism and the absence of genetic differentiation along PP. In contrast, FI showed a strong and significant differentiation from Pacific Patagonian populations. Higher levels of genetic diversity were also recorded in the FI population, together with a more expanded genealogy supporting the hypothesis of glacial persistence of the species in these islands. Haplotype genealogy, and mismatch analyses in the FI population recognized an older and more complex demographic history than in PP. Demographic reconstructions along PP suggest a post-LGM expansion process (7.5 ka), also supported by neutrality tests, mismatch distribution and maximum parsimony haplotype genealogies. Migration rate estimations showed evidence of asymmetrical gene flow from PP to FI. The absence of genetic differentiation, the presence of a single dominant haplotype, high estimated migration rates, and marked signal of recent demographic growth, support the hypothesis of rapid post-glacial expansion in N. mytilina along PP. This expansion could have been sustained by larval and rafting-mediated dispersal of adults from northernmost populations following the Cape Horn Current System. Marked genetic differentiation between PP and FI could be explained through differences in their respective glacial histories. During the LGM, Pacific Patagonia (PP) was almost fully covered by the Patagonian Ice Sheet, while sheet coverage in the FI ice was restricted to small cirques and valleys. As previously recorded in the sister-species N. magellanica, the FI rather than represent a classical glacial refugium for N. mytilina, seems to represent a sink area and/or a secondary contact zone. Accordingly, historical and contemporary processes, contrasting glacial histories between the analyzed sectors, as well as life history traits constitute the main factors explaining the current biogeographical patterns of most shallow Patagonian marine benthic organisms.	[Gonzalez-Wevar, Claudio A.; Gerard, Karin] GAIA Antartica Univ Magallanes, Dept Recursos Nat, Bulnes 01890, Punta Arenas, Chile; [Gonzalez-Wevar, Claudio A.; Rosenfeld, Sebastian; Segovia, Nicolas I.; Hune, Mathias; Ojeda, Jaime; Mansilla, Andres; Poulin, Elie] Univ Chile, Fac Ciencias, Dept Ciencias Ecol, IEB, Las Palmeras 3425, Santiago, Chile; [Gonzalez-Wevar, Claudio A.; Rosenfeld, Sebastian; Gerard, Karin; Ojeda, Jaime; Mansilla, Andres] Univ Magallanes, Lab Macroalgas Antarticas & Subantarticas, Casilla 113-D, Punta Arenas, Chile; [Hune, Mathias] Fdn Ictiol, Providencia Santiago, Chile; [Brickle, Paul] SAERI, POB 609, Stanley Cottage, Stanley, Falkland Island; [Diaz, Angie] Univ Concepcion, Dept Zool, Fac Ciencias Nat & Oceanog, Concepcion, Chile	Universidad de Chile; Universidad de Magallanes; Universidad de Concepcion	Gonzalez-Wevar, CA (corresponding author), GAIA Antartica Univ Magallanes, Dept Recursos Nat, Bulnes 01890, Punta Arenas, Chile.; Gonzalez-Wevar, CA (corresponding author), Univ Chile, Fac Ciencias, Dept Ciencias Ecol, IEB, Las Palmeras 3425, Santiago, Chile.; Gonzalez-Wevar, CA (corresponding author), Univ Magallanes, Lab Macroalgas Antarticas & Subantarticas, Casilla 113-D, Punta Arenas, Chile.	claudio.gonzalez@umag.cl	Gérard, Karin/AAC-4911-2021; Ojeda, Jaime/HHN-1455-2022; Gerard, Karin/H-6245-2014; Poulin, Elie/C-2654-2012; González-Wevar, Claudio Alejandro/AAD-6513-2021; Hüne, Mathias/ABE-6000-2020; Diaz, Angie/I-8033-2016	Gérard, Karin/0000-0003-0596-1348; Poulin, Elie/0000-0001-7736-0969; Diaz, Angie/0000-0003-4944-588X; Rosenfeld, Sebastian/0000-0002-4363-8018; Brickle, Paul/0000-0002-9870-3518	Fondecyt [3120075, 3130677, 1151336, 1140940]; Initiation Fondecyt Project [11140087]; Instituto de Ecologia y Biodiversidad IEB [P05-002 ICM, PFB 023]; postdoctorate fellowship CD GAIA/UMAG	Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); Initiation Fondecyt Project; Instituto de Ecologia y Biodiversidad IEB; postdoctorate fellowship CD GAIA/UMAG	This study was completely funded by different projects and institutions including a post-doctorate fellowship (Fondecyt 3120075) and an Initiation Fondecyt Project (11140087) to CAG-W. We also appreciate the following projects: AD (postdoctorate Fondecyt project 3130677), KG (postdoctorate fellowship CD GAIA/UMAG), EP (regular Fondecyt project 1151336), and AM (regular Fondecyt project 1140940). Finally, we mostly appreciate the support of the projects P05-002 ICM and PFB 023 (Instituto de Ecologia y Biodiversidad IEB) to EP, AM, SR, JO and CAG-W and CD GAIA Antartica Universidad de Magallanes to CAG-W and KG. There was no additional external funding received for this study.r This study was completely funded by different projects and institutions including a post-doctorate fellowship (Fondecyt 3120075) and an Initiation Fondecyt Project (11140087) to CAG-W. We also appreciate the following projects: AD (postdoctorate Fondecyt project 3130677), KG (postdoctorate fellowship CD GAIA/UMAG), EP (regular Fondecyt project 1151336), and AM (regular Fondecyt project 1140940). Finally, we mostly appreciate the support of the projects P05-002 ICM and PFB 023 (Instituto de Ecologia y Biodiversidad IEB) to EP, AM, SR, JO and CAG-W and CD GAIA Antartica Universidad de Magallanes to CAG-W and KG. There was no additional external funding received for this study. All the specimens were collected under the Chilean legislation (Technical Memorandum P. INV No 429/2015 SUBPESCA). Permits to undertake field studies and collect specimens in Falkland Islands was issued by the Environmental Planning Department, the Falkland Islands Government. We mostly appreciate the comments and suggestions of the reviewers (Dr. Tom DeVries and an anonymous one) who helped us significantly to improve the manuscript. We recognize the SCAR AntEco and EBA programs, CAML and SAERI, for encouraging and supporting Antarctic and Subantarctic evolutionary biology studies. This manuscript contributes to the SCAR 'State of Antarctic Ecosystem' (AntEco) programme.	Acha EM, 2004, J MARINE SYST, V44, P83, DOI 10.1016/j.jmarsys.2003.09.005; Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Allcock AL, 2012, TRENDS ECOL EVOL, V27, P520, DOI 10.1016/j.tree.2012.05.009; Ayre DJ, 2009, MOL ECOL, V18, P1887, DOI 10.1111/j.1365-294X.2009.04127.x; BASTIDA R, 1992, OCEANOL ACTA, V15, P687; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; Beerli P, 2010, GENETICS, V185, P313, DOI 10.1534/genetics.109.112532; BENNETT KD, 1991, J BIOGEOGR, V18, P103, DOI 10.2307/2845248; Billard E, 2015, POLAR BIOL, V38, P2021, DOI 10.1007/s00300-015-1762-4; Bird CE, 2007, MOL ECOL, V16, P3173, DOI 10.1111/j.1365-294X.2007.03385.x; Bowden DA, 2006, MAR ECOL PROG SER, V316, P1, DOI 10.3354/meps316001; Bowden DA, 2009, MAR BIOL, V156, P2033, DOI 10.1007/s00227-009-1235-9; BRATTSTROM H, 1983, SARSIA, V68, P289, DOI 10.1080/00364827.1983.10420583; Cardenas J, 2009, ANDEAN GEOL, V36, P81, DOI 10.4067/S0718-71062009000100007; de Aranzamendi MC, 2014, J EXP MAR BIOL ECOL, V460, P53, DOI 10.1016/j.jembe.2014.06.008; Ceballos SG, 2016, HEREDITY, V116, P372, DOI 10.1038/hdy.2015.106; Ceballos SG, 2012, MAR BIOL, V159, P499, DOI 10.1007/s00227-011-1830-4; Clapperton C. M., 1976, J GLACIOL, V17, P73, DOI [DOI 10.1017/S0022143000030732, 10.3189/S0022143000030732, DOI 10.3189/S0022143000030732]; CLAPPERTON CM, 1994, REV CHIL HIST NAT, V67, P369; Clark R, 1998, J QUATERNARY SCI, V13, P95; Cowen RK, 2009, ANNU REV MAR SCI, V1, P443, DOI 10.1146/annurev.marine.010908.163757; Crame JA, 1997, J BIOGEOGR, V24, P1, DOI 10.1111/j.1365-2699.1997.tb00045.x; Cumming RA, 2014, J BIOGEOGR, V41, P2357, DOI 10.1111/jbi.12376; Dambach J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046283; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; de Aranzamendi MC, 2011, MAR BIOL, V158, P2405, DOI 10.1007/s00227-011-1742-3; De Aranzamendi MC, 2009, J MOLLUS STUD, V75, P241, DOI 10.1093/mollus/eyp025; Denton GH, 2010, SCIENCE, V328, P1652, DOI 10.1126/science.1184119; Palma RE, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032206; Excoffier L, 2009, ANNU REV ECOL EVOL S, V40, P481, DOI 10.1146/annurev.ecolsys.39.110707.173414; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Filatov DA, 2009, BIOINFORMATICS, V25, P3189, DOI 10.1093/bioinformatics/btp572; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; Fraser CI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069138; Fraser CI, 2012, TRENDS ECOL EVOL, V27, P462, DOI 10.1016/j.tree.2012.04.011; Fraser CI, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-203; Gillespie RG, 2012, TRENDS ECOL EVOL, V27, P47, DOI 10.1016/j.tree.2011.08.009; Goldstien SJ, 2006, MOL ECOL, V15, P3259, DOI 10.1111/j.1365-294X.2006.02977.x; Gonzalez-Wevar CA, 2013, MOL ECOL, V22, P5221, DOI 10.1111/mec.12465; Gonzalez-Wevar CA, 2011, MOL ECOL, V20, P1936, DOI 10.1111/j.1365-294X.2011.05065.x; Gonzalez-Wevar C, 2015, J HERED, V106, P439, DOI 10.1093/jhered/esv005; Gonzalez-Wevar CA, 2016, POLAR BIOL, V39, P77, DOI 10.1007/s00300-014-1620-9; Gonzalez-Wevar CA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131289; Gonzalez-Wevar CA, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-139; Gonzalez-Wevar CA, 2011, DEEP-SEA RES PT II, V58, P220, DOI 10.1016/j.dsr2.2010.05.026; Gonzalez-Wevar CA, 2010, MOL PHYLOGENET EVOL, V56, P115, DOI 10.1016/j.ympev.2010.02.001; Gordillo S, 2005, SCI MAR, V69, P337, DOI 10.3989/scimar.2005.69s2337; Gordillo S, 2010, I PATAGON CHILE, V37, P5; Gordillo S, 2008, REV GEOL CHILE, V35, P321; Green BS, 2004, J EXP MAR BIOL ECOL, V299, P115, DOI 10.1016/j.jembe.2003.09.001; Guller M, 2016, J MOLLUS STUD, V82, P80, DOI 10.1093/mollus/eyv036; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hein AS, 2010, QUATERNARY SCI REV, V29, P1212, DOI 10.1016/j.quascirev.2010.01.020; Heusser CJ, 1998, PALAEOGEOGR PALAEOCL, V141, P277, DOI 10.1016/S0031-0182(98)00053-4; Hewitt G, 2000, NATURE, V405, P907, DOI 10.1038/35016000; Hewitt GM, 2004, PHILOS T R SOC B, V359, P183, DOI 10.1098/rstb.2003.1388; Hewitt GM, 1999, BIOL J LINN SOC, V68, P87, DOI 10.1111/j.1095-8312.1999.tb01160.x; Hewitt GM, 1996, BIOL J LINN SOC, V58, P247, DOI 10.1111/j.1095-8312.1996.tb01434.x; Hey J, 2007, P NATL ACAD SCI USA, V104, P2785, DOI 10.1073/pnas.0611164104; Himes CMT, 2008, J BIOGEOGR, V35, P1415, DOI 10.1111/j.1365-2699.2008.01895.x; Hodgson DA, 2014, QUATERNARY SCI REV, V100, P137, DOI 10.1016/j.quascirev.2013.12.001; Hudson RR, 2000, GENETICS, V155, P2011; Hune M, 2015, POLAR BIOL, V38, P607, DOI 10.1007/s00300-014-1623-6; Hulton NRJ, 2002, QUATERNARY SCI REV, V21, P233, DOI 10.1016/S0277-3791(01)00103-2; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jakob SS, 2009, MOL BIOL EVOL, V26, P907, DOI 10.1093/molbev/msp012; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; KNOX GA, 1960, PROC R SOC SER B-BIO, V152, P577, DOI 10.1098/rspb.1960.0068; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Leese F, 2010, NATURWISSENSCHAFTEN, V97, P583, DOI 10.1007/s00114-010-0674-y; Leese F, 2008, FRONT ZOOL, V5, DOI 10.1186/1742-9994-5-19; Lessa EP, 2010, MOL ECOL, V19, P3031, DOI 10.1111/j.1365-294X.2010.04734.x; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Macaya EC, 2010, MAR ECOL PROG SER, V420, P103, DOI 10.3354/meps08893; Maggs CA, 2008, ECOLOGY, V89, pS108, DOI 10.1890/08-0257.1; Marin JC, 2013, MOL ECOL, V22, P463, DOI 10.1111/mec.12111; Marko PB, 2004, MOL ECOL, V13, P597, DOI 10.1046/j.1365-294X.2004.02096.x; Marko PB, 2010, MOL ECOL, V19, P146, DOI 10.1111/j.1365-294X.2009.04417.x; McCulloch RD, 2000, J QUATERNARY SCI, V15, P409, DOI 10.1002/1099-1417(200005)15:4<409::AID-JQS539>3.0.CO;2-#; McCulloch RD, 2005, GEOGR ANN, V87, P1; McMahon SM, 2011, TRENDS ECOL EVOL, V26, P249, DOI 10.1016/j.tree.2011.02.012; Miller KJ, 2008, J ANIM ECOL, V77, P713, DOI 10.1111/j.1365-2656.2008.01387.x; Miloslavich Patricia, 2011, PLoS ONE, V6, P1, DOI [10.1371/journal.pone.0018318, 10.1371/journal.pone.0021326]; Moreno PI, 2003, J QUATERNARY SCI, V18, P787, DOI 10.1002/jqs.801; Morrone JJ, 2011, J BIOGEOGR, V38, P2078, DOI 10.1111/j.1365-2699.2011.02553.x; Near TJ, 2012, P NATL ACAD SCI USA, V109, P3434, DOI 10.1073/pnas.1115169109; Nielsen R, 2001, GENETICS, V158, P885; Nikula R, 2010, MAR ECOL PROG SER, V405, P221, DOI 10.3354/meps08523; Nunez JD, 2015, MAR BIOL, V162, P595, DOI 10.1007/s00227-014-2607-3; Nunez JJ, 2010, REV BIOL MAR OCEANOG, V45, P565, DOI 10.4067/S0718-19572010000400005; Nunez JJ, 2011, MOL PHYLOGENET EVOL, V58, P343, DOI 10.1016/j.ympev.2010.11.026; O'Connor MI, 2007, P NATL ACAD SCI USA, V104, P1266, DOI 10.1073/pnas.0603422104; Papadopoulou A, 2009, MOL PHYLOGENET EVOL, V53, P935, DOI 10.1016/j.ympev.2009.08.027; Pardinas UFJ, 2011, BIOL J LINN SOC, V103, P495, DOI 10.1111/j.1095-8312.2011.01679.x; PARMESAN C, 2006, ANNU REV ECOL EVOL, V37, P1, DOI DOI 10.1146/annurev.ecolsys.37.091305.110035; Pastorino MJ, 2002, J BIOGEOGR, V29, P1167, DOI 10.1046/j.1365-2699.2002.00731.x; Paulay G, 2006, INTEGR COMP BIOL, V46, P269, DOI 10.1093/icb/icj027; Peck LS, 2016, POLAR BIOL, V39, P2273, DOI 10.1007/s00300-016-1894-1; Pons O, 1996, GENETICS, V144, P1237; Posada D, 2001, TRENDS ECOL EVOL, V16, P37, DOI 10.1016/S0169-5347(00)02026-7; Powell AWB, 1973, PATELLID LIMPETS WOR, P1; Provan J, 2008, TRENDS ECOL EVOL, V23, P564, DOI 10.1016/j.tree.2008.06.010; Rabassa J, 2005, J S AM EARTH SCI, V20, P81, DOI 10.1016/j.jsames.2005.07.004; Reid David G., 2000, Bulletin of the Natural History Museum Zoology Series, V66, P109; Reisser CMO, 2011, MOL ECOL, V20, P3399, DOI 10.1111/j.1365-294X.2011.05185.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rosenfeld S., 2016, THESIS; Rosenfeld S, 2015, ZOOKEYS, P49, DOI 10.3897/zookeys.519.9676; Ruzzante DE, 2008, MOL ECOL, V17, P2234, DOI 10.1111/j.1365-294X.2008.03738.x; Ruzzante DE, 2006, MOL ECOL, V15, P2949, DOI 10.1111/j.1365-294X.2006.03010.x; Ruzzante DE, 2011, BIOL J LINN SOC, V103, P514, DOI 10.1111/j.1095-8312.2011.01682.x; Sanchez R, 2011, MAR ECOL PROG SER, V434, P121, DOI 10.3354/meps09184; Schneider S, 1999, GENETICS, V152, P1079; Sersic AN, 2011, BIOL J LINN SOC, V103, P475, DOI 10.1111/j.1095-8312.2011.01656.x; SLATKIN M, 1991, GENETICS, V129, P555; SLATKIN M, 1995, GENETICS, V139, P457; Taberlet P, 1998, MOL ECOL, V7, P453, DOI 10.1046/j.1365-294x.1998.00289.x; Thatje S, 2005, TRENDS ECOL EVOL, V20, P534, DOI 10.1016/j.tree.2005.07.010; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Toro JE, 2004, AQUAC RES, V35, P1466, DOI 10.1111/j.1365-2109.2004.01172.x; Valdovinos C, 2005, REV CHIL HIST NAT, V78, P497; Valdovinos C, 2003, ECOGRAPHY, V26, P139, DOI 10.1034/j.1600-0587.2003.03349.x; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Victoriano PF, 2008, MOL ECOL, V17, P2397, DOI 10.1111/j.1365-294X.2008.03741.x; Vidal MA, 2012, AUSTRAL ECOL, V37, P67, DOI 10.1111/j.1442-9993.2011.02241.x; Wares JP, 2001, EVOLUTION, V55, P2455; Waters JM, 2008, J BIOGEOGR, V35, P417, DOI 10.1111/j.1365-2699.2007.01724.x; WEBB T, 1992, ANNU REV ECOL SYST, V23, P141, DOI 10.1146/annurev.es.23.110192.001041; Wilson P, 2002, QUATERNARY SCI REV, V21, P1821, DOI 10.1016/S0277-3791(02)00008-2; Wilson P, 2008, J QUATERNARY SCI, V23, P461, DOI 10.1002/jqs.1156; Xia X, 2001, J HERED, V92, P371, DOI 10.1093/jhered/92.4.371; Xu JW, 2009, MOL ECOL, V18, P904, DOI 10.1111/j.1365-294X.2008.04070.x; Zattara EE, 2005, J BIOGEOGR, V32, P5, DOI 10.1111/j.1365-2699.2004.01164.x; Zemlak TS, 2011, MOL ECOL, V20, P5280, DOI 10.1111/j.1365-294X.2011.05352.x; Zemlak TS, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-67; Zemlak TS, 2008, MOL ECOL, V17, P5049, DOI 10.1111/j.1365-294X.2008.03987.x	136	12	12	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161963	10.1371/journal.pone.0161963	http://dx.doi.org/10.1371/journal.pone.0161963			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598461	gold, Green Published, Green Submitted			2022-12-26	WOS:000383254800030
J	Tsoi, TH; Chan, CF; Chan, WL; Chiu, KF; Wong, WT; Ng, CF; Wong, KL				Tsoi, Tik-Hung; Chan, Chi-Fai; Chan, Wai-Lun; Chiu, Ka-Fung; Wong, Wing-Tak; Ng, Chi-Fai; Wong, Ka-Leung			Urinary Polyamines: A Pilot Study on Their Roles as Prostate Cancer Detection Biomarkers	PLOS ONE			English	Article							DIGITAL RECTAL EXAMINATION; MARKERS; SPERMINE; ANTIGEN; TISSUE; SPECTROSCOPY; PSA; N-1,N-12-DIACETYLSPERMINE; MULTICENTER; DIAGNOSIS	Current screening methods towards prostate cancer (PCa) are not without limitations. Research work has been on-going to assess if there are other better tests suitable for primary or secondary screening of PCa to supplement the serum prostate specific antigen (PSA) test, which fails to work accurately in a grey zone of 4-10ng/ml. In this pilot study, the potential roles of urinary polyamines as prostate cancer biomarkers were evaluated. PCa, benign prostatic hyperplasia (BPH) patients and healthy controls (HC) showing PSA>4.0ng/ml were enrolled in the study. Their urine samples were obtained, and the urinary levels of putrescine (Put), spermidine (Spd) and spermine (Spm) were determined by ultra-high performance liquid chromatography coupled with triple quadrupole mass spectrometer (UPLC-MS/MS). Receiver operating characteristics (ROC) curve and Student's t-test were used to evaluate their diagnostic accuracies. Among the three biogenic polyamines, Spm had demonstrated a good diagnostic performance when comparing their levels in PCa patients with BPH patients (1.47 in PCa vs 5.87 in BPH; p<0.0001). Results are in accordance with transrectal ultrasound prostatic biopsy (TRUSPB) results, with an area under curve (AUC) value of 0.83 +/- 0.03. Therefore urinary Spm shows potential to serve as a novel PCa diagnostic biomarker, which in turn can help to address the limited sensitivity and specificity problem of serum PSA test.	[Tsoi, Tik-Hung; Chan, Chi-Fai; Wong, Wing-Tak] Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China; [Chan, Wai-Lun] Natl Univ Singapore, Dept Chem, 21 Lower Kent Ridge Rd, Singapore, Singapore; [Chiu, Ka-Fung; Ng, Chi-Fai] Chinese Univ Hong Kong, SH Ho Urol Ctr, Div Urol, Dept Surg, Shatin, Hong Kong, Peoples R China; [Wong, Ka-Leung] Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China	Hong Kong Polytechnic University; National University of Singapore; Chinese University of Hong Kong; Hong Kong Baptist University	Wong, WT (corresponding author), Hong Kong Polytech Univ, Dept Appl Biol & Chem Technol, Hong Kong, Hong Kong, Peoples R China.; Ng, CF (corresponding author), Chinese Univ Hong Kong, SH Ho Urol Ctr, Div Urol, Dept Surg, Shatin, Hong Kong, Peoples R China.; Wong, KL (corresponding author), Hong Kong Baptist Univ, Dept Chem, Kowloon Tong, Hong Kong, Peoples R China.	w.t.wong@polyu.edu.hk; ngcf@surgery.cuhk.edu.hk; klwong@hkbu.edu.hk	CHAN, Kulice Wai-Lun/E-3888-2016; Ng, Chi-Fai/E-5134-2011; Chi-fai, NG/AAV-8270-2021	CHAN, Kulice Wai-Lun/0000-0002-3995-5985; Ng, Chi-Fai/0000-0002-1723-9646; Wong, Wing-tak/0000-0002-3453-1825; Chan, Chi Fai/0000-0002-7236-4052	Hong Kong Research Grants Council [HKBU 203013, HKPolyU 5032/11P]	Hong Kong Research Grants Council(Hong Kong Research Grants Council)	The authors thank the staffs and patients of this pilot study for their important contributions and are grateful for the financial support from the grants from The Hong Kong Research Grants Council (HKBU 203013 and HKPolyU 5032/11P), http://www.ugc.edu.hk/eng/rgc/.	Bachrach U, 2004, AMINO ACIDS, V26, P307, DOI 10.1007/s00726-004-0076-6; Battaglia V, 2014, AMINO ACIDS, V46, P511, DOI 10.1007/s00726-013-1529-6; BENSON MC, 1992, J UROLOGY, V147, P815, DOI 10.1016/S0022-5347(17)37393-7; Bhavsar T, 2013, SEMIN ONCOL, V40, P259, DOI 10.1053/j.seminoncol.2013.04.002; BONSNES RW, 1945, J BIOL CHEM, V158, P581; Casero RA, 2009, BIOCHEM J, V421, P323, DOI 10.1042/BJ20090598; Catalona WJ, 2011, J UROLOGY, V185, P1650, DOI 10.1016/j.juro.2010.12.032; Chan ESY, 2012, CHINESE MED J-PEKING, V125, P2432, DOI 10.3760/cma.j.issn.0366-6999.2012.14.006; Cheng LL, 2001, FEBS LETT, V494, P112, DOI 10.1016/S0014-5793(01)02329-8; Djavan B, 1999, UROLOGY, V54, P517, DOI 10.1016/S0090-4295(99)00153-3; Downes MR, 2007, BJU INT, V99, P263, DOI 10.1111/j.1464-410X.2006.06610.x; FAIR WR, 1975, J UROLOGY, V114, P88, DOI 10.1016/S0022-5347(17)66951-9; Ferro M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067687; Giskeodegard GF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062375; Goodwin AC, 2008, PROSTATE, V68, P766, DOI 10.1002/pros.20735; Hakkinen MR, 2013, J CHROMATOGR B, V941, P81, DOI 10.1016/j.jchromb.2013.10.009; Hiramatsu K, 2005, CLIN CANCER RES, V11, P2986, DOI 10.1158/1078-0432.CCR-04-2275; Hiramatsu K, 1997, J CANCER RES CLIN, V123, P539, DOI 10.1007/s004320050102; HORN Y, 1984, CANCER RES, V44, P4675; Jamaspishvili T, 2010, PROSTATE CANCER P D, V13, P12, DOI 10.1038/pcan.2009.31; JUNG K, 1991, EUR J CLIN CHEM CLIN, V29, P725; Lee SH, 2003, CANCER LETT, V201, P121, DOI 10.1016/S0304-3835(03)00014-4; Leveque J, 2000, BREAST CANCER RES TR, V60, P99, DOI 10.1023/A:1006319818530; Li J, 2015, BOUND VALUE PROBL, DOI 10.1186/s13661-014-0269-1; Liu R, 2013, ANAL CHIM ACTA, V791, P36, DOI 10.1016/j.aca.2013.06.044; LOSER C, 1990, CANCER, V65, P958, DOI 10.1002/1097-0142(19900215)65:4<958::AID-CNCR2820650423>3.0.CO;2-Z; Ng CF, 2014, INT UROL NEPHROL, V46, P711, DOI 10.1007/s11255-013-0582-0; Rigau M, 2013, INT J MOL SCI, V14, P12620, DOI 10.3390/ijms140612620; RUSSELL DH, 1971, NATURE-NEW BIOL, V233, P144, DOI 10.1038/newbio233144a0; Schipper RG, 2003, BIOCHEM SOC T, V31, P375, DOI 10.1042/BST0310375; Schroder FH, 1998, JNCI-J NATL CANCER I, V90, P1817, DOI 10.1093/jnci/90.23.1817; Serkova NJ, 2008, PROSTATE, V68, P620, DOI 10.1002/pros.20727; Siegel RL, 2015, CA-CANCER J CLIN, V65, P5, DOI 10.3322/caac.21254; Soda K, 2011, J EXP CLIN CANC RES, V30, DOI 10.1186/1756-9966-30-95; Swanson MG, 2003, MAGN RESON MED, V50, P944, DOI 10.1002/mrm.10614; Telesca D, 2008, BIOMETRICS, V64, P10, DOI 10.1111/j.1541-0420.2007.00825.x; Thomas T, 2003, J CELL MOL MED, V7, P113, DOI 10.1111/j.1582-4934.2003.tb00210.x; van der Graaf M, 2000, MAGN RESON MATER PHY, V10, P153, DOI 10.1016/S1352-8661(00)00082-X; van Gils MPMQ, 2007, CLIN CANCER RES, V13, P939, DOI 10.1158/1078-0432.CCR-06-2679; VanCangh PJ, 1996, UROLOGY, V48, P67, DOI 10.1016/S0090-4295(96)00613-9; Vargas AJ, 2014, NUTR CANCER, V66, P1144, DOI 10.1080/01635581.2014.949801; Wagenlehner FME, 2013, EUR UROL, V63, P521, DOI 10.1016/j.eururo.2012.06.003; Wilkosz J, 2011, CENT EUR J UROL, V64, P9, DOI 10.5173/ceju.2011.01.art2; Wu CL, 2001, UROLOGY, V57, P925, DOI 10.1016/S0090-4295(01)00930-X	44	28	31	3	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162217	10.1371/journal.pone.0162217	http://dx.doi.org/10.1371/journal.pone.0162217			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598335	gold, Green Published, Green Submitted			2022-12-26	WOS:000383254800048
J	Ngufor, C; Critchley, J; Fagbohoun, J; N'Guessan, R; Todjinou, D; Rowland, M				Ngufor, Corine; Critchley, Jessica; Fagbohoun, Josias; N'Guessan, Raphael; Todjinou, Damien; Rowland, Mark			Chlorfenapyr (A Pyrrole Insecticide) Applied Alone or as a Mixture with Alpha-Cypermethrin for Indoor Residual Spraying against Pyrethroid Resistant Anopheles gambiae sl: An Experimental Hut Study in Cove, Benin	PLOS ONE			English	Article							CULEX-QUINQUEFASCIATUS MOSQUITOS	Background Indoor spraying of walls and ceilings with residual insecticide remains a primary method of malaria control. Insecticide resistance in malaria vectors is a growing problem. Novel insecticides for indoor residual spraying (IRS) which can improve the control of pyrethroid resistant malaria vectors are urgently needed. Insecticide mixtures have the potential to improve efficacy or even to manage resistance in some situations but this possibility remains under-explored experimentally. Chlorfenapyr is a novel pyrrole insecticide which has shown potential to improve the control of mosquitoes which are resistant to current WHO-approved insecticides. Method The efficacy of IRS with chlorfenapyr applied alone or as a mixture with alpha-cypermeththrin (a pyrethroid) was evaluated in experimental huts in Cove, Southern Benin against wild free flying pyrethroid resistant Anopheles gambiae sl. Comparison was made with IRS with alpha-cypermethrin alone. Fortnightly 30-minute in situ cone bioassays were performed to assess the residual efficacy of the insecticides on the treated hut walls. Results Survival rates of wild An gambiae from the Cove hut site in WHO resistance bioassays performed during the trial were >90% with permethrin and deltamethrin treated papers. Mortality of free-flying mosquitoes entering the experimental huts was 4% in the control hut. Mortality with alpha-cypermethrin IRS did not differ from the control (5%, P>0.656). The highest mortality was achieved with chlorfenapyr alone (63%). The alpha-cypermethrin + chlorfenapyr mixture killed fewer mosquitoes than chlorfenapyr alone (43% vs. 63%, P<0.001). While the cone bioassays showed a more rapid decline in residual mortality with chlorfenapyr IRS to <30% after only 2 weeks, fortnightly mortality rates of wild free-flying An gambiae entering the chlorfenapyr IRS huts were consistently high (50-70%) and prolonged, lasting over 4 months. Conclusion IRS with chlorfenapyr shows potential to significantly improve the control of malaria transmission in pyrethroid resistant areas compared to pyrethroid IRS or the mixture. Thirty minute in situ cone bioassays are not predictive of the performance of chlorfenapyr IRS under field conditions.	[Ngufor, Corine; Critchley, Jessica; N'Guessan, Raphael; Rowland, Mark] London Sch Hyg & Trop Med, London, England; [Ngufor, Corine; Fagbohoun, Josias; Todjinou, Damien] Ctr Rech Entomol Cotonou, Cotonou, Benin	University of London; London School of Hygiene & Tropical Medicine; Entomological Research Center of Cotonou (CREC)	Ngufor, C (corresponding author), London Sch Hyg & Trop Med, London, England.; Ngufor, C (corresponding author), Ctr Rech Entomol Cotonou, Cotonou, Benin.	corine.ngufor@lshtm.ac.uk		NGuessan, Raphael/0000-0003-4930-4534; Ngufor, Corine/0000-0002-7755-9609	BASF	BASF(BASF)	This work was supported by a grant from BASF to the London School of Hygiene and Tropical Medicine.	Aikpon R, 2013, PARASITE VECTOR, V6, DOI 10.1186/1756-3305-6-192; [Anonymous], 2013, WHO REC INS IND RES; [Anonymous], 2006, WHOCDSWHOPESGCDPP200; BLACK BC, 1994, PESTIC BIOCHEM PHYS, V50, P115, DOI 10.1006/pest.1994.1064; Edi CVA, 2012, EMERG INFECT DIS, V18, P1508, DOI 10.3201/eid1809.120262; Essandoh J, 2013, MALARIA J, V12, DOI 10.1186/1475-2875-12-404; N'Guessan R, 2007, ACTA TROP, V102, P69, DOI 10.1016/j.actatropica.2007.03.003; N'Guessan R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087710; N'Guessan R, 2009, TROP MED INT HEALTH, V14, P389, DOI 10.1111/j.1365-3156.2009.02245.x; Ngufor C, 2015, MALARIA J, V14; Ngufor C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083897; Ngufor C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-343; Oxborough RM, 2010, T ROY SOC TROP MED H, V104, P639, DOI 10.1016/j.trstmh.2010.07.008; Oxborough RM, 2015, MALARIA J, V14, DOI 10.1186/s12936-015-0639-x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Rowland M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069516; WHO, 2013, WORLD MALARIA REPORT 2013, P1; WHO (World Health Organization), 2011, TECHN BAS COORD ACT; World Health Organization, 2012, WHO GLOB MAL PROGR G	19	22	23	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162210	10.1371/journal.pone.0162210	http://dx.doi.org/10.1371/journal.pone.0162210			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588945	gold, Green Submitted, Green Published, Green Accepted			2022-12-26	WOS:000382877800037
J	Bedasso, K; Bedaso, A; Feyera, F; Gebeyehu, A; Yohannis, Z				Bedasso, Kufa; Bedaso, Asres; Feyera, Fetuma; Gebeyehu, Abebaw; Yohannis, Zegeye			Prevalence of Common Mental Disorders and Associated Factors among People with Glaucoma Attending Outpatient Clinic at Menelik II Referral Hospital, Addis Ababa, Ethiopia	PLOS ONE			English	Article							PSYCHIATRIC MORBIDITY; POPULATION; POVERTY	Background The burden of blindness from glaucoma is high. Therefore, people suffering from a serious eye disease such as glaucoma, which can lead to blindness, usually have an emotional disturbance on the patient. Untreated psychiatric illness is associated with increased morbidity and increased costs of care. Objective This study aimed to assess prevalence of common mental disorders and associated factors among people with Glaucoma attending Menelik II referral hospital, Addis Ababa, Ethiopia, 2014. Methods Institution based Cross-sectional study design was conducted in the Department of Ophthalmology Menelik II Referral Hospital from April 10 to May 15, 2014. 423 participants who had undergone through investigation, examination and diagnosed as patients of glaucoma were selected randomly from the glaucoma clinic. Data were collected through face to face interview using Self Reporting Questionnaire consisted of 20 items. Study subjects who scored >= 11 from SRQ-20 were considered as having common mental disorders. Bivariate and multivariable logistic regression analysis with 95% CI were done and variables with P<0.05 in the final model were identified as independent factors associated with common mental disorders. Results Four hundred five patients with glaucoma were included in our study with response rate of 95.7% and 64.5% were males. The average age was 59 +/- 13.37 years. Common mental disorders were observed in 23.2% of Glaucoma patients. It is quite obvious that levels of CMDs were high among patients with glaucoma. There was a significant association between age, sex, chronic physical illness, income and duration of illness at P < 0.05. Conclusion and Recommendation Symptoms of common mental disorders were the commonest comorbidities among patients with glaucoma. It will be better to assess and treat Common mental disorders as a separate illness in patients with glaucoma.	[Bedasso, Kufa] Menelik II Hlth Sci Coll, Dept Psychiat, Addis Ababa, Ethiopia; [Bedaso, Asres] Hawassa Univ, Coll Med & Hlth Sci, Sch Nursing & Midwifery, Hawassa, Ethiopia; [Feyera, Fetuma] Debre Markos Univ, Coll Med & Hlth Sci, Dept Nursing, POB 296, Debre Markos, Ethiopia; [Gebeyehu, Abebaw] Univ Gondar, Coll Med & Hlth Sci, Inst Publ Hlth, Gondar, Ethiopia; [Yohannis, Zegeye] Amanuel Mental Specialized Hosp, Dept Psychiat, POB 1976, Addis Ababa, Ethiopia	Hawassa University; University of Gondar	Bedasso, K (corresponding author), Menelik II Hlth Sci Coll, Dept Psychiat, Addis Ababa, Ethiopia.	kufbed@gmail.com	Tilahune, Asres Bedaso/AAP-9118-2020; Tilahune, Asres Bedaso/AAP-9464-2020	Tilahune, Asres Bedaso/0000-0001-7859-0264; Worku, Abebaw Gebeyehu/0000-0002-1146-3399				Bank World, COUNTR LEND GROUPS L; Dawodo OA, J MED BIOM RES, V3, P42; Dawodu O. A., 2004, Journal of Medicine and Biomedical Research, V3, P42; GIEL R, 1968, PSYCHIAT NEUROL NEUR, V71, P169; Goldberg D, 1992, COMMON MENTAL DISORD, P1324; Gomez J., 1987, LIAISON PSYCHIAT MEN, V3, P356; JACOBSSON L, 1985, ACTA PSYCHIAT SCAND, V71, P417, DOI 10.1111/j.1600-0447.1985.tb02542.x; Kong XM, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2013-004632; Leekassa R, 2004, LEPROSY REV, V75, P367; Lopez AD, 1995, GLOBAL BURDEN DIS RI, V14, P375; Mitsonis C, ANN GEN PSYCHIAT, V200, P510; Muinde T, 2013, JOECSA, V14; Musisi S, 2001, MAKERERE U MED SCH J, V35, P4; Nyman SR, 2010, BRIT J OPHTHALMOL, V94, P1427, DOI 10.1136/bjo.2009.164814; Oheari JU, 1992, W AFR J MED, V11, P234; Patel V, 2003, B WORLD HEALTH ORGAN, V81, P609; Patel V, 2006, RISK FACTORS COMMON, V189, P547; Pothen M, 2003, INT J SOC PSYCHIATR, V49, P119, DOI 10.1177/0020764003049002005; Saulo V., 2010, BA BRAZIL, V13, P1; Weich S, 1998, BMJ-BRIT MED J, V317, P115, DOI 10.1136/bmj.317.7151.115; WHO, GEND DISP MENT HLTH; WHO, 2011, R SECR; World Health Organization, 2001, WORLD HLTH REPORT 20, V123, P435; World Health Organization Division of Mental Health, 1994, US GUID SELF REP QUE, V5, P655	24	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161442	10.1371/journal.pone.0161442	http://dx.doi.org/10.1371/journal.pone.0161442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27584147	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600030
J	Mayer, N; Lopa, S; Talo, G; Lovati, AB; Pasdeloup, M; Riboldi, SA; Moretti, M; Mallein-Gerin, F				Mayer, Nathalie; Lopa, Silvia; Talo, Giuseppe; Lovati, Arianna B.; Pasdeloup, Marielle; Riboldi, Stefania A.; Moretti, Matteo; Mallein-Gerin, Frederic			Interstitial Perfusion Culture with Specific Soluble Factors Inhibits Type I Collagen Production from Human Osteoarthritic Chondrocytes in Clinical-Grade Collagen Sponges	PLOS ONE			English	Article							HUMAN ARTICULAR CHONDROCYTES; BONE MORPHOGENETIC PROTEIN-2; CARTILAGE REPAIR; MATRIX SYNTHESIS; SCAFFOLDS; IMPLANTATION; KNEE; EXPRESSION; DEFECTS; JOINTS	Articular cartilage has poor healing ability and cartilage injuries often evolve to osteoarthritis. Cell-based strategies aiming to engineer cartilaginous tissue through the combination of biocompatible scaffolds and articular chondrocytes represent an alternative to standard surgical techniques. In this context, perfusion bioreactors have been introduced to enhance cellular access to oxygen and nutrients, hence overcoming the limitations of static culture and improving matrix deposition. Here, we combined an optimized cocktail of soluble factors, the BIT (BMP-2, Insulin, Thyroxin), and clinical-grade collagen sponges with a bidirectional perfusion bioreactor, namely the oscillating perfusion bioreactor (OPB), to engineer in vitro articular cartilage by human articular chondrocytes (HACs) obtained from osteoarthritic patients. After amplification, HACs were seeded and cultivated in collagen sponges either in static or dynamic conditions. Chondrocyte phenotype and the nature of the matrix synthesized by HACs were assessed using western blotting and immunohistochemistry analyses. Finally, the stability of the cartilaginous tissue produced by HACs was evaluated in vivo by subcutaneous implantation in nude mice. Our results showed that perfusion improved the distribution and quality of cartilaginous matrix deposited within the sponges, compared to static conditions. Specifically, dynamic culture in the OPB, in combination with the BIT cocktail, resulted in the homogeneous production of extracellular matrix rich in type II collagen. Remarkably, the production of type I collagen, a marker of fibrous tissues, was also inhibited, indicating that the association of the OPB with the BIT cocktail limits fibrocartilage formation, favoring the reconstruction of hyaline cartilage.	[Mayer, Nathalie; Pasdeloup, Marielle; Mallein-Gerin, Frederic] Univ Lyon 1, Lab Tissue Biol & Therapeut Engn, CNRS, UMR 5305, Lyon, France; [Mayer, Nathalie; Pasdeloup, Marielle; Mallein-Gerin, Frederic] Univ Lyon, Inst Biol & Chem Prot, Lyon, France; [Lopa, Silvia; Talo, Giuseppe; Lovati, Arianna B.; Moretti, Matteo] IRCCS Galeazzi Orthopaed Inst, Cell & Tissue Engn Lab, Milan, Italy; [Riboldi, Stefania A.] Bioengn Labs Srl, Meda, Italy; [Moretti, Matteo] EOC, Regenerat Med Technol Lab, Lugano, Switzerland; [Moretti, Matteo] SIRM, Lugano, Switzerland; [Moretti, Matteo] Fdn Cardiocentro Ticino, Lugano, Switzerland	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; IRCCS Istituto Ortopedico Galeazzi	Mallein-Gerin, F (corresponding author), Univ Lyon 1, Lab Tissue Biol & Therapeut Engn, CNRS, UMR 5305, Lyon, France.; Mallein-Gerin, F (corresponding author), Univ Lyon, Inst Biol & Chem Prot, Lyon, France.	f.mallein-gerin@ibcp.fr	Moretti, Matteo/AIC-6221-2022; Lopa, Silvia/G-3455-2015; Lovati, Arianna Barbara/J-8213-2016; Talo, Giuseppe/K-6361-2016	Moretti, Matteo/0000-0002-7301-1208; Lopa, Silvia/0000-0003-0410-5814; Lovati, Arianna Barbara/0000-0002-5230-9718; Mayer, Nathalie/0000-0002-6123-8990; Talo, Giuseppe/0000-0003-1976-5073	Rhone-Alpes Region; French National Centre for Scientific Research (CNRS); Universite Claude Bernard Lyon 1; Italian Ministry of Health; Bioengineering Laboratories S.r.l.	Rhone-Alpes Region(Region Auvergne-Rhone-Alpes); French National Centre for Scientific Research (CNRS)(Centre National de la Recherche Scientifique (CNRS)); Universite Claude Bernard Lyon 1; Italian Ministry of Health(Ministry of Health, Italy); Bioengineering Laboratories S.r.l.	NM held a CMIRA Explora' doc 2011 fellowship from the Rhone-Alpes Region (en.rhonealpes.fr). This work was financially supported by the French National Centre for Scientific Research (CNRS, www.cnrs.fr), the Universite Claude Bernard Lyon 1 (www.univ-lyon1.fr) and by the Italian Ministry of Health (www.salute.gov.it). The CNRS provided support in the form of salary for FMG and MP and the CNRS and the Universite Claude Bernard Lyon 1 provided support in the form of research materials. The Italian Ministry of Health provided support in the form of salaries for SL, GT, ABL, and MM and of research materials. These funders did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Bioengineering Laboratories S.r.l. provided support in the form of salary for SR, but it did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of the authors are articulated in the 'author contributions' section.	Asawa Y, 2009, TISSUE ENG PT A, V15, P1109, DOI 10.1089/ten.tea.2007.0218; Bartlett W, 2005, J BONE JOINT SURG BR, V87B, P640, DOI 10.1302/0301-620X.87B5.15905; BRITTBERG M, 1994, NEW ENGL J MED, V331, P889, DOI 10.1056/NEJM199410063311401; Cheng M, 2009, TISSUE ENG PT A, V15, P645, DOI 10.1089/ten.tea.2008.0077; Claus S, 2012, TISSUE ENG PART C-ME, V18, P104, DOI [10.1089/ten.TEC.2011.0259, 10.1089/ten.tec.2011.0259]; Colombini A, 2015, TISSUE ENG PT A, V21, P793, DOI [10.1089/ten.tea.2014.0279, 10.1089/ten.TEA.2014.0279]; Davisson T, 2002, TISSUE ENG, V8, P807, DOI 10.1089/10763270260424169; Dell'Accio F, 2001, ARTHRITIS RHEUM-US, V44, P1608, DOI 10.1002/1529-0131(200107)44:7<1608::AID-ART284>3.0.CO;2-T; Fitzgerald JB, 2008, J BIOL CHEM, V283, P6735, DOI 10.1074/jbc.M708670200; Gouttenoire M, 2004, BIORHEOLOGY, V41, P535; Hangody L, 2003, J BONE JOINT SURG AM, V85A, P25, DOI 10.2106/00004623-200300002-00004; Hautier A, 2008, GROWTH FACTORS, V26, P201, DOI 10.1080/08977190802242488; Horas U, 2003, J BONE JOINT SURG AM, V85A, P185, DOI 10.2106/00004623-200302000-00001; Knutsen G, 2004, J BONE JOINT SURG AM, V86A, P455, DOI 10.2106/00004623-200403000-00001; Lafont JE, 2016, OSTEOARTHR CARTILAGE, V24, P856, DOI 10.1016/j.joca.2015.11.017; Legendre F, 2013, TISSUE ENG PART C-ME, V19, P550, DOI [10.1089/ten.tec.2012.0508, 10.1089/ten.TEC.2012.0508]; LEGUELLEC D, 1994, HISTOCHEM J, V26, P695, DOI 10.1007/BF00158202; Liu G, 2007, J BIOL CHEM, V282, P20407, DOI 10.1074/jbc.M608383200; Lopa S, 2015, BIOTECHNOL BIOENG, V112, P1457, DOI 10.1002/bit.25557; Martin I, 2001, OSTEOARTHR CARTILAGE, V9, P112, DOI 10.1053/joca.2000.0366; Moretti M, 2008, BIO-MED MATER ENG, V18, P273, DOI 10.3233/BME-2008-0536; Moretti MG, 2010, PUB, Patent No. US2010/ 0297233 A1; Oliveira JT, 2009, J TISSUE ENG REGEN M, V3, P493, DOI 10.1002/term.184; Ollitrault D, 2015, TISSUE ENG PART C-ME, V21, P133, DOI [10.1089/ten.TEC.2013.0724, 10.1089/ten.tec.2013.0724]; Pazzano D, 2000, BIOTECHNOL PROGR, V16, P893, DOI 10.1021/bp000082v; Pei M, 2002, FASEB J, V16, P1691, DOI 10.1096/fj.02-0083fje; Raimondi MT, 2011, BIOMECH MODEL MECHAN, V10, P259, DOI 10.1007/s10237-010-0232-8; Roberts S, 2009, KNEE, V16, P398, DOI 10.1016/j.knee.2009.02.004; Sabatino MA, 2015, J TISSUE ENG REGEN M, V9, P1394, DOI 10.1002/term.1661; Santoro R, 2010, BIOMATERIALS, V31, P8946, DOI 10.1016/j.biomaterials.2010.08.009; Shahin K, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023119; Valcourt U, 2002, J BIOL CHEM, V277, P33545, DOI 10.1074/jbc.M202086200; Valonen PK, 2010, BIOMATERIALS, V31, P2193, DOI 10.1016/j.biomaterials.2009.11.092; VONDERMARK K, 1977, NATURE, V267, P531, DOI 10.1038/267531a0; Wendt D, 2006, BIORHEOLOGY, V43, P481; Yamaoka H, 2010, J BIOMED MATER RES A, V93A, P123, DOI 10.1002/jbm.a.32509; Yang KGA, 2006, OSTEOARTHR CARTILAGE, V14, P561, DOI 10.1016/j.joca.2005.12.002	37	12	12	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161479	10.1371/journal.pone.0161479	http://dx.doi.org/10.1371/journal.pone.0161479			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584727	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600033
J	Arnold, MD; Gruber, C; Flokova, K; Miersch, O; Strnad, M; Novak, O; Wasternack, C; Hause, B				Arnold, Monika D.; Gruber, Cornelia; Flokova, Kristyna; Miersch, Otto; Strnad, Miroslav; Novak, Ondrej; Wasternack, Claus; Hause, Bettina			The Recently Identified Isoleucine Conjugate of cis-12-Oxo-Phytodienoic Acid Is Partially Active in cis-12-Oxo-Phytodienoic Acid-Specific Gene Expression of Arabidopsis thaliana	PLOS ONE			English	Article							ALLENE-OXIDE-CYCLASE; 12-OXO-PHYTODIENOIC ACID; JASMONIC ACID; SEED; OXYLIPINS; OPR3; CYCLOPENTENONES; BIOSYNTHESIS; ACCUMULATION; GERMINATION	Oxylipins of the jasmonate family are active as signals in plant responses to biotic and abiotic stresses as well as in development. Jasmonic acid (JA), its precursor cis-12-oxo-phytodienoic acid (OPDA) and the isoleucine conjugate of JA (JA-Ile) are the most prominent members. OPDA and JA-Ile have individual signalling properties in several processes and differ in their pattern of gene expression. JA-Ile, but not OPDA, is perceived by the SCFCOI1-JAZ co-receptor complex. There are, however, numerous processes and genes specifically induced by OPDA. The recently identified OPDA-Ile suggests that OPDA specific responses might be mediated upon formation of OPDA-Ile. Here, we tested OPDA-Ile-induced gene expression in wild type and JA-deficient, JA-insensitive and JA-Ile-deficient mutant background. Tests on putative conversion of OPDA-Ile during treatments revealed only negligible conversion. Expression of two OPDA-inducible genes, GRX480 and ZAT10, by OPDA-Ile could be detected in a JA-independent manner in Arabidopsis seedlings but less in flowering plants. The data suggest a bioactivity in planta of OPDA-Ile.	[Arnold, Monika D.; Gruber, Cornelia; Hause, Bettina] Leibniz Inst Plant Biochem, Dept Cell & Metab Biol, Halle, Saale, Germany; [Flokova, Kristyna; Miersch, Otto; Strnad, Miroslav; Novak, Ondrej; Wasternack, Claus] Inst Expt Bot AS CR, Ctr Reg Hana Biotechnol & Agr Res, Lab Growth Regulators, Olomouc, Czech Republic; [Flokova, Kristyna; Miersch, Otto; Strnad, Miroslav; Novak, Ondrej; Wasternack, Claus] Palacky Univ, Olomouc, Czech Republic; [Miersch, Otto; Wasternack, Claus] Leibniz Inst Plant Biochem, Dept Mol Signal Proc, Halle, Saale, Germany	Leibniz Institut fur Pflanzenbiochemie; Czech Academy of Sciences; Institute of Experimental Botany of the Czech Academy of Sciences; Palacky University Olomouc; Leibniz Institut fur Pflanzenbiochemie	Hause, B (corresponding author), Leibniz Inst Plant Biochem, Dept Cell & Metab Biol, Halle, Saale, Germany.	bhause@ipb-halle.de	Strnad, Miroslav/H-1858-2014; NOVAK, Ondrej/F-7031-2014; Floková, Kristýna/K-2888-2014	Strnad, Miroslav/0000-0002-2806-794X; NOVAK, Ondrej/0000-0003-3452-0154; Flokova, Kristyna/0000-0002-5558-0669	Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness - European Social Fund [CZ.1.07/2.3.00/20.0165]; Czech Science Foundation [GA14-34792 S]; Ministry of Education, Youth and Sports of the Czech Republic [LO1204]; Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness-European Social Fund [CZ.1.07/2.3.00/20.0165]	Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness - European Social Fund; Czech Science Foundation(Grant Agency of the Czech Republic); Ministry of Education, Youth and Sports of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness-European Social Fund	This study was funded by the Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness - European Social Fund (project CZ.1.07/2.3.00/20.0165), by the Czech Science Foundation (No. GA14-34792 S) and the Ministry of Education, Youth and Sports of the Czech Republic (the National Program for Sustainability I, No. LO1204) to KF, ON, MS and CW.; The authors thank Eva Hirnerova and Gerd Balcke for excellent assistance related to hormone analyses. We are grateful for financial support by the Palacky University Olomouc, Czech Republic, from the program Interhana: Operational Program Education for Competitiveness-European Social Fund (project CZ.1.07/2.3.00/20.0165), by the Czech Science Foundation (No. GA14-34792 S) and the Ministry of Education, Youth and Sports of the Czech Republic (the National Program for Sustainability I, No. LO1204) to K.F., O.N., M.S. and C.W.	Balbi V, 2008, NEW PHYTOL, V177, P301, DOI 10.1111/j.1469-8137.2007.02292.x; Balcke GU, 2012, PLANT METHODS, V8, DOI 10.1186/1746-4811-8-47; Bottcher C, 2009, FEBS J, V276, P4693, DOI 10.1111/j.1742-4658.2009.07195.x; Bosch M, 2014, PLANT PHYSIOL, V166, P396, DOI 10.1104/pp.114.237388; Chehab EW, 2011, PLANT PHYSIOL, V156, P770, DOI 10.1104/pp.111.174169; Chini A, 2007, NATURE, V448, P666, DOI 10.1038/nature06006; Czechowski T, 2005, PLANT PHYSIOL, V139, P5, DOI 10.1104/pp.105.063743; Dave A, 2016, J EXP BOT, V67, P2277, DOI 10.1093/jxb/erw028; Dave A, 2011, PLANT CELL, V23, P583, DOI 10.1105/tpc.110.081489; Dueckershoff K, 2008, BBA-PROTEINS PROTEOM, V1784, P1975, DOI 10.1016/j.bbapap.2008.09.003; Ellis C, 2002, PLANTA, V215, P549, DOI 10.1007/s00425-002-0787-4; Flokova K, 2016, PHYTOCHEMISTRY, V122, P230, DOI 10.1016/j.phytochem.2015.11.012; Fonseca S, 2009, NAT CHEM BIOL, V5, P344, DOI 10.1038/nchembio.161; Goetz S, 2012, PLANT PHYSIOL, V158, P1715, DOI 10.1104/pp.111.192658; Guranowski A, 2007, FEBS LETT, V581, P815, DOI 10.1016/j.febslet.2007.01.049; Katsir L, 2008, P NATL ACAD SCI USA, V105, P7100, DOI 10.1073/pnas.0802332105; KRAMELL R, 1988, TETRAHEDRON, V44, P5791, DOI 10.1016/S0040-4020(01)81437-X; Mueller S, 2008, PLANT CELL, V20, P768, DOI 10.1105/tpc.107.054809; Park SW, 2013, P NATL ACAD SCI USA, V110, P9559, DOI 10.1073/pnas.1218872110; De Leon IP, 2012, MOL PLANT PATHOL, V13, P960, DOI 10.1111/j.1364-3703.2012.00806.x; Savchenko TV, 2014, BIOCHEMISTRY-MOSCOW+, V79, P362, DOI 10.1134/S0006297914040051; Savchenko T, 2014, PLANT SIGNAL BEHAV, V9, DOI 10.4161/psb.28304; Schaller F, 2000, PLANTA, V210, P979, DOI 10.1007/s004250050706; Scholl RL, 2000, PLANT PHYSIOL, V124, P1477, DOI 10.1104/pp.124.4.1477; Sheard LB, 2010, NATURE, V468, P400, DOI 10.1038/nature09430; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Stelmach BA, 1998, PHYTOCHEMISTRY, V47, P539, DOI 10.1016/S0031-9422(97)00547-5; Stenzel I, 2012, J EXP BOT, V63, P6125, DOI 10.1093/jxb/ers261; Stintzi A, 2000, P NATL ACAD SCI USA, V97, P10625, DOI 10.1073/pnas.190264497; Stintzi A, 2001, P NATL ACAD SCI USA, V98, P12837, DOI 10.1073/pnas.211311098; Stitz M, 2011, PLANT PHYSIOL, V157, P341, DOI 10.1104/pp.111.178582; Strassner J, 2002, PLANT J, V32, P585, DOI 10.1046/j.1365-313X.2002.01449.x; Stumpe M, 2010, NEW PHYTOL, V188, P740, DOI 10.1111/j.1469-8137.2010.03406.x; Taki N, 2005, PLANT PHYSIOL, V139, P1268, DOI 10.1104/pp.105.067058; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Wasternack C, 2013, ANN BOT-LONDON, V111, P1021, DOI 10.1093/aob/mct067; Wasternack C., 2015, NEW BIOTECHNOL; Yamamoto Y, 2015, PHYTOCHEMISTRY, V116, P48, DOI 10.1016/j.phytochem.2015.03.008; Yan YX, 2007, PLANT CELL, V19, P2470, DOI 10.1105/tpc.107.050708; ZIMMERMAN DC, 1978, LIPIDS, V13, P313, DOI 10.1007/BF02533720	40	14	14	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162829	10.1371/journal.pone.0162829	http://dx.doi.org/10.1371/journal.pone.0162829			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611078	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900173
J	Condello, G; Capranica, L; Stager, J; Forte, R; Falbo, S; Di Baldassarre, A; Segura-Garcia, C; Pesce, C				Condello, Giancarlo; Capranica, Laura; Stager, Joel; Forte, Roberta; Falbo, Simone; Di Baldassarre, Angela; Segura-Garcia, Cristina; Pesce, Caterina			Physical Activity and Health Perception in Aging: Do Body Mass and Satisfaction Matter? A Three-Path Mediated Link	PLOS ONE			English	Article							QUALITY-OF-LIFE; 6 EUROPEAN COUNTRIES; OLDER-ADULTS; MUSCLE MASS; EXERCISE; DISSATISFACTION; VALIDATION; NUTRITION; OBESITY; IMAGE	Although ageing people could benefit from healthy diet and physical activity to maintain health and quality of life, further understandings of the diet-and physical activity-related mechanisms that may cause changes in health and quality of life perception are necessary. The purpose of the study was to investigate the effect of eating attitudes, body mass and image satisfaction, and exercise dependence in the relationship between physical activity and health and quality of life perception in older individuals. Hundred and seventy-nine late middle-aged, (55-64 yrs), young-old (65-74 yrs), and old (75-84 yrs) senior athletes (n = 56), physically active (n = 58) or sedentary adults (n = 65) were submitted to anthropometric evaluations (body mass, height) and self-reportedquestionnaires: Body Image Dimensional Assessment, Exercise Dependence Scale, Eating Attitude Test, and Short Form Health Survey (Physical Component Summary [PCS] and Mental Component Summary [MCS] of and health and quality of life perception). Senior athletes, physically active, and sedentary participants subgroups differed (P<0.05) from each other in body mass index (BMI) and several components of body image and exercise dependence. Senior athletes showed, compared to their sedentary counterparts, further differences (P<0.05) in eating attitudes and in both PCS and MCS. Mediation analysis showed that the relationship between physical activity habit and MCS, but not PCS, was indirectly explained by a serial mediation chain composed of objective BMI and subjective body image (dis) satisfaction. Findings confirm the relevant role of physically active life habits for older individuals to perceive good physical and mental health. The novelty of the three-path mediated link between physical activity level and mental health perception suggests that the beneficial effect of a physically active lifestyle on weight control can positively impinge on the cognitive-emotional dimension of mental health by ensuring the maintenance, also at older age, of a satisfactory body image.	[Condello, Giancarlo; Capranica, Laura; Forte, Roberta; Falbo, Simone; Pesce, Caterina] Univ Rome Foro Ital, Dept Movement Human & Hlth Sci, Rome, Italy; [Stager, Joel] Indiana Univ, Dept Kinesiol, Bloomington, IN 47405 USA; [Di Baldassarre, Angela] G dAnnunzio Univ Chieti Pescara, Dept Med & Aging Sci, Chieti, Italy; [Segura-Garcia, Cristina] Magna Graecia Univ Catanzaro, Dept Hlth Sci, Catanzaro, Italy	Foro Italico University of Rome; Indiana University System; Indiana University Bloomington; G d'Annunzio University of Chieti-Pescara; Magna Graecia University of Catanzaro	Condello, G (corresponding author), Univ Rome Foro Ital, Dept Movement Human & Hlth Sci, Rome, Italy.	giancarlo.condello@gmail.com	C, Segura-Garcia/I-8978-2014; Di Baldassarre, Angela/D-5402-2014; Laura, Capranica/AFW-3460-2022; Condello, Giancarlo/AAC-8365-2020	C, Segura-Garcia/0000-0002-5756-3045; Di Baldassarre, Angela/0000-0002-4473-4909; Condello, Giancarlo/0000-0001-5092-3258; Pesce, Caterina/0000-0002-4245-3898; Capranica, Laura/0000-0003-3073-7655	Ministero dell'Istruzione, dell'Universita e della Ricerca [2010KL2Y73]	Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR))	This study was supported by the Ministero dell'Istruzione, dell'Universita e della Ricerca (2010KL2Y73) ADB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmed T, 2010, CLIN INTERV AGING, V5, P207; Amarantos E, 2001, J GERONTOL A-BIOL, V56, P54, DOI 10.1093/gerona/56.suppl_2.54; Backmand H, 2010, INT J SPORTS MED, V31, P751, DOI 10.1055/s-0030-1255109; Baker J, 2010, EUR REV AGING PHYS A, V7, P3, DOI 10.1007/s11556-009-0054-9; Borg C, 2008, GERIATR NURS, V29, P48, DOI 10.1016/j.gerinurse.2007.05.002; Bratland-Sanda S, 2013, EUR J SPORT SCI, V13, P499, DOI 10.1080/17461391.2012.740504; Centers for Disease Control and Prevention, 2016, THE HEALTH EFFECTS O; Chan JSY, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00097; Cohen J., 1988, STATISTICAL POWER AN, DOI DOI 10.1234/12345678; Dahl AK, 2013, EPIDEMIOL REV, V35, P22, DOI 10.1093/epirev/mxs002; Dionigi R., 2002, World Leisure Journal, V44, P4; Drewnowski A, 2001, J GERONTOL A-BIOL, V56, P89, DOI 10.1093/gerona/56.suppl_2.89; Duncan DT, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-20; Egorov AY, 2013, J BEHAV ADDICT, V2, P199, DOI 10.1556/JBA.2.2013.4.2; Eime RM, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2156-9; Eisele M, 2015, BRIT J GEN PRACT, V65, pE716, DOI 10.3399/bjgp15X687337; European Commission, 2014, SPECIAL EUROBAROMETE; European Commission, 2013, EU JOINT PROGRAMMING; Forte R, 2015, INT J ENV RES PUB HE, V12, P11328, DOI 10.3390/ijerph120911328; Gandek B, 1998, J CLIN EPIDEMIOL, V51, P1171, DOI 10.1016/S0895-4356(98)00109-7; Gariballa S, 2011, HANDBOOK OF BEHAVIOR, FOOD AND NUTRITION, P3099, DOI 10.1007/978-0-387-92271-3_192; GARNER DM, 1982, PSYCHOL MED, V12, P871, DOI 10.1017/S0033291700049163; Hallal PC, 2012, LANCET, V380, P247, DOI 10.1016/S0140-6736(12)60646-1; Han TS, 2013, BEST PRACT RES CL EN, V27, P509, DOI 10.1016/j.beem.2013.04.012; Hausenblas HA, 2006, PSYCHOL HEALTH, V21, P33, DOI 10.1080/14768320500105270; Hausenblas HA, 2002, PSYCHOL HEALTH, V17, P387, DOI 10.1080/0887044022000004894; Hayes AF, 2013, INTRO MEDIATION MODE, P85; Hogan S, 2012, J WOMEN AGING, V24, P329, DOI 10.1080/08952841.2012.708589; Jankowski GS, 2016, J HEALTH PSYCHOL, V21, P550, DOI 10.1177/1359105314531468; Koeneman MA, 2011, INT J BEHAV NUTR PHY, V8, DOI 10.1186/1479-5868-8-142; Konig HH, 2010, HEALTH QUAL LIFE OUT, V8, DOI 10.1186/1477-7525-8-143; Landolfi E, 2013, SPORTS MED, V43, P111, DOI 10.1007/s40279-012-0013-x; Layte R, 2013, J AM GERIATR SOC, V61, pS299, DOI 10.1111/jgs.12198; Leow MKS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067138; Mangweth-Matzek B, 2014, CURR OPIN PSYCHIATR, V27, P431, DOI 10.1097/YCO.0000000000000102; Marshall Catherine, 2012, Can J Diet Pract Res, V73, pe241, DOI 10.3148/73.2.2012.e241; McCabe MP, 2004, J PSYCHOSOM RES, V56, P675, DOI 10.1016/S0022-3999(03)00129-6; Mura Gioia, 2013, Clin Pract Epidemiol Ment Health, V9, P125, DOI 10.2174/1745017901309010125; Netuveli G, 2006, J EPIDEMIOL COMMUN H, V60, P357, DOI 10.1136/jech.2005.040071; Netuveli G, 2008, BRIT MED BULL, V85, P113, DOI 10.1093/bmb/ldn003; Office of Disease Prevention and Health Promotion, 2016, HLTH PEOPL 2020; Office of Disease Prevention and health Promotion, 2016, HEALTHY PEOPLE 2020; Osness WH, 1996, FUNCTIONAL FITNESS A, P32; Pan CW, 2015, SCI REP-UK, V5, DOI 10.1038/srep17301; Piacentini MF, 2009, CONT SPORT LEISURE E, P227; Prakash RS, 2015, ANNU REV PSYCHOL, V66, P769, DOI 10.1146/annurev-psych-010814-015249; Rejeski WJ, 2001, J GERONTOL A-BIOL, V56, P23, DOI 10.1093/gerona/56.suppl_2.23; Rosenbloom Christine, 2006, Holist Nurs Pract, V20, P161; Roy M, 2015, J AGING HEALTH, V27, P220, DOI 10.1177/0898264314546715; Rutten A, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-14; Sallinen J, 2008, J SPORT MED PHYS FIT, V48, P190; Segura-Garcia C, 2012, EAT WEIGHT DISORD-ST, V17, pE219, DOI 10.3275/8271; Shroff H. P., 2009, HDB ASSESSMENT METHO, P115; Smith PJ, 2010, HYPERTENSION, V55, P1331, DOI 10.1161/HYPERTENSIONAHA.109.146795; Spirduso WW, 2005, PHYS DIMENSIONS AGIN, P233; Svantesson Ulla, 2015, J Clin Med Res, V7, P585, DOI 10.14740/jocmr2021w; Thompson D, 2015, EXERC SPORT SCI REV, V43, P67, DOI 10.1249/JES.0000000000000039; Tiggemann Marika, 2004, Body Image, V1, P29, DOI 10.1016/S1740-1445(03)00002-0; Tiggemann M, 2013, BODY IMAGE, V10, P624, DOI 10.1016/j.bodyim.2013.07.003; Ware J, 1998, HOW TO SCORE THE SF, P97; World Health Organisation, 2011, GLOBAL STRATEGY ON D; Wroblewski AP, 2011, PHYSICIAN SPORTSMED, V39, P172, DOI 10.3810/psm.2011.09.1933; Young BW, 2011, PSYCHOL SPORT EXERC, V12, P168, DOI 10.1016/j.psychsport.2010.09.004	63	22	23	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160805	10.1371/journal.pone.0160805	http://dx.doi.org/10.1371/journal.pone.0160805			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611689	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900010
J	Powell, MK; Benkova, K; Selinger, P; Dogosi, M; Lunackova, IK; Koutnikova, H; Lastikova, J; Roubickova, A; Spurkova, Z; Laclova, L; Eis, V; Sach, J; Heneberg, P				Powell, Marta K.; Benkova, Kamila; Selinger, Pavel; Dogosi, Marek; Lunackova, Iva Kinkorova; Koutnikova, Hana; Lastikova, Jarmila; Roubickova, Alena; Spurkova, Zuzana; Laclova, Lucie; Eis, Vaclav; Sach, Josef; Heneberg, Petr			Opportunistic Infections in HIV-Infected Patients Differ Strongly in Frequencies and Spectra between Patients with Low CD4(+) Cell Counts Examined Postmortem and Compensated Patients Examined Antemortem Irrespective of the HAART Era	PLOS ONE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; AIDS-DEFINING ILLNESSES; POSITIVE PATIENTS; VIRUS-INFECTION; AUTOPSIED PATIENTS; CHANGING PATTERNS; NECROPSY FINDINGS; DEATH; MORTALITY; BACTEREMIA	Objective AIDS-related mortality has changed dramatically with the onset of highly active antiretroviral therapy (HAART), which has even allowed compensated HIV-infected patients to withdraw from secondary therapy directed against opportunistic pathogens. However, in recently autopsied HIV-infected patients, we observed that associations with a broad spectrum of pathogens remain, although detailed analyses are lacking. Therefore, we focused on the possible frequency and spectrum shifts in pathogens associated with autopsied HIV-infected patients. Design We hypothesized that the pathogens frequency and spectrum changes found in HIV-infected patients examined postmortem did not recapitulate the changes found previously in HIV-infected patients examined antemortem in both the pre-and post-HAART eras. Because this is the first comprehensive study originating from Central and Eastern Europe, we also compared our data with those obtained in the West and Southwest Europe, USA and Latin America. Methods We performed autopsies on 124 HIV-infected patients who died from AIDS or other co-mor-bidities in the Czech Republic between 1985 and 2014. The pathological findings were retrieved from the full postmortem examinations and autopsy records. Results We collected a total of 502 host-pathogen records covering 82 pathogen species, a spectrum that did not change according to patients' therapy or since the onset of the epidemics, which can probably be explained by the fact that even recently deceased patients were usually decompensated (in 95% of the cases, the last available CD4(+) cell count was falling below 200 cells*mu l-1) regardless of the treatment they received. The newly identified pathogen taxa in HIV-infected patients included Acinetobacter calcoaceticus, Aerococcus viridans and Escherichia hermannii. We observed a very limited overlap in both the spectra and frequencies of the pathogen species found postmortem in HIV-infected patients in Europe, the USA and Latin America. Conclusions The shifts documented previously in compensated HIV-infected patients examined antemortem in the post-HAART era are not recapitulated in mostly decompensated HIV-infected patients examined postmortem.	[Powell, Marta K.; Eis, Vaclav; Sach, Josef; Heneberg, Petr] Charles Univ Prague, Fac Med 3, Prague, Czech Republic; [Powell, Marta K.; Benkova, Kamila; Selinger, Pavel; Dogosi, Marek; Lunackova, Iva Kinkorova; Koutnikova, Hana; Lastikova, Jarmila; Roubickova, Alena; Spurkova, Zuzana; Laclova, Lucie] Na Bulovce Hosp, Pathol Anat Dept, Prague, Czech Republic; [Selinger, Pavel; Laclova, Lucie] Charles Univ Prague, Fac Med 2, Dept Forens Med, Prague, Czech Republic; [Dogosi, Marek] Charles Univ Prague, Fac Med 1, Dept Forens Med & Toxicol, Prague, Czech Republic; [Lunackova, Iva Kinkorova] Biopticka Lab Sro, Plzen, Czech Republic; [Eis, Vaclav; Sach, Josef] Teaching Hosp Kralovske Vinohrady, Dept Pathol, Prague, Czech Republic	Charles University Prague; Bulovka University Hospital; Charles University Prague; Charles University Prague; University Hospital Vinohrady	Heneberg, P (corresponding author), Charles Univ Prague, Fac Med 3, Prague, Czech Republic.	petr.heneberg@lf3.cuni.cz	Powell, Marta/E-1317-2017; Heneberg, Petr/C-1881-2012; Walmsley, Alena/G-7471-2018	Powell, Marta/0000-0002-3277-0873; Heneberg, Petr/0000-0002-0703-951X; Walmsley, Alena/0000-0001-7316-6472	Charles University in Prague [UNCE 204015, PRVOUK P31/2012, GAUK 235215, 260276/SVV/2016]; Czech Science Foundation [15-03834Y]	Charles University in Prague; Czech Science Foundation(Grant Agency of the Czech Republic)	This study was supported by the Charles University in Prague projects UNCE 204015, PRVOUK P31/2012, GAUK 235215 and 260276/SVV/2016, and by the Czech Science Foundation project 15-03834Y. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansari NA, 2002, INT J TUBERC LUNG D, V6, P55; BRENNER DJ, 1982, J CLIN MICROBIOL, V15, P703, DOI 10.1128/JCM.15.4.703-713.1982; Cox JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033685; Cox JA, 2010, AIDS REV, V12, P183; Cury PM, 2003, PATHOL RES PRACT, V199, P811, DOI 10.1078/0344-0338-00500; Dang AT, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-153; Eza D, 2006, PATHOL RES PRACT, V202, P767, DOI 10.1016/j.prp.2006.07.005; Garcia-Jardon M, 2010, TROP DOCT, V40, P81, DOI 10.1258/td.2010.090465; Guerra I, 2001, PATHOL RES PRACT, V197, P165, DOI 10.1078/0344-0338-00028; Guimaraes LC, 2012, REV INST MED TROP SP, V54, P89, DOI 10.1590/S0036-46652012000200006; HARVEY RL, 1991, REV INFECT DIS, V13, P139; Hofman P, 1999, PATHOL RES PRACT, V195, P209, DOI 10.1016/S0344-0338(99)80037-5; HUI AN, 1984, HUM PATHOL, V15, P670; Iroezindu M. O., 2013, Journal of AIDS and Clinical Research, P002; Ives NJ, 2001, J INFECTION, V42, P134, DOI 10.1053/jinf.2001.0810; Katano H, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-229; Li P, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-0870-7; LUCAS SB, 1993, AIDS, V7, P1569, DOI 10.1097/00002030-199312000-00005; Manfredi R, 1997, Infez Med, V5, P23; Martinelli F, 1999, J CLIN MICROBIOL, V37, P2042, DOI 10.1128/JCM.37.6.2042-2044.1999; MCKENZIE R, 1991, MEDICINE, V70, P326, DOI 10.1097/00005792-199109000-00004; MICHALANY J, 1987, ANN PATHOL, V7, P15; Mocroft A, 2013, CLIN INFECT DIS, V57, P1038, DOI 10.1093/cid/cit423; Mocroft A, 1998, LANCET, V352, P1725, DOI 10.1016/S0140-6736(98)03201-2; MOHAR A, 1992, AIDS, V6, P467, DOI 10.1097/00002030-199205000-00005; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; PILLAY D, 1993, AIDS, V7, P969, DOI 10.1097/00002030-199307000-00010; Popescu GA, 2004, EMERG INFECT DIS, V10, P1335, DOI 10.3201/eid1007.030567; Razeq JH, 1999, EMERG INFECT DIS, V5, P838, DOI 10.3201/eid0506.990622; Soriano V, 2000, AIDS, V14, P282; Tong YQ, 2014, JUNDISHAPUR J MICROB, V7, DOI 10.5812/jjm.18138; Uh Y, 2002, J KOREAN MED SCI, V17, P113, DOI 10.3346/jkms.2002.17.1.113; Weber R, 2013, HIV MED, V14, P195, DOI 10.1111/j.1468-1293.2012.01051.x; WILKES MS, 1988, LANCET, V2, P85	34	12	12	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162704	10.1371/journal.pone.0162704	http://dx.doi.org/10.1371/journal.pone.0162704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611681	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900152
J	Nick, JA; Caceres, SM; Kret, JE; Poch, KR; Strand, M; Faino, AV; Nichols, DP; Saavedra, MT; Taylor-Cousar, JL; Geraci, MW; Burnham, EL; Fessler, MB; Suratt, BT; Abraham, E; Moss, M; Malcolm, KC				Nick, Jerry A.; Caceres, Silvia M.; Kret, Jennifer E.; Poch, Katie R.; Strand, Matthew; Faino, Anna V.; Nichols, David P.; Saavedra, Milene T.; Taylor-Cousar, Jennifer L.; Geraci, Mark W.; Burnham, Ellen L.; Fessler, Michael B.; Suratt, Benjamin T.; Abraham, Edward; Moss, Marc; Malcolm, Kenneth C.			Extremes of Interferon-Stimulated Gene Expression Associate with Worse Outcomes in the Acute Respiratory Distress Syndrome	PLOS ONE			English	Article							ACUTE LUNG INJURY; BRONCHOALVEOLAR LAVAGE FLUID; NEUTROPHIL APOPTOSIS; CIGARETTE-SMOKING; BLOOD NEUTROPHILS; CLINICAL-OUTCOMES; INFLUENZA-VIRUS; LIPOPOLYSACCHARIDE; ARDS; SUSCEPTIBILITY	Acute Respiratory Distress Syndrome (ARDS) severity may be influenced by heterogeneity of neutrophil activation. Interferon-stimulated genes (ISG) are a broad gene family induced by Type I interferons, often as a response to viral infections, which evokes extensive immunomodulation. We tested the hypothesis that over-or under-expression of immunomodulatory ISG by neutrophils is associated with worse clinical outcomes in patients with ARDS. Genome-wide transcriptional profiles of circulating neutrophils isolated from patients with sepsis-induced ARDS (n = 31) and healthy controls (n = 19) were used to characterize ISG expression. Hierarchical clustering of expression identified 3 distinct subject groups with Low, Mid and High ISG expression. ISG accounting for the greatest variability in expression were identified (MX1, IFIT1, and ISG15) and used to analyze a prospective cohort at the Colorado ARDS Network site. One hundred twenty ARDS patients from four urban hospitals were enrolled within 72 hours of initiation of mechanical ventilation. Circulating neutrophils were isolated from patients and expression of ISG determined by PCR. Samples were stratified by standard deviation from the mean into High (n = 21), Mid, (n = 82) or Low (n = 17) ISG expression. Clinical outcomes were compared between patients with High or Low ISG expression to those with Mid-range expression. At enrollment, there were no differences in age, gender, co-existing medical conditions, or type of physiologic injury between cohorts. After adjusting for age, race, gender and BMI, patients with either High or Low ISG expression had significantly worse clinical outcomes than those in the Mid for number of 28-day ventilator-and ICU-free days (P = 0.0006 and 0.0004), as well as 90-day mortality and 90-day home with unassisted breathing (P = 0.02 and 0.004). These findings suggest extremes of ISG expression by circulating neutrophils from ARDS patients recovered early in the syndrome are associated with poorer clinical outcomes.	[Nick, Jerry A.; Caceres, Silvia M.; Poch, Katie R.; Saavedra, Milene T.; Taylor-Cousar, Jennifer L.; Malcolm, Kenneth C.] Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA; [Nichols, David P.] Natl Jewish Hlth, Dept Pediat, Denver, CO USA; [Strand, Matthew; Faino, Anna V.] Natl Jewish Hlth, Div Biostat & Bioinformat, Denver, CO USA; [Nick, Jerry A.; Saavedra, Milene T.; Taylor-Cousar, Jennifer L.; Geraci, Mark W.; Burnham, Ellen L.; Moss, Marc; Malcolm, Kenneth C.] Univ Colorado, Denver Sch Med, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO 80045 USA; [Kret, Jennifer E.] St Louis Cty Dept Publ Hlth, Berkeley, MO USA; [Fessler, Michael B.] NIEHS, Immun Inflammat & Dis Lab, NIH, POB 12233, Res Triangle Pk, NC 27709 USA; [Suratt, Benjamin T.] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; [Abraham, Edward] Wake Forest Sch Med, Off Dean, Winston Salem, NC USA	National Jewish Health; National Jewish Health; National Jewish Health; University of Colorado System; University of Colorado Anschutz Medical Campus; National Institutes of Health (NIH) - USA; NIH National Institute of Environmental Health Sciences (NIEHS); University of Vermont; Wake Forest University	Malcolm, KC (corresponding author), Natl Jewish Hlth, Dept Med, Denver, CO 80206 USA.; Malcolm, KC (corresponding author), Univ Colorado, Denver Sch Med, Div Pulm Sci & Crit Care Med, Dept Med, Aurora, CO 80045 USA.	malcolmk@njhealth.org	, Ben/L-5749-2019; Strand, Matt/AAU-3762-2021; Fessler, Michael B/C-6323-2019	Strand, Matt/0000-0002-9083-5989; Fessler, Michael B/0000-0002-8262-8613; Nichols, David/0000-0001-8611-7960; Malcolm, Kenneth/0000-0002-8097-6059	NIH [R01HL090991, P01 HL068743, Z01 ES102005]; NIH NHLBI ARDS Network; Cystic Fibrosis Foundation [NICK14G0]; Rebecca Runyon Bryan Chair for Cystic Fibrosis; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES102005] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH NHLBI ARDS Network; Cystic Fibrosis Foundation(Italian Cystic Fibrosis Research Foundation); Rebecca Runyon Bryan Chair for Cystic Fibrosis; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	Funding provided by NIH R01HL090991 JAN, NIH P01 HL068743 MBS, NIH Z01 ES102005 (Intramural Research Program, NIEHS) MBS, NIH NHLBI ARDS Network MM, Cystic Fibrosis Foundation (NICK14G0) JAN and Rebecca Runyon Bryan Chair for Cystic Fibrosis.	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; Aggarwal A, 2000, EUR RESPIR J, V15, P895, DOI 10.1034/j.1399-3003.2000.15e14.x; Arcaroli J, 2005, SHOCK, V24, P300, DOI 10.1097/01.shk.0000180621.52058.e1; Bellingan G, 2014, LANCET RESP MED, V2, P98, DOI 10.1016/S2213-2600(13)70259-5; Bode JG, 2007, ARCH BIOCHEM BIOPHYS, V462, P254, DOI 10.1016/j.abb.2007.03.033; Borregaard N, 1997, BLOOD, V89, P3503, DOI 10.1182/blood.V89.10.3503.3503_3503_3521; Brazma A, 2001, NAT GENET, V29, P365, DOI 10.1038/ng1201-365; Brukman A, 2006, J VIROL, V80, P6345, DOI 10.1128/JVI.00554-06; Brundage JF, 2006, LANCET INFECT DIS, V6, P303, DOI 10.1016/S1473-3099(06)70466-2; Brundage JF, 2008, EMERG INFECT DIS, V14, P1193, DOI 10.3201/eid1408.071313; Buckley JM, 2006, J LEUKOCYTE BIOL, V80, P731, DOI 10.1189/jlb.0506312; Calfee CS, 2011, AM J RESP CRIT CARE, V183, P1660, DOI 10.1164/rccm.201011-1802OC; Carrero JA, 2004, J EXP MED, V200, P535, DOI 10.1084/jem.20040769; Eidson KM, 2002, J VIROL, V76, P2180, DOI 10.1128/JVI.76.5.2180-2191.2002; Ely EW, 2002, ANN INTERN MED, V136, P25, DOI 10.7326/0003-4819-136-1-200201010-00007; Fan HK, 2004, J ENDOTOXIN RES, V10, P71, DOI 10.1179/096805104225003997; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Fialkow L, 2006, CRIT CARE, V10, DOI 10.1186/cc5090; Gao L, 2009, AM J PHYSIOL-LUNG C, V296, pL713, DOI 10.1152/ajplung.90269.2008; Golpon HA, 2004, AM J RESP CELL MOL, V31, P595, DOI 10.1165/rcmb.2004-0008OC; Goodman RB, 1996, AM J RESP CRIT CARE, V154, P602, DOI 10.1164/ajrccm.154.3.8810593; Halminen M, 1997, PEDIATR RES, V41, P647, DOI 10.1203/00006450-199705000-00008; HASLETT C, 1985, AM J PATHOL, V119, P101; HUDSON LD, 1995, AM J RESP CRIT CARE, V151, P293, DOI 10.1164/ajrccm.151.2.7842182; Iribarren C, 2000, CHEST, V117, P163, DOI 10.1378/chest.117.1.163; Ivashkiv LB, 2014, NAT REV IMMUNOL, V14, P36, DOI 10.1038/nri3581; Kangelaris KN, 2012, CHEST, V141, P1160, DOI 10.1378/chest.11-1766; Kelly-Scumpia KM, 2010, J EXP MED, V207, P319, DOI 10.1084/jem.20091959; Kotla S, 2008, VIROLOGY, V374, P399, DOI 10.1016/j.virol.2008.01.022; Kumthip K, 2012, J VIROL, V86, P8581, DOI 10.1128/JVI.00533-12; Lamb NJ, 1999, CRIT CARE MED, V27, P1738, DOI 10.1097/00003246-199909000-00007; Landolt-Marticorena C, 2009, ANN RHEUM DIS, V68, P1440, DOI 10.1136/ard.2008.093146; Lee KS, 2008, RESP MED, V102, P464, DOI 10.1016/j.rmed.2007.10.001; Lesur O, 2000, CRIT CARE MED, V28, P3814, DOI 10.1097/00003246-200012000-00010; Levy Mitchell M, 2003, Intensive Care Med, V29, P530; Limaye AP, 2008, JAMA-J AM MED ASSOC, V300, P413, DOI 10.1001/jama.300.4.413; Malcolm KC, 2003, J BIOL CHEM, V278, P15693, DOI 10.1074/jbc.M212033200; Malcolm KC, 2003, AM J PHYSIOL-LUNG C, V284, pL663, DOI 10.1152/ajplung.00094.2002; Malcolm KC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021958; Mancuso G, 2007, J IMMUNOL, V178, P3126, DOI 10.4049/jimmunol.178.5.3126; MARTIN TR, 1991, AM REV RESPIR DIS, V144, P254, DOI 10.1164/ajrccm/144.2.254; Mascellino MT, 2001, J MED MICROBIOL, V50, P49, DOI 10.1099/0022-2615-50-1-49; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Matthay MA, 2011, AM J RESP CRIT CARE, V184, P561, DOI 10.1164/rccm.201012-2090OC; McCullers JA, 2006, CLIN MICROBIOL REV, V19, P571, DOI 10.1128/CMR.00058-05; McNamee LA, 2006, INFECT IMMUN, V74, P6707, DOI 10.1128/IAI.00789-06; Metz P, 2013, J HEPATOL, V59, P1331, DOI 10.1016/j.jhep.2013.07.033; Metzger DW, 2013, J IMMUNOL, V191, P2047, DOI 10.4049/jimmunol.1301152; MILBERG JA, 1995, JAMA-J AM MED ASSOC, V273, P306, DOI 10.1001/jama.273.4.306; Morris AE, 2007, CHEST, V131, P342, DOI 10.1378/chest.06-1709; Moss M, 1996, JAMA-J AM MED ASSOC, V275, P50, DOI 10.1001/jama.275.1.50; Moss M, 2002, CRIT CARE MED, V30, P1679, DOI 10.1097/00003246-200208000-00001; O'Connell RM, 2004, J EXP MED, V200, P437, DOI 10.1084/jem.20040712; Parker D, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1003951; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Ramilo O, 2007, BLOOD, V109, P2066, DOI 10.1182/blood-2006-02-002477; Ramilo O, 2009, CELL HOST MICROBE, V6, P199, DOI 10.1016/j.chom.2009.08.007; Rice TW, 2012, JAMA-J AM MED ASSOC, V307, P795, DOI 10.1001/jama.2012.137; Rice TW, 2011, JAMA-J AM MED ASSOC, V306, P1574, DOI 10.1001/jama.2011.1435; RIVKIND AI, 1991, CIRC SHOCK, V33, P48; ROERS A, 1994, J INFECT DIS, V169, P807, DOI 10.1093/infdis/169.4.807; Rothberg MB, 2008, AM J MED, V121, P258, DOI 10.1016/j.amjmed.2007.10.040; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schoenfeld DA, 2002, CRIT CARE MED, V30, P1772, DOI 10.1097/00003246-200208000-00016; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; SELLERS TF, 1961, J EXP MED, V114, P237, DOI 10.1084/jem.114.2.237; Silva E, 2007, INTENSIVE CARE MED; Stetson DB, 2006, IMMUNITY, V25, P373, DOI 10.1016/j.immuni.2006.08.007; Sun K, 2008, NAT MED, V14, P558, DOI 10.1038/nm1765; Truwit JD, 2014, NEW ENGL J MED, V370, P2191, DOI 10.1056/NEJMoa1401520; Ware LB, 2000, NEW ENGL J MED, V342, P1334, DOI 10.1056/NEJM200005043421806; Wright HJ, 2008, J IMMUNOL, V181, P5775, DOI 10.4049/jimmunol.181.8.5775; Zaas AK, 2009, CELL HOST MICROBE, V6, P207, DOI 10.1016/j.chom.2009.07.006; 2004, NAT REV GENET, V5, P229, DOI DOI 10.1038/NRG1297	76	20	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162490	10.1371/journal.pone.0162490	http://dx.doi.org/10.1371/journal.pone.0162490			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606687	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600050
J	Chen, WL; Liao, BL; Hu, FY; Nie, JM; Lan, Y; Li, HQ; Lu, RC; Gao, Y; Song, YX; Zhao, QX; Zheng, YH; Tang, XP; Cai, WP				Chen, Weilie; Liao, Baolin; Hu, Fengyu; Nie, Jingmin; Lan, Yun; Li, Huiqin; Lu, Ruichao; Gao, Yanqing; Song, Yuxia; Zhao, Qingxia; Zheng, Yuhuang; Tang, Xiaoping; Cai, Weiping			Changing Epidemiology of Hepatitis C Virus Genotype among Patients with Human Immunodeficiency Virus/Hepatitis C Virus Co-Infection in China	PLOS ONE			English	Article							RANDOMIZED-TRIAL; PLUS RIBAVIRIN; INFECTION; PREVALENCE; THERAPY; UPDATE	Background Co-infection with hepatitis C virus (HCV) has become the most common cause of death in human immunodeficiency virus (HIV) infected patients on antiretroviral therapy. The distribution of HCV genotypes varies with geographical regions and time, and limited studies have focused on the HCV genotype in HIV/HCV co-infection. Methods The distribution of HCV genotypes was evaluated in 414 patients with HIV/HCV co-infection in three regions (South, Central and Northwest) of China from 2008 to 2010. The NS5B region of HCV was characterized using nested reverse transcription polymerase chain reaction. Nucleotide sequences obtained were subjected to phylogenetic analysis, and genotypes were assigned using published reference genotypes. Results Genotype 3 was the most prevalent HCV strain (36.2%), followed by genotype 6 (30.0%), genotype 1 (28.5%), genotype 2 (5.1%), and genotype 5 (0.2%). The distribution varied geographically. Genotype 6 (37.6%) was the predominant strain while genotype 1 (20.2%) was less common in the South compared to the Central and Northwest regions (all P < 0.001). The distribution also varied temporally. There was no significant difference in genotype distribution in Guangdong (a province in the South region), between patient cohorts from 2005-2008 and 2009-2010. However, outside Guangdong, genotypes 3 and 6a became significantly more prevalent (22.4% vs. 42.2%, P<0.001; 8.0% vs. 19.8%, P = 0.004), and genotype 1 less prevalent (54.4% vs. 26.6%, P<0.001) over time. Conclusion The most dramatic shift in genotypic distribution was the movement of HCV genotypes 3 and 6a outside of Guangdong in HIV/HCV co-infected patients. This movement appeared closely associated with transmission via injected drug use.	[Chen, Weilie; Liao, Baolin; Hu, Fengyu; Nie, Jingmin; Lan, Yun; Tang, Xiaoping; Cai, Weiping] Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China; [Li, Huiqin] Yunnan Prov Infect Dis Hosp, Dept Infect Dis, Kunming, Yunnan, Peoples R China; [Lu, Ruichao] Guangxi Zhuang Autonomous Reg Longtan Hosp, Dept Infect Dis, Guangxi, Peoples R China; [Gao, Yanqing] Capital Med Univ, Beijing Youan Hosp, Dept Infect Dis, Beijing, Peoples R China; [Song, Yuxia] Xinjiang 6 Peoples Hosp, Dept Infect Dis, Xinjiang, Peoples R China; [Zhao, Qingxia] Zhenzhou 6 Peoples Hosp, Dept Infect Dis, Zhenzhou, Peoples R China; [Zheng, Yuhuang] Zhongnan Univ, Xiangya Hosp 2, Dept Infect Dis, Changsha, Hunan, Peoples R China	Guangzhou Medical University; Capital Medical University; Central South University	Tang, XP; Cai, WP (corresponding author), Guangzhou Med Univ, Guangzhou Peoples Hosp 8, Dept Infect Dis, Guangzhou, Guangdong, Peoples R China.	xtang@21cn.com; gz8hcwp@126.com			Chinese National Key Technologies R&D Program for the 12th Five-year Plan [2012ZX10001003-003]; Special Project to Benefit the People of Guangzhou Municipal Science and Technology Bureau [201300000092, 2014Y2-00149]; National Natural Science Foundation of China [81201286]	Chinese National Key Technologies R&D Program for the 12th Five-year Plan; Special Project to Benefit the People of Guangzhou Municipal Science and Technology Bureau; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants from Chinese National Key Technologies R&D Program for the 12th Five-year Plan (2012ZX10001003-003), the Special Project to Benefit the People of Guangzhou Municipal Science and Technology Bureau (201300000092 and 2014Y2-00149) and National Natural Science Foundation of China (81201286). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antaki N, 2010, LIVER INT, V30, P342, DOI 10.1111/j.1478-3231.2009.02188.x; Cui Y, 2013, J GASTROEN HEPATOL, V28, P7, DOI 10.1111/jgh.12220; Fried MW, 2002, NEW ENGL J MED, V347, P975, DOI 10.1056/NEJMoa020047; Fu Y, 2011, J VIRAL HEPATITIS, V18, P42, DOI 10.1111/j.1365-2893.2010.01280.x; Fu YSH, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047324, 10.1371/journal.pone.0028006]; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Ioannou GN, 2013, HEPATOLOGY, V57, P249, DOI 10.1002/hep.25800; Ju W, 2015, VIROL J, V12, DOI 10.1186/s12985-015-0341-1; Kim AY, 2009, GASTROENTEROLOGY, V137, P795, DOI 10.1053/j.gastro.2009.06.040; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Manns MP, 2001, LANCET, V358, P958, DOI 10.1016/S0140-6736(01)06102-5; Messina JP, 2015, HEPATOLOGY, V61, P77, DOI 10.1002/hep.27259; Mutimer D, 2014, J HEPATOL, V60, P392, DOI 10.1016/j.jhep.2013.11.003; Omata M, 2012, HEPATOL INT, V6, P409, DOI 10.1007/s12072-012-9342-y; Piroth L, 2015, CLIN INFECT DIS, V61, P817, DOI 10.1093/cid/civ381; Rao HY, 2014, J GASTROEN HEPATOL, V29, P545, DOI 10.1111/jgh.12398; Rong X, 2014, ARCH VIROL, V159, P3231, DOI 10.1007/s00705-014-2185-1; Shang H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010631; Sulkowski MS, 2013, ANN INTERN MED, V159, P86, DOI 10.7326/0003-4819-159-2-201307160-00654; Sulkowski MS, 2012, LIVER INT, V32, P129, DOI 10.1111/j.1478-3231.2011.02719.x; Tan Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003608	22	8	15	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161844	10.1371/journal.pone.0161844	http://dx.doi.org/10.1371/journal.pone.0161844			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603929	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200027
J	Jin, YL; Chen, PY; Zhang, YF; Tian, G; Feng, HQ; Hou, YM				Jin, Yinli; Chen, Peiyu; Zhang, Yanfang; Tian, Guo; Feng, Hongqiang; Hou, Youming			Effect of Water on Survival and Development of Diapausing Eggs of Apolygus lucorum (Hemiptera: Miridae)	PLOS ONE			English	Article							MULTIPLE CROPS; BT COTTON; TERMINATION; TEMPERATURE; PHOTOPERIOD; MOISTURE; BEETLE; LIFE; BUG	The green mirid bug Apolygus lucorum is a regional pest of multiple crops in northern China, and the survival and development of diapausing eggs during winter plays an important role in the population dynamics of this species. The effect of water on the survival and development of A. lucorum eggs was investigated using laboratory-induced diapause. Diapausing eggs were exposed to various humidity regimes under three conditions: (1) termination of diapause with exposure to warm long-day (WLD) conditions (i.e., 26 +/- 1 degrees C and 75 +/- 5% relative humidity (RH) under a photoperiod of 16 hours light and 8 hours dark), (2) termination of diapause by chilling at 4 degrees C, or (3) during the post-diapause stage, i.e., from transfer to WLD conditions after chilling, until the hatching of nymphs. The results indicate that water availability is crucial for the post-diapause resumption of development of A. lucorum. However, exposure to excessive moisture was detrimental, as indicated by a decrease in diapause termination rate and a prolonged pre-hatching period of diapausing eggs, compared to limited moisture conditions. This implies that both too dry and too humid environmental conditions would suppress survival and postpone hatching of overwintered A. lucorum eggs, and might explain why this pest has not caused severe damage in either southern or western China where the respective climates are very humid or dry.	[Jin, Yinli; Hou, Youming] Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou 350002, Fujian, Peoples R China; [Jin, Yinli; Chen, Peiyu; Zhang, Yanfang; Tian, Guo; Feng, Hongqiang] Henan Acad Agr Sci, Henan Key Lab Crop Pest Control,Inst Plant Protec, Key Lab Integrated Pest Management Crops Southern, Int Joint Res Lab Crop Protect Henan,Biol Pestici, Zhengzhou 450002, Henan, Peoples R China; [Chen, Peiyu] Nanyang Acad Agr Sci, Nanyang 473008, Henan, Peoples R China	Fujian Agriculture & Forestry University; Henan Academy of Agricultural Sciences	Hou, YM (corresponding author), Fujian Agr & Forestry Univ, Dept Plant Protect, Fujian Prov Key Lab Insect Ecol, Fuzhou 350002, Fujian, Peoples R China.; Feng, HQ (corresponding author), Henan Acad Agr Sci, Henan Key Lab Crop Pest Control,Inst Plant Protec, Key Lab Integrated Pest Management Crops Southern, Int Joint Res Lab Crop Protect Henan,Biol Pestici, Zhengzhou 450002, Henan, Peoples R China.	feng_hq@163.com; ymhou@fafu.edu.cn		Hou, Youming/0000-0001-7984-9688; jin, yinli/0000-0002-5889-2166; Feng, Hongqiang/0000-0002-1171-248X	Special Fund for Agro-Scientific Research in the Public Interest [201103012-7]; Chinese Ministry of Agriculture [2014ZX08012-004]	Special Fund for Agro-Scientific Research in the Public Interest; Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	This work was financially supported by the Special Fund for Agro-Scientific Research in the Public Interest (201103012-7) and the Chinese Ministry of Agriculture (2014ZX08012-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDO Y, 1972, Applied Entomology and Zoology, V7, P142; Barns HF, 1943, J ANIM ECOL, V12, P137, DOI 10.2307/1373; [陈培育 CHEN Pei-yu], 2010, [河南农业大学学报, Journal of Henan Agricultural University], V44, P83; Chen PY, 2010, THESIS; DUNN OJ, 1964, TECHNOMETRICS, V6, P241, DOI 10.2307/1266041; Feng HQ, 2012, J ECON ENTOMOL, V105, P1921, DOI 10.1603/EC12193; Feng HQ, 2012, ENVIRON ENTOMOL, V41, P1606, DOI 10.1603/EN12099; Higaki M, 2012, J INSECT PHYSIOL, V58, P56, DOI 10.1016/j.jinsphys.2011.09.014; Hoff PD, 2009, SPRINGER TEXTS STAT, P1, DOI 10.1007/978-0-387-92407-6_1; Jiang XF, 2010, J INSECT PHYSIOL, V56, P1325, DOI 10.1016/j.jinsphys.2010.04.016; [金银利 Jin Yinli], 2015, [植物保护, Plant Protection], V41, P179; [金银利 Jin Yinli], 2015, [植物保护, Plant Protection], V41, P149; Kostal V, 2006, J INSECT PHYSIOL, V52, P113, DOI 10.1016/j.jinsphys.2005.09.008; KRYSAN JL, 1978, J INSECT PHYSIOL, V24, P535, DOI 10.1016/0022-1910(78)90055-0; Li GP, 2011, CROP PROT, V30, P1573, DOI 10.1016/j.cropro.2011.08.015; Lu Y. H., 2008, ACTA PHYTOPHYLACICA, V35, P215; Lu YanHui, 2011, Outlooks on Pest Management, V22, P248, DOI 10.1564/22dec02; Lu YH, 2010, APPL ENTOMOL ZOOL, V45, P387, DOI 10.1303/aez.2010.387; Lu YH, 2010, CROP PROT, V29, P1026, DOI 10.1016/j.cropro.2010.03.017; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; Lu YH, 2008, BIOL CONTROL MIRIDS, P151; Nahrung HF, 1999, ENTOMOL EXP APPL, V93, P201, DOI 10.1023/A:1003878911300; National Bureau of Statistics of China, NAT DAT; Pan HS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094190; R Core Team, 2012, R LANG ENV STAT COMP; Ritz C, 2008, USE R, P1; TAUBER MJ, 1976, ANNU REV ENTOMOL, V21, P81, DOI 10.1146/annurev.en.21.010176.000501; Terao M, 2012, J INSECT PHYSIOL, V58, P737, DOI 10.1016/j.jinsphys.2012.02.009; [田彩红 Tian Caihong], 2013, [植物保护, Plant Protection], V39, P56; Wu KM, 2008, SCIENCE, V321, P1676, DOI 10.1126/science.1160550; Zhuo De-Gan, 2011, Acta Entomologica Sinica, V54, P136	31	4	4	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161657	10.1371/journal.pone.0161657	http://dx.doi.org/10.1371/journal.pone.0161657			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603210	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255200021
J	Lin, GG; Zhang, K; Yi, L; Han, YX; Xie, JH; Li, JM				Lin, Guigao; Zhang, Kuo; Yi, Lang; Han, Yanxi; Xie, Jiehong; Li, Jinming			National Prociency Testing Result of CYP2D6*10 Genotyping for Adjuvant Tamoxifen Therapy in China	PLOS ONE			English	Article							CYP2D6; ASSOCIATION; METABOLITE; PHENOTYPE; SURVIVAL; VKORC1; IMPACT	Tamoxifen has been successfully used for treating breast cancer and preventing cancer recurrence. Cytochrome P450 2D6 (CYP2D6) plays a key role in the process of metabolizing tamoxifen to its active moiety, endoxifen. Patients with variants of the CYP2D6 gene may not receive the full benefit of tamoxifen treatment. The CYP2D6* 10 variant (the most common variant in Asians) was analyzed to optimize the prescription of tamoxifen in China. To ensure referring clinicians have accurate information for genotype-guided tamoxifen treatment, the Chinese National Center for Clinical Laboratories (NCCL) organized a national proficiency testing (PT) to evaluate the performance of laboratories providing CYP2D6* 10 genotyping. Ten genomic DNA samples with CYP2D6 wild-type or CYP2D6* 10 variants were validated by PCR-sequencing and sent to 28 participant laboratories. The genotyping results and pharmacogenomic test reports were submitted and evaluated by NCCL experts. Additional information regarding the number of samples tested, the accreditation/certification status, and detecting technology was also requested. Thirty-one data sets were received, with a corresponding analytical sensitivity of 98.2%(548/558 challenges; 95% confidence interval: 96.7-99.1%) and an analytic specificity of 96.5% (675/682; 95% confidence interval: 97.9-99.5%). Overall, 25/28 participants correctly identified CYP2D6* 10 status in 10 samples; however, two laboratories made serious genotyping errors. Most of the essential information was included in the 20 submitted CYP2D6* 10 test reports. The majority of Chinese laboratories are reliable for detecting the CYP2D6* 10 variant; however, several issues revealed in this study underline the importance of PT schemes in continued external assessment and provision of guidelines.	[Lin, Guigao; Zhang, Kuo; Han, Yanxi; Xie, Jiehong; Li, Jinming] Beijing Hosp, Natl Ctr Gerontol, Beijing, Peoples R China; [Lin, Guigao; Zhang, Kuo; Yi, Lang; Han, Yanxi; Xie, Jiehong; Li, Jinming] Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China; [Lin, Guigao; Zhang, Kuo; Han, Yanxi; Xie, Jiehong; Li, Jinming] Beijing Hosp, Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China; [Yi, Lang] Chinese Acad Med Sci, Grad Sch, Peking Union Med Coll, Beijing, Peoples R China	Beijing Hospital; Beijing Hospital; Beijing Hospital; Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College	Li, JM (corresponding author), Beijing Hosp, Natl Ctr Gerontol, Beijing, Peoples R China.; Li, JM (corresponding author), Beijing Hosp, Natl Ctr Clin Labs, Beijing, Peoples R China.; Li, JM (corresponding author), Beijing Hosp, Beijing Engn Res Ctr Lab Med, Beijing, Peoples R China.	jmli@nccl.org.cn			Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China [201402018]; Beijing Natural Science Foundation [7164295]	Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China; Beijing Natural Science Foundation(Beijing Natural Science Foundation)	This work was supported by the Special Fund for Health-scientific Research in the Public Interest from National Population and Family Planning Commission of the P R China (No. 201402018) and Beijing Natural Science Foundation (7164295).	Garcia-Sepulveda CA, 2010, MOL BIOL REP, V37, P1883, DOI 10.1007/s11033-009-9624-1; ALLEN KE, 1980, BRIT J PHARMACOL, V71, P83, DOI 10.1111/j.1476-5381.1980.tb10912.x; Beck JC, 2001, CANCER EPIDEM BIOMAR, V10, P551; BROLY F, 1991, DNA CELL BIOL, V10, P545, DOI 10.1089/dna.1991.10.545; Davies C, 2011, LANCET, V378, P771, DOI 10.1016/S0140-6736(11)60993-8; Davies C, 2013, LANCET, V381, P805, DOI 10.1016/S0140-6736(12)61963-1; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; Jordan VC, 2003, NAT REV DRUG DISCOV, DOI [10.1016/S0140-6736(11)60993-8, DOI 10.1016/S0140-6736(11)60993-8]; Kiyotani K, 2008, CANCER SCI, V99, P995, DOI 10.1111/j.1349-7006.2008.00780.x; Kiyotani K, 2012, BREAST CANCER RES TR, V131, P137, DOI 10.1007/s10549-011-1777-7; Lin GG, 2015, J CARDIOVASC PHARM, V66, P129, DOI 10.1097/FJC.0000000000000254; Lin GG, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134174; Madlensky L, 2011, CLIN PHARMACOL THER, V89, P718, DOI 10.1038/clpt.2011.32; Pratt VM, 2010, J MOL DIAGN, V12, P835, DOI 10.2353/jmoldx.2010.100090; Qian JC, 2013, PHARMACOGENOMICS, V14, P1731, DOI 10.2217/pgs.13.160; Swen JJ, 2011, CLIN PHARMACOL THER, V89, P662, DOI 10.1038/clpt.2011.34; Tang KF, 2015, J ZHEJIANG UNIV-SC B, V16, P191, DOI 10.1631/jzus.B1400282; Wu AHB, 2013, ARCH PATHOL LAB MED, V137, P1232, DOI 10.5858/arpa.2012-0261-CP; Xu Y, 2008, ANN ONCOL, V19, P1423, DOI 10.1093/annonc/mdn155; Yi L, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148081	21	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162361	10.1371/journal.pone.0162361	http://dx.doi.org/10.1371/journal.pone.0162361			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603206	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200061
J	Ouellette, SB; Noel, BM; Parker, LL				Ouellette, Steven B.; Noel, Brett M.; Parker, Laurie L.			A Cell-Based Assay for Measuring Endogenous BcrAbl Kinase Activity and Inhibitor Resistance	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; DIFFERENTIAL SENSITIVITY; PEPTIDE BIOSENSOR; DRUG DISCOVERY; ABL ACTIVITY; FOLLOW-UP; IMATINIB; NILOTINIB; CANCER; PHOSPHORYLATION	Kinase enzymes are an important class of drug targets, particularly in cancer. Cell-based kinase assays are needed to understand how potential kinase inhibitors act on their targets in a physiologically relevant context. Current cell-based kinase assays rely on antibody-based detection of endogenous substrates, inaccurate disease models, or indirect measurements of drug action. Here we expand on previous work from our lab to introduce a 96-well plate compatible approach for measuring cell-based kinase activity in disease-relevant human chronic myeloid leukemia cell lines using an exogenously added, multi-functional peptide substrate. Our cellular models natively express the BcrAbl oncogene and are either sensitive or have acquired resistance to well-characterized BcrAbl tyrosine kinase inhibitors. This approach measures IC50 values comparable to established methods of assessing drug potency, and its robustness indicates that it can be employed in drug discovery applications. This medium-throughput assay could bridge the gap between single target focused, high-throughput in vitro assays and lower-throughput cell-based follow-up experiments.	[Ouellette, Steven B.; Noel, Brett M.; Parker, Laurie L.] Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA; [Ouellette, Steven B.; Noel, Brett M.] KinaSense LLC, W Lafayette, IN 47901 USA; [Parker, Laurie L.] Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Mason Canc Ctr, Minneapolis, MN 55455 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Minnesota System; University of Minnesota Twin Cities	Ouellette, SB; Parker, LL (corresponding author), Purdue Univ, Dept Med Chem & Mol Pharmacol, Coll Pharm, Purdue Ctr Canc Res, W Lafayette, IN 47907 USA.; Ouellette, SB (corresponding author), KinaSense LLC, W Lafayette, IN 47901 USA.; Parker, LL (corresponding author), Univ Minnesota Twin Cities, Dept Biochem Mol Biol & Biophys, Mason Canc Ctr, Minneapolis, MN 55455 USA.	souellette@kinasense.com; llparker@umn.edu	Parker, Laurie L/C-1510-2010	Parker, Laurie L/0000-0002-6234-3346	National Institutes of Health [R00CA127161, R21CA160129]; NATIONAL CANCER INSTITUTE [R00CA127161, R21CA160129, R01CA182543] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by the National Institutes of Health through grants R00CA127161 and R21CA160129, nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the National Institutes of Health through grants R00CA127161 and R21CA160129. The authors would like to thank Matthew Martin and Broxton Davis for assisting in experimental procedures.	[Anonymous], 2010, Drug Discov Today Technol, V7, pe1, DOI 10.1016/j.ddtec.2010.04.002; Boros K, 2015, ONCOTARGET, V6, P25575, DOI 10.18632/oncotarget.4669; Brummendorf TH, 2015, BRIT J HAEMATOL, V168, P69, DOI 10.1111/bjh.13108; Cassuto O, 2012, ONCOTARGET, V3, P1557; Cortes JE, 2012, NEW ENGL J MED, V367, P2075, DOI 10.1056/NEJMoa1205127; Cui W, 2015, CHEM COMMUN, V51, P362, DOI 10.1039/c4cc07453j; Drew AE, 2011, J BIOMOL SCREEN, V16, P164, DOI 10.1177/1087057110394657; Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867; Dufies M, 2011, ONCOTARGET, V2, P874, DOI 10.18632/oncotarget.360; Eadie LN, 2014, CLIN PHARMACOL THER, V95, P294, DOI 10.1038/clpt.2013.208; Eglen Richard M, 2008, Curr Chem Genomics, V1, P2, DOI 10.2174/1875397300801010002; Folkvord S, 2010, INT J RADIAT ONCOL, V78, P555, DOI 10.1016/j.ijrobp.2010.04.036; Frietsch JJ, 2014, ONCOTARGET, V5, P5257, DOI 10.18632/oncotarget.2072; Gioia R, 2011, BLOOD, V118, P2211, DOI 10.1182/blood-2010-10-313692; Hsu J, 2013, J BIOMOL SCREEN, V18, P890, DOI 10.1177/1087057113489881; Iversen PW, 2004, ASSAY GUIDANCE MANUA; Jabbour E, 2014, AM J HEMATOL, V89, P547, DOI 10.1002/ajh.23691; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kim SH, 2014, HAEMATOLOGICA, V99, P1191, DOI 10.3324/haematol.2013.096776; Kim Yeo-Kyeoung, 2014, Chonnam Med J, V50, P102, DOI 10.4068/cmj.2014.50.3.102; Kitagawa D, 2013, GENES CELLS, V18, P110, DOI 10.1111/gtc.12022; Li H, 2004, BIOCHEMISTRY-US, V43, P1599, DOI 10.1021/bi035597k; Lipchik AM, 2015, J AM CHEM SOC, V137, P2484, DOI 10.1021/ja507164a; Lipchik AM, 2012, BIOCHEMISTRY-US, V51, P7515, DOI 10.1021/bi300970h; Lu LH, 2009, BIOCHEMISTRY-US, V48, P3600, DOI 10.1021/bi8020923; Mahon FX, 2000, BLOOD, V96, P1070, DOI 10.1182/blood.V96.3.1070.015k17_1070_1079; Mand MR, 2010, J BIOMOL SCREEN, V15, P434, DOI 10.1177/1087057110363307; Mathrubutham MF, 2009, PROCEEDINGS OF THE 1; Mizutani T, 2010, CLIN CANCER RES, V16, P3964, DOI 10.1158/1078-0432.CCR-10-0548; Morris MC, 2013, BBA-PROTEINS PROTEOM, V1834, P1387, DOI 10.1016/j.bbapap.2013.01.025; Okabe S, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-32; Pan XY, 2015, ORG BIOMOL CHEM, V13, P7050, DOI 10.1039/c5ob00430f; Peled N, 2013, CELL ONCOL, V36, P277, DOI 10.1007/s13402-013-0133-9; Placzek EA, 2010, ANAL BIOCHEM, V397, P73, DOI 10.1016/j.ab.2009.09.048; Rezende Vinícius Marcondes, 2013, Rev. Bras. Hematol. Hemoter., V35, P103, DOI 10.5581/1516-8484.20130030; Saglio G, 2010, NEW ENGL J MED, V362, P2251, DOI 10.1056/NEJMoa0912614; Smith AL, 2009, J MED CHEM, V52, P6189, DOI 10.1021/jm901081g; Tang C, 2011, LEUKEMIA LYMPHOMA, V52, P2139, DOI 10.3109/10428194.2011.591013; Tang JB, 2012, CHEMBIOCHEM, V13, P665, DOI 10.1002/cbic.201100763; Warmuth M, 2007, CURR OPIN ONCOL, V19, P55, DOI 10.1097/CCO.0b013e328011a25f; White D, 2007, J CLIN ONCOL, V25, P4445, DOI 10.1200/JCO.2006.09.9499; Wittman MD, 2009, J MED CHEM, V52, P7360, DOI 10.1021/jm900786r; Xu WC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048867; Yang TY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056627; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang JM, 2009, NAT REV CANCER, V9, P28, DOI 10.1038/nrc2559	46	4	4	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161748	10.1371/journal.pone.0161748	http://dx.doi.org/10.1371/journal.pone.0161748			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598410	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800019
J	Cho, YS; Kim, BS; Sim, CK; Kim, I; Lee, MS				Cho, Yeon Sook; Kim, Byung Soo; Sim, Chan Kyu; Kim, Inki; Lee, Myeong Sup			Establishment of IL-7 Expression Reporter Human Cell Lines, and Their Feasibility for High-Throughput Screening of IL-7-Upregulating Chemicals	PLOS ONE			English	Article							EPITHELIAL-CELLS; DNA METHYLATION; IN-VIVO; INTERLEUKIN-7; BIOLOGY; MICE; RNA; IDENTIFICATION; HOMEOSTASIS; TARGET	Interleukin-7 (IL-7) is a cytokine essential for T cell homeostasis, and is clinically important. However, the regulatory mechanism of IL-7 gene expression is not well known, and a systematic approach to screen chemicals that regulate IL-7 expression has not yet been developed. In this study, we attempted to develop human reporter cell lines using CRISPR/Cas9-mediated genome editing technology. For this purpose, we designed donor DNA that contains an enhanced green fluorescent protein (eGFP) gene, drug selection cassette, and modified homologous arms which are considered to enhance the translation of the eGFP reporter transcript, and also a highly efficient single-guide RNA with a minimal off-target effect to target the IL-7 start codon region. By applying this system, we established IL-7 eGFP reporter cell lines that could report IL-7 gene transcription based on the eGFP protein signal. Furthermore, we utilized the cells to run a pilot screen campaign for IL-7-upregulating chemicals in a high-throughput format, and identified a chemical that can up-regulate IL-7 gene transcription. Collectively, these results suggest that our IL-7 reporter system can be utilized in large-scale chemical library screening to reveal novel IL-7 regulatory pathways and to identify potential drugs for development of new treatments in immunodeficiency disease.	[Cho, Yeon Sook; Kim, Byung Soo; Sim, Chan Kyu; Lee, Myeong Sup] Univ Ulsan, Coll Med, Asan Med Ctr, Lab Mol Immunol & Med MoIM,Dept Biomed Sci, Seoul 05505, South Korea; [Kim, Inki] Univ Ulsan, Coll Med, Asan Inst Life Sci, Dept Convergence Med, Seoul 05505, South Korea	University of Ulsan; University of Ulsan	Lee, MS (corresponding author), Univ Ulsan, Coll Med, Asan Med Ctr, Lab Mol Immunol & Med MoIM,Dept Biomed Sci, Seoul 05505, South Korea.	myeong@amc.seoul.kr			Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare [HI14C2449]	Korea Health Technology R&D Project through the Korea Health Industry Development Institute - Ministry of Health and Welfare	This study was supported by the Korea Health Technology R&D Project through the Korea Health Industry Development Institute, funded by the Ministry of Health and Welfare [granted to MSL; grant number HI14C2449]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arslan AD, 2013, J BIOMOL SCREEN, V18, P180, DOI 10.1177/1087057112459901; Baker M, 2014, NAT BIOTECHNOL, V32, P309, DOI 10.1038/nbt.2863; Baylin Stephen B, 2005, Nat Clin Pract Oncol, V2 Suppl 1, pS4, DOI 10.1038/ncponc0354; Calvo SE, 2009, P NATL ACAD SCI USA, V106, P7507, DOI 10.1073/pnas.0810916106; Carrette F, 2012, SEMIN IMMUNOL, V24, P209, DOI 10.1016/j.smim.2012.04.010; Ceredig R, 2012, SEMIN IMMUNOL, V24, P159, DOI 10.1016/j.smim.2012.02.004; Christman JK, 2002, ONCOGENE, V21, P5483, DOI 10.1038/sj.onc.1205699; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Dansithong W, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136930; Gao JB, 2015, INT J MOL SCI, V16, P10267, DOI 10.3390/ijms160510267; Hara T, 2012, J IMMUNOL, V189, P1577, DOI 10.4049/jimmunol.1200586; Hasson SA, 2015, ACS CHEM BIOL, V10, P1188, DOI 10.1021/cb5010417; Hollenbach PW, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009001; Hrabeta J, 2015, INT J ONCOL, V47, P971, DOI 10.3892/ijo.2015.3066; Hsu PD, 2014, CELL, V157, P1262, DOI 10.1016/j.cell.2014.05.010; Iolyeva M, 2013, BLOOD, V122, P2271, DOI 10.1182/blood-2013-01-478073; Kim Grace Yoonhee, 2011, Immune Netw, V11, P1, DOI 10.4110/in.2011.11.1.1; Kim JY, 2011, TOXICOLOGY, V289, P91, DOI 10.1016/j.tox.2011.07.014; Mackall CL, 2011, NAT REV IMMUNOL, V11, P330, DOI 10.1038/nri2970; Mali P, 2013, NAT METHODS, V10, P957, DOI [10.1038/NMETH.2649, 10.1038/nmeth.2649]; Mali P, 2013, SCIENCE, V339, P823, DOI 10.1126/science.1232033; Mazzucchelli R, 2007, NAT REV IMMUNOL, V7, P144, DOI 10.1038/nri2023; Mazzucchelli RI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007637; McCamish M, 2011, MABS-AUSTIN, V3, P209, DOI 10.4161/mabs.3.2.15005; McGough JM, 2008, MOL CANCER RES, V6, P1841, DOI 10.1158/1541-7786.MCR-08-0280; Miller CN, 2013, INT IMMUNOL, V25, P471, DOI 10.1093/intimm/dxt012; Morre M, 2012, TARGET ONCOL, V7, P55, DOI 10.1007/s11523-012-0210-4; Naito Y, 2015, BIOINFORMATICS, V31, P1120, DOI 10.1093/bioinformatics/btu743; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Onder L, 2012, BLOOD, V120, P4675, DOI 10.1182/blood-2012-03-416859; Oshima S, 2004, MOL CELL BIOL, V24, P6298, DOI 10.1128/MCB.24.14.6298-6310.2004; Pellegrini M, 2011, CELL, V144, P601, DOI 10.1016/j.cell.2011.01.011; Petrilli AM, 2014, AM J TRANSL RES, V6, P471; Ribeiro AR, 2013, J IMMUNOL, V191, P1200, DOI 10.4049/jimmunol.1203042; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Sekai M, 2013, MOL IMMUNOL, V54, P378, DOI 10.1016/j.molimm.2013.01.002; Shalapour S, 2010, EUR J IMMUNOL, V40, P2391, DOI 10.1002/eji.201040441; Sim CK, 2016, CANCER IMMUNOL IMMUN, V65, P663, DOI 10.1007/s00262-016-1830-9; Song H, 2007, INT J IMMUNOGENET, V34, P107, DOI 10.1111/j.1744-313X.2007.00658.x; Stiborova M, 2011, BBA-PROTEINS PROTEOM, V1814, P175, DOI 10.1016/j.bbapap.2010.05.016; Wang XQ, 2004, NUCLEIC ACIDS RES, V32, P1382, DOI 10.1093/nar/gkh305; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	42	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161899	10.1371/journal.pone.0161899	http://dx.doi.org/10.1371/journal.pone.0161899			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589392	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800023
J	Huh, CW; Youn, YH; Jung, DH; Park, JJ; Kim, JH; Park, H				Huh, Cheal Wung; Youn, Young Hoon; Jung, Da Hyun; Park, Jae Jun; Kim, Jie-Hyun; Park, Hyojin			Early Attempts to Eradicate Helicobacter pylori after Endoscopic Resection of Gastric Neoplasm Significantly Improve Eradication Success Rates	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; TRIPLE THERAPY; ANTIMICROBIAL RESISTANCE; SUBMUCOSAL DISSECTION; REVISED EDITION; PATIENT FACTORS; CANCER; ULCER; INFECTION; OMEPRAZOLE	Purpose After endoscopic resection (ER) of gastric tumors, eradication of Helicobacter pylori (H. pylori) infection is advised to reduce metachronous recurrence. Optimal timing of such therapy (yet to be established) was investigated herein, examining early active and late scarring stages of post-ER iatrogenic ulcers. Materials and Methods Analysis included 514 patients who received proton-pump inhibitor (PPI)-based triple therapy for H. pylori eradication after ER for gastric neoplasms between January 2008 and June 2015. Clinicopathologic characteristics, particularly the timing of triple therapy, were used to compare eradication rates, assigning patients to early-(<= 2 weeks), intermediate( 2-8 weeks), and late-phase (>= 8 weeks) treatment groups. Results H. pylori eradication rates differed significantly by timing of triple therapy after ER (early, 90.0%; intermediate, 76.2%, late, 72.4%; p < .001). However, eradication success rates were not significantly affected by age, smoking, alcohol consumption, preexisting comorbidity, method of ER, size and location of iatrogenic ulcer, and duration of therapeutic regimen. Early initiation of H. pylori eradication was also identified as a significant independent predictor of eradication success in multivariate analysis (Odds ratio = 3.67, 95% CI 2.18-6.16; p < .001). Conclusion In patients undergoing ER of gastric tumors, early post-ER attempts at eradication of H. pylori offer the best chance of eradication success.	[Huh, Cheal Wung; Youn, Young Hoon; Jung, Da Hyun; Park, Jae Jun; Kim, Jie-Hyun; Park, Hyojin] Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea	Yonsei University; Yonsei University Health System	Youn, YH (corresponding author), Yonsei Univ, Coll Med, Gangnam Severance Hosp, Dept Internal Med, Seoul, South Korea.	dryoun@yuhs.ac	Kim, Jie-Hyun/Q-9061-2019	Kim, Jie-Hyun/0000-0002-9198-3326; Huh, Cheal Wung/0000-0001-7327-8503; Youn, Young Hoon/0000-0002-0071-229X; park, hyojin/0000-0003-4814-8330; Jung, Da Hyun/0000-0001-6668-3113				Asaka M, 2010, HELICOBACTER, V15, P1, DOI 10.1111/j.1523-5378.2009.00738.x; BLAIR AJ, 1987, J CLIN INVEST, V79, P582, DOI 10.1172/JCI112850; Cheon JH, 2008, HELICOBACTER, V13, P564, DOI 10.1111/j.1523-5378.2008.00647.x; Choi J, 2014, CLIN GASTROENTEROL H, V12, P793, DOI 10.1016/j.cgh.2013.09.057; Choi KS, 2011, GASTROINTEST ENDOSC, V73, P942, DOI 10.1016/j.gie.2010.12.032; CUTLER AF, 1993, AM J GASTROENTEROL, V88, P505; Fock KM, 2009, J GASTROEN HEPATOL, V24, P1587, DOI 10.1111/j.1440-1746.2009.05982.x; Fukase K, 2008, LANCET, V372, P392, DOI 10.1016/S0140-6736(08)61159-9; Gerrits MM, 2006, LANCET INFECT DIS, V6, P699, DOI 10.1016/S1473-3099(06)70627-2; Gisbert JP, 2001, EUR J GASTROEN HEPAT, V13, P1303, DOI 10.1097/00042737-200111000-00007; GRAHAM DY, 1992, GASTROENTEROLOGY, V102, P493, DOI 10.1016/0016-5085(92)90095-G; Jung DH, 2015, ENDOSCOPY, V47, P1119, DOI 10.1055/s-0034-1392537; Jung DH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124725; Kakushima N, 2004, GASTROINTEST ENDOSC, V59, pAB90; Kakushima N, 2006, J GASTROEN HEPATOL, V21, P1586, DOI 10.1111/j.1440-1746.2006.04321.x; Kato M, 2013, GUT, V62, P1425, DOI 10.1136/gutjnl-2011-301647; Kim SG, 2014, J GASTROEN HEPATOL, V29, P1371, DOI 10.1111/jgh.12607; Kim SG, 2011, J GASTRIC CANCER, V11, P146, DOI 10.5230/jgc.2011.11.3.146; LABENZ J, 1994, SCAND J GASTROENTERO, V29, P1070, DOI 10.3109/00365529409094890; Lee JY, 2014, DIGEST DIS SCI, V59, P1235, DOI 10.1007/s10620-014-3093-7; Lee JW, 2013, HELICOBACTER, V18, P206, DOI 10.1111/hel.12031; Lee SH, 2012, DIGEST DIS SCI, V57, P429, DOI 10.1007/s10620-011-1941-2; Leung WK, 2004, GUT, V53, P1244, DOI 10.1136/gut.2003.034629; Ma JL, 2012, J NATL CANCER I, V104, P488, DOI 10.1093/jnci/djs003; Maehata Y, 2012, GASTROINTEST ENDOSC, V75, P39, DOI 10.1016/j.gie.2011.08.030; Malfertheiner P, 1999, ALIMENT PHARM THERAP, V13, P703, DOI 10.1046/j.1365-2036.1999.00535.x; Moayyedi P, 1997, J GASTROENTEROL, V32, P24, DOI 10.1007/BF01213292; SAKITA T, 1971, GASTROENTEROLOGY, V60, P835; Seo SI, 2015, HELICOBACTER, V20, P424, DOI 10.1111/hel.12221; Shin WG, 2016, HELICOBACTER, V21, P266, DOI 10.1111/hel.12279; Uemura N, 1997, CANCER EPIDEM BIOMAR, V6, P639; Wong BCY, 2004, JAMA-J AM MED ASSOC, V291, P187, DOI 10.1001/jama.291.2.187; Yazbek PB, 2015, DIGEST DIS SCI, V60, P2901, DOI 10.1007/s10620-015-3712-y; Yuan YH, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008337.pub2	34	6	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162258	10.1371/journal.pone.0162258	http://dx.doi.org/10.1371/journal.pone.0162258			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588679	Green Submitted, gold, Green Published			2022-12-26	WOS:000382877800044
J	Juszczak, GR; Miller, M				Juszczak, Grzegorz R.; Miller, Michal			Detour Behavior of Mice Trained with Transparent, Semitransparent and Opaque Barriers	PLOS ONE			English	Article							STRESS-INDUCED ANALGESIA; OBJECT RETRIEVAL; COGNITIVE DEFICITS; EXECUTIVE FUNCTION; RECEPTOR AGONIST; RHESUS-MONKEYS; MOTOR DEFICITS; REACHING TASK; PERFORMANCE; PHENCYCLIDINE	Detour tasks are commonly used to study problem solving skills and inhibitory control in canids and primates. However, there is no comparable detour test designed for rodents despite its significance for studying the development of executive skills. Furthermore, mice offer research opportunities that are not currently possible to achieve when primates are used. Therefore, the aim of the study was to translate the classic detour task to mice and to compare obtained data with key findings obtained previously in other mammals. The experiment was performed with V-shaped barriers and was based on the water escape paradigm. The study showed that an apparently simple task requiring mice to move around a small barrier constituted in fact a challenge that was strongly affected by the visibility of the target. The most difficult task involved a completely transparent barrier, which forced the mice to resolve a conflict between vision and tactile perception. The performance depended both on the inhibitory skills and on previous experiences. Additionally, all mice displayed a preference for one side of the barrier and most of them relied on the egocentric strategy. Obtained results show for the first time that the behavior of mice subjected to the detour task is comparable to the behavior of other mammals tested previously with free-standing barriers. This detailed characterization of the detour behavior of mice constitutes the first step toward the substitution of rodents for primates in laboratory experiments employing the detour task.	[Juszczak, Grzegorz R.; Miller, Michal] Inst Genet & Anim Breeding, Dept Anim Behav, Jastrzebiec, Poland	Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences	Juszczak, GR (corresponding author), Inst Genet & Anim Breeding, Dept Anim Behav, Jastrzebiec, Poland.	g.juszczak@ighz.pl	Juszczak, Grzegorz R/A-1339-2008	Miller, Michal/0000-0001-7445-8100; Juszczak, Grzegorz/0000-0002-0976-6905	S.VI.2 intramural grant, Institute of Genetics and Animal Breeding	S.VI.2 intramural grant, Institute of Genetics and Animal Breeding	This work was supported by an S.VI.2 intramural grant, Institute of Genetics and Animal Breeding, http://www.ighz.edu.pl/(GRJ). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvernhe A, 2008, J NEUROSCI, V28, P7324, DOI 10.1523/JNEUROSCI.1909-08.2008; Berthouex P. M., 2002, STAT ENV ENG; Cannon CE, 2013, NEUROPHARMACOLOGY, V64, P191, DOI 10.1016/j.neuropharm.2012.05.003; CHAPUIS N, 1987, ANIM LEARN BEHAV, V15, P174, DOI 10.3758/BF03204960; CHAPUIS N, 1983, Q J EXP PSYCHOL-B, V35, P213, DOI 10.1080/14640748308400906; CHAPUIS N, 1987, Q J EXP PSYCHOL-B, V39, P49; Chapuis N, 1987, COGNITIVE PROCESS, P97, DOI DOI 10.1007/978-94-009-3531-0_7; Dettmer AM, 2015, DEV PSYCHOBIOL, V57, P349, DOI 10.1002/dev.21285; DIAMOND A, 1990, ANN NY ACAD SCI, V608, P637, DOI 10.1111/j.1749-6632.1990.tb48913.x; Edgin JO, 2008, J INT NEUROPSYCH SOC, V14, P90, DOI 10.1017/S1355617708080053; Elsworth JD, 2012, NEUROPHARMACOLOGY, V62, P1442, DOI 10.1016/j.neuropharm.2011.08.026; Ersche KD, 2011, BIOL PSYCHIAT, V70, P754, DOI 10.1016/j.biopsych.2011.06.033; Etienne AS, 1998, NATURE, V396, P161, DOI 10.1038/24151; FRANK H, 1982, ANIM BEHAV, V30, P95, DOI 10.1016/S0003-3472(82)80241-8; Gray RA, 2006, AIDS RES HUM RETROV, V22, P1031, DOI 10.1089/aid.2006.22.1031; Grieves RM, 2013, LEARN MOTIV, V44, P81, DOI 10.1016/j.lmot.2012.08.001; HUGHES C, 1993, DEV PSYCHOL, V29, P498, DOI 10.1037/0012-1649.29.3.498; Igloi K, 2009, HIPPOCAMPUS, V19, P1199, DOI 10.1002/hipo.20595; Jentsch JD, 1999, PSYCHOPHARMACOLOGY, V142, P78, DOI 10.1007/s002130050865; Jentsch JD, 1997, SCIENCE, V277, P953, DOI 10.1126/science.277.5328.953; Jentsch JD, 1999, NEUROSCIENCE, V90, P823, DOI 10.1016/S0306-4522(98)00481-3; Jentsch JD, 2000, BIOL PSYCHIAT, V48, P415, DOI 10.1016/S0006-3223(00)00926-4; Jovalekic A, 2011, BEHAV BRAIN RES, V222, P279, DOI 10.1016/j.bbr.2011.02.035; Juszczak GR, 2008, PHYSIOL BEHAV, V95, P400, DOI 10.1016/j.physbeh.2008.07.003; Kohler W., 1925, MENTALITY APES; LOCKMAN JJ, 1984, CHILD DEV, V55, P482; Lockman JJ, 1987, COGNITIVE PROCESS, P250; Mogil JS, 1996, P NATL ACAD SCI USA, V93, P3048, DOI 10.1073/pnas.93.7.3048; Murai T, 2014, BEHAV BRAIN RES, V261, P26, DOI 10.1016/j.bbr.2013.11.036; Murai T, 2013, BEHAV BRAIN RES, V246, P125, DOI 10.1016/j.bbr.2013.02.019; Nakazawa S, 2015, PSYCHOPHARMACOLOGY B; Noldus LPJJ, 2001, BEHAV RES METH INS C, V33, P398, DOI 10.3758/BF03195394; Osthaus B, 2010, ANIM COGN, V13, P881, DOI 10.1007/s10071-010-0331-z; PANOCKA I, 1986, BRAIN RES, V397, P156, DOI 10.1016/0006-8993(86)91380-6; Pongracz P, 2001, ANIM BEHAV, V62, P1109, DOI 10.1006/anbe.2001.1866; POUCET B, 1983, ANIM BEHAV, V31, P594, DOI 10.1016/S0003-3472(83)80083-9; Pryce CR, 2004, ANN NY ACAD SCI, V1032, P245, DOI 10.1196/annals.1314.030; RESTLE F, 1957, PSYCHOL REV, V64, P217, DOI 10.1037/h0040678; Richter SH, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00154; Roberts WA, 2007, J EXP PSYCHOL-ANIM B, V33, P79, DOI 10.1037/0097-7403.33.2.79; Roitberg BZ, 2002, NEUROSURGERY, V50, P137, DOI 10.1097/00006123-200201000-00022; Santos LR, 1999, J COMP PSYCHOL, V113, P186; Smith BP, 2010, ANIM BEHAV, V80, P155, DOI 10.1016/j.anbehav.2010.04.017; Smith SM, 2013, NEUROPHARMACOLOGY, V64, P215, DOI 10.1016/j.neuropharm.2012.06.013; Spiers HJ, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00125; Tavor I, 2016, SCIENCE, V352, P216, DOI 10.1126/science.aad8127; TAYLOR JR, 1990, BEHAV NEUROSCI, V104, P564, DOI 10.1037/0735-7044.104.4.564; TAYLOR JR, 1990, BRAIN, V113, P617, DOI 10.1093/brain/113.3.617; Tunur T, 2010, LEARN MEMORY, V17, P328, DOI 10.1101/lm.1818410; Uslaner JM, 2013, PSYCHOPHARMACOLOGY, V225, P21, DOI 10.1007/s00213-012-2788-8; van Meer PJK, 2015, EUR J PHARMACOL, V759, P3, DOI 10.1016/j.ejphar.2015.02.055; Vlamings PHJM, 2010, ANIM COGN, V13, P273, DOI 10.1007/s10071-009-0265-5; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Vorhees CV, 2014, ILAR J, V55, P310, DOI 10.1093/ilar/ilu013; Walker SC, 2006, EUR J NEUROSCI, V23, P3119, DOI 10.1111/j.1460-9568.2006.04826.x; Wallis JD, 2001, EUR J NEUROSCI, V13, P1797, DOI 10.1046/j.0953-816x.2001.01546.x; Wynne CDL, 2004, BEHAV PROCESS, V67, P281, DOI 10.1016/j.beproc.2004.04.007; Zentall TR, 2002, J GEN PSYCHOL, V129, P328, DOI 10.1080/00221300209602102; Zentall TR, 2001, BEHAV PROCESS, V54, P65, DOI 10.1016/S0376-6357(01)00150-4; Zucca P, 2005, ANIM COGN, V8, P122, DOI 10.1007/s10071-004-0243-x	60	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162018	10.1371/journal.pone.0162018	http://dx.doi.org/10.1371/journal.pone.0162018			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588753	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800027
J	Pietan, LL; Spradling, TA; Demastes, JW				Pietan, Lucas L.; Spradling, Theresa A.; Demastes, James W.			The Mitochondrial Cytochrome Oxidase Subunit I Gene Occurs on a Minichromosome with Extensive Heteroplasmy in Two Species of Chewing Lice, Geomydoecus aurei and Thomomydoecus minor	PLOS ONE			English	Article							POCKET GOPHER HOSTS; HUMAN-BODY LOUSE; GENOME; SEQUENCE; DNA; TRICHODECTIDAE; PHTHIRAPTERA; MALLOPHAGA; EVOLUTION; PRIMERS	In animals, mitochondrial DNA (mtDNA) typically occurs as a single circular chromosome with 13 protein-coding genes and 22 tRNA genes. The various species of lice examined previously, however, have shown mitochondrial genome rearrangements with a range of chromosome sizes and numbers. Our research demonstrates that the mitochondrial genomes of two species of chewing lice found on pocket gophers, Geomydoecus aurei and Thomomydoecus minor, are fragmented with the 1,536 base-pair (bp) cytochrome-oxidase subunit I (cox1) gene occurring as the only protein-coding gene on a 1,916-1,964 bp mini-circular chromosome in the two species, respectively. The cox1 gene of T. minor begins with an atypical start codon, while that of G. aurei does not. Components of the non-protein coding sequence of G. aurei and T. minor include a tRNA (isoleucine) gene, inverted repeat sequences consistent with origins of replication, and an additional non-coding region that is smaller than the non-coding sequence of other lice with such fragmented mitochondrial genomes. Sequences of cox1 minichromosome clones for each species reveal extensive length and sequence heteroplasmy in both coding and noncoding regions. The highly variable non-gene regions of G. aurei and T. minor have little sequence similarity with one another except for a 19-bp region of phylogenetically conserved sequence with unknown function.	[Pietan, Lucas L.; Spradling, Theresa A.; Demastes, James W.] Univ Northern Iowa, Dept Biol, Cedar Falls, IA 50614 USA	University of Northern Iowa	Demastes, JW (corresponding author), Univ Northern Iowa, Dept Biol, Cedar Falls, IA 50614 USA.	Jim.Demastes@uni.edu			National Science Foundation [DEB 1445708]; Dr. Dave Swanson Genetics Research Award; Division Of Environmental Biology [1445708] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Dr. Dave Swanson Genetics Research Award; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This project was funded by National Science Foundation award DEB 1445708 to JWD, TAS. LLP received research support via The Dr. Dave Swanson Genetics Research Award. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aphasizhev R, 2014, BIOCHIMIE, V100, P125, DOI 10.1016/j.biochi.2014.01.003; AVISE JC, 1987, ANNU REV ECOL SYST, V18, P489, DOI 10.1146/annurev.es.18.110187.002421; BARNES WM, 1992, GENE, V112, P29, DOI 10.1016/0378-1119(92)90299-5; Bernt M, 2013, MOL PHYLOGENET EVOL, V69, P313, DOI 10.1016/j.ympev.2012.08.023; Cameron SL, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-394; Demastes JW, 2012, J PARASITOL, V98, P262, DOI 10.1645/GE-2904.1; Dong WG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-751; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EMERSON K C, 1981, Miscellaneous Publications of the Entomological Society of America, V12, P1; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FOX TD, 1987, ANNU REV GENET, V21, P67, DOI 10.1146/annurev.ge.21.120187.000435; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gissi C, 2008, HEREDITY, V101, P301, DOI 10.1038/hdy.2008.62; HAFNER MS, 1994, SCIENCE, V265, P1087, DOI 10.1126/science.8066445; HELLENTHAL RA, 1984, J MED ENTOMOL, V21, P432, DOI 10.1093/jmedent/21.4.432; Herd K., 2012, The Open Genomics Journal, V5, P14, DOI 10.2174/1875693X01205010014; Johansson ML, 2012, MOL BIOL REP, V39, P9009, DOI 10.1007/s11033-012-1772-z; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kirkness EF, 2010, P NATL ACAD SCI USA, V107, P12168, DOI 10.1073/pnas.1003379107; Krzywinski J, 2006, MOL PHYLOGENET EVOL, V39, P417, DOI 10.1016/j.ympev.2006.01.006; Lin MT, 2002, HUM MOL GENET, V11, P133, DOI 10.1093/hmg/11.2.133; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lundberg KS, 1991, GENE, P108; Lunt DH, 1996, INSECT MOL BIOL, V5, P153, DOI 10.1111/j.1365-2583.1996.tb00049.x; Lyal C.H.C., 1985, Bulletin of the British Museum (Natural History) Entomology, V51, P187; NADLER SA, 1989, ANN ENTOMOL SOC AM, V82, P109, DOI 10.1093/aesa/82.1.109; PAGE RDM, 1995, SYST ENTOMOL, V20, P129, DOI 10.1111/j.1365-3113.1995.tb00087.x; Price R.D., 2003, ILL NAT HIS SURV SPE; Ramesh A, 2012, MOL BIOCHEM PARASIT, V183, P32, DOI 10.1016/j.molbiopara.2012.01.004; Reed DL, 2000, J PARASITOL, V86, P951, DOI 10.1645/0022-3395(2000)086[0951:SPOHHB]2.0.CO;2; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Shao R, 2015, SCI REP, P5; Shao RF, 2009, GENOME RES, V19, P904, DOI 10.1101/gr.083188.108; Wei DD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033973; Wong RG, 2015, MITOCHONDRION, V25, P76, DOI 10.1016/j.mito.2015.10.006; Xiong HY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073329; Yukuhiro K, 2002, MOL BIOL EVOL, V19, P1385, DOI 10.1093/oxfordjournals.molbev.a004200; Zink RM, 2008, MOL ECOL, V17, P2107, DOI 10.1111/j.1365-294X.2008.03737.x	38	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162248	10.1371/journal.pone.0162248	http://dx.doi.org/10.1371/journal.pone.0162248			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589589	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800042
J	Song, DL; Xi, XY; Huang, SM; Liang, GQ; Sun, JW; Zhou, W; Wang, XB				Song, Dali; Xi, Xiangyin; Huang, Shaomin; Liang, Guoqing; Sun, Jingwen; Zhou, Wei; Wang, Xiubin			Short-Term Responses of Soil Respiration and C-Cycle Enzyme Activities to Additions of Biochar and Urea in a Calcareous Soil	PLOS ONE			English	Article							SANDY LOAM SOIL; CARBON MINERALIZATION; NITROGEN-FERTILIZATION; AGRONOMIC PERFORMANCE; PLANT PRODUCTIVITY; ORGANIC-CARBON; WATER; DECOMPOSITION; DYNAMICS; LITTER	Biochar (BC) addition to soil is a proposed strategy to enhance soil fertility and crop productivity. However, there is limited knowledge regarding responses of soil respiration and C-cycle enzyme activities to BC and nitrogen (N) additions in a calcareous soil. A 56-day incubation experiment was conducted to investigate the combined effects of BC addition rates (0, 0.5, 1.0, 2.5 and 5.0% by mass) and urea (U) application on soil nutrients, soil respiration and C-cycle enzyme activities in a calcareous soil in the North China Plain. Our results showed soil pH values in both U-only and U plus BC treatments significantly decreased within the first 14 days and then stabilized, and CO(2)emission rate in all U plus BC soils decreased exponentially, while there was no significant difference in the contents of soil total organic carbon (TOC), dissolved organic carbon (DOC), total nitrogen (TN), and C/N ratio in each treatment over time. At each incubation time, soil pH, electrical conductivity (EC), TOC, TN, C/N ratio, DOC and cumulative CO2 emission significantly increased with increasing BC addition rate, while soil potential activities of the four hydrolytic enzymes increased first and then decreased with increasing BC addition rate, with the largest values in the U + 1.0% BC treatment. However, phenol oxidase activity in all U plus BC soils showed a decreasing trend with the increase of BC addition rate. Our results suggest that U plus BC application at a rate of 1% promotes increases in hydrolytic enzymes, does not highly increase C/N and C mineralization, and can improve in soil fertility.	[Song, Dali; Liang, Guoqing; Sun, Jingwen; Zhou, Wei; Wang, Xiubin] Chinese Acad Agr Sci, Inst Agr Resource & Reg Planning, Minist Agr, Key Lab Plant Nutr & Nutrient Cycling, Beijing 100081, Peoples R China; [Song, Dali; Xi, Xiangyin] Southwest Univ, Chongqing 400715, Peoples R China; [Huang, Shaomin] Henan Acad Agr Sci, Inst Plant Nutrient & Environm Resources, Zhengzhou 450002, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Agricultural Resources & Regional Planning, CAAS; Ministry of Agriculture & Rural Affairs; Southwest University - China; Henan Academy of Agricultural Sciences	Wang, XB (corresponding author), Chinese Acad Agr Sci, Inst Agr Resource & Reg Planning, Minist Agr, Key Lab Plant Nutr & Nutrient Cycling, Beijing 100081, Peoples R China.	wangxiubin@caas.cn			National Natural Science Foundation of China [31372135]; National Basic Research Program of China [2013CB127405]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work has been funded by the National Natural Science Foundation of China (No. 31372135) and the National Basic Research Program of China (2013CB127405) (website: http://www.973.gov.cn/AreaAppl.aspx). The funders had a role in study design, data collection and analysis, decision to publish.	Ai C, 2015, BIOL FERT SOILS, V51, P465, DOI 10.1007/s00374-015-0994-3; Bailey VL, 2011, SOIL BIOL BIOCHEM, V43, P296, DOI 10.1016/j.soilbio.2010.10.014; Bandick AK, 1999, SOIL BIOL BIOCHEM, V31, P1471, DOI 10.1016/S0038-0717(99)00051-6; Beesley L, 2011, SOIL BIOL BIOCHEM, V43, P188, DOI 10.1016/j.soilbio.2010.09.035; Biederman LA, 2013, GCB BIOENERGY, V5, P202, DOI 10.1111/gcbb.12037; Bruun EW, 2012, SOIL BIOL BIOCHEM, V46, P73, DOI 10.1016/j.soilbio.2011.11.019; Bruun EW, 2011, BIOMASS BIOENERG, V35, P1182, DOI 10.1016/j.biombioe.2010.12.008; Bruun S, 2014, EUR J SOIL SCI, V65, P52, DOI 10.1111/ejss.12073; Burns RG, 2013, SOIL BIOL BIOCHEM, V58, P216, DOI 10.1016/j.soilbio.2012.11.009; Cely P, 2014, SOLID EARTH, V5, P585, DOI 10.5194/se-5-585-2014; Cheng CH, 2008, GEOCHIM COSMOCHIM AC, V72, P1598, DOI 10.1016/j.gca.2008.01.010; Cross A, 2011, SOIL BIOL BIOCHEM, V43, P2127, DOI 10.1016/j.soilbio.2011.06.016; Cullen D., 1996, Biochemistry and molecular biology III., P295; Cusack DF, 2011, ECOLOGY, V92, P621, DOI 10.1890/10-0459.1; Czimczik CI, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002798; Dai ZM, 2013, J SOIL SEDIMENT, V13, P989, DOI 10.1007/s11368-013-0698-y; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Ding WX, 2010, GEODERMA, V155, P381, DOI 10.1016/j.geoderma.2009.12.023; El-Mahrouky M, 2015, PEDOSPHERE, V25, P46, DOI 10.1016/S1002-0160(14)60075-8; El-Naggar AH, 2015, CHEMOSPHERE, V138, P67, DOI 10.1016/j.chemosphere.2015.05.052; Fan FL, 2012, SOIL BIOL BIOCHEM, V55, P70, DOI 10.1016/j.soilbio.2012.06.008; Fang YY, 2015, SOIL BIOL BIOCHEM, V80, P136, DOI 10.1016/j.soilbio.2014.10.006; Garland JL, 2010, APPL SOIL ECOL, V44, P262, DOI 10.1016/j.apsoil.2010.01.003; Ge GF, 2010, PLANT SOIL, V326, P31, DOI 10.1007/s11104-009-0186-8; Grandy AS, 2008, SCI TOTAL ENVIRON, V404, P297, DOI 10.1016/j.scitotenv.2007.11.013; Helfrich M, 2008, SOIL BIOL BIOCHEM, V40, P1823, DOI 10.1016/j.soilbio.2008.03.006; IBI, 2012, STANDARDIZED PRODUCT; Jones DL, 2012, SOIL BIOL BIOCHEM, V45, P113, DOI 10.1016/j.soilbio.2011.10.012; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Keith A, 2015, SOIL BIOL BIOCHEM, V88, P372, DOI 10.1016/j.soilbio.2015.06.007; Kindler R, 2011, GLOBAL CHANGE BIOL, V17, P1167, DOI 10.1111/j.1365-2486.2010.02282.x; Kuzyakov Y, 2014, SOIL BIOL BIOCHEM, V70, P229, DOI 10.1016/j.soilbio.2013.12.021; Laird DA, 2010, GEODERMA, V158, P443, DOI 10.1016/j.geoderma.2010.05.013; Lammirato C, 2011, SOIL BIOL BIOCHEM, V43, P1936, DOI 10.1016/j.soilbio.2011.05.021; Lee KH, 2003, FOREST ECOL MANAG, V185, P263, DOI 10.1016/S0378-1127(03)00164-6; Lehmann J, 2011, SOIL BIOL BIOCHEM, V43, P1812, DOI 10.1016/j.soilbio.2011.04.022; Lesturgez G, 2006, AGR ECOSYST ENVIRON, V114, P239, DOI 10.1016/j.agee.2005.10.020; Lin Y, 2012, CHEMOSPHERE, V87, P151, DOI 10.1016/j.chemosphere.2011.12.007; Lu WW, 2014, SOIL BIOL BIOCHEM, V76, P12, DOI 10.1016/j.soilbio.2014.04.029; Masto RE, 2013, ECOL ENG, V58, P314, DOI 10.1016/j.ecoleng.2013.07.011; McBeath AV, 2009, ORG GEOCHEM, V40, P1161, DOI 10.1016/j.orggeochem.2009.09.006; Mukherjee A, 2014, SCI TOTAL ENVIRON, V487, P26, DOI 10.1016/j.scitotenv.2014.03.141; Nguyen BT, 2009, ORG GEOCHEM, V40, P846, DOI 10.1016/j.orggeochem.2009.05.004; Ni K, 2012, J SOIL SEDIMENT, V12, P1007, DOI 10.1007/s11368-012-0529-6; Ouyang L, 2014, SOIL RES, V52, P46, DOI 10.1071/SR13186; Paz-Ferreiro J, 2014, J SOIL SEDIMENT, V14, P483, DOI 10.1007/s11368-013-0806-z; Piotrowska A, 2012, GEODERMA, V189, P72, DOI 10.1016/j.geoderma.2012.04.018; Prayogo C, 2014, BIOL FERT SOILS, V50, P695, DOI 10.1007/s00374-013-0884-5; Sinsabaugh RL, 2010, SOIL BIOL BIOCHEM, V42, P391, DOI 10.1016/j.soilbio.2009.10.014; Smider B, 2014, AGR ECOSYST ENVIRON, V191, P99, DOI 10.1016/j.agee.2014.01.024; Song YY, 2014, EUR J SOIL BIOL, V61, P72, DOI 10.1016/j.ejsobi.2014.02.001; Spokas KA, 2011, CHEMOSPHERE, V85, P869, DOI 10.1016/j.chemosphere.2011.06.108; Steiner C, 2007, PLANT SOIL, V291, P275, DOI 10.1007/s11104-007-9193-9; Sui YH, 2016, SCI TOTAL ENVIRON, V544, P203, DOI 10.1016/j.scitotenv.2015.11.079; Tammeorg P, 2014, AGR ECOSYST ENVIRON, V191, P108, DOI 10.1016/j.agee.2014.01.007; Tejada M, 2006, SOIL BIOL BIOCHEM, V38, P1413, DOI 10.1016/j.soilbio.2005.10.017; Van Zwieten L, 2010, PLANT SOIL, V327, P235, DOI 10.1007/s11104-009-0050-x; Wang JY, 2012, CATENA, V96, P83, DOI 10.1016/j.catena.2012.03.009; Wang RZ, 2015, SOIL BIOL BIOCHEM, V81, P159, DOI 10.1016/j.soilbio.2014.11.015; Wang XB, 2015, APPL SOIL ECOL, V96, P265, DOI 10.1016/j.apsoil.2015.08.018; Zhang AF, 2012, PLANT SOIL, V351, P263, DOI 10.1007/s11104-011-0957-x; Zhou XB, 2012, SOIL BIOL BIOCHEM, V47, P67, DOI 10.1016/j.soilbio.2011.05.012; Zibilske LM, 2007, SOIL SCI SOC AM J, V71, P133, DOI 10.2136/sssaj2006.0167; Zimmerman AR, 2011, SOIL BIOL BIOCHEM, V43, P1169, DOI 10.1016/j.soilbio.2011.02.005	64	11	15	11	82	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161694	10.1371/journal.pone.0161694	http://dx.doi.org/10.1371/journal.pone.0161694			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589265	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800013
J	Dickens, JA; Ordonez, A; Chambers, JE; Beckett, AJ; Patel, V; Malzer, E; Dominicus, CS; Bradley, J; Peden, AA; Prior, IA; Lomas, DA; Marciniak, SJ				Dickens, Jennifer A.; Ordonez, Adriana; Chambers, Joseph E.; Beckett, Alison J.; Patel, Vruti; Malzer, Elke; Dominicus, Caia S.; Bradley, Jayson; Peden, Andrew A.; Prior, Ian A.; Lomas, David A.; Marciniak, Stefan J.			The endoplasmic reticulum remains functionally connected by vesicular transport after its fragmentation in cells expressing Z-alpha(1)-antitrypsin	FASEB JOURNAL			English	Article						ER stress; homotypic fusion; serpin; SNARE	UNFOLDED PROTEIN RESPONSE; NF-KAPPA-B; ALPHA(1)-ANTITRYPSIN DEFICIENCY; MAMMALIAN-CELLS; RUSSELL BODIES; ER; ALPHA-1-ANTITRYPSIN; ACCUMULATION; POLYMERS; FUSION	alpha(1)-Antitrypsin is a serine protease inhibitor produced in the liver that is responsible for the regulation of pulmonary inflammation. The commonest pathogenic genemutation yields Z-alpha(1)-antitrypsin, which has a propensity to self-associate forming polymers that become trapped in inclusions of endoplasmic reticulum (ER). It is unclear whether these inclusions are connected to the main ER network in Z-alpha(1)-antitrypsin-expressing cells. Using live cell imaging, we found that despite inclusions containing an immobile matrix of polymeric alpha(1)-antitrypsin, small ER resident proteins can diffuse freely within them. Inclusions have many features to suggest they represent fragmented ER, and some are physically separated from the tubular ER network, yet we observed cargo to be transported between them in a cytosol-dependent fashion that is sensitive to N-ethylmaleimide and dependent on Sar1 and sec22B. We conclude that protein recycling occurs between ER inclusions despite their physical separation.	[Dickens, Jennifer A.; Ordonez, Adriana; Chambers, Joseph E.; Patel, Vruti; Malzer, Elke; Dominicus, Caia S.; Bradley, Jayson; Marciniak, Stefan J.] Cambridge Inst Med Res, Cambridge, England; [Dickens, Jennifer A.; Chambers, Joseph E.; Marciniak, Stefan J.] Univ Cambridge, Dept Med, Cambridge, England; [Beckett, Alison J.; Peden, Andrew A.] Univ Sheffield, Dept Biomed Sci, Sheffield, S Yorkshire, England; [Prior, Ian A.] Univ Liverpool, Inst Translat Med, Liverpool, Merseyside, England; [Lomas, David A.] UCL, UCL Resp, London, England	University of Cambridge; University of Cambridge; University of Sheffield; University of Liverpool; University of London; University College London	Marciniak, SJ (corresponding author), Univ Cambridge, Cambridge Inst Med Res, Wellcome Trust MRC Bldg,Hills Rd, Cambridge CB2 0XY, England.	sjm20@cam.ac.uk	Chambers, Joseph/Z-5212-2019	Chambers, Joseph/0000-0003-4675-0053; Marciniak, Stefan/0000-0001-8472-7183; Peden, Andrew/0000-0003-0144-7712; Prior, Ian/0000-0002-4055-5161	Medical Research Council (MRC) Clinical Research Training Fellowship; Academy of Medical Sciences; MRC; University College London Hospitals National Institute for Health Research (NIHR) Biomedical Research Centre (London, United Kingdom); Alphal Foundation; Wellcome Trust Strategic Award [100140]; Wellcome Trust equipment grant [093026]; Biotechnology and Biological Sciences Research Council [BB/L014416/1, BB/L002841/1] Funding Source: researchfish; Medical Research Council [MR/N024842/1, G1000277, G0901786, G1002610, G0601840] Funding Source: researchfish; National Institute for Health Research [NF-SI-0513-10070] Funding Source: researchfish; BBSRC [BB/L002841/1, BB/L014416/1] Funding Source: UKRI; MRC [G0601840, G1002610, MR/N024842/1, G0901786, G1000277] Funding Source: UKRI	Medical Research Council (MRC) Clinical Research Training Fellowship(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Academy of Medical Sciences(Academy of Medical Sciences (AMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); University College London Hospitals National Institute for Health Research (NIHR) Biomedical Research Centre (London, United Kingdom); Alphal Foundation; Wellcome Trust Strategic Award(Wellcome Trust); Wellcome Trust equipment grant(Wellcome Trust); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	J.A.D. was funded by a Medical Research Council (MRC) Clinical Research Training Fellowship and a starter grant from the Academy of Medical Sciences; S.J.M. is a MRC Senior Clinical Research Fellow. D.A.L. is funded by the MRC and by the University College London Hospitals National Institute for Health Research (NIHR) Biomedical Research Centre (London, United Kingdom), and is an NIHR Senior Investigator. The work was also supported by the Alphal Foundation. The Cambridge Institute for Medical Research microscopy core facility is supported by a Wellcome Trust Strategic Award (100140) and a Wellcome Trust equipment grant (093026).	Anwar K, 2012, J CELL BIOL, V197, P209, DOI 10.1083/jcb.201111115; BARLOWE C, 1993, NATURE, V365, P347, DOI 10.1038/365347a0; Belorgey D, 2011, METHODS, V53, P255, DOI 10.1016/j.ymeth.2010.11.008; BLOCK MR, 1988, P NATL ACAD SCI USA, V85, P7852, DOI 10.1073/pnas.85.21.7852; Breusegem SY, 2014, METHOD ENZYMOL, V534, P155, DOI 10.1016/B978-0-12-397926-1.00009-3; Costantini LM, 2012, TRAFFIC, V13, P643, DOI 10.1111/j.1600-0854.2012.01336.x; Davies MJ, 2009, J BIOL CHEM, V284, P18202, DOI 10.1074/jbc.M109.010744; Dickens JA, 2011, DRUG DES DEV THER, V5, P391, DOI 10.2147/DDDT.S14018; Donaldson JG, 2005, BBA-MOL CELL RES, V1744, P364, DOI 10.1016/j.bbamcr.2005.03.001; Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883; ERIKSSON S, 1986, NEW ENGL J MED, V314, P736, DOI 10.1056/NEJM198603203141202; ERIKSSON S, 1964, ACTA MED SCAND, V175, P197; GLICK BS, 1987, NATURE, V326, P309, DOI 10.1038/326309a0; Gordon DE, 2010, TRAFFIC, V11, P1191, DOI 10.1111/j.1600-0854.2010.01087.x; GRAHAM KS, 1990, J BIOL CHEM, V265, P20463; Granell S, 2008, MOL BIOL CELL, V19, P572, DOI 10.1091/mbc.E07-06-0587; Hay JC, 1997, CELL, V89, P149, DOI 10.1016/S0092-8674(00)80191-9; Hidvegi T, 2005, J BIOL CHEM, V280, P39002, DOI 10.1074/jbc.M508652200; HSU SM, 1982, AM J CLIN PATHOL, V77, P26; Kroeger H, 2009, J BIOL CHEM, V284, P22793, DOI 10.1074/jbc.M109.027102; Kucharz K, 2011, J CEREBR BLOOD F MET, V31, P1663, DOI 10.1038/jcbfm.2011.37; KUGE O, 1994, J CELL BIOL, V125, P51, DOI 10.1083/jcb.125.1.51; Lawless MW, 2004, J IMMUNOL, V172, P5722, DOI 10.4049/jimmunol.172.9.5722; LIEBERMAN J, 1972, SCIENCE, V175, P63, DOI 10.1126/science.175.4017.63; LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W; Lomas DA, 2006, AM J RESP CRIT CARE, V173, P1072, DOI 10.1164/rccm.200511-1797PP; LOMAS DA, 1992, NATURE, V357, P605, DOI 10.1038/357605a0; Malzer E, 2013, J CELL SCI, V126, P1406, DOI 10.1242/jcs.117614; Miranda E, 2010, HEPATOLOGY, V52, P1078, DOI 10.1002/hep.23760; Ordonez A, 2013, HEPATOLOGY, V57, P2049, DOI 10.1002/hep.26173; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Ostrovsky O, 2009, P NATL ACAD SCI USA, V106, P11600, DOI 10.1073/pnas.0902626106; Roussel BD, 2013, HUM MOL GENET, V22, P4616, DOI 10.1093/hmg/ddt310; Schekman R, 1996, SCIENCE, V271, P1526, DOI 10.1126/science.271.5255.1526; Schmidt BZ, 2005, AM J PHYSIOL-GASTR L, V289, pG444, DOI 10.1152/ajpgi.00237.2004; Shim SH, 2012, P NATL ACAD SCI USA, V109, P13978, DOI 10.1073/pnas.1201882109; VALETTI C, 1991, J CELL BIOL, V115, P983, DOI 10.1083/jcb.115.4.983; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045; West JB, 2010, RESP PHYSIOL NEUROBI, V170, P202, DOI 10.1016/j.resp.2009.12.010; Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200	41	18	18	0	11	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4083	4097		10.1096/fj.201600430R	http://dx.doi.org/10.1096/fj.201600430R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601439	Green Accepted, Green Published, hybrid			2022-12-26	WOS:000388201500015
J	Abubakari, A; Jahn, A				Abubakari, Abdulai; Jahn, Albrecht			Maternal Dietary Patterns and Practices and Birth Weight in Northern Ghana	PLOS ONE			English	Article							CHILD UNDERNUTRITION; PREGNANT-WOMEN; MICRONUTRIENTS; ASSOCIATION; ORIGINS; DISEASE; HEALTH	Background Adequate maternal nutrition is a key factor for achieving good pregnancy outcomes. Moreover, inadequate dietary intake during pregnancy is considered an important contributor to maternal malnutrition in developing countries. Although some studies have examined the effect of the entire diet on birth outcome, most studies have been very narrow because they considered the effect of single nutrient. The single nutrient approach is a major setback because usually several nutrient deficiencies are more likely to occur than single deficiencies especially in low-income settings. Objectives The main aim of this study was to investigate the association between maternal dietary patterns, and practices and birth weight in Northern Ghana. Participant Settings A facility-based cross-sectional survey was performed in two districts in the Northern Region of Ghana. The selected districts were the Tamale Metropolis and Savelugu-Nanton District. These districts were purposively sampled to represent a mix of urban, peri-urban and rural populations, therefore ensuring that the distribution in social groups of the study population was similar to the entire population of the region. In all, 578 mothers who were drawing antenatal and postnatal care services were interviewed using a questionnaire, which asked the mothers about their frequency of consumption of individual foods per week since they became pregnant or when they were pregnant. Statistical Analysis We determined dietary patterns by applying a factor analysis with a varimax rotation using STATA. Multivariate analysis was used to establish association between maternal factors and dietary patterns. Logistic regression was used to assess the association between dietary practices and patterns and birth weight. Results Women who ate outside the home twice a week (OR = 1.6 & 95% CI; 1.1-2.45, P; 0.017) and those who practiced 'pica' (OR = 1.7 & 95% CI; 1.16-2.75, P; 0.008) had increased odds for low birth. Two dietary patterns were identified-namely 'health conscious' and 'non-health conscious'. Health conscious diet (OR = 0.23 95% CI 0.12-0.45 per standard deviation change in scores, P; < 0.0001) and dietary diversity score (OR = 0.10 95% CI 0.04-0.13 per standard deviation change in scores, P; < 0.0001) showed a protective effect for low birth weight respectively after adjusting for gestational age. Conclusion Mothers who practiced good nutrition such as consuming foods across and within the various food groups were less likely to have low birth weight babies. Our findings buttress the importance of optimal nutrition during pregnancy.	[Abubakari, Abdulai] Univ Dev Studies, Sch Allied Hlth Sci, Community Nutr Dept, Tamale, Ghana; [Abubakari, Abdulai; Jahn, Albrecht] Heidelberg Univ, Inst Publ Hlth, Fac Med, Heidelberg, Germany	University for Development Studies; Ruprecht Karls University Heidelberg	Abubakari, A (corresponding author), Univ Dev Studies, Sch Allied Hlth Sci, Community Nutr Dept, Tamale, Ghana.; Abubakari, A (corresponding author), Heidelberg Univ, Inst Publ Hlth, Fac Med, Heidelberg, Germany.	abubakariabdulai@yahoo.com		Abubakari, Abdulai/0000-0002-7906-9419				Abu-Saad K, 2010, EPIDEMIOL REV, V32, P5, DOI 10.1093/epirev/mxq001; Abubakari A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135641; Addo AA, 2006, AFR NUTR EP C 15 18; Ahmad Muhammad Owais, 2011, J Ayub Med Coll Abbottabad, V23, P77; Ali Fatima, 2014, J Ayub Med Coll Abbottabad, V26, P506; Annan R. A., 2015, African Journal of Food, Agriculture, Nutrition and Development, V15, P9838; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Arkkola T, 2008, PUBLIC HEALTH NUTR, V11, P176, DOI 10.1017/S1368980007000420; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Black RE, 2001, BRIT J NUTR, V85, pS193, DOI 10.1079/BJN2000314; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Christian P, 2010, ANNU REV NUTR, V30, P83, DOI 10.1146/annurev.nutr.012809.104813; Clausen T, 2005, EUR J ENDOCRINOL, V153, P887, DOI 10.1530/eje.1.02034; Colon-Ramos U, 2015, NUTRIENTS, V7, P1318, DOI 10.3390/nu7021318; Cuco G, 2006, EUR J CLIN NUTR, V60, P364, DOI 10.1038/sj.ejcn.1602324; Dixon LB, 2008, J AM DIET ASSOC, V108, P1837, DOI 10.1016/j.jada.2008.08.020; Fall CHD, 2003, J NUTR, V133, p1747S, DOI 10.1093/jn/133.5.1747S; FAO, 2012, GUID MEAS HOUS IND D; FAO & WHO, 1996, PREP US FOOD BAS DIE; Federman D G, 1997, Conn Med, V61, P207; Ghana Demographic and Health Survey, 2010, STUD FAMILY PLANN, V41, P307; Gluckman PD, 2004, PEDIATR RES, V56, P311, DOI 10.1203/01.PDR.0000135998.08025.FB; Godfrey K M, 2001, Public Health Nutr, V4, P611; Haider BA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-S3-S19; Hanley B, 2010, BRIT J NUTR, V104, pS1, DOI 10.1017/S0007114510003338; Hu FB, 2002, CURR OPIN LIPIDOL, V13, P3, DOI 10.1097/00041433-200202000-00002; HUDSON GJ, 1995, BRIT J NUTR, V73, P551, DOI 10.1079/BJN19950058; Institute of Medicine, 2009, WEIGHT GAIN PREGNANC; Institute of Medicine (IOM), 1990, NUTR PREGN 1; Khoushabi F, 2014, OPEN J OBSTET GYNECO, V2014, DOI [10.4236/ojog.2014.411090, DOI 10.4236/OJOG.2014.411090]; King JC, 2000, AM J CLIN NUTR, V71, p1218S, DOI 10.1093/ajcn/71.5.1218s; Kish L, 1965, SURVEY SAMPLING; Knudsen VK, 2008, EUR J CLIN NUTR, V62, P463, DOI 10.1038/sj.ejcn.1602745; Kramer MS, 2003, J NUTR, V133, p1592S, DOI 10.1093/jn/133.5.1592S; Lee SE, 2013, PUBLIC HEALTH NUTR, V16, P1340, DOI 10.1017/S1368980012004417; Newby PK, 2004, NUTR REV, V62, P177, DOI [10.1111/j.1753-4887.2004.tb00040.x, 10.1301/rn.2004.may.177-203]; Northstone K, 2008, EUR J CLIN NUTR, V62, P931, DOI 10.1038/sj.ejcn.1602789; Nti Christina A, 2008, Nutr Res Pract, V2, P35, DOI 10.4162/nrp.2008.2.1.35; Quarshie K, 2006, AFR NUTR EP C 2006 1; Rainville AJ, 1998, J AM DIET ASSOC, V98, P293, DOI 10.1016/S0002-8223(98)00069-8; Ramlal RT, 2015, NUTRIENTS, V7, P584, DOI 10.3390/nu7010584; Rasmussen KM, 2010, OBSTET GYNECOL, V116, P1191, DOI 10.1097/AOG.0b013e3181f60da7; Ruel MT, 2003, J NUTR, V133, p3911S, DOI 10.1093/jn/133.11.3911S; Rush D, 2001, J Health Popul Nutr, V19, pS217; Saaka M, 2012, INT J CHILD HEALTH N, V1, P148, DOI 10.6000/1929-4247.2012.01.02.6; The Vanuatu National Statistics Office, 2009, NAT POP HOUS CENS AN, V2; Thompson JMD, 2010, BRIT J NUTR, V103, P1665, DOI 10.1017/S0007114509993606; Torheim LE, 2010, J NUTR, V140, p2051S, DOI 10.3945/jn.110.123463; Victora CG, 2008, LANCET, V371, P340, DOI 10.1016/S0140-6736(07)61692-4; WHO, 2010, INT STAT CLASS DIS R; Wolff Cindy Brattan, 1995, Nutrition and Health (Bicester), V10, P121; World Bank and International Monetry Fund, 2012, FOOD PRIC NUTR MILL	52	38	40	0	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162285	10.1371/journal.pone.0162285	http://dx.doi.org/10.1371/journal.pone.0162285			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611597	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900073
J	Guensch, DP; Yu, J; Nadeshalingam, G; Fischer, K; Shearer, J; Friedrich, MG				Guensch, Dominik P.; Yu, Janelle; Nadeshalingam, Gobinath; Fischer, Kady; Shearer, Jane; Friedrich, Matthias G.			Evidence for Acute Myocardial and Skeletal Muscle Injury after Serial Transthoracic Shocks in Healthy Swine	PLOS ONE			English	Article							ACID-BINDING PROTEIN; CARDIOVASCULAR-MAGNETIC-RESONANCE; DEFIBRILLATION; RECOVERY; ELECTROPORATION; CARDIOVERSION; MEMBRANE	Background Previous serological studies have shown controversial results whether defibrillation or cardioversion can cause myocardial injury. Cardiovascular Magnetic Resonance (CMR) can be used to detect myocardial edema, hyperemia and capillary leak as features of acute myocardial injury. The aim of this study was to assess for myocardial and skeletal muscle injury in swine following transthoracic shocks. Methods Seventeen anaesthetized swine were examined, with 11 undergoing five synchronized transthoracic shocks (200J). Myocardial and skeletal muscle injury were assessed at baseline and up to 5h post-shock employing T1 mapping, T2 mapping, early and late gadolinium enhancement. Serologic markers (cFABP, TnI, CK, and CK-MB) and myocardial tissue were assessed by standard histology methods. Results In myocardial regions within the shock path, T1 and T2 were significantly increased compared to remote myocardium in the same animals. The early gadolinium enhancement ratio between the left-ventricular myocardium and the right pectoral muscle was also increased compared to control animals. After the shocks cFABP and CK were significantly elevated. After shock application, the regions identified as abnormal by CMR showed significantly increased interstitial and myocardial cell areas in histological analysis. This increased cell area suggests significant cellular and interstitial edema. Conclusion Our pilot study data indicate that serial defibrillator shocks lead to acute skeletal muscle and myocardial injury. CMR is a useful tool to detect and localize myocardial and skeletal muscle injury early after transthoracic shocks in vivo. In the future the technique could potentially be used as an additional tool for quality control such as verifying insufficient local shock application in non-responders after cardioversion or to develop safer shock forms.	[Guensch, Dominik P.; Yu, Janelle; Nadeshalingam, Gobinath; Fischer, Kady; Friedrich, Matthias G.] Montreal Heart Inst, Philippa & Marvin Carsley CMR Ctr, Montreal, PQ, Canada; [Guensch, Dominik P.; Fischer, Kady] Univ Bern, Univ Hosp Bern, Dept Anaesthesiol & Pain Therapy, Inselspital, Bern, Switzerland; [Guensch, Dominik P.] Univ Bern, Univ Hosp Bern, Inst Diagnost Intervent & Paediat Radiol, Inselspital, Bern, Switzerland; [Friedrich, Matthias G.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Friedrich, Matthias G.] McGill Univ, Dept Radiol, Montreal, PQ, Canada; [Shearer, Jane] Univ Calgary, Fac Kinesiol, Calgary, AB, Canada	Universite de Montreal; University of Bern; University Hospital of Bern; University of Bern; University Hospital of Bern; McGill University; McGill University; University of Calgary	Guensch, DP (corresponding author), Montreal Heart Inst, Philippa & Marvin Carsley CMR Ctr, Montreal, PQ, Canada.; Guensch, DP (corresponding author), Univ Bern, Univ Hosp Bern, Dept Anaesthesiol & Pain Therapy, Inselspital, Bern, Switzerland.; Guensch, DP (corresponding author), Univ Bern, Univ Hosp Bern, Inst Diagnost Intervent & Paediat Radiol, Inselspital, Bern, Switzerland.	dominik.guensch@gmail.com	; Friedrich, Matthias/H-8474-2015	Gunsch, Dominik/0000-0003-4127-4086; Friedrich, Matthias/0000-0003-1204-5647; Fischer, Kady/0000-0002-7765-4550	Montreal Heart Institute Foundation; Canadian Foundation for Innovation; Fonds de Recherche Sante Quebec	Montreal Heart Institute Foundation; Canadian Foundation for Innovation(Canada Foundation for Innovation); Fonds de Recherche Sante Quebec	Funding was provided by the Montreal Heart Institute Foundation, the Canadian Foundation for Innovation and the Fonds de Recherche Sante Quebec. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alaiti MA, 2009, PACE, V32, P800, DOI 10.1111/j.1540-8159.2009.02370.x; Allan JJ, 1997, J AM COLL CARDIOL, V30, P1052, DOI 10.1016/S0735-1097(97)00260-X; Azzazy HME, 2006, CLIN CHEM, V52, P19, DOI 10.1373/clinchem.2005.056143; Berg MD, 2008, PEDIATR CRIT CARE ME, V9, P429, DOI 10.1097/PCC.0b013e318172e9f8; Bunai Yasuo, 2003, Leg Med (Tokyo), V5 Suppl 1, pS302, DOI 10.1016/S1344-6223(02)00156-6; Daidoji H, 2012, J CARD FAIL, V18, P556, DOI 10.1016/j.cardfail.2012.04.006; de Caen AR, 2015, CIRCULATION, V132, pS526, DOI 10.1161/CIR.0000000000000266; del Rey Sanchez JM, 2002, REV ESP CARDIOL, V55, P227; Ferreira VM, 2013, JACC-CARDIOVASC IMAG, V6, P1048, DOI 10.1016/j.jcmg.2013.03.008; Ferreira VM, 2012, J CARDIOVASC MAGN R, V14, DOI 10.1186/1532-429X-14-42; Friedrich MG, 2009, J AM COLL CARDIOL, V53, P1475, DOI 10.1016/j.jacc.2009.02.007; Friedrich MG, 1998, CIRCULATION, V97, P1802, DOI 10.1161/01.CIR.97.18.1802; Giri S, 2009, J CARDIOVASC MAGN R, V11, DOI 10.1186/1532-429X-11-56; Gissel H, 2005, ANN NY ACAD SCI, V1066, P272, DOI 10.1196/annals.1363.024; Hendel RC, 2006, J AM COLL CARDIOL, V48, P1475, DOI 10.1016/j.jacc.2006.07.003; Kellman P, 2014, J CARDIOVASC MAGN R, V16, DOI 10.1186/1532-429X-16-2; Mazove OL, 2006, KARDIOLOGIYA, V46, P43; Messroghli DR, 2004, MAGN RESON MED, V52, P141, DOI 10.1002/mrm.20110; Santos Elizabete Silva dos, 2006, Arq Bras Cardiol, V86, P191; Skulec R, 2006, RESUSCITATION, V70, P423, DOI 10.1016/j.resuscitation.2006.02.003; Soar J, 2015, RESUSCITATION, V95, P100, DOI 10.1016/j.resuscitation.2015.07.016; TOVAR O, 1992, AM J PHYSIOL, V263, pH1128, DOI 10.1152/ajpheart.1992.263.4.H1128; Vogel U, 1998, INTENS CARE MED, V24, P743, DOI 10.1007/s001340050656; Wang YT, 2012, AM J PHYSIOL-HEART C, V303, pH439, DOI 10.1152/ajpheart.01121.2011	24	11	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162245	10.1371/journal.pone.0162245	http://dx.doi.org/10.1371/journal.pone.0162245			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611090	Green Published, gold			2022-12-26	WOS:000383255900069
J	Kim, DK; Beaven, MA; Kulinski, JM; Desai, A; Bandara, G; Bai, Y; Prussin, C; Schwartz, LB; Komarow, H; Metcalfe, DD; Olivera, A				Kim, Do-Kyun; Beaven, Michael A.; Kulinski, Joseph M.; Desai, Avanti; Bandara, Geethani; Bai, Yun; Prussin, Calman; Schwartz, Lawrence B.; Komarow, Hirsh; Metcalfe, Dean D.; Olivera, Ana			Regulation of Reactive Oxygen Species and the Antioxidant Protein DJ-1 in Mastocytosis	PLOS ONE			English	Article							FC-EPSILON-RI; PARKINSONS-DISEASE; MAST-CELLS; DIAGNOSTIC-CRITERIA; OXIDATIVE DAMAGE; CANCER-CELLS; ROS; ACTIVATION; STRESS; MUTATION	Neoplastic accumulation of mast cells in systemic mastocytosis (SM) associates with activating mutations in the receptor tyrosine kinase KIT. Constitutive activation of tyrosine kinase oncogenes has been linked to imbalances in oxidant/antioxidant mechanisms in other myeloproliferative disorders. However, the impact of KIT mutations on the redox status in SM and the potential therapeutic implications are not well understood. Here, we examined the regulation of reactive oxygen species (ROS) and of the antioxidant protein DJ-1 (PARK-7), which increases with cancer progression and acts to lessen oxidative damage to malignant cells, in relationship with SM severity. ROS levels were increased in both indolent (ISM) and aggressive variants of the disease (ASM). However, while DJ-1 levels were reduced in ISM with lower mast cell burden, they rose in ISM with higher mast cell burden and were significantly elevated in patients with ASM. Studies on mast cell lines revealed that activating KIT mutations induced constant ROS production and consequent DJ-1 oxidation and degradation that could explain the reduced levels of DJ-1 in the ISM population, while IL-6, a cytokine that increases with disease severity, caused a counteracting transcriptional induction of DJ-1 which would protect malignant mast cells from oxidative damage. A mouse model of mastocytosis recapitulated the biphasic changes in DJ-1 and the escalating IL-6, ROS and DJ-1 levels as mast cells accumulate, findings which were reversed with anti-IL-6 receptor blocking antibody. Our findings provide evidence of increased ROS and a biphasic regulation of the antioxidant DJ-1 in variants of SM and implicate IL-6 in DJ-1 induction and expansion of mast cells with KIT mutations. We propose consideration of IL-6 blockade as a potential adjunctive therapy in the treatment of patients with advanced mastocytosis, as it would reduce DJ-1 levels making mutation-positive mast cells vulnerable to oxidative damage.	[Kim, Do-Kyun; Kulinski, Joseph M.; Desai, Avanti; Bandara, Geethani; Bai, Yun; Prussin, Calman; Komarow, Hirsh; Metcalfe, Dean D.; Olivera, Ana] NIAID, Mast Cell Biol Sect, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA; [Beaven, Michael A.] NHLBI, Lab Mol Immunol, Bldg 10, Bethesda, MD 20892 USA; [Schwartz, Lawrence B.] Virginia Commonwealth Univ, Dept Internal Med, Richmond, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); Virginia Commonwealth University	Olivera, A (corresponding author), NIAID, Mast Cell Biol Sect, Lab Allerg Dis, NIH, 9000 Rockville Pike, Bethesda, MD 20892 USA.	ana.olivera@nih.gov			Division of Intramural Research Programs within NIAID, NIH [AI001206]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI14C1175]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001206, ZIAAI000249] Funding Source: NIH RePORTER	Division of Intramural Research Programs within NIAID, NIH; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Division of Intramural Research Programs within NIAID, NIH (AI001206). Dr. Do-Kyun Kim was supported by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health & Welfare, Republic of Korea (grant number: HI14C1175).	Akin C, 2014, IMMUNOL ALLERGY CLIN, V34, P207, DOI 10.1016/j.iac.2014.02.003; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Bauer G, 2014, ANTICANCER RES, V34, P1467; Brockow K, 2005, CLIN IMMUNOL, V115, P216, DOI 10.1016/j.clim.2005.01.011; Brockow K, 2002, J ALLERGY CLIN IMMUN, V109, P82, DOI 10.1067/mai.2002.120524; Brockow K, 2010, CHEM IMMUNOL ALLERGY, V95, P110, DOI 10.1159/000315946; BUTTERFIELD JH, 1988, LEUKEMIA RES, V12, P345, DOI 10.1016/0145-2126(88)90050-1; Chan EC, 2013, EXP HEMATOL, V41, P870, DOI 10.1016/j.exphem.2013.05.005; Chan JYH, 2015, PHARMACOL THERAPEUT, V156, P69, DOI 10.1016/j.pharmthera.2015.09.005; Choi J, 2006, J BIOL CHEM, V281, P10816, DOI 10.1074/jbc.M509079200; Clements CM, 2006, P NATL ACAD SCI USA, V103, P15091, DOI 10.1073/pnas.0607260103; Demehri S, 2006, EXP HEMATOL, V34, P284, DOI 10.1016/j.exphem.2005.11.015; FRIEDMAN BS, 1989, AM J MED, V87, P649; Gangemi S, 2015, ALLERGY, V70, P436, DOI 10.1111/all.12571; Garcia-Montero AC, 2006, BLOOD, V108, P2366, DOI 10.1182/blood-2006-04-015545; GRANERUS G, 1983, J INVEST DERMATOL, V80, P410, DOI 10.1111/1523-1747.ep12555351; Guo YQ, 2012, CANCER TREAT REV, V38, P904, DOI 10.1016/j.ctrv.2012.04.007; Harris IS, 2015, CANCER CELL, V27, P211, DOI 10.1016/j.ccell.2014.11.019; Hartmann K, 2013, J ALLERGY CLIN IMMUN, V132, P232, DOI 10.1016/j.jaci.2012.11.008; He XY, 2011, J DIGEST DIS, V12, P131, DOI 10.1111/j.1751-2980.2011.00488.x; Hoermann G, 2014, ALLERGY, V69, P810, DOI 10.1111/all.12409; Hole PS, 2013, BLOOD, V122, P3322, DOI 10.1182/blood-2013-04-491944; Horny HP, 2008, MASTOCYTOSIS; Hulleman JD, 2007, BIOCHEMISTRY-US, V46, P5776, DOI 10.1021/bi7001778; Jayavelu AK, 2016, LEUKEMIA, V30, P473, DOI 10.1038/leu.2015.234; Kim DK, 2013, J ALLERGY CLIN IMMUN, V131, P1653, DOI 10.1016/j.jaci.2012.10.012; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kim SJ, 2012, FREE RADICAL BIO MED, V53, P936, DOI 10.1016/j.freeradbiomed.2012.05.035; Kirshenbaum AS, 2003, LEUKEMIA RES, V27, P677, DOI 10.1016/S0145-2126(02)00343-0; Kristensen T, 2013, J MOL DIAGN, V15, P355, DOI 10.1016/j.jmoldx.2012.12.003; Malhotra D, 2008, AM J RESP CRIT CARE, V178, P592, DOI 10.1164/rccm.200803-380OC; Martinat C, 2004, PLOS BIOL, V2, P1754, DOI 10.1371/journal.pbio.0020327; Matsui T, 2000, BIOCHEM BIOPH RES CO, V276, P742, DOI 10.1006/bbrc.2000.3545; Mayado A, 2016, LEUKEMIA, V30, P124, DOI 10.1038/leu.2015.176; Meulener MC, 2006, P NATL ACAD SCI USA, V103, P12517, DOI 10.1073/pnas.0601891103; Miller DW, 2003, J BIOL CHEM, V278, P36588, DOI 10.1074/jbc.M304272200; Nagakubo D, 1997, BIOCHEM BIOPH RES CO, V231, P509, DOI 10.1006/bbrc.1997.6132; Ooe H, 2006, NEUROSCI LETT, V406, P165, DOI 10.1016/j.neulet.2006.06.067; Pelicano H, 2004, DRUG RESIST UPDATE, V7, P97, DOI 10.1016/j.drup.2004.01.004; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2777, DOI 10.1089/ars.2009.2804; Raninga Prahlad V, 2014, Oncoscience, V1, P95; Reddy MM, 2011, LEUKEMIA, V25, P281, DOI 10.1038/leu.2010.263; Schumann C, 2016, MOL PHARMACEUT, V13, P2070, DOI 10.1021/acs.molpharmaceut.6b00205; Schwartz LB, 1995, J CLIN INVEST, V96, P2702, DOI 10.1172/JCI118337; Shi SY, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8415; Siegel AM, 2013, J ALLERGY CLIN IMMUN, V132, P1388, DOI 10.1016/j.jaci.2013.08.045; Sly LM, 2008, J IMMUNOL, V181, P3850, DOI 10.4049/jimmunol.181.6.3850; Smrz D, 2013, J IMMUNOL METHODS, V390, P52, DOI 10.1016/j.jim.2013.01.008; Sperr WR, 2002, INT ARCH ALLERGY IMM, V128, P136, DOI 10.1159/000059404; Suh YA, 1999, NATURE, V401, P79, DOI 10.1038/43459; Suzuki Y, 2003, J IMMUNOL, V171, P6119, DOI 10.4049/jimmunol.171.11.6119; Swindle EJ, 2004, J BIOL CHEM, V279, P48751, DOI 10.1074/jbc.M409738200; Swindle EJ, 2007, J IMMUNOL, V179, P7059, DOI 10.4049/jimmunol.179.10.7059; Takahashi-Niki K, 2004, BIOCHEM BIOPH RES CO, V320, P389, DOI 10.1016/j.bbrc.2004.05.187; Teodosio C, 2013, J ALLERGY CLIN IMMUN, V131, P1213, DOI 10.1016/j.jaci.2012.12.674; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Trivedi R, 2016, EUR J PHARMACOL, V784, P99, DOI 10.1016/j.ejphar.2016.04.014; Tsuboi Y, 2008, FEBS LETT, V582, P2643, DOI 10.1016/j.febslet.2008.06.043; TSUJIMURA T, 1994, BLOOD, V83, P2619; Valent P, 2001, LEUKEMIA RES, V25, P603, DOI 10.1016/S0145-2126(01)00038-8; Vasseur S, 2009, P NATL ACAD SCI USA, V106, P1111, DOI 10.1073/pnas.0812745106; Xu XM, 2010, J CELL SCI, V123, P1644, DOI 10.1242/jcs.063222; Yu H, 2014, NAT REV CANCER, V14, P736, DOI 10.1038/nrc3818	63	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162831	10.1371/journal.pone.0162831	http://dx.doi.org/10.1371/journal.pone.0162831			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611333	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900175
J	McCann, J; Schneeweiss, GM; Stuessy, TF; Villasenor, JL; Weiss-Schneeweiss, H				McCann, Jamie; Schneeweiss, Gerald M.; Stuessy, Tod F.; Villasenor, Jose L.; Weiss-Schneeweiss, Hanna			The Impact of Reconstruction Methods, Phylogenetic Uncertainty and Branch Lengths on Inference of Chromosome Number Evolution in American Daisies (Melampodium, Asteraceae)	PLOS ONE			English	Article							CHARACTER-STATE RECONSTRUCTION; KARYOTYPE EVOLUTION; DISCRETE CHARACTERS; BAYESIAN-ESTIMATION; LIKELIHOOD APPROACH; DNA-SEQUENCES; MODEL; POLYPLOIDY; SPECIATION; TREES	Chromosome number change (polyploidy and dysploidy) plays an important role in plant diversification and speciation. Investigating chromosome number evolution commonly entails ancestral state reconstruction performed within a phylogenetic framework, which is, however, prone to uncertainty, whose effects on evolutionary inferences are insufficiently understood. Using the chromosomally diverse plant genus Melampodium (Asteraceae) as model group, we assess the impact of reconstruction method (maximum parsimony, maximum likelihood, Bayesian methods), branch length model (phylograms versus chrono-grams) and phylogenetic uncertainty (topological and branch length uncertainty) on the inference of chromosome number evolution. We also address the suitability of the maximum clade credibility (MCC) tree as single representative topology for chromosome number reconstruction. Each of the listed factors causes considerable incongruence among chromosome number reconstructions. Discrepancies between inferences on the MCC tree from those made by integrating over a set of trees are moderate for ancestral chromosome numbers, but severe for the difference of chromosome gains and losses, a measure of the directionality of dysploidy. Therefore, reliance on single trees, such as the MCC tree, is strongly discouraged and model averaging, taking both phylogenetic and model uncertainty into account, is recommended. For studying chromosome number evolution, dedicated models implemented in the program CHROMEVOL and ordered maximum parsimony may be most appropriate. Chromosome number evolution in Melampodium follows a pattern of bidirectional dysploidy (starting from x = 11 to x = 9 and x = 14, respectively) with no prevailing direction.	[McCann, Jamie; Schneeweiss, Gerald M.; Stuessy, Tod F.; Weiss-Schneeweiss, Hanna] Univ Vienna, Dept Bot & Biodivers Res, Rennweg 14, A-1030 Vienna, Austria; [Stuessy, Tod F.] Ohio State Univ, Dept Evolut Ecol & Organismal Biol, Herbarium, 318 W 12th Ave, Columbus, OH 43210 USA; [Villasenor, Jose L.] Univ Nacl Autonoma Mexico, Dept Bot, Inst Biol, Tercer Circuito S-N Ciudad Univ Delegac Coyoacan, Mexico City 04510, DF, Mexico	University of Vienna; University System of Ohio; Ohio State University; Universidad Nacional Autonoma de Mexico	Schneeweiss, GM (corresponding author), Univ Vienna, Dept Bot & Biodivers Res, Rennweg 14, A-1030 Vienna, Austria.	gerald.schneeweiss@univie.ac.at	Villasenor, Jose Luis/R-9719-2019; Schneeweiss, Hanna/B-4011-2013; Schneeweiss, Gerald M./B-4344-2013; McCann, Jamie/AAP-9923-2020	Schneeweiss, Gerald M./0000-0003-2811-3317; McCann, Jamie/0000-0003-2310-4462; Schneeweiss, Hanna/0000-0002-9530-6808	Austrian Science Fund (FWF) [P18201, P25131]; Hertha-Firnberg postdoctoral fellowship [T-218]; Austrian Science Fund (FWF) [P 25131] Funding Source: researchfish	Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); Hertha-Firnberg postdoctoral fellowship(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This work was supported by Austrian Science Fund (FWF; http://www.fwf.ac.at) grant numbers P18201 (to T.F.S.) and P25131 (to H.W.S.), Hertha-Firnberg postdoctoral fellowship T-218 (to H.W.S.). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayala FJ, 2005, P NATL ACAD SCI USA, V102, P6535, DOI 10.1073/pnas.0501847102; Baele G, 2012, MOL BIOL EVOL, V29, P2157, DOI 10.1093/molbev/mss084; Bakker FT, 2000, AM J BOT, V87, P727, DOI 10.2307/2656859; Beardsley PM, 2004, AM J BOT, V91, P474, DOI 10.3732/ajb.91.3.474; Bloch C, 2009, MOL PHYLOGENET EVOL, V53, P220, DOI 10.1016/j.ympev.2009.02.021; Bollback JP, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-88; Bremer K, 1997, P NATL ACAD SCI USA, V94, P9188, DOI 10.1073/pnas.94.17.9188; Britton T, 2007, SYSTEMATIC BIOL, V56, P741, DOI 10.1080/10635150701613783; Brown JM, 2010, SYST BIOL, V59, P145, DOI 10.1093/sysbio/syp081; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; CANNE JM, 1983, RHODORA, V85, P355; Chacon J, 2014, SYST BOT, V39, P415, DOI 10.1600/036364414X680852; Colless D.H., 1982, SYST ZOOL, V31, P100, DOI DOI 10.2307/2413420; Cunningham CW, 1998, TRENDS ECOL EVOL, V13, P361, DOI 10.1016/S0169-5347(98)01382-2; Cunningham CW, 1999, SYST BIOL, V48, P665, DOI 10.1080/106351599260238; Cusimano N, 2014, TAXON, V63, P721, DOI 10.12705/634.14; De Storme N, 2014, CURR PLANT BIOL, V1, P10, DOI 10.1016/j.cpb.2014.09.002; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duchene S, 2015, J EXP ZOOL PART B, V324, P517, DOI 10.1002/jez.b.22638; Enke N, 2008, TAXON, V57, P756, DOI 10.1002/tax.573008; Escudero M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085266; Faria R, 2010, TRENDS ECOL EVOL, V25, P660, DOI 10.1016/j.tree.2010.07.008; Glick L, 2014, MOL BIOL EVOL, V31, P1914, DOI 10.1093/molbev/msu122; Goldblatt P, 1997, ANN MO BOT GARD, V84, P285, DOI 10.2307/2400005; Grant V., 1981, PLANT SPECIATION; Hansen AK, 2006, SYST BOT, V31, P138, DOI 10.1600/036364406775971769; Heled J, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-221; Hennequin S, 2010, MOL PHYLOGENET EVOL, V55, P47, DOI 10.1016/j.ympev.2010.01.001; Hipp AL, 2007, EVOLUTION, V61, P2175, DOI 10.1111/j.1558-5646.2007.00183.x; Hoffmann AA, 2008, ANNU REV ECOL EVOL S, V39, P21, DOI 10.1146/annurev.ecolsys.39.110707.173532; Huelsenbeck JP, 2003, SYST BIOL, V52, P641, DOI 10.1080/10635150390235467; Huelsenbeck JP, 2001, SYST BIOL, V50, P351, DOI 10.1080/106351501300317978; Jang TS, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-136; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; Kadane JB, 2004, J AM STAT ASSOC, V99, P279, DOI 10.1198/016214504000000269; Kagale S, 2014, PLANT CELL, V26, P2777, DOI 10.1105/tpc.114.126391; KASS RE, 1995, J AM STAT ASSOC, V90, P773, DOI 10.1080/01621459.1995.10476572; Kay KM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-36; KEIL DJ, 1988, AM J BOT, V75, P652, DOI 10.2307/2444199; Kirkpatrick M, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000501; Kuzoff RK, 1998, MOL BIOL EVOL, V15, P251, DOI 10.1093/oxfordjournals.molbev.a025922; Leitch AR, 2008, SCIENCE, V320, P481, DOI 10.1126/science.1153585; Lewis PO, 2001, SYST BIOL, V50, P913, DOI 10.1080/106351501753462876; Litsios G, 2012, SYST BIOL, V61, P533, DOI 10.1093/sysbio/syr124; Lysak MA, 2006, P NATL ACAD SCI USA, V103, P5224, DOI 10.1073/pnas.0510791103; Maddison WP, 2011, MESQUITE MODULAR SYS; Mandakova T, 2008, PLANT CELL, V20, P2559, DOI 10.1105/tpc.108.062166; Mandakova T, 2010, PLANT CELL, V22, P2277, DOI 10.1105/tpc.110.074526; Mayrose I, 2010, SYST BIOL, V59, P132, DOI 10.1093/sysbio/syp083; Nielsen R, 2002, SYST BIOL, V51, P729, DOI 10.1080/10635150290102393; Pagel M, 1999, SYST BIOL, V48, P612, DOI 10.1080/106351599260184; Pagel M, 2004, SYST BIOL, V53, P673, DOI 10.1080/10635150490522232; Pagel M, 2008, PHILOS T R SOC B, V363, P3955, DOI 10.1098/rstb.2008.0178; Pagel M, 2006, AM NAT, V167, P808, DOI 10.1086/503444; Pellicer J, 2014, NEW PHYTOL, V201, P1484, DOI 10.1111/nph.12617; Pirie MD, 2012, TAXON, V61, P652, DOI 10.1002/tax.613013; Posada D, 2004, SYST BIOL, V53, P793, DOI 10.1080/10635150490522304; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; R Core Team, 2013, R LANG ENV STAT COMP; Rice A, 2015, NEW PHYTOL, V206, P19, DOI 10.1111/nph.13191; ROHLF FJ, 1990, EVOLUTION, V44, P1671, DOI 10.1111/j.1558-5646.1990.tb03855.x; Ronquist F, 2004, TRENDS ECOL EVOL, V19, P475, DOI 10.1016/j.tree.2004.07.002; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Royer-Carenzi M, 2013, MATH BIOSCI, V242, P95, DOI 10.1016/j.mbs.2012.12.003; Samuel R, 2003, AM J BOT, V90, P496, DOI 10.3732/ajb.90.3.496; Schneeweiss GM, 2013, MOL PHYLOGENET EVOL, V69, P634, DOI 10.1016/j.ympev.2013.07.015; Schubert I, 2011, TRENDS GENET, V27, P207, DOI 10.1016/j.tig.2011.03.004; Sousa A, 2015, BOT J LINN SOC, V177, P15, DOI 10.1111/boj.12231; STEBBINS G. L., 1971, Chromosomal evolution in higher plants.; Stuessy T.F., 2014, PLANT SYSTEMATICS OR; STUESSY TF, 1971, AM J BOT, V58, P732, DOI 10.2307/2441471; Stuessy TF, 2011, TAXON, V60, P436, DOI 10.1002/tax.602013; Sukumaran J, 2010, BIOINFORMATICS, V26, P1569, DOI 10.1093/bioinformatics/btq228; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Turner B. L., 1996, Phytologia, V81, P348; Vanderpoorten A, 2006, SYSTEMATIC BIOL, V55, P957, DOI 10.1080/10635150601088995; Weiss-Schneeweiss H, 2013, CYTOGENET GENOME RES, V140, P137, DOI 10.1159/000351727; Weiss-Schneeweiss H., 2013, PHYS STRUCTURE BEHAV, V2, P209, DOI DOI 10.1007/978-3-7091-1160-4_13; Weiss-Schneeweiss H, 2012, EVOLUTION, V66, P211, DOI 10.1111/j.1558-5646.2011.01424.x; Weiss-Schneeweiss H, 2009, INT J PLANT SCI, V170, P1168, DOI 10.1086/605876; Xiang QY, 2008, J SYST EVOL, V46, P349, DOI 10.3724/SP.J.1002.2008.08056; Yamane K, 2003, AM J BOT, V90, P339, DOI 10.3732/ajb.90.3.339; Yang Z, 2014, Molecular Evolution: A Statistical Approach, P1, DOI 10.1093/acprof:oso/9780199602605.001.0001; [No title captured]	84	11	12	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162299	10.1371/journal.pone.0162299	http://dx.doi.org/10.1371/journal.pone.0162299			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611687	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900074
J	Yan, XD; Liu, JF; Ye, ZX; Huang, JH; He, F; Xiao, W; Hu, XY; Luo, ZJ				Yan, Xiaodong; Liu, Juanfang; Ye, Zhengxu; Huang, Jinghui; He, Fei; Xiao, Wei; Hu, Xueyu; Luo, Zhuojing			CaMKII-Mediated CREB Phosphorylation Is Involved in Ca2+-Induced BDNF mRNA Transcription and Neurite Outgrowth Promoted by Electrical Stimulation	PLOS ONE			English	Article							PROTEIN-KINASE-II; NERVE GROWTH-FACTOR; ACTIVITY-DEPENDENT EXPRESSION; LONG-TERM POTENTIATION; ROOT GANGLION NEURONS; NEUROTROPHIC FACTOR; PC12 CELLS; CALCIUM-CHANNELS; AXON REGENERATION; GENE-EXPRESSION	Electrical stimulation (ES)-triggered up-regulation of brain-derived neurotrophic factor (BDNF) and neurite outgrowth in cultured rat postnatal dorsal root ganglion neurons (DRGNs) is calcium (Ca2+)-dependent. The effects of increased Ca2+ on BDNF up-regulation and neurite outgrowth remain unclear. We showed here that ES increased phosphorylation of the cAMP-response element binding protein (CREB). Blockade of Ca2+ suppressed CREB phosphorylation and neurite outgrowth. Down-regulation of phosphorylated (p)-CREB reduced BDNF transcription and neurite outgrowth triggered by ES. Furthermore, blockade of calmodulin-dependent protein kinase II (CaMKII) using the inhibitors KN93 or KN62 reduced p-CREB, and specific knockdown of the CaMKII alpha or CaMKII beta subunit was sufficient to suppress p-CREB. Recombinant BDNF or hyperforin reversed the effects of Ca2+ blockade and CaMKII knockdown. Taken together, these data establish a potential signaling pathway of Ca2+-CaMKII-CREB in neuronal activation. To our knowledge, this is the first report of the mechanisms of Ca2+-dependent BDNF transcription and neurite outgrowth triggered by ES. These findings might help further investigation of complex molecular signaling networks in ES-triggered nerve regeneration in vivo.	[Yan, Xiaodong; Ye, Zhengxu; Huang, Jinghui; Xiao, Wei; Hu, Xueyu; Luo, Zhuojing] Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China; [Yan, Xiaodong] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed, Xian 710038, Peoples R China; [Liu, Juanfang] Fourth Mil Med Univ, Dept Clin Aerosp Med, Xian 710032, Peoples R China; [He, Fei] Fourth Mil Med Univ, Basic Unit, Dept Hereditary & Dev, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Hu, XY; Luo, ZJ (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Orthopaed, Xian 710032, Peoples R China.	huxueyu@fmmu.edu.cn; zjluo@fmmu.edu.cn			National Natural Science Foundation of China [30770571, 81401001, 81101352]; Elite Talent Cultivation Programme of Tangdu hospital [20125087]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Elite Talent Cultivation Programme of Tangdu hospital	This work was supported by the National Natural Science Foundation of China (No. 30770571, 81401001 and 81101352, ZL) and Elite Talent Cultivation Programme of Tangdu hospital (No. 20125087, XH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful for the support in part from the National Natural Science Foundation of China (No. 30770571, 81401001, and 81101352) and the Elite Talent Cultivation Programme of Tangdu hospital (No. 20125087). We thank Dan Geng, Lifeng Lan, Wei Hu, Li Liang, and Ruichen Wang for technical support.	Bangaru MLY, 2015, NEUROSCIENCE, V300, P116, DOI 10.1016/j.neuroscience.2015.05.007; Barat E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041793; Boss V, 2001, J NEUROSCI, V21, P18, DOI 10.1523/JNEUROSCI.21-01-00018.2001; Boyadjieva NI, 2013, ALCOHOL CLIN EXP RES, V37, P1370, DOI 10.1111/acer.12104; Buchholz M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122946; Chang YJ, 2013, BBA-GEN SUBJECTS, V1830, P4130, DOI 10.1016/j.bbagen.2013.04.007; Curtis J, 1999, J NEUROSCI RES, V58, P88, DOI 10.1002/(SICI)1097-4547(19991001)58:1<88::AID-JNR9>3.3.CO;2-I; ERNFORS P, 1991, NEURON, V7, P165, DOI 10.1016/0896-6273(91)90084-D; Figurov A, 1996, NATURE, V381, P706, DOI 10.1038/381706a0; Gao Y, 2004, NEURON, V44, P609, DOI 10.1016/j.neuron.2004.10.030; Gau D, 2002, NEURON, V34, P245, DOI 10.1016/S0896-6273(02)00656-6; Gibon J, 2013, INT J NEUROPSYCHOPH, V16, P189, DOI 10.1017/S146114571100188X; Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3; Gordon T, 2009, MOTOR CONTROL, V13, P412, DOI 10.1123/mcj.13.4.412; Guo Y, 2012, EXP CELL RES, V318, P2004, DOI 10.1016/j.yexcr.2012.04.015; Heiser JH, 2013, J NEUROCHEM, V127, DOI 10.1111/jnc.12376; Heist EK, 1998, CELL CALCIUM, V23, P103; Hook SS, 2001, ANNU REV PHARMACOL, V41, P471, DOI 10.1146/annurev.pharmtox.41.1.471; Hu Y, 2014, J MOL NEUROSCI, V53, P600, DOI 10.1007/s12031-013-0226-y; Huang C, 2009, BRAIN RES, V1257, P75, DOI 10.1016/j.brainres.2008.11.088; Huang JH, 2010, GLIA, V58, P622, DOI 10.1002/glia.20951; Juretic N, 2012, CELL PHYSIOL BIOCHEM, V29, P919, DOI 10.1159/000188068; Kohn J, 1999, J NEUROSCI, V19, P5393; Kornhauser JM, 2002, NEURON, V34, P221, DOI 10.1016/S0896-6273(02)00655-4; Krizsan-Agbas D, 2003, EUR J NEUROSCI, V18, P2760, DOI 10.1111/j.1460-9568.2003.03029.x; Lauterborn JC, 1996, J NEUROSCI, V16, P7428; Leinninger GM, 2004, FASEB J, V18, P1544, DOI 10.1096/fj.04-1581fje; Leuner K, 2013, HIPPOCAMPUS, V23, P40, DOI 10.1002/hipo.22052; Li Y, 2014, NEUROCHEM INT, V75, P96, DOI 10.1016/j.neuint.2014.06.004; Lichvarova L, 2012, GEN PHYSIOL BIOPHYS, V31, P473, DOI 10.4149/gpb_2012_054; Ma TC, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.582460; Mao ZX, 1999, SCIENCE, V286, P785, DOI 10.1126/science.286.5440.785; Masse T, 1997, J NEUROSCI, V17, P924; Mishra S, 2005, J BIOL CHEM, V280, P37536, DOI 10.1074/jbc.M504971200; Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X; Morales S, 2007, AM J PHYSIOL-CELL PH, V292, pC553, DOI 10.1152/ajpcell.00096.2006; Morgado-Valle C, 1998, CELL TISSUE RES, V291, P217, DOI 10.1007/s004410050992; Mullen LM, 2012, BRAIN RES, V1430, P25, DOI 10.1016/j.brainres.2011.10.054; Nagendran T, 2011, NEUROSCIENCE, V199, P548, DOI 10.1016/j.neuroscience.2011.09.048; Nomura T, 1997, BRAIN RES, V766, P129, DOI 10.1016/S0006-8993(97)00535-0; Peirson SN, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng073; Rajnicek AM, 1997, J CELL SCI, V110, P2915; Rice FL, 1998, DEV BIOL, V198, P57, DOI 10.1006/dbio.1998.8861; Riquelme D, 2011, ANTIOXID REDOX SIGN, V14, P1245, DOI 10.1089/ars.2010.3238; Roehm PC, 2008, MOL CELL NEUROSCI, V37, P376, DOI 10.1016/j.mcn.2007.10.014; Saito A, 2013, GENES CELLS, V18, P533, DOI 10.1111/gtc.12054; Sakagami H, 2005, EUR J NEUROSCI, V22, P2697, DOI 10.1111/j.1460-9568.2005.04463.x; Sato T, 2008, INVEST OPHTH VIS SCI, V49, P4641, DOI 10.1167/iovs.08-2049; SHENG M, 1991, SCIENCE, V252, P1427, DOI 10.1126/science.1646483; Shieh PB, 1998, NEURON, V20, P727, DOI 10.1016/S0896-6273(00)81011-9; Spencer TK, 2008, MOL CELL NEUROSCI, V38, P110, DOI 10.1016/j.mcn.2008.02.005; SUN PQ, 1994, GENE DEV, V8, P2527, DOI 10.1101/gad.8.21.2527; Swulius MT, 2008, CELL MOL LIFE SCI, V65, P2637, DOI 10.1007/s00018-008-8086-2; Tai YL, 2008, J CELL SCI, V121, P2301, DOI 10.1242/jcs.026906; Takemura M, 2009, J BIOL CHEM, V284, P28554, DOI 10.1074/jbc.M109.006296; Takeshita M, 2011, CHEM RES TOXICOL, V24, P1845, DOI 10.1021/tx200160g; Tao X, 2002, NEURON, V33, P383, DOI 10.1016/S0896-6273(01)00561-X; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Tashima K, 1996, J NEUROCHEM, V66, P57; TIMMUSK T, 1995, J CELL BIOL, V128, P185, DOI 10.1083/jcb.128.1.185; Udina E, 2008, EXP NEUROL, V210, P238, DOI 10.1016/j.expneurol.2007.11.007; Ulmann L, 2009, NEUROSCIENCE, V159, P514, DOI 10.1016/j.neuroscience.2009.01.018; Vitolo OV, 2002, P NATL ACAD SCI USA, V99, P13217, DOI 10.1073/pnas.172504199; Wang WJ, 2011, CELL MOL NEUROBIOL, V31, P459, DOI 10.1007/s10571-010-9639-0; Wayman GA, 2008, NEURON, V59, P914, DOI 10.1016/j.neuron.2008.08.021; Wood M, 2006, BIOELECTROMAGNETICS, V27, P328, DOI 10.1002/bem.20214; Wood MD, 2009, J NEURAL ENG, V6, DOI 10.1088/1741-2560/6/4/046003; Wu GY, 1996, SCIENCE, V274, P972, DOI 10.1126/science.274.5289.972; Yan XD, 2014, NEUROCHEM RES, V39, P129, DOI 10.1007/s11064-013-1197-7; Zha XM, 2001, HEARING RES, V156, P53, DOI 10.1016/S0378-5955(01)00267-2; Zhang HY, 2014, BBA-MOL CELL RES, V1843, P2967, DOI 10.1016/j.bbamcr.2014.09.010; Zhao LX, 2003, J NEUROSCI, V23, P4228	72	52	54	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162784	10.1371/journal.pone.0162784	http://dx.doi.org/10.1371/journal.pone.0162784			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611779	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900166
J	Kandeel, A; Dawson, P; Labib, M; Said, M; El-Refai, S; El-Gohari, A; Talaat, M				Kandeel, Amr; Dawson, Patrick; Labib, Manal; Said, Mayar; El-Refai, Samir; El-Gohari, Amani; Talaat, Maha			Morbidity, Mortality, and Seasonality of Influenza Hospitalizations in Egypt, November 2007-November 2014	PLOS ONE			English	Article							RESPIRATORY-SYNCYTIAL-VIRUS; A H1N1 VIRUS; PREGNANT-WOMEN; INFECTIONS; SURVEILLANCE; CHILDREN; EPIDEMICS; DISEASE; ILLNESS; BURDEN	Background Influenza typically comprises a substantial portion of acute respiratory infections, a leading cause of mortality worldwide. However, influenza epidemiology data are lacking in Egypt. We describe seven years of Egypt's influenza hospitalizations from a multi-site influenza surveillance system. Methods Syndromic case definitions identified individuals with severe acute respiratory infection (SARI) admitted to eight hospitals in Egypt. Standardized demographic and clinical data were collected. Nasopharyngeal and oropharyngeal swabs were tested for influenza using real-time reverse transcription polymerase chain reaction and typed as influenza A or B, and influenza A specimens subtyped. Results From November 2007-November 2014, 2,936/17,441 (17%) SARI cases were influenza-positive. Influenza-positive patients were more likely to be older, female, pregnant, and have chronic condition(s) (all p<0.05). Among them, 53 (2%) died, and death was associated with older age, five or more days from symptom onset to hospitalization, chronic condition(s), and influenza A (all p<0.05). An annual seasonal influenza pattern occurred from July-June. Each season, the proportion of the season's influenza-positive cases peaked during November-May (19-41%). Conclusions In Egypt, influenza causes considerable morbidity and mortality and influenza SARI hospitalization patterns mirror those of the Northern Hemisphere. Additional assessment of influenza epidemiology in Egypt may better guide disease control activities and vaccine policy.	[Kandeel, Amr; Labib, Manal; El-Refai, Samir; El-Gohari, Amani] Egypt Minist Hlth, Cairo, Egypt; [Dawson, Patrick; Said, Mayar; Talaat, Maha] US Naval Med Res Unit 3, Cairo, Egypt; [Dawson, Patrick; Talaat, Maha] US Ctr Dis Control & Prevent, Global Dis Detect Ctr, Cairo, Egypt	Egyptian Knowledge Bank (EKB); Ministry of Health & Population - Egypt; Naval Medical Research Center (NMRC); Naval Medical Research Unit - No. 3 (NAMRU-3)	Dawson, P (corresponding author), US Naval Med Res Unit 3, Cairo, Egypt.; Dawson, P (corresponding author), US Ctr Dis Control & Prevent, Global Dis Detect Ctr, Cairo, Egypt.	ptd2103@cumc.columbia.edu			Global Emerging Infections Surveillance Program (GEIS) [GEIS847705.821000.25GB.E0018]; U.S. Centers for Disease Control and Prevention	Global Emerging Infections Surveillance Program (GEIS); U.S. Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	The study was funded through the Global Emerging Infections Surveillance Program (GEIS) GEIS847705.821000.25GB.E0018 and by the U.S. Centers for Disease Control and Prevention. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdelwhab EM, 2015, VIRULENCE, V6, P6, DOI 10.4161/21505594.2014.992662; Al-Abdallat M, 2016, INFLUENZA OTHER RESP, V10, P91, DOI 10.1111/irv.12354; Al-Awaidy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144186; [Anonymous], 2014, Wkly Epidemiol Rec, V89, P161; [Anonymous], AV CAND VACC VIR POT; Azziz-Baumgartner E, 2012, B WHO, V90; BARKER WH, 1980, AM J EPIDEMIOL, V112, P798, DOI 10.1093/oxfordjournals.aje.a113052; Baumgartner EA, 2012, J INFECT DIS, V206, P838, DOI 10.1093/infdis/jis467; Cox S, 2006, OBSTET GYNECOL, V107, P1315, DOI 10.1097/01.AOG.0000218702.92005.bb; Creanga AA, 2010, OBSTET GYNECOL, V115, P717, DOI 10.1097/AOG.0b013e3181d57947; Echevarria-Zuno S, 2009, LANCET, V374, P2072, DOI 10.1016/S0140-6736(09)61638-X; El Kholy AA, 2014, J INFECT DEV COUNTR, V8, P1285, DOI 10.3855/jidc.4682; Glezen WP, 2000, JAMA-J AM MED ASSOC, V283, P499, DOI 10.1001/jama.283.4.499; GLEZEN WP, 1987, AM REV RESPIR DIS, V136, P550, DOI 10.1164/ajrccm/136.3.550; Gomaa M. R., 2014, J INFECT DIS; Horimoto T, 2001, CLIN MICROBIOL REV, V14, P129, DOI 10.1128/CMR.14.1.129-149.2001; Khattab A, 2013, ASIAN PAC J TROP MED, V6, P693, DOI 10.1016/S1995-7645(13)60120-0; Lee N, 2010, THORAX, V65, P510, DOI 10.1136/thx.2009.130799; Lowen AC, 2007, PLOS PATHOG, V3, P1470, DOI 10.1371/journal.ppat.0030151; Lozano R, 2012, LANCET, V380, P2095, DOI 10.1016/S0140-6736(12)61728-0; MCKINNEY WP, 1990, ARCH INTERN MED, V150, P213, DOI 10.1001/archinte.150.1.213; MULLOOLY JP, 1986, PUBLIC HEALTH REP, V101, P205; Nair H, 2011, LANCET, V378, P1917, DOI 10.1016/S0140-6736(11)61051-9; Neuzil KM, 2000, J PEDIATR-US, V137, P856, DOI 10.1067/mpd.2000.110445; Periolo N, 2015, J CLIN VIROL, V64, P52, DOI 10.1016/j.jcv.2015.01.009; Radin JM, 2012, J INFECT DIS, V206, pS14, DOI 10.1093/infdis/jis606; Rowlinson E, 2013, J INFECT DIS, V208, pS189, DOI 10.1093/infdis/jit457; Schluger NW, ACUTE RESP INFECT MA; Schroedl A, 2010, EMERG INFECT DIS, V16, P161, DOI 10.3201/eid1601.090560; Shafik CF, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-350; Simonsen L, 1997, AM J PUBLIC HEALTH, V87, P1944, DOI 10.2105/AJPH.87.12.1944; Tallo VL, 2014, INFLUENZA OTHER RESP, V8, P159, DOI 10.1111/irv.12223; Tamfum JJM, 2012, J INFECT DIS, V206, pS36, DOI 10.1093/infdis/jis537; Templeton KE, 2004, J CLIN MICROBIOL, V42, P1564, DOI 10.1128/JCM.42.4.1564-1569.2004; Thompson WW, 2003, JAMA-J AM MED ASSOC, V289, P179, DOI 10.1001/jama.289.2.179; U.S. Centers for Disease Control and Prevention, 2005, SEAS INFL VACC EFF; U.S. Centers for Disease Control and Prevention International Emerging Infections Program (IEIP): Thailand, DESCR CLIN PNEUM; U.S. Central Intelligence Agency, EG WORLD FACTB; United Nations Development Program, HUM DEV REP 2014; Viboud C, 2004, EUR J EPIDEMIOL, V19, P1055, DOI 10.1007/s10654-004-2450-9; WHO/GIP, 2003, CUM NUMB CONF HUM CA; World Health Organization, PAHO CDC GEN PROT IN; World Health Organization, GLOB EP SURV STAND I; World Health Organization, INT SURV REC HUM INF; World Health Organization, GLOB HLTH OBS DAT RE; World Health Organization, WORLD HLTH STAT 2014; World Health Organization (WHO), WHO GLOB TECHN CONS; World Lung Foundation, INFLUENZA	48	17	17	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161301	10.1371/journal.pone.0161301	http://dx.doi.org/10.1371/journal.pone.0161301			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607330	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255600004
J	Aravantinou, M; Frank, I; Hallor, M; Singer, R; Tharinger, H; Kenney, J; Gettie, A; Grasperge, B; Blanchard, J; Salazar, A; Piatak, M; Lifson, JD; Robbiani, M; Derby, N				Aravantinou, Meropi; Frank, Ines; Hallor, Magnus; Singer, Rachel; Tharinger, Hugo; Kenney, Jessica; Gettie, Agegnehu; Grasperge, Brooke; Blanchard, James; Salazar, Andres; Piatak, Michael, Jr.; Lifson, Jeffrey D.; Robbiani, Melissa; Derby, Nina			PolyICLC Exerts Pro- and Anti-HIV Effects on the DC-T Cell Milieu In Vitro and In Vivo	PLOS ONE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; POLYINOSINIC-POLYCYTIDYLIC ACID; IMMATURE DENDRITIC CELLS; NONHUMAN-PRIMATES; RHESUS MACAQUES; SIV INFECTION; DISEASE PROGRESSION; TARGETED VACCINE; IMMUNE-RESPONSES; L-LYSINE	Myeloid dendritic cells (mDCs) contribute to both HIV pathogenesis and elicitation of antiviral immunity. Understanding how mDC responses to stimuli shape HIV infection outcomes will inform HIV prevention and treatment strategies. The long double-stranded RNA (dsRNA) viral mimic, polyinosinic polycytidylic acid (polyIC, PIC) potently stimulates DCs to focus Th1 responses, triggers direct antiviral activity in vitro, and boosts anti-HIV responses in vivo. Stabilized polyICLC (PICLC) is being developed for vaccine adjuvant applications in humans, making it critical to understand how mDC sensing of PICLC influences HIV infection. Using the monocyte-derived DC (moDC) model, we sought to describe how PICLC (vs. other dsRNAs) impacts HIV infection within DCs and DC-T cell mixtures. We extended this work to in vivo macaque rectal transmission studies by administering PICLC with or before rectal SIVmac239 (SIVwt) or SIVmac239 Delta Nef (SIV Delta Nef) challenge. Like PIC, PICLC activated DCs and T cells, increased expression of alpha(4)beta(7) and CD169, and induced type IIFN responses in vitro. The type of dsRNA and timing of dsRNA exposure differentially impacted in vitro DC-driven HIV infection. Rectal PICLC treatment similarly induced DC and T cell activation and pro-and anti-HIV factors locally and systemically. Importantly, this did not enhance SIV transmission in vivo. Instead, SIV acquisition was marginally reduced after a single high dose challenge. Interestingly, in the PICLC-treated, SIV Delta Nef-infected animals, SIV Delta Nef viremia was higher, in line with the importance of DC and T cell activation in SIV Delta Nef replication. In the right combination anti-HIV strategy, PICLC has the potential to limit HIV infection and boost HIV immunity.	[Aravantinou, Meropi; Frank, Ines; Hallor, Magnus; Singer, Rachel; Tharinger, Hugo; Kenney, Jessica; Robbiani, Melissa; Derby, Nina] Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA; [Hallor, Magnus] Linkoping Univ, Linkoping, Sweden; [Gettie, Agegnehu] Rockefeller Univ, Aaron Diamond AIDS Res Ctr, 1230 York Ave, New York, NY 10021 USA; [Grasperge, Brooke; Blanchard, James] Tulane Univ, Hlth Sci Ctr, Tulane Natl Primate Res Ctr, Covington, LA USA; [Salazar, Andres] Oncovir Inc, Washington, DC USA; [Piatak, Michael, Jr.; Lifson, Jeffrey D.] Leidos Biomed Res Inc, AIDS & Canc Virus Program, Frederick Natl Lab, Frederick, MD USA	Population Council; Linkoping University; Rockefeller University; Tulane University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Derby, N (corresponding author), Populat Council, Ctr Biomed Res, 1230 York Ave, New York, NY 10021 USA.	nderby@popcouncil.org			National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases [R37 AI040877, R01 AI040877-19]; National Cancer Institute, NIH [HHSN261200800001E]; Tulane National Primate Research Center [P51OD011104]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI040877, U24AI126683] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [T32OD011124] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Tulane National Primate Research Center; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases Grants R37 AI040877 to MR and R01 AI040877-19 to ND and in part with federal funds from the National Cancer Institute, NIH, under Contract No. HHSN261200800001E. The content of this publication does not necessarily reflect the views or policies of the Department of Health and Human Services, nor does mention of trade names, commercial products, or organizations imply endorsement by the U.S. Government. Partial support was also provided to the Tulane National Primate Research Center by base Grant P51OD011104.	Alpert MD, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002890; [Anonymous], 2011, GUIDE CARE USE LAB A; Ansari AA, 2011, J IMMUNOL, V186, P1044, DOI 10.4049/jimmunol.1003052; Avril T, 2009, J IMMUNOTHER, V32, P353, DOI 10.1097/CJI.0b013e31819d29bf; BLACK PL, 1992, INT J IMMUNOPHARMACO, V14, P1341, DOI 10.1016/0192-0561(92)90005-6; Blanchet FP, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-6; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Byrareddy SN, 2014, NAT MED, V20, P1397, DOI 10.1038/nm.3715; Caskey M, 2011, J EXP MED, V208, P2357, DOI 10.1084/jem.20111171; Chertova E, 2002, J VIROL, V76, P5315, DOI 10.1128/JVI.76.11.5315-5325.2002; Cicala C, 2009, P NATL ACAD SCI USA, V106, P20877, DOI 10.1073/pnas.0911796106; Cline AN, 2005, J MED PRIMATOL, V34, P303; Conforti R, 2010, CANCER RES, V70, P490, DOI 10.1158/0008-5472.CAN-09-1890; Cunningham AL, 2010, CURR OPIN MICROBIOL, V13, P524, DOI 10.1016/j.mib.2010.06.002; de Jong MAWP, 2010, J IMMUNOL, V185, P1633, DOI 10.4049/jimmunol.0904137; Derby N, 2011, CURR OPIN HIV AIDS, V6, P379, DOI 10.1097/COH.0b013e3283499d63; Derdeyn CA, 2000, J VIROL, V74, P8358, DOI 10.1128/JVI.74.18.8358-8367.2000; Flynn BJ, 2011, P NATL ACAD SCI USA, V108, P7131, DOI 10.1073/pnas.1103869108; Frank I, 2002, J VIROL, V76, P2936, DOI 10.1128/JVI.76.6.2936-2951.2002; Fukazawa Y, 2012, NAT MED, V18, P1673, DOI 10.1038/nm.2934; Gesuete R, 2016, STROKE, V47, P262, DOI 10.1161/STROKEAHA.115.010329; Goode D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097767; Gowen BB, 2007, J IMMUNOL, V178, P5200, DOI 10.4049/jimmunol.178.8.5200; Guerra-Perez N, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149491; Guerra-Perez N, 2015, J IMMUNOL, V194, P2415, DOI 10.4049/jimmunol.1402623; Gummuluru S, 2014, J INFECT DIS, V210, pS641, DOI 10.1093/infdis/jiu442; Hartman LLR, 2014, J PEDIAT HEMATOL ONC, V36, P451, DOI 10.1097/MPH.0000000000000047; Hladik F, 2008, NAT REV IMMUNOL, V8, P447, DOI 10.1038/nri2302; Hu W, 2015, P NATL ACAD SCI USA, V112, P13994, DOI 10.1073/pnas.1510760112; Izquierdo-Useros N, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004146; Izquierdo-Useros N, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001448; Jaroenpool J, 2007, CELL IMMUNOL, V250, P91, DOI 10.1016/j.cellimm.2008.01.009; Jasny E, 2012, JAIDS-J ACQ IMM DEF, V61, P425, DOI 10.1097/QAI.0b013e318266be53; Johnson RP, 1999, J VIROL, V73, P4952, DOI 10.1128/JVI.73.6.4952-4961.1999; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kim WK, 2015, AIDS RES HUM RETROV, V31, P696, DOI [10.1089/aid.2015.0003, 10.1089/AID.2015.0003]; Lee AW, 2002, VACCINE, V20, pA8, DOI 10.1016/S0264-410X(02)00382-1; LEVY HB, 1975, J INFECT DIS, V132, P434, DOI 10.1093/infdis/132.4.434; Li QS, 2014, J IMMUNOL, V193, P3113, DOI 10.4049/jimmunol.1400820; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Longhi MP, 2009, J EXP MED, V206, P1589, DOI 10.1084/jem.20090247; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Martin-Gayo E., 2016, C RETR OPP INF BOST; Martinelli E, 2013, JAIDS J ACQUIRED IMM; Martinelli E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002109; Martins KA, 2015, EXPERT REV VACCINES, V14, P447, DOI 10.1586/14760584.2015.966085; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Messmer D, 2000, J VIROL, V74, P2406, DOI 10.1128/JVI.74.5.2406-2413.2000; Miller EA, 2016, C RETR OPP INF BOST; Morse MA, 2011, CLIN CANCER RES, V17, P4844, DOI 10.1158/1078-0432.CCR-11-0891; Nagai T, 2003, J IMMUNOL, V171, P5233, DOI 10.4049/jimmunol.171.10.5233; Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Nicodemus CF, 2010, IMMUNOTHERAPY-UK, V2, P137, DOI 10.2217/IMT.10.8; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Okada H, 2011, J CLIN ONCOL, V29, P330, DOI 10.1200/JCO.2010.30.7744; Paijo J, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005546; Pantel A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001759; Park H, 2013, J IMMUNOL, V190, P4103, DOI 10.4049/jimmunol.1202958; Peng G, 2007, BLOOD, V110, P393, DOI 10.1182/blood-2006-10-051763; Peretti S, 2005, BLOOD, V106, P1305, DOI 10.1182/blood-2004-12-4899; Petit C, 2001, VIROLOGY, V286, P225, DOI 10.1006/viro.2001.0984; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Pion M, 2006, J EXP MED, V203, P2887, DOI 10.1084/jem.20061519; Puryear WB, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003291; REED L. J., 1938, AMER JOUR HYG, V27, P493; Rempel H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001967; Rodriguez-Plata MT, 2012, J IMMUNOL, V188, P6036, DOI 10.4049/jimmunol.1200267; Salisch NC, 2010, J IMMUNOL, V184, P476, DOI 10.4049/jimmunol.0902781; Sanders RW, 2002, J VIROL, V76, P7812, DOI 10.1128/JVI.76.15.7812-7821.2002; Sandler NG, 2014, NATURE, V511, P601, DOI 10.1038/nature13554; Saulle I, 2016, AIDS RES HUM RETROV, V32, P129, DOI [10.1089/AID.2015.0019, 10.1089/aid.2015.0019]; Shey MS, 2015, INNATE IMMUN-LONDON, V21, P99, DOI 10.1177/1753425913513815; Sloan DD, 2015, C RETR OPP INF BOST; St Gelais C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034521; Stahl-Hennig C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000373; Steinman RM, 2007, NATURE, V449, P419, DOI 10.1038/nature06175; Stopak KS, 2007, J BIOL CHEM, V282, P3539, DOI 10.1074/jbc.M610138200; TALMADGE JE, 1985, CANCER RES, V45, P1058; Tewari K, 2010, VACCINE, V28, P7256, DOI 10.1016/j.vaccine.2010.08.098; Thielen BK, 2010, J BIOL CHEM, V285, P27753, DOI 10.1074/jbc.M110.102822; Thompson EA, 2015, J IMMUNOL, V195, P1015, DOI 10.4049/jimmunol.1500078; Trapp S, 2009, J VIROL, V83, P884, DOI 10.1128/JVI.00023-08; Trumpfheller C, 2008, P NATL ACAD SCI USA, V105, P2574, DOI 10.1073/pnas.0711976105; Turville SG, 2004, BLOOD, V103, P2170, DOI 10.1182/blood-2003-09-3129; Turville SG, 2008, NAT METHODS, V5, P75, DOI 10.1038/NMETH1137; Turville SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003162; Vagenas P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012891; Vagenas P, 2009, JAIDS-J ACQ IMM DEF, V52, P433, DOI 10.1097/QAI.0b013e3181b880f3; van der Kuyl AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000257; Wang LL, 2002, J CLIN INVEST, V110, P1175, DOI 10.1172/JCI200215536; Wang YC, 2005, J VIROL, V79, P14355, DOI 10.1128/JVI.79.22.14355-14370.2005; Whitney JB, 2015, C RETR OPP INF BOST; Whitney JB, 2016, C RETR OPP INF BOST; Wonderlich ER, 2012, VIRULENCE, V3, P647, DOI 10.4161/viru.22491; Wong JP, 2009, CURR PHARM DESIGN, V15, P1269, DOI 10.2174/138161209787846775; Wong JP, 2005, VACCINE, V23, P2266, DOI 10.1016/j.vaccine.2005.01.037; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Wyand MS, 1996, J VIROL, V70, P3724, DOI 10.1128/JVI.70.6.3724-3733.1996; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Zhang FW, 2009, CELL HOST MICROBE, V6, P54, DOI 10.1016/j.chom.2009.05.008	101	9	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161730	10.1371/journal.pone.0161730	http://dx.doi.org/10.1371/journal.pone.0161730			33	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603520	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200023
J	Belmont, TFD; Palmeira, DK; da Silva, AS; Vilar, KD; Medeiros, FS; Vasconcelos, LRS; dos Anjos, ACM; Hatzlhofer, BLD; Pitta, MGD; Bezerra, MAC; Araujo, AD; Rego, MJBD; Moura, P; Cavalcanti, MDM				de Mendonca Belmont, Taciana Furtado; Palmeira, Kleyton do O.; da Silva, Andreia Soares; Vilar, Kamila de Melo; Medeiros, Fernanda Silva; Silva Vasconcelos, Luydson Richardson; Mendona dos Anjos, Ana Claudia; Domingues Hatzlhofer, Betania Lucena; da Rocha Pitta, Maira Galdino; Cavalcanti Bezerra, Marcos Andre; Araujo, Aderson da Silva; Barreto de Melo Rego, Moacyr Jesus; Moura, Patricia; Mendona Cavalcanti, Maria do Socorro			Single Nucleotide Polymorphisms at+191 and+292 of Galectin-3 Gene (LGALS3) Related to Lower GAL-3 Serum Levels Are Associated with Frequent Respiratory Tract Infection and Vaso-Occlusive Crisis in Children with Sickle Cell Anemia	PLOS ONE			English	Article							INFLAMMATION; SECRETION; RELEASE; FAMILY; INJURY	Introduction Patients with sickle cell anemia (SCA) may present chronic hemolytic anemia, vaso-occlusion and respiratory tract infection (RTI) episodes. Galectin-3 (GAL-3) is a multifunctional protein involved in inflammation, apoptosis, adhesion and resistance to reactive oxygen species. Studies point to a dual role for GAL-3 as both a circulation damage-associated molecular pattern and a cell membrane associated pattern recognition receptor. Objective To investigate associations between the SNPs of GAL-3 gene (LGALS3) and serum levels with RTI and vaso-occlusive crisis (VOC) in children with SCA. Materials and Methods SNPs +191 and +292 in LGALS3 were studied using the TaqMan real-time PCR system; GAL-3 serum levels were measured by ELISA. The study included 79 children with SCA ranging from 2 to 12 years old. Results GAL-3 serum levels were associated with LGALS3 +191 and +292 genotypes (p < 0.0001; p = 0.0169, respectively). LGALS3 +191, AA genotype was associated with low and CC with higher levels of GAL-3. For LGALS3 +292, the CC genotype was associated with lower GAL-3 and AA with higher levels. Patients with Frequency of RTI (FRTI) >= 1 presented higher frequency of +191AA (p = 0.0263) and +292AC/CC genotypes (p = 0.0320). SNP +292 was associated with Frequency of VOC (FVOC) (p = 0.0347), whereas no association was shown with SNP + 191 and FVOC. However, CA/AC and AA/CC genotypes with lower GAL-3 levels showed a higher frequency in patients with FRTI >= 1 (p = 0.0170; p = 0.0138, respectively). Also, patients with FVOC >= 1 presented association with CA/AC (p = 0.0228). LGALS3 +191 and +292 combined genotypes related to low (p = 0.0263) and intermediate expression (p = 0.0245) were associated with FRTI >= 1. Lower GAL-3 serum levels were associated with FRTI >= 1 (p = 0.0426) and FVOC >= 1 (p = 0.0012). Conclusion Variation of GAL-3 serum levels related to SNPs at +191 and +292 may constitute a susceptibility factor for RTI and VOC frequency.	[de Mendonca Belmont, Taciana Furtado; Moura, Patricia; Mendona Cavalcanti, Maria do Socorro] Rede Nordeste Biotecnol, Programa Doutorado, Recife, PE, Brazil; [Palmeira, Kleyton do O.; da Silva, Andreia Soares; Medeiros, Fernanda Silva; Moura, Patricia; Mendona Cavalcanti, Maria do Socorro] Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil; [Palmeira, Kleyton do O.; da Silva, Andreia Soares; Medeiros, Fernanda Silva; Moura, Patricia; Mendona Cavalcanti, Maria do Socorro] Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil; [Vilar, Kamila de Melo; da Rocha Pitta, Maira Galdino; Barreto de Melo Rego, Moacyr Jesus] Univ Fed Pernambuco, LINAT, Recife, PE, Brazil; [Silva Vasconcelos, Luydson Richardson] CPqAM FIOCRUZ PE, Ctr Pesquisas Aggeu Magalhaes, Recife, PE, Brazil; [Mendona dos Anjos, Ana Claudia; Araujo, Aderson da Silva] Fundacao Hematol & Hemoterapia Pernambuco HEMOPE, Recife, PE, Brazil; [Domingues Hatzlhofer, Betania Lucena; Cavalcanti Bezerra, Marcos Andre] Univ Fed Pernambuco, Dept Ciencias Biol, Recife, PE, Brazil	Universidade de Pernambuco (UPE); Universidade de Pernambuco (UPE); Universidade Federal de Pernambuco; Fundacao Oswaldo Cruz; Universidade Federal de Pernambuco	Moura, P (corresponding author), Rede Nordeste Biotecnol, Programa Doutorado, Recife, PE, Brazil.; Moura, P (corresponding author), Univ Pernambuco, Inst Ciencias Biol, Recife, PE, Brazil.; Moura, P (corresponding author), Univ Pernambuco, Fac Ciencias Med, Recife, PE, Brazil.	patricia.moura@upe.br	Pitta, Maira G R/H-8433-2013; Moura, Patricia M M F/H-7233-2018; Vasconcelos, Luydson/AAC-4907-2020; Rêgo, Moacyr/I-6782-2013	Vasconcelos, Luydson/0000-0002-1625-3358; Rêgo, Moacyr/0000-0002-1883-6012; Moura, Patricia/0000-0003-4259-388X; Soares da Silva, Andreia/0000-0003-1600-6899	National Council for Scientific and Technological Development (CNPq); Higher Education Personnel Training Coordination (Capes); Foundation for Science and Technology of the State of Pernambuco (FACEPE)	National Council for Scientific and Technological Development (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Higher Education Personnel Training Coordination (Capes)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Foundation for Science and Technology of the State of Pernambuco (FACEPE)(Fundacao de Amparo a Ciencia e Tecnologia do Estado de Pernambuco (FACEPE))	This work was supported by the National Council for Scientific and Technological Development (CNPq), the Higher Education Personnel Training Coordination (Capes) and the Foundation for Science and Technology of the State of Pernambuco (FACEPE). The funders had no role in study design, data collection, analysis, decision to publish, or preparation of the manuscript.	Aslan M, 2000, ANN NY ACAD SCI, V899, P375; BARONDES SH, 1994, J BIOL CHEM, V269, P20807; Chen HJ, 2012, NEUROSCI LETT, V518, P1, DOI 10.1016/j.neulet.2012.02.065; Davis LG, 1986, BASIC METHODS MOL BI, P338; Di Lella S, 2011, BIOCHEMISTRY-US, V50, P7842, DOI 10.1021/bi201121m; Dover G, 2003, HEMATOLOGY INFANCY C, P790; Dumic J, 2006, BBA-GEN SUBJECTS, V1760, P616, DOI 10.1016/j.bbagen.2005.12.020; Farnworth SL, 2008, AM J PATHOL, V172, P395, DOI 10.2353/ajpath.2008.070870; Hebbel RP, 2014, HEMATOL ONCOL CLIN N, V28, P181, DOI 10.1016/j.hoc.2013.11.005; Henderson NC, 2009, IMMUNOL REV, V230, P160, DOI 10.1111/j.1600-065X.2009.00794.x; Hoppe CC, 2014, HEMATOL ONCOL CLIN N, V28, P265, DOI 10.1016/j.hoc.2013.11.006; Hu CY, 2011, CLIN RHEUMATOL, V30, P1227, DOI 10.1007/s10067-011-1741-2; Hughes RC, 1999, BBA-GEN SUBJECTS, V1473, P172, DOI 10.1016/S0304-4165(99)00177-4; Ipek G, 2015, CARDIOLOGY, V132, P105, DOI 10.1159/000431354; Kadrofske MM, 1998, ARCH BIOCHEM BIOPHYS, V349, P7, DOI 10.1006/abbi.1997.0447; Kaul DK, 2000, BLOOD, V95, P368, DOI 10.1182/blood.V95.2.368; Madrigal-Matute J, 2014, J AM HEART ASSOC, V3, DOI 10.1161/JAHA.114.000785; Mehul B, 1997, J CELL SCI, V110, P1169; Mendonca TF, 2010, BLOOD CELL MOL DIS, V44, P224, DOI 10.1016/j.bcmd.2010.02.004; Menon RP, 1999, EUR J BIOCHEM, V264, P569, DOI 10.1046/j.1432-1327.1999.00671.x; Moon BK, 2001, AM J PATHOL, V159, P1055, DOI 10.1016/S0002-9440(10)61780-4; Newlaczyl AU, 2011, CANCER LETT, V313, P123, DOI 10.1016/j.canlet.2011.09.003; Nieminen J, 2007, J BIOL CHEM, V282, P1374, DOI 10.1074/jbc.M604506200; Pena SDJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017063; Quinn CT, 2016, EXP BIOL MED MAYWOOD; Raimond J, 1997, MAMM GENOME, V8, P706, DOI 10.1007/s003359900548; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Sano H, 2003, J CLIN INVEST, V112, P389, DOI 10.1172/JCI200317592; Sato S, 2009, IMMUNOL REV, V230, P172, DOI 10.1111/j.1600-065X.2009.00790.x; Steinberg MH, 2009, THESCIENTIFICWORLDJO, V9, P46, DOI 10.1100/tsw.2009.10; ten Oever J, 2013, EUR J CLIN MICROBIOL, V32, P1605, DOI 10.1007/s10096-013-1919-4; Torres LD, 2016, CYTOKINE, V80, P18, DOI 10.1016/j.cyto.2016.02.012; Yu F, 2002, J BIOL CHEM, V277, P15819, DOI 10.1074/jbc.M200154200; ZUBERI RI, 1994, CELL IMMUNOL, V156, P1, DOI 10.1006/cimm.1994.1148	34	5	5	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162297	10.1371/journal.pone.0162297	http://dx.doi.org/10.1371/journal.pone.0162297			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603703	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200055
J	Li, ZZ; Zhang, TT; Lin, ZC; Hou, CZ; Zhang, J; Men, YQ; Li, HS; Gao, JG				Li, Zhenzu; Zhang, Tingting; Lin, Zhuchun; Hou, Congzhe; Zhang, Jian; Men, Yuqin; Li, Huashun; Gao, Jiangang			Lgl1 Is Required for Olfaction and Development of Olfactory Bulb in Mice	PLOS ONE			English	Article							ROSTRAL MIGRATORY STREAM; GANGLIONIC EMINENCE; POLARITY COMPLEX; KNOCKOUT MICE; NULL MICE; NEURONS; BRAIN; GENE; DIFFERENTIATION; EXPRESSION	Lethal giant larvae 1 (Lgl1) was initially identified as a tumor suppressor in Drosophila and functioned as a key regulator of epithelial polarity and asymmetric cell division. In this study, we generated Lgl1 conditional knockout mice mediated by Pax2-Cre, which is expressed in olfactory bulb (OB). Next, we examined the effects of Lgl1 loss in the OB. First, we determined the expression patterns of Lgl1 in the neurogenic regions of the embryonic dorsal region of the LGE (dLGE) and postnatal OB. Furthermore, the Lgl1 conditional mutants exhibited abnormal morphological characteristics of the OB. Our behavioral analysis exhibited greatly impaired olfaction in Lgl1 mutant mice. To elucidate the possible mechanisms of impaired olfaction in Lgl1 mutant mice, we investigated the development of the OB. Interestingly, reduced thickness of the MCL and decreased density of mitral cells (MCs) were observed in Lgl1 mutant mice. Additionally, we observed a dramatic loss in SP8(+) interneurons (e.g. calretinin and GABAergic/non-dopaminergic interneurons) in the GL of the OB. Our results demonstrate that Lgl1 is required for the development of the OB and the deletion of Lgl1 results in impaired olfaction in mice.	[Li, Zhenzu; Zhang, Tingting; Zhang, Jian; Men, Yuqin; Gao, Jiangang] Shandong Univ, Inst Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China; [Lin, Zhuchun] Jinan First Peoples Hosp, Jinan 250011, Shandong, Peoples R China; [Hou, Congzhe] Shandong Univ, Hosp 2, Jinan 250000, Shandong, Peoples R China; [Li, Huashun] Tongji Univ, Shanghai East Hosp, Adv Inst Translat Med, Sch Med,SARITEX Ctr Stem Cell Engn Translat Med, Shanghai 200123, Peoples R China; [Li, Huashun] Chinese Acad Sci, Shanghai Adv Res Inst, Ctr Stem Cell&Nanomed, Shanghai 200123, Peoples R China; [Li, Huashun] Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Mol Biol Neural Dev, Shenzhen 518000, Guangdong, Peoples R China	Shandong University; Shandong University; Tongji University; Chinese Academy of Sciences; Shanghai Advanced Research Institute, CAS; Chinese Academy of Sciences; Shenzhen Institute of Advanced Technology, CAS	Gao, JG (corresponding author), Shandong Univ, Inst Dev Biol, Sch Life Sci, Jinan 250100, Shandong, Peoples R China.; Li, HS (corresponding author), Tongji Univ, Shanghai East Hosp, Adv Inst Translat Med, Sch Med,SARITEX Ctr Stem Cell Engn Translat Med, Shanghai 200123, Peoples R China.; Li, HS (corresponding author), Chinese Acad Sci, Shanghai Adv Res Inst, Ctr Stem Cell&Nanomed, Shanghai 200123, Peoples R China.; Li, HS (corresponding author), Chinese Acad Sci, Shenzhen Inst Adv Technol, Shenzhen Key Lab Mol Biol Neural Dev, Shenzhen 518000, Guangdong, Peoples R China.	huashunli@tongji.edu.cn; jggao@sdu.edu.cn		Zhang, Jian/0000-0001-6231-0301	National Basic Research Program (973) of China [2014CB541703]; National Natural Science Foundation of China [30871436, 30973297, 31171194]; Shandong Provincial Science and Technology Key Program [2009GG10002039]; Shenzhen Committee for Technological Renovation [ZDSY20120617112838879]; Shenzhen Peacock Plan [KQCX20130628112914292]; Shandong Provincial Natural Science Foundation of China [ZR2013CQ041]	National Basic Research Program (973) of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Provincial Science and Technology Key Program; Shenzhen Committee for Technological Renovation; Shenzhen Peacock Plan; Shandong Provincial Natural Science Foundation of China(Natural Science Foundation of Shandong Province)	This work was supported by grants from the National Basic Research Program (973) of China (2014CB541703); the National Natural Science Foundation of China (30871436, 30973297 and 31171194); Shandong Provincial Science and Technology Key Program (2009GG10002039); Shenzhen Committee for Technological Renovation (ZDSY20120617112838879) and Shenzhen Peacock Plan (KQCX20130628112914292); and Shandong Provincial Natural Science Foundation of China (ZR2013CQ041).	Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Bell SM, 2003, P NATL ACAD SCI USA, V100, P12195, DOI 10.1073/pnas.2134310100; Capilla-Gonzalez V, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00147; Congzhe H, 2014, DEV BIOL, V395, P167, DOI [10.1016/j.ydbio.2014.07.007, DOI 10.1016/J.YDBIO.2014.07.007]; Dahan I, 2012, MOL BIOL CELL, V23, P591, DOI 10.1091/mbc.E11-01-0015; EDWARDS DA, 1972, BEHAV BIOL, V7, P823, DOI 10.1016/S0091-6773(72)80174-3; Ke MT, 2013, NAT NEUROSCI, V16, P1154, DOI 10.1038/nn.3447; Klezovitch O, 2004, GENE DEV, V18, P559, DOI 10.1101/gad.1178004; Kosaka K, 1998, NEUROSCI RES, V30, P101, DOI 10.1016/S0168-0102(98)00002-9; KOSAKA T, 1985, BRAIN RES, V343, P166, DOI 10.1016/0006-8993(85)91172-2; Kosaka T, 2012, NEUROSCI RES, V73, P24, DOI 10.1016/j.neures.2012.02.013; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; LOIS C, 1994, SCIENCE, V264, P1145, DOI 10.1126/science.8178174; Lopez-Mascaraque L, 2002, CELL DEATH DIFFER, V9, P1279, DOI 10.1038/sj.cdd.4401076; LUSKIN MB, 1993, NEURON, V11, P173, DOI 10.1016/0896-6273(93)90281-U; Nagayama S, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00098; Nathan BP, 2004, BEHAV BRAIN RES, V150, P1, DOI 10.1016/S0166-4328(03)00219-5; Ohyama T, 2004, GENESIS, V38, P195, DOI 10.1002/gene.20017; Pencea V, 2003, J COMP NEUROL, V463, P402, DOI 10.1002/cne.10746; Plant PJ, 2003, NAT CELL BIOL, V5, P301, DOI 10.1038/ncb948; Prosser HM, 2007, EUR J NEUROSCI, V26, P3339, DOI 10.1111/j.1460-9568.2007.05958.x; Schablitzky S, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00045; Schimanski CC, 2005, ONCOGENE, V24, P3100, DOI 10.1038/sj.onc.1208520; Schmouth JF, 2012, MOL CELL BIOL, V32, P1296, DOI 10.1128/MCB.06016-11; Sosulski DL, 2011, NATURE, V472, P213, DOI 10.1038/nature09868; Stenman J, 2003, J NEUROSCI, V23, P167; Tallquist MD, 2000, GENESIS, V26, P113, DOI 10.1002/(SICI)1526-968X(200002)26:2<113::AID-GENE3>3.0.CO;2-2; Wang T, 2011, DEV CELL, V21, P431, DOI 10.1016/j.devcel.2011.07.007; Wichterle H, 1997, NEURON, V18, P779, DOI 10.1016/S0896-6273(00)80317-7; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Yoshihara S, 2005, DEVELOPMENT, V132, P751, DOI 10.1242/dev.01619; Yun K, 2001, DEVELOPMENT, V128, P193; Zarnescu DC, 2005, DEV CELL, V8, P43, DOI 10.1016/j.devcel.2004.10.020	33	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162126	10.1371/journal.pone.0162126	http://dx.doi.org/10.1371/journal.pone.0162126			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603780	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255200046
J	Stevenson, KT; Peterson, MN; Bradshaw, A				Stevenson, Kathryn T.; Peterson, M. Nils; Bradshaw, Amy			How Climate Change Beliefs among US Teachers Do and Do Not Translate to Students	PLOS ONE			English	Article							CHANGE KNOWLEDGE; EDUCATION; SKEPTICISM; PERCEPTIONS; ADOLESCENTS; RISK	Research suggests climate change beliefs among science teachers mirror those of the general public, raising questions of whether teachers may be perpetuating polarization of public opinion through their classrooms. We began answering these questions with a survey of middle school science teachers (n = 24) and their students (n = 369) in North Carolina, USA. Similar to previous studies, we found that though nearly all (92.1%) of students had teachers who believe that global warming is happening, few (12%) are in classrooms with teachers who recognize that global warming is anthropogenic. We found that teacher beliefs that global warming is happening and student climate change knowledge were the strongest predictors of student belief that global warming is happening and human caused. Conversely, teacher beliefs about human causes of global warming had no relationship with student beliefs, suggesting that science teachers' low recognition of the causes of global warming is not necessarily problematic in terms of student outcomes. These findings may be explained by previous research suggesting adolescents interpret scientific information relatively independently of ideological constraints. Though teacher polarization may be problematic in its own right, it appears that as long as climate change information is presented in classrooms, students deduce anthropogenic causes.	[Stevenson, Kathryn T.; Peterson, M. Nils] North Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA; [Bradshaw, Amy] NC State Univ, Dept Zool, Raleigh, NC USA	University of North Carolina; North Carolina State University; University of North Carolina; North Carolina State University	Stevenson, KT (corresponding author), North Carolina State Univ, Fisheries Wildlife & Conservat Biol Program, Dept Forestry & Environm Resources, Raleigh, NC 27695 USA.	kathryn_stevenson@ncsu.edu		Stevenson, Kathryn/0000-0002-5577-5861; Peterson, Nils/0000-0002-4246-1206	North Carolina Sea Grant [2012-R/12-HCE-5]	North Carolina Sea Grant	North Carolina Sea Grant for funded this work (Project # 2012-R/12-HCE-5): https://ncseagrant.ncsu.edu/ in a grant awarded to MNP and KTS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold HE, 2009, J ENVIRON EDUC, V40, P27, DOI 10.3200/JOEE.40.3.27-36; Bedford D, 2015, J GEOG, V115, P1; Blandford C, 2009, CLIMATE CHANGE PERCE; Capstick S, 2015, WIRES CLIM CHANGE, V6, P35, DOI 10.1002/wcc.321; Cook J, 2016, ENVIRON RES LETT, V11, DOI 10.1088/1748-9326/11/4/048002; Cook J, 2013, ENVIRON RES LETT, V8, DOI 10.1088/1748-9326/8/2/024024; Corner A, 2015, WIRES CLIM CHANGE, V6, P523, DOI 10.1002/wcc.353; Desimone LM, 2004, EDUC EVAL POLICY AN, V26, P1, DOI 10.3102/01623737026001001; Flora JA, 2014, CLIMATIC CHANGE, V127, P419, DOI 10.1007/s10584-014-1274-1; Hamilton LC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138208; Hamilton LC, 2011, CLIMATIC CHANGE, V104, P231, DOI 10.1007/s10584-010-9957-8; Harish Alon, 2012, ABCNEWS 0802; Hornsey MJ, 2016, NAT CLIM CHANGE, V6, P622, DOI [10.1038/nclimate2943, 10.1038/NCLIMATE2943]; Howe PD, 2015, NAT CLIM CHANGE, V5, P596, DOI 10.1038/nclimate2583; Kahan DM, 2012, NAT CLIM CHANGE, V2, P732, DOI 10.1038/NCLIMATE1547; Kahan DM, 2012, HDB RISK THEORY EPIS, V1; Leiserowitz A, 2011, AM TEENSKNOWLEDGE CL, P2; Leiserowitz A., 2010, RACE ETHNICITY PUBLI; McBeth B., 2008, NATL ENV LITERACY AS; McCright AM, 2010, POPUL ENVIRON, V32, P66, DOI 10.1007/s11111-010-0113-1; Mead E, 2012, ATL J COMMUN, V20, P31, DOI 10.1080/15456870.2012.637027; Moser SC, 2011, OXFORD HDB CLIMATE C, P161; Ojala M, 2015, J YOUTH STUD, V18, P1135, DOI 10.1080/13676261.2015.1020927; Ojala M, 2013, SUSTAINABILITY-BASEL, V5, P2191, DOI 10.3390/su5052191; Pew Research Center, 2014, CLIM CHANG KEY DAT P; Plutzer E, 2016, SCIENCE, V351, P664, DOI 10.1126/science.aab3907; Sears DO, 1999, J POLIT, V61, P1, DOI 10.2307/2647773; Shi J, 2016, NAT CLIM CHANGE, V6, P759, DOI [10.1038/NCLIMATE2997, 10.1038/nclimate2997]; Shi J, 2015, RISK ANAL, V35, P2183, DOI 10.1111/risa.12406; Sina M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147201; Smith N, 2012, RISK ANAL, V32, P1021, DOI 10.1111/j.1539-6924.2012.01801.x; Stevenson KT, 2014, CLIMATIC CHANGE, V126, P293, DOI 10.1007/s10584-014-1228-7; Taber F., 2009, International Journal of Environmental & Science Education, V4, P97; Tobler C, 2012, CLIMATIC CHANGE, V114, P189, DOI 10.1007/s10584-011-0393-1; Younger M, 2008, AM J PREV MED, V35, P517, DOI 10.1016/j.amepre.2008.08.017	35	25	26	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161462	10.1371/journal.pone.0161462	http://dx.doi.org/10.1371/journal.pone.0161462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603667	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255200014
J	Kinyua, AW; Yang, DJ; Chang, I; Kim, KW				Kinyua, Ann W.; Yang, Dong Joo; Chang, Inik; Kim, Ki Woo			Steroidogenic Factor 1 in the Ventromedial Nucleus of the Hypothalamus Regulates Age-Dependent Obesity	PLOS ONE			English	Article							RECEPTOR MESSENGER-RNA; BROWN ADIPOSE-TISSUE; SYMPATHETIC ACTIVITY; FEEDING-BEHAVIOR; BODY-WEIGHT; LEPTIN; RATS; HOMEOSTASIS; NEURONS; LESIONS	The ventromedial nucleus of the hypothalamus (VMH) is important for the regulation of whole body energy homeostasis and lesions in the VMH are reported to result in massive weight gain. The nuclear receptor steroidogenic factor 1 (SF-1) is a known VMH marker as it is exclusively expressed in the VMH region of the brain. SF-1 plays a critical role not only in the development of VMH but also in its physiological functions. In this study, we generated prenatal VMH-specific SF-1 KO mice and investigated age-dependent energy homeostasis regulation by SF-1. Deletion of SF-1 in the VMH resulted in dysregulated insulin and leptin homeostasis and late onset obesity due to increased food intake under normal chow and high fat diet conditions. In addition, SF-1 ablation was accompanied by a marked reduction in energy expenditure and physical activity and this effect was significantly pronounced in the aged mice. Taken together, our data indicates that SF-1 is a key component in the VMH-mediated regulation of energy homeostasis and implies that SF-1 plays a protective role against metabolic stressors including aging and high fat diet.	[Kinyua, Ann W.; Yang, Dong Joo; Kim, Ki Woo] Yonsei Univ, Wonju Coll Med, Dept Pharmacol, Wonju 26426, South Korea; [Kinyua, Ann W.; Yang, Dong Joo; Kim, Ki Woo] Yonsei Univ, Wonju Coll Med, Dept Global Med Sci, Wonju 26426, South Korea; [Chang, Inik] Yonsei Univ, Dept Oral Biol, Coll Dent, Seoul 03722, South Korea; [Kim, Ki Woo] UT Southwestern Med Ctr, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA; [Kim, Ki Woo] UT Southwestern Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA	Yonsei University; Yonsei University; Yonsei University; Yonsei University Health System; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Kim, KW (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Pharmacol, Wonju 26426, South Korea.; Kim, KW (corresponding author), Yonsei Univ, Wonju Coll Med, Dept Global Med Sci, Wonju 26426, South Korea.; Kim, KW (corresponding author), UT Southwestern Med Ctr, Div Hypothalam Res, Dept Internal Med, Dallas, TX 75390 USA.; Kim, KW (corresponding author), UT Southwestern Med Ctr, Dept Pharmacol, Dallas, TX 75390 USA.	kiwoo@yonsei.ac.kr	Kim, Ki Woo Woo/AAW-9645-2021	Kim, Ki Woo Woo/0000-0002-7790-1515	Small and Medium Business Administration (Technological Innovation RD Program) [S2178403]; National Research Foundation [2016R1C1B3012748, 2014K1A3A1A19066980, 2016R1A5A2008630]; Global PhD Fellowship [NRF-2015H1A2A1032009]	Small and Medium Business Administration (Technological Innovation RD Program); National Research Foundation; Global PhD Fellowship	This work was supported by Small and Medium Business Administration (Technological Innovation R&D Program S2178403), National Research Foundation (2016R1C1B3012748 and 2014K1A3A1A19066980 for K.W.K. and 2016R1A5A2008630 for I. C.), and Global PhD Fellowship (NRF-2015H1A2A1032009 for D. J. Y.).	Barbera MJ, 2001, J BIOL CHEM, V276, P1486, DOI 10.1074/jbc.M006246200; Bartelt A, 2012, CURR OPIN LIPIDOL, V23, P190, DOI 10.1097/MOL.0b013e328352dcef; BAUMGARTNER RN, 1995, J GERONTOL A-BIOL, V50, pM307, DOI 10.1093/gerona/50A.6.M307; BERTHOUD HR, 1979, ENDOCRINOLOGY, V105, P146, DOI 10.1210/endo-105-1-146; Bingham NC, 2008, ENDOCRINOLOGY, V149, P2138, DOI 10.1210/en.2007-1200; Borg MA, 1997, J CLIN INVEST, V99, P361, DOI 10.1172/JCI119165; Collins Sheila, 2011, Front Endocrinol (Lausanne), V2, P102, DOI 10.3389/fendo.2011.00102; Dhillon H, 2006, NEURON, V49, P191, DOI 10.1016/j.neuron.2005.12.021; Elmquist JK, 1998, J COMP NEUROL, V395, P535; Gu ZY, 2012, AGE, V34, P1393, DOI 10.1007/s11357-011-9312-7; Hondares E, 2006, ENDOCRINOLOGY, V147, P2829, DOI 10.1210/en.2006-0070; IKEDA Y, 1995, MOL ENDOCRINOL, V9, P478, DOI 10.1210/me.9.4.478; Kim KW, 2012, J CLIN INVEST, V122, P2578, DOI 10.1172/JCI62848; Kim KW, 2011, P NATL ACAD SCI USA, V108, P10673, DOI 10.1073/pnas.1102364108; King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007; Klockener T, 2011, NAT NEUROSCI, V14, P911, DOI 10.1038/nn.2847; Lowell BB, 2000, NATURE, V404, P652, DOI 10.1038/35007527; Majdic G, 2002, ENDOCRINOLOGY, V143, P607, DOI 10.1210/en.143.2.607; Martin-Gronert Malgorzata S, 2013, Med Wieku Rozwoj, V17, P7; Mercer JG, 1996, FEBS LETT, V387, P113, DOI 10.1016/0014-5793(96)00473-5; Muller DC, 1996, SEMIN NEPHROL, V16, P289; Nedergaard J, 2005, BBA-MOL BASIS DIS, V1740, P293, DOI 10.1016/j.bbadis.2005.02.003; NICHOLLS DG, 1984, PHYSIOL REV, V64, P1, DOI 10.1152/physrev.1984.64.1.1; Parker KL, 1998, MOL CELL ENDOCRINOL, V145, P15, DOI 10.1016/S0303-7207(98)00164-6; SAKAGUCHI T, 1988, INT J OBESITY, V12, P285; SAKAGUCHI T, 1988, BRAIN RES BULL, V20, P461, DOI 10.1016/0361-9230(88)90135-9; SHIMAZU T, 1991, BRAIN RES BULL, V27, P501, DOI 10.1016/0361-9230(91)90149-E; SHINODA K, 1995, DEV DYNAM, V204, P22, DOI 10.1002/aja.1002040104; Stanford KI, 2013, J CLIN INVEST, V123, P215, DOI 10.1172/JCI62308; Tong QC, 2007, CELL METAB, V5, P383, DOI 10.1016/j.cmet.2007.04.001; Williams KW, 2012, NAT NEUROSCI, V15, P1350, DOI 10.1038/nn.3217; Xu Y, 2010, CELL METAB, V12, P88, DOI 10.1016/j.cmet.2010.05.002; Zhao LP, 2008, MOL ENDOCRINOL, V22, P1403, DOI 10.1210/me.2008-0034; Ziegler DR, 2002, J COMP NEUROL, V448, P217, DOI 10.1002/cne.10257	34	13	14	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162352	10.1371/journal.pone.0162352	http://dx.doi.org/10.1371/journal.pone.0162352			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598259	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800056
J	Xin, C; Johnstone, M; Wang, NL; Wang, RKK				Xin, Chen; Johnstone, Murray; Wang, Ningli; Wang, Ruikang K.			OCT Study of Mechanical Properties Associated with Trabecular Meshwork and Collector Channel Motion in Human Eyes	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; AQUEOUS OUTFLOW SYSTEM; OPEN-ANGLE GLAUCOMA; PRESSURE-DEPENDENT CHANGES; INTRAOCULAR-PRESSURE; SUBSTRATUM STIFFNESS; LATRUNCULIN B; GRADED-LEVELS; MECHANOTRANSDUCERS YAP; EXTRACELLULAR-MATRIX	We report the use of a high-resolution optical coherence tomography (OCT) imaging platform to identify and quantify pressure-dependent aqueous outflow system (AOS) tissue relationships and to infer mechanical stiffness through examination of tissue properties in ex vivo human eyes. Five enucleated human eyes are included in this study, with each eye prepared with four equal-sized quadrants, each encompassing 90 degrees of the limbal circumference. In radial limbal segments perfusion pressure within Schlemm's canal (SC) is controlled by means of a perfusion cannula inserted into the canal lumen, while the other end of the cannula leads to a reservoir at a height that can control the pressure in the cannula. The OCT system images the sample with a spatial resolution of about 5 mu m from the trabecular meshwork (TM) surface. Geometric parameters are quantified from the 2D OCT images acquired from the sample subjected to controlled changes in perfusion pressures; parameters include area and height of the lumen of SC, collector channel entrances (CCE) and intrascleral collector channels (ISCC). We show that 3D OCT imaging permits the identification of 3-D relationships of the SC, CCE and ISCC lumen dimensions. Collagen flaps or leaflets are found at CCE that are attached or hinged at only one end, whilst the flaps are connected to the TM by cylindrical structures spanning SC. Increasing static SC pressures resulted in SC lumen enlargement with corresponding enlargement of the CCE and ISCC lumen. Pressure-dependent SC lumen area and height changes are significant at the 0.01 levels for ANOVA, and at the 0.05 for both polynomial curves and Tukey paired comparisons. Dynamic measurements demonstrate a synchronous increase in SC, CCE and ISCC lumen height in response to pressure changes from 0 to 10, 30 or 50 mm Hg, respectively, and the response time is within the 50-millisecond range. From the measured SC volume and corresponding IOP values, we demonstrate that an elastance curve can be developed to infer the mechanical stiffness of the TM by means of quantifying pressure-dependent SC volume changes over a 2 mm radial region of SC. Our study finds pressure-dependent motion of the TM that corresponds to collagen leaflet configuration motion at CCE; the synchronous tissue motion also corresponds with synchrony of SC and CCE lumen dimension changes.	[Xin, Chen; Wang, Ruikang K.] Univ Washington, Dept Bioengn, Seattle, WA 98195 USA; [Johnstone, Murray; Wang, Ruikang K.] Univ Washington, Dept Ophthalmol, Seattle, WA 98104 USA; [Xin, Chen; Wang, Ningli] Capital Med Univ, Beijing TongRen Hosp, Beijing TongRen Eye Ctr, Beijing 100730, Peoples R China; [Xin, Chen] Capital Med Univ, Beijing AnZhen Hosp, Dept Ophthalmol, Beijing 100029, Peoples R China	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Capital Medical University; Capital Medical University	Wang, RKK (corresponding author), Univ Washington, Dept Bioengn, Seattle, WA 98195 USA.; Wang, RKK (corresponding author), Univ Washington, Dept Ophthalmol, Seattle, WA 98104 USA.	wangrk@uw.edu	Wang, Ruikang/L-3889-2019; Johnstone, Murray/ABG-3511-2020	Wang, Ruikang/0000-0001-5169-8822; Johnstone, Murray/0000-0003-2136-2433	National Eye Institute [R01EY024158-01]; W.H. Coulter Foundation Translational Research Partnership Program; NATIONAL EYE INSTITUTE [R01EY024158] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); W.H. Coulter Foundation Translational Research Partnership Program; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was funded by the National Eye Institute (R01EY024158-01), W.H. Coulter Foundation Translational Research Partnership Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACOTT TS, 1988, INVEST OPHTH VIS SCI, V29, P90; Ascher KW, 1961, AMERICAN LECTURE SER; Ascher KW, 1942, AM J OPHTHALMOL, V25, P31; Asher K.W., 1942, AM J OPHTHALMOL, V25, P1301; ASHTON N, 1952, BRIT J OPHTHALMOL, V36, P265, DOI 10.1136/bjo.36.5.265; Bentley MD, 2016, INVEST OPHTH VIS SCI, V57, P1153, DOI 10.1167/iovs.15-17753; Bradley JMB, 2003, INVEST OPHTH VIS SCI, V44, P5174, DOI 10.1167/iovs.03-0213; Clark AF, 2012, INVEST OPHTH VIS SCI, V53, P2473, DOI 10.1167/iovs.12-9483g; CLARK AF, 1994, INVEST OPHTH VIS SCI, V35, P281; CLARK AF, 1995, INVEST OPHTH VIS SCI, V36, P478; Dong R, BIOENG C 2004 P IEEE, P188; Fercher AF, 2003, REP PROG PHYS, V66, P239, DOI [10.1088/0034-4885/66/2/204, 10.2184/lsj.31.635]; FRIBERG TR, 1985, JAMA-J AM MED ASSOC, V253, P1755, DOI 10.1001/jama.253.12.1755; FRIBERG TR, 1987, AM J OPHTHALMOL, V103, P523, DOI 10.1016/S0002-9394(14)74275-8; Gelman S, 2008, ANESTHESIOLOGY, V108, P735, DOI 10.1097/ALN.0b013e3181672607; Gonzalez JM, 2014, CLIN EXP OPHTHALMOL, V42, P502, DOI 10.1111/ceo.12255; Gonzalez JM, 2013, INVEST OPHTH VIS SCI, V54, P1039, DOI 10.1167/iovs.12-10479; GRIERSON I, 1975, EXP EYE RES, V20, P523, DOI 10.1016/0014-4835(75)90219-5; GRIERSON I, 1974, EXP EYE RES, V19, P21, DOI 10.1016/0014-4835(74)90068-2; GRIERSON I, 1975, EXP EYE RES, V20, P505, DOI 10.1016/0014-4835(75)90218-3; GRIERSON I, 1975, AM J OPHTHALMOL, V80, P863, DOI 10.1016/0002-9394(75)90284-6; Grieshaber MC, 2010, EYE, V24, P1220, DOI 10.1038/eye.2009.317; Grieshaber MC, 2010, INVEST OPHTH VIS SCI, V51, P1498, DOI 10.1167/iovs.09-4327; Hann CR, 2014, INVEST OPHTH VIS SCI, V55, P5834, DOI 10.1167/iovs.14-14128; Hann CR, 2011, EXP EYE RES, V92, P104, DOI 10.1016/j.exer.2010.12.010; Hariri S, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.106013; Heijl A, 2009, OPHTHALMOLOGY, V116, P2271, DOI 10.1016/j.ophtha.2009.06.042; HUANG D, 1991, SCIENCE, V254, P1178, DOI 10.1126/science.1957169; Johnson D, 1997, ARCH OPHTHALMOL-CHIC, V115, P375, DOI 10.1001/archopht.1997.01100150377011; JOHNSTONE M, 1980, INVEST OPHTH VIS SCI, V19, P835; Johnstone M, 2016, GLAUCOMA RES CLIN AD; JOHNSTONE MA, 1973, AM J OPHTHALMOL, V75, P365, DOI 10.1016/0002-9394(73)91145-8; JOHNSTONE MA, 1979, INVEST OPHTH VIS SCI, V18, P44; Johnstone MA, 1994, AM J OPHTHALMOL, V78, P630; Johnstone M, 2011, EXP EYE RES, V92, P318, DOI 10.1016/j.exer.2011.03.011; Johnstone M, 2010, GLAUCOMA BOOK: A PRACTICAL, EVIDENCE-BASED APPROACH TO PATIENT CARE, P65, DOI 10.1007/978-0-387-76700-0_7; Johnstone MA, 2014, J OCUL PHARMACOL TH, V30, P88, DOI 10.1089/jop.2013.0224; Jung SM, 2013, AM J PHYSIOL-HEART C, V305, pH803, DOI 10.1152/ajpheart.00103.2013; Junglas B, 2012, AM J PATHOL, V180, P2386, DOI 10.1016/j.ajpath.2012.02.030; Kagemann L, 2014, INVEST OPHTH VIS SCI, V55, P1805, DOI 10.1167/iovs.13-13264; Kagemann L, 2010, INVEST OPHTH VIS SCI, V51, P4054, DOI 10.1167/iovs.09-4559; KELLY RP, 1992, CIRCULATION, V86, P513, DOI 10.1161/01.CIR.86.2.513; Last JA, 2011, INVEST OPHTH VIS SCI, V52, P2147, DOI 10.1167/iovs.10-6342; Li GR, 2014, INVEST OPHTH VIS SCI, V55, P3737, DOI 10.1167/iovs.13-13700; Li P, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.4.046013; Li P, 2013, BIOMED OPT EXPRESS, V4, P2051, DOI 10.1364/BOE.4.002051; Li P, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.1.016012; Li P, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.7.076026; Li P, 2011, BIOMED OPT EXPRESS, V2, P3109, DOI 10.1364/BOE.2.003109; Liton PB, 2005, BIOCHEM BIOPH RES CO, P337; Luna C, 2009, INVEST OPHTH VIS SCI, V50, P5805, DOI 10.1167/iovs.09-3796; Morgan JT, 2015, ONCOTARGET, V6, P15362, DOI 10.18632/oncotarget.3798; Morgan JT, 2015, EXP EYE RES, V132, P174, DOI 10.1016/j.exer.2015.01.025; PEDERSON JE, 1978, INVEST OPHTH VIS SCI, V17, P377; PHELPS CD, 1982, AM J OPHTHALMOL, V93, P423, DOI 10.1016/0002-9394(82)90132-5; PHELPS CD, 1978, OPHTHALMOLOGY, V85, P276; Quick CM, 2008, AM J PHYSIOL-HEART C, V294, pH2144, DOI 10.1152/ajpheart.00781.2007; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; Raghunathan VK, 2015, INVEST OPHTH VIS SCI, V56, P4447, DOI 10.1167/iovs.15-16739; Raghunathan VK, 2013, INVEST OPHTH VIS SCI, V54, P378, DOI 10.1167/iovs.12-11007; Rohen J W, 1968, Albrecht Von Graefes Arch Klin Exp Ophthalmol, V176, P309, DOI 10.1007/BF00421587; ROHEN JW, 1993, EXP EYE RES, V56, P683, DOI 10.1006/exer.1993.1085; Santhanam L, 2010, CIRC RES, V107, P117, DOI 10.1161/CIRCRESAHA.109.215228; SCHIRMER KE, 1971, ARCH OPHTHALMOL-CHIC, V85, P263, DOI 10.1001/archopht.1971.00990050265001; SCHIRMER KE, 1969, CAN J OPHTHALMOLOGY, V4, P40; Schlunck G, 2008, INVEST OPHTH VIS SCI, V49, P262, DOI 10.1167/iovs.07-0956; Shi GH, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.1.016016; Song SZ, 2013, J BIOMED OPT, V18, DOI 10.1117/1.JBO.18.12.121505; Stamer WD, 2012, CURR OPIN OPHTHALMOL, V23, P135, DOI 10.1097/ICU.0b013e32834ff23e; Sun YC, 2015, QUANT IMAGING MED SU, V5, P171, DOI 10.3978/j.issn.2223-4292.2014.11.15; Susanna R, 2015, TRANSL VIS SCI TECHN, V4, DOI 10.1167/tvst.4.2.1; SUSON EB, 1969, ARCH OPHTHALMOL-CHIC, V81, P808, DOI 10.1001/archopht.1969.00990010810010; Thomasy SM, 2013, EXP EYE RES, V113, P66, DOI 10.1016/j.exer.2013.05.014; Thomasy SM, 2012, INVEST OPHTH VIS SCI, V53, P952, DOI 10.1167/iovs.11-8526; Tovar-Vidales T, 2008, INVEST OPHTH VIS SCI, V49, P622, DOI 10.1167/iovs.07-0835; Tumminia SJ, 1998, INVEST OPHTH VIS SCI, V39, P1361; VANBUSKIRK EM, 1982, INVEST OPHTH VIS SCI, V22, P625; Vittal V, 2005, INVEST OPHTH VIS SCI, V46, P2857, DOI 10.1167/iovs.05-0075; Wang F, 2012, J BIOMED OPT, V17, DOI 10.1117/1.JBO.17.11.116008; WEINREB RN, 1984, AM J OPHTHALMOL, V98, P784, DOI 10.1016/0002-9394(84)90698-6; Wood JA, 2011, INVEST OPHTH VIS SCI, V52, P9298, DOI 10.1167/iovs.11-7857; Xue W, 2007, INVEST OPHTH VIS SCI, V48, P3184, DOI 10.1167/iovs.06-1403; Yin X, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.8.086020; Yip CYY, 2009, ARTERIOSCL THROM VAS, V29, P936, DOI 10.1161/ATVBAHA.108.182394; Zhong L, 2006, P I MECH ENG H, V220, P647, DOI 10.1243/09544119JEIM123	85	24	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162048	10.1371/journal.pone.0162048	http://dx.doi.org/10.1371/journal.pone.0162048			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598990	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800034
J	Akimova, A; Nunez-Riboni, I; Kempf, A; Taylor, MH				Akimova, Anna; Nunez-Riboni, Ismael; Kempf, Alexander; Taylor, Marc H.			Spatially-Resolved Influence of Temperature and Salinity on Stock and Recruitment Variability of Commercially Important Fishes in the North Sea	PLOS ONE			English	Article							HERRING CLUPEA-HARENGUS; COD GADUS-MORHUA; PLAICE PLEURONECTES-PLATESSA; SPRAT SPRATTUS-SPRATTUS; LONG-TERM TRENDS; ATLANTIC COD; SPAWNING STOCK; CLASS STRENGTH; REGIME SHIFTS; POPULATION-STRUCTURE	Understanding of the processes affecting recruitment of commercially important fish species is one of the major challenges in fisheries science. Towards this aim, we investigated the relation between North Sea hydrography (temperature and salinity) and fish stock variables (recruitment, spawning stock biomass and pre-recruitment survival index) for 9 commercially important fishes using spatially-resolved cross-correlation analysis. We used high-resolution (0.2 degrees x 0.2 degrees) hydrographic data fields matching the maximal temporal extent of the fish population assessments (1948-2013). Our approach allowed for the identification of regions in the North Sea where environmental variables seem to be more influential on the fish stocks, as well as the regions of a lesser or nil influence. Our results confirmed previously demonstrated negative correlations between temperature and recruitment of cod and plaice and identified regions of the strongest correlations (German Bight for plaice and north-western North Sea for cod). We also revealed a positive correlation between herring spawning stock biomass and temperature in the Orkney-Shetland area, as well as a negative correlation between sole pre-recruitment survival index and temperature in the German Bight. A strong positive correlation between sprat stock variables and salinity in the central North Sea was also found. To our knowledge the results concerning correlations between North Sea hydrography and stocks' dynamics of herring, sole and sprat are novel. The new information about spatial distribution of the correlation provides an additional help to identify mechanisms underlying these correlations. As an illustration of the utility of these results for fishery management, an example is provided that incorporates the identified environmental covariates in stock-recruitment models.	[Akimova, Anna; Nunez-Riboni, Ismael; Kempf, Alexander; Taylor, Marc H.] Thunen Inst Sea Fisheries, Hamburg, Germany	Johann Heinrich von Thunen Institute	Akimova, A (corresponding author), Thunen Inst Sea Fisheries, Hamburg, Germany.	anna.akimova@thuenen.de	Nunez-Riboni, Ismael/HGB-9167-2022; Taylor, Marc/AAI-6598-2021	Taylor, Marc/0000-0001-9730-6994; Akimova, Anna/0000-0003-4161-4140				AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Algen A, 1980, DISTRIBUTION ABUNDAN, V1980; Alheit J, 2014, J MARINE SYST, V131, P21, DOI 10.1016/j.jmarsys.2013.11.002; Aschan M, 2009, DEEP-SEA RES PT II, V56, P2012, DOI 10.1016/j.dsr2.2008.11.012; Bannister R.C.A., 1974, EARLY LIFE HIST FISH, P21; Baumann H, 2009, J SEA RES, V61, P234, DOI 10.1016/j.seares.2009.01.004; Beaugrand G, 2004, PROG OCEANOGR, V60, P245, DOI 10.1016/j.pocean.2004.02.018; Beaugrand G, 2003, NATURE, V426, P661, DOI 10.1038/nature02164; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Becker G.A., 1997, DTSCH HYDROGR Z, V49, P135; Bonhommeau S, 2008, MAR ECOL PROG SER, V373, P71, DOI 10.3354/meps07696; Brander KM, 2005, ICES J MAR SCI, V62, P339, DOI 10.1016/j.icesjms.2004.07.029; Brunel T, 2007, FISH OCEANOGR, V16, P336, DOI 10.1111/j.1365-2419.2007.00435.x; Chavez FP, 2003, SCIENCE, V299, P217, DOI 10.1126/science.1075880; Cheung WWL, 2010, GLOBAL CHANGE BIOL, V16, P24, DOI 10.1111/j.1365-2486.2009.01995.x; Cook RM, 2005, ICES J MAR SCI, V62, P1322, DOI 10.1016/j.icesjms.2005.04.023; CORTEN A, 1992, ICES MAR SC, V195, P402; CORTEN A, 1990, NETH J SEA RES, V25, P227, DOI 10.1016/0077-7579(90)90024-B; Corten A, 2003, PROG OCEANOGR, V58, P285, DOI 10.1016/j.pocean.2003.08.008; Corten A, 1999, J SEA RES, V42, P191, DOI 10.1016/S1385-1101(99)00030-1; Corten A, 2013, ICES J MAR SCI, V70, P1, DOI 10.1093/icesjms/fss187; Curry RG, 2001, J PHYS OCEANOGR, V31, P3374, DOI 10.1175/1520-0485(2001)031<3374:OGCCAW>2.0.CO;2; Cury P, 2000, ICES J MAR SCI, V57, P603, DOI 10.1006/jmsc.2000.0712; Cushing D.H., 1982, CLIMATE FISHERIES; CUSHING DH, 1990, ADV MAR BIOL, V26, P249, DOI 10.1016/S0065-2881(08)60202-3; Daan N, 2005, ICES J MAR SCI, V62, P177, DOI 10.1016/j.icesjms.2004.08.020; Daewel U, 2011, CAN J FISH AQUAT SCI, V68, P426, DOI 10.1139/F10-164; DESILVA SS, 1973, MAR BIOL, V20, P282, DOI 10.1007/BF00354272; Dethlefsen V, 1996, ICES J MAR SCI, V53, P1024, DOI 10.1006/jmsc.1996.0128; Dickey-Collas M, 2010, ICES J MAR SCI, V67, P1875, DOI 10.1093/icesjms/fsq033; Dickson R. R., 1971, DTSCH HYDROGR Z, V24, P97; Drinkwater KF, 2006, PROG OCEANOGR, V68, P134, DOI 10.1016/j.pocean.2006.02.011; Emery W. J., 2004, DATA ANAL METHODS PH, V2nd; Engelhard GH, 2014, ICES J MAR SCI, V71, P90, DOI 10.1093/icesjms/fst087; Fonds M., 1995, EFFECT WINTER TEMPER; Fox CJ, 2000, J SEA RES, V44, P159, DOI 10.1016/S1385-1101(00)00039-3; Gladics AJ, 2015, J MARINE SYST, V146, P72, DOI 10.1016/j.jmarsys.2014.06.015; Glantz M. H., 1992, CLIMATE VARIABILITY; Groger JP, 2010, ICES J MAR SCI, V67, P454, DOI 10.1093/icesjms/fsp259; Gulev SK, 2013, NATURE, V499, P464, DOI 10.1038/nature12268; Hart P.J., 2002, HDB FISH BIOL FISHER; HAWG, 2015, REP HERR ASS WORK GR; Heath M, 1997, J SEA RES, V38, P413, DOI 10.1016/S1385-1101(97)00045-2; Heath MR, 2008, FISH RES, V93, P92, DOI 10.1016/j.fishres.2008.02.014; Heath MR, 2005, ICES J MAR SCI, V62, P847, DOI 10.1016/j.icesjms.2005.01.023; Heintz RA, 2013, DEEP-SEA RES PT II, V94, P150, DOI 10.1016/j.dsr2.2013.04.006; Heyen H, 1998, TELLUS A, V50, P545, DOI 10.1034/j.1600-0870.1998.00012.x; Hirata FE, 2013, GEOPHYS RES LETT, V40, P3337, DOI 10.1002/grl.50632; Hjermann DO, 2013, MAR ECOL PROG SER, V480, P263, DOI 10.3354/meps10315; Hjollo SS, 2009, J MARINE SYST, V78, P180, DOI 10.1016/j.jmarsys.2009.06.001; Houde E.D., 1987, American Fisheries Society Symposium, P17; Hufnagl M, 2015, PROG OCEANOGR, V138, P486, DOI 10.1016/j.pocean.2014.04.029; Hufnagl M, 2013, J SEA RES, V84, P26, DOI 10.1016/j.seares.2012.10.007; ICES, 1990, SPRAT BIOL WORKSH CO; ICES, 2014, 2013ACOM48 ICES CM; ICES, 2015, STOCK ASS; ILES TC, 1994, NETH J SEA RES, V32, P399, DOI 10.1016/0077-7579(94)90017-5; Iles TC, 1998, J SEA RES, V39, P41, DOI 10.1016/S1385-1101(97)00022-1; Kempf A, 2013, FISH OCEANOGR, V22, P174, DOI 10.1111/fog.12013; Kempf A, 2009, CAN J FISH AQUAT SCI, V66, P633, DOI 10.1139/F09-022; Kirtman B., 2013, CLIMATE CHANGE 2013, P953; Lacroix G, 2013, J SEA RES, V84, P13, DOI 10.1016/j.seares.2012.07.010; LAST JM, 1987, J CONSEIL, V44, P73; Lee A.J., 1980, ELSEVIER OCEANOG SER, V24, P467, DOI DOI 10.1016/S0422-9894(08)71359-X; Lees K, 2006, FISH FISH, V7, P104, DOI 10.1111/j.1467-2979.2006.00215.x; Levi D, 2003, SCI MAR, V67, P259, DOI 10.3989/scimar.2003.67s1259; LIVEZEY RE, 1983, MON WEATHER REV, V111, P46, DOI 10.1175/1520-0493(1983)111<0046:SFSAID>2.0.CO;2; Locarnini R. A., 2010, NOAA ATLAS NESDIS, V68, P1; MARAVELIAS CD, 1995, SCI MAR, V59, P427; Maravelias CD, 1997, MAR ECOL PROG SER, V159, P151, DOI 10.3354/meps159151; Margonski P, 2010, PROG OCEANOGR, V87, P277, DOI 10.1016/j.pocean.2010.08.003; Martinez E, 2009, SCIENCE, V326, P1253, DOI 10.1126/science.1177012; Matei D, 2012, SCIENCE, V335, P76, DOI 10.1126/science.1210299; Meyer EMI, 2011, J MARINE SYST, V86, P35, DOI 10.1016/j.jmarsys.2011.02.001; Montero-Serra I, 2015, GLOBAL CHANGE BIOL, V21, P144, DOI 10.1111/gcb.12747; MUNK P, 1993, MAR ECOL PROG SER, V99, P17, DOI 10.3354/meps099017; Myers RA, 1998, REV FISH BIOL FISHER, V8, P285, DOI 10.1023/A:1008828730759; Nash RDM, 2005, FISH OCEANOGR, V14, P279, DOI 10.1111/j.1365-2419.2005.00336.x; Nash RDM, 2012, J MARINE SYST, V93, P58, DOI 10.1016/j.jmarsys.2011.09.009; Neat FC, 2014, J APPL ECOL, V51, P1564, DOI 10.1111/1365-2664.12343; Nicolas D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088447; Nielsen EE, 2009, MAR ECOL PROG SER, V376, P213, DOI 10.3354/meps07798; Nissling A, 2014, HYDROBIOLOGIA, V514; Nunez I, 2016, AHOI V18 11 FIGSHARE; Nunez-Riboni I, 2015, J MARINE SYST, V151, P15, DOI 10.1016/j.jmarsys.2015.06.003; O'Brien CM, 2000, NATURE, V404, P142, DOI 10.1038/35004654; Ojaveer E, 2010, REV FISH BIOL FISHER, V20, P203, DOI 10.1007/s11160-009-9130-5; Olsen EM, 2011, P ROY SOC B-BIOL SCI, V278, P504, DOI 10.1098/rspb.2010.1465; Otterlei E, 1999, CAN J FISH AQUAT SCI, V56, P2099, DOI 10.1139/cjfas-56-11-2099; Ottersen G, 2013, MAR ECOL PROG SER, V480, P205, DOI 10.3354/meps10249; Payne MR, 2010, ICES J MAR SCI, V67, P1939, DOI 10.1093/icesjms/fsq036; Payne MR, 2009, ICES J MAR SCI, V66, P272, DOI 10.1093/icesjms/fsn211; Peck MA, 2012, J MARINE SYST, V93, P77, DOI 10.1016/j.jmarsys.2011.08.005; Pecuchet L, 2014, ICEJ MARINE SCI J, V72, P1323; PEPIN P, 1991, CAN J FISH AQUAT SCI, V48, P503, DOI 10.1139/f91-065; Phillips ID, 2002, INT J CLIMATOL, V22, P197, DOI 10.1002/joc.726; Planque B, 2003, SCI MAR, V67, P211, DOI 10.3989/scimar.2003.67s1211; Planque B, 1999, CAN J FISH AQUAT SCI, V56, P2069, DOI 10.1139/cjfas-56-11-2069; Poulsen NA, 2011, MAR ECOL PROG SER, V436, P231, DOI 10.3354/meps09246; Punt AE, 2014, ICES J MAR SCI, V71, P2208, DOI 10.1093/icesjms/fst057; Pyper BJ, 1998, CAN J FISH AQUAT SCI, V55, P2127; Raab K, 2012, MAR ECOL PROG SER, V470, P101, DOI 10.3354/meps09919; Reid PC, 2003, FISH OCEANOGR, V12, P260, DOI 10.1046/j.1365-2419.2003.00252.x; Righton D, 2007, J MAR BIOL ASSOC UK, V87, P599, DOI 10.1017/S0025315407054641; Rijnsdorp AD, 1996, ICES J MAR SCI, V53, P1199, DOI 10.1006/jmsc.1996.0145; RIJNSDORP AD, 1992, NETH J SEA RES, V29, P173, DOI 10.1016/0077-7579(92)90018-A; Rijnsdorp AD, 1995, NETH J SEA RES, V34, P237, DOI 10.1016/0077-7579(95)90031-4; Rijnsdorp AD, 2009, ICES J MAR SCI, V66, P1570, DOI 10.1093/icesjms/fsp056; Rogers S., 2001, N SEA FISH FISHERIES; Schott F, 1966, ERGANZUNGSHEFT DTSCH, P58; Segers FHID, 2007, ICES J MAR SCI, V64, P60, DOI 10.1093/icesjms/fsl002; Shepherd J.G., 1984, Rapports et Proces-Verbaux des Reunions Conseil International pour l'Exploration de la Mer, V185, P255; Skern-Mauritzen M, 2016, FISH FISH, V17, P165, DOI 10.1111/faf.12111; Sparrevohn CR, 2013, FISH OCEANOGR, V22, P400, DOI 10.1111/fog.12030; Speirs DC, 2010, FISH RES, V106, P474, DOI 10.1016/j.fishres.2010.09.023; Stenseth N., 2004, MARINE ECOSYSTEMS CL; Stenseth NC, 2003, P ROY SOC B-BIOL SCI, V270, P2087, DOI 10.1098/rspb.2003.2415; Subbey S, 2014, ICES J MAR SCI, V71, P2307, DOI 10.1093/icesjms/fsu148; Teal LR, 2008, MAR ECOL PROG SER, V358, P219, DOI 10.3354/meps07367; Tortonese E., 1986, FISHES NE ATLANTIC M, V2; Turrell WR, 1996, ICES J MAR SCI, V53, P899, DOI 10.1006/jmsc.1996.0112; van der Veer HW, 1999, MAR ECOL PROG SER, V184, P245, DOI 10.3354/meps184245; van der Veer HW, 2000, ICES J MAR SCI, V57, P202, DOI 10.1006/jmsc.1999.0523; VANDERLAND MA, 1991, NETH J SEA RES, V27, P277, DOI 10.1016/0077-7579(91)90030-5; VANDERVEER HW, 1990, MAR ECOL PROG SER, V64, P1, DOI 10.3354/meps064001; Vert-pre KA, 2013, P NATL ACAD SCI USA, V110, P1779, DOI 10.1073/pnas.1214879110; Voss R, 2011, ICES J MAR SCI, V68, P1379, DOI 10.1093/icesjms/fsr061; WALTERS CJ, 1988, CAN J FISH AQUAT SCI, V45, P1848, DOI 10.1139/f88-217; WGMIXFISH, 2015, 2015ACOM21 WGMIXFISH; WGNSSK, 2015, 2015ACOM13 WGNSSK IC; WKNSEA, 2015, BENCHM WORKSH N SEA; Wright PJ, 2006, J FISH BIOL, V69, P181, DOI 10.1111/j.1095-8649.2006.01262.x; Wright PJ, 2006, FISH RES, V77, P148, DOI 10.1016/j.fishres.2005.10.008; Wu BY, 2015, J CLIMATE, V28, P6841, DOI 10.1175/JCLI-D-14-00274.1	134	25	25	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161917	10.1371/journal.pone.0161917	http://dx.doi.org/10.1371/journal.pone.0161917			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584155	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600073
J	Marty, L; Vigouroux, A; Aumont-Nicaise, M; Dessaux, Y; Faure, D; Morera, S				Marty, Loic; Vigouroux, Armelle; Aumont-Nicaise, Magali; Dessaux, Yves; Faure, Denis; Morera, Solange			Structural Basis for High Specificity of Amadori Compound and Mannopine Opine Binding in Bacterial Pathogens	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC transporter; crystal structure; host-pathogen interaction; isothermal titration calorimetry (ITC); x-ray crystallography; DFG; mannopine; opine; periplasmic binding protein; plant pathogen	AGROBACTERIUM-TUMEFACIENS; TI-PLASMID; PLANT TRANSFORMATION; OCTOPINE SYNTHASE; CATABOLISM GENES; GABA BINDING; AMINO-ACID; PROTEIN; POPULATIONS; SUBSTRATE	Agrobacterium tumefaciens pathogens genetically modify their host plants to drive the synthesis of opines in plant tumors. Opines are either sugar phosphodiesters or the products of condensed amino acids with ketoacids or sugars. They are Agrobacterium nutrients and imported into the bacterial cell via periplasmic-binding proteins (PBPs) and ABC-transporters. Mannopine, an opine from the mannityl-opine family, is synthesized from an intermediate named deoxy-fructosyl-glutamine (DFG), which is also an opine and abundant Amadori compound (a name used for any derivative of aminodeoxysugars) present in decaying plant materials. The PBP MotA is responsible for mannopine import in mannopine-assimilating agrobacteria. In the nopaline-opine type agrobacteria strain, SocA protein was proposed as a putative mannopine binding PBP, and AttC protein was annotated as a mannopine binding-like PBP. Structural data on mannityl-opine-PBP complexes is currently lacking. By combining affinity data with analysis of seven x-ray structures at high resolution, we investigated the molecular basis of MotA, SocA, and AttC interactions with mannopine and its DFG precursor. Our work demonstrates that AttC is not a mannopine-binding protein and reveals a specific binding pocket for DFG in SocA with an affinity in nanomolar range. Hence, mannopine would not be imported into nopaline-type agrobacteria strains. In contrast, MotA binds both mannopine and DFG. We thus defined one mannopine and two DFG binding signatures. Unlike mannopine-PBPs, selective DFG-PBPs are present in a wide diversity of bacteria, including Actinobacteria, -,-, and -proteobacteria, revealing a common role of this Amadori compound in pathogenic, symbiotic, and opportunistic bacteria.	[Marty, Loic; Vigouroux, Armelle; Aumont-Nicaise, Magali; Dessaux, Yves; Faure, Denis; Morera, Solange] Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, Ave Terrasse, F-91198 Gif Sur Yvette, France	CEA; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay	Morera, S (corresponding author), Univ Paris Saclay, Univ Paris Sud, CNRS, Inst Integrat Biol Cell I2BC,CEA, Ave Terrasse, F-91198 Gif Sur Yvette, France.	solange.morera@i2bc.paris-saclay.fr		morera, solange/0000-0001-7781-0448	FRISBI [ANR-10-INSB-05-01]	FRISBI	This work has benefited from the I2BC crystallization platform and @ TOME-2, both supported by FRISBI ANR-10-INSB-05-01. We acknowledge SOLEIL for provision of synchrotron radiation facilities (proposals ID 20130869 and 20140774) in using Proxima beamlines. We are grateful to Gavin Fox for critical reading of the manuscript.	Baek CH, 2005, FEMS MICROBIOL ECOL, V53, P221, DOI 10.1016/j.femsec.2004.12.008; Baek CH, 2003, J BACTERIOL, V185, P513, DOI 10.1128/JB.185.2.513-524.2003; Berntsson RPA, 2010, FEBS LETT, V584, P2606, DOI 10.1016/j.febslet.2010.04.043; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; CHILTON WS, 1995, PHYTOCHEMISTRY, V40, P619, DOI 10.1016/0031-9422(93)00283-L; DEPICKER A, 1982, Journal of Molecular and Applied Genetics, V1, P561; DESSAUX Y, 1987, MOL GEN GENET, V208, P301, DOI 10.1007/BF00330457; DESSAUX Y, 1993, PHYTOCHEMISTRY, V34, P31, DOI 10.1016/S0031-9422(00)90778-7; Dessaux Y., 1998, RHIZOBIACEAE MOL BIO, P173, DOI DOI 10.1007/978-94-011-5060-6_9; El Sahili A, 2015, PLOS PATHOG, V11, DOI 10.1371/journal.ppat.1005071; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Flores-Mireles AL, 2012, MOL MICROBIOL, V84, P845, DOI 10.1111/j.1365-2958.2012.08061.x; Gelvin SB, 2003, MICROBIOL MOL BIOL R, V67, P16, DOI 10.1128/MMBR.67.1.16-37.2003; GUYON P, 1993, MOL PLANT MICROBE IN, V6, P92, DOI 10.1094/MPMI-6-092; HACK E, 1980, PLANT PHYSIOL, V65, P949, DOI 10.1104/pp.65.5.949; Hong SB, 1997, J BACTERIOL, V179, P4831, DOI 10.1128/jb.179.15.4831-4840.1997; HONG SB, 1994, J BACTERIOL, V176, P3576, DOI 10.1128/JB.176.12.3576-3583.1994; HONG SB, 1993, J BACTERIOL, V175, P401, DOI 10.1128/JB.175.2.401-410.1993; Karplus PA, 2012, SCIENCE, V336, P1030, DOI [10.1126/science.121823, 10.1126/science.1218231]; Kim H, 1997, J BACTERIOL, V179, P7559, DOI 10.1128/jb.179.23.7559-7572.1997; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lang JL, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004444; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Oger P, 1998, MOL MICROBIOL, V27, P277, DOI 10.1046/j.1365-2958.1998.00671.x; Oger P, 1997, NAT BIOTECHNOL, V15, P369, DOI 10.1038/nbt0497-369; Oger PM, 2004, MICROB ECOL, V47, P96, DOI 10.1007/s00248-003-2012-9; OH BH, 1993, J BIOL CHEM, V268, P11348; Pitzschke A, 2010, EMBO J, V29, P1021, DOI 10.1038/emboj.2010.8; Planamente S, 2012, MOL MICROBIOL, V86, P1085, DOI 10.1111/mmi.12043; Planamente S, 2010, J BIOL CHEM, V285, P30294, DOI 10.1074/jbc.M110.140715; Pons JL, 2009, NUCLEIC ACIDS RES, V37, pW485, DOI 10.1093/nar/gkp368; Sakaguchi A, 2005, BIOCHEM BIOPH RES CO, V336, P1074, DOI 10.1016/j.bbrc.2005.08.230; Savka MA, 1997, NAT BIOTECHNOL, V15, P363, DOI 10.1038/nbt0497-363; SCHARDL CL, 1983, MOL GEN GENET, V191, P10, DOI 10.1007/BF00330882; SCHELL J, 1979, PROC R SOC SER B-BIO, V204, P251, DOI 10.1098/rspb.1979.0026; Stamp AL, 2011, PROTEINS, V79, P2352, DOI 10.1002/prot.23060; TATE ME, 1982, CARBOHYD RES, V104, P105, DOI 10.1016/S0008-6215(00)82224-7; Tempe J., 1983, Molecular genetics of the bacteria-plant interaction., P14; WILSON M, 1995, APPL ENVIRON MICROB, V61, P2151, DOI 10.1128/AEM.61.6.2151-2158.1995; Yu J, 2015, P NATL ACAD SCI USA, V112, P5243, DOI 10.1073/pnas.1415037112; Zhu J, 2000, J BACTERIOL, V182, P3885, DOI 10.1128/JB.182.14.3885-3895.2000	41	15	15	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22638	22649		10.1074/jbc.M116.745562	http://dx.doi.org/10.1074/jbc.M116.745562			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609514	Green Published, hybrid			2022-12-26	WOS:000386760600024
J	Lin, Y; Krogh-Andersen, K; Pelletier, J; Marcotte, H; Ostenson, CG; Hammarstrom, L				Lin, Yin; Krogh-Andersen, Kasper; Pelletier, Julien; Marcotte, Harold; Ostenson, Claes-Goran; Hammarstrom, Lennart			Oral Delivery of Pentameric Glucagon-Like Peptide-1 by Recombinant Lactobacillus in Diabetic Rats	PLOS ONE			English	Article							SINGLE-CHAIN ANTIBODY; LACTOCOCCUS-LACTIS; INSULIN-RESISTANCE; GLUCOSE; INCRETIN; RELEASE; GLP-1; EXPRESSION; GLYCEMIA; PLASMA	Glucagon-like peptide-1 (GLP-1) is an incretin hormone produced by intestinal cells and stimulates insulin secretion from the pancreas in a glucose-dependent manner. Exogenously supplied GLP-1 analogues are used in the treatment of type 2 diabetes. An anti-diabetic effect of Lactobacillus in lowering plasma glucose levels and its use as a vehicle for delivery of protein and antibody fragments has been shown previously. The aim of this study was to employ lactobacilli as a vehicle for in situ production and delivery of GLP-1 analogue to normalize blood glucose level in diabetic GK (Goto-Kakizaki) rats. In this study, we designed pentameric GLP-1 (5xGLP-1) analogues which were both expressed in a secreted form and anchored to the surface of lactobacilli. Intestinal trypsin sites were introduced within 5xGLP-1, leading to digestion of the pentamer into an active monomeric form. The E. coli-produced 5xGLP-1 peptides delivered by intestinal intubation to GK rats resulted in a significant improvement of glycemic control demonstrated by an intraperitoneal glucose tolerance test. Meanwhile, the purified 5xGLP-1 (trypsin-digested) from the Lactobacillus cultures stimulated insulin secretion from HIT-T15 cells, similar to the E. coli-produced 5xGLP-1 peptides. When delivered by gavage to GK rats, non-expressor L. paracasei significantly lowered the blood glucose level but 5xGLP-1 expression did not provide an additional anti-diabetic effect, possibly due to the low levels produced. Our results indicate that lactobacilli themselves might be used as an alternative treatment method for type 2 diabetes, but further work is needed to increase the expression level of GLP-1 by lactobacilli in order to obtain a significant insulinotropic effect in vivo.	[Lin, Yin; Krogh-Andersen, Kasper; Marcotte, Harold; Hammarstrom, Lennart] Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Immunol & Transfus Med, Dept Lab Med, SE-14186 Stockholm, Sweden; [Pelletier, Julien; Ostenson, Claes-Goran] M1 03 Karolinska Univ Hosp, Karolinska Inst, Rolf Luft Res Ctr Diabet & Endocrinol, Dept Mol Med & Surg, SE-17176 Stockholm, Sweden	Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Hammarstrom, L (corresponding author), Karolinska Univ Hosp Huddinge, Karolinska Inst, Div Clin Immunol & Transfus Med, Dept Lab Med, SE-14186 Stockholm, Sweden.	lennart.hammarstrom@ki.se	Marcotte, Harold/P-9375-2017	Marcotte, Harold/0000-0002-7168-349X	Novo Nordisk Foundation [53101003]; China Scholarship Council; Swedish Research Council; Swedish Diabetes Association	Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); China Scholarship Council(China Scholarship Council); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Diabetes Association	This work was funded by a grant from the Novo Nordisk Foundation, grant number: 53101003 (http://www.novonordiskfonden.dk/en/content/foundations-grants). YL was financially supported by the China Scholarship Council, www.csc.edu.cn. CGO was Funded by Swedish Research Council, www.vr.se, and Swedish Diabetes Association, www.sdf.se. The Novo Nordisk foundation and other funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acedo-Felix E, 2003, INT J SYST EVOL MICR, V53, P67, DOI 10.1099/ijs.0.02325-0; Agarwal P, 2014, PHARM RES-DORDR, V31, P3404, DOI 10.1007/s11095-014-1430-3; Akash MSH, 2013, CURR DIABETES REV, V9, P387, DOI 10.2174/15733998113099990069; Andersen KK, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-126; Araujo Francisca, 2012, J Diabetes Sci Technol, V6, P1486; Arulmozhi DK, 2006, EUR J PHARM SCI, V28, P96, DOI 10.1016/j.ejps.2006.01.003; Bond Aaron, 2006, Proc (Bayl Univ Med Cent), V19, P281; Burcelin R, 1999, METABOLISM, V48, P252, DOI 10.1016/S0026-0495(99)90043-4; Chae SY, 2008, BIOCONJUGATE CHEM, V19, P334, DOI 10.1021/bc700292v; Chaikomin R, 2005, AM J PHYSIOL-ENDOC M, V289, pE504, DOI 10.1152/ajpendo.00099.2005; Chia CW, 2008, J CLIN ENDOCR METAB, V93, P3703, DOI 10.1210/jc.2007-2109; Martin MC, 2011, APPL ENVIRON MICROB, V77, P2174, DOI 10.1128/AEM.02690-10; Donnelly D, 2012, BRIT J PHARMACOL, V166, P27, DOI 10.1111/j.1476-5381.2011.01687.x; Duan FF, 2015, DIABETES, V64, P1794, DOI 10.2337/db14-0635; Fehmann HC, 1997, INSULINOTROPIC GUT H; Garber AJ, 2011, DIABETES CARE, V34, pS279, DOI 10.2337/dc11-s231; Gunaydin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096409; HERBERT V, 1965, J CLIN ENDOCR METAB, V25, P1375, DOI 10.1210/jcem-25-10-1375; Holst JJ, 2007, PHYSIOL REV, V87, P1409, DOI 10.1152/physrev.00034.2006; Hsieh FC, 2013, NUTR METAB, V10, DOI 10.1186/1743-7075-10-35; Hui HX, 2002, EUR J ENDOCRINOL, V146, P863, DOI 10.1530/eje.0.1460863; Joseph JW, 2000, DIABETOLOGIA, V43, P1319, DOI 10.1007/s001250051529; Kruger C, 2002, NAT BIOTECHNOL, V20, P702, DOI 10.1038/nbt0702-702; Kumar V, 2014, ROBBINS COTRAN PATHO; Kuo P, 2008, REGUL PEPTIDES, V146, P1, DOI 10.1016/j.regpep.2007.09.032; Levy JC, 2006, DIABETIC MED, V23, P14, DOI 10.1111/j.1464-5491.2006.01833e.x; Lin CH, 2014, BRIT J NUTR, V111, P1712, DOI 10.1017/S0007114513003656; Marcotte H, 2006, J APPL MICROBIOL, V100, P256, DOI 10.1111/j.1365-2672.2005.02786.x; Mathiesen G, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-425; Maze A, 2010, J BACTERIOL, V192, P2647, DOI 10.1128/JB.00076-10; Muller C, 2015, MOL MED, V21, P969, DOI 10.2119/molmed.2015.00267; Naito E, 2011, J APPL MICROBIOL, V110, P650, DOI 10.1111/j.1365-2672.2010.04922.x; Nauck MA, 1999, DIABETOLOGIA, V42, P373, DOI 10.1007/s001250051165; Nguyen HN, 2011, BIOMATERIALS, V32, P2673, DOI 10.1016/j.biomaterials.2010.12.044; Ostenson CG, 2007, DIABETES OBES METAB, V9, P180, DOI 10.1111/j.1463-1326.2007.00787.x; OSTENSON CG, 1986, MOL CELL ENDOCRINOL, V45, P215, DOI 10.1016/0303-7207(86)90150-4; Panwar H, 2013, DIABETES-METAB RES, V29, P103, DOI 10.1002/dmrr.2376; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; SANTERRE RF, 1981, P NATL ACAD SCI-BIOL, V78, P4339, DOI 10.1073/pnas.78.7.4339; Shirazi R, 2013, P NATL ACAD SCI USA, V110, P16199, DOI 10.1073/pnas.1306799110; Simon MC, 2015, DIABETES CARE, V38, P1827, DOI 10.2337/dc14-2690; Steidler L, 2003, NAT BIOTECHNOL, V21, P785, DOI 10.1038/nbt840; Steidler L, 2000, SCIENCE, V289, P1352, DOI 10.1126/science.289.5483.1352; Steinert RE, 2009, CLIN PHARMACOL THER, V86, P644, DOI 10.1038/clpt.2009.159; SUZUKI S, 1989, ENDOCRINOLOGY, V125, P3109, DOI 10.1210/endo-125-6-3109; Tabuchi M, 2003, BIOSCI BIOTECH BIOCH, V67, P1421, DOI 10.1271/bbb.67.1421; Wells JM, 2008, NAT REV MICROBIOL, V6, P349, DOI 10.1038/nrmicro1840; Yassin K, 2011, Int J Biomed Sci, V7, P131; Youn YS, 2008, EUR J PHARM BIOPHARM, V68, P667, DOI 10.1016/j.ejpb.2007.07.009; Yun SI, 2009, J APPL MICROBIOL, V107, P1681, DOI 10.1111/j.1365-2672.2009.04350.x	50	15	19	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162733	10.1371/journal.pone.0162733	http://dx.doi.org/10.1371/journal.pone.0162733			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610615	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900159
J	Naraballobh, W; Trakooljul, N; Murani, E; Brunner, R; Krischek, C; Janisch, S; Wicke, M; Ponsuksili, S; Wimmers, K				Naraballobh, Watcharapong; Trakooljul, Nares; Murani, Eduard; Brunner, Ronald; Krischek, Carsten; Janisch, Sabine; Wicke, Michael; Ponsuksili, Siriluck; Wimmers, Klaus			Transient Shifts of Incubation Temperature Reveal Immediate and Long-Term Transcriptional Response in Chicken Breast Muscle Underpinning Resilience and Phenotypic Plasticity	PLOS ONE			English	Article							MEAT QUALITY; EGGSHELL TEMPERATURE; GROWTH; GENE; EMBRYOS; PERFORMANCE; DISRUPTION; EXPRESSION; TOLERANCE; TISSUE	Variations in egg incubation temperatures can have acute or long-term effects on gene transcription in avian species. Altered gene expression may, in turn, affect muscle traits in poultry and indirectly influence commercial production. To determine how changes in eggshell temperature affect gene expression, incubation temperatures were varied [36.8 degrees C (low), 37.8 degrees C (control), 38.8 degrees C (high)] at specific time periods reflecting two stages of myogenesis [embryonic days (ED) 7-10 and 10-13]. Gene expression was compared between interventions and matching controls by microarrays in broiler breast muscle at ED10 or ED13 and post-hatch at day 35. Early (ED7-10) high incubation temperature (H10 Delta C) resulted in 1370 differentially expressed genes (DEGs) in embryos. Ingenuity pathway analysis revealed temporary activation of cell maintenance, organismal development, and survival ability genes, but these effects were not maintained in adults. Late high incubation temperature (ED10-13) (H13 Delta C) had slightly negative impacts on development of cellular components in embryos, but a cumulative effect was observed in adults, in which tissue development and nutrition metabolism were affected. Early low incubation temperature (L10 Delta C) produced 368 DEGs, most of which were down-regulated and involved in differentiation and formation of muscle cells. In adults, this treatment down-regulated pathways of transcriptional processes, but up-regulated cell proliferation. Late low temperature incubation (L13 Delta C) produced 795 DEGs in embryos, and activated organismal survival and post-transcriptional regulation pathways. In adults this treatment activated cellular and organ development, nutrition and small molecule activity, and survival rate, but deactivated size of body and muscle cells. Thermal interventions during incubation initiate immediate and delayed transcriptional responses that are specific for timing and direction of treatment. Interestingly, the transcriptional response to transiently decreased incubation temperature, which did not affect the phenotypes, prompts compensatory effects reflecting resilience. In contrast, higher incubation temperature triggers gene expression and has long-term effects on the phenotype. These mechanisms of considerable phenotypic plasticity contribute to the biodiversity and broaden the basis for managing poultry populations.	[Naraballobh, Watcharapong; Trakooljul, Nares; Murani, Eduard; Brunner, Ronald; Ponsuksili, Siriluck; Wimmers, Klaus] Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, D-18196 Dummerstorf, Germany; [Krischek, Carsten] Fdn Univ Vet Med, Inst Food Qual & Food Safety, D-30173 Hannover, Germany; [Janisch, Sabine; Wicke, Michael] Univ Gottingen, Dept Anim Sci, Qual Food Anim Origin, D-37037 Gottingen, Germany	Forschungsinstitut fur Nutztierbiologie (FBN); University of Veterinary Medicine Hannover, Foundation; University of Gottingen	Wimmers, K (corresponding author), Leibniz Inst Farm Anim Biol FBN, Inst Genome Biol, D-18196 Dummerstorf, Germany.	wimmers@fbn-dummerstorf.de	naraballobh, watcharapong/HIR-1593-2022; Wimmers, Klaus/AAF-9434-2020	Trakooljul, Nares/0000-0002-3214-2498; Wimmers, Klaus/0000-0002-9523-6790	German Research Foundation (DFG) [WE 4079/4-1, WI 1754/15-1, WI 2072/9-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	This study was funded by the German Research Foundation (DFG www.dfg.de; WE 4079/4-1, WI 1754/15-1, WI 2072/9-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASAKURA A, 1993, MOL CELL BIOL, V13, P7153, DOI 10.1128/MCB.13.11.7153; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Cooper GM., 2000, CELL MOL APPROACH, P63; Cordova G, 2015, J CELL BIOCHEM, V116, P1880, DOI 10.1002/jcb.25143; Du WG, 2015, BIOL REV, V90, P19, DOI 10.1111/brv.12089; Duchene S, 2008, DOMEST ANIM ENDOCRIN, V34, P1, DOI 10.1016/j.domaniend.2006.09.002; Hadad Yair, FEATHERLESS FEATHERE; Hammond CL, 2007, J EXP BIOL, V210, P2667, DOI 10.1242/jeb.005751; Herceg Z, 2001, NAT GENET, V29, P206, DOI 10.1038/ng725; HERNANDEZ N, 1993, GENE DEV, V7, P1291, DOI 10.1101/gad.7.7b.1291; Janisch S, 2015, POULTRY SCI, V94, P2581, DOI 10.3382/ps/pev239; Jia CX, 2010, AUK, V127, P926, DOI 10.1525/auk.2010.09254; Joseph NS, 2006, POULTRY SCI, V85, P932, DOI 10.1093/ps/85.5.932; Krischek C, 2013, BRIT POULTRY SCI, V54, P5, DOI 10.1080/00071668.2013.763901; Krischek C, 2016, MOL REPROD DEV, V83, P71, DOI 10.1002/mrd.22596; LILL A, 1979, CONDOR, V81, P225, DOI 10.2307/1367621; Lourens A, 2005, POULTRY SCI, V84, P914, DOI 10.1093/ps/84.6.914; Loyau T, 2015, ANIMAL, V9, P76, DOI 10.1017/S1751731114001931; Maltby V, 2004, BRIT POULTRY SCI, V45, P491, DOI 10.1080/00071660412331286190; MILLER JB, 1986, J CELL BIOL, V103, P2197, DOI 10.1083/jcb.103.6.2197; MILLER JB, 1987, TRENDS NEUROSCI, V10, P325, DOI 10.1016/0166-2236(87)90089-0; Naraballobh W, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2671-9; Oster M, 2014, ACTA PHYSIOL, V210, P202, DOI 10.1111/apha.12192; Piestun Y, 2009, POULTRY SCI, V88, P2677, DOI 10.3382/ps.2009-00231; Piestun Y, 2009, J APPL PHYSIOL, V106, P233, DOI 10.1152/japplphysiol.91090.2008; Pinchuck S, 2011, EFFECT THERMAL MANIP, P44; Pruitt KD, 2014, NUCLEIC ACIDS RES, V42, pD756, DOI 10.1093/nar/gkt1114; Seaberg B, 2015, MOL CELL BIOL, V35, P1238, DOI 10.1128/MCB.01071-14; STOCKDALE FE, 1992, DEV BIOL, V154, P284, DOI 10.1016/0012-1606(92)90068-R; Stricker S, 2002, DEV BIOL, V245, P95, DOI 10.1006/dbio.2002.0640; Um M, 2001, MOL CELL BIOL, V21, P2435, DOI 10.1128/MCB.21.7.2435-2448.2001; Wang Qiong, 2007, Yichuan, V29, P1089, DOI 10.1360/yc-007-1089; WEBB DR, 1987, CONDOR, V89, P874, DOI 10.2307/1368537; Werner C, 2008, ARCH TIERZUCHT, V51, P11; Yamauchi J, 1997, BIOCHEM BIOPH RES CO, V234, P406, DOI 10.1006/bbrc.1997.6653; Yang XR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117607; Zerbo O, 2013, J AUTISM DEV DISORD, V43, P25, DOI 10.1007/s10803-012-1540-x	38	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162485	10.1371/journal.pone.0162485	http://dx.doi.org/10.1371/journal.pone.0162485			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611643	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900113
J	Ramachandran, GK; Yong, WP; Yeow, CH				Ramachandran, Gokula Krishnan; Yong, Wei Peng; Yeow, Chen Hua			Identification of Gastric Cancer Biomarkers Using H-1 Nuclear Magnetic Resonance Spectrometry	PLOS ONE			English	Article							BREAST-CANCER; IN-VIVO; GLYCOGEN-METABOLISM; MR SPECTROSCOPY; CERVICAL-CANCER; PROTON; CELLS; 2D; 3D; MICROENVIRONMENT	Existing gastric cancer diagnosing methods were invasive, hence, a reliable non-invasive gastric cancer diagnosing method is needed. As a starting point, we used H-1 NMR for identifying gastric cancer biomarkers using a panel of gastric cancer spheroids and normal gastric spheroids. We were able to identify 8 chemical shift biomarkers for gastric cancer spheroids. Our data suggests that the cancerous and non-cancerous spheroids significantly differ in the lipid composition and energy metabolism. These results encourage the translation of these biomarkers into in-vivo gastric cancer detection methodology using MRI-MS.	[Ramachandran, Gokula Krishnan; Yeow, Chen Hua] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Yong, Wei Peng] Singapore NCIS, Natl Univ Canc Inst, Dept Haematol Oncol, Singapore, Singapore	National University of Singapore; National University of Singapore	Yeow, CH (corresponding author), Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore.	bieych@nus.edu.sg	Yong, Wei-Peng/Y-7260-2018; Yeow, Raye Chen-Hua/AAA-3635-2020	Yong, Wei-Peng/0000-0003-4404-3777; Yeow, Raye Chen-Hua/0000-0002-6210-4548; Ramachandran, Gokula Krishnan/0000-0001-5365-4348	MOE Academic research fund (AcRF) Tier-1 grant [R397-000-143-133]	MOE Academic research fund (AcRF) Tier-1 grant	This research is funded by the MOE Academic research fund (AcRF) Tier-1 grant (R397-000-143-133) awarded to YCH at National University of Singapore, Singapore. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r This research is funded by the MOE Academic research fund (AcRF) Tier-1 grant (R397-000143-133) awarded to YCH at National University of Singapore, Singapore.	Alonso AP, 2010, PLANT PHYSIOL, V153, P915, DOI 10.1104/pp.110.155713; Arrowsmith CH, 2012, NAT REV DRUG DISCOV, V11, P384, DOI 10.1038/nrd3674; Baker BM, 2012, J CELL SCI, V125, P3015, DOI 10.1242/jcs.079509; Bellis AD, 2013, BIOTECHNOL BIOENG, V110, P563, DOI 10.1002/bit.24718; BIANCHI E, 1965, J ORG CHEM, V30, P754, DOI 10.1021/jo01014a024; Bolan P. J., 2003, MAGNETIC RESONANCE M, V50, P1; Bolan PJ, 2005, BREAST CANCER RES, V7, P149, DOI 10.1186/bcr1202; Bondock S, 2008, EUR J MED CHEM, V43, P2122, DOI 10.1016/j.ejmech.2007.12.009; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Busse A, 2013, CLIN EXP METASTAS, V30, P781, DOI 10.1007/s10585-013-9578-5; CARY PD, 1978, EUR J BIOCHEM, V89, P475, DOI 10.1111/j.1432-1033.1978.tb12551.x; Chitcholtan K, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-38; Choi C, 2012, NAT MED, V18, P624, DOI 10.1038/nm.2682; FLORIAN CL, 1995, CANCER RES, V55, P420; Foty R, 2011, JOVE-J VIS EXP, DOI 10.3791/2720; Gillies RJ, 2005, ANNU REV BIOMED ENG, V7, P287, DOI 10.1146/annurev.bioeng.7.060804.100411; Grande S, 2011, NMR BIOMED, V24, P68, DOI 10.1002/nbm.1557; Hamilton G, 2011, NMR BIOMED, V24, P784, DOI 10.1002/nbm.1622; Heerschap A, 1997, ANTICANCER RES, V17, P1455; HERS HG, 1976, ANNU REV BIOCHEM, V45, P167, DOI 10.1146/annurev.bi.45.070176.001123; Hong YQ, 2013, MICROBIOL-SGM, V159, P2316, DOI 10.1099/mic.0.069823-0; Huang YQ, 2015, SCI REP-UK, V5, DOI 10.1038/srep08390; Ivascu A, 2007, INT J ONCOL, V31, P1403; Jacobs MA, 2004, J MAGN RESON IMAGING, V19, P68, DOI 10.1002/jmri.10427; Jayalakshmi K, 2011, NMR BIOMED, V24, P335, DOI 10.1002/nbm.1594; Jordan B.F., 2005, NMR BIOMED, V18, P430; Jordan NF, 2005, NMR BIOMED, V18, P430, DOI 10.1002/nbm.977; Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027; Kanavos P, 2006, ANN ONCOL, V17, P15, DOI 10.1093/annonc.mdl983; Karnjanapratum S, 2012, INT J BIOL MACROMOL, V51, P720, DOI 10.1016/j.ijbiomac.2012.07.006; Kennedy J.P., 1967, J MACROMOL SCI CHEM, V1, P345, DOI [10.1080/10601326708053976, DOI 10.1080/10601326708053976]; Kilonda A, 2003, ARKIVOC, P3, DOI 10.3998/ark.5550190.0004.402; Klein A., 1988, EUROPEAN JOURNAL OF, V171, P643; Kojima H, 2013, GLYCOCONJUGATE J, V30, P257, DOI 10.1007/s10719-012-9436-8; LAMBLIN G, 1991, BIOCHEM J, V275, P199, DOI 10.1042/bj2750199; Lee JM, 2013, LAB INVEST, V93, P528, DOI 10.1038/labinvest.2013.41; LIN JK, 1992, FOOD CHEM TOXICOL, V30, P695, DOI 10.1016/0278-6915(92)90165-H; LIN JK, 1983, FOOD CHEM TOXICOL, V21, P143, DOI 10.1016/0278-6915(83)90228-4; Lin R. Z., 2008, BIOTECHNOL J, V3, P139; Luca AC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059689; Mahon MM, 2004, NMR BIOMED, V17, P1, DOI 10.1002/nbm.830; Manganas LN, 2007, SCIENCE, V318, P980, DOI 10.1126/science.1147851; Marjanovic ND, 2013, CLIN CHEM, V59, P168, DOI 10.1373/clinchem.2012.184655; Meisamy S, 2004, RADIOLOGY, V233, P424, DOI 10.1148/radiol.2332031285; Muncey HJ, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-496; NEGENDANK W, 1992, NMR BIOMED, V5, P303, DOI 10.1002/nbm.1940050518; Odeh F., 2012, DRUG DELIV, V19, P1; Podo F, 1999, NMR BIOMED, V12, P413, DOI 10.1002/(SICI)1099-1492(199911)12:7<413::AID-NBM587>3.0.CO;2-U; Pore Y., 2008, DIG J NANOMATER BIOS, V3, P293; Pourhoseingholi Mohamad Amin, 2015, Gastroenterol Hepatol Bed Bench, V8, P19; Radermacher KA, 2012, NMR BIOMED, V25, P514, DOI 10.1002/nbm.1765; Razzak Md, 2015, INT J ORG CHEM, V5, P264; Rugge M., 2006, WORLD J GASTROENTERO, V12, P23; RUIZCABELLO J, 1992, NMR BIOMED, V5, P226, DOI 10.1002/nbm.1940050506; Saito K, 2008, ANTICANCER RES, V28, P1899; Schiavoni G, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00090; SOWERS LC, 1988, J BIOL CHEM, V263, P14794; Steindl C., 2005, CARBOHYD RES, P340; Stenman K, 2011, BIOMARK INSIGHTS, V6, P39, DOI 10.4137/BMI.S6794; Teneberg S, 2004, GLYCOBIOLOGY, V14, P187, DOI 10.1093/glycob/cwh015; Ting Y ., 2009, J BIOL CHEM, V284, P21526, DOI [10.1074/jbc.M109.014761, DOI 10.1074/JBC.M109.014761]; Umbehr M, 2009, EUR UROL, V55, P575, DOI 10.1016/j.eururo.2008.10.019; URENJAK J, 1993, J NEUROSCI, V13, P981, DOI 10.1523/jneurosci.13-03-00981.1993; Vissers MCM, 2014, BIOCHEM SOC T, V42, P945, DOI 10.1042/BST20140118; VLIEGENTHART JFG, 1981, PURE APPL CHEM, V53, P45, DOI 10.1351/pac198153010045; Wang HJ, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-121; Xia JG, 2011, NAT PROTOC, V6, P743, DOI 10.1038/nprot.2011.319; Yokota H, 2007, J MAGN RESON IMAGING, V25, P992, DOI 10.1002/jmri.20902; Yong J. K., 1989, J KOSOMBE, V10, P285; Yu GL, 2002, CARBOHYD RES, V337, P433, DOI 10.1016/S0008-6215(02)00009-5; Zietkowski D, 2013, NMR BIOMED, V26, P1096, DOI 10.1002/nbm.2923; Zois CE, 2014, BIOCHEM PHARMACOL, V92, P3, DOI 10.1016/j.bcp.2014.09.001	73	6	6	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162222	10.1371/journal.pone.0162222	http://dx.doi.org/10.1371/journal.pone.0162222			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611679	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900061
J	Ssengooba, W; Respeito, D; Mambuque, E; Blanco, S; Bulo, H; Mandomando, I; de Jong, BC; Cobelens, FG; Garcia-Basteiro, AL				Ssengooba, Willy; Respeito, Durval; Mambuque, Edson; Blanco, Silvia; Bulo, Helder; Mandomando, Inacio; de Jong, Bouke C.; Cobelens, Frank G.; Garcia-Basteiro, Alberto L.			Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Delays for Tuberculosis Diagnosis?	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; HIV; TRANSMISSION; BURDEN; INDIA; TB	Introduction Early diagnosis and initiation to appropriate treatment is vital for tuberculosis (TB) control. The XpertMTB/ RIF (Xpert) assay offers rapid TB diagnosis and quantitative estimation of bacterial burden through Cycle threshold (Ct) values. We assessed whether the Xpert Ct value is associated with delayed TB diagnosis as a potential monitoring tool for TB control programme performance. Materials and Methods This analysis was nested in a prospective study under the routine TB surveillance procedures of the National TB Control Program in Manhica district, Maputo province, Mozambique. Presumptive TB patients were tested using smear microscopy and Xpert. We explored the association between Xpert Ct values and self-reporteddelay of Xpert-positive TB patients as recorded at the time of diagnosis enrolment. Patients with > 60 days of TB symptoms were considered to have long delays. Results Of 1,483 presumptive TB cases, 580 were diagnosed as TB of whom 505 (87.0%) were due to pulmonary TB and 302 (94.1%) were Xpert positive. Ct values (range, 9.7-46.4) showed a multimodal distribution. The median (IQR) delay was 30 (30-45) days. Ct values showed no correlation with delay (R-2 = 0.001, p = 0.621), nor any association with long delays: adjusted odds ratios (AOR) (95% confidence interval [CI]) comparing to > 28 cycles 0.99 (0.50-1.96; p = 0.987) for 23-28 cycles, 0.93 (0.50-1.74; p = 0.828) for 16-22 cycles; 1.05 (0.47-2.36; p = 0.897) for < 16 cycles. Being HIV-negative (AOR [95% CI]), 2.05 (1.193.51, p = 0.009) and rural residence 1.74 (1.08-2.81, p = 0.023), were independent predictors of long delays. Conclusion Xpert Ct values were not associated with patient delay for TB diagnosis and cannot be used as an indicator of TB control program performance.	[Ssengooba, Willy; Cobelens, Frank G.; Garcia-Basteiro, Alberto L.] Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands; [Ssengooba, Willy; Cobelens, Frank G.; Garcia-Basteiro, Alberto L.] Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Acad Med Ctr, Amsterdam, Netherlands; [Ssengooba, Willy; Blanco, Silvia; Garcia-Basteiro, Alberto L.] Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain; [Ssengooba, Willy] Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda; [Respeito, Durval; Mambuque, Edson; Blanco, Silvia; Bulo, Helder; Mandomando, Inacio; Garcia-Basteiro, Alberto L.] Ctr Invest Saude Manhica, Maputo, Mozambique; [Mandomando, Inacio] Minist Saude, Inst Nacl Saude, Maputo, Mozambique; [de Jong, Bouke C.] Inst Trop Med, Mycobacteriol Unit, Antwerp, Belgium; [Cobelens, Frank G.] KNCV TB Fdn, The Hague, Netherlands	University of Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam; ISGlobal; CRESIB; University of Barcelona; Hospital Clinic de Barcelona; Makerere University; Centro de Investigacao em Saude de Manhica; Institute of Tropical Medicine (ITM); KNCV Tuberculosis Foundation	Ssengooba, W (corresponding author), Univ Amsterdam, Dept Global Hlth, Amsterdam, Netherlands.; Ssengooba, W (corresponding author), Univ Amsterdam, Amsterdam Inst Global Hlth & Dev, Acad Med Ctr, Amsterdam, Netherlands.; Ssengooba, W (corresponding author), Univ Barcelona, Hosp Clin, ISGlobal, Barcelona Ctr Int Hlth Res CRESIB, Barcelona, Spain.; Ssengooba, W (corresponding author), Makerere Univ, Coll Hlth Sci, Dept Med Microbiol, Kampala, Uganda.	willyssengooba@gmail.com	Ssengooba, Willy/ABE-2168-2020; Mandomando, Inacio/ABD-8007-2020; de Jong, Bouke/A-3636-2013	Ssengooba, Willy/0000-0002-1643-110X; Mandomando, Inacio/0000-0002-1078-2187; de Jong, Bouke/0000-0002-1017-4675	European Union	European Union(European Commission)	This work was supported by the Erasmus Mundus Joint Doctorate Program of the European Union through a training grant to WS.; This work was supported by the Erasmus Mundus Joint Doctorate Program of the European Union through a training grant to WS. We thank all study participants in the district of Manhica for their participation in the study and the National Control Program (Dr Ivan Manhica, Luis Faife) and Health Services of the district (Fausta Temba) for their support. The authors wish to thank the CISM laboratory & health care staff, as well as data clerks involved in the study	Arinaminpathy N, 2015, NATURE, V528, pS60, DOI 10.1038/nature16045; Belkina TV, 2014, BMC INFECT DIS, V14, DOI 10.1186/s12879-014-0624-y; Buregyeya E, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-586; Cohen GM, 2014, JAIDS-J ACQ IMM DEF, V67, pE88, DOI 10.1097/QAI.0000000000000309; Corbett EL, 2010, B WORLD HEALTH ORGAN, V88, P13, DOI 10.2471/BLT.08.055467; Dharmadhikari AS, 2014, INT J TUBERC LUNG D, V18, P1019, DOI 10.5588/ijtld.13.0834; Esmail H, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0437; Garcia-Basteiro AL, 2015, EUR RESPIR J, V45, P547, DOI 10.1183/09031936.00145714; Garcia-Basteiro AL, 2014, LANCET, V383, P215, DOI 10.1016/S0140-6736(14)60069-6; Gonzalez R, 2012, HIV MED, V13, P581, DOI 10.1111/j.1468-1293.2012.01018.x; Gosoniu GD, 2008, INT J TUBERC LUNG D, V12, P848; Hanrahan CF, 2014, AM J RESP CRIT CARE, V189, P1426, DOI 10.1164/rccm.201312-2140OC; Lawn SD, 2011, AIDS, V25, P2190, DOI 10.1097/QAD.0b013e32834cda4e; Lin X, 2008, INT J TUBERC LUNG D, V12, P288; Lopez-Varela E, 2016, EUR RESPIR J, V47, P1003, DOI 10.1183/13993003.01454-2015; Mahendradhata Y, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-393; Makwakwa L, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-132; Marino S, 2016, PLOS COMPUT BIOL, V12, DOI 10.1371/journal.pcbi.1004804; Ngamvithayapong J, 2001, INT J TUBERC LUNG D, V5, P1013; Osei E, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1922-z; RILEY RL, 1995, AM J EPIDEMIOL, V142, P3, DOI 10.1093/oxfordjournals.aje.a117542; Saifodine A, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-559; Sendagire I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014459; Sreeramareddy CT, 2014, INT J TUBERC LUNG D, V18, P255, DOI 10.5588/ijtld.13.0585; Takarinda KC, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1437-7; Tiemersma EW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017601; WHO, GLOB TUB REP 2014; Yuen CM, 2015, LANCET, V386, P2334, DOI 10.1016/S0140-6736(15)00322-0	28	10	11	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162833	10.1371/journal.pone.0162833	http://dx.doi.org/10.1371/journal.pone.0162833			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611466	Green Published, gold			2022-12-26	WOS:000383255900176
J	Pareek, CS; Smoczynski, R; Kadarmideen, HN; Dziuba, P; Blaszczyk, P; Sikora, M; Walendzik, P; Grzybowski, T; Pierzchala, M; Horbanczuk, J; Szostak, A; Ogluszka, M; Zwierzchowski, L; Czarnik, U; Fraser, L; Sobiech, P; Wasowicz, K; Gelfand, B; Feng, YP; Kumar, D				Pareek, Chandra Shekhar; Smoczynski, Rafal; Kadarmideen, Haja N.; Dziuba, Piotr; Blaszczyk, Pawel; Sikora, Marcin; Walendzik, Paulina; Grzybowski, Tomasz; Pierzchala, Mariusz; Horbanczuk, Jaroslaw; Szostak, Agnieszka; Ogluszka, Magdalena; Zwierzchowski, Lech; Czarnik, Urszula; Fraser, Leyland; Sobiech, Przemyslaw; Wasowicz, Krzysztof; Gelfand, Brian; Feng, Yaping; Kumar, Dibyendu			Single Nucleotide Polymorphism Discovery in Bovine Pituitary Gland Using RNA-Seq Technology	PLOS ONE			English	Article							GENOME; CATTLE; ASSOCIATION; SEQUENCE; GROWTH; IDENTIFICATION; LIVESTOCK; GENOTYPE; PROGRESS; TRAITS	Examination of bovine pituitary gland transcriptome by strand-specific RNA-seq allows detection of putative single nucleotide polymorphisms (SNPs) within potential candidate genes (CGs) or QTLs regions as well as to understand the genomics variations that contribute to economic trait. Here we report a breed-specific model to successfully perform the detection of SNPs in the pituitary gland of young growing bulls representing Polish Holstein-Friesian (HF), Polish Red, and Hereford breeds at three developmental ages viz., six months, nine months, and twelve months. A total of 18 bovine pituitary gland polyA transcriptome libraries were prepared and sequenced using the Illumina NextSeq 500 platform. Sequenced FastQ databases of all 18 young bulls were submitted to NCBI-SRA database with NCBI-SRA accession numbers SRS1296732. For the investigated young bulls, a total of 113,882,3098 raw paired-end reads with a length of 156 bases were obtained, resulting in an approximately 63 million paired-end reads per library. Breed-wise, a total of 515.38, 215.39, and 408.04 million paired-end reads were obtained for Polish HF, Polish Red, and Hereford breeds, respectively. Burrows-Wheeler Aligner (BWA) read alignments showed 93.04%, 94.39%, and 83.46% of the mapped sequencing reads were properly paired to the Polish HF, Polish Red, and Hereford breeds, respectively. Constructed breed-specific SNP-db of three cattle breeds yielded at 13,775,885 SNPs. On an average 765,326 breed-specific SNPs per young bull were identified. Using two stringent filtering parameters, i.e., a minimum 10 SNP reads per base with an accuracy >= 90% and a minimum 10 SNP reads per base with an accuracy = 100%, SNP-db records were trimmed to construct a highly reliable SNP-db. This resulted in a reduction of 95,7% and 96,4% cut-off mark of constructed raw SNP-db. Finally, SNP discoveries using RNA-Seq data were validated by KASP (TM) SNP genotyping assay. The comprehensive QTLs/CGs analysis of 76 QTLs/CGs with RNA-seq data identified KCNIP4, CCSER1, DPP6, MAP3K5 and GHR CGs with highest SNPs hit loci in all three breeds and developmental ages. However, CAST CG with more than 100 SNPs hits were observed only in Polish HF and Hereford breeds. These findings are important for identification and construction of novel tissue specific SNP-db and breed specific SNP-db dataset by screening of putative SNPs according to QTL db and candidate genes for bovine growth and reproduction traits, one can develop genomic selection strategies for growth and reproductive traits.	[Pareek, Chandra Shekhar; Smoczynski, Rafal; Dziuba, Piotr; Blaszczyk, Pawel; Sikora, Marcin; Walendzik, Paulina] Nicolaus Copernicus Univ, Div Funct Genom Biol & Biomed Res, Ctr Modern Interdisciplinary Technol, Torun, Poland; [Kadarmideen, Haja N.] Univ Copenhagen, Fac Hlth & Med Sci, Dept Large Anim Sci, Copenhagen, Denmark; [Grzybowski, Tomasz] Nicolaus Copernicus Univ, Inst Forens Med, Dept Mol & Forens Genet, Ludwik Rydygier Coll Med, Bydgoszcz, Poland; [Pierzchala, Mariusz; Horbanczuk, Jaroslaw; Szostak, Agnieszka; Ogluszka, Magdalena; Zwierzchowski, Lech] Polish Acad Sci, Inst Genet & Anim Breeding, Jastrzebiec, Poland; [Czarnik, Urszula; Fraser, Leyland] Univ Warmia & Mazury, Fac Anim Bioengn, Olsztyn, Poland; [Sobiech, Przemyslaw; Wasowicz, Krzysztof] Univ Warmia & Mazury, Fac Vet Med, Olsztyn, Poland; [Gelfand, Brian; Feng, Yaping; Kumar, Dibyendu] Rutgers State Univ, Waksman Inst Microbiol, Piscataway, NJ USA	Nicolaus Copernicus University; University of Copenhagen; Nicolaus Copernicus University; Institute of Genetics & Animal Biotechnology, Polish Academy of Sciences; Polish Academy of Sciences; University of Warmia & Mazury; University of Warmia & Mazury; Rutgers State University New Brunswick	Pareek, CS (corresponding author), Nicolaus Copernicus Univ, Div Funct Genom Biol & Biomed Res, Ctr Modern Interdisciplinary Technol, Torun, Poland.	pareekcs@umk.pl	pareek, chandra/M-2751-2014; Grzybowski, Tomasz/A-1676-2015; Horbanczuk, Jaroslaw/ABD-8389-2021; Pierzchala, Mariusz/G-1052-2013	pareek, chandra/0000-0002-0329-787X; Grzybowski, Tomasz/0000-0001-6228-6460; Pierzchala, Mariusz/0000-0001-7001-1336; Sikora, Marcin/0000-0003-2022-4434; Czarnik, Urszula/0000-0002-9065-2197; Kadarmideen, Haja/0000-0001-6294-382X; Szostak, Agnieszka/0000-0003-3578-0492; Fraser, Leyland/0000-0002-2997-9991; Horbanczuk, Jaroslaw Olav/0000-0002-7561-0941; Wasowicz, Krzysztof/0000-0002-9496-3144	National Science Centre, Krakow, Poland [2012/05/B/NZ2/01629]; entitled "Analiza transkryptomow genomu Bos taurus przy zastosowaniu technologii sekwencjonowania kolejnej generacji"	National Science Centre, Krakow, Poland; entitled "Analiza transkryptomow genomu Bos taurus przy zastosowaniu technologii sekwencjonowania kolejnej generacji"	This research paper was financially supported by National Science Centre, Krakow, Poland, Project No. 2012/05/B/NZ2/01629; entitled "Analiza transkryptomow genomu Bos taurus przy zastosowaniu technologii sekwencjonowania kolejnej generacji".	Anders S, 2015, BIOINFORMATICS, V31, P166, DOI 10.1093/bioinformatics/btu638; Bai YS, 2012, J ANIM SCI BIOTECHNO, V3, DOI 10.1186/2049-1891-3-8; Baldwin RL VI, 2012, GENE REGUL SYST BIO, V6, P67, DOI 10.4137/GRSB.S9687; Bolormaa S, 2011, J ANIM SCI, V89, P1684, DOI 10.2527/jas.2010-3079; Canovas A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102551; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; Chitwood JL, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-350; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; Djari A, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-307; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Fortes MRS, 2012, J ANIM SCI, V90, P2894, DOI 10.2527/jas.2011-4601; GEORGES M, 1995, GENETICS, V139, P907; Gibbs RA, 2009, SCIENCE, V324, P528, DOI 10.1126/science.1167936; GUO SW, 1992, BIOMETRICS, V48, P361, DOI 10.2307/2532296; Hayes B, 2010, GENOME, V53, P876, DOI 10.1139/G10-076; He H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064356; Henshall JM, 2012, GENET SEL EVOL, V44, DOI 10.1186/1297-9686-44-12; Hu ZL, 2016, NUCLEIC ACIDS RES, V44, pD827, DOI 10.1093/nar/gkv1233; Huang W, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030244; KBioscience, 2009, PRIMERPICKER LIT KAS; Koringa PG, 2013, GENE, V530, P119, DOI 10.1016/j.gene.2013.07.061; Kumar S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-684; Lee TH, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-162; Li C, 2004, J ANIM SCI, V82, P1; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lindholm-Perry AK, 2012, ANIM GENET, V43, P216, DOI 10.1111/j.1365-2052.2011.02232.x; Martin M, 2011, EMBNET J, V17; Morsci NS, 2006, ANIM GENET, V37, P554, DOI 10.1111/j.1365-2052.2006.01528.x; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Pareek CS, 2011, BRIEF FUNCT GENOMICS, V10, P165, DOI 10.1093/bfgp/elr019; Pareek CS, 2011, J APPL GENET, V52, P413, DOI 10.1007/s13353-011-0057-x; Pareek CS, 2016, P PAG; Pauciullo A, 2015, ANIM GENET, V46, P122, DOI 10.1111/age.12261; Perez-Enciso M, 2010, ANIM GENET, V41, P561, DOI 10.1111/j.1365-2052.2010.02057.x; Qian X, 2014, OMICS, V18, P98, DOI 10.1089/omi.2013.0110; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Tan AC, 2008, CANCER BIOL THER, V7, P137, DOI 10.4161/cbt.7.1.5199; Villanueva B, 2004, J ANIM SCI, V82, P1305; Wang WX, 2011, SCI REP-UK, V1, DOI 10.1038/srep00055; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Zhou Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113881; Zhu MJ, 2007, INT J BIOL SCI, V3, P420	44	14	15	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161370	10.1371/journal.pone.0161370	http://dx.doi.org/10.1371/journal.pone.0161370			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606429	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600006
J	Savastio, S; Cadario, F; Genoni, G; Bellomo, G; Bagnati, M; Secco, G; Picchi, R; Giglione, E; Bona, G				Savastio, Silvia; Cadario, Francesco; Genoni, Giulia; Bellomo, Giorgio; Bagnati, Marco; Secco, Gioel; Picchi, Raffaella; Giglione, Enza; Bona, Gianni			Vitamin D Deficiency and Glycemic Status in Children and Adolescents with Type 1 Diabetes Mellitus	PLOS ONE			English	Article							BETA-CELL FUNCTION; D SUPPLEMENTATION; INSULIN-RESISTANCE; GLUCOSE-METABOLISM; ONSET; PREVALENCE; D-3; ASSOCIATION; CALCITRIOL; DISEASE	Background Vitamin D (25OHD) effects on glycemic control are unclear in children and adolescents with type 1 diabetes. Aims of this study were to investigate 25OHD status among children with T1DM and its relationship with insulin sensitivity and glycemic status. Subjects and Methods A cross sectional study was carried out between 2008-2014. A total of 141 patients had a T1DM >12 months diagnosis and were enrolled in the present study. Of these 35 (24.8%) were migrants and 106 (75.2%) Italians (T2). We retrospectively analyzed data at the onset of the disease (T0)( 64 subjects) and 12-24 months before the last visit (T1,124 subjects). Fasting glucose, glycated hemoglobin (HbA1c), 25OHD levels and daily insulin requirement were evaluated and Cholecalciferol 1000 IU/day supplementation for the management of vitamin D insufficiency (<75 nmol/L) was systematically added. Results A generalized 25OHD insufficiency was found at each study time, particularly in migrants. At T0, the 25OHD levels were inversely related to diabetic keto-acidosis (DKA) severity (p<0.05). At T1 and T2, subjects with 25OHD <= 25nmol/L (10 ng/mL) showed higher daily insulin requirement (p<0.05) and HbA1c values (p<0.01) than others vitamin D status. The 25OHD levels were negatively related with HbA1c (p<0.001) and daily insulin dose (p<0.05) during follow up. There was a significant difference in 25OHD ( p<0.01) between subjects with different metabolic control ( HbA1c <7.5%, 7.5-8%,>8%), both at T1 and T2. In supplemented subjects, we found a significant increase in 25OHD levels (p<0.0001) and decrease of HbA1c (p<0.001) between T1 and T2, but this was not significant in the migrants subgroup. Multivariate regression analysis showed a link between HbA1c and 25OHD levels (p<0.001). Conclusions Children with T1DM show a generalized 25OHD deficiency that impact on metabolic status and glycemic homeostasis. Vitamin D supplementation improves glycemic control and should be considered as an additional therapy.	[Savastio, Silvia; Cadario, Francesco; Genoni, Giulia; Picchi, Raffaella; Giglione, Enza; Bona, Gianni] Univ Piemonte Orientale, Div Pediat, Dept Hlth Sci, Novara, Italy; [Cadario, Francesco] IRCAD, Novara, Italy; [Bellomo, Giorgio; Bagnati, Marco] Univ Piemonte Orientale, Cent Lab Maggiore della Carita Hosp, Novara, Italy; [Secco, Gioel] Osped Santi Antonio & Biagio & Cesare Arrigo, Div Cardiol, Alessandria, Italy	University of Eastern Piedmont Amedeo Avogadro; University of Eastern Piedmont Amedeo Avogadro; Azienda Ospedaliera SS Antonio Biagio Cesare Arrigo	Savastio, S (corresponding author), Univ Piemonte Orientale, Div Pediat, Dept Hlth Sci, Novara, Italy.	savastio.silvia@gmail.com	Cadario, Francesco/AAA-1240-2019; Secco, Gioel Gabrio/AAC-7522-2022; Savastio, Silvia/AAC-6475-2022	Secco, Gioel Gabrio/0000-0002-9998-7049; Savastio, Silvia/0000-0002-5867-3246; Cadario, Francesco/0000-0001-8808-834X	Ministry of Health [RF-2010-2304835]	Ministry of Health	The paper is part of a project (RF-2010-2304835) funded by the Ministry of Health. The grant had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r The paper is part of a project (RF-2010-2304835) funded by the Ministery of Health. The grant had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2010, J CLIN ENDOCR METAB, V95, P471, DOI 10.1210/jc.2009-1773; Al-Timimi DJ, 2013, J CLIN DIAGN RES, V7, P2686, DOI 10.7860/JCDR/2013/6712.3733; Aljabri KS, 2010, ANN SAUDI MED, V30, P454, DOI 10.4103/0256-4947.72265; Amer Diabet Assoc, 2013, DIABETES CARE, V36, pS67, DOI [10.2337/dc13-S067, 10.2337/dc10-S062, 10.2337/dc12-s064, 10.2337/dc11-S062]; Barengolts E, 2013, ENDOCR PRACT, V19, P497, DOI 10.4158/EP12263.RA; Bener A, 2009, ACTA DIABETOL, V46, P183, DOI 10.1007/s00592-008-0071-6; Bergman P, 2013, PLOS ONE, P8; Billaudel B, 1998, DIABETES METAB, V24, P344; Bizzarri C, 2010, DIABETES CARE, V33, P1962, DOI [10.2337/dc10-0814, 10.2337/dc10-1168]; Bock G, 2011, DIABETES-METAB RES, V27, P942, DOI 10.1002/dmrr.1276; BOURLON PM, 1999, J ENDOCRINOL, V160, P87, DOI DOI 10.1677/JOE.0.1600087; Cacciari E, 2006, J ENDOCRINOL INVEST, V29, P581, DOI 10.1007/BF03344156; Cadario F, 2015, PLOS ONE, P10; Cadario F, 2014, ACTA DIABETOL, V51, P263, DOI 10.1007/s00592-013-0514-6; Chiu KC, 2004, AM J CLIN NUTR, V79, P820; Christakos S, 2003, J CELL BIOCHEM, V88, P695, DOI 10.1002/jcb.10423; Cigolini M, 2006, DIABETES CARE, V29, P722, DOI 10.2337/diacare.29.03.06.dc05-2148; Dutta D, 2013, INDIAN J MED RES, V138, P853; Feng RN, 2015, DIABETES RES CLIN PR, V108, pE71, DOI 10.1016/j.diabres.2014.12.008; FITZPATRICK TB, 1988, ARCH DERMATOL, V124, P869, DOI 10.1001/archderm.124.6.869; Franchi B, 2014, EUR J PEDIATR, V173, P477, DOI 10.1007/s00431-013-2204-3; Gabbay MAL, 2012, ARCH PEDIAT ADOL MED, V166, P601, DOI 10.1001/archpediatrics.2012.164; Greer RM, 2007, MED J AUSTRALIA, V187, P59, DOI 10.5694/j.1326-5377.2007.tb01130.x; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Holick MF, 2008, CURR DIABETES REP, V8, P393, DOI 10.1007/s11892-008-0068-0; Huynh T, 2009, PEDIATR DIABETES, V10, P38, DOI 10.1111/j.1399-5448.2008.00439.x; Hypponen E, 2001, LANCET, V358, P1500, DOI 10.1016/S0140-6736(01)06580-1; Kelly A, 2011, ARCH DIS CHILD, V96, P447, DOI 10.1136/adc.2010.187591; Kostoglou-Athanassiou I, 2013, THER ADV ENDOCRINOL, V4, P122, DOI 10.1177/2042018813501189; Liu Y, 2015, MED ONCOL, V32, DOI 10.1007/s12032-014-0434-5; Martin CA, 2016, NUTRITION, V32, P21, DOI 10.1016/j.nut.2015.07.007; Nwosu BU, 2012, J PEDIATR ENDOCR MET, V25, P181, DOI 10.1515/jpem-2011-0403; Nwosu BU, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099646; Ordooei M, 2014, MINERVA PEDIAT; Ou HY, 2011, EUR J CLIN INVEST, V41, P1195, DOI 10.1111/j.1365-2362.2011.02525.x; Pitocco D, 2006, DIABETIC MED, V23, P920, DOI 10.1111/j.1464-5491.2006.01921.x; Raab J, 2014, DIABETOLOGIA, V57, P902, DOI 10.1007/s00125-014-3181-4; Ryu OH, 2014, ENDOCR J, V61, P167, DOI 10.1507/endocrj.EJ13-0356; SERGEEV IN, 1995, ENDOCRINOLOGY, V136, P2852, DOI 10.1210/en.136.7.2852; Strobel F, 2014, HORM METAB RES, V46, P54, DOI 10.1055/s-0033-1358453; Tunc O, 2011, J PEDIATR ENDOCR MET, V24, P1037, DOI 10.1515/JPEM.2011.213; van Schoor NM, 2011, BEST PRACT RES CL EN, V25, P671, DOI 10.1016/j.beem.2011.06.007; Zipitis CS, 2008, ARCH DIS CHILD, V93, P512, DOI 10.1136/adc.2007.128579; Zittermann Armin, 2014, Adv Exp Med Biol, V810, P106	44	32	36	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162554	10.1371/journal.pone.0162554	http://dx.doi.org/10.1371/journal.pone.0162554			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607348	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255600064
J	El Azami, M; Hammers, A; Jung, JL; Costes, N; Bouet, R; Lartizien, C				El Azami, Meriem; Hammers, Alexander; Jung, Julien; Costes, Nicolas; Bouet, Romain; Lartizien, Carole			Detection of Lesions Underlying Intractable Epilepsy on T1-Weighted MRI as an Outlier Detection Problem	PLOS ONE			English	Article							FOCAL CORTICAL DYSPLASIA; VOXEL-BASED MORPHOMETRY; HUMAN BRAIN; AUTOMATED DETECTION; IMPROVES DETECTION; CLASSIFICATION; MATTER; ATLAS	Pattern recognition methods, such as computer aided diagnosis (CAD) systems, can help clinicians in their diagnosis by marking abnormal regions in an image. We propose a machine learning system based on a one-class support vector machine (OC-SVM) classifier for the detection of abnormalities in magnetic resonance images (MRI) applied to patients with intractable epilepsy. The system learns the features associated with healthy control subjects, allowing a voxelwise assessment of the deviation of a test subject pattern from the learned patterns. While any number of various features can be chosen and learned, here we focus on two texture parameters capturing image patterns associated with epileptogenic lesions on T1-weighted brain MRI e.g. heterotopia and blurred junction between the grey and white matter. The CAD output consists of patient specific 3D maps locating clusters of suspicious voxels ranked by size and degree of deviation from control patterns. System performance was evaluated using realistic simulations of challenging detection tasks as well as clinical data of 77 healthy control subjects and of eleven patients (13 lesions). It was compared to that of a mass univariate statistical parametric mapping (SPM) single subject analysis based on the same set of features. For all simulations, OC-SVM yielded significantly higher values of the area under the ROC curve (AUC) and higher sensitivity at low false positive rate. For the clinical data, both OC-SVM and SPM successfully detected 100% of the lesions in the MRI positive cases (3/13). For the MRI negative cases (10/13), OC-SVM detected 7/10 lesions and SPM analysis detected 5/10 lesions. In all experiments, OC-SVM produced fewer false positive detections than SPM. OC-SVM may be a versatile system for unbiased lesion detection.	[El Azami, Meriem; Lartizien, Carole] Univ Lyon 1, CREATIS, F-69622 Villeurbanne, France; [El Azami, Meriem; Lartizien, Carole] Univ Lyon 1, CNRS, UMR5220, F-69622 Villeurbanne, France; [El Azami, Meriem; Lartizien, Carole] Univ Lyon 1, INSERM, U1206, F-69622 Villeurbanne, France; [El Azami, Meriem; Lartizien, Carole] Univ Lyon 1, INSA Lyon, F-69622 Villeurbanne, France; [Hammers, Alexander] Neurodis Fdn, Lyon, France; [Hammers, Alexander] Kings Coll London, Div Imaging Sci & Biomed Engn, PET Ctr, London, England; [Jung, Julien; Bouet, Romain] Lyon Neurosci Res Ctr, INSERM, CNRS, U1028,UMR5292, Lyon, France; [Costes, Nicolas] CERMEP Imagerie Vivant, Lyon, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute for Engineering & Systems Sciences (INSIS); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Institut National des Sciences Appliquees de Lyon - INSA Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; University of London; King's College London; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); CHU Lyon; Institut National de la Sante et de la Recherche Medicale (Inserm)	El Azami, M (corresponding author), Univ Lyon 1, CREATIS, F-69622 Villeurbanne, France.; El Azami, M (corresponding author), Univ Lyon 1, CNRS, UMR5220, F-69622 Villeurbanne, France.; El Azami, M (corresponding author), Univ Lyon 1, INSERM, U1206, F-69622 Villeurbanne, France.; El Azami, M (corresponding author), Univ Lyon 1, INSA Lyon, F-69622 Villeurbanne, France.	meriem.elazami@creatis.insa-lyon.fr	Costes, Nicolas/D-4452-2013; Lartizien, Carole/H-4447-2014; Lachaux, Jean-Philippe/K-1681-2017; Lartizien, Carole/M-6991-2019; Hammers, Alexander/D-9982-2015	Costes, Nicolas/0000-0002-2954-9262; Lartizien, Carole/0000-0001-7594-4231; Jung, Julien/0000-0002-9274-0086; Bouet, Romain/0000-0002-3690-2976; Hammers, Alexander/0000-0001-9530-4848	LABEX PRIMES of Universite de Lyon within the program "Investissements d'Avenir" [ANR-11-LABX-0063, ANR-11-IDEX-0007]	LABEX PRIMES of Universite de Lyon within the program "Investissements d'Avenir"(French National Research Agency (ANR))	This work was supported by the LABEX PRIMES (ANR-11-LABX-0063) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Drs Jean Isnard and Genevieve Demarquay from the Hospices Civils de Lyon for permission to use the imaging data from patients under their care; and Sandrine Bouvard and Phillipe Ryvlin from Lyon Neuroscience Research Center for providing the data for normal control subjects. This work was supported by the LABEX PRIMES (ANR-11-LABX-0063) of Universite de Lyon, within the program "Investissements d'Avenir" (ANR-11-IDEX-0007) operated by the French National Research Agency (ANR).	Ahmed B, 2015, EPILEPSY BEHAV, V48, P21, DOI 10.1016/j.yebeh.2015.04.055; [Anonymous], MRI NEGATIVE EPILEPS; Antel SB, 2003, NEUROIMAGE, V19, P1748, DOI 10.1016/S1053-8119(03)00226-X; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Ashburner J, 2007, NEUROIMAGE, V38, P95, DOI 10.1016/j.neuroimage.2007.07.007; Barkovich AJ, 1996, J CLIN NEUROPHYSIOL, V13, P481, DOI 10.1097/00004691-199611000-00003; Bernasconi A, 2011, NAT REV NEUROL, V7, P99, DOI 10.1038/nrneurol.2010.199; Besson P, 2008, BRAIN, V131, P3246, DOI 10.1093/brain/awn224; Blumcke I, 2011, EPILEPSIA, V52, P158, DOI 10.1111/j.1528-1167.2010.02777.x; Bowman A.W., 1997, OXFORD STAT SCI SERI; Bruggemann JM, 2007, EPILEPSY RES, V77, P93, DOI 10.1016/j.eplepsyres.2007.09.004; Cantor-Rivera D, 2015, COMPUT MED IMAG GRAP, V41, P14, DOI 10.1016/j.compmedimag.2014.07.002; Colliot O, 2006, NEUROIMAGE, V29, P162, DOI 10.1016/j.neuroimage.2005.07.021; Duchesne S, 2006, NEUROIMAGE, V29, P557, DOI 10.1016/j.neuroimage.2005.07.052; El Azami M, 2013, INT WORKSHOP PATTERN, P90, DOI 10.1109/PRNI.2013.32; Fauser S, 2004, BRAIN, V127, P2406, DOI 10.1093/brain/awh277; Focke NK, 2012, NEUROIMAGE, V59, P356, DOI 10.1016/j.neuroimage.2011.07.068; Friston KJ, 2005, NEUROIMAGE, V25, P661, DOI 10.1016/j.neuroimage.2005.01.013; Friston KJ, 1999, NEUROIMAGE, V10, P385, DOI 10.1006/nimg.1999.0484; Guigue V., 2005, PERCEPTION SYSTMES I; Haibo He, 2009, IEEE Transactions on Knowledge and Data Engineering, V21, P1263, DOI 10.1109/TKDE.2008.239; Hammers, 2015, MRI NEGATIVE EPILEPS, P28; Hammers A, 2003, HUM BRAIN MAPP, V19, P224, DOI 10.1002/hbm.10123; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Hong SJ, 2014, NEUROLOGY, V83, P48, DOI 10.1212/WNL.0000000000000543; Huppertz HJ, 2009, EPILEPSIA, V50, P155, DOI 10.1111/j.1528-1167.2008.01734.x; Huppertz HJ, 2005, EPILEPSY RES, V67, P35, DOI 10.1016/j.eplepsyres.2005.07.009; Keihaninejad S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033096; Klein A, 2009, NEUROIMAGE, V46, P786, DOI 10.1016/j.neuroimage.2008.12.037; Kotsiantis S., 2006, GESTS INT T COMPUTER, V30, P25, DOI DOI 10.1007/978-0-387-09823-4_45; Lerner JT, 2009, EPILEPSIA, V50, P1310, DOI 10.1111/j.1528-1167.2008.01998.x; Manly BFJ, 2006, CHAPMAN HALL TEXTS S; Markou M, 2003, SIGNAL PROCESS, V83, P2499, DOI 10.1016/j.sigpro.2003.07.019; Mazziotta J, 2001, PHILOS T R SOC B, V356, P1293, DOI 10.1098/rstb.2001.0915; Meagher D, 1980, OCTREE ENCODING NEW; Mourao-Miranda J, 2011, NEUROIMAGE, V58, P793, DOI 10.1016/j.neuroimage.2011.06.042; Petrick N, 2013, MED PHYS, V40, DOI 10.1118/1.4816310; Sato JR, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00178; Scholkopf B, 2001, NEURAL COMPUT, V13, P1443, DOI 10.1162/089976601750264965; Srivastava S, 2005, NEUROIMAGE, V27, P253, DOI 10.1016/j.neuroimage.2005.03.045; TAYLOR DC, 1971, J NEUROL NEUROSUR PS, V34, P369, DOI 10.1136/jnnp.34.4.369; Tellez-Zenteno JF, 2010, EPILEPSY RES, V89, P310, DOI 10.1016/j.eplepsyres.2010.02.007; Thesen T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016430; Vapnik V., 1998, STAT LEARNING THEORY; Wagner J, 2011, BRAIN, V134, P2844, DOI 10.1093/brain/awr204	46	22	22	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161498	10.1371/journal.pone.0161498	http://dx.doi.org/10.1371/journal.pone.0161498			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603778	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200016
J	Frank, ASK; Carthey, AJR; Banks, PB				Frank, Anke S. K.; Carthey, Alexandra J. R.; Banks, Peter B.			Does Historical Coexistence with Dingoes Explain Current Avoidance of Domestic Dogs? Island Bandicoots Are Naive to Dogs, unlike Their Mainland Counterparts	PLOS ONE			English	Article							PREDATOR-RECOGNITION; TOXOPLASMA-GONDII; PERAMELES GUNNII; CATS; CONSERVATION; MANAGEMENT; AUSTRALIA; TASMANIA; WILDLIFE; IMPACTS	Introduced predators have a global reputation for causing declines and extinctions of native species. Native prey naivete towards novel predators is thought to be a key reason for predator impacts. However, naivete is not necessarily forever: where coexistence establishes, it is likely that naivete will be reduced through adaptation, and the once alien predator will eventually become recognised by prey. For example, native marsupial bandicoots in Sydney avoid backyards with domestic dogs (C. lupus familiaris), but not domestic cats (Felis catus), even though cats and dogs were both introduced about 200 years ago (Carthey and Banks 2012). The authors attributed bandicoots' recognition of dogs to long-term exposure to a close relative of dogs, dingoes that arrived in Australia 4000 years ago. Here, we test a prediction of this hypothesis by taking the study to Tasmania, where dingoes have never been present but where domestic dogs also arrived about 200 years ago. We use a similar survey design to that of Carthey and Banks (2012): asking Hobart residents to report on pet-ownership, bandicoot sightings and scats within their backyards, as well as an array of yard characteristic control variables. We predicted that if long term experience with dingoes enabled mainland bandicoots to recognise domestic dogs, then Tasmanian bandicoots, which are inexperienced with dingoes, would not recognise domestic dogs. Our results indicate that Tasmanian bandicoots are naive to both dogs and cats after only 200 years of coexistence, supporting our hypothesis and the notion that naivete in native prey towards alien predators (as observed on the mainland) may eventually be overcome.	[Frank, Anke S. K.] Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia; [Frank, Anke S. K.] Univ Cologne, Inst Bot, Cologne, Germany; [Carthey, Alexandra J. R.] Macquarie Univ, Dept Biol Sci, N Ryde, NSW 2109, Australia; [Banks, Peter B.] Univ Sydney, Sch Life & Environm Sci, Sydney, NSW 2006, Australia	University of Tasmania; University of Cologne; Macquarie University; University of Sydney	Frank, ASK (corresponding author), Univ Tasmania, Sch Biol Sci, Hobart, Tas 7001, Australia.; Frank, ASK (corresponding author), Univ Cologne, Inst Bot, Cologne, Germany.	anke.frank@utas.edu.au	Frank, Anke S. K./J-7789-2014	Frank, Anke S. K./0000-0002-0177-4898; Banks, Peter/0000-0002-4340-6495; Carthey, Alexandra Jane Repin/0000-0002-0472-2217	ARC Discovery Grant [DP140104413]	ARC Discovery Grant(Australian Research Council)	This work was supported by (http://www.hobartcity.com.au/Environment/Dr_Edward_Hall_Environment_Grants) (AF) and ARC Discovery Grant DP140104413 (PB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRESTI A, 1992, STAT SCI, V7, P131, DOI DOI 10.1214/SS/1177011454; Angold PG, 2006, SCI TOTAL ENVIRON, V360, P196, DOI 10.1016/j.scitotenv.2005.08.035; Balme J, 2016, J ARCHAEOLO IN PRESS; Banks PB, 1998, J MAMMAL, V79, P1260, DOI 10.2307/1383017; Banks PB, 2007, TRENDS ECOL EVOL, V22, P229, DOI 10.1016/j.tree.2007.02.006; Bilney R, 2015, WILDLIFE AUSTR, V52, P28; Bilney RJ, 2011, ANIM BIOL, V61, P29, DOI 10.1163/157075511X554400; Blackburn TM, 2004, SCIENCE, V305, P1955, DOI 10.1126/science.1101617; BLACKHALL S, 1980, AUST WILDLIFE RES, V7, P191, DOI 10.1071/WR9800191; Blumstein DT, 2000, BEHAV ECOL, V11, P528, DOI 10.1093/beheco/11.5.528; Blumstein DT, 2002, ANIM CONSERV, V5, P87, DOI 10.1017/S1367943002002123; Blumstein DT, 1996, OIKOS, V77, P569, DOI 10.2307/3545948; Bonnaud E, 2011, BIOL INVASIONS, V13, P581, DOI 10.1007/s10530-010-9851-3; Boyce J, 2006, ENVIRON HIST-US, V11, P102, DOI 10.1093/envhis/11.1.102; Brown JS, 2004, ECOL LETT, V7, P999, DOI 10.1111/j.1461-0248.2004.00661.x; Burbidge A.A., 2014, P15; BURBIDGE AA, 1989, BIOL CONSERV, V50, P143, DOI 10.1016/0006-3207(89)90009-8; Calver MC, 2011, BIOL CONSERV, V144, P1895, DOI 10.1016/j.biocon.2011.04.015; Carthey AJR, 2015, OIKOS, V89, P932; Carthey AJR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031804; Committee TSS, 2008, EPBC ACT LIST THREAT; Cox GW, 2004, ALIEN SPECIES EVOLUT; Cox JG, 2006, TRENDS ECOL EVOL, V21, P674, DOI 10.1016/j.tree.2006.07.011; Daniels GD, 2006, BIOL CONSERV, V133, P326, DOI 10.1016/j.biocon.2006.06.011; Daniels GD, 2011, BIODIVERS CONSERV, V20, P3517, DOI 10.1007/s10531-011-0139-4; Denny E., 2010, REV CAT ECOLOGY MANA; Dickman Christopher R., 2009, Human-Wildlife Conflicts, V3, P41; Dowle M, 2009, EUR J WILDLIFE RES, V55, P45, DOI 10.1007/s10344-008-0212-9; Driessen MM, 1996, WILDLIFE RES, V23, P721, DOI 10.1071/WR9960721; Gerard A, 2014, NATURWISSENSCHAFTEN, V101, P921, DOI 10.1007/s00114-014-1233-8; GUILER E R, 1970, Australian Journal of Zoology, V18, P49, DOI 10.1071/ZO9700049; HIATT B, 1967, OCEANIA, V38, P99, DOI 10.1002/j.1834-4461.1967.tb00947.x; Hocking Gregory J., 1996, Records of the Queen Victoria Museum, V103, P163; Holderness-Roddam B, 2014, AUSTRALAS J ENV MAN, V21, P441, DOI 10.1080/14486563.2014.952787; Hudgens BR, 2011, OECOLOGIA, V165, P699, DOI 10.1007/s00442-010-1761-7; Hughes J, 2013, BIOL CONSERV, V157, P341, DOI 10.1016/j.biocon.2012.07.005; Hughes NK, 2012, ECOL LETT, V15, P1326, DOI 10.1111/j.1461-0248.2012.01856.x; HUTCHISON WM, 1969, BMJ-BRIT MED J, V4, P806, DOI 10.1136/bmj.4.5686.806-b; Jacob J, 2000, OIKOS, V91, P131, DOI 10.1034/j.1600-0706.2000.910112.x; Johnson C, 2006, AUSTR MAMMAL EXTINCT; Johnson CN, 2003, HOLOCENE, V13, P941, DOI 10.1191/0959683603hl682fa; Jose Danielle P., 2002, Australian Mammalogy, V24, P213; KOTLER BP, 1991, ECOLOGY, V72, P2249, DOI 10.2307/1941575; KRUUK H, 1981, J APPL ECOL, V18, P197, DOI 10.2307/2402489; McArthur M, 2000, ASIA PAC J CLIN NUTR, V9, P215, DOI 10.1046/j.1440-6047.2000.00192.x; McLean IG, 1996, BIOL CONSERV, V75, P51, DOI 10.1016/0006-3207(95)00038-0; McLean IG, 1999, BIOL CONSERV, V87, P123, DOI 10.1016/S0006-3207(98)00024-X; Medina FM, 2011, GLOBAL CHANGE BIOL, V17, P3503, DOI 10.1111/j.1365-2486.2011.02464.x; Morley CG, 2006, CONSERVATION EVIDENC, V3, P3; Nogales M, 2013, BIOSCIENCE, V63, P804, DOI 10.1525/bio.2013.63.10.7; Obendorf DL, 1996, J WILDLIFE DIS, V32, P623, DOI 10.7589/0090-3558-32.4.623; Oskarsson MCR, 2011, P ROYAL SOC LONDON B; Pemberton David, 2008, Papers and Proceedings of the Royal Society of Tasmania, V142, P13; Richardson DM, 2011, FIFTY YEARS OF INVASION ECOLOGY: THE LEGACY OF CHARLES ELTON, P409; Salo P, 2007, P ROY SOC B-BIOL SCI, V274, P1237, DOI 10.1098/rspb.2006.0444; Sand H, 2006, P R SOC B, V273, P1421, DOI 10.1098/rspb.2005.3447; Taborsky M., 1988, Notornis, V35, P197; Tambling CJ, 2015, BEHAV ECOL SOCIOBIOL, V69, P1153, DOI 10.1007/s00265-015-1929-6; Tchabovsky AV, 2001, J ETHOL, V19, P105, DOI 10.1007/s101640170006; Villemey A, 2013, BIOL CONSERV, V158, P147, DOI 10.1016/j.biocon.2012.08.007; WEAVERS B W, 1989, Australian Zoologist, V25, P83	61	11	12	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161447	10.1371/journal.pone.0161447	http://dx.doi.org/10.1371/journal.pone.0161447			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603517	Green Published, gold			2022-12-26	WOS:000383255200013
J	Lu, MK; Chen, CM; Duann, JR; Ziemann, U; Chen, JC; Chiou, SM; Tsai, CH				Lu, Ming-Kuei; Chen, Chun-Ming; Duann, Jeng-Ren; Ziemann, Ulf; Chen, Jui-Cheng; Chiou, Shang-Ming; Tsai, Chon-Haw			Investigation of Motor Cortical Plasticity and Corticospinal Tract Diffusion Tensor Imaging in Patients with Parkinsons Disease and Essential Tremor	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; TIMING-DEPENDENT PLASTICITY; WHITE-MATTER INVOLVEMENT; THETA-BURST STIMULATION; INTRACORTICAL INHIBITION; CORTICOCORTICAL INHIBITION; CORTEX EXCITABILITY; RESTING TREMOR; FACILITATION; DYSFUNCTION	Parkinson's disease (PD) and essential tremor (ET) are characterized with motor dysfunctions. Motor circuit dysfunctions can be complementarily investigated by paired associative stimulation (PAS)-induced long-term potentiation (LTP)-like plasticity and diffusion tensor imaging (DTI) of the corticospinal tract (CST). Three groups of twelve subjects with moderate severity PD, ET with intention tremor and healthy controls (HC) were studied. The primary motor cortex (M1) excitability, measured by motor evoked potential (MEP) amplitude and by short-interval and long-interval intracortical inhibition (SICI and LICI) was compared between the three groups before and after PAS. The DTI measures of fractional anisotropy (FA) and mean diffusivity (MD) were acquired. PAS effects and DTI data were simultaneously examined between groups. PAS increased MEP amplitude in HC but not in PD and ET. SICI and LICI were significantly reduced after PAS irrespective of groups. No significant differences of the mean FA and MD were found between groups. There was no significant correlation between the PAS effects and the DTI measures. Findings suggest that both PD and ET with intention tremor have impairment of the associative LTP-like corticospinal excitability change in M1. The microstructure of the CST is not relevant to the deficiency of M1 associative plasticity in PD and ET.	[Lu, Ming-Kuei; Chen, Jui-Cheng; Tsai, Chon-Haw] China Med Univ Hosp, Dept Neurol, Neurosci Lab, Taichung, Taiwan; [Lu, Ming-Kuei; Chen, Jui-Cheng; Chiou, Shang-Ming; Tsai, Chon-Haw] China Med Univ, Sch Med, Coll Med, Taichung, Taiwan; [Lu, Ming-Kuei; Chen, Chun-Ming; Chen, Jui-Cheng; Tsai, Chon-Haw] China Med Univ, Grad Inst Neural & Cognit Sci, Coll Med, Taichung, Taiwan; [Chen, Chun-Ming] China Med Univ Hosp, Dept Radiol, Taichung, Taiwan; [Duann, Jeng-Ren] Natl Cent Univ, Inst Cognit Neurosci, Zhongli, Taiwan; [Duann, Jeng-Ren] Univ Calif San Diego, Inst Neural Computat, La Jolla, CA 92093 USA; [Ziemann, Ulf] Univ Tubingen, Dept Neurol & Stroke, Tubingen, Germany; [Ziemann, Ulf] Univ Tubingen, Hertie Inst Clin Brain Res, Tubingen, Germany; [Chiou, Shang-Ming] China Med Univ Hosp, Dept Neurosurg, Taichung, Taiwan	China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; National Central University; University of California System; University of California San Diego; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; China Medical University Taiwan; China Medical University Hospital - Taiwan	Lu, MK; Tsai, CH (corresponding author), China Med Univ Hosp, Dept Neurol, Neurosci Lab, Taichung, Taiwan.; Lu, MK; Tsai, CH (corresponding author), China Med Univ, Sch Med, Coll Med, Taichung, Taiwan.; Lu, MK; Tsai, CH (corresponding author), China Med Univ, Grad Inst Neural & Cognit Sci, Coll Med, Taichung, Taiwan.	d4297@mail.cmuh.org.tw; d8079@mail.cmuh.org.tw	Lu, Ming-Kuei/AAF-3338-2020; Ziemann, Ulf/AAY-9125-2020; Lu, Ming-Kuei/M-2435-2013	Lu, Ming-Kuei/0000-0002-2768-4399; Lu, Ming-Kuei/0000-0002-2768-4399	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW105-TDU-B-212-133019]; National Science Council [NSC99-2314-B-039-017-MY2, 102-2320-B-039-001]; Ministry of Science and Technology [MOST103-2314-B-039-032-MY2]; "Aim for the Top University Plan" of the China Medical University and Ministry of Education, Taiwan	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; National Science Council(Ministry of Science and Technology, Taiwan); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); "Aim for the Top University Plan" of the China Medical University and Ministry of Education, Taiwan	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW105-TDU-B-212-133019) and by grants from the National Science Council (NSC99-2314-B-039-017-MY2 and 102-2320-B-039-001), the Ministry of Science and Technology (MOST103-2314-B-039-032-MY2) and "Aim for the Top University Plan" of the China Medical University and Ministry of Education, Taiwan.	Berardelli A, 1996, BRAIN, V119, P71, DOI 10.1093/brain/119.1.71; Carson RG, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00823; Chu J, 2009, NEUROLOGY, V72, P842, DOI 10.1212/01.wnl.0000343881.27524.e8; Chuang WL, 2014, MOVEMENT DISORD, V29, P501, DOI 10.1002/mds.25809; Cohen J.E., 1988, STAT POWER ANAL BEHA; Dan Y, 2004, NEURON, V44, P23, DOI 10.1016/j.neuron.2004.09.007; Deuschl G, 2000, BRAIN, V123, P1568, DOI 10.1093/brain/123.8.1568; Deuschl G, 1998, MOVEMENT DISORD, V13, P2, DOI 10.1002/mds.870131303; Florian J, 2007, EUR J NEUROSCI, V25, P3461, DOI 10.1111/j.1460-9568.2007.05603.x; Gattellaro G, 2009, AM J NEURORADIOL, V30, P1222, DOI 10.3174/ajnr.A1556; Hallett Mark, 2012, Parkinsonism Relat Disord, V18 Suppl 1, pS85, DOI 10.1016/S1353-8020(11)70027-X; Hamada M, 2014, J NEUROSCI, V34, P12837, DOI 10.1523/JNEUROSCI.1960-14.2014; Hanajima R, 2000, BRAIN DEV-JPN, V22, pS132; Hanajima R, 1996, J NEUROL SCI, V140, P109, DOI 10.1016/0022-510X(96)00100-1; Helmich RC, 2012, BRAIN, V135, P3206, DOI 10.1093/brain/aws023; Huang YZ, 2005, NEURON, V45, P201, DOI 10.1016/j.neuron.2004.12.033; Hubers A, 2012, BRAIN STIMUL, V5, P297, DOI 10.1016/j.brs.2011.03.008; Kishore A, 2014, CEREB CORTEX, V24, P2055, DOI 10.1093/cercor/bht058; Klein JC, 2011, HUM BRAIN MAPP, V32, P896, DOI 10.1002/hbm.21077; Kloppel S, 2008, NEUROIMAGE, V40, P1782, DOI 10.1016/j.neuroimage.2008.01.019; Kojovic M, 2015, MOVEMENT DISORD, V30, P1098, DOI 10.1002/mds.26167; Krivanekova L, 2011, EUR J NEUROSCI, V34, P1292, DOI 10.1111/j.1460-9568.2011.07849.x; Kujirai K, 2006, J NEUROPHYSIOL, V96, P1337, DOI 10.1152/jn.01140.2005; KUJIRAI T, 1993, J PHYSIOL-LONDON, V471, P501, DOI 10.1113/jphysiol.1993.sp019912; Lefaucheur JP, 2005, CLIN NEUROPHYSIOL, V116, P244, DOI 10.1016/j.clinph.2004.11.017; Lin CC, 2013, EUR J RADIOL, V82, pE610, DOI 10.1016/j.ejrad.2013.06.016; Lindenbach D, 2013, NEUROSCI BIOBEHAV R, V37, P2737, DOI 10.1016/j.neubiorev.2013.09.008; Lu MK, 2015, CLIN NEUROPHYSIOL, V126, P2330, DOI 10.1016/j.clinph.2015.02.010; Lu MK, 2015, 1 INT BRAIN STIM C S, P342; MacKinnon CD, 2005, ANN NEUROL, V58, P516, DOI 10.1002/ana.20599; Meunier S, 2012, EUR J NEUROSCI, V35, P975, DOI 10.1111/j.1460-9568.2012.08034.x; Morgante F, 2006, BRAIN, V129, P1059, DOI 10.1093/brain/awl031; Muller-Dahlhaus JFM, 2008, EXP BRAIN RES, V187, P467, DOI 10.1007/s00221-008-1319-7; Muller-Dahlhaus Florian, 2010, Front Synaptic Neurosci, V2, P34, DOI 10.3389/fnsyn.2010.00034; Ni Z, 2013, NEUROLOGY, V80, P1746, DOI 10.1212/WNL.0b013e3182919029; Pasquereau B, 2016, BRAIN, V139, P127, DOI 10.1093/brain/awv312; Peurala SH, 2008, CLIN NEUROPHYSIOL, V119, P2291, DOI 10.1016/j.clinph.2008.05.031; Raethjen J, 2012, CLIN NEUROPHYSIOL, V123, P61, DOI 10.1016/j.clinph.2011.09.024; RIDDING MC, 1995, ANN NEUROL, V37, P181, DOI 10.1002/ana.410370208; Romeo S, 1998, MUSCLE NERVE, V21, P1304, DOI 10.1002/(SICI)1097-4598(199810)21:10<1304::AID-MUS9>3.0.CO;2-F; Rosenkranz K, 2006, EUR J NEUROSCI, V23, P822, DOI 10.1111/j.1460-9568.2006.04605.x; Russmann H, 2009, CLIN NEUROPHYSIOL, V120, P1204, DOI 10.1016/j.clinph.2009.04.005; Saini J, 2012, PARKINSONISM RELAT D, V18, P477, DOI 10.1016/j.parkreldis.2012.01.006; Schwingenschuh P, 2010, MOVEMENT DISORD, V25, P560, DOI 10.1002/mds.23019; Shahed J, 2007, PARKINSONISM RELAT D, V13, P67, DOI 10.1016/j.parkreldis.2006.05.033; Stefan K, 2002, J PHYSIOL-LONDON, V543, P699, DOI 10.1113/jphysiol.2002.023317; Stefan K, 2000, BRAIN, V123, P572, DOI 10.1093/brain/123.3.572; Udupa K, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00128; Wolters A, 2005, J PHYSIOL-LONDON, V565, P1039, DOI 10.1113/jphysiol.2005.084954; Worker A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112638; Zamir O, 2012, CLIN NEUROPHYSIOL, V123, P815, DOI 10.1016/j.clinph.2011.07.051; Ziemann U, 2004, J NEUROSCI, V24, P1666, DOI 10.1523/JNEUROSCI.5016-03.2004	52	12	13	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162265	10.1371/journal.pone.0162265	http://dx.doi.org/10.1371/journal.pone.0162265			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603204	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200051
J	Frickmann, H; Wiemer, D; Frey, C; Hagen, RM; Hinz, R; Podbielski, A; Koller, T; Warnke, P				Frickmann, Hagen; Wiemer, Dorothea; Frey, Claudia; Hagen, Ralf Matthias; Hinz, Rebecca; Podbielski, Andreas; Koeller, Thomas; Warnke, Philipp			Low Enteric Colonization with Multidrug-Resistant Pathogens in Soldiers Returning from Deployments-Experience from the Years 2007-2015	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; CARBAPENEMASE-PRODUCING ENTEROBACTERIACEAE; CLINICAL ESCHERICHIA-COLI; ANTIMICROBIAL RESISTANCE; STAPHYLOCOCCUS-AUREUS; CHROMOGENIC MEDIUM; FECAL CARRIAGE; ANTIBIOTIC-RESISTANCE; INFECTION; RISK	This assessment describes the enteric colonization of German soldiers 8-12 weeks after returning from mostly but not exclusively subtropical or tropical deployment sites with third-generation cephalosporin-resistant Enterobacteriaceae, vancomycin-resistant enterococci (VRE), and methicillin-resistant Staphylococcus aureus (MRSA). Between 2007 and 2015, 828 stool samples from returning soldiers were enriched in nonselective broth and incubated on selective agars for Enterobacteriaceae expressing extended-spectrum beta-lactamases (ESBL), VRE and MRSA. Identification and resistance testing of suspicious colonies was performed using MALDI-TOF-MS, VITEK-II and agar diffusion gradient testing (bioMerieux, Marcy-l'Etoile, France). Isolates with suspicion of ESBL were characterized by ESBL/ampC disc-(ABCD)-testing and molecular approaches (PCR, Sanger sequencing). Among the returnees, E. coli with resistance against third-generation cephalosporins (37 ESBL, 1 ESBL + ampC, 1 uncertain mechanism) were found in 39 instances (4.7%). Associated quinolone resistance was found in 46.2% of these isolates. Beta-lactamases of the bla(CTX-M) group 1 predominated among the ESBL mechanisms, followed by the blaCTX-M group 9, and bla(SHV). VRE of vanA-type was isolated from one returnee (0.12%). MRSA was not isolated at all. There was no clear trend regarding the distribution of resistant isolates during the assessment period. Compared with colonization with resistant bacteria described in civilians returning from the tropics, the colonization in returned soldiers is surprisingly low and stable. This finding, together with high colonization rates found in previous screenings on deployment, suggests a loss of colonization during the 8- to 12-week period between returning from the deployments and assessment.	[Frickmann, Hagen; Wiemer, Dorothea; Frey, Claudia; Hinz, Rebecca] German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany; [Frickmann, Hagen; Podbielski, Andreas; Koeller, Thomas; Warnke, Philipp] Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany; [Hagen, Ralf Matthias] NATO Ctr Excellence Mil Med, Deployment Hlth Surveillance Capabil, Munich, Germany	Bernhard Nocht Institut fur Tropenmedizin; University of Rostock; NATO (North Atlantic Treaty Organisation)	Frickmann, H (corresponding author), German Armed Forces Hosp Hamburg, Bernhard Nocht Inst, Dept Trop Med, Hamburg, Germany.; Frickmann, H (corresponding author), Univ Med Rostock, Inst Med Microbiol Virol & Hyg, Rostock, Germany.	Frickmann@bnitm.de	Hagen, Ralf Matthias/AAA-1723-2021					Alabi AS, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-455; Barguigua A, 2013, MICROB PATHOGENESIS, V61-62, P16, DOI 10.1016/j.micpath.2013.04.010; Bercion R, 2009, J INFECT DEV COUNTR, V3, P187, DOI 10.3855/jidc.34; Bonnet R, 2004, ANTIMICROB AGENTS CH, V48, P1, DOI 10.1128/AAC.48.1.1-14.2004; Bossaer JB, 2011, SUPPORT CARE CANCER, V19, P231, DOI 10.1007/s00520-009-0808-y; Cullik A, 2010, J MED MICROBIOL, V59, P580, DOI 10.1099/jmm.0.016188-0; Diederen B, 2005, J CLIN MICROBIOL, V43, P1925, DOI 10.1128/JCM.43.4.1925-1927.2005; Frickmann H., 2015, BIOMED RES INT, V2015, DOI DOI 10.1155/2015/573904; Girlich D, 2014, CLIN MICROBIOL INFEC, V20, P350, DOI 10.1111/1469-0691.12325; Gurnee EA, 2015, J INFECT DIS, V212, P1862, DOI 10.1093/infdis/jiv278; Haas EJ, 2010, INFECT CONT HOSP EP, V31, P1038, DOI 10.1086/655464; Habeeb MA, 2013, PAK J MED SCI, V29, P540, DOI 10.12669/pjms.292.3144; Hagen RM, 2015, EUR J MICROBIOL IMMU, V5, P281, DOI 10.1556/1886.2015.00037; Helm F., 2013, WEHRMED WEHRPHARM, V1, P40; Hovhannisyan G, 2015, MIKROBIOLOGIE, V25, P5; Huang TD, 2010, J CLIN MICROBIOL, V48, P2091, DOI 10.1128/JCM.02342-09; Ingram PR, 2011, J MED MICROBIOL, V60, P715, DOI 10.1099/jmm.0.029140-0; Jazmati N, 2016, J CLIN MICROBIOL, V54, P467, DOI 10.1128/JCM.02926-15; Joensen KG, 2014, J CLIN MICROBIOL, V52, P1501, DOI 10.1128/JCM.03617-13; Jones SL, 2006, TROP MED INT HEALTH, V11, P1725, DOI 10.1111/j.1365-3156.2006.01731.x; Kalra L, 2013, AM J INFECT CONTROL, V41, P1253, DOI 10.1016/j.ajic.2013.05.021; Kanoksil M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054714; Kantele A, 2015, CLIN INFECT DIS, V60, P837, DOI 10.1093/cid/ciu957; Karami N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083030; Klare I, 2012, DIAGN MICR INFEC DIS, V74, P171, DOI 10.1016/j.diagmicrobio.2012.06.020; Lohr IH, 2013, J ANTIMICROB CHEMOTH, V68, P1043, DOI 10.1093/jac/dks502; Loulergue J, 2006, EUR J CLIN MICROBIOL, V25, P407, DOI 10.1007/s10096-006-0144-9; Lubbert C, 2015, INT J MED MICROBIOL, V305, P148, DOI 10.1016/j.ijmm.2014.12.001; Manyahi Joel, 2014, BMC Res Notes, V7, P500, DOI 10.1186/1756-0500-7-500; Matar MJ, 2006, CLIN INFECT DIS, V42, P1506, DOI 10.1086/503675; Murk JLAN, 2009, J CLIN MICROBIOL, V47, P1885, DOI 10.1128/JCM.01406-08; Obeng-Nkrumah N, 2013, AM J TROP MED HYG, V89, P960, DOI 10.4269/ajtmh.12-0642; Ongut G, 2014, CLIN LAB, V60, P1213, DOI 10.7754/Clin.Lab.2013.130812; Ongut G, 2013, J MED MICROBIOL, V62, P661, DOI 10.1099/jmm.0.052845-0; Paltansing S, 2013, EMERG INFECT DIS, V19, P1206, DOI [10.3201/eid1908.130257, 10.3201/eid.1908.130257]; Peirano G, 2011, J TRAVEL MED, V18, P299, DOI 10.1111/j.1708-8305.2011.00548.x; Pitout JDD, 2004, J CLIN MICROBIOL, V42, P5715, DOI 10.1128/JCM.42.12.5715-5721.2004; Rahbar Mohammad, 2008, Pak J Biol Sci, V11, P496, DOI 10.3923/pjbs.2008.496.498; Raji MA, 2013, J INFECT PUBLIC HEAL, V6, P431, DOI 10.1016/j.jiph.2013.05.002; Rieg S, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-015-1225-0; Ruppe E, 2015, CLIN INFECT DIS, V61, P593, DOI 10.1093/cid/civ333; Schaumburg F, 2013, J ANTIMICROB CHEMOTH, V68, P2140, DOI 10.1093/jac/dkt164; Seid J, 2005, ACTA TROP, V95, P143, DOI 10.1016/j.actatropica.2005.05.009; Seni Jeremiah, 2013, BMC Res Notes, V6, P298, DOI 10.1186/1756-0500-6-298; Severin JA, 2012, TROP MED INT HEALTH, V17, P455, DOI 10.1111/j.1365-3156.2011.02949.x; Severin JA, 2010, J ANTIMICROB CHEMOTH, V65, P465, DOI 10.1093/jac/dkp471; Sire JM, 2007, J INFECT DEV COUNTR, V1, P263, DOI 10.3855/jidc.362; Tsu JHL, 2015, UROLOGY, V85, P15, DOI 10.1016/j.urology.2014.07.078; Ubeda C, 2010, J CLIN INVEST, V120, P4332, DOI 10.1172/JCI43918; Vandersee S., 2011, Hygiene Medizin, V36, P384; Weinstock DM, 2007, BIOL BLOOD MARROW TR, V13, P615, DOI 10.1016/j.bbmt.2007.01.078; Zhang H, 2014, CHINESE MED J-PEKING, V127, P2429, DOI 10.3760/cma.j.issn.0366-6999.20131538	52	16	16	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162129	10.1371/journal.pone.0162129	http://dx.doi.org/10.1371/journal.pone.0162129			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598775	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800042
J	He, F; Zhang, W; Zhang, GQ				He, Feng; Zhang, Wei; Zhang, Guoqiang			A Differential Evolution Algorithm Based on Nikaido-Isoda Function for Solving Nash Equilibrium in Nonlinear Continuous Games	PLOS ONE			English	Article							STRATEGY; MARKETS; MODELS	A differential evolution algorithm for solving Nash equilibrium in nonlinear continuous games is presented in this paper, called NIDE (Nikaido-Isoda differential evolution). At each generation, parent and child strategy profiles are compared one by one pairwisely, adapting Nikaido-Isoda function as fitness function. In practice, the NE of nonlinear game model with cubic cost function and quadratic demand function is solved, and this method could also be applied to non-concave payoff functions. Moreover, the NIDE is compared with the existing Nash Domination Evolutionary Multiplayer Optimization (NDEMO), the result showed that NIDE was significantly better than NDEMO with less iterations and shorter running time. These numerical examples suggested that the NIDE method is potentially useful.	[He, Feng; Zhang, Wei; Zhang, Guoqiang] Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China; [Zhang, Guoqiang] Xuchang Univ, Xuchang, Peoples R China	Tianjin University; Xuchang University	Zhang, GQ (corresponding author), Tianjin Univ, Coll Management & Econ, Tianjin, Peoples R China.; Zhang, GQ (corresponding author), Xuchang Univ, Xuchang, Peoples R China.	zgq@tju.edu.cn	He, Feng/HHS-6457-2022	He, Feng/0000-0002-1996-0744	National Natural Science Foundation of China [71320107003, 71532009]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This manuscript is supported by National Natural Science Foundation of China (71320107003, 71532009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldick R., 2000, LINEAR SUPPLY FUNCTI; Baldick R., 2001, CAPACITY CONSTRAINED; Eaves BC, 1999, J ECON DYN CONTROL, V23, P1249, DOI 10.1016/S0165-1889(98)00073-6; Hajimirsadeghi Hossein, 2009, Proceedings of the 2009 World Congress on Nature & Biologically Inspired Computing (NaBIC 2009), P1532, DOI 10.1109/NABIC.2009.5393669; Koh A, 2012, APPL SOFT COMPUT, V12, P161, DOI 10.1016/j.asoc.2011.08.056; Latorre MD, 2003, IEEE T POWER SYST, V18, P611, DOI 10.1109/TPWRS.2003.810900; Lee KH, 2003, IEEE T POWER SYST, V18, P830, DOI 10.1109/TPWRS.2002.807067; McKelvey R., 1992, TECHNICAL REPORT; Moitre D, 2002, ELECTR POW SYST RES, V60, P153, DOI 10.1016/S0378-7796(01)00174-2; Nikaido H., 1955, PAC J MATH, V5, P807, DOI DOI 10.2140/PJM.1955.5.807; Park JB, 2001, IEEE T POWER SYST, V16, P847, DOI 10.1109/59.962436; Peydayesh M., 2010, P IEEE POW EN SOC GE, P1, DOI [10.1109/PES.2010.5589876, DOI 10.1109/PES.2010.5589876]; Price K, 2006, NAT COMP SER, DOI 10.1007/3-540-31306-0; Pu XS, 2013, INT J BIFURCAT CHAOS, V23, DOI 10.1142/S0218127413500533; Sahraei-Ardakani M, 2008, 2008 IEEE SYMPOSIUM ON COMPUTATIONAL INTELLIGENCE AND GAMES, P276, DOI 10.1109/CIG.2008.5035650; Son YS, 2004, IEEE T EVOLUT COMPUT, V8, P305, DOI 10.1109/TEVC.2004.832862; Song YQ, 2003, ELECTR POW SYST RES, V67, P45, DOI 10.1016/S0378-7796(03)00042-7; Storn R, 1997, J GLOBAL OPTIM, V11, P341, DOI 10.1023/A:1008202821328; Storn R.M., 1995, DIFFERENTIAL EVOLUTI, V23; Wang X, 2004, IEEE T POWER SYST, V19, P1348, DOI 10.1109/TPWRS.2004.831237; Weber J. D., 1999, 1999 IEEE Power Engineering Society Summer Meeting. Conference Proceedings (Cat. No. 99CH36364), P682, DOI 10.1109/PESS.1999.787399; Wei JY, 1999, OPER RES, V47, P102, DOI 10.1287/opre.47.1.102; Wen FS, 2001, POWER ENG REV IEEE, V21, P24; Zhang Yu-bo, 2003, Proceedings of the CSEE, V23, P80	25	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161634	10.1371/journal.pone.0161634	http://dx.doi.org/10.1371/journal.pone.0161634			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589229	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800012
J	Min, YW; Hong, YS; Ko, EJ; Lee, JY; Ahn, KD; Bae, JM; Rhee, PL				Min, Yang Won; Hong, Yun Soo; Ko, Eun-Ju; Lee, Ji-Yeon; Ahn, Ki Duck; Bae, Je Moon; Rhee, Poong-Lyul			Nitrergic Pathway Is the Main Contributing Mechanism in the Human Gastric Fundus Relaxation: An In Vitro Study	PLOS ONE			English	Article							NONADRENERGIC NONCHOLINERGIC RELAXATION; VASOACTIVE INTESTINAL POLYPEPTIDE; NITRIC-OXIDE SYNTHASE; FUNCTIONAL DYSPEPSIA; SMOOTH-MUSCLE; NEUROTRANSMITTER; TRANSMISSION; STOMACH; PEPTIDE; ACCOMMODATION	Background Human gastric fundus relaxation is mediated by intrinsic inhibitory pathway. We investigated the roles of nitrergic and purinergic pathways, two known inhibitory factors in gastric motility, on spontaneous and nerve-evoked contractions in human gastric fundus muscles. Methods Gastric fundus muscle strips (12 circular and 13 longitudinal) were obtained from patients without previous gastrointestinal motility disorder who underwent gastrectomy for stomach cancer. Using these specimens, we examined basal tone, peak, amplitude, and frequency of spontaneous contractions, and peak and nadir values under electrical field stimulation (EFS, 150 V, 0.3 ms, 10 Hz, 20 s). To examine responses to purinergic and nitrergic inhibition without cholinergic innervation, atropine (muscarinic antagonist, 1 mu M), MRS2500 (a purinergic P2Y1 receptor antagonist, 1 mu M), and N-nitro-L-arginine (L-NNA, a nitric oxide synthase inhibitor, 100 mu M) were added sequentially for spontaneous and electrically-stimulated contractions. Tetrodotoxin was used to confirm any neuronal involvement. Results In spontaneous contraction, L-NNA increased basal tone and peak in both muscle layers, while amplitude and frequency were unaffected. EFS (up to 10 Hz) uniformly induced initial contraction and subsequent relaxation in a frequency-dependent manner. Atropine abolished initial on-contraction and induced only relaxation during EFS. While MRS2500 showed no additional influence, L-NNA reversed relaxation (p = 0.012 in circular muscle, and p = 0.006 in longitudinal muscle). Tetrodotoxin abolished any EFS-induced motor response. Conclusions The relaxation of human gastric fundus muscle is reduced by nitrergic inhibition. Hence, nitrergic pathway appears to be the main mechanism for the human gastric fundus relaxation.	[Min, Yang Won; Hong, Yun Soo; Rhee, Poong-Lyul] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea; [Ko, Eun-Ju; Lee, Ji-Yeon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Biomed Res Inst, Seoul, South Korea; [Ahn, Ki Duck; Bae, Je Moon] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Surg, Seoul, South Korea	Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Rhee, PL (corresponding author), Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Med, Seoul, South Korea.	plrhee@skku.edu		Rhee, Poong-Lyul/0000-0003-0495-5296				Andrews CN, 2007, AM J PHYSIOL-GASTR L, V292, pG1359, DOI 10.1152/ajpgi.00403.2006; Baccari MC, 2001, REGUL PEPTIDES, V98, P27, DOI 10.1016/S0167-0115(00)00225-1; BEREZIN I, 1994, AM J PHYSIOL, V266, pC981, DOI 10.1152/ajpcell.1994.266.4.C981; Boeckxstaens GE, 1997, COMP BIOCHEM PHYS A, V118, P925, DOI 10.1016/S0300-9629(97)00022-4; BOECKXSTAENS GE, 1992, ARCH INT PHARMACOD T, V318, P107; BULT H, 1990, NATURE, V345, P346, DOI 10.1038/345346a0; BURNSTOCK G, 1972, BRIT J PHARMACOL, V46, P234, DOI 10.1111/j.1476-5381.1972.tb06868.x; BURNSTOCK G, 1963, NATURE, V200, P581, DOI 10.1038/200581a0; BURNSTOCK G, 1986, ARCH INT PHARMACOD T, V280, P1; Curro D, 2004, BRIT J PHARMACOL, V143, P785, DOI 10.1038/sj.bjp.0705993; Curro D, 2002, N-S ARCH PHARMACOL, V366, P578, DOI 10.1007/s00210-002-0633-z; DAMATO M, 1992, J AUTONOM NERV SYST, V37, P175, DOI 10.1016/0165-1838(92)90039-J; DESAI KM, 1991, NATURE, V351, P477, DOI 10.1038/351477a0; DESAI KM, 1994, BRIT J PHARMACOL, V113, P1197, DOI 10.1111/j.1476-5381.1994.tb17124.x; FAHRENKRUG J, 1993, PHARMACOL TOXICOL, V72, P354, DOI 10.1111/j.1600-0773.1993.tb01344.x; Jenkinson KM, 2000, BRIT J PHARMACOL, V130, P1627, DOI 10.1038/sj.bjp.0703481; Kuiken SD, 2002, GUT, V51, P212, DOI 10.1136/gut.51.2.212; LEFEBVRE RA, 1992, BRIT J PHARMACOL, V106, P173, DOI 10.1111/j.1476-5381.1992.tb14311.x; LEFEBVRE RA, 1995, BRIT J PHARMACOL, V116, P2017, DOI 10.1111/j.1476-5381.1995.tb16406.x; LEFEBVRE RA, 1993, GEN PHARMACOL, V24, P257, DOI 10.1016/0306-3623(93)90301-D; LI CG, 1990, EUR J PHARMACOL, V191, P303; Min YW, 2014, J NEUROGASTROENTEROL, V20, P318, DOI 10.5056/jnm13098; Nan JF, 2015, J NEUROGASTROENTEROL, V21, P103, DOI 10.5056/jnm14096; RAND MJ, 1992, CLIN EXP PHARMACOL P, V19, P147, DOI 10.1111/j.1440-1681.1992.tb00433.x; SHUTTLEWORTH CWR, 1995, REGUL PEPTIDES, V56, P101, DOI 10.1016/0167-0115(95)00013-2; Sinn DH, 2010, AM J PHYSIOL-GASTR L, V299, pG1198, DOI 10.1152/ajpgi.00523.2009; Tack J, 2004, GASTROENTEROLOGY, V127, P1239, DOI 10.1053/j.gastro.2004.05.030; Tack J, 1998, GASTROENTEROLOGY, V115, P1346, DOI 10.1016/S0016-5085(98)70012-5; Tack J, 2002, GUT, V51, P219, DOI 10.1136/gut.51.2.219; Toda N, 2005, PHARMACOL REV, V57, P315, DOI 10.1124/pr.57.3.4; Tonini M, 2000, BRIT J PHARMACOL, V129, P12, DOI 10.1038/sj.bjp.0702977; WARD SM, 1994, CELL TISSUE RES, V275, P513, DOI 10.1007/BF00318820	32	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162146	10.1371/journal.pone.0162146	http://dx.doi.org/10.1371/journal.pone.0162146			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589594	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877800033
J	Okuchi, Y; Imajo, M; Mizuno, R; Kamioka, Y; Miyoshi, H; Taketo, MM; Nagayama, S; Sakai, Y; Matsuda, M				Okuchi, Yoshihisa; Imajo, Masamichi; Mizuno, Rei; Kamioka, Yuji; Miyoshi, Hiroyuki; Taketo, Makoto Mark; Nagayama, Satoshi; Sakai, Yoshiharu; Matsuda, Michiyuki			Identification of Aging-Associated Gene Expression Signatures That Precede Intestinal Tumorigenesis	PLOS ONE			English	Article							HEMATOPOIETIC STEM-CELLS; COLORECTAL-CANCER; EPIGENETIC DRIFT; ABERRANT CRYPTS; MURINE COLON; APC GENE; IN-VIVO; METHYLATION; NEOPLASIA; DISEASE	Aging-associated alterations of cellular functions have been implicated in various disorders including cancers. Due to difficulties in identifying aging cells in living tissues, most studies have focused on aging-associated changes in whole tissues or certain cell pools. Thus, it remains unclear what kinds of alterations accumulate in each cell during aging. While analyzing several mouse lines expressing fluorescent proteins (FPs), we found that expression of FPs is gradually silenced in the intestinal epithelium during aging in units of single crypt composed of clonal stem cell progeny. The cells with low FP expression retained the wildtype Apc allele and the tissues composed of them did not exhibit any histological abnormality. Notably, the silencing of FPs was also observed in intestinal adenomas and the surrounding normal mucosae of Apc-mutant mice, and mediated by DNA methylation of the upstream promoter. Our genome-wide analysis then showed that the silencing of FPs reflects specific gene expression alterations during aging, and that these alterations occur in not only mouse adenomas but also human sporadic and hereditary (familial adenomatous polyposis) adenomas. Importantly, pharmacological inhibition of DNA methylation, which suppresses adenoma development in Apc-mutant mice, reverted the aging-associated silencing of FPs and gene expression alterations. These results identify aging-associated gene expression signatures that are heterogeneously induced by DNA methylation and precede intestinal tumorigenesis triggered by Apc inactivation, and suggest that pharmacological inhibition of the signature genes could be a novel strategy for the prevention and treatment of intestinal tumors.	[Okuchi, Yoshihisa; Mizuno, Rei; Kamioka, Yuji; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Pathol, Kyoto, Japan; [Okuchi, Yoshihisa; Mizuno, Rei; Kamioka, Yuji; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Med, Dept Biol Dis, Kyoto, Japan; [Okuchi, Yoshihisa; Mizuno, Rei] Kyoto Univ, Grad Sch Med, Dept Surg, Kyoto, Japan; [Imajo, Masamichi; Matsuda, Michiyuki] Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Kyoto, Japan; [Kamioka, Yuji] Kyoto Univ, Innovat Technohub Integrated Med Bioimaging, Kyoto, Japan; [Miyoshi, Hiroyuki; Taketo, Makoto Mark] Kyoto Univ, Grad Sch Med, Dept Pharmacol, Kyoto, Japan; [Nagayama, Satoshi] Japanese Fdn Canc Res, Canc Inst Hosp, Dept Surg Gastroenterol, Gastroenterol Ctr, Tokyo, Japan	Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Kyoto University; Japanese Foundation for Cancer Research	Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Pathol, Kyoto, Japan.; Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Med, Dept Biol Dis, Kyoto, Japan.; Matsuda, M (corresponding author), Kyoto Univ, Grad Sch Biostudies, Lab Bioimaging & Cell Signaling, Kyoto, Japan.	matsuda.michiyuki.2c@kyoto-u.ac.jp	Imajo, Masamichi/O-2140-2018	Imajo, Masamichi/0000-0003-0115-5840; Miyoshi, Hiroyuki/0000-0001-7400-0714; Matsuda, Michiyuki/0000-0002-5876-9969; Okuchi, Yoshihisa/0000-0003-3009-6990	Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, and Science (MEXT); Japan Agency for Medical Research and Development (AMED); MEXT; Naito Foundation;  [25870363]; Grants-in-Aid for Scientific Research [15H05949] Funding Source: KAKEN	Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, and Science (MEXT); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Naito Foundation(Naito Memorial Foundation); ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	YO and MM were supported by the Platform Project for Supporting Drug Discovery and Life Science Research (Platform for Dynamic Approaches to Living System) from the Ministry of Education, Culture, Sports, and Science (MEXT) and the Japan Agency for Medical Research and Development (AMED) (http://www.jst.go.jp/EN/index.html), and by a Grant-in-Aid for Scientific Research on Innovative Areas "Resonance Biology" of MEXT (https://kaken.nii.ac.jp/grant/KAKENHI-PLANNED-15H05949/). MM was also supported by the Naito Foundation (https://www.naito-f.or.jp/en/). MI was supported by a Grant-in-Aid for Young Scientists (B) (25870363) (https://kaken.nii.ac.jp/en/grant/KAKENHI-PROJECT-25870363/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Adams PD, 2015, CELL STEM CELL, V16, P601, DOI 10.1016/j.stem.2015.05.002; Aoki K, 2009, NAT PROTOC, V4, P1623, DOI 10.1038/nprot.2009.175; Baylin SB, 2006, NAT REV CANCER, V6, P107, DOI 10.1038/nrc1799; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Beerman I, 2015, CELL STEM CELL, V16, P613, DOI 10.1016/j.stem.2015.05.009; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; Bratic A, 2013, J CLIN INVEST, V123, P951, DOI 10.1172/JCI64125; Cesari M, 2006, ANTIOXID REDOX SIGN, V8, P609, DOI 10.1089/ars.2006.8.609; Chhabra P, 2013, STEM CELL TRANSL MED, V2, P328, DOI 10.5966/sctm.2012-0116; CLARK SJ, 1994, NUCLEIC ACIDS RES, V22, P2990, DOI 10.1093/nar/22.15.2990; Cohen HJ, 1997, J GERONTOL A-BIOL, V52, pM201, DOI 10.1093/gerona/52A.4.M201; Cracowski JL, 2002, TRENDS PHARMACOL SCI, V23, P360, DOI 10.1016/S0165-6147(02)02053-9; DORER DR, 1994, CELL, V77, P993, DOI 10.1016/0092-8674(94)90439-1; Esteller M, 2007, HUM MOL GENET, V16, pR50, DOI 10.1093/hmg/ddm018; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Fearon ER, 2011, ANNU REV PATHOL-MECH, V6, P479, DOI 10.1146/annurev-pathol-011110-130235; Feinberg AP, 2006, NAT REV GENET, V7, P21, DOI 10.1038/nrg1748; Flach J, 2014, NATURE, V512, P198, DOI 10.1038/nature13619; Florian MC, 2012, CELL STEM CELL, V10, P520, DOI 10.1016/j.stem.2012.04.007; GRODEN J, 1991, CELL, V66, P589, DOI 10.1016/0092-8674(81)90021-0; Haigis KM, 2002, P NATL ACAD SCI USA, V99, P8927, DOI 10.1073/pnas.132275099; Haigis KM, 2003, NAT GENET, V33, P33, DOI 10.1038/ng1055; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hiratsuka T, 2015, ELIFE, V4, DOI 10.7554/eLife.05178; Issa JP, 2014, J CLIN INVEST, V124, P24, DOI 10.1172/JCI69735; ISSA JPJ, 1994, NAT GENET, V7, P536, DOI 10.1038/ng0894-536; Jones PA, 2007, CELL, V128, P683, DOI 10.1016/j.cell.2007.01.029; JOSLYN G, 1991, CELL, V66, P601, DOI 10.1016/0092-8674(81)90022-2; Kamioka Y, 2012, CELL STRUCT FUNCT, V37, P65, DOI 10.1247/csf.11045; KINZLER KW, 1991, SCIENCE, V253, P661, DOI 10.1126/science.1651562; Kochel TJ, 2015, PROSTAG OTH LIPID M, V116, P99, DOI 10.1016/j.prostaglandins.2014.11.003; LAIRD PW, 1995, CELL, V81, P197, DOI 10.1016/0092-8674(95)90329-1; Lao VV, 2011, NAT REV GASTRO HEPAT, V8, P686, DOI 10.1038/nrgastro.2011.173; Linhart HG, 2007, GENE DEV, V21, P3110, DOI 10.1101/gad.1594007; Luo YX, 2014, GASTROENTEROL REP, V2, P16, DOI 10.1093/gastro/got039; MCLELLAN EA, 1988, CANCER RES, V48, P6187; MEHTALI M, 1990, GENE, V91, P179, DOI 10.1016/0378-1119(90)90086-7; Miyoshi H, 2013, NAT PROTOC, V8, P2471, DOI 10.1038/nprot.2013.153; Mizuno R, 2014, J EXP MED, V211, P1123, DOI 10.1084/jem.20132112; Moreno-Gonzalez I, 2011, SEMIN CELL DEV BIOL, V22, P482, DOI 10.1016/j.semcdb.2011.04.002; MOSER AR, 1990, SCIENCE, V247, P322, DOI 10.1126/science.2296722; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; NISHISHO I, 1991, SCIENCE, V253, P665, DOI 10.1126/science.1651563; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X; Oshima H, 1997, CANCER RES, V57, P1644; OSHIMA M, 1995, P NATL ACAD SCI USA, V92, P4482, DOI 10.1073/pnas.92.10.4482; Rossi DJ, 2007, NATURE, V447, P725, DOI 10.1038/nature05862; Sabates-Beliver J, 2007, MOL CANCER RES, V5, P1263, DOI 10.1158/1541-7786.MCR-07-0267; Shibata D, 2009, J PATHOL, V217, P199, DOI 10.1002/path.2461; SU LK, 1992, SCIENCE, V256, P668, DOI 10.1126/science.1350108; Timp W, 2013, NAT REV CANCER, V13, P497, DOI 10.1038/nrc3486; Vogelstein B, 2013, SCIENCE, V339, P1546, DOI 10.1126/science.1235122; Warr MR, 2013, NATURE, V494, P323, DOI 10.1038/nature11895	55	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162300	10.1371/journal.pone.0162300	http://dx.doi.org/10.1371/journal.pone.0162300			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589228	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800048
J	Jung, MG; Kim, SS; Yu, JH; Shin, KS				Jung, Mun-Gu; Kim, Sung Su; Yu, Jae-Hyuk; Shin, Kwang-Soo			Characterization of gprK Encoding a Putative Hybrid G-Protein-Coupled Receptor in Aspergillus fumigatus	PLOS ONE			English	Article							NONRIBOSOMAL PEPTIDE SYNTHETASE; YEAST SACCHAROMYCES-CEREVISIAE; FILAMENTOUS FUNGUS; CANDIDA-ALBICANS; SUPEROXIDE-DISMUTASE; GLIOTOXIN PRODUCTION; GALLERIA-MELLONELLA; SEXUAL DEVELOPMENT; NEUROSPORA-CRASSA; NIDULANS	The G-protein-coupled receptor (GPCR) family represents the largest and most varied collection of membrane embedded proteins that are sensitized by ligand binding and interact with heterotrimeric G proteins. Despite their presumed critical roles in fungal biology, the functions of the GPCR family members in the opportunistic human pathogen Aspergillus fumigatus are largely unknown, as only two (GprC and GprD) of the 15 predicted GPCRs have been studied. Here, we characterize the gprK gene, which is predicted to encode a hybrid GPCR with both 7-transmembrane and regulator of G-protein signaling (RGS) domains. The deletion of gprK causes severely impaired asexual development coupled with reduced expression of key developmental activators. Moreover, Delta gprK results in hyper-activation of germination even in the absence of carbon source, and elevated expression and activity of the protein kinase A PkaC1. Furthermore, proliferation of the Delta gprK mutant is restricted on the medium when pentose is the sole carbon source, suggesting that GprK may function in external carbon source sensing. Notably, the absence of gprK results in reduced tolerance to oxidative stress and significantly lowered mRNA levels of the stress-response associated genes sakA and atfA. Activities of catalases and SODs are severely decreased in the Delta gprK mutant, indicating that GprK may function in proper activation of general stress response. The Delta gprK mutant is also defective in gliotoxin (GT) production and slightly less virulent toward the greater wax moth, Galleria mellonella. Transcriptomic studies reveal that a majority of transporters are down-regulated by Delta gprK. In summary, GprK is necessary for proper development, GT production, and oxidative stress response, and functions in down-regulating the PKA-germination pathway.	[Jung, Mun-Gu; Shin, Kwang-Soo] Daejeon Univ, Dept Life Sci, Daejeon, South Korea; [Kim, Sung Su] Daejeon Univ, Dept Biomed Lab Sci, Daejeon, South Korea; [Yu, Jae-Hyuk] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA; [Yu, Jae-Hyuk] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA	Daejeon University; Daejeon University; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Shin, KS (corresponding author), Daejeon Univ, Dept Life Sci, Daejeon, South Korea.; Yu, JH (corresponding author), Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA.; Yu, JH (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	jyu1@wisc.edu; shinks@dju.kr	Yu, Jae-Hyuk/A-2343-2008; Shin, Kwang-Soo/W-3001-2019	Yu, Jae-Hyuk/0000-0002-6530-8407	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science and Technology [NRF-2013R1A1A2057724]; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology [2011-0031955]	Basic Science Research Program through National Research Foundation of Korea - Ministry of Education, Science and Technology; Intelligent Synthetic Biology Center of Global Frontier Project - Ministry of Education, Science and Technology	This work was primarily supported by the Basic Science Research Program through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology (NRF-2013R1A1A2057724) to K.S. Shin. The work at UW was supported by the Intelligent Synthetic Biology Center of Global Frontier Project funded by the Ministry of Education, Science and Technology (2011-0031955) grants to J.H. Yu. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Affeldt KJ, 2014, MBIO, V5, DOI 10.1128/mBio.01501-14; Affeldt KJ, 2012, TOXINS, V4, P695, DOI 10.3390/toxins4090695; Akhtar N, 2015, MICROBIOL-SGM, V161, P1435, DOI 10.1099/mic.0.000088; Balibar CJ, 2006, BIOCHEMISTRY-US, V45, P15029, DOI 10.1021/bi061845b; Bardwell L, 2004, PEPTIDES, V25, P1465, DOI 10.1016/j.peptides.2003.10.022; BEAUCHAM.C, 1971, ANAL BIOCHEM, V44, P276, DOI 10.1016/0003-2697(71)90370-8; Boeckstaens M, 2007, MOL MICROBIOL, V64, P534, DOI 10.1111/j.1365-2958.2007.05681.x; Bok JW, 2006, INFECT IMMUN, V74, P6761, DOI 10.1128/IAI.00780-06; Bok JW, 2004, EUKARYOT CELL, V3, P527, DOI 10.1128/EC.3.2.527-535.2004; Brakhage AA, 2013, NAT REV MICROBIOL, V11, P21, DOI 10.1038/nrmicro2916; Brunner K, 2008, CURR GENET, V54, P283, DOI 10.1007/s00294-008-0217-7; Cabrera IE, 2015, G3-GENES GENOM GENET, V5, P2729, DOI 10.1534/g3.115.020974; Chen JG, 2004, METHOD ENZYMOL, V389, P338; Chen JG, 2003, SCIENCE, V301, P1728, DOI 10.1126/science.1087790; Chung KS, 2001, J BIOL CHEM, V276, P40190, DOI 10.1074/jbc.M100341200; Cockrill BA, 1999, ANNU REV MED, V50, P303, DOI 10.1146/annurev.med.50.1.303; Cramer RA, 2006, EUKARYOT CELL, V5, P972, DOI 10.1128/EC.00049-06; Dagenais TRT, 2009, CLIN MICROBIOL REV, V22, P447, DOI 10.1128/CMR.00055-08; DOWNEY RJ, 1994, MICROBIOS, V78, P35; Feldbrugge M, 2004, CURR OPIN MICROBIOL, V7, P666, DOI 10.1016/j.mib.2004.10.006; Fillinger S, 2002, MOL MICROBIOL, V44, P1001, DOI 10.1046/j.1365-2958.2002.02933.x; Fuchs BB, 2010, VIRULENCE, V1, P475, DOI 10.4161/viru.1.6.12985; Galagan JE, 2005, NATURE, V438, P1105, DOI 10.1038/nature04341; Gehrke A, 2010, APPL ENVIRON MICROB, V76, P3989, DOI 10.1128/AEM.00052-10; Gruber S, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-108; Han KH, 2004, MOL MICROBIOL, V51, P1333, DOI 10.1111/j.1365-2958.2003.03940.x; Han KH, 2004, MOL MICROBIOL, V53, P529, DOI 10.1111/j.1365-2958.2004.04163.x; Johnston CA, 2007, P NATL ACAD SCI USA, V104, P17317, DOI 10.1073/pnas.0704751104; Kafer E, 1977, Adv Genet, V19, P33, DOI 10.1016/S0065-2660(08)60245-X; Karpichev IV, 2002, J BIOL CHEM, V277, P19609, DOI 10.1074/jbc.M202045200; Kawasaki L, 2002, MOL MICROBIOL, V45, P1153, DOI 10.1046/j.1365-2958.2002.03087.x; Kraakman L, 1999, MOL MICROBIOL, V32, P1002, DOI 10.1046/j.1365-2958.1999.01413.x; Lafon A, 2005, GENETICS, V171, P71, DOI 10.1534/genetics.105.040584; Lafon A, 2006, FUNGAL GENET BIOL, V43, P490, DOI 10.1016/j.fgb.2006.02.001; Lambou K, 2010, MOL MICROBIOL, V75, P910, DOI 10.1111/j.1365-2958.2009.07024.x; Lara-Rojas F, 2011, MOL MICROBIOL, V80, P436, DOI 10.1111/j.1365-2958.2011.07581.x; Lemaire K, 2004, MOL CELL, V16, P293, DOI 10.1016/j.molcel.2004.10.004; Li L, 2007, ANNU REV MICROBIOL, V61, P423, DOI 10.1146/annurev.micro.61.080706.093432; Li LD, 2006, EUKARYOT CELL, V5, P1287, DOI 10.1128/EC.00109-06; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenz MC, 2000, GENETICS, V154, P609; Lyons TJ, 2004, P NATL ACAD SCI USA, V101, P5506, DOI 10.1073/pnas.0306324101; Mah JH, 2006, EUKARYOT CELL, V5, P1585, DOI 10.1128/EC.00192-06; Maidan MM, 2005, BIOCHEM SOC T, V33, P291, DOI 10.1042/BST0330291; Maidan MM, 2005, MOL BIOL CELL, V16, P1971, DOI 10.1091/mbc.E04-09-0780; McCudden CR, 2005, CELL MOL LIFE SCI, V62, P551, DOI 10.1007/s00018-004-4462-3; Miller TL, 1999, ENDOCRINOLOGY, V140, P4152, DOI 10.1210/en.140.9.4152; Miwa T, 2004, EUKARYOT CELL, V3, P919, DOI 10.1128/EC.3.4.919-931.2004; Morris AJ, 1999, PHYSIOL REV, V79, P1373, DOI 10.1152/physrev.1999.79.4.1373; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ni M, 2005, EUKARYOT CELL, V4, P1465, DOI 10.1128/EC.4.8.1465-1476.2005; Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332; Paris S, 2003, APPL ENVIRON MICROB, V69, P1581, DOI 10.1128/AEM.69.3.1581-1588.2003; Reeves EP, 2004, MYCOPATHOLOGIA, V158, P73, DOI 10.1023/B:MYCO.0000038434.55764.16; Scharf DH, 2012, APPL MICROBIOL BIOT, V93, P467, DOI 10.1007/s00253-011-3689-1; Schrettl M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000952; Seo JA, 2004, MOL MICROBIOL, V53, P1611, DOI 10.1111/j.1365-2958.2004.04232.x; Shin KS, 2015, BIOCHEM BIOPH RES CO, V463, P428, DOI 10.1016/j.bbrc.2015.05.090; Sugui JA, 2007, EUKARYOT CELL, V6, P1562, DOI 10.1128/EC.00141-07; Szewczyk E, 2006, NAT PROTOC, V1, P3111, DOI 10.1038/nprot.2006.405; Tomee JFC, 2000, CLIN EXP ALLERGY, V30, P476, DOI 10.1046/j.1365-2222.2000.00796.x; Unkles SE, 2001, EMBO J, V20, P6246, DOI 10.1093/emboj/20.22.6246; WAYNE LG, 1986, ANAL BIOCHEM, V157, P89, DOI 10.1016/0003-2697(86)90200-9; Xue CY, 2008, FEMS MICROBIOL REV, V32, P1010, DOI 10.1111/j.1574-6976.2008.00131.x; Xue T, 2004, ARCH MICROBIOL, V182, P346, DOI 10.1007/s00203-004-0707-z; Xue Y, 1998, EMBO J, V17, P1996, DOI 10.1093/emboj/17.7.1996; Yu JH, 2006, J MICROBIOL, V44, P145; Yu JH, 2004, FUNGAL GENET BIOL, V41, P973, DOI 10.1016/j.fgb.2004.08.001; Yun CW, 1998, BIOCHEM BIOPH RES CO, V252, P29, DOI 10.1006/bbrc.1998.9600	69	25	25	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161312	10.1371/journal.pone.0161312	http://dx.doi.org/10.1371/journal.pone.0161312			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584150	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600020
J	Xu, XH; Wang, JT; Li, M; Liu, YL				Xu, Xiaohua; Wang, Jiin-Tarng; Li, Min; Liu, Yilun			TIMELESS Suppresses the Accumulation of Aberrant CDC45 center dot MCM2-7 center dot GINS Replicative Helicase Complexes on Human Chromatin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell cycle; cyclin-dependent kinase (CDK); DNA binding protein; DNA helicase; DNA replication; protein complex	CYCLIN-DEPENDENT KINASES; DNA-REPLICATION; CELL-CYCLE; S-PHASE; MCM2-7 HELICASE; SACCHAROMYCES-CEREVISIAE; RETINOBLASTOMA PROTEIN; INTERACTING PROTEIN; HUMAN FIBROBLASTS; UBIQUITIN LIGASE	The replication licensing factor CDC6 recruits the MCM2-7 replicative helicase to the replication origin, where MCM2-7 is activated to initiate DNA replication. MCM2-7 is activated by both the CDC7-Dbf4 kinase and cyclin-dependent kinase and via interactions with CDC45 and go-ichi-ni-san complex (GINS) to form the CDC45MCM2-7GINS (CMG) helicase complex. TIMELESS (TIM) is important for the subsequent coupling of CMG activity to DNA polymerases for efficient DNA synthesis. However, the mechanism by which TIM regulates CMG activity for proper replication fork progression remains unclear. Here we show that TIM interacts with MCM2-7 prior to the initiation of DNA replication. TIM depletion in various human cell lines results in the accumulation of aberrant CMG helicase complexes on chromatin. Importantly, the presence of these abnormal CMG helicase complexes is not restricted to cells undergoing DNA synthesis. Furthermore, even though these aberrant CMG complexes interact with the DNA polymerases on human chromatin, these complexes are not phosphorylated properly by cyclin-dependent kinase/CDC7-Dbf4 kinase and exhibit reduced DNA unwinding activity. This phenomenon coincides with a significant accumulation of the p27 and p21 replication inhibitors, reduced chromatin association of CDC6 and cyclin E, and a delay in S phase entry. Our results provide the first evidence that TIM is required for the correct chromatin association of the CMG complex to allow efficient DNA replication.	[Xu, Xiaohua; Wang, Jiin-Tarng; Li, Min; Liu, Yilun] City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, 1500 E Duarte Rd, Duarte, CA 91010 USA	City of Hope; Beckman Research Institute of City of Hope	Liu, YL (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Dept Canc Genet & Epigenet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	yiliu@coh.org	Li, Min/J-9652-2017; liu, yi/GXE-9662-2022	Li, Min/0000-0002-7776-6536; xu, xioahua/0000-0003-3790-6386	NCI, National Institutes of Health [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572, R01CA151245] Funding Source: NIH RePORTER	NCI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	The research reported in this publication included work performed in the Analytical Cytometry and Drug Discovery and Structural Biology Cores supported by the NCI, National Institutes of Health under Award P30CA33572. We thank Dr. Nancy Linford for comments and expert editing of the manuscript.	Aparicio T, 2006, CELL DIV, V1, DOI 10.1186/1747-1028-1-18; Averbeck NB, 2014, CELL CYCLE, V13, P2509, DOI 10.4161/15384101.2015.941743; Bando M, 2009, J BIOL CHEM, V284, P34355, DOI 10.1074/jbc.M109.065730; Bashir T, 2004, NATURE, V428, P190, DOI 10.1038/nature02330; BELL SP, 1992, NATURE, V357, P128, DOI 10.1038/357128a0; Biggar KK, 2009, CURR GENOMICS, V10, P573, DOI 10.2174/138920209789503905; Binne UK, 2007, NAT CELL BIOL, V9, P225, DOI 10.1038/ncb1532; Bochman ML, 2008, MOL CELL, V31, P287, DOI 10.1016/j.molcel.2008.05.020; Bruck I, 2011, J BIOL CHEM, V286, P36414, DOI 10.1074/jbc.M111.282822; Bruck I, 2011, J BIOL CHEM, V286, P18602, DOI 10.1074/jbc.M111.226332; Bruck I, 2011, J BIOL CHEM, V286, P14157, DOI 10.1074/jbc.M111.218305; Calzada A, 2005, GENE DEV, V19, P1905, DOI 10.1101/gad.337205; Caracciolo V, 2006, ONCOGENE, V25, P5294, DOI 10.1038/sj.onc.1209681; Chau BN, 2003, NAT REV CANCER, V3, P130, DOI 10.1038/nrc993; Chou DM, 2006, P NATL ACAD SCI USA, V103, P18143, DOI 10.1073/pnas.0609251103; Coleman TR, 1996, CELL, V87, P53, DOI 10.1016/S0092-8674(00)81322-7; Costa A, 2011, NAT STRUCT MOL BIOL, V18, P471, DOI 10.1038/nsmb.2004; Dimitrova DS, 1999, J CELL BIOL, V146, P709, DOI 10.1083/jcb.146.4.709; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Edwards MC, 2002, J BIOL CHEM, V277, P33049, DOI 10.1074/jbc.M204438200; Foss EJ, 2001, GENETICS, V157, P567; Furstenthal L, 2001, NAT CELL BIOL, V3, P715, DOI 10.1038/35087026; Furstenthal L, 2001, J CELL BIOL, V152, P1267, DOI 10.1083/jcb.152.6.1267; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Gamper AM, 2013, NUCLEIC ACIDS RES, V41, P10334, DOI 10.1093/nar/gkt833; Geley S, 2001, J CELL BIOL, V153, P137, DOI 10.1083/jcb.153.1.137; Gotter AL, 2003, J MOL BIOL, V331, P167, DOI 10.1016/S0022-2836(03)00633-8; Gotter AL, 2000, NAT NEUROSCI, V3, P755, DOI 10.1038/77653; Guillou E, 2010, GENE DEV, V24, P2812, DOI 10.1101/gad.608210; Harbour JW, 1999, CELL, V98, P859, DOI 10.1016/S0092-8674(00)81519-6; Hateboer G, 1998, MOL CELL BIOL, V18, P6679, DOI 10.1128/MCB.18.11.6679; Heller RC, 2011, CELL, V146, P80, DOI 10.1016/j.cell.2011.06.012; Hsu JY, 2002, NAT CELL BIOL, V4, P358, DOI 10.1038/ncb785; Ilves I, 2010, MOL CELL, V37, P247, DOI 10.1016/j.molcel.2009.12.030; Im JS, 2009, P NATL ACAD SCI USA, V106, P15628, DOI 10.1073/pnas.0908039106; Ishimi Y, 2003, J BIOL CHEM, V278, P24644, DOI 10.1074/jbc.M213252200; Ji P, 2004, MOL CELL, V16, P47, DOI 10.1016/j.molcel.2004.09.029; Katou Y, 2003, NATURE, V424, P1078, DOI 10.1038/nature01900; Kemp MG, 2010, J BIOL CHEM, V285, P16562, DOI 10.1074/jbc.M110.110304; Kim J, 2008, CELL CYCLE, V7, P146, DOI 10.4161/cc.7.2.5282; Komamura-Kohno Y, 2006, FEBS J, V273, P1224, DOI 10.1111/j.1742-4658.2006.05146.x; Labib K, 2010, GENE DEV, V24, P1208, DOI 10.1101/gad.1933010; Leman AR, 2010, J CELL SCI, V123, P660, DOI 10.1242/jcs.057984; Lim SH, 2013, DEVELOPMENT, V140, P3079, DOI 10.1242/dev.091744; Lu ZM, 2010, CELL CYCLE, V9, P2342, DOI 10.4161/cc.9.12.11988; Lunn CL, 2010, CELL CYCLE, V9, P4533, DOI 10.4161/cc.9.22.13789; Mailand N, 2005, CELL, V122, P915, DOI 10.1016/j.cell.2005.08.013; Maric M, 2014, SCIENCE, V346, P440, DOI 10.1126/science.1253596; Masai H, 2005, IUBMB LIFE, V57, P323, DOI 10.1080/15216540500092419; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Mayer ML, 2004, MOL BIOL CELL, V15, P1736, DOI 10.1091/mbc.E03-08-0619; McFarlane RJ, 2010, CELL CYCLE, V9, P700, DOI 10.4161/cc.9.4.10676; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Moritani M, 2013, J BIOCHEM, V154, P363, DOI 10.1093/jb/mvt062; Morris L, 2000, NAT CELL BIOL, V2, P232, DOI 10.1038/35008660; Nedelcheva MN, 2005, J MOL BIOL, V347, P509, DOI 10.1016/j.jmb.2005.01.041; Numata Y, 2010, J BIOCHEM, V147, P917, DOI 10.1093/jb/mvq028; Ohtani K, 1998, ONCOGENE, V17, P1777, DOI 10.1038/sj.onc.1202105; Park H, 1999, YEAST, V15, P35, DOI 10.1002/(SICI)1097-0061(19990115)15:1<35::AID-YEA340>3.0.CO;2-R; Porras A, 1999, J VIROL, V73, P3102; Powell SK, 2015, EMBO J, V34, P531, DOI 10.15252/embj.201488307; Rabitsch KP, 2001, CURR BIOL, V11, P1001, DOI 10.1016/S0960-9822(01)00274-3; Raderschall E, 1999, P NATL ACAD SCI USA, V96, P1921, DOI 10.1073/pnas.96.5.1921; Randell JCW, 2010, MOL CELL, V40, P353, DOI 10.1016/j.molcel.2010.10.017; Remus D, 2009, CELL, V139, P719, DOI 10.1016/j.cell.2009.10.015; SHERR CJ, 1995, GENE DEV, V9, P1149, DOI 10.1101/gad.9.10.1149; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Sheu YJ, 2010, NATURE, V463, P113, DOI 10.1038/nature08647; Smith KD, 2009, J CELL BIOL, V187, P15, DOI 10.1083/jcb.200905006; Smith-Roe SL, 2011, CELL CYCLE, V10, P1618, DOI 10.4161/cc.10.10.15613; Tanaka TU, 1997, CELL, V90, P649, DOI 10.1016/S0092-8674(00)80526-7; Thangavel S, 2010, MOL CELL BIOL, V30, P1382, DOI 10.1128/MCB.01290-09; Unsal-Kacmaz K, 2007, MOL CELL BIOL, V27, P3131, DOI 10.1128/MCB.02190-06; Wang JT, 2014, CELL REP, V7, P848, DOI 10.1016/j.celrep.2014.03.037; WEINBERG RA, 1995, CELL, V81, P323, DOI 10.1016/0092-8674(95)90385-2; Woodward AM, 2006, J CELL BIOL, V173, P673, DOI 10.1083/jcb.200602108; Xu XH, 2009, EMBO J, V28, P3005, DOI 10.1038/emboj.2009.235; Yoshizawa-Sugata N, 2007, J BIOL CHEM, V282, P2729, DOI 10.1074/jbc.M605596200; Yung Y, 2007, J CELL BIOL, V178, P741, DOI 10.1083/jcb.200703034	79	11	12	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22544	22558		10.1074/jbc.M116.719963	http://dx.doi.org/10.1074/jbc.M116.719963			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587400	hybrid, Green Published			2022-12-26	WOS:000386760600016
J	Gonzalez-Alvaro, I; Castrejon, I; Ortiz, AM; Toledano, E; Castaneda, S; Garcia-Vadillo, A; Carmona, L				Gonzalez-Alvaro, Isidoro; Castrejon, Isabel; Ortiz, Ana M.; Toledano, Esther; Castaneda, Santos; Garcia-Vadillo, Alberto; Carmona, Loreto		EMECAR Study Grp	Cut-Offs and Response Criteria for the Hospital Universitario La Princesa Index (HUPI) and Their Comparison to Widely-Used Indices of Disease Activity in Rheumatoid Arthritis	PLOS ONE			English	Article							C-REACTIVE PROTEIN; ACTIVITY SCORE; SEDIMENTATION-RATE; VALIDATION; THERAPIES; REMISSION; CONSENSUS; SOCIETY; GENDER; VALUES	Objective To estimate cut-off points and to establish response criteria for the Hospital Universitario La Princesa Index (HUPI) in patients with chronic polyarthritis. Methods Two cohorts, one of early arthritis (Princesa Early Arthritis Register Longitudinal [PEARL] study) and other of long-term rheumatoid arthritis (Estudio de la Morbilidad y Expresion Clinica de la Artritis Reumatoide [EMECAR]) including altogether 1200 patients were used to determine cut-off values for remission, and for low, moderate and high activity through receiver operating curve (ROC) analysis. The areas under ROC (AUC) were compared to those of validated indexes (SDAI, CDAI, DAS28). ROC analysis was also applied to establish minimal and relevant clinical improvement for HUPI. Results The best cut-off points for HUPI are 2, 5 and 9, classifying RA activity as remission if <= 2, low disease activity if > 2 and <= 5), moderate if > 5 and < 9 and high if >= 9. HUPI's AUC to discriminate between low-moderate activity was 0.909 and between moderate-high activity 0.887. DAS28's AUCs were 0.887 and 0.846, respectively; both indices had higher accuracy than SDAI (AUCs: 0.832 and 0.756) and CDAI (AUCs: 0.789 and 0.728). HUPI discriminates remission better than DAS28-ESR in early arthritis, but similarly to SDAI. The HUPI cut-off for minimal clinical improvement was established at 2 and for relevant clinical improvement at 4. Response criteria were established based on these cut-off values. Conclusions The cut-offs proposed for HUPI perform adequately in patients with either early or long term arthritis.	[Gonzalez-Alvaro, Isidoro; Ortiz, Ana M.; Castaneda, Santos; Garcia-Vadillo, Alberto] Hosp Univ Princesa, IIS IP, Dept Rheumatol, Madrid, Spain; [Castrejon, Isabel] Rush Univ, Med Ctr, Div Rheumatol, Chicago, IL 60612 USA; [Toledano, Esther] Hosp Clin San Carlos, Dept Rheumatol, IdISSC, Madrid, Spain; [Carmona, Loreto] Inst Salud Musculoesquelet, Madrid, Spain	Rush University; Hospital Clinico San Carlos	Gonzalez-Alvaro, I (corresponding author), Hosp Univ Princesa, IIS IP, Dept Rheumatol, Madrid, Spain.	isidoro.ga@ser.es	Castrejon, Isabel/ABH-5293-2020; Hernandez, Antonio Naranjo/E-7910-2010; Carmona, Loreto/A-2748-2014; Sanmarti, Raimon/M-4434-2017	Hernandez, Antonio Naranjo/0000-0002-2013-6664; Carmona, Loreto/0000-0002-4401-2551; Casado, Enrique/0000-0001-8839-6430; Garcia Vadillo, Alberto/0000-0003-3262-8364; Castrejon, MD, PhD, Isabel/0000-0003-1811-2417; Sanmarti, Raimon/0000-0002-8864-3806; Gratacos, Jordi/0000-0003-4007-4103; BELMONTE-SERRANO, MIGUEL ANGEL/0000-0002-4874-0433	Ministerio de Economia y Competitividad (Instituto de Salud Carlos III) [RD12/0009/0017, PI14/00442]; Fondo Europeo de Desarrollo Regional (FEDER); Spanish Society of Rheumatology; Spanish Foundation of Rheumatology; Aventis	Ministerio de Economia y Competitividad (Instituto de Salud Carlos III); Fondo Europeo de Desarrollo Regional (FEDER)(European Commission); Spanish Society of Rheumatology; Spanish Foundation of Rheumatology; Aventis(Sanofi-Aventis)	Support was provided by grants RD12/0009/0017 and PI14/00442 to IG-A from the Ministerio de Economia y Competitividad (Instituto de Salud Carlos III) and co-funded by Fondo Europeo de Desarrollo Regional (FEDER). The EMECAR study was funded by the Spanish Society of Rheumatology, the Spanish Foundation of Rheumatology, and by an independent research grant from Aventis. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahlmen M, 2010, ANN RHEUM DIS, V69, P230, DOI 10.1136/ard.2008.102244; Aletaha D, 2005, CLIN EXP RHEUMATOL, V23, pS100; ARNETT FC, 1988, ARTHRITIS RHEUM, V31, P315, DOI 10.1002/art.1780310302; Fernandez IC, 2010, REUMATOL CLIN, V6, P33, DOI 10.1016/j.reuma.2009.12.003; Castrejon I, 2008, CLIN EXP RHEUMATOL, V26, P769; Castrejon I, 2013, ARTHRIT CARE RES, V65, P518, DOI 10.1002/acr.21854; Castrejon I, 2010, J RHEUMATOL, V37, P1439, DOI 10.3899/jrheum.091333; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Felson DT, 2011, ARTHRITIS RHEUM-US, V63, P573, DOI 10.1002/art.30129; Gonzalez-Alvaro I, 2015, RHEUMATOLOGY, V54, P1200, DOI 10.1093/rheumatology/keu461; Gonzalez-Alvaro I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029492; Gonzalez-Alvaro I, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2561; Hallert E, 2003, ANN RHEUM DIS, V62, P667, DOI 10.1136/ard.62.7.667; Inoue E, 2007, ANN RHEUM DIS, V66, P407, DOI 10.1136/ard.2006.054205; Leeb BF, 2007, J RHEUMATOL, V34, P2382; PINALS RS, 1981, ARTHRITIS RHEUM, V24, P1308, DOI 10.1002/art.1780241012; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Radovits BJ, 2008, ANN RHEUM DIS, V67, P1127, DOI 10.1136/ard.2007.079913; Saleem B, 2006, CLIN EXP RHEUMATOL, V24, pS33; Sanmarti R, 2015, REUMATOL CLIN, V11, P279, DOI [10.1016/J.REUMA.2015.05.001, 10.1016/j.reuma.2015.05.001]; Smolen JS, 2014, ANN RHEUM DIS, V73, P492, DOI 10.1136/annrheumdis-2013-204573; Sokka T, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2591; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B	23	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161727	10.1371/journal.pone.0161727	http://dx.doi.org/10.1371/journal.pone.0161727			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603313	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200022
J	Ibinda, F; Zarnack, HC; Newton, CR				Ibinda, Fredrick; Zarnack, Hans-Christoph; Newton, Charles R.			Sodium Disturbances in Children Admitted to a Kenyan Hospital: Magnitude, Outcome and Associated Factors	PLOS ONE			English	Article							DEMOGRAPHIC SURVEILLANCE SYSTEM; SEVERE FALCIPARUM-MALARIA; KILIFI HEALTH; HYPONATREMIA; HYPERNATREMIA; DEHYDRATION; VASOPRESSIN; PREVALENCE; SEIZURES; DEATH	Background Perturbations of blood sodium are the most frequently encountered electrolyte disorder in sick children, and may influence fluid therapy. We examined the frequency of blood sodium perturbations, and factors and outcomes associated with hyponatremia in children admitted to a rural Kenyan hospital and investigated the risk factors associated with deaths in hyponatremic children. Methods Plasma sodium levels and other laboratory parameters were measured in children admitted to a rural Kenyan hospital. Clinical measurements were collected using standard forms and entered into a computer database. The proportion of children admitted with hyponatremia was determined. Logistic regression models were used to investigate factors associated with hyponatremia, and death in those with hyponatremia. Results Abnormal plasma sodium occurred in 46.6%(95% confidence interval (95% CI) 43.5-49.6%) of 1026 pediatric admissions. Hyponatremia occurred in 44.4% (95% CI 41.4-47.5%) and hypernatremia in 2.1% (95% CI 1.3-3.0%). Malaria (40.8%) was the most common underlying primary diagnosis in hyponatremic children. Malaria, hyperglycemia, wasting, high creatinine levels and preserved consciousness were associated with hyponatremia. Pallor and seizures were associated with increased mortality in hyponatremic children. Conclusions Sodium disturbances are common in pediatric admissions to a County hospital in rural Kenya. Seizures and pallor were predictors of mortality in hyponatremic children.	[Ibinda, Fredrick; Zarnack, Hans-Christoph; Newton, Charles R.] Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, POB 230-80108, Kilifi, Kenya; [Newton, Charles R.] Univ Oxford, Dept Psychiat, Oxford, England	University of Oxford	Newton, CR (corresponding author), Ctr Geog Med Res Coast, KEMRI Wellcome Trust Res Programme, POB 230-80108, Kilifi, Kenya.; Newton, CR (corresponding author), Univ Oxford, Dept Psychiat, Oxford, England.	cnewton@kemri-wellcome.org	Newton, Charles RJC/B-7578-2014	Newton, Charles RJC/0000-0002-6999-5507	Wellcome Trust Senior Clinical Fellowship [083744]; Wellcome Trust masters training fellowship [101140]	Wellcome Trust Senior Clinical Fellowship(Wellcome Trust); Wellcome Trust masters training fellowship	This study was supported by the Wellcome Trust Senior Clinical Fellowship to Professor Charles Newton (No. 083744). Fredrick Ibinda was supported by the Wellcome Trust masters training fellowship (101140).	ANDERSON RJ, 1985, ANN INTERN MED, V102, P164, DOI 10.7326/0003-4819-102-2-164; ARIEFF AI, 1992, BRIT MED J, V304, P1218, DOI 10.1136/bmj.304.6836.1218; Ayus JC, 2008, AM J PHYSIOL-RENAL, V295, pF619, DOI 10.1152/ajprenal.00502.2007; Carter JA, 2004, EPILEPSIA, V45, P978, DOI 10.1111/j.0013-9580.2004.65103.x; Day NPJ, 2000, CRIT CARE MED, V28, P1833, DOI 10.1097/00003246-200006000-00025; Dunn K, 1997, J PAEDIATR CHILD H, V33, P26, DOI 10.1111/j.1440-1754.1997.tb00986.x; Ellison DH, 2007, NEW ENGL J MED, V356, P2064, DOI 10.1056/NEJMcp066837; English MC, 1996, ARCH DIS CHILD, V74, P201, DOI 10.1136/adc.74.3.201; FINBERG L, 1955, PEDIATRICS, V16, P1; Foster BA, 2014, J PEDIATR-US, V165, P163, DOI 10.1016/j.jpeds.2014.01.040; GORDILLO G, 1957, PEDIATRICS, V20, P303; Halawa I, 2011, EPILEPSIA, V52, P410, DOI 10.1111/j.1528-1167.2010.02939.x; Hanson J, 2009, AM J TROP MED HYG, V80, P141, DOI 10.4269/ajtmh.2009.80.141; Hoorn EJ, 2006, NEPHROL DIAL TRANSPL, V21, P70, DOI 10.1093/ndt/gfi082; Ibinda F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122606; Kariuki SM, 2015, NEUROLOGY, V84, P1838, DOI 10.1212/WNL.0000000000001542; Kariuki SM, 2011, BRAIN, V134, P1519, DOI 10.1093/brain/awr051; KATZ MA, 1973, NEW ENGL J MED, V289, P843, DOI 10.1056/NEJM197310182891607; MACAULAY D, 1961, ARCH DIS CHILD, V36, P543, DOI 10.1136/adc.36.189.543; Maitland K, 2011, NEW ENGL J MED, V364, P2483, DOI 10.1056/NEJMoa1101549; Mcnab S, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009457.pub2; Mcnab S, 2015, LANCET, V385, P1190, DOI 10.1016/S0140-6736(14)61459-8; MILLER LH, 1967, ANN TROP MED PARASIT, V61, P265, DOI 10.1080/00034983.1967.11686487; Mishra SK, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-24; Moritz ML, 1999, PEDIATRICS, V104, P435, DOI 10.1542/peds.104.3.435; Mung'Ala-Odera V, 2004, AM J TROP MED HYG, V71, P64, DOI 10.4269/ajtmh.2004.71.64; Ndila C, 2014, GLOBAL HEALTH ACTION, V7, DOI 10.3402/gha.v7.25593; R Core Team, 2021, R LANGUAGE ENV STAT; Scott JAG, 2012, INT J EPIDEMIOL, V41, P650, DOI 10.1093/ije/dys062; Sharf R E, 1993, Arch Fam Med, V2, P647, DOI 10.1001/archfami.2.6.647; Sodarangani M, 2008, LANCET NEUROL, V7, P145, DOI [10.1016/SI474-4422(07)70331-9, 10.1016/S1474-4422(07)70331-9]; Sowunmi A, 2000, J TROP PEDIATRICS, V46, P195, DOI 10.1093/tropej/46.4.195; Thwaites CL, 2015, LANCET, V385, P362, DOI 10.1016/S0140-6736(14)60236-1; WHO, 2013, GUID MAN COMM CHILDH; Zilberberg Marya D, 2008, BMC Pulm Med, V8, P16, DOI 10.1186/1471-2466-8-16	35	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161320	10.1371/journal.pone.0161320	http://dx.doi.org/10.1371/journal.pone.0161320			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603309	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200012
J	Jing, QH; Tang, YT; Qian, DJ; Lu, Y; Jiang, YX				Jing, Qinghe; Tang, Yating; Qian, Dongjin; Lu, Yi; Jiang, Yongxiang			Posterior Corneal Characteristics of Cataract Patients with High Myopia	PLOS ONE			English	Article							REFRACTIVE ERROR; AXIAL LENGTH; ASTIGMATISM; ANTERIOR; AGE; CHINESE	Purpose To evaluate the characteristics of the posterior corneal surface in patients with high myopia before cataract surgery. Methods We performed a cross-sectional study at the Eye and ENT Hospital of Fudan University, Shanghai, China. Corneal astigmatism and axial length were measured with a rotating Scheimpflug camera (Pentacam) and partial coherence interferometry (IOLMaster) in a high-myopia study group of 167 eyes (axial length >= 26 mm) and a control group of 150 eyes (axial length > 20 mm and < 25 mm). Results Total corneal astigmatism and anterior corneal astigmatism values were higher in the high-myopia group than in the control group. There was no significant difference in posterior corneal astigmatism between the high-myopia study group and the control group. In the study group, the mean posterior corneal astigmatism (range 0 - -0.9 diopters) was -0.29 diopters (D) +/- 0.17 standard deviations (SD). The steep corneal meridian was aligned vertically (60 degrees-120 degrees) in 87.43% of eyes for the posterior corneal surface, and did not change with increasing age. There was a significant correlation (r = 0.235, p = 0.002) between posterior corneal astigmatism and anterior corneal astigmatism, especially when the anterior corneal surface showed with-the-rule (WTR) astigmatism(r = 0.452, p = 0.000). There was a weak negative correlation between posterior corneal astigmatism and age (r = -0.15, p = 0.053) in the high-myopia group. Compared with total corneal astigmatism values, the anterior corneal measurements alone overestimated WTR astigmatism by a mean of 0.27 +/- 0.18 D in 68.75% of eyes, underestimated against-the-rule (ATR) astigmatism by a mean of 0.41 +/- 0.28 D in 88.89% of eyes, and underestimated oblique astigmatism by a mean of 0.24 +/- 0.13 D in 63.64% of eyes. Conclusions Posterior corneal astigmatism decreased with age and remained as ATR astigmatism in most cases of high myopia. There was a significant correlation between posterior corneal astigmatism and anterior corneal astigmatism when anterior corneal astigmatism was WTR. If posterior corneal astigmatism is not accounted for when selecting toric intraocular lenses for high-myopia patients, the use of anterior corneal astigmatism measurements alone will lead to overestimation of WTR astigmatism and underestimation of ATR and oblique astigmatism.	[Jing, Qinghe; Tang, Yating; Qian, Dongjin; Lu, Yi; Jiang, Yongxiang] Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai, Peoples R China; [Jing, Qinghe; Tang, Yating; Qian, Dongjin; Lu, Yi; Jiang, Yongxiang] State Hlth Minist, Key Lab Myopia, Shanghai, Peoples R China; [Jing, Qinghe; Tang, Yating; Qian, Dongjin; Lu, Yi; Jiang, Yongxiang] Key Lab Visual Impairment & Restorat Shanghai, Shanghai, Peoples R China	Fudan University	Jiang, YX (corresponding author), Fudan Univ, Dept Ophthalmol & Vis Sci, Eye & ENT Hosp, Shanghai, Peoples R China.; Jiang, YX (corresponding author), State Hlth Minist, Key Lab Myopia, Shanghai, Peoples R China.; Jiang, YX (corresponding author), Key Lab Visual Impairment & Restorat Shanghai, Shanghai, Peoples R China.	yongxiang_jiang@163.com			Nature Science Foundation of China [81270989]; Nature Science Foundation of Xinjiang Uygur Autonomous Region [2015211C225]	Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nature Science Foundation of Xinjiang Uygur Autonomous Region	Nature Science Foundation of China grant: 81270989 recipient: Yi Lu (the funder had a role in study design and decision to publish the manuscript). Nature Science Foundation of Xinjiang Uygur Autonomous Region grant: 2015211C225 recipient: Yongxiang Jiang (the funder had a role in study design and decision to publish the manuscript).	Carney LG, 1997, INVEST OPHTH VIS SCI, V38, P311; Goggin M, 2015, J REFRACT SURG, V31, P98, DOI 10.3928/1081597X-20150122-04; GOH WSH, 1994, OPHTHAL PHYSL OPT, V14, P378, DOI 10.1111/j.1475-1313.1994.tb00128.x; Ho JD, 2010, CORNEA, V29, P632, DOI 10.1097/ICO.0b013e3181c2965f; Kaye SB, 1997, J CATARACT REFR SURG, V23, P1496, DOI 10.1016/S0886-3350(97)80020-X; Koch DD, 2012, J CATARACT REFR SURG, V38, P2080, DOI 10.1016/j.jcrs.2012.08.036; Kohnen T, 2013, J CATARACT REFR SURG, V39, P1795, DOI 10.1016/j.jcrs.2013.10.017; Konstantopoulos A, 2007, BRIT J OPHTHALMOL, V91, P551, DOI 10.1136/bjo.2006.103408; Leo SW, 2011, J AAPOS, V15, P181, DOI 10.1016/j.jaapos.2010.09.020; Liang YB, 2009, OPHTHALMOLOGY, V116, P2119, DOI 10.1016/j.ophtha.2009.04.040; Lin LLK, 1999, OPTOMETRY VISION SCI, V76, P275, DOI 10.1097/00006324-199905000-00013; Mencucci R, 2014, CLIN OUTCOMES ROTATI; Miyake T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117194; Mutti DO, 2007, INVEST OPHTH VIS SCI, V48, P2510, DOI 10.1167/iovs.06-0562; Nemeth G, 2014, CORNEA, V33, P1214, DOI 10.1097/ICO.0000000000000238; Pan CW, 2013, AM J OPHTHALMOL, V156, P1021, DOI 10.1016/j.ajo.2013.06.005; Qian X, 2013, CHIN J PRACT OPHTHAL, V31, P557; Shankar H, 2008, J CATARACT REFR SURG, V34, P103, DOI 10.1016/j.jcrs.2007.09.013; Tonn B, 2015, INVEST OPHTH VIS SCI, V56, P291, DOI 10.1167/iovs.14-15659; Tuft SJ, 2004, J CATARACT REFR SURG, V30, P1045, DOI 10.1016/j.jcrs.2003.09.053; Ueno Y, 2014, J REFRACT SURG, V30, P192, DOI 10.3928/1081597X-20140218-01; Xu L, 2005, OPHTHALMOLOGY, V112, P1676, DOI 10.1016/j.ophtha.2005.05.015; Yang J, 2015, PLOS ONE, V10; Yin G, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043172	24	9	11	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162012	10.1371/journal.pone.0162012	http://dx.doi.org/10.1371/journal.pone.0162012			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603713	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200035
J	Kasbaoui, N; Cooper, J; Mills, DS; Burman, O				Kasbaoui, Naima; Cooper, Jonathan; Mills, Daniel S.; Burman, Oliver			Effects of Long-Term Exposure to an Electronic Containment System on the Behaviour and Welfare of Domestic Cats	PLOS ONE			English	Article							COGNITIVE BIAS; FELIS-CATUS; VIRTUAL FENCES; ANXIETY; STRESS; JUDGMENT; HORSES; RISK; CLASSIFICATION; VOCALIZATIONS	Free-roaming cats are exposed to a variety of risks, including involvement in road traffic accidents. One way of mitigating these risks is to contain cats, for example using an electronic boundary fence system that delivers an electric 'correction' via a collar if a cat ignores a warning cue and attempts to cross the boundary. However, concerns have been expressed over the welfare impact of such systems. Our aim was to determine if long-term exposure to an electronic containment system was associated with reduced cat welfare. We compared 46 owned domestic cats: 23 cats that had been contained by an electronic containment system for more than 12 months (AF group); and 23 cats with no containment system that were able to roam more widely (C group). We assessed the cats' behavioural responses and welfare via four behavioural tests (unfamiliar person test; novel object test; sudden noise test; cognitive bias test) and an owner questionnaire. In the unfamiliar person test, C group lip-licked more than the AF group, whilst the AF group looked at, explored and interacted more with the unfamiliar person than C group. In the novel object test, the AF group looked at and explored the object more than C group. No significant differences were found between AF and C groups for the sudden noise or cognitive bias tests. Regarding the questionnaire, C group owners thought their cats showed more irritable behaviour and AF owners thought that their cats toileted inappropriately more often than C owners. Overall, AF cats were less neophobic than C cats and there was no evidence of significant differences between the populations in general affective state. These findings indicate that an electronic boundary fence with clear pre-warning cues does not impair the long term quality of life of cats.	[Kasbaoui, Naima; Cooper, Jonathan; Mills, Daniel S.; Burman, Oliver] Lincoln Univ, Sch Life Sci, Anim Behav Cognit & Welf Res Grp, Lincoln LN6 7DL, Lincs, England	University of Lincoln	Kasbaoui, N (corresponding author), Lincoln Univ, Sch Life Sci, Anim Behav Cognit & Welf Res Grp, Lincoln LN6 7DL, Lincs, England.	nkasbaoui@lincoln.ac.uk		Cooper, Jonathan/0000-0002-9014-4395	University of Lincoln	University of Lincoln	This work was funded partly from a charitable donation provided to the University of Lincoln by Feline Friends (Derbyshire) for the purposes of research into the welfare of cats and partly by the University of Lincoln. The donor had no influence on the specific use of the donation, the design, execution or interpretation of the work undertaken, but we are grateful to them for supplying funds to address this contentious issue in cat welfare.	Ainsworth M., 1978, PATTERNS ATTACHMENT; Amat M, 2009, APPL ANIM BEHAV SCI, V121, P134, DOI 10.1016/j.applanim.2009.09.012; Appukuttan D, 2014, J ORAL SCI, V56, P151, DOI 10.2334/josnusd.56.151; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; Berny P, 2010, VET J, V183, P255, DOI 10.1016/j.tvjl.2009.03.034; Briefer EF, 2013, APPL ANIM BEHAV SCI, V146, P45, DOI 10.1016/j.applanim.2013.03.007; Brydges NM, 2011, ANIM BEHAV, V81, P169, DOI 10.1016/j.anbehav.2010.09.030; Buffington CAT, 2006, JAVMA-J AM VET MED A, V228, P722, DOI 10.2460/javma.228.5.722; Burman OHP, 2008, ANIM BEHAV, V76, P801, DOI 10.1016/j.anbehav.2008.02.014; Burman OHP, 2009, PHYSIOL BEHAV, V98, P345, DOI 10.1016/j.physbeh.2009.06.012; CARLSTEAD K, 1993, ZOO BIOL, V12, P321, DOI 10.1002/zoo.1430120403; Clubb R, 2007, APPL ANIM BEHAV SCI, V102, P303, DOI 10.1016/j.applanim.2006.05.033; Companion Animal Welfare Council , 2012, US EL PULS TRAIN AID; Conrad CD, 2010, PROG NEURO-PSYCHOPH, V34, P742, DOI 10.1016/j.pnpbp.2009.11.003; de Winter JCF, 2009, MULTIVAR BEHAV RES, V44, P147, DOI 10.1080/00273170902794206; Dehasse J, 1997, APPL ANIM BEHAV SCI, V52, P365, DOI 10.1016/S0168-1591(96)01135-5; Destrez A, 2014, APPL ANIM BEHAV SCI, V154, P30, DOI 10.1016/j.applanim.2014.01.005; Destrez A, 2013, APPL ANIM BEHAV SCI, V148, P28, DOI 10.1016/j.applanim.2013.07.016; Dickman CR, 2015, APPL ANIM BEHAV SCI, V173, P76, DOI 10.1016/j.applanim.2014.09.021; Doyle RE, 2010, BEHAV PROCESS, V83, P349, DOI 10.1016/j.beproc.2010.01.019; Doyle RE, 2010, APPL ANIM BEHAV SCI, V122, P28, DOI 10.1016/j.applanim.2009.11.003; Duhautois B, 2010, B ACAD VET FRANCE, V163, P167; Ellis SLH, 2015, ANTHROZOOS, V28, P625, DOI 10.1080/08927936.2015.1070005; FIELD A., 2009, DESCOBRINDO ESTATIST, V2; Finka LR, 2015, THESIS; Fitzgerald KT, 2010, TOP COMPANION ANIM M, V25, P213, DOI 10.1053/j.tcam.2010.09.006; Freymond SB, 2014, APPL ANIM BEHAV SCI, V158, P34, DOI 10.1016/j.applanim.2014.06.006; Ghirlanda S, 2003, ANIM BEHAV, V66, P15, DOI 10.1006/anbe.2003.2174; Grigg EK, 2012, J FELINE MED SURG; Grupe DW, 2013, NAT REV NEUROSCI, V14, P488, DOI 10.1038/nrn3524; Gunaseelan S, 2013, ANTHROZOOS, V26, P199, DOI 10.2752/175303713X13636846944123; Guy NC, 2014, J VET BEHAV, V9, P78, DOI 10.1016/j.jveb.2013.11.001; Harding EJ, 2004, NATURE, V427, P312, DOI 10.1038/427312a; Hillmann E, 2003, APPL ANIM BEHAV SCI, V81, P99, DOI 10.1016/S0168-1591(02)00254-X; Horwitz DF, 1997, APPL ANIM BEHAV SCI, V52, P129, DOI 10.1016/S0168-1591(96)01073-8; Huynh TN, 2011, BEHAV BRAIN RES, V222, P212, DOI 10.1016/j.bbr.2011.03.038; Jouven M, 2012, RANGELAND J, V34, P111, DOI 10.1071/RJ11044; KAISER HF, 1970, PSYCHOMETRIKA, V35, P401, DOI 10.1007/BF02291817; Karagiannis CI, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0373-1; Kendall K, 2008, J VET BEHAV, V3, P244, DOI 10.1016/j.jveb.2008.03.001; Kitts-Morgan SE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120513; Lansade L, 2012, BEHAV PROCESS, V91, P94, DOI 10.1016/j.beproc.2012.06.003; Lansade L, 2008, APPL ANIM BEHAV SCI, V115, P182, DOI 10.1016/j.applanim.2008.06.011; Lee C, 2009, APPL ANIM BEHAV SCI, V119, P15, DOI 10.1016/j.applanim.2009.03.010; Lepczyk CA, 2015, APPL ANIM BEHAV SCI, V173, P29, DOI 10.1016/j.applanim.2015.07.002; Levine E, 2005, APPL ANIM BEHAV SCI, V90, P325, DOI 10.1016/j.applanim.2004.07.006; MCCUNE S, 1995, APPL ANIM BEHAV SCI, V45, P109, DOI 10.1016/0168-1591(95)00603-P; Mendl M, 2010, CURR BIOL, V20, pR839, DOI 10.1016/j.cub.2010.08.030; Mendl M, 2009, APPL ANIM BEHAV SCI, V118, P161, DOI 10.1016/j.applanim.2009.02.023; Mertens C., 1991, Anthrozoos, V4, P214, DOI 10.2752/089279391787057062; Mertens C., 1989, Anthrozoos, V2, P83, DOI 10.2752/089279389787058109; Meyer I, 2014, J VET BEHAV, V9, P143, DOI 10.1016/j.jveb.2014.03.002; Mills DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018448; Moretti L, 2015, ANIM BEHAV, V107, P159, DOI 10.1016/j.anbehav.2015.06.008; Neilson J, 2004, J FELINE MED SURG, V6, P5, DOI 10.1016/j.jfms.2003.09.008; Nicastro N, 2003, J COMP PSYCHOL, V117, P44, DOI 10.1037/0735-7036.117.1.44; Paul ES, 2005, NEUROSCI BIOBEHAV R, V29, P469, DOI 10.1016/j.neubiorev.2005.01.002; PODBERSCEK AL, 1991, APPL ANIM BEHAV SCI, V31, P119, DOI 10.1016/0168-1591(91)90159-U; Potter A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135109; RESCORLA RA, 1979, J EXP PSYCHOL ANIM B, V5, P152, DOI 10.1037/0097-7403.5.2.152; Rochlitz I, 2003, VET REC, V153, P549, DOI 10.1136/vr.153.18.549; Schwabe L, 2008, NEUROBIOL LEARN MEM, V90, P495, DOI 10.1016/j.nlm.2008.07.015; Schwartz S, 2002, J AM VET MED ASSOC, V220, P1028, DOI 10.2460/javma.2002.220.1028; Seksel K, 1998, AUST VET J, V76, P317, DOI 10.1111/j.1751-0813.1998.tb12353.x; Shrestha B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018046; Stanton LA, 2015, APPL ANIM BEHAV SCI, V173, P3, DOI 10.1016/j.applanim.2015.04.001; Stella JL, 2011, JAVMA-J AM VET MED A, V238, P67, DOI 10.2460/javma.238.1.67; Sung W, 2006, AM J VET RES, V67, P1500, DOI 10.2460/ajvr.67.9.1500; Tami G, 2011, ANIM WELFARE, V20, P185; Thomas RL, 2014, URBAN ECOSYST, V17, P911, DOI 10.1007/s11252-014-0360-5; Tibbs TM, 1995, INFLUENCE ELECT DIVE; Tiedemann AR, 1999, USDA FOR SERV PNW RE, pU1; Toukhsati SR, 2012, ANTHROZOOS, V25, P61, DOI 10.2752/175303712X13240472427195; Umstatter C, 2015, RANGELAND ECOL MANAG, V68, P100, DOI 10.1016/j.rama.2014.12.004; Umstatter C, 2011, COMPUT ELECTRON AGR, V75, P10, DOI 10.1016/j.compag.2010.10.005; van den Bos R, 1998, APPL ANIM BEHAV SCI, V59, P323, DOI 10.1016/S0168-1591(98)00147-6; WIEPKEMA PR, 1993, ANIM WELFARE, V2, P195	77	9	9	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162073	10.1371/journal.pone.0162073	http://dx.doi.org/10.1371/journal.pone.0162073			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27602572	Green Accepted, Green Submitted, gold, Green Published			2022-12-26	WOS:000383255200038
J	Kim, J; Choi, GH; Ko, KH; Kim, JO; Oh, SH; Park, YS; Kim, OJ; Kim, NK				Kim, Jinkwon; Choi, Gun Ho; Ko, Ki Han; Kim, Jung Oh; Oh, Seung Hun; Park, Young Seok; Kim, Ok Joon; Kim, Nam Keun			Association of the Single Nucleotide Polymorphisms in microRNAs 130b, 200b, and 495 with Ischemic Stroke Susceptibility and Post-Stroke Mortality	PLOS ONE			English	Article							HUMAN PLATELET MICRORNA; CARDIOVASCULAR-DISEASE; EXPRESSION; MEGAKARYOCYTOPOIESIS; INFLAMMATION; BIOGENESIS; ACTIVATION; MIR-196A2; NETWORKS; MIR-146A	The microRNA (miRNA) is a small non-coding RNA molecule that modulates gene expression at the posttranscriptional level. Platelets have a crucial role in both hemostasis and thrombosis, a condition that can occlude a cerebral artery and cause ischemic stroke. miR-130b, miR-200b, and miR-495 are potential genetic modulators involving platelet production and activation. We hypothesized that single nucleotide polymorphisms (SNPs) in these miRNAs might potentially contribute to the susceptibility to ischemic stroke and post-stroke mortality. This study included 523 ischemic stroke patients and 400 control subjects. We investigated the association of three miRNA SNPs (miR-130bT>C, miR-200bT>C, and miR-495A>C) with ischemic stroke prevalence and post-stroke mortality. In the multivariate logistic regression, there was no statistically significant difference in the distribution of miR-130bT>C, miR-200bT>C, or miR-495A>C between the ischemic stroke and control groups. In the subgroup analysis based on ischemic stroke subtype, the miR-200b CC genotype was less frequently found in the large-artery atherosclerosis stroke subtype compared with controls (TT+CT vs CC; adjusted odds ratio for CC, 0.506; 95% confidence interval, 0.265-0.965). During a mean follow-up period of 4.80 +/- 2.11 years after stroke onset, there were 106 all-cause deaths among the 523 stroke patients. Multivariate Cox regression analysis did not find a significant association between post-stroke mortality and three miRNA SNPs. Our findings suggest that the functional SNP of miR-200b might be responsible for the susceptibility to large-artery atherosclerotic stroke.	[Kim, Jinkwon; Oh, Seung Hun; Kim, Ok Joon] CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam 13496, South Korea; [Choi, Gun Ho; Ko, Ki Han; Kim, Jung Oh; Kim, Nam Keun] CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam 13496, South Korea; [Park, Young Seok] Chungbuk Natl Univ, Chungbuk Natl Univ Hosp, Dept Neurosurg, Cheongju 28644, South Korea; [Kim, Nam Keun] CHA Univ, Coll Life Sci, Dept Biomed Sci, 335 Pangyo Ro, Songnam 13488, South Korea	Pochon Cha University; Pochon Cha University; Chungbuk National University; Chungbuk National University Hospital; Pochon Cha University	Kim, OJ (corresponding author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Dept Neurol, Songnam 13496, South Korea.; Kim, NK (corresponding author), CHA Univ, Sch Med, CHA Bundang Med Ctr, Inst Clin Res, Songnam 13496, South Korea.; Kim, NK (corresponding author), CHA Univ, Coll Life Sci, Dept Biomed Sci, 335 Pangyo Ro, Songnam 13488, South Korea.	okjun77@cha.ac.kr; nkkim@cha.ac.kr	Kim, Jinkwon/N-1878-2018; Kim, Jinkwon/AAR-6729-2021	Kim, Jinkwon/0000-0003-0156-9736; Kim, Jinkwon/0000-0003-0156-9736; Kim, Jung Oh/0000-0002-4171-2034	grant of the Korea Healthcare technology RD Project [HI15C1972010015, HI16C1559]; Ministry for Health, Welfare & Family Affairs, Republic of Korea; Basic Science Research Program through National Research Foundation of Korea Grants - Korean Government, Republic of Korea [2014R1A1A1002067, 2015R1D1A1A09057432]	grant of the Korea Healthcare technology RD Project; Ministry for Health, Welfare & Family Affairs, Republic of Korea(Ministry of Health & Welfare (MOHW), Republic of Korea); Basic Science Research Program through National Research Foundation of Korea Grants - Korean Government, Republic of Korea	This study was partly supported by a grant of the Korea Healthcare technology R&D Project (HI15C1972010015 and HI16C1559), Ministry for Health, Welfare & Family Affairs, Republic of Korea and by Basic Science Research Program through National Research Foundation of Korea Grants funded by the Korean Government (2014R1A1A1002067, 2015R1D1A1A09057432), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADAMS HP, 1993, STROKE, V24, P35, DOI 10.1161/01.STR.24.1.35; Akbiyik F, 2004, BLOOD, V104, P1361, DOI 10.1182/blood-2004-03-0926; Bray PF, 2007, HEMATOL ONCOL CLIN N, V21, P633, DOI 10.1016/j.hoc.2007.06.002; Chu SG, 2010, J THROMB HAEMOST, V8, P148, DOI 10.1111/j.1538-7836.2009.03584.x; Colangelo T, 2013, NEOPLASIA, V15, P1204, DOI 10.1593/neo.13998; Cui L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089019; Dangwal S, 2012, THROMB HAEMOSTASIS, V108, P599, DOI 10.1160/TH12-03-0211; Duan XM, 2014, J DIABETES COMPLICAT, V28, P705, DOI 10.1016/j.jdiacomp.2014.04.012; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Fuentes E, 2015, LIFE SCI, V133, P29, DOI 10.1016/j.lfs.2015.04.016; Garzon R, 2006, P NATL ACAD SCI USA, V103, P5078, DOI 10.1073/pnas.0600587103; Gatsiou A, 2012, CURR VASC PHARMACOL, V10, P524, DOI 10.2174/157016112801784611; Harker LA, 1998, SEMIN HEMATOL, V35, P241; Hong KS, 2013, J STROKE, V15, P2, DOI 10.5853/jos.2013.15.1.2; Huan TX, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7601; Huang SL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117007; Huntzinger E, 2011, NAT REV GENET, V12, P99, DOI 10.1038/nrg2936; IWAMOTO T, 1995, STROKE, V26, P52, DOI 10.1161/01.STR.26.1.52; Jeon YJ, 2013, ARTERIOSCL THROM VAS, V33, P420, DOI 10.1161/ATVBAHA.112.300251; Kaplan ZS, 2011, HEMATOL-AM SOC HEMAT, P51, DOI 10.1182/asheducation-2011.1.51; Kondkar AA, 2010, J THROMB HAEMOST, V8, P369, DOI 10.1111/j.1538-7836.2009.03700.x; Laffont B, 2013, BLOOD, V122, P253, DOI 10.1182/blood-2013-03-492801; Landry P, 2009, NAT STRUCT MOL BIOL, V16, P961, DOI 10.1038/nsmb.1651; Li HY, 2011, BRIT J HAEMATOL, V155, P298, DOI 10.1111/j.1365-2141.2011.08859.x; McManus DD, 2015, NAT REV CARDIOL, V12, P711, DOI 10.1038/nrcardio.2015.101; Nagalla S, 2011, BLOOD, V117, P5189, DOI 10.1182/blood-2010-09-299719; Obsteter J, 2015, MOL GENET GENOM MED, V3, P30, DOI 10.1002/mgg3.110; Opalinska JB, 2010, BLOOD, V116, pE128, DOI 10.1182/blood-2010-06-292920; Osman A, 2011, PLATELETS, V22, P433, DOI 10.3109/09537104.2011.560305; Rieger JK, 2015, DRUG METAB DISPOS, V43, P884, DOI 10.1124/dmd.114.062844; Ryan BM, 2010, NAT REV CANCER, V10, P389, DOI 10.1038/nrc2867; Salomonis N, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000553; Sevinsky JR, 2004, MOL CELL BIOL, V24, P4534, DOI 10.1128/MCB.24.10.4534-4545.2004; Simon LM, 2014, BLOOD, V123, pE37, DOI 10.1182/blood-2013-12-544692; Skol AD, 2006, NAT GENET, V38, P209, DOI 10.1038/ng1706; Slaby O, 2012, J CELL MOL MED, V16, P8, DOI 10.1111/j.1582-4934.2011.01359.x; Stakos DA, 2013, PLATELETS, V24, P579, DOI 10.3109/09537104.2012.724483; Suresh S, 2011, J CELL COMMUN SIGNAL, V5, P183, DOI 10.1007/s12079-011-0139-x; Undi Ram Babu, 2013, Adv Hematol, V2013, P695754, DOI 10.1155/2013/695754; van Rooij E, 2012, NAT REV DRUG DISCOV, V11, P860, DOI 10.1038/nrd3864; Weng Z, 2010, BLOOD, V116, P2579, DOI 10.1182/blood-2010-03-277236; Yu TT, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1031-5; Zhang ZZ, 2017, MOL NEUROBIOL, V54, P2776, DOI 10.1007/s12035-016-9865-7; Zhu RX, 2014, NEUROCHEM RES, V39, P1709, DOI 10.1007/s11064-014-1364-5	44	18	19	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162519	10.1371/journal.pone.0162519	http://dx.doi.org/10.1371/journal.pone.0162519			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603512	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200073
J	Mandel, JR; Ramsey, AJ; Iorizzo, M; Simon, PW				Mandel, Jennifer R.; Ramsey, Adam J.; Iorizzo, Massimo; Simon, Philipp W.			Patterns of Gene Flow between Crop and Wild Carrot, Daucus carota (Apiaceae) in the United States	PLOS ONE			English	Article							MITOCHONDRIAL-DNA; NATURAL-POPULATIONS; CULTIVATED CARROTS; INHERITANCE; DIVERSITY; CHLOROPLAST; EVOLUTION; TRANSGENE; RECOMBINATION; INTROGRESSION	Studies of gene flow between crops and their wild relatives have implications for both management practices for cultivation and understanding the risk of transgene escape. These types of studies may also yield insight into population dynamics and the evolutionary consequences of gene flow for wild relatives of crop species. Moreover, the comparison of genetic markers with different modes of inheritance, or transmission, such as those of the nuclear and chloroplast genomes, can inform the relative risk of transgene escape via pollen versus seed. Here we investigate patterns of gene flow between crop and wild carrot, Daucus carota (Apiaceae) in two regions of the United States. We employed 15 nuclear simple sequence repeat (SSR) markers and one polymorphic chloroplast marker. Further, we utilized both conventional population genetic metrics along with Shannon diversity indices as the latter have been proposed to be more sensitive to allele frequency changes and differentiation. We found that populations in both regions that were proximal to crop fields showed lower levels of differentiation to the crops than populations that were located farther away. We also found that Shannon measures were more sensitive to differences in both genetic diversity and differentiation in our study. Finally, we found indirect evidence of paternal transmission of chloroplast DNA and accompanying lower than expected levels of chloroplast genetic structure amongst populations as might be expected if chloroplast DNA genes flow through both seed and pollen. Our findings of substantial gene flow for both nuclear and chloroplast markers demonstrate the efficiency of both pollen and seed to transfer genetic information amongst populations of carrot.	[Mandel, Jennifer R.; Ramsey, Adam J.] Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA; [Mandel, Jennifer R.] Univ Memphis, W Harry Feinstone Ctr Genom Res, Memphis, TN 38152 USA; [Iorizzo, Massimo] North Carolina State Univ, Plants Human Hlth Inst, Dept Hort Sci, Kannapolis, NC USA; [Simon, Philipp W.] Univ Wisconsin Madison, Vegetable Crops Unit, USDA ARS, Madison, WI USA	University of Memphis; University of Memphis; University of North Carolina; North Carolina State University; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison	Mandel, JR (corresponding author), Univ Memphis, Dept Biol Sci, Memphis, TN 38152 USA.; Mandel, JR (corresponding author), Univ Memphis, W Harry Feinstone Ctr Genom Res, Memphis, TN 38152 USA.	jmandel@memphis.edu	Iorizzo, Massimo/AAJ-3952-2020; Ramsey, Adam/AAB-2376-2021	Iorizzo, Massimo/0000-0002-0032-8247; Simon, Philipp/0000-0001-6978-6062; Mandel, Jennifer/0000-0003-3539-2991	United States Department of Agriculture-National Institute of Food and Agriculture Award [2014-33522-21826]; Nantucket Biodiversity Initiative Grant; W. Harry Feinstone Center for Genomic Research equipment support; ARS [ARS-0425034] Funding Source: Federal RePORTER	United States Department of Agriculture-National Institute of Food and Agriculture Award; Nantucket Biodiversity Initiative Grant; W. Harry Feinstone Center for Genomic Research equipment support; ARS(United States Department of Agriculture (USDA)USDA Agricultural Research Service)	This work was supported by the United States Department of Agriculture-National Institute of Food and Agriculture Award 2014-33522-21826 to JRM; Nantucket Biodiversity Initiative Grant to AJR; and the W. Harry Feinstone Center for Genomic Research equipment support to JRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson M. S., 2010, GENE FLOW CROPS THEI; [Anonymous], 2016, GENETICALLY ENG CROP, DOI [10.17226/23395, DOI 10.17226/23395]; Baranski R., 2008, TRANSGENIC PLANT J, V2, P18; Barr CM, 2005, NEW PHYTOL, V168, P39, DOI 10.1111/j.1469-8137.2005.01492.x; Bartsch D, 1999, MOL ECOL, V8, P1733, DOI 10.1046/j.1365-294x.1999.00769.x; Bartsch D, 2004, INTROGRESSION GENETI; BOBLENZ K, 1990, MOL GEN GENET, V220, P489, DOI 10.1007/BF00391760; Breton S, 2015, GENOME, V58, P423, DOI 10.1139/gen-2015-0090; Burt A, 2006, GENES CONFLICT BIOL; Campbell LG, 2016, APPL PLANT SCI, V4, DOI 10.3732/apps.1500114; Cavagnaro PF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-386; Chapman MA, 2006, NEW PHYTOL, V170, P429, DOI 10.1111/j.1469-8137.2006.01710.x; Davidar P, 2015, AM J BOT, V102, P129, DOI 10.3732/ajb.1400404; Dechaine JM, 2009, NEW PHYTOL, V184, P828, DOI 10.1111/j.1469-8137.2009.02964.x; DEWET JMJ, 1975, ECON BOT, V29, P99, DOI 10.1007/BF02863309; Earl DA, 2011, CONSERV GENET RESOUR, V4, P359, DOI DOI 10.1007/S12686-011-9548-7; Ellis JR, 2008, HEREDITY, V100, P574, DOI 10.1038/hdy.2008.11; Ellstrand NC, 1999, ANNU REV ECOL SYST, V30, P539, DOI 10.1146/annurev.ecolsys.30.1.539; Ellstrand NC, 2013, ANNU REV ECOL EVOL S, V44, P325, DOI 10.1146/annurev-ecolsys-110512-135840; Ellstrand NC, 2010, EVOL APPL, V3, P494, DOI 10.1111/j.1752-4571.2010.00140.x; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Gressel J, 2015, PEST MANAG SCI, V71, P658, DOI 10.1002/ps.3850; Hamilton MB, 1999, MOL ECOL, V8, P521; HARRIS SA, 1991, TAXON, V40, P393, DOI 10.2307/1223218; Hauser TP, 2002, CONSERV GENET, V3, P75; Hauser TP, 2001, GENET RESOUR CROP EV, V48, P499, DOI 10.1023/A:1012051731933; HEYWOOD VH, 1983, ISRAEL J BOT, V32, P51; Iorizzo M, 2016, NAT GENET, V48, P657, DOI 10.1038/ng.3565; Iorizzo M, 2013, AM J BOT, V100, P930, DOI 10.3732/ajb.1300055; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; Kwit C, 2011, TRENDS BIOTECHNOL, V29, P284, DOI 10.1016/j.tibtech.2011.02.003; LACEY EP, 1982, OIKOS, V39, P83, DOI 10.2307/3544535; Mandel JR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136303; Mandel JR, 2013, CONSERV GENET, V14, P31, DOI 10.1007/s10592-012-0421-3; Mandel JR, 2012, J HERED, V103, P418, DOI 10.1093/jhered/esr142; McCauley DE, 2013, NEW PHYTOL, V200, P966, DOI 10.1111/nph.12431; Milne RI, 2000, MOL ECOL, V9, P541, DOI 10.1046/j.1365-294x.2000.00906.x; Mogensen HL, 1996, AM J BOT, V83, P383, DOI 10.2307/2446172; Nassar Nagib M. A., 2002, Genetics and Molecular Research, V1, P298; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2012, BIOINFORMATICS, V28, P2537, DOI 10.1093/bioinformatics/bts460; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pritchard JK, 2000, GENETICS, V155, P945; REBOUD X, 1994, HEREDITY, V72, P132, DOI 10.1038/hdy.1994.19; Rohr Heike, 1999, Progress in Botany, V60, P39; Rokas A, 2003, TRENDS ECOL EVOL, V18, P411, DOI 10.1016/S0169-5347(03)00125-3; RONFORT J, 1995, THEOR APPL GENET, V91, P150, DOI 10.1007/BF00220872; Rong J, 2010, ANN BOT-LONDON, V106, P285, DOI 10.1093/aob/mcq108; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Schierenbeck KA, 2009, BIOL INVASIONS, V11, P1093, DOI 10.1007/s10530-008-9388-x; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; SHANNON CE, 1948, BELL SYST TECH J, V27, P623, DOI 10.1002/j.1538-7305.1948.tb00917.x; Sherwin WB, 2006, MOL ECOL, V15, P2857, DOI 10.1111/j.1365-294X.2006.02992.x; Sherwin WB, 2015, MOL ECOL RESOUR, V15, P1259, DOI 10.1111/1755-0998.12458; Simon Philipp W., 2008, P327, DOI 10.1007/978-0-387-74110-9_8; Smouse PE, 2015, MOL ECOL RESOUR, V15, P1375, DOI 10.1111/1755-0998.12422; Snow AA, 2010, NEW PHYTOL, V186, P537, DOI 10.1111/j.1469-8137.2009.03172.x; Snow AA, 2003, ECOL APPL, V13, P279, DOI 10.1890/1051-0761(2003)013[0279:ABTRHA]2.0.CO;2; STEINBORN R, 1995, THEOR APPL GENET, V91, P632, DOI 10.1007/BF00223290; Stewart CN, 2003, NAT REV GENET, V4, P806, DOI 10.1038/nrg1179; Szklarczyk M, 2014, THEOR APPL GENET, V127, P1689, DOI 10.1007/s00122-014-2331-x; UMEHARA M, 2005, PLANT BIOTECHOL, V22, P497, DOI DOI 10.5511/PLANTBI0TECHN0L0GY.22.497; Vivek BS, 1999, THEOR APPL GENET, V98, P669, DOI 10.1007/s001220051119; WADE MJ, 1988, EVOLUTION, V42, P995, DOI 10.1111/j.1558-5646.1988.tb02518.x; Wang W, 2014, NEW PHYTOL, V202, P679, DOI 10.1111/nph.12428; Warwick SI, 2005, CROP FERALITY AND VOLUNTEERISM, P9; WHITLOCK MC, 1990, EVOLUTION, V44, P1717, DOI [10.2307/2409501, 10.1111/j.1558-5646.1990.tb05243.x]; Wiel C. van de, 2003, EUCARPIA leafy vegetables 2003. Proceedings of the EUCARPIA Meeting on Leafy Vegetables Genetics and Breeding, Noordwijkerhout, Netherlands, 19-21 March 2003, P111; WIJNHEIJMER EHM, 1989, EUPHYTICA, V40, P147, DOI 10.1007/BF00023309; Wilson GA, 2003, GENETICS, V163, P1177; WRIGHT S, 1951, ANN EUGENIC, V15, P323; Xu JP, 2005, GENOME, V48, P951, DOI [10.1139/g05-082, 10.1139/G05-082]; [No title captured]	74	14	16	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161971	10.1371/journal.pone.0161971	http://dx.doi.org/10.1371/journal.pone.0161971			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603516	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200033
J	Spector, J; Kodippili, GC; Ritchie, K; Low, PS				Spector, Jeff; Kodippili, Gayani C.; Ritchie, Ken; Low, Philip S.			Single Molecule Studies of the Diffusion of Band 3 in Sickle Cell Erythrocytes	PLOS ONE			English	Article							HEINZ BODIES; MEMBRANE SKELETON; HEMOGLOBIN; DEFORMABILITY; GLYCOPHORIN; SENESCENT; TRACKING; ANKYRIN; BINDING; DISEASE	Sickle cell disease (SCD) is caused by an inherited mutation in hemoglobin that leads to sickle hemoglobin (HbS) polymerization and premature HbS denaturation. Previous publications have shown that HbS denaturation is followed by binding of denatured HbS (a.k.a. hemichromes) to band 3, the consequent clustering of band 3 in the plane of the erythrocyte membrane that in turn promotes binding of autologous antibodies to the clustered band 3, and removal of the antibody-coated erythrocytes from circulation. Although each step of the above process has been individually demonstrated, the fraction of band 3 that is altered by association with denatured HbS has never been determined. For this purpose, we evaluated the lateral diffusion of band 3 in normal cells, reversibly sickled cells (RSC), irreversibly sickled cells (ISC), and hemoglobin SC erythrocytes (HbSC) in order to estimate the fraction of band 3 that was diffusing more slowly due to hemichrome-induced clustering. We labeled fewer than ten band 3 molecules per intact erythrocyte with a quantum dot to avoid perturbing membrane structure and we then monitored band 3 lateral diffusion by single particle tracking. We report here that the size of the slowly diffusing population of band 3 increases in the sequence: normal cells<HbSC<RSC<ISC. We also demonstrate that the size of the compartment in which band 3 is free to diffuse decreases roughly in the same order, with band 3 diffusing in two compartments of sizes 35 and 71 nm in normal cells, but only a single compartment in HbSC cells (58 nm), RSC (45 nm) and ISC (36 nm). These data suggest that the mobility of band 3 is increasingly constrained during SCD progression, suggesting a global impact of the mutated hemoglobin on erythrocyte membrane properties.	[Spector, Jeff; Ritchie, Ken] Purdue Univ, Dept Phys, W Lafayette, IN 47907 USA; [Kodippili, Gayani C.; Low, Philip S.] Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Low, PS (corresponding author), Purdue Univ, Dept Chem, W Lafayette, IN 47907 USA.	plow@purdue.edu		Low, Philip/0000-0001-9042-5528	National Institutes of Health [GM24417-36]; National Science Foundation [0646633]	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF))	PSL acknowledges funding from the National Institutes of Health (GM24417-36) and use of shared Purdue Cancer Center facilities supported by P30 CA023168. KR acknowledges funding from the National Science Foundation (Grant #0646633). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; CORBETT JD, 1993, J CLIN INVEST, V91, P208, DOI 10.1172/JCI116172; GELLES J, 1988, NATURE, V331, P450, DOI 10.1038/331450a0; HAVELL TC, 1978, AM J HEMATOL, V4, P9, DOI 10.1002/ajh.2830040103; Huang Z, 2003, BIOPHYS J, V85, P2374, DOI 10.1016/S0006-3495(03)74661-X; INGRAM VM, 1957, NATURE, V180, P326, DOI 10.1038/180326a0; KAY MMB, 1983, P NATL ACAD SCI-BIOL, V80, P1631, DOI 10.1073/pnas.80.6.1631; Kodippili GC, 2012, J BIOL CHEM, V287, P4129, DOI 10.1074/jbc.M111.294439; Kodippili GC, 2009, BLOOD, V113, P6237, DOI 10.1182/blood-2009-02-205450; Lee JCM, 2001, BIOPHYS J, V81, P3178, DOI 10.1016/S0006-3495(01)75954-1; Liu SC, 1996, J CLIN INVEST, V97, P29, DOI 10.1172/JCI118402; LOW PS, 1985, SCIENCE, V227, P531, DOI 10.1126/science.2578228; LUTZ HU, 1987, P NATL ACAD SCI USA, V84, P7368, DOI 10.1073/pnas.84.21.7368; Rees DC, 2010, LANCET, V376, P2018, DOI 10.1016/S0140-6736(10)61029-X; Ritchie K, 2005, BIOPHYS J, V88, P2266, DOI 10.1529/biophysj.104.054106; SCHLUTER K, 1986, P NATL ACAD SCI USA, V83, P6137, DOI 10.1073/pnas.83.16.6137; Stuart MJ, 2004, LANCET, V364, P1343, DOI 10.1016/S0140-6736(04)17192-4; Tomishige M, 1998, J CELL BIOL, V142, P989, DOI 10.1083/jcb.142.4.989; Tomishige M, 1999, MOL BIOL CELL, V10, P2475, DOI 10.1091/mbc.10.8.2475; WALDER JA, 1984, J BIOL CHEM, V259, P238; WAUGH SM, 1985, BIOCHEMISTRY-US, V24, P34, DOI 10.1021/bi00322a006; WAUGH SM, 1986, J CLIN INVEST, V78, P1155, DOI 10.1172/JCI112696	22	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162514	10.1371/journal.pone.0162514	http://dx.doi.org/10.1371/journal.pone.0162514			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598991	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800074
J	Yamashita, Y; Wang, LQ; Nanba, F; Ito, C; Toda, T; Ashida, H				Yamashita, Yoko; Wang, Liuqing; Nanba, Fumio; Ito, Chiaki; Toda, Toshiya; Ashida, Hitoshi			Procyanidin Promotes Translocation of Glucose Transporter 4 in Muscle of Mice through Activation of Insulin and AMPK Signaling Pathways	PLOS ONE			English	Article							MODEL DB/DB MICE; GLUCOSE-UPTAKE; ALPHA-GLUCOSIDASE; SKELETAL-MUSCLE; GLUT4 TRANSLOCATION; DIETARY POLYPHENOLS; PLASMA-MEMBRANE; PROTEIN-KINASE; BLOOD-GLUCOSE; IN-VITRO	Procyanidins are the oligomeric or polymeric forms of epicatechin and catechin. In this study, we isolated and purified dimer to tetramer procyanidins from black soybean seed coat and investigated the anti-hyperglycemic effects by focusing on glucose transporter 4 (GLUT4) translocation and the underlying molecular mechanism in skeletal muscle of mice. The anti-hyperglycemic effects of procyanidins were also compared with those of monomer (-)-epicatechin (EC) and major anthocyanin, cyanidin-3-O-beta-glucoside (C3G). To investigate GLUT4 translocation and its related signaling pathways, ICR mice were orally given procyanidins, EC and C3G in water at 10 mu g/kg body weight. The mice were sacrificed 60 min after the dose of polyphenols, and soleus muscle was extracted from the hind legs. The results showed that trimeric and tetrameric procyanidins activated both insulin-and AMPK-signaling pathways to induce GLUT4 translocation in muscle of ICR mice. We confirmed that procyanidins suppressed acute hyperglycemia with an oral glucose tolerance test in a dose-dependent manner. Of these beneficial effects, cinnamtannin A2, one of the tetramers, was the most effective. In conclusion, procyanidins, especially cinnamtannin A2, significantly ameliorate postprandial hyperglycemia at least in part by promoting GLUT4 translocation to the plasma membrane by activating both insulin-and AMPK-signaling pathways.	[Yamashita, Yoko; Wang, Liuqing; Ashida, Hitoshi] Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan; [Nanba, Fumio; Ito, Chiaki; Toda, Toshiya] Fujicco Co Ltd, Res Dev, Kobe, Hyogo 6508558, Japan	Kobe University	Ashida, H (corresponding author), Kobe Univ, Grad Sch Agr Sci, Dept Agrobiosci, Kobe, Hyogo 6578501, Japan.	ashida@kobe-u.ac.jp			Cross-ministerial Strategic Innovation Promotion Program by Cabinet Office, Government of Japan; JSPS KAKENHI [26850082]; Fujicco Co. Ltd.	Cross-ministerial Strategic Innovation Promotion Program by Cabinet Office, Government of Japan; JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Fujicco Co. Ltd.	This work was supported by Cross-ministerial Strategic Innovation Promotion Program by Cabinet Office, Government of Japan, and JSPS KAKENHI Grant-in-Aid for Young Scientists (B) Grant Number 26850082 (YY). Fujicco Co. Ltd. partly funded the investigations described in the present manuscript. Fujicco Co. Ltd. provided support in the form of salaries for authors [FN, CI, TT], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abe Y, 2008, TETRAHEDRON LETT, V49, P6413, DOI 10.1016/j.tetlet.2008.08.087; Adisakwattana S, 2010, INT J FOOD SCI NUTR, V61, P295, DOI 10.3109/09637480903455963; Beecher GR, 2004, PHARM BIOL, V42, P2, DOI 10.3109/13880200490893474; Benalla W, 2010, CURR DIABETES REV, V6, P247, DOI 10.2174/157339910791658826; Brasnyo P, 2011, BRIT J NUTR, V106, P383, DOI 10.1017/S0007114511000316; Breen DM, 2008, BIOCHEM BIOPH RES CO, V374, P117, DOI 10.1016/j.bbrc.2008.06.104; Carling D, 2012, BIOCHEM J, V445, P11, DOI 10.1042/BJ20120546; Claussnitzer M, 2011, MOL NUTR FOOD RES, V55, pS26, DOI 10.1002/mnfr.201000372; Czech MP, 1999, J BIOL CHEM, V274, P1865, DOI 10.1074/jbc.274.4.1865; Dao TMA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020700; DEFRONZO RA, 1992, DIABETES CARE, V15, P318, DOI 10.2337/diacare.15.3.318; DEFRONZO RA, 1988, DIABETES, V37, P667, DOI 10.2337/diab.37.6.667; Garber AJ, 2012, HEART FAIL CLIN, V8, P563, DOI 10.1016/j.hfc.2012.06.004; Gonzalez-Abuin N, 2015, CURR MED CHEM, V22, P39; Gonzalez-Abuin N, 2012, J AGR FOOD CHEM, V60, P9055, DOI 10.1021/jf3010349; Habtemariam S, 2014, CURR PHARM BIOTECHNO, V15, P391, DOI 10.2174/1389201015666140617104643; Hanhineva K, 2010, INT J MOL SCI, V11, P1365, DOI 10.3390/ijms11041365; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Hardie DG, 2011, P NUTR SOC, V70, P92, DOI 10.1017/S0029665110003915; Huang SH, 2007, CELL METAB, V5, P237, DOI 10.1016/j.cmet.2007.03.006; Ishikawa A, 2007, J NUTR SCI VITAMINOL, V53, P166, DOI 10.3177/jnsv.53.166; Kanamoto Y, 2011, J AGR FOOD CHEM, V59, P8985, DOI 10.1021/jf201471p; Kang C, 2010, FOOD CHEM TOXICOL, V48, P2366, DOI 10.1016/j.fct.2010.05.073; Kawabata K, 2011, MOL NUTR FOOD RES, V55, P467, DOI 10.1002/mnfr.201000267; Kim JS, 2000, BIOSCI BIOTECH BIOCH, V64, P2458, DOI 10.1271/bbb.64.2458; Koh LW, 2010, J AGR FOOD CHEM, V58, P148, DOI 10.1021/jf903011g; Leto D, 2012, NAT REV MOL CELL BIO, V13, P383, DOI 10.1038/nrm3351; Lin CL, 2008, MOL NUTR FOOD RES, V52, P930, DOI 10.1002/mnfr.200700437; Minakawa M, 2012, BIOCHEM BIOPH RES CO, V422, P469, DOI 10.1016/j.bbrc.2012.05.017; Minakawa M, 2011, J CLIN BIOCHEM NUTR, V48, P237, DOI 10.3164/jcbn.10-119; Mohankumar SK, 2013, J NUTR BIOCHEM, V24, P445, DOI 10.1016/j.jnutbio.2012.01.006; Nilsson Peter M, 2012, Lakartidningen, V109, P1549; Nishiumi S, 2007, BIOSCI BIOTECH BIOCH, V71, P2343, DOI 10.1271/bbb.70342; Nishiumi S, 2010, J AGR FOOD CHEM, V58, P12916, DOI 10.1021/jf102840w; O'Neill HM, 2013, MOL CELL ENDOCRINOL, V366, P135, DOI 10.1016/j.mce.2012.06.019; Okamoto M, 2008, DIABETOLOGIA, V51, P827, DOI 10.1007/s00125-008-0944-9; Pereira DF, 2011, NUTRITION, V27, P1161, DOI 10.1016/j.nut.2011.01.008; Pinent M, 2012, CRIT REV FOOD SCI, V52, P569, DOI 10.1080/10408398.2010.501533; Schafer A, 2007, DIABETES RES CLIN PR, V77, P41, DOI 10.1016/j.diabres.2006.10.011; Serra A, 2010, BRIT J NUTR, V103, P944, DOI 10.1017/S0007114509992741; Shabrova EV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024634; Sheena A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025747; Shoji T, 2003, J AGR FOOD CHEM, V51, P3806, DOI 10.1021/jf0300184; Speakman JR, 2011, MOL ASPECTS MED, V32, P159, DOI 10.1016/j.mam.2011.07.001; Steinberg GR, 2009, PHYSIOL REV, V89, P1025, DOI 10.1152/physrev.00011.2008; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tadera K, 2006, J NUTR SCI VITAMINOL, V52, P149, DOI 10.3177/jnsv.52.149; Ueda M, 2008, BIOCHEM BIOPH RES CO, V377, P286, DOI 10.1016/j.bbrc.2008.09.128; Ueda M, 2013, BIOFACTORS, V39, P457, DOI 10.1002/biof.1085; Vu V, 2013, J MOL ENDOCRINOL, V51, P155, DOI 10.1530/JME-13-0059; Wu ZX, 2015, NAT PROD RES, V29, P988, DOI 10.1080/14786419.2014.965165; Yamamoto N, 2011, PHYTOTHER RES, V25, P1218, DOI 10.1002/ptr.3416; Yamashita Y, 2012, J NUTR SCI, V1, DOI 10.1017/jns.2012.2; Yamashita Y, 2013, BIOSCI BIOTECH BIOCH, V77, P888, DOI 10.1271/bbb.130095; Yamashita Y, 2012, ARCH BIOCHEM BIOPHYS, V527, P95, DOI 10.1016/j.abb.2012.03.018; Zhang ZF, 2010, PHYTOMEDICINE, V17, P14, DOI 10.1016/j.phymed.2009.09.007	57	40	42	6	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161704	10.1371/journal.pone.0161704	http://dx.doi.org/10.1371/journal.pone.0161704			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598258	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800016
J	Stanton, C; Clune, J				Stanton, Christopher; Clune, Jeff			Curiosity Search: Producing Generalists by Encouraging Individuals to Continually Explore and Acquire Skills throughout Their Lifetime	PLOS ONE			English	Article							MOTIVATION; DIVERSITY; ROBOTS; WILD	Natural animals are renowned for their ability to acquire a diverse and general skill set over the course of their lifetime. However, research in artificial intelligence has yet to produce agents that acquire all or even most of the available skills in non-trivial environments. One candidate algorithm for encouraging the production of such individuals is Novelty Search, which pressures organisms to exhibit different behaviors from other individuals. However, we hypothesized that Novelty Search would produce sub-populations of specialists, in which each individual possesses a subset of skills, but no one organism acquires all or most of the skills. In this paper, we propose a new algorithm called Curiosity Search, which is designed to produce individuals that acquire as many skills as possible during their lifetime. We show that in a multiple-skill maze environment, Curiosity Search does produce individuals that explore their entire domain, while a traditional implementation of Novelty Search produces specialists. However, we reveal that when modified to encourage intra-life behavioral diversity, Novelty Search can produce organisms that explore almost as much of their environment as Curiosity Search, although Curiosity Search retains a significant performance edge. Finally, we show that Curiosity Search is a useful helper objective when combined with Novelty Search, producing individuals that acquire significantly more skills than either algorithm alone.	[Stanton, Christopher; Clune, Jeff] Univ Wyoming, Dept Comp Sci, Laramie, WY 82071 USA	University of Wyoming	Stanton, C (corresponding author), Univ Wyoming, Dept Comp Sci, Laramie, WY 82071 USA.	cstanto3@uwyo.edu						Benson-Amram S, 2013, ANIM BEHAV, V85, P349, DOI 10.1016/j.anbehav.2012.11.003; Benson-Amram S, 2012, P ROY SOC B-BIOL SCI, V279, P4087, DOI 10.1098/rspb.2012.1450; Berlyne D.E., 1960, CONFLICT AROUSAL CUR, DOI [10.1037/11164-000, DOI 10.1037/11164-000]; Clune J, 2015, PREPRINT; Cully A, 2015, NATURE, V521, P503, DOI 10.1038/nature14422; Dayan P, 2002, NEURON, V36, P285, DOI 10.1016/S0896-6273(02)00963-7; Deb K, 2002, IEEE T EVOLUT COMPUT, V6, P182, DOI 10.1109/4235.996017; Delarboulas P, 2010, PPSN 11, pXI; Dewsbury R, 2012, DAILY MAIL ONLIN JUN; Griffin AS, 2014, ANIM BEHAV, V92, P221, DOI 10.1016/j.anbehav.2014.04.009; Hornby Gregory S., 2006, AUTOMATED ANTENNA DE; Hornby GS, 2005, IEEE T ROBOT, V21, P402, DOI 10.1109/TRO.2004.839222; Ngo H, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00833; Kakade S, 2000, NEUROSCIENCE, V96, P651; Kohler W., 1924, MENTALITY APES; Koza J. R., 2003, GENETIC PROGRAMMING; Krulwich R., 2013, 60 WILD COYOTES PATR; Lee S., 2013, LNCS, V7835, P540, DOI DOI 10.1007/978-3-642-37192-954; Lehman J, 2011, EVOL COMPUT, V19, P189, DOI 10.1162/EVCO_a_00025; Mnih V, 2015, NATURE, V518, P529, DOI 10.1038/nature14236; Mouret JB, 2012, EVOL COMPUT, V20, P91, DOI 10.1162/EVCO_a_00048; Mouret J.-B., 2010, WCCI 2010 IEEE WORLD, P4079; Nguyen A., 2015, P GEN EV COMP C; Pape Leo, 2012, Front Neurorobot, V6, P6, DOI 10.3389/fnbot.2012.00006; Patrick Matthew, 2010, 2010 IEEE Information Theory Workshop (ITW 2010), P249, DOI 10.1109/ITW.2010.5593348; Salge C, 2013, CORR; Schmidhuber J., 1991, P INT C SIM AD BEH A, P222; Soltoggio A, 2009, GEN EV COMP C; Spinka M, 2001, Q REV BIOL, V76, P141, DOI 10.1086/393866; Stanley KO, 2002, EVOL COMPUT, V10, P99, DOI 10.1162/106365602320169811; Toffolo A, 2003, EVOL COMPUT, V11, P151, DOI 10.1162/106365603766646816; Velez R, 2014, GECCO'14: PROCEEDINGS OF THE 2014 GENETIC AND EVOLUTIONARY COMPUTATION CONFERENCE, P737, DOI 10.1145/2576768.2598225; Weng JY, 2001, SCIENCE, V291, P599, DOI 10.1126/science.291.5504.599; WHITE RW, 1959, PSYCHOL REV, V66, P297, DOI 10.1037/h0040934; Woolley B, 2011, GEN EV COMP C; Zhang G, 2014, COUPLING EVOLUTION I, P852	37	10	10	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162235	10.1371/journal.pone.0162235	http://dx.doi.org/10.1371/journal.pone.0162235			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589267	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800040
J	Sushames, A; Edwards, A; Thompson, F; McDermott, R; Gebel, K				Sushames, Ashleigh; Edwards, Andrew; Thompson, Fintan; McDermott, Robyn; Gebel, Klaus			Validity and Reliability of Fitbit Flex for Step Count, Moderate to Vigorous Physical Activity and Activity Energy Expenditure	PLOS ONE			English	Article							ACTIVITY MONITORS; ACCELEROMETER; CALIBRATION; VALIDATION	Objectives To examine the validity and reliability of the Fitbit Flex against direct observation for measuring steps in the laboratory and against the Actigraph for step counts in free-living conditions and for moderate-to-vigorous physical activity (MVPA) and activity energy expenditure (AEE) overall. Methods Twenty-five adults (12 females, 13 males) wore a Fitbit Flex and an Actigraph GT3X+ during a laboratory based protocol (including walking, incline walking, running and stepping) and free-living conditions during a single day period to examine measurement of steps, AEE and MVPA. Twenty-four of the participants attended a second session using the same protocol. Results Intraclass correlations (ICC) for test-retest reliability of the Fitbit Flex were strong for walking (ICC = 0.57), moderate for stair stepping (ICC = 0.34), and weak for incline walking (ICC = 0.22) and jogging (ICC = 0.26). The Fitbit significantly undercounted walking steps in the laboratory (absolute proportional difference: 21.2%, 95%CI 13.0-29.4%), but it was more accurate, despite slightly over counting, for both jogging (6.4%, 95%CI 3.7-9.0%) and stair stepping (15.5%, 95%CI 10.1-20.9%). The Fitbit had higher coefficients of variation (C-v) for step counts compared to direct observation and the Actigraph. In free-living conditions, the average MVPA minutes were lower in the Fitbit (35.4 minutes) compared to the Actigraph (54.6 minutes), but AEE was greater from the Fitbit (808.1 calories) versus the Actigraph (538.9 calories). The coefficients of variation were similar for AEE for the Actigraph (C-v = 36.0) and Fitbit (C-v = 35.0), but lower in the Actigraph (C-v = 25.5) for MVPA against the Fitbit (C-v = 32.7). Conclusion The Fitbit Flex has moderate validity for measuring physical activity relative to direct observation and the Actigraph. Test-rest reliability of the Fitbit was dependant on activity type and had greater variation between sessions compared to the Actigraph. Physical activity surveillance studies using the Fitbit Flex should consider the potential effect of measurement reactivity and undercounting of steps.	[Sushames, Ashleigh; Edwards, Andrew] James Cook Univ, Coll Healthcare Sci, Cairns, Qld, Australia; [Sushames, Ashleigh; Thompson, Fintan; McDermott, Robyn; Gebel, Klaus] James Cook Univ, Coll Publ Hlth Med & Vet Sci, Ctr Chron Dis Prevent, Cairns, Qld, Australia; [Edwards, Andrew] Univ St Mark & St John, Fac Sport & Hlth Sci, Plymouth, Devon, England; [Gebel, Klaus] Univ Sydney, Sydney Sch Publ Hlth, Prevent Res Collaborat, Sydney, NSW, Australia	James Cook University; James Cook University; University of Sydney	Sushames, A (corresponding author), James Cook Univ, Coll Healthcare Sci, Cairns, Qld, Australia.; Sushames, A (corresponding author), James Cook Univ, Coll Publ Hlth Med & Vet Sci, Ctr Chron Dis Prevent, Cairns, Qld, Australia.	ashleigh.sushames@my.jcu.edu.au	Gebel, Klaus/W-5681-2019; Gebel, Klaus/J-5280-2014	Gebel, Klaus/0000-0003-0330-7756; Gebel, Klaus/0000-0003-0330-7756	Research Infrastructure Block Grant (RIBG) through College of Public Health, Medical and Veterinary Sciences at James Cook University	Research Infrastructure Block Grant (RIBG) through College of Public Health, Medical and Veterinary Sciences at James Cook University	A Research Infrastructure Block Grant (RIBG) was received by KG and AS through the College of Public Health, Medical and Veterinary Sciences at James Cook University. This funding was used to purchase the Actigraph and Fitbit Flex devices. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams SA, 2005, AM J EPIDEMIOL, V161, P389, DOI 10.1093/aje/kwi054; Australian Bureau of Statistics, 2013, AUSTR HLTH SURV PHYS; Borg G., 1998, BORGS PERCEIVED EXER; Bouchard C., 2012, PHYS ACTIVITY HLTH; Bravata DM, 2007, JAMA-J AM MED ASSOC, V298, P2296, DOI 10.1001/jama.298.19.2296; Case MA, 2015, JAMA-J AM MED ASSOC, V313, P625, DOI 10.1001/jama.2014.17841; Conroy MB, 2011, MED SCI SPORT EXER, V43, P1568, DOI 10.1249/MSS.0b013e31820b9395; Dengel DR, 2014, OPEN SPORTS MED J, V8, P11, DOI DOI 10.2174/1874387001408010011; Department of Health, 2014, PHYS ACT SED BEH GUI; Dierker KE, 2014, MED SCI SPORT EXER, V46, P792, DOI 10.1249/01.mss.0000495877.54448.6c; Dontje Manon L., 2015, Journal of Medical Engineering & Technology, V39, P286, DOI 10.3109/03091902.2015.1050125; Evenson KR, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0183-7; Evenson KR, 2009, RES Q EXERCISE SPORT, V80, P355, DOI 10.1080/02701367.2009.10599570; Evenson KR, 2008, J SPORT SCI, V26, P1557, DOI 10.1080/02640410802334196; Ferguson T, 2015, INT J BEHAV NUTR PHY, V12, DOI 10.1186/s12966-015-0201-9; Freedson PS, 1998, MED SCI SPORT EXER, V30, P777, DOI 10.1097/00005768-199805000-00021; Kooiman TJM, 2015, BMC SPORTS SCI MED R, V7, DOI 10.1186/s13102-015-0018-5; Lee JA, 2015, J SPORT SCI, V33, P991, DOI 10.1080/02640414.2014.981848; Lee JA, 2015, J EXERC SCI FIT, V13, P16, DOI 10.1016/j.jesf.2014.11.002; Maher CA, 2014, J MED INTERNET RES, V16, DOI 10.2196/jmir.2952; Noah AJ SD, 2013, J MED ENG TECHNOL, V37, P465; Paul S.S., 2015, BMJ OPEN SPORT EXERC, V1, DOI [DOI 10.1136/BMJSEM-2015-000013, 10.1136/bmjsem-2015-000013]; Physical Activity Guidelines Advisory Committee, 2008, PHYS ACT GUID ADV CO; Plasqui G, 2007, OBESITY, V15, P2371, DOI 10.1038/oby.2007.281; Strath SJ, 2013, CIRCULATION, V128, P2259, DOI 10.1161/01.cir.0000435708.67487.da; Sushames AJ, 2015, PUBLIC HEALTH, V129, P1656, DOI 10.1016/j.puhe.2015.07.024; Takacs J, 2014, J SCI MED SPORT, V17, P496, DOI 10.1016/j.jsams.2013.10.241; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Tudor-Locke C, 2015, MED SCI SPORT EXER, V47, P839, DOI 10.1249/MSS.0000000000000476; Van Hoye K, 2015, INT J ENV RES PUB HE, V12, P6561, DOI 10.3390/ijerph120606561; Vanhelst Jeremy, 2012, BMC Res Notes, V5, P187, DOI 10.1186/1756-0500-5-187; WHO, 2010, GLOB REC PHYS ACT HL, V1st, P15	32	78	81	4	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161224	10.1371/journal.pone.0161224	http://dx.doi.org/10.1371/journal.pone.0161224			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589592	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000382877800006
J	Romero, OA; Verdura, S; Torres-Diz, M; Gomez, A; Moran, S; Condom, E; Esteller, M; Villanueva, A; Sanchez-Cespedes, M				Romero, O. A.; Verdura, S.; Torres-Diz, M.; Gomez, A.; Moran, S.; Condom, E.; Esteller, M.; Villanueva, A.; Sanchez-Cespedes, M.			Sensitization of retinoids and corticoids to epigenetic drugs in MYC-activated lung cancers by antitumor reprogramming	ONCOGENE			English	Article							CHROMATIN REMODELING COMPLEXES; C-MYC; SWI/SNF COMPLEX; CELL-LINES; NUCLEOSOME DISRUPTION; ACID RECEPTOR; BRG1 COMPLEX; DIFFERENTIATION; EXPRESSION; GENE	Components of the SWI/SNF chromatin remodeling complex, including BRG1 (also SMARCA4), are inactivated in cancer. Among other functions, SWI/SNF orchestrates the response to retinoid acid (RA) and glucocorticoids (GC) involving downregulation of MYC. The epigenetic drugs SAHA and azacytidine, as well as RA and GC, are currently being used to treat some malignancies but their therapeutic potential in lung cancer is not well established. Here we aimed to determine the possible therapeutic effects of azacytidine and SAHA (A/S) alone or in combination with GC plus RA (GC/RA) in lung cancers with either BRG1 inactivation or MYC amplification. In vitro, responses to GC/RA treatment were more effective in MYC-amplified cells. These effects were mediated by BRG1 and involved a reprogramming towards prodifferentiation gene expression signatures and downregulation of MYC. In MYC-amplified cells, administration of GC/RA enhanced the cell growth inhibitory effects of A/S which, in turn, accentuated the prodifferentiation features promoted by GC/RA. Finally, these treatments improved overall survival of mice orthotopically implanted with MYC-amplified, but not BRG1-mutant, cells and reduced tumor cell viability and proliferation. We propose that the combination of epigenetic treatments with retinoids and corticoids of MYC-driven lung tumors constitute a strategy for therapeutic intervention in this otherwise incurable disease.	[Romero, O. A.; Verdura, S.; Torres-Diz, M.; Sanchez-Cespedes, M.] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program, Genes & Canc Grp, Barcelona, Spain; [Gomez, A.; Moran, S.; Esteller, M.] Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program, Can Epigenet Grp, Barcelona, Spain; [Condom, E.] Bellvitge Hosp, Dept Pathol, Barcelona, Spain; [Villanueva, A.] Bellvitge Biomed Res Inst IDIBELL, Catalan Inst Oncol, Translat Res Lab, Barcelona, Spain	Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Institut d'Investigacio Biomedica de Bellvitge (IDIBELL); Bellvitge University Hospital; University of Barcelona; Catalan Institute of Oncology; Institut d'Investigacio Biomedica de Bellvitge (IDIBELL)	Sanchez-Cespedes, M (corresponding author), Hosp Duran & Reynals, Bellvitge Biomed Res Inst IDIBELL, Canc Epigenet & Biol Program, Genes & Canc Grp, Av Gran Via Hosp 199-203, Barcelona 08908, Spain.	mscespedes@idibell.cat	Romero, Octavio A./AAA-8078-2020; verdura, Sara/AAC-3696-2022; Sanchez-Cespedes, Montse/H-8485-2012; Esteller, Manel/L-5956-2014; torres-diz, manuel/ABG-1024-2021; Moran, Sebastian/G-5293-2013	Romero, Octavio A./0000-0003-0229-6530; verdura, Sara/0000-0001-8980-0423; Sanchez-Cespedes, Montse/0000-0002-6045-5627; Esteller, Manel/0000-0003-4490-6093; torres-diz, manuel/0000-0002-5487-8113; condom, enric/0000-0003-0142-3729; Moran, Sebastian/0000-0003-4192-8983	Spanish MINECO [SAF2011-22897]; Institute of Health Carlos III (ISCIII) [PIE13/ 00022]; RTICC [RD12/0036/0045, RD12/0036/0039]; Fundacion Cientifica Asociacion Espanola Contra el Cancer [GCB14-2170]; Spanish MINECO; European Union Seventh Framework Programme (FP7/2007-13) [HEALTH-F2-2010-258677-CURELUNG]	Spanish MINECO(Spanish Government); Institute of Health Carlos III (ISCIII); RTICC(Instituto de Salud Carlos III); Fundacion Cientifica Asociacion Espanola Contra el Cancer; Spanish MINECO(Spanish Government); European Union Seventh Framework Programme (FP7/2007-13)	We thank Patricia Cabral (Genes and Cancer Group) at IDIBELL for technical assistance. This work was supported by the grants from the Spanish MINECO SAF2011-22897, Institute of Health Carlos III (ISCIII)-PIE13/ 00022 ( ONCOPROFILE) and RTICC (RD12/0036/0045 to MS-C and RD12/0036/ 0039 to ME) and a grant from the Fundacion Cientifica Asociacion Espanola Contra el Cancer-GCB14-2170. MT-D is supported by a fellowship from the Spanish MINECO. Funding was also provided by the European Union Seventh Framework Programme (FP7/2007-13), under grant agreement HEALTH-F2-2010-258677-CURELUNG.	Angulo B, 2008, J PATHOL, V214, P347, DOI 10.1002/path.2267; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; BOGUE CW, 1994, AM J PHYSIOL, V266, pL448, DOI 10.1152/ajplung.1994.266.4.L448; Bonastre E, 2015, CANCER RES, V75, P1287, DOI 10.1158/0008-5472.CAN-14-2444; Borczuk AC, 2003, AM J PATHOL, V163, P1949, DOI 10.1016/S0002-9440(10)63553-5; Castillo SD, 2012, CANCER RES, V72, P176, DOI 10.1158/0008-5472.CAN-11-3506; Cheng SWG, 1999, NAT GENET, V22, P102, DOI 10.1038/8811; Chi TH, 2003, IMMUNITY, V19, P169, DOI 10.1016/S1074-7613(03)00199-7; CHIBA H, 1994, NUCLEIC ACIDS RES, V22, P1815, DOI 10.1093/nar/22.10.1815; Collins SJ, 2002, LEUKEMIA, V16, P1896, DOI 10.1038/sj.leu.2402718; de la Serna IL, 2001, NAT GENET, V27, P187, DOI 10.1038/84826; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; Facchini LM, 1997, MOL CELL BIOL, V17, P100, DOI 10.1128/MCB.17.1.100; Farrants AKO, 1997, MOL CELL BIOL, V17, P895, DOI 10.1128/MCB.17.2.895; Flajollet S, 2007, MOL CELL ENDOCRINOL, V270, P23, DOI 10.1016/j.mce.2007.02.004; Fryer CJ, 1998, NATURE, V393, P88, DOI 10.1038/30032; GERADTS J, 1993, CELL GROWTH DIFFER, V4, P799; Greenberg AK, 2002, AM J RESP CELL MOL, V27, P320, DOI 10.1165/rcmb.4710; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Hopfinger G, 2014, ANN HEMATOL, V93, P459, DOI 10.1007/s00277-014-2009-0; Johnson TA, 2008, MOL BIOL CELL, V19, P3308, DOI 10.1091/mbc.E08-02-0123; Juergens RA, 2011, CANCER DISCOV, V1, P598, DOI 10.1158/2159-8290.CD-11-0214; KWON H, 1994, NATURE, V370, P477, DOI 10.1038/370477a0; Liu SV, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00135; Maeda Y, 2007, PHYSIOL REV, V87, P219, DOI 10.1152/physrev.00028.2006; Malpel S, 2000, DEVELOPMENT, V127, P3057; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Medina PP, 2008, HUM MUTAT, V29, P617, DOI 10.1002/humu.20730; Nagl NG, 2006, CANCER RES, V66, P1289, DOI 10.1158/0008-5472.CAN-05-3427; Pal S, 2003, MOL CELL BIOL, V23, P7475, DOI 10.1128/MCB.23.21.7475-7487.2003; PETERSON CL, 1994, P NATL ACAD SCI USA, V91, P2905, DOI 10.1073/pnas.91.8.2905; Pottier N, 2008, JNCI-J NATL CANCER I, V100, P1792, DOI 10.1093/jnci/djn416; Rodriguez-Nieto S, 2011, HUM MUTAT, V32, pE1999, DOI 10.1002/humu.21415; Romero OA, 2014, ONCOGENE, V33, P2681, DOI 10.1038/onc.2013.227; Romero OA, 2014, CANCER DISCOV, V4, P292, DOI 10.1158/2159-8290.CD-13-0799; Romero OA, 2012, EMBO MOL MED, V4, P603, DOI 10.1002/emmm.201200236; Rutz HP, 2002, LANCET, V360, P1969, DOI 10.1016/S0140-6736(02)11922-2; SAFFIOTTI U, 1967, CANCER-AM CANCER SOC, V20, P857, DOI 10.1002/1097-0142(1967)20:5&lt;857::AID-CNCR2820200545&gt;3.0.CO;2-3; San-Miguel JF, 2014, LANCET ONCOL, V15, P1195, DOI 10.1016/S1470-2045(14)70440-1; Sandoval J, 2011, EPIGENETICS-US, V6, P692, DOI 10.4161/epi.6.6.16196; Schenk T, 2014, BRIT J CANCER, V111, P2039, DOI 10.1038/bjc.2014.412; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Shi Wei, 2009, Proc Am Thorac Soc, V6, P558, DOI 10.1513/pats.200905-031RM; Siegel D, 2009, J HEMATOL ONCOL, V2, DOI 10.1186/1756-8722-2-31; Sionov RV, 2008, ADV CANCER RES, V101, P127, DOI 10.1016/S0065-230X(08)00406-5; Sivak LE, 1997, ONCOGENE, V15, P1937, DOI 10.1038/sj.onc.1201363; THULASI R, 1993, J BIOL CHEM, V268, P18306; Vendetti FP, 2013, EXPERT OPIN BIOL TH, V13, P1273, DOI 10.1517/14712598.2013.819337; Wilson BG, 2011, NAT REV CANCER, V11, P481, DOI 10.1038/nrc3068	50	7	7	1	8	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1287	1296		10.1038/onc.2016.296	http://dx.doi.org/10.1038/onc.2016.296			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27593925	Green Accepted			2022-12-26	WOS:000395861300012
J	Shimura, M; Shindou, H; Szyrwiel, L; Tokuoka, SM; Hamano, F; Matsuyama, S; Okamoto, M; Matsunaga, A; Kita, Y; Ishizaka, Y; Yamauchi, K; Kohmura, Y; Lobinski, R; Shimizu, I; Shimizu, T				Shimura, Mari; Shindou, Hideo; Szyrwiel, Lukasz; Tokuoka, Suzumi M.; Hamano, Fumie; Matsuyama, Satoshi; Okamoto, Mayumi; Matsunaga, Akihiro; Kita, Yoshihiro; Ishizaka, Yukihito; Yamauchi, Kazuto; Kohmura, Yoshiki; Lobinski, Ryszard; Shimizu, Isao; Shimizu, Takao			Imaging of intracellular fatty acids by scanning X-ray fluorescence microscopy	FASEB JOURNAL			English	Article						glycerophospholipid; labeling; cellular membrane; lipid metabolism; visualization	LIPID MEDIATORS; METABOLISM; MEMBRANE; CELLS; INFLAMMATION; DYNAMICS; DISEASES; TARGETS; ENZYMES; SYSTEM	Fatty acids are taken up by cells and incorporated into complex lipids such as neutral lipids and glycerophospholipids. Glycerophospholipids are major constituents of cellular membranes. More than 1000 molecular species of glycerophospholipids differ in their polar head groups and fatty acid compositions. They are related to cellular functions and diseases and have been well analyzed by mass spectrometry. However, intracellular imaging of fatty acids and glycerophospholipids has not been successful due to insufficient resolution using conventional methods. Here, we developed a method for labeling fatty acids with bromine (Br) and applied scanning X-ray fluorescence microscopy (SXFM) to obtain intracellular Br mapping data with submicrometer resolution. Mass spectrometry showed that cells took up Br-labeled fatty acids and metabolized them mainly into glycerophospholipids in CHO cells. Most Br signals observed by SXFM were in the perinuclear region. Higher resolution revealed a spot-like distribution of Br in the cytoplasm. The current method enabled successful visualization of intracellular Br-labeled fatty acids. Single-element labeling combined with SXFM technology facilitates the intracellular imaging of fatty acids, which provides a new tool to determine dynamic changes in fatty acids and their derivatives at the single-cell level.	[Shimura, Mari; Matsunaga, Akihiro; Ishizaka, Yukihito] Natl Ctr Global Hlth & Med, Dept Intractable Dis, Tokyo 1628655, Japan; [Shindou, Hideo; Shimizu, Takao] Natl Ctr Global Hlth & Med, Lipid Signaling Res Inst, Tokyo, Japan; [Shimura, Mari; Szyrwiel, Lukasz; Kohmura, Yoshiki] Riken SPring 8 Ctr, Sayo, Hyogo, Japan; [Shindou, Hideo] Agcy Med Res & Development Core Res Evolutionary, Tokyo, Japan; [Szyrwiel, Lukasz; Lobinski, Ryszard] UPPA, CNRS, LCABIE, Unite Mixte Rech 5254, Pau, France; [Szyrwiel, Lukasz] Wroclaw Med Univ, Dept Chem Drugs, Wroclaw, Poland; [Tokuoka, Suzumi M.; Hamano, Fumie; Kita, Yoshihiro; Shimizu, Takao] Univ Tokyo, Grad Sch Med, Dept Lipid, Tokyo, Japan; [Hamano, Fumie; Kita, Yoshihiro] Univ Tokyo, Grad Sch Med, Life Sci Core Facil, Tokyo, Japan; [Matsuyama, Satoshi; Yamauchi, Kazuto] Osaka Univ, Grad Sch Engn, Dept Precis Sci & Technol, Osaka, Japan; [Okamoto, Mayumi; Shimizu, Isao] Waseda Univ, Sch Adv Sci & Engn, Res Inst Sci & Engn, Tokyo, Japan; [Okamoto, Mayumi] Natl Ctr Global Hlth & Med, Dept Pathol & Immunol, Res Inst, Chiba, Japan	National Center for Global Health & Medicine - Japan; National Center for Global Health & Medicine - Japan; RIKEN; Centre National de la Recherche Scientifique (CNRS); Universite de Pau et des Pays de l'Adour; Wroclaw Medical University; University of Tokyo; University of Tokyo; Osaka University; Waseda University; National Center for Global Health & Medicine - Japan	Shimura, M (corresponding author), Natl Ctr Global Hlth & Med, Dept Intractable Dis, Tokyo 1628655, Japan.; Shindou, H (corresponding author), Natl Ctr Global Hlth & Med, Dept Lipid Signaling, Res Inst, Tokyo 1628655, Japan.	mshimura@ri.ncgm.go.jp; hsindou-tky@umin.net	Okamoto, Mayumi/L-5885-2017; Matsunaga, Akihiro/AAU-3255-2021; Shimizu, Takao/AAV-7052-2021	Okamoto, Mayumi/0000-0001-7708-3455; Lobinski, Ryszard/0000-0003-1908-2029; Szyrwiel, Lukasz/0000-0003-1983-2950	Japan Society for the Promotion of Science (JSPS) [24229003, 26460380]; National Center for Global Health and Medicine Grant [24-001]; Takeda Science Foundation; Core Research for Evolutionary Science and Technology (CREST) from the Japan Science and Technology Agency; Agency for Medical Research and Development (AMED)-CREST; Shimadzu Co.; ONO Pharmaceutical Co., Ltd.; European Union [PIEF-GA-2012-329969]; Grants-in-Aid for Scientific Research [26286077] Funding Source: KAKEN	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); National Center for Global Health and Medicine Grant; Takeda Science Foundation(Takeda Science Foundation (TSF)); Core Research for Evolutionary Science and Technology (CREST) from the Japan Science and Technology Agency; Agency for Medical Research and Development (AMED)-CREST(Japan Agency for Medical Research and Development (AMED)); Shimadzu Co.; ONO Pharmaceutical Co., Ltd.(Ono Pharmaceutical Co Ltd); European Union(European Commission); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The authors thank Daisuke Hishikawa and Yoshikazu Takahashi [National Center for Global Health and Medicine (NCGM), Tokyo, Japan] and Ayako Kobayashi (University of Tokyo) for providing technical support, Tetsuya Ishikawa (Riken) for providing advice and encouragement during this study, and Keizo Waku (Teikyo University, Itabashi, Japan) for constructive comments. This work was supported by Japan Society for the Promotion of Science (JSPS) Grants-in-Aid for Scientific Research (KAKENHI) Grants 24229003 (to T.S.) and 26460380 (to H.S.); National Center for Global Health and Medicine Grant 24-001 (to T.S.); the Takeda Science Foundation (T.S.); Core Research for Evolutionary Science and Technology (CREST) from the Japan Science and Technology Agency (to M.S., S.M., and K.Y.); and Agency for Medical Research and Development (AMED)-CREST (to H.S.). S.M.-T., F.H., Y.K., and T.S. are affiliated with the Department of Lipidomics, the University of Tokyo, which is financially supported by Shimadzu Co. and ONO Pharmaceutical Co., Ltd. L.S. is supported by a Marie Curie Intra-European Fellowship from the European Union (PIEF-GA-2012-329969). None of the authors received support from any organization or has a financial relationship with any organization that might have an interest in the submitted work. There are no other relationships or activities that could have influenced this research.	Antonny B, 2015, TRENDS CELL BIOL, V25, P427, DOI 10.1016/j.tcb.2015.03.004; Bankaitis VA, 2012, CURR BIOL, V22, pR414, DOI 10.1016/j.cub.2012.03.004; Burkemper JL, 2015, J MED CHEM, V58, P8542, DOI 10.1021/acs.jmedchem.5b01035; Chilton FH, 2014, NUTRIENTS, V6, P1993, DOI 10.3390/nu6051993; Coleman RA, 2004, PROG LIPID RES, V43, P134, DOI 10.1016/S0163-7827(03)00051-1; Elvington SM, 2005, J BIOL CHEM, V280, P40957, DOI 10.1074/jbc.M507926200; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Grevengoed TJ, 2014, ANNU REV NUTR, V34, P1, DOI 10.1146/annurev-nutr-071813-105541; Harayama T., 2014, METABOLISM, V20, P295; Hashidate-Yoshida T, 2015, ELIFE, V4, DOI 10.7554/eLife.06328; Hishikawa D, 2014, J LIPID RES, V55, P799, DOI 10.1194/jlr.R046094; Houten SM, 2016, ANNU REV PHYSIOL, V78, P23, DOI 10.1146/annurev-physiol-021115-105045; Jakobsson A, 2006, PROG LIPID RES, V45, P237, DOI 10.1016/j.plipres.2006.01.004; Jindal A, 2014, J LABELLED COMPD RAD, V57, P463, DOI 10.1002/jlcr.3205; Lang L., 2011, THERANOSTICS, V1; Matsuyama S, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2349594; Matsuyama S, 2006, REV SCI INSTRUM, V77, DOI 10.1063/1.2358699; Matsuyama S, 2009, X-RAY SPECTROM, V38, P89, DOI 10.1002/xrs.1123; Mimura H, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4539; Mimura H, 2010, NAT PHYS, V6, P122, DOI 10.1038/NPHYS1457; Palonpon AF, 2013, CURR OPIN CHEM BIOL, V17, P708, DOI 10.1016/j.cbpa.2013.05.021; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Scaglia N, 2014, CELL CYCLE, V13, P859, DOI 10.4161/cc.27767; Serhan CN, 2008, NAT REV IMMUNOL, V8, P349, DOI 10.1038/nri2294; Shimizu T, 2009, ANNU REV PHARMACOL, V49, P123, DOI 10.1146/annurev.pharmtox.011008.145616; Shimura M, 2005, CANCER RES, V65, P4998, DOI 10.1158/0008-5472.CAN-05-0373; Shindou H, 2009, J BIOL CHEM, V284, P1, DOI 10.1074/jbc.R800046200; van Meer G, 2008, NAT REV MOL CELL BIO, V9, P112, DOI 10.1038/nrm2330; Varnai P, 2006, BBA-MOL CELL BIOL L, V1761, P957, DOI 10.1016/j.bbalip.2006.03.019; Watkins PA, 2008, J BIOL CHEM, V283, P1773, DOI 10.1074/jbc.R700037200; Yabashi M, 2014, J SYNCHROTRON RADIAT, V21, P976, DOI 10.1107/S1600577514016415; Yalcin EB, 2015, J HISTOCHEM CYTOCHEM, V63, P762, DOI 10.1369/0022155415596202; Zhao FJ, 2014, TRENDS PLANT SCI, V19, P183, DOI 10.1016/j.tplants.2013.12.001	33	13	15	0	15	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4149	4158		10.1096/fj.201600569R	http://dx.doi.org/10.1096/fj.201600569R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601443	Green Published, hybrid			2022-12-26	WOS:000388201500021
J	Germain, N; Viltart, O; Loyens, A; Bruchet, C; Nadin, K; Wolowczuk, I; Estour, B; Galusca, B				Germain, Natacha; Viltart, Odile; Loyens, Anne; Bruchet, Celine; Nadin, Katia; Wolowczuk, Isabelle; Estour, Bruno; Galusca, Bogdan			Interleukin-7 Plasma Levels in Human Differentiate Anorexia Nervosa, Constitutional Thinness and Healthy Obesity	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; NECROSIS-FACTOR-ALPHA; PEPTIDE YY; FEMALE ADOLESCENTS; INSULIN-RESISTANCE; ADIPOSE-TISSUE; IMMUNE-SYSTEM; GROWTH-FACTOR; GHRELIN; APPETITE	Introduction Interleukin-7 (IL-7) is a cytokine involved in energy homeostasis as demonstrated in rodents. Anorexia nervosa is characterized by restrained eating behavior despite adaptive orexigenic regulation profile including high ghrelin plasma levels. Constitutional thinness is a physiological condition of resistance to weight gain with physiological anorexigenic profile including high Peptide YY plasma level. Healthy obesity can be considered as a physiological state of resistance to weight loss with opposite appetite regulating profile to constitutional thinness including low Peptide YY plasma level. No studies in IL-7 are yet available in those populations. Therefore we evaluated circadian plasma levels of IL-7 in anorexia nervosa compared to constitutional thinness, healthy obese and control females. Materials and Methods 10 restrictive-type anorexia nervosa women, 5 bingeing/purging anorexia nervosa woman, 5 recovered restrictive anorexia nervosa women, 4 bulimic females, 10 constitutional thinness women, 7 healthy obese females, and 10 normalweight women controls were enrolled in this cross-sectional study, performed in endocrinology unit and academic laboratory. Twelve-point circadian profiles of plasma IL-7 levels were measured in each subject. Results 24h mean IL-7 plasma levels (pg/ml, mean +/- SEM) were decreased in restrictive-type anorexia nervosa (123.4 +/- 14.4, p<0.0037), bingeing/purging anorexia nervosa (24.2 +/- 5.6, p<0.001), recovered restrictive anorexia nervosa (64.2 +/- 16.1, p = 0.01) and healthy obese patients (51 +/- 3.2, p<0.001) compared to controls (187.7 +/- 28.6). Bulimic patients (197.4 +/- 42.7) and constitutional thinness patients (264.3 +/- 35.8) were similar to controls. Conclusions Low IL-7 is part of the adaptive profile in restrictive-type anorexia nervosa, confirming its difference with constitutional thinness. Healthy obesity, with low IL-7, is once again in mirror image of constitutional thinness with normal high IL-7.	[Germain, Natacha; Bruchet, Celine; Nadin, Katia; Estour, Bruno; Galusca, Bogdan] CHU St Etienne, Div Endocrinol Diabet Metab & Eating Disorders, St Etienne, France; [Germain, Natacha; Bruchet, Celine; Nadin, Katia; Estour, Bruno; Galusca, Bogdan] TAPE Eating Disorders Addict & Extreme Bodyweight, EA 7423, St Etienne, France; [Viltart, Odile; Loyens, Anne] Univ Lille, INSERM, CHU Lille,Neurosci & Canc, UMR S 1172,JPArc Jean Pierre AUBERT Res Ctr, F-59000 Lille, France; [Wolowczuk, Isabelle] Univ Lille, CNRS, INSERM, CHU Lille,Inst Pasteur Lille,U1019,UMR8204,CIIL, F-59000 Lille, France	CHU de St Etienne; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; CHU Lille; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; CHU Lille; Universite de Lille	Germain, N (corresponding author), CHU St Etienne, Div Endocrinol Diabet Metab & Eating Disorders, St Etienne, France.; Germain, N (corresponding author), TAPE Eating Disorders Addict & Extreme Bodyweight, EA 7423, St Etienne, France.	natacha.germain@chu-st-etienne.fr		wolowczuk, isabelle/0000-0001-6692-6904				ALDERSON MR, 1991, J EXP MED, V173, P923, DOI 10.1084/jem.173.4.923; [Anonymous], 1994, NUTR REV, V52, P213; Balligand JL, 1998, EUR J ENDOCRINOL, V138, P415, DOI 10.1530/eje.0.1380415; Benedict C, 2007, BRAIN BEHAV IMMUN, V21, P1058, DOI 10.1016/j.bbi.2007.04.004; Brambilla F, 2001, PSYCHIAT RES, V103, P107, DOI 10.1016/S0165-1781(01)00283-9; Carolan E, 2015, J IMMUNOL; Challet E, 2015, DIABETES OBES METAB, V17, P76, DOI 10.1111/dom.12516; Cummings DE, 2002, NEW ENGL J MED, V346, P1623, DOI 10.1056/NEJMoa012908; Estour B, 2010, J CLIN ENDOCR METAB, V95, P2203, DOI 10.1210/jc.2009-2608; Exley MA, 2014, J ENDOCRINOL, V223, pR41, DOI 10.1530/JOE-13-0516; Galusca B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122040; Galusca B, 2012, J CLIN ENDOCR METAB, V97, P2012, DOI 10.1210/jc.2011-3396; Germain N, 2014, NUTR DIABETES, V4, DOI 10.1038/nutd.2014.17; Germain N, 2009, PSYCHONEUROENDOCRINO, V34, P413, DOI 10.1016/j.psyneuen.2008.10.001; Germain N, 2007, AM J CLIN NUTR, V85, P967, DOI 10.1093/ajcn/85.4.967; Germain N, 2010, J CLIN ENDOCR METAB, V95, P3057, DOI 10.1210/jc.2009-2196; GOODWIN RG, 1989, P NATL ACAD SCI USA, V86, P302, DOI 10.1073/pnas.86.1.302; Kahl KG, 2004, PSYCHONEUROENDOCRINO, V29, P13, DOI 10.1016/S0306-4530(02)00131-2; Karelis AD, 2005, J CLIN ENDOCR METAB, V90, P4145, DOI 10.1210/jc.2005-0482; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Labrecque N, 2015, J BIOL RHYTHM, V30, P277, DOI 10.1177/0748730415577723; le Roux CW, 2006, ENDOCRINOLOGY, V147, P3, DOI 10.1210/en.2005-0972; Lee M, 2015, DIABETOLOGIA, V58, P2361, DOI 10.1007/s00125-015-3684-7; Lucas R, 2013, CYTOKINE, V64, P310, DOI 10.1016/j.cyto.2013.05.025; Lucas S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040351; Macia L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009953; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; MAZESS RB, 1990, AM J CLIN NUTR, V51, P1106, DOI 10.1093/ajcn/51.6.1106; MORRISSEY PJ, 1989, J EXP MED, V169, P707, DOI 10.1084/jem.169.3.707; Nakai Y, 1999, J CLIN ENDOCR METAB, V84, P1226, DOI 10.1210/jc.84.4.1226; NAMEN AE, 1988, NATURE, V333, P571, DOI 10.1038/333571a0; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Nova E, 2002, BRIT J NUTR, V88, P183, DOI 10.1079/BJN2002608; Ostlund RE, 1996, J CLIN ENDOCR METAB, V81, P3909, DOI 10.1210/jc.81.11.3909; Petrovsky N, 1998, CYTOKINE, V10, P307, DOI 10.1006/cyto.1997.0289; Rallon NI, 2011, JAIDS-J ACQ IMM DEF, V58, P436, DOI 10.1097/QAI.0b013e318231de37; Saad MF, 1998, J CLIN ENDOCR METAB, V83, P453, DOI 10.1210/jc.83.2.453; Saidijam M, 2014, INDIAN J MED RES, V140, P238; Stock S, 2005, J CLIN ENDOCR METAB, V90, P2161, DOI 10.1210/jc.2004-1251; Tani A, 2014, J INFLAMM RES, V7, P1, DOI 10.2147/JIR.S52728; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; WATANABE M, 1995, J CLIN INVEST, V95, P2945, DOI 10.1172/JCI118002; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	43	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161890	10.1371/journal.pone.0161890	http://dx.doi.org/10.1371/journal.pone.0161890			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611669	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900035
J	Goh, S; Ngugi, D; Lizundia, R; Hostettler, I; Woods, K; Ballingall, K; MacHugh, ND; Morrison, WI; Weir, W; Shiels, B; Werling, D				Goh, Shan; Ngugi, Daniel; Lizundia, Regina; Hostettler, Isabel; Woods, Kerry; Ballingall, Keith; MacHugh, Niall D.; Morrison, W. Ivan; Weir, Willie; Shiels, Brian; Werling, Dirk			Identification of Theileria lestoquardi Antigens Recognized by CD8(+) T Cells	PLOS ONE			English	Article							MAJOR HISTOCOMPATIBILITY COMPLEX; MALIGNANT OVINE THEILERIOSIS; SCHIZONT-INFECTED CELLS; II DRB1 LOCUS; TROPICAL THEILERIOSIS; TISSUE-CULTURE; PARVA; SHEEP; ANNULATA; RESPONSES	As part of an international effort to develop vaccines for Theileria lestoquardi, we undertook a limited screen to test T. lestoquardi orthologues of antigens recognised by CD8(+) T lymphocyte responses against T. annulata and T. parva in cattle. Five MHC defined sheep were immunized by live T. lestoquardi infection and their CD8(+) T lymphocyte responses determined. Thirteen T. lestoquardi orthologues of T. parva and T. annulata genes, previously shown to be targets of CD8(+) T lymphocyte responses of immune cattle, were expressed in autologous fibroblasts and screened for T cell recognition using an IFN gamma assay. Genes encoding T. lestoquardi antigens Tl8 (putative cysteine proteinase, 349 aa) or Tl9 (hypothetical secreted protein, 293 aa) were recognise by T cells from one animal that displayed a unique MHC class I genotype. Antigenic 9-mer peptide epitopes of Tl8 and Tl9 were identified through peptide scans using CD8(+) T cells from the responding animal. These experiments identify the first T. lestoquardi antigens recognised by CD8(+) T cell responses linked to specific MHC class I alleles.	[Goh, Shan; Ngugi, Daniel; Lizundia, Regina; Werling, Dirk] Royal Vet Coll, Dept Pathol & Pathogen Biol, Hawkshead Lane, Hatfield AL9 7TA, Herts, England; [Hostettler, Isabel] Univ Bern, Vetsuisse Fac, Inst Parasitol, Laenggassstr 122, CH-3012 Bern, Switzerland; [Woods, Kerry] Univ Bern, Vetsuisse Fac, Inst Anim Pathol, Laenggassstr 122, CH-3012 Bern, Switzerland; [Ballingall, Keith] Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [MacHugh, Niall D.; Morrison, W. Ivan] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin Inst, Easter Bush EH25 9RG, Midlothian, Scotland; [Weir, Willie; Shiels, Brian] Univ Glasgow, Coll Med Vet & Life Sci, Inst Biodivers Anim Hlth & Comparat Med, Bearsden Rd, Glasgow G61 1QH, Lanark, Scotland	University of London; University of London Royal Veterinary College; University of Bern; University of Bern; Moredun Research Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Glasgow	Goh, S (corresponding author), Royal Vet Coll, Dept Pathol & Pathogen Biol, Hawkshead Lane, Hatfield AL9 7TA, Herts, England.	sgoh@rvc.ac.uk	Goh, Shan/A-7261-2010; Werling, Dirk/F-5555-2013; Ballingall, Keith/T-1262-2019	Goh, Shan/0000-0002-9028-0303; Werling, Dirk/0000-0001-5411-4044; Shiels, Brian/0000-0001-7595-2514; Weir, William/0000-0001-8648-666X	EU Seventh Framework Programme for Research (FP7) [245145-PIROVAC]	EU Seventh Framework Programme for Research (FP7)	The work was funded by the EU Seventh Framework Programme for Research (FP7), grant number 245145-PIROVAC, http://www.theileria.org/pirovac/. The funder had no role in study design, data collection and interpretation, or the decision to submit work for publication.	Abdigoudarzi M, 2013, J ARTHROPOD-BORNE DI, V7, P164; Ahmed BM, 2013, VACCINE, V31, P4775, DOI 10.1016/j.vaccine.2013.08.004; Ali AM, 2008, VACCINE, V26, pG17, DOI 10.1016/j.vaccine.2008.10.009; Bakheit MA, 2006, PARASITOL RES, V100, P161, DOI 10.1007/s00436-006-0255-3; Bakheit M, 2006, ANN NY ACAD SCI, V1081, P463, DOI 10.1196/annals.1373.065; Ballingall KT, 2011, TISSUE ANTIGENS, V77, P546, DOI 10.1111/j.1399-0039.2011.01637.x; Ballingall KT, 2010, IMMUNOGENETICS, V62, P31, DOI 10.1007/s00251-009-0410-y; El Hussein AM, 1993, SUD J VET RES, V12, P51; El-Imam A. H., 2015, Jordan Journal of Biological Sciences (JJBS), V8, P165; EMERY DL, 1980, IMMUNOLOGY, V40, P229; GODDEERIS BM, 1986, EUR J IMMUNOL, V16, P1243, DOI 10.1002/eji.1830161010; Graham SP, 2008, INFECT IMMUN, V76, P685, DOI 10.1128/IAI.01244-07; Graham SP, 2006, P NATL ACAD SCI USA, V103, P3286, DOI 10.1073/pnas.0511273103; Hall R, 1999, TROP MED INT HEALTH, V4, pA78, DOI 10.1046/j.1365-3156.1999.00454.x; Hansen AM, 2014, IMMUNOGENETICS, V66, P705, DOI 10.1007/s00251-014-0802-5; HAWA NJ, 1981, VET PARASITOL, V9, P91, DOI 10.1016/0304-4017(81)90026-1; Hayashida K, 2012, MBIO, V3, DOI 10.1128/mBio.00204-12; Hibbs AR, 2004, CONFOCAL MICROSCOPY; HOOSHMANDRAD P, 1993, PARASITOL RES, V79, P195, DOI 10.1007/BF00931892; HOOSHMANDRAD P, 1985, DEV BIOLOGICALS, V62, P119; Jeong JY, 2012, APPL ENVIRON MICROB, V78, P5440, DOI 10.1128/AEM.00844-12; Leemans I, 1997, VET PARASITOL, V69, P9, DOI 10.1016/S0304-4017(96)01098-9; Leemans I, 2001, PARASITOL RES, V87, P768, DOI 10.1007/s004360100388; Macdonald IK, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001149; Machugh ND, 2008, PARASITE IMMUNOL, V30, P385, DOI 10.1111/j.1365-3024.2008.01038.x; MacHugh ND, 2011, INFECT IMMUN, V79, P2059, DOI 10.1128/IAI.01285-10; MacHugh ND, 2009, EUR J IMMUNOL, V39, P2459, DOI 10.1002/eji.200939227; MCKEEVER DJ, 1994, P NATL ACAD SCI USA, V91, P1959, DOI 10.1073/pnas.91.5.1959; Miltiadou D, 2005, IMMUNOGENETICS, V57, P499, DOI 10.1007/s00251-005-0008-y; Morrison WI, 2009, PARASITOLOGY, V136, P1415, DOI 10.1017/S0031182009990916; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Razmi G, 2013, J PARASITOL, V99, P77, DOI 10.1645/GE-3202.1; Seitzer U, 2008, VACCINE, V26, pG24, DOI 10.1016/j.vaccine.2008.10.039; Seitzer U, 2010, PARASITOL RES, V106, P1085, DOI 10.1007/s00436-010-1747-8; Shiels B, 2006, INT J PARASITOL, V36, P9, DOI 10.1016/j.ijpara.2005.09.002; Shkap V, 2003, VET PARASITOL, V115, P247, DOI 10.1016/S0304-4017(03)00214-0; Shkap V, 2007, TRENDS PARASITOL, V23, P420, DOI 10.1016/j.pt.2007.07.003; Sparagano OAE, 2006, ANN NY ACAD SCI, V1081, P505, DOI 10.1196/annals.1373.075; Svitek N, 2014, VET RES, V45, DOI 10.1186/1297-9716-45-50; Taha KM, 2011, PARASITOL RES, V109, P1525, DOI 10.1007/s00436-011-2428-y; Taha KM, 2010, PARASITOL RES, V107, P1009, DOI 10.1007/s00436-010-1968-x; Taracha ELN, 1997, J IMMUNOL, V159, P4539; Walker JG, 2014, VET PARASITOL, V199, P206, DOI 10.1016/j.vetpar.2013.11.008; Woods KL, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003346; Zakian A, 2014, VET PARASITOL, V203, P322, DOI 10.1016/j.vetpar.2014.04.007; Zia-ur-Rehman, 2010, PAK J ZOOL, V42, P639	46	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162571	10.1371/journal.pone.0162571	http://dx.doi.org/10.1371/journal.pone.0162571			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611868	Green Published, Green Accepted, gold			2022-12-26	WOS:000383255900128
J	Yi, B; Chen, L; Sa, RN; Zhong, RQ; Xing, H; Zhang, HF				Yi, Bao; Chen, Liang; Sa, Renna; Zhong, Ruqing; Xing, Huan; Zhang, Hongfu			Transcriptome Profile Analysis of Breast Muscle Tissues from High or Low Levels of Atmospheric Ammonia Exposed Broilers (Gallus gallus)	PLOS ONE			English	Article							ANTI-MYOSTATIN ANTIBODY; AFFECTS PERFORMANCE; GROWTH-PERFORMANCE; GENETIC-PARAMETERS; POULTRY HOUSES; LAYER HOUSES; CHICKENS; HYPERAMMONEMIA; EMISSIONS; DUST	Atmospheric ammonia is a common problem in poultry industry. High concentrations of aerial ammonia cause great harm to broilers' health and production. For the consideration of human health, the limit exposure concentration of ammonia in houses is set at 25 ppm. Previous reports have shown that 25 ppm is still detrimental to livestock, especially the gastrointestinal tract and respiratory tract, but the negative relationship between ammonia exposure and the tissue of breastmuscle of broilers is still unknown. In the present study, 25 ppm ammonia in poultry houses was found to lower slaughter performance and breast yield. Then, high-throughput RNA sequencing was utilized to identify differentially expressed genes in breastmuscle of broiler chickens exposed to high (25 ppm) or low (3 ppm) levels of atmospheric ammonia. The transcriptome analysis showed that 163 genes (fold change >= 2 or <= 0.5; P-value < 0.05) were differentially expressed between Ammonia25 (treatment group) and Ammonia3 (control group), including 96 down-regulated and 67 up-regulated genes. qRT-PCR analysis validated the transcriptomic results of RNA sequencing. Gene Ontology (GO) functional annotation analysis revealed potential genes, processes and pathways with putative involvement in growth and development inhibition of breastmuscle in broilers caused by aerial ammonia exposure. This study facilitates understanding of the genetic architecture of the chicken breastmuscle transcriptome, and has identified candidate genes for breastmuscle response to atmospheric ammonia exposure.	[Yi, Bao; Chen, Liang; Sa, Renna; Zhong, Ruqing; Xing, Huan; Zhang, Hongfu] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS	Zhang, HF (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.	zhanghongfu@caas.cn		Yi, Bao/0000-0003-0295-3035	National Natural Science Foundation of China [31601979]; National Key Research and Development Program of China [2016YFD0500501]; Agricultural Science and Technology Innovation Program [ASTIP-IAS07]; National Science and Technology Support Program in China [2012BAD39B01]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Research and Development Program of China; Agricultural Science and Technology Innovation Program; National Science and Technology Support Program in China	This research was supported by the National Natural Science Foundation of China (31601979), National Key Research and Development Program of China (2016YFD0500501), the Agricultural Science and Technology Innovation Program (ASTIP-IAS07) and National Science and Technology Support Program (2012BAD39B01) in China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALMASHHADANI EH, 1985, POULTRY SCI, V64, P2056, DOI 10.3382/ps.0642056; ANDERSON DP, 1964, AVIAN DIS, V8, P369, DOI 10.2307/1587967; Beker A, 2004, J APPL POULTRY RES, V13, P5, DOI 10.1093/japr/13.1.5; Bellinge RHS, 2005, ANIM GENET, V36, P1, DOI 10.1111/j.1365-2052.2004.01229.x; Berri C, 2001, POULTRY SCI, V80, P833, DOI 10.1093/ps/80.7.833; CARLILE FS, 1984, WORLD POULTRY SCI J, V40, P99, DOI 10.1079/WPS19840008; CAVENY DD, 1981, POULTRY SCI, V60, P513, DOI 10.3382/ps.0600513; CHARLES D. R., 1966, BRIT POULTRY SCI, V7, P189, DOI 10.1080/00071668608415623; David B, 2015, ANIMALS-BASEL, V5, P886, DOI 10.3390/ani5030389; Dawkins MS, 2004, NATURE, V427, P342, DOI 10.1038/nature02226; DEATON JW, 1982, POULTRY SCI, V61, P1815, DOI 10.3382/ps.0611815; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Homidan AA, 2003, WORLD POULTRY SCI J, V59, P340, DOI 10.1079/WPS20030021; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; JOHNSON RW, 1991, POULTRY SCI, V70, P1132, DOI 10.3382/ps.0701132; Juri R, 2016, NUCL ACIDS RES; Kim YS, 2007, POULTRY SCI, V86, P1196, DOI 10.1093/ps/86.6.1196; Kim YS, 2006, POULTRY SCI, V85, P1062, DOI 10.1093/ps/85.6.1062; Koerkamp PWGG, 1998, BRIT POULTRY SCI, V39, P379, DOI 10.1080/00071669888935; Koerkamp PWGG, 1998, J AGR ENG RES, V70, P79, DOI 10.1006/jaer.1998.0275; Kristensen HH, 2000, WORLD POULTRY SCI J, V56, P235, DOI 10.1079/WPS20000018; Le Bihan-Duval E, 1999, POULTRY SCI, V78, P822, DOI 10.1093/ps/78.6.822; Miles DM, 2004, POULTRY SCI, V83, P1650, DOI 10.1093/ps/83.10.1650; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Ni JQ, 2012, ENVIRON SCI POLICY, V22, P25, DOI 10.1016/j.envsci.2012.06.001; Nkukwana TT, 2014, LIVEST SCI, V161, P139, DOI 10.1016/j.livsci.2014.01.001; OYETUNDE OOF, 1978, CAN VET J, V19, P187; Qian LL, 2015, SCI REP-UK, V5, DOI 10.1038/srep14435; Qiu J, 2013, P NATL ACAD SCI USA, V110, P18162, DOI 10.1073/pnas.1317049110; Qiu J, 2012, AM J PHYSIOL-ENDOC M, V303, pE983, DOI 10.1152/ajpendo.00183.2012; REECE FN, 1980, POULTRY SCI, V59, P486, DOI 10.3382/ps.0590486; Reece FN, 1980, POULTRY SCI, V59; Reisz-Porszasz S, 2003, AM J PHYSIOL-ENDOC M, V285, pE876, DOI 10.1152/ajpendo.00107.2003; Reuter JA, 2015, MOL CELL, V58, P586, DOI 10.1016/j.molcel.2015.05.004; Ritz CW, 2004, J APPL POULTRY RES, V13, P684, DOI 10.1093/japr/13.4.684; Rodgers BD, 2008, ENDOCR REV, V29, P513, DOI 10.1210/er.2008-0003; Salarpour A, 2015, J ANIM PHYSIOL AN N, V99, P237, DOI 10.1111/jpn.12235; Salim HM, 2014, WORLD POULTRY SCI J, V70, P839, DOI 10.1017/S0043933914000890; Stern RA, 2015, ANIMAL, V9, P992, DOI 10.1017/S1751731115000117; Wang YM, 2010, J ANIM VET ADV, V9, P2802, DOI 10.3923/javaa.2010.2802.2806; Wathes CM, 1997, BRIT POULTRY SCI, V38, P14, DOI 10.1080/00071669708417936; Wei FX, 2015, GENET MOL RES, V14, P3160, DOI 10.4238/2015.April.10.27; WHYTE RT, 1993, WORLD POULTRY SCI J, V49, P139, DOI 10.1079/WPS19930012; Yahav S, 2004, ANIM RES, V53, P289, DOI 10.1051/animres:2004015; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zerehdaran S, 2004, POULTRY SCI, V83, P521, DOI 10.1093/ps/83.4.521; Zhang JZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123596	47	17	21	4	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162631	10.1371/journal.pone.0162631	http://dx.doi.org/10.1371/journal.pone.0162631			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611572	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255900138
J	DeJonge, RE; Liu, XP; Deig, CR; Heller, S; Koehler, KR; Hashino, E				DeJonge, Rachel E.; Liu, Xiao-Ping; Deig, Christopher R.; Heller, Stefan; Koehler, Karl R.; Hashino, Eri			Modulation of Wnt Signaling Enhances Inner Ear Organoid Development in 3D Culture	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; OTIC PLACODE INDUCTION; SEMICIRCULAR CANAL FORMATION; FGF; MOUSE; FATE; DIFFERENTIATION; CATENIN; XENOPUS; MORPHOGENESIS	Stem cell-derived inner ear sensory epithelia are a promising source of tissues for treating patients with hearing loss and dizziness. We recently demonstrated how to generate inner ear sensory epithelia, designated as inner ear organoids, from mouse embryonic stem cells (ESCs) in a self-organizing 3D culture. Here we improve the efficiency of this culture system by elucidating how Wnt signaling activity can drive the induction of otic tissue. We found that a carefully timed treatment with the potent Wnt agonist CHIR99021 promotes induction of otic vesicles-a process that was previously self-organized by unknown mechanisms. The resulting otic-like vesicles have a larger lumen size and contain a greater number of Pax8/Pax2-positive otic progenitor cells than organoids derived without the Wnt agonist. Additionally, these otic-like vesicles give rise to large inner ear organoids with hair cells whose morphological, biochemical and functional properties are indistinguishable from those of vestibular hair cells in the postnatal mouse inner ear. We conclude that Wnt signaling plays a similar role during inner ear organoid formation as it does during inner ear development in the embryo.	[DeJonge, Rachel E.; Deig, Christopher R.; Koehler, Karl R.; Hashino, Eri] Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA; [DeJonge, Rachel E.; Koehler, Karl R.; Hashino, Eri] Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA; [Liu, Xiao-Ping] Boston Childrens Hosp, FM Kirby Neurobiol Ctr, Dept Otolaryngol, Boston, MA USA; [Liu, Xiao-Ping] Harvard Med Sch, Boston, MA 02115 USA; [Heller, Stefan] Stanford Univ, Dept Otolaryngol Head & Neck Surg, Palo Alto, CA 94305 USA	Indiana University System; Indiana University Bloomington; Indiana University System; Indiana University Bloomington; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Stanford University	Koehler, KR; Hashino, E (corresponding author), Indiana Univ Sch Med, Dept Otolaryngol Head & Neck Surg, Indianapolis, IN 46202 USA.; Koehler, KR; Hashino, E (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, Indianapolis, IN 46202 USA.	krkoehle@iupui.edu; ehashino@iupui.edu		Koehler, Karl/0000-0002-0685-538X; Moore, Rachel/0000-0002-6281-0821	National Institute of Health [R01 DC013294]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC013294] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This work was supported by a National Institute of Health grant R01 DC013294 (to EH).	Ahrens K, 2005, DEV BIOL, V288, P40, DOI 10.1016/j.ydbio.2005.07.022; Ai ZY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150936; Brown AS, 2015, DEV BIOL, V399, P177, DOI 10.1016/j.ydbio.2015.01.001; Durruthy-Durruthy R, 2014, CELL, V157, P964, DOI 10.1016/j.cell.2014.03.036; Forristall CA, 2014, DEV DYNAM, V243, P1262, DOI [10.1002/DVDY.24116, 10.1002/dvdy.24116]; Freter S, 2008, DEVELOPMENT, V135, P3415, DOI 10.1242/dev.026674; Freyer L, 2010, DEV DYNAM, V239, P1708, DOI 10.1002/dvdy.22308; Geng RS, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148339; Grocott T, 2012, DEV BIOL, V370, P3, DOI 10.1016/j.ydbio.2012.06.028; Groves AK, 2014, DEV BIOL, V389, P2, DOI 10.1016/j.ydbio.2013.11.027; Groves AK, 2012, DEVELOPMENT, V139, P245, DOI 10.1242/dev.067074; Hans S, 2007, DEVELOPMENT, V134, P2449, DOI 10.1242/dev.000448; Jacques BE, 2012, DEVELOPMENT, V139, P4395, DOI 10.1242/dev.080358; Jansson L, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00066; Koehler KR, 2014, NAT PROTOC, V9, P1229, DOI 10.1038/nprot.2014.100; Koehler KR, 2013, NATURE, V500, P217, DOI 10.1038/nature12298; Koehler KR, 2011, BMC NEUROSCI, V12, DOI 10.1186/1471-2202-12-82; Ladher RK, 2000, SCIENCE, V290, P1965, DOI 10.1126/science.290.5498.1965; Ladher RK, 2005, GENE DEV, V19, P603, DOI 10.1101/gad.1273605; Liu XP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11508; Martin K, 2006, DEVELOPMENT, V133, P877, DOI 10.1242/dev.02267; McCarroll MN, 2012, DEVELOPMENT, V139, P2740, DOI 10.1242/dev.076075; Munnamalai V, 2013, SEMIN CELL DEV BIOL, V24, P480, DOI 10.1016/j.semcdb.2013.03.008; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Noda T, 2012, DEV BIOL, V362, P83, DOI 10.1016/j.ydbio.2011.11.019; Ohyama T, 2006, DEVELOPMENT, V133, P865, DOI 10.1242/dev.02271; Oshima K, 2010, CELL, V141, P704, DOI 10.1016/j.cell.2010.03.035; Park BY, 2008, DEV BIOL, V324, P108, DOI 10.1016/j.ydbio.2008.09.009; Phillips BT, 2004, DEVELOPMENT, V131, P923, DOI 10.1242/dev.00978; Rakowiecki S, 2013, DEVELOPMENT, V140, P1730, DOI 10.1242/dev.092882; Riccomagno MM, 2005, GENE DEV, V19, P1612, DOI 10.1101/gad.1303905; Sai XR, 2015, FRONT PHARMACOL, V6, DOI 10.3389/fphar.2015.00019; Schimmang T, 2007, INT J DEV BIOL, V51, P473, DOI 10.1387/ijdb.072334ts; Shi FX, 2014, J NEUROSCI, V34, P6470, DOI 10.1523/JNEUROSCI.4305-13.2014; St-Jeannet JP, 2014, DEV BIOL, V389, P13, DOI 10.1016/j.ydbio.2014.02.011; Stevens CB, 2003, DEV BIOL, V261, P149, DOI 10.1016/S0012-1606(03)00297-5; Urness LD, 2010, DEV BIOL, V340, P595, DOI 10.1016/j.ydbio.2010.02.016; Vendrell V, 2000, DEVELOPMENT, V127, P2011; Wright KD, 2015, BMC DEV BIOL, V15, DOI 10.1186/s12861-015-0083-8	39	36	39	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162508	10.1371/journal.pone.0162508	http://dx.doi.org/10.1371/journal.pone.0162508			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607106	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600053
J	Kim, S; Sundaresan, V; Zhou, L; Kahveci, T				Kim, Sebo; Sundaresan, Varsha; Zhou, Lei; Kahveci, Tamer			Integrating Domain Specific Knowledge and Network Analysis to Predict Drug Sensitivity of Cancer Cell Lines	PLOS ONE			English	Article							PHASE-I SAFETY; KINASE INHIBITOR; PHARMACOKINETICS; TRIAL	One of fundamental challenges in cancer studies is that varying molecular characteristics of different tumor types may lead to resistance to certain drugs. As a result, the same drug can lead to significantly different results in different types of cancer thus emphasizing the need for individualized medicine. Individual prediction of drug response has great potential to aid in improving the clinical outcome and reduce the financial costs associated with prescribing chemotherapy drugs to which the patient's tumor might be resistant. In this paper we develop a network based classifier (NBC) method for predicting sensitivity of cell lines to anticancer drugs from transcriptome data. In the literature, this strategy has been used for predicting cancer types. Here, we extend it to estimate sensitivity of cells from different tumor types to various anticancer drugs. Furthermore, we incorporate domain specific knowledge such as the use of apoptotic gene list and clinical dose information in our method to impart biological significance to the prediction. Our experimental results suggest that our network based classifier (NBC) method outperforms existing classifiers in estimating sensitivity of cell lines for different drugs.	[Kim, Sebo; Kahveci, Tamer] Univ Florida, Dept Comp & Informat Sci & Engn, Gainesville, FL 32611 USA; [Sundaresan, Varsha; Zhou, Lei] Univ Florida, Coll Med, Dept Mol Genet & Microbiol, Gainesville, FL USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida	Kim, S; Kahveci, T (corresponding author), Univ Florida, Dept Comp & Informat Sci & Engn, Gainesville, FL 32611 USA.	sebkim@cise.ufl.edu; tamer@cise.ufl.edu			National Science Foundation (NSF) [1262451]; NSF [1262451]; NIH [R01GM106174]; UF Informatics Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM106174] Funding Source: NIH RePORTER	National Science Foundation (NSF)(National Science Foundation (NSF)National Research Foundation of Korea); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UF Informatics Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This paper is partially funded by National Science Foundation (NSF) under award number 1262451. This funding from NSF is the only source. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This paper is partially funded by NSF under award number 1262451 (TK) NIH R01GM106174 (LZ) and an award from UF Informatics Institute (TK&LZ).	Ay A, 2014, CANCER INFORM, V13, P15, DOI 10.4137/CIN.S14025; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; Baselga J, 2010, CLIN CANCER RES, V16, P4876, DOI 10.1158/1078-0432.CCR-10-0748; Berlow N, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-239; BLANEY SM, 1993, CANCER RES, V53, P1032; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Burris HA, 2005, J CLIN ONCOL, V23, P5305, DOI 10.1200/JCO.2005.16.584; Chabot GG, 1997, CLIN PHARMACOKINET, V33, P245, DOI 10.2165/00003088-199733040-00001; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Costello JC, 2014, NAT BIOTECHNOL, V32, P1202, DOI 10.1038/nbt.2877; Cunningham P., 2007, UCDCSI20074, DOI [10.1145/3459665, DOI 10.1145/3459665]; DeAngelo DJ, 2013, LEUKEMIA, V27, P1628, DOI 10.1038/leu.2013.38; Deininger MW, 2008, CLIN CANCER RES, V14, P4027, DOI 10.1158/1078-0432.CCR-07-5015; Deng YM, 2014, MOL CLIN ONCOL, V2, P116, DOI 10.3892/mco.2013.190; Drucker H, 1997, ADV NEUR IN, V9, P155; Goetz MP, 2005, J CLIN ONCOL, V23, P1078, DOI 10.1200/JCO.2005.09.119; Haura EB, 2010, CLIN CANCER RES, V16, P2450, DOI 10.1158/1078-0432.CCR-09-1920; Heewon Park, 2014, ROBUST PREDICTION AN; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hsu C.W., 2003, PRACTICAL GUIDE SUPP; Liu H, 1995, PROC INT C TOOLS ART, P388, DOI 10.1109/TAI.1995.479783; Murphy Kevin P., 2006, NAIVE BAYES CLASSIFI; O'Neil BH, 2011, J CLIN ONCOL, V29, P2350, DOI 10.1200/JCO.2010.33.9432; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Rokach L., 2005, DATA MIN KNOWL DISC; Sarker D, 2008, CLIN CANCER RES, V14, P2075, DOI 10.1158/1078-0432.CCR-07-1466; Sawyers C, 2004, NATURE, V432, P294, DOI 10.1038/nature03095; Schwartz GK, 2011, BRIT J CANCER, V104, P1862, DOI 10.1038/bjc.2011.177; Sellers WR, 1999, J CLIN INVEST, V104, P1655, DOI 10.1172/JCI9053; Strumberg D, 2007, ONCOLOGIST, V12, P426, DOI 10.1634/theoncologist.12-4-426; Urruticoechea A, 2010, CURR PHARM DESIGN, V16, P3, DOI 10.2174/138161210789941847; WIERNIK PH, 1987, CANCER RES, V47, P2486; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Yufang Qin, 2015, NETWORK FLOW BASED M; Zhang NQ, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004498; Zhou WJ, 2012, BRIT J PHARMACOL, V166, P1669, DOI 10.1111/j.1476-5381.2012.01849.x; Zou H, 2005, J R STAT SOC B, V67, P301, DOI 10.1111/j.1467-9868.2005.00503.x	37	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162173	10.1371/journal.pone.0162173	http://dx.doi.org/10.1371/journal.pone.0162173			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607242	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600024
J	Zadravec, P; Mareckova, L; Petrokova, H; Hodnik, V; Nanut, MP; Anderluh, G; Strukelj, B; Maly, P; Berlec, A				Zadravec, Petra; Mareckova, Lucie; Petrokova, Hana; Hodnik, Vesna; Nanut, Milica Perisic; Anderluh, Gregor; Strukelj, Borut; Maly, Petr; Berlec, Ales			Development of Recombinant Lactococcus lactis Displaying Albumin-Binding Domain Variants against Shiga Toxin 1 B Subunit	PLOS ONE			English	Article							CONTROLLED GENE-EXPRESSION; ESCHERICHIA-COLI INFECTIONS; SURFACE DISPLAY; GROWTH; INHIBITION; ANTIBODIES; TRANSPORT; PROTEINS; SCAFFOLD; STRAINS	Infections with shiga toxin-producing bacteria, like enterohemorrhagic Escherichia coli and Shigella dysenteriae, represent a serious medical problem. No specific and effective treatment is available for patients with these infections, creating a need for the development of new therapies. Recombinant lactic acid bacterium Lactococcus lactis was engineered to bind Shiga toxin by displaying novel designed albumin binding domains (ABD) against Shiga toxin 1 B subunit (Stx1B) on their surface. Functional recombinant Stx1B was produced in Escherichia coli and used as a target for selection of 17 different ABD variants (named S1B) from the ABD scaffold-derived high-complex combinatorial library in combination with a five-round ribosome display. Two most promising S1Bs (S1B22 and S1B26) were characterized into more details by ELISA, surface plasmon resonance and microscale thermophoresis. Addition of S1Bs changed the subcellular distribution of Stx1B, completely eliminating it from Golgi apparatus most likely by interfering with its retrograde transport. All ABD variants were successfully displayed on the surface of L. lactis by fusing to the Usp45 secretion signal and to the peptidoglycan-binding C terminus of AcmA. Binding of Stx1B by engineered lactococcal cells was confirmed using flow cytometry and whole cell ELISA. Lactic acid bacteria prepared in this study are potentially useful for the removal of Shiga toxin from human intestine.	[Zadravec, Petra; Nanut, Milica Perisic; Strukelj, Borut; Berlec, Ales] Jozef Stefan Inst, Dept Biotechnol, Jamova 39, SI-1000 Ljubljana, Slovenia; [Zadravec, Petra; Strukelj, Borut] Univ Ljubljana, Fac Pharm, Chair Pharmaceut Biol, Askerceva 7, SI-1000 Ljubljana, Slovenia; [Mareckova, Lucie; Petrokova, Hana; Maly, Petr] BIOCEV Res Ctr, Inst Biotechnol CAS, Lab Ligand Engn, Vvi, Prumyslova 595, Vestec 25250, Czech Republic; [Hodnik, Vesna; Anderluh, Gregor] Univ Ljubljana, Dept Biol, Biotech Fac, Jamnikarjeva 101, Ljubljana 1000, Slovenia; [Hodnik, Vesna; Anderluh, Gregor] Natl Inst Chem, Hajdrihova 19, Ljubljana 1000, Slovenia	Slovenian Academy of Sciences & Arts (SASA); Jozef Stefan Institute; University of Ljubljana; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences; University of Ljubljana; National Institute of Chemistry - Slovenia	Berlec, A (corresponding author), Jozef Stefan Inst, Dept Biotechnol, Jamova 39, SI-1000 Ljubljana, Slovenia.	ales.berlec@ijs.si	Berlec, Aleš/AAG-5922-2019; Marečková, Lucie/G-9720-2014; Anderluh, Gregor/C-6905-2014; Petroková, Hana/AAN-2763-2021; Petrokova, Hana/H-2563-2014; Malý, Petr/H-5962-2014	Berlec, Aleš/0000-0002-8095-6998; Marečková, Lucie/0000-0002-8300-2305; Anderluh, Gregor/0000-0002-9916-8465; Malý, Petr/0000-0001-8118-0581; Perisic Nanut, Milica/0000-0003-2314-2733	Slovenian Research Agency [P4-0127]; Slovene human resources development and scholarship fund; ERDF [BIOCEV CZ.1.05/1.1.00/02.0109]; Academy of Sciences of the Czech Republic [SAZU-16-01]; Slovenian Academy of Sciences and Arts [SAZU-16-01];  [RVO: 86652036]	Slovenian Research Agency(Slovenian Research Agency - Slovenia); Slovene human resources development and scholarship fund; ERDF(European Commission); Academy of Sciences of the Czech Republic(Czech Academy of Sciences); Slovenian Academy of Sciences and Arts; 	This work was supported by Slovenian Research Agency grant P4-0127, by Slovene human resources development and scholarship fund, by Bilateral mobility project between Academy of Sciences of the Czech Republic and Slovenian Academy of Sciences and Arts (No. SAZU-16-01) and by BIOCEV CZ.1.05/1.1.00/02.0109 from the ERDF and the institutional research concept RVO: 86652036.	Ahmad JN, 2012, PROTEINS, V80, P774, DOI 10.1002/prot.23234; ASHKENAZI S, 1989, J CLIN MICROBIOL, V27, P1145, DOI 10.1128/JCM.27.6.1145-1150.1989; Berlec A, 2013, APPL MICROBIOL BIOT, V97, P4333, DOI 10.1007/s00253-013-4722-3; Berlec A, 2011, APPL ENVIRON MICROB, V77, P1292, DOI 10.1128/AEM.02102-10; Bondos SE, 2003, ANAL BIOCHEM, V316, P223, DOI 10.1016/S0003-2697(03)00059-9; BUIST G, 1995, J BACTERIOL, V177, P1554, DOI 10.1128/jb.177.6.1554-1563.1995; deRuyter PGGA, 1996, APPL ENVIRON MICROB, V62, P3662, DOI 10.1128/AEM.62.10.3662-3667.1996; Dieye Y, 2001, J BACTERIOL, V183, P4157, DOI 10.1128/JB.183.14.4157-4166.2001; Gebauer M, 2009, CURR OPIN CHEM BIOL, V13, P245, DOI 10.1016/j.cbpa.2009.04.627; Johannes L, 2010, NAT REV MICROBIOL, V8, P105, DOI 10.1038/nrmicro2279; Keir LS, 2012, DRUG DES DEV THER, V6, P195, DOI 10.2147/DDDT.S25757; Kim JH, 1996, J CELL BIOL, V134, P1387, DOI 10.1083/jcb.134.6.1387; Kuchar M, 2014, PROTEINS, V82, P975, DOI 10.1002/prot.24472; KUIPERS OP, 1993, EUR J BIOCHEM, V216, P281, DOI 10.1111/j.1432-1033.1993.tb18143.x; Kuipers OP, 1998, J BIOTECHNOL, V64, P15, DOI 10.1016/S0168-1656(98)00100-X; Lindholm A, 2004, APPL ENVIRON MICROB, V70, P2061, DOI 10.1128/AEM.70.4.2061-2071.2004; Lipovsek D, 2004, J IMMUNOL METHODS, V290, P51, DOI 10.1016/j.jim.2004.04.008; Mareckova L, 2015, PROTEIN CELL, V6, P774, DOI 10.1007/s13238-015-0194-9; Melton-Celsa AR, 2014, MICROBIOL SPECTR, V2, DOI 10.1128/microbiolspec.EHEC-0013-2013; Mierau I, 2005, APPL MICROBIOL BIOT, V68, P705, DOI 10.1007/s00253-005-0107-6; Mohsin M, 2015, INT J MED MICROBIOL, V305, P20, DOI 10.1016/j.ijmm.2014.10.003; Neri P, 2011, VACCINE, V29, P5340, DOI 10.1016/j.vaccine.2011.05.093; OBRIEN AD, 1987, MICROBIOL REV, V51, P206, DOI 10.1128/MMBR.51.2.206-220.1987; Ogawa M, 2001, INT J FOOD MICROBIOL, V68, P135, DOI 10.1016/S0168-1605(01)00465-2; Oneda H, 1999, J BIOCHEM-TOKYO, V126, P905, DOI 10.1093/oxfordjournals.jbchem.a022533; Paton AW, 2000, NAT MED, V6, P265, DOI 10.1038/73111; Paton JC, 1998, CLIN MICROBIOL REV, V11, P450, DOI 10.1128/CMR.11.3.450; Pinyon RA, 2004, J INFECT DIS, V189, P1547, DOI 10.1086/383417; Rahal EA, 2015, FRONT CELL INFECT MI, V5, DOI 10.3389/fcimb.2015.00024; Ravnikar M, 2010, APPL ENVIRON MICROB, V76, P6928, DOI 10.1128/AEM.00190-10; Reissbrodt R, 2009, FEMS MICROBIOL LETT, V290, P62, DOI 10.1111/j.1574-6968.2008.01405.x; Richter A, 2014, FEBS LETT, V588, P213, DOI 10.1016/j.febslet.2013.11.006; Sandvig K, 1996, PHYSIOL REV, V76, P949, DOI 10.1152/physrev.1996.76.4.949; Sandvig K, 2001, TOXICON, V39, P1629, DOI 10.1016/S0041-0101(01)00150-7; Skrlec K, 2015, TRENDS BIOTECHNOL, V33, P408, DOI 10.1016/j.tibtech.2015.03.012; Steen A, 2005, FEBS J, V272, P2854, DOI 10.1111/j.1742-4658.2005.04706.x; Steen A, 2003, J BIOL CHEM, V278, P23874, DOI 10.1074/jbc.M211055200; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; Zadravec P, 2015, BIOENGINEERED, V6, P179, DOI 10.1080/21655979.2015.1040956; Zadravec P, 2015, APPL ENVIRON MICROB, V81, P2098, DOI 10.1128/AEM.03694-14; Zadravec P, 2014, PROTEIN ENG DES SEL, V27, P21, DOI 10.1093/protein/gzt059	41	16	17	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162625	10.1371/journal.pone.0162625	http://dx.doi.org/10.1371/journal.pone.0162625			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606705	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255600070
J	Carrere-Kremer, S; Rubbo, PA; Pisoni, A; Bendriss, S; Marin, G; Peries, M; Bollore, K; Terru, D; Godreuil, S; Bourdin, A; Van de Perre, P; Tuaillon, E				Carrere-Kremer, Severine; Rubbo, Pierre-Alain; Pisoni, Amandine; Bendriss, Sophie; Marin, Gregory; Peries, Marianne; Bollore, Karine; Terru, Dominique; Godreuil, Sylvain; Bourdin, Arnaud; Van de Perre, Philippe; Tuaillon, Edouard			High IFN-gamma Release and Impaired Capacity of Multi-Cytokine Secretion in IGRA Supernatants Are Associated with Active Tuberculosis	PLOS ONE			English	Article							T-CELL RESPONSES; LATENT TUBERCULOSIS; DIAGNOSIS; ASSAYS; INFECTION; CD4(+); VACCINE; ADULTS; TOOL	Interferon gamma (IFN-gamma) release assays (IGRAs) detect Mycobacterium tuberculosis (Mtb) infection regardless of the active (ATB) or latent (LTBI) forms of tuberculosis (TB). In this study, Mtb-specific T cell response against region of deletion 1 (RD1) antigens were explored by a microbead multiplex assay performed in T-SPOT TB assay (T-SPOT) supernatants from 35 patients with ATB and 115 patients with LTBI. T-SPOT is positive when over 7 IFN-gamma secreting cells (SC)/250 000 peripheral blood mononuclear cells (PBMC) are enumerated. However, over 100 IFN-gamma SC /250 000 PBMC were more frequently observed in the ATB group compared to the LTBI group. By contrast, lower cytokine concentrations and lower cytokine productions relative to IFN-gamma secretion were observed for IL 4, IL-12, TNF-alpha, GM-CSF, Eotaxin and IFN-alpha when compared to LTBI. Thus, high IFN-gamma release and low cytokine secretions in relation with IFN-gamma production appeared as signatures of ATB, corroborating that multicytokine Mtb-specific response against RD1 antigens reflects host capacity to contain TB reactivation. In this way, testing cytokine profile in IGRA supernatants would be helpful to improve ATB screening strategy including immunologic tests.	[Carrere-Kremer, Severine; Rubbo, Pierre-Alain; Pisoni, Amandine; Peries, Marianne; Bollore, Karine; Van de Perre, Philippe; Tuaillon, Edouard] Univ Montpellier, UMR1058, INSERM, EFS, Montpellier, France; [Carrere-Kremer, Severine; Rubbo, Pierre-Alain; Bollore, Karine; Van de Perre, Philippe; Tuaillon, Edouard] Univ Montpellier, Montpellier, France; [Pisoni, Amandine; Bendriss, Sophie; Terru, Dominique; Godreuil, Sylvain; Van de Perre, Philippe; Tuaillon, Edouard] CHRU Montpellier, Dept Bacteriol Virol, Montpellier, France; [Bourdin, Arnaud] CHRU Montpellier, Dept Pneumol, Montpellier, France; [Marin, Gregory] CHRU Montpellier, Dept Med Informat, Montpellier, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier; Universite de Montpellier; CHU de Montpellier	Carrere-Kremer, S; Tuaillon, E (corresponding author), Univ Montpellier, UMR1058, INSERM, EFS, Montpellier, France.; Carrere-Kremer, S; Tuaillon, E (corresponding author), Univ Montpellier, Montpellier, France.; Tuaillon, E (corresponding author), CHRU Montpellier, Dept Bacteriol Virol, Montpellier, France.	severine.kremer@yahoo.fr; e-tuaillon@chu-montpellier.fr	Van de Perre, Philippe/B-9692-2008	Van de Perre, Philippe/0000-0002-3912-0427; godreuil, sylvain/0000-0003-3436-0082; Tuaillon, Edouard/0000-0001-5866-9530	INSERM DHOS (AFSSAPS) [2010-A00422-37]; CHRU Montpellier; Fondation de France	INSERM DHOS (AFSSAPS); CHRU Montpellier; Fondation de France(Fondation de France)	This work was supported by the INSERM DHOS grant (AFSSAPS no 2010-A00422-37) and by CHRU Montpellier. SCK was funded by the Fondation de France. The INSERM DHOS grant (AFSSAPS no 2010-A00422-37) did not provide any support in the form of salaries for authors, and did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The Fondation de France provided support in the form of salaries for SCK.	Abel B, 2010, AM J RESP CRIT CARE, V181, P1407, DOI 10.1164/rccm.200910-1484OC; Barry CE, 2009, NAT REV MICROBIOL, V7, P845, DOI 10.1038/nrmicro2236; Beveridge NER, 2007, EUR J IMMUNOL, V37, P3089, DOI 10.1002/eji.200737504; Biraro IA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146098; Biselli R, 2010, CLIN MICROBIOL INFEC, V16, P1282, DOI 10.1111/j.1469-0691.2009.03104.x; Borgstrom E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043438; Chee CBE, 2009, EUR J CLIN MICROBIOL, V28, P667, DOI 10.1007/s10096-008-0670-8; Chegou NN, 2014, EUR RESPIR J, V43, P1472, DOI 10.1183/09031936.00151413; Chen T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144705; Day CL, 2008, J INFECT DIS, V197, P990, DOI 10.1086/529048; Day CL, 2011, J IMMUNOL, V187, P2222, DOI 10.4049/jimmunol.1101122; Geldenhuys H, 2015, VACCINE, V33, P3592, DOI 10.1016/j.vaccine.2015.05.036; Harari A, 2011, NAT MED, V17, P372, DOI 10.1038/nm.2299; Jenum S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101224; Kim S, 2015, J MOL DIAGN, V17, P90, DOI 10.1016/j.jmoldx.2014.08.005; Kobashi Y, 2010, LUNG, V188, P283, DOI 10.1007/s00408-010-9238-3; Lavender TW, 2013, CLIN MICROBIOL INFEC, V19, P1078, DOI 10.1111/1469-0691.12129; Lew W, 2008, ANN INTERN MED, V149, P123, DOI 10.7326/0003-4819-149-2-200807150-00008; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Little KM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124525; Mamishi S, 2014, EUR J CLIN MICROBIOL, V33, P2111, DOI 10.1007/s10096-014-2190-z; Masson L, 2015, CLIN INFECT DIS, V61, P260, DOI 10.1093/cid/civ298; Metcalfe JZ, 2011, J INFECT DIS, V204, pS1120, DOI 10.1093/infdis/jir410; Pai M, 2014, CLIN MICROBIOL REV, V27, P3, DOI 10.1128/CMR.00034-13; Pollock KM, 2013, J INFECT DIS, V208, P952, DOI 10.1093/infdis/jit265; Ritz N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037535; Rozot V, 2015, CLIN INFECT DIS, V60, P432, DOI 10.1093/cid/ciu795; Rubbo PA, 2012, J CLIN MICROBIOL, V50, P1711, DOI 10.1128/JCM.00117-12; Sargentini V, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-99; Soares AP, 2008, J IMMUNOL, V180, P3569, DOI 10.4049/jimmunol.180.5.3569; Suter-Riniker F, 2011, CLIN VACCINE IMMUNOL, V18, P1395, DOI 10.1128/CVI.05013-11; Tebruegge M, 2015, AM J RESP CRIT CARE, V192, P485, DOI 10.1164/rccm.201501-0059OC; Wang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051338; WHO, 2014, GLOB TUB REP 2014; Wold S, 2001, CHEMOMETR INTELL LAB, V58, P109, DOI 10.1016/S0169-7439(01)00155-1	35	6	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162137	10.1371/journal.pone.0162137	http://dx.doi.org/10.1371/journal.pone.0162137			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603919	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200047
J	Maffey, L; Vega, CG; Mino, S; Garaicoechea, L; Parreno, V				Maffey, Lucia; Vega, Celina G.; Mino, Samuel; Garaicoechea, Lorena; Parreno, Viviana			Anti-VP6 VHH: An Experimental Treatment for Rotavirus A-Associated Disease	PLOS ONE			English	Article							SINGLE-DOMAIN ANTIBODY; LACTOBACILLUS-RHAMNOSUS GG; INDUCED DIARRHEA; MONOCLONAL-ANTIBODIES; IN-VITRO; PASSIVE PROTECTION; CONFER PROTECTION; CONTROLLED-TRIAL; FRAGMENTS; RESPONSES	Species A Rotaviruses (RVA) remain a leading cause of mortality in children under 5 years of age. Current treatment options are limited. We assessed the efficacy of two VP6-specific llama-derived heavy chain antibody fragments (VHH) -2KD1 and 3B2- as an oral prophylactic and therapeutic treatment against RVA-induced diarrhea in a neonatal mouse model inoculated with virulent murine RVA (ECw, G16P[16]I7). Joint therapeutic administration of 2KD1+3B2 (200 mu g/dose) successfully reduced diarrhea duration, RVA infection severity and virus shedding in feces. While the same dose of 2KD1 or 3B2 (200 mu g) significantly reduced duration of RVA-induced diarrhea, 2KD1 was more effective in diminishing the severity of intestinal infection and RVA shedding in feces, perhaps because 2KD1 presented higher binding affinity for RVA particles than 3B2. Neither prophylactic nor therapeutic administration of the VHH interfered with the host's humoral immune response against RVA. When 2KD1 (200 mu g) was administered after diarrhea development, it also significantly reduced RVA intestinal infection and fecal shedding. Host antibody responses against the oral VHH treatment were not detected, nor did viral escape mutants. Our findings show that oral administration of anti-VP6 VHH constitute, not only an effective prophylactic treatment against RVA-associated diarrhea, but also a safe therapeutic tool against RVA infection, even once diarrhea is present. Anti-VP6 VHH could be used complementary to ongoing vaccination, especially in populations that have shown lower immunization efficacy. These VHH could also be scaled-up to develop pediatric medication or functional food like infant milk formulas that might help treat RVA diarrhea.	[Maffey, Lucia; Vega, Celina G.; Mino, Samuel; Garaicoechea, Lorena; Parreno, Viviana] INTA Castelar, Inst Virol, Ctr Invest Ciencias Vet & Agron, Buenos Aires, DF, Argentina; [Maffey, Lucia; Vega, Celina G.; Garaicoechea, Lorena; Parreno, Viviana] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina	Instituto Nacional de Tecnologia Agropecuaria (INTA); Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)	Parreno, V (corresponding author), INTA Castelar, Inst Virol, Ctr Invest Ciencias Vet & Agron, Buenos Aires, DF, Argentina.; Parreno, V (corresponding author), Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina.	parreno.viviana@inta.gob.ar		Mino, Samuel/0000-0003-1048-8532; Vega, Celina/0000-0002-0644-7263; parreno, viviana/0000-0003-0385-5592; Maffey, Lucia/0000-0002-1411-8355	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina through the Proyecto Investigacion Cientifica y Tecnologica [328-10]; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina through the Proyecto INTABIO AF [03-2010]; Convocatoria Alimentos Funcionales, Fondo Argentino Sectorial (FONARSEC) through the Proyecto Nacional de Salud Animal [1115053]; Instituto Nacional de Tecnologia Agropecuaria through the Programa Nacional de Biotecnologia [1131032]	Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina through the Proyecto Investigacion Cientifica y Tecnologica; Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina through the Proyecto INTABIO AF; Convocatoria Alimentos Funcionales, Fondo Argentino Sectorial (FONARSEC) through the Proyecto Nacional de Salud Animal; Instituto Nacional de Tecnologia Agropecuaria through the Programa Nacional de Biotecnologia	This work received support from Agencia Nacional de Promocion Cientifica y Tecnologica, Argentina through the following grants: Proyecto Investigacion Cientifica y Tecnologica No 328-10, Proyecto INTABIO AF No 03-2010. Convocatoria Alimentos Funcionales, Fondo Argentino Sectorial (FONARSEC) and from Instituto Nacional de Tecnologia Agropecuaria through the following grants: Proyecto Nacional de Salud Animal No 1115053 and Programa Nacional de Biotecnologia No 1131032.; We would like to thank Dr. Ulrich Desselberger for his kind help with the manuscript and his valuable suggestions. We are very grateful for the technical assistance of Fatima Torales for caring for the animals and Dr. Marina Bok and M.Sci. Josefina Baztarrica for useful assistance throughout the experimental procedures. We would also like to thank Dr. Osvaldo Zabal and Diego Compaired for technical support. We are thankful to Dr. Alejandro Castello for providing ECw RVA strains used in this work. VP, CGV and LLG are members of CONICET Scientist Carrier, Argentina. LM has a PhD scholarship from CONICET, Argentina.	Aladin F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032949; Arbabi-ghahroudi M, 2005, PROKARYOTIC EXPRESSI, P501; Bae EA, 2000, BIOL PHARM BULL, V23, P1122, DOI 10.1248/bpb.23.1122; Burns JW, 1996, SCIENCE, V272, P104, DOI 10.1126/science.272.5258.104; Cornaglia E, 1989, REV LATINOAM MICROBI, P59; Corthesy B, 2006, J VIROL, V80, P10692, DOI 10.1128/JVI.00927-06; COULSON BS, 1990, J CLIN MICROBIOL, V28, P1367, DOI 10.1128/JCM.28.6.1367-1374.1990; Daugherty AL, 2006, ADV DRUG DELIVER REV, V58, P686, DOI 10.1016/j.addr.2006.03.011; Dolk E, 2005, APPL ENVIRON MICROB, V71, P442, DOI 10.1128/AEM.71.1.442-450.2005; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Estes MK, 2001, FIELDS VIROLOGY, P1347; Feng NG, 2013, J VIROL, V87, P8307, DOI 10.1128/JVI.00619-13; Frenken LGJ, 2000, J BIOTECHNOL, V78, P11, DOI 10.1016/S0168-1656(99)00228-X; Garaicoechea L, 2008, J VIROL, V82, P9753, DOI 10.1128/JVI.00436-08; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Gomez-Sebastian S, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-59; Grandy G, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-253; Greenberg HB, 2009, GASTROENTEROLOGY, V136, P1939, DOI 10.1053/j.gastro.2009.02.076; Gunaydin G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096409; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HAMERSCASTERMAN C, 1993, NATURE, V363, P446, DOI 10.1038/363446a0; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Hodgins DC, 1999, J VIROL, V73, P186, DOI 10.1128/JVI.73.1.186-197.1999; Inagaki M, 2010, BIOSCI BIOTECH BIOCH, V74, P680, DOI 10.1271/bbb.90862; Ismaili A, 2007, BIOTECHNOL APPL BIOC, V47, P11, DOI 10.1042/BA20060071; Kim DH, 2000, BIOL PHARM BULL, V23, P356, DOI 10.1248/bpb.23.356; Lanata CF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072788; Lentz EM, 2012, PLANTA, V236, P703, DOI 10.1007/s00425-012-1642-x; LITTLE LM, 1982, INFECT IMMUN, V38, P755, DOI 10.1128/IAI.38.2.755-763.1982; Maffey L, 2015, REV ARGENT MICROBIOL, V47, P368, DOI 10.1016/j.ram.2015.09.005; MATSUI SM, 1989, J CLIN MICROBIOL, V27, P780, DOI 10.1128/JCM.27.4.780-782.1989; Mine Yoshinori, 2002, Journal of Medicinal Food, V5, P159, DOI 10.1089/10966200260398198; Mino S, 2013, VET MICROBIOL, V161, P239, DOI 10.1016/j.vetmic.2012.07.033; Mrukowicz J, 2008, J PEDIATR GASTR NUTR, V46, pS32, DOI 10.1097/MPG.0b013e31816f79b0; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; OFFIT PA, 1986, J VIROL, V58, P700, DOI 10.1128/JVI.58.2.700-703.1986; Pant N, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-86; Pant N, 2006, J INFECT DIS, V194, P1580, DOI 10.1086/508747; Pant N, 2011, FUTURE MICROBIOL, V6, P583, DOI [10.2217/fmb.11.32, 10.2217/FMB.11.32]; Parashar UD, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f7204; Parreno V, 1999, J GEN VIROL, V80, P1417, DOI 10.1099/0022-1317-80-6-1417; Pellis M, 2012, ARCH BIOCHEM BIOPHYS, V526, P114, DOI 10.1016/j.abb.2012.04.023; Preidis GA, 2012, J PEDIATR GASTR NUTR, V55, P299, DOI 10.1097/MPG.0b013e31824d2548; Reilly RM, 1997, CLIN PHARMACOKINET, V32, P313, DOI 10.2165/00003088-199732040-00004; Saif L, 1997, ADV EXP MED BIOL, V412, P397; Sarker SA, 1998, PEDIATR INFECT DIS J, V17, P1149, DOI 10.1097/00006454-199812000-00010; Sarker SA, 2001, J PEDIATR GASTR NUTR, V32, P19, DOI 10.1097/00005176-200101000-00009; Sarker SA, 2007, J HEALTH POPUL NUTR, V25, P465; Sarker SA, 2013, GASTROENTEROLOGY, V145, P740, DOI 10.1053/j.gastro.2013.06.053; SVENSSON L, 1987, J GEN VIROL, V68, P1993, DOI 10.1099/0022-1317-68-7-1993; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tate JE, 2016, CLIN INFECT DIS, V62, pS96, DOI 10.1093/cid/civ1013; Tate JE, 2012, LANCET INFECT DIS, V12, P136, DOI 10.1016/S1473-3099(11)70253-5; Teran CG, 2009, INT J INFECT DIS, V13, P518, DOI 10.1016/j.ijid.2008.09.014; Tokuhara D, 2013, J CLIN INVEST, V123, P3829, DOI 10.1172/JCI70266; van der Linden RHJ, 1999, BBA-PROTEIN STRUCT M, V1431, P37, DOI 10.1016/S0167-4838(99)00030-8; van der Vaart JM, 2006, VACCINE, V24, P4130, DOI 10.1016/j.vaccine.2006.02.045; Vanlandschoot P, 2011, ANTIVIR RES, V92, P389, DOI 10.1016/j.antiviral.2011.09.002; Vega C, 2011, VET IMMUNOL IMMUNOP, V142, P156, DOI 10.1016/j.vetimm.2011.05.003; Vega CG, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003334; Vega CG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042788; VESIKARI T, 1985, J PEDIATR-US, V107, P189, DOI 10.1016/S0022-3476(85)80123-2; Ward R, 2009, PEDIATR INFECT DIS J, V28, pS57, DOI 10.1097/INF.0b013e3181967c16; *WHO UNICEF, 2006, IMPL NEW REC CLIN MA; Yuan LJ, 1996, J VIROL, V70, P3075, DOI 10.1128/JVI.70.5.3075-3083.1996; Zhang Z, 2013, PATHOG DIS, V67, P184, DOI 10.1111/2049-632X.12030	66	17	17	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162351	10.1371/journal.pone.0162351	http://dx.doi.org/10.1371/journal.pone.0162351			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603013	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255200059
J	Bahler, C; Signorell, A; Reich, O				Bahler, Caroline; Signorell, Andri; Reich, Oliver			Health Care Utilisation and Transitions between Health Care Settings in the Last 6 Months of Life in Switzerland	PLOS ONE			English	Article							SMALL-AREA ANALYSIS; OLDER-PEOPLE; RETROSPECTIVE ANALYSIS; END; PLACE; DEATH; PATIENT; HOSPITALIZATIONS; PREFERENCES; POPULATION	Background Many efforts are undertaken in Switzerland to enable older and/or chronically ill patients to stay home longer at the end-of-life. One of the consequences might be an increased need for hospitalisations at the end-of-life, which goes along with burdensome transitions for patients and higher health care costs for the society. Aim We aimed to examine the health care utilisation in the last six months of life, including transitions between health care settings, in a Swiss adult population. Methods The study population consisted of 11'310 decedents of 2014 who were insured at the Helsana Group, the leading health insurance in Switzerland. Descriptive statistics were used to analyse the health care utilisation by age group, taking into account individual and regional factors. Zero-inflated Poisson regression model was used to predict the number of transitions. Results Mean age was 78.1 in men and 83.8 in women. In the last six months of life, 94.7% of the decedents had at least one consultation; 61.6% were hospitalised at least once, with a mean length of stay of 28.3 days; and nursing home stays were seen in 47.4% of the decedents. Over the same time period, 64.5% were transferred at least once, and 12.9% experienced at least one burdensome transition. Main predictors for transitions were age, sex and chronic conditions. A high density of home care nurses was associated with a decrease, whereas a high density of ambulatory care physicians was associated with an increase in the number of transitions. Conclusions Health care utilisation was high in the last six months of life and a considerable number of decedents were being transferred. Advance care planning might prevent patients from numerous and particularly from burdensome transitions.	[Bahler, Caroline; Signorell, Andri; Reich, Oliver] Helsana Insurance Grp, Dept Hlth Sci, CH-8081 Zurich, Switzerland		Reich, O (corresponding author), Helsana Insurance Grp, Dept Hlth Sci, CH-8081 Zurich, Switzerland.	oliver.reich@helsana.ch			Helsana Group	Helsana Group	Helsana Group provided support in the form of salaries for authors [CB, OR, AS] but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Abarshi E, 2010, PALLIATIVE MED, V24, P166, DOI 10.1177/0269216309351381; Abel J, 2009, PALLIATIVE MED, V23, P616, DOI 10.1177/0269216309106460; Bach PB, 2004, JAMA-J AM MED ASSOC, V292, P2765, DOI 10.1001/jama.292.22.2765; Barnato AE, 2007, MED CARE, V45, P386, DOI 10.1097/01.mlr.0000255248.79308.41; Beernaert K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137251; Berlin C, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-289; Bundesamt fur Gesundheit und Schweizerische Konferenz der kantonalen Gesundheitsdirektorinnen und -direktoren, 2012, NAT STRAT PALL CAR 2; Bundesamt fur Statistik [Swiss Federal Statistical Office], 2013, STAT HILF PFLEG HAUS; Bundesamt fur Statistik [Swiss Federal Statistical Office], 2015, NOM RAUML GLIED; Bundesamt fur Statistik [Swiss Federal Statistical Office], 2013, STAT SOZ I SOMED; Burge Frederick I, 2005, BMC Palliat Care, V4, P3, DOI 10.1186/1472-684X-4-3; Chitnis XA, 2013, BMJ SUPPORT PALLIAT, V3, P422, DOI 10.1136/bmjspcare-2012-000424; Dowling-Castronovo A, 2002, GERONTOLOGIST, V42, P82, DOI 10.1093/geront/42.suppl_3.54; Evans G, 2011, J EVAL CLIN PRACT, V17, P1045, DOI 10.1111/j.1365-2753.2010.01471.x; FMH [Swiss Medical Association], 2013, ARZTESTATISTIK; Fried TR, 1999, ANN INTERN MED, V131, P109, DOI 10.7326/0003-4819-131-2-199907200-00006; Gielen B, 2010, HEALTH POLICY, V97, P53, DOI 10.1016/j.healthpol.2010.03.002; Gomez-Batiste X, 2007, J PAIN SYMPTOM MANAG, V33, P584, DOI 10.1016/j.jpainsymman.2007.02.019; Hedinger D, 2015, BMC GERIATR, V15, DOI 10.1186/s12877-015-0111-3; Hedinger D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113236; Hollander MJ, 2007, CAN J AGING, V26, P149, DOI 10.3138/cja.26.suppl_1.149; Huber CA, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1030; JACOB JA, 2015, JAMA J AM MED ASSOC, V314, P761; Kardamanidis K, 2007, MED J AUSTRALIA, V187, P383, DOI 10.5694/j.1326-5377.2007.tb01306.x; Kaspers PJ, 2013, PALLIATIVE MED, V27, P544, DOI 10.1177/0269216312457212; Klauss G, 2005, BMC HEALTH SERV RES, V5, DOI 10.1186/1472-6963-5-33; Klinkenberg M, 2005, HEALTH SOC CARE COMM, V13, P420, DOI 10.1111/j.1365-2524.2005.00567.x; Ko W, 2014, BMC CANCER, V14, DOI 10.1186/1471-2407-14-960; Lawson Beverley, 2006, BMC Palliat Care, V5, P4, DOI 10.1186/1472-684X-5-4; Matter-Walstra K, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-119; Morrison RS, 2008, ARCH INTERN MED, V168, P1783, DOI 10.1001/archinte.168.16.1783; Organisation for Economic Co-operation and Development (OECD), 2013, LIF EXP BIRTH; Perrels AJ, 2014, PALLIATIVE MED, V28, P220, DOI 10.1177/0269216313510341; Pollock K, 2015, BMJ-BRIT MED J, V351, DOI 10.1136/bmj.h4855; Reich O, 2013, BMC HEALTH SERV RES, V13, DOI 10.1186/1472-6963-13-116; Simoens S, 2010, J PALLIAT MED, V13, P1365, DOI 10.1089/jpm.2010.0212; Switzerland GfK, 2009, BEV PALL CAR; Teno JM, 2013, JAMA-J AM MED ASSOC, V309, P470, DOI 10.1001/jama.2012.207624; Van den Block L, 2007, BMC HEALTH SERV RES, V7, DOI 10.1186/1472-6963-7-69; Van den Block L, 2007, JAMA-J AM MED ASSOC, V298, P1638, DOI 10.1001/jama.298.14.1638; Van den Block Lieve, 2007, BMC Palliat Care, V6, P6; van den Block L, 2015, EUR J PUBLIC HEALTH, V25, P569, DOI 10.1093/eurpub/ckv039; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	43	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0160932	10.1371/journal.pone.0160932	http://dx.doi.org/10.1371/journal.pone.0160932			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IT	27598939	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800004
J	Fernandes, FF; de Oliveira, LL; Landgraf, TN; Peron, G; Costa, MV; Coelho-Castelo, AAM; Bonato, VLD; Roque-Barreira, MC; Panunto-Castelo, A				Fernandes, Fabr-Cio Freitas; de Oliveira, Leandro Licursi; Landgraf, Taise Natali; Peron, Gabriela; Costa, Marcelo Vieira; Coelho-Castelo, Arlete A. M.; Bonato, Vania L. D.; Roque-Barreira, Maria-Cristina; Panunto-Castelo, Ademilson			Detrimental Effect of Fungal 60-kDa Heat Shock Protein on Experimental Paracoccidioides brasiliensis Infection	PLOS ONE			English	Article							ANTIINFLAMMATORY CYTOKINES; GLYCOPROTEIN GP43; IMMUNE-RESPONSE; HUMAN MONOCYTES; EXPRESSION; GENE; PATHOGENESIS; PURIFICATION; PROTECTION; SPECIATION	The genus Paracoccidioides comprises species of dimorphic fungi that cause paracocci-dioidomycosis (PCM), a systemic disease prevalent in Latin America. Here, we investigated whether administration of native 60-kDa heat shock protein of P. brasiliensis (nPbHsp60) or its recombinant counterpart (rPbHsp60) affected the course of experimental PCM. Mice were subcutaneously injected with nPbHsp60 or rPbHsp60 emulsified in complete's Freund Adjuvant (CFA) at three weeks after intravenous injection of P. brasiliensis yeasts. Infected control mice were injected with CFA or isotonic saline solution alone. Thirty days after the nPbHsp60 or rPbHsp60 administration, mice showed remarkably increased fungal load, tissue inflammation, and granulomas in the lungs, liver, and spleen compared with control mice. Further, rPbHsp60 treatment (i) decreased the known protective effect of CFA against PCM and (ii) increased the concentrations of IL-17, TNF-alpha, IL-12, IFN-gamma, IL-4, IL-10, and TGF-beta in the lungs. Together, our results indicated that PbHsp60 induced a harmful immune response, exacerbated inflammation, and promoted fungal dissemination. Therefore, we propose that PbHsp60 contributes to the fungal pathogenesis.	[Fernandes, Fabr-Cio Freitas; Roque-Barreira, Maria-Cristina] Univ Sao Paulo, Ribeirao Preto Sch Med, Dept Cellular & Mol Biol, Ribeirao Preto, SP, Brazil; [de Oliveira, Leandro Licursi] Univ Fed Vicosa, Dept Gen Biol, Vicosa, MG, Brazil; [Landgraf, Taise Natali; Coelho-Castelo, Arlete A. M.; Bonato, Vania L. D.] Univ Sao Paulo, Sch Med Ribeirao Preto, Dept Biochem & Immunol, Ribeirao Preto, SP, Brazil; [Peron, Gabriela] Univ Estadual Campinas, Inst Biol, Dept Struct & Funct Biol, Campinas, SP, Brazil; [Costa, Marcelo Vieira; Panunto-Castelo, Ademilson] Univ Sao Paulo, Ribeirao Preto Fac Philosophy Sci & Letters, Dept Biol, Ribeirao Preto, SP, Brazil	Universidade de Sao Paulo; Universidade Federal de Vicosa; Universidade de Sao Paulo; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo	Panunto-Castelo, A (corresponding author), Univ Sao Paulo, Ribeirao Preto Fac Philosophy Sci & Letters, Dept Biol, Ribeirao Preto, SP, Brazil.	apcastelo@usp.br	Bonato, Vania LD/C-3509-2015; Landgraf, Taise/H-7145-2013; Roque-Barreira, Maria-Cristina/A-4552-2008; de Oliveira, Leandro Licursi/D-3616-2009; Castelo, Ademilson Panunto/C-8501-2012	Bonato, Vania LD/0000-0003-4189-2685; Landgraf, Taise/0000-0003-2084-7340; Roque-Barreira, Maria-Cristina/0000-0001-7425-0908; de Oliveira, Leandro Licursi/0000-0003-4353-7011; Castelo, Ademilson Panunto/0000-0003-0148-0133; Peron, Gabriela/0000-0002-9863-7565	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [2009/14777-1, 2013/12278-3, 2009/03235-3, 2012/08552-0]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	APC (Grant #2009/14777-1, and #2013/12278-3), FFF (# 2009/03235-3), and TNL (# 2012/08552-0) were supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alekseeva MG, 2015, BIOCHEMISTRY-MOSCOW+, V80, P1303, DOI 10.1134/S0006297915100119; Soares RDA, 2008, INFECT IMMUN, V76, P4214, DOI 10.1128/IAI.00753-07; Bethlem E P, 1999, Curr Opin Pulm Med, V5, P319, DOI 10.1097/00063198-199909000-00010; Blotta MHSL, 1999, AM J TROP MED HYG, V61, P390, DOI 10.4269/ajtmh.1999.61.390; Bolhassani A, 2008, EXPERT REV VACCINES, V7, P1185, DOI 10.1586/14760584.7.8.1185; Bonfim CV, 2009, MED MYCOL, V47, P722, DOI 10.3109/13693780802641425; CALICH VLG, 1979, MYCOPATHOLOGIA, V66, P175, DOI 10.1007/BF00683967; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Coutinho Ziadir Francisco, 2002, Cad. Saúde Pública, V18, P1441, DOI 10.1590/S0102-311X2002000500037; Cunha DA, 2002, CLIN DIAGN LAB IMMUN, V9, P374, DOI 10.1128/CDLI.9.2.374-377.2002; de Brito T, 1994, Rev Inst Med Trop Sao Paulo, V36, P185, DOI 10.1590/S0036-46651994000200016; de Oliveira LL, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000183; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Falkowska-Podstawka M., 2003, Polish Journal of Veterinary Sciences, V6, P61; Fernandes VC, 2011, MICROBES INFECT, V13, P1062, DOI 10.1016/j.micinf.2011.06.004; Fernandes VC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017885; Hernandez O, 2011, YEAST, V28, P771, DOI 10.1002/yea.1902; Izacc SMS, 2001, MED MYCOL, V39, P445, DOI 10.1080/714031053; Junger WG, 1996, J TRAUMA, V40, P702, DOI 10.1097/00005373-199605000-00004; KAUFMANN SHE, 1990, IMMUNOL TODAY, V11, P129, DOI 10.1016/0167-5699(90)90050-J; Kurokawa CS, 2007, MICROBIOL IMMUNOL, V51, P421, DOI 10.1111/j.1348-0421.2007.tb03929.x; Kurokawa Cilmery Suemi, 1998, Revista do Instituto de Medicina Tropical de Sao Paulo, V40, P125, DOI 10.1590/S0036-46651998000300001; LOPES JD, 1994, BRAZ J MED BIOL RES, V27, P2309; Martinez R, 2015, REV INST MED TROP SP, V57, P11, DOI 10.1590/S0036-46652015000700004; Matute DR, 2006, MOL BIOL EVOL, V23, P65, DOI 10.1093/molbev/msj008; McInturff JE, 2005, J INVEST DERMATOL, V125, P1, DOI 10.1111/j.0022-202X.2004.23459.x; Moingeon P, 2003, CURR OPIN MICROBIOL, V6, P462, DOI 10.1016/j.mib.2003.08.002; Nicola AM, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-158; Alegre-Maller ACP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003317; Peracoli MTS, 2003, MICROBES INFECT, V5, P413, DOI 10.1016/S1286-4579(03)00040-6; Reis BS, 2008, VACCINE, V26, P5461, DOI 10.1016/j.vaccine.2008.07.097; Restrepo A, 2015, REV INST MED TROP SP, V57, P5, DOI 10.1590/S0036-46652015000700003; Ribeiro AM, 2010, VACCINE, V28, P1528, DOI 10.1016/j.vaccine.2009.11.062; Rittner GMG, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001519; ROBLEDO MA, 1982, AM REV RESPIR DIS, V125, P563, DOI 10.1164/arrd.1982.125.5.563; Romani L, 2011, NAT REV IMMUNOL, V11, P275, DOI 10.1038/nri2939; SANBLAS G, 1977, MYCOPATHOLOGIA, V62, P77, DOI 10.1007/BF01259396; SEVERO LC, 1979, MYCOPATHOLOGIA, V67, P115; Teixeira MM, 2009, MOL PHYLOGENET EVOL, V52, P273, DOI 10.1016/j.ympev.2009.04.005; UEDA AK, 1987, MYCOPATHOLOGIA, V98, P27, DOI 10.1007/BF00431014; Vabulas RM, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a004390; VICENTINI AP, 1994, INFECT IMMUN, V62, P1465, DOI 10.1128/IAI.62.4.1465-1469.1994; Ward NS, 2008, CLIN CHEST MED, V29, P617, DOI 10.1016/j.ccm.2008.06.010; Zugel U, 1999, CLIN MICROBIOL REV, V12, P19, DOI 10.1128/CMR.12.1.19	44	8	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162486	10.1371/journal.pone.0162486	http://dx.doi.org/10.1371/journal.pone.0162486			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598463	gold, Green Submitted, Green Published			2022-12-26	WOS:000383254800070
J	Kim, JS; Choi, J; Hahn, HJ; Lee, YB; Yu, DS; Kim, JW				Kim, Jung Soo; Choi, Jinyoung; Hahn, Hyung-Jin; Lee, Young-Bok; Yu, Dong-Soo; Kim, Jin-Wou			Association of Macrophage Migration Inhibitory Factor Polymorphisms with Total Plasma IgE Levels in Patients with Atopic Dermatitis in Korea	PLOS ONE			English	Article							JUVENILE IDIOPATHIC ARTHRITIS; MIF PROMOTER POLYMORPHISMS; TOTAL SERUM IGE; FACTOR GENE; REGION POLYMORPHISM; ASTHMA; ONSET; SUSCEPTIBILITY; EPIDEMIOLOGY; POPULATION	The macrophage migration inhibitory factor (MIF) gene is located on human chromosome 22q11.2 and is linked to atopic phenotypes. Plasma MIF and log [total IgE] levels are significantly elevated in atopic dermatitis (AD) patients. The aim of this study was to evaluate the relationship between two MIF polymorphisms, -173 G to C and -794 CATT(5-8), and total plasma IgE levels in AD patients in Korea. We performed PCR-RFLP analysis in 178 AD patients and 80 control subjects to determine whether MIF SNPs are associated with susceptibility to AD. Plasma total IgE and MIF levels were determined, and then logistic regression analyses were performed to determine the associations between a SNP or haplotype and plasma total IgE or MIF levels. The -173 G/C polymorphism, located in the MIF promoter, was significantly associated with AD; the odds ratios (ORs) for the CC homozygotes and GC heterozygotes were 9.3 and 2.5, respectively. The MIF C/5-CATT and the MIF C/7-CATT haplotypes were significantly associated with AD; the ORs for the MIF C/5-CATT and MIF C/7-CATT haplotypes were 9.7 and 4.5, respectively. Log [total IgE] levels were highly associated with the MIF -794 7-CATT polymorphism. Notably, the MIF C/7-CATT haplotype was associated with a decrease in plasma log [total IgE] levels in a gene dose-dependent manner. Although log [MIF] levels were not associated with the MIF polymorphisms, the frequencies of the MIF C/5-CATT haplotype-containing genotypes decreased in order of MIF levels. Our results demonstrate that MIF promoter polymorphisms in the -173 C allele and the MIF C/5-CATT and C/7-CATT haplotypes were significantly associated with an increased risk for AD. In particular, the -794 7-CATT locus and the MIF C/7-CATT haplotype were significantly associated with decreased total IgE levels in the plasma, suggesting that these polymorphisms might be a marker for intrinsic AD rather than extrinsic AD that shows high total IgE levels and presence of allergen-specific IgE.	[Kim, Jung Soo; Choi, Jinyoung; Hahn, Hyung-Jin; Lee, Young-Bok; Yu, Dong-Soo; Kim, Jin-Wou] Catholic Univ Korea, Dept Dermatol, Coll Med, Uijongbu City, Kyonggi Do, South Korea	Catholic University of Korea	Kim, JW (corresponding author), Catholic Univ Korea, Dept Dermatol, Coll Med, Uijongbu City, Kyonggi Do, South Korea.	jwkim52@catholic.ac.kr	LEE, YOUNG BOK/AAZ-6426-2021	Choi, Jin Young/0000-0002-3641-2504	Korea Health 21 R&D Project, Ministry of Health Welfare, Korea [01-PJ3-PG6-01GN09-003]	Korea Health 21 R&D Project, Ministry of Health Welfare, Korea	This study was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare (http://english.mohw.go.kr/front_eng/index.jsp), Korea (01-PJ3-PG6-01GN09-003) to JWK. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdis CA, 1999, J INVEST DERMATOL, V113, P628, DOI 10.1046/j.1523-1747.1999.00720.x; Barton A, 2003, GENES IMMUN, V4, P487, DOI 10.1038/sj.gene.6364014; Baugh JA, 2002, GENES IMMUN, V3, P170, DOI 10.1038/sj.gene.6363867; CALANDRA T, 1994, J EXP MED, V179, P1895, DOI 10.1084/jem.179.6.1895; Calandra T, 2003, NAT REV IMMUNOL, V3, P791, DOI 10.1038/nri1200; De Benedetti F, 2003, ARTHRITIS RHEUM, V48, P1398, DOI 10.1002/art.10882; Donn R, 2002, ARTHRITIS RHEUM-US, V46, P2402, DOI 10.1002/art.10492; Donn RP, 2004, J INVEST DERMATOL, V123, P484, DOI 10.1111/j.0022-202X.2004.23314.x; Donn RP, 2001, ARTHRITIS RHEUM-US, V44, P1782, DOI 10.1002/1529-0131(200108)44:8<1782::AID-ART314>3.0.CO;2-#; HANIFIN JM, 1980, ACTA DERM-VENEREOL, P44; Hizawa N, 2004, AM J RESP CRIT CARE, V169, P1014, DOI 10.1164/rccm.200307-933OC; ISHIZAKA K, 1984, ANNU REV IMMUNOL, V2, P159, DOI 10.1146/annurev.immunol.2.1.159; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Lee YB, 2008, KOREAN J ASTHMA ALLE, V28, P53; Lue HQ, 2002, MICROBES INFECT, V4, P449, DOI 10.1016/S1286-4579(02)01560-5; Ma L, 2014, INT J DERMATOL, V53, pE75, DOI 10.1111/j.1365-4632.2012.05597.x; Magalhaes ES, 2009, FASEB J, V23, P1262, DOI 10.1096/fj.08-124248; Melotti P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0114274; MEYERS DA, 1994, GENOMICS, V23, P464, DOI 10.1006/geno.1994.1524; Miyagaki T, 2015, J DERMATOL SCI, V78, P89, DOI 10.1016/j.jdermsci.2015.02.010; Mizue Y, 2005, P NATL ACAD SCI USA, V102, P14410, DOI 10.1073/pnas.0507189102; Morales-Zambrano R, 2014, INT J CLIN EXP MED, V7, P2605; Nagata Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115593; Rodriguez-Sosa M, 2003, INFECT IMMUN, V71, P1247, DOI 10.1128/IAI.71.3.1247-1254.2003; Roger T, 2001, NATURE, V414, P920, DOI 10.1038/414920a; Sanchez E, 2006, GENES IMMUN, V7, P433, DOI 10.1038/sj.gene.6364310; Schmid P, 2001, ALLERGY, V56, P841, DOI 10.1034/j.1398-9995.2001.00144.x; Shimizu T, 2005, GENES IMMUN, V6, P285, DOI 10.1038/sj.gene.6364191; Shimizu T, 1999, J ALLERGY CLIN IMMUN, V104, P659, DOI 10.1016/S0091-6749(99)70339-8; Shimizu T, 1997, BIOCHEM BIOPH RES CO, V240, P173, DOI 10.1006/bbrc.1997.7633; Shin HD, 2005, ALLERGY, V60, P1146, DOI 10.1111/j.1398-9995.2005.00839.x; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Tokura Y, 2010, J DERMATOL SCI, V58, P1, DOI 10.1016/j.jdermsci.2010.02.008; Watarai H, 2000, P NATL ACAD SCI USA, V97, P13251, DOI 10.1073/pnas.230445397; Wollenberg A, 2000, ALLERGY, V55, P205, DOI 10.1034/j.1398-9995.2000.00115.x; Wu J, 2009, TISSUE ANTIGENS, V73, P302, DOI 10.1111/j.1399-0039.2008.01206.x; Wu J, 2009, J DERMATOL SCI, V53, P212, DOI 10.1016/j.jdermsci.2008.11.002; Wuthrich B, 2003, J INVEST ALLERG CLIN, V13, P1	38	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162477	10.1371/journal.pone.0162477	http://dx.doi.org/10.1371/journal.pone.0162477			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598332	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800068
J	Meneton, P; Lemogne, C; Herquelot, E; Bonenfant, S; Larson, MG; Vasan, RS; Menard, J; Goldberg, M; Zins, M				Meneton, Pierre; Lemogne, Cedric; Herquelot, Eleonore; Bonenfant, Sebastien; Larson, Martin G.; Vasan, Ramachandran S.; Menard, Joel; Goldberg, Marcel; Zins, Marie			A Global View of the Relationships between the Main Behavioural and Clinical Cardiovascular Risk Factors in the GAZEL Prospective Cohort	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; OBSTRUCTIVE SLEEP-APNEA; BODY-MASS INDEX; PHYSICAL-ACTIVITY; METAANALYSIS; STROKE; ASSOCIATION; DEPRESSION; COUNTRIES; OUTCOMES	Although it has been recognized for a long time that the predisposition to cardiovascular diseases (CVD) is determined by many risk factors and despite the common use of algorithms incorporating several of these factors to predict the overall risk, there has yet been no global description of the complex way in which CVD risk factors interact with each other. This is the aim of the present study which investigated all existing relationships between the main CVD risk factors in a well-characterized occupational cohort. Prospective associations between 12 behavioural and clinical risk factors (gender, age, parental history of CVD, non-moderate alcohol consumption, smoking, physical inactivity, obesity, hypertension, dyslipidemia, diabetes, sleep disorder, depression) were systematically tested using Cox regression in 10,736 middle-aged individuals free of CVD at baseline and followed over 20 years. In addition to independently predicting CVD risk (HRs from 1.18 to 1.97 in multivariable models), these factors form a vast network of associations where each factor predicts, and/or is predicted by, several other factors (n = 47 with p<0.05, n = 37 with p<0.01, n = 28 with p<0.001, n = 22 with p<0.0001). Both the number of factors associated with a given factor (1 to 9) and the strength of the associations (HRs from 1.10 to 6.12 in multivariable models) are very variable, suggesting that all the factors do not have the same influence within this network. These results show that there is a remarkably extensive network of relationships between the main CVD risk factors which may have not been sufficiently taken into account, notably in preventive strategies aiming to lower CVD risk.	[Meneton, Pierre] Univ Paris 13, Univ Paris 06, Sorbonne Univ, INSERM,U1142,LIMICS,UMR S 1142, Paris, France; [Lemogne, Cedric] Univ Paris 05, Hop Univ Paris Ouest, AP HP, Ctr Psychiat & Neurosci,INSERM,U894, Paris, France; [Herquelot, Eleonore; Bonenfant, Sebastien; Goldberg, Marcel; Zins, Marie] UVSQ, INSERM, UMS 011, Villejuif, France; [Herquelot, Eleonore; Bonenfant, Sebastien; Goldberg, Marcel; Zins, Marie] VIMA, UMR S 1168, Villejuif, France; [Larson, Martin G.] Boston Univ, Dept Biostat, Dept Math & Stat, Boston, MA 02215 USA; [Vasan, Ramachandran S.] Boston Univ, Dept Med, Framingham Heart Study, Boston, MA 02215 USA; [Menard, Joel] Univ Paris 05, Hop Univ Paris Ouest, AP HP, INSERM,CIC1418, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Universite Paris 13; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; Boston University; Boston University; Framingham Heart Study; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Europeen Georges-Pompidou - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite	Meneton, P (corresponding author), Univ Paris 13, Univ Paris 06, Sorbonne Univ, INSERM,U1142,LIMICS,UMR S 1142, Paris, France.	pierre.meneton@spim.jussieu.fr	Zins, Marie/AAX-6551-2021; Goldberg, Marcel/I-7834-2012; Lemogne, Cédric/Q-6091-2019; Ramachandran, Vasan/Y-2527-2019; Meneton, Pierre/T-1216-2019	Goldberg, Marcel/0000-0002-6161-5880; Ramachandran, Vasan/0000-0001-7357-5970; Lemogne, Cedric/0000-0002-3487-4721	EDF-GDF; Institut National pour la Sante et la Recherche Medicale (INSERM); Cohortes Sante TGIR Program; Agence nationale de la recherche (ANR); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); Association Robert Debre pour la Recherche Medicale; INSERM	EDF-GDF; Institut National pour la Sante et la Recherche Medicale (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); Cohortes Sante TGIR Program; Agence nationale de la recherche (ANR)(French National Research Agency (ANR)); Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET); Association Robert Debre pour la Recherche Medicale; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission)	The GAZEL Cohort Study was funded by EDF-GDF and the Institut National pour la Sante et la Recherche Medicale (INSERM), and received grants from the Cohortes Sante TGIR Program, Agence nationale de la recherche (ANR) and Agence francaise de securite sanitaire de l'environnement et du travail (AFSSET). The present analyses were funded by the Association Robert Debre pour la Recherche Medicale and by INSERM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison P., 2001, SAGE U PAPER SERIES, V7136; Angelakopoulou A, 2012, EUR HEART J, V33, P393, DOI 10.1093/eurheartj/ehr225; Anthony David, 2014, FP Essent, V421, P11; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; CASTELLI WP, 1983, AM HEART J, V106, P1191, DOI 10.1016/0002-8703(83)90174-6; De Backer G, 2012, EUR J PREV CARDIOL, V19, P14, DOI 10.1177/2047487312448988; Dong JY, 2013, ATHEROSCLEROSIS, V229, P489, DOI 10.1016/j.atherosclerosis.2013.04.026; Erhardt L, 2009, ATHEROSCLEROSIS, V205, P23, DOI 10.1016/j.atherosclerosis.2009.01.007; Fiedorowicz JG, 2014, CURR PSYCHIAT REP, V16, DOI 10.1007/s11920-014-0492-6; Ganna A, 2015, LANCET, V386, P533, DOI 10.1016/S0140-6736(15)60175-1; Geleijnse JM, 2004, EUR J PUBLIC HEALTH, V14, P235, DOI 10.1093/eurpub/14.3.235; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Goldberg M, 2007, INT J EPIDEMIOL, V36, P32, DOI 10.1093/ije/dyl247; Guo XF, 2013, CURR HYPERTENS REP, V15, P703, DOI 10.1007/s11906-013-0403-y; Hopkins P N, 1986, Cardiol Clin, V4, P3; Kannel WB, 2004, AM HEART J, V148, P16, DOI 10.1016/j.ahj.2003.10.022; Kannel William B, 2002, J Gend Specif Med, V5, P27; Kannel WB, 2009, AM J CARDIOL, V103, P426, DOI 10.1016/j.amjcard.2008.09.098; Kashani M, 2013, J CARDIOVASC NURS, V28, pE18, DOI 10.1097/JCN.0b013e318294b206; Katzmarzyk PT, 2012, CAN J PUBLIC HEALTH, V103, P147, DOI 10.1007/BF03404221; Kivimaki M, 2012, LANCET, V380, P1491, DOI 10.1016/S0140-6736(12)60994-5; Kotseva K, 2016, EUR J PREV CARDIOL, V23, P636, DOI 10.1177/2047487315569401; Le Port A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051593; Li J, 2013, CURR OPIN CARDIOL, V28, P575, DOI 10.1097/HCO.0b013e328364289c; Li J, 2012, INT J ENV RES PUB HE, V9, P391, DOI 10.3390/ijerph9020391; Lu Y, 2014, LANCET, V383, P970, DOI 10.1016/S0140-6736(13)61836-X; Martin-Timon I, 2014, WORLD J DIABETES, V5, P444, DOI 10.4239/wjd.v5.i4.444; Merlotti C, 2014, DIABETES OBES METAB, V16, P719, DOI 10.1111/dom.12270; Metzger MH, 2002, J CLIN EPIDEMIOL, V55, P48, DOI 10.1016/S0895-4356(01)00409-7; Murray Christopher JL, 2003, Popul Health Metr, V1, P1, DOI 10.1186/1478-7954-1-1; Noordzij M, 2013, NEPHROL DIAL TRANSPL, V28, P2670, DOI 10.1093/ndt/gft355; O'Donnell MJ, 2010, LANCET, V376, P112, DOI 10.1016/S0140-6736(10)60834-3; Payne RA, 2012, BRIT J CLIN PHARMACO, V74, P396, DOI 10.1111/j.1365-2125.2012.04219.x; Peters SAE, 2014, LANCET, V383, P1973, DOI 10.1016/S0140-6736(14)60040-4; Peters SAE, 2013, STROKE, V44, P2394, DOI 10.1161/STROKEAHA.113.001624; Price JF, 1997, EPIDEMIOLOGY, V8, P584, DOI 10.1097/00001648-199709000-00018; Ronksley Paul E, 2011, BMJ, V342, pd671, DOI 10.1136/bmj.d671; Siontis GCM, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e3318; Tamers SL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087653; Tuomilehto J, 2004, ATHEROSCLEROSIS SUPP, V5, P9, DOI 10.1016/j.atherosclerosissup.2004.03.006; Van der Kooy K, 2007, INT J GERIATR PSYCH, V22, P613, DOI 10.1002/gps.1723; WALLACE RB, 1987, EPIDEMIOL REV, V9, P95, DOI 10.1093/oxfordjournals.epirev.a036310; Wang X, 2013, INT J CARDIOL, V169, P207, DOI 10.1016/j.ijcard.2013.08.088; White IR, 2010, STAT MED, V29, P2920, DOI 10.1002/sim.3944; Willis A, 2012, J ROY SOC MED, V105, P348, DOI 10.1258/jrsm.2012.110193; Yusuf S, 2004, LANCET, V364, P937, DOI 10.1016/S0140-6736(04)17018-9; Zins M, 2009, ADV LIFE COURSE RES, V14, P135, DOI 10.1016/j.alcr.2010.02.003	47	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162386	10.1371/journal.pone.0162386	http://dx.doi.org/10.1371/journal.pone.0162386			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598908	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800063
J	Tschudin-Sutter, S; Braissant, O; Erb, S; Stranden, A; Bonkat, G; Frei, R; Widmer, AF				Tschudin-Sutter, Sarah; Braissant, Olivier; Erb, Stefan; Stranden, Anne; Bonkat, Gernot; Frei, Reno; Widmer, Andreas F.			Growth Patterns of Clostridium difficile - Correlations with Strains, Binary Toxin and Disease Severity: A Prospective Cohort Study	PLOS ONE			English	Article							SEVERE INFECTION; RIBOTYPE; MORTALITY; DIARRHEA; DEATH	A broad spectrum of symptoms has been associated with C. difficile infection (CDI). Several studies indicate that toxin-production correlates with growth rates of C. difficile. This study aimed to correlate growth rates of C. difficile with disease severity and strain characteristics. From 01/2003 to 10/2011, strains from a prospective cohort of all inpatients with CDI at the University Hospital Basel, Switzerland were analyzed regarding binary toxin, presence of the tcdC deletion and ribotype. Isothermal microcalorimetry was performed to determine growth rates, quantified by the Gompertz function. Ordered logistic regression models were used to correlate disease severity with strain features and clinical characteristics. Among 199 patients, 31 (16%) were infected with binary toxin-producing strains, of which the tcdC gene-deletion nt117 was detected in 9 (4%). Disease severity was classified as mild in 130 patients (65.3%), as severe in 59 patients (29.7%) and as severe/complicated in 10 patients (5.0%). Growth rates were inversely associated with disease severity in univariable (OR 0.514, 95% CI 0.29-0.91, p = 0.023) and multivariable analyses (OR 0.51, 95% CI 0.26-0.97, p = 0.040). While none of the strain characteristics such as presence of the tcdC gene deletion or binary toxin predicted CDI severity, growth rates were inversely correlated with disease severity. Further investigations are needed to analyze growth-regulators and respective correlations with the level of toxin production in C. difficile, which may be important determinants of disease severity.	[Tschudin-Sutter, Sarah; Erb, Stefan; Stranden, Anne; Widmer, Andreas F.] Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland; [Braissant, Olivier] Univ Basel, Lab Biomech & Biocalorimetry, Basel, Switzerland; [Bonkat, Gernot] Univ Basel Hosp, Dept Urol, Basel, Switzerland; [Frei, Reno] Univ Basel Hosp, Div Clin Microbiol, Basel, Switzerland	University of Basel; University of Basel; University of Basel; University of Basel	Tschudin-Sutter, S (corresponding author), Univ Basel Hosp, Div Infect Dis & Hosp Epidemiol, Basel, Switzerland.	Sarah.Tschudin@uhbs.ch	Braissant, Olivier/AAO-2371-2020; Tschudin-Sutter, Sarah/K-2212-2019	Braissant, Olivier/0000-0003-0659-755X; Tschudin-Sutter, Sarah/0000-0003-4875-5368	"Antibacterial Europe ASPIRE Research awards" by Pfizer International Operations; Swiss National Science Foundation grant [PBBSP3-134499]	"Antibacterial Europe ASPIRE Research awards" by Pfizer International Operations; Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF))	This study was supported by an unrestricted educational grant "Antibacterial Europe ASPIRE Research awards 2011" by Pfizer International Operations. S. Tschudin-Sutter is the recipient of a Swiss National Science Foundation grant (PBBSP3-134499). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by an unrestricted educational grant "Antibacterial Europe ASPIRE Research awards 2011" by Pfizer International Operations. S. Tschudin-Sutter is the recipient of a Swiss National Science Foundation grant (PBBSP3-134499).	Bacci S, 2011, EMERG INFECT DIS, V17, P976, DOI [10.3201/eid1706.101483, 10.3201/eid/1706.101483]; Barbut F, 2005, J MED MICROBIOL, V54, P181, DOI 10.1099/jmm.0.45804-0; Bauer MP, 2011, LANCET, V377, P63, DOI 10.1016/S0140-6736(10)61266-4; Braissant O, 2015, METHODS, V76, P27, DOI 10.1016/j.ymeth.2014.10.009; Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x; Carlson PE, 2013, ANAEROBE, V24, P109, DOI 10.1016/j.anaerobe.2013.04.003; Cloud J, 2009, CLIN GASTROENTEROL H, V7, P868, DOI 10.1016/j.cgh.2009.05.018; Debast SB, 2014, CLIN MICROBIOL INFEC, V20, P1, DOI 10.1111/1469-0691.12418; Fenner L, 2008, J CLIN MICROBIOL, V46, P328, DOI 10.1128/JCM.01503-07; Goldenberg SD, 2011, J INFECTION, V62, P355, DOI 10.1016/j.jinf.2011.03.001; Goorhuis A, 2011, CLIN INFECT DIS, V53, P860, DOI 10.1093/cid/cir549; Hundsberger T, 1997, EUR J BIOCHEM, V244, P735, DOI 10.1111/j.1432-1033.1997.t01-1-00735.x; Indra A, 2008, J MED MICROBIOL, V57, P1377, DOI 10.1099/jmm.0.47714-0; Kyne L, 2002, CLIN INFECT DIS, V34, P346, DOI 10.1086/338260; Magill SS, 2014, NEW ENGL J MED, V370, P1198, DOI 10.1056/NEJMoa1306801; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Rao K, 2015, CLIN INFECT DIS, V61, P233, DOI 10.1093/cid/civ254; See I, 2014, CLIN INFECT DIS; Sirard S, 2011, J CLIN MICROBIOL, V49, P4040, DOI 10.1128/JCM.05053-11; Stubbs SLJ, 1999, J CLIN MICROBIOL, V37, P461, DOI 10.1128/JCM.37.2.461-463.1999; Verdoorn BP, 2010, DIAGN MICR INFEC DIS, V66, P24, DOI 10.1016/j.diagmicrobio.2009.08.015; Walk ST, 2012, CLIN INFECT DIS, V55, P1661, DOI 10.1093/cid/cis786; Warny M, 2005, LANCET, V366, P1079, DOI 10.1016/S0140-6736(05)67420-X; Wilson V, 2010, CLIN INFECT DIS, V50, pE77, DOI 10.1086/653012; Winsor CP, 1932, P NATL ACAD SCI USA, V18, P1, DOI 10.1073/pnas.18.1.1	25	12	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161711	10.1371/journal.pone.0161711	http://dx.doi.org/10.1371/journal.pone.0161711			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598309	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800017
J	Orini, M; Taggart, P; Srinivasan, N; Hayward, M; Lambiase, PD				Orini, Michele; Taggart, Peter; Srinivasan, Neil; Hayward, Martin; Lambiase, Pier D.			Interactions between Activation and Repolarization Restitution Properties in the Intact Human Heart: In-Vivo Whole-Heart Data and Mathematical Description	PLOS ONE			English	Article							ACTION-POTENTIAL DURATION; CONDUCTION-VELOCITY RESTITUTION; T-WAVE ALTERNANS; SHORT-TERM-MEMORY; VENTRICULAR-FIBRILLATION; ADRENERGIC-STIMULATION; SPATIAL-DISPERSION; MECHANISMS; INDUCTION; CLASSIFICATION	Background The restitution of the action potential duration (APDR) and conduction velocity (CVR) are mechanisms whereby cardiac excitation and repolarization adapt to changes in heart rate. They modulate the vulnerability to dangerous arrhythmia, but the mechanistic link between restitution and arrhythmogenesis remains only partially understood. Methods This paper provides an experimental and theoretical study of repolarization and excitation restitution properties and their interactions in the intact human epicardium. The interdependence between excitation and repolarization dynamic is studied in 8 patients (14 restitution protocols, 1722 restitution curves) undergoing global epicardial mapping with multi-electrode socks before open heart surgery. A mathematical description of the contribution of both repolarization and conduction dynamics to the steepness of the APDR slope is proposed. Results This study demonstrates that the APDR slope is a function of both activation and repolarization dynamics. At short cycle length, conduction delay significantly increases the APDR slope by interacting with the diastolic interval. As predicted by the proposed mathematical formulation, the APDR slope was more sensitive to activation time prolongation than to the simultaneous shortening of repolarization time. A steep APDR slope was frequently identified, with 61% of all cardiac sites exhibiting an APDR slope >1, suggesting that a slope >1 may not necessarily promote electrical instability in the human epicardium. APDR slope did not change for different activation or repolarization times, and it was not a function of local baseline APD. However, it was affected by the spatial organization of electrical excitation, suggesting that in tissue APDR is not a unique function of local electrophysiological properties. Spatial heterogeneity in both activation and repolarization restitution contributed to the increase in the modulated dispersion of repolarization, which for short cycle length was as high as 250 ms. Heterogeneity in conduction velocity restitution can translate into both activation and repolarization dispersion and increase cardiac instability. The proposed mathematical formulation shows an excellent agreement with the experimental data (correlation coefficient r = 0.94) and provides a useful tool for the understanding of the complex interactions between activation and repolarization restitution properties as well as between their measurements.	[Orini, Michele; Taggart, Peter; Srinivasan, Neil; Lambiase, Pier D.] UCL, Inst Cardiovasc Sci, London, England; [Orini, Michele; Srinivasan, Neil; Lambiase, Pier D.] St Bartholomews Hosp, Barts Heart Ctr, London, England; [Hayward, Martin] Univ Coll London Hosp, Heart Hosp, London, England	University of London; University College London; University of London; Queen Mary University London; University College London Hospitals NHS Foundation Trust; University of London; University College London	Orini, M (corresponding author), UCL, Inst Cardiovasc Sci, London, England.; Orini, M (corresponding author), St Bartholomews Hosp, Barts Heart Ctr, London, England.	m.orini@ucl.ac.uk	Lambiase, Pier/L-8534-2019; Orini, Michele/ABF-6272-2020; Orini, Michele/H-3937-2015	Lambiase, Pier/0000-0002-9055-9267; Orini, Michele/0000-0001-5773-0344; Orini, Michele/0000-0001-5773-0344; Srinivasan, Neil/0000-0002-4423-6547	Marie Curie Intra-European Fellowships for Career Development (IEF), FP7-PEOPLE-IEF; British Heart Foundation Fellowship; University College London Hospital Biomedicine NIHR Grant; MRC [G0901819] Funding Source: UKRI; Medical Research Council [G0901819] Funding Source: researchfish	Marie Curie Intra-European Fellowships for Career Development (IEF), FP7-PEOPLE-IEF; British Heart Foundation Fellowship(British Heart Foundation); University College London Hospital Biomedicine NIHR Grant; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by Marie Curie Intra-European Fellowships for Career Development (IEF), call identifier FP7-PEOPLE-2013-IEF: MO; British Heart Foundation Fellowship: NS; and University College London Hospital Biomedicine NIHR Grant: PL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banville I, 2002, J CARDIOVASC ELECTR, V13, P1141, DOI 10.1046/j.1540-8167.2002.01141.x; Cao JM, 1999, CIRC RES, V84, P1318, DOI 10.1161/01.RES.84.11.1318; Cherry EM, 2004, AM J PHYSIOL-HEART C, V286, pH2332, DOI 10.1152/ajpheart.00747.2003; Child N, 2015, HEART RHYTHM, V12, P1644, DOI 10.1016/j.hrthm.2015.04.013; Chinushi M, 2003, J CARDIOVASC ELECTR, V14, P632, DOI 10.1046/j.1540-8167.2003.03028.x; Coronel R, 2006, HEART RHYTHM, V3, P1043, DOI 10.1016/j.hrthm.2006.05.027; Coronel R, 2009, HEART RHYTHM, V6, P537, DOI 10.1016/j.hrthm.2009.01.013; Dorenkamp M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054768; Echebarria B, 2007, PHYS REV E, V76, DOI 10.1103/PhysRevE.76.051911; Fenton FH, 2002, CHAOS, V12, P852, DOI 10.1063/1.1504242; Finlay MC, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00213; Fox JJ, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.138101; FRANZ MR, 1988, J CLIN INVEST, V82, P972, DOI 10.1172/JCI113706; Franz MR, 2003, J CARDIOVASC ELECTR, V14, pS140, DOI 10.1046/j.1540.8167.90303.x; Garfinkel A, 2000, P NATL ACAD SCI USA, V97, P6061, DOI 10.1073/pnas.090492697; Gelzer ARM, 2008, CIRCULATION, V118, P1123, DOI 10.1161/CIRCULATIONAHA.107.738013; Hanson B, 2014, FRONT PHYSIOL, V5, DOI 10.3389/fphys.2014.00414; Hanson B, 2009, CIRC-ARRHYTHMIA ELEC, V2, P162, DOI 10.1161/CIRCEP.108.785352; Ideker RE, 2002, J CARDIOVASC ELECTR, V13, P1173, DOI 10.1046/j.1540-8167.2002.01173.x; Koller ML, 1998, AM J PHYSIOL-HEART C, V275, pH1635, DOI 10.1152/ajpheart.1998.275.5.H1635; Laurita KR, 1998, CIRCULATION, V98, P2774, DOI 10.1161/01.CIR.98.24.2774; Mironov S, 2008, CIRCULATION, V118, P17, DOI 10.1161/CIRCULATIONAHA.107.737254; Narayan SM, 2007, J AM COLL CARDIOL, V50, P2385, DOI 10.1016/j.jacc.2007.10.011; Nash MP, 2006, EXP PHYSIOL, V91, P339, DOI 10.1113/expphysiol.2005.031070; Orini M, 2015, COMPUT CARDIOL CONF, V42, P545, DOI 10.1109/CIC.2015.7410968; Orini M, 2015, ENG MED BIOL SOC EMB, DOI [10.1016/j.pbiomolbio.2014.06.004, DOI 10.1016/J.PBIOMOLBIO.2014.06.004]; Orini M, 2014, IEEE T BIO-MED ENG, V61, P308, DOI 10.1109/TBME.2013.2289304; Otani NF, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.021910; Pak HN, 2004, J CARDIOVASC ELECTR, V15, P1357, DOI 10.1046/j.1540-8167.2004.03569.x; Pastore JM, 1999, CIRCULATION, V99, P1385, DOI 10.1161/01.CIR.99.10.1385; Potse M, 2009, AM J PHYSIOL-HEART C, V297, pH792, DOI 10.1152/ajpheart.00064.2009; Pueyo E, 2016, J MOL CELL CARDIOL, V97, P93, DOI 10.1016/j.yjmcc.2016.05.003; Pueyo E, 2011, BIOPHYS J, V101, P2892, DOI 10.1016/j.bpj.2011.09.060; Qu ZL, 2000, CIRCULATION, V102, P1664, DOI 10.1161/01.CIR.102.14.1664; Qu ZL, 1999, AM J PHYSIOL-HEART C, V276, pH269, DOI 10.1152/ajpheart.1999.276.1.H269; Ramirez J, 2015, J ELECTROCARDIOL, V48, P551, DOI 10.1016/j.jelectrocard.2015.04.002; Scacchi S, 2009, MATH BIOSCI, V219, P113, DOI 10.1016/j.mbs.2009.03.004; Srinivasan NT, 2016, AM J PHYSL HEART CIR; Stevenson WG, 2005, J CARDIOVASC ELECTR, V16, P1017, DOI 10.1111/j.1540-8167.2005.50155.x; Taggart P, 2003, CIRCULATION, V107, P285, DOI 10.1161/01.CIR.0000044941.13346.74; Taggart P, 2014, PROG BIOPHYS MOL BIO, V115, P252, DOI 10.1016/j.pbiomolbio.2014.06.004; ten Tusscher KHWJ, 2006, AM J PHYSIOL-HEART C, V291, pH1088, DOI 10.1152/ajpheart.00109.2006; van Duijvenboden S, 2015, AM J PHYSIOL-HEART C, V309, pH2108, DOI 10.1152/ajpheart.00560.2015; van Duijvenboden S, 2015, IEEE ENG MED BIO, P76, DOI 10.1109/EMBC.2015.7318304; Watanabe MA, 2001, J CARDIOVASC ELECTR, V12, P196, DOI 10.1046/j.1540-8167.2001.00196.x; Wei N, 2015, J THEOR BIOL, V367, P21, DOI 10.1016/j.jtbi.2014.11.014; Weiss JN, 2006, CIRC RES, V98, P1244, DOI 10.1161/01.RES.0000224540.97431.f0; Weiss JN, 2015, J MOL CELL CARDIOL, V82, P136, DOI 10.1016/j.yjmcc.2015.02.017; Wyatt R. F., 1980, IEEE 1980 Frontiers of Engineering in Health Care, P22; Zhou X, 2015, CIRCULATION, V132	50	33	33	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161765	10.1371/journal.pone.0161765	http://dx.doi.org/10.1371/journal.pone.0161765			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588688	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800017
J	Yan, Q; Cui, XX; Lin, S; Gan, SP; Xing, H; Dou, DL				Yan, Qiang; Cui, Xiaoxia; Lin, Shuai; Gan, Shuping; Xing, Han; Dou, Daolong			GmCYP82A3, a Soybean Cytochrome P450 Family Gene Involved in the Jasmonic Acid and Ethylene Signaling Pathway, Enhances Plant Resistance to Biotic and Abiotic Stresses	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; PHYTOPHTHORA ROOT-ROT; FUNCTIONAL GENOMICS; NICOTIANA-TABACUM; CELL-DEATH; SOJAE; ARABIDOPSIS; DEFENSE; EXPRESSION; TOLERANCE	The cytochrome P450 monooxygenases (P450s) represent a large and important enzyme superfamily in plants. They catalyze numerous monooxygenation/hydroxylation reactions in biochemical pathways, P450s are involved in a variety of metabolic pathways and participate in the homeostasis of phytohormones. The CYP82 family genes specifically reside in dicots and are usually induced by distinct environmental stresses. However, their functions are largely unknown, especially in soybean (Glycine max L.). Here, we report the function of GmCYP82A3, a gene from soybean CYP82 family. Its expression was induced by Phytophthora sojae infection, salinity and drought stresses, and treatment with methyl jasmonate (MeJA) or ethephon (ETH). Its expression levels were consistently high in resistant cultivars. Transgenic Nicotiana benthamiana plants overexpressing GmCYP82A3 exhibited strong resistance to Botrytis cinerea and Phytophthora parasitica, and enhanced tolerance to salinity and drought stresses. Furthermore, transgenic plants were less sensitive to jasmonic acid (JA), and the enhanced resistance was accompanied with increased expression of the JA/ET signaling pathway-related genes.	[Yan, Qiang; Lin, Shuai; Dou, Daolong] Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China; [Cui, Xiaoxia; Gan, Shuping; Xing, Han] Nanjing Agr Univ, Natl Ctr Soybean Improvement, Natl Key Lab Crop Genet & Germplasm Enhancement, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Nanjing Agricultural University	Dou, DL (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Nanjing, Jiangsu, Peoples R China.	ddou@njau.edu.cn	Dou, Daolong/AAW-1678-2021	Dou, Daolong/0000-0001-5226-6642; Yan, Qiang/0000-0003-2461-5133	National Science and Technology Major Projects [2014ZX0800910B]; National Natural Science Foundation of China [31171831]; Jiangsu Planned Projects for Postdoctoral Research Funds [1501046A]	National Science and Technology Major Projects; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Planned Projects for Postdoctoral Research Funds	This work was supported by grants from National Science and Technology Major Projects (2014ZX0800910B), Daolong Dou, http://www.nmp.gov.cn/; National Natural Science Foundation of China (31171831), Daolong Dou, http://www.nsfc.gov.cn/nsfc/cen/2016sqsl/index.html; Jiangsu Planned Projects for Postdoctoral Research Funds (1501046A), Qiang Yan, http://bsh.jshrss.gov.cn/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berim A, 2013, J BIOL CHEM, V288, P1795, DOI 10.1074/jbc.M112.420448; Berrocal-Lobo M, 2002, PLANT J, V29, P23, DOI 10.1046/j.1365-313x.2002.01191.x; Burnham KD, 2003, CROP SCI, V43, P1610, DOI 10.2135/cropsci2003.1610; Chai CY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067670; Cheng MC, 2013, PLANT PHYSIOL, V162, P1566, DOI [10.1104/pp.113.221911, 10.1104]; Clemente TE, 2009, PLANT PHYSIOL, V151, P1030, DOI 10.1104/pp.109.146282; CORBINEAU F, 1988, PLANT GROWTH REGUL, V7, P157; Dorrance AE, 2003, PLANT DIS, V87, P308, DOI 10.1094/PDIS.2003.87.3.308; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Frank MR, 1996, PLANT PHYSIOL, V110, P1035, DOI 10.1104/pp.110.3.1035; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Garcia-Abellan JO, 2015, PHYSIOL PLANTARUM, V155, P296, DOI 10.1111/ppl.12320; Guttikonda SK, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-243; Han YP, 2008, EUPHYTICA, V162, P231, DOI 10.1007/s10681-007-9558-4; Hoagland D. R., 1950, CALIF AES C, V347, P357; HORSCH RB, 1985, COLD SPRING HARB SYM, V50, P433, DOI 10.1101/SQB.1985.050.01.054; Hua W, 2014, PLANT SCI, V232, P1, DOI [10.1016/j.plantsci.2014.12.010, DOI 10.1016/J.PLANTSCI.2014.12.010]; Hwang IS, 2010, PLANT PHYSIOL, V152, P948, DOI 10.1104/pp.109.147827; Kazan K, 2015, TRENDS PLANT SCI, V20, P219, DOI 10.1016/j.tplants.2015.02.001; Kruse T, 2008, CHEM BIOL, V15, P149, DOI 10.1016/j.chembiol.2008.01.008; Lee S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-65; Lee S, 2010, P NATL ACAD SCI USA, V107, P21205, DOI 10.1073/pnas.1009975107; Lee S, 2014, THEOR APPL GENET, V127, P429, DOI 10.1007/s00122-013-2229-z; Lee S, 2013, THEOR APPL GENET, V126, P1121, DOI 10.1007/s00122-013-2040-x; Liu F, 2010, CELL RES, V20, P539, DOI 10.1038/cr.2010.36; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lorenzo O, 2005, CURR OPIN PLANT BIOL, V8, P532, DOI 10.1016/j.pbi.2005.07.003; Lorenzo O, 2004, PLANT CELL, V16, P1938, DOI 10.1105/tpc.022319; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Mideros S, 2007, PHYTOPATHOLOGY, V97, P655, DOI 10.1094/PHYTO-97-5-0655; Mizutani M, 2012, BIOL PHARM BULL, V35, P824, DOI 10.1248/bpb.35.824; Mizutani M, 2010, ANNU REV PLANT BIOL, V61, P291, DOI 10.1146/annurev-arplant-042809-112305; Murgia I, 2011, J PLANT PHYSIOL, V168, P894, DOI 10.1016/j.jplph.2010.11.020; Mushrush GW, 2006, J ENVIRON SCI HEAL A, V41, P2495, DOI 10.1080/10934520600927591; Nelson DR, 2004, PLANT PHYSIOL, V135, P756, DOI 10.1104/pp.104.039826; Nguyen VT, 2012, CROP SCI, V52, P2481, DOI 10.2135/cropsci2011.09.0466; Peng JY, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004664; Penninckx IAMA, 1998, PLANT CELL, V10, P2103, DOI 10.1105/tpc.10.12.2103; Pieterse CMJ, 2012, ANNU REV CELL DEV BI, V28, P489, DOI 10.1146/annurev-cellbio-092910-154055; Pieterse CMJ, 2009, NAT CHEM BIOL, V5, P308, DOI 10.1038/nchembio.164; Porta H, 2002, PLANT PHYSIOL, V130, P15, DOI 10.1104/pp.010787; Pozo MJ, 2008, NEW PHYTOL, V180, P511, DOI 10.1111/j.1469-8137.2008.02578.x; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Rajcan I, 2005, J CROP IMPROV, V14, P145, DOI 10.1300/J411v14n01_07; Ralston L, 2001, ARCH BIOCHEM BIOPHYS, V393, P222, DOI 10.1006/abbi.2001.2483; Ranathunge K, 2008, PHYTOPATHOLOGY, V98, P1179, DOI 10.1094/PHYTO-98-11-1179; Schmitthenner AF, 1994, 143 OH AGR RES DEV C; Schopfer CR, 1998, MOL GEN GENET, V258, P315, DOI 10.1007/s004380050736; Siminszky B, 2005, P NATL ACAD SCI USA, V102, P14919, DOI 10.1073/pnas.0506581102; Solano R, 1998, GENE DEV, V12, P3703, DOI 10.1101/gad.12.23.3703; Staswick PE, 2004, PLANT CELL, V16, P2117, DOI 10.1105/tpc.104.023549; Sugimoto T, 2011, BREEDING SCI, V61, P511, DOI 10.1270/jsbbs.61.511; Sun LQ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6372; Takemura T, 2013, PHYTOCHEMISTRY, V91, P100, DOI 10.1016/j.phytochem.2012.02.013; Thines B, 2007, NATURE, V448, P661, DOI 10.1038/nature05960; Thomas R, 2007, PLANT PHYSIOL, V144, P299, DOI 10.1104/pp.106.091090; TOOLEY PW, 1984, PHYTOPATHOLOGY, V74, P1209, DOI 10.1094/Phyto-74-1209; Tucker DM, 2010, CROP SCI, V50, P628, DOI 10.2135/cropsci2009.03.0161; Tyler BM, 2008, STADLER GEN, P67, DOI 10.1007/978-0-387-76723-9_6; Tyler BM, 2007, MOL PLANT PATHOL, V8, P1, DOI 10.1111/j.1364-3703.2006.00373.x; Van der Ent S, 2009, NEW PHYTOL, V183, P419, DOI 10.1111/j.1469-8137.2009.02851.x; Vega-Sanchez ME, 2005, PHYSIOL MOL PLANT P, V66, P175, DOI 10.1016/j.pmpp.2005.07.001; WALKER AK, 1984, CROP SCI, V24, P490, DOI 10.2135/cropsci1984.0011183X002400030014x; Wang HH, 2012, CROP SCI, V52, P609, DOI 10.2135/cropsci2011.06.0336; Wang HH, 2010, PLANT GENOME-US, V3, P23, DOI 10.3835/plantgenome2009.12.0029; Wen C.-K, 2015, ETHYLENE IN PLANTS, P73, DOI [10.1007/978-94-017-9484-8, DOI 10.1007/978-94-017-9484-8]; Weng CR, 2007, EUPHYTICA, V158, P81, DOI 10.1007/s10681-007-9428-0; Wu X, 2011, PLANT BREEDING, V130, P144, DOI 10.1111/j.1439-0523.2010.01799.x; Zeng WenTao, 2015, Journal of Nanjing Agricultural University, V38, P787; Zhao Y, 2014, PLANT PHYSIOL, V164, P1068, DOI 10.1104/pp.113.227595; Zhou LC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-49	71	60	63	2	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162253	10.1371/journal.pone.0162253	http://dx.doi.org/10.1371/journal.pone.0162253			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588421	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800043
J	Kang, J; Kim, W; Lee, S; Kwon, D; Chun, J; Son, B; Kim, E; Lee, JM; Youn, H; Youn, B				Kang, J.; Kim, W.; Lee, S.; Kwon, D.; Chun, J.; Son, B.; Kim, E.; Lee, J-M; Youn, H.; Youn, B.			TFAP2C promotes lung tumorigenesis and aggressiveness through miR-183-and miR-33a-mediated cell cycle regulation	ONCOGENE			English	Article							AP-2-GAMMA TRANSCRIPTION FACTOR; CANCER CELLS; BREAST-CANCER; TUMOR-SUPPRESSOR; GENE-EXPRESSION; AP-2 FAMILY; PROTEIN; RADIORESISTANCE; INHIBITION; GROWTH	Non-small cell lung cancer (NSCLC) remains one of the leading causes of death worldwide, and thus new molecular targets need to be identified to improve treatment efficacy. Although epidermal growth factor receptor (EGFR)/KRAS mutation-driven lung tumorigenesis is well understood, the mechanism of EGFR/KRAS-independent signal activation remains elusive. Enhanced TFAP2C (transcription factor activating enhancer-binding protein 2C) expression is associated with poor prognosis in some types of cancer patients, but little is known of its relation with the pathogenesis of lung cancer. In the present study, we found that TFAP2C overexpression was associated with cell cycle activation and NSCLC cell tumorigenesis. Interestingly, TFAP2C blocked AKAP12mediated cyclin D1 inhibition by inducing the overexpression of oncogenic microRNA (miRNA)-183 and simultaneously activated cyclin-dependent kinase 6-mediated cell cycle progression by downregulating tumor-suppressive miRNA-33a. In a mouse xenograft model, TFAP2C promoted lung tumorigenesis and disease aggressiveness via the miR-183 and miR-33a pathways. The study provides a mechanism of mitogenic and oncogenic signaling via two functionally opposed miRNAs and suggests that TFAP2Cinduced cell cycle hyperactivation contributes to lung tumorigenesis.	[Kang, J.; Lee, S.; Kwon, D.; Chun, J.; Son, B.; Kim, E.; Youn, B.] Pusan Natl Univ, Dept Integrated Biol Sci, Busan, South Korea; [Kim, W.; Youn, B.] Pusan Natl Univ, Dept Biol Sci, 303 Biol Bldg, Busan 46241, South Korea; [Kim, W.] Pusan Natl Univ, Integrat Grad Program, Ship & Offshore Plant Technol Ocean Energy Resour, Busan, South Korea; [Lee, J-M] Pusan Natl Univ, Dept Naval Architecture & Ocean Engn, Busan, South Korea; [Youn, H.] Sejong Univ, Dept Integrat Biosci & Biotechnol, 209 Neungdong ro, Seoul 05006, South Korea	Pusan National University; Pusan National University; Pusan National University; Pusan National University; Sejong University	Youn, B (corresponding author), Pusan Natl Univ, Dept Biol Sci, 303 Biol Bldg, Busan 46241, South Korea.; Youn, H (corresponding author), Sejong Univ, Dept Integrat Biosci & Biotechnol, 209 Neungdong ro, Seoul 05006, South Korea.	hsyoun@sejong.ac.kr; bhyoun72@pusan.ac.kr	Kim, EunGi/AAZ-6121-2021		National Research Foundation of Korea - Ministry of Science, ICT & Future Planning [2014R1A1A1A05002112, 2013M2A2A7042502]; Ministry of Education [2013R1A1A2059832, 2014R1A1A2004061]; Ministry of Science, ICT & Future Planning through GCRC-SOP [2011-0030013]	National Research Foundation of Korea - Ministry of Science, ICT & Future Planning; Ministry of Education; Ministry of Science, ICT & Future Planning through GCRC-SOP	This work was supported by the National Research Foundation of Korea funded by the Ministry of Science, ICT & Future Planning (2014R1A1A1A05002112 and 2013M2A2A7042502), the Ministry of Education (2013R1A1A2059832 to W Kim and 2014R1A1A2004061 to H Youn) and the Ministry of Science, ICT & Future Planning through GCRC-SOP (2011-0030013).	Akakura S, 2008, CANCER RES, V68, P5096, DOI 10.1158/0008-5472.CAN-07-5619; Aqeilan RI, 2004, CANCER RES, V64, P8256, DOI 10.1158/0008-5472.CAN-04-2055; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baines AT, 2011, FUTURE MED CHEM, V3, P1787, DOI [10.4155/FMC.11.121, 10.4155/fmc.11.121]; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bogachek MV, 2014, CANCER CELL, V25, P748, DOI 10.1016/j.ccr.2014.04.008; Braganca J, 2002, J BIOL CHEM, V277, P8559, DOI 10.1074/jbc.M110850200; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Cirera-Salinas D, 2012, CELL CYCLE, V11, P922, DOI 10.4161/cc.11.5.19421; Croce CM, 2009, NAT REV GENET, V10, P704, DOI 10.1038/nrg2634; Cyr AR, 2015, ONCOGENE, V34, P436, DOI 10.1038/onc.2013.569; Eckert D, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-13-246; Ettinger DS, 2010, J NATL COMPR CANC NE, V8, P740, DOI 10.6004/jnccn.2010.0056; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Gee JMW, 2009, J PATHOL, V217, P32, DOI 10.1002/path.2430; Grossel MJ, 2006, CELL CYCLE, V5, P266, DOI 10.4161/cc.5.3.2385; Guin S, 2015, ACTA PHARMACOL SIN, V36, P291, DOI 10.1038/aps.2014.129; He AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-279; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hilger-Eversheim K, 2000, GENE, V260, P1, DOI 10.1016/S0378-1119(00)00454-6; Hou J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010312; Huang MH, 2013, MOL ONCOL, V7, P112, DOI 10.1016/j.molonc.2012.09.002; Hynes NE, 2005, NAT REV CANCER, V5, P341, DOI 10.1038/nrc1609; Imielinski M, 2014, J CLIN INVEST, V124, P1582, DOI 10.1172/JCI72763; Janku F, 2010, NAT REV CLIN ONCOL, V7, P401, DOI 10.1038/nrclinonc.2010.64; Kim E, 2014, CANCER RES, V74, P5520, DOI 10.1158/0008-5472.CAN-14-0735; Kim W, 2015, EXP DERMATOL, V24, P611, DOI 10.1111/exd.12735; Kim W, 2011, RADIAT RES, V176, P539, DOI 10.1667/RR2609.1; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwon T, 2016, ONCOTARGET, V7, P7193, DOI 10.18632/oncotarget.6887; Landis MW, 2006, CANCER CELL, V9, P13, DOI 10.1016/j.ccr.2005.12.019; Lazar V, 2013, BMC MED GENOMICS, V6, DOI 10.1186/1755-8794-6-53; Leung WKC, 2015, CANCER LETT, V362, P97, DOI 10.1016/j.canlet.2015.03.023; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lin H, 2013, EXP MOL PATHOL, V94, P73, DOI 10.1016/j.yexmp.2012.08.004; Liu H, 2007, EMBO REP, V8, P394, DOI 10.1038/sj.embor.7400909; Mansi L, 2011, B CANCER, V98, P1019, DOI 10.1684/bdc.2011.1380; Musgrove EA, 2011, NAT REV CANCER, V11, P558, DOI 10.1038/nrc3090; Odegaard E, 2006, GYNECOL ONCOL, V100, P462, DOI 10.1016/j.ygyno.2005.09.022; Okayama H, 2012, CANCER RES, V72, P100, DOI 10.1158/0008-5472.CAN-11-1403; Perkins SM, 2015, BREAST CANCER RES TR, V152, P519, DOI 10.1007/s10549-015-3492-2; Shai A, 2015, CANCER RES, V75, P3167, DOI 10.1158/0008-5472.CAN-14-3701; Su B, 2006, CANCER RES, V66, P5599, DOI 10.1158/0008-5472.CAN-05-4123; Su B, 2010, J BIOL CHEM, V285, P4578, DOI 10.1074/jbc.M109.073494; Williams CMJ, 2009, EMBO J, V28, P3591, DOI 10.1038/emboj.2009.290; Williamson JA, 1996, GENOMICS, V35, P262, DOI 10.1006/geno.1996.0351; Wong PP, 2012, MOL CELL BIOL, V32, P1633, DOI 10.1128/MCB.06373-11; Woodfield GW, 2010, GENE CHROMOSOME CANC, V49, P948, DOI 10.1002/gcc.20807; Yamagata N, 2003, CLIN CANCER RES, V9, P4695; Yang HJ, 2013, J BIOL CHEM, V288, P2965, DOI 10.1074/jbc.M112.385989; Yang HJ, 2011, BIOCHEM PHARMACOL, V82, P524, DOI 10.1016/j.bcp.2011.05.027; Yoon DK, 2007, CANCER LETT, V254, P111, DOI 10.1016/j.canlet.2007.02.017; Zhang LQ, 2015, TUMOR BIOL, V36, P8121, DOI 10.1007/s13277-015-3550-8; Zhou JD, 2015, CANCER BIOL THER, V16, P846, DOI 10.1080/15384047.2015.1030545	56	43	43	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	11					1585	1596		10.1038/onc.2016.328	http://dx.doi.org/10.1038/onc.2016.328			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP5ZR	27593936				2022-12-26	WOS:000397458100012
J	Haji-Ghassemi, O; Gilbert, M; Spence, J; Schur, MJ; Parker, MJ; Jenkins, ML; Burke, JE; van Faassen, H; Young, NM; Evans, SV				Haji-Ghassemi, Omid; Gilbert, Michel; Spence, Jenifer; Schur, Melissa J.; Parker, Matthew J.; Jenkins, Meredith L.; Burke, John E.; van Faassen, Henk; Young, N. Martin; Evans, Stephen V.			Molecular Basis for Recognition of the Cancer Glycobiomarker, LacdiNAc (GalNAc[14]GlcNAc), by Wisteria floribunda Agglutinin	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						biomarker; cancer; carbohydrate; carbohydrate-binding protein; lectin; structural biology; x-ray crystallography; agglutinin; glycobiomarker	HUMAN PERIPHERAL LYMPHOCYTES; WISTARIA-FLORIBUNDA; LEGUME LECTIN; HEPATOCELLULAR-CARCINOMA; LINKED OLIGOSACCHARIDES; N-ACETYLGALACTOSAMINE; ROBINIA-PSEUDOACACIA; SCHISTOSOMA-MANSONI; MASS-SPECTROMETRY; SOPHORA-JAPONICA	Aberrant glycosylation and the overexpression of specific carbohydrate epitopes is a hallmark of many cancers, and tumor-associated oligosaccharides are actively investigated as targets for immunotherapy and diagnostics. Wisteria floribunda agglutinin (WFA) is a legume lectin that recognizes terminal N-acetylgalactosaminides with high affinity. WFA preferentially binds the disaccharide LacdiNAc (-d-GalNAc-[14]-d-GlcNAc), which is associated with tumor malignancy in leukemia, prostate, pancreatic, ovarian, and liver cancers and has shown promise in cancer glycobiomarker detection. The mechanism of specificity for WFA recognition of LacdiNAc is not fully understood. To address this problem, we have determined affinities and structure of WFA in complex with GalNAc and LacdiNAc. Affinities toward Gal, GalNAc, and LacdiNAc were measured via surface plasmon resonance, yielding K-D values of 4.67 x 10(-4) m, 9.24 x 10(-5) m, and 5.45 x 10(-6) m, respectively. Structures of WFA in complex with LacdiNAc and GalNAc have been determined to 1.80-2.32 angstrom resolution. These high resolution structures revealed a hydrophobic groove complementary to the GalNAc and, to a minor extent, to the back-face of the GlcNAc sugar ring. Remarkably, the contribution of this small hydrophobic surface significantly increases the observed affinity for LacdiNAc over GalNAc. Tandem MS sequencing confirmed the presence of two isolectin forms in commercially available WFA differing only in the identities of two amino acids. Finally, the WFA carbohydrate binding site is similar to a homologous lectin isolated from Vatairea macrocarpa in complex with GalNAc, which, unlike WFA, binds not only GalNAc but also terminal Ser/Thr O-linked GalNAc (Tn antigen).	[Haji-Ghassemi, Omid; Spence, Jenifer; Parker, Matthew J.; Jenkins, Meredith L.; Burke, John E.; Evans, Stephen V.] Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8P 3P6, Canada; [Gilbert, Michel; Schur, Melissa J.; van Faassen, Henk; Young, N. Martin] Natl Res Council Canada, Human Hlth Therapeut, Ottawa, ON K1A 0R6, Canada	University of Victoria; National Research Council Canada	Evans, SV (corresponding author), Univ Victoria, Dept Biochem & Microbiol, POB 3055 STN CSC, Victoria, BC V8P 3P6, Canada.	svevans@uvic.ca	Burke, John/H-3922-2019	Burke, John/0000-0001-7904-9859; Jenkins, Meredith/0000-0002-0685-5048; Gilbert, Michel/0000-0002-0204-4408; Schur, Melissa/0000-0002-6047-1416; Haji-Ghassemi, Omid/0000-0003-0116-005X; Evans, Stephen/0000-0002-0366-4027	NIGMS, National Institutes of Health Grant [GM62116]; Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM062116] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health Grant; Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); University of Saskatchewan; Government of Saskatchewan; Western Economic Diversification Canada; National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We gratefully acknowledge the technical assistance of Nicholas I. Brodie and Evgeniy V. Petrotchenko at the Genome British Columbia Proteomics Centre, Vancouver Island Technology Park. We thank Dr. Greg Hussack for help with the SPR analysis, Dr. Evgeny Vinogradov for NMR analysis, and Jacek Stupak for mass spectrometry analysis of the LacdiNAc beta-pNP. The glycan array facility of the Center for Functional Glycomics was supported by NIGMS, National Institutes of Health Grant GM62116. Research described in this paper was performed at the Canadian Light Source, which is supported by the Canada Foundation for Innovation, Natural Sciences and Engineering Research Council of Canada, the University of Saskatchewan, the Government of Saskatchewan, Western Economic Diversification Canada, the National Research Council Canada, and the Canadian Institutes of Health Research.	BAKER DA, 1983, BIOCHEMISTRY-US, V22, P2741, DOI 10.1021/bi00280a023; Bernatchez S, 2005, J BIOL CHEM, V280, P4792, DOI 10.1074/jbc.M407767200; Blixt O, 2004, P NATL ACAD SCI USA, V101, P17033, DOI 10.1073/pnas.0407902101; Bojarova P, 2009, GLYCOBIOLOGY, V19, P509, DOI 10.1093/glycob/cwp010; Chandra NR, 2001, PROTEIN ENG, V14, P857, DOI 10.1093/protein/14.11.857; Che MI, 2014, ONCOTARGET, V5, P3673, DOI 10.18632/oncotarget.1981; Collaborative Computational Project, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI DOI 10.1107/S0907444994003112; De Hoff PL, 2009, MOL GENET GENOMICS, V282, P1, DOI 10.1007/s00438-009-0460-8; Do KY, 1997, GLYCOBIOLOGY, V7, P183, DOI 10.1093/glycob/7.2.183; Drickamer K, 2002, GENOME BIOL, V3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Frederiksen RF, 2015, J BIOL CHEM, V290, P5354, DOI 10.1074/jbc.M114.607291; Fujiyoshi M, 2015, J GASTROENTEROL, V50, P1134, DOI 10.1007/s00535-015-1063-2; Garcia-Pino A, 2006, J MOL BIOL, V361, P153, DOI 10.1016/j.jmb.2006.06.006; HANKINS CN, 1988, PLANT PHYSIOL, V86, P67, DOI 10.1104/pp.86.1.67; Hirano K, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/981627; Huang J, 2007, MOL CANCER RES, V5, P543, DOI 10.1158/1541-7786.MCR-06-0431; Iio E, 2016, INT J CANCER, V138, P1462, DOI 10.1002/ijc.29880; Ikehara Y, 2006, GLYCOBIOLOGY, V16, P777, DOI 10.1093/glycob/cwl005; Karplus PA, 2015, CURR OPIN STRUC BIOL, V34, P60, DOI 10.1016/j.sbi.2015.07.003; Kitamura N, 2003, INT J CANCER, V105, P533, DOI 10.1002/ijc.11115; Kuno A, 2013, SCI REP-UK, V3, DOI 10.1038/srep01065; KUROKAWA T, 1976, J BIOL CHEM, V251, P5686; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Loris R, 1998, BBA-PROTEIN STRUCT M, V1383, P9, DOI 10.1016/S0167-4838(97)00182-9; Machado E, 2011, GLYCOBIOLOGY, V21, P376, DOI 10.1093/glycob/cwq170; Matsuda A, 2015, ANAL CHEM, V87, P7274, DOI 10.1021/acs.analchem.5b01329; Matsuda A, 2010, HEPATOLOGY, V52, P174, DOI 10.1002/hep.23654; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; MODY R, 1995, J PHARMACOL TOX MET, V33, P1, DOI 10.1016/1056-8719(94)00052-6; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Namdjou DJ, 2008, CHEMBIOCHEM, V9, P1632, DOI 10.1002/cbic.200700775; Narimatsu H, 2015, EXPERT REV PROTEOMIC, V12, P683, DOI 10.1586/14789450.2015.1084874; NYAME K, 1989, J BIOL CHEM, V264, P3235; PALCIC M M, 1991, Glycobiology, V1, P205, DOI 10.1093/glycob/1.2.205; Petrotchenko EV, 2014, METHODS MOL BIOL, V1156, P447, DOI 10.1007/978-1-4939-0685-7_30; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Pohleven J, 2012, J BIOL CHEM, V287, P10602, DOI 10.1074/jbc.M111.317263; Rabijns A, 2001, PROTEINS, V44, P470, DOI 10.1002/prot.1112; Sasaki N, 2007, BIOCHEM BIOPH RES CO, V354, P522, DOI 10.1016/j.bbrc.2007.01.015; Sato T, 2003, J BIOL CHEM, V278, P47534, DOI 10.1074/jbc.M308857200; Sato T., 2014, Google Patents, Patent No. [WO2014098112 A1, 2014098112]; Schietinger A, 2008, SEMIN IMMUNOL, V20, P276, DOI 10.1016/j.smim.2008.07.001; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; SHARON N, 1990, FASEB J, V4, P3198, DOI 10.1096/fasebj.4.14.2227211; Soga K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083886; Sogabe M, 2014, J PROTEOME RES, V13, P1624, DOI 10.1021/pr401109n; Sousa BL, 2016, INT J BIOCHEM CELL B, V72, P27, DOI 10.1016/j.biocel.2015.12.016; SRIVATSAN J, 1994, J PARASITOL, V80, P884, DOI 10.2307/3283435; Sugahara D, 2015, PROTEOMICS, V15, P2921, DOI 10.1002/pmic.201400443; SUGII S, 1980, BIOCHEMISTRY-US, V19, P1192, DOI 10.1021/bi00547a024; Tamaki N, 2015, HEPATOL RES, V45, pE82, DOI 10.1111/hepr.12466; Toyoda H, 2016, LIVER INT, V36, P293, DOI 10.1111/liv.12907; TOYOSHIMA S, 1971, BIOCHEMISTRY-US, V10, P4457, DOI 10.1021/bi00800a016; TOYOSHIMA S, 1975, J BIOL CHEM, V250, P1655; Vaguine AA, 1999, ACTA CRYSTALLOGR D, V55, P191, DOI 10.1107/S0907444998006684; VanDamme EJM, 1995, PLANT MOL BIOL, V29, P579, DOI 10.1007/BF00020986; VanDamme EJM, 1997, PLANT MOL BIOL, V33, P523, DOI 10.1023/A:1005781103418; VANDENEIJNDEN DH, 1995, BIOCHEM SOC T, V23, P175, DOI 10.1042/bst0230175; Xu YF, 2005, IMMUNOL CELL BIOL, V83, P440, DOI 10.1111/j.1440-1711.2005.01347.x; Yamaguchi T, 2016, ANN SURG ONCOL, V23, P671, DOI 10.1245/s10434-015-4878-4; Yoshida K, 1999, AUST J PLANT PHYSIOL, V26, P495, DOI 10.1071/PP99048; Young NM, 1996, GLYCOCONJUGATE J, V13, P575, DOI 10.1007/BF00731445; YOUNG NM, 1995, J BIOL CHEM, V270, P2563, DOI 10.1074/jbc.270.6.2563; YUAN M, 1986, CANCER RES, V46, P4841	65	36	36	0	21	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					24085	24095		10.1074/jbc.M116.750463	http://dx.doi.org/10.1074/jbc.M116.750463			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27601469	Green Published, hybrid			2022-12-26	WOS:000388498100025
J	Fan, DY; Li, YF; Zhao, LY; Li, ZP; Huang, LL; Yan, X				Fan, Dongying; Li, Yanfang; Zhao, Lingyun; Li, Zhengpeng; Huang, Lili; Yan, Xia			Study on Interactions between the Major Apple Valsa Canker Pathogen Valsa mali and Its Biocontrol Agent Saccharothrix yanglingensis Hhs.015 Using RT-qPCR	PLOS ONE			English	Article							TIME QUANTITATIVE PCR; VAR. MALI; QUANTIFICATION; ARABIDOPSIS; RESISTANCE; PECTINASES; SYSTEM; GROWTH; PLANTS	The mechanism of biocontrol agent Saccharothrix yanglingensis Hhs.015 action against Valsa mali, a major apple Valsa canker pathogen, was examined using a novel, sensitive (minimum detection limit 100 pg/mu L) and reliably RT-qPCR technique. Prior to lesion formation, total concentration of V. mali in the bark showed a significant decrease (p<0.05) after 24 h of Hhs.015 treatment. This was more pronounced at 48 and 96 h post treatment. After lesion formation, levels of V. mali remained constant at the boundary between infected and uninfected bark tissues, although the relative expansion rate of the lesion was significantly reduced (p<0.05). Gene expression levels of endo-polygalacturonase, a marker for fungal pathogenicity, were sharply reduced while host induced resistance callose synthase levels increased significantly (p<0.05) at the boundary bark at 9 d after Hhs.015 treatment. The results showed that biocontrol agent Hhs.015 prevented infection of V. mali by inhibiting pathogen growth, down-regulating pathogenicity factor expression and inducing a high level of host resistance.	[Fan, Dongying; Li, Yanfang; Zhao, Lingyun; Li, Zhengpeng; Huang, Lili; Yan, Xia] Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China; [Fan, Dongying; Li, Yanfang; Zhao, Lingyun; Yan, Xia] Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China; [Li, Zhengpeng; Huang, Lili] Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China	Northwest A&F University - China; Northwest A&F University - China; Northwest A&F University - China	Huang, LL; Yan, X (corresponding author), Northwest A&F Univ, State Key Lab Crop Stress Biol Arid Areas, Yangling, Shaanxi, Peoples R China.; Yan, X (corresponding author), Northwest A&F Univ, Coll Life Sci, Yangling, Shaanxi, Peoples R China.; Huang, LL (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Shaanxi, Peoples R China.	huanglili@nwsuaf.edu.cn; yania@nwsuaf.edu.cn	li, yan/GTI-4638-2022		National Natural Science Foundation of China [31101476]; Science Technology Research and Development Program of Shaanxi province [2013K01-45]; Science and technology planning project of Yangling demonstration zone [2014NY-41]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science Technology Research and Development Program of Shaanxi province; Science and technology planning project of Yangling demonstration zone	This work was supported by the National Natural Science Foundation of China (31101476), Science Technology Research and Development Program of Shaanxi province (2013K01-45), and Science and technology planning project of Yangling demonstration zone (2014NY-41).	Aidemark M, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-27; Ananda K, 2002, CAN J MICROBIOL, V48, P871, DOI 10.1139/W02-080; Baric S, 2011, EUR J PLANT PATHOL, V129, P455, DOI 10.1007/s10658-010-9706-x; Bisognin C, 2008, PHYTOPATHOLOGY, V98, P153, DOI 10.1094/PHYTO-98-2-0153; Bohm J, 1999, J PHYTOPATHOL, V147, P409, DOI 10.1111/j.1439-0434.1999.tb03842.x; Brunner K, 2009, ANAL BIOANAL CHEM, V395, P1385, DOI 10.1007/s00216-009-3083-3; Castillo UF, 2002, MICROBIOL-SGM, V148, P2675, DOI 10.1099/00221287-148-9-2675; Compant S, 2005, APPL ENVIRON MICROB, V71, P4951, DOI 10.1128/AEM.71.9.4951-4959.2005; Daniels B, 2012, EUR J PLANT PATHOL, V134, P821, DOI 10.1007/s10658-012-0058-6; Elad Y, 1999, EUR J PLANT PATHOL, V105, P177, DOI 10.1023/A:1008753629207; Gachon C, 2004, PLANT PHYSIOL BIOCH, V42, P367, DOI 10.1016/j.plaphy.2004.04.001; Gao ZuoPeng, 2009, Acta Phytophylacica Sinica, V36, P410; Gasic K., 2004, Plant Molecular Biology Reporter, V22, P437, DOI 10.1007/BF02772687; Ginzinger DG, 2002, EXP HEMATOL, V30, P503, DOI 10.1016/S0301-472X(02)00806-8; Gummadi SN, 2003, PROCESS BIOCHEM, V38, P987, DOI 10.1016/S0032-9592(02)00203-0; Gusberti M, 2012, PLANT DIS, V96, P1791, DOI 10.1094/PDIS-12-11-1058-RE; Hammerschmidt R, 1999, PHYSIOL MOL PLANT P, V55, P77, DOI 10.1006/pmpp.1999.0215; Hernandez-Suarez M., 2011, American Journal of Agricultural and Biological Sciences, V6, P189, DOI 10.3844/ajabssp.2011.189.195; Hoondal GS, 2002, APPL MICROBIOL BIOT, V59, P409, DOI 10.1007/s00253-002-1061-1; Ingle CA, 1996, P NATL ACAD SCI USA, V93, P12926, DOI 10.1073/pnas.93.23.12926; Ke XW, 2013, AUSTRALAS PLANT PATH, V42, P85, DOI 10.1007/s13313-012-0158-y; Keer JT, 2003, J MICROBIOL METH, V53, P175, DOI 10.1016/S0167-7012(03)00025-3; Lee DH, 2007, PLANT PATHOLOGY J, V23, P37, DOI 10.5423/PPJ.2007.23.2.037; Leisova L, 2006, J MICROBIOL METH, V67, P446, DOI 10.1016/j.mimet.2006.04.018; Li WL, 2012, PLANT CELL REP, V31, P905, DOI 10.1007/s00299-011-1211-y; Miles LA, 2012, BIOCONTROL, V57, P697, DOI 10.1007/s10526-012-9442-6; Musetti R, 2010, PHYTOPATHOLOGY, V100, P390, DOI 10.1094/PHYTO-100-4-0390; Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716; Nolan T, 2006, NAT PROTOC, V1, P1559, DOI 10.1038/nprot.2006.236; Paolacci AR, 2009, BMC MOL BIOL, V10, DOI 10.1186/1471-2199-10-11; Pirselova B, 2013, ACTA PHYSIOL PLANT, V35, P635, DOI 10.1007/s11738-012-1103-y; Rezzonico F, 2005, MOL PLANT MICROBE IN, V18, P991, DOI 10.1094/MPMI-18-0991; TAMURA O, 1982, Annals of the Phytopathological Society of Japan, V48, P490, DOI 10.3186/jjphytopath.48.490; Tewoldemedhin YT, 2011, EUR J PLANT PATHOL, V129, P637, DOI 10.1007/s10658-010-9728-4; Wang CX, 2014, TOXINS, V6, P1139, DOI 10.3390/toxins6031139; Wang Lei, 2009, Acta Phytopathologica Sinica, V39, P549; Wang XL, 2014, ECOL EVOL, V4, P1369, DOI 10.1002/ece3.1030; Yan X, 2012, ANTON LEEUW INT J G, V101, P141, DOI 10.1007/s10482-011-9631-9; Yin ZY, 2013, WORLD J MICROB BIOT, V29, P1563, DOI 10.1007/s11274-013-1320-6	39	4	6	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162174	10.1371/journal.pone.0162174	http://dx.doi.org/10.1371/journal.pone.0162174			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611855	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900051
J	Kletting, P; Schuchardt, C; Kulkarni, HR; Shahinfar, M; Singh, A; Glatting, G; Baum, RP; Beer, AJ				Kletting, Peter; Schuchardt, Christiane; Kulkarni, Harshad R.; Shahinfar, Mostafa; Singh, Aviral; Glatting, Gerhard; Baum, Richard P.; Beer, Ambros J.			Investigating the Effect of Ligand Amount and Injected Therapeutic Activity: A Simulation Study for Lu-177-Labeled PSMA-Targeting Peptides	PLOS ONE			English	Article							MEMBRANE ANTIGEN PSMA; PROSTATE-CANCER; IN-VITRO; DOSIMETRY; LU-177-OCTREOTATE; SOFTWARE	In molecular radiotherapy with Lu-177-labeled prostate specific membrane antigen (PSMA) peptides, kidney and/or salivary glands doses limit the activity which can be administered. The aim of this work was to investigate the effect of the ligand amount and injected activity on the tumor-to-normaltissue biologically effective dose (BED) ratio for Lu-177-labeled PSMA peptides. For this retrospective study, a recently developed physiologically based pharmacokinetic model was adapted for PSMA targeting peptides. General physiological parameters were taken from the literature. Individual parameters were fitted to planar gamma camera measurements (Lu-177-PSMA I&T) of five patients with metastasizing prostate cancer. Based on the estimated parameters, the pharmacokinetics of tumor, salivary glands, kidneys, total body and red marrow was simulated and time-integrated activity coefficients were calculated for different peptide amounts. Based on these simulations, the absorbed doses and BEDs for normal tissue and tumor were calculated for all activities leading to a maximal tolerable kidney BED of 10 Gy(2.5)/cycle, a maximal salivary gland absorbed dose of 7.5 Gy/cycle and a maximal red marrow BED of 0.25 Gy(15)/cycle. The fits yielded coefficients of determination > 0.85, acceptable relative standard errors and low parameter correlations. All estimated parameters were in a physiologically reasonable range. The amounts (for 2(5)-2(9) nmol) and pertaining activities leading to a maximal tumor dose, considering the defined maximal tolerable doses to organs of risk, were calculated to be 272 +/- 253 nmol (452 +/- 420 mu g) and 7.35 +/- 5.1 GBq. Using the actually injected amount (235 +/- 155 mu g) and the same maximal tolerable doses, the potential improvement for the tumor BED was 1-3 fold. The results suggest that currently given amounts for therapy are in the appropriate order of magnitude for many lesions. However, for lesions with high binding site density or lower perfusion, optimizing the peptide amount and activity might improve the tumor-to-kidney and tumor-to-salivary glands BED ratio considerably.	[Kletting, Peter; Beer, Ambros J.] Univ Ulm, Dept Nucl Med, Ulm, Germany; [Schuchardt, Christiane; Kulkarni, Harshad R.; Shahinfar, Mostafa; Singh, Aviral; Baum, Richard P.] Zent Klin Bad Berka, THERANOST Ctr Mol Radiotherapy & Mol Imaging PET, Bad Berka, Germany; [Glatting, Gerhard] Heidelberg Univ, Med Fac Mannheim, Univ Med Mannheim, Med Radiat Phys Radiat Protect, Mannheim, Germany	Ulm University; Zentralklinik Bad Berka; Ruprecht Karls University Heidelberg	Kletting, P (corresponding author), Univ Ulm, Dept Nucl Med, Ulm, Germany.	peter.kletting@uniklinik-ulm.de	Beer, Ambros J./AAA-5539-2022; Glatting, Gerhard/ABF-2506-2020	Beer, Ambros J./0000-0001-9042-7806; Glatting, Gerhard/0000-0001-7916-1576; Kletting, Peter/0000-0003-3654-3667	Deutsche Forschungsgemeinschaft (German Research Foundation) [DFG KL 2742/2-1, BE 4393/1-1, GL 236/11-1]	Deutsche Forschungsgemeinschaft (German Research Foundation)(German Research Foundation (DFG))	The authors gratefully acknowledge grants by the Deutsche Forschungsgemeinschaft (German Research Foundation, DFG KL 2742/2-1, BE 4393/1-1 and GL 236/11-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barone R, 2005, J NUCL MED, V46, p99S; Barrett PHR, 1998, METABOLISM, V47, P484, DOI 10.1016/S0026-0495(98)90064-6; Baum R., 2015, NUKLEARMEDIZINER, V38, P145, DOI [10.1055/s-0035-1549991, DOI 10.1055/S-0035-1549991]; Baum RP, 2016, J NUCL MED, V57, P1006, DOI 10.2967/jnumed.115.168443; Ben Jemaa A, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-171; Bolch WE, 2009, J NUCL MED, V50, P477, DOI 10.2967/jnumed.108.056036; Breau RH, 2013, CUAJ-CAN UROL ASSOC, V7, P189, DOI 10.5489/cuaj.1338; BUBECK B, 1993, SEMIN NUCL MED, V23, P73, DOI 10.1016/S0001-2998(05)80064-9; Cremonesi M, 2010, Q J NUCL MED MOL IM, V54, P37; Cunha AC, 2006, CANCER LETT, V236, P229, DOI 10.1016/j.canlet.2005.05.021; DALE RG, 1985, BRIT J RADIOL, V58, P515, DOI 10.1259/0007-1285-58-690-515; Delker A, 2016, EUR J NUCL MED MOL I, V43, P42, DOI 10.1007/s00259-015-3174-7; Glatting G, 2007, MED PHYS, V34, P4285, DOI 10.1118/1.2794176; Hardiansyah D, 2016, EUR J NUCL MED MOL I, V43, P871, DOI 10.1007/s00259-015-3248-6; Hindorf C, 2010, EUR J NUCL MED MOL I, V37, P1238, DOI 10.1007/s00259-010-1422-4; Hobbs RF, 2013, Q J NUCL MED MOL IM, V57, P79; Holland JP, 2010, J NUCL MED, V51, P1293, DOI 10.2967/jnumed.110.076174; Kabasakal L, 2015, EUR J NUCL MED MOL I, V42, P1976, DOI 10.1007/s00259-015-3125-3; Kal HB, 2003, INT J RADIAT ONCOL, V57, P1116, DOI 10.1016/S0360-3016(03)01455-X; Kletting P, 2013, MED PHYS, V40, DOI 10.1118/1.4820367; Kletting P, 2016, J NUCL MED, V57, P503, DOI 10.2967/jnumed.115.164699; Kletting P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127934; Kletting P, 2012, MED PHYS, V39, P5708, DOI 10.1118/1.4747266; Kletting P, 2009, Z MED PHYS, V19, P200, DOI 10.1016/j.zemedi.2009.05.003; Konijnenberg M, 2011, Q J NUCL MED MOL IM, V55, P44; Kratochwil C, 2015, J NUCL MED, V56, P293, DOI 10.2967/jnumed.114.147181; Luczynska E, 2015, MED SCI MONITOR, V21, P153, DOI 10.12659/MSM.891401; O'Keefe DS, 2004, PROSTATE, V58, P200, DOI 10.1002/pros.10319; Pfestroff A, 2015, EUR J NUCL MED MOL I, V42, P1971, DOI 10.1007/s00259-015-3186-3; Sabet A, 2013, EJNMMI RES, V3, DOI 10.1186/2191-219X-3-82; Schuchardt Christiane, 2013, Recent Results Cancer Res, V194, P519, DOI 10.1007/978-3-642-27994-2_30; Schuler E, 2016, ACTA ONCOL, V55, P68, DOI 10.3109/0284186X.2015.1027001; Schwenzer NF, 2008, NMR BIOMED, V21, P598, DOI 10.1002/nbm.1231; Siegel JA, 1999, J NUCL MED, V40, p37S; Smith-Jones PM, 2000, CANCER RES, V60, P5237; Stabin MG, 2005, J NUCL MED, V46, P1023; Strigari L, 2014, EUR J NUCL MED MOL I, V41, P1976, DOI 10.1007/s00259-014-2824-5; TROYER JK, 1995, INT J CANCER, V62, P552, DOI 10.1002/ijc.2910620511; Wang XN, 2011, MOL CANCER THER, V10, P1728, DOI 10.1158/1535-7163.MCT-11-0191; Weineisen M, 2015, J NUCL MED, V56, P1169, DOI 10.2967/jnumed.115.158550; Weineisen M, 2014, EJNMMI RES, V4, DOI 10.1186/s13550-014-0063-1; Winter G, 2014, ANNUAL CONGRESS EANM, P200; Zechmann CM, 2014, EUR J NUCL MED MOL I, V41, P1280, DOI 10.1007/s00259-014-2713-y	43	18	18	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162303	10.1371/journal.pone.0162303	http://dx.doi.org/10.1371/journal.pone.0162303			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611841	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900076
J	Li, L; Li, CR; Zhong, H; Tao, YJ; Yuan, YS; Pan, CW				Li, Lan; Li, Cairui; Zhong, Hua; Tao, Yijin; Yuan, Yuansheng; Pan, Chen-Wei			Estimated Cerebrospina Fluid Pressure and the 5-Year Incidence of Primary Open-Angle Glaucoma in a Chinese Population	PLOS ONE			English	Article							YUNNAN MINORITY EYE; PREVALENCE	Purpose We aim to assess the longitudinal association between baseline estimated cerebrospinal fluid pressure (CSFP) and 5-year incident primaryopen angle glaucoma (POAG) in a population-based sample of Bai Chinese living in rural China. Methods Among the 2133 Bai Chinese aged 50 years or older who had participated in the baseline examination of the Yunnan Minority Eye Study, 1520 (71.3%) attended the follow-up examination after five years and 1485 were at risk of developing POAG. Participants underwent comprehensive ophthalmic examinations at both baseline and follow-up surveys. CSFP in mmHg was estimated as 0.55 x body mass index (kg/m2) + 0.16 x diastolic blood pressure (mmHg)-0.18 x age (years)-1.91. Glaucoma was defined using the International Society of Geographical and Epidemiological Ophthalmology Classification criteria. Multivariate logistic regression models were established to determine the association between baseline CSFP and incident POAG. Results After a mean follow-up time of 5 years, 19 new cases of POAG were detected, with an incidence rate of 1.3% (95% confidence interval, 0.7-1.9%). In multivariate logistic regression analysis, after adjusting for age, gender, education, intraocular pressure, central corneal thickness, hypertension and diabetes, no significant associations, nor any trends, were evident between baseline estimated CSFP and incident POAG. The association between estimated CSFP per mmHg increase in baseline and 5-year incidence of POAG was also nonsignificant, with adjusted relative risk of 0.96 (P = 0.11) in multivariate analysis. Conclusions This longitudinal cohort study does not support previously observed cross-sectional association between estimated CSFP and POAG in population-based studies.	[Li, Lan] First Hosp Kunming, Dept Ophthalmol, Kunming, Peoples R China; [Li, Cairui] Dali Univ, Affiliated Hosp, Dali, Peoples R China; [Zhong, Hua; Tao, Yijin; Yuan, Yuansheng] Kunming Med Univ, Dept Ophthalmol, Affiliated Hosp 1, Kunming, Peoples R China; [Pan, Chen-Wei] Soochow Univ, Coll Med, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China	Dali University; Kunming Medical University; Soochow University - China	Pan, CW (corresponding author), Soochow Univ, Coll Med, Sch Publ Hlth, Jiangsu Key Lab Prevent & Translat Med Geriatr Di, Suzhou, Peoples R China.	pcwonly@gmail.com	Pan, Chen-Wei/L-7174-2019	Pan, Chen-Wei/0000-0003-3362-4613	National Natural Science Foundation of China [81460085, 81160121, 81371016]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was funded by the National Natural Science Foundation of China under grant No. 81460085, No. 81160121 and No. 81371016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by the National Natural Science Foundation of China under grant No. 81460085, No. 81160121 and No. 81371016.	Baskaran M, 2015, JAMA OPHTHALMOL, V133, P874, DOI 10.1001/jamaophthalmol.2015.1110; Berdahl JP, 2008, OPHTHALMOLOGY, V115, P763, DOI 10.1016/j.ophtha.2008.01.013; Foster PJ, 2002, BRIT J OPHTHALMOL, V86, P238, DOI 10.1136/bjo.86.2.238; He MG, 2006, INVEST OPHTH VIS SCI, V47, P2782, DOI 10.1167/iovs.06-0051; Hollands H, 2013, JAMA-J AM MED ASSOC, V309, P2035, DOI 10.1001/jama.2013.5099; Jonas JB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086678; Jonas JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082284; Jonas JB, 2011, ACTA OPHTHALMOL, V89, P505, DOI 10.1111/j.1755-3768.2010.01915.x; Killer HE, 2009, J GLAUCOMA, V18, P172, DOI 10.1097/IJG.0b013e31819aa4f9; Lee SH, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148412; Li J, 2012, INVEST OPHTH VIS SCI, V53, P4498, DOI 10.1167/iovs.12-9429; Li L, 2015, CORNEA, V34, P1564, DOI 10.1097/ICO.0000000000000637; Marek B, 2014, BRIT J OPHTHALMOL, V98, P721, DOI 10.1136/bjophthalmol-2013-303884; Narayanaswamy A, 2013, INVEST OPHTH VIS SCI, V54, P4621, DOI 10.1167/iovs.13-11950; Promelle V, 2016, ACTA RADIOL OPEN, V5, DOI 10.1177/2058460115624275; Roy CU, 2013, PLOS ONE, V8, DOI DOI 10.1371/JOURNAL.PONE.0082151; Siaudvytyte L, 2015, EYE, V29, P1242, DOI 10.1038/eye.2015.127; Tham YC, 2014, OPHTHALMOLOGY, V121, P2081, DOI 10.1016/j.ophtha.2014.05.013; Wang Ningli, 2013, J Glaucoma, V22 Suppl 5, pS11, DOI 10.1097/IJG.0b013e31829349a2; Wang YX, 2010, AM J OPHTHALMOL, V150, P917, DOI 10.1016/j.ajo.2010.06.037; Wilensky J T, 1991, Trans Am Ophthalmol Soc, V89, P757; Yang DY, 2014, INVEST OPHTH VIS SCI, V55, P3067, DOI 10.1167/iovs.13-13657; Yang Y, 2010, MED HYPOTHESES, V74, P31, DOI 10.1016/j.mehy.2009.08.024; Zhong H, 2012, INVEST OPHTH VIS SCI, V53, P3221, DOI 10.1167/iovs.11-9306	24	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162862	10.1371/journal.pone.0162862	http://dx.doi.org/10.1371/journal.pone.0162862			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611879	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900181
J	Zaw, KK; Ohnmar, M; Hlaing, MM; Oo, YTN; Win, SS; Htike, MMT; Aye, PP; Shwe, S; Htwe, MT; Thein, ZM				Zaw, Ko-Ko; Ohnmar, Mya; Hlaing, Moh-Moh; Oo, Yin-Thet-Nu; Win, Swe-Swe; Htike, Maung-Maung-Than; Aye, Phyu-Phyu; Shwe, Sein; Htwe, Moe-Thida; Thein, Zaw-Moe			Betel Quid and Oral Potentially Malignant Disorders in a Periurban Township in Myanmar	PLOS ONE			English	Article							ARECA NUT; EPIDEMIOLOGY; TOBACCO	This study aims to describe betel quid chewing practice and compare oral potentially malignant disorders between chewers and non-chewers of betel quid among residents in Dagon Myothit (East) Township, Myanmar. The study used a cross-sectional design conducted with a representative sample of 542 adults aged 18 years and above in the township. The trained interviewers collected data using a pretested structured questionnaire. On-site oral examination was done for suspected oral lesions. The mean age of the respondents was 45 years and 59% were women. Fifty-two percent of the respondents were currently in the habit of chewing betel quids (72% of men and 39% of women). Among 284 current betel quid chewers, 240 (85%) chewed betel quids together with tobacco. Out of 284 current betel quid chewers, 24 (8.5%) were found to have oral potentially malignant disorders; out of 258 betel quid non-chewers, only 1 (0.4%) was found to have oral potentially malignant disorders. This highlights the growing importance of smokeless tobacco use as public health problem.	[Zaw, Ko-Ko; Ohnmar, Mya; Hlaing, Moh-Moh; Oo, Yin-Thet-Nu] Dept Med Res Lower Myanmar, Yangon, Myanmar; [Win, Swe-Swe; Shwe, Sein; Htwe, Moe-Thida; Thein, Zaw-Moe] Univ Dent Med, Yangon, Myanmar; [Htike, Maung-Maung-Than] Minist Hlth, Int Hlth Div, Nayphyitaw, Myanmar; [Aye, Phyu-Phyu] Dept Publ Hlth, Nayphyitaw, Myanmar		Zaw, KK (corresponding author), Dept Med Res Lower Myanmar, Yangon, Myanmar.	zawkzaw@gmail.com	Zaw, Ko-Ko/HGF-2385-2022; Thein, Zaw/AAU-6039-2020		Department of Medical Research;  [200630868]	Department of Medical Research; 	This work was supported by grant number 200630868 and the Department of Medical Research, http://www.dmrlm.gov.mm/. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Floraa MS, WHO S E ASIA J PUBLI, V169; Gupta A, 2007, ACTA CYTOL, V51, P788, DOI 10.1159/000325843; Gupta PC, 2004, ANN ACAD MED SINGAP, V33, P31; Gupta PC, 2002, ADDICT BIOL, V7, P77, DOI 10.1080/13556210020091437; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2004, IARC Monogr Eval Carcinog Risks Hum, V85, P1; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P1; Lee CH, 2011, INT J CANCER, V129, P1741, DOI 10.1002/ijc.25809; Mazahir S, 2006, SUBST ABUSE TREAT PR, V1, DOI 10.1186/1747-597X-1-10; Ministry of Information, ENC MYANM CD ROM; Patton LL, 2008, J AM DENT ASSOC, V139, P896, DOI 10.14219/jada.archive.2008.0276; Rahman M, 2006, BEHAV RISK FACTORS N; Secretan B, 2009, LANCET ONCOL, V10, P1033, DOI 10.1016/S1470-2045(09)70326-2; WHO, 2011, NONC DIS RISK FACT S; WHO IARC, 1985, IARC MON EV CARC RIS, V37, P1	14	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162081	10.1371/journal.pone.0162081	http://dx.doi.org/10.1371/journal.pone.0162081			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611195	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900044
J	Clausen, AN; Aupperle, RL; Sisante, JFV; Wilson, DR; Billinger, SA				Clausen, Ashley N.; Aupperle, Robin L.; Sisante, Jason-Flor V.; Wilson, David R.; Billinger, Sandra A.			Pilot Investigation of PTSD, Autonomic Reactivity, and Cardiovascular Health in Physically Healthy Combat Veterans	PLOS ONE			English	Article							POSTTRAUMATIC-STRESS-DISORDER; FLOW-MEDIATED DILATION; CORONARY-HEART-DISEASE; WORLD-WAR-II; VIETNAM VETERANS; RATE-VARIABILITY; PHYSIOLOGICAL-RESPONSES; ENDOTHELIAL FUNCTION; AEROBIC EXERCISE; BRACHIAL-ARTERY	Posttraumatic stress disorder (PTSD), and combat-related PTSD in particular, has been associated with increased rates of cardiovascular disease, and cardiovascular-related death. However, less research has examined possible factors that may link PTSD to poorer cardiovascular health in combat veteran populations. The current pilot study investigated whether psychological symptomology and autonomic reactivity to emotional scripts would relate to poorer cardiovascular health in combat veterans without a current diagnosis of cardiovascular disease. Male veterans (N = 24), who served in combat since Operation Iraqi Freedom, completed a semi-structured interview and self-report measures to assess psychological symptomology. Autonomic reactivity, measured using heart rate variability (HRV; low to high frequency ratio), was obtained during script-driven imagery of emotional memories. Cardiovascular health was assessed using flow-mediated dilation (FMD) of the brachial artery. Correlational analyses and discriminant analysis were used to assess the relationship between psychological symptoms (PTSD, depression, anger, as measured via self-report), autonomic reactivity to emotional scripts (HRV), and FMD. Overall, veterans in the current study showed poor cardiovascular health despite their relatively young age and lack of behavioral risk factors, with 15/24 exhibiting impaired FMD (FMD < 5%). Psychological symptomology was not associated with FMD; whereas autonomic reactivity to emotional (compared to neutral) scripts was found to relate to FMD. Autonomic reactivity to negative scripts correctly classified 76.5% of veterans as having impaired versus normative FMD. Results from this pilot study highlight the importance of cardiovascular screening with combat veterans despite psychological diagnosis. Results also support the need for longitudinal research assessing the use of autonomic reactivity to emotionally valenced stimuli as a potential risk factor for poorer cardiovascular health.	[Clausen, Ashley N.; Aupperle, Robin L.] Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA; [Clausen, Ashley N.; Aupperle, Robin L.] Laureate Inst Brain Res, Tulsa, OK 74136 USA; [Sisante, Jason-Flor V.; Wilson, David R.; Billinger, Sandra A.] Univ Kansas, Med Ctr, Dept Phys Therapy & Rehabil Sci, Kansas City, KS 66103 USA	University of Tulsa; Laureate Institute for Brain Research, Inc.; University of Kansas; University of Kansas Medical Center	Clausen, AN (corresponding author), Univ Tulsa, Dept Psychol, Tulsa, OK 74104 USA.; Clausen, AN (corresponding author), Laureate Inst Brain Res, Tulsa, OK 74136 USA.	aclausen@laureateinstitute.org	Clausen, Ashley N/W-5627-2019; Aupperle, Robin/AAU-8550-2020	Clausen, Ashley N/0000-0002-1773-7733; 	University of Missouri-Kansas City's Women's Council Graduate Assistant; Department of Psychology at the University of Missouri-Kansas City; University of Missouri Research Board; Heartland Institute for Clinical and Translational Research [UL1TR000001]; Eunice Kennedy Shriver National Institute of Child Health and Human Development [K01HD067318, T32HD057850]; Georgia Holland Endowment Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD057850] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [K23MH108707] Funding Source: NIH RePORTER	University of Missouri-Kansas City's Women's Council Graduate Assistant; Department of Psychology at the University of Missouri-Kansas City; University of Missouri Research Board; Heartland Institute for Clinical and Translational Research; Eunice Kennedy Shriver National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Georgia Holland Endowment Fund; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This research was partially supported by the University of Missouri-Kansas City's Women's Council Graduate Assistant Funding, and start-up funds from the Department of Psychology at the University of Missouri-Kansas City, and the University of Missouri Research Board and Heartland Institute for Clinical and Translational Research (UL1TR000001), awarded to Dr. Robin Aupperle. Dr. Sandra Billinger was supported in part by K01HD067318 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. JFS was supported in part by T32HD057850 from the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health and Human Development. The KU Research in Exercise and Cardiovascular Health laboratory space was supported by the Georgia Holland Endowment Fund. The authors report no relationship with the industry.	American Psychiatric Association, 2000, DIAGN STAT MAN 4 TEX; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Aupperle RL, 2012, ARCH GEN PSYCHIAT, V69, P360, DOI 10.1001/archgenpsychiatry.2011.1539; Babor T.F., 1992, AUDIT ALCOHOL USE DI; Beck AT., 1996, MANUAL BECK DEPRESSI; Bedi US, 2007, J NATL MED ASSOC, V99, P642; Billinger SA, 2016, INT J NEUROSCI, P1; Billinger SA, 2012, J NEUROL PHYS THER, V36, P159, DOI 10.1097/NPT.0b013e318274d082; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Blumenthal JA, 2005, JAMA-J AM MED ASSOC, V293, P1626, DOI 10.1001/jama.293.13.1626; Boscarino JA, 2006, ANN EPIDEMIOL, V16, P248, DOI 10.1016/j.annepidem.2005.03.009; Boscarino JA, 1999, ANN BEHAV MED, V21, P227, DOI 10.1007/BF02884839; Boscarino JA, 2008, PSYCHOSOM MED, V70, P668, DOI 10.1097/PSY.0b013e31817bccaf; Buckley TC, 2004, J TRAUMA STRESS, V17, P163, DOI 10.1023/B:JOTS.0000022623.01190.f0; Carney Robert M, 2009, Cleve Clin J Med, V76 Suppl 2, pS13, DOI 10.3949/ccjm.76.s2.03; Christopher M, 2004, CLIN PSYCHOL REV, V24, P75, DOI 10.1016/j.cpr.2003.12.003; Cohen BE, 2009, JAMA-J AM MED ASSOC, V302, P489, DOI 10.1001/jama.2009.1084; Cohen H, 2000, SEMIN ARTHRITIS RHEU, V29, P217, DOI 10.1016/S0049-0172(00)80010-4; Cohen H, 1997, BIOL PSYCHIAT, V41, P627, DOI 10.1016/S0006-3223(96)00525-2; Cohen H, 2001, BRIT J PSYCHIAT, V179, P167, DOI 10.1192/bjp.179.2.167; Cohen H, 1998, BIOL PSYCHIAT, V44, P1054, DOI 10.1016/S0006-3223(97)00475-7; Cooper DC, 2010, PSYCHOSOM MED, V72, P122, DOI 10.1097/PSY.0b013e3181cdbfc0; COX DA, 1989, CIRCULATION, V80, P458, DOI 10.1161/01.CIR.80.3.458; Dalli E, 2002, REV ESP CARDIOL, V55, P928, DOI 10.1016/S0300-8932(02)76731-6; Elder GH, 1997, AM J PSYCHIAT, V154, P330; Friedman Matthew J., 1995, P507; Grenon SM, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.003010; Guthikonda S, 2007, ARTERIOSCL THROM VAS, V27, P1172, DOI 10.1161/ATVBAHA.106.131011; Harris KF, 2003, PSYCHOSOM MED, V65, P402, DOI 10.1097/01.PSY.0000035720.08842.9F; Holman EA, 2008, ARCH GEN PSYCHIAT, V65, P73, DOI 10.1001/archgenpsychiatry.2007.6; KAWACHI I, 1994, CIRCULATION, V90, P2225, DOI 10.1161/01.CIR.90.5.2225; Kemp AH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030777; KESSLER RC, 1995, ARCH GEN PSYCHIAT, V52, P1048, DOI 10.1001/archpsyc.1995.03950240066012; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Klabunde R. E., 2005, CARDIOVASCULAR PHYSL, V2nd; Kluding PM, 2015, PHYS THER, V95, P223, DOI 10.2522/ptj.20140108; Kobayashi K, 2004, ATHEROSCLEROSIS, V173, P13, DOI 10.1016/j.atherosclerosis.2003.10.013; Kubzansky LD, 2007, ARCH GEN PSYCHIAT, V64, P109, DOI 10.1001/archpsyc.64.1.109; LEUNG WH, 1993, LANCET, V341, P1496, DOI 10.1016/0140-6736(93)90634-S; Lindauer RTL, 2006, PSYCHOSOM MED, V68, P33, DOI 10.1097/01.psy.0000188566.35902.e7; Moravec Christine S, 2008, Cleve Clin J Med, V75 Suppl 2, pS35; Narita K, 2008, PSYCHONEUROENDOCRINO, V33, P305, DOI 10.1016/j.psyneuen.2007.11.013; Narita K, 2007, INT PSYCHOGERIATR, V19, P947, DOI 10.1017/S1041610206004571; O'Toole BI, 2008, J PSYCHOSOM RES, V64, P33, DOI 10.1016/j.jpsychores.2007.07.006; Olshansky B, 2008, CIRCULATION, V118, P863, DOI 10.1161/CIRCULATIONAHA.107.760405; Orr SP, 1998, J TRAUMA STRESS, V11, P155, DOI 10.1023/A:1024421502881; ORR SP, 1990, J CONSULT CLIN PSYCH, V58, P329, DOI 10.1037/0022-006X.58.3.329; Orr SP, 2003, ARCH GEN PSYCHIAT, V60, P283, DOI 10.1001/archpsyc.60.3.283; ORR SP, 1995, J ABNORM PSYCHOL, V104, P75, DOI 10.1037/0021-843X.104.1.75; Pagani M, 2001, AUTON NEUROSCI-BASIC, V90, P76, DOI 10.1016/S1566-0702(01)00270-3; Page WF, 2001, MIL MED, V166, P803, DOI 10.1093/milmed/166.9.803; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; PITMAN RK, 1990, J ABNORM PSYCHOL, V99, P49, DOI 10.1037/0021-843X.99.1.49; PITMAN RK, 1987, ARCH GEN PSYCHIAT, V44, P970; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Rausch SM, 2006, INT J STRESS MANAGE, V13, P273, DOI DOI 10.1037/1072-5245.13.3.273; Richardson LK, 2010, AUST NZ J PSYCHIAT, V44, P4, DOI 10.3109/00048670903393597; Rosenheck RA, 2007, HEALTH AFFAIR, V26, P1720, DOI 10.1377/hlthaff.26.6.1720; Schnurr PP, 1999, J NERV MENT DIS, V187, P353, DOI 10.1097/00005053-199906000-00004; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Solter V, 2002, CROAT MED J, V43, P685; Stillman AN, 2013, PSYCHOSOM MED, V75, P537, DOI 10.1097/PSY.0b013e31829a0ae3; Tan G, 2011, APPL PSYCHOPHYS BIOF, V36, P27, DOI 10.1007/s10484-010-9141-y; Tarvainen MP, 2009, IEEE ENG MED BIO, P1, DOI 10.1109/IEMBS.2009.5332678; Thayer JF, 2007, BIOL PSYCHOL, V74, P224, DOI 10.1016/j.biopsycho.2005.11.013; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Thijssen DHJ, 2011, AM J PHYSIOL-HEART C, V300, pH2, DOI 10.1152/ajpheart.00471.2010; Violanti J.M., 2006, INT J STRESS MANAGE, V13, P541, DOI DOI 10.1037/1072-5245.13.4.541; Vogelzangs N, 2010, J AFFECT DISORDERS, V125, P241, DOI 10.1016/j.jad.2010.02.112; Walczewska J, 2011, EUR HEART J, V32, P730, DOI 10.1093/eurheartj/ehq354; Wentworth BA, 2013, CARDIOL REV, V21, P16, DOI 10.1097/CRD.0b013e318265343b; Widlansky ME, 2003, J AM COLL CARDIOL, V42, P1149, DOI 10.1016/S0735-1097(03)00994-X; World Health Organization, 1992, INT STAT CLASS DIS R; Xhyheri B, 2012, PROG CARDIOVASC DIS, V55, P321, DOI 10.1016/j.pcad.2012.09.001; Yeboah J, 2007, CIRCULATION, V115, P2390, DOI 10.1161/CIRCULATIONAHA.106.678276	76	7	7	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162547	10.1371/journal.pone.0162547	http://dx.doi.org/10.1371/journal.pone.0162547			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27607181	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255600063
J	Baese-Berk, MM; Dilley, LC; Schmidt, S; Morrill, TH; Pitt, MA				Baese-Berk, Melissa M.; Dilley, Laura C.; Schmidt, Stephanie; Morrill, Tuuli H.; Pitt, Mark A.			Revisiting Neil Armstrongs Moon-Landing Quote: Implications for Speech Perception, Function Word Reduction, and Acoustic Ambiguity	PLOS ONE			English	Article							RECOGNITION; HYPOTHESIS; HEAR	Neil Armstrong insisted that his quote upon landing on the moon was misheard, and that he had said one small step for a man, instead of one small step for man. What he said is unclear in part because function words like a can be reduced and spectrally indistinguishable from the preceding context. Therefore, their presence can be ambiguous, and they may disappear perceptually depending on the rate of surrounding speech. Two experiments are presented examining production and perception of reduced tokens of for and for a in spontaneous speech. Experiment 1 investigates the distributions of several acoustic features of for and for a. The results suggest that the distributions of for and for a overlap substantially, both in terms of temporal and spectral characteristics. Experiment 2 examines perception of these same tokens when the context speaking rate differs. The perceptibility of the function word a varies as a function of this context speaking rate. These results demonstrate that substantial ambiguity exists in the original quote from Armstrong, and that this ambiguity may be understood through context speaking rate.	[Baese-Berk, Melissa M.] Univ Oregon, Dept Linguist, Eugene, OR 97403 USA; [Dilley, Laura C.; Schmidt, Stephanie] Michigan State Univ, Dept Commun Sci & Disorders, E Lansing, MI 48824 USA; [Morrill, Tuuli H.] George Mason Univ, Program Linguist, Dept English, Fairfax, VA 22030 USA; [Pitt, Mark A.] Ohio State Univ, Dept Psychol, Columbus, OH 43210 USA	University of Oregon; Michigan State University; George Mason University; University System of Ohio; Ohio State University	Dilley, LC (corresponding author), Michigan State Univ, Dept Commun Sci & Disorders, E Lansing, MI 48824 USA.	ldilley@msu.edu		Baese-Berk, Melissa/0000-0002-4855-9319	National Science Foundation [0847653, 1431063]	National Science Foundation(National Science Foundation (NSF))	This work was supported by the National Science Foundation (0847653 and 1431063) to LD, http://www.nsf.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMSON AS, 1968, J ACOUST SOC AM, V44, P377, DOI 10.1121/1.1970569; [Anonymous], 2006, BBC NEWS; Baese-Berk MM, 2014, PSYCHOL SCI, V25, P1546, DOI 10.1177/0956797614533705; Barr DJ, 2013, J MEM LANG, V68, P255, DOI 10.1016/j.jml.2012.11.001; Bell A, 2003, J ACOUST SOC AM, V113, P1001, DOI 10.1121/1.1534836; Boersma P., 2015, PRAAT; Cole RA, 1979, PERCEPTION PRODUCTIO; Collingridge DS, 2013, J MIX METHOD RES, V7, P81, DOI 10.1177/1558689812454457; Crouch I, 2012, NEW YORKER NEWS DESK; Dilley LC, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.01002; Dilley LC, 2010, PSYCHOL SCI, V21, P1664, DOI 10.1177/0956797610384743; Dilley LC, 2010, J MEM LANG, V63, P274, DOI 10.1016/j.jml.2010.06.003; Ernestus M, 2002, BRAIN LANG, V81, P162, DOI 10.1006/brln.2001.2514; Ernestus M, 2011, J PHONETICS, V39, P253, DOI 10.1016/S0095-4470(11)00055-6; Heffner CC, 2013, LANG COGNITIVE PROC, V28, P1275, DOI 10.1080/01690965.2012.672229; Johnson Keith., 2004, SPONTANEOUS SPEECH D, P29; Jones E. M., 1995, APOLLO 11 LUNAR SURF; LEHISTE I, 1972, J ACOUST SOC AM, V51, P2018, DOI 10.1121/1.1913062; Mattys SL, 2007, J EXP PSYCHOL HUMAN, V33, P960, DOI 10.1037/0096-1523.33.4.960; Mitterer H, 2008, J MEM LANG, V59, P133, DOI 10.1016/j.jml.2008.02.004; Morrill T, 2015, PSYCHON B REV, V22, P1451, DOI 10.3758/s13423-015-0820-9; Morrill TH, 2014, COGNITION, V131, P69, DOI 10.1016/j.cognition.2013.12.006; Shockey L., 2008, SOUND PATTERNS SPOKE; Stevens K.N., 2000, ACOUSTIC PHONETICS, V30	25	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0155975	10.1371/journal.pone.0155975	http://dx.doi.org/10.1371/journal.pone.0155975			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603209	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255200001
J	Fisher, JT; Heim, N; Code, S; Paczkowski, J				Fisher, Jason T.; Heim, Nicole; Code, Sandra; Paczkowski, John			Grizzly Bear Noninvasive Genetic Tagging Surveys: Estimating the Magnitude of Missed Detections	PLOS ONE			English	Article							MARK-RECAPTURE POPULATION; URSUS-ARCTOS; OCCUPANCY ESTIMATION; BIODIVERSITY LOSS; NATIONAL-PARK; DENSITY; BIAS; HETEROGENEITY; CONSERVATION; CARNIVORES	Sound wildlife conservation decisions require sound information, and scientists increasingly rely on remotely collected data over large spatial scales, such as noninvasive genetic tagging (NGT). Grizzly bears (Ursus arctos), for example, are difficult to study at population scales except with noninvasive data, and NGT via hair trapping informs management over much of grizzly bears' range. Considerable statistical effort has gone into estimating sources of heterogeneity, but detection error-arising when a visiting bear fails to leave a hair sample-has not been independently estimated. We used camera traps to survey grizzly bear occurrence at fixed hair traps and multi-method hierarchical occupancy models to estimate the probability that a visiting bear actually leaves a hair sample with viable DNA. We surveyed grizzly bears via hair trapping and camera trapping for 8 monthly surveys at 50 (2012) and 76 (2013) sites in the Rocky Mountains of Alberta, Canada. We used multimethod occupancy models to estimate site occupancy, probability of detection, and conditional occupancy at a hair trap. We tested the prediction that detection error in NGT studies could be induced by temporal variability within season, leading to underestimation of occupancy. NGT via hair trapping consistently underestimated grizzly bear occupancy at a site when compared to camera trapping. At best occupancy was underestimated by 50%; at worst, by 95%. Probability of false absence was reduced through successive surveys, but this mainly accounts for error imparted by movement among repeated surveys, not necessarily missed detections by extant bears. The implications of missed detections and biased occupancy estimates for density estimation-which form the crux of management plans-require consideration. We suggest hair-trap NGT studies should estimate and correct detection error using independent survey methods such as cameras, to ensure the reliability of the data upon which species management and conservation actions are based.	[Fisher, Jason T.; Heim, Nicole] Alberta Innovates Technol Futures, Ecosyst Management Unit, 3,4476 Markham St, Victoria, BC V8Z 7X8, Canada; [Fisher, Jason T.; Heim, Nicole] Univ Victoria, Sch Environm Studies, STN CSC, POB 3060, Victoria, BC V8W 3R4, Canada; [Code, Sandra; Paczkowski, John] Alberta Environm & Pk, Pk Div, Suite 201,800 Railway Ave, Canmore, AB T1W 1P1, Canada	Alberta Innovates; University of Victoria	Fisher, JT (corresponding author), Alberta Innovates Technol Futures, Ecosyst Management Unit, 3,4476 Markham St, Victoria, BC V8Z 7X8, Canada.; Fisher, JT (corresponding author), Univ Victoria, Sch Environm Studies, STN CSC, POB 3060, Victoria, BC V8W 3R4, Canada.	Jason.fisher@albertainnovates.ca			Alberta Environment and Parks; Alberta Innovates-Technology Futures; Natural Sciences and Engineering Research Council of Canada; Yellowstone	Alberta Environment and Parks; Alberta Innovates-Technology Futures; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Yellowstone	This work was primarily funded by Alberta Environment and Parks and Alberta Innovates-Technology Futures under the grant title "East Slopes Predators Project." Scholarship funding was granted to Nicole Heim by Natural Sciences and Engineering Research Council of Canada and Yellowstone to Yukon to Conservation Initiative. Alberta Innovates-Technology Futures provided support in the form of salaries for authors JTF and NH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Alberta Environment and Parks provided support in the form of salaries for authors SC and JP, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the "author contributions" section.	Benn B, 2002, URSUS, V13, P213; Boulanger J, 2004, J MAMMAL, V85, P618, DOI 10.1644/BRB-134; Boulanger J, 2004, J WILDLIFE MANAGE, V68, P457, DOI 10.2193/0022-541X(2004)068[0457:SDABID]2.0.CO;2; Boulanger J, 2002, URSUS, V13, P137; Boulanger J, 2008, ECOL APPL, V18, P577, DOI 10.1890/06-1941.1; Boulanger J, 2006, URSUS, V17, P149, DOI 10.2192/1537-6176(2006)17[149:AETODM]2.0.CO;2; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Burton AC, 2015, J APPL ECOL, V52, P675, DOI 10.1111/1365-2664.12432; Campbell Lori A., 2008, P223; Cardinale BJ, 2012, NATURE, V486, P59, DOI 10.1038/nature11148; Crooks KR, 2011, PHILOS T R SOC B, V366, P2642, DOI 10.1098/rstb.2011.0120; Crooks KR, 2002, CONSERV BIOL, V16, P488, DOI 10.1046/j.1523-1739.2002.00386.x; Diaz S, 2006, PLOS BIOL, V4, P1300, DOI 10.1371/journal.pbio.0040277; Efford MG, 2014, ECOLOGY, V95, P1341, DOI 10.1890/13-1497.1; Efford MG, 2014, METHODS ECOL EVOL, V5, P599, DOI 10.1111/2041-210X.12169; Efford MG, 2012, ECOSPHERE, V3, DOI 10.1890/ES11-00308.1; Efford MG, 2009, ENVIRON ECOL STAT SE, V3, P255, DOI 10.1007/978-0-387-78151-8_11; Festa- Bianchet M., 2010, STATUS GRIZZLY BEAR; Fisher JT, 2013, CAN J ZOOL, V91, P706, DOI 10.1139/cjz-2013-0022; Fisher JT, 2014, CONSERV BIOL, V28, P1249, DOI 10.1111/cobi.12302; Fisher JT, 2014, J WILDLIFE MANAGE, V78, P1087, DOI 10.1002/jwmg.750; Gardner B, 2010, J WILDLIFE MANAGE, V74, P318, DOI 10.2193/2009-101; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Heim N.A., 2015, COMPLEX EFFECTS HUMA; Hines JE., 2006, PRESENCESOFTWARE EST; Hooper DU, 2012, NATURE, V486, P105, DOI 10.1038/nature11118; Kendall KC, 2008, J WILDLIFE MANAGE, V72, P1693, DOI 10.2193/2008-007; Kendall KC, 2009, J WILDLIFE MANAGE, V73, P3, DOI 10.2193/2008-330; Kendall WL, 2013, ECOLOGY, V94, P610, DOI 10.1890/12-1720.1; Kendall WL, 2009, J APPL ECOL, V46, P1182, DOI 10.1111/j.1365-2664.2009.01732.x; Laliberte AS, 2004, BIOSCIENCE, V54, P123, DOI 10.1641/0006-3568(2004)054[0123:RCONAC]2.0.CO;2; Lee TM, 2011, P ROY SOC B-BIOL SCI, V278, P1329, DOI 10.1098/rspb.2010.1877; Lindenmayer DB, 2010, BIOL CONSERV, V143, P1317, DOI 10.1016/j.biocon.2010.02.013; Long RA, 2008, NONINVASIVE SURVEY M; Long Robert A., 2008, P8; Lukacs PM, 2005, MOL ECOL, V14, P3909, DOI 10.1111/j.1365-294X.2005.02717.x; MacKenzie D. I., 2017, OCCUPANCY ESTIMATION; MacKenzie DI, 2005, J WILDLIFE MANAGE, V69, P849, DOI 10.2193/0022-541X(2005)069[0849:WATIWP]2.0.CO;2; MacKenzie DI, 2002, ECOLOGY, V83, P2248, DOI 10.1890/0012-9658(2002)083[2248:ESORWD]2.0.CO;2; Manel S, 2003, TRENDS ECOL EVOL, V18, P189, DOI 10.1016/S0169-5347(03)00008-9; McKelvey KS, 2004, J WILDLIFE MANAGE, V68, P453, DOI 10.2193/0022-541X(2004)068[0453:PRAAGC]2.0.CO;2; McKelvey KS, 2004, J WILDLIFE MANAGE, V68, P439, DOI 10.2193/0022-541X(2004)068[0439:GEAWPE]2.0.CO;2; Mills LS, 2000, ECOL APPL, V10, P283, DOI 10.2307/2641002; Mooers AO, 2010, BIOSCIENCE, V60, P843, DOI 10.1525/bio.2010.60.10.11; Mowat G, 2005, WILDLIFE BIOL, V11, P31, DOI 10.2981/0909-6396(2005)11[31:GUAABB]2.0.CO;2; Mowat G, 2000, J WILDLIFE MANAGE, V64, P183, DOI 10.2307/3802989; Nichols JD, 2008, J APPL ECOL, V45, P1321, DOI 10.1111/j.1365-2664.2008.01509.x; Nielsen SE, 2004, BIOL CONSERV, V120, P101, DOI 10.1016/j.biocon.2004.02.020; O'Connell A, 2011, CAMERA TRAPS IN ANIMAL ECOLOGY: METHODS AND ANALYSES, pV; Paetkau D, 2004, J WILDLIFE MANAGE, V68, P449, DOI 10.2193/0022-541X(2004)068[0449:TONOMI]2.0.CO;2; Paetkau D, 2003, MOL ECOL, V12, P1375, DOI 10.1046/j.1365-294X.2003.01820.x; Poole KG, 2001, WILDLIFE BIOL, V7, P105, DOI 10.2981/wlb.2001.014; Proctor MF, 2004, CAN J ZOOL, V82, P1108, DOI 10.1139/z04-077; Roon DA, 2003, MOL ECOL NOTES, V3, P163, DOI 10.1046/j.1471-8286.2003.00358.x; Rota CT, 2009, J APPL ECOL, V46, P1173, DOI 10.1111/j.1365-2664.2009.01734.x; Rovang S, 2015, WILDLIFE BIOL, V21, P68, DOI 10.2981/wlb.00033; Rowcliffe JM, 2008, J APPL ECOL, V45, P1228, DOI 10.1111/j.1365-2664.2008.01473.x; Schwartz CC, 2006, WILDLIFE MONOGR, P1; Schwartz Charles C., 2003, Ursus (Knoxville), V14, P109; Stetz JB, 2015, J FISH WILDL MANAG, V6, P191, DOI 10.3996/122013-JFWM-085; Stewart FEC, 2016, ECOL EVOL, V6, P1493, DOI 10.1002/ece3.1921; Taberlet P, 1999, TRENDS ECOL EVOL, V14, P323, DOI 10.1016/S0169-5347(99)01637-7; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Waits LP, 2005, J WILDLIFE MANAGE, V69, P1419, DOI 10.2193/0022-541X(2005)69[1419:NGSTFW]2.0.CO;2; Weaver JL, 1996, CONSERV BIOL, V10, P964, DOI 10.1046/j.1523-1739.1996.10040964.x; Whittington J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134446; Zedrosser A, 2009, OECOLOGIA, V160, P847, DOI 10.1007/s00442-009-1343-8	67	9	9	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161055	10.1371/journal.pone.0161055	http://dx.doi.org/10.1371/journal.pone.0161055			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603134	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200010
J	Guan, F; Zhai, XF; Duan, JZ; Zhang, MX; Hou, BR				Guan, Fang; Zhai, Xiaofan; Duan, Jizhou; Zhang, Meixia; Hou, Baorong			Influence of Sulfate-Reducing Bacteria on the Corrosion Behavior of High Strength Steel EQ70 under Cathodic Polarization	PLOS ONE			English	Article							PROTECTED HIGH-STRENGTH; DIRECT ELECTRON UPTAKE; LOW-ALLOY STEELS; CARBON-STEEL; HYDROGEN EMBRITTLEMENT; SEAWATER; IRON; BIOFILMS; BIOCORROSION; SULFIDE	Certain species of sulfate- reducing bacteria (SRB) use cathodes as electron donors for metabolism, and this electron transfer process may influence the proper protection potential choice for structures. The interaction between SRB and polarized electrodes had been the focus of numerous investigations. In this paper, the impact of cathodic protection (CP) on Desulfovibrio caledoniens metabolic activity and its influence on highs trength steel EQ70 were studied by bacterial analyses and electrochemical measurements. The results showed that EQ70 under -0.85 V-SCE CP had a higher corrosion rate than that without CP, while EQ70 with -1.05 V-SCE had a lower corrosion rate. The enhanced SRB metabolic activity at -0.85 V-SCE was most probably caused by the direct electron transfer from the electrode polarized at -0.85 V-SCE. This direct electron transfer pathway was unavailable in -1.05 V-SCE. In addition, the application of cathodic protection led to the transformation of sulfide rusts into carbonates rusts. These observations have been employed to provide updated recommendations for the optimum CP potential for steel structures in the presence of SRB.	[Guan, Fang; Zhai, Xiaofan; Duan, Jizhou; Zhang, Meixia; Hou, Baorong] Chinese Acad Sci, Inst Oceanol, Marine Corros & Protect Ctr, 7 Nanhai Rd, Qingdao 266071, Peoples R China; [Guan, Fang; Zhang, Meixia] Univ Chinese Acad Sci, Beijing 100049, Peoples R China	Chinese Academy of Sciences; Institute of Oceanology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Duan, JZ (corresponding author), Chinese Acad Sci, Inst Oceanol, Marine Corros & Protect Ctr, 7 Nanhai Rd, Qingdao 266071, Peoples R China.	duanjz@qdio.ac.cn			National Basic Research Program of China (973 Program) [2014CB643304]	National Basic Research Program of China (973 Program)(National Basic Research Program of China)	The present work was supported by the National Basic Research Program of China (973 Program) (Grant No. 2014CB643304). JD received the funding.	AWagner P., 1993, INTERRELATIONSHIP MA; Bai PP, 2015, CORROS SCI, V93, P109, DOI 10.1016/j.corsci.2015.01.024; Bao Q, 2012, CORROS SCI, V65, P405, DOI 10.1016/j.corsci.2012.08.044; Batt C, 2002, BRIT CORROS J, V37, P194, DOI 10.1179/000705902225006606; Beese-Vasbender PF, 2015, ELECTROCHIM ACTA, V167, P321, DOI 10.1016/j.electacta.2015.03.184; Cao C.N., 2002, ELECTROCHEMICAL IMPE; Chen X., CORROSION SCI, V101, P1; Cordas CM, 2008, ELECTROCHIM ACTA, V54, P29, DOI 10.1016/j.electacta.2008.02.041; Dawn E. H, 2004, APPL ENVIRON MICROB, V70, P1234; de Romero M., 2009, CATHODIC PROTECTION; de Romero M. F., 2008, CORROSION 2008; deSaravia SGG, 1997, BIOFOULING, V11, P1, DOI 10.1080/08927019709378317; Dinh HT, 2004, NATURE, V427, P829, DOI 10.1038/nature02321; Geelhoed JS, 2011, ENVIRON SCI TECHNOL, V45, P815, DOI 10.1021/es102842p; Guezennec J, 1988, 1 EUR FED CORR WORKS, P256; Heidelberg JF, 2004, NAT BIOTECHNOL, V22, P554, DOI 10.1038/nbt959; Hernandez G, 1994, CORROS REV, V1-2, P29; Kajiyama F, 1999, CORROSION, V55, P74, DOI 10.5006/1.3283968; Kim JG, 2001, CORROS SCI, V43, P2011, DOI 10.1016/S0010-938X(01)00015-4; Kornberg RD, 2005, TRENDS BIOCHEM SCI, V30, P235, DOI 10.1016/j.tibs.2005.03.011; Li FS, 2012, ADV MATER RES-SWITZ, V368-373, P42, DOI 10.4028/www.scientific.net/AMR.368-373.42; Little B., 1995, MAT SCI FORUM; Lojou E, 2002, ELECTROANAL, V14, P913, DOI 10.1002/1521-4109(200207)14:13<913::AID-ELAN913>3.0.CO;2-N; Malard E, 2008, ELECTROCHIM ACTA, V54, P8, DOI 10.1016/j.electacta.2008.05.075; Mehanna M, 2008, ELECTROCHIM ACTA, V54, P140, DOI 10.1016/j.electacta.2008.02.101; Miranda E, 2006, CORROS SCI, V48, P2417, DOI 10.1016/j.corsci.2005.09.005; Muyzer G, 2008, NAT REV MICROBIOL, V6, P441, DOI 10.1038/nrmicro1892; Niu LN, 2012, APPL MECH MATER, V117-119, P1905, DOI 10.4028/www.scientific.net/AMM.117-119.1905; Pineau S, 2008, CORROS SCI, V50, P1099, DOI 10.1016/j.corsci.2007.11.029; Refait P, 2013, CORROS SCI, V71, P32, DOI 10.1016/j.corsci.2013.01.042; ROBINSON MJ, 1994, CORROSION, V50, P626, DOI 10.5006/1.3293536; Rosenbaum M, 2011, BIORESOURCE TECHNOL, V102, P324, DOI 10.1016/j.biortech.2010.07.008; Sherar BWA, 2011, CORROS SCI, V53, P955, DOI 10.1016/j.corsci.2010.11.027; Starosvetsky D, 2010, CORROS SCI, V52, P1536, DOI 10.1016/j.corsci.2010.01.013; Venzlaff H, 2013, CORROS SCI, V66, P88, DOI 10.1016/j.corsci.2012.09.006; Villano M, 2011, BIORESOURCE TECHNOL, V102, P3193, DOI 10.1016/j.biortech.2010.10.146; Vincent KA, 2007, CHEM REV, V107, P4366, DOI 10.1021/cr050191u; Voordeckers JW, 2010, APPL ENVIRON MICROB, V76, P2371, DOI 10.1128/AEM.02250-09; Wan Y, 2010, ELECTROCHIM ACTA, V55, P1528, DOI 10.1016/j.electacta.2009.10.009; Wang XH, 2014, INT J ELECTROCHEM SC, V9, P8199; Wei JC, 2010, ENVIRON SCI TECHNOL, V44, P3187, DOI 10.1021/es903758m; Xu DK, 2016, BIOELECTROCHEMISTRY, V110, P52, DOI 10.1016/j.bioelechem.2016.03.003; Xu D, 2014, INT BIODETER BIODEGR, V91, P74, DOI 10.1016/j.ibiod.2014.03.014; Xu DK, 2013, CORROS SCI, V77, P385, DOI 10.1016/j.corsci.2013.07.044; Yi HN, 2009, BIOSENS BIOELECTRON, V24, P3498, DOI 10.1016/j.bios.2009.05.004; Yu L, 2013, ELECTROCHEM COMMUN, V26, P101, DOI 10.1016/j.elecom.2012.10.022; Yu L, 2011, ELECTROCHIM ACTA, V56, P9041, DOI 10.1016/j.electacta.2011.05.086; Yuan SJ, 2013, CORROS SCI, V74, P353, DOI 10.1016/j.corsci.2013.04.058; Zhang JX, 2010, ANTI-CORROS METHOD M, V57, P249, DOI [10.1108/000355910110758961, 10.1108/00035591011075896]; Zhang L, 2012, CORROSION, V68, P713, DOI 10.5006/0521; Zhao X., 2007, SULFATE REDUCING BAC; Zhu Y, 2007, MATER CORROS, V58, P447, DOI 10.1002/maco.200604030	52	43	51	2	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162315	10.1371/journal.pone.0162315	http://dx.doi.org/10.1371/journal.pone.0162315			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603928	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200057
J	Hammami, P; Lancelot, R; Lesnoff, M				Hammami, Pachka; Lancelot, Renaud; Lesnoff, Matthieu			Modelling the Dynamics of Post-Vaccination Immunity Rate in a Population of Sahelian Sheep after a Vaccination Campaign against Peste des Petits Ruminants Virus	PLOS ONE			English	Article							BIRTH SEX-RATIOS; ANTIBODIES; COLOSTRUM; LIVESTOCK; DISEASES; GOATS	Background Peste des petits ruminants (PPR) is an acute infectious viral disease affecting domestic small ruminants (sheep and goats) and some wild ruminant species in Africa, the Middle East and Asia. A global PPR control strategy based on mass vaccination-in regions where PPR is endemic-was recently designed and launched by international organizations. Sahelian Africa is one of the most challenging endemic regions for PPR control. Indeed, strong seasonal and annual variations in mating, mortality and offtake rates result in a complex population dynamics which might in turn alter the population post-vaccination immunity rate (PIR), and thus be important to consider for the implementation of vaccination campaigns. Methods In a context of preventive vaccination in epidemiological units without PPR virus transmission, we developed a predictive, dynamic model based on a seasonal matrix population model to simulate PIR dynamics. This model was mostly calibrated with demographic and epidemiological parameters estimated from a long-term follow-up survey of small ruminant herds. We used it to simulate the PIR dynamics following a single PPR vaccination campaign in a Sahelian sheep population, and to assess the effects of (i) changes in offtake rate related to the Tabaski (a Muslim feast following the lunar calendar), and (ii) the date of implementation of the vaccination campaigns. Results The persistence of PIR was not influenced by the Tabaski date. Decreasing the vaccination coverage from 100 to 80% had limited effects on PIR. However, lower vaccination coverage did not provide sufficient immunity rates (PIR < 70%). As a trade-off between model predictions and other considerations like animal physiological status, and suitability for livestock farmers, we would suggest to implement vaccination campaigns in September-October. This model is a first step towards better decision support for animal health authorities. It might be adapted to other species, livestock farming systems or diseases.	[Hammami, Pachka; Lancelot, Renaud] Ctr Cooperat Int Rech Agron Dev Cirad, UMR Controle Malad Anim Exot & Emergentes Cmaee, Campus Int Baillarguet, F-34398 Montpellier, France; [Hammami, Pachka; Lancelot, Renaud] INRA, UMR Cmaee 1309, Campus Int Baillarguet, F-34398 Montpellier, France; [Lesnoff, Matthieu] Cirad, UMR Syst Elevage Mediterraneens & Trop Selmet, F-34398 Montpellier, France; [Lesnoff, Matthieu] INRA, UMR Selmet, Campus Int Baillarguet, F-34398 Montpellier, France; [Lesnoff, Matthieu] Montpellier Supagro, UMR Selmet, Campus Int Baillarguet, F-34398 Montpellier, France	CIRAD; INRAE; CIRAD; INRAE; Institut Agro; Montpellier SupAgro	Hammami, P (corresponding author), Ctr Cooperat Int Rech Agron Dev Cirad, UMR Controle Malad Anim Exot & Emergentes Cmaee, Campus Int Baillarguet, F-34398 Montpellier, France.; Hammami, P (corresponding author), INRA, UMR Cmaee 1309, Campus Int Baillarguet, F-34398 Montpellier, France.	pachka.hammami@cirad.fr	Lancelot, Renaud/HGE-1086-2022	Lancelot, Renaud/0000-0002-5826-5242; Hammami, Pachka/0000-0002-7490-6257	Bill and Melinda Gates Foundation; OIE World Animal Health and Welfare Fund; Cirad; Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal); Directorate of Veterinary Services (DSV, Dakar, Senegal)	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); OIE World Animal Health and Welfare Fund; Cirad; Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal); Directorate of Veterinary Services (DSV, Dakar, Senegal)	This study was conducted in the frame of the project "Vaccine Standard and Pilot Approach for the Progressive Control and Eradication of PPR in Africa" (VSPA), funded by the Bill and Melinda Gates Foundation, the OIE World Animal Health and Welfare Fund, and Cirad. Sheep demographic data were collected during the joint research programme "Pathologie et Productivite des Petits Ruminants" co-funded by the Institut Senegalais de Recherches Agricoles (Isra, Dakar, Senegal), the Directorate of Veterinary Services (DSV, Dakar, Senegal), and Cirad.	Adams W, 2005, WORKING THE SAHEL; Agresti A., 2013, CATEGORICAL DATA ANA, V3rd ed.; Albina E, 2013, VET MICROBIOL, V165, P38, DOI 10.1016/j.vetmic.2012.12.013; ALSABBAGH TA, 1995, J ANIM SCI, V73, P2860; Alves AC, 2015, J DAIRY SCI, V98, P3706, DOI 10.3168/jds.2014-7992; ANDERSON RM, 1982, SCIENCE, V215, P1053, DOI 10.1126/science.7063839; [Anonymous], 2006, CARBON LAND WATER GL; [Anonymous], 2012, UNDP CLIMATE CHANGE; ATA FA, 1989, VET REC, V124, P590, DOI 10.1136/vr.124.22.590; Awa DN, 2002, PREV VET MED, V55, P265, DOI 10.1016/S0167-5877(02)00013-2; Bacaer N, 2009, B MATH BIOL, V71, P1781, DOI 10.1007/s11538-009-9426-6; Balamurugan Vinayagamurthy, 2012, Virologica Sinica, V27, P228, DOI 10.1007/s12250-012-3249-6; Baron MD, 2016, ADV VIRUS RES, V95, P1, DOI 10.1016/bs.aivir.2016.02.001; Berg C, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.3985; Bidjeh Kebkiba, 1999, Cahiers Agricultures, V8, P219; Bodjo S.C., 2006, BIOKEMISTRI, V18, P99, DOI DOI 10.4314/BI0KEM.V18I2.56408; Brisson M, 2003, MED DECIS MAKING, V23, P76, DOI 10.1177/0272989X02239651; Burnham K.P., 2002, PRACTICAL INFORM THE, V2nd ed., DOI [DOI 10.1007/B97636, 10.1007/b97636]; Caswell, 2000, MATRIX POPULATION MO; Collett D, 2003, C&H TEXT STAT SCI, P45; Coward C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004359; Davis CL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059465; Delville PL, 2002, SOC NATURE SAHEL; Diallo A, 2007, VACCINE, V25, P5591, DOI 10.1016/j.vaccine.2007.02.013; Diallo A, 1989, Rev Elev Med Vet Pays Trop, V42, P311; Diallo A., 2003, VVolume 114, P113; El Arbi AS, 2014, EMERG INFECT DIS, V20, P334, DOI 10.3201/eid2002.131345; El-Yuguda AD, 2013, VET WORLD, V6, P807, DOI 10.14202/vetworld.2013.807-811; Ettair M, 2012, REMESA ATELIER CONJO; Farougou S, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.544; Faugere O, 1990, REV ELEV MED VET PAY, V43; FINE PEM, 1993, EPIDEMIOL REV, V15, P265, DOI 10.1093/oxfordjournals.epirev.a036121; Haight R.G, 1989, POPULATION HARVESTIN, V27; Hashemi M, 2008, SMALL RUMINANT RES, V75, P204, DOI 10.1016/j.smallrumres.2007.11.002; Jones BA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149982; KENT JP, 1995, BEHAV ECOL SOCIOBIOL, V36, P101, DOI 10.1007/BF00170714; KENT JP, 1992, BEHAV ECOL SOCIOBIOL, V30, P151, DOI 10.1007/BF00166697; Kihu SM, 2015, PASTORALISM, V5, DOI 10.1186/s13570-015-0029-6; Kihu SM, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0401-1; Kivaria FM, 2013, ONDERSTEPOORT J VET, V80, DOI 10.4102/ojvr.v80i1.593; Kong XF, 2004, INT IMMUNOPHARMACOL, V4, P975, DOI 10.1016/j.intimp.2004.03.008; Lancelot R., 1998, Revue d'Elevage et de Medecine Veterinaire des Pays Tropicaux, V51, P135; LEBRETON JD, 1992, ECOL MONOGR, V62, P67, DOI 10.2307/2937171; Lesnoff M, 1999, AGR SYST, V61, P207, DOI 10.1016/S0308-521X(99)00053-0; Lesnoff M, 2000, PREV VET MED, V46, P113, DOI 10.1016/S0167-5877(00)00139-2; Lesnoff M, 2015, ANIMAL, V9, P1888, DOI 10.1017/S175173111500124X; Lesnoff M, 2004, PREV VET MED, V62, P101, DOI 10.1016/j.prevetmed.2003.11.009; Lesnoff M, 2003, MATH COMPUT MODEL, V37, P945, DOI 10.1016/S0895-7177(03)00110-9; Lesnoff M, 2009, EPIDEMIOL INFECT, V137, P1405, DOI 10.1017/S0950268809002453; Lesnoff M, 2001, REV ELEV MED VET PAY, V54; Lesnoff M, 2014, CALCULATION DEMOGRAP, P41; Lesnoff M, 2000, THESIS; Lesnoff M, 2011, QUAE; Lesnoff M, 2010, TROP ANIM HEALTH PRO, V42, P1155, DOI 10.1007/s11250-010-9540-3; LIBEAU G, 1995, RES VET SCI, V58, P50, DOI 10.1016/0034-5288(95)90088-8; Mariner JC, 2005, PREV VET MED, V69, P245, DOI 10.1016/j.prevetmed.2005.02.001; Matser A, 2009, ECOL LETT, V12, P1298, DOI 10.1111/j.1461-0248.2009.01378.x; McCullagh P, 1989, GEN LINEAR MODELS; Mopate L. Y., 2014, Open Journal of Animal Sciences, V4, P175; Moulin CH, 1993, THESIS; Nantoume H., 2011, Livestock Research for Rural Development, V23, P110; NAPIER KM, 1974, J REPROD FERTIL, V39, P391, DOI 10.1530/jrf.0.0390391; Niewiesk S, 2015, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00446; Nowak R, 2006, REPROD NUTR DEV, V46, P431, DOI 10.1051/rnd:2006023; Nsubuga P, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P997; OIE FAO, 2015, GLOB STRAT CONTR ERR; PLOWRIGHT W, 1969, RES VET SCI, V10, P373; Roeder P, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0139; Rousseau R, 1954, INFORM GEOGRAPHIQUE, V18, P68, DOI [10.3406/ingeo.1954.1368, DOI 10.3406/INGEO.1954.1368]; Ryan TJ, 2006, VET MICROBIOL, V112, P211, DOI 10.1016/j.vetmic.2005.11.025; Sarr J, 1994, RES COORD M FAO AEA, P195; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Sow A, 2008, REV ELEV MED VET PAY, V61; STEM C, 1993, PREV VET MED, V16, P141, DOI 10.1016/0167-5877(93)90084-7; Texeira M, 2008, ECOL MODEL, V217, P197, DOI 10.1016/j.ecolmodel.2008.06.027; The R Core Team, 2015, R LANG ENV STAT COMP, P3366; Thombare N.N., 2009, AGR EC RES REV, V22, P319, DOI 10.22004/ag.econ.57469; Trabucco A, 2009, CGIAR CONSORT SPATIA; Tuljapurkar S., 1997, STRUCTURED POPULATIO, V18; Zahur AB, 2009, PAK VET J, V29, P174; Zahur A.B., 2014, J BIOSCI MED, V2, P27, DOI DOI 10.4236/JBM.2014.26005	81	9	9	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161769	10.1371/journal.pone.0161769	http://dx.doi.org/10.1371/journal.pone.0161769			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603710	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255200025
J	Zhai, HC; Gong, WK; Tan, YN; Liu, AY; Song, WW; Li, JW; Deng, ZY; Kong, LL; Gong, JW; Shang, HH; Chen, TT; Ge, Q; Shi, YZ; Yuan, YL				Zhai, Huanchen; Gong, Wankui; Tan, Yunna; Liu, Aiying; Song, Weiwu; Li, Junwen; Deng, Zhuying; Kong, Linglei; Gong, Juwu; Shang, Haihong; Chen, Tingting; Ge, Qun; Shi, Yuzhen; Yuan, Youlu			Identification of Chromosome Segment Substitution Lines of Gossypium barbadense Introgressed in G. hirsutum and Quantitative Trait Locus Mapping for Fiber Quality and Yield Traits	PLOS ONE			English	Article							UPLAND COTTON CULTIVARS; DENSITY LINKAGE MAP; QTL ANALYSIS; LYCOPERSICON PENNELLII; MORPHOLOGICAL TRAITS; GENOME SEQUENCE; L.; CONSTRUCTION; IMPROVEMENT; POPULATION	Chromosome segment substitution lines MBI9804, MBI9855, MBI9752, and MBI9134, which were obtained by advanced backcrossing and continuously inbreeding from an interspecific cross between CCRI36, a cultivar of upland cotton (Gossypium hirsutum) as the recurrent parent, and Hai1, a cultivar of sea island cotton (G. barbadense) as the donor parent, were used to construct a multiple parent population of (MBI9804xMBI9855)x(M-BI9752xMBI9134). The segregating generations of double-crossed F-1 and F-2 and F-2:3 were used to map the quantitative trait locus (QTL) for fiber quality and yield-related traits. The recovery rate of the recurrent parent CCRI36 in the four parental lines was from 94.3%-96.9%. Each of the parental lines harbored 12-20 introgressed segments from Hai1across 21 chromosomes. The number of introgressed segments ranged from 1 to 27 for the individuals in the three generations, mostly from 9 to 18, which represented a genetic length of between 126 cM and 246 cM. A total of 24 QTLs controlling fiber quality and 11 QTLs controlling yield traits were detected using the three segregating generations. These QTLs were distributed across 11 chromosomes and could collectively explain 1.78%-20.27% of the observed phenotypic variations. Sixteen QTLs were consistently detected in two or more generations, four of them were for fiber yield traits and 12 were for fiber quality traits. One introgressed segment could significantly reduce both lint percentage and fiber micronaire. This study provides useful information for gene cloning and marker-assisted breeding for excellent fiber quality.	[Zhai, Huanchen; Gong, Wankui; Tan, Yunna; Liu, Aiying; Song, Weiwu; Li, Junwen; Deng, Zhuying; Kong, Linglei; Gong, Juwu; Shang, Haihong; Chen, Tingting; Ge, Qun; Shi, Yuzhen; Yuan, Youlu] Chinese Acad Agr Sci, State Key Lab Cotton Biol, Key Lab Biol & Genet Breeding Cotton, Inst Cotton Res,Minist Agr, Anyang, Henan, Peoples R China; [Zhai, Huanchen] Henan Univ Technol, Coll Bioengn, Zhengzhou, Henan, Peoples R China	Chinese Academy of Agricultural Sciences; Institute of Cotton Research, CAAS; Ministry of Agriculture & Rural Affairs; Henan University of Technology	Shi, YZ; Yuan, YL (corresponding author), Chinese Acad Agr Sci, State Key Lab Cotton Biol, Key Lab Biol & Genet Breeding Cotton, Inst Cotton Res,Minist Agr, Anyang, Henan, Peoples R China.	shiyzmb@126.com; youluyuan@hotmail.com	Gǒng, Wànkuí/AAL-5622-2020	Gǒng, Wànkuí/0000-0002-8556-0669	National Natural Science Foundation of China [31101188]; National High Technology Research and Development Program of China [2012AA101108]; National Basic Research Program of China (973 Project) [2010CB126000]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Basic Research Program of China (973 Project)(National Basic Research Program of China)	This work was funded by the National Natural Science Foundation of China (31101188) to YZS, the National High Technology Research and Development Program of China (2012AA101108) to YLY, and the National Basic Research Program of China (973 Project) (2010CB126000) to YLY.	Cao ZB, 2014, THEOR APPL GENET, V127, P587, DOI 10.1007/s00122-013-2241-3; Clement JD, 2012, FIELD CROP RES, V128, P1, DOI 10.1016/j.fcr.2011.12.002; ESHED Y, 1995, GENETICS, V141, P1147; ESHED Y, 1994, EUPHYTICA, V79, P175, DOI 10.1007/BF00022516; He Rui, 2014, Acta Agronomica Sinica, V40, P457; Jenkins JN, 2006, CROP SCI, V46, P1169, DOI 10.2135/cropsci2005.08-0269; Jenkins JN, 2007, CROP SCI, V47, P561, DOI 10.2135/cropsci2006.06.0396; Jenkins JN, 2012, EUPHYTICA, V187, P161, DOI 10.1007/s10681-011-0580-1; Jiang CX, 1998, P NATL ACAD SCI USA, V95, P4419, DOI 10.1073/pnas.95.8.4419; Lacape JM, 2010, BMC PLANT BIOL, V10, DOI 10.1186/1471-2229-10-132; Lacape JM, 2005, J HERED, V96, P441, DOI 10.1093/jhered/esi052; Li FG, 2015, NAT BIOTECHNOL, V33, P524, DOI 10.1038/nbt.3208; Li FG, 2014, NAT GENET, V46, P567, DOI 10.1038/ng.2987; Li L, 2008, THESIS; Li XN, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00432; Liang Yan, 2010, Molecular Plant Breeding, V8, P221; Liu JY, 2000, ACTA BOT SIN, V42, P991; Liu QM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127938; Ma LiuJun, 2013, Cotton Science, V25, P486; McCarty JC, 2006, EUPHYTICA, V152, P99, DOI 10.1007/s10681-006-9183-7; Mei M, 2004, THEOR APPL GENET, V108, P280, DOI 10.1007/s00122-003-1433-7; Ning ZY, 2014, EUPHYTICA, V195, P143, DOI 10.1007/s10681-013-0990-3; Paterson A. H., 1993, Plant Molecular Biology Reporter, V11, P122, DOI 10.1007/BF02670470; Paterson AH, 2003, THEOR APPL GENET, V106, P384, DOI 10.1007/s00122-002-1025-y; Percy RG, 2006, CROP SCI, V46, P1311, DOI 10.2135/cropsci2005.08-0284; REINISCH AJ, 1994, GENETICS, V138, P829; Saha S, 2008, PLANT BREEDING, V127, P612, DOI 10.1111/j.1439-0523.2008.01532.x; Saha S, 2006, GENETICS, V172, P1927, DOI 10.1534/genetics.105.053371; Saha S, 2010, THEOR APPL GENET, V120, P1193, DOI 10.1007/s00122-009-1247-3; Said JI, 2015, MOL GENET GENOMICS, V290, P1003, DOI [10.1007/s00438-015-1021-y, 10.1007/s00438-014-0963-9]; Said JI, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-776; Shen XL, 2007, EUPHYTICA, V155, P371, DOI 10.1007/s10681-006-9338-6; Shi YZ, 2015, J INTEGR PLANT BIOL, V57, P450, DOI 10.1111/jipb.12288; Smith CW, 1997, CROP SCI, V37, P1775, DOI 10.2135/cropsci1997.0011183X003700060019x; Song XL, 2005, GENOME, V48, P378, DOI 10.1139/G04-126; Stelly DM, 2005, CROP SCI, V45, P2663, DOI 10.2135/cropsci2004.0642; Sun QA, 2010, MOL BIOL REP, V37, P3319, DOI 10.1007/s11033-009-9918-3; Tang SY, 2015, EUPHYTICA, V201, P195, DOI [10.1007/s10681-014-1189-y, 10.1007/s10681-]; van Berloo R, 2008, J HERED, V99, P232, DOI 10.1093/jhered/esm109; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Wan XY, 2008, GENETICS, V179, P2239, DOI 10.1534/genetics.108.089862; Wang B, 2012, THEOR APPL GENET, V125, P1263, DOI 10.1007/s00122-012-1911-x; Wang HT, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130742; Wang JK, 2006, GENET RES, V88, P93, DOI 10.1017/S0016672306008408; Wang KB, 2012, NAT GENET, V44, P1098, DOI 10.1038/ng.2371; Wang P, 2012, THEOR APPL GENET, V124, P1415, DOI 10.1007/s00122-012-1797-7; [王为 WANG Wei], 2009, [棉花学报, Cotton Science], V21, P394; Xu ZZ, 2015, PLANT CELL REP, V34, P1177, DOI 10.1007/s00299-015-1776-y; Yu JW, 2013, THEOR APPL GENET, V126, P275, DOI 10.1007/s00122-012-1980-x; Yu JZ, 2014, MOL GENET GENOMICS, V289, P1347, DOI 10.1007/s00438-014-0930-5; Zhang J, 2000, COTTON SCI, V12, P267, DOI DOI 10.3969/J.ISSN.1002-7807.2000.05.012; Zhang JF, 2014, EUPHYTICA, V198, P1, DOI 10.1007/s10681-014-1094-4; [张金凤 Zhang Jinfeng], 2012, [植物遗传资源学报, Journal of Plant Genetic Resources], V13, P773; Zhang K, 2012, MOL BREEDING, V29, P335, DOI 10.1007/s11032-011-9549-y; Zhang TZ, 2015, NAT BIOTECHNOL, V33, P531, DOI 10.1038/nbt.3207; Zhang Z, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135430; Zhang ZS, 2009, MOL BREEDING, V24, P49, DOI 10.1007/s11032-009-9271-1; Zhu Y, 2010, J NANOMATER, V2010, P8	58	24	28	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0159101	10.1371/journal.pone.0159101	http://dx.doi.org/10.1371/journal.pone.0159101			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603312	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200002
J	Zhao, W; Yao, F; Zhang, MC; Jing, T; Zhang, S; Hou, L; Zou, XY				Zhao, Wei; Yao, Feng; Zhang, Mengchen; Jing, Ting; Zhang, Shuang; Hou, Lin; Zou, Xiangyang			The Potential Roles of the G1LEA and G3LEA Proteins in Early Embryo Development and in Response to Low Temperature and High Salinity in Artemia sinica	PLOS ONE			English	Article							EMBRYOGENESIS ABUNDANT PROTEIN; LEA PROTEINS; DESICCATION TOLERANCE; BRINE SHRIMP; GENE; STRESS; MITOCHONDRIA; EXPRESSION; MOTIF; ACTS	Late embryogenesis abundant proteins (LEA) are stress resistance-related proteins that play crucial roles in protecting against desiccation, cold and high salinity in a variety of animals and plants. However, the expression pattern, distribution and functions of LEA proteins in the post-diapause period of Artemia sinica, and under high salinity and low temperature stresses, remain unknown. In this study, the complete cDNA sequences of the group 1 LEA (As-g1lea) and group 3 LEA (As-g3lea) genes from A. sinica were cloned. The expression patterns and location of As-G1LEA and As-G1LEA were investigated. The protein abundances of As-G1LEA, As-G3LEA and Trehalase were analyzed during different developmental stages of the embryo and under low temperature and high salinity stresses in A. sinica. The full-length cDNA of As-g1lea was 960 bp, encoding a 182 amino acid protein, and As-g3lea was 2089 bp, encoding a 364 amino acid protein. As-g1lea and As-g3lea showed their highest expressions at 0 h of embryonic development and both showed higher relative expression in embryonic, rather than adult, development stages. The abundances of As-G1LEA, As-G3LEA and trehalose were upregulated under low temperature and downregulated under high salinity stress. These two genes did not show any tissue or organ specific expression. Our results suggested that these LEA proteins might play a pivotal role in stress tolerance in A. sinica	[Zhao, Wei; Yao, Feng; Zhang, Mengchen; Jing, Ting; Zhang, Shuang; Hou, Lin] Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China; [Zou, Xiangyang] Dalian Med Univ, Dept Biol, Dalian, Peoples R China	Liaoning Normal University; Dalian Medical University	Hou, L (corresponding author), Liaoning Normal Univ, Coll Life Sci, Dalian, Peoples R China.; Zou, XY (corresponding author), Dalian Med Univ, Dept Biol, Dalian, Peoples R China.	houlin@lnnu.edu.cn; zouxiangyang@126.com			National Natural Science Foundation of China [31272644, 31572607]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	Funding was provided by the National Natural Science Foundation of China (31272644, 31572607).; This work was supported by grants from the National Natural Science Foundation of China [grant numbers 31272644, 31572607].	ANDERSON E, 1970, J ULTRA MOL STRUCT R, V32, P497, DOI 10.1016/S0022-5320(70)80025-9; Battaglia M, 2008, PLANT PHYSIOL, V148, P6, DOI 10.1104/pp.108.120725; Browne J, 2002, NATURE, V416, P38, DOI 10.1038/416038a; Candat A, 2014, PLANT CELL, V26, P3148, DOI 10.1105/tpc.114.127316; Chakrabortee S, 2012, MOL BIOSYST, V8, P210, DOI 10.1039/c1mb05263b; Chu B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085343; Clegg James S., 2002, P129; Conte FP, 2007, INT REV CYTOL, V91, P46; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1992, ANNU REV PHYSIOL, V54, P579, DOI 10.1146/annurev.ph.54.030192.003051; DURE L, 1981, BIOCHEMISTRY-US, V20, P4162, DOI 10.1021/bi00517a033; DURE L, 1993, PLANT J, V3, P363, DOI 10.1046/j.1365-313X.1993.t01-18-00999.x; Dure L, 2001, PROTEIN PEPTIDE LETT, V8, P115, DOI 10.2174/0929866013409643; Elbein AD, 2003, GLYCOBIOLOGY, V13, p17R, DOI 10.1093/glycob/cwg047; Eom JW, 1996, PLANT SCI, V115, P17, DOI 10.1016/0168-9452(96)04332-4; Goyal K, 2005, BIOCHEM J, V388, P151, DOI 10.1042/BJ20041931; Goyal K, 2003, J BIOL CHEM, V278, P12977, DOI 10.1074/jbc.M212007200; Grelet J, 2005, PLANT PHYSIOL, V137, P157, DOI 10.1104/pp.104.052480; Hand SC, 2011, ANNU REV PHYSIOL, V73, P115, DOI 10.1146/annurev-physiol-012110-142203; Hatanaka R, 2013, INSECT BIOCHEM MOLEC, V43, P1055, DOI 10.1016/j.ibmb.2013.08.004; Hengherr S, 2011, PHYSIOL BIOCHEM ZOOL, V84, P249, DOI 10.1086/659314; Jiang LJ, 2007, ACTA BIOCH BIOPH SIN, V39, P351, DOI 10.1111/j.1745-7270.2007.00287.x; Kuenen D. J., 1938, Zoologische Mededeelingen Leiden, V20, P222; Liu Yun, 2010, Sheng Wu Gong Cheng Xue Bao, V26, P569; Ma XC, 2005, CRYOBIOLOGY, V51, P15, DOI 10.1016/j.cryobiol.2005.04.007; MacRae TH, 2010, CELL MOL LIFE SCI, V67, P2405, DOI 10.1007/s00018-010-0311-0; Manfre AJ, 2006, PLANT PHYSIOL, V140, P140, DOI 10.1104/pp.105.072967; Menze Michael A., 2009, Communicative & Integrative Biology, V2, P428; Menze MA, 2009, J BIOL CHEM, V284, P10714, DOI 10.1074/jbc.C900001200; Moore DS, 2016, CRYOBIOLOGY, V73, P240, DOI 10.1016/j.cryobiol.2016.07.003; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sharon MA, 2009, BIOCHEM CELL BIOL, V87, P415, DOI [10.1139/o09-001, 10.1139/O09-001]; Tolleter D, 2007, PLANT CELL, V19, P1580, DOI 10.1105/tpc.107.050104; Tolleter D, 2010, BBA-BIOMEMBRANES, V1798, P1926, DOI 10.1016/j.bbamem.2010.06.029; Tompa K, 2012, Methods Mol Biol, V895, P167, DOI 10.1007/978-1-61779-927-3_13; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Toxopeus J, 2014, CELL STRESS CHAPERON, V19, P939, DOI 10.1007/s12192-014-0518-3; Tunnacliffe A, 2007, NATURWISSENSCHAFTEN, V94, P791, DOI 10.1007/s00114-007-0254-y; Wolkers WF, 2011, BIOCHIM BIOPHYS ACTA, V1544, P196	39	6	6	2	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162272	10.1371/journal.pone.0162272	http://dx.doi.org/10.1371/journal.pone.0162272			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603306	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255200052
J	Boudreault, S; Martenon-Brodeur, C; Caron, M; Garant, JM; Tremblay, MP; Armero, VES; Durand, M; Lapointe, E; Thibault, P; Tremblay-Letourneau, M; Perreault, JP; Scott, MS; Lemay, G; Bisaillon, M				Boudreault, Simon; Martenon-Brodeur, Camille; Caron, Marie; Garant, Jean-Michel; Tremblay, Marie-Pier; Armero, Victoria E. S.; Durand, Mathieu; Lapointe, Elvy; Thibault, Philippe; Tremblay-Letourneau, Maude; Perreault, Jean-Pierre; Scott, Michelle S.; Lemay, Guy; Bisaillon, Martin			Global Profiling of the Cellular Alternative RNA Splicing Landscape during Virus-Host Interactions	PLOS ONE			English	Article							REOVIRUS REPLICATION; GENE-EXPRESSION; NUCLEAR EXPORT; PROTEIN; IDENTIFICATION; INHIBITION; APOPTOSIS; ICP27; CYCLE; TRANSCRIPTOME	Alternative splicing (AS) is a central mechanism of genetic regulation which modifies the sequence of RNA transcripts in higher eukaryotes. AS has been shown to increase both the variability and diversity of the cellular proteome by changing the composition of resulting proteins through differential choice of exons to be included in mature mRNAs. In the present study, alterations to the global RNA splicing landscape of cellular genes upon viral infection were investigated using mammalian reovirus as a model. Our study provides the first comprehensive portrait of global changes in the RNA splicing signatures that occur in eukaryotic cells following infection with a human virus. We identify 240 modified alternative splicing events upon infection which belong to transcripts frequently involved in the regulation of gene expression and RNA metabolism. Using mass spectrometry, we also confirm modifications to transcript-specific peptides resulting from AS in virus-infected cells. These findings provide additional insights into the complexity of virus-host interactions as these splice variants expand proteome diversity and function during viral infection.	[Boudreault, Simon; Martenon-Brodeur, Camille; Caron, Marie; Garant, Jean-Michel; Tremblay, Marie-Pier; Armero, Victoria E. S.; Tremblay-Letourneau, Maude; Perreault, Jean-Pierre; Scott, Michelle S.; Bisaillon, Martin] Univ Sherbrooke, Fac Med Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada; [Durand, Mathieu; Lapointe, Elvy; Thibault, Philippe] Univ Sherbrooke, Lab Genom Fonct, Sherbrooke, PQ J1E 4K8, Canada; [Lemay, Guy] Univ Montreal, Fac Med, Dept Microbiol Infectiol & Immunol, Montreal, PQ H3C 3J7, Canada	University of Sherbrooke; University of Sherbrooke; Universite de Montreal	Bisaillon, M (corresponding author), Univ Sherbrooke, Fac Med Sci Sante, Dept Biochim, Sherbrooke, PQ J1E 4K8, Canada.	Martin.Bisaillon@USherbrooke.ca	Garant, Jean-Michel/AAA-1692-2019	Garant, Jean-Michel/0000-0002-0559-5598	Centre de recherche du Centre hospitalier universitaire de Sherbrooke; Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; Natural Sciences and Engineering Research Council of Canada; FRQ-S; Universite de Sherbrooke Research Chair in Structure and Genomic RNA	Centre de recherche du Centre hospitalier universitaire de Sherbrooke; Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); FRQ-S; Universite de Sherbrooke Research Chair in Structure and Genomic RNA	This work was supported by grants from the Centre de recherche du Centre hospitalier universitaire de Sherbrooke (MB and JPP), the Faculte de medecine et des sciences de la sante de l'Universite de Sherbrooke (MB and JPP), and the Natural Sciences and Engineering Research Council of Canada (GL). JPP holds the Universite de Sherbrooke Research Chair in Structure and Genomic RNA. MB is a Chercheur-boursier Senior from the Fonds de recherche du Quebec-Sante (FRQ-S), and SB holds graduate training awards from the FRQ-S and Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akusjarvi G, 2008, FRONT BIOSCI-LANDMRK, V13, P5006, DOI 10.2741/3059; Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Alvarez E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073723; Anczukow O, 2012, NAT STRUCT MOL BIOL, V19, P220, DOI 10.1038/nsmb.2207; Artimo Panu, 2012, Nucleic Acids Res, V40, pW597, DOI 10.1093/nar/gks400; Bailey TL, 2009, NUCLEIC ACIDS RES, V37, pW202, DOI 10.1093/nar/gkp335; Barnhart MD, 2013, CELL REP, V5, P909, DOI 10.1016/j.celrep.2013.10.012; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkr1065, 10.1093/nar/gkp985]; Bauman John A, 2011, Bioeng Bugs, V2, P125; Bergeron J, 1998, VIROLOGY, V246, P199, DOI 10.1006/viro.1998.9188; Biamonti G, 2014, SEMIN CELL DEV BIOL, V32, P30, DOI 10.1016/j.semcdb.2014.03.016; Black DL, 2003, ANNU REV BIOCHEM, V72, P291, DOI 10.1146/annurev.biochem.72.121801.161720; Boehme KW, 2013, J VIROL, V87, P12967, DOI 10.1128/JVI.02080-13; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Brosseau JP, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gkt1287; Bryant HE, 2001, J VIROL, V75, P4376, DOI 10.1128/JVI.75.9.4376-4385.2001; Chakrabarty R, 2015, INVEST NEW DRUG, V33, P761, DOI 10.1007/s10637-015-0216-8; Clements D, 2014, ONCOLYTIC VIROTHER, V3, P69, DOI 10.2147/OV.S51321; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; DANIS C, 1993, BIOCHEM CELL BIOL, V71, P81, DOI 10.1139/o93-012; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; Dowling D, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-18; Drissi R, 2015, MOL CELL PROTEOMICS, V14, P2002, DOI 10.1074/mcp.M115.048991; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Fackenthal JD, 2008, DIS MODEL MECH, V1, P37, DOI 10.1242/dmm.000331; Faustino NA, 2003, GENE DEV, V17, P419, DOI 10.1101/gad.1048803; FORTES P, 1994, EMBO J, V13, P704, DOI 10.1002/j.1460-2075.1994.tb06310.x; Germann S, 2012, J NUCLEIC ACIDS, V2012, DOI 10.1155/2012/269570; Gong J, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00167; Grosso AR, 2008, EMBO REP, V9, P1087, DOI 10.1038/embor.2008.189; Gustin KE, 2002, J VIROL, V76, P8787, DOI 10.1128/JVI.76.17.8787-8796.2002; Gustin KE, 2001, EMBO J, V20, P240, DOI 10.1093/emboj/20.1.240; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hoyt CC, 2004, J VIROL, V78, P6360, DOI 10.1128/JVI.78.12.6360-6369.2004; Jiao XL, 2012, BIOINFORMATICS, V28, P1805, DOI 10.1093/bioinformatics/bts251; Johansson C, 2013, NAT REV MICROBIOL, V11, P239, DOI 10.1038/nrmicro2984; Karni R, 2007, NAT STRUCT MOL BIOL, V14, P185, DOI 10.1038/nsmb1209; Klinck R, 2008, CANCER RES, V68, P657, DOI 10.1158/0008-5472.CAN-07-2580; Kobayashi T, 2009, J VIROL, V83, P2892, DOI 10.1128/JVI.01495-08; Kohl C, 2015, BATS VIRUSES NEW FRO, P203; Kosugi S, 2009, P NATL ACAD SCI USA, V106, P10171, DOI 10.1073/pnas.0900604106; Kushner DB, 2003, P NATL ACAD SCI USA, V100, P15764, DOI 10.1073/pnas.2536857100; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; LeFave CV, 2011, EMBO J, V30, P4084, DOI 10.1038/emboj.2011.259; Li B, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-323; Lindberg A, 2002, VIROLOGY, V294, P189, DOI 10.1006/viro.2001.1301; Lu CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059092; Matera AG, 2014, NAT REV MOL CELL BIO, V15, P108, DOI 10.1038/nrm3742; McCormick AL, 2007, HUMAN HERPESVIRUSES: BIOLOGY, THERAPY, AND IMMUNOPROPHYLAXIS, P324; Mitchell A, 2015, NUCLEIC ACIDS RES, V43, pD213, DOI 10.1093/nar/gku1243; Muranyi W, 2002, SCIENCE, V297, P854, DOI 10.1126/science.1071506; Nagy PD, 2012, NAT REV MICROBIOL, V10, P137, DOI 10.1038/nrmicro2692; Okoro Danielle R, 2012, Genes Cancer, V3, P311, DOI 10.1177/1947601912455323; Oltean S, 2014, ONCOGENE, V33, P5311, DOI 10.1038/onc.2013.533; Ooms LS, 2012, J VIROL, V86, P10979, DOI 10.1128/JVI.01172-12; Ooms LS, 2010, J BIOL CHEM, V285, P41604, DOI 10.1074/jbc.M110.176255; Pan D, 2011, BRIT J CANCER, V105, P1012, DOI 10.1038/bjc.2011.325; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Petersen JM, 2000, MOL CELL BIOL, V20, P8590, DOI 10.1128/MCB.20.22.8590-8601.2000; Petersen JM, 2001, P NATL ACAD SCI USA, V98, P8590, DOI 10.1073/pnas.151240998; Pimienta G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124638; Prudencio M, 2015, NAT NEUROSCI, V18, P1175, DOI 10.1038/nn.4065; REISSIG M, 1956, J EXP MED, V104, P289, DOI 10.1084/jem.104.3.289; Rudd P, 2005, J GEN VIROL, V86, P1489, DOI 10.1099/vir.0.80628-0; Rutkowski AJ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8126; Sandekian V, 2015, VIROLOGY, V483, P229, DOI 10.1016/j.virol.2015.04.020; SANDRIGOLDIN RM, 1995, J VIROL, V69, P6063, DOI 10.1128/JVI.69.10.6063-6076.1995; Schurch NJ, 2016, RNA, V22, P839, DOI 10.1261/rna.053959.115; Sciabica KS, 2003, EMBO J, V22, P1608, DOI 10.1093/emboj/cdg166; Scott ES, 2001, J VIROL, V75, P8818, DOI 10.1128/JVI.75.18.8818-8830.2001; Storey JD, 2003, P NATL ACAD SCI USA, V100, P9440, DOI 10.1073/pnas.1530509100; Szklarczyk D, 2015, NUCLEIC ACIDS RES, V43; Tyler KL, 2001, TRENDS MICROBIOL, V9, P560, DOI 10.1016/S0966-842X(01)02103-5; Venables JP, 2008, CANCER RES, V68, P9525, DOI 10.1158/0008-5472.CAN-08-1769; Venables JP, 2009, NAT STRUCT MOL BIOL, V16, P670, DOI 10.1038/nsmb.1608; Walsh D, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a012351; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Y, 2014, CANCER CELL, V26, P374, DOI 10.1016/j.ccr.2014.07.010; Wang ZF, 2008, RNA, V14, P802, DOI 10.1261/rna.876308; Warzecha CC, 2009, RNA BIOL, V6, P546, DOI 10.4161/rna.6.5.9606; Yang D., 2009, RNA VIRUSES HOST GEN; Yue ZY, 1996, J VIROL, V70, P3497, DOI 10.1128/JVI.70.6.3497-3501.1996; Zhu YF, 2014, MOL CELL PROTEOMICS, V13, P1552, DOI 10.1074/mcp.M113.031203; Zurney J, 2009, J VIROL, V83, P2178, DOI 10.1128/JVI.01787-08	85	32	32	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161914	10.1371/journal.pone.0161914	http://dx.doi.org/10.1371/journal.pone.0161914			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598998	gold, Green Published, Green Submitted			2022-12-26	WOS:000383254800024
J	Kang, MH; Jeong, KJ; Kim, WY; Lee, HJ; Gong, G; Suh, N; Gyorffy, B; Kim, S; Jeong, SY; Mills, GB; Park, YY				Kang, M-H; Jeong, K. J.; Kim, W. Y.; Lee, H. J.; Gong, G.; Suh, N.; Gyorffy, B.; Kim, S.; Jeong, S-Y; Mills, G. B.; Park, Y-Y			Musashi RNA- binding protein 2 regulates estrogen receptor 1 function in breast cancer	ONCOGENE			English	Article							HUR; ALPHA; EXPRESSION; STABILITY; SUBSETS; REVEALS	Musashi RNA-binding protein 2 (MSI2) has important roles in human cancer. However, the regulatory mechanisms by which MSI2 alters breast cancer pathophysiology have not been clearly identified. Here we demonstrate that MSI2 directly regulates estrogen receptor 1 (ESR1), which is a well-known therapeutic target and has been shown to reflect clinical outcomes in breast cancer. Based on gene expression data analysis, we found that MSI2 expression was highly enriched in estrogen receptor (ER)-positive breast cancer and that MSI2 expression was significantly correlated with ESR1 expression, including expression of ESR1 downstream target genes. In addition, MSI2 levels were associated with clinical outcomes. MSI2 influenced breast cancer cell growth by altering ESR1 function. MSI2 alters ESR1 by binding specific sites in ESR1 RNA and by increasing ESR1 protein stability. Taken together, our findings identified a novel regulatory mechanism of MSI2 as an upstream regulator of ESR1 and revealed the clinical relevance of the RNA-binding protein MSI2 in breast cancer.	[Kang, M-H; Park, Y-Y] Ulsan Coll Med, Dep Convergence Med, Seoul, South Korea; [Jeong, K. J.; Mills, G. B.] MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77001 USA; [Kim, W. Y.] Korea Univ, Dept Surg, Seoul, South Korea; [Lee, H. J.; Gong, G.] ASAN Med Ctr, Dept Pathol, Seoul, South Korea; [Suh, N.] Chun Hyang Univ, Coll Med Sci, Dept Med Engn, Asan, South Korea; [Gyorffy, B.] Semmelweis Univ, 2 Dept Pediat, MTA TTK lendulet Canc biomarker Res Group, Budapest, Hungary; [Kim, S.] Anging Res Inst, Korea Res Inst Biosci & Biotechnol, Dacjeon, Hungary; [Jeong, S-Y; Park, Y-Y] ASAN Inst Life Sci, ASAN Med Ctr, Seoul, South Korea; [Park, Y-Y] Univ Ulsan Coll Med, Dept Convergence Med, 88 Olympic, Seoul 05505, South Korea	University of Ulsan; University of Texas System; UTMD Anderson Cancer Center; Korea University; University of Ulsan; Asan Medical Center; Semmelweis University; University of Ulsan	Park, YY (corresponding author), Ulsan Coll Med, Dep Convergence Med, Seoul, South Korea.	yypark@amc.seoul.kr	Jeong, Kangjin/HGT-9268-2022; Gyorffy, Balazs/AAA-9135-2021	Gyorffy, Balazs/0000-0002-5772-3766; Mills, Gordon/0000-0002-0144-9614	Ministry of Education [NRF-2014R1A1A2053529, NRF-2013R1A1A2064367]; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea [HI15C0972]; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	Ministry of Education; Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health and Welfare, Republic of Korea; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Ministry of Education (NRF-2014R1A1A2053529 to Y-YP; NRF-2013R1A1A2064367 to M-HK) and by a grant of the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), funded by the Ministry of Health and Welfare, Republic of Korea (HI15C0972 to Y-YP).	Anji A, 2016, BIOMOLECULES, V6, DOI 10.3390/biom6010004; Bennett CG, 2016, NUCLEIC ACIDS RES, V44, P3788, DOI 10.1093/nar/gkw207; Calaluce R, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-126; Carroll JS, 2006, MOL ENDOCRINOL, V20, P1707, DOI 10.1210/me.2005-0334; Ciriello G, 2015, CELL, V163, P506, DOI 10.1016/j.cell.2015.09.033; DeSantis CE, 2014, CA-CANCER J CLIN, V64, P252, DOI 10.3322/caac.21235; Eeckhoute J, 2007, CANCER RES, V67, P6477, DOI 10.1158/0008-5472.CAN-07-0746; Gerstberger S, 2014, NAT REV GENET, V15, P829, DOI 10.1038/nrg3813; Heinonen M, 2007, CLIN CANCER RES, V13, P6959, DOI 10.1158/1078-0432.CCR-07-1432; Hosey AM, 2007, J NATL CANCER I, V99, P1683, DOI 10.1093/jnci/djm207; Katz Y, 2014, ELIFE, V3, DOI 10.7554/eLife.03915; Lee HJ, 2014, ANN SURG ONCOL, V21, P1561, DOI 10.1245/s10434-013-3456-x; Licata LA, 2010, BREAST CANCER RES TR, V122, P55, DOI 10.1007/s10549-009-0517-8; Morrow PKH, 2009, ANNU REV MED, V60, P153, DOI 10.1146/annurev.med.60.061107.145152; Oh DS, 2006, J CLIN ONCOL, V24, P1656, DOI 10.1200/JCO.2005.03.2755; Okano H, 2002, J CELL SCI, V115, P1355; Park YY, 2012, CARCINOGENESIS, V33, P1843, DOI 10.1093/carcin/bgs167; Park YY, 2012, EMBO MOL MED, V4, P52, DOI 10.1002/emmm.201100187; Wang MH, 2015, AM J CANCER RES, V5, P1089; Wang S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7517; Wolff AC, 2014, ARCH PATHOL LAB MED, V138, P241, DOI 10.5858/arpa.2013-0953-SA; Woo HH, 2009, ONCOGENE, V28, P1176, DOI 10.1038/onc.2008.469; Wurth L, 2015, BBA-GENE REGUL MECH, V1849, P881, DOI 10.1016/j.bbagrm.2014.10.001; Zhao ZB, 2015, CHEM BIOL, V22, P1608, DOI 10.1016/j.chembiol.2015.10.011	24	44	45	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	12					1745	1752		10.1038/onc.2016.327	http://dx.doi.org/10.1038/onc.2016.327			8	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EP6AP	27593929				2022-12-26	WOS:000397460600013
J	Zhou, Y; Wang, X; Sun, L; Zhou, L; Ma, TC; Song, L; Wu, JG; Li, JL; Ho, WZ				Zhou, Yu; Wang, Xu; Sun, Li; Zhou, Li; Ma, Tong-Cui; Song, Li; Wu, Jian-Guo; Li, Jie-Liang; Ho, Wen-Zhe			Toll-like receptor 3-activated macrophages confer anti-HCV activity to hepatocytes through exosomes	FASEB JOURNAL			English	Article						exosomes; miRNA; hepatitis C virus	HEPATITIS-C VIRUS; MHC CLASS-II; IMMUNE-RESPONSES; NS3/4A PROTEASE; T-CELLS; INFECTION; INTERFERON; EXPRESSION; INDUCTION; MICRORNAS	Exosomes are a class of cell-released small vesicles that mediate intercellular communication by delivering functional factors to recipient cells. During hepatitis C virus (HCV) infection, the interaction between liver resident macrophages and hepatocytes is a key component in liver innate immunity. In this study, we explored the role of exosomes in the delivery of innate anti-HCV factors to hepatocytes from macrophages. We showed that supernatant from TLR3-activated macrophage cultures could efficiently inhibit HCV replication in Huh7 cells. This macrophage-mediated anti-HCV activity was through exosomes because inhibiting exosomes could abrogate the action of macrophages. Further analyses demonstrated that TLR3-activated macrophages release exosomes that contain anti-HCV microRNA (miRNA)-29 family members. Inhibiting miRNA29 could restore HCV replication. These findings suggest a novel antiviral mechanism in liver innate immunity against HCV infection and provide insights to support further studies on developing exosome-based delivery system for disease treatment.	[Zhou, Yu; Ho, Wen-Zhe] Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA; [Wang, Xu; Sun, Li; Zhou, Li; Ma, Tong-Cui; Song, Li; Wu, Jian-Guo; Li, Jie-Liang; Ho, Wen-Zhe] Wuhan Univ, Sch Basic Med Sci, State Key Lab Virol, Wuhan 430072, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Wuhan University	Zhou, Y; Ho, WZ (corresponding author), Temple Univ, Lewis Katz Sch Med, Dept Pathol & Lab Med, Philadelphia, PA 19140 USA.	yu.zhou@temple.edu; wenzheho@temple.edu		Wu, Jianguo/0000-0002-8326-2895	U.S. National Institutes of Health, National Institute on Drug Abuse [DA022177, DA041302, DA040329]; National Natural Science Foundation of China [81271334, 81571962]; Development Program (973) from Ministry of Science and Technology of China [2012CB518901]; National Science and Technology Major Project of China [2014ZX10001003-005]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA041302, R21DA040329, R01DA022177] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Development Program (973) from Ministry of Science and Technology of China(National Basic Research Program of China); National Science and Technology Major Project of China; NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by Grants DA022177 and DA041302 (to W.-Z.H.) and Grant DA040329 (to J.-L.L.) from the U.S. National Institutes of Health, National Institute on Drug Abuse, Grants 81271334 and 81571962 from National Natural Science Foundation of China, Grant 2012CB518901 from the Development Program (973) from Ministry of Science and Technology of China, and Grant 2014ZX10001003-005 from the National Science and Technology Major Project of China. The authors declare no conflicts of interest.	Abusamra AJ, 2005, BLOOD CELL MOL DIS, V35, P169, DOI 10.1016/j.bcmd.2005.07.001; Bandyopadhyay S, 2011, J INFECT DIS, V203, P1753, DOI 10.1093/infdis/jir186; Battaglia AM, 2000, ANN PHARMACOTHER, V34, P487, DOI 10.1345/aph.19183; Buschow SI, 2010, IMMUNOL CELL BIOL, V88, P851, DOI 10.1038/icb.2010.64; De Toro J, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00203; Federici C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088193; Foy E, 2005, P NATL ACAD SCI USA, V102, P2986, DOI 10.1073/pnas.0408707102; Gale M, 2005, NATURE, V436, P939, DOI 10.1038/nature04078; Gibbings DJ, 2009, NAT CELL BIOL, V11, P1143, DOI 10.1038/ncb1929; Heydtmann M, 2009, J VIROL, V83, P2796, DOI 10.1128/JVI.00996-08; Hoffmann TW, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-109; Horner SM, 2012, J VIROL, V86, P3112, DOI 10.1128/JVI.06727-11; Hu Guoku, 2012, Frontiers in Genetics, V3, P56, DOI 10.3389/fgene.2012.00056; Jaworski E, 2014, J BIOL CHEM, V289, P22284, DOI 10.1074/jbc.M114.549659; Jaworski E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096778; Joyce DP, 2016, INT J CANCER, V139, P1443, DOI 10.1002/ijc.30179; Kanda T, 2007, J VIROL, V81, P12375, DOI 10.1128/JVI.01695-07; Kaukinen P, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-66; Koziel MJ, 2005, CLIN INFECT DIS, V41, pS25, DOI 10.1086/429492; Lemon SM, 2010, J BIOL CHEM, V285, P22739, DOI 10.1074/jbc.R109.099556; Li K, 2005, P NATL ACAD SCI USA, V102, P2992, DOI 10.1073/pnas.0408824102; Meckes DG, 2011, J VIROL, V85, P12844, DOI 10.1128/JVI.05853-11; Mittelbrunn M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1285; Negash AA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003330; Park SH, 2014, IMMUNITY, V40, P13, DOI 10.1016/j.immuni.2013.12.010; Parolini I, 2009, J BIOL CHEM, V284, P34211, DOI 10.1074/jbc.M109.041152; Rabinowits G, 2009, CLIN LUNG CANCER, V10, P42, DOI 10.3816/CLC.2009.n.006; Raposo G, 2013, J CELL BIOL, V200, P373, DOI 10.1083/jcb.201211138; Revie D, 2014, WORLD J GASTROENTERO, V20, P2777, DOI 10.3748/wjg.v20.i11.2777; Sampey GC, 2014, J NEUROVIROL, V20, P199, DOI 10.1007/s13365-014-0238-6; Stone Louise, 2016, Nat Rev Urol, V13, P297, DOI 10.1038/nrurol.2016.88; Stone Louise, 2016, Nat Rev Urol, V13, P298, DOI 10.1038/nrurol.2016.78; Sulkowski MS, 2002, JAMA-J AM MED ASSOC, V288, P199, DOI 10.1001/jama.288.2.199; Thery C, 2002, NAT REV IMMUNOL, V2, P569, DOI 10.1038/nri855; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Niel G, 2006, IMMUNITY, V25, P885, DOI 10.1016/j.immuni.2006.11.001; Wang X, 2009, BLOOD, V113, P671, DOI 10.1182/blood-2008-09-175000; Wang Y, 2013, J VIRAL HEPATITIS, V20, P385, DOI 10.1111/jvh.12040; Wang YZ, 2015, HEPAT MON, V15, DOI 10.5812/hepatmon.29282; Wang YZ, 2014, INNATE IMMUN-LONDON, V20, P3, DOI 10.1177/1753425913478991; Yang L, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00138; Ye L, 2009, HEPATOLOGY, V49, P753, DOI 10.1002/hep.22715; Zhou Y, 2010, IMMUNOLOGY, V131, P40, DOI 10.1111/j.1365-2567.2010.03270.x; Zhu X, 2015, CELL MICROBIOL, V17, P105, DOI 10.1111/cmi.12339	46	34	39	1	29	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4132	4140		10.1096/fj.201600696R	http://dx.doi.org/10.1096/fj.201600696R			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27605546	Green Published			2022-12-26	WOS:000388201500019
J	Fan, Y; He, JJ				Fan, Yan; He, Johnny J.			HIV-1 Tat Induces Unfolded Protein Response and Endoplasmic Reticulum Stress in Astrocytes and Causes Neurotoxicity through Glial Fibrillary Acidic Protein (GFAP) Activation and Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endoplasmic reticulum stress (ER stress); glial cell; human immunodeficiency virus (HIV); neuron; unfolded protein response (UPR); Glial fibrillary acidic protein; HIV-1 Tat; astrocytes; endoplasmic reticulum stress; unfolded protein response	HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; MONOCYTE CHEMOATTRACTANT PROTEIN-1; POLYMERASE-CHAIN-REACTION; ALEXANDER-DISEASE; HIV-1-ASSOCIATED DEMENTIA; INTERMEDIATE-FILAMENTS; TRANSGENIC MICE; NEURONAL DAMAGE; CELLULAR RESERVOIRS	HIV-1 Tat is a major culprit for HIV/neuroAIDS. One of the consistent hallmarks of HIV/neuroAIDS is reactive astrocytes or astrocytosis, characterized by increased cytoplasmic accumulation of the intermediate filament glial fibrillary acidic protein (GFAP). We have shown that that Tat induces GFAP expression in astrocytes and that GFAP activation is indispensable for astrocyte-mediated Tat neurotoxicity. However, the underlying molecular mechanisms are not known. In this study, we showed that Tat expression or GFAP expression led to formation of GFAP aggregates and induction of unfolded protein response (UPR) and endoplasmic reticulum (ER) stress in astrocytes. In addition, we demonstrated that GFAP up-regulation and aggregation in astrocytes were necessary but also sufficient for UPR/ER stress induction in Tat-expressing astrocytes and for astrocyte-mediated Tat neurotoxicity. Importantly, we demonstrated that inhibition of Tat- or GFAP-induced UPR/ER stress by the chemical chaperone 4-phenylbutyrate significantly alleviated astrocyte-mediated Tat neurotoxicity in vitro and in the brain of Tat-expressing mice. Taken together, these results show that HIV-1 Tat expression leads to UPR/ER stress in astrocytes, which in turn contributes to astrocyte-mediated Tat neurotoxicity, and raise the possibility of developing HIV/neuroAIDS therapeutics targeted at UPR/ER stress.	[Fan, Yan; He, Johnny J.] Univ North Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center	He, JJ (corresponding author), Univ North Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	johnny.he@unthsc.edu	Fan, Yan/F-5107-2018		NINDS, National Institutes of Health [R01NS065785, R01094108, R01MH092673]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094108, R01NS065785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043162] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NINDS, National Institutes of Health Grants R01NS065785, R01094108, and R01MH092673 (to J. J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akay C, 2012, NEUROPATH APPL NEURO, V38, P175, DOI 10.1111/j.1365-2990.2011.01215.x; Albini A, 1996, NAT MED, V2, P1371, DOI 10.1038/nm1296-1371; Aprea S, 2006, J NEUROSCI, V26, P4054, DOI 10.1523/JNEUROSCI.0603-06.2006; Bagasra O, 1996, AIDS, V10, P573, DOI 10.1097/00002030-199606000-00002; Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136; Benelli R, 2000, J INFECT DIS, V182, P1643, DOI 10.1086/317597; BLUM AL, 1979, INTERNIST, V20, P162; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Burdo TH, 2013, IMMUNOL REV, V254, P102, DOI 10.1111/imr.12068; Caporello E, 2006, J NEUROCHEM, V98, P146, DOI 10.1111/j.1471-4159.2006.03863.x; Castilla J, 2004, CURR MOL MED, V4, P397, DOI 10.2174/1566524043360654; CHARLES AC, 1991, NEURON, V6, P983, DOI 10.1016/0896-6273(91)90238-U; Chigurupati S, 2009, J BIOL CHEM, V284, P18323, DOI 10.1074/jbc.M109.020891; CHIU FC, 1985, J NEUROIMMUNOL, V8, P283, DOI 10.1016/S0165-5728(85)80067-9; Cho KJ, 2009, NEUROSCIENCE, V163, P1128, DOI 10.1016/j.neuroscience.2009.07.048; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Coulombe PA, 2004, NAT CELL BIOL, V6, P699, DOI 10.1038/ncb0804-699; Dash PK, 2011, J NEUROSCI, V31, P3148, DOI 10.1523/JNEUROSCI.5473-10.2011; de Paulis A, 2000, J IMMUNOL, V165, P7171, DOI 10.4049/jimmunol.165.12.7171; Deshpande M, 2005, NEUROTOX RES, V7, P183, DOI 10.1007/BF03036448; Ding M, 1998, MOL BRAIN RES, V62, P77, DOI 10.1016/S0169-328X(98)00240-X; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Ellis RJ, 1997, ARCH NEUROL-CHICAGO, V54, P416, DOI 10.1001/archneur.1997.00550160054016; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; Eugenin EA, 2007, P NATL ACAD SCI USA, V104, P3438, DOI 10.1073/pnas.0611699104; Fan Y, 2015, CURR HIV RES, V13, P55, DOI 10.2174/1570162X13666150121115804; Fan Y, 2011, J NEUROIMMUNE PHARM, V6, P121, DOI 10.1007/s11481-010-9217-8; FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Gavriil ES, 2000, BIOCHEM BIOPH RES CO, V267, P252, DOI 10.1006/bbrc.1999.1894; Gorry PR, 2003, CURR HIV RES, V1, P463, DOI 10.2174/1570162033485122; Hagemann TL, 2005, HUM MOL GENET, V14, P2443, DOI 10.1093/hmg/ddi248; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; HELLAND DE, 1991, J VIROL, V65, P4547, DOI 10.1128/JVI.65.8.4547-4549.1991; Hoozemans JJM, 2005, ACTA NEUROPATHOL, V110, P165, DOI 10.1007/s00401-005-1038-0; Irish BP, 2009, AM J INFECT DIS, V5, P231, DOI 10.3844/ajidsp.2009.231.258; Jones M, 1998, J NEUROPATH EXP NEUR, V57, P563, DOI 10.1097/00005072-199806000-00004; Kaul M, 2001, NATURE, V410, P988, DOI 10.1038/35073667; Kaul M, 2005, CELL DEATH DIFFER, V12, P878, DOI 10.1038/sj.cdd.4401623; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; Kondo S, 2005, NAT CELL BIOL, V7, P186, DOI 10.1038/ncb1213; Kruman II, 1998, EXP NEUROL, V154, P276, DOI 10.1006/exnr.1998.6958; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Lindl KA, 2007, NEUROPATH APPL NEURO, V33, P658, DOI 10.1111/j.1365-2990.2007.00866.x; Liu Y, 2002, J BIOL CHEM, V277, P23854, DOI 10.1074/jbc.M200773200; Liu Y, 2000, NAT MED, V6, P1380, DOI 10.1038/82199; Liu ZQ, 2014, J NEUROVIROL, V20, P278, DOI 10.1007/s13365-014-0245-7; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; MENNERICK S, 1994, NATURE, V368, P59, DOI 10.1038/368059a0; Messam CA, 2000, J NEUROVIROL, V6, pS90; Messing A, 1998, AM J PATHOL, V152, P391; Messing A, 1998, INT J DEV BIOL, V42, P1019; Mignot C, 2004, CELL MOL LIFE SCI, V61, P369, DOI 10.1007/s00018-003-3143-3; Mimori S, 2012, BIOL PHARM BULL, V35, P84, DOI 10.1248/bpb.35.84; New DR, 1998, J BIOL CHEM, V273, P17852, DOI 10.1074/jbc.273.28.17852; Norenburg M., 1997, ASTROCYTES BRAIN AGI; Norman JP, 2007, J IMMUNOL, V178, P869, DOI 10.4049/jimmunol.178.2.869; Nottet HSLM, 1996, J IMMUNOL, V156, P1284; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Pekny M, 2001, Prog Brain Res, V132, P23; Valero IP, 2014, J INT AIDS SOC, V17, P61, DOI 10.7448/IAS.17.4.19578; Peruzzi F, 2006, FRONT BIOSCI-LANDMRK, V11, P708, DOI 10.2741/1829; PRICE RW, 1988, J INFECT DIS, V158, P1079, DOI 10.1093/infdis/158.5.1079; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; REEVES SA, 1989, P NATL ACAD SCI USA, V86, P5178, DOI 10.1073/pnas.86.13.5178; Rodriguez D, 2001, AM J HUM GENET, V69, P1134, DOI 10.1086/323799; Sabri F, 1999, VIROLOGY, V264, P370, DOI 10.1006/viro.1999.9998; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; Shi B, 1998, J NEUROVIROL, V4, P281, DOI 10.3109/13550289809114529; Soto C, 2003, NAT REV NEUROSCI, V4, P49, DOI 10.1038/nrn1007; Speth C, 2002, J VIROL, V76, P3179, DOI 10.1128/JVI.76.7.3179-3188.2002; Sullivan SM, 2007, J BIOL CHEM, V282, P29414, DOI 10.1074/jbc.M704152200; Tanaka KF, 2007, GLIA, V55, P617, DOI 10.1002/glia.20486; Tewari M, 2015, J NEUROCHEM, V132, P464, DOI 10.1111/jnc.12953; Tirasophon W, 1998, GENE DEV, V12, P1812, DOI 10.1101/gad.12.12.1812; TOMOKANE N, 1991, AM J PATHOL, V138, P875; Ton Hoai, 2013, J AIDS Clin Res, V4, P255; TORNATORE C, 1994, NEUROLOGY, V44, P481, DOI 10.1212/WNL.44.3_Part_1.481; VASSAR R, 1991, CELL, V64, P365, DOI 10.1016/0092-8674(91)90645-F; Vitkovic L, 1995, CURR TOP MICROBIOL, V202, P105; Vitkovic L, 1995, BRAIN BEHAV IMMUN, V9, P378, DOI 10.1006/brbi.1995.1035; Williams K C, 1996, J NeuroAIDS, V1, P31; Yuen KY, 1997, J INFECTION, V34, P29, DOI 10.1016/S0163-4453(97)80006-0; Zhou BY, 2004, MOL CELL NEUROSCI, V27, P296, DOI 10.1016/j.mcn.2004.07.003; Zhou BY, 2004, NEUROSCI LETT, V359, P155, DOI 10.1016/j.neulet.2004.02.012; Zou W, 2007, AM J PATHOL, V171, P1923, DOI 10.2353/ajpath.2007.070333; Zou W, 2010, GLIA, V58, P1640, DOI 10.1002/glia.21038	90	49	49	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22819	22829		10.1074/jbc.M116.731828	http://dx.doi.org/10.1074/jbc.M116.731828			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609520	Green Published, hybrid			2022-12-26	WOS:000386760600038
J	Resto, M; Kim, BH; Fernandez, AG; Abraham, BJ; Zhao, KJ; Lewis, BA				Resto, Melissa; Kim, Bong-Hyun; Fernandez, Alfonso G.; Abraham, Brian J.; Zhao, Keji; Lewis, Brian A.			O-GlcNAcase Is an RNA Polymerase II Elongation Factor Coupled to Pausing Factors SPT5 and TIF1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						metabolism; O-GlcNAcylation; RNA polymerase II; transcription; transcription elongation factor	TRANSCRIPTION IN-VITRO; 7SK SNRNP COMPLEX; P-TEFB; DROSOPHILA-MELANOGASTER; FUNCTIONAL-ANALYSIS; CHRONIC DISEASE; PROMOTER; GENES; RELEASE; PHOSPHORYLATION	We describe here the identification and functional characterization of the enzyme O-GlcNAcase (OGA) as an RNA polymerase II elongation factor. Using in vitro transcription elongation assays, we show that OGA activity is required for elongation in a crude nuclear extract system, whereas in a purified system devoid of OGA the addition of rOGA inhibited elongation. Furthermore, OGA is physically associated with the known RNA polymerase II (pol II) pausing/elongation factors SPT5 and TRIM28-KAP1-TIF1, and a purified OGA-SPT5-TIF1 complex has elongation properties. Lastly, ChIP-seq experiments show that OGA maps to the transcriptional start site/5 ends of genes, showing considerable overlap with RNA pol II, SPT5, TRIM28-KAP1-TIF1, and O-GlcNAc itself. These data all point to OGA as a component of the RNA pol II elongation machinery regulating elongation genome-wide. Our results add a novel and unexpected dimension to the regulation of elongation by the insertion of O-GlcNAc cycling into the pol II elongation regulatory dynamics.	[Resto, Melissa; Fernandez, Alfonso G.; Lewis, Brian A.] NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA; [Kim, Bong-Hyun] Leidos Biomed Res Inc, Frederick Natl Lab Canc Res, Frederick, MD 21702 USA; [Abraham, Brian J.] Boston Univ, Bioinformat Program, Boston, MA 02215 USA; [Abraham, Brian J.; Zhao, Keji] NHLBI, Lab Epigenome Biol, NIH, Bldg 10, Bethesda, MD 20892 USA; [Fernandez, Alfonso G.] St Jude Childrens Res Hosp, 332 N Lauderdale St, Memphis, TN 38105 USA; [Abraham, Brian J.] Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Boston University; National Institutes of Health (NIH) - USA; NIH National Heart Lung & Blood Institute (NHLBI); St Jude Children's Research Hospital; Massachusetts Institute of Technology (MIT); Whitehead Institute	Lewis, BA (corresponding author), NCI, Transcript Regulat & Biochem Unit, Metab Branch, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	phdbiochemist@gmail.com	Abraham, Brian/C-2230-2019	Abraham, Brian/0000-0001-8085-3027; Lewis, Brian/0000-0002-8321-0665	NCI Intramural Program; NHLBI Intramural Program; National Institutes of Health; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [ZIAHL005801] Funding Source: NIH RePORTER	NCI Intramural Program(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI Intramural Program; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by the NCI Intramural Program (to B. A. L.) and the NHLBI Intramural Program (to K. Z.), National Institutes of Health. The authors declare they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Adamson TE, 2003, METHOD ENZYMOL, V371, P264; Adelman K, 2005, MOL CELL, V17, P103, DOI 10.1016/j.molcel.2004.11.028; Bai X, 2013, DEV BIOL, V373, P422, DOI 10.1016/j.ydbio.2012.10.008; Bai XY, 2010, CELL, V142, P133, DOI 10.1016/j.cell.2010.05.028; Baranello L, 2016, CELL, V165, P357, DOI 10.1016/j.cell.2016.02.036; BENGAL E, 1991, MOL CELL BIOL, V11, P1195, DOI 10.1128/MCB.11.3.1195; Bond MR, 2013, ANNU REV NUTR, V33, P205, DOI 10.1146/annurev-nutr-071812-161240; Bunch H, 2014, NAT STRUCT MOL BIOL, V21, P876, DOI 10.1038/nsmb.2878; Cetinbas N, 2006, BIOCHEMISTRY-US, V45, P3835, DOI 10.1021/bi052370b; Chao SH, 2000, J BIOL CHEM, V275, P28345, DOI 10.1074/jbc.C000446200; Chen FX, 2015, CELL, V162, P1003, DOI 10.1016/j.cell.2015.07.042; Cheng B, 2007, J BIOL CHEM, V282, P21901, DOI 10.1074/jbc.M702936200; Cheng B, 2012, MOL CELL, V45, P38, DOI 10.1016/j.molcel.2011.10.022; Cheng B, 2009, METHODS, V48, P346, DOI 10.1016/j.ymeth.2009.02.026; Core LJ, 2012, CELL REP, V2, P1025, DOI 10.1016/j.celrep.2012.08.034; Core LJ, 2008, SCIENCE, V322, P1845, DOI 10.1126/science.1162228; Das S, 2010, J PROTEOME RES, V9, P6696, DOI 10.1021/pr100843x; Deplus R, 2013, EMBO J, V32, P645, DOI 10.1038/emboj.2012.357; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Donner AJ, 2010, NAT STRUCT MOL BIOL, V17, P194, DOI 10.1038/nsmb.1752; Durning SP, 2016, J BIOL CHEM, V291, P2107, DOI 10.1074/jbc.M115.693580; FLORES O, 1989, J BIOL CHEM, V264, P8913; Gardini A, 2014, MOL CELL, V56, P128, DOI 10.1016/j.molcel.2014.08.004; Glover-Cutter K, 2009, MOL CELL BIOL, V29, P5455, DOI 10.1128/MCB.00637-09; Guo JN, 2013, CHEM REV, V113, P8583, DOI 10.1021/cr400105n; Hahne H, 2013, J PROTEOME RES, V12, P927, DOI 10.1021/pr300967y; Haltiwanger RS, 1998, J BIOL CHEM, V273, P3611, DOI 10.1074/jbc.273.6.3611; Hart GW, 2011, ANNU REV BIOCHEM, V80, P825, DOI 10.1146/annurev-biochem-060608-102511; Hart T, 2015, CELL, V163, DOI 10.1016/j.cell.2015.11.015; Harwood KR, 2014, J CELL SCI, V127, P1857, DOI 10.1242/jcs.113233; Iyengar S, 2011, J BIOL CHEM, V286, P26267, DOI 10.1074/jbc.R111.252569; Keembiyehetty C, 2015, J BIOL CHEM, V290, P7097, DOI 10.1074/jbc.M114.617779; KRUMM A, 1992, GENE DEV, V6, P2201, DOI 10.1101/gad.6.11.2201; Kwiatkowski N, 2014, NATURE, V511, P616, DOI 10.1038/nature13393; Lagerlof O, 2016, SCIENCE, V351, P1293, DOI 10.1126/science.aad5494; Lewis BA, 2016, J BIOL CHEM, V291, P14056, DOI 10.1074/jbc.M115.684365; Lewis BA, 2014, J BIOL CHEM, V289, P34440, DOI 10.1074/jbc.R114.595439; Lewis BA, 2013, BBA-GENE REGUL MECH, V1829, P1202, DOI 10.1016/j.bbagrm.2013.09.003; Love DC, 2010, P NATL ACAD SCI USA, V107, P7413, DOI 10.1073/pnas.0911857107; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Maldonado E, 1996, METHOD ENZYMOL, V274, P72; Mandal SS, 2004, P NATL ACAD SCI USA, V101, P7572, DOI 10.1073/pnas.0401493101; McNamara RP, 2016, GENOM DATA, V7, P250, DOI 10.1016/j.gdata.2016.01.019; McNamara RP, 2016, MOL CELL, V61, P39, DOI 10.1016/j.molcel.2015.11.004; Muse GW, 2007, NAT GENET, V39, P1507, DOI 10.1038/ng.2007.21; Nechaev S, 2010, SCIENCE, V327, P335, DOI 10.1126/science.1181421; Nilson KA, 2015, MOL CELL, V59, P576, DOI 10.1016/j.molcel.2015.06.032; O'Donnell N, 2004, MOL CELL BIOL, V24, P1680, DOI 10.1128/MCB.24.4.1680-1690.2004; Okada T, 2009, GLYCOBIOLOGY, V19, P368, DOI 10.1093/glycob/cwn145; Park JM, 2001, MOL CELL, V8, P9, DOI 10.1016/S1097-2765(01)00296-9; PRICE DH, 1989, MOL CELL BIOL, V9, P1465, DOI 10.1128/MCB.9.4.1465; Rahl PB, 2010, CELL, V141, P432, DOI 10.1016/j.cell.2010.03.030; Ranuncolo SM, 2012, J BIOL CHEM, V287, P23549, DOI 10.1074/jbc.M111.330910; ROUGVIE AE, 1988, CELL, V54, P795, DOI 10.1016/S0092-8674(88)91087-2; Slawson C, 2011, NAT REV CANCER, V11, P678, DOI 10.1038/nrc3114; Smith ER, 2008, P NATL ACAD SCI USA, V105, P8575, DOI 10.1073/pnas.0804379105; Stadelmayer B, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6531; STROBL LJ, 1992, EMBO J, V11, P3307, DOI 10.1002/j.1460-2075.1992.tb05409.x; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; Teo CF, 2016, GLYCOBIOLOGY, V26, P1198, DOI 10.1093/glycob/cww043; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Vaidyanathan K, 2014, J BIOL CHEM, V289, P34466, DOI 10.1074/jbc.R114.591560; Voet D., 2011, BIOCHEMISTRY-US, P566; Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395; Wada T, 1998, GENE DEV, V12, P343, DOI 10.1101/gad.12.3.343; Wang T, 2015, SCIENCE, V350, P1096, DOI 10.1126/science.aac7041; Weber A, 2005, MOL CELL BIOL, V25, P147, DOI 10.1128/mcb.25.1.147-161.2005; Wen YX, 1999, GENE DEV, V13, P1774, DOI 10.1101/gad.13.14.1774; Wu CH, 2003, GENE DEV, V17, P1402, DOI 10.1101/gad.1091403; Yamada T, 2006, MOL CELL, V21, P227, DOI 10.1016/j.molcel.2005.11.024; Yamaguchi Y, 2002, MOL CELL BIOL, V22, P2918, DOI 10.1128/MCB.22.9.2918-2927.2002; Yamaguchi Y, 1999, CELL, V97, P41, DOI 10.1016/S0092-8674(00)80713-8; Yu M, 2015, SCIENCE, V350, P1383, DOI 10.1126/science.aad2338; Yuzwa SA, 2008, NAT CHEM BIOL, V4, P483, DOI 10.1038/nchembio.96; Zeitlinger J, 2007, NAT GENET, V39, P1512, DOI 10.1038/ng.2007.26	75	17	18	1	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22703	22713		10.1074/jbc.M116.751420	http://dx.doi.org/10.1074/jbc.M116.751420			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601472	Green Published, hybrid			2022-12-26	WOS:000386760600029
J	Valabhoju, V; Agrawal, S; Sen, R				Valabhoju, Vishalini; Agrawal, Sonia; Sen, Ranjan			Molecular Basis of NusG-mediated Regulation of Rho-dependent Transcription Termination in Bacteria	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						allosteric regulation; bacteria; fluorescence; RNA polymerase; transcription termination; NusG; Rho	COLI RNA-POLYMERASE; ESCHERICHIA-COLI; ELONGATION COMPLEX; DEFECTIVE-MUTANTS; DNA; ACTIVATION; MECHANISM; LOCATION; RELEASE; PROTEIN	The bacterial transcription elongation factor NusG stimulates the Rho-dependent transcription termination through a direct interaction with Rho. The mechanistic basis of NusG dependence of the Rho function is not known. Here, we describe Rho* mutants I168V, R221C/A, and P235H that do not require NusG for their termination function. These Rho* mutants have acquired new properties, which otherwise would have been imparted by NusG. A detailed analyses revealed that they have more stable interactions at the secondary RNA binding sites of Rho, which reduced the lag in initiating its ATPase as well as the translocase activities. These more stable interactions arose from the significant spatial re-orientations of the P, Q, and R structural loops of the Rho central channel. We propose that NusG imparts similar conformational changes in the central channel of Rho, yielding faster isomerization of the open to the closed hexameric states of the latter during its RNA-loading step. This acceleration stabilizes the Rho-RNA interactions at many terminators having suboptimal rut sites, thus making Rho-NusG interactions so essential in vivo. Finally, identification of the NusG binding sites on the Rho hexamer led us to conclude that the former exerts its effect allosterically.	[Valabhoju, Vishalini; Agrawal, Sonia; Sen, Ranjan] Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Tuljaguda Complex,4-1-714 Mouzamjahi Rd, Hyderabad 500001, Andhra Pradesh, India; [Valabhoju, Vishalini] Manipal Univ, Grad Studies, Manipal 576104, Karnataka, India	Department of Biotechnology (DBT) India; Centre for DNA Fingerprinting & Diagnostics (CDFD); Manipal Academy of Higher Education (MAHE)	Sen, R (corresponding author), Ctr DNA Fingerprinting & Diagnost, Transcript Lab, Tuljaguda Complex,4-1-714 Mouzamjahi Rd, Hyderabad 500001, Andhra Pradesh, India.	rsen@cdfd.org.in	Sen, Ranjan/AAP-7075-2021		DBT-Center of Excellence in Microbial Physiology; Center for DNA Fingerprinting and Diagnostics; University Grant Commission (UGC)	DBT-Center of Excellence in Microbial Physiology; Center for DNA Fingerprinting and Diagnostics; University Grant Commission (UGC)(University Grants Commission, India)	This work was supported in part by DBT-Center of Excellence in Microbial Physiology and Center for DNA Fingerprinting and Diagnostics intramural funding. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a University Grant Commission (UGC) Senior Research Fellow during the period of this study.	Banerjee S, 2006, J MICROBIOL, V44, P11; Burns CM, 1999, J BIOL CHEM, V274, P5245, DOI 10.1074/jbc.274.8.5245; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Chalissery J, 2011, J MOL BIOL, V405, P49, DOI 10.1016/j.jmb.2010.10.044; Cheeran A, 2005, J MOL BIOL, V352, P28, DOI 10.1016/j.jmb.2005.06.052; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Dutta D, 2008, J BIOL CHEM, V283, P20243, DOI 10.1074/jbc.M801926200; Harinarayanan R, 2003, J MOL BIOL, V332, P31, DOI 10.1016/S0022-2836(03)00753-8; Kalarickal NC, 2010, J MOL BIOL, V395, P966, DOI 10.1016/j.jmb.2009.12.022; KUMAR KP, 1990, BIOCHEMISTRY-US, V29, P317, DOI 10.1021/bi00454a003; Lakowicz JR, 1999, PRINCIPLES FLUORESCE; Mooney RA, 2009, MOL CELL, V33, P97, DOI 10.1016/j.molcel.2008.12.021; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Neely MN, 1998, MOL MICROBIOL, V28, P1255, DOI 10.1046/j.1365-2958.1998.00890.x; Pasman Z, 2000, BIOCHEMISTRY-US, V39, P5573, DOI 10.1021/bi992658z; PEREIRA S, 1995, J MOL BIOL, V251, P30, DOI 10.1006/jmbi.1995.0413; Peters JM, 2012, GENE DEV, V26, P2621, DOI 10.1101/gad.196741.112; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Qayyum MZ, 2016, J BIOL CHEM, V291, P8090, DOI 10.1074/jbc.M115.701268; Ranjan A, 2013, NUCLEIC ACIDS RES, V41, P6839, DOI 10.1093/nar/gkt336; Sen R, 2003, METHOD ENZYMOL, V370, P598; Sen R., 2014, NUS FACTORS ESCHERIC; Shashni R, 2014, NUCLEIC ACIDS RES, V42, P9677, DOI 10.1093/nar/gku690; Skordalakes E, 2003, CELL, V114, P135, DOI 10.1016/S0092-8674(03)00512-9; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Tomar SK, 2013, CHEM REV, V113, P8604, DOI 10.1021/cr400064k; Washburn RS, 1996, J MOL BIOL, V260, P332, DOI 10.1006/jmbi.1996.0404; Yakhnin AV, 2016, J BIOL CHEM, V291, P5299, DOI 10.1074/jbc.M115.704189	29	25	25	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22386	22403		10.1074/jbc.M116.745364	http://dx.doi.org/10.1074/jbc.M116.745364			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27605667	hybrid, Green Published			2022-12-26	WOS:000386760600004
J	Feng, WC; Liu, MY; Chen, DG; Yiu, R; Fang, FC; Lei, BF				Feng, Wenchao; Liu, Mengyao; Chen, Daniel G.; Yiu, Rossana; Fang, Ferric C.; Lei, Benfang			Contemporary Pharyngeal and Invasive emm1 and Invasive emm12 Group A Streptococcus Isolates Exhibit Similar In Vivo Selection for CovRS Mutants in Mice	PLOS ONE			English	Article							2-COMPONENT REGULATORY SYSTEM; HYALURONIC-ACID CAPSULE; VIRULENCE FACTORS; UNITED-STATES; DISEASE; INFECTION; CLONE; EPIDEMIOLOGY; EXPRESSION; PHENOTYPE	Group A Streptococcus (GAS) causes diverse infections ranging from common pharyngitis to rare severe invasive infections. Invasive GAS isolates can have naturalmutations in the virulence regulator CovRS, which result in enhanced expression of multiple virulence genes, suppressed the expression of the protease SpeB, and increased virulence. It is believed that CovRS mutations arise during human infections with GAS carrying wild-type CovRS and are not transmissible. CovRS mutants of invasive GAS of the emm1 genotype arise readily during experimental infection in mice. It is possible that invasive GAS arises from pharyngeal GAS through rare genetic mutations that confer the capacity of mutated GAS to acquire covRS mutations during infection. The objective of this study was to determine whether contemporary pharyngeal emm1 GAS isolates have a reduced propensity to acquire CovRS mutations in vivo compared with invasive emm1 GAS and whether emm3, emm12, and emm28 GAS acquire CovRS mutants in mouse infection. The propensity of invasive and pharyngeal emm1 and invasive emm3, emm12, and emm28 SpeB(A+) isolates to acquire variants with the SpeB(A-) phenotype was determined during subcutaneous infection of mice. The majority of both invasive and pharyngeal emm1 SpeB(A+) isolates and two of three emm12 isolates, but not emm3 and emm28 isolates, were found to acquire SpeB(A-) variants during skin infection in mice. All analyzed SpeB(A-) variants of emm1 and emm12 GAS from the mouse infection acquired covRS mutations and produced more platelet-activating factor acetylhydrolase SsE. Thus, contemporary invasive and pharyngeal emm1 GAS isolates and emm12 GAS have a similar capacity to acquire covRS mutations in vivo. The rarity of severe invasive infections caused by GAS does not appear to be attributable to a reduced ability of pharyngeal isolates to acquire CovRS mutations.	[Feng, Wenchao; Liu, Mengyao; Chen, Daniel G.; Lei, Benfang] Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59718 USA; [Yiu, Rossana; Fang, Ferric C.] Harborview Med Ctr, Clin Microbiol Lab, Seattle, WA USA; [Yiu, Rossana; Fang, Ferric C.] Univ Washington, Sch Med, Seattle, WA 98195 USA	Montana State University System; Montana State University Bozeman; Harborview Medical Center; University of Washington; University of Washington Seattle	Lei, BF (corresponding author), Montana State Univ, Dept Microbiol & Immunol, Bozeman, MT 59718 USA.	blei@montana.edu		Fang, Ferric/0000-0002-3243-110X; Lei, Benfang Lei/0000-0001-8133-6021	National Institutes of Health [AI095704, AI097703, GM110732]; Montana University System Research Initiative [51040-MUSRI2015-03]; Montana State Agricultural Experimental Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI095704, R21AI097703] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110732] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Montana University System Research Initiative; Montana State Agricultural Experimental Station; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by grants AI095704, AI097703, and GM110732 from the National Institutes of Health, Montana University System Research Initiative 51040-MUSRI2015-03, and the Montana State Agricultural Experimental Station.	Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Aziz RK, 2004, MOL MICROBIOL, V51, P123, DOI 10.1046/j.1365-2958.2003.03797.x; Beres SB, 2002, P NATL ACAD SCI USA, V99, P10078, DOI 10.1073/pnas.152298499; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carroll RK, 2011, J CLIN INVEST, V121, P1956, DOI 10.1172/JCI45169; Chaussee MS, 1999, INFECT IMMUN, V67, P1715; CLEARY PP, 1992, LANCET, V339, P518, DOI 10.1016/0140-6736(92)90339-5; Cockerill FR, 1997, JAMA-J AM MED ASSOC, V277, P38, DOI 10.1001/jama.277.1.38; Cole JN, 2006, FASEB J, V20, P1745, DOI 10.1096/fj.06-5804fje; Cole JN, 2011, NAT REV MICROBIOL, V9, P724, DOI 10.1038/nrmicro2648; Cole JN, 2010, MBIO, V1, DOI 10.1128/mBio.00191-10; Engleberg NC, 2004, INFECT IMMUN, V72, P623, DOI 10.1128/IAI.72.2.623-628.2004; Engleberg NC, 2001, J INFECT DIS, V183, P1043, DOI 10.1086/319291; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Flores AR, 2014, J INFECT DIS, V209, P1520, DOI 10.1093/infdis/jit674; Friaes A, 2015, MBIO, V6, DOI 10.1128/mBio.01780-15; Heath A, 1999, INFECT IMMUN, V67, P5298, DOI 10.1128/IAI.67.10.5298-5305.1999; Ikebe T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000832; Kansal RG, 2010, J INFECT DIS, V201, P855, DOI 10.1086/651019; Kappeler KV, 2009, INFECT IMMUN, V77, P5411, DOI 10.1128/IAI.00373-09; KATZ AR, 1992, CLIN INFECT DIS, V14, P298, DOI 10.1093/clinids/14.1.298; Kazmi SU, 2001, INFECT IMMUN, V69, P4988, DOI 10.1128/IAI.69.8.4988-4995.2001; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Li JQ, 2014, INFECT IMMUN, V82, P1579, DOI 10.1128/IAI.01458-13; Li JQ, 2013, INFECT IMMUN, V81, P974, DOI 10.1128/IAI.01218-12; Liu GH, 2013, INFECT IMMUN, V81, P3128, DOI 10.1128/IAI.00398-13; Liu GL, 2015, IEEE VTS VEH TECHNOL; Liu MY, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002624; Maamary PG, 2012, FASEB J, V26, P4675, DOI 10.1096/fj.12-212142; Miller EW, 2015, MOL MICROBIOL, V98, P473, DOI 10.1111/mmi.13136; Miyoshi-Akiyama T, 2006, J INFECT DIS, V193, P1677, DOI 10.1086/504263; MUSSER JM, 1995, INFECT IMMUN, V63, P994, DOI 10.1128/IAI.63.3.994-1003.1995; Nasser W, 2014, P NATL ACAD SCI USA, V111, pE1768, DOI 10.1073/pnas.1403138111; National Research Council (US) Committee, 2011, GUIDE CARE USE LAB A, DOI [DOI 10.17226/12910, 10.17226/12910]; Nelson GE, 2016, CLIN INFECT DIS, V63, P478, DOI 10.1093/cid/ciw248; O'Brien KL, 2002, CLIN INFECT DIS, V35, P268, DOI 10.1086/341409; O'Loughlin RE, 2007, CLIN INFECT DIS, V45, P853, DOI 10.1086/521264; Olsen RJ, 2015, INFECT IMMUN, V83, P4750, DOI 10.1128/IAI.00989-15; Shea PR, 2011, P NATL ACAD SCI USA, V108, P5039, DOI 10.1073/pnas.1016282108; Stetzner ZW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129417; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Turner Claire E, 2015, mBio, V6, pe00622, DOI 10.1128/mBio.00622-15; Walker MJ, 2007, NAT MED, V13, P981, DOI 10.1038/nm1612; Zhu H, 2009, INFECT IMMUN, V77, P5225, DOI 10.1128/IAI.00636-09; Zhu LC, 2015, MBIO, V6, DOI 10.1128/mBio.01378-15	46	11	11	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162742	10.1371/journal.pone.0162742	http://dx.doi.org/10.1371/journal.pone.0162742			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611332	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900162
J	da Silva, FRC; Cibulski, SP; Daudt, C; Weber, MN; Guimaraes, LLB; Streck, AF; Mayer, FQ; Roehe, PM; Canal, CW				da Silva, Flavio R. C.; Cibulski, Samuel P.; Daudt, Cintia; Weber, Matheus N.; Guimaraes, Lorena L. B.; Streck, Andre F.; Mayer, Fabiana Q.; Roehe, Paulo M.; Canal, Cludio W.			Novel Bovine Papillomavirus Type Discovered by Rolling-Circle Amplification Coupled with Next-Generation Sequencing	PLOS ONE			English	Article							TEAT PAPILLOMATOSIS; COMPLETE GENOMES; REPLICATION; CLASSIFICATION; IDENTIFICATION; CLONING; MODELS; CATTLE	Currently, fifteen bovine papillomavirus (BPV) types have been identified and classified into four genera: Deltapapillomavirus, Epsilonpapillomavirus, Dyoxipapillomavirus, and Xipapillomavirus. Here, the complete genome sequence of a new BPV type (BPV 04AC14) recovered from a papillomatous lesion is reported. The genome is 7,282 bp in length and exhibits the classic genetic organization and motifs of the members of Papillomaviridae. Maximum likelihood phylogenetic analyses revealed that BPV 04AC14 clusters with members of the Xipapillomavirus genus. The nucleotide sequence of the L1 capsid protein of the novel BPV is closely related to its counterpart, BPV3, with which it shares 79% similarity. These findings suggest that this virus is a new BPV type of the Xipapillomavirus genus.	[da Silva, Flavio R. C.; Cibulski, Samuel P.; Daudt, Cintia; Weber, Matheus N.; Guimaraes, Lorena L. B.; Canal, Cludio W.] Univ Fed Rio Grande do Sul, Fac Vet, Lab Virol, Porto Alegre, RS, Brazil; [da Silva, Flavio R. C.] Univ Fed Acre Rio Branco, Ctr Ciencias Biol & Nat, Acre, Brazil; [Streck, Andre F.] Univ Caxias Sul, Caxias Do Sul, RS, Brazil; [Mayer, Fabiana Q.] Fundacao Estadual Pesquisa Agr, IPVDF, Lab Biol Mol, Eldorado Do Sul, RS, Brazil; [Roehe, Paulo M.] Univ Fed Rio Grande do Sul, Lab Virol, Dept Microbiol Imunol & Parasitol, Porto Alegre, RS, Brazil	Universidade Federal do Rio Grande do Sul; Universidade Federal do Acre (UFAC); Universidade de Caxias do Sul; Universidade Federal do Rio Grande do Sul	Canal, CW (corresponding author), Univ Fed Rio Grande do Sul, Fac Vet, Lab Virol, Porto Alegre, RS, Brazil.	claudio.canal@ufrgs.br	Mayer, Fabiana Q/K-2279-2015; Cibulski, Samuel P/G-5190-2017; MAYER, FABIANA QUOOS/AAV-2264-2020; Weber, Matheus/B-2956-2019; Canal, Cláudio W./J-7253-2012; ROEHE, PAULO MICHEL/K-1208-2012	Mayer, Fabiana Q/0000-0002-9324-8536; MAYER, FABIANA QUOOS/0000-0002-9324-8536; Canal, Cláudio W./0000-0002-0621-243X; ROEHE, PAULO MICHEL/0000-0002-2370-7661; Weber, Matheus/0000-0001-8282-6778; Streck, Andre Felipe/0000-0002-4798-0777; Cibulski, Samuel/0000-0003-0503-8692	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES); Fundacao de Amparo a Pesquisa do Estado do Acre (FAPAC)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fundacao de Amparo a Pesquisa do Estado do Acre (FAPAC)	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq), Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) and Fundacao de Amparo a Pesquisa do Estado do Acre (FAPAC) supported this study. CWC and PMR are CNPq productivity research fellows. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Batista MVA, 2013, VET J, V197, P368, DOI 10.1016/j.tvjl.2013.01.019; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Borzacchiello G, 2008, VET RES, V39, DOI 10.1051/vetres:2008022; Bravo Ignacio G., 2015, Evolution Medicine and Public Health, P32, DOI 10.1093/emph/eov003; Bravo IG, 2010, TRENDS MICROBIOL, V18, P432, DOI 10.1016/j.tim.2010.07.008; Campo MS, 2002, VIRUS RES, V89, P249, DOI 10.1016/S0168-1702(02)00193-4; Chan HM, 2001, ONCOGENE, V20, P6152, DOI 10.1038/sj.onc.1204793; Dahiya A, 2000, MOL CELL BIOL, V20, P6799, DOI 10.1128/MCB.20.18.6799-6805.2000; de Villiers EM, 2004, VIROLOGY, V324, P17, DOI 10.1016/j.virol.2004.03.033; de Villiers EM, 2013, VIROLOGY, V445, P2, DOI 10.1016/j.virol.2013.04.023; Desaintes C, 1996, SEMIN CANCER BIOL, V7, P339, DOI 10.1006/scbi.1996.0043; Dezen D, 2010, RES VET SCI, V88, P436, DOI 10.1016/j.rvsc.2009.10.006; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Forslund O, 1999, J GEN VIROL, V80, P2437, DOI 10.1099/0022-1317-80-9-2437; Harbour JW, 2000, CURR OPIN CELL BIOL, V12, P685, DOI 10.1016/S0955-0674(00)00152-6; Hatama S, 2008, J GEN VIROL, V89, P158, DOI 10.1099/vir.0.83334-0; Hatama S, 2011, ARCH VIROL, V156, P1281, DOI 10.1007/s00705-011-0970-7; JACKSON ME, 1991, MOL CARCINOGEN, V4, P382, DOI 10.1002/mc.2940040510; Lehoux M, 2009, PUBLIC HEALTH GENOM, V12, P268, DOI 10.1159/000214918; Liu X, 2006, J BIOL CHEM, V281, P578, DOI 10.1074/jbc.M508455200; Liu XF, 2010, J VIROL, V84, P4264, DOI 10.1128/JVI.02214-09; LU JZJ, 1993, J VIROL, V67, P7131, DOI 10.1128/JVI.67.12.7131-7139.1993; Ma TL, 1999, P NATL ACAD SCI USA, V96, P382, DOI 10.1073/pnas.96.2.382; Maeda Y, 2007, VET MICROBIOL, V121, P242, DOI 10.1016/j.vetmic.2006.12.015; Munday JS, 2010, VET PATHOL, V47, P254, DOI 10.1177/0300985809358604; Niel C, 2005, J GEN VIROL, V86, P1343, DOI 10.1099/vir.0.80794-0; Ogawa T, 2007, J GEN VIROL, V88, P1934, DOI 10.1099/vir.0.82794-0; PATEL KR, 1987, J GEN VIROL, V68, P2117, DOI 10.1099/0022-1317-68-8-2117; Posada D, 2001, MOL BIOL EVOL, V18, P897, DOI 10.1093/oxfordjournals.molbev.a003890; Rector A, 2005, VIROLOGY, V331, P449, DOI 10.1016/j.virol.2004.10.033; Rector A, 2004, J VIROL, V78, P4993, DOI 10.1128/JVI.78.10.4993-4998.2004; Rector A, 2013, VIROLOGY, V445, P213, DOI 10.1016/j.virol.2013.05.007; Rijsewijk FAM, 2011, ARCH VIROL, V156, P1097, DOI 10.1007/s00705-011-0971-6; Scase T, 2010, EQUINE VET J, V42, P738, DOI 10.1111/j.2042-3306.2010.00311.x; Stevaux O, 2002, CURR OPIN CELL BIOL, V14, P684, DOI 10.1016/S0955-0674(02)00388-5; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tomita Y, 2007, VIRUS GENES, V35, P243, DOI 10.1007/s11262-006-0055-y; Tozato CC, 2013, BRAZ J MICROBIOL, V44, P905, DOI 10.1590/S1517-83822013005000057; Van Doorslaer K, 2007, J GEN VIROL, V88, P1484, DOI 10.1099/vir.0.82615-0; Van Doorslaer K, 2013, NUCLEIC ACIDS RES, V41, pD571, DOI 10.1093/nar/gks984; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164; Zheng ZM, 2006, FRONT BIOSCI-LANDMRK, V11, P2286, DOI 10.2741/1971; Zhu W, 2012, ARCH VIROL, V157, P85, DOI 10.1007/s00705-011-1140-7	44	21	21	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162345	10.1371/journal.pone.0162345	http://dx.doi.org/10.1371/journal.pone.0162345			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606703	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600040
J	He, XY; Singh, PK; Dreisigacker, S; Singh, S; Lillemo, M; Duveiller, E				He, Xinyao; Singh, Pawan K.; Dreisigacker, Susanne; Singh, Sukhwinder; Lillemo, Morten; Duveiller, Etienne			Dwarfing Genes Rht-B1b and Rht-D1b Are Associated with Both Type I FHB Susceptibility and Low Anther Extrusion in Two Bread Wheat Populations	PLOS ONE			English	Article							FUSARIUM-HEAD-BLIGHT; QUANTITATIVE TRAIT LOCI; TRITICUM-AESTIVUM L; WINTER-WHEAT; POLLEN PRODUCTION; GREEN-REVOLUTION; EUROPEAN WHEAT; PLANT HEIGHT; RESISTANCE; QTLS	It has been well documented that dwarfing genes Rht-B1b and Rht-D1b are associated with Type I susceptibility to Fusarium head blight (FHB) in wheat; but the underlying mechanism has not been well delineated. Anther extrusion (AE) has also been related to Type I resistance for initial FHB infection, where high AE renders FHB resistance. In this study, two doubled haploid populations were used to investigate the impact of the two dwarfing genes on FHB resistance and AE, and to elucidate the role of AE in Rht-mediated FHB susceptibility. Both populations were derived by crossing the FHB susceptible cultivar 'Ocoroni F86' (Rht-B1a/Rht-D1b) with an FHB resistant variety (Rht-B1b/Rht-D1a), which was 'TRAP#1/BOW//Taigu derivative' in one population (the TO population) and 'Ivan/Soru# 2' in the other (the IO population). Field experiments were carried out from 2010 to 2012 in El Batan, Mexico, where spray inoculation was adopted and FHB index, plant height (PH), and AE were evaluated, with the latter two traits showing always significantly negative correlations with FHB severity. The populations were genotyped with the DArTseq GBS platform, the two dwarfing genes and a few SSRs for QTL analysis, and the results indicated that Rht-B1b and Rht-D1b collectively accounted for 0-41% of FHB susceptibility and 13-23% of reduced AE. It was also observed that three out of the four AE QTL in the TO population and four out of the five AE QTL in the IO population were associated with FHB resistance. Collectively, our results demonstrated the effects of Rht-B1b and Rht-D1b on Type I FHB susceptibility and reducing AE, and proposed that their impacts on Type I FHB susceptibility may partly be explained by their effects on reducing AE. The implication of the relationship between the two dwarfing genes and AE for hybrid wheat breeding was also discussed.	[He, Xinyao; Singh, Pawan K.; Dreisigacker, Susanne; Singh, Sukhwinder; Duveiller, Etienne] Int Maize & Wheat Improvement Ctr CIMMYT, Apdo Postal 6-641, Mexico City 06600, DF, Mexico; [He, Xinyao; Lillemo, Morten] Norwegian Univ Life Sci, Dept Plant Sci, POB 5003, NO-1432 As, Norway	CGIAR; International Maize & Wheat Improvement Center (CIMMYT); Norwegian University of Life Sciences	Singh, PK (corresponding author), Int Maize & Wheat Improvement Ctr CIMMYT, Apdo Postal 6-641, Mexico City 06600, DF, Mexico.	pk.singh@cgiar.org	Lillemo, Morten/H-9406-2019	Lillemo, Morten/0000-0002-8594-8794; Singh, Pawan/0000-0003-4610-3120	CGIAR Research Program on Wheat; 'Seeds of Discovery'-Sustainable Modernization of Traditional Agriculture project (MasAgro); CGIAR scholarship by the Research Council of Norway, through NFR project [208340/H30]	CGIAR Research Program on Wheat(CGIAR); 'Seeds of Discovery'-Sustainable Modernization of Traditional Agriculture project (MasAgro); CGIAR scholarship by the Research Council of Norway, through NFR project(CGIAR)	This work was supported by CGIAR Research Program on Wheat and 'Seeds of Discovery'-Sustainable Modernization of Traditional Agriculture project (MasAgro). Xinyao He was financially supported by a CGIAR scholarship, provided by the Research Council of Norway, through NFR project 208340/H30. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Financial support by the CGIAR Research Program on Wheat and 'Seeds of Discovery'-Sustainable Modernization of Traditional Agriculture project (MasAgro) is gratefully acknowledged. The first author was financially supported by a CGIAR scholarship, provided by the Research Council of Norway, through NFR project 208340/H30-Breeding for Fusarium resistance in wheat. The authors are grateful to Prof. Asmund Bjornstad, Norwegian University of Life Sciences, for his kind instruction on AE phenotyping, and to Francisco Lopez, Javier Segura and Nerida Lozano for technical assistance.	ATASHIRANG G, 1978, CROP SCI, V18, P267, DOI 10.2135/cropsci1978.0011183X001800020018x; Bai GH, 2004, ANNU REV PHYTOPATHOL, V42, P135, DOI 10.1146/annurev.phyto.42.040803.140340; Buerstmayr H, 2009, PLANT BREEDING, V128, P1, DOI 10.1111/j.1439-0523.2008.01550.x; Buerstmayr H, 2013, RAUMBERG GUMPENSTEIN, P69; Buerstmayr M, 2015, THEOR APPL GENET, V128, P1519, DOI 10.1007/s00122-015-2527-8; Buerstmayr M, 2012, THEOR APPL GENET, V125, P1751, DOI 10.1007/s00122-012-1951-2; Cheng H, 2004, DEVELOPMENT, V131, P1055, DOI 10.1242/dev.00992; COUTURE L, 1982, CAN J PLANT SCI, V62, P29, DOI 10.4141/cjps82-004; DEVRIES AP, 1972, EUPHYTICA, V21, P185, DOI 10.1007/BF00036759; Draeger R, 2007, THEOR APPL GENET, V115, P617, DOI 10.1007/s00122-007-0592-3; Dreisigacker S, 2011, P 21 INT TRIT MAPP I, P105; Duveiller E, 2014, MYCOTOXIN REDUCTION IN GRAIN CHAINS, P220; Emrich K, 2008, THEOR APPL GENET, V117, P65, DOI 10.1007/s00122-008-0753-z; Gilbert J, 2013, CAN J PLANT PATHOL, V35, P149, DOI 10.1080/07060661.2013.772921; Graham S, 2009, J PHYTOPATHOL, V157, P580, DOI 10.1111/j.1439-0434.2008.01524.x; He XY, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158052; He XY, 2014, EUPHYTICA, V195, P383, DOI 10.1007/s10681-013-1002-3; He XY, 2013, THEOR APPL GENET, V126, P2655, DOI 10.1007/s00122-013-2163-0; He XY, 2013, EUR J PLANT PATHOL, V136, P123, DOI 10.1007/s10658-012-0146-7; Hedden P, 2003, TRENDS GENET, V19, P5, DOI 10.1016/S0168-9525(02)00009-4; Hilton AJ, 1999, PLANT PATHOL, V48, P202, DOI 10.1046/j.1365-3059.1999.00339.x; Holzapfel J, 2008, THEOR APPL GENET, V117, P1119, DOI 10.1007/s00122-008-0850-z; JOHNSON JW, 1973, CROP SCI, V13, P92, DOI 10.2135/cropsci1973.0011183X001300010029x; JOPPA LR, 1968, CROP SCI, V8, P487, DOI 10.2135/cropsci1968.0011183X000800040028x; Klahr A, 2007, EUPHYTICA, V154, P17, DOI 10.1007/s10681-006-9264-7; Kubo K, 2013, J PHYTOPATHOL, V161, P308, DOI 10.1111/jph.12060; Langer SM, 2014, PLANT BREEDING, V133, P433, DOI 10.1111/pbr.12192; Li HH, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1424-5; Liu SY, 2013, THEOR APPL GENET, V126, P2485, DOI 10.1007/s00122-013-2149-y; Liu SY, 2009, CROP SCI, V49, P1955, DOI 10.2135/cropsci2009.03.0115; Lu QX, 2013, THEOR APPL GENET, V126, P317, DOI 10.1007/s00122-012-1981-9; Lu QX, 2011, CROP SCI, V51, P2430, DOI 10.2135/cropsci2010.12.0671; Lv C, 2014, CROP J, V2, P70, DOI 10.1016/j.cj.2013.10.004; Mao SL, 2010, EUPHYTICA, V174, P343, DOI 10.1007/s10681-010-0128-9; Mesterhazy A, 1995, PLANT BREEDING, V114, P377, DOI 10.1111/j.1439-0523.1995.tb00816.x; Miedaner T, 2008, CROP SCI, V48, P2115, DOI 10.2135/cropsci2008.02.0107; Miedaner T, 2011, MOL BREEDING, V28, P647, DOI 10.1007/s11032-010-9516-z; Osman M, 2015, EUPHYTICA, V205, P521, DOI 10.1007/s10681-015-1425-0; Pugh GW, 1933, J AGRIC RES, V46, P0771; Saville RJ, 2012, J EXP BOT, V63, P1271, DOI 10.1093/jxb/err350; SCHROEDER HW, 1963, PHYTOPATHOLOGY, V53, P831; Skinnes H, 2010, PLANT BREEDING, V129, P149, DOI 10.1111/j.1439-0523.2009.01731.x; Skinnes H, 2008, CEREAL RES COMMUN, V36, P223, DOI 10.1556/CRC.36.2008.Suppl.B.19; Srinivasachary, 2008, THEOR APPL GENET, V116, P1145, DOI 10.1007/s00122-008-0742-2; Srinivasachary, 2009, THEOR APPL GENET, V118, P695, DOI 10.1007/s00122-008-0930-0; Stack R. W., 1994, VISUAL SCALE ESTIMAT, P1095; STRANGE RN, 1971, PHYSIOL PLANT PATHOL, V1, P141, DOI 10.1016/0048-4059(71)90023-3; STRANGE RN, 1974, PHYSIOL PLANT PATHOL, V4, P277, DOI 10.1016/0048-4059(74)90015-0; STRANGE RN, 1978, T BRIT MYCOL SOC, V70, P201, DOI 10.1016/S0007-1536(78)80031-X; Van Ooijen J, 2009, MAPQTL 6 SOFTWARE MA, V64; Van Ooijen JW, 2006, SOFTWARE CALCULATION; Voorrips RE, 2002, J HERED, V93, P77, DOI 10.1093/jhered/93.1.77; Voss HH, 2008, PLANT BREEDING, V127, P333, DOI 10.1111/j.1439-0523.2008.01518.x; Yan W, 2011, PLANT PATHOL, V60, P506, DOI 10.1111/j.1365-3059.2011.02426.x; Zhu H, 1999, THEOR APPL GENET, V99, P1221, DOI 10.1007/s001220051328	55	12	12	4	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162499	10.1371/journal.pone.0162499	http://dx.doi.org/10.1371/journal.pone.0162499			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606928	Green Accepted, gold, Green Submitted, Green Published			2022-12-26	WOS:000383255600052
J	Frontalini, F; Curzi, D; Cesarini, E; Canonico, B; Giordano, FM; De Matteis, R; Bernhard, JM; Pieretti, N; Gu, B; Eskelsen, JR; Jubb, AM; Zhao, L; Pierce, EM; Gobbi, P; Papa, S; Coccioni, R				Frontalini, Fabrizio; Curzi, Davide; Cesarini, Erica; Canonico, Barbara; Giordano, Francesco M.; De Matteis, Rita; Bernhard, Joan M.; Pieretti, Nadia; Gu, Baohua; Eskelsen, Jeremy R.; Jubb, Aaron M.; Zhao, Linduo; Pierce, Eric M.; Gobbi, Pietro; Papa, Stefano; Coccioni, Rodolfo			Mercury-Pollution Induction of Intracellular Lipid Accumulation and Lysosomal Compartment Amplification in the Benthic Foraminifer Ammonia parkinsoniana	PLOS ONE			English	Article							HEAVY-METAL POLLUTION; NILE-RED; GENE-EXPRESSION; ACRIDINE-ORANGE; IN-SITU; BIOMARKERS; RESPONSES; DROPLETS; CELLS; INDICATORS	Heavy metals such as mercury (Hg) pose a significant health hazard through bioaccumulation and biomagnification. By penetrating cell membranes, heavy metal ions may lead to pathological conditions. Here we examined the responses of Ammonia parkinsoniana, a benthic foraminiferan, to different concentrations of Hg in the artificial sea water. Confocal images of untreated and treated specimens using fluorescent probes (Nile Red and Acridine Orange) provided an opportunity for visualizing the intracellular lipid accumulation and acidic compartment regulation. With increased Hg over time, we observed an increased number of lipid droplets, which may have acted as a detoxifying organelle where Hg is sequestered and biologically inactivated. Further, Hg seems to promote the proliferation of lysosomes both in terms of number and dimension that, at the highest level of Hg, resulted in cell death. We report, for the first time, the presence of Hg within the foraminiferal cell: at the basal part of pores, in the organic linings of the foramen/septa, and as cytoplasmic accumulations.	[Frontalini, Fabrizio; Pieretti, Nadia; Coccioni, Rodolfo] Univ Urbino, Dept Pure & Appl Sci, Urbino, Italy; [Curzi, Davide; Cesarini, Erica; Canonico, Barbara; Giordano, Francesco M.; De Matteis, Rita; Gobbi, Pietro; Papa, Stefano] Univ Urbino, Dept Biomol Sci, Urbino, Italy; [Bernhard, Joan M.] Woods Hole Oceanog Inst, Dept Geol & Geophys, Woods Hole, MA 02543 USA; [Gu, Baohua; Eskelsen, Jeremy R.; Jubb, Aaron M.; Zhao, Linduo; Pierce, Eric M.] Oak Ridge Natl Lab, Div Environm Sci, POB 2008, Oak Ridge, TN 37831 USA	University of Urbino; University of Urbino; Woods Hole Oceanographic Institution; United States Department of Energy (DOE); Oak Ridge National Laboratory	Frontalini, F (corresponding author), Univ Urbino, Dept Pure & Appl Sci, Urbino, Italy.	fabrizio.frontalini@uniurb.it	Gobbi, Pietro/J-2566-2012; Jubb, Aaron/G-4538-2013; De+Matteis, Rita/AAG-6904-2019; Eskelsen, Jeremy/S-5927-2016; Frontalini, Fabrizio/C-4819-2008; Pierce, Eric M/G-1615-2011; Jubb, Aaron/CAA-2223-2022; Bernhard, Joan/M-3260-2013	Gobbi, Pietro/0000-0003-4705-0833; Jubb, Aaron/0000-0001-6875-1079; Eskelsen, Jeremy/0000-0003-2828-9099; Frontalini, Fabrizio/0000-0002-0425-9306; Pierce, Eric M/0000-0002-4951-1931; Jubb, Aaron/0000-0001-6875-1079; DE MATTEIS, Rita/0000-0003-4665-4547; Bernhard, Joan/0000-0003-2121-625X; Canonico, Barbara/0000-0003-3383-715X	PRIN Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (protocollo RMTLYR); Investment in Science Fund at WHOI; Office of Biological and Environmental Research, US Department of Energy (DOE) as part of the Mercury Science Focus Area at Oak Ridge National Laboratory; DOE [DE-AC05-00OR22725]	PRIN Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (protocollo RMTLYR); Investment in Science Fund at WHOI; Office of Biological and Environmental Research, US Department of Energy (DOE) as part of the Mercury Science Focus Area at Oak Ridge National Laboratory(United States Department of Energy (DOE)); DOE(United States Department of Energy (DOE))	The research for this paper was partially made possible by the financial support from the PRIN 2010-2011 Ministero dell'Istruzione, dell'Universita e della Ricerca (MIUR) (protocollo 2010RMTLYR) to RC. JMB acknowledges support from The Investment in Science Fund at WHOI. BG, JRE, AJ, LZ, and EMP were supported in part by the Office of Biological and Environmental Research, US Department of Energy (DOE) as part of the Mercury Science Focus Area at Oak Ridge National Laboratory, which is managed by UT-Battelle LLC for the DOE under contract DE-AC05-00OR22725.	ALVE E, 1995, J FORAMIN RES, V25, P190, DOI 10.2113/gsjfr.25.3.190; Anderson O.R., 1991, BIOL FORAMINIFERA, P335; Artal MC, 2013, ENVIRON TOXICOL CHEM, V32, P908, DOI 10.1002/etc.2128; Braeckman B, 1999, TISSUE CELL, V31, P223, DOI 10.1054/tice.1999.0021; BRESLER V, 1995, J FORAMIN RES, V25, P267, DOI 10.2113/gsjfr.25.3.267; Ciacci C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036937; Clarkson TW, 2006, CRIT REV TOXICOL, V36, P609, DOI 10.1080/10408440600845619; DELNOMDEDIEU M, 1992, CHEM-BIOL INTERACT, V81, P243, DOI 10.1016/0009-2797(92)90081-U; Diaz G, 2007, EUR J HISTOCHEM, V51, P213; Diaz G, 2008, MICRON, V39, P819, DOI 10.1016/j.micron.2008.01.001; Dondero F, 2006, COMP BIOCHEM PHYS C, V143, P150, DOI 10.1016/j.cbpc.2006.01.005; Eisler R, 2006, MERCURY HAZARDS LIVI; Frontalini F, 2008, ESTUAR COAST SHELF S, V76, P404, DOI 10.1016/j.ecss.2007.07.024; Frontalini F, 2015, EUR J HISTOCHEM, V59, P1, DOI 10.4081/ejh.2015.2460; Frontalini Fabrizio, 2011, Revue de Micropaleontologie, V54, P115, DOI 10.1016/j.revmic.2011.03.001; Gentes S, 2015, ENVIRON SCI TECHNOL, V49, P14560, DOI 10.1021/acs.est.5b03586; Goldstein J., 2018, SCANNING ELECT MICRO, V4th ed.; Goldstein ST, 1999, MODERN FORAMINIFERA, P37; Gomiero A, 2013, SCI TOTAL ENVIRON, V442, P534, DOI 10.1016/j.scitotenv.2012.10.023; Grasselli E, 2013, CHEMOSPHERE, V91, P1123, DOI 10.1016/j.chemosphere.2013.01.016; GREENSPAN P, 1985, J LIPID RES, V26, P781; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Gu B, 2014, BIOGEOSCIENCES, V11, P5259, DOI 10.5194/bg-11-5259-2014; Gu BH, 2011, P NATL ACAD SCI USA, V108, P1479, DOI 10.1073/pnas.1008747108; GUTKNECHT J, 1981, J MEMBRANE BIOL, V61, P61, DOI 10.1007/BF01870753; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Le Cadre V, 2006, ENVIRON POLLUT, V143, P304, DOI 10.1016/j.envpol.2005.11.033; Lee J.J., 1991, BIOL FORAMINIFERA; Loumbourdis NS, 2004, ENVIRON POLLUT, V129, P299, DOI 10.1016/j.envpol.2003.10.010; Marigomez I, 1996, ARCH ENVIRON CON TOX, V31, P54, DOI 10.1007/BF00203907; Mascotti K, 2000, TRANSFUSION, V40, P693, DOI 10.1046/j.1537-2995.2000.40060693.x; Mason RP, 1996, ENVIRON SCI TECHNOL, V30, P1835, DOI 10.1021/es950373d; Mok WJ, 2014, FOOD CHEM, V147, P340, DOI 10.1016/j.foodchem.2013.09.157; Moore MN, 2006, AUTOPHAGY, V2, P217, DOI 10.4161/auto.2663; Moore MN, 2006, MAR ENVIRON RES, V61, P278, DOI 10.1016/j.marenvres.2005.10.005; Morvan J, 2004, AQUAT LIVING RESOUR, V17, P317, DOI 10.1051/alr:2004034; Munoz L, 2015, ECOTOX ENVIRON SAFE, V113, P241, DOI 10.1016/j.ecoenv.2014.11.036; Murphy G, 2008, AM J RESP CELL MOL, V38, P532, DOI 10.1165/rcmb.2007-0204OC; Nicholson S, 2003, CHEMOSPHERE, V52, P1147, DOI 10.1016/S0045-6535(03)00328-X; Nigam R, 2009, MAR POLLUT BULL, V59, P362, DOI 10.1016/j.marpolbul.2009.08.014; Paoli L, 2015, ENVIRON SCI POLLUT R, V22, P15891, DOI 10.1007/s11356-015-4807-x; PREVOT P, 1986, J PROTOZOOL, V33, P42, DOI 10.1111/j.1550-7408.1986.tb05553.x; Raspanti E, 2009, CHEMOSPHERE, V76, P48, DOI 10.1016/j.chemosphere.2009.02.030; Reed S.J.B, 2005, ELECT MICROPROBE ANA; Rowan-Carroll A, 2013, ENVIRON MOL MUTAGEN, V54, P240, DOI 10.1002/em.21768; SACKETT DL, 1987, ANAL BIOCHEM, V167, P228, DOI 10.1016/0003-2697(87)90157-6; Salucci S, 2010, MICRON, V41, P966, DOI 10.1016/j.micron.2010.07.002; Saraswat R, 2004, MAR POLLUT BULL, V48, P91, DOI 10.1016/S0025-326X(03)00330-8; Schaefer JK, 2011, P NATL ACAD SCI USA, V108, P8714, DOI 10.1073/pnas.1105781108; Schonfeld J, 2012, MAR MICROPALEONTOL, V94-95, P1, DOI 10.1016/j.marmicro.2012.06.001; Sen Gupta BL, 1999, MODERN FORAMINIFERA, P3; Stankovic S, 2013, ENV CHEM SUSTAINABLE, P151; Stankovic S, 2014, ENVIRON CHEM LETT, V12, P63, DOI 10.1007/s10311-013-0430-6; Sun LB, 2013, AQUAT TOXICOL, V126, P148, DOI 10.1016/j.aquatox.2012.11.002; Thiam AR, 2013, NAT REV MOL CELL BIO, V14, P775, DOI 10.1038/nrm3699; TRAGANOS F, 1994, METHOD CELL BIOL, V41, P185; Ung CY, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-212; Vasanthi LA, 2013, CHEMOSPHERE, V91, P1156, DOI 10.1016/j.chemosphere.2013.01.021; Yanko V, 1998, J FORAMIN RES, V28, P177; Yanko V, 1999, MODERN FORAMINIFERA, P217; Yorimitsu T, 2005, CELL DEATH DIFFER, V12, P1542, DOI 10.1038/sj.cdd.4401765	61	15	15	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162401	10.1371/journal.pone.0162401	http://dx.doi.org/10.1371/journal.pone.0162401			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603511	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200063
J	Laleg, K; Cassan, D; Barron, C; Prabhasankar, P; Micard, V				Laleg, Karima; Cassan, Denis; Barron, Cecile; Prabhasankar, Pichan; Micard, Valerie			Structural, Culinary, Nutritional and Anti-Nutritional Properties of High Protein, Gluten Free, 100% Legume Pasta	PLOS ONE			English	Article							ANTINUTRITIONAL FACTORS; STARCH DIGESTIBILITY; GLYCEMIC RESPONSE; PHYTIC ACID; CELIAC-DISEASE; FREE SPAGHETTI; DIETARY FIBER; QUALITY; WHEAT; CHICKPEA	Wheat pasta has a compact structure built by a gluten network entrapping starch granules resulting in a low glycemic index, but is nevertheless unsuitable for gluten-intolerant people. High protein gluten-free legume flours, rich in fibers, resistant starch and minerals are thus a good alternative for gluten-free pasta production. In this study, gluten-free pasta was produced exclusively from faba, lentil or black-gram flours. The relationship between their structure, their cooking and Rheological properties and their in-vitro starch digestion was analyzed and compared to cereal gluten-free commercial pasta. Trypsin inhibitory activity, phytic acid and a-galactosides were determined in flours and in cooked pasta. All legume pasta were rich in protein, resistant starch and fibers. They had a thick but weak protein network, which is built during the pasta cooking step. This particular structure altered pasta springiness and increased cooking losses. Black-gram pasta, which is especially rich in soluble fibers, differed from faba and lentil pasta, with high springiness (0.85 vs. 0.75) and less loss during cooking. In comparison to a commercial cereal gluten-free pasta, all the legume pasta lost less material during cooking but was less cohesive and springy. Interestingly, due to their particular composition and structure, lentil and faba pasta released their starch more slowly than the commercial gluten-free pasta during the in-vitro digestion process. Anti-nutritional factors in legumes, such as trypsin inhibitory activity and a-galactosides were reduced by up to 82% and 73%, respectively, by pasta processing and cooking. However, these processing steps had a minor effect on phytic acid. This study demonstrates the advantages of using legumes for the production of gluten-free pasta with a low glycemic index and high nutritional quality.	[Laleg, Karima; Cassan, Denis; Barron, Cecile; Micard, Valerie] Univ Montpellier, UMR IATE, CIRAD, INRA,Montpellier SupAgro, Montpellier, France; [Laleg, Karima] INRA, CRNH Auvergne, UNH, UMR 1019, Clermont Ferrand, France; [Prabhasankar, Pichan] Cent Food Technol Res Inst, CSIR, Mysore, Karnataka, India	CIRAD; INRAE; Institut Agro; Montpellier SupAgro; Universite de Montpellier; INRAE; Council of Scientific & Industrial Research (CSIR) - India; CSIR - Central Food Technological Research Institute (CFTRI)	Micard, V (corresponding author), Univ Montpellier, UMR IATE, CIRAD, INRA,Montpellier SupAgro, Montpellier, France.	valerie.micard@supagro.fr		MICARD, VALERIE/0000-0002-5193-9136	"Qualiment Institute Carnot" as part of the "VEGAGE" project; INRA, Clermont-Ferrand, France; INRA	"Qualiment Institute Carnot" as part of the "VEGAGE" project; INRA, Clermont-Ferrand, France; INRA	This work was carried out with the financial support of "Qualiment Institute Carnot" as part of the "VEGAGE" project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are very grateful to P. K. Shetty H (Pondicherry University, Pondicherry, India), GEMEF industries (Aix-en-Provence, France) and Celnat (Saint-Germain-Laprade, France) for kindly providing black-gram, faba bean and lentil flours, respectively. The authors thank S. Walrand (INRA, Clermont-Ferrand, France) coordinator of VEGAGE project, financial support of this work, for helpful discussion. The authors also thank C. Cherbut (INRA, Paris) and E. Rock (INRA, Clermont) for initiating the collaborative project "Improvement of plant proteins-based staple foods" funded by INRA between INRA and CSIR-CFTRI (India) which gave some preliminary results on black gram, initiating the present work. Authors are indebted to L. Saulnier (INRA, BIA, Nantes, France) and G. Conejero (INRA, Montpellier, France) for sugar analysis and PHIV access facilities, respectively. The authors would like to thank J. Bonicel, T-M. Lasserre and A. Putois (UMR IATE, Montpellier, France) for their technical assistance.	Asif M, 2013, CRIT REV FOOD SCI, V53, P1168, DOI 10.1080/10408398.2011.574804; Bjorck I, 2000, BRIT J NUTR, V83, pS149; Bock JE, 2015, CEREAL CHEM, V92, P460, DOI 10.1094/CCHEM-07-14-0152-R; Boye J, 2010, FOOD RES INT, V43, P414, DOI 10.1016/j.foodres.2009.09.003; Brijesh T, 2012, PULSE CHEM TECHNOLOG; Buleon A, 1998, INT J BIOL MACROMOL, V23, P85, DOI 10.1016/S0141-8130(98)00040-3; Campion B, 2009, THEOR APPL GENET, V118, P1211, DOI 10.1007/s00122-009-0975-8; DESHPANDE SS, 1984, J FOOD SCI, V49, P516, DOI 10.1111/j.1365-2621.1984.tb12456.x; Elli L, 2015, WORLD J GASTROENTERO, V21, P7110, DOI 10.3748/wjg.v21.i23.7110; ENGLYST HN, 1994, ANALYST, V119, P1497, DOI 10.1039/an9941901497; ENGLYST HN, 1988, J ASSOC OFF ANA CHEM, V71, P808; Englyst KN, 1999, AM J CLIN NUTR, V69, P448; *FAO, 1970, FAO NUTR STUD, V24; Flores-Silva PC, 2014, INT J FOOD SCI TECH, V49, P1985, DOI 10.1111/ijfs.12529; Frias J, 1997, Z LEBENSM UNTERS F A, V204, P66, DOI 10.1007/s002170050039; Gallegos-Infante JA, 2010, FOOD CHEM, V119, P1544, DOI 10.1016/j.foodchem.2009.09.040; Girigowda K, 2005, PLANT FOOD HUM NUTR, V60, P173, DOI 10.1007/s11130-005-9552-3; Giuberti G, 2015, FOOD CHEM, V175, P43, DOI 10.1016/j.foodchem.2014.11.127; Goni I, 2003, FOOD CHEM, V81, P511, DOI 10.1016/S0308-8146(02)00480-6; Greffeuille V, 2015, FOOD FUNCT, V6, P2996, DOI [10.1039/c5fo00382b, 10.1039/C5FO00382B]; Guillon F, 2002, BRIT J NUTR, V88, pS293, DOI 10.1079/BJN2002720; Gupta RK, 2015, J FOOD SCI TECH MYS, V52, P676, DOI 10.1007/s13197-013-0978-y; Honke J, 1998, Z LEBENSM UNTERS F A, V206, P279, DOI 10.1007/s002170050257; HOOVER R, 1985, STARKE, V37, P181, DOI 10.1002/star.19850370602; Hou A, 2009, INT J AGRON, V2009, DOI 10.1155/2009/484571; HOVE EL, 1979, NEW ZEAL J AGR RES, V22, P41, DOI 10.1080/00288233.1979.10420841; JENKINS DJA, 1987, AM J CLIN NUTR, V45, P946, DOI 10.1093/ajcn/45.5.946; JENKINS DJA, 1983, DIABETES CARE, V6, P155, DOI 10.2337/diacare.6.2.155; Laleg K, 2016, FOOD FUNCT, V7, P1196, DOI [10.1039/C5FO01231G, 10.1039/c5fo01231g]; LATTA M, 1980, J AGR FOOD CHEM, V28, P1313, DOI 10.1021/jf60232a049; Lee AR, 2007, J HUM NUTR DIET, V20, P423, DOI 10.1111/j.1365-277X.2007.00763.x; Ludvigsson JF, 2014, GUT, V63, P1210, DOI 10.1136/gutjnl-2013-306578; Ma Z, 2011, FOOD RES INT, V44, P2534, DOI 10.1016/j.foodres.2010.12.017; MacGregor E. A, 1980, POLYM IN NATURE; Mansueto P, 2014, J AM COLL NUTR, V33, P39, DOI 10.1080/07315724.2014.869996; Marengo M, 2015, LWT-FOOD SCI TECHNOL, V63, P511, DOI 10.1016/j.lwt.2015.03.070; Marti A, 2013, TRENDS FOOD SCI TECH, V31, P63, DOI 10.1016/j.tifs.2013.03.001; Martinez-Villaluenga C, 2008, CRIT REV FOOD SCI, V48, P301, DOI 10.1080/10408390701326243; Midorikawa K, 2001, BIOCHEM BIOPH RES CO, V288, P552, DOI 10.1006/bbrc.2001.5808; Molvig L, 1997, P NATL ACAD SCI USA, V94, P8393, DOI 10.1073/pnas.94.16.8393; Morel MH, 2000, CEREAL CHEM, V77, P685, DOI 10.1094/CCHEM.2000.77.5.685; Multari S, 2015, COMPR REV FOOD SCI F, V14, P511, DOI 10.1111/1541-4337.12146; Padalino L, 2015, INT J FOOD SCI NUTR, V66, P148, DOI 10.3109/09637486.2014.959897; Pastor-Cavada E, 2014, FOOD CHEM, V163, P97, DOI 10.1016/j.foodchem.2014.04.078; Petitot M, 2010, FOOD BIOPHYS, V5, P284, DOI 10.1007/s11483-010-9170-3; Petitot M, 2010, FOOD BIOPHYS, V5, P309, DOI 10.1007/s11483-010-9180-1; Petitot M, 2010, FOOD RES INT, V43, P634, DOI 10.1016/j.foodres.2009.07.020; Petitot M, 2009, TRENDS FOOD SCI TECH, V20, P521, DOI 10.1016/j.tifs.2009.06.005; Petitot M, 2009, FOOD CHEM, V116, P401, DOI 10.1016/j.foodchem.2009.01.001; Piecyk M, 2012, FOOD CHEM, V135, P1057, DOI 10.1016/j.foodchem.2012.05.051; Rosa-Sibakov N, 2016, LWT-FOOD SCI TECHNOL, V67, P27, DOI 10.1016/j.lwt.2015.11.032; Sanchez-Chino X, 2015, NUTR CANCER, V67, P401, DOI 10.1080/01635581.2015.1004729; Sandhu KS, 2008, CARBOHYD POLYM, V71, P245, DOI 10.1016/j.carbpol.2007.05.036; SAULNIER L, 1995, CARBOHYD POLYM, V26, P279, DOI 10.1016/0144-8617(95)00020-8; Simopoulos AP, 2003, OMEGA 6 OMEGA 3 ESSE; Sozer N, 2009, FOOD HYDROCOLLOID, V23, P849, DOI 10.1016/j.foodhyd.2008.03.016; Suneja Y, 2011, FOOD RES INT, V44, P621, DOI 10.1016/j.foodres.2010.12.020; SUSHEELAMMA NS, 1974, J SCI FOOD AGR, V25, P665, DOI 10.1002/jsfa.2740250608; Takeoka GR, 1997, J AGR FOOD CHEM, V45, P3395, DOI 10.1021/jf970264d; THIBAULT JF, 1979, LEBENSM WISS TECHNOL, V12, P247; THOMPSON LU, 1984, J FOOD SCI, V49, P1228, DOI 10.1111/j.1365-2621.1984.tb10443.x; Torres A, 2007, FOOD CHEM, V101, P202, DOI 10.1016/j.foodchem.2006.01.018; Torres A, 2006, J AGR FOOD CHEM, V54, P6685, DOI 10.1021/jf0606095; Troccoli A, 2000, J CEREAL SCI, V32, P99, DOI 10.1006/jcrs.2000.0322; Vasagam KPK, 2011, AQUACULT NUTR, V17, pE188, DOI 10.1111/j.1365-2095.2009.00748.x; Vidal-Valverde C, 1998, Z LEBENSM UNTERS F A, V207, P140, DOI 10.1007/s002170050308; Wang N, 2009, LWT-FOOD SCI TECHNOL, V42, P842, DOI 10.1016/j.lwt.2008.10.007; WHO, 2007, WHO TECH REP SER, V935, P1; Wu JHY, 2015, BRIT J NUTR, V114, P448, DOI 10.1017/S0007114515002056; Zhao YH, 2005, J FOOD SCI, V70, pS371, DOI 10.1111/j.1365-2621.2005.tb11458.x	70	64	64	2	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160721	10.1371/journal.pone.0160721	http://dx.doi.org/10.1371/journal.pone.0160721			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603917	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200007
J	Park, H; Konda, KA; Roberts, CP; Maguina, JL; Leon, SR; Clark, JL; Coates, TJ; Caceres, CF; Klausner, JD				Park, Hayoung; Konda, Kelika A.; Roberts, Chelsea P.; Maguina, Jorge L.; Leon, Segundo R.; Clark, Jesse L.; Coates, Thomas J.; Caceres, Carlos F.; Klausner, Jeffrey D.			Risk Factors Associated with Incident Syphilis in a Cohort of High-Risk Men in Peru	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; MALE SEX PARTNERS; HIV-INFECTION; GAY; TRANSMISSION; NOTIFICATION; PREVALENCE; PREVENTION; REDUCE; WOMEN	Background Syphilis is concentrated among high-risk groups, but the epidemiology of syphilis reinfection is poorly understood. We characterized factors associated with syphilis incidence, including reinfection, in a high-risk cohort in Peru. Methods Participants in the NIMH CPOL trial were assessed at baseline and 2 annual visits with HIV/STI testing and behavioral surveys. Participants diagnosed with syphilis also attended 4- and 9-month visits. All participants underwent syphilis testing with RPR screening and TPPA confirmation. Antibiotic treatment was provided according to CDC guidelines. Reinfection was defined as a 4-fold titer increase or recurrence of seroreactivity after successful treatment with subsequent negative RPR titers. The longitudinal analysis used a Possion generalized estimating equations model with backward selection of variables in the final model (criteria P <0.02). Results Of 2,709 participants, 191 (7.05%) were RPR-reactive (median 1:8, range 1:1-1:1024) with TPPA confirmation. There were 119 total cases of incident syphilis, which included both reinfection and first-time incident cases. In the bivariate analysis, the oldest 2 quartiles of age (incidence ratio (IR) 3.84; P <0.001 and IR 8.15; P <0.001) and being MSM/TW (IR 6.48; P <0.001) were associated with higher risk of incident syphilis infection. Of the sexual risk behaviors, older age of sexual debut (IR 12.53; P <0.001), not being in a stable partnership (IR 1.56, P = 0.035), higher number of sex partners (IR 3.01; P <0.001), unprotected sex in the past 3 months (IR 0.56; P = 0.003), HIV infection at baseline (IR 3.98; P <0.001) and incident HIV infection during the study period (IR 6.26; P = 0.003) were all associated with incident syphilis. In the multivariable analysis, older age group (adjusted incidence ratio (aIR) 6.18; P <0.001), men reporting having sex with a man (aIR 4.63; P <0.001), and incident HIV infection (aIR 4.48; P = 0.008) were significantly associated. Conclusions We report a high rate of syphilis reinfection among high-risk men who have evidence of previous syphilis infection. Our findings highlight the close relationship between HIV incidence with both incident syphilis and syphilis reinfection. Further studies on syphilis reinfection are needed to understand patterns of syphilis reinfection and new strategies beyond periodic testing of high-risk individuals based on HIV status are needed.	[Park, Hayoung; Konda, Kelika A.; Roberts, Chelsea P.; Clark, Jesse L.; Coates, Thomas J.; Klausner, Jeffrey D.] Univ Calif Los Angeles, David Geffen Sch Med, Program Global Hlth, Los Angeles, CA 90095 USA; [Konda, Kelika A.; Leon, Segundo R.; Caceres, Carlos F.] Univ Peruana Cayetano Heredia, Unidad Salud Sexualidad & Desarrollo Humano, Lima, Peru; [Maguina, Jorge L.] Univ Peruana Ciencias Aplicadas, Escuela Med, Lima, Peru	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Universidad Peruana Cayetano Heredia; Universidad Peruana de Ciencias Aplicadas (UPC)	Klausner, JD (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Program Global Hlth, Los Angeles, CA 90095 USA.	JDKlausner@mednet.ucla.edu	Maguiña, Jorge L./AGQ-6299-2022; Leon, Segundo Ramos/J-3058-2019; Oliveira, Claudia DL/G-8618-2011	Maguiña, Jorge L./0000-0002-4136-7795; Leon, Segundo Ramos/0000-0002-5630-5714; Caceres, Carlos F./0000-0002-8101-0790; Park, Hayoung/0000-0001-8703-5764; Clark, Jesse/0000-0001-5862-6530	National Institute of Health [U10MH61536, R25MH087222]; South America Program in HIV Research (SAPHIR) [NIH R25 MH087222];  [U10 MH61536]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI099727] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R25MH087222, U10MH061536] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South America Program in HIV Research (SAPHIR); ; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	Grant number U10MH61536 from the National Institute of Health supported KAK, JLM, SRL, JLC, TJC, and CFC. Grant number R25MH087222 for the South America Program in HIV Research by the National Institute of Health supported HP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the study participants and study staff of the National Institute of Mental Health (NIMH) Collaborative HIV/STI Prevention Trial in Peru, funded by Grant number U10 MH61536. HP was supported by the South America Program in HIV Research (SAPHIR), NIH R25 MH087222.	Caceres CF, 2007, AIDS, V21, pS59; Callegari FM, 2014, AIDS BEHAV, V18, pS104, DOI 10.1007/s10461-013-0533-x; Carcamo CP, 2012, LANCET INFECT DIS, V12, P765, DOI 10.1016/S1473-3099(12)70144-5; Clark JL, 2007, SEX TRANSM DIS, V34, P309, DOI 10.1097/01.olq.0000240289.84094.93; Clark JL, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-65; Cohen MS, 1998, LANCET, V351, P5, DOI 10.1016/S0140-6736(98)90002-2; Down I, 2012, SEX HEALTH, V9, P472, DOI 10.1071/SH12023; Ehlman DC, 2010, SEX TRANSM DIS, V37, P478, DOI 10.1097/OLQ.0b013e3181e212cb; Fleming DT, 1999, SEX TRANSM INFECT, V75, P3, DOI 10.1136/sti.75.1.3; Gray RT, 2011, SEX TRANSM DIS, V38, P1151, DOI 10.1097/OLQ.0b013e318238b85d; GREENBLATT RM, 1988, AIDS, V2, P47, DOI 10.1097/00002030-198802000-00008; Klausner JD, 1998, J INFECT DIS, V177, P1766, DOI 10.1086/517442; Klausner JD, 2004, AIDS CARE, V16, P964, DOI 10.1080/09540120412331292471; Konda KA, 2013, SEX TRANSM DIS, V40, P569, DOI 10.1097/OLQ.0b013e3182956eeb; Lama JR, 2006, J INFECT DIS, V194, P1459, DOI 10.1086/508548; Long CM, 2006, SEX TRANSM DIS, V33, P151, DOI 10.1097/01.olq.0000204506.06551.5f; Lynn WA, 2004, LANCET INFECT DIS, V4, P456, DOI 10.1016/S1473-3099(04)01061-8; Magro CM, 1996, HUM PATHOL, V27, P1066, DOI 10.1016/S0046-8177(96)90285-3; NIMH Collaborative HIV/STD Prevention Trial Group, 2007, AIDS, V21 Suppl 2, pS29; Ogilvie GS, 2009, CLIN INFECT DIS, V48, P1554, DOI 10.1086/598997; Pathela P, 2015, CLIN INFECT DIS, V61, P281, DOI 10.1093/cid/civ289; Peeling RW, 2004, LANCET, V364, P1561, DOI 10.1016/S0140-6736(04)17327-3; Phipps W, 2009, SEX TRANSM DIS, V36, P331, DOI 10.1097/OLQ.0b013e3181990c85; Snowden JM, 2010, SEX TRANSM DIS, V37, P75, DOI 10.1097/OLQ.0b013e3181c03434; Solomon MM, 2014, CLIN INFECT DIS, V59, P1020, DOI 10.1093/cid/ciu450; STAMM WE, 1988, JAMA-J AM MED ASSOC, V260, P1429, DOI 10.1001/jama.260.10.1429; Taylor MM, 2010, SEX TRANSM DIS, V37, P767, DOI 10.1097/OLQ.0b013e3181e65e8b	27	8	9	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162156	10.1371/journal.pone.0162156	http://dx.doi.org/10.1371/journal.pone.0162156			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602569	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200048
J	Wang, FH; Lu, JM; Wen, J; Ebihara, A; Li, DZ				Wang, Fan-Hong; Lu, Jin-Mei; Wen, Jun; Ebihara, Atsushi; Li, De-Zhu			Applying DNA Barcodes to Identify Closely Related Species of Ferns: A Case Study of the Chinese Adiantum (Pteridaceae)	PLOS ONE			English	Article							RETICULATE EVOLUTION; MEISHANIANUM PTERIDACEAE; MOLECULAR EVIDENCE; CHLOROPLAST DNA; HYBRID ORIGIN; LAND PLANTS; NUCLEAR-DNA; PRIMER SETS; TRNL-F; IDENTIFICATION	DNA barcoding is a fast-developing technique to identify species by using short and standard DNA sequences. Universal selection of DNA barcodes in ferns remains unresolved. In this study, five plastid regions (rbcL, matK, trnH-psbA, trnL-F and rps4-trnS) and eight nuclear regions (ITS, pgiC, gapC, LEAFY, ITS2, IBR3_2, DET1, and SQD1_1) were screened and evaluated in the fern genus Adiantum from China and neighboring areas. Due to low primer universality (matK) and/or the existence of multiple copies (ITS), the commonly used barcodes matK and ITS were not appropriate for Adiantum. The PCR amplification rate was extremely low in all nuclear genes except for IBR3_2. rbcL had the highest PCR amplification rate (94.33%) and sequencing success rate (90.78%), while trnH-psbA had the highest species identification rate (75%). With the consideration of discriminatory power, cost-efficiency and effort, the two-barcode combination of rbcL + trnH-psbA seems to be the best choice for barcoding Adiantum, and perhaps basal polypod ferns in general. The nuclear IBR3_2 showed 100% PCR amplification success rate in Adiantum, however, it seemed that only diploid species could acquire clean sequences without cloning. With cloning, IBR3_2 can successfully distinguish cryptic species and hybrid species from their related species. Because hybridization and allopolyploidy are common in ferns, we argue for including a selected group of nuclear loci as barcodes, especially via the next-generation sequencing, as it is much more efficient to obtain single-copy nuclear loci without the cloning procedure.	[Wang, Fan-Hong; Lu, Jin-Mei; Li, De-Zhu] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China; [Wang, Fan-Hong] Univ Chinese Acad Sci, Coll Life Sci, Beijing, Peoples R China; [Wen, Jun] Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA; [Ebihara, Atsushi] Natl Museum Nat & Sci, Dept Bot, Tsukuba, Ibaraki, Japan	Chinese Academy of Sciences; Kunming Institute of Botany, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Smithsonian Institution; Smithsonian National Museum of Natural History; National Museum of Nature and Science	Li, DZ (corresponding author), Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China.; Wen, J (corresponding author), Smithsonian Inst, Dept Bot, Natl Museum Nat Hist, Washington, DC 20560 USA.	wenj@si.edu; dzl@mail.kib.ac.cn	Li, De-Zhu/G-8203-2011	Li, De-Zhu/0000-0002-4990-724X	National Key Basic Research Program of China [2014CB954100]; Project of Knowledge Innovation Program of the Chinese Academy of Sciences [KSCX2-EW-J-24]; Applied Fundmental Research Foundation of Yunnan Province [2014GA003, 2014FB168]; Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences [2009-LSF-GBOWS-01]; National Natural Science Foundation of China [31070199]	National Key Basic Research Program of China(National Basic Research Program of China); Project of Knowledge Innovation Program of the Chinese Academy of Sciences(Chinese Academy of Sciences); Applied Fundmental Research Foundation of Yunnan Province; Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	The study was supported by The National Key Basic Research Program of China (Grant No. 2014CB954100), the Project of Knowledge Innovation Program of the Chinese Academy of Sciences (Grant No. KSCX2-EW-J-24), and the Applied Fundmental Research Foundation of Yunnan Province (Grants No. 2014GA003, 2014FB168), and the Research Fund for the Large-scale Scientific Facilities of the Chinese Academy of Sciences (Grant No. 2009-LSF-GBOWS-01), the National Natural Science Foundation of China (Grant No. 31070199).	Adjie B, 2007, J PLANT RES, V120, P129, DOI 10.1007/s10265-006-0032-5; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; BARRINGTON DS, 1989, AM FERN J, V79, P55, DOI 10.2307/1547160; Burgess KS, 2011, METHODS ECOL EVOL, V2, P333, DOI 10.1111/j.2041-210X.2011.00092.x; Bybee SM, 2011, GENOME BIOL EVOL, V3, P1312, DOI 10.1093/gbe/evr106; Chang HM, 2009, AM FERN J, V99, P61, DOI 10.1640/0002-8444-99.2.61; Chao YS, 2012, INT J MOL SCI, V13, P4523, DOI 10.3390/ijms13044523; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Chen CW, 2013, ANN BOT-LONDON, V111, P663, DOI 10.1093/aob/mct004; Chen CW, 2012, AM J BOT, V99, pE223, DOI 10.3732/ajb.1100498; Ching RC, 1983, B BOT RES, V3, P2; Ching RC, 1957, ACTA PHYTOTAX SINICA, V6, P301; Ching RC, 1940, SUNYATSENIA, V5, P201; Coissac E, 2016, MOL ECOL, V25, P1423, DOI 10.1111/mec.13549; de Groot GA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016371; DeSalle R, 2006, CONSERV BIOL, V20, P1545, DOI 10.1111/j.1523-1739.2006.00543.x; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dyer RJ, 2012, ANN BOT-LONDON, V110, P1515, DOI 10.1093/aob/mcs202; Ebihara A, 2005, AM J BOT, V92, P1535, DOI 10.3732/ajb.92.9.1535; Ebihara A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015136; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Hajibabaei M, 2007, TRENDS GENET, V23, P167, DOI 10.1016/j.tig.2007.02.001; Hebert PDN, 2005, SYST BIOL, V54, P852, DOI 10.1080/10635150500354886; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hollingsworth PM, 2016, PHILOS T R SOC B, V371, DOI 10.1098/rstb.2015.0338; Hollingsworth PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019254; Ishikawa H, 2002, J PLANT RES, V115, P65, DOI 10.1007/s102650200010; Jaruwattanaphan T, 2013, SYST BOT, V38, P15, DOI 10.1600/036364413X661980; Juslen A, 2011, TAXON, V60, P1284, DOI 10.1002/tax.605005; Kiebala M, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0011875, 10.1371/journal.pone.0013102]; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2015, TRENDS ECOL EVOL, V30, P25, DOI 10.1016/j.tree.2014.10.008; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Kuo LY, 2011, MOL PHYLOGENET EVOL, V59, P556, DOI 10.1016/j.ympev.2011.03.010; Lave A, 1977, J CRAMER; Li DZ, 2011, P NATL ACAD SCI USA, V108, P19641, DOI 10.1073/pnas.1104551108; Li FW, 2010, MOL ECOL RESOUR, V10, P92, DOI 10.1111/j.1755-0998.2009.02745.x; Li FW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026597; Lin Y.X., 1990, FLORA REIPUBLICAE PO, V3, P173; Lin YX, 1980, ACTA PHYTOTAX SINICA, V18, P101; Lin YX, 2013, FLORA CHINA, V2-3, P238; Liu YC, 2009, NOVON, V19, P59, DOI 10.3417/2007055; Lovis JD, 1977, ADV BOT RES, V4, P229, DOI DOI 10.1016/S0065-2296(08)60371-7; Lu JM, 2012, J PLANT RES, V125, P237, DOI 10.1007/s10265-011-0441-y; Ma XY, 2010, BIOL PHARM BULL, V33, P1919, DOI 10.1248/bpb.33.1919; Manton I., 1950, PROBLEMS CYTOLOGY EV; Mao Xing-Xing, 2014, Plant Diversity and Resources, V36, P453, DOI 10.7677/ynzwyj201414012; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; Meyer CP, 2005, PLOS BIOL, V3, P2229, DOI 10.1371/journal.pbio.0030422; NEUHAUS H, 1987, CURR GENET, V11, P251, DOI 10.1007/BF00355398; Nitta JH, 2011, AM J BOT, V98, P1782, DOI 10.3732/ajb.1000484; OLMSTEAD RG, 1994, AM J BOT, V81, P1205, DOI 10.2307/2445483; Packer L, 2009, MOL ECOL RESOUR, V9, P42, DOI 10.1111/j.1755-0998.2009.02631.x; Pham Van The, 2013, Taiwania, V58, P151, DOI 10.6165/tai.2013.58.151; Pryer KM, 2010, MOL ECOL RESOUR, V10, P979, DOI 10.1111/j.1755-0998.2010.02858.x; Qian Y. Y., 1992, Acta Botanica Austro Sinica, P37; Reid JD, 2006, INT J PLANT SCI, V167, P529, DOI 10.1086/501071; Rothfels CJ, 2014, SYST BIOL, V63, P31, DOI 10.1093/sysbio/syt058; Rothfels CJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076957; Schneider H, 2006, MOL ECOL NOTES, V6, P989, DOI 10.1111/j.1471-8286.2006.01424.x; Schneider H, 2013, J SYST EVOL, V51, P142, DOI 10.1111/j.1759-6831.2012.00226.x; Schuettpelz E, 2008, SYST BOT, V33, P621, DOI 10.1600/036364408786500127; Schuettpelz E, 2007, TAXON, V56, P1037, DOI 10.2307/25065903; Schuettpelz E, 2007, MOL PHYLOGENET EVOL, V44, P1172, DOI 10.1016/j.ympev.2007.04.011; Schuettpelz E, 2006, TAXON, V55, P897, DOI 10.2307/25065684; Sessa EB, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-104; Shepherd LD, 2008, MOL PHYLOGENET EVOL, V49, P240, DOI 10.1016/j.ympev.2008.06.015; Smith AR, 2006, TAXON, V55, P705, DOI 10.2307/25065646; Smith MA, 2005, PHILOS T R SOC B, V360, P1825, DOI 10.1098/rstb.2005.1714; Spooner DM, 2016, J SYST EVOL, V54, P191, DOI 10.1111/jse.12203; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tryon R.M., 1990, FAMILIES GENERA VASC, V1, P230, DOI DOI 10.1007/978-3-662-02604-5_42; Wang L, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-158; Wang Y, 2015, PHYTOTAXA, V236, P266, DOI 10.11646/phytotaxa.236.3.7; [王莹 Wang Ying], 2015, [科学通报, Chinese Science Bulletin], V60, P922; Wen J, 2015, J SYST EVOL, V53, P477, DOI 10.1111/jse.12181; Will KW, 2005, SYST BIOL, V54, P844, DOI 10.1080/10635150500354878; Xiang JY, 2015, J SYST EVOL, V53, P2, DOI 10.1111/jse.12141; Yang JB, 2013, BMC EVOL BIOL, V13, DOI [10.1186/1471-2148-13-84, 10.1186/1471-244X-13-150]; Zhang GF, 2006, FLORA YUNNANICA, V20, P308; Zhang RS, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-74; Zhang WY, 2014, SYST BOT, V39, P1034, DOI 10.1600/036364414X682616	85	91	96	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160611	10.1371/journal.pone.0160611	http://dx.doi.org/10.1371/journal.pone.0160611			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603700	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200005
J	Du, SH; Li, ZD; Chen, C; Tan, WK; Chi, ZX; Kwang, TW; Xu, XH; Wang, S				Du, Shou-Hui; Li, Zhendong; Chen, Can; Tan, Wee-Kiat; Chi, Zhixia; Kwang, Timothy Weixin; Xu, Xue-Hu; Wang, Shu			Co-Expansion of Cytokine-Induced Killer Cells and V.9V delta 2 T Cells for CAR T-Cell Therapy	PLOS ONE			English	Article							ANTIGEN-PRESENTING CELLS; GAMMA; IMMUNOTHERAPY; RECEPTOR; LYMPHOCYTES; SPECIFICITY; ACTIVATION; EXPRESSION	Gamma delta (gamma delta) T cells and cytokine-induced killer (CIK) cells, which are a heterogeneous population of T lymphocytes and natural killer T (NKT) cells, have been separately expanded ex vivo and shown to be capable of targeting and mediating cytotoxicity against various tumor cells in a major histocompatibility complex-unrestricted manner. However, the co-expansion and co-administration of these immune cells have not been explored. In this study we describe an efficient method to expand simultaneously both CIK and V gamma 9V delta 2 T cells, termed as CIKZ cells, from human peripheral blood mononuclear cells (PBMCs) using Zometa, interferon-gamma (IFN-gamma), interleukin 2 (IL-2), anti-CD3 antibody and engineered K562 feeder cells expressing CD64, CD137L and CD86. A 21-day culture of PBMCs with this method yielded nearly 20,000-fold expansion of CIKZ cells with gamma delta T cells making up over 20% of the expanded population. The expanded CIKZ cells exhibited antitumor cytotoxicity and could be modified to express anti-CD19 chimeric antigen receptor (CAR), anti-CEA CAR, and anti-HER2 CAR to enhance their specificity and cytotoxicity against CD19-, CEA-, or HER2-positive tumor cells. The tumor inhibitory activity of anti-CD19 CAR-modified CIKZ cells was further demonstrated in vivo in a Raji tumor mouse model. The findings herein substantiate the feasibility of co-expanding CIK and gamma delta cells for adoptive cellular immunotherapy applications such as CAR T-cell therapy against cancer.	[Du, Shou-Hui; Li, Zhendong; Tan, Wee-Kiat; Chi, Zhixia; Wang, Shu] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Tan, Wee-Kiat; Wang, Shu] Inst Bioengn & Nanotechnol, Singapore 138669, Singapore; [Chen, Can; Kwang, Timothy Weixin] Tessa Therapeut Pte Ltd, Singapore 239351, Singapore; [Xu, Xue-Hu] Guangzhou Med Univ, Dept Gastrointestinal Surg, Affiliated Hosp 3, Guangzhou 510150, Guangdong, Peoples R China	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Institute of Bioengineering & Nanotechnology (IBN); Guangzhou Medical University	Wang, S (corresponding author), Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore.; Wang, S (corresponding author), Inst Bioengn & Nanotechnol, Singapore 138669, Singapore.	dbsws@nus.edu.sg	wang, shu/H-6744-2012	Kwang, Timothy/0000-0003-4029-3533	National Medical Research Council [NMRC/CIRG/1367/2013, NMRC/CIRG/1406/2014]; Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore); Tessa Therapeutics, Pte Ltd. Singapore; Singapore Ministry of Health's National Medical Research Council [NMRC/CIRG/1367/2013, NMRC/CIRG/1406/2014]	National Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore)(Agency for Science Technology & Research (A*STAR)); Tessa Therapeutics, Pte Ltd. Singapore; Singapore Ministry of Health's National Medical Research Council(National Medical Research Council, Singapore)	Funding that supported this study was provided to SW from the National Medical Research Council - NMRC/CIRG/1367/2013, NMRC/CIRG/1406/2014 (http://www.nmrc.gov.sg/index.html), Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore; http://www.ibn.a-star.edu.sg/), and Tessa Therapeutics, Pte Ltd. Singapore (http://www.tessatherapeutics.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Singapore Ministry of Health's National Medical Research Council (NMRC/CIRG/1367/2013; NMRC/CIRG/1406/2014), Institute of Bioengineering and Nanotechnology (Biomedical Research Council, Agency for Science, Technology and Research, Singapore), and Tessa Therapeutics, Pte Ltd. Singapore.	Agrati C, 2006, INT IMMUNOL, V18, P11, DOI 10.1093/intimm/dxh337; Alexander AAZ, 2008, CLIN CANCER RES, V14, P4232, DOI 10.1158/1078-0432.CCR-07-4912; Bonanno G, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-129; Butler MO, 2014, IMMUNOL REV, V257, P191, DOI 10.1111/imr.12129; CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285; Deniger DC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00636; Deniger DC, 2014, CLIN CANCER RES, V20, P5708, DOI 10.1158/1078-0432.CCR-13-3451; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Dotti G, 2014, IMMUNOL REV, V257, P107, DOI 10.1111/imr.12131; Fournie JJ, 2013, CELL MOL IMMUNOL, V10, P35, DOI 10.1038/cmi.2012.39; GAJEWSKI TF, 1988, J IMMUNOL, V140, P4245; Gogoi D, 2013, INDIAN J MED RES, V138, P755; Hombach AA, 2013, MOL THER, V21, P2268, DOI 10.1038/mt.2013.192; Kelly-Rogers J, 2006, HUM IMMUNOL, V67, P863, DOI 10.1016/j.humimm.2006.08.292; Kobayashi H, 2011, CANCER IMMUNOL IMMUN, V60, P1075, DOI 10.1007/s00262-011-1021-7; Kondo M, 2011, JOVE-J VIS EXP, DOI 10.3791/3182; Krug C, 2014, CANCER IMMUNOL IMMUN, V63, P999, DOI 10.1007/s00262-014-1572-5; Legut M, 2015, CELL MOL IMMUNOL, V12, P656, DOI 10.1038/cmi.2015.28; Li YX, 2010, J TRANSL MED, V8, DOI 10.1186/1479-5876-8-104; Linn YC, 2002, BRIT J HAEMATOL, V116, P78, DOI 10.1046/j.1365-2141.2002.03247.x; Lopez RD, 2001, CANCER IMMUNOL IMMUN, V49, P629, DOI 10.1007/s002620000148; Marin V, 2010, HAEMATOL-HEMATOL J, V95, P2144, DOI 10.3324/haematol.2010.026310; Mesiano G, 2012, EXPERT OPIN BIOL TH, V12, P673, DOI 10.1517/14712598.2012.675323; Nakajima J, 2010, EUR J CARDIO-THORAC, V37, P1191, DOI 10.1016/j.ejcts.2009.11.051; Olioso P, 2009, HEMATOL ONCOL, V27, P130, DOI 10.1002/hon.886; Rischer M, 2004, BRIT J HAEMATOL, V126, P583, DOI 10.1111/j.1365-2141.2004.05077.x; Rosenberg SA, 2015, SCIENCE, V348, P62, DOI 10.1126/science.aaa4967; Shirasu N, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/292436; Singh H, 2008, CANCER RES, V68, P2961, DOI 10.1158/0008-5472.CAN-07-5600; Sluijter BJR, 2010, CLIN IMMUNOL, V137, P221, DOI 10.1016/j.clim.2010.07.009; Suhoski MM, 2007, MOL THER, V15, P981, DOI 10.1038/mt.sj.6300134; Vantourout P, 2013, NAT REV IMMUNOL, V13, P88, DOI 10.1038/nri3384; Wada I, 2014, CANCER MED-US, V3, P362, DOI 10.1002/cam4.196; Wang QJ, 2011, J IMMUNOL METHODS, V366, P43, DOI 10.1016/j.jim.2011.01.002; Wongkajornsilp A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078980; Zhang H, 2007, J IMMUNOL, V179, P4910, DOI 10.4049/jimmunol.179.7.4910; Zhang JY, 2012, J CANCER RES CLIN, V138, P1057, DOI 10.1007/s00432-012-1179-1	37	34	38	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161820	10.1371/journal.pone.0161820	http://dx.doi.org/10.1371/journal.pone.0161820			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598655	Green Submitted, gold, Green Published			2022-12-26	WOS:000383254800021
J	Edinger, N; Lebendiker, M; Klein, S; Zigler, M; Langut, Y; Levitzki, A				Edinger, Nufar; Lebendiker, Mario; Klein, Shoshana; Zigler, Maya; Langut, Yael; Levitzki, Alexander			Targeting polyIC to EGFR over-expressing cells using a dsRNA binding protein domain tethered to EGF	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; DOUBLE-STRANDED-RNA; TOLL-LIKE RECEPTOR-3; NF-KAPPA-B; CANCER-CELLS; I INTERFERONS; TUMOR-CELLS; KINASE PKR; APOPTOSIS; TLR3	Selective delivery of drugs to tumor cells can increase potency and reduce toxicity. In this study, we describe a novel recombinant chimeric protein, dsRBEC, which can bind polyIC and deliver it selectively into EGFR over-expressing tumor cells. dsRBEC, comprises the dsRNA binding domain (dsRBD) of human PKR (hPKR), which serves as the polyIC binding moiety, fused to human EGF (hEGF), the targeting moiety. dsRBEC shows high affinity towards EGFR and triggers ligand-induced endocytosis of the receptor, thus leading to the selective internalization of polyIC into EGFR over-expressing tumor cells. The targeted delivery of polyIC by dsRBEC induced cellular apoptosis and the secretion of IFN-beta and other pro-inflammatory cytokines. dsRBEC-delivered polyIC is much more potent than naked polyIC and is expected to reduce the toxicity caused by systemic delivery of polyIC.	[Edinger, Nufar; Klein, Shoshana; Zigler, Maya; Langut, Yael; Levitzki, Alexander] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, Jerusalem, Israel; [Lebendiker, Mario] Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Prot Purificat Unit, Wolfson Ctr Appl Struct Biol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem	Levitzki, A (corresponding author), Hebrew Univ Jerusalem, Alexander Silberman Inst Life Sci, Dept Biol Chem, Unit Cellular Signaling, Jerusalem, Israel.	alex.levitzki@mail.huji.ac.il			European Research Council (ERC) [249898]	European Research Council (ERC)(European Research Council (ERC)European Commission)	This work was supported by European Research Council (ERC) Advanced Grant No. 249898 (A.L.) [https://erc.europa.eu/funding-andgrants].	Abourbeh G, 2012, IUBMB LIFE, V64, P324, DOI 10.1002/iub.1002; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; ARMSTRONG DK, 1994, CANCER RES, V54, P5280; Bekisz J, 2010, PHARMACEUTICALS, V3, P994, DOI 10.3390/ph3040994; Besch R, 2009, J CLIN INVEST, V119, P2399, DOI 10.1172/JCI37155; BURGESS RR, 1991, METHOD ENZYMOL, V208, P3; Busse D, 2000, J BIOL CHEM, V275, P6987, DOI 10.1074/jbc.275.10.6987; Caron NJ, 2004, BIOCHEM BIOPH RES CO, V319, P12, DOI 10.1016/j.bbrc.2004.04.180; CONNOR J, 1985, J CELL BIOL, V101, P582, DOI 10.1083/jcb.101.2.582; ENGELKE DR, 1990, ANAL BIOCHEM, V191, P396, DOI 10.1016/0003-2697(90)90238-5; Galli R, 2010, J IMMUNOL, V184, P6658, DOI 10.4049/jimmunol.0902401; Gambara G, 2015, J CELL MOL MED, V19, P327, DOI 10.1111/jcmm.12379; Garcia-Cattaneo A, 2012, P NATL ACAD SCI USA, V109, P9053, DOI 10.1073/pnas.1115091109; Gatti G, 2013, EUR J IMMUNOL, V43, P1849, DOI 10.1002/eji.201242902; Hertzog PJ, 2012, IMMUNOL CELL BIOL, V90, P471, DOI 10.1038/icb.2012.15; HOMAN ER, 1972, TOXICOL APPL PHARM, V23, P579, DOI 10.1016/0041-008X(72)90098-1; Hutchinson MH, 2006, J CHROMATOGR A, V1128, P125, DOI 10.1016/j.chroma.2006.06.050; Jiang Q, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-12; Jiang XJ, 2003, MOL BIOL CELL, V14, P858, DOI 10.1091/mbc.E02-08-0532; Joubran S, 2014, BIOCONJUGATE CHEM, V25, P1644, DOI 10.1021/bc500252a; Kalali BN, 2008, J IMMUNOL, V181, P2694, DOI 10.4049/jimmunol.181.4.2694; Kang J, 2007, ANAL BIOCHEM, V365, P147, DOI 10.1016/j.ab.2007.03.003; KROWN SE, 1985, J BIOL RESP MODIF, V4, P640; Leonard JN, 2008, P NATL ACAD SCI USA, V105, P258, DOI 10.1073/pnas.0710779105; Li M, 2004, PROTEIN EXPRES PURIF, V33, P1, DOI 10.1016/j.pep.2003.08.023; Marenchino M, 2009, PROTEIN EXPRES PURIF, V63, P112, DOI 10.1016/j.pep.2008.09.010; Matsumoto M, 2008, ADV DRUG DELIVER REV, V60, P805, DOI 10.1016/j.addr.2007.11.005; Mellert K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052473; Moiseeva EP, 2007, CARCINOGENESIS, V28, P435, DOI 10.1093/carcin/bgl171; Nanduri S, 1998, EMBO J, V17, P5458, DOI 10.1093/emboj/17.18.5458; Nicholson RI, 2001, EUR J CANCER, V37, pS9, DOI 10.1016/s0959-8049(01)00231-3; Orita T, 2013, CURR EYE RES, V38, P53, DOI 10.3109/02713683.2012.721044; Palchetti S, 2015, J BIOL CHEM, V290, P5470, DOI 10.1074/jbc.M114.601625; PELLETIER B, 1988, J BIOCHEM BIOPH METH, V16, P63, DOI 10.1016/0165-022X(88)90104-2; Pohar J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092391; Salaun B, 2007, CLIN CANCER RES, V13, P4565, DOI 10.1158/1078-0432.CCR-07-0274; Salaun B, 2006, J IMMUNOL, V176, P4894, DOI 10.4049/jimmunol.176.8.4894; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schaffert D, 2011, PHARM RES-DORDR, V28, P731, DOI 10.1007/s11095-010-0225-4; Shir A, 2011, CLIN CANCER RES, V17, P1033, DOI 10.1158/1078-0432.CCR-10-1140; Singh A, 2015, MICROB CELL FACT, V14, DOI 10.1186/s12934-015-0222-8; Sun RL, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.178798; Takahashi Hirokazu, 2014, PLoS One, V9, pe82624, DOI 10.1371/journal.pone.0082624; Thomas T, 1999, J CELL PHYSIOL, V179, P257, DOI 10.1002/(SICI)1097-4652(199906)179:3<257::AID-JCP3>3.0.CO;2-4; Tsai SY, 2015, J IMMUNOL, V195, P4426, DOI 10.4049/jimmunol.1500378; Tsumoto K, 2003, PROTEIN EXPRES PURIF, V28, P1, DOI 10.1016/S1046-5928(02)00641-1; VANDEVIJVER MJ, 1991, J BIOL CHEM, V266, P7503; Vercammen E, 2008, CLIN MICROBIOL REV, V21, P13, DOI 10.1128/CMR.00022-07; Vitale G, 2007, ANN SURG, V246, P259, DOI 10.1097/01.sla.0000261460.07110.f2; Welsh RM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002352; Yamaguchi S, 2013, BIOTECHNOL J, V8, P17, DOI 10.1002/biot.201200025; Yamashita M, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002581; ZABRISKIE DW, 1988, BIOTECHNOL BIOENG, V32, P100, DOI 10.1002/bit.260320114; Zheng XF, 2004, RNA, V10, P1934, DOI 10.1261/rna.7150804; Zigler M, 2016, CANC IMMUNOL R UNPUB	55	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162321	10.1371/journal.pone.0162321	http://dx.doi.org/10.1371/journal.pone.0162321			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598772	gold, Green Published, Green Submitted			2022-12-26	WOS:000383254800052
J	Quigley, AS; Veres, SP; Kreplak, L				Quigley, Andrew S.; Veres, Samuel P.; Kreplak, Laurent			Bowstring Stretching and Quantitative Imaging of Single Collagen Fibrils via Atomic Force Microscopy	PLOS ONE			English	Article							DESMIN INTERMEDIATE-FILAMENTS; MECHANICAL-PROPERTIES; DISCRETE PLASTICITY; TENSILE PROPERTIES; I FIBRILS; FIBERS; TENDON; MUTATIONS; MOLECULES; PACKING	Collagen is the primary structural protein in animals. Serving as nanoscale biological ropes, collagen fibrils are responsible for providing strength to a variety of connective tissues such as tendon, skin, and bone. Understanding structure-function relationships in collagenous tissues requires the ability to conduct a variety of mechanical experiments on single collagen fibrils. Though significant advances have been made, certain tests are not possible using the techniques currently available. In this report we present a new atomic force microscopy (AFM) based method for tensile manipulation and subsequent nanoscale structural assessment of single collagen fibrils. While the method documented here cannot currently capture force data during loading, it offers the great advantage of allowing structural assessment after subrupture loading. To demonstrate the utility of this technique, we describe the results of 23 tensile experiments in which collagen fibrils were loaded to varying levels of strain and subsequently imaged in both the hydrated and dehydrated states. We show that following a dehydration-rehydration cycle (necessary for sample preparation), fibrils experience an increase in height and decrease in radial modulus in response to one loading-unloading cycle to strain <5%. This change is not altered by a second cycle to strain >5%. In fibril segments that ruptured during their second loading cycle, we show that the fibril structure is affected away from the rupture site in the form of discrete permanent deformations. By comparing the severity of select damage sites in both hydrated and dehydrated conditions, we demonstrate that dehydration masks damage features, leading to an underestimate of the degree of structural disruption. Overall, the method shows promise as a powerful tool for the investigation of structure-function relationships in nanoscale fibrous materials.	[Quigley, Andrew S.; Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada; [Veres, Samuel P.; Kreplak, Laurent] Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada; [Veres, Samuel P.] St Marys Univ, Div Engn, Halifax, NS, Canada	Dalhousie University; Dalhousie University; Saint Marys University - Canada	Kreplak, L (corresponding author), Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS, Canada.; Kreplak, L (corresponding author), Dalhousie Univ, Sch Biomed Engn, Halifax, NS, Canada.	kreplak@dal.ca		Veres, Samuel/0000-0001-6308-4836; kreplak, laurent/0000-0001-9370-9809	National Science and Engineering Research Council of Canada [355291]; Canadian Graduate Scholarship from the National Science and Engineering Research Council of Canada; Nova Scotia Graduate Scholarship from the Nova Scotia Government	National Science and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Graduate Scholarship from the National Science and Engineering Research Council of Canada; Nova Scotia Graduate Scholarship from the Nova Scotia Government	Discovery grant number 355291 from the National Science and Engineering Research Council of Canada (LK). This work was supported by a Canadian Graduate Scholarship from the National Science and Engineering Research Council of Canada (AQ), and a Nova Scotia Graduate Scholarship from the Nova Scotia Government (AQ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baldwin SJ, 2016, J MECH BEHAV BIOMED, V60, P356, DOI 10.1016/j.jmbbm.2016.02.004; Baldwin SJ, 2014, BIOPHYS J, V107, P1794, DOI 10.1016/j.bpj.2014.09.003; BOULIGAND Y, 1985, BIOL CELL, V54, P143, DOI 10.1111/j.1768-322X.1985.tb00389.x; Bozec L, 2007, BIOPHYS J, V92, P70, DOI 10.1529/biophysj.106.085704; Carlisle CR, 2010, ACTA BIOMATER, V6, P2997, DOI 10.1016/j.actbio.2010.02.050; Carlisle CR, 2009, BIOMATERIALS, V30, P1205, DOI 10.1016/j.biomaterials.2008.11.006; COOPER A, 1969, BIOCHEM J, V112, P515, DOI 10.1042/bj1120515; Dutov P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0145711; Eyre DR, 2005, TOP CURR CHEM, V247, P207, DOI 10.1007/b103828; Gautieri A, 2009, J MECH BEHAV BIOMED, V2, P130, DOI 10.1016/j.jmbbm.2008.03.001; Grant CA, 2009, BIOPHYS J, V97, P2985, DOI 10.1016/j.bpj.2009.09.010; HODGE AJ, 1960, P NATL ACAD SCI USA, V46, P186, DOI 10.1073/pnas.46.2.186; HULMES DJS, 1995, BIOPHYS J, V68, P1661, DOI 10.1016/S0006-3495(95)80391-7; Kreplak L, 2009, J MOL BIOL, V385, P1043, DOI 10.1016/j.jmb.2008.10.095; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; LILLIE JH, 1977, J ULTRA MOL STRUCT R, V58, P134, DOI 10.1016/S0022-5320(77)90025-9; Liu W, 2010, J THROMB HAEMOST, V8, P1030, DOI 10.1111/j.1538-7836.2010.03745.x; Liu YH, 2016, INTERFACE FOCUS, V6, DOI 10.1098/rsfs.2015.0080; Miles CA, 2005, J MOL BIOL, V346, P551, DOI 10.1016/j.jmb.2004.12.001; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Orgel JPRO, 2001, STRUCTURE, V9, P1061, DOI 10.1016/S0969-2126(01)00669-4; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; RAMACHANDRAN GN, 1968, BIOPOLYMERS, V6, P1649, DOI 10.1002/bip.1968.360061109; Shen ZLL, 2011, BIOPHYS J, V100, P3008, DOI 10.1016/j.bpj.2011.04.052; Shen ZLL, 2010, BIOPHYS J, V99, P1986, DOI 10.1016/j.bpj.2010.07.021; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Streeter I, 2011, SOFT MATTER, V7, P3373, DOI 10.1039/c0sm01192d; Svensson RB, 2013, BIOPHYS J, V104, P2476, DOI 10.1016/j.bpj.2013.04.033; Svensson RB, 2012, J APPL PHYSIOL, V112, P419, DOI 10.1152/japplphysiol.01172.2011; Svensson RB, 2010, BIOPHYS J, V99, P4020, DOI 10.1016/j.bpj.2010.11.018; Svensson RB, 2010, J MECH BEHAV BIOMED, V3, P112, DOI 10.1016/j.jmbbm.2009.01.005; Veres SP, 2014, MATRIX BIOL, V33, P54, DOI 10.1016/j.matbio.2013.07.003; Veres SP, 2013, J ORTHOP RES, V31, P731, DOI 10.1002/jor.22292; Veres SP, 2012, BIOPHYS J, V102, P2876, DOI 10.1016/j.bpj.2012.05.022; Yang L, 2012, J MECH BEHAV BIOMED, V6, P148, DOI 10.1016/j.jmbbm.2011.11.008	35	9	9	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161951	10.1371/journal.pone.0161951	http://dx.doi.org/10.1371/journal.pone.0161951			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598334	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800028
J	Zhong, HJ; Yuan, Y; Xie, WR; Chen, MH; He, XX				Zhong, Hao-Jie; Yuan, Yu; Xie, Wen-Rui; Chen, Mei-Hui; He, Xing-Xiang			Type 2 Diabetes Mellitus Is Associated with More Serious Small Intestinal Mucosal Injuries	PLOS ONE			English	Article							GUT MICROBIOTA; BACTERIAL OVERGROWTH; INFLAMMATION; PREVALENCE; TRANSIT; RATS	Background Clinical and experimental research has revealed that diabetes mellitus (DM) is characterized by intestinal hypomotility, gut microbial dysbiosis, increased gut permeability, microcirculation disorders, circulatory changes, and dysfunction of intestinal stem cells, which may be linked to inflammation of intestinal mucosa. However, the relationship between type 2 DM (T2DM) and macroscopic small intestinal mucosal injuries is still unclear. Therefore, we retrospectively studied capsule endoscopy data to determine the relationship between T2DM and small intestinal mucosal injuries. Materials and Methods We compared the records of 38 T2DM patients with those of 152 non-DM patients for small intestinal mucosal injuries. Different types of mucosal injuries and Lewis scores were compared between T2DM and non-DM patients. The relationships between patients with or without different types of diabetic complications and the Lewis score was assessed. Moreover, the relationships between insulin resistance and Lewis score, between HbA1c and Lewis score, were also both assessed. Results The prevalence of a villous edema in subjects with T2DM was significantly higher than in those without DM (P < 0.001), but incidence of ulcers was not different (P = 1.000). With T2DM, the Lewis score was also significantly higher (P = 0.002). In addition, subjects with diabetic nephropathy showed significantly higher Lewis scores than patients without diabetic nephropathy (P = 0.033). In Pearson's correlation tests, the homeostasis model assessment of insulin resistance (HOMA-IR) value was correlated positively with the Lewis score (gamma = 0.175, P = 0.015), but no statistical correlation was found between HbA1c level and Lewis score (gamma = 0.039, P = 0.697). Conclusions Subjects with T2DM, especially those with diabetic nephropathy, have higher Lewis scores and more serious small intestinal mucosal lesions.	[Zhong, Hao-Jie; Yuan, Yu; Xie, Wen-Rui; Chen, Mei-Hui; He, Xing-Xiang] Guangdong Pharmaceut Univ, Dept Gastroenterol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China	Guangdong Pharmaceutical University	He, XX (corresponding author), Guangdong Pharmaceut Univ, Dept Gastroenterol, Affiliated Hosp 1, Guangzhou, Guangdong, Peoples R China.	hexingxiangtongxun@126.com		Zhong, Hao-Jie/0000-0001-6586-756X				American Diabetes Association, 2015, Clin Diabetes, V33, P97, DOI 10.2337/diaclin.33.2.97; Boden G, 2011, CURR OPIN ENDOCRINOL, V18, P139, DOI 10.1097/MED.0b013e3283444b09; Bytzer P, 2002, AM J GASTROENTEROL, V97, P604; Cani PD, 2009, GUT, V58, P1091, DOI 10.1136/gut.2008.165886; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Cani PD, 2009, CURR PHARM DESIGN, V15, P1546, DOI 10.2174/138161209788168164; Caunedo-Alvarez A, 2010, REV ESP ENFERM DIG, V102, P80, DOI 10.4321/s1130-01082010000200002; D'Addio F, 2015, CELL STEM CELL, V17, P486, DOI 10.1016/j.stem.2015.07.010; Endo H, 2014, GASTROINTEST ENDOSC, V80, P826, DOI 10.1016/j.gie.2014.03.024; Everard A, 2013, P NATL ACAD SCI USA, V110, P9066, DOI 10.1073/pnas.1219451110; Fu RG, 2011, RENAL FAILURE, V33, P615, DOI 10.3109/0886022X.2011.581404; Gralnev IM, 2008, ALIMENT PHARM THERAP, V27, P146, DOI 10.1111/j.1365-2036.2007.03556.x; Harsch IA, 2003, EUR J PHARMACOL, V481, P249, DOI 10.1016/j.ejphar.2003.09.019; Horton F, 2014, DIABETIC MED, V31, P559, DOI 10.1111/dme.12360; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Jawa A, 2004, MED CLIN N AM, V88, P1001, DOI 10.1016/j.mcna.2004.04.012; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Lewis BS, 2005, ENDOSCOPY, V37, P960, DOI 10.1055/s-2005-870353; MAGNUSSON M, 1991, GUT, V32, P754, DOI 10.1136/gut.32.7.754; Moreno-Navarrete JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037160; Matsushita Y, 2013, J GASTROENTEROL, V48, P633, DOI 10.1007/s00535-012-0660-6; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; MOGENSEN CE, 1987, KIDNEY INT, V31, P673, DOI 10.1038/ki.1987.50; Muccioli GG, 2010, MOL SYST BIOL, V6, DOI 10.1038/msb.2010.46; Ojetti V, 2009, EUR REV MED PHARMACO, V13, P419; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Rana S, 2011, DIABETES TECHNOL THE, V13, P1115, DOI 10.1089/dia.2011.0078; Sambuceti G, 2009, STEM CELLS, V27, P399, DOI 10.1634/stemcells.2008-0800; Sato J, 2014, DIABETES CARE, V37, P2343, DOI 10.2337/dc13-2817; Song SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134321; Takeuchi K, 1997, J PHARMACOL EXP THER, V281, P200; Thomas Hugh, 2015, Nat Rev Endocrinol, V11, P688, DOI 10.1038/nrendo.2015.184; Toyry JP, 1996, DIABETES, V45, P308, DOI 10.2337/diabetes.45.3.308; Virally-Monod M, 1998, DIABETES METAB, V24, P530; Wang M, 2015, SCI REP-UK, V5, DOI 10.1038/srep11503; Yamamoto Yasuhiko, 2013, Front Endocrinol (Lausanne), V4, P105, DOI 10.3389/fendo.2013.00105; Zhou MG, 2015, DIABETES CARE, V38, P72, DOI 10.2337/dc14-1100	38	15	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162354	10.1371/journal.pone.0162354	http://dx.doi.org/10.1371/journal.pone.0162354			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598308	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800057
J	Fa, JE; Olivero, J; Farfan, MA; Lewis, J; Yasuoka, H; Noss, A; Hattori, S; Hirai, M; Kamgaing, TOW; Carpaneto, G; Germi, F; Marquez, AL; Duarte, J; Duda, R; Gallois, S; Riddell, M; Nasi, R				Fa, John E.; Olivero, Jesus; Angel Farfan, Miguel; Lewis, Jerome; Yasuoka, Hirokazu; Noss, Andrew; Hattori, Shiho; Hirai, Masaaki; Kamgaing, Towa O. W.; Carpaneto, Giuseppe; Germi, Francesco; Luz Marquez, Ana; Duarte, Jesus; Duda, Romain; Gallois, Sandrine; Riddell, Michael; Nasi, Robert			Differences between Pygmy and Non-Pygmy Hunting in Congo Basin Forests	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; BUSHMEAT; WILDLIFE; IMPACTS; CHOICE; MARKET; TRADE; GAME	We use data on game harvest from 60 Pygmy and non-Pygmy settlements in the Congo Basin forests to examine whether hunting patterns and prey profiles differ between the two hunter groups. For each group, we calculate hunted animal numbers and biomass available per inhabitant, P, per year (harvest rates) and killed per hunter, H, per year (extraction rates). We assess the impact of hunting of both hunter groups from estimates of numbers and biomass of prey species killed per square kilometre, and by examining the proportion of hunted taxa of low, medium and high population growth rates as a measure of their vulnerability to overhunting. We then map harvested biomass (kg(-1)P(-1)Yr(-1)) of bushmeat by Pygmies and non-Pygmies throughout the Congo Basin. Hunting patterns differ between Pygmies and non-Pygmies; Pygmies take larger and different prey and non-Pygmies sell more for profit. We show that non-Pygmies have a potentially more severe impact on prey populations than Pygmies. This is because non-Pygmies hunt a wider range of species, and twice as many animals are taken per square kilometre. Moreover, in non-Pygmy settlements there was a larger proportion of game taken of low population growth rate. Our harvest map shows that the non-Pygmy population may be responsible for 27 times more animals harvested than the Pygmy population. Such differences indicate that the intense competition that may arise from the more widespread commercial hunting by non-Pygmies is a far more important constraint and source of conflict than are protected areas.	[Fa, John E.] Manchester Metropolitan Univ, Sch Sci & Environm, Div Biol & Conservat Ecol, Manchester M1 5GD, Lancs, England; [Fa, John E.] CIFOR Headquarters, Ctr Int Forestry Res CIFOR, Bogor 16115, Indonesia; [Olivero, Jesus; Angel Farfan, Miguel; Luz Marquez, Ana] Univ Malaga, Fac Ciencias, Dept Biol Anim, Grp Biogeog Diversidad & Conservac, Campus Teatinos S-N, E-29071 Malaga, Spain; [Lewis, Jerome] UCL, Dept Anthropol, 14 Taviton St, London WC1H 0BW, England; [Yasuoka, Hirokazu; Kamgaing, Towa O. W.] Kyoto Univ, Ctr African Area Studies, Sakyo Ku, 46 Yoshida Shimoadachi Cho, Kyoto 6068501, Japan; [Noss, Andrew] Univ Florida, Dept Geog, 3141 Turlington Hall, Gainesville, FL 32611 USA; [Hattori, Shiho] Tenri Univ, Fac Int Studies, 1050 Somanouchi, Tenri, Nara 6328510, Japan; [Hirai, Masaaki] Japan Forest Technol Assoc, Chiyoda Ku, 7 Rokubancho, Tokyo 1020085, Japan; [Kamgaing, Towa O. W.] Minist Forestry & Wildlife, POB 14794, Yaounde, Cameroon; [Carpaneto, Giuseppe; Germi, Francesco] Univ Roma Tre, Dipartimento Sci, Rome, Italy; [Duarte, Jesus] Ofitecma, Calle Colombia 5, Ronda 29400, Spain; [Duda, Romain; Gallois, Sandrine] Univ Autonoma Barcelona, Ethnoecol Lab, E-08193 Barcelona, Spain; [Duda, Romain; Gallois, Sandrine] MNHN Musee Homme, Dept Hommes, Nat, Soc, 17 Pl Trocadero, F-75116 Paris, France; [Riddell, Michael] UN House, Bioclimate Res & Dev, 4 Hunter Sq, Edinburgh EH1 1QW, Midlothian, Scotland; [Nasi, Robert] CIFOR Headquarters, Consultat Grp Int Agr Res, Jalan CIFOR, Bogor 16115, Indonesia; [Germi, Francesco] 46 2F2 Elm Row, Edinburgh EH7 4AH, Midlothian, Scotland	Manchester Metropolitan University; CGIAR; Center for International Forestry Research (CIFOR); Universidad de Malaga; University of London; University College London; Kyoto University; State University System of Florida; University of Florida; Roma Tre University; Autonomous University of Barcelona; Museum National d'Histoire Naturelle (MNHN); CGIAR; Center for International Forestry Research (CIFOR)	Fa, JE (corresponding author), Manchester Metropolitan Univ, Sch Sci & Environm, Div Biol & Conservat Ecol, Manchester M1 5GD, Lancs, England.; Fa, JE (corresponding author), CIFOR Headquarters, Ctr Int Forestry Res CIFOR, Bogor 16115, Indonesia.	jfa949@gmail.com	Duarte, Jesus/ABE-3009-2020; Gallois, Sandrine/AAG-4964-2019; Kamgaing, Towa O. William/U-6301-2019; Duda, Romain/ABD-9678-2020; Márquez, Ana Luz/K-8345-2014; Nasi, Robert/P-2382-2019; Olivero, Jesús/K-8727-2014; Farfan Aguilar, Miguel Angel/K-8783-2014	Gallois, Sandrine/0000-0002-4354-7685; Kamgaing, Towa O. William/0000-0002-5653-9019; Márquez, Ana Luz/0000-0001-5586-9334; Nasi, Robert/0000-0001-9739-3135; Olivero, Jesús/0000-0003-1714-0360; YASUOKA, Hirokazu/0000-0001-5066-1534; DUARTE DUARTE, JESUS/0000-0002-4952-154X; Fa, Julia E./0000-0002-3611-8487; FA, Julia Elizabeth/0000-0002-1572-9828; Farfan Aguilar, Miguel Angel/0000-0002-4617-6517; CARPANETO, Giuseppe Maria/0000-0002-6874-3463	Department for International Development (DFID); United States Agency for International Development (USAID); Leverhulme Trust [RP2011-R-045]; European Union's Seventh Framework Programme (FP7) / ERC [FP7-261971-LEK]; USAID; UKAID; CGIAR Fund; Grants-in-Aid for Scientific Research [16H05661, 15H02598] Funding Source: KAKEN	Department for International Development (DFID); United States Agency for International Development (USAID)(United States Agency for International Development (USAID)CGIAR); Leverhulme Trust(Leverhulme Trust); European Union's Seventh Framework Programme (FP7) / ERC; USAID(United States Agency for International Development (USAID)); UKAID(CGIAR); CGIAR Fund(CGIAR); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	Funded by Department for International Development (DFID), the United States Agency for International Development (USAID), and the Leverhulme Trust (grant RP2011-R-045).; We are grateful to Roger Fotso, Allard Blom, Jacob Willie, David Wilkie, Nikki Tagg and Mark Infield for providing us with additional information on study sites. Data supplied by Romain Duda and Sandrine Gallois were collected under the European Union's Seventh Framework Programme (FP7/2007-2013) / ERC grant agreement nr. FP7-261971-LEK to Reyes-Garcia. We thank USAID, UKAID, the CGIAR Fund and the Leverhulme Trust (grant RP2011-R-045) for providing core financial support for this study. This work was also part of and was conducted as part of the CGIAR Research Program on Forests, Trees and Agroforestry.	Adams W.M., 2007, CONSERV SOC, V5, P147, DOI DOI 10.2307/26392879; [Anonymous], 2014, WORLD URB PROSP 2014; Arambiza E, 2006, HUM ORGAN, V65, P20, DOI 10.17730/humo.65.1.86y8rem7ugf8497u; BAHUCHET S, 1993, MAN BIOSPH, V13, P37; Bahuchet S., 1985, ETHNOS, V1, P6; Beltran J., 2000, BEST PRACT PROTECT A, V4; Bennett EL, 2002, CONSERV BIOL, V16, P590, DOI 10.1046/j.1523-1739.2002.01637.x; Bennett EL., 2000, HUNTING WILDLIFE TRO; Berkes F, 2007, P NATL ACAD SCI USA, V104, P15188, DOI 10.1073/pnas.0702098104; Bikaba D, 2010, INDIGENOUS PEOPLES C, P49; Bobo Kadiri S., 2015, African Study Monographs Supplementary Issue, V51, P119; Bobo Kadiri S., 2011, Human Dimensions of Wildlife, V16, P445, DOI 10.1080/10871209.2011.608219; BODMER RE, 1995, ECOL APPL, V5, P872, DOI 10.2307/2269338; Brechin S., 2003, CONTESTED NATURE PRO; Brockington Dan, 2002, FORTRESS CONSERVATIO; Carpaneto G.M., 1989, Hystrix, V1, P1; CONSERVATION INTERNATIONAL, IND PEOPL CONS INT P; Counsell, 2016, PROTECTED AREAS CONG; Curran B., 2009, CONSERV SOC, V7, P30, DOI [10.4103/0972-4923.54795, DOI 10.4103/0972-4923.54795]; DunningJr J. B., 2007, CRC HDB AVIAN BODY M, VSecond; Fa JE, 2005, BIOL CONSERV, V121, P167, DOI 10.1016/j.biocon.2004.04.016; Fa JE, 2002, CONSERV BIOL, V16, P232, DOI 10.1046/j.1523-1739.2002.00275.x; Fa JE, 2015, CONSERV BIOL, V29, P805, DOI 10.1111/cobi.12441; Fa JE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112367; Fa John E., 2001, Conservation Biology Series (Cambridge), V6, P203; Friedl MA, 2010, REMOTE SENS ENVIRON, V114, P168, DOI 10.1016/j.rse.2009.08.016; HARAKO R, 1976, Kyoto University African Studies, V10, P37; Hart JA, 2000, BIOL RESOURCE MANAGE, P106; HART JA, 1978, HUM ECOL, V6, P325, DOI 10.1007/BF00889029; HAWKES K, 1982, AM ETHNOL, V9, P379, DOI 10.1525/ae.1982.9.2.02a00100; Hoare AL, 2007, RESOURCE RIGHTS TIMB; Ichikawa M, 1983, AFR STUDY MONOGR, V4, P55, DOI [10.14989/68001, DOI 10.14989/68001]; Ingram DJ, 2015, ECOL SOC, V20, DOI 10.5751/ES-07823-200340; IUCN, IUCN RED LIST THREAT; IUCN W. UNEP, 1980, WORLD CONS STRAT; Jerozolimski A, 2003, BIOL CONSERV, V111, P415, DOI 10.1016/S0006-3207(02)00310-5; Kingdon J., 2013, MAMMALS AFRICA; Kitanishi K., 1995, AFR STUDY MONOGR, V16, P73, DOI [DOI 10.14989/68133, 10.14989/68133]; Kumpel NF, 2007, CONSERV SCI PRACT, V2, P73; Lewis Jerome, 2014, SOCIAL ORIGINS LANGU, P77, DOI [10.1093/acprof:oso/9780199665327.003.0007, DOI 10.1093/ACPROF:OSO/9780199665327.003.0007]; Lupo KD, 2005, J ANTHROPOL ARCHAEOL, V24, P335, DOI 10.1016/j.jaa.2005.02.002; Mavah GA, 2015, THESIS; Mbomio Ngomo D, 2009, PLAN MANEJO RIO CAMP; McShane TO, 2011, BIOL CONSERV, V144, P966, DOI 10.1016/j.biocon.2010.04.038; Nasi R, 2011, INT FOREST REV, V13, P355, DOI 10.1505/146554811798293872; Nelson J., 2003, INDIGENOUS PEOPLES P; Noss A, 2000, BIOL RESOURCE MANAGE, P282; Olivero J, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0144499; Patin E, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000448; Redford K., 1996, TRADITIONAL PEOPLES; Redford K. H., 2007, 29 WILDL CONS SOC; Redford K. H., 2006, 25 WCS; REDFORD KH, 1987, AM ANTHROPOL, V89, P650, DOI 10.1525/aa.1987.89.3.02a00070; REDFORD KH, 1993, CONSERV BIOL, V7, P248, DOI 10.1046/j.1523-1739.1993.07020248.x; Riddell M, 2011, THESIS; Riddell M, 2013, CONSERV SOC, V11, P199, DOI 10.4103/0972-4923.121002; Robinson J., 2000, HUNTING SUSTAINABILI; Roe D., 2009, COMMUNITY MANAGEMENT; Sarkar S, 2011, BIOL CONSERV, V144, P979, DOI 10.1016/j.biocon.2010.03.008; Schmidt-Soltau K, 2005, PLAN DEV PEUPLES AUT; Schneider A, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/044003; Schneider A, 2010, REMOTE SENS ENVIRON, V114, P1733, DOI 10.1016/j.rse.2010.03.003; Takeuchi K, 1995, ZOOARCHAEOLOGY, V4, P27; TANNO T, 1976, Kyoto University African Studies, V10, P101; Terashima H., 1983, AFRICAN STUDY MONOGR, V3, P71; Usongo L, 2004, INT J SUST DEV WORLD, V11, P119, DOI 10.1080/13504500409469816; van Vliet N, 2012, ORYX, V46, P196, DOI 10.1017/S0030605311000202; VANSINA J, 1995, J AFR HIST, V36, P173, DOI 10.1017/S0021853700034101; Vickers W. T., 1980, WORKING PAPERS S AM, V2, P7; White F, 1983, SERIES NATURAL RESOU, VXX; Wilkie DS, 1999, BIODIVERS CONSERV, V8, P927, DOI 10.1023/A:1008877309871; Wilshusen PR, CONTESTED NATURE PRO, P41; WWF, 1996, IND PEOPL CONS WWF S; Yasuoka H., 2014, AFR STUDY MONOGR SUP, V49, P115, DOI 10.14989/189625; Yasuoka Hirokazu, 2006, African Study Monographs Supplementary Issue, V33, P95	75	15	15	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161703	10.1371/journal.pone.0161703	http://dx.doi.org/10.1371/journal.pone.0161703			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589384	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800014
J	Nakao, M; Endo, S; Nakao, S; Yoshida, M; Matsuda, T				Nakao, Megumi; Endo, Shota; Nakao, Shinichi; Yoshida, Munehito; Matsuda, Tetsuya			Augmented Endoscopic Images Overlaying Shape Changes in Bone Cutting Procedures	PLOS ONE			English	Article							SPINAL NAVIGATION; MICROENDOSCOPIC DISKECTOMY; TUMOR SURGERY; REGISTRATION; ACCURACY; FUTURE	In microendoscopic discectomy for spinal disorders, bone cutting procedures are performed in tight spaces while observing a small portion of the target structures. Although optical tracking systems are able to measure the tip of the surgical tool during surgery, the poor shape information available during surgery makes accurate cutting difficult, even if preoperative computed tomography and magnetic resonance images are used for reference. Shape estimation and visualization of the target structures are essential for accurate cutting. However, time-varying shape changes during cutting procedures are still challenging issues for intraoperative navigation. This paper introduces a concept of endoscopic image augmentation that overlays shape changes to support bone cutting procedures. This framework handles the history of the location of the measured drill tip as a volume label and visualizes the remains to be cut overlaid on the endoscopic image in real time. A cutting experiment was performed with volunteers, and the feasibility of this concept was examined using a clinical navigation system. The efficacy of the cutting aid was evaluated with respect to the shape similarity, total moved distance of a cutting tool, and required cutting time. The results of the experiments showed that cutting performance was significantly improved by the proposed framework.	[Nakao, Megumi; Endo, Shota; Matsuda, Tetsuya] Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan; [Nakao, Shinichi; Yoshida, Munehito] Wakayama Med Univ, Dept Orthoped Surg, Wakayama, Japan	Kyoto University; Wakayama Medical University	Nakao, M (corresponding author), Kyoto Univ, Grad Sch Informat, Sakyo Ku, Kyoto, Japan.	megumi@i.kyoto-u.ac.jp		Nakao, Megumi/0000-0002-5508-4366	JSPS [15H03032]; Center of Innovation (COI) Program from Japan Science and Technology Agency (JST)	JSPS(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Center of Innovation (COI) Program from Japan Science and Technology Agency (JST)(Japan Science & Technology Agency (JST))	This research was supported by the JSPS Grant-in-Aid for Scientific Research (B) (15H03032); URL: https://www.jsps.go.jp/english/e-grants/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the JSPS Grant-in-Aid for Scientific Research (B) (15H03032). This work was also supported by the Center of Innovation (COI) Program from the Japan Science and Technology Agency (JST). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We would like to thank Keiho Imanishi, Tomoaki Takemura, Kotaro Minato, and Takashi Takahashi for participating in a valuable discussion on the system design and experiments.	Agus M, 2013, PRESENCE, V12, P110; Bichlmeier C, 2009, IEEE T MED IMAGING, V28, P1498, DOI 10.1109/TMI.2009.2018622; Cartiaux O, 2014, ANN BIOMED ENG, V42, P205, DOI 10.1007/s10439-013-0890-7; Cartiaux O, 2013, COMPUT AIDED SURG, V18, P19, DOI 10.3109/10929088.2012.744096; Edwards PJ, 2000, IEEE T MED IMAGING, V19, P1082, DOI 10.1109/42.896784; Foley K.T., 1997, TECH NEUROSURG, V3, P301; Haouchine N, 2015, IEEE T VIS COMPUT GR, V21, P584, DOI 10.1109/TVCG.2014.2377772; Helm PA, 2015, IEEE T MED IMAGING, V34, P1738, DOI 10.1109/TMI.2015.2391200; Imanishi K, 2013, INT J COMPUT ASS RAD, V5, P461; Johnson JP, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13532; Kockro RA, 2009, NEUROSURGERY, V65, P795, DOI 10.1227/01.NEU.0000349918.36700.1C; Liao HE, 2010, IEEE T BIO-MED ENG, V57, P1476, DOI 10.1109/TBME.2010.2040278; Luan S, 2012, COMPUT METH PROG BIO, V108, P151, DOI 10.1016/j.cmpb.2012.02.007; Mori M, 2010, INT J COMPUT ASS RAD, V5, pS414; Morris D, 2006, IEEE COMPUT GRAPH, V26, P48, DOI 10.1109/MCG.2006.140; Nakagawa H, 2005, INT J SPINE SURG, P2; Nakao M, 2015, IEEE INT S MIX AUG R, P176; Park P, 2015, OPER NEUROSURG, V11, P259, DOI 10.1227/NEU.0000000000000726; Rahmathulla G, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13516; Righesso O, 2007, NEUROSURGERY, V61, P545, DOI 10.1227/01.NEU.0000290901.00320.F5; Schouten R, 2012, J CLIN NEUROSCI, V19, P1137, DOI 10.1016/j.jocn.2012.01.020; Smith N, 2013, EUR SPINE J, V22, P2458, DOI 10.1007/s00586-013-2848-8; Tjardes T, 2010, EUR SPINE J, V19, P25, DOI 10.1007/s00586-009-1091-9; Vankipuram M, 2010, J BIOMED INFORM, V43, P661, DOI 10.1016/j.jbi.2010.05.016; Wang JC, 2014, IEEE T BIO-MED ENG, V61, P1295, DOI 10.1109/TBME.2014.2301191; Wang XW, 2010, IEEE T MED IMAGING, V29, P1213, DOI 10.1109/TMI.2009.2028341; Wen R, 2013, INT J COMPUT ASS RAD, V8, P1015, DOI 10.1007/s11548-013-0897-4	27	3	3	2	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161815	10.1371/journal.pone.0161815	http://dx.doi.org/10.1371/journal.pone.0161815			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584732	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600063
J	Xu, J; Han, R; Kim, DW; Mo, JH; Jin, YD; Rha, KS; Kim, YM				Xu, Jun; Han, Ruining; Kim, Dae Woo; Mo, Ji-Hun; Jin, Yongde; Rha, Ki-Sang; Kim, Yong Min			Role of Interleukin-10 on Nasal Polypogenesis in Patients with Chronic Rhinosinusitis with Nasal Polyps	PLOS ONE			English	Article							THYMIC STROMAL LYMPHOPOIETIN; CELL-ACTIVATING FACTOR; STAPHYLOCOCCUS-AUREUS; EPITHELIAL-CELLS; PROTEIN-A; T-CELLS; EXPRESSION; INFLAMMATION; IL-10; PATHOGENESIS	Background and Objectives Interleukin 10 (IL-10) is a potent anti-inflammatory cytokine. The dysregulation of IL-10 is associated with an enhanced immunopathologic response to infection, as well as with an increased risk for developing numerous autoimmune diseases. In this study, we investigated IL-10 expression in chronic rhinosinusitis with nasal polyps (CRSwNP) and assessed the possible role of IL-10 in the pathogenesis of CRSwNP. Materials and Methods Thirty-five patients with CRSwNP, 12 patients with chronic rhinosinusitis without NP (CRSsNP) and 10 control subjects were enrolled in this study. NP tissues and uncinated tissues (UT) were collected for analysis. Dispersed NP cells (DNPCs) were cultured in the presence or absence of IL-25 and IL-10, and a flow cytometric assay was performed to identify the constitutive cell populations of the DNPCs. Murine NP (n = 18) models were used for the in vivo experiments. Real-time PCR, immunohistochemistry, western blotting analysis and ELISA were performed to measure the expression levels of the selected inflammatory cytokines and inflammation-associated molecules. Results The mRNA expression levels of IL-10, IL-5, IL-17A, IL-25 and interferon gamma (IFN-gamma) were significantly higher in the NP tissues than in the UT tissues. Strong positive correlations were observed between IL-10 and a variety of inflammatory cytokines (IL-5, IL-17A, IL-25, IFN-gamma) and inflammation-associated molecules (B-cell activating factor; BAFF, CD19). Other than the IL-25 to IL-10 ratio, the expression ratios of the other measured inflammatory cytokines to IL-10 were significantly lower in the CRSwNP group than in the CRSsNP or control groups. Administrating IL-25 into the cultured DNPCs significantly increased the production of IL-10, but administrating IL-10 had no effect on the production of IL-25. Conclusion Increased expression of IL-10, IL-10 related inflammatory cytokine, and IL-10 related B cell activation indicated that IL-10, a potent anti-inflammatory cytokine, has a pivotal role in the pathogenesis of CRSwNPs.	[Xu, Jun; Han, Ruining; Rha, Ki-Sang; Kim, Yong Min] Chungnam Natl Univ, Res Inst Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Daejeon, South Korea; [Kim, Dae Woo] Seoul Natl Univ, Boramae Med Ctr, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Seoul, South Korea; [Mo, Ji-Hun] Dankook Univ, Dept Otorhinolaryngol Head & Neck Surg, Coll Med, Cheonan, South Korea; [Xu, Jun; Han, Ruining; Jin, Yongde] Yanbian Univ Hosp, Dept Otorhinolaryngol Head & Neck Surg, Yanji, Peoples R China	Chungnam National University; Seoul National University (SNU); Seoul National University Hospital; Dankook University; Yanbian University	Kim, YM (corresponding author), Chungnam Natl Univ, Res Inst Med Sci, Dept Otorhinolaryngol Head & Neck Surg, Sch Med, Daejeon, South Korea.	entkym@cnu.ac.kr	; Mo, Ji-Hun/E-5586-2011	Rha, Ki-Sang/0000-0001-9981-057X; Kim, Yong Min/0000-0001-5414-8332; Mo, Ji-Hun/0000-0003-1331-364X	research fund of Chungnam National University	research fund of Chungnam National University	This work was supported by research fund of Chungnam National University 2014.	Ba L, 2015, ALLERGY ASTHMA IMMUN, V7, P346, DOI 10.4168/aair.2015.7.4.346; Baba S, 2015, ALLERGY ASTHMA CL IM, V11, DOI 10.1186/s13223-015-0100-2; Bachert C, 1997, J ALLERGY CLIN IMMUN, V99, P837, DOI 10.1016/S0091-6749(97)80019-X; BUELENS C, 1995, EUR J IMMUNOL, V25, P2668, DOI 10.1002/eji.1830250940; Cao PP, 2009, J ALLERGY CLIN IMMUN, V124, P478, DOI 10.1016/j.jaci.2009.05.017; Escotte S, 2006, AM J RESP CELL MOL, V34, P348, DOI 10.1165/rcmb.2005-0191OC; Esmaeilzadeh H, 2015, CLIN IMMUNOL, V160, P349, DOI 10.1016/j.clim.2015.05.012; Fokkens WJ, 2012, RHINOLOGY, V50, P1, DOI 10.4193/Rhin20.600; Fokkens W, 2007, RHINOLOGY, P1; Frodermann V, 2011, J INFECT DIS, V204, P253, DOI 10.1093/infdis/jir276; Gong J, 2013, AM J OTOLARYNG, V34, P183, DOI 10.1016/j.amjoto.2012.10.003; Higaki T, 2012, CLIN EXP ALLERGY, V42, P1217, DOI 10.1111/j.1365-2222.2012.04015.x; Hunter CA, 1997, J IMMUNOL, V158, P3311; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; Jin J, 2014, LARYNGOSCOPE, V124, pE151, DOI 10.1002/lary.24472; Jin J, 2014, EUR ARCH OTO-RHINO-L, V271, P1097, DOI 10.1007/s00405-013-2683-x; Kato A, 2008, J ALLERGY CLIN IMMUN, V121, P1385, DOI 10.1016/j.jaci.2008.03.002; Kim DW, 2016, LARYNGOSCOPE, V126, pE265, DOI 10.1002/lary.26004; Kim DW, 2011, AM J RHINOL ALLERGY, V25, pE255, DOI 10.2500/ajra.2011.25.3727; Konig K, 2016, ALLERGY ASTHMA CL IM, V12, DOI 10.1186/s13223-016-0123-3; Krysko O, 2011, ALLERGY, V66, P396, DOI 10.1111/j.1398-9995.2010.02498.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Leng J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007589; Liu Z, 2009, ALLERGY, V64, P149, DOI 10.1111/j.1398-9995.2008.01847.x; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Malagutti N, 2008, AM J RHINOL, V22, P468, DOI 10.2500/ajr.2008.22.3210; de Castro MCM, 2013, AM J RHINOL ALLERGY, V27, pE32, DOI 10.2500/ajra.2013.27.3868; Ndishimye Pacifique, 2015, Clujul Med, V88, P164, DOI 10.15386/cjmed-459; O'Garra A, 2008, IMMUNOL REV, V223, P114, DOI 10.1111/j.1600-065X.2008.00635.x; Okano M, 2016, ALLERGOL INT, V65, P96, DOI 10.1016/j.alit.2015.08.005; Okano M, 2015, J ALLERGY CLIN IMMUN, V136, P343, DOI 10.1016/j.jaci.2014.10.058; Okano M, 2014, ALLERGOL INT, V63, P563, DOI 10.2332/allergolint.14-OA-0703; Okano M, 2009, J ALLERGY CLIN IMMUN, V123, P868, DOI 10.1016/j.jaci.2009.01.047; Othieno C, 1999, INFECT IMMUN, V67, P5730, DOI 10.1128/IAI.67.11.5730-5735.1999; Ouyang WJ, 2011, ANNU REV IMMUNOL, V29, P71, DOI 10.1146/annurev-immunol-031210-101312; Ozkara S, 2012, EUR ARCH OTO-RHINO-L, V269, P2519, DOI 10.1007/s00405-012-1967-x; Park SJ, 2013, J ALLERGY CLIN IMMUN, V131, P772, DOI 10.1016/j.jaci.2012.12.671; Patou J, 2008, J ALLERGY CLIN IMMUN, V121, P110, DOI 10.1016/j.jaci.2007.08.059; Peric A, 2012, B-ENT, V8, P25; Peric A, 2011, ALLERGOL IMMUNOPATH, V39, P133, DOI 10.1016/j.aller.2010.05.001; Peric A, 2013, INDIAN J OTOLARYNGOL, V65, pS295, DOI 10.1007/s12070-011-0447-8; Peric A, 2010, ACTA CLIN CROAT, V49, P395; Peric Aleksandar, 2010, Kulak Burun Bogaz Ihtis Derg, V20, P111; Riechelmann H, 2005, CLIN EXP ALLERGY, V35, P1186, DOI 10.1111/j.1365-2222.2005.02316.x; Sachse F, 2006, CLIN EXP IMMUNOL, V144, P534, DOI 10.1111/j.1365-2249.2006.03089.x; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sendide K, 2005, J IMMUNOL, V175, P5324, DOI 10.4049/jimmunol.175.8.5324; Shen Y, 2011, SCAND J IMMUNOL, V74, P176, DOI 10.1111/j.1365-3083.2011.02546.x; Shen Y, 2014, ASIAN PAC J ALLERGY, V32, P300, DOI 10.12932/AP0469.32.4.2014; Shi J, 2009, J INVEST ALLERG CLIN, V19, P276; Shin HW, 2015, J ALLERGY CLIN IMMUN, V135, P1476, DOI 10.1016/j.jaci.2015.01.003; Van Bruaene N, 2008, J ALLERGY CLIN IMMUN, V121, P1435, DOI 10.1016/j.jaci.2008.02.018; Vu AT, 2010, J ALLERGY CLIN IMMUN, V126, P985, DOI 10.1016/j.jaci.2010.09.002; Wu DW, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000002998; Yang X, 2000, EUR J IMMUNOL, V30, P382, DOI 10.1002/1521-4141(200002)30:2<382::AID-IMMU382>3.0.CO;2-L; Yoon YH, 2014, RHINOLOGY, V52, P390, DOI [10.4193/Rhin13.154, 10.4193/Rhino13.154]; Zhang N, 2008, J ALLERGY CLIN IMMUN, V122, P961, DOI 10.1016/j.jaci.2008.07.008; Zhang Q, 2013, ACTA OTO-LARYNGOL, V133, P165, DOI 10.3109/00016489.2012.717713	58	24	25	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161013	10.1371/journal.pone.0161013	http://dx.doi.org/10.1371/journal.pone.0161013			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584662	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600012
J	Song, RS; Tolentino, R; Sobie, EA; Neves-Zaph, SR				Song, Roy S.; Tolentino, Rosa; Sobie, Eric A.; Neves-Zaph, Susana R.			Cross-regulation of Phosphodiesterase 1 and Phosphodiesterase 2 Activities Controls Dopamine-mediated Striatal alpha-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid (AMPA) Receptor Trafficking	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; OXIDE SYNTHASE PHOSPHORYLATION; MEDIUM SPINY NEURONS; NITRIC-OXIDE; PROTEIN-KINASE; NMDA RECEPTOR; RAT-BRAIN; IN-VIVO; SYNAPTIC-TRANSMISSION; HIPPOCAMPAL-NEURONS	Dopamine, a key striatal neuromodulator, increases synaptic strength by promoting surface insertion and/or retention of AMPA receptors (AMPARs). This process is mediated by the phosphorylation of the GluA1 subunit of AMPAR by cyclic nucleotide-dependent kinases, making cyclic nucleotide phosphodiesterases (PDEs) potential regulators of synaptic strength. In this study, we examined the role of phosphodiesterase 2 (PDE2), a medium spiny neuron-enriched and cGMP-activated PDE, in AMPAR trafficking. We found that inhibiting PDE2 resulted in enhancement of dopamine-induced surface GluA1 expression in dopamine receptor 1-expressing medium spiny neurons. Using pharmacological and genetic approaches, we found that inhibition of PDE1 resulted in a decrease in surface AMPAR levels because of the allosteric activation of PDE2. The cross-regulation of PDE1 and PDE2 activities results in counter-intuitive control of surface AMPAR expression, making it possible to regulate the directionality and magnitude of AMPAR trafficking.	[Song, Roy S.; Tolentino, Rosa; Sobie, Eric A.; Neves-Zaph, Susana R.] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, 1 Gustave L Levy Pl,Box 1215, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai	Neves-Zaph, SR (corresponding author), Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, 1 Gustave L Levy Pl,Box 1215, New York, NY 10029 USA.	Susana.neves@mssm.edu		Neves-Zaph, Susana/0000-0002-3388-0054	NIGMS, National Institutes of Health [P41 GM103313]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK087650] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103313, T32GM062754] Funding Source: NIH RePORTER	NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Dr. Masago Ishikawa and Dr. Eric Sweet for technical assistance and Dr. Manuela Zaccolo, Dr. Robbert Havekes, and Dr. Jin Zhang for reagents. We also thank Dr. Joe Beavo, Dr. Ravi Iyengar, Dr. Paul Kenny, and Dr. Robert Blitzer for helpful discussions. VCell is funded by NIGMS, National Institutes of Health Grant P41 GM103313.	Bhalla US, 1999, SCIENCE, V283, P381, DOI 10.1126/science.283.5400.381; Boess FG, 2004, NEUROPHARMACOLOGY, V47, P1081, DOI 10.1016/j.neuropharm.2004.07.040; Calabresi P, 1999, J NEUROSCI, V19, P2489; Carlezon WA, 2009, NEUROPHARMACOLOGY, V56, P122, DOI 10.1016/j.neuropharm.2008.06.075; Castro LRV, 2006, CIRCULATION, V113, P2221, DOI 10.1161/CIRCULATIONAHA.105.599241; CHARBONNEAU H, 1990, P NATL ACAD SCI USA, V87, P288, DOI 10.1073/pnas.87.1.288; Cherry JA, 1999, J COMP NEUROL, V407, P287; Conti M, 2014, J GEN PHYSIOL, V143, P29, DOI 10.1085/jgp.201311083; EIGENTHALER M, 1992, EUR J BIOCHEM, V205, P471, DOI 10.1111/j.1432-1033.1992.tb16803.x; ERNEUX C, 1981, EUR J BIOCHEM, V115, P503; Esteban JA, 2003, NAT NEUROSCI, V6, P136, DOI 10.1038/nn997; Francis SH, 2011, PHYSIOL REV, V91, P651, DOI 10.1152/physrev.00030.2010; Fujishige K, 1999, EUR J BIOCHEM, V266, P1118, DOI 10.1046/j.1432-1327.1999.00963.x; Fujishige K, 1999, J BIOL CHEM, V274, P18438, DOI 10.1074/jbc.274.26.18438; Gao C, 2006, J NEUROCHEM, V98, P1664, DOI 10.1111/j.1471-4159.2006.03999.x; Gasser C, 2014, P NATL ACAD SCI USA, V111, P8803, DOI 10.1073/pnas.1321600111; Goraya TA, 2005, CELL SIGNAL, V17, P789, DOI 10.1016/j.cellsig.2004.12.017; Goraya TA, 2004, J BIOL CHEM, V279, P40494, DOI 10.1074/jbc.M313441200; Graybiel AM, 2005, CURR OPIN NEUROBIOL, V15, P638, DOI 10.1016/j.conb.2005.10.006; Heiman M, 2008, CELL, V135, P738, DOI 10.1016/j.cell.2008.10.028; Hwangpo TA, 2012, J BIOL CHEM, V287, P13674, DOI 10.1074/jbc.M111.320705; IWAMOTO T, 2003, THE JOURNAL OF BIOLO, V278, P16936, DOI DOI 10.1074/JBC.C300075200; Jager R, 2012, J BIOL CHEM, V287, P1210, DOI 10.1074/jbc.M111.263806; KAKIUCHI S, 1970, BIOCHEM BIOPH RES CO, V41, P1104, DOI 10.1016/0006-291X(70)90199-3; KAWABE J, 1994, J BIOL CHEM, V269, P16554; Kelly MP, 2014, CELL SIGNAL, V26, P383, DOI 10.1016/j.cellsig.2013.10.007; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; KURODA S, 2001, THE JOURNAL OF NEURO, V21, P5693; Leroy MJ, 1996, BIOCHEMISTRY-US, V35, P10194, DOI 10.1021/bi952711t; Lin DTS, 2010, SYNAPSE, V64, P460, DOI 10.1002/syn.20750; Loughney K, 1999, GENE, V234, P109, DOI 10.1016/S0378-1119(99)00171-7; Mangiavacchi S, 2004, J NEUROCHEM, V88, P1261, DOI 10.1046/j.1471-4159.2003.02248.x; Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899; Martinez SE., 2007, CYCLIC NUCLEOTIDE PH, P55; MARTINS TJ, 1982, J BIOL CHEM, V257, P1973; MARTINS TJ, 1982, THE JOURNAL OF BIOLO, V257, P1973; McCahill A, 2005, CELL SIGNAL, V17, P1158, DOI 10.1016/j.cellsig.2005.04.003; MERY PF, 1993, J BIOL CHEM, V268, P26286; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Mika D, 2015, P NATL ACAD SCI USA, V112, P2023, DOI 10.1073/pnas.1419992112; Mironov SL, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-29; MONS N, 1994, MOL BRAIN RES, V22, P236, DOI 10.1016/0169-328X(94)90052-3; Neves SR, 2008, CELL, V133, P666, DOI 10.1016/j.cell.2008.04.025; Neves-Zaph SR, 2015, METHODS MOL BIOL, V1294, P203, DOI 10.1007/978-1-4939-2537-7_16; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Nishi A, 2008, J NEUROSCI, V28, P10460, DOI 10.1523/JNEUROSCI.2518-08.2008; Noyama K, 2003, NEUROSCI RES, V45, P141, DOI 10.1016/S0168-0102(02)00208-0; Omori K, 2007, CIRC RES, V100, P309, DOI 10.1161/01.RES.0000256354.95791.f1; Pandit J, 2009, P NATL ACAD SCI USA, V106, P18225, DOI 10.1073/pnas.0907635106; Perino A, 2012, CIRC RES, V111, P482, DOI 10.1161/CIRCRESAHA.111.262899; Plattner F, 2015, NAT NEUROSCI, V18, P1094, DOI 10.1038/nn.4066; Polito M, 2015, ENEURO, V2, DOI 10.1523/ENEURO.0060-15.2015; Polito M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00211; Rameau GA, 2004, J BIOL CHEM, V279, P14307, DOI 10.1074/jbc.M311103200; Rameau GA, 2007, J NEUROSCI, V27, P3445, DOI 10.1523/JNEUROSCI.4799-06.2007; Rathje M, 2013, P NATL ACAD SCI USA, V110, P14426, DOI 10.1073/pnas.1312982110; REPASKE DR, 1993, NEUROSCIENCE, V56, P673, DOI 10.1016/0306-4522(93)90364-L; Rivero-Gutierrez B, 2014, ANAL BIOCHEM, V467, P1, DOI 10.1016/j.ab.2014.08.027; Rosman GJ, 1997, GENE, V191, P89, DOI 10.1016/S0378-1119(97)00046-2; Routh BN, 2009, J NEUROPHYSIOL, V102, P2288, DOI 10.1152/jn.00082.2009; Russwurm C, 2015, J BIOL CHEM, V290, P11936, DOI 10.1074/jbc.M114.595769; Sammut S, 2007, J NEUROCHEM, V103, P1145, DOI 10.1111/j.1471-4159.2007.04811.x; Sample V, 2012, NAT CHEM BIOL, V8, P375, DOI [10.1038/NCHEMBIO.799, 10.1038/nchembio.799]; Sankaranarayanan S, 2000, BIOPHYS J, V79, P2199, DOI 10.1016/S0006-3495(00)76468-X; Serulle Y, 2007, NEURON, V56, P670, DOI 10.1016/j.neuron.2007.09.016; Sharma RK, 2006, INT J MOL MED, V18, P95; SHARMA RK, 1986, THE JOURNAL OF BIOLO, V261, P1322; Snyder GL, 2000, J NEUROSCI, V20, P4480, DOI 10.1523/JNEUROSCI.20-12-04480.2000; Sobie EA, 2009, BIOPHYS J, V96, P1264, DOI 10.1016/j.bpj.2008.10.056; Soderling SH, 1999, P NATL ACAD SCI USA, V96, P7071, DOI 10.1073/pnas.96.12.7071; Song RS, 2013, P NATL ACAD SCI USA, V110, P15437, DOI 10.1073/pnas.1311783110; SONNENBURG WK, 1991, THE JOURNAL OF BIOLO, V266, P17655; Stangherlin A, 2011, CIRC RES, V108, P929, DOI 10.1161/CIRCRESAHA.110.230698; Stephenson DT, 2012, NEUROSCIENCE, V226, P145, DOI 10.1016/j.neuroscience.2012.09.011; Stone JR, 1996, BIOCHEMISTRY-US, V35, P1093, DOI 10.1021/bi9519718; Sun X, 2005, J NEUROSCI, V25, P7342, DOI 10.1523/JNEUROSCI.4603-04.2005; Surapisitchat J, 2007, CIRC RES, V101, P811, DOI 10.1161/CIRCRESAHA.107.154229; Surmeier DJ, 2007, TRENDS NEUROSCI, V30, P228, DOI 10.1016/j.tins.2007.03.008; Taylor SS, 2013, BBA-PROTEINS PROTEOM, V1834, P1271, DOI 10.1016/j.bbapap.2013.03.007; TRAUT TW, 1994, MOL CELL BIOCHEM, V140, P1, DOI 10.1007/BF00928361; Tritsch NX, 2012, NEURON, V76, P33, DOI 10.1016/j.neuron.2012.09.023; Tsvetanova NG, 2014, NAT CHEM BIOL, V10, P1061, DOI 10.1038/nchembio.1665; Tukey DS, 2013, J BIOL CHEM, V288, P35297, DOI 10.1074/jbc.M113.516690; van Staveren WCG, 2003, J COMP NEUROL, V467, P566, DOI 10.1002/cne.10955; WELLS JN, 1988, METHOD ENZYMOL, V159, P489; West AR, 2011, FRONT SYST NEUROSCI, V5, DOI 10.3389/fnsys.2011.00055; West AR, 2004, J NEUROSCI, V24, P1924, DOI 10.1523/JNEUROSCI.4470-03.2004; WOLIN MS, 1982, THE JOURNAL OF BIOLO, V257, P13312; Wykes V, 2002, J NEUROCHEM, V83, P37, DOI 10.1046/j.1471-4159.2002.01106.x; Zhao CY, 2016, J MOL CELL CARDIOL, V91, P215, DOI 10.1016/j.yjmcc.2016.01.004; Zhao CY, 2015, J MOL CELL CARDIOL, V88, P29, DOI 10.1016/j.yjmcc.2015.09.011	91	9	9	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23257	23267		10.1074/jbc.M116.749747	http://dx.doi.org/10.1074/jbc.M116.749747			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27605670	Green Published, hybrid			2022-12-26	WOS:000387224800034
J	Feigerle, JT; Weil, PA				Feigerle, Jordan T.; Weil, P. Anthony			The C Terminus of the RNA Polymerase II Transcription Factor IID (TFIID) Subunit Taf2 Mediates Stable Association of Subunit Taf14 into the Yeast TFIID Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						gene expression; RNA polymerase II; transcription coactivator; transcription regulation; yeast; ribosomes; TFIID; Taf14; Taf2; YEATS domain	TATA-BINDING PROTEIN; DEPENDENT INITIATOR FUNCTION; CORE PROMOTER ELEMENT; SACCHAROMYCES-CEREVISIAE; YEATS DOMAIN; ACTIVATED TRANSCRIPTION; HISTONE CROTONYLATION; MULTIPROTEIN COMPLEX; GENE-TRANSCRIPTION; CELL-GROWTH	The evolutionarily conserved RNA polymerase II transcription factor D (TFIID) complex is composed of TATA box-binding protein (TBP) and 13 TBP-associated factors (Tafs). The mechanisms by which many Taf subunits contribute to the essential function of TFIID are only poorly understood. To address this gap in knowledge, we present the results of a molecular genetic dissection of the TFIID subunit Taf2. Through systematic site-directed mutagenesis, we have discovered 12 taf2 temperature-sensitive (ts) alleles. Two of these alleles display growth defects that can be strongly suppressed by overexpression of the yeast-specific TFIID subunit TAF14 but not by overexpression of any other TFIID subunit. In Saccharomyces cerevisiae, Taf14 is also a constituent of six other transcription-related complexes, making interpretation of its role in each of these complexes difficult. Although Taf14 is not conserved as a TFIID subunit in metazoans, it is conserved through its chromatin-binding YEATS domain. Based on the Taf2-Taf14 genetic interaction, we demonstrate that Taf2 and Taf14 directly interact and mapped the Taf2-Taf14 interaction domains. We used this information to identify a Taf2 separation-of-function variant (Taf2-C). Although Taf2-C no longer interacts with Taf14 in vivo or in vitro, it stably incorporates into the TFIID complex. In addition, purified Taf2-C mutant TFIID is devoid of Taf14, making this variant a powerful reagent for determining the role of Taf14 in TFIID function. Furthermore, we characterized the mechanism through which Taf14 suppresses taf2(ts) alleles, shedding light on how Taf2-Taf14 interaction contributes to TFIID complex organization and identifying a potential role for Taf14 in mediating TFIID-chromatin interactions.	[Feigerle, Jordan T.; Weil, P. Anthony] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA	Vanderbilt University	Weil, PA (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Nashville, TN 37232 USA.	tony.weil@vanderbilt.edu			National Institutes of Health [R01 GM115892, T32 GM008554]; National Institutes of Health Center Core Grant [5P30CA068485-18]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM115892, T32GM008554] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health Center Core Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported in part by National Institutes of Health Grant R01 GM115892 (to P. A. W.) and National Institutes of Health Center Core Grant 5P30CA068485-18. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.r Supported by National Institutes of Health Grant T32 GM008554.	Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3; Andrews FH, 2016, NAT CHEM BIOL, V12, P396, DOI 10.1038/nchembio.2065; Bai Y, 1997, MOL CELL BIOL, V17, P3081, DOI 10.1128/MCB.17.6.3081; Basehoar AD, 2004, CELL, V116, P699, DOI 10.1016/S0092-8674(04)00205-3; Bieniossek C, 2013, NATURE, V493, P699, DOI 10.1038/nature11791; BOEKE JD, 1987, METHOD ENZYMOL, V154, P164; Bonnet J, 2014, GENE DEV, V28, P1999, DOI 10.1101/gad.250225.114; Brachmann CB, 1998, YEAST, V14, P115; Brand M, 1999, SCIENCE, V286, P2151, DOI 10.1126/science.286.5447.2151; Burke TW, 1997, GENE DEV, V11, P3020, DOI 10.1101/gad.11.22.3020; Cairns BR, 1996, MOL CELL BIOL, V16, P3308; Chalkley GE, 1999, EMBO J, V18, P4835, DOI 10.1093/emboj/18.17.4835; Cianfrocco MA, 2013, CELL, V152, P120, DOI 10.1016/j.cell.2012.12.005; Dabrowski S, 1998, PROTEIN EXPRES PURIF, V14, P131, DOI 10.1006/prep.1998.0945; DYNLACHT BD, 1991, CELL, V66, P563, DOI 10.1016/0092-8674(81)90019-2; Gangloff YG, 2001, MOL CELL BIOL, V21, P1841, DOI 10.1128/MCB.21.5.1841-1853.2001; Garbett KA, 2007, MOL CELL BIOL, V27, P297, DOI 10.1128/MCB.01558-06; Gazit K, 2009, J BIOL CHEM, V284, P26286, DOI 10.1074/jbc.M109.011486; Gietz RD, 2007, NAT PROTOC, V2, P31, DOI 10.1038/nprot.2007.13; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B; Guermah M, 2001, MOL CELL BIOL, V21, P6882, DOI 10.1128/MCB.21.20.6882-6894.2001; Hahn S, 2011, GENETICS, V189, P705, DOI 10.1534/genetics.111.127019; HENRY NL, 1994, GENE DEV, V8, P2868, DOI 10.1101/gad.8.23.2868; HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2; Huisinga KL, 2004, MOL CELL, V13, P573, DOI 10.1016/S1097-2765(04)00087-5; Jacobson RH, 2000, SCIENCE, V288, P1422, DOI 10.1126/science.288.5470.1422; Kabani M, 2005, BIOCHEM BIOPH RES CO, V332, P398, DOI 10.1016/j.bbrc.2005.04.158; Kaufmann J, 1996, GENE DEV, V10, P873, DOI 10.1101/gad.10.7.873; Kaufmann J, 1998, MOL CELL BIOL, V18, P233, DOI 10.1128/MCB.18.1.233; Klebanow ER, 1997, J BIOL CHEM, V272, P9436; Klebanow ER, 1996, J BIOL CHEM, V271, P13706, DOI 10.1074/jbc.271.23.13706; Knutson BA, 2011, MOL CELL BIOL, V31, P818, DOI 10.1128/MCB.00687-10; Kraemer SM, 2001, MOL CELL BIOL, V21, P1737, DOI 10.1128/MCB.21.5.1737-1746.2001; Kushnirov VV, 2000, YEAST, V16, P857, DOI 10.1002/1097-0061(20000630)16:9<857::AID-YEA561>3.0.CO;2-B; Ladurner AG, 2003, MOL CELL, V11, P365, DOI 10.1016/S1097-2765(03)00035-2; Lauberth SM, 2013, CELL, V152, P1021, DOI 10.1016/j.cell.2013.01.052; Layer JH, 2013, J BIOL CHEM, V288, P23273, DOI 10.1074/jbc.M113.486829; Layer JH, 2010, J BIOL CHEM, V285, P15489, DOI 10.1074/jbc.M110.104810; Leurent C, 2004, EMBO J, V23, P719, DOI 10.1038/sj.emboj.7600111; Leurent C, 2002, EMBO J, V21, P3424, DOI 10.1093/emboj/cdf342; Li XY, 2000, SCIENCE, V288, P1242, DOI 10.1126/science.288.5469.1242; Li YY, 2016, MOL CELL, V62, P181, DOI 10.1016/j.molcel.2016.03.028; Lim CY, 2004, GENE DEV, V18, P1606, DOI 10.1101/gad.1193404; Lin CQ, 2010, MOL CELL, V37, P429, DOI 10.1016/j.molcel.2010.01.026; Liu WL, 2009, GENE DEV, V23, P1510, DOI 10.1101/gad.1790709; Louder RK, 2016, NATURE, V531, P604, DOI 10.1038/nature17394; Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387; Matangkasombut O, 2000, GENE DEV, V14, P951; Mizzen CA, 1996, CELL, V87, P1261, DOI 10.1016/S0092-8674(00)81821-8; Moqtaderi Z, 1996, P NATL ACAD SCI USA, V93, P14654, DOI 10.1073/pnas.93.25.14654; MUMBERG D, 1994, NUCLEIC ACIDS RES, V22, P5767, DOI 10.1093/nar/22.25.5767; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Oelgeschlager T, 1996, NATURE, V382, P735, DOI 10.1038/382735a0; Olave I, 1998, GENE DEV, V12, P1621, DOI 10.1101/gad.12.11.1621; Papai G, 2011, CURR OPIN GENET DEV, V21, P219, DOI 10.1016/j.gde.2011.01.009; Papai G, 2010, NATURE, V465, P956, DOI 10.1038/nature09080; Papai G, 2009, STRUCTURE, V17, P363, DOI 10.1016/j.str.2009.01.006; Plaschka C, 2016, NATURE, V533, P353, DOI 10.1038/nature17990; POON D, 1991, MOL CELL BIOL, V11, P4809, DOI 10.1128/MCB.11.10.4809; POON D, 1994, J BIOL CHEM, V269, P23135; POON D, 1995, P NATL ACAD SCI USA, V92, P8224, DOI 10.1073/pnas.92.18.8224; RAY BL, 1991, CURR GENET, V20, P25, DOI 10.1007/BF00312761; REESE JC, 1994, NATURE, V371, P523, DOI 10.1038/371523a0; Reiss DJ, 2011, J BIOL CHEM, V286, P44726, DOI 10.1074/jbc.M111.290684; Rhee HS, 2012, NATURE, V483, P295, DOI 10.1038/nature10799; Robinson MM, 2005, MOL CELL BIOL, V25, P945, DOI 10.1128/MCB.25.3.945-957.2005; Sanders SL, 2000, J BIOL CHEM, V275, P13895, DOI 10.1074/jbc.275.18.13895; Sanders SL, 2002, MOL CELL BIOL, V22, P6000, DOI 10.1128/MCB.22.16.6000-6013.2002; Sanders SL, 2002, MOL CELL BIOL, V22, P4723, DOI 10.1128/MCB.22.13.4723-4738.2002; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schulze JM, 2010, MOL GENET GENOMICS, V283, P365, DOI 10.1007/s00438-010-0523-x; Schulze JM, 2009, BIOCHEM CELL BIOL, V87, P65, DOI 10.1139/O08-111; Shanle EK, 2015, GENE DEV, V29, P1795, DOI 10.1101/gad.269977.115; Shao HS, 2005, MOL CELL BIOL, V25, P206, DOI 10.1128/MCB.25.1.206-219.2005; Shen WC, 2003, EMBO J, V22, P3395, DOI 10.1093/emboj/cdg336; Singh MV, 2004, MOL CELL BIOL, V24, P4929, DOI 10.1128/MCB.24.11.4929-4942.2004; Takahashi H, 2011, CELL, V146, P92, DOI 10.1016/j.cell.2011.06.005; TANESE N, 1991, GENE DEV, V5, P2212, DOI 10.1101/gad.5.12a.2212; Thomas MC, 2006, CRIT REV BIOCHEM MOL, V41, P105, DOI 10.1080/10409230600648736; Tora L, 2002, GENE DEV, V16, P673, DOI 10.1101/gad.976402; Trowitzsch S, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7011; van Nuland R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073495; Vermeulen M, 2007, CELL, V131, P58, DOI 10.1016/j.cell.2007.08.016; VERRIJZER CP, 1994, SCIENCE, V264, P933, DOI 10.1126/science.8178153; WELCH MD, 1994, MOL BIOL CELL, V5, P617, DOI 10.1091/mbc.5.6.617; WOONTNER M, 1991, MOL CELL BIOL, V11, P4555, DOI 10.1128/MCB.11.9.4555; Yakovchuk P, 2010, J MOL BIOL, V397, P57, DOI 10.1016/j.jmb.2010.01.025; Yang JY, 2015, NUCLEIC ACIDS RES, V43, pW174, DOI 10.1093/nar/gkv342; Yoshikawa K, 2011, YEAST, V28, P349, DOI 10.1002/yea.1843; Zhang ZJ, 2015, ELIFE, V4, DOI 10.7554/eLife.07777	90	9	10	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22721	22740		10.1074/jbc.M116.751107	http://dx.doi.org/10.1074/jbc.M116.751107			20	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587401	hybrid, Green Published			2022-12-26	WOS:000386760600031
J	Feng, SM; Zhao, YC; Xu, YX; Ning, SK; Huo, W; Hou, M; Gao, G; Ji, JG; Guo, R; Xu, DY				Feng, Sumin; Zhao, Yichao; Xu, Yixi; Ning, Shaokai; Huo, Wei; Hou, Mei; Gao, Ge; Ji, Jianguo; Guo, Rong; Xu, Dongyi			Ewing Tumor-associated Antigen 1 Interacts with Replication Protein A to Promote Restart of Stalled Replication Forks	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA damage; DNA damage response; DNA recombination; DNA repair; DNA replication; ATR; ETAA1; Ewing tumor-associated antigen 1; RPA; stalled replication fork restart; ATR; replication stress	DNA-DAMAGE RESPONSE; SINGLE-STRANDED-DNA; RPA-SSDNA; CHECKPOINT; ACTIVATION; PATHWAYS; SMARCAL1; REPAIR; XRCC4	The replication protein A (RPA) complex binds single-stranded DNA generated at stalled replication forks and recruits other DNA repair proteins to promote recovery of these forks. Here, we identify Ewing tumor-associated antigen 1 (ETAA1), which has been linked to susceptibility to pancreatic cancer, as a new repair protein that is recruited to stalled forks by RPA. We demonstrate that ETAA1 interacts with RPA through two regions, each of which resembles two previously identified RPA-binding domains, RPA70N-binding motif and RPA32C-binding motif, respectively. In response to replication stress, ETAA1 is recruited to stalled forks where it colocalizes with RPA, and this recruitment is diminished when RPA is depleted. Notably, inactivation of the ETAA1 gene increases the collapse level of the stalled replication forks and decreases the recovery efficiency of these forks. Moreover, epistasis analysis shows that ETAA1 stabilizes stalled replication forks in an ataxia telangiectasia and Rad3-related protein (ATR)-independent manner. Thus, our results reveal that ETAA1 is a novel RPA-interacting protein that promotes restart of stalled replication forks.	[Feng, Sumin; Zhao, Yichao; Xu, Yixi; Ning, Shaokai; Huo, Wei; Hou, Mei; Gao, Ge; Ji, Jianguo; Guo, Rong; Xu, Dongyi] Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China	Peking University	Guo, R; Xu, DY (corresponding author), Peking Univ, Sch Life Sci, State Key Lab Prot & Plant Gene Res, Beijing 100871, Peoples R China.	guorong@pku.edu.cn; xudongyi@pku.edu.cn		Xu, Dongyi/0000-0001-5711-2618	National Basic Research Program of China [2013CB911002]; National Natural Science Foundation of China [31271435, 31370836]	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported in part by the National Basic Research Program of China Grant 2013CB911002 and the National Natural Science Foundation of China Grants 31271435 and 31370836. The authors declare that they have no conflicts of interest with the contents of this article.	Bansbach CE, 2009, GENE DEV, V23, P2405, DOI 10.1101/gad.1839909; Byun TS, 2005, GENE DEV, V19, P1040, DOI 10.1101/gad.1301205; Childs EJ, 2015, NAT GENET, V47, P911, DOI 10.1038/ng.3341; Ciccia A, 2009, GENE DEV, V23, P2415, DOI 10.1101/gad.1832309; Cong L, 2013, SCIENCE, V339, P819, DOI 10.1126/science.1231143; Davies SL, 2007, NAT STRUCT MOL BIOL, V14, P677, DOI 10.1038/nsmb1267; Driscoll R, 2009, GENE DEV, V23, P2359, DOI 10.1101/gad.1860609; Elia AEH, 2015, MOL CELL, V60, P280, DOI 10.1016/j.molcel.2015.09.011; Fanning E, 2006, NUCLEIC ACIDS RES, V34, P4126, DOI 10.1093/nar/gkl550; Feldkamp MD, 2014, BIOCHEMISTRY-US, V53, P3052, DOI 10.1021/bi500252w; Gong ZH, 2011, J BIOL CHEM, V286, P22308, DOI 10.1074/jbc.M111.222869; Iftode C, 1999, CRIT REV BIOCHEM MOL, V34, P141, DOI 10.1080/10409239991209255; Jackson SP, 2002, CARCINOGENESIS, V23, P687, DOI 10.1093/carcin/23.5.687; Katsube T, 2011, J RADIAT RES, V52, P415, DOI 10.1269/jrr.10168; Lambert S, 2005, BIOCHIMIE, V87, P591, DOI 10.1016/j.biochi.2004.10.020; Liu SF, 2011, J BIOL CHEM, V286, P22314, DOI 10.1074/jbc.M111.222802; Marechal A, 2014, MOL CELL, V53, P235, DOI 10.1016/j.molcel.2013.11.002; Petermann E, 2010, NAT REV MOL CELL BIO, V11, P683, DOI 10.1038/nrm2974; Sogo JM, 2002, SCIENCE, V297, P599, DOI 10.1126/science.1074023; Stauffer ME, 2004, J BIOL CHEM, V279, P25638, DOI 10.1074/jbc.M400029200; Tercero JA, 2003, MOL CELL, V11, P1323, DOI 10.1016/S1097-2765(03)00169-2; Toledo LI, 2013, CELL, V155, P1088, DOI 10.1016/j.cell.2013.10.043; Wold MS, 1997, ANNU REV BIOCHEM, V66, P61, DOI 10.1146/annurev.biochem.66.1.61; Xie S, 2014, FEBS J, V281, P3382, DOI 10.1111/febs.12867; Xing MT, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7233; Xu X, 2008, MOL CELL BIOL, V28, P7345, DOI 10.1128/MCB.01079-08; Yuan JS, 2009, GENE DEV, V23, P2394, DOI 10.1101/gad.1836409; Zou L, 2003, SCIENCE, V300, P1542, DOI 10.1126/science.1083430	28	37	39	1	20	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					21956	21962		10.1074/jbc.C116.747758	http://dx.doi.org/10.1074/jbc.C116.747758			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27601467	hybrid, Green Published			2022-12-26	WOS:000386332600011
J	Mallet, JD; Dorr, MM; Desgarnier, MCD; Bastien, N; Gendron, SP; Rochette, PJ				Mallet, Justin D.; Dorr, Marie M.; Desgarnier, Marie-Catherine Drigeard; Bastien, Nathalie; Gendron, Sebastien P.; Rochette, Patrick J.			Faster DNA Repair of Ultraviolet-Induced Cyclobutane Pyrimidine Dimers and Lower Sensitivity to Apoptosis in Human Corneal Epithelial Cells than in Epidermal Keratinocytes	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; XERODERMA-PIGMENTOSUM; MOLECULAR-MECHANISMS; XPC PROTEIN; DAMAGED DNA; UV DAMAGE; PHOTOPRODUCTS; LIGHT; P53; EPIDEMIOLOGY	Absorption of UV rays by DNA generates the formation of mutagenic cyclobutane pyrimidine dimers (CPD) and pyrimidine (6-4) pyrimidone photoproducts (6-4PP). These damages are the major cause of skin cancer because in turn, they can lead to signature UV mutations. The eye is exposed to UV light, but the cornea is orders of magnitude less prone to UV-induced cancer. In an attempt to shed light on this paradox, we compared cells of the corneal epithelium and the epidermis for UVB-induced DNA damage frequency, repair and cell death sensitivity. We found similar CPD levels but a 4-time faster UVB-induced CPD, but not 6-4PP, repair and lower UV-induced apoptosis sensitivity in corneal epithelial cells than epidermal. We then investigated levels of DDB2, a UV-induced DNA damage recognition protein mostly impacting CPD repair, XPC, essential for the repair of both CPD and 6-4PP and p53 a protein upstream of the genotoxic stress response. We found more DDB2, XPC and p53 in corneal epithelial cells than in epidermal cells. According to our results analyzing the protein stability of DDB2 and XPC, the higher level of DDB2 and XPC in corneal epithelial cells is most likely due to an increased stability of the protein. Taken together, our results show that corneal epithelial cells have a better efficiency to repair UV-induced mutagenic CPD. On the other hand, they are less prone to UV-induced apoptosis, which could be related to the fact that since the repair is more efficient in the HCEC, the need to eliminate highly damaged cells by apoptosis is reduced.	[Mallet, Justin D.; Dorr, Marie M.; Desgarnier, Marie-Catherine Drigeard; Bastien, Nathalie; Gendron, Sebastien P.; Rochette, Patrick J.] Univ Laval, Hop St Sacrement, CHU Quebec, Axe Med Regeneratrice,Ctr Rech, Quebec City, PQ, Canada; [Mallet, Justin D.; Dorr, Marie M.; Desgarnier, Marie-Catherine Drigeard; Bastien, Nathalie; Gendron, Sebastien P.; Rochette, Patrick J.] Univ Laval, LOEX, Ctr Rech Organogenese Expt, Quebec City, PQ, Canada; [Mallet, Justin D.; Dorr, Marie M.; Desgarnier, Marie-Catherine Drigeard; Bastien, Nathalie; Gendron, Sebastien P.; Rochette, Patrick J.] Univ Laval, Dept Ophtalmol & ORL Chirurg Cerv Faciale, Quebec City, PQ, Canada	Laval University; Laval University; Laval University	Rochette, PJ (corresponding author), Univ Laval, Hop St Sacrement, CHU Quebec, Axe Med Regeneratrice,Ctr Rech, Quebec City, PQ, Canada.; Rochette, PJ (corresponding author), Univ Laval, LOEX, Ctr Rech Organogenese Expt, Quebec City, PQ, Canada.; Rochette, PJ (corresponding author), Univ Laval, Dept Ophtalmol & ORL Chirurg Cerv Faciale, Quebec City, PQ, Canada.	Patrick.rochette@orlo.ulaval.ca	Rochette, Patrick/HHN-2300-2022	Rochette, Patrick/0000-0002-0678-8869	Natural Sciences and Engineering Research Council of Canada; Reseau de recherche en sante de la vision du FRQS;  [RGPIN-2016-05864]	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Reseau de recherche en sante de la vision du FRQS; 	This work was supported by Grant number: RGPIN-2016-05864; Funding agency: Natural Sciences and Engineering Research Council of Canada; Website: http://www.nserc-crsng.gc.ca. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors are grateful to La Banque de cellules du LOEX for providing NHEK and to La Banque de tissus oculaires du CUO de Quebec, supported by the Reseau de recherche en sante de la vision du FRQS for providing eye specimens.	Adimoolam S, 2003, DNA REPAIR, V2, P947, DOI 10.1016/S1568-7864(03)00087-9; Alekseev S, 2005, CANCER RES, V65, P10298, DOI 10.1158/0008-5472.CAN-05-2295; ANANTHASWAMY HN, 1990, PHOTOCHEM PHOTOBIOL, V52, P1119, DOI 10.1111/j.1751-1097.1990.tb08452.x; [Anonymous], 1985, MUTAT RES, DOI 10.1016/j.mrrev.2008.09.001; Araujo SJ, 2000, GENE DEV, V14, P349; Armstrong BK, 2001, J PHOTOCH PHOTOBIO B, V63, P8, DOI 10.1016/S1011-1344(01)00198-1; Barckhausen C, 2014, ONCOGENE, V33, P1964, DOI 10.1038/onc.2013.141; Batista LFZ, 2009, MUTAT RES-REV MUTAT, V681, P197, DOI 10.1016/j.mrrev.2008.09.001; BERGSTRESSER PR, 1978, J INVEST DERMATOL, V70, P280, DOI 10.1111/1523-1747.ep12541516; Bernstein C, 2002, MUTAT RES-REV MUTAT, V511, P145, DOI 10.1016/S1383-5742(02)00009-1; BOETTNER EA, 1962, INVEST OPHTH VISUAL, V1, P776; Brash DE, 2005, SEMIN CANCER BIOL, V15, P97, DOI 10.1016/j.semcancer.2004.08.006; Brash DE, 2001, J INVEST DERMATOL, V117, P1234, DOI 10.1046/j.0022-202x.2001.01554.x; BRASH DE, 1988, PHOTOCHEM PHOTOBIOL, V48, P59; Brash DE, 2015, PHOTOCHEM PHOTOBIOL, V91, P15, DOI 10.1111/php.12377; BRULS WAG, 1984, PHOTOCHEM PHOTOBIOL, V40, P485, DOI 10.1111/j.1751-1097.1984.tb04622.x; Choy CKM, 2011, OPTOMETRY VISION SCI, V88, P507, DOI 10.1097/OPX.0b013e31820e9fe2; Cleaver JE, 2005, NAT REV CANCER, V5, P564, DOI 10.1038/nrc1652; Cook BE, 1999, OPHTHALMOLOGY, V106, P746, DOI 10.1016/S0161-6420(99)90161-6; Eden E, 2011, SCIENCE, V331, P764, DOI 10.1126/science.1199784; El Ghissassi F, 2009, LANCET ONCOL, V10, P751, DOI 10.1016/S1470-2045(09)70213-X; Ferguson-Yates BE, 2008, CARCINOGENESIS, V29, P70, DOI 10.1093/carcin/bgm244; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; Friedberg EC, 2001, NAT REV CANCER, V1, P22, DOI 10.1038/35094000; FRIEDBERG EC, 1995, TRENDS BIOCHEM SCI, V20, P381, DOI 10.1016/S0968-0004(00)89082-9; Germain L, 1999, PATHOBIOLOGY, V67, P140, DOI 10.1159/000028064; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Han WN, 2011, J BIOL CHEM, V286, P22825, DOI 10.1074/jbc.M111.222349; He JS, 2014, J BIOL CHEM, V289, P27278, DOI 10.1074/jbc.M114.589812; He YY, 2008, CANCER RES, V68, P3752, DOI 10.1158/0008-5472.CAN-07-6138; Hey T, 2002, BIOCHEMISTRY-US, V41, P6583, DOI 10.1021/bi012202t; Higa K, 2005, EXP EYE RES, V81, P218, DOI 10.1016/j.exer.2005.01.023; Holmquist GP, 1997, MUTAT RES-REV MUTAT, V386, P69, DOI 10.1016/S1383-5742(96)00045-2; HUTCHINSON F, 1994, MUTAT RES-FUND MOL M, V309, P11, DOI 10.1016/0027-5107(94)90037-X; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2012, IARC Monogr Eval Carcinog Risks Hum, V100, P11; JIANG N, 1993, BIOCHEMISTRY-US, V32, P472, DOI 10.1021/bi00053a011; Jin SK, 2001, J CELL SCI, V114, P4139; Kao AA, 2012, OPHTHALMOLOGY, V119, P1773, DOI 10.1016/j.ophtha.2012.02.049; KIM JK, 1995, PHOTOCHEM PHOTOBIOL, V62, P44, DOI 10.1111/j.1751-1097.1995.tb05236.x; KIM JK, 1995, EUR J BIOCHEM, V228, P849, DOI 10.1111/j.1432-1033.1995.0849m.x; Knezevic D, 2007, P NATL ACAD SCI USA, V104, P11286, DOI 10.1073/pnas.0701318104; Kobayashi N, 1998, J INVEST DERMATOL, V110, P806, DOI 10.1046/j.1523-1747.1998.00178.x; KRAEMER KH, 1984, CARCINOGENESIS, V5, P511, DOI 10.1093/carcin/5.4.511; Krauthammer M, 2012, NAT GENET, V44, P1006, DOI 10.1038/ng.2359; Kulms D, 2002, SKIN PHARMACOL APPL, V15, P342, DOI 10.1159/000064539; LEBKOWSKI JS, 1985, P NATL ACAD SCI USA, V82, P8606, DOI 10.1073/pnas.82.24.8606; LEE GA, 1994, OPHTHALMOLOGY, V101, P360; Lerman S., 1980, RADIANT ENERGY EYE, P73; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mallet JD, 2013, PHOTOCH PHOTOBIO SCI, V12, P1310, DOI 10.1039/c3pp25408a; Mallet JD, 2011, PHOTOCHEM PHOTOBIOL, V87, P1363, DOI 10.1111/j.1751-1097.2011.00977.x; MCGREGOR WG, 1991, MOL CELL BIOL, V11, P1927, DOI 10.1128/MCB.11.4.1927; MILLER JH, 1983, ANNU REV GENET, V17, P215, DOI 10.1146/annurev.ge.17.120183.001243; Mitchell DL, 1985, MUTAT RES, V143, P109; Moser J, 2005, DNA REPAIR, V4, P571, DOI 10.1016/j.dnarep.2005.01.001; NANCE MA, 1992, AM J MED GENET, V42, P68, DOI 10.1002/ajmg.1320420115; Newton R, 1996, LANCET, V347, P1450, DOI 10.1016/S0140-6736(96)91685-2; Nijhof JGW, 2007, CARCINOGENESIS, V28, P792, DOI 10.1093/carcin/bgl213; NORREN DV, 1974, VISION RES, V14, P1237, DOI 10.1016/0042-6989(74)90222-3; Norval M, 2007, PHOTOCH PHOTOBIO SCI, V6, P232, DOI 10.1039/b700018a; Oh KS, 2011, PHOTOCHEM PHOTOBIOL, V87, P729, DOI 10.1111/j.1751-1097.2011.00909.x; Oh KS, 2011, J INVEST DERMATOL, V131, P785, DOI 10.1038/jid.2010.352; Pfeifer GP, 2012, PHOTOCH PHOTOBIO SCI, V11, P90, DOI 10.1039/c1pp05144j; Pfeifer GP, 1997, PHOTOCHEM PHOTOBIOL, V65, P270, DOI 10.1111/j.1751-1097.1997.tb08560.x; Premi S, 2015, SCIENCE, V347, P842, DOI 10.1126/science.1256022; Ramkumar HL, 2011, SURV OPHTHALMOL, V56, P348, DOI 10.1016/j.survophthal.2011.03.001; Ramos T, 2015, STEM CELLS INT, V2015, DOI 10.1155/2015/601731; Reinstein DZ, 2008, J REFRACT SURG, V24, P571, DOI 10.3928/1081597X-20080601-05; Rochette PJ, 2008, MECH AGEING DEV, V129, P207, DOI 10.1016/j.mad.2007.12.007; Rochette PJ, 2006, PHOTOCHEM PHOTOBIOL, V82, P1370, DOI 10.1562/2004-12-01-RA-390; Rodust PM, 2009, BRIT J DERMATOL, V161, P107, DOI 10.1111/j.1365-2133.2009.09458.x; Rogers HW, 2015, JAMA DERMATOL, V151, P1081, DOI 10.1001/jamadermatol.2015.1187; SAGE E, 1993, PHOTOCHEM PHOTOBIOL, V57, P163, DOI 10.1111/j.1751-1097.1993.tb02273.x; Sasaki H, 2011, EYE CONTACT LENS, V37, P191, DOI 10.1097/ICL.0b013e31821fbf29; Seo YR, 2004, EXP MOL MED, V36, P505, DOI 10.1038/emm.2004.64; Shields CL, 2004, SURV OPHTHALMOL, V49, P3, DOI 10.1016/j.survophthal.2003.10.008; Shimmura S, 2006, OCUL SURF, V4, P74, DOI 10.1016/S1542-0124(12)70029-0; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Sun EC, 1997, CANCER EPIDEM BIOMAR, V6, P73; TAYLOR HR, 1989, PHOTOCHEM PHOTOBIOL, V50, P489, DOI 10.1111/j.1751-1097.1989.tb05553.x; Thilly W G, 1983, Basic Life Sci, V23, P337; Tornaletti S, 1996, BIOESSAYS, V18, P221, DOI 10.1002/bies.950180309; Wang QE, 2004, CARCINOGENESIS, V25, P1033, DOI 10.1093/carcin/bgh085; Wittschieben BO, 2005, J BIOL CHEM, V280, P39982, DOI 10.1074/jbc.M507854200; Xu GG, 2000, J INVEST DERMATOL, V114, P628, DOI 10.1046/j.1523-1747.2000.00943.x; Yoon T, 2005, ONCOGENE, V24, P469, DOI 10.1038/sj.onc.1208211; YOUNG RW, 1994, OPTOMETRY VISION SCI, V71, P125, DOI 10.1097/00006324-199402000-00013; Zhang WG, 2001, P NATL ACAD SCI USA, V98, P13948, DOI 10.1073/pnas.241353198	88	24	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162212	10.1371/journal.pone.0162212	http://dx.doi.org/10.1371/journal.pone.0162212			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611318	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900058
J	Kim, SY; Sim, CK; Zhang, QY; Tang, H; Brunmeir, R; Pan, H; Karnani, N; Han, WP; Zhang, KL; Xu, F				Kim, Sun-Yee; Sim, Choon Kiat; Zhang, Qiongyi; Tang, Hui; Brunmeir, Reinhard; Pan, Hong; Karnani, Neerja; Han, Weiping; Zhang, Kangling; Xu, Feng			An Alternative Strategy for Pan-acetyl-lysine Antibody Generation	PLOS ONE			English	Article							ENRICHMENT; METABOLISM; TARGETS	Lysine acetylation is an important post-translational modification in cell signaling. In acetylome studies, a high-quality pan-acetyl-lysine antibody is key to successful enrichment of acetylated peptides for subsequent mass spectrometry analysis. Here we show an alternative method to generate polyclonal pan-acetyl-lysine antibodies using a synthesized random library of acetylated peptides as the antigen. Our antibodies are tested to be specific for acetyl-lysine peptides/proteins via ELISA and dot blot. When pooled, five of our antibodies show broad reactivity to acetyl-lysine peptides, complementing a commercial antibody in terms of peptide coverage. The consensus sequence of peptides bound by our antibody cocktail differs slightly from that of the commercial antibody. Lastly, our antibodies are tested in a proof-of-concept to analyze the acetylome of HEK293 cells. In total we identified 1557 acetylated peptides from 416 proteins. We thus demonstrated that our antibodies are well-qualified for acetylome studies and can complement existing commercial antibodies.	[Kim, Sun-Yee; Sim, Choon Kiat; Zhang, Qiongyi; Brunmeir, Reinhard; Pan, Hong; Karnani, Neerja; Xu, Feng] Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore; [Tang, Hui; Zhang, Kangling] Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA; [Han, Weiping] Agcy Sci Technol & Res, Lab Metab Med, Singapore Bioimaging Consortium, Singapore, Singapore; [Han, Weiping; Xu, Feng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore; [Han, Weiping; Xu, Feng] Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore	Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); University of Texas System; University of Texas Medical Branch Galveston; Agency for Science Technology & Research (A*STAR); A*STAR - Institute of Bioengineering & Bioimaging (IBB); A*STAR - Singapore Bioimaging Consortium (SBIC); National University of Singapore; National University of Singapore	Xu, F (corresponding author), Agcy Sci Technol & Res, Singapore Inst Clin Sci, Singapore, Singapore.; Zhang, KL (corresponding author), Univ Texas Med Branch, Dept Pharmacol & Toxicol, Galveston, TX 77555 USA.; Zhang, KL; Xu, F (corresponding author), Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Biochem, Singapore, Singapore.; Xu, F (corresponding author), Duke NUS Grad Med Sch, Cardiovasc & Metab Disorders Program, Singapore, Singapore.	kazhang@utmb.edu; xu_feng@sics.a-star.edu.sg	Sim, Choon Kiat/B-1820-2014	Sim, Choon Kiat/0000-0002-7871-2134; Brunmeir, Reinhard/0000-0001-7545-2819; KIM, Sun-Yee/0000-0002-8061-2271; Karnani, Neerja/0000-0002-5301-409X; Xu, Feng/0000-0003-2016-7521	Agency for Science, Technology and Research (A*STAR) of Singapore; A*STAR of Singapore	Agency for Science, Technology and Research (A*STAR) of Singapore(Agency for Science Technology & Research (A*STAR)); A*STAR of Singapore(Agency for Science Technology & Research (A*STAR))	This work was supported by the intramural funding from the Agency for Science, Technology and Research (A*STAR) of Singapore to FX. Funding for the open-access charge was provided by A*STAR of Singapore. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chen Y, 2007, MOL CELL PROTEOMICS, V6, P812, DOI 10.1074/mcp.M700021-MCP200; Choudhary C, 2014, NAT REV MOL CELL BIO, V15, P536, DOI 10.1038/nrm3841; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Colaert N, 2009, NAT METHODS, V6, P786, DOI 10.1038/nmeth1109-786; Franzel B, 2015, PROTEOMICS, V15, P44, DOI 10.1002/pmic.201400015; Gu W, 1997, CELL, V90, P595, DOI 10.1016/S0092-8674(00)80521-8; Guan KL, 2010, NAT PROTOC, V5, P1583, DOI 10.1038/nprot.2010.117; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Huynh Mai-Loan, 2009, V519, P507, DOI 10.1007/978-1-59745-281-6_34; Kim SY, 2016, ARCH BIOCHEM BIOPHYS, V598, P1, DOI 10.1016/j.abb.2016.03.025; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140619; Kim SY, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133448; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; LHERNAULT SW, 1985, BIOCHEMISTRY-US, V24, P473, DOI 10.1021/bi00323a034; Lundby A, 2012, CELL REP, V2, P419, DOI 10.1016/j.celrep.2012.07.006; MEGEE PC, 1990, SCIENCE, V247, P841, DOI 10.1126/science.2106160; Qiang LP, 2005, J IMMUNOASS IMMUNOCH, V26, P13, DOI 10.1081/IAS-200041153; Suka N, 2001, MOL CELL, V8, P473, DOI 10.1016/S1097-2765(01)00301-X; Svinkina T, 2015, MOL CELL PROTEOMICS, V14, P2429, DOI 10.1074/mcp.O114.047555; Verdin E, 2015, NAT REV MOL CELL BIO, V16, P258, DOI 10.1038/nrm3931; Weinert BT, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001902; Winter D, 2015, METHODS MOL BIOL, V1295, P259, DOI 10.1007/978-1-4939-2550-6_20; Xu Wei, 2013, Methods Mol Biol, V981, P137, DOI 10.1007/978-1-62703-305-3_11; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	24	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162528	10.1371/journal.pone.0162528	http://dx.doi.org/10.1371/journal.pone.0162528			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606599	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600057
J	Lin, ZG; Page, P; Li, L; Qin, Y; Zhang, YY; Hu, FL; Neumann, P; Zheng, HQ; Dietemann, V				Lin, Zheguang; Page, Paul; Li, Li; Qin, Yao; Zhang, Yingying; Hu, Fuliang; Neumann, Peter; Zheng, Huoqing; Dietemann, Vincent			Go East for Better Honey Bee Health: Apis cerana Is Faster at Hygienic Behavior than A. mellifera	PLOS ONE			English	Article							VARROA-JACOBSONI OUD; AMERICAN FOULBROOD; COLONY LOSSES; BROOD; HYMENOPTERA; RESISTANCE; DISEASE; APIDAE; DESTRUCTOR; RESPONSES	The poor health status of the Western honey bee, Apis mellifera, compared to its Eastern counterpart, Apis cerana, is remarkable. This has been attributed to lower pathogen prevalence in A. cerana colonies and to their ability to survive infestations with the ectoparasitic mite, Varroa destructor. These properties have been linked to an enhanced removal of dead or unhealthy immature bees by adult workers in this species. Although such hygienic behavior is known to contribute to honey bee colony health, comparative data of A. mellifera and A. cerana in performing this task are scarce. Here, we compare for the first time the removal of freeze-killed brood in one population of each species and over two seasons in China. Our results show that A. cerana was significantly faster than A. mellifera at both opening cell caps and removing freeze-killed brood. The fast detection and removal of diseased brood is likely to limit the proliferation of pathogenic agents. Given our results can be generalized to the species level, a rapid hygienic response could contribute to the better health of A. cerana. Promoting the fast detection and removal of worker brood through adapted breeding programs could further improve the social immunity of A. mellifera colonies and contribute to a better health status of the Western honey bee worldwide.	[Lin, Zheguang; Li, Li; Qin, Yao; Zhang, Yingying; Hu, Fuliang; Zheng, Huoqing] Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China; [Page, Paul; Dietemann, Vincent] Agroscope, Swiss Bee Res Ctr, Bern, Switzerland; [Neumann, Peter] Univ Bern, Inst Bee Hlth, Vetsuisse Fac, Bern, Switzerland; [Neumann, Peter] Chiang Mai Univ, Dept Biol, Bee Protect Lab, Fac Sci, Chiang Mai, Thailand; [Neumann, Peter; Dietemann, Vincent] Univ Pretoria, Dept Zool & Entomol, Social Insect Res Grp, Pretoria, South Africa	Zhejiang University; Swiss Federal Research Station Agroscope; University of Bern; Chiang Mai University; University of Pretoria	Zheng, HQ (corresponding author), Zhejiang Univ, Coll Anim Sci, Hangzhou, Zhejiang, Peoples R China.	hqzheng@zju.edu.cn	Zheng, Huoqing/AAQ-3307-2021; Neumann, Peter/C-9964-2015	Neumann, Peter/0000-0001-5163-5215	Modern Agro-industry Technology Research System [CARS-45]; Science and Technology Department of Zhejiang Province, China [2012C12906-19]; Fundamental Research Funds for the Central Universities; Swiss National Science Foundation grant [31003A_147363]; Vinetum Foundation	Modern Agro-industry Technology Research System; Science and Technology Department of Zhejiang Province, China; Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); Vinetum Foundation	This work was supported by Modern Agro-industry Technology Research System (No. CARS-45) and Science and Technology Department of Zhejiang Province, China (No. 2012C12906-19) to F.H., by the Fundamental Research Funds for the Central Universities to H.Z., by a Swiss National Science Foundation grant (No. 31003A_147363) to V.D. and P.N. and by the Vinetum Foundation to P.N. All of the funding bodies had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ai HX, 2012, J INVERTEBR PATHOL, V109, P160, DOI 10.1016/j.jip.2011.10.006; Palacio MA, 2010, APIDOLOGIE, V41, P602, DOI 10.1051/apido/2010022; ANDERSON DL, 1989, MITES PATHOGENS EURO; Athreya S.V.R., 2013, Current Biotica, V7, P101; BOECKING O, 1992, EXP APPL ACAROL, V16, P321, DOI 10.1007/BF01218574; Breeze TD, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082996; Briggs CJ, 1996, THEOR POPUL BIOL, V50, P149, DOI 10.1006/tpbi.1996.0027; Buchler R, 2013, J APICULT RES, V52, DOI 10.3896/IBRA.1.52.1.07; BURGETT M, 1985, J ECON ENTOMOL, V78, P1154, DOI 10.1093/jee/78.5.1154; Chantawannakul P, 2016, APIDOLOGIE, V47, P301, DOI 10.1007/s13592-015-0407-5; Chen YP, 2006, J INVERTEBR PATHOL, V92, P152, DOI 10.1016/j.jip.2006.03.010; Chen YW, 2000, J APICULT RES, V39, P169, DOI 10.1080/00218839.2000.11101038; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Danka RG, 2013, APIDOLOGIE, V44, P447, DOI 10.1007/s13592-013-0195-8; de Guzman LI, 2015, J APICULT RES, V54, P216, DOI 10.1080/00218839.2015.1117294; Ellis JD, 2005, BEE WORLD, V86, P88, DOI 10.1080/0005772X.2005.11417323; GILLIAM M, 1983, APIDOLOGIE, V14, P29, DOI 10.1051/apido:19830103; GILLIAM M, 1988, J INVERTEBR PATHOL, V52, P314, DOI 10.1016/0022-2011(88)90141-3; Gramacho KP, 2003, BEHAV ECOL SOCIOBIOL, V54, P472, DOI 10.1007/s00265-003-0643-y; Harbo JR, 1999, J ECON ENTOMOL, V92, P261, DOI 10.1093/jee/92.2.261; Highfield AC, 2009, APPL ENVIRON MICROB, V75, P7212, DOI 10.1128/AEM.02227-09; Jung JW, 2014, J ASIA-PAC ENTOMOL, V17, P639, DOI 10.1016/j.aspen.2014.01.012; Li JL, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0047955, 10.1371/journal.pone.0052699]; Liang Q, 2009, BEE PROTECTION; Masterman R, 2000, J INSECT BEHAV, V13, P87, DOI 10.1023/A:1007767626594; Meunier J, 2015, PHILOS T R SOC B, V370, DOI 10.1098/rstb.2014.0102; MILNE CP, 1985, ANN ENTOMOL SOC AM, V78, P841, DOI 10.1093/aesa/78.6.841; Mondet F, 2016, SCI REP-UK, V6, DOI 10.1038/srep25444; Mondet F, 2015, SCI REP-UK, V5, DOI 10.1038/srep10454; Moritz RFA, 2010, APIDOLOGIE, V41, P227, DOI 10.1051/apido/2010010; Neumann P, 2012, TRENDS PARASITOL, V28, P353, DOI 10.1016/j.pt.2012.06.004; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Page P, 2016, SCI REP-UK, V6, DOI 10.1038/srep27210; Pajuelo AG, 2008, J APICULT RES, V47, P84, DOI 10.1080/00218839.2008.11101429; PENG YS, 1987, J INVERTEBR PATHOL, V49, P54, DOI 10.1016/0022-2011(87)90125-X; PENG YSC, 1987, J INVERTEBR PATHOL, V49, P259, DOI [10.1016/0022-2011(87)90125-X, 10.1016/0022-2011(87)90057-7]; Rasolofoarivao H, 2015, GENET MOL RES, V14, P5879, DOI 10.4238/2015.June.1.5; RATH W, 1990, APIDOLOGIE, V21, P311, DOI 10.1051/apido:19900406; ROSENKRANZ P, 1993, J APICULT RES, V32, P89, DOI 10.1080/00218839.1993.11101292; Rosenkranz P, 2010, J INVERTEBR PATHOL, V103, pS96, DOI 10.1016/j.jip.2009.07.016; ROTHENBUHLER WC, 1964, AM ZOOL, V4, P111; Soroker V, 2011, APIDOLOGIE, V42, P192, DOI 10.1051/apido/2010047; Spivak M, 1998, APIDOLOGIE, V29, P291, DOI 10.1051/apido:19980308; Spivak M, 2001, APIDOLOGIE, V32, P555, DOI 10.1051/apido:2001103; Spivak M, 1998, BEE WORLD, V79, P169, DOI 10.1080/0005772X.1998.11099408; Spivak M, 2003, J NEUROBIOL, V55, P341, DOI 10.1002/neu.10219; Spivak M, 1998, J ECON ENTOMOL, V91, P64, DOI 10.1093/jee/91.1.64; Strange JP, 2009, J ECON ENTOMOL, V102, P485, DOI 10.1603/029.102.0204; Sumpter DJT, 2004, J ANIM ECOL, V73, P51, DOI 10.1111/j.1365-2656.2004.00776.x; Tentcheva D, 2004, APPL ENVIRON MICROB, V70, P7185, DOI 10.1128/AEM.70.12.7185-7191.2004; Topolska G, 2010, J APICULT RES, V49, P126, DOI 10.3896/IBRA.1.49.1.27; Toufailia HMA, 2015, J APICULT RES, V53, P555; Wilfert L, 2016, SCIENCE, V351, P594, DOI 10.1126/science.aac9976; Wilson-Rich N, 2009, ANNU REV ENTOMOL, V54, P405, DOI 10.1146/annurev.ento.53.103106.093301; Woltedji D, 2012, J PROTEOME RES, V11, P4526, DOI 10.1021/pr300298w; Xonis C., 2015, Bulgarian Journal of Agricultural Science, V21, P674; Yanez O, 2015, J APICULT RES, V54, P179, DOI 10.1080/00218839.2015.1128145; Yang Guan-Huang, 2005, Acta Entomologica Sinica, V48, P401; Zhao HX, 2015, GENET MOL RES, V14, P6482, DOI 10.4238/2015.June.12.1	59	23	29	0	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162647	10.1371/journal.pone.0162647	http://dx.doi.org/10.1371/journal.pone.0162647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606819	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600071
J	Divino, F; Corado, ADG; Naveca, FG; Stefani, MMA; Bello, G				Divino, Flavia; Guerra Corado, Andre de Lima; Naveca, Felipe Gomes; Stefani, Mariane M. A.; Bello, Gonzalo			High Prevalence and Onward Transmission of Non-Pandemic HIV-1 Subtype B Clades in Northern and Northeastern Brazilian Regions	PLOS ONE			English	Article							POPULATION-DYNAMICS; GENETIC DIVERSITY; DRUG-RESISTANCE; ALGORITHMS	The Human immunodeficiency virus type-1 (HIV-1) epidemic in Brazil is mainly driven by the subtype B pandemic lineage (B-PANDEMIC), while Caribbean non-pandemic subtype B clades (B-CAR) seem to account for a very low fraction of HIV-infections in this country. The molecular characteristics of the HIV-1 subtype B strains disseminated in the Northern and Northeastern Brazilian regions, however, have not been explored so far. In this study, we estimate the prevalence of the HIV-1 B-PANDEMIC and B-CAR clades across different Brazilian regions and we reconstruct the spatiotemporal dynamics of dissemination of the major Brazilian B-CAR clades. A total of 2,682 HIV-1 subtype B pol sequences collected from 21 different Brazilian states from the five country regions between 1998 and 2013 were analyzed. Maximum Likelihood phylogenetic analyses revealed that the B-CAR strains reached 16 out 21 Brazilian states here analyzed. The B-CAR clades comprise a low fraction (< 10%) of subtype B infections in most Brazilian states analyzed, with exception of Roraima (41%), Amazonas (14%) and Maranhao (14%). Bayesian phylogeographic analyses indicate that B-CAR strains originally from the Hispaniola and Trinidad and Tobago were introduced at multiple times into different states from all Brazilian regions and a few of those strains, probably introduced into Roraima, Maranhao and Sao Paulo between the late 1970s and the early 1980s, established secondary outbreaks in the Brazilian population. These results support that the HIV-1 subtype B epidemics in some Brazilian states from the Northern and Northeastern regions display a unique molecular pattern characterized by the high prevalence of B-CAR lineages, which probably reflects a strong epidemiological link with the HIV-1 epidemics in the Caribbean region.	[Divino, Flavia; Bello, Gonzalo] Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil; [Guerra Corado, Andre de Lima; Naveca, Felipe Gomes] Fundacao Oswaldo Cruz, Inst Leonidas & Maria Deane, Manaus, Amazonas, Brazil; [Stefani, Mariane M. A.] Univ Fed Goias, Trop Pathol & Publ Hlth Inst, Goiania, Go, Brazil	Fundacao Oswaldo Cruz; Fundacao Oswaldo Cruz; Universidade Federal de Goias	Bello, G (corresponding author), Fiocruz MS, Inst Oswaldo Cruz, Lab AIDS & Imunol Mol, Rio De Janeiro, RJ, Brazil.	gbellobr@gmail.com	Naveca, Felipe/H-1130-2012; Bentancor, Gonzalo Jose Bello/N-7377-2019; Bello, Gonzalo/E-6842-2013	Naveca, Felipe/0000-0002-2888-1060; Bentancor, Gonzalo Jose Bello/0000-0002-2724-2793; 	Public Health Service from the "Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro" (FAPERJ) [E-26/110.439/2014]; "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq) [472896/2012-1]; Instituto Oswaldo Cruz-FIOCRUZ	Public Health Service from the "Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro" (FAPERJ)(Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ)); "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Instituto Oswaldo Cruz-FIOCRUZ	GB was supported by Public Health Service grants E-26/110.439/2014 from the "Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro" (FAPERJ) and 472896/2012-1 from the "Conselho Nacional de Desenvolvimento Cientifico e Tecnologico" (CNPq). FD was funded by a fellowship from Instituto Oswaldo Cruz- FIOCRUZ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral EF, 2005, ONLINE J MIGRATION P; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Arouck R, 2000, LUSOTOPIE, P67; Bielejec F, 2011, BIOINFORMATICS, V27, P2910, DOI 10.1093/bioinformatics/btr481; Brazilian (2015) Ministry of Health, 2015, AIDS EP B; Brindeiro RM, 2003, AIDS, V17, P1063, DOI 10.1097/00002030-200305020-00016; Cabello M, 2015, AIDS, V29, P483, DOI 10.1097/QAD.0000000000000552; Cabello M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106045; Chen J.J., 2011, MODEL SIMUL ENG, V2011, P1, DOI DOI 10.1371/J0URNAL.P0NE.0025286; Corbin H.P, 2007, BRAZILIAN MIGRATION; da Costa CM, 2016, AIDS RES HUM RETROVI; Soares CMPD, 2014, J INT AIDS SOC, V17, DOI 10.7448/IAS.17.1.19042; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Diniz A.M.A., 2005, CAD GEOGRAFIA, V15, P23; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2002, GENETICS, V161, P1307; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Ferreira MAR, 2008, CAN J STAT, V36, P355, DOI 10.1002/cjs.5550360302; Gilbert MTP, 2007, P NATL ACAD SCI USA, V104, P18566, DOI 10.1073/pnas.0705329104; Guimaraes ML, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141372; Guindon S, 2005, NUCLEIC ACIDS RES, V33, pW557, DOI 10.1093/nar/gki352; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Heemskerk M, 2009, EUROPEAN REV LATIN A, P5; Heemskerk Marieke, 2015, SURINAME MIGRATION P; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Lemey P, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000520; Leonardi V., 2000, FRONTEIRAS AMAZONICA; Martins CC, 2011, AN 3 S POS GRAD REL; Mendoza Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095360; Pereira Mariana Cunha, 2006, Estud. av., V20, P209; Pessoa R, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152499; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A, 2007, TRACER V1 6; Rambaut A., 2014, FIGTREE V14 TREE FIG; Silva LD, 2016, AIDS RES HUM RETROV, V32, P373, DOI [10.1089/aid.2015.0280, 10.1089/AID.2015.0280]; Soares CL, 2011, PRACS REV HUMANIDADE, V4, P129; Stefani MMA, 2007, J CLIN VIROL, V39, P205, DOI 10.1016/j.jcv.2007.04.012; Suchard MA, 2009, BIOINFORMATICS, V25, P1370, DOI 10.1093/bioinformatics/btp244; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Vale Ana Lia Farias, 2006, Estud. av., V20, P255; Zehender G, 2010, JAIDS-J ACQ IMM DEF, V55, P156, DOI 10.1097/QAI.0b013e3181eb3002	42	13	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162112	10.1371/journal.pone.0162112	http://dx.doi.org/10.1371/journal.pone.0162112			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603317	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200042
J	Ichimura, K; Matoba, T; Nakano, K; Tokutome, M; Honda, K; Koga, J; Egashira, K				Ichimura, Kenzo; Matoba, Tetsuya; Nakano, Kaku; Tokutome, Masaki; Honda, Katsuya; Koga, Jun-ichiro; Egashira, Kensuke			A Translational Study of a New Therapeutic Approach for Acute Myocardial Infarction: Nanoparticle-Mediated Delivery of Pitavastatin into Reperfused Myocardium Reduces Ischemia-Reperfusion Injury in a Preclinical Porcine Model	PLOS ONE			English	Article								Background There is an unmet need to develop an innovative cardioprotective modality for acute myocardial infarction, for which interventional reperfusion therapy is hampered by ischemiareperfusion (IR) injury. We recently reported that bioabsorbable poly(lactic acid/glycolic acid) (PLGA) nanoparticle-mediated treatment with pitavastatin (pitavastatin-NP) exerts a cardioprotective effect in a rat IR injury model by activating the PI3K-Akt pathway and inhibiting inflammation. To obtain preclinical proof-of-concept evidence, in this study, we examined the effect of pitavastatin-NP on myocardial IR injury in conscious and anesthetized pig models. Methods and Results Eighty-four Bama mini-pigs were surgically implanted with a pneumatic cuff occluder at the left circumflex coronary artery (LCx) and telemetry transmitters to continuously monitor electrocardiogram as well as to monitor arterial blood pressure and heart rate. The LCx was occluded for 60 minutes, followed by 24 hours of reperfusion under conscious conditions. Intravenous administration of pitavastatin-NP containing >= 8 mg/body of pitavastatin 5 minutes before reperfusion significantly reduced infarct size; by contrast, pitavastatin alone (8 mg/body) showed no therapeutic effects. Pitavastatin-NP produced anti-apoptotic effects on cultured cardiomyocytes in vitro. Cardiac magnetic resonance imaging performed 4 weeks after IR injury revealed that pitavastatin-NP reduced the extent of left ventricle remodeling. Importantly, pitavastatin-NP exerted no significant effects on blood pressure, heart rate, or serum biochemistry. Exploratory examinations in anesthetized pigs showed pharmacokinetic analysis and the effects of pitavastatin-NP on no-reflow phenomenon. Conclusions NP-mediated delivery of pitavastatin to IR-injured myocardium exerts cardioprotective effects on IR injury without apparent adverse side effects in a preclinical conscious pig model. Thus, pitavastatin-NP represents a novel therapeutic modality for IR injury in acute myocardial infarction.	[Ichimura, Kenzo; Matoba, Tetsuya; Tokutome, Masaki; Honda, Katsuya] Kyushu Univ, Grad Sch Med Sci, Dept Cardiovasc Med, Fukuoka, Japan; [Nakano, Kaku; Koga, Jun-ichiro; Egashira, Kensuke] Kyushu Univ, Dept Cardiovasc Res Dev & Translat Med, Ctr Cardiovasc Disrupt Innovat, Fukuoka, Japan	Kyushu University; Kyushu University	Egashira, K (corresponding author), Kyushu Univ, Dept Cardiovasc Res Dev & Translat Med, Ctr Cardiovasc Disrupt Innovat, Fukuoka, Japan.	egashira@cardiol.med.kyushu-u.ac.jp	MIZEKA, PANU/A-3952-2017; Ichimura, Kenzo/AAC-9485-2020	Ichimura, Kenzo/0000-0002-5734-335X; Matoba, Tetsuya/0000-0003-4563-304X	Ministry of Education, Science, and Culture, Tokyo, Japan [26461131, 25461135, 25293185]; Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan; Intractable diseases overcome research project from Japan Agency for Medical Research and development	Ministry of Education, Science, and Culture, Tokyo, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan; Intractable diseases overcome research project from Japan Agency for Medical Research and development(Japan Agency for Medical Research and Development (AMED))	This study was supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Science, and Culture, Tokyo, Japan, under grant numbers 26461131 (K. Nakano), 25461135 (T. Matoba) and 25293185 (K. Egashira), by Health Science Research Grants (Research on Translational Research, Intractable Diseases, and Nanomedicine) from the Ministry of Health Labor and Welfare, Tokyo, Japan (K. Egashira), and by the Intractable diseases overcome research project from Japan Agency for Medical Research and development (K. Egashira).	Acharya S, 2011, ADV DRUG DELIVER REV, V63, P170, DOI 10.1016/j.addr.2010.10.008; BARDAJI A, 1990, CARDIOVASC RES, V24, P227, DOI 10.1093/cvr/24.3.227; Bodi V, 2014, INT J CARDIOL, V175, P138, DOI 10.1016/j.ijcard.2014.05.003; Bune LT, 2013, PHYSIOL REP, V1, DOI [10.1002/PHY2.3, 10.1002/phy2.3]; Chen L, 2011, HYPERTENSION, V57, P343, DOI 10.1161/HYPERTENSIONAHA.110.157032; FLETCHER PJ, 1981, CIRC RES, V49, P618, DOI 10.1161/01.RES.49.3.618; Fujino T, 2012, MITOCHONDRION, V12, P449, DOI 10.1016/j.mito.2012.06.002; Heusch G, 2011, J MOL CELL CARDIOL, V50, P951, DOI 10.1016/j.yjmcc.2011.02.016; Ikeda G, 2016, SCI REP-UK, V6, DOI 10.1038/srep20467; Ishikita A, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.116.003872; Kapur NK, 2013, CIRCULATION, V128, P328, DOI 10.1161/CIRCULATIONAHA.112.000029; Katsuki S, 2014, CIRCULATION, V129, P896, DOI 10.1161/CIRCULATIONAHA.113.002870; Kehl F, 2002, ANESTHESIOLOGY, V96, P675, DOI 10.1097/00000542-200203000-00025; Kimura S, 2008, CIRCULATION, V118, pS65, DOI 10.1161/CIRCULATIONAHA.107.740613; Kubo M, 2009, ARTERIOSCL THROM VAS, V29, P796, DOI 10.1161/ATVBAHA.108.182584; Liu Y, 2008, COMPARATIVE MED, V58, P580; Lonborg J, 2010, CIRC-CARDIOVASC INTE, V3, P34, DOI 10.1161/CIRCINTERVENTIONS.109.905521; Ludman A, 2009, PHARMACOL THERAPEUT, V122, P30, DOI 10.1016/j.pharmthera.2009.01.002; Malliaras K, 2013, CIRCULATION, V128, P2764, DOI 10.1161/CIRCULATIONAHA.113.002863; Mozaffarian D, 2015, CIRCULATION, V131, pE29, DOI 10.1161/CIR.0000000000000152; Nagaoka K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132451; Nakano Y, 2016, SCI REP-UK, V6, DOI 10.1038/srep29601; Nakashiro S, 2016, ARTERIOSCL THROM VAS, V36, P491, DOI 10.1161/ATVBAHA.115.307057; Oda S, 2010, J VASC SURG, V52, P412, DOI 10.1016/j.jvs.2010.03.020; PFEFFER JM, 1991, AM J PHYSIOL, V260, pH1406, DOI 10.1152/ajpheart.1991.260.5.H1406; Qi HP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065147; Saxena V, 2006, INT J PHARMACEUT, V308, P200, DOI 10.1016/j.ijpharm.2005.11.003; Stone GW, 2016, J AM COLL CARDIOL, V67, P1674, DOI 10.1016/j.jacc.2016.01.069; Suzuki Y, 2008, CATHETER CARDIO INTE, V71, P100, DOI 10.1002/ccd.21329; Suzuki Y, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/195483; Van Allen NR, 2012, MED GAS RES, V2, DOI 10.1186/2045-9912-2-22; Vinten-Johansen J, 2004, CARDIOVASC RES, V61, P481, DOI 10.1016/j.cardiores.2003.10.011; Yellon DM, 2007, NEW ENGL J MED, V357, P1121, DOI 10.1056/NEJMra071667; Zweier JL, 2006, CARDIOVASC RES, V70, P181, DOI 10.1016/j.cardiores.2006.02.025	34	27	28	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162425	10.1371/journal.pone.0162425	http://dx.doi.org/10.1371/journal.pone.0162425			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603665	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200064
J	Wichert, A				Wichert, Andreas			The Quantum Binding Problem in the Context of Associative Memory	PLOS ONE			English	Article							SIMILARITY; MODEL	We present a method to solve the binding problem by using a quantum algorithm for the retrieval of associations from associative memory during visual scene analysis. The problem is solved by mapping the information representing different objects into superposition by using entanglement and Grover's amplification algorithm.	[Wichert, Andreas] Univ Lisbon, INESC ID, Dept Comp Sci & Engn, Oporto, Portugal; [Wichert, Andreas] Univ Lisbon, Inst Super Tecn, Oporto, Portugal	INESC-ID; Universidade de Lisboa; Universidade de Lisboa; Instituto Superior Tecnico	Wichert, A (corresponding author), Univ Lisbon, INESC ID, Dept Comp Sci & Engn, Oporto, Portugal.; Wichert, A (corresponding author), Univ Lisbon, Inst Super Tecn, Oporto, Portugal.	andreas.wichert@tecnico.ulisboa.pt	Wichert, Andreas/E-2494-2012	Wichert, Andreas/0000-0002-2179-4378	Fundacao para a Ciencia e a Tecnologia (FCT) [UID/CEC/50021/2013]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission)	This work was supported by national funds through Fundacao para a Ciencia e a Tecnologia (FCT) with reference UID/CEC/50021/2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aaronson S, 2015, NAT PHYS, V11, P291, DOI 10.1038/nphys3272; Aimeur E, 2013, MACH LEARN, V90, P261, DOI 10.1007/s10994-012-5316-5; Brassard G, 1998, QUANTUM COUNTING; Giovannetti V, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.160501; Gross C. G., 1977, LATERALIZATION NERVO, P109; Grover L. K., 1998, Proceedings of the Thirtieth Annual ACM Symposium on Theory of Computing, P53, DOI 10.1145/276698.276712; Grover L. K., 1996, Proceedings of the Twenty-Eighth Annual ACM Symposium on the Theory of Computing, P212, DOI 10.1145/237814.237866; Grover LK, 1998, PHYS REV LETT, V80, P4329, DOI 10.1103/PhysRevLett.80.4329; Grover LK, 1997, PHYS REV LETT, V79, P325, DOI 10.1103/PhysRevLett.79.325; Harrow AW, 2009, PHYS REV LETT, V103, DOI 10.1103/PhysRevLett.103.150502; Hecht-Nielsen R, 1989, NEUR NETW 1989 IJCNN; Islam M. S., 2009, Information Technology Journal, V8, P208, DOI 10.3923/itj.2009.208.213; Kosko B., 1992, NEURAL NETWORKS FUZZ; Kosslyn S.M., 1994, IMAGE BRAIN RESOLUTI; MCCLELLAND JL, 1985, J EXP PSYCHOL GEN, V114, P159, DOI 10.1037/0096-3445.114.2.159; OSHERSON DN, 1987, J MATH PSYCHOL, V31, P93, DOI 10.1016/0022-2496(87)90038-1; Palm G., 1982, NEURAL ASSEMBLIES AL; Palm G., 1997, ASS PROCESSING PROCE, P307; Palm G, 1990, GEHIRN KOGNITION, P164; Posner M. I., 1994, IMAGES MIND; Rosenbaum D, 2009, PHYS REV A, V79, DOI 10.1103/PhysRevA.79.052310; Sacramento J, 2012, BIOL CYBERN, V106, P123, DOI 10.1007/s00422-012-0488-4; STEINBUCH K, 1961, KYBERNETIK, V1, P36, DOI 10.1007/BF00293853; Tapp, 2000, ARXIVQUANTPH0005055; Tay N, 2010, COGN COMPUT, P1; TVERSKY A, 1977, PSYCHOL REV, V84, P327, DOI 10.1037/h0026750; Ventura D, 1999, FOUND PHYS LETT, V12, P547, DOI 10.1023/A:1021695125245; Ventura D, 2000, INFORM SCIENCES, V124, P273, DOI 10.1016/S0020-0255(99)00101-2; Ventura D, 1988, NEUR NETW P 1998 IEE, V1, P509; Wichert A, 2002, NEUROCOMPUTING, V48, P741, DOI 10.1016/S0925-2312(01)00671-3; Wichert A, 2001, CONNECT SCI, V13, P1, DOI 10.1080/05940090010022693; Wichert A, 2008, NEUROCOMPUTING, V71, P2806, DOI 10.1016/j.neucom.2007.08.019; Wichert A, 2013, J LOGIC COMPUT, V23, P627, DOI 10.1093/logcom/exs010; Wichert A, 2009, COGN COMPUT, V1, P342, DOI 10.1007/s12559-009-9027-6; Wichert A, 2011, COGN COMPUT, V3, P311, DOI 10.1007/s12559-010-9064-1; WILLSHAW DJ, 1969, NATURE, V222, P960, DOI 10.1038/222960a0; Wittek P, 2014, QUANTUM MACHINE LEARNING: WHAT QUANTUM COMPUTING MEANS TO DATA MINING, P1	37	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162312	10.1371/journal.pone.0162312	http://dx.doi.org/10.1371/journal.pone.0162312			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603782	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200056
J	Hansen, VL; Schilkey, FD; Miller, RD				Hansen, Victoria Leigh; Schilkey, Faye Dorothy; Miller, Robert David			Transcriptomic Changes Associated with Pregnancy in a Marsupial, the Gray Short-Tailed Opossum Monodelphis domestica	PLOS ONE			English	Article							DIFFERENTIAL EXPRESSION ANALYSIS; OXYTOCIN RECEPTOR; GENE-EXPRESSION; SMINTHOPSIS-CRASSICAUDATA; SPATIOTEMPORAL EXPRESSION; CONVERGENT EVOLUTION; HOUSEKEEPING GENES; ESTROGEN-RECEPTORS; PLACENTA; PROGESTERONE	Live birth has emerged as a reproductive strategy many times across vertebrate evolution; however, mammals account for the majority of viviparous vertebrates. Marsupials are a mammalian lineage that last shared a common ancestor with eutherians (placental mammals) over 148 million years ago. Marsupials are noted for giving birth to highly altricial young after a short gestation, and represent humans' most distant viviparous mammalian relatives. Here we ask what insight can be gained into the evolution of viviparity in mammals specifically and vertebrates in general by analyzing the global uterine transcriptome in a marsupial. Transcriptome analyses were performed using NextGen sequencing of uterine RNA samples from the gray short-tailed opossum, Monodelphis domestica. Samples were collected from late stage pregnant, virgin, and non-pregnant experienced breeders. Three different algorithms were used to determine differential expression, and results were confirmed by quantitative PCR. Over 900 opossum gene transcripts were found to be significantly more abundant in the pregnant uterus than non-pregnant, and over 1400 less so. Most with increased abundance were genes related to metabolism, immune systems processes, and transport. This is the first study to characterize the transcriptomic differences between pregnant, non-pregnant breeders, and virgin marsupial uteruses and helps to establish a set of pregnancy-associated genes in the opossum. These observations allowed for comparative analyses of the differentially transcribed genes with other mammalian and non-mammalian viviparous species, revealing similarities in pregnancy related gene expression over 300 million years of amniote evolution.	[Hansen, Victoria Leigh; Miller, Robert David] Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA; [Schilkey, Faye Dorothy] New Mexico IDeA Networks Biomed Res Excellence, Natl Ctr Genome Resources, Santa Fe, NM USA; [Hansen, Victoria Leigh] Natl Sci Fdn, Div Integrat Organismal Syst, 4201 Wilson Blvd, Arlington, VA 22230 USA	University of New Mexico; National Center for Genome Resources (NCGR); National Science Foundation (NSF)	Hansen, VL (corresponding author), Univ New Mexico, Dept Biol, Ctr Evolutionary & Theoret Immunol, Albuquerque, NM 87131 USA.; Hansen, VL (corresponding author), Natl Sci Fdn, Div Integrat Organismal Syst, 4201 Wilson Blvd, Arlington, VA 22230 USA.	vhansen@unm.edu		Miller, Robert/0000-0002-8479-8819	National Science Foundation [IOS-1353123]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM110907] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The National Science Foundation funded this research under grant number IOS-1353123 (http://www.nsf.gov/awardsearch/showAward?AWD_ID=1353123). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Asahina T, 1998, HORM RES, V50, P37, DOI 10.1159/000053122; Baardman ME, 2013, BIOL REPROD, V88, DOI 10.1095/biolreprod.112.102442; Baker Michelle L., 2004, Journal of Mammalian Evolution, V11, P1, DOI 10.1023/B:JOMM.0000029143.39776.ec; Bininda-Emonds ORP, 2007, NATURE, V446, P507, DOI 10.1038/nature05634; BLACKBURN DG, 1992, AM ZOOL, V32, P313; Brandley MC, 2012, GENOME BIOL EVOL, V4, P394, DOI 10.1093/gbe/evs013; Carter AM, 2013, ANNU REV ANIM BIOSCI, V1, P443, DOI 10.1146/annurev-animal-031412-103653; Chen H, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-35; Chern SR, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-106; Chern SR, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-127; CORSO G, 1988, Archivio Italiano di Anatomia e di Embriologia, V93, P237; Corso G, 2000, J MORPHOL, V243, P153, DOI 10.1002/(SICI)1097-4687(200002)243:2<153::AID-JMOR4>3.0.CO;2-Q; Crespi B, 2004, AM NAT, V163, P635, DOI 10.1086/382734; Drewlo S, 2012, PLACENTA, V33, P952, DOI 10.1016/j.placenta.2012.09.007; Elliot MG, 2009, PLACENTA, V30, P949, DOI 10.1016/j.placenta.2009.08.004; Enders AC, 2012, PLACENTA, V33, P319, DOI 10.1016/j.placenta.2012.02.008; Freyer C, 2007, PLACENTA, V28, P249, DOI 10.1016/j.placenta.2006.03.007; Freyer C, 2003, J EXP ZOOL PART A, V299A, P59, DOI 10.1002/jez.a.10291; Freyer C, 2002, J ANAT, V201, P101, DOI 10.1046/j.1469-7580.2002.00084.x; Freyer C, 2009, J EXP ZOOL PART B, V312B, P545, DOI 10.1002/jez.b.21239; Furukawa S, 2014, J TOXICOL PATHOL, V27, P11, DOI 10.1293/tox.2013-0060; Garratt M, 2013, P NATL ACAD SCI USA, V110, P7760, DOI 10.1073/pnas.1305018110; Goff LA, 2012, ANALYSIS EXPLORATION; Goytain A, 2005, BIOCHEM BIOPH RES CO, V330, P701, DOI 10.1016/j.bbrc.2005.03.037; Hedges SB, 2003, TRENDS GENET, V19, P200, DOI 10.1016/S0168-9525(03)00053-2; Hesse M, 2000, EMBO J, V19, P5060, DOI 10.1093/emboj/19.19.5060; KEYS JL, 1988, BIOL REPROD, V39, P473, DOI 10.1095/biolreprod39.2.473; Killian JK, 2001, MAMM GENOME, V12, P513, DOI 10.1007/s003350020026; Kimura T, 1996, ENDOCRINOLOGY, V137, P780, DOI 10.1210/en.137.2.780; Kin K, 2014, BIOL REPROD, V90, DOI 10.1095/biolreprod.113.115139; Kostka G, 2001, MOL CELL BIOL, V21, P7025, DOI 10.1128/MCB.21.20.7025-7034.2001; Kumar S, 1998, NATURE, V392, P917, DOI 10.1038/31927; Laird MK, 2014, J MORPHOL, V275, P1081, DOI 10.1002/jmor.20282; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Liu YW, 2014, BIOINFORMATICS, V30, P301, DOI 10.1093/bioinformatics/btt688; Lynch VJ, 2015, CELL REP, V10, P551, DOI 10.1016/j.celrep.2014.12.052; Maiti K, 2011, ENDOCRINOLOGY, V152, P2448, DOI 10.1210/en.2010-0979; Matsuura W, 2009, BIOSCI BIOTECH BIOCH, V73, P1142, DOI 10.1271/bbb.80910; Meller M, 2005, PLACENTA, V26, P601, DOI 10.1016/j.placenta.2004.09.009; Mess A, 2006, J EXP ZOOL PART B, V306B, P140, DOI 10.1002/jez.b.21079; Mi HY, 2013, NUCLEIC ACIDS RES, V41, pD377, DOI 10.1093/nar/gks1118; MOLL R, 1983, LAB INVEST, V49, P599; Mossman HW, 1987, VERTEBRATE FETAL MEM; Murphy WJ, 2001, SCIENCE, V294, P2348, DOI 10.1126/science.1067179; Okumu LA, 2010, REPRODUCTION, V140, P143, DOI 10.1530/REP-10-0113; PADYKULA HA, 1982, J REPROD FERTIL, P95; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; RENFREE MB, 1994, J REPROD FERTIL, V102, P433; Robbins JR, 2012, CURR OPIN MICROBIOL, V15, P36, DOI 10.1016/j.mib.2011.11.006; Roberts A, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-3-r22; ROBERTS CT, 1994, J REPROD FERTIL, V100, P105; ROBERTS RM, 1988, J REPROD FERTIL, V82, P875, DOI 10.1530/jrf.0.0820875; Robinson MD, 2010, BIOINFORMATICS, V26, P139, DOI 10.1093/bioinformatics/btp616; Rose R, 2000, HORM BEHAV, V37, P163, DOI 10.1006/hbeh.1999.1568; Samborski A, 2013, BIOL REPROD, V89, DOI 10.1095/biolreprod.113.112177; Shaw G, 1999, BIOL REPROD, V60, P611, DOI 10.1095/biolreprod60.3.611; Spencer TE, 2002, FRONT BIOSCI-LANDMRK, V7, pD1879, DOI 10.2741/spencer; SPENCER TE, 1995, BIOL REPROD, V53, P1527, DOI 10.1095/biolreprod53.6.1527; Spencer TE, 2008, REPRODUCTION, V135, P165, DOI 10.1530/REP-07-0327; STONEROOK MJ, 1992, BIOL REPROD, V46, P290, DOI 10.1095/biolreprod46.2.290; Terzidou V, 2005, J CLIN ENDOCR METAB, V90, P237, DOI 10.1210/jc.2004-0277; Thomas PD, 2006, NUCLEIC ACIDS RES, V34, pW645, DOI 10.1093/nar/gkl229; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Tyndale-Biscoe H, 1987, REPROD PHYSL MAMMALS; Umylny B, 2011, TAG BASED NEXT GENER, P449; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; VANDEBERG JL, 1990, AUST J ZOOL, V37, P235, DOI 10.1071/ZO9890235; VandeBerg John L., 1997, ILAR J, V38, P4; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wathes DC, 1999, J ENDOCRINOL, V161, P143, DOI 10.1677/joe.0.1610143; Whittington CM, 2015, MOL BIOL EVOL, V32, P3114, DOI 10.1093/molbev/msv177; Wildman DE, 2006, P NATL ACAD SCI USA, V103, P3203, DOI 10.1073/pnas.0511344103; Yamashita K, 2013, MOL PHYLOGENET EVOL, V67, P520, DOI 10.1016/j.ympev.2013.02.017	75	16	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161608	10.1371/journal.pone.0161608	http://dx.doi.org/10.1371/journal.pone.0161608			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598793	gold, Green Submitted, Green Published			2022-12-26	WOS:000383254800013
J	Kong, PL; Looi, LM; Lau, TP; Cheah, PL				Kong, Po-Lian; Looi, Lai-Meng; Lau, Tze-Pheng; Cheah, Phaik-Leng			Assessment of Telomere Length in Archived Formalin-Fixed, Paraffinized Human Tissue Is Confounded by Chronological Age and Storage Duration	PLOS ONE			English	Article							IN-SITU HYBRIDIZATION; DIPLOID CELL STRAINS; COLORECTAL-CANCER; EMBEDDED TISSUE; DNA EXTRACTION; CIGARETTE-SMOKING; HUMAN FIBROBLASTS; BIOMARKER; INSTABILITY; ATTRITION	Telomeres shorten with physiological aging but undergo substantial restoration during cancer immortalization. Increasingly, cancer studies utilize the archive of formalin-fixed, paraffin-embedded (FFPE) tissues in diagnostic pathology departments. Conceptually, such studies would be confounded by physiological telomere attrition and loss of DNA integrity from prolonged tissue storage. Our study aimed to investigate these two confounding factors. 145 FFPE tissues of surgically-resected, non-diseased appendixes were retrieved from our pathology archive, from years 2008 to 2014. Cases from 2013 to 2014 were categorized by patient chronological age (0-20 years, 21-40 years, 41-60 years, >60 years). Telomere lengths of age categories were depicted by telomere/chromosome 2 centromere intensity ratio (TCR) revealed by quantitative fluorescence in situ hybridization. Material from individuals aged 0-20 years from years 2013/2014, 2011/2012, 2009/2010, and 2008 were compared for storage effect. Telomere integrity was assessed by telomere fluorescence intensity (TFI). Epithelial TCRs (mean +/- SD) for the respective age groups were 4.84 +/- 2.08, 3.64 +/- 1.21, 2.03 +/- 0.37, and 1.93 +/- 0.45, whereas corresponding stromal TCRs were 5.16 +/- 2.55, 3.84 +/- 1.36, 2.49 +/- 1.20, and 2.93 +/- 1.24. A trend of inverse correlation with age in both epithelial and stromal tissues is supported by r = -0.69, p < 0.001 and r = -0.42, p < 0.001 respectively. Epithelial TFIs (mean +/- SD) of years 2013/2014, 2011/2012, 2009/2010 and 2008 were 852.60 +/- 432.46, 353.04 +/- 127.12, 209.24 +/- 55.57 and 429.22 +/- 188.75 respectively. Generally, TFIs reduced with storage duration (r = -0.42, p < 0.001). Our findings agree that age-related telomere attrition occurs in normal somatic tissues, and suggest that an age-based reference can be established for telomere studies on FFPE tissues. We also showed that FFPE tissues archived beyond 2 years are suboptimal for telomere analysis.	[Kong, Po-Lian; Looi, Lai-Meng; Lau, Tze-Pheng; Cheah, Phaik-Leng] Univ Malaya, Dept Pathol, Fac Med, Kuala Lumpur, Federal Te, Malaysia	Universiti Malaya	Looi, LM (corresponding author), Univ Malaya, Dept Pathol, Fac Med, Kuala Lumpur, Federal Te, Malaysia.	looilm@ummc.edu.my	Looi, Lai Meng/AAB-9403-2019; Lau, Tzepheng/AAE-2843-2022; Looi, Lai Meng/A-3382-2009	Looi, Lai Meng/0000-0001-8325-0117; Looi, Lai Meng/0000-0001-8325-0117	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research grant [UM.0000017/HIR.C1]; University of Malaya Research Grant (UMRG) [RP016D-13HTM]; Unit	University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research grant; University of Malaya Research Grant (UMRG); Unit	This study was funded by University of Malaya/Ministry of Higher Education (UM/MOHE) High Impact Research grant (Grant number: UM.0000017/HIR.C1) and University of Malaya Research Grant (UMRG) (Grant number: RP016D-13HTM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.r We thank the Unit for Research Support and Education (PURSuE), Department of Pathology, Faculty of Medicine, University of Malaya for assistance in retrieval of archived FFPE tissues and provision of unstained FFPE tissue sections.	ALLSOPP RC, 1995, EXP CELL RES, V219, P130, DOI 10.1006/excr.1995.1213; Alter BP, 2012, HAEMATOL-HEMATOL J, V97, P353, DOI 10.3324/haematol.2011.055269; Augustine TA, 2015, BRIT J CANCER, V112, P313, DOI 10.1038/bjc.2014.561; Bass BP, 2014, ARCH PATHOL LAB MED, V138, P1520, DOI 10.5858/arpa.2013-0691-RA; Bekaert S, 2005, ANTICANCER RES, V25, P3011; Bekaert S, 2004, DEV BIOL, V274, P15, DOI 10.1016/j.ydbio.2004.06.023; Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Bryan TM, 1997, NAT MED, V3, P1271, DOI 10.1038/nm1197-1271; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; COUNTER CM, 1992, EMBO J, V11, P1921, DOI 10.1002/j.1460-2075.1992.tb05245.x; Dlouha D, 2014, PHYSIOL RES, V63, pS343, DOI 10.33549/physiolres.932856; DUBEAU L, 1986, CANCER RES, V46, P2964; Friedrich U, 2000, MECH AGEING DEV, V119, P89, DOI 10.1016/S0047-6374(00)00173-1; Furugori E, 2000, J CANCER RES CLIN, V126, P481, DOI 10.1007/s004320000137; Gillio-Tos A, 2007, PATHOLOGY, V39, P345, DOI 10.1080/00313020701329757; Gnanapragasam VJ, 2010, BJU INT, V105, P274, DOI 10.1111/j.1464-410X.2009.08665.x; GREER CE, 1994, PCR METH APPL, V3, pS113; Guan JZ, 2007, MOL CELL BIOCHEM, V304, P353, DOI 10.1007/s11010-007-9518-2; HAMMOND DW, 1994, J CLIN PATHOL, V47, P508, DOI 10.1136/jcp.47.6.508; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9; HAYFLICK L, 1961, EXP CELL RES, V25, P585, DOI 10.1016/0014-4827(61)90192-6; Heaphy CM, 2011, J CELL MOL MED, V15, P1227, DOI 10.1111/j.1582-4934.2011.01284.x; Hou LF, 2015, EBIOMEDICINE, V2, P591, DOI 10.1016/j.ebiom.2015.04.008; Hung NA, 2016, MODERN PATHOL, V29, P212, DOI 10.1038/modpathol.2015.156; Jenkins EC, 2012, AM J MED GENET A, V158A, P1060, DOI 10.1002/ajmg.a.35275; LEVY MZ, 1992, J MOL BIOL, V225, P951, DOI 10.1016/0022-2836(92)90096-3; Ludyga N, 2012, VIRCHOWS ARCH, V460, P131, DOI 10.1007/s00428-011-1184-9; McGrath M, 2007, CANCER EPIDEM BIOMAR, V16, P815, DOI 10.1158/1055-9965.EPI-06-0961; Meeker AK, 2004, CLIN CANCER RES, V10, P3317, DOI 10.1158/1078-0432.CCR-0984-03; Meeker AK, 2002, AM J PATHOL, V160, P1259, DOI 10.1016/S0002-9440(10)62553-9; Merkelbach S, 1997, AM J PATHOL, V150, P1537; Montpetit AJ, 2014, NURS RES, V63, P289, DOI 10.1097/NNR.0000000000000037; Nakamura K, 2000, CANCER LETT, V158, P179, DOI 10.1016/S0304-3835(00)00521-8; Narath R, 2005, CYTOM PART A, V68A, P113, DOI 10.1002/cyto.a.20190; O'Sullivan J, 2006, CANCER EPIDEM BIOMAR, V15, P573, DOI 10.1158/1055-9965.EPI-05-0542; O'Sullivan JN, 2004, CYTOM PART A, V58A, P120, DOI 10.1002/cyto.a.20006; O'Sullivan JN, 2002, NAT GENET, V32, P280, DOI 10.1038/ng989; Rane JK, 2016, EUR UROL, V69, P551, DOI 10.1016/j.eururo.2015.09.039; Sedivy JM, 1998, P NATL ACAD SCI USA, V95, P9078, DOI 10.1073/pnas.95.16.9078; Shay JW, 1997, EUR J CANCER, V33, P787, DOI 10.1016/S0959-8049(97)00062-2; Shen YQ, 2011, LABMEDICINE, V42, P478, DOI 10.1309/LM030FHMRRUWKQWH; Spilsbury A, 2015, J NEUROSCI, V35, P1659, DOI 10.1523/JNEUROSCI.2925-14.2015; Svenson U, 2009, BBA-MOL BASIS DIS, V1792, P317, DOI 10.1016/j.bbadis.2009.01.017; Takubo K, 1999, AGE, V22, P95, DOI 10.1007/s11357-999-0011-6; Takubo K, 2010, GERIATR GERONTOL INT, V10, pS197, DOI 10.1111/j.1447-0594.2010.00605.x; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Wang JH, 2013, NEUROSCI BULL, V29, P649, DOI 10.1007/s12264-013-1379-y; Xie R, 2011, J HISTOCHEM CYTOCHEM, V59, P356, DOI 10.1369/0022155411398488; Zhang CA, 2015, HUM MOL GENET, V24, P5356, DOI 10.1093/hmg/ddv252	54	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161720	10.1371/journal.pone.0161720	http://dx.doi.org/10.1371/journal.pone.0161720			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598341	gold, Green Submitted, Green Published			2022-12-26	WOS:000383254800018
J	Strickland, BA; Vilella, FJ; Belant, JL				Strickland, Bradley A.; Vilella, Francisco J.; Belant, Jerrold L.			Scale-Dependent Habitat Selection and Size-Based Dominance in Adult Male American Alligators	PLOS ONE			English	Article							HOME-RANGE; BODY-SIZE; POPULATION; MOVEMENTS; ECOLOGY; RIVER; PREY	Habitat selection is an active behavioral process that may vary across spatial and temporal scales. Animals choose an area of primary utilization (i.e., home range) then make decisions focused on resource needs within patches. Dominance may affect the spatial distribution of conspecifics and concomitant habitat selection. Size-dependent social dominance hierarchies have been documented in captive alligators, but evidence is lacking from wild populations. We studied habitat selection for adult male American alligators (Alligator mississippiensis; n = 17) on the Pearl River in central Mississippi, USA, to test whether habitat selection was scale-dependent and individual resource selectivity was a function of conspecific body size. We used K-select analysis to quantify selection at the home range scale and patches within the home range to determine selection congruency and important habitat variables. In addition, we used linear models to determine if body size was related to selection patterns and strengths. Our results indicated habitat selection of adult male alligators was a scale-dependent process. Alligators demonstrated greater overall selection for habitat variables at the patch level and less at the home range level, suggesting resources may not be limited when selecting a home range for animals in our study area. Further, diurnal habitat selection patterns may depend on thermoregulatory needs. There was no relationship between resource selection or home range size and body size, suggesting size-dependent dominance hierarchies may not have influenced alligator resource selection or space use in our sample. Though apparent habitat suitability and low alligator density did not manifest in an observed dominance hierarchy, we hypothesize that a change in either could increase intraspecific interactions, facilitating a dominance hierarchy. Due to the broad and diverse ecological roles of alligators, understanding the factors that influence their social dominance and space use can provide great insight into their functional role in the ecosystem.	[Strickland, Bradley A.] Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA; [Vilella, Francisco J.] Mississippi State Univ, US Geol Survey, Mississippi Cooperat Fish & Wildlife Res Unit, Mississippi State, MS 39762 USA; [Belant, Jerrold L.] Mississippi State Univ, Carnivore Ecol Lab, Forest & Wildlife Res Ctr, Mississippi State, MS 39762 USA; [Strickland, Bradley A.] Florida Int Univ, Dept Biol Sci, Marine Sci Program, Miami, FL 33199 USA	Mississippi State University; Mississippi State University; United States Department of the Interior; United States Geological Survey; Mississippi State University; State University System of Florida; Florida International University	Strickland, BA (corresponding author), Mississippi State Univ, Dept Wildlife Fisheries & Aquaculture, Mississippi State, MS 39762 USA.; Strickland, BA (corresponding author), Florida Int Univ, Dept Biol Sci, Marine Sci Program, Miami, FL 33199 USA.	bstri007@fiu.edu	Belant, Jerrold/HDM-7749-2022	Strickland, Bradley/0000-0001-6443-7672	Mississippi Department of Wildlife, Fisheries and Parks [14-16-0009-1543]; Berryman Institute [10-7400-0471-CA]; Institutional Animal Care and Use Committee of Mississippi State University [12-016]	Mississippi Department of Wildlife, Fisheries and Parks; Berryman Institute; Institutional Animal Care and Use Committee of Mississippi State University	Funding by Mississippi Department of Wildlife, Fisheries and Parks (award number 14-16-0009-1543) and Berryman Institute (award number 10-7400-0471-CA) was instrumental in data collection.r Funding was provided by Mississippi Department of Wildlife, Fisheries and Parks (award number 14-16-0009-1543) and Berryman Institute (award number 10-7400-0471-CA). We are grateful to R. Flynt, C. Hunt, and S. Edwards of MDWFP for project support and coordination. We thank B. Leopold and R. Iglay for comments to an earlier version of this manuscript and suggestions for analysis. We also appreciate the thoughtful comments of anonymous reviewers to improve the manuscript. A. Smith and S. Godfrey provided valuable assistance in the field. Thanks to C. Kochanny and A. Rosenblatt for radio design and attachment. Animal capture and handling procedures were conducted under the auspices of protocol 12-016 from the Institutional Animal Care and Use Committee of Mississippi State University. Any use of trade, firm, or product names is for descriptive purposes only and does not imply endorsement by the U.S. Government.	Beacham JL, 2003, BEHAVIOUR, V140, P1275, DOI 10.1163/156853903771980594; Belant JL, 2010, POLAR BIOL, V33, P31, DOI 10.1007/s00300-009-0682-6; Bondavalli C, 1999, ECOSYSTEMS, V2, P49, DOI 10.1007/s100219900057; Boyce MS, 2002, ECOL MODEL, V157, P281, DOI 10.1016/S0304-3800(02)00200-4; Boyce MS, 2006, DIVERS DISTRIB, V12, P269, DOI 10.1111/j.1366-9516.2006.00243.x; Burnham K. P., 2002, MODEL SELECTION MULT, V2nd; Calenge C, 2005, ECOL MODEL, V186, P143, DOI 10.1016/j.ecolmodel.2004.12.005; Calenge C, 2007, J STAT SOFTW, V22, P1; Calsbeek R, 2002, J ANIM ECOL, V71, P513, DOI 10.1046/j.1365-2656.2002.00619.x; Chabreck, 1963, P SE ASS GAME FISH C, V17, P47; Chabreck RH, 1965, P SE ASS GAME FISH C, V19, P102; COOPER CM, 1985, HYDROBIOLOGIA, V126, P193, DOI 10.1007/BF00007496; Cox MC, 2011, ESTIMATION ALLIGATOR, V5045, P1; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; DREWS C, 1990, HERPETOL J, V1, P514; Estevez I, 2007, APPL ANIM BEHAV SCI, V103, P185, DOI 10.1016/j.applanim.2006.05.025; French AR, 2005, BIOTROPICA, V37, P96, DOI 10.1111/j.1744-7429.2005.04051.x; FRETWELL S D, 1972, P217; Garrick L. D., 1978, B AM MUS NAT HIST, V160, P153; GILES LW, 1949, J WILDLIFE MANAGE, V13, P16, DOI 10.2307/3796122; GOODWIN TM, 1979, J HERPETOL, V13, P157, DOI 10.2307/1563922; Grant PBC, 2010, HERPETOL CONSERV BIO, V5, P456; HUTTON J, 1989, AM ZOOL, V29, P1033; JOANEN T., 1972, P ANN C SE ASS GAME, V26, P252; Johnson CJ, 2002, J ANIM ECOL, V71, P225, DOI 10.1046/j.1365-2656.2002.00595.x; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kaminski, 2005, GAYLORD MEMORIAL LAB, P93; KAUFMANN JH, 1983, BIOL REV, V58, P1, DOI 10.1111/j.1469-185X.1983.tb00379.x; Kay WR, 2004, WILDLIFE RES, V31, P495, DOI 10.1071/WR04037; KENNEDY M, 1993, OIKOS, V68, P158, DOI 10.2307/3545322; Lang J.W., 1987, P273; Lehtinen RM, 1997, ENVIRON BIOL FISH, V49, P7, DOI 10.1023/A:1007346430221; Lewis JD, 2014, SOUTHEAST NAT, V13, P261, DOI 10.1656/058.013.0208; May R, 2008, J APPL ECOL, V45, P1382, DOI 10.1111/j.1365-2664.2008.01527.x; Mayor SJ, 2009, ECOSCIENCE, V16, P238, DOI 10.2980/16-2-3238; Mazzotti FJ, 2009, ECOL INDIC, V9, pS137, DOI 10.1016/j.ecolind.2008.06.008; MCILHENNY EA, 1935, ALLIGATORS LIFE HIST; McLoughlin PD, 2010, J ANIM ECOL, V79, P4, DOI 10.1111/j.1365-2656.2009.01613.x; Murphy TM, 1977, DISTRIBUTION MOVEMEN; Nifong JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0083953; Nifong JC, 2013, J EXP MAR BIOL ECOL, V440, P185, DOI 10.1016/j.jembe.2013.01.002; Oro D, 2008, ECOLOGY, V89, P838, DOI 10.1890/06-1936.1; Piller KR, 2004, T AM FISH SOC, V133, P1004, DOI 10.1577/T03-047.1; Reale D, 2007, BIOL REV, V82, P291, DOI 10.1111/j.1469-185X.2007.00010.x; Rettie WJ, 2000, ECOGRAPHY, V23, P466, DOI 10.1034/j.1600-0587.2000.230409.x; Rosenblatt AE, 2013, ESTUAR COAST SHELF S, V135, P182, DOI 10.1016/j.ecss.2013.10.008; Rosenblatt AE, 2011, J ANIM ECOL, V80, P786, DOI 10.1111/j.1365-2656.2011.01830.x; ROSENZWEIG ML, 1991, AM NAT, V137, pS5, DOI 10.1086/285137; Ryberg WA, 2002, J EXP ZOOL, V294, P325, DOI 10.1002/jez.10207; Said S, 2005, LANDSCAPE ECOL, V20, P1003, DOI 10.1007/s10980-005-7518-8; Sartain BT, 2013, R BARNETT BACKWATER, V5056, P1; Sartain BT, 2013, AQUATIC PLANT COMMUN, V5057, P1; SAVINO JF, 1982, T AM FISH SOC, V111, P255, DOI 10.1577/1548-8659(1982)111&lt;255:PIBLBA&gt;2.0.CO;2; SPRINGER JT, 1979, J WILDLIFE MANAGE, V43, P926, DOI 10.2307/3808276; Staton M.A., 1975, Memoria Soc Cienc nat La Salle, VNo. 101, P237; Strickland BA, 2015, SPATIAL ECOLOGY POPU; Subalusky AL, 2009, BIOL CONSERV, V142, P1507, DOI 10.1016/j.biocon.2009.02.019; SWIHART RK, 1988, ECOLOGY, V69, P393, DOI 10.2307/1940437; Tucker AD, 1997, WILDLIFE RES, V24, P379, DOI 10.1071/WR95073; USDA, 2012, NAT AGR IM PROGR; VLIET KA, 1989, AM ZOOL, V29, P1019; Watanabe YY, 2013, AQUAT BIOL, V18, P1, DOI 10.3354/ab00489; Webb KK, 2009, J WILDLIFE MANAGE, V73, P566, DOI 10.2193/2006-294; Wersal R.M., 2006, GEORESOUR I REP, V5003, P1; White G.C., 1990, ANAL WILDLIFE RADIO; Wilson RR, 2012, WILDLIFE BIOL, V18, P424, DOI 10.2981/12-044; Zuur AF, 2010, METHODS ECOL EVOL, V1, P3, DOI 10.1111/j.2041-210X.2009.00001.x	67	6	6	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161814	10.1371/journal.pone.0161814	http://dx.doi.org/10.1371/journal.pone.0161814			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588947	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800019
J	Terry, L; Cassels, N; Lu, K; Acton, JH; Margrain, TH; North, RV; Fergusson, J; White, N; Wood, A				Terry, Louise; Cassels, Nicola; Lu, Kelly; Acton, Jennifer H.; Margrain, Tom H.; North, Rachel V.; Fergusson, James; White, Nick; Wood, Ashley			Automated Retinal Layer Segmentation Using Spectral Domain Optical Coherence Tomography: Evaluation of Inter-Session Repeatability and Agreement between Devices	PLOS ONE			English	Article							MACULAR THICKNESS MEASUREMENTS; NERVE-FIBER; SD-OCT; IMAGE-ANALYSIS; REPRODUCIBILITY; DEGENERATION; EYES; CLASSIFICATION; FUNDUS; SIZE	Retinal and intra-retinal layer thicknesses are routinely generated from optical coherence tomography (OCT) images, but on-board software capabilities and image scaling assumptions are not consistent across devices. This study evaluates the device-independent Iowa Reference Algorithms ( Iowa Institute for Biomedical Imaging) for automated intra-retinal layer segmentation and image scaling for three OCT systems. Healthy participants (n = 25) underwent macular volume scans using a Cirrus HD-OCT (Zeiss), 3D-OCT 1000 (Topcon), and a non-commercial long-wavelength (1040nm) OCT on two occasions. Mean thickness of 10 intra-retinal layers was measured in three ETDRS subfields ( fovea, inner ring and outer ring) using the Iowa Reference Algorithms. Where available, total retinal thicknesses were measured using on-board software. Measured axial eye length (AEL)-dependent scaling was used throughout, with a comparison made to the system-specific fixed-AEL scaling. Inter-session repeatability and agreement between OCT systems and segmentation methods was assessed. Inter-session coefficient of repeatability (CoR) for the foveal subfield total retinal thickness was 3.43 mu m, 4.76 mu m, and 5.98 mu m for the Zeiss, Topcon, and long-wavelength images respectively. For the commercial software, CoR was 4.63 mu m (Zeiss) and 7.63 mu m (Topcon). The Iowa Reference Algorithms demonstrated higher repeatability than the on-board software and, in addition, reliably segmented all 10 intra-retinal layers. With fixed-AEL scaling, the algorithm produced significantly different thickness values for the three OCT devices (P<0.05), with these discrepancies generally characterized by an overall offset (bias) and correlations with axial eye length for the foveal subfield and outer ring (P<0.05). This correlation was reduced to an insignificant level in all cases when AEL-dependent scaling was used. Overall, the Iowa Reference Algorithms are viable for clinical and research use in healthy eyes imaged with these devices, however ocular biometry is required for accurate quantification of OCT images.	[Terry, Louise; Cassels, Nicola; Lu, Kelly; Acton, Jennifer H.; Margrain, Tom H.; North, Rachel V.; Fergusson, James; White, Nick; Wood, Ashley] Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales; [Fergusson, James; White, Nick] Cardiff Univ, Vis Sci Bioimaging Labs, Cardiff, S Glam, Wales	Cardiff University; Cardiff University	Wood, A (corresponding author), Cardiff Univ, Sch Optometry & Vis Sci, Cardiff, S Glam, Wales.	wooda2@cardiff.ac.uk	Acton, Jennifer/AAU-3307-2021	Acton, Jennifer/0000-0002-0347-7651; North, Rachel Valerie/0000-0002-6657-5099; Terry, Louise/0000-0002-6200-8230	Cardiff University; Medical Research Council; School of Optometry and Vision Sciences	Cardiff University; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); School of Optometry and Vision Sciences	This work was funded by Cardiff University. VSBL acknowledges the Medical Research Council and School of Optometry and Vision Sciences for support.	Abramoff Michael D, 2010, IEEE Rev Biomed Eng, V3, P169, DOI 10.1109/RBME.2010.2084567; ANSI, 2000, Z136 ANSI ORL LAS I, V168; Antony B, 2011, BIOMED OPT EXPRESS, V2, P2403, DOI 10.1364/BOE.2.002403; Avery RL, 2006, OPHTHALMOLOGY, V113, P363, DOI 10.1016/j.ophtha.2005.11.019; BENNETT AG, 1994, GRAEF ARCH CLIN EXP, V232, P361, DOI 10.1007/BF00175988; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Boey PY, 2014, CAN J OPHTHALMOL, V49, P489, DOI 10.1016/j.jcjo.2014.06.013; Browning DJ, 2007, OPHTHALMOLOGY, V114, P525, DOI 10.1016/j.ophtha.2006.06.052; Buchser NM, 2012, INVEST OPHTH VIS SCI, V53, P3742, DOI 10.1167/iovs.11-8432; Bussel II, 2014, BRIT J OPHTHALMOL, V98, P15, DOI 10.1136/bjophthalmol-2013-304326; Chiu SJ, 2010, OPT EXPRESS, V18, P19413, DOI 10.1364/OE.18.019413; Chopovska Y, 2011, OPHTHALMOLOGICA, V225, P27, DOI 10.1159/000316693; CHYLACK LT, 1993, ARCH OPHTHALMOL-CHIC, V111, P831, DOI 10.1001/archopht.1993.01090060119035; Drexler W, 2008, PROG RETIN EYE RES, V27, P45, DOI 10.1016/j.preteyeres.2007.07.005; Farsiu S, 2014, OPHTHALMOLOGY, V121, P162, DOI 10.1016/j.ophtha.2013.07.013; Forooghian F, 2008, INVEST OPHTH VIS SCI, V49, P4290, DOI 10.1167/iovs.08-2113; Garcia-Martin E, 2012, RETINA-J RET VIT DIS, V32, P1581, DOI 10.1097/IAE.0b013e318242b838; Garcia-Martin E, 2011, ACTA OPHTHALMOL, V89, pE23, DOI 10.1111/j.1755-3768.2010.02045.x; Garvin MK, 2013, INVEST OPHTH VIS SCI, V54, P6998, DOI 10.1167/iovs.13-12131; Garvin MK, 2009, IEEE T MED IMAGING, V28, P1436, DOI 10.1109/TMI.2009.2016958; Giani A, 2010, AM J OPHTHALMOL, V150, P815, DOI 10.1016/j.ajo.2010.06.025; GRUBBS FE, 1950, ANN MATH STAT, V21, P27, DOI 10.1214/aoms/1177729885; Hee MR, 1996, OPHTHALMOLOGY, V103, P1260, DOI 10.1016/S0161-6420(96)30512-5; Jia YL, 2014, OPHTHALMOLOGY, V121, P1435, DOI 10.1016/j.ophtha.2014.01.034; Kanagasingam Y, 2014, PROG RETIN EYE RES, V38, P20, DOI 10.1016/j.preteyeres.2013.10.002; Kotera Y, 2011, INVEST OPHTH VIS SCI, V52, P1412, DOI 10.1167/iovs.10-5572; Lee K, 2010, AUTOMATED INTRARETIN; LITTMANN H, 1982, KLIN MONATSBL AUGENH, V180, P286, DOI 10.1055/s-2008-1055068; Lujan BJ, 2011, INVEST OPHTH VIS SCI, V52, P1486, DOI 10.1167/iovs.10-5946; Martin DF, 2012, OPHTHALMOLOGY, V119, DOI 10.1016/j.ophtha.2012.03.053; Martinez-de-la-Casa JM, 2012, INVEST OPHTH VIS SCI, V53, P6214, DOI 10.1167/iovs.12-9875; Parravano M, 2010, INVEST OPHTH VIS SCI, V51, P4788, DOI 10.1167/iovs.09-4976; Povazay B, 2003, OPT EXPRESS, V11, P1980, DOI 10.1364/OE.11.001980; Povazay B, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2773728; PULIAFITO CA, 1995, OPHTHALMOLOGY, V102, P217; Rao HL, 2010, OPHTHALMOLOGY, V117, P1692, DOI 10.1016/j.ophtha.2010.01.031; Rashid A, 2014, REPORODUCIBILITY TOT; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; Sohn EH, 2013, INVEST OPHTH VIS SCI, V54, P4184, DOI 10.1167/iovs.12-10420; Spaide RF, 2008, AM J OPHTHALMOL, V146, P496, DOI 10.1016/j.ajo.2008.05.032; Thevenaz P, 1998, IEEE T IMAGE PROCESS, V7, P27, DOI 10.1109/83.650848; Thomson Kelsey L, 2015, Alzheimers Dement (Amst), V1, P136, DOI 10.1016/j.dadm.2015.03.001; Vas S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059809, 10.1371/journal.pone.0073990]; Wolf-Schnurrbusch UEK, 2009, INVEST OPHTH VIS SCI, V50, P3432, DOI 10.1167/iovs.08-2970; Wood A, 2011, AM J OPHTHALMOL, V152, P1030, DOI 10.1016/j.ajo.2011.05.021	45	40	40	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162001	10.1371/journal.pone.0162001	http://dx.doi.org/10.1371/journal.pone.0162001			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588683	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000382877800026
J	Perez, M; Ladero, V; Redruello, B; del Rio, B; Fernandez, L; Rodriguez, JM; Martin, M; Fernandez, M; Alvarez, MA				Perez, Marta; Ladero, Victor; Redruello, Begoma; del Rio, Beatriz; Fernandez, Leonides; Miguel Rodriguez, Juan; Cruz Martin, Ma; Fernandez, Maria; Alvarez, Miguel A.			Mastitis Modifies the Biogenic Amines Profile in Human Milk, with Significant Changes in the Presence of Histamine, Putrescine and Spermine	PLOS ONE			English	Article							BREAST-MILK; SYNTHETIC POLYAMINES; RAT MILK; ACIDS; PRETERM; MOTHERS; ORIGIN	Biogenic amines (BAs) are low molecular weight nitrogenous organic compounds with different biological activities. Putrescine, spermidine and spermine are essential for the development of the gut and immune system of newborns, and are all found in human milk. Little is known, however, about the role of histamine, tyramine or cadaverine in breast milk. Nor is it known whether mastitis alters the BA composition of milk. The BA profile of human milk, and the influence of mastitis on BA concentrations, were therefore investigated. Putrescine, spermidine and spermine were the main BAs detected. In mastitis-affected milk, the concentrations of putrescine, spermine and histamine were higher.	[Perez, Marta; Ladero, Victor; Redruello, Begoma; del Rio, Beatriz; Cruz Martin, Ma; Fernandez, Maria; Alvarez, Miguel A.] IPLA CSIC, Inst Prod Lacteos Asturias, Paseo Rio Linares S-N, Villaviciosa 33300, Spain; [Fernandez, Leonides; Miguel Rodriguez, Juan] Univ Complutense Madrid, Dept Nutr Bromatol & Tecnol Alimentos, Avda Puerta de Hierro, E-28040 Madrid, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Productos Lacteos de Asturias (IPLA); Complutense University of Madrid	Fernandez, M (corresponding author), IPLA CSIC, Inst Prod Lacteos Asturias, Paseo Rio Linares S-N, Villaviciosa 33300, Spain.	mfernandez@ipla.csic.es	Martin, Maria Cruz/F-2152-2013; Alvarez, Miguel A./F-2535-2013; Martín, María/HDL-9512-2022; Rodriguez, Juan Miguel/ABB-6650-2020; Arias-Alvarez, M/L-6169-2014; Perez, Marta/A-6239-2015; Ladero, Victor/B-6807-2008; Redruello, Begoña/A-2204-2016; Fernández, Leonides/N-7521-2019; del Rio, Beatriz/L-3082-2014	Martin, Maria Cruz/0000-0003-1975-6775; Alvarez, Miguel A./0000-0001-9607-7480; Rodriguez, Juan Miguel/0000-0002-1285-9686; Arias-Alvarez, M/0000-0001-7907-7454; Perez, Marta/0000-0002-1059-3677; Ladero, Victor/0000-0002-7613-3745; Fernández, Leonides/0000-0003-2380-0767; Redruello, Begona/0000-0003-1787-5594; del Rio, Beatriz/0000-0001-8107-1975	Spanish Ministry of Economy and Competitiveness [AGL2013-45431-R, AGL2013-41980P]; Plan for Science, Technology and Innovation of the Principality of Asturias [GRUPIN14-137]; European Regional Development Funds [GRUPIN14-137]; FPU (Programa de Formacion del Profesorado Universitario) fellowship from the Spanish Ministry of Education, Culture and Sport	Spanish Ministry of Economy and Competitiveness(Spanish Government); Plan for Science, Technology and Innovation of the Principality of Asturias; European Regional Development Funds(European Commission); FPU (Programa de Formacion del Profesorado Universitario) fellowship from the Spanish Ministry of Education, Culture and Sport	This work was performed with the financial support of the Spanish Ministry of Economy and Competitiveness (AGL2013-45431-R and AGL2013-41980P) and the GRUPIN14-137 project (which is co-financed by the Plan for Science, Technology and Innovation of the Principality of Asturias 2014-2017 and the European Regional Development Funds). M.P. was the recipient of an FPU (Programa de Formacion del Profesorado Universitario) fellowship from the Spanish Ministry of Education, Culture and Sport.	Ali MA, 2014, J HUM NUTR DIET, V27, P459, DOI 10.1111/jhn.12156; Ali MA, 2013, J HUM NUTR DIET, V26, P164, DOI 10.1111/jhn.12097; Aryeetey RNO, 2009, BREASTFEED MED, V4, P161, DOI 10.1089/bfm.2008.0131; AURAND LW, 1980, J ANIM SCI, V50, P783, DOI 10.2527/jas1980.505783x; BUTS JP, 1995, J PEDIATR GASTR NUTR, V21, P44, DOI 10.1097/00005176-199507000-00007; Chanphai P, 2016, INT J BIOL MACROMOL, V92, P515, DOI [10.1016/j.ijbiomac.2016.07.049, DOI 10.1016/J.IJBI0MAC.2016.07.049]; Contreras GA, 2011, J MAMMARY GLAND BIOL, V16, P339, DOI 10.1007/s10911-011-9234-0; Correa MF, 2015, CHEM BIOL DRUG DES, V85, P461, DOI 10.1111/cbdd.12431; D'Agostino L, 2006, IUBMB LIFE, V58, P75, DOI 10.1080/15216540600662525; Dubeau S, 2010, BIOMACROMOLECULES, V11, P1507, DOI 10.1021/bm100144v; Essemine J, 2011, INT J BIOL MACROMOL, V49, P201, DOI 10.1016/j.ijbiomac.2011.04.016; Fernandez L, 2013, PHARMACOL RES, V69, P1, DOI 10.1016/j.phrs.2012.09.001; Fetherston CM, 2006, BREASTFEED MED, V1, P136, DOI 10.1089/bfm.2006.1.136; Fiechter G, 2013, J CHROMATOGR B, V927, P191, DOI 10.1016/j.jchromb.2012.12.006; Gomez-Gallego C, 2013, BR J NUTR, V11, P1; Gregory KE, 2013, CURR PEDIAT REP, V1; Hettinga KA, 2009, VET MICROBIOL, V137, P384, DOI 10.1016/j.vetmic.2009.01.016; Hunt KM, 2013, BREASTFEED MED, V8, P105, DOI 10.1089/bfm.2011.0141; Jimenez E, 2015, J HUM LACT, V31, P406, DOI 10.1177/0890334415585078; Jimenez E, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-288; Ladero V, 2010, CURR NUTR FOOD SCI, V6, P145, DOI 10.2174/157340110791233256; Linares DM, 2011, CRIT REV FOOD SCI, V51, P691, DOI 10.1080/10408398.2011.582813; Mizuno K, 2012, J HUM LACT, V28, P529, DOI 10.1177/0890334412455946; Moon TC, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00569; Pegg AE, 2013, CHEM RES TOXICOL, V26, P1782, DOI 10.1021/tx400316s; Plaza-Zamora J, 2013, BRIT J NUTR, V110, P524, DOI 10.1017/S0007114512005284; Ploszaj T, 1997, COMP BIOCHEM PHYS B, V118, P45, DOI 10.1016/S0305-0491(97)00018-7; POLLACK PF, 1992, AM J CLIN NUTR, V56, P371, DOI 10.1093/ajcn/56.2.371; Redruello B, 2013, FOOD CHEM, V139, P1029, DOI 10.1016/j.foodchem.2013.01.071; ROMAIN N, 1992, PEDIATR RES, V32, P58, DOI 10.1203/00006450-199207000-00011; Sabater-Molina M, 2009, NUTRITION, V25, P940, DOI 10.1016/j.nut.2009.01.017; Shahid M, 2010, BIOMEDICAL ASPECTS OF HISTAMINE: CURRENT PERSPECTIVES, P3, DOI 10.1007/978-90-481-9349-3_1; Thomas T, 2001, CELL MOL LIFE SCI, V58, P244, DOI 10.1007/PL00000852; ZIA S, 1987, AM J VET RES, V48, P1617	34	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162426	10.1371/journal.pone.0162426	http://dx.doi.org/10.1371/journal.pone.0162426			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584695	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600132
J	Tian, YF; Gawlak, G; Tian, XY; Shah, AS; Sarich, N; Citi, S; Birukova, AA				Tian, Yufeng; Gawlak, Grzegorz; Tian, Xinyong; Shah, Alok S.; Sarich, Nicolene; Citi, Sandra; Birukova, Anna A.			Role of Cingulin in Agonist-induced Vascular Endothelial Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelium; lung injury; permeability; Rho (Rho GTPase); signal transduction; vascular biology	NUCLEOTIDE EXCHANGE FACTOR; TIGHT JUNCTIONS; BARRIER DYSFUNCTION; GENE-EXPRESSION; CLAUDIN-2 EXPRESSION; PULMONARY-EDEMA; CELL-ADHESION; IN-VIVO; RHO; GEF-H1	Agonist-induced activation of Rho GTPase signaling leads to endothelial cell (EC) permeability and may culminate in pulmonary edema, a devastating complication of acute lung injury. Cingulin is an adaptor protein first discovered in epithelium and is involved in the organization of the tight junctions. This study investigated the role of cingulin in control of agonist-induced lung EC permeability via interaction with RhoA-specific activator GEF-H1. The siRNA-induced cingulin knockdown augmented thrombin-induced EC permeability monitored by measurements of transendothelial electrical resistance and endothelial cell permeability for macromolecules. Increased thrombin-induced permeability in ECs with depleted cingulin was associated with increased activation of GEF-H1 and RhoA detected in pulldown activation assays. Increased GEF-H1 association with cingulin was essential for down-regulation of thrombin-induced RhoA barrier disruptive signaling. Using cingulin-truncated mutants, we determined that GEF-H1 interaction with the rod + tail domain of cingulin was required for inactivation of GEF-H1 and endothelial cell barrier preservation. The results demonstrate the role for association of GEF-H1 with cingulin as the mechanism of RhoA pathway inactivation and rescue of EC barrier after agonist challenge.	[Tian, Yufeng; Gawlak, Grzegorz; Tian, Xinyong; Shah, Alok S.; Sarich, Nicolene; Birukova, Anna A.] Univ Chicago, Sect Pulm & Crit Care Med, Dept Med, 5841 S Maryland Ave,MC 6026, Chicago, IL 60637 USA; [Citi, Sandra] Univ Geneva, Dept Cell Biol, CH-1205 Geneva, Switzerland	University of Chicago; University of Geneva	Birukova, AA (corresponding author), Univ Chicago, Sect Pulm & Crit Care Med, Dept Med, 5841 S Maryland Ave,MC 6026, Chicago, IL 60637 USA.	abirukov@medicine.bsd.uchicago.edu			National Institutes of Health Grants from NHLBI [HL107920, HL130431]; National Institutes of Health Grant from NIGMS [GM114171]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL130431, R01HL107920, R56HL107920] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM114171] Funding Source: NIH RePORTER	National Institutes of Health Grants from NHLBI; National Institutes of Health Grant from NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants HL107920 and HL130431 from NHLBI and National Institutes of Health Grant GM114171 from NIGMS. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Aijaz S, 2005, DEV CELL, V8, P777, DOI 10.1016/j.devcel.2005.03.003; Amerongen GPV, 2000, CIRC RES, V87, P335, DOI 10.1161/01.RES.87.4.335; Bazzoni G, 2006, THROMB HAEMOSTASIS, V95, P36, DOI 10.1160/TH05-07-0488; Beckers CML, 2010, THROMB HAEMOSTASIS, V103, P40, DOI 10.1160/TH09-06-0403; Benais-Pont G, 2003, J CELL BIOL, V160, P729, DOI 10.1083/jcb.200211047; Birukov KG, 2013, COMPR PHYSIOL, V3, P429, DOI 10.1002/cphy.c100066; Birukova AA, 2006, AM J PHYSIOL-LUNG C, V290, pL540, DOI 10.1152/ajplung.00259.2005; Birukova AA, 2004, FASEB J, V18, P1879, DOI 10.1096/fj.04-2328com; Birukova AA, 2004, J CELL PHYSIOL, V201, P55, DOI 10.1002/jcp.20055; Birukova AA, 2007, FASEB J, V21, P2776, DOI 10.1096/fj.06-7660com; Birukova AA, 2016, CELL SIGNAL, V28, P541, DOI 10.1016/j.cellsig.2016.02.015; Birukova AA, 2013, MOL BIOL CELL, V24, P2678, DOI 10.1091/mbc.E13-02-0098; Birukova AA, 2013, MICROVASC RES, V87, P50, DOI 10.1016/j.mvr.2012.12.006; Birukova AA, 2010, AM J PHYSIOL-LUNG C, V298, pL837, DOI 10.1152/ajplung.00263.2009; Birukova AA, 2009, AM J RESP CELL MOL, V40, P99, DOI 10.1165/rcmb.2008-0099OC; Bogatcheva NV, 2002, BIOCHEMISTRY-MOSCOW+, V67, P75, DOI 10.1023/A:1013904231324; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; Cherfils J, 2013, PHYSIOL REV, V93, P269, DOI 10.1152/physrev.00003.2012; Citi S, 2000, J STRUCT BIOL, V131, P135, DOI 10.1006/jsbi.2000.4284; CITI S, 1988, NATURE, V333, P272, DOI 10.1038/333272a0; Citi Sandra, 2014, Small GTPases, V5, P1, DOI 10.4161/21541248.2014.973760; Citi S, 2009, ANN NY ACAD SCI, V1165, P88, DOI 10.1111/j.1749-6632.2009.04053.x; Corada M, 1999, P NATL ACAD SCI USA, V96, P9815, DOI 10.1073/pnas.96.17.9815; Cordenonsi M, 1999, J CELL BIOL, V147, P1569, DOI 10.1083/jcb.147.7.1569; Dejana E, 2009, CELL TISSUE RES, V335, P17, DOI 10.1007/s00441-008-0694-5; Dubrovskyi O, 2013, LAB INVEST, V93, P254, DOI 10.1038/labinvest.2012.159; Fukata Y, 2001, TRENDS PHARMACOL SCI, V22, P32, DOI 10.1016/S0165-6147(00)01596-0; Garcia Joe G. N., 1996, Seminars in Thrombosis and Hemostasis, V22, P309, DOI 10.1055/s-2007-999025; Garcia-Mata R, 2006, METHOD ENZYMOL, V406, P425, DOI 10.1016/S0076-6879(06)06031-9; Gawlak G, 2014, FASEB J, V28, P3249, DOI 10.1096/fj.13-245142; Geiger B, 2001, CURR OPIN CELL BIOL, V13, P584, DOI 10.1016/S0955-0674(00)00255-6; Guillemot L, 2004, J CELL SCI, V117, P5245, DOI 10.1242/jcs.01399; Guillemot L, 2006, MOL BIOL CELL, V17, P3569, DOI 10.1091/mbc.E06-02-0122; Guillemot L, 2012, J CELL SCI, V125, P5005, DOI 10.1242/jcs.101261; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Kaibuchi K, 1999, ANNU REV BIOCHEM, V68, P459, DOI 10.1146/annurev.biochem.68.1.459; Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200; Krendel M, 2002, NAT CELL BIOL, V4, P294, DOI 10.1038/ncb773; Le Guelte A, 2011, BIOL CELL, V103, P593, DOI 10.1042/BC20110069; LO SK, 1985, J APPL PHYSIOL, V58, P1421, DOI 10.1152/jappl.1985.58.5.1421; Mammoto A, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2774; Mehta D, 2006, PHYSIOL REV, V86, P279, DOI 10.1152/physrev.00012.2005; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Ogita H, 2010, P JPN ACAD B-PHYS, V86, P621, DOI 10.2183/pjab.86.621; Paschoud S, 2008, MOL MEMBR BIOL, V25, P1, DOI 10.1080/09687680701474009; Ren Y, 1998, J BIOL CHEM, V273, P34954, DOI 10.1074/jbc.273.52.34954; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Schossleitner K, 2016, ARTERIOSCL THROM VAS, V36, P647, DOI 10.1161/ATVBAHA.115.307032; Terry SJ, 2011, NAT CELL BIOL, V13, P159, DOI 10.1038/ncb2156; Tian XY, 2014, J BIOL CHEM, V289, P5168, DOI 10.1074/jbc.M113.493924; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Tsukita S, 2009, ANN NY ACAD SCI, V1165, P44, DOI 10.1111/j.1749-6632.2009.04056.x; Vikis Haris G, 2004, Methods Mol Biol, V261, P175; Zebda N, 2013, J BIOL CHEM, V288, P18290, DOI 10.1074/jbc.M112.432757	54	15	15	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23681	23692		10.1074/jbc.M116.720763	http://dx.doi.org/10.1074/jbc.M116.720763			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27590342	hybrid, Green Published			2022-12-26	WOS:000387884400028
J	Huang, HC; Svoboda, RA; Lazenby, AJ; Saowapa, J; Chaika, N; Ding, K; Wheelock, MJ; Johnson, KR				Huang, Huocong; Svoboda, Robert A.; Lazenby, Audrey J.; Saowapa, Jintana; Chaika, Nina; Ding, Ke; Wheelock, Margaret J.; Johnson, Keith R.			Up-regulation of N-cadherin by Collagen I-activated Discoidin Domain Receptor 1 in Pancreatic Cancer Requires the Adaptor Molecule Shc1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							PROTEIN-TYROSINE KINASE; MESENCHYMAL TRANSITION; CELL-ADHESION; PYK2; EXPRESSION; INHIBITION; PROMOTES; BINDING; SRC; IDENTIFICATION	Pancreatic ductal adenocarcinomas are highly malignant cancers characterized by extensive invasion into surrounding tissues, metastasis to distant organs, and a limited response to therapy. A main feature of pancreatic ductal adenocarcinomas is desmoplasia, which leads to extensive deposition of collagen I. We have demonstrated that collagen I can induce epithelialmesenchymal transition (EMT) in pancreatic cancer cells. A hallmark of EMT is an increase in the expression of the mesenchymal cadherin N-cadherin. Previously we showed up-regulation of N-cadherin promotes tumor cell invasion and that collagen I-induced EMT is mediated by two collagen receptors, alpha 2 beta 1-integrin and discoidin domain receptor 1 (DDR1). DDR1 is a receptor-tyrosine kinase widely expressed during embryonic development and in many adult tissues and is also highly expressed in many different cancers. In the signaling pathway initiated by collagen, we have shown proline-rich tyrosine kinase 2 (Pyk2) is downstream of DDR1. In this study we found isoform b of DDR1 is responsible for collagen I-induced up-regulation of N-cadherin and tyrosine 513 of DDR1b is necessary. Knocking down Shc1, which binds to tyrosine 513 of DDR1b via its PTB (phosphotyrosine binding) domain, eliminates the upregulation of N-cadherin. The signaling does not require a functional SH2 domain or the tyrosine residues commonly phosphorylated in Shc1 but is mediated by the interaction between a short segment of the central domain of Shc1 and the proline-rich region of Pyk2. Taken together, these data illustrate DDR1b, but not DDR1a, mediates collagen I-induced N-cadherin up-regulation, and Shc1 is involved in this process by coupling to both DDR1 and Pyk2.	[Huang, Huocong; Wheelock, Margaret J.; Johnson, Keith R.] Univ Nebraska Med Ctr, Dept Biochem & Mol Biol, Coll Med, Omaha, NE 68198 USA; [Svoboda, Robert A.; Saowapa, Jintana; Wheelock, Margaret J.; Johnson, Keith R.] Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, 987696 Nebraska Med Ctr, Omaha, NE 68198 USA; [Lazenby, Audrey J.] Univ Nebraska Med Ctr, Dept Pathol & Microbiol, Coll Med, Omaha, NE 68198 USA; [Chaika, Nina; Wheelock, Margaret J.; Johnson, Keith R.] Univ Nebraska Med Ctr, Eppley Inst Res Canc & Allied Dis, Omaha, NE 68198 USA; [Ding, Ke] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, State Key Lab Resp Dis, 190 Kaiyuan Ave, Guangzhou 510530, Guangdong, Peoples R China; [Johnson, Keith R.] Univ Nebraska Med Ctr, Fred & Pamela Buffett Canc Ctr, Omaha, NE 68198 USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; State Key Laboratory of Respiratory Disease; University of Nebraska System; University of Nebraska Medical Center	Johnson, KR (corresponding author), Univ Nebraska Med Ctr, Dept Oral Biol, Coll Dent, 987696 Nebraska Med Ctr, Omaha, NE 68198 USA.	kjohnsonr@unmc.edu		Huang, Huocong/0000-0002-6345-4566; Ding, Ke/0000-0001-9016-812X	National Institutes of Health [U54CA163120, P50CA127297, U01CA111294, P30CA036727, R01GM051188, R21CA137401]; NIGMS, National Institutes of Health [P30GM106397]; Nebraska Department of Health and Human Services; NATIONAL CANCER INSTITUTE [P50CA127297, U54CA163120, P30CA036727, U01CA111294, R21CA137401] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P30GM106397, R01GM051188] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIGMS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Nebraska Department of Health and Human Services; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grants U54CA163120 (to S. Batra), P50CA127297 and U01CA111294 (to M. A. Hollingsworth), P30CA036727 (to K. H. Cowan), R01GM051188 (to M. J. W. and K. R. J.), and R21CA137401 (K. R. J.) and an Institutional Development Award (IDeA) from the NIGMS, National Institutes of Health Grant P30GM106397 (to K. R. J.) and a grant from the Nebraska Department of Health and Human Services (to K. R. J.). K. R. J. receives royalties from the sale of one of the antibodies used in these studies. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health or the Department of Health and Human Services of the State of Nebraska.	Aguilera K. Y., 2014, CANC RES S19, V74, p182a; Aguilera KY, 2014, CANCER RES, V74, P1032, DOI 10.1158/0008-5472.CAN-13-2800; ALEXANDROPOULOS K, 1995, P NATL ACAD SCI USA, V92, P3110, DOI 10.1073/pnas.92.8.3110; Ali-Rahmani F, 2016, CANCER RES, V76, P1560, DOI 10.1158/0008-5472.CAN-15-2401; Ambrogio C, 2016, NAT MED, V22, P270, DOI 10.1038/nm.4041; Bhattacharya SK, 2012, BIOORG MED CHEM LETT, V22, P7523, DOI 10.1016/j.bmcl.2012.10.039; Bishop AC, 2000, NATURE, V407, P395, DOI 10.1038/35030148; Bruns Christiane J., 1999, Neoplasia (New York), V1, P50, DOI 10.1038/sj.neo.7900005; Chen M, 2000, MOL CELL BIOL, V20, P7867, DOI 10.1128/MCB.20.21.7867-7880.2000; Dikic I, 1998, J BIOL CHEM, V273, P14301, DOI 10.1074/jbc.273.23.14301; Faure C, 2013, CELL MOL LIFE SCI, V70, P137, DOI 10.1007/s00018-012-1075-5; Feig C, 2012, CLIN CANCER RES, V18, P4266, DOI 10.1158/1078-0432.CCR-11-3114; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; Fukumoto Y, 2008, EXP CELL RES, V314, P52, DOI 10.1016/j.yexcr.2007.07.024; Gao MS, 2013, J MED CHEM, V56, P3281, DOI 10.1021/jm301824k; Grignani F, 1998, CANCER RES, V58, P14; Hingorani SR, 2005, CANCER CELL, V7, P469, DOI 10.1016/j.ccr.2005.04.023; Iansante V, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8882; ILLC D, 1995, NATURE, V377, P539; JOHNSON KR, 1993, EXP CELL RES, V207, P252, DOI 10.1006/excr.1993.1191; Kamohara H, 2001, FASEB J, V15, P2724, DOI 10.1096/fj.01-0359fje; Kim H, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI DOI 10.1111/CHS0.12019; Kohno T, 2008, BIOCHEM J, V410, P513, DOI 10.1042/BJ20070665; Lakkakorpi PT, 2003, J BIOL CHEM, V278, P11502, DOI 10.1074/jbc.M206579200; Lemeer S, 2012, J PROTEOMICS, V75, P3465, DOI 10.1016/j.jprot.2011.10.007; LEV S, 1995, NATURE, V376, P737, DOI 10.1038/376737a0; Li X, 1999, J BIOL CHEM, V274, P8917, DOI 10.1074/jbc.274.13.8917; Li YP, 2015, J MED CHEM, V58, P3287, DOI 10.1021/jm5012319; Lind J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096488; Machida K, 2007, MOL CELL, V26, P899, DOI 10.1016/j.molcel.2007.05.031; Maeda M, 2005, J CELL SCI, V118, P873, DOI 10.1242/jcs.01634; Mahadevan D, 2007, MOL CANCER THER, V6, P1186, DOI 10.1158/1535-7163.MCT-06-0686; Migliaccio E, 1997, EMBO J, V16, P706, DOI 10.1093/emboj/16.4.706; Nakajima S, 2004, CLIN CANCER RES, V10, P4125, DOI 10.1158/1078-0432.CCR-0578-03; Nemoto S, 2002, SCIENCE, V295, P2450, DOI 10.1126/science.1069004; Nieman MT, 1999, J CELL BIOL, V147, P631, DOI 10.1083/jcb.147.3.631; Northey JJ, 2013, J BIOL CHEM, V288, P5210, DOI 10.1074/jbc.M112.424804; Okigaki M, 2003, P NATL ACAD SCI USA, V100, P10740, DOI 10.1073/pnas.1834348100; Remmers N, 2013, CLIN CANCER RES, V19, P1981, DOI 10.1158/1078-0432.CCR-12-2662; Rui YN, 2015, AUTOPHAGY, V11, P812, DOI 10.1080/15548627.2015.1034402; Ryan DP, 2014, NEW ENGL J MED, V371, P2140, DOI 10.1056/NEJMc1412266; Saksela K, 2012, FEBS LETT, V586, P2609, DOI 10.1016/j.febslet.2012.04.042; Sanjay A, 2001, J CELL BIOL, V152, P181, DOI 10.1083/jcb.152.1.181; SASAKI H, 1995, J BIOL CHEM, V270, P21206, DOI 10.1074/jbc.270.36.21206; Sheffield P, 1999, PROTEIN EXPRES PURIF, V15, P34, DOI 10.1006/prep.1998.1003; Shintani Y, 2008, J CELL BIOL, V180, P1277, DOI 10.1083/jcb.200708137; Shintani Y, 2008, INT J CANCER, V122, P71, DOI 10.1002/ijc.23027; Shintani Y, 2006, MOL BIOL CELL, V17, P2963, DOI 10.1091/mbc.E05-12-1123; Shintani Y, 2006, CANCER RES, V66, P11745, DOI 10.1158/0008-5472.CAN-06-2322; Shokat K, 2002, DRUG DISCOV TODAY, V7, P872, DOI 10.1016/S1359-6446(02)02391-7; Smith MJ, 2006, MOL CELL BIOL, V26, P8461, DOI 10.1128/MCB.01491-06; Sorokin A, 2001, J BIOL CHEM, V276, P21521, DOI 10.1074/jbc.M008869200; TANAKA M, 1995, MOL CELL BIOL, V15, P6829; Valencia K, 2012, CLIN CANCER RES, V18, P969, DOI 10.1158/1078-0432.CCR-11-1686; Valiathan RR, 2012, CANCER METAST REV, V31, P295, DOI 10.1007/s10555-012-9346-z; vanderGeer P, 1996, CURR BIOL, V6, P1435, DOI 10.1016/S0960-9822(96)00748-8; vanderGeer P, 1996, P NATL ACAD SCI USA, V93, P963, DOI 10.1073/pnas.93.3.963; Vogel W, 1997, MOL CELL, V1, P13, DOI 10.1016/S1097-2765(00)80003-9; Vogel W, 1999, FASEB J, V13, pS77, DOI 10.1096/fasebj.13.9001.s77; Wahl JK, 2003, J BIOL CHEM, V278, P17269, DOI 10.1074/jbc.M211452200; Whatcott CJ., 2012, DESMOPLASIA CHEMORES; Wheelock MJ, 2008, J CELL SCI, V121, P727, DOI 10.1242/jcs.000455; Wheelock MJ, 2003, ANNU REV CELL DEV BI, V19, P207, DOI 10.1146/annurev.cellbio.19.011102.111135; Wills MKB, 2012, BIOCHEM J, V447, P1, DOI 10.1042/BJ20120769; Xiong WC, 1998, J CELL SCI, V111, P1981; Yang G, 2009, PROTEOMICS, V9, P4944, DOI 10.1002/pmic.200800762; Yilmaz M, 2009, CANCER METAST REV, V28, P15, DOI 10.1007/s10555-008-9169-0; Zhao M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149231; Zheng XF, 2015, NATURE, V527, P525, DOI 10.1038/nature16064	69	37	40	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23208	23223		10.1074/jbc.M116.740605	http://dx.doi.org/10.1074/jbc.M116.740605			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27605668	Green Published, hybrid			2022-12-26	WOS:000387224800030
J	Yeh, JJ; Wang, YC; Kao, CH				Yeh, Jun-Jun; Wang, Yu-Chiao; Kao, Chia-Hung			Asthma-Chronic Obstructive Pulmonary Disease Overlap Syndrome Associated with Risk of Pulmonary Embolism	PLOS ONE			English	Article							POPULATION-BASED-COHORT; DEEP-VEIN THROMBOSIS; COPD OVERLAP; ENDOTHELIAL DYSFUNCTION; MANAGEMENT; METAANALYSIS; PREVALENCE; BIOMARKERS; INCREASES; EVENTS	Purpose We conducted a cohort study to clarify this relationship between asthma-chronic obstructive pulmonary disease (COPD) overlap syndrome (ACOS) and pulmonary embolism (PE). Methods From the National Health Insurance Research Database of Taiwan, we identified patients who had a diagnosis of asthma and a diagnosis of COPD (defined as ACOS) and concurrent treatment between January 1999 and December 2009 (ACOS cohort: n = 14,150; non-ACOS cohort: n = 55,876). Cox proportional hazards regression analysis was performed to determine the adjusted hazard ratios (aHRs) for PE of the ACOS cohort compared with the non-ACOS cohort. Results Comparing the ACOS cohort with the non-ACOS cohort, the aHR of PE was 2.08 (95% confidence intervals [ CIs]: 1.56-2.76). The risk of PE was higher in ACOS cohort than non-ACOS cohort, regardless of age, sex, comorbidity, inhaled corticosteroids (ICSs) and oral steroids (OSs) used. For ages ranging from 20 to 65 years, the aHR of PE was 2.53 (95% CI: 1.44-4.44) in the ACOS cohort. ACOS patients using ICSs (aHR: 1.97, 95% CI: 1.29-3.01) or OSs (aHR: 1.97, 95% CI: 1.46-2.65), the risk of PE was higher than in the non-ACOS cohort. The risk of PE increased with the number of outpatient visits and hospitalizations necessitated, ranging from 2.32 (95% CI: 1.54-3.52) in patients having 3-9 visits to 4.20 (95% CI: 2.74-6.44) for those having > 9 visits. Conclusions ACOS is associated with increased risk of PE, particularly patients with a high frequency of AE-even in young adults or people without comorbidities.	[Yeh, Jun-Jun] Chia Yi Christian Hosp, Ditmanson Med Fdn, Chiayi, Taiwan; [Yeh, Jun-Jun] Chia Nan Univ Pharm & Sci, Tainan, Taiwan; [Yeh, Jun-Jun] Meiho Univ, Pingtung, Taiwan; [Wang, Yu-Chiao] China Med Univ Hosp, Management Off Hlth Data, Taichung, Taiwan; [Wang, Yu-Chiao] China Med Univ, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan; [Kao, Chia-Hung] China Med Univ Hosp, PET Ctr, Taichung, Taiwan; [Kao, Chia-Hung] Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan	Chia Nan University of Pharmacy & Science; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; Asia University Taiwan	Kao, CH (corresponding author), China Med Univ, Grad Inst Clin Med Sci, Coll Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, Dept Nucl Med, Taichung, Taiwan.; Kao, CH (corresponding author), China Med Univ Hosp, PET Ctr, Taichung, Taiwan.; Kao, CH (corresponding author), Asia Univ, Dept Bioinformat & Med Engn, Taichung, Taiwan.	d10040@mail.cmuh.org.tw			Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence [MOHW 105-TDU-B-212-133019]; Academia Sinica Taiwan Biobank Stroke Biosignature Project [BM10501010037]; NRPB Stroke Clinical Trial Consortium [MOST 104-2325-B-039 -005]; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; China Medical University Hospital	Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence; Academia Sinica Taiwan Biobank Stroke Biosignature Project; NRPB Stroke Clinical Trial Consortium; Tseng-Lien Lin Foundation, Taichung, Taiwan; Taiwan Brain Disease Foundation, Taipei, Taiwan; Katsuzo and Kiyo Aoshima Memorial Funds, Japan; CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan; China Medical University Hospital	This study is supported in part by Taiwan Ministry of Health and Welfare Clinical Trial and Research Center of Excellence (MOHW 105-TDU-B-212-133019), China Medical University Hospital, Academia Sinica Taiwan Biobank Stroke Biosignature Project (BM10501010037), NRPB Stroke Clinical Trial Consortium (MOST 104-2325-B-039 -005), Tseng-Lien Lin Foundation, Taichung, Taiwan, Taiwan Brain Disease Foundation, Taipei, Taiwan, and Katsuzo and Kiyo Aoshima Memorial Funds, Japan; and CMU under the Aim for Top University Plan of the Ministry of Education, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Alshabanat A, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136065; Bagot CN, 2008, BRIT J HAEMATOL, V143, P180, DOI 10.1111/j.1365-2141.2008.07323.x; Barnes PJ, 2015, J ALLERGY CLIN IMMUN, V136, P531, DOI 10.1016/j.jaci.2015.05.052; Becattini C, 2016, CHEST, V149, P192, DOI 10.1378/chest.15-0808; Braman SS, 2015, ALLERGY ASTHMA PROC, V36, P11, DOI 10.2500/aap.2015.36.3802; Budhiraja R, 2004, CIRCULATION, V109, P159, DOI 10.1161/01.CIR.0000102381.57477.50; Cannegieter SC, 2015, BLOOD, V125, P229, DOI 10.1182/blood-2014-06-577783; Chen WJ, 2014, COPD, V11, P438, DOI 10.3109/15412555.2013.813927; Cheng SL, 2014, DRUG DES DEV THER, V8, P601, DOI 10.2147/DDDT.S63100; Christenson SA, 2015, AM J RESP CRIT CARE, V191, P758, DOI 10.1164/rccm.201408-1458OC; Chung WS, 2015, THROMB HAEMOSTASIS, V114, P812, DOI 10.1160/TH14-10-0868; Chung WS, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000755; Chung WS, 2014, EUR RESPIR J, V43, P801, DOI 10.1183/09031936.00043313; Condliffe R, 2014, THORAX, V69, P174, DOI 10.1136/thoraxjnl-2013-204667; D'Urzo A, 2015, EXPERT OPIN PHARMACO, V16, P1845, DOI 10.1517/14656566.2015.1067682; de Marco R, 2015, EUR RESPIR J, V46, P671, DOI 10.1183/09031936.00008615; de Marco R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062985; Dentali F, 2016, THROMB HAEMOSTASIS, V115, P399, DOI 10.1160/TH15-02-0172; Fimognari Filippo Luca, 2008, Int J Chron Obstruct Pulmon Dis, V3, P89; Ghebre MA, 2015, J ALLERGY CLIN IMMUN, V135, P63, DOI 10.1016/j.jaci.2014.06.035; Huang WC, 2015, INT J CHRONIC OBSTR, V10, P2121, DOI 10.2147/COPD.S92062; Kahn SR, 2015, BLOOD, V126; King PT, 2015, CLIN TRANSL MED, V4, DOI 10.1186/s40169-015-0068-z; Knoflach M, 2005, ARCH INTERN MED, V165, P2521, DOI 10.1001/archinte.165.21.2521; Kumbhare S, 2016, ANN AM THORAC SOC, V13, P803, DOI 10.1513/AnnalsATS.201508-554OC; Levi M, 2003, CRIT CARE MED, V31, pS238, DOI 10.1097/01.CCM.0000057849.53689.65; Majoor CJ, 2013, EUR RESPIR J, V42, P655, DOI 10.1183/09031936.00150312; Meyer G, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0122-z; Motte S, 2016, EUR RESPIR J, V47, P203, DOI 10.1183/13993003.00281-2015; O'Connell C, 2015, BLOOD, V125, P1877, DOI 10.1182/blood-2014-08-551879; Parulekar AD, 2016, CURR OPIN PULM MED, V22, P59, DOI 10.1097/MCP.0000000000000231; Phillips CL, 2012, THORAX, V67, P639, DOI 10.1136/thoraxjnl-2011-200874; Piovella F, 2016, CLIN RESPIR J, V10, P545, DOI 10.1111/crj.12264; Reddel HK, 2015, J ALLERGY CLIN IMMUN, V136, P546, DOI 10.1016/j.jaci.2015.06.043; Rizkallah J, 2009, CHEST, V135, P786, DOI 10.1378/chest.08-1516; Sneeboer M, 2015, EUR RESPIR J, V46, DOI 10.1183/13993003.congress-2015.PA4567; Sneeboer MMS, 2016, J ALLERGY CLIN IMMUN, V137, P1727, DOI 10.1016/j.jaci.2015.10.038; Sneeboer MMS, 2016, THROMB RES, V140, P46, DOI 10.1016/j.thromres.2016.02.010; Stuijver DJE, 2013, CHEST, V143, P1337, DOI 10.1378/chest.12-1446; Torres-Macho J, 2013, AM J EMERG MED, V31, P1646, DOI 10.1016/j.ajem.2013.08.037; van Boven JFM, 2016, CHEST, V149, P1011, DOI 10.1016/j.chest.2015.12.002; van den Berge M, 2011, CHEST, V139, P412, DOI 10.1378/chest.10-1210; Wanner A, 2010, AM J RESP CRIT CARE, V182, P1344, DOI 10.1164/rccm.201001-0038PP; Wedzicha JA, 2016, AM J RESP CRIT CARE, V193, P937, DOI 10.1164/rccm.201601-0015ED; Woods JA, 2014, INT J CHRONIC OBSTR, V9, P421, DOI 10.2147/COPD.S51012; Yoo HHB, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010222.pub3	46	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162483	10.1371/journal.pone.0162483	http://dx.doi.org/10.1371/journal.pone.0162483			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611495	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900112
J	Zeng, Y; Hu, XP; Suh, SJ				Zeng, Yuan; Hu, Xing Ping; Suh, Sang-Jin			Characterization of Antibacterial Activities of Eastern Subterranean Termite, Reticulitermes flavipes, against Human Pathogens	PLOS ONE			English	Article							CASSETTE CHROMOSOME MEC; IMMUNE-RESPONSE; ANTIMICROBIAL PEPTIDES; FUNGAL PATHOGENS; INSECT IMMUNITY; PROTEIN; ANTIFUNGAL; INFECTION; BACTERIA; GENES	The emergence and dissemination of multidrug resistant bacterial pathogens necessitate research to find new antimicrobials against these organisms. We investigated antimicrobial production by eastern subterranean termites, Reticulitermes flavipes, against a panel of bacteria including three multidrug resistant (MDR) and four non-MDR human pathogens. We determined that the crude extract of naive termites had a broad-spectrum activity against the non-MDR bacteria but it was ineffective against the three MDR pathogens Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus (MRSA), and Acinetobacter baumannii. Heat or trypsin treatment resulted in a complete loss of activity suggesting that antibacterial activity was proteinaceous in nature. The antimicrobial activity changed dramatically when the termites were fed with either heat-killed P. aeruginosa or MRSA. Heat-killed P. aeruginosa induced activity against P. aeruginosa and MRSA while maintaining or slightly increasing activity against non-MDR bacteria. Heat-killed MRSA induced activity specifically against MRSA, altered the activity against two other Gram-positive bacteria, and inhibited activity against three Gram-negative bacteria. Neither the naive termites nor the termites challenged with heat-killed pathogens produced antibacterial activity against A. baumannii. Further investigation demonstrated that hemolymph, not the hindgut, was the primary source of antibiotic activity. This suggests that the termite produces these antibacterial activities and not the hindgut microbiota. Two-dimensional gel electrophoretic analyses of 493 hemolymph protein spots indicated that a total of 38 and 65 proteins were differentially expressed at least 2.5-fold upon being fed with P. aeruginosa and MRSA, respectively. Our results provide the first evidence of constitutive and inducible activities produced by R. flavipes against human bacterial pathogens.	[Zeng, Yuan; Hu, Xing Ping] Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA; [Suh, Sang-Jin] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University	Hu, XP (corresponding author), Auburn Univ, Dept Entomol & Plant Pathol, Auburn, AL 36849 USA.; Suh, SJ (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	huxingp@auburn.edu; suhsang@auburn.edu	Zeng, Yuan/R-3106-2018	Zeng, Yuan/0000-0003-2813-8960; Suh, Sang-Jin/0000-0002-4597-0137	National Institute of Food and Agriculture/United States Department of Agriculture Hatch program [ALA015-1-15005]; Auburn University Intramural Grant Program; Auburn University Detection and Food Safety Peaks of Excellence program [USDA 2005-3439415674A]; NSF EPSCoR [NSF-EPS11-58862]	National Institute of Food and Agriculture/United States Department of Agriculture Hatch program; Auburn University Intramural Grant Program; Auburn University Detection and Food Safety Peaks of Excellence program; NSF EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))	This study was supported by the National Institute of Food and Agriculture/United States Department of Agriculture Hatch program (ALA015-1-15005), unrestricted industry funds, the Auburn University Intramural Grant Program, the Auburn University Detection and Food Safety Peaks of Excellence program (USDA 2005-3439415674A) and NSF EPSCoR (NSF-EPS11-58862).	Adams MD, 2008, J BACTERIOL, V190, P8053, DOI 10.1128/JB.00834-08; An CJ, 2010, FEBS J, V277, P148, DOI 10.1111/j.1742-4658.2009.07465.x; Anju KM, 2015, WORLD J MICROB BIOT, V31, P621, DOI 10.1007/s11274-015-1816-3; Beck G, 1996, J BIOL CHEM, V271, P11035, DOI 10.1074/jbc.271.19.11035; Benz J, 2014, CURR OPIN MICROBIOL, V17, P1, DOI 10.1016/j.mib.2013.11.002; BERTANI G, 1951, J BACTERIOL, V62, P293, DOI 10.1128/JB.62.3.293-300.1951; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brown SE, 2009, INSECT BIOCHEM MOLEC, V39, P792, DOI 10.1016/j.ibmb.2009.09.004; Bulet P, 1999, DEV COMP IMMUNOL, V23, P329, DOI 10.1016/S0145-305X(99)00015-4; Bulmer MS, 2010, INSECT MOL BIOL, V19, P669, DOI 10.1111/j.1365-2583.2010.01023.x; Bulmer MS, 2009, P NATL ACAD SCI USA, V106, P12652, DOI 10.1073/pnas.0904063106; Bulmer MS, 2004, MOL BIOL EVOL, V21, P2256, DOI 10.1093/molbev/msh236; Bulmer MS, 2006, MOL BIOL EVOL, V23, P317, DOI 10.1093/molbev/msj037; Chouvenc T, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1885; Chouvenc T, 2009, J INVERTEBR PATHOL, V101, P130, DOI 10.1016/j.jip.2009.04.005; Dossey AT, 2010, NAT PROD REP, V27, P1737, DOI 10.1039/c005319h; FAULHABER LM, 1992, IMMUNOLOGY, V75, P378; Finnerty CM, 1999, PROTEIN SCI, V8, P242; Gao Q., 2014, SOCIAL IMMUNITY EXPR, DOI [10.1128/AEM.03193-12, DOI 10.1128/AEM.03193-12]; Haine ER, 2008, SCIENCE, V322, P1257, DOI 10.1126/science.1165265; Hamilton C, 2012, DEV COMP IMMUNOL, V36, P372, DOI 10.1016/j.dci.2011.07.008; HOLLOWAY BW, 1979, MICROBIOL REV, V43, P73, DOI 10.1128/MMBR.43.1.73-102.1979; Hu XP, 2004, ENVIRON ENTOMOL, V33, P197, DOI 10.1603/0046-225X-33.2.197; Hussain A, 2012, AFR J MICROBIOL RES, V6, P995, DOI 10.5897/AJMR11.1078; Ito T, 2001, ANTIMICROB AGENTS CH, V45, P1323, DOI 10.1128/AAC.45.5.1323-1336.2001; James SG, 1996, APPL ENVIRON MICROB, V62, P2783, DOI 10.1128/AEM.62.8.2783-2788.1996; Katayama Y, 2000, ANTIMICROB AGENTS CH, V44, P1549, DOI 10.1128/AAC.44.6.1549-1555.2000; Kim YS, 2000, J BIOL CHEM, V275, P32721, DOI 10.1074/jbc.M003934200; Lamberty M, 2001, J BIOL CHEM, V276, P4085, DOI 10.1074/jbc.M002998200; LILLEENGEN K, 1948, ACTA PATHOLOGICA M S, V77, P1; Liu L, 2015, SCI REP-UK, V5, DOI 10.1038/srep15106; Masson F, 2015, J INNATE IMMUN, V7, P290, DOI 10.1159/000368928; Matsuura K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000813; Parker BJ, 2013, APPL ENVIRON MICROB, V79, P2455, DOI 10.1128/AEM.03193-12; Rosengaus RB, 2014, FRONT MICROBIOL, V5, DOI 10.3389/fmicb.2014.00607; Rosengaus RB, 2007, NATURWISSENSCHAFTEN, V94, P25, DOI 10.1007/s00114-006-0151-9; Sadd BM, 2006, CURR BIOL, V16, P1206, DOI 10.1016/j.cub.2006.04.047; Sen R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123391; Shin SW, 1998, INSECT BIOCHEM MOLEC, V28, P827, DOI 10.1016/S0965-1748(98)00077-0; Shrestha S, 2010, J INSECT PHYSIOL, V56, P324, DOI 10.1016/j.jinsphys.2009.11.008; Sitohy MZ, 2014, FUNCT FOODS HEALTH D, V4, P451; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Suetsugu Y, 2013, G3-GENES GENOM GENET, V3, P1481, DOI 10.1534/g3.113.006239; SUN SC, 1990, SCIENCE, V250, P1729, DOI 10.1126/science.2270488; SUN SC, 1991, EUR J BIOCHEM, V196, P247, DOI 10.1111/j.1432-1033.1991.tb15811.x; Taniai K, 2006, INSECT MOL BIOL, V15, P269, DOI 10.1111/j.1365-2583.2006.00639.x; Terrapon N, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4636; Thompson GJ, 2003, INSECT MOL BIOL, V12, P1, DOI 10.1046/j.1365-2583.2003.00381.x; Tzou P, 2002, CURR OPIN MICROBIOL, V5, P102, DOI 10.1016/S1369-5274(02)00294-1; Yi HY, 2014, APPL MICROBIOL BIOT, V98, P5807, DOI 10.1007/s00253-014-5792-6; Zeng Y, 2014, ADV RES, V2, P455	51	7	8	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162249	10.1371/journal.pone.0162249	http://dx.doi.org/10.1371/journal.pone.0162249			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611223	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900070
J	Zhang, J; Zhang, SC; Li, LT; Xing, Y; Cao, MQ; Wu, JH; Jiang, B; Zhang, T				Zhang, Jian; Zhang, Shichuan; Li, Lintao; Xing, Yan; Cao, Maoqiu; Wu, Jinhua; Jiang, Bin; Zhang, Ting			Effects of Ionizing Radiation on Physical Properties of Peripherally Inserted Central Catheter	PLOS ONE			English	Article							CENTRAL VENOUS CATHETERS; BLOOD-STREAM INFECTION; CANCER-PATIENTS; COMPLICATIONS; CHEMOTHERAPY; METAANALYSIS; RADIOTHERAPY; PLACEMENT; RISK	Peripherally inserted central catheter (PICC) has been widely used to treat cancer patients. It is unknown whether or not it can be applied safely during radiotherapy. The study aimed to investigate the direct effects of gamma radiation on physical properties of PICC. A total of 60 catheters were included in this study. Thirty PICCs were exposed to a radiation field, and another 30 PICCs received radiation in a 3-cm homogeneity water equivalent phantom and then were irradiated. Each group was divided into three subgroups: 10 PICCs were given conventional fractionation, 2 Gy per fraction, 5 fractions per week; 10 PICCs were continuously given hypofractionation, 10 Gy per fraction, for 6 weeks; and 10 PICCs were given mock radiation as controls. The physical properties of these catheters were analyzed after radiation. None of the PICCs leaked under 300-kPa airflow pressure lasting 15 seconds. Fracture force values and liquid velocity values of all PICCs were within the normal range. The liquid velocity values of the control groups were higher than the two groups that received radiation (P < 0.05), and there was no difference between the two irradiation groups (P > 0.05). There were no statistical differences among the conventional fractionation group, hypofractionation group, and control group when compared to the fracture force values in two parts (P > 0.05). The physical property of PICC is quite stable with a clinically relevant dose of gamma radiation. It is likely that PICC can be used safely in patients receiving radiotherapy, although further in vivo and clinical studies are required.	[Zhang, Jian; Zhang, Shichuan; Li, Lintao; Xing, Yan; Cao, Maoqiu; Wu, Jinhua; Zhang, Ting] Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China; [Jiang, Bin] Sichuan Canc Hosp, Dept Thorac Surg, Chengdu, Sichuan, Peoples R China; [Zhang, Jian; Jiang, Bin] Sichuan Canc Hosp, Dept Nursing, Chengdu, Sichuan, Peoples R China; [Zhang, Ting] Sichuan Canc Hosp, Dept Gynecol Oncol, Chengdu, Sichuan, Peoples R China		Zhang, T (corresponding author), Sichuan Canc Hosp, Dept Radiat Oncol, Chengdu, Sichuan, Peoples R China.; Zhang, T (corresponding author), Sichuan Canc Hosp, Dept Gynecol Oncol, Chengdu, Sichuan, Peoples R China.	sccancerhospital@outlook.com						Alexandrou E, 2014, CRIT CARE MED, V42, P536, DOI 10.1097/CCM.0b013e3182a667f0; Bai XH, 2013, J CANCER RES THER, V9, P664, DOI 10.4103/0973-1482.126475; Breugom AJ, 2015, LANCET ONCOL, V16, P200, DOI 10.1016/S1470-2045(14)71199-4; Burns Tim, 2010, Radiol Manage, V32, P28; Chopra V, 2015, ANN INTERN MED, V163, pS1, DOI 10.7326/M15-0744; Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737; Chopra V, 2013, LANCET, V382, P311, DOI 10.1016/S0140-6736(13)60592-9; Chopra V, 2012, JAMA-J AM MED ASSOC, V308, P1527, DOI 10.1001/jama.2012.12704; Chopra V, 2012, AM J MED, V125, P733, DOI 10.1016/j.amjmed.2012.04.010; Cotogni P, 2013, JPEN-PARENTER ENTER, V37, P375, DOI 10.1177/0148607112460552; Gunderson LL, 2007, CLINICAL RADIATION O; Leung TK, 2011, CANCER NURS, V34, pE25, DOI 10.1097/NCC.0b013e3181f1ad6f; Linnemann B, 2014, SEMIN THROMB HEMOST, V40, P382, DOI 10.1055/s-0034-1371005; Matsuzaki A, 2006, SUPPORT CARE CANCER, V14, P153, DOI 10.1007/s00520-005-0848-x; Pikwer A, 2012, ANAESTHESIA, V67, P65, DOI 10.1111/j.1365-2044.2011.06911.x; Simone CB, 2015, TRANSL LUNG CANCER R, V4, P545, DOI 10.3978/j.issn.2218-6751.2015.10.05; Uygun I, 2011, ACTA CIR BRAS, V26, P404, DOI 10.1590/S0102-86502011000500014; Walker G., 2013, BR J NURS, V22, pS9, DOI DOI 10.12968/BJ0N.2013.22.SUP19.S9	18	3	3	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162837	10.1371/journal.pone.0162837	http://dx.doi.org/10.1371/journal.pone.0162837			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611595	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900177
J	Baumann, JH; Townsend, JE; Courtney, TA; Aichelman, HE; Davies, SW; Lima, FP; Castillo, KD				Baumann, Justin H.; Townsend, Joseph E.; Courtney, Travis A.; Aichelman, Hannah E.; Davies, Sarah W.; Lima, Fernando P.; Castillo, Karl D.			Temperature Regimes Impact Coral Assemblages along Environmental Gradients on Lagoonal Reefs in Belize	PLOS ONE			English	Article							CLIMATE-CHANGE; BLEACHING EVENT; LIFE-HISTORIES; RESILIENCE; EUTROPHICATION; DECLINE; MODEL; CIRCULATION; ADAPTATION; STRESSORS	Coral reefs are increasingly threatened by global and local anthropogenic stressors such as rising seawater temperature, nutrient enrichment, sedimentation, and overfishing. Although many studies have investigated the impacts of local and global stressors on coral reefs, we still do not fully understand how these stressors influence coral community structure, particularly across environmental gradients on a reef system. Here, we investigate coral community composition across three different temperature and productivity regimes along a nearshore-offshore gradient on lagoonal reefs of the Belize Mesoamerican Barrier Reef System (MBRS). A novel metric was developed using ultra-high-resolution satellite-derived estimates of sea surface temperatures (SST) to classify reefs as exposed to low (low(TP)), moderate (mod(TP)), or high (high(TP)) temperature parameters over 10 years (2003 to 2012). Coral species richness, abundance, diversity, density, and percent cover were lower at high(TP) sites relative to low(TP) and mod(TP) sites, but these coral community traits did not differ significantly between low(TP) and mod(TP) sites. Analysis of coral life history strategies revealed that high(TP) sites were dominated by hardy stress-tolerant and fast-growing weedy coral species, while low(TP) and mod(TP) sites consisted of competitive, generalist, weedy, and stress-tolerant coral species. Satellite-derived estimates of Chlorophyll-a (chl-a) were obtained for 13-years (2003-2015) as a proxy for primary production. Chl-a concentrations were highest at high(TP) sites, medial at mod(TP) sites, and lowest at low(TP) sites. Notably, thermal parameters correlated better with coral community traits between site types than productivity, suggesting that temperature (specifically number of days above the thermal bleaching threshold) played a greater role in defining coral community structure than productivity on the MBRS. Dominance of weedy and stress-tolerant genera at high(TP) sites suggests that corals utilizing these two life history strategies may be better suited to cope with warmer oceans and thus may warrant protective status under climate change.	[Baumann, Justin H.; Townsend, Joseph E.; Courtney, Travis A.; Aichelman, Hannah E.; Davies, Sarah W.; Castillo, Karl D.] Univ N Carolina, Dept Marine Sci, 3202 Murray & Venable Halls, Chapel Hill, NC 27599 USA; [Courtney, Travis A.; Davies, Sarah W.] Northeastern Univ, Dept Marine & Environm Sci, 430 Nahant Rd, Nahant, MA USA; [Courtney, Travis A.] Univ Calif San Diego, Scripps Inst Oceanog, 9500 Gilman Dr, La Jolla, CA 92093 USA; [Lima, Fernando P.] Univ Porto, Ctr Invest Biodiversidade & Recursos Genet, CIBIO InBIO, Campus Agr Vairao, Vairao, Portugal	University of North Carolina; University of North Carolina Chapel Hill; Northeastern University; University of California System; University of California San Diego; Scripps Institution of Oceanography; Universidade do Porto	Baumann, JH (corresponding author), Univ N Carolina, Dept Marine Sci, 3202 Murray & Venable Halls, Chapel Hill, NC 27599 USA.	baumannj@live.unc.edu	Lima, Fernando P./C-1398-2008	Lima, Fernando P./0000-0001-9575-9834; Baumann, Justin/0000-0003-0113-0491; Courtney, Travis/0000-0002-1868-9630	Rufford Foundation [15802-1]; National Science Foundation [OCE 1459522]; Department of Defense NDSEG fellowship; Directorate For Geosciences [1459522] Funding Source: National Science Foundation	Rufford Foundation; National Science Foundation(National Science Foundation (NSF)); Department of Defense NDSEG fellowship(United States Department of Defense); Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	This work was supported by the Rufford Foundation (http://www.rufford.org) Small Grant to JHB (15802-1); National Science Foundation (Oceanography) (nsf.gov) to KDC (OCE 1459522); Department of Defense NDSEG fellowship to JHB.	Alvarez-Filip L, 2009, P ROY SOC LOND B BIO; Alvarez-Filip L, 2013, SCI REP-UK, V3, DOI 10.1038/srep03486; Alvarez-Filip L, 2011, ECOL APPL, V21, P2223, DOI 10.1890/10-1563.1; Andrefouet S, 2002, CORAL REEFS, V21, P43, DOI 10.1007/s00338-001-0199-0; Anthony KRN, 1999, J EXP MAR BIOL ECOL, V232, P85, DOI 10.1016/S0022-0981(98)00099-9; Aronson RB, 2004, ECOLOGY, V85, P1876, DOI 10.1890/03-0108; Aronson RB, 2002, MAR BIOL, V141, P435, DOI 10.1007/s00227-002-0842-5; Barshis DJ, 2013, P NATL ACAD SCI USA, V110, P1387, DOI 10.1073/pnas.1210224110; Bell PRF, 2014, AMBIO, V43, P361, DOI 10.1007/s13280-013-0443-1; BELL PRF, 1992, WATER RES, V26, P553, DOI 10.1016/0043-1354(92)90228-V; Brown BE, 1997, CORAL REEFS, V16, pS129, DOI 10.1007/s003380050249; Buglass S, 2016, MAR POLLUT BULL, V104, P198, DOI 10.1016/j.marpolbul.2016.01.038; Burke L., 2004, REEFS RISK CARIBBEAN; Carilli J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034418; Carilli JE, 2009, MAR POLLUT BULL, V58, P1835, DOI 10.1016/j.marpolbul.2009.07.024; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carrillo L, 2015, CONT SHELF RES, V109, P164, DOI 10.1016/j.csr.2015.09.014; Castillo KD, 2012, NAT CLIM CHANGE, V2, P756, DOI [10.1038/nclimate1577, 10.1038/NCLIMATE1577]; Chin TM, 2013, ALGORITHM THEORETICA, V1, P13; Chollett I, 2012, LIMNOL OCEANOGR, V57, P1233, DOI 10.4319/lo.2012.57.4.1233; Cooper TF, 2007, ESTUAR COAST SHELF S, V74, P458, DOI 10.1016/j.ecss.2007.05.020; Cortes J., 1990, CORAL REEFS GOLFO DU; Cramer K, 2010, P 2010 AGU OC SCI M; Cramer KL, 2015, MAR POLLUT BULL, V96, P176, DOI 10.1016/j.marpolbul.2015.05.031; Cramer KL, 2012, ECOL LETT, V15, P561, DOI 10.1111/j.1461-0248.2012.01768.x; D'Croz L, 2001, B MAR SCI, V69, P203; Dale MRT, 2002, ECOSCIENCE, V9, P162, DOI 10.1080/11956860.2002.11682702; Darling ES, 2013, GLOBAL CHANGE BIOL, V19, P1930, DOI 10.1111/gcb.12191; Darling ES, 2012, ECOL LETT, V15, P1378, DOI 10.1111/j.1461-0248.2012.01861.x; Done T.J., 1982, Coral Reefs, V1, P95, DOI 10.1007/BF00301691; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2007, P NATL ACAD SCI USA, V104, P5483, DOI 10.1073/pnas.0610122104; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Fine M, 2013, GLOBAL CHANGE BIOL, V19, P3640, DOI 10.1111/gcb.12356; Frieler K, 2013, NAT CLIM CHANGE, V3, P165, DOI 10.1038/NCLIMATE1674; Game ET, 2008, CONSERV BIOL, V22, P1619, DOI 10.1111/j.1523-1739.2008.01037.x; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; Ginsburg R, 2003, ATOLL RES B, V496; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; Graham NAJ, 2014, CURR OPIN ENV SUST, V7, P9, DOI 10.1016/j.cosust.2013.11.023; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Greenstein BJ, 1998, CORAL REEFS, V17, P249, DOI 10.1007/s003380050125; Grottoli AG, 2006, NATURE, V440, P1186, DOI 10.1038/nature04565; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; HUNTE W, 1992, MAR BIOL, V114, P625, DOI 10.1007/BF00357259; Jackson JBC, 2001, SCIENCE, V293, P629, DOI 10.1126/science.1059199; JOKIEL PL, 1990, CORAL REEFS, V8, P155, DOI 10.1007/BF00265006; Lirman D, 2007, MAR POLLUT BULL, V54, P779, DOI 10.1016/j.marpolbul.2006.12.014; Loya Y, 2001, ECOL LETT, V4, P122, DOI 10.1046/j.1461-0248.2001.00203.x; Marubini F, 1999, MAR ECOL PROG SER, V188, P117, DOI 10.3354/meps188117; McClanahan TR, 2008, MAR BIOL, V153, P755, DOI 10.1007/s00227-007-0844-4; McClanahan TR, 2014, CURR OPIN ENV SUST, V7, P59, DOI 10.1016/j.cosust.2013.11.028; McClanahan TR, 2003, ECOSYSTEMS, V6, P551, DOI 10.1007/s10021-002-0104-x; Moberg F, 1999, ECOL ECON, V29, P2151; Polonia ARM, 2015, SCI TOTAL ENVIRON, V537, P139, DOI 10.1016/j.scitotenv.2015.07.102; Oksanen J., 2013, PACKAGE VEGAN R PACK, V254, P20; Oliver TA, 2011, CORAL REEFS, V30, P429, DOI 10.1007/s00338-011-0721-y; P Grime J., 2012, EVOLUTIONARY STRATEG, DOI [DOI 10.1002/9781118223246, 10.1002/9781118223246]; Paris CB, 2008, CORAL REEFS, V27, P773, DOI 10.1007/s00338-008-0396-1; Paris CB, 2007, MAR ECOL PROG SER, V347, P285, DOI 10.3354/meps06985; Perry CT, 2003, CORAL REEFS, V22, P427, DOI 10.1007/s00338-003-0330-5; Pineda J, 2013, LIMNOL OCEANOGR, V58, P1531, DOI 10.4319/lo.2013.58.5.1531; Prouty NG, 2008, CORAL REEFS, V27, P727, DOI 10.1007/s00338-008-0413-4; Sheng JY, 2004, OCEAN DYNAM, V54, P232, DOI 10.1007/s10236-003-0074-3; Sheng JY, 2003, J PHYS OCEANOGR, V33, P2049, DOI 10.1175/1520-0485(2003)033<2049:ANSOCI>2.0.CO;2; Simons RA, 2011, ERDDAP ENV RES DIVIS; Soto I, 2011, J MARINE BIOL, V2011; Szmant AM, 2002, ESTUARIES, V25, P743, DOI 10.1007/BF02804903; Tang LQ, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC002930; Team RC, 2012, R LANG ENV STAT COMP; Thompson DM, 2009, P ROY SOC B-BIOL SCI, V276, P2893, DOI 10.1098/rspb.2009.0591; Thurber RLV, 2014, GLOBAL CHANGE BIOL, V20, P544, DOI 10.1111/gcb.12450; Torres JL, 2002, CARIBB J SCI, V38, P222; van Hooidonk R, 2015, GLOBAL CHANGE BIOL, V21, P3389, DOI 10.1111/gcb.12901; van Woesik R, 1999, MAR FRESHWATER RES, V50, P427, DOI 10.1071/MF97046; van Woesik R, 2011, MAR ECOL PROG SER, V434, P67, DOI 10.3354/meps09203; van Woesik R, 2012, ECOL EVOL, V2, P2474, DOI 10.1002/ece3.363; West K, 2001, MAR POLLUT BULL, V42, P864, DOI 10.1016/S0025-326X(01)00040-6; Wild C, 2011, MAR FRESHWATER RES, V62, P205, DOI 10.1071/MF10254; Wooldridge S, 2005, MAR ECOL PROG SER, V295, P157, DOI 10.3354/meps295157; Wooldridge SA, 2009, MAR ECOL PROG SER, V396, P145, DOI 10.3354/meps08310; Wooldridge SA, 2009, MAR POLLUT BULL, V58, P745, DOI 10.1016/j.marpolbul.2008.12.013; Zaneveld JR, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11833	85	18	18	3	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162098	10.1371/journal.pone.0162098	http://dx.doi.org/10.1371/journal.pone.0162098			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606598	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600017
J	Chow, LH; Chen, YH; Wu, WC; Chang, EP; Huang, EYK				Chow, Lok-Hi; Chen, Yuan-Hao; Wu, Wan-Chuan; Chang, En-Pei; Huang, Eagle Yi-Kung			Sex Difference in Oxytocin-Induced Anti-Hyperalgesia at the Spinal Level in Rats with Intraplantar Carrageenan-Induced Inflammation	PLOS ONE			English	Article							ANGIOTENSIN-IV; MORPHINE ANTINOCICEPTION; ELECTRICAL-STIMULATION; CEREBROSPINAL-FLUID; INDUCED ANALGESIA; OPIOID RECEPTORS; CORD; PAIN; AMINOPEPTIDASE; MICE	Previously, we demonstrated intrathecal administration of oxytocin strongly induced anti-hyperalgesia in male rats. By using an oxytocin-receptor antagonist (atosiban), the descending oxytocinergic pathway was found to regulate inflammatory hyperalgesia in our previous study using male rats. The activity of this neural pathway is elevated during hyperalgesia, but whether this effect differs in a sex-dependent manner remains unknown. We conducted plantar tests on adult male and female virgin rats in which paw inflammation was induced using carrageenan. Exogenous (i.t.) application of oxytocin exerted no anti-hyperalgesic effect in female rats, except at an extremely high dose. Female rats exhibited similar extent of hyperalgesia to male rats did when the animals received the same dose of carrageenan. When atosiban was administered alone, the severity of hyperalgesia was not increased in female rats. Moreover, insulin-regulated aminopeptidase (IRAP) was expressed at higher levels in the spinal cords of female rats compared with those of male rats. Oxytocin-induced anti-hyperalgesia exhibits a sex-dependent difference in rats. This difference can partially result from the higher expression of IRAP in the spinal cords of female rats, because IRAP functions as an enzyme that degrades oxytocin. Our study confirms the existence of a sex difference in oxytocin-induced anti-hyperalgesia at the spinal level in rats.	[Wu, Wan-Chuan; Chang, En-Pei; Huang, Eagle Yi-Kung] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Chow, Lok-Hi] Natl Def Med Ctr, Dept Anesthesiol, Taipei, Taiwan; [Chow, Lok-Hi] Taipei Vet Gen Hosp, Dept Anesthesiol, Taipei, Taiwan; [Chow, Lok-Hi] Natl Yang Ming Univ, Sch Med, Dept Anesthesiol, Taipei, Taiwan; [Chen, Yuan-Hao] Natl Def Med Ctr, Tri Serv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan	National Defense Medical Center; National Defense Medical Center; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; National Defense Medical Center; Tri-Service General Hospital	Huang, EYK (corresponding author), Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan.	eyh58@mail.ndmctsgh.edu.tw	Chen, Yuan-Hao/U-6870-2019	Chen, Yuan-Hao/0000-0002-0570-4328	National Science Council, Taiwan, ROC [NSC 96-2320-B-016-020-MY3, NSC 99-2320-B-016-002-MY3]	National Science Council, Taiwan, ROC(Ministry of Science and Technology, Taiwan)	This study was supported by the grants (NSC 96-2320-B-016-020-MY3 and NSC 99-2320-B-016-002-MY3) from National Science Council, Taiwan, ROC.	Albiston AL, 2001, J BIOL CHEM, V276, P48623, DOI 10.1074/jbc.C100512200; ARLETTI R, 1993, NEUROPEPTIDES, V24, P125, DOI 10.1016/0143-4179(93)90075-L; Cheng BC, 2012, PEPTIDES, V36, P9, DOI 10.1016/j.peptides.2012.03.019; Chow LH, 2004, J BIOMED SCI, V11, P717, DOI 10.1159/000081817; Chow LH, 2004, CAN J ANAESTH, V51, P905, DOI 10.1007/BF03018888; Chow LH, 2013, PEPTIDES, V39, P21, DOI 10.1016/j.peptides.2012.10.012; Condes-Lara M, 2006, BRAIN RES, V1081, P126, DOI 10.1016/j.brainres.2006.01.050; Condes-Lara M, 2005, BRAIN RES, V1045, P124, DOI 10.1016/j.brainres.2005.03.020; Condes-Lara M, 2007, BRAIN RES, V1160, P20, DOI 10.1016/j.brainres.2007.05.031; Condes-Lara M, 2009, EUR J NEUROSCI, V30, P1056, DOI 10.1111/j.1460-9568.2009.06899.x; DADDONA MM, 1994, NEUROREPORT, V5, P1833, DOI 10.1097/00001756-199409080-00037; Eliava M, 2016, NEURON, V89, P1291, DOI 10.1016/j.neuron.2016.01.041; Gao L, 2004, REGUL PEPTIDES, V120, P53, DOI 10.1016/j.regpep.2004.02.011; Horio J, 1999, BIOCHEM BIOPH RES CO, V262, P269, DOI 10.1006/bbrc.1999.1184; Lee HJ, 2009, PROG NEUROBIOL, V88, P127, DOI 10.1016/j.pneurobio.2009.04.001; LUNDEBERG T, 1994, NEUROSCI LETT, V170, P153, DOI 10.1016/0304-3940(94)90262-3; MADRAZO I, 1987, APPL NEUROPHYSIOL, V50, P427; Martinez-Lorenzan G, 2008, PAIN, V140, P265, DOI 10.1016/j.pain.2008.08.015; Miranda-Cardenas Y, 2006, PAIN, V122, P182, DOI 10.1016/j.pain.2006.01.029; Nomura M, 2002, PLACENTA, V23, P631, DOI 10.1053/plac.2002.0861; Petersson M, 1996, NEUROSCI LETT, V212, P87, DOI 10.1016/0304-3940(96)12773-7; Petersson M, 2001, PEPTIDES, V22, P1479, DOI 10.1016/S0196-9781(01)00469-7; Puder BA, 2001, J NEUROSCI RES, V64, P53, DOI 10.1002/jnr.1053; Reeta K, 2006, REGUL PEPTIDES, V135, P85, DOI 10.1016/j.regpep.2006.04.004; Robinson DA, 2002, J PHYSIOL-LONDON, V540, P593, DOI 10.1113/jphysiol.2001.013492; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; TAKAGI T, 1985, HORM METAB RES, V17, P308, DOI 10.1055/s-2007-1013526; Uhl-Bronner S, 2005, NEUROSCIENCE, V135, P147, DOI 10.1016/j.neuroscience.2005.05.025; XU XJ, 1994, NEUROREPORT, V5, P750, DOI 10.1097/00001756-199403000-00003; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; Yamasue H, 2009, PSYCHIAT CLIN NEUROS, V63, P129, DOI 10.1111/j.1440-1819.2009.01944.x; YANG J, 1994, SPINE, V19, P867, DOI 10.1097/00007632-199404150-00001; Yang J, 2007, PEPTIDES, V28, P1113, DOI 10.1016/j.peptides.2007.03.003; YIRMIYA R, 1990, BRAIN RES, V537, P169, DOI 10.1016/0006-8993(90)90354-E; Yu SQ, 2003, BRAIN RES, V983, P13, DOI 10.1016/S0006-8993(03)03019-1	35	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162218	10.1371/journal.pone.0162218	http://dx.doi.org/10.1371/journal.pone.0162218			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606886	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255600031
J	Adam, AP; Lowery, AM; Martino, N; Alsaffar, H; Vincent, PA				Adam, Alejandro P.; Lowery, Anthony M.; Martino, Nina; Alsaffar, Hiba; Vincent, Peter A.			Src Family Kinases Modulate the Loss of Endothelial Barrier Function in Response to TNF-alpha: Crosstalk with p38 Signaling	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; TYROSINE PHOSPHORYLATION; VE-CADHERIN; VASCULAR-PERMEABILITY; PARACELLULAR PATHWAY; SEVERE SEPSIS; SERUM-LEVELS; KAPPA-B; ACTIVATION; MOUSE	Activation of Src Family Kinase (SFK) signaling is required for the increase in endothelial permeability induced by a variety of cytokines and growth factors. However, we previously demonstrated that activation of endogenous SFKs by expression of dominant negative C-terminal Src Kinase (DN-Csk) is not sufficient to decrease endothelial adherens junction integrity. Basal SFK activity has been observed in normal venular endothelia and was not associated with increased basal permeability. The basal SFK activity however was found to contribute to increased sensitivity of the venular endothelium to inflammatory mediator-induced leakage. How SFK activation achieves this is still not well understood. Here, we show that SFK activation renders human dermal microvascular endothelial cells susceptible to low doses of TNF-alpha. Treatment of DN-Csk-expressing cells with 50 pg/ml TNF-alpha induced a loss of TEER as well as drastic changes in the actin cytoskeleton and focal adhesion proteins. This synergistic effect was independent of ROCK or NF-kappa B activity. TNF-alpha induced p38 signaling was required for the synergistic effect on barrier function, and activation of the p38 MAPK alone was also able to induce changes in permeability only in monolayers with active SFKs. These results suggest that the activation of endogenous levels of SFK renders the endothelial barrier more susceptible to low, physiologic doses of TNF-alpha through activation of p38 which leads to a loss of endothelial tight junctions.	[Adam, Alejandro P.; Lowery, Anthony M.; Martino, Nina; Alsaffar, Hiba; Vincent, Peter A.] Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA; [Adam, Alejandro P.] Albany Med Coll, Dept Ophthalmol, Albany, NY 12208 USA	Albany Medical College; Albany Medical College	Adam, AP; Vincent, PA (corresponding author), Albany Med Coll, Dept Mol & Cellular Physiol, Albany, NY 12208 USA.; Adam, AP (corresponding author), Albany Med Coll, Dept Ophthalmol, Albany, NY 12208 USA.	adama1@mail.amc.edu; vincenp@mail.amc.edu	Adam, Alejandro/M-6541-2013	Adam, Alejandro/0000-0001-6285-7235	American Heart Association [13SDG17100110]; NIH [R01 HL77870]	American Heart Association(American Heart Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by a American Heart Association grant 13SDG17100110 to APA and NIH R01 HL77870 to PAV. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; Adam AP, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/272858; Aird WC, 2003, BLOOD, V101, P3765, DOI 10.1182/blood-2002-06-1887; Andriopoulou P, 1999, ARTERIOSCL THROM VAS, V19, P2286, DOI 10.1161/01.ATV.19.10.2286; Angelini DJ, 2006, AM J PHYSIOL-LUNG C, V291, pL1232, DOI 10.1152/ajplung.00109.2006; Arican O, 2005, MEDIAT INFLAMM, P273, DOI 10.1155/MI.2005.273; Aveleira CA, 2010, DIABETES, V59, P2872, DOI 10.2337/db09-1606; Birukova AA, 2005, AM J PHYSIOL-LUNG C, V289, pL75, DOI 10.1152/ajplung.00447.2004; BRAVERMAN IM, 1986, J INVEST DERMATOL, V86, P577, DOI 10.1111/1523-1747.ep12355222; BULL RH, 1992, BRIT J DERMATOL, V126, P436, DOI 10.1111/j.1365-2133.1992.tb11815.x; Clark PR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120075; Clauss M, 2001, BLOOD, V97, P1321, DOI 10.1182/blood.V97.5.1321; DAMAS P, 1992, ANN SURG, V215, P356, DOI 10.1097/00000658-199204000-00009; Eliceiri BP, 1999, MOL CELL, V4, P915, DOI 10.1016/S1097-2765(00)80221-X; Esser S, 1998, J CELL SCI, V111, P1853; Garcia-Ponce A, 2015, THROMB HAEMOSTASIS, V113, P20, DOI 10.1160/TH14-04-0298; Gavard J, 2006, NAT CELL BIOL, V8, P1223, DOI 10.1038/ncb1486; Goldberg PL, 2002, AM J PHYSIOL-LUNG C, V282, pL146, DOI 10.1152/ajplung.2002.282.1.L146; Gong P, 2008, J BIOL CHEM, V283, P13437, DOI 10.1074/jbc.M707986200; Han JY, 2013, BLOOD, V122, P4140, DOI 10.1182/blood-2013-03-491423; HOBER D, 1993, AM J TROP MED HYG, V48, P324, DOI 10.4269/ajtmh.1993.48.324; Honda K, 2007, CARCINOGENESIS, V28, P2074, DOI 10.1093/carcin/bgm112; Huot J, 1997, CIRC RES, V80, P383, DOI 10.1161/01.RES.80.3.383; IMAMOTO A, 1993, CELL, V73, P1117, DOI 10.1016/0092-8674(93)90641-3; Klinghoffer RA, 1999, EMBO J, V18, P2459, DOI 10.1093/emboj/18.9.2459; Knezevic N, 2009, J EXP MED, V206, P2761, DOI 10.1084/jem.20090652; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Kuppers V, 2014, CELL TISSUE RES, V355, P577, DOI 10.1007/s00441-014-1812-1; Lamalice L, 2006, J BIOL CHEM, V281, P34009, DOI 10.1074/jbc.M603928200; Lampugnani MG, 1997, J CELL SCI, V110, P2065; Young HL, 2007, AM J RESP CELL MOL, V37, P485, DOI 10.1165/rcmb.2006-0439OC; Lowell CA, 1996, J CELL BIOL, V133, P895, DOI 10.1083/jcb.133.4.895; Lowell CA, 1996, BLOOD, V87, P1780; Lula JF, 2009, EUR J HEART FAIL, V11, P825, DOI 10.1093/eurjhf/hfp105; Marcos-Ramiro B, 2014, THROMB HAEMOSTASIS, V112, P1088, DOI 10.1160/TH14-04-0299; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Meerbrey KL, 2011, P NATL ACAD SCI USA, V108, P3665, DOI 10.1073/pnas.1019736108; Millan J, 2010, BMC BIOL, V8, DOI 10.1186/1741-7007-8-11; MILLAR AB, 1989, LANCET, V2, P712, DOI 10.1016/S0140-6736(89)90772-1; NADA S, 1993, CELL, V73, P1125, DOI 10.1016/0092-8674(93)90642-4; Okada M, 2012, INT J BIOL SCI, V8, P1385, DOI 10.7150/ijbs.5141; Oldenburg J, 2014, CELL TISSUE RES, V355, P545, DOI 10.1007/s00441-013-1792-6; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Paul R, 2001, NAT MED, V7, P222, DOI 10.1038/84675; Piegeler T, 2014, BMC ANESTHESIOL, V14, DOI 10.1186/1471-2253-14-57; Piegeler T, 2014, ANESTHESIOLOGY, V120, P1414, DOI 10.1097/ALN.0000000000000174; Raingeaud J, 1996, MOL CELL BIOL, V16, P1247; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V331, P1, DOI 10.1016/j.bbrc.2005.03.012; ROTEN R, 1991, AM REV RESPIR DIS, V143, P590, DOI 10.1164/ajrccm/143.3.590; Schmedt C, 1998, NATURE, V394, P901, DOI 10.1038/29802; Schmedt C, 2001, J EXP MED, V193, P815, DOI 10.1084/jem.193.7.815; Shasby DM, 2002, AM J PHYSIOL-LUNG C, V282, pL1330, DOI 10.1152/ajplung.00329.2001; Shivanna M, 2010, INVEST OPHTH VIS SCI, V51, P1575, DOI 10.1167/iovs.09-4343; Sidibe A, 2014, AM J PHYSIOL-HEART C, V307, pH448, DOI 10.1152/ajpheart.00773.2013; Sidibe A, 2014, AM J PHYSIOL-HEART C, V307, pH455, DOI 10.1152/ajpheart.00774.2013; SORIANO P, 1991, CELL, V64, P693, DOI 10.1016/0092-8674(91)90499-O; Spindler V, 2010, CARDIOVASC RES, V87, P243, DOI 10.1093/cvr/cvq086; STEIN PL, 1994, GENE DEV, V8, P1999, DOI 10.1101/gad.8.17.1999; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Sun CX, 2012, ARTERIOSCL THROM VAS, V32, P2444, DOI 10.1161/ATVBAHA.112.252205; Takatsuka A, 2008, DEV BIOL, V315, P474, DOI 10.1016/j.ydbio.2008.01.004; Takayama Y, 1999, J BIOL CHEM, V274, P2291, DOI 10.1074/jbc.274.4.2291; Thomas SM, 1997, ANNU REV CELL DEV BI, V13, P513, DOI 10.1146/annurev.cellbio.13.1.513; Trani M, 2015, CURR OPIN HEMATOL, V22, P267, DOI 10.1097/MOH.0000000000000137; vanOers NSC, 1996, IMMUNITY, V5, P429, DOI 10.1016/S1074-7613(00)80499-9; Weis S, 2004, J CLIN INVEST, V113, P885, DOI 10.1172/JCI200420702; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; Yagi R, 2007, EMBO J, V26, P1234, DOI 10.1038/sj.emboj.7601595; Yang Guang, 2010, J Cardiovasc Dis Res, V1, P29, DOI 10.4103/0975-3583.59983; Ye XB, 2008, J EXP MED, V205, P1303, DOI 10.1084/jem.20071393	70	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161975	10.1371/journal.pone.0161975	http://dx.doi.org/10.1371/journal.pone.0161975			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603666	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200034
J	Chiu, HC; Huang, WR; Liao, TL; Wu, HY; Munir, M; Shih, WL; Liu, HJ				Chiu, Hung-Chuan; Huang, Wei-Ru; Liao, Tsai-Ling; Wu, Hung-Yi; Munir, Muhammad; Shih, Wing-Ling; Liu, Hung-Jen			Suppression of Vimentin Phosphorylation by the Avian Reovirus p17 through Inhibition of CDK1 and Plk1 Impacting the G2/M Phase of the Cell Cycle	PLOS ONE			English	Article							AUTOGRAPHA-CALIFORNICA NUCLEOPOLYHEDROVIRUS; MOUTH-DISEASE VIRUS; POLO-LIKE KINASE-1; DNA-DAMAGE; NONSTRUCTURAL PROTEIN; INTERPHASE REQUIRES; CHECKPOINT PATHWAY; ACTIVATION; EXPRESSION; ARREST	The p17 protein of avian reovirus (ARV) causes cell cycle retardation in a variety of cell lines; however, the underlying mechanism(s) by which p17 regulates the cell cycle remains largely unknown. We demonstrate for the first time that p17 interacts with CDK1 and vimentin as revealed by reciprocal co-immunoprecipitation and GST pull-down assays. Both in vitro and in vivo studies indicated that direct interaction of p17 and CDK1/vimentin was mapped within the amino terminus (aa 1-60) of p17 and central region (aa 27-118) of CDK1/vimentin. Furthermore, p17 was found to occupy the Plk1-binding site within the vimentin, thereby blocking Plk1 recruitment to CDK1-induced vimentin phosphorylation at Ser 56. Interaction of p17 to CDK1 or vimentin interferes with CDK1-catalyzed phosphorylation of vimentin at Ser 56 and subsequently vimentin phosphorylation at Ser 82 by Plk1. Furthermore, we have identified upstream signaling pathways and cellular factor(s) targeted by p17 and found that p17 regulates inhibitory phosphorylation of CDK1 and blocks vimentin phosphorylation at Ser 56 and Ser 82. The p17-mediated inactivation of CDK1 is dependent on several mechanisms, which include direct interaction with CDK1, p17-mediated suppression of Plk1 by activating the Tpr/p53 and ATM/Chk1/PP2A pathways, and p17-mediated cdc25C degradation via an ubiquitin-proteasome pathway. Additionally, depletion of p53 with a shRNA as well as inhibition of ATM and vimentin by inhibitors diminished virus yield while Tpr and CDK1 knockdown increased virus yield. Taken together, results demonstrate that p17 suppresses both CDK1 and Plk1functions, disrupts vimentin phosphorylation, causes G2/M cell cycle arrest and thus benefits virus replication.	[Chiu, Hung-Chuan; Huang, Wei-Ru; Liu, Hung-Jen] Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan; [Liu, Hung-Jen] Natl Chung Hsing Univ, Agr Biotechnol Ctr, Taichung 402, Taiwan; [Liu, Hung-Jen] Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan; [Liao, Tsai-Ling] Taichung Vet Gen Hosp, Dept Med Res, Taichung 402, Taiwan; [Wu, Hung-Yi] Natl Pingtung Univ Sci & Technol, Dept Vet Med, Pingtung 912, Taiwan; [Munir, Muhammad] Pirbright Inst, Pirbright, England; [Shih, Wing-Ling] Natl Pingtung Univ Sci & Technol, Dept Biol Sci & Technol, Pingtung 912, Taiwan	National Chung Hsing University; National Chung Hsing University; National Chung Hsing University; Taichung Veterans General Hospital; National Pingtung University Science & Technology; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Pirbright Institute; National Pingtung University Science & Technology	Liu, HJ (corresponding author), Natl Chung Hsing Univ, Inst Mol Biol, Taichung 402, Taiwan.; Liu, HJ (corresponding author), Natl Chung Hsing Univ, Rong Hsing Res Ctr Translat Med, Taichung 402, Taiwan.	hjliu5257@nchu.edu.tw	Munir, Muhammad/T-4965-2019	Munir, Muhammad/0000-0002-7889-1398; Munir, Muhammad/0000-0003-4038-0370; Huang, Wei-Ru/0000-0002-2508-8374; chiu, hung-chuan/0000-0001-6219-4937; Liu, Hung-Jen/0000-0002-1460-1494	Taichung Veterans General Hospital [TCVGHNCHU1047602, TCVGH-NCHU1057603]; National Chung Hsing University [TCVGHNCHU1047602, TCVGH-NCHU1057603]; Ministry of Science and Technology of Taiwan [MOST 102-2321-B-005-012]; Ministry of Education of Taiwan under the Aiming for Top University (ATU) plan; Biotechnology and Biological Sciences Research Council [BBS/E/I/00001852] Funding Source: researchfish; BBSRC [BBS/E/I/00001852] Funding Source: UKRI	Taichung Veterans General Hospital; National Chung Hsing University; Ministry of Science and Technology of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Education of Taiwan under the Aiming for Top University (ATU) plan; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by grants from Taichung Veterans General Hospital (TCVGHNCHU1047602 & TCVGH-NCHU1057603), National Chung Hsing University (TCVGHNCHU1047602 & TCVGH-NCHU1057603), the Ministry of Science and Technology of Taiwan (MOST 102-2321-B-005-012), and the Ministry of Education of Taiwan, under the Aiming for Top University (ATU) plan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Advani SJ, 2000, P NATL ACAD SCI USA, V97, P10996, DOI 10.1073/pnas.200375297; Advani SJ, 2000, J VIROL, V74, P8, DOI 10.1128/JVI.74.1.8-15.2000; Armer H, 2008, J VIROL, V82, P10556, DOI 10.1128/JVI.00907-08; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Belyavskyi M, 1998, P NATL ACAD SCI USA, V95, P11205, DOI 10.1073/pnas.95.19.11205; Bhattacharya B, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-7; Braunagel SC, 1998, VIROLOGY, V244, P195, DOI 10.1006/viro.1998.9097; Chen F, 2002, P NATL ACAD SCI USA, V99, P1990, DOI 10.1073/pnas.032428899; Chen YI, 2008, J VIROL METHODS, V151, P95, DOI 10.1016/j.jviromet.2008.03.016; Chi PI, 2013, J BIOL CHEM, V288, P3571, DOI 10.1074/jbc.M112.390245; Costas C, 2005, J VIROL, V79, P2141, DOI 10.1128/JVI.79.4.2141-2150.2005; Dalal SN, 1999, MOL CELL BIOL, V19, P4465; Davy CE, 2005, J VIROL, V79, P3998, DOI 10.1128/JVI.79.7.3998-4011.2005; Du N, 2014, J VIROL, V88, P5816, DOI 10.1128/JVI.03826-13; Falck J, 2001, NATURE, V410, P842, DOI 10.1038/35071124; Fattaey A, 1997, Prog Cell Cycle Res, V3, P233; Fournier N, 1999, ONCOGENE, V18, P4015, DOI 10.1038/sj.onc.1202775; Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046; FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.biochem.63.1.345; Funasaka T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00878; Furnari B, 1997, SCIENCE, V277, P1495, DOI 10.1126/science.277.5331.1495; Ghosh S, 2011, J VIRAL HEPATITIS, V18, pE568, DOI 10.1111/j.1365-2893.2011.01487.x; Gladue DP, 2013, J VIROL, V87, P6794, DOI 10.1128/JVI.00448-13; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; HAMANAKA R, 1995, J BIOL CHEM, V270, P21086, DOI 10.1074/jbc.270.36.21086; HE JL, 1995, J VIROL, V69, P6705, DOI 10.1128/JVI.69.11.6705-6711.1995; Hrimech M, 2000, EMBO J, V19, P3956, DOI 10.1093/emboj/19.15.3956; Huang WR, 2011, J BIOL CHEM, V286, P30780, DOI 10.1074/jbc.M111.257154; Huang WR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133699; Jackman MR, 1997, CANCER SURV, V29, P47; Jang YJ, 2007, J BIOL CHEM, V282, P2473, DOI 10.1074/jbc.M605480200; Ji WT, 2009, BIOCHEM BIOPH RES CO, V384, P301, DOI 10.1016/j.bbrc.2009.04.116; Jung YS, 2010, CELL SIGNAL, V22, P1003, DOI 10.1016/j.cellsig.2010.01.013; Kanlaya R, 2010, MOL BIOSYST, V6, P795, DOI 10.1039/b923864f; Kastan MB, 2000, NAT REV MOL CELL BIO, V1, P179, DOI 10.1038/35043058; Kitagawa M, 1996, EMBO J, V15, P7060, DOI 10.1002/j.1460-2075.1996.tb01097.x; Kitay MK, 1996, J VIROL, V70, P7885, DOI 10.1128/JVI.70.11.7885-7893.1996; Kotani S, 1998, MOL CELL, V1, P371, DOI 10.1016/S1097-2765(00)80037-4; Li SY, 2009, J VIROL, V83, P8340, DOI 10.1128/JVI.00711-09; Lin PY, 2011, ARCH VIROL, V156, P1917, DOI 10.1007/s00705-011-1063-3; Liu HJ, 2005, BIOCHEM BIOPH RES CO, V336, P709, DOI 10.1016/j.bbrc.2005.08.149; Loncarek J, 2010, CURR BIOL, V20, P1277, DOI 10.1016/j.cub.2010.05.050; McKenzie L, 2010, CELL CYCLE, V9, P4200, DOI 10.4161/cc.9.20.13532; Melchionna R, 2000, NAT CELL BIOL, V2, P762, DOI 10.1038/35036406; Palii SS, 2013, CELL CYCLE, V12, P1105, DOI 10.4161/cc.24127; Paull TT, 2000, CURR BIOL, V10, P886, DOI 10.1016/S0960-9822(00)00610-2; Peng CY, 1997, SCIENCE, V277, P1501, DOI 10.1126/science.277.5331.1501; Plummer EM, 2012, NANOMEDICINE-UK, V7, P877, DOI [10.2217/nnm.11.185, 10.2217/NNM.11.185]; Poggioli GJ, 2001, J VIROL, V75, P7429, DOI 10.1128/JVI.75.16.7429-7434.2001; Sanchez Y, 1997, SCIENCE, V277, P1497, DOI 10.1126/science.277.5331.1497; Shmulevitz M, 2002, J VIROL, V76, P609, DOI 10.1128/JVI.76.2.609-618.2002; SPANDIDOS DA, 1976, J VIROL, V19, P968, DOI 10.1128/JVI.19.3.968-976.1976; Stiff T, 2006, EMBO J, V25, P5775, DOI 10.1038/sj.emboj.7601446; van Vugt MATM, 2001, J BIOL CHEM, V276, P41656, DOI 10.1074/jbc.M101831200; Vazquez-Iglesias L, 2009, J VIROL, V83, P10163, DOI 10.1128/JVI.01080-09; Wang XH, 2011, J MICROBIOL BIOTECHN, V21, P366, DOI 10.4014/jmb.1010.10003; Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091; Ye M, 1999, J VIROL, V73, P1320, DOI 10.1128/JVI.73.2.1320-1330.1999; Yu JT, 2004, J CELL BIOL, V164, P487, DOI 10.1083/JCB.200310059; Zafrullah M, 1997, J VIROL, V71, P9045, DOI 10.1128/JVI.71.12.9045-9053.1997; Zhao RY, 2005, CELL RES, V15, P143, DOI 10.1038/sj.cr.7290279	61	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162356	10.1371/journal.pone.0162356	http://dx.doi.org/10.1371/journal.pone.0162356			30	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603133	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200060
J	Daubenspeck, JM; Liu, RH; Dybvig, K				Daubenspeck, James M.; Liu, Runhua; Dybvig, Kevin			Rhamnose Links Moonlighting Proteins to Membrane Phospholipid in Mycoplasmas	PLOS ONE			English	Article							ELONGATION-FACTOR TU; ALPHA-ENOLASE; MASS-SPECTROMETRY; CELL-SURFACE; AUTOANTIBODIES; IDENTIFICATION; PLASMODIUM; PNEUMONIAE; AUTOIMMUNE; ADHERENCE	Many proteins that have a primary function as a cytoplasmic protein are known to have the ability to moonlight on the surface of nearly all organisms. An example is the glycolytic enzyme enolase, which can be found on the surface of many types of cells from bacteria to human. Surface enolase is not enzymatic because it is monomeric and oligomerization is required for glycolytic activity. It can bind various molecules and activate plasminogen. Enolase lacks a signal peptide and the mechanism by which it attaches to the surface is unknown. We found that treatment of whole cells of the murine pathogen Mycoplasma pulmonis with phospholipase D released enolase and other common moonlighting proteins. Glycostaining suggested that the released proteins were glycosylated. Cytoplasmic and membrane-bound enolase was isolated by immunoprecipitation. No post-translational modification was detected on cytoplasmic enolase, but membrane enolase was associated with lipid, phosphate and rhamnose. Treatment with phospholipase released the lipid and phosphate from enolase but not the rhamnose. The site of rhamnosylation was identified as a glutamine residue near the C-terminus of the protein. Rhamnose has been found in all species of mycoplasma examined but its function was previously unknown. Mycoplasmas are small bacteria with have no peptidoglycan, and rhamnose in these organisms is also not associated with polysaccharide. We suggest that rhamnose has a central role in anchoring proteins to the membrane by linkage to phospholipid, which may be a general mechanism for the membrane association of moonlighting proteins in mycoplasmas and perhaps other bacteria.	[Daubenspeck, James M.; Liu, Runhua; Dybvig, Kevin] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham	Dybvig, K (corresponding author), Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA.	dybvig@uab.edu	Liu, Runhua/K-2388-2019	Liu, Runhua/0000-0002-0892-6946	National Institutes of Health [AI63909]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063909] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the National Institutes of Health (AI63909) to KD. The NIH had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antikainen J, 2007, FEMS IMMUNOL MED MIC, V51, P526, DOI 10.1111/j.1574-695X.2007.00330.x; Arfi Y, 2016, P NATL ACAD SCI USA, V113, P5406, DOI 10.1073/pnas.1600546113; Balasubramanian S, 2009, INFECT IMMUN, V77, P3533, DOI 10.1128/IAI.00081-09; Bao SJ, 2014, BMC VET RES, V10, DOI 10.1186/s12917-014-0223-6; Bolland JR, 2012, FEMS MICROBIOL LETT, V331, P25, DOI 10.1111/j.1574-6968.2012.02551.x; Butterfield DA, 2009, J NEUROCHEM, V111, P915, DOI 10.1111/j.1471-4159.2009.06397.x; Capello M, 2011, FEBS J, V278, P1064, DOI 10.1111/j.1742-4658.2011.08025.x; Chen HJ, 2011, MICROB PATHOGENESIS, V51, P285, DOI 10.1016/j.micpath.2011.03.012; Dallo SF, 2002, MOL MICROBIOL, V46, P1041, DOI 10.1046/j.1365-2958.2002.03207.x; Daubenspeck JM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0143362; Daubenspeck JM, 2009, MOL MICROBIOL, V72, P1235, DOI 10.1111/j.1365-2958.2009.06720.x; Decker BL, 2006, J BIOL CHEM, V281, P14523, DOI 10.1074/jbc.M600911200; EDER K, 1992, J CHROMATOGR, V607, P55, DOI 10.1016/0021-9673(92)87054-C; FERRANTE G, 1986, J BIOL CHEM, V261, P7062; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; Ghosh AK, 2011, MEM I OSWALDO CRUZ, V106, P85, DOI 10.1590/S0074-02762011000900011; Godier A, 2013, J THROMB HAEMOST, V11, P26, DOI 10.1111/jth.12064; Grover RK, 2014, SCIENCE, V343, P656, DOI 10.1126/science.1246135; Henderson B, 2011, INFECT IMMUN, V79, P3476, DOI 10.1128/IAI.00179-11; Hoelzle LE, 2007, FEMS IMMUNOL MED MIC, V49, P215, DOI 10.1111/j.1574-695X.2006.00184.x; Jordan DS, 2013, MOL MICROBIOL, V90, P1046, DOI 10.1111/mmi.12415; Jordan DS, 2013, MOL MICROBIOL, V89, P918, DOI 10.1111/mmi.12320; KOCHETKO.NK, 1965, TETRAHEDRON, V21, P2029, DOI 10.1016/S0040-4020(01)98342-5; Kornspan JD, 2012, J LIPIDS, V2012, DOI 10.1155/2012/640762; LAWSON AM, 1971, J AM CHEM SOC, V93, P1014; Layh-Schmitt G, 2000, MICROBIOL-UK, V146, P741, DOI 10.1099/00221287-146-3-741; Lopez-Alemany R, 2003, THROMB HAEMOSTASIS, V90, P724, DOI 10.1160/TH03-04-0291; Mani M, 2015, NUCLEIC ACIDS RES, V43, pD277, DOI 10.1093/nar/gku954; Peng B, 2013, J PROTEOME RES, V12, P1789, DOI 10.1021/pr3011342; RAZIN S, 1963, J GEN MICROBIOL, V33, P471, DOI 10.1099/00221287-33-3-471; Ren GY, 2004, J AUTOIMMUN, V23, P161, DOI 10.1016/j.jaut.2004.06.003; Robinson MW, 2013, OPEN BIOL, V3, DOI 10.1098/rsob.130017; Saulot V, 2002, ARTHRITIS RHEUM, V46, P1196, DOI 10.1002/art.10252; Schmidl SR, 2010, MOL CELL PROTEOMICS, V9, P1228, DOI 10.1074/mcp.M900267-MCP200; Schreiner SA, 2012, VET MICROBIOL, V156, P88, DOI 10.1016/j.vetmic.2011.10.010; Shaw BM, 2012, INFECT IMMUN, V80, P704, DOI 10.1128/IAI.06009-11; Simmons WL, 2007, J BACTERIOL, V189, P1905, DOI 10.1128/JB.01512-06; Song Z, 2012, PLOS ONE, V7; Vega-Rodriguez J, 2014, P NATL ACAD SCI USA, V111, pE492, DOI 10.1073/pnas.1315517111; Wang WF, 2016, MOL BIOSYST, V12, P1420, DOI 10.1039/c5mb00550g; WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6; Yavlovich A, 2007, INFECT IMMUN, V75, P5716, DOI 10.1128/IAI.01049-07; ZINBO M, 1970, J AM CHEM SOC, V92, P2105, DOI 10.1021/ja00710a052	43	13	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162505	10.1371/journal.pone.0162505	http://dx.doi.org/10.1371/journal.pone.0162505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603308	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255200072
J	Gonzalez, C; Esteban, R; Canals, C; Muniz-Diaz, E; Nogues, N				Gonzalez, Cecilia; Esteban, Rosa; Canals, Carme; Muniz-Diaz, Eduardo; Nogues, Nuria			Stabilization of Transfected Cells Expressing Low-Incidence Blood Group Antigens: Novel Methods Facilitating Their Use as Reagent-Cells	PLOS ONE			English	Article							HUMAN PLATELET ANTIBODIES; INTRACELLULAR TREHALOSE; MEMBRANE STABILITY; MAMMALIAN-CELLS; MOLECULAR-BASIS; FLOW-CYTOMETRY; K562 CELLS; PRESERVATION; LINES; TRANSDUCTION	Background The identification of erythrocyte antibodies in the serum of patients rely on panels of human red blood cells (RBCs), which coexpress many antigens and are not easily available for low-incidence blood group phenotypes. These problems have been addressed by generating cell lines expressing unique blood group antigens, which may be used as an alternative to human RBCs. However, the use of cell lines implies several drawbacks, like the requirement of cell culture facilities and the high cost of cryopreservation. The application of cell stabilization methods could facilitate their use as reagent cells in clinical laboratories. Methods We generated stably-transfected cells expressing low-incidence blood group antigens (Di(a) and Lu-a). High-expresser clones were used to assess the effect of TransFix (R) treatment and lyophilization as cell preservation methods. Cells were kept at 4 degrees C and cell morphology, membrane permeability and antigenic properties were evaluated at several time-points after treatment. Results TransFix (R) addition to cell suspensions allows cell stabilization and proper antigen detection for at least 120 days, despite an increase in membrane permeability and a reduction in antigen expression levels. Lyophilized cells showed minor morphological changes and antigen expression levels were rather conserved at days 1, 15 and 120, indicating a high stability of the freeze-dried product. These stabilized cells have been proved to react specifically with human sera containing alloantibodies. Conclusions Both stabilization methods allow long-term preservation of the transfected cells antigenic properties and may facilitate their distribution and use as reagent-cells expressing low-incidence antigens, overcoming the limited availability of such rare RBCs.	[Gonzalez, Cecilia; Esteban, Rosa; Canals, Carme; Muniz-Diaz, Eduardo; Nogues, Nuria] Banc Sang & Teixits, Immunohematol Lab, Barcelona, Spain		Nogues, N (corresponding author), Banc Sang & Teixits, Immunohematol Lab, Barcelona, Spain.	nnogues@bst.cat			Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias, Spain [PI020749]; Diagnostic Grifols; Ministerio de Ciencia e Innovacion (MICINN)-Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, within the TRACE program, Spain [TRA2009_0331]	Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias, Spain(Instituto de Salud Carlos III); Diagnostic Grifols; Ministerio de Ciencia e Innovacion (MICINN)-Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica, within the TRACE program, Spain(Ministry of Science and Innovation, Spain (MICINN))	This project was supported in part by a grant from the Instituto de Salud Carlos III, Fondo de Investigaciones Sanitarias (grant number: PI020749), Spain, URL:(http://www.eng.isciii.es/ISCIII/es/general/index.shtml). Additional funding was provided by Diagnostic Grifols and the Ministerio de Ciencia e Innovacion (MICINN)-Plan Nacional de Investigacion Cientifica, Desarrollo e Innovacion Tecnologica 2008-2011, in a collaborative agreement within the TRACE program (grant number: TRA2009_0331), Spain. The funders had no role in study design, data collection and analysis, or preparation of the manuscript. Diagnostic Grifols agreed with the publication of these data.	Albertorio F, 2007, J AM CHEM SOC, V129, P10567, DOI 10.1021/ja0731266; Barnett D, 1996, CYTOMETRY, V26, P216, DOI 10.1002/(SICI)1097-0320(19960915)26:3<216::AID-CYTO6>3.0.CO;2-C; Barnett D, 2000, BRIT J HAEMATOL, V108, P784, DOI 10.1046/j.1365-2141.2000.01932.x; Barnett D, 1998, BRIT J HAEMATOL, V102, P553; Barnett D, 1999, CYTOMETRY, V38, P88; Beckmann R, 1998, BLOOD, V92, P4428, DOI 10.1182/blood.V92.11.4428.423k15_4428_4438; Bikoue A, 2002, J IMMUNOL METHODS, V266, P19, DOI 10.1016/S0022-1759(02)00094-7; Buchanan SS, 2010, PLOS ONE, V5; CALDWELL CW, 1994, CYTOMETRY, V16, P243, DOI 10.1002/cyto.990160308; Canonico B, 2004, J IMMUNOL METHODS, V295, P67, DOI 10.1016/j.jim.2004.09.013; Canonico B, 2010, CYTOM PART B-CLIN CY, V78B, P267, DOI 10.1002/cyto.b.20510; CHAUDHURI A, 1994, J BIOL CHEM, V269, P7835; Chen T, 2001, CRYOBIOLOGY, V43, P168, DOI 10.1006/cryo.2001.2360; Crowe JH, 1998, ANNU REV PHYSIOL, V60, P73, DOI 10.1146/annurev.physiol.60.1.73; CROWE JH, 1983, ARCH BIOCHEM BIOPHYS, V220, P477, DOI 10.1016/0003-9861(83)90438-1; CROWE LM, 1984, BIOCHIM BIOPHYS ACTA, V769, P141, DOI 10.1016/0005-2736(84)90017-8; CROWE LM, 1988, BIOCHIM BIOPHYS ACTA, V946, P193, DOI 10.1016/0005-2736(88)90392-6; Eroglu A, 2000, NAT BIOTECHNOL, V18, P163, DOI 10.1038/72608; Esteban R, 2004, VOX SANGUINIS S3, V87, P38; Foxcroft Z, 2007, VOX SANG, V93, P300, DOI 10.1111/j.1423-0410.2007.00951.x; FRIEND C, 1971, P NATL ACAD SCI USA, V68, P378; Hayashi T, 2011, TRANSFUSION MED, V21, P199, DOI 10.1111/j.1365-3148.2010.01064.x; Hayashi T, 2014, BLOOD TRANSFUS-ITALY, V12, pS273, DOI 10.2450/2012.0126-12; Hildinger M, 1999, J VIROL, V73, P4083, DOI 10.1128/JVI.73.5.4083-4089.1999; Iwamoto S, 1998, INT J HEMATOL, V68, P257; Jani IV, 2001, J IMMUNOL METHODS, V257, P145; Janossy G, 2006, Patent No. [WO/ 2006/ 090096, 2006090096]; Kanias T, 2006, CELL PRESERV TECHNOL, V4, P253, DOI 10.1089/cpt.2006.9996; Laroche V, 2005, TRANSFUSION, V45, P1909, DOI 10.1111/j.1537-2995.2005.00638.x; Lopez GH, 2012, VOX SANG, V102, P171, DOI 10.1111/j.1423-0410.2011.01532.x; Natan D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005240; Parsons SF, 1997, BLOOD, V89, P4219, DOI 10.1182/blood.V89.11.4219; Puig T, 2002, GENE THER, V9, P1472, DOI 10.1038/sj.gt.3301826; Rigal D., 2005, Vox Sanguinis, V89, P23; Rindler V, 1999, CRYOBIOLOGY, V38, P2, DOI 10.1006/cryo.1998.2143; Rindler V, 1999, CRYOBIOLOGY, V39, P228, DOI 10.1006/cryo.1999.2204; RUSSO DCW, 1994, BLOOD, V84, P3518; Sidoux-Walter F, 2000, BLOOD, V96, P1566, DOI 10.1182/blood.V96.4.1566.h8001566_1566_1573; Smythe JS, 1996, BLOOD, V87, P2968, DOI 10.1182/blood.V87.7.2968.bloodjournal8772968; Stoll C, 2011, TRANSFUS MED HEMOTH, V38, P89, DOI 10.1159/000326900; Wang LL, 2012, CYTOM PART A, V81A, P567, DOI 10.1002/cyto.a.22060; Wozniak MJ, 2012, TRANSFUSION, V52, P1458, DOI 10.1111/j.1537-2995.2011.03490.x; Yazdanbakhsh K, 2000, AM J HEMATOL, V63, P114, DOI 10.1002/(SICI)1096-8652(200003)63:3<114::AID-AJH2>3.0.CO;2-Z; Zhang SZ, 2010, J ZHEJIANG UNIV-SC B, V11, P889, DOI 10.1631/jzus.B1000184; Zhou XL, 2010, CRYOLETTERS, V31, P147	45	3	3	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161968	10.1371/journal.pone.0161968	http://dx.doi.org/10.1371/journal.pone.0161968			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603310	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255200032
J	Saltychev, M; Vastamaki, H; Mattie, R; McCormick, Z; Vastamaki, M; Laimi, K				Saltychev, Mikhail; Vastamaki, Heidi; Mattie, Ryan; McCormick, Zachary; Vastamaki, Martti; Laimi, Katri			Psychometric Properties of the Pain Numeric Rating Scale When Applied to Multiple Body Regions among Professional Musicians	PLOS ONE			English	Article							VISUAL ANALOG SCALE; RELIABILITY; INTENSITY	Background Despite the broad popularity of a numeric rating scale (NRS) its psychometric properties are not well known. The objective was to determine if there is any difference in the discrimination ability of the NRS when used for measuring pain severity separately in different body regions. Methods Cross-sectional survey study of 630 professional musicians. Item Response Theory (IRT) was used to define the psychometric properties of the NRS. Results The discrimination ability of the pain NRS was dependent on the body area to which it was applied. The discrimination was low 0.5 (95% CI 0.4. to 0.7) for the hand region and perfect for the shoulder and upper part of the neck-3.2 (95% CI 1.2 to 5.2) and 10.5 (95% CI 10.0 to 10.9), respectively. Both shoulder and neck NRSs showed a great shift towards higher levels of pain severity meaning that the ability of the NRS to discriminate low levels of pain is poor. NRS scores obtained from all other regions did not demonstrate any discrimination ability. Conclusions The pain NRS might have different psychometric properties depending on the body area to which it is applied. Overall, the modest discrimination ability of the pain NRS implies that it should be used in screening questionnaires with some reservations.	[Saltychev, Mikhail; Laimi, Katri] Turku Univ Hosp, Dept Phys & Rehabil Med, Turku, Finland; [Saltychev, Mikhail; Laimi, Katri] Univ Turku, Turku, Finland; [Vastamaki, Heidi; Vastamaki, Martti] Orton Fdn, Orton Res Inst, Helsinki, Finland; [Mattie, Ryan] Stanford Univ Hosp & Clin, Dept Orthoped Surg Phys Med & Rehabil, Stanford, CA USA; [McCormick, Zachary] Northwestern McGaw Med Ctr, Rehabil Inst Chicago, Dept Phys Med & Rehabil, Chicago, IL USA	University of Turku; University of Turku; Stanford University; Shirley Ryan AbilityLab	Saltychev, M (corresponding author), Turku Univ Hosp, Dept Phys & Rehabil Med, Turku, Finland.	mikhail.saltychev@gmail.com			Finnish Social Insurance Institution [9752]	Finnish Social Insurance Institution	This work was supported by Finnish Social Insurance Institution, grant 9752.	Baker F., 2001, BASICS ITEM RESPONSE; Becker J, 2007, PAIN MED, V8, pS129, DOI 10.1111/j.1526-4637.2007.00377.x; Bijur PE, 2001, ACAD EMERG MED, V8, P1153, DOI 10.1111/j.1553-2712.2001.tb01132.x; Boonstra AM, 2008, INT J REHABIL RES, V31, P165, DOI 10.1097/MRR.0b013e3282fc0f93; Breivik H, 2008, BRIT J ANAESTH, V101, P17, DOI 10.1093/bja/aen103; Edelen MO, 2010, J GERONTOL A-BIOL, V65, P778, DOI 10.1093/gerona/glp215; Hawker GA, 2011, ARTHRIT CARE RES, V63, pS240, DOI 10.1002/acr.20543; JENSEN MP, 1986, PAIN, V27, P117, DOI 10.1016/0304-3959(86)90228-9; Kersten P, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099485; KREMER E, 1981, PAIN, V10, P241, DOI 10.1016/0304-3959(81)90199-8; Milojevic KG, 2004, AM J EMERG MED, V22, P238, DOI 10.1016/j.ajem.2004.02.022; Schroeder J, 2007, J PAIN S, V8, pS66; THOMEE R, 1995, SCAND J REHABIL MED, V27, P145; Yu CH, 2013, SIMPLE GUIDE ITEM RE	14	11	11	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161874	10.1371/journal.pone.0161874	http://dx.doi.org/10.1371/journal.pone.0161874			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603011	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200029
J	Xiao, Y; Liu, JS; Peng, Y; Xiong, X; Huang, L; Yang, HX; Zhang, J; Tao, LJ				Xiao, Yun; Liu, Jishi; Peng, Yu; Xiong, Xuan; Huang, Ling; Yang, Huixiang; Zhang, Jian; Tao, Lijian			GSTA3 Attenuates Renal Interstitial Fibrosis by Inhibiting TGF-Beta-Induced Tubular Epithelial-Mesenchymal Transition and Fibronectin Expression	PLOS ONE			English	Article							TUBULOINTERSTITIAL FIBROSIS; OXIDATIVE STRESS; MYOFIBROBLASTS; TRANSCRIPTION; ACTIVATION; INSIGHTS; KIDNEY	Tubular epithelial-mesenchymal transition (EMT) has been widely accepted as the underlying mechanisms of renal interstitial fibrosis (RIF). The production of reactive oxygen species (ROS) plays a vital role in tubular EMT process. The purpose of this study was to investigate the involved molecular mechanisms in TGF-beta-induced EMT and identify the potential role of glutathione S-transferase alpha 3 (GSTA3) in this process. The iTRAQ screening was performed to identify protein alterations of the rats underwent unilateral-ureteral obstruction (UUO). Protein expression of GSTA3 in patients with obstructive nephropathy and UUO rats was detected by immunohistochemistry. Protein and mRNA expression of GSTA3 in UUO rats and NRK-52E cells were determined by Western blot and RT-PCR. siRNA and overexpression plasmid were transfected specifically to assess the role of GSTA3 in RIF. The generation of ROS was measured by dichlorofluorescein fluorescence analysis. GSTA3 protein and mRNA expression was significantly reduced in UUO rats. Immunohistochemical analysis revealed that GSTA3 expression was reduced in renal cortex in UUO rats and patients with obstructive nephropathy. Treating with TGF-beta 1 down-regulated GSTA3 expression in NRK-52E cells, which have been found to be correlated with the decreased expression in E-cadherin and megalin and increased expression in alpha-smooth muscle actin. Furthermore, knocking down GSTA3 in NRK-52 cells led to increased production of ROS and tubular EMT, whereas overexpressing GSTA3 ameliorated ROS production and prevented the occurrence of tubular EMT. GSTA3 plays a protective role against tubular EMT in renal fibrosis, suggesting GSTA3 is a potential therapeutic target for RIF.	[Xiao, Yun; Liu, Jishi; Peng, Yu; Xiong, Xuan; Huang, Ling; Tao, Lijian] Cent S Univ, Xiangya Hosp, Div Nephrol, Changsha 410078, Peoples R China; [Xiao, Yun] Guangzhou Med Univ, Div Nephrol, Affiliated Hosp 1, Guangzhou 510120, Guangdong, Peoples R China; [Tao, Lijian] Cent S Univ, State Key Lab Med Genet China, Changsha 410078, Hunan, Peoples R China; [Yang, Huixiang] Cent S Univ, Div Digest Med, Xiangya Hosp, Changsha 410078, Hunan, Peoples R China; [Zhang, Jian] Ohio State Univ, Dept Microbial Infect & Immun, Columbus, OH 43210 USA	Central South University; Guangzhou Medical University; Central South University; Central South University; University System of Ohio; Ohio State University	Tao, LJ (corresponding author), Cent S Univ, Xiangya Hosp, Div Nephrol, Changsha 410078, Peoples R China.; Tao, LJ (corresponding author), Cent S Univ, State Key Lab Med Genet China, Changsha 410078, Hunan, Peoples R China.	lijiantt_tao@sina.com	TAO, Li/HIR-4254-2022	Zhang, Jian/0000-0002-9523-5296	National Natural Science Foundation of China [81370547]; CHINA-CANADA Joint Health Research Initiative Foundation [81061120524/H07]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); CHINA-CANADA Joint Health Research Initiative Foundation	This work was supported by the National Natural Science Foundation of China (Grants NO. 81370547), and the CHINA-CANADA Joint Health Research Initiative Foundation (Grants NO. 81061120524/H07).; This work was supported by the National Natural Science Foundation of China (Grants NO. 81370547), and the CHINA-CANADA Joint Health Research Initiative Foundation (Grants NO. 81061120524/H07). We thank Dr. Jian Zhang (The Ohio State University) for his critical reading and editing of our manuscript.	Boor P, 2010, NAT REV NEPHROL, V6, P643, DOI 10.1038/nrneph.2010.120; Bottinger EP, 2002, J AM SOC NEPHROL, V13, P2600, DOI 10.1097/01.ASN.0000033611.79556.AE; Broekema M, 2007, J AM SOC NEPHROL, V18, P165, DOI 10.1681/ASN.2005070730; Djamali A, 2005, AM J TRANSPLANT, V5, P500, DOI 10.1111/j.1600-6143.2004.00713.x; Djamali A, 2007, AM J PHYSIOL-RENAL, V293, pF445, DOI 10.1152/ajprenal.00037.2007; Fotouhi-Ardakani N, 1999, BIOCHEM J, V339, P685, DOI 10.1042/0264-6021:3390685; Gonzalez J, 2013, BIOCHEM BIOPH RES CO, V438, P257, DOI 10.1016/j.bbrc.2013.07.025; Grande MT, 2009, NAT REV NEPHROL, V5, P319, DOI 10.1038/nrneph.2009.74; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Hwang M, 2006, EXP MOL PATHOL, V81, P48, DOI 10.1016/j.yexmp.2005.11.005; Il Gum S, 2007, J ETHNOPHARMACOL, V112, P568, DOI 10.1016/j.jep.2007.05.014; Ilic Z, 2010, TOXICOL APPL PHARM, V242, P241, DOI 10.1016/j.taap.2009.10.008; Kalluri R, 2009, J CLIN INVEST, V119, P1420, DOI 10.1172/JCI39104; Khodo SN, 2012, J AM SOC NEPHROL, V23, P1967, DOI 10.1681/ASN.2012040373; Kim SK, 2003, J PHARMACOL EXP THER, V305, P353, DOI 10.1124/jpet.102.045153; Lan HY, 2003, J AM SOC NEPHROL, V14, P1535, DOI 10.1097/01.ASN.0000067632.04658.B8; Li Q, 2012, J CELL BIOCHEM, V11, P415; Lin SL, 2005, J AM SOC NEPHROL, V16, P2702, DOI 10.1681/ASN.2005040435; Liu QJ, 2011, AM J NEPHROL, V34, P142, DOI 10.1159/000329325; Liu YH, 2006, KIDNEY INT, V69, P213, DOI 10.1038/sj.ki.5000054; McWalter GK, 2004, J NUTR, V134, p3499S, DOI 10.1093/jn/134.12.3499S; Radford MG, 1997, J AM SOC NEPHROL, V8, P199; Radisky DC, 2007, J CELL BIOCHEM, V101, P830, DOI 10.1002/jcb.21186; Rhyu DY, 2005, J AM SOC NEPHROL, V16, P667, DOI 10.1681/ASN.2004050425; Unwin RD, 2010, NAT PROTOC, V5, P1574, DOI 10.1038/nprot.2010.123; Vaziri ND, 2003, KIDNEY INT, V63, P186, DOI 10.1046/j.1523-1755.2003.00711.x; YAMADA T, 1992, CYTOGENET CELL GENET, V61, P125, DOI 10.1159/000133388; Zeisberg M, 2009, J CLIN INVEST, V119, P1429, DOI 10.1172/JCI36183; Zhang XH, 2003, AM J PHYSIOL-RENAL, V284, pF82, DOI 10.1152/ajprenal.00200.2002; Zhang XL, 2015, INT J MOL MED, V35, P1747, DOI 10.3892/ijmm.2015.2170	30	15	15	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160855	10.1371/journal.pone.0160855	http://dx.doi.org/10.1371/journal.pone.0160855			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27602565	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255200008
J	Zoicas, I; Reichel, M; Gulbins, E; Kornhuber, J				Zoicas, Iulia; Reichel, Martin; Gulbins, Erich; Kornhuber, Johannes			Role of Acid Sphingomyelinase in the Regulation of Social Behavior and Memory	PLOS ONE			English	Article							INDUCED AVOIDANCE IMPAIRMENT; MICE; AMITRIPTYLINE; PIRACETAM; DEPRESSION; RATS; INHIBITION; DISEASE; DRUGS	Major depressive disorder is often associated with deficits in social and cognitive functioning. Mice transgenic for acid sphingomyelinase (t-ASM) were previously shown to have a depressive-like phenotype, which could be normalized by antidepressant treatment. Here, we investigated whether t-ASM mice show deficits in social behavior and memory performance, and whether these possible deficits might be normalized by amitriptyline treatment. Our results revealed that ASM overexpression altered the behavior of mice in a sex-dependent manner. As such, t-ASM female, but not male, mice showed an impaired social preference and a depressive-and anxiogenic-like phenotype, which could be normalized by amitriptyline treatment. Both male and female t-ASM mice showed unaltered preference for social novelty, novel object recognition, and social and object discrimination abilities. Amitriptyline treatment impaired novel object recognition and object discrimination abilities in female, but not in male, wild-type mice, while female t-ASM mice showed unaltered novel object recognition and object discrimination abilities. This study suggests that female t-ASM mice represent a model of depression with comorbid anxiety and social deficits, without memory impairments. It further suggests that ASM overexpression has a protective role against the detrimental effects of amitriptyline on female, but not on male, non-social (object) memory.	[Zoicas, Iulia; Reichel, Martin; Kornhuber, Johannes] Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Univ Hosp, Erlangen, Germany; [Gulbins, Erich] Univ Duisburg Essen, Dept Mol Biol, Essen, Germany	University of Erlangen Nuremberg; University of Duisburg Essen	Zoicas, I (corresponding author), Univ Erlangen Nurnberg, Dept Psychiat & Psychotherapy, Univ Hosp, Erlangen, Germany.	iulia.zoicas@uk-erlangen.de	Kornhuber, Johannes/B-9613-2014	Kornhuber, Johannes/0000-0002-8096-3987; Reichel, Martin/0000-0001-7886-2784; Zoicas, Iulia/0000-0001-7187-3181	BMBF [01EE1401G/OptiMD]	BMBF(Federal Ministry of Education & Research (BMBF))	This study was supported by BMBF grant 01EE1401G/OptiMD to JK and EG. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We gratefully thank Juliana Monti for technical assistance. This study was supported by BMBF grant 01EE1401G/OptiMD to JK and EG.	ALBOUZ S, 1981, BIOMED EXPRESS, V35, P218; Avota E, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001290; Belmaker RH, 2008, NEW ENGL J MED, V358, P55, DOI [10.1056/NEJMra073096, 10.1038/nrdp.2016.65]; Carvalho AF, 2014, CNS NEUROL DISORD-DR, V13, P1819; Christoffersen GRJ, 1998, PROG NEURO-PSYCHOPH, V22, P211, DOI 10.1016/S0278-5846(97)00104-8; Damoiseaux VA, 2014, CLIN PHARMACOKINET, V53, P509, DOI 10.1007/s40262-014-0145-2; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Everss E, 2005, BEHAV BRAIN RES, V159, P235, DOI 10.1016/j.bbr.2004.11.004; Gulbins E, 2013, NAT MED, V19, P934, DOI 10.1038/nm.3214; HURWITZ R, 1994, BIOL CHEM H-S, V375, P447, DOI 10.1515/bchm3.1994.375.7.447; Ishikawa M, 2013, BIOL PHARM BULL, V36, P682; Kornhuber J, 2005, J NEURAL TRANSM, V112, P1583, DOI 10.1007/s00702-005-0374-5; Kornhuber J, 2010, CELL PHYSIOL BIOCHEM, V26, P9, DOI 10.1159/000315101; Lukas M, 2013, PSYCHONEUROENDOCRINO, V38, P916, DOI 10.1016/j.psyneuen.2012.09.018; Marisco PC, 2013, NEUROCHEM RES, V38, P1704, DOI 10.1007/s11064-013-1072-6; Nadler JJ, 2004, GENES BRAIN BEHAV, V3, P303, DOI 10.1111/j.1601-183X.2004.00071.x; Orsetti M, 2007, INT J NEUROPSYCHOPH, V10, P345, DOI 10.1017/S1461145706006705; Parra A, 2002, NEUROSCI RES COMMUN, V31, P135, DOI 10.1002/nrc.10046; Pavone F, 1997, BEHAV BRAIN RES, V89, P229, DOI 10.1016/S0166-4328(97)00066-1; Quillin RC, 2015, HEPATOL RES, V45, P305, DOI 10.1111/hepr.12352; Sansone M, 1999, PHARMACOL BIOCHEM BE, V62, P613, DOI 10.1016/S0091-3057(98)00202-0; SCHNEIDER PB, 1967, J LIPID RES, V8, P202; Tabatadze N, 2010, J NEUROSCI RES, V88, P2940, DOI 10.1002/jnr.22438; Tse WS, 2004, J NERV MENT DIS, V192, P260, DOI 10.1097/01.nmd.0000120884.60002.2b; Wang YL, 2016, EUR J PHARMACOL, V779, P59, DOI 10.1016/j.ejphar.2016.03.013; Wegner MS, 2014, BIOCHEM PHARMACOL, V92, P577, DOI 10.1016/j.bcp.2014.10.007; Zoicas I, 2016, BEHAV BRAIN RES, V297, P323, DOI 10.1016/j.bbr.2015.10.034	27	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162498	10.1371/journal.pone.0162498	http://dx.doi.org/10.1371/journal.pone.0162498			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598773	gold, Green Submitted, Green Published			2022-12-26	WOS:000383254800072
J	Iqbal, S; Hoque, MT				Iqbal, Sumaiya; Hoque, Md Tamjidul			Estimation of Position Specific Energy as a Feature of Protein Residues from Sequence Alone for Structural Classification	PLOS ONE			English	Article							BACKBONE TORSION ANGLES; ACCESSIBLE SURFACE-AREA; SECONDARY STRUCTURE; INTRINSIC DISORDER; STRUCTURE PREDICTION; REGIONS; RECOGNITION; ACCURATE; BINDING	A set of features computed from the primary amino acid sequence of proteins, is crucial in the process of inducing a machine learning model that is capable of accurately predicting three-dimensional protein structures. Solutions for existing protein structure prediction problems are in need of features that can capture the complexity of molecular level interactions. With a view to this, we propose a novel approach to estimate position specific estimated energy (PSEE) of a residue using contact energy and predicted relative solvent accessibility (RSA). Furthermore, we demonstrate PSEE can be reasonably estimated based on sequence information alone. PSEE is useful in identifying the structured as well as unstructured or, intrinsically disordered region of a protein by computing favorable and unfavorable energy respectively, characterized by appropriate threshold. The most intriguing finding, verified empirically, is the indication that the PSEE feature can effectively classify disorder versus ordered residues and can segregate different secondary structure type residues by computing the constituent energies. PSEE values for each amino acid strongly correlate with the hydrophobicity value of the corresponding amino acid. Further, PSEE can be used to detect the existence of critical binding regions that essentially undergo disorder-to-order transitions to perform crucial biological functions. Towards an application of disorder prediction using the PSEE feature, we have rigorously tested and found that a support vector machine model informed by a set of features including PSEE consistently outperforms a model with an identical set of features with PSEE removed. In addition, the new disorder predictor, DisPredict2, shows competitive performance in predicting protein disorder when compared with six existing disordered protein predictors.	[Iqbal, Sumaiya; Hoque, Md Tamjidul] Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA	University of Louisiana System; University of New Orleans	Hoque, MT (corresponding author), Univ New Orleans, Dept Comp Sci, New Orleans, LA 70148 USA.	thoque@uno.edu		Iqbal, Sumaiya/0000-0001-7700-4374	Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF [(2013-16)-RD-A-19]	Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF	Both the authors gratefully acknowledge the Louisiana Board of Regents through the Board of Regents Support Fund, LEQSF (2013-16)-RD-A-19.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Berman HM, 1999, NUCLEIC ACIDS RES, V28, P135; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2005, J MOL BIOL, V347, P827, DOI 10.1016/j.jmb.2005.01.071; Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Eickholt J, 2013, BMC BIOINFORMATICS, V14, DOI 10.1186/1471-2105-14-88; Faraggi E, 2012, J COMPUT CHEM, V33, P259, DOI 10.1002/jcc.21968; Faraggi E, 2009, PROTEINS, V74, P847, DOI 10.1002/prot.22193; Fischer E., 1894, BER DTSCH CHEM GES, V27, P2985, DOI DOI 10.1002/CBER.18940270364; Hoque MT, 2016, J COMPUT CHEM, V37, P1119, DOI 10.1002/jcc.24298; Iqbal S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141551; Iqbal S, 2015, J THEOR BIOL, V380, P380, DOI 10.1016/j.jtbi.2015.06.012; Iqbal S, 2014, 2014 17TH INTERNATIONAL CONFERENCE ON COMPUTER AND INFORMATION TECHNOLOGY (ICCIT), P110, DOI 10.1109/ICCITechn.2014.7073113; Ishida T, 2008, BIOINFORMATICS, V24, P1344, DOI 10.1093/bioinformatics/btn195; Ishida T, 2007, NUCLEIC ACIDS RES, V35, pW460, DOI 10.1093/nar/gkm363; Islam MN, 2016, J THEOR BIOL, V389, P60, DOI 10.1016/j.jtbi.2015.10.015; Jones DT, 2015, BIOINFORMATICS, V31, P857, DOI 10.1093/bioinformatics/btu744; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Kozlowski LP, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-111; McGuffin LJ, 2008, BIOINFORMATICS, V24, P1798, DOI 10.1093/bioinformatics/btn326; Meiler J, 2001, J MOL MODEL, V7, P360, DOI 10.1007/s008940100038; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; MIYAZAWA S, 1985, MACROMOLECULES, V18, P534, DOI 10.1021/ma00145a039; Mizianty Marcin J, 2013, Intrinsically Disord Proteins, V1, pe24428, DOI 10.4161/idp.24428; Mizianty MJ, 2010, BIOINFORMATICS, V26, pi489, DOI 10.1093/bioinformatics/btq373; Monastyrskyy B, 2014, PROTEINS, V82, P127, DOI 10.1002/prot.24391; Monastyrskyy B, 2011, PROTEINS, V79, P107, DOI 10.1002/prot.23161; Noivirt-Brik O, 2009, PROTEINS, V77, P210, DOI 10.1002/prot.22586; Pawlicki S, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-273; Petsko G., 2004, PROTEIN STRUCTURE FU; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Sharma A, 2013, J THEOR BIOL, V320, P41, DOI 10.1016/j.jtbi.2012.12.008; Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893; Sing T., 2009, VISUALIZING PERFORMA; Sirota FL, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S1-S15; Thomas PD, 1996, P NATL ACAD SCI USA, V93, P11628, DOI 10.1073/pnas.93.21.11628; Tien MZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080635; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Walsh I, 2012, BIOINFORMATICS, V28, P503, DOI 10.1093/bioinformatics/btr682; Ward JJ, 2004, J MOL BIOL, V337, P635, DOI 10.1016/j.jmb.2004.02.002; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; YOUDEN WJ, 1950, BIOMETRICS, V6, P172, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zhang T, 2012, J BIOMOL STRUCT DYN, V29, P799, DOI 10.1080/073911012010525022; Zhang T, 2010, PROTEINS, V78, P3353, DOI 10.1002/prot.22842	52	7	7	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161452	10.1371/journal.pone.0161452	http://dx.doi.org/10.1371/journal.pone.0161452			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588752	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800009
J	Stacey, W; Bhave, S; Uht, RM				Stacey, Winfred; Bhave, Shreyas; Uht, Rosalie M.			Mechanisms by Which 17 beta-Estradiol (E2) Suppress Neuronal cox-2 Gene Expression	PLOS ONE			English	Article							NF-KAPPA-B; ESTROGEN-RECEPTOR-ALPHA; HISTONE H4 ACETYLATION; TRANSCRIPTIONAL REPRESSION; ALZHEIMERS-DISEASE; BETA; BRAIN; CYCLOOXYGENASE-2; RECRUITMENT; PROMOTER	E2 attenuates inflammatory responses by suppressing expression of pro-inflammatory genes. Given that inflammation is increasingly being associated with neurodegenerative and psychiatric processes, we sought to elucidate mechanisms by which E2 down-regulates a component of an inflammatory response, cyclooxygenase-2 (COX-2) expression. Although inflammatory processes in the brain are usually associated with microglia and astrocytes, we found that the COX-2 gene (cox-2) was expressed in a neuronal context, specifically in an amygdalar cell line (AR-5). Given that COX-2 has been reported to be in neurons in the brain, and that the amygdala is a site involved in neurodegenerative and neuropsychiatric processes, we investigated mechanisms by which E2 could down-regulate cox-2 expression in the AR-5 line. These cells express estrogen receptors alpha (ER alpha) and beta (ER beta), and as shown here cox-2. At the level of RNA, E2 and the ER beta selective ligand diarylpropionitrile (DPN) both attenuated gene expression, whereas the ERa selective ligand propyl pyrazole triol (PPT) had no effect. Neither ligand increased ER beta at the cox-2 promoter. Rather, DPN decreased promoter occupancy of NF-kappa B p65 and histone 4 (H4) acetylation. Treatment with the non-specific HDAC inhibitor Trichostatin A (TSA) counteracted DPN's repressive effects on cox-2 expression. In keeping with the TSA effect, E2 and DPN increased histone deacetylase one (HDAC1) and switch-independent 3A (Sin3A) promoter occupancy. Lastly, even though E2 increased CpG methylation, DPN did not. Taken together, the pharmacological data indicate that ER beta contributes to neuronal cox-2 expression, as measured by RNA levels. Furthermore, ER ligands lead to increased recruitment of HDAC1, Sin3A and a concomitant reduction of p65 occupancy and Ac-H4 levels. None of the events, however, are associated with a significant recruitment of ER beta at the promoter. Thus, ER beta directs recruitment to the cox-2 promoter, but does so in the absence of being recruited itself.	[Stacey, Winfred; Bhave, Shreyas; Uht, Rosalie M.] Univ North Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Ft Worth, TX 76107 USA; [Stacey, Winfred; Bhave, Shreyas; Uht, Rosalie M.] Univ North Texas Hlth Sci Ctr, Inst Hlth Aging, Ctr Alzheimers & Neurodegenerat Dis Res, Ft Worth, TX 76107 USA; [Stacey, Winfred] US Army, Inst Surg Res, 3698 Chambers Pass,BHT 1, Jbsa Ft Sam Houston, TX 78234 USA		Uht, RM (corresponding author), Univ North Texas Hlth Sci Ctr, Grad Sch Biomed Sci, Ft Worth, TX 76107 USA.; Uht, RM (corresponding author), Univ North Texas Hlth Sci Ctr, Inst Hlth Aging, Ctr Alzheimers & Neurodegenerat Dis Res, Ft Worth, TX 76107 USA.	rosalie.uht@unthsc.edu	Bhave, Shreyas/N-1309-2019		National Institutes of Health [R01-MH082900]; RMU University of North Texas Health Science Center; Doctoral Student Bridge Grant; Neurobiology of Aging Predoctoral Training Grant	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); RMU University of North Texas Health Science Center; Doctoral Student Bridge Grant; Neurobiology of Aging Predoctoral Training Grant	This work was supported by National Institutes of Health, R01-MH082900, RMU University of North Texas Health Science Center, Doctoral Student Bridge Grant, WS and Neurobiology of Aging Predoctoral Training Grant - Associate Fellow, WS.	Andreasson KI, 2001, J NEUROSCI, V21, P8198; Ashburner BP, 2001, MOL CELL BIOL, V21, P7065, DOI 10.1128/MCB.21.20.7065-7077.2001; Baker AE, 2004, ENDOCRINOLOGY, V145, P5021, DOI 10.1210/en.2004-0619; Bartels AL, 2010, CURR NEUROPHARMACOL, V8, P62, DOI 10.2174/157015910790909485; Behl C, 2002, NAT REV NEUROSCI, V3, P433, DOI 10.1038/nrn846; Brown CM, 2010, ENDOCRINOLOGY, V151, P4916, DOI 10.1210/en.2010-0371; Bruce-Keller AJ, 2000, ENDOCRINOLOGY, V141, P3646, DOI 10.1210/en.141.10.3646; Clarke DL, 2008, J IMMUNOL, V181, P3503, DOI 10.4049/jimmunol.181.5.3503; Compton DR, 2004, J MED CHEM, V47, P5872, DOI 10.1021/jm049631k; Cui J, 2013, TRENDS MOL MED, V19, P197, DOI 10.1016/j.molmed.2012.12.007; Cvoro A, 2006, MOL CELL, V21, P555, DOI 10.1016/j.molcel.2006.01.014; Gao ZG, 2005, J BIOL CHEM, V280, P21091, DOI 10.1074/jbc.M500754200; Ghizzoni M, 2011, DRUG DISCOV TODAY, V16, P504, DOI 10.1016/j.drudis.2011.03.009; Grzenda A, 2009, BBA-GENE REGUL MECH, V1789, P443, DOI 10.1016/j.bbagrm.2009.05.007; Hassig CA, 1997, CELL, V89, P341, DOI 10.1016/S0092-8674(00)80214-7; Hewett SJ, 2006, PHARMACOL THERAPEUT, V112, P335, DOI 10.1016/j.pharmthera.2005.04.011; Ho L, 2001, ARCH NEUROL-CHICAGO, V58, P487, DOI 10.1001/archneur.58.3.487; Huang YF, 1999, NAT NEUROSCI, V2, P867, DOI 10.1038/13165; Hur K, 2003, BIOCHEM BIOPH RES CO, V310, P844, DOI 10.1016/j.bbrc.2003.09.095; Ito K, 2000, MOL CELL BIOL, V20, P6891, DOI 10.1128/MCB.20.18.6891-6903.2000; Jadhav RR, 2015, CLIN EPIGENETICS, V7, DOI 10.1186/s13148-015-0045-9; Kaufmann WE, 1996, P NATL ACAD SCI USA, V93, P2317, DOI 10.1073/pnas.93.6.2317; Kushner PJ, 2000, J STEROID BIOCHEM, V74, P311, DOI 10.1016/S0960-0760(00)00108-4; Laherty CD, 1997, CELL, V89, P349, DOI 10.1016/S0092-8674(00)80215-9; Lalmansingh AS, 2008, ENDOCRINOLOGY, V149, P346, DOI 10.1210/en.2007-0372; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Li R, 2005, FRONT BIOSCI-LANDMRK, V10, P257, DOI 10.2741/1525; Li R, 2014, MOL CELL ENDOCRINOL; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Marques M, 2013, NUCLEIC ACIDS RES, V41, P8094, DOI 10.1093/nar/gkt595; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Mulchahey JJ, 1999, ENDOCRINOLOGY, V140, P251, DOI 10.1210/en.140.1.251; Nettles KW, 2008, MOL ENDOCRINOL, V22, P263, DOI 10.1210/me.2007-0324; Ospina JA, 2004, AM J PHYSIOL-HEART C, V286, pH2010, DOI 10.1152/ajpheart.00481.2003; Pelzer T, 2001, BIOCHEM BIOPH RES CO, V286, P1153, DOI 10.1006/bbrc.2001.5519; Poulin SP, 2011, PSYCHIAT RES-NEUROIM, V194, P7, DOI 10.1016/j.pscychresns.2011.06.014; Pozzi S, 2006, ANN NY ACAD SCI, V1089, P302, DOI 10.1196/annals.1386.035; Rao JS, 2011, TRANSL PSYCHIAT, V1, DOI 10.1038/tp.2011.27; Rocha S, 2003, MOL CELL, V12, P15, DOI 10.1016/S1097-2765(03)00223-5; Sarvari M, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-82; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; SCOTT SA, 1991, NEUROLOGY, V41, P351, DOI 10.1212/WNL.41.3.351; Sharma D, 2012, ENDOCRINOLOGY, V153, P2353, DOI 10.1210/en.2011-1002; Song SH, 2001, CANCER RES, V61, P4628; Spence RD, 2013, J NEUROSCI, V33, P10924, DOI 10.1523/JNEUROSCI.0886-13.2013; Stossi F, 2006, J BIOL CHEM, V281, P16272, DOI 10.1074/jbc.M513405200; Straub RH, 2007, ENDOCR REV, V28, P521, DOI 10.1210/er.2007-0001; Sunday L, 2006, AM J PHYSIOL-ENDOC M, V291, pE261, DOI 10.1152/ajpendo.00550.2005; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Vegeto E, 2006, ENDOCRINOLOGY, V147, P2263, DOI 10.1210/en.2005-1330; Vegeto E, 2002, MOL PSYCHIATR, V7, P236, DOI 10.1038/sj.mp.4001007; Vrtacnik P, 2014, BIOCHEM MEDICA, V24, P329, DOI 10.11613/BM.2014.035; Wang DB, 2012, EUR J MED RES, V17, DOI 10.1186/2047-783X-17-12; Xing DQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036890; YAMAGATA K, 1993, NEURON, V11, P371, DOI 10.1016/0896-6273(93)90192-T; Zhao YC, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.3010626; Zhong HH, 2002, MOL CELL, V9, P625, DOI 10.1016/S1097-2765(02)00477-X	57	6	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161430	10.1371/journal.pone.0161430	http://dx.doi.org/10.1371/journal.pone.0161430			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588681	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877800008
J	Niemietz, CJ; Sauer, V; Stella, J; Fleischhauer, L; Chandhok, G; Guttmann, S; Avsar, Y; Guo, SL; Ackermann, EJ; Gollob, J; Monia, BP; Zibert, A; Schmidt, HHJ				Niemietz, Christoph J.; Sauer, Vanessa; Stella, Jacqueline; Fleischhauer, Lutz; Chandhok, Gursimran; Guttmann, Sarah; Avsar, Yesim; Guo, Shuling; Ackermann, Elizabeth J.; Gollob, Jared; Monia, Brett P.; Zibert, Andree; Schmidt, Hartmut H. -J.			Evaluation of Therapeutic Oligonucleotides for Familial Amyloid Polyneuropathy in Patient-Derived Hepatocyte-Like Cells	PLOS ONE			English	Article							PLURIPOTENT STEM-CELLS; LIVER-TRANSPLANTATION; RNA INTERFERENCE; TRANSTHYRETIN; GENERATION; ANTISENSE; URINE; TAFAMIDIS; DISEASE; DIFFERENTIATION	Familial amyloid polyneuropathy (FAP) is caused by mutations of the transthyretin (TTR) gene, predominantly expressed in the liver. Two compounds that knockdown TTR, comprising a small interfering RNA (siRNA; ALN-TTR-02) and an antisense oligonucleotide (ASO; IONIS-TTRRx), are currently being evaluated in clinical trials. Since primary hepatocytes from FAP patients are rarely available for molecular analysis and commercial tissue culture cells or animal models lack the patient-specific genetic background, this study uses primary cells derived from urine of FAP patients. Urine-derived cells were reprogrammed to induced pluripotent stem cells (iPSCs) with high efficiency. Hepatocyte-like cells (HLCs) showing typical hepatic marker expression were obtained from iPSCs of the FAP patients. TTR mRNA expression of FAP HLCs almost reached levels measured in human hepatocytes. To assess TTR knockdown, siTTR1 and TTR-ASO were introduced to HLCs. A significant downregulation (>80%) of TTR mRNA was induced in the HLCs by both oligonucleotides. TTR protein present in the cell culture supernatant of HLCs was similarly downregulated. Gene expression of other hepatic markers was not affected by the therapeutic oligonucleotides. Our data indicate that urine cells (UCs) after reprogramming and hepatic differentiation represent excellent primary human target cells to assess the efficacy and specificity of novel compounds.	[Niemietz, Christoph J.; Sauer, Vanessa; Stella, Jacqueline; Fleischhauer, Lutz; Chandhok, Gursimran; Guttmann, Sarah; Avsar, Yesim; Zibert, Andree; Schmidt, Hartmut H. -J.] Univ Klinikum Munster, Klin Transplantat Med, Albert Schweitzer Campus 1,Gebaude A14, D-48149 Munster, Germany; [Guo, Shuling; Ackermann, Elizabeth J.; Monia, Brett P.] Ionis Pharmaceut Inc, 2855 Gazelle Ct, Carlsbad, CA 92010 USA; [Gollob, Jared] Alnylam Pharmaceut Inc, 300 Third St 3, Cambridge, MA 02142 USA	Ionis Pharmaceuticals, Inc.	Schmidt, HHJ (corresponding author), Univ Klinikum Munster, Klin Transplantat Med, Albert Schweitzer Campus 1,Gebaude A14, D-48149 Munster, Germany.	hepar@ukmuenster.de		Zibert, Andree/0000-0002-5188-450X; Niemietz, Christoph/0000-0002-9393-8748; Fleischhauer, Lutz/0000-0002-0234-5446; Schmidt, Hartmut/0000-0002-2402-7764	Forderwettbewerb Translationale Stammzellforschung des Landes NRW [w1403ts011a]; grant of the " Innovative Medizinische Forschung" (IMF); Ionis Pharmaceuticals; Alnylam Pharmaceuticals	Forderwettbewerb Translationale Stammzellforschung des Landes NRW; grant of the " Innovative Medizinische Forschung" (IMF); Ionis Pharmaceuticals; Alnylam Pharmaceuticals	Part of the work was supported by the "Forderwettbewerb Translationale Stammzellforschung des Landes NRW (w1403ts011a)" and a grant of the " Innovative Medizinische Forschung" (IMF) dedicated to Y. Avsar. In addition, Ionis Pharmaceuticals and Alnylam Pharmaceuticals provided support in the form of salaries for authors S. Guo, EA, BM (Ionis Pharmaceuticals, Inc.) and JG (Alnylam Pharmaceuticals, Inc.), but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. Both funders supported research materials. The specific roles of these authors are articulated in the 'author contributions' section.; We are grateful to O. Nadzemova for excellent technical assistance. Part of the work was supported by the "Forderwettbewerb Translationale Stammzellforschung des Landes NRW (w1403ts011a)" and a grant of the " Innovative Medizinische Forschung" (IMF) dedicated to Y. Avsar. All authors reviewed and approved the manuscript.	Aasen T, 2010, NAT PROTOC, V5, P371, DOI 10.1038/nprot.2009.241; Ackermann EJ, 2012, AMYLOID, V19, P43, DOI 10.3109/13506129.2012.673140; Afzal MZ, 2015, JOVE-J VIS EXP, DOI 10.3791/52032; Al-Nbaheen M, 2013, STEM CELL REV REP, V9, P32, DOI 10.1007/s12015-012-9365-8; ANDO Y, 1995, BIOCHEM BIOPH RES CO, V211, P354, DOI 10.1006/bbrc.1995.1820; Basma H, 2009, GASTROENTEROLOGY, V136, P990, DOI 10.1053/j.gastro.2008.10.047; Benson MD, 2006, MUSCLE NERVE, V33, P609, DOI 10.1002/mus.20503; Butler JS, 2016, AMYLOID, V23, P109, DOI 10.3109/13506129.2016.1160882; Chen Y, 2015, STEM CELL REP, V5, P22, DOI 10.1016/j.stemcr.2015.04.017; Coelho T, 2013, J NEUROL, V260, P2802, DOI 10.1007/s00415-013-7051-7; Coelho T, 2013, NEW ENGL J MED, V369, P819, DOI 10.1056/NEJMoa1208760; Coelho T, 2012, NEUROLOGY, V79, P785, DOI 10.1212/WNL.0b013e3182661eb1; COLON W, 1992, BIOCHEMISTRY-US, V31, P8654, DOI 10.1021/bi00151a036; Davidson BL, 2011, NAT REV GENET, V12, P329, DOI 10.1038/nrg2968; Drozd AM, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0112-3; Foss TR, 2005, BIOCHEMISTRY-US, V44, P15525, DOI 10.1021/bi051608t; Guan X, 2014, STEM CELL RES, V12, P467, DOI 10.1016/j.scr.2013.12.004; Isono K, 2014, STEM CELL RES, V12, P574, DOI 10.1016/j.scr.2014.01.004; JACOBSON DR, 1990, AM J HUM GENET, V47, P127; Jia B, 2014, LIFE SCI, V108, P22, DOI 10.1016/j.lfs.2014.05.004; Juliano R, 2008, NUCLEIC ACIDS RES, V36, P4158, DOI 10.1093/nar/gkn342; Kole R, 2012, NAT REV DRUG DISCOV, V11, P125, DOI 10.1038/nrd3625; Kurosawa T, 2005, BIOCHEM BIOPH RES CO, V337, P1012, DOI 10.1016/j.bbrc.2005.09.142; Lai ZH, 1996, BIOCHEMISTRY-US, V35, P6470, DOI 10.1021/bi952501g; Lee SH, 2013, EUR J PHARM BIOPHARM, V85, P5, DOI 10.1016/j.ejpb.2013.03.021; Leung A, 2013, STEM CELL REP, V1, P451, DOI 10.1016/j.stemcr.2013.10.003; Li D, 2016, STEM CELL REP, V6, P717, DOI 10.1016/j.stemcr.2016.04.001; Li RH, 2010, CELL STEM CELL, V7, P51, DOI 10.1016/j.stem.2010.04.014; Lin TX, 2009, NAT METHODS, V6, P805, DOI [10.1038/NMETH.1393, 10.1038/nmeth.1393]; Lorenzer C, 2015, J CONTROL RELEASE, V203, P1, DOI 10.1016/j.jconrel.2015.02.003; Maherali N, 2009, CURR BIOL, V19, P1718, DOI 10.1016/j.cub.2009.08.025; Merlini G, 2003, NEW ENGL J MED, V349, P583, DOI 10.1056/NEJMra023144; Merlini G, 2013, J CARDIOVASC TRANSL, V6, P1011, DOI 10.1007/s12265-013-9512-x; Niemietz C, 2015, MOLECULES, V20, P17944, DOI 10.3390/molecules201017944; Okamoto S, 2009, LIVER TRANSPLANT, V15, P1229, DOI 10.1002/lt.21817; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Olofsson BO, 2002, TRANSPLANTATION, V73, P745, DOI 10.1097/00007890-200203150-00015; Plante-Bordeneuve V, 2013, HAND CLINIC, V115, P643, DOI 10.1016/B978-0-444-52902-2.00038-2; Pomfret EA, 1998, TRANSPLANTATION, V65, P918, DOI 10.1097/00007890-199804150-00010; Propsting MJ, 2000, BIOCHEM BIOPH RES CO, V279, P970, DOI 10.1006/bbrc.2000.4048; Propsting MJ, 1999, BIOCHEM BIOPH RES CO, V260, P313, DOI 10.1006/bbrc.1999.0906; Quarta CC, 2012, JACC-CARDIOVASC IMAG, V5, P755, DOI 10.1016/j.jcmg.2012.02.015; Sauer V, 2016, CELL TRANSP IN PRESS; Schwartz RE, 2014, BIOTECHNOL ADV, V32, P504, DOI 10.1016/j.biotechadv.2014.01.003; Sehgal A, 2013, J HEPATOL, V59, P1354, DOI 10.1016/j.jhep.2013.05.045; Si-Tayeb K, 2016, DIS MODEL MECH, V9, P81, DOI 10.1242/dmm.022277; Sipe JD, 2012, AMYLOID, V19, P167, DOI 10.3109/13506129.2012.734345; Slamecka J, 2016, CELL CYCLE, V15, P234, DOI 10.1080/15384101.2015.1121332; Sterneckert JL, 2014, NAT REV GENET, V15, P625, DOI 10.1038/nrg3764; Suhr OB, 2015, ORPHANET J RARE DIS, V10, DOI 10.1186/s13023-015-0326-6; Tsankov AM, 2015, NAT BIOTECHNOL, V33, P1182, DOI 10.1038/nbt.3387; Wang C.W., 2016, IEEE J SEL AREA COMM, V30, P2016, DOI DOI 10.1089/CELL.2015.0015; Xue YT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070573; Zemany L, 2015, DIABETES, V64, P1603, DOI 10.2337/db14-0970; Zhou T, 2012, NAT PROTOC, V7, P2080, DOI 10.1038/nprot.2012.115; Zhou T, 2011, J AM SOC NEPHROL, V22, P1221, DOI 10.1681/ASN.2011010106	56	17	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161455	10.1371/journal.pone.0161455	http://dx.doi.org/10.1371/journal.pone.0161455			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584576	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600031
J	Qian, YW; Li, C; Jiang, AP; Ge, SF; Gu, P; Fan, XQ; Li, TS; Jin, X; Wang, JH; Wang, ZL				Qian, Yi-Wen; Li, Chuan; Jiang, Ai-Ping; Ge, Shengfang; Gu, Ping; Fan, Xianqun; Li, Tai-Sheng; Jin, Xia; Wang, Jian-Hua; Wang, Zhi-Liang			HIV-1 gp120 Glycoprotein Interacting with Dendritic Cell-specific Intercellular Adhesion Molecule 3-grabbing Non-integrin (DC-SIGN) Down-Regulates Tight Junction Proteins to Disrupt the Blood Retinal Barrier and Increase Its Permeability	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; VIRAL TRANS-INFECTION; MATRIX METALLOPROTEINASES; CEREBROSPINAL-FLUID; CAPTURE HIV-1; EBOLA-VIRUS; INHIBITORS; COMPARTMENTS; ASSOCIATION; ASTROCYTES	Approximately 70% of HIV-1 infected patients acquire ocular opportunistic infections and manifest eye disorders during the course of their illness. The mechanisms by which pathogens invade the ocular site, however, are unclear. Under normal circumstances, vascular endothelium and retinal pigment epithelium(RPE), which possess a well developed tight junction complex, form the blood-retinal barrier (BRB) to prevent pathogen invasion. We hypothesize that disruption of the BRB allows pathogen entry into ocular sites. The hypothesis was tested using in vitro models. We discovered that human RPE cells could bind to either HIV-1 gp120 glycoproteins or HIV-1 viral particles. Furthermore, the binding was mediated by dendritic cell-specific intercellular adhesion molecule 3-grabbing non-integrin (DC-SIGN) expressed on RPE cells. Upon gp120 binding to DC-SIGN, cellular NF-kappa B signaling was triggered, leading to the induction of matrix metalloproteinases, which subsequently degraded tight junction proteins and disrupted the BRB integrity. DC-SIGN knockdown or prior blocking with a specific antibody abolished gp120-induced matrix metalloproteinase expression and reduced the degradation of tight junction proteins. This study elucidates a novel mechanism by which HIV, type 1 invades ocular tissues and provides additional insights into the translocation or invasion process of ocular complication-associated pathogens.	[Qian, Yi-Wen; Li, Chuan; Ge, Shengfang; Gu, Ping; Fan, Xianqun; Wang, Zhi-Liang] Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Ophthalmol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China; [Jiang, Ai-Ping; Jin, Xia; Wang, Jian-Hua] Chinese Acad Sci, Key Lab Mol Virol & Immunol, Shanghai 200031, Peoples R China; [Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Viral Dis & Vaccine Translat Res Unit, Shanghai 200031, Peoples R China; [Jin, Xia] Chinese Acad Sci, Inst Pasteur Shanghai, Vaccine Ctr, Shanghai 200031, Peoples R China; [Li, Tai-Sheng] Chinese Acad Med Sci, Peking Union Med Coll Hosp, Dept Infect Dis, Beijing 100730, Peoples R China	Shanghai Jiao Tong University; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Le Reseau International des Instituts Pasteur (RIIP); Chinese Academy of Medical Sciences - Peking Union Medical College; Peking Union Medical College Hospital	Wang, ZL (corresponding author), Shanghai Jiao Tong Univ, Peoples Hosp 9, Dept Ophthalmol, 639 Zhizaoju Rd, Shanghai 200011, Peoples R China.; Wang, JH (corresponding author), Chinese Acad Sci, Inst Pasteur Shanghai, 320 Yueyang Rd, Shanghai 200031, Peoples R China.	jh_wang@sibs.ac.cn; ophwzl@163.com			National Grant Program on Key Infectious Disease Grant [2014ZX10001003]; Natural Science Foundation of China [81572001]; Natural Science Foundation of China-National Institutes of Health Joint Grant [81561128009]; Science and Technology Commission of Shanghai [15ZR1425400]; National High Technology Research and Development Program (863 Program) [2015AA020311]	National Grant Program on Key Infectious Disease Grant; Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China-National Institutes of Health Joint Grant; Science and Technology Commission of Shanghai(Science & Technology Commission of Shanghai Municipality (STCSM)); National High Technology Research and Development Program (863 Program)(National High Technology Research and Development Program of China)	This work was supported by National Grant Program on Key Infectious Disease Grant 2014ZX10001003, Natural Science Foundation of China Grant 81572001, and the Natural Science Foundation of China-National Institutes of Health Joint Grant 81561128009 (to J. H. W.). This work was also supported by Science and Technology Commission of Shanghai Grant 15ZR1425400 and National High Technology Research and Development Program (863 Program) Grant 2015AA020311 (to Z. L. W.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABLASHI D V, 1987, Journal of Experimental Pathology (New York), V3, P693; Alvarez CP, 2002, J VIROL, V76, P6841, DOI 10.1128/JVI.76.13.6841-6844.2002; Ambiya Vikas, 2012, Med J Armed Forces India, V68, P214, DOI 10.1016/j.mjafi.2012.01.006; Baribaud Frederic, 2002, Expert Opin Ther Targets, V6, P423, DOI 10.1517/14728222.6.4.423; Bwaka MA, 1999, J INFECT DIS, V179, pS1, DOI 10.1086/514308; Chen Y, 2013, EVID-BASED COMPL ALT, V2013, P1, DOI 10.1155/2013/245958; Cioni C, 2002, NEUROSCI LETT, V330, P299, DOI 10.1016/S0304-3940(02)00814-5; Craigo JK, 2006, CURR OPIN HIV AIDS, V1, P97, DOI 10.1097/01.COH.0000200507.27578.26; Cunningham ET, 1998, NEW ENGL J MED, V339, P236, DOI 10.1056/NEJM199807233390406; Erickson Kathryn K., 2007, Angiogenesis, V10, P103, DOI 10.1007/s10456-007-9067-z; Fanning AS, 1998, J BIOL CHEM, V273, P29745, DOI 10.1074/jbc.273.45.29745; Gardner TW, 2002, SURV OPHTHALMOL, V47, pS253, DOI 10.1016/S0039-6257(02)00387-9; Geijtenbeek TBH, 2000, CELL, V100, P587, DOI 10.1016/S0092-8674(00)80694-7; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gringhuis SI, 2010, NAT IMMUNOL, V11, P419, DOI 10.1038/ni.1858; Halary F, 2002, IMMUNITY, V17, P653, DOI 10.1016/S1074-7613(02)00447-8; Han Y, 2011, AIDS, V25, P1925, DOI 10.1097/QAD.0b013e32834b3578; Harrington PR, 2009, AIDS, V23, P907, DOI 10.1097/QAD.0b013e3283299129; Hu N, 2014, BRAIN RES, V1551, P13, DOI 10.1016/j.brainres.2014.01.015; Jang JW, 2014, J NEUROL SCI, V339, P75, DOI 10.1016/j.jns.2014.01.024; Jiang AP, 2016, J VIROL, V90, P2928, DOI 10.1128/JVI.03008-15; Jiang AP, 2015, J VIROL, V89, P8050, DOI 10.1128/JVI.01021-15; Lambert V, 2003, FASEB J, V17, P2290, DOI 10.1096/fj.03-0113fje; Lambert V, 2002, AM J PATHOL, V161, P1247, DOI 10.1016/S0002-9440(10)64401-X; Louboutin JP, 2011, EUR J NEUROSCI, V34, P2015, DOI 10.1111/j.1460-9568.2011.07908.x; Louboutin JP, 2010, J NEUROPATH EXP NEUR, V69, P801, DOI 10.1097/NEN.0b013e3181e8c96f; LOUBOUTIN JP, 2012, SCI WORLD J, V2012, DOI DOI 10.1100/2012/482575; Miyoshi J, 2005, ADV DRUG DELIVER REV, V57, P815, DOI 10.1016/j.addr.2005.01.008; Nakamuta S, 2008, J NEUROVIROL, V14, P186, DOI 10.1080/13550280801993630; Ng WT, 2005, CLIN EXP OPHTHALMOL, V33, P317, DOI 10.1111/j.1442-9071.2005.01001.x; Peng CH, 2005, OPHTHALMOLOGICA, V219, P101, DOI 10.1159/000083269; Rahner C, 2004, J CELL SCI, V117, P3307, DOI 10.1242/jcs.01181; Ricardo-Dukelow M, 2007, J NEUROIMMUNOL, V185, P37, DOI 10.1016/j.jneuroim.2007.01.004; Rizzolo LJ, 2011, PROG RETIN EYE RES, V30, P296, DOI 10.1016/j.preteyeres.2011.06.002; Sarkar R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059073; Schnell G, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000395; SCHRECK R, 1992, J EXP MED, V175, P1181, DOI 10.1084/jem.175.5.1181; Shah A, 2011, BIOCHEM BIOPH RES CO, V414, P112, DOI 10.1016/j.bbrc.2011.09.033; Shah A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021261; Shah A, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-96; Sharew G, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/965627; Silverstein PS, 2012, CURR HIV RES, V10, P369, DOI 10.2174/157016212802138724; Singh D, 2015, FRONT MOL BIOSCI, V2, DOI 10.3389/fmolb.2015.00019; SKOLNIK PR, 1989, AM J OPHTHALMOL, V107, P361, DOI 10.1016/0002-9394(89)90659-4; Steen B, 1998, INVEST OPHTH VIS SCI, V39, P2194; Strain MC, 2005, J VIROL, V79, P1772, DOI 10.1128/JVI.79.3.1772-1788.2005; Svicher V, 2014, CURR HIV-AIDS REP, V11, P186, DOI 10.1007/s11904-014-0207-y; Tan SY, 2014, LAB INVEST, V94, P777, DOI 10.1038/labinvest.2014.72; TERVO T, 1986, LANCET, V1, P379; Thorne JE, 2006, OPHTHALMOLOGY, V113, P1432, DOI 10.1016/j.ophtha.2006.03.021; Tietz S, 2015, J CELL BIOL, V209, P493, DOI 10.1083/jcb.201412147; Varkey JB, 2015, NEW ENGL J MED, V372, P2423, DOI 10.1056/NEJMoa1500306; Wang S, 2015, INVEST OPHTH VIS SCI, V56, P2971, DOI 10.1167/iovs.14-15874; Wang ZL, 2012, AM J OPHTHALMOL, V153, P363, DOI 10.1016/j.ajo.2011.07.018; Yukl SA, 2013, J INFECT DIS, V208, P1212, DOI 10.1093/infdis/jit308	55	3	4	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22977	22987		10.1074/jbc.M116.744615	http://dx.doi.org/10.1074/jbc.M116.744615			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27605665	hybrid, Green Published			2022-12-26	WOS:000387224800011
J	Cox, D; Selig, E; Griffin, MDW; Carver, JA; Ecroyd, H				Cox, Dezerae; Selig, Emily; Griffin, Michael D. W.; Carver, John A.; Ecroyd, Heath			Small Heat-shock Proteins Prevent -Synuclein Aggregation via Transient Interactions and Their Efficacy Is Affected by the Rate of Aggregation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						-synuclein (a-synuclein); amyloid; analytical ultracentrifugation; fibril; molecular chaperone; Parkinson disease; protein aggregation; small heat shock protein (sHsp); synuclein	ALPHA-B-CRYSTALLIN; AMYLOID FIBRIL FORMATION; NATIVELY UNFOLDED PROTEINS; APOLIPOPROTEIN C-II; MOLECULAR CHAPERONE; PARKINSONS-DISEASE; SUBUNIT EXCHANGE; LEWY BODIES; ANALYTICAL ULTRACENTRIFUGATION; POLYGLUTAMINE AGGREGATION	The aggregation of -synuclein (-syn) into amyloid fibrils is associated with neurodegenerative diseases, collectively referred to as the -synucleinopathies. In vivo, molecular chaperones, such as the small heat-shock proteins (sHsps), normally act to prevent protein aggregation; however, it remains to be determined how aggregation-prone -syn evades sHsp chaperone action leading to its disease-associated deposition. This work examines the molecular mechanism by which two canonical sHsps, B-crystallin (B-c) and Hsp27, interact with aggregation-prone -syn to prevent its aggregation in vitro. Both sHsps are very effective inhibitors of -syn aggregation, but no stable complex between the sHsps and -syn was detected, indicating that the sHsps inhibit -syn aggregation via transient interactions. Moreover, the ability of these sHsps to prevent -syn aggregation was dependent on the kinetics of aggregation; the faster the rate of aggregation (shorter the lag phase), the less effective the sHsps were at inhibiting fibril formation of -syn. Thus, these findings indicate that the rate at which -syn aggregates in cells may be a significant factor in how it evades sHsp chaperone action in the -synucleinopathies.	[Cox, Dezerae; Ecroyd, Heath] Univ Wollongong, Illawarra Hlth & Med Res Inst, Wollongong, NSW 2522, Australia; [Cox, Dezerae; Ecroyd, Heath] Univ Wollongong, Sch Biol Sci, Wollongong, NSW 2522, Australia; [Selig, Emily; Griffin, Michael D. W.] Univ Melbourne, Dept Biochem & Mol Biol, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3052, Australia; [Carver, John A.] Australian Natl Univ, Res Sch Chem, Acton, ACT 2601, Australia	University of Wollongong; University of Wollongong; University of Melbourne; Australian National University	Ecroyd, H (corresponding author), Northfields Ave, Wollongong, NSW 2522, Australia.	heathe@uow.edu.au	Cox, Dezerae/I-7265-2019; Carver, John Adrian/J-3825-2014	Cox, Dezerae/0000-0002-5345-8360; Carver, John Adrian/0000-0002-2441-8108; Ecroyd, Heath/0000-0001-7574-0044; Selig, Emily/0000-0002-3012-6814	Australian Department of Health and Aging; University of Wollongong; Australian Postgraduate Award; Australian Research Council [FT110100586, FT140100544]; Australian National Health and Medical Research Council [1068087]	Australian Department of Health and Aging(Australian Government); University of Wollongong; Australian Postgraduate Award(Australian Government); Australian Research Council(Australian Research Council); Australian National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by grants from the Australian Department of Health and Aging and the University of Wollongong. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by an Australian Postgraduate Award.r Supported by Australian Research Council Future Fellowships FT110100586 and FT140100544.r Supported by an Australian National Health and Medical Research Council project Grant 1068087.	Ahmad MF, 2008, J MOL BIOL, V375, P1040, DOI 10.1016/j.jmb.2007.11.019; Aquilina JA, 2013, J BIOL CHEM, V288, P13602, DOI 10.1074/jbc.M112.443812; Aquilina JA, 2004, J BIOL CHEM, V279, P28675, DOI 10.1074/jbc.M403348200; Arrigo AP, 2007, FEBS LETT, V581, P3665, DOI 10.1016/j.febslet.2007.04.033; Baba M, 1998, AM J PATHOL, V152, P879; Bakthisaran R, 2016, BBA-GEN SUBJECTS, V1860, P167, DOI 10.1016/j.bbagen.2015.09.017; Bakthisaran R, 2015, BBA-PROTEINS PROTEOM, V1854, P291, DOI 10.1016/j.bbapap.2014.12.019; Balbo A., 2005, PROTEIN PROTEIN INTE; Bartels T, 2011, NATURE, V477, P107, DOI 10.1038/nature10324; Bartelt-Kirbach B, 2014, CELL STRESS CHAPERON, V19, P145, DOI [10.1007/s12192-013-0452-9, 10.1007/s12192-013-0465-4]; Benesch JLP, 2008, J BIOL CHEM, V283, P28513, DOI 10.1074/jbc.M804729200; Binger KJ, 2013, FASEB J, V27, P1214, DOI 10.1096/fj.12-220657; Bova MP, 2000, J BIOL CHEM, V275, P1035, DOI 10.1074/jbc.275.2.1035; Bruinsma IB, 2011, PROTEINS, V79, P2956, DOI 10.1002/prot.23152; Campbell BCV, 2001, J NEUROCHEM, V76, P87, DOI 10.1046/j.1471-4159.2001.00021.x; Carver JA, 2003, IUBMB LIFE, V55, P661, DOI 10.1080/15216540310001640498; Carver JA, 2002, J MOL BIOL, V318, P815, DOI 10.1016/S0022-2836(02)00144-4; Cohen SIA, 2011, J CHEM PHYS, V135, DOI 10.1063/1.3608916; Cox D, 2014, BBA-MOL BASIS DIS, V1842, P1830, DOI 10.1016/j.bbadis.2014.06.024; Davidson WS, 1998, J BIOL CHEM, V273, P9443, DOI 10.1074/jbc.273.16.9443; Dettmer U, 2013, J BIOL CHEM, V288, P6371, DOI 10.1074/jbc.M112.403311; Devlin GL, 2003, J BIOL CHEM, V278, P48644, DOI 10.1074/jbc.M308376200; Ecroyd H, 2007, BIOCHEM J, V401, P129, DOI 10.1042/BJ20060981; Ehrnsperger M, 1997, EMBO J, V16, P221, DOI 10.1093/emboj/16.2.221; Esposito G, 2013, J BIOL CHEM, V288, P17844, DOI 10.1074/jbc.M112.448639; Feder ME, 1999, ANNU REV PHYSIOL, V61, P243, DOI 10.1146/annurev.physiol.61.1.243; Fu XM, 2004, BIOCHEM BIOPH RES CO, V316, P291, DOI 10.1016/j.bbrc.2004.02.053; GAESTEL M, 1991, J BIOL CHEM, V266, P14721; Ghahghaei A, 2007, BBA-PROTEINS PROTEOM, V1774, P102, DOI 10.1016/j.bbapap.2006.10.002; Haley DA, 1998, J MOL BIOL, V277, P27, DOI 10.1006/jmbi.1997.1611; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Hatters DM, 2001, J BIOL CHEM, V276, P33755, DOI 10.1074/jbc.M105285200; Hayes D, 2009, J BIOL CHEM, V284, P18801, DOI 10.1074/jbc.M109.011353; Healy EF, 2014, CELL BIOCHEM BIOPHYS, V69, P275, DOI 10.1007/s12013-013-9795-1; Hochberg GKA, 2014, P NATL ACAD SCI USA, V111, pE1562, DOI 10.1073/pnas.1322673111; HORWITZ J, 1992, P NATL ACAD SCI USA, V89, P10449, DOI 10.1073/pnas.89.21.10449; Horwitz J, 1998, METHOD ENZYMOL, V290, P365, DOI 10.1016/S0076-6879(98)90032-5; HORWITZ J, 2005, PROTEIN FOLDING HD 2, P858; Howlett GJ, 2006, CURR OPIN CHEM BIOL, V10, P430, DOI 10.1016/j.cbpa.2006.08.017; JAKOB U, 1993, J BIOL CHEM, V268, P1517; Jenco JM, 1998, BIOCHEMISTRY-US, V37, P4901, DOI 10.1021/bi972776r; Jovcevski B, 2015, CHEM BIOL, V22, P186, DOI 10.1016/j.chembiol.2015.01.001; KATO K, 1994, J BIOL CHEM, V269, P11274; Knowles TPJ, 2009, SCIENCE, V326, P1533, DOI 10.1126/science.1178250; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Kulig M, 2012, BIOCHEM J, V448, P343, DOI 10.1042/BJ20121187; Laganowsky A, 2010, PROTEIN SCI, V19, P1031, DOI 10.1002/pro.380; LANDRY J, 1992, J BIOL CHEM, V267, P794; Leak RK, 2014, J CELL COMMUN SIGNAL, V8, P293, DOI 10.1007/s12079-014-0243-9; Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702; Lee GJ, 1997, EMBO J, V16, P659, DOI 10.1093/emboj/16.3.659; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lelj-Garolla B, 2006, J BIOL CHEM, V281, P8169, DOI 10.1074/jbc.M512553200; Lindner RA, 2001, BIOCHEM J, V354, P79, DOI 10.1042/0264-6021:3540079; Mainz A, 2015, NAT STRUCT MOL BIOL, V22, P898, DOI 10.1038/nsmb.3108; MAROTEAUX L, 1988, J NEUROSCI, V8, P2804; Marti MJ, 2003, MOVEMENT DISORD, V18, pS21, DOI 10.1002/mds.10560; McLean PJ, 2002, J NEUROCHEM, V83, P846, DOI 10.1046/j.1471-4159.2002.01190.x; MIESBAUER LR, 1994, J BIOL CHEM, V269, P12494; Munishkina LA, 2004, J MOL RECOGNIT, V17, P456, DOI 10.1002/jmr.699; Narhi L, 1999, J BIOL CHEM, V274, P9843, DOI 10.1074/jbc.274.14.9843; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Outeiro TF, 2006, BIOCHEM BIOPH RES CO, V351, P631, DOI 10.1016/j.bbrc.2006.10.085; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Raman B, 2005, BIOCHEM J, V392, P573, DOI 10.1042/BJ20050339; Rekas A, 2004, J MOL BIOL, V340, P1167, DOI 10.1016/j.jmb.2004.05.054; Rekas A, 2007, FEBS J, V274, P6290, DOI 10.1111/j.1742-4658.2007.06144.x; Robertson AL, 2010, P NATL ACAD SCI USA, V107, P10424, DOI 10.1073/pnas.0914773107; Ruschak AM, 2007, P NATL ACAD SCI USA, V104, P12341, DOI 10.1073/pnas.0703306104; Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0; Shammas SL, 2011, BIOPHYS J, V101, P1681, DOI 10.1016/j.bpj.2011.07.056; Shtilerman MD, 2002, BIOCHEMISTRY-US, V41, P3855, DOI 10.1021/bi0120906; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Sun Y, 2005, CELL MOL LIFE SCI, V62, P2460, DOI 10.1007/s00018-005-5190-4; Treweek TM, 2015, CELL MOL LIFE SCI, V72, P429, DOI 10.1007/s00018-014-1754-5; Uversky VN, 2007, J NEUROCHEM, V103, P17, DOI 10.1111/j.1471-4159.2007.04764.x; Uversky VN, 2002, FEBS LETT, V515, P99, DOI 10.1016/S0014-5793(02)02446-8; Uversky VN, 2002, NEUROTOXICOLOGY, V23, P527, DOI 10.1016/S0161-813X(02)00067-0; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102; Van Montfort R, 2002, ADV PROTEIN CHEM, V59, P105; Vos MJ, 2008, BIOCHEMISTRY-US, V47, P7001, DOI 10.1021/bi800639z; Walker J. M, 2005, PROTEOMICS PROTOCOLS; Walther DM, 2015, CELL, V161, P919, DOI 10.1016/j.cell.2015.03.032; Wang J, 2008, NEUROBIOL AGING, V29, P586, DOI 10.1016/j.neurobiolaging.2006.11.009; Waudby CA, 2010, BIOPHYS J, V98, P843, DOI 10.1016/j.bpj.2009.10.056; Weinreb PH, 1996, BIOCHEMISTRY-US, V35, P13709, DOI 10.1021/bi961799n; Wilhelmus MMM, 2006, BRAIN RES, V1089, P67, DOI 10.1016/j.brainres.2006.03.058; Wood SJ, 1999, J BIOL CHEM, V274, P19509, DOI 10.1074/jbc.274.28.19509; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	92	74	77	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22618	22629		10.1074/jbc.M116.739250	http://dx.doi.org/10.1074/jbc.M116.739250			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587396	Green Published, hybrid, Green Submitted			2022-12-26	WOS:000386760600022
J	Dyachok, J; Earnest, S; Iturraran, EN; Cobb, MH; Ross, EM				Dyachok, Julia; Earnest, Svetlana; Iturraran, Erica N.; Cobb, Melanie H.; Ross, Elliott M.			Amino Acids Regulate mTORC1 by an Obligate Two-step Mechanism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						amino acid; cell signaling; lysosome; mammalian target of rapamycin (mTOR); mTOR complex (mTORC); protein kinase; S6 kinase	P70 S6 KINASE; RAG GTPASES; LEUCINE SENSOR; GAP ACTIVITY; SUFFICIENCY; ACTIVATION; ARGININE; COMPLEX; TARGET; GROWTH	The mechanistic target of rapamycin complex 1 (mTORC1) coordinates cell growth with its nutritional, hormonal, energy, and stress status. Amino acids are critical regulators of mTORC1 that permit other inputs to mTORC1 activity. However, the roles of individual amino acids and their interactions in mTORC1 activation are not well understood. Here we demonstrate that activation of mTORC1 by amino acids includes two discrete and separable steps: priming and activation. Sensitizing mTORC1 activation by priming amino acids is a prerequisite for subsequent stimulation of mTORC1 by activating amino acids. Priming is achieved by a group of amino acids that includes l-asparagine, l-glutamine, l-threonine, l-arginine, l-glycine, l-proline, l-serine, l-alanine, and l-glutamic acid. The group of activating amino acids is dominated by l-leucine but also includes l-methionine, l-isoleucine, and l-valine. l-Cysteine predominantly inhibits priming but not the activating step. Priming and activating steps differ in their requirements for amino acid concentration and duration of treatment. Priming and activating amino acids use mechanisms that are distinct both from each other and from growth factor signaling. Neither step requires intact tuberous sclerosis complex of proteins to activate mTORC1. Concerted action of priming and activating amino acids is required to localize mTORC1 to lysosomes and achieve its activation.	[Dyachok, Julia; Earnest, Svetlana; Iturraran, Erica N.; Cobb, Melanie H.; Ross, Elliott M.] Univ Texas Southwestern Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Dyachok, Julia; Iturraran, Erica N.; Ross, Elliott M.] Univ Texas Southwestern Med Ctr Dallas, Green Ctr Syst Biol, Dallas, TX 75390 USA; [Dyachok, Julia] Univ Texas Southwestern Med Ctr Dallas, McDermott Ctr Growth & Dev, Dallas, TX 75390 USA; [Iturraran, Erica N.] St Georges Univ, Sch Vet Med, True Blue, Grenada	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Ross, EM (corresponding author), UT Southwestern Med Ctr, Dept Pharmacol, 6001 Forest Pk Rd, Dallas, TX 75390 USA.	Elliott.Ross@UTSouthwestern.edu		Ross, Elliott M./0000-0002-0252-8197; Cobb, Melanie/0000-0003-0833-5473	Cancer Prevention and Research Institute of Texas [RP120695]; National Institutes of Health [R01GM30355, R01DK34128]; NATIONAL CANCER INSTITUTE [P30CA142543] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK034128, R37DK034128] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM030355] Funding Source: NIH RePORTER	Cancer Prevention and Research Institute of Texas; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by Cancer Prevention and Research Institute of Texas Grant RP120695 and National Institutes of Health Grants R01GM30355 and R01DK34128. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Al-Awadi F, 2008, ANTICANCER RES, V28, P2541; Ban H, 2004, INT J MOL MED, V13, P537; Bar-Peled L, 2013, SCIENCE, V340, P1100, DOI 10.1126/science.1232044; Brugarolas JB, 2003, CANCER CELL, V4, P147, DOI 10.1016/S1535-6108(03)00187-9; Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078; Carroll B, 2016, ELIFE, V5, DOI 10.7554/eLife.11058; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Dibble CC, 2013, NAT CELL BIOL, V15, P555, DOI 10.1038/ncb2763; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Duran RV, 2012, MOL CELL, V47, P349, DOI 10.1016/j.molcel.2012.05.043; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Han JM, 2012, CELL, V149, P410, DOI 10.1016/j.cell.2012.02.044; Hara K, 1998, J BIOL CHEM, V273, P14484, DOI 10.1074/jbc.273.23.14484; Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003; Inoki K, 2012, CURR OPIN NEPHROL HY, V21, P251, DOI 10.1097/MNH.0b013e3283520f38; ISHII T, 1981, J BIOL CHEM, V256, P2387; Jewell JL, 2015, SCIENCE, V347, P194, DOI 10.1126/science.1259472; Jung J, 2015, MOL CELL BIOL, V35, P2479, DOI 10.1128/MCB.00125-15; Kim JS, 2015, SCI REP-UK, V5, DOI 10.1038/srep09502; Kim J, 2011, NAT CELL BIOL, V13, P132, DOI 10.1038/ncb2152; Korolchuk VI, 2011, NAT CELL BIOL, V13, P453, DOI 10.1038/ncb2204; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lin J, 2010, CANCER RES, V70, P2397, DOI 10.1158/0008-5472.CAN-09-3648; Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053; Manning BD, 2002, MOL CELL, V10, P151, DOI 10.1016/S1097-2765(02)00568-3; Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031; Menon S, 2014, CELL, V156, P771, DOI 10.1016/j.cell.2013.11.049; Milkereit R, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms8250; Murphy G, 2011, GUT, V60, P618, DOI 10.1136/gut.2010.225854; Nicklin P, 2009, CELL, V136, P521, DOI 10.1016/j.cell.2008.11.044; Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319; Pearce LR, 2010, NAT REV MOL CELL BIO, V11, P9, DOI 10.1038/nrm2822; Peng M, 2014, CELL, V159, P122, DOI 10.1016/j.cell.2014.08.038; Perl A, 2015, ANN NY ACAD SCI, V1346, P33, DOI 10.1111/nyas.12756; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Rebsamen M, 2015, NATURE, V519, P477, DOI 10.1038/nature14107; Roux PP, 2007, J BIOL CHEM, V282, P14056, DOI 10.1074/jbc.M700906200; Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535; Sancak Y, 2010, CELL, V141, P290, DOI 10.1016/j.cell.2010.02.024; Thomas JD, 2014, CANCER CELL, V26, P754, DOI 10.1016/j.ccell.2014.09.008; Wang SY, 2015, SCIENCE, V347, P188, DOI 10.1126/science.1257132; Wauson EM, 2012, MOL CELL, V47, P851, DOI 10.1016/j.molcel.2012.08.001; Wolfson RL, 2016, SCIENCE, V351, P43, DOI 10.1126/science.aab2674; Yao K, 2008, J NUTR, V138, P867, DOI 10.1093/jn/138.5.867; Ye JB, 2012, P NATL ACAD SCI USA, V109, P6904, DOI 10.1073/pnas.1204176109; Yoon MS, 2015, MOL CELL, V58, P549, DOI 10.1016/j.molcel.2015.03.028; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	49	45	46	0	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22414	22426		10.1074/jbc.M116.732511	http://dx.doi.org/10.1074/jbc.M116.732511			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587390	Green Published, hybrid			2022-12-26	WOS:000386760600006
J	Nakamura, A; Tasaki, T; Ishiwata, D; Yamamoto, M; Okuni, Y; Visootsat, A; Maximilien, M; Noji, H; Uchiyama, T; Samejima, M; Igarashi, K; Iino, R				Nakamura, Akihiko; Tasaki, Tomoyuki; Ishiwata, Daiki; Yamamoto, Mayuko; Okuni, Yasuko; Visootsat, Akasit; Maximilien, Morice; Noji, Hiroyuki; Uchiyama, Taku; Samejima, Masahiro; Igarashi, Kiyohiko; Iino, Ryota			Single-molecule Imaging Analysis of Binding, Processive Movement, and Dissociation of Cellobiohydrolase Trichoderma reesei Cel6A and Its Domains on Crystalline Cellulose	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cellulase; cellulose; enzyme kinetics; enzyme mechanism; microscopic imaging; molecular motor; processivity; protein domain; single-molecule biophysics	BIOMASS RECALCITRANCE; CEL7A; SURFACE; HYDROLYSIS; MICROCRYSTALS; ADSORPTION; ENZYMES; SYSTEM; MODULE; MOTION	Trichoderma reesei Cel6A (TrCel6A) is a cellobiohydrolase that hydrolyzes crystalline cellulose into cellobiose. Here we directly observed the reaction cycle (binding, surface movement, and dissociation) of single-molecule intact TrCel6A, isolated catalytic domain (CD), cellulose-binding module (CBM), and CBM and linker (CBM-linker) on crystalline cellulose I. The CBM-linker showed a binding rate constant almost half that of intact TrCel6A, whereas those of the CD and CBM were only one-tenth of intact TrCel6A. These results indicate that the glycosylated linker region largely contributes to initial binding on crystalline cellulose. After binding, all samples showed slow and fast dissociations, likely caused by the two different bound states due to the heterogeneity of cellulose surface. The CBM showed much higher specificity to the high affinity site than to the low affinity site, whereas the CD did not, suggesting that the CBM leads the CD to the hydrophobic surface of crystalline cellulose. On the cellulose surface, intact molecules showed slow processive movements (8.8 +/- 5.5 nm/s) and fast diffusional movements (30-40 nm/s), whereas the CBM-Linker, CD, and a catalytically inactive full-length mutant showed only fast diffusional movements. These results suggest that both direct binding and surface diffusion contribute to searching of the hydrolysable point of cellulose chains. The duration time constant for the processive movement was 7.7 s, and processivity was estimated as 68 +/- 42. Our results reveal the role of each domain in the elementary steps of the reaction cycle and provide the first direct evidence of the processive movement of TrCel6A on crystalline cellulose.	[Nakamura, Akihiko; Ishiwata, Daiki; Yamamoto, Mayuko; Okuni, Yasuko; Iino, Ryota] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan; [Iino, Ryota] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan; [Nakamura, Akihiko; Iino, Ryota] Grad Univ Adv Studies SOKENDAI, Dept Funct Mol Sci, Sch Phys Sci, Hayama, Kanagawa 2400193, Japan; [Tasaki, Tomoyuki; Noji, Hiroyuki] Univ Tokyo, Grad Sch Engn, Dept Appl Chem, Tokyo 1138656, Japan; [Visootsat, Akasit] Kasetsart Univ, Dept Biochem, Fac Sci, Bangkok 10900, Thailand; [Maximilien, Morice] Natl Chem Engn Inst Paris, F-75005 Paris, France; [Uchiyama, Taku; Samejima, Masahiro; Igarashi, Kiyohiko] Univ Tokyo, Grad Sch Agr & Life Sci, Dept Biomat Sci, Tokyo 1138657, Japan; [Igarashi, Kiyohiko] VTT Tech Res Ctr Finland, FI-02044 Espoo, Vtt, Finland	National Institutes of Natural Sciences (NINS) - Japan; Okazaki Institute for Integrative Bioscience (OIIB); National Institutes of Natural Sciences (NINS) - Japan; Institute for Molecular Science (IMS); Graduate University for Advanced Studies - Japan; University of Tokyo; Kasetsart University; University of Tokyo; VTT Technical Research Center Finland	Iino, R (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan.	iino@ims.ac.jp	Nakamura, Akihiko/U-1988-2019; Igarashi, Kiyohiko/E-6799-2016; Iino, Ryota/B-7746-2011	Nakamura, Akihiko/0000-0003-0409-5759; Igarashi, Kiyohiko/0000-0001-5152-7177; Iino, Ryota/0000-0003-0110-5704; VISOOTSAT, AKASIT/0000-0002-1258-6745	Ministry of Education, Culture, Sports, Science, and Technology [16H00789, 16H00858, 15H04366, 15H06898]; Imaging Science Project of the Center for Novel Science Initiatives, National Institutes of Natural Sciences Grants [IS271006, IS281005]; ORION project of Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences; Grants-in-Aid for Scientific Research [24114008, 16H00789, 26000011, 15K07383] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science, and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Imaging Science Project of the Center for Novel Science Initiatives, National Institutes of Natural Sciences Grants; ORION project of Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work is supported by Grants-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology 16H00789, 16H00858, and 15H04366 (to R. I.) and 15H06898 (to A. N.); Imaging Science Project of the Center for Novel Science Initiatives, National Institutes of Natural Sciences Grants IS271006 and IS281005 (to R. I.), and ORION project of Okazaki Institute for Integrative Bioscience, National Institutes of Natural Sciences (to R. I.). The authors declare that they have no conflicts of interest with the contents of this article.	Beckham GT, 2012, CURR OPIN BIOTECH, V23, P338, DOI 10.1016/j.copbio.2011.11.030; Beckham GT, 2011, J PHYS CHEM B, V115, P4118, DOI 10.1021/jp1106394; Boisset C, 2000, APPL ENVIRON MICROB, V66, P1444, DOI 10.1128/AEM.66.4.1444-1452.2000; Boraston AB, 2004, BIOCHEM J, V382, P769, DOI 10.1042/BJ20040892; Brady SK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10149; Bu LT, 2009, J PHYS CHEM B, V113, P10994, DOI 10.1021/jp904003z; Bustamante C, 2004, ANNU REV BIOCHEM, V73, P705, DOI 10.1146/annurev.biochem.72.121801.161542; Carrard G, 1999, EUR J BIOCHEM, V262, P637, DOI 10.1046/j.1432-1327.1999.00455.x; CHANZY H, 1985, FEBS LETT, V184, P285, DOI 10.1016/0014-5793(85)80623-2; Chundawat SPS, 2011, ANNU REV CHEM BIOMOL, V2, P121, DOI 10.1146/annurev-chembioeng-061010-114205; Creagh AL, 1996, P NATL ACAD SCI USA, V93, P12229, DOI 10.1073/pnas.93.22.12229; DAVIES G, 1995, STRUCTURE, V3, P853, DOI 10.1016/S0969-2126(01)00220-9; Greenleaf WJ, 2007, ANNU REV BIOPH BIOM, V36, P171, DOI 10.1146/annurev.biophys.36.101106.101451; Himmel ME, 2007, SCIENCE, V315, P804, DOI 10.1126/science.1137016; Igarashi K., 2012, Journal of Applied Glycoscience, V59, P105, DOI 10.5458/jag.jag.JAG-2011_029; Igarashi K, 2011, SCIENCE, V333, P1279, DOI 10.1126/science.1208386; Igarashi K, 2009, J BIOL CHEM, V284, P36186, DOI 10.1074/jbc.M109.034611; Imai T, 1998, FEBS LETT, V432, P113, DOI 10.1016/S0014-5793(98)00845-X; Isojima H, 2016, NAT CHEM BIOL, V12, P290, DOI [10.1038/NCHEMBIO.2028, 10.1038/nchembio.2028]; Jeoh T, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-10; Joo C, 2008, ANNU REV BIOCHEM, V77, P51, DOI 10.1146/annurev.biochem.77.070606.101543; Jung J, 2013, J BIOL CHEM, V288, P24164, DOI 10.1074/jbc.M113.455758; Kairdolf BA, 2013, ANNU REV ANAL CHEM, V6, P143, DOI 10.1146/annurev-anchem-060908-155136; Kipper K, 2005, BIOCHEM J, V385, P527, DOI 10.1042/BJ20041144; Koivula A, 2002, J AM CHEM SOC, V124, P10015, DOI 10.1021/ja012659q; Liu YS, 2011, J BIOL CHEM, V286, P11195, DOI 10.1074/jbc.M110.216556; Minagawa Y, 2013, J BIOL CHEM, V288, P32700, DOI 10.1074/jbc.M113.506329; Nakamura A, 2014, J AM CHEM SOC, V136, P4584, DOI 10.1021/ja4119994; Nimlos MR, 2012, J BIOL CHEM, V287, P20603, DOI 10.1074/jbc.M112.358184; Nishiyama Y, 2003, J AM CHEM SOC, V125, P14300, DOI 10.1021/ja037055w; Palonen H, 1999, APPL ENVIRON MICROB, V65, P5229; Payne CM, 2015, CHEM REV, V115, P1308, DOI 10.1021/cr500351c; Payne CM, 2013, P NATL ACAD SCI USA, V110, P14646, DOI 10.1073/pnas.1309106110; REINIKAINEN T, 1995, PROTEINS, V22, P392, DOI 10.1002/prot.340220409; ROUVINEN J, 1990, SCIENCE, V249, P380, DOI 10.1126/science.2377893; Shibafuji Y, 2014, J BIOL CHEM, V289, P14056, DOI 10.1074/jbc.M113.546085; STAHLBERG J, 1991, BIO-TECHNOL, V9, P286, DOI 10.1038/nbt0391-286; Sugimoto N, 2012, LANGMUIR, V28, P14323, DOI 10.1021/la302352k; TOMME P, 1988, EUR J BIOCHEM, V170, P575, DOI 10.1111/j.1432-1033.1988.tb13736.x; Ueno Hiroshi, 2014, J Biol Chem, V289, P31212, DOI 10.1074/jbc.M114.598177; Wilson DB, 2011, CURR OPIN MICROBIOL, V14, P259, DOI 10.1016/j.mib.2011.04.004; Wu M, 2013, J BIOL CHEM, V288, P33107, DOI 10.1074/jbc.M113.502765; Yildiz A, 2003, SCIENCE, V300, P2061, DOI 10.1126/science.1084398	43	32	32	2	35	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22404	22413		10.1074/jbc.M116.752048	http://dx.doi.org/10.1074/jbc.M116.752048			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609516	Green Published, hybrid			2022-12-26	WOS:000386760600005
J	Lee, JY; Qi, Z; Greene, EC				Lee, Ja Yil; Qi, Zhi; Greene, Eric C.			ATP hydrolysis Promotes Duplex DNA Release by the RecA Presynaptic Complex	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATP; DNA recombination; DNA repair; homologous recombination; single-molecule biophysics	SINGLE-STRANDED-DNA; HOMOLOGY SEARCH; SACCHAROMYCES-CEREVISIAE; PROTEIN; RECOMBINATION; EXCHANGE; FILAMENTS; RAD51; MECHANISMS; MOLECULES	Homologous recombination is an important DNA repair pathway that plays key roles in maintaining genome stability. Escherichia coli RecA is an ATP-dependent DNA-binding protein that catalyzes the DNA strand exchange reactions in homologous recombination. RecA assembles into long helical filaments on single-stranded DNA, and these presynaptic complexes are responsible for locating and pairing with a homologous duplex DNA. Recent single molecule studies have provided new insights into RecA behavior, but the potential influence of ATP in the reactions remains poorly understood. Here we examine how ATP influences the ability of the RecA presynaptic complex to interact with homologous dsDNA. We demonstrate that over short time regimes, RecA presynaptic complexes sample heterologous dsDNA similarly in the presence of either ATP or ATPS, suggesting that initial interactions do not depend on ATP hydrolysis. In addition, RecA stabilizes pairing intermediates in three-base steps, and stepping energetics is seemingly unaltered in the presence of ATP. However, the overall dissociation rate of these paired intermediates with ATP is approximate to 4-fold higher than with ATPS. These experiments suggest that ATP plays an unanticipated role in promoting the turnover of captured duplex DNA intermediates as RecA attempts to align homologous sequences during the early stages of recombination.	[Lee, Ja Yil; Greene, Eric C.] Columbia Univ, Dept Biochem & Mol Biophys, Black Bldg Rm 536,650 West 168th St, New York, NY 10032 USA; [Qi, Zhi] Peking Univ, Ctr Quantitat Biol, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China; [Qi, Zhi] Peking Univ, Ctr Life Sci, Acad Adv Interdisciplinary Studies, Beijing 100871, Peoples R China	Columbia University; Peking University; Peking University	Greene, EC (corresponding author), Columbia Univ, Dept Biochem & Mol Biophys, Black Bldg Rm 536,650 West 168th St, New York, NY 10032 USA.	ecg2108@cumc.columbia.edu	LEE, JA YIL/S-2207-2016	LEE, JA YIL/0000-0002-5726-9022	National Institutes of Health [R356M118026]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R35GM118026] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R356M118026 (to E. C. G.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Barzel A, 2008, NAT REV GENET, V9, P27, DOI 10.1038/nrg2224; Bell JC, 2012, NATURE, V491, P274, DOI 10.1038/nature11598; Bianco P R, 1998, Front Biosci, V3, pD570; Chen ZC, 2008, NATURE, V453, P489, DOI 10.1038/nature06971; CLARK AJ, 1965, P NATL ACAD SCI USA, V53, P451, DOI 10.1073/pnas.53.2.451; Conway AB, 2004, NAT STRUCT MOL BIOL, V11, P791, DOI 10.1038/nsmb795; Cox MM, 2007, NAT REV MOL CELL BIO, V8, P127, DOI 10.1038/nrm2099; Cox MM, 2000, NATURE, V404, P37, DOI 10.1038/35003501; COX MM, 1994, TRENDS BIOCHEM SCI, V19, P217, DOI 10.1016/0968-0004(94)90025-6; Cox MM, 2001, P NATL ACAD SCI USA, V98, P8173, DOI 10.1073/pnas.131004998; Cromie GA, 2001, MOL CELL, V8, P1163, DOI 10.1016/S1097-2765(01)00419-1; Danilowicz C, 2014, NUCLEIC ACIDS RES, V42, P526, DOI 10.1093/nar/gkt867; Danilowicz C, 2012, NUCLEIC ACIDS RES, V40, P1717, DOI 10.1093/nar/gkr855; Filippo JS, 2008, ANNU REV BIOCHEM, V77, P229, DOI 10.1146/annurev.biochem.77.061306.125255; Forget AL, 2012, NATURE, V482, P423, DOI 10.1038/nature10782; Galletto R, 2006, NATURE, V443, P875, DOI 10.1038/nature05197; Gibb B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087922; Gibb B, 2012, ANAL CHEM, V84, P7607, DOI 10.1021/ac302117z; GONDA DK, 1986, J BIOL CHEM, V261, P3087; GONDA DK, 1983, CELL, V34, P647, DOI 10.1016/0092-8674(83)90397-5; Greene EC, 2010, METHOD ENZYMOL, V472, P293, DOI 10.1016/S0076-6879(10)72006-1; HSIEH P, 1992, P NATL ACAD SCI USA, V89, P6492, DOI 10.1073/pnas.89.14.6492; Hunter N, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016618; Jiang LL, 2014, PHYS REV E, V90, DOI 10.1103/PhysRevE.90.022704; Joo C, 2006, CELL, V126, P515, DOI 10.1016/j.cell.2006.06.042; Kates-Harbeck J, 2013, PHYS REV E, V88, DOI 10.1103/PhysRevE.88.012702; KIM JI, 1992, J BIOL CHEM, V267, P16444; KIM JI, 1992, J BIOL CHEM, V267, P16438; Kowalczykowski SC, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016410; Lee JY, 2015, SCIENCE, V349, P977, DOI 10.1126/science.aab2666; MENETSKI JP, 1985, J MOL BIOL, V181, P281, DOI 10.1016/0022-2836(85)90092-0; MENETSKI JP, 1990, P NATL ACAD SCI USA, V87, P21, DOI 10.1073/pnas.87.1.21; Morrical SW, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a016444; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Prentiss M, 2015, CRIT REV BIOCHEM MOL, V50, P453, DOI 10.3109/10409238.2015.1092943; Qi Z, 2016, METHODS, V105, P62, DOI 10.1016/j.ymeth.2016.03.027; Qi Z, 2015, CELL, V160, P856, DOI 10.1016/j.cell.2015.01.029; Ragunathan K, 2012, ELIFE, V1, DOI 10.7554/eLife.00067; REHRAUER WM, 1993, J BIOL CHEM, V268, P1292; Renkawitz J, 2013, MOL CELL, V50, P261, DOI 10.1016/j.molcel.2013.02.020; Renkawitz J, 2014, NAT REV MOL CELL BIO, V15, P369, DOI 10.1038/nrm3805; ROSSELLI W, 1991, EMBO J, V10, P4391, DOI 10.1002/j.1460-2075.1991.tb05017.x; Savir Y, 2010, MOL CELL, V40, P388, DOI 10.1016/j.molcel.2010.10.020; Sheridan SD, 2008, NUCLEIC ACIDS RES, V36, P4057, DOI 10.1093/nar/gkn352; Symington LS, 2014, GENETICS, V198, P795, DOI 10.1534/genetics.114.166140; VanLoock MS, 2003, STRUCTURE, V11, P187, DOI 10.1016/S0969-2126(03)00003-0; VONHIPPEL PH, 1989, J BIOL CHEM, V264, P675; Weiner A, 2009, NAT REV MICROBIOL, V7, P748, DOI 10.1038/nrmicro2206; Yu X, 2001, P NATL ACAD SCI USA, V98, P8419, DOI 10.1073/pnas.111005398	49	21	22	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22218	22230		10.1074/jbc.M116.740563	http://dx.doi.org/10.1074/jbc.M116.740563			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27587394	Green Published, hybrid			2022-12-26	WOS:000386332600033
J	He, Y; Yan, DY; Zheng, DP; Hu, ZM; Li, HW; Li, JL				He, Yue; Yan, Daoyu; Zheng, Dianpeng; Hu, Zhiming; Li, Hongwei; Li, Jinlong			Cell Division Cycle 6 Promotes Mitotic Slippage and Contributes to Drug Resistance in Paclitaxel-Treated Cancer Cells	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA CELLS; DNA-REPLICATION; PROTEIN CDC6; CHECKPOINT; SPINDLE; ARREST; MICROTUBULES; MITOSIS; EXIT; INHIBITION	Paclitaxel (PTX) is an antimitotic drug that possesses potent anticancer activity, but its therapeutic potential in the clinic has been hindered by drug resistance. Here, we reporta mechanism by which cancer cells can exit from the PTX-induced mitotic arrest, i.e. mitotic slippage, and avoid subsequent death resulting in drug resistance. In cells experiencing mitotic slippage, Cdc6 protein level was significantly upregulated, Cdk1 activity was inhibited, and Cohesin/Rad21 was cleaved as a result. Cdc6 depletion by RNAi or Norcantharidin inhibited PTX-induced Cdc6 up-regulation, maintained Cdk1 activity, and repressed Cohesin/Rad21 cleavage. In all, this resulted in reduced mitotic slippage and reversal of PTX resistance. Moreover, in synchronized cells, the role of Cdc6 in mitotic exit under PTX pressure was also confirmed. This study indicates that Cdc6 may promote mitotic slippage by inactivation of Cdk1. Targeting of Cdc6 may serve as a promising strategy for enhancing the anticancer activity of PTX.	[He, Yue; Yan, Daoyu; Zheng, Dianpeng; Hu, Zhiming; Li, Hongwei; Li, Jinlong] Southern Med Univ, Sch Biotechnol, Inst Biotherapy, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Li, HW; Li, JL (corresponding author), Southern Med Univ, Sch Biotechnol, Inst Biotherapy, Guangzhou, Guangdong, Peoples R China.	hongwei1@yahoo.com; lijinlong@smu.edu.cn			National Natural Science Foundation of China [81272482, 81373122]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by the grants from National Natural Science Foundation of China Grants 81272482 (JL), and in part from National Natural Science Foundation of China Grants 81373122 (ZH), http://www.nsfc.gov.cn/.	Bekier ME, 2009, MOL CANCER THER, V8, P1646, DOI 10.1158/1535-7163.MCT-08-1084; Bharadwaj R, 2004, ONCOGENE, V23, P2016, DOI 10.1038/sj.onc.1207374; Borlado LR, 2008, CARCINOGENESIS, V29, P237, DOI 10.1093/carcin/bgm268; Brito DA, 2008, J CELL BIOL, V182, P623, DOI 10.1083/jcb.200805072; Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043; Calzada A, 2001, NATURE, V412, P355, DOI 10.1038/35085610; Chen SS, 2013, AM J CHINESE MED, V41, P665, DOI 10.1142/S0192415X13500468; Chen SS, 2013, INT J MOL MED, V32, P43, DOI 10.3892/ijmm.2013.1359; Chiang PC, 2010, BIOCHEM PHARMACOL, V79, P162, DOI 10.1016/j.bcp.2009.08.022; Clay-Farrace L, 2003, EMBO J, V22, P704, DOI 10.1093/emboj/cdg046; Demidenko ZN, 2008, ONCOGENE, V27, P4402, DOI 10.1038/onc.2008.82; El Dika M, 2014, DEV BIOL, V396, P67, DOI 10.1016/j.ydbio.2014.09.023; Elledge SJ, 1996, SCIENCE, V274, P1664, DOI 10.1126/science.274.5293.1664; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; Giovinazzi S, 2013, CELL CYCLE, V12, P2598, DOI 10.4161/cc.25591; Huang HC, 2009, CANCER CELL, V16, P347, DOI 10.1016/j.ccr.2009.08.020; Flores ML, 2012, BREAST CANCER RES TR, V133, P917, DOI 10.1007/s10549-011-1864-9; Misiukiewicz K, 2014, ANTI-CANCER DRUG, V25, P561, DOI 10.1097/CAD.0000000000000086; Murphy N, 2005, J CLIN PATHOL, V58, P525, DOI 10.1136/jcp.2004.018895; Ojima I, 2014, BIOORGAN MED CHEM, V22, P5060, DOI 10.1016/j.bmc.2014.02.036; Orth JD, 2011, CANCER RES, V71, P4608, DOI 10.1158/0008-5472.CAN-11-0412; Perkins G, 1998, MOL CELL, V2, P23, DOI 10.1016/S1097-2765(00)80110-0; Rohnalter V, 2015, ONCOTARGET, V6, P40005, DOI 10.18632/oncotarget.5552; Semple JW, 2004, BIOTECHNOL ADV, V22, P621, DOI 10.1016/j.biotechadv.2004.06.001; Sun YX, 2009, CELL, V137, P123, DOI 10.1016/j.cell.2009.01.040; Wu Z, 2009, NEOPLASIA, V11, P66, DOI 10.1593/neo.81048; Xiao J, 2013, NEOPLASMA; Yim H, 2010, P NATL ACAD SCI USA, V107, P19742, DOI 10.1073/pnas.1013557107; Yu CC, 2012, INT J ONCOL, V41, P1050, DOI 10.3892/ijo.2012.1511; Zhang S, 2014, ONCOGENE, V33, P116, DOI 10.1038/onc.2013.96; Zhang SJ, 2012, CELL SIGNAL, V24, P1803, DOI 10.1016/j.cellsig.2012.05.009; Zhu Y, 2014, CELL CYCLE, V13, DOI 10.4161/cc.28672	32	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162633	10.1371/journal.pone.0162633	http://dx.doi.org/10.1371/journal.pone.0162633			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611665	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900139
J	Kozak, RP; Urbanowicz, PA; Punyadeera, C; Reiding, KR; Jansen, BC; Royle, L; Spencer, DI; Fernandes, DL; Wuhrer, M				Kozak, Radoslaw P.; Urbanowicz, Paulina A.; Punyadeera, Chamindie; Reiding, Karli R.; Jansen, Bas C.; Royle, Louise; Spencer, Daniel I.; Fernandes, Daryl L.; Wuhrer, Manfred			Variation of Human Salivary O-Glycome	PLOS ONE			English	Article							LINKED OLIGOSACCHARIDES; STRUCTURAL-ANALYSIS; PROTEOMIC ANALYSIS; BLOOD-GROUP; GLYCOSYLATION; PROTEINS; GLYCANS; GLYCOPROTEINS; BIOMARKER; RELEASE	The study of saliva O-glycosylation is receiving increasing attention due to the potential of glycans for disease biomarkers, but also due to easy access and non-invasive collection of saliva as biological fluid. Saliva is rich in glycoproteins which are secreted from the bloodstream or produced by salivary glands. Mucins, which are highly O-glycosylated proteins, are particularlyabundant in human saliva. Their glycosylation is associated with blood group and secretor status, and represents a reservoir of potential disease biomarkers. This study aims to analyse and compare O-glycans released from whole human mouth saliva collected 3 times a day from a healthy individual over a 5 days period. O-linked glycans were released by hydrazinolysis, labelled with procainamide and analysed by ultra-high performance liquid chromatography with fluorescence detection (UHPLC-FLR) coupled to electrospray ionization mass spectrometry (ESI-MS/MS). The sample preparation method showed excellent reproducibility and can therefore be used for biomarker discovery. Our data demonstrates that the O-glycosylation in human saliva changes significantly during the day. These changes may be related to changes in the salivary concentrations of specific proteins.	[Kozak, Radoslaw P.; Urbanowicz, Paulina A.; Royle, Louise; Spencer, Daniel I.; Fernandes, Daryl L.] Ludger Ltd, Culham Sci Ctr, Abingdon, Oxon, England; [Punyadeera, Chamindie] Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Biomed Sci, 60 Musk Ave, Kelvin Grove, Australia; [Reiding, Karli R.; Jansen, Bas C.; Wuhrer, Manfred] Leiden Univ, Med Ctr, Ctr Prote & Metabol, Leiden, Netherlands	Culham Science Centre; UK Atomic Energy Authority; Queensland University of Technology (QUT); Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Kozak, RP (corresponding author), Ludger Ltd, Culham Sci Ctr, Abingdon, Oxon, England.	rad.kozak@ludger.com	Wuhrer, Manfred/ABE-9168-2020; Punyadeera, Chamindie K/L-9038-2013	Wuhrer, Manfred/0000-0002-0814-4995; Punyadeera, Chamindie K/0000-0001-9039-8259; Jansen, Bas Cornelis/0000-0001-8617-0980	European Union [278535]	European Union(European Commission)	This work was supported by the European Union's Seventh Framework Program (FP7-Health-F5-2011) under grant agreement no 278535 (HighGlycan). Ludger Ltd is a commercial bioscience company specialising in development and validation of glycoprofiling technology. The following authors declare competing financial interest(s): RPK, PAU, LR, DIS, DLF are employed by Ludger Ltd. In addition, products from Ludger were used in this research. This does not alter our adherence to PLOS ONE policies on sharing data and materials.; This work was supported by the European Union's Seventh Framework Program (FP7-Health-F5-2011) under grant agreement no 278535 (HighGlycan).	Adamczyk B, 2012, BBA-GEN SUBJECTS, V1820, P1347, DOI 10.1016/j.bbagen.2011.12.001; Amado Francisco M. L., 2007, P347, DOI 10.1007/978-1-59745-432-2_16; Ambatipudi KS, 2009, J PROTEOME RES, V8, P5093, DOI 10.1021/pr900478h; Amerongen AVN, 2002, ORAL DIS, V8, P12, DOI 10.1034/j.1601-0825.2002.1o816.x; Amerongen AVN, 1995, GLYCOBIOLOGY, V5, P733, DOI 10.1093/glycob/5.8.733; Bocklandt S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014821; Borzym-Kluczyk M, 2011, CLIN CHEM LAB MED, V49, P885, DOI 10.1515/CCLM.2011.137; Cabras T, 2009, J PROTEOME RES, V8, P4126, DOI 10.1021/pr900212u; Chaudhury NMA, 2016, MOL CELL PROTEOMICS, V15, P1048, DOI 10.1074/mcp.M115.052993; Clerc F, 2016, GLYCOCONJUGATE J, V33, P309, DOI 10.1007/s10719-015-9626-2; DOMON B, 1988, GLYCOCONJUGATE J, V5, P397, DOI 10.1007/BF01049915; Dowling P, 2008, J PROTEOMICS, V71, P168, DOI 10.1016/j.jprot.2008.04.004; EDGAR WM, 1992, BRIT DENT J, V172, P305, DOI 10.1038/sj.bdj.4807861; Epstein JB, 2000, CANCER-AM CANCER SOC, V89, P2258, DOI 10.1002/1097-0142(20001201)89:11<2258::AID-CNCR14>3.0.CO;2-Z; Everest-Dass AV, 2013, J AM SOC MASS SPECTR, V24, P895, DOI 10.1007/s13361-013-0610-4; Everest-Dass AV, 2012, GLYCOBIOLOGY, V22, P1465, DOI 10.1093/glycob/cws112; Fleissig Y, 2010, ORAL DIS, V16, P831, DOI 10.1111/j.1601-0825.2010.01696.x; Foo JYY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048452; Gornik O, 2012, BBA-GEN SUBJECTS, V1820, P1318, DOI 10.1016/j.bbagen.2011.12.004; Harvey DJ, 2009, PROTEOMICS, V9, P3796, DOI 10.1002/pmic.200900096; Helmerhorst EJ, 2007, J DENT RES, V86, P680, DOI 10.1177/154405910708600802; Hofman LF, 2001, J NUTR, V131, p1621S, DOI 10.1093/jn/131.5.1621S; Hu S, 2008, CLIN CANCER RES, V14, P6246, DOI 10.1158/1078-0432.CCR-07-5037; Hu S, 2010, METHODS MOL BIOL, V666, P31, DOI 10.1007/978-1-60761-820-1_3; Jaeken J, 2007, ANNU REV GENOM HUM G, V8, P261, DOI 10.1146/annurev.genom.8.080706.092327; Karlsson NG, 2004, J AM SOC MASS SPECTR, V15, P659, DOI 10.1016/j.jasms.2004.01.002; Karlsson NG, 2009, GLYCOBIOLOGY, V19, P288, DOI 10.1093/glycob/cwn136; Kaufman E, 2002, CRIT REV ORAL BIOL M, V13, P197, DOI 10.1177/154411130201300209; Kawashima H, 2012, BIOL PHARM BULL, V35, P1637, DOI 10.1248/bpb.b12-00412; Kozak RP, 2015, ANAL BIOCHEM, V486, P38, DOI 10.1016/j.ab.2015.06.006; Kozak RP, 2014, ANAL BIOCHEM, V453, P29, DOI 10.1016/j.ab.2014.02.030; Kozak RP, 2012, ANAL BIOCHEM, V423, P119, DOI 10.1016/j.ab.2012.01.002; Lamont R. J., 2010, ORAL MICROBIOLOGY GL; Merry AH, 2002, ANAL BIOCHEM, V304, P91, DOI 10.1006/abio.2002.5620; Mohamed R, 2012, CLIN TRANSL MED, V1, DOI 10.1186/2001-1326-1-19; Nilsson MF, 1999, INFECT IMMUN, V67, P2561, DOI 10.1128/IAI.67.5.2561-2566.1999; Ovchinnikov DA, 2014, BIOMARK INSIGHTS, V9, P53, DOI [10.4137/BMI.S16199, 10.4137/BMIMI.S16199]; PATEL T, 1993, BIOCHEMISTRY-US, V32, P679, DOI 10.1021/bi00053a037; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Punyadeera C, 2011, J IMMUNOL METHODS, V373, P19, DOI 10.1016/j.jim.2011.07.013; Royle Louise, 2006, V347, P125; SCHENKELS LCPM, 1995, CRIT REV ORAL BIOL M, V6, P161, DOI 10.1177/10454411950060020501; Schulz BL, 2007, GLYCOBIOLOGY, V17, P698, DOI 10.1093/glycob/cwm036; Schulz BL, 2013, CRIT REV BIOTECHNOL, V33, P246, DOI 10.3109/07388551.2012.687361; Schulz BL, 2002, ANAL CHEM, V74, P6088, DOI 10.1021/ac025890a; Sondej Melissa, 2009, Clin Proteomics, V5, P52, DOI 10.1007/s12014-008-9021-0; SPIRO RG, 1974, J BIOL CHEM, V249, P5704; Srivastava A, 2008, ARCH ORAL BIOL, V53, P1058, DOI 10.1016/j.archoralbio.2008.05.006; Ten Cate AR, 1998, ORAL HISTOLOGY DEV S, VFifth; Thomsson KA, 2005, GLYCOBIOLOGY, V15, P791, DOI 10.1093/glycob/cwi059; Zad M, 2015, CLIN ORAL INVEST, V19, P2147, DOI 10.1007/s00784-015-1495-3; Zauber H, 2012, PROTEOMICS, V12, P2221, DOI 10.1002/pmic.201100228; Zauner G, 2012, BIOL CHEM, V393, P687, DOI 10.1515/hsz-2012-0144; Zhang AH, 2012, APPL BIOCHEM BIOTECH, V168, P1718, DOI 10.1007/s12010-012-9891-5; [张丽华 Zhang Lihua], 2010, [工业水处理, Industrial Water Treatment], V30, P5	55	11	11	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162824	10.1371/journal.pone.0162824	http://dx.doi.org/10.1371/journal.pone.0162824			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610614	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900172
J	Pamphlett, R; Jew, SK				Pamphlett, Roger; Jew, Stephen Kum			Age-Related Uptake of Heavy Metals in Human Spinal Interneurons	PLOS ONE			English	Article							AMYOTROPHIC-LATERAL-SCLEROSIS; MULTIPLE-SCLEROSIS; INTERMEDIATE ZONE; NEURONS; CORD; ALS; MOTONEURONS; DYSFUNCTION; MECHANISMS	Toxic heavy metals have been implicated in the loss of spinal motoneurons in amyotrophic lateral sclerosis/motor neuron disease (ALS/MND). Motoneuron loss in the spinal anterior horn is severe in ALS/MND at the time of death, making this tissue unsuitable for examination. We therefore examined spinal cords of people without muscle weakness to look for any presence of heavy metals that could make these neurons susceptible to damage. Spinal cord samples from 50 individuals aged 1-95 y who had no clinical or histopathological evidence of spinal motoneuron loss were studied. Seven mu m formalin-fixed paraffin-embedded sections were stained for heavy metals with silver nitrate autometallography (AMG(HM)) which detects intracellular mercury, silver or bismuth. Neurons in the spinal cord were classified as interneurons or alpha-motoneurons based on their site and cell body diameter. Spinal interneurons containing heavy metals were present in 8 of 24 people (33%) aged 61-95 y, but not at younger ages. These AMG(HM) interneurons were most numerous in the lumbar spinal cord, with moderate numbers in the caudal cervical cord, few in the rostral cervical cord, and almost none in the thoracic cord. All people with AMG(HM) interneurons had occasional AMG(HM) staining in alpha-motoneurons as well. In one man AMG(HM) staining was present in addition in dorsomedial nucleus and sensory neurons. In conclusion, heavy metals are present in many spinal interneurons, and in a few alpha-motoneurons, in a large proportion of older people. Damage to inhibitory interneurons from toxic metals in later life could result in excitotoxic injury to motoneurons and may underlie motoneuron injury or loss in conditions such as ALS/MND, multiple sclerosis, sarcopenia and calf fasciculations.	[Pamphlett, Roger; Jew, Stephen Kum] Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Discipline Pathol, Sydney, NSW, Australia; [Pamphlett, Roger] Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia	University of Sydney; University of Sydney	Pamphlett, R (corresponding author), Univ Sydney, Sydney Med Sch, Brain & Mind Ctr, Discipline Pathol, Sydney, NSW, Australia.; Pamphlett, R (corresponding author), Royal Prince Alfred Hosp, Dept Neuropathol, Sydney, NSW, Australia.	roger.pamphlett@sydney.edu.au		Pamphlett, Roger/0000-0003-3326-7273	Aimee Stacey Memorial and Ignacy Burnett Bequests; Multiple Sclerosis Research Australia; University of Sydney; NSW Office for Health and Medical Research; Royal Prince Alfred Hospital Sydney; Trish MS Research Foundation; Levy Foundation; Collier Charitable Fund; Medical Advances Without Animals Trust; FIL Foundation	Aimee Stacey Memorial and Ignacy Burnett Bequests; Multiple Sclerosis Research Australia; University of Sydney(University of Sydney); NSW Office for Health and Medical Research; Royal Prince Alfred Hospital Sydney; Trish MS Research Foundation; Levy Foundation; Collier Charitable Fund; Medical Advances Without Animals Trust; FIL Foundation	This work was supported by the Aimee Stacey Memorial and Ignacy Burnett Bequests. The Multiple Sclerosis Research Australia Brain Bank at the Brain and Mind Centre in Sydney, Australia is supported by Multiple Sclerosis Research Australia, the University of Sydney, the NSW Office for Health and Medical Research, Royal Prince Alfred Hospital Sydney, the Trish MS Research Foundation, the Levy Foundation, the Collier Charitable Fund, the Medical Advances Without Animals Trust, and the FIL Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AI-Chalabi A, 2014, LANCET NEUROL, V13, P1108, DOI 10.1016/S1474-4422(14)70219-4; Aragones JM, 2016, AMYOTROPH LATERAL SC, V8421, P1; Brettschneider J, 2014, ACTA NEUROPATHOL, V128, P423, DOI 10.1007/s00401-014-1299-6; Callaghan B, 2011, NEURODEGENER DIS, V8, P1, DOI 10.1159/000315405; Eisen AA, 1997, SPINAL CORD DIS BASI, P175; Fermont J, 2009, AMYOTROPH LATERAL SC, P1; FUNG SJ, 1987, BRAIN RES, V402, P230, DOI 10.1016/0006-8993(87)90029-1; Gautier G, 2010, AMYOTROPH LATERAL SC, V11, P379, DOI 10.3109/17482960903426543; Gilmore CP, 2009, BRAIN PATHOL, V19, P642, DOI 10.1111/j.1750-3639.2008.00228.x; HARVEY DG, 1979, ARCH NEUROL-CHICAGO, V36, P615, DOI 10.1001/archneur.1979.00500460049005; Hortobagyi T, 2006, EXERC SPORT SCI REV, V34, P29, DOI 10.1097/00003677-200601000-00007; Ismail A, 2013, J NEUROL NEUROSUR PS, V84, P79, DOI 10.1136/jnnp-2012-303326; Johnson FO, 2009, NEUROTOXICOLOGY, V30, P761, DOI 10.1016/j.neuro.2009.07.010; Kale Shubha P, 2005, Int J Environ Res Public Health, V2, P14, DOI 10.3390/ijerph2005010014; Kasarskis E J, 1993, Prog Clin Biol Res, V380, P299; KAWAMURA Y, 1977, J NEUROPATH EXP NEUR, V36, P861, DOI 10.1097/00005072-197709000-00010; Kiernan MC, 2011, LANCET, V377, P942, DOI 10.1016/S0140-6736(10)61156-7; Lacorte E, 2016, NEUROSCI BIOBEHAV R, V66, P61, DOI 10.1016/j.neubiorev.2016.04.007; LEXELL J, 1991, J ANAT, V174, P239; Li W, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8201; Morahan JM, 2007, AM J MED GENET B, V144B, P885, DOI 10.1002/ajmg.b.30543; Narici MV, 2010, BRIT MED BULL, V95, P139, DOI 10.1093/bmb/ldq008; Ramirez-Jarquin UN, 2014, NEUROPHARMACOLOGY, V82, P101, DOI 10.1016/j.neuropharm.2013.10.003; OYANAGI K, 1989, ACTA NEUROPATHOL, V77, P343, DOI 10.1007/BF00687368; Pacyna EG, 2010, ATMOS ENVIRON, V44, P2487, DOI 10.1016/j.atmosenv.2009.06.009; Pamphlett R, 1998, J NEUROPATH EXP NEUR, V57, P360; Pamphlett Roger, 2013, Acta Neuropathol Commun, V1, P13, DOI 10.1186/2051-5960-1-13; Pearson KG., 2013, PRINCIPLES NEURAL SC, p790; Peters TL, 2016, NEUROTOXICOLOGY, V54, P119, DOI 10.1016/j.neuro.2016.03.022; Pugdahl K, 2007, J NEUROL NEUROSUR PS, V78, P746, DOI 10.1136/jnnp.2006.098533; Ravits JM, 2009, NEUROLOGY, V73, P805, DOI 10.1212/WNL.0b013e3181b6bbbd; Selin N. E., 2008, GLOBAL BIOGEOCHEM CY, V22, P2; SHEFNER JM, 1992, MUSCLE NERVE, V15, P1265, DOI 10.1002/mus.880151108; Sparks DL, 2002, NAT REV NEUROSCI, V3, P952, DOI 10.1038/nrn986; Stoltenberg M, 2000, HISTOCHEM J, V32, P645, DOI 10.1023/A:1004115130843; TAKAHASHI H, 1992, ACTA NEUROPATHOL, V84, P465, DOI 10.1007/BF00304464; Terao S, 1996, ACTA NEUROPATHOL, V92, P109, DOI 10.1007/s004010050497; TOMLINSON BE, 1977, J NEUROL SCI, V34, P213, DOI 10.1016/0022-510X(77)90069-7; Turner MR, 2015, J NEUROL NEUROSUR PS, V86, P667, DOI 10.1136/jnnp-2014-308946; Turner MR, 2012, AMYOTROPH LATERAL SC, V13, P245, DOI 10.3109/17482968.2011.636050; Vogt J, 2009, ANN NEUROL, V66, P310, DOI 10.1002/ana.21719	41	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162260	10.1371/journal.pone.0162260	http://dx.doi.org/10.1371/journal.pone.0162260			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611334	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900071
J	Ren, J; Yuan, W; Wang, RH; Wang, QP; Li, Y; Xue, CF; Yan, YL; Ma, XW; Tan, L; Liu, Z				Ren, Juan; Yuan, Wei; Wang, Ruihua; Wang, Qiuping; Li, Yi; Xue, Chaofan; Yan, Yanli; Ma, Xiaowei; Tan, Li; Liu, Zi			Dosimetric Comparison between Three-Dimensional Magnetic Resonance Imaging-Guided and Conventional Two-Dimensional Point A-Based Intracavitary Brachytherapy Planning for Cervical Cancer	PLOS ONE			English	Article							DOSE-VOLUME PARAMETERS; COMPUTED-TOMOGRAPHY; CARCINOMA; RADIATION; RECOMMENDATIONS; OPTIMIZATION; BLADDER; ORGANS; TERMS; RISK	Objective The purpose of this study was to comprehensively compare the 3-dimensional (3D) magnetic resonance imaging (MRI)-guided and conventional 2-dimensional (2D) point A-based intracavitary brachytherapy (BT) planning for cervical cancer with regard to target dose coverage and dosages to adjacent organs-at risk (OARs). Methods A total of 79 patients with cervical cancer were enrolled to receive 2D point A-based BT planning and then immediately to receive 3D planning between October 2011 and April 2013 at the First Hospital Affiliated to Xi'an Jiao Tong University (Xi'an, China). The dose-volume histogram (DVH) parameters for gross tumor volume (GTV), high-risk clinical target volume (HR-CTV), intermediate-risk clinical target volume (IR-CTV) and OARs were compared between the 2D and 3D planning. Results In small tumors, there was no significant difference in most of the DVHs between 2D and 3D planning (all p>0.05). While in big tumors, 3D BT planning significantly increased the DVHs for most of the GTV, HR-CTV and IR-CTV, and some OARs compared with 2D planning (all P<0.05). In 3D planning, DVHs for GTV, HR-CTV, IR-CTV and some OARs were significantly higher in big tumors than in small tumors (all p<0.05). In contrast, in 2D planning, DVHs for almost all of the HR-CTV and IR-CTV were significantly lower in big tumors (all p<0.05). In eccentric tumors, 3D planning significantly increased dose coverage but decreased dosages to OARs compared with 2D planning (p<0.05). In tumors invading adjacent tissues, the target dose coverage in 3D planning was generally significantly higher than in 2D planning (P<0.05); the dosages to the adjacent rectum and bladder were significantly higher but those to sigmoid colon were lower in 3D planning (all P<0.05). Conclusions 3D MRI image-guided BT planning exhibits advantages over 2D planning in a complex way, generally showing advantages for the treatment of cervical cancer except small tumors.	[Ren, Juan; Yuan, Wei; Wang, Ruihua; Li, Yi; Liu, Zi] Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Oncol, Dept Radiotherapy, Xian, Shaanxi, Peoples R China; [Wang, Qiuping] Xi An Jiao Tong Univ, Affiliated Hosp 1, Dept Imaging, Xian, Shaanxi, Peoples R China; [Xue, Chaofan; Yan, Yanli; Ma, Xiaowei; Tan, Li] Xi An Jiao Tong Univ, Sch Med, Xian, Shaanxi, Peoples R China	Xi'an Jiaotong University; Xi'an Jiaotong University; Xi'an Jiaotong University	Ren, J (corresponding author), Xi An Jiao Tong Univ, Affiliated Hosp 1, Ctr Oncol, Dept Radiotherapy, Xian, Shaanxi, Peoples R China.	869491533@qq.com			National Natural Science Foundation of China [31201060/C0709, 30973175/H1621, 81172490/H1621]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study (including the study design and performance, data collection and analysis, preparation of the manuscript) was supported by the National Natural Science Foundation of China (Juan Ren: 31201060/C0709, 30973175/H1621, 81172490/H1621) (http://www.nsfc.gov.cn/).	Chargari C, 2009, INT J RADIAT ONCOL, V74, P133, DOI 10.1016/j.ijrobp.2008.06.1912; Charvolin JY, 2001, B CANCER, V88, P1207; De Brabandere M, 2008, RADIOTHER ONCOL, V88, P217, DOI 10.1016/j.radonc.2007.10.026; Dimopoulos JCA, 2009, RADIOTHER ONCOL, V93, P311, DOI 10.1016/j.radonc.2009.07.001; Dimopoulos JCA, 2009, INT J RADIAT ONCOL, V75, P56, DOI 10.1016/j.ijrobp.2008.10.033; Haie-Meder C, 2005, RADIOTHER ONCOL, V74, P235, DOI 10.1016/j.radonc.2004.12.015; Hashim N, 2014, ASIAN PAC J CANCER P, V15, P5259, DOI 10.7314/APJCP.2014.15.13.5259; ICRU, 1985, 38 ICRU; Ju SG, 2013, J RADIAT RES, V54, P349, DOI 10.1093/jrr/rrs091; Kirisits C, 2005, INT J RADIAT ONCOL, V62, P901, DOI 10.1016/j.ijrobp.2005.02.040; Koom WS, 2007, INT J RADIAT ONCOL, V68, P1446, DOI 10.1016/j.ijrobp.2007.02.009; Lindegaard JC, 2008, INT J RADIAT ONCOL, V71, P756, DOI 10.1016/j.ijrobp.2007.10.032; Ma DJ, 2011, RADIOTHER ONCOL, V98, P139, DOI 10.1016/j.radonc.2010.10.004; Madan R, 2014, ASIAN PAC J CANCER P, V15, P4717, DOI 10.7314/APJCP.2014.15.11.4717; Nakano T, 2005, CANCER-AM CANCER SOC, V103, P92, DOI 10.1002/cncr.20734; Onal C, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-95; Petsuksiri J, 2012, ASIAN PAC J CANCER P, V13, P1713, DOI 10.7314/APJCP.2012.13.5.1713; Potter R, 2006, RADIOTHER ONCOL, V78, P67, DOI 10.1016/j.radonc.2005.11.014; Potter R, 2007, RADIOTHER ONCOL, V83, P148, DOI 10.1016/j.radonc.2007.04.012; Sadozye AH, 2012, CURR ONCOL REP, V14, P519, DOI 10.1007/s11912-012-0275-3; Tanderup K, 2010, RADIOTHER ONCOL, V94, P173, DOI 10.1016/j.radonc.2010.01.001; Tharavichitkul E, 2011, J RADIAT RES, V52, P634, DOI 10.1269/jrr.10154; Viswanathan AN, 2007, INT J RADIAT ONCOL, V68, P491, DOI 10.1016/j.ijrobp.2006.12.021; Wang B, 2009, BRACHYTHERAPY, V8, P240, DOI 10.1016/j.brachy.2008.10.004; Zwahlen D, 2009, INT J RADIAT ONCOL, V74, P1157, DOI 10.1016/j.ijrobp.2008.09.010	25	3	3	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161932	10.1371/journal.pone.0161932	http://dx.doi.org/10.1371/journal.pone.0161932			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611853	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900038
J	Tsai, LT; Liao, KM; Jang, Y; Hu, FC; Wu, WC				Tsai, Li-Ting; Liao, Kuo-Meng; Jang, Yuh; Hu, Fu-Chang; Wu, Wei-Chi			Detecting Visual Function Abnormality with a Contrast-Dependent Visual Test in Patients with Type 2 Diabetes	PLOS ONE			English	Article							RETINOPATHY; SENSITIVITY; MELLITUS; ACUITY; PERIMETRY; DISEASE; PREVALENCE; DEMENTIA; RETINA; RISK	In addition to diabetic retinopathy, diabetes also causes early retinal neurodegeneration and other eye problems, which cause various types of visual deficits. This study used a computer-based visual test (Macular Multi-Function Assessment (MMFA)) to assess contrast-dependent macular visual function in patients with type 2 diabetes to collect more visual information than possible with only the visual acuity test. Because the MMFA is a newly developed test, this study first compared the agreement and discriminative ability of the MMFA and the Early Treatment Diabetic Retinopathy Study (ETDRS) contrast acuity charts. Then symbol discrimination performances of diabetic patients and controls were evaluated at 4 contrast levels using the MMFA. Seventy-seven patients and 45 controls participated. The agreement between MMFA and ETDRS scores was examined by fitting three-level linear mixed-effect models to estimate the intraclass correlation coefficients (ICCs). The estimated areas under the receiver operating characteristic (ROC) curve were used to compare the discriminative ability of diseased versus non-diseased participants between the two tests. The MMFA scores of patients and controls were compared with multiple linear regression analysis after adjusting the effects of age, sex, hypertension and cataract. Results showed that the scores of the MMFA and ETDRS tests displayed high levels of agreement and acceptable and similar discriminative ability. The MMFA performance was correlated with the severity of diabetic retinopathy. Most of the MMFA scores differed significantly between the diabetic patients and controls. In the low contrast condition, the MMFA scores were significantly lower for 006Eon-DR patients than for controls. The potential utility of the MMFA as an easy screening tool for contrast-dependent visual function and for detecting early functional visual change in patients with type 2 diabetes is discussed.	[Tsai, Li-Ting] Univ Alabama Birmingham, Dept Occupat Therapy, Grad Certificate Low Vis Rehabil, Birmingham, AL USA; [Tsai, Li-Ting; Jang, Yuh] Natl Taiwan Univ, Coll Med, Sch Occupat Therapy, Taipei, Taiwan; [Liao, Kuo-Meng] Taipei City Hosp, Zhong Xiao Branch, Dept Endocrine & Metab, Taipei, Taiwan; [Hu, Fu-Chang] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei, Taiwan; [Wu, Wei-Chi] Chang Gung Mem Hosp, Dept Ophthalmol, Gueishan Township, Taoyuan County, Taiwan; [Wu, Wei-Chi] Chang Gung Univ, Sch Med, Gueishan Township, Taoyuan County, Taiwan	University of Alabama System; University of Alabama Birmingham; National Taiwan University; Taipei City Hospital; National Taiwan University; Chang Gung Memorial Hospital; Chang Gung University	Wu, WC (corresponding author), Chang Gung Mem Hosp, Dept Ophthalmol, Gueishan Township, Taoyuan County, Taiwan.; Wu, WC (corresponding author), Chang Gung Univ, Sch Med, Gueishan Township, Taoyuan County, Taiwan.	weichi666@gmail.com		JANG, YUH/0000-0003-2332-8319	Minister of Science and Technology Research Grants [NSC 99-2314-B-002-138-MY3, MOST 104-2314-B-182A-100-MY2]; Chang Gung Memorial Hospital Research Grants [CMRPG3E0521, CMRPG3E0522]; Department of Endocrine and Metabolism, Zhong-Xiao Branch of Taipei City Hospital in Taiwan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079626] Funding Source: NIH RePORTER	Minister of Science and Technology Research Grants; Chang Gung Memorial Hospital Research Grants; Department of Endocrine and Metabolism, Zhong-Xiao Branch of Taipei City Hospital in Taiwan; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by the Minister of Science and Technology Research Grants (NSC 99-2314-B-002-138-MY3, MOST 104-2314-B-182A-100-MY2), and Chang Gung Memorial Hospital Research Grants (CMRPG3E0521 and CMRPG3E0522). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by the Department of Endocrine and Metabolism, Zhong-Xiao Branch of Taipei City Hospital in Taiwan. The authors would like to thank the diabetes educators of the Department of Endocrine and Metabolism, Zhong-Xiao Branch, Taipei City Hospital, Yuh-Fon Liu, Yi-Hsiu Chen, and Rui-Xiang Fan, for helping with data collection and case referral. The first author also thanks Jen-Hung Chen, a computer engineer, for help with developing the MMFA, and Fan-Ya Su, a research assistant, for assisting with data collection.	[Anonymous], 1991, OPHTHALMOLOGY, V98, P786, DOI DOI 10.1016/S0161-6420(13)38012-9; ANSTIS SM, 1974, VISION RES, V14, P589, DOI 10.1016/0042-6989(74)90049-2; Antonetti DA, 2006, DIABETES, V55, P2401, DOI 10.2337/db05-1635; Arend O, 1997, INVEST OPHTH VIS SCI, V38, P1819; Balcer LJ, 2012, J NEUROL SCI, V318, P119, DOI 10.1016/j.jns.2012.03.009; Biessels GJ, 2006, LANCET NEUROL, V5, P64, DOI 10.1016/S1474-4422(05)70284-2; Bikbova G, 2012, CURR DIABETES REV, V8, P294, DOI 10.2174/157339912800840479; Billino J, 2008, VISION RES, V48, P1254, DOI 10.1016/j.visres.2008.02.014; Chan AHS, 2005, BEHAV INFORM TECHNOL, V24, P81, DOI 10.1080/0144929042000267073; Chen KL, 2009, J REHABIL MED, V41, P273, DOI 10.2340/16501977-0319; Chen SJ, 2008, ACTA DIABETOL, V45, P7, DOI 10.1007/s00592-007-0012-9; Cheng G, 2012, INTERN MED J, V42, P484, DOI 10.1111/j.1445-5994.2012.02758.x; Cole ED, 2016, CLIN EXP OPHTHALMOL, V44, P289, DOI 10.1111/ceo.12711; CRASSINI B, 1988, PERCEPTION, V17, P315, DOI 10.1068/p170315; Davies N, 2003, VISION RES, V43, P2377, DOI 10.1016/S0042-6989(03)00405-X; Ewing FME, 1998, ENDOCR REV, V19, P462, DOI 10.1210/er.19.4.462; Felmingham KL, 2004, NEUROPSYCHOLOGY, V18, P564, DOI 10.1037/0894-4105.18.3.564; Gualtieri M, 2011, INVEST OPHTH VIS SCI, V52, P1151, DOI 10.1167/iovs.09-3705; Hansen MB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139148; Hart W. M., 1987, ADLERS PHYSL EYE CLI, P429; Ismail GM, 1998, OPHTHAL PHYSL OPT, V18, P3, DOI 10.1016/S0275-5408(97)00043-4; Kaiserman I, 2005, AM J OPHTHALMOL, V139, P498, DOI 10.1016/j.ajo.2004.10.022; LEVI DM, 1985, VISION RES, V25, P963, DOI 10.1016/0042-6989(85)90207-X; Majaj NJ, 2002, VISION RES, V42, P1165, DOI 10.1016/S0042-6989(02)00045-7; Miles WR, 1930, J GEN PSYCHOL, V3, P412, DOI 10.1080/00221309.1930.9918218; Nittala MG, 2012, RETINA-J RET VIT DIS, V32, P1302, DOI 10.1097/IAE.0b013e3182365a24; Pitsas C, 2015, INT J OPHTHALMOL-CHI, V8, P1013, DOI 10.3980/j.issn.2222-3959.2015.05.29; Rizzo MR, 2010, DIABETES CARE, V33, P2169, DOI 10.2337/dc10-0389; Ruta LM, 2013, DIABETIC MED, V30, P387, DOI 10.1111/dme.12119; Schreiber AK, 2015, WORLD J DIABETES, V6, P432, DOI 10.4239/wjd.v6.i3.432; Scialfa CT, 2013, J GERONTOL B-PSYCHOL, V68, P522, DOI 10.1093/geronb/gbs086; Simo R, 2012, BRIT J OPHTHALMOL, V96, P1285, DOI 10.1136/bjophthalmol-2012-302005; Spry PGD, 2005, J GLAUCOMA, V14, P11, DOI 10.1097/01.ijg.0000145813.46848.b8; Stavrou Efty P, 2003, Clin Exp Optom, V86, P152; Stavrou EP, 2005, ACTA OPHTHALMOL SCAN, V83, P574, DOI 10.1111/j.1600-0420.2005.00527.x; Stitt AW, 2013, CLIN SCI, V125, P1, DOI 10.1042/CS20120588; Sukha AY, 2009, OPTOMETRY VISION SCI, V86, P1086, DOI 10.1097/OPX.0b013e3181b48635; To L, 2013, VISION RES, V90, P15, DOI 10.1016/j.visres.2013.04.011; Trauzettel-Klosinski S, 2003, GRAEF ARCH CLIN EXP, V241, P988, DOI 10.1007/s00417-003-0757-y; Tsai LT, 2013, J VIS, V13, P582; Verma A, 2009, EYE, V23, P1824, DOI 10.1038/eye.2009.184; West BW., 2015, LINEAR MIXED MODELS, V2; Wilkinson CP, 2003, OPHTHALMOLOGY, V110, P1677, DOI 10.1016/S0161-6420(03)00475-5; Zhang JY, 2007, INVEST OPHTH VIS SCI, V48, P2383, DOI 10.1167/iovs.06-1195; Zhang XY, 2013, INT J BIOCHEM CELL B, V45, P1525, DOI 10.1016/j.biocel.2013.03.002; Zimmet P, 2001, NATURE, V414, P782, DOI 10.1038/414782a; [No title captured]	47	6	6	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162383	10.1371/journal.pone.0162383	http://dx.doi.org/10.1371/journal.pone.0162383			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611680	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900087
J	Yang, SH; Gao, YH; Zhang, SL; Zhang, Q; Sun, DX				Yang, Shaohua; Gao, Yahui; Zhang, Shengli; Zhang, Qin; Sun, Dongxiao			Identification of Genetic Associations and Functional Polymorphisms of SAA1 Gene Affecting Milk Production Traits in Dairy Cattle	PLOS ONE			English	Article							SERUM-AMYLOID-A; PROTEIN; PERCENTAGE; COWS; DNA	Our initial RNA sequencing (RNA-seq) revealed that the Serum amyloid A1 (SAA1) gene was differentially expressed in the mammary glands of lactating Holstein cows with extremely high versus low phenotypic values of milk protein and fat percentage. To further validate the genetic effect and potential molecular mechanisms of SAA1 gene involved in regulating milk production traits in dairy cattle, we herein performed a study through genotype-phenotype associations. Six identified SNPs were significantly associated with one or more milk production traits (0.00002< P < 0.0025), providing additional evidence for the potential role of SAA1 variants in milk production traits in dairy cows. Subsequently, both luciferase assay and electrophoretic mobility shift assay (EMSA) clearly demonstrated that the allele A of g.-963C> A increased the promoter activity by binding the PARP factor while allele C did not. Bioinformatics analysis indicated that the secondary structure of SAA protein changed by the substitution A/G in the locus c. +2510A>G. Our findings were the first to reveal the significant associations of the SAA1 gene with milk production traits, providing basis for further biological function validation, and two identified SNPs, g.-963C>A and c. +2510A>G, may be considered as genetic markers for breeding in dairy cattle.	[Yang, Shaohua; Gao, Yahui; Zhang, Shengli; Zhang, Qin; Sun, Dongxiao] China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet & Breeding, Minist Agr,Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	Sun, DX (corresponding author), China Agr Univ, Coll Anim Sci & Technol, Key Lab Anim Genet & Breeding, Minist Agr,Natl Engn Lab Anim Breeding, Beijing 100193, Peoples R China.	sundx@cau.edu.cn			National Science and Technology Programs of China [2013AA102504, 2011BAD28B02, 2014ZX08009-053B]; Beijing Natural Science Foundation [6152013]; Beijing Dairy Industry Innovation Team [BAIC06-2016]; earmarked fund for Modern Agro-industry Technology Research System [CARS-37]; Program for Changjiang Scholar and Innovation Research Team in University [IRT1191]	National Science and Technology Programs of China; Beijing Natural Science Foundation(Beijing Natural Science Foundation); Beijing Dairy Industry Innovation Team; earmarked fund for Modern Agro-industry Technology Research System; Program for Changjiang Scholar and Innovation Research Team in University	This work was financially supported by the National Science and Technology Programs of China (2013AA102504, 2011BAD28B02, 2014ZX08009-053B), Beijing Natural Science Foundation (6152013), the Beijing Dairy Industry Innovation Team (BAIC06-2016), the earmarked fund for Modern Agro-industry Technology Research System (CARS-37) and the Program for Changjiang Scholar and Innovation Research Team in University (IRT1191). The authors would also like to appreciate the Dairy Data Center of China for providing the official EBVs data. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aljanabi SM, 1997, NUCLEIC ACIDS RES, V25, P4692, DOI 10.1093/nar/25.22.4692; Bagnato A, 2008, J DAIRY SCI, V91, P767, DOI 10.3168/jds.2007-0507; Bionaz M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033268; BOVENHUIS H, 1992, J DAIRY SCI, V75, P2549, DOI 10.3168/jds.S0022-0302(92)78017-5; Browning SR, 2007, AM J HUM GENET, V81, P1084, DOI 10.1086/521987; Canovas A, 2010, MAMM GENOME, V21, P592, DOI 10.1007/s00335-010-9297-z; Capon F, 2004, HUM MOL GENET, V13, P2361, DOI 10.1093/hmg/ddh273; Caroli AM, 2009, J DAIRY SCI, V92, P5335, DOI 10.3168/jds.2009-2461; Cole JB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-408; Cui XG, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-226; Eckersall PD, 2001, VET REC, V148, P35, DOI 10.1136/vr.148.2.35; Frizzell KM, 2009, J BIOL CHEM, V284, P33926, DOI 10.1074/jbc.M109.023879; Goddard ME, 2007, J ANIM BREED GENET, V124, P323, DOI 10.1111/j.1439-0388.2007.00702.x; Gronlund U, 2003, J DAIRY RES, V70, P379, DOI 10.1017/S0022029903006484; Huang W, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-711; Huang YQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066160; Hunt R, 2009, METHODS MOL BIOL, V578, P23, DOI 10.1007/978-1-60327-411-1_2; Ishii I, 2004, BIOCHEM J, V381, P113, DOI 10.1042/BJ20040243; Islas-Trejo A, 2010, 9 WORLD C GEN APPL L, V2, P343; Jacobsen S, 2005, VET IMMUNOL IMMUNOP, V104, P21, DOI 10.1016/j.vetimm.2004.09.031; Jia MW, 2004, BIOPOLYMERS, V73, P16, DOI 10.1002/bip.10496; Kho Y, 2008, BIOSCI BIOTECH BIOCH, V72, P70, DOI 10.1271/bbb.70374; Kimchi-Sarfaty C, 2007, SCIENCE, V315, P525, DOI 10.1126/science.1135308; KluveBeckerman B, 1997, BIOCHEM J, V322, P663, DOI 10.1042/bj3220663; Kolbehdari D, 2009, J ANIM BREED GENET, V126, P216, DOI 10.1111/j.1439-0388.2008.00793.x; Kovacevic-Filipovic M, 2012, VET IMMUNOL IMMUNOP, V145, P120, DOI 10.1016/j.vetimm.2011.10.015; Kraus WL, 2008, CURR OPIN CELL BIOL, V20, P294, DOI 10.1016/j.ceb.2008.03.006; Kraus WL, 2003, CELL, V113, P677, DOI 10.1016/S0092-8674(03)00433-1; Krishnakumar R, 2010, MOL CELL, V39, P8, DOI 10.1016/j.molcel.2010.06.017; Liu ZJ, 2004, AQUACULTURE, V238, P1, DOI 10.1016/j.aquaculture.2004.05.027; Martin P, 2002, REPROD NUTR DEV, V42, P433, DOI 10.1051/rnd:2002036; Nackley AG, 2006, SCIENCE, V314, P1930, DOI 10.1126/science.1131262; O'Mahony MC, 2006, RES VET SCI, V80, P155, DOI 10.1016/j.rvsc.2005.05.005; Olsen HG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076695; Said RS, 2016, BIOCHEM PHARMACOL, V103, P140, DOI 10.1016/j.bcp.2016.01.019; SIBYLLE G, 2000, FASEB J, V14, P1159; Stasio L. di, 2000, Zootecnica e Nutrizione Animale, V26, P69; Wang Xuting, 2005, Toxicol Appl Pharmacol, V207, P84, DOI 10.1016/j.taap.2004.09.024; Wickramasinghe S, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-45; Wickramasinghe S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018895; Zi C, 2013, INT J MOL SCI, V14, P24126, DOI 10.3390/ijms141224126	41	5	5	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162195	10.1371/journal.pone.0162195	http://dx.doi.org/10.1371/journal.pone.0162195			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610623	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900055
J	Miguel, RDV; Calla, NEQ; Pavelko, SD; Cherpes, TL				Miguel, Rodolfo D. Vicetti; Calla, Nirk E. Quispe; Pavelko, Stephen D.; Cherpes, Thomas L.			Intravaginal Chlamydia trachomatis Challenge Infection Elicits T(H)1 and T(H)17 Immune Responses in Mice That Promote Pathogen Clearance and Genital Tract Damage	PLOS ONE			English	Article							CD4(+) T-CELLS; DISEASE TOLERANCE; VACCINE; STRAINS; MOUSE; SUSCEPTIBILITY; REINFECTION; RESISTANCE; MODELS	While ascension of Chlamydia trachomatis into the upper genital tract of women can cause pelvic inflammatory disease and Fallopian tube damage, most infections elicit no symptoms or overt upper genital tract pathology. Consistent with this asymptomatic clinical presentation, genital C. trachomatis infection of women generates robust T(H)2 immunity. As an animal model that modeled this response would be invaluable for delineating bacterial pathogenesis and human host defenses, herein we explored if pathogen-specific T(H)2 immunity is similarly elicited by intravaginal (ivag) infection of mice with oculogenital C. trachomatis serovars. Analogous to clinical infection, ascension of primary C. trachomatis infection into the mouse upper genital tract produced no obvious tissue damage. Clearance of ivag challenge infection was mediated by interferon (IFN)-gamma-producing CD4(+) T cells, while IFN-gamma signaling blockade concomitant with a single ivag challenge promoted tissue damage by enhancing Chlamydia-specific T(H)17 immunity. Likewise, IFN-gamma and IL-17 signaling blockade or CD4(+) T cell depletion eliminated the genital pathology produced in untreated controls by multiple ivag challenge infections. Conversely, we were unable to detect formation of pathogen-specific T(H)2 immunity in C. trachomatis-infected mice. Together, our work revealed C. trachomatis infection of mice generates T(H)1 and T(H)17 immune responses that promote pathogen clearance and immunopathological tissue damage. Absence of Chlamydia-specific T(H)2 immunity in these mice newly highlights the need to identify experimental models of C. trachomatis genital infection that more closely recapitulate the human host response.	[Miguel, Rodolfo D. Vicetti; Calla, Nirk E. Quispe; Pavelko, Stephen D.; Cherpes, Thomas L.] Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA; [Cherpes, Thomas L.] Ohio State Univ, Coll Med, Dept Obstet & Gynecol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University	Miguel, RDV (corresponding author), Ohio State Univ, Coll Med, Dept Microbial Infect & Immun, Columbus, OH 43210 USA.	vicettimiguel.1@osu.edu	Miguel, Rodolfo D Vicetti/H-8651-2019; Quispe Calla, Nirk/B-8621-2018	Miguel, Rodolfo D Vicetti/0000-0002-2494-8184; Quispe Calla, Nirk/0000-0001-8829-4549	Ohio State University College of Medicine; NIH/NCI [P30 CA016058]; NATIONAL CANCER INSTITUTE [P30CA016058] Funding Source: NIH RePORTER	Ohio State University College of Medicine(Ohio State University); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding was provided by The Ohio State University College of Medicine. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Authors appreciate support provided by The Ohio State University's Comparative Pathology and Mouse Phenotyping Shared Resource (supported by grant P30 CA016058 from the NIH/NCI), Micro-imaging Lab (a component of the Wright Center of Innovation in Biomedical Imaging), and University Laboratory Animal Resources, the financial support provided by The Ohio State University College of Medicine, and the professional guidance provided by Ann E. Thompson.	Andrew DW, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076664; Batteiger B. E., 2014, MANDELL DOUGLAS BENN, P2154; Bernstein-Hanley I, 2006, GENES IMMUN, V7, P122, DOI 10.1038/sj.gene.6364285; Brunham RC, 2005, J INFECT DIS, V192, P1836, DOI 10.1086/497341; Brunham RC, 2005, NAT REV IMMUNOL, V5, P149, DOI 10.1038/nri1551; Brunham RC, 2015, SCIENCE, V348, P1322, DOI 10.1126/science.aac6528; Brunham RC, 2015, NEW ENGL J MED, V372, P2039, DOI 10.1056/NEJMra1411426; Cochrane M, 2010, FUTURE MICROBIOL, V5, P1833, DOI [10.2217/fmb.10.148, 10.2217/FMB.10.148]; Coers J, 2008, J IMMUNOL, V180, P6237, DOI 10.4049/jimmunol.180.9.6237; De Clercq E, 2013, INFECT IMMUN, V81, P3060, DOI 10.1128/IAI.00357-13; Dirks JAMC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121433; Dong XH, 2014, INFECT IMMUN, V82, P1833, DOI 10.1128/IAI.01668-13; Gondek DC, 2012, J IMMUNOL, V189, P2441, DOI 10.4049/jimmunol.1103032; Gottlieb SL, 2010, J INFECT DIS, V201, pS190, DOI 10.1086/652401; Harris SR, 2012, NAT GENET, V44, P413, DOI 10.1038/ng.2214; ITO JI, 1984, J INFECT DIS, V150, P577, DOI 10.1093/infdis/150.4.577; Lena S, 2005, J INFECT DIS, V191, pS78, DOI 10.1086/425289; Lyons Joseph M., 2005, Journal of Microbiology Immunology and Infection, V38, P383; Marks E, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001179; Medzhitov R, 2012, SCIENCE, V335, P936, DOI 10.1126/science.1214935; Miguel RDV, 2015, J MICROBIOL METH, V119, P79, DOI 10.1016/j.mimet.2015.10.003; Miguel RDV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058565; Miguel RDV, 2012, MED HYPOTHESES, V79, P713, DOI 10.1016/j.mehy.2012.07.032; Miguel RDV, 2012, AM J REPROD IMMUNOL, V68, P499, DOI 10.1111/aji.12008; Miguel RDV, 2012, J IMMUNOL METHODS, V384, P191, DOI 10.1016/j.jim.2012.07.018; Miguel RDV, 2012, J IMMUNOL, V189, P3449, DOI 10.4049/jimmunol.1103054; Morre SA, 2000, INFECT IMMUN, V68, P7209, DOI 10.1128/IAI.68.12.7209-7211.2000; Morrison RP, 2002, INFECT IMMUN, V70, P2741, DOI 10.1128/IAI.70.6.2741-2751.2002; MORRISON RP, 1995, INFECT IMMUN, V63, P4661, DOI 10.1128/IAI.63.12.4661-4668.1995; Morrison SG, 2000, INFECT IMMUN, V68, P6979, DOI 10.1128/IAI.68.12.6979-6987.2000; Olsen AW, 2015, J INFECT DIS; Peipert JF, 2003, NEW ENGL J MED, V349, P2424, DOI 10.1056/NEJMcp030542; Raberg L, 2007, SCIENCE, V318, P812, DOI 10.1126/science.1148526; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Soares MP, 2014, TRENDS IMMUNOL, V35, P483, DOI 10.1016/j.it.2014.08.001; Stary G, 2015, SCIENCE, V348, DOI 10.1126/science.aaa8205; VanVoorhis WC, 1997, INFECT IMMUN, V65, P2175, DOI 10.1128/IAI.65.6.2175-2182.1997; Vasilevsky S, 2014, CLIN MICROBIOL REV, V27, P346, DOI 10.1128/CMR.00105-13; Wang SH, 1999, EUR J IMMUNOL, V29, P3782, DOI 10.1002/(SICI)1521-4141(199911)29:11<3782::AID-IMMU3782>3.0.CO;2-B; Yeruva L, 2013, PATHOG DIS, V68, P88, DOI 10.1111/2049-632X.12052; Yu H, 2014, VACCINE, V32, P4672, DOI 10.1016/j.vaccine.2014.06.002; Yu H, 2011, J IMMUNOL, V186, P3615, DOI 10.4049/jimmunol.1002952	42	27	27	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162445	10.1371/journal.pone.0162445	http://dx.doi.org/10.1371/journal.pone.0162445			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606424	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255600046
J	Yang, QZ; Wang, F; Rao, JP				Yang, Qingzhen; Wang, Feng; Rao, Jingping			Effect of Putrescine Treatment on Chilling Injury, Fatty Acid Composition and Antioxidant System in Kiwifruit	PLOS ONE			English	Article							LOW-TEMPERATURE STORAGE; ETHYLENE BIOSYNTHESIS; BREAKDOWN INCIDENCE; HYDROGEN-PEROXIDE; HEAT-TREATMENT; ASCORBIC-ACID; FRUIT-QUALITY; POLYAMINES; TOLERANCE; GLUTATHIONE	We investigated the effects of different concentrations (0, 1, 2 and 4 mM) of putrescine on chilling injury, fruit quality, ethylene production rate, fatty acid composition and the antioxidant system of cold-stored kiwifruit (Actinidia chinensis Planch. var. chinensis 'Hongyang'). We achieved a significant decrease in ethylene production, maintained fruit quality and alleviated chilling injury during storage via treatment with 2 mM putrescine. Furthermore, putrescine treatment inhibited increases in superoxide anion production rate and H2O2 concentration, while maintaining higher membrane lipid unsaturation as well as increased activities of superoxide dismutase and catalase. In addition, putrescine treatment enhanced the activities of antioxidant enzymes related to the ascorbate-glutathione cycle while causing higher levels of ascorbic acid and reduced glutathione. Our results suggest that induced tolerance against chilling injury via putrescine treatment in cold-stored kiwifruit may be due to enhanced antioxidant activity, increased unsaturation of membrane lipids, and inhibited ethylene production.	[Yang, Qingzhen; Rao, Jingping] Northwest A&F Univ, Coll Hort, Yangling 712100, Shaanxi, Peoples R China; [Yang, Qingzhen; Wang, Feng] Yuncheng Univ, Dept Life Sci, Yuncheng 044000, Shanxi Province, Peoples R China	Northwest A&F University - China; Yuncheng University	Rao, JP (corresponding author), Northwest A&F Univ, Coll Hort, Yangling 712100, Shaanxi, Peoples R China.	raojingpingxn@163.com			National Science and Technology Pillar Program during the Twelfth Five-year Plan Period of China [2015BAD16B03]	National Science and Technology Pillar Program during the Twelfth Five-year Plan Period of China	This research was supported by the National Science and Technology Pillar Program (No. 2015BAD16B03) during the Twelfth Five-year Plan Period of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBI H, 1984, METHOD ENZYMOL, V105, P121; Aghdam MS, 2013, SCI HORTIC-AMSTERDAM, V156, P73, DOI 10.1016/j.scienta.2013.03.028; ARPAIA ML, 1985, J AM SOC HORTIC SCI, V110, P200; Barman K, 2011, SCI HORTIC-AMSTERDAM, V130, P795, DOI 10.1016/j.scienta.2011.09.005; Ben-Amor M, 1999, PLANT CELL ENVIRON, V22, P1579, DOI 10.1046/j.1365-3040.1999.00509.x; Burdon J, 2014, POSTHARVEST BIOL TEC, V94, P41, DOI 10.1016/j.postharvbio.2014.03.005; Cao SF, 2011, FOOD CHEM, V127, P1777, DOI 10.1016/j.foodchem.2011.02.059; Cao SF, 2009, J AGR FOOD CHEM, V57, P8439, DOI 10.1021/jf902114y; CASTILLO FJ, 1988, ENVIRON EXP BOT, V28, P231, DOI 10.1016/0098-8472(88)90033-0; Cheng SC, 2015, POSTHARVEST BIOL TEC, V109, P130, DOI 10.1016/j.postharvbio.2015.05.012; DHINDSA RS, 1981, J EXP BOT, V32, P93, DOI 10.1093/jxb/32.1.93; EDWARDS EA, 1990, PLANTA, V180, P278, DOI 10.1007/BF00194008; Gerasopoulos D, 2005, POSTHARVEST BIOL TEC, V36, P303, DOI 10.1016/j.postharvbio.2005.01.005; KAMPFENKEL K, 1995, ANAL BIOCHEM, V225, P165, DOI 10.1006/abio.1995.1127; Khan AS, 2007, POSTHARVEST BIOL TEC, V46, P36, DOI 10.1016/j.postharvbio.2007.03.018; Khosroshahi Mohammad Reza Zokaee, 2008, International Journal of Postharvest Technology and Innovation, V1, P278, DOI 10.1504/IJPTI.2008.021462; Ma QS, 2014, POSTHARVEST BIOL TEC, V97, P102, DOI 10.1016/j.postharvbio.2014.05.018; MARRE E, 1958, BIOCHIM BIOPHYS ACTA, V30, P453, DOI 10.1016/0006-3002(58)90089-1; Martínez-Téllez M. A., 2008, Rev. Chapingo Ser.Hortic, V14, P243; Martinez-Tellez MA, 2002, BIOCHEM BIOPH RES CO, V295, P98, DOI 10.1016/S0006-291X(02)00631-9; Maul P, 2008, PLANT CELL ENVIRON, V31, P752, DOI 10.1111/j.1365-3040.2008.01793.x; Mirdehghan SH, 2007, POSTHARVEST BIOL TEC, V44, P26, DOI 10.1016/j.postharvbio.2006.11.010; Mirdehghan SH, 2007, POSTHARVEST BIOL TEC, V44, P19, DOI 10.1016/j.postharvbio.2006.11.001; Murshed R, 2014, PHYSIOL MOL BIOL PLA, V20, P15, DOI 10.1007/s12298-013-0209-z; NAKANO Y, 1981, PLANT CELL PHYSIOL, V22, P867; Noctor G, 1998, ANNU REV PLANT PHYS, V49, P249, DOI 10.1146/annurev.arplant.49.1.249; PATTERSON BD, 1984, ANAL BIOCHEM, V139, P487, DOI 10.1016/0003-2697(84)90039-3; Qiao Yongjin, 2006, Food Science, China, V27, P246; Rui HJ, 2010, J SCI FOOD AGR, V90, P1557, DOI 10.1002/jsfa.3993; Saba MK, 2012, J AGR FOOD CHEM, V60, P8947, DOI 10.1021/jf302088e; Sfakiotakis E, 2005, POSTHARVEST BIOL TEC, V38, P169, DOI 10.1016/j.postharvbio.2005.06.010; Shen WY, 2000, PLANT PHYSIOL, V124, P431, DOI 10.1104/pp.124.1.431; Singh SP, 2013, INT J FOOD SCI TECH, V48, P363, DOI 10.1111/j.1365-2621.2012.03196.x; SMITH TA, 1985, ANNU REV PLANT PHYS, V36, P117, DOI 10.1146/annurev.pp.36.060185.001001; Song LL, 2009, FOOD CHEM, V114, P1216, DOI 10.1016/j.foodchem.2008.10.080; Walden R, 1997, PLANT PHYSIOL, V113, P1009, DOI 10.1104/pp.113.4.1009; Wang A. G., 1990, PLANT PHYSL COMMUN, V6, P55; Wang Q, 2012, SCI HORTIC-AMSTERDAM, V144, P195, DOI 10.1016/j.scienta.2012.07.018; Wongsheree T, 2009, POSTHARVEST BIOL TEC, V51, P91, DOI 10.1016/j.postharvbio.2008.05.015; Yang QZ, 2013, J SCI FOOD AGR, V93, P3691, DOI 10.1002/jsfa.6195; Yang QZ, 2012, HORTIC ENVIRON BIOTE, V53, P505, DOI 10.1007/s13580-012-0101-8; Zhang ZK, 2010, HORTSCIENCE, V45, P1713, DOI 10.21273/HORTSCI.45.11.1713	42	30	32	5	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162159	10.1371/journal.pone.0162159	http://dx.doi.org/10.1371/journal.pone.0162159			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607076	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600023
J	Tanaka, A; Furubayashi, T; Matsushita, A; Inoue, D; Kimura, S; Katsumi, H; Sakane, T; Yamamoto, A				Tanaka, Akiko; Furubayashi, Tomoyuki; Matsushita, Akifumi; Inoue, Daisuke; Kimura, Shunsuke; Katsumi, Hidemasa; Sakane, Toshiyasu; Yamamoto, Akira			Nasal Absorption of Macromolecules from Powder Formulations and Effects of Sodium Carboxymethyl Cellulose on Their Absorption	PLOS ONE			English	Article							IN-VITRO EVALUATION; DRUG-DELIVERY; INSULIN; MUCOADHESIVE; IMPROVEMENT; SUSPENSION	The nasal absorption of macromolecules from powder formulations and the effect of sodium carboxymethyl cellulose (CMC-Na) as a pharmaceutical excipient on their absorption were studied. Model macromolecules were fluorescein isothiocyanate-labeled dextran (average molecular weight of 4.4kDa, FD4) and insulin. The plasma concentration of FD4 after application of the powder containing 50% starch (control) was higher than that after application of the solution, and the absorption from 50% starch powder was enhanced by the substitution of starch with CMC-Na. The fractional absorption of FD4 after administration of the CMC-Na powder formulation was 30% and 40% higher than that after administration from the solution and the starch powder, respectively. The nasal absorption of insulin from the powder and the effect of CMC-Na were similar with those of FD4. The effective absorption of FD4 and insulin after application of powder with CMC-Na could be due to the increase in the nasal residence of FD4 and insulin. No damage in the nasal mucosa or dysfunction of the mucociliary clearance was observed after application of the drug powder and CMC-Na. The present findings indicate that nasal delivery of powder formulations with the addition of CMC-Na as an excipient is a promising approach for improving the nasal absorption of macromolecules.	[Tanaka, Akiko; Matsushita, Akifumi; Katsumi, Hidemasa; Sakane, Toshiyasu; Yamamoto, Akira] Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina, Kyoto 6078414, Japan; [Furubayashi, Tomoyuki; Inoue, Daisuke] Shujitsu Univ, Sch Pharm, Kita Ku, Nishikawara, Okayama 7038516, Japan; [Kimura, Shunsuke] Doshisha Womens Coll Liberal Arts, Fac Pharmaceut Sci, Kyotanabe, Kyoto 6100395, Japan; [Sakane, Toshiyasu] Kobe Pharmaceut Univ, Dept Pharmaceut Technol, Higashinada Ku, Motoyamakita Machi 4-19-1, Kobe, Hyogo 6588558, Japan	Kyoto Pharmaceutical University; Kobe Pharmaceutical University	Sakane, T (corresponding author), Kyoto Pharmaceut Univ, Dept Biopharmaceut, Yamashina, Kyoto 6078414, Japan.; Sakane, T (corresponding author), Kobe Pharmaceut Univ, Dept Pharmaceut Technol, Higashinada Ku, Motoyamakita Machi 4-19-1, Kobe, Hyogo 6588558, Japan.	sakane@mb.kyoto-phu.ac.jp		Inoue, Daisuke/0000-0003-0219-4331				Dong ZQ, 2011, J PHARM SCI-US, V100, P1866, DOI 10.1002/jps.22428; du Plessis LH, 2010, INT J PHARMACEUT, V385, P181, DOI 10.1016/j.ijpharm.2009.10.031; Fetih G, 2005, J CONTROL RELEASE, V106, P287, DOI 10.1016/j.jconrel.2005.05.017; Harris AS, 1993, J DRUG TARGET, V1, P101, DOI 10.3109/10611869308996066; He L, 2007, J CONTROL RELEASE, V122, P94, DOI 10.1016/j.jconrel.2007.06.017; HIRAI S, 1981, INT J PHARM, V7, P317; HUSSAIN AA, 1979, J PHARM SCI, V68, P1196, DOI 10.1002/jps.2600680942; Inoue D, 2013, BIOL PHARM BULL, V36, P966, DOI 10.1248/bpb.b12-01076; Irifune M, 1999, Auris Nasus Larynx, V26, P49, DOI 10.1016/S0385-8146(98)00062-5; Ishikawa F, 2002, PHARM RES-DORDR, V19, P1097, DOI 10.1023/A:1019881706159; Ishikawa F, 2001, INT J PHARM, V224, P105, DOI 10.1016/S0378-5173(01)00736-0; Krug N, 2005, ALLERGY, V60, P354, DOI 10.1111/j.1398-9995.2005.00703.x; Li M, 2016, MOL PHARMACEUT, V13, P885, DOI 10.1021/acs.molpharmaceut.5b00802; LIU FY, 1993, PHARMACEUT RES, V10, P228, DOI 10.1023/A:1018934810512; Lu HT, 2011, XENOBIOTICA, V41, P567, DOI 10.3109/00498254.2011.563877; Makidon PE, 2010, J AEROSOL MED PULM D, V23, P77, DOI 10.1089/jamp.2009.0766; Marttin E, 1998, ADV DRUG DELIVER REV, V29, P13, DOI 10.1016/S0169-409X(97)00059-8; Merchant HA, 2006, AAPS PHARMSCITECH, V7, DOI 10.1208/pt070378; OKUDA M, 1986, Rhinology (Utrecht), V24, P113; Pennington J, 2008, DRUG DEV IND PHARM, V34, P923, DOI [10.1080/03639040802149046, 10.1080/03639040802149046 ]; Rajendran NN, 2011, INT J PHARM SCI RES, V2, P3136; SATIR P, 1990, ANNU REV PHYSIOL, V52, P137, DOI 10.1146/annurev.ph.52.030190.001033; SCHIPPER NGM, 1991, PHARMACEUT RES, V8, P807, DOI 10.1023/A:1015830907632; SLEIGH MA, 1988, AM REV RESPIR DIS, V137, P726, DOI 10.1164/ajrccm/137.3.726; Tozaki H, 1997, J PHARM SCI, V86, P1016, DOI 10.1021/js970018g; Ugwoke MI, 2005, ADV DRUG DELIVER REV, V57, P1640, DOI 10.1016/j.addr.2005.07.009; Wang YX, 2014, NANOMEDICINE-UK, V9, P451, DOI [10.2217/nnm.13.102, 10.2217/NNM.13.102]; YAMAMOTO A, 1994, PHARMACEUT RES, V11, P1496, DOI 10.1023/A:1018968611962	28	14	15	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0159150	10.1371/journal.pone.0159150	http://dx.doi.org/10.1371/journal.pone.0159150			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598527	Green Submitted, gold, Green Published			2022-12-26	WOS:000383254800001
J	Vasco, G; Gazzellini, S; Petrarca, M; Lispi, ML; Pisano, A; Zazza, M; Della Bella, G; Castelli, E; Bertini, E				Vasco, Gessica; Gazzellini, Simone; Petrarca, Maurizio; Lispi, Maria Luisa; Pisano, Alessandra; Zazza, Marco; Della Bella, Gessica; Castelli, Enrico; Bertini, Enrico			Functional and Gait Assessment in Children and Adolescents Affected by Friedreich's Ataxia: A One-Year Longitudinal Study	PLOS ONE			English	Article							CLINICAL-FEATURES; DISEASE SEVERITY; PROGRESSION; VARIABILITY; IDEBENONE; HYPERTROPHY; PARAMETERS; BALANCE; SCALE	Friedreich's ataxia is the most common autosomal recessive form of neurodegenerative ataxia. We present a longitudinal study on the gait pattern of children and adolescents affected by Friedreich's ataxia using Gait Analysis and the Scale for the Assessment and Rating of Ataxia (SARA). We assessed the spectrum of changes over 12 months of the gait characteristics and the relationship between clinical and instrumental evaluations. We enrolled 11 genetically confirmed patients affected by Friedreich's ataxia in this study together with 13 normally developing age-matched subjects. Eight patients completed a 12-month follow-up under the same protocol. By comparing the gait parameters of Friedreich's ataxia with the control group, we found significant differences for some relevant indexes. In particular, the increased knee and ankle extension in stance revealed a peculiar bio-mechanical pattern, which correlated reliably with SARA Total, Gait and Sitting scores. The knee pattern showed its consistency also at the follow-up: Knee extension increased from 6.8 +/- 3.5 degrees to -0.5 +/- 3.7 degrees and was significantly correlated with the SARA total score. This feature anticipated the loss of the locomotor function in two patients. In conclusion, our findings demonstrate that the selective and segmental analysis of kinetic/kinematic features of ataxic gait, in particular the behavior of the knee, provides sensitive measures to detect specific longitudinal and functional alterations, more than the SARA scale, which however has proved to be a reliable and practical assessment tool. Functional outcomes measures integrated by instrumental evaluation increase their sensitivity, reliability and suitability for the follow-up of the disease progression and for the application in clinical trials and in rehabilitative programs.	[Vasco, Gessica; Gazzellini, Simone; Petrarca, Maurizio; Lispi, Maria Luisa; Pisano, Alessandra; Della Bella, Gessica; Castelli, Enrico] IRCCS Bambino Gesu Childrens Hosp, Movement Anal & Robot Lab MARLab, Neurorehabil Unit, Dept Neurosci, Rome, Italy; [Vasco, Gessica; Bertini, Enrico] IRCCS Bambino Gesu Childrens Hosp, Dept Neurosci, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy; [Zazza, Marco] Bambino Gesu Pediat Hosp, IRCCS, Dept Neurosci, Neurol Unit, Rome, Italy	IRCCS Bambino Gesu; IRCCS Bambino Gesu; IRCCS Bambino Gesu	Vasco, G (corresponding author), IRCCS Bambino Gesu Childrens Hosp, Movement Anal & Robot Lab MARLab, Neurorehabil Unit, Dept Neurosci, Rome, Italy.; Vasco, G (corresponding author), IRCCS Bambino Gesu Childrens Hosp, Dept Neurosci, Unit Neuromuscular & Neurodegenerat Disorders, Rome, Italy.	gessica.vasco@opbg.net	Petrarca, Maurizio/B-4181-2019; Gazzellini, Simone/AAC-2721-2019; Bertini, Enrico/ABG-1278-2020; bella, gessica della/AAA-8011-2020; Petrarca, Maurizio/GWZ-3714-2022; Bertini, Enrico/A-2284-2014	bella, gessica della/0000-0002-7160-0092; Petrarca, Maurizio/0000-0002-7330-3569; Bertini, Enrico/0000-0001-9276-4590	Italian Ministry of Health [201501X003626]	Italian Ministry of Health(Ministry of Health, Italy)	MP reports research funding from the Italian Ministry of Health (Grant number 201501X003626). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bastian AJ, 2006, CURR OPIN NEUROBIOL, V16, P645, DOI 10.1016/j.conb.2006.08.016; BECK RJ, 1981, J BONE JOINT SURG AM, V63, P1452, DOI 10.2106/00004623-198163090-00012; Bell KJ, 2002, J PEDIATR ORTHOPED, V22, P677, DOI 10.1097/00004694-200209000-00020; Brandsma R, 2014, DEV MED CHILD NEUROL, V56, P556, DOI 10.1111/dmcn.12369; Burk K, 2013, J NEUROCHEM, V126, P118, DOI 10.1111/jnc.12318; Campuzano V, 1996, SCIENCE, V271, P1423, DOI 10.1126/science.271.5254.1423; Croarkin E, 2009, J NEUROL PHYS THER, V33, P144, DOI 10.1097/NPT.0b013e3181b5112e; Delatycki MB, 2012, J CHILD NEUROL, V27, P1133, DOI 10.1177/0883073812448230; Delatycki MB, 2009, J NEUROL, V256, P36, DOI 10.1007/s00415-009-1007-y; Friedman LS, 2010, MOVEMENT DISORD, V25, P426, DOI 10.1002/mds.22912; Gouelle A, 2013, GAIT POSTURE, V38, P461, DOI 10.1016/j.gaitpost.2013.01.013; HARDING AE, 1981, BRAIN, V104, P589, DOI 10.1093/brain/104.3.589; Hausse AO, 2002, HEART, V87, P346, DOI 10.1136/heart.87.4.346; Ilg W, 2008, BRAIN, V131, P2913, DOI 10.1093/brain/awn246; Ilg W, 2007, BRAIN, V130, P786, DOI 10.1093/brain/awl376; Klopstock T, 1999, ACTA NEUROPATHOL, V97, P139, DOI 10.1007/s004010050966; Koeppen AH, 2013, J NEUROPATH EXP NEUR, V72, P78, DOI 10.1097/NEN.0b013e31827e5762; Marelli C, 2012, MOVEMENT DISORD, V27, P135, DOI 10.1002/mds.23879; Milne SC, 2014, CEREBELLUM, V13, P677, DOI 10.1007/s12311-014-0583-2; Mitoma H, 2000, J NEUROL SCI, V174, P22, DOI 10.1016/S0022-510X(99)00329-9; Morton SM, 2003, J NEUROPHYSIOL, V89, P1844, DOI 10.1152/jn.00787.2002; Morton SM, 2010, MOVEMENT DISORD, V25, P1944, DOI 10.1002/mds.23169; Palliyath S, 1998, MOVEMENT DISORD, V13, P958, DOI 10.1002/mds.870130616; Pandolfo M, 2009, J NEUROL, V256, P3, DOI 10.1007/s00415-009-1002-3; Parkinson MH, 2013, J NEUROCHEM, V126, P103, DOI 10.1111/jnc.12317; Patla AE, 2003, IEEE ENG MED BIOL, V22, P48, DOI 10.1109/MEMB.2003.1195695; Perry J, 2010, GAIT ANALYSIS: NORMAL AND PATHOLOGICAL FUNCTION, SECOND EDITION, P1; Pineda M, 2008, EUR J PAEDIATR NEURO, V12, P470, DOI 10.1016/j.ejpn.2007.11.006; Rustin P, 2002, FREE RADICAL RES, V36, P467, DOI 10.1080/10715760290021333; Schiff M, 2016, BRAIN, V139, DOI 10.1093/brain/aww085; Schmitz-Hubsch T, 2006, NEUROLOGY, V66, P1717, DOI 10.1212/01.wnl.0000219042.60538.92; Schniepp R, 2014, J NEUROL, V261, P213, DOI 10.1007/s00415-013-7189-3; Schniepp R, 2012, MOVEMENT DISORD, V27, P125, DOI 10.1002/mds.23978; Serrao M, 2012, CEREBELLUM, V11, P194, DOI 10.1007/s12311-011-0296-8; Stolze H, 2002, J NEUROL NEUROSUR PS, V73, P310, DOI 10.1136/jnnp.73.3.310; Tai G, 2015, J NEUROL NEUROSUR PS, V86, P660, DOI 10.1136/jnnp-2014-308022	36	16	16	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162463	10.1371/journal.pone.0162463	http://dx.doi.org/10.1371/journal.pone.0162463			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598307	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800067
J	Kim, HS; Jung, M; Choi, SK; Moon, WK; Kim, SJ				Kim, Hoe Suk; Jung, Minji; Choi, Sul Ki; Moon, Woo Kyung; Kim, Seung Ja			Different Biological Action of Oleic Acid in ALDH(high) and ALDH(low) Subpopulations Separated from Ductal Carcinoma In Situ of Breast Cancer	PLOS ONE			English	Article							FATTY-ACID; STEM-CELLS; PROLIFERATION; ACTIVATION; MARKERS; PROGRESSION; LIPOGENESIS; METABOLISM; EXPRESSION; APOPTOSIS	The mechanisms underlying breast cancer progression of ductal carcinoma in situ (DCIS) associated with fatty acids are largely unknown. In the present study, we compared the action of oleic acid (OA) on two human DCIS cell lines, MCF10DCIS. COM (ER/PR/HER2-negative) and SUM225 (HER2 overexpressed). OA led to a significant increase in proliferation, migration, lipid accumulation and the expression of lipogenic proteins, such as SREBP-1, FAS and ACC-1, in MCF10DCIS. COM cells but not SUM225 cells. The ALDH(high) subpopulation analyzed by the ALDEFLUOR assay was approximately 39.2 +/- 5.3% of MCF10DCIS. COM cells but was small (3.11 +/- 0.9%) in SUM225 cells. We further investigated the different biological action of OA in the distinct ALDH(low) and ALDH(high) subpopulations of MCF10DCIS. COM cells. OA led to an increase in the expression of ALDH1A1, ALDH1A2 and ALDH1A3 in MCF10DCIS. COM cells. SREBP-1 and ACC-1 were highly expressed in ALDH(high) cells relative to ALDH(low) cells, whereas FAS was higher in ALDH(low) cells. In the presence of OA, ALDH(high) cells were more likely to proliferate and migrate and displayed significantly high levels of SREBP-1 and FAS and strong phosphorylation of FAK and AKT relative to ALDH(low) cells. This study suggests that OA could be a critical risk factor to promote the proliferation and migration of ALDH(high) cells in DCIS, leading to breast cancer progression.	[Kim, Hoe Suk; Jung, Minji; Moon, Woo Kyung] Seoul Natl Univ Hosp, Dept Radiol, 101 Daehak Ro, Seoul, South Korea; [Choi, Sul Ki; Moon, Woo Kyung] Seoul Natl Univ, Coll Med, Dept Biomed Sci, 101 Daehak Ro, Seoul, South Korea; [Kim, Seung Ja] Sheikh Khalifa Specialty Hosp, Dept Radiol, Abu Dhabi, U Arab Emirates	Seoul National University (SNU); Seoul National University Hospital; Seoul National University (SNU)	Moon, WK (corresponding author), Seoul Natl Univ Hosp, Dept Radiol, 101 Daehak Ro, Seoul, South Korea.; Moon, WK (corresponding author), Seoul Natl Univ, Coll Med, Dept Biomed Sci, 101 Daehak Ro, Seoul, South Korea.; Kim, SJ (corresponding author), Sheikh Khalifa Specialty Hosp, Dept Radiol, Abu Dhabi, U Arab Emirates.	moonwk@snu.ac.kr; winnerkim89@gmail.com			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology [2013R1A1A2009043]; SNUH Research Fund [03-2013-0060]; Brain Korea 21 (BK21) program	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education, Science and Technology; SNUH Research Fund; Brain Korea 21 (BK21) program(Ministry of Education & Human Resources Development (MOEHRD), Republic of Korea)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF, http://www.nrf.re.kr/) funded by the Ministry of Education, Science and Technology (2013R1A1A2009043) and partly supported by grant no. 03-2013-0060 from the SNUH Research Fund (http://www.snuh.org/). Suk Ki Choi is the recipient of a fellowship from the Brain Korea 21 (BK21) program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ballehaninna UK, 2011, J CLIN ONCOL, V29, pE97, DOI 10.1200/JCO.2010.32.6850; Behbod F, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2358; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Charafe-Jauffret E, 2010, CLIN CANCER RES, V16, P45, DOI 10.1158/1078-0432.CCR-09-1630; Croker AK, 2012, BREAST CANCER RES TR, V133, P75, DOI 10.1007/s10549-011-1692-y; Currie MJ, 2013, HUM PATHOL, V44, P402, DOI 10.1016/j.humpath.2012.06.004; Fay MP, 1997, CANCER RES, V57, P3979; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Guo DL, 2014, CURR PHARM DESIGN, V20, P2619, DOI 10.2174/13816128113199990486; Hardy S, 2000, CANCER RES, V60, P6353; Hardy S, 2003, J BIOL CHEM, V278, P31861, DOI 10.1074/jbc.M300190200; Hardy S, 2005, J BIOL CHEM, V280, P13285, DOI 10.1074/jbc.M410922200; Knudsen ES, 2013, CELL CYCLE, V12, P2042, DOI 10.4161/cc.25065; Kunju LP, 2011, MODERN PATHOL, V24, P786, DOI 10.1038/modpathol.2011.8; Lee MM, 2000, ANNU REV NUTR, V20, P221, DOI 10.1146/annurev.nutr.20.1.221; Li S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097330; Liu ZH, 2013, ONCOL LETT, V5, P1395, DOI 10.3892/ol.2013.1160; MacLennan M, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2646; Menendez JA, 2005, ANN ONCOL, V16, P359, DOI 10.1093/annonc/mdi090; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Muggerud AA, 2010, MOL ONCOL, V4, P357, DOI 10.1016/j.molonc.2010.06.007; Navarro-Tito N, 2010, INT J BIOCHEM CELL B, V42, P306, DOI 10.1016/j.biocel.2009.11.010; Ou JF, 2001, P NATL ACAD SCI USA, V98, P6027, DOI 10.1073/pnas.111138698; Pala V, 2001, J NATL CANCER I, V93, P1088, DOI 10.1093/jnci/93.14.1088; Pandey PR, 2013, ONCOGENE, V32, P5111, DOI 10.1038/onc.2012.519; Pape-Zambito D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100488; Park SY, 2010, CLIN CANCER RES, V16, P876, DOI 10.1158/1078-0432.CCR-09-1532; Porter D, 2003, MOL CANCER RES, V1, P362; Shekhar MPV, 2013, ONCOTARGET, V4, P231, DOI 10.18632/oncotarget.818; Soto-Guzman A, 2008, MOL CELL ENDOCRINOL, V294, P81, DOI 10.1016/j.mce.2008.08.003; Soto-Guzman A, 2013, PROSTAG LEUKOTR ESS, V88, P243, DOI 10.1016/j.plefa.2012.12.003; Soto-Guzman A, 2010, CLIN EXP METASTAS, V27, P505, DOI 10.1007/s10585-010-9340-1; Swinnen JV, 2006, CURR OPIN CLIN NUTR, V9, P358, DOI 10.1097/01.mco.0000232894.28674.30; Tait LR, 2007, INT J CANCER, V120, P2127, DOI 10.1002/ijc.22572; Tsukabe M, 2013, ONCOLOGY-BASEL, V85, P248, DOI 10.1159/000355476; Virnig BA, 2010, J NATL CANCER I, V102, P170, DOI 10.1093/jnci/djp482; Zhong Y, 2013, CANCER CELL INT, V13, DOI 10.1186/1475-2867-13-60	38	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0160835	10.1371/journal.pone.0160835	http://dx.doi.org/10.1371/journal.pone.0160835			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589390	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877800005
J	Lu, ZM; Li, XF				Lu, Zhe-Ming; Li, Xin-Feng			Attack Vulnerability of Network Controllability	PLOS ONE			English	Article							COMPLEX NETWORKS; RANDOM-WALKS; SYNCHRONIZATION; DYNAMICS; ROBUSTNESS; EVOLUTION	Controllability of complex networks has attracted much attention, and understanding the robustness of network controllability against potential attacks and failures is of practical significance. In this paper, we systematically investigate the attack vulnerability of network controllability for the canonical model networks as well as the real-world networks subject to attacks on nodes and edges. The attack strategies are selected based on degree and betweenness centralities calculated for either the initial network or the current network during the removal, among which random failure is as a comparison. It is found that the node-based strategies are often more harmful to the network controllability than the edge-based ones, and so are the recalculated strategies than their counterparts. The Barabasi-Albert scale-free model, which has a highly biased structure, proves to be the most vulnerable of the tested model networks. In contrast, the Erdos-Renyi random model, which lacks structural bias, exhibits much better robustness to both node-based and edge-based attacks. We also survey the control robustness of 25 real-world networks, and the numerical results show that most real networks are control robust to random node failures, which has not been observed in the model networks. And the recalculated betweenness-based strategy is the most efficient way to harm the controllability of real-world networks. Besides, we find that the edge degree is not a good quantity to measure the importance of an edge in terms of network controllability.	[Lu, Zhe-Ming; Li, Xin-Feng] Zhejiang Univ, Sch Aeronaut & Astronaut, Hangzhou, Zhejiang, Peoples R China	Zhejiang University	Lu, ZM (corresponding author), Zhejiang Univ, Sch Aeronaut & Astronaut, Hangzhou, Zhejiang, Peoples R China.	zheminglu@zju.edu.cn						Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; [Anonymous], [No title captured], DOI DOI 10.1103/PhysRevE.69.066133; [Anonymous], 1991, APPL NONLINEAR CONTR; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Balaji S, 2006, J MOL BIOL, V360, P213, DOI 10.1016/j.jmb.2006.04.029; Banerjee SJ, 2012, ARXIV12093737; Batagelj V., 2006, PAJEK DATASETS; Bechhoefer J, 2005, REV MOD PHYS, V77, P783, DOI 10.1103/RevModPhys.77.783; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Boguna M, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.047104; Brandes U, 2007, INT J BIFURCAT CHAOS, V17, P2303, DOI 10.1142/S0218127407018403; Caldarelli G., 2007, SCALE FREE NETWORKS; Christian RR, 1999, ECOL MODEL, V117, P99, DOI 10.1016/S0304-3800(99)00022-8; Cross R., 2004, HIDDEN POWER SOCIAL; Dorogovtsev S. N., 2013, EVOLUTION NETWORKS B; Dunne JA, 2002, P NATL ACAD SCI USA, V99, P12917, DOI 10.1073/pnas.192407699; ERDOS P, 1960, B INT STATIST INST, V38, P343; GABOW HN, 1976, J ACM, V23, P221, DOI 10.1145/321941.321942; Gonzalez MC, 2004, INT J MOD PHYS C, V15, P45, DOI 10.1142/S0129183104005577; HAUTUS MLJ, 1969, P K NED AKAD A MATH, V72, P443; Holme P, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.026107; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kalman R. E., 1963, SIAM J CONTROL     A, V1, P152, DOI [DOI 10.1137/0301010, 10.1137/0301010]; LIN CT, 1974, IEEE T AUTOMAT CONTR, VAC19, P201, DOI 10.1109/TAC.1974.1100557; Liu B, 2008, IEEE T AUTOMAT CONTR, V53, P1009, DOI 10.1109/TAC.2008.919548; Liu YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044459; Liu YY, 2011, NATURE, V473, P167, DOI 10.1038/nature10011; Lombardi A, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.056110; Luenberger D. G., 1979, INTRO DYNAMIC SYSTEM; MARTINEZ ND, 1991, ECOL MONOGR, V61, P367, DOI 10.2307/2937047; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Milo R, 2004, SCIENCE, V303, P1538, DOI 10.1126/science.1089167; Milo R, 2002, SCIENCE, V298, P824, DOI 10.1126/science.298.5594.824; Moreno Y, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.066130; Motter AE, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.016116; Motter AE, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.065102; Nepusz T, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.016107; Nepusz T, 2012, NAT PHYS, V8, P568, DOI [10.1038/nphys2327, 10.1038/NPHYS2327]; Newman MEJ, 1999, PHYS LETT A, V263, P341, DOI 10.1016/S0375-9601(99)00757-4; Nie S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089066; Noh JD, 2004, PHYS REV LETT, V92, DOI 10.1103/PhysRevLett.92.118701; NORLEN K, 2002, P INT TEL SOC 14 BIE; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Porfiri M, 2010, PHYSICA D, V239, P454, DOI 10.1016/j.physd.2010.01.012; Posfai M, 2013, SCI REP-UK, V3, DOI 10.1038/srep01067; Pu CL, 2012, PHYSICA A, V391, P4420, DOI 10.1016/j.physa.2012.04.019; Rahman A, 2009, SIAM J CONTROL OPTIM, V48, P162, DOI 10.1137/060674909; Rosvall M, 2008, P NATL ACAD SCI USA, V105, P1118, DOI 10.1073/pnas.0706851105; Rugh W, 1996, LINEAR SYSTEM THEORY, V2; Shmulevich I., 2010, PROB BOOL NETW; Sole RV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026102; Sznajd-Weron K, 2000, INT J MOD PHYS C, V11, P1157, DOI 10.1142/S0129183100000936; Tu YH, 2000, NATURE, V406, P353, DOI 10.1038/35019222; van Duijn MAJ, 2003, J MATH SOCIOL, V27, P153, DOI 10.1080/00222500305889; Wang WX, 2012, PHYS REV E, V85, DOI 10.1103/PhysRevE.85.026115; Wang XF, 2002, IEEE T CIRCUITS-I, V49, P54, DOI 10.1109/81.974874; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Yan G, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.218703; Yuan ZZ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3447; [No title captured]	61	21	26	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162289	10.1371/journal.pone.0162289	http://dx.doi.org/10.1371/journal.pone.0162289			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588941	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800046
J	Matthews, FE; Bennett, H; Wittenberg, R; Jagger, C; Dening, T; Brayne, C				Matthews, Fiona E.; Bennett, Holly; Wittenberg, Raphael; Jagger, Carol; Dening, Tom; Brayne, Carol		Cognitive Function Ageing Studies	Who Lives Where and Does It Matter? Changes in the Health Profiles of Older People Living in Long Term Care and the Community over Two Decades in a High Income Country	PLOS ONE			English	Article							QUALITY-OF-LIFE; COGNITIVE FUNCTION; RISK-FACTORS; ALZHEIMERS-DISEASE; HOME RESIDENTS; DEMENTIA; PREVALENCE; POPULATION; DEPRESSION; ENGLAND	Background There have been fundamental shifts in the attitude towards, access to and nature of long term care in high income countries. The proportion and profile of the older population living in such settings varies according to social, cultural, and economic characteristics as well as governmental policies. Changes in the profiles of people in different settings are important for policy makers and care providers. Although details will differ, how change occurs across time is important to all, including lower and middle income countries developing policies themselves. Here change is examined across two decades in England. Methods and Findings Using the two Cognitive Function and Ageing Studies (CFAS I: 77% response, CFAS II: 56% response), two population based studies of older people carried out in the same areas conducted two decades apart, the study diagnosis of dementia using the Automated Geriatric Examination for Computer Assisted Taxonomy, health and wellbeing were examined, focusing on long term care. The proportion of individuals with three or more health conditions increased for everyone living in long term care between CFAS I (47.6%, 95% CI: 42.3-53.1) and CFAS II (62.7%, 95% CI: 54.8-70.0) and was consistently higher in those without dementia compared to those with dementia in both studies. Functional impairment measured by activities of daily living increased in assisted living facilities from 48% (95% CI: 44%-52%) to 67% (95% CI: 62%-71%). Conclusions Health profiles of residents in long term care have changed dramatically over time. Dementia prevalence and reporting multiple health conditions have increased. Receiving care in the community puts pressure on unpaid carers and formal services; these results have implications for policies about supporting people at home as well as for service provision within long term care including quality of care, health management, cost, and the development of a skilled, caring, and informed workforce.	[Matthews, Fiona E.] Cambridge Inst Publ Hlth, Cambridge Biomed Campus, Biostat Unit, MRC, Forvie Site,Robinson Way, Cambridge, England; [Matthews, Fiona E.; Jagger, Carol] Newcastle Univ, Inst Hlth & Soc, Edwardson Bldg,Campus Ageing & Vital, Newcastle Upon Tyne, Tyne & Wear, England; [Bennett, Holly; Brayne, Carol] Univ Cambridge, Sch Clin Med, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England; [Wittenberg, Raphael] London Sch Econ & Polit Sci, Personal Social Serv Res Unit, Houghton St, London, England; [Dening, Tom] Univ Nottingham, Inst Mental Hlth, Triumph Rd, Nottingham, England	MRC Biostatistics Unit; University of Cambridge; Newcastle University - UK; University of Cambridge; University of London; London School Economics & Political Science; University of Nottingham	Brayne, C (corresponding author), Univ Cambridge, Sch Clin Med, Cambridge Inst Publ Hlth, Dept Publ Hlth & Primary Care, Cambridge, England.	cb105@medschl.cam.ac.uk	Matthews, Fiona/O-6932-2015; Brayne, Carol/AAA-4285-2020; Dening, Tom/E-1335-2013; Morris, Josephine D./F-3366-2018	Matthews, Fiona/0000-0002-1728-2388; Brayne, Carol/0000-0001-5307-663X; Dening, Tom/0000-0003-3387-4241; Morris, Josephine D./0000-0001-9404-5602; Jagger, Carol/0000-0002-6377-9926	Medical Research Council [G0601022, G9901400]; MRC [G9901400, MC_U105292687, G0601022] Funding Source: UKRI; Medical Research Council [MC_U105292687] Funding Source: researchfish; National Institute for Health Research [NF-SI-0611-10084] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	CFAS II has been funded through a grant from the Medical Research Council (grant number G0601022). CFAS I was also funded through the Medical Research Council (grant number G9901400). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anstey KJ, 2007, AM J GERIAT PSYCHIAT, V15, P497, DOI 10.1097/JGP.0b013e31802e21d8; Arfken CL, 2011, PSYCHOTHER PSYCHOSOM, V80, P325, DOI 10.1159/000324795; Bolton M., 2012, CAMPAIGN END LONELIN; Bowman C, 2004, AGE AGEING, V33, P561, DOI 10.1093/ageing/afh177; Caffrey C, 2012, NCHS DATA BRIEF, V91; Campbell Stern M, 1993, BRIT MED J, V306; CFAS, COGN FUNCT AG STUD C; Darton R, 2012, HEALTH SOC CARE COMM, V20, P87, DOI 10.1111/j.1365-2524.2011.01022.x; DCLG, LAYING FDN HOUS STRA; DH/SCLG&CP/SCPI/SR, LIV WELL DEM NAT DEM; England N, NHS 5 YEAR FORW VIEW; Galea S, 2007, ANN EPIDEMIOL, V17, P643, DOI 10.1016/j.annepidem.2007.03.013; Gordon AL, 2014, AGE AGEING, V43, P97, DOI 10.1093/ageing/aft077; Hajek A, 2016, J AM MED DIR ASSOC, V17, P300, DOI 10.1016/j.jamda.2015.10.015; Jagger C, 2011, BMC GERIATR, V11, DOI 10.1186/1471-2318-11-21; Kendig H, 2010, AGE AGEING, V39, P342, DOI 10.1093/ageing/afq016; KIYAK HA, 1994, GERONTOLOGIST, V34, P324, DOI 10.1093/geront/34.3.324; Laukkanen P, 2001, AGE AGEING, V30, P489, DOI 10.1093/ageing/30.6.489; Lithgow S, 2012, INT J GERIATR PSYCH, V27, P785, DOI 10.1002/gps.2784; Luppa M, 2008, DEMENT GERIATR COGN, V26, P65, DOI 10.1159/000144027; Luppa M, 2010, AGE AGEING, V39, P31, DOI 10.1093/ageing/afp202; Mann AH, 2000, INT J GERIATR PSYCH, V15, P1105, DOI 10.1002/1099-1166(200012)15:12<1105::AID-GPS252>3.0.CO;2-W; Martin-Garcia S, 2013, INT PSYCHOGERIATR, V25, P1077, DOI 10.1017/S1041610213000458; Matthews FE, 2004, BMC PUBLIC HEALTH, V4, DOI 10.1186/1471-2458-4-12; Matthews FE, 2013, LANCET, V382, P1405, DOI 10.1016/S0140-6736(13)61570-6; ONS, 2013, WHAT DOES 2011 CENS; Prince M., 2013, WORLD ALZHEIMER REPO; Rafnsson SB, 2017, AGING MENT HEALTH, V21, P104, DOI 10.1080/13607863.2015.1088510; Ready RE, 2004, INT J GERIATR PSYCH, V19, P256, DOI 10.1002/gps.1075; Schubert CC, 2006, J AM GERIATR SOC, V54, P104, DOI 10.1111/j.1532-5415.2005.00543.x; Spiers NA, 2005, J GERONTOL A-BIOL, V60, P248, DOI 10.1093/gerona/60.2.248; Stewart R, 2014, AGE AGEING, V43, P562, DOI 10.1093/ageing/afu062; van der Lee J, 2015, AGING MENT HEALTH, P1, DOI [10.1080/13607863.2015.1102196, DOI 10.1080/13607863.2015.1102196]; Victor CR, 2005, AGEING SOC, V25, P357, DOI 10.1017/S0144686X04003332	34	28	28	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161705	10.1371/journal.pone.0161705	http://dx.doi.org/10.1371/journal.pone.0161705			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589586	Green Published, Green Accepted, gold			2022-12-26	WOS:000382877800015
J	Sartorius, T; Hennige, AM; Fritsche, A; Haring, HU				Sartorius, Tina; Hennige, Anita M.; Fritsche, Andreas; Haring, Hans-Ulrich			Sustained Treatment with Insulin Detemir in Mice Alters Brain Activity and Locomotion	PLOS ONE			English	Article							PEOPLE	Aims Recent studies have identified unique brain effects of insulin detemir (Levemir (R)). Due to its pharmacologic properties, insulin detemir may reach higher concentrations in the brain than regular insulin. This might explain the observed increased brain stimulation after acute insulin detemir application but it remained unclear whether chronic insulin detemir treatment causes alterations in brain activity as a consequence of overstimulation. Methods In mice, we examined insulin detemir's prolonged brain exposure by continuous subcutaneous (s.c.) application using either micro-osmotic pumps or daily s.c. injections and performed continuous radiotelemetric electrocorticography and locomotion recordings. Results Acute intracerebroventricular injection of insulin detemir activated cortical and locomotor activity significantly more than regular insulin in equimolar doses (0.94 and 5.63mU in total), suggesting an enhanced acute impact on brain networks. However, given continuously s.c., insulin detemir significantly reduced cortical activity (theta: 21.3 +/- 6.1% vs. 73.0 +/- 8.1%, P<0.001) and failed tomaintain locomotion, while regular insulin resulted in an increase of both parameters. Conclusions The data suggest that permanently-increased insulin detemir levels in the brain convert its hyperstimulatory effects and finally mediate impairments in brain activity and locomotion. This observation might be considered when human studies with insulin detemir are designed to target the brain in order to optimize treatment regimens.	[Sartorius, Tina; Hennige, Anita M.; Fritsche, Andreas; Haring, Hans-Ulrich] Univ Tubingen, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Dept Internal Med, Tubingen, Germany; [Sartorius, Tina; Hennige, Anita M.; Fritsche, Andreas; Haring, Hans-Ulrich] German Ctr Diabet Res DZD, Tubingen, Germany; [Sartorius, Tina; Hennige, Anita M.; Fritsche, Andreas; Haring, Hans-Ulrich] Univ Tuebingen IDM, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany	Eberhard Karls University of Tubingen; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Sartorius, T (corresponding author), Univ Tubingen, Div Endocrinol Diabetol Vasc Dis Nephrol & Clin C, Dept Internal Med, Tubingen, Germany.; Sartorius, T (corresponding author), German Ctr Diabet Res DZD, Tubingen, Germany.; Sartorius, T (corresponding author), Univ Tuebingen IDM, Helmholtz Ctr Munich, Inst Diabet Res & Metab Dis, Tubingen, Germany.	tina.sartorius@med.uni-tuebingen.de			Novo Nordisk (Bagsvaerd, Denmark); Deutsche Forschungsgemeinschaft [HE 3653/3-1]; German Federal Ministry of Education and Research (BMBF) [DLR01GI0925]; Open Access Publishing Fund of University of Tuebingen	Novo Nordisk (Bagsvaerd, Denmark)(Novo Nordisk); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); Open Access Publishing Fund of University of Tuebingen	This study was supported by grants from Novo Nordisk (Bagsvaerd, Denmark) to Hans-Ulrich Haring and the Deutsche Forschungsgemeinschaft to Anita M. Hennige (HE 3653/3-1). We further acknowledge support by the German Federal Ministry of Education and Research (BMBF; DLR01GI0925) to the German Center for Diabetes Research (DZD e.V.) and support by Open Access Publishing Fund of University of Tuebingen.	Begg DP, 2015, DIABETES, V64, P2457, DOI 10.2337/db14-1364; Born J, 2002, NAT NEUROSCI, V5, P514, DOI 10.1038/nn849; Cesarovic N, 2011, JOVE-J VIS EXP, DOI 10.3791/3260; Claxton A, 2015, J ALZHEIMERS DIS, V44, P897, DOI 10.3233/JAD-141791; Hallschmid M, 2010, DIABETES, V59, P1101, DOI 10.2337/db09-1493; Hennige AM, 2009, DIABETOLOGIA, V52, P2416, DOI 10.1007/s00125-009-1522-5; Hennige AM, 2006, DIABETOLOGIA, V49, P1274, DOI 10.1007/s00125-006-0192-9; Herring RA, 2015, DIABETES OBES METAB, V17, P459, DOI 10.1111/dom.12434; Kramer K, 2003, PHYSIOL GENOMICS, V13, P197, DOI 10.1152/physiolgenomics.00164.2002; MARSHALL S, 1984, J BIOL CHEM, V259, P6376; Mesaros A, 2008, CELL METAB, V7, P236, DOI 10.1016/j.cmet.2008.01.007; Rosenstock J, 2008, DIABETOLOGIA, V51, P408, DOI 10.1007/s00125-007-0911-x; Rossetti P, 2008, DIABETES, V57, P746, DOI 10.2337/db07-1433; Sartorius T, 2012, DIABETES, V61, P1669, DOI 10.2337/db11-1521; Sartorius T, 2012, FASEB J, V26, P1799, DOI 10.1096/fj.11-191023; Tschritter O, 2012, DIABETOLOGIA, V55, P175, DOI 10.1007/s00125-011-2309-z; Tschritter O, 2009, DIABETES OBES METAB, V11, P1017, DOI 10.1111/j.1463-1326.2009.01085.x; Tschritter O, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001196; Tschritter O, 2009, J CLIN ENDOCR METAB, V94, P4600, DOI 10.1210/jc.2009-0469; van Golen LW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094483	20	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162124	10.1371/journal.pone.0162124	http://dx.doi.org/10.1371/journal.pone.0162124			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589235	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800030
J	Li, Y; Liu, HH; Xia, MD; Gong, HP				Li, Yang; Liu, Huihui; Xia, Mengdie; Gong, Haipeng			Lysine and the Na+/K+ Selectivity in Mammalian Voltage-Gated Sodium Channels	PLOS ONE			English	Article							MOLECULAR-DYNAMICS SIMULATIONS; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; ION SELECTIVITY; EEEE MOTIF; PORE; MODEL; CA2+; PERMEATION; CONDUCTION	Voltage-gated sodium (Na-v) channels are critical in the generation and transmission of neuronal signals in mammals. The crystal structures of several prokaryotic Na-v channels determined in recent years inspire the mechanistic studies on their selection upon the permeable cations (especially between Na+ and K+ ions), a property that is proposed to be mainly determined by residues in the selectivity filter. However, the mechanism of cation selection in mammalian Na-v channels lacks direct explanation at atomic level due to the difference in amino acid sequences between mammalian and prokaryotic Na-v homologues, especially at the constriction site where the DEKA motif has been identified to determine the Na+/K+ selectivity in mammalian Na-v channels but is completely absent in the prokaryotic counter-parts. Among the DEKA residues, Lys is of the most importance since its mutation to Arg abolishes the Na+/K+ selectivity. In this work, we modeled the pore domain of mammalian Na-v channels by mutating the four residues at the constriction site of a prokaryotic Na-v channel (NavRh) to DEKA, and then mechanistically investigated the contribution of Lys in cation selection using molecular dynamics simulations. The DERA mutant was generated as a comparison to understand the loss of ion selectivity caused by the K-to-R mutation. Simulations and free energy calculations on the mutants indicate that Lys facilitates Na+/K+ selection by electrostatically repelling the cation to a highly Na+-selective location sand-wiched by the carboxylate groups of Asp and Glu at the constriction site. In contrast, the electrostatic repulsion is substantially weakened when Lys is mutated to Arg, because of two intrinsic properties of the Arg side chain: the planar geometric design and the sparse charge distribution of the guanidine group.	[Li, Yang; Liu, Huihui; Xia, Mengdie; Gong, Haipeng] Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China	Tsinghua University	Gong, HP (corresponding author), Tsinghua Univ, Sch Life Sci, MOE Key Lab Bioinformat, Beijing 100084, Peoples R China.	hgong@tsinghua.edu.cn		Liu, Huihui/0000-0003-3181-8289	Ministry of Science and Technology of China [2015CB910100]; National Natural Science Foundation of China [31470033]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by funds from the Ministry of Science and Technology of China (#2015CB910100) and by the National Natural Science Foundation of China (#31470033, http://www.nsfc.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Azam SS, 2010, J MOL LIQ, V153, P95, DOI 10.1016/j.molliq.2010.01.005; Boda D, 2007, BIOPHYS J, V93, P1960, DOI 10.1529/biophysj.107.105478; Boiteux C, 2014, P NATL ACAD SCI USA, V111, P3454, DOI 10.1073/pnas.1320907111; Carnevale V, 2011, J PHYS CHEM LETT, V2, P2504, DOI 10.1021/jz2011379; Catterall WA, 2000, NEURON, V26, P13, DOI 10.1016/S0896-6273(00)81133-2; Catterall WA, 2014, ANNU REV PHARMACOL, V54, P317, DOI 10.1146/annurev-pharmtox-011112-140232; Catterall WA, 2014, EXP PHYSIOL, V99, P35, DOI 10.1113/expphysiol.2013.071969; Chakrabarti N, 2013, P NATL ACAD SCI USA, V110, P11331, DOI 10.1073/pnas.1309452110; Charalambous K, 2011, BIOCHEMISTRY-US, V50, P6742, DOI 10.1021/bi200942y; Chen R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093267; Corry B, 2012, J AM CHEM SOC, V134, P1840, DOI 10.1021/ja210020h; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1023/A:1022627411411; Csanyi E, 2012, BBA-BIOMEMBRANES, V1818, P592, DOI 10.1016/j.bbamem.2011.10.029; Dudev T, 2014, J AM CHEM SOC, V136, P3553, DOI 10.1021/ja4121132; Dudev T, 2012, J PHYS CHEM B, V116, P10703, DOI 10.1021/jp304925a; Dudev T, 2012, PHYS CHEM CHEM PHYS, V14, P12451, DOI 10.1039/c2cp00036a; Dudev T, 2010, J AM CHEM SOC, V132, P2321, DOI 10.1021/ja909280g; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Favre I, 1996, BIOPHYS J, V71, P3110, DOI 10.1016/S0006-3495(96)79505-X; Feller SE, 2000, J PHYS CHEM B, V104, P7510, DOI 10.1021/jp0007843; FELLER SE, 1995, J CHEM PHYS, V103, P4613, DOI 10.1063/1.470648; Furini S, 2014, BIOPHYS J, V106, P2175, DOI 10.1016/j.bpj.2014.04.005; Furini S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002476; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Karplus M, 2002, NAT STRUCT BIOL, V9, P646, DOI 10.1038/nsb0902-646; Koishi R, 2004, J BIOL CHEM, V279, P9532, DOI 10.1074/jbc.M313100200; KOLLMAN P, 1993, CHEM REV, V93, P2395, DOI 10.1021/cr00023a004; Korkosh VS, 2014, J GEN PHYSIOL, V144, P231, DOI 10.1085/jgp.201411226; Li Y, 2015, PROTEIN CELL, V6, P413, DOI 10.1007/s13238-015-0152-6; Lipkind GM, 2000, BIOCHEMISTRY-US, V39, P8161, DOI 10.1021/bi000486w; Lipkind GM, 2008, J GEN PHYSIOL, V131, P523, DOI 10.1085/jgp.200809991; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Mackerell Jr AD, EXTENDING TREATMENT, DOI [10.1002/jcc.20065, DOI 10.1002/JCC.20065]; Mahdavi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133000; Mahdavi S, 2014, TOXINS, V6, P3454, DOI 10.3390/toxins6123454; Mahdavi S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105300; Mantegazza M, 2010, LANCET NEUROL, V9, P413, DOI 10.1016/S1474-4422(10)70059-4; MARTYNA GJ, 1994, J CHEM PHYS, V101, P4177, DOI 10.1063/1.467468; McCusker EC, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2077; MIYAMOTO S, 1992, J COMPUT CHEM, V13, P952, DOI 10.1002/jcc.540130805; Noskov SY, 2004, NATURE, V431, P830, DOI 10.1038/nature02943; Payandeh J, 2012, NATURE; Payandeh J, 2011, NATURE, V475, P353, DOI 10.1038/nature10238; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Schlief T, 1996, EUR BIOPHYS J BIOPHY, V25, P75, DOI 10.1007/s002490050020; Stock L, 2013, J PHYS CHEM B, V117, P3782, DOI 10.1021/jp401403b; Sun YM, 1997, J GEN PHYSIOL, V110, P693, DOI 10.1085/jgp.110.6.693; Tikhonov DB, 2012, MOL PHARMACOL, V82, P97, DOI 10.1124/mol.112.078212; Ulmschneider MB, 2013, P NATL ACAD SCI USA, V110, P6364, DOI 10.1073/pnas.1214667110; Xia MD, 2013, BIOPHYS J, V104, P2401, DOI 10.1016/j.bpj.2013.04.035; Yu Frank H, 2004, Sci STKE, V2004, pre15, DOI 10.1126/stke.2532004re15; Yue LX, 2002, J GEN PHYSIOL, V120, P845, DOI 10.1085/jgp.20028699; Zakon HH, 2012, P NATL ACAD SCI USA, V109, P10619, DOI 10.1073/pnas.1201884109; Zhang X, 2013, CELL RES, V23, P409, DOI 10.1038/cr.2012.173; Zhang X, 2012, NATURE, V486, P130, DOI 10.1038/nature11054; ZWANZIG RW, 1955, J CHEM PHYS, V23, P1915, DOI 10.1063/1.1740604	58	8	8	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162413	10.1371/journal.pone.0162413	http://dx.doi.org/10.1371/journal.pone.0162413			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584582	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600131
J	Song, J; Xue, C; Preisser, JS; Cramer, DW; Houck, KL; Liu, G; Folsom, AR; Couper, D; Yu, FL; Dong, JF				Song, Jaewoo; Xue, Cheng; Preisser, John S.; Cramer, Drake W.; Houck, Katie L.; Liu, Guo; Folsom, Aaron R.; Couper, David; Yu, Fuli; Dong, Jing-Fei			Association of Single Nucleotide Polymorphisms in the ST3GAL4 Gene with VWF Antigen and Factor VIII Activity	PLOS ONE			English	Article							VON-WILLEBRAND-FACTOR; HUMAN VONWILLEBRAND-FACTOR; COAGULATION-FACTOR-VIII; PLASMA FACTOR-VIII; BLOOD-GROUP-A; ASIALOGLYCOPROTEIN RECEPTOR; SIALIC-ACID; TRANSCRIPTIONAL REGULATION; ENDOTHELIAL-CELLS; GROUP-B	VWF is extensively glycosylated with biantennary core fucosylated glycans. Most N-linked and O-linked glycans on VWF are sialylated. FVIII is also glycosylated, with a glycan structure similar to that of VWF. ST3GAL sialyltransferases catalyze the transfer of sialic acids in the alpha 2,3 linkage to termini of N- and O-glycans. This sialic acid modification is critical for VWF synthesis and activity. We analyzed genetic and phenotypic data from the Atherosclerosis Risk in Communities (ARIC) study for the association of single nucleotide polymorphisms (SNPs) in the ST3GAL4 gene with plasma VWF levels and FVIII activity in 12,117 subjects. We also analyzed ST3GAL4 SNPs found in 2,535 subjects of 26 ethnicities from the 1000 Genomes (1000G) project for ethnic diversity, SNP imputation, and ST3GAL4 haplotypes. We identified 14 and 1,714 ST3GAL4 variants in the ARIC GWAS and 1000G data-bases respectively, with 46% being ethnically diverse in their allele frequencies. Among the 14 ST3GAL4 SNPs found in ARIC GWAS, the intronic rs2186717, rs7928391, and rs11220465 were associated with VWF levels and with FVIII activity after adjustment for age, BMI, hypertension, diabetes, ever-smoking status, and ABO. This study illustrates the power of next-generation sequencing in the discovery of new genetic variants and a significant ethnic diversity in the ST3GAL4 gene. We discuss potential mechanisms through which these intronic SNPs regulate ST3GAL4 biosynthesis and the activity that affects VWF and FVIII.	[Song, Jaewoo; Cramer, Drake W.; Houck, Katie L.; Dong, Jing-Fei] BloodWorks Northwest Res Inst, Seattle, WA 98104 USA; [Song, Jaewoo] Yonsei Univ, Dept Lab Med, Coll Med, Seoul, South Korea; [Xue, Cheng; Yu, Fuli] Baylor Coll Med, Mol & Human Genet Dept, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [Preisser, John S.; Couper, David] Univ N Carolina, Dept Biostat, Chapel Hill, NC USA; [Liu, Guo] Sichuan Univ, Dept Otolaryngol Head & Neck Surg, West China Hosp, Chengdu, Peoples R China; [Folsom, Aaron R.] Univ Minnesota, Sch Publ Hlth, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Yu, Fuli] Tianjin Med Univ Gen Hosp, Inst Neurol, Tianjin 300052, Peoples R China; [Dong, Jing-Fei] Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA	Yonsei University; Yonsei University Health System; Baylor College of Medicine; University of North Carolina; University of North Carolina Chapel Hill; Sichuan University; University of Minnesota System; University of Minnesota Twin Cities; Tianjin Medical University; University of Washington; University of Washington Seattle	Dong, JF (corresponding author), BloodWorks Northwest Res Inst, Seattle, WA 98104 USA.; Yu, FL (corresponding author), Baylor Coll Med, Mol & Human Genet Dept, Human Genome Sequencing Ctr, Houston, TX 77030 USA.; Yu, FL (corresponding author), Tianjin Med Univ Gen Hosp, Inst Neurol, Tianjin 300052, Peoples R China.; Dong, JF (corresponding author), Univ Washington, Sch Med, Dept Med, Div Hematol, Seattle, WA 98195 USA.	fyu@bcm.edu; jfdong@bloodworksnw.org		Song, Jaewoo/0000-0002-1877-5731; Couper, David/0000-0002-4313-9235	Atherosclerosis Risk in Communities research contracts (ARIC consortium) [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; National Heart, Lung, and Blood Institute [HL71895, HL85769]; National Heart, Lung, and Blood Institute contracts [HL71895, HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, HHSN268201100012C, R01HL087641, R01HL59367, R01HL086694, HL085769]; National Human Genome Research Institute [U01HG004402]; National Institutes of Health [HHSN268200625226C]; National Institutes of Health and NIH Roadmap for Medical Research [UL1RR025005]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025005] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL059367, R01HL087641, R01HL085769, R01HL071895, R01HL086694] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U01HG004402] Funding Source: NIH RePORTER	Atherosclerosis Risk in Communities research contracts (ARIC consortium); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Heart, Lung, and Blood Institute contracts; National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institutes of Health and NIH Roadmap for Medical Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	This work is supported by Atherosclerosis Risk in Communities research contracts N01-HC-55015, N01-HC-55016, N01-HC-55018, N01-HC55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022 (ARIC consortium); and research grants HL71895 (JFD) and HL85769 (JFD) from the National Heart, Lung, and Blood Institute. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The Atherosclerosis Risk in Communities Study is carried out as a collaborative study supported by National Heart, Lung, and Blood Institute contracts (HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C), R01HL087641, R01HL59367, R01HL086694; HL71895 and HL085769; National Human Genome Research Institute contract U01HG004402; and National Institutes of Health contract HHSN268200625226C. The authors thank the staff and participants of the ARIC study for their important contributions. Infrastructure was partly supported by Grant Number UL1RR025005, a component of the National Institutes of Health and NIH Roadmap for Medical Research.	Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; BASTIDA E, 1988, THROMB HAEMOSTASIS, V60, P30; Bellissimo DB, 2012, BLOOD, V119, P2135, DOI 10.1182/blood-2011-10-384610; Bovenschen N, 2005, J THROMB HAEMOST, V3, P1257, DOI 10.1111/j.1538-7836.2005.01389.x; Campos M, 2012, BLOOD, V119, P1929, DOI 10.1182/blood-2011-10-383661; Campos M, 2011, BLOOD, V117, P5224, DOI 10.1182/blood-2010-08-300152; Canis K, 2012, BIOCHEM J, V447, P217, DOI 10.1042/BJ20120810; CONLAN MG, 1993, THROMB HAEMOSTASIS, V70, P380; DEBEIRE P, 1983, FEBS LETT, V151, P22, DOI 10.1016/0014-5793(83)80334-2; DEMARCO L, 1981, J CLIN INVEST, V68, P321, DOI 10.1172/JCI110259; Ellies LG, 2002, P NATL ACAD SCI USA, V99, P10042, DOI 10.1073/pnas.142005099; Everett LA, 2014, BLOOD, V123, P3697, DOI 10.1182/blood-2014-02-554501; Fahs SA, 2014, BLOOD, V123, P3706, DOI 10.1182/blood-2014-02-555151; FEDERICI AB, 1988, BLOOD, V71, P947; FOLSOM AR, 1993, ARTERIOSCLER THROMB, V13, P1829, DOI 10.1161/01.ATV.13.12.1829; Grahn A, 2001, GLYCOCONJUGATE J, V18, P759, DOI 10.1023/A:1021199300718; Grewal PK, 2008, NAT MED, V14, P648, DOI 10.1038/nm1760; HIRONAKA T, 1992, J BIOL CHEM, V267, P8012; ISAACS NW, 1995, CURR OPIN STRUC BIOL, V5, P391, DOI 10.1016/0959-440X(95)80102-2; Johnsen JM, 2013, BLOOD, V122, P590, DOI 10.1182/blood-2013-02-485094; Kamphuisen PW, 1998, THROMB HAEMOSTASIS, V79, P323; Kitagawa H, 1996, J BIOL CHEM, V271, P931, DOI 10.1074/jbc.271.2.931; Kono M, 1997, GLYCOBIOLOGY, V7, P469, DOI 10.1093/glycob/7.4.469; Lenting PJ, 2010, HAEMOPHILIA, V16, P194, DOI 10.1111/j.1365-2516.2010.02320.x; LOLLAR P, 1988, J BIOL CHEM, V263, P10451; Lopes AA, 2000, THROMB HAEMOSTASIS, V83, P683; MATSUI T, 1992, J BIOL CHEM, V267, P8723; McGrath RT, 2010, BLOOD, V115, P2666, DOI 10.1182/blood-2009-09-241547; Morange PE, 2005, BRIT J HAEMATOL, V128, P91, DOI 10.1111/j.1365-2141.2004.05275.x; PAPP AC, 1989, THROMB HAEMOSTASIS, V61, P15; Park EI, 2005, P NATL ACAD SCI USA, V102, P17125, DOI 10.1073/pnas.0508537102; Sadler JE, 1998, ANNU REV BIOCHEM, V67, P395, DOI 10.1146/annurev.biochem.67.1.395; SAMOR B, 1989, GLYCOCONJUGATE J, V6, P263, DOI 10.1007/BF01047846; Schilow WF, 2004, THROMB HAEMOSTASIS, V92, P427; Schunkert H, 2011, NAT GENET, V43, P333, DOI [10.1038/ng.784, 10.1161/CIRCGENETICS.111.960443]; Seitz EM, 2006, NUCLEIC ACIDS RES, V34, P2847, DOI 10.1093/nar/gkl355; SODETZ JM, 1977, J BIOL CHEM, V252, P5538; SODETZ JM, 1979, J BIOL CHEM, V254, P754; Taniguchi A, 2001, GLYCOBIOLOGY, V11, P241, DOI 10.1093/glycob/11.3.241; Taniguchi A, 2001, BIOCHEM BIOPH RES CO, V287, P1148, DOI 10.1006/bbrc.2001.5709; TITANI K, 1986, BIOCHEMISTRY-US, V25, P3171, DOI 10.1021/bi00359a015; Tracy RB, 1997, GENE DEV, V11, P3423, DOI 10.1101/gad.11.24.3423; Vindevoghel L, 1997, J BIOL CHEM, V272, P10196; VLOT AJ, 1995, BLOOD, V85, P3150, DOI 10.1182/blood.V85.11.3150.bloodjournal85113150; VOORBERG J, 1991, J CELL BIOL, V113, P195, DOI 10.1083/jcb.113.1.195; WAGNER DD, 1987, BLOOD, V69, P27; Wang QY, 2013, J THROMB HAEMOST, V11, P261, DOI 10.1111/jth.12093; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184	48	8	8	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0160757	10.1371/journal.pone.0160757	http://dx.doi.org/10.1371/journal.pone.0160757			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584569	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600011
J	Susanti, D; Loganathan, U; Mukhopadhyay, B				Susanti, Dwi; Loganathan, Usha; Mukhopadhyay, Biswarup			A Novel F-420-dependent Thioredoxin Reductase Gated by Low Potential FAD A TOOL FOR REDOX REGULATION IN AN ANAEROBE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SP-NOV REPRESENTS; ESCHERICHIA-COLI; 8-HYDROXY-5-DEAZAFLAVIN-REDUCING HYDROGENASE; METHANOBACTERIUM-THERMOAUTOTROPHICUM; BIOCHEMICAL-CHARACTERIZATION; THERMOPLASMA-ACIDOPHILUM; METHANOCOCCUS-JANNASCHII; METHANOPYRUS-KANDLERI; REDUCED THIOREDOXIN; CRYSTAL-STRUCTURE	A recent report suggested that the thioredoxin-dependent metabolic regulation, which is widespread in all domains of life, existed in methanogenic archaea about 3.5 billion years ago. We now show that the respective electron delivery enzyme (thioredoxin reductase, TrxR), although structurally similar to flavin-containing NADPH-dependent TrxRs (NTR), lacked an NADPH-binding site and was dependent on reduced coenzyme F-420 (F420H2), a stronger reductant with a mid-point redox potential (E'(0)) of -360 mV; E'(0) of NAD(P)H is -320 mV. Because F-420 is a deazaflavin, this enzyme was named deazaflavin-dependent flavin-containing thioredoxin reductase (DFTR). It transferred electrons from F420H2 to thioredoxin via protein-bound flavin; K-m values for thioredoxin and F420H2 were 6.3 and 28.6 mu M, respectively. The E'(0) of DFTR-bound flavin was approximately -389 mV, making electron transfer from NAD(P) H or F420H2 to flavin endergonic. However, under high partial pressures of hydrogen prevailing on early Earth and present day deep-sea volcanoes, the potential for the F-420/F420H2 pair could be as low as -425 mV, making DFTR efficient. The presence of DFTR exclusively in ancient methanogens and mostly in the early Earth environment of deep-sea volcanoes and DFTR's characteristics suggest that the enzyme developed on early Earth and gave rise to NTR. A phylogenetic analysis revealed six more novel-type TrxR groups and suggested that the broader flavin-containing disulfide oxidoreductase family is more diverse than previously considered. The unprecedented structural similarities between an F-420-dependent enzyme (DFTR) and an NADPH-dependent enzyme (NTR) brought new thoughts to investigations on F-420 systems involved in microbial pathogenesis and antibiotic production.	[Susanti, Dwi; Loganathan, Usha; Mukhopadhyay, Biswarup] Virginia Tech, Dept Biochem, Blacksburg, VA 24061 USA; [Mukhopadhyay, Biswarup] Virginia Tech, Biocomplex Inst, Blacksburg, VA 24061 USA; [Mukhopadhyay, Biswarup] Virginia Tech, Virginia Tech Caril Sch Med, Blacksburg, VA 24061 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University	Mukhopadhyay, B (corresponding author), Dept Biochem, Engel Hall,340 West Campus Dr, Blacksburg, VA 24061 USA.	biswarup@vt.edu		Mukhopadhyay, Biswarup/0000-0003-0736-0298	National Aeronautics and Space Administration Astrobiology: Exobiology and Evolutionary Biology Grant [NNX13AI05G]; Virginia Tech Agricultural Experiment Station Hatch Program, CRIS Project [VA-160021]	National Aeronautics and Space Administration Astrobiology: Exobiology and Evolutionary Biology Grant; Virginia Tech Agricultural Experiment Station Hatch Program, CRIS Project	This work was supported by National Aeronautics and Space Administration Astrobiology: Exobiology and Evolutionary Biology Grant NNX13AI05G (to B. M.) and Virginia Tech Agricultural Experiment Station Hatch Program, CRIS Project VA-160021. The authors declare that they have no conflicts of interest with the contents of this article.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Amegbey GY, 2003, BIOCHEMISTRY-US, V42, P8001, DOI 10.1021/bi030021g; Arner ESJ, 2000, EUR J BIOCHEM, V267, P6102, DOI 10.1046/j.1432-1327.2000.01701.x; Arner ESJ, 1996, BIOCHEM BIOPH RES CO, V225, P268, DOI 10.1006/bbrc.1996.1165; Aufhammer SW, 2005, PROTEIN SCI, V14, P1840, DOI 10.1110/ps.041289805; Balsera M, 2013, PLANTA, V237, P619, DOI 10.1007/s00425-012-1803-y; Berk H, 1998, FEBS LETT, V438, P124, DOI 10.1016/S0014-5793(98)01288-5; Blommel PG, 2007, PROTEIN EXPRES PURIF, V55, P53, DOI 10.1016/j.pep.2007.04.013; Boone David R., 1993, P35; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brochier C, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r17; Buchanan BB, 2002, PHOTOSYNTH RES, V73, P215, DOI 10.1023/A:1020407432008; Buey RM, 2017, MOL PLANT, V10, P212, DOI 10.1016/j.molp.2016.06.019; Bult CJ, 1996, SCIENCE, V273, P1058, DOI 10.1126/science.273.5278.1058; Castresana J, 2000, MOL BIOL EVOL, V17, P540, DOI 10.1093/oxfordjournals.molbev.a026334; Ceh K, 2009, BIOCHEMISTRY-US, V48, P10098, DOI 10.1021/bi901104d; CHEN JS, 1974, BIOCHIM BIOPHYS ACTA, V371, P283, DOI 10.1016/0005-2795(74)90025-7; Cheng ZY, 2007, BIOCHEMISTRY-US, V46, P7875, DOI 10.1021/bi700442r; Choi KP, 2002, J BACTERIOL, V184, P2420, DOI 10.1128/JB.184.9.2420-2428.2002; CLELAND WW, 1964, BIOCHEMISTRY-US, V3, P480, DOI 10.1021/bi00892a002; de Poorter LMI, 2005, MICROBIOL-SGM, V151, P1697, DOI 10.1099/mic.0.27679-0; DIMARCO AA, 1990, ANNU REV BIOCHEM, V59, P355, DOI 10.1146/annurev.biochem.59.1.355; Dym O, 2001, PROTEIN SCI, V10, P1712, DOI 10.1110/ps.12801; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; EIRICH LD, 1979, J BACTERIOL, V140, P20, DOI 10.1128/JB.140.1.20-27.1979; ELLIS KJ, 1982, METHOD ENZYMOL, V87, P405; Graham DE, 2003, ARCH MICROBIOL, V180, P455, DOI 10.1007/s00203-003-0614-8; Graham DE, 2002, NAT PROD REP, V19, P133, DOI 10.1039/b103714p; Grimaldi P, 2008, EXTREMOPHILES, V12, P553, DOI 10.1007/s00792-008-0161-y; HAASE P, 1992, EUR J BIOCHEM, V203, P527, DOI 10.1111/j.1432-1033.1992.tb16579.x; Hamill MJ, 2008, BIOCHEMISTRY-US, V47, P9738, DOI 10.1021/bi800676g; HAMMEL KE, 1983, P NATL ACAD SCI-BIOL, V80, P3681, DOI 10.1073/pnas.80.12.3681; Harms C, 1998, MICROBIOL-UK, V144, P793, DOI 10.1099/00221287-144-3-793; Hendrickson EL, 2008, J BACTERIOL, V190, P4818, DOI 10.1128/JB.00255-08; Hendrickson EL, 2007, P NATL ACAD SCI USA, V104, P8930, DOI 10.1073/pnas.0701157104; Hernandez HH, 2008, BIOCHEMISTRY-US, V47, P9728, DOI 10.1021/bi8006753; Hicks M. A., 2014, PROTEIN FAMILIES REL, P127; Hirt RP, 2002, TRENDS PARASITOL, V18, P302, DOI 10.1016/S1471-4922(02)02293-6; Hocking WP, 2015, ARCHAEA, V2015, DOI 10.1155/2015/235384; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1977, J BIOL CHEM, V252, P4600; HOLMGREN A, 1989, J BIOL CHEM, V264, P13963; Hosoya-Matsuda N, 2009, MOL PLANT, V2, P336, DOI 10.1093/mp/ssn077; HUBER R, 1986, ARCH MICROBIOL, V144, P324, DOI 10.1007/BF00409880; JACOBSON FS, 1982, J BIOL CHEM, V257, P3385; JANNASCH HW, 1985, SCIENCE, V229, P717, DOI 10.1126/science.229.4715.717; Jeon SJ, 2002, EUR J BIOCHEM, V269, P5423, DOI 10.1046/j.1432-1033.2002.03231.x; Johnson EF, 2005, J BIOL CHEM, V280, P38776, DOI 10.1074/jbc.M503492200; Johnson EF., 2007, P INT S MICR SULF ME, P202; JOHNSON TC, 1984, J BACTERIOL, V158, P1061, DOI 10.1128/JB.158.3.1061-1069.1984; JONES WJ, 1983, ARCH MICROBIOL, V136, P254, DOI 10.1007/BF00425213; Kanzok SM, 2002, METHOD ENZYMOL, V347, P370; Kashima Y, 2003, ARCH BIOCHEM BIOPHYS, V418, P179, DOI 10.1016/j.abb.2003.08.002; Kemmer G, 2010, NAT PROTOC, V5, P267, DOI 10.1038/nprot.2009.182; KIENER A, 1983, SYST APPL MICROBIOL, V4, P305, DOI 10.1016/S0723-2020(83)80017-4; Kumar AK, 2015, BIOCHEMISTRY-US, V54, P3122, DOI 10.1021/acs.biochem.5b00137; Kumar AK, 2011, ACTA CRYSTALLOGR F, V67, P775, DOI 10.1107/S1744309111017234; KUMAR S, 1992, EUR J BIOCHEM, V207, P435, DOI 10.1111/j.1432-1033.1992.tb17068.x; KURR M, 1991, ARCH MICROBIOL, V156, P239, DOI 10.1007/BF00262992; Lee DY, 2000, BIOCHEMISTRY-US, V39, P6652, DOI 10.1021/bi000035b; Lennon BW, 1999, PROTEIN SCI, V8, P2366; LIN XL, 1986, J BACTERIOL, V168, P444, DOI 10.1128/jb.168.1.444-448.1986; Lu J, 2014, FREE RADICAL BIO MED, V66, P75, DOI 10.1016/j.freeradbiomed.2013.07.036; MASSEY V, 1978, BIOCHEMISTRY-US, V17, P9, DOI 10.1021/bi00594a002; MAYHEW SG, 1978, EUR J BIOCHEM, V85, P535, DOI 10.1111/j.1432-1033.1978.tb12269.x; McCarver AC, 2014, FEBS J, V281, P4598, DOI 10.1111/febs.12964; MCFARLAN SC, 1992, J BIOL CHEM, V267, P10561; MOORE EC, 1964, J BIOL CHEM, V239, P3453; Mukhopadhyay B, 2000, BBA-GEN SUBJECTS, V1475, P191, DOI 10.1016/S0304-4165(00)00064-7; MUTH E, 1987, EUR J BIOCHEM, V169, P571, DOI 10.1111/j.1432-1033.1987.tb13647.x; Ojha S, 2007, PLOS COMPUT BIOL, V3, P1268, DOI 10.1371/journal.pcbi.0030121; Palfey B. A., 1998, COMPREHENSIVE BIOL C, P88; Patel MP, 1998, FEMS MICROBIOL LETT, V166, P155, DOI 10.1111/j.1574-6968.1998.tb13197.x; Pei JM, 2007, BIOINFORMATICS, V23, P802, DOI 10.1093/bioinformatics/btm017; Pieulle L, 2011, J BIOL CHEM, V286, P7812, DOI 10.1074/jbc.M110.197988; PRONGAY AJ, 1992, J BIOL CHEM, V267, P25181; Purwantini E, 1996, J BACTERIOL, V178, P2861, DOI 10.1128/jb.178.10.2861-2866.1996; PURWANTINI E, 1992, ANAL BIOCHEM, V205, P342, DOI 10.1016/0003-2697(92)90446-E; Purwantini E, 1997, FEMS MICROBIOL LETT, V146, P129, DOI 10.1016/S0378-1097(96)00465-X; Purwantini E, 2016, J BACTERIOL, V198, P2020, DOI 10.1128/JB.01035-15; Purwantini E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081985; Reott MA, 2009, J BACTERIOL, V191, P3384, DOI 10.1128/JB.01665-08; Robichon C, 2011, APPL ENVIRON MICROB, V77, P4634, DOI 10.1128/AEM.00119-11; Rocco CJ, 2008, PLASMID, V59, P231, DOI 10.1016/j.plasmid.2008.01.001; Ruggiero A, 2009, BBA-PROTEINS PROTEOM, V1794, P554, DOI 10.1016/j.bbapap.2008.11.011; Sarin R, 2006, GENE, V376, P107, DOI 10.1016/j.gene.2006.02.012; Seedorf H, 2007, FEBS J, V274, P1588, DOI 10.1111/j.1742-4658.2007.05706.x; SEGERER A, 1988, SYST APPL MICROBIOL, V10, P161, DOI 10.1016/S0723-2020(88)80031-6; Sheehan R, 2015, J IND MICROBIOL BIOT, V42, P965, DOI 10.1007/s10295-015-1592-y; Susanti D, 2014, P NATL ACAD SCI USA, V111, P2608, DOI 10.1073/pnas.1324240111; Susanti D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045313; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; THELANDER L, 1967, J BIOL CHEM, V242, P852; THELANDER L, 1968, EUR J BIOCHEM, V4, P407, DOI 10.1111/j.1432-1033.1968.tb00227.x; WALSH C, 1986, ACCOUNTS CHEM RES, V19, P216, DOI 10.1021/ar00127a004; Yang XQ, 2010, J BACTERIOL, V192, P1370, DOI 10.1128/JB.01035-09	96	19	20	0	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23084	23100		10.1074/jbc.M116.750208	http://dx.doi.org/10.1074/jbc.M116.750208			17	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27590343	Green Published, hybrid			2022-12-26	WOS:000387224800020
J	Laqmani, A; Kurfurst, M; Butscheidt, S; Sehner, S; Schmidt-Holtz, J; Behzadi, C; Nagel, HD; Adam, G; Regier, M				Laqmani, Azien; Kurfuerst, Maximillian; Butscheidt, Sebastian; Sehner, Susanne; Schmidt-Holtz, Jakob; Behzadi, Cyrus; Nagel, Hans Dieter; Adam, Gerhard; Regier, Marc			CT Pulmonary Angiography at Reduced Radiation Exposure and Contrast Material Volume Using Iterative Model Reconstruction and iDose(4) Technique in Comparison to FBP	PLOS ONE			English	Article							MULTIDETECTOR COMPUTED-TOMOGRAPHY; FILTERED BACK-PROJECTION; IMPROVED IMAGE QUALITY; CHEST CT; INDUCED NEPHROTOXICITY; DIAGNOSTIC-ACCURACY; CLINICAL-TRIAL; 80 KVP; EMBOLISM; REDUCTION	Purpose To assess image quality of CT pulmonary angiography (CTPA) at reduced radiation exposure (RD-CTPA) and contrast medium (CM) volume using two different iterative reconstruction (IR) algorithms (iDose(4) and iterative model reconstruction (IMR)) in comparison to filtered back projection (FBP). Materials and Methods 52 patients (body weight < 100 kg, mean BMI: 23.9) with suspected pulmonary embolism (PE) underwent RD-CTPA (tube voltage: 80 kV; mean CTDIvol: 1.9 mGy) using 40 ml CM. Data were reconstructed using FBP and two different IR algorithms (iDose(4) and IMR). Subjective and objective image quality and conspicuity of PE were assessed in central, segmental, and subsegmental arteries. Results Noise reduction of 55% was achieved with iDose(4) and of 85% with IMR compared to FBP. Contrast-to-noise ratio significantly increased with iDose(4) and IMR compared to FBP (p<0.05). Subjective image quality was rated significantly higher at IMR reconstructions in comparison to iDose(4) and FBP. Conspicuity of central and segmental PE significantly improved with the use of IMR. In subsegmental arteries, iDose(4) was superior to IMR. Conclusion CTPA at reduced radiation exposure and contrast medium volume is feasible with the use of IMR, which provides improved image quality and conspicuity of pulmonary embolism in central and segmental arteries.	[Laqmani, Azien; Kurfuerst, Maximillian; Butscheidt, Sebastian; Schmidt-Holtz, Jakob; Behzadi, Cyrus; Adam, Gerhard; Regier, Marc] Univ Med Ctr Hamburg Eppendorf, Dept Intervent & Diagnost Radiol & Nucl Med, Hamburg, Germany; [Sehner, Susanne] Univ Med Ctr Hamburg Eppendorf, Dept Med Biometry & Epidemiol, Hamburg, Germany	University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Hamburg; University Medical Center Hamburg-Eppendorf	Laqmani, A (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Intervent & Diagnost Radiol & Nucl Med, Hamburg, Germany.	a.laqmani@uke.de	Regier, Marc/G-8781-2018; Regier, Marc/W-5427-2019					Apfaltrer P, 2014, EUR J RADIOL, V83, P322, DOI 10.1016/j.ejrad.2013.11.005; Buhk JH, 2013, ROFO-FORTSCHR RONTG, V185, P741, DOI 10.1055/s-0033-1335937; Costello JE, 2013, AM J ROENTGENOL, V201, P1283, DOI 10.2214/AJR.12.9720; Ghaye B, 2001, RADIOLOGY, V219, P629, DOI 10.1148/radiology.219.3.r01jn32629; Haage P, 2000, AM J ROENTGENOL, V174, P1049, DOI 10.2214/ajr.174.4.1741049; Henes FOG, 2012, J THORAC IMAG, V27, P113, DOI 10.1097/RTI.0b013e31820b8696; Holmquist F, 2009, ACTA RADIOL, V50, P181, DOI 10.1080/02841850802657269; Jones SE, 2005, RADIOLOGY, V237, P329, DOI 10.1148/radiol.2371041520; Kalra MK, 2015, RADIOGRAPHICS, V35, P1706, DOI 10.1148/rg.2015150118; Kalra MK, 2013, AM J ROENTGENOL, V201, pW235, DOI 10.2214/AJR.12.9569; Katzberg RW, 2010, RADIOLOGY, V256, P21, DOI 10.1148/radiol.10092000; Khawaja RDA, 2014, J COMPUT ASSIST TOMO, V38, P613, DOI 10.1097/RCT.0000000000000087; Kim MJ, 2009, J COMPUT ASSIST TOMO, V33, P416, DOI 10.1097/RCT.0b013e318181fab5; Laqmani A, 2016, EUR RADIOL, V26, P216, DOI 10.1007/s00330-015-3810-4; Laqmani A, 2014, EUR J RADIOL, V83, P1962, DOI 10.1016/j.ejrad.2014.06.016; Lee J, 2010, ANN EMERG MED, V56, P591, DOI 10.1016/j.annemergmed.2010.05.027; Lell MM, 2015, INVEST RADIOL, V50, P161, DOI 10.1097/RLI.0000000000000119; Lu GM, 2014, EUR RADIOL, V24, P3260, DOI 10.1007/s00330-014-3365-9; Mayo-Smith WW, 2014, RADIOLOGY, V273, P657, DOI 10.1148/radiol.14132328; McCollough CH, 2008, HEALTH PHYS, V95, P508, DOI 10.1097/01.HP.0000326343.35884.03; Mehta D, 2011, EPOS, DOI [10.1594/ecr2011/C-1938, DOI 10.1594/ECR2011/C-1938, 10.1594/ecr2011/C-1938.2011]; Mehta D., 2013, MED PHYS INT, V1, P147; Morcos SK, 1999, EUR RADIOL, V9, P1602, DOI 10.1007/s003300050894; Nash K, 2002, AM J KIDNEY DIS, V39, P930, DOI 10.1053/ajkd.2002.32766; Noel PB, 2011, AM J ROENTGENOL, V197, P1404, DOI 10.2214/AJR.11.6907; Nyman U, 2008, ACTA RADIOL, V49, P658, DOI 10.1080/02841850802050762; Padole A, 2014, AM J ROENTGENOL, V203, P772, DOI 10.2214/AJR.13.12312; Pontana F, 2013, RADIOLOGY, V267, P609, DOI 10.1148/radiol.12120414; Remy-Jardin M, 2007, RADIOLOGY, V245, P315, DOI 10.1148/radiol.2452070397; RemyJardin M, 1997, RADIOLOGY, V204, P157, DOI 10.1148/radiology.204.1.9205239; Safriel Y, 2002, CLIN IMAG, V26, P101, DOI 10.1016/S0899-7071(01)00366-7; Singh T, 2011, J MED IMAG RADIAT ON, V55, P143, DOI 10.1111/j.1754-9485.2011.02243.x; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Stein PD, 2006, NEW ENGL J MED, V354, P2317, DOI 10.1056/NEJMoa052367; Szucs-Farkas Z, 2014, INVEST RADIOL, V49, P201, DOI 10.1097/RLI.0000000000000016; Szucs-Farkas Z, 2011, AM J ROENTGENOL, V197, pW852, DOI 10.2214/AJR.11.6750; Szucs-Farkas Z, 2009, INVEST RADIOL, V44, P793, DOI 10.1097/RLI.0b013e3181bfe230; Szucs-Farkas Z, 2008, INVEST RADIOL, V43, P871, DOI 10.1097/RLI.0b013e3181875e86; Winer-Muram HT, 2004, RADIOLOGY, V233, P806, DOI 10.1148/radiol.2333031744; You SY, 2007, J COMPUT ASSIST TOMO, V31, P677, DOI 10.1097/RCT.0b013e318038d8fb; Yuki H, 2015, ACTA RADIOL; Yuki H, 2014, J CARDIOVASC COMPUT, V8, P115, DOI 10.1016/j.jcct.2013.12.010; Zhang F, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150766	43	14	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162429	10.1371/journal.pone.0162429	http://dx.doi.org/10.1371/journal.pone.0162429			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611448				2022-12-26	WOS:000383255900098
J	Scharnweber, K; Strandberg, U; Karlsson, K; Eklov, P				Scharnweber, Kristin; Strandberg, Ursula; Karlsson, Konrad; Eklov, Peter			Decrease of Population Divergence in Eurasian Perch (Perca fluviatilis) in Browning Waters: Role of Fatty Acids and Foraging Efficiency	PLOS ONE			English	Article							DISSOLVED ORGANIC-CARBON; FRESH-WATER; HERBIVOROUS ZOOPLANKTON; ECOLOGICAL SPECIATION; FISH COMMUNITIES; LIPID-METABOLISM; LAKES; SESTON; LIMITATION; SELECTION	Due to altered biogeochemical processes related to climate change, highly colored dissolved organic carbon (DOC) from terrestrial sources will lead to a water "brownification" in many freshwater systems of the Northern Hemisphere. This will create deteriorated visual conditions that have been found to affect habitat-specific morphological variations in Eurasian perch (Perca fluviatilis) in a previous study. So far, potential drivers and ultimate causes of these findings have not been identified. We conducted a field study to investigate the connection between morphological divergence and polyunsaturated fatty acid (PUFA) composition of perch from six lakes across a gradient of DOC concentration. We expected a decrease in the prevalence of PUFAs, which are important for perch growth and divergence with increasing DOC concentrations, due to the restructuring effects of DOC on aquatic food webs. In general, rate of morphological divergence in perch decreased with increasing DOC concentrations. Proportions of specific PUFAs (22:6n-3, 18:3n-3, 20:5n-3, and 20:4n-6) identified to primarily contribute to overall differences between perch caught in clear and brown-water lakes tended to be connected to overall decline of morphological divergence. However, no overall significant relationship was found, indicating no severe limitation of essential fatty acids for perch inhabiting brown water lakes. We further broaden our approach by conducting a laboratory experiment on foraging efficiency of perch. Therefore, we induced pelagic and littoral phenotypes by differences in habitat-structure and feeding mode and recorded attack rate in a feeding experiment. Generally, fish were less efficient in foraging on littoral prey (Ephemeroptera) when visual conditions were degraded by brown water color. We concluded that browning water may have a strong effect on the forager's ability to find particular food resources, resulting in the reduced development of evolutionary traits, such as habitat-specific morphological divergence.	[Scharnweber, Kristin; Eklov, Peter] Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden; [Strandberg, Ursula] Univ Eastern Finland, Dept Biol, Joensuu, Finland; [Karlsson, Konrad] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden	Uppsala University; University of Eastern Finland; Stockholm University	Scharnweber, K (corresponding author), Uppsala Univ, Evolutionary Biol Ctr, Dept Ecol & Genet, Uppsala, Sweden.	kristin.scharnweber@ebc.uu.se			Swedish Research Council Formas; Swedish Research Council VR; Academy of Finland [263350]; German Academic Exchange Service (DAAD); Olsson Borghs Stifelse	Swedish Research Council Formas(Swedish Research CouncilSwedish Research Council Formas); Swedish Research Council VR(Swedish Research Council); Academy of Finland(Academy of Finland); German Academic Exchange Service (DAAD)(Deutscher Akademischer Austausch Dienst (DAAD)); Olsson Borghs Stifelse	Financial support came from the Swedish Research Council Formas, and the Swedish Research Council VR to PE, the Academy of Finland (grant number 263350) to US, and the German Academic Exchange Service (DAAD), and Olsson Borghs Stifelse to KS.	Abrahams M, 1997, BEHAV ECOL SOCIOBIOL, V40, P169, DOI 10.1007/s002650050330; Algesten G, 2004, GLOBAL CHANGE BIOL, V10, P141, DOI 10.1111/j.1365-2486.2003.00721.x; Anderson MJ, 2008, PERMANOVA PRIMER GUI; Ask J, 2009, LIMNOL OCEANOGR, V54, P2034, DOI 10.4319/lo.2009.54.6.2034; Atwood TB, 2013, NAT GEOSCI, V6, P191, DOI 10.1038/ngeo1734; Bartels P, 2016, ECOSYSTEMS, V19, P955, DOI 10.1007/s10021-016-9978-x; Bartels P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043641; Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Bell JG, 2003, AQUACULTURE, V218, P491, DOI 10.1016/S0044-8486(02)00370-8; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Bookstein F. L, 1991, MORPHOMETRIC TOOLS F; Brett MT, 1997, FRESHWATER BIOL, V38, P483, DOI 10.1046/j.1365-2427.1997.00220.x; Brothers S, 2014, LIMNOL OCEANOGR, V59, P1388, DOI 10.4319/lo.2014.59.4.1388; Craig N, 2015, LIMNOL OCEANOGR, V60, P2079, DOI 10.1002/lno.10153; Dall SRX, 2012, ECOL LETT, V15, P1189, DOI 10.1111/j.1461-0248.2012.01846.x; Dalsgaard J, 2003, ADV MAR BIOL, V46, P225, DOI 10.1016/S0065-2881(03)46005-7; EKLOV P, 1992, ANIM BEHAV, V44, P313, DOI 10.1016/0003-3472(92)90037-A; Estlander S, 2010, J FISH BIOL, V77, P241, DOI 10.1111/j.1095-8649.2010.02682.x; Faithfull CL, 2011, LIMNOL OCEANOGR, V56, P1703, DOI 10.4319/lo.2011.56.5.1703; Finstad AG, 2014, ECOL LETT, V17, P36, DOI 10.1111/ele.12201; FREDRICKSON HL, 1986, FEMS MICROBIOL ECOL, V38, P381, DOI 10.1111/j.1574-6968.1986.tb01751.x; Frost PC, 2003, J N AM BENTHOL SOC, V22, P51, DOI 10.2307/1467977; Galloway AWE, 2014, FRESHWATER BIOL, V59, P1902, DOI 10.1111/fwb.12394; Gutseit K, 2007, FRESHWATER BIOL, V52, P28, DOI 10.1111/j.1365-2427.2006.01668.x; Happel A, 2015, J GREAT LAKES RES, V41, P172, DOI 10.1016/j.jglr.2015.03.025; Heintz RA, 2004, T AM FISH SOC, V133, P559, DOI 10.1577/T03-035.1; Hendry AP, 2009, CAN J FISH AQUAT SCI, V66, P1383, DOI 10.1139/F09-074; Hilt S, 2013, FRESHWATER BIOL, V58, P2027, DOI 10.1111/fwb.12188; Hiltunen M, 2015, LIMNOL OCEANOGR, V60, P303, DOI 10.1002/lno.10028; JONES RI, 1992, HYDROBIOLOGIA, V229, P73, DOI 10.1007/BF00006992; Jonsson M, 2013, CAN J FISH AQUAT SCI, V70, P1685, DOI 10.1139/cjfas-2013-0150; Karlsson J, 2015, ECOLOGY, V96, P2870, DOI 10.1890/15-0515.1; Karlsson J, 2009, NATURE, V460, P506, DOI 10.1038/nature08179; Keller W, 2006, ENVIRON MONIT ASSESS, V115, P419, DOI 10.1007/s10661-006-7237-x; Kelly JR, 2012, MAR ECOL PROG SER, V446, P1, DOI 10.3354/meps09559; Klingenberg CP, 2016, DEV GENES EVOL, V226, P113, DOI 10.1007/s00427-016-0539-2; Klingenberg CP, 2011, MOL ECOL RESOUR, V11, P353, DOI 10.1111/j.1755-0998.2010.02924.x; Lau DCP, 2013, LIMNOL OCEANOGR, V58, P1149, DOI 10.4319/lo.2013.58.4.1149; Lau DCP, 2012, FRESHWATER BIOL, V57, P24, DOI 10.1111/j.1365-2427.2011.02690.x; Lebret K, 2012, LIMNOL OCEANOGR, V57, P727, DOI 10.4319/lo.2012.57.3.0727; Lepisto L, 1998, HYDROBIOLOGIA, V370, P89, DOI 10.1023/A:1017014330045; Litzow MA, 2006, MAR ECOL PROG SER, V315, P1, DOI 10.3354/meps315001; Mirman D., 2016, CROWTH CURVE ANAL VI; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Muller-Navarra DC, 2006, ARCH HYDROBIOL, V167, P501, DOI 10.1127/0003-9136/2006/0167-0501; Muller-Navarra DC, 2004, NATURE, V427, P69, DOI 10.1038/nature02210; Murray DS, 2014, AQUACULTURE, V431, P85, DOI 10.1016/j.aquaculture.2014.03.039; Napolitano GE, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P21; Olsson J, 2005, EVOL ECOL RES, V7, P1109; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Parrish CC, 1998, LIPIDS IN FRESHWATER ECOSYSTEMS, P4; Persson J, 2006, FRESHWATER BIOL, V51, P887, DOI 10.1111/j.1365-2427.2006.01540.x; PERSSON L, 1986, ECOLOGY, V67, P355, DOI 10.2307/1938578; Petrisic MG, 2013, GEOMICROBIOL J, V30, P291, DOI 10.1080/01490451.2012.688789; Puebla O, 2009, J FISH BIOL, V75, P960, DOI 10.1111/j.1095-8649.2009.02358.x; R Core Team, R LANG ENV STAT COMP; Rasanen K, 2008, ECOL LETT, V11, P624, DOI 10.1111/j.1461-0248.2008.01176.x; Ranaker L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102002; Ranaker L, 2012, FRESHWATER BIOL, V57, P1761, DOI 10.1111/j.1365-2427.2012.02836.x; Ravet JL, 2010, ECOLOGY, V91, P180, DOI 10.1890/08-2037.1; Rengefors K, 2012, HARMFUL ALGAE, V18, P65, DOI 10.1016/j.hal.2012.04.005; Revenga C, 2005, PHILOS T ROY SOC B, V360, P397, DOI 10.1098/rstb.2004.1595; Roulet N, 2006, NATURE, V444, P283, DOI 10.1038/444283a; Rueffler C, 2006, TRENDS ECOL EVOL, V21, P238, DOI 10.1016/j.tree.2006.03.003; Sargent J, 1999, AQUACULTURE, V179, P217, DOI 10.1016/S0044-8486(99)00191-X; Scharnweber K, 2016, ECOSPHERE, V7, DOI 10.1002/ecs2.1387; Schindler DE, 1997, SCIENCE, V277, P248, DOI 10.1126/science.277.5323.248; Schindler DE, 2008, ALGAL BOWL OVERFERTI, DOI [10.1111/fwb.12188, DOI 10.1111/FWB.12188]; Seehausen O, 2006, CURR BIOL, V16, pR334, DOI 10.1016/j.cub.2006.03.080; Shoup DE, 2009, T AM FISH SOC, V138, P1018, DOI 10.1577/T09-015.1; Smith TB, 1996, ANNU REV ECOL SYST, V27, P111, DOI 10.1146/annurev.ecolsys.27.1.111; Solomon CT, 2015, ECOSYSTEMS, V18, P376, DOI 10.1007/s10021-015-9848-y; Stasko AD, 2012, ENVIRON REV, V20, P173, DOI [10.1139/A2012-010, 10.1139/a2012-010]; Strandberg U, 2015, ECOSPHERE, V6, DOI 10.1890/ES14-00382.1; Streelman JT, 2003, TRENDS ECOL EVOL, V18, P126; Svanback R, 2003, OIKOS, V102, P273, DOI 10.1034/j.1600-0706.2003.12657.x; Svanback R, 2002, OECOLOGIA, V131, P61, DOI 10.1007/s00442-001-0861-9; Tocher DR, 2003, REV FISH SCI, V11, P107, DOI 10.1080/713610925; Vadeboncoeur Y, 2003, LIMNOL OCEANOGR, V48, P1408, DOI 10.4319/lo.2003.48.4.1408; Volk C, 2012, AQUAT ECOL, V46, P85, DOI 10.1007/s10452-011-9383-7; Vonlanthen P, 2012, NATURE, V482, P357, DOI 10.1038/nature10824; Vrede T, 2011, OIKOS, V120, P886, DOI 10.1111/j.1600-0706.2010.18939.x; Wagner CE, 2012, NATURE, V487, P366, DOI 10.1038/nature11144; Wood PJ, 1997, ENVIRON MANAGE, V21, P203, DOI 10.1007/s002679900019; Xu XL, 2002, LIPIDS, V37, P297, DOI 10.1007/s11745-002-0894-2; YANG XW, 1994, CAN J FISH AQUAT SCI, V51, P1391, DOI 10.1139/f94-139; Zhang J, 2010, LIMNOL OCEANOGR, V55, P30, DOI 10.4319/lo.2010.55.1.0030	87	7	7	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162470	10.1371/journal.pone.0162470	http://dx.doi.org/10.1371/journal.pone.0162470			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610617	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900107
J	Treloar, C; McCredie, L; Lloyd, AR				Treloar, Carla; McCredie, Luke; Lloyd, Andrew R.			The Prison Economy of Needles and Syringes: What Opportunities Exist for Blood Borne Virus Risk Reduction When Prices Are so High?	PLOS ONE			English	Article							HEPATITIS-C; EXCHANGE; MAINTENANCE; PREVALENCE; INJECTION; PROGRAMS; PEOPLE	Aim A formal Needle and Syringe Program (NSP) is not provided in Australian prisons. Injecting equipment circulates in prisons as part of an informal and illegal economy. This paper examined how this economy generates blood-borne virus (BBV) risk and risk mitigation opportunities for inmates. Method The HITS-p cohort recruited New South Wales inmates who had reported ever injecting drugs and who had a negative HCV serological test within 12 months prior to enrolment. For this study, qualitative interviews were conducted with 30 participants enrolled in HITS-p. Participants included 10 women and were incarcerated in 12 prisons. Results A needle/syringewas nominated as being typically priced in the 'inside' prison economy at $100-$150, with a range of $50-$350. Purchase or hire of equipment was paid for in cash (including transactions that occurred outside prison) and in exchange for drugs and other commodities. A range of other resources was required to enable successful needle/syringe economies, especially relationships with visitors and other prisoners, and violence to ensure payment of debts. Strategies to mitigate BBV risk included retaining one needle/syringe for personal use while hiring out others, keeping drug use (and ownership of equipment) "quiet", stealing used equipment from the prison health clinic, and manufacture of syringes from other items available in the prison. Conclusions The provision of prison NSP would disrupt the inside economies built around contraband needles/syringes, as well as minimise BBV risk. However, any model of prison NSP should	[Treloar, Carla] UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia; [McCredie, Luke; Lloyd, Andrew R.] UNSW Australia, Sch Med Sci, Inflammat & Infect Res Ctr, Sydney, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney	Treloar, C (corresponding author), UNSW Australia, Ctr Social Res Hlth, Sydney, NSW, Australia.	c.treloar@unsw.edu.au	Lloyd, Andrew/AFJ-8960-2022; Lloyd, Andrew/AAF-6071-2022; Lloyd, Andrew/E-7334-2017	Lloyd, Andrew/0000-0001-6277-8887; Lloyd, Andrew/0000-0001-6277-8887; Treloar, Carla/0000-0002-8230-0386	National Health and Medical Research Council [APP1016351]; NSW Health; NHMRC Fellowship [APP1043067]	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); NSW Health; NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This project was funded by the National Health and Medical Research Council (APP1016351) and NSW Health. The funders had no direct role in the conduct of this research or the presentation of findings. ARL is supported by NHMRC Fellowship (APP1043067). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen-Scott LK, 2014, INT J PUBLIC HEALTH, V59, P3, DOI 10.1007/s00038-013-0526-6; Boelen L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0100749; Bonnycastle KD, 2011, HOWARD J CRIM JUSTIC, V50, P17; Bonnycastle KD, 2011, PRISON J, V91, P325, DOI 10.1177/0032885511409893; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [DOI 10.1191/1478088706QP063OA, 10.1191/1478088706qp063oa]; Bretana N, 2015, EMERG INFECT DIS, V21; Butler T, 2015, REPORT 2004 2010 201; Cooke DJ, 2008, CRIM JUSTICE BEHAV, V35, P1065, DOI 10.1177/0093854808318867; Copes H, 2010, VICTIMS OFFENDERS, V6, P1, DOI 10.1080/15564886.2011.534005; Crewe B., 2006, HOWARD J CRIM JUST, V45, P347, DOI [DOI 10.1111/j.1468-2311.2006.00428.x, 10.1111/j.1468-2311.2006.00428.x, DOI 10.1111/J.1468-2311.2006.00428.X]; de Viggiani N, 2007, SOCIOL HEALTH ILL, V29, P115, DOI 10.1111/j.1467-9566.2007.00474.x; Degenhardt L, 2010, LANCET, V376, P285, DOI 10.1016/S0140-6736(10)60742-8; Dolan K, 2003, ADDICTION, V98, P153, DOI 10.1046/j.1360-0443.2003.00309.x; Dolan K, 2010, EUROPEAN J EPIDEMIOL; Dolan KA, 1998, DRUG ALCOHOL REV, V17, P153, DOI 10.1080/09595239800186951; Fetherston J, 2013, J SUBST USE, V18, P65, DOI 10.3109/14659891.2012.760008; Hughes R, 2003, J OFFENDER REHABIL, V37, P47, DOI [10.1300/J076v37n03_03, DOI 10.1300/J076V37N03_03]; Hughes RA, 2000, EUR ADDICT RES, V6, P20, DOI 10.1159/000019005; Kalinich D, 1987, J CRIME JUSTICE, V10, P1; KALINICH DB, 1985, CRIM JUSTICE BEHAV, V12, P435, DOI 10.1177/0093854885012004003; Lankenau Stephen E, 2001, Prison J, V81, P142; Larney S, 2013, HEPATOLOGY, V58, P1215, DOI 10.1002/hep.26387; Levy MH, 2012, MED J AUSTRALIA, V197, P382, DOI 10.5694/mja12.10228; Lines R, 2005, INT J PRISON HEALTH, V1, P49, DOI 10.1080/17449200500157085; Luciani F, 2014, ADDICTION, V109, P1695, DOI 10.1111/add.12643; Mjaland K, 2014, PUNISHM SOC, V16, P336, DOI 10.1177/1462474514527149; Nathani J, 2010, DRUG ALCOHOL REV, V29, P413, DOI 10.1111/j.1465-3362.2009.00165.x; Rhodes T., 2002, INT J DRUG POLICY, V13, P85, DOI [10.1016/S0955-3959(02)00007-5, DOI 10.1016/S0955-3959(02)00007-5]; Rhodes T, 2009, INT J DRUG POLICY, V20, P193, DOI 10.1016/j.drugpo.2008.10.003; Sarang A, 2010, SUBST USE MISUSE, V45, P813, DOI 10.3109/10826081003590938; Stafford J, 2016, FINDINGS ILLICIT DRU; Stover H, 2016, DRUG-EDUC PREV POLIC, V23, P103, DOI 10.3109/09687637.2016.1148117; Stover H., 2003, International Journal of Drug Policy, V14, P437, DOI 10.1016/j.drugpo.2003.08.001; Tompkins CNE, 2016, DRUG-EDUC PREV POLIC, V23, P144, DOI 10.3109/09687637.2015.1085490; Tompkins CNE, 2013, INT J PRISON HEALTH, V9, P68, DOI 10.1108/17449201311326943; Treloar C, 2015, HARM REDUCT J, V12, DOI 10.1186/s12954-015-0045-2; UNODC, 2015, HDB START MAN NEEDL; WELLFORD C, 1967, J CRIM LAW CRIMINOL, V58, P197, DOI 10.2307/1140837; Wright NMJ, 2015, INT J PRISON HEALTH, V11, P17, DOI 10.1108/IJPH-09-2014-0032	39	16	16	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162399	10.1371/journal.pone.0162399	http://dx.doi.org/10.1371/journal.pone.0162399			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611849	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900089
J	Wendling, RJ; Christensen, AM; Quast, AD; Atzet, SK; Mann, BK				Wendling, Rian J.; Christensen, Amanda M.; Quast, Arthur D.; Atzet, Sarah K.; Mann, Brenda K.			Effect of Carboxymethylation on the Rheological Properties of Hyaluronan	PLOS ONE			English	Article							SODIUM HYALURONATE; ACID; OSTEOARTHRITIS; SUBSTITUTION; HYDROGELS; EFFICACY; STARCH; SAFETY; WATER; KNEE	Chemical modifications made to hyaluronan to enable covalent crosslinking to forma hydrogel or to attach other molecules may alter the physical properties as well, which have physiological importance. Here we created carboxymethyl hyaluronan (CMHA) with varied degree of modification and investigated the effect on the viscosity of CMHA solutions. Viscosity decreased initially as modification increased, with a minimum viscosity for about 3040% modification. This was followed by an increase in viscosity around 45-50% modification. The pH of the solution had a variable effect on viscosity, depending on the degree of carboxymethyl modification and buffer. The presence of phosphates in the buffer led to decreased viscosity. We also compared large-scale production lots of CMHA to lab-scale and found that large-scale required extended reaction times to achieve the same degree of modification. Finally, thiolated CMHA was disulfide crosslinked to create hydrogels with increased viscosity and shear-thinning aspects compared to CMHA solutions.	[Wendling, Rian J.; Mann, Brenda K.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Christensen, Amanda M.; Atzet, Sarah K.; Mann, Brenda K.] SentrX Anim Care Inc, Salt Lake City, UT 84108 USA; [Quast, Arthur D.] Univ Utah, Dept Chem, Salt Lake City, UT 84112 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Mann, BK (corresponding author), Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA.; Mann, BK (corresponding author), SentrX Anim Care Inc, Salt Lake City, UT 84108 USA.	bmann@eyegatepharma.com			University of Utah; SentrX Animal Care	University of Utah; SentrX Animal Care	RW was supported by an Undergraduate Research Opportunities Program award from the University of Utah. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The remaining authors received no specific funding for this work. SentrX Animal Care provided support in the form of salaries for authors AC, SKA, and BKM, and research materials, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Almond A, 2005, CARBOHYD RES, V340, P907, DOI 10.1016/j.carres.2005.01.014; Ambrosio L, 1999, J MACROMOL SCI PURE, VA36, P991, DOI 10.1080/10601329908951195; Brandt FS, 2008, CLIN INTERV AGING, V3, P153; Brandt KD, 2001, CLIN ORTHOP RELAT R, P130; Calinescu C, 2007, INT J PHARMACEUT, V343, P18, DOI 10.1016/j.ijpharm.2007.04.017; Chen WYJ, 1999, WOUND REPAIR REGEN, V7, P79, DOI 10.1046/j.1524-475X.1999.00079.x; Choi JI, 2010, CARBOHYD POLYM, V79, P1080, DOI 10.1016/j.carbpol.2009.10.041; Choi KY, 2012, COLLOID SURFACE B, V99, P82, DOI 10.1016/j.colsurfb.2011.10.029; Fakhari A, 2013, ACTA BIOMATER, V9, P7081, DOI 10.1016/j.actbio.2013.03.005; Falcone SJ, 2006, J BIOMED MATER RES A, V76A, P721, DOI 10.1002/jbm.a.30623; Fraser JRE, 1997, J INTERN MED, V242, P27, DOI 10.1046/j.1365-2796.1997.00170.x; Gatej L, 2005, BIOMACROMOLECULES, V6, P61, DOI 10.1021/bm040050m; GIBBS DA, 1968, BIOPOLYMERS, V6, P777, DOI 10.1002/bip.1968.360060603; GOA KL, 1994, DRUGS, V47, P536, DOI 10.2165/00003495-199447030-00009; Juni P, 2007, ARTHRITIS RHEUM-US, V56, P3610, DOI 10.1002/art.23026; Kogan G., 2007, HYALURONIC ACID, V47, P393; Krause WE, 2001, BIOMACROMOLECULES, V2, P65, DOI 10.1021/bm0055798; Li H, 2004, BIOMACROMOLECULES, V5, P895, DOI 10.1021/bm034463j; Mann BK., 2012, INT J CELL BIOL; Pasqui D, 2012, POLYMERS-BASEL, V4, P1517, DOI 10.3390/polym4031517; Patil KP, 2011, J BIOSCI BIOENG, V111, P286, DOI 10.1016/j.jbiosc.2010.10.012; Petta D, 2016, FRONT BIOENG BIOT C, DOI [10.3389/conf.FBIOE.2016.01.01092, DOI 10.3389/CONF.FBIOE.2016.01.01092]; Prestwich GD, 2008, CURR PHARM BIOTECHNO, V9, P242, DOI 10.2174/138920108785161523; Reddy K.J., 2013, J BIOSCI BIOTECHNOL, V2, P173; Schante CE, 2011, CARBOHYD POLYM, V85, P469, DOI 10.1016/j.carbpol.2011.03.019; Scott JE, 2002, BIOMACROMOLECULES, V3, P547, DOI 10.1021/bm010170j; Shi XW, 2006, J APPL POLYM SCI, V100, P4689, DOI 10.1002/app.23040; Shu XZ, 2002, BIOMACROMOLECULES, V3, P1304, DOI 10.1021/bm025603c; Stern R, 2007, BIOTECHNOL ADV, V25, P537, DOI 10.1016/j.biotechadv.2007.07.001; Stojanovic Z, 2005, STARCH-STARKE, V57, P79, DOI 10.1002/star.200400342; Toole BP, 1997, J INTERN MED, V242, P35, DOI 10.1046/j.1365-2796.1997.00171.x; Vanderhooft JL, 2007, BIOMACROMOLECULES, V8, P2883, DOI 10.1021/bm0703564; Wang J, 2005, J COLLOID INTERF SCI, V291, P75, DOI 10.1016/j.jcis.2005.04.095; Williams DL, 2013, INT J BIOMATER, V2013, DOI 10.1155/2013/460437; Williams DL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099766; Yue W, 2012, CARBOHYD POLYM, V89, P709, DOI 10.1016/j.carbpol.2012.03.081	36	5	7	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162849	10.1371/journal.pone.0162849	http://dx.doi.org/10.1371/journal.pone.0162849			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611817	Green Published, gold			2022-12-26	WOS:000383255900180
J	Maki, S				Maki, Syou			Magnetothermal Convection of Water with the Presence or Absence of a Magnetic Force Acting on the Susceptibility Gradient	PLOS ONE			English	Article							SUPERCONDUCTING MAGNET; ARCHIMEDES LEVITATION; PARAMAGNETIC FLUID; CRYSTAL-GROWTH; FIELD; SEPARATION; CRYSTALLIZATION; LYSOZYME; QUALITY; AIR	Heat transfer of magnetothermal convection with the presence or absence of the magnetic force acting on the susceptibility gradient (f(sc)) was examined by three-dimensional numerical computations. Thermal convection of water enclosed in a shallow cylindrical vessel (diameter over vessel height = 6.0) with the Rayleigh-Benard model was adopted as the model, under the conditions of Prandtl number 6.0 and Ra number 7000, respectively. The momentum equations of convection were nondimensionalized, which involved the term of f(sc) and the term of magnetic force acting on the magnetic field gradient (f(b)). All the computations resulted in axisymmetric steady rolls. The values of the averaged Nu, the averaged velocity components U, V, and W, and the isothermal distributions and flow patterns were almost completely the same, regardless of the presence or absence of the term of f(sc). As a result, we found that the effect of f(sc) was extremely small, although much previous research emphasized the effect with paramagnetic solutions under an unsteady state. The magnitude of f(sc) depends not only on magnetic conditions (magnitudes of magnetic susceptibility and magnetic flux density), but also on the thermal properties of the solution (thermal conductivity, thermal diffusivity, and viscosity). Therefore the effect of f(b) becomes dominant on the magnetothermal convection. Active control over the density gradient with temperature will be required to advance heat transfer with the effect of f(sc).	[Maki, Syou] Osaka Ohtani Univ, Fac Pharm, Lab Mol Chem, 3-11-1 Nishikiori Kita, Tondabayashi City, Osaka 5848540, Japan		Maki, S (corresponding author), Osaka Ohtani Univ, Fac Pharm, Lab Mol Chem, 3-11-1 Nishikiori Kita, Tondabayashi City, Osaka 5848540, Japan.	makisyo@osaka-ohtani.ac.jp			JSPS (Japan Society for the Promotion of Science) KAKENHI [15K04669]	JSPS (Japan Society for the Promotion of Science) KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	The author, S. Maki, received the following specific funding for this work. JSPS (Japan Society for the Promotion of Science) KAKENHI (Grant-in-Aid for Scientific Research) (C) (Grant number 15K04669).	Akamatsu M, 2003, NUMER HEAT TR A-APPL, V43, P9, DOI [10.1080/10407780307301, 10.1080/10407780390122547]; [Anonymous], 1986, CRC HDB PHYS; Astier JP, 1998, ACTA CRYSTALLOGR D, V54, P703, DOI 10.1107/S0907444997020052; Ataka M, 2002, ACTA CRYSTALLOGR D, V58, P1708, DOI 10.1107/S0907444902014415; BEAUGNON E, 1991, NATURE, V349, P470, DOI 10.1038/349470a0; Berry M. V., 1997, European Journal of Physics, V18, P307, DOI 10.1088/0143-0807/18/4/012; BRAITHWAITE D, 1991, NATURE, V354, P134, DOI 10.1038/354134a0; Bund A, 2005, J PHYS CHEM B, V109, P19845, DOI 10.1021/jp053341d; Catherall AT, 2003, NATURE, V422, P579, DOI 10.1038/422579a; Chandrasekhar C., 1961, HYDRODYNAMIC HYDROMA, P68; Chie K, 2003, J PHYS CHEM B, V107, P14374, DOI 10.1021/jp030688c; Coey JMD, 2007, J SOLID STATE ELECTR, V11, P711, DOI 10.1007/s10008-006-0254-4; Duan WY, 2005, J PHYS CHEM B, V109, P13445, DOI 10.1021/jp050469m; Faraday M., 1847, LONDON EDINBURGH DUB, V31, P401, DOI DOI 10.1080/14786444708645886; Filar P, 2006, J HEAT TRANS-T ASME, V128, P183, DOI 10.1115/1.2142334; Fujiwara Y, 2006, MOL PHYS, V104, P1659, DOI 10.1080/00268970600643556; Hayashi S, 2010, IEEE T APPL SUPERCON, V20, P945, DOI 10.1109/TASC.2010.2040161; HELLUMS JD, 1964, AICHE J, V10, P110, DOI 10.1002/aic.690100131; Hirt C. W., 1975, TECH REP; Holman J. P., 1992, HEAT TRANSFER, P663; Huang J, 1998, PHYS REV E, V57, P5564, DOI 10.1103/PhysRevE.57.5564; Kaneda M, 2002, J HEAT TRANS-T ASME, V124, P17, DOI 10.1115/1.1418369; Kimura T, 2000, CHEM LETT, P1294, DOI 10.1246/cl.2000.1294; Krause A, 2007, ELECTROCHIM ACTA, V52, P6338, DOI 10.1016/j.electacta.2007.04.054; Landau LD, 1960, ELECTRODYNAMICS CONT, V8, P142; Leventis N, 2005, J AM CHEM SOC, V127, P4988, DOI 10.1021/ja043169b; Leventis N, 2007, J SOLID STATE ELECTR, V11, P727, DOI 10.1007/s10008-006-0193-0; Lin SX, 2000, BIOCHEM BIOPH RES CO, V275, P274, DOI 10.1006/bbrc.2000.3294; Lopez-Alcaraz P, 2007, EUR PHYS J E, V24, P145, DOI 10.1140/epje/i2007-10225-1; Maki S, 2004, J CRYST GROWTH, V261, P557, DOI 10.1016/j.jcrysgro.2003.09.033; Maki S, 2002, J HEAT TRANS-T ASME, V124, P667, DOI 10.1115/1.1482082; Maki S, 2014, J FOOD ENG, V120, P31, DOI 10.1016/j.jfoodeng.2013.07.006; Maki S, 2013, J PHYS SOC JPN, V82, DOI 10.7566/JPSJ.82.033402; Motokawa M, 1998, PHYSICA B, V256, P618, DOI 10.1016/S0921-4526(98)00583-3; Mutschke G, 2010, ELECTROCHIM ACTA, V55, P9060, DOI 10.1016/j.electacta.2010.08.046; Nishikawa K., 1992, HEAT TRANSFER, P457; OBrien RN, 1997, J APPL ELECTROCHEM, V27, P573, DOI 10.1023/A:1018402813235; Ozoe H, 1998, NUMER HEAT TR B-FUND, V33, P355, DOI 10.1080/10407799808915038; Poodt PWG, 2006, CRYST GROWTH DES, V6, P2275, DOI 10.1021/cg0600546; Rabah KL, 2004, J ELECTROANAL CHEM, V571, P85, DOI 10.1016/j.jelechem.2004.04.014; Tagawa T, 2002, INT J HEAT MASS TRAN, V45, P267, DOI 10.1016/S0017-9310(01)00149-1; Takayama T, 2004, PHYSICA B, V346, P272, DOI 10.1016/j.physb.2004.01.064; Tanimoto Y, 2001, INT J APPL ELECTROM, V14, P311; Tanimoto Y, 2005, ENV SCI, V18, P53; Udagawa C, 2014, J PHYS CHEM B, V118, P4889, DOI 10.1021/jp5015675; Uetake H, 1999, J APPL PHYS, V85, P5735, DOI 10.1063/1.370268; Uhlemann M, 2005, J ELECTROCHEM SOC, V152, pC817, DOI 10.1149/1.2073167; WAKAYAMA NI, 1993, COMBUST FLAME, V93, P207, DOI 10.1016/0010-2180(93)90103-A; Wakayama NI, 1997, J CRYST GROWTH, V178, P653, DOI 10.1016/S0022-0248(97)00149-8; Waskaas M, 1999, J PHYS CHEM B, V103, P4876, DOI 10.1021/jp984730t; Weier T, 2007, ELECTROCHEM COMMUN, V9, P2479, DOI 10.1016/j.elecom.2007.07.026; Yang YJ, 2003, LANGMUIR, V19, P9446, DOI 10.1021/la0345688; Yin DC, 2004, J CRYST GROWTH, V270, P184, DOI 10.1016/j.jcrysgro.2004.05.106; Yokoi H, 2005, J APPL PHYS, V97, DOI 10.1063/1.1861394	54	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0160090	10.1371/journal.pone.0160090	http://dx.doi.org/10.1371/journal.pone.0160090			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606823	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600001
J	Wu, HL; Feng, JY; Lv, WT; Huang, QL; Fu, MS; Cai, MX; He, QQ; Shang, J				Wu, Huali; Feng, Junyi; Lv, Wenting; Huang, Qiaoling; Fu, Mengsi; Cai, Minxuan; He, Qiangqiang; Shang, Jing			Developmental Neurotoxic Effects of Percutaneous Drug Delivery: Behavior and Neurochemical Studies in C57BL/6 Mice	PLOS ONE			English	Article							PITUITARY-ADRENAL AXIS; 5-HT1A RECEPTOR; TACROLIMUS OINTMENT; TOPICAL APPLICATION; ATOPIC-DERMATITIS; RETINOIC ACID; SKIN; SYSTEM; BRAIN; HYDROQUINONE	Dermatosis often as a chronic disease requires effective long-term treatment; a comprehensive evaluation of mental health of dermatology drug does not receive enough attention. An interaction between dermatology and psychiatry has been increasingly described. Substantial evidence has accumulated that psychological stress can be associated with pigmentation, endocrine and immune systems in skin to create the optimal responses against pathogens and other physicochemical stressors to maintain or restore internal homeostasis. Additionally, given the common ectodermal origin shared by the brain and skin, we are interested in assessing how disruption of skin systems (pigmentary, endocrine and immune systems) may play a key role in brain functions. Thus, we selected three drugs (hydroquinone, isotretinoin, tacrolimus) with percutaneous excessive delivery to respectively intervene in these systems and then evaluate the potential neurotoxic effects. Firstly, C57BL/6 mice were administrated a dermal dose of hydroquinone cream, isotretinoin gel or tacrolimus ointment (2%, 0.05%, 0.1%, respectively, 5 times of the clinical dose). Behavioral testing was performed and levels of proteins were measured in the hippocampus. It was found that mice treated with isotretinoin or tacrolimus, presented a lower activity in open-field test and obvious depressive-like behavior in tail suspension test. Besides, they damaged cytoarchitecture, reduced the level of 5-HT-5-HT1A/1B system and increased the expression of apoptosis-related proteins in the hippocampus. To enable sensitive monitoring the dose-response characteristics of the consecutive neurobehavioral disorders, mice received gradient concentrations of hydroquinone (2%, 4%, 6%). Subsequently, hydroquinone induced behavioral disorders and hippocampal dysfunction in a dose-dependent response. When doses were high as 6% which was 3 times higher than 2% dose, then 100% of mice exhibited depressive-like behavior. Certainly, 6% hydroquinone exposure elicited the most serious impairment of hippocampal structure and survival. The fact that higher doses of hydroquinone are associated with a greater risk of depression is further indication that hydroquinone is responsible for the development of depression. These above data demonstrated that chronic administration of different dermatology drugs contributed into common mental distress. This surprising discovery of chemical stressors stimulating the hippocampal dysfunction, paves the way for exciting areas of study on the cross-talk between the skin and the brain, as well as is suggesting how to develop effective and safe usage of dermatological drugs in daily practice.	[Wu, Huali; Feng, Junyi; Lv, Wenting; Huang, Qiaoling; Fu, Mengsi; Cai, Minxuan; Shang, Jing] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Wu, Huali; Feng, Junyi; Lv, Wenting; Huang, Qiaoling; Fu, Mengsi; Cai, Minxuan; Shang, Jing] China Pharmaceut Univ, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing, Jiangsu, Peoples R China; [He, Qiangqiang] Chinese Acad Sci, Northwest Inst Plateau Biol, Qinghai Key Lab Tibetan Med Pharmacol & Safety Ev, Xining, Qinghai Provinc, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; Chinese Academy of Sciences	Shang, J (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.; Shang, J (corresponding author), China Pharmaceut Univ, Jiangsu Key Lab TCM Evaluat & Translat Res, Nanjing, Jiangsu, Peoples R China.	shangjing21cn@163.com			National Science and Technology Infrastructure Program of China [2012BAI30B001]; One Hundred Person Project of The Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province [Y229461211]; Science and Technology Plan Projects in Qinghai Province [2015-ZJ-733]	National Science and Technology Infrastructure Program of China; One Hundred Person Project of The Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province; Science and Technology Plan Projects in Qinghai Province	This study was supported by (1) National Science and Technology Infrastructure Program of China (2012BAI30B001) Prof Jing Shang, (2) One Hundred Person Project of The Chinese Academy of Sciences, Applied Basic Research Programs of Qinghai Province (Y229461211) Prof Jing Shang, and (3) Science and Technology Plan Projects in Qinghai Province (2015-ZJ-733) Prof Jing Shang.	Akhavan A, 2003, AM J CLIN DERMATOL, V4, P473, DOI 10.2165/00128071-200304070-00004; Alenina N, 2015, BEHAV BRAIN RES, V277, P49, DOI 10.1016/j.bbr.2014.07.038; Alikhan FS, 2011, CUTAN OCUL TOXICOL, V30, P175, DOI 10.3109/15569527.2011.560914; ANGEL A, 1972, TOXICOL APPL PHARM, V21, P214, DOI 10.1016/0041-008X(72)90064-6; Arck PC, 2003, AM J PATHOL, V162, P803, DOI 10.1016/S0002-9440(10)63877-1; Borovaya A, 2013, INT J DERMATOL, V52, P1040, DOI 10.1111/ijd.12169; Bremner JD, 2012, J CLIN PSYCHIAT, V73, P37, DOI 10.4088/JCP.10r05993; Claudet I, 2015, PEDIATR EMERG CARE, V31, P44, DOI 10.1097/PEC.0000000000000301; CloezTayarani I, 1997, P NATL ACAD SCI USA, V94, P9899, DOI 10.1073/pnas.94.18.9899; Draelos ZD, 2010, CUTIS, V86, P153; English JC, 2005, FOOD CHEM TOXICOL, V43, P483, DOI 10.1016/j.fct.2004.11.015; Ganceviciene R, 2009, BRIT J DERMATOL, V160, P345, DOI 10.1111/j.1365-2133.2008.08959.x; Harada M, 2000, Ryoikibetsu Shokogun Shirizu, P86; Hategan A, 2015, J NEUROPSYCH CLIN N, V27, pE140, DOI 10.1176/appi.neuropsych.14010011; Hazama Y, 2016, BIOL PHARM BULL, V39, P343, DOI 10.1248/bpb.b15-00727; Hiramoto K, 2011, CLIN EXP DERMATOL, V36, P52, DOI 10.1111/j.1365-2230.2010.03777.x; Jaako-Movits K, 2005, EUR J NEUROSCI, V22, P2871, DOI 10.1111/j.1460-9568.2005.04481.x; Jiang S, 2016, EVID-BASED COMPL ALT, V2047412, P25; Korabel Hanna, 2008, Przegl Lek, V65, P244; LAMMER EJ, 1985, NEW ENGL J MED, V313, P837, DOI 10.1056/NEJM198510033131401; Lee WS, 2016, KOREAN J INTERN MED, V31, P779, DOI 10.3904/kjim.2015.066; Liao S, 2012, EXP DERMATOL, V21, P635, DOI 10.1111/j.1600-0625.2012.01531.x; Mielke H, 2011, TOXICOL LETT, V204, P190, DOI 10.1016/j.toxlet.2011.04.032; Mitchell A, 1919, BRIT MED J, V1919, P465, DOI 10.1136/bmj.2.3067.465; Muller-Rover S, 2001, J INVEST DERMATOL, V117, P3, DOI 10.1046/j.0022-202x.2001.01377.x; Nordlind K, 2008, EXP DERMATOL, V17, P301, DOI 10.1111/j.1600-0625.2007.00670.x; Palchaudhuri M, 2005, CELL TISSUE RES, V321, P159, DOI 10.1007/s00441-005-1112-x; Panhans-Gross A, 2001, J ALLERGY CLIN IMMUN, V107, P345, DOI 10.1067/mai.2001.112600; Paterson LM, 2013, MED RES REV, V33, P54, DOI 10.1002/med.20245; Ping FF, 2012, NEUROSCI LETT, V514, P173, DOI 10.1016/j.neulet.2012.02.087; Popova NK, 2013, REV NEUROSCIENCE, V24, P191, DOI 10.1515/revneuro-2012-0082; Schettler T, 2006, INT J ANDROL, V29, P134, DOI 10.1111/j.1365-2605.2005.00567.x; Schuller E, 2004, J ALLERGY CLIN IMMUN, V114, P137, DOI 10.1016/j.jaci.2004.03.021; Seo DH, 2012, APPL MICROBIOL BIOT, V95, P1417, DOI 10.1007/s00253-012-4297-4; Skobowiat C, 2016, EXP DERMATOL, V25, P120, DOI 10.1111/exd.12890; Skobowiat C, 2015, J INVEST DERMATOL, V135, P1638, DOI 10.1038/jid.2014.450; Skobowiat C, 2011, AM J PHYSIOL-ENDOC M, V301, pE484, DOI [10.1152/ajpendo.00217.2011, 10.1152/ajpendo.00217.2011.]; Slominski A, 2005, DERMATOLOGY, V211, P199, DOI 10.1159/000087012; Slominski A, 2005, FASEB J, V19, P176, DOI 10.1096/fj.04-2079rev; Slominski Andrzej, 2008, Drug Discov Today Dis Mech, V5, P137; Slominski AT, 2012, ADV ANAT EMBRYOL CEL, V212, P1; Slominski AT, 2013, ENDOCR REV, V34, P827, DOI 10.1210/er.2012-1092; STERU L, 1985, PSYCHOPHARMACOLOGY, V85, P367, DOI 10.1007/BF00428203; Tobin DJ, 2006, CHEM SOC REV, V35, P52, DOI 10.1039/b505793k; Topping DC, 2007, FOOD CHEM TOXICOL, V45, P70, DOI 10.1016/j.fct.2006.07.019; Undre NA, 2009, BRIT J DERMATOL, V160, P665, DOI 10.1111/j.1365-2133.2008.08974.x; VANE F M, 1988, Skin Pharmacology, V1, P237; Wijdicks EFM, 2001, LIVER TRANSPLANT, V7, P937, DOI 10.1053/jlts.2001.27475; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Wu H, 2014, SCI WORLD J, DOI 10.1155/2014/237356; Wu HL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089663; Zhou J, 2014, J DERMATOL SCI, V73, P110, DOI 10.1016/j.jdermsci.2013.09.005	52	6	6	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162570	10.1371/journal.pone.0162570	http://dx.doi.org/10.1371/journal.pone.0162570			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606422	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600066
J	Cai, SR; Qiu, AQ; Broekman, BFP; Wong, EQ; Gluckman, PD; Godfrey, KM; Saw, SM; Soh, SE; Kwek, K; Chong, YS; Meaney, MJ; Kramer, MS; Rifkin-Graboi, A				Cai, Shirong; Qiu, Anqi; Broekman, Birit F. P.; Wong, Eric Qinlong; Gluckman, Peter D.; Godfrey, Keith M.; Saw, Seang Mei; Soh, Shu-E; Kwek, Kenneth; Chong, Yap-Seng; Meaney, Michael J.; Kramer, Michael S.; Rifkin-Graboi, Anne		GUSTO Study Grp	The Influence of Gestational Diabetes on Neurodevelopment of Children in the First Two Years of Life: A Prospective Study	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; IRON-DEFICIENCY ALTERS; ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; EXPLICIT MEMORY PERFORMANCE; AUDITORY RECOGNITION MEMORY; MISMATCH NEGATIVITY MMN; NEUROCOGNITIVE-DEVELOPMENT; NEWBORN-INFANTS; SCHOOL-AGE; LONG-TERM	Objective Analyze the relation of gestational diabetes and maternal blood glucose levels to early cognitive functions in the first two years of life. Methods In a prospective Singaporean birth cohort study, pregnant women were screened for gestational diabetes at 26-28 weeks gestation using a 75-g oral glucose tolerance test. Four hundred and seventy three children (n = 74 and n = 399 born to mothers with and without gestational diabetes respectively) underwent neurocognitive assessments at 6, 18, and/or 24 month, including electrophysiology during an attentional task and behavioral measures of attention, memory and cognition. Results Gestational diabetes is related to left hemisphere EPmax amplitude differences (oddball versus standard) at both six (P = 0.039) and eighteen months (P = 0.039), with mean amplitudes suggesting offspring of mothers with gestational diabetes exhibit greater neuronal activity to standard stimuli and less to oddball stimuli. Associations between 2-hour maternal glucose levels and the difference in EPmax amplitude were marginal at 6 months [adjusted beta = -0.19 (95% CI: -0.42 to +0.04) mu V, P = 0.100] and significant at 18 months [adjusted beta = -0.27 (95% CI: -0.49 to -0.06) mu V, P = 0.014], and the EPmax amplitude difference (oddball-standard) associated with the Bayley Scales of Infant and toddler Development-III cognitive score at 24 months [beta = 0.598 (95% CI: 0.158 to 1.038), P = 0.008]. Conclusion Gestational diabetes and maternal blood glucose levels are associated with offspring neuronal activity during an attentional task at both six and eighteen months. Such electrophysiological differences are likely functionally important, having been previously linked to attention problems later in life.	[Cai, Shirong; Chong, Yap-Seng; Kramer, Michael S.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Obstet & Gynaecol, Singapore, Singapore; [Qiu, Anqi; Broekman, Birit F. P.; Wong, Eric Qinlong; Gluckman, Peter D.; Soh, Shu-E; Chong, Yap-Seng; Meaney, Michael J.; Rifkin-Graboi, Anne] ASTAR, Singapore Inst Clin Sci, Singapore, Singapore; [Qiu, Anqi] Natl Univ Singapore, Dept Biomed Engn, Singapore, Singapore; [Qiu, Anqi] Natl Univ Singapore, Clin Imaging Res Ctr, Singapore, Singapore; [Broekman, Birit F. P.] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Psychol Med, Singapore, Singapore; [Gluckman, Peter D.] Univ Auckland, Liggins Inst, Auckland, New Zealand; [Godfrey, Keith M.] Univ Southampton, MRC Lifecourse Epidemiol Unit, Southampton, Hants, England; [Godfrey, Keith M.] Univ Southampton, NIHR Southampton Biomed Res Ctr, Southampton, Hants, England; [Godfrey, Keith M.] Univ Hosp Southampton NHS Fdn Trust, Southampton, Hants, England; [Saw, Seang Mei] Natl Univ Singapore, Saw Swee Hock Sch Publ Hlth, Singapore, Singapore; [Soh, Shu-E] Natl Univ Singapore, Natl Univ Hlth Syst, Yong Loo Lin Sch Med, Dept Pediat, Singapore, Singapore; [Kwek, Kenneth] KK Womens & Childrens Hosp, Dept Maternal & Fetal Med, Singapore, Singapore; [Meaney, Michael J.] McGill Univ, Dept Psychiat, Fac Med, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Fac Med, Montreal, PQ, Canada; [Kramer, Michael S.] McGill Univ, Dept Pediat, Fac Med, Montreal, PQ, Canada	National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Institute for Clinical Sciences (SICS); National University of Singapore; National University of Singapore; National University of Singapore; University of Auckland; University of Southampton; University of Southampton; University of Southampton; University Hospital Southampton NHS Foundation Trust; National University of Singapore; National University of Singapore; KK Women's & Children's Hospital; McGill University; McGill University; McGill University	Rifkin-Graboi, A (corresponding author), ASTAR, Singapore Inst Clin Sci, Singapore, Singapore.	anne_rifkin@sics.a-star.edu.sg	Meaney, Michael/N-5931-2019; Qiu, Anqi/H-2267-2011; Rifkin-Graboi, Anne/AFM-0959-2022; Rifkin-Graboi, Anne/AAH-3658-2022	Qiu, Anqi/0000-0002-0215-6338; Rifkin-Graboi, Anne/0000-0002-7641-4678; SOH, SHU E/0000-0002-0790-4200; Chong, Yap Seng/0000-0002-7232-8473; Godfrey, Keith/0000-0002-4643-0618; Cai, Shirong/0000-0002-0650-2234	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Program; Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore [NMRC/TCR/004-NUS/2008, NMRC/TCR/012-NUHS/2014]; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; Abbott Nutrition Research and Development Asia-Pacific Center; MRC [MC_UP_A620_1017, MC_UU_12011/4] Funding Source: UKRI; Medical Research Council [MC_UU_12011/4, MC_UP_A620_1017] Funding Source: researchfish; National Institute for Health Research [NF-SI-0515-10042] Funding Source: researchfish	Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Program; Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore; Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore; Abbott Nutrition Research and Development Asia-Pacific Center; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This research is supported by the Singapore National Research Foundation under its Translational and Clinical Research (TCR) Flagship Program and administered by the Singapore Ministry of Health's National Medical Research Council (NMRC), Singapore- NMRC/TCR/004-NUS/2008; NMRC/TCR/012-NUHS/2014. Additional funding is provided by the Singapore Institute for Clinical Sciences, Agency for Science Technology and Research (A*STAR), Singapore and Abbott Nutrition Research and Development Asia-Pacific Center. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Barry RJ, 2003, CLIN NEUROPHYSIOL, V114, P184, DOI 10.1016/S1388-2457(02)00363-2; Bayley N., 2019, BAYLEY SCALES INFANT; Bell R, 2008, BJOG-INT J OBSTET GY, V115, P445, DOI 10.1111/j.1471-0528.2007.01644.x; Buckley BS, 2012, DIABETIC MED, V29, P844, DOI 10.1111/j.1464-5491.2011.03541.x; Cai SR, 2015, AM J CLIN NUTR, V101, P326, DOI 10.3945/ajcn.114.095414; Chee CYI, 2005, J AFFECT DISORDERS, V89, P157, DOI 10.1016/j.jad.2005.09.004; COWAN N, 1993, J EXP PSYCHOL LEARN, V19, P909, DOI 10.1037/0278-7393.19.4.909; DeBoer T, 2005, DEV MED CHILD NEUROL, V47, P525, DOI 10.1017/S0012162205001039; deReginer RA, 2000, J PEDIATR-US, V137, P777, DOI 10.1067/mpd.2000.109149; Deregnier RA, 2007, DEV NEUROPSYCHOL, V31, P379, DOI 10.1080/87565640701229524; Dionne G, 2008, PEDIATRICS, V122, pE1073, DOI 10.1542/peds.2007-3028; Fellman V, 2004, PEDIATR RES, V56, P291, DOI 10.1203/01.PDR.0000132750.97066.B9; Franken IHA, 2005, BIOL PSYCHOL, V70, P161, DOI 10.1016/j.biopsycho.2005.01.007; Fraser A, 2014, CURR DIABETES REP, V14, DOI 10.1007/s11892-014-0489-x; Fraser A, 2014, DIABETOLOGIA, V57, P102, DOI 10.1007/s00125-013-3065-z; Fraser A, 2012, EXP DIABETES RES, DOI 10.1155/2012/963735; Hay WW, 2012, CURR DIABETES REP, V12, P4, DOI 10.1007/s11892-011-0243-6; Ibanez G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135849; JACOBSON SW, 1992, CHILD DEV, V63, P711; Jenum AK, 2012, EUR J ENDOCRINOL, V166, P317, DOI 10.1530/EJE-11-0866; Jing HK, 2006, BRAIN DEV-JPN, V28, P247, DOI 10.1016/j.braindev.2005.09.002; Jing H, 2007, DEV NEUROPSYCHOL, V31, P349, DOI 10.1080/87565640701229227; Jorgenson LA, 2003, DEV NEUROSCI-BASEL, V25, P412, DOI 10.1159/000075667; Koschack J, 2003, PSYCHOL MED, V33, P481, DOI 10.1017/S0033291702007067; Kushnerenko EV, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00595; Linder K, 2015, J CLIN ENDOCRINOLOGY; Nelson CA, 2000, BEHAV NEUROSCI, V114, P950, DOI 10.1037//0735-7044.114.5.950; Nelson CA, 2003, J PEDIATR-US, V142, P575, DOI 10.1067/mpd.2003.210; Nelson CA, 2008, J AM ACAD CHILD PSY, V47, P1252, DOI 10.1097/CHI.0b013e318185a6d8; Nold JL, 2004, PEDIATR CLIN N AM, V51, P619, DOI 10.1016/j.pcl.2004.01.003; Nomura Y, 2012, ARCH PEDIAT ADOL MED, V166, P337, DOI 10.1001/archpediatrics.2011.784; Oades RD, 1996, BIOL PSYCHOL, V43, P163, DOI 10.1016/0301-0511(96)05189-7; Ornoy A, 1999, ARCH DIS CHILD-FETAL, V81, pF10, DOI 10.1136/fn.81.1.F10; Ornoy A, 2001, J PEDIATR ENDOCR MET, V14, P681; Ornoy Asher, 2005, Pediatr Endocrinol Rev, V3, P104; Rao R, 2003, J NUTR, V133, P3215, DOI 10.1093/jn/133.10.3215; Riggins T, 2010, ADV CHILD DEV BEHAV, V38, P73; Riggins T, 2009, DEV NEUROPSYCHOL, V34, P762, DOI 10.1080/87565640903265145; RIZZO TA, 1994, AM J OBSTET GYNECOL, V171, P706, DOI 10.1016/0002-9378(94)90086-8; Rustad JK, 2011, PSYCHONEUROENDOCRINO, V36, P1276, DOI 10.1016/j.psyneuen.2011.03.005; Sheese Brad E, 2009, Cogn Neuropsychiatry, V14, P332, DOI 10.1080/13546800902844064; Siddappa AM, 2004, PEDIATR RES, V55, P1034, DOI 10.1203/01.pdr.0000127021.38207.62; Soh SE, 2013, INT J EPIDEMIOL; Stenninger E, 1998, ARCH DIS CHILD-FETAL, V79, pF174, DOI 10.1136/fn.79.3.F174; Thiagayson P, 2013, GEN HOSP PSYCHIAT, V35, P112, DOI 10.1016/j.genhosppsych.2012.11.006; THOMPSON RF, 1966, PSYCHOL REV, V73, P16, DOI 10.1037/h0022681; van den Heuvel MI, 2015, SOC COGN AFFECT NEUR, V10, P453, DOI 10.1093/scan/nsu075; Veena SR, 2010, ARCH DIS CHILD, V95, P347, DOI 10.1136/adc.2009.165159; Wong L., 2001, SMJ Singapore Medical Journal, V42, P517; Yoncheva Y, 2014, NEUROIMAGE, V97, P262, DOI 10.1016/j.neuroimage.2014.04.006	51	28	28	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162113	10.1371/journal.pone.0162113	http://dx.doi.org/10.1371/journal.pone.0162113			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603522	Green Accepted, Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200043
J	Han, JM; Guo, RH; Li, JQ; Guan, C; Chen, Y; Zhao, W				Han, Jimin; Guo, Ronghui; Li, Jiaqi; Guan, Chen; Chen, Yu; Zhao, Wei			Organ Mass Variation in a Toad Headed Lizard Phrynocephalus vlangalii in Response to Hypoxia and Low Temperature in the Qinghai-Tibet Plateau, China	PLOS ONE			English	Article							HIGH-ALTITUDE; PHENOTYPIC PLASTICITY; BREATHING PATTERN; ADAPTATION; TOLERANCE; VERTEBRATES; DIVERGENCE; QUATERNARY; GRADIENT; HISTORY	Hypoxia and low temperature at high altitudes are the main environmental pressures for alpine animals, inducing phenotypic plasticity at several levels. To investigate the effect of these variables on the organ mass of Phrynocephalus vlangalii, 138 individuals belonging to four populations living along an altitudinal gradient in the Qinghai-Tibet Plateau (China) were dissected to remove heart, lungs, stomach, and intestinal tract. Organ dry mass, individuals' sex, and body mass, as well as mean annual temperature and average air pressure (calculated from a 30-year-data series obtained from the National Climatic Data Center) were subjected to two-way analyses of covariance and generalized linear mixed models (GLMMs). Except for the heart, organ mass varied significantly among populations, although only lung and stomach mass increased significantly with increasing altitude. Males' heart and lung mass was higher than that of females, which might be due to their different behavior and reproductive efforts. GLMM analyses indicated that air pressure had a positive effect on heart, lung and intestinal tract mass, whereas temperature had a negative effect on these three organs. In order to explain the effect of hypoxia and low temperature on P. vlangalii's organ mass, further rigorous study on respiration, energy budget and food intake was encouraged.	[Han, Jimin; Guo, Ronghui; Guan, Chen; Chen, Yu; Zhao, Wei] Lanzhou Univ, Sch Life Sci, Lanzhou, Gansu, Peoples R China; [Li, Jiaqi] Minist Environm Protect, Nanjing Inst Environm Sci, Nanjing, Jiangsu, Peoples R China	Lanzhou University	Zhao, W (corresponding author), Lanzhou Univ, Sch Life Sci, Lanzhou, Gansu, Peoples R China.	zhaowei@lzu.edu.cn			Fundamental Research Funds for the Central Universities [lzujbky-2014-93]; National Nature grants [31200287, 31471988]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); National Nature grants	The Fundamental Research Funds for the Central Universities, W Zhao (lzujbky-2014-93, http://kyc.lzu.edu.cn/lzupage/B20100520025646.html); National Nature grants W Zhao (31200287, http://www.nsfc.gov.cn/Portal0/default152.htm); National Nature grants, Liu NF (31471988, http://www.nsfc.gov.cn/Portal0/default152.htm).	Beall CM, 2007, P NATL ACAD SCI USA, V104, P8655, DOI 10.1073/pnas.0701985104; Favre A, 2015, BIOL REV, V90, P236, DOI 10.1111/brv.12107; Fonseca EM, 2012, COMP BIOCHEM PHYS A, V162, P281, DOI 10.1016/j.cbpa.2012.03.020; Hammond KA, 2001, J EXP BIOL, V204, P1991; He JZ, 2013, COMP BIOCHEM PHYS A, V165, P207, DOI 10.1016/j.cbpa.2013.03.007; He JZ, 2013, J EXP ZOOL PART A, V319A, P117, DOI 10.1002/jez.1776; Hicks JW, 1999, AM J PHYSIOL-REG I, V277, pR18, DOI 10.1152/ajpregu.1999.277.1.R18; Hochachka PW, 2001, COMP BIOCHEM PHYS B, V130, P435, DOI 10.1016/S1096-4959(01)00408-0; Jin YT, 2013, MOL PHYLOGENET EVOL, V68, P259, DOI 10.1016/j.ympev.2013.03.022; Jin YT, 2014, MOL PHYLOGENET EVOL, V71, P288, DOI 10.1016/j.ympev.2013.11.004; Kelly SA, 2012, COMPR PHYSIOL, V2, P1417, DOI 10.1002/cphy.c110008; Lei FM, 2014, CURR ZOOL, V60, P149, DOI 10.1093/czoolo/60.2.149; Li JQ, 2014, HERPETOL J, V24, P17; Liao JC, 2010, MAMM BIOL, V75, P381, DOI 10.1016/j.mambio.2009.11.003; Lu SS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125751; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Mingji C, 2015, HEART, V101, P1054, DOI 10.1136/heartjnl-2014-307158; Mortola JP, 2000, ANNU REV PHYSIOL, V62, P847, DOI 10.1146/annurev.physiol.62.1.847; Munns SL, 1998, PHYSIOL ZOOL, V71, P267, DOI 10.1086/515913; Naeije R, 2010, PROG CARDIOVASC DIS, V52, P456, DOI 10.1016/j.pcad.2010.03.004; Qi Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041130; Qi Y, 2011, ASIAN HERPETOL RES, V2, P110, DOI 10.3724/SP.J.1245.2011.00110; Ramirez JM, 2007, ANNU REV PHYSIOL, V69, P113, DOI 10.1146/annurev.physiol.69.031905.163111; Storz JF, 2010, J EXP BIOL, V213, P4125, DOI 10.1242/jeb.048181; Wang Shuo-guo, 2004, Sichuan Daxue Xuebao (Ziran Kexueban), V41, P403; Wang Z, 2014, OECOLOGIA, V174, P639, DOI 10.1007/s00442-013-2811-8; Wang Z, 2013, ASIAN HERPETOL RES, V4, P214, DOI 10.3724/SP.J.1245.2013.00214; Wu YY, 2015, ECOL EVOL, V5, P5138, DOI 10.1002/ece3.1783; Xin Y, 2015, COMP BIOCHEM PHYS B, V188, P31, DOI 10.1016/j.cbpb.2015.06.004; Zhang DF, 2000, ENVIRON GEOL, V39, P1352, DOI 10.1007/s002540000174; Zhang Y, 2015, COMP BIOCHEM PHYS A, V190, P9, DOI 10.1016/j.cbpa.2015.08.013; Zhao KT, 1979, J INNER MONGOLIA U, V2, P111	32	8	9	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162572	10.1371/journal.pone.0162572	http://dx.doi.org/10.1371/journal.pone.0162572			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603795	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255200076
J	Ciappuccini, R; Aide, N; Blanchard, D; Rame, JP; de Raucourt, D; Michels, JJ; Babin, E; Bardet, S				Ciappuccini, Renaud; Aide, Nicolas; Blanchard, David; Rame, Jean-Pierre; de Raucourt, Dominique; Michels, Jean-Jacques; Babin, Emmanuel; Bardet, Stephane			Incremental Value of a Dedicated Head and Neck Acquisition during F-18-FDG PET/CT in Patients with Differentiated Thyroid Cancer	PLOS ONE			English	Article							POINT-SPREAD FUNCTION; HIGH-RESOLUTION HEAD; TIME-OF-FLIGHT; LYMPH-NODE; TOMOGRAPHY/COMPUTED TOMOGRAPHY; PROGNOSTIC VALUE; FDG-PET/CT; RECURRENT; CARCINOMA; IMPACT	Objectives F-18-FDG-PET/CT is a useful tool used to evidence persistent/recurrent disease (PRD) in patients with differentiated thyroid cancer and iodine-refractory lesions. The aim of this study was to compare the diagnostic value at the cervical level of the routine whole-body (WB) acquisition and that of a complementary head and neck (HN) acquisition, performed successively during the same PET/CT study. Methods PET/CT studies combining WB and HN acquisitions performed in 85 consecutive patients were retrospectively reviewed by two nuclear medicine physicians. F-18-FDG uptake in cervical lymph nodes (LN) or in the thyroid bed was assessed. Among the 85 patients, the PET/CT results of the 26 who subsequently underwent neck surgery were compared with surgical and pathological reports. The size of each largest nodal metastasis was assessed by a pathologist. Results In the 85 patients, inter-observer agreement was excellent for both WB and HN PET/CT interpretation. Of the 26 patients who underwent surgery, 25 had pathology proven PRD in the neck. Of these 25 patients, 15 displayed FDG uptake on either WB or HN PET. In these 15 patients, HN PET detected more malignant lesions than WB PET did (21/27 = 78% vs. 12/27 = 44%, P = 0.006). Node/background ratios were significantly higher on HN than on WB PET (P<0.0001). Three false-negative studies (20%) on WB PET were upstaged as true-positive on HN PET. The mean size of the largest LN metastasis was 3 mm for the LN detected neither on WB nor on HN PET, 7 mm for the metastasis detected on HN but not WB PET, and 13 mm for those detected on both acquisitions (P = 0.0004). Receiver-Operating Characteristic analysis showed that area under the curve was higher for HN PET than for WB PET (0.97 [95% CI, 0.90-0.99] vs 0.88 [95% CI, 0.78-0.95], P = 0.009). Conclusions HN acquisition improves the ability to detect PRD in the neck compared with WB acquisition alone. We recommend systematically adding an HN acquisition when PET/CT is performed to detect PRD in the neck.	[Ciappuccini, Renaud; Aide, Nicolas; Bardet, Stephane] Francois Baclesse Canc Ctr, Dept Nucl Med, Caen, France; [Ciappuccini, Renaud; Aide, Nicolas; Bardet, Stephane] Francois Baclesse Canc Ctr, Thyroid Unit, Caen, France; [Ciappuccini, Renaud; Babin, Emmanuel] Normandie Univ, INSERM, Canc & Prevent U1086, Caen, France; [Aide, Nicolas] Francois Baclesse Canc Ctr, INSERM, BioTICLA Unit, U1199, Caen, France; [Aide, Nicolas] Normandie Univ, Caen, France; [Aide, Nicolas] Univ Hosp, Dept Nucl Med, Caen, France; [Blanchard, David; Rame, Jean-Pierre; de Raucourt, Dominique] Francois Baclesse Canc Ctr, Dept Head & Neck Surg, Caen, France; [Michels, Jean-Jacques] Francois Baclesse Canc Ctr, Dept Pathol, Caen, France; [Babin, Emmanuel] Univ Hosp, Dept Head & Neck Surg, Caen, France	UNICANCER; Centre Francois Baclesse; UNICANCER; Centre Francois Baclesse; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Centre Francois Baclesse; CHU de Caen NORMANDIE; UNICANCER; Centre Francois Baclesse; UNICANCER; Centre Francois Baclesse; CHU de Caen NORMANDIE	Ciappuccini, R (corresponding author), Francois Baclesse Canc Ctr, Dept Nucl Med, Caen, France.; Ciappuccini, R (corresponding author), Francois Baclesse Canc Ctr, Thyroid Unit, Caen, France.; Ciappuccini, R (corresponding author), Normandie Univ, INSERM, Canc & Prevent U1086, Caen, France.	r.ciappuccini@baclesse.unicancer.fr	Marie-José, Lucas/ABE-1443-2020; Ciappuccini, Renaud/ABD-8805-2020; AIDE, Nicolas/K-6547-2015	Ciappuccini, Renaud/0000-0002-5181-8182; AIDE, Nicolas/0000-0001-9207-0847; Babin, Emmanuel/0000-0002-3568-8955				Aide N, 2009, J CLIN ENDOCR METAB, V94, P2075, DOI 10.1210/jc.2008-2313; Avram AM, 2015, J CLIN ENDOCR METAB, V100, P1895, DOI 10.1210/jc.2014-4043; Bardet S, 2015, J CLIN ENDOCR METAB, V100, P132, DOI 10.1210/jc.2014-1199; Bellevre D, 2014, EUR J NUCL MED MOL I, V41, P1103, DOI 10.1007/s00259-014-2689-7; Boellaard R, 2015, EUR J NUCL MED MOL I, V42, P328, DOI 10.1007/s00259-014-2961-x; Boellaard R, 2010, EUR J NUCL MED MOL I, V37, P181, DOI 10.1007/s00259-009-1297-4; Chatziioannou SN, 2014, ACAD RADIOL, V21, P58, DOI 10.1016/j.acra.2013.09.017; Cheng G, 2013, EUR J NUCL MED MOL I, V40, P779, DOI 10.1007/s00259-013-2343-9; Choi JS, 2009, AM J ROENTGENOL, V193, P871, DOI 10.2214/AJR.09.2386; Cooper DS, 2009, THYROID, V19, P1167, DOI 10.1089/thy.2009.0110; Davison JM, 2008, CLIN NUCL MED, V33, P464, DOI 10.1097/RLU.0b013e31817792c9; Durante C, 2013, ENDOCR-RELAT CANCER, V20, pR141, DOI 10.1530/ERC-13-0066; Freudenberg LS, 2007, EUR RADIOL, V17, P3139, DOI 10.1007/s00330-007-0682-2; Grunwald F, 1999, EUR J NUCL MED, V26, P1547, DOI 10.1007/s002590050493; Haugen BR, 2016, THYROID, V26, P1, DOI 10.1089/thy.2015.0020; Hughes DT, 2012, ANN SURG ONCOL, V19, P2951, DOI 10.1245/s10434-012-2380-9; Hwang HS, 2011, LARYNGOSCOPE, V121, P487, DOI 10.1002/lary.21227; Kadrmas DJ, 2009, J NUCL MED, V50, P1315, DOI 10.2967/jnumed.109.063016; Kunawudhi A, 2012, CLIN NUCL MED, V37, P561, DOI 10.1097/RLU.0b013e318252d30e; Lasnon C, 2012, CLIN NUCL MED, V37, P971, DOI 10.1097/RLU.0b013e318251e3d1; Leboulleux S, 2009, J CLIN ENDOCR METAB, V94, P1310, DOI 10.1210/jc.2008-1747; PACINI F, 1992, J CLIN ENDOCR METAB, V74, P1401, DOI 10.1210/jc.74.6.1401; Robbins KT, 2002, ARCH OTOLARYNGOL, V128, P751, DOI 10.1001/archotol.128.7.751; Rodrigues RS, 2009, J NUCL MED, V50, P1205, DOI 10.2967/jnumed.109.062075; Rogasch JMM, 2015, EJNMMI RES, V5, DOI 10.1186/s13550-015-0111-5; Schluter B, 2001, J NUCL MED, V42, P71; Teoh EJ, 2016, EUR RADIOL, V26, P576, DOI 10.1007/s00330-015-3832-y; Travagli JP, 1998, J CLIN ENDOCR METAB, V83, P2675, DOI 10.1210/jc.83.8.2675; Wang WP, 2000, J CLIN ENDOCR METAB, V85, P1107, DOI 10.1210/jc.85.3.1107; Weber T, 2012, HORM METAB RES, V44, P904, DOI 10.1055/s-0032-1316351; Yim JH, 2011, J CLIN ENDOCR METAB, V96, P2049, DOI 10.1210/jc.2010-2298	31	7	7	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162482	10.1371/journal.pone.0162482	http://dx.doi.org/10.1371/journal.pone.0162482			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598385	Green Submitted, gold, Green Published			2022-12-26	WOS:000383254800069
J	Kim, E; Kim, Y				Kim, Eunseong; Kim, Yonggyun			Translational Control of Host Gene Expression by a Cys-Motif Protein Encoded in a Bracovirus	PLOS ONE			English	Article							COTESIA-PLUTELLAE BRACOVIRUS; CAMPOLETIS-SONORENSIS ICHNOVIRUS; INHIBITORY FACTOR; DIAMONDBACK MOTH; IMMUNOSUPPRESSIVE ROLE; HEMOCYTE POPULATION; CHELONUS-INANITUS; PARASITIC WASP; POLYDNAVIRUS; IDENTIFICATION	Translational control is a strategy that various viruses use to manipulate their hosts to suppress acute antiviral response. Polydnaviruses, a group of insect double-stranded DNA viruses symbiotic to some endoparasitoid wasps, are divided into two genera: ichnovirus (IV) and bracovirus (BV). In IV, some Cys-motif genes are known as host translation-inhibitory factors (HTIF). The genome of endoparasitoid wasp Cotesia plutellae contains a Cys-motif gene (Cp-TSP13) homologous to an HTIF known as teratocyte-secretory protein 14 (TSP14) of Microplitis croceipes. Cp-TSP13 consists of 129 amino acid residues with a predicted molecular weight of 13.987 kDa and pI value of 7.928. Genomic DNA region encoding its open reading frame has three introns. Cp-TSP13 possesses six conserved cysteine residues as other Cys-motif genes functioning as HTIF. Cp-TSP13 was expressed in Plutella xylostella larvae parasitized by C. plutellae. C. plutellae bracovirus (CpBV) was purified and injected into non-parasitized P. xylostella that expressed Cp-TSP13. Cp-TSP13 was cloned into a eukaryotic expression vector and used to infect Sf9 cells to transiently express Cp-TSP13. The synthesized Cp-TSP13 protein was detected in culture broth. An overlaying experiment showed that the purified Cp-TSP13 entered hemocytes. It was localized in the cytosol. Recombinant Cp-TSP13 significantly inhibited protein synthesis of secretory proteins when it was added to in vitro cultured fat body. In addition, the recombinant Cp-TSP13 directly inhibited the translation of fat body mRNAs in in vitro translation assay using rabbit reticulocyte lysate. Moreover, the recombinant Cp-TSP13 significantly suppressed cellular immune responses by inhibiting hemocyte-spreading behavior. It also exhibited significant insecticidal activities by both injection and feeding routes. These results indicate that Cp-TSP13 is a viral HTIF.	[Kim, Eunseong; Kim, Yonggyun] Andong Natl Univ, Dept Bioresource Sci, Andong 36729, South Korea	Andong National University	Kim, Y (corresponding author), Andong Natl Univ, Dept Bioresource Sci, Andong 36729, South Korea.	hosanna@andong.ac.kr			framework of international cooperation program [2014K2A2A2000441]	framework of international cooperation program	This study was supported by a grant (2014K2A2A2000441) under the framework of international cooperation program managed by National Research Foundation of Korea. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali MR, 2015, INSECT MOL BIOL, V24, P13, DOI 10.1111/imb.12132; Armitage SAO, 2012, BMC EVOL BIOL, V12, DOI 10.1186/1471-2148-12-53; Asgari S, 2006, ARCH INSECT BIOCHEM, V61, P146, DOI 10.1002/arch.20109; Bae S, 2004, COMP BIOCHEM PHYS A, V138, P39, DOI 10.1016/j.cbpb.2004.02.018; Barandoc KP, 2010, COMP BIOCHEM PHYS B, V156, P129, DOI 10.1016/j.cbpb.2010.03.001; Barandoc KP, 2009, COMP BIOCHEM PHYS D, V4, P218, DOI 10.1016/j.cbd.2009.03.003; Basio NAM, 2003, PHYSIOL ENTOMOL, V31, P341; Beliveau C, 2015, J VIROL, V89, P8909, DOI 10.1128/JVI.01001-15; Bezier A, 2009, SCIENCE, V323, P926, DOI 10.1126/science.1166788; Bezier A, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0047; BHANDARI V, 1992, BIOCHEM BIOPH RES CO, V188, P57, DOI 10.1016/0006-291X(92)92349-3; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Burke GR, 2015, J VIROL, V89, P9511, DOI 10.1128/JVI.01388-15; Burke GR, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004660; Burke GR, 2014, MOL ECOL, V23, P890, DOI 10.1111/mec.12648; Burke GR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003348; Burke GR, 2012, J VIROL, V86, P3293, DOI 10.1128/JVI.06434-11; Calvete JJ, 2005, TOXICON, V45, P1063, DOI 10.1016/j.toxicon.2005.02.024; Chen YF, 2011, VIROLOGY, V414, P42, DOI 10.1016/j.virol.2011.03.009; Chevignon G, 2015, INSECT BIOCHEM MOLEC, V62, P86, DOI 10.1016/j.ibmb.2014.12.008; Chevignon G, 2014, J VIROL, V88, P8795, DOI 10.1128/JVI.00209-14; Choi JY, 2009, ARCH VIROL, V154, P1313, DOI 10.1007/s00705-009-0441-6; Consoli FL, 2004, COMP BIOCHEM PHYS B, V137, P463, DOI 10.1016/j.cbpc.2004.02.001; Cui LW, 1997, ARCH INSECT BIOCHEM, V36, P251, DOI 10.1002/(SICI)1520-6327(1997)36:4<251::AID-ARCH2>3.0.CO;2-V; Dahlman DL, 2003, INSECT MOL BIOL, V12, P527, DOI 10.1046/j.1365-2583.2003.00439.x; Dahlman DL, 1991, BIOL CONTROL, V1, P118, DOI 10.1016/1049-9644(91)90110-L; Einerwold J, 2001, BIOCHEMISTRY-US, V40, P14404, DOI 10.1021/bi011499s; Etebari K, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-446; FLEMING JAGW, 1991, P NATL ACAD SCI USA, V88, P9770, DOI 10.1073/pnas.88.21.9770; Furihata S, 2014, J INVERTEBR PATHOL, V115, P26, DOI 10.1016/j.jip.2013.10.013; Gill TA, 2013, INSECT MOL BIOL, V22, P341, DOI 10.1111/imb.12022; Hanington PC, 2008, INSECT BIOCHEM MOLEC, V38, P596, DOI 10.1016/j.ibmb.2008.02.002; HARWOOD SH, 1994, VIROLOGY, V205, P381, DOI 10.1006/viro.1994.1659; He ZH, 2003, J MOL MED-JMM, V81, P600, DOI 10.1007/s00109-003-0474-3; Hepat R, 2013, J INVERTEBR PATHOL, V114, P34, DOI 10.1016/j.jip.2013.05.004; Herniou EA, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2013.0051; Ibrahim AMA, 2007, DEV COMP IMMUNOL, V31, P978, DOI 10.1016/j.dci.2006.11.005; Ibrahim AMA, 2006, J INSECT PHYSIOL, V52, P943, DOI 10.1016/j.jinsphys.2006.06.001; Kaeslin M, 2005, J INSECT PHYSIOL, V51, P1330, DOI 10.1016/j.jinsphys.2005.08.003; Kim Y, 2005, ARCH INSECT BIOCHEM, V59, P230, DOI 10.1002/arch.20074; Kim Yonggyun, 2006, Journal of Asia-Pacific Entomology, V9, P37, DOI 10.1016/S1226-8615(08)60273-3; Kim Yonggyun, 2007, Journal of Asia-Pacific Entomology, V10, P181, DOI 10.1016/S1226-8615(08)60351-9; Kumar S, 2016, DEV COMP IMMUNOL, V54, P97, DOI 10.1016/j.dci.2015.09.003; Kumar S, 2014, COMP BIOCHEM PHYS A, V177, P27, DOI 10.1016/j.cbpa.2014.07.017; Kwon B, 2008, DEV COMP IMMUNOL, V32, P932, DOI 10.1016/j.dci.2008.01.005; Kwon B, 2010, J INSECT PHYSIOL, V56, P650, DOI 10.1016/j.jinsphys.2010.01.013; Lee S, 2008, ARCH INSECT BIOCHEM, V67, P157, DOI 10.1002/arch.20218; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Louis F, 2013, J VIROL, V87, P9649, DOI 10.1128/JVI.00886-13; Nalini M, 2007, J INSECT PHYSIOL, V53, P1283, DOI 10.1016/j.jinsphys.2007.07.004; Ng TH, 2014, DEV COMP IMMUNOL, V46, P129, DOI 10.1016/j.dci.2014.04.002; Ote M, 2005, COMP BIOCHEM PHYS B, V141, P314, DOI 10.1016/j.cbpc.2005.04.005; Park B, 2011, BMB REP, V44, P393, DOI 10.5483/BMBRep.2011.44.6.393; Park B, 2011, IMMUNITY, V34, P505, DOI 10.1016/j.immuni.2011.01.018; Pestova TV, 2001, P NATL ACAD SCI USA, V98, P7029, DOI 10.1073/pnas.111145798; Pohl M, 2013, BIOSYSTEMS, V114, P31, DOI 10.1016/j.biosystems.2013.07.003; Prasad SV, 2014, DEV COMP IMMUNOL, V44, P152, DOI 10.1016/j.dci.2013.12.001; Ragan EJ, 2010, J BIOL CHEM, V285, P29642, DOI 10.1074/jbc.M110.125419; Rana RL, 2002, INSECT BIOCHEM MOLEC, V32, P1507, DOI 10.1016/S0965-1748(02)00071-1; Ribeiro C, 1999, J INSECT PHYSIOL, V45, P677, DOI 10.1016/S0022-1910(99)00043-8; SAS Institute, 1989, SAS STAT US GUID REL; Savary S, 1999, INSECT MOL BIOL, V8, P319, DOI 10.1046/j.1365-2583.1999.83130.x; Schmucker D, 2009, GENE DEV, V23, P147, DOI 10.1101/gad.1752909; SHELBY KS, 1994, J GEN VIROL, V75, P2285, DOI 10.1099/0022-1317-75-9-2285; Shelby KS, 1997, INSECT BIOCHEM MOLEC, V27, P263, DOI 10.1016/S0965-1748(96)00095-1; STOLTZ DB, 1990, J GEN VIROL, V71, P1051, DOI 10.1099/0022-1317-71-5-1051; Strand MR, 2013, CURR OPIN VIROL, V3, P587, DOI 10.1016/j.coviro.2013.06.004; Strand MR, 2010, INSECT VIROLOGY, P171; Surakasi VP, 2011, INSECT MOL BIOL, V20, P609, DOI 10.1111/j.1365-2583.2011.01091.x; Svitkin YV, 2001, RNA, V7, P1743; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Valzania L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095104; VINSON SB, 1976, ANNU REV ENTOMOL, V21, P109, DOI 10.1146/annurev.en.21.010176.000545; Volkoff AN, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000923; Webb BA, 2006, VIROLOGY, V347, P160, DOI 10.1016/j.virol.2005.11.010; WEBB BA, 1994, ARCH INSECT BIOCHEM, V26, P147, DOI 10.1002/arch.940260208; Wyler T, 2003, J GEN VIROL, V84, P1151, DOI 10.1099/vir.0.18830-0; Yeh Jennifer E, 2015, Genes Cancer, V6, P153; Yu RX, 2007, J INSECT PHYSIOL, V53, P22, DOI 10.1016/j.jinsphys.2006.09.011	79	3	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161661	10.1371/journal.pone.0161661	http://dx.doi.org/10.1371/journal.pone.0161661			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598941	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800014
J	Atanelishvili, I; Shirai, Y; Akter, T; Noguchi, A; Ash, KT; Misra, S; Ghatak, S; Silver, RM; Bogatkevich, GS				Atanelishvili, Ilia; Shirai, Yuichiro; Akter, Tanjina; Noguchi, Atsushi; Ash, Kurt T.; Misra, Suniti; Ghatak, Sibnath; Silver, Richard M.; Bogatkevich, Galina S.			D1398G Variant of MET Is Associated with Impaired Signaling of Hepatocyte Growth Factor in Alveolar Epithelial Cells and Lung Fibroblasts	PLOS ONE			English	Article							TYROSINE KINASE RECEPTOR; SYSTEMIC-SCLEROSIS; C-MET; CASPASE CLEAVAGE; GENE-TRANSFER; FIBROSIS; APOPTOSIS; EXPRESSION; PROTOONCOGENE; AMERICAN	Pulmonary fibrosis represents the terminal stage of a diverse group of lung diseases including scleroderma associated interstitial lung disease. The molecular mechanisms underlying the pathogenesis of lung fibrosis are not well understood and there is a great need for more effective treatment for this lethal disease. We recently discovered a small fragment of hepatocyte growth factor (HGF) receptor MET as a peptide designated "M10," with strong antifi-brotic properties. Furthermore, we showed that aspartic acid at position 1398 of MET is essential for M10 generation. The current study was undertaken to investigate the D1398G variant of MET in which aspartic acid at position 1398 was mutated to glycine resulting in loss of M10. We demonstrate that lung fibroblasts, A549, and primary alveolar epithelial cells (AEC) expressing D1398G MET exhibit reduced auto-phosphorylation on tyrosine residues and reduced activation of Ras and MAPK. HGF treatment of scleroderma lung fibroblasts as well as HGF treatment of TGF beta-treated normal lung fibroblasts transfected with wild type MET is associated with decreased collagen, connective tissue growth factor (CTGF, CCN2) and smooth muscle alpha-actin (SMA). However, HGF has no such effects in cells transfected with MET D1398G. Cisplatin- and FasL-induced apoptosis is significantly reduced in AEC transfected with MET wild type, but not in AEC transfected with MET D1398G. We conclude that the D1398G variant of MET is associated with compromised phosphorylation and impaired HGF signaling in lung fibroblasts and AEC, two cell types implicated in the pathogenesis of pulmonary fibrosis associated with scleroderma. Ongoing studies will explore the frequency of this variant and its relationship to pulmonary outcomes in scleroderma patients.	[Atanelishvili, Ilia; Shirai, Yuichiro; Akter, Tanjina; Noguchi, Atsushi; Ash, Kurt T.; Silver, Richard M.; Bogatkevich, Galina S.] Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA; [Shirai, Yuichiro] Nippon Med Sch, Dept Allergy & Rheumatol, Tokyo, Japan; [Misra, Suniti; Ghatak, Sibnath] Med Univ South Carolina, Dept Regenerat Med & Cell Biol, Charleston, SC USA	Medical University of South Carolina; Nippon Medical School; Medical University of South Carolina	Bogatkevich, GS (corresponding author), Med Univ South Carolina, Dept Med, Div Rheumatol & Immunol, Charleston, SC 29425 USA.	bogatkev@musc.edu		Ash, Kurt/0000-0002-4460-9673	Clinical Research Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases [P60 AR062755]; Scleroderma Foundation; South Carolina COBRE for Developmentally Based Cardiovascular Diseases (NIH-NIGMS) [P30 GM103342]	Clinical Research Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases; Scleroderma Foundation; South Carolina COBRE for Developmentally Based Cardiovascular Diseases (NIH-NIGMS)	This study was funded by the Multidisciplinary Clinical Research Center grant from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (P60 AR062755 to GSB and RMS) and by Scleroderma Foundation (to GSB). Imaging core was supported by South Carolina COBRE for Developmentally Based Cardiovascular Diseases (NIH-NIGMS P30 GM103342). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akter T, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0411-1; Atanelishvili I, 2016, TRANSL RES, V170, P99, DOI 10.1016/j.trsl.2015.12.009; Atanelishvili I, 2014, AM J RESP CELL MOL, V50, P893, DOI 10.1165/rcmb.2013-0317OC; Bhogal RK, 2005, J CLIN IMMUNOL, V25, P592, DOI 10.1007/s10875-005-7827-3; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P3468, DOI 10.1002/art.22874; Bogatkevich GS, 2007, ARTHRITIS RHEUM-US, V56, P2432, DOI 10.1002/art.22713; Bogatkevich GS, 2001, J BIOL CHEM, V276, P45184, DOI 10.1074/jbc.M106441200; Bogatkevich GS, 2012, RHEUMATOL CURR RES S, VS1, pe001; Campbell SL, 1998, ONCOGENE, V17, P1395, DOI 10.1038/sj.onc.1202174; Crestani Bruno, 2012, Proc Am Thorac Soc, V9, P158, DOI 10.1513/pats.201202-018AW; DEAN M, 1985, NATURE, V318, P385, DOI 10.1038/318385a0; Dohi M, 2000, AM J RESP CRIT CARE, V162, P2302, DOI 10.1164/ajrccm.162.6.9908097; Foveau B, 2007, CELL DEATH DIFFER, V14, P752, DOI 10.1038/sj.cdd.4402080; GALIMI F, 1993, STEM CELLS, V11, P22; Gazdhar A, 2013, HUM GENE THER, V24, P105, DOI 10.1089/hum.2012.098; Greidinger EL, 1998, CHEST, V114, P801, DOI 10.1378/chest.114.3.801; Grotegut S, 2006, EMBO J, V25, P3534, DOI 10.1038/sj.emboj.7601213; Inoue H, 2003, FASEB J, V17, pA468; Kawaguchi Y, 2002, J RHEUMATOL, V29, P1877; Krishnan E, 2005, EUR J EPIDEMIOL, V20, P855, DOI 10.1007/s10654-005-2210-5; Leask Andrew, 2002, Curr Rheumatol Rep, V4, P136, DOI 10.1007/s11926-002-0009-x; Lee YH, 2008, AM J PHYSIOL-LUNG C, V294, pL778, DOI 10.1152/ajplung.00410.2007; Lefebvre J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.377; LIEBER M, 1976, INT J CANCER, V17, P62, DOI 10.1002/ijc.2910170110; LONGATI P, 1994, ONCOGENE, V9, P49; Ma PC, 2003, CANCER METAST REV, V22, P309, DOI 10.1023/A:1023768811842; McNearney TA, 2007, ARTHRIT RHEUM-ARTHR, V57, P318, DOI 10.1002/art.22532; Mizuno S, 2005, FASEB J, V19, P580, DOI 10.1096/fj.04-1535fje; Moeller HB, 2010, P NATL ACAD SCI USA, V107, P424, DOI 10.1073/pnas.0910683107; NAKAMURA T, 1991, Progress in Growth Factor Research, V3, P67, DOI 10.1016/0955-2235(91)90014-U; NALDINI L, 1991, ONCOGENE, V6, P501; Nietert PJ, 2005, J RHEUMATOL, V32, P1888; Okazaki S, 2010, RHEUMATOL INT, V30, P871, DOI 10.1007/s00296-009-1068-3; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rodrigues G A, 1993, EXS, V65, P167; Schoenfeld SR, 2015, RHEUM DIS CLIN N AM, V41, P237, DOI 10.1016/j.rdc.2014.12.005; Silver RM, 2012, CURR OPIN RHEUMATOL, V24, P642, DOI 10.1097/BOR.0b013e328356d9dc; Steen V, 2012, ARTHRITIS RHEUM-US, V64, P2986, DOI 10.1002/art.34482; Thomason P, 2000, J CELL SCI, V113, P3141; Tulasne D, 2004, MOL CELL BIOL, V24, P10328, DOI 10.1128/MCB.24.23.10328-10339.2004; van den Hoogen F, 2013, ARTHRITIS RHEUM-US, V65, P2737, DOI 10.1002/art.38098; Varga JA, 2008, RHEUM DIS CLIN N AM, V34, P115, DOI 10.1016/j.rdc.2007.11.002; VIGNA E, 1994, CELL MOL BIOL, V40, P597; Watanabe M, 2005, MOL THER, V12, P58, DOI 10.1016/j.ymthe.2005.02.019; YANAGITA K, 1993, J BIOL CHEM, V268, P21212; Zimmer Y, 2010, CANCER LETT, V289, P228, DOI 10.1016/j.canlet.2009.08.017	46	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162357	10.1371/journal.pone.0162357	http://dx.doi.org/10.1371/journal.pone.0162357			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584154	Green Submitted, Green Published, gold			2022-12-26	WOS:000382855600130
J	Reppschlager, K; Gosselin, J; Dangelmaier, CA; Thomas, DH; Carpino, N; McKenzie, SE; Kunapuli, SP; Tsygankov, AY				Reppschlaeger, Kevin; Gosselin, Jeanne; Dangelmaier, Carol A.; Thomas, Dafydd H.; Carpino, Nick; McKenzie, Steven E.; Kunapuli, Satya P.; Tsygankov, Alexander Y.			TULA-2 Protein Phosphatase Suppresses Activation of Syk through the GPVI Platelet Receptor for Collagen by Dephosphorylating Tyr(P)(346), a Regulatory Site of Syk	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						platelet; protein phosphorylation; signaling; spleen tyrosine kinase (Syk); tyrosine-protein kinase (tyrosine kinase); tyrosine-protein phosphatase (tyrosine phosphatase); GPVI receptor; ITAM; TULA-2	TYROSINE KINASE SYK; LINKER REGION TYROSINES; CELL ANTIGEN RECEPTOR; IN-VIVO; INTEGRIN ALPHA(IIB)BETA(3); PHARMACOLOGICAL ANALYSES; PHOSPHOLIPASE C-GAMMA-2; CARBOXYL-TERMINUS; STRUCTURAL BASIS; GLYCOPROTEIN-VI	Protein-tyrosine phosphatase TULA-2 has been shown to regulate receptor signaling in several cell types, including platelets. Platelets are critical for maintaining vascular integrity; this function is mediated by platelet aggregation in response to recognition of the exposed basement membrane collagen by the GPVI receptor, which is non-covalently associated with the signal-transducing FcR polypeptide chain. Our previous studies suggested that TULA-2 plays an important role in negatively regulating signaling through GPVI-FcR and indicated that the tyrosine-protein kinase Syk is a key target of the regulatory action of TULA-2 in platelets. However, the molecular basis of the down-regulatory effect of TULA-2 on Syk activation via FcR remained unclear. In this study, we demonstrate that suppression of Syk activation by TULA-2 is mediated, to a substantial degree, by dephosphorylation of Tyr(P)(346), a regulatory site of Syk, which becomes phosphorylated soon after receptor ligation and plays a critical role in initiating the process that yields fully activated Syk. TULA-2 is capable of dephosphorylating Tyr(P)(346) with high efficiency, thus controlling the overall activation of Syk, but is less efficient in dephosphorylating other regulatory sites of this kinase. Therefore, dephosphorylation of Tyr(P)(346) may be considered an important checkpoint in the regulation of Syk activation process. Putative biological functions of TULA-2-mediated dephosphorylation of Tyr(P)(346) may include deactivation of receptor-activated Syk or suppression of Syk activation by suboptimal stimulation.	[Reppschlaeger, Kevin; Gosselin, Jeanne; Tsygankov, Alexander Y.] Temple Univ, Dept Microbiol & Immunol, Lewis Katz Sch Med, Philadelphia, PA 19140 USA; [Kunapuli, Satya P.] Temple Univ, Lewis Katz Sch Med, Dept Physiol, Philadelphia, PA 19140 USA; [Dangelmaier, Carol A.; Thomas, Dafydd H.; Kunapuli, Satya P.; Tsygankov, Alexander Y.] Temple Univ, Lewis Katz Sch Med, Sol Sherry Thrombosis Res Ctr, Philadelphia, PA 19140 USA; [Carpino, Nick] SUNY Stony Brook, Dept Mol Genet & Microbiol, Stony Brook, NY 11794 USA; [McKenzie, Steven E.] Thomas Jefferson Univ, Cardeza Fdn Hematol Res, Philadelphia, PA 19107 USA; [Reppschlaeger, Kevin] Ernst Moritz Arndt Univ Greifswald, D-17489 Greifswald, Germany; [Gosselin, Jeanne] Polytech Clermont Ferrand, Ingenieur Genie Biol, F-63178 Clermont Ferrand, Auvergne, France; [Thomas, Dafydd H.] PMV Pharmaceut, Cranbury Township, NJ 08512 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; Pennsylvania Commonwealth System of Higher Education (PCSHE); Temple University; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Jefferson University; Ernst Moritz Arndt Universitat Greifswald; Universite Clermont Auvergne (UCA)	Tsygankov, AY (corresponding author), Temple Univ, Lewis Katz Sch Med, Kresge Bldg,Rm 506,3440 N Broad St, Philadelphia, PA 19140 USA.	tsygan@temple.edu	Tsygankov, Alexander Y/K-6205-2017	Fechtner, Kevin/0000-0003-3841-0331; McKenzie, Steven/0000-0003-2654-8560	American Heart Association [13IRG14230008]; National Institutes of Health [HL93231, HL118593, HL110860]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL110860, R01HL118593, R01HL093231] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported in whole or part by American Heart Association Grant 13IRG14230008 (to A. Y. T.) and National Institutes of Health Grants HL93231 and HL118593 (to S. P. K.) and HL110860 (to S. E. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Agrawal R, 2008, J CELL BIOCHEM, V104, P953, DOI 10.1002/jcb.21678; Asazuma N, 2000, J BIOL CHEM, V275, P33427, DOI 10.1074/jbc.M001439200; Back SH, 2013, CELL MOL LIFE SCI, V70, P1269, DOI 10.1007/s00018-012-1203-2; Bauer M, 2001, THROMB HAEMOSTASIS, V85, P331, DOI 10.1055/s-0037-1615689; BLAKE RA, 1994, FEBS LETT, V353, P212, DOI 10.1016/0014-5793(94)01037-4; Bohnenberger H, 2011, EUR J IMMUNOL, V41, P1550, DOI 10.1002/eji.201041326; Briddon SJ, 1999, BIOCHEM J, V338, P203, DOI 10.1042/0264-6021:3380203; Bye AP, 2016, J THROMB HAEMOST, V14, P918, DOI 10.1111/jth.13302; Carpino N, 2004, IMMUNITY, V20, P37, DOI 10.1016/S1074-7613(03)00351-0; Carpino N, 2002, MOL CELL BIOL, V22, P7491, DOI 10.1128/MCB.22.21.7491-7500.2002; Chen XW, 2010, J BIOL CHEM, V285, P31268, DOI 10.1074/jbc.M110.114181; Cieniewicz B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090196; CLARK EA, 1994, J BIOL CHEM, V269, P28859; Collingwood TS, 2007, J BIOL CHEM, V282, P30920, DOI 10.1074/jbc.M706870200; Couture C, 1997, EUR J BIOCHEM, V246, P447, DOI 10.1111/j.1432-1033.1997.00447.x; COUTURE C, 1994, P NATL ACAD SCI USA, V91, P5301, DOI 10.1073/pnas.91.12.5301; DANIEL JL, 1994, BIOCHEM J, V302, P617, DOI 10.1042/bj3020617; de Castro RO, 2010, J BIOL CHEM, V285, P26674, DOI 10.1074/jbc.M110.134262; de Castro RO, 2012, J BIOL CHEM, V287, P8194, DOI 10.1074/jbc.M111.326850; Dunster JL, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004589; Feshchenko EA, 2004, ONCOGENE, V23, P4690, DOI 10.1038/sj.onc.1207627; Furlong MT, 1997, BBA-MOL CELL RES, V1355, P177, DOI 10.1016/S0167-4889(96)00131-0; Gradler U, 2013, J MOL BIOL, V425, P309, DOI 10.1016/j.jmb.2012.11.007; Groesch TD, 2006, J MOL BIOL, V356, P1222, DOI 10.1016/j.jmb.2005.11.095; Hong JJ, 2002, J BIOL CHEM, V277, P31703, DOI 10.1074/jbc.M201362200; Keshvara LM, 1997, J BIOL CHEM, V272, P10377; Kleinman H, 2006, ACTA CRYSTALLOGR F, V62, P218, DOI 10.1107/S1744309106003320; Kowanetz K, 2004, J BIOL CHEM, V279, P32786, DOI 10.1074/jbc.M403759200; Kulathu Y, 2008, EMBO J, V27, P1333, DOI 10.1038/emboj.2008.62; KUROSAKI T, 1995, J EXP MED, V182, P1815, DOI 10.1084/jem.182.6.1815; Law CL, 1996, MOL CELL BIOL, V16, P1305; Law DA, 1999, BLOOD, V93, P2645, DOI 10.1182/blood.V93.8.2645.408k13_2645_2652; Luis BS, 2014, FEBS J, V281, P696, DOI 10.1111/febs.12615; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Mikhailik A, 2007, MOL CELL, V27, P486, DOI 10.1016/j.molcel.2007.06.015; Newman TN, 2014, IMMUNOL CELL BIOL, V92, P837, DOI 10.1038/icb.2014.60; Quek LS, 2000, BLOOD, V96, P4246; Raguz J, 2007, FEBS LETT, V581, P4767, DOI 10.1016/j.febslet.2007.08.077; San Luis B, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.177634; Simon M, 2005, J BIOL CHEM, V280, P4510, DOI 10.1074/jbc.M410326200; Smirnova EV, 2008, VIROLOGY, V372, P10, DOI 10.1016/j.virol.2007.10.012; Thien CBF, 1999, J IMMUNOL, V162, P7133; Thomas DH, 2010, BLOOD, V116, P2570, DOI 10.1182/blood-2010-02-268136; Tiganis T, 2007, BIOCHEM J, V402, P1, DOI 10.1042/BJ20061548; Tsang E, 2008, J BIOL CHEM, V283, P32650, DOI 10.1074/jbc.M806340200; Tsygankov AY, 2008, IUBMB LIFE, V60, P224, DOI 10.1002/iub.36; Tsygankov AY, 2013, J CELL PHYSIOL, V228, P43, DOI 10.1002/jcp.24128; Tsygankov AY, 2009, CELL MOL LIFE SCI, V66, P2949, DOI 10.1007/s00018-009-0071-x; TSYGANKOV AY, 1994, J LEUKOCYTE BIOL, V55, P289, DOI 10.1002/jlb.55.3.289; Tsygankov AY, 2003, FRONT BIOSCI-LANDMRK, V8, pS595, DOI 10.2741/1106; TSYGANKOV AY, 1994, J BIOL CHEM, V269, P7792; Watson SP, 1999, THROMB HAEMOSTASIS, V82, P365; Watson SP, 1998, IMMUNOL TODAY, V19, P260, DOI 10.1016/S0167-5699(98)01267-5; Yan QR, 2013, MOL CELL BIOL, V33, P2188, DOI 10.1128/MCB.01637-12; YANAGA F, 1995, BIOCHEM J, V311, P471, DOI 10.1042/bj3110471; Zhang J, 2000, J BIOL CHEM, V275, P35442, DOI 10.1074/jbc.M004549200; Zhang J, 2002, MOL CELL BIOL, V22, P8144, DOI 10.1128/MCB.22.23.8144-8154.2002; Zhang J, 2015, STEM CELL REP, V5, P633, DOI 10.1016/j.stemcr.2015.08.006; Zhang YJ, 2008, P NATL ACAD SCI USA, V105, P11760, DOI 10.1073/pnas.0708583105; Zhou YH, 2015, BLOOD, V126, P2871, DOI 10.1182/blood-2015-02-631135	60	19	20	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22427	22441		10.1074/jbc.M116.743732	http://dx.doi.org/10.1074/jbc.M116.743732			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609517	Green Published, hybrid			2022-12-26	WOS:000386760600007
J	Yoshitake, J; Soeda, Y; Ida, T; Sumioka, A; Yoshikawa, M; Matsushita, K; Akaike, T; Takashima, A				Yoshitake, Jun; Soeda, Yoshiyuki; Ida, Tomoaki; Sumioka, Akio; Yoshikawa, Misato; Matsushita, Kenji; Akaike, Takaaki; Takashima, Akihiko			Modification of Tau by 8-Nitroguanosine 3,5-Cyclic Monophosphate (8-Nitro-cGMP): EFFECTS OF NITRIC OXIDE-LINKED CHEMICAL MODIFICATION ON TAU AGGREGATION	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alzheimer disease; chemical modification; oxidative stress; protein aggregation; Tau protein (Tau); tauopathy; 8-nitro-cGMP; S-guanylation; cysteine modification	PAIRED HELICAL FILAMENTS; PROTEIN S-GUANYLATION; ALZHEIMERS-DISEASE; FRONTOTEMPORAL DEMENTIA; BETA-STRUCTURE; OLIGOMERS; MODEL; NEURODEGENERATION; TAUOPATHIES; DEFENSE	Neurofibrillar tangles caused by intracellular hyperphosphorylated tau inclusion and extracellular amyloid peptide deposition are hallmarks of Alzheimer's disease. Tau contains one or two cysteine residues in three or four repeats of the microtubule binding region following alternative splicing of exon 10, and formation of intermolecular cysteine disulfide bonds accelerates tau aggregation. 8-Nitroguanosine 3,5-cyclic monophosphate (8-nitro-cGMP) acts as a novel second messenger of nitric oxide (NO) by covalently binding cGMP to cysteine residues by electrophilic properties, a process termed protein S-guanylation. Here we studied S-guanylation of tau and its effects on tau aggregation. 8-Nitro-cGMP exposure induced S-guanylation of tau both in vitro and in tau-overexpressed HEK293T cells. S-guanylated tau inhibited heparin-induced tau aggregation in a thioflavin T assay. Atomic force microscopy observations indicated that S-guanylated tau could not form tau granules and fibrils. Further biochemical analyses showed that S-guanylated tau was inhibited at the step of tau oligomer formation. In P301L tau-expressing Neuro2A cells, 8-nitro-cGMP treatment significantly reduced the amount of sarcosyl-insoluble tau. NO-linked chemical modification on cysteine residues of tau could block tau aggregation, and therefore, increasing 8-nitro-cGMP levels in the brain could become a potential therapeutic strategy for Alzheimer's disease.	[Yoshitake, Jun; Soeda, Yoshiyuki; Yoshikawa, Misato] Natl Ctr Geriatr & Gerontol, Dept Aging Neurobiol, 7-430 Morioka Cho, Obu, Aichi 4748511, Japan; [Yoshitake, Jun; Matsushita, Kenji] Natl Ctr Geriatr & Gerontol, Dept Oral Dis Res, 7-430 Morioka Cho, Obu, Aichi 4748511, Japan; [Ida, Tomoaki; Akaike, Takaaki] Tohoku Univ, Grad Sch Med, Dept Environm Hlth Sci & Mol Toxicol, Aoba Ku, 2-1 Seiryo Machi, Sendai, Miyagi 9808575, Japan; [Sumioka, Akio; Takashima, Akihiko] Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan	National Center for Geriatrics & Gerontology; National Center for Geriatrics & Gerontology; Tohoku University; Gakushuin University	Takashima, A (corresponding author), Gakushuin Univ, Grad Sch Sci, Dept Life Sci, Toshima Ku, 1-5-1 Mejiro, Tokyo 1718588, Japan.	20160021@gakushuin.ac.jp			Mext; National Center for Geriatrics and Gerontology	Mext(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); National Center for Geriatrics and Gerontology	This work was supported by Mext grant-in-aid projects Scientific Research on Innovation Area (Brain Protein Aging and Dementia Control (to A. T.) and Brain Environment (to A. T.)), Mext Strategic Research Program for Brain Science (Integrated Research on Neuropsychiatric Disorders) (to A. T.), and an intramural grant of the National Center for Geriatrics and Gerontology (to A. T.).	Alam MS, 2002, INFECT IMMUN, V70, P3130, DOI 10.1128/IAI.70.6.3130-3142.2002; Balez R, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/3806157; Barghorn S, 2002, BIOCHEMISTRY-US, V41, P14885, DOI 10.1021/bi026469j; Braak H, 1996, ACTA NEUROL SCAND, V93, P3; BREDT DS, 1990, NATURE, V347, P768, DOI 10.1038/347768a0; Colton CA, 2006, P NATL ACAD SCI USA, V103, P12867, DOI 10.1073/pnas.0601075103; Crouch PJ, 2005, J NEUROSCI, V25, P672, DOI 10.1523/JNEUROSCI.4276-04.2005; Fujii S, 2010, J BIOL CHEM, V285, P23970, DOI 10.1074/jbc.M110.145441; Gotz J, 2007, BRAIN PATHOL, V17, P91, DOI 10.1111/j.1750-3639.2007.00051.x; Hardingham N, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00190; Hatakeyama S, 2004, J NEUROCHEM, V91, P299, DOI 10.1111/j.1471-4159.2004.02713.x; IGNARRO LJ, 1987, P NATL ACAD SCI USA, V84, P9265, DOI 10.1073/pnas.84.24.9265; Ito C, 2013, MOL CELL, V52, P794, DOI 10.1016/j.molcel.2013.10.024; Kimura T, 2010, J BIOL CHEM, V285, P38692, DOI 10.1074/jbc.M110.136630; Maeda S, 2007, BIOCHEMISTRY-US, V46, P3856, DOI 10.1021/bi061359o; Manczak M, 2006, HUM MOL GENET, V15, P1437, DOI 10.1093/hmg/ddl066; Nakashima H, 2004, FREE RADICAL BIO MED, V37, P176, DOI 10.1016/j.freeradbiomed.2004.04.037; Perl DP, 2010, MT SINAI J MED, V77, P32, DOI 10.1002/msj.20157; Sahara N, 2007, EUR J NEUROSCI, V25, P3020, DOI 10.1111/j.1460-9568.2007.05555.x; SAMUEL W, 1994, NEUROLOGY, V44, P2081, DOI 10.1212/WNL.44.11.2081; Sawa T, 2007, NAT CHEM BIOL, V3, P727, DOI 10.1038/nchembio.2007.33; SCHWEERS O, 1995, P NATL ACAD SCI USA, V92, P8463, DOI 10.1073/pnas.92.18.8463; Siuda J, 2014, PARKINSONISM RELAT D, V20, P957, DOI 10.1016/j.parkreldis.2014.06.004; Soeda Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms10216; Takashima A, 2013, J ALZHEIMERS DIS, V37, P565, DOI 10.3233/JAD-130653; Ueno H, 2007, BIOCHEM BIOPH RES CO, V358, P602, DOI 10.1016/j.bbrc.2007.04.176; von Bergen M, 2001, J BIOL CHEM, V276, P48165, DOI 10.1074/jbc.M105196200; von Bergen M, 2000, P NATL ACAD SCI USA, V97, P5129, DOI 10.1073/pnas.97.10.5129; Walker S, 2012, J BIOL CHEM, V287, P9591, DOI 10.1074/jbc.M111.336107; Wittmann CW, 2001, SCIENCE, V293, P711, DOI 10.1126/science.1062382; Zhao Y, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/316523	31	15	15	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22714	22720		10.1074/jbc.M116.734350	http://dx.doi.org/10.1074/jbc.M116.734350			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601475	Green Published, hybrid			2022-12-26	WOS:000386760600030
J	Al-Gaadi, KA; Hassaballa, AA; Tola, E; Kayad, AG; Madugundu, R; Alblewi, B; Assiri, F				Al-Gaadi, Khalid A.; Hassaballa, Abdalhaleem A.; Tola, ElKamil; Kayad, Ahmed G.; Madugundu, Rangaswamy; Alblewi, Bander; Assiri, Fahad			Prediction of Potato Crop Yield Using Precision Agriculture Techniques	PLOS ONE			English	Article							SATELLITE	Crop growth and yield monitoring over agricultural fields is an essential procedure for food security and agricultural economic return prediction. The advances in remote sensing have enhanced the process of monitoring the development of agricultural crops and estimating their yields. Therefore, remote sensing and GIS techniques were employed, in this study, to predict potato tuber crop yield on three 30 ha center pivot irrigated fields in an agricultural scheme located in the Eastern Region of Saudi Arabia. Landsat-8 and Sentinel-2 satellite images were acquired during the potato growth stages and two vegetation indices (the normalized difference vegetation index (NDVI) and the soil adjusted vegetation index (SAVI)) were generated from the images. Vegetation index maps were developed and classified into zones based on vegetation health statements, where the stratified random sampling points were accordingly initiated. Potato yield samples were collected 2-3 days prior to the harvest time and were correlated to the adjacent NDVI and SAVI, where yield prediction algorithms were developed and used to generate prediction yield maps. Results of the study revealed that the difference between predicted yield values and actual ones (prediction error) ranged between 7.9 and 13.5% for Landsat-8 images and between 3.8 and 10.2% for Sentinel-2 images. The relationship between actual and predicted yield values produced R-2 values ranging between 0.39 and 0.65 for Landsat-8 images and between 0.47 and 0.65 for Sentinel-2 images. Results of this study revealed a considerable variation in field productivity across the three fields, where high-yield areas produced an average yield of above 40 t ha(-1); while, the low-yield areas produced, on the average, less than 21 t ha(-1). Identifying such great variation in field productivity will assist farmers and decision makers in managing their practices.	[Al-Gaadi, Khalid A.; Hassaballa, Abdalhaleem A.; Tola, ElKamil; Madugundu, Rangaswamy] King Saud Univ, PARC, Riyadh, Saudi Arabia; [Al-Gaadi, Khalid A.; Kayad, Ahmed G.] King Saud Univ, Dept Agr Engn, Coll Food & Agr Sci, Riyadh, Saudi Arabia; [Alblewi, Bander; Assiri, Fahad] Saudi Agr Dev Co INMA, Wadi Eddawasir, Saudi Arabia	King Saud University; King Saud University	Hassaballa, AA (corresponding author), King Saud Univ, PARC, Riyadh, Saudi Arabia.	ahassaballa@ksu.edu.sa	Kayad, Ahmed/E-7601-2017; Hassaballa, Abdalhaleem/AAB-7566-2022; Hassaballa, Abdalhaleem/AAV-4851-2021; Tola, ElKamil/AAX-8777-2021; Tola, ElKamil/E-8523-2017; Madugundu, Rangaswamy/N-9214-2013	Kayad, Ahmed/0000-0003-3396-938X; Hassaballa, Abdalhaleem/0000-0001-5881-7273; Tola, ElKamil/0000-0003-0927-9688; Madugundu, Rangaswamy/0000-0002-5326-4785	King Saud University; Vice Deanship of Research Chairs; Saudi Agricultural Development Company (INMA)	King Saud University(King Saud University); Vice Deanship of Research Chairs; Saudi Agricultural Development Company (INMA)	This study was financially supported by King Saud University, Vice Deanship of Research Chairs. I declare that the Saudi Agricultural Development Company (INMA) has provided the support in the form of making the field (the study area) available for data collection. However, INMA did not have any additional role in the data collection and analysis, decision to publish, the preparation of this manuscript, or any financial commitment.	Baez-Gonzalez AD, 2005, AGRON J, V97, P418, DOI 10.2134/agronj2005.0418; Baez-Gonzalez AD, 2002, CROP SCI, V42, P1943, DOI 10.2135/cropsci2002.1943; Bala SK, 2009, INT J REMOTE SENS, V30, P2491, DOI 10.1080/01431160802552744; Dadhwal V. K., 2000, Indian Journal of Agricultural Economics, V55, P55; Doraiswamy PC, 2003, PHOTOGRAMM ENG REM S, V69, P665, DOI 10.14358/PERS.69.6.665; Elhag M, 2016, INT J REMOTE SENS, V14, P1495; Funk C, 2009, REMOTE SENS ENVIRON, V113, P115, DOI 10.1016/j.rse.2008.08.015; Gat N, 2000, ESTIMATING SUGAR BEE; GopalaPillai S, 1999, T ASAE, V42, P1911, DOI 10.13031/2013.13356; GROTEN SME, 1993, INT J REMOTE SENS, V14, P1495, DOI 10.1080/01431169308953983; Hassaballa A. A., 2011, 2011 Proceedings of the International Conference on Space Science and Communication (IconSpace 2011), P20, DOI 10.1109/IConSpace.2011.6015844; Hassaballa A. Abdalla, 2013, CASP J APPL SCI RES, V2, P182; Hassaballa AA, 2014, ARAB J GEOSCI, V7, P2831, DOI 10.1007/s12517-013-0990-6; Haverkort AJ, 1995, CURRENT ISSUES PRODU, V3, P396; HUETE A R, 1988, Remote Sensing of Environment, V25, P295; Jayanthi H, 2003, THESIS; Lamb DW, 1999, WEED RES, V39, P481, DOI 10.1046/j.1365-3180.1999.00167.x; Lillesand T.M., 1994, REMOTE SENSING IMAGE, Vthird, P750; Liu WT, 2002, INT J REMOTE SENS, V23, P1161, DOI 10.1080/01431160110076126; Lobell DB, 2005, AGRON J, V97, P241; Los SO, 1998, THESIS; Magri Antoni, 2005, Precision Agriculture, V6, P87, DOI 10.1007/s11119-004-0687-7; Miura T, 2000, IEEE T GEOSCI REMOTE, V38, P1399, DOI 10.1109/36.843034; Nash J.E., 1970, J HYDROL, V370, P139, DOI [10.1016/0022-1694(70)90255-6, DOI 10.1016/0022-1694(70)90255-6]; Palaniswami MS, 2008, HORTICULTURE SCI SER, V09, P167; PRINCE SD, 1990, EAST SCH AG, P169; Rasmussen MS, 1997, INT J REMOTE SENS, V18, P1059, DOI 10.1080/014311697218575; Reynolds CA, 2000, INT J REMOTE SENS, V21, P3487, DOI 10.1080/014311600750037516; Rouse Haas, 1973, MONITORING VERNAL AD, DOI DOI 10.1002/MRM.26868; Sawasawa Haig L S, 2003, THESIS; Senay GB, 1998, T ASAE, V41, P489, DOI 10.13031/2013.17170; SHARMA T, 1993, INT J REMOTE SENS, V14, P2509, DOI 10.1080/01431169308904289; Tan GX, 2003, ECOL MODEL, V168, P357, DOI 10.1016/S0304-3800(03)00146-7; Taylor J. C., 1997, Precision agriculture '97. Volume II. Technology, IT and management. Papers presented at the First European Conference on Precision Agriculture, Warwick University, UK, 7-10 September 1997., P713; Yang ChengHai, 2000, Precision Agriculture, V2, P7, DOI 10.1023/A:1009928431735; Yang P., 2004, P 20 ISPRS C P COMMI, P150	36	75	75	2	74	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162219	10.1371/journal.pone.0162219	http://dx.doi.org/10.1371/journal.pone.0162219			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611577	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900060
J	Baumgartner, S; Mensink, RP; Plat, J				Baumgartner, Sabine; Mensink, Ronald P.; Plat, Jogchum			Effects of a Plant Sterol or Stanol Enriched Mixed Meal on Postprandial Lipid Metabolism in Healthy Subjects	PLOS ONE			English	Article							NONFASTING TRIGLYCERIDES; HEART-DISEASE; FATTY-ACIDS; CHOLESTEROL; LIPEMIA; PLASMA; RISK; LIPOPROTEINS; CONSUMPTION; MARGARINE	Background Evidence is increasing that plant sterols and stanols not only lower fasting serum low-density lipoprotein concentrations, but also those of triglycerides (TG). Insight into effects of these components on postprandial TG metabolism, an emerging risk factor for cardiovascular disease, is missing. Objective Our objective was to examine the 8-hour postprandial response after consuming plant sterol or stanol enriched margarine as part of a mixed meal. Methods This postprandial study was part of a randomized crossover study in which 42 subjects consumed plant sterol enriched (3 g/d plant sterols), plant stanol enriched (3 g/d plant stanols), and control margarines for 4 weeks. After each period, subjects consumed a shake enriched with 3g plant sterols (sterol period), 3g plant stanols (stanol period) or no addition (control period). Subjects received a second shake with no addition after 4 hours. Results TG and apoB48 incremental areas under the curves (iAUC) of the total (0-8h) and 1st meal response (0-4h) were comparable between the meals and in all age categories (I: 18-35y, II: 36-52y, III: 53-69y). In subjects aged 53-69y, TG iAUC after the 2nd meal (4-8h) was higher in the stanol period as compared with the sterol (63.1 +/- 53.0 mmol/L/min; P < 0.01) and the control period (43.2 +/- 52.4 mmol/L/min; P < 0.05). ApoB48 iAUC after the 2nd meal was higher after the stanol than after the sterol period (67.1 +/- 77.0 mg/L/min; P < 0.05) and tended to be higher than after the control period (43.1 +/- 64.5 mg/L/min; P = 0.08) in subjects aged 53-69y. These increased postprandial responses may be due to reduced lipoprotein lipase activity, since postprandial apoCIII/II ratios were increased after stanol consumption compared with the control meal. Conclusion Postprandial TG and apoB48 responses are age-dependently increased after plant stanol consumption, which might be related to a changed clearance of triglyceride-rich lipoproteins.	[Baumgartner, Sabine; Mensink, Ronald P.; Plat, Jogchum] Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands	Maastricht University; Maastricht University Medical Centre (MUMC)	Baumgartner, S (corresponding author), Maastricht Univ, Med Ctr, NUTRIM Sch Nutr & Translat Res Metab, Dept Human Biol, Maastricht, Netherlands.	sabine.baumgartner@maastrichtuniversity.nl			Netherlands Organization for Scientific Research (TOP) [91208006]	Netherlands Organization for Scientific Research (TOP)(Netherlands Organization for Scientific Research (NWO))	The project was funded by the Netherlands Organization for Scientific Research, http://www.nwo.nl (TOP grant No. 91208006). Prof J. Plat received the funding. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal S, 2007, JAMA-J AM MED ASSOC, V298, P309, DOI 10.1001/jama.298.3.309; Baumgartner S, 2013, ATHEROSCLEROSIS, V227, P414, DOI 10.1016/j.atherosclerosis.2013.01.012; Beaumier-Gallon G, 1998, ATHEROSCLEROSIS, V141, pS81, DOI 10.1016/S0021-9150(98)00223-8; Brouns F, 2005, NUTR RES REV, V18, P145, DOI 10.1079/NRR2005100; Cohn JS, 2006, CLIN LAB MED, V26, P773, DOI 10.1016/j.cll.2006.07.003; COHN JS, 1993, J LIPID RES, V34, P2033; De Smet E, 2012, MOL NUTR FOOD RES, V56, P1058, DOI 10.1002/mnfr.201100722; Demonty I, 2013, EUR J NUTR, V52, P153, DOI 10.1007/s00394-011-0297-x; Demonty I, 2006, AM J CLIN NUTR, V84, P1534, DOI 10.1093/ajcn/84.6.1534; Fielding B, 2011, P NUTR SOC, V70, P342, DOI 10.1017/S002966511100084X; Fransen HP, 2007, J NUTR, V137, P1301, DOI 10.1093/jn/137.5.1301; Grundy SM, 2014, J CLIN LIPIDOL, V8, P29, DOI 10.1016/j.jacl.2013.12.005; Gylling H, 2012, EUR J NUTR, V51, P615, DOI 10.1007/s00394-011-0249-5; Gylling H, 2014, ATHEROSCLEROSIS, V232, P346, DOI 10.1016/j.atherosclerosis.2013.11.043; Hegele RA, 2014, LANCET DIABETES ENDO, V2, P655, DOI 10.1016/S2213-8587(13)70191-8; Hovenkamp E, 2008, PROG LIPID RES, V47, P37, DOI 10.1016/j.plipres.2007.10.001; Jackson KG, 2012, ATHEROSCLEROSIS, V220, P237, DOI 10.1016/j.atherosclerosis.2011.09.047; Jackson KG, 2010, ATHEROSCLEROSIS, V208, P246, DOI 10.1016/j.atherosclerosis.2009.06.030; Jong MC, 1999, ARTERIOSCL THROM VAS, V19, P472, DOI 10.1161/01.ATV.19.3.472; Masson CJ, 2011, J NUTR, V141, P816, DOI 10.3945/jn.110.136432; Moens SJB, 2014, CURR OPIN LIPIDOL, V25, P418, DOI 10.1097/MOL.0000000000000130; Naissides M, 2004, ATHEROSCLEROSIS, V177, P401, DOI 10.1016/j.atherosclerosis.2004.07.025; Naumann E, 2008, J AM COLL NUTR, V27, P117, DOI 10.1080/07315724.2008.10719683; Nordestgaard BG, 2007, JAMA-J AM MED ASSOC, V298, P299, DOI 10.1001/jama.298.3.299; Plat J, 2012, ATHEROSCLEROSIS, V225, P521, DOI 10.1016/j.atherosclerosis.2012.09.018; Relas H, 2001, BRIT J NUTR, V85, P141, DOI 10.1079/BJN2000231; Relas H, 2000, METABOLISM, V49, P473, DOI 10.1016/S0026-0495(00)80011-6; Rideout TC, 2010, MOL NUTR FOOD RES, V54, pS7, DOI 10.1002/mnfr.201000027; Sanders TAB, 2011, AM J CLIN NUTR, V94, P1433, DOI 10.3945/ajcn.111.017459; Sarwar N, 2009, CURR OPIN LIPIDOL, V20, P275, DOI 10.1097/MOL.0b013e32832dd4dc; Schonewille M, 2014, J LIPID RES, V55, P2554, DOI 10.1194/jlr.M052407; Silva KKDR, 2005, EUR J NUTR, V44, P377, DOI 10.1007/s00394-004-0538-3; Varbo A, 2013, J AM COLL CARDIOL, V61, P427, DOI 10.1016/j.jacc.2012.08.1026; Wallace TM, 2004, DIABETES CARE, V27, P1487, DOI 10.2337/diacare.27.6.1487; WILSON DE, 1983, METABOLISM, V32, P514, DOI 10.1016/0026-0495(83)90016-1; Xiao CT, 2012, BBA-MOL CELL BIOL L, V1821, P736, DOI 10.1016/j.bbalip.2011.09.019; Zheng CY, 2014, CURR OPIN LIPIDOL, V25, P35, DOI 10.1097/MOL.0000000000000040	37	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160396	10.1371/journal.pone.0160396	http://dx.doi.org/10.1371/journal.pone.0160396			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611192	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900005
J	Enoru, JO; Yang, B; Krishnamachari, S; Villanueva, E; DeMaio, W; Watanyar, A; Chinnasamy, R; Arterburn, JB; Perez, RG				Enoru, Julius O.; Yang, Barbara; Krishnamachari, Sesha; Villanueva, Ernesto; DeMaio, William; Watanyar, Adiba; Chinnasamy, Ramesh; Arterburn, Jeffrey B.; Perez, Ruth G.			Preclinical Metabolism, Pharmacokineticsand In Vivo Analysis of New Blood-Brain-Barrier Penetrant Fingolimod Analogues: FTY720-C2 and FTY720-Mitoxy	PLOS ONE			English	Article							PROTEIN PHOSPHATASE 2A; TYROSINE-HYDROXYLASE PHOSPHORYLATION; RELAPSING MULTIPLE-SCLEROSIS; SYNUCLEIN TRANSGENIC MICE; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; DOPAMINERGIC CELLS; ALZHEIMERS-DISEASE; RECEPTOR MODULATOR; DRUG FTY720	Parkinson's disease (PD) is a neurodegenerative aging disorder in which postmortemPD brain exhibits neuroinflammation, as well as synucleinopathy-associated protein phosphatase 2A (PP2A) enzymatic activity loss. Based on our translational research, we began evaluating the PD-repurposing-potential of an anti-inflammatory, neuroprotective, and PP2A stimulatory oral drug that is FDA-approved for multiple sclerosis, FTY720 (fingolimod, Gilenya 1). We also designed two new FTY720 analogues, FTY720-C2 and FTY720Mitoxy, with modifications that affect drug potency and mitochondrial localization, respectively. Herein, we describe the metabolic stability and metabolic profiling of FTY720-C2 and FTY720-Mitoxy in liver microsomes and hepatocytes. Using mouse, rat, dog, monkey, and human liver microsomes the intrinsic clearance of FTY720-C2 was 22.5, 79.5, 6.0, 20.2 and 18.3 similar to L/min/mg; and for FTY720-Mitoxy was 1.8, 7.8, 1.4, 135.0 and 17.5 mu L/min/mg, respectively. In hepatocytes, both FTY720-C2 and FTY720-Mitoxy were metabolized from the octyl side chain, generating a series of carboxylic acids similar to the parent FTY720, but without phosphorylated metabolites. To assess absorption and distribution, we gave equivalent single intravenous (IV) or oral doses of FTY720-C2 or FTY720-Mitoxy to C57BL/ 6 mice, with two mice per time point evaluated. After IV delivery, both FTY720-C2 and FTY720-Mitoxy were rapidly detected in plasma and brain; and reached peak concentrations at the first sampling time points. After oral dosing, FTY720-C2 was present in plasma and brain, although FTY720-Mitoxy was not orally bioavailable. Brain-to-plasma ratio of both compounds increased time-dependently, suggesting a preferential partitioning to the brain. PP2A activity in mouse adrenal gland increased similar to 2-fold after FTY720-C2 or FTY720Mitoxy, as compared to untreated controls. In summary, FTY720-C2 and FTY720-Mitoxy both (i) crossed the blood-brain-barrier; (ii) produced metabolites similar to FTY720, except without phosphorylated species that cause S1P(1)-mediated-immunosuppression; and (iii) stimulated in vivo PP2A activity, all of which encourage additional preclinical assessment.	[Enoru, Julius O.; DeMaio, William; Watanyar, Adiba] Ric Biosci LLC, In Vitro & Mol Metab Lab, Concord, OH USA; [Yang, Barbara; Krishnamachari, Sesha; Villanueva, Ernesto; Perez, Ruth G.] Texas Tech Univ Hlth Sci Ctr El Paso, Paul L Foster Sch Med, Ctr Emphasis Neurosci, Dept Biomed Sci,Grad Sch Biomed Sci, El Paso, TX 79905 USA; [Chinnasamy, Ramesh; Arterburn, Jeffrey B.] New Mexico State Univ, Dept Chem & Biochem, Las Cruces, NM 88003 USA	New Mexico State University	Perez, RG (corresponding author), Texas Tech Univ Hlth Sci Ctr El Paso, Paul L Foster Sch Med, Ctr Emphasis Neurosci, Dept Biomed Sci,Grad Sch Biomed Sci, El Paso, TX 79905 USA.	ruth.g.perez@ttuhsc.edu	Perez, Ruth G./AAK-9844-2020		Lizanell and Colbert Coldwell Foundation; Texas Tech University Health Sciences Center El Paso Startup Funds; Ricerca Biosciences, LLC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS042094] Funding Source: NIH RePORTER	Lizanell and Colbert Coldwell Foundation; Texas Tech University Health Sciences Center El Paso Startup Funds; Ricerca Biosciences, LLC; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Funding for the project was provided by the Lizanell and Colbert Coldwell Foundation and by Texas Tech University Health Sciences Center El Paso Startup Funds to RGP. These funders played no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Much of the work was contracted with Ricerca Biosciences, LLC, who provided support in the form of salaries to these authors (JOE, WDM, and AW). The commercial entity did not play any additional role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. All authors of the manuscript assisted with experimental design, data generation, data analysis, and figure and manuscript preparation, and manuscript editing, as described in the Author Contributions section.	Albert R, 2005, J MED CHEM, V48, P5373, DOI 10.1021/jm050242f; Alerte TNM, 2008, NEUROSCI LETT, V435, P24, DOI 10.1016/j.neulet.2008.02.014; Alexander Garrett E, 2004, Dialogues Clin Neurosci, V6, P259; Banerjee R, 2009, BBA-MOL BASIS DIS, V1792, P651, DOI 10.1016/j.bbadis.2008.11.007; Banks WA, 2010, FORUM NUTR, V63, P102, DOI 10.1159/000264398; Benskey M. J., 2016, J NEUROCHEM; Billich A, 2003, J BIOL CHEM, V278, P47408, DOI 10.1074/jbc.M307687200; BLASCHKO H, 1967, BIOCHEM J, V104, P545, DOI 10.1042/bj1040545; Brinkmann V, 2002, J BIOL CHEM, V277, P21453, DOI 10.1074/jbc.C200176200; Brinkmann V, 2010, NAT REV DRUG DISCOV, V9, P883, DOI 10.1038/nrd3248; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Corcoran NM, 2010, J CLIN NEUROSCI, V17, P1025, DOI 10.1016/j.jocn.2010.04.020; Deogracias R, 2012, P NATL ACAD SCI USA, V109, P14230, DOI 10.1073/pnas.1206093109; Di Pardo A, 2014, HUM MOL GENET, V23, P2251, DOI 10.1093/hmg/ddt615; Doi Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061988; Farrell KF, 2014, J NEUROCHEM, V128, P536, DOI 10.1111/jnc.12481; Fathi AR, 2002, ANAL BIOCHEM, V310, P208, DOI 10.1016/S0003-2697(02)00377-9; Gao F, 2012, PHARMACOL BIOCHEM BE, V103, P187, DOI 10.1016/j.pbb.2012.08.025; Gong CX, 2000, J BIOL CHEM, V275, P5535, DOI 10.1074/jbc.275.8.5535; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; GRUNDKEIQBAL I, 1986, J BIOL CHEM, V261, P6084; Hait NC, 2014, NAT NEUROSCI, V17, P971, DOI 10.1038/nn.3728; Henchcliffe C, 2008, NAT CLIN PRACT NEURO, V4, P600, DOI 10.1038/ncpneuro0924; Jin Y, 2011, DRUG METAB DISPOS, V39, P191, DOI 10.1124/dmd.110.035378; Kappos L, 2006, NEW ENGL J MED, V355, P1124, DOI 10.1056/NEJMoa052643; Kovarik JM, 2004, THER DRUG MONIT, V26, P585, DOI 10.1097/00007691-200412000-00001; Kovarik JM, 2005, J CLIN PHARMACOL, V45, P446, DOI 10.1177/0091270004274288; Kovarik JM, 2004, BRIT J CLIN PHARMACO, V57, P586, DOI 10.1111/j.1365-2125.2003.02065.x; Kovarik JM, 2007, BIOPHARM DRUG DISPOS, V28, P97, DOI 10.1002/bdd.535; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee KW, 2011, J NEUROSCI, V31, P6963, DOI 10.1523/JNEUROSCI.6513-10.2011; Lesage S, 2013, ANN NEUROL, V73, P459, DOI 10.1002/ana.23894; Liu F, 2005, EUROPEAN J NEUROSCIE, V22; Loeb V, 2010, J BIOL CHEM, V285, P7334, DOI 10.1074/jbc.M109.061051; Lou HY, 2010, J BIOL CHEM, V285, P17648, DOI 10.1074/jbc.M110.100867; Martin LJ, 2014, NEUROBIOL AGING, V35, P1132, DOI 10.1016/j.neurobiolaging.2013.11.008; Martin LJ, 2006, J NEUROSCI, V26, P41, DOI 10.1523/JNEUROSCI.4308-05.2006; Matloubian M, 2004, NATURE, V427; Meno-Tetang GML, 2006, DRUG METAB DISPOS, V34, P1480, DOI 10.1124/dmd.105.009001; Motulsky HJ, 2007, PRISM VERSION 5 0 ST; Noda H, 2013, J NEUROIMMUNOL, V256, P13, DOI 10.1016/j.jneuroim.2012.12.005; Oaks JJ, 2013, BLOOD, V122, P1923, DOI 10.1182/blood-2013-03-492181; Parihar MS, 2009, INT J BIOCHEM CELL B, V41, P2015, DOI 10.1016/j.biocel.2009.05.008; Pasanen P, 2014, NEUROBIOL AGING, V35, DOI 10.1016/j.neurobiolaging.2014.03.024; Paugh SW, 2003, FEBS LETT, V554, P189, DOI 10.1016/S0014-5793(03)01168-2; Peng XMM, 2005, J CELL SCI, V118, P3523, DOI 10.1242/jcs.02481; Perez RG, 2004, J NEUROCHEM, V89, P1318, DOI 10.1111/j.1471-4159.2004.02423.x; Perez RG, 2002, J NEUROSCI, V22, P3090, DOI 10.1523/JNEUROSCI.22-08-03090.2002; Perrotti D, 2008, CANCER METAST REV, V27, P159, DOI 10.1007/s10555-008-9119-x; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Porras J. L., 2014, POTENTIAL CONTRIBUTI, P51; Sharma S, 2011, J PHARMACOL PHARMACO, V2, P49, DOI 10.4103/0976-500X.77118; Sidhu A, 2004, FASEB J, V18, P637, DOI 10.1096/fj.03-1112rev; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Snelder N, 2014, DRUG METAB DISPOS, V42, P1367, DOI 10.1124/dmd.113.056770; Sospedra M, 2005, ANNU REV IMMUNOL, V23, P683, DOI 10.1146/annurev.immunol.23.021704.115707; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Tehranian R, 2006, J NEUROCHEM, V99, P1188, DOI 10.1111/j.1471-4159.2006.04146.x; Thangada S, 2010, J EXP MED, V207, P1475, DOI 10.1084/jem.20091343; van Eersel J, 2010, P NATL ACAD SCI USA, V107, P13888, DOI 10.1073/pnas.1009038107; Vargas-Medrano J, 2014, ACS MED CHEM LETT, V5, P782, DOI 10.1021/ml500128g; Wei Y, 2011, ANN NEUROL, V69, P119, DOI 10.1002/ana.22186; Wu J, 2012, NEUROSCIENCE, V207, P288, DOI 10.1016/j.neuroscience.2012.01.028; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795; Zollinger M, 2011, DRUG METAB DISPOS, V39, P199, DOI 10.1124/dmd.110.035907	65	9	9	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162162	10.1371/journal.pone.0162162	http://dx.doi.org/10.1371/journal.pone.0162162			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611691	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900049
J	Jeong, JH; Woo, YJ; Chua, S; Jo, YH				Jeong, Jae Hoon; Woo, Young Jae; Chua, Streamson, Jr.; Jo, Young-Hwan			Single-Cell Gene Expression Analysis of Cholinergic Neurons in the Arcuate Nucleus of the Hypothalamus	PLOS ONE			English	Article							ANOREXIGENIC PROOPIOMELANOCORTIN NEURONS; NEUROPEPTIDE-Y NEURONS; MUSCARINIC ACETYLCHOLINE-RECEPTORS; REGULATES GLUCOSE-HOMEOSTASIS; NERVOUS-SYSTEM CONTROL; POMC NEURONS; FOOD-INTAKE; ENERGY-BALANCE; AGRP NEURONS; INSULIN SENSITIVITY	The cholinoceptive system in the hypothalamus, in particular in the arcuate nucleus (ARC), plays a role in regulating food intake. Neurons in the ARC contain multiple neuropeptides, amines, and neurotransmitters. To study molecular and neurochemical heterogeneity of ARC neurons, we combine single-cell qRT-PCR and single-cell whole transcriptome amplification methods to analyze expression patterns of our hand-picked 60 genes in individual neurons in the ARC. Immunohistochemical and single-cell qRT-PCR analyses show choline acetyltransferase (ChAT)-expressing neurons in the ARC. Gene expression patterns are remarkably distinct in each individual cholinergic neuron. Two-thirds of cholinergic neurons express tyrosine hydroxylase (Th) mRNA. A large subset of these Th-positive cholinergic neurons is GABAergic as they express the GABA synthesizing enzyme glutamate decarboxylase and vesicular GABA transporter transcripts. Some cholinergic neurons also express the vesicular glutamate transporter transcript gene. POMC and POMC-processing enzyme transcripts are found in a subpopulation of cholinergic neurons. Despite this heterogeneity, gene expression patterns in individual cholinergic cells appear to be highly regulated in a cell-specific manner. In fact, membrane receptor transcripts are clustered with their respective intracellular signaling and downstream targets. This novel population of cholinergic neurons may be part of the neural circuitries that detect homeostatic need for food and control the drive to eat.	[Jeong, Jae Hoon; Chua, Streamson, Jr.; Jo, Young-Hwan] Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10467 USA; [Woo, Young Jae] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA; [Jo, Young-Hwan] Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine	Jo, YH (corresponding author), Albert Einstein Coll Med, Dept Med, Div Endocrinol, Bronx, NY 10467 USA.; Jo, YH (corresponding author), Albert Einstein Coll Med, Dept Mol Pharmacol, Bronx, NY 10467 USA.	young-hwan.jo@einstein.yu.edu		Jo, Young-Hwan/0000-0001-6939-8000; Woo, Young/0000-0002-9233-5099	NIDDK [RO1DK092246]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK092246, P30DK026687, P30DK057521] Funding Source: NIH RePORTER	NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by NIDDK (RO1DK092246) to Y.-H.J.	Acuna-Goycolea C, 2009, J NEUROSCI, V29, P1503, DOI 10.1523/JNEUROSCI.5147-08.2009; Aponte Y, 2011, NAT NEUROSCI, V14, P351, DOI 10.1038/nn.2739; Berglund ED, 2012, J CLIN INVEST, V122, P1000, DOI 10.1172/JCI59816; Brown DA, 2010, J MOL NEUROSCI, V41, P340, DOI 10.1007/s12031-010-9377-2; Butler AA, 2000, ENDOCRINOLOGY, V141, P3518, DOI 10.1210/en.141.9.3518; Caulfield MP, 1998, PHARMACOL REV, V50, P279; Challis BG, 2004, P NATL ACAD SCI USA, V101, P4695, DOI 10.1073/pnas.0306931101; Claret M, 2007, J CLIN INVEST, V117, P2325, DOI 10.1172/JCI31516; Coll AP, 2004, J CLIN ENDOCR METAB, V89, P2557, DOI 10.1210/jc.2004-0428; Dvinge H, 2009, BIOINFORMATICS, V25, P3325, DOI 10.1093/bioinformatics/btp578; Fu LY, 2010, J NEUROSCI, V30, P10205, DOI 10.1523/JNEUROSCI.2098-10.2010; Gautam D, 2006, CELL METAB, V4, P363, DOI 10.1016/j.cmet.2006.09.008; Guo L, 2004, P NATL ACAD SCI USA, V101, P11797, DOI 10.1073/pnas.0403165101; Huang H, 2011, J NEUROPHYSIOL, V106, P1191, DOI 10.1152/jn.00740.2010; Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6; Jeong JH, 2015, MOL METAB, V4, P483, DOI 10.1016/j.molmet.2015.03.006; Jo YH, 2005, NEURON, V48, P1055, DOI 10.1016/j.neuron.2005.10.021; Jo YH, 2002, J NEUROBIOL, V53, P618, DOI 10.1002/neu.10147; Koch M, 2015, NATURE, V519, P45, DOI 10.1038/nature14260; Krashes MJ, 2013, CELL METAB, V18, P588, DOI 10.1016/j.cmet.2013.09.009; Lee DK, 2015, NATURE COMM IN PRESS; Lee DK, 2015, PLOS ONE IN PRESS; Lee DK, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7618; Lin HV, 2010, DIABETES, V59, P337, DOI 10.2337/db09-1303; Liu TM, 2012, NEURON, V73, P511, DOI 10.1016/j.neuron.2011.11.027; Meister B, 2006, EUR J NEUROSCI, V24, P2731, DOI 10.1111/j.1460-9568.2006.05157.x; Mineur YS, 2011, SCIENCE, V332, P1330, DOI 10.1126/science.1201889; Morton GJ, 2006, NATURE, V443, P289, DOI 10.1038/nature05026; Parton LE, 2007, NATURE, V449, P228, DOI 10.1038/nature06098; Qi Y, 2015, J NEUROSCI, V35, P13171, DOI 10.1523/JNEUROSCI.0855-15.2015; Qiu J, 2014, CELL METAB, V19, P682, DOI 10.1016/j.cmet.2014.03.004; Qiu J, 2010, J NEUROSCI, V30, P1560, DOI 10.1523/JNEUROSCI.4816-09.2010; Roepke TA, 2011, J NEUROSCI, V31, P11825, DOI 10.1523/JNEUROSCI.1395-11.2011; Rossi J, 2011, CELL METAB, V13, P195, DOI 10.1016/j.cmet.2011.01.010; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Seeley RJ, 2003, NAT REV NEUROSCI, V4, P901, DOI 10.1038/nrn1245; Sohn JW, 2013, FRONT NEUROSCI-SWITZ, V7, DOI 10.3389/fnins.2013.00085; Sohn JW, 2011, NEURON, V71, P488, DOI 10.1016/j.neuron.2011.06.012; Team RC, 2015, R LANG ENV STAT COMP; Tong QC, 2008, NAT NEUROSCI, V11, P998, DOI 10.1038/nn.2167; van den Pol AN, 2012, NEURON, V76, P98, DOI 10.1016/j.neuron.2012.09.014; van den Pol AN, 2009, J NEUROSCI, V29, P4622, DOI 10.1523/JNEUROSCI.3249-08.2009; Wardlaw SL, 2011, EUR J PHARMACOL, V660, P213, DOI 10.1016/j.ejphar.2010.10.107; Williams KW, 2010, J NEUROSCI, V30, P2472, DOI 10.1523/JNEUROSCI.3118-09.2010; Woolf NJ, 1999, TRENDS NEUROSCI, V22, P540, DOI 10.1016/S0166-2236(99)01474-5; Xu Y, 2010, NAT NEUROSCI, V13, P1457, DOI 10.1038/nn.2664; Yamada M, 2001, NATURE, V410, P207, DOI 10.1038/35065604; Yaswen L, 1999, NAT MED, V5, P1066, DOI 10.1038/12506; Yeo GSH, 2012, NAT NEUROSCI, V15, P1343, DOI 10.1038/nn.3211; Zhang XB, 2015, J NEUROSCI, V35, P14966, DOI 10.1523/JNEUROSCI.0293-15.2015	50	29	33	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162839	10.1371/journal.pone.0162839	http://dx.doi.org/10.1371/journal.pone.0162839			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611685	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900178
J	Ouyang, Y; Xie, JY; Yang, M; Zhang, XY; Ren, H; Wang, WM; Chen, N				Ouyang, Yan; Xie, Jingyuan; Yang, Meng; Zhang, Xiaoyan; Ren, Hong; Wang, Weiming; Chen, Nan			Underweight Is an Independent Risk Factor for Renal Function Deterioration in Patients with IgA Nephropathy	PLOS ONE			English	Article							BODY-MASS INDEX; OBESITY-RELATED GLOMERULOPATHY; KIDNEY-DISEASE; METABOLIC SYNDROME; NATURAL-HISTORY; SERUM C3; COMPLEMENT; ASSOCIATION; PROGRESSION; MORTALITY	Studies on the relationship between body mass index (BMI) and renal progression in IgA Nephropathy (IgAN) were limited, especially for underweight patients with IgAN. To elucidate the clinical features and effect of underweight on renal function deterioration in this disease, we recruited IgAN patients with diagnostic age >= 18 years old and a baseline estimated glomerular filtration rate (eGFR) >= 15 ml/min/1.73m(2) from our center between 1985 and 2014. Patients secondary to systemic diseases or follow-up less than 6 months were excluded. All patients' clinical data at renal biopsy and during follow-up were recorded. Renal outcome was defined as end-stage kidney disease (ESRD). Baseline body mass index (BMI) was calculated by weight (kg) over squared height (m(2)). According to WHO Asian guideline, BMI was categorized as follows: <18.5kg/m(2) (underweight), 18.5-22.99kg/m(2) (normal weight), 23-27.49kg/m(2) (overweight) and obese (>= 27.5 kg/m(2)). Of 930 primary IgAN patients enrolled in this study, mean age at renal biopsy was 37.6 years and 49.2% were men. Totally, 114 (12.3%) ESRD occurred after a mean follow-up of 47.1 months. More ESRD happened in underweight patients (17.3%) compared to patients with normal weight (13.2%), overweight (11.0%) or obesity (9.5%). By multivariate Cox regression analysis, underweight was independently associated with a higher risk of ESRD after adjustment for demographic characteristics and clinical variables (HR: 3.5, 95% CI: 1.3-9.5, P = 0.01) comparing to normal weight. Underweight patients had lower hemoglobin, serum uric acid, triglycerides, cholesterol and lymphocyte counts than patients with normal weight. Furthermore, BMI was positively correlated with serum C3 (r = 0.25, p <0.001). Our research finds that underweight is an independent risk factor for kidney disease progression in IgAN, which might be associated with malnutrition status and decreased C3 levels.	[Ouyang, Yan; Xie, Jingyuan; Yang, Meng; Zhang, Xiaoyan; Ren, Hong; Wang, Weiming; Chen, Nan] Shanghai Jiao Tong Univ, Sch Med, Dept Nephrol, Inst Nephrol,Ruijin Hosp, Shanghai 200025, Peoples R China	Shanghai Jiao Tong University	Chen, N (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Dept Nephrol, Inst Nephrol,Ruijin Hosp, Shanghai 200025, Peoples R China.	cnrj100@126.com	Xie, Jingyuan/AAX-2708-2021; xie, jing/GRY-1689-2022		National Basic Research Program of China 973 [2012CB517604, 2012CB517701]; Health industry research projects [201002010]; National Key Technology RD Program [2011BAI10B06, 12-5]; National Natural Science Foundation of China [81570598, 81370015]; Shanghai Municipal Education Commission, Gaofeng Clinical Medicine Grant [20152207]; Shanghai Science and Technology Committee [14430721000]	National Basic Research Program of China 973(National Basic Research Program of China); Health industry research projects; National Key Technology RD Program(National Key Technology R&D Program); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Education Commission, Gaofeng Clinical Medicine Grant; Shanghai Science and Technology Committee(Shanghai Science & Technology Committee)	NC is supported by grants from the National Basic Research Program of China 973 (No. 2012CB517604, No. 2012CB517701, http://www.nsfc.gov.cn/), Health industry research projects (No. 201002010, http://www.moh.gov.cn), and National Key Technology R&D Program (12-5) (No. 2011BAI10B06, http://www.nsfc.gov.cn/). JX is supported by the National Natural Science Foundation of China (No. 81570598, 81370015, http://www.nsfc.gov.cn/), Shanghai Municipal Education Commission, Gaofeng Clinical Medicine Grant (20152207, http://www.shmec.gov.cn), Shanghai Science and Technology Committee (No. 14430721000, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286; Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3; BAUMGARTNER RN, 1995, OBES RES, V3, P73, DOI 10.1002/j.1550-8528.1995.tb00124.x; Berthoux F, 2013, NEPHROL DIAL TRANSPL, V28, P160, DOI 10.1093/ndt/gft286; Bonnet F, 2001, AM J KIDNEY DIS, V37, P720, DOI 10.1016/S0272-6386(01)80120-7; Cederholm T, 2015, CLIN NUTR, V34, P335, DOI 10.1016/j.clnu.2015.03.001; Chen HM, 2008, AM J KIDNEY DIS, V52, P58, DOI 10.1053/j.ajkd.2008.02.303; CHOY LN, 1992, J BIOL CHEM, V267, P12736; de Boer IH, 2009, AM J KIDNEY DIS, V54, P1043, DOI 10.1053/j.ajkd.2009.07.018; Dittmann K, 2013, BMC NEPHROL, V14, DOI 10.1186/1471-2369-14-87; Donadio JV, 2002, NEW ENGL J MED, V347, P738, DOI 10.1056/NEJMra020109; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Elsayed EF, 2008, AM J KIDNEY DIS, V52, P29, DOI 10.1053/j.ajkd.2008.02.363; Evans M, 2005, AM J KIDNEY DIS, V46, P863, DOI 10.1053/j.ajkd.2005.07.040; Fouque D, 2007, NEPHROL DIAL TRANSPL, V22, P45, DOI 10.1093/ndt/gfm020; Gabrielsson BG, 2003, OBES RES, V11, P699, DOI 10.1038/oby.2003.100; Gao BX, 2016, EUR J INTERN MED, V29, P46, DOI 10.1016/j.ejim.2015.11.020; GERMINARIO R, 1993, METABOLISM, V42, P574, DOI 10.1016/0026-0495(93)90215-A; Hartley G H, 2001, EDTNA ERCA J, V27, P101; Hashimoto A, 2012, AM J PATHOL, V181, P1338, DOI 10.1016/j.ajpath.2012.06.038; Hernandez-Mijares A, 2012, EUR J CLIN INVEST, V42, P503, DOI 10.1111/j.1365-2362.2011.02606.x; Hsu CY, 2006, ANN INTERN MED, V144, P21, DOI 10.7326/0003-4819-144-1-200601030-00006; Ikizler TA, 2008, CURR OPIN NEPHROL HY, V17, P162, DOI 10.1097/MNH.0b013e3282f5dbce; Iseki K, 2004, KIDNEY INT, V65, P1870, DOI 10.1111/j.1523-1755.2004.00582.x; Janssen I, 2004, AM J CLIN NUTR, V79, P379; Kalantar-Zadeh K, 2005, AM J KIDNEY DIS, V46, P489, DOI 10.1053/j.ajkd.2005.05.020; Kambham N, 2001, KIDNEY INT, V59, P1498, DOI 10.1046/j.1523-1755.2001.0590041498.x; Kataoka H, 2012, CLIN EXP NEPHROL, V16, P706, DOI 10.1007/s10157-012-0613-7; Khedr A, 2011, J RENAL NUTR, V21, P455, DOI 10.1053/j.jrn.2010.12.001; Kim SJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040495; Kiryluk K, 2013, ANNU REV MED, V64, P339, DOI 10.1146/annurev-med-041811-142014; Komatsu H, 2004, INTERNAL MED, V43, P1023, DOI 10.2169/internalmedicine.43.1023; Kovesdy CP, 2007, AM J KIDNEY DIS, V49, P581, DOI 10.1053/j.ajkd.2007.02.277; Kovesdy CP, 2009, SEMIN NEPHROL, V29, P3, DOI 10.1016/j.semnephrol.2008.10.002; Krikken JA, 2007, KIDNEY INT, V71, P260, DOI 10.1038/sj.ki.5002011; Kwan BCH, 2007, CLIN J AM SOC NEPHRO, V2, P992, DOI 10.2215/CJN.04221206; Leavey SF, 2001, NEPHROL DIAL TRANSPL, V16, P2386, DOI 10.1093/ndt/16.12.2386; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Li LS, 2004, KIDNEY INT, V66, P920, DOI 10.1111/j.1523-1755.2004.00837.x; McCarthy M, 2004, LANCET, V364, P2169, DOI 10.1016/S0140-6736(04)17613-7; Muneyuki T, 2013, KIDNEY INT, V84, P1254, DOI 10.1038/ki.2013.222; Muscari A, 1998, ACTA CARDIOL, V53, P345; Muscari A, 2000, EUR HEART J, V21, P1081, DOI 10.1053/euhj.1999.2013; Nakayama K, 2008, J CLIN LAB ANAL, V22, P114, DOI 10.1002/jcla.20227; Obermayr RP, 2009, NEPHROL DIAL TRANSPL, V24, P2421, DOI 10.1093/ndt/gfp075; Ogden CL, 2003, ENDOCRIN METAB CLIN, V32, P741, DOI 10.1016/S0889-8529(03)00074-4; Onat A, 2005, CLIN SCI, V108, P129, DOI 10.1042/CS20040198; Othman M, 2009, NEPHRON CLIN PRACT, V113, pC16, DOI 10.1159/000228071; Ricardo AC, 2015, AM J KIDNEY DIS, V65, P412, DOI 10.1053/j.ajkd.2014.09.016; Roos A, 2006, J AM SOC NEPHROL, V17, P1724, DOI 10.1681/ASN.2005090923; SCHENA FP, 1990, AM J MED, V89, P209; Shimamoto M, 2015, J CLIN LAB ANAL, V29, P353, DOI 10.1002/jcla.21778; Sowers JR, 2007, KIDNEY INT, V71, P719, DOI 10.1038/sj.ki.5002006; Tomino Y, 2000, J CLIN LAB ANAL, V14, P220, DOI 10.1002/1098-2825(2000)14:5<220::AID-JCLA4>3.3.CO;2-U; Tsuboi N, 2013, CLIN EXP NEPHROL, V17, P379, DOI 10.1007/s10157-012-0719-y; Vivante A, 2012, ARCH INTERN MED, V172, P1644, DOI 10.1001/2013.jamainternmed.85; Wang LP, 2010, J CLIN PATHOL, V63, P697, DOI 10.1136/jcp.2009.074278; Wang WM, 2013, CONTRIB NEPHROL, V181, P75, DOI 10.1159/000348460; Whitlock G, 2009, LANCET, V373, P1083, DOI 10.1016/S0140-6736(09)60318-4; Xie J, 2016, J AM SOC NEPHROL; Xie JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038904; Zhou FD, 2009, NEPHROL DIAL TRANSPL, V24, P870, DOI 10.1093/ndt/gfn554; Zhou XJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061208; ZIMMER B, 1982, EUR J IMMUNOL, V12, P426, DOI 10.1002/eji.1830120513	64	26	27	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162044	10.1371/journal.pone.0162044	http://dx.doi.org/10.1371/journal.pone.0162044			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611091	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900043
J	Stearns, NA; Zhou, SX; Petri, M; Binder, SR; Pisetsky, DS				Stearns, Nancy A.; Zhou, Shuxia; Petri, Michelle; Binder, Steven R.; Pisetsky, David S.			The Use of Poly-L-Lysine as a Capture Agent to Enhance the Detection of Antinuclear Antibodies by ELISA	PLOS ONE			English	Article							SYSTEMIC-LUPUS-ERYTHEMATOSUS; LINKED-IMMUNOSORBENT-ASSAY; ACID-BINDING POLYMERS; ENZYME-IMMUNOASSAY; IMMUNOFLUORESCENCE ASSAY; ANTIINFLAMMATORY AGENTS; AUTOANTIBODY DETECTION; DEFINED SPECIFICITIES; MULTIPLEX IMMUNOASSAY; RECOMBINANT ANTIGENS	Antibodies to nuclear antigens (antinuclear antibodies or ANAs) are the serological hallmark of systemic lupus erythematosus (SLE). These antibodies bind diverse nuclear antigens that include DNA, histones and non-histone proteins as well as complexes of proteins with DNA and RNA. Because of the frequency of ANA expression in SLE, testing is an important component of clinical evaluation as well as determination of eligibility for clinical trials or utilization of certain therapies. Immunofluorescence assays have been commonly used for this purpose although this approach can be limited by issues of throughput, variability and difficulty in determining positivity. ELISA and multiplex assays are also useful approaches although these assays may give an incomplete picture of antibodies present. To develop a sensitive and quantitative ANA assay, we have explored an ELISA platformin which plates are pre-coated with a positively charged nucleic acid binding polymer (NABP) to increase adherence of antigens containing DNA or RNA. As a source of antigens, we have used supernatants of Jurkat cells undergoing apoptosis in vitro. As results presented show, a poly-L-lysine (PLL) pre-coat significantly enhances detection of antibodies to DNA as well as antigens such as histones, SSA, SSB and RNP. Comparison of the ELISA assay with the PLL pre-coat with a multiplex assay using the BioPlex (R) 2200 system indicated good agreement in results for a panel of lupus sera. Together, these studies indicate that a pre-coat with a positively charged polymer can increase the sensitivity of an ANA ELISA using as antigens molecules released from dead and dying cells. This assay platform may facilitate ANA testing by providing an ensemble of antigens more similar in composition and structure with antigens present in vivo, with a NABP promoting adherence via charge-charge interactions.	[Stearns, Nancy A.; Pisetsky, David S.] Duke Univ, Med Ctr, Dept Med, Div Rheumatol & Immunol, Durham, NC 27710 USA; [Pisetsky, David S.] VA Med Ctr, Med Res Serv, Durham, NC 27705 USA; [Zhou, Shuxia; Binder, Steven R.] Bio Rad Labs Clin Diagnost Grp, 400 Alfred Nobel Dr, Hercules, CA USA; [Petri, Michelle] Johns Hopkins Univ, Sch Med, Div Rheumatol, 1830 East Monument St,Suite 7500, Baltimore, MD USA	Duke University; Johns Hopkins University	Pisetsky, DS (corresponding author), Duke Univ, Med Ctr, Dept Med, Div Rheumatol & Immunol, Durham, NC 27710 USA.; Pisetsky, DS (corresponding author), VA Med Ctr, Med Res Serv, Durham, NC 27705 USA.	david.pisetsky@duke.edu		Binder, Steven/0000-0003-4091-2090	VA Merit Review; Alliance for Lupus Research; National Institutes of Health [AR43727]; Bio-Rad	VA Merit Review(US Department of Veterans Affairs); Alliance for Lupus Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bio-Rad	This study received funding from VA Merit Review, Alliance for Lupus Research, and National Institutes of Health AR43727. Co-authors Shuxia Zhou and Steven R. Binder received salary from Bio-Rad, a commercial company, during this study. The contributions of Bio-Rad relate to the performance of the comparative study, establishment of cut-off values and review of the manuscript. Bio-Rad did not have any additional role in the study design, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Agmon-Levin N, 2014, ANN RHEUM DIS, V73, P17, DOI 10.1136/annrheumdis-2013-203863; Al Sawah S, 2015, LUPUS SCI MED, V2, DOI 10.1136/lupus-2014-000066; Gonzalez DA, 2011, IMMUNOL LETT, V140, P30, DOI 10.1016/j.imlet.2011.06.001; Bardin N, 2009, AUTOIMMUNITY, V42, P63, DOI 10.1080/08916930802354906; Bell CW, 2006, AM J PHYSIOL-CELL PH, V291, pC1318, DOI 10.1152/ajpcell.00616.2005; BenoreParsons M, 1997, BIOTECHNIQUES, V23, P128, DOI 10.2144/97231st04; Bernardini S, 2004, CLIN CHEM LAB MED, V42, P1155, DOI 10.1515/CCLM.2004.235; Binder SR, 2006, LUPUS, V15, P412, DOI 10.1191/0961203306lu2326oa; Choi JJ, 2004, SCAND J IMMUNOL, V60, P159, DOI 10.1111/j.0300-9475.2004.01470.x; Choy JS, 2012, TRENDS BIOCHEM SCI, V37, P425, DOI 10.1016/j.tibs.2012.06.006; Copple SS, 2012, AM J CLIN PATHOL, V137, P825, DOI 10.1309/AJCPICNFG7UCES1S; Copple SS, 2011, AM J CLIN PATHOL, V135, P678, DOI 10.1309/AJCP6R8EELGODAYW; Dieker J, 2016, ARTHRITIS RHEUMATOL, V68, P462, DOI 10.1002/art.39417; Dieker JW, 2005, J IMMUNOL METHODS, V296, P83, DOI 10.1016/j.jim.2004.10.010; Fangtham M, 2013, CURR RHEUMATOL REP, V15, DOI 10.1007/s11926-013-0360-0; Faria AC, 2005, J RHEUMATOL, V32, P1267; Fritzler MJ, 2003, J RHEUMATOL, V30, P2374; Furie R, 2011, ARTHRITIS RHEUM-US, V63, P3918, DOI 10.1002/art.30613; Gansen A, 2009, P NATL ACAD SCI USA, V106, P15308, DOI 10.1073/pnas.0903005106; Gniewek RA, 1997, CLIN DIAGN LAB IMMUN, V4, P185, DOI 10.1128/CDLI.4.2.185-188.1997; Hayashi N, 2001, CLIN CHEM, V47, P1649; Hayashi N, 2008, MOD RHEUMATOL, V18, P153, DOI 10.1007/s10165-008-0028-1; Holl EK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069413; Ippolito A, 2011, LUPUS, V20, P250, DOI 10.1177/0961203310385738; Isenberg DA, 1997, BRIT J RHEUMATOL, V36, P229; JENSEN DE, 1976, J BIOL CHEM, V251, P7198; KAVAI M, 1982, J IMMUNOL METHODS, V48, P169, DOI 10.1016/0022-1759(82)90191-0; Kavanaugh A, 2000, ARCH PATHOL LAB MED, V124, P71; Khorasanizadeh S, 2004, CELL, V116, P259, DOI 10.1016/S0092-8674(04)00044-3; KLOTZ JL, 1979, J IMMUNOL METHODS, V29, P155, DOI 10.1016/0022-1759(79)90065-6; KORNBERG RD, 1989, METHOD ENZYMOL, V170, P3; Krysko DV, 2011, TRENDS IMMUNOL, V32, P157, DOI 10.1016/j.it.2011.01.005; Lee J, 2011, P NATL ACAD SCI USA, V108, P14055, DOI 10.1073/pnas.1105777108; Meroni PL, 2010, ANN RHEUM DIS, V69, P1420, DOI 10.1136/ard.2009.127100; Moder KG, 2007, J RHEUMATOL, V34, P978; Munoz LE, 2010, NAT REV RHEUMATOL, V6, P280, DOI 10.1038/nrrheum.2010.46; Munoz LE, 2009, ARTHRITIS RHEUM-US, V60, P1733, DOI 10.1002/art.24535; N'Soukpoe-Kossi CN, 2007, DNA CELL BIOL, V26, P28, DOI 10.1089/dna.2006.9999; Nakajima A, 2008, J BIOL CHEM, V283, P24128, DOI 10.1074/jbc.M802996200; Op De Beeck K, 2012, AUTOIMMUN REV, V12, P137, DOI 10.1016/j.autrev.2012.02.013; Pisetsky DS, 2012, EXPERT REV CLIN IMMU, V8, P1, DOI [10.1586/eci.11.82, 10.1586/ECI.11.82]; Pisetsky DS, 2010, AUTOIMMUN REV, V10, P35, DOI 10.1016/j.autrev.2010.07.007; RUBIN RL, 1983, J IMMUNOL METHODS, V63, P359, DOI 10.1016/S0022-1759(83)80009-X; Satoh M, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00181; Schiller M, 2008, CELL DEATH DIFFER, V15, P183, DOI 10.1038/sj.cdd.4402239; SEKINE H, 1969, BIOCHIM BIOPHYS ACTA, V174, P202, DOI 10.1016/0005-2787(69)90243-3; Shao WH, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3206; Shovman O, 2005, ANN NY ACAD SCI, V1050, P380, DOI 10.1196/annals.1313.120; Sjowall C, 2008, J RHEUMATOL, V35, P1994; Solomon DH, 2002, ARTHRIT RHEUM-ARTHR, V47, P434, DOI 10.1002/art.10561; Stearns NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040862; STOKES RP, 1982, J CLIN PATHOL, V35, P566, DOI 10.1136/jcp.35.5.566; Suer W, 2004, J AUTOIMMUN, V22, P325, DOI 10.1016/j.jaut.2004.02.002; SUTJITA M, 1989, J CLIN LAB ANAL, V3, P34, DOI 10.1002/jcla.1860030108; TAN EM, 1989, ADV IMMUNOL, V44, P93, DOI 10.1016/S0065-2776(08)60641-0; Tan EM, 1999, ARTHRITIS RHEUM, V42, P455, DOI 10.1002/1529-0131(199904)42:3<455::AID-ANR10>3.0.CO;2-3; Tan EM, 1997, ARTHRITIS RHEUM-US, V40, P1601, DOI 10.1002/art.1780400909; Tan EM, 2014, ARTHRITIS RES THER, V16, DOI 10.1186/ar4482; Tench CM, 2000, LUPUS, V9, P374, DOI 10.1191/096120300678828451; Ullal AJ, 2011, J AUTOIMMUN, V36, P173, DOI 10.1016/j.jaut.2011.02.001; Urbonaviciute V, 2008, J EXP MED, V205, P3007, DOI 10.1084/jem.20081165; van Bavel CC, 2011, ANN RHEUM DIS, V70, P201, DOI 10.1136/ard.2010.129320; van Bavel CC, 2010, MOL IMMUNOL, V48, P248, DOI 10.1016/j.molimm.2010.08.003; van Vollenhoven RF, 2012, ANN RHEUM DIS, V71, P1343, DOI 10.1136/annrheumdis-2011-200937; Wahren M, 1998, J AUTOIMMUN, V11, P29, DOI 10.1006/jaut.1997.0173; Wallace DJ, 2009, ARTHRIT RHEUM-ARTHR, V61, P1168, DOI 10.1002/art.24699; Wirestam L, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0856-2; Zhang Y, 2015, J CONTROL RELEASE, V213, pE136, DOI 10.1016/j.jconrel.2015.05.230	68	16	17	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161818	10.1371/journal.pone.0161818	http://dx.doi.org/10.1371/journal.pone.0161818			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611194	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255900031
J	Gemmati, D; Burini, F; Talarico, A; Fabbri, M; Bertocco, C; Vigliano, M; Moratelli, S; Cuneo, A; Serino, ML; Avato, FM; Tisato, V; Gaudio, RM				Gemmati, Donato; Burini, Francesco; Talarico, Anna; Fabbri, Matteo; Bertocco, Cesare; Vigliano, Marco; Moratelli, Stefano; Cuneo, Antonio; Serino, Maria Luisa; Avato, Francesco Maria; Tisato, Veronica; Gaudio, Rosa Maria			The Active Metabolite of Warfarin (3 '-Hydroxywarfarin) and Correlation with INR, Warfarin and Drug Weekly Dosage in Patients under Oral Anticoagulant Therapy: A Pharmacogenetics Study	PLOS ONE			English	Article							VKORC1 GENOTYPES; GENE VARIANTS; HUMAN PLASMA; CYP2C9; POLYMORPHISMS; VALIDATION; GUIDELINES; ASSAYS; OLD; LC	Objectives Warfarin oral anticoagulant therapy (OAT) requires regular and frequent drug adjustment monitored by INR. Interindividual variability, drug and diet interferences, and genetics (VKORC1 and CYP2C9) make the maintenance/reaching of stable INR a not so easy task. HPLC assessment of warfarin/enantiomers was suggested as a valid monitoring-tool along with INR, but definite results are still lacking. We evaluated possible correlations between INR, warfarin/3'-hydroxywarfarin, and drug weekly dosage aimed at searching novel alternatives to OAT monitoring. VKORC1/CYP2C9 pharmacogenetics investigation was performed to account for the known influence on warfarin homeostasis. Methods 133 OAT patients were recruited and assessed for warfarin/3'-hydroxywarfarin serum levels (HPLC), INR, and VKORC1 and CYP2C9 genotypes. A subgroup of 52 patients were monitored in detail (5 consecutive controls; c0-c4) till the target INR was reached. Correlation analyses were performed in both groups Results In the whole OAT group both warfarin and 3'-hydroxywarfarin correlate with INR at comparable degree (r(2) = 0.0388 and 0.0362 respectively). Conversely, warfarin weekly dosage better correlates with warfarin than with 3'-hydroxywarfarin (r(2) = 0.0975 and r(2) = 0.0381 respectively), but considering together warfarin plus 3'-hydroxywarfarin the correlation strongly increased (r(2) = 0.1114; p<0.0001). Interestingly, 3'-hydroxywarfarin reached a strong correlation at c4 respect to warfarin (r(2) = 0.2157 and r(2) = 0.0549; p = 0.0005 and p = 0.0944 respectively) seeming less affected by drug adjustments in the subgroup of 52 patients who started OAT. The multivariate analyses aimed at estimating the true contribution of 3'-hydroxywarfarin on INR value ascribed it the unique significant value (p = 0.0021) in spite of warfarin who lost association. The pharmacogenetics studies confirmed that patients carrying the VKORC1 variant-allele required lower warfarin maintenance dosage and that the combination of VKORC1 and CYP2C9 yielded a warfarin responsive index (WRI) inversely related to the number variant alleles Conclusion Our results overall suggest that 3'-hydroxywarfarin monitoring could be of great advantage in INR monitoring respect to classical warfarin assessment showing significant contribution also in multivariate analysis. Therefore, additional active metabolites should be recognized and investigated as novel useful indicators.	[Gemmati, Donato; Burini, Francesco; Vigliano, Marco; Moratelli, Stefano; Cuneo, Antonio; Serino, Maria Luisa] Univ Ferrara, Dept Biomed & Specialty Surg Sci, Sect Med Biochem Mol Biol & Genet, Ctr Haemostasis & Thrombosis, Ferrara, Italy; [Talarico, Anna; Fabbri, Matteo; Bertocco, Cesare; Avato, Francesco Maria; Gaudio, Rosa Maria] Univ Ferrara, Sect Med & Publ Hlth, Dept Med Sci, Ferrara, Italy; [Tisato, Veronica] Univ Ferrara, Dept Morphol Surg & Expt Med, Ferrara, Italy; [Tisato, Veronica] Univ Ferrara, LTTA Ctr, Ferrara, Italy	University of Ferrara; University of Ferrara; University of Ferrara; University of Ferrara	Gemmati, D (corresponding author), Univ Ferrara, Dept Biomed & Specialty Surg Sci, Sect Med Biochem Mol Biol & Genet, Ctr Haemostasis & Thrombosis, Ferrara, Italy.	d.gemmati@unife.if	Tisato, Veronica/K-4525-2016; Serino, Maria Luisa/AAC-7368-2022; Cuneo, Antonio/K-7617-2016; Fabri, Matteo/AAH-4639-2020	Fabri, Matteo/0000-0001-6343-3944; Gemmati, Donato/0000-0001-6213-6120; Tisato, Veronica/0000-0001-8448-066X				Ageno W, 2012, CHEST, V141, pE44S, DOI 10.1378/chest.11-2292; Benmira Sihame, 2010, Recent Pat Cardiovasc Drug Discov, V5, P120; Borkowski Andrew A, 2014, Recent Pat Biotechnol, V8, P110, DOI 10.2174/1872208309666140904112003; Dahal K, 2016, CHEST, V149, P951, DOI 10.1378/chest.15-1719; Gage BF, 2008, J THROMB THROMBOLYS, V25, P45, DOI 10.1007/s11239-007-0104-y; Gemmati D, 2004, WOUND REPAIR REGEN, V12, P512, DOI 10.1111/j.1067-1927.2004.012503.x; Gemmati D, 2006, J VASC SURG, V44, P554, DOI 10.1016/j.jvs.2006.05.011; Gemmati D, 2009, J VASC SURG, V50, P1444, DOI 10.1016/j.jvs.2009.07.103; Harbrecht U, 2011, HAMOSTASEOLOGIE, V31, P21, DOI 10.5482/ha-1149; John JM, 2006, FUTUR CARDIOL, V2, P29, DOI 10.2217/14796678.2.1.29; Johnson JA, 2011, CLIN PHARMACOL THER, V90, P625, DOI 10.1038/clpt.2011.185; Johnson JA, 2015, TRENDS CARDIOVAS MED, V25, P33, DOI 10.1016/j.tcm.2014.09.001; Jones DR, 2011, J CHROMATOGR B, V879, P1056, DOI 10.1016/j.jchromb.2011.03.022; Jorgensen AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044064; Keeling D, 2011, BRIT J HAEMATOL, V154, P311, DOI 10.1111/j.1365-2141.2011.08753.x; Langley MR, 2009, J MOL DIAGN, V11, P216, DOI 10.2353/jmoldx.2009.080123; Lee K, 2015, CLIN PHARMACOKINET, V54, P517, DOI 10.1007/s40262-014-0219-1; Li JZ, 2015, NUTR METAB CARDIOVAS, V25, P706, DOI 10.1016/j.numecd.2015.03.013; Liu HQ, 2015, NANOSCALE RES LETT, V10, P1, DOI 10.1186/s11671-015-0959-3; Marsalek P, 2015, ANAL BIOANAL CHEM, V407, P7849, DOI 10.1007/s00216-015-8954-1; Mazzaccara C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071505; Miyagata Y, 2011, INT HEART J, V52, P44, DOI 10.1536/ihj.52.44; Mushiroda T, 2006, J HUM GENET, V51, P249, DOI 10.1007/s10038-005-0354-5; Obayashi K, 2006, CLIN PHARMACOL THER, V80, P169, DOI 10.1016/j.clpt.2006.04.010; Osman A, 2005, J CHROMATOGR B, V826, P75, DOI 10.1016/j.jchromb.2005.08.011; Perez-Andreu V, 2009, CURR DRUG METAB, V10, P632, DOI 10.2174/138920009789375432; Ring PR, 2000, J PHARMACEUT BIOMED, V22, P573, DOI 10.1016/S0731-7085(00)00232-6; Schulman S, 2012, BLOOD, V119, P3016, DOI 10.1182/blood-2011-10-378950; Scordo MG, 2002, CLIN PHARMACOL THER, V72, P702, DOI 10.1067/mcp.2002.129321; Shaik AN, 2016, J CHROMATOGR B, V1008, P164, DOI 10.1016/j.jchromb.2015.11.036; Suarez-Kurtz G, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00191; Timson DJ, 2015, CURRENT DRUG TARGETS; Tisato V, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/423407; Tognazzo S, 2006, J VASC SURG, V44, P815, DOI 10.1016/j.jvs.2006.06.006; White Pamela J, 2010, J Pharm Pract, V23, P194, DOI 10.1177/0897190010362177; WHITLON DS, 1978, BIOCHEMISTRY-US, V17, P1371, DOI 10.1021/bi00601a003; Wittkowsky Ann K, 2003, Semin Vasc Med, V3, P221; Yang LM, 2010, THROMB RES, V125, pE159, DOI 10.1016/j.thromres.2009.10.017; Zuo Z, 2010, J PHARMACEUT BIOMED, V52, P305, DOI 10.1016/j.jpba.2010.01.005	39	10	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162084	10.1371/journal.pone.0162084	http://dx.doi.org/10.1371/journal.pone.0162084			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606428	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600016
J	Kaliyappan, R; Viswanathan, S; Suthanthiram, B; Subbaraya, U; Somasundram, SM; Muthu, M				Kaliyappan, Raja; Viswanathan, Sriram; Suthanthiram, Backiyarani; Subbaraya, Uma; Somasundram, Saraswathi Marimuthu; Muthu, Mayilvaganan			Evolutionary Expansion of WRKY Gene Family in Banana and Its Expression Profile during the Infection of Root Lesion Nematode, Pratylenchus coffeae	PLOS ONE			English	Article							TRANSCRIPTION FACTOR; KNOT NEMATODE; ARABIDOPSIS; DEFENSE; RESISTANCE; IMMUNITY; RICE	The WRKY family of transcription factors orchestrate the reprogrammed expression of the complex network of defense genes at various biotic and abiotic stresses. Within the last 96 million years, three rounds of Musa polyploidization events had occurred from selective pressure causing duplication of MusaWRKYs with new activities. Here, we identified a total of 153 WRKY transcription factors available from the DH Pahang genome. Based on their phylogenetic relationship, the MusaWRKYs available with complete gene sequence were classified into the seven common WRKY sub-groups. Synteny analyses data revealed paralogous relationships, with 17 MusaWRKY gene pairs originating from the duplication events that had occurred within the Musa lineage. We also found 15 other MusaWRKY gene pairs originating from much older duplication events that had occurred along Arecales and Poales lineage of commelinids. Based on the synonymous and nonsynonymous substitution rates, the fate of duplicated MusaWRKY genes was predicted to have undergone sub-functionalization in which the duplicated gene copies retain a subset of the ancestral gene function. Also, to understand the regulatory roles of MusaWRKY during a biotic stress, Illumina sequencing was performed on resistant and susceptible cultivars during the infection of root lesion nematode, Pratylenchus coffeae. The differential WRKY gene expression analysis in nematode resistant and susceptible cultivars during challenged and unchallenged conditions had distinguished: 1) MusaWRKYs participating in general banana defense mechanism against P.coffeae common to both susceptible and resistant cultivars, 2) MusaWRKYs that may aid in the pathogen survival as suppressors of plant triggered immunity, 3) MusaWRKYs that may aid in the host defense as activators of plant triggered immunity and 4) cultivar specific MusaWRKY regulation. Mainly, MusaWRKY52, -69 and -92 are found to be P.coffeae specific and can act as activators or repressors in a defense pathway. Overall, this preliminary study in Musa provides the basis for understanding the evolution and regulatory mechanism of MusaWRKY during nematode stress.	[Kaliyappan, Raja; Viswanathan, Sriram; Suthanthiram, Backiyarani; Subbaraya, Uma; Somasundram, Saraswathi Marimuthu; Muthu, Mayilvaganan] ICAR Natl Res Ctr Banana, Crop Improvement Div, Tiruchirappalli, Tamil Nadu, India	Indian Council of Agricultural Research (ICAR); ICAR - National Research Centre for Banana	Suthanthiram, B (corresponding author), ICAR Natl Res Ctr Banana, Crop Improvement Div, Tiruchirappalli, Tamil Nadu, India.	backiyarani@gmail.com			Indian Council for Agricultural Research [2000711005]	Indian Council for Agricultural Research	This work was supported by the Indian Council for Agricultural Research, grant no. 2000711005.	Adachi H, 2015, PLANT CELL; Ali MA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102360; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Backiyarani S, 2014, PHYSIOL MOL PLANT P, V86, P11, DOI 10.1016/j.pmpp.2014.02.002; Bauters L, 2014, MOL PLANT PATHOL, V15, P352, DOI 10.1111/mpp.12098; Bhattarai KK, 2010, PLANT J, V63, P229, DOI 10.1111/j.1365-313X.2010.04232.x; D'Hont A, 2012, NATURE, V488, P213, DOI 10.1038/nature11241; Danchin EGJ, 2010, P NATL ACAD SCI USA, V107, P17651, DOI 10.1073/pnas.1008486107; Deslandes L, 2003, P NATL ACAD SCI USA, V100, P8024, DOI 10.1073/pnas.1230660100; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Flagel LE, 2009, NEW PHYTOL, V183, P557, DOI 10.1111/j.1469-8137.2009.02923.x; Food and Agriculture Organization of the United Nations, 2014, FAOSTAT DAT 2013; Grunewald W, 2008, PLANT PHYSIOL, V148, P358, DOI 10.1104/pp.108.119131; Grunewald W, 2013, EMBO REP, V14, P1136, DOI 10.1038/embor.2013.169; Haegeman A, 2011, MOL BIOCHEM PARASIT, V178, P7, DOI 10.1016/j.molbiopara.2011.04.001; Holub EB, 2001, NAT REV GENET, V2, P516, DOI 10.1038/35080508; Huh SU, 2015, SCI REP-UK, V5, DOI 10.1038/srep07981; Hurst LD, TRENDS GENETICS, V18, P486; Ibrahim HMM, 2011, EXP PARASITOL, V127, P90, DOI 10.1016/j.exppara.2010.06.037; Ishihama N, 2011, PLANT CELL, V23, P1153, DOI 10.1105/tpc.110.081794; Kyndt T, 2012, NEW PHYTOL, V196, P887, DOI 10.1111/j.1469-8137.2012.04311.x; Le Roux C, 2015, CELL, V161, P1074, DOI 10.1016/j.cell.2015.04.025; Lescot M, 2002, NUCLEIC ACIDS RES, V30, P325, DOI 10.1093/nar/30.1.325; Lippok B, 2007, MOL PLANT MICROBE IN, V20, P420, DOI 10.1094/MPMI-20-4-0420; Meng Y, 2012, MOL PLANT MICROBE IN, V25, P1492, DOI 10.1094/MPMI-04-12-0082-R; Olivier Garsmeur, 2013, POLYPLOIDE CYTOGENET, P16; Petitot AS, 2008, TREE GENET GENOMES, V4, P379, DOI 10.1007/s11295-007-0117-x; Nguyen PV, 2014, RICE, V7, DOI 10.1186/s12284-014-0023-4; Rinerson CI, 2015, BMC PLANT BIOL, V15, DOI 10.1186/s12870-015-0456-y; Schluttenhofer C, 2015, PLANT PHYSIOL, V167, P295, DOI 10.1104/pp.114.251769; Smant G, 2011, GENOMICS AND MOLECULAR GENETICS OF PLANT-NEMATODE INTERACTIONS, P273, DOI 10.1007/978-94-007-0434-3_13; Somssich IE, 1998, TRENDS PLANT SCI, V3, P86, DOI 10.1016/S1360-1385(98)01199-6; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tripathi P, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-270; Wang M, 2014, HORTIC RES-ENGLAND, V1, DOI 10.1038/hortres.2014.16; Wang YY, 2015, BIOL DIRECT, V10, DOI 10.1186/s13062-015-0076-3; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xu XP, 2006, PLANT CELL, V18, P1310, DOI 10.1105/tpc.105.037523	38	14	16	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162013	10.1371/journal.pone.0162013	http://dx.doi.org/10.1371/journal.pone.0162013			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603787	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200036
J	Zhang, XH; Li, M; Zhang, BC; Chen, KM; He, KW				Zhang, Xuehan; Li, Meng; Zhang, Bicheng; Chen, Kangming; He, Kongwang			Development of a Sandwich ELISA for EHEC O157:H7 Intimin gamma 1	PLOS ONE			English	Article							ESCHERICHIA-COLI O157H7; REAL-TIME PCR; EPEC; IDENTIFICATION; ANTIBODIES; O157-H7; GENES; CELLS	Enterohemorrhagic Escherichia coli (EHEC) O157:H7 is a zoonotic pathogen of worldwide importance that causes foodborne infections in humans. Intimin gamma 1 (intimin gamma 1) is one of the most important outer membrane proteins required for EHEC's intimate adhesion to epithelial cells. Here, we generated a polyclonal antibody (pAb) and a monoclonal antibody (mAb) against intimin gamma 1 to develop a double antibody sandwich ELISA (DAS-ELISA) with increased sensitivity and specificity for measuring EHEC O157: H7. To achieve this goal, a rabbit pAb was used as a capture antibody, and a mouse mAb was a detection antibody. No cross-reactivity was observed with the other genera of pathogenic bacteria tested with the DAS-ELISA, which included Salmonella enteritidis, Shigella flexneri type 2, Listeria monocytogenes, Streptococcus suis type 2, and other 18 serotype E. coli. Detection limits of the DAS-ELISA were 1 x 10(3) CFU/mL for EHEC O157:H7 cultures, 1 x 10(4) CFU/g before enrichment, and 1 x 10(2) CFU/g after enrichment of contaminated samples. Field samples (n = 498) were tested using a previously established duplex-PCR method and compared to our DAS-ELISA. The DAS-ELISA had a specificity of 94.4%, a sensitivity of 91.5% and accuracy of 94.0% compared with duplex-PCR. The DAS-ELISA developed here can be applied to EHEC O157:H7 quantification in food, animal, and environmental samples.	[Zhang, Xuehan; Li, Meng; Zhang, Bicheng; He, Kongwang] Jiangsu Acad Agr Sci, Inst Vet Med, Natl Ctr Engn Res Vet Bioprod, Key Lab Engn Res Vet Bioprod,Agr Minist, Nanjing 210014, Jiangsu, Peoples R China; [Zhang, Xuehan; Li, Meng; Zhang, Bicheng; He, Kongwang] Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China; [Zhang, Xuehan; Li, Meng; Zhang, Bicheng; He, Kongwang] State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Province, Nanjing 210014, Jiangsu, Peoples R China; [Chen, Kangming] Kansas State Univ, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA	Jiangsu Academy of Agricultural Sciences; Kansas State University	Zhang, XH; He, KW (corresponding author), Jiangsu Acad Agr Sci, Inst Vet Med, Natl Ctr Engn Res Vet Bioprod, Key Lab Engn Res Vet Bioprod,Agr Minist, Nanjing 210014, Jiangsu, Peoples R China.; Zhang, XH; He, KW (corresponding author), Jiangsu Coinnovat Ctr Prevent & Control Important, Yangzhou 225009, Jiangsu, Peoples R China.; Zhang, XH; He, KW (corresponding author), State Key Lab Breeding Base, Key Lab Food Qual & Safety Jiangsu Province, Nanjing 210014, Jiangsu, Peoples R China.	liuxuehan1996@hotmail.com; kwh2003@263.net		zhang, xuehan/0000-0002-0647-2266	Jiangsu province agricultural science and technology independent innovation funds [CX(16)1028]; National Natural Science Foundation of China [31572503]	Jiangsu province agricultural science and technology independent innovation funds; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Jiangsu province agricultural science and technology independent innovation funds (CX(16)1028) and the National Natural Science Foundation of China (31572503). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aidar-Ugrinovich L, 2007, INT J FOOD MICROBIOL, V115, P297, DOI 10.1016/j.ijfoodmicro.2006.10.046; Barletta F, 2009, J CLIN MICROBIOL, V47, P1915, DOI 10.1128/JCM.00608-09; Blanco A, 2004, J CLIN MICROBIOL, V42, P645, DOI 10.1128/JCM.42.2.645-651.2004; Blanco M, 2006, J MED MICROBIOL, V55, P1165, DOI 10.1099/jmm.0.46518-0; CEBULA TA, 1995, J CLIN MICROBIOL, V33, P248, DOI 10.1128/JCM.33.1.248-250.1995; Chen H, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096366; Deisingh AK, 2004, J APPL MICROBIOL, V96, P419, DOI 10.1111/j.1365-2672.2003.02170.x; Desmarchelier PM, 1998, J CLIN MICROBIOL, V36, P1801, DOI 10.1128/JCM.36.6.1801-1804.1998; Ferens WA, 2011, FOODBORNE PATHOG DIS, V8, P465, DOI 10.1089/fpd.2010.0673; Fields PI, 1997, J CLIN MICROBIOL, V35, P1066, DOI 10.1128/JCM.35.5.1066-1070.1997; GANNON VPJ, 1992, APPL ENVIRON MICROB, V58, P3809, DOI 10.1128/AEM.58.12.3809-3815.1992; He XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076368; Karch H, 2005, INT J MED MICROBIOL, V295, P405, DOI 10.1016/j.ijmm.2005.06.009; Kerr P, 2001, J APPL MICROBIOL, V90, P543, DOI 10.1046/j.1365-2672.2001.01281.x; Kim Seong-Hee, 2005, J Vet Sci, V6, P41; KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0; Li BG, 2012, APPL ENVIRON MICROB, V78, P5297, DOI 10.1128/AEM.00794-12; Li BG, 1997, MOL CELL PROBE, V11, P397, DOI 10.1006/mcpr.1997.0132; Li L, 2011, ACTA AGRI BOREALI SI, V26, P58, DOI [10.7668/hbnxb.2011.06.012, DOI 10.7668/HBNXB.2011.06.012]; Li Y, 2004, J FOOD PROTECT, V67, P27, DOI 10.4315/0362-028X-67.1.27; Luo L, 2014, HUBEI AGR SCI, V53, DOI [10.1371/journal.pone.0091632, DOI 10.1371/JOURNAL.PONE.0091632]; Mohammed HO, 2015, J FOOD PROTECT, V78, P1812, DOI 10.4315/0362-028X.JFP-14-596; Rabinovitz BC, 2012, J DAIRY SCI, V95, P3318, DOI 10.3168/jds.2011-5093; RIDGE SE, 1993, J CLIN MICROBIOL, V31, P1256, DOI 10.1128/JCM.31.5.1256-1261.1993; ROGER V, 1992, CURR MICROBIOL, V25, P197, DOI 10.1007/BF01570719; SCHMIDT H, 1994, MED MICROBIOL IMMUN, V183, P23; Shen ZQ, 2014, GUT PATHOG, V6, DOI 10.1186/1757-4749-6-14; Son WG, 2002, CLIN DIAGN LAB IMMUN, V9, P46, DOI 10.1128/CDLI.9.1.46-53.2002; Vandekerchove DGF, 2002, VET MICROBIOL, V88, P351, DOI 10.1016/S0378-1135(02)00125-6; WADOLKOWSKI EA, 1990, INFECT IMMUN, V58, P2438, DOI 10.1128/IAI.58.8.2438-2445.1990; Zhang XJ, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0085007, 10.1186/1748-717X-9-64]; Zhang XH, 2011, VACCINE, V29, P3923, DOI 10.1016/j.vaccine.2011.02.007; Zhou ZM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008700	33	9	9	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162274	10.1371/journal.pone.0162274	http://dx.doi.org/10.1371/journal.pone.0162274			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603508	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200053
J	Multini, LC; Wilke, ABB; Suesdek, L; Marrelli, MT				Multini, Laura Cristina; Bruno Wilke, Andre Barretto; Suesdek, Lincoln; Marrelli, Mauro Toledo			Population Genetic Structure of Aedes fluviatilis (Diptera: Culicidae)	PLOS ONE			English	Article							IMMATURE MOSQUITOS DIPTERA; COLOMBIAN ATLANTIC COAST; SAO-PAULO; MUNICIPAL PARKS; MICROSATELLITE MARKERS; ECOLOGICAL ASPECTS; 1ST REPORT; CITY; EXPANSION; SOFTWARE	Although Aedes fluviatilis is an anthropophilic mosquito found abundantly in urban environments, its biology, epidemiological potential and genetic characteristics are poorly understood. Climate change and urbanization processes that result in environmental modifications benefit certain anthropophilic mosquito species such as Ae. fluviatilis, greatly increasing their abundance in urban areas. To gain a better understanding of whether urbanization processes modulate the genetic structure of this species in the city of Sao Paulo, we used eight microsatellite loci to genetically characterize Ae. fluviatilis populations collected in nine urban parks in the city of Sao Paulo. Our results show that there is high gene flow among the populations of this species, heterozygosity deficiency and low genetic structure and that the species may have undergone a recent population expansion. There are two main hypotheses to explain these findings: (i) Ae. fluviatilis populations have undergone a population expansion as a result of urbanization; and (ii) as urbanization of the city of Sao Paulo occurred recently and was quite intense, the structuring of these populations cannot be observed yet, apart from in the populations of Ibirapuera and Piqueri parks, where the first signs of structuring have appeared. We believe that the expansion found in Ae. fluviatilis populations is probably correlated with the unplanned urbanization of the city of Sao Paulo, which transformed green areas into urbanized areas, as well as the increasing population density in the city.	[Multini, Laura Cristina; Bruno Wilke, Andre Barretto; Marrelli, Mauro Toledo] Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Sao Paulo, SP, Brazil; [Multini, Laura Cristina; Suesdek, Lincoln; Marrelli, Mauro Toledo] Univ Sao Paulo, Inst Med Trop Sao Paulo, Sao Paulo, SP, Brazil; [Suesdek, Lincoln] Inst Butantan, Lab Parasitol, Sao Paulo, SP, Brazil	Universidade de Sao Paulo; Universidade de Sao Paulo; Instituto Butantan	Wilke, ABB (corresponding author), Univ Sao Paulo, Dept Epidemiol, Fac Saude Publ, Sao Paulo, SP, Brazil.	andrewilke@usp.br	Suesdek, Lincoln/C-7943-2013; Marrelli, Mauro/H-2568-2013; Wilke, Andre B B/J-9973-2014	Suesdek, Lincoln/0000-0001-6829-738X; Marrelli, Mauro/0000-0002-0312-8777; Wilke, Andre B B/0000-0002-6629-7666; Multini, Laura Cristina/0000-0002-1322-9889	State of Sao Paulo Research Foundation (FAPESP) [2013/15313-4]; FAPESP [2013/22347-2, 2012/19117-2]; CNPq [311805/2014-0]	State of Sao Paulo Research Foundation (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This work was supported by the State of Sao Paulo Research Foundation (FAPESP) for providing financial support (grant 2013/15313-4, www.fapesp.br). LCM was the recipient of a fellowship from FAPESP (2013/22347-2, www.fapesp.br), and ABBW was the recipient of a postdoctoral fellowship from FAPESP (2012/19117-2, www.fapesp.br). LS is the recipient of a CNPq grant (311805/2014-0, www.cnpq.br). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baton LA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059619; Beebe NW, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002361; Belisario CJ, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0879-1; Bello F, 2009, GENET MOL RES, V8, P1179, DOI 10.4238/vol8-3gmr652; Bello FJ, 2014, GENET MOL RES, V13, P4110, DOI 10.4238/2014.May.30.6; Brown JE, 2011, P ROY SOC B-BIOL SCI, V278, P2446, DOI 10.1098/rspb.2010.2469; Brown JE, 2014, EVOLUTION, V68, P514, DOI 10.1111/evo.12281; Wilke ABB, 2014, PARASITE VECTOR, V7, DOI 10.1186/s13071-014-0468-8; Carlsson J, 2008, J HERED, V99, P616, DOI 10.1093/jhered/esn048; Ceretti W, 2016, J ARTHROPOD-BORNE DI, V10, P102; Ceretti W, 2015, J AM MOSQUITO CONTR, V31, P172, DOI 10.2987/14-6457R; Ceretti W, 2014, J AM MOSQUITO CONTR, V30, P268, DOI 10.2987/14-6403R.1; Chambers EW, 2007, J HERED, V98, P202, DOI 10.1093/jhered/esm015; Chapuis MP, 2007, MOL BIOL EVOL, V24, P621, DOI 10.1093/molbev/msl191; Chaves LF, 2010, Q REV BIOL, V85, P27, DOI 10.1086/650284; Cornuet JM, 1996, GENETICS, V144, P2001; DAVIS Nelson C., 1931, American Journal of Tropical Medicine, V11, P21; de Carvalho GC, 2014, J VECTOR ECOL, V39, P146, DOI 10.1111/j.1948-7134.2014.12081.x; Descloux E, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001470; Donnelly MJ, 2001, MOL BIOL EVOL, V18, P1353, DOI 10.1093/oxfordjournals.molbev.a003919; Edillo FE, 2007, J MED ENTOMOL, V44, P145, DOI 10.1603/0022-2585(2007)44[145:ASOBAM]2.0.CO;2; Edman J.D., 1988, Miscellaneous Publications of the Entomological Society of America, P43; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Fonseca DM, 2006, AM J TROP MED HYG, V74, P284, DOI 10.4269/ajtmh.2006.74.284; Forattini OP, 2002, CULICIDOLOGIA MED; GOMES AD, 1985, REV SAUDE PUBL, V19, P190, DOI 10.1590/S0034-89101985000200009; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Honorio NA, 2015, CAD SAUDE PUBLICA, V31, P906, DOI 10.1590/0102-311XPE020515; Ibanez-Justicia A, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-0865-7; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Kasai N, 1979, THESIS; LaDeau SL, 2015, FUNCT ECOL, V29, P889, DOI 10.1111/1365-2435.12487; Laporta GZ, 2006, REV BRAS ENTOMOL, V50, P125, DOI 10.1590/S0085-56262006000100019; Levy MZ, 2014, P ROY SOC B-BIOL SCI, V281, DOI 10.1098/rspb.2014.1003; Li YJ, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003301; Louise C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137851; McGaughran A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087317; McKinney M. L., 2008, Urban Ecosystems, V11, P161, DOI 10.1007/s11252-007-0045-4; Medeiros-Sousa AR, 2013, J AM MOSQUITO CONTR, V29, P275, DOI 10.2987/12-6304R.1; Michel AP, 2006, GENETICS, V173, P1389, DOI 10.1534/genetics.106.059667; Mirabello L, 2006, HEREDITY, V97, P438, DOI 10.1038/sj.hdy.6800913; Monteiro FA, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003167; Moreira LA, 2009, CELL, V139, P1268, DOI 10.1016/j.cell.2009.11.042; Multini LC, 2015, PARASITE VECTOR, V8, DOI 10.1186/s13071-015-1256-9; NASCI RS, 1981, MOSQ NEWS, V41, P808; Olanratmanee P, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0001913; Paaijmans KP, 2013, GLOBAL CHANGE BIOL, V19, P2373, DOI 10.1111/gcb.12240; Pascual M, 2006, P NATL ACAD SCI USA, V103, P5829, DOI 10.1073/pnas.0508929103; PATTON D R, 1975, Wildlife Society Bulletin, V3, P171; Porretta D, 2005, MOL ECOL NOTES, V5, P48, DOI 10.1111/j.1471-8286.2004.00826.x; Pudovkin AI, 1996, GENETICS, V144, P383; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Samson DM, 2015, J VECTOR ECOL, V40, P46, DOI 10.1111/jvec.12131; StatSoft I., 2004, STAT DAT AN SOFTW SY; Taipe-Lagos CB, 2003, REV SAUDE PUBL, V37, P275, DOI 10.1590/S0034-89102003000300002; Tason de Camargo M.V., 1983, Memorias do Instituto Oswaldo Cruz, V78, P83; Tauil P L, 2001, Cad Saude Publica, V17 Suppl, P99, DOI 10.1590/S0102-311X2001000700018; Tchouassi DP, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0003364; Urbinatti PR, 2001, REV SAUDE PUBL, V35, P461, DOI 10.1590/S0034-89102001000500009; Piccinali RV, 2015, INFECT GENET EVOL, V34, P143, DOI 10.1016/j.meegid.2015.05.030; Venkatesan M, 2010, MOL ECOL, V19, P1573, DOI 10.1111/j.1365-294X.2010.04577.x; Vezzani D, 2006, VET PARASITOL, V136, P259, DOI 10.1016/j.vetpar.2005.10.026; WRBU, 2015, SYST CAT CUL; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zielke DE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099093	67	17	17	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162328	10.1371/journal.pone.0162328	http://dx.doi.org/10.1371/journal.pone.0162328			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598889	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800053
J	Ogiso, H; Ito, H; Ando, T; Arioka, Y; Kanbe, A; Ando, K; Ishikawa, T; Saito, K; Hara, A; Moriwaki, H; Shimizu, M; Seishima, M				Ogiso, Hideyuki; Ito, Hiroyasu; Ando, Tatsuya; Arioka, Yuko; Kanbe, Ayumu; Ando, Kazuki; Ishikawa, Tetsuya; Saito, Kuniaki; Hara, Akira; Moriwaki, Hisataka; Shimizu, Masahito; Seishima, Mitsuru			The Deficiency of Indoleamine 2,3-Dioxygenase Aggravates the CCl4-Induced Liver Fibrosis in Mice	PLOS ONE			English	Article							INDUCED HEPATITIS MODEL; REGULATORY T-CELLS; CARBON-TETRACHLORIDE; DENDRITIC CELLS; RAT-LIVER; FULMINANT-HEPATITIS; KUPFFER CELLS; TNF-ALPHA; TRYPTOPHAN; INJURY	In the present study, we examined the role of indoleamine 2,3-dioxygenase (IDO) in the development of CCl4-induced hepatic fibrosis. The liver fibrosis induced by repetitive administration with CCl4 was aggravated in IDO-KO mice compared to WT mice. In IDO-KO mice treated with CCl4, the number of several inflammatory cells and the expression of pro-inflammatory cytokines increased in the liver. In the results, activated hepatic stellate cells (HSCs) and fibrogenic factors on HSCs increased after repetitive CCl4 administration in IDO-KO mice compared to WT mice. Moreover, the treatment with L-tryptophan aggravated the CCl4-induced hepatic fibrosis in WT mice. Our findings demonstrated that the IDO deficiency enhanced the inflammation in the liver and aggravated liver fibrosis in repetitive CCl4-treated mice.	[Ogiso, Hideyuki; Ito, Hiroyasu; Ando, Tatsuya; Arioka, Yuko; Kanbe, Ayumu; Ando, Kazuki; Seishima, Mitsuru] Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu, Japan; [Moriwaki, Hisataka; Shimizu, Masahito] Gifu Univ, Grad Sch Med, Dept Internal Med 1, Gifu, Japan; [Ishikawa, Tetsuya] Nagoya Univ, Dept Med Technol, Sch Hlth Sci, Nagoya, Aichi, Japan; [Saito, Kuniaki] Kyoto Univ, Grad Sch Med, Human Hlth Sci, Kyoto, Japan; [Saito, Kuniaki] Fac Med, Kyoto, Japan; [Hara, Akira] Gifu Univ, Grad Sch Med, Dept Tumor Pathol, Gifu, Japan	Gifu University; Gifu University; Nagoya University; Kyoto University; Gifu University	Ito, H (corresponding author), Gifu Univ, Grad Sch Med, Dept Informat Clin Med, Gifu, Japan.	hito@gifu-u.ac.jp		Arioka, Yuko/0000-0002-1792-8812				Abu-Tair L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082571; Bahcecioglu IH, 2004, CELL BIOCHEM FUNCT, V22, P359, DOI 10.1002/cbf.1114; Bataller R, 2005, J CLIN INVEST, V115, P209, DOI 10.1172/JCI200524282; CHATAMRA K, 1981, BRIT J EXP PATHOL, V62, P283; Chi Victor, 2007, J Vis Exp, P308, DOI 10.3791/308; Chung DJ, 2009, BLOOD, V114, P555, DOI 10.1182/blood-2008-11-191197; Dai Y, 1995, J PHARMACOL EXP THER, V275, P1614; Fan XB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082190; Feng Yibin, 2010, Chin Med, V5, P33, DOI 10.1186/1749-8546-5-33; Friedman SL, 2000, J BIOL CHEM, V275, P2247, DOI 10.1074/jbc.275.4.2247; Frumento G, 2002, J EXP MED, V196, P459, DOI 10.1084/jem.20020121; GEERTS A, 1988, J HEPATOL, V6, P50, DOI 10.1016/S0168-8278(88)80461-6; GRESSNER AM, 1992, HEPATOLOGY, V16, P1250; Gressner AM, 1996, KIDNEY INT, V49, pS39; Hoshi M, 2010, J IMMUNOL, V185, P3305, DOI 10.4049/jimmunol.0901150; Hoshi M, 2009, LEUKEMIA RES, V33, P39, DOI 10.1016/j.leukres.2008.05.023; Inagaki Y, 2007, GUT, V56, P284, DOI 10.1136/gut.2005.088690; Ito H, 2014, IMMUNOLOGY; Ito H, 2010, J IMMUNOL, V185, P4554, DOI 10.4049/jimmunol.0904173; Ito H, 2009, J IMMUNOL, V182, P391, DOI 10.4049/jimmunol.182.1.391; Iwamoto N, 2009, LIVER INT, V29, P277, DOI 10.1111/j.1478-3231.2008.01748.x; Kuales MA, 2011, HISTOL HISTOPATHOL, V26, P997, DOI 10.14670/HH-26.997; Li D, 2012, CELL BIOCHEM FUNCT, V30, P309, DOI 10.1002/cbf.2803; Lim HJ, 2011, MOL CELLS, V31, P123, DOI 10.1007/s10059-011-0016-8; Moffett JR, 2003, IMMUNOL CELL BIOL, V81, P247, DOI 10.1046/j.1440-1711.2003.t01-1-01177.x; Murakami Y, 2012, CYTOKINE, V59, P245, DOI 10.1016/j.cyto.2012.04.022; Murata S, 2014, INT J MOL SCI, V15, P5412, DOI 10.3390/ijms15045412; Ogawa K, 2012, CANCER SCI, V103, P951, DOI 10.1111/j.1349-7006.2012.02237.x; Ohtaki H, 2014, BBA-MOL BASIS DIS, V1842, P1464, DOI 10.1016/j.bbadis.2014.04.015; Sakaida I, 1998, J HEPATOL, V28, P298, DOI 10.1016/0168-8278(88)80017-5; Sato A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092515; Schmidt SK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063301; Sierra-Filardi E, 2014, J IMMUNOL, V192, P3858, DOI 10.4049/jimmunol.1302821; Su GL, 2002, AM J PHYSIOL-GASTR L, V283, pG256, DOI 10.1152/ajpgi.00550.2001; Tarao K, 2013, SCAND J GASTROENTERO, V48, P729, DOI 10.3109/00365521.2013.782064; Terness P, 2002, J EXP MED, V196, P447, DOI 10.1084/jem.20020052; TOMASI A, 1987, BIOCHEM J, V246, P313, DOI 10.1042/bj2460313; Yan YP, 2010, J IMMUNOL, V185, P5953, DOI 10.4049/jimmunol.1001628; Zhang DY, 2012, HEPATOLOGY, V56, P769, DOI 10.1002/hep.25670; Zhang X, 2004, WORLD J GASTROENTERO, V10, P610, DOI 10.3748/wjg.v10.i4.610	40	18	18	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162183	10.1371/journal.pone.0162183	http://dx.doi.org/10.1371/journal.pone.0162183			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598994	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800044
J	Okpeku, M; Esmailizadeh, A; Adeola, AC; Shu, LP; Zhang, YS; Wang, YZ; Sanni, TM; Imumorin, IG; Peters, SO; Zhang, JJ; Dong, Y; Wang, W				Okpeku, Moses; Esmailizadeh, Ali; Adeola, Adeniyi C.; Shu, Liping; Zhang, Yesheng; Wang, Yangzi; Sanni, Timothy M.; Imumorin, Ikhide G.; Peters, Sunday O.; Zhang, Jiajin; Dong, Yang; Wang, Wen			Genetic Variation of Goat Interferon Regulatory Factor 3 Gene and Its Implication in Goat Evolution	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; POSITIVE SELECTION; FACTOR FAMILY; EXPRESSION; IRF3	The immune systems are fundamentally vital for evolution and survival of species; as such, selection patterns in innate immune loci are of special interest in molecular evolutionary research. The interferon regulatory factor (IRF) gene family control many different aspects of the innate and adaptive immune responses in vertebrates. Among these, IRF3 is known to take active part in very many biological processes. We assembled and evaluated 1356 base pairs of the IRF3 gene coding region in domesticated goats from Africa (Nigeria, Ethiopia and South Africa) and Asia (Iran and China) and the wild goat (Capra aegagrus). Five segregating sites with. value of 0.0009 for this gene demonstrated a low diversity across the goats' populations. Fu and Li tests were significantly positive but Tajima's D test was significantly negative, suggesting its deviation from neutrality. Neighbor joining tree of IRF3 gene in domesticated goats, wild goat and sheep showed that all domesticated goats have a closer relationship than with the wild goat and sheep. Maximum likelihood tree of the gene showed that different domesticated goats share a common ancestor and suggest single origin. Four unique haplotypes were observed across all the sequences, of which, one was particularly common to African goats (MOCH-K14-0425, Poitou and WAD). In assessing the evolution mode of the gene, we found that the codon model d(N)/d(S) ratio for all goats was greater than one. Phylogenetic Analysis by Maximum Likelihood (PAML) gave a omega(0) (d(N)/d(S)) value of 0.067 with LnL value of -6900.3 for the first Model (M1) while omega 2 = 1.667 in model M2 with LnL value of -6900.3 with positive selection inferred in 3 codon sites. Mechanistic empirical combination (MEC) model for evaluating adaptive selection pressure on particular codons also confirmed adaptive selection pressure in three codons (207, 358 and 408) in IRF3 gene. Positive diversifying selection inferred with recent evolutionary changes in domesticated goat IRF3 led us to conclude that the gene evolution may have been influenced by domestication processes in goats.	[Okpeku, Moses; Esmailizadeh, Ali; Adeola, Adeniyi C.; Shu, Liping; Zhang, Yesheng; Wang, Yangzi; Dong, Yang; Wang, Wen] Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China; [Okpeku, Moses] Niger Delta Univ, Dept Anim Sci, Ammassoma, Bayelsa State, Nigeria; [Zhang, Jiajin] Yunnan Agr Univ, Sch Sci & Informat Engn, Kunming 650201, Peoples R China; [Dong, Yang] Kunming Univ Sci & Technol, Coll Life Sci, Lab Appl Genom & Synthet Biol, Kunming 650500, Peoples R China; [Sanni, Timothy M.] Fed Univ Agr, Dept Anim Breeding & Genet, Abeokuta, Ogun State, Nigeria; [Esmailizadeh, Ali] Shahid Bahonar Univ Kerman, Dept Anim Sci, PB 76169-133, Kerman, Iran; [Imumorin, Ikhide G.] Cornell Univ, Coll Agr & Life Sci, Anim Genet & Genom Lab, Off Int Programs, Ithaca, NY 14853 USA; [Peters, Sunday O.] Berry Coll, Dept Anim Sci, Mt Berry, GA USA	Chinese Academy of Sciences; Kunming Institute of Zoology; Yunnan Agricultural University; Kunming University of Science & Technology; University of Agriculture, Abeokuta; Shahid Bahonar University of Kerman (SBUK); Cornell University	Wang, W (corresponding author), Chinese Acad Sci, Kunming Inst Zool, State Key Lab Genet Resources & Evolut, Kunming 650223, Yunnan, Peoples R China.	wwang@mail.kiz.ac.cn	Peters, Sunday/AAE-9683-2021; Okpeku, Moses/T-8184-2019; Esmailizadeh, Ali/N-9005-2016; Esmailizadeh, Ali K./D-7252-2011; Wang, Wen/AAP-9873-2020; Adeola, Adeniyi Charles/GQH-3891-2022	Okpeku, Moses/0000-0002-8337-6294; Esmailizadeh, Ali/0000-0003-0986-6639; Esmailizadeh, Ali K./0000-0003-0986-6639; Adeola, Adeniyi Charles/0000-0001-5171-7878; Peters, Sunday/0000-0002-0216-926X	Chinese Academy of Sciences Fellowship [Y302851081]; Education Trust Fund (TETFUND), Nigeria [NDU/TETFUND/2013/0004]; "973" project [2013CB835200]; Chinese Academy of Sciences (CAS) International Post-doctoral Fellowship	Chinese Academy of Sciences Fellowship; Education Trust Fund (TETFUND), Nigeria; "973" project(National Basic Research Program of China); Chinese Academy of Sciences (CAS) International Post-doctoral Fellowship	This work was supported by the Chinese Academy of Sciences Fellowship for Postdoctoral and Visiting Scholars from Developing Countries, Grant Number Y302851081, awarded to Dr. Moses Okpeku; Education Trust Fund (TETFUND), Nigeria, Grant Number NDU/TETFUND/2013/0004, awarded to Dr. Moses Okpeku; and "973" project (Grant No. 2013CB835200) to Dr. Wen Wang.; We thank Dr. Wei Chen and Dr. Xueyan Li for their valuable comments and suggestions and proof reading of the manuscript. Kunming Institute of Zoology (KIZ), Kunming China is appreciated for hosting Dr. Moses Okpeku for the Chinese Academy of Sciences (CAS) International Post-doctoral Fellowship for Visiting Scholars from Developing Countries. All members of the Wen Wang Team in KIZ are appreciated for the warm support given to Dr. Moses Okpeku and his family.	Agalioti T, 2000, CELL, V103, P667, DOI 10.1016/S0092-8674(00)00169-0; Agrafioti I, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-23; AU WC, 1995, P NATL ACAD SCI USA, V92, P11657, DOI 10.1073/pnas.92.25.11657; Aziz M. A., 2010, Lohmann Information, V45, P42; Barreiro LB, 2008, NAT GENET, V40, P340, DOI 10.1038/ng.78; Boulila M, 2013, J GENET, V92, P11, DOI 10.1007/s12041-013-0211-9; Chattopadhyay S, 2010, EMBO J, V29, P1762, DOI 10.1038/emboj.2010.50; Codoner FM, 2008, EVOL BIOINFORM, V4, P29; Cui QH, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-21; de Lendonck LY, 2014, CELL MOL LIFE SCI, V71, P3873, DOI 10.1007/s00018-014-1653-9; de Lendonck LY, 2013, P NATL ACAD SCI USA, V110, pE3189, DOI 10.1073/pnas.1219221110; Di Paolo NC, 2013, CELL REP, V3, P1840, DOI 10.1016/j.celrep.2013.05.025; Dong Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1606-1; Ijaz N, 2015, PAK J AGR SCI, V52, P1113; Jann OC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-216; Joshi MB, 2004, MOL BIOL EVOL, V21, P454, DOI 10.1093/molbev/msh038; Kimball J. W., 2012, HAPLOTYPES; LEE YH, 1995, MOL BIOL EVOL, V12, P231; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Olson-Manning CF, 2013, MOL BIOL EVOL, V30, P14, DOI 10.1093/molbev/mss204; Pal C, 2001, GENETICS, V158, P927; Rabo JS, 1996, SMALL RUMINANT RES, V21, P161, DOI 10.1016/0921-4488(96)00855-3; Ranjith-Kumar CT, 2007, J BIOL CHEM, V282, P17696, DOI 10.1074/jbc.M700209200; Rausher MD, 2013, EVOLUTION, V67, P34, DOI 10.1111/j.1558-5646.2012.01771.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Sun F, 2010, J IMMUNOL, V185, P7573, DOI 10.4049/jimmunol.1002401; Swanson WJ, 2003, MOL BIOL EVOL, V20, P18, DOI 10.1093/oxfordjournals.molbev.a004233; TAJIMA F, 1989, GENETICS, V123, P585; Takaoka A, 2008, CANCER SCI, V99, P467, DOI 10.1111/j.1349-7006.2007.00720.x; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; The International HapMap Consortium, 2003, INT HAPMAP PROJ, P789; Vamathevan JJ, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-273; Wright KM, 2010, GENETICS, V184, P483, DOI 10.1534/genetics.109.110411; Yang JR, 2012, P NATL ACAD SCI USA, V109, pE831, DOI 10.1073/pnas.1117408109; Yang PY, 2010, NAT IMMUNOL, V11, P487, DOI 10.1038/ni.1876; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088	39	2	3	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161962	10.1371/journal.pone.0161962	http://dx.doi.org/10.1371/journal.pone.0161962			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598391	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800029
J	Nisa-Martinez, R; Molina-Sanchez, MD; Toro, N				Nisa-Martinez, Rafael; Dolores Molina-Sanchez, Mara; Toro, Nicolas			Host Factors Influencing the Retrohoming Pathway of Group II Intron RmInt1, Which Has an Intron-Encoded Protein Naturally Devoid of Endonuclease Activity	PLOS ONE			English	Article							ESCHERICHIA-COLI; SINORHIZOBIUM-MELILOTI; RHIZOBIUM-LEGUMINOSARUM; RIBOZYME CORE; RNASE H2; REPAIR; IDENTIFICATION; RETROMOBILITY; FLUORESCENCE; MUTAGENESIS	Bacterial group II introns are self-splicing catalytic RNAs and mobile retroelements that have an open reading frame encoding an intron-encoded protein (IEP) with reverse transcriptase (RT) and RNA splicing or maturase activity. Some IEPs carry a DNA endonuclease (En) domain, which is required to cleave the bottom strand downstream from the intron-insertion site for target DNA-primed reverse transcription (TPRT) of the inserted intron RNA. Host factors complete the insertion of the intron. By contrast, the major retrohoming pathway of introns with IEPs naturally lacking endonuclease activity, like the Sinorhizobium meliloti intron RmInt1, is thought to involve insertion of the intron RNA into the template for lagging strand DNA synthesis ahead of the replication fork, with possible use of the nascent strand to prime reverse transcription of the intron RNA. The host factors influencing the retrohoming pathway of such introns have not yet been described. Here, we identify key candidates likely to be involved in early and late steps of RmInt1 retrohoming. Some of these host factors are common to En(+) group II intron retrohoming, but some have different functions. Our results also suggest that the retrohoming process of RmInt1 may be less dependent on the intracellular free Mg2+ concentration than those of other group II introns.	[Nisa-Martinez, Rafael; Dolores Molina-Sanchez, Mara; Toro, Nicolas] CSIC, Struct Dynam & Funct Rhizobacterial Genomes, Dept Soil Microbiol & Symbiot Syst, Estn Expt Zaidin, Calle Prof Albareda 1, E-18008 Granada, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Experimental del Zaidin (EEZ)	Toro, N (corresponding author), CSIC, Struct Dynam & Funct Rhizobacterial Genomes, Dept Soil Microbiol & Symbiot Syst, Estn Expt Zaidin, Calle Prof Albareda 1, E-18008 Granada, Spain.	nicolas.toro@eez.csic.es	Molina-Sánchez, Maria Dolores/J-1925-2016; Toro, Nicolas/K-4909-2014	Molina-Sánchez, Maria Dolores/0000-0002-3627-9360; Toro, Nicolas/0000-0002-3614-807X	 [BIO2014-51953-P]		This work was funded by BIO2014-51953-P (https://sede.micinn.gob.es/).	Baker-Austin C, 2005, MICROBIOL-SGM, V151, P2637, DOI 10.1099/mic.0.28076-0; Beauregard A, 2008, ANNU REV GENET, V42, P587, DOI 10.1146/annurev.genet.42.110807.091549; Becker A, 2009, J BIOTECHNOL, V140, P45, DOI 10.1016/j.jbiotec.2008.11.006; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Calloni G, 2012, CELL REP, V1, P251, DOI 10.1016/j.celrep.2011.12.007; Chillon I, 2014, RNA, V20, P2000, DOI 10.1261/rna.047407.114; Chon H, 2013, NUCLEIC ACIDS RES, V41, P3130, DOI 10.1093/nar/gkt027; Cooper DL, 2015, MOL MICROBIOL, V95, P769, DOI 10.1111/mmi.12899; Coros CJ, 2009, MOL CELL, V34, P250, DOI 10.1016/j.molcel.2009.03.014; Coros CJ, 2008, RNA, V14, P2634, DOI 10.1261/rna.1247608; Costa M, 1997, J MOL BIOL, V274, P353, DOI 10.1006/jmbi.1997.1416; Enyeart PJ, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-2; Froschauer EM, 2004, FEMS MICROBIOL LETT, V237, P49, DOI 10.1016/j.femsle.2004.06.013; Goldfless SJ, 2006, MOL CELL, V21, P595, DOI 10.1016/j.molcel.2006.01.025; Gregan J, 2001, GENE DEV, V15, P2229, DOI 10.1101/gad.201301; KOVACH ME, 1994, BIOTECHNIQUES, V16, P800; Lambowitz AM, 2004, ANNU REV GENET, V38, P1, DOI 10.1146/annurev.genet.38.072902.091600; Lambowitz AM, 2010, COLD SPRING HARB PER, V3, DOI [DOI 10.1101/CSHPERSPECT.A003616, 10.1101/cshperspect.a003616]; Lehmann K, 2003, CRIT REV BIOCHEM MOL, V38, P249, DOI 10.1080/713609236; LIBEREK K, 1988, P NATL ACAD SCI USA, V85, P6632, DOI 10.1073/pnas.85.18.6632; Martinez-Abarca F, 2004, NUCLEIC ACIDS RES, V32, P2880, DOI 10.1093/nar/gkh616; Martinez-Abarca F, 2000, MOL MICROBIOL, V38, P917, DOI 10.1046/j.1365-2958.2000.02197.x; Massoni SC, 2012, J BACTERIOL, V194, P5325, DOI 10.1128/JB.00674-12; Mastroianni M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003121; Matsuura M, 1997, GENE DEV, V11, P2910, DOI 10.1101/gad.11.21.2910; MICHEL F, 1989, GENE, V82, P5, DOI 10.1016/0378-1119(89)90026-7; MICHEL F, 1995, ANNU REV BIOCHEM, V64, P435, DOI 10.1146/annurev.bi.64.070195.002251; Michel F, 2009, TRENDS BIOCHEM SCI, V34, P189, DOI 10.1016/j.tibs.2008.12.007; MOL CD, 1995, NATURE, V374, P381, DOI 10.1038/374381a0; Molina-Sanchez MD, 2015, GENOMIC ELEMENTS HLT, P195; Nisa-Martinez R, 2007, NUCLEIC ACIDS RES, V35, P214, DOI 10.1093/nar/gkl1072; Nisa-Martinez R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084056; Pobigaylo N, 2008, MOL PLANT MICROBE IN, V21, P219, DOI 10.1094/MPMI-21-2-0219; Pobigaylo N, 2006, APPL ENVIRON MICROB, V72, P4329, DOI 10.1128/AEM.03072-05; POENIE M, 1990, CELL CALCIUM, V11, P85, DOI 10.1016/0143-4160(90)90062-Y; PRENTKI P, 1984, GENE, V29, P303, DOI 10.1016/0378-1119(84)90059-3; PYLE AM, 2008, THE ROYAL SOCIETY OF, P201; ROBERTSEN BK, 1981, PLANT PHYSIOL, V67, P389, DOI 10.1104/pp.67.3.389; Rychlik MP, 2010, MOL CELL, V40, P658, DOI 10.1016/j.molcel.2010.11.001; Sambrook, 1989, MOL CLONING LAB MANU, P68; SCHAFER A, 1994, GENE, V145, P69, DOI 10.1016/0378-1119(94)90324-7; Smith D, 2005, GENE DEV, V19, P2477, DOI 10.1101/gad.1345105; Toro N, 2003, ENVIRON MICROBIOL, V5, P143, DOI 10.1046/j.1462-2920.2003.00398.x; Toro N, 2007, FEMS MICROBIOL REV, V31, P342, DOI 10.1111/j.1574-6976.2007.00068.x; Truong DM, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005422; Truong DM, 2013, P NATL ACAD SCI USA, V110, pE3800, DOI 10.1073/pnas.1315742110; Udvardi M, 2013, ANNU REV PLANT BIOL, V64, P781, DOI 10.1146/annurev-arplant-050312-120235; VILLADAS PJ, 1995, FEMS MICROBIOL ECOL, V17, P161, DOI 10.1111/j.1574-6941.1995.tb00139.x; Wais RJ, 2002, MOL PLANT MICROBE IN, V15, P1245, DOI 10.1094/MPMI.2002.15.12.1245; Yao J, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003469	50	7	7	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162275	10.1371/journal.pone.0162275	http://dx.doi.org/10.1371/journal.pone.0162275			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588750	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800045
J	Wang, WC; Chen, SY; Zhang, XZ				Wang, Wen-Cai; Chen, Si-Yun; Zhang, Xian-Zhi			Chloroplast Genome Evolution in Actinidiaceae: clpP Loss, Heterogenous Divergence and Phylogenomic Practice	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; PLASTID GENOMES; INDEPENDENT TRANSFERS; MAXIMUM-LIKELIHOOD; MITOCHONDRIAL-DNA; GENE LOSSES; ANGIOSPERMS; REPEAT; CAMPANULACEAE; BIOGEOGRAPHY	Actinidiaceae is a well-known economically important plant family in asterids. To elucidate the chloroplast (cp) genome evolution within this family, here we present complete genomes of three species from two sister genera (Clematoclethra and Actinidia) in the Actinidiaceae via genome skimming technique. Comparative analyses revealed that the genome structure and content were rather conservative in three cp genomes in spite of different inheritance pattern, i.e. paternal in Actinidia and maternal in Clematoclethra. The clpP gene was lacked in all the three sequenced cp genomes examined here indicating that the clpP gene loss is likely a conspicuous synapomorphic characteristic during the cp genome evolution of Actinidiaceae. Comprehensive sequence comparisons in Actinidiaceae cp genomes uncovered that there were apparently heterogenous divergence patterns among the cpDNA regions, suggesting a preferred data-partitioned analysis for cp phylogenomics. Twenty non-coding cpDNA loci with fast evolutionary rates are further identified as potential molecular markers for systematics studies of Actinidiaceae. Moreover, the cp phylogenomic analyses including 31 angiosperm plastomes strongly supported the monophyly of Actinidia, being sister to Clematoclethra in Actinidiaceae which locates in the basal asterids, Ericales.	[Zhang, Xian-Zhi] Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Wang, Wen-Cai] Queen Mary Univ London, Sch Biol & Chem Sci, Mile End Rd, London, England; [Chen, Si-Yun] Chinese Acad Sci, Kunming Inst Bot, Germplasm Bank Wild Species, Kunming, Yunnan, Peoples R China	Northwest A&F University - China; University of London; Queen Mary University London; Chinese Academy of Sciences; Kunming Institute of Botany, CAS	Zhang, XZ (corresponding author), Northwest A&F Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China.	zhangxianzhi@nwsuaf.edu.cn		chen (CHEN), si yun (Si-Yun)/0000-0002-1730-5420	Northwest AF University [2452016052, Z109021509]	Northwest AF University	This study was funded by the Basic Science Fund (grant no. 2452016052) and Doctor Startup Fund (grant no. Z109021509) from Northwest A&F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barrett CF, 2016, NEW PHYTOL, V209, P855, DOI 10.1111/nph.13617; Barrett CF, 2014, MOL BIOL EVOL, V31, P3095, DOI 10.1093/molbev/msu252; Bock DG, 2014, NEW PHYTOL, V201, P1021, DOI 10.1111/nph.12560; Byng JW, 2016, BOT J LINN SOC, V181, P1, DOI 10.1111/boj.12385; Chat J, 2004, AM J BOT, V91, P736, DOI 10.3732/ajb.91.5.736; Chat J, 1999, THEOR APPL GENET, V99, P314, DOI 10.1007/s001220051238; Chumley TW, 2006, MOL BIOL EVOL, V23, P2175, DOI 10.1093/molbev/msl089; Cosner ME, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-27; Cronn R, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn502; Cusimano N, 2016, NEW PHYTOL, V210, P680, DOI 10.1111/nph.13784; Daniell H, 2016, GENOME BIOL, V17, DOI 10.1186/s13059-016-1004-2; Delsuc F, 2005, NAT REV GENET, V6, P361, DOI 10.1038/nrg1603; Dodsworth S, 2014, SYST BIOL, P1; Dodsworth S, 2015, TRENDS PLANT SCI, V20, P525, DOI 10.1016/j.tplants.2015.06.012; Dong WP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077965; Downie SR, 2015, SYST BOT, V40, P336, DOI 10.1600/036364415X686620; Doyle JJ, 1987, PHYTOCHEM B, V19, P11, DOI 10.1016/j.bse.2009.07.003; Dugas DV, 2015, SCI REP-UK, V5, DOI 10.1038/srep16958; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fajardo D, 2013, TREE GENET GENOMES, V9, P489, DOI 10.1007/s11295-012-0573-9; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Frazer KA, 2004, NUCLEIC ACIDS RES, V32, pW273, DOI 10.1093/nar/gkh458; Givnish TJ, 2016, CLADISTICS, V32, P581, DOI 10.1111/cla.12153; Guisinger MM, 2008, P NATL ACAD SCI USA, V105, P18424, DOI 10.1073/pnas.0806759105; Hao WJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108291; Hinchliff CE, 2015, P NATL ACAD SCI USA, V112, P12764, DOI 10.1073/pnas.1423041112; Huang HT, 2016, SYST BIOL, V65, P357, DOI 10.1093/sysbio/syu046; Huang HW, 2013, ACTINIDIA TAXONOMY R; Jansen RK, 2011, MOL BIOL EVOL, V28, P835, DOI 10.1093/molbev/msq261; Jiang W, 2014, MOL PHYLOGENET EVOL, V80, P308, DOI 10.1016/j.ympev.2014.08.006; Jones SS, 2014, PLANT SYST EVOL, V300, P1421, DOI 10.1007/s00606-013-0971-y; Katoh Kazutaka, 2013, Mol Biol Evol, V30, P772, DOI 10.1093/molbev/mst010; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Khakhlova O, 2006, PLANT J, V46, P85, DOI 10.1111/j.1365-313X.2006.02673.x; Kim KJ, 2004, DNA RES, V11, P247, DOI 10.1093/dnares/11.4.247; Knox EB, 2014, P NATL ACAD SCI USA, V111, P11097, DOI 10.1073/pnas.1403363111; Ku C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062548; Kurtz S, 2001, NUCLEIC ACIDS RES, V29, P4633, DOI 10.1093/nar/29.22.4633; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Li JQ, 2002, SYST BOT, V27, P408; Li JQ, 2007, FLORA CHINA, V12, P334, DOI DOI 10.3233/BME-141227; Logacheva MD, 2014, GENOME BIOL EVOL, V6, P238, DOI 10.1093/gbe/evu001; Lohse M, 2013, NUCLEIC ACIDS RES, V41, pW575, DOI 10.1093/nar/gkt289; Ma PF, 2015, SCI REP-UK, V5, DOI 10.1038/srep11608; Ma PF, 2014, SYST BIOL, V63, P933, DOI 10.1093/sysbio/syu054; Magee Alan M, 2010, Genome Res, V20, P1700, DOI 10.1101/gr.111955.110; Male PJG, 2014, MOL ECOL RESOUR, V14, P966, DOI 10.1111/1755-0998.12246; Matsuoka Y, 2002, MOL BIOL EVOL, V19, P2084, DOI 10.1093/oxfordjournals.molbev.a004033; Millen RS, 2001, PLANT CELL, V13, P645, DOI 10.1105/tpc.13.3.645; Miller M.A., 2010, P GAT COMP ENV WORKS; Ming R, 2011, ANNU REV PLANT BIOL, V62, P485, DOI 10.1146/annurev-arplant-042110-103914; Molina J, 2014, MOL BIOL EVOL, V31, P793, DOI 10.1093/molbev/msu051; Raubeson LA, 2007, PLANT DIVERSITY EVOL, P45; Renner SS, 2014, AM J BOT, V101, P1588, DOI 10.3732/ajb.1400196; Ruhfel BR, 2014, BMC EVOL BIOL, V14, DOI 10.1186/1471-2148-14-23; Schattner P, 2005, NUCLEIC ACIDS RES, V33, pW686, DOI 10.1093/nar/gki366; Schelkunov MI, 2015, GENOME BIOL EVOL, V7, P1179, DOI 10.1093/gbe/evv019; Shaw J, 2005, AM J BOT, V92, P142, DOI 10.3732/ajb.92.1.142; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; Sloan DB, 2014, MOL PHYLOGENET EVOL, V72, P82, DOI 10.1016/j.ympev.2013.12.004; Sloan DB, 2012, GENOME BIOL EVOL, V4, P294, DOI 10.1093/gbe/evs006; Soltis DE, 2011, AM J BOT, V98, P704, DOI 10.3732/ajb.1000404; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Straub SCK, 2012, AM J BOT, V99, P349, DOI 10.3732/ajb.1100335; Streicher JW, 2016, SYST BIOL, V65, P128, DOI 10.1093/sysbio/syv058; Swofford DL., 2003, PAUP PHYLOGENETIC AN; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Ueda M, 2007, GENE, V402, P51, DOI 10.1016/j.gene.2007.07.019; Weitemier K, 2015, PEERJ, V2, DOI 10.7717/peerj.718; Weitemier K, 2014, APPL PLANT SCI, V2, DOI 10.3732/apps.1400042; Wicke S, 2015, REGNUM VEG, V158, P9; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Wu CS, 2015, GENOME BIOL EVOL, V7, P2000, DOI 10.1093/gbe/evv125; Wyman SK, 2004, BIOINFORMATICS, V20, P3252, DOI 10.1093/bioinformatics/bth352; Yang JK, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0053939, 10.1371/journal.pone.0073053]; Yang JB, 2014, MOL ECOL RESOUR, V14, P1024, DOI 10.1111/1755-0998.12251; Yao XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129347; Zanne AE, 2014, NATURE, V506, P89, DOI 10.1038/nature12872; Zhang N, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144701; Zhang XZ, 2016, MOL PHYLOGENET EVOL, V96, P118, DOI 10.1016/j.ympev.2015.11.025; Zhang YJ, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021342, 10.1371/journal.pone.0020596]; Zhao H, 2015, SCI REPORTS, V5, P5018	84	34	35	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162324	10.1371/journal.pone.0162324	http://dx.doi.org/10.1371/journal.pone.0162324			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589600	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877800051
J	Bradshaw, D; Raghwani, J; Jacka, B; Sacks-Davis, R; Lamoury, F; Down, I; Prestage, G; Applegate, TL; Hellard, M; Sasadeusz, J; Dore, GJ; Pybus, OG; Matthews, GV; Danta, M				Bradshaw, Daniel; Raghwani, Jayna; Jacka, Brendan; Sacks-Davis, Rachel; Lamoury, Francois; Down, Ian; Prestage, Garrett; Applegate, Tanya L.; Hellard, Margaret; Sasadeusz, Joe; Dore, Gregory J.; Pybus, Oliver G.; Matthews, Gail V.; Danta, Mark			Venue-Based Networks May Underpin HCV Transmissions amongst HIV-Infected Gay and Bisexual Men	PLOS ONE			English	Article							HEPATITIS-C VIRUS; POSITIVE MEN; PHYLOGENETIC ANALYSIS; SEQUENCE-ANALYSIS; RISK-FACTORS; SEX; PREVALENCE; SYDNEY; COHORT; RNA	Background This study aimed to investigate the potential influence of venue-based networks on HCV transmission in HIV-positive gay and bisexual men (GBM). Methods This was a prospectively recruited cohort of HIV-infected GBM with recently-acquired HCV infection resident in Melbourne and Sydney. Clinical and demographic data were collected together with blood samples for HCV sequencing. Phylogenies were inferred and clusters of individuals infected with HCV with genetic sequence homology were identified. Venues used for sourcing sexual partners were identified; sourcing partners from the same venue was considered a potential social link. Using the Jaccard similarity coefficient, associations were identified between the network of sites where men sourced sex partners and transmission relationships as defined by phylogenetic clustering. Results Forty individuals were recruited, of whom 62.5% were considered to have sexually-and 37.5% IDU-acquired HCV. Venue use was consistent with men being members of a more sexually adventurous gay community subculture. Six phylogenetically-determined pairs or clusters were identified, comprising fifteen (15/28, 53.6%) individuals. Participants belonging to phylogenetic clusters were observed within the same networks. There was a significant correlation between the network and phylogenetic clustering when both cities were considered simultaneously (p = 0.005), raising the possibility that social connections may be important for HCV transmissions. Conclusions Venue-based network elicitation is a promising approach for elucidating HCV transmissions amongst HIV-infected GBM. Public health approaches targeting individuals and venues prominent within networks may reduce onward HCV transmission.	[Bradshaw, Daniel; Jacka, Brendan; Lamoury, Francois; Down, Ian; Prestage, Garrett; Applegate, Tanya L.; Dore, Gregory J.; Matthews, Gail V.] UNSW Australia, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia; [Bradshaw, Daniel] Brighton & Sussex Univ Hosp NHS Trust, Dept HIV GU Med, Brighton, E Sussex, England; [Raghwani, Jayna; Pybus, Oliver G.] Univ Oxford, Dept Zool, Oxford, England; [Sacks-Davis, Rachel; Hellard, Margaret] Univ Melbourne, Burnet Inst, Melbourne, Vic, Australia; [Sasadeusz, Joe] Royal Melbourne Hosp, Dept Infect Dis, Melbourne, Vic, Australia; [Danta, Mark] UNSW Australia, St Vincents Clin Sch, Sydney, NSW, Australia	University of New South Wales Sydney; Kirby Institute; Brighton and Sussex University Hospitals NHS Trust; University of Brighton; University of Oxford; Burnet Institute; University of Melbourne; Royal Melbourne Hospital; University of New South Wales Sydney	Bradshaw, D (corresponding author), UNSW Australia, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia.; Bradshaw, D (corresponding author), Brighton & Sussex Univ Hosp NHS Trust, Dept HIV GU Med, Brighton, E Sussex, England.	daniel.bradshaw@bsuh.nhs.uk	Sacks-Davis, Rachel/H-3277-2019; matthews, gail/AAG-8626-2022; matthews, gail/AFL-8501-2022; Dore, Gregory John/ABD-5665-2021; Jacka, Brendan/T-3553-2018; Pybus, Oliver G/B-2640-2012	Dore, Gregory John/0000-0002-4741-2622; Jacka, Brendan/0000-0002-5910-853X; Pybus, Oliver G/0000-0002-8797-2667; Applegate, Tanya/0000-0002-8657-4261; Matthews, Gail/0000-0002-1048-6396; Down, Ian/0000-0001-9275-8692; Prestage, Garrett/0000-0003-3917-8992; Bradshaw, Daniel/0000-0001-7186-2482; Sacks-Davis, Rachel/0000-0003-0860-2762; Raghwani, Jayna/0000-0001-8538-4995	Australian National Health and Medical Research Council Project Grant [568859]	Australian National Health and Medical Research Council Project Grant(National Health and Medical Research Council (NHMRC) of Australia)	The work was supported by Australian National Health and Medical Research Council Project Grant [Grant no 568859]. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam BD, 2008, AIDS EDUC PREV, V20, P420, DOI 10.1521/aeap.2008.20.5.420; Bradshaw D, 2015, J INFECT DIS, V211, P736, DOI 10.1093/infdis/jiu550; Danta M, 2007, AIDS, V21, P983, DOI 10.1097/QAD.0b013e3281053a0c; De P, 2004, SEX TRANSM INFECT, V80, P280, DOI 10.1136/sti.2003.007187; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Drummond AJ, 2012, MOL BIOL EVOL, V29, P1969, DOI 10.1093/molbev/mss075; Fierer D, 2011, C RETR OPP INF BOSTO; Fierer Daniel S., 2011, Morbidity and Mortality Weekly Report, V60, P945; Gorbach Pamina M, 2011, J Acquir Immune Defic Syndr, V56, P176, DOI 10.1097/QAI.0b013e3181ff9750; Gray RR, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-131; Green A.I., 2014, SEXUAL FIELDS SOCIOL; Hagan H, 2015, AIDS, V29, P2335, DOI 10.1097/QAD.0000000000000834; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; Hue S, 2005, P NATL ACAD SCI USA, V102, P4425, DOI 10.1073/pnas.0407534102; Jacka B, 2014, HEPATOLOGY, V60, P1571, DOI 10.1002/hep.27310; Jin FY, 2010, SEX TRANSM INFECT, V86, P25, DOI 10.1136/sti.2009.038182; Kippax S, 1998, AIDS CARE, V10, P677, DOI 10.1080/09540129848307; Kuiken C, 2005, BIOINFORMATICS, V21, P379, DOI 10.1093/bioinformatics/bth485; Lamoury FMJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131437; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lattimore S, 2011, SEX TRANSM DIS, V38, P221, DOI 10.1097/OLQ.0b013e3181f2ebe1; Martin TCS, 2013, AIDS, V27, P2551, DOI 10.1097/QAD.0b013e32836381cc; Matthews GV, 2011, CLIN INFECT DIS, V52, P803, DOI 10.1093/cid/ciq200; Meng SA, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-117; Miller M, 2010, P GAT COMP ENV WOKRS; Murphy DG, 2007, J CLIN MICROBIOL, V45, P1102, DOI 10.1128/JCM.02366-06; Nishijima T, 2014, JAIDS-J ACQ IMM DEF, V65, P213, DOI 10.1097/QAI.0000000000000044; Osmond DH, 2007, AM J PUBLIC HEALTH, V97, P1677, DOI 10.2105/AJPH.2005.062851; Phang CW, 2008, SEX TRANSM INFECT, V84, P217, DOI 10.1136/sti.2007.028787; Prestage G, 2015, AIDS BEHAV, V19, P2224, DOI 10.1007/s10461-015-1027-9; Prestage G, 2015, AIDS BEHAV, V19, P1905, DOI 10.1007/s10461-015-1032-z; Rozanov M, 2004, NUCLEIC ACIDS RES, V32, pW654, DOI 10.1093/nar/gkh419; Sacks-Davis R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047335; Sanchez C, 2013, LIVER INT, V33, P1357, DOI 10.1111/liv.12212; Schmidt AJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017781; Shapiro B, 2006, MOL BIOL EVOL, V23, P7, DOI 10.1093/molbev/msj021; Simpson W, STATA USERGROUP 1ST; Sun HY, 2012, J CLIN MICROBIOL, V50, P781, DOI 10.1128/JCM.06014-11; van de Laar T, 2009, GASTROENTEROLOGY, V136, P1609, DOI 10.1053/j.gastro.2009.02.006; Vanhommerig JW, 2014, JAIDS-J ACQ IMM DEF, V66, pE111, DOI 10.1097/QAI.0000000000000208; Vogel M, 2010, LIVER INT, V30, P1169, DOI 10.1111/j.1478-3231.2010.02305.x; Wandeler G, 2012, CLIN INFECT DIS, V55, P1408, DOI 10.1093/cid/cis694; Woods CK, 2012, J CLIN MICROBIOL, V50, P1936, DOI 10.1128/JCM.06689-11; Wylie JL, 2007, HEALTH PLACE, V13, P617, DOI 10.1016/j.healthplace.2006.09.002	45	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162002	10.1371/journal.pone.0162002	http://dx.doi.org/10.1371/journal.pone.0162002			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27584149	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600083
J	Mishra, DK; Veena, U; Kaliki, S; Kethiri, AR; Sangwan, VS; Ali, MH; Naik, MN; Singh, V				Mishra, Dilip Kumar; Veena, Uppala; Kaliki, Swathi; Kethiri, Abhinav Reddy; Sangwan, Virender S.; Ali, Mohammed Hasnat; Naik, Milind N.; Singh, Vivek			Differential Expression of Stem Cell Markers in Ocular Surface Squamous Neoplasia	PLOS ONE			English	Article							CANCER; CARCINOMA; CORNEAL; CONJUNCTIVAL; MEMBRANE; CD117; HEAD; NECK; P63	Ocular Surface Squamous Neoplasm (OSSN) is the neoplasia arising from the conjunctiva, cornea and limbus. OSSN ranges from mild, moderate, severe dysplasia, carcinoma in situ (CIS) to squamous cell carcinoma (SCC). Recent findings on cancer stem cells theory indicate that population of stem-like cell as in neoplasia determines its heterogeneity and complexity leading to varying tumor development of metastatic behavior and recurrence. Cancer stem cell markers are not much explored in the cases of OSSN. In the present study, we aim to evaluate the expression of stem cells using stem cell markers mainly p63, ABCG2, c-KIT (CD117) and CD44 in OSSN tissue, which could have prognostic significance. The present study tries for the first time to explore expression of these stem markers in the cases of OSSN. These cases are subdivided into two groups. One group comprises of carcinoma in situ (n = 6) and the second group comprises of invasive carcinoma (n = 6). The mean age at presentation was 52 years; with 53 years for CIS group and 52 years for SCC group. From each group section from the paraffin block were taken for the IHC staining of p63, c-Kit, ABCG2 and CD44. Our experiments show high expression of P63 and CD44 in the cases of CIN and SCC. Both CIS and SCC displayed positive staining with p63, with more than 80% cells staining positive. However minimal expression of c-kit in both CIN and SCC. But surprisingly we got high expression of ABCG2 in cases of carcinoma in situ as compared to that of invasive squamous cell carcinoma. More than 50% of cells showed CD44 positivity in both CIS and SCC groups. Our results show for the first time that these four stem cells especially the limbal epithelium stem cells play a vital role in the genesis of OSSN but we need to explore more cases before establishing its clinical and biological significance.	[Mishra, Dilip Kumar; Veena, Uppala] LV Prasad Eye Inst, Ophthalm Pathol Lab, Hyderabad, Telangana, India; [Kaliki, Swathi; Naik, Milind N.] LV Prasad Eye Inst, Operat Eyesight Universal Inst Eye Canc, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Sangwan, Virender S.; Singh, Vivek] LV Prasad Eye Inst, Champalimaud Translat Ctr Eye Res, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Sangwan, Virender S.; Singh, Vivek] LV Prasad Eye Inst, Tej Kohli Cornea Inst, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Sangwan, Virender S.; Singh, Vivek] LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Sangwan, Virender S.; Singh, Vivek] LV Prasad Eye Inst, Ctr Ocular Regenerat, Hyderabad, Telangana, India; [Ali, Mohammed Hasnat] LV Prasad Eye Inst, Clin Epidemiol & Biostat, Hyderabad, Telangana, India; [Kethiri, Abhinav Reddy; Singh, Vivek] Manipal Univ, Manipal, Karnataka, India	L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; L. V. Prasad Eye Institute; Manipal Academy of Higher Education (MAHE)	Mishra, DK (corresponding author), LV Prasad Eye Inst, Ophthalm Pathol Lab, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Champalimaud Translat Ctr Eye Res, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Tej Kohli Cornea Inst, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Prof Brien Holden Eye Res Ctr, Hyderabad, Telangana, India.; Singh, V (corresponding author), LV Prasad Eye Inst, Ctr Ocular Regenerat, Hyderabad, Telangana, India.; Singh, V (corresponding author), Manipal Univ, Manipal, Karnataka, India.	dilip@lvpei.org; viveksingh@lvpei.org	Kaliki, Swathi/C-2529-2018; Singh, Vivek/C-4574-2013; Sangwan, Virender Singh/AAA-1091-2022	Singh, Vivek/0000-0003-3958-5635; Sangwan, Virender Singh/0000-0002-8229-4158; Kethiri, Abhinav Reddy/0000-0001-9286-4591	Hyderabad Eye Research Foundation in Hyderabad, India; Operation Eyesight Universal Institute for Eye cancer in Hyderabad, India; Champalimaud Foundation in Lisbon, Portugal; Champalimaud foundation; Research Grant by SERB [SERB/LS-599/2013]	Hyderabad Eye Research Foundation in Hyderabad, India; Operation Eyesight Universal Institute for Eye cancer in Hyderabad, India; Champalimaud Foundation in Lisbon, Portugal; Champalimaud foundation; Research Grant by SERB	This work was supported by the Hyderabad Eye Research Foundation in Hyderabad, India, the Operation Eyesight Universal Institute for Eye cancer in Hyderabad, India, the Champalimaud Foundation in Lisbon, Portugal, and the Champalimaud foundation and Research Grant by SERB (Vivek Singh: SERB/LS-599/2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adesina A, 2013, LANCET ONCOL, V14, pE152, DOI 10.1016/S1470-2045(12)70598-3; Bancroft JD, 2008, THEORY AND PRACTICE; Basu Sayan, 2015, OPHTHALMOLOGY; Bhagwandin VJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148807; Boldrup L, 2007, J PATHOL, V213, P384, DOI 10.1002/path.2237; Botchkarev VA, 2014, P53 P63 P73 EPIDERMI; Chauhan S, 2014, ARCH PATHOL LAB MED, V138, P1488, DOI 10.5858/arpa.2013-0353-OA; Chen JS, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-7; Chui J, 2011, AM J PATHOL, V178, P817, DOI 10.1016/j.ajpath.2010.10.037; Kobayashi NCC, 2015, REV ASSOC MED BRAS, V61, P86, DOI 10.1590/1806-9282.61.01.086; Emanuel P, 2005, MODERN PATHOL, V18, P645, DOI 10.1038/modpathol.3800329; ERIE JC, 1986, OPHTHALMOLOGY, V93, P176; Fan HJ, 2013, HISTOPATHOLOGY, V62, P1028, DOI 10.1111/his.12111; FURNER BB, 1989, ARCH DERMATOL, V125, P287; Gonfloni S, 2015, INT J DEV BIOL, V59, P87, DOI 10.1387/ijdb.150045sg; Kamal S, 2015, OPHTHALMOLOGY, V122, P1688, DOI 10.1016/j.ophtha.2015.04.027; Kim BH, 2013, GRAEF ARCH CLIN EXP, V251, P2569, DOI 10.1007/s00417-013-2450-0; KONO M, 1990, J THORAC IMAG, V5, P61, DOI 10.1097/00005382-199001000-00010; Ksander BR, 2014, NATURE, V511, P353, DOI 10.1038/nature13426; Lee GA, 1997, AUST NZ J OPHTHALMOL, V25, P269, DOI 10.1111/j.1442-9071.1997.tb01514.x; LEE GA, 1995, SURV OPHTHALMOL, V39, P429, DOI 10.1016/S0039-6257(05)80054-2; LEE GA, 1992, ARCH OPHTHALMOL-CHIC, V110, P525, DOI 10.1001/archopht.1992.01080160103042; Li XT, 2015, SCI REP-UK, V5, DOI 10.1038/srep13157; Margaritescu C, 2011, ROM J MORPHOL; Mittal R, 2013, SAUDI J OPHTHALMOL, V27, P177, DOI 10.1016/j.sjopt.2013.07.002; Nagata M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093164; Qian X, 2015, CRIT REV ONCOL HEMAT, V95, P337, DOI 10.1016/j.critrevonc.2015.03.009; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Salcedo-Hernandez RA, 2016, G ITAL DERMATOL VENE; Sudha B, 2008, INDIAN J MED RES, V128, P149; TABBARA KF, 1988, OPHTHALMOLOGY, V95, P318; Tabin G, 1997, OPHTHALMOLOGY, V104, P485, DOI 10.1016/S0161-6420(97)30287-5; Ujevic I, 1973, ROSTR ZENTRALBL BAKT, V128, P173; ULLRICH A, 1990, CELL, V61, P203, DOI 10.1016/0092-8674(90)90801-K; Xie J, 2014, AM J CANCER RES, V4, P698; Yang J, 1997, INT OPHTHALMOL CLIN, V37, P73, DOI 10.1097/00004397-199703740-00007; Yang YM, 2008, CANCER INVEST, V26, P741, DOI 10.1080/07357900801901856; Youssef NS, 2014, INT J CLIN EXP PATHO, V7, P5725	38	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161800	10.1371/journal.pone.0161800	http://dx.doi.org/10.1371/journal.pone.0161800			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584160	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600060
J	Hu, Y; Su, H; Liu, C; Wang, Z; Huang, L; Wang, Q; Liu, S; Chen, S; Zhou, J; Li, P; Chen, Z; Liu, H; Qing, G				Hu, Y.; Su, H.; Liu, C.; Wang, Z.; Huang, L.; Wang, Q.; Liu, S.; Chen, S.; Zhou, J.; Li, P.; Chen, Z.; Liu, H.; Qing, G.			DEPTOR is a direct NOTCH1 target that promotes cell proliferation and survival in T-cell leukemia	ONCOGENE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; GAMMA-SECRETASE INHIBITORS; MULTIPLE-MYELOMA; BETA-TRCP; INCREASES CHEMOSENSITIVITY; GLUCOCORTICOID RESISTANCE; UBIQUITIN LIGASE; MTOR INHIBITOR; ACTIVATION; EXPRESSION	Aberrant activation of NOTCH1 signaling plays a vital role in the pathogenesis of T-cell acute lymphoblastic leukemia (T-ALL). Yet the molecular events downstream of NOTCH1 that drive T-cell leukemogenesis remain incompletely understood. Starting from genome-wide gene-expression profiling to seek important NOTCH1 transcriptional targets, we identified DEP-domain containing mTOR-interacting protein (DEPTOR), which was previously shown to be important in multiple myeloma but remains functionally unclear in other hematological malignancies. Mechanistically, we demonstrated NOTCH1 directly bound to and activated the human DEPTOR promoter in T-ALL cells. DEPTOR depletion abolished cellular proliferation, attenuated glycolytic metabolism and enhanced cell death, while ectopically expressed DEPTOR significantly promoted cell growth and glycolysis. We further showed that DEPTOR depletion inhibited while its overexpression enhanced AKT activation in T-ALL cells. Importantly, AKT inhibition completely abrogated DEPTOR-mediated cell growth advantages. Moreover, DEPTOR depletion in a human T-ALL xenograft model significantly delayed T-ALL onset and caused a substantial decrease of AKT activation in leukemic blasts. We thus reveal a novel mechanism involved in NOTCH1-driven leukemogenesis, identifying the transcriptional control of DEPTOR and its regulation of AKT as additional key elements of the leukemogenic program activated by NOTCH1.	[Hu, Y.; Liu, C.; Wang, Z.] Huazhong Univ Sci & Technol, Tongji Med Coll, Sch Pharm, Wuhan, Peoples R China; [Su, H.; Chen, Z.] Huazhong Univ Sci & Technol, Union Hosp, Tongji Med Coll, Inst Hematol, Wuhan, Peoples R China; [Huang, L.; Zhou, J.] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Hematol, Wuhan, Peoples R China; [Wang, Q.; Chen, S.] Soochow Univ, Affiliated Hosp 1, Jiangsu Inst Hematol, Key Lab Thrombosis & Hemostasis,Minist Hlth, Suzhou, Peoples R China; [Liu, S.] Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Dept Pediat Hematol, Wuhan, Peoples R China; [Li, P.] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, South China Inst Stem Cell Biol & Regenerat Med, Key Lab Regenerat Biol, Guangzhou, Guangdong, Peoples R China; [Liu, H.; Qing, G.] Wuhan Univ, Inst Med Res, 185 Donghu Rd, Wuhan 430071, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology; Huazhong University of Science & Technology; Soochow University - China; Huazhong University of Science & Technology; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Wuhan University	Liu, H; Qing, G (corresponding author), Wuhan Univ, Inst Med Res, 185 Donghu Rd, Wuhan 430071, Peoples R China.	hudanliu@whu.edu.cn; qingguoliang@whu.edu.cn	Li, Peng/AER-7520-2022; Huang, Liang/I-3299-2019; Huang, Liang/L-6106-2013	Huang, Liang/0000-0002-8370-3232; Huang, Liang/0000-0002-8370-3232; Li, Peng/0000-0003-4530-2400	National Natural Science Foundation of China [81470332, 81272211, 81372205]; New Investigator Foundation, State Education Ministry of China [20120142120097]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New Investigator Foundation, State Education Ministry of China	We thank Drs Warren Pear (University of Pennsylvania, Philadelphia, PA, US), Hongbing Shu and Zan Huang (Wuhan University, Wuhan, People's Republic of China), Yi Sun (Zhejiang University, Hangzhou, People's Republic of China) for sharing reagents. This work was supported by grants from the National Natural Science Foundation of China, 81470332 and 81272211 to HL, and 81372205 to GQ and New Investigator Foundation, State Education Ministry of China 20120142120097 to HL.	Bruneau S, 2013, BLOOD, V122, P1833, DOI 10.1182/blood-2013-03-488486; Connell P, 2001, NAT CELL BIOL, V3, P93, DOI 10.1038/35050618; Dohda T, 2007, EXP CELL RES, V313, P3141, DOI 10.1016/j.yexcr.2007.04.027; Duan SS, 2011, MOL CELL, V44, P317, DOI 10.1016/j.molcel.2011.09.005; Gao DM, 2011, MOL CELL, V44, P290, DOI 10.1016/j.molcel.2011.08.030; Haferlach T, 2010, J CLIN ONCOL, V28, P2529, DOI 10.1200/JCO.2009.23.4732; Herranz D, 2014, NAT MED, V20, P1130, DOI 10.1038/nm.3665; Hu YF, 2015, MOL CANCER THER, V14, P289, DOI 10.1158/1535-7163.MCT-14-0501; Khwaja SS, 2010, J CLIN INVEST, V120, P2537, DOI 10.1172/JCI41277; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Laplante M, 2012, CELL METAB, V16, P202, DOI 10.1016/j.cmet.2012.07.008; Liu HD, 2010, GENE DEV, V24, P2395, DOI 10.1101/gad.1975210; Lu B, 2015, CELL MOL LIFE SCI, V72, P821, DOI 10.1007/s00018-014-1704-2; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Medyouf H, 2011, J EXP MED, V208, P1809, DOI 10.1084/jem.20110121; Mendes RD, 2014, BLOOD, V124, P567, DOI 10.1182/blood-2014-03-562751; Meng ZX, 2013, NAT MED, V19, P640, DOI 10.1038/nm.3144; O'Neil J, 2007, J EXP MED, V204, P1813, DOI 10.1084/jem.20070876; Paganin M, 2011, BLOOD REV, V25, P83, DOI 10.1016/j.blre.2010.09.004; Palomero T, 2008, CLIN CANCER RES, V14, P5314, DOI 10.1158/1078-0432.CCR-07-4864; Palomero T, 2008, CELL CYCLE, V7, P965, DOI 10.4161/cc.7.8.5753; Palomero T, 2007, NAT MED, V13, P1203, DOI 10.1038/nm1636; Pear WS, 1996, J EXP MED, V183, P2283, DOI 10.1084/jem.183.5.2283; Peterson TR, 2009, CELL, V137, P873, DOI 10.1016/j.cell.2009.03.046; Piovan E, 2013, CANCER CELL, V24, P766, DOI 10.1016/j.ccr.2013.10.022; Proud CG, 2009, J MOL CELL BIOL, V1, P61, DOI 10.1093/jmcb/mjp012; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Qing GL, 2006, CELL RES, V16, P895, DOI 10.1038/sj.cr.7310109; Real PJ, 2009, NAT MED, V15, P50, DOI 10.1038/nm.1900; Ren P, 2015, J PATHOL, V235, P90, DOI 10.1002/path.4429; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Schnell SA, 2015, BLOOD, V125, P2806, DOI 10.1182/blood-2014-10-608448; Taipale M, 2010, NAT REV MOL CELL BIO, V11, P515, DOI 10.1038/nrm2918; Thompson BJ, 2007, J EXP MED, V204, P1825, DOI 10.1084/jem.20070872; van Stralen E, 2009, EXP HEMATOL, V37, P78, DOI 10.1016/j.exphem.2008.08.006; Van Vlierberghe P, 2012, J CLIN INVEST, V122, P3398, DOI 10.1172/JCI61269; Wang HF, 2014, P NATL ACAD SCI USA, V111, P705, DOI 10.1073/pnas.1315023111; Wang HF, 2011, P NATL ACAD SCI USA, V108, P14908, DOI 10.1073/pnas.1109023108; Wang ZW, 2012, NEOPLASIA, V14, P368, DOI 10.1593/neo.12542; Weng AP, 2006, GENE DEV, V20, P2096, DOI 10.1101/gad.1450406; Weng AP, 2004, SCIENCE, V306, P269, DOI 10.1126/science.1102160; Xiao YR, 2015, HAEMATOLOGICA, V100, P585, DOI 10.3324/haematol.2014.118612; Ye W, 2015, J HEMATOL ONCOL, V8, DOI 10.1186/s13045-015-0156-y; Zhang HR, 2013, J INT MED RES, V41, P584, DOI 10.1177/0300060513480920; Zhang HR, 2013, INT J MOL MED, V31, P1127, DOI 10.3892/ijmm.2013.1299; Zhao YC, 2011, MOL CELL, V44, P304, DOI 10.1016/j.molcel.2011.08.029	46	30	32	1	15	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1038	1047		10.1038/onc.2016.275	http://dx.doi.org/10.1038/onc.2016.275			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27593934				2022-12-26	WOS:000395371500002
J	Peng, XY; Moore, M; Mathur, A; Zhou, Y; Sun, HX; Gan, Y; Herazo-Maya, JD; Kaminski, N; Hu, XY; Pan, HY; Ryu, CW; Osafo-Addo, A; Homer, RJ; Feghali-Bostwick, C; Fares, WH; Gulati, M; Hu, BQ; Lee, CG; Elias, JA; Herzog, EL				Peng, Xueyan; Moore, Meagan; Mathur, Aditi; Zhou, Yang; Sun, Huanxing; Gan, Ye; Herazo-Maya, Jose D.; Kaminski, Naftali; Hu, Xinyuan; Pan, Hongyi; Ryu, Changwan; Osafo-Addo, Awo; Homer, Robert J.; Feghali-Bostwick, Carol; Fares, Wassim H.; Gulati, Mridu; Hu, Buqu; Lee, Chun-Geun; Elias, Jack A.; Herzog, Erica L.			Plexin C1 deficiency permits synaptotagmin 7-mediated macrophage migration and enhances mammalian lung fibrosis	FASEB JOURNAL			English	Article						idiopathic pulmonary fibrosis; immunology; semaphorin 7a; scleroderma; interstitial lung disease	IDIOPATHIC PULMONARY-FIBROSIS; SEMAPHORIN 7A; SYSTEMIC-SCLEROSIS; GROWTH-FACTOR; MONOCYTES; RECEPTOR; CELLS; MECHANISMS; MEMBRANE; BETA	Pulmonary fibrosis is a progressive and often fatal condition that is believed to be partially orchestrated by macrophages. Mechanisms that control migration of these cells into and within the lung remain undefined. We evaluated the contributions of the semaphorin receptor, plexin C1 (PLXNC1), and the exocytic calcium sensor, synaptotagmin 7 (Syt7), in these processes. We evaluated the role of PLXNC1 in macrophage migration by using Boyden chambers and scratch tests, characterized its contribution to experimentally induced lung fibrosis in mice, and defined the mechanism for our observations. Our findings reveal that relative to control participants, patients with idiopathic pulmonary fibrosis demonstrate excessive monocyte migration and underexpression of PLXNC1 in the lungs and circulation, a finding that is recapitulated in the setting of scleroderma-related interstitial lung disease. Relative to wild type, PLXNC1(-/-) mouse macrophages are excessively migratory, and PLXNC1(-/-) mice show exacerbated collagen accumulation in response to either inhaled bleomycin or inducible lung targeted TGF-beta 1 overexpression. These findings are ameliorated by replacement of PLXNC1 on bone marrow-derived cells or by genetic deletion of Syt7. These data demonstrate the previously unrecognized observation that PLXNC1 deficiency permits Syt7-mediated macrophage migration and enhances mammalian lung fibrosis.	[Peng, Xueyan; Moore, Meagan; Mathur, Aditi; Sun, Huanxing; Gan, Ye; Herazo-Maya, Jose D.; Kaminski, Naftali; Hu, Xinyuan; Pan, Hongyi; Ryu, Changwan; Osafo-Addo, Awo; Fares, Wassim H.; Gulati, Mridu; Hu, Buqu; Herzog, Erica L.] Yale Sch Med, Dept Pulm Crit Care & Sleep Med, New Haven, CT USA; [Homer, Robert J.] Yale Sch Med, Dept Pathol, New Haven, CT USA; [Zhou, Yang; Lee, Chun-Geun; Elias, Jack A.] Brown Univ, Warren Alpert Sch Med, Dept Mol Microbiol & Immunol, Providence, RI 02912 USA; [Feghali-Bostwick, Carol] Med Univ South Carolina, Sch Med, Dept Med, Charleston, SC USA	Yale University; Yale University; Brown University; Medical University of South Carolina	Herzog, EL (corresponding author), Yale Univ, Sch Med, Yale Ctr Interstitial Lung Dis, Dept Internal Med,Sect Pulm Crit Care & Sleep Med, 300 Cedar St,POB 208057,TAC 441 South, New Haven, CT 06520 USA.	erica.herzog@yale.edu	homer, robert/P-3884-2019; Herazo-Maya, Jose/ABG-7214-2021; Lee, Chun Geun/AAC-2838-2021	homer, robert/0000-0002-2055-5885; Lee, Chun Geun/0000-0002-9514-3658; ryu, changwan/0000-0001-6211-4327; Fares, Wassim/0000-0001-9462-8103; Kaminski, Naftali/0000-0001-5917-4601	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) [R01-HL109233, U01-HL112702, R01-HL125850-01A1]; American Thoracic Society; Scleroderma Foundation; Greenfield Foundation; Yale Interstitial Lung Disease Center of Excellence; NIH NHLBI Grants [R01-HL115813, P01-HL114501, U01-HL108638, UH2-HL123876-01, U01-HL108642, RC2-HL 101715]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001863] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL108642, U01HL112702, R01HL115813, R01HL109233, T32HL007778, P01HL114501, R01HL125850, U01HL108638, RC2HL101715, UH2HL123876] Funding Source: NIH RePORTER	U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); American Thoracic Society; Scleroderma Foundation; Greenfield Foundation; Yale Interstitial Lung Disease Center of Excellence; NIH NHLBI Grants; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by U.S. National Institutes of Health (NIH) National Heart, Lung, and Blood Institute (NHLBI) Grants R01-HL109233, U01-HL112702, and R01-HL125850-01A1 (to E.L.H.); grants from the American Thoracic Society, Scleroderma Foundation, Greenfield Foundation, and Yale Interstitial Lung Disease Center of Excellence (to E.L.H.); and by NIH NHLBI Grants R01-HL115813 (to C.G.L), P01-HL114501 (to J.A.E.), U01-HL108638 (to J.A.E.), UH2-HL123876-01 (to J.A.E); U01-HL108642 (to N.K.), and RC2-HL 101715 (to N.K).	Abid SH, 2001, CURR OPIN ONCOL, V13, P242, DOI 10.1097/00001622-200107000-00006; Bacaj T, 2013, NEURON, V80, P947, DOI 10.1016/j.neuron.2013.10.026; Bauer Y, 2015, AM J RESP CELL MOL, V52, P217, DOI 10.1165/rcmb.2013-0310OC; Becker SM, 2009, IMMUNOBIOLOGY, V214, P495, DOI 10.1016/j.imbio.2008.11.006; Blackwell TS, 2014, AM J RESP CRIT CARE, V189, P214, DOI 10.1164/rccm.201306-1141WS; Chabbert-de Ponnat I, 2005, INT IMMUNOL, V17, P439, DOI 10.1093/intimm/dxh224; Chakrabarti S, 2003, J CELL BIOL, V162, P543, DOI 10.1083/jcb.200305131; Colvin RA, 2010, NAT IMMUNOL, V11, P495, DOI 10.1038/ni.1878; Czibener C, 2006, J CELL BIOL, V174, P997, DOI 10.1083/jcb.200605004; Czopik AK, 2006, IMMUNITY, V24, P591, DOI 10.1016/j.immuni.2006.03.013; Davies John Q, 2005, Methods Mol Biol, V290, P105; Gan Y, 2011, ARTHRITIS RHEUM-US, V63, P2484, DOI 10.1002/art.30386; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Granja T, 2014, MUCOSAL IMMUNOL, V7, P879, DOI 10.1038/mi.2013.104; Herzog EL, 2014, ARTHRITIS RHEUMATOL, V66, P1967, DOI 10.1002/art.38702; Huebner RH, 2008, BIOTECHNIQUES, V44, P507, DOI 10.2144/000112729; Kang SJ, 2012, J IMMUNOL, V188, P1108, DOI 10.4049/jimmunol.1102084; Karmouty-Quintana H, 2015, FASEB J, V29, P50, DOI 10.1096/fj.14-260182; King TE, 2014, NEW ENGL J MED, V370, P2083, DOI 10.1056/NEJMoa1402582; Landsman L, 2007, J IMMUNOL, V179, P3488, DOI 10.4049/jimmunol.179.6.3488; Lazova R, 2009, AM J DERMATOPATH, V31, P177, DOI 10.1097/DAD.0b013e318196672d; Lee CG, 2004, J EXP MED, V200, P377, DOI 10.1084/jem.20040104; Lewis Myra J, 2003, Am J Clin Pathol, V120 Suppl, pS3; Li YY, 2007, BIOCHEM BIOPH RES CO, V362, P658, DOI 10.1016/j.bbrc.2007.08.023; Liu H, 2014, TRANSL NEURODEGENER, V3, DOI 10.1186/2047-9158-3-7; Ma B, 2015, CANCER RES, V75, P487, DOI 10.1158/0008-5472.CAN-13-3339; Majumdar S, 1999, EUR RESPIR J, V14, P251, DOI 10.1034/j.1399-3003.1999.14b03.x; Mathai SK, 2010, LAB INVEST, V90, P812, DOI 10.1038/labinvest.2010.73; Murray LA, 2011, INT J BIOCHEM CELL B, V43, P154, DOI 10.1016/j.biocel.2010.10.013; Neuland K, 2014, J CELL SCI, V127, P5218, DOI 10.1242/jcs.153742; Raghu G, 2012, NEW ENGL J MED, V366, P1968, DOI 10.1056/NEJMoa1113354; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Reilkoff RA, 2013, AM J RESP CRIT CARE, V187, P180, DOI 10.1164/rccm.201206-1109OC; Richeldi L, 2014, NEW ENGL J MED, V370, P2071, DOI 10.1056/NEJMoa1402584; Scott GA, 2008, J INVEST DERMATOL, V128, P151, DOI 10.1038/sj.jid.5700974; Scott GA, 2009, J INVEST DERMATOL, V129, P954, DOI 10.1038/jid.2008.329; STEEN VD, 1985, ARTHRITIS RHEUM-US, V28, P759, DOI 10.1002/art.1780280706; Sultana H, 2012, J IMMUNOL, V189, P3150, DOI 10.4049/jimmunol.1201140; Suzuki K, 2007, NATURE, V446, P680, DOI 10.1038/nature05652; Tashkin DP, 2006, NEW ENGL J MED, V354, P2655, DOI 10.1056/NEJMoa055120; Thannickal VJ, 2004, ANNU REV MED, V55, P395, DOI 10.1146/annurev.med.55.091902.103810; Tourkina E, 2011, FIBROGENESIS TISSUE, V4, DOI 10.1186/1755-1536-4-15; VANHEE D, 1994, AM J RESP CRIT CARE, V150, P1049, DOI 10.1164/ajrccm.150.4.7921435; Vogel DYS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-23; Wagner GR, 1997, LANCET, V349, P1311, DOI 10.1016/S0140-6736(96)07336-9; Zhou Y, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007096; Zhu S, 2009, AM J PHYSIOL-LUNG C, V297, pL97, DOI 10.1152/ajplung.90283.2008	47	32	33	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4056	4070		10.1096/fj.201600373R	http://dx.doi.org/10.1096/fj.201600373R			15	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27609773	Green Published			2022-12-26	WOS:000388201500013
J	Boortz, KA; Syring, KE; Pound, LD; Wang, YD; Oeser, JK; O'Brien, RM				Boortz, Kayla A.; Syring, Kristen E.; Pound, Lynley D.; Wang, Yingda; Oeser, James K.; O'Brien, Richard M.			Functional Analysis of Mouse G6pc1 Mutations Using a Novel In Situ Assay for Glucose-6-Phosphatase Activity and the Effect of Mutations in Conserved Human G6PC1/G6PC2 Amino Acids on G6PC2 Protein Expression	PLOS ONE			English	Article							SUBUNIT-RELATED PROTEIN; GLYCOGEN-STORAGE-DISEASE; PHOSPHOHISTIDINE-ENZYME INTERMEDIATE; STIMULATED INSULIN-SECRETION; G-6-PASE CATALYTIC SUBUNIT; FASTING GLUCOSE-LEVELS; BODY-MASS INDEX; PHENOME-WIDE; MISSING HERITABILITY; GENE-EXPRESSION	Elevated fasting blood glucose (FBG) has been associated with increased risk for development of type 2 diabetes. Single nucleotide polymorphisms (SNPs) in G6PC2 are the most important common determinants of variations in FBG in humans. Studies using G6pc2 knockout mice suggest that G6pc2 regulates the glucose sensitivity of insulin secretion. G6PC2 and the related G6PC1 and G6PC3 genes encode glucose-6-phosphatase catalytic subunits. This study describes a functional analysis of 22 non-synonymous G6PC2 SNPs, that alter amino acids that are conserved in human G6PC1, mouse G6pc1 and mouse G6pc2, with the goal of identifying variants that potentially affect G6PC2 activity/expression. Published data suggest strong conservation of catalytically important amino acids between all four proteins and the related G6PC3 isoform. Because human G6PC2 has very low glucose-6-phosphatase activity we used an indirect approach, examining the effect of these SNPs on mouse G6pc1 activity. Using a novel in situ functional assay for glucose-6-phosphatase activity we demonstrate that the amino acid changes associated with the human G6PC2 rs144254880 (Arg79Gln), rs149663725 (Gly114Arg) and rs2232326 (Ser324Pro) SNPs reduce mouse G6pc1 enzyme activity without affecting protein expression. The Arg79Gln variant alters an amino acid mutation of which, in G6PC1, has previously been shown to cause glycogen storage disease type 1a. We also demonstrate that the rs368 382511 (Gly8Glu), rs138726309 (His177Tyr), rs2232323 (Tyr207Ser) rs374055555 (Arg293Trp), rs2232326 (Ser324Pro), rs137857125 (Pro313Leu) and rs2232327 (Pro340-Leu) SNPs confer decreased G6PC2 protein expression. In summary, these studies identify multiple G6PC2 variants that have the potential to be associated with altered FBG in humans.	[Boortz, Kayla A.; Syring, Kristen E.; Pound, Lynley D.; Wang, Yingda; Oeser, James K.; O'Brien, Richard M.] Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA	Vanderbilt University	O'Brien, RM (corresponding author), Vanderbilt Univ, Dept Mol Physiol & Biophys, Sch Med, Nashville, TN 37232 USA.	richard.obrien@vanderbilt.edu			National Institute of Diabetes and Digestive and Kidney Diseases [DK092589]; NIH [DK092589]; Vanderbilt Molecular Endocrinology Training Program [5T32 DK07563]; NIH, Vanderbilt Diabetes Research Training Center [P60 DK20593]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020593, R01DK092589, T32DK007563] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Molecular Endocrinology Training Program; NIH, Vanderbilt Diabetes Research Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Research in the laboratory of RO'B was supported by National Institute of Diabetes and Digestive and Kidney Diseases grant DK092589 to RO'B and by NIH grant P60 DK20593, which supports the Vanderbilt Diabetes Research Training Center. KES and LDP were supported by the Vanderbilt Molecular Endocrinology Training Program grant 5T32 DK07563. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to John Hutton (1948-2012) for the numerous insights he contributed to this project. The following graduate students contributed to these studies: Courtney Copeland, Peter Kropp, Bethany Carboneau, Elijah Trefts and Brandon Bout. We thank Dr. Chris Newgard for providing the 832/13 cell line. Research in the laboratory of R.O'B. was supported by NIH grant DK092589 to R.O'B. and by NIH grant P60 DK20593, which supports the Vanderbilt Diabetes Research Training Center. K. E. S. and L. D. P. were supported by the Vanderbilt Molecular Endocrinology Training Program grant 5T32 DK07563. R.O'B. is the guarantor of this work, had full access to all the data, and takes full responsibility for the integrity of data and the accuracy of data analysis.	Abdul-Ghani MA, 2009, DIABETES CARE, V32, pS194, DOI 10.2337/dc09-S309; Arden SD, 1999, DIABETES, V48, P531, DOI 10.2337/diabetes.48.3.531; Baerenwald DA, 2013, DIABETOLOGIA, V56, P1306, DOI 10.1007/s00125-013-2875-3; Bain JR, 2004, DIABETES, V53, P2190, DOI 10.2337/diabetes.53.9.2190; Banka S, 2013, ORPHANET J RARE DIS, V8, DOI 10.1186/1750-1172-8-84; Bell GI, 1996, ANNU REV PHYSIOL, V58, P171, DOI 10.1146/annurev.physiol.58.1.171; Bischof LJ, 2001, DIABETES, V50, P502, DOI 10.2337/diabetes.50.3.502; Boortz KA, 2016, ENDOCRINOLOGY, V157, P3002, DOI 10.1210/en.2016-1245; Bouatia-Naji N, 2008, SCIENCE, V320, P1085, DOI 10.1126/science.1156849; Bouatia-Naji N, 2010, DIABETES, V59, P2662, DOI 10.2337/db10-0389; Boustead JN, 2004, J MOL ENDOCRINOL, V32, P33, DOI 10.1677/jme.0.0320033; Chen WM, 2008, J CLIN INVEST, V118, P2620, DOI 10.1172/JCI34566; Chou JY, 2008, HUM MUTAT, V29, P921, DOI 10.1002/humu.20772; Collier JJ, 2007, AM J PHYSIOL-ENDOC M, V293, pE48, DOI 10.1152/ajpendo.00357.2006; Coutinho M, 1999, DIABETES CARE, V22, P233, DOI 10.2337/diacare.22.2.233; Denny JC, 2013, NAT BIOTECHNOL, V31, P1102, DOI 10.1038/nbt.2749; Denny JC, 2011, AM J HUM GENET, V89, P529, DOI 10.1016/j.ajhg.2011.09.008; Denny JC, 2010, BIOINFORMATICS, V26, P1205, DOI 10.1093/bioinformatics/btq126; Dupuis J, 2010, NAT GENET, V42, P105, DOI 10.1038/ng.520; Ghosh A, 2002, J BIOL CHEM, V277, P32837, DOI 10.1074/jbc.M201853200; Ghosh A, 2004, J BIOL CHEM, V279, P12479, DOI 10.1074/jbc.M313271200; GRUPE A, 1995, CELL, V83, P69, DOI 10.1016/0092-8674(95)90235-X; Hohmeier HE, 2000, DIABETES, V49, P424, DOI 10.2337/diabetes.49.3.424; Horikoshi M, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005230; Hornbuckle LA, 2001, AM J PHYSIOL-ENDOC M, V281, pE713, DOI 10.1152/ajpendo.2001.281.4.E713; Hornbuckle LA, 2004, AM J PHYSIOL-ENDOC M, V286, pE795, DOI 10.1152/ajpendo.00455.2003; Hu C, 2009, DIABETOLOGIA, V52, P451, DOI 10.1007/s00125-008-1241-3; Hutton JC, 2009, J BIOL CHEM, V284, P29241, DOI 10.1074/jbc.R109.025544; Iynedjian P, 2009, CELL MOL LIFE SCI, V66, P27, DOI 10.1007/s00018-008-8322-9; JACOBY DB, 1989, J BIOL CHEM, V264, P17623; Lawes CMM, 2004, DIABETES CARE, V27, P2836; LEI KJ, 1995, J BIOL CHEM, V270, P11882, DOI 10.1074/jbc.270.20.11882; Lei KJ, 1996, NAT GENET, V13, P203, DOI 10.1038/ng0696-203; Lin SR, 2015, MOL GENET METAB, V114, P41, DOI 10.1016/j.ymgme.2014.11.012; Llewellyn CH, 2013, INT J OBESITY, V37, P1506, DOI 10.1038/ijo.2013.30; Lu G, 2013, SCI WORLD J, DOI 10.1155/2013/424617; Mahajan A, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1004876; Manning AK, 2012, NAT GENET, V44, P659, DOI 10.1038/ng.2274; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Marmugi A, 2016, DIABETES, V65, P1009, DOI 10.2337/db15-1334; Martin CC, 2002, J MOL ENDOCRINOL, V29, P205, DOI 10.1677/jme.0.0290205; Martin CC, 2001, J BIOL CHEM, V276, P25197, DOI 10.1074/jbc.M101549200; Matschinsky Franz M, 2005, Curr Diab Rep, V5, P171, DOI 10.1007/s11892-005-0005-4; Mithieux G, 1997, EUR J ENDOCRINOL, V136, P137, DOI 10.1530/eje.0.1360137; Morris AP, 2012, NAT GENET, V44, P981, DOI 10.1038/ng.2383; Newgard CB, 1997, DIABETOLOGIA, V40, pS42, DOI 10.1007/s001250051398; NOGUCHI T, 1987, J BIOL CHEM, V262, P14366; O'Brien RM, 2013, CURR DIABETES REP, V13, P768, DOI 10.1007/s11892-013-0422-8; Osbak KK, 2009, HUM MUTAT, V30, P1512, DOI 10.1002/humu.21110; Pan CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023157; Pan CJ, 1998, J BIOL CHEM, V273, P6144, DOI 10.1074/jbc.273.11.6144; Pedersen KB, 2007, AM J PHYSIOL-ENDOC M, V292, pE788, DOI 10.1152/ajpendo.00510.2006; Petrolonis AJ, 2004, J BIOL CHEM, V279, P13976, DOI 10.1074/jbc.M307756200; Pound LD, 2013, DIABETES, V62, P1547, DOI 10.2337/db12-1067; Pulley J, 2010, CTS-CLIN TRANSL SCI, V3, P42, DOI 10.1111/j.1752-8062.2010.00175.x; Reiling E, 2009, DIABETOLOGIA, V52, P1866, DOI 10.1007/s00125-009-1413-9; Ritchie MD, 2013, CIRCULATION, V127, P1377, DOI 10.1161/CIRCULATIONAHA.112.000604; Roden DM, 2008, CLIN PHARMACOL THER, V84, P362, DOI 10.1038/clpt.2008.89; Scott RA, 2012, NAT GENET, V44, P991, DOI 10.1038/ng.2385; Shameer K, 2014, HUM GENET, V133, P95, DOI 10.1007/s00439-013-1355-7; Shameli Afshin, 2007, Rev Diabet Stud, V4, P25, DOI 10.1900/RDS.2007.4.25; SPETH M, 1986, FEBS LETT, V202, P32, DOI 10.1016/0014-5793(86)80643-3; Streeper RS, 1998, P NATL ACAD SCI USA, V95, P9208, DOI 10.1073/pnas.95.16.9208; Towle HC, 2005, TRENDS ENDOCRIN MET, V16, P489, DOI 10.1016/j.tem.2005.10.003; Trinh K, 1997, J BIOL CHEM, V272, P24837, DOI 10.1074/jbc.272.40.24837; Visscher PM, 2012, AM J HUM GENET, V90, P7, DOI 10.1016/j.ajhg.2011.11.029; Wall ML, 2015, DIABETES, V64, P2129, DOI 10.2337/db14-0745; Wang D, 2006, ENDOCRINOLOGY, V147, P350, DOI 10.1210/en.2005-1014; Wang Y, 2007, DIABETOLOGIA, V50, P774, DOI 10.1007/s00125-006-0564-1; Wessel J, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms6897; Wood AR, 2014, NAT GENET, V46, P1173, DOI 10.1038/ng.3097; Yang J, 2015, NAT GENET, V47, P1114, DOI 10.1038/ng.3390	73	5	6	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162439	10.1371/journal.pone.0162439	http://dx.doi.org/10.1371/journal.pone.0162439			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611587	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900099
J	Chen, DF; Zheng, JX; Gerasimcik, N; Lagerstedt, K; Sjogren, H; Abrahamsson, J; Fogelstrand, L; Martensson, IL				Chen, Dongfeng; Zheng, Junxiong; Gerasimcik, Natalija; Lagerstedt, Kristina; Sjogren, Helene; Abrahamsson, Jonas; Fogelstrand, Linda; Martensson, Inga-Lill			The Expression Pattern of the Pre-B Cell Receptor Components Correlates with Cellular Stage and Clinical Outcome in Acute Lymphoblastic Leukemia	PLOS ONE			English	Article							SURROGATE LIGHT-CHAIN; TRANSCRIPTION FACTORS; DNA METHYLATION; CHILDHOOD; DIFFERENTIATION; SIGNATURES; CLASSIFICATION; ACTIVATION; CHECKPOINT; SELECTION	Precursor-B cell receptor (pre-BCR) signaling represents a crucial checkpoint at the pre-B cell stage. Aberrant pre-BCR signaling is considered as a key factor for B-cell precursor acute lymphoblastic leukemia (BCP-ALL) development. BCP-ALL are believed to be arrested at the pre-BCR checkpoint independent of pre-BCR expression. However, the cellular stage at which BCP-ALL are arrested and whether this relates to expression of the pre-BCR components (IGHM, IGLL1 and VPREB1) is still unclear. Here, we show differential protein expression and copy number variation (CNV) patterns of the pre-BCR components in pediatric BCP-ALL. Moreover, analyzing six BCP-ALL data sets (n = 733), we demonstrate that TCF3-PBX1 ALL express high levels of IGHM, IGLL1 and VPREB1, and are arrested at the pre-B stage. By contrast, ETV6-RUNX1 ALL express low levels of IGHM or VPREB1, and are arrested at the pro-B stage. Irrespective of subtype, ALL with high levels of IGHM, IGLL1 and VPREB1 are arrested at the pre-B stage and correlate with good prognosis in high-risk pediatric BCP-ALL (n = 207). Our findings suggest that BCP-ALL are arrested at different cellular stages, which relates to the expression pattern of the pre-BCR components that could serve as prognostic markers for high-risk pediatric BCP-ALL patients.	[Chen, Dongfeng; Zheng, Junxiong; Gerasimcik, Natalija; Lagerstedt, Kristina; Martensson, Inga-Lill] Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden; [Sjogren, Helene; Fogelstrand, Linda] Sahlgrens Univ Hosp, Dept Clin Chem, Gothenburg, Sweden; [Abrahamsson, Jonas] Queen Silvia Childrens Hosp, Gothenburg, Sweden; [Fogelstrand, Linda] Univ Gothenburg, Inst Biomed, Dept Clin Chem & Transfus Med, Gothenburg, Sweden	University of Gothenburg; Sahlgrenska University Hospital; Queen Silvia Children's Hospital; University of Gothenburg	Martensson, IL (corresponding author), Univ Gothenburg, Inst Med, Dept Rheumatol & Inflammat Res, Gothenburg, Sweden.	lill.martensson@rheuma.gu.se	Gerasimcik, Natalija/M-4350-2019; Abrahamsson, Jonas/I-5786-2012	Gerasimcik, Natalija/0000-0001-9680-035X; Abrahamsson, Jonas/0000-0002-9240-3522; Martensson, Inga-Lill/0000-0003-3415-0560	Barncancerfonden [TJ2014-0083]; Cancerfonden [CAN2014/886]; Assar Gabrielsson Fond [FB 15-57]; Lions Cancerfond; ALF; IngaBritt och Arne Lundbergs Forskning Stiftelse; Stiftelsen Wilhelm och Martina Lundgrens Vetenskap; Adlerbertska forskningsstiftelsen	Barncancerfonden; Cancerfonden(Swedish Cancer Society); Assar Gabrielsson Fond; Lions Cancerfond; ALF; IngaBritt och Arne Lundbergs Forskning Stiftelse; Stiftelsen Wilhelm och Martina Lundgrens Vetenskap; Adlerbertska forskningsstiftelsen	This work has been supported by grants from: Barncancerfonden (TJ2014-0083, DC, http://www.barncancerfonden.se), Cancerfonden (CAN2014/886, ILM, https://www.cancerfonden.se/), Assar Gabrielsson Fond (FB 15-57, DC, http://www.agfond.se/), Lions Cancerfond (2012:20, DC, http://www.lionscancerfond.se/), ALF (GBG, ILM, http://www.fou.nu/is/alfgbg), IngaBritt och Arne Lundbergs Forskning Stiftelse (ILM, http://www.lundbergsstiftelsen.se/en/home/), Stiftelsen Wilhelm och Martina Lundgrens Vetenskap (DC, http://www.wmlundgren.se/), Adlerbertska forskningsstiftelsen (DC, http://www.gu.se/forskning/stipendier/gustipendier/adlerbertska_forskningsstiftelsen). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson A, 2005, P NATL ACAD SCI USA, V102, P19069, DOI 10.1073/pnas.0506637102; Andersson A, 2010, BMC MED GENOMICS, V3, DOI 10.1186/1755-8794-3-6; Buchner M, 2015, IMMUNOL REV, V263, P192, DOI 10.1111/imr.12235; Chen ZS, 2015, NATURE, V521, P357, DOI 10.1038/nature14231; Chiaretti S, 2014, MEDITERR J HEMATOL I, V6, DOI 10.4084/MJHID.2014.073; Clark MR, 2014, NAT REV IMMUNOL, V14, P69, DOI 10.1038/nri3570; Conley ME, 2010, J IMMUNOL, V184, P1127, DOI 10.4049/jimmunol.0990113; Den Boer ML, 2009, LANCET ONCOL, V10, P125, DOI 10.1016/S1470-2045(08)70339-5; Eswaran J, 2015, LEUKEMIA, V29, P1623, DOI 10.1038/leu.2015.113; Figueroa ME, 2013, J CLIN INVEST, V123, P3099, DOI 10.1172/JCI66203; Geng HM, 2015, CANCER CELL, V27, P409, DOI 10.1016/j.ccell.2015.02.003; Gisler R, 2002, J IMMUNOL, V168, P5130, DOI 10.4049/jimmunol.168.10.5130; Harrison CJ, 2013, HEMATOL-AM SOC HEMAT, P118, DOI 10.1182/asheducation-2013.1.118; Harvey RC, 2010, BLOOD, V116, P4874, DOI 10.1182/blood-2009-08-239681; Herzog S, 2009, NAT REV IMMUNOL, V9, P195, DOI 10.1038/nri2491; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Kohrer S, 2016, LEUKEMIA, V30, P1246, DOI 10.1038/leu.2016.9; Kuiper RP, 2007, LEUKEMIA, V21, P1258, DOI 10.1038/sj.leu.2404691; Lee ST, 2012, NUCLEIC ACIDS RES, V40, P11339, DOI 10.1093/nar/gks957; Lemmers B, 2000, LEUKEMIA, V14, P2103, DOI 10.1038/sj.leu.2401932; Li ZG, 2009, BLOOD, V114, P4486, DOI 10.1182/blood-2009-04-218123; Lin YC, 2010, NAT IMMUNOL, V11, P635, DOI 10.1038/ni.1891; Martensson IL, 2010, FEBS LETT, V584, P2572, DOI 10.1016/j.febslet.2010.04.057; MELCHERS F, 1993, IMMUNOL TODAY, V14, P60, DOI 10.1016/0167-5699(93)90060-X; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Mullighan CG, 2009, NEW ENGL J MED, V360, P470, DOI 10.1056/NEJMoa0808253; Mundt C, 2006, INT IMMUNOL, V18, P163, DOI 10.1093/intimm/dxh359; Nordlund J, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r105; Rajewsky K, 1996, NATURE, V381, P751, DOI 10.1038/381751a0; Rickert RC, 2013, NAT REV IMMUNOL, V13, P578, DOI 10.1038/nri3487; Ross ME, 2003, BLOOD, V102, P2951, DOI 10.1182/blood-2003-01-0338; Somasundaram R, 2015, BLOOD, V126, P144, DOI 10.1182/blood-2014-12-575688; Tijchon E, 2013, LEUKEMIA, V27, P541, DOI 10.1038/leu.2012.293; Tsuzuki S, 2004, P NATL ACAD SCI USA, V101, P8443, DOI 10.1073/pnas.0402063101; Vardiman JW, 2009, BLOOD, V114, P937, DOI 10.1182/blood-2009-03-209262; Yeoh EJ, 2002, CANCER CELL, V1, P133, DOI 10.1016/S1535-6108(02)00032-6	36	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162638	10.1371/journal.pone.0162638	http://dx.doi.org/10.1371/journal.pone.0162638			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611867	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900142
J	Cho, U; Kim, HM; Park, HS; Kwon, OJ; Lee, A; Jeong, SW				Cho, Uiju; Kim, Hae-Mi; Park, Hong Sik; Kwon, Oh-Joo; Lee, Ahwon; Jeong, Seong-Whan			Nuclear Expression of GS28 Protein: A Novel Biomarker that Predicts Worse Prognosis in Cervical Cancers	PLOS ONE			English	Article							GOLGI-SNARE; COMPLEX; APOPTOSIS; TRANSPORT; TARGETS	Objective The protein GS28 (28-kDa Golgi SNARE protein) has been described as a SNARE (Soluble N-ethylmaleimide-sensitive factor attachment protein receptors) protein family member that plays a critical role in mammalian ER-Golgi or intra-Golgi vesicle transport. Little is known about the possible roles of GS28 in pathological conditions. The purpose of this study was to evaluate GS28 expression in cervical cancer tissues and explore its correlation with clinicopathological features and prognosis. Methods We investigated GS28 expression in 177 cervical cancer tissues by using immunohistochemistry and evaluated the correlation of GS28 expression with clinicopathological features, the expression of p53 and Bcl-2, and prognosis of cervical cancer patients. Immunoblotting was performed using six freshly frozen cervical cancer tissues to confirm the subcellular localization of GS28. Results Immunoreactivity of GS28 was observed in both nuclear and cytoplasmic compartments of cervical cancer cells. High nuclear expression of GS28 was associated with advanced tumor stages (P = 0.036) and negative expression of p53 (P = 0.036). In multivariate analyses, patients with high nuclear expression of GS28 showed significantly worse overall survival (OS) (hazard ratio = 3.785, P = 0.003) and progression-free survival (PFS) (hazard ratio = 3.019, P = 0.008), compared to those with low or no nuclear expression. It was also a reliable, independent prognostic marker in subgroups of patients with early stage T1 and negative lymph node metastasis in OS (P = 0.008 and 0.019, respectively). The nuclear expression of GS28 was confirmed by immunoblotting. Conclusion High nuclear expression of GS28 is associated with poor prognosis in early-stage cervical cancer patients. GS28 might be a novel prognostic marker and a potential therapeutic target in cervical cancer treatment.	[Cho, Uiju; Park, Hong Sik] Catholic Univ Korea, St Vincents Hosp, Dept Hosp Pathol, Coll Med, Suwon, South Korea; [Kim, Hae-Mi; Kwon, Oh-Joo; Jeong, Seong-Whan] Catholic Univ Korea, Dept Biochem, Coll Med, Seoul, South Korea; [Lee, Ahwon] Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Hosp Pathol, Seoul, South Korea	Catholic University of Korea; Catholic University of Korea; Catholic University of Korea; Seoul St. Mary's Hospital	Jeong, SW (corresponding author), Catholic Univ Korea, Dept Biochem, Coll Med, Seoul, South Korea.; Lee, A (corresponding author), Catholic Univ Korea, Coll Med, Seoul St Marys Hosp, Dept Hosp Pathol, Seoul, South Korea.	klee@catholic.ac.kr; swjeong@catholic.ac.kr		Cho, Uiju/0000-0002-6229-8418	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education [NRF-2013R1A1A2011752]	Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Education(National Research Foundation of KoreaMinistry of Education (MOE), Republic of KoreaNational Research Council for Economics, Humanities & Social Sciences, Republic of Korea)	The research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education (NRF-2013R1A1A2011752) (http://www.nrf.re.kr/nrf_tot_cms/index.jsp?pmi-sso-return2=none). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Iida M, 2014, MOL CLIN ONCOL, V2, P647, DOI 10.3892/mco.2014.324; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20107, 10.3322/caac.20115]; Lando M, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000719; Lee HO, 2011, KOREAN J PHYSIOL PHA, V15, P149, DOI 10.4196/kjpp.2011.15.3.149; Lin KY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017193; Lu M, 2008, MOL CELL ENDOCRINOL, V287, P72, DOI 10.1016/j.mce.2008.01.028; Maekawa M, 2009, GENES CELLS, V14, P1003, DOI 10.1111/j.1365-2443.2009.01325.x; Mancini M, 2000, J CELL BIOL, V149, P603, DOI 10.1083/jcb.149.3.603; McAdam AJ, 2015, ROBBINS COTRAN PATHO, V9; McNew JA, 1998, FEBS LETT, V435, P89, DOI 10.1016/S0014-5793(98)01044-8; MELLMAN I, 1992, CELL, V68, P829, DOI 10.1016/0092-8674(92)90027-A; Meng JH, 2015, BBA-REV CANCER, V1856, P1, DOI 10.1016/j.bbcan.2015.04.002; Nagahama M, 1996, J CELL BIOL, V133, P507, DOI 10.1083/jcb.133.3.507; Naydenov NG, 2012, J BIOL CHEM, V287, P5928, DOI 10.1074/jbc.M111.278358; Pecorelli S, 2009, INT J GYNECOL OBSTET, V105, P107, DOI 10.1016/j.ijgo.2009.02.009; Qiu JT, 2012, GYNECOL ONCOL, V127, P472, DOI 10.1016/j.ygyno.2012.08.008; Riggs KA, 2012, J CELL SCI, V125, P3827, DOI 10.1242/jcs.102566; Rippo MR, 2000, FASEB J, V14, P2047, DOI 10.1096/fj.99-1028com; Rosenbaum EE, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.585166; Ruan Q, 2004, EXP CELL RES, V294, P51, DOI 10.1016/j.yexcr.2003.10.022; Subramaniam VN, 1996, SCIENCE, V272, P1161, DOI 10.1126/science.272.5265.1161; Sun NK, 2012, BIOCHEM J, V444, P303, DOI 10.1042/BJ20112223; Tai GH, 2004, MOL BIOL CELL, V15, P4011, DOI 10.1091/mbc.e03-12-0876; Ulloa F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119707; Volchuk A, 2004, MOL BIOL CELL, V15, P1506, DOI 10.1091/mbc.E03-08-0625; Wilson C, 2011, BIOCHEM J, V433, P1, DOI 10.1042/BJ20101058; Wlodkowic D, 2009, LEUKEMIA RES, V33, P1440, DOI 10.1016/j.leukres.2009.05.025; Zhang Q, 2005, J HISTOCHEM CYTOCHEM, V53, P1371, DOI 10.1369/jhc.4A6508.2005; Zhou RY, 2015, EUR J OBSTET GYN R B, V195, P210, DOI 10.1016/j.ejogrb.2015.10.006	29	11	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162623	10.1371/journal.pone.0162623	http://dx.doi.org/10.1371/journal.pone.0162623			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611086	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255900134
J	Demond, H; Trapphoff, T; Dankert, D; Heiligentag, M; Grummer, R; Horsthemke, B; Eichenlaub-Ritter, U				Demond, Hannah; Trapphoff, Tom; Dankert, Deborah; Heiligentag, Martyna; Gruemmer, Ruth; Horsthemke, Bernhard; Eichenlaub-Ritter, Ursula			Preovulatory Aging In Vivo and In Vitro Affects Maturation Rates, Abundance of Selected Proteins, Histone Methylation Pattern and Spindle Integrity in Murine Oocytes	PLOS ONE			English	Article							SUBCORTICAL MATERNAL COMPLEX; EARLY EMBRYONIC-DEVELOPMENT; PREANTRAL FOLLICLE CULTURE; MOUSE OOCYTES; CHROMOSOME MISALIGNMENT; REPRODUCTIVE TOXICOLOGY; MESSENGER-RNA; HETEROCHROMATIN; MSY2; EXPRESSION	Delayed ovulation and delayed fertilization can lead to reduced developmental competence of the oocyte. In contrast to the consequences of postovulatory aging of the oocyte, hardly anything is known about the molecular processes occurring during oocyte maturation if ovulation is delayed (preovulatory aging). We investigated several aspects of oocyte maturation in two models of preovulatory aging: an in vitro follicle culture and an in vivo mouse model in which ovulation was postponed using the GnRH antagonist cetrorelix. Both models showed significantly reduced oocyte maturation rates after aging. Furthermore, in vitro preovulatory aging deregulated the protein abundance of the maternal effect genes Smarca4 and Nlrp5, decreased the levels of histone H3K9 trimethylation and caused major deterioration of chromosome alignment and spindle conformation. Protein abundance of YBX2, an important regulator of mRNA stability, storage and recruitment in the oocyte, was not affected by in vitro aging. In contrast, in vivo preovulatory aging led to reduction in Ybx2 transcript and YBX2 protein abundance. Taken together, preovulatory aging seems to affect various processes in the oocyte, which could explain the low maturation rates and the previously described failures in fertilization and embryonic development.	[Demond, Hannah; Horsthemke, Bernhard] Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany; [Trapphoff, Tom; Heiligentag, Martyna; Eichenlaub-Ritter, Ursula] Univ Bielefeld, Inst Gene Technol Microbiol, Bielefeld, Germany; [Dankert, Deborah; Gruemmer, Ruth] Univ Duisburg Essen, Univ Hosp Essen, Inst Anat, Essen, Germany	University of Duisburg Essen; University of Bielefeld; University of Duisburg Essen	Horsthemke, B (corresponding author), Univ Duisburg Essen, Univ Hosp Essen, Inst Human Genet, Essen, Germany.	bernhard.horsthemke@uni-due.de		Demond, Hannah/0000-0003-4706-4792	German Research Foundation (DFG) [EI 199/7-1, GR 1138/12-1, HO 949/21-1, FOR 1041]	German Research Foundation (DFG)(German Research Foundation (DFG))	The study has been supported by the German Research Foundation (DFG, www.dfg.de, EI 199/7-1 vertical bar GR 1138/12-1 vertical bar HO 949/21-1 and FOR 1041). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adriaens I, 2004, HUM REPROD, V19, P398, DOI 10.1093/humrep/deh074; Al-Inany H, 2007, REPROD BIOMED ONLINE, V14, P640, DOI 10.1016/S1472-6483(10)61059-0; Al-Inany HG, 2011, HUM REPROD UPDATE, V17, P435, DOI 10.1093/humupd/dmr004; Bittner AK, 2011, FERTIL STERIL, V95, P2390, DOI 10.1016/j.fertnstert.2011.03.022; Bultman SJ, 2006, GENE DEV, V20, P1744, DOI 10.1101/gad.1435106; Carey TS, 2015, MOL CELL BIOL, V35, P4158, DOI 10.1128/MCB.00546-15; Clarke HJ, 2012, POSTTRANSCRIPTIONAL; Cortvrindt RG, 2002, HUM REPROD UPDATE, V8, P243, DOI 10.1093/humupd/8.3.243; Dankert D, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108907; Dean W, 2003, SEMIN CELL DEV BIOL, V14, P93, DOI 10.1016/S1084-9521(02)00141-6; Dejardin J, 2015, TRENDS GENET, V31, P661, DOI 10.1016/j.tig.2015.09.003; Demant M, 2012, HUM REPROD, V27, P1096, DOI 10.1093/humrep/der453; Eymery A, 2016, DEVELOPMENT; Fernandes R, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.093583; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Han LS, 2015, SCI REP-UK, V5, DOI 10.1038/srep15366; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kageyama S, 2007, REPRODUCTION, V133, P85, DOI 10.1530/REP-06-0025; Kang MK, 2011, BMB REP, V44, P147, DOI 10.5483/BMBRep.2011.44.3.147; Kim B, 2014, DEV BIOL, V386, P331, DOI 10.1016/j.ydbio.2013.12.025; Kim J, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1005970; Li L, 2008, DEV CELL, V15, P416, DOI 10.1016/j.devcel.2008.07.010; Li L, 2013, MOL ASPECTS MED, V34, P919, DOI 10.1016/j.mam.2013.01.003; Li L, 2010, DEVELOPMENT, V137, P859, DOI 10.1242/dev.039487; Lu YQ, 2016, MOL HUM REPROD, V22, P252, DOI 10.1093/molehr/gaw001; Manosalva I, 2010, THERIOGENOLOGY, V74, P1539, DOI 10.1016/j.theriogenology.2010.06.024; Medvedev S, 2008, DEV BIOL, V321, P205, DOI 10.1016/j.ydbio.2008.06.016; Medvedev S, 2011, BIOL REPROD, V85, P575, DOI 10.1095/biolreprod.111.091710; Nath S, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00060; Ohsugi M, 2008, DEVELOPMENT, V135, P259, DOI 10.1242/dev.011445; Peters AHFM, 2001, CELL, V107, P323, DOI 10.1016/S0092-8674(01)00542-6; Richter JD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002758; Roberts R, 2002, HUM REPROD, V17, P2950, DOI 10.1093/humrep/17.11.2950; Sanchez F, 2012, J ASSIST REPROD GEN, V29, P141, DOI 10.1007/s10815-011-9690-x; SMITS LJ, 1995, MED HYPOTHESES, V45, P441, DOI 10.1016/0306-9877(95)90218-X; Smitz J, 2010, HUM REPROD UPDATE, V16, P395, DOI 10.1093/humupd/dmp056; Sun FY, 2004, MUTAGENESIS, V19, P13, DOI 10.1093/mutage/geg040; Tong ZB, 2000, NAT GENET, V26, P267, DOI 10.1038/81547; Trapphoff T, 2016, HUM REPROD, V31, P133, DOI 10.1093/humrep/dev279; Trapphoff T, 2013, FERTIL STERIL, V100, P1758, DOI 10.1016/j.fertnstert.2013.08.021; Trapphoff T, 2010, HUM REPROD, V25, P3025, DOI 10.1093/humrep/deq278; van de Werken C, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6868; van den Berg IM, 2011, HUM REPROD, V26, P1181, DOI 10.1093/humrep/der030; Vogt E, 2009, REPROD BIOMED ONLINE, V19, P352, DOI 10.1016/S1472-6483(10)60169-1; Yang F, 2012, INT J DEV BIOL, V56, P889, DOI 10.1387/ijdb.120246rd; Yang JX, 2005, P NATL ACAD SCI USA, V102, P5755, DOI 10.1073/pnas.0408718102; Yu JY, 2002, BIOL REPROD, V67, P1093, DOI 10.1095/biolreprod67.4.1093; Yu JY, 2001, BIOL REPROD, V65, P1260, DOI 10.1095/biolreprod65.4.1260; Yu XJ, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5887; Zhu K, 2015, MOL HUM REPROD, V21, P320, DOI 10.1093/molehr/gau116	50	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162722	10.1371/journal.pone.0162722	http://dx.doi.org/10.1371/journal.pone.0162722			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611906	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900155
J	Kampmann, C; Abu-Tair, T; Gokce, S; Lampe, C; Reinke, J; Mengel, E; Hennermann, JB; Wiethoff, CM				Kampmann, Christoph; Abu-Tair, Tariq; Goekce, Seyfullah; Lampe, Christina; Reinke, Joerg; Mengel, Eugen; Hennermann, Julia B.; Wiethoff, Christiane M.			Heart and Cardiovascular Involvement in Patients with Mucopolysaccharidosis Type IVA (Morquio-A Syndrome)	PLOS ONE			English	Article							LEFT-VENTRICULAR MASS; AORTIC-VALVE-REPLACEMENT; WALL STRESS; DIAGNOSIS; CHILDREN; GROWTH; CONTRACTILITY; DYSFUNCTION; VALIDATION; FAILURE	Background Mucopolysaccharidosis (MPS) IVA is a rare lysosomal storage disorder with multiple skeletal and non-skeletal abnormalities requiring multiple surgical interventions. It is well known that patients with MPS IVA suffer from tachycardia, but cardiac and hemodynamic alterations have not been reported to date. We investigated the cardiovascular and hemodynamic alterations in patients with MPS IVA and developed a possible patho-mechanism for cardiovascular deterioration during anesthesia. Material and Methods In this observational study, serial cardiac examinations were performed in 54 patients with MPS IVA who were followed at the Children's Hospital of the Mainz Medical University (Mainz, Germany) between 1991 and 2014 (follow-up 1-24 years; median 5.8 years). Results were compared with data from a large central European cohort of more than 2000 healthy infants and children. Results None of the patients had arterial hypertension, but 4% had evidence of increased pulmonary artery pressure. Patients developed aortic root extension up to 6.9 standard deviations above normal. Left-sided valve leaflet thickening occurred in 26 patients (five with valve disease). Patients had lower left ventricular dimensions (z: -1.02 +/- 0.1), lower stroke volumes (z: -2.3 +/- 0.17), lower left ventricular mass (z: -1.5 +/- 0.21), but higher wall thickness (z: +0.8 +/- 0.16), and higher work index (z: + 2.5 +/- 0.2) compared to healthy control subjects. Cardiac output was preserved by an increase in heart rate of 21%. Sixty % of patients showed impaired diastolic filling; heart rate (99.0 +/- 1.8 vs. 92.0 +/- 2.1 bpm), age (18.0 +/- 1.8 vs. 14.2 +/- 1 years), and cardiothoracic ratio (61.6 +/- 3.6% vs. 55 +/- 4.2%) of these patients were higher compared to those with normal filling. Conclusions The results of this study suggest an age-progressive disproportion of the intra-thoracic organs of patients with MPS IVA, which is accompanied by aortic root extension and thickened left ventricles, with reduced stroke volumes, impaired diastolic filling patterns, and increased heart rates.	[Kampmann, Christoph; Abu-Tair, Tariq; Wiethoff, Christiane M.] Mainz Med Univ, Ctr Dis Childhood & Adolescence, Div Pediat Cardiol & Congenital Heart Dis, Mainz, Germany; [Goekce, Seyfullah; Lampe, Christina; Reinke, Joerg; Mengel, Eugen; Hennermann, Julia B.] Mainz Med Univ, Ctr Dis Childhood & Adolescence, Div Metab Dis Villa Metab, Mainz, Germany		Kampmann, C (corresponding author), Mainz Med Univ, Ctr Dis Childhood & Adolescence, Div Pediat Cardiol & Congenital Heart Dis, Mainz, Germany.	kampmann@mail.uni-mainz.de			Miller Medical Communications (Brindle, Lancashire, UK); BioMarin Europe Ltd. (London, UK)	Miller Medical Communications (Brindle, Lancashire, UK); BioMarin Europe Ltd. (London, UK)	Support for third-party writing assistance for this manuscript, provided by Miller Medical Communications (Brindle, Lancashire, UK), was provided by BioMarin Europe Ltd. (London, UK). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Support for third-party writing assistance for this manuscript, provided by Miller Medical Communications (Brindle, Lancashire, UK), was provided by BioMarin Europe Ltd. (London, UK).	Barry MO, 2006, J HEART VALVE DIS, V15, P839; Braunlin EA, 2011, J INHERIT METAB DIS, V34, P1183, DOI 10.1007/s10545-011-9359-8; COLAN SD, 1984, J AM COLL CARDIOL, V4, P715, DOI 10.1016/S0735-1097(84)80397-6; COLAN SD, 1992, J AM COLL CARDIOL, V19, P619, DOI 10.1016/S0735-1097(10)80282-7; DESIMONE G, 1995, J AM COLL CARDIOL, V25, P1056, DOI 10.1016/0735-1097(94)00540-7; DESIMONE G, 1992, J AM COLL CARDIOL, V20, P1251, DOI 10.1016/0735-1097(92)90385-Z; DEVEREUX RB, 1977, CIRCULATION, V55, P613, DOI 10.1161/01.CIR.55.4.613; DEVEREUX RB, 1986, AM J CARDIOL, V57, P450, DOI 10.1016/0002-9149(86)90771-X; Douglas P S, 1986, Cardiovasc Clin, V17, P103; DOUGLAS PS, 1987, J AM COLL CARDIOL, V9, P945, DOI 10.1016/S0735-1097(87)80253-X; Foster RE, 1998, AM HEART J, V136, P269, DOI 10.1053/hj.1998.v136.89405; GAASCH WH, 1975, AM J CARDIOL, V36, P193, DOI 10.1016/0002-9149(75)90525-1; Hendriksz CJ, 2013, MOL GENET METAB, V110, P54, DOI 10.1016/j.ymgme.2013.04.002; IRELAND MA, 1981, BRIT HEART J, V46, P113; JOHN RM, 1990, ARCH DIS CHILD, V65, P746, DOI 10.1136/adc.65.7.746; Kampmann C, 2000, HEART, V83, P667, DOI 10.1136/heart.83.6.667; Miwa K, 2008, CLIN CARDIOL, V31, P328, DOI 10.1002/clc.20227; Montano AM, 2008, AM J MED GENET A, V146A, P1286, DOI 10.1002/ajmg.a.32281; Muenzer J, 2004, J PEDIATR-US, V144, pS27, DOI 10.1016/j.jpeds.2004.01.052; Nicolini F, 2008, HEART SURG FORUM, V11, pE96, DOI 10.1532/HSF98.20071197; Pagel PS, 2009, J CARDIOTHOR VASC AN, V23, P855, DOI 10.1053/j.jvca.2008.12.009; REICHEK N, 1982, CIRCULATION, V65, P99, DOI 10.1161/01.CIR.65.1.99; Roelandt J, 1980, Eur Heart J, V1, P375; Schmailzl KJG, 1994, KARDIALE ULTRASCHALL; STROBECK JE, 1981, HERZ, V6, P275; TEICHHOLZ LE, 1976, AM J CARDIOL, V37, P7, DOI 10.1016/0002-9149(76)90491-4; Yasuda E, 2013, MOL GENET METAB, V109, P301, DOI 10.1016/j.ymgme.2013.04.009; Zile MR, 2002, CIRCULATION, V105, P1387, DOI 10.1161/hc1102.105289	28	23	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162612	10.1371/journal.pone.0162612	http://dx.doi.org/10.1371/journal.pone.0162612			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610627	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900133
J	Vasconcellos, AD; Viranyi, Z; Range, F; Ades, C; Scheidegger, JK; Mostl, E; Kotrschal, K				Vasconcellos, Angelica da Silva; Viranyi, Zsofia; Range, Friederike; Ades, Cesar; Scheidegger, Joerdis Kristin; Moestl, Erich; Kotrschal, Kurt			Training Reduces Stress in Human-Socialised Wolves to the Same Degree as in Dogs	PLOS ONE			English	Article							HUMAN-ANIMAL RELATIONSHIP; POSITIVE REINFORCEMENT; ENVIRONMENTAL ENRICHMENT; PLASMA-CORTISOL; ZOO ANIMALS; CHRONIC CORTICOSTERONE; BEHAVIORAL-RESPONSES; SALIVARY CORTISOL; RHESUS MACAQUES; WELFARE	The welfare of animals in captivity is of considerable societal concern. A major source of stress, especially for wild animals, is the lack of control over their environment, which includes not being able to avoid contact with human beings. Paradoxically, some studies have shown that interactions with human beings may improve the welfare of wild animals in captivity. Here, we investigated the behavioural (behaviours indicative of cooperation or stress) and physiological (variations in salivary cortisol concentrations) effects of the increasingly used practice of training wild animals as a way to facilitate handling and/or as behavioural enrichment. We evaluated the effects of indoor training sessions with familiar caretakers on nine human-socialised individuals of a wild species, the wolf (Canis lupus), in comparison to nine individuals of its domesticated form, the dog (Canis lupus familiaris). All animals were raised and kept in intraspecific packs under identical conditions-in accordance with the social structure of the species-in order to control for socialisation with human beings and familiarity with training. We also collected saliva samples of trainers to measure GC and testosterone concentrations, to control for the effects of trainers' stress levels on the responses of the animals. During the training sessions, separated from pack members, the animals stayed voluntarily close to the trainers and mostly adequately performed requested behaviours, indicating concentration to the task. Similarly to dogs, the salivary cortisol level of wolves-used as an index of stress-dropped during these sessions, pointing to a similar stress-reducing effect of the training interaction in both subspecies. The responses to the requested behaviours and the reduction in salivary cortisol level of wolves and dogs varied across trainers, which indicates that the relaxing effect of training has a social component. This points to another factor affecting the welfare of animals during the sessions, beside the rewarding effect of getting food and control over the situation by successfully completing a task. As all responses performed by the animals corresponded to cues already familiar to them, the reported effects were likely due to the above cited factors rather than to a learning process. Our results support previous findings suggesting that training is a potentially powerful tool for improving welfare in some wild social canids by creating structured and positive interactions between these animals and their human caretakers.	[Vasconcellos, Angelica da Silva] Pontificia Univ Catolica Minas Gerais, Program Postgrad Vertebrate Biol, Belo Horizonte, MG, Brazil; [Vasconcellos, Angelica da Silva; Ades, Cesar] Univ Sao Paulo, Inst Psychol, Sao Paulo, SP, Brazil; [Vasconcellos, Angelica da Silva; Viranyi, Zsofia; Range, Friederike; Scheidegger, Joerdis Kristin; Kotrschal, Kurt] Wolf Sci Ctr, Enrstbrunn, Austria; [Viranyi, Zsofia; Range, Friederike] Univ Vienna, Med Univ Vienna, Univ Vet Med Vienna, Messerli Res Inst, Vienna, Austria; [Moestl, Erich] Univ Vet Med, Unit Physiol Pathophysiol & Expt Endocrinol, Dept Biomed Sci, Vienna, Austria; [Kotrschal, Kurt] Univ Vienna, Dept Behav Biol, Vienna, Austria	Pontificia Universidade Catolica de Minas Gerais; Universidade de Sao Paulo; Medical University of Vienna; University of Veterinary Medicine Vienna; University of Vienna; University of Veterinary Medicine Vienna; University of Vienna	Vasconcellos, AD (corresponding author), Pontificia Univ Catolica Minas Gerais, Program Postgrad Vertebrate Biol, Belo Horizonte, MG, Brazil.; Vasconcellos, AD (corresponding author), Univ Sao Paulo, Inst Psychol, Sao Paulo, SP, Brazil.; Vasconcellos, AD (corresponding author), Wolf Sci Ctr, Enrstbrunn, Austria.	angelicavasconcellos@gmail.com	Vasconcellos, Angélica S/J-2024-2014	Vasconcellos, Angélica S/0000-0003-2326-0713; Range, Friederike/0000-0003-3127-5536	Sao Paulo Research Foundation [2009/14258-4]; Coordination for the Improvement of Higher Education Personnel [BEX 5274/09-5]; Austrian Science Fund [P21244-B17, I 1271-B24]; European Research Council under the European Union's Seventh Framework Programme (FP)/ERC [311870]; Vienna Science and Technology Fund [CS11-026]; Austrian Ministry of Science; University of Vienna; Veterinary University Vienna	Sao Paulo Research Foundation(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Coordination for the Improvement of Higher Education Personnel(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Austrian Science Fund(Austrian Science Fund (FWF)); European Research Council under the European Union's Seventh Framework Programme (FP)/ERC(European Research Council (ERC)); Vienna Science and Technology Fund; Austrian Ministry of Science; University of Vienna; Veterinary University Vienna	ASV was supported by Sao Paulo Research Foundation (Project no. 2009/14258-4, http://www.fapesp.br/en) and Coordination for the Improvement of Higher Education Personnel (project grant BEX 5274/09-5, http://www.capes.gov.br). FR was financially supported by the Austrian Science Fund (project P21244-B17, https://www.fwf.ac.at/en/) and the European Research Council under the European Union's Seventh Framework Programme (FP/2007-2013, https://erc.europa.eu/)/ERC Grant Agreement n. 311870, ZV by the Austrian Science Fund (project I 1271-B24, https://www.fwf.ac.at/en/) and the Vienna Science and Technology Fund (project CS11-026, www.wwtf.at). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are grateful to Agatha Sacramento Rodrigues and Vinicius Frayze David for statistical advice. The Wolf Science Center was established by Kurt Kotrschal, Friederike Range and Zsofia Viranyi in 2008 based on a private society; we are grateful for support by the Austrian Ministry of Science, by the University of Vienna, the Veterinary University Vienna and a number of private sponsors. We are particularly grateful to our team of trainers, Bea Belenyi, Marianne Heberlein, Christina Mayer, Marleen Hentrup, Rita Takacs, for the daily routine care, handling and training of the animals. We also thank two anonymous reviewers for their thorough work and their constructive comments on the manuscript. Dr. Ades passed away before the submission of the final version of this manuscript. Dr. Vasconcellos accepts responsibility for the integrity and validity of the data collected and analysed.	Alliger AA, 2011, J APPL ANIM WELF SCI, V14, P271, DOI 10.1080/10888705.2011.600153; Anderson Ursula S., 2002, Journal of Applied Animal Welfare Science, V5, P125, DOI 10.1207/S15327604JAWS0502_03; Baker K, 2004, ANIM WELFARE, V13, P239; Baker KC, 2009, J APPL ANIM WELF SCI, V12, P236, DOI 10.1080/10888700902956011; Bardgett ME, 1996, PHYSIOL BEHAV, V59, P1111, DOI 10.1016/0031-9384(95)02172-8; Bassett L, 2007, APPL ANIM BEHAV SCI, V102, P223, DOI 10.1016/j.applanim.2006.05.029; BAYNE KAL, 1993, CONTEMP TOP LAB ANIM, V32, P6; Beerda B, 1998, APPL ANIM BEHAV SCI, V58, P365, DOI 10.1016/S0168-1591(97)00145-7; Bergamasco L, 2010, APPL ANIM BEHAV SCI, V125, P56, DOI 10.1016/j.applanim.2010.03.002; Bloomsmith M. A., 1999, American Journal of Primatology, V49, P35; BODNOFF SR, 1995, J NEUROSCI, V15, P61; Boitani L., 2003, NATURE ENV SERIES; Brauer J, 2013, APPL ANIM BEHAV SCI, V148, P138, DOI 10.1016/j.applanim.2013.07.009; Broom D M, 1991, Behav Processes, V25, P117, DOI 10.1016/0376-6357(91)90014-Q; BROOM DM, 1986, BRIT VET J, V142, P524, DOI 10.1016/0007-1935(86)90109-0; BROOM DM, 1991, J ANIM SCI, V69, P4167, DOI 10.2527/1991.69104167x; Burman OHP, 2008, BIOL LETTERS, V4, P330, DOI 10.1098/rsbl.2008.0113; Cafazzo S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098594; Carlstead Kathy, 1996, P317; Carlstead K, 2009, ZOO BIOL, V28, P589, DOI 10.1002/zoo.20289; CARPENTER E, 1980, ANIMALS ETHICS REPOR; Carrasco L, 2009, ANIM WELFARE, V18, P9; Chamove A.S., 1989, P183; Cibulski L, 2014, BEHAV PROCESS, V103, P129, DOI 10.1016/j.beproc.2013.11.013; Claxton AM, 2011, APPL ANIM BEHAV SCI, V133, P1, DOI 10.1016/j.applanim.2011.03.002; Clubb R, 2003, NATURE, V425, P473, DOI 10.1038/425473a; Coleman K, 2010, APPL ANIM BEHAV SCI, V124, P142, DOI 10.1016/j.applanim.2010.02.008; Conrad CD, 1996, BEHAV NEUROSCI, V110, P1321, DOI 10.1037/0735-7044.110.6.1321; Coppola CL, 2006, PHYSIOL BEHAV, V87, P537, DOI 10.1016/j.physbeh.2005.12.001; Creel S, 2001, TRENDS ECOL EVOL, V16, P491, DOI 10.1016/S0169-5347(01)02227-3; De Rouck M, 2005, ANIM WELFARE, V14, P229; Deldalle S, 2014, J VET BEHAV, V9, P58, DOI 10.1016/j.jveb.2013.11.004; FRANK H, 1983, BEHAV PROCESS, V8, P363, DOI 10.1016/0376-6357(83)90024-4; Gacsi M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006584; Ginsburg B.E., 1987, Perspectives in Vertebrate Science, V4, P401; Greiveldinger L, 2007, PHYSIOL BEHAV, V92, P675, DOI 10.1016/j.physbeh.2007.05.012; Griffin JA, 2012, ANIMALS AFFECT US EX; Hagen K, 2004, APPL ANIM BEHAV SCI, V85, P203, DOI 10.1016/j.applanim.2003.11.007; HANSON JD, 1976, BEHAV BIOL, V16, P333, DOI 10.1016/S0091-6773(76)91460-7; Hare B, 2002, SCIENCE, V298, P1634, DOI 10.1126/science.1072702; Haubenhofer DK, 2007, SOC ANIM, V15, P127, DOI 10.1163/156853007X187090; Haubenhofer Dorit Karla, 2006, Journal of Applied Animal Welfare Science, V9, P165, DOI 10.1207/s15327604jaws0902_5; Haverbeke A, 2008, APPL ANIM BEHAV SCI, V113, P110, DOI 10.1016/j.applanim.2007.11.010; Hemetsberger J, 2010, INTERACT STUD, V11, P380, DOI 10.1075/is.11.3.03hem; HEMSWORTH PH, 1993, ANIM WELFARE, V2, P33; Hennessy MB, 1998, APPL ANIM BEHAV SCI, V61, P63, DOI 10.1016/S0168-1591(98)00179-8; Herzog H., 2010, SOME WE LOVE SOME WE; Hogan LA, 2011, APPL ANIM BEHAV SCI, V134, P217, DOI 10.1016/j.applanim.2011.07.010; Horn L, 2013, ANIM COGN, V16, P435, DOI 10.1007/s10071-012-0584-9; Horvath Z, 2008, HORM BEHAV, V54, P107, DOI 10.1016/j.yhbeh.2008.02.002; Hosey G., 2014, INT J COMP PSYCHOL, V27, P117, DOI [10.5811/westjem.2011.5.6700, 10.46867/ijcp.2014.27.01.01, DOI 10.46867/IJCP.2014.27.01.01]; Hosey G, 2013, J APPL ANIM WELF SCI, V16, P338, DOI 10.1080/10888705.2013.827916; Hosey GR, 2000, ANIM WELFARE, V9, P343; HUBRECHT RC, 1993, APPL ANIM BEHAV SCI, V37, P345, DOI 10.1016/0168-1591(93)90123-7; Inglis IR., 1983, EXPLORATION ANIMALS, P72; Jones AC, 2006, HORM BEHAV, V50, P393, DOI 10.1016/j.yhbeh.2006.04.007; Kalbe C, 2010, GENES BRAIN BEHAV, V9, P75, DOI 10.1111/j.1601-183X.2009.00536.x; KIRSCHBAUM C, 1989, NEUROPSYCHOBIOLOGY, V22, P150, DOI 10.1159/000118611; Klinghammer E, 1987, MAN WOLF ADV ISSUES, P31; Kotrschal K., 2012, WOLF HUND MENSCH GES; Lambeth SP, 2006, AM J PRIMATOL, V68, P245, DOI 10.1002/ajp.20148; Ligout S, 2010, J VET BEHAV, V5, P49, DOI DOI 10.1016/J.JVEB.2009.09.027; LINE SW, 1990, LAB ANIM, V24, P213, DOI 10.1258/002367790780866245; Luescher AU, 2009, APPL ANIM BEHAV SCI, V117, P63, DOI 10.1016/j.applanim.2008.11.001; Maloney MA, 2007, AM J PRIMATOL, V69, P53; Manciocco A, 2009, APPL ANIM BEHAV SCI, V120, P100, DOI 10.1016/j.applanim.2009.05.007; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; MASON JW, 1968, PSYCHOSOM MED, V30, P576, DOI 10.1097/00006842-196809000-00020; McBride SD, 2001, ANIM WELFARE, V10, P173; McCormick Wanda, 2003, P9; McDougall PT, 2006, ANIM CONSERV, V9, P39, DOI 10.1111/j.1469-1795.2005.00004.x; MCEWEN BS, 1995, CURR OPIN NEUROBIOL, V5, P205, DOI 10.1016/0959-4388(95)80028-X; McGowan RTS, 2014, ANIM COGN, V17, P577, DOI 10.1007/s10071-013-0688-x; McKinley Jean, 2003, Journal of Applied Animal Welfare Science, V6, P209, DOI 10.1207/S15327604JAWS0603_06; Mech L. D., 2007, WOLVES BEHAV ECOLOGY; Melfi V, 2013, APPL ANIM BEHAV SCI, V147, P299, DOI 10.1016/j.applanim.2013.04.011; MELLEN JD, 1991, ZOO BIOL, V10, P95, DOI 10.1002/zoo.1430100202; Miklosi A., 2007, DOG BEHAV EVOLUTION; Miklosi A, 2013, TRENDS COGN SCI, V17, P287, DOI 10.1016/j.tics.2013.04.005; Minier DE, 2011, APPL ANIM BEHAV SCI, V132, P178, DOI 10.1016/j.applanim.2011.04.009; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Normando S, 2009, APPL ANIM BEHAV SCI, V116, P211, DOI 10.1016/j.applanim.2008.10.005; Norusis MJ, 2010, IBM SPSS STAT 19 ADV, P35; O'Brien JK, 2008, ANIM WELFARE, V17, P125; Owen Y, 2011, J APPL ANIM WELF SCI, V14, P124, DOI 10.1080/10888705.2011.551625; Packard Jane M., 2003, P35; Patzl M, 1990, ENTWICKLUNG BIOTIN S; Pomerantz O, 2009, AM J PRIMATOL, V71, P687, DOI 10.1002/ajp.20703; POOLE TB, 1987, ZOO BIOL, V6, P315, DOI 10.1002/zoo.1430060406; Price EE, 2007, APPL ANIM BEHAV SCI, V103, P255, DOI 10.1016/j.applanim.2006.05.021; Range F, 2007, ANIM BEHAV, V73, P1033, DOI 10.1016/j.anbehav.2006.07.015; Range F, 2015, P ROY SOC B-BIOL SCI, V282, DOI 10.1098/rspb.2015.0220; Range Friederike, 2014, Front Psychol, V5, P1582, DOI 10.3389/fpsyg.2014.01582; Range F, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00868; Range F, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086559; Reimers M, 2007, HORM BEHAV, V51, P428, DOI 10.1016/j.yhbeh.2006.12.011; Rennie LJ, 2003, ANIM WELFARE, V12, P591; Riemer S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101237; Rochais C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00108; Rooney NJ, 2011, APPL ANIM BEHAV SCI, V132, P169, DOI 10.1016/j.applanim.2011.03.007; SALZEN E. A., 1962, SYMPOSIA ZOOL SOC LONDON, V8, P199; Sambrook TD, 1997, ANIM WELFARE, V6, P207; SAPOLSKY RM, 1990, BIOL PSYCHIAT, V28, P862, DOI 10.1016/0006-3223(90)90568-M; SAPOLSKY RM, 1983, AM J PRIMATOL, V5, P365, DOI 10.1002/ajp.1350050406; Savastano Gina, 2003, Journal of Applied Animal Welfare Science, V6, P247, DOI 10.1207/S15327604JAWS0603_09; Schalke E, 2007, APPL ANIM BEHAV SCI, V105, P369, DOI 10.1016/j.applanim.2006.11.002; Schapiro SJ, 1996, APPL ANIM BEHAV SCI, V48, P159, DOI 10.1016/0168-1591(96)01038-6; Scott JP., 1965, GENETICS SOCIAL BEHA; Shiverdecker MD, 2013, PHYSIOL BEHAV, V109, P75, DOI 10.1016/j.physbeh.2012.12.002; Shyne A, 2010, J APPL ANIM WELF SCI, V13, P56, DOI 10.1080/10888700903372069; Tallet C, 2008, DEV PSYCHOBIOL, V50, P147, DOI 10.1002/dev.20254; THOMSEN CE, 1974, ANIM BEHAV, V22, P144, DOI 10.1016/S0003-3472(74)80063-1; Udell MAR, 2008, ANIM BEHAV, V76, P1767, DOI 10.1016/j.anbehav.2008.07.028; Veissier I, 2007, PHYSIOL BEHAV, V92, P429, DOI 10.1016/j.physbeh.2006.11.008; VINCENT IC, 1992, RES VET SCI, V53, P342, DOI 10.1016/0034-5288(92)90137-Q; VINING RF, 1983, ANN CLIN BIOCHEM, V20, P329, DOI 10.1177/000456328302000601; Waiblinger S, 2003, APPL ANIM BEHAV SCI, V84, P23, DOI 10.1016/S0168-1591(03)00148-5; Ward SJ, 2013, APPL ANIM BEHAV SCI, V147, P179, DOI 10.1016/j.applanim.2013.05.008; Westlund K, 2014, APPL ANIM BEHAV SCI, V152, P1, DOI 10.1016/j.applanim.2013.12.009; Wielkiewicz R. M., 1980, COPING HLTH, P1; Young LJ, 2005, J COMP NEUROL, V493, P51, DOI 10.1002/cne.20771; Young RJ, 2004, ANIM WELFARE, V13, P225	123	16	16	3	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162389	10.1371/journal.pone.0162389	http://dx.doi.org/10.1371/journal.pone.0162389			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611784	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900088
J	Mistry, H; Sharma, P; Mahato, S; Saravanan, R; Kumar, PA; Bhandari, V				Mistry, Hiral; Sharma, Paresh; Mahato, Sudipta; Saravanan, R.; Kumar, P. Anand; Bhandari, Vasundhra			Prevalence and Characterization of Oxacillin Susceptible mecA-Positive Clinical Isolates of Staphylococcus aureus Causing Bovine Mastitis in India	PLOS ONE			English	Article							METHICILLIN-RESISTANT; ANTIMICROBIAL SUSCEPTIBILITY; PCR ASSAY; MRSA; STRAINS; EMERGENCE; INFECTIONS; HOMOLOG; CLONE	Bovine mastitis caused by multidrug resistant Staphylococcus aureus is a huge problem reported worldwide, resulting in prolonged antibiotic treatment and death of livestock. The current study is focused on surveillance of antibiotic susceptibility along with genotypic and phenotypic characterization of the pathogenic S. aureus strains causing mastitis in India. One hundred and sixty seven milk samples were collected from mastitis-affected cows from different farms in India resulting in thirty nine isolated S. aureus strains. Antibiotic sensitivity profiling revealed the majority of the strains (n = 24) to be multidrug resistant and eleven strains showed reduced susceptibility to vancomycin (MICs = 2 mu g/ml). All strains were oxacillin sensitive, but 19 strains were positive for the mecA gene, which revealed the occurrence of oxacillin susceptible mecA positive strains (OS-MRSA) for the first time from India. Additionally, 32 strains were positive for the pvl gene, a virulence determinant; of these 17 were also OS-MRSA strains. Molecular characterization based on multilocus sequence typing (MLST), spa typing, agr typing and SCCmec classification revealed strains belonging to different groups. Moreover, strains showed spa types (t2526, t9602) and MLST sequence types, ST-72, ST-88 and ST-239 which have been earlier reported in human infections. The prevalence of OS-MRSA strains indicates the importance of including both the genetic and phenotypic tests in characterizing S. aureus strains. Increased genotypic variability with strain related to human infections and pvl positive isolates indicates a worrisome situation with the possibility of bilateral transfer.	[Mistry, Hiral; Sharma, Paresh; Mahato, Sudipta; Bhandari, Vasundhra] Natl Inst Anim Biotechnol DBT, Hyderabad, Andhra Pradesh, India; [Saravanan, R.] Breeding Vet Coll & Res Inst, Dept Anim Genet & Breeding, Namakkal, Tamil Nadu, India; [Kumar, P. Anand] SVVU, Dept Vet Microbiol, NTR Coll Vet Sci, Gannavaram, Andhra Pradesh, India; [Bhandari, Vasundhra] Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad, Andhra Pradesh, India	Department of Biotechnology (DBT) India; National Institute of Animal Biotechnology (NIAB); Tamil Nadu Veterinary & Animal Sciences University; Sri Venkateswara Veterinary University; University of Hyderabad	Bhandari, V (corresponding author), Natl Inst Anim Biotechnol DBT, Hyderabad, Andhra Pradesh, India.; Bhandari, V (corresponding author), Univ Hyderabad, Sch Life Sci, Dept Anim Biol, Hyderabad, Andhra Pradesh, India.	vasundhra23@gmail.com	Ramasamy, Saravanan/ADW-8513-2022	Ramasamy, Saravanan/0000-0003-2409-0357; BHANDARI, VASUNDHRA/0000-0002-1930-1722	National Institute of Animal Biotechnology Hyderabad; Department of Biotechnology, India [BT/PR8856/ADV/90/157/2013]; Fast Track Young Scientist Grant Science and Engineering Research Board, India [SERB/LS173/2014]	National Institute of Animal Biotechnology Hyderabad; Department of Biotechnology, India(Department of Biotechnology (DBT) India); Fast Track Young Scientist Grant Science and Engineering Research Board, India	Funded by Intramural funds from National Institute of Animal Biotechnology Hyderabad and extramural funding by Department of Biotechnology, India project (BT/PR8856/ADV/90/157/2013) and Fast Track Young Scientist Grant Science and Engineering Research Board, India (SERB/LS173/2014).	Awandkar SP., 2013, BIOLIFE, V1, P139; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Bouchiat C., 2015, New Microbes and New Infections, V7, P15, DOI 10.1016/j.nmni.2015.05.003; Chadwick SG, 2013, J CLIN MICROBIOL, V51, P2541, DOI 10.1128/JCM.00417-13; Chandrasekaran D., 2014, Journal of Applied and Natural Science, V6, P786; Conceicao T, 2015, J ANTIMICROB CHEMOTH, V70, P3200, DOI 10.1093/jac/dkv261; Cui SH, 2009, J ANTIMICROB CHEMOTH, V64, P680, DOI 10.1093/jac/dkp275; Dufour P, 2002, CLIN INFECT DIS, V35, P819, DOI 10.1086/342576; Ebert MD, 2009, EMERG RADIOL, V16, P159, DOI 10.1007/s10140-008-0706-5; Fessler A, 2010, J ANTIMICROB CHEMOTH, V65, P619, DOI 10.1093/jac/dkq021; Garcia-Alvarez L, 2011, LANCET INFECT DIS, V11, P595, DOI 10.1016/S1473-3099(11)70126-8; Haran KP, 2012, J CLIN MICROBIOL, V50, P688, DOI 10.1128/JCM.05214-11; Hiramatsu K, 2001, Lancet Infect Dis, V1, P147, DOI 10.1016/S1473-3099(01)00091-3; Hiramatsu K, 1997, LANCET, V350, P1670, DOI 10.1016/S0140-6736(97)07324-8; Hiramatsu K, 2001, TRENDS MICROBIOL, V9, P486, DOI 10.1016/S0966-842X(01)02175-8; Hososaka Yasuko, 2007, Journal of Infection and Chemotherapy, V13, P79, DOI 10.1007/s10156-006-0502-7; Huber H, 2010, EUROSURVEILLANCE, V15, P7; Kaliwal BB, 2011, VET WORLD, V4, P158; Kumar R, 2011, J BIOSCIENCES, V36, P175, DOI 10.1007/s12038-011-9004-6; Kumar VA, 2013, J CLIN MICROBIOL, V51, P318, DOI 10.1128/JCM.01040-12; Kutar K., 2015, Indian Journal of Comparative Microbiology, Immunology and Infectious Diseases, V36, P22, DOI 10.5958/0974-0147.2015.00005.7; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI [DOI 10.4135/9781446279281.N7, DOI 10.1271/BBB.67.1048]; Li LP, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116699; Lina G, 2003, APPL ENVIRON MICROB, V69, P18, DOI 10.1128/AEM.69.1.18-23.2003; Liu CL, 2015, J MICROBIOL IMMUNOL, V48, P490, DOI 10.1016/j.jmii.2014.03.003; Marshall BM, 2011, CLIN MICROBIOL REV, V24, P718, DOI 10.1128/CMR.00002-11; Mubarack HM, 2012, VET WORLD, V5, P352, DOI 10.5455/vetworld.2012.352-355; Nam HM, 2011, FOODBORNE PATHOG DIS, V8, P231, DOI 10.1089/fpd.2010.0661; Okolie CE, 2015, BMC MICROBIOL, V15, DOI 10.1186/s12866-015-0490-9; Overesch G, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-30; Park KH, 2015, J ANTIMICROB CHEMOTH, V70, P1185, DOI 10.1093/jac/dku475; Pournaras S, 2013, FUTURE MICROBIOL, V8, P1365, DOI 10.2217/fmb.13.118; Prashanth K, 2011, J GLOB INFECT DIS, V3, P115, DOI 10.4103/0974-777X.81686; Pu WX, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088134; Radostits OM, 2007, VET MED-US, V9th, P174; Sarker SD, 2007, METHODS, V42, P321, DOI 10.1016/j.ymeth.2007.01.006; Sharff KA, 2012, J CLIN MICROBIOL, V50, P4151, DOI 10.1128/JCM.01564-12; Stegger M, 2012, CLIN MICROBIOL INFEC, V18, P395, DOI 10.1111/j.1469-0691.2011.03715.x; Sudhan N. A., 2005, Indian Journal of Animal Research, V39, P127; Sumathi BR, 2008, VET WORLD, V1, P37; Voss A, 2005, EMERG INFECT DIS, V11, P1965, DOI 10.3201/eid1112.050428; Wang DF, 2015, INFECT GENET EVOL, V31, P9, DOI 10.1016/j.meegid.2014.12.039; Wayne P., 2014, M100S24 CLSI, V34, P50; Weese JS, 2010, ILAR J, V51, P233, DOI 10.1093/ilar.51.3.233; Weese JS, 2010, VET MICROBIOL, V140, P418, DOI 10.1016/j.vetmic.2009.01.039; Witte W, 2007, EMERG INFECT DIS, V13, P255, DOI 10.3201/eid1302.060924; Zhang KY, 2005, J CLIN MICROBIOL, V43, P5026, DOI 10.1128/JCM.43.10.5026-5033.2005	47	41	42	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162256	10.1371/journal.pone.0162256	http://dx.doi.org/10.1371/journal.pone.0162256			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603123	Green Published, gold			2022-12-26	WOS:000383255200050
J	Turner, RJ; Eikmans, M; Bajema, IM; Bruijn, JA; Baelde, HJ				Turner, R. J.; Eikmans, M.; Bajema, I. M.; Bruijn, J. A.; Baelde, H. J.			Stability and Species Specificity of Renal VEGF-A Splicing Patterns in Kidney Disease	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; DIABETIC-NEPHROPATHY; LUPUS NEPHRITIS; EXPRESSION; PODOCYTES; OVEREXPRESSION; GLOMERULI; INDUCTION; REJECTION; ISOFORMS	Vascular endothelial growth factor A (VEGF-A) is essential for maintaining the glomerular filtration barrier. Absolute renal levels of VEGF-A change in patients with diabetic nephropathy and inflammatory kidney diseases, but whether changes in the renal splicing patterns of VEGF-A play a role remains unclear. In this study, we investigated mRNA splicing patterns of pro-angiogenic isoforms of VEGF-A in glomeruli and whole kidney samples from human patients with kidney disease and from mouse models of kidney disease. Kidney biopsies were obtained from patients with acute rejection following kidney transplantation, patients with diabetic nephropathy, and control subjects. In addition, kidney samples were obtained from mice with lupus nephritis, mice with diabetes mellitus, and control mice. The relative expression of each VEGF-A splice variant was measured using RT-PCR followed by quantitative fragment analysis. The pattern of renal VEGF-A splice variants was unchanged in diabetic nephropathy and lupus nephritis and was stable throughout disease progression in acute transplant rejection and diabetic nephropathy; these results suggest renal VEGF-A splicing stability during kidney disease. The splicing patterns were species-specific; in the control human kidney samples, VEGF-A 121 was the dominant isoform, whereas VEGF-A 164 was the dominant isoform measured in the mouse kidney samples.	[Turner, R. J.; Bajema, I. M.; Bruijn, J. A.; Baelde, H. J.] Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands; [Eikmans, M.] Leiden Univ, Dept Immunohematol & Blood Transfus, Med Ctr, Leiden, Netherlands	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Turner, RJ (corresponding author), Leiden Univ, Dept Pathol, Med Ctr, Leiden, Netherlands.	r.j.turner@lumc.nl		baelde, Hans/0000-0002-1214-500X	Dutch National Science Academy (KNAW)	Dutch National Science Academy (KNAW)	We thank Pascal Bus for his help with the animal experiments. We thank the Dutch National Science Academy (KNAW) for awarding this study the Van Walree award for presentation on an international scientific conference.	Avihingsanon Y, 2009, KIDNEY INT, V75, P1340, DOI 10.1038/ki.2009.75; Baelde HJ, 2007, KIDNEY INT, V71, P637, DOI 10.1038/sj.ki.5002101; Bates DO, 2006, CLIN SCI, V110, P575, DOI 10.1042/CS20050292; Bertuccio C, 2011, J BIOL CHEM, V286, P39933, DOI 10.1074/jbc.M111.241620; Bortoloso E, 2004, EUR J ENDOCRINOL, V150, P799, DOI 10.1530/eje.0.1500799; Botermans JM, 2011, CLIN J AM SOC NEPHRO, V6, P1207, DOI 10.2215/CJN.07820910; BRUIJN JA, 1988, AM J PATHOL, V130, P639; Eremina V, 2003, J CLIN INVEST, V111, P707, DOI 10.1172/JCI200317423; Eremina V, 2008, NEW ENGL J MED, V358, P1129, DOI 10.1056/NEJMoa0707330; Esquibies AE, 2014, RESP RES, V15, DOI 10.1186/1465-9921-15-32; Ferrara N, 2001, AM J PHYSIOL-CELL PH, V280, pC1358, DOI 10.1152/ajpcell.2001.280.6.C1358; HOUCK KA, 1992, J BIOL CHEM, V267, P26031; Kamba T, 2006, AM J PHYSIOL-HEART C, V290, pH560, DOI 10.1152/ajpheart.00133.2005; Keyt BA, 1996, J BIOL CHEM, V271, P7788, DOI 10.1074/jbc.271.13.7788; Kitagawa N, 2006, DIABETES RES CLIN PR, V73, P150, DOI 10.1016/j.diabres.2005.12.008; LIKE AA, 1976, SCIENCE, V193, P415, DOI 10.1126/science.180605; Navarro C, 2002, LUPUS, V11, P21, DOI 10.1191/0961203302lu131oa; Oltean S, 2015, J AM SOC NEPHROL, V26, P1889, DOI 10.1681/ASN.2014040350; Racusen LC, 1999, KIDNEY INT, V55, P713, DOI 10.1046/j.1523-1755.1999.00299.x; Rintala SE, 2006, TRANSPLANT P, V38, P3236, DOI 10.1016/j.transproceed.2006.10.049; ROBERTS WG, 1995, J CELL SCI, V108, P2369; SIMON M, 1995, AM J PHYSIOL-RENAL, V268, pF240, DOI 10.1152/ajprenal.1995.268.2.F240; Thilo F, 2012, NEPHROL DIAL TRANSPL, V27, P921, DOI 10.1093/ndt/gfr457; TIMPL R, 1989, EUR J BIOCHEM, V180, P487, DOI 10.1111/j.1432-1033.1989.tb14673.x; Van Vliet AI, 2001, J PATHOL, V193, P256; Veron D, 2010, AM J PATHOL, V177, P2225, DOI 10.2353/ajpath.2010.091146; Veron D, 2010, KIDNEY INT, V77, P989, DOI 10.1038/ki.2010.64; Wang HH, 2015, J AM SOC NEPHROL, V26, P314, DOI 10.1681/ASN.2013090985; Wang LY, 2015, INT J BIOCHEM CELL B, V58, P17, DOI 10.1016/j.biocel.2014.10.030; Whittle C, 1999, CLIN SCI, V97, P303, DOI 10.1042/CS19990016; Woolard J, 2009, MICROCIRCULATION, V16, P572, DOI 10.1080/10739680902997333	31	5	6	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162166	10.1371/journal.pone.0162166	http://dx.doi.org/10.1371/journal.pone.0162166			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598902	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800043
J	Zhao, HY; Wang, DD; Chen, L; Liu, XY; Yan, H				Zhao, Hongya; Wang, Debby D.; Chen, Long; Liu, Xinyu; Yan, Hong			Identifying Multi-Dimensional Co-Clusters in Tensors Based on Hyperplane Detection in Singular Vector Spaces	PLOS ONE			English	Article							GENE-EXPRESSION DATA; GEOMETRIC BICLUSTERING ALGORITHM; VALUE DECOMPOSITION; MICROARRAY DATA; CAENORHABDITIS-ELEGANS; INTEGRATIVE ANALYSIS; MULTIPLE-SCLEROSIS; MATRIX	Co-clustering, often called biclustering for two-dimensional data, has found many applications, such as gene expression data analysis and text mining. Nowadays, a variety of multidimensional arrays (tensors) frequently occur in data analysis tasks, and co-clustering techniques play a key role in dealing with such datasets. Co-clusters represent coherent patterns and exhibit important properties along all the modes. Development of robust co-clustering techniques is important for the detection and analysis of these patterns. In this paper, a co-clustering method based on hyperplane detection in singular vector spaces (HDSVS) is proposed. Specifically in this method, higher-order singular value decomposition (HOSVD) transforms a tensor into a core part and a singular vector matrix along each mode, whose row vectors can be clustered by a linear grouping algorithm (LGA). Meanwhile, hyperplanar patterns are extracted and successfully supported the identification of multi-dimensional co-clusters. To validate HDSVS, a number of synthetic and biological tensors were adopted. The synthetic tensors attested a favorable performance of this algorithm on noisy or overlapped data. Experiments with gene expression data and lineage data of embryonic cells further verified the reliability of HDSVS to practical problems. Moreover, the detected co-clusters are well consistent with important genetic pathways and gene ontology annotations. Finally, a series of comparisons between HDSVS and state-of-the-art methods on synthetic tensors and a yeast gene expression tensor were implemented, verifying the robust and stable performance of our method.	[Zhao, Hongya] Shenzhen Polytech, Ind Ctr, Shenzhen, Peoples R China; [Wang, Debby D.; Chen, Long; Liu, Xinyu; Yan, Hong] City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China; [Wang, Debby D.] Caritas Inst Higher Educ, Hong Kong, Hong Kong, Peoples R China	ShenZhen Polytechnic; City University of Hong Kong	Chen, L (corresponding author), City Univ Hong Kong, Dept Elect Engn, Kowloon, Hong Kong, Peoples R China.	ee.chenlong@my.cityu.edu.hk			Hong Kong Research Grants Council (Project CityU) [11214814]; National Natural Science Funds of China [31100958]	Hong Kong Research Grants Council (Project CityU); National Natural Science Funds of China(National Natural Science Foundation of China (NSFC))	This work is supported by the Hong Kong Research Grants Council (Project CityU 11214814) and the National Natural Science Funds of China (Project No. 31100958).	An JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042431; [Anonymous], [No title captured]; Bao ZR, 2006, P NATL ACAD SCI USA, V103, P2707, DOI 10.1073/pnas.0511111103; Bergmann S, 2003, PHYS REV E, V67, DOI 10.1103/PhysRevE.67.031902; Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456; Busygin S, 2008, COMPUT OPER RES, V35, P2964, DOI 10.1016/j.cor.2007.01.005; Chen HC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071680; Cheng KO, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-210; Cheng Y, 2000, Proc Int Conf Intell Syst Mol Biol, V8, P93; Comon P, 2014, IEEE SIGNAL PROC MAG, V31, P44, DOI 10.1109/MSP.2014.2298533; Dhillon I. S., 2003, Journal of Machine Learning Research, V3, P1265, DOI 10.1162/153244303322753661; Dhillon I. S., 2001, KDD-2001. Proceedings of the Seventh ACM SIGKDD International Conference on Knowledge Discovery and Data Mining, P269, DOI 10.1145/502512.502550; Du Z, 2014, CELL, V156, P359, DOI 10.1016/j.cell.2013.11.046; Eren K, 2013, BRIEF BIOINFORM, V14, P279, DOI 10.1093/bib/bbs032; Gan XC, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-209; Garcia-Escudero LA, 2009, J R STAT SOC B, V71, P301, DOI 10.1111/j.1467-9868.2008.00682.x; HARTIGAN JA, 1972, J AM STAT ASSOC, V67, P123, DOI 10.2307/2284710; Hecker M, 2013, MOL NEUROBIOL, V48, P737, DOI 10.1007/s12035-013-8463-1; Hochreiter S, 2010, BIOINFORMATICS, V26, P1520, DOI 10.1093/bioinformatics/btq227; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang H., 2008, P 14 ACM SIGKDD INT, P327; Hundeshagen A, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-140; Kluger Y, 2003, GENOME RES, V13, P703, DOI 10.1101/gr.648603; Kolda TG, 2009, SIAM REV, V51, P455, DOI 10.1137/07070111X; Lam BSY, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.041906; Lenstra A.K., 1982, ANN DISCRETE MATH, V16, P201, DOI [10.1016/S0304-0208(08)72452-6, DOI 10.1016/S0304-0208(08)72452-6]; Madeira SC, 2004, IEEE ACM T COMPUT BI, V1, P24, DOI 10.1109/TCBB.2004.2; Moore JL, 2013, DEVELOPMENT, V140, P3266, DOI 10.1242/dev.096040; Oghabian A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090801; Omberg L, 2007, P NATL ACAD SCI USA, V104, P18371, DOI 10.1073/pnas.0709146104; Pascual-Montano A, 2006, IEEE T PATTERN ANAL, V28, P403, DOI 10.1109/TPAMI.2006.60; Pison G, 2006, COMPSTAT 2006: PROCEEDINGS IN COMPUTATIONAL STATISTICS, P43, DOI 10.1007/978-3-7908-1709-6_4; Ponnapalli SP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028072; Pontes B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0115497; Prelic A, 2006, BIOINFORMATICS, V22, P1122, DOI 10.1093/bioinformatics/btl060; Shao JF, 2013, J BIOL CHEM, V288, P33411, DOI 10.1074/jbc.M113.487975; Sill M, 2011, BIOINFORMATICS, V27, P2089, DOI 10.1093/bioinformatics/btr322; Van Aelst S, 2006, COMPUT STAT DATA AN, V50, P1287, DOI 10.1016/j.csda.2004.11.011; Wang DZ, 2013, J THEOR BIOL, V317, P200, DOI 10.1016/j.jtbi.2012.10.012; Weiland S, 2010, IEEE T SIGNAL PROCES, V58, P1171, DOI 10.1109/TSP.2009.2034308; Wu T., 2016, ARXIV160300395; Xu R, 2005, IEEE T NEURAL NETWOR, V16, P645, DOI 10.1109/TNN.2005.845141; Yang WH, 2011, IEEE T KNOWL DATA EN, V23, P568, DOI 10.1109/TKDE.2010.150; Zhao HY, 2008, J THEOR BIOL, V251, P264, DOI 10.1016/j.jtbi.2007.11.030; Zhao HY, 2012, CURR BIOINFORM, V7, P43, DOI 10.2174/157489312799304413; Zhao HY, 2009, PATTERN RECOGN, V42, P2578, DOI 10.1016/j.patcog.2009.03.016; Zhao L, 2005, P 2005 ACM SIGMOD IN, P694	50	9	9	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162293	10.1371/journal.pone.0162293	http://dx.doi.org/10.1371/journal.pone.0162293			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598575	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800051
J	Ando, Y; Oku, T; Tsuji, T				Ando, Yusuke; Oku, Teruaki; Tsuji, Tsutomu			Platelet Supernatant Suppresses LPS-Induced Nitric Oxide Production from Macrophages Accompanied by Inhibition of NF-kappa B Signaling and Increased Arginase-1 Expression	PLOS ONE			English	Article							IN-VIVO; SYNTHASE; METABOLISM; INDUCTION; INJURY; CYTOKINES; PATTERN; ROLES	We previously reported that mouse bone marrow-derived macrophages (BMDMs) that had been co-cultured with platelets exhibited lower susceptibility to bacterial lipopolysaccharide (LPS) and produced lower levels of nitric oxide (NO) and inflammatory cytokines including TNF-alpha and IL-6. The suppression of macrophage responses was mediated, at least in part, by platelet supernatant. In the present study, we assessed phenotypic changes of BMDMs induced by incubation with the supernatant from thrombin-activated platelets (PLT-sup) and found that BMDMs cultured with PLT-sup (PLT-BMDMs) expressed a lower level of inducible NO synthase (iNOS) and a higher level of arginase-1, both of which are involved in the L-arginine metabolism, upon stimulation with LPS or zymosan. We also examined possible modulation of the NF-kappa B signaling pathway and observed suppression of I kappa B alpha phosphorylation and a decrease of NF-kappa B p65 expression in LPS-stimulated PLT-BMDMs. These results suggest that PLT-sup suppresses inflammatory responses of BMDMs via negative regulation of NF-kappa B signaling leading to lowered expression of iNOS and enhanced L-arginine catabolism by arginase-1.	[Ando, Yusuke; Oku, Teruaki; Tsuji, Tsutomu] Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Tokyo, Japan	Hoshi University	Tsuji, T (corresponding author), Hoshi Univ, Sch Pharm & Pharmaceut Sci, Dept Microbiol, Tokyo, Japan.	tsuji@hoshi.ac.jp		Ando, Yukio/0000-0001-7115-9105	Ministry of Education, Culture, Sports, Science and Technology of Japan; Japan Agency for Medical Research and Development (AMED); Hoshi University Otani Research Grants	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Hoshi University Otani Research Grants	This work was supported in part by the Ministry of Education, Culture, Sports, Science and Technology of Japan, by Japan Agency for Medical Research and Development (AMED), and by Hoshi University Otani Research Grants.	Akaike T, 2000, IMMUNOLOGY, V101, P300, DOI 10.1046/j.1365-2567.2000.00142.x; Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Ando Y, 2016, PLATELETS, V27, P344, DOI 10.3109/09537104.2015.1103369; Ash DE, 2004, J NUTR, V134, p2760S, DOI 10.1093/jn/134.10.2760S; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bronte V, 2005, NAT REV IMMUNOL, V5, P641, DOI 10.1038/nri1668; Chandra S, 2012, BRIT J PHARMACOL, V165, P506, DOI 10.1111/j.1476-5381.2011.01584.x; Chang CP, 2013, CELL DEATH DIFFER, V20, P515, DOI 10.1038/cdd.2012.146; Daley JM, 2010, J LEUKOCYTE BIOL, V87, P59, DOI 10.1189/jlb.0409236; El Kasmi KC, 2008, NAT IMMUNOL, V9, P1399, DOI 10.1038/ni.1671; Gallardo-Soler A, 2008, MOL ENDOCRINOL, V22, P1394, DOI 10.1210/me.2007-0525; Garcia-Bonilla L, 2014, J IMMUNOL, V193, P2531, DOI 10.4049/jimmunol.1400918; Gleissner CA, 2008, ARTERIOSCL THROM VAS, V28, P1920, DOI 10.1161/ATVBAHA.108.169417; Gobert AP, 2000, INFECT IMMUN, V68, P4653, DOI 10.1128/IAI.68.8.4653-4657.2000; Griscavage JM, 1996, P NATL ACAD SCI USA, V93, P3308, DOI 10.1073/pnas.93.8.3308; He LZ, 2013, AM J PATHOL, V182, P2407, DOI 10.1016/j.ajpath.2013.02.032; Heemskerk S, 2009, NAT REV NEPHROL, V5, P629, DOI 10.1038/nrneph.2009.155; Hesse M, 2001, J IMMUNOL, V167, P6533, DOI 10.4049/jimmunol.167.11.6533; Liu VWT, 2008, CARDIOVASC RES, V77, P19, DOI 10.1016/j.cardiores.2007.06.024; MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323; Martinez F.O., 2014, F1000PRIME REP, V6, DOI DOI 10.12703/P6-13; Morris SM, 2009, BRIT J PHARMACOL, V157, P922, DOI 10.1111/j.1476-5381.2009.00278.x; Morris SM, 2002, ANNU REV NUTR, V22, P87, DOI 10.1146/annurev.nutr.22.110801.140547; Munder M, 2006, BLOOD, V108, P1627, DOI 10.1182/blood-2006-11-010389; Munder M, 2009, BRIT J PHARMACOL, V158, P638, DOI 10.1111/j.1476-5381.2009.00291.x; Muraille E, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00603; Numata M, 1998, J IMMUNOL, V160, P3031; Oeckinghaus A, 2011, NAT IMMUNOL, V12, P695, DOI 10.1038/ni.2065; Oku T, 2005, BIOCHEM J, V387, P325, DOI 10.1042/BJ20041020; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; Park BS, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.97; Pauleau AL, 2004, J IMMUNOL, V172, P7565, DOI 10.4049/jimmunol.172.12.7565; Pesce JT, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000371; Qualls JE, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000955; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Roszer T, 2015, MEDIAT INFLAMM, V2015, DOI 10.1155/2015/816460; Sass G, 2001, J CLIN INVEST, V107, P439, DOI 10.1172/JCI10613; Schofield L, 2005, NAT REV IMMUNOL, V5, P722, DOI 10.1038/nri1686; Schulte W, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/165974; Sonoki T, 1997, J BIOL CHEM, V272, P3689, DOI 10.1074/jbc.272.6.3689; Titheradge MA, 1999, BBA-BIOENERGETICS, V1411, P437, DOI 10.1016/S0005-2728(99)00031-6; Vincent JL, 2000, AM J RESP CRIT CARE, V161, P1781, DOI 10.1164/ajrccm.161.6.9812004; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Xiang BG, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3657; XIE QW, 1994, J BIOL CHEM, V269, P4705; Xu WM, 2002, CELL RES, V12, P311, DOI 10.1038/sj.cr.7290133	47	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162208	10.1371/journal.pone.0162208	http://dx.doi.org/10.1371/journal.pone.0162208			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588757	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800036
J	May, M; Relich, RF				May, Meghan; Relich, Ryan F.			A Comprehensive Systems Biology Approach to Studying Zika Virus	PLOS ONE			English	Article							TRANSMISSION; INFECTION; SERVER; SELECTON	Zika virus (ZIKV) is responsible for an ongoing and intensifying epidemic in the Western Hemisphere. We examined the complete predicted proteomes, glycomes, and selectomes of 33 ZIKV strains representing temporally diverse members of the African lineage, the Asian lineage, and the current outbreak in the Americas. Derivation of the complete selectome is an 'omics' approach to identify distinct evolutionary pressures acting on different features of an organism. Employment of the M8 model did not show evidence of global diversifying selection acting on the ZIKV polyprotein; however, a mixed effect model of evolution showed strong evidence (P<0.05) for episodic diversifying selection acting on specific sites. Single nucleotide polymorphisms (SNPs) were predictably frequent across strains relative to the derived consensus sequence. None of the 9 published detection procedures utilize targets that share 100% identity across the 33 strains examined, indicating that ZIKV escape from molecular detection is predictable. The predicted O-linked glycome showed marked diversity across strains; however, the N-linked glycome was highly stable. All Asian and American strains examined were predicted to include glycosylation of E protein ASN(154), a modification proposed to mediate neurotropism, whereas the modification was not predicted for African strains. SNP diversity, episodic diversifying selection, and differential glycosylation, particularly of ASN(154), may have major biological implications for ZIKV disease. Taken together, the systems biology perspective of ZIKV indicates: a.) The recently emergent Asian/American N-glycotype is mediating the new and emerging neuropathogenic potential of ZIKV; and b.) further divergence at specific sites is predictable as endemnicity is established in the Americas.	[May, Meghan] Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA; [May, Meghan] Seacoast Biomed Sci Inst, York, ME 03911 USA; [Relich, Ryan F.] Indiana Univ Sch Med, Dept Pathol & Lab Med, Indianapolis, IN 46202 USA	University of New England - Maine; Indiana University System; Indiana University Bloomington	May, M (corresponding author), Univ New England, Coll Osteopath Med, Dept Biomed Sci, Biddeford, ME 04005 USA.; May, M (corresponding author), Seacoast Biomed Sci Inst, York, ME 03911 USA.	mmay3@une.edu			sbsi-innovation-fund/parny	sbsi-innovation-fund/parny	This work was supported by the following source of funding: http://www.seacoastbiomedicalscience.org/#!sbsi-innovation-fund/parny (MM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2016, BMJ, V353, pi3182, DOI 10.1136/bmj.i3182; Arzuza-Ortega L, 2016, EMERG INFECT DIS, V22, P925, DOI 10.3201/eid2205.151934; Ayres CFJ, 2016, LANCET, V16; Balm MND, 2012, J MED VIROL, V84, P1501, DOI 10.1002/jmv.23241; Baronti C, 2014, GENOME ANNOUNCEMENTS, V2, DOI 10.1128/genomeA.00500-14; Beasley DWC, 2005, CURR MOL MED, V5, P835, DOI 10.2174/156652405774962272; Beasley DWC, 2005, J VIROL, V79, P8339, DOI 10.1128/JVI.79.13.8339-8347.2005; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Berthet N, 2014, VECTOR-BORNE ZOONOT, V14, P862, DOI 10.1089/vbz.2014.1607; Besnard M, 2014, Euro Surveill, V19; Brasil P, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004636; Brasil P, 2016, LANCET, V387, P1482, DOI 10.1016/S0140-6736(16)30058-7; BUCKLEY A, 1988, J GEN VIROL, V69, P1913, DOI 10.1099/0022-1317-69-8-1913; Cauchemez S, 2016, LANCET, V387, P2125, DOI 10.1016/S0140-6736(16)00651-6; Chauhan JS, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0067008, 10.1371/journal.pone.0080000]; Cunha MS, 2016, GENOME ANNOUNCEMENTS, V4, DOI 10.1128/genomeA.00032-16; Deckard DT, 2016, MMWR-MORBID MORTAL W, V65, P372, DOI 10.15585/mmwr.mm6514a3; DICK GWA, 1952, T ROY SOC TROP MED H, V46, P509, DOI 10.1016/0035-9203(52)90042-4; Dirlikov E, 2016, MMWR MORB MORTAL WKL; Doron-Faigenboim A, 2005, BIOINFORMATICS, V21, P2101, DOI 10.1093/bioinformatics/bti259; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Enfissi A, 2016, LANCET, V387, P227, DOI 10.1016/S0140-6736(16)00003-9; Faria NR, 2016, SCIENCE, V352, P345, DOI 10.1126/science.aaf5036; Favoretto S, 2016, 1 DETECTION IN PRESS; Faye O, 2008, J CLIN VIROL, V43, P96, DOI 10.1016/j.jcv.2008.05.005; Faye O, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002636; Faye O, 2013, VIROL J, V10, DOI 10.1186/1743-422X-10-311; Fonseca K, 2014, AM J TROP MED HYG, V91, P1035, DOI 10.4269/ajtmh.14-0151; Foy BD, 2011, EMERG INFECT DIS, V17, P880, DOI 10.3201/eid1705.101939; Franchini M, 2016, BLOOD TRANSFUS-ITALY, V14, P93, DOI 10.2450/2015.0187-15; Gardner LM, 2016, LANCET INFECT DIS; Gasteiger E, 2003, NUCLEIC ACIDS RES, V31, P3784, DOI 10.1093/nar/gkg563; Grard G, 2014, PLOS NEGLECT TROP D, V8, DOI 10.1371/journal.pntd.0002681; Grard G, 2010, J GEN VIROL, V91, P87, DOI 10.1099/vir.0.014506-0; Haddow AD, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001477; Hamel R, 2015, J VIROL, V89, P8880, DOI 10.1128/JVI.00354-15; Hills SL, 2016, MMWR-MORBID MORTAL W, V65, P215, DOI 10.15585/mmwr.mm6508e2; Kuno G, 2007, ARCH VIROL, V152, P687, DOI 10.1007/s00705-006-0903-z; Lanciotti RS, 2008, EMERG INFECT DIS, V14, P1232, DOI 10.3201/eid1408.080287; Lanciotti RS, 2016, EMERG INFECT DIS, V22, P933, DOI 10.3201/eid2205.160065; Lednicky J, 2016, PLOS NEGLECT TROP D, V10, DOI 10.1371/journal.pntd.0004687; MACNAMARA FN, 1954, T ROY SOC TROP MED H, V48, P139, DOI 10.1016/0035-9203(54)90006-1; May M, 2008, MICROB PATHOGENESIS, V45, P38, DOI 10.1016/j.micpath.2008.02.002; Mlakar J, 2016, NEW ENGL J MED, V374, P951, DOI 10.1056/NEJMoa1600651; Murrell B, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002764; Musso D, 2014, EUROSURVEILLANCE, V19, P6, DOI 10.2807/1560-7917.ES2014.19.14.20761; Musso D, 2016, CLIN MICROBIOL REV, V29, P487, DOI 10.1128/CMR.00072-15; Olabode AS, 2015, VIROLOGY, V482, P202, DOI 10.1016/j.virol.2015.03.029; Ossowski S, 2010, SCIENCE, V327, P92, DOI 10.1126/science.1180677; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; Pyke Alyssa T, 2014, PLoS Curr, V6, DOI 10.1371/currents.outbreaks.4635a54dbffba2156fb2fd76dc49f65e; Rasmussen SA, 2016, NEW ENGL J MED, V374, P1981, DOI 10.1056/NEJMsr1604338; Robinson O, 2016, MOL BIOL EVOLUTION; Roze B, 2016, EUROSURVEILLANCE, V21, P8, DOI 10.2807/1560-7917.ES.2016.21.9.30154; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sirohi D, 2016, SCIENCE, V352, P467, DOI 10.1126/science.aaf5316; Stern A, 2007, NUCLEIC ACIDS RES, V35, pW506, DOI 10.1093/nar/gkm382; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tang HL, 2016, CELL STEM CELL, V18, P587, DOI 10.1016/j.stem.2016.02.016; Tappe D, 2014, EUROSURVEILLANCE, V19, P12, DOI 10.2807/1560-7917.ES2014.19.4.20685; Thiery G, 2016, INTENSIVE CARE MED; Waggoner JJ, 2016, J CLIN MICROBIOL, V54, P860, DOI 10.1128/JCM.00279-16; WOLFE MS, 1982, LANCET, V2, P1306; Wong PSJ, 2013, PLOS NEGLECT TROP D, V7, DOI 10.1371/journal.pntd.0002348; World Health Organization, ZIK VIR FACT SHEET; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Zanluca C, 2015, MEM I OSWALDO CRUZ, V110, P569, DOI 10.1590/0074-02760150192; Zhu Z, 2016, EMERG MICROBES INFEC, V5, DOI 10.1038/emi.2016.48	68	10	11	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161355	10.1371/journal.pone.0161355	http://dx.doi.org/10.1371/journal.pone.0161355			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584813	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600023
J	Wikenius, E; Moe, V; Kjellevold, M; Smith, L; Lyle, R; Waagbo, R; Page, CM; Myhre, AM				Wikenius, Ellen; Moe, Vibeke; Kjellevold, Marian; Smith, Lars; Lyle, Robert; Waagbo, Rune; Page, Christian Magnus; Myhre, Anne Margrethe			The Association between Hair Cortisol and Self-Reported Symptoms of Depression in Pregnant Women	PLOS ONE			English	Article							EDINBURGH POSTNATAL DEPRESSION; MENTAL-HEALTH; MATERNAL CORTISOL; YOUNG-ADULTS; STRESS; SCALE; EXPOSURE; DISEASE; DETERMINANTS; VALIDATION	Depression has been linked to an imbalance in cortisol. Until recently, cortisol has been studied by measuring concentrations at single time points in blood or saliva samples. Cortisol concentrations vary with circadian rhythm and experiences, from time point to time point. The measurement of hair cortisol concentration (HCC) is a new method of accessing mean, long-term cortisol concentrations. Recent studies show positive associations between depression and HCC, and prenatal maternal cortisol is thought to influence the developing fetus. We therefore examined the association between HCC and self-reported symptoms of depression in second trimester pregnant women. Participants were 181 women, recruited between September 2011 and October 2013 to the Little-in-Norway (LiN)-study. These women answered the Edinburgh Postnatal Depression Rating Scale (EPDS) on self-reported symptoms of depression, and one cm maternal scalp hair was collected and analyzed for cortisol concentrations. Multiple regression analyses did not show depressive symptoms as a predictor for HCC in our selection of pregnant women, while gestational age was significantly related. In conclusion, our study indicated that symptoms of depression during pregnancy did not predict HCC, but further studies of clinically depressed, pregnant women using gestational age as an adjustment variable are warranted.	[Wikenius, Ellen; Page, Christian Magnus; Myhre, Anne Margrethe] Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway; [Moe, Vibeke; Smith, Lars] Univ Oslo, Fac Social Sci, Dept Psychol, Oslo, Norway; [Moe, Vibeke] Ctr Child & Adolescent Mental Hlth Eastern & Sout, Oslo, Norway; [Kjellevold, Marian; Waagbo, Rune] Natl Inst Nutr & Seafood Res NIFES, Bergen, Norway; [Lyle, Robert] Univ Oslo, Sch Pharm, Fac Math & Nat Sci, Oslo, Norway; [Lyle, Robert] Oslo Univ Hosp, Dept Med Genet, Oslo, Norway; [Myhre, Anne Margrethe] Oslo Univ Hosp, Child & Adolescent Mental Hlth Res Unit, Oslo, Norway	University of Oslo; University of Oslo; University of Oslo; University of Oslo; University of Oslo	Wikenius, E (corresponding author), Univ Oslo, Fac Med, Inst Clin Med, Oslo, Norway.	ellen.wikenius@medisin.uio.no	Waagbø, Rune/M-4567-2019; Kjellevold, Marian/Q-6334-2019; Kjellevold, Marian/C-2973-2012; Page, Christian/J-7129-2019	Kjellevold, Marian/0000-0001-7070-5784; Kjellevold, Marian/0000-0001-7070-5784; Page, Christian/0000-0002-1897-3666; Waagbo, Rune/0000-0001-6075-3221; Moe, Vibeke/0000-0002-8436-8341	The Research Council of Norway; Child and Adolescent Mental Health Eastern and Southern Norway (RUBP)	The Research Council of Norway(Research Council of Norway); Child and Adolescent Mental Health Eastern and Southern Norway (RUBP)	The participants of this subsample came from the Little in Norway study, which was sponsored by The Research Council of Norway. Child and Adolescent Mental Health Eastern and Southern Norway (RUBP) funded the hair cortisol analyses.	Barker DJP, 2003, EUR J EPIDEMIOL, V18, P733, DOI 10.1023/A:1025388901248; Bennett HA, 2004, OBSTET GYNECOL, V103, P698, DOI 10.1097/01.AOG.0000116689.75396.5f; Berle JO, 2003, J AFFECT DISORDERS, V76, P151, DOI 10.1016/S0165-0327(02)00082-4; Beydoun H, 2008, PAEDIATR PERINAT EP, V22, P438, DOI 10.1111/j.1365-3016.2008.00951.x; Boumba VA, 2006, INT J TOXICOL, V25, P143, DOI 10.1080/10915810600683028; Braig S, 2015, PSYCHONEUROENDOCRINO, V52, P289, DOI 10.1016/j.psyneuen.2014.12.006; COX JL, 1987, BRIT J PSYCHIAT, V150, P782, DOI 10.1192/bjp.150.6.782; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; Davis EP, 2010, CHILD DEV, V81, P131, DOI 10.1111/j.1467-8624.2009.01385.x; Dettenborn L, 2010, PSYCHONEUROENDOCRINO, V35, P1404, DOI 10.1016/j.psyneuen.2010.04.006; Dettenborn L, 2012, STRESS, V15, P348, DOI [10.3109/10253890.2011.619239, 10.3109/10253890.2012.654479]; Dowlati Y, 2010, NEUROPSYCH DIS TREAT, V6, P393; Gerber M, 2013, STRESS, V16, P593, DOI 10.3109/10253890.2013.823599; Gerber M, 2013, NEUROPSYCHOBIOLOGY, V68, P100, DOI 10.1159/000351735; Gibson J, 2009, ACTA PSYCHIAT SCAND, V119, P350, DOI 10.1111/j.1600-0447.2009.01363.x; Gow R, 2010, FORENSIC SCI INT, V196, P32, DOI 10.1016/j.forsciint.2009.12.040; Hamel AF, 2011, CLIN CHIM ACTA, V412, P382, DOI 10.1016/j.cca.2010.10.019; Vives AH, 2015, J PSYCHIATR RES, V70, P38, DOI [10.1016/j.psychires.2015.08.007, 10.1016/j.jpsychires.2015.08.007]; Kalra S, 2007, CLIN INVEST MED, V30, pE103, DOI 10.25011/cim.v30i2.986; Karlen J, 2011, BMC CLIN PATHOL, V11, DOI 10.1186/1472-6890-11-12; Kirschbaum C, 2009, PSYCHONEUROENDOCRINO, V34, P32, DOI 10.1016/j.psyneuen.2008.08.024; LeWinn KZ, 2009, INT J EPIDEMIOL, V38, P1700, DOI 10.1093/ije/dyp200; Manenschijn L, 2011, STEROIDS, V76, P1032, DOI 10.1016/j.steroids.2011.04.005; McKlveen JM, 2013, BIOL PSYCHIAT, V74, P672, DOI 10.1016/j.biopsych.2013.03.024; Meyer JS, 2012, ENDOCRINOLOGY, V153, P4120, DOI 10.1210/en.2012-1226; MURRAY L, 1990, BRIT J PSYCHIAT, V157, P288, DOI 10.1192/bjp.157.2.288; Pragst F, 2006, CLIN CHIM ACTA, V370, P17, DOI 10.1016/j.cca.2006.02.019; Raikkonen K, 2011, STRESS, V14, P590, DOI 10.3109/10253890.2011.602147; Raul JS, 2004, CLIN BIOCHEM, V37, P1105, DOI 10.1016/j.clinbiochem.2004.02.010; SACHAR EJ, 1967, ARCH GEN PSYCHIAT, V17, P554; Skjothaug T, 2015, INFANT MENT HEALTH J, V36, P104, DOI 10.1002/imhj.21485; Skoluda N, 2012, PSYCHONEUROENDOCRINO, V37, P611, DOI 10.1016/j.psyneuen.2011.09.001; Spijker J, 2002, BRIT J PSYCHIAT, V181, P208, DOI 10.1192/bjp.181.3.208; Stalder T, 2014, PSYCHONEUROENDOCRINO, V47, P26, DOI 10.1016/j.psyneuen.2014.04.021; StatisticsNorway, 2014, BEF UTD; Staufenbiel SM, 2015, PSYCHONEUROENDOCRINO, V60, P182, DOI 10.1016/j.psyneuen.2015.06.011; Staufenbiel SM, 2015, J CLIN ENDOCR METAB, V100, P2456, DOI 10.1210/jc.2014-4328; Staufenbiel SM, 2013, PSYCHONEUROENDOCRINO, V38, P1220, DOI 10.1016/j.psyneuen.2012.11.015; Van Uum SHM, 2008, STRESS, V11, P483, DOI 10.1080/10253890801887388; Wei JX, 2015, J AFFECT DISORDERS, V175, P299, DOI 10.1016/j.jad.2015.01.023; Weinstock M, 2008, NEUROSCI BIOBEHAV R, V32, P1073, DOI 10.1016/j.neubiorev.2008.03.002; Wells S, 2014, STRESS, V17, P334, DOI 10.3109/10253890.2014.930432; Wennig R, 2000, FORENSIC SCI INT, V107, P5, DOI 10.1016/S0379-0738(99)00146-2; Wosu AC, 2013, ANN EPIDEMIOL, V23, P797, DOI 10.1016/j.annepidem.2013.09.006; Young EA, 2001, NEUROPSYCHOPHARMACOL, V25, P267, DOI 10.1016/S0893-133X(00)00236-0	45	19	19	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161804	10.1371/journal.pone.0161804	http://dx.doi.org/10.1371/journal.pone.0161804			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV3WN	27584584	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600061
J	Moreno, E; Plata, C; Rodriguez-Gama, A; Argaiz, ER; Vazquez, N; Leyva-Rios, K; Islas, L; Cutler, C; Pacheco-Alvarez, D; Mercado, A; Carino-Cortes, R; Castaneda-Bueno, M; Gamba, G				Moreno, Erika; Plata, Consuelo; Rodriguez-Gama, Alejandro; Argaiz, Eduardo R.; Vazquez, Norma; Leyva-Rios, Karla; Islas, Leon; Cutler, Christopher; Pacheco-Alvarez, Diana; Mercado, Adriana; Carino-Cortes, Raquel; Castaneda-Bueno, Maria; Gamba, Gerardo			The European Eel NCC Gene Encodes a Thiazide-resistant Na-Cl Cotransporter	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cardiovascular disease; renal physiology; sodium transport; structure-function; transporter	CATION-CHLORIDE-COTRANSPORTERS; SENSITIVE NA+; INTRACELLULAR CHLORIDE; MUTATIONS; HYPERTENSION; KINASES; FAMILY; SPAK; PATHOPHYSIOLOGY; TRANSPORTERS	The thiazide-sensitive Na-Cl cotransporter (NCC) is the major pathway for salt reabsorption in the mammalian distal convoluted tubule. NCC plays a key role in the regulation of blood pressure. Its inhibition with thiazides constitutes the primary baseline therapy for arterial hypertension. However, the thiazide-binding site in NCC is unknown. Mammals have only one gene encoding for NCC. The eel, however, contains a duplicate gene. NCC is an ortholog of mammalian NCC and is expressed in the kidney. NCC is present in the apical membrane of the rectum. Here we cloned and functionally characterized NCC from the European eel. The cRNA encodes a 1043-amino acid membrane protein that, when expressed in Xenopus oocytes, functions as an Na-Cl cotransporter with two major characteristics, making it different from other known NCCs. First, eel NCC is resistant to thiazides. Single-point mutagenesis supports that the absence of thiazide inhibition is, at least in part, due to the substitution of a conserved serine for a cysteine at position 379. Second, NCC is not activated by low-chloride hypotonic stress, although the unique Ste20-related proline alanine-rich kinase (SPAK) binding site in the amino-terminal domain is conserved. Thus, NCC exhibits significant functional differences from NCCs that could be helpful in defining several aspects of the structure-function relationship of this important cotransporter.	[Moreno, Erika; Plata, Consuelo; Argaiz, Eduardo R.; Vazquez, Norma; Castaneda-Bueno, Maria; Gamba, Gerardo] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Dept Nephrol & Mineral Metab, Mexico City 14080, DF, Mexico; [Rodriguez-Gama, Alejandro; Argaiz, Eduardo R.; Vazquez, Norma; Leyva-Rios, Karla; Gamba, Gerardo] Univ Nacl Autonoma Mexico, Mol Physiol Unit, Inst Invest Biomed, Mexico City 14080, DF, Mexico; [Islas, Leon] Univ Nacl Autonoma Mexico, Fac Med, Dept Physiol, Mexico City 04510, DF, Mexico; [Cutler, Christopher] Georgia Southern Univ, Dept Biol, Statesboro, GA 30460 USA; [Pacheco-Alvarez, Diana] Univ Panamer, Escuela Med, Mexico City 03920, DF, Mexico; [Mercado, Adriana] Inst Nacl Cardiol Ignacio Chavez, Dept Nephrol, Mexico City 14080, DF, Mexico; [Carino-Cortes, Raquel] Univ Autonoma Estado Hidalgo, Sch Med, Pachuca 42034, Hidalgo, Mexico	Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran - Mexico; Universidad Nacional Autonoma de Mexico; Universidad Nacional Autonoma de Mexico; University System of Georgia; Georgia Southern University; Universidad Panamericana - Ciudad de Mexico; National Institute of Cardiology - Mexico; Universidad Autonoma del Estado de Hidalgo	Gamba, G (corresponding author), Vasco de Quiroga 15, Mexico City 14080, DF, Mexico.	gamba@biomedicas.unam.mx	Plata, Consuelo/M-6461-2019; Mercado, Adriana/AAR-6143-2021; CASTANEDA-BUENO, MARIA/GYR-1202-2022; Cariño-Cortes, Raquel/E-5302-2018; Gamba, Gerardo/P-4873-2016; Plata, Consuelo/M-4482-2015	Mercado, Adriana/0000-0002-6881-0160; Argaiz, Eduardo/0000-0002-5542-6098; Carino, Raquel/0000-0003-4776-3534; Pacheco-Alvarez, Diana/0000-0001-5454-9267; Rodriguez Gama, Alejandro/0000-0003-3257-5549; Gamba, Gerardo/0000-0002-4378-9043; Plata, Consuelo/0000-0001-9340-8950; Castaneda-Bueno, Maria/0000-0002-5801-3504; Moreno Martinez, Reyna Erika/0000-0002-7563-0379	Consejo Nacional de Ciencia y Tecnologia (CONACYT) [222918, 165815, 188712]; National Science Foundation [NSF-IOS 0844818]	Consejo Nacional de Ciencia y Tecnologia (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); National Science Foundation(National Science Foundation (NSF))	This work was supported by the Consejo Nacional de Ciencia y Tecnologia (CONACYT) Grants 222918 (to E. M.) and 165815 and 188712 (to G. G.) and National Science Foundation Grant NSF-IOS 0844818 (to C. C.). The authors declare that they have no conflicts of interest with the contents of this article.	Alper SL, 2013, MOL ASPECTS MED, V34, P494, DOI 10.1016/j.mam.2012.07.009; Appel LJ, 2002, JAMA-J AM MED ASSOC, V288, P3039, DOI 10.1001/jama.288.23.3039; Bazua-Valenti S, 2015, J AM SOC NEPHROL, V26, P1781, DOI 10.1681/ASN.2014050470; Boyden LM, 2012, NATURE, V482, P98, DOI 10.1038/nature10814; Castaneda-Bueno M, 2010, AM J PHYSIOL-RENAL, V299, pF1111, DOI 10.1152/ajprenal.00412.2010; Chavez-Canales M, 2014, HYPERTENSION, V64, P1047, DOI 10.1161/HYPERTENSIONAHA.114.04036; Coady MJ, 2010, AM J PHYSIOL-CELL PH, V298, pC124, DOI 10.1152/ajpcell.00220.2009; Cutler CP, 2008, COMP BIOCHEM PHYS B, V149, P63, DOI 10.1016/j.cbpb.2007.08.007; de Jong JC, 2003, J BIOL CHEM, V278, P24302, DOI 10.1074/jbc.M303101200; DUMONT JN, 1972, J MORPHOL, V136, P153, DOI 10.1002/jmor.1051360203; GAMBA G, 1993, P NATL ACAD SCI USA, V90, P2749, DOI 10.1073/pnas.90.7.2749; Gamba G, 2005, PHYSIOL REV, V85, P423, DOI 10.1152/physrev.00011.2004; GAMBA G, 1994, J BIOL CHEM, V269, P17713; Gamba G, 2009, AM J PHYSIOL-RENAL, V297, pF838, DOI 10.1152/ajprenal.00159.2009; Hoover RS, 2003, J AM SOC NEPHROL, V14, P271, DOI 10.1097/01.ASN.0000043903.93452.D0; James PA, 2014, JAMA-J AM MED ASSOC, V311, P1809, DOI 10.1001/jama.2013.284427; Lagnaz D, 2014, AM J PHYSIOL-RENAL, V307, pF275, DOI 10.1152/ajprenal.00574.2013; Louis-Dit-Picard H, 2012, NAT GENET, V44, P456, DOI 10.1038/ng.2218; Mercado A, 2000, J BIOL CHEM, V275, P30326, DOI 10.1074/jbc.M003112200; Moes AD, 2014, PFLUG ARCH EUR J PHY, V466, P107, DOI 10.1007/s00424-013-1407-9; Monroy A, 2000, AM J PHYSIOL-RENAL, V279, pF161, DOI 10.1152/ajprenal.2000.279.1.F161; Moreno E, 2006, J BIOL CHEM, V281, P17266, DOI 10.1074/jbc.M602614200; Mutig K, 2011, J BIOL CHEM, V286, P30200, DOI 10.1074/jbc.M111.222968; Arroyo JP, 2013, MOL ASPECTS MED, V34, P288, DOI 10.1016/j.mam.2012.05.002; Pacheco-Alvarez D, 2006, J BIOL CHEM, V281, P28755, DOI 10.1074/jbc.M603773200; Piala AT, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005050; Plata C, 2001, AM J PHYSIOL-RENAL, V280, pF574, DOI 10.1152/ajprenal.2001.280.4.F574; Ponce-Coria J, 2008, P NATL ACAD SCI USA, V105, P8458, DOI 10.1073/pnas.0802966105; Richardson C, 2008, J CELL SCI, V121, P675, DOI 10.1242/jcs.025312; Sabath E, 2004, AM J PHYSIOL-RENAL, V287, pF195, DOI 10.1152/ajprenal.00044.2004; Scholl UI, 2009, P NATL ACAD SCI USA, V106, P5842, DOI 10.1073/pnas.0901749106; Simon DB, 1996, NAT GENET, V12, P24, DOI 10.1038/ng0196-24; Tovar-Palacio C, 2004, AM J PHYSIOL-RENAL, V287, pF570, DOI 10.1152/ajprenal.00124.2004; Vazquez N, 2002, AM J PHYSIOL-RENAL, V282, pF599, DOI 10.1152/ajprenal.00284.2001; Wang YF, 2009, AM J PHYSIOL-REG I, V296, pR1650, DOI 10.1152/ajpregu.00119.2009; Watanabe S, 2011, COMP BIOCHEM PHYS A, V159, P427, DOI 10.1016/j.cbpa.2011.04.009; Welker P, 2008, AM J PHYSIOL-RENAL, V295, pF789, DOI 10.1152/ajprenal.90227.2008; Wilson FH, 2001, SCIENCE, V293, P1107, DOI 10.1126/science.1062844; Xu J, 2005, AM J PHYSIOL-CELL PH, V289, pC493, DOI 10.1152/ajpcell.00030.2005	39	6	6	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22472	22481		10.1074/jbc.M116.742783	http://dx.doi.org/10.1074/jbc.M116.742783			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587391	Green Published, hybrid			2022-12-26	WOS:000386760600010
J	Bezawork-Geleta, A; Dong, LF; Rohlena, J; Neuzil, J				Bezawork-Geleta, Ayenachew; Dong, Lanfeng; Rohlena, Jakub; Neuzil, Jiri			The Assembly Factor SDHAF2 Is Dispensable for Flavination of the Catalytic Subunit of Mitochondrial Complex II in Breast Cancer Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cancer biology; cell biology; mammal; mitochondria; mitochondrial respiratory chain complex; SDH assembly factor; SDHA; complex II assembly; flavinylation; mitochondrial complex II; succinate dehydrogenase; flavin adenine dinucleotide; flavination; assembly factor; SDHAF2; cancer cells	SUCCINATE-UBIQUINONE OXIDOREDUCTASE; GASTROINTESTINAL STROMAL TUMORS; FLAVINYLATION FACTOR SDH5; RESPIRATORY-CHAIN; PYRUVATE CARBOXYLATION; BINDING-SITE; DEHYDROGENASE; MUTATIONS; GENE; FLAVOPROTEIN	Mitochondrial complex II or succinate dehydrogenase (SDH) is at the crossroads of oxidative phosphorylation and the tricarboxylic acid cycle. It has been shown that Sdh5 (SDHAF2/SDH5 in mammals) is required for flavination of the subunit Sdh1 (SDHA in human cells) in yeast. Here we demonstrate that in human breast cancer cells, SDHAF2/SDH5 is dispensable for SDHA flavination. In contrast to yeast, CRISPR-Cas9 nickase-mediated SDHAF2 KO breast cancer cells feature flavinated SDHA and retain fully assembled and functional complex II, as well as normal mitochondrial respiration. Our data show that SDHA flavination is independent of SDHAF2 in breast cancer cells, employing an alternative mechanism.	[Bezawork-Geleta, Ayenachew; Dong, Lanfeng; Neuzil, Jiri] Griffith Univ, Sch Med Sci, Southport, Qld 4222, Australia; [Rohlena, Jakub; Neuzil, Jiri] Acad Sci Czech Republic, Inst Biotechnol, Prague 25250, Czech Republic	Griffith University; Czech Academy of Sciences; Institute of Biotechnology of the Czech Academy of Sciences	Bezawork-Geleta, A; Neuzil, J (corresponding author), Griffith Univ, Mitochondria Apoptosis & Canc Res Grp, Sch Med Sci, Menzies Hlth Inst Queensland, Southport, Qld 4222, Australia.	a.bezawork-geleta@griffith.edu.au; j.neuzil@griffith.edu.au	DONG, LANFENG/S-8805-2019; Neuzil, Jiri/H-7204-2014; Rohlena, Jakub/H-6699-2014	Neuzil, Jiri/0000-0002-2478-2460; Rohlena, Jakub/0000-0001-5427-6502; Dong, Lanfeng/0000-0002-9857-6352; Bezawork-Geleta, Ayenachew/0000-0001-5404-5093	Australian Research Council; Griffith University New Researcher grant; Czech Research Foundation [15-02203S, 16-22823S]; BIOCEV [CZ.1.05/1.1.00/02.0109]	Australian Research Council(Australian Research Council); Griffith University New Researcher grant; Czech Research Foundation; BIOCEV	This work was supported by a grant from the Australian Research Council, a Griffith University New Researcher grant, Czech Research Foundation Grants 15-02203S and 16-22823S, and funding from BIOCEV (Grant CZ.1.05/1.1.00/02.0109). The authors declare that they have no conflicts of interest with the contents of this article.	Acin-Perez R, 2014, CELL METAB, V19, P1020, DOI 10.1016/j.cmet.2014.04.015; Ackrell BAC, 2000, FEBS LETT, V466, P1, DOI 10.1016/S0014-5793(99)01749-4; Bafunno V, 2004, J BIOL CHEM, V279, P95, DOI 10.1074/jbc.M308230200; Bardella C, 2011, BBA-BIOENERGETICS, V1807, P1432, DOI 10.1016/j.bbabio.2011.07.003; Bezawork-Geleta A, 2015, SCI REP-UK, V5, DOI 10.1038/srep17397; Bezawork-Geleta A, 2014, FASEB J, V28, P1794, DOI 10.1096/fj.13-242420; Birch-Machin MA, 2000, ANN NEUROL, V48, P330, DOI 10.1002/1531-8249(200009)48:3<330::AID-ANA7>3.0.CO;2-A; BOURGERON T, 1995, NAT GENET, V11, P144, DOI 10.1038/ng1095-144; Cardaci S, 2015, NAT CELL BIOL, V17, P1317, DOI 10.1038/ncb3233; Cecchini G, 2003, ANNU REV BIOCHEM, V72, P77, DOI 10.1146/annurev.biochem.72.121801.161700; Dong LF, 2008, ONCOGENE, V27, P4324, DOI 10.1038/onc.2008.69; Dong LF, 2011, J BIOL CHEM, V286, P3717, DOI 10.1074/jbc.M110.186643; Eletsky A, 2012, BIOCHEMISTRY-US, V51, P8475, DOI 10.1021/bi301171u; Favier J, 2015, NAT REV ENDOCRINOL, V11, P101, DOI 10.1038/nrendo.2014.188; Ghezzi D, 2009, NAT GENET, V41, P654, DOI 10.1038/ng.378; Grimm S, 2013, BBA-BIOENERGETICS, V1827, P565, DOI 10.1016/j.bbabio.2012.09.009; Guzy RD, 2008, MOL CELL BIOL, V28, P718, DOI 10.1128/MCB.01338-07; Hao HX, 2009, SCIENCE, V325, P1139, DOI 10.1126/science.1175689; Hechtman JF, 2015, GENE CHROMOSOME CANC, V54, P177, DOI 10.1002/gcc.22230; Huang SB, 2013, PLANT J, V73, P429, DOI 10.1111/tpj.12041; Italiano A, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-408; Kluckova K, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.110; Kluckova Katarina, 2015, Methods Mol Biol, V1265, P181, DOI 10.1007/978-1-4939-2288-8_14; Kluckova K, 2013, BBA-BIOENERGETICS, V1827, P552, DOI 10.1016/j.bbabio.2012.10.015; Kounosu A, 2014, FEBS LETT, V588, P1058, DOI 10.1016/j.febslet.2014.02.022; Lemarie A, 2011, CELL DEATH DIFFER, V18, P338, DOI 10.1038/cdd.2010.93; Liu J, 2013, J BIOL CHEM, V288, P29965, DOI 10.1074/jbc.M113.450106; Lussey-Lepoutre C, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9784; Maio N, 2016, CELL METAB, V23, P292, DOI 10.1016/j.cmet.2015.12.005; Maklashina E, 2016, J BIOL CHEM, V291, P2904, DOI 10.1074/jbc.M115.690396; McNeil MB, 2013, BIOCHEMISTRY-US, V52, P7628, DOI 10.1021/bi401006a; Mcneil MB, 2012, J BIOL CHEM, V287, P18418, DOI 10.1074/jbc.M111.293803; Miyadera H, 2003, P NATL ACAD SCI USA, V100, P473, DOI 10.1073/pnas.0237315100; Nath AK, 2015, CELL REP, V10, P694, DOI 10.1016/j.celrep.2015.01.010; Parfait B, 2000, HUM GENET, V106, P236, DOI 10.1007/s004390051033; Pesta D, 2012, METHODS MOL BIOL, V810, P25, DOI 10.1007/978-1-61779-382-0_3; Piruat JI, 2004, MOL CELL BIOL, V24, P10933, DOI 10.1128/MCB.24.24.10933-10940.2004; Quinlan CL, 2012, J BIOL CHEM, V287, P27255, DOI 10.1074/jbc.M112.374629; Rutter J, 2010, MITOCHONDRION, V10, P393, DOI 10.1016/j.mito.2010.03.001; Siebels I, 2013, BBA-BIOENERGETICS, V1827, P1156, DOI 10.1016/j.bbabio.2013.06.005; Sun F, 2005, CELL, V121, P1043, DOI 10.1016/j.cell.2005.05.025; Tan AS, 2015, CELL METAB, V21, P81, DOI 10.1016/j.cmet.2014.12.003; Van Vranken JG, 2015, CRIT REV BIOCHEM MOL, V50, P168, DOI 10.3109/10409238.2014.990556; Vondrusova Magdalena, 2015, Methods Mol Biol, V1265, P195, DOI 10.1007/978-1-4939-2288-8_15; Wittig I, 2007, MOL CELL PROTEOMICS, V6, P1215, DOI 10.1074/mcp.M700076-MCP200; Yan B, 2015, BMC CANCER, V15, DOI 10.1186/s12885-015-1394-7; Zafreen L, 2016, ARCH BIOCHEM BIOPHYS, V604, P47, DOI 10.1016/j.abb.2016.06.006	47	10	11	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 7	2016	291	41					21414	21420		10.1074/jbc.C116.755017	http://dx.doi.org/10.1074/jbc.C116.755017			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	DZ6UX	27587393	hybrid, Green Published			2022-12-26	WOS:000385999200007
J	Buesa, I; Aira, Z; Azkue, JJ				Buesa, Itsaso; Aira, Zigor; Jatsu Azkue, Jon			Regulation of Nociceptive Plasticity Threshold and DARPP-32 Phosphorylation in Spinal Dorsal Horn Neurons by Convergent Dopamine and Glutamate Inputs	PLOS ONE			English	Article							LONG-TERM POTENTIATION; NR2B-CONTAINING NMDA RECEPTORS; SUBSTANTIA-GELATINOSA NEURONS; EVOKED FIELD POTENTIALS; LATE-PHASE LTP; PREFRONTAL CORTEX; SYNAPTIC PLASTICITY; NR2B SUBUNIT; TYROSINE PHOSPHORYLATION; MEDIATED PHOSPHORYLATION	Dopamine can influence NMDA receptor function and regulate glutamate-triggered long-term changes in synaptic strength in several regions of the CNS. In spinal cord, regulation of the threshold of synaptic plasticity may determine the proneness to undergo sensitization and hyperresponsiveness to noxious input. In the current study, we increased endogenous dopamine levels in the dorsal horn by using re-uptake inhibitor GBR 12935. During the so-induced hyperdopaminergic transmission, conditioning low-frequency (1 Hz) stimulation (LFS) to the sciatic nerve induced long-termpotentiation (LTP) of C-fiber-evoked potentials in dorsal horn neurons. The magnitude of LTP was attenuated by blockade of either dopamine D1-like receptors (D1LRs) by with SCH 23390 or NMDA receptor subunit NR2B with antagonist Ro25-6981. Conditioning LFS during GBR 12935 administration increased phosphorylation of dopamine-and cAMP-regulated phosphoprotein of Mr 32kDa (DARPP-32) at threonine 34 residue in synaptosomal (P3) fraction of dorsal horn homogenates, as assessed by Western blot analysis, which was partially prevented by NR2B blockade prior to conditioning stimulation. Conditioning LFS also was followed by higher co-localization of phosphorylated form of NR2B at tyrosine 1472 and pDARPP-32(Thr34)-with postsynaptic marker PSD-95 in transverse L5 dorsal horn sections. Such increase could be significantly attenuated by D1LR blockade with SCH 23390. The current results support that coincidental endogenous recruitment of D1LRs and NR2B in dorsal horn synapses plays a role in regulating afferent-induced nociceptive plasticity. Parallel increases in DARPP-32 phosphorylationupon LTP induction suggests a role for this phosphoprotein as intracellular detector of convergent D1L- and NMDA receptor activation.	[Buesa, Itsaso; Aira, Zigor; Jatsu Azkue, Jon] Univ Basque Country UPV EHU, Sch Med & Dent, Dept Neurosci, Leioa 48940, Bizkaia, Spain	University of Basque Country	Azkue, JJ (corresponding author), Univ Basque Country UPV EHU, Sch Med & Dent, Dept Neurosci, Leioa 48940, Bizkaia, Spain.	jonjatsu.azkue@ehu.eus	Aira, Zigor/ABG-4661-2020; Buesa, Itsaso/ABF-6852-2020; Azkue, Jon Jatsu/H-2023-2015	BUESA SOBERA, ITXASO/0000-0002-2448-8819; Azkue, Jon Jatsu/0000-0002-8609-5500	Basque Government (Eusko Jaurlaritza) [IT782-13]; Ministerio de Economia y Compettividad(Spanish Government) [SAF2013-44533-P]	Basque Government (Eusko Jaurlaritza); Ministerio de Economia y Compettividad(Spanish Government)	This work was supported by the Basque Government (Eusko Jaurlaritza), Grant IT782-13 to JJA, URL: http://www.euskadi.eus and by the Ministerio de Economia y Compettividad(Spanish Government), Grant SAF2013-44533-P to JJA, URL: www.mineco.gob.es.	Abe T, 2005, EUR J NEUROSCI, V22, P1445, DOI 10.1111/j.1460-9568.2005.04340.x; Abraham WC, 1997, PROG NEUROBIOL, V52, P303, DOI 10.1016/S0301-0082(97)00018-X; Aira Z, 2016, J NEUROSCI, V36, P5661, DOI 10.1523/JNEUROSCI.2469-15.2016; Aira Z, 2016, NEUROSCI LETT, V618, P152, DOI 10.1016/j.neulet.2016.03.006; Aira Z, 2014, PAIN, V155, P2526, DOI 10.1016/j.pain.2014.09.012; Aira Z, 2013, PAIN, V154, P1865, DOI 10.1016/j.pain.2013.06.009; Aldridge GM, 2008, J NEUROSCI METH, V172, P250, DOI 10.1016/j.jneumeth.2008.05.003; Azkue JJ, 2003, PAIN, V106, P373, DOI 10.1016/j.pain.2003.08.007; Barraud Q, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013306; Bateup HS, 2008, NAT NEUROSCI, V11, P932, DOI 10.1038/nn.2153; BECK H, 1995, J NEUROSCI METH, V58, P193, DOI 10.1016/0165-0270(94)00176-H; Bennett GJ, 2000, J PAIN SYMPTOM MANAG, V19, pS2; Buesa I, 2006, NEUROPHARMACOLOGY, V50, P585, DOI 10.1016/j.neuropharm.2005.11.005; Calabresi P, 2000, J NEUROSCI, V20, P8443, DOI 10.1523/JNEUROSCI.20-22-08443.2000; Cao J, 2011, NEUROPHARMACOLOGY, V60, P921, DOI 10.1016/j.neuropharm.2011.01.034; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Chen Y, 2014, BRAIN RES, V1570, P43, DOI 10.1016/j.brainres.2014.05.001; Fernandez E, 2006, PLOS COMPUT BIOL, V2, P1619, DOI 10.1371/journal.pcbi.0020176; Flores-Hernandez J, 2002, J NEUROPHYSIOL, V88, P3010, DOI 10.1152/jn.00361.2002; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Gao X, 2001, BRAIN RES BULL, V54, P391, DOI 10.1016/S0361-9230(00)00460-3; Gu XP, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-76; Gurden H, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-22-j0003.2000; Hebb Donald O., 1949, ORG BEHAV; HEMMINGS HC, 1984, NATURE, V310, P503, DOI 10.1038/310503a0; HOKFELT T, 1979, ACTA PHYSIOL SCAND, V107, P393, DOI 10.1111/j.1748-1716.1979.tb06491.x; Hotte M, 2007, SYNAPSE, V61, P24, DOI 10.1002/syn.20339; Kim HY, 2015, PAIN, V156, P618, DOI 10.1097/01.j.pain.0000460354.09622.ec; Kim JYV, 2015, J NEUROSCI, V35, P6307, DOI 10.1523/JNEUROSCI.3481-14.2015; Kolomiets B, 2009, CEREB CORTEX, V19, P2708, DOI 10.1093/cercor/bhp047; Lapirot O, 2011, PAIN, V152, P1821, DOI 10.1016/j.pain.2011.03.030; Larsson M, 2011, NEUROSCIENTIST, V17, P256, DOI 10.1177/1073858409349913; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Lemon N, 2006, J NEUROSCI, V26, P7723, DOI 10.1523/JNEUROSCI.1454-06.2006; Li CC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026065; Li Q, 2004, J NEUROSCI, V24, P4070, DOI 10.1523/JNEUROSCI.0346-04.2004; Li ZC, 2011, J NEUROSCI, V31, P17527, DOI 10.1523/JNEUROSCI.3806-11.2011; LIU XG, 1995, NEUROSCI LETT, V191, P43, DOI 10.1016/0304-3940(95)11553-0; Liu XG, 2015, CURR PHARM DESIGN, V21, P895; Liu Y, 2014, ANESTH ANALG, V118, P1345, DOI 10.1213/ANE.0000000000000202; Luo XQ, 2014, BRAIN RES, V1542, P167, DOI 10.1016/j.brainres.2013.10.008; Matsuda Y, 2006, J NEUROSCI, V26, P4803, DOI 10.1523/JNEUROSCI.5312-05.2006; Missale C, 2006, CURR TOP MED CHEM, V6, P801, DOI 10.2174/156802606777057562; Murphy JA, 2014, J NEUROSCI, V34, P869, DOI 10.1523/JNEUROSCI.4538-13.2014; Napolitano F, 2010, J NEUROSCI, V30, P11043, DOI 10.1523/JNEUROSCI.1682-10.2010; Navakkode S, 2007, NEUROPHARMACOLOGY, V52, P1547, DOI 10.1016/j.neuropharm.2007.02.010; Nishi A, 2005, P NATL ACAD SCI USA, V102, P1199, DOI 10.1073/pnas.0409138102; Nishi A, 1997, J NEUROSCI, V17, P8147; Ogawa M, 2007, NEUROSCI RES, V57, P467, DOI 10.1016/j.neures.2006.11.011; Oliveira RF, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002383; Otani S, 2003, CEREB CORTEX, V13, P1251, DOI 10.1093/cercor/bhg092; Pedersen LM, 2008, ACTA PHYSIOL, V192, P421, DOI 10.1111/j.1748-1716.2007.01756.x; Petrenko AB, 2003, ANESTH ANALG, V97, P1108, DOI 10.1213/01.ANE.0000081061.12235.55; Qu S, 2006, EXP BRAIN RES, V168, P152, DOI 10.1007/s00221-005-0075-1; Qu XX, 2009, EXP NEUROL, V215, P298, DOI 10.1016/j.expneurol.2008.10.018; RANDIC M, 1993, J NEUROSCI, V13, P5228, DOI 10.1523/JNEUROSCI.13-12-05228.1993; Roggenhofer E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062520; Romero-Calvo I, 2010, ANAL BIOCHEM, V401, P318, DOI 10.1016/j.ab.2010.02.036; Rygh LJ, 1999, PAIN, V82, P305, DOI 10.1016/S0304-3959(99)00056-1; Sandkuhler J, 1998, EUR J NEUROSCI, V10, P2476, DOI 10.1046/j.1460-9568.1998.00278.x; SEEBURG PH, 1995, RECENT PROG HORM RES, V50, P19; Sheynikhovich D, 2013, J NEUROSCI, V33, P13914, DOI 10.1523/JNEUROSCI.0466-13.2013; SKAGERBERG G, 1985, BRAIN RES, V342, P340, DOI 10.1016/0006-8993(85)91134-5; Stramiello M, 2008, NEUROPHARMACOLOGY, V55, P871, DOI 10.1016/j.neuropharm.2008.06.053; Svenningsson P, 2004, ANNU REV PHARMACOL, V44, P269, DOI 10.1146/annurev.pharmtox.44.101802.121415; Tamae A, 2005, J PHYSIOL-LONDON, V568, P243, DOI 10.1113/jphysiol.2005.091843; Taniguchi W, 2011, PAIN, V152, P95, DOI 10.1016/j.pain.2010.09.034; Tseng KY, 2004, J NEUROSCI, V24, P5131, DOI 10.1523/JNEUROSCI.1021-04.2004; Ultenius C, 2006, NEUROSCI LETT, V399, P85, DOI 10.1016/j.neulet.2006.01.018; WALAAS SI, 1984, J NEUROSCI, V4, P84; WANG YT, 1994, NATURE, V369, P233, DOI 10.1038/369233a0; Xia TJ, 2014, ANESTH ANALG, V119, P1208, DOI 10.1213/ANE.0000000000000394; Yang HW, 2005, J NEUROPHYSIOL, V94, P961, DOI 10.1152/jn.01324.2004; Yang LH, 2016, NEUROSCI LETT, V626, P135, DOI 10.1016/j.neulet.2015.12.044; Yang X, 2009, PAIN, V144, P162, DOI 10.1016/j.pain.2009.04.005; Youn DH, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/654257; Yu XM, 1997, SCIENCE, V275, P674, DOI 10.1126/science.275.5300.674; Zhang MJ, 2014, NEUROBIOL DIS, V68, P104, DOI 10.1016/j.nbd.2014.04.010; Zhou LJ, 2008, EXP NEUROL, V212, P507, DOI 10.1016/j.expneurol.2008.04.034	79	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162416	10.1371/journal.pone.0162416	http://dx.doi.org/10.1371/journal.pone.0162416			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610622	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900094
J	Jalkanen, J; Maksimow, M; Hollmen, M; Jalkanen, S; Hakovirta, H				Jalkanen, Juho; Maksimow, Mikael; Hollmen, Maija; Jalkanen, Sirpa; Hakovirta, Harri			Compared to Intermittant Claudication Critical Limb Ischemia Is Associated with Elevated Levels of Cytokines	PLOS ONE			English	Article							PERIPHERAL ARTERIAL-DISEASE; ATHEROSCLEROSIS; INFLAMMATION; MORTALITY; RISK; CHEMOKINES; PATHWAYS; MARKERS; CANCER	Critical limb ischemia (CLI) is the advanced stage of peripheral artery disease (PAD) and associated with an extremely poor clinical outcome. In order to understand the possible role of circulating cytokines and poor outcome associated with CLI we compared the circulating cytokine profile of patients with CLI against patients with intermittent claudication (IC). The levels of 48 circulating cytokines were examined in 226 consecutive patients with peripheral artery disease (PAD) admitted for elective, non-urgent, invasive treatment of IC or CLI. The PAD patient cohort was evenly distributed between subjects with IC (46.5%) and CLI (53.5%). As accustomed in PAD, CLI was associated with higher age, chronic kidney disease and diabetes when compared to IC (P < 0.01 for all). In multivariable linear regression modeling taking into account the baseline differences between IC and CLI groups CLI was independently associated with elevated levels of a large number of cytokines: IL-1 beta, IL-1ra, IL-2R alpha, IL-4, IL-6, IL-10, IFN-gamma, GM-CSF, G-CSF (P < 0.01 for all), and IL-2, IL-7, IL-12, IL-13, IL-17, bFGF, VEGF, SCGF-beta (P < 0.05 for all). The current findings indicate that CLI is associated with a circulating cytokine profile, which resembles serious medical conditions such as severe pancreatitis, sepsis, or even cancer. Compared to IC, CLI is a systemic inflammatory condition, which may explain the extremely poor outcome associated with it.	[Jalkanen, Juho; Hakovirta, Harri] Turku Univ Hosp, Dept Vasc Surg, Turku, Finland; [Jalkanen, Juho; Hakovirta, Harri] Turku Univ, Turku, Finland; [Maksimow, Mikael; Hollmen, Maija; Jalkanen, Sirpa] Turku Univ, Dept Microbiol & Immunol, Medicity Res Lab, Turku, Finland	University of Turku; University of Turku; University of Turku	Jalkanen, J (corresponding author), Turku Univ Hosp, Dept Vasc Surg, Turku, Finland.; Jalkanen, J (corresponding author), Turku Univ, Turku, Finland.	juho.jalkanen@utu.fi	Hollmén, Maija/B-5831-2017; Hakovirta, Harri/ABD-2437-2020	Hollmén, Maija/0000-0002-3250-7653; Hakovirta, Harri/0000-0002-1518-045X; Jalkanen, Juho/0000-0002-1693-8293	Academy of Finland; Sigrid Juselius Foundation; Orion Research Foundation; Clinical Research Fund (EVO) of Turku University Hospital	Academy of Finland(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Orion Research Foundation; Clinical Research Fund (EVO) of Turku University Hospital	The study was supported by the Academy of Finland, the Sigrid Juselius Foundation, the Orion Research Foundation, and the Clinical Research Fund (EVO) of Turku University Hospital. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ait-Oufella H, 2011, ARTERIOSCL THROM VAS, V31, P969, DOI 10.1161/ATVBAHA.110.207415; Allison MA, 2012, ARTERIOSCL THROM VAS, V32, P140, DOI 10.1161/ATVBAHA.111.235234; Bown MJ, 2001, EUR J VASC ENDOVASC, V22, P485, DOI 10.1053/ejvs.2001.1522; CRIQUI MH, 1992, NEW ENGL J MED, V326, P381, DOI 10.1056/NEJM199202063260605; Criqui MH, 2015, CIRC RES, V116, P1509, DOI 10.1161/CIRCRESAHA.116.303849; Diehm C, 2009, CIRCULATION, V120, P2053, DOI 10.1161/CIRCULATIONAHA.109.865600; Findley CM, 2008, J AM COLL CARDIOL, V52, P387, DOI 10.1016/j.jacc.2008.02.045; Fowkes FGR, 2013, LANCET, V382, P1329, DOI 10.1016/S0140-6736(13)61249-0; Golomb BA, 2006, CIRCULATION, V114, P688, DOI 10.1161/CIRCULATIONAHA.105.593442; Gray BH, 2010, ANN VASC SURG, V24, P349, DOI 10.1016/j.avsg.2009.07.034; Hansson GK, 2005, NEW ENGL J MED, V352, P1685, DOI 10.1056/NEJMra043430; Hansson GK, 2011, NAT IMMUNOL, V12, P204, DOI 10.1038/ni.2001; Hirsch AT, 2001, JAMA-J AM MED ASSOC, V286, P1317, DOI 10.1001/jama.286.11.1317; Jalkanen J, 2016, SPRINGERPLUS, V5, DOI 10.1186/s40064-015-1651-x; Jalkanen J, 2015, CIRC RES, V116, P1206, DOI 10.1161/CIRCRESAHA.116.305715; JELNES R, 1986, BRIT MED J, V293, P1137, DOI 10.1136/bmj.293.6555.1137; Karinen Heikki, 2010, Duodecim, V126, P443; Koene RJ, 2016, CIRCULATION, V133, P1104, DOI 10.1161/CIRCULATIONAHA.115.020406; Li JJ, 2005, MED HYPOTHESES, V64, P694, DOI 10.1016/j.mehy.2004.11.043; Li LH, 2017, CYTOKINE, V89, P173, DOI 10.1016/j.cyto.2015.12.017; Libby P, 2002, NATURE, V420, P868, DOI 10.1161/ATVBAHA.108.179705; Morganti M, 2002, BIOMED PHARMACOTHER, V56, P317, DOI 10.1016/S0753-3322(02)00242-1; Nieminen A, 2014, CRIT CARE, V18, DOI 10.1186/cc13885; Norgren L, 2007, EUR J VASC ENDOVASC, V33, pS5, DOI 10.1016/j.ejvs.2006.09.024; Olumuyiwa-Akeredolu OOO, 2016, CURR PHARM DESIGN, V22, P918, DOI 10.2174/1381612822666151209153535; Reinecke H, 2015, EUR HEART J, V36, P932, DOI 10.1093/eurheartj/ehv006; Rolin J, 2014, J LEUKOCYTE BIOL, V95, P575, DOI 10.1189/jlb.1113571; Rollins KE, 2013, BRIT J SURG, V100, P1002, DOI 10.1002/bjs.9127; Rooke TW, 2011, J VASC SURG, V54, pE32, DOI 10.1016/j.jvs.2011.09.001; Ross J S, 2001, Am J Clin Pathol, V116 Suppl, pS97; Sampson UKA, 2014, GLOB HEART, V9, P145, DOI 10.1016/j.gheart.2013.12.008; Stehr A, 2010, EUR J VASC ENDOVASC, V39, P330, DOI 10.1016/j.ejvs.2009.09.025; Tedgui A, 2006, PHYSIOL REV, V86, P515, DOI 10.1152/physrev.00024.2005; Tendera M, 2012, TURK KARDIYOL DERN A, V40, P5, DOI 10.1093/eurheartj/ehr211; Teraa M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055592; Watt DG, 2015, SURGERY, V157, P362, DOI 10.1016/j.surg.2014.09.009; Zernecke A, 2014, ARTERIOSCL THROM VAS, V34, P742, DOI 10.1161/ATVBAHA.113.301655	37	19	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162353	10.1371/journal.pone.0162353	http://dx.doi.org/10.1371/journal.pone.0162353			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611073	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900082
J	Ronchetti, SA; Machiavelli, LI; Quinteros, FA; Duvilanski, BH; Cabilla, JP				Ronchetti, Sonia A.; Machiavelli, Leticia I.; Quinteros, Fernanda A.; Duvilanski, Beatriz H.; Cabilla, Jimena P.			Nitric Oxide Plays a Key Role in Ovariectomy-Induced Apoptosis in Anterior Pituitary: Interplay between Nitric Oxide Pathway and Estrogen	PLOS ONE			English	Article							SENSITIVE-GUANYLYL CYCLASE; PROGRAMMED CELL-DEATH; PROLACTIN-RELEASE; INTERFERON-GAMMA; GENE-EXPRESSION; RAT; SYNTHASE; GLAND; HORMONE; INDUCTION	Changes in the estrogenic status produce deep changes in pituitary physiology, mainly because estrogens (E2) are one of the main regulators of pituitary cell population. Also, E2 negatively regulate pituitary neuronal nitric oxide synthase (nNOS) activity and expression and may thereby modulate the production of nitric oxide (NO), an important regulator of cell death and survival. Little is known about how ovary ablation affects anterior pituitary cell remodelling and molecular mechanisms that regulate this process have not yet been elucidated. In this work we used freshly dispersed anterior pituitaries as well as cell cultures from ovariectomized female rats in order to study whether E2 deficiency induces apoptosis in the anterior pituitary cells, the role of NO in this process and effects of E2 on the NO pathway. Our results showed that cell activity gradually decreases after ovariectomy (OVX) as a consequence of cell death, which is completely prevented by a pan-caspase inhibitor. Furthermore, there is an increase of fragmented nuclei and DNA cleavage thereby presenting the first direct evidence of the existence of apoptosis in the anterior pituitary gland after OVX. NO production and soluble guanylyl cyclase (sGC) expression in anterior pituitary cells increased concomitantly to the apoptosis. Inhibition of both, NO synthase (NOS) and sGC activities prevented the drop of cell viability after OVX, showing for the first time that increased NO levels and sGC activity observed post-OVX play a key role in the induction of apoptosis. Conversely, E2 and prolactin treatments decreased nNOS expression and activity in pituitary cells from OVX rats in a time-and E2 receptor-dependent manner, thus suggesting interplay between NO and E2 pathways in anterior pituitary.	[Ronchetti, Sonia A.; Machiavelli, Leticia I.; Quinteros, Fernanda A.; Duvilanski, Beatriz H.; Cabilla, Jimena P.] Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, Dept Quim Biol, Buenos Aires, DF, Argentina; [Ronchetti, Sonia A.; Duvilanski, Beatriz H.; Cabilla, Jimena P.] Univ Buenos Aires, Fac Med, Inst Invest Biomed INBIOMED UBA CONICET, Buenos Aires, DF, Argentina	University of Buenos Aires; University of Buenos Aires	Cabilla, JP (corresponding author), Univ Buenos Aires, Fac Farm & Bioquim, IQUIFIB, Dept Quim Biol, Buenos Aires, DF, Argentina.; Cabilla, JP (corresponding author), Univ Buenos Aires, Fac Med, Inst Invest Biomed INBIOMED UBA CONICET, Buenos Aires, DF, Argentina.	jcabilla@ffyb.uba.ar			Consejo Nacional de Investigaciones Cientificas y Tecnicas [PIP 2012 1038, PIP 5536]; Agencia Nacional de Promocion Cientifica y Tecnologica [PICT 2010 1668, PICT 2013 1324]; Universidad de Buenos Aires [B100473]	Consejo Nacional de Investigaciones Cientificas y Tecnicas(Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET)); Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Universidad de Buenos Aires(University of Buenos Aires)	This work was supported by Consejo Nacional de Investigaciones Cientificas y Tecnicas (PIP 2012 1038 to JPC and PIP 5536 to BHD), Agencia Nacional de Promocion Cientifica y Tecnologica (PICT 2010 1668 to BHD and PICT 2013 1324 to JPC), and Universidad de Buenos Aires (B100473 to BHD).	Aoki MD, 2001, HISTOCHEM CELL BIOL, V116, P215; Berman JR, 1998, UROLOGY, V51, P650, DOI 10.1016/S0090-4295(97)00683-3; BILLIG H, 1993, ENDOCRINOLOGY, V133, P2204, DOI 10.1210/en.133.5.2204; Bohlen HG, 2015, COMPR PHYSIOL, V5, P803, DOI 10.1002/cphy.c140052; BRYANT CE, 1995, J ENDOCRINOL, V146, P149, DOI 10.1677/joe.0.1460149; Cabilla JP, 2006, ENDOCRINOLOGY, V147, P4311, DOI 10.1210/en.2006-0367; Cabilla JP, 2009, AM J PHYSIOL-ENDOC M, V296, pE731, DOI 10.1152/ajpendo.90795.2008; Candolfi M, 2006, FRONT HORM RES, V35, P9, DOI 10.1159/000094260; Candolfi M, 2004, NEUROENDOCRINOLOGY, V80, P83, DOI 10.1159/000081313; CARBAJOPEREZ E, 1990, CELL TISSUE RES, V261, P333, DOI 10.1007/BF00318674; Ceccatelli S, 1997, BRAIN RES BULL, V44, P533, DOI 10.1016/S0361-9230(97)00239-6; CECCATELLI S, 1993, P NATL ACAD SCI USA, V90, P11292, DOI 10.1073/pnas.90.23.11292; Corbacho AM, 2003, FEBS LETT, V544, P171, DOI 10.1016/S0014-5793(03)00499-X; Dawn B, 2002, ANN NY ACAD SCI, V962, P18, DOI 10.1111/j.1749-6632.2002.tb04053.x; de Tassigny XD, 2009, J NEUROCHEM, V109, P214, DOI 10.1111/j.1471-4159.2009.05949.x; Dogusan Z, 2001, J NEUROIMMUNOL, V120, P58, DOI 10.1016/S0165-5728(01)00420-9; DREWETT N, 1993, NEUROENDOCRINOLOGY, V57, P89; DUVILANSKI BH, 1995, P NATL ACAD SCI USA, V92, P170, DOI 10.1073/pnas.92.1.170; Feil Robert, 2008, V184, P529; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Garrel G, 1998, ENDOCRINOLOGY, V139, P2163, DOI 10.1210/en.139.4.2163; Gonzalez-Hernandez T, 2000, J HISTOCHEM CYTOCHEM, V48, P1639, DOI 10.1177/002215540004801207; Grams AE, 2010, NEUROENDOCRINOLOGY, V92, P128, DOI 10.1159/000314196; Grisham MB, 1996, METHOD ENZYMOL, V268, P237; Kim YM, 1997, J BIOL CHEM, V272, P31138, DOI 10.1074/jbc.272.49.31138; Kim YM, 1999, CIRC RES, V84, P253, DOI 10.1161/01.RES.84.3.253; Krumenacker J, 2004, BRAIN RES BULL, V62, P505, DOI 10.1016/S0361-9230(03)00102-3; Leong SK, 2002, ANN NY ACAD SCI, V962, P161, DOI 10.1111/j.1749-6632.2002.tb04066.x; Liu LM, 1999, CELL DEATH DIFFER, V6, P937, DOI 10.1038/sj.cdd.4400578; MacRitchie AN, 1997, CIRC RES, V81, P355, DOI 10.1161/01.RES.81.3.355; Poliandri AHB, 2004, FREE RADICAL BIO MED, V37, P1463, DOI 10.1016/j.freeradbiomed.2004.07.017; Qian X, 1999, ENDOCRINE, V11, P123, DOI 10.1385/ENDO:11:2:123; Quinteros FA, 2007, TOXICOL APPL PHARM, V218, P79, DOI 10.1016/j.taap.2006.10.017; Raso GM, 1999, J NEUROCHEM, V73, P2272, DOI 10.1046/j.1471-4159.1999.0732272.x; RHODE PR, 1991, MOL CELL ENDOCRINOL, V82, P1, DOI 10.1016/0303-7207(91)90003-B; Sahni D, 2006, PITUITARY, P19; Seifert R, 2015, PHARMACOL THERAPEUT, V148, P154, DOI 10.1016/j.pharmthera.2014.12.002; Seilicovich A, 2010, J NEUROENDOCRINOL, V22, P758, DOI 10.1111/j.1365-2826.2010.02010.x; Sharina IG, 2011, NITRIC OXIDE-BIOL CH, V25, P265, DOI 10.1016/j.niox.2011.08.001; Shimojo T, 1999, EXP CELL RES, V247, P38, DOI 10.1006/excr.1998.4310; Spady TJ, 1999, ENDOCRINE, V11, P217, DOI 10.1385/ENDO:11:3:217; Taimor G, 2000, CARDIOVASC RES, V45, P588, DOI 10.1016/S0008-6363(99)00272-2; Tamura K, 2000, LIFE SCI, V66, pPL259, DOI 10.1016/S0024-3205(00)00488-4; Valenti L, 2003, CELL IMMUNOL, V221, P50, DOI 10.1016/S0008-8749(03)00064-9; Vankelecom H, 1997, MOL CELL ENDOCRINOL, V129, P157, DOI 10.1016/S0303-7207(97)04054-9; Vankelecom H, 1997, J HISTOCHEM CYTOCHEM, V45, P847, DOI 10.1177/002215549704500609; VANNESSELROOIJ JHJ, 1992, CARCINOGENESIS, V13, P277, DOI 10.1093/carcin/13.2.277; Velardez MO, 2004, ENDOCRINOLOGY, V145, P2064, DOI 10.1210/en.2003-1263; Velardez MO, 2003, HORM RES, V60, P111, DOI 10.1159/000072521; Wink DA, 2011, J LEUKOCYTE BIOL, V89, P873, DOI 10.1189/jlb.1010550; Xia Y, 2004, ENDOCRINOLOGY, V145, P4550, DOI 10.1210/en.2004-0327; Zaldivar V, 2009, NEUROENDOCRINOLOGY, V90, P292, DOI 10.1159/000235618; Zarate S, 2009, AM J PHYSIOL-ENDOC M, V296, pE664, DOI 10.1152/ajpendo.90785.2008	55	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162455	10.1371/journal.pone.0162455	http://dx.doi.org/10.1371/journal.pone.0162455			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611913	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900103
J	Schneeberger, VE; Allaj, V; Gardner, EE; Poirier, JT; Rudin, CM				Schneeberger, Valentina E.; Allaj, Viola; Gardner, Eric E.; Poirier, J. T.; Rudin, Charles M.			Quantitation of Murine Stroma and Selective Purification of the Human Tumor Component of Patient-Derived Xenografts for Genomic Analysis	PLOS ONE			English	Article							CANCER-CELL-LINES; PANCREATIC-CANCER; DRUG DEVELOPMENT; READ ALIGNMENT; MOUSE MODELS; METASTASIS; SAMPLES; PROGRESSION; ONCOLOGY; PLATFORM	Patient-derived xenograft (PDX) mouse models are increasingly used for preclinical therapeutic testing of human cancer. A limitation in molecular and genetic characterization of PDX tumors is the presence of integral murine stroma. This is particularly problematic for genomic sequencing of PDX models. Rapid and dependable approaches for quantitating stromal content and purifying the malignant human component of these tumors are needed. We used a recently developed technique exploiting species-specific polymerase chain reaction (PCR) amplicon length (ssPAL) differences to define the fractional composition of murine and human DNA, which was proportional to the fractional composition of cells in a series of lung cancer PDX lines. We compared four methods of human cancer cell isolation: fluorescence-activated cell sorting (FACS), an immunomagnetic mouse cell depletion (MCD) approach, and two distinct EpCAM-based immunomagnetic positive selection methods. We further analyzed DNA extracted from the resulting enriched human cancer cells by targeted sequencing using a clinically validated multi-gene panel. Stromal content varied widely among tumors of similar histology, but appeared stable over multiple serial tumor passages of an individual model. FACS and MCD were superior to either positive selection approach, especially in cases of high stromal content, and consistently allowed high quality human-specific genomic profiling. ssPAL is a dependable approach to quantitation of murine stromal content, and MCD is a simple, efficient, and high yield approach to human cancer cell isolation for genomic analysis of PDX tumors.	[Schneeberger, Valentina E.; Allaj, Viola; Poirier, J. T.; Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA; [Schneeberger, Valentina E.; Allaj, Viola; Poirier, J. T.; Rudin, Charles M.] Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA; [Gardner, Eric E.] Johns Hopkins Univ, Pharmacol Grad Training Program, Baltimore, MD USA; [Poirier, J. T.; Rudin, Charles M.] Weill Cornell Med Coll, Dept Med, New York, NY USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Johns Hopkins University; Cornell University	Poirier, JT; Rudin, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Mol Pharmacol & Chem Program, 1275 York Ave, New York, NY 10021 USA.; Poirier, JT; Rudin, CM (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Med, 1275 York Ave, New York, NY 10021 USA.; Poirier, JT; Rudin, CM (corresponding author), Weill Cornell Med Coll, Dept Med, New York, NY USA.	poirierj@mskcc.org; rudinc@mskcc.org	Rudin, Charles/R-2530-2019	Rudin, Charles/0000-0001-5204-3465; Poirier, John/0000-0001-9795-5644; Gardner, Eric/0000-0002-1552-2675	National Cancer Institute [P30 CA008748]; LUNGevity Foundation Career Development Award; NATIONAL CANCER INSTITUTE [P30CA008748] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); LUNGevity Foundation Career Development Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by National Cancer Institute P30 CA008748 - JTP CMR - and LUNGevity Foundation Career Development Award-JTP. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BURGKURLAND CL, 1986, CANCER RES, V46, P5730; Cheng DT, 2015, J MOL DIAGN, V17, P251, DOI 10.1016/j.jmoldx.2014.12.006; Cibulskis K, 2013, NAT BIOTECHNOL, V31, P213, DOI 10.1038/nbt.2514; Conway T, 2012, BIOINFORMATICS, V28, pI172, DOI 10.1093/bioinformatics/bts236; Curry JM, 2014, SEMIN ONCOL, V41, P217, DOI 10.1053/j.seminoncol.2014.03.003; Dangles-Marie V, 2007, CANCER RES, V67, P398, DOI 10.1158/0008-5472.CAN-06-0594; Daniel VC, 2009, CANCER RES, V69, P3364, DOI 10.1158/0008-5472.CAN-08-4210; Das Thakur M, 2014, J PATHOL, V232, P103, DOI 10.1002/path.4285; Engels B, 2012, SEMIN CANCER BIOL, V22, P41, DOI 10.1016/j.semcancer.2011.12.008; Ewing AD, 2015, NAT METHODS, V12, P623, DOI [10.1038/NMETH.3407, 10.1038/nmeth.3407]; Gillet JP, 2013, JNCI-J NATL CANCER I, V105, P452, DOI 10.1093/jnci/djt007; Gorges TM, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-178; Gray DR, 2004, CANCER RES, V64, P1712, DOI 10.1158/0008-5472.CAN-03-2700; Henderson VC, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001489; Hidalgo M, 2014, CANCER DISCOV, V4, P998, DOI 10.1158/2159-8290.CD-14-0001; Huang PG, 2011, COMPARATIVE MED, V61, P227; Karagiannis GS, 2012, MOL CANCER RES, V10, P1403, DOI 10.1158/1541-7786.MCR-12-0307; Khaled WT, 2014, SEMIN CELL DEV BIOL, V27, P54, DOI 10.1016/j.semcdb.2014.04.003; Kris MG, 2014, JAMA-J AM MED ASSOC, V311, P1998, DOI 10.1001/jama.2014.3741; LEFRANCOIS D, 1989, INT J CANCER, V44, P871, DOI 10.1002/ijc.2910440521; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MT, 2010, BIOTECHNIQUES, V48, P211, DOI 10.2144/000113363; Liu J, 2011, J CLIN VIROL, V50, P308, DOI 10.1016/j.jcv.2010.12.009; Malaney P, 2014, CANCER LETT, V344, P1, DOI 10.1016/j.canlet.2013.10.010; Mita MM, 2013, EXPERT OPIN INV DRUG, V22, P317, DOI 10.1517/13543784.2013.759557; Quail DF, 2013, NAT MED, V19, P1423, DOI 10.1038/nm.3394; Raimondi C, 2013, EXPERT REV MOL DIAGN, V13, P499, DOI [10.1586/ERM.13.33, 10.1586/erm.13.33]; Rosfjord E, 2014, BIOCHEM PHARMACOL, V91, P135, DOI 10.1016/j.bcp.2014.06.008; Rossello FJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0074432; Rubio-Viqueira B, 2006, CLIN CANCER RES, V12, P4652, DOI 10.1158/1078-0432.CCR-06-0113; Siolas D, 2013, CANCER RES, V73, P5315, DOI 10.1158/0008-5472.CAN-13-1069; Tichet M, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7993; Travis WD, 2015, J THORAC ONCOL, V10, P1243, DOI 10.1097/JTO.0000000000000630; Tso KY, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1172; van der Gun BTF, 2010, CARCINOGENESIS, V31, P1913, DOI 10.1093/carcin/bgq187; Von Hoff DD, 2011, J CLIN ONCOL, V29, P4548, DOI 10.1200/JCO.2011.36.5742; Whatcott CJ, 2015, CLIN CANCER RES, V21, P3561, DOI 10.1158/1078-0432.CCR-14-1051; Whittle JR, 2015, BREAST CANCER RES, V17, DOI 10.1186/s13058-015-0523-1; Yalcin B, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-3-r18	40	31	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160587	10.1371/journal.pone.0160587	http://dx.doi.org/10.1371/journal.pone.0160587			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611664	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900009
J	Wang, JX; Zhu, SL; Wang, J; Lin, Y; Pei, YW; Sun, DP; Zhang, Y; Wang, XJ; Xu, WB; Ding, SJ				Wang, Jian-xing; Zhu, Shuang-li; Wang, Jing; Lin, Yi; Pei, Yao-wen; Sun, Da-peng; Zhang, Yong; Wang, Xian-jun; Xu, Wen-bo; Ding, Shu-jun			Seroprevalence of Enterovirus A71 and Coxsackievirus A16 in Healthy People in Shandong Province, China	PLOS ONE			English	Article							MOUTH-DISEASE; 71 INFECTION; FOOT; HAND; SEROEPIDEMIOLOGY; CHILDREN; OUTBREAK; VACCINE; EPIDEMIC; EFFICACY	Background Hand, foot, and mouth disease has become very common in mainland of China in recent years, and enterovirus A71 and coxsackievirus A16 are its major etiologic factors. Here we investigated the seroprevalence of enterovirus A71 and coxsackievirus A16 based on a large group of healthy individuals in Shandong province, China. Methods A total of 1378 healthy individuals were tested for serum neutralizing antibodies against enterovirus A71 and coxsackievirus A16 using a micro neutralization test. Results The overall seroprevalence of enterovirus A71 neutralizing antibodies was 74.75%. It increased significantly from 48.84% in children aged 0-1 years old to 88.64% in those aged 20-29 years (p < 0.01) and decreased to 85.71% in adults > 40 years old with a significant gender-specific difference (p < 0.01). The overall coxsackievirus A16 antibody prevalence was 71.77%. It increased significantly from 39.53% in children aged 0-1 years to 80.68% in those aged 10-19 years (p < 0.01) and decreased to 75.63% in adults > 40 years without a gender-specific difference. Nearly 50% of the children < 1 year were susceptible to enterovirus A71 infection versus 40% to coxsackievirus A16 infection. Sample collection time and place also played a role in the enterovirus A71 and coxsackievirus A16 positive rates. The overall rates in January were significantly lower than those in April and August (p < 0.01); enterovirus A71 positive rates in Jinan city (capital city of Shandong province) were lower than those in Jining city and Zibo city (p < 0.05); and oxsackievirus A16 positive rates in Jining city were significantly higher than those in Jinan city and Zibo city (p < 0.01). Conclusion There were significant differences among age groups, locations, and time points in the seroprevalence rates of enterovirus A71 and coxsackievirus A16 neutralizing antibodies in healthy people in Shandong province.	[Wang, Jian-xing; Wang, Jing; Lin, Yi; Pei, Yao-wen; Sun, Da-peng; Wang, Xian-jun; Ding, Shu-jun] Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Communicable Dis Control &, Inst Viral Dis Control & Prevent, Jinan 250014, Shandong, Peoples R China; [Zhu, Shuang-li; Zhang, Yong; Xu, Wen-bo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Natl Hlth & Family Planning Commiss China, WHO WPRO Reg Polio Reference Lab, Beijing 102206, Peoples R China; [Zhu, Shuang-li; Zhang, Yong; Xu, Wen-bo] Chinese Ctr Dis Control & Prevent, Natl Inst Viral Dis Control & Prevent, Natl Hlth & Family Planning Commiss China, Key Lab Med Virol & Viral Dis, Beijing 102206, Peoples R China; [Wang, Jing] Shandong Univ, Sch Publ Hlth, Jinan 250012, Shandong, Peoples R China	Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Chinese Center for Disease Control & Prevention; National Institute for Viral Disease Control & Prevention, Chinese Center for Disease Control & Prevention; Shandong University	Ding, SJ (corresponding author), Shandong Ctr Dis Control & Prevent, Shandong Prov Key Lab Communicable Dis Control &, Inst Viral Dis Control & Prevent, Jinan 250014, Shandong, Peoples R China.	dsj_jn@126.com		Zhang, Yong/0000-0002-2692-5437	Science and Technology Development Plan of Shandong Province [2009GG10002055]; Shandong Natural Science Foundation [ZR2013HM052]; Shandong Medical Science and Technology Development Program [2013WS0157]	Science and Technology Development Plan of Shandong Province; Shandong Natural Science Foundation(Natural Science Foundation of Shandong Province); Shandong Medical Science and Technology Development Program	This study was supported by Science and Technology Development Plan of Shandong Province to Xianjun Wang (http://www.sdstc.gov.cn) (Grant No. 2009GG10002055); Shandong Natural Science Foundation to Xianjun Wang (http://www.sdnsf.gov.cn) (Grant No. ZR2013HM052); and Shandong Medical Science and Technology Development Program to Xianjun Wang (http://www.sdwsjs.gov.cn) (Grant No. 2013WS0157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad K, 2000, LANCET, V356, P1338, DOI 10.1016/S0140-6736(05)74253-7; Akhmadishina LV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097404; Ang LW, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-270; Ang LW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127999; Bian LL, 2015, EXPERT REV ANTI-INFE, V13, P1061, DOI 10.1586/14787210.2015.1058156; Bible JM, 2007, REV MED VIROL, V17, P371, DOI 10.1002/rmv.538; Castro Ceyla M.O., 2005, Rev. Inst. Med. trop. S. Paulo, V47, P65, DOI 10.1590/S0036-46652005000200002; Chang L, 2007, NEW ENGL J MED, V356, P1226, DOI 10.1056/NEJMoa065954; Chang LY, 1999, PEDIATR INFECT DIS J, V18, P1092, DOI 10.1097/00006454-199912000-00013; Chang LY, 1999, LANCET, V354, P1682, DOI 10.1016/S0140-6736(99)04434-7; Chau BNT, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0021116, 10.1371/journal.pone.0025969]; Chen SC, 2007, AM J TROP MED HYG, V77, P188, DOI 10.4269/ajtmh.2007.77.188; Fan XL, 2013, VIRUS GENES, V46, P1, DOI 10.1007/s11262-012-0814-x; Feng XB, 2015, SCI REP-UK, V5, DOI 10.1038/srep11700; Gomes MDC, 2002, MEM I OSWALDO CRUZ, V97, P47, DOI 10.1590/S0074-02762002000100006; Gu HY, 2014, PEDIATR INFECT DIS J, V33, P1302, DOI 10.1097/INF.0000000000000467; Ho MT, 1999, NEW ENGL J MED, V341, P929, DOI 10.1056/NEJM199909233411301; Horwood PF, 2016, EMERG INFECT DIS, V22, P92, DOI 10.3201/eid2201.151323; Huang CC, 1999, NEW ENGL J MED, V341, P936, DOI 10.1056/NEJM199909233411302; Huang Y, 2015, J MED VIROL, V87, P1471, DOI 10.1002/jmv.24200; Ji H, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-248; Juhela S, 1998, J MED VIROL, V54, P226, DOI 10.1002/(SICI)1096-9071(199803)54:3&lt;226::AID-JMV14&gt;3.0.CO;2-F; Kehle J, 2003, J NEUROVIROL, V9, P126, DOI 10.1080/13550280390173364; Li JX, 2016, EXPERT REV VACCINES, V15, P129, DOI 10.1586/14760584.2016.1096782; Li LL, 2005, J CLIN MICROBIOL, V43, P3835, DOI 10.1128/JCM.43.8.3835-3839.2005; Li RC, 2014, NEW ENGL J MED, V370, P829, DOI 10.1056/NEJMoa1303224; Li W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080515; Li W, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-322; Lim CT, 2015, EPIDEMIOL INFECT, P1; Linsuwanon P, 2014, J BIOMED SCI, V21, DOI 10.1186/1423-0127-21-16; Liu LD, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0448-7; Liu WY, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0096051, 10.1371/journal.pone.0088077]; Ooi EE, 2002, EMERG INFECT DIS, V8, P995, DOI 10.3201/eid0809.010397; Ooi MH, 2007, CLIN INFECT DIS, V44, P646, DOI 10.1086/511073; Pallansch M, 2013, FIELDS VIROLOGY, V1, P490; Rabenau HF, 2010, MED MICROBIOL IMMUN, V199, P45, DOI 10.1007/s00430-009-0133-6; Khanh TH, 2012, EMERG INFECT DIS, V18, P2002, DOI 10.3201/eid1812.120929; Wong KT, 2000, NEW ENGL J MED, V342, P356; Xing WJ, 2014, LANCET INFECT DIS, V14, P308, DOI 10.1016/S1473-3099(13)70342-6; Yan JJ, 2001, J MED VIROL, V65, P331, DOI 10.1002/jmv.2038; Yang F, 2011, CLIN INFECT DIS, V53, P400, DOI 10.1093/cid/cir346; Yang Q, 2016, VIROL J, V13, DOI 10.1186/s12985-016-0571-x; Zeng HR, 2015, SCI REP-UK, V5, DOI 10.1038/srep10550; Zeng M, 2012, J CLIN VIROL, V53, P285, DOI 10.1016/j.jcv.2011.12.025; Zhang Y, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-94; Zhang Y, 2013, BIOMED ENVIRON SCI, V26, P875, DOI 10.3967/bes2013.015; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027895; Zhang Y, 2010, J CLIN MICROBIOL, V48, P619, DOI 10.1128/JCM.02338-09; Zhang Y, 2009, J CLIN VIROL, V44, P262, DOI 10.1016/j.jcv.2009.02.002; Zhu FC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037206; Zhu FC, 2014, NEW ENGL J MED, V370, P818, DOI 10.1056/NEJMoa1304923; Zhu Z, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-300	52	10	11	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162373	10.1371/journal.pone.0162373	http://dx.doi.org/10.1371/journal.pone.0162373			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611441	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900085
J	Weirich, F; Gremer, L; Mirecka, EA; Schiefer, S; Hoyer, W; Heise, H				Weirich, Franziska; Gremer, Lothar; Mirecka, Ewa A.; Schiefer, Stephanie; Hoyer, Wolfgang; Heise, Henrike			Structural Characterization of Fibrils from Recombinant Human Islet Amyloid Polypeptide by Solid-State NMR: The Central FGAILS Segment Is Part of the beta-Sheet Core	PLOS ONE			English	Article							RESOLUTION 3-DIMENSIONAL STRUCTURE; DYNAMIC NUCLEAR-POLARIZATION; CHEMICAL-SHIFTS; ROTATING SOLIDS; HUMAN AMYLIN; FULL-LENGTH; CORRELATION SPECTROSCOPY; RESONANCE ASSIGNMENTS; MOLECULAR-STRUCTURE; SECONDARY STRUCTURE	Amyloid deposits formed from islet amyloid polypeptide (IAPP) are a hallmark of type 2 diabetes mellitus and are known to be cytotoxic to pancreatic beta-cells. The molecular structure of the fibrillar form of IAPP is subject of intense research, and to date, different models exist. We present results of solid-state NMR experiments on fibrils of recombinantly expressed and uniformly C-13, N-15-labeled human IAPP in the non-amidated, free acid form. Complete sequential resonance assignments and resulting constraints on secondary structure are shown. A single set of chemical shifts is found for most residues, which is indicative of a high degree of homogeneity. The core region comprises three to four beta-sheets. We find that the central 23-FGAILS-28 segment, which is of critical importance for amyloid formation, is part of the core region and forms a beta-strand in our sample preparation. The eight N-terminal amino acid residues of IAPP, forming a ring-like structure due to a disulfide bridge between residues C2 and C7, appear to be well defined but with an increased degree of flexibility. This study supports the elucidation of the structural basis of IAPP amyloid formation and highlights the extent of amyloid fibril polymorphism.	[Weirich, Franziska; Gremer, Lothar; Hoyer, Wolfgang; Heise, Henrike] Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany; [Weirich, Franziska; Gremer, Lothar; Mirecka, Ewa A.; Schiefer, Stephanie; Hoyer, Wolfgang; Heise, Henrike] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany	Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf	Heise, H (corresponding author), Res Ctr Julich, Inst Complex Syst, Struct Biochem ICS 6, D-52425 Julich, Germany.; Heise, H (corresponding author), Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany.	h.heise@fz-juelich.de	Gremer, Lothar/H-9128-2013; Heise, Henrike/A-7703-2010; Hoyer, Wolfgang/H-6193-2013	Gremer, Lothar/0000-0001-7065-5027; Heise, Henrike/0000-0002-9081-3894; Hoyer, Wolfgang/0000-0003-4301-5416; Weirich, Franziska/0000-0001-8279-3566	Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf; DFG [HE 3243/4-1]	Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf; DFG(German Research Foundation (DFG))	This work was supported by the Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf and the DFG (HE 3243/4-1).r The authors acknowledge access to the Julich-Dusseldorf Biomolecular NMR Center that is jointly run by Forschungszentrum Julich and Heinrich-Heine-University Dusseldorf. This work was supported by the Entrepreneur Foundation at the Heinrich-Heine-University of Dusseldorf and the DFG (HE 3243/4-1).	Abedini A, 2013, FEBS LETT, V587, P1119, DOI 10.1016/j.febslet.2013.01.017; Alexandrescu AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056467; Andronesi OC, 2005, J AM CHEM SOC, V127, P12965, DOI 10.1021/ja0530164; Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/00268979809483251; Bedrood S, 2012, J BIOL CHEM, V287, P5235, DOI 10.1074/jbc.M111.327817; Betts M. J., 2003, BIOINFORMATICS GENET, DOI 10.1002/0470867302.ch14; BILLETER M, 1982, J MOL BIOL, V155, P321, DOI 10.1016/0022-2836(82)90008-0; BLOEMBERGEN N, 1949, PHYSICA, V15, P386, DOI 10.1016/0031-8914(49)90114-7; Buchanan LE, 2013, P NATL ACAD SCI USA, V110, P19285, DOI 10.1073/pnas.1314481110; Colvin MT, 2015, J AM CHEM SOC, V137, P7509, DOI 10.1021/jacs.5b03997; Cope SM, 2013, BIOPHYS J, V105, P1661, DOI 10.1016/j.bpj.2013.08.026; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Fung BM, 2000, J MAGN RESON, V142, P97, DOI 10.1006/jmre.1999.1896; Gardiennet C, 2008, J BIOMOL NMR, V40, P239, DOI 10.1007/s10858-008-9229-3; Gath J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090659; Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268; Hansen DF, 2010, J AM CHEM SOC, V132, P7589, DOI 10.1021/ja102090z; HARTMANN SR, 1962, PHYS REV, V128, P2042, DOI 10.1103/PhysRev.128.2042; Heise H, 2005, P NATL ACAD SCI USA, V102, P15871, DOI 10.1073/pnas.0506109102; Heise H, 2001, J MAGN RESON, V150, P198, DOI 10.1006/jmre.2001.2343; Hohwy M, 2002, J CHEM PHYS, V117, P4973, DOI 10.1063/1.1488136; Hohwy M, 1999, J CHEM PHYS, V110, P7983, DOI 10.1063/1.478702; Jaikaran ETAS, 2001, BBA-MOL BASIS DIS, V1537, P179, DOI 10.1016/S0925-4439(01)00078-3; Jaikaran ETAS, 2001, J MOL BIOL, V308, P515, DOI 10.1006/jmbi.2001.4593; Jayasinghe SA, 2004, J BIOL CHEM, V279, P48420, DOI 10.1074/jbc.M406853200; KAHN SE, 1990, DIABETES, V39, P634, DOI 10.2337/diabetes.39.5.634; Kajava AV, 2005, J MOL BIOL, V348, P247, DOI 10.1016/j.jmb.2005.02.029; Kosicka I, 2014, PROTEIN EXPRES PURIF, V99, P119, DOI 10.1016/j.pep.2014.04.002; Lange A, 2002, J AM CHEM SOC, V124, P9704, DOI 10.1021/ja026691b; Lewandowski JR, 2011, J AM CHEM SOC, V133, P14686, DOI 10.1021/ja203736z; Lewandowski JR, 2013, ACCOUNTS CHEM RES, V46, P2018, DOI 10.1021/ar300334g; Lopez del Amo JM, 2012, ANGEW CHEM INT EDIT, V51, P6136, DOI 10.1002/anie.201200965; Lu JX, 2013, CELL, V154, P1257, DOI 10.1016/j.cell.2013.08.035; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; Lutz TA, 2010, AM J PHYSIOL-REG I, V298, pR1475, DOI 10.1152/ajpregu.00703.2009; Madine J, 2008, J AM CHEM SOC, V130, P14990, DOI 10.1021/ja802483d; Martin OA, 2010, J BIOMOL NMR, V46, P217, DOI 10.1007/s10858-010-9396-x; Mirecka EA, 2014, J BIOTECHNOL, V191, P221, DOI 10.1016/j.jbiotec.2014.06.006; MORRIS GA, 1979, J AM CHEM SOC, V101, P760, DOI 10.1021/ja00497a058; Ni QZ, 2013, ACCOUNTS CHEM RES, V46, P1933, DOI 10.1021/ar300348n; Nielsen JT, 2009, ANGEW CHEM INT EDIT, V48, P2118, DOI 10.1002/anie.200804198; Nilsson MR, 1999, J MOL BIOL, V294, P1375, DOI 10.1006/jmbi.1999.3286; Paravastu AK, 2008, P NATL ACAD SCI USA, V105, P18349, DOI 10.1073/pnas.0806270105; Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850; SAITO H, 1986, MAGN RESON CHEM, V24, P835, DOI 10.1002/mrc.1260241002; Sauvee C, 2013, ANGEW CHEM INT EDIT, V52, P10858, DOI 10.1002/anie.201304657; Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695; Schutz AK, 2015, ANGEW CHEM INT EDIT, V54, P331, DOI 10.1002/anie.201408598; Seidel K, 2004, PHYS CHEM CHEM PHYS, V6, P5090, DOI 10.1039/b411689e; Sharma D, 2000, J BIOMOL NMR, V18, P165, DOI 10.1023/A:1008398416292; Shen Y, 2013, J BIOMOL NMR, V56, P227, DOI 10.1007/s10858-013-9741-y; Stevens TJ, 2011, J BIOMOL NMR, V51, P437, DOI 10.1007/s10858-011-9569-2; Sumner MO, 2004, J MOL BIOL, V335, P1279, DOI DOI 10.1016/J.JMB.2003.11.048; Tenidis K, 2000, J MOL BIOL, V295, P1055, DOI 10.1006/jmbi.1999.3422; Tuttle MD, 2016, NAT STRUCT MOL BIOL, V23, P409, DOI 10.1038/nsmb.3194; Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173; Tycko R, 2014, PROTEIN SCI, V23, P1528, DOI 10.1002/pro.2544; Van Melckebeke H, 2010, J AM CHEM SOC, V132, P13765, DOI [10.1021/ja104213J, 10.1021/ja104213j]; Verel R, 2001, J MAGN RESON, V150, P81, DOI 10.1006/jmre.2001.2310; WESTERMARK P, 1990, P NATL ACAD SCI USA, V87, P5036, DOI 10.1073/pnas.87.13.5036; Westermark P, 2011, PHYSIOL REV, V91, P795, DOI 10.1152/physrev.00042.2009; Wiltzius JJW, 2008, PROTEIN SCI, V17, P1467, DOI 10.1110/ps.036509.108; WISHART DS, 1994, J BIOMOL NMR, V4, P171; WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471; Xiao YL, 2015, NAT STRUCT MOL BIOL, V22, P499, DOI 10.1038/nsmb.2991	67	32	32	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161243	10.1371/journal.pone.0161243	http://dx.doi.org/10.1371/journal.pone.0161243			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607147	Green Published, gold			2022-12-26	WOS:000383255600003
J	Bless, PJ; Ribera, JM; Schmutz, C; Zeller, A; Mausezahl, D				Bless, Philipp J.; Ribera, Joan Muela; Schmutz, Claudia; Zeller, Andreas; Mausezahl, Daniel			Acute Gastroenteritis and Campylobacteriosis in Swiss Primary Care: The Viewpoint of General Practitioners	PLOS ONE			English	Article							HEMOLYTIC-UREMIC SYNDROME; RISK-FACTORS; ANTIBIOTIC-TREATMENT; INFECTIOUS DIARRHEA; SURVEILLANCE; COMMUNITY; NETHERLANDS; SALMONELLA; MANAGEMENT; PATHOGENS	Acute gastroenteritis (AG) is frequently caused by infectious intestinal diseases (IID) including food- and waterborne pathogens of public health importance. Among these pathogens, Campylobacter spp. plays a major role. Many European countries monitor selected IIDs within disease surveillance systems. In Switzerland, the information on IIDs is restricted to limited surveillance data, while no data is available for AG. We conducted a qualitative study among Swiss general practitioners (GPs) to investigate the case management of AG and campylobacteriosis patients, the associated disease burden and the determinants leading to registration in the National Notification System for Infectious Diseases (NNSID). Interviews were conducted with a semi-structured questionnaire and underwent inductive content analysis based on Grounded Theory. The questionnaire was repeatedly adapted to capture emerging themes until the point of theoretical saturation. GPs perceived AG and campylobacteriosis of little relevance to their daily work and public health in general. According to GP self-estimates each consults about two cases of AG per week and diagnoses a median of five campylobacteriosis cases per year. A large proportion of AG cases receives telephone consultations only and gets medical advice from the practice nurse. Antibiotic therapy is considered useful and stool diagnostics are performed for about a fifth of consulting AG patients. Stool diagnostics ("test") and antibiotic therapy ("treat") are interrelated and follow four strategies: "Wait & See", "Treat & See", "Treat & Test", and "Test & See". AG case management is diverse and includes different triage steps. A small proportion of AG patients have stool diagnostics performed and only positive tested patients are reported to the NNSID. As a result severe cases and cases with a history of travel abroad are overrepresented in the NNSID. The use of multiplex PCR panels in routine diagnostics likely leads to improved case management and higher case numbers in surveillance systems.	[Bless, Philipp J.; Schmutz, Claudia; Mausezahl, Daniel] Swiss Trop & Publ Hlth Inst, Basel, Switzerland; [Bless, Philipp J.; Schmutz, Claudia; Mausezahl, Daniel] Univ Basel, Basel, Switzerland; [Ribera, Joan Muela] Partners Appl Social Sci PASS Suisse, Neuchatel, Switzerland; [Zeller, Andreas] Univ Basel, Ctr Primary Hlth Care, Basel, Switzerland	University of Basel; Swiss Tropical & Public Health Institute; University of Basel; University of Basel	Mausezahl, D (corresponding author), Swiss Trop & Publ Hlth Inst, Basel, Switzerland.; Mausezahl, D (corresponding author), Univ Basel, Basel, Switzerland.	daniel.maeusezahl@unibas.ch	Schmutz, Claudia/H-5444-2019; Ribera, JM/B-8181-2009	Schmutz, Claudia/0000-0002-1028-0718; Ribera, JM/0000-0003-1042-6024; muela ribera, joan/0000-0003-2111-6275	Swiss Federal Office of Public Health [12.007954]; Swiss Federal Office of Public Health, Division of Communicable Diseases	Swiss Federal Office of Public Health; Swiss Federal Office of Public Health, Division of Communicable Diseases	The Swiss Federal Office of Public Health funded the study as part of a project studying the epidemiology of campylobacteriosis among the Swiss population, Contract Number: 12.007954, URL: www.bag.admin.ch. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank the participants of the pilot study and the study participants. We kindly thank Sonia Ferroni Yameogo, Meike-Kathrin Zuske and Susanna Hausmann-Muela for their commitment in interviewing physicians, and Amena Briet, from the Swiss Tropical and Public Health Institute, for her critical language editing. The support of the Swiss Federal Office of Public Health, Division of Communicable Diseases for the study is gratefully acknowledged.	[Anonymous], 2016, 818101126 SR FED DEP; Baumgartner A, 2011, J FOOD PROTECT, V74, P2048, DOI 10.4315/0362-028X.JFP-11-228; Binnicker MJ, 2015, J CLIN MICROBIOL, V53, P3723, DOI 10.1128/JCM.02103-15; Bless PJ, 2014, EUR J EPIDEMIOL, V29, P527, DOI 10.1007/s10654-014-9917-0; Crim SM, 2015, MMWR-MORBID MORTAL W, V64, P495; De Wit MAS, 2001, EPIDEMIOL INFECT, V127, P389, DOI 10.1017/S0950268801006082; Doorduyn Y, 2010, EPIDEMIOL INFECT, V138, P1391, DOI 10.1017/S095026881000052X; DuPont HL, 2014, NEW ENGL J MED, V370, P1532, DOI 10.1056/NEJMra1301069; DuPont HL, 2009, NEW ENGL J MED, V361, P1560, DOI 10.1056/NEJMcp0904162; European Food Safety Authority, 2015, EFSA J, V13, DOI 10.2903/j.efsa.2015.4036; European Food Safety Authority and European Centre for Disease Prevention and Control, 2015, EFSA J, V13, DOI [10.2903/j.efsa.2015.4329, DOI 10.2903/J.EFSA.2015.43291560-7917.ES.2016.21.6.30130]; Flahault A, 2006, STAT METHODS MED RES, V15, P413, DOI 10.1177/0962280206071639; Friesema IHM, 2012, EPIDEMIOL INFECT, V140, P1780, DOI 10.1017/S0950268811002652; Gilliss Debra, 2011, Morbidity and Mortality Weekly Report, V60, P749; Gras LM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042599; Guerrant RL, 2001, CLIN INFECT DIS, V32, P331, DOI 10.1086/318514; Hennessy TW, 2004, CLIN INFECT DIS, V38, pS203, DOI 10.1086/381588; Huhulescu S, 2009, INFECTION, V37, P103, DOI 10.1007/s15010-008-8106-z; Janiec J, 2012, EPIDEMIOL INFECT, V140, P2045, DOI 10.1017/S0950268811002822; Karsten C, 2009, EUR J CLIN MICROBIOL, V28, P935, DOI 10.1007/s10096-009-0729-1; Ke BX, 2012, FOODBORNE PATHOG DIS, V9, P47, DOI 10.1089/fpd.2011.0964; Kubota K, 2011, J FOOD PROTECT, V74, P1592, DOI 10.4315/0362-028X.JFP-10-387; Lorenzoni L, 2014, LANCET, V384, P83, DOI 10.1016/S0140-6736(14)60571-7; McNulty CAM, 2014, BRIT J GEN PRACT, V64, pE24, DOI 10.3399/bjgp14X676429; McNulty CAM, 2012, BMC FAM PRACT, V13, DOI 10.1186/1471-2296-13-77; Morgan D.R., 2015, CLIN INFECT DIS, P334; Neimann J, 2003, EPIDEMIOL INFECT, V130, P353, DOI 10.1017/S0950268803008355; Nichols GL, 2012, BMJ OPEN, V2, DOI 10.1136/bmjopen-2012-001179; Niederer L, 2012, APPL ENVIRON MICROB, V78, P288, DOI 10.1128/AEM.06194-11; Painter JA, 2013, EMERG INFECT DIS, V19, P407, DOI 10.3201/eid1903.111866; Safdar N, 2002, JAMA-J AM MED ASSOC, V288, P996, DOI 10.1001/jama.288.8.996; Scallan E, 2006, FOODBORNE PATHOG DIS, V3, P432, DOI 10.1089/fpd.2006.3.432; Scallan E, 2011, EMERG INFECT DIS, V17, P16, DOI [10.3201/eid1701.P21101, 10.3201/eid1701.091101p2]; Scallan Elaine, 2005, Eur J Gen Pract, V11, P136; Scherer K, 2006, J FOOD PROTECT, V69, P757, DOI 10.4315/0362-028X-69.4.757; Schielke A, 2014, BMC INFECT DIS, V14, DOI 10.1186/1471-2334-14-30; Schmid H., 2012, FOODBORNE OUTBREAKS; Schmutz C, 2016, EUROSURVEILLANCE, V21, P9, DOI [10.2807/1560-7917.ES.2016.21.6.30130, 10.2807/1560-791730130]; SCHORR D, 1994, ZBL HYG UMWELTMED, V196, P327; Schweiger A, 2005, SCHWEIZ MED FORUM, V5, P714; Spina A, 2015, CLIN MICROBIOL INFEC, V21, P719, DOI 10.1016/j.cmi.2015.04.007; Tam CC, 2012, CLIN INFECT DIS, V54, P1275, DOI 10.1093/cid/cis028; Tam CC, 2012, GUT, V61, P69, DOI 10.1136/gut.2011.238386; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Van Cauteren D, 2015, EPIDEMIOL INFECT, V143, P2532, DOI 10.1017/S0950268814003884; van den Brandhof Winette E, 2006, BMC Fam Pract, V7, P56, DOI 10.1186/1471-2296-7-56; van Pelt W, 2003, EPIDEMIOL INFECT, V130, P431, DOI 10.1017/S0950268803008392; Wessels E, 2014, CLIN MICROBIOL INFEC, V20, pO182, DOI 10.1111/1469-0691.12364; Wong CS, 2000, NEW ENGL J MED, V342, P1930, DOI 10.1056/NEJM200006293422601	49	5	5	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161650	10.1371/journal.pone.0161650	http://dx.doi.org/10.1371/journal.pone.0161650			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603141	Green Published, gold, Green Accepted, Green Submitted			2022-12-26	WOS:000383255200020
J	An, D; Cui, YJ; Liu, X; Jia, SQ; Zheng, SY; Che, XP; Liu, Z; Zhang, XD; Zhu, DH; Li, SM				An, Dong; Cui, Yongjin; Liu, Xu; Jia, Shiqiang; Zheng, Shuyun; Che, Xiaoping; Liu, Zhe; Zhang, Xiaodong; Zhu, Dehai; Li, Shaoming			Effects of Varieties, Producing Areas, Ears, and Ear Positions of Single Maize Kernels on Near-Infrared Spectra for Identification and Traceability	PLOS ONE			English	Article							WHEAT; SPECTROSCOPY; GENOTYPES; STARCH; ORIGIN	The effects of varieties, producing areas, ears, and ear positions of maize on near-infrared (NIR) spectra were investigated to determine the factors causing the differences in NIR fingerprints of maize varieties. A total of 130 inbred lines were grown in two regions in China, and 12,350 kernel samples were analyzed through NIR spectroscopy. Spectral differences among varieties, producing areas, ears, and ear positions were determined and compared on the basis of pretreated spectra. The bands at 1300-1470, 1768-1949, 2010-2064, and 2235-2311 nm were mainly affected by the producing area. Band selection and principal component analysis were applied to improve the influence of variety on NIR spectra by processing the pretreated spectra. The degrees of the influence of varieties, producing areas, ears, and ear positions were calculated, and the percentages of the influence of varieties, producing areas, ears, and ear positions were 45.40%, 42.66%, 8.22%, and 3.72%, respectively. Therefore, genetic differences among maize inbred lines are the main factors accounted for NIR spectral differences. Producing area is a secondary factor. These results could provide a reference for researchers who authenticate varieties, perform geographical origin traceabilities, and conduct maize seed breeding.	[An, Dong; Cui, Yongjin; Liu, Xu; Jia, Shiqiang; Liu, Zhe; Zhang, Xiaodong; Zhu, Dehai; Li, Shaoming] China Agr Univ, Coll Informat & Elect Engn, Beijing 100083, Peoples R China; [An, Dong] Minist Educ, Modern Precis Agr Syst Integrat Res Key Lab, Beijing 100083, Peoples R China; [Li, Shaoming] Minist Agr, Key Lab Agr Informat Acquisit Technol Beijing, Beijing 100083, Peoples R China; [Zheng, Shuyun; Che, Xiaoping] Beijing Kings Nower Seed S&T CO LTD, Beijing 100080, Peoples R China	China Agricultural University; Ministry of Agriculture & Rural Affairs	An, D (corresponding author), China Agr Univ, Coll Informat & Elect Engn, Beijing 100083, Peoples R China.; An, D (corresponding author), Minist Educ, Modern Precis Agr Syst Integrat Res Key Lab, Beijing 100083, Peoples R China.	andongcau@163.com		Lee, Mijoon/0000-0001-7432-0427	Development and application of grating type near infrared analyzer and its common model [2014YQ470377]; China Agricultural University Education Foundation Dabeinong Education funds [1081-2413001]; National Special Fund for Agro-scientific Research in the Public Interest [201203052]; Beijing Kings Nower Seed ST CO., LTD	Development and application of grating type near infrared analyzer and its common model; China Agricultural University Education Foundation Dabeinong Education funds; National Special Fund for Agro-scientific Research in the Public Interest; Beijing Kings Nower Seed ST CO., LTD	The authors gratefully acknowledge the financial support provided by Development and application of grating type near infrared analyzer and its common model (grant no. 2014YQ470377 to Dong An), China Agricultural University Education Foundation Dabeinong Education funds (grant no. 1081-2413001 to Dong An), and National Special Fund for Agro-scientific Research in the Public Interest (grant no. 201203052 to Dong An). Coauthors Shuyun Zheng and Xiaoping Che are employed by Beijing Kings Nower Seed S&T CO., LTD. Beijing Kings Nower Seed S&T CO., LTD provided support in the form of salaries for authors SZ and XC, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Baxter IR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087628; Cozzolino D, 2014, FOOD RES INT, V60, P262, DOI 10.1016/j.foodres.2013.08.034; Fox G, 2011, FIELD CROP RES, V120, P380, DOI 10.1016/j.fcr.2010.11.007; Garcia I, 2007, ANAL CHIM ACTA, V587, P222, DOI 10.1016/j.aca.2007.01.054; Garcia-Molina MD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152292; Huang YY, 2011, SPECTROSC SPECT ANAL, V31, P2706, DOI 10.3964/j.issn.1000-0593(2011)10-2706-05; Jia SQ, 2015, J CEREAL SCI, V63, P21, DOI 10.1016/j.jcs.2014.07.003; Kindred DR, 2008, J CEREAL SCI, V48, P46, DOI 10.1016/j.jcs.2007.07.010; Redaelli R, 2013, J CEREAL SCI, V57, P193, DOI 10.1016/j.jcs.2012.09.003; Tallada JG, 2009, J CEREAL SCI, V50, P381, DOI 10.1016/j.jcs.2009.08.003; Wickramasinghe HAM, 2005, FOOD CHEM, V93, P9, DOI 10.1016/j.foodchem.2004.08.049; Zhao HY, 2014, FOOD CHEM, V152, P316, DOI 10.1016/j.foodchem.2013.11.122; Zhao HY, 2013, FOOD CHEM, V138, P1902, DOI 10.1016/j.foodchem.2012.11.037	13	8	8	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161489	10.1371/journal.pone.0161489	http://dx.doi.org/10.1371/journal.pone.0161489			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598344	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800009
J	Chiou, JW; Fu, B; Chou, RH; Yu, C				Chiou, Jian Wei; Fu, Brian; Chou, Ruey-Hwang; Yu, Chin			Blocking the Interactions between Calcium-Bound S100A12 Protein and the V Domain of RAGE Using Tranilast	PLOS ONE			English	Article							GLYCATION END-PRODUCTS; CELL-SURFACE RECEPTOR; BINDING PROTEINS; THERAPEUTIC TARGET; NONINVASIVE MARKER; STRUCTURAL BASIS; SINGLE RECEPTOR; FECAL S100A12; CALGRANULIN-C; NF-KB	The receptor for advanced glycation end products (RAGE), a transmembrane receptor in the immunoglobulin superfamily, is involved in several inflammatory processes. RAGE induces cellular signaling pathways upon binding with various ligands, such as advanced glycation end products (AGEs), beta-amyloids, and S100 proteins. The solution structure of S100A12 and the V ligand-binding region of RAGE have been reported previously. Using heteronuclear NMR spectroscopy to conduct H-1-N-15 heteronuclear single quantum coherence (HSQC) titration experiments, we identified and mapped the binding interface between S100A12 and the V domain of RAGE. The NMR chemical shift data were used as the constraints for the High Ambiguity Driven biomolecular DOCKing (HADDOCK) calculation to generate a structural model of the S100A12-V domain complex. In addition, tranilast (an anti-allergic drug) showed strong interaction with S100A12 in the H-1-N-15 HSQC titration, fluorescence experiments, and WST-1 assay. The results also indicated that tranilast was located at the binding site between S100A12 and the V domain, blocking interaction between these two proteins. Our results provide the mechanistic details for a structural model and reveal a potential precursor for an inhibitor for pro-inflammatory diseases, which could be useful for the development of new drugs.	[Chiou, Jian Wei; Yu, Chin] Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan; [Fu, Brian] Northwood High Sch, Irvine, CA 92620 USA; [Chou, Ruey-Hwang] China Med Univ, Grad Inst Canc Biol, Taichung 40402, Taiwan; [Chou, Ruey-Hwang] China Med Univ, Ctr Mol Med, Taichung 40402, Taiwan; [Chou, Ruey-Hwang] Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan	National Tsing Hua University; China Medical University Taiwan; China Medical University Taiwan; Asia University Taiwan	Yu, C (corresponding author), Natl Tsing Hua Univ, Dept Chem, Hsinchu 30013, Taiwan.; Chou, RH (corresponding author), China Med Univ, Grad Inst Canc Biol, Taichung 40402, Taiwan.; Chou, RH (corresponding author), China Med Univ, Ctr Mol Med, Taichung 40402, Taiwan.; Chou, RH (corresponding author), Asia Univ, Dept Biotechnol, Taichung 41354, Taiwan.	rhchou@gmail.com; cyu.nthu@gmail.com	Chou, Ruey-Hwang/K-8541-2013	Chou, Ruey-Hwang/0000-0002-2297-2180	Ministry of Science and Technology (MOST) Taiwan [MOST 103-2113-M-007-017-MY3, MOST 104-2320-B-039-031]; China Medical University, Taiwan [CMU104-S-02]	Ministry of Science and Technology (MOST) Taiwan(Ministry of Science and Technology, Taiwan); China Medical University, Taiwan(China Medical University)	This research was supported by the Ministry of Science and Technology (MOST) Taiwan (Grant number MOST 103-2113-M-007-017-MY3). The partition of WST-1 assay was supported by the Ministry of Science and Technology (MOST) Taiwan (Grant number MOST 104-2320-B-039-031) and China Medical University (Grant number CMU104-S-02), Taiwan. MOST: https://www.most.gov.tw/. China Medical University: http://www.cmu.edu.tw/.	Austermann J, 2008, J BIOL CHEM, V283, P29331, DOI 10.1074/jbc.M806145200; Bhattacharya S, 2004, BBA-MOL CELL RES, V1742, P69, DOI 10.1016/j.bbamcr.2004.09.002; Bierhaus A, 2009, DIABETOLOGIA, V52, P2251, DOI 10.1007/s00125-009-1458-9; BURSTEIN EA, 1973, PHOTOCHEM PHOTOBIOL, V18, P263, DOI 10.1111/j.1751-1097.1973.tb06422.x; Darakhshan S, 2015, PHARMACOL RES, V91, P15, DOI 10.1016/j.phrs.2014.10.009; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; de Jong NSH, 2006, INFLAMM BOWEL DIS, V12, P566, DOI 10.1097/01.ibd.0000227626.72271.91; Deane R, 2012, J CLIN INVEST, V122, P1377, DOI 10.1172/JCI58642; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Dominguez C, 2004, STRUCTURE, V12, P633, DOI 10.1016/j.str.2004.03.004; Dominguez C, 2003, J AM CHEM SOC, V125, P1731, DOI 10.1021/ja026939x; Donato R, 2003, MICROSC RES TECHNIQ, V60, P540, DOI 10.1002/jemt.10296; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Fritz G, 2011, TRENDS BIOCHEM SCI, V36, P625, DOI 10.1016/j.tibs.2011.08.008; Gebhardt C, 2008, J EXP MED, V205, P275, DOI 10.1084/jem.20070679; GOTTSCH JD, 1995, INVEST OPHTH VIS SCI, V36, P1541; GUIGNARD F, 1995, BIOCHEM J, V309, P395, DOI 10.1042/bj3090395; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hsieh HL, 2003, BIOCHEM BIOPH RES CO, V307, P375, DOI 10.1016/S0006-291X(03)01190-2; Huang S, 2012, ONCOGENE, V31, P4164, DOI 10.1038/onc.2011.590; Huang YK, 2016, J BIOL CHEM, V291, P14300, DOI 10.1074/jbc.M116.722215; Huang YK, 2016, J BIOL CHEM; Hubbard S.J, 1993, NACCESS, V2; Hung KW, 2013, J BIOMOL NMR, V57, P313, DOI 10.1007/s10858-013-9781-3; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; Jensen JL, 2015, ACTA CRYSTALLOGR D, V71, P1176, DOI 10.1107/S1399004715004216; Kaiser T, 2007, GUT, V56, P1706, DOI 10.1136/gut.2006.113431; Kallinich T, 2010, ANN RHEUM DIS, V69, P677, DOI 10.1136/ard.2009.114363; Kang JH, 2015, IMMUNOLOGY, V144, P79, DOI 10.1111/imm.12352; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Kokkola R, 2005, SCAND J IMMUNOL, V61, P1, DOI 10.1111/j.0300-9475.2005.01534.x; Kosaki A, 2004, J CLIN ENDOCR METAB, V89, P5423, DOI 10.1210/jc.2003-032223; Lakowicz J.R., 2013, PRINCIPLES FLUORESCE; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Lewit-Bentley A, 2000, CURR OPIN STRUC BIOL, V10, P637, DOI 10.1016/S0959-440X(00)00142-1; Li D, 2016, TUMOR BIOL, V37, P6551, DOI 10.1007/s13277-015-4460-5; Marsche G, 2007, FASEB J, V21, P1145, DOI 10.1096/fj.06-7439com; McClintock KA, 2003, J BIOL CHEM, V278, P6251, DOI 10.1074/jbc.M210622200; Mohan SK, 2013, BIOCHEM BIOPH RES CO, V434, P328, DOI 10.1016/j.bbrc.2013.03.049; Moroz OV, 2009, J MOL BIOL, V391, P536, DOI 10.1016/j.jmb.2009.06.004; Moroz OV, 2009, BMC BIOCHEM, V10, DOI 10.1186/1471-2091-10-11; Moroz OV, 2003, MICROSC RES TECHNIQ, V60, P581, DOI 10.1002/jemt.10300; Murakami Y, 2006, BIOINFORMATICS, V22, P1794, DOI 10.1093/bioinformatics/btl171; NEEPER M, 1992, J BIOL CHEM, V267, P14998; Nlatsumoto S, 2008, BIOCHEMISTRY-US, V47, P12299, DOI 10.1021/bi800910v; Oesterle A, 2015, ARTERIOSCL THROM VAS, V35, P2496, DOI 10.1161/ATVBAHA.115.302072; Penumutchu SR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103947; Ramasamy R, 2009, J LEUKOCYTE BIOL, V86, P505, DOI 10.1189/jlb.0409230; Rety S, 2000, STRUCTURE, V8, P175, DOI 10.1016/S0969-2126(00)00093-9; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Shishibori T, 1999, BIOCHEM J, V338, P583, DOI 10.1042/0264-6021:3380583; Sousa MM, 2000, LAB INVEST, V80, P1101, DOI 10.1038/labinvest.3780116; Tan AS, 2000, J IMMUNOL METHODS, V238, P59, DOI 10.1016/S0022-1759(00)00156-3; Tsukatani T, 2008, J MICROBIOL METH, V75, P109, DOI 10.1016/j.mimet.2008.05.016; Wicki R, 1996, CELL CALCIUM, V20, P459, DOI 10.1016/S0143-4160(96)90087-1; Wilsmann-Theis D, 2016, J EUR ACAD DERMATOL, V30, P1165, DOI 10.1111/jdv.13269; WL D, 2002, PYMOL MOL GRAPHICS S; Xie J, 2007, J BIOL CHEM, V282, P4218, DOI 10.1074/jbc.M608888200; Xue J, 2014, BIOCHEMISTRY-US, V53, P3327, DOI 10.1021/bi500046t; Xue J, 2011, STRUCTURE, V19, P722, DOI 10.1016/j.str.2011.02.013; Yamagishi SI, 2008, CURR PHARM DESIGN, V14, P487, DOI 10.2174/138161208783597416; Yan SD, 1996, NATURE, V382, P685, DOI 10.1038/382685a0; Yang Z, 2007, J ALLERGY CLIN IMMUN, V119, P106, DOI 10.1016/j.jaci.2006.08.021; Zeng S, 2004, HEPATOLOGY, V39, P422, DOI 10.1002/hep.20045; Zill H, 2001, BIOCHEM BIOPH RES CO, V288, P1108, DOI 10.1006/bbrc.2001.5901; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2	68	16	16	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162000	10.1371/journal.pone.0162000	http://dx.doi.org/10.1371/journal.pone.0162000			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598566	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800031
J	da Silva, ES; Mulinge, M; Lemaire, M; Masquelier, C; Beraud, C; Rybicki, A; Servais, JY; Iserentant, G; Schmit, JC; Seguin-Devaux, C; Bercoff, DP				da Silva, Eveline Santos; Mulinge, Martin; Lemaire, Morgane; Masquelier, Cecile; Beraud, Cyprien; Rybicki, Arkadiusz; Servais, Jean-Yves; Iserentant, Gilles; Schmit, Jean-Claude; Seguin-Devaux, Carole; Bercoff, Danielle Perez			The Envelope Cytoplasmic Tail of HIV-1 Subtype C Contributes to Poor Replication Capacity through Low Viral Infectivity and Cell-to-Cell Transmission	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; TYPE-1 MATRIX PROTEIN; PRIMARY HUMAN MACROPHAGES; ENV-MEDIATED FUSION; GLYCOPROTEIN INCORPORATION; VIROLOGICAL SYNAPSES; SURFACE EXPRESSION; CLATHRIN ADAPTER; PLASMA-MEMBRANE; TRANSMEMBRANE PROTEINS	The cytoplasmic tail (gp41CT) of the HIV-1 envelope (Env) mediates Env incorporation into virions and regulates Env intracellular trafficking. Little is known about the functional impact of variability in this domain. To address this issue, we compared the replication of recombinant virus pairs carrying the full Env (Env viruses) or the Env ectodomain fused to the gp41CT of NL4.3 (EnvEC viruses) (12 subtype C and 10 subtype B pairs) in primary CD4+ T-cells and monocyte-derived-macrophages (MDMs). In CD4+ T-cells, replication was as follows: B-EnvEC = B-Env>C-EnvEC>C-Env, indicating that the gp41CT of subtype C contributes to the low replicative capacity of this subtype. In MDMs, in contrast, replication capacity was comparable for all viruses regardless of subtype and of gp41CT. In CD4+ T-cells, viral entry, viral release and viral gene expression were similar. However, infectivity of free virions and cell-to-cell transmission of C-Env viruses released by CD4+ T-cells was lower, suggestive of lower Env incorporation into virions. Subtype C matrix only minimally rescued viral replication and failed to restore infectivity of free viruses and cell-to-cell transmission. Taken together, these results show that polymorphisms in the gp41CT contribute to viral replication capacity and suggest that the number of Env spikes per virion may vary across subtypes. These findings should be taken into consideration in the design of vaccines.	[da Silva, Eveline Santos; Mulinge, Martin; Lemaire, Morgane; Masquelier, Cecile; Beraud, Cyprien; Rybicki, Arkadiusz; Servais, Jean-Yves; Iserentant, Gilles; Schmit, Jean-Claude; Seguin-Devaux, Carole; Bercoff, Danielle Perez] Luxembourg Inst Hlth, Dept Infect & Immun, 29 Rue Henri Koch, L-4354 Esch Sur Alzette, Luxembourg; [Schmit, Jean-Claude] Ctr Hosp Luxembourg, Serv Natl Malad Infect, 4 Rue Ernest Barble, L-1210 Luxembourg, Luxembourg	Luxembourg Institute of Health; Luxembourg Hospital Center	Bercoff, DP (corresponding author), Luxembourg Inst Hlth, Dept Infect & Immun, 29 Rue Henri Koch, L-4354 Esch Sur Alzette, Luxembourg.	danielle.perezbercoff@lih.lu	Mulinge, Martin/GWU-7942-2022	Seguin-Devaux, Carole/0000-0003-0636-5222; mulinge, martin/0000-0001-9613-5425; Beraud, Cyprien/0000-0002-5503-6938; Perez Bercoff, Danielle/0000-0003-4415-0150	Luxembourg Ministry of Research and Education MESR [REC-LRTV20101106]; Fonds National de la Recherche AFR [PHD-09-115, PHD-08-074, AFR-6012272]; Luxembourg Ministry of Research and Education Grants [MESR LRTV20100604, REC-LRTV10131106]; Fonds National de la Recherche (AFR grants) [PHD-09-115, PHD-08-074, AFR-6012272]	Luxembourg Ministry of Research and Education MESR; Fonds National de la Recherche AFR(Luxembourg National Research Fund); Luxembourg Ministry of Research and Education Grants; Fonds National de la Recherche (AFR grants)(Luxembourg National Research Fund)	This work was supported by the Luxembourg Ministry of Research and Education MESR Grant# REC-LRTV20101106, and Fonds National de la Recherche AFR grant# PHD-09-115 ESS, #PHD-08-074 MM and AFR-6012272 CB (http://fnr.lu/funding-instruments/afr).; This work was supported by the Luxembourg Ministry of Research and Education Grants #MESR LRTV20100604 and REC-LRTV10131106. ESS, MM and CB were supported by PhD fellowships from the Fonds National de la Recherche (AFR grants #PHD-09-115, #PHD-08-074 and AFR-6012272 respectively).	ADACHI A, 1986, J VIROL, V59, P284, DOI 10.1128/JVI.59.2.284-291.1986; Akari H, 2000, J VIROL, V74, P4891, DOI 10.1128/JVI.74.10.4891-4893.2000; Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955; Arien KK, 2005, J VIROL, V79, P8979, DOI 10.1128/JVI.79.14.8979-8990.2005; Arts EJ, 2006, INFECT SUBT C HIV 1; Baatz F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021535; Ball SC, 2003, J VIROL, V77, P1021, DOI 10.1128/JVI.77.2.1021-1038.2003; Batonick M, 2005, VIROLOGY, V342, P190, DOI 10.1016/j.virol.2005.08.001; Bauby H, 2010, TRAFFIC, V11, P455, DOI 10.1111/j.1600-0854.2010.01036.x; Beaumont E, 2009, J VIROL, V83, P9875, DOI 10.1128/JVI.01213-09; Berlioz-Torrent C, 1999, J VIROL, V73, P1350, DOI 10.1128/JVI.73.2.1350-1361.1999; Bhakta SJ, 2011, RETROVIROLOGY, V8, DOI 10.1186/1742-4690-8-37; Blanco J, 2004, J BIOL CHEM, V279, P51305, DOI 10.1074/jbc.M408547200; Blot G, 2003, J VIROL, V77, P6931, DOI 10.1128/JVI.77.12.6931-6945.2003; Blot G, 2006, J MOL BIOL, V364, P1034, DOI 10.1016/j.jmb.2006.09.080; Blumenthal R, 2012, J BIOL CHEM, V287, P40841, DOI 10.1074/jbc.R112.406272; BOSCH ML, 1989, SCIENCE, V244, P694, DOI 10.1126/science.2541505; Brandano L, 2012, J VIROL, V86, P2347, DOI 10.1128/JVI.06047-11; BRASSEUR R, 1990, BIOCHIM BIOPHYS ACTA, V1029, P267, DOI 10.1016/0005-2736(90)90163-I; Bultmann A, 2001, J VIROL, V75, P5263, DOI 10.1128/JVI.75.11.5263-5276.2001; Byland R, 2007, MOL BIOL CELL, V18, P414, DOI 10.1091/mbc.E06-06-0535; Camus G, 2007, MOL BIOL CELL, V18, P3193, DOI 10.1091/mbc.E06-12-1147; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Centlivre M, 2006, AIDS, V20, P657, DOI 10.1097/01.aids.0000216365.38572.2f; Centlivre M, 2005, J CLIN INVEST, V115, P348, DOI 10.1172/JCI200522873; Chan DC, 1997, CELL, V89, P263, DOI 10.1016/S0092-8674(00)80205-6; Checkley MA, 2013, J VIROL, V87, P3561, DOI 10.1128/JVI.03299-12; Checkley MA, 2011, J MOL BIOL, V410, P582, DOI 10.1016/j.jmb.2011.04.042; Chen P, 2007, J VIROL, V81, P12582, DOI 10.1128/JVI.00381-07; Chojnacki J, 2012, SCIENCE, V338, P524, DOI 10.1126/science.1226359; Constantino AA, 2011, NEUROTOX RES, V20, P277, DOI 10.1007/s12640-011-9241-3; Cosson P, 1996, EMBO J, V15, P5783, DOI 10.1002/j.1460-2075.1996.tb00964.x; da Silva ES, 2013, RETROVIROLOGY, V10, DOI 10.1186/1742-4690-10-54; Dale BM, 2013, IMMUNOL REV, V251, P113, DOI 10.1111/imr.12022; DALGLEISH AG, 1984, NATURE, V312, P763, DOI 10.1038/312763a0; De Candia C, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-259; de Oliveira T, 2005, BIOINFORMATICS, V21, P3797, DOI 10.1093/bioinformatics/bti607; Denek M, 2007, J CELL BIOL, V177, P329, DOI 10.1083/jcb.200609050; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; Deschambeault J, 1999, J VIROL, V73, P5010, DOI 10.1128/JVI.73.6.5010-5017.1999; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Doms RW, 2000, J CELL BIOL, V151, pF9, DOI 10.1083/jcb.151.2.F9; Dragic T, 1996, NATURE, V381, P667, DOI 10.1038/381667a0; DUBAY JW, 1992, J VIROL, V66, P6616, DOI 10.1128/JVI.66.11.6616-6625.1992; Durham ND, 2015, J VIROL, V89, P9324, DOI 10.1128/JVI.00655-15; Durham ND, 2012, J VIROL, V86, P7484, DOI 10.1128/JVI.00230-12; Edwards TG, 2002, J VIROL, V76, P2683, DOI 10.1128/JVI.76.6.2683-2691.2002; Egan MA, 1996, J VIROL, V70, P6547, DOI 10.1128/JVI.70.10.6547-6556.1996; Emerson V, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-43; Emerson V, 2010, J VIROL, V84, P1355, DOI 10.1128/JVI.01641-09; FACKE M, 1993, J VIROL, V67, P4972; Feng Y, 1996, SCIENCE, V272, P872, DOI 10.1126/science.272.5263.872; Fledderman EL, 2010, BIOCHEMISTRY-US, V49, P9551, DOI 10.1021/bi101245j; FREED EO, 1990, P NATL ACAD SCI USA, V87, P4650, DOI 10.1073/pnas.87.12.4650; FREED EO, 1995, J VIROL, V69, P1984, DOI 10.1128/JVI.69.3.1984-1989.1995; FREED EO, 1994, J VIROL, V68, P5311, DOI 10.1128/JVI.68.8.5311-5320.1994; Freed EO, 1996, J VIROL, V70, P341, DOI 10.1128/JVI.70.1.341-351.1996; FREED EO, 1995, J VIROL, V69, P3949, DOI 10.1128/JVI.69.6.3949-3954.1995; Fultz PN, 2001, J VIROL, V75, P278, DOI 10.1128/JVI.75.1.278-291.2001; Gonzalez SA, 1996, J VIROL, V70, P6384; GOTTLINGER HG, 1991, P NATL ACAD SCI USA, V88, P3195, DOI 10.1073/pnas.88.8.3195; Gousset K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000015; Groppelli E, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004518; HALLENBERGER S, 1992, NATURE, V360, P358, DOI 10.1038/360358a0; Haller C, 2008, BIOL CHEM, V389, P1253, DOI 10.1515/BC.2008.143; Hourioux C, 2000, AIDS RES HUM RETROV, V16, P1141, DOI 10.1089/088922200414983; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; HUNTER E, 1990, CURR TOP MICROBIOL, V157, P187; Iwatani Y, 2001, VIRUS RES, V74, P75, DOI 10.1016/S0168-1702(00)00249-5; Jacobs GB, 2012, VIRUSES-BASEL, V4, P1830, DOI 10.3390/v4091830; Jiang JY, 2007, J VIROL, V81, P9999, DOI 10.1128/JVI.00592-07; Johnson DC, 2002, J VIROL, V76, P1, DOI 10.1128/JVI.76.1.1-8.2002; Jolly C, 2004, TRAFFIC, V5, P643, DOI 10.1111/j.1600-0854.2004.00209.X; Jouve M, 2007, CELL HOST MICROBE, V2, P85, DOI 10.1016/j.chom.2007.06.011; Kalia V, 2003, J VIROL, V77, P3634, DOI 10.1128/JVI.77.6.3634-3646.2003; Koppensteiner H, 2012, J VIROL, V86, P2826, DOI 10.1128/JVI.05915-11; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; LABRANCHE CC, 1995, J VIROL, V69, P5217, DOI 10.1128/JVI.69.9.5217-5227.1995; Lambele M, 2007, J VIROL, V81, P125, DOI 10.1128/JVI.01659-06; Lee SF, 2000, J BIOL CHEM, V275, P15809, DOI 10.1074/jbc.M000601200; Lee YM, 1997, J VIROL, V71, P1443, DOI 10.1128/JVI.71.2.1443-1452.1997; Liu L, 2012, J VIROL, V86, P11242, DOI 10.1128/JVI.00544-12; Lodge R, 1997, EMBO J, V16, P695, DOI 10.1093/emboj/16.4.695; LODGE R, 1994, J VIROL, V68, P4857, DOI 10.1128/JVI.68.8.4857-4861.1994; Lopez-Verges S, 2006, P NATL ACAD SCI USA, V103, P14947, DOI 10.1073/pnas.0602941103; MADDON PJ, 1986, CELL, V47, P333, DOI 10.1016/0092-8674(86)90590-8; MAMMANO F, 1995, J VIROL, V69, P3824, DOI 10.1128/JVI.69.6.3824-3830.1995; Mao YD, 2012, NAT STRUCT MOL BIOL, V19, P893, DOI 10.1038/nsmb.2351; Micoli KJ, 2000, THE JOURNAL OF BIOLO, P27508, DOI [10.1016/j.jviromet.2005.10.008, DOI 10.1016/J.JVIROMET.2005.10.008]; MILLER MA, 1991, AIDS RES HUM RETROV, V7, P511, DOI 10.1089/aid.1991.7.511; Monel B, 2012, J VIROL, V86, P3924, DOI 10.1128/JVI.06478-11; Mulinge M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060566; Murakami T, 2000, J VIROL, V74, P3548, DOI 10.1128/JVI.74.8.3548-3554.2000; Murakami T, 2000, P NATL ACAD SCI USA, V97, P343, DOI 10.1073/pnas.97.1.343; Muranyi W, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003198; Murooka TT, 2012, NATURE, V490, P283, DOI 10.1038/nature11398; Murray JL, 2005, J VIROL, V79, P11742, DOI 10.1128/JVI.79.18.11742-11751.2005; NABEL G, 1987, NATURE, V326, P711, DOI 10.1038/326711a0; Ohno H, 1997, VIROLOGY, V238, P305, DOI 10.1006/viro.1997.8839; Ohno H, 1996, J BIOL CHEM, V271, P29009, DOI 10.1074/jbc.271.46.29009; OHNO H, 1995, SCIENCE, V269, P1872, DOI 10.1126/science.7569928; Ono A, 2000, J VIROL, V74, P2855, DOI 10.1128/JVI.74.6.2855-2866.2000; OWENS RJ, 1991, P NATL ACAD SCI USA, V88, P3987, DOI 10.1073/pnas.88.9.3987; Pan ZG, 1996, AM J PATHOL, V149, P903; Perez-Bercoff D, 2007, J VIROL, V81, P4540, DOI 10.1128/JVI.01620-06; Piller SC, 2000, J VIROL, V74, P11717, DOI 10.1128/JVI.74.24.11717-11723.2000; Pollakis G, 2004, J VIROL, V78, P2841, DOI 10.1128/JVI.78.6.2841-2852.2004; Postler TS, 2013, J VIROL, V87, P2, DOI 10.1128/JVI.02053-12; Postler TS, 2012, CELL HOST MICROBE, V11, P181, DOI 10.1016/j.chom.2011.12.005; Qi ML, 2015, P NATL ACAD SCI USA, V112, P7575, DOI 10.1073/pnas.1504174112; Qi ML, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003278; Radding W, 1996, BIOCHEM BIOPH RES CO, V218, P192, DOI 10.1006/bbrc.1996.0034; Rangel HR, 2003, J VIROL, V77, P9069, DOI 10.1128/JVI.77.16.9069-9073.2003; ROWELL JF, 1995, J IMMUNOL, V155, P473; Roy NH, 2013, J VIROL, V87, P7516, DOI 10.1128/JVI.00790-13; Rudnicka D, 2009, J VIROL, V83, P6234, DOI 10.1128/JVI.00282-09; Ruggiero E, 2008, J VIROL, V82, P7773, DOI 10.1128/JVI.00695-08; Ruiz A, 2013, VIROLOGY, V435, P395, DOI 10.1016/j.virol.2012.10.030; Sala M, 2006, CURR OPIN HIV AIDS, V1, P108, DOI 10.1097/01.COH.0000203835.01350.b4; Salemi M, 2005, J MOL EVOL, V60, P598, DOI 10.1007/s00239-004-0206-5; Sattentau QJ, 2010, VIRUSES-BASEL, V2, P1306, DOI 10.3390/v2061306; Sharova N, 2005, EMBO J, V24, P2481, DOI 10.1038/sj.emboj.7600707; Sourisseau M, 2007, J VIROL, V81, P1000, DOI 10.1128/JVI.01629-06; Sowinski S, 2008, NAT CELL BIOL, V10, P211, DOI 10.1038/ncb1682; SPEARMAN P, 1994, J VIROL, V68, P3232, DOI 10.1128/JVI.68.5.3232-3242.1994; Steckbeck JD, 2014, VIRUSES-BASEL, V6, P284, DOI 10.3390/v6010284; Steckbeck JD, 2013, J GEN VIROL, V94, P1, DOI 10.1099/vir.0.046508-0; Steckbeck JD, 2011, J BIOL CHEM, V286, P27156, DOI 10.1074/jbc.M111.258855; Struck D, 2014, NUCLEIC ACIDS RES, V42, DOI 10.1093/nar/gku739; Tang C, 2004, P NATL ACAD SCI USA, V101, P517, DOI 10.1073/pnas.0305665101; Tedbury PR, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003739; Van Laethem K, 2006, J VIROL METHODS, V132, P181, DOI 10.1016/j.jviromet.2005.10.008; Van Laethem K, 2005, J VIROL METHODS, V123, P25, DOI 10.1016/j.jviromet.2004.09.003; Wang LP, 2000, J IMMUNOL, V164, P5369, DOI 10.4049/jimmunol.164.10.5369; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; Welsch S, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030036; WILK T, 1992, VIROLOGY, V189, P167, DOI 10.1016/0042-6822(92)90692-I; Wyatt R, 1998, SCIENCE, V280, P1884, DOI 10.1126/science.280.5371.1884; Wyma DJ, 2000, J VIROL, V74, P9381, DOI 10.1128/JVI.74.20.9381-9387.2000; Wyss S, 2001, J VIROL, V75, P2982, DOI 10.1128/JVI.75.6.2982-2992.2001; Wyss S, 2005, J VIROL, V79, P12231, DOI 10.1128/JVI.79.19.12231-12241.2005; YU XF, 1993, J VIROL, V67, P4386, DOI 10.1128/JVI.67.7.4386-4390.1993; YU XF, 1993, J VIROL, V67, P213, DOI 10.1128/JVI.67.1.213-221.1993; YUAN X, 1993, J VIROL, V67, P6387, DOI 10.1128/JVI.67.11.6387-6394.1993; Zhang H, 1999, CURR BIOL, V9, P1271, DOI 10.1016/S0960-9822(99)80511-9; Zhu Y, 2007, CHEM BIOL DRUG DES, V70, P311, DOI 10.1111/j.1747-0285.2007.00564.x	146	2	2	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161596	10.1371/journal.pone.0161596	http://dx.doi.org/10.1371/journal.pone.0161596			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598717	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800012
J	Kalle, S; Tanner, R; Arund, J; Tomson, R; Luman, M; Fridolin, I				Kalle, Sigrid; Tanner, Risto; Arund, Jurgen; Tomson, Ruth; Luman, Merike; Fridolin, Ivo			4-Pyridoxic Acid in the Spent Dialysate: Contribution to Fluorescence and Optical Monitoring	PLOS ONE			English	Article							PERFORMANCE LIQUID-CHROMATOGRAPHY; CORONARY-ARTERY-DISEASE; VITAMIN SUPPLEMENTATION; PYRIDOXAL-PHOSPHATE; RENAL-INSUFFICIENCY; VASCULAR-DISEASE; RISK-FACTORS; METABOLISM; PLASMA; HOMOCYSTEINE	Aim In this work we estimated the contribution of the fluorescence of 4-pyridoxic acid (4-PA) to the total fluorescence of spent dialysate with the aim of evaluating the on-line monitoring of removal of this vitamin B-6 metabolite from the blood of patients with end-stage renal disease (ESRD). Methods Spectrofluorometric analysis of spent dialysate, collected from hemodialysis and hemodiafiltration sessions of 10 patients receiving regularly pyridoxine injections after dialysis treatment, was performed in the range of Ex/Em 220-500 nm. 4-PA in dialysate samples was identified and quantified using HPLC with fluorescent and MS/MS detection. Results Averaged HPLC chromatogram of spent dialysate had many peaks in the wavelength region of Ex320/Em430 nm where 4-PA was the highest peak with contribution of 42.2 +/- 17.0% at the beginning and 47.7 +/- 18.0% in the end of the dialysis. High correlation (R = 0.88-0.95) between 4-PA concentration and fluorescence intensity of spent dialysate was found in the region of Ex310-330/Em415-500 nm, respectively. Conclusion 4-PA elimination from the blood of ESRD patients can be potentially followed using monitoring of the fluorescence of the spent dialysate during dialysis treatments.	[Kalle, Sigrid; Tanner, Risto; Arund, Jurgen; Tomson, Ruth; Luman, Merike; Fridolin, Ivo] Tallinn Univ Technol, Dept Biomed Engn, Technomedicum, Tallinn, Estonia; [Luman, Merike] North Estonian Med Ctr, Ctr Nephrol, Tallinn, Estonia	Tallinn University of Technology	Kalle, S (corresponding author), Tallinn Univ Technol, Dept Biomed Engn, Technomedicum, Tallinn, Estonia.	sigrid.kalle@ttu.ee	Fridolin, Ivo/AAE-8365-2019; Fridolin, Ivo/H-5406-2015	Fridolin, Ivo/0000-0001-7374-4287; Tanner, Risto/0000-0001-6926-2752; Luman, Merike/0000-0003-4721-149X; Kontus, Sigrid/0000-0003-1378-5452; Arund, Jurgen/0000-0002-4894-6853	European Union through the European Regional Development Fund; Estonian Ministry of Education and Research [IUT19-02]	European Union through the European Regional Development Fund(European Commission); Estonian Ministry of Education and Research(Ministry of Education and Research, Estonia)	We would like to thank all the participating patients. The study was supported by the European Union through the European Regional Development Fund and the Estonian Ministry of Education and Research (https://www.hm.ee/en) under institutional research funding IUT19-02. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLMAN MA, 1989, MED J AUSTRALIA, V150, P130, DOI 10.5694/j.1326-5377.1989.tb136390.x; ANTONELLA T, 1991, BIOCHEM SOC T, V19, pS344, DOI 10.1042/bst019344s; Bor MV, 2003, CLIN CHEM, V49, P155, DOI 10.1373/49.1.155; Busch M, 2010, NEPHRON CLIN PRACT, V114, pC38, DOI 10.1159/000245068; Cabo R, 2014, CLIN CHIM ACTA, V433, P150, DOI 10.1016/j.cca.2014.03.003; Coburn SP, 2002, AM J CLIN NUTR, V75, P57, DOI 10.1093/ajcn/75.1.57; Combs G. F., 2008, VITAMINS FUNDAMENTAL, P318; DESCOMBES E, 1993, KIDNEY INT, V43, P1319, DOI 10.1038/ki.1993.185; Descombes E, 2000, ARTIF ORGANS, V24, P773, DOI 10.1046/j.1525-1594.2000.06553.x; Graham IM, 1997, JAMA-J AM MED ASSOC, V277, P1775, DOI 10.1001/jama.277.22.1775; Holmar J, 2012, WORLD C MED PHYS BIO, P71; Holmar J, 2011, IFMBE P, p[14, 45]; HUBER AM, 1964, J NUTR, V82, P371, DOI 10.1093/jn/82.3.371; JONES ME, 1965, ANNU REV BIOCHEM, V34, P381; Kalle S, P 5 M UR TOX CARD DI; KELSAY J, 1968, J NUTR, V94, P490, DOI 10.1093/jn/94.4.490; KLEINER MJ, 1980, AM J CLIN NUTR, V33, P1612, DOI 10.1093/ajcn/33.7.1612; LEKLEM JE, 1990, J NUTR, V120, P1503, DOI 10.1093/jn/120.suppl_11.1503; Levine S, 2002, FOOD CHEM TOXICOL, V40, P1449, DOI 10.1016/S0278-6915(02)00072-8; Lindner A, 2002, AM J KIDNEY DIS, V39, P134, DOI 10.1053/ajkd.2002.29904; Mahuren JD, 1997, METHOD ENZYMOL, V280, P22; MAKRIS A, 1974, NUTR METAB, V16, P337; Mayer EL, 1996, J AM COLL CARDIOL, V27, P517, DOI 10.1016/0735-1097(95)00508-0; Morrison HI, 1996, JAMA-J AM MED ASSOC, V275, P1893, DOI 10.1001/jama.275.24.1893; PAGANI R, 1991, BIOCHIM BIOPHYS ACTA, V1077, P233, DOI 10.1016/0167-4838(91)90063-6; Percudani R, 2003, EMBO REP, V4, P850, DOI 10.1038/sj.embor.embor914; REDDY SK, 1958, J BIOL CHEM, V233, P691; Robinson K, 1998, CIRCULATION, V97, P437; ROBINSON K, 1995, CIRCULATION, V92, P2825, DOI 10.1161/01.CIR.92.10.2825; ROSE DP, 1975, AM J CLIN NUTR, V28, P872, DOI 10.1093/ajcn/28.8.872; Rubi B, 2012, MED HYPOTHESES, V78, P179, DOI 10.1016/j.mehy.2011.10.021; Silva V. R. da, 2012, Present knowledge in nutrition, P307; Ueland PM., 1992, ATHEROSCLEROTIC CARD, P183	33	1	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162346	10.1371/journal.pone.0162346	http://dx.doi.org/10.1371/journal.pone.0162346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598005	gold, Green Published, Green Submitted			2022-12-26	WOS:000383254800055
J	Langkammer, C; Pirpamer, L; Seiler, S; Deistung, A; Schweser, F; Franthal, S; Homayoon, N; Katschnig-Winter, P; Koegl-Wallner, M; Pendl, T; Stoegerer, EM; Wenzel, K; Fazekas, F; Ropele, S; Reichenbach, JR; Schmidt, R; Schwingenschuh, P				Langkammer, Christian; Pirpamer, Lukas; Seiler, Stephan; Deistung, Andreas; Schweser, Ferdinand; Franthal, Sebastian; Homayoon, Nina; Katschnig-Winter, Petra; Koegl-Wallner, Mariella; Pendl, Tamara; Stoegerer, Eva Maria; Wenzel, Karoline; Fazekas, Franz; Ropele, Stefan; Reichenbach, Jurgen Rainer; Schmidt, Reinhold; Schwingenschuh, Petra			Quantitative Susceptibility Mapping in Parkinson's Disease	PLOS ONE			English	Article							SUBSTANTIA-NIGRA; BRAIN IRON; RATING-SCALE; MOVEMENT; PROGRESSION; VALIDATION; DEPOSITION; DIAGNOSIS; NUCLEUS; QSM	Background Quantitative susceptibility mapping (QSM) and R2* relaxation rate mapping have demonstrated increased iron deposition in the substantia nigra of patients with idiopathic Parkinson's disease (PD). However, the findings in other subcortical deep gray matter nuclei are converse and the sensitivity of QSM and R2* for morphological changes and their relation to clinical measures of disease severity has so far been investigated only sparsely. Methods The local ethics committee approved this study and all subjects gave written informed consent. 66 patients with idiopathic Parkinson's disease and 58 control subjects underwent quantitative MRI at 3T. Susceptibility and R2* maps were reconstructed from a spoiled multi-echo 3D gradient echo sequence. Mean susceptibilities and R2* rates were measured in subcortical deep gray matter nuclei and compared between patients with PD and controls as well as related to clinical variables. Results Compared to control subjects, patients with PD had increased R2* values in the substantia nigra. QSM also showed higher susceptibilities in patients with PD in substantia nigra, in the nucleus ruber, thalamus, and globus pallidus. Magnetic susceptibility of several of these structures was correlated with the levodopa-equivalent daily dose (LEDD) and clinical markers of motor and non-motor disease severity (total MDS-UPDRS, MDS-UPDRS-I and II). Disease severity as assessed by the Hoehn & Yahr scale was correlated with magnetic susceptibility in the substantia nigra. Conclusion The established finding of higher R2* rates in the substantia nigra was extended by QSM showing superior sensitivity for PD-related tissue changes in nigrostriatal dopaminergic pathways. QSM additionally reflected the levodopa-dosage and disease severity. These results suggest a more widespread pathologic involvement and QSM as a novel means for its investigation, more sensitive than current MRI techniques.	[Langkammer, Christian; Pirpamer, Lukas; Seiler, Stephan; Franthal, Sebastian; Homayoon, Nina; Katschnig-Winter, Petra; Koegl-Wallner, Mariella; Pendl, Tamara; Stoegerer, Eva Maria; Wenzel, Karoline; Fazekas, Franz; Ropele, Stefan; Schmidt, Reinhold; Schwingenschuh, Petra] Med Univ Graz, Dept Neurol, Graz, Austria; [Deistung, Andreas; Reichenbach, Jurgen Rainer] Univ Jena, Med Phys Grp, Univ Hosp, Jena, Germany; [Schweser, Ferdinand] SUNY Buffalo, Buffalo Neuroimaging Anal Ctr, Dept Neurol, Buffalo, NY USA; [Schweser, Ferdinand] SUNY Buffalo, MRI Mol & Translat Imaging Ctr, Clin & Translat Res Ctr, Buffalo, NY USA; [Reichenbach, Jurgen Rainer] Univ Jena, Michael Stifel Ctr Data Driven & Simulat Sci Jena, Jena, Germany; [Schwingenschuh, Petra] Med Univ Graz, Div Neuroradiol, Dept Radiol, Graz, Austria	Medical University of Graz; Friedrich Schiller University of Jena; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Friedrich Schiller University of Jena; Medical University of Graz	Langkammer, C (corresponding author), Med Univ Graz, Dept Neurol, Graz, Austria.	christian.langkammer@medunigraz.at	Schmidt, Reinhold/E-1137-2014; Langkammer, Christian/AAC-9044-2020; Deistung, Andreas/AAN-9412-2021; Schweser, Ferdinand/Q-6932-2019; Reichenbach, Jürgen R./B-4333-2011	Schweser, Ferdinand/0000-0003-0399-9211; Reichenbach, Jürgen R./0000-0002-2640-0630; Deistung, Andreas/0000-0002-2427-1302; Langkammer, Christian/0000-0002-7097-9707; Pirpamer, Lukas/0000-0002-4390-9703	Austrian Science Fund [KLI-523, I-904]; Austrian federal state of Steiermark; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001412] Funding Source: NIH RePORTER	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian federal state of Steiermark; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	CL and LP were supported by the Austrian Science Fund (projects KLI-523 and I-904). The PROMOVE study was supported by the Austrian federal state of Steiermark. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; CL and LP were supported by the Austrian Science Fund (projects KLI-523 and I-904). The PROMOVE study was supported by the Austrian federal state of Steiermark.	Azuma M, 2016, AM J NEURORADIOL, V37, P782, DOI 10.3174/ajnr.A4645; Berg Daniela, 2006, Top Magn Reson Imaging, V17, P5, DOI 10.1097/01.rmr.0000245461.90406.ad; Blazejewska AI, 2015, J MAGN RESON IMAGING, V41, P1065, DOI 10.1002/jmri.24644; Deistung A, 2013, NEUROIMAGE, V65, P299, DOI 10.1016/j.neuroimage.2012.09.055; Devos D, 2014, ANTIOXID REDOX SIGN, V21, P195, DOI 10.1089/ars.2013.5593; Du GW, 2016, MOVEMENT DISORD, V31, P317, DOI 10.1002/mds.26417; Dusek P, 2015, J TRACE ELEM MED BIO, V31, P193, DOI 10.1016/j.jtemb.2014.05.007; Dusek P, 2013, INT REV NEUROBIOL, V110, P195, DOI 10.1016/B978-0-12-410502-7.00010-7; Dusek P, 2012, NEUROBIOL DIS, V46, P1, DOI 10.1016/j.nbd.2011.12.054; Esterhammer R, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0145493; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetz CG, 2008, MOVEMENT DISORD, V23, P2129, DOI 10.1002/mds.22340; Grolez G, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0331-3; Guan XJ, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3489; HALLGREN B, 1958, J NEUROCHEM, V3, P41, DOI 10.1111/j.1471-4159.1958.tb12607.x; Harrison MB, 2009, MOVEMENT DISORD, V24, P224, DOI 10.1002/mds.22335; He NY, 2015, HUM BRAIN MAPP, V36, P4407, DOI 10.1002/hbm.22928; HOEHN MM, 1967, NEUROLOGY, V17, P427, DOI 10.1212/WNL.17.5.427; HUGHES AJ, 1992, J NEUROL NEUROSUR PS, V55, P181, DOI 10.1136/jnnp.55.3.181; Langkammer C, 2014, NEURODEGENER DIS, V13, P189, DOI 10.1159/000353756; Langkammer C, 2013, RADIOLOGY, V267, P551, DOI 10.1148/radiol.12120707; Langkammer C, 2012, NEUROIMAGE, V62, P1593, DOI 10.1016/j.neuroimage.2012.05.049; Langkammer C, 2010, RADIOLOGY, V257, P455, DOI 10.1148/radiol.10100495; Li W, 2011, NEUROIMAGE, V55, P1645, DOI 10.1016/j.neuroimage.2010.11.088; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Liu T, 2013, RADIOLOGY, V269, P216, DOI 10.1148/radiol.13121991; Lotfipour AK, 2012, J MAGN RESON IMAGING, V35, P48, DOI 10.1002/jmri.22752; Murakami Y, 2015, AM J NEURORADIOL, V36, P1102, DOI 10.3174/ajnr.A4260; Barbosa JHO, 2015, MAGN RESON IMAGING, V33, P559, DOI 10.1016/j.mri.2015.02.021; Parashos SA, 2014, JAMA NEUROL, V71, P710, DOI 10.1001/jamaneurol.2014.391; Rouault TA, 2013, NAT REV NEUROSCI, V14, P551, DOI 10.1038/nrn3453; Schafer A, 2012, HUM BRAIN MAPP, V33, P2831, DOI 10.1002/hbm.21404; Schmidt R, 2003, LANCET, V361, P2046, DOI 10.1016/S0140-6736(03)13616-1; Schweser F, 2012, NEUROIMAGE, V62, P2083, DOI 10.1016/j.neuroimage.2012.05.067; Schweser F, 2011, NEUROIMAGE, V54, P2789, DOI 10.1016/j.neuroimage.2010.10.070; Sian-Hulsmann J, 2011, J NEUROCHEM, V118, P939, DOI 10.1111/j.1471-4159.2010.07132.x; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stebbins GT, 2013, MOVEMENT DISORD, V28, P668, DOI 10.1002/mds.25383; Sukstanskii AL, 2014, MAGN RESON MED, V71, P345, DOI 10.1002/mrm.24629; Sun HF, 2015, NEUROIMAGE, V105, P486, DOI 10.1016/j.neuroimage.2014.11.010; Tomlinson CL, 2010, MOVEMENT DISORD, V25, P2649, DOI 10.1002/mds.23429; Tremblay L, 2015, MOVEMENT DISORD, V30, P1155, DOI 10.1002/mds.26199; Ulla M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057904; Wolters EC, 2009, PARKINSONISM RELAT D, V15, pS6, DOI 10.1016/S1353-8020(09)70770-9; Wu B, 2012, NEUROIMAGE, V59, P297, DOI 10.1016/j.neuroimage.2011.07.019; Yoo K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125455; Zollei L, 2010, NEUROIMAGE, V51, P206, DOI 10.1016/j.neuroimage.2010.01.101	47	122	128	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162460	10.1371/journal.pone.0162460	http://dx.doi.org/10.1371/journal.pone.0162460			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598250	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800066
J	Morita, R; Kihira, M; Nakatsu, Y; Nomoto, Y; Ogawa, M; Ohashi, K; Mizuno, K; Tachikawa, T; Ishimoto, Y; Morishita, Y; Tsuji, T				Morita, Ritsuko; Kihira, Miho; Nakatsu, Yousuke; Nomoto, Yohei; Ogawa, Miho; Ohashi, Kazumasa; Mizuno, Kensaku; Tachikawa, Tetsuhiko; Ishimoto, Yukitaka; Morishita, Yoshihiro; Tsuji, Takashi			Coordination of Cellular Dynamics Contributes to Tooth Epithelium Deformations	PLOS ONE			English	Article							3-DIMENSIONAL CULTURE; MORPHOGENESIS; ACTIN; CELLS; SHAPE; MOVEMENT; MOTILITY; TISSUE; ARCHITECTURE; DROSOPHILA	The morphologies of ectodermal organs are shaped by appropriate combinations of several deformation modes, such as invagination and anisotropic tissue elongation. However, how multicellular dynamics are coordinated during deformation processes remains to be elucidated. Here, we developed a four-dimensional (4D) analysis system for tracking cell movement and division at a single-cell resolution in developing tooth epithelium. The expression patterns of a Fucci probe clarified the region-and stage-specific cell cycle patterns within the tooth germ, which were in good agreement with the pattern of the volume growth rate estimated from tissue-level deformation analysis. Cellular motility was higher in the regions with higher growth rates, while the mitotic orientation was significantly biased along the direction of tissue elongation in the epithelium. Further, these spatio-temporal patterns of cellular dynamics and tissue-level deformation were highly correlated with that of the activity of cofilin, which is an actin depolymerization factor, suggesting that the coordination of cellular dynamics via actin remodeling plays an important role in tooth epithelial morphogenesis. Our system enhances the understanding of how cellular behaviors are coordinated during ectodermal organogenesis, which cannot be observed from histological analyses.	[Morita, Ritsuko; Ogawa, Miho; Tsuji, Takashi] Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan; [Kihira, Miho; Nakatsu, Yousuke; Nomoto, Yohei] Tokyo Univ Sci, Grad Sch Ind Sci & Technol, Dept Biol Sci & Technol, Katsushika Ku, Tokyo 1258585, Japan; [Ohashi, Kazumasa; Mizuno, Kensaku] Tohoku Univ, Grad Sch Life Sci, Dept Biomol Sci, Sendai, Miyagi 9808578, Japan; [Tachikawa, Tetsuhiko] Showa Univ, Dept Oral Pathol, Sch Dent, Shinagawa Ku, Tokyo 1428555, Japan; [Ishimoto, Yukitaka] Akita Prefectural Univ, Dept Machine Intelligence & Syst Engn, Yurihonjo, Akita 0150055, Japan; [Morishita, Yoshihiro] RIKEN Quantitat Biol Ctr, Lab Dev Morphogeometry, Kobe, Hyogo 6500047, Japan; [Morita, Ritsuko] RIKEN Ctr Dev Biol, Lab Tissue Microenvironm, Kobe, Hyogo 6500047, Japan; [Tsuji, Takashi] Organ Technol Inc, Tokyo 1010048, Japan; [Tsuji, Takashi] RIKEN Ctr Dev Biol, Lab Organ Regenerat, Kobe, Hyogo 6500047, Japan	Tokyo University of Science; Tokyo University of Science; Tohoku University; Showa University; Akita Prefectural University; RIKEN; RIKEN; RIKEN	Tsuji, T (corresponding author), Tokyo Univ Sci, Res Inst Sci & Technol, Noda, Chiba 2788510, Japan.; Tsuji, T (corresponding author), Organ Technol Inc, Tokyo 1010048, Japan.; Tsuji, T (corresponding author), RIKEN Ctr Dev Biol, Lab Organ Regenerat, Kobe, Hyogo 6500047, Japan.	t-tsuji@cdb.riken.jp	Ishimoto, Yukitaka/AAG-9588-2021; Ohashi, Kazumasa/U-7028-2019; Morita, Ritsuko/AAY-6642-2021	Ishimoto, Yukitaka/0000-0001-5570-4513; Ohashi, Kazumasa/0000-0001-7617-403X; Morita, Ritsuko/0000-0001-6550-8778	Organ Technologies Inc.;  [2311152]; Grants-in-Aid for Scientific Research [16K07335] Funding Source: KAKEN	Organ Technologies Inc.; ; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was partially funded by a Grant-in-Aid for Scientific Research on Innovative Areas (No. 2311152) to TT and Organ Technologies Inc. This work was performed under an Invention Agreement between Tokyo University of Science, RIKEN and Organ Technologies Inc. TT is a director at Organ Technologies Inc. The specific role of this author is articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abe T, 2011, GENESIS, V49, P579, DOI 10.1002/dvg.20753; Ando R, 2002, P NATL ACAD SCI USA, V99, P12651, DOI 10.1073/pnas.202320599; Arima S, 2011, DEVELOPMENT, V138, P4763, DOI 10.1242/dev.068023; Biggs LC, 2014, SEMIN CELL DEV BIOL, V25, P11, DOI 10.1016/j.semcdb.2014.01.007; Bischoff M, 2009, DEVELOPMENT, V136, P2403, DOI 10.1242/dev.035410; Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523; Carlier MF, 1997, J CELL BIOL, V136, P1307, DOI 10.1083/jcb.136.6.1307; Davila M, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-40; Eiraku M, 2011, NATURE, V472, P51, DOI 10.1038/nature09941; Fernandez-Suarez M, 2008, NAT REV MOL CELL BIO, V9, P929, DOI 10.1038/nrm2531; Gorfinkiel N, 2011, CURR OPIN CELL BIOL, V23, P531, DOI 10.1016/j.ceb.2011.06.002; Gros J, 2010, CURR BIOL, V20, P1993, DOI 10.1016/j.cub.2010.09.063; Gurniak CB, 2005, DEV BIOL, V278, P231, DOI 10.1016/j.ydbio.2004.11.010; Heng YW, 2010, INT J BIOCHEM CELL B, V42, P1622, DOI 10.1016/j.biocel.2010.04.007; Higuchi O, 1996, FEBS LETT, V396, P81, DOI 10.1016/0014-5793(96)01072-1; Ikeda E, 2009, P NATL ACAD SCI USA, V106, P13475, DOI 10.1073/pnas.0902944106; Jamora C, 2002, NAT CELL BIOL, V4, pE101, DOI 10.1038/ncb0402-e101; Jernvall J, 2000, MECH DEVELOP, V92, P19, DOI 10.1016/S0925-4773(99)00322-6; Jernvall J, 2012, DEVELOPMENT, V139, P3487, DOI 10.1242/dev.085084; Keller PJ, 2013, SCIENCE, V340, P1184, DOI 10.1126/science.1234168; Kuure S, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001176; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; Lee KG, 2007, CELL CYCLE, V6, P1487; Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522; McMahon A, 2008, SCIENCE, V322, P1546, DOI 10.1126/science.1167094; Monier B, 2015, NATURE, V518, P245, DOI 10.1038/nature14152; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Morishita Y, 2014, J THEOR BIOL, V357, P74, DOI 10.1016/j.jtbi.2014.04.027; Nakao K, 2007, NAT METHODS, V4, P227, DOI 10.1038/nmeth1012; Nowotschin S, 2009, ORGANOGENESIS, V5, P217, DOI 10.4161/org.5.4.10939; O'Brien LE, 2002, NAT REV MOL CELL BIO, V3, P531, DOI 10.1038/nrm859; Pollard TD, 2009, SCIENCE, V326, P1208, DOI 10.1126/science.1175862; Rottner K, 2011, CURR OPIN CELL BIOL, V23, P569, DOI 10.1016/j.ceb.2011.07.003; Sakaue-Sawano A, 2008, CELL, V132, P487, DOI 10.1016/j.cell.2007.12.033; Sasai Y, 2013, NATURE, V493, P318, DOI 10.1038/nature11859; St Johnston D, 2011, CURR OPIN CELL BIOL, V23, P540, DOI 10.1016/j.ceb.2011.07.005; Takaoka K, 2011, NAT CELL BIOL, V13, P743, DOI 10.1038/ncb2251; Takigawa-Imamura H, 2015, J THEOR BIOL, V382, P284, DOI 10.1016/j.jtbi.2015.07.006; Tang N, 2011, SCIENCE, V333, P342, DOI 10.1126/science.1204831; Thesleff I, 2003, J CELL SCI, V116, P1647, DOI 10.1242/jcs.00410; Tomer R, 2012, NAT METHODS, V9, P755, DOI [10.1038/NMETH.2062, 10.1038/nmeth.2062]; Tomura M, 2008, P NATL ACAD SCI USA, V105, P10871, DOI 10.1073/pnas.0802278105; Wyngaarden LA, 2010, DEVELOPMENT, V137, P2551, DOI 10.1242/dev.046987; Yonemura S, 2011, CURR OPIN CELL BIOL, V23, P515, DOI 10.1016/j.ceb.2011.07.001	44	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161336	10.1371/journal.pone.0161336	http://dx.doi.org/10.1371/journal.pone.0161336			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588418	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877800007
J	Wang, J; Zhang, B; Wu, H; Cai, J; Sui, X; Wang, Y; Li, H; Qiu, Y; Wang, T; Chen, Z; Zhu, Q; Xia, H; Song, W; Xiang, AP				Wang, J.; Zhang, B.; Wu, H.; Cai, J.; Sui, X.; Wang, Y.; Li, H.; Qiu, Y.; Wang, T.; Chen, Z.; Zhu, Q.; Xia, H.; Song, W.; Xiang, A. P.			CD51 correlates with the TGF-beta pathway and is a functional marker for colorectal cancer stem cells	ONCOGENE			English	Article							INITIATING CELLS; PHENOTYPIC CHARACTERIZATION; METASTATIC CAPACITY; POOR-PROGNOSIS; COLON; ALPHA; MOUSE; TARGET; TUMORS; OVEREXPRESSION	Colorectal cancer (CRC) is one of the top three most prevalent and deadly cancers. A cancer stem cell (CSC) sub-population that is characterized by the abilities of tumor initiation, self-renewal, metastasis and resistance to chemotherapy can suggest new therapeutic targets. However, no such sub-population has been conclusively identified for CRC, and we lack any marker to identify cells with all of the above characteristics. Here, we report that CD51(+) CRC cells displayed greater sphere-forming and tumorigenic capacities, increased migratory and invasive potentials, and enhanced chemoresistance compared with CD51(-) CRC cells. CD51 knockdown reduced the side population, sphere formation, cell motility and inhibited tumor incidence and metastasis in an in vivo tumor model. Furthermore, CD51 could bind transforming growth factor beta (TGF-beta) receptors, and that it upregulated TGF-beta/Smad signaling. These results indicate that CD51 is a novel functional marker for colorectal CSCs which may provide an therapeutic target for the efficient elimination of colorectal CSCs.	[Wang, J.; Zhang, B.; Wu, H.; Xia, H.; Xiang, A. P.] Sun Yat Sen Univ, Zhongshan Sch Med, Affiliated Guangzhou Women & Childrens Hosp, Program Stem Cells & Regenerat Med, Guangzhou, Guangdong, Peoples R China; [Wang, J.; Zhang, B.; Wu, H.; Cai, J.; Wang, Y.; Li, H.; Qiu, Y.; Wang, T.; Xiang, A. P.] Sun Yat Sen Univ, Key Lab Stem Cells & Tissue Engn, Ctr Stem Cell Biol & Tissue Engn, Minist Educ, 74,Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China; [Cai, J.; Xiang, A. P.] Sun Yat Sen Univ, Zhongshan Sch Med, Affiliated Hosp 3, Biotherapy Ctr, Guangzhou, Guangdong, Peoples R China; [Sui, X.; Zhu, Q.] Xi An Jiao Tong Univ, Coll Med, Affiliated Hosp 1, Dept Oncol, Xian, Peoples R China; [Chen, Z.; Song, W.] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal Pancreat Surg, Guangzhou, Guangdong, Peoples R China; [Xiang, A. P.] Sun Yat Sen Univ, Zhongshan Sch Med, Dept Biochem, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University; Sun Yat Sen University; Xi'an Jiaotong University; Sun Yat Sen University; Sun Yat Sen University	Xiang, AP (corresponding author), Sun Yat Sen Univ, Key Lab Stem Cells & Tissue Engn, Ctr Stem Cell Biol & Tissue Engn, Minist Educ, 74,Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.; Song, W (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Gastrointestinal Surg, 58 Zhongshan 2nd Rd, Guangzhou 510080, Guangdong, Peoples R China.	songwu@mail.sysu.edu.cn; xiangp@mail.sysu.edu.cn	Cai, Jianye/GOK-2676-2022	Wu, Hao-Xiang/0000-0001-6719-7133	National Basic Research Program of China [2012CBA01302]; National Natural Science Foundation of China [81425016, 81270646]; Natural Science Foundation of Guangdong Province [S2013030013305, S20120011190, 2015A030312013]; Key Scientific and Technological Projects of Guangdong Province [2014B020226002, 2015B020226004, 2014B020228003, 2015B020228001]; Key Scientific and Technological Program of Guangzhou City [201400000003-3, 201508020262, 201300000089]; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	National Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Guangdong Province(National Natural Science Foundation of Guangdong Province); Key Scientific and Technological Projects of Guangdong Province; Key Scientific and Technological Program of Guangzhou City; Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS)	This work was supported by the National Basic Research Program of China (2012CBA01302); the National Natural Science Foundation of China (81425016, 81270646); the Natural Science Foundation of Guangdong Province (S2013030013305, S20120011190, 2015A030312013); the Key Scientific and Technological Projects of Guangdong Province (2014B020226002, 2015B020226004, 2014B020228003, 2015B020228001); Key Scientific and Technological Program of Guangzhou City (201400000003-3, 201508020262, 201300000089); Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme (GDUPS, 2013).	Abetov D, 2015, TUMOR BIOL, V36, P1339, DOI 10.1007/s13277-015-3198-4; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Callahan JF, 2002, J MED CHEM, V45, P999, DOI 10.1021/jm010493y; Chu P, 2009, INT J CANCER, V124, P1312, DOI 10.1002/ijc.24061; Clevers H, 2011, NAT MED, V17, P313, DOI 10.1038/nm.2304; Colak S, 2014, CELL DEATH DIFFER, V21, P1170, DOI 10.1038/cdd.2014.37; Dalerba P, 2007, P NATL ACAD SCI USA, V104, P10158, DOI 10.1073/pnas.0703478104; Derynck R, 2014, CURR OPIN CELL BIOL, V31, P56, DOI 10.1016/j.ceb.2014.09.001; Du L, 2008, CLIN CANCER RES, V14, P6751, DOI 10.1158/1078-0432.CCR-08-1034; Emmink BL, 2011, GASTROENTEROLOGY, V141, P269, DOI 10.1053/j.gastro.2011.03.052; Fang DD, 2010, BRIT J CANCER, V102, P1265, DOI 10.1038/sj.bjc.6605610; Gao WC, 2013, GASTROENTEROLOGY, V145, P636, DOI 10.1053/j.gastro.2013.05.049; Gemei M, 2013, CANCER-AM CANCER SOC, V119, P729, DOI 10.1002/cncr.27794; Ha SY, 2014, J CLIN PATHOL, V67, P576, DOI 10.1136/jclinpath-2013-202163; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Haraguchi N, 2010, J CLIN INVEST, V120, P3326, DOI 10.1172/JCI42550; Henderson NC, 2013, NAT MED, V19, P1617, DOI 10.1038/nm.3282; Ho MM, 2007, CANCER RES, V67, P4827, DOI 10.1158/0008-5472.CAN-06-3557; Hu YF, 2009, J IMMUNOL METHODS, V347, P70, DOI 10.1016/j.jim.2009.06.008; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ikushima H, 2009, CELL STEM CELL, V5, P504, DOI 10.1016/j.stem.2009.08.018; Ito M, 2002, BLOOD, V100, P3175, DOI 10.1182/blood-2001-12-0207; Jiang MH, 2014, CELL RES, V24, P1466, DOI 10.1038/cr.2014.149; Ke Q, 2013, HUM MOL GENET, V22, P2221, DOI 10.1093/hmg/ddt074; Lathia JD, 2010, CELL STEM CELL, V6, P421, DOI 10.1016/j.stem.2010.02.018; Levin TG, 2010, GASTROENTEROLOGY, V139, P2072, DOI 10.1053/j.gastro.2010.08.053; Li WQ, 2015, BIOMATERIALS, V39, P75, DOI 10.1016/j.biomaterials.2014.10.056; Liu SP, 2013, GASTROENTEROLOGY, V144, P1031, DOI 10.1053/j.gastro.2013.01.046; Lotti F, 2013, J EXP MED, V210, P2851, DOI 10.1084/jem.20131195; Lu HH, 2014, NAT CELL BIOL, V16, P1105, DOI 10.1038/ncb3041; Lu XJ, 2008, PERSPECT MED CHEM, V2, P57; Munger JS, 1999, CELL, V96, P319, DOI 10.1016/S0092-8674(00)80545-0; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Oskarsson T, 2014, CELL STEM CELL, V14, P306, DOI 10.1016/j.stem.2014.02.002; Pan QZ, 2015, STEM CELLS, V33, P354, DOI 10.1002/stem.1850; Pang R, 2010, CELL STEM CELL, V6, P603, DOI 10.1016/j.stem.2010.04.001; Park CY, 2009, MOL THER, V17, P219, DOI 10.1038/mt.2008.254; Pinho S, 2013, J EXP MED, V210, P1351, DOI 10.1084/jem.20122252; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Savagner P, 2001, BIOESSAYS, V23, P912, DOI 10.1002/bies.1132; Seguin L, 2015, TRENDS CELL BIOL, V25, P234, DOI 10.1016/j.tcb.2014.12.006; Seguin L, 2014, NAT CELL BIOL, V16, P457, DOI 10.1038/ncb2953; Song LB, 2012, GASTROENTEROLOGY, V143, P995, DOI 10.1053/j.gastro.2012.06.033; Su YJ, 2011, EMBO J, V30, P3186, DOI 10.1038/emboj.2011.211; Tang KH, 2013, CANCER RES, V73, P2322, DOI 10.1158/0008-5472.CAN-12-2991; Thien A, 2015, DEV CELL, V32, P617, DOI 10.1016/j.devcel.2015.01.026; Tirino V, 2013, FASEB J, V27, P13, DOI 10.1096/fj.12-218222; Todaro M, 2008, CELL CYCLE, V7, P309, DOI 10.4161/cc.7.3.5389; Todaro M, 2014, CELL STEM CELL, V14, P342, DOI 10.1016/j.stem.2014.01.009; Todaro M, 2010, GASTROENTEROLOGY, V138, P2151, DOI 10.1053/j.gastro.2009.12.063; Tsai JH, 2013, GENE DEV, V27, P2192, DOI 10.1101/gad.225334.113; Vaillant F, 2008, CANCER RES, V68, P7711, DOI 10.1158/0008-5472.CAN-08-1949; Vaiopoulos AG, 2012, STEM CELLS, V30, P363, DOI 10.1002/stem.1031; Vermeulen L, 2008, P NATL ACAD SCI USA, V105, P13427, DOI 10.1073/pnas.0805706105; Vogetseder A, 2013, INT J CANCER, V133, P2362, DOI 10.1002/ijc.28267; Waisberg J, 2014, ANTICANCER RES, V34, P5599; Wang J, 2016, ONCOGENE, V35, P3139, DOI 10.1038/onc.2015.370; WERSTO RP, 1991, CANCER, V67, P106, DOI 10.1002/1097-0142(19910101)67:1<106::AID-CNCR2820670120>3.0.CO;2-I; Wilson BJ, 2011, CURR COLORECT CANC R, V7, P128, DOI 10.1007/s11888-011-0093-2; Wu ZM, 2015, CELL STEM CELL, V17, P47, DOI 10.1016/j.stem.2015.05.016; Xu S, 2015, ONCOGENE, V34, P1520, DOI 10.1038/onc.2014.95; Yan M, 2013, MOL CELL PROTEOMICS, V12, P3271, DOI 10.1074/mcp.M112.025460; Yang CP, 2015, ONCOTARGET, V6, P27714, DOI 10.18632/oncotarget.4663; Yang L, 2014, MODERN PATHOL, V27, P775, DOI 10.1038/modpathol.2013.189; Ye X, 2015, NATURE, V525, P256, DOI 10.1038/nature14897; Yuan JH, 2014, CANCER CELL, V25, P666, DOI 10.1016/j.ccr.2014.03.010; Zeuner A, 2014, CELL STEM CELL, V15, P692, DOI 10.1016/j.stem.2014.11.012	67	17	18	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1351	1363		10.1038/onc.2016.299	http://dx.doi.org/10.1038/onc.2016.299			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27593923				2022-12-26	WOS:000395862500004
J	Kosic, M; Arsikin-Csordas, K; Paunovic, V; Firestone, RA; Ristic, B; Mircic, A; Petricevic, S; Bosnjak, M; Zogovic, N; Mandic, M; Bumbasirevic, V; Trajkovic, V; Harhaji-Trajkovic, L				Kosic, Milica; Arsikin-Csordas, Katarina; Paunovic, Verica; Firestone, Raymond A.; Ristic, Biljana; Mircic, Aleksandar; Petricevic, Sasa; Bosnjak, Mihajlo; Zogovic, Nevena; Mandic, Milos; Bumbasirevic, Vladimir; Trajkovic, Vladimir; Harhaji-Trajkovic, Ljubica			Synergistic Anticancer Action of Lysosomal Membrane Permeabilization and Glycolysis Inhibition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DETERGENT N-DODECYLIMIDAZOLE; CYTOCHROME-C RELEASE; CELL-DEATH; OXIDATIVE STRESS; CANCER-CELLS; PROSTATE-CANCER; LYSOSOMOTROPIC DETERGENTS; GLUCOSE-METABOLISM; CROSS-TALK; IN-VITRO	We investigated the in vitro and in vivo anticancer effect of combining lysosomal membrane permeabilization (LMP)-inducing agent N-dodecylimidazole (NDI) with glycolytic inhibitor 2-deoxy-D-glucose (2DG). NDI-triggered LMP and 2DG-mediated glycolysis block synergized in inducing rapid ATP depletion, mitochondrial damage, and reactive oxygen species production, eventually leading to necrotic death of U251 glioma cells but not primary astrocytes. NDI/2DG-induced death of glioma cells was partly prevented by lysosomal cathepsin inhibitor E64 and antioxidant alpha-tocopherol, suggesting the involvement of LMP and oxidative stress in the observed cytotoxicity. LMP-inducing agent chloroquine also displayed a synergistic anticancer effect with 2DG, whereas glucose deprivation or glycolytic inhibitors iodoacetate and sodium fluoride synergistically cooperated with NDI, thus further indicating that the anticancer effect of NDI/2DG combination was indeed due to LMP and glycolysis block. The two agents synergistically induced ATP depletion, mitochondrial depolarization, oxidative stress, and necrotic death also in B16 mouse melanoma cells. Moreover, the combined oral administration of NDI and 2DG reduced in vivo melanoma growth in C57BL/6 mice by inducing necrotic death of tumor cells, without causing liver, spleen, or kidney toxicity. Based on these results, we propose that NDI-triggered LMP causes initial mitochondrial damage that is further increased by 2DG due to the lack of glycolytic ATP required to maintain mitochondrial health. This leads to a positive feedback cycle of mitochondrial dysfunction, ATP loss, and reactive oxygen species production, culminating in necrotic cell death. Therefore, the combination of LMP-inducing agents and glycolysis inhibitors seems worthy of further exploration as an anticancer strategy.	[Kosic, Milica; Arsikin-Csordas, Katarina; Paunovic, Verica; Ristic, Biljana; Mandic, Milos; Trajkovic, Vladimir] Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Dr Subotica 1, Belgrade 11000, Serbia; [Mircic, Aleksandar; Bosnjak, Mihajlo; Bumbasirevic, Vladimir] Univ Belgrade, Sch Med, Inst Histol & Embryol, Visegradska 26, Belgrade 11000, Serbia; [Petricevic, Sasa] Inst Biomed Res, Pasterova 2, Belgrade 11000, Serbia; [Zogovic, Nevena; Harhaji-Trajkovic, Ljubica] Univ Belgrade, Inst Biol Res, Despot Stefan Blvd 142, Belgrade 11000, Serbia; [Firestone, Raymond A.] 30 West 72 St,Apartment 10A, New York, NY 10023 USA	University of Belgrade; University of Belgrade; University of Belgrade	Trajkovic, V (corresponding author), Univ Belgrade, Sch Med, Inst Microbiol & Immunol, Dr Subotica 1, Belgrade 11000, Serbia.; Harhaji-Trajkovic, L (corresponding author), Univ Belgrade, Inst Biol Res, Despot Stefan Blvd 142, Belgrade 11000, Serbia.	vtrajkovic@med.bg.ac.rs; buajk@yahoo.com	Kosic, Milica/E-6689-2016	Kosic, Milica/0000-0003-2925-8470; Zogovic, Nevena/0000-0003-4240-3193; Harhaji-Trajkovic, Ljubica/0000-0001-8757-555X; Mandic, Milos/0000-0001-9280-1021; Ristic, Biljana/0000-0002-7255-6556; Paunovic, Verica/0000-0002-4912-7761; bosnjak, mihajlo/0000-0002-5973-8275; Trajkovic, Vladimir/0000-0002-8061-2968	Ministry of Education, Science, and Technological Development of the Republic of Serbia [41025, 173053]	Ministry of Education, Science, and Technological Development of the Republic of Serbia	This work was supported by Ministry of Education, Science, and Technological Development of the Republic of Serbia Grants 41025 (to V. T.) and 173053 (to L. H.-T.). The authors declare that they have no conflicts of interest with the contents of this article.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Bell SE, 1998, BRIT J CANCER, V78, P1464, DOI 10.1038/bjc.1998.708; Ben Sahra I, 2010, AUTOPHAGY, V6, P670, DOI 10.4161/auto.6.5.12434; Boya P, 2008, ONCOGENE, V27, P6434, DOI 10.1038/onc.2008.310; Boya P, 2003, ONCOGENE, V22, P3927, DOI 10.1038/sj.onc.1206622; Boya P, 2003, J EXP MED, V197, P1323, DOI 10.1084/jem.20021952; BOYER MJ, 1993, BRIT J CANCER, V67, P81, DOI 10.1038/bjc.1993.13; Cheng G, 2012, CANCER RES, V72, P2634, DOI 10.1158/0008-5472.CAN-11-3928; Cheong JH, 2011, MOL CANCER THER, V10, P2350, DOI 10.1158/1535-7163.MCT-11-0497; Chinopoulos C, 2011, FEBS LETT, V585, P1255, DOI 10.1016/j.febslet.2011.04.004; Colell A, 2007, CELL, V129, P983, DOI 10.1016/j.cell.2007.03.045; Dehay B, 2012, P NATL ACAD SCI USA, V109, P9611, DOI 10.1073/pnas.1112368109; Denamur S, 2011, FREE RADICAL BIO MED, V51, P1656, DOI 10.1016/j.freeradbiomed.2011.07.015; DiPaola RS, 2008, PROSTATE, V68, P1743, DOI 10.1002/pros.20837; DREWINKO B, 1976, CANCER BIOCHEM BIOPH, V1, P187; Dwarakanath BS, 2009, J CANCER RES THER, V5, P27, DOI 10.4103/0973-1482.55137; Fath MA, 2009, CANCER BIOL THER, V8, P1228, DOI 10.4161/cbt.8.13.8631; FIRESTONE RA, 1979, J MED CHEM, V22, P1130, DOI 10.1021/jm00195a026; FIRESTONE RA, 1982, J MED CHEM, V25, P539, DOI 10.1021/jm00347a012; Fuchs Y, 2015, NAT REV MOL CELL BIO, V16, P329, DOI 10.1038/nrm3999; Ganapathy-Kanniappan S, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-152; Ghosh M, 2011, FEBS LETT, V585, P623, DOI 10.1016/j.febslet.2010.12.043; Glunde K, 2003, NEOPLASIA, V5, P533, DOI 10.1016/S1476-5586(03)80037-4; Gottlieb E, 2003, CELL DEATH DIFFER, V10, P709, DOI 10.1038/sj.cdd.4401231; Gundersen HJG, 1999, J MICROSC-OXFORD, V193, P199, DOI 10.1046/j.1365-2818.1999.00457.x; HACKENBROCK CR, 1966, J CELL BIOL, V30, P269, DOI 10.1083/jcb.30.2.269; Hardie DG, 2012, NAT REV MOL CELL BIO, V13, P251, DOI 10.1038/nrm3311; Jelluma N, 2006, MOL CANCER RES, V4, P319, DOI 10.1158/1541-7786.MCR-05-0061; Kallunki T, 2013, ONCOGENE, V32, P1995, DOI 10.1038/onc.2012.292; Kaludjerovic GN, 2005, INT J CANCER, V116, P479, DOI 10.1002/ijc.21080; Kim JS, 2003, BIOCHEM BIOPH RES CO, V304, P463, DOI 10.1016/S0006-291X(03)00618-1; Kim S, 2013, SCI WORLD J, DOI 10.1155/2013/175702; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Kurtoglu M, 2007, MOL CANCER THER, V6, P3049, DOI 10.1158/1535-7163.MCT-07-0310; Lee J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018367; Los M, 2002, MOL BIOL CELL, V13, P978, DOI 10.1091/mbc.01-05-0272; MACK P, 1988, EUR J CANCER CLIN ON, V24, P1433, DOI 10.1016/0277-5379(88)90333-1; Malhotra R, 1999, J BIOL CHEM, V274, P12567, DOI 10.1074/jbc.274.18.12567; Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294; Matsushita M, 2007, J BIOL CHEM, V282, P6763, DOI 10.1074/jbc.M609876200; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MILLER DK, 1983, J CELL BIOL, V97, P1841, DOI 10.1083/jcb.97.6.1841; Mohanti BK, 1996, INT J RADIAT ONCOL, V35, P103, DOI 10.1016/S0360-3016(96)85017-6; Mueller WM, 1998, ENDOCRINOLOGY, V139, P551, DOI 10.1210/en.139.2.551; Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Orrenius S, 2007, ANNU REV PHARMACOL, V47, P143, DOI 10.1146/annurev.pharmtox.47.120505.105122; Palermo C, 2008, TRENDS PHARMACOL SCI, V29, P22, DOI 10.1016/j.tips.2007.10.011; Parzych KR, 2014, ANTIOXID REDOX SIGN, V20, P460, DOI 10.1089/ars.2013.5371; Ramirez-Peinado S, 2013, J BIOL CHEM, V288, P30387, DOI 10.1074/jbc.M113.490581; Repnik U, 2010, MITOCHONDRION, V10, P662, DOI 10.1016/j.mito.2010.07.008; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Sato T, 2008, J IMMUNOL, V181, P197, DOI 10.4049/jimmunol.181.1.197; Seitz C, 2013, INT J CANCER, V132, P2682, DOI 10.1002/ijc.27935; Simons AL, 2007, INT J RADIAT ONCOL, V69, P1222, DOI 10.1016/j.ijrobp.2007.07.2343; Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z; Sottnik JL, 2011, CLIN EXP METASTAS, V28, P865, DOI 10.1007/s10585-011-9417-5; Tagg SLC, 2008, BRIT J CANCER, V99, P1842, DOI 10.1038/sj.bjc.6604752; Tait SWG, 2010, DEV CELL, V18, P802, DOI [10.1016/j.devcel.2010.03.014, 10.1016/j.devce1.2010.03.014]; Terman A, 2006, IUBMB LIFE, V58, P531, DOI 10.1080/15216540600904885; Traber MG, 2007, FREE RADICAL BIO MED, V43, P4, DOI 10.1016/j.freeradbiomed.2007.03.024; Vucicevic L, 2014, AUTOPHAGY, V10, P2362, DOI 10.4161/15548627.2014.984270; Wang K, 2011, AUTOPHAGY, V7, P297, DOI 10.4161/auto.7.3.14502; Wang L, 2016, ONCOTARGET, V7, P7, DOI DOI 10.3389/FMICB.2016.00593; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; WEBSTER HDF, 1965, J CELL BIOL, V26, P885; WILSON PD, 1987, J CELL BIOL, V104, P1223, DOI 10.1083/jcb.104.5.1223; WILSON PD, 1989, CANCER RES, V49, P507; Workman P, 2010, BRIT J CANCER, V102, P1555, DOI 10.1038/sj.bjc.6605642; Xi HB, 2011, CANCER CHEMOTH PHARM, V67, P899, DOI 10.1007/s00280-010-1391-0; Yang WS, 2016, TRENDS CELL BIOL, V26, P165, DOI 10.1016/j.tcb.2015.10.014; Yonekawa T, 2013, ESSAYS BIOCHEM, V55, P105, DOI [10.1042/BSE0550105, 10.1042/bse0550105]; Yoon YH, 2010, INVEST OPHTH VIS SCI, V51, P6030, DOI 10.1167/iovs.10-5278; Zagorodna O, 2012, ONCOGENE, V31, P2738, DOI 10.1038/onc.2011.454; Zhang DS, 2014, CANCER LETT, V355, P176, DOI 10.1016/j.canlet.2014.09.003; Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506	76	9	10	1	16	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22936	22948		10.1074/jbc.M116.752113	http://dx.doi.org/10.1074/jbc.M116.752113			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27587392	Green Published, hybrid			2022-12-26	WOS:000387224800007
J	Le, NH; Molle, V; Eynard, N; Miras, M; Stella, A; Bardou, F; Galandrin, S; Guillet, V; Andre-Leroux, G; Bellinzoni, M; Alzari, P; Mourey, L; Burlet-Schiltz, O; Daffe, M; Marrakchi, H				Nguyen-Hung Le; Molle, Virginie; Eynard, Nathalie; Miras, Mathieu; Stella, Alexandre; Bardou, Fabienne; Galandrin, Segolene; Guillet, Valerie; Andre-Leroux, Gwenaelle; Bellinzoni, Marco; Alzari, Pedro; Mourey, Lionel; Burlet-Schiltz, Odile; Daffe, Mamadou; Marrakchi, Hedia			Ser/Thr Phosphorylation Regulates the Fatty Acyl-AMP Ligase Activity of FadD32, an Essential Enzyme in Mycolic Acid Biosynthesis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell wall; lipid metabolism; mycobacteria; post-translational modification (PTM); protein phosphorylation	MYCOBACTERIUM-TUBERCULOSIS; PROTEIN-KINASES; SYNTHASE; MECHANISM; SYSTEM; PHOSPHATASES; EXPRESSION; INHIBITORS; CATALYZES; TARGETS	Mycolic acids are essential components of the mycobacterial cell envelope, and their biosynthetic pathway is a well known source of antituberculous drug targets. Among the promising new targets in the pathway, FadD32 is an essential enzyme required for the activation of the long meromycolic chain of mycolic acids and is essential for mycobacterial growth. Following the in-depth biochemical, biophysical, and structural characterization of FadD32, we investigated its putative regulation via post-translational modifications. Comparison of the fatty acyl-AMP ligase activity between phosphorylated and dephosphorylated FadD32 isoforms showed that the native protein is phosphorylated by serine/threonine protein kinases and that this phosphorylation induced a significant loss of activity. Mass spectrometry analysis of the native protein confirmed the post-translational modifications and identified Thr-552 as the phosphosite. Phosphoablative and phosphomimetic FadD32 mutant proteins confirmed both the position and the importance of the modification and its correlation with the negative regulation of FadD32 activity. Investigation of the mycolic acid condensation reaction catalyzed by Pks13, involving FadD32 as a partner, showed that FadD32 phosphorylation also impacts the condensation activity. Altogether, our results bring to light FadD32 phosphorylation by serine/threonine protein kinases and its correlation with the enzyme-negative regulation, thus shedding a new horizon on the mycolic acid biosynthesis modulation and possible inhibition strategies for this promising drug target.	[Nguyen-Hung Le; Eynard, Nathalie; Miras, Mathieu; Stella, Alexandre; Bardou, Fabienne; Galandrin, Segolene; Guillet, Valerie; Mourey, Lionel; Burlet-Schiltz, Odile; Daffe, Mamadou; Marrakchi, Hedia] Univ Toulouse, Inst Pharmacol & Biol Struct, CNRS, UPS, Toulouse, France; [Molle, Virginie] Univ Montpellier, Lab Dynam Interact Membranaires Normales & Pathol, CNRS, UMR 5235, Pl Eugene Bataillon, F-34095 Montpellier 05, France; [Andre-Leroux, Gwenaelle; Bellinzoni, Marco; Alzari, Pedro] Inst Pasteur, Unite Microbiol Struct, 25 Rue Docteur Roux, F-75724 Paris 15, France	Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris	Daffe, M; Marrakchi, H (corresponding author), Inst Pharmacol & Biol Struct, 205 Route Narbonne,BP 64182, F-31077 Toulouse 4, France.	mamadou.daffe@ipbs.fr; hedia.marrakchi@ipbs.fr	Mourey, Lionel/B-5662-2009; MOLLE, Virginie/D-4050-2019; Marrakchi, Hedia/AAF-2657-2020	Mourey, Lionel/0000-0002-8259-1259; MOLLE, Virginie/0000-0002-6573-3411; Le, Nguyen-Hung/0000-0001-8659-6949; Marrakchi, Hedia/0000-0003-2749-5966; Alzari, Pedro/0000-0002-4233-1903; Bellinzoni, Marco/0000-0002-8887-6917; Schiltz, Odile/0000-0002-3606-2356	European Union NM4TB [LSHP-CT-2005-018923]; Agence Nationale de la Recherche, FASMY [ANR-14-CE16-0012]; French Foreign Office (Ministere des Affaires Etrangeres); Region Midi-Pyrenees; European funds (Fonds Europeens de Developpement Regional, FEDER); Toulouse Metropole; French Ministry of Research; Investissement d'Avenir Infrastructures Nationales en Biologie et SanteProgram (ProFI, Proteomics French Infrastructure Project) [ANR-10-INBS-08]	European Union NM4TB; Agence Nationale de la Recherche, FASMY(French National Research Agency (ANR)); French Foreign Office (Ministere des Affaires Etrangeres); Region Midi-Pyrenees(Region Provence-Alpes-Cote d'AzurRegion Occitanie); European funds (Fonds Europeens de Developpement Regional, FEDER); Toulouse Metropole; French Ministry of Research(Ministry of Research, FranceEuropean Commission); Investissement d'Avenir Infrastructures Nationales en Biologie et SanteProgram (ProFI, Proteomics French Infrastructure Project)(French National Research Agency (ANR))	This work was supported in part by European Union NM4TB, Grant LSHP-CT-2005-018923, and the Agence Nationale de la Recherche, FASMY, Grant ANR-14-CE16-0012. The authors declare that they have no conflicts of interest with the contents of this article.r Supported by a fellowship from the French Foreign Office (Ministere des Affaires Etrangeres).r Supported in part by the Region Midi-Pyrenees, European funds (Fonds Europeens de Developpement Regional, FEDER), Toulouse Metropole, and the French Ministry of Research with the Investissement d'Avenir Infrastructures Nationales en Biologie et SanteProgram (ProFI, Proteomics French Infrastructure Project, ANR-10-INBS-08).	Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0; Baronian G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0119907; Bekesova S, 2015, FRONT PLANT SCI, V6, DOI 10.3389/fpls.2015.00336; Bellinzoni M, 2007, STRUCTURE, V15, P863, DOI 10.1016/j.str.2007.06.002; Boldrin F, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkq235; Carroll P, 2011, APPL ENVIRON MICROB, V77, P5040, DOI 10.1128/AEM.02880-10; Corrales RM, 2012, J BIOL CHEM, V287, P26187, DOI 10.1074/jbc.M112.373209; Cortes M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029306; Duckworth BP, 2012, CURR TOP MED CHEM, V12, P766; Forti F, 2009, J BIOTECHNOL, V140, P270, DOI 10.1016/j.jbiotec.2009.02.001; Fortuin S, 2015, FRONT MICROBIOL, V6, DOI 10.3389/fmicb.2015.00006; Galandrin S, 2013, J BIOMOL SCREEN, V18, P576, DOI 10.1177/1087057112474691; Gavalda S, 2014, CHEM BIOL, V21, P1660, DOI 10.1016/j.chembiol.2014.10.011; Gavalda S, 2009, J BIOL CHEM, V284, P19255, DOI 10.1074/jbc.M109.006940; Gokhale RS, 2007, CURR OPIN STRUC BIOL, V17, P736, DOI 10.1016/j.sbi.2007.08.021; Guillet V, 2016, J BIOL CHEM, V291, P7973, DOI 10.1074/jbc.M115.712612; Kaur P, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005923; Khan S, 2010, J BIOL CHEM, V285, P37860, DOI 10.1074/jbc.M110.143131; Kinoshita-Kikuta E, 2015, METHODS MOL BIOL, V1295, P323, DOI 10.1007/978-1-4939-2550-6_24; Kuhn ML, 2016, ACS INFECT DIS, V2, P579, DOI 10.1021/acsinfecdis.6b00082; Leger M, 2009, CHEM BIOL, V16, P510, DOI 10.1016/j.chembiol.2009.03.012; Marrakchi H, 2014, CHEM BIOL, V21, P67, DOI 10.1016/j.chembiol.2013.11.011; Molle V, 2006, J BIOL CHEM, V281, P30094, DOI 10.1074/jbc.M601691200; Molle V, 2010, MOL MICROBIOL, V78, P1591, DOI 10.1111/j.1365-2958.2010.07446.x; Molle V, 2010, PROTEOMICS, V10, P3910, DOI 10.1002/pmic.201000316; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Noens EE, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-27; Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200; Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101; Prisic S, 2010, P NATL ACAD SCI USA, V107, P7521, DOI 10.1073/pnas.0913482107; Sajid A, 2015, ANNU REV MICROBIOL, V69, P527, DOI 10.1146/annurev-micro-020415-111342; Sajid A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017871; Sani M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000794; Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x; Shirude PS, 2012, ACS MED CHEM LETT, V3, P736, DOI 10.1021/ml300134b; Slama N, 2011, BIOCHEM BIOPH RES CO, V412, P401, DOI 10.1016/j.bbrc.2011.07.051; Stanley SA, 2013, P NATL ACAD SCI USA, V110, P11565, DOI 10.1073/pnas.1302114110; Trivedi OA, 2004, NATURE, V428, P441, DOI 10.1038/nature02384; Vergnolle O, 2013, J BIOL CHEM, V288, P28116, DOI 10.1074/jbc.M113.495549; Veyron-Churlet R, 2010, J BIOL CHEM, V285, P12714, DOI 10.1074/jbc.M110.105189; Veyron-Churlet R, 2009, J BIOL CHEM, V284, P6414, DOI 10.1074/jbc.M806537200; Vilcheze C, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004115; Wehenkel A, 2008, BBA-PROTEINS PROTEOM, V1784, P193, DOI 10.1016/j.bbapap.2007.08.006; Xie LX, 2015, INT J BIOCHEM CELL B, V59, P193, DOI 10.1016/j.biocel.2014.11.010; Zuber B, 2008, J BACTERIOL, V190, P5672, DOI 10.1128/JB.01919-07	45	11	11	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22793	22805		10.1074/jbc.M116.748053	http://dx.doi.org/10.1074/jbc.M116.748053			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27590338	Green Published, hybrid			2022-12-26	WOS:000386760600036
J	Cossellu, G; Motta, V; Dioni, L; Angelici, L; Vigna, L; Farronato, G; Pesatori, AC; Bollati, V				Cossellu, Gianguido; Motta, Valeria; Dioni, Laura; Angelici, Laura; Vigna, Luisella; Farronato, Giampietro; Pesatori, Angela Cecilia; Bollati, Valentina			Titanium and Zirconium Levels Are Associated with Changes in MicroRNAs Expression: Results from a Human Cross-Sectional Study on Obese Population	PLOS ONE			English	Article							METAL; OSTEOBLAST; MIRNA; STABILITY; TOXICITY; CELLS; IONS	Objectives In this study on 90 individuals we aimed at evaluating the microRNAs (miRNAs) expression profile associated with personal levels of Titanium (Ti) and Zirconium (Zr) traced in hair samples. Ti and Zr materials are broadly used for dental implants but the biological reactions triggered by a long term presence of these materials in the oral cavity still need to be assessed. MiRNAs are mechanisms that need to be investigated as they play a fundamental role in the control of gene expression following external stimuli and contribute to a wide range of pathophysiological processes. Methods Using the TaqMan 1 Low-Density Array, we assessed the expression levels of 377 human miRNAs in peripheral blood of 90 subjects. Hair samples were analyzed for Ti and Zr content using Inductively Coupled Plasma-Mass Spectrometry. We performed multivariable regression analysis to investigate the effects of Ti and Zr exposure on miRNA expression levels. We used the Ingenuity Pathway Analysis (IPA) software to explore the functional role of the investigated miRNAs and the related target genes. Results Seven miRNAs (miR-99b, miR-142-5p, miR-152, miR-193a-5p, miR-323-3p, miR-335, miR-494) resulted specifically associated with Zr levels. The functional target analysis showed that miRNAs are involved in mechanisms such as inflammation, skeletal and connective tissue disorders. Conclusions Our data suggest that Zr is more bioactive than Ti and show that miRNAs are relevant molecular mechanisms sensitive to Zr exposure.	[Cossellu, Gianguido; Farronato, Giampietro] Univ Milan, Dept Biomed Surg & Dent Sci, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Via Commenda 10, I-20122 Milan, Italy; [Motta, Valeria; Dioni, Laura; Angelici, Laura; Pesatori, Angela Cecilia; Bollati, Valentina] Univ Milan, EPIGET Epidemiol Epigenet & Toxicol Lab, Dept Clin Sci & Community Hlth, Milan, Italy; [Vigna, Luisella; Pesatori, Angela Cecilia] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Workers Hlth Protect & Promot Unit, Milan, Italy; [Pesatori, Angela Cecilia] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Epidemiol Unit, Milan, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan; University of Milan; IRCCS Ca Granda Ospedale Maggiore Policlinico; IRCCS Ca Granda Ospedale Maggiore Policlinico	Cossellu, G (corresponding author), Univ Milan, Dept Biomed Surg & Dent Sci, Fdn IRCCS Ca Granda, Osped Maggiore Policlin, Via Commenda 10, I-20122 Milan, Italy.	gianguido.cossellu@unimi.it	Angelici, Laura/AAC-2633-2019; pesatori, angela/K-5742-2016	Vigna, Luisella/0000-0001-5014-721X; Cossellu, Gianguido/0000-0001-6442-5591; pesatori, angela/0000-0002-0261-3252; Bollati, Valentina/0000-0002-0370-9598; Angelici, Laura/0000-0003-3731-1606	EU Programme "Ideas" [ERC-2011-StG 282413]	EU Programme "Ideas"	This project received support from the EU Programme "Ideas" (ERC-2011-StG 282413 to Dr. V. Bollati).	Ahmad I, 1998, INT J PERIODONT REST, V18, P455; An J, 2014, TOXICOL LETT, V229, P158, DOI 10.1016/j.toxlet.2014.06.002; Backes C, 2010, NUCLEIC ACIDS RES, V38, P4476, DOI 10.1093/nar/gkq167; Bass D A, 2001, Altern Med Rev, V6, P472; Bennett WD, 2004, J APPL PHYSIOL, V97, P821, DOI 10.1152/japplphysiol.01403.2003; Bollati V, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-1137; Bollati V, 2010, ENVIRON HEALTH PERSP, V118, P763, DOI 10.1289/ehp.0901300; CHOWDHURY BA, 1987, PROG FOOD NUTR SCI, V11, P55; Covacci V, 1999, BIOMATERIALS, V20, P371, DOI 10.1016/S0142-9612(98)00182-3; Depprich Rita, 2008, Head Face Med, V4, P30, DOI 10.1186/1746-160X-4-30; Flatebo RS, 2006, J PERIODONTOL, V77, P1201, DOI 10.1902/jop.2006.050406; ICHIKAWA Y, 1992, J PROSTHET DENT, V68, P322, DOI 10.1016/0022-3913(92)90338-B; Jacobs JJ, 1998, J BONE JOINT SURG AM, V80A, P268, DOI 10.2106/00004623-199802000-00015; Jaishankar Monisha, 2014, Interdiscip Toxicol, V7, P60, DOI 10.2478/intox-2014-0009; Jenkins DW, 1979, EPA600479049; Ji WD, 2013, CARCINOGENESIS, V34, P446, DOI 10.1093/carcin/bgs343; Jin Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064434; Kelly JR, 2008, DENT MATER, V24, P289, DOI 10.1016/j.dental.2007.05.005; Kohal RJ, 2013, DENT MATER, V29, P763, DOI 10.1016/j.dental.2013.04.003; Li Y, 2010, J DENT RES, V89, P493, DOI 10.1177/0022034510363675; Linkevicius T, 2008, INT J ORAL MAX IMPL, V23, P449; Mackay IM, 2002, NUCLEIC ACIDS RES, V30, P1292, DOI 10.1093/nar/30.6.1292; Motta V, 2013, TOXICOL SCI, V132, P307, DOI 10.1093/toxsci/kft013; Olmedo D, 2002, J MATER SCI-MATER M, V13, P793, DOI 10.1023/A:1016131310025; Olmedo DG, 2008, J MATER SCI-MATER M, V19, P3049, DOI 10.1007/s10856-008-3438-x; Palmieri A, 2008, J MATER SCI-MATER M, V19, P2471, DOI 10.1007/s10856-008-3386-5; Palmieri A, 2008, CLIN IMPLANT DENT R, V10, P200, DOI 10.1111/j.1708-8208.2007.00078.x; Piconi C, 1999, BIOMATERIALS, V20, P1, DOI 10.1016/S0142-9612(98)00010-6; Puchyr RF, 1998, BIOL TRACE ELEM RES, V62, P167, DOI 10.1007/BF02783969; Raffaelli L, 2008, J BIOMED MATER RES A, V86A, P959, DOI 10.1002/jbm.a.31693; Ray P, 2008, CELL CYCLE, V7, P2826, DOI 10.4161/cc.7.18.6752; Ryu HW, 2015, TOX RESEARCH, V31, P1, DOI 10.5487/TR.2015.31.1.001; Soto-Alvaredo J, 2014, METALLOMICS, V6, P1702, DOI 10.1039/c4mt00133h; Spalinger MR, 2015, INFLAMM BOWEL DIS, V21, P645, DOI 10.1097/MIB.0000000000000297; Valko M, 2005, CURR MED CHEM, V12, P1161, DOI 10.2174/0929867053764635; Vemula S, 2010, BLOOD, V115, P1785, DOI 10.1182/blood-2009-08-237222; Wang ZL, 2009, J BIOL CHEM, V284, P28599, DOI 10.1074/jbc.M109.047282; Warashina H, 2003, BIOMATERIALS, V24, P3655, DOI 10.1016/S0142-9612(03)00120-0; Yang HC, 2003, DRUG CHEM TOXICOL, V26, P75, DOI 10.1081/DCT-120020403	39	14	14	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161916	10.1371/journal.pone.0161916	http://dx.doi.org/10.1371/journal.pone.0161916			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611787	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900037
J	Gu, FY; Xiao, Q; Chu, LW; Yu, K; Matthews, CE; Hsing, AW; Caporaso, NE				Gu, Fangyi; Xiao, Qian; Chu, Lisa W.; Yu, Kai; Matthews, Charles E.; Hsing, Ann W.; Caporaso, Neil E.			Sleep Duration and Cancer in the NIH-AARP Diet and Health Study Cohort	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; RETIRED-PERSONS DIET; BREAST-CANCER; AMERICAN-ASSOCIATION; POSTMENOPAUSAL WOMEN; NATIONAL-INSTITUTES; OHSAKI COHORT; RISK; METAANALYSIS; DEPRESSION	Background Very few studies have examined sleep duration in relation to cancer incidence with the exception of breast cancer. Methods We assessed the associations between sleep duration and incidences of total and 18 site-specific cancers in the NIH-AARP Health and Diet Study cohort, with 173,327 men and 123,858 women aged 51-72 years at baseline. Self-reportedsleep duration categories were assessed via questionnaire. We used multivariable Cox proportional hazards regression to estimate hazard ratios (HR) and 95% confidence intervals (CI), using 7-8 hours/night as the reference. Results We observed a significantly increased risk of stomach cancer among male short sleepers (multivariable HR5-6 vs. 7-8 hours = 1.29; 95% CI: 1.05, 1.59; P-trend = 0.03). We also observed suggestive associations in either short or long sleepers, which did not reach overall significance (P-trend > 0.05), including increased risks in male short sleepers for cancers of head and neck (HR<5vs. 7-8 hours = 1.39; 95% CI: 1.00-1.95), bladder (HR5-6vs. 7-8 hours = 1.10; 95% CI: 1.00-1.20), thyroid (HR<5 vs. 7-8 hours = 2.30; 95% CI: 1.06, 5.02), Non-Hodgkin Lymphoma (NHL) (HR5-6vs. 7-8 hours = 1.17; 95% CI: 1.02-1.33), and myeloma (HR<5vs. 7-8 hours = 2.06; 95% CI: 1.20-3.51). In women, the suggestive associations include a decreased total cancer risk (HR<5vs. 7-8 hours = 0.9; 95% CI: 0.83-0.99) and breast cancer risk (HR<5vs. 7-8 hours = 0.84; 95% CI: 0.71-0.98) among short sleepers. A decreased ovarian cancer risk (HR >= 9 vs. 7-8 hours = 0.50; 95% CI: 0.26-0.97) and an increased NHL risk (HR >= 9 vs. 7-8 hours = 1.45; 95% CI: 1.00-2.11) were observed among long sleepers. Conclusion In an older population, we observed an increased stomach cancer risk in male short sleepers and suggestive associations with short or long sleep duration for many cancer risks in both genders.	[Gu, Fangyi; Xiao, Qian; Yu, Kai; Matthews, Charles E.; Caporaso, Neil E.] NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA; [Chu, Lisa W.; Hsing, Ann W.] Canc Prevent Inst Calif, Fremont, CA USA; [Chu, Lisa W.; Hsing, Ann W.] Stanford Canc Inst, Palo Alto, CA USA; [Hsing, Ann W.] Stanford Univ, Dept Hlth Res & Policy, Sch Med, Stanford, CA 94305 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Cancer Prevention Institute of California; Stanford Cancer Institute; Stanford University	Gu, FY (corresponding author), NCI, Div Canc Epidemiol & Genet, Bethesda, MD 20892 USA.	Guf@mail.nih.gov	matthews, Charles e/E-8073-2015	matthews, Charles e/0000-0001-8037-3103	Intramural Research Program of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute; NATIONAL CANCER INSTITUTE [ZIACP010196] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Authors are supported by the Intramural Research Program of the Division of Cancer Epidemiology and Genetics at the National Cancer Institute. The sponsor had no role in the design and conduct of the study; the collection, analysis, and interpretation of the data; or the preparation, review, or approval of the manuscript.	Anisimov VN, 2003, CRIT REV ONCOL HEMAT, V46, P221, DOI 10.1016/S1040-8428(03)00021-0; BLIWISE DL, 1993, J CLIN PSYCHOL, V49, P471, DOI 10.1002/1097-4679(199307)49:4<471::AID-JCLP2270490403>3.0.CO;2-7; Bliwise DL, 2007, SLEEP, V30, P1614, DOI 10.1093/sleep/30.12.1614; Cappuccio FP, 2010, DIABETES CARE, V33, P414, DOI 10.2337/dc09-1124; Ferrone C, 2010, J CLIN ONCOL, V28, P4045, DOI 10.1200/JCO.2010.27.9992; Fischer W, 2009, CURR TOP MICROBIOL, V337, P129, DOI 10.1007/978-3-642-01846-6_5; Foley DJ, 2007, AM J GERIAT PSYCHIAT, V15, P344, DOI 10.1097/01.JGP.0000249385.50101.67; Fujiwara Y, 2012, J GASTROENTEROL, V47, P760, DOI 10.1007/s00535-012-0601-4; Girschik J, 2013, AM J EPIDEMIOL, V177, P316, DOI 10.1093/aje/kws422; Haus EL, 2013, SLEEP MED REV, V17, P273, DOI 10.1016/j.smrv.2012.08.003; Horne J, 2011, BIOL PSYCHOL, V87, P1, DOI 10.1016/j.biopsycho.2010.10.004; Jiao L, 2013, BRIT J CANCER, V108, P213, DOI 10.1038/bjc.2012.561; Kakizaki M, 2008, BRIT J CANCER, V99, P1502, DOI 10.1038/sj.bjc.6604684; Kakizaki M, 2008, BRIT J CANCER, V99, P176, DOI 10.1038/sj.bjc.6604425; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Luo JH, 2013, AM J EPIDEMIOL, V177, P42, DOI 10.1093/aje/kws193; Magee L, 2012, SLEEP MED REV, V16, P231, DOI 10.1016/j.smrv.2011.05.005; Malik SW, 2005, PRIMARY CARE, V32, P475, DOI 10.1016/j.pop.2005.02.011; McElroy JA, 2006, J SLEEP RES, V15, P241, DOI 10.1111/j.1365-2869.2006.00523.x; Michaud D, 2005, J REGISTRY MANAGE, V2, P70; Monk TH, 2013, J SLEEP RES, V22, P201, DOI 10.1111/jsr.12003; Patel SR, 2009, OBES REV, V10, P61, DOI 10.1111/j.1467-789X.2009.00664.x; Pinheiro SP, 2006, CANCER RES, V66, P5521, DOI 10.1158/0008-5472.CAN-05-4652; Qian X, 2014, BR J CANC; Qin YY, 2014, INT J CANCER, V134, P1166, DOI 10.1002/ijc.28452; Schatzkin A, 2001, AM J EPIDEMIOL, V154, P1119, DOI 10.1093/aje/154.12.1119; Straif K, 2007, LANCET ONCOL, V8, P1065, DOI 10.1016/S1470-2045(07)70373-X; Sturgeon SR, 2012, CANCER CAUSE CONTROL, V23, P547, DOI 10.1007/s10552-012-9912-2; Thompson FE, 2008, PUBLIC HEALTH NUTR, V11, P183, DOI 10.1017/S1368980007000419; Uemura N, 2001, NEW ENGL J MED, V345, P784, DOI 10.1056/NEJMoa001999; Verkasalo PK, 2005, CANCER RES, V65, P9595, DOI 10.1158/0008-5472.CAN-05-2138; Vogtmann E, 2013, SLEEP, V36, P1437, DOI 10.5665/sleep.3032; Webb PM, 2001, GUT, V49, P347, DOI 10.1136/gut.49.3.347; Wu AH, 2013, INT J CANCER, V132, P891, DOI 10.1002/ijc.27653; Xie FJ, 2013, WORLD J GASTROENTERO, V19, P6098, DOI 10.3748/wjg.v19.i36.6098; Zhang XH, 2013, SLEEP, V36, P681, DOI 10.5665/sleep.2626; Zizi F, 2010, CURR DIABETES REP, V10, P43, DOI 10.1007/s11892-009-0082-x	38	43	45	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161561	10.1371/journal.pone.0161561	http://dx.doi.org/10.1371/journal.pone.0161561			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611440	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900020
J	Song, NJ; Kim, S; Jang, BH; Chang, SH; Yun, UJ; Park, KM; Waki, H; Li, DY; Tontonoz, P; Park, KW				Song, No-Joon; Kim, Suji; Jang, Byung-Hyun; Chang, Seo-Hyuk; Yun, Ui Jeong; Park, Ki-Moon; Waki, Hironori; Li, Dean Y.; Tontonoz, Peter; Park, Kye Won			Small Molecule-Induced Complement Factor D (Adipsin) Promotes Lipid Accumulation and Adipocyte Differentiation	PLOS ONE			English	Article							ACYLATION-STIMULATING PROTEIN; ACTIVATED RECEPTOR-GAMMA; PPAR-GAMMA; ADIPOSE-TISSUE; TRIGLYCERIDE SYNTHESIS; OBESITY; EXPRESSION; BIOLOGY; BINDING; PHOSPHORYLATION	Adipocytes are differentiated by various transcriptional cascades integrated on the master regulator, Ppar gamma. To discover new genes involved in adipocyte differentiation, preadipocytes were treated with three newly identified pro-adipogenic small molecules and GW7845 (a Ppar gamma agonist) for 24 hours and transcriptional profiling was analyzed. Four genes, Peroxisome proliferator-activated receptor gamma (Ppar gamma), human complement factor D homolog (Cfd), Chemokine (C-C motif) ligand 9 (Ccl9), and GIPC PDZ Domain Containing Family Member 2 (Gipc2) were induced by at least two different small molecules but not by GW7845. Cfd and Ccl9 expressions were specific to adipocytes and they were altered in obese mice. Small hairpinRNA (shRNA) mediated knockdown of Cfd in preadipocytes inhibited lipid accumulation and expression of adipocyte markers during adipocyte differentiation. Overexpression of Cfd promoted adipocyte differentiation, increased C3a production, and led to induction of C3a receptor (C3aR) target gene expression. Similarly, treatments with C3a or C3aR agonist (C4494) also promoted adipogenesis. C3aR knockdown suppressed adipogenesis and impaired the pro-adipogenic effects of Cfd, further suggesting the necessity for C3aR signaling in Cfd-mediated pro-adipogenic axis. Together, these data show the action of Cfd in adipogenesis and underscore the application of small molecules to identify genes in adipocytes.	[Song, No-Joon; Kim, Suji; Jang, Byung-Hyun; Chang, Seo-Hyuk; Yun, Ui Jeong; Park, Ki-Moon; Park, Kye Won] Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Suwon 16419, South Korea; [Waki, Hironori] Univ Tokyo, Grad Sch Med, Dept Diabet & Metab Dis, Tokyo 1138655, Japan; [Li, Dean Y.] Univ Utah, Dept Med, Program Mol Med, 15 North 2030 East, Salt Lake City, UT 84112 USA; [Tontonoz, Peter] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Tontonoz, Peter] Univ Calif Los Angeles, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA	Sungkyunkwan University (SKKU); University of Tokyo; Utah System of Higher Education; University of Utah; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Park, KW (corresponding author), Sungkyunkwan Univ, Dept Food Sci & Biotechnol, Suwon 16419, South Korea.	kwpark@skku.edu	Waki, Hironori/AAE-3942-2020	Waki, Hironori/0000-0002-5302-9793; Park, Kye Won/0000-0003-2771-249X	Basic Science Research Program through the National Research Foundation of Korea (NRF) [NRF-2016M3A9B6903451]; Ministry of Education, Science and Technology, Republic of Korea	Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology, Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This study was supported by grants (NRF-2016M3A9B6903451) funded by the Basic Science Research Program through the National Research Foundation of Korea (NRF, www.nrf.re.kr), the Ministry of Education, Science and Technology, Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baek K, 2014, BMB REP, V47, P587, DOI 10.5483/BMBRep.2014.47.10.176; BALDO A, 1993, J CLIN INVEST, V92, P1543, DOI 10.1172/JCI116733; Bartelt A, 2014, NAT REV ENDOCRINOL, V10, P24, DOI 10.1038/nrendo.2013.204; Brown JD, 2007, CIRCULATION, V115, P518, DOI 10.1161/CIRCULATIONAHA.104.475673; Choi JH, 2011, NATURE, V477, P477, DOI 10.1038/nature10383; Choi JH, 2010, NATURE, V466, P451, DOI 10.1038/nature09291; CHOY LN, 1992, J BIOL CHEM, V267, P12736; Ding S, 2004, NAT BIOTECHNOL, V22, P833, DOI 10.1038/nbt987; Engstrom G, 2005, DIABETES, V54, P570, DOI 10.2337/diabetes.54.2.570; FLIER JS, 1987, SCIENCE, V237, P405, DOI 10.1126/science.3299706; Kang S, 2007, J BIOL CHEM, V282, P14515, DOI 10.1074/jbc.M700030200; Kim CS, 2003, FEBS LETT, V548, P125, DOI 10.1016/S0014-5793(03)00728-2; Kim JH, 2015, ARCH PHARM RES, V38, P302, DOI 10.1007/s12272-015-0559-x; LASSAR AB, 1986, CELL, V47, P649, DOI 10.1016/0092-8674(86)90507-6; Lefterova MI, 2008, GENE DEV, V22, P2941, DOI 10.1101/gad.1709008; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Lo JC, 2014, CELL, V158, P41, DOI 10.1016/j.cell.2014.06.005; LOWELL BB, 1990, ENDOCRINOLOGY, V126, P1514, DOI 10.1210/endo-126-3-1514; Mamane Y, 2009, DIABETES, V58, P2006, DOI 10.2337/db09-0323; Morgan BP, 2015, NAT REV DRUG DISCOV, V14, P857, DOI 10.1038/nrd4657; Paglialunga S, 2007, J ENDOCRINOL, V194, P293, DOI 10.1677/JOE-07-0205; Park KW, 2008, MOL ENDOCRINOL, V22, P2038, DOI 10.1210/me.2007-0454; Park KW, 2010, J LIPID RES, V51, P2775, DOI 10.1194/jlr.M008490; Park KW, 2009, MOL CELL BIOL, V29, P3905, DOI 10.1128/MCB.00002-09; Pattrick M, 2009, MOL IMMUNOL, V46, P755, DOI 10.1016/j.molimm.2008.09.013; ROSEN BS, 1989, SCIENCE, V244, P1483, DOI 10.1126/science.2734615; Rosen CJ, 2006, NAT CLIN PRACT RHEUM, V2, P35, DOI 10.1038/ncprheum0070; SISSONS JGP, 1976, NEW ENGL J MED, V294, P461, DOI 10.1056/NEJM197602262940902; Song NJ, 2013, J LIPID RES, V54, P1385, DOI 10.1194/jlr.M035576; TAPSCOTT SJ, 1988, SCIENCE, V242, P405, DOI 10.1126/science.3175662; Tontonoz P, 1998, CELL, V93, P241, DOI 10.1016/S0092-8674(00)81575-5; Tontonoz P, 2008, ANNU REV BIOCHEM, V77, P289, DOI 10.1146/annurev.biochem.77.061307.091829; Waki H, 2007, CELL METAB, V5, P357, DOI 10.1016/j.cmet.2007.03.010; Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859; WHITE RT, 1992, J BIOL CHEM, V267, P9210; Xia Z, 2002, J BIOL CHEM, V277, P45874, DOI 10.1074/jbc.M207281200; YASRUEL Z, 1991, LIPIDS, V26, P495, DOI 10.1007/BF02536592; Zipfel PF, 2009, NAT REV IMMUNOL, V9, P729, DOI 10.1038/nri2620	38	56	57	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162228	10.1371/journal.pone.0162228	http://dx.doi.org/10.1371/journal.pone.0162228			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611793	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900063
J	Stires, H; Saboya, M; Globerman, SP; Cohick, WS				Stires, Hillary; Saboya, Mariana; Globerman, Samantha P.; Cohick, Wendie S.			Peroral Estradiol Is Sufficient to Induce Carcinogen-Induced Mammary Tumorigenesis in Ovariectomized Rats without Progesterone	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; BREAST-CANCER; OVARIAN HORMONES; BODY-WEIGHT; FOOD-INTAKE; 17-BETA-ESTRADIOL; SENSITIVITY; TAMOXIFEN; EXPOSURE; ROUTE	A role for estrogens in breast cancer is widely accepted, however, recent evidence highlights that timing and exposure levels are important in determining whether they elicit harmful versus beneficial effects. The rat chemical carcinogen model has been widely used to study the effects of estrogens but conclusions on the levels that lead to tumor development and an absolute requirement for progesterone (P4) are lacking. A newer method of hormone administration mixes hormones with nut butter for peroral consumption allowing for a less stressful method of long-termadministration with lower spikes in serum estradiol (E2) levels. The present study was designed to determine if estrogens alone at a physiological dose can drive carcinogen-induced tumors in ovariectomized (OVX) rats or if P4 is also required using this method of hormone administration. Short-termstudies were conducted to determine the dose of estrogen (E) that would lead to increased uterine weight following OVX. Subsequently, rats were OVX on postnatal day (PND) 40 then treated daily with E (600 mu g/kg/day), P4 (15 mg/kg/day), or the combination. On PND 50, all rats were injected with nitrosomethylurea to induce mammary tumors. Uterine weights, body weights, and serum E2 levels were measured to demonstrate the efficacy of the method for increasing E2 levels during long-termtreatment. After 26 weeks, tumor incidence was similar in Sham, E, and E + P4 animals indicating that E was sufficient to induce tumorigenesis when hormone levels were normalized by this method. This study demonstrates peroral administration can be used in long-termstudies to elucidate relationships between different types and levels of steroid hormones.	[Stires, Hillary; Saboya, Mariana; Globerman, Samantha P.; Cohick, Wendie S.] Rutgers State Univ, Dept Anim Sci, New Brunswick, NJ 08901 USA	Rutgers State University New Brunswick	Cohick, WS (corresponding author), Rutgers State Univ, Dept Anim Sci, New Brunswick, NJ 08901 USA.	cohick@aesop.rutgers.edu		Saboya, Mariana/0000-0001-5793-0020; Stires, Hillary/0000-0002-0177-2024				Arques O, 2012, STANDARDIZED RELATIV; Aupperlee MD, 2007, ENDOCRINOLOGY, V148, P2290, DOI 10.1210/en.2006-1721; Banks E, 2003, LANCET, V362, P419, DOI 10.1016/S0140-6736(03)14065-2; BARTOSHUK LM, 1988, CHEM SENSES, V13, P517, DOI 10.1093/chemse/13.4.517; Bigsby RA, 2002, CANCER LETT, V179, P113, DOI 10.1016/S0304-3835(02)00032-0; Blank EW, 2008, P NATL ACAD SCI USA, V105, P3527, DOI 10.1073/pnas.0710535105; Brisken C, 2015, ENDOCRINOLOGY, V156, P3442, DOI 10.1210/en.2015-1392; Brisken C, 2013, NAT REV CANCER, V13, P385, DOI 10.1038/nrc3518; Chan M, 2014, J NEUROENDOCRINOL, V26, P386, DOI 10.1111/jne.12159; Clarke RB, 1997, CANCER RES, V57, P4987; Diep CH, 2015, J MOL ENDOCRINOL, V54, pR31, DOI 10.1530/JME-14-0252; Fournier A, 2008, BREAST CANCER RES TR, V107, P103, DOI 10.1007/s10549-007-9523-x; Gleason CE, 2005, ANN NY ACAD SCI, V1052, P93, DOI 10.1196/annals.1347.007; GOTTARDIS MM, 1987, CANCER RES, V47, P4020; GRUBBS CJ, 1985, J NATL CANCER I, V74, P927; Haisenleder DJ, 2011, ENDOCRINOLOGY, V152, P4443, DOI 10.1210/en.2011-1501; Hilakivi-Clarke L, 2013, J MAMMARY GLAND BIOL, V18, P25, DOI 10.1007/s10911-013-9274-8; Isaksson IM, 2011, SCAND J CLIN LAB INV, V71, P583, DOI 10.3109/00365513.2011.596944; Jagger CJ, 1996, J CLIN INVEST, V98, P2351, DOI 10.1172/JCI119047; JORDAN VC, 1976, EUR J CANCER, V12, P419, DOI 10.1016/0014-2964(76)90030-X; Kerdelhue B, 2002, BREAST CANCER RES TR, V73, P13, DOI 10.1023/A:1015239128480; Kopper Nathan W, 2009, Drug Des Devel Ther, V2, P193; Kupfer D, 1987, Reprod Toxicol, V1, P147; Liu J, 2015, NEUROSCIENCE, V290, P103, DOI 10.1016/j.neuroscience.2015.01.042; LONGCOPE C, 1985, J STEROID BIOCHEM, V23, P1065, DOI 10.1016/0022-4731(85)90068-8; Lubet RA, 1998, CARCINOGENESIS, V19, P1345, DOI 10.1093/carcin/19.8.1345; Mirkin S, 2015, MATURITAS, V81, P28, DOI 10.1016/j.maturitas.2015.02.266; Mohammed H, 2015, NATURE, V523, P313, DOI 10.1038/nature14583; Newbold RR, 2001, REPROD TOXICOL, V15, P245, DOI 10.1016/S0890-6238(01)00130-7; OCONNELL MB, 1995, J CLIN PHARMACOL, V35, pS18, DOI 10.1002/j.1552-4604.1995.tb04143.x; OHI Y, 1992, VIRCHOWS ARCH B, V62, P365, DOI 10.1007/BF02899705; Polanco TA, 2010, ALCOHOL CLIN EXP RES, V34, P1879, DOI 10.1111/j.1530-0277.2010.01276.x; Rajkumar L, 2001, P NATL ACAD SCI USA, V98, P11755, DOI 10.1073/pnas.201393798; Rossouw JE, 2002, JAMA-J AM MED ASSOC, V288, P321, DOI 10.1001/jama.288.3.321; Russo J, 1999, BREAST CANCER RES TR, V53, P217, DOI 10.1023/A:1006186719322; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/nmeth.2019, 10.1038/NMETH.2019]; SCHWARTZ SM, 1981, AM J PHYSIOL, V240, pE499, DOI 10.1152/ajpendo.1981.240.5.E499; Stevenson JC, 2009, CLIMACTERIC, V12, P86, DOI 10.1080/13697130903007389; Strom JO, 2008, SCAND J CLIN LAB INV, V68, P814, DOI 10.1080/00365510802409703; Swanson SM, 2003, ANTICANCER RES, V23, P3207; Theodorsson A, 2005, SCAND J CLIN LAB INV, V65, P699, DOI 10.1080/00365510500375206; VERDEAL K, 1982, EUR J CANCER CLIN ON, V18, P1171, DOI 10.1016/0277-5379(82)90099-2; WADE GN, 1975, J COMP PHYSIOL PSYCH, V88, P183, DOI 10.1037/h0076186; WADE GN, 1972, PHYSIOL BEHAV, V8, P523, DOI 10.1016/0031-9384(72)90340-X; Witte MM, 2010, GEN COMP ENDOCR, V166, P520, DOI 10.1016/j.ygcen.2010.01.006	45	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162662	10.1371/journal.pone.0162662	http://dx.doi.org/10.1371/journal.pone.0162662			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611094	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900147
J	Witzel, TC; Rodger, AJ; Burns, FM; Rhodes, T; Weatherburn, P				Witzel, T. Charles; Rodger, Alison J.; Burns, Fiona M.; Rhodes, Tim; Weatherburn, Peter			HIV Self-Testing among Men Who Have Sex with Men (MSM) in the UK: A Qualitative Study of Barriers and Facilitators, Intervention Preferences and Perceived Impacts	PLOS ONE			English	Article							ACCEPTABILITY	Introduction Innovative strategies, such as HIV self-testing (HIVST), could increase HIV testing rates and diagnosis. Evidence to inform the design of an HIVST intervention in the UK is scarce with very little European data on this topic. This study aims to understand values and preferences for HIVST interventions targeting MSM in the UK. We explore the acceptability of HIVST among MSM in the context of known barriers and facilitators to testing for HIV; assess preferences for, and the concerns about, HIVST. Methods Six focus group discussions (FGD) were conducted with 47 MSM in London, Manchester and Plymouth. HIVST as a concept was discussed and participants were asked to construct their ideal HIVST intervention. OraQuick (TM) and BioSure (TM) kits were then demonstrated and participants commented on procedure, design and instructions. FGDs were recorded and transcribed verbatim, then analysed thematically. Results Convenience and confidentiality of HIVST was seen to facilitate testing. Issues with domestic privacy problematised confidentiality. HIVST kits and instructions were thought to be unnecessarily complicated, and did not cater to the required range of abilities. The window period was the most important element of an HIVST, with strong preference for 4th generation testing. Kits which used a blood sample were more popular than those using saliva due to higher perceived accuracy although phobia of needles and/or blood meant some would only access HIVST if a saliva sample option was available. A range of access options was important to maintain convenience and privacy. HIVST kits were assumed to increase frequency of testing, with concerns related to the dislocation of HIVST from sexual health care pathways and services. Discussion Utility of HIVST arises from relatively high levels of confidentiality and convenience. Until 4th generation assays are available HIVST will be seen as supplementary in a UK context.	[Witzel, T. Charles; Weatherburn, Peter] London Sch Hyg & Trop Med, Sigma Res, Dept Social & Environm Hlth Res, Publ Hlth & Policy, London, England; [Rodger, Alison J.; Burns, Fiona M.] UCL, Res Dept Infect & Populat Hlth, London, England; [Rhodes, Tim] London Sch Hyg & Trop Med, Dept Social & Environm Hlth Res, Publ Hlth & Policy, London, England	University of London; London School of Hygiene & Tropical Medicine; University of London; University College London; University of London; London School of Hygiene & Tropical Medicine	Witzel, TC (corresponding author), London Sch Hyg & Trop Med, Sigma Res, Dept Social & Environm Hlth Res, Publ Hlth & Policy, London, England.	Charles.witzel@lshtm.ac.uk	Rhodes, Tim/DNJ-9679-2022; Weatherburn, Peter/AAC-2701-2019	Weatherburn, Peter/0000-0002-4950-6163; Witzel, T Charles/0000-0003-4262-261X; Rhodes, Tim/0000-0003-2400-9838	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme [RP-PG-1212-20006]; National Institute for Health Research; PANTHEON [RP-PG-1212-20006]; National Institute for Health Research [RP-PG-1212-20006] Funding Source: researchfish	National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme(National Institute for Health Research (NIHR)); National Institute for Health Research(National Institute for Health Research (NIHR)); PANTHEON; National Institute for Health Research(National Institute for Health Research (NIHR))	This paper summarises independent research funded by the National Institute for Health Research (NIHR) under its Programme Grants for Applied Research Programme (grant reference number RP-PG-1212-20006). The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health. This research is being conducted as part of a National Institute for Health Research funded programme grant called PANTHEON; a collaborative project between University College London, the London School of Hygiene and Tropical Medicine, the Medical Research Council and others. The grant number for PANTHEON (under which this project falls) is RP-PG-1212-20006. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2021, HIV TESTING NEW HIV; Banda J, 2015, BODY SOC, V21, P24, DOI 10.1177/1357034X14528391; Bilardi JE, 2013, AIDS BEHAV, V17, P2093, DOI 10.1007/s10461-012-0395-7; Dodds C, 2007, BMJ-BRIT MED J, V334, P1329, DOI 10.1136/bmj.39245.570093.BE; Figueroa C, 2015, AIDS BEHAV, V19, P1949, DOI 10.1007/s10461-015-1097-8; Flowers P, 2017, HIV MED, V18, P245, DOI 10.1111/hiv.12420; Flowers P, 2013, HIV MED, V14, P92, DOI 10.1111/j.1468-1293.2012.01041.x; Glasgow RE, 2013, JAIDS-J ACQ IMM DEF, V63, pS26, DOI 10.1097/QAI.0b013e3182920286; Ibitoye M, 2014, AIDS BEHAV, V18, P933, DOI 10.1007/s10461-013-0668-9; Johnson C, 2014, AIDS BEHAV, V18, pS391, DOI 10.1007/s10461-014-0832-x; KATZ D, 2012, ACCEPTABILITY EASE U; Knussen C, 2014, AIDS CARE, V26, P297, DOI 10.1080/09540121.2013.824543; Krause J, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-735; Lorenc T, 2011, HEALTH EDUC RES, V26, P834, DOI 10.1093/her/cyr064; Love My Town, 2015, ALL UK TOWNS CIT POP; Mavedzenge SN, 2013, CLIN INFECT DIS, V57, P126, DOI 10.1093/cid/cit156; McDaid LM, 2016, HIV MED, V17, P683, DOI 10.1111/hiv.12373; Michie S, 2011, IMPLEMENT SCI, V6, DOI 10.1186/1748-5908-6-42; National AIDS Trust, 2015, HIV PREV ENGL HIGH P; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Skingsley A, 2015, HIV UK 2015 SITUATIO; Westrop SJ, 2013, CONTR HIV EP ANT AV; Witzel TC, BMJ OPEN IN PRESS; Yin Z, 2014, HIV UK 2014 REPORT D	24	59	64	2	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162713	10.1371/journal.pone.0162713	http://dx.doi.org/10.1371/journal.pone.0162713			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611777	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000383255900153
J	Baghbaderani, BA; Tian, XH; Cadet, JS; Shah, K; Walde, A; Tran, H; Kovarcik, DP; Clarke, D; Fellner, T				Baghbaderani, Behnam Ahmadian; Tian, Xinghui; Cadet, Jean Scotty; Shah, Kevan; Walde, Amy; Tran, Huan; Kovarcik, Don Paul; Clarke, Diana; Fellner, Thomas			A Newly Defined and Xeno-Free Culture Medium Supports Every-Other-Day Medium Replacement in the Generation and Long-Term Cultivation of Human Pluripotent Stem Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SELF-RENEWAL; EXPRESSION; DIFFERENTIATION; DIMERIZATION; DERIVATION; PATHWAYS; BLOOD	Human pluripotent stem cells (hPSCs) present an unprecedented opportunity to advance human health by offering an alternative and renewable cell resource for cellular therapeutics and regenerative medicine. The present demand for high quality hPSCs for use in both research and clinical studies underscores the need to develop technologies that will simplify the cultivation process and control variability. Here we describe the development of a robust, defined and xeno-free hPSC medium that supports reliable propagation of hPSCs and generation of human induced pluripotent stem cells (hiPSCs) from multiple somatic cell types; long-term serial subculturing of hPSCs with every-other-day (EOD) medium replacement; and banking fully characterized hPSCs. The hPSCs cultured in this medium for over 40 passages are genetically stable, retain high expression levels of the pluripotency markers TRA-1-60, TRA-1-81, Oct-3/4 and SSEA-4, and readily differentiate into ectoderm, mesoderm and endoderm. Importantly, the medium plays an integral role in establishing a cGMP-compliant process for the manufacturing of hiPSCs that can be used for generation of clinically relevant cell types for cell replacement therapy applications.	[Baghbaderani, Behnam Ahmadian; Tian, Xinghui; Cadet, Jean Scotty; Shah, Kevan; Walde, Amy; Tran, Huan; Kovarcik, Don Paul; Clarke, Diana; Fellner, Thomas] Lonza Walkersville Inc, Walkersville, MD 21793 USA		Baghbaderani, BA (corresponding author), Lonza Walkersville Inc, Walkersville, MD 21793 USA.	behnam.ahmadianbaghbaderani@lonza.com		Shah, Kevan/0000-0002-6284-2030; Ahmadian Baghbaderani, Behnam/0000-0001-6033-625X				Amit M, 2004, BIOL REPROD, V70, P837, DOI 10.1095/biolreprod.103.021147; Baghbaderani B. A., 2015, BIOPROCESS INT, V13, P10; Baghbaderani BA, 2015, STEM CELL REP, V5, P647, DOI 10.1016/j.stemcr.2015.08.015; Beattie GM, 2005, STEM CELLS, V23, P489, DOI 10.1634/stemcells.2004-0279; Chen GK, 2011, NAT METHODS, V8, P424, DOI [10.1038/nmeth.1593, 10.1038/NMETH.1593]; Dowey SN, 2012, NAT PROTOC, V7, P2013, DOI 10.1038/nprot.2012.121; Eiselleova L, 2009, STEM CELLS, V27, P1847, DOI 10.1002/stem.128; Guenther MG, 2010, CELL STEM CELL, V7, P249, DOI 10.1016/j.stem.2010.06.015; Guha P, 2013, CELL STEM CELL, V12, P407, DOI 10.1016/j.stem.2013.01.006; Levenstein ME, 2006, STEM CELLS, V24, P568, DOI 10.1634/stemcells.2005-0247; Levenstein ME, 2008, STEM CELLS, V26, P3099, DOI 10.1634/stemcells.2007-1056; Li J, 2007, DIFFERENTIATION, V75, P299, DOI 10.1111/j.1432-0436.2006.00143.x; Lotz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056289; Lu J, 2006, P NATL ACAD SCI USA, V103, P5688, DOI 10.1073/pnas.0601383103; Ludwig TE, 2006, NAT BIOTECHNOL, V24, P185, DOI 10.1038/nbt1177; Ludwig TE, 2006, NAT METHODS, V3, P637, DOI 10.1038/NMETH902; Nakagawa M, 2014, SCI REP-UK, V4, DOI 10.1038/srep03594; Newman AM, 2010, CELL STEM CELL, V7, P258, DOI 10.1016/j.stem.2010.06.016; Nie Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088012; Okita K, 2013, STEM CELLS, V31, P458, DOI 10.1002/stem.1293; Okita K, 2011, NAT METHODS, V8, P409, DOI [10.1038/NMETH.1591, 10.1038/nmeth.1591]; Plotnikov AN, 1999, CELL, V98, P641, DOI 10.1016/S0092-8674(00)80051-3; Rodin S, 2014, NAT PROTOC, V9, P2354, DOI 10.1038/nprot.2014.159; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Rodin S, 2010, NAT BIOTECHNOL, V28, P611, DOI 10.1038/nbt.1620; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier Ludovic, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01d04s4; Ward CM, 2004, EXP CELL RES, V293, P229, DOI 10.1016/j.yexcr.2003.10.017; Xiao L, 2006, STEM CELLS, V24, P1476, DOI 10.1634/stemcells.2005-0299; Yu PZ, 2011, CELL STEM CELL, V8, P326, DOI 10.1016/j.stem.2011.01.001	31	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161229	10.1371/journal.pone.0161229	http://dx.doi.org/10.1371/journal.pone.0161229			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606941	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600002
J	Benitez-Porres, J; Alvero-Cruz, JR; de Albornoz, MC; Correas-Gomez, L; Barrera-Exposito, J; Dorado-Guzman, M; Moore, JB; Carnero, EA				Benitez-Porres, Javier; Ramon Alvero-Cruz, Jose; Carrillo de Albornoz, Margarita; Correas-Gomez, Lorena; Barrera-Exposito, Jesus; Dorado-Guzman, Manuel; Moore, Justin B.; Carnero, Elvis A.			The Influence of 2-Year Changes in Physical Activity, Maturation, and Nutrition on Adiposity in Adolescent Youth	PLOS ONE			English	Article							ACTIVITY QUESTIONNAIRE; BIOLOGICAL MATURATION; SELF-PERCEPTIONS; SKELETAL AGE; MATURITY; VALIDATION; CHILDREN; DECLINE; GROWTH; GIRLS	The aim of this longitudinal study was to explore temporal patterns of physical activity (PA) and adiposity in Spanish adolescents. Eighty healthy adolescents were followed over a 2-year period (42 girls and 38 boys). A PA score was estimated using the Physical Activity Questionnaire for Adolescents (PAQ-A). Adiposity was assessed by anthropometric measurements; body mass index (BMI) and fat mass percent (FMP) were calculated using standard equations. Sexual maturity was estimated by percentage of predicted adult stature. Dietary intake was assessed by a self-administered food-frequency questionnaire. Three assessments were performed: September 2011 (S1), 2012 (S2), and 2013 (S3). A repeated-measures ANOVA was conducted to examine temporal changes in PA and FMP and sex change in maturation categories (two factor mixed-design, 2x2x3). A stepwise linear regression was conducted in order to estimate the predictors of FMP change. Significant changes for FMP were found between S1, S2, and S3 (23.41 +/- 8.24 vs. 21.89 +/- 7.82 vs. 22.05 +/- 8.06, p < 0.05; respectively); a significant interaction of FMP with sex was observed (F = 4.387, p < 0.05 for S2-S3), but not for maturation. PA at S2 was significantly higher than S3 (2.58 +/- 0.72 vs. 2.29 +/- 0.73, p < 0.001). An interaction between PA change and sex was statically significant (F = 4.889, p < 0.05 for S2-S3). A reduction in PA was observed after the S2 period without changes in adiposity. In contrast, a significant reduction in FMP was seen between S1 and S2, while PA did not significantly change. There were no significant differences for nutritional variables between S1 and S3, and nutrition was not a determinant of the changes in PA or FMP. Our results suggest that body composition changes observed during adolescence are not driven by changes in PA. Moreover, the interaction analysis suggests that PA behavior is affected by sex, but is not modified by maturation.	[Benitez-Porres, Javier; Correas-Gomez, Lorena; Barrera-Exposito, Jesus; Dorado-Guzman, Manuel; Carnero, Elvis A.] Univ Malaga, Biodynam & Body Composit Lab, Malaga, Spain; [Ramon Alvero-Cruz, Jose; Carrillo de Albornoz, Margarita] Univ Malaga, Exercise Physiol Lab, Malaga, Spain; [Moore, Justin B.] Wake Forest Sch Med, Dept Family & Community Med, Winston Salem, NC USA; [Carnero, Elvis A.] Florida Hosp, Translat Res Inst Metab & Diabet, Orlando, FL USA	Universidad de Malaga; Universidad de Malaga; Wake Forest University; Adventist Health Services; AdventHealth	Benitez-Porres, J (corresponding author), Univ Malaga, Biodynam & Body Composit Lab, Malaga, Spain.	benitez@uma.es	Correas-Gómez, Lorena/F-8722-2015; Moore, Justin B/B-9357-2012; Benítez-Porres, Javier/R-5211-2019	Correas-Gómez, Lorena/0000-0002-1838-8993; Moore, Justin B/0000-0003-4059-0538; Benítez-Porres, Javier/0000-0001-7546-7965	Spanish Ministry of Education, Culture and Sport [AP2010-0583]; Spanish Ministry of Economy and Competitiveness [DEP2011-30565]	Spanish Ministry of Education, Culture and Sport(Spanish Government); Spanish Ministry of Economy and Competitiveness(Spanish Government)	This work was supported by: JBP, AP2010-0583, Spanish Ministry of Education, Culture and Sport: https://www.boe.es/diario_boe/txt.php?id=BOE-A-2012-14470; and EAC, DEP2011-30565, Spanish Ministry of Economy and Competitiveness: http://www.boe.es/diario_boe/txt.php?id=BOE-A-2012-1299. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison KR, 2007, CAN J PUBLIC HEALTH, V98, P97, DOI 10.1007/BF03404317; Bacil Eliane Denise Araújo, 2015, Rev. paul. pediatr., V33, P114, DOI 10.1016/j.rpped.2014.11.003; Bauman AE, 2002, AM J PREV MED, V23, P5, DOI 10.1016/S0749-3797(02)00469-5; Benefice E, 2001, AM J HUM BIOL, V13, P808, DOI 10.1002/ajhb.1126; Cade J, 2002, PUBLIC HEALTH NUTR, V5, P567, DOI 10.1079/PHN2001318; COLE TJ, 1994, STAT MED, V13, P2477, DOI 10.1002/sim.4780132311; Crocker PRE, 1997, MED SCI SPORT EXER, V29, P1344, DOI 10.1097/00005768-199710000-00011; Cumming SP, 2014, SCAND J MED SCI SPOR, V24, pe20, DOI 10.1111/sms.12103; Cumming SP, 2008, J ADOLESCENT HEALTH, V42, P480, DOI 10.1016/j.jadohealth.2007.10.005; Davison KK, 2007, SOC SCI MED, V64, P2391, DOI 10.1016/j.socscimed.2007.02.033; de Onis M, 2009, ARCH PEDIATRIE, V16, P47, DOI 10.1016/j.arcped.2008.10.010; Dumith SC, 2012, PUBLIC HEALTH NUTR, V15, P2237, DOI 10.1017/S1368980012000948; Dumith SC, 2011, INT J EPIDEMIOL, V40, P685, DOI 10.1093/ije/dyq272; Fawkner S, 2014, J SPORT SCI, V32, P392, DOI 10.1080/02640414.2013.825733; Hallal PC, 2006, SPORTS MED, V36, P1019, DOI 10.2165/00007256-200636120-00003; Ham SA, 2007, MED SCI SPORT EXER, V39, P52, DOI 10.1249/01.mss.0000235886.17229.42; KHAMIS HJ, 1994, PEDIATRICS, V94, P504; Kimm SYS, 2002, NEW ENGL J MED, V347, P709, DOI 10.1056/NEJMoa003277; Kimm SYS, 2005, LANCET, V366, P301, DOI 10.1016/S0140-6736(05)66837-7; Knowles AM, 2009, J ADOLESCENCE, V32, P555, DOI 10.1016/j.adolescence.2008.06.001; Kowalski KC, 1997, PEDIATR EXERC SCI, V9, P174, DOI 10.1123/pes.9.2.174; Livingstone MBE, 2004, BRIT J NUTR, V92, pS213, DOI 10.1079/BJN20041169; Malina R.M., 2004, GROWTH MATURATION PH, V2nd ed., DOI DOI 10.1016/j.jsams.2011.04.003; Malina RM, 2005, CLIN J SPORT MED, V15, P125, DOI 10.1097/01.jsm.0000164287.42066.63; Malina RM, 2007, CLIN J SPORT MED, V17, P362, DOI 10.1097/JSM.0b013e31815400f4; Marfell-Jones M, 2006, INT STANDARDS ANTHRO; Martinez-Gomez D, 2011, MED CLIN-BARCELONA, V136, P13, DOI 10.1016/j.medcli.2010.05.013; MARTINMORENO JM, 1993, INT J EPIDEMIOL, V22, P512, DOI 10.1093/ije/22.3.512; Moore JB, 2014, AM J PREV MED, V46, P289, DOI 10.1016/j.amepre.2013.11.001; Nader PR, 2008, JAMA-J AM MED ASSOC, V300, P295, DOI 10.1001/jama.300.3.295; Nelson MC, 2006, PEDIATRICS, V118, pE1627, DOI 10.1542/peds.2006-0926; Reilly JJ, 2011, INT J OBESITY, V35, P891, DOI 10.1038/ijo.2010.222; Sallis JF, 2000, MED SCI SPORT EXER, V32, P963, DOI 10.1097/00005768-200009000-00012; Sherar LB, 2007, MED SCI SPORT EXER, V39, P830, DOI 10.1249/mss.0b013e3180335c3c; Sherar LB, 2010, PEDIATR EXERC SCI, V22, P332, DOI 10.1123/pes.22.3.332; SLAUGHTER MH, 1988, HUM BIOL, V60, P709; Smart JEH, 2012, J PHYS ACT HEALTH, V9, P86, DOI 10.1123/jpah.9.1.86; Spruijt-Metz D, 2011, J RES ADOLESCENCE, V21, P129, DOI 10.1111/j.1532-7795.2010.00719.x; Staiano AE, 2013, AM J HUM BIOL, V25, P473, DOI 10.1002/ajhb.22380; Telama R, 2000, MED SCI SPORT EXER, V32, P1617; Telama R, 2009, OBESITY FACTS, V2, P187, DOI 10.1159/000222244; Thompson AM, 2003, MED SCI SPORT EXER, V35, P1684, DOI 10.1249/01.MSS.0000089244.44914.1F; Twisk JWR, 2002, INT J SPORTS MED, V23, pS44	43	15	15	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162395	10.1371/journal.pone.0162395	http://dx.doi.org/10.1371/journal.pone.0162395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27607063	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255600043
J	Cunze, S; Kochmann, J; Koch, LK; Klimpel, S				Cunze, Sarah; Kochmann, Judith; Koch, Lisa K.; Klimpel, Sven			Aedes albopictus and Its Environmental Limits in Europe	PLOS ONE			English	Article							TEMPERATURE; CULICIDAE; RAINFALL; DYNAMICS; DIPTERA	The Asian tiger mosquito Aedes albopictus, native to South East Asia, is listed as one of the worst invasive vector species worldwide. In Europe the species is currently restricted to Southern Europe, but due to the ongoing climate change, Ae. albopictus is expected to expand its potential range further northwards. In addition to modelling the habitat suitability for Ae. albopictus under current and future climatic conditions in Europe by means of the maximum entropy approach, we here focused on the drivers of the habitat suitability prediction. We explored the most limiting factors for Aedes albopictus in Europe under current and future climatic conditions, a method which has been neglected in species distribution modelling so far. Ae. albopictus is one of the best-studied mosquito species, which allowed us to evaluate the applied Maxent approach for most limiting factor mapping. We identified three key limiting factors for Ae. albopictus in Europe under current climatic conditions: winter temperature in Eastern Europe, summer temperature in Southern Europe. Model findings were in good accordance with commonly known establishment thresholds in Europe based on climate chamber experiments and derived from the geographical distribution of the species. Under future climatic conditions low winter temperature were modelled to remain the most limiting factor in Eastern Europe, whereas in Central Europe annual mean temperature and summer temperatures were modelled to be replaced by summer precipitation, respectively, as most limiting factors. Changes in the climatic conditions in terms of the identified key limiting factors will be of great relevance regarding the invasive potential of the Ae. albopictus. Thus, our results may help to understand the key drivers of the suggested range expansion under climate change and may help to improve monitoring programmes. The applied approach of investigating limiting factors has proven to yield valuable results and may also provide valuable insights into the drivers of the prediction of current and future distribution of other species. This might be particularly interesting for other vector species that are of increasing public health concerns.	[Cunze, Sarah; Kochmann, Judith; Koch, Lisa K.; Klimpel, Sven] Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Max von Laue Str 13, D-60438 Frankfurt, Germany; [Cunze, Sarah; Kochmann, Judith; Koch, Lisa K.; Klimpel, Sven] Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Senckenberganlage 25, D-60325 Frankfurt, Germany	Goethe University Frankfurt; Senckenberg Biodiversitat & Klima- Forschungszentrum (BiK-F); Senckenberg Gesellschaft fur Naturforschung (SGN)	Cunze, S (corresponding author), Goethe Univ Frankfurt, Inst Ecol Evolut & Divers, Max von Laue Str 13, D-60438 Frankfurt, Germany.; Cunze, S (corresponding author), Senckenberg Gesell Nat Forsch, Senckenberg Biodivers & Climate Res Ctr, Senckenberganlage 25, D-60325 Frankfurt, Germany.	sarahcunze@gmail.com	Kochmann, Judith/AAG-3574-2021	Koch, Lisa/0000-0002-3064-8401; Kochmann, Judith/0000-0001-6312-7859	ERA-Net BiodivERsA; Deutsche Forschungsgemeinschaft [DFG KL 2087/6-1]; Austrian Science Fund [FWF I-1437]; Agence de la Recherche, BiodivERsA call for research proposals [ANR-13-EBID-0007-01]; German Federal Ministry of Food and Agriculture BMEL through the Federal Office for Agriculture and Food BLE [2819105115]	ERA-Net BiodivERsA; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Austrian Science Fund(Austrian Science Fund (FWF)); Agence de la Recherche, BiodivERsA call for research proposals; German Federal Ministry of Food and Agriculture BMEL through the Federal Office for Agriculture and Food BLE	The present study was funded by the ERA-Net BiodivERsA (www.biodiversa.org/), with the national funders Deutsche Forschungsgemeinschaft (www.dfg.de/) DFG KL 2087/6-1, Austrian Science Fund (www.fwf.ac.at/en/) FWF I-1437, and Agence de la Recherche (http://www.agence-nationalerecherche.fr/) ANR-13-EBID-0007-01 as part of the 2012-13 BiodivERsA call for research proposals and by the German Federal Ministry of Food and Agriculture BMEL (www.bmel.de/) through the Federal Office for Agriculture and Food BLE (www.ble.de/), grant number 2819105115. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alto BW, 2001, J MED ENTOMOL, V38, P548, DOI 10.1603/0022-2585-38.4.548; Baldwin RA, 2009, ENTROPY, V11, P854, DOI 10.3390/e11040854; Bonizzoni M, 2013, TRENDS PARASITOL, V29, P460, DOI 10.1016/j.pt.2013.07.003; Brady OJ, 2014, PARASITE VECTOR, V7, DOI 10.1186/1756-3305-7-338; Caminade C, 2012, J R SOC INTERFACE, V9, P2708, DOI 10.1098/rsif.2012.0138; Cunze S, 2015, ENVIRON MODELL SOFTW, V72, P250, DOI 10.1016/j.envsoft.2015.05.004; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2010, METHODS ECOL EVOL, V1, P330, DOI 10.1111/j.2041-210X.2010.00036.x; Fischer D, 2011, GLOBAL PLANET CHANGE, V78, P54, DOI 10.1016/j.gloplacha.2011.05.008; Hawley W.A., 1988, Journal of the American Mosquito Control Association, V4, P1; Knudsen AB, 1996, J AM MOSQUITO CONTR, V12, P177; Koch LK, 2015, PARASITOLOGY RES; Kraemer MUG, 2015, SCI DATA, V2, DOI 10.1038/sdata.2015.35; Kuemmerle T, 2011, ECOL APPL, V21, P830, DOI 10.1890/10-0073.1; Li GQ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131659; Medlock JM, 2015, B ENTOMOL RES, V105, P637, DOI 10.1017/S0007485315000103; Medlock JM, 2006, J VECTOR ECOL, V31, P292, DOI 10.3376/1081-1710(2006)31[292:AOTPFS]2.0.CO;2; Pachauri R. K., 2015, CLIMATE CHANGE 2014; Paupy C, 2009, MICROBES INFECT, V11, P1177, DOI 10.1016/j.micinf.2009.05.005; Phillips S., 2004, MAXIMUM ENTROPY APPR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Roiz D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014800; Roiz D, 2010, VECTOR-BORNE ZOONOT, V10, P811, DOI 10.1089/vbz.2009.0098; Schroeder Boris, 2000, Zeitschrift fuer Oekologie und Naturschutz, V8, P195; Straetemans M, 2008, EURO SURVEILLANCE B, V13; Thomas SM, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-100; Tran A, 2013, INT J ENV RES PUB HE, V10, P1698, DOI 10.3390/ijerph10051698; Warren DL, 2011, ECOL APPL, V21, P335, DOI 10.1890/10-1171.1	28	36	39	1	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162116	10.1371/journal.pone.0162116	http://dx.doi.org/10.1371/journal.pone.0162116			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603669	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200044
J	Zonato, V; Fedele, G; Kyriacou, CP				Zonato, Valeria; Fedele, Giorgio; Kyriacou, Charalambos P.			An Intronic Polymorphism in couch potato Is Not Distributed Clinally in European Drosophila melanogaster Populations nor Does It Affect Diapause Inducibility	PLOS ONE			English	Article							CHROMOSOME INVERSION POLYMORPHISMS; CLIMATIC ADAPTATION; LATITUDINAL CLINES; NATURAL-SELECTION; LIFE-HISTORY; GENE; EXPRESSION; ASSOCIATIONS; ALLELES; TRAITS	couch potato (cpo) encodes an RNA binding protein that has been reported to be expressed in the peripheral and central nervous system of embryos, larvae and adults, including the major endocrine organ, the ring gland. A polymorphism in the D. melanogaster cpo gene coding region displays a latitudinal cline in frequency in North American populations, but as cpo lies within the inversion In(3R)Payne, which is at high frequencies and itself shows a strong cline on this continent, interpretation of the cpo cline is not straightforward. A second downstream SNP in strong linkage disequilibrium with the first has been claimed to be primarily responsible for the latitudinal cline in diapause incidence in USA populations. Here, we investigate the frequencies of these two cpo SNPs in populations of Drosophila throughout continental Europe. The advantage of studying cpo variation in Europe is the very low frequency of In(3R)Payne, which we reveal here, does not appear to be clinally distributed. We observe a very different geographical scenario for cpo variation from the one in North America, suggesting that the downstream SNP does not play a role in diapause. In an attempt to verify whether the SNPs influence diapause we subsequently generated lines with different combinations of the two cpo SNPs on known timeless (tim) genetic backgrounds, because polymorphism in the clock gene tim plays a significant role in diapause inducibility. Our results reveal that the downstream cpo SNP does not seem to play any role in diapause induction in European populations in contrast to the upstream coding cpo SNP. Consequently, all future diapause studies on strains of D. melanogaster should initially determine their tim and cpo status.	[Zonato, Valeria; Fedele, Giorgio; Kyriacou, Charalambos P.] Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England	University of Leicester	Kyriacou, CP (corresponding author), Univ Leicester, Dept Genet, Univ Rd, Leicester LE1 7RH, Leics, England.	cpk@leicester.ac.uk	Fedele, Giorgio/ABE-3247-2020	Fedele, Giorgio/0000-0002-9878-0070	European Commission (6th Framework, EUCLOCK) [018741]; Marie Curie ITN INsec TIME [316790]; BBSRC; Erasmus studentship	European Commission (6th Framework, EUCLOCK); Marie Curie ITN INsec TIME; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Erasmus studentship	CPK gratefully acknowledges BBSRC for studentship and the European Commission (6th Framework, EUCLOCK grant no 018741 and Marie Curie ITN INsec TIME grant no 316790), which supported VZ. GF was supported by an Erasmus studentship.	Anderson AR, 2005, MOL ECOL, V14, P851, DOI 10.1111/j.1365-294X.2005.02445.x; BELLEN HJ, 1992, GENE DEV, V6, P2125, DOI 10.1101/gad.6.11.2125; BELLEN HJ, 1992, GENETICS, V131, P365; Cogni R, 2014, EVOLUTION, V68, P538, DOI 10.1111/evo.12291; COSTA R, 1992, P ROY SOC B-BIOL SCI, V250, P43, DOI 10.1098/rspb.1992.0128; DAVID JR, 1988, TRENDS GENET, V4, P106, DOI 10.1016/0168-9525(88)90098-4; Duman JG, 2004, J INSECT PHYSIOL, V50, P259, DOI 10.1016/j.jinsphys.2003.12.003; Emerson KJ, 2009, TRENDS GENET, V25, P217, DOI 10.1016/j.tig.2009.03.009; Glasscock E, 2005, GENETICS, V169, P2137, DOI 10.1534/genetics.104.028357; Graveley BR, 2011, NATURE, V471, P473, DOI 10.1038/nature09715; Harvie PD, 1998, GENETICS, V149, P217; Hoffmann AA, 2007, GENETICA, V129, P133, DOI 10.1007/s10709-006-9010-z; HUDSON RR, 1987, GENETICS, V116, P153; Kankare M, 2011, J INSECT PHYSL; Kankare Maaria, 2010, BMC Ecology, V10, P3, DOI 10.1186/1472-6785-10-3; King R. C., 1970, Int. Rev. Cytol., V28, P125, DOI 10.1016/S0074-7696(08)62542-5; KNIBB WR, 1981, GENETICS, V98, P833; KNIBB WR, 1982, GENETICA, V58, P213, DOI 10.1007/BF00128015; Kolaczkowski B, 2011, GENETICS, V187, P245, DOI 10.1534/genetics.110.123059; Lee SF, 2011, MOL ECOL, V20, P2973, DOI 10.1111/j.1365-294X.2011.05155.x; Li H, 2004, BIOINFORMATICS; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Liu Q, 1997, GENOME RES, V7, P389, DOI 10.1101/gr.7.4.389; Machado HE, 2016, MOL ECOL; OAKESHOTT JG, 1982, EVOLUTION, V36, P86, DOI 10.1111/j.1558-5646.1982.tb05013.x; Paaby AB, 2010, MOL ECOL, V19, P760, DOI 10.1111/j.1365-294X.2009.04508.x; Ragland GJ, 2010, P NATL ACAD SCI USA, V107, P14909, DOI 10.1073/pnas.1007075107; Rosato E, 1997, NUCLEIC ACIDS RES, V25, P455, DOI 10.1093/nar/25.3.455; Salminen TS, 2015, SCI REP-UK, V5, DOI 10.1038/srep11197; Sandrelli F, 2007, SCIENCE, V316, P1898, DOI 10.1126/science.1138426; SAUNDERS DS, 1989, P NATL ACAD SCI USA, V86, P3748, DOI 10.1073/pnas.86.10.3748; Sawyer LA, 2006, GENETICS, V174, P465, DOI 10.1534/genetics.106.058792; Schmidt PS, 2008, P NATL ACAD SCI USA, V105, P16207, DOI 10.1073/pnas.0805485105; Schmidt PS, 2005, EVOLUTION, V59, P2616, DOI 10.1111/j.0014-3820.2005.tb00974.x; Schmidt PS, 2005, EVOLUTION, V59, P1721, DOI 10.1111/j.0014-3820.2005.tb01821.x; Sezgin E, 2004, GENETICS, V168, P923, DOI 10.1534/genetics.104.027649; TAJIMA F, 1989, GENETICS, V123, P585; Tauber E, 2007, SCIENCE, V316, P1895, DOI 10.1126/science.1138412; Tauber M.J., 1986, SEASONAL ADAPTATIONS; Teets NM, 2008, AM J PHYSIOL-REG I, V294, pR1938, DOI 10.1152/ajpregu.00459.2007; Umina PA, 2005, SCIENCE, V308, P691, DOI 10.1126/science.1109523; Williams KD, 1993, DIAPAUSE DROSOPHILA; Zhang Q, 2011, J INSECT PHYSL; Zhao XQ, 2016, MOL BIOL EVOL, V33, P707, DOI 10.1093/molbev/msv263	45	8	8	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162370	10.1371/journal.pone.0162370	http://dx.doi.org/10.1371/journal.pone.0162370			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598401	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800059
J	Dashper, SG; Catmull, DV; Liu, SW; Myroforidis, H; Zalizniak, I; Palamara, JEA; Huq, NL; Reynolds, EC				Dashper, Stuart G.; Catmull, Deanne V.; Liu, Sze-Wei; Myroforidis, Helen; Zalizniak, Ilya; Palamara, Joseph E. A.; Huq, N. Laila; Reynolds, Eric C.			Casein Phosphopeptide-Amorphous Calcium Phosphate Reduces Streptococcus mutans Biofilm Development on Glass Ionomer Cement and Disrupts Established Biofilms	PLOS ONE			English	Article							ENAMEL SUBSURFACE LESIONS; FREE CHEWING GUM; CPP-ACP AGENT; IN-SITU; REMINERALIZATION; NANOCOMPLEXES; DENTISTRY; FLUORIDE; MERCURY; CARIES	Glass ionomer cements (GIC) are dental restorative materials that are suitable for modification to help prevent dental plaque (biofilm) formation. The aim of this study was to determine the effects of incorporating casein phosphopeptide-amorphous calcium phosphate (CPP-ACP) into a GIC on the colonisation and establishment of Streptococcus mutans biofilms and the effects of aqueous CPP-ACP on established S mutans biofilms. S. mutans biofilms were either established in flow cells before a single ten min exposure to 1% w/v CPP-ACP treatment or cultured in static wells or flow cells with either GIC or GIC containing 3% w/w CPP-ACP as the substratum. The biofilms were then visualised using confocal laser scanning microscopy after BacLight LIVE/DEAD staining. A significant decrease in biovolume and average thickness of S. mutans biofilms was observed in both static and flow cell assays when 3% CPP-ACP was incorporated into the GIC substratum. A single ten min treatment with aqueous 1% CPP-ACP resulted in a 58% decrease in biofilm biomass and thickness of established S. mutans biofilms grown in a flow cell. The treatment also significantly altered the structure of these biofilms compared with controls. The incorporation of 3% CPP-ACP into GIC significantly reduced S. mutans biofilm development indicating another potential anticariogenic mechanism of this material. Additionally aqueous CPP-ACP disrupted established S. mutans biofilms. The use of CPP-ACP containing GIC combined with regular CPP-ACP treatment may lower S. mutans challenge.	[Dashper, Stuart G.; Catmull, Deanne V.; Liu, Sze-Wei; Myroforidis, Helen; Zalizniak, Ilya; Palamara, Joseph E. A.; Huq, N. Laila; Reynolds, Eric C.] Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia	University of Melbourne	Reynolds, EC (corresponding author), Univ Melbourne, Oral Hlth Cooperat Res Ctr, Melbourne Dent Sch, Inst Bio21, Melbourne, Vic, Australia.	e.reynolds@unimelb.edu	Huq, Laila/A-2861-2012	Huq, Laila/0000-0001-7788-4797; Dashper, Stuart/0000-0003-0106-8691; Rahma, Indah/0000-0002-6855-1146	Australian Government, Department of Industry, Innovation and Science [20080108]	Australian Government, Department of Industry, Innovation and Science(Australian GovernmentDepartment of Industry, Innovation and Science)	Supported by the Australian Government, Department of Industry, Innovation and Science. Grant ID 20080108. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Zraikat H, 2011, DENT MATER, V27, P235, DOI 10.1016/j.dental.2010.10.008; Allaker RP, 2010, J DENT RES, V89, P1175, DOI 10.1177/0022034510377794; Beyth N, 2008, DENT MATER, V24, P732, DOI 10.1016/j.dental.2007.08.003; Brownawell Amy M, 2005, Toxicol Rev, V24, P1, DOI 10.2165/00139709-200524010-00001; Busscher HJ, 2010, J DENT RES, V89, P657, DOI 10.1177/0022034510368644; Cai F, 2003, AUST DENT J, V48, P240, DOI 10.1111/j.1834-7819.2003.tb00037.x; CATE JMT, 1995, J DENT RES, V74, P1266; Cochrane NJ, 2008, CARIES RES, V42, P88, DOI 10.1159/000113161; Cochrane NJ, 2012, CARIES RES, V46, P147, DOI 10.1159/000337240; Cross KJ, 2016, BIOCHEMISTRY-US, V55, P4316, DOI 10.1021/acs.biochem.6b00522; Dashper SG, 2013, J DENT, V41, P521, DOI 10.1016/j.jdent.2013.03.010; Emamieh Shila, 2015, J Conserv Dent, V18, P192, DOI 10.4103/0972-0707.157240; Forsten L, 1998, BIOMATERIALS, V19, P503, DOI 10.1016/S0142-9612(97)00130-0; Heydorn A, 2000, MICROBIOL-UK, V146, P2409, DOI 10.1099/00221287-146-10-2409; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; Luczaj-Cepowicz E, 2014, POSTEP HIG MED DOSW, V68, P23, DOI 10.5604/17322693.1086069; Mackert JR, 1997, CRIT REV ORAL BIOL M, V8, P410, DOI 10.1177/10454411970080040401; Magos L, 2006, ANN CLIN BIOCHEM, V43, P257, DOI 10.1258/000456306777695654; Marsh PD, 2003, MICROBIOL-SGM, V149, P279, DOI 10.1099/mic.0.26082-0; Mazzaoui SA, 2003, J DENT RES, V82, P914, DOI 10.1177/154405910308201113; McCabe JF, 2009, DENT MATER J, V28, P37; Milnar FJ, 2007, COMPEND CONTIN ED DE, V28, P238; Milnar Frank J, 2007, Compend Contin Educ Dent, V28, P234; Morgan MV, 2008, CARIES RES, V42, P171, DOI 10.1159/000128561; Nongonierma AB, 2012, CARIES RES, V46, P234, DOI 10.1159/000338381; Okada K, 2001, DENT MATER, V17, P34, DOI 10.1016/S0109-5641(00)00053-1; Oshiro Maki, 2007, J Oral Sci, V49, P115, DOI 10.2334/josnusd.49.115; Peric T, 2015, CLIN ORAL INVEST, V13, P1; Plonka KA, 2013, PEDIAT DENT, V35, p8E; Rahiotis C, 2008, J DENT, V36, P272, DOI 10.1016/j.jdent.2008.01.005; Rahiotis C, 2007, J DENT, V35, P695, DOI 10.1016/j.jdent.2007.05.008; Reynolds E C, 1998, Spec Care Dentist, V18, P8, DOI 10.1111/j.1754-4505.1998.tb01353.x; Reynolds EC, 1997, J DENT RES, V76, P1587, DOI 10.1177/00220345970760091101; Reynolds EC, 2003, J DENT RES, V82, P206, DOI 10.1177/154405910308200311; Rose RK, 2000, CARIES RES, V34, P427, DOI 10.1159/000016618; Rose RK, 2000, ARCH ORAL BIOL, V45, P569, DOI 10.1016/S0003-9969(00)00017-0; Paiva LFS, 2014, BRAZ ORAL RES, V28, P266, DOI 10.1590/1807-3107BOR-2014.vol28.0034; Schupbach P, 1996, J DENT RES, V75, P1779, DOI 10.1177/00220345960750101101; Selwitz RH, 2007, LANCET, V369, P51, DOI 10.1016/S0140-6736(07)60031-2; Shen P, 2001, J DENT RES, V80, P2066, DOI 10.1177/00220345010800120801; Sousa RP, 2009, J DENT, V37, P44, DOI 10.1016/j.jdent.2008.08.009; Wen ZZT, 2006, J BACTERIOL, V188, P2983, DOI 10.1128/JB.188.8.2983-2992.2006; WILSON AD, 1972, BRIT DENT J, V132, P133, DOI 10.1038/sj.bdj.4802810; Xie D, 2011, DENT MATER, V27, P487, DOI 10.1016/j.dental.2011.02.006; Yamaguchi K, 2006, J DENT, V34, P230, DOI 10.1016/j.jdent.2005.06.005	45	19	20	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162322	10.1371/journal.pone.0162322	http://dx.doi.org/10.1371/journal.pone.0162322			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589264	Green Published, gold			2022-12-26	WOS:000382877800049
J	Twardziok, M; Kleinsimon, S; Rolff, J; Jager, S; Eggert, A; Seifert, G; Delebinski, CI				Twardziok, Monika; Kleinsimon, Susann; Rolff, Jana; Jaeger, Sebastian; Eggert, Angelika; Seifert, Georg; Delebinski, Catharina I.			Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma	PLOS ONE			English	Article							ACID INDUCE APOPTOSIS; X-LINKED INHIBITOR; OLEANOLIC ACID; BETULINIC ACID; IN-VIVO; OSTEOSARCOMA CELLS; MISTLETOE EXTRACT; DRUG-COMBINATIONS; NATURAL-PRODUCTS; LUNG-CANCER	Ewing sarcoma is the second most common bone cancer in children and adolescents, with poor prognosis and outcome in similar to 70% of initial diagnoses and 10-15% of relapses. Hydrophobic triterpene acids and hydrophilic lectins and viscotoxins from European mistletoe (Viscum album L.) demonstrate anticancer properties, but have not yet been investigated for Ewing sarcoma. Commercial Viscum album L. extracts are aqueous, excluding the insoluble triterpenes. We recreated a total mistletoe effect by combining an aqueous extract (viscum) and a triterpene extract (TT) solubilized with cyclodextrins. Ewing sarcoma cells were treated with viscum, TT and viscumTT in vitro, ex vivo and in vivo. In vitro and ex vivo treatment of Ewing sarcoma cells with viscum inhibited proliferation and induced apoptosis in a dose-dependent fashion, while viscumTT combination treatment generated a synergistic effect. Apoptosis occurred via intrinsic and extrinsic apoptotic pathways, evidenced by activation of both CASP8 and CASP9. We show that viscumTT treatment shifts the balance of apoptotic regulatory proteins towards apoptosis, mainly via CLSPN, MCL1, BIRC5 and XIAP downregulation. ViscumTT also demonstrated strong antitumor activity in a cell line- and patient-derived mouse model, and may be considered an adjuvant therapy option for pediatric patients with Ewing sarcoma.	[Twardziok, Monika; Kleinsimon, Susann; Eggert, Angelika; Seifert, Georg; Delebinski, Catharina I.] Univ Med Berlin, Charite, Otto Heubner Ctr Pediat & Adolescent Med OHC, Dept Pediat Oncol Hematol, Berlin, Germany; [Twardziok, Monika] Free Univ Berlin, Inst Pharm, Dept Biol, Chem,Pharm, Berlin, Germany; [Rolff, Jana] EPO GmbH, Expt Pharmacol & Oncol, Berlin, Germany; [Jaeger, Sebastian] Birken AG, Niefern Oschelbronn, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin	Seifert, G (corresponding author), Univ Med Berlin, Charite, Otto Heubner Ctr Pediat & Adolescent Med OHC, Dept Pediat Oncol Hematol, Berlin, Germany.	georg.seifert@charite.de	Eggert, Angelika/AAE-6907-2022	Eggert, Angelika/0000-0003-3476-8184; Delebinski, Catharina/0000-0003-2527-4385	Software AG-Stiftung (Darmstadt, Germany); Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag; EPO GmbH; Birken AG	Software AG-Stiftung (Darmstadt, Germany); Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag; EPO GmbH; Birken AG	This work was supported by the Software AG-Stiftung (Darmstadt, Germany) and the Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag. EPO GmbH and Birken AG provided support in the form of salaries for authors JR and SJ respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Software AG-Stiftung (Darmstadt, Germany) and the Federal Ministry for Economic Affairs and Energy on the basis of a decision by the German Bundestag. EPO GmbH and Birken AG provided support in the form of salaries for authors JR and SJ respectively, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank K. Astrahantseff for comments on and editing of the manuscript.	Akl MR, 2014, EUR J PHARMACOL, V740, P209, DOI 10.1016/j.ejphar.2014.07.011; Amer B, 2013, PHARM BIOL, V51, P981, DOI 10.3109/13880209.2013.773520; Bache M, 2014, INT J MOL SCI, V15, P19777, DOI 10.3390/ijms151119777; Bantel H, 1999, CANCER RES, V59, P2083; Braun JM, 2002, ANTICANCER RES, V22, P4187; Bussing A, 1998, CANCER LETT, V130, P57, DOI 10.1016/S0304-3835(98)00124-4; Chakravarti B, 2012, J ETHNOPHARMACOL, V142, P72, DOI 10.1016/j.jep.2012.04.015; Choi SH, 2014, MOL CANCER, V13, DOI 10.1186/1476-4598-13-211; Coumar MS, 2013, CANCER TREAT REV, V39, P802, DOI 10.1016/j.ctrv.2013.02.002; de Almagro M. C., 2012, Experimental Oncology, V34, P200; Decaudin D, 1998, INT J ONCOL, V12, P141; Delebinski CI, 2012, CELL PROLIFERAT, V45, P176, DOI 10.1111/j.1365-2184.2011.00801.x; Delebinski CI, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0133892; Duan ZF, 2009, CANCER CHEMOTH PHARM, V63, P681, DOI 10.1007/s00280-008-0785-8; Ehrhardt H, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.53; FOUNGBE S, 1991, J ETHNOPHARMACOL, V33, P221, DOI 10.1016/0378-8741(91)90080-W; Frantz M, 2000, ARZNEIMITTEL-FORSCH, V50, P471; FRANZ H, 1981, BIOCHEM J, V195, P481, DOI 10.1042/bj1950481; Fulda S, 1999, KLIN PADIATR, V211, P319, DOI 10.1055/s-2008-1043808; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; Greve B, 2012, STRAHLENTHER ONKOL, V188, P1038, DOI 10.1007/s00066-012-0223-z; He XJ, 2012, J AGR FOOD CHEM, V60, P9430, DOI 10.1021/jf3026925; Hingorani P, 2013, PEDIATR BLOOD CANCER, V60, P35, DOI 10.1002/pbc.24290; Hua YQ, 2011, INVEST NEW DRUG, V29, P258, DOI 10.1007/s10637-009-9354-1; Huber R, 2010, EUR J CLIN PHARMACOL, V66, P889, DOI 10.1007/s00228-010-0830-5; Ito Y, 2001, MOL PHARMACOL, V59, P1094, DOI 10.1124/mol.59.5.1094; Jager S, 2007, PLANTA MED, V73, P157, DOI 10.1055/s-2007-967106; JAGGY C, 1995, ARZNEIMITTEL-FORSCH, V45-2, P905; Ji HF, 2009, EMBO REP, V10, P194, DOI 10.1038/embor.2009.12; JUNG ML, 1990, CANCER LETT, V51, P103, DOI 10.1016/0304-3835(90)90044-X; Kaatsch P. S. C., 2014, GERMAN CHILDHOOD CAN; Kashkar H, 2010, CLIN CANCER RES, V16, P4496, DOI 10.1158/1078-0432.CCR-10-1664; Kim MS, 2000, GEN PHARMACOL-VASC S, V34, P349, DOI 10.1016/S0306-3623(01)00072-6; Klingbeil MFG, 2013, ONCOL REP, V30, P2316, DOI 10.3892/or.2013.2732; Konopleva M, 2004, CANCER RES, V64, P7927, DOI 10.1158/0008-5472.CAN-03-2402; Leal AS, 2013, ORG BIOMOL CHEM, V11, P1726, DOI 10.1039/c3ob00011g; Liby K, 2009, CANCER PREV RES, V2, P1050, DOI 10.1158/1940-6207.CAPR-09-0085; Lin Patrick P., 2011, Sarcoma, V2011, P276463, DOI 10.1155/2011/276463; Lopez J, 2010, CURR OPIN CELL BIOL, V22, P872, DOI 10.1016/j.ceb.2010.08.025; Lucio KA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028596; Mackintosh Carlos, 2013, Recent Pat Biotechnol, V7, P98; Maletzki C, 2013, CANCER IMMUNOL IMMUN, V62, P1283, DOI 10.1007/s00262-013-1455-1; Marvibaigi M, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/785479; May WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080060; Nhiem NX, 2013, J NAT PROD, V76, P495, DOI 10.1021/np300490v; Obexer P, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00197; Orhan DD, 2006, Z NATURFORSCH C, V61, P26; Park YK, 2012, ONCOL REP, V28, P2227, DOI 10.3892/or.2012.2026; Paronetto MP, 2013, INT J CELL BIOL, V2013, P12; Petronelli A, 2009, CANCER LETT, V282, P214, DOI 10.1016/j.canlet.2009.03.018; Ryu K, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-187; Seifert G, 2008, CANCER LETT, V264, P218, DOI 10.1016/j.canlet.2008.01.036; Shyu MH, 2010, J AGR FOOD CHEM, V58, P6110, DOI 10.1021/jf100574j; Society AC, 2014, AM CANC SOC CANC FAC; Soica C, 2014, MOLECULES, V19, P4924, DOI 10.3390/molecules19044924; Stahl M, 2011, PEDIATR BLOOD CANCER, V57, P549, DOI 10.1002/pbc.23040; Struh CM, 2012, PHYTOTHER RES, V26, P1507, DOI 10.1002/ptr.4604; Struh CM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062168; Amaral AT, 2014, ADV ANAT PATHOL, V21, P44, DOI 10.1097/PAP.0000000000000003; Timoshenko AV, 2000, BIOSCIENCE REP, V20, P199, DOI 10.1023/A:1005519603863; Ucar EO, 2012, GENET MOL RES, V11, P2801, DOI 10.4238/2012.August.24.5; Van Huyen JPD, 2006, CANCER LETT, V243, P32, DOI 10.1016/j.canlet.2005.11.016; von Levetzow C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019305; von Schoen-Angerer T, 2014, J GASTROINTEST LIVER, V23, P449, DOI 10.15403/jgld.2014.1121.234.acpy; Wei JT, 2013, J APPL TOXICOL, V33, P756, DOI 10.1002/jat.2725; Yan SL, 2010, TOXICOL IN VITRO, V24, P842, DOI 10.1016/j.tiv.2009.12.008; Yang XL, 2012, MOLECULES, V17, P11435, DOI 10.3390/molecules171011435	67	21	25	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0159749	10.1371/journal.pone.0159749	http://dx.doi.org/10.1371/journal.pone.0159749			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589063	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800002
J	Prigozhin, DM; Papavinasasundaram, KG; Baer, CE; Murphy, KC; Moskaleva, A; Chen, TY; Alber, T; Sassetti, CM				Prigozhin, Daniil M.; Papavinasasundaram, Kadamba G.; Baer, Christina E.; Murphy, Kenan C.; Moskaleva, Alisa; Chen, Tony Y.; Alber, Tom; Sassetti, Christopher M.			Structural and Genetic Analyses of the Mycobacterium tuberculosis Protein Kinase B Sensor Domain Identify a Potential Ligand-binding Site	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							SER/THR KINASE; PKNB; VIRULENCE; SYSTEM; TOOL	Monitoring the environment with serine/threonine protein kinases is critical for growth and survival of Mycobacterium tuberculosis, a devastating human pathogen. Protein kinase B (PknB) is a transmembrane serine/threonine protein kinase that acts as an essential regulator of mycobacterial growth and division. The PknB extracellular domain (ECD) consists of four repeats homologous to penicillin-binding protein and serine/threonine kinase associated (PASTA) domains, and binds fragments of peptidoglycan. These properties suggest that PknB activity is modulated by ECD binding to peptidoglycan substructures, however, the molecular mechanisms underpinning PknB regulation remain unclear. In this study, we report structural and genetic characterization of the PknB ECD. We determined the crystal structures of overlapping ECD fragments at near atomic resolution, built a model of the full ECD, and discovered a region on the C-terminal PASTA domain that has the properties of a ligand-binding site. Hydrophobic interaction between this surface and a bound molecule of citrate was observed in a crystal structure. Our genetic analyses in M. tuberculosis showed that nonfunctional alleles were produced either by deletion of any of single PASTA domain or by mutation of individual conserved residues lining the putative ligand-binding surface of the C-terminal PASTA repeat. These results define two distinct structural features necessary for PknB signal transduction, a fully extended ECD and a conserved, membrane-distal putative ligand-binding site.	[Prigozhin, Daniil M.; Moskaleva, Alisa; Chen, Tony Y.; Alber, Tom] Univ Calif Berkeley, Dept Mol & Cell Biol, Inst QB3, 229 Stanley Hall, Berkeley, CA 94720 USA; [Papavinasasundaram, Kadamba G.; Baer, Christina E.; Murphy, Kenan C.; Sassetti, Christopher M.] Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA; [Prigozhin, Daniil M.] Univ Cambridge, MRC Lab Mol Biol, Dept Med, Mol Immun Unit, Cambridge CB2 0QH, England	University of California System; University of California Berkeley; University of Massachusetts System; University of Massachusetts Worcester; MRC Laboratory Molecular Biology; University of Cambridge	Sassetti, CM (corresponding author), Univ Massachusetts, Sch Med, Dept Microbiol & Physiol Syst, Worcester, MA 01655 USA.	sassetti@umassmed.edu	Chen, Tony/AAU-1761-2020; Murphy, Kenan/AHB-4771-2022	Murphy, Kenan/0000-0002-3677-2876; Prigozhin, Daniil M/0000-0003-2075-0231; Baer, Christina/0000-0002-8909-2583	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy [DE-AC02-05CH11231]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI068135, R01AI064282] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070962] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to James Holton, George Meigs, and Jane Tanamachi for assistance with Beamline 8.3.1 at the Lawrence Berkeley National Laboratory Advanced Light Source. We thank Dirk Schnappinger for sharing the various mycobacterial promoter and expression plasmids used in this study. The Advanced Light Source is supported by the Director, Office of Science, Office of Basic Energy Sciences, of the United States Department of Energy under Contract DE-AC02-05CH11231.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alber T, 2009, CURR OPIN STRUC BIOL, V19, P650, DOI 10.1016/j.sbi.2009.10.017; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Barthe P, 2010, STRUCTURE, V18, P606, DOI 10.1016/j.str.2010.02.013; Brown Amanda Claire, 2008, V465, P337, DOI 10.1007/978-1-59745-207-6_23; Cavazos A, 2012, J MOL BIOL, V422, P488, DOI 10.1016/j.jmb.2012.06.011; Chao J, 2010, BBA-PROTEINS PROTEOM, V1804, P620, DOI 10.1016/j.bbapap.2009.09.008; Chawla Y, 2014, J BIOL CHEM, V289, P13858, DOI 10.1074/jbc.M114.563536; Debarbouille M, 2009, J BACTERIOL, V191, P4070, DOI 10.1128/JB.01813-08; Echenique J, 2004, INFECT IMMUN, V72, P2434, DOI 10.1128/IAI.72.4.2434-2437.2004; Ehrt S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni013; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Fiuza M, 2008, J BIOL CHEM, V283, P18099, DOI 10.1074/jbc.M802615200; Gee CL, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002525; Good MC, 2004, J MOL BIOL, V339, P459, DOI 10.1016/j.jmb.2004.03.063; Jones G, 2006, J BACTERIOL, V188, P7470, DOI 10.1128/JB.00800-06; Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105; MacDowell AA, 2004, J SYNCHROTRON RADIAT, V11, P447, DOI 10.1107/S0909049504024835; Mieczkowski C, 2008, EMBO J, V27, P3186, DOI 10.1038/emboj.2008.236; Mir M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002182; Molle V, 2010, MOL MICROBIOL, V75, P1064, DOI 10.1111/j.1365-2958.2009.07041.x; Murphy Kenan C, 2015, Methods Mol Biol, V1285, P177, DOI 10.1007/978-1-4939-2450-9_10; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Paracuellos P, 2010, J MOL BIOL, V404, P847, DOI 10.1016/j.jmb.2010.10.012; Pashley CA, 2003, FEMS MICROBIOL LETT, V229, P211, DOI 10.1016/S0378-1097(03)00823-1; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Ruggiero A, 2011, BIOCHEM J, V435, P33, DOI 10.1042/BJ20101643; Schnappinger Dirk, 2015, Methods Mol Biol, V1285, P151, DOI 10.1007/978-1-4939-2450-9_9; Shah IM, 2008, CELL, V135, P486, DOI 10.1016/j.cell.2008.08.039; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Turapov O, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150025; van Kessel JC, 2007, NAT METHODS, V4, P147, DOI 10.1038/nmeth996; Wheeler TJ, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-7	34	20	20	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22961	22969		10.1074/jbc.M116.731760	http://dx.doi.org/10.1074/jbc.M116.731760			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27601474	Green Published, Green Accepted, hybrid			2022-12-26	WOS:000387224800009
J	Chan, H; Pearson, CS; Green, CM; Li, Z; Zhang, J; Belfort, G; Shekhtman, A; Li, HM; Belfort, M				Chan, Hon; Pearson, C. Seth; Green, Cathleen M.; Li, Zhong; Zhang, Jing; Belfort, Georges; Shekhtman, Alex; Li, Hongmin; Belfort, Marlene			Exploring Intein Inhibition by Platinum Compounds as an Antimicrobial Strategy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						inhibition mechanism; intein; metal ion-protein interaction; Mycobacterium tuberculosis; protein drug interaction; protein splicing	PROTEIN; CISPLATIN; COMPLEXES; BINDING; SYSTEM; FEATURES	Inteins, self-splicing protein elements, interrupt genes and proteins in many microbes, including the human pathogen Mycobacterium tuberculosis. Using conserved catalytic nucleophiles at their N- and C-terminal splice junctions, inteins are able to excise out of precursor polypeptides. The splicing of the intein in the mycobacterial recombinase RecA is specifically inhibited by the widely used cancer therapeutic cisplatin, cis-[Pt(NH3)(2)Cl-2], and this compound inhibits mycobacterial growth. Mass spectrometric and crystallographic studies of Pt(II) binding to the RecA intein revealed a complex in which two platinum atoms bind at N- and C-terminal catalytic cysteine residues. Kinetic analyses of NMR spectroscopic data support a two-step binding mechanism in which a Pt(II) first rapidly interacts reversibly at the N terminus followed by a slower, first order irreversible binding event involving both the N and C termini. Notably, the ligands of Pt(II) compounds that are required for chemotherapeutic efficacy and toxicity are no longer bound to the metal atom in the intein adduct. The lack of ammine ligands and need for phosphine represent a springboard for future design of platinum-based compounds targeting inteins. Because the intein splicing mechanism is conserved across a range of pathogenic microbes, developing these drugs could lead to novel, broad range antimicrobial agents.	[Chan, Hon; Pearson, C. Seth; Green, Cathleen M.; Belfort, Marlene] SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA; [Chan, Hon; Pearson, C. Seth; Green, Cathleen M.; Belfort, Marlene] SUNY Albany, RNA Inst, Albany, NY 12222 USA; [Shekhtman, Alex] SUNY Albany, Dept Chem, Albany, NY 12222 USA; [Chan, Hon; Pearson, C. Seth; Belfort, Georges] Rensselaer Polytech Inst, Howard P Isermann Dept Chem & Biol Engn, Troy, NY 12180 USA; [Chan, Hon; Pearson, C. Seth; Belfort, Georges] Rensselaer Polytech Inst, Ctr Biotechnol & Interdisciplinary Studies, Troy, NY 12180 USA; [Li, Zhong; Zhang, Jing; Li, Hongmin] New York State Dept Hlth, Lab Computat & Struct Biol, Wadsworth Ctr, Albany, NY 12208 USA; [Li, Hongmin] SUNY Albany, Dept Biomed Sci, Albany, NY 12201 USA	State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; State University of New York (SUNY) System; State University of New York (SUNY) Albany; Rensselaer Polytechnic Institute; Rensselaer Polytechnic Institute; State University of New York (SUNY) System; Wadsworth Center; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Belfort, M (corresponding author), SUNY Albany, Dept Biol Sci, Albany, NY 12222 USA.; Belfort, M (corresponding author), SUNY Albany, RNA Inst, Albany, NY 12222 USA.	mbelfort@albany.edu	Li, Hongmin/ABI-2439-2020	Li, Hongmin/0000-0002-8684-5308; Li, Zhong/0000-0002-1039-7000; Shekhtman, Alexander/0000-0003-2649-2675	LSBR; NSLSII; SMB; SSRL under NIH-NIGMS [P41GM111244, P41GM103393]; DOE BER [DE-SC0012704]; DOE BES contract [DE-AC02-76SF00515]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM039422, P41GM103393, R01GM044844, R01GM085006, T32GM067545, P41GM111244, R01GM039422] Funding Source: NIH RePORTER	LSBR; NSLSII; SMB; SSRL under NIH-NIGMS; DOE BER(United States Department of Energy (DOE)); DOE BES contract(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Matthew Stanger for help in purifying protein and rendering figures for this manuscript; Dr. Danielle Fabris and Michael Miller for help with the mass spectrometry experiments; Dr. Stephen Lippard for providing platinum compounds Pttfbz and phenanthriplatin, comments on the manuscript, and insight into platinum chemistry; Dr. Brian Murray for help with modeling kinetics; Dr. Subhabrata Majumder for help in NMR analysis; and Dr. Vivian Stojanoff at the Brookhaven National Laboratory for help in x-ray diffraction data collection. We also thank the NSLS-SSRL user transition program supported jointly by the LSBR, NSLSII and SMB, SSRL under NIH-NIGMS Grants P41GM111244 and P41GM103393, and DOE BER contracts DE-SC0012704. SSRL is operated under DOE BES contract DE-AC02-76SF00515.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Boal AK, 2009, J AM CHEM SOC, V131, P14196, DOI 10.1021/ja906363t; Brown ED, 2016, NATURE, V529, P336, DOI 10.1038/nature17042; Callahan BP, 2013, BIOTECHNOL BIOENG, V110, P1565, DOI 10.1002/bit.24821; Cavanagh J, 2007, PROTEIN NMR SPECTROSCOPY: PRINCIPLES AND PRACTICE, 2ND EDITION, P1; Chen Helen H. W., 2010, Metal-Based Drugs, P430939, DOI 10.1155/2010/430939; Chen SM, 2013, CHEM COMMUN, V49, P1226, DOI 10.1039/c2cc38517a; Chen W, 2012, J AM CHEM SOC, V134, P2500, DOI 10.1021/ja211010g; Chong SR, 1998, NUCLEIC ACIDS RES, V26, P5109, DOI 10.1093/nar/26.22.5109; Cohen SM, 2001, PROG NUCLEIC ACID RE, V67, P93, DOI 10.1016/S0079-6603(01)67026-0; Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200; Du ZM, 2011, J AM CHEM SOC, V133, P10275, DOI 10.1021/ja203209f; Du ZM, 2010, J MOL BIOL, V400, P755, DOI 10.1016/j.jmb.2010.05.044; Eryilmaz E, 2014, J BIOL CHEM, V289, P14506, DOI 10.1074/jbc.R113.540302; Ferraro G, 2015, CHEM COMMUN, V51, P9436, DOI 10.1039/c5cc01751c; Gangopadhyay JP, 2003, ANAL CHEM, V75, P2456, DOI 10.1021/ac020756b; Hiraga K, 2005, J MOL BIOL, V354, P916, DOI 10.1016/j.jmb.2005.09.088; Hunt L. B., 1984, PLATIN MET REV, V28, P76; Johnstone TC, 2014, ANTICANCER RES, V34, P471; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Keller R., 2004, COMPUTER AIDED RESON, V1; LOKKEN SJ, 1963, INORG CHEM, V2, P562, DOI 10.1021/ic50007a034; Marasco D, 2015, DALTON T, V44, P10392, DOI 10.1039/c5dt01279a; Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785; Matteelli A, 2014, CLIN EPIDEMIOL, V6, P111, DOI 10.2147/CLEP.S35839; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; McNulty DE, 2003, PROTEIN EXPRES PURIF, V27, P365, DOI 10.1016/S1046-5928(02)00610-1; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park GY, 2012, P NATL ACAD SCI USA, V109, P11987, DOI 10.1073/pnas.1207670109; Paulus H, 2000, ANNU REV BIOCHEM, V69, P447, DOI 10.1146/annurev.biochem.69.1.447; Paulus H, 2003, FRONT BIOSCI, V8, pS1157, DOI 10.2741/1195; Pearson CS, 2015, BIOMOL NMR ASSIGN, V9, P235, DOI 10.1007/s12104-014-9581-z; Peck SH, 2011, CHEM BIOL, V18, P619, DOI 10.1016/j.chembiol.2011.02.014; Perler FB, 2002, NUCLEIC ACIDS RES, V30, P383, DOI 10.1093/nar/30.1.383; PIETROKOVSKI S, 1994, PROTEIN SCI, V3, P2340, DOI 10.1002/pro.5560031218; Pruchnik H, 2015, J ORGANOMET CHEM, V791, P124, DOI 10.1016/j.jorganchem.2015.05.050; Skretas G, 2005, J MOL BIOL, V349, P464, DOI 10.1016/j.jmb.2005.04.009; Topilina NI, 2014, MOBILE DNA-UK, V5, DOI 10.1186/1759-8753-5-5; Van Roey P, 2007, J MOL BIOL, V367, P162, DOI 10.1016/j.jmb.2006.12.050; Vila-Perello M, 2010, CELL, V143, P191, DOI 10.1016/j.cell.2010.09.031; Wilson JJ, 2012, J MED CHEM, V55, P5326, DOI 10.1021/jm3002857; Wood DW, 1999, NAT BIOTECHNOL, V17, P889, DOI 10.1038/12879; World Health Organization, 2015, GLOB TUB REP 2015; Zhang LY, 2011, J BIOL CHEM, V286, P1277, DOI 10.1074/jbc.M110.171124	44	21	21	1	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22661	22670		10.1074/jbc.M116.747824	http://dx.doi.org/10.1074/jbc.M116.747824			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609519	hybrid, Green Published			2022-12-26	WOS:000386760600026
J	Tsai, WC; Gayatri, S; Reineke, LC; Sbardella, G; Bedford, MT; Lloyd, RE				Tsai, Wei-Chih; Gayatri, Sitaram; Reineke, Lucas C.; Sbardella, Gianluca; Bedford, Mark T.; Lloyd, Richard E.			Arginine Demethylation of G3BP1 Promotes Stress Granule Assembly	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						mRNA; post-translational modification (PTM); protein arginine N-methyltransferase 5 (PRMT5); RNA binding protein; stress granule; G3BP1; protein arginine N-methyltransferase (PRMT)	DOMAIN-CONTAINING PROTEIN; RNA-BINDING PROTEINS; CELL-FREE FORMATION; MESSENGER-RNA; HISTONE DEMETHYLATION; DEPENDENT MECHANISM; PROCESSING BODIES; PHASE-SEPARATION; CANCER-CELLS; P-BODIES	Stress granules (SGs) are cytoplasmic condensates of stalled messenger ribonucleoprotein complexes (mRNPs) that form when eukaryotic cells encounter environmental stress. RNA-binding proteins are enriched for arginine methylation and facilitate SG assembly through interactions involving regions of low amino acid complexity. How methylation of specific RNA-binding proteins regulates RNA granule assembly has not been characterized. Here, we examined the potent SG-nucleating protein Ras-GAP SH3-binding protein 1 (G3BP1), and found that G3BP1 is differentially methylated on specific arginine residues by protein arginine methyltransferase (PRMT) 1 and PRMT5 in its RGG domain. Several genetic and biochemical interventions that increased methylation repressed SG assembly, whereas interventions that decreased methylation promoted SG assembly. Arsenite stress quickly and reversibly decreased asymmetric arginine methylation on G3BP1. These data indicate that arginine methylation in the RGG domain prevents large SG assembly and rapid demethylation is a novel signal that regulates SG formation.	[Tsai, Wei-Chih; Reineke, Lucas C.; Lloyd, Richard E.] Baylor Coll Med, Dept Mol Virol & Microbiol, One Baylor Plaza, Houston, TX 77030 USA; [Gayatri, Sitaram; Bedford, Mark T.] Univ Texas MD Anderson Canc Ctr, Dept Epigenet & Mol Carcinogenesis, Smithville, TX 78957 USA; [Sbardella, Gianluca] Univ Salerno, Epigenet Med Chem Lab, Dipartimento Farm, Via Giovanni Paolo 2 132, I-84084 Salerno, Italy	Baylor College of Medicine; University of Texas System; UTMD Anderson Cancer Center; University of Salerno	Lloyd, RE (corresponding author), Baylor Coll Med, Dept Mol Virol & Microbiol, One Baylor Plaza, Houston, TX 77030 USA.	rlloyd@bcm.edu	Gayatri, Sitaram/GLT-7340-2022; Sbardella, Gianluca/E-2823-2010	Sbardella, Gianluca/0000-0003-0748-1145	National Institutes of Health Public Health Service Grant [AI50237]; NCI Cancer Center Support Grant [P30CA125123]; Integrated Microscopy Core at Baylor College of Medicine; National Institutes of Health [HD007495, DK56338, CA125123]; Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; National Institutes of Health funding [DK062248]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U54HD007495] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P30HD007495, T32HD007495] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050237, R01AI050237] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R56DK062248, P30DK056338, R01DK062248] Funding Source: NIH RePORTER	National Institutes of Health Public Health Service Grant; NCI Cancer Center Support Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Integrated Microscopy Core at Baylor College of Medicine; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dan L. Duncan Cancer Center; John S. Dunn Gulf Coast Consortium for Chemical Genomics; National Institutes of Health funding(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was funded by National Institutes of Health Public Health Service Grant AI50237 and NCI Cancer Center Support Grant (P30CA125123). Additional support was provided by the Integrated Microscopy Core at Baylor College of Medicine with funding from the National Institutes of Health (HD007495, DK56338, and CA125123), the Dan L. Duncan Cancer Center, and the John S. Dunn Gulf Coast Consortium for Chemical Genomics. Work in the laboratory of Mark T. Bedford is supported by National Institutes of Health funding (DK062248). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alahari S, 2015, ENDOCRINOLOGY, V156, P3012, DOI 10.1210/en.2015-1262; Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anderson P, 2008, TRENDS BIOCHEM SCI, V33, P141, DOI 10.1016/j.tibs.2007.12.003; Arimoto K, 2008, NAT CELL BIOL, V10, P1324, DOI 10.1038/ncb1791; Arimoto-Matsuzaki K, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10252; Aulas A, 2015, J CELL BIOL, V209, P73, DOI 10.1083/jcb.201408092; Aulas A, 2012, MOL NEURODEGENER, V7, DOI 10.1186/1750-1326-7-54; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Bikkavilli RK, 2011, J CELL SCI, V124, P2310, DOI 10.1242/jcs.084046; Bottger A, 2015, BIOCHEM J, V468, P191, DOI 10.1042/BJ20150278; Bosco DA, 2010, HUM MOL GENET, V19, P4160, DOI 10.1093/hmg/ddq335; Brown JAL, 2011, MOL CELL BIOL, V31, P4417, DOI 10.1128/MCB.05987-11; Chan-Penebre E, 2015, NAT CHEM BIOL, V11, P432, DOI [10.1038/NCHEMBIO.1810, 10.1038/nchembio.1810]; Chang BS, 2007, SCIENCE, V318, P444, DOI 10.1126/science.1145801; Chen C, 2011, NAT REV MOL CELL BIO, V12, P629, DOI 10.1038/nrm3185; Cheng DH, 2012, METHOD ENZYMOL, V512, P71, DOI 10.1016/B978-0-12-391940-3.00004-4; Courchet J, 2008, J BIOL CHEM, V283, P32131, DOI 10.1074/jbc.M802927200; De Leeuw F, 2007, EXP CELL RES, V313, P4130, DOI 10.1016/j.yexcr.2007.09.017; Decker CJ, 2007, J CELL BIOL, V179, P437, DOI 10.1083/jcb.200704147; Dolzhanskaya N, 2006, J CELL SCI, V119, P1933, DOI 10.1242/jcs.02882; Eisinger-Mathason TSK, 2008, MOL CELL, V31, P722, DOI 10.1016/j.molcel.2008.06.025; Elbaum-Garfinkle S, 2015, P NATL ACAD SCI USA, V112, P7189, DOI 10.1073/pnas.1504822112; Eram MS, 2016, ACS CHEM BIOL, V11, P772, DOI 10.1021/acschembio.5b00839; Fuhrmann J, 2015, CHEM REV, V115, P5413, DOI 10.1021/acs.chemrev.5b00003; Gal J., 2010, NEUROBIOL AGING, V32, pe27; Gilks N, 2004, MOL BIOL CELL, V15, P5383, DOI 10.1091/mbc.E04-08-0715; Goulet I, 2008, HUM MOL GENET, V17, P3055, DOI 10.1093/hmg/ddn203; Han TNW, 2012, CELL, V149, P768, DOI 10.1016/j.cell.2012.04.016; Jain S, 2016, CELL, V164, P487, DOI 10.1016/j.cell.2015.12.038; Johnson ME, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-0914-4; Kaehler C, 2015, EXP CELL RES, V334, P114, DOI 10.1016/j.yexcr.2015.02.022; Kato M, 2012, CELL, V149, P753, DOI 10.1016/j.cell.2012.04.017; Kedersha N, 2002, BIOCHEM SOC T, V30, P963, DOI 10.1042/BST0300963; Kedersha N, 2002, MOL BIOL CELL, V13, P195, DOI 10.1091/mbc.01-05-0221; Kedersha N, 2005, J CELL BIOL, V169, P871, DOI 10.1083/jcb.200502088; Kedersha N, 2016, J CELL BIOL, V212, P845, DOI 10.1083/jcb.201508028; Kedersha N, 2013, TRENDS BIOCHEM SCI, V38, P494, DOI 10.1016/j.tibs.2013.07.004; Kedersha NL, 1999, J CELL BIOL, V147, P1431, DOI 10.1083/jcb.147.7.1431; Kimball SR, 2003, AM J PHYSIOL-CELL PH, V284, pC273, DOI 10.1152/ajpcell.00314.2002; Kobayashi T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035820; Kozubowski L, 2011, EUKARYOT CELL, V10, P1396, DOI 10.1128/EC.05087-11; Kryukov GV, 2016, SCIENCE, V351, P1214, DOI 10.1126/science.aad5214; Kwon S, 2007, GENE DEV, V21, P3381, DOI 10.1101/gad.461107; Lee J, 2005, J BIOL CHEM, V280, P32890, DOI 10.1074/jbc.M506944200; Lee YH, 2011, CELL CYCLE, V10, P1343, DOI 10.4161/cc.10.9.15379; Lee YJ, 2014, FEBS J, V281, P352, DOI 10.1111/febs.12606; Leung AKL, 2011, MOL CELL, V42, P489, DOI 10.1016/j.molcel.2011.04.015; Li YR, 2013, J CELL BIOL, V201, P361, DOI 10.1083/jcb.201302044; Lin Y, 2015, MOL CELL, V60, P208, DOI 10.1016/j.molcel.2015.08.018; Linder B, 2008, HUM MOL GENET, V17, P3236, DOI 10.1093/hmg/ddn219; Mavrakis KJ, 2016, SCIENCE, V351, P1208, DOI 10.1126/science.aad5944; McDonald KK, 2011, HUM MOL GENET, V20, P1400, DOI 10.1093/hmg/ddr021; Molliex A, 2015, CELL, V163, P123, DOI 10.1016/j.cell.2015.09.015; Morales Y, 2016, ARCH BIOCHEM BIOPHYS, V590, P138, DOI 10.1016/j.abb.2015.11.030; Mowen KA, 2004, MOL CELL, V15, P559, DOI 10.1016/j.molcel.2004.06.042; Nott TJ, 2015, MOL CELL, V57, P936, DOI 10.1016/j.molcel.2015.01.013; Ohn T, 2008, NAT CELL BIOL, V10, P1224, DOI 10.1038/ncb1783; Ong SE, 2004, NAT METHODS, V1, P119, DOI 10.1038/NMETH715; Poulard C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087982; Reijns MAM, 2008, J CELL SCI, V121, P2463, DOI 10.1242/jcs.024976; Reineke LC, 2015, MBIO, V6, DOI 10.1128/mBio.02486-14; Reineke LC, 2013, VIROLOGY, V436, P255, DOI 10.1016/j.virol.2012.11.017; Reineke LC, 2012, MOL BIOL CELL, V23, P3499, DOI 10.1091/mbc.E12-05-0385; Sahoo PK, 2012, BIOL OPEN, V1, P109, DOI 10.1242/bio.2011023; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Stoecklin G, 2004, EMBO J, V23, P1313, DOI 10.1038/sj.emboj.7600163; Takahashi M, 2013, MOL CELL BIOL, V33, P815, DOI 10.1128/MCB.00763-12; Thedieck K, 2013, CELL, V154, P859, DOI 10.1016/j.cell.2013.07.031; Tourriere H, 2003, J CELL BIOL, V160, P823, DOI 10.1083/jcb.200212128; Tradewell ML, 2012, HUM MOL GENET, V21, P136, DOI 10.1093/hmg/ddr448; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; White JP, 2007, CELL HOST MICROBE, V2, P295, DOI 10.1016/j.chom.2007.08.006; Yamaguchi A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049267; Yang YZ, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7428; Yang YZ, 2013, NAT REV CANCER, V13, P37, DOI 10.1038/nrc3409	75	100	103	12	34	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22671	22685		10.1074/jbc.M116.739573	http://dx.doi.org/10.1074/jbc.M116.739573			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601476	Green Published, hybrid			2022-12-26	WOS:000386760600027
J	Chi, A; Wen, SJ; Monga, M; Almubarak, M; He, XQ; Rojanasakul, Y; Tse, W; Remick, SC				Chi, Alexander; Wen, Sijin; Monga, Manish; Almubarak, Mohammed; He, Xiaoqing; Rojanasakul, Yon; Tse, William; Remick, Scot C.			Definitive Upfront Stereotactic Ablative Radiotherapy Combined with Image-Guided, Intensity Modulated Radiotherapy (IG-IMRT) or IG-IMRT Alone for Locally Advanced Non-Small Cell Lung Cancer	PLOS ONE			English	Article							TUMOR-CONTROL; RADIATION; CONCURRENT; EXPERIENCE; TOXICITY; TRIAL	Background Image-guided (IG) intensity-modulated radiotherapy (IMRT) enables maximal tumor margin reduction for the sparing of organs at risk (OARs) when used to treat locally advanced non-small cell lung cancer (NSCLC) with definitive chemo-radiation. It also allows for the incorporation of stereotactic ablative radiotherapy (SABR) into the treatment regimen. Here, we describe our initial experience in combining definitive upfront SABR to the primary lesion with chemo-radiation delivered with conventionally fractionated IG-IMRT to the remaining regional disease; along with clinical outcome following chemo-radiation with conventionally fractionated IG-IMRT alone in the treatment of locally advanced NSCLC. Methods The clinical outcome of 29 patients with locally advanced NSCLC who underwent conventionally fractionated IG-IMRT, or definitive upfront SABR followed by IG-IMRT combined with chemotherapy (induction, concurrent, or both) was retrospectively reviewed. Results After a median follow up of 23.7 months, the median overall survival (OS) and progression-free survival (PFS) were 19.8 and 11.3 months, respectively. The 2 year local, regional, and distant control was 60%, 62%, and 38%, respectively. No local failure was observed in 3 patients following SABR + IG-IMRT while 6/26 patients failed locally following IG-IMRT alone. SABR + IG-IMRT was well tolerated. No >= grade 3 radiation-related toxicity was observed. Conclusion Definitive upfront SABR followed by IG-IMRT in selected patients with locally advanced NSCLC warrants further investigation in future clinical trials, while chemo-radiation with IG-IMRT alone was well tolerated.	[Chi, Alexander] West Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA; [Wen, Sijin] West Virginia Univ, Sch Publ Hlth, Dept Biostat, Morgantown, WV 26506 USA; [Monga, Manish] Bristol Meyers Squibb, Oncol, Princeton, NJ USA; [Almubarak, Mohammed; Remick, Scot C.] West Virginia Univ, Mary Babb Randolph Canc Ctr, Div Hematol & Oncol, Morgantown, WV 26506 USA; [He, Xiaoqing; Rojanasakul, Yon] West Virginia Univ, Dept Pharmaceut Sci, Morgantown, WV 26506 USA; [Tse, William] Univ Louisville, James Graham Brown Canc Ctr, Dept Hematol, Louisville, KY 40292 USA	West Virginia University; West Virginia University; West Virginia University; West Virginia University; University of Louisville	Chi, A (corresponding author), West Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA.	achiaz2010@gmail.com		Wen, Sijin/0000-0002-6955-2917	NIGMS NIH HHS [U54 GM104942] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM104942] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Auperin A, 2010, J CLIN ONCOL, V28, P2181, DOI 10.1200/JCO.2009.26.2543; Ball D, 2013, J THORAC ONCOL, V8, P315, DOI 10.1097/JTO.0b013e31827dc74d; Bradley JD, 2015, LANCET ONCOL, V16, P187, DOI 10.1016/S1470-2045(14)71207-0; Bral S, 2010, INT J RADIAT ONCOL, V77, P1352, DOI 10.1016/j.ijrobp.2009.06.075; Cannon DM, 2013, J CLIN ONCOL, V31, P4343, DOI 10.1200/JCO.2013.51.5353; Chi A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00151; Chi A, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00156; Chi A, 2010, RADIOTHER ONCOL, V94, P1, DOI 10.1016/j.radonc.2009.12.008; Curran WJ, 2011, J NATL CANCER I, V103, P1452, DOI 10.1093/jnci/djr325; Donato V, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00286; Fowler JF, 2004, INT J RADIAT ONCOL, V60, P1241, DOI 10.1016/j.ijrobp.2004.07.691; Guckenberger M, 2012, STRAHLENTHER ONKOL, V188, P894, DOI 10.1007/s00066-012-0161-9; Ihle NT, 2012, JNCI-J NATL CANCER I, V104, P228, DOI 10.1093/jnci/djr523; Jiang ZQ, 2012, INT J RADIAT ONCOL, V83, P332, DOI 10.1016/j.ijrobp.2011.06.1963; Kong FM, 2005, INT J RADIAT ONCOL, V63, P324, DOI 10.1016/j.ijrobp.2005.02.010; Liao ZXX, 2010, INT J RADIAT ONCOL, V76, P775, DOI 10.1016/j.ijrobp.2009.02.032; Meng DQ, 2013, LUNG CANCER, V81, P1, DOI 10.1016/j.lungcan.2013.03.019; Onishi H, 2007, J THORAC ONCOL, V2, pS94, DOI 10.1097/JTO.0b013e318074de34; Soliman M, 2013, RADIOTHER ONCOL, V106, P299, DOI 10.1016/j.radonc.2012.12.008; Sura S, 2008, RADIOTHER ONCOL, V87, P17, DOI 10.1016/j.radonc.2008.02.005; Toulany M, 2007, MOL CANCER RES, V5, P863, DOI 10.1158/1541-7786.MCR-06-0297; Toulany M, 2006, CLIN CANCER RES, V12, P4119, DOI 10.1158/1078-0432.CCR-05-2454	22	2	2	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162453	10.1371/journal.pone.0162453	http://dx.doi.org/10.1371/journal.pone.0162453			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611833	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900102
J	Duprey-Diaz, MV; Blagburn, JM; Blanco, RE				Duprey-Diaz, Mildred V.; Blagburn, Jonathan M.; Blanco, Rosa E.			Exogenous Modulation of Retinoic Acid Signaling Affects Adult RGC Survival in the Frog Visual System after Optic Nerve Injury	PLOS ONE			English	Article							VITAMIN-A-DEFICIENCY; MIDBRAIN DOPAMINERGIC-NEURONS; CILIARY NEUROTROPHIC FACTOR; FIBROBLAST GROWTH FACTOR-2; GANGLION-CELL DEATH; RANA-PIPIENS; UP-REGULATION; SPINAL-CORD; X-RECEPTOR; INTRACEREBRAL HEMORRHAGE	After lesions to the mammalian optic nerve, the great majority of retinal ganglion cells (RGCs) die before their axons have even had a chance to regenerate. Frog RGCs, on the other hand, suffer only an approximately 50% cell loss, and we have previously investigated the mechanisms by which the application of growth factors can increase their survival rate. Retinoic acid (RA) is a vitamin A-derived lipophilic molecule that plays major roles during development of the nervous system. The RA signaling pathway is also present in parts of the adult nervous system, and components of it are upregulated after injury in peripheral nerves but not in the CNS. Here we investigate whether RA signaling affects long-term RGC survival at 6 weeks after axotomy. Intraocular injection of all-trans retinoic acid (ATRA), the retinoic acid receptor (RAR) type-alpha agonist AM80, the RAR beta agonist CD2314, or the RAR. agonist CD1530, returned axotomized RGC numbers to almost normal levels. On the other hand, inhibition of RA synthesis with disulfiram, or of RAR receptors with the pan-RAR antagonist Ro-41-5253, or the RAR beta antagonist LE135E, greatly reduced the survival of the axotomized neurons. Axotomy elicited a strong activation of the MAPK, STAT3 and AKT pathways; this activation was prevented by disulfiram or by RAR antagonists. Finally, addition of exogenous ATRA stimulated the activation of the first two of these pathways. Future experiments will investigate whether these strong survival-promoting effects of RA are mediated via the upregulation of neurotrophins.	[Duprey-Diaz, Mildred V.; Blanco, Rosa E.] Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA; [Duprey-Diaz, Mildred V.; Blagburn, Jonathan M.; Blanco, Rosa E.] Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA	University of Puerto Rico; University of Puerto Rico Medical Sciences Campus; University of Puerto Rico; University of Puerto Rico Medical Sciences Campus	Blanco, RE (corresponding author), Univ Puerto Rico, Sch Med, Dept Anat & Neurobiol, San Juan, PR 00936 USA.; Blanco, RE (corresponding author), Univ Puerto Rico, Inst Neurobiol, Med Sci Campus, San Juan, PR 00901 USA.	rosa.blanco@upr.edu		Blagburn, Jonathan/0000-0002-7681-2764	NIGMS grant [GM116692, GM061838]; NINDS grant [NS081726]; NSF [DBI 0115825]; DoD [52680-RT-ISP]; NIMHD [G12 MD007600]; NIH [GM116692, NS081726, NIGMS GM061838]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R25GM061838, SC3GM116692, P20GM103642] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [SC1NS081726] Funding Source: NIH RePORTER; National Institute on Minority Health and Health Disparities [G12MD007600] Funding Source: NIH RePORTER	NIGMS grant; NINDS grant; NSF(National Science Foundation (NSF)); DoD(United States Department of Defense); NIMHD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by NIGMS grant GM116692 to REB and NINDS grant NS081726 to JMB. MVD was supported in part by NIGMS grant GM061838 and a teaching assistantship from the University of Puerto Rico Medical Sciences Campus. The Institute Pascal confocal microscope was funded by NSF DBI 0115825, DoD 52680-RT-ISP and NIMHD G12 MD007600 (RCMI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; REB is supported by NIH grant GM116692, JMB by NIH grant NS081726. MVD was supported by NIH grant NIGMS GM061838 and a teaching assistantship from the University of Puerto Rico Medical Sciences Campus. The Institute confocal microscope was funded by NSF DBI 0115825, DoD 52680-RT-ISP and NIMHD G12 MD007600 (Research Centers for Minority Institutions). We also want to thank Dr. Maria Sosa and Dr. Jorge Miranda for valuable comments on the manuscript.	Agudo M, 2010, NEUROBIOL DIS, V37, P147, DOI 10.1016/j.nbd.2009.09.018; ALLENBY G, 1993, P NATL ACAD SCI USA, V90, P30, DOI 10.1073/pnas.90.1.30; Arrieta O, 2005, EUR J CLIN INVEST, V35, P201, DOI 10.1111/j.1365-2362.2005.01467.x; Barber AJ, 1998, J CLIN INVEST, V102, P783, DOI 10.1172/JCI2425; Bastien J, 2004, GENE, V328, P1, DOI 10.1016/j.gene.2003.12.005; BEAZLEY LD, 1986, VISION RES, V26, P543, DOI 10.1016/0042-6989(86)90003-9; Blanco RE, 2000, J COMP NEUROL, V423, P646; Blanco RE, 2008, J NEUROSCI RES, V86, P3382, DOI 10.1002/jnr.21793; Canon E, 2004, MOL BIOL CELL, V15, P5583, DOI 10.1091/mbc.E04-05-0439; Chambon P, 1996, FASEB J, V10, P940, DOI 10.1096/fasebj.10.9.8801176; Chen L, 2014, NEUROPHARMACOLOGY, V78, P3, DOI 10.1016/j.neuropharm.2012.12.004; Chen N, 2008, FASEB J, V22, P236, DOI 10.1096/fj.07-8739com; Chung JJ, 2000, MOL BRAIN RES, V83, P52, DOI 10.1016/S0169-328X(00)00196-0; Cocco S, 2002, NEUROSCIENCE, V115, P475, DOI 10.1016/S0306-4522(02)00423-2; Corcoran JPT, 2004, EUR J NEUROSCI, V20, P896, DOI 10.1111/j.1460-9568.2004.03563.x; Denisenko-Nehrbass NI, 2001, MOL BRAIN RES, V87, P246, DOI 10.1016/S0169-328X(01)00002-X; Denisenko-Nehrbass NI, 2000, NEURON, V27, P359, DOI 10.1016/S0896-6273(00)00043-X; Dong D, 1999, J BIOL CHEM, V274, P23695, DOI 10.1074/jbc.274.34.23695; Driscoll WJ, 1999, MOL PHARMACOL, V55, P1067, DOI 10.1124/mol.55.6.1067; Duprey-Diaz MV, 2016, J CHEM NEUROANAT, V77, P80, DOI 10.1016/j.jchemneu.2016.05.008; Duprey-Diaz MV, 2012, J CHEM NEUROANAT, V46, P35, DOI 10.1016/j.jchemneu.2012.08.003; Duprey-Diaz MV, 2002, J COMP NEUROL, V454, P456, DOI 10.1002/cne.10451; Esteves M, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00020; Etchamendy N, 2003, BEHAV BRAIN RES, V145, P37, DOI 10.1016/S0166-4328(03)00099-8; Ferrari N, 1998, MOL CELL BIOL, V18, P6482, DOI 10.1128/MCB.18.11.6482; Goncalves MB, 2015, J NEUROSCI, V35, P15731, DOI 10.1523/JNEUROSCI.1339-15.2015; Goodman T, 2012, HIPPOCAMPUS, V22, P2171, DOI 10.1002/hipo.22037; GOTOH Y, 1991, NATURE, V349, P251, DOI 10.1038/349251a0; Hernandez-Pedro N, 2008, TRANSL RES, V152, P31, DOI 10.1016/j.trsl.2008.05.007; Hou NL, 2015, MOL NEUROBIOL, V51, P633, DOI 10.1007/s12035-014-8741-6; HUMPHREY MF, 1987, J COMP NEUROL, V266, P209, DOI 10.1002/cne.902660207; Jacobs S, 2006, P NATL ACAD SCI USA, V103, P3902, DOI 10.1073/pnas.0511294103; Janesick A, 2014, DEVELOPMENT, V141, P2260, DOI 10.1242/dev.103705; Jarvis CI, 2010, EUR J NEUROSCI, V32, P1246, DOI 10.1111/j.1460-9568.2010.07426.x; Jiang W, 2012, J NEUROCHEM, V121, P932, DOI 10.1111/j.1471-4159.2012.07697.x; Jokic N, 2007, J NEUROCHEM, V103, P1821, DOI 10.1111/j.1471-4159.2007.04893.x; Kagechika H, 2002, CURR MED CHEM, V9, P591, DOI 10.2174/0929867024606975; Kampmann E, 2007, NEUROSCI LETT, V426, P18, DOI 10.1016/j.neulet.2007.07.039; KAPLAN DR, 1993, NEURON, V11, P321, DOI 10.1016/0896-6273(93)90187-V; Katsuki H, 2009, J NEUROCHEM, V110, P707, DOI 10.1111/j.1471-4159.2009.06171.x; Kawahara K, 2014, J ALZHEIMERS DIS, V42, P587, DOI 10.3233/JAD-132720; Kharasch ED, 1999, DRUG METAB DISPOS, V27, P717; KLIEWER SA, 1992, NATURE, V355, P446, DOI 10.1038/355446a0; Kolarcik Christi L, 2012, Am J Neurodegener Dis, V1, P130; Kurauchi Y, 2011, J NEUROCHEM, V116, P323, DOI 10.1111/j.1471-4159.2010.06916.x; Lee HR, 2014, J NEUROSCI RES, V92, P1581, DOI 10.1002/jnr.23421; Lee YW, 2012, J CELL BIOCHEM, V113, P2920, DOI 10.1002/jcb.24170; Levin LA, 1996, ARCH OPHTHALMOL-CHIC, V114, P488, DOI 10.1001/archopht.1996.01100130484027; Lewin GR, 1996, ANNU REV NEUROSCI, V19, P289, DOI 10.1146/annurev.ne.19.030196.001445; Maden M, 2007, NAT REV NEUROSCI, V8, P755, DOI 10.1038/nrn2212; Martin KRG, 2003, INVEST OPHTH VIS SCI, V44, P4357, DOI 10.1167/iovs.02-1332; Masia S, 2007, MOL ENDOCRINOL, V21, P2391, DOI 10.1210/me.2007-0062; Matsushita H, 2014, J NEUROSCI RES, V92, P1024, DOI 10.1002/jnr.23379; Matsushita H, 2011, J CEREBR BLOOD F MET, V31, P222, DOI 10.1038/jcbfm.2010.80; McCaffery P, 2006, J NEUROBIOL, V66, P780, DOI 10.1002/neu.20237; MCCAFFERY P, 1994, P NATL ACAD SCI USA, V91, P7772, DOI 10.1073/pnas.91.16.7772; McCaffery P, 1999, MECH DEVELOP, V85, P201; MCCAFFERY P, 1992, DEVELOPMENT, V115, P371; Mey J, 2006, J NEUROBIOL, V66, P757, DOI 10.1002/neu.20238; Mic FA, 2003, P NATL ACAD SCI USA, V100, P7135, DOI 10.1073/pnas.1231422100; Mills KJ, 1996, CELL GROWTH DIFFER, V7, P327; Misner DL, 2001, P NATL ACAD SCI USA, V98, P11714, DOI 10.1073/pnas.191369798; Napoli JL, 2012, BBA-MOL CELL BIOL L, V1821, P152, DOI 10.1016/j.bbalip.2011.05.004; Ningaraj NS, 2001, J BIOMED SCI, V8, P104; Nishikiori N, 2008, CLIN OPHTHALMOL, V2, P233; Oztokatli H, 2012, FASEB J, V26, P617, DOI 10.1096/fj.11-192450; Plump AS, 2002, NEURON, V33, P219, DOI 10.1016/S0896-6273(01)00586-4; Qi XR, 2015, CEREB CORTEX, V25, P75, DOI 10.1093/cercor/bht203; QUIGLEY HA, 1995, INVEST OPHTH VIS SCI, V36, P774; Ransom J, 2014, J NEUROCHEM, V129, P366, DOI 10.1111/jnc.12620; Rios-Munoz W, 2005, J NEUROCHEM, V93, P1422, DOI 10.1111/j.1471-4159.2005.03129.x; Ruhl R, 2015, PLOS GENET, V11, DOI 10.1371/journal.pgen.1005213; Sakamoto K, 2010, EUR J PHARMACOL, V635, P56, DOI 10.1016/j.ejphar.2010.03.001; SCALIA F, 1985, BRAIN RES, V344, P267, DOI 10.1016/0006-8993(85)90804-2; Shearer KD, 2012, TRENDS NEUROSCI, V35, P733, DOI 10.1016/j.tins.2012.08.005; Shinozaki Y, 2007, NEUROSCIENCE, V147, P153, DOI 10.1016/j.neuroscience.2007.04.032; SNIDER WD, 1994, CELL, V77, P627, DOI 10.1016/0092-8674(94)90048-5; Sockanathan S, 1998, CELL, V94, P503, DOI 10.1016/S0092-8674(00)81591-3; Soto I, 2006, J NEUROCHEM, V96, P82, DOI 10.1111/j.1471-4159.2005.03510.x; Soto I, 2003, J NEUROSCI RES, V73, P507, DOI 10.1002/jnr.10673; Soto I, 2006, BRAIN RES, V1103, P65, DOI 10.1016/j.brainres.2006.05.062; Stoney P.N., 2015, BRAIN STRUCT FUNCT; Takenaga M, 2009, BIOL PHARM BULL, V32, P225, DOI 10.1248/bpb.32.225; THOENEN H, 1995, SCIENCE, V270, P593, DOI 10.1126/science.270.5236.593; Thompson Haskell Gloria, 2002, J Comp Neurol, V452, P228; Umemiya H, 1997, BIOCHEM BIOPH RES CO, V233, P121, DOI 10.1006/bbrc.1997.6414; Vega-Melendez GS, 2014, J NEUROSCI RES, V92, P13, DOI 10.1002/jnr.23303; von Bartheld CS, 1998, HISTOL HISTOPATHOL, V13, P437, DOI 10.14670/HH-13.437; VONHOLST A, 1995, MOL CELL NEUROSCI, V6, P185; Wang X, 1998, NEUROSCI LETT, V240, P9, DOI 10.1016/S0304-3940(97)00927-0; WUARIN L, 1991, DEV BIOL, V144, P429, DOI 10.1016/0012-1606(91)90435-6; Zetterstrom RH, 1999, EUR J NEUROSCI, V11, P407, DOI 10.1046/j.1460-9568.1999.00444.x	92	9	9	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162626	10.1371/journal.pone.0162626	http://dx.doi.org/10.1371/journal.pone.0162626			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611191	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900135
J	Magnussen, B; Gradel, KO; Jensen, TG; Kolmos, HJ; Pedersen, C; Vinholt, PJ; Lassen, AT				Magnussen, Bjarne; Gradel, Kim Oren; Jensen, Thoger Gorm; Kolmos, Hans Jorn; Pedersen, Court; Vinholt, Pernille Just; Lassen, Annmarie Touborg			Association between Hypoalbuminaemia and Mortality in Patients with Community-Acquired Bacteraemia Is Primarily Related to Acute Disorders	PLOS ONE			English	Article							C-REACTIVE PROTEIN; SERUM-ALBUMIN; ORGAN FAILURE; SEVERE SEPSIS; INFLAMMATION; DISEASE; INTERLEUKIN-6; MALNUTRITION; MORBIDITY; ILLNESS	We sought to investigate whether hypoalbuminaemia was mainly caused by acute or chronic factors in patients with community-acquired bacteraemia. In this population-based study, we considered 1844 adult cases of community-acquired bacteraemia that occurred in Funen, Denmark between 2000 and 2008. We used a stepwise prognostic predisposition-insult-response-organ dysfunction (PIRO) logistic regression model by initially including age and comorbidity, then added bacterial species, and finally sepsis severity. The models were furthermoreanalysed using receiver operating characteristic (ROC) curves. Outcomes comprised mortality incidence on days 0-30 and 31-365 after the bacteraemia episode. Each step was performed with and without baseline albumin level measured on the date of bacteraemia. In 422 patients, their latest albumin measurement taken 8-30 days before the date of bacteraemia was also used in the analysis together with the baseline albumin level. For each decrease of 1g/L in plasma albumin level, the odds ratios (95% confidence intervals) of mortality in the period of 0-30 days after bacteraemia were 0.86 (0.84-0.88) in both predisposition (P) and predisposition-insult (PI) models and 0.87 (0.85-0.89) in the full PIRO-model. The AUC values were 0.78 and 0.66 for mortality in the period of 0-30 days in the model comprising only predisposition factors with and without albumin levels added as a factor, respectively. The AUC values in the full PIRO-model were 0.81 and 0.73 with and without consideration of albumin levels, respectively. A higher proportion of patients died within 30 days if there was a decrease in the albumin level between days 8 and 30 before bacteraemia and the actual bacteraemia date. A single plasma albumin measurement on the bacteraemia date was a better prognostic predictor of short-termmortality than the sepsis severity score.	[Magnussen, Bjarne; Gradel, Kim Oren] Odense Univ Hosp, Ctr Clin Epidemiol, South, Sdr Blvd 29,Entrance 101,4th Floor, DK-5000 Odense C, Denmark; [Magnussen, Bjarne; Gradel, Kim Oren] Univ Southern Denmark, Inst Clin Res, Res Unit Clin Epidemiol, Sdr Blvd 29,Entrance 101,4th Floor, DK-5000 Odense C, Denmark; [Jensen, Thoger Gorm; Kolmos, Hans Jorn] Odense Univ Hosp, Dept Clin Microbiol, JB Winsloews Vej 21,2nd Floor, DK-5000 Odense C, Denmark; [Pedersen, Court] Odense Univ Hosp, Dept Infect Dis, Sdr Blvd 29,Entrance 20, DK-5000 Odense C, Denmark; [Vinholt, Pernille Just] Odense Univ Hosp, Dept Clin Biochem & Pharmacol, Sdr Blvd 29,Entrance 40, DK-5000 Odense, Denmark; [Lassen, Annmarie Touborg] Odense Univ Hosp, Dept Emergency Med, Klovervaenget 25,Entrance 63-65, DK-5000 Odense, Denmark	University of Southern Denmark; Odense University Hospital; University of Southern Denmark; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital; University of Southern Denmark; Odense University Hospital	Magnussen, B (corresponding author), Odense Univ Hosp, Ctr Clin Epidemiol, South, Sdr Blvd 29,Entrance 101,4th Floor, DK-5000 Odense C, Denmark.; Magnussen, B (corresponding author), Univ Southern Denmark, Inst Clin Res, Res Unit Clin Epidemiol, Sdr Blvd 29,Entrance 101,4th Floor, DK-5000 Odense C, Denmark.	bjarne.magnussen@rsyd.dk	Gradel, Kim/AAC-6171-2019; Lassen, Annmarie/AAA-5816-2019	Gradel, Kim/0000-0002-5611-2031; Just Vinholt, Pernille/0000-0002-2035-0169; Magnussen, Bjarne/0000-0001-5553-020X; Jensen, Thoger Gorm/0000-0002-3889-0016; Lassen, Annmarie/0000-0003-4942-6152				Altman DG, 2001, BMJ-BRIT MED J, V323, P224, DOI 10.1136/bmj.323.7306.224; Artero A, 2010, J CRIT CARE, V25, P276, DOI 10.1016/j.jcrc.2009.12.004; Baron E.J., 1999, MANUAL CLIN MICROBIO, V7th; Beathard GA, 1975, SERUM PROTEIN ABNORM; Bishara J, 1997, EUR J CLIN MICROBIOL, V16, P563, DOI 10.1007/BF02447917; Blunt MC, 1998, ANAESTHESIA, V53, P755, DOI 10.1046/j.1365-2044.1998.00488.x; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; CUZICK J, 1985, STAT MED, V4, P87, DOI 10.1002/sim.4780040112; Danesh J, 1998, JAMA-J AM MED ASSOC, V279, P1477, DOI 10.1001/jama.279.18.1477; Don BR, 2004, SEMIN DIALYSIS, V17, P432, DOI 10.1111/j.0894-0959.2004.17603.x; DOWEIKO JP, 1991, JPEN-PARENTER ENTER, V15, P476, DOI 10.1177/0148607191015004476; Engelman DT, 1999, J THORAC CARDIOV SUR, V118, P866, DOI 10.1016/S0022-5223(99)70056-5; FLECK A, 1989, P NUTR SOC, V48, P347, DOI 10.1079/PNS19890050; Franch-Arcas G, 2001, CLIN NUTR, V20, P265, DOI 10.1054/clnu.2001.0438; Goldwasser P, 1997, J CLIN EPIDEMIOL, V50, P693, DOI 10.1016/S0895-4356(97)00015-2; Gradel KO, 2011, CLIN MICROBIOL INFEC, V17, P627, DOI 10.1111/j.1469-0691.2010.03284.x; Gradel KO, 2013, APMIS, V121, P835, DOI 10.1111/apm.12040; Hansson LO, 1997, SCAND J CLIN LAB INV, V57, P111, DOI 10.1080/00365519709056378; HEINRICH PC, 1990, BIOCHEM J, V265, P621, DOI 10.1042/bj2650621; Hills M., 1993, STAT MODELS EPIDEMIO, P271; Honda H, 2006, AM J KIDNEY DIS, V47, P139, DOI 10.1053/j.ajkd.2005.09.014; Howell MD, 2011, CRIT CARE MED, V39, P322, DOI 10.1097/CCM.0b013e3182037a8e; Johnson AM, 1999, CLIN CHEM LAB MED, V37, P91, DOI 10.1515/CCLM.1999.017; Kaysen GA, 1998, J AM SOC NEPHROL, V9, P2368; Klein S, 1990, Gastroenterology, V99, P1845; KNAUS WA, 1991, CHEST, V100, P1619, DOI 10.1378/chest.100.6.1619; LEIBOVICI L, 1993, AGE AGEING, V22, P431, DOI 10.1093/ageing/22.6.431; Levy MM, 2003, CRIT CARE MED, V31, P1250, DOI 10.1097/01.CCM.0000050454.01978.3B; Lynge E, 2011, SCAND J PUBLIC HEALT, V39, P30, DOI 10.1177/1403494811401482; Macdonald SPJ, 2014, ACAD EMERG MED, V21, P1257, DOI 10.1111/acem.12515; McCluskey A, 1996, ANAESTHESIA, V51, P724, DOI 10.1111/j.1365-2044.1996.tb07883.x; Pedersen CB, 2011, SCAND J PUBLIC HEALT, V39, P22, DOI 10.1177/1403494810387965; Peters Jr T., 1996, ALL ALBUMIN BIOCH GE, P251; Pierrakos C, 2010, CRIT CARE, V14, DOI 10.1186/cc8872; Rigaud D, 2000, AM J CLIN NUTR, V72, P355; ROTHSCHILD MA, 1988, HEPATOLOGY, V8, P385, DOI 10.1002/hep.1840080234; Rubulotta F, 2009, CRIT CARE MED, V37, P1329, DOI 10.1097/CCM.0b013e31819d5db1; Sitges-Serra A, 1998, Curr Opin Clin Nutr Metab Care, V1, P9, DOI 10.1097/00075197-199801000-00003; Sogaard M, 2011, CLIN INFECT DIS, V52, P61, DOI 10.1093/cid/ciq069; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Vincent JL, 2003, ANN SURG, V237, P319, DOI 10.1097/00000658-200303000-00005; WEINSTEIN MP, 1983, REV INFECT DIS, V5, P35, DOI 10.1093/clinids/5.1.35; WHITELAW DA, 1992, J AM GERIATR SOC, V40, P996, DOI 10.1111/j.1532-5415.1992.tb04475.x; Yeun J Y, 1998, Am J Kidney Dis, V32, pS118, DOI 10.1016/S0272-6386(98)70174-X	45	25	26	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160466	10.1371/journal.pone.0160466	http://dx.doi.org/10.1371/journal.pone.0160466			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611431	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900007
J	da Silva, EC; Roriz, AKC; Eickemberg, M; Mello, AL; Cortes, EBQ; Feitosa, CA; Medeiros, JMB; Ramos, LB				da Silva, Emanuelle Cruz; Carneiro Roriz, Anna Karla; Eickemberg, Michaela; Mello, Adriana Lima; Quadros Cortes, Elvira Barbosa; Feitosa, Caroline Alves; Barreto Medeiros, Jairza Maria; Ramos, Lilian Barbosa			Factors Associated with Anemia in the Institutionalized Elderly	PLOS ONE			English	Article							PREVALENCE; HEALTH	As a common problem in long-term care facilities (LTCFs), anemia affects 25-63% of the elderly. The aim of the present study was to describe the prevalence and characteristics of anemia and its associated factors in the institutionalized elderly. The cross-sectional study was carried out with three hundred thirteen individuals aged >= 60 years, of both genders, living in long-term care facilities for the elderly in Salvador, Bahia, Brazil. Poisson regression (PR) with robust variance estimates was used to assess the factors related to anemia. The prevalence of anemia was 38%. Mild anemia was predominant in both genders (male: 26.8%; female: 21.1%), as normocytic and normochromic anemia, with no anisocytosis (69.75%). Anemia was associated with thinness (PR: 1.68; 95% CI: 1.04-2.72) and with moderate (PR: 1.98; 95% CI: 1.07-3.63) and total (PR: 2.61; 95% CI: 1.34-5.07) dependence in the final model. Severe dependence exhibited borderline significance (PR: 1.94; 95% CI: 1.00-3.77). The prevalence of anemia was high in the institutionalized elderly in both genders, with characteristics suggesting chronic diseases as the causal factor, and the frequency of occurrence was higher in thinness elderly with moderate to total dependence.	[da Silva, Emanuelle Cruz; Barreto Medeiros, Jairza Maria; Ramos, Lilian Barbosa] Univ Fed Bahia UFBA, Univ Fed Bahia, Food Nutr & Hlth Grad Program, Salvador, BA, Brazil; [da Silva, Emanuelle Cruz; Carneiro Roriz, Anna Karla; Eickemberg, Michaela; Mello, Adriana Lima; Ramos, Lilian Barbosa] Univ Fed Bahia, Aging Related Res & Intervent Ctr, Salvador, BA, Brazil; [Carneiro Roriz, Anna Karla; Mello, Adriana Lima; Barreto Medeiros, Jairza Maria; Ramos, Lilian Barbosa] Univ Fed Bahia, Sch Nutr, Dept Nutr Sci, Salvador, BA, Brazil; [Eickemberg, Michaela; Feitosa, Caroline Alves] Univ Fed Bahia, Collect Hlth Inst, Collect Hlth Grad Program, Salvador, BA, Brazil; [Eickemberg, Michaela; Feitosa, Caroline Alves] Bahian Sch Med & Publ Hlth, Salvador, BA, Brazil; [Quadros Cortes, Elvira Barbosa] Univ Fed Bahia, Fac Med, Dept Med, Salvador, BA, Brazil	Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia; Universidade Federal da Bahia	da Silva, EC (corresponding author), Univ Fed Bahia UFBA, Univ Fed Bahia, Food Nutr & Hlth Grad Program, Salvador, BA, Brazil.; da Silva, EC (corresponding author), Univ Fed Bahia, Aging Related Res & Intervent Ctr, Salvador, BA, Brazil.	emanuelle_cruz@hotmail.com	BARRETOMEDEIROS, JAIRZA MARIA/AAF-6159-2021; Wachholz, Patrick/G-5142-2010	Wachholz, Patrick/0000-0002-4474-009X; C. RORIZ, ANNA KARLA/0000-0002-1768-5646	Bahia State Research Foundation - FAPESB [PET 0007/2013]	Bahia State Research Foundation - FAPESB	The present study was funded by Bahia State Research Foundation - FAPESB (grant PET 0007/2013 to LBR; URL: http://www.fapesb.ba.gov.br/). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Academy of Family Physicians American Dietetic Association, 2002, PHYS GUID NUTR CHRON; Andres E, 2013, GERIATR GERONTOL INT, V13, P519, DOI 10.1111/ggi.12017; Andres E, 2008, EUR J INTERN MED, V19, P488, DOI 10.1016/j.ejim.2008.01.016; [Anonymous], 2002, DIABETES CARE S1, V26, pS5; Nakashima ATA, 2012, NUTRITION, V28, P640, DOI 10.1016/j.nut.2011.09.016; Astor BC, 2002, ARCH INTERN MED, V162, P1401, DOI 10.1001/archinte.162.12.1401; Azeredo Z, 2003, REV FACUL MED LISBOA, V8, P199; Balducci L, 2006, CRIT REV ONCOL HEMAT, V58, P156, DOI 10.1016/j.critrevonc.2005.09.003; Bosco RD, 2013, CAD SAUDE PUBLICA, V29, P1322, DOI 10.1590/S0102-311X2013000700007; Cereda E, 2011, J AM MED DIR ASSOC, V12, P174, DOI 10.1016/j.jamda.2010.11.013; CHUMLEA WC, 1985, J AM GERIATR SOC, V33, P116, DOI 10.1111/j.1532-5415.1985.tb02276.x; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Corona LP, 2014, REV SAUDE PUBL, V48, P723, DOI 10.1590/S0034-8910.2014048005039; Du Bois D, 1989, NUTRITION, V5, P863; Eknoyan G, 2002, AM J KIDNEY DIS, V39, pS14, DOI 10.1053/ajkd.2002.30939; Janssen I, 2000, J APPL PHYSIOL, V89, P465, DOI 10.1152/jappl.2000.89.2.465; Janssen I, 2004, AM J EPIDEMIOL, V159, P413, DOI 10.1093/aje/kwh058; Jelliffe D B, 1966, Monogr Ser World Health Organ, V53, P3; Kyle UG, 2004, CLIN NUTR, V23, P1430, DOI 10.1016/j.clnu.2004.09.012; Macedo VF, 2011, REV BRAS GERIATR GER, V5, P214; MAHONEY F I, 1965, Md State Med J, V14, P61; Morley JE, 2012, J AM MED DIR ASSOC, V13, P191, DOI 10.1016/j.jamda.2011.12.057; Onem Y, 2010, ARCH GERONTOL GERIAT, V50, P56, DOI 10.1016/j.archger.2009.01.010; Sgnaolin Vanessa, 2013, Rev. Bras. Hematol. Hemoter., V35, P115, DOI 10.5581/1516-8484.20130032; Stauffer ME, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084943; Tettamanti M, 2010, HAEMATOL-HEMATOL J, V95, P1849, DOI 10.3324/haematol.2010.023101; Tseng CK, 2012, ARCH GERONTOL GERIAT, V55, P77, DOI 10.1016/j.archger.2011.06.019; World Health Organization, 2011, HAEM CONC DIAGN AN A; World Health Organization, 1995, WHO TECHN REP SER	29	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162240	10.1371/journal.pone.0162240	http://dx.doi.org/10.1371/journal.pone.0162240			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607057	Green Published, gold			2022-12-26	WOS:000383255600032
J	Li, MY; Liu, XY; Liu, ZX; Sun, Y; Liu, MX; Wang, XL; Zhang, HF; Zheng, XB; Zhang, ZG				Li, Mengying; Liu, Xinyu; Liu, Zhixi; Sun, Yi; Liu, Muxing; Wang, Xiaoli; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang			Glycoside Hydrolase MoGls2 Controls Asexual/Sexual Development, Cell Wall Integrity and Infectious Growth in the Rice Blast Fungus	PLOS ONE			English	Article							RETICULUM GLUCOSIDASE-II; ENDOPLASMIC-RETICULUM; MAGNAPORTHE-GRISEA; SACCHAROMYCES-CEREVISIAE; TRANSCRIPTION FACTOR; CANDIDA-ALBICANS; N-GLYCOSYLATION; USTILAGO-MAYDIS; QUALITY-CONTROL; PATHOGENICITY	N-linked glycosylation is a way of glycosylation for newly synthesized protein, which plays a key role in the maturation and transport of proteins. Glycoside hydrolases (GHs) are essential in this process, and are involved in processing of N-linked glycoproteins or degradation of carbohydrate structures. Here, we identified and characterized MoGls2 in Magnaporthe oryzae, which is a yeast glucosidase II homolog Gls2 and is required for trimming the final glucose in N-linked glycans and normal cell wall synthesis. Target deletion of MoGLS2 in M. oryzae resulted in a reduced mycelial growth, an increased conidial production, delayed conidial germination and loss the ability of sexual reproduction. Pathogenicity assays revealed that the Delta Mogls2 mutant showed significantly decreased in virulence and infectious growth. Further studies showed that the mutant was less sensitive to salt and osmotic stress, and increased sensitivity to cell wall stresses. Additionally, the Delta Mogls2 mutant showed a defect in cell wall integrity. Our results indicate that MoGls2 is a key protein for the growth and development of M. oryzae, involving in the regulation of asexual/sexual development, stress response, cell wall integrity and infectious growth.	[Li, Mengying; Liu, Xinyu; Sun, Yi; Liu, Muxing; Wang, Xiaoli; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang] Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China; [Li, Mengying; Liu, Xinyu; Sun, Yi; Liu, Muxing; Wang, Xiaoli; Zhang, Haifeng; Zheng, Xiaobo; Zhang, Zhengguang] Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing 210095, Jiangsu, Peoples R China; [Liu, Zhixi] Agr Bur Ningxiang Cty, Changsha 410600, Hunan, Peoples R China	Nanjing Agricultural University	Zhang, HF (corresponding author), Nanjing Agr Univ, Dept Plant Pathol, Coll Plant Protect, Nanjing 210095, Jiangsu, Peoples R China.; Zhang, HF (corresponding author), Minist Educ, Key Lab Integrated Management Crop Dis & Pests, Nanjing 210095, Jiangsu, Peoples R China.	hfzhang@njau.edu.cn			Natural Science Foundation of China [31471736]; Fundamental Research Funds for the Central Universities [KYZ201304]; Agriculture Innovation Foundation of Jiangsu Province of China [CX(15)1054]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Agriculture Innovation Foundation of Jiangsu Province of China	This study was supported by the Natural Science Foundation of China (Grant No: 31471736 to H. Zhang), the Fundamental Research Funds for the Central Universities (Grant No: KYZ201304 to H. Zhang), and the Agriculture Innovation Foundation of Jiangsu Province of China (Grant No: CX(15)1054 to Z. Zhang). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Breitling J, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a013359; Chen XL, 2014, PLANT CELL, V26, P1360, DOI 10.1105/tpc.114.123588; Choi WB, 1997, PLANT CELL, V9, P1973, DOI 10.1105/tpc.9.11.1973; D'Alessio C, 1999, J BIOL CHEM, V274, P25899, DOI 10.1074/jbc.274.36.25899; D'Alessio C, 2015, CURR PROTEIN PEPT SC, V16, P31, DOI 10.2174/1389203716666150213160438; Dean R, 2012, MOL PLANT PATHOL, V13, P414, DOI 10.1111/j.1364-3703.2011.00783.x; deJong JC, 1997, NATURE, V389, P244, DOI 10.1038/38418; Fanchiotti S, 1998, J CELL BIOL, V143, P625, DOI 10.1083/jcb.143.3.625; Fernandez-Alvarez A, 2013, PLANT CELL, V25, P4676, DOI 10.1105/tpc.113.115691; Frade-Perez MD, 2010, ANTON LEEUW INT J G, V98, P291, DOI 10.1007/s10482-010-9437-1; Geysens S, 2005, APPL ENVIRON MICROB, V71, P2910, DOI 10.1128/AEM.71.6.2910-2924.2005; HAMER JE, 1988, SCIENCE, V239, P288, DOI 10.1126/science.239.4837.288; HENRISSAT B, 1993, BIOCHEM J, V293, P781, DOI 10.1042/bj2930781; HOWARD RJ, 1991, P NATL ACAD SCI USA, V88, P11281, DOI 10.1073/pnas.88.24.11281; Jeon J, 2008, MOL PLANT MICROBE IN, V21, P525, DOI 10.1094/MPMI-21-5-0525; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; Kong LA, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002526; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mora-Montes HM, 2007, EUKARYOT CELL, V6, P2184, DOI 10.1128/EC.00350-07; Qi ZQ, 2012, MOL PLANT PATHOL, V13, P677, DOI 10.1111/j.1364-3703.2011.00779.x; Satoh T, 2016, SCI REP-UK, V6, DOI 10.1038/srep20575; Schirawski J, 2005, PLANT CELL, V17, P3532, DOI 10.1105/tpc.105.036285; Simons JF, 1998, EMBO J, V17, P396, DOI 10.1093/emboj/17.2.396; Strasser R, 2016, GLYCOBIOLOGY, V26, P926, DOI 10.1093/glycob/cww023; STROUS GJ, 1987, J BIOL CHEM, V262, P3620; Talbot NJ, 2003, ANNU REV MICROBIOL, V57, P177, DOI 10.1146/annurev.micro.57.030502.090957; TALBOT NJ, 1993, PLANT CELL, V5, P1575, DOI 10.1105/tpc.5.11.1575; Trombetta ES, 1996, J BIOL CHEM, V271, P27509, DOI 10.1074/jbc.271.44.27509; Wang JM, 2013, MOL PLANT PATHOL, V14, P470, DOI 10.1111/mpp.12020; Wilkinson BM, 2006, J BIOL CHEM, V281, P6325, DOI 10.1074/jbc.M510455200; Zhang HF, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002450; Zhang HF, 2010, CURR GENET, V56, P517, DOI 10.1007/s00294-010-0319-x; Zhang HF, 2009, FEMS MICROBIOL LETT, V293, P160, DOI 10.1111/j.1574-6968.2009.01524.x	34	10	10	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162243	10.1371/journal.pone.0162243	http://dx.doi.org/10.1371/journal.pone.0162243			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607237	gold, Green Published			2022-12-26	WOS:000383255600033
J	Otis, MJD; Ayena, JC; Tremblay, LE; Fortin, PE; Menelas, BAJ				Otis, Martin J. -D.; Ayena, Johannes C.; Tremblay, Louis E.; Fortin, Pascal E.; Menelas, Bob-Antoine J.			Use of an Enactive Insole for Reducing the Risk of Falling on Different Types of Soil Using Vibrotactile Cueing for the Elderly	PLOS ONE			English	Article							PARKINSONS-DISEASE PATIENTS; RHYTHMIC AUDITORY-STIMULATION; FUNCTIONAL MOBILITY; GAIT; CUES; PEOPLE; WALKING; PREVENTION; STRATEGIES; FLOOR	Background Our daily activities imply displacements on various types of soil. For persons with gait disorder or losing functional autonomy, walking on some types of soil could be challenging because of the risk of falling it represents. Methods In this paper, we present, in a first part, the use of an enactive shoe for an automatic differentiation of several types of soil. In a second part, using a second improved prototype (an enactive insole), twelve participants with Parkinson's disease (PD) and nine age-matched controls have performed the Timed Up and Go (TUG) test on six types of soil with and without cueing. The frequency of the cueing was set at 10% above the cadence computed at the lower risk of falling (walking over the concrete). Depending on the cadence computed at the lower risk, the enactive insole activates a vibrotactile cueing aiming to improve gait and balance control. Finally, a risk index is computed using gait parameters in relation to given type of soil. Results The frequency analysis of the heel strike vibration allows the differentiation of various types of soil. The risk computed is associated to an appropriate rhythmic cueing in order to improve balance and gait impairment. The results show that a vibrotactile cueing could help to reduce the risk of falling. Conclusions Firstly, this paper demonstrates the feasibility of reducing the risk of falling while walking on different types of soil using vibrotactile cueing. We found a significant difference and a significant decrease in the computed risks of falling for most of types of soil especially for deformable soils which can lead to fall. Secondly, heel strike provides an approximation of the impulse response of the soil that can be analyzed with time and frequency-domain modeling. From these analyses, an index is computed enabling differentiation the types of soil.	[Otis, Martin J. -D.; Ayena, Johannes C.] Univ Quebec Chicoutimi UQAC, REPARTI Ctr, Dept Appl Sci, Chicoutimi, PQ, Canada; [Tremblay, Louis E.] Univ Quebec Chicoutimi, Dept Hlth Sci, Chicoutimi, PQ, Canada; [Fortin, Pascal E.] McGill Univ, Ctr Intelligent Machine, Dept Elect Engn & Comp, Montreal, PQ, Canada; [Menelas, Bob-Antoine J.] Univ Quebec Chicoutimi, Dept Math & Comp Sci, Chicoutimi, PQ, Canada	University of Quebec; University of Quebec Chicoutimi; University of Quebec; University of Quebec Chicoutimi; McGill University; University of Quebec; University of Quebec Chicoutimi	Ayena, JC (corresponding author), Univ Quebec Chicoutimi UQAC, REPARTI Ctr, Dept Appl Sci, Chicoutimi, PQ, Canada.	cossoun-johannes.ayena1@uqac.ca	Ayena, Johannes/AAJ-6842-2020	Ayena, Johannes/0000-0003-4104-8070; Fortin, Pascal E./0000-0002-0704-9590	Natural Sciences and Engineering Research Council of Canada (NSERC) [418235-2012]	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work is supported by the financial support of the Natural Sciences and Engineering Research Council of Canada (NSERC), under the grant number 418235-2012.	Arias P, 2008, EXP BRAIN RES, V186, P589, DOI 10.1007/s00221-007-1263-y; Arias P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009675; Ayub S., 2012, COMPUTER INFORMATICS, V107, P123; Azizah G, 2001, CHARACTERISTICS BAIT; Bamberg SJM, 2008, IEEE T INF TECHNOL B, V12, P413, DOI 10.1109/TITB.2007.899493; Basta D, 2011, OTOL NEUROTOL, V32, P1492, DOI 10.1097/MAO.0b013e31823827ec; Bensmaia SJ, 2003, SOMATOSENS MOT RES, V20, P33, DOI 10.1080/0899022031000083825; Bhatt T, 2009, J NEUROPHYSIOL, V101, P948, DOI 10.1152/jn.91004.2008; Boulos MNK, 2011, BIOMED ENG ONLINE, V10, DOI 10.1186/1475-925X-10-24; Brassard S, 2012, P 2 ACM WORKSH MOB S, P1; Brooks CA, 2005, IEEE T ROBOT, V21, P1185, DOI 10.1109/TRO.2005.855994; Cappellini G, 2010, J NEUROPHYSIOL, V103, P746, DOI 10.1152/jn.00499.2009; Chan A, 2005, EUR C 2005 S HAPT IN; Chang JT, 2004, BRIT MED J, V328, P680, DOI 10.1136/bmj.328.7441.680; COHEN HH, 1994, J SAFETY RES, V25, P19, DOI 10.1016/0022-4375(94)90004-3; Collins EG, 2008, ROB AUT IEEE INT C M; DAVIS PR, 1983, ERGONOMICS, V26, P51, DOI 10.1080/00140138308963312; Dozza M, 2004, ENG MED BIOL SOC 26; Filiatroult J, 2007, CAN J AGING, V26, P213, DOI 10.3138/cja.26.3.213; Frazzitta G, 2009, MOVEMENT DISORD, V24, P1139, DOI 10.1002/mds.22491; GABELL A, 1984, J GERONTOL, V39, P662, DOI 10.1093/geronj/39.6.662; Galica AM, 2009, GAIT POSTURE, V30, P383, DOI 10.1016/j.gaitpost.2009.07.005; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gates DH, 2012, GAIT POSTURE, V35, P36, DOI 10.1016/j.gaitpost.2011.08.001; Gottschall JS, 2011, J APPL BIOMECH, V27, P355, DOI 10.1123/jab.27.4.355; Gyllensten IC, 2011, IEEE T BIO-MED ENG, V58, P2656, DOI 10.1109/TBME.2011.2160723; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hoepflinger MA, 2010, ROB AUT ICRA IEEE IN; Howe TE, 2003, CLIN REHABIL, V17, P363, DOI 10.1191/0269215503cr621oa; Janssen M, 2010, GAIT POSTURE, V31, P213, DOI 10.1016/j.gaitpost.2009.10.008; Jenkins ME, 2009, PARKINSONISM RELAT D, V15, P697, DOI 10.1016/j.parkreldis.2009.04.004; Kang H. G., 2008, N AM C BIOM; Kim J. W., 2004, J GLOBAL POSITION SY, V3, P273, DOI DOI 10.5081/JGPS.3.1.273; Kisung K, 2010, SICE ANN C; Kobayashi Y, 2008, IEEE T NEUR SYS REH, V16, P99, DOI 10.1109/TNSRE.2007.910283; Kyriacou E, 2003, BIOMED ENG ONLINE, V2, DOI 10.1186/1475-925X-2-7; Larson AC, 2007, INT ROB SYST IEEE IN; Levesque V, 2005, BLINDNESS TECHNOLOGY, P19; Lewis GN, 2000, BRAIN, V123, P2077, DOI 10.1093/brain/123.10.2077; Lohnes CA, 2011, GAIT POSTURE, V33, P478, DOI 10.1016/j.gaitpost.2010.12.029; Lord SR, 2010, CLIN GERIATR MED, V26, P569, DOI 10.1016/j.cger.2010.06.002; Magaa M, 2008, HAPT AUD VIS ENV GAM; Mak MKY, 2009, J NEUROL, V256, P742, DOI 10.1007/s00415-009-5007-8; Marigold DS, 2005, J NEUROPHYSIOL, V94, P1733, DOI 10.1152/jn.00019.2005; McIntosh GC, 1997, J NEUROL NEUROSUR PS, V62, P22, DOI 10.1136/jnnp.62.1.22; Menant JC, 2009, GAIT POSTURE, V29, P392, DOI 10.1016/j.gaitpost.2008.10.057; Menelas Bob-Antoine J., 2012, Serious Games Development and Applications. Proceedings Third International Conference, SGDA 2012, P31, DOI 10.1007/978-3-642-33687-4_3; Milosevic M., 2013, BOD SENS NETW BSN 20; Milosevic M, 2013, BOD SENS NETW BSN IE; Moreau C, 2008, J NEURAL TRANSM, V115, P1431, DOI 10.1007/s00702-008-0099-3; Muir SW, 2008, PHYS THER, V88, P449, DOI 10.2522/ptj.20070251; Noshadi H, 2010, BIOSIGNALS 2010: PROCEEDINGS OF THE THIRD INTERNATIONAL CONFERENCE ON BIO-INSPIRED SYSTEMS AND SIGNAL PROCESSING, P264; Otis MJD, 2012, SYST MAN CYB SMC IEE; Paradiso J. A., 2004, CHI 04 HUM FACT COMP, P1341, DOI DOI 10.1145/985921.986059; Parsons J, 2015, DISABILITY REHABILIT, V38, P1; Pawlak-Osinska K, 2011, CESK SLOV NEUROL N, V74, P669; PODSIADLO D, 1991, J AM GERIATR SOC, V39, P142, DOI 10.1111/j.1532-5415.1991.tb01616.x; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; Rocha PA, 2014, CLIN NEUROL NEUROSUR, V124, P127, DOI 10.1016/j.clineuro.2014.06.026; Suteerawattananon M, 2004, J NEUROL SCI, V219, P63, DOI 10.1016/j.jns.2003.12.007; Thaut MH, 1996, MOVEMENT DISORD, V11, P193, DOI 10.1002/mds.870110213; Thrane Gyrd, 2007, BMC Geriatr, V7, P1, DOI 10.1186/1471-2318-7-1; Tiest WMB, 2010, VISION RES, V50, P2775, DOI 10.1016/j.visres.2010.10.005; TINETTI ME, 1986, J AM GERIATR SOC, V34, P119, DOI 10.1111/j.1532-5415.1986.tb05480.x; Visell Y, 2010, HAPT S IEEE MARCH; Weiss A, 2010, MED ENG PHYS, V32, P119, DOI 10.1016/j.medengphy.2009.10.015; Weiss C, 2008, INT ROB SYST IEEE IN; Weiss C, 2006, INT ROB SYST IEEE IN; Willems AM, 2006, DISABIL REHABIL, V28, P721, DOI 10.1080/09638280500386569; Yang W, 2015, ASCE-ASME J RISK U B, V1, DOI 10.1115/1.4029751; Yu M, 2010, J MED SYST, V34, P787, DOI 10.1007/s10916-009-9293-6; Yuwono M, 2012, BIOMED ENG ONLINE, V11, DOI 10.1186/1475-925X-11-9; Zampieri C, 2011, PARKINSONISM RELAT D, V17, P277, DOI 10.1016/j.parkreldis.2010.08.001; Zampieri C, 2010, J NEUROL NEUROSUR PS, V81, P171, DOI 10.1136/jnnp.2009.173740	75	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162107	10.1371/journal.pone.0162107	http://dx.doi.org/10.1371/journal.pone.0162107			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603211	gold, Green Published, Green Submitted, Green Accepted			2022-12-26	WOS:000383255200041
J	Binder, WJ; Cervantes, KS; Meachen, JA				Binder, Wendy J.; Cervantes, Kassaundra S.; Meachen, Julie A.			Measures of Relative Dentary Strength in Rancho La Brea Smilodon fatalis over Time	PLOS ONE			English	Article							MANDIBULAR CORPUS; GROWTH; MALNUTRITION; PATTERNS; DENSITY	The late Pleistocene megafaunal extinction of approximately 12,000 years ago, included the demise of Smilodon fatalis, a hypercarnivore from the Rancho La Brea deposits, which has been studied across time by looking at different deposits or pits to determine morphological size and shape changes and trends during this time. To better understand functional aspects of these changes, this study focused on a measure of jaw strength over time, which can give an indication of morphological changes within the jaw that cannot be seen using surface morphometrics. By radiographing dentaries, cortical bone can be seen, which provides an estimate of resistance to bending forces while biting, and can be measured and used as an indicator of jaw strength. Measurements were taken at repeatable locations on the dentary of the depth of the cortical bone, and of a standardized measure of cortical bone, which allows for the comparison between different individuals. Specimens included those of five different pits ranging from about 37 Kybp to 13 Kybp (just before the extinction of S. fatalis). No significant difference was found in the depth of jaws at any of the measurement points from any of the pits. However, significant differences were found in both the actual thickness of cortical bone, and the standardized thickness of cortical bone at the lower P4 between pit 13 (which had the lowest amount of bone) and pit 61/67 (which had the highest). These conclusions support other studies that have shown that individuals in pit 13 were under physiological and perhaps dietary stress, which may be reflected in the deposition of cortical bone, while the opposite trend is seen in the individuals in pit 61/67. Our results further support findings suggesting Smilodon did not appear to be morphologically most vulnerable right before its extinction.	[Binder, Wendy J.; Cervantes, Kassaundra S.] Loyola Marymount Univ, Dept Biol, Los Angeles, CA 90045 USA; [Meachen, Julie A.] Des Moines Univ, Dept Anat, Des Moines, IA USA	Loyola Marymount University	Binder, WJ (corresponding author), Loyola Marymount Univ, Dept Biol, Los Angeles, CA 90045 USA.	wendy.binder@lmu.edu		Binder, Wendy/0000-0003-2580-7567	LMU Rains Research Assistant grant	LMU Rains Research Assistant grant	KC was supported by the LMU Rains Research Assistant grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We would like to thank A. Farrell, G. Takeuchi, S. Cox, and J. Harris for their help with and access to the research collection at the Page Museum. We would also like to thank B. Van Valkenburgh, C. Ruff, R. O'Keefe, F. Therrien and one anonymous reviewer for discussion that improved this paper. WB and KC want to thank LMU for a Rains Research Assistant grant to KC.	Alippi RM, 2002, ARCH ORAL BIOL, V47, P47, DOI 10.1016/S0003-9969(01)00089-9; Biknevicius AR, 1997, ZOOL J LINN SOC-LOND, V120, P139; BIKNEVICIUS AR, 1992, J ZOOL, V228, P479, DOI 10.1111/j.1469-7998.1992.tb04450.x; BIKNEVICIUS AR, 1992, ANAT RECORD, V232, P157, DOI 10.1002/ar.1092320118; Binder WJ, 2010, J VERTEBR PALEONTOL, V30, P255, DOI 10.1080/02724630903413016; Binder WJ, 2002, J VERTEBR PALEONTOL, V22, P423, DOI 10.1671/0272-4634(2002)022[0423:TVITFA]2.0.CO;2; DeSantis LRG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052453; Devlin MJ, 2013, J ENDOCRINOL, V217, P69, DOI 10.1530/JOE-12-0403; Friscia AR, 2008, PALAIOS, V23, P35, DOI 10.2110/palo.2005.p05-143r; Goswami A, 2015, P NATL ACAD SCI USA, V112, P4891, DOI 10.1073/pnas.1403667112; Hattori S, 2013, CALCIFIED TISSUE INT, V93, P540, DOI 10.1007/s00223-013-9787-6; Ibarra Y, 2015, PALAEOGEOGR PALAEOCL, V422, P36, DOI 10.1016/j.palaeo.2015.01.012; Koch PL, 2006, ANNU REV ECOL EVOL S, V37, P215, DOI 10.1146/annurev.ecolsys.34.011802.132415; Laabs BJC, 2013, EARTH PLANET SC LETT, V361, P16, DOI 10.1016/j.epsl.2012.11.018; Lesmeister DB, 2015, WILDLIFE MONOGR, V191, P1, DOI 10.1002/wmon.1015; Lobe SL, 2006, J ANAT, V208, P795, DOI 10.1111/j.1469-7580.2006.00565.x; Meachen JA, 2014, J EVOLUTION BIOL, V27, P714, DOI 10.1111/jeb.12340; Melis C, 2009, GLOBAL ECOL BIOGEOGR, V18, P724, DOI 10.1111/j.1466-8238.2009.00480.x; O'Keefe FR, 2014, PALAEONTOL ELECTRON, V17; O'Keefe F. Robin, 2009, Contributions in Science (Los Angeles), P1; Romano T, 2015, REPROD FERT DEVELOP, V27, P823, DOI 10.1071/RD13388; Romano T, 2010, BONE, V47, P1054, DOI 10.1016/j.bone.2010.08.020; Therrien F, 2005, ZOOL J LINN SOC-LOND, V145, P393, DOI 10.1111/j.1096-3642.2005.00194.x; Troyer EM, 2014, J MAMMAL, V95, P421, DOI 10.1644/13-MAMM-A-164.1	24	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162270	10.1371/journal.pone.0162270	http://dx.doi.org/10.1371/journal.pone.0162270			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598462	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800050
J	da Silva, BD; Lima, KF; Goncalves, LR; da Silveira, MB; Moraes, KCM				da Silva, Brenda de Oliveira; Lima, Kelvin Furtado; Goncalves, Leticia Rocha; da Silveira, Marina Bonfogo; Moraes, Karen C. M.			MicroRNA Profiling of the Effect of the Heptapeptide Angiotensin-(1-7) in A549 Lung Tumor Cells Reveals a Role for miRNA149-3p in Cellular Migration Processes	PLOS ONE			English	Article							CANCER; GROWTH; ACTIN; ANGIOGENESIS; XENOGRAFTS; EXPRESSION; REPRESSION; REDUCTION; MOTILITY; CHORDOMA	Lung cancer is one of the most frequent types of cancer in humans and a leading cause of death worldwide. The high mortality rates are correlated with late diagnosis, which leads to high rates of metastasis found in patients. Thus, despite all the improvement in therapeutic approaches, the development of new drugs that control cancer cell migration and metastasis are required. The heptapeptide angiotensin-(1-7) [ ang-(1-7)] has demonstrated the ability to control the growth rates of human lung cancer cells in vitro and in vivo, and the elucidation of central elements that control the fine-tuning of cancer cells migration in the presence of the ang-(1-7), will support the development of new therapeutic approaches. Ang(1-7) is a peptide hormone of the renin-angiotensin system (RAS) and this study investigates the modulatory effect of the heptapeptide on the expression pattern of microRNAs (miRNAs) in lung tumor cells, to elucidate mechanistic concerns about the effect of the peptide in the control of tumor migratory processes. Our primary aim was to compare the miRNA profiling between treated and untreated-heptapeptide cells to characterize the relevant molecule that modulates cellular migration rates. The analyses selected twenty one miRNAs, which are differentially expressed between the groups; however, statistical analyses indicated miRNA-149-3p as a relevant molecule. Once functional analyses were performed, we demonstrated that miRNA-149-3p plays a role in the cellular migration processes. This information could be useful for future investigations on drug development.	[da Silva, Brenda de Oliveira] Univ Fed Ouro Preto, Nucleo Pesquisa Biol, Ouro Preto, MG, Brazil; [Lima, Kelvin Furtado] Univ Estadual Paulista, Inst Chem, Araraquara, SP, Brazil; [Goncalves, Leticia Rocha; da Silveira, Marina Bonfogo; Moraes, Karen C. M.] Univ Estadual Paulista, Mol Biol Lab, Dept Biol, Biosci Inst, Rio Claro, SP, Brazil	Universidade Federal de Ouro Preto; Universidade Estadual Paulista; Universidade Estadual Paulista	Moraes, KCM (corresponding author), Univ Estadual Paulista, Mol Biol Lab, Dept Biol, Biosci Inst, Rio Claro, SP, Brazil.	Karenmor@rc.unesp.com	de+Moraes, Karen/AAU-1429-2021		Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo [475586/2012-3, 2014/07671-2]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [475586/2012-3]; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2014/07671-2]	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico - Fundacao de Amparo a Pesquisa do Estado de Sao Paulo; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP))	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico-GRant # 475586/2012-3 - KCMM Fundacao de Amparo a Pesquisa do Estado de Sao Paulo - Grante #2014/07671-2 - MBS.; We thank the professors who donate the cell lines for this study (Priolli DG, Santos RAS and Valente V) and the professor Santos AF for the machine ViiA (TM) 7 Real-Time PCR System. This study was supported by research grants from the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) (475586/2012-3) and Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP-2014/07671-2). The authors report no conflict of interest.	Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Ambros V, 2003, CELL, V113, P673, DOI 10.1016/S0092-8674(03)00428-8; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; BECKNER ME, 1995, CANCER RES, V55, P2140; Cao X, 2016, SCI REP-UK, V6, DOI 10.1038/srep21592; Carlier MF, 2015, CELL MOL LIFE SCI, V72, P3051, DOI 10.1007/s00018-015-1914-2; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; da Silva W, 2016, MOL CELL BIOCHEM, V411, P363, DOI 10.1007/s11010-015-2598-5; Edelstein-Keshet L, 2016, CELL SYSTEMS, V2; Edwards BK, 2005, JNCI-J NATL CANCER I, V97, P1407, DOI 10.1093/jnci/dji289; Ekambaram P, 2011, CANCER METAST REV, V30, P397, DOI 10.1007/s10555-011-9297-9; Ferreira AJ, 2005, BRAZ J MED BIOL RES, V38, P499, DOI 10.1590/S0100-879X2005000400003; Ferreira AJ, 2001, HYPERTENSION, V38, P665, DOI 10.1161/01.HYP.38.3.665; Gallagher PE, 2011, CURR CANCER DRUG TAR, V11, P394; Gallagher PE, 2004, CARCINOGENESIS, V25, P2045, DOI 10.1093/carcin/bgh236; Hoffmann C, 2016, ONCOTARGET, V11, DOI 10.18632/oncotarget.7327; Khajah MA, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150861; Klip A, 2014, AM J PHYSIOL-CELL PH, V306, pC879, DOI 10.1152/ajpcell.00069.2014; Koseoglu S, 2015, BLOOD, V126, P651, DOI 10.1182/blood-2014-12-618744; Lamalice L, 2007, CIRC RES, V100, P782, DOI 10.1161/01.RES.0000259593.07661.1e; Li W, 2015, SCI REP-UK, V5, DOI 10.1038/srep16506; Long C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066676; Loot AE, 2002, CIRCULATION, V105, P1548, DOI 10.1161/01.CIR.0000013847.07035.B9; McPherson CM, 2006, J NEUROSURG-SPINE, V5, P277, DOI 10.3171/spi.2006.5.4.277; Meijer HA, 2013, SCIENCE, V340, P82, DOI 10.1126/science.1231197; Menon J, 2007, CANCER RES, V67, P2809, DOI 10.1158/0008-5472.CAN-06-3614; Miyamoto Kei, 2011, Commun Integr Biol, V4, P582, DOI 10.4161/cib.4.5.16491; Munjal A, 2015, NATURE, V524, P351, DOI 10.1038/nature14603; NOBES CD, 1995, CELL, V81, P53, DOI 10.1016/0092-8674(95)90370-4; Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523; Ozsolak F, 2008, GENE DEV, V22, P3172, DOI 10.1101/gad.1706508; Passos-Silva DG, 2013, CLIN SCI, V124, P443, DOI 10.1042/CS20120461; Passos-Silva DG, 2015, TRENDS PHARMACOL SCI, V36, P310, DOI 10.1016/j.tips.2015.03.001; Pernier J, 2016, DEV CELL, V36, P201, DOI 10.1016/j.devcel.2015.12.024; Reck M, 2014, ANN ONCOL, V25, P27, DOI 10.1093/annonc/mdu199; Reid HM, 2011, CELL SIGNAL, V23, P700, DOI 10.1016/j.cellsig.2010.12.003; Santos RAS, 2003, P NATL ACAD SCI USA, V100, P8258, DOI 10.1073/pnas.1432869100; Schanen BC, 2011, GENOMICS, V97, P1, DOI 10.1016/j.ygeno.2010.10.005; Soto-Pantoja DR, 2009, MOL CANCER THER, V8, P1676, DOI 10.1158/1535-7163.MCT-09-0161; Su Z, 2006, KIDNEY INT, V69, P2212, DOI 10.1038/sj.ki.5001509; Szabo G, 2013, NAT REV GASTRO HEPAT, V10, P542, DOI 10.1038/nrgastro.2013.87; Tang J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092082; Valastyan S, 2011, CELL, V147, P275, DOI 10.1016/j.cell.2011.09.024; Verano-Braga T, 2012, J PROTEOME RES, V11, P3370, DOI 10.1021/pr3001755; Wakelee HA, 2007, J CLIN ONCOL, V25, P472, DOI 10.1200/JCO.2006.07.2983; Walcott BP, 2012, LANCET ONCOL, V13, pE69, DOI 10.1016/S1470-2045(11)70337-0; Wilczynska A, 2015, CELL DEATH DIFFER, V22, P22, DOI 10.1038/cdd.2014.112; Yin YK, 2013, ANTICANCER RES, V33, P1499; Zhang Wei, 2013, Transl Respir Med, V1, DOI 10.1186/2213-0802-1-12; Zheng B, 2009, FEBS J, V276, P2669, DOI 10.1111/j.1742-4658.2009.06986.x; Zheng S, 2015, BIOCHEM BIOPH RES CO, V460, P333, DOI 10.1016/j.bbrc.2015.03.035	52	12	12	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162094	10.1371/journal.pone.0162094	http://dx.doi.org/10.1371/journal.pone.0162094			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598578	gold, Green Published			2022-12-26	WOS:000383254800041
J	Nole, P; Duijndam, B; Stenman, A; Juhlin, CC; Kozyra, M; Larsson, C; Ingelman-Sundberg, M; Johansson, I				Nole, Paola; Duijndam, Britt; Stenman, Adam; Juhlin, C. Christofer; Kozyra, Mikael; Larsson, Catharina; Ingelman-Sundberg, Magnus; Johansson, Inger			Human Cytochrome P450 2W1 Is Not Expressed in Adrenal Cortex and Is Only Rarely Expressed in Adrenocortical Carcinomas	PLOS ONE			English	Article							COLORECTAL-CANCER; CYP2W1; ENZYME; TUMORS	Human cytochome P450 2W1 (CYP2W1) enzyme is expressed in fetal colon and in colon tumors. The level of expression is higher in colon metastases than in the parent tumors and the enzyme is a possible drug target for treatment of colorectal cancer, as demonstrated in mouse xenograft studies. A previous study published in this journal reported that CYP2W1 is highly expressed in normal and transformed adrenal tissue. However, adrenal expression of CYP2W1 protein was not seen in previous studies in our research group. To clarify this inconsistency, we have used qRT-PCR and Western blotting with CYP2W1-specific antibodies to probe a panel of 27 adrenocortical carcinomas and 35 normal adrenal cortex samples. CYP2W1 mRNA expression is seen in all samples. However, significant CYP2W1 protein expression was found in only one tumor sample (a testosterone-producing adrenocortical carcinoma) and not in any normal tissue. Differences in the specificity of the CYP2W1 antibodies used in the two studies may explain the apparent discrepancy. We conclude that normal adrenal tissue lacks P450 2W1 enzyme expression; also, adrenocortical carcinomas generally do not express the enzyme. This information thus underline the colon cancer specificity of CYP2W1 enzyme expression and has implications for the development of anti-colon cancer therapies based on CYP2W1 as a drug target, since 2W1-dependent bioactivation of prodrugs for CYP2W1 will not take place in normal adrenal tissue or other non-transformed tissues.	[Nole, Paola; Duijndam, Britt; Kozyra, Mikael; Ingelman-Sundberg, Magnus; Johansson, Inger] Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Stenman, Adam; Juhlin, C. Christofer; Larsson, Catharina] Karolinska Univ Hosp, Karolinska Inst, Dept Oncol Pathol, Stockholm, Sweden; [Stenman, Adam; Juhlin, C. Christofer; Larsson, Catharina] Karolinska Univ Hosp, Canc Ctr Karolinska, Stockholm, Sweden	Karolinska Institutet; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska University Hospital	Johansson, I (corresponding author), Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden.	inger.johansson@ki.se	Ingelman-Sundberg, Magnus/ABD-9302-2021; Stenman, Adam/AAI-3866-2021; Juhlin, Carl Christofer/C-1125-2016	Stenman, Adam/0000-0003-3248-7629; Juhlin, Carl Christofer/0000-0002-5945-9081	Vetenskapsradet (The Swedish Research Council); Cancerfonden (The Swedish Cancer Society)	Vetenskapsradet (The Swedish Research Council)(Swedish Research Council); Cancerfonden (The Swedish Cancer Society)(Swedish Cancer Society)	The funders Vetenskapsradet (The Swedish Research Council) and Cancerfonden (The Swedish Cancer Society) had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasson A, 2013, BIOPRESERV BIOBANK, V11, P366, DOI 10.1089/bio.2013.0038; Choong E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122820; Edler D, 2009, EUR J CANCER, V45, P705, DOI 10.1016/j.ejca.2008.11.031; Gomez A, 2007, PHARMACOGENOMICS, V8, P1315, DOI 10.2217/14622416.8.10.1315; Gomez A, 2010, MOL PHARMACOL, V78, P1004, DOI 10.1124/mol.110.067652; Guo J, 2016, DRUG METAB REV, V48, P369, DOI 10.1080/03602532.2016.1188939; Juhlin CC, 2015, J CLIN ENDOCR METAB, V100, pE493, DOI 10.1210/jc.2014-3282; Karlgren M, 2006, BIOCHEM BIOPH RES CO, V341, P451, DOI 10.1016/j.bbrc.2005.12.200; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Ronchi CL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105855; Sheldrake HM, 2013, J MED CHEM, V56, P6273, DOI 10.1021/jm4000209; Stenstedt K, 2014, ACTA ONCOL, V53, P885, DOI 10.3109/0284186X.2014.887224; Stenstedt K, 2012, ANTICANCER RES, V32, P3869; Travica S, 2013, CLIN CANCER RES, V19, P2952, DOI 10.1158/1078-0432.CCR-13-0238	14	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162379	10.1371/journal.pone.0162379	http://dx.doi.org/10.1371/journal.pone.0162379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598485	gold, Green Published, Green Submitted			2022-12-26	WOS:000383254800060
J	Opalach, C; Romaszko, J; Jaracz, M; Kuchta, R; Borkowska, A; Bucinski, A				Opalach, Cezary; Romaszko, Jerzy; Jaracz, Marcin; Kuchta, Robert; Borkowska, Alina; Bucinski, Adam			Coping Styles and Alcohol Dependence among Homeless People	PLOS ONE			English	Article							OF-THE-LITERATURE; MENTAL-DISORDERS; VOLUME LOSS; HEALTH; MORTALITY; CONSUMPTION; POPULATION; PREVALENCE; COUNTRIES; GERMANY	Background and Objectives The ways in which homeless individuals cope with stress may differ from those relied upon by the members of the general population and these differences may either be the result or the cause of their living conditions. The aim of the study was to determine the preferred coping style among the homeless and its relationship with alcohol dependence. Methods The study included 78 homeless individuals and involved the collection of demographic, sociological, psychological and medical data from each participant. Coping styles relied upon when dealing with stressful situations were assessed using a Polish adaptation of the Coping Inventory for Stressful Situations. Alcohol dependence was assessed using the Michigan Alcoholism Screening Test (MAST) and a quantitative analysis of alcohol consumption. Results Men accounted for 91.93% of the study population. Nearly 75% of the subjects met the alcohol dependence criterion. Significant relationships were observed between the individual's age, preferred coping style and alcohol consumption level. As an individual's age increased, the use of emotion-oriented coping styles decreased, while an increase in alcohol consumption was associated with a more frequent use of emotion-and avoidance-oriented strategies. Conclusions The findings of this study, similarly to those of many other studies of homeless individuals but investigating other areas (e.g. epidemiology of tuberculosis and traumatic injuries), are an exaggerated representation of associations observed in the general population. The results describe a group of people living on the margins of the society, often suffering from extremely advanced alcoholism, with clear evident psychodegradation. The presence of specific ways of coping with stress related to excessive alcohol consumption in this group of individuals may interfere with active participation in support programmes provided for the homeless and may further exacerbate their problems.	[Opalach, Cezary] Univ Warmia & Mazury, Fac Theol, Ul Kard Hozjusza 15, PL-11041 Olsztyn, Poland; [Romaszko, Jerzy] Univ Warmia & Mazury, Dept Family Med, Ul Warszawska 30, PL-10082 Olsztyn, Poland; [Jaracz, Marcin; Borkowska, Alina] Nicolaus Copernicus Univ Torun, Dept Clin Neuropsychol, Ludwik Rydygier Coll Med Bydgoszcz, Ul M Curie Sklodowskiej 9, PL-85094 Bydgoszcz, Poland; [Kuchta, Robert] Municipal Social Welf Ctr Olsztyn, Ul Towarowa 18, PL-10417 Olsztyn, Poland; [Bucinski, Adam] Nicolaus Copernicus Univ Torun, Ludwik Rydygier Coll Med Bydgoszcz, Dept Biopharm, Ul A Jurasza 2, PL-85089 Bydgoszcz, Poland	University of Warmia & Mazury; University of Warmia & Mazury; Nicolaus Copernicus University; Nicolaus Copernicus University	Romaszko, J (corresponding author), Univ Warmia & Mazury, Dept Family Med, Ul Warszawska 30, PL-10082 Olsztyn, Poland.	jerzy.romaszko@uwm.edu.pl	Romaszko, Jerzy/AAJ-8112-2020	Romaszko, Jerzy/0000-0002-7929-6822; Opalach, Cezary/0000-0002-3669-5524; Bucinski, Adam/0000-0002-0558-9139				Agartz I, 1999, ARCH GEN PSYCHIAT, V56, P356, DOI 10.1001/archpsyc.56.4.356; Amore K, 2011, EUROPEAN J HOMELESSN, P5; Anderson P.Anderson, 2008, ALCOHOL EUROPE PUBLI; [Anonymous], 2013, DYNAMICS INVOLUTION; Antonovsky A, 1980, HLTH STRESS COPING, Vxiv; Baggett TP, 2013, JAMA INTERN MED, V173, P189, DOI 10.1001/jamainternmed.2013.1604; Beijer U, 2011, SCAND J PUBLIC HEALT, V39, P121, DOI 10.1177/1403494810393554; Beresford TP, 2006, ALCOHOL CLIN EXP RES, V30, P1866, DOI 10.1111/j.1530-0277.2006.00223.x; Bernardin F, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00078; Braun Eszter, 2015, Psychiatr Hung, V30, P60; Busch-Geertsema V., 2014, EXTENT PROFILE HOMEL; Coohey C, 2016, HEALTH SOC WORK, V41, P111, DOI 10.1093/hsw/hlw008; Dalley JW, 2008, PHARMACOL BIOCHEM BE, V90, P250, DOI 10.1016/j.pbb.2007.12.021; DELABRY LO, 1992, J STUD ALCOHOL, V53, P25, DOI 10.15288/jsa.1992.53.25; Egli M, 2012, NEUROSCI BIOBEHAV R, V36, P2179, DOI 10.1016/j.neubiorev.2012.07.010; Fazel S, 2008, PLOS MED, V5, P1670, DOI 10.1371/journal.pmed.0050225; Fekadu A, 2014, BMC MED, V12, DOI 10.1186/s12916-014-0138-x; Ferguson KM, 2010, COMMUNITY MENT HLT J, V46, P296, DOI 10.1007/s10597-009-9264-x; Fichter MM, 2001, ACTA PSYCHIAT SCAND, V103, P94, DOI 10.1034/j.1600-0447.2001.00217.x; Horvath TB, 1975, CLIN SPECTRUM EPIDEM; Hwang SW, 2001, CAN MED ASSOC J, V164, P229; Israel N, 2010, AM J COMMUN PSYCHOL, V46, P49, DOI 10.1007/s10464-010-9326-9; KARHUNEN PJ, 1994, BRIT MED J, V308, P1663, DOI 10.1136/bmj.308.6945.1663; Kril JJ, 1997, NEUROSCIENCE, V79, P983, DOI 10.1016/S0306-4522(97)00083-3; Lazarus R. S., 1984, STRESS APPRAISAL COP; Lazarus R. S., 1984, STRESS APPRAISAL COP, P19; Lippert AM, 2015, SOCIOL INQ, V85, P343, DOI 10.1111/soin.12080; Ly A, 2015, CAN J PSYCHIAT, V60, P475, DOI 10.1177/070674371506001103; Medlow S, 2014, J ADOLESCENCE, V37, P531, DOI 10.1016/j.adolescence.2014.04.003; Morikawa Suimei, 2011, Nihon Koshu Eisei Zasshi, V58, P331; Moselhy HF, 2001, ALCOHOL ALCOHOLISM, V36, P357, DOI 10.1093/alcalc/36.5.357; Nickasch B, 2009, J AM ACAD NURSE PRAC, V21, P39, DOI 10.1111/j.1745-7599.2008.00371.x; Nielsen SF, 2011, LANCET, V377, P2205, DOI 10.1016/S0140-6736(11)60747-2; Noel X, 2013, CURR OPIN NEUROBIOL, V23, P632, DOI 10.1016/j.conb.2013.01.018; Nusselder WJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073979; Ohtsu T, 2011, ACTA MED OKAYAMA, V65, P387; Parker James D. A, 1990, COPING INVENTORY STR; Penley JA, 2002, J BEHAV MED, V25, P551, DOI 10.1023/A:1020641400589; Pfefferbaum A, 1997, ALCOHOL CLIN EXP RES, V21, P521, DOI 10.1111/j.1530-0277.1997.tb03798.x; Phelan JC, 1999, AM J PUBLIC HEALTH, V89, P1334, DOI 10.2105/AJPH.89.9.1334; Poland CSOo, NAYION CENS 2011 RES; Popova S, 2007, ALCOHOL ALCOHOLISM, V42, P465, DOI 10.1093/alcalc/agl124; Rhoades H, 2011, DRUG ALCOHOL DEPEN, V118, P320, DOI 10.1016/j.drugalcdep.2011.04.011; Ron M A, 1983, Psychol Med Monogr Suppl, V3, P1; Salize HJ, 2002, ADDICTION, V97, P1593, DOI 10.1046/j.1360-0443.2002.00235.x; Schanzer B, 2007, AM J PUBLIC HEALTH, V97, P464, DOI 10.2105/AJPH.2005.076190; SELYE H, 1949, RES PUBL ASSOC RES N, V29, P3; SELZER ML, 1971, AM J PSYCHIAT, V127, P1653, DOI 10.1176/ajp.127.12.1653; Szczepaniak P., 2005, KWESTIONARIUSZ RADZE; Thompson S, 2010, EVAL PROGRAM PLANN, V33, P418, DOI 10.1016/j.evalprogplan.2010.02.002; Thomsen R L, 2000, Ugeskr Laeger, V162, P1205; Toro PA, 2014, AM J COMMUN PSYCHOL, V53, P134, DOI 10.1007/s10464-014-9632-8; Yoon Changgyo, 2011, J Prev Med Public Health, V44, P267, DOI 10.3961/jpmph.2011.44.6.267	53	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162381	10.1371/journal.pone.0162381	http://dx.doi.org/10.1371/journal.pone.0162381			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IT	27598582	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800061
J	Sundaram, K; Rahman, MA; Mitra, S; Knoell, DL; Woodiga, SA; King, SJ; Wewers, MD				Sundaram, Kruthika; Rahman, Mohd. Akhlakur; Mitra, Srabani; Knoell, Daren L.; Woodiga, Shireen A.; King, Samantha J.; Wewers, Mark D.			I kappa B zeta Regulates Human Monocyte Pro-Inflammatory Responses Induced by Streptococcus pneumoniae	PLOS ONE			English	Article							COMMUNITY-ACQUIRED PNEUMONIA; GELATINASE-ASSOCIATED LIPOCALIN; RESPIRATORY EPITHELIAL-CELLS; PNEUMOCOCCAL PNEUMONIA; VIRULENCE FACTORS; NUCLEAR-PROTEIN; LUNG EPITHELIUM; OCULAR SURFACE; DISEASE; MICE	Pneumococcal lung infections represent a major cause of death worldwide. Single nucleotide polymorphisms (SNPs) in the NFKBIZ gene, encoding the transcription factor I kappa B zeta, are associated with increased susceptibility to invasive pneumococcal disease. We hence analyzed how I kappa B zeta might regulate inflammatory responses to pneumococcal infection. We first demonstrate that I kappa B zeta is expressed in human blood monocytes but not in bronchial epithelial cells, in response to wild type pneumococcal strain D39. D39 transiently induced I kappa B zeta in a dose dependent manner, with subsequent induction of downstream molecules involved in host defense. Of these molecules, I kappa B zeta knockdown reduced the expression of IL-6 and GMCSF. Furthermore, I kappa B zeta overexpression increased the activity of IL-6 and GMCSF promoters, supporting the knockdown findings. Pneumococci lacking either pneumolysin or capsule still induced I kappa B zeta. While inhibition of TLR1/TLR2 blocked D39 induced I kappa B zeta expression, TLR4 inhibition did not. Blockade of p38 MAP kinase and NF kappa B suppressed D39 induced I kappa B zeta. Overall, our data demonstrates that I.B. regulates monocyte inflammatory responses to Streptococcus pneumoniae by promoting the production of IL-6 and GMCSF.	[Sundaram, Kruthika; Mitra, Srabani; Wewers, Mark D.] Ohio State Univ, Med Ctr, Pulm Allergy Crit Care & Sleep Med, Dept Internal Med,Davis Heart & Lung Res Inst, Columbus, OH 43210 USA; [Rahman, Mohd. Akhlakur; Knoell, Daren L.] Ohio State Univ, Coll Pharm, Dept Pharm, Columbus, OH 43210 USA; [Rahman, Mohd. Akhlakur; Knoell, Daren L.; Woodiga, Shireen A.; King, Samantha J.; Wewers, Mark D.] Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA; [Woodiga, Shireen A.; King, Samantha J.] Nationwide Childrens Hosp, Ctr Microbial Pathogenesis, Res Inst, Columbus, OH USA; [King, Samantha J.] Ohio State Univ, Dept Pediat, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Nationwide Childrens Hospital; Research Institute at Nationwide Children's Hospital; University System of Ohio; Ohio State University	Wewers, MD (corresponding author), Ohio State Univ, Med Ctr, Pulm Allergy Crit Care & Sleep Med, Dept Internal Med,Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.; Wewers, MD (corresponding author), Ohio State Univ, Ctr Microbial Interface Biol, Columbus, OH 43210 USA.	wewers.2@osu.edu	Sundaram, Kruthika/J-4010-2019; Wewers, Mark/AAB-6202-2021; Wewers, Mark/H-8317-2015	Sundaram, Kruthika/0000-0003-0510-424X; Wewers, Mark/0000-0002-7079-5633	National Institute of Health [HL076278, HL089440]	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	MDW received grants HL076278 and HL089440 from National Institute of Health to support this work.	Adamou JE, 1998, INFECT IMMUN, V66, P820, DOI 10.1128/IAI.66.2.820-822.1998; ANDERSSON B, 1989, Respiration, V55, P49; Antunes G, 2002, EUR RESPIR J, V20, P990, DOI 10.1183/09031936.02.00295102; Barthelson R, 1998, INFECT IMMUN, V66, P1439, DOI 10.1128/IAI.66.4.1439-1444.1998; Bergeron Y, 1998, INFECT IMMUN, V66, P912, DOI 10.1128/IAI.66.3.912-922.1998; Bogaert D, 2004, LANCET INFECT DIS, V4, P144, DOI 10.1016/S1473-3099(04)00938-7; Chapman SJ, 2010, GENES IMMUN, V11, P319, DOI 10.1038/gene.2009.76; Cowland JB, 2006, J IMMUNOL, V176, P5559, DOI 10.4049/jimmunol.176.9.5559; Crum NF, 2004, CLIN INFECT DIS, V39, P1148, DOI 10.1086/424522; Currie AJ, 2004, J PEDIATR-US, V144, P512, DOI 10.1016/j.jpeds.2003.10.034; Dessing MC, 2008, CELL MICROBIOL, V10, P237, DOI 10.1111/j.1462-5822.2007.01035.x; Eto A, 2003, BIOCHEM BIOPH RES CO, V301, P495, DOI 10.1016/S0006-291X(02)03082-6; Fillion I, 2001, J IMMUNOL, V166, P7353, DOI 10.4049/jimmunol.166.12.7353; Gavrilin MA, 2006, P NATL ACAD SCI USA, V103, P141, DOI 10.1073/pnas.0504271103; Goto Y, 2004, AM J RESP CELL MOL, V30, P620, DOI 10.1165/rcmb.2003-0312OC; Haruta H, 2001, J BIOL CHEM, V276, P12485, DOI 10.1074/jbc.C100075200; Henriques-Normark B, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a010215; Jedrzejas MJ, 2001, MICROBIOL MOL BIOL R, V65, P187, DOI 10.1128/MMBR.65.2.187-207.2001; Jose R, 2015, LANCET, V385, P52, DOI 10.1016/S0140-6736(15)60367-1; Kadioglu A, 2008, NAT REV MICROBIOL, V6, P288, DOI 10.1038/nrmicro1871; Kannan Y, 2011, BLOOD, V117, P2855, DOI 10.1182/blood-2010-07-294702; Kao CY, 2008, J BIOL CHEM, V283, P15309, DOI [10.1074/jbc.M708289200, 10.1074/jbc.M804331200]; Karin M., REGULATION AP 1 ACTI; Karlsen JR, 2010, J BIOL CHEM, V285, P14088, DOI 10.1074/jbc.M109.017129; Kitamura H, 2000, FEBS LETT, V485, P53, DOI 10.1016/S0014-5793(00)02185-2; Koppe U, 2012, CELL MICROBIOL, V14, P460, DOI 10.1111/j.1462-5822.2011.01746.x; Lauw FN, 2002, J IMMUNOL, V168, P372, DOI 10.4049/jimmunol.168.1.372; Lorenz J, 2011, EUR RESPIR J, V37, P648, DOI 10.1183/09031936.00200009; Malley R, 2003, P NATL ACAD SCI USA, V100, P1966, DOI 10.1073/pnas.0435928100; Mayer AK, DIFFERENTIAL RECOGNI; Motoyama M, 2005, J BIOL CHEM, V280, P7444, DOI 10.1074/jbc.M412738200; Mushtaq N, 2011, J ALLERGY CLIN IMMUN, V127, P1236, DOI 10.1016/j.jaci.2010.11.039; Muta T, 2006, VITAM HORM, V74, P301, DOI 10.1016/S0083-6729(06)74012-2; Naghavi M, 2015, LANCET, V385, P117, DOI 10.1016/S0140-6736(14)61682-2; O'Brien KL, 2009, LANCET, V374, P893, DOI 10.1016/S0140-6736(09)61204-6; Okamoto K, 2010, NATURE, V464, P1381, DOI 10.1038/nature08922; Paterson GK, 2006, MICROBIOL-SGM, V152, P285, DOI 10.1099/mic.0.28551-0; Pittet LA, 2011, AM J RESP CELL MOL, V45, P573, DOI 10.1165/rcmb.2010-0210OC; Quinton LJ, 2007, J IMMUNOL, V178, P1896, DOI 10.4049/jimmunol.178.3.1896; Raices RM, 2008, CYTOKINE, V44, P234, DOI 10.1016/j.cyto.2008.08.004; Ruiz-Gonzalez A, 1999, AM J MED, V106, P385, DOI 10.1016/S0002-9343(99)00050-9; Schmeck B, STREPTOCOCCUS PNEUMO; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Seshadri S, 2009, J IMMUNOL, V183, P5358, DOI 10.4049/jimmunol.0802736; Shiina T, 2004, J BIOL CHEM, V279, P55493, DOI 10.1074/jbc.M409770200; Steinwede K, 2011, J IMMUNOL, V187, P5346, DOI 10.4049/jimmunol.1101413; Sundaram K, 2015, AM J RESP CELL MOL, V53, P400, DOI 10.1165/rcmb.2014-0370OC; Talbot UM, 1996, INFECT IMMUN, V64, P3772, DOI 10.1128/IAI.64.9.3772-3777.1996; Ueta M, 2005, INVEST OPHTH VIS SCI, V46, P579, DOI 10.1167/iovs.04-1055; Ueta M, 2008, INVEST OPHTH VIS SCI, V49, P3387, DOI 10.1167/iovs.08-1691; vanderPoll T, 1997, J INFECT DIS, V176, P439, DOI 10.1086/514062; Xu F, MODULATION INFLAMMAT; Yamamoto K, 2014, AM J RESP CELL MOL, V50, P253, DOI 10.1165/rcmb.2013-0114OC; Yamazaki S, 2001, J BIOL CHEM, V276, P27657, DOI 10.1074/jbc.M103426200	54	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161931	10.1371/journal.pone.0161931	http://dx.doi.org/10.1371/journal.pone.0161931			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27597997	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800025
J	Gradidge, PJL; Norris, SA; Jaff, NG; Crowther, NJ				Gradidge, Philippe Jean-Luc; Norris, Shane A.; Jaff, Nicole G.; Crowther, Nigel J.			Metabolic and Body Composition Risk Factors Associated with Metabolic Syndrome in a Cohort of Women with a High Prevalence of Cardiometabolic Disease	PLOS ONE			English	Article							CARDIOVASCULAR RISK; AFRICAN WOMEN; ENDOCRINE TRANSITION; INSULIN SENSITIVITY; ABDOMINAL ADIPOSITY; SERUM ADIPONECTIN; FAT MASS; POPULATION; ULTRASOUND; VALIDATION	Background The aetiology of the metabolic syndrome and the inter-relationship between risk factors for this syndrome are poorly understood. The purpose of this investigation was to determine the risk factors for metabolic syndrome and their interactions in a cohort of women with a high prevalence of metabolic syndrome. Materials and Methods Abdominal and whole body composition (ultrasound and dual-energy X-ray absorptiometry), blood pressure, and cardiometabolic and demographic factors were measured in a cross-sectional study of 702 black African women from Soweto, Johannesburg. Data was analysed using multivariate logistic regression. Results Metabolic syndrome was present in 49.6% of the study cohort. Logistic regression analysis demonstrated that adiponectin (odds ratio [95% CIs]: 0.84 [0.77, 0.92], p<0.0005) and abdominal subcutaneous fat (0.56 [0.39, 0.79], p = 0.001) reduced metabolic syndrome risk whilst insulin resistance (1.31 [1.16, 1.48], p<0.0005) and trunk fat-free soft-tissue mass (1.34 [1.10, 1.61], p = 0.002) increased risk. Within this group of risk factors, the relationship of adiponectin with metabolic syndrome risk, when analysed across adiponectin hexiles, was the least affected by adjustment for the other risk factors. Conclusions Adiponectin has a significant protective role against metabolic syndrome and is independent of other risk factors. The protective and possible augmentive effects of abdominal subcutaneous fat and lean trunk mass, respectively on metabolic syndrome risk demonstrate the existence of novel interactions between body composition and cardiometabolic disease.	[Gradidge, Philippe Jean-Luc] Univ Witwatersrand, Fac Hlth Sci, CESSM, Johannesburg, South Africa; [Gradidge, Philippe Jean-Luc; Norris, Shane A.; Jaff, Nicole G.] Univ Witwatersrand, Fac Hlth Sci, MRC, Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa; [Jaff, Nicole G.; Crowther, Nigel J.] Univ Witwatersrand, Fac Hlth Sci, Natl Hlth Lab Serv, Dept Chem Pathol, Johannesburg, South Africa	University of Witwatersrand; University of Witwatersrand; National Health Laboratory Service; University of Witwatersrand	Gradidge, PJL (corresponding author), Univ Witwatersrand, Fac Hlth Sci, CESSM, Johannesburg, South Africa.; Gradidge, PJL (corresponding author), Univ Witwatersrand, Fac Hlth Sci, MRC, Wits Dev Pathways Hlth Res Unit, Johannesburg, South Africa.	philippe.gradidge@wits.ac.za	Norris, Shane/C-4664-2014; Gradidge, Philippe/ABE-4070-2020; Gradidge, Philippe/R-5183-2017	Norris, Shane/0000-0001-7124-3788; Gradidge, Philippe/0000-0001-5225-1184; Gradidge, Philippe/0000-0001-5225-1184; Crowther, Nigel/0000-0002-5766-1745	Wellcome Trust (UK) [092097/Z/10/Z]	Wellcome Trust (UK)(Wellcome Trust)	This study was financially supported by the Wellcome Trust (UK) (grant number 092097/Z/10/Z).	Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Borel AL, 2015, INT J OBESITY, V39, P495, DOI 10.1038/ijo.2014.163; Cohen DE, 2013, SEMIN LIVER DIS, V33, P380, DOI 10.1055/s-0033-1358519; Crowther NJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048883; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Ferris WF, 2005, HORM METAB RES, V37, P695, DOI 10.1055/s-2005-870580; Frayn KN, 2002, DIABETOLOGIA, V45, P1201, DOI 10.1007/s00125-002-0873-y; Garg M K, 2012, Indian J Endocrinol Metab, V16, P116, DOI 10.4103/2230-8210.91206; Goedecke JH, 2015, DIABETOLOGIA, V58, P2647, DOI 10.1007/s00125-015-3720-7; Golan R, 2012, DIABETES CARE, V35, P640, DOI 10.2337/dc11-1583; Gradidge PJL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132914; Gradidge PJL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-934; Grundy SM, 2008, ARTERIOSCL THROM VAS, V28, P629, DOI 10.1161/ATVBAHA.107.151092; Guven A, 2012, INT J MED SCI, V9, P786, DOI 10.7150/ijms.4563; Jaff NG, 2015, METABOLISM, V64, P1031, DOI 10.1016/j.metabol.2015.05.009; Jaff NG, 2014, MENOPAUSE, V21, P1225, DOI [10.1097/GME.0000000000000235, 10.1097/gme.0000000000000235]; Koh SB, 2011, YONSEI MED J, V52, P234, DOI 10.3349/ymj.2011.52.2.234; Kraja AT, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-28; Yubero-Serrano EM, 2013, EXP MOL MED, V45, DOI 10.1038/emm.2013.53; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Meigs JB, 2003, DIABETES, V52, P2160, DOI 10.2337/diabetes.52.8.2160; Meilleur KG, 2010, J CLIN ENDOCR METAB, V95, P3517, DOI 10.1210/jc.2009-2765; Overland S, 2013, ADDICTION, V108, P2019, DOI 10.1111/add.12313; Pietrobelli A, 1999, AM J CLIN NUTR, V69, P614; Richter LM, 2004, PAEDIATR PERINAT EP, V18, P290, DOI 10.1111/j.1365-3016.2004.00572.x; Rolfe ED, 2010, OBESITY, V18, P625, DOI 10.1038/oby.2009.309; Rolfe EDL, 2011, OBESITY, V19, P1892, DOI 10.1038/oby.2011.213; Schlecht I, 2014, METABOLISM, V63, P1512, DOI 10.1016/j.metabol.2014.07.012; Senekal M, 2003, ETHNIC DIS, V13, P109; Shen W, 2006, OBESITY, V14, P727, DOI 10.1038/oby.2006.83; Tremblay AJ, 2004, CLIN BIOCHEM, V37, P785, DOI 10.1016/j.clinbiochem.2004.03.008; Twisk JWR, 1996, J EPIDEMIOL COMMUN H, V50, P505, DOI 10.1136/jech.50.5.505; Van Pelt RE, 2002, AM J PHYSIOL-ENDOC M, V282, pE1023, DOI 10.1152/ajpendo.00467.2001; Wang J, 2009, ANN HUM BIOL, V36, P110, DOI 10.1080/03014460802585079; Williams MJ, 1997, AM J CLIN NUTR, V65, P855, DOI 10.1093/ajcn/65.3.855; Zhang LJ, 2013, INT J CARDIOL, V167, P250, DOI 10.1016/j.ijcard.2011.12.079	36	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162247	10.1371/journal.pone.0162247	http://dx.doi.org/10.1371/journal.pone.0162247			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589387	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800041
J	Li, XY; Duan, XB; Yang, K; Zhang, W; Zhang, CJ; Fu, LF; Ren, Z; Wang, CX; Wu, JH; Lu, RX; Ye, YR; He, MY; Nie, C; Yang, NB; Wang, J; Yang, HM; Liu, X; Tan, W				Li, Xinyang; Duan, Xiaobo; Yang, Kai; Zhang, Wei; Zhang, Changjiang; Fu, Longfei; Ren, Zhe; Wang, Changxi; Wu, Jinghua; Lu, Ruxue; Ye, Yanrui; He, Mengying; Nie, Chao; Yang, Naibo; Wang, Jian; Yang, Huanming; Liu, Xiao; Tan, Wen			Comparative Analysis of Immune Repertoires between Bactrian Camel's Conventional and Heavy-Chain Antibodies	PLOS ONE			English	Article							MINIMAL RESIDUAL DISEASE; ANTIGEN-BINDING; LYMPHOBLASTIC-LEUKEMIA; ROBUST PIPELINE; FV FRAGMENT; DOMAIN; IMMUNOGLOBULINS; NANOBODIES; STABILITY; GERMLINE	Compared to classical antibodies, camel heavy chain antibodies (HCAbs) are smaller in size due to lack of the light chain and the first constant domain of the heavy chain (CH1 region). The variable regions of HCAbs (VHHs) are more soluble and stable than that of conventional antibodies (VHs). Even with such simple structure, they are still functional in antigen binding. Although HCAbs have been extensively investigated over the past two decades, most efforts have been based upon low throughput sequence analysis, and there are only limited reports trying to analyze and describe the complete immune repertoire (IR) of camel HCAbs. Here we leveraged the high-throughput data generated by Next Generation Sequencing (NGS) of the variable domains of the antibody heavy chains from three Bactrian camels to conduct in-depth comparative analyses of the immunoglobulin repertoire. These include analyses of the complementary determining region 3 (CDR3) length and distribution, mutation rate, antibody characteristic amino acids, the distribution of the cysteine (Cys) codons, and the non-classical VHHs. We found that there is higher diversity in the CDR2 than in the other sub-regions, and there is a higher mutation rate in the VHHs than in the VHs (P < 0.05). In addition to substitutions at amino acid (AA) residue positions NO. 49/50/52 between VH and VHH clones, we also observed other substitutions at the positions NO. 40/54/57/96/101 that could lead to additional structural alterations. We also found that VH-derived VHH clones, referred to as non-classical VHH clones in this study, accounted for about 8% of all clones. Further, only 5%-10% clones had the Trp > Arg AA substitution at the first position of framework 4 for all types of clones. We present, for the first time, a relatively complete picture of the Bactrian camel antibody immune repertoire, including conventional antibody (Ab) and HCAbs, using PCR and in silico analysis based on high-throughput NGS data.	[Duan, Xiaobo; Zhang, Changjiang; Ye, Yanrui; He, Mengying; Tan, Wen] South China Univ Technol, Sch Biosci & Bioengn, Guangdong Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510006, Guangdong, Peoples R China; [Li, Xinyang; Yang, Kai; Zhang, Wei; Fu, Longfei; Ren, Zhe; Wang, Changxi; Wu, Jinghua; Nie, Chao; Yang, Naibo; Wang, Jian; Yang, Huanming; Liu, Xiao] BGI Shenzhen, Shenzhen 518083, Peoples R China; [Liu, Xiao] Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark; [Duan, Xiaobo; Zhang, Changjiang; Ye, Yanrui; Tan, Wen] South China Univ Technol, Sch Biosci & Bioengn, Key Lab Ind Biotechnol, Guangdong Higher Educ Inst, Guangzhou 510006, Guangdong, Peoples R China; [Duan, Xiaobo; Zhang, Changjiang; Ye, Yanrui; Tan, Wen] South China Univ Technol, Sch Biosci & Bioengn, Preincubator Innovat Drugs & Med, Guangzhou 510006, Guangdong, Peoples R China; [Lu, Ruxue] Zhangye City Bur Anim Husb & Vet, Zhangye 734000, Gansu, Peoples R China; [Wang, Jian; Yang, Huanming] James D Watson Inst Genome Sci, Hangzhou 310058, Zhejiang, Peoples R China; [Tan, Wen] Guangdong Univ Technol, Inst Biomed & Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China	South China University of Technology; Beijing Genomics Institute (BGI); University of Copenhagen; South China University of Technology; South China University of Technology; Guangdong University of Technology	Tan, W (corresponding author), South China Univ Technol, Sch Biosci & Bioengn, Guangdong Prov Key Lab Fermentat & Enzyme Engn, Guangzhou 510006, Guangdong, Peoples R China.; Liu, X (corresponding author), BGI Shenzhen, Shenzhen 518083, Peoples R China.; Liu, X (corresponding author), Univ Copenhagen, Dept Biol, DK-2200 Copenhagen, Denmark.; Tan, W (corresponding author), South China Univ Technol, Sch Biosci & Bioengn, Key Lab Ind Biotechnol, Guangdong Higher Educ Inst, Guangzhou 510006, Guangdong, Peoples R China.; Tan, W (corresponding author), South China Univ Technol, Sch Biosci & Bioengn, Preincubator Innovat Drugs & Med, Guangzhou 510006, Guangdong, Peoples R China.; Tan, W (corresponding author), Guangdong Univ Technol, Inst Biomed & Pharmaceut Sci, Guangzhou 510006, Guangdong, Peoples R China.	liuxiao@genomics.cn; went@gdut.edu.cn	Liu, Xiao/P-2732-2015	Liu, Xiao/0000-0002-8073-0534; Zhang, Wei/0000-0002-6968-6974; Ren, Zhe/0000-0002-9042-2383	BGI-Shenzhen-South China University of Technology, Renovation foundation [SW20130804]; Guangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering	BGI-Shenzhen-South China University of Technology, Renovation foundation; Guangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering	This work was supported by BGI-Shenzhen-South China University of Technology, Renovation foundation (SW20130804). The website of BGI-Shenzhen is http://www.genomics.cn/en/index. The website of South China University of Technology is http://www.scut.edu.cn/. Tan W and Liu X received the funding. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Dr. Brock Peters and Mr. Yi Liu for revising the manuscript. This work was supported by BGI-Shenzhen-South China University of Technology, Renovation foundation (SW20130804). We also acknowledge the supports of Guangdong Provincial Key Laboratory of Fermentation and Enzyme Engineering.	Arbabi-Ghahroudi M, 2005, CANCER METAST REV, V24, P501, DOI 10.1007/s10555-005-6193-1; BIRD RE, 1988, SCIENCE, V242, P423, DOI 10.1126/science.3140379; Conrath K, 2005, J MOL BIOL, V350, P112, DOI 10.1016/j.jmb.2005.04.050; Conrath KE, 2001, ANTIMICROB AGENTS CH, V45, P2807, DOI 10.1128/AAC.45.10.2807-2812.2001; DAVIES J, 1994, FEBS LETT, V339, P285, DOI 10.1016/0014-5793(94)80432-X; DeKosky BJ, 2013, NAT BIOTECHNOL, V31, P166, DOI 10.1038/nbt.2492; Deschacht N, 2010, J IMMUNOL, V184, P5696, DOI 10.4049/jimmunol.0903722; Dumoulin M, 2002, PROTEIN SCI, V11, P500, DOI 10.1110/ps.34602; Faham M, 2012, BLOOD, V120, P5173, DOI 10.1182/blood-2012-07-444042; Fridy PC, 2014, NAT METHODS, V11, P1253, DOI [10.1038/NMETH.3170, 10.1038/nmeth.3170]; Ghahroudi MA, 1997, FEBS LETT, V414, P521, DOI 10.1016/S0014-5793(97)01062-4; Griffin LM, 2014, J IMMUNOL METHODS, V405, P35, DOI 10.1016/j.jim.2014.01.003; Harmsen MM, 2007, APPL MICROBIOL BIOT, V77, P13, DOI 10.1007/s00253-007-1142-2; Klarenbeek A, 2015, MABS-AUSTIN, V7, P693, DOI 10.1080/19420862.2015.1046648; LESK AM, 1988, NATURE, V335, P188, DOI 10.1038/335188a0; Li ZF, 2015, SCI REP-UK, V5, DOI 10.1038/srep10092; Liu BH, 2012, BIOINFORMATICS, V28, P2870, DOI 10.1093/bioinformatics/bts563; MUYLDERMANS S, 1994, PROTEIN ENG, V7, P1129, DOI 10.1093/protein/7.9.1129; Muyldermans S, 2009, VET IMMUNOL IMMUNOP, V128, P178, DOI 10.1016/j.vetimm.2008.10.299; Muyldermans S, 2013, ANNU REV BIOCHEM, V82, P775, DOI 10.1146/annurev-biochem-063011-092449; Nguyen VK, 1998, J MOL BIOL, V275, P413, DOI 10.1006/jmbi.1997.1477; Nguyen VK, 2000, EMBO J, V19, P921, DOI 10.1093/emboj/19.5.921; Pardon E, 2014, NAT PROTOC, V9, P674, DOI 10.1038/nprot.2014.039; Reddy ST, 2010, NAT BIOTECHNOL, V28, P965, DOI 10.1038/nbt.1673; Romer T, 2011, CURR OPIN BIOTECH, V22, P882, DOI 10.1016/j.copbio.2011.06.007; Rothbauer U, 2006, NAT METHODS, V3, P887, DOI 10.1038/NMETH953; Shugay M, 2014, NAT METHODS, V11, P653, DOI [10.1038/NMETH.2960, 10.1038/nmeth.2960]; SKERRA A, 1988, SCIENCE, V240, P1038, DOI 10.1126/science.3285470; Weinstein JA, 2009, SCIENCE, V324, P807, DOI 10.1126/science.1170020; Willuda J, 1999, CANCER RES, V59, P5758; Wu D, 2014, CLIN CANCER RES, V20, P4540, DOI 10.1158/1078-0432.CCR-13-3231; Zhang W, 2015, GENETICS, V201, P459, DOI 10.1534/genetics.115.176735	32	18	18	4	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161801	10.1371/journal.pone.0161801	http://dx.doi.org/10.1371/journal.pone.0161801			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588755	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800018
J	Scherer, SD; Bauer, J; Schmaus, A; Neumaier, C; Herskind, C; Veldwijk, MR; Wenz, F; Sleeman, JP				Scherer, Sandra D.; Bauer, Jochen; Schmaus, Anja; Neumaier, Christian; Herskind, Carsten; Veldwijk, Marlon R.; Wenz, Frederik; Sleeman, Jonathan P.			TGF-beta 1 Is Present at High Levels in Wound Fluid from Breast Cancer Patients Immediately Post-Surgery, and Is Not Increased by Intraoperative Radiation Therapy (IORT)	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; KILOVOLTAGE X-RAYS; TGF-BETA; RADIOTHERAPY IORT; CONSERVING SURGERY; LYMPHATIC REGENERATION; LY2157299 MONOHYDRATE; SIGNALING PATHWAY; HYALURONIC-ACID; INHIBITOR	In patients with low-risk breast cancer, intraoperative radiotherapy (IORT) during breast-conserving surgery is a novel and convenient treatment option for delivering a single high dose of irradiation directly to the tumour bed. However, edema and fibrosis can develop after surgery and radiotherapy, which can subsequently impair quality of life. TGF-beta is a strong inducer of the extracellular matrix component hyaluronan (HA). TGF-beta expression and HA metabolism can be modulated by irradiation experimentally, and are involved in edema and fibrosis. We therefore hypothesized that IORT may regulate these factors. Wound fluid (WF) draining from breast lumpectomy sites was collected and levels of TGF-beta 1 and HA were determined by ELISA. Proliferation and marker expression was analyzed in primary lymphatic endothelial cells (LECs) treated with recombinant TGF-beta or WF. Our results show that IORT does not change TGF-beta 1 or HA levels in wound fluid draining from breast lumpectomy sites, and does not lead to accumulation of sHA oligosaccharides. Nevertheless, concentrations of TGF-beta 1 were high in WF from patients regardless of IORT, at concentrations well above those associated with fibrosis and the suppression of LEC identity. Consistently, we found that TGF-beta in WF is active and inhibits LEC proliferation. Furthermore, all three TGF-beta isoforms inhibited LEC proliferation and suppressed LEC marker expression at pathophysiologically relevant concentrations. Given that TGF-beta contributes to edema and plays a role in the regulation of LEC identity, we suggest that inhibition of TGF-beta directly after surgery might prevent the development of side effects such as edema and fibrosis.	[Scherer, Sandra D.; Bauer, Jochen; Schmaus, Anja; Sleeman, Jonathan P.] Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim, Mannheim, Germany; [Scherer, Sandra D.; Bauer, Jochen; Schmaus, Anja; Sleeman, Jonathan P.] Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany; [Neumaier, Christian; Herskind, Carsten; Veldwijk, Marlon R.] Heidelberg Univ, Univ Med Mannheim, Dept Radiat Oncol, Med Fac Mannheim, Mannheim, Germany; [Bauer, Jochen] Univ Wurzburg, Inst Anat & Cell Biol, Wurzburg, Germany	Ruprecht Karls University Heidelberg; Helmholtz Association; Karlsruhe Institute of Technology; Ruprecht Karls University Heidelberg; University of Wurzburg	Sleeman, JP (corresponding author), Heidelberg Univ, Med Fac Mannheim, Ctr Biomed & Med Technol Mannheim, Mannheim, Germany.; Sleeman, JP (corresponding author), Karlsruhe Inst Technol, Inst Toxicol & Genet, Eggenstein Leopoldshafen, Germany.	sleeman@medma.uni-heidelberg.de	Sleeman, Jonathan P/H-2515-2013; Herskind, Carsten/J-2457-2019	Sleeman, Jonathan P/0000-0003-1718-7687; Herskind, Carsten/0000-0001-6554-5907	Carl Zeiss Meditec AG; Klinikum Mannheim GmbH (Franz-Volhard-Stiftungsprofessur fur Mikrovaskulare Biologie und Pathobiologie); Deutsche Forschungsgemeinschaft Schwerpunkt Programm "tumor vessel interface" [SPP1190]	Carl Zeiss Meditec AG; Klinikum Mannheim GmbH (Franz-Volhard-Stiftungsprofessur fur Mikrovaskulare Biologie und Pathobiologie); Deutsche Forschungsgemeinschaft Schwerpunkt Programm "tumor vessel interface"	This work was supported by: Carl Zeiss Meditec AG: CH FW; Klinikum Mannheim GmbH (Franz-Volhard-Stiftungsprofessur fur Mikrovaskulare Biologie und Pathobiologie): JPS; and Deutsche Forschungsgemeinschaft Schwerpunkt Programm SPP1190 "tumor vessel interface": JPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren UM, 1997, FREE RADICAL BIO MED, V23, P996, DOI 10.1016/S0891-5849(97)00098-1; Aiba-Kojima E, 2007, WOUND REPAIR REGEN, V15, P511, DOI 10.1111/j.1524-475X.2007.00259.x; Akhurst RJ, 2012, NAT REV DRUG DISCOV, V11, P790, DOI 10.1038/nrd3810; Al'Qteishat A, 2006, BRAIN, V129, P2158, DOI 10.1093/brain/awl139; Albeiroti S, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/790203; Alvarado MD, 2014, BREAST CANCER RES TR, V143, P135, DOI 10.1007/s10549-013-2782-9; Andarawewa KL, 2007, CANCER RES, V67, P8662, DOI 10.1158/0008-5472.CAN-07-1294; Anscher MS, 2008, INT J RADIAT ONCOL, V71, P829, DOI 10.1016/j.ijrobp.2008.02.046; Anscher MS, 2010, ONCOLOGIST, V15, P350, DOI 10.1634/theoncologist.2009-S101; Anscher MS, 2006, INT J RADIAT ONCOL, V65, P876, DOI 10.1016/j.ijrobp.2006.02.051; ANSCHER MS, 1990, RADIAT RES, V122, P77, DOI 10.2307/3577586; Avraham T, 2010, AM J PATHOL, V177, P3202, DOI 10.2353/ajpath.2010.100594; Avraham T, 2010, AM J PHYSIOL-CELL PH, V299, pC589, DOI 10.1152/ajpcell.00535.2009; Bogdahn U, 2011, NEURO-ONCOLOGY, V13, P132, DOI 10.1093/neuonc/noq142; Brown LC, 2015, INT J WOMENS HEALTH, V7, P449, DOI 10.2147/IJWH.S55552; Chajara A, 2000, ARTERIOSCL THROM VAS, V20, P1480, DOI 10.1161/01.ATV.20.6.1480; Chod J, 2008, EUR J GYNAECOL ONCOL, V29, P613; Clavin NW, 2008, AM J PHYSIOL-HEART C, V295, pH2113, DOI 10.1152/ajpheart.00879.2008; Curigliano G, 2005, BREAST CANCER RES TR, V93, P35, DOI 10.1007/s10549-005-3381-1; Daar E, 2010, APPL RADIAT ISOTOPES, V68, P746, DOI 10.1016/j.apradiso.2009.10.022; Delaney G, 2005, CANCER-AM CANCER SOC, V104, P1129, DOI 10.1002/cncr.21324; Della Sala SW, 2006, EUR J RADIOL, V59, P222, DOI 10.1016/j.ejrad.2006.03.003; Fieber C, 2004, J CELL SCI, V117, P359, DOI 10.1242/jcs.00831; Franko AJ, 1997, RADIAT RES, V147, P245, DOI 10.2307/3579426; Gao F, 2010, MATRIX BIOL, V29, P107, DOI 10.1016/j.matbio.2009.11.002; Herbertz S, 2015, DRUG DES DEV THER, V9, P4479, DOI 10.2147/DDDT.S86621; Jiang DH, 2011, PHYSIOL REV, V91, P221, DOI 10.1152/physrev.00052.2009; Jung H, 2011, CYTOTECHNOLOGY, V63, P57, DOI 10.1007/s10616-010-9327-4; Keshtgar MRS, 2013, BREAST CANCER RES TR, V140, P519, DOI 10.1007/s10549-013-2641-8; KONG FM, 1995, ANN SURG, V222, P155, DOI 10.1097/00000658-199508000-00007; Kraus-Tiefenbacher U, 2006, ONKOLOGIE, V29, P77, DOI 10.1159/000091160; Kraus-Tiefenbacher U, 2003, ONKOLOGIE, V26, P596, DOI 10.1159/000074158; Kraus-Tiefenbacher U, 2010, INT J RADIAT ONCOL, V77, P1140, DOI 10.1016/j.ijrobp.2009.06.008; Krishnan L, 2001, CANCER, V91, P2282, DOI 10.1002/1097-0142(20010615)91:12<2282::AID-CNCR1259>3.0.CO;2-0; KUMAR S, 1989, INT J CANCER, V44, P445, DOI 10.1002/ijc.2910440311; Laverty HG, 2009, CYTOKINE GROWTH F R, V20, P305, DOI 10.1016/j.cytogfr.2009.07.002; Leask A, 2004, FASEB J, V18, P816, DOI 10.1096/fj.03-1273rev; Li YJ, 2000, AM J RESP CELL MOL, V23, P411, DOI 10.1165/ajrcmb.23.3.4102; Liao S, 2011, CLIN CANCER RES, V17, P1415, DOI 10.1158/1078-0432.CCR-10-2429; Mead AL, 2003, INVEST OPHTH VIS SCI, V44, P3394, DOI 10.1167/iovs.02-0978; Monzon ME, 2010, J BIOL CHEM, V285, P26126, DOI 10.1074/jbc.M110.135194; Moran MS, 2009, SEMIN RADIAT ONCOL, V19, P244, DOI 10.1016/j.semradonc.2009.05.007; Moritake T, 2012, INT J RADIAT ONCOL, V84, pE95, DOI 10.1016/j.ijrobp.2012.02.013; Morris JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090353; MORTIMER PS, 1991, BRIT J RADIOL, V64, P1140, DOI 10.1259/0007-1285-64-768-1140; Oka M, 2008, BLOOD, V111, P4571, DOI 10.1182/blood-2007-10-120337; ONO I, 1995, J DERMATOL SCI, V10, P241, DOI 10.1016/0923-1811(95)00454-Z; ONO I, 1995, BURNS, V21, P352, DOI 10.1016/0305-4179(95)00005-4; Pohlers D, 2009, BBA-MOL BASIS DIS, V1792, P746, DOI 10.1016/j.bbadis.2009.06.004; Rice LM, 2015, J CLIN INVEST, V125, P2795, DOI 10.1172/JCI77958; Rodon J, 2015, CLIN CANCER RES, V21, P553, DOI 10.1158/1078-0432.CCR-14-1380; Ruano-Ravina A, 2011, CANCER LETT, V313, P15, DOI 10.1016/j.canlet.2011.08.020; Sanford LP, 1997, DEVELOPMENT, V124, P2659; Santiago B, 2005, J INVEST DERMATOL, V125, P450, DOI 10.1111/j.0022-202X.2005.23859.x; Schmaus A, 2014, BRIT J CANCER, V111, P559, DOI 10.1038/bjc.2014.332; Schmaus A, 2014, CANCER METAST REV, V33, P1059, DOI 10.1007/s10555-014-9532-2; Sperk E, 2012, BREAST CANCER RES TR, V135, P253, DOI 10.1007/s10549-012-2168-4; Sugiyama Y, 1998, J INVEST DERMATOL, V110, P116, DOI 10.1046/j.1523-1747.1998.00093.x; Suzuki Y, 2012, KIDNEY INT, V81, P865, DOI 10.1038/ki.2011.464; Termeer C, 2002, J EXP MED, V195, P99, DOI 10.1084/jem.20001858; Toole BP, 2004, NAT REV CANCER, V4, P528, DOI 10.1038/nrc1391; Vaidya JS, 2014, LANCET, V383, P603, DOI 10.1016/S0140-6736(13)61950-9; Vaidya JS, 2010, LANCET, V376, P91, DOI 10.1016/S0140-6736(10)60837-9; Veldwijk MR, 2015, TRANSL CANCER RES, V4, P173, DOI 10.3978/j.issn.2218.676X.2015.04.01; Voelcker V, 2008, EXP DERMATOL, V17, P100, DOI 10.1111/j.1600-0625.2007.00638.x; Warren LEG, 2014, INT J RADIAT ONCOL, V88, P565, DOI 10.1016/j.ijrobp.2013.11.232; Wenz F, 2015, BREAST CARE, V10, P247, DOI 10.1159/000437194; Wenz F, 2010, INT J RADIAT ONCOL, V77, P1309, DOI 10.1016/j.ijrobp.2009.06.085; Wenz F, 2008, BREAST, V17, P617, DOI 10.1016/j.breast.2008.05.009; WEST DC, 1985, SCIENCE, V228, P1324, DOI 10.1126/science.2408340; Wu M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092857; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yu L, 2003, KIDNEY INT, V64, P844, DOI 10.1046/j.1523-1755.2003.00162.x	73	10	10	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162221	10.1371/journal.pone.0162221	http://dx.doi.org/10.1371/journal.pone.0162221			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589056	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877800038
J	Stirzaker, C; Song, JZ; Ng, W; Du, Q; Armstrong, NJ; Locke, WJ; Statham, AL; French, H; Pidsley, R; Valdes-Mora, F; Zotenko, E; Clark, SJ				Stirzaker, C.; Song, J. Z.; Ng, W.; Du, Q.; Armstrong, N. J.; Locke, W. J.; Statham, A. L.; French, H.; Pidsley, R.; Valdes-Mora, F.; Zotenko, E.; Clark, S. J.			Methyl-CpG-binding protein MBD2 plays a key role in maintenance and spread of DNA methylation at CpG islands and shores in cancer	ONCOGENE			English	Article							TUMOR-SUPPRESSOR GENES; DOMAIN PROTEIN-2; X-CHROMOSOME; CHROMATIN; PROMOTER; HYPERMETHYLATION; REPRESSION; COMPLEX; ASSOCIATION; EXPRESSION	Cancer is characterised by DNA hypermethylation and gene silencing of CpG island-associated promoters, including tumoursuppressor genes. The methyl-CpG-binding domain (MBD) family of proteins bind to methylated DNA and can aid in the mediation of gene silencing through interaction with histone deacetylases and histone methyltransferases. However, the mechanisms responsible for eliciting CpG island hypermethylation in cancer, and the potential role that MBD proteins play in modulation of the methylome remain unclear. Our previous work demonstrated that MBD2 preferentially binds to the hypermethylated GSTP1 promoter CpG island in prostate cancer cells. Here, we use functional genetic approaches to investigate if MBD2 plays an active role in reshaping the DNA methylation landscape at this locus and genome-wide. First, we show that loss of MBD2 results in inhibition of both maintenance and spread of de novo methylation of a transfected construct containing the GSTP1 promoter CpG island in prostate cancer cells and Mbd2(-/-) mouse fibroblasts. De novo methylation was rescued by transient expression of Mbd2 in Mbd2(-/-) cells. Second, we show that MBD2 depletion triggers significant hypomethylation genome-wide in prostate cancer cells with concomitant loss of MBD2 binding at promoter and enhancer regulatory regions. Finally, CpG islands and shores that become hypomethylated after MBD2 depletion in LNCaP cancer cells show significant hypermethylation in clinical prostate cancer samples, highlighting a potential active role of MBD2 in promoting cancer-specific hypermethylation. Importantly, co-immunoprecipiation of MBD2 shows that MBD2 associates with DNA methyltransferase enzymes 1 and 3A. Together our results demonstrate that MBD2 has a critical role in `rewriting' the cancer methylome at specific regulatory regions.	[Stirzaker, C.; Song, J. Z.; Ng, W.; Du, Q.; Locke, W. J.; Statham, A. L.; French, H.; Pidsley, R.; Valdes-Mora, F.; Zotenko, E.; Clark, S. J.] Garvan Inst Med Res, Genom & Epigenet Div, Epigenet Res Lab, Sydney, NSW, Australia; [Stirzaker, C.; Clark, S. J.] Univ NSW, St Vincents Clin Sch, Sydney, NSW, Australia; [Armstrong, N. J.] Murdoch Univ, SEIT, Math & Stat, Murdoch, WA, Australia	Garvan Institute of Medical Research; University of New South Wales Sydney; Murdoch University	Clark, SJ (corresponding author), Garvan Inst Med Res, Genom & Epigenet Div, 384 Victoria St, Sydney, NSW 2010, Australia.	s.clark@garvan.org.au	Mora, Fatima Valdes/AAB-9728-2021; Armstrong, Nicola J./AAF-3045-2021; Locke, Warwick/G-3152-2017; Clark, Susan J/B-2272-2008; French, Hugh/L-7817-2014	Mora, Fatima Valdes/0000-0001-7490-0114; Armstrong, Nicola J./0000-0002-4477-293X; Locke, Warwick/0000-0002-9281-0363; Clark, Susan J/0000-0001-5925-5030; Stirzaker, Clare/0000-0001-5601-3140; Pidsley, Ruth/0000-0002-1386-1374; Du, Qian/0000-0003-3393-681X; French, Hugh/0000-0001-7464-6929	National Health and Medical Research Council project grants [1029584, 1088144]; NHMRC Fellowship [1063559]	National Health and Medical Research Council project grants; NHMRC Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	We thank Brigid O'Gorman for preparation of figures and reviewing the manuscript. Mouse fibroblast Mbd2 - / - and wild-type cells were gratefully received as a gift from Adrian Bird. The results published here are in part based upon data generated by the TCGA Research Network: http://cancergenome.nih.gov/. We thank the Ramaciotti Centre, University of New South Wales (Sydney, Australia) for conducting the Affymetrix array experiments and the Australian Genome Research Facility for the HM450K arrays. This work is supported by National Health and Medical Research Council project grants (1029584 and 1088144) and NHMRC Fellowship to SJC (1063559) The contents of the published material are solely the responsibility of the administering institution and individual authors and do not reflect the views of the NHMRC.	Abeshouse A, 2015, CELL, V163, P1011, DOI 10.1016/j.cell.2015.10.025; Auriol E, 2005, NUCLEIC ACIDS RES, V33, P4243, DOI 10.1093/nar/gki729; Ballestar E, 2005, BIOCHEM CELL BIOL, V83, P374, DOI 10.1139/o05-035; Barr H, 2007, MOL CELL BIOL, V27, P3750, DOI 10.1128/MCB.02204-06; Baubec T, 2014, CURR OPIN GENET DEV, V25, P85, DOI 10.1016/j.gde.2013.11.015; Baubec T, 2013, CELL, V153, P480, DOI 10.1016/j.cell.2013.03.011; Baylin SB, 2011, NAT REV CANCER, V11, P726, DOI 10.1038/nrc3130; Berger J, 2005, BIOCHEM SOC T, V33, P1537, DOI 10.1042/BST0331537; Bert SA, 2013, CANCER CELL, V23, P9, DOI 10.1016/j.ccr.2012.11.006; BESTOR TH, 1988, GENE, V74, P9, DOI 10.1016/0378-1119(88)90238-7; Bibikova M, 2011, GENOMICS, V98, P288, DOI 10.1016/j.ygeno.2011.07.007; Boeke J, 2000, J BIOL CHEM, V275, P34963, DOI 10.1074/jbc.M005929200; Cai Y, 2014, ONCOGENE, V33, P2157, DOI 10.1038/onc.2013.178; Chatagnon A, 2011, EPIGENETICS-US, V6, P1295, DOI 10.4161/epi.6.11.17875; Chatagnon A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009665; Chatagnon A, 2009, CARCINOGENESIS, V30, P28, DOI 10.1093/carcin/bgn240; Coolen MW, 2010, NAT CELL BIOL, V12, P235, DOI 10.1038/ncb2023; Doi A, 2009, NAT GENET, V41, P1350, DOI 10.1038/ng.471; Du P, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-587; Du Q, 2015, EPIGENOMICS-UK, V7, P1051, DOI 10.2217/epi.15.39; Ernst J, 2012, NAT METHODS, V9, P215, DOI 10.1038/nmeth.1906; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Fraga MF, 2003, NUCLEIC ACIDS RES, V31, P1765, DOI 10.1093/nar/gkg249; GARTLER SM, 1983, ANNU REV GENET, V17, P155, DOI 10.1146/annurev.ge.17.120183.001103; Gunther K, 2013, NUCLEIC ACIDS RES, V41, P3010, DOI 10.1093/nar/gkt035; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Kalyuga M, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001461; Klose RJ, 2006, TRENDS BIOCHEM SCI, V31, P89, DOI 10.1016/j.tibs.2005.12.008; Lopez-Serra L, 2008, ONCOGENE, V27, P3556, DOI 10.1038/sj.onc.1211022; Lopez-Serra L, 2006, CANCER RES, V66, P8342, DOI 10.1158/0008-5472.CAN-06-1932; Magdinier F, 2001, P NATL ACAD SCI USA, V98, P4990, DOI 10.1073/pnas.101617298; McLean CY, 2010, NAT BIOTECHNOL, V28, P495, DOI 10.1038/nbt.1630; Menafra R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099603; Mian OY, 2011, MOL CANCER RES, V9, P1152, DOI 10.1158/1541-7786.MCR-11-0252; Millar DS, 1999, ONCOGENE, V18, P1313, DOI 10.1038/sj.onc.1202415; Mohammed H, 2016, NAT PROTOC, V11, P316, DOI 10.1038/nprot.2016.020; Mohammed H, 2013, CELL REP, V3, P342, DOI 10.1016/j.celrep.2013.01.010; MOHANDAS T, 1981, SCIENCE, V211, P393, DOI 10.1126/science.6164095; Ng HH, 2000, MOL CELL BIOL, V20, P1394, DOI 10.1128/MCB.20.4.1394-1406.2000; Ng HH, 1999, NAT GENET, V23, P58, DOI 10.1038/12659; Pulukuri SM, 2006, ONCOGENE, V25, P4559, DOI 10.1038/sj.onc.1209462; Ritchie ME, 2015, NUCLEIC ACIDS RES, V43, DOI 10.1093/nar/gkv007; Saito M, 2002, J BIOL CHEM, V277, P35434, DOI 10.1074/jbc.M203455200; Sansom OJ, 2003, NAT GENET, V34, P145, DOI 10.1038/ng1155; Song JZ, 2002, ONCOGENE, V21, P1048, DOI 10.1038/sj.onc.1205153; Stefanska B, 2011, CANCER RES, V71, P5891, DOI 10.1158/0008-5472.CAN-10-3823; Stirzaker C, 2004, CANCER RES, V64, P3871, DOI 10.1158/0008-5472.CAN-03-3690; Stirzaker C, 2014, TRENDS GENET, V30, P75, DOI 10.1016/j.tig.2013.11.004; Wade PA, 1999, NAT GENET, V23, P62, DOI 10.1038/12664; Wang LQ, 2013, MOL CELL BIOL, V33, P4106, DOI 10.1128/MCB.00144-13; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924	55	40	44	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1328	1338		10.1038/onc.2016.297	http://dx.doi.org/10.1038/onc.2016.297			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27593931				2022-12-26	WOS:000395862500002
J	Izrailit, J; Jaiswal, A; Zheng, W; Moran, MF; Reedijk, M				Izrailit, J.; Jaiswal, A.; Zheng, W.; Moran, M. F.; Reedijk, M.			Cellular stress induces TRB3/USP9x-dependent Notch activation in cancer	ONCOGENE			English	Article							E3 UBIQUITIN LIGASE; BREAST-CANCER; POOR-PROGNOSIS; BETA-CATENIN; MIND BOMB; ER STRESS; TRB3; PROTEIN; ENDOCYTOSIS; DEGRADATION	Expression of the Notch ligand JAG1 and Notch pathway activation promote poor prognosis, basal-like breast cancer. We have recently shown that the pseudokinase Tribbles homolog 3 (TRB3) regulates JAG1 expression in this malignancy. TRB3 is a stress and metabolic sensor, and here we show that nutrient deprivation or endoplasmic reticulum stress markedly upregulate TRB3, which serves as a scaffold for the deubiquitinase USP9x. USP9x in turn stimulates JAG1 activity through two mechanisms: (1) through TRB3 deubiquitination and stabilization, and (2) through deubiquitination and activation of Mind Bomb 1, an E3 ligase required for JAG1 ubiquitination-mediated endocytosis and Notch activation. These USP9x activities are confined to the signal-sending cell of a cell pair undergoing Notch signaling. We demonstrate that USP9x is required for TRB3 upregulation and Notch activation in response to cellular stress in basal-like breast cancer cells. These data suggest that TRB3 functions as a sensor of tumor microenvironmental stress and together with USP9x induces the cell survival and tumor-promoting activities of Notch. These findings identify a novel mechanism by which cancer cells survive in their hostile environment and provide potential therapeutic targets in breast cancer.	[Izrailit, J.; Jaiswal, A.; Zheng, W.; Reedijk, M.] Ontario Canc Inst, Campbell Family Inst Canc Res, Toronto, ON, Canada; [Izrailit, J.; Jaiswal, A.; Reedijk, M.] Univ Toronto, Princess Margaret Hosp, Ontario Canc Inst, Dept Med Biophys, Toronto, ON, Canada; [Moran, M. F.] Hosp Sick Children, Program Mol Struct & Funct, Toronto, ON, Canada; [Moran, M. F.] Univ Toronto, Dept Med Genet, Toronto, ON, Canada; [Reedijk, M.] Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, 610 Univ Ave,Suite 3-130, Toronto, ON M5G 2M9, Canada	University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Reedijk, M (corresponding author), Univ Hlth Network, Princess Margaret Canc Ctr, Dept Surg Oncol, 610 Univ Ave,Suite 3-130, Toronto, ON M5G 2M9, Canada.	michael.reedijk@uhn.ca	Moran, Michael/GYD-3631-2022		Canadian Breast Cancer Foundation; Ontario Ministry of Health and Long Term Care	Canadian Breast Cancer Foundation(Canadian Cancer Society (CCS)); Ontario Ministry of Health and Long Term Care(Ministry of Health and Long-Term Care, Ontario)	This study was supported by funds to MR from the Canadian Breast Cancer Foundation. This research was funded in part by the Ontario Ministry of Health and Long Term Care. The views expressed do not necessarily reflect those of the OMOHLTC. We thank J Tong for technical support, and B Martin and P Taylor for bioinformatic support.	Ackerman D, 2014, TRENDS CELL BIOL, V24, P472, DOI 10.1016/j.tcb.2014.06.001; Bowers AJ, 2003, ONCOGENE, V22, P2823, DOI 10.1038/sj.onc.1206367; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Dobens LL, 2012, DEV DYNAM, V241, P1239, DOI 10.1002/dvdy.23822; Du KY, 2009, MOL ENDOCRINOL, V23, P475, DOI 10.1210/me.2008-0284; Dupont S, 2009, CELL, V136, P123, DOI 10.1016/j.cell.2008.10.051; Hansson EM, 2010, J CELL SCI, V123, P2931, DOI 10.1242/jcs.073239; Harris DR, 2012, CANCER BIOL THER, V13, P1319, DOI 10.4161/cbt.21792; Hua F, 2011, J CELL SCI, V124, P3235, DOI 10.1242/jcs.082875; Irshad K, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118201; Itoh M, 2003, DEV CELL, V4, P67, DOI 10.1016/S1534-5807(02)00409-4; Izrailit J, 2013, P NATL ACAD SCI USA, V110, P1714, DOI 10.1073/pnas.1214014110; Jin YJ, 2002, J BIOL CHEM, V277, P46980, DOI 10.1074/jbc.M208585200; Kamitani T, 1997, J BIOL CHEM, V272, P28557, DOI 10.1074/jbc.272.45.28557; Koo BK, 2005, DEVELOPMENT, V132, P3459, DOI 10.1242/dev.01922; Koritzinsky M, 2013, J CELL BIOL, V203, P615, DOI 10.1083/jcb.201307185; Lai EC, 2001, DEV CELL, V1, P783, DOI 10.1016/S1534-5807(01)00092-2; Li D, 2014, FRONT ONCOL, V4, DOI 10.3389/fonc.2014.00254; Li ST, 2011, IMMUNITY, V35, P426, DOI 10.1016/j.immuni.2011.06.014; Lohan F, 2013, BIOCHEM SOC T, V41, P1096, DOI 10.1042/BST20130105; Meloty-Kapella L, 2012, DEV CELL, V22, P1299, DOI 10.1016/j.devcel.2012.04.005; Mouchantaf R, 2006, J BIOL CHEM, V281, P38738, DOI 10.1074/jbc.M605959200; Murray RZ, 2004, MOL BIOL CELL, V15, P1591, DOI 10.1091/mbc.E03-08-0630; Nagelkerke A, 2013, BREAST CANCER RES, V15, DOI 10.1186/bcr3373; Nichols JT, 2007, J CELL BIOL, V176, P445, DOI 10.1083/jcb.200609014; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Ord D, 2007, EXP CELL RES, V313, P3556, DOI 10.1016/j.yexcr.2007.07.017; Ohoka N, 2005, EMBO J, V24, P1243, DOI 10.1038/sj.emboj.7600596; Ohoka N, 2010, BIOCHEM BIOPH RES CO, V392, P289, DOI 10.1016/j.bbrc.2009.12.175; Ossipova O, 2009, DEV CELL, V17, P222, DOI 10.1016/j.devcel.2009.06.010; Overstreet E, 2004, DEVELOPMENT, V131, P5355, DOI 10.1242/dev.01434; Pal A, 2014, BREAST CANCER RES, V16, DOI 10.1186/s13058-014-0461-3; Parks AL, 2000, DEVELOPMENT, V127, P1373; Qi L, 2006, SCIENCE, V312, P1763, DOI 10.1126/science.1123374; Reedijk M, 2005, CANCER RES, V65, P8530, DOI 10.1158/0008-5472.CAN-05-1069; Reedijk M, 2008, BREAST CANCER RES TR, V111, P439, DOI 10.1007/s10549-007-9805-3; Salazar M, 2009, J CLIN INVEST, V119, P1359, DOI 10.1172/JCI37948; Schwarzer R, 2006, CELL SIGNAL, V18, P899, DOI 10.1016/j.cellsig.2005.08.002; Taya S, 1999, GENES CELLS, V4, P757, DOI 10.1046/j.1365-2443.1999.00297.x; Tong JF, 2014, MOL CELL PROTEOMICS, V13, P1644, DOI 10.1074/mcp.M114.038596; Tseng LC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093394; VANDENHEUVEL S, 1993, SCIENCE, V262, P2050, DOI 10.1126/science.8266103; Vara D, 2011, CELL DEATH DIFFER, V18, P1099, DOI 10.1038/cdd.2011.32; Wang WD, 2004, DEVELOPMENT, V131, P5367, DOI 10.1242/dev.01413; Wang Y, 2015, J THORAC DIS, V7, P672, DOI 10.3978/j.issn.2072-1439.2015.04.28; Weinmaster G, 2011, DEV CELL, V21, P134, DOI 10.1016/j.devcel.2011.06.006; Wennemers M, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2934; Xie Y, 2013, J BIOL CHEM, V288, P2976, DOI 10.1074/jbc.M112.430066; Zhou M, 2015, BIOCHEM BIOPH RES CO, V459, P333, DOI 10.1016/j.bbrc.2015.02.115; Zhou Y, 2008, CELL SIGNAL, V20, P942, DOI 10.1016/j.cellsig.2008.01.010	50	35	35	0	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1048	1057		10.1038/onc.2016.276	http://dx.doi.org/10.1038/onc.2016.276			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27593927				2022-12-26	WOS:000395371500003
J	McGettigan, BM; McMahan, RH; Luo, YH; Wang, XXX; Orlicky, DJ; Porsche, C; Levi, M; Rosen, HR				McGettigan, Brett M.; McMahan, Rachel H.; Luo, Yuhuan; Wang, Xiaoxin X.; Orlicky, David J.; Porsche, Cara; Levi, Moshe; Rosen, Hugo R.			Sevelamer Improves Steatohepatitis, Inhibits Liver and Intestinal Farnesoid X Receptor (FXR), and Reverses Innate Immune Dysregulation in a Mouse Model of Non-alcoholic Fatty Liver Disease	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACID-BINDING; INSULIN-RESISTANCE; FIBROSIS; MICE; ACTIVATION; CELLS; EPIDEMIOLOGY; INFLAMMATION; CHOLESTEROL; CONTRIBUTES	Bile acid sequestrants are synthetic polymers that bind bile acids in the gut and are used to treat dyslipidemia and hyperphosphatemia. Recently, these agents have been reported to lower blood glucose and increase insulin sensitivity by altering bile acid signaling pathways. In this study, we assessed the efficacy of sevelamer in treating mice with non-alcoholic fatty liver disease (NAFLD). We also analyzed how sevelamer alters inflammation and bile acid signaling in NAFLD livers. Mice were fed a low-fat or Western diet for 12 weeks followed by a diet-plus-sevelamer regimen for 2 or 12 weeks. At the end of treatment, disease severity was assessed, hepatic leukocyte populations were examined, and expression of genes involved in farnesoid X receptor (FXR) signaling in the liver and intestine was analyzed. Sevelamer treatment significantly reduced liver steatosis and lobular inflammation. Sevelamer-treated NAFLD livers had notably fewer pro-inflammatory infiltrating macrophages and a significantly greater fraction of alternatively activated Kupffer cells compared with controls. Expression of genes involved in FXR signaling in the liver and intestine was significantly altered in mice with NAFLD as well as in those treated with sevelamer. In a mouse model of NAFLD, sevelamer improved disease and counteracted innate immune cell dysregulation in the liver. This study also revealed a dysregulation of FXR signaling in the liver and intestine of NAFLD mice that was counteracted by sevelamer treatment.	[McGettigan, Brett M.; McMahan, Rachel H.; Porsche, Cara; Rosen, Hugo R.] Univ Colorado, Dept Gastroenterol & Hepatol, Aurora, CO 80045 USA; [Luo, Yuhuan; Wang, Xiaoxin X.; Levi, Moshe] Univ Colorado, Dept Renal Dis & Hypertens, Aurora, CO 80045 USA; [Orlicky, David J.] Univ Colorado, Dept Pathol, Aurora, CO 80045 USA; [McGettigan, Brett M.; Rosen, Hugo R.] Univ Colorado, Dept Immunol & Microbiol, Aurora, CO 80045 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Rosen, HR (corresponding author), Div GI Hepatol, B-158,Acad Off Bldg 1,12631 E 17th Ave,Rm 7614, Aurora, CO 80045 USA.	hugo.rosen@ucdenver.edu	McGettigan, Brett/AAT-2828-2021	McGettigan, Brett/0000-0002-3120-0123	Veterans Affairs Merit Review grant; National Institute of Health [5K01DK096025]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK096025, P30DK048520] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM008497] Funding Source: NIH RePORTER	Veterans Affairs Merit Review grant(US Department of Veterans Affairs); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by a Veterans Affairs Merit Review grant (to H. R. R.) and National Institute of Health Grant 5K01DK096025 (to R. H. M.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Anstee QM, 2006, INT J EXP PATHOL, V87, P1, DOI 10.1111/j.0959-9673.2006.00465.x; Argo CK, 2009, J HEPATOL, V51, P371, DOI 10.1016/j.jhep.2009.03.019; Braunersreuther V, 2012, WORLD J GASTROENTERO, V18, P727, DOI 10.3748/wjg.v18.i8.727; Braunlin W, 2002, KIDNEY INT, V62, P611, DOI 10.1046/j.1523-1755.2002.00459.x; Charlton MR, 2011, GASTROENTEROLOGY, V141, P1249, DOI 10.1053/j.gastro.2011.06.061; Cheng QQ, 2015, MOL ENDOCRINOL, V29, P571, DOI 10.1210/me.2014-1337; Chiang JYL, 2009, J LIPID RES, V50, P1955, DOI 10.1194/jlr.R900010-JLR200; Claria J, 2012, GUT, V61, P792, DOI 10.1136/gutjnl-2011-301968; Feldstein AE, 2004, HEPATOLOGY, V40, P185, DOI 10.1002/hep.20283; Gaemers IC, 2011, BBA-MOL BASIS DIS, V1812, P447, DOI 10.1016/j.bbadis.2011.01.003; Harach T, 2012, SCI REP-UK, V2, DOI 10.1038/srep00430; Hossain N, 2009, CLIN GASTROENTEROL H, V7, P1224, DOI 10.1016/j.cgh.2009.06.007; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Jiang CT, 2015, J CLIN INVEST, V125, P386, DOI 10.1172/JCI76738; Kalaany NY, 2006, ANNU REV PHYSIOL, V68, P159, DOI 10.1146/annurev.physiol.68.033104.152158; Kanda H, 2006, J CLIN INVEST, V116, P1494, DOI 10.1172/JCI26498; Kobayashi M, 2007, DIABETES, V56, P239, DOI 10.2337/db06-0353; Kong B, 2009, J PHARMACOL EXP THER, V328, P116, DOI 10.1124/jpet.108.144600; Kotas ME, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025478; Lanaspa MA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3434; Lesmana CRA, 2009, J DIGEST DIS, V10, P201, DOI 10.1111/j.1751-2980.2009.00386.x; Levene AP, 2012, HISTOPATHOLOGY, V61, P141, DOI 10.1111/j.1365-2559.2011.04145.x; Longato L, 2013, FIBROGENESIS TISSUE, V6, DOI 10.1186/1755-1536-6-14; Mas E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007929; Matsubara T, 2013, MOL CELL ENDOCRINOL, V368, P17, DOI 10.1016/j.mce.2012.05.004; McMahan RH, 2013, J BIOL CHEM, V288, P11761, DOI 10.1074/jbc.M112.446575; Morinaga H, 2015, DIABETES, V64, P1120, DOI 10.2337/db14-1238; Perdiguero EG, 2015, NATURE, V518, P547, DOI 10.1038/nature13989; Pols TWH, 2011, J HEPATOL, V54, P1263, DOI 10.1016/j.jhep.2010.12.004; Potthoff MJ, 2013, AM J PHYSIOL-GASTR L, V304, pG371, DOI 10.1152/ajpgi.00400.2012; Rastogi Anjay, 2013, Ther Adv Cardiovasc Dis, V7, P322, DOI 10.1177/1753944713513061; Ratziu V, 2000, GASTROENTEROLOGY, V118, P1117, DOI 10.1016/S0016-5085(00)70364-7; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schulz C, 2012, SCIENCE, V336, P86, DOI 10.1126/science.1219179; Staels B, 2010, CURR DIABETES REP, V10, P70, DOI 10.1007/s11892-009-0087-5; Szabo G, 2012, J HEPATOL, V57, P642, DOI 10.1016/j.jhep.2012.03.035; Takahashi Y, 2012, WORLD J GASTROENTERO, V18, P2300, DOI 10.3748/wjg.v18.i19.2300; Taniai M, 2009, HEPATOL RES, V39, P685, DOI 10.1111/j.1872-034X.2009.00507.x; Thomas C, 2008, NAT REV DRUG DISCOV, V7, P678, DOI 10.1038/nrd2619; Tuominen Iina, 2015, Hepatology, V62, P646, DOI 10.1002/hep.27910; Vernon G, 2011, ALIMENT PHARM THER, V34, P274, DOI 10.1111/j.1365-2036.2011.04724.x; Wan JH, 2014, HEPATOLOGY, V59, P130, DOI 10.1002/hep.26607; Watanabe M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038286; Wree A, 2013, NAT REV GASTRO HEPAT, V10, P627, DOI 10.1038/nrgastro.2013.149; Yao J, 2014, WORLD J GASTROENTERO, V20, P14430, DOI 10.3748/wjg.v20.i39.14430	45	25	25	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					23058	23067		10.1074/jbc.M116.731042	http://dx.doi.org/10.1074/jbc.M116.731042			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27605663	hybrid, Green Published			2022-12-26	WOS:000387224800018
J	Gade, P; Kimball, AS; DiNardo, AC; Gangwal, P; Ross, DD; Boswell, HS; Keay, SK; Kalvakolanu, DV				Gade, Padmaja; Kimball, Amy S.; DiNardo, Angela C.; Gangwal, Priyamvada; Ross, Douglas D.; Boswell, H. Scott; Keay, Susan K.; Kalvakolanu, Dhananjaya V.			Death-associated Protein Kinase-1 Expression and Autophagy in Chronic Lymphocytic Leukemia Are Dependent on Activating Transcription Factor-6 and CCAAT/Enhancer-binding Protein-beta	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell signaling; cytokine action; endoplasmic reticulum stress (ER stress); transcription factor; tumor suppressor gene	ENDOPLASMIC-RETICULUM STRESS; BCL-X-L; DAP-KINASE; CELL-DEATH; IFN-GAMMA; B-CELLS; MEDIATED PHOSPHORYLATION; HEPATOCELLULAR-CARCINOMA; SIGNALING PATHWAY; DRUG-RESISTANCE	Expression of DAPK1, a critical regulator of autophagy and apoptosis, is lost in a wide variety of tumors, although the mechanisms are unclear. A transcription factor complex consisting of ATF6 (an endoplasmic reticulum-resident factor) and C/EBP- is required for the IFN--induced expression of DAPK1. IFN--induced proteolytic processing of ATF6 and phosphorylation of C/EBP- are obligatory for the formation of this transcriptional complex. We report that defects in this pathway fail to control growth of chronic lymphocytic leukemia (CLL). Consistent with these observations, IFN- and chemotherapeutics failed to activate autophagy in CLL patient samples lacking ATF6 and/or C/EBP-. Together, these results identify a molecular basis for the loss of DAPK1 expression in CLL.	[Gade, Padmaja; DiNardo, Angela C.; Gangwal, Priyamvada; Kalvakolanu, Dhananjaya V.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Kimball, Amy S.; Ross, Douglas D.; Keay, Susan K.] Univ Maryland, Sch Med, Dept Med, Baltimore, MD 21201 USA; [Ross, Douglas D.] Univ Maryland, Sch Med, Greenebaum Comprehens Canc Ctr, Baltimore, MD 21201 USA; [Ross, Douglas D.; Keay, Susan K.] Baltimore Vet Affairs Med Ctr, Baltimore, MD 21201 USA; [Boswell, H. Scott] Indianapolis Vet Affairs Med Ctr, Indianapolis, IN 46202 USA	University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; US Department of Veterans Affairs; Veterans Health Administration (VHA); Baltimore VA Medical Center	Kalvakolanu, DV (corresponding author), Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA.	dkalvako@umaryland.edu			National Institutes of Health [CA78282]; University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE [R01CA078282] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Maryland Greenebaum Cancer Center; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by National Institutes of Health Grant CA78282 (to D. V. K.), and Cigarette Restitution funds from the University of Maryland Greenebaum Cancer Center. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baumeister P, 2005, MOL CELL BIOL, V25, P4529, DOI 10.1128/MCB.25.11.4529-4540.2005; Begleiter A, 1996, LEUKEMIA LYMPHOMA, V23, P187, DOI 10.3109/10428199609054821; Bialik S, 2014, APOPTOSIS, V19, P316, DOI 10.1007/s10495-013-0926-3; Burgler S, 2015, CRIT REV IMMUNOL, V35, P417, DOI 10.1615/CritRevImmunol.v35.i5.50; Buggins AGS, 2010, CANCER RES, V70, P7523, DOI 10.1158/0008-5472.CAN-10-1634; Burger JA, 2009, BLOOD, V113, P3050, DOI 10.1182/blood-2008-07-170415; Burgler S, 2015, J IMMUNOL, V194, P827, DOI 10.4049/jimmunol.1401350; Chen KG, 2012, CLIN CANCER RES, V18, P1863, DOI 10.1158/1078-0432.CCR-11-1590; Chiorazzi N, 2005, NEW ENGL J MED, V352, P804, DOI 10.1056/NEJMra041720; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; Eisenberg-Lerner A, 2012, CELL DEATH DIFFER, V19, P788, DOI 10.1038/cdd.2011.149; Furuya T, 2010, MOL CELL, V38, P500, DOI 10.1016/j.molcel.2010.05.009; Gade P, 2008, MOL CELL BIOL, V28, P2528, DOI 10.1128/MCB.00784-07; Gade P, 2014, MOL CELL BIOL, V34, P4033, DOI 10.1128/MCB.00397-14; Gade P, 2012, P NATL ACAD SCI USA, V109, P10316, DOI 10.1073/pnas.1119273109; Gade P, 2009, INT J CANCER, V125, P1566, DOI 10.1002/ijc.24493; Galluzzi L, 2016, TRENDS CELL BIOL, V26, P1, DOI 10.1016/j.tcb.2015.11.001; Galluzzi L, 2015, EMBO J, V34, P856, DOI 10.15252/embj.201490784; GALTON DAG, 1966, CAN MED ASSOC J, V94, P1005; Gao YX, 2004, CLIN CHIM ACTA, V349, P173, DOI 10.1016/j.cccn.2004.07.006; Gonzalez-Gomez P, 2003, ONCOL REP, V10, P1031; Gozuacik D, 2008, CELL DEATH DIFFER, V15, P1875, DOI 10.1038/cdd.2008.121; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Harding HP, 2002, ANNU REV CELL DEV BI, V18, P575, DOI 10.1146/annurev.cellbio.18.011402.160624; Harrison B, 2008, J BIOL CHEM, V283, P9999, DOI 10.1074/jbc.M706040200; Haze K, 1999, MOL BIOL CELL, V10, P3787, DOI 10.1091/mbc.10.11.3787; Hoare M, 2011, SEMIN CANCER BIOL, V21, P397, DOI 10.1016/j.semcancer.2011.09.004; Inbal B, 2002, J CELL BIOL, V157, P455, DOI 10.1083/jcb.200109094; KAMIJO R, 1994, SCIENCE, V263, P1612, DOI 10.1126/science.7510419; Kissil JL, 1997, ONCOGENE, V15, P403, DOI 10.1038/sj.onc.1201172; Klionsky DJ, 2007, NAT REV MOL CELL BIO, V8, P931, DOI 10.1038/nrm2245; Komatsu M, 2012, PHARMACOL RES, V66, P457, DOI 10.1016/j.phrs.2012.07.004; Kubisch J, 2013, SEMIN CANCER BIOL, V23, P252, DOI 10.1016/j.semcancer.2013.06.009; Lagneaux L, 1998, BLOOD, V91, P2387, DOI 10.1182/blood.V91.7.2387.2387_2387_2396; Mahoney E, 2012, BLOOD, V120, P1262, DOI 10.1182/blood-2011-12-400184; Moscat J, 2007, TRENDS BIOCHEM SCI, V32, P95, DOI 10.1016/j.tibs.2006.12.002; Moscat J, 2009, CELL, V137, P1001, DOI 10.1016/j.cell.2009.05.023; Narayan Gopeshwar, 2003, Mol Cancer, V2, P24, DOI 10.1186/1476-4598-2-24; Os A, 2013, CELL REP, V4, P566, DOI 10.1016/j.celrep.2013.07.011; Panasci L, 2001, CLIN CANCER RES, V7, P454; PERILLO NL, 1993, MECH AGEING DEV, V67, P173, DOI 10.1016/0047-6374(93)90121-7; Raval A, 2007, CELL, V129, P879, DOI 10.1016/j.cell.2007.03.043; Reyes E, 1998, AM J HEMATOL, V57, P93, DOI 10.1002/(SICI)1096-8652(199802)57:2<93::AID-AJH1>3.0.CO;2-W; Roy SK, 2000, J BIOL CHEM, V275, P12626, DOI 10.1074/jbc.275.17.12626; Rutkowski DT, 2004, TRENDS CELL BIOL, V14, P20, DOI 10.1016/j.tcb.2003.11.001; Schmeisser H, 2013, AUTOPHAGY, V9, P683, DOI 10.4161/auto.23921; Sedlacek HH, 1996, INT J ONCOL, V9, P1143, DOI 10.3892/ijo.9.6.1143; Shanmugam R, 2012, CLIN CANCER RES, V18, P360, DOI 10.1158/1078-0432.CCR-10-3022; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Simpson DJ, 2002, ONCOGENE, V21, P1217, DOI 10.1038/sj.onc.1205195; So A, 2009, CANCER METAST REV, V28, P219, DOI 10.1007/s10555-008-9180-5; Stacchini A, 1999, LEUKEMIA RES, V23, P127, DOI 10.1016/S0145-2126(98)00154-4; Subramani S, 2013, EMBO REP, V14, P143, DOI 10.1038/embor.2012.220; Tamura T, 2000, IMMUNITY, V13, P155, DOI 10.1016/S1074-7613(00)00016-9; Thyrell L, 2004, J BIOL CHEM, V279, P24152, DOI 10.1074/jbc.M312219200; Tomizawa M, 2003, ANTICANCER RES, V23, P351; Wu XP, 2014, INT J CANCER, V135, P61, DOI 10.1002/ijc.28649; Young ARJ, 2009, GENE DEV, V23, P798, DOI 10.1101/gad.519709; Zaki M, 2000, LEUKEMIA RES, V24, P611, DOI 10.1016/S0145-2126(00)00022-9; Zalckvar E, 2009, AUTOPHAGY, V5, P720, DOI 10.4161/auto.5.5.8625; Zalckvar E, 2009, EMBO REP, V10, P285, DOI 10.1038/embor.2008.246; Zhao J, 2015, J CLIN INVEST, V125, P2707, DOI 10.1172/JCI70805	62	11	11	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22030	22042		10.1074/jbc.M116.725796	http://dx.doi.org/10.1074/jbc.M116.725796			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27590344	hybrid, Green Published			2022-12-26	WOS:000386332600018
J	Bondo, KJ; Pearl, DL; Janecko, N; Boerlin, P; Reid-Smith, RJ; Parmley, J; Jardine, CM				Bondo, Kristin J.; Pearl, David L.; Janecko, Nicol; Boerlin, Patrick; Reid-Smith, Richard J.; Parmley, Jane; Jardine, Claire M.			Impact of Season, Demographic and Environmental Factors on Salmonella Occurrence in Raccoons (Procyon lotor) from Swine Farms and Conservation Areas in Southern Ontario	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; ANTIMICROBIAL RESISTANCE; ESCHERICHIA-COLI; FLORIDA RACCOONS; FECAL SAMPLES; PREVALENCE; FOOD; INFECTIONS; SURVIVAL; MANURE	Salmonella has been detected in the feces of many wildlife species, including raccoons (Procyon lotor), but little is known about the epidemiology of Salmonella in wildlife living in different habitat types. Our objective was to investigate demographic, temporal, and climatic factors associated with the carriage of Salmonella in raccoons and their environment on swine farms and conservation areas. Using a repeated cross-sectional study design, we collected fecal samples from raccoons and environmental samples (soil, manure pits, dumpsters) on 5 swine farms and 5 conservation areas in Ontario, Canada once every five weeks from May to November, 2011-2013. Salmonellawas detected in 26% (279/1093; 95% CI 22.9-28.2) of raccoon fecal samples, 6% (88/1609; 95% CI 4.5-6.8) of soil samples, 30% (21/69; 95% CI 20.0-42.7) of manure pit samples, and 23% (7/31; 95% CI 9.6-41.0) of dumpster samples. Of samples testing positive for Salmonella, antimicrobial resistance was detected in 5% (14/279; 95% CI 2.8-8.3) of raccoon fecal, 8% (7/89; 95% CI 3.2-15.5) of soil, 10% (2/21; 95% CI 1.2-30.4) of manure pit, and 0/7 dumpster samples. Usingmulti-level multivariable logistic regression analyses, we found location type (swine farmor conservation area) was not a significant explanatory variable for Salmonella occurrence in raccoon feces or soil (p > 0.05). However, detection of Salmonella in raccoon feces was associated with rainfall, season, and sex with various interaction effects among these variables. We detected a variety of Salmonella serovars that infect humans and livestock in the feces of raccoons indicating that raccoons living near humans, regardless of location type, may play a role in the epidemiology of salmonellosis in livestock and humans in southwestern Ontario.	[Bondo, Kristin J.; Boerlin, Patrick; Reid-Smith, Richard J.; Parmley, Jane; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Guelph, ON, Canada; [Pearl, David L.; Janecko, Nicol; Reid-Smith, Richard J.] Univ Guelph, Dept Populat Med, Guelph, ON, Canada; [Janecko, Nicol; Reid-Smith, Richard J.; Parmley, Jane] Publ Hlth Agcy Canada, Ctr Foodborne Environm & Zoonot Infect Dis, Guelph, ON, Canada; [Janecko, Nicol] Univ Vet & Pharmaceut Sci Brno, Dept Biol & Wildlife Dis, Brno, Czech Republic; [Parmley, Jane; Jardine, Claire M.] Univ Guelph, Dept Pathobiol, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada	University of Guelph; University of Guelph; Public Health Agency of Canada; University of Veterinary Sciences Brno; University of Guelph	Jardine, CM (corresponding author), Univ Guelph, Dept Pathobiol, Guelph, ON, Canada.; Jardine, CM (corresponding author), Univ Guelph, Dept Pathobiol, Canadian Wildlife Hlth Cooperat, Guelph, ON, Canada.	cjardi01@uoguelph.ca			National Science and Engineering Research Council (NSERC); United States Department of Agriculture (USDA); Ontario Graduate Scholarship (OGS	National Science and Engineering Research Council (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); United States Department of Agriculture (USDA)(United States Department of Agriculture (USDA)); Ontario Graduate Scholarship (OGS(Ontario Graduate Scholarship)	Funding was provided by the National Science and Engineering Research Council (NSERC; CMJ). KJB received support through the United States Department of Agriculture (USDA) and an Ontario Graduate Scholarship (OGS). In-kind support was provided by the Public Health Agency of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Gomez-Aldapa CA, 2011, SALMONELLA - A DANGEROUS FOODBORNE PATHOGEN, P21; Allen SE, 2013, J WILDLIFE DIS, V49, P432, DOI 10.7589/2012-05-142; Andres S, 2013, ZOONOSES PUBLIC HLTH, V60, P355, DOI 10.1111/j.1863-2378.2012.01542.x; Arrus KM, 2006, LIVEST SCI, V102, P226, DOI 10.1016/j.livsci.2006.03.021; Baquero F, 2008, CURR OPIN BIOTECH, V19, P260, DOI 10.1016/j.copbio.2008.05.006; Barza M, 2002, CLIN INFECT DIS, V34, pS126, DOI 10.1086/340250; Behravesh CB, 2010, PEDIATRICS, V126, P477, DOI 10.1542/peds.2009-3273; Berger CN, 2010, ENVIRON MICROBIOL, V12, P2385, DOI 10.1111/j.1462-2920.2010.02297.x; BIGLER WJ, 1974, ARCH ENVIRON HEALTH, V28, P261, DOI 10.1080/00039896.1974.10666483; Bolton FJ, 1999, EPIDEMIOL INFECT, V122, P7, DOI 10.1017/S0950268898001915; Bondo KJ, 2016, ZOONOSES PUBLIC HLTH, V63, P303, DOI 10.1111/zph.12232; Bondo KJ, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0563-x; Broadfoot JD, 2001, ECOL APPL, V11, P295, DOI 10.1890/1051-0761(2001)011[0295:RASPMF]2.0.CO;2; Chamberlain MJ, 2003, J WILDLIFE MANAGE, V67, P334, DOI 10.2307/3802775; Chen HM, 2013, PEDIATR NEONATOL, V54, P147, DOI 10.1016/j.pedneo.2013.01.010; Cole D, 2005, EMERG INFECT DIS, V11, P935; Colwell RR, 2009, MICROBIOL MONOGR, V10, P121, DOI 10.1007/7171_2009_1; Cowled BD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046310; Davies RH, 1996, J VET MED B, V43, P119, DOI 10.1111/j.1439-0450.1996.tb00295.x; Dohoo I., 2014, VET EPIDEMIOLOGIC RE, V2nd; Essex Regional Conservation Authority (ERCA), 2020, ESS REG CONS AUTH 20, P1; Finley R, 2007, CAN VET J, V48, P69; Forshell LP, 2006, REV SCI TECH OIE, V25, P541, DOI 10.20506/rst.25.2.1683; FRITZELL EK, 1978, CAN J ZOOL, V56, P260, DOI 10.1139/z78-035; Funk J, 2004, J SWINE HEALTH PROD, V12, P246; Garcia R, 2010, APPL ENVIRON MICROB, V76, P5025, DOI 10.1128/AEM.00628-10; Gehrt SD, 1997, J MAMMAL, V78, P921, DOI 10.2307/1382952; Gorski L, 2011, APPL ENVIRON MICROB, V77, P2734, DOI 10.1128/AEM.02321-10; Government of Canada, 2015, CAN INT PROGR ANT RE; Government of Canada, 2013, OV FOODNET CAN FORM; Government of Canada, 2011, CAN INT PROGR ANT RE; Government of Canada, 2014, FOODNET CAN 2010 ANN; Government of Canada, 2012, NAT ENT SURV PROGR N; Greig J, 2015, ZOONOSES PUBLIC HLTH, V62, P269, DOI 10.1111/zph.12147; Haley BJ, 2009, APPL ENVIRON MICROB, V75, P1248, DOI 10.1128/AEM.01648-08; HART RP, 1985, APPL ENVIRON MICROB, V49, P1276, DOI 10.1128/AEM.49.5.1276-1281.1985; Hilbert F, 2012, FOOD RES INT, V45, P603, DOI 10.1016/j.foodres.2011.08.015; Hohmann EL, 2001, CLIN INFECT DIS, V32, P263, DOI 10.1086/318457; Jacobsen CS, 2012, FOOD RES INT, V45, P557, DOI 10.1016/j.foodres.2011.07.026; Jardine C, 2011, J WILDLIFE DIS, V47, P344, DOI 10.7589/0090-3558-47.2.344; Kalwasinska A, 2013, ENVIRON SCI-PROC IMP, V15, P1078, DOI 10.1039/c3em30728j; Kinde H, 1997, AVIAN DIS, V41, P392, DOI 10.2307/1592195; KOURANY M, 1970, AM J TROP MED HYG, V19, P632, DOI 10.4269/ajtmh.1970.19.632; KOURANY M, 1976, AM J TROP MED HYG, V25, P449, DOI 10.4269/ajtmh.1976.25.449; Kozak GK, 2009, APPL ENVIRON MICROB, V75, P559, DOI 10.1128/AEM.01821-08; Leonard EK, 2011, ZOONOSES PUBLIC HLTH, V58, P140, DOI 10.1111/j.1863-2378.2009.01320.x; Levantesi C, 2012, FOOD RES INT, V45, P587, DOI 10.1016/j.foodres.2011.06.037; Luque I, 2009, VET MICROBIOL, V134, P396, DOI 10.1016/j.vetmic.2008.08.015; Martinez-Urtaza J, 2004, APPL ENVIRON MICROB, V70, P4030, DOI 10.1128/AEM.70.7.4030-4034.2004; Martinez-Urtaza J, 2004, APPL ENVIRON MICROB, V70, P2089, DOI 10.1128/AEM.70.4.2089-2097.2004; McLaughlin MR, 2012, WATER RES, V46, P4949, DOI 10.1016/j.watres.2012.06.023; Mead PS, 1999, EMERG INFECT DIS, V5, P607, DOI 10.3201/eid0505.990502; Miller S, 2015, J WILDLIFE DIS, V51, P60, DOI 10.7589/2014-02-046; MORSE EV, 1976, AM J PUBLIC HEALTH, V66, P82, DOI 10.2105/AJPH.66.1.82; MORSE EV, 1983, J ENVIRON SCI HEAL A, V18, P541, DOI 10.1080/10934528309375122; Navarro-Gonzalez N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051614; Newell D. G., 2003, Microbial food safety in animal agriculture: current topics, P211, DOI 10.1002/9780470752616.ch22; Pedersen K, 2006, J WILDLIFE DIS, V42, P46, DOI 10.7589/0090-3558-42.1.46; Pesapane R, 2013, ECOHEALTH, V10, P115, DOI 10.1007/s10393-013-0838-2; Potter AS, 2011, J WILDLIFE DIS, V47, P880, DOI 10.7589/0090-3558-47.4.880; Ram JL, 2007, WATER RES, V41, P3605, DOI 10.1016/j.watres.2007.04.013; REILLY WJ, 1981, VET REC, V108, P553, DOI 10.1136/vr.108.26.553; RIVEST P, 1981, CAN J ZOOL, V59, P1755, DOI 10.1139/z81-241; Rodriguez A, 2006, J FOOD PROTECT, V69, P2576, DOI 10.4315/0362-028X-69.11.2576; Rosatte R, 2010, J MAMMAL, V91, P122, DOI 10.1644/08-MAMM-A-201R2.1; Saeed A.M., 1999, SALMONELLA ENTERICA, V1st; Schiellerup P, 2001, Ugeskr Laeger, V163, P5677; Smith K, 2000, CAMPYLOBACTER, P483; SONENSHINE DE, 1972, J WILDLIFE MANAGE, V36, P838, DOI 10.2307/3799438; Su LH, 2005, J ANTIMICROB CHEMOTH, V55, P846, DOI 10.1093/jac/dki116; Teale CJ, 2002, J APPL MICROBIOL, V92, p85S, DOI 10.1046/j.1365-2672.92.5s1.20.x; Thomas JL, 2013, J APPL MICROBIOL, V114, P907, DOI 10.1111/jam.12079; Thomas MK, 2013, FOODBORNE PATHOG DIS, V10, P639, DOI 10.1089/fpd.2012.1389; THOMASON BM, 1975, APPL MICROBIOL, V30, P764, DOI 10.1128/AEM.30.5.764-767.1975; Varma JK, 2005, EMERG INFECT DIS, V11, P943; Very KJ, 2016, ZOONOSES PUBLIC HLTH, V63, P223, DOI 10.1111/zph.12222; Veterinary Drugs Directorate, 2009, CAT ANT DRUGS BAS IM; Vugia DJ, 2004, CLIN INFECT DIS, V38, pS149, DOI 10.1086/381581; WHITE FH, 1975, ARCH ENVIRON HEALTH, V30, P602, DOI 10.1080/00039896.1975.10666788; Winfield MD, 2003, APPL ENVIRON MICROB, V69, P3687, DOI 10.1128/AEM.69.7.3687-3694.2003; You YW, 2006, APPL ENVIRON MICROB, V72, P5777, DOI 10.1128/AEM.00791-06; Young I, 2009, EPIDEMIOL INFECT, V137, P1217, DOI 10.1017/S0950268809002635; Ziemer CJ, 2010, J ANIM SCI, V88, pE84, DOI 10.2527/jas.2009-2331	83	16	16	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161497	10.1371/journal.pone.0161497	http://dx.doi.org/10.1371/journal.pone.0161497			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611198	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900018
J	Pogue, SL; Taura, T; Bi, MY; Yun, Y; Sho, A; Mikesell, G; Behrens, C; Sokolovsky, M; Hallak, H; Rosenstock, M; Sanchez, E; Chen, HM; Berenson, J; Doyle, A; Nock, S; Wilson, DS				Pogue, Sarah L.; Taura, Tetsuya; Bi, Mingying; Yun, Yong; Sho, Angela; Mikesell, Glen; Behrens, Collette; Sokolovsky, Maya; Hallak, Hussein; Rosenstock, Moti; Sanchez, Eric; Chen, Haiming; Berenson, James; Doyle, Anthony; Nock, Steffen; Wilson, David S.			Targeting Attenuated Interferon-alpha to Myeloma Cells with a CD38 Antibody Induces Potent Tumor Regression with Reduced Off-Target Activity	PLOS ONE			English	Article							MULTIPLE-MYELOMA; MONOCLONAL-ANTIBODIES; CANCER-IMMUNOTHERAPY; RANDOMIZED-TRIALS; BONE-MARROW; IFN-ALPHA; MAINTENANCE; DELIVERY; THERAPY; PROTEIN	Interferon-alpha (IFN alpha) has been prescribed to effectively treat multiple myeloma (MM) and other malignancies for decades. Its use has waned in recent years, however, due to significant toxicity and a narrow therapeutic index (TI). We sought to improve IFN alpha's TI by, first, attaching it to an anti-CD38 antibody, thereby directly targeting it to MM cells, and, second, by introducing an attenuating mutation into the IFN alpha portion of the fusion protein rendering it relatively inactive on normal, CD38 negative cells. This anti-CD38-IFN alpha(attenuated) immunocytokine, or CD38-Attenukine (TM), exhibits 10,000-fold increased specificity for CD38 positive cells in vitro compared to native IFN alpha and, significantly, is similar to 6,000-fold less toxic to normal bone marrow cells in vitro than native IFN alpha. Moreover, the attenuating mutation significantly decreases IFN alpha biomarker activity in cynomolgus macaques indicating that this approach may yield a better safety profile in humans than native IFN alpha or a non-attenuated IFN alpha immunocytokine. In human xenograft MM tumor models, anti-CD38-IFN alpha(attenuated) exerts potent anti-tumor activity in mice, inducing complete tumor regression in most cases. Furthermore, anti-CD38-IFN alpha(attenuated) is more efficacious than standard MM treatments (lenalidomide, bortezomib, dexamethasone) and exhibits strong synergy with lenalidomide and with bortezomib in xenograft models. Our findings suggest that tumor-targeted attenuated cytokines such as IFN alpha can promote robust tumor killing while minimizing systemic toxicity.	[Pogue, Sarah L.; Taura, Tetsuya; Bi, Mingying; Yun, Yong; Sho, Angela; Mikesell, Glen; Nock, Steffen; Wilson, David S.] Teva Pharmaceut, Global Branded Biol Div, Redwood City, CA USA; [Behrens, Collette; Doyle, Anthony] Teva Pharmaceut, Global Branded Biol Div, Sydney, NSW, Australia; [Sokolovsky, Maya; Hallak, Hussein; Rosenstock, Moti] Teva Pharmaceut, Global Branded Biol Div, Netanya, Israel; [Sanchez, Eric; Chen, Haiming; Berenson, James] Inst Myeloma & Bone Canc Res, West Hollywood, CA USA	Teva Pharmaceutical Industries	Pogue, SL (corresponding author), Teva Pharmaceut, Global Branded Biol Div, Redwood City, CA USA.	Sarah.Pogue@tevapharm.com			Teva Pharmaceuticals; Teva	Teva Pharmaceuticals(Teva Pharmaceutical Industries); Teva(Teva Pharmaceutical Industries)	All studies presented in this manuscript were funded solely by Teva Pharmaceuticals and was not by any outside sources. Teva Pharmaceuticals provided support in the form of salaries for authors SP, TT, MB, YY, AS, GM, CB, MS, HH, MR, AD, SN, and DW, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section. Authors JB, HC, and ES are part of a non-profit organization, Institute of Myeloma and Bone Cancer Research, which performed studies in this manuscript. Teva Pharmaceuticals funded these studies.; We thank Darlene Jenkins, Ph.D., a writer funded by Teva, for providing drafts and edits of this manuscript. We gratefully acknowledge Maxwell Stevens and Teresa Domagala for provision of reagents and Simon Tout for thorough review of this manuscript.	Al-Zahrani H, 2003, LEUKEMIA LYMPHOMA, V44, P471, DOI 10.1080/1042819021000055066; Belardelli F, 2002, CYTOKINE GROWTH F R, V13, P119, DOI 10.1016/S1359-6101(01)00022-3; Boccadoro M, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-18; Campbell RA, 2006, INT J ONCOL, V28, P1409; Campbell Richard A, 2008, Curr Protoc Pharmacol, VChapter 14, DOI 10.1002/0471141755.ph1409s40; Chillemi A, 2014, FRONT BIOSCI-LANDMRK, V19, P152, DOI 10.2741/4201; Committee NRCU, 2011, GUIDE FOR THE CARE A; de Weers M, 2011, J IMMUNOL, V186, P1840, DOI 10.4049/jimmunol.1003032; Dryden MW, 2005, VET THER, V6, P15; Durocher Y, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e9; El-Amm J, 2015, AM J CLIN ONCOL-CANC, V38, P315, DOI 10.1097/COC.0b013e3182a4676b; Frey K, 2011, INTEGR BIOL-UK, V3, P468, DOI 10.1039/c0ib00099j; Friedman RM, 2008, BRIT J CLIN PHARMACO, V65, P158, DOI 10.1111/j.1365-2125.2007.03055.x; Fritz E, 2000, ANN ONCOL, V11, P1427, DOI 10.1023/A:1026548226770; Garcin G, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4016; Huang TH, 2007, J IMMUNOL, V179, P6881, DOI 10.4049/jimmunol.179.10.6881; Jeon S, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-240; Kim D, 2012, LEUKEMIA, V26, P2530, DOI 10.1038/leu.2012.140; Kirkwood J, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.33078; Lin P, 2004, AM J CLIN PATHOL, V121, P482, DOI 10.1039/74R4TB90BUWH27JX; List T, 2013, CLIN PHARMACOL-ADV A, V5, P29, DOI 10.2147/CPAA.S49231; LUDWIG H, 1995, ANN ONCOL, V6, P467, DOI 10.1093/oxfordjournals.annonc.a059217; McLaughlin F, 2002, BONE, V30, P924, DOI 10.1016/S8756-3282(02)00737-8; MELLSTEDT H, 1979, LANCET, V1, P245; OBrien S, 1996, LEUKEMIA LYMPHOMA, V23, P247, DOI 10.3109/10428199609054827; Olfert ED, 1993, GUIDE CARE USE EXPT; Osborn BL, 2002, J PHARMACOL EXP THER, V303, P540, DOI 10.1124/jpet.102.037002; OZZELLO L, 1993, BREAST CANCER RES TR, V25, P265, DOI 10.1007/BF00689841; Padovan E, 2002, J LEUKOCYTE BIOL, V71, P669; Pasche N, 2012, DRUG DISCOV TODAY, V17, P583, DOI 10.1016/j.drudis.2012.01.007; Piehler J, 2000, J BIOL CHEM, V275, P40425, DOI 10.1074/jbc.M006854200; Raab MS, 2009, LANCET, V374, P324, DOI 10.1016/S0140-6736(09)60221-X; Rizza P, 2010, AUTOIMMUNITY, V43, P204, DOI 10.3109/08916930903510880; Rossi EA, 2011, BLOOD, V118, P1877, DOI 10.1182/blood-2011-03-343145; Rossi EA, 2009, BLOOD, V114, P3864, DOI 10.1182/blood-2009-06-228890; Rozewski DM, 2012, AAPS J, V14, P872, DOI 10.1208/s12248-012-9401-2; Santonocito AM, 2004, LEUKEMIA RES, V28, P469, DOI 10.1016/j.leukres.2003.09.015; Schaar CG, 2005, ANN ONCOL, V16, P634, DOI 10.1093/annonc/mdi125; SCHLESINGER JJ, 1983, VIROLOGY, V125, P8, DOI 10.1016/0042-6822(83)90059-4; Siegel R, 2014, CA-CANCER J CLIN, V64, P9, DOI 10.3322/caac.21208; Sondergeld P, 2015, CLIN ADV HEMATOL ONC, V13, P599; Stewart WEI, 1981, INTERFERON SYSTEM, P135; Thakur ML, 1997, J IMMUNOTHER, V20, P194, DOI 10.1097/00002371-199705000-00004; Trown PW, 1986, CANCER S, V57, P1648; Xuan CY, 2010, BLOOD, V115, P2864, DOI 10.1182/blood-2009-10-250555; Yang XM, 2014, CANCER CELL, V25, P37, DOI 10.1016/j.ccr.2013.12.004; Yoo EM, 2015, J INTERF CYTOK RES, V35, P281, DOI 10.1089/jir.2014.0125	47	27	29	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162472	10.1371/journal.pone.0162472	http://dx.doi.org/10.1371/journal.pone.0162472			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611189	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900109
J	Uhde, AK; Herder, V; Khan, MA; Ciurkiewicz, M; Schaudien, D; Teich, R; Floess, S; Baumgartner, W; Huehn, J; Beineke, A				Uhde, Ann-Kathrin; Herder, Vanessa; Khan, Muhammad Akram; Ciurkiewicz, Malgorzata; Schaudien, Dirk; Teich, Rene; Floess, Stefan; Baumgaertner, Wolfgang; Huehn, Jochen; Beineke, Andreas			Viral Infection of the Central Nervous System Exacerbates Interleukin-10 Receptor Deficiency-Mediated Colitis in SJL Mice	PLOS ONE			English	Article							INFLAMMATORY-BOWEL-DISEASE; THEILERS MURINE ENCEPHALOMYELITIS; REGULATORY T-CELLS; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; BLOOD-BRAIN-BARRIER; MULTIPLE-SCLEROSIS; VIRUS-INFECTION; CROHNS-DISEASE; CYTOKINE PRODUCTION; MATRIX METALLOPROTEINASES	Theiler's murine encephalomyelitis virus (TMEV)-infection is a widely used animal model for studying demyelinating disorders, including multiple sclerosis (MS). The immunosuppressive cytokine Interleukin (IL)-10 counteracts hyperactive immune responses and critically controls immune homeostasis in infectious and autoimmune disorders. In order to investigate the effect of signaling via Interleukin-10 receptor (IL-10R) in infectious neurological diseases, TMEV-infected SJL mice were treated with IL-10R blocking antibody (Ab) in the acute and chronic phase of the disease. The findings demonstrate that (i) Ab-mediated IL-10 neutralization leads to progressive colitis with a reduction in Foxp3(+) regulatory T cells and increased numbers of CD8(+)CD44(+) memory T cells as well as activated CD4(+)CD69(+) and CD8(+)CD69(+) T cells in uninfected mice. (ii) Concurrent acute TMEV-infection worsened enteric disease-mediated by IL-10R neutralization. Virus-triggered effects were associated with an enhanced activation of CD4(+) T helper cells and CD8(+) cytotoxic T lymphocytes and augmented cytokine expression. By contrast, (iii) IL-10R neutralization during chronic TMEV-infection was not associated with enhanced peripheral immunopathology but an increased CD3(+) T cell influx in the spinal cord. IL-10R neutralization causes a breakdown in peripheral immune tolerance in genetically predisposed mice, which leads to immune-mediated colitis, resembling inflammatory bowel disease. Hyperactive immune state following IL-10R blockade is enhanced by central nervous system-restricted viral infection in a disease phase-dependent manner.	[Uhde, Ann-Kathrin; Herder, Vanessa; Khan, Muhammad Akram; Ciurkiewicz, Malgorzata; Baumgaertner, Wolfgang; Beineke, Andreas] Univ Vet Med Hannover, Dept Pathol, Hannover, Germany; [Herder, Vanessa; Khan, Muhammad Akram; Ciurkiewicz, Malgorzata; Baumgaertner, Wolfgang; Beineke, Andreas] Ctr Syst Neurosci, Hannover, Germany; [Khan, Muhammad Akram] PMAS Arid Agr Univ, Dept Pathobiol, Fac Vet & Anim Sci, Rawalpindi, Pakistan; [Schaudien, Dirk] Fraunhofer Inst Toxicol & Expt Med ITEM, Hannover, Germany; [Teich, Rene; Floess, Stefan; Huehn, Jochen] Helmholtz Ctr Infect Res, Expt Immunol, Braunschweig, Germany	University of Veterinary Medicine Hannover, Foundation; Arid Agriculture University; Fraunhofer Gesellschaft; Helmholtz Association; Helmholtz-Center for Infection Research	Beineke, A (corresponding author), Univ Vet Med Hannover, Dept Pathol, Hannover, Germany.; Beineke, A (corresponding author), Ctr Syst Neurosci, Hannover, Germany.	andreas.beineke@tiho-hannover.de	Herder, Vanessa/AAG-6647-2020	Khan, Muhammad Akram/0000-0003-2137-9614; Ciurkiewicz, Malgorzata/0000-0001-6277-7366; Herder, Vanessa/0000-0003-4814-1382	Deutsche Forschungsgemeinschaft (DFG) [BE 4200/1-2, HU 1300/5-2]; Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of Ministry of Science and Culture of Lower Saxony	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of Ministry of Science and Culture of Lower Saxony	This study was supported by the Deutsche Forschungsgemeinschaft (DFG, BE 4200/1-2; HU 1300/5-2) and in part by a grant from the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors would like to thank Bettina Buck, Petra Grunig, Kerstin Schone, Caroline Schutz, Danuta Waschke, Kirsten Lohr and Beate Pietzsch for the excellent technical support. The BeAn-strain of TMEV was a generous gift of Prof. Dr. H. L. Lipton (Department of Microbiology-Immunology, University of Illinois, Chicago, IL, USA). This study was supported by the Deutsche Forschungsgemeinschaft (DFG, BE 4200/1-2; HU 1300/5-2) and in part by a grant from the Niedersachsen-Research Network on Neuroinfectiology (N-RENNT) of the Ministry of Science and Culture of Lower Saxony.	Alkhawajah MM, 2013, MULT SCLER J, V19, P259, DOI 10.1177/1352458512461393; Bai FW, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000610; Ban H, 2008, MOL MED REP, V1, P647, DOI 10.3892/mmr_00000006; Begue B, 2011, AM J GASTROENTEROL, V106, P1544, DOI 10.1038/ajg.2011.112; Belz GT, 2009, IMMUNOL CELL BIOL, V87, P364, DOI 10.1038/icb.2009.22; Berer K, 2011, NATURE, V479, P538, DOI 10.1038/nature10554; Bosca-Watts Marta Maia, 2015, World J Gastrointest Pathophysiol, V6, P1, DOI 10.4291/wjgp.v6.i1.1; Bowen JL, 2009, J IMMUNOL, V183, P6971, DOI 10.4049/jimmunol.0902193; Brand S, 2009, GUT, V58, P1152, DOI 10.1136/gut.2008.163667; Brooks DG, 2006, NAT MED, V12, P1301, DOI 10.1038/nm1492; Calderon-Gomez E, 2016, GASTROENTEROLOGY; Charles PC, 1999, J NEUROIMMUNOL, V100, P64, DOI 10.1016/S0165-5728(99)00189-7; Chastain EML, 2012, IMMUNOL REV, V245, P227, DOI 10.1111/j.1600-065X.2011.01076.x; Creery WD, 1996, EUR J IMMUNOL, V26, P1273, DOI 10.1002/eji.1830260614; Das R, 2006, GENE DEV, V20, P1100, DOI 10.1101/gad.1397406; DELPRETE G, 1993, J IMMUNOL, V150, P353; Doria A, 2008, AUTOIMMUN REV, V8, P24, DOI 10.1016/j.autrev.2008.07.019; Ebert EC, 2009, CLIN EXP IMMUNOL, V155, P65, DOI 10.1111/j.1365-2249.2008.03802.x; Ejrnaes M, 2006, J EXP MED, V203, P2461, DOI 10.1084/jem.20061462; Embry Ashton F., 2004, Journal of Nutritional & Environmental Medicine (Abingdon), V14, P307, DOI 10.1080/13590840500088289; Ercolini AM, 2009, CLIN EXP IMMUNOL, V155, P1, DOI 10.1111/j.1365-2249.2008.03834.x; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Franke A, 2010, NAT GENET, V42, P292, DOI 10.1038/ng.553; Frede N, 2014, BMC IMMUNOL, V15, DOI 10.1186/1471-2172-15-10; Funderburg NT, 2013, IMMUNOLOGY, V140, P87, DOI 10.1111/imm.12114; Garcia-Vega E, 2004, BEHAV RES THER, V42, P367, DOI 10.1016/S0005-7967(03)00146-3; Gerhauser I, 2007, J NEUROPATH EXP NEUR, V66, P809, DOI 10.1097/nen.0b013e3181461f31; Gerhauser I, 2007, J NEUROIMMUNOL, V188, P86, DOI 10.1016/j.jneuroim.2007.05.019; Glocker EO, 2011, ANN NY ACAD SCI, V1246, P102, DOI 10.1111/j.1749-6632.2011.06339.x; Glocker EO, 2009, NEW ENGL J MED, V361, P2033, DOI 10.1056/NEJMoa0907206; Groters S, 2005, ACTA NEUROPATHOL, V110, P369, DOI 10.1007/s00401-005-1055-z; Groux H, 1996, J EXP MED, V184, P19, DOI 10.1084/jem.184.1.19; Hadis U, 2011, IMMUNITY, V34, P237, DOI 10.1016/j.immuni.2011.01.016; Hang L, 2013, J IMMUNOL, V191, P1927, DOI 10.4049/jimmunol.1201457; Hansenne I, 2009, NEUROIMMUNOMODULAT, V16, P35, DOI 10.1159/000179665; Hansmann F, 2012, ACTA NEUROPATHOL, V124, P127, DOI 10.1007/s00401-012-0942-3; Heinrich F, 2015, VET IMMUNOL IMMUNOP, V168, P140, DOI 10.1016/j.vetimm.2015.10.015; Herder V, 2014, BRAIN PATHOL; Herder V, 2012, J NEUROIMMUNOL, V249, P27, DOI 10.1016/j.jneuroim.2012.04.010; Herder V, 2012, J NEUROIMMUNOL, V244, P84, DOI 10.1016/j.jneuroim.2012.01.010; Hou WQ, 2014, J VIROL, V88, P8479, DOI 10.1128/JVI.00724-14; Hou WQ, 2009, J EXP MED, V206, P313, DOI 10.1084/jem.20082030; Ito S, 1999, BLOOD, V93, P1456, DOI 10.1182/blood.V93.5.1456; Iyer SS, 2012, CRIT REV IMMUNOL, V32, P23, DOI 10.1615/CritRevImmunol.v32.i1.30; James JA, 1998, J IMMUNOL, V160, P502; Jin YH, 2007, J VIROL, V81, P11690, DOI 10.1128/JVI.01034-07; Jin YH, 2013, J VIROL, V87, P11538, DOI 10.1128/JVI.01967-13; Kaser A, 2010, ANNU REV IMMUNOL, V28, P573, DOI 10.1146/annurev-immunol-030409-101225; Kayama H, 2012, INT IMMUNOL, V24, P673, DOI 10.1093/intimm/dxs094; Kreutzer M, 2012, BRAIN PATHOL, V22, P454, DOI 10.1111/j.1750-3639.2011.00541.x; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Kullberg MC, 2006, J EXP MED, V203, P2485, DOI 10.1084/jem.20061082; Kummerfeld M, 2012, INTERVIROLOGY, V55, P401, DOI 10.1159/000336563; Kummerfeld M, 2009, J VIROL METHODS, V160, P185, DOI 10.1016/j.jviromet.2009.04.030; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Lassmann Hans, 2009, Rinsho Shinkeigaku, V49, P715; Lee JC, 2011, J CLIN INVEST, V121, P4170, DOI 10.1172/JCI59255; Li BF, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7131; Li J, 2004, AM J GASTROENTEROL, V99, P1129, DOI 10.1111/j.1572-0241.2004.04155.x; Lin CC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4551; Lin MT, 1998, VIROLOGY, V245, P270, DOI 10.1006/viro.1998.9170; Lindsey JW, 1996, IMMUNOGENETICS, V44, P292, DOI 10.1007/s002510050126; Lipton H L, 1976, UCLA Forum Med Sci, P263; LIPTON HL, 1975, INFECT IMMUN, V11, P1147, DOI 10.1128/IAI.11.5.1147-1155.1975; Lord JD, 2015, WORLD J GASTROENTERO, V21, P11236, DOI 10.3748/wjg.v21.i40.11236; Lord JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136485; Loscher W, 2005, PROG NEUROBIOL, V76, P22, DOI 10.1016/j.pneurobio.2005.04.006; Lutz C, 2015, CLIN EXP IMMUNOL, V181, P343, DOI 10.1111/cei.12635; MALEFYT RD, 1991, J EXP MED, V174, P915; Mardini HE, 2004, DIGEST DIS SCI, V49, P492, DOI 10.1023/B:DDAS.0000020509.23162.cc; Marlow GJ, 2013, WORLD J GASTROENTERO, V19, P3931, DOI 10.3748/wjg.v19.i25.3931; Massacesi L, 2002, CLIN NEUROL NEUROSUR, V104, P177, DOI 10.1016/S0303-8467(02)00035-5; Matullo CM, 2010, J VIROL, V84, P312, DOI 10.1128/JVI.00727-09; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Meddings JB, 2000, GASTROENTEROLOGY, V119, P1019, DOI 10.1053/gast.2000.18152; Meinl E, 2008, J NEUROL SCI, V274, P42, DOI 10.1016/j.jns.2008.06.032; Monteyne P, 1997, IMMUNOL REV, V159, P163, DOI 10.1111/j.1600-065X.1997.tb01014.x; Moore KW, 2001, ANNU REV IMMUNOL, V19, P683, DOI 10.1146/annurev.immunol.19.1.683; Moore TC, 2012, J VIROL, V86, P10841, DOI 10.1128/JVI.01402-12; Moran CJ, 2013, INFLAMM BOWEL DIS, V19, P115, DOI 10.1002/ibd.22974; Mosser DM, 2008, IMMUNOL REV, V226, P205, DOI 10.1111/j.1600-065X.2008.00706.x; Murray PD, 1998, J NEUROSCI, V18, P7306; Navarrete-Talloni MJ, 2010, BRAIN PATHOL, V20, P890, DOI 10.1111/j.1750-3639.2010.00383.x; Niino M, 2014, J NEUROIMMUNOL, V270, P86, DOI 10.1016/j.jneuroim.2014.03.011; Norman JM, 2015, CELL, V160, P447, DOI 10.1016/j.cell.2015.01.002; Nouri M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106335; Ochoa-Reparaz J, 2009, J IMMUNOL, V183, P6041, DOI 10.4049/jimmunol.0900747; Owens GP, 2009, ANN NEUROL, V65, P639, DOI 10.1002/ana.21641; Pachner AR, 2011, J NEUROIMMUNOL, V232, P35, DOI 10.1016/j.jneuroim.2010.09.026; Pan WH, 2011, CURR PHARM DESIGN, V17, P3729, DOI 10.2174/138161211798220918; Peltoniemi J, 2002, J NEUROIMMUNOL, V132, P83, DOI 10.1016/S0165-5728(02)00312-0; Podojil JR, 2013, J AUTOIMMUN, V44, P71, DOI 10.1016/j.jaut.2013.04.001; Pringproa K, 2008, INT J DEV NEUROSCI, V26, P283, DOI 10.1016/j.ijdevneu.2008.01.008; Rakoff-Nahoum S, 2006, IMMUNITY, V25, P319, DOI 10.1016/j.immuni.2006.06.010; Richards MH, 2011, J AUTOIMMUN, V36, P142, DOI 10.1016/j.jaut.2010.12.005; Richter K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003735; Rocha CS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085923; RODRIGUEZ M, 1994, J IMMUNOL, V153, P3811; Rodriguez M, 1996, J IMMUNOL, V157, P5699; Roe K, 2012, J GEN VIROL, V93, P1193, DOI 10.1099/vir.0.040899-0; ROSE NR, 1973, CLIN EXP IMMUNOL, V15, P281; Rothaug M, 2016, BBA-MOL CELL RES, V1863, P1218, DOI 10.1016/j.bbamcr.2016.03.018; Sabat R, 2010, CYTOKINE GROWTH F R, V21, P331, DOI 10.1016/j.cytogfr.2010.09.002; SADOVNICK AD, 1989, NEW ENGL J MED, V321, P762; Saraiva M, 2010, NAT REV IMMUNOL, V10, P170, DOI 10.1038/nri2711; Seehusen F, 2010, BRAIN PATHOL, V20, P551, DOI 10.1111/j.1750-3639.2009.00332.x; Shim JO, 2014, J HUM GENET, V59, P337, DOI 10.1038/jhg.2014.32; Shouval DS, 2014, ADV IMMUNOL, V122, P177, DOI 10.1016/B978-0-12-800267-4.00005-5; SMITH QR, 1993, ADV EXP MED BIOL, V331, P83; SOUZA CMD, 1974, J IMMUNOL, V112, P1369; Spencer SD, 1998, J EXP MED, V187, P571, DOI 10.1084/jem.187.4.571; Stasi C, 2008, DIGEST DIS, V26, P156, DOI 10.1159/000116774; Tamaki H, 2006, GASTROENTEROLOGY, V131, P1110, DOI 10.1053/j.gastro.2006.08.023; Trandem K, 2011, J VIROL, V85, P6822, DOI 10.1128/JVI.00510-11; Tsunoda I, 1996, J NEUROPATH EXP NEUR, V55, P673, DOI 10.1097/00005072-199606000-00001; Tsunoda I, 2008, FUTURE VIROL, V3, P579, DOI 10.2217/17460794.3.6.579; Uhlig HH, 2014, GASTROENTEROLOGY, V147, P990, DOI 10.1053/j.gastro.2014.07.023; Ulrich R, 2008, NEUROPATH APPL NEURO, V34, P603, DOI 10.1111/j.1365-2990.2008.00956.x; Ulrich R, 2005, DEV NEUROSCI-BASEL, V27, P408, DOI 10.1159/000088455; Ulrich R, 2006, J NEUROPATH EXP NEUR, V65, P783, DOI 10.1097/01.jnen.0000229990.32795.0d; Ulrich R, 2010, J CELL MOL MED, V14, P434, DOI 10.1111/j.1582-4934.2008.00646.x; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Visser J, 2009, ANN NY ACAD SCI, V1165, P195, DOI 10.1111/j.1749-6632.2009.04037.x; Wang J, 2014, J EXP MED, V211, P2397, DOI 10.1084/jem.20140625; Yacyshyn B, 1996, DIGEST DIS SCI, V41, P2493, DOI 10.1007/BF02100148; Yoon SI, 2006, J BIOL CHEM, V281, P35088, DOI 10.1074/jbc.M606791200; Yu YJ, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009835; Zhang XM, 2004, INT IMMUNOL, V16, P249, DOI 10.1093/intimm/dxh029; Zigmond E, 2014, IMMUNITY, V40, P720, DOI 10.1016/j.immuni.2014.03.012	129	8	8	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161883	10.1371/journal.pone.0161883	http://dx.doi.org/10.1371/journal.pone.0161883			36	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611574	Green Submitted, Green Published, gold, Green Accepted			2022-12-26	WOS:000383255900034
J	Thangarajah, T; Shahbazi, S; Pendegrass, CJ; Lambert, S; Alexander, S; Blunn, GW				Thangarajah, Tanujan; Shahbazi, Shirin; Pendegrass, Catherine J.; Lambert, Simon; Alexander, Susan; Blunn, Gordon W.			Tendon Reattachment to Bone in an Ovine Tendon Defect Model of Retraction Using Allogenic and Xenogenic Demineralised Bone Matrix Incorporated with Mesenchymal Stem Cells	PLOS ONE			English	Article							ROTATOR CUFF REPAIR; ARTHROSCOPIC REPAIR; IN-VIVO; AUGMENTATION; INTEGRITY; TEARS; SUPRASPINATUS; INSERTION; GROWTH	Background Tendon-bone healing following rotator cuff repairs is mainly impaired by poor tissue quality. Demineralised bone matrix promotes healing of the tendon-bone interface but its role in the treatment of tendon tears with retraction has not been investigated. We hypothesized that cortical demineralised bone matrix used with minimally manipulated mesenchymal stem cells will result in improved function and restoration of the tendon-bone interface with no difference between xenogenic and allogenic scaffolds. Materials and Methods In an ovine model, the patellar tendon was detached from the tibial tuberosity and a complete distal tendon transverse defect measuring 1 cm was created. Suture anchors were used to reattach the tendon and xenogenic demineralised bone matrix + minimally manipulated mesenchymal stem cells (n = 5), or allogenic demineralised bone matrix + minimally manipulated mesenchymal stem cells (n = 5) were used to bridge the defect. Graft incorporation into the tendon and its effect on regeneration of the enthesis was assessed using histomorphometry. Force plate analysis was used to assess functional recovery. Results Compared to the xenograft, the allograft was associated with significantly higher functional weight bearing at 6 (P = 0.047), 9 (P = 0.028), and 12 weeks (P = 0.009). In the allogenic group this was accompanied by greater remodeling of the demineralised bone matrix into tendon-like tissue in the region of the defect (p = 0.015), and a more direct type of enthesis characterized by significantly more fibrocartilage (p = 0.039). No failures of tendon-bone healing were noted in either group. Conclusion Demineralised bone matrix used with minimally manipulated mesenchymal stem cells promotes healing of the tendon-bone interface in an ovine model of acute tendon retraction, with superior mechanical and histological results associated with use of an allograft.	[Thangarajah, Tanujan; Shahbazi, Shirin; Pendegrass, Catherine J.; Blunn, Gordon W.] Royal Natl Orthopaed Hosp Trust, Univ Coll London, Inst Orthopaed & Musculoskeletal Sci, Div Surg & Intervent Sci,John Scales Ctr Biomed E, Brockley Hill, Stanmore HA7 4LP, Middx, England; [Lambert, Simon; Alexander, Susan] Royal Natl Orthopaed Hosp, Shoulder & Elbow Serv, Stanmore HA7 4LP, Middx, England	University of London; University College London; Royal National Orthopaedic Hospital NHS Trust; University of London; University College London; Royal National Orthopaedic Hospital NHS Trust	Thangarajah, T (corresponding author), Royal Natl Orthopaed Hosp Trust, Univ Coll London, Inst Orthopaed & Musculoskeletal Sci, Div Surg & Intervent Sci,John Scales Ctr Biomed E, Brockley Hill, Stanmore HA7 4LP, Middx, England.	tanujan1@hotmail.com	Lambert, Simon/I-1444-2019		Engineering and Physical Sciences Research Council (EPSRC) Proof of Concept; 'EPRSC Proof of Concept' grant; EPSRC [EP/I019103/1, EP/J017620/1] Funding Source: UKRI	Engineering and Physical Sciences Research Council (EPSRC) Proof of Concept; 'EPRSC Proof of Concept' grant; EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This study was funded by The Engineering and Physical Sciences Research Council (EPSRC) Proof of Concept. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was funded by: 'EPRSC Proof of Concept' grant.	Aerssens J, 1998, ENDOCRINOLOGY, V139, P663, DOI 10.1210/en.139.2.663; Aurora A, 2012, J SHOULDER ELB SURG, V21, P1064, DOI 10.1016/j.jse.2011.05.014; Awad HA, 1999, TISSUE ENG, V5, P267, DOI 10.1089/ten.1999.5.267; Bishop J, 2006, J SHOULDER ELB SURG, V15, P290, DOI 10.1016/j.jse.2005.09.017; Black LL, 2007, VET THER, V8, P272; Carr AJ, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19800; Chung SW, 2013, AM J SPORT MED, V41, P1674, DOI 10.1177/0363546513485719; Chung SW, 2011, AM J SPORT MED, V39, P2099, DOI 10.1177/0363546511415659; Deniz G, 2014, ARCH ORTHOP TRAUM SU, V134, P985, DOI 10.1007/s00402-014-2009-5; Dines David M, 2007, Instr Course Lect, V56, P13; Dorman Lisa J, 2012, Biomed Sci Instrum, V48, P81; Galatz LM, 2004, J BONE JOINT SURG AM, V86A, P219, DOI 10.2106/00004623-200402000-00002; Gulati BR, 2013, CELLS TISSUES ORGANS, V198, P377, DOI 10.1159/000358231; Halder AM, 2002, J BONE JOINT SURG AM, V84A, P780, DOI 10.2106/00004623-200205000-00013; Hernigou P, 2005, J BONE JOINT SURG AM, V87A, P1430, DOI 10.2106/JBJS.D.02215; Hernigou P, 2006, J BONE JOINT SURG AM, V88A, P2565, DOI 10.2106/JBJS.E.01455; Hernigou P, 2014, INT ORTHOP, V38, P1811, DOI 10.1007/s00264-014-2391-1; Hsu SL, 2013, J SURG RES, DOI [10.1016/j.jss.2013.09.025, DOI 10.1016/J.JSS.2013.09.025PMID]; Iannotti JP, 2006, J BONE JOINT SURG AM, V88A, P1238, DOI 10.2106/JBJS.E.00524; Juncosa-Melvin N, 2006, TISSUE ENG, V12, P369, DOI 10.1089/ten.2006.12.369; Kalia P, 2006, TISSUE ENG, V12, P1617, DOI 10.1089/ten.2006.12.1617; Kalia P, 2009, TISSUE ENG PT A, V15, P3689, DOI [10.1089/ten.tea.2008.0676, 10.1089/ten.TEA.2008.0676]; Kilicoglu OI, 2012, ACTA ORTHOP TRAUMATO, V46, P443, DOI 10.3944/AOTT.2012.2748; Klepps S, 2004, AM J SPORT MED, V32, P1716, DOI 10.1177/0363546504265262; Liu GP, 2010, TISSUE ENG PT A, V16, P971, DOI [10.1089/ten.tea.2009.0516, 10.1089/ten.TEA.2009.0516]; Lovric V, 2012, AM J SPORT MED, V40, P2365, DOI 10.1177/0363546512457648; Ma CB, 2007, AM J SPORT MED, V35, P597, DOI 10.1177/0363546506296312; Merolla Giovanni, 2014, Muscles Ligaments Tendons J, V4, P425; NEER CS, 1983, J BONE JOINT SURG AM, V65, P1232, DOI 10.2106/00004623-198365090-00003; Oryan A, 2014, J ORTHOP SURG RES, V9, DOI 10.1186/1749-799X-9-18; Pietrzak WS, 2012, CELL TISSUE BANK, V13, P653, DOI 10.1007/s10561-011-9286-9; Raposio E, 2014, PLAST RECONSTR SURG, V133, P1406, DOI 10.1097/PRS.0000000000000170; Schwarting T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116833; Sclamberg SG, 2004, J SHOULDER ELB SURG, V13, P538, DOI 10.1016/j.jse.2004.03.005; Sun J, 2015, MOL MED REP, V12, P4230, DOI 10.3892/mmr.2015.3954; Sundar S, 2009, J BIOMED MATER RES B, V88B, P115, DOI 10.1002/jbm.b.31157; Tashjian RZ, 2010, AM J SPORT MED, V38, P2435, DOI 10.1177/0363546510382835; Thangarajah T, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115587495; Thomopoulos S, 2010, J MUSCULOSKEL NEURON, V10, P35; Thompson SM, 2011, J SHOULDER ELB SURG, V20, P899, DOI 10.1016/j.jse.2011.01.005; URIST MR, 1965, SCIENCE, V150, P893, DOI 10.1126/science.150.3698.893; Yokoya S, 2008, AM J SPORT MED, V36, P1298, DOI 10.1177/0363546508314416; Yokoya S, 2012, AM J SPORT MED, V40, P1259, DOI 10.1177/0363546512442343	43	20	20	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161473	10.1371/journal.pone.0161473	http://dx.doi.org/10.1371/journal.pone.0161473			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606597	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600007
J	Parker, GJ; Leppert, T; Anex, DS; Hilmer, JK; Matsunami, N; Baird, L; Stevens, J; Parsawar, K; Durbin-Johnson, BP; Rocke, DM; Nelson, C; Fairbanks, DJ; Wilson, AS; Rice, RH; Woodward, SR; Bothner, B; Hart, BR; Leppert, M				Parker, Glendon J.; Leppert, Tami; Anex, Deon S.; Hilmer, Jonathan K.; Matsunami, Nori; Baird, Lisa; Stevens, Jeffery; Parsawar, Krishna; Durbin-Johnson, Blythe P.; Rocke, David M.; Nelson, Chad; Fairbanks, Daniel J.; Wilson, Andrew S.; Rice, Robert H.; Woodward, Scott R.; Bothner, Brian; Hart, Bradley R.; Leppert, Mark			Demonstration of Protein-Based Human Identification Using the Hair Shaft Proteome	PLOS ONE			English	Article							KERATIN GENE FAMILY; FORENSIC IDENTIFICATION; GENOME SEQUENCE; DNA EXTRACTION; TANDEM; PEPTIDES; REVEALS; PRESERVATION; NEANDERTHAL; PRINCIPLES	Human identification from biological material is largely dependent on the ability to characterize genetic polymorphisms in DNA. Unfortunately, DNA can degrade in the environment, sometimes below the level at which it can be amplified by PCR. Protein however is chemically more robust than DNA and can persist for longer periods. Protein also contains genetic variation in the form of single amino acid polymorphisms. These can be used to infer the status of non-synonymous single nucleotide polymorphism alleles. To demonstrate this, we used mass spectrometry-based shotgun proteomics to characterize hair shaft proteins in 66 European-American subjects. A total of 596 single nucleotide polymorphism alleles were correctly imputed in 32 loci from 22 genes of subjects' DNA and directly validated using Sanger sequencing. Estimates of the probability of resulting individual non-synonymous single nucleotide polymorphism allelic profiles in the European population, using the product rule, resulted in a maximum power of discrimination of 1 in 12,500. Imputed non-synonymous single nucleotide polymorphism profiles from European-American subjects were considerably less frequent in the African population (maximum likelihood ratio = 11,000). The converse was true for hair shafts collected from an additional 10 subjects with African ancestry, where some profiles were more frequent in the African population. Genetically variant peptides were also identified in hair shaft datasets from six archaeological skeletal remains (up to 260 years old). This study demonstrates that quantifiable measures of identity discrimination and biogeographic background can be obtained from detecting genetically variant peptides in hair shaft protein, including hair from bioarchaeological contexts.	[Parker, Glendon J.; Fairbanks, Daniel J.] Utah Valley Univ, Dept Biol, Orem, UT 84058 USA; [Parker, Glendon J.; Leppert, Tami] Prot Based Identificat Technol LLC, Orem, UT 84058 USA; [Leppert, Tami; Matsunami, Nori; Baird, Lisa; Stevens, Jeffery; Leppert, Mark] Univ Utah, Dept Human Genet, Salt Lake City, UT USA; [Parker, Glendon J.; Anex, Deon S.; Hart, Bradley R.] Lawrence Livermore Natl Lab, Forens Sci Ctr, Livermore, CA USA; [Hilmer, Jonathan K.; Bothner, Brian] Montana State Univ, Dept Chem & Biochem, Bozeman, MT 59717 USA; [Parsawar, Krishna; Nelson, Chad] Univ Utah, Mass Spectrometry & Prote Core Facil, Salt Lake City, UT USA; [Durbin-Johnson, Blythe P.; Rocke, David M.] Univ Calif Davis, Dept Publ Hlth Sci, Davis, CA 95616 USA; [Wilson, Andrew S.] Univ Bradford, Sch Archaeol Sci, Bradford, W Yorkshire, England; [Rice, Robert H.] Univ Calif Davis, Dept Environm Toxicol, Davis, CA 95616 USA; [Woodward, Scott R.] Sorenson Mol Geneal Fdn, Salt Lake City, UT USA	Utah System of Higher Education; Utah Valley University; Utah System of Higher Education; University of Utah; United States Department of Energy (DOE); Lawrence Livermore National Laboratory; Montana State University System; Montana State University Bozeman; Utah System of Higher Education; University of Utah; University of California System; University of California Davis; University of Bradford; University of California System; University of California Davis	Parker, GJ (corresponding author), Utah Valley Univ, Dept Biol, Orem, UT 84058 USA.; Parker, GJ (corresponding author), Prot Based Identificat Technol LLC, Orem, UT 84058 USA.; Parker, GJ (corresponding author), Lawrence Livermore Natl Lab, Forens Sci Ctr, Livermore, CA USA.	glendon.parker@uvu.edu	Fairbanks, Daniel J./ABH-9948-2020; Rice, Robert/AAP-7813-2021	Parker, Glendon/0000-0003-2937-5853; Anex, Deon/0000-0002-3491-9379; Hilmer, Jonathan/0000-0002-1494-6353; wilson, andrew/0000-0003-1346-937X	Utah Governors Office of Commercial Development [121668, 132043]; Scholarship Activities Committee of the College of Science and Health at Utah Valley University; Murdock Charitable Trust; NIH from the COBRE Program of the National Center for Research Resources [P20RR020185, 1P20RR024237]; U.S. Department of Energy by Lawrence Livermore National Laboratory [DE-AC5207NA27344, B601942]; Lung GO Sequencing Project [HL-102923]; WHI Sequencing Project [HL-102924]; Broad GO Sequencing Project [HL-102925]; Seattle GO Sequencing Project [HL-102926]; Heart GO Sequencing Project [HL-103010]; National Institutes of Justice [2011-DN-BX-K543]; National Institute of Environmental Health Sciences [2 P42 ES04699]; National Center for Advancing Translational Sciences (NIH) [UL1 TR000002]; U.S. Department of Energy by Lawrence Liver-more National Laboratory [DE-AC52-07NA27344]; College of Science & Health at Utah Valley University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR001067] Funding Source: NIH RePORTER	Utah Governors Office of Commercial Development; Scholarship Activities Committee of the College of Science and Health at Utah Valley University; Murdock Charitable Trust; NIH from the COBRE Program of the National Center for Research Resources; U.S. Department of Energy by Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Lung GO Sequencing Project; WHI Sequencing Project; Broad GO Sequencing Project; Seattle GO Sequencing Project; Heart GO Sequencing Project; National Institutes of Justice; National Institute of Environmental Health Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); National Center for Advancing Translational Sciences (NIH); U.S. Department of Energy by Lawrence Liver-more National Laboratory(United States Department of Energy (DOE)); College of Science & Health at Utah Valley University; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	The authors wish to thank the Technology Commercialization Innovation Program (Contracts #121668, #132043) of the Utah Governors Office of Commercial Development, the Scholarship Activities Committee of the College of Science and Health at Utah Valley University, and Murdock Charitable Trust and NIH Grant Numbers P20RR020185 and 1P20RR024237 from the COBRE Program of the National Center for Research Resources for support of the MSU mass spectrometry facility. Part of this work was performed under the auspices of the U.S. Department of Energy by Lawrence Livermore National Laboratory under Contract DE-AC5207NA27344 and subcontract B601942. The authors would like to thank the NHLBI GO Exome Sequencing Project and its ongoing studies which produced and provided exome variant calls for comparison: the Lung GO Sequencing Project (HL-102923), the WHI Sequencing Project (HL-102924), the Broad GO Sequencing Project (HL-102925), the Seattle GO Sequencing Project (HL-102926) and the Heart GO Sequencing Project (HL-103010). Work conducted on African American and Kenyan samples was supported by National Institutes of Justice grant 2011-DN-BX-K543, National Institute of Environmental Health Sciences grant 2 P42 ES04699, and the National Center for Advancing Translational Sciences (NIH) grant #UL1 TR000002. GJP and TL were affiliated with Protein-Based Identification Technologies LLC (PBIT). The funder provided support in the form of salaries for authors GJP and TL, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'Authors Contributions' section.; The authors thank Jacquie Howard and Melissa Huntzinger for database construction and technical assistance, Dr. Bruce Weir (University of Washington, Seattle) for helpful statistical advice, direction and critical reading of the manuscript, Dr. Katelyn Mason (Lawrence Liver-more National Laboratory) for critical reading of the manuscript, and Drs. Haagen Klaus (George Mason University) and Jacinda Sampson (Stanford University) for their advice. We acknowledge the technical support of the University of Utah Health Sciences Center DNA sequencing, and Mass Spectrometry and Proteomics, Core Facilities. We thank the Division of Biotechnology, and the Department of Biology, in the College of Science & Health at Utah Valley University for space and resources to conduct the study. The authors thank the Technology Commercialization Innovation Program of the Utah Governor's Office of Commercial Development, the Scholarship Activities Committee of the College of Science & Health at Utah Valley University, the Murdock Charitable Trust, the COBRE Program of the National Center for Research Resources, and the National Institutes of Health. Part of this work was performed under the auspices of the U.S. Department of Energy by Lawrence Liver-more National Laboratory under Contract DE-AC52-07NA27344.	Agarwala R, 2015, NUCLEIC ACIDS RES, V43, pD6, DOI 10.1093/nar/gku1130; Allentoft ME, 2012, P ROY SOC B-BIOL SCI, V279, P4724, DOI 10.1098/rspb.2012.1745; ALTMAN DG, 1994, BRIT MED J, V309, P102, DOI 10.1136/bmj.309.6947.102; Altshuler D, 2010, NATURE, V467, P1061, DOI 10.1038/nature09534; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Altshuler DM, 2010, NATURE, V467, P52, DOI 10.1038/nature09298; [Anonymous], PLOS ONE; [Anonymous], 2009, STRENGTHENING FORENS; Bada JL, 1999, PHILOS T ROY SOC B, V354, P77, DOI 10.1098/rstb.1999.0361; Barthelemy NR, 2012, ANAL BIOCHEM, V421, P43, DOI 10.1016/j.ab.2011.10.011; Beck M, 2011, CURR OPIN BIOTECH, V22, P3, DOI 10.1016/j.copbio.2010.09.002; Bengtsson CF, 2012, ANN ANAT, V194, P17, DOI 10.1016/j.aanat.2011.03.013; Bowden PE, 2005, J INVEST DERMATOL, V124, pXV, DOI 10.1111/j.0022-202X.2005.23647.x; Brautbar N, 1999, TOXICOL IND HEALTH, V15, P532, DOI 10.1177/074823379901500602; Bryc K, 2010, P NATL ACAD SCI USA, V107, P786, DOI 10.1073/pnas.0909559107; Bunger MK, 2007, J PROTEOME RES, V6, P2331, DOI 10.1021/pr0700908; Butler JM, 2010, FUNDAMENTALS OF FORENSIC DNA TYPING, P1; Callaway E, 2013, NATURE, V503, P18, DOI 10.1038/503018a; Cann HM, 2002, SCIENCE, V296, P261; Cottrell JS, 2011, J PROTEOMICS, V74, P1842, DOI 10.1016/j.jprot.2011.05.014; Coulombe PA, 2002, CURR OPIN CELL BIOL, V14, P110, DOI 10.1016/S0955-0674(01)00301-5; Craig R, 2004, BIOINFORMATICS, V20, P1466, DOI 10.1093/bioinformatics/bth092; Curran JM, 2002, SCI JUSTICE, V42, P29, DOI 10.1016/S1355-0306(02)71794-2; Deedrick D.W., 2004, FORENSIC SCI COMMUNI, V6; Disotell TR, 2012, AM J PHYS ANTHROPOL, V149, P24, DOI 10.1002/ajpa.22159; Edson J, 2013, FORENSIC SCI INT-GEN, V7, P180, DOI 10.1016/j.fsigen.2012.10.001; Evert I.W., 1998, INTERPRETING DNA EVI, V1st; Fenyo D, 2010, METHODS MOL BIOL, V673, P189, DOI 10.1007/978-1-60761-842-3_11; Fu WQ, 2013, NATURE, V493, P216, DOI 10.1038/nature11690; Gelman A, 2003, BAYESIAN DATA ANAL, DOI [10.1038/nature11632, DOI 10.1038/NATURE11632]; Ghesquiere B, 2014, MASS SPECTROM REV, V33, P147, DOI 10.1002/mas.21386; Graffy EA, 2005, J FORENSIC SCI, V50, P1119; Guenther CA, 2014, NAT GENET, V46, P748, DOI 10.1038/ng.2991; Handsaker RE, 2011, NAT GENET, V43, P269, DOI 10.1038/ng.768; Hoopmann MR, 2013, CURR OPIN BIOTECH, V24, P31, DOI 10.1016/j.copbio.2012.10.013; Houck MM, 2002, J FORENSIC SCI, V47, P964; Ishihama Y, 2005, MOL CELL PROTEOMICS, V4, P1265, DOI 10.1074/mcp.M500061-MCP200; JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056; Jeong JH, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.000513; Jia J, 2014, FORENSIC SCI INT-GEN, V8, P187, DOI 10.1016/j.fsigen.2013.09.004; Kidd KK, 2006, FORENSIC SCI INT, V164, P20, DOI 10.1016/j.forsciint.2005.11.017; Kim JJ, 2010, INT J LEGAL MED, V124, P125, DOI 10.1007/s00414-009-0389-9; Laatsch CN, 2014, PEERJ, V2, DOI 10.7717/peerj.506; Lam H, 2011, METHODS, V54, P424, DOI 10.1016/j.ymeth.2011.01.007; Lanning KA, 2009, J FORENSIC SCI, V54, P1198, DOI 10.1111/j.1556-4029.2009.01139.x; Lazaridis I, 2014, NATURE, V513, P409, DOI 10.1038/nature13673; Lee CH, 2012, NAT STRUCT MOL BIOL, V19, P707, DOI 10.1038/nsmb.2330; Lee YJ, 2006, MOL CELL PROTEOMICS, V5, P789, DOI 10.1074/mcp.M500278-MCP200; LINDAHL T, 1993, NATURE, V362, P709, DOI 10.1038/362709a0; Liu F, 2014, HUM GENET, V133, P587, DOI 10.1007/s00439-013-1394-0; MARSHALL RC, 1985, J FORENSIC SCI SOC, V25, P57, DOI 10.1016/S0015-7368(85)72363-8; Mays S., 2013, SCI DEAD GUIDELINE D; McNevin D, 2005, FORENSIC SCI INT, V153, P237, DOI 10.1016/j.forsciint.2005.05.006; McNevin D, 2005, FORENSIC SCI INT, V153, P247, DOI 10.1016/j.forsciint.2005.05.005; Melton T, 2005, J FORENSIC SCI, V50, P73; Mendez FL, 2016, AM J HUM GENET, V98, P728, DOI 10.1016/j.ajhg.2016.02.023; Miyake B, 1990, Forensic Sci Rev, V2, P25; Nesvizhskii AI, 2010, J PROTEOMICS, V73, P2092, DOI 10.1016/j.jprot.2010.08.009; Oien C.T., 2009, FORENSIC SCI COMMUNI, V11; Orlando L, 2013, NATURE, V499, P74, DOI 10.1038/nature12323; Ottoni C, 2009, NATURWISSENSCHAFTEN, V96, P267, DOI 10.1007/s00114-008-0478-5; Paabo S, 2004, ANNU REV GENET, V38, P645, DOI 10.1146/annurev.genet.37.110801.143214; Phillips C, 2013, ELECTROPHORESIS, V34, P1151, DOI 10.1002/elps.201200621; Pinhasi R, 2011, P NATL ACAD SCI USA, V108, P8611, DOI 10.1073/pnas.1018938108; Poinar HN, 1999, P NATL ACAD SCI USA, V96, P8426, DOI 10.1073/pnas.96.15.8426; Pruner-Bey Franz Ignace, 1864, ANTHR REV, V2, P1; Ramos-Fernandez A, 2008, MOL CELL PROTEOMICS, V7, P1748, DOI 10.1074/mcp.M800122-MCP200; Rasmussen M, 2011, SCIENCE, V334, P94, DOI 10.1126/science.1211177; Rasmussen M, 2010, NATURE, V463, P757, DOI 10.1038/nature08835; Reich DE, 2001, NATURE, V411, P199, DOI 10.1038/35075590; Rice RH, 2011, J COSMET SCI, V62, P229; Robertsona KS, 2007, AUSTR J FORENSIC SCI, V39, P107, DOI [10.1016/j.fsigen.2019.102210, DOI 10.1016/J.FSIGEN.2019.102210]; Robinson NE, 2002, P NATL ACAD SCI USA, V99, P5283, DOI 10.1073/pnas.082102799; Rogers MA, 2005, J INVEST DERMATOL, V124, P536, DOI 10.1111/j.0022-202X.2004.23530.x; Rogers MA, 2004, DIFFERENTIATION, V72, P527, DOI 10.1111/j.1432-0436.2004.07209006.x; Sarkissian CD, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003296; Sheynkman GM, 2014, J PROTEOME RES, V13, P228, DOI 10.1021/pr4009207; Shteynberg D, 2013, MOL CELL PROTEOMICS, V12, P2383, DOI 10.1074/mcp.R113.027797; Soares P, 2010, CURR BIOL, V20, pR174, DOI 10.1016/j.cub.2009.11.054; Solazzo C, 2014, ANAL CHEM, V86, P567, DOI 10.1021/ac4026362; Tennessen JA, 2012, SCIENCE, V337, P64, DOI 10.1126/science.1219240; Thompson A.H., 2013, TREATISE GEOCHEMISTR, DOI [10.1016/B978-0-08-095975-7.01227-4, DOI 10.1016/B978-0-08-095975-7.01227-4]; Triggs CM, 2002, FORENSIC SCI INT, V128, P108, DOI 10.1016/S0379-0738(02)00168-8; van Oorschot Roland Ah, 2010, Investig Genet, V1, P14, DOI 10.1186/2041-2223-1-14; Wadsworth C, 2014, RAPID COMMUN MASS SP, V28, P605, DOI 10.1002/rcm.6821; Wang XJ, 2012, J PROTEOME RES, V11, P1009, DOI 10.1021/pr200766z; Weir B. S., 1996, GENETIC DATA ANAL; Wilson AS, 2007, BRIT J DERMATOL, V157, P450, DOI 10.1111/j.1365-2133.2007.07973.x; Wilson Andrew S., 2008, P123, DOI 10.1201/9781420069921.ch6; Wilson AS, 2013, MEN ARE GONE COME SH, P145; Wilson AS., 2007, FORENSIC HUMAN IDENT, P147; ZWEIG MH, 1993, CLIN CHEM, V39, P561	92	62	64	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160653	10.1371/journal.pone.0160653	http://dx.doi.org/10.1371/journal.pone.0160653			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603779	gold, Green Published			2022-12-26	WOS:000383255200006
J	Robbins, MM; Ando, C; Fawcett, KA; Grueter, CC; Hedwig, D; Iwata, Y; Lodwick, JL; Masi, S; Salmi, R; Stoinski, TS; Todd, A; Vercellio, V; Yamagiwa, J				Robbins, Martha M.; Ando, Chieko; Fawcett, Katherine A.; Grueter, Cyril C.; Hedwig, Daniela; Iwata, Yuji; Lodwick, Jessica L.; Masi, Shelly; Salmi, Roberta; Stoinski, Tara S.; Todd, Angelique; Vercellio, Veronica; Yamagiwa, Juichi			Behavioral Variation in Gorillas: Evidence of Potential Cultural Traits	PLOS ONE			English	Article							TOOL USE; WILD CHIMPANZEES; CAPUCHIN MONKEYS; FOOD AVAILABILITY; ANIMAL CULTURES; MOUNTAIN; TRADITIONS; EVOLUTION; DIET; TRANSMISSION	The question of whether any species except humans exhibits culture has generated much debate, partially due to the difficulty of providing conclusive evidence from observational studies in the wild. A starting point for demonstrating the existence of culture that has been used for many species including chimpanzees and orangutans is to show that there is geographic variation in the occurrence of particular behavioral traits inferred to be a result of social learning and not ecological or genetic influences. Gorillas live in a wide variety of habitats across Africa and they exhibit flexibility in diet, behavior, and social structure. Here we apply the 'method of exclusion' to look for the presence/absence of behaviors that could be considered potential cultural traits in well-habituated groups from five study sites of the two species of gorillas. Of the 41 behaviors considered, 23 met the criteria of potential cultural traits, of which one was foraging related, nine were environment related, seven involved social interactions, five were gestures, and one was communication related. There was a strong positive correlation between behavioral dissimilarity and geographic distance among gorilla study sites. Roughly half of all variation in potential cultural traits was intraspecific differences (i.e. variability among sites within a species) and the other 50% of potential cultural traits were differences between western and eastern gorillas. Further research is needed to investigate if the occurrence of these traits is influenced by social learning. These findings emphasize the importance of investigating cultural traits in African apes and other species to shed light on the origin of human culture.	[Robbins, Martha M.; Grueter, Cyril C.; Hedwig, Daniela] Max Planck Inst Evolutionary Anthropol, Leipzig, Germany; [Ando, Chieko; Iwata, Yuji] Kyoto Prefectural Univ, Grad Sch Life & Environm Sci, Kyoto, Japan; [Fawcett, Katherine A.; Stoinski, Tara S.; Vercellio, Veronica] Dian Fossey Gorilla Fund Int, Atlanta, GA USA; [Grueter, Cyril C.] Univ Western Australia, Sch Anat Physiol & Human Biol, Perth, WA 6009, Australia; [Lodwick, Jessica L.] SUNY Stony Brook, Interdept Doctoral Program Anthropol Sci, Stony Brook, NY 11794 USA; [Masi, Shelly] Univ Paris Diderot Paris 7 Ecoanthropol & Ethnobi, CNRS, Natl Ctr Sci Res, Museum Natl Nat 1Hist,Musee Homme, Paris, France; [Salmi, Roberta] Univ Georgia, Dept Anthropol, Athens, GA 30602 USA; [Todd, Angelique] World Wildlife Fund CAR, Bangui, Cent Afr Republ; [Yamagiwa, Juichi] Kyoto Univ, Grad Sch Sci, Kyoto, Japan	Max Planck Society; Kyoto Prefectural University; University of Western Australia; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Centre National de la Recherche Scientifique (CNRS); Museum National d'Histoire Naturelle (MNHN); UDICE-French Research Universities; Universite Paris Cite; University System of Georgia; University of Georgia; Kyoto University	Robbins, MM (corresponding author), Max Planck Inst Evolutionary Anthropol, Leipzig, Germany.	robbins@eva.mpg.de	Hedwig, Daniela/ABH-7241-2020; Todd, Angelique/AAR-3087-2021; salmi, roberta/AAD-6267-2021	Salmi, Roberta/0000-0001-5745-2014; Grueter, Cyril C./0000-0001-8770-8148; Todd, Angelique/0000-0002-9207-4925	Max Planck Society; WWF (CAR); WCS	Max Planck Society(Max Planck SocietyFoundation CELLEX); WWF (CAR); WCS	This work was supported by the Max Planck Society.; We thank the following organizations for permission to work at the various field sites: Uganda Wildlife Authority, Uganda National Council of Science and Technology, Rwanda Development Board, Gabon National Center of Scientific Research and Technology, Gabon Agence Nationale des Parcs Nationaux, the Ministries of Education and Water and Forests of CAR and Republic of Congo for permission to work in Dzanga-Ndoki National Park. We also thank the administration of Dzanga-Sangha Protected Areas in CAR for logistic support. Special thanks go to Terence Fuh Neba for contributing to observations of the gorillas at Bai Hokou, the local Ba'Aka trackers of the Primate Habituation Program at Bai Hokou camp, Dzanga-Ndoki NP, and all for their irreplaceable help, great humour and courage. We thank WWF (CAR) and WCS for support and logistical assistance, the numerous field and research assistants, and the skilled BaAka trackers, without whom the habituation of gorillas would not have been possible at Mondika. In Gabon, we are also greatly indebted to all field assistants of Moukalaba-Doudou National Park and the people in the villages of Doussala, Konzi, and Mboungou for their kind support and hospitality. We also thank all the researchers and data technicians at Karisoke who helped with data collection as well as the field assistants of the Institute of Tropical Forest Conservation in Bwindi. Thanks to Jessica Junker and Nicole Seiler for help creating Fig 1. We appreciate useful comments from Claudio Tennie and two anonymous reviewers on a previous version of this manuscript. We thank Diane Doran-Sheehy, Kevin Langergraber, and Christophe Boesch for helpful discussions during the course of this project.	Allen J, 2013, SCIENCE, V340, P485, DOI 10.1126/science.1231976; Bastian ML, 2012, BEHAVIOUR, V149, P275, DOI 10.1163/156853912X636726; Bastian ML, 2010, AM J PHYS ANTHROPOL, V143, P175, DOI 10.1002/ajpa.21304; Boesch C, 2003, EVOL ANTHROPOL, V12, P82, DOI 10.1002/evan.10106; Boinski S, 2000, AM ANTHROPOL, V102, P741, DOI 10.1525/aa.2000.102.4.741; Breuer T, 2005, PLOS BIOL, V3, P2041, DOI 10.1371/journal.pbio.0030380; Byrne RW, 2007, PHILOS T R SOC B, V362, P577, DOI 10.1098/rstb.2006.1996; Byrne RW, 2011, ANIM COGN, V14, P683, DOI 10.1007/s10071-011-0403-8; Cipolletta C, 2004, AM J PRIMATOL, V64, P193, DOI 10.1002/ajp.20072; Dean LG, 2014, BIOL REV, V89, P284, DOI 10.1111/brv.12053; Dindo M, 2008, P ROY SOC B-BIOL SCI, V275, P187, DOI 10.1098/rspb.2007.1318; Doran DM, 1998, EVOL ANTHROPOL, V6, P120; Doran-Sheehy D, 2009, AM J PHYS ANTHROPOL, V140, P727, DOI 10.1002/ajpa.21118; Doran-Sheeny DM, 2009, AM J PRIMATOL, V71, P1011, DOI 10.1002/ajp.20743; Gagneux P, 1999, P NATL ACAD SCI USA, V96, P5077, DOI 10.1073/pnas.96.9.5077; Ganas J, 2004, INT J PRIMATOL, V25, P1043, DOI 10.1023/B:IJOP.0000043351.20129.44; Genty E, 2009, ANIM COGN, V12, P527, DOI 10.1007/s10071-009-0213-4; Groves CP, 2003, CAM S BIO EVOL ANTHR, V35, P15; Grueter CC, 2014, PHYSIOL BEHAV, V127, P13, DOI 10.1016/j.physbeh.2014.01.009; Grueter CC, 2013, BEHAV PROCESS, V100, P160, DOI 10.1016/j.beproc.2013.09.006; Grueter CC, 2013, AM J PRIMATOL, V75, P267, DOI 10.1002/ajp.22102; Harcourt A.H., 2007, GORILLA SOC CONFLICT; Head JS, 2011, INT J PRIMATOL, V32, P755, DOI 10.1007/s10764-011-9499-6; Hedwig D, 2015, ANIM COGN, V18, P423, DOI 10.1007/s10071-014-0812-6; Hedwig D, 2014, BEHAVIOUR, V151, P1091, DOI 10.1163/1568539X-00003175; HEYES CM, 1994, BIOL REV, V69, P207, DOI 10.1111/j.1469-185X.1994.tb01506.x; Hirata S, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P487; Hohmann G, 2003, CURR ANTHROPOL, V44, P563, DOI 10.1086/377649; Iwata Y, 2007, PRIMATES, V48, P77, DOI 10.1007/s10329-006-0003-4; Jaeggi AV, 2010, AM J PRIMATOL, V72, P62, DOI 10.1002/ajp.20752; Kendal RL, 2010, LEARN BEHAV, V38, P187, DOI 10.3758/LB.38.3.187; Kinani JF, 2015, AM J PRIMATOL, V77, P353, DOI 10.1002/ajp.22351; Koops K, 2015, SCI REP-UK, V5, DOI 10.1038/srep12456; Koops K, 2015, SCI REP-UK, V5, DOI 10.1038/srep11356; Koops K, 2013, ANIM BEHAV, V85, P175, DOI 10.1016/j.anbehav.2012.10.022; Kopps AM, 2012, ANIM BEHAV, V84, P1347, DOI 10.1016/j.anbehav.2012.08.029; Krutzen M, 2011, CURR BIOL, V21, P1808, DOI 10.1016/j.cub.2011.09.017; Krutzen M, 2005, P NATL ACAD SCI USA, V102, P8939, DOI 10.1073/pnas.0500232102; Laland KN, 2011, PHILOS T R SOC B, V366, P958, DOI 10.1098/rstb.2010.0328; Laland KN, 2006, TRENDS ECOL EVOL, V21, P542, DOI 10.1016/j.tree.2006.06.005; Laland KN, 2006, EVOL ANTHROPOL, V15, P95, DOI 10.1002/evan.20093; Laland KN, 2003, EVOL ANTHROPOL, V12, P150, DOI 10.1002/evan.10111; Langergraber KE, 2012, P NATL ACAD SCI USA, V109, P15716, DOI 10.1073/pnas.1211740109; Langergraber KE, 2011, P ROY SOC B-BIOL SCI, V278, P408, DOI 10.1098/rspb.2010.1112; Leca JB, 2010, ANIM BEHAV, V79, P117, DOI 10.1016/j.anbehav.2009.09.035; Lodwick J, 2014, LINKS FORAGING STRAT; Lonsdorf EV, 2004, NATURE, V428, P715, DOI 10.1038/428715a; Luncz LV, 2012, CURR BIOL, V22, P922, DOI 10.1016/j.cub.2012.03.031; Masi S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129254; Masi S, 2009, AM J PRIMATOL, V71, P91, DOI 10.1002/ajp.20629; Mc Grew WC, 2001, CURR ANTHROPOL, V42, P148, DOI 10.1086/318441; McGrew W.C., 1992, CHIMPANZEE MAT CULTU; Mobius Y, 2008, ANIM BEHAV, V76, P37, DOI 10.1016/j.anbehav.2008.01.008; Muller CA, 2010, CURR BIOL, V20, P1171, DOI 10.1016/j.cub.2010.04.037; Nakamura M, 2000, PRIMATES, V41, P237, DOI 10.1007/BF02557594; Nishida T, 2009, PRIMATES, V50, P23, DOI 10.1007/s10329-008-0109-y; Ottoni EB, 2008, EVOL ANTHROPOL, V17, P171, DOI 10.1002/evan.20185; Panger MA, 2002, AM J PHYS ANTHROPOL, V119, P52, DOI 10.1002/ajpa.10103; Perry S, 2003, CURR ANTHROPOL, V44, P241, DOI 10.1086/345825; Perry S, 2011, PHILOS T R SOC B, V366, P988, DOI 10.1098/rstb.2010.0317; Perry S, 2009, ANIM COGN, V12, P705, DOI 10.1007/s10071-009-0230-3; Pika S, 2003, AM J PRIMATOL, V60, P95, DOI 10.1002/ajp.10097; Ramsey G, 2007, BEHAV BRAIN SCI, V30, P1; Robbins MM, 2008, INT J PRIMATOL, V29, P999, DOI 10.1007/s10764-008-9275-4; Robbins MM, 2011, PRIMATES PERSPECTIVE, P326; Rogers ME, 2004, AM J PRIMATOL, V64, P173, DOI 10.1002/ajp.20071; Roy J, 2014, BIOL LETTERS, V1, P10; Salmi R, 2014, AM J PHYS ANTHROPOL, V155, P379, DOI 10.1002/ajpa.22575; Salmi R, 2013, ETHOLOGY, V119, P831, DOI 10.1111/eth.12122; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024400; Santorelli CJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016863; Sapolsky RM, 2004, PLOS BIOL, V2, P534, DOI 10.1371/journal.pbio.0020106; Sawyer SC, 2009, FOLIA PRIMATOL, V80, P83, DOI 10.1159/000217680; Schoning C, 2008, J HUM EVOL, V55, P48, DOI 10.1016/j.jhevol.2007.12.002; Scott J, 2007, INT J PRIMATOL, V28, P761, DOI 10.1007/s10764-007-9161-5; Silk Joan B., 2012, P552; Taylor AB, 2003, GORILLA BIOL MULTIDI; Tennie C, 2008, AM J PRIMATOL, V70, P584, DOI 10.1002/ajp.20532; Tennie C, 2009, PHILOS T R SOC B, V364, P2405, DOI 10.1098/rstb.2009.0052; Thalmann OH, 2007, MOL BIOL EVOL, V24, P146, DOI 10.1093/molbev/msl160; Thornton A, 2011, PHILOS T R SOC B, V366, P978, DOI 10.1098/rstb.2010.0312; Thornton A, 2010, P ROY SOC B-BIOL SCI, V277, P3623, DOI 10.1098/rspb.2010.0611; Thornton A, 2009, ANIM BEHAV, V78, P255, DOI 10.1016/j.anbehav.2009.04.021; van Schaik CP, 2006, BEHAVIOUR, V143, P839, DOI 10.1163/156853906778017944; van Schaik CP, 2013, PHILOS T R SOC B, V368, DOI 10.1098/rstb.2012.0339; van Schaik CP, 2011, PHILOS T R SOC B, V366, P1008, DOI 10.1098/rstb.2010.0304; van Schaik CP, 1999, J HUM EVOL, V36, P719, DOI 10.1006/jhev.1999.0304; van Schaik CP, 2003, SCIENCE, V299, P102, DOI 10.1126/science.1078004; Watts DP, 2001, MOUNTAIN GORILLAS 3; Whiten A, 2001, BEHAVIOUR, V138, P1481, DOI 10.1163/156853901317367717; Whiten A, 1999, NATURE, V399, P682, DOI 10.1038/21415; Whiten A, 2012, EVOLUTION PRIMATE SO, P681; Whiten A, 2007, PHILOS T R SOC B, V362, P603, DOI 10.1098/rstb.2006.1998; Whiten A, 2007, CURR BIOL, V17, P1038, DOI 10.1016/j.cub.2007.05.031; Whiten A, 2011, PHILOS T R SOC B, V366, P997, DOI 10.1098/rstb.2010.0334; Wright E, 2015, AM J PHYS ANTHROPOL, V158, P487, DOI 10.1002/ajpa.22808; Xue YL, 2015, SCIENCE, V348, P242, DOI 10.1126/science.aaa3952; Yamagiwa J, 2003, PRIMATES, V44, P359, DOI 10.1007/s10329-003-0049-5; Yamagiwa J, 2014, PRIMATES CETACEANS F; Yamakoshi G, 1998, AM J PHYS ANTHROPOL, V106, P283, DOI 10.1002/(SICI)1096-8644(199807)106:3<283::AID-AJPA2>3.0.CO;2-O	100	46	49	2	103	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160483	10.1371/journal.pone.0160483	http://dx.doi.org/10.1371/journal.pone.0160483			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603668	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200004
J	Roy, PS; Rao, GJN; Jena, S; Samal, R; Patnaik, A; Patnaik, SSC; Jambhulkar, NN; Sharma, S; Mohapatra, T				Roy, Pritesh Sundar; Rao, Gundimeda Jwala Narasimha; Jena, Sudipta; Samal, Rashmita; Patnaik, Ashok; Patnaik, Sasank Sekhar Chyau; Jambhulkar, Nitiprasad Namdeorao; Sharma, Srigopal; Mohapatra, Trilochan			Nuclear and Chloroplast DNA Variation Provides Insights into Population Structure and Multiple Origin of Native Aromatic Rices of Odisha, India	PLOS ONE			English	Article							ORYZA-SATIVA L.; GENETIC DIVERSITY; UPLAND RICE; SSR MARKERS; GERMPLASM; SEQUENCE; CLASSIFICATION; DOMESTICATION; VARIETIES; LANDRACE	A large number of short grain aromatic rice suited to the agro-climatic conditions and local preferences are grown in niche areas of different parts of India and their diversity is evolved over centuries as a result of selection by traditional farmers. Systematic characterization of these specialty rices has not been attempted. An effort was made to characterize 126 aromatic short grain rice landraces, collected from 19 different districts in the State of Odisha, from eastern India. High level of variation for grain quality and agronomic traits among these aromatic rices was observed and genotypes having desirable phenotypic traits like erect flag leaf, thick culm, compact and dense panicles, short plant stature, early duration, superior yield and grain quality traits were identified. A total of 24 SSR markers corresponding to the hyper variable regions of rice chromosomes were used to understand the genetic diversity and to establish the genetic relationship among the aromatic short grain rice landraces at nuclear genome level. SSR analysis of 126 genotypes from Odisha and 10 genotypes from other states revealed 110 alleles with an average of 4.583 and the Nei's genetic diversity value (He) was in the range of 0.034-0.880 revealing two sub-populations SP 1 (membership percentage-27.1%) and SP 2 (72.9%). At the organelle genomic level for the C/A repeats in PS1D sequence of chloroplasts, eight different plastid sub types and 33 haplo-types were detected. The japonica (Nipponbare) subtype (6C7A) was detected in 100 genotypes followed by O. rufipogon (KF428978) subtype (6C6A) in 13 genotypes while indica (93-11) sub type (8C8A) was seen in 14 genotypes. The tree constructed based on haplo-types suggests that short grain aromatic landraces might have independent origin of these plastid subtypes. Notably a wide range of diversity was observed among these landraces cultivated in different parts confined to the State of Odisha.	[Roy, Pritesh Sundar; Rao, Gundimeda Jwala Narasimha; Jena, Sudipta; Samal, Rashmita; Patnaik, Ashok; Patnaik, Sasank Sekhar Chyau; Jambhulkar, Nitiprasad Namdeorao; Sharma, Srigopal; Mohapatra, Trilochan] Natl Rice Res Inst, Cuttack, Odisha, India; [Mohapatra, Trilochan] DARE, ICAR, New Delhi, India	Indian Council of Agricultural Research (ICAR); ICAR - National Rice Research Institute	Rao, GJN (corresponding author), Natl Rice Res Inst, Cuttack, Odisha, India.	gjnrao@gmail.com			institutional project of ICAR-National Rice Research Institute (ICAR-NRRI)	institutional project of ICAR-National Rice Research Institute (ICAR-NRRI)	This work is carried out under institutional project of ICAR-National Rice Research Institute (ICAR-NRRI).	Ahuja SC, 1995, BASMATI RICE SCENTED; ANDERSON JA, 1993, GENOME, V36, P181, DOI 10.1139/g93-024; Anumalla M, 2014, J CHEM PHYS BIOL SCI, V5, P1726; Bao JS, 2006, GENET RESOUR CROP EV, V53, P323, DOI 10.1007/s10722-004-6145-6; Bhattacharjee P, 2002, INT J FOOD SCI TECH, V37, P1, DOI 10.1046/j.1365-2621.2002.00541.x; Cheng CY, 2003, MOL BIOL EVOL, V20, P67, DOI 10.1093/molbev/msg004; Choudhury B, 2013, SPRINGERPLUS, V2, DOI 10.1186/2193-1801-2-228; Choudhury DR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113094; Choudhury PR, 2001, EUPHYTICA, V118, P243, DOI 10.1023/A:1017554600145; Courtois B, 2012, CROP SCI, V52, P1663, DOI 10.2135/cropsci2011.11.0588; Das B, 2013, BMC GENET, V14, DOI 10.1186/1471-2156-14-71; Das SR, 2012, IRRI TECHNICAL B, V16; Borba TCD, 2009, GENETICA, V137, P293, DOI 10.1007/s10709-009-9380-0; Dela Cruz N., 2000, AROMATIC RICES, P16; Dellaporta SL, 1983, PLANT MOL BIOL REP, V1, P19, DOI DOI 10.1007/BF02712670; Earl DA, 2012, CONSERV GENET RESOUR, V4, P359, DOI 10.1007/s12686-011-9548-7; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Garris AJ, 2005, GENETICS, V169, P1631, DOI 10.1534/genetics.104.035642; Giraud G, 2013, INT FOOD AGRIBUS MAN, V16, P2; GLASZMANN JC, 1987, THEOR APPL GENET, V74, P21, DOI 10.1007/BF00290078; Hashimoto Z, 2004, THEOR APPL GENET, V109, P1586, DOI 10.1007/s00122-004-1794-6; Hien NL, 2007, TROPICS, V16, P343; Huang FaSong, 1998, Chinese Journal of Rice Science, V12, P172; Ishii T, 2000, THEOR APPL GENET, V100, P1257, DOI 10.1007/s001220051432; Ishikawa R, 2002, THEOR APPL GENET, V104, P976, DOI 10.1007/s00122-001-0807-y; Joshi RK, 2010, BIORES B, V4, P213; Juliano BO., 1985, RICE CHEM TECHNOLOGY; Juneja S, 2006, CURR SCI INDIA, V91, P1079; Khatam MM, 2003, PAKISTAN J BIOL SCI, V6, P511; Kibria K, 2008, BANGL J BOT, V37, P141; Kim H, 2014, SCI WORLD J, DOI 10.1155/2014/683045; Krishna Naik R., 2005, ANDHRA AGR J, V52, P52; Krishna Veni B, 2006, ORYZA, V43, P320; Li CB, 2006, NEW PHYTOL, V170, P185, DOI 10.1111/j.1469-8137.2005.01647.x; Lin HY, 2012, BOT STUD, V53, P363; Lu FH, 2012, GENET RES, V94, P179, DOI 10.1017/S0016672312000390; Mathure S, 2011, EUPHYTICA, V179, P237, DOI 10.1007/s10681-010-0294-9; McCouch SR, 2002, DNA RES, V9, P199, DOI 10.1093/dnares/9.6.199; Nachimuthu VV, 2015, RICE, V8, DOI 10.1186/s12284-015-0062-5; Nadaf AB, 2006, CURR SCI INDIA, V91, P1533; Nakamura I, 1997, BREEDING SCI, V47, P385; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Oka H. I., 1988, Origin of cultivated rice.; Okoshi M, 2016, GENET RESOUR CROP EV, V63, P199, DOI 10.1007/s10722-015-0239-1; Pachauri V, 2010, J PLANT BIOCHEM BIOT, V19, P127, DOI 10.1007/BF03263333; Panda D, 2014, INT RES J ENV SCI, V3, P80; Patnaik A, 2014, INDIAN J GENET PL BR, V74, P537; Patra BC, 2003, GENET RESOUR CROP EV, V50, P825, DOI 10.1023/A:1025963411919; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Prathepha Preecha, 2008, Pak J Biol Sci, V11, P26, DOI 10.3923/pjbs.2008.26.33; Pritchard JK, 2000, GENETICS, V155, P945; Pusadee T, 2009, P NATL ACAD SCI USA, V106, P13880, DOI 10.1073/pnas.0906720106; Rabbani MA, 2008, ELECTRON J BIOTECHN, V11, DOI 10.2225/vol11-issue3-fulltext-3; Rajamani S, 2004, ANDHRA AGR J, V51, P36; Ramasamy RK, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-431; Rana JC, 2009, GENET RESOUR CROP EV, V56, P963, DOI 10.1007/s10722-009-9415-5; Ranawake AL, 2013, J U RUHUNA, V1, P3, DOI DOI 10.4038/JUR.V1I1.6150; Rathi S, 2014, INDIAN J GENET PL BR, V74, P238, DOI 10.5958/0975-6906.2014.00161.8; Roy PS, 2016, BMC ECOL, V16, DOI 10.1186/s12898-016-0086-8; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sadeghi S. M., 2011, World Applied Sciences Journal, V13, P1229; Sang T, 2013, CURR OPIN PLANT BIOL, V16, P139, DOI 10.1016/j.pbi.2013.03.003; Singh H, 2010, MOL BREEDING, V25, P359, DOI 10.1007/s11032-009-9328-1; Singh RK, 2000, AROMATIC RICES, P292; Skuza L, 2013, COMPREHENSIVE SURVEY OF INTERNATIONAL SOYBEAN RESEARCH - GENETICS, PHYSIOLOGY, AGRONOMY AND NITROGEN RELATIONSHIPS, P553, DOI 10.5772/52028; Song MT, 2002, KOREAN J GENETIC, V24, P397; Subedi S., 2011, Journal of Agricultural Research (Lahore), V49, P83; Takahashi R, 2008, J HERED, V99, P593, DOI 10.1093/jhered/esn041; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tiranti B, 2007, MOL ECOL, V16, P4942, DOI 10.1111/j.1365-294X.2007.03566.x; Vinita Pachauri, 2013, Australian Journal of Crop Science, V7, P923; Yadav RB, 2007, J AGR TECHNOLOGY, V3, P203; Zhang PF, 2011, PLOS ONE, V6, DOI [10.1371/journal.pone.0020827, 10.1371/journal.pone.0027565]; Zhao WG, 2013, EUPHYTICA, V191, P9, DOI 10.1007/s10681-012-0820-z	75	10	10	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162268	10.1371/journal.pone.0162268	http://dx.doi.org/10.1371/journal.pone.0162268			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598392	gold, Green Published, Green Submitted			2022-12-26	WOS:000383254800049
J	Fujimoto, T; Inoue, T; Maki, K; Inoue-Mochita, M; Tanihara, H				Fujimoto, Tomokazu; Inoue, Toshihiro; Maki, Kei; Inoue-Mochita, Miyuki; Tanihara, Hidenobu			Vascular Endothelial Growth Factor-A Increases the Aqueous Humor Outflow Facility	PLOS ONE			English	Article							MULTIPLE PROINFLAMMATORY CYTOKINES; PROTEIN-KINASE INHIBITOR; OPEN-ANGLE GLAUCOMA; INTRAOCULAR-PRESSURE; MACULAR DEGENERATION; INTRAVITREAL BEVACIZUMAB; NONGLAUCOMATOUS NORMALS; SIGNAL-TRANSDUCTION; INJECTIONS; THERAPY	Purpose Anti-vascular endothelial growth factor (VEGF) antibody therapy is an effective treatment for ocular angiogenesis. Although the intraocular pressure of some patients increases after anti-VEGF therapy, the effects of VEGF-A on the aqueous humor outflow pathway remain unknown. This study investigated the effects of VEGF-A on the aqueous humor outflow pathway. Methods We used human recombinant VEGF121 and VEGF165. Trabecular meshwork (TM) and Schlemm's canal endothelial (SCE) cells were isolated from the eyes of cynomolgus monkeys. Expression of mRNA coding four VEGF receptors, VEGFR1 (FLT1), VEGFR2 (KDR), neuropilin-1, and neuropilin-2, was examined by RT-PCR. To evaluate the permeability of cell monolayers, we measured transendothelial electrical resistance (TEER). The outflow facility was measured in perfused porcine anterior segment organ cultures treated with 30 ng/mL VEGF121 for 48 h. Results Four VEGF-A-related receptor mRNAs were expressed in TM and SCE cells. The TEER of TM cells was not significantly affected by VEGF121 or VEGF165 treatment. In contrast, the TEER of SCE cells was significantly lower 48 h after treatment with 30 ng/mL VEGF121 to 69.4 +/- 12.2% of baseline (n = 10), which was a significant difference compared with the control (P = 0.0001). VEGF165 (30 ng/mL) decreased the TEER of SCE cells at 48 h after treatment to 72.3 +/- 14.1% compared with the baseline (n = 10), which was not a significant difference compared with the control (P = 0.0935). Ki8751, a selective VEGFR2 inhibitor, completely suppressed the effect of VEGF121 on SCE cell permeability, although ZM306416, a selective VEGFR1 inhibitor, did not affect the VEGF121-induced decrease in TEER. Perfusion with 30 ng/mL of VEGF121 for 48 h significantly increased the outflow facility compared with the control (47.8 +/- 28.5%, n = 5, P = 0.013). Conclusions These results suggest that VEGF-A may regulate the conventional aqueous outflow of SCE cells through VEGFR2.	[Fujimoto, Tomokazu; Inoue, Toshihiro; Maki, Kei; Inoue-Mochita, Miyuki; Tanihara, Hidenobu] Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan	Kumamoto University	Inoue, T (corresponding author), Kumamoto Univ, Fac Life Sci, Dept Ophthalmol, Kumamoto, Japan.	noel@da2.so-net.ne.jp		Fujimoto, Tomokazu/0000-0002-4867-1925; Inoue, Toshihiro/0000-0003-3769-7609	Japan Society for the Promotion of Science KAKENHI [26293375, 15K15636, 26462664]	Japan Society for the Promotion of Science KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	HT received Japan Society for the Promotion of Science KAKENHI, Grant Numbers 26293375 and 15K15636 (https://www.jsps.go.jp/english/index.html). TI received Japan Society for the Promotion of Science KAKENHI, Grant Number 26462664.	Adelman RA, 2010, J OCUL PHARMACOL TH, V26, P105, DOI 10.1089/jop.2009.0076; ALVARADO J, 1984, OPHTHALMOLOGY, V91, P564; ALVARADO JA, 1986, ARCH OPHTHALMOL-CHIC, V104, P1517; Ba J, 2015, DRUG DES DEV THER, V9, DOI 10.2147/DDDT.S86269; Falkenstein IA, 2007, RETINA-J RET VIT DIS, V27, P1044, DOI 10.1097/IAE.0b013e3180592ba6; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Fujimoto T, 2012, INVEST OPHTH VIS SCI, V53, P7097, DOI 10.1167/iovs.12-9989; Funk M, 2009, OPHTHALMOLOGY, V116, P2393, DOI 10.1016/j.ophtha.2009.05.039; Funk M, 2009, INVEST OPHTH VIS SCI, V50, P1025, DOI 10.1167/iovs.08-2510; Gismondi M, 2009, J GLAUCOMA, V18, P658, DOI 10.1097/IJG.0b013e31819c4893; Good TJ, 2011, BRIT J OPHTHALMOL, V95, P1111, DOI 10.1136/bjo.2010.180729; Heier JS, 2012, OPHTHALMOLOGY, V119, P2537, DOI 10.1016/j.ophtha.2012.09.006; Honjo M, 2001, INVEST OPHTH VIS SCI, V42, P137; Inoue T, 2012, J CATARACT REFR SURG, V38, P1389, DOI 10.1016/j.jcrs.2012.04.028; Kameda T, 2012, INVEST OPHTH VIS SCI, V53, P3092, DOI 10.1167/iovs.11-8018; Kim JE, 2008, AM J OPHTHALMOL, V146, P930, DOI 10.1016/j.ajo.2008.07.007; Koch S, 2011, BIOCHEM J, V437, P169, DOI 10.1042/BJ20110301; Martin DF, 2011, NEW ENGL J MED, V364, P1897, DOI 10.1056/NEJMoa1102673; Mathalone N, 2012, GRAEF ARCH CLIN EXP, V250, P1435, DOI 10.1007/s00417-012-1981-0; Ohira S, 2015, INVEST OPHTH VIS SCI, V56, P3541, DOI 10.1167/iovs.14-15918; Quigley HA, 2006, BRIT J OPHTHALMOL, V90, P262, DOI 10.1136/bjo.2005.081224; ROHEN JW, 1983, OPHTHALMOLOGY, V90, P758; Sohn HJ, 2011, AM J OPHTHALMOL, V152, P686, DOI 10.1016/j.ajo.2011.03.033; Syriani E, 2009, INVEST OPHTH VIS SCI, V50, P3833, DOI 10.1167/iovs.08-2924; Tan JCH, 2006, CURR OPIN OPHTHALMOL, V17, P168; Tseng JJ, 2012, J GLAUCOMA, V21, P241, DOI 10.1097/IJG.0b013e31820d7d19; Tsuboi N, 2012, INVEST OPHTH VIS SCI, V53, P6702, DOI 10.1167/iovs.12-10376	27	13	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161332	10.1371/journal.pone.0161332	http://dx.doi.org/10.1371/journal.pone.0161332			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584577	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600021
J	Janssen, KMJ; Westra, J; Chalan, P; Boots, AMH; de Smit, MJ; van Winkelhoff, AJ; Vissink, A; Brouwer, E				Janssen, Koen M. J.; Westra, Johanna; Chalan, Paulina; Boots, Annemieke M. H.; de Smit, Menke J.; van Winkelhoff, Arie Jan; Vissink, Arjan; Brouwer, Elisabeth			Regulatory CD4+T-Cell Subsets and Anti-Citrullinated Protein Antibody Repertoire: Potential Biomarkers for Arthritis Development in Seropositive Arthralgia Patients?	PLOS ONE			English	Article							RHEUMATOID-ARTHRITIS; T-CELLS; PERIPHERAL-BLOOD; SYNOVIAL-FLUID; TNF-ALPHA; PRECEDE; ONSET; AUTOANTIBODIES; INFLAMMATION	Objective Seropositive arthralgia patients (SAP) are at high risk of developing rheumatoid arthritis (RA). This prospective study aimed to determine whether altered peripheral regulatory T-cells (Tregs) and defined subsets, besides a broadened anti-citrullinated protein antibody (ACPA) response, may qualify as biomarkers for RA development in SAP. Methods Thirty-four consecutive SAP were prospectively assessed every 6 months for minimally 2 years. At inclusion, peripheral Treg (CD4(+)CD25(+)FoxP3(+)) numbers and subsets, defined as CD45RA(+)FoxP3(low) naive Tregs (Fr I), CD45RA(-)FoxP3(high) activated Tregs (Fr II) and CD45RA(-)FoxP3(low) non-Tregs (Fr III), were compared to age-and sex-matched healthy controls (HC, n = 16) and treatment-naive RA patients (n = 12). SAP that developed RA were compared to non-switchers and analyzed for Treg numbers and Treg subsets at inclusion. Also, Treg numbers and subsets were compared in switched SAP before and at diagnosis. To assess the ACPA repertoire, IgG and IgA reactivity was measured against citrullinated peptides from fibrinogen, alpha-enolase and vimentin. Results Treg numbers were similar between HC, SAP and RA patients. Although the bonafide Treg subsets Fr I and Fr II were comparable between groups, Fr III was increased in SAP compared to HC (p = 0.01). Fourteen (41%) SAP developed RA during follow-up. Their Treg numbers and subsets were comparable to non-switched SAP. At RA diagnosis, Treg numbers in switched SAP were similar to 6 months before. Switched SAP displayed a more diverse IgG ACPA repertoire compared to non-switched SAP (p = 0.046) and showed more IgA reactivity than non-switched SAP reaching significance for Fib1 only (p = 0.047). Conclusion Numbers of Total Treg and bonafide Treg subsets are not indicative for RA development in SAP, opposed to the ACPA repertoire.	[Janssen, Koen M. J.; Vissink, Arjan] Univ Groningen, Univ Med Ctr Groningen, Dept Oral & Maxillofacial Surg, Groningen, Netherlands; [Westra, Johanna; Chalan, Paulina; Boots, Annemieke M. H.; Brouwer, Elisabeth] Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands; [de Smit, Menke J.; van Winkelhoff, Arie Jan] Univ Groningen, Univ Med Ctr Groningen, Ctr Dent & Oral Hyg, Groningen, Netherlands; [van Winkelhoff, Arie Jan] Univ Groningen, Univ Med Ctr Groningen, Dept Med Microbiol, Groningen, Netherlands	University of Groningen; University of Groningen; University of Groningen; University of Groningen	Brouwer, E (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Rheumatol & Clin Immunol, Groningen, Netherlands.	e.brouwer@umcg.nl	Brouwer, Elisabeth/AAL-9029-2020	Brouwer, Elisabeth/0000-0002-5652-4423				Alvarado-Sanchez B, 2006, J AUTOIMMUN, V27, P110, DOI 10.1016/j.jaut.2006.06.005; Arend WP, 2012, NAT REV RHEUMATOL, V8, P573, DOI 10.1038/nrrheum.2012.134; Brink M, 2013, ARTHRITIS RHEUM-US, V65, P899, DOI 10.1002/art.37835; Cao D, 2003, EUR J IMMUNOL, V33, P215, DOI 10.1002/immu.200390024; Chalan P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079370; Demoruelle MK, 2014, CURR OPIN RHEUMATOL, V26, P64, DOI 10.1097/BOR.0000000000000017; Ehrenstein MR, 2004, J EXP MED, V200, P277, DOI 10.1084/jem.20040165; Han GM, 2008, CELL IMMUNOL, V253, P92, DOI 10.1016/j.cellimm.2008.05.007; Hunt L, 2016, ANN RHEUM DIS, V75, P1884, DOI 10.1136/annrheumdis-2015-207991; Jang E, 2011, J IMMUNOL, V186, P1546, DOI 10.4049/jimmunol.1002942; Janssen KMJ, 2015, ARTHRITIS RES THER, V17, DOI 10.1186/s13075-015-0690-6; Karlson EW, 2016, RHEUMATOLOGY, V55, P6, DOI 10.1093/rheumatology/keu287; Klareskog L, 2008, ANNU REV IMMUNOL, V26, P651, DOI 10.1146/annurev.immunol.26.021607.090244; Kokkonen H, 2011, ARTHRITIS RES THER, V13, DOI 10.1186/ar3237; Kokkonen H, 2010, ARTHRITIS RHEUM-US, V62, P383, DOI 10.1002/art.27186; Lawson CA, 2006, RHEUMATOLOGY, V45, P1210, DOI 10.1093/rheumatology/kel089; Liu MF, 2005, SCAND J IMMUNOL, V62, P312, DOI 10.1111/j.1365-3083.2005.01656.x; Matsuki F, 2013, BIOCHEM BIOPH RES CO, V438, P778, DOI 10.1016/j.bbrc.2013.05.120; Miyara M, 2011, AUTOIMMUN REV, V10, P744, DOI 10.1016/j.autrev.2011.05.004; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Morgan ME, 2003, ARTHRITIS RHEUM, V48, P1452, DOI 10.1002/art.11063; Mottonen M, 2005, CLIN EXP IMMUNOL, V140, P360, DOI 10.1111/j.1365-2249.2005.02754.x; Nie H, 2013, NAT MED, V19, P322, DOI 10.1038/nm.3085; Nielen MMJ, 2004, ARTHRITIS RHEUM-US, V50, P380, DOI 10.1002/art.20018; Ponchel F, 2014, ANN RHEUM DIS, V73, P2047, DOI 10.1136/annrheumdis-2013-203566; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; Samson M, 2012, ARTHRITIS RHEUM-US, V64, P2499, DOI 10.1002/art.34477; Shi J, 2014, ANN RHEUM DIS, V73, P780, DOI 10.1136/annrheumdis-2013-204154; Smolen JS, 2015, NAT REV RHEUMATOL, V11, P276, DOI 10.1038/nrrheum.2015.8; van Amelsfort JMR, 2004, ARTHRITIS RHEUM, V50, P2775, DOI 10.1002/art.20499; van de Sande MGH, 2011, ANN RHEUM DIS, V70, P772, DOI 10.1136/ard.2010.139527; van de Stadt LA, 2011, ANN RHEUM DIS, V70, P128, DOI 10.1136/ard.2010.132662; van de Stadt LA, 2013, ANN RHEUM DIS, V72, P1920, DOI 10.1136/annrheumdis-2012-202127; van der Geest KSM, 2014, EXP GERONTOL, V60, P190, DOI 10.1016/j.exger.2014.11.005; Wang WH, 2012, RHEUMATOL INT, V32, P887, DOI 10.1007/s00296-010-1710-0; Willemze A, 2012, NAT REV RHEUMATOL, V8, P144, DOI 10.1038/nrrheum.2011.204	36	17	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0162101	10.1371/journal.pone.0162101	http://dx.doi.org/10.1371/journal.pone.0162101			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27585422	gold, Green Published, Green Submitted			2022-12-26	WOS:000382855600103
J	Chan, DW; Hui, WWY; Wang, JJ; Yung, MMH; Hui, LMN; Qin, Y; Liang, RR; Leung, THY; Xu, D; Chan, KKL; Yao, KM; Tsang, BK; Ngan, HYS				Chan, D. W.; Hui, W. W. Y.; Wang, J. J.; Yung, M. M. H.; Hui, L. M. N.; Qin, Y.; Liang, R. R.; Leung, T. H. Y.; Xu, D.; Chan, K. K. L.; Yao, K-M; Tsang, B. K.; Ngan, H. Y. S.			DLX1 acts as a crucial target of FOXM1 to promote ovarian cancer aggressiveness by enhancing TGF-beta/SMAD4 signaling	ONCOGENE			English	Article							FORKHEAD BOX M1; ENDOTHELIAL GROWTH-FACTOR; TRANSCRIPTION FACTOR; TGF-BETA; MESENCHYMAL TRANSITION; CELL-PROLIFERATION; GENE-EXPRESSION; POOR-PROGNOSIS; INVASION; MIGRATION	Recent evidence from a comprehensive genome analysis and functional studies have revealed that FOXM1 is a crucial metastatic regulator that drives cancer progression. However, the regulatory mechanism by which FOXM1 exerts its metastatic functions in cancer cells remains obscure. Here, we report that DLX1 acts as a FOXM1 downstream target, exerting pro-metastatic function in ovarian cancers. Both FOXM1 isoforms (FOXM1B or FOXM1C) could transcriptionally upregulate DLX1 through two conserved binding sites, located at + 61 to + 69bp downstream (TFBS1) and -675 to -667bp upstream (TFBS2) of the DLX1 promoter, respectively. This regulation was further accentuated by the significant correlation between the nuclear expression of FOXM1 and DLX1 in high-grade serous ovarian cancers. Functionally, the ectopic expression of DLX1 promoted ovarian cancer cell growth, cell migration/ invasion and intraperitoneal dissemination of ovarian cancer in mice, whereas small interfering RNA-mediated DLX1 knockdown in FOXM1-overexpressing ovarian cancer cells abrogated these oncogenic capacities. In contrast, depletion of FOXM1 by shRNAi only partially attenuated tumor growth and exerted almost no effect on cell migration/invasion and the intraperitoneal dissemination of DLX1-overexpressing ovarian cancer cells. Furthermore, the mechanistic studies showed that DLX1 positively modulates transforming growth factor-beta (TGF-beta) signaling by upregulating PAI-1 and JUNB through direct interaction with SMAD4 in the nucleus upon TGF-beta 1 induction. Taken together, these data strongly suggest that DLX1 has a pivotal role in FOXM1 signaling to promote cancer aggressiveness through intensifying TGF-beta/SMAD4 signaling in high-grade serous ovarian cancer cells.	[Chan, D. W.; Hui, W. W. Y.; Yung, M. M. H.; Hui, L. M. N.; Liang, R. R.; Leung, T. H. Y.; Chan, K. K. L.; Ngan, H. Y. S.] Univ Hong Kong, Dept Obstet & Gynaecol, Hong Kong, Hong Kong, Peoples R China; [Wang, J. J.; Yao, K-M] Univ Hong Kong, Sch Biomed Sci, Hong Kong, Hong Kong, Peoples R China; [Wang, J. J.; Qin, Y.] Univ Hong Kong, Ctr Genom Sci, LKS Fac Med, Hong Kong, Hong Kong, Peoples R China; [Xu, D.] Shanghai Jiao Tong Univ, Dept Med Lab Sci, Sch Med, Shanghai, Peoples R China; [Xu, D.] Hudson Inst Med Res, Clayton, Vic, Australia; [Tsang, B. K.] Macau Univ Sci & Technol, Macau Inst Appl Res Med & Hlth, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Tsang, B. K.] Univ Ottawa, Dept Obstet & Gynaecol, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Tsang, B. K.] Univ Ottawa, Dept Cellular & Mol Med, Interdisciplinary Sch Hlth Sci, Ottawa, ON, Canada; [Tsang, B. K.] Ottawa Hosp Res Inst, Chron Dis Program, Ottawa, ON, Canada	University of Hong Kong; University of Hong Kong; University of Hong Kong; Shanghai Jiao Tong University; Hudson Institute of Medical Research; Macau University of Science & Technology; University of Ottawa; University of Ottawa; University of Ottawa; Ottawa Hospital Research Institute	Chan, DW (corresponding author), Univ Hong Kong, Dept Obstet & Gynaecol, LKS Fac Med, L747 Lab Block,21 Sassoon Rd, Pokfulam, Hong Kong, Peoples R China.	dwchan@hku.hk	Chan, David/O-9896-2018; YUNG, Mingo Ming Ho/AHB-5775-2022; Leung, Rongrui/GQY-7360-2022; /C-4457-2009; Wang, Junwen/D-3700-2011	Chan, David/0000-0002-6951-3467; YUNG, Mingo Ming Ho/0000-0003-0903-1164; /0000-0002-5923-0869; Wang, Junwen/0000-0002-4432-4707; Ngan, Hextan Y S/0000-0003-3945-159X	Wong Check She Charitable Foundation; NATIONAL CANCER INSTITUTE [P30CA015083] Funding Source: NIH RePORTER	Wong Check She Charitable Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Dr Shigeru Chiba (Division of Hematology, Institute of Clinical Medicine, University of Tsukuba, Japan) for providing pTracer-CMV-DLX1-Flag plasmid, Professor Makoto Mark Taketo (Graduate School of Medicine, Kyoto University, Sakyo, Kyoto, Japan) for providing Myc-tagged SMAD4 expressing plasmid, and Prof. George Tsao (Department of Anatomy, The University of Hong Kong) for providing HOSE 6-3, HOSE 17-1 and HOSE 11-12. This study was supported by Wong Check She Charitable Foundation.	Bao B, 2011, J CELL BIOCHEM, V112, P2296, DOI 10.1002/jcb.23150; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Cantile M, 2005, J CELL PHYSIOL, V205, P202, DOI 10.1002/jcp.20384; Chan DW, 2008, J PATHOL, V215, P245, DOI 10.1002/path.2355; Chan DW, 2009, BRIT J CANCER, V101, P1433, DOI 10.1038/sj.bjc.6605316; Chan DW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052578; Chan DW, 2011, J PATHOL, V225, P525, DOI 10.1002/path.2901; Chiba S, 2003, P NATL ACAD SCI USA, V100, P15577, DOI 10.1073/pnas.2536757100; Cobos I, 2005, NAT NEUROSCI, V8, P1059, DOI 10.1038/nn1499; Cobos I, 2007, NEURON, V54, P873, DOI 10.1016/j.neuron.2007.05.024; Costa RH, 2003, HEPATOLOGY, V38, P1331, DOI 10.1016/j.hep.2003.09.034; Dai B, 2007, ONCOGENE, V26, P6212, DOI 10.1038/sj.onc.1210443; Dennler S, 1998, EMBO J, V17, P3091, DOI 10.1093/emboj/17.11.3091; Eeckhoute J, 2009, J CELL SCI, V122, P4027, DOI 10.1242/jcs.054916; Gusarova GA, 2007, J CLIN INVEST, V117, P99, DOI 10.1172/JCI27527; Hara F, 2007, AM J PATHOL, V170, P1594, DOI 10.2353/ajpath.2007.061025; He W, 2006, CELL, V125, P929, DOI 10.1016/j.cell.2006.03.045; Huang C, 2012, CANCER RES, V72, P655, DOI 10.1158/0008-5472.CAN-11-3102; Jakowlew SB, 2006, CANCER METAST REV, V25, P435, DOI 10.1007/s10555-006-9006-2; Jonk LJC, 1998, J BIOL CHEM, V273, P21145, DOI 10.1074/jbc.273.33.21145; Kalinichenko VV, 2004, GENE DEV, V18, P830, DOI 10.1101/gad.1200704; Kim IM, 2005, J BIOL CHEM, V280, P22278, DOI 10.1074/jbc.M500936200; Koo CY, 2012, BBA-GENE REGUL MECH, V1819, P28, DOI 10.1016/j.bbagrm.2011.09.004; Lam AKY, 2013, FRONT ONCOL, V3, DOI 10.3389/fonc.2013.00011; Lam AY, 2013, FRONT MOL CELL ONCOL, V3, P1; Laoukili J, 2007, BBA-REV CANCER, V1775, P92, DOI 10.1016/j.bbcan.2006.08.006; Le TN, 2007, J BIOL CHEM, V282, P19071, DOI 10.1074/jbc.M607486200; Levy S, 2002, MAMM GENOME, V13, P510, DOI 10.1007/s00335-002-2175-6; Lezot F, 2008, J CELL PHYSIOL, V216, P688, DOI 10.1002/jcp.21448; Li JP, 2012, FEBS LETT, V586, P3761, DOI 10.1016/j.febslet.2012.09.016; Li MJ, 2010, BIOINFORMATICS, V26, P2897, DOI 10.1093/bioinformatics/btq540; Lin SW, 2007, EXP CELL RES, V313, P602, DOI 10.1016/j.yexcr.2006.11.003; Lin SW, 2001, CLIN EXP METASTAS, V18, P493; Lok GTM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023790; Maira M, 2010, J NEURODEV DISORD, V2, P48, DOI [10.1007/s11689-009-9035-6, 10.1007/s11689-009-9040-9]; Matys V, 2006, NUCLEIC ACIDS RES, V34, pD108, DOI 10.1093/nar/gkj143; Merlo GR, 2000, INT J DEV BIOL, V44, P619; Morini M, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-649; Moustakas A, 2009, DEVELOPMENT, V136, P3699, DOI 10.1242/dev.030338; Myatt S.S., 2008, CANCER, V8, P242, DOI DOI 10.1038/NRC2223-C2; Papageorgis P, 2015, J ONCOL, V2015, DOI 10.1155/2015/587193; Park HJ, 2011, EMBO MOL MED, V3, P21, DOI 10.1002/emmm.201000107; Pleasure SJ, 2000, NEURON, V28, P727, DOI 10.1016/S0896-6273(00)00149-5; Potter GB, 2009, MOL CELL NEUROSCI, V40, P167, DOI 10.1016/j.mcn.2008.10.003; Qin J, 2011, NUCLEIC ACIDS RES, V39, pW430, DOI 10.1093/nar/gkr332; Rao ZY, 2010, CARCINOGENESIS, V31, P1576, DOI 10.1093/carcin/bgq150; Raychaudhuri P, 2011, CANCER RES, V71, P4329, DOI 10.1158/0008-5472.CAN-11-0640; Sanders DA, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r6; Shiou SR, 2006, J BIOL CHEM, V281, P33971, DOI 10.1074/jbc.M607010200; Starkova J, UP REGULATION HOMEOD; Sundqvist A, 2013, ONCOGENE, V32, P3606, DOI 10.1038/onc.2012.370; Tan YF, 2010, CANCER RES, V70, P9197, DOI 10.1158/0008-5472.CAN-10-1568; Teng Y, 2014, CELL PHYSIOL BIOCHEM, V33, P717, DOI 10.1159/000358647; Trinh BQ, 2011, ONCOGENE, V30, P2718, DOI 10.1038/onc.2011.4; Wang JW, 2006, BIOCHEM BIOPH RES CO, V348, P1261, DOI 10.1016/j.bbrc.2006.07.198; Wang ZW, 2007, CANCER RES, V67, P8293, DOI 10.1158/0008-5472.CAN-07-1265; Wen N, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-134; Wierstra I, 2013, ADV CANCER RES, V119, P191, DOI 10.1016/B978-0-12-407190-2.00016-2; Wierstra I, 2013, ADV CANCER RES, V118, P97, DOI 10.1016/B978-0-12-407173-5.00004-2; Xia JT, 2012, PANCREAS, V41, P629, DOI 10.1097/MPA.0b013e31823bcef2; Xue JF, 2014, J CLIN INVEST, V124, P564, DOI 10.1172/JCI71104; Yang N, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.333; Zeng JP, 2009, J PATHOL, V218, P419, DOI 10.1002/path.2530; Zhang LM, 2012, INT J BIOL SCI, V8, P1178, DOI 10.7150/ijbs.4458; Zhang YJ, 2008, CANCER RES, V68, P8733, DOI 10.1158/0008-5472.CAN-08-1968	65	33	36	1	10	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR 9	2017	36	10					1404	1416		10.1038/onc.2016.307	http://dx.doi.org/10.1038/onc.2016.307			13	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2TG	27593933	Green Published, hybrid			2022-12-26	WOS:000395862500009
J	Xu, H; Chakrabarty, Y; Philmus, B; Mehta, AP; Bhandari, D; Hohmann, HP; Begley, TP				Xu, Hui; Chakrabarty, Yindrila; Philmus, Benjamin; Mehta, Angad P.; Bhandari, Dhananjay; Hohmann, Hans-Peter; Begley, Tadhg P.			Identification of the First Riboflavin Catabolic Gene Cluster Isolated from Microbacterium maritypicum G10	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cloning; enzyme mechanism; flavoprotein; quorum sensing; riboflavin; Vitamin B2; catabolism; lyase; reconstitution	BACTERIAL-DEGRADATION; MICROBIOLOGICAL ASPECTS; CATALYTIC MECHANISM; ACID THIAMINE; ACETIC-ACID; LUMICHROME; METABOLISM; OXIDATION	Riboflavin is a common cofactor, and its biosynthetic pathway is well characterized. However, its catabolic pathway, despite intriguing hints in a few distinct organisms, has never been established. This article describes the isolation of a Microbacterium maritypicum riboflavin catabolic strain, and the cloning of the riboflavin catabolic genes. RcaA, RcaB, RcaD, and RcaE were overexpressed and biochemically characterized as riboflavin kinase, riboflavin reductase, ribokinase, and riboflavin hydrolase, respectively. Based on these activities, a pathway for riboflavin catabolism is proposed.	[Xu, Hui; Chakrabarty, Yindrila; Philmus, Benjamin; Mehta, Angad P.; Bhandari, Dhananjay; Hohmann, Hans-Peter; Begley, Tadhg P.] Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station	Begley, TP (corresponding author), Texas A&M Univ, Dept Chem, College Stn, TX 77843 USA.; Begley, TP (corresponding author), 3474 TAMU,ILSB Rm 2107, College Stn, TX 77843 USA.	begley@tamu.edu		Philmus, Benjamin/0000-0003-2085-0873	National Institutes of Health [DK44083]; Robert A. Welch Foundation [A-0034]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK044083, R37DK044083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Robert A. Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by the National Institutes of Health Grant DK44083 and Robert A. Welch Foundation Grant A-0034. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bacher A, 1980, Methods Enzymol, V66, P652; Cheng L, 2011, MOL BIOSYST, V7, P920, DOI 10.1039/c0mb00237b; da Cruz MDF, 2015, FASEB J, V29; Foster JW, 1944, J BACTERIOL, V47, P27, DOI 10.1128/JB.47.1.27-41.1944; Foster JW, 1944, J BACTERIOL, V48, P97, DOI 10.1128/JB.48.1.97-111.1944; HARKNESS DR, 1965, J BIOL CHEM, V240, P4089; IM WB, 1970, J BIOL CHEM, V245, P6269; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kincaid VA, 2012, BIOCHEMISTRY-US, V51, P545, DOI 10.1021/bi201347n; Luzhetskii A. N., 2001, Genetika, V37, P1340; Marchena M, 2011, J PHYS CHEM B, V115, P2424, DOI 10.1021/jp110134f; MAZODIER P, 1989, J BACTERIOL, V171, P3583, DOI 10.1128/jb.171.6.3583-3585.1989; Mukherjee T, 2010, COMPREHENSIVE NATURAL PRODUCTS II: CHEMISTRY AND BIOLOGY, VOL 7: COFACTORS, P649; Mukherjee T, 2011, BBA-PROTEINS PROTEOM, V1814, P1585, DOI 10.1016/j.bbapap.2011.06.018; NEAL RA, 1969, J BIOL CHEM, V244, P5201; NEAL RA, 1968, J BIOL CHEM, V243, P4634; NEAL RA, 1970, J BIOL CHEM, V245, P2599; Phillips DA, 1999, P NATL ACAD SCI USA, V96, P12275, DOI 10.1073/pnas.96.22.12275; Rajamani S, 2008, MOL PLANT MICROBE IN, V21, P1184, DOI 10.1094/MPMI-21-9-1184; SMYRNIOTIS PZ, 1958, J AM CHEM SOC, V80, P2541, DOI 10.1021/ja01543a047; Unno M, 2007, NAT PROD REP, V24, P553, DOI 10.1039/b604180a; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yamamoto K, 2015, APPL ENVIRON MICROB, V81, P7360, DOI 10.1128/AEM.02166-15; YANAGITA T, 1956, J BIOL CHEM, V221, P593; Yang C. S., 1971, METHOD ENZYMOL, V18, P571	25	8	9	2	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23506	23515		10.1074/jbc.M116.729871	http://dx.doi.org/10.1074/jbc.M116.729871			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27590337	hybrid, Green Published			2022-12-26	WOS:000387884400013
J	Wang, ZN; DiDonato, JA; Buffa, J; Comhair, SA; Aronica, MA; Dweik, RA; Lee, NA; Lee, JJ; Thomassen, MJ; Kavuru, M; Erzurum, SC; Hazen, SL				Wang, Zeneng; DiDonato, Joseph A.; Buffa, Jennifer; Comhair, Suzy A.; Aronica, Mark A.; Dweik, Raed A.; Lee, Nancy A.; Lee, James J.; Thomassen, Mary Jane; Kavuru, Mani; Erzurum, Serpil C.; Hazen, Stanley L.			Eosinophil Peroxidase Catalyzed Protein Carbamylation Participates in Asthma	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						asthma; eosinophil; inflammation; peroxidase; post-translational modification (PTM)	ENVIRONMENTAL TOBACCO-SMOKE; LOW-DENSITY-LIPOPROTEIN; HYDROGEN-PEROXIDE; NITRIC-OXIDE; ALLERGIC-ASTHMA; MOUSE MODEL; IN-VIVO; SINONASAL POLYPOSIS; LIPID-PEROXIDATION; THIOCYANATE LEVELS	The biochemical mechanisms through which eosinophils contribute to asthma pathogenesis are unclear. Here we show eosinophil peroxidase (EPO), an abundant granule protein released by activated eosinophils, contributes to characteristic asthma-related phenotypes through oxidative posttranslational modification (PTM) of proteins in asthmatic airways through a process called carbamylation. Using a combination of studies we now show EPO uses plasma levels of the pseudohalide thiocyanate (SCN-) as substrate to catalyze protein carbamylation, as monitored by PTM of protein lysine residues into N-E-carbamyllysine (homocitrulline), and contributes to the pathophysiological sequelae of eosinophil activation. Studies using EPO-deficient mice confirm EPO serves as a major enzymatic source for protein carbamylation during eosinophilic inflammatory models, including aeroallergen challenge. Clinical studies similarly revealed significant enrichment in carbamylation of airway proteins recovered from atopic asthmatics versus healthy controls in response to segmental allergen challenge. Protein-bound homocitrulline is shown to be co-localized with EPO within human asthmatic airways. Moreover, pathophysiologically relevant levels of carbamylated protein either incubated with cultured human airway epithelial cells in vitro, or provided as an aerosolized exposure in non-sensitized mice, induced multiple asthma-associated phenotypes including induction of mucin, Th2 cytokines, IFN, TGF, and epithelial cell apoptosis. Studies with scavenger receptor-A1 null mice reveal reduced IL-13 generation following exposure to aerosolized carbamylated protein, but no changes in other asthma-related phenotypes. In summary, EPO-mediated protein carbamylation is promoted during allergen-induced asthma exacerbation, and can both modulate immune responses and trigger a cascade of many of the inflammatory signals present in asthma.	[Wang, Zeneng; DiDonato, Joseph A.; Buffa, Jennifer; Hazen, Stanley L.] Cleveland Clin, Dept Cellular & Mol Med, Cleveland, OH 44195 USA; [Comhair, Suzy A.; Aronica, Mark A.; Dweik, Raed A.; Erzurum, Serpil C.] Cleveland Clin, Dept Pathobiol, Cleveland, OH 44195 USA; [Dweik, Raed A.; Erzurum, Serpil C.] Cleveland Clin, Dept Pulm Med, Cleveland, OH 44195 USA; [Hazen, Stanley L.] Cleveland Clin, Dept Cardiovasc Med, Cleveland, OH 44195 USA; [Lee, Nancy A.; Lee, James J.] Mayo Clin, Dept Biochem & Mol Biol, Scottsdale, AZ 85259 USA; [Thomassen, Mary Jane] East Carolina Univ, Div Pulm Crit Care & Sleep Med, Greenville, NC 27834 USA; [Kavuru, Mani] Thomas Jefferson Univ & Hosp, Div Pulm & Crit Care Med, Philadelphia, PA 19107 USA	Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Cleveland Clinic Foundation; Mayo Clinic; Mayo Clinic Phoenix; University of North Carolina; East Carolina University; Jefferson University	Hazen, SL (corresponding author), Cleveland Clin, Dept Cellular & Mol Med, Lerner Res Inst, 9500 Euclid Ave,NC-10, Cleveland, OH 44195 USA.	hazens@ccf.org	Hazen, Stanley L/ABD-5845-2021; Wang, Zeneng/AAK-6119-2021		AB SCIEX Center of Innovation award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000439] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL081064, R01HL124165, R56HL058723, U10HL109250, R01HL058723, R01HL130819, P01HL076491, P01HL103453] Funding Source: NIH RePORTER	AB SCIEX Center of Innovation award; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	We thank S. Horkko, University of Oulu, Finland, for the generous gift of the carbamylation-specific single chain antibody. We thank G. Chang and L. Ruple for assistance in measuring pulmonary function and also E. R. Rodriguez for immunohistochemical staining. Mass spectrometry studies were performed on instruments housed in a facility in part supported through an AB SCIEX Center of Innovation award.	Abu-Soud HM, 2001, BIOCHEMISTRY-US, V40, P11866, DOI 10.1021/bi011206v; Albert CJ, 2003, J BIOL CHEM, V278, P8942, DOI 10.1074/jbc.M211634200; Andreadis AA, 2003, FREE RADICAL BIO MED, V35, P213, DOI 10.1016/S0891-5849(03)00278-8; Apostolov EO, 2009, ARTERIOSCL THROM VAS, V29, P1622, DOI 10.1161/ATVBAHA.109.189795; Arlandson M, 2001, J BIOL CHEM, V276, P215, DOI 10.1074/jbc.M004881200; BABIOR BM, 1976, J CLIN INVEST, V58, P989, DOI 10.1172/JCI108553; Bae CJ, 2011, TOXICOL SCI, V120, P349, DOI 10.1093/toxsci/kfr004; Barnes PJ, 2001, RESPIR RES, V2, P64, DOI 10.1186/rr39; BOBB D, 1971, ANAL BIOCHEM, V40, P209, DOI 10.1016/0003-2697(71)90094-7; Bousquet J, 2010, J ALLERGY CLIN IMMUN, V126, P926, DOI 10.1016/j.jaci.2010.07.019; BOVERIS A, 1972, BIOCHEM J, V128, P617, DOI 10.1042/bj1280617; Boyce JA, 2012, J ALLERGY CLIN IMMUN, V129, P335, DOI 10.1016/j.jaci.2011.12.968; Brennan ML, 2003, AMINO ACIDS, V25, P365, DOI 10.1007/s00726-003-0023-y; Brennan ML, 2002, J BIOL CHEM, V277, P17415, DOI 10.1074/jbc.M112400200; Cannady SB, 2007, J ALLERGY CLIN IMMUN, V120, P1346, DOI 10.1016/j.jaci.2007.07.067; Carr AC, 1998, BBA-LIPID LIPID MET, V1392, P254, DOI 10.1016/S0005-2760(98)00038-1; Chandler JD, 2013, BRIT J PHARMACOL, V169, P1166, DOI 10.1111/bph.12206; Chandler JD, 2015, AM J RESP CELL MOL, V53, P193, DOI 10.1165/rcmb.2014-0208OC; CHEN Y, 1990, ARCH ENVIRON HEALTH, V45, P163, DOI 10.1080/00039896.1990.9936710; CHILMONCZYK BA, 1993, NEW ENGL J MED, V328, P1665, DOI 10.1056/NEJM199306103282303; Citardi MJ, 2006, AM J RHINOL, V20, P353, DOI 10.2500/ajr.2006.20.2858; Comhair SAA, 2005, AM J PATHOL, V166, P663, DOI 10.1016/S0002-9440(10)62288-2; Comhair SAA, 2010, ANTIOXID REDOX SIGN, V12, P93, DOI [10.1089/ars.2008.2425, 10.1089/ARS.2008.2425]; Corren J, 2011, CURR OPIN PULM MED, V17, P29, DOI 10.1097/MCP.0b013e3283413105; CURNUTTE JT, 1974, NEW ENGL J MED, V290, P593, DOI 10.1056/NEJM197403142901104; Demkowska I, 2011, J EXPO SCI ENV EPID, V21, P656, DOI 10.1038/jes.2011.19; Denzler KL, 2001, J IMMUNOL, V167, P1672, DOI 10.4049/jimmunol.167.3.1672; Droge W, 2002, PHYSIOL REV, V82, P47, DOI 10.1152/physrev.00018.2001; El-Gamal D, 2014, KIDNEY INT, V86, P923, DOI 10.1038/ki.2014.218; Fahy JV, 2002, CHEST, V122, p320S, DOI 10.1378/chest.122.6_suppl.320S; Fragoso MA, 2004, J PHYSIOL-LONDON, V561, P183, DOI 10.1113/jphysiol.2004.071548; Fulkerson PC, 2013, NAT REV DRUG DISCOV, V12, P117, DOI 10.1038/nrd3838; Galijasevic S, 2006, BIOCHEMISTRY-US, V45, P1255, DOI 10.1021/bi051438k; Gould NS, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-119; Guilloteau LA, 2003, INFECT IMMUN, V71, P621, DOI 10.1128/IAI.71.2.621-628.2003; Halwani R, 2011, AM J RESP CELL MOL, V44, P127, DOI 10.1165/rcmb.2010-0027TR; Hazen SL, 1996, J BIOL CHEM, V271, P23080, DOI 10.1074/jbc.271.38.23080; Holzer M, 2011, ANTIOXID REDOX SIGN, V14, P2337, DOI 10.1089/ars.2010.3640; Hufnagl K, 2003, CLIN EXP IMMUNOL, V133, P170, DOI 10.1046/j.1365-2249.2003.02210.x; HUSGAFVELPURSIAINEN K, 1987, INT ARCH OCC ENV HEA, V59, P337, DOI 10.1007/BF00405277; Jacobsen EA, 2014, CLIN EXP ALLERGY, V44, P1119, DOI 10.1111/cea.12358; Jacobsen EA, 2012, BLOOD, V120, P3882, DOI 10.1182/blood-2012-06-330845; Jiang L, 2014, ANN ALLERG ASTHMA IM, V113, P137, DOI 10.1016/j.anai.2014.05.030; Jin BY, 2009, P NATL ACAD SCI USA, V106, P17343, DOI 10.1073/pnas.0907409106; Kim DY, 2011, BRIT J PHARMACOL, V162, P210, DOI 10.1111/j.1476-5381.2010.01033.x; Koeth RA, 2013, J AM SOC NEPHROL, V24, P853, DOI 10.1681/ASN.2012030254; KRAUS LM, 1991, J LAB CLIN MED, V118, P555; Kunjathoor VV, 2002, J BIOL CHEM, V277, P49982, DOI 10.1074/jbc.M209649200; Lacy F, 2000, HYPERTENSION, V36, P878, DOI 10.1161/01.HYP.36.5.878; Lacy F, 1998, J HYPERTENS, V16, P291, DOI 10.1097/00004872-199816030-00006; Lankford SM, 2005, IN VITRO CELL DEV-AN, V41, P217; Lauer ME, 2009, J BIOL CHEM, V284, P5313, DOI 10.1074/jbc.M807979200; Lee KS, 2005, FASEB J, V19, P1033, DOI 10.1096/fj.04-3309fje; Li DZ, 1998, J BIOL CHEM, V273, P6812, DOI 10.1074/jbc.273.12.6812; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; MacPherson JC, 2001, J IMMUNOL, V166, P5763, DOI 10.4049/jimmunol.166.9.5763; Menzies D, 2006, JAMA-J AM MED ASSOC, V296, P1742, DOI 10.1001/jama.296.14.1742; Mitra SN, 2000, REDOX REP, V5, P215, DOI 10.1179/135100000101535771; Morgan PE, 2011, FREE RADICAL BIO MED, V51, P1815, DOI 10.1016/j.freeradbiomed.2011.08.008; Morgan WJ, 2004, NEW ENGL J MED, V351, P1068, DOI 10.1056/NEJMoa032097; Mydel P, 2010, J IMMUNOL, V184, P6882, DOI 10.4049/jimmunol.1000075; Nicholls SJ, 2009, J LIPID RES, V50, pS346, DOI 10.1194/jlr.R800086-JLR200; OLEA F, 1992, J ANAL TOXICOL, V16, P258, DOI 10.1093/jat/16.4.258; Podrez EA, 2000, FREE RADICAL BIO MED, V28, P1717, DOI 10.1016/S0891-5849(00)00229-X; Poliakov E, 2003, FASEB J, V17, P2209, DOI 10.1096/fj.03-0086com; Sanders PN, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006135; Scanlon CEO, 1996, ATHEROSCLEROSIS, V121, P23, DOI 10.1016/0021-9150(95)05672-6; Shiue I, 2015, ENVIRON SCI POLLUT R, V22, P5952, DOI 10.1007/s11356-014-3777-8; SLUNGAARD A, 1991, J BIOL CHEM, V266, P4903; Son JN, 2011, INT J CARDIOL, V146, P428, DOI 10.1016/j.ijcard.2010.10.098; Speer T, 2014, EUR HEART J, V35, P3021, DOI 10.1093/eurheartj/ehu111; Stark G R, 1977, Methods Enzymol, V47, P129; STARK GR, 1965, BIOCHEMISTRY-US, V4, P588, DOI 10.1021/bi00879a032; STARK GR, 1960, J BIOL CHEM, V235, P3177; STARK RG, 1964, J BIOL CHEM, V239, P1411; Sullivan PW, 2014, J ASTHMA, V51, P769, DOI 10.3109/02770903.2014.906607; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Tahboub YR, 2005, J BIOL CHEM, V280, P26129, DOI 10.1074/jbc.M503027200; Takeyama K, 1999, P NATL ACAD SCI USA, V96, P3081, DOI 10.1073/pnas.96.6.3081; Talib J, 2014, BIOCHEM J, V457, P89, DOI 10.1042/BJ20131135; THOMAS EL, 1994, INFECT IMMUN, V62, P529, DOI 10.1128/IAI.62.2.529-535.1994; Wang Z, 2007, NAT MED, V13, P1176, DOI 10.1038/nm1637; Wedes SH, 2011, J PEDIATR-US, V159, P248, DOI 10.1016/j.jpeds.2011.01.029; Wedes SH, 2009, CTS-CLIN TRANSL SCI, V2, P112, DOI 10.1111/j.1752-8062.2009.00095.x; WEVER R, 1982, BIOCHIM BIOPHYS ACTA, V709, P212, DOI 10.1016/0167-4838(82)90463-0; Wijkstrom-Frei C, 2003, AM J RESP CELL MOL, V29, P206, DOI 10.1165/rcmb.2002-0152OC; Wu WJ, 2000, J CLIN INVEST, V105, P1455, DOI 10.1172/JCI9702; Wu WJ, 1999, J BIOL CHEM, V274, P25933, DOI 10.1074/jbc.274.36.25933; Wu WJ, 1999, BIOCHEMISTRY-US, V38, P3538, DOI 10.1021/bi982401l; Xu WL, 2014, REDOX BIOL, V2, P513, DOI 10.1016/j.redox.2014.01.004; Xu X, 2009, SURGERY, V146, P506, DOI 10.1016/j.surg.2009.03.022; Yu M, 2011, J CLIN INVEST, V121, P3133, DOI 10.1172/JCI43598; Zhang RL, 2002, J BIOL CHEM, V277, P46116, DOI 10.1074/jbc.M209124200; Zhang RL, 2002, BLOOD, V99, P1802, DOI 10.1182/blood.V99.5.1802.h8001802_1802_1810; Zheng S, 2003, IMMUNITY, V18, P619, DOI 10.1016/S1074-7613(03)00114-6	95	22	22	0	7	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22118	22135		10.1074/jbc.M116.750034	http://dx.doi.org/10.1074/jbc.M116.750034			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27587397	Green Published, hybrid			2022-12-26	WOS:000386332600026
J	Arcipowski, KM; Bulic, M; Gurbuxani, S; Licht, JD				Arcipowski, Kelly M.; Bulic, Marinka; Gurbuxani, Sandeep; Licht, Jonathan D.			Loss of Mll3 Catalytic Function Promotes Aberrant Myelopoiesis	PLOS ONE			English	Article							ACUTE MYELOID-LEUKEMIA; CHROMATIN REMODELING GENES; BILE-ACID HOMEOSTASIS; MYELODYSPLASTIC SYNDROMES; SOMATIC MUTATIONS; LYSINE-4 METHYLTRANSFERASES; COLORECTAL-CANCER; CELL CARCINOMA; CRUCIAL ROLES; STEM-CELLS	Two of the most common myeloid malignancies, myelodysplastic syndrome (MDS) and acute myeloid leukemia (AML), are associated with exceedingly low survival rates despite recent therapeutic advances. While their etiology is not completely understood, evidence suggests that certain chromosomal abnormalities contribute to MDS and AML progression. Among the most frequent chromosomal abnormalities in these disorders are alterations of chromosome 7: either complete loss of one copy of chromosome 7 (-7) or partial deletion of 7q (del(7q)), both of which increase the risk of progression from MDS to AML and are associated with chemoresistance. Notably, 7q36.1, a critical minimally deleted region in 7q, includes the gene encoding the histone methyltransferase mixed-lineage leukemia 3 (MLL3), which is also mutated in a small percentage of AML patients. However, the mechanisms by which MLL3 loss contributes to malignancy are unknown. Using an engineered mouse model expressing a catalytically inactive form of Mll3, we found a significant shift in hematopoiesis toward the granulocyte/macrophage lineage, correlating with myeloid infiltration and enlargement of secondary lymphoid organs. Therefore, we propose that MLL3 loss in patients may contribute to the progression of MDS and AML by promoting myelopoiesis.	[Arcipowski, Kelly M.; Bulic, Marinka; Licht, Jonathan D.] Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA; [Gurbuxani, Sandeep] Univ Chicago, Med Ctr, Dept Clin Hematol Hematopathol, Chicago, IL 60637 USA; [Licht, Jonathan D.] Univ Florida, Hlth Canc Ctr, Gainesville, FL 32611 USA	Northwestern University; Feinberg School of Medicine; University of Chicago; University of Chicago Medical Center; State University System of Florida; University of Florida	Licht, JD (corresponding author), Northwestern Univ, Feinberg Sch Med, Div Hematol Oncol, Chicago, IL 60611 USA.; Licht, JD (corresponding author), Univ Florida, Hlth Canc Ctr, Gainesville, FL 32611 USA.	jdlicht@ufl.edu	Licht, Jonathan/AAL-9184-2020; Licht, Jonathan/L-4239-2019	Licht, Jonathan/0000-0002-3942-1369; 	NIH/NCI [R01CA180475]; Leukemia and Lymphoma Society SCOR Award; NIH Oncogenesis and Developmental Biology Training Grant [T32CA080621-11]; Northwestern University Mouse Histology and Phenotyping Laboratory; Cancer Center Support Grant [NCI CA060553]; NATIONAL CANCER INSTITUTE [R01CA180475] Funding Source: NIH RePORTER	NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society SCOR Award; NIH Oncogenesis and Developmental Biology Training Grant; Northwestern University Mouse Histology and Phenotyping Laboratory; Cancer Center Support Grant; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by NIH/NCI Grant R01CA180475 and a Leukemia and Lymphoma Society SCOR Award (to J.D.L.) and NIH T32CA080621-11 Oncogenesis and Developmental Biology Training Grant (to K.M.A.). This work was also supported in part by the Northwestern University Mouse Histology and Phenotyping Laboratory and a Cancer Center Support Grant (NCI CA060553).	Ananthanarayanan M, 2011, AM J PHYSIOL-GASTR L, V300, pG771, DOI 10.1152/ajpgi.00499.2010; Ashktorab H, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008879; Biankin AV, 2012, NATURE, V491, P399, DOI 10.1038/nature11547; Braun T, 2013, BEST PRACT RES CL HA, V26, P327, DOI 10.1016/j.beha.2013.09.003; Burckstummer T, 2013, NAT METHODS, V10, P965, DOI 10.1038/nmeth.2609; Cerami E, 2012, CANCER DISCOV, V2, P401, DOI 10.1158/2159-8290.CD-12-0095; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; Chen C, 2014, CANCER CELL, V25, P652, DOI 10.1016/j.ccr.2014.03.016; Dohner K, 1998, BLOOD, V92, P4031, DOI 10.1182/blood.V92.11.4031.423k55_4031_4035; Dolnik A, 2012, BLOOD, V120, pE83, DOI 10.1182/blood-2011-12-401471; Elias HK, 2014, ONCOGENE, V33, P5139, DOI 10.1038/onc.2013.520; Ellis MJ, 2012, NATURE, V486, P353, DOI 10.1038/nature11143; Estey E, 2006, LANCET, V368, P1894, DOI 10.1016/S0140-6736(06)69780-8; Fenaux P, 2009, LANCET ONCOL, V10, P223, DOI 10.1016/S1470-2045(09)70003-8; Fujimoto A, 2012, NAT GENET, V44, P760, DOI 10.1038/ng.2291; Gao JJ, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2004088; Gao YB, 2014, NAT GENET, V46, P1097, DOI 10.1038/ng.3076; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Herz HM, 2014, MOL CELL, V53, P859, DOI 10.1016/j.molcel.2014.02.033; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Hu DQ, 2013, MOL CELL BIOL, V33, P4745, DOI 10.1128/MCB.01181-13; Kanchi KL, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4156; Kim DH, 2015, HEPATOLOGY, V61, P1012, DOI 10.1002/hep.27578; Kim DH, 2011, MOL ENDOCRINOL, V25, P2076, DOI 10.1210/me.2011-1198; Kim DH, 2009, MOL ENDOCRINOL, V23, P1556, DOI 10.1210/me.2009-0099; Kotini AG, 2015, NAT BIOTECHNOL, V33, P646, DOI 10.1038/nbt.3178; Kuhn MWM, 2012, BLOOD, V119, pE67, DOI 10.1182/blood-2011-09-380444; Lee J, 2009, P NATL ACAD SCI USA, V106, P8513, DOI 10.1073/pnas.0902873106; Lee J, 2008, P NATL ACAD SCI USA, V105, P19229, DOI 10.1073/pnas.0810100105; Lee S, 2008, MOL ENDOCRINOL, V22, P1312, DOI 10.1210/me.2008-0012; Lee S, 2006, P NATL ACAD SCI USA, V103, P15392, DOI 10.1073/pnas.0607313103; Lee S, 2009, MOL ENDOCRINOL, V23, P610, DOI 10.1210/me.2008-0455; Ley TJ, 2013, NEW ENGL J MED, V368, P2059, DOI 10.1056/NEJMoa1301689; Li WD, 2013, BLOOD, V121, P1478, DOI 10.1182/blood-2012-12-470559; Lindberg J, 2013, EUR UROL, V63, P702, DOI 10.1016/j.eururo.2012.11.053; Lowenberg B, 1999, NEW ENGL J MED, V341, P1051, DOI 10.1056/NEJM199909303411407; Lu QJ, 2013, J AUTOIMMUN, V41, P1, DOI 10.1016/j.jaut.2013.01.010; Mansour MR, 2014, SCIENCE, V346, P1373, DOI 10.1126/science.1259037; Nikoloski G, 2010, NAT GENET, V42, P665, DOI 10.1038/ng.620; Parsons DW, 2011, SCIENCE, V331, P435, DOI 10.1126/science.1198056; Pellagatti A, 2010, LEUKEMIA, V24, P756, DOI 10.1038/leu.2010.31; Puente X.S., 2015, NATURE; Rankin EB, 2015, MOL GENET METAB, V116, P24, DOI 10.1016/j.ymgme.2015.07.004; Ruault M, 2002, GENE, V284, P73, DOI 10.1016/S0378-1119(02)00392-X; Seita J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040321; Shetty V, 2000, BLOOD, V96, P1388, DOI 10.1182/blood.V96.4.1388.h8001388_1388_1392; Valekunja UK, 2013, P NATL ACAD SCI USA, V110, P1554, DOI 10.1073/pnas.1214168110; Visconte V, 2014, BLOOD RES, V49, P216, DOI 10.5045/br.2014.49.4.216; Zang ZJ, 2012, NAT GENET, V44, P570, DOI 10.1038/ng.2246; Zhang L, 2015, LEUKEMIA RES, V39, P6, DOI 10.1016/j.leukres.2014.10.006	50	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162515	10.1371/journal.pone.0162515	http://dx.doi.org/10.1371/journal.pone.0162515			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610619	Green Submitted, gold, Green Published			2022-12-26	WOS:000383255900120
J	Chae, KJ; Jin, GY; Jung, HN; Kwon, KS; Choi, H; Lee, YC; Chung, MJ; Park, HS				Chae, Kum Ju; Jin, Gong Yong; Jung, Hyun Nyeong; Kwon, Keun Sang; Choi, Hyemi; Lee, Yong Chul; Chung, Myoung Ja; Park, Ho Sung			Differentiating Smoking-Related Interstitial Fibrosis (SRIF) from Usual Interstitial Pneumonia (UIP) with Emphysema Using CT Features Based on Pathologically Proven Cases	PLOS ONE			English	Article							COMBINED PULMONARY-FIBROSIS; PROGRESSION; SURVIVAL; SOCIETY; DISEASE; LUNG	Objective To differentiate smoking-related interstitial fibrosis (SRIF) from usual interstitial pneumonia (UIP) with emphysema on CT in combined pulmonary fibrosis and emphysema (CPFE) patients. Materials and Methods This study was approved by the institutional review board and informed consent was waived. We included 65 patients who underwent lung biopsy under the suspicion of UIP pattern on HRCT, and after radiologic-pathologic correlation, they were divided into three groups: UIP without emphysema (n = 30), UIP with emphysema (n = 26), and SRIF (n = 9). The quantitative extent of emphysema in the entire lung was visually assessed and fibrotic patterns were qualitatively analyzed based on six characteristics (asymmetry, juxta-subpleural sparing, emphysema beside the honeycombing area, absence of ground grass attenuation/reticulation in honeycombing area, inhomogeneous honeycombing, and absence of honeycombing in the upper lobes). Kaplan-Meier analysis was used for survival analysis, and logistic regression with a receiver operating characteristic curve was used to predict the possibility of SRIF. Results In qualitative analysis of fibrotic patterns, SRIF tended to exhibit more than three of six fibrotic features, whereas UIP with emphysema demonstrated about two of these characteristics (p = 0.035). In addition, SRIF had a higher extent of emphysema than UIP with emphysema when they have same amount of fibrosis (p = 0.014). In patients with SRIF, 5-year survival rate was 85.7%, while it was 40.7% in UIP with emphysema patients (p = 0.035). Conclusion Fibrotic CT patterns and survival rate differed between SRIF and UIP with emphysema among CPFE patients, which explains the variable prognosis of CPFE.	[Chae, Kum Ju; Jin, Gong Yong; Jung, Hyun Nyeong] Chonbuk Natl Univ, Med Sch & Hosp, Inst Med Sci, Dept Radiol,Res Inst Clin Med, Jeonju, Jeonbuk, South Korea; [Kwon, Keun Sang] Chonbuk Natl Univ, Med Sch & Hosp, Inst Med Sci, Dept Prevent Med,Res Inst Clin Med, Jeonju, Jeonbuk, South Korea; [Choi, Hyemi] Chonbuk Natl Univ, Dept Stat, Jeonju, Jeonbuk, South Korea; [Choi, Hyemi] Chonbuk Natl Univ, Inst Appl Stat, Jeonju, Jeonbuk, South Korea; [Lee, Yong Chul] Chonbuk Natl Univ, Med Sch & Hosp, Inst Med Sci, Dept Internal Med,Res Inst Clin Med, Jeonju, Jeonbuk, South Korea; [Chung, Myoung Ja; Park, Ho Sung] Chonbuk Natl Univ, Res Inst Clin Med, Dept Pathol, Sch Med, Jeonju, Jeonbuk, South Korea; [Chae, Kum Ju] Seoul Natl Univ Hosp, Dept Radiol, Seoul, South Korea	Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Jeonbuk National University; Seoul National University (SNU); Seoul National University Hospital	Jin, GY (corresponding author), Chonbuk Natl Univ, Med Sch & Hosp, Inst Med Sci, Dept Radiol,Res Inst Clin Med, Jeonju, Jeonbuk, South Korea.	gyjin@chonbuk.ac.kr						Akagi T, 2009, RESP MED, V103, P1209, DOI 10.1016/j.rmed.2009.02.001; American Thoracic Society, 1995, AM J RESP CRIT CARE, V152, P1107; Chae KJ, 2015, EUR RADIOL, V25, P2326, DOI 10.1007/s00330-015-3617-3; CHAN KL, 1987, J AM COLL CARDIOL, V9, P549, DOI 10.1016/S0735-1097(87)80047-5; Cottin V, 2005, EUR RESPIR J, V26, P586, DOI 10.1183/09031936.05.00021005; Cottin V, 2009, CHEST, V136, P1, DOI 10.1378/chest.09-0538; Coward William R, 2010, Ther Adv Respir Dis, V4, P367, DOI 10.1177/1753465810379801; Gietema HA, 2011, ACAD RADIOL, V18, P661, DOI 10.1016/j.acra.2011.01.011; Hansell DM, 2008, RADIOLOGY, V246, P697, DOI 10.1148/radiol.2462070712; Inomata M, 2014, BMC PULM MED, V14, DOI 10.1186/1471-2466-14-104; Jankowich MD, 2012, CHEST, V141, P222, DOI 10.1378/chest.11-1062; Katzenstein ALA, 2012, MODERN PATHOL, V25, pS68, DOI 10.1038/modpathol.2011.154; Katzenstein ALA, 2010, HUM PATHOL, V41, P316, DOI 10.1016/j.humpath.2009.09.003; Kawabata Y, 2008, HISTOPATHOLOGY, V53, P707, DOI 10.1111/j.1365-2559.2008.03183.x; Kitaguchi Y, 2013, RESP MED, V107, P1986, DOI 10.1016/j.rmed.2013.06.015; Kundel HL, 2003, RADIOLOGY, V228, P303, DOI 10.1148/radiol.2282011860; Kurashima K, 2010, RESPIROLOGY, V15, P843, DOI 10.1111/j.1440-1843.2010.01778.x; Matsuoka S, 2015, J COMPUT ASSIST TOMO, V39, P153, DOI 10.1097/RCT.0000000000000184; Mejia M, 2009, CHEST, V136, P10, DOI 10.1378/chest.08-2306; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Robin X, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-77; Ryerson CJ, 2013, CHEST, V144, P234, DOI 10.1378/chest.12-2403; Silva CIS, 2008, RADIOLOGY, V247, P251, DOI 10.1148/radiol.2471070369; Silva CIS, 2008, RADIOLOGY, V246, P288, DOI 10.1148/radiol.2453061881; Sugino K, 2014, RESPIROLOGY, V19, P239, DOI 10.1111/resp.12207; Travis WD, 2013, AM J RESP CRIT CARE, V188, P733, DOI 10.1164/rccm.201308-1483ST; Washko GR, 2010, ACAD RADIOL, V17, P48, DOI 10.1016/j.acra.2009.07.016	27	12	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162231	10.1371/journal.pone.0162231	http://dx.doi.org/10.1371/journal.pone.0162231			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611866	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900064
J	Jones, DL; Cook, R; Potter, JE; Miron-Shatz, T; Chakhtoura, N; Spence, A; Byrne, MM				Jones, Deborah Lynne; Cook, Ryan; Potter, JoNell Efantis; Miron-Shatz, Talya; Chakhtoura, Nahida; Spence, Andrew; Byrne, Margaret M.			Fertility Desires among Women Living with HIV	PLOS ONE			English	Article							CONJOINT-ANALYSIS; INFECTED WOMEN; REPRODUCTIVE-AGE; INTENTIONS; CARE; PREFERENCES; PREGNANCY; CONVERSATIONS; WILLINGNESS; PROVIDERS	Objective Rates of pregnancy among women living with HIV (WLHIV) have increased with the availability of effective HIV treatment. Planning for pregnancy and childbirth is an increasingly important element of HIV care. Though rates of unintended pregnancies are high among women in general, among couples affected by HIV, significant planning and reproductive decisions must be considered to prevent negative health consequences for WLHIV and their neonates. To gain insight into this reproductive decision-making process among WLHIV, this study explored women's knowledge, attitudes and practices regarding fertility planning, reproductive desires, and safer conception practices. It was hypothesized that pregnancy desires would be influenced by partners, families, the potential risk of HIV transmission to infants, and physicians' recommendations. Methods WLHIV of childbearing age were recruited from urban South Florida, and completed an assessment of demographics (N = 49), fertility desires and a conjoint survey of factors associated with reproductive decision-making. Results Using conjoint analysis, we found that different decision paths exist for different types of women: Younger women and those with less education desired children if their partners wanted children; reproductive desires among those with less education, and with less HIV pregnancy-related knowledge, displayed a trend toward additional emphasis on their family's desires. Conversely, older women and those with more education appeared to place more importance on physician endorsement in their plans for childbearing. Conclusions Results of this study highlight the importance of ongoing preconception counselling for all women of reproductive age during routine HIV care. Counselling should be tailored to patient characteristics, and physicians should consider inclusion of families and/or partners in the process.	[Jones, Deborah Lynne; Cook, Ryan; Spence, Andrew] Univ Miami, Miller Sch Med, Psychiat & Behav Sci, Miami, FL 33136 USA; [Potter, JoNell Efantis; Chakhtoura, Nahida] Univ Miami, Miller Sch Med, Obstet & Gynecol, Miami, FL 33136 USA; [Miron-Shatz, Talya] Ono Acad Coll, Kiryat Ono, Israel; [Miron-Shatz, Talya] Ctr Med Publ Interest, New York, NY USA; [Byrne, Margaret M.] Univ Miami, Miller Sch Med, Epidemiol & Publ Hlth, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami	Jones, DL (corresponding author), Univ Miami, Miller Sch Med, Psychiat & Behav Sci, Miami, FL 33136 USA.	djones@med.miami.edu		Cook, Ryan/0000-0001-8754-995X; Jones, Deborah/0000-0002-4106-8891	University of Miami Miller School of Medicine's Scientific Advisory Committee [UM SAC 2013-33]; Miami Center for AIDS Research [P30AI073961]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI073961] Funding Source: NIH RePORTER	University of Miami Miller School of Medicine's Scientific Advisory Committee; Miami Center for AIDS Research; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This study was funded by a grant from the University of Miami Miller School of Medicine's Scientific Advisory Committee (UM SAC 2013-33), with support from the Miami Center for AIDS Research (P30AI073961) and the women participating, without whom this research would not be possible.	Centers for Disease Control and Prevention, PRECONCEPTION HEALTH; Chen JL, 2001, FAM PLANN PERSPECT, V33, P144, DOI 10.2307/2673717; Coll AS, 2016, AIDS CARE, V28, P513, DOI 10.1080/09540121.2015.1112349; Cuca YP, 2015, QUAL HEALTH RES; Cunningham CE, 2014, SCH MENT HEALTH, V6, P1, DOI 10.1007/s12310-013-9110-8; De la Cruz NG, 2011, AIDS BEHAV, V15, P1233, DOI 10.1007/s10461-010-9788-7; Finger JL, 2012, AIDS PATIENT CARE ST, V26, P173, DOI 10.1089/apc.2011.0225; Finocchario-Kessler S, 2010, AIDS BEHAV, V14, P1106, DOI 10.1007/s10461-009-9637-8; Finocchario-Kessler S, 2010, AIDS PATIENT CARE ST, V24, P317, DOI 10.1089/apc.2009.0293; Francois-Xavier Bagnoud (FXB), 2012, HIV PREC CAR TOOLK; Garbers S, 2013, J WOMENS HEALTH, V22, P930, DOI 10.1089/jwh.2013.4247; GREEN PE, 1990, J MARKETING, V54, P3, DOI 10.2307/1251756; GREEN PE, 1978, J CONSUM RES, V5, P103, DOI 10.1086/208721; Hauser JR, MARKETING RES MODELI, P141; Hoyt MJ, 2012, INFECT DIS OBSTET GY; JACCARD J, 1986, J CONSUM RES, V12, P463, DOI 10.1086/208530; Jean J, 2015, HLTH CARE WOMEN INT, DOI 10.1080/07399332.2015.1107068; Jones DL, 2010, OPEN ACCESS J CONTR, V1, P23; Kateeb ET, 2014, J PUBLIC HEALTH DENT, V74, P234, DOI 10.1111/jphd.12052; Kuhfeld W. F., 2010, MARKETING RES METHOD; Lee SJ, 2013, AIDS CARE, V25, P1592, DOI 10.1080/09540121.2013.793272; Loutfy MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055747; Loutfy MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007925; LOUVIERE JJ, 1988, J TRANSP ECON POLICY, V22, P93; Magnus M, 2013, AIDS PATIENT CARE ST, V27, P297, DOI 10.1089/apc.2012.0423; Martins RK, 2009, CLIN PSYCHOL REV, V29, P283, DOI 10.1016/j.cpr.2009.02.001; Miller WB, 2002, J APPL BIOBEHAV RES, V7, P1, DOI 10.1111/j.1751-9861.2002.tb00073.x; Nattabi B, 2009, AIDS BEHAV, V13, P949, DOI 10.1007/s10461-009-9537-y; Orme B, 2010, GETTING STARTED CONJ, P77; Orme BK, SAWTOOTH SOFTWARE C, P209; Rahangdale L, 2014, JAIDS-J ACQ IMM DEF, V65, P306, DOI 10.1097/QAI.0000000000000014; Rodriguez Violeta J, 2017, J Int Assoc Provid AIDS Care, V16, P133, DOI 10.1177/2325957415612127; Rollnick S, 2008, COPD, V5, P203, DOI [10.1080/15412550802093108, DOI 10.1080/15412550802093108]; Ryan M, 2000, BMJ-BRIT MED J, V320, P1530, DOI 10.1136/bmj.320.7248.1530; Sivell S, 2012, PATIENT EDUC COUNS, V88, P209, DOI 10.1016/j.pec.2012.03.012; Smith ML, 2014, BREAST CANCER RES TR, V145, P83, DOI 10.1007/s10549-014-2909-7; Squires KE, 2011, AIDS PATIENT CARE ST, V25, P279, DOI 10.1089/apc.2010.0228; Steiner RJ, 2013, AIDS, V27, pS113, DOI 10.1097/QAD.0000000000000059; Steiner RJ, 2013, AM J PUBLIC HEALTH, V103, P1357, DOI 10.2105/AJPH.2013.301265; Sutton MY, 2014, JAIDS-J ACQ IMM DEF, V65, P350, DOI 10.1097/QAI.0000000000000054; Trimble C, 2013, HEALTH AFFAIR, V32, P436, DOI 10.1377/hlthaff.2012.1214	41	24	24	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160190	10.1371/journal.pone.0160190	http://dx.doi.org/10.1371/journal.pone.0160190			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27610626	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900003
J	Kryukov, K; Imanishi, T				Kryukov, Kirill; Imanishi, Tadashi			Human Contamination in Public Genome Assemblies	PLOS ONE			English	Article							DNA	Contamination in genome assembly can lead to wrong or confusing results when using such genome as reference in sequence comparison. Although bacterial contamination is well known, the problem of human-originated contamination received little attention. In this study we surveyed 45,735 available genome assemblies for evidence of human contamination. We used lineage specificity to distinguish between contamination and conservation. We found that 154 genome assemblies contain fragments that with high confidence originate as contamination from human DNA. Majority of contaminating human sequences were present in the reference human genome assembly for over a decade. We recommend that existing contaminated genomes should be revised to remove contaminated sequence, and that new assemblies should be thoroughly checked for presence of human DNA before submitting them to public databases.	[Kryukov, Kirill; Imanishi, Tadashi] Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa, Japan	Tokai University	Imanishi, T (corresponding author), Tokai Univ, Sch Med, Dept Mol Life Sci, Isehara, Kanagawa, Japan.	imanishi@tokai.ac.jp	Imanishi, Tadashi/R-3076-2019	Imanishi, Tadashi/0000-0002-1182-9127	Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan [13800633]; Japan Initiative for Global Research Network on Infectious Diseases (JGRID) Grant from the Ministry of Education, Culture, Sport, Science and Technology of Japan [15666369]; Japan Agency for Medical Research and Development (AMED); Tokai University School of Medicine	Health Labour Sciences Research Grant from the Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Japan Initiative for Global Research Network on Infectious Diseases (JGRID) Grant from the Ministry of Education, Culture, Sport, Science and Technology of Japan; Japan Agency for Medical Research and Development (AMED)(Japan Agency for Medical Research and Development (AMED)); Tokai University School of Medicine	This research was partially supported by the Health Labour Sciences Research Grant [13800633] from the Ministry of Health, Labour and Welfare of Japan, and by the Japan Initiative for Global Research Network on Infectious Diseases (JGRID) Grant [15666369] from the Ministry of Education, Culture, Sport, Science and Technology of Japan, and Japan Agency for Medical Research and Development (AMED). Funding for open access charge was provided by Tokai University School of Medicine.	Agarwala R, 2016, NUCLEIC ACIDS RES, V44, pD7, DOI [10.1093/nar/gkv1290, 10.1093/nar/gku1130]; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Bejerano G, 2004, SCIENCE, V304, P1321, DOI 10.1126/science.1098119; Benson DA, 2015, NUCLEIC ACIDS RES, V43, pD30, DOI 10.1093/nar/gku1216; HANDT O, 1994, EXPERIENTIA, V50, P524, DOI 10.1007/BF01921720; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; Kent WJ, 2001, GENOME RES, V11, P1541, DOI 10.1101/gr.183201; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Longo MS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016410; Merchant S, 2014, PEERJ, V2, DOI 10.7717/peerj.675; Morgulis A, 2006, J COMPUT BIOL, V13, P1028, DOI 10.1089/cmb.2006.13.1028; Pilli E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052524; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Rosenbloom KR, 2015, NUCLEIC ACIDS RES, V43, pD670, DOI 10.1093/nar/gku1177; Strong MJ, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004437; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Tatusova T, 2015, NUCLEIC ACIDS RES, V43, pD599, DOI 10.1093/nar/gku1062	17	33	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162424	10.1371/journal.pone.0162424	http://dx.doi.org/10.1371/journal.pone.0162424			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611326	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900097
J	Stutika, C; Mietzsch, M; Gogol-Doring, A; Weger, S; Sohn, M; Chen, W; Heilbronn, R				Stutika, Catrin; Mietzsch, Mario; Gogol-Doering, Andreas; Weger, Stefan; Sohn, Madlen; Chen, Wei; Heilbronn, Regine			Comprehensive Small RNA-Seq of Adeno-Associated Virus (AAV)-Infected Human Cells Detects Patterns of Novel, Non-Coding AAV RNAs in the Absence of Cellular miRNA Regulation	PLOS ONE			English	Article							DNA-REPLICATION; GENE-EXPRESSION; ADENOVIRUS REPLICATION; MICRORNAS; TYPE-2; TRANSCRIPTION; REVEALS; GENOMES; ORIGIN; INTEGRATION	Most DNA viruses express small regulatory RNAs, which interfere with viral or cellular gene expression. For adeno-associated virus (AAV), a small ssDNA virus with a complex biphasic life cycle miRNAs or other small regulatory RNAs have not yet been described. This is the first comprehensive Illumina-based RNA-Seq analysis of small RNAs expressed by AAV alone or upon co-infection with helper adenovirus or HSV. Several hotspots of AAV-specific small RNAs were detected mostly close to or within the AAV-ITR and apparently transcribed from the newly identified anti-p5 promoter. An additional small RNA hotspot was located downstream of the p40 promoter, from where transcription of non-coding RNAs associated with the inhibition of adenovirus replication were recently described. Parallel detection of known Ad and HSV miRNAs indirectly validated the newly identified small AAV RNA species. The predominant small RNAs were analyzed on Northern blots and by human argonaute protein-mediated co-immunoprecipitation. None of the small AAV RNAs showed characteristics of bona fide miRNAs, but characteristics of alternative RNA processing indicative of differentially regulated AAV promoter-associated small RNAs. Furthermore, the AAV-induced regulation of cellular miRNA levels was analyzed at different time points post infection. In contrast to other virus groups AAV infection had virtually no effect on the expression of cellular miRNA, which underscores the long-established concept that wild-type AAV infection is apathogenic.	[Stutika, Catrin; Mietzsch, Mario; Weger, Stefan; Heilbronn, Regine] Charite, Inst Virol, Campus Benjamin Franklin, Berlin, Germany; [Gogol-Doering, Andreas] Tech Hsch Mittelhessen, Giessen, Germany; [Sohn, Madlen; Chen, Wei] Max Delbruck Ctr Mol Med, Berlin Inst Med Syst Biol, Lab Funct Genom & Syst Biol, Berlin, Germany; [Mietzsch, Mario] Univ Florida, Dept Biochem & Mol Biol, Struct Biol Ctr, McKnight Brain Inst, Gainesville, FL 32610 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Helmholtz Association; Max Delbruck Center for Molecular Medicine; State University System of Florida; University of Florida	Heilbronn, R (corresponding author), Charite, Inst Virol, Campus Benjamin Franklin, Berlin, Germany.	regine.heilbronn@charite.de	Heilbronn, Regine/E-1349-2013; Mietzsch, Mario/AAU-4233-2021	Heilbronn, Regine/0000-0001-6412-3278; Mietzsch, Mario/0000-0001-8957-3363; Weger, Stefan/0000-0002-0906-5252	Sonnenfeld-Stiftung, Berlin; Charite Universitatsmedizin Berlin	Sonnenfeld-Stiftung, Berlin; Charite Universitatsmedizin Berlin	RH received funding by the Sonnenfeld-Stiftung, Berlin; http://www.sonnenfeld-stiftung.de/. CS received a Ph.D. scholarship from Charite Universitatsmedizin Berlin.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Andersson MG, 2005, J VIROL, V79, P9556, DOI 10.1128/JVI.79.15.9556-9565.2005; Aparicio O, 2006, J VIROL, V80, P1376, DOI 10.1128/JVI.80.3.1376-1384.2006; Aparicio O, 2010, NUCLEIC ACIDS RES, V38, P750, DOI 10.1093/nar/gkp1028; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bellutti F, 2015, J VIROL, V89, P1608, DOI 10.1128/JVI.02336-14; BLACKLOW NR, 1967, P NATL ACAD SCI USA, V58, P1410, DOI 10.1073/pnas.58.4.1410; Brister JR, 2000, J VIROL, V74, P7762, DOI 10.1128/JVI.74.17.7762-7771.2000; Brister JR, 1999, J VIROL, V73, P9325, DOI 10.1128/JVI.73.11.9325-9336.1999; BULLER RML, 1981, J VIROL, V40, P241, DOI 10.1128/JVI.40.1.241-247.1981; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Damm K, 2015, METHODS MOL BIOL, V1296, P41, DOI 10.1007/978-1-4939-2547-6_5; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Flores O, 2013, J VIROL, V87, P6589, DOI 10.1128/JVI.00504-13; FLOTTE TR, 1993, J BIOL CHEM, V268, P3781; Furuse Y, 2013, VIROLOGY, V447, P140, DOI 10.1016/j.virol.2013.08.024; GEORGFRIES B, 1984, VIROLOGY, V134, P64, DOI 10.1016/0042-6822(84)90272-1; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Haberman RP, 2000, J VIROL, V74, P8732, DOI 10.1128/JVI.74.18.8732-8739.2000; Harris CJ, 2015, NUCLEIC ACIDS RES, V43, P7590, DOI 10.1093/nar/gkv604; HAUSWIRTH WW, 1977, VIROLOGY, V78, P488, DOI 10.1016/0042-6822(77)90125-8; He SM, 2008, CRIT REV MICROBIOL, V34, P175, DOI [10.1080/10408410802482008, 10.1080/10408410802482008 ]; HEILBRONN R, 1990, J VIROL, V64, P3012, DOI 10.1128/JVI.64.6.3012-3018.1990; Huser D, 2014, J VIROL, V88, P11253, DOI 10.1128/JVI.01356-14; Jing XJ, 2001, VIROLOGY, V291, P140, DOI 10.1006/viro.2001.1192; Jurak I, 2010, J VIROL, V84, P4659, DOI 10.1128/JVI.02725-09; Keam Simon P., 2015, Life-Basel, V5, P1638, DOI 10.3390/life5041638; Kim SW, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1235; Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644; Kincaid RP, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003018; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; KOTIN RM, 1990, P NATL ACAD SCI USA, V87, P2211, DOI 10.1073/pnas.87.6.2211; Kozomara A, 2014, NUCLEIC ACIDS RES, V42, pD68, DOI 10.1093/nar/gkt1181; Langenberger D, 2009, BIOINFORMATICS, V25, P2298, DOI 10.1093/bioinformatics/btp419; Langmead Ben, 2010, Curr Protoc Bioinformatics, VChapter 11, DOI 10.1002/0471250953.bi1107s32; Lin YT, 2010, RNA, V16, P1540, DOI 10.1261/rna.1967910; MCPHERSON RA, 1985, VIROLOGY, V147, P217, DOI 10.1016/0042-6822(85)90243-0; Meshesha Mesfin K, 2012, Open Virol J, V6, P38, DOI 10.2174/1874357901206010038; Mietzsch M, 2014, J VIROL, V88, P2991, DOI 10.1128/JVI.03371-13; Munson DJ, 2012, ARCH VIROL, V157, P1677, DOI 10.1007/s00705-012-1345-4; Pereira DJ, 1997, J VIROL, V71, P1079, DOI 10.1128/JVI.71.2.1079-1088.1997; Qiu JM, 2002, J VIROL, V76, P12435, DOI 10.1128/JVI.76.24.12435-12447.2002; Rother S, 2011, BIOCHIMIE, V93, P1905, DOI 10.1016/j.biochi.2011.07.032; Seila AC, 2008, SCIENCE, V322, P1849, DOI 10.1126/science.1162253; Son KN, 2015, J VIROL, V89, P9383, DOI 10.1128/JVI.01299-15; Sonntag F, 2010, P NATL ACAD SCI USA, V107, P10220, DOI 10.1073/pnas.1001673107; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; Stilwell JL, 2004, MOL THER, V9, P337, DOI 10.1016/j.ymthe.2003.11.007; Stutika C, 2016, J VIROL, V90, P1278, DOI 10.1128/JVI.02750-15; Taft RJ, 2009, NAT GENET, V41, P572, DOI 10.1038/ng.312; THOMSON BJ, 1994, VIROLOGY, V204, P304, DOI 10.1006/viro.1994.1535; Timpe JA, 2006, J VIROL, V80, P7807, DOI 10.1128/JVI.00198-06; Tuddenham L, 2012, J VIROL, V86, P1638, DOI 10.1128/JVI.05911-11; Tycowski KT, 2015, GENE DEV, V29, P567, DOI 10.1101/gad.259077.115; Umbach JL, 2008, NATURE, V454, P780, DOI 10.1038/nature07103; Wang LN, 2015, J GEN VIROL, V96, P2780, DOI 10.1099/jgv.0.000229; Wang XS, 1997, J VIROL, V71, P3077, DOI 10.1128/JVI.71.4.3077-3082.1997; Wang XS, 1996, J VIROL, V70, P1668, DOI 10.1128/JVI.70.3.1668-1677.1996; Weger S, 2016, J VIROL, V90, P3981, DOI 10.1128/JVI.03120-15; WEINDLER FW, 1991, J VIROL, V65, P2476, DOI 10.1128/JVI.65.5.2476-2483.1991; Winter K, 2012, J VIROL, V86, P5099, DOI 10.1128/JVI.06991-11; Yan BX, 2012, CELL MOL LIFE SCI, V69, P2833, DOI 10.1007/s00018-012-0953-1; Yang JS, 1999, J VIROL, V73, P9468, DOI 10.1128/JVI.73.11.9468-9477.1999; Zhao HX, 2015, VIROLOGY, V478, P99, DOI 10.1016/j.virol.2015.01.033	65	7	7	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161454	10.1371/journal.pone.0161454	http://dx.doi.org/10.1371/journal.pone.0161454			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611072	gold, Green Submitted, Green Accepted, Green Published			2022-12-26	WOS:000383255900017
J	Val-Laillet, D; Meurice, P; Clouard, C				Val-Laillet, David; Meurice, Paul; Clouard, Caroline			Familiarity to a Feed Additive Modulates Its Effects on Brain Responses in Reward and Memory Regions in the Pig Model	PLOS ONE			English	Article							APPETITE SUPPRESSING PROPERTIES; BODY-WEIGHT CONTROL; SWEET ORANGE AROMA; OLFACTORY STIMULATION; CHEMICAL-COMPOUNDS; FOOD PREFERENCES; ESSENTIAL OIL; DOMESTIC PIG; FLAVOR; TASTE	Brain responses to feed flavors with or without a feed additive (FA) were investigated in piglets familiarized or not with this FA. Sixteen piglets were allocated to 2 dietary treatments from weaning until d 37: the naive group (NAI) received a standard control feed and the familiarized group (FAM) received the same feed added with a FA mainly made of orange extracts. Animals were subjected to a feed transition at d 16 post-weaning, and to 2-choice feeding tests at d 16 and d 23. Production traits of the piglets were assessed up to d 28 post-weaning. From d 26 onwards, animals underwent 2 brain imaging sessions (positron emission tomography of (18)FDG) under anesthesia to investigate the brain activity triggered by the exposure to the flavors of the feed with (FA) or without (C) the FA. Images were analyzed with SPM8 and a region of interest (ROI)-based small volume correction (p < 0.05, k >= 25 voxels per cluster). The brain ROI were selected upon their role in sensory evaluation, cognition and reward, and included the prefrontal cortex, insular cortex, fusiformgyrus, limbic system and corpus striatum. The FAM animals showed a moderate preference for the novel post-transition FA feed compared to the C feed on d 16, i.e., day of the feed transition (67% of total feed intake). The presence or absence of the FA in the diet from weaning had no impact on body weight, average daily gain, and feed efficiency of the animals over the whole experimental period (p >= 0.10). Familiar feed flavors activated the prefrontal cortex. The amygdala, insular cortex, and prepyriformarea were only activated in familiarized animals exposed to the FA feed flavor. The perception of FA feed flavor in the familiarized animals activated the dorsal striatum differently than the perception of the C feed flavor in naive animals. Our data demonstrated that the perception of FA in familiarized individuals induced different brain responses in regions involved in reward anticipation and/or perception processes than the familiar control feed flavor in naive animals. Chronic exposure to the FA might be necessary for positive hedonic effects, but familiarity only cannot explain them.	[Val-Laillet, David; Meurice, Paul; Clouard, Caroline] INRA, ADNC UR1341, St Gilles, France	INRAE	Val-Laillet, D (corresponding author), INRA, ADNC UR1341, St Gilles, France.	david.val-laillet@rennes.inra.fr	Clouard, Caroline/K-1255-2014; Val-Laillet, David/B-4328-2008; VAL-LAILLET, David/AAH-6454-2021	Clouard, Caroline/0000-0002-5562-6057; Val-Laillet, David/0000-0002-6256-7737; 	Phode Sciences (Terssac, France); BPI France	Phode Sciences (Terssac, France); BPI France	The study was funded by Phode Sciences (Terssac, France-http://www.phode.com/en/) and BPI France (http://www.bpifrance.fr/)-formerly OSEO. Phode Science participated to the discussion of the experimental protocol and results but had no role in decision to publish or preparation of the manuscript. BPI France had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The study was funded by Phode Sciences (Terssac, France-http://www.phode.com/en/) and BPI France (http://www.bpifrance.fr/-formerly OSEO). Phode Science participated to the discussion of the experimental protocol and results but had no role in decision to publish or preparation of the manuscript. BPI France had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The sensory functional ingredients were provided by Phode Laboratories (Terssac, France). The authors would like to thank our partners from Phode Sciences, who participated to the discussion of the experimental protocols and results: Virginie Noirot, Pierre Etienne, Maxime Champagnac, and Daniel Eclache, as well as Bertrand Medina (Laboratoires Phode) for proofreading. The authors acknowledge Charles-Henri Malbert who initially developed the brain imaging protocol in pigs and part of the data processing method. The authors also gratefully acknowledge the efforts and cooperation of the technical staff, and especially Alain Chauvin, Francis Legouevec, Regis Janvier and Vincent Piedvache for participating in this study and taking care of the animals.	Astell KJ, 2013, PLANT FOOD HUM NUTR, V68, P213, DOI 10.1007/s11130-013-0361-1; Brooks SJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060393; Burger KS, 2014, NEUROIMAGE, V99, P122, DOI 10.1016/j.neuroimage.2014.05.066; CAMPBELL RG, 1976, ANIM PROD, V23, P417, DOI 10.1017/S0003356100031536; Cautela D, 2008, J AGR FOOD CHEM, V56, P5407, DOI 10.1021/jf8006823; Chambers ES, 2009, J PHYSIOL-LONDON, V587, P1779, DOI 10.1113/jphysiol.2008.164285; Chang KM, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/946537; Clouard C, 2014, J ANIM SCI, V92, P2133, DOI 10.2527/jas.2013-6809; Clouard C, 2012, ANIMAL, V6, P118, DOI 10.1017/S1751731111001315; Clouard C, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00861; Clouard C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037968; Clouard C, 2012, APPL ANIM BEHAV SCI, V138, P36, DOI 10.1016/j.applanim.2012.01.016; Conrad MS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107650; Conrad MS, 2012, DEV NEUROSCI-BASEL, V34, P291, DOI 10.1159/000339311; Danilova V, 2002, METH NE FRO NEUROSCI, P247; Faturi CB, 2010, PROG NEURO-PSYCHOPH, V34, P605, DOI 10.1016/j.pnpbp.2010.02.020; Frank GKW, 2008, NEUROIMAGE, V39, P1559, DOI 10.1016/j.neuroimage.2007.10.061; Gattuso G, 2007, MOLECULES, V12, P1641, DOI 10.3390/12081641; Gaultier A, 2011, EUR J NEUROSCI, V34, P1500, DOI 10.1111/j.1460-9568.2011.07848.x; Goes TC, 2012, J ALTERN COMPLEM MED, V18, P798, DOI 10.1089/acm.2011.0551; Hassani OK, 2001, J NEUROPHYSIOL, V85, P2477, DOI 10.1152/jn.2001.85.6.2477; Henkin RI, 2001, J COMPUT ASSIST TOMO, V25, P493, DOI 10.1097/00004728-200107000-00001; Jacela JY, 2010, J SWINE HEALTH PROD, V18, P27, DOI 10.4148/2378-5977.7069; Jafarzadeh Mehdi, 2013, Adv Biomed Res, V2, P10, DOI 10.4103/2277-9175.107968; KENNEDY JM, 1972, ANIM BEHAV, V20, P706, DOI 10.1016/S0003-3472(72)80142-8; KING RH, 1979, AUST J EXP AGR, V19, P695, DOI 10.1071/EA9790695; Komiya M, 2006, BEHAV BRAIN RES, V172, P240, DOI 10.1016/j.bbr.2006.05.006; Komori T, 1995, EUR NEUROPSYCHOPHARM, V5, P477, DOI 10.1016/0924-977X(95)00020-P; KOMORI T, 1995, NEUROIMMUNOMODULAT, V2, P174, DOI 10.1159/000096889; Langendijk P, 2007, LIVEST SCI, V108, P284, DOI 10.1016/j.livsci.2007.01.083; Lehrner J, 2000, PHYSIOL BEHAV, V71, P83, DOI 10.1016/S0031-9384(00)00308-5; Lyly M, 2009, EUR J NUTR, V48, P251, DOI 10.1007/s00394-009-0009-y; Morrone LA, 2007, PHARMACOL RES, V55, P255, DOI 10.1016/j.phrs.2006.11.010; Nishijo H, 1992, Asia Pac J Clin Nutr, V1, P3; Rolls ET, 2006, PHILOS T R SOC B, V361, P1123, DOI 10.1098/rstb.2006.1852; Saikali S, 2010, J NEUROSCI METH, V192, P102, DOI 10.1016/j.jneumeth.2010.07.041; Saiyudthong S, 2011, PHYTOTHER RES, V25, P858, DOI 10.1002/ptr.3325; Schdne F, 2006, J ANIM PHYSIOL AN N, V90, P500; Shen J, 2005, NEUROSCI LETT, V380, P289, DOI 10.1016/j.neulet.2005.01.058; Simitzis PE, 2008, PHYSIOL BEHAV, V93, P529, DOI 10.1016/j.physbeh.2007.10.013; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Stice E, 2013, AM J CLIN NUTR, V98, P1377, DOI 10.3945/ajcn.113.069443; Stohs SJ, 2013, PLANT FOOD HUM NUTR, V68, P329, DOI 10.1007/s11130-013-0376-7; Tanida M, 2005, BRAIN RES, V1058, P44, DOI 10.1016/j.brainres.2005.07.048; Val-Laillet D, 2015, NEUROIMAGE-CLIN, V8, P1, DOI 10.1016/j.nicl.2015.03.016; Wilson DA, 2003, NEUROSCI BIOBEHAV R, V27, P307, DOI 10.1016/S0149-7634(03)00050-2; Yamamoto T, 2006, ARCH HISTOL CYTOL, V69, P243, DOI 10.1679/aohc.69.243; Yi LT, 2008, LIFE SCI, V82, P741, DOI 10.1016/j.lfs.2008.01.007	48	6	6	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162660	10.1371/journal.pone.0162660	http://dx.doi.org/10.1371/journal.pone.0162660			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610625	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900146
J	Hofmann, E; Faller, N; Limacher, A; Mean, M; Tritschler, T; Rodondi, N; Aujesky, D				Hofmann, Eveline; Faller, Nicolas; Limacher, Andreas; Mean, Marie; Tritschler, Tobias; Rodondi, Nicolas; Aujesky, Drahomir			Educational Level, Anticoagulation Quality, and Clinical Outcomes in Elderly Patients with Acute Venous Thromboembolism: A Prospective Cohort Study	PLOS ONE			English	Article							DEEP-VEIN THROMBOSIS; POPULATION-BASED-COHORT; ATRIAL-FIBRILLATION; ORAL ANTICOAGULATION; PULMONARY-EMBOLISM; RISK-FACTORS; BLEEDING RISK; MEDICATION ADHERENCE; WARFARIN THERAPY; RECURRENCE	Whether the level of education is associated with anticoagulation quality and clinical outcomes in patients with acute venous thromboembolism (VTE) is uncertain. We thus aimed to investigate the association between educational level and anticoagulation quality and clinical outcomes in elderly patients with acute VTE. We studied 817 patients aged >= 65 years with acute VTE from a Swiss prospective multicenter cohort study (09/2009-12/2013). We defined three educational levels: 1) less than high school, 2) high school, and 3) post-secondary degree. The primary outcome was the anticoagulation quality, expressed as the percentage of time spent in the therapeutic INR range (TTR). Secondary outcomes were the time to a first recurrent VTE and major bleeding. We adjusted for potential con-founders and periods of anticoagulation. Overall, 56% of patients had less than high school, 25% a high school degree, and 18% a post-secondary degree. The mean percentage of TTR was similar across educational levels (less than high school, 61%; high school, 64%; and post-secondary, 63%; P = 0.36). Within three years of follow-up, patients with less than high school, high school, and a post-secondary degree had a cumulative incidence of recurrent VTE of 14.2%, 12.9%, and 16.4%, and a cumulative incidence of major bleeding of 13.3%, 15.1%, and 15.4%, respectively. After adjustment, educational level was neither associated with anticoagulation quality nor with recurrent VTE or major bleeding. In elderly patients with VTE, we did not find an association between educational level and anticoagulation quality or clinical outcomes.	[Hofmann, Eveline; Faller, Nicolas; Mean, Marie; Tritschler, Tobias; Rodondi, Nicolas; Aujesky, Drahomir] Univ Bern, Univ Hosp Bern, Dept Gen Internal Med, Bern, Switzerland; [Limacher, Andreas] Univ Bern, Dept Clin Res, Clin Trials Unit Bern, Bern, Switzerland; [Limacher, Andreas] Univ Bern, Inst Social & Prevent Med, Bern, Switzerland; [Mean, Marie] Univ Lausanne Hosp, Dept Gen Internal Med, Lausanne, Switzerland	University of Bern; University Hospital of Bern; University of Bern; University of Bern; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV)	Faller, N (corresponding author), Univ Bern, Univ Hosp Bern, Dept Gen Internal Med, Bern, Switzerland.	Nicolas.Faller@insel.ch	Tritschler, Tobias/ABH-1772-2021	Tritschler, Tobias/0000-0002-8775-0511; Rodondi, Nicolas/0000-0001-9083-6896; Mean, Marie/0000-0003-0477-7899; , Nicolas/0000-0003-1647-9311; Hofmann, Eveline/0000-0003-3357-2438	Swiss National Science Foundation [33CSCO-122659/139470]	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission)	This study was supported by the Swiss National Science Foundation (grant 33CSCO-122659/139470).	Aiyagari V, 2015, J STROKE CEREBROVASC, V24, P290, DOI 10.1016/j.jstrokecerebrovasdis.2014.08.002; Arnsten JH, 1997, AM J MED, V103, P11, DOI 10.1016/S0002-9343(97)90048-6; Bertomeu-Gonzalez V, 2015, CLIN CARDIOL, V38, P357, DOI 10.1002/clc.22397; Cressman AM, 2015, AM HEART J, V170, P133, DOI 10.1016/j.ahj.2015.03.014; Davis NJ, 2005, ANN PHARMACOTHER, V39, P632, DOI 10.1345/aph.1E464; Costa GLD, 2012, CLIN THER, V34, P1511, DOI 10.1016/j.clinthera.2012.06.002; Costa GLD, 2011, AGE AGEING, V40, P375, DOI 10.1093/ageing/afr020; Dlott JS, 2014, CIRCULATION, V129, P1407, DOI 10.1161/CIRCULATIONAHA.113.002601; Eichinger S, 2008, ARCH INTERN MED, V168, P1678, DOI 10.1001/archinte.168.15.1678; Eichinger S, 2010, CIRCULATION, V121, P1630, DOI 10.1161/CIRCULATIONAHA.109.925214; Fang MC, 2006, J GEN INTERN MED, V21, P841, DOI 10.1111/j.1525-1497.2006.00537.x; Fang MC, 2011, J AM COLL CARDIOL, V58, P395, DOI 10.1016/j.jacc.2011.03.031; Fine JP, 1999, J AM STAT ASSOC, V94, P496, DOI 10.2307/2670170; Gage BF, 2006, AM HEART J, V151, P713, DOI 10.1016/j.ahj.2005.04.017; Ganz DA, 2007, JAMA-J AM MED ASSOC, V297, P77, DOI 10.1001/jama.297.1.77; Gasse C, 2005, THROMB HAEMOSTASIS, V94, P537, DOI 10.1160/TH05-03-0166; Goldman DP, 2002, P NATL ACAD SCI USA, V99, P10929, DOI 10.1073/pnas.162086599; Heit JA, 2000, ARCH INTERN MED, V160, P761, DOI 10.1001/archinte.160.6.761; Heit JA, 2011, BLOOD, V118, P4992, DOI 10.1182/blood-2011-05-357343; Ho PM, 2009, CIRCULATION, V119, P3028, DOI 10.1161/CIRCULATIONAHA.108.768986; Hu A, 2006, J CARDIOVASC NURS, V21, P169, DOI 10.1097/00005082-200605000-00003; Huisman M, 2013, EPIDEMIOL REV, V35, P84, DOI 10.1093/epirev/mxs010; Iorio A, 2010, ARCH INTERN MED, V170, P1710, DOI 10.1001/archinternmed.2010.367; Isma N, 2013, J THROMB THROMBOLYS, V36, P58, DOI 10.1007/s11239-012-0858-8; Jakobsson C, 2010, J THROMB HAEMOST, V8, P1242, DOI 10.1111/j.1538-7836.2010.03836.x; JohnsonGreene D, 1997, ARCH CLIN NEUROPSYCH, V12, P635, DOI 10.1016/S0887-6177(96)00046-7; Kauffman YS, 2015, PHARMACOTHERAPY, V35, P740, DOI 10.1002/phar.1616; Kneeland PP, 2010, PATIENT PREFER ADHER, V4, P51; Leiss W, 2015, J GEN INTERN MED, V30, P17, DOI 10.1007/s11606-014-2993-8; Lip GYH, 2011, J AM COLL CARDIOL, V57, P173, DOI 10.1016/j.jacc.2010.09.024; Louzada ML, 2012, CIRCULATION, V126, P448, DOI 10.1161/CIRCULATIONAHA.111.051920; Mcrae S, 2006, LANCET, V368, P371, DOI 10.1016/S0140-6736(06)69110-1; Mean M, 2013, J THROMB THROMBOLYS, V36, P475, DOI 10.1007/s11239-013-0875-2; Melamed OC, 2011, AM J MANAG CARE, V17, P232; NIEUWENHUIS HK, 1991, BLOOD, V78, P2337, DOI 10.1182/blood.V78.9.2337.2337; Novacek G, 2010, GASTROENTEROLOGY, V139, P779, DOI 10.1053/j.gastro.2010.05.026; Olesen JB, 2011, J THROMB HAEMOST, V9, P1460, DOI 10.1111/j.1538-7836.2011.04378.x; Perreault S, 2005, BRIT J CLIN PHARMACO, V59, P564, DOI 10.1111/j.1365-2125.2005.02355.x; Pisters R, 2010, CHEST, V138, P1093, DOI 10.1378/chest.10-0134; Platt AB, 2008, PHARMACOEPIDEM DR S, V17, P853, DOI 10.1002/pds.1556; Razouki Z, 2014, J THROMB HAEMOST, V12, P628, DOI 10.1111/jth.12530; Rodriguez F, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.113.000170; Rose AJ, 2010, J THROMB HAEMOST, V8, P2182, DOI 10.1111/j.1538-7836.2010.03996.x; Rose AJ, 2013, CHEST, V143, P751, DOI 10.1378/chest.12-1119; ROSENDAAL FR, 1993, THROMB HAEMOSTASIS, V69, P236; Ruiz-Gimenez N, 2008, THROMB HAEMOSTASIS, V100, P26, DOI 10.1160/TH08-03-0193; Schulman S, 2005, J THROMB HAEMOST, V3, P692, DOI 10.1111/j.1538-7836.2005.01204.x; Seeman T, 2008, SOC SCI MED, V66, P72, DOI 10.1016/j.socscimed.2007.08.027; Shireman TI, 2006, CHEST, V130, P1390, DOI 10.1378/chest.130.5.1390; Wang Y, 2013, J THROMB THROMBOLYS, V36, P416, DOI 10.1007/s11239-013-0872-5; Wells PS, 2014, JAMA-J AM MED ASSOC, V311, P717, DOI 10.1001/jama.2014.65; Witt DM, 2009, BLOOD, V114, P952, DOI 10.1182/blood-2009-02-207928; Zoller B, 2012, THROMB RES, V129, P577, DOI 10.1016/j.thromres.2011.07.050	53	3	3	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162108	10.1371/journal.pone.0162108	http://dx.doi.org/10.1371/journal.pone.0162108			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606617	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600018
J	van Dixhoorn, IDE; Reimert, I; Middelkoop, J; Bolhuis, JE; Wisselink, HJ; Koerkamp, PWGG; Kemp, B; Stockhofe-Zurwieden, N				van Dixhoorn, Ingrid D. E.; Reimert, Inonge; Middelkoop, Jenny; Bolhuis, J. Elizabeth; Wisselink, Henk J.; Koerkamp, Peter W. G. Groot; Kemp, Bas; Stockhofe-Zurwieden, Norbert			Enriched Housing Reduces Disease Susceptibility to Co-Infection with Porcine Reproductive and Respiratory Virus (PRRSV) and Actinobacillus pleuropneumoniae (A. pleuropneumoniae) in Young Pigs	PLOS ONE			English	Article							INDIVIDUAL COPING CHARACTERISTICS; ENVIRONMENTAL ENRICHMENT; GROWING PIGS; LEUKOCYTE SUBPOPULATIONS; PERIPHERAL-BLOOD; IMMUNE-RESPONSES; STRESS HORMONES; LACTATING SOWS; FINISHING PIGS; GROWTH-RATE	Until today, anti-microbial drugs have been the therapy of choice to combat bacterial diseases. Resistance against antibiotics is of growing concern in man and animals. Stress, caused by demanding environmental conditions, can reduce immune protection in the host, influencing the onset and outcome of infectious diseases. Therefore psychoneuro-immunological intervention may prove to be a successful approach to diminish the impact of diseases and antibiotics use. This study was designed to investigate the effect of social and environmental enrichment on the impact of disease, referred to as "disease susceptibility", in pigs using a co-infection model of PRRSV and A. pleuropneumoniae. Twenty-eight pigs were raised in four pens under barren conditions and twenty-eight other pigs were raised in four pens under enriched conditions. In the enriched pens a combination of established social and environmental enrichment factors were introduced. Two pens of the barren (BH) and two pens of the enriched housed (EH) pigs were infected with PRRSV followed by A. pleuropneumoniae, the other two pens in each housing treatment served as control groups. We tested if differences in disease susceptibility in terms of pathological and clinical outcome were related to the different housing regimes and if this was reflected in differences in behavioural and immunological states of the animals. Enriched housed pigs showed a faster clearance of viral PRRSV RNA in blood serum (p = 0.014) and histologically 2.8 fold less interstitial pneumonia signs in the lungs (p = 0.014). More barren housed than enriched housed pigs developed lesions in the lungs (OR = 19.2, p = 0.048) and the lesions in the barren housed pigs showed a higher total pathologic tissue damage score (p<0.001) than those in enriched housed pigs. EH pigs showed less stress-related behaviour and differed immunologically and clinically from BH pigs. We conclude that enriched housing management reduces disease susceptibility to co-infection of PRRSV and A. pleuropneumoniae in pigs. Enrichment positively influences behavioural state, immunological response and clinical outcome in pigs.	[van Dixhoorn, Ingrid D. E.] Univ Wageningen & Res Ctr, Livestock Res, Wageningen, Netherlands; [Reimert, Inonge; Middelkoop, Jenny; Bolhuis, J. Elizabeth; Kemp, Bas] Univ Wageningen & Res Ctr, Adaptat Physiol Grp, Wageningen, Netherlands; [Wisselink, Henk J.; Stockhofe-Zurwieden, Norbert] Univ Wageningen & Res Ctr, Cent Vet Inst, Lelystad, Netherlands; [Koerkamp, Peter W. G. Groot] Univ Wageningen & Res Ctr, Farm Technol Grp, Wageningen, Netherlands	Wageningen University & Research; Wageningen University & Research; Wageningen University & Research; Wageningen University & Research	van Dixhoorn, IDE (corresponding author), Univ Wageningen & Res Ctr, Livestock Res, Wageningen, Netherlands.	ingrid.vandixhoorn@wur.nl	Koerkamp, Peter WG Groot/D-2807-2013; Wisselink, Henk/AAL-6283-2020	Koerkamp, Peter WG Groot/0000-0002-3935-4071; Wisselink, Henk/0000-0002-3747-8054; van Dixhoorn, Ingrid/0000-0003-3642-2523	Dutch Ministry of Economic Affairs	Dutch Ministry of Economic Affairs(Ministry of Economic Affairs, Netherlands)	This work was funded by the Dutch Ministry of Economic Affairs.	Amory JR, 2006, VET REC, V158, P260, DOI 10.1136/vr.158.8.260; Averos X, 2010, APPL ANIM BEHAV SCI, V127, P73, DOI 10.1016/j.applanim.2010.09.010; Beattie VE, 2005, ANIM SCI, V80, P307, DOI 10.1079/ASC40040307; Beattie VE, 2000, ANIM SCI, V70, P443, DOI 10.1017/S1357729800051791; BEATTIE VE, 1995, ANIM WELFARE, V4, P207; Becker PM, 2012, VET MICROBIOL, V154, P316, DOI 10.1016/j.vetmic.2011.07.011; Biondi M, 1997, PSYCHOTHER PSYCHOSOM, V66, P3, DOI 10.1159/000289101; Bolhuis JE, 2007, LIVEST SCI, V109, P108, DOI 10.1016/j.livsci.2007.01.100; Bolhuis JE, 2013, ANIM COGN, V16, P845, DOI 10.1007/s10071-013-0646-7; Bolhuis JE, 2006, APPL ANIM BEHAV SCI, V101, P68, DOI 10.1016/j.applanim.2006.01.001; Bolhuis JE, 2005, APPL ANIM BEHAV SCI, V93, P213, DOI 10.1016/j.applanim.2005.01.006; Bolhuis JE, 2005, ANIM BEHAV, V69, P1085, DOI 10.1016/j.anbehav.2004.09.013; Bolhuis JE, 2003, PHYSIOL BEHAV, V79, P289, DOI 10.1016/S0031-9384(03)00090-8; Bracke MBM, 2013, J AGR ENVIRON ETHIC, V26, P847, DOI 10.1007/s10806-012-9410-2; Camerlink I, 2014, J ANIM SCI, V92, P2612, DOI 10.2527/jas.2013-7220; Camerlink I, 2012, APPL ANIM BEHAV SCI, V142, P11, DOI 10.1016/j.applanim.2012.09.004; Chaloupkova H, 2007, J ANIM SCI, V85, P1741, DOI 10.2527/jas.2006-504; Chaloupkova H, 2007, APPL ANIM BEHAV SCI, V103, P25, DOI 10.1016/j.applanim.2006.04.020; Cho JG, 2006, THERIOGENOLOGY, V66, P655, DOI 10.1016/j.theriogenology.2006.04.024; Corzo CA, 2010, VIRUS RES, V154, P185, DOI 10.1016/j.virusres.2010.08.016; DANTZER R, 1989, LIFE SCI, V44, P1995, DOI 10.1016/0024-3205(89)90345-7; de Jong IC, 2000, PHYSIOL BEHAV, V68, P571, DOI 10.1016/S0031-9384(99)00212-7; Di Martino G, 2013, RES VET SCI, V95, P1271, DOI 10.1016/j.rvsc.2013.08.012; Doeschl-Wilson AB, 2009, J ANIM SCI, V87, P1638, DOI 10.2527/jas.2008-1447; Douglas C, 2012, APPL ANIM BEHAV SCI, V139, P65, DOI 10.1016/j.applanim.2012.02.018; Elenkov IJ, 1999, TRENDS ENDOCRIN MET, V10, P359, DOI 10.1016/S1043-2760(99)00188-5; Elenkov IJ, 1999, BEST PRACT RES CL EN, V13, P583, DOI 10.1053/beem.1999.0045; EWALD C, 1994, BERL MUNCH TIERARZTL, V107, P256; Frossard JP, 2012, VET MICROBIOL, V158, P308, DOI 10.1016/j.vetmic.2012.03.004; GALINA L, 1994, VET REC, V134, P60, DOI 10.1136/vr.134.3.60; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; Gomez-Laguna J, 2009, VIRAL IMMUNOL, V22, P261, DOI 10.1089/vim.2009.0003; HENSEL A, 1993, J AEROSOL MED, V6, P73, DOI 10.1089/jam.1993.6.73; Jirawattanapong P, 2010, RES VET SCI, V88, P11, DOI 10.1016/j.rvsc.2009.06.007; Jirtle RL, 2007, NAT REV GENET, V8, P253, DOI 10.1038/nrg2045; KAMP EM, 1987, VET MICROBIOL, V13, P249, DOI 10.1016/0378-1135(87)90087-3; KHANSARI DN, 1990, IMMUNOL TODAY, V11, P170, DOI 10.1016/0167-5699(90)90069-L; Kimman TG, 2009, VACCINE, V27, P3704, DOI 10.1016/j.vaccine.2009.04.022; Kutzer T, 2009, APPL ANIM BEHAV SCI, V121, P16, DOI 10.1016/j.applanim.2009.08.004; Lamontagne L, 2003, VIRAL IMMUNOL, V16, P395, DOI 10.1089/088282403322396181; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Marketon JIW, 2008, CELL IMMUNOL, V252, P16, DOI 10.1016/j.cellimm.2007.09.006; Melotti L, 2011, APPL ANIM BEHAV SCI, V133, P144, DOI 10.1016/j.applanim.2011.05.018; Meulenberg JJM, 2000, VET RES, V31, P11, DOI 10.1051/vetres:2000054; Morgan SB, 2013, VET MICROBIOL, V163, P13, DOI 10.1016/j.vetmic.2012.11.024; Nielsen EK, 2000, ACTA AGR SCAND A-AN, V50, P30, DOI 10.1080/090647000423906; Nielsen J, 2003, VET IMMUNOL IMMUNOP, V93, P135, DOI 10.1016/S0165-2427(03)00068-0; Oostindjer M, 2010, J ANIM SCI, V88, P3554, DOI 10.2527/jas.2010-2940; Oostindjer M, 2011, APPL ANIM BEHAV SCI, V134, P31, DOI 10.1016/j.applanim.2011.06.011; Padgett DA, 2003, TRENDS IMMUNOL, V24, P444, DOI 10.1016/S1471-4906(03)00173-X; Poltorak A, 1999, PNEUMOLOGIE, V53; Proudfoot K, 2015, VET J, V206, P15, DOI 10.1016/j.tvjl.2015.05.024; Pruett Stephen B., 2003, Pathophysiology, V9, P133, DOI 10.1016/S0928-4680(03)00003-8; Reimert I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108700; ROEPSTORFF A, 1990, VET PARASITOL, V36, P245, DOI 10.1016/0304-4017(90)90036-B; Rossow KD, 1998, VET PATHOL, V35, P1, DOI 10.1177/030098589803500101; Schroder-Petersen DL, 2001, VET J, V162, P196, DOI 10.1053/tvjl.2001.0605; Shi KC, 2008, VET MICROBIOL, V129, P367, DOI 10.1016/j.vetmic.2007.11.020; Skjerve E, 1998, INT J FOOD MICROBIOL, V45, P195, DOI 10.1016/S0168-1605(98)00162-7; Sneddon IA, 2000, ANIM WELFARE, V9, P373; Stege H, 2001, PREV VET MED, V50, P153, DOI 10.1016/S0167-5877(01)00194-5; Thanawongnuwech R, 2010, VIRUS RES, V154, P133, DOI 10.1016/j.virusres.2010.09.003; Tonepohl B, 2012, APPL ANIM BEHAV SCI, V140, P137, DOI 10.1016/j.applanim.2012.05.002; Turner SP, 2006, APPL ANIM BEHAV SCI, V96, P245, DOI 10.1016/j.applanim.2005.06.009; Tuyttens FAM, 2005, APPL ANIM BEHAV SCI, V92, P261, DOI 10.1016/j.applanim.2005.05.007; Van Gucht S, 2004, VET IMMUNOL IMMUNOP, V102, P165, DOI 10.1016/j.vetimm.2004.09.006; Velthuis AGJ, 2002, EPIDEMIOL INFECT, V129, P203, DOI 10.1017/S0950268802007252; Weesendorp E, 2014, VET MICROBIOL, V174, P127, DOI 10.1016/j.vetmic.2014.09.010; Weesendorp E, 2013, VET MICROBIOL, V163, P1, DOI 10.1016/j.vetmic.2012.09.013; WENSVOORT G, 1991, VET QUART, V13, P121, DOI 10.1080/01652176.1991.9694296	70	39	39	3	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161832	10.1371/journal.pone.0161832	http://dx.doi.org/10.1371/journal.pone.0161832			24	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606818	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600011
J	Amador, A; Huitron-Resendiz, S; Roberts, AJ; Kamenecka, TM; Solt, LA; Burris, TP				Amador, Ariadna; Huitron-Resendiz, Salvador; Roberts, Amanda J.; Kamenecka, Theodore M.; Solt, Laura A.; Burris, Thomas P.			Pharmacological Targeting the REV-ERBs in Sleep/Wake Regulation	PLOS ONE			English	Article							EYE-MOVEMENT SLEEP; CIRCADIAN CLOCK; CAFFEINE DEPENDENCE; METABOLIC SYNDROME; WAKE PATTERNS; MODAFINIL; DOPAMINE; ALPHA; AMPHETAMINE; DURATION	The circadian clock maintains appropriate timing for a wide range of behaviors and physiological processes. Circadian behaviors such as sleep and wakefulness are intrinsically dependent on the precise oscillation of the endogenous molecular machinery that regulates the circadian clock. The identical core clock machinery regulates myriad endocrine and metabolic functions providing a link between sleep and metabolic health. The REV-ERBs (REV-ERB alpha and REV-ERB beta) are nuclear receptors that are key regulators of the molecular clock and have been successfully targeted using small molecule ligands. Recent studies in mice suggest that REV-ERB-specific synthetic agonists modulate metabolic activity as well as alter sleep architecture, inducing wakefulness during the light period. Therefore, these small molecules represent unique tools to extensively study REV-ERB regulation of sleep and wakefulness. In these studies, our aim was to further investigate the therapeutic potential of targeting the REV-ERBs for regulation of sleep by characterizing efficacy, and optimal dosing time of the REV-ERB agonist SR9009 using electroencephalographic (EEG) recordings. Applying different experimental paradigms in mice, our studies establish that SR9009 does not lose efficacy when administered more than once a day, nor does tolerance develop when administered once a day over a three-day dosing regimen. Moreover, through use of a time response paradigm, we determined that although there is an optimal time for administration of SR9009 in terms of maximal efficacy, there is a 12-hour window in which SR9009 elicited a response. Our studies indicate that the REV-ERBs are potential therapeutic targets for treating sleep problems as those encountered as a consequence of shift work or jet lag.	[Amador, Ariadna; Kamenecka, Theodore M.; Solt, Laura A.] Scripps Res Inst, Dept Mol Therapeut, Jupiter, FL 34583 USA; [Huitron-Resendiz, Salvador; Roberts, Amanda J.] Scripps Res Inst, Dept Mol & Cellular Neurosci, La Jolla, CA 92037 USA; [Burris, Thomas P.] St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO 63104 USA	Scripps Research Institute; Scripps Research Institute; Saint Louis University	Burris, TP (corresponding author), St Louis Univ, Sch Med, Dept Physiol & Pharmacol, St Louis, MO 63104 USA.	burristp@slu.edu	Burris, Thomas/B-3886-2016	Burris, Thomas/0000-0003-2922-4449	National Institute of Mental Health [MH093429]	National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was funded by a grant from the National Institute of Mental Health (MH093429) to TPB. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandin C, 2015, INT J OBESITY, V39, P828, DOI 10.1038/ijo.2014.182; Banerjee S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6759; Baraldo M, 2008, EXPERT OPIN DRUG MET, V4, P175, DOI 10.1517/17425255.4.2.175; Bernstein GA, 2002, DRUG ALCOHOL DEPEN, V66, P1, DOI 10.1016/S0376-8716(01)00181-8; Bourgin P, 2000, J NEUROSCI, V20, P7760; Brown SA, 2012, DEV CELL, V22, P477, DOI 10.1016/j.devcel.2012.02.007; Cao JJ, 2011, ACS MED CHEM LETT, V2, P48, DOI 10.1021/ml1002025; Cappuccio FP, 2011, EUR HEART J, V32, P1484, DOI 10.1093/eurheartj/ehr007; Chang ST, 2010, CHINESE J PHYSIOL, V53, P318, DOI 10.4077/CJP.2010.AMK067; Cho H, 2012, NATURE, V485, P123, DOI 10.1038/nature11048; Chun SK, 2014, ACS CHEM BIOL, V9, P703, DOI 10.1021/cb400752k; Chung S, 2014, CELL, V157, P858, DOI 10.1016/j.cell.2014.03.039; Crumbley C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017290; Crumbley C, 2010, J BIOL CHEM, V285, P35386, DOI 10.1074/jbc.M110.129288; Danaceau JP, 2007, EUR J PHARMACOL, V559, P46, DOI 10.1016/j.ejphar.2006.11.045; Edgar DM, 1997, J PHARMACOL EXP THER, V283, P757; Fang B, 2014, CELL, V159, P1140, DOI 10.1016/j.cell.2014.10.022; Franken P, 2006, P NATL ACAD SCI USA, V103, P7118, DOI 10.1073/pnas.0602006103; Garaulet M, 2010, INT J OBESITY, V34, P1667, DOI 10.1038/ijo.2010.118; Gilbert R M, 1984, Prog Clin Biol Res, V158, P185; Golombek DA, 2010, PHYSIOL REV, V90, P1063, DOI 10.1152/physrev.00009.2009; HALBERG F, 1969, ANNU REV PHYSIOL, V31, P675, DOI 10.1146/annurev.ph.31.030169.003331; Hart CL, 2008, NEUROPSYCHOPHARMACOL, V33, P761, DOI 10.1038/sj.npp.1301472; Hedlund PB, 2005, BIOL PSYCHIAT, V58, P831, DOI 10.1016/j.biopsych.2005.05.012; Huitron-Resendiz S, 2004, SLEEP, V27, P857, DOI 10.1093/sleep/27.5.857; Huitron-Resendiz S, 2005, J NEUROSCI, V25, P5465, DOI 10.1523/JNEUROSCI.4501-04.2005; Jones HA, 2005, EXP CLIN PSYCHOPHARM, V13, P259, DOI 10.1037/1064-1297.13.3.259; JUERGENS S, 1991, J SUBST ABUSE TREAT, V8, P43, DOI 10.1016/0740-5472(91)90026-7; Kennaway DJ, 2007, AM J PHYSIOL-REG I, V293, pR1528, DOI 10.1152/ajpregu.00018.2007; Knutson KL, 2010, BEST PRACT RES CL EN, V24, P731, DOI 10.1016/j.beem.2010.07.001; Kopp C, 2002, EUR J NEUROSCI, V16, P1099, DOI 10.1046/j.1460-9568.2002.02156.x; KROBOTH PD, 1983, DRUG INTEL CLIN PHAR, V17, P495, DOI 10.1177/106002808301700701; Kronholm E, 2011, J SLEEP RES, V20, P288, DOI 10.1111/j.1365-2869.2010.00899.x; Laposky A, 2005, SLEEP, V28, P395, DOI 10.1093/sleep/28.4.395; LEMMER B, 1987, CHRONOBIOL INT, V4, P319, DOI 10.3109/07420528709083522; Lemmer B, 2007, PHYSIOL BEHAV, V90, P285, DOI 10.1016/j.physbeh.2006.09.006; LETT BT, 1989, PSYCHOPHARMACOLOGY, V98, P357, DOI 10.1007/BF00451687; Loland CJ, 2012, BIOL PSYCHIAT, V72, P405, DOI 10.1016/j.biopsych.2012.03.022; LUCAS EA, 1980, PSYCHOPHARMACOLOGY, V68, P179, DOI 10.1007/BF00432138; Macdermct H G, 1925, Can Med Assoc J, V15, P658; Malcolm R, 2006, AM J DRUG ALCOHOL AB, V32, P577, DOI 10.1080/00952990600920425; Mang GM, 2016, SLEEP, V39, P589, DOI 10.5665/sleep.5534; MIGNOT E, 1994, SLEEP, V17, P436, DOI 10.1093/sleep/17.5.436; Milagro FI, 2012, CHRONOBIOL INT, V29, P1180, DOI 10.3109/07420528.2012.719967; Moller-Levet CS, 2013, P NATL ACAD SCI USA, V110, pE1132, DOI 10.1073/pnas.1217154110; MROSOVSKY N, 1994, CHRONOBIOL INT, V11, P232, DOI 10.3109/07420529409067792; Nguyen TL, 2011, SYNAPSE, V65, P733, DOI 10.1002/syn.20892; Nielsen LS, 2011, OBES REV, V12, P78, DOI 10.1111/j.1467-789X.2010.00724.x; Nishino S, 1998, Sleep Res Online, V1, P49; Novak M, 1997, DRUG SAFETY, V16, P133, DOI 10.2165/00002018-199716020-00005; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; REINBERG A, 1986, INT J CLIN PHARM RES, V6, P33; RITSCHEL WA, 1994, METHOD FIND EXP CLIN, V16, P57; Roehrs T, 2002, PSYCHOPHARMACOLOGY, V161, P137, DOI 10.1007/s00213-002-1041-2; Rothman RB, 2001, SYNAPSE, V39, P32, DOI 10.1002/1098-2396(20010101)39:1<32::AID-SYN5>3.0.CO;2-3; Ruiz-Lozano T, 2016, CLIN NUTR, V35, P1308, DOI 10.1016/j.clnu.2016.02.007; Rush CR, 2002, BEHAV PHARMACOL, V13, P105, DOI 10.1097/00008877-200203000-00002; SEIDEL WF, 1985, PSYCHOPHARMACOLOGY, V87, P194, DOI 10.1007/BF00431806; Shiromani PJ, 2004, AM J PHYSIOL-REG I, V287, pR47, DOI 10.1152/ajpregu.00138.2004; Solt LA, 2012, NATURE, V485, P62, DOI 10.1038/nature11030; TOURET M, 1995, NEUROSCI LETT, V189, P43, DOI 10.1016/0304-3940(95)11448-6; TREDGER JM, 1977, XENOBIOTICA, V7, P481; TUREK FW, 1986, CLIN NEUROPHARMACOL, V9, P83; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Uguen M, 2013, BRIT J PHARMACOL, V169, P632, DOI 10.1111/bph.12149; Wisorl JP, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-20; Zhang EE, 2010, NAT REV MOL CELL BIO, V11, P764, DOI 10.1038/nrm2995; Zolkowska D, 2009, J PHARMACOL EXP THER, V329, P738, DOI 10.1124/jpet.108.146142	68	9	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162452	10.1371/journal.pone.0162452	http://dx.doi.org/10.1371/journal.pone.0162452			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603791	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200066
J	Boon, MY; Henry, BI; Chu, BS; Basahi, N; Suttle, CM; Luu, C; Leung, H; Hing, S				Boon, Mei Ying; Henry, Bruce Ian; Chu, Byoung Sun; Basahi, Nour; Suttle, Catherine May; Luu, Chi; Leung, Harry; Hing, Stephen			Fractal Dimension Analysis of Transient Visual Evoked Potentials: Optimisation and Applications	PLOS ONE			English	Article							STRANGE ATTRACTORS; TIME-SERIES; CHILDREN; VEP; DYNAMICS; REVERSAL	Purpose The visual evoked potential (VEP) provides a time series signal response to an external visual stimulus at the location of the visual cortex. The major VEP signal components, peak latency and amplitude, may be affected by disease processes. Additionally, the VEP contains fine detailed and non-periodic structure, of presently unclear relevance to normal function, which may be quantified using the fractal dimension. The purpose of this study is to provide a systematic investigation of the key parameters in the measurement of the fractal dimension of VEPs, to develop an optimal analysis protocol for application. Methods VEP time series were mathematically transformed using delay time, tau, and embedding dimension, m, parameters. The fractal dimension of the transformed data was obtained from a scaling analysis based on straight line fits to the numbers of pairs of points with separation less than r versus log(r) in the transformed space. Optimal tau, m, and scaling analysis were obtained by comparing the consistency of results using different sampling frequencies. The optimised method was then piloted on samples of normal and abnormal VEPs. Results Consistent fractal dimension estimates were obtained using tau = 4 ms, designating the fractal dimension = D-2 of the time series based on embedding dimension m = 7 (for 3606 Hz and 5000 Hz), m = 6 (for 1803 Hz) and m = 5 (for 1000Hz), and estimating D-2 for each embedding dimension as the steepest slope of the linear scaling region in the plot of log(C(r)) vs log(r) provided the scaling region occurred within the middle third of the plot. Piloting revealed that fractal dimensions were higher from the sampled abnormal than normal achromatic VEPs in adults (p = 0.02). Variances of fractal dimension were higher from the abnormal than normal chromatic VEPs in children (p = 0.01). Conclusions A useful analysis protocol to assess the fractal dimension of transformed VEPs has been developed.	[Boon, Mei Ying; Chu, Byoung Sun; Basahi, Nour; Suttle, Catherine May] UNSW Australia, Sch Optometry & Vis Sci, Sydney, NSW, Australia; [Henry, Bruce Ian] UNSW Australia, Sch Math & Stat, Sydney, NSW, Australia; [Luu, Chi] Royal Victorian Eye & Ear Hosp, Ctr Eye Res Australia, East Melbourne, Vic, Australia; [Luu, Chi] Univ Melbourne, Melbourne Med Sch, Dept Surg Ophthalmol, Parkville, Vic, Australia; [Leung, Harry; Hing, Stephen] Pk Rd Eye, Hurstville, NSW, Australia; [Chu, Byoung Sun] Catholic Univ Daegu, Sch Optometry & Vis Sci, Gyeongsangbuk Do, South Korea; [Suttle, Catherine May] City Univ London, Sch Hlth Sci Optometry & Visual Sci, London, England; [Leung, Harry] Southern Ophthalmol, Kogarah, NSW, Australia	University of New South Wales Sydney; University of New South Wales Sydney; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Catholic University of Daegu; City University London	Boon, MY (corresponding author), UNSW Australia, Sch Optometry & Vis Sci, Sydney, NSW, Australia.	m.boon@unsw.edu.au	Boon, Mei Ying/F-2194-2016; Henry, Bruce/AAE-6824-2020	Boon, Mei Ying/0000-0002-9759-8402; Henry, Bruce/0000-0002-4387-6155; Suttle, Catherine/0000-0001-8694-195X; Luu, Chi/0000-0002-7604-7097	UNSW Australia Goldstar Award grant	UNSW Australia Goldstar Award grant	This study was supported by a UNSW Australia Goldstar Award grant. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank the participants and their families for volunteering. We thank Tiong Peng Yap for providing transient VEPs recorded at 5000 Hz sampling frequency for analysis. This study was supported by a UNSW Australia Goldstar Award grant.	Almurshedi A, 2015, RES J APPL SCI ENG T, V9, P106; ARLE JE, 1990, ELECTROEN CLIN NEURO, V75, P296, DOI 10.1016/0013-4694(90)90108-V; ARNOLD JC, 1973, EDUC PSYCHOL MEAS, V33, P301, DOI 10.1177/001316447303300209; Boon MY, 2007, VISION RES, V47, P2124, DOI 10.1016/j.visres.2007.04.019; Boon MY, 2008, J VISION, V8, DOI 10.1167/8.1.6; Boon MY, 2009, J VISION, V9, DOI 10.1167/9.6.22; Boon MY, 2011, 13 BIENN SCI M 7 ED; Casaleggio A, 1999, BIOL CYBERN, V81, P279, DOI 10.1007/s004220050562; Codina C, 2011, DEVELOPMENTAL SCI, V14, P725, DOI 10.1111/j.1467-7687.2010.01017.x; ECKMANN JP, 1992, PHYSICA D, V56, P185, DOI 10.1016/0167-2789(92)90023-G; GRASSBERGER P, 1983, PHYSICA D, V9, P189, DOI 10.1016/0167-2789(83)90298-1; GRASSBERGER P, 1983, PHYS REV LETT, V50, P346, DOI 10.1103/PhysRevLett.50.346; Henry B., 2001, NONLINEAR BIOMEDICAL, V2, P1; JANOSI IM, 1994, PHYS REV E, V49, P2756, DOI 10.1103/PhysRevE.49.2756; Kanski J. J., 1989, CLIN OPHTHALMOLOGY S; KOSTELICH EJ, 1989, PHYS SCRIPTA, V40, P436, DOI 10.1088/0031-8949/40/3/030; Lai YC, 1998, PHYSICA D, V115, P1, DOI 10.1016/S0167-2789(97)00230-3; Lehmann D, 1994, Int J Neurosci, V74, P239; Levene H., 1960, CONTRIBUTIONS PROBAB, P278; MAIER J, 1987, VISION RES, V27, P165, DOI 10.1016/0042-6989(87)90179-9; MCCULLOCH DL, 1994, ARCH OPHTHALMOL-CHIC, V112, P510, DOI 10.1001/archopht.1994.01090160086026; Mizrach B, 1996, J ECON BEHAV ORGAN, V30, P369, DOI 10.1016/S0167-2681(96)00875-X; MOSES LE, 1952, PSYCHOMETRIKA, V17, P239; Muller V, 2003, COGNITIVE BRAIN RES, V16, P104, DOI 10.1016/S0926-6410(02)00225-2; Muller V, 2001, EXP BRAIN RES, V137, P103, DOI 10.1007/s002210000638; Odom JV, 2010, DOC OPHTHALMOL, V120, P111, DOI 10.1007/s10633-009-9195-4; Odom JV, 2004, DOC OPHTHALMOL, V108, P115, DOI 10.1023/B:DOOP.0000036790.67234.22; Oner A, 2004, DOC OPHTHALMOL, V109, P223, DOI 10.1007/s10633-004-7098-y; PENG CK, 1994, PHYS REV E, V49, P1685, DOI 10.1103/PhysRevE.49.1685; Pompe MT, 2006, VISUAL NEUROSCI, V23, P447, DOI 10.1017/S0952523806233108; Pompe MT, 2012, J OPT SOC AM A, V29, pA69, DOI 10.1364/JOSAA.29.000A69; Pompe MT, 2010, OPHTHAL PHYSL OPT, V30, P693, DOI 10.1111/j.1475-1313.2010.00739.x; SCHMEISSER ET, 1993, INVEST OPHTH VIS SCI, V34, P1265; SHAPIRO SS, 1965, BIOMETRIKA, V52, P591, DOI 10.2307/2333709; Shawkat FS, 1998, EYE, V12, P863, DOI 10.1038/eye.1998.219; Sloper J, 2016, J AAPOS, V20, P1, DOI 10.1016/j.jaapos.2015.09.013; TSONIS A, 1992, CHAOS THEORY APPL; Tsonis AA, 2009, CLIM DYNAM, V33, P1069, DOI 10.1007/s00382-008-0469-4; Zhang M, 2004, J VISION, V4, P32, DOI 10.1167/4.1.4	39	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161565	10.1371/journal.pone.0161565	http://dx.doi.org/10.1371/journal.pone.0161565			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598422	Green Accepted, Green Published, gold			2022-12-26	WOS:000383254800010
J	Grindel, A; Guggenberger, B; Eichberger, L; Poppelmeyer, C; Gschaider, M; Tosevska, A; Mare, G; Briskey, D; Brath, H; Wagner, KH				Grindel, Annemarie; Guggenberger, Bianca; Eichberger, Lukas; Poeppelmeyer, Christina; Gschaider, Michaela; Tosevska, Anela; Mare, George; Briskey, David; Brath, Helmut; Wagner, Karl-Heinz			Oxidative Stress, DNA Damage and DNA Repair in Female Patients with Diabetes Mellitus Type 2	PLOS ONE			English	Article							BETA-CELL FAILURE; INSULIN-RESISTANCE; GLYCEMIC CONTROL; COMET ASSAY; GLUTATHIONE; ASSOCIATION; BASE; QUANTIFICATION; COMPLICATIONS; PATHOGENESIS	Background Diabetes mellitus type 2 (T2DM) is associated with oxidative stress which in turn can lead to DNA damage. The aim of the present study was to analyze oxidative stress, DNA damage and DNA repair in regard to hyperglycemic state and diabetes duration. Methods Female T2DM patients (n = 146) were enrolled in the MIKRODIAB study and allocated in two groups regarding their glycated hemoglobin (HbA1c) level (HbA1c <= 7.5%, n = 74; HbA1c> 7.5%, n = 72). In addition, tertiles according to diabetes duration (DD) were created (DDI = 6.94 +/- 3.1 y, n = 49; DDII = 13.35 +/- 1.1 y, n = 48; DDIII = 22.90 +/- 7.3 y, n = 49). Oxidative stress parameters, including ferric reducing ability potential, malondialdehyde, oxidized and reduced glutathione, reduced thiols, oxidized LDL and F2-Isoprostane as well as the activity of antioxidant enzymes superoxide dismutase, catalase and glutathione peroxidase were measured. Damage to DNA was analyzed in peripheral blood mononuclear cells and whole blood with single cell gel electrophoresis. DNA base excision repair capacity was tested with the modified comet repair assay. Additionally, mRNA expressions of nine genes related to base excision repair were analyzed in a subset of 46 matched individuals. Results No significant differences in oxidative stress parameters, antioxidant enzyme activities, damage to DNA and base excision repair capacity, neither between a HbA1c cut off /> 7.5%, nor between diabetes duration was found. A significant up-regulation in mRNA expression was found for APEX1, LIG3 and XRCC1 in patients with > 7.5% HbA1c. Additionally, we observed higher total cholesterol, LDL-cholesterol, LDL/HDL-cholesterol, triglycerides,Framingham risk score, systolic blood pressure, BMI and lower HDL-cholesterol in the hyperglycemic group. Conclusion BMI, blood pressure and blood lipid status were worse in hyperglycemic individuals. However, no major disparities regarding oxidative stress, damage to DNA and DNA repair were present which might be due to good medical treatment with regular health checks in T2DM patients in Austria.	[Grindel, Annemarie; Guggenberger, Bianca; Eichberger, Lukas; Poeppelmeyer, Christina; Gschaider, Michaela; Tosevska, Anela; Mare, George; Wagner, Karl-Heinz] Univ Vienna, Dept Nutr Sci Emerging Field Oxidat Stress & DNA, Vienna, Austria; [Grindel, Annemarie; Wagner, Karl-Heinz] Univ Vienna, Res Platform Act Ageing, Vienna, Austria; [Briskey, David] Univ Queensland, Sch Human Movement & Nutr Sci, St Lucia, Qld, Australia; [Brath, Helmut] Hlth Ctr South, Diabet Outpatient Clin, Vienna, Austria	University of Vienna; University of Vienna; University of Queensland	Grindel, A; Wagner, KH (corresponding author), Univ Vienna, Dept Nutr Sci Emerging Field Oxidat Stress & DNA, Vienna, Austria.; Grindel, A; Wagner, KH (corresponding author), Univ Vienna, Res Platform Act Ageing, Vienna, Austria.	annemarie.grindel@univie.ac.at; karl-heinz.wagner@univie.ac.at	Wagner, Karl-Heinz/B-9098-2013	Wagner, Karl-Heinz/0000-0002-1683-7265; Tosevska, Anela/0000-0002-0892-7068	Open Access Publishing Fund of the University of Vienna	Open Access Publishing Fund of the University of Vienna	This article was supported by the Open Access Publishing Fund of the University of Vienna. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aebi H, 1984, Methods Enzymol, V105, P121; Al-Salmani K, 2011, FREE RADICAL BIO MED, V51, P719, DOI 10.1016/j.freeradbiomed.2011.05.020; Algire C, 2012, CANCER PREV RES, V5, P536, DOI 10.1158/1940-6207.CAPR-11-0536; Aouacheri O, 2015, CAN J DIABETES, V39, P44, DOI 10.1016/j.jcjd.2014.03.002; Azqueta A, 2013, DNA REPAIR, V12, P1007, DOI 10.1016/j.dnarep.2013.07.011; Azqueta A, 2013, TOXICOL IN VITRO, V27, P768, DOI 10.1016/j.tiv.2012.12.006; Azqueta A, 2009, MUTAT RES-GEN TOX EN, V674, P101, DOI 10.1016/j.mrgentox.2008.10.013; Bandeira SD, 2013, INT J MOL SCI, V14, P3265, DOI 10.3390/ijms14023265; Benzie IFF, 1996, ANAL BIOCHEM, V239, P70, DOI 10.1006/abio.1996.0292; Beutler E, 1984, GLUTATHIONE PEROXIDA; Blasiak J, 2004, MUTAT RES-FUND MOL M, V554, P297, DOI 10.1016/j.mrfmmm.2004.05.011; Bondor CI, 2015, INT UROL NEPHROL, V47, P1173, DOI 10.1007/s11255-015-1004-2; Boon AC, 2012, FREE RADICAL BIO MED, V52, P2120, DOI 10.1016/j.freeradbiomed.2012.03.002; Brenerman BM, 2014, CARCINOGENESIS, V35, P2643, DOI 10.1093/carcin/bgu225; Briskey DR, 2014, J PHARMACEUT BIOMED, V90, P161, DOI 10.1016/j.jpba.2013.11.028; Brownlee M, 2001, NATURE, V414, P813, DOI 10.1038/414813a; Calabrese V, 2012, BBA-MOL BASIS DIS, V1822, P729, DOI 10.1016/j.bbadis.2011.12.003; CALDECOTT KW, 1994, MOL CELL BIOL, V14, P68, DOI 10.1128/MCB.14.1.68; Choi SW, 2005, DIABETIC MED, V22, P1347, DOI 10.1111/j.1464-5491.2005.01647.x; D'Agostino RB, 2008, CIRCULATION, V118, pE86, DOI 10.1161/CIRCULATIONAHA.108.190154; de Beer JC, 2014, BRIT J CANCER, V110, P2361, DOI 10.1038/bjc.2014.150; Dincer Y, 2002, MUTAT RES-FUND MOL M, V505, P75, DOI 10.1016/S0027-5107(02)00143-4; Ellenberger T, 2008, ANNU REV BIOCHEM, V77, P313, DOI 10.1146/annurev.biochem.77.061306.123941; Fiorentino TV, 2013, CURR PHARM DESIGN, V19, P5695, DOI 10.2174/1381612811319320005; Guariguata L, 2014, DIABETES RES CLIN PR, V103, P137, DOI 10.1016/j.diabres.2013.11.002; Gupta S, 2013, J DIABETES COMPLICAT, V27, P548, DOI 10.1016/j.jdiacomp.2013.07.005; Ha CY, 2012, CLIN ENDOCRINOL, V76, P674, DOI 10.1111/j.1365-2265.2011.04244.x; Hawkins CL, 2009, FREE RADICAL BIO MED, V46, P965, DOI 10.1016/j.freeradbiomed.2009.01.007; HISSIN PJ, 1976, ANAL BIOCHEM, V74, P214, DOI 10.1016/0003-2697(76)90326-2; HU ML, 1994, METHOD ENZYMOL, V233, P380; Ibarra-Costilla E, 2010, ACTA DIABETOL, V47, pS111, DOI 10.1007/s00592-009-0149-9; Kahn SE, 2001, J CLIN ENDOCR METAB, V86, P4047, DOI 10.1210/jc.86.9.4047; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kasuga M, 2006, J CLIN INVEST, V116, P1756, DOI 10.1172/JCI29189; KOENIG RJ, 1976, NEW ENGL J MED, V295, P417, DOI 10.1056/NEJM197608192950804; Kumawat Manjulata, 2013, N Am J Med Sci, V5, P213, DOI 10.4103/1947-2714.109193; Lee SC, 2015, CHINESE MED J-PEKING, V128, P1543, DOI 10.4103/0366-6999.157693; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Manoel-Caetano FS, 2012, GENE, V511, P151, DOI 10.1016/j.gene.2012.09.090; Marin MT, 2015, J DIABETES COMPLICAT, V29, P679, DOI 10.1016/j.jdiacomp.2015.03.015; MARKLUND S, 1974, EUR J BIOCHEM, V47, P469; Merecz A, 2015, ADV MED SCI-POLAND, V60, P220, DOI 10.1016/j.advms.2015.04.001; Mittendorfer B, 2005, CURR OPIN CLIN NUTR, V8, P367, DOI 10.1097/01.mco.0000172574.64019.98; Moskalev AA, 2013, AGEING RES REV, V12, P661, DOI 10.1016/j.arr.2012.02.001; Mullner E, 2014, J HUM NUTR DIET, V27, P468, DOI 10.1111/jhn.12168; Mullner E, 2013, MOL NUTR FOOD RES, V57, P328, DOI 10.1002/mnfr.201200343; Nakhjavani M, 2010, LIPIDS, V45, P321, DOI 10.1007/s11745-010-3401-8; Njajou OT, 2009, DIABETES-METAB RES, V25, P733, DOI 10.1002/dmrr.1011; Preis SR, 2009, CIRCULATION, V119, P1728, DOI 10.1161/CIRCULATIONAHA.108.829176; Prentki M, 2006, J CLIN INVEST, V116, P1802, DOI 10.1172/JCI29103; Ramel A, 2004, EUR J NUTR, V43, P2, DOI 10.1007/s00394-004-0432-z; Schupp N, 2008, ATHEROSCLEROSIS, V199, P278, DOI 10.1016/j.atherosclerosis.2007.11.016; Shah NR, 2015, J MOL CELL CARDIOL, V86, P147, DOI 10.1016/j.yjmcc.2015.07.005; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Tupe RS, 2014, BRIT J BIOMED SCI, V71, P93, DOI 10.1080/09674845.2014.11669971; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; Xavier DJ, 2015, MUTAT RES-FUND MOL M, V776, P98, DOI 10.1016/j.mrfmmm.2015.01.016; Xavier DJ, 2014, DIABETES RES CLIN PR, V105, P356, DOI 10.1016/j.diabres.2014.06.004	58	36	39	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162082	10.1371/journal.pone.0162082	http://dx.doi.org/10.1371/journal.pone.0162082			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598300	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800037
J	Wei, T; Chisholm, J; Sanfcaon, H				Wei, Ting; Chisholm, Joan; Sanfcaon, Helene			Characterization of a Non-Canonical Signal Peptidase Cleavage Site in a Replication Protein from Tomato Ringspot Virus	PLOS ONE			English	Article							CO-TRANSLATIONAL TRANSLOCATION; NTB-VPG PROTEIN; ENDOPLASMIC-RETICULUM; INTERNAL SIGNAL; RNA VIRUSES; SEQUENCE; NEPOVIRUS; REGION; DOMAIN; ASSOCIATION	The NTB-VPg polyprotein from tomato ringspot virus is an integral membrane replication protein associated with endoplasmic reticulum membranes. A signal peptidase (SPase) cleavage was previously detected in the C-terminal region of NTB-VPg downstream of a 14 amino acid (aa)-long hydrophobic region (termed TM2). However, the exact location of the cleavage site was not determined. Using in vitro translation assays, we show that the SPase cleavage site is conserved in the NTB-VPg protein from various ToRSV isolates, although the rate of cleavage varies from one isolate to another. Systematic site-directed mutagenesis of the NTB-VPg SPase cleavage sites of two ToRSV isolates allowed the identification of sequences that affect cleavage efficiency. We also present evidence that SPase cleavage in the ToRSV-Rasp2 isolate occurs within a GAAGG sequence likely after the AAG (GAAG/G). Mutation of a downstream MAAV sequence to AAAV resulted in SPase cleavage at both the natural GAAG/G and the mutated AAA/V sequences. Given that there is a distance of seven aa between the two cleavage sites, this indicates that there is flexibility in the positioning of the cleavage sites relative to the inner surface of the membrane and the SPase active site. SPase cleavage sites are typically located 3-7 aa downstream of the hydrophobic region. However, the NTB-VPg GAAG/G cleavage site is located 17 aa downstream of the TM2 hydrophobic region, highlighting unusual features of the NTB-VPg SPase cleavage site. A putative 11 aa-long amphipathic helix was identified immediately downstream of the TM2 region and five aa upstream of the GAAG/G cleavage site. Based on these results, we present an updated topology model in which the hydrophobic and amphipathic domains form a long tilted helix or a bent helix in the membrane lipid bilayer, with the downstream cleavage site(s) oriented parallel to the membrane inner surface.	[Wei, Ting; Sanfcaon, Helene] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [Chisholm, Joan; Sanfcaon, Helene] Agr & Agri Food Canada, Summerland Res & Dev Ctr, Summerland, BC, Canada; [Wei, Ting] Shaanxi Univ Sci & Technol, Sch Environm Sci & Engn, Xian, Shaanxi, Peoples R China	University of British Columbia; Agriculture & Agri Food Canada; Shaanxi University of Science & Technology	Sanfcaon, H (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.; Sanfcaon, H (corresponding author), Agr & Agri Food Canada, Summerland Res & Dev Ctr, Summerland, BC, Canada.	Helene.Sanfacon@agr.gc.ca		Sanfacon, Helene/0000-0003-3807-3590	Natural Sciences and Engineering Research Council of Canada [122249-2010-RGPIN]; Chinese Science Council	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Chinese Science Council	This manuscript was funded in part by the Natural Sciences and Engineering Research Council of Canada (http://www.nserc-crsng.gc.ca/, Grant 122249-2010-RGPIN awarded to HS). TW was supported by a Graduate Student Fellowship from the Chinese Science Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auclair SM, 2012, PROTEIN SCI, V21, P13, DOI 10.1002/pro.757; Bintintan I, 2010, J BIOL CHEM, V285, P8572, DOI 10.1074/jbc.M109.083394; Chisholm J, 2007, VIROLOGY, V368, P133, DOI 10.1016/j.virol.2007.06.032; CHOO KH, 2008, BMC BIOINFORMATI S12, V9, pS15, DOI DOI 10.1186/1471-2105-9-S12-S15; FOLZ RJ, 1988, J BIOL CHEM, V263, P2070; Guermeur Y, 1999, BIOINFORMATICS, V15, P413, DOI 10.1093/bioinformatics/15.5.413; Han SM, 2003, J VIROL, V77, P523, DOI 10.1128/JVI.77.1.523-534.2003; King RD, 1997, COMPUT APPL BIOSCI, V13, P473; KRAUSSLICH HG, 1988, BIOCHIMIE, V70, P119, DOI 10.1016/0300-9084(88)90166-6; Laliberte JF, 2010, ANNU REV PHYTOPATHOL, V48, P69, DOI 10.1146/annurev-phyto-073009-114239; Le Gall O, 2008, ARCH VIROL, V153, P715, DOI 10.1007/s00705-008-0041-x; Moradpour D, 2013, CURR TOP MICROBIOL, V369, P113, DOI 10.1007/978-3-642-27340-7_5; NILSSON I, 1994, J CELL BIOL, V126, P1127, DOI 10.1083/jcb.126.5.1127; Nilsson I, 2002, FEBS LETT, V516, P106, DOI 10.1016/S0014-5793(02)02511-5; NOTHWEHR SF, 1989, J BIOL CHEM, V264, P4642; NOTHWEHR SF, 1990, J BIOL CHEM, V265, P17202; NOTHWEHR SF, 1990, J BIOL CHEM, V265, P21797; NOTHWEHR SF, 1989, J BIOL CHEM, V264, P3979; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Pene V, 2009, J VIRAL HEPATITIS, V16, P705, DOI 10.1111/j.1365-2893.2009.01118.x; PERLMAN D, 1983, J MOL BIOL, V167, P391, DOI 10.1016/S0022-2836(83)80341-6; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Robakis T, 2008, J BIOL CHEM, V283, P36369, DOI 10.1074/jbc.M807527200; Romero-Brey I, 2014, VIRUSES-BASEL, V6, P2826, DOI 10.3390/v6072826; Rost B, 1996, METHOD ENZYMOL, V266, P525; ROTT ME, 1995, J GEN VIROL, V76, P465, DOI 10.1099/0022-1317-76-2-465; Sanfacon H, 2005, CAN J BOT, V83, P1529, DOI 10.1139/b05-121; Sanfacon H., 2006, Floriculture, ornamental and plant biotechnology, P540; Sanfacon H, 2013, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00313; Sanfacon H, 2009, ARCH VIROL, V154, P899, DOI 10.1007/s00705-009-0367-z; SHELNESS GS, 1993, J BIOL CHEM, V268, P5201; VONHEIJNE G, 1983, EUR J BIOCHEM, V133, P17; VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635; Walker M, 2015, ARCH VIROL, V160, P543, DOI 10.1007/s00705-014-2240-y; Wang AM, 2004, J GEN VIROL, V85, P535, DOI 10.1099/vir.0.19612-0; Yeagle PL, 2007, BBA-BIOMEMBRANES, V1768, P530, DOI 10.1016/j.bbamem.2006.11.018; Zhang G, 2006, J VIROL, V80, P10847, DOI 10.1128/JVI.00789-06; Zhang SC, 2005, J VIROL, V79, P11752, DOI 10.1128/JVI.79.18.11752-11765.2005	38	1	1	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162223	10.1371/journal.pone.0162223	http://dx.doi.org/10.1371/journal.pone.0162223			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589230	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877800039
J	Chang, SS; Yamaguchi, H; Xia, W; Lim, SO; Khotskaya, Y; Wu, Y; Chang, WC; Liu, Q; Hung, MC				Chang, S-S; Yamaguchi, H.; Xia, W.; Lim, S-O; Khotskaya, Y.; Wu, Y.; Chang, W-C; Liu, Q.; Hung, M-C			Aurora A kinase activates YAP signaling in triple-negative breast cancer	ONCOGENE			English	Article							TO-MESENCHYMAL TRANSITION; HIPPO PATHWAY; CELL-MIGRATION; PROTEIN; PHOSPHORYLATION; KIBRA; COMPLEX; CHEMORESISTANCE; REGULATOR; TAZ	The Yes-associated protein (YAP) is an effector that transduces the output of the Hippo pathway to transcriptional modulation. Considering the role of YAP in cancers, this protein has emerged as a key node in malignancy development. In this study, we determined that Aurora A kinase acts as a positive regulator for YAP-mediated transcriptional machinery. Specifically, YAP associates with Aurora A predominantly in the nucleus. Activation of Aurora A can impinge on YAP activity through direct phosphorylation. Moreover, aberrant expression of YAP and Aurora A signaling is highly correlated with triple-negative breast cancer (TNBC). We herein provide evidence to establish the functional relevance of this newly discovered regulatory axis in TNBC.	[Chang, S-S; Yamaguchi, H.; Xia, W.; Lim, S-O; Hung, M-C] Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 108, Houston, TX 77030 USA; [Chang, S-S; Hung, M-C] Univ Texas Houston, Grad Sch Biomed Sci Houston, Canc Biol Program, Houston, TX USA; [Khotskaya, Y.] Univ Texas Houston, MD Anderson Canc Ctr, Sheikh Khalifa Bin Zayed Nahyan Inst Personalized, Houston, TX USA; [Wu, Y.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Breast Med Oncol, Houston, TX USA; [Chang, W-C; Hung, M-C] China Med Univ, Ctr Mol Med, Taichung, Taiwan; China Med Univ, Grad Inst Canc Biol, Taichung, Taiwan; [Liu, Q.] Sun Yat Sen Univ, Ctr Canc, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou, Peoples R China; [Liu, Q.] Dalian Med Univ, First Affiliated Hosp, Collaborat Innovat Ctr Onco, Inst Canc Stem Cell, Dalian, Peoples R China; [Hung, M-C] Asia Univ, Dept Biotechnol, Taichung, Taiwan	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; China Medical University Taiwan; China Medical University Taiwan; State Key Lab Oncology South China; Sun Yat Sen University; Dalian Medical University; Asia University Taiwan	Hung, MC (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Mol & Cellular Oncol, 1515 Holcombe Blvd,Unit 108, Houston, TX 77030 USA.	mhung@mdanderson.org	Hung, Mien-Chie/ABD-5911-2021; Lim, Seung-Oe/D-3703-2011	Hung, Mien-Chie/0000-0003-4317-4740; 	National Institutes of Health [CA109311, CA099031]; Cancer Center Support [CA016672]; National Breast Cancer Foundation; Patel Memorial Breast Cancer Endowment Fund; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; Ministry of Science and Technology; International Research-intensive Centers of Excellence in Taiwan (I-RiCE) [MOST 105-2911-I-002-302]; Ministry of Health and Welfare, China Medical University Hospital Cancer Research Center of Excellence [MOHW105-TDU-B-212-134003]; Center for Biological Pathways at MD Anderson and Ting Tsung and Wei Fong Chao Research Fund; NATIONAL CANCER INSTITUTE [P30CA016672] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Center Support; National Breast Cancer Foundation; Patel Memorial Breast Cancer Endowment Fund; University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund; Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); International Research-intensive Centers of Excellence in Taiwan (I-RiCE); Ministry of Health and Welfare, China Medical University Hospital Cancer Research Center of Excellence; Center for Biological Pathways at MD Anderson and Ting Tsung and Wei Fong Chao Research Fund; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by the following: National Institutes of Health grants (CA109311, CA099031 and Cancer Center Support Grant CA016672); National Breast Cancer Foundation; Patel Memorial Breast Cancer Endowment Fund; The University of Texas MD Anderson-China Medical University and Hospital Sister Institution Fund (to M-CH); Ministry of Science and Technology, International Research-intensive Centers of Excellence in Taiwan (I-RiCE; MOST 105-2911-I-002-302); Ministry of Health and Welfare, China Medical University Hospital Cancer Research Center of Excellence (MOHW105-TDU-B-212-134003); Center for Biological Pathways at MD Anderson and Ting Tsung and Wei Fong Chao Research Fund. We also thank Tamara K Locke of the Department of Scientific Publications at The University of Texas MD Anderson Cancer Center for her editorial assistance.	Baumgartner R, 2010, DEV CELL, V18, P309, DOI 10.1016/j.devcel.2009.12.013; Bayliss R, 2003, MOL CELL, V12, P851, DOI 10.1016/S1097-2765(03)00392-7; Camargo FD, 2007, CURR BIOL, V17, P2054, DOI 10.1016/j.cub.2007.10.039; Cammareri P, 2010, CANCER RES, V70, P4655, DOI 10.1158/0008-5472.CAN-09-3953; Chen J, 2012, CURR BIOL, V22, P1582, DOI 10.1016/j.cub.2012.06.074; Cordenonsi M, 2011, CELL, V147, P759, DOI 10.1016/j.cell.2011.09.048; D'Assoro AB, 2014, ONCOGENE, V33, P599, DOI 10.1038/onc.2012.628; Do TV, 2014, ONCOGENE, V33, P539, DOI 10.1038/onc.2012.632; Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019; Eyers PA, 2003, CURR BIOL, V13, P691, DOI 10.1016/S0960-9822(03)00166-0; Genevet A, 2010, DEV CELL, V18, P300, DOI 10.1016/j.devcel.2009.12.011; Guan Z, 2007, CANCER RES, V67, P10436, DOI 10.1158/0008-5472.CAN-07-1379; Gyorffy B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082241; Hao YW, 2008, J BIOL CHEM, V283, P5496, DOI 10.1074/jbc.M709037200; Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007; Jiao S, 2014, CANCER CELL, V25, P166, DOI 10.1016/j.ccr.2014.01.010; Johnson R, 2014, NAT REV DRUG DISCOV, V13, P63, DOI 10.1038/nrd4161; Kapoor A, 2014, CELL, V158, P185, DOI 10.1016/j.cell.2014.06.003; Karthigeyan D, 2011, MED RES REV, V31, P757, DOI 10.1002/med.20203; Kim M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6370; Lamar JM, 2012, P NATL ACAD SCI USA, V109, pE2441, DOI 10.1073/pnas.1212021109; Lau AN, 2014, EMBO J, V33, P468, DOI 10.1002/embj.201386082; Lee DF, 2012, CELL STEM CELL, V11, P179, DOI 10.1016/j.stem.2012.05.020; Lens SMA, 2010, NAT REV CANCER, V10, P825, DOI 10.1038/nrc2964; Li CW, 2016, CANCER RES, V76, P1451, DOI 10.1158/0008-5472.CAN-15-1941; Liu-Chittenden Y, 2012, GENE DEV, V26, P1300, DOI 10.1101/gad.192856.112; Moroishi T, 2015, NAT REV CANCER, V15, P73, DOI 10.1038/nrc3876; Nikonova AS, 2013, CELL MOL LIFE SCI, V70, P661, DOI 10.1007/s00018-012-1073-7; Nishio H, 2004, P NATL ACAD SCI USA, V101, P11257, DOI 10.1073/pnas.0401343101; Paleologou KE, 2008, J BIOL CHEM, V283, P16895, DOI 10.1074/jbc.M800747200; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Poon CLC, 2012, CURR BIOL, V22, P1587, DOI 10.1016/j.cub.2012.06.075; Rosenbluh J, 2012, CELL, V151, P1457, DOI 10.1016/j.cell.2012.11.026; Sanjana NE, 2014, NAT METHODS, V11, P783, DOI 10.1038/nmeth.3047; Skibinski A, 2014, CELL REP, V6, P1059, DOI 10.1016/j.celrep.2014.02.038; Song SM, 2015, CLIN CANCER RES, V21, P2580, DOI 10.1158/1078-0432.CCR-14-2191; Sun SG, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9402; Sun Y, 2015, AM J TRANSL RES, V7, P319; Toji S, 2004, GENES CELLS, V9, P383, DOI 10.1111/j.1356-9597.2004.00732.x; Wang G, 2004, J VIROL, V78, P7097, DOI 10.1128/JVI.78.13.7097-7111.2004; Wang LH, 2010, CANCER RES, V70, P9118, DOI 10.1158/0008-5472.CAN-10-1246; Wang WQ, 2015, NAT CELL BIOL, V17, P490, DOI 10.1038/ncb3113; Xia WY, 2004, CLIN CANCER RES, V10, P3815, DOI 10.1158/1078-0432.CCR-03-0527; Xiao L, 2011, J BIOL CHEM, V286, P36304, DOI 10.1074/jbc.M111.246850; Yabuta N, 2011, CELL CYCLE, V10, P2724, DOI 10.4161/cc.10.16.16873; Yang H, 2006, INT J CANCER, V119, P2304, DOI 10.1002/ijc.22154; Yang J, 2013, INT J CANCER, V133, P2706, DOI 10.1002/ijc.28277; Yu FX, 2013, GENE DEV, V27, P355, DOI 10.1101/gad.210773.112; Yu JZ, 2010, DEV CELL, V18, P288, DOI 10.1016/j.devcel.2009.12.012; Zhang K, 2014, ONCOTARGET, V5, P12916, DOI 10.18632/oncotarget.2682; Zhang L, 2012, J BIOL CHEM, V287, P34069, DOI 10.1074/jbc.M112.385518; Zhang WY, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005049; Zhao B, 2008, GENE DEV, V22, P1962, DOI 10.1101/gad.1664408; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zhao YL, 2014, CANCER RES, V74, P4493, DOI 10.1158/0008-5472.CAN-13-2712; Zorba A, 2014, ELIFE, V3, DOI 10.7554/eLife.02667	57	33	36	0	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	MAR	2017	36	9					1265	1275		10.1038/onc.2016.292	http://dx.doi.org/10.1038/onc.2016.292			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EN2SV	27593935				2022-12-26	WOS:000395861300010
J	Riggs, JW; Rockwell, NC; Cavales, PC; Callis, J				Riggs, John W.; Rockwell, Nathan C.; Cavales, Philip C.; Callis, Judy			Identification of the Plant Ribokinase and Discovery of a Role for Arabidopsis Ribokinase in Nucleoside Metabolism	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						carbohydrate metabolism; carbohydrate processing; enzyme; nucleoside; nucleotide metabolism; phosphorylation; plant biochemistry; carbohydrate kinase	ESCHERICHIA-COLI RIBOKINASE; ADENOSINE KINASE; DEGRADATION; FAMILY; PURIFICATION; MONOVALENT; SEQUENCE; PROTEIN; RIBOSE; ACTIVATION	Ribose can be used for energy or as a component of several important biomolecules, but for it to be used in either capacity it must first be phosphorylated by ribokinase (RBSK). RBSK proteins are part of the phosphofructokinase-B (pfkB) family of carbohydrate kinases. Sequence comparisons of pfkB proteins from the model plant Arabidopsis thaliana with the human and Escherichia coli RBSK identified a single candidate RBSK, At1g17160 (AtRBSK). AtRBSK is more similar to predicted RBSKs from other plant species and known mammalian and prokaryotic RBSK than to all other PfkB proteins in Arabidopsis. AtRBSK contains a predicted chloroplast transit peptide, and we confirmed plastid localization using AtRBSK fused to YFP. Structure prediction software verified that the AtRBSK sequence mapped onto a known RBSK structure. Kinetic parameters of purified recombinant AtRBSK were determined to be K-mribose = 150 m +/- 17 m, K-mATP = 45 m +/- 5.6 m, and k(cat) = 2.0 s(-1). Substrate inhibition was observed for AtRBSK (K-iATP = 2.44 mm +/- 0.36 mm), as has been demonstrated for other RBSK proteins. Ribose accumulated in Arabidopsis plants lacking AtRBSK. Such plants grew normally unless media was supplemented with ribose, which led to chlorosis and growth inhibition. Both chlorosis and ribose accumulation were abolished upon the introduction of a transgene expressing AtRBSK-MYC, demonstrating that the loss of protein is responsible for ribose hypersensitivity. Ribose accumulation in plants lacking AtRBSK was reduced in plants also deficient in the nucleoside ribohydrolase NSH1, linking AtRBSK activity to nucleoside metabolism.	[Riggs, John W.; Rockwell, Nathan C.; Cavales, Philip C.; Callis, Judy] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA	University of California System; University of California Davis	Callis, J (corresponding author), Univ Calif Davis, 1 Shields Ave, Davis, CA 95616 USA.	jcallis@ucdavis.edu		Callis, Judy/0000-0002-0622-078X	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy [DE-FG02-09ER16077, DE-SC0002175]; Eric and Louise Conn Graduate Student Fellowship in Plant Biochemistry	Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy(United States Department of Energy (DOE)); Eric and Louise Conn Graduate Student Fellowship in Plant Biochemistry	This work was supported by the Division of Chemical Sciences, Geosciences, and Biosciences, Office of Basic Energy Sciences of the United States Department of Energy Grants DE-FG02-09ER16077 and DE-SC0002175 and a Eric and Louise Conn Graduate Student Fellowship in Plant Biochemistry (to J. R.). The authors declare they have no conflict of interest with the contents of this article.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson CE, 2002, J MOL BIOL, V315, P409, DOI 10.1006/jmbi.2001.5248; BABUL J, 1978, J BIOL CHEM, V253, P4350; Cabrera R, 2010, ARCH BIOCHEM BIOPHYS, V502, P23, DOI 10.1016/j.abb.2010.06.024; Chuvikovsky DV, 2006, BIOORGAN MED CHEM, V14, P6327, DOI 10.1016/j.bmc.2006.05.057; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Edgar RC, 2004, BMC BIOINFORMATICS, V5, P1, DOI 10.1186/1471-2105-5-113; Emanuelsson O, 1999, PROTEIN SCI, V8, P978, DOI 10.1110/ps.8.5.978; Fiehn Oliver, 2006, V323, P439; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; HOPE JN, 1986, J BIOL CHEM, V261, P7663; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; IIDA A, 1984, J BACTERIOL, V158, P674, DOI 10.1128/JB.158.2.674-682.1984; Jung B, 2011, PLANT J, V65, P703, DOI 10.1111/j.1365-313X.2010.04455.x; Jung B, 2009, PLANT CELL, V21, P876, DOI 10.1105/tpc.108.062612; Kraft E., 2007, THESIS; Lager I, 2003, FEBS LETT, V553, P85, DOI 10.1016/S0014-5793(03)00976-1; Maj MC, 2002, BIOCHEMISTRY-US, V41, P4059, DOI 10.1021/bi0119161; Nakagawa T, 2007, J BIOSCI BIOENG, V104, P34, DOI 10.1263/jbb.104.34; Parducci RE, 2006, BIOCHEMISTRY-US, V45, P9291, DOI 10.1021/bi060026o; Park J, 2008, CELL MOL LIFE SCI, V65, P2875, DOI 10.1007/s00018-008-8123-1; Park J, 2007, FEBS LETT, V581, P3211, DOI 10.1016/j.febslet.2007.06.009; Paul R, 2015, ADV EXP MED BIOL, V842, P293, DOI 10.1007/978-3-319-11280-0_19; PERIGNON JL, 1987, BIOCHIM BIOPHYS ACTA, V928, P130, DOI 10.1016/0167-4889(87)90113-3; Quiroga-Roger D, 2015, BIOMETALS, V28, P401, DOI 10.1007/s10534-015-9844-x; Riegler H, 2011, NEW PHYTOL, V191, P349, DOI 10.1111/j.1469-8137.2011.03711.x; Rockwell NC, 2007, BMC BIOINFORMATICS, V8, P1, DOI 10.1186/1471-2105-8-123; Rogers JS, 1999, MOL BIOL EVOL, V16, P1079, DOI 10.1093/oxfordjournals.molbev.a026197; SCHAFER G, 1977, PLANT PHYSIOL, V60, P286, DOI 10.1104/pp.60.2.286; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Sigrell JA, 1998, STRUCTURE, V6, P183, DOI 10.1016/S0969-2126(98)00020-3; Stone J., 1998, EFFICIENT LIB PARALL; Terasawa K, 2005, PLANT CELL PHYSIOL, V46, P649, DOI 10.1093/pcp/pci070; Weckwerth W, 2004, PROTEOMICS, V4, P78, DOI 10.1002/pmic.200200500; Zrenner R, 2006, ANNU REV PLANT BIOL, V57, P805, DOI 10.1146/annurev.arplant.57.032905.105421; Zybailov B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001994	36	16	17	6	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22572	22582		10.1074/jbc.M116.754689	http://dx.doi.org/10.1074/jbc.M116.754689			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601466	Green Published, hybrid			2022-12-26	WOS:000386760600018
J	Chen, L; Zhang, J; Xu, J; Wan, L; Teng, KX; Xiang, J; Zhang, R; Huang, ZB; Liu, YM; Li, WH; Liu, X				Chen, Lan; Zhang, Ju; Xu, Jie; Wan, Lu; Teng, Kaixuan; Xiang, Jin; Zhang, Rui; Huang, Zebo; Liu, Yongmei; Li, Wenhua; Liu, Xin			rBm alpha TX14 Increases the Life Span and Promotes the Locomotion of Caenorhabditis Elegans	PLOS ONE			English	Article							OXIDATIVE STRESS; SCORPION TOXINS; RESPONSE GENES; BREAST-CANCER; TUMOR-GROWTH; C. ELEGANS; VENOM; IDENTIFICATION; NEMATODE; CHANNEL	The scorpion has been extensively used in various pharmacological profiles or as food supplies. The exploration of scorpion venom has been reported due to the presence of recombinant peptides. rBm alpha TX14 is an alpha-neurotoxin extracted from the venom gland of the East Asian scorpion Buthus martensii Karsch and can affect ion channel conductance. Here, we investigated the functions of rBm alpha TX14 using the Caenorhabditis elegans model. Using western blot analysis, rBm alpha TX14 was shown to be expressed both in the cytoplasm and inclusion bodies in the E.coli Rosetta (DE3) strain. Circular dichroism spectroscopy analysis demonstrated that purified rBm alpha TX14 retained its biological structures. Next, feeding nematodes with E.coli Rosetta (DE3) expressing rBm alpha TX14 caused extension of the life span and promoted the locomotion of the nematodes. In addition, we identified several genes that play various roles in the life span and locomotion of C. elegans through microarray analysis and quantitative real-time PCR. Furthermore, if the amino acid site H-15 of rBm alpha TX14 was mutated, rBm alpha TX14 no longer promoted the C. elegans life span. In conclusion, the results not only demonstrated the functions and mechanism of rBm alpha TX14 in C. elegans, but also provided the new sight in the utility of recombinant peptides from scorpion venom.	[Chen, Lan; Zhang, Ju; Xu, Jie; Wan, Lu; Teng, Kaixuan; Xiang, Jin; Zhang, Rui; Huang, Zebo; Liu, Yongmei; Liu, Xin] Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Wuhan 430071, Peoples R China; [Chen, Lan; Zhang, Ju; Xu, Jie; Wan, Lu; Teng, Kaixuan; Xiang, Jin; Zhang, Rui; Huang, Zebo; Liu, Yongmei; Liu, Xin] Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Peoples R China; [Li, Wenhua] Wuhan Univ, Sch Life Sci, Wuhan 430071, Peoples R China; [Huang, Zebo] Guangdong Pharmaceut Univ, Guangdong Prov Key Lab Biotechnol Drug Candidates, Sch Biosci & Biopharmaceut, Guangzhou 510006, Guangdong, Peoples R China	Wuhan University; Wuhan University; Wuhan University; Guangdong Pharmaceutical University	Liu, X (corresponding author), Wuhan Univ, Key Lab Combinatorial Biosynth & Drug Discovery, Minist Educ, Wuhan 430071, Peoples R China.; Liu, X (corresponding author), Wuhan Univ, Sch Pharmaceut Sci, Wuhan 430071, Peoples R China.	lx@whu.edu.cn	Huang, Zebo/AAF-2382-2019	Huang, Zebo/0000-0003-2431-3741	National Program on Key Basic Research Project (973 Program) [2010CB529804]; National Natural Science Foundation of China [31400155, 81472550, 81274048]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by National Program on Key Basic Research Project (973 Program, No. 2010CB529804), which is received by XL. The work was also supported by the National Natural Science Foundation of China. XL received the fundings which number is 31400155 or 81472550;ZBH received the funding which number is 81274048.The URLs of the funder's website is (http://www.nsfc.gov.cn). All the fundings have role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This study was supported by National Program on Key Basic Research Project (973 Program, No. 2010CB529804) and the National Natural Science Foundation of China (Grant No. 31400155, 81472550 and 81274048). The DNA sequence of rBm alpha TX14 was kindly provided by Prof. Zhijian Cao (College of Life Sciences, Wuhan University).	Bea RD, 2015, PEPTIDES, V68, P228, DOI 10.1016/j.peptides.2014.10.008; Cantacessi C, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-266; Cao LY, 2012, PEPTIDES, V36, P213, DOI 10.1016/j.peptides.2012.04.010; Cao ZJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3602; Cecchim AL, 2006, TOXICOL APPL PHARM, V217, P196, DOI 10.1016/j.taap.2006.09.003; Chen G, 2015, MOL NUTR FOOD RES, V59, P293, DOI 10.1002/mnfr.201400483; Chen S, 2009, P NATL ACAD SCI USA, V106, P1496, DOI 10.1073/pnas.0802674106; Conde R, 2000, FEBS LETT, V471, P165, DOI 10.1016/S0014-5793(00)01384-3; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; Dai H, 2012, PROTEIN EXPRES PURIF, V82, P325, DOI 10.1016/j.pep.2012.02.001; Du Q, 2015, TOXINS, V7, P219, DOI 10.3390/toxins7020219; Eom HJ, 2013, TOXICOL APPL PHARM, V270, P106, DOI 10.1016/j.taap.2013.03.028; Escoubas P, 2004, TOXICON, V43, P555, DOI 10.1016/j.toxicon.2004.02.007; Ewald CY, 2015, NATURE, V519, P97, DOI 10.1038/nature14021; Franzen J, 2012, ECOTOXICOLOGY, V21, P557, DOI 10.1007/s10646-011-0816-9; Gaglia MM, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003133; Gao SB, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7323; Gao SB, 2011, P NATL ACAD SCI USA, V108, P2557, DOI 10.1073/pnas.1012346108; Haskins KA, 2008, DEV CELL, V15, P87, DOI 10.1016/j.devcel.2008.05.006; Hill AJ, 2014, CURR BIOL, V24, P2399, DOI 10.1016/j.cub.2014.08.040; Honda Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023527; Kramer LB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014291; Legros C, 2005, BBA-GEN SUBJECTS, V1723, P91, DOI 10.1016/j.bbagen.2005.01.008; Li WH, 2014, MOL NUTR FOOD RES, V58, P863, DOI 10.1002/mnfr.201300404; Liu P, 2011, J PHYSIOL-LONDON, V589, P101, DOI 10.1113/jphysiol.2010.200683; MacNeil LT, 2013, CELL, V153, P240, DOI 10.1016/j.cell.2013.02.049; Ortiz E, 2015, TOXICON, V93, P125, DOI 10.1016/j.toxicon.2014.11.233; Paek J, 2012, CELL METAB, V16, P526, DOI 10.1016/j.cmet.2012.09.007; Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908; Pinkston-Gosse J, 2007, NAT GENET, V39, P1403, DOI 10.1038/ng.2007.1; Possani LD, 1999, EUR J BIOCHEM, V264, P287, DOI 10.1046/j.1432-1327.1999.00625.x; Possani LD, 2000, BIOCHIMIE, V82, P861, DOI 10.1016/S0300-9084(00)01167-6; Qin C, 2014, MOL PHARMACEUT, V11, P3233, DOI 10.1021/mp400691z; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Razani B, 2001, J CLIN INVEST, V108, P1553, DOI 10.1172/JCI14611; Rechavi O, 2014, CELL, V158, P277, DOI 10.1016/j.cell.2014.06.020; Samuelson AV, 2007, GENE DEV, V21, P2976, DOI 10.1101/gad.1588907; Sharma V, 2016, BIOINFORM BIOL INSIG, V10, P1, DOI 10.4137/BBI.S37130; Shen EZ, 2014, NATURE, V508, P128, DOI 10.1038/nature13012; Simmer F, 2003, PLOS BIOL, V1, P77, DOI 10.1371/journal.pbio.0000012; Sloan EK, 2004, ONCOGENE, V23, P7893, DOI 10.1038/sj.onc.1208062; Stone CE, 2009, DEV BIOL, V329, P201, DOI 10.1016/j.ydbio.2009.02.030; Tatar M, 2005, CELL METAB, V2, P281, DOI 10.1016/j.cmet.2005.10.006; Ueno S, 2012, BIOCHEM BIOPH RES CO, V420, P552, DOI 10.1016/j.bbrc.2012.03.032; Velazquez-Marrero C, 2014, J BIOL CHEM, V289, P29261, DOI 10.1074/jbc.M114.604306; Viswanathan M, 2005, DEV CELL, V9, P605, DOI 10.1016/j.devcel.2005.09.017; Voisine C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000504; Wang K, 2006, BIOTECHNOL LETT, V28, P1767, DOI 10.1007/s10529-006-9155-y; Wang T, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109977; Wen Q, 2012, NEURON, V76, P750, DOI 10.1016/j.neuron.2012.08.039; Williams TM, 2005, J BIOL CHEM, V280, P25134, DOI 10.1074/jbc.M501186200; Zhang HR, 2012, BIOCHEM J, V441, P417, DOI 10.1042/BJ20110621; Zhu SY, 2000, TOXICON, V38, P1653, DOI 10.1016/S0041-0101(00)00081-7; Zugasti O, 2005, GENOME RES, V15, P1402, DOI 10.1101/gr.3935405	54	2	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161847	10.1371/journal.pone.0161847	http://dx.doi.org/10.1371/journal.pone.0161847			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611314	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900032
J	Morishita, F; Yadav, RP; Eang, MT; Saint, S; Nishikiori, N				Morishita, Fukushi; Yadav, Rajendra-Prasad; Eang, Mao Tan; Saint, Saly; Nishikiori, Nobuyuki			Mitigating Financial Burden of Tuberculosis through Active Case Finding Targeting Household and Neighbourhood Contacts in Cambodia	PLOS ONE			English	Article							XPERT MTB/RIF ASSAY; PULMONARY TUBERCULOSIS; DIAGNOSIS; IMPACT; COSTS; LEVEL; TB	Background Despite free TB services available in public health facilities, TB patients often face severe financial burden due to TB. WHO set a new global target that no TB-affected families experience catastrophic costs due to TB. To monitor the progress and strategize the optimal approach to achieve the target, there is a great need to assess baseline cost data, explore potential proxy indicators for catastrophic costs, and understand what intervention mitigates financial burden. In Cambodia, nationwide active case finding (ACF) targeting household and neighbourhood contacts was implemented alongside routine passive case finding (PCF). We analyzed household cost data from ACF and PCF to determine the financial benefit of ACF, update the baseline cost data, and explore whether any dissaving patterns can be a proxy for catastrophic costs in Cambodia. Methods In this cross-sectional comparative study, structured interviews were carried out with 108 ACF patients and 100 PCF patients. Direct and indirect costs, costs before and during treatment, costs as percentage of annual household income and dissaving patterns were compared between the two groups. Results The median total costs were lower by 17% in ACF than in PCF ($240.7 [IQR 65.5-594.6] vs $290.5 [IQR 113.6-813.4], p = 0.104). The median costs before treatment were significantly lower in ACF than in PCF ($5.1 [IQR 1.5-25.8] vs $22.4 [IQR 4.4-70.8], p < 0.001). Indirect costs constituted the largest portion of total costs (72.3% in ACF and 61.5% in PCF). Total costs were equivalent to 11.3% and 18.6% of annual household income in ACF and PCF, respectively. ACF patients were less likely to dissave to afford TB-related expenses. Costs as percentage of annual household income were significantly associated with an occurrence of selling property (p = 0.02 for ACF, p = 0.005 for PCF). Conclusions TB-affected households face severe financial hardship in Cambodia. ACF has the great potential to mitigate the costs incurred particularly before treatment. Social protection schemes that can replace lost income are critically needed to compensate for the most devastating costs in TB. An occurrence of selling household property can be a useful proxy for catastrophic cost in Cambodia.	[Morishita, Fukushi; Nishikiori, Nobuyuki] WHO, Reg Off Western Pacific, Manila, Philippines; [Yadav, Rajendra-Prasad] WHO, Representat Off Philippines, Manila, Philippines; [Eang, Mao Tan; Saint, Saly] Minist Hlth, Natl Ctr TB & Leprosy Control, Phnom Penh, Cambodia	WHO Western Pacific Regional Office; World Health Organization; WHO Western Pacific Regional Office; World Health Organization	Morishita, F (corresponding author), WHO, Reg Off Western Pacific, Manila, Philippines.	morishita.fukushi@gmail.com		Yadav, Rajendra Prasad/0000-0002-0398-1313; Nishikiori, Nobuyuki/0000-0003-0962-8868	Government of Japan through Ministry of Health, Labour and Welfare; Government of the Republic of Korea through Korean Centers for Disease Control Prevention; Stop TB Partnership's TB REACH Initiative; Government of Canada; Bill and Melinda Gates Foundation	Government of Japan through Ministry of Health, Labour and Welfare(Ministry of Health, Labour and Welfare, Japan); Government of the Republic of Korea through Korean Centers for Disease Control Prevention; Stop TB Partnership's TB REACH Initiative; Government of Canada(CGIAR); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation)	The study was conducted by World Health Organization with the financial support from the Government of Japan through Ministry of Health, Labour and Welfare and from the Government of the Republic of Korea through Korean Centers for Disease Control & Prevention. The main intervention (active case finding) was a part of project activities funded by the Stop TB Partnership's TB REACH Initiative. TB REACH is primarily supported by the Government of Canada, with additional funding from the Bill and Melinda Gates Foundation. The authors alone are responsible for the views expressed in this publication and they do not necessarily represent the decisions or policies of the WHO.	Alavi Seyed Mohammad, 2014, Tanaffos, V13, P14; Annear PL., 2015, HLTH SYSTEMS TRANSIT; [Anonymous], 2015, WHOHTMTB201519; [Anonymous], 2009, IMPL HLTH EQ FUNDS G; [Anonymous], 2011, REP 2 NAT TUB PREV S; [Anonymous], 2013, WHOHTMTB201311; [Anonymous], 2014, TUB REP 2013 KINGD C; [Anonymous], 2014, WHOHTMTB20148; [Anonymous], 2005, WHOHTMTB2005325; [Anonymous], 2012, CAMB SOC SEC FORM EC; Bigdeli M, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0146147; Chen S, 2015, INT CON DISTR COMP S, P1, DOI 10.1109/ICDCS.2015.9; Creswell J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094465; Eang MT, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-469; Foster N, 2015, SOC SCI MED, V130, P42, DOI 10.1016/j.socscimed.2015.01.046; Jackson S, 2006, INT J TUBERC LUNG D, V10, P1104; Jacobs B, 2016, INT J EQUITY HEALTH, V15, DOI 10.1186/s12939-016-0383-z; Kamolratanakul P, 1999, INT J TUBERC LUNG D, V3, P596; KNCV Tuberculosis Foundation WHO the Japan Anti-Tuberculosis Association, 2009, TOOL EST PAT COSTS T; Kranzer K, 2013, INT J TUBERC LUNG D, V17, P432, DOI 10.5588/ijtld.12.0743; Kuznetsov VN, 2014, INT J CIRCUMPOL HEAL, P73; Laokri S, 2013, B WORLD HEALTH ORGAN, V91, P277, DOI 10.2471/BLT.12.110015; Lonnroth K, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001693; Lonnroth K, 2010, LANCET, V375, P1814, DOI 10.1016/S0140-6736(10)60483-7; Madan J, 2015, BMC HEALTH SERV RES, V15, DOI 10.1186/s12913-015-1138-z; Mauch V, 2013, INT J TUBERC LUNG D, V17, P381, DOI 10.5588/ijtld.12.0368; Morishita F, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150405; Morishita F, 2015, WEST PAC SURVEILL RE, V6, DOI [10.2471/WPSAR.2014.5.4.005, 10.5365/wpsar.2014.5.4.005]; National Center for Tuberculosis and Leprosy Control, 2011, NAT HLTH STRAT PLAN; Negin J, 2015, INT J INFECT DIS, V32, P135, DOI 10.1016/j.ijid.2014.11.018; Nishikiori N, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-97; Pichenda K, 2012, INT J TUBERC LUNG D, V16, P828, DOI 10.5588/ijtld.11.0688; Pocock S.J., 2013, CLIN TRIALS PRACTICA; Rachow A, 2012, CLIN INFECT DIS, V54, P1388, DOI 10.1093/cid/cis190; Richter LM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086225; Storla DG, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-15; Tanimura T, 2014, EUR RESPIR J, V43, P1763, DOI 10.1183/09031936.00193413; Theron G, 2011, AM J RESP CRIT CARE, V184, P132, DOI 10.1164/rccm.201101-0056OC; Ukwaja K, 2012, INT J TUBERC LUNG D, V16; Wang CS, 2008, INFECTION, V36, P335, DOI 10.1007/s15010-008-7199-8; Wingfield T, 2014, PLOS MED, V11, DOI 10.1371/journal.pmed.1001675; World Health Organization, 2013, SYST SCREEN ACT TUB; World Health Organization, 2014, 67 WORLD HLTH ASS 20; World Health Organization, 2015, WHOHTMTB201522; WorldHealthOrganization, 2013, AUT REAL TIM NUCL AM; Yadav RP, 2014, AM J TROP MED HYG, V90, P866, DOI 10.4269/ajtmh.13-0419	46	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162796	10.1371/journal.pone.0162796	http://dx.doi.org/10.1371/journal.pone.0162796			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611908	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900168
J	Bellon, MR; Ntandou-Bouzitou, GD; Caracciolo, F				Bellon, Mauricio R.; Ntandou-Bouzitou, Gervais D.; Caracciolo, Francesco			On-Farm Diversity and Market Participation Are Positively Associated with Dietary Diversity of Rural Mothers in Southern Benin, West Africa	PLOS ONE			English	Article							NUTRITIONAL-STATUS; HEALTH; POLICY; SCALE; BIODIVERSITY; ADEQUACY; ANDES	Objective The objective of this study is to test the extent to which, under different opportunities for market participation, the diversity of plant species rural households grow or collect (on-farm diversity), and the variety of foods mothers purchase (market diversity) are associated with their dietary diversity. Methods Rural households from three districts in southern Benin were interviewed during dry (n = 472) and wet (n = 482) seasons between 2011 and 2012. Villages within districts and their households were selected randomly according to market accessibility, with a mother selected from each household. Information on on-farm diversity was collected using a semi-structured questionnaire. Market diversity was obtained through a 7-day food frequency questionnaire that elicited if foods were purchased. Dietary diversity was derived from a quantitative 24-hour food recall. A system of three simultaneous equations via a Generalized Methods of Moments was estimated to address potential endogeneity between dietary diversity and on-farm diversity and market diversity. Results Results show rich on-farm diversity with more than 65 different edible plant species grown or collected by households. More than 70% of foods consumed by mothers were purchased in 55 market places. More than 50% of mothers met minimum dietary diversity with at least 5 food groups consumed. Diagnostic tests indicated the existence of endogeneity. Econometric results showed that on-farm and market diversities were positively associated with mothers' dietary diversity (p < 0.05) once market opportunities, seasonality and other socioeconomic factors were controlled for. Conclusion Results provide evidence of a positive relationship between on-farm diversity and dietary diversity among participant mothers. They demonstrate the important contribution of market diversity to their dietary diversity. Links among these three facets of diversity suggest that production for self-consumption and food purchases complement rather than replace each other in their contribution to dietary diversity and thus dietary quality.	[Bellon, Mauricio R.] Biovers Int, Maccarese, Italy; [Ntandou-Bouzitou, Gervais D.] Biovers Int, Cotonou, Benin; [Caracciolo, Francesco] Univ Naples Federico II, Portici, Italy	Alliance; Bioversity International; Alliance; Bioversity International; University of Naples Federico II	Bellon, MR (corresponding author), Biovers Int, Maccarese, Italy.	m.bellon@cgiar.org	Bellon, Mauricio/L-9546-2019; Caracciolo, Francesco/D-6147-2013	Caracciolo, Francesco/0000-0001-9430-7529; Bellon, Mauricio/0000-0003-0642-3402	Bill and Melinda Gates Foundation [OPP53227]; Ministry of Agriculture; Centre communal pour la promotion de l'agriculture (CeCPA) of Bohicon; Centre communal pour la promotion de l'agriculture (CeCPA) of Allada; Centre communal pour la promotion de l'agriculture (CeCPA) of Toffo; University of Abomey Calavi	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Ministry of Agriculture(Gida Tarim Ve Hayvancilik Bakanligi); Centre communal pour la promotion de l'agriculture (CeCPA) of Bohicon; Centre communal pour la promotion de l'agriculture (CeCPA) of Allada; Centre communal pour la promotion de l'agriculture (CeCPA) of Toffo; University of Abomey Calavi	This work was supported by Bill and Melinda Gates Foundation grant OPP53227, http://www.gatesfoundation.org/, MRB. CGIAR Research Program on Agriculture for Nutrition and Health led by IFPRI, http://www.a4nh.cgiar.org/, no specific grant number, funded part of the time of MRB and GNB. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.; We thank Laurian Unnevehr, Janet Lauderdale, Jon Hellin and four anonymous reviewers for comments on an earlier version and Arwen Bailey for editorial assistance. We are grateful to study participants and local communities for their full support and to the University of Abomey Calavi and the extension services of the Ministry of Agriculture, the Centre communal pour la promotion de l'agriculture (CeCPA) of Bohicon, Allada and Toffo for their guidance and support.	Adelman I., 2003, REV ECON HOUSEHOLD, V1, P33, DOI [10.1023/A:1021847430758, DOI 10.1023/A:1021847430758]; Anderson C. L., 2010, Seed trade in rural markets: implications for crop diversity and agricultural development, P31; Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Arimond M, 2010, J NUTR, V140, p2059S, DOI 10.3945/jn.110.123414; Barrett CB, 2008, FOOD POLICY, V33, P299, DOI 10.1016/j.foodpol.2007.10.005; Bellon MR, 2015, WORLD DEV, V70, P162, DOI 10.1016/j.worlddev.2015.01.014; BELLON MR, 1993, ECON DEV CULT CHANGE, V41, P763, DOI 10.1086/452047; Berti PR, 2015, P NATL ACAD SCI USA, V112, pE5656, DOI 10.1073/pnas.1517006112; BRUNDY JM, 1971, REV ECON STAT, V53, P207, DOI 10.2307/1937965; Cameron A. C., 2013, REGRESSION ANAL COUN, V53, DOI [10.1017/CBO9781139013567, DOI 10.1017/CBO9781139013567]; Cameron C., 2005, MICROECONOMETRICS US, P1056; Carletto G, 2015, J DEV STUD, V51, P945, DOI 10.1080/00220388.2015.1018908; Chamberlin J, 2013, WORLD DEV, V41, P245, DOI 10.1016/j.worlddev.2012.06.004; Daniels M, 2014, M REACH CONSENSUS GL; DEJANVRY A, 1995, WORLD DEV, V23, P1349, DOI 10.1016/0305-750X(95)00056-I; Delisle H, 2012, BRIT J NUTR, V107, P1534, DOI 10.1017/S0007114511004661; Dercon S, 2005, 194 FCND IFPRI, V2005; Devaux A, 2009, FOOD POLICY, V34, P31, DOI 10.1016/j.foodpol.2008.10.007; Dillon A, 2015, J DEV STUD, V51, P976, DOI 10.1080/00220388.2015.1018902; Erenstein O, 2006, AGR ECOSYST ENVIRON, V117, P205, DOI 10.1016/j.agee.2006.03.033; Fan S., 2013, SUBSISTENCE PROFIT T; Faul F, 2009, BEHAV RES METHODS, V41, P1149, DOI 10.3758/BRM.41.4.1149; Food and Agriculture Organization of the United Nations, 2011, PROF NUTR PAYS REP B; Gibson RS., 2008, INT FOOD POLICY RES; Gomez MI, 2013, FOOD POLICY, V42, P129, DOI 10.1016/j.foodpol.2013.06.009; Hayashi Fumio, 2000, ECONOMETRICS; Hazell P, 2010, WORLD DEV, V38, P1349, DOI 10.1016/j.worlddev.2009.06.012; Heckman JJ, 2005, ECONOMETRICA, V73, P669, DOI 10.1111/j.1468-0262.2005.00594.x; Hirvonen K, 2014, 69 EDRI IFPRI; Honfo F. G., 2010, African Journal of Food Science, V4, P184; Hong Rathavuth, 2006, Int J Equity Health, V5, P15, DOI 10.1186/1475-9276-5-15; INSD, 2022, CINQ REC GEN POP HAB; Institut National de la Statistique et de l'Analyse Economique, 2004, CAH VILL QUART VILL; Institut National de la Statistique et de l'Analyse Economique (INSAE), 2014, ENQ GRAPP IND MULT M; Institut National de la Statistique (INS) au Niger and Macro International Inc, 2007, ENQ DEM SANT 2006; Jones AD, 2014, FOOD POLICY, V46, P1, DOI 10.1016/j.foodpol.2014.02.001; Keding GB, 2012, FOOD SECUR, V4, P129, DOI 10.1007/s12571-011-0163-y; Keleman A, 2013, HUM ECOL, V41, P683, DOI 10.1007/s10745-013-9566-z; Key N, 2000, AM J AGR ECON, V82, P245, DOI 10.1111/0002-9092.00022; Khoury CK, 2014, P NATL ACAD SCI USA, V111, P4001, DOI 10.1073/pnas.1313490111; Lemay-Boucher P, 2014, J INT DEV, V26, P46, DOI 10.1002/jid.2839; Luckett BG, 2015, PUBLIC HEALTH NUTR, V18, P2479, DOI 10.1017/S136898001500169X; M'Kaibi FK, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-1755-9; Magnani R, 1997, SAMPLING GUIDE; Malapit HJL, 2015, J DEV STUD, V51, P1097, DOI 10.1080/00220388.2015.1018904; McDermott J, 2015, FOOD SECUR, V7, P593, DOI 10.1007/s12571-015-0462-9; Muhanji G, 2011, INT J AGR SUSTAIN, V9, P194, DOI 10.3763/ijas.2010.0561; Muller C, 2009, FOOD POLICY, V34, P166, DOI 10.1016/j.foodpol.2008.10.010; Nichols A, 2007, STATA J, V7, P507, DOI 10.1177/1536867X0700700403; Oyarzun PJ, 2013, ECOL FOOD NUTR, V52, P515, DOI 10.1080/03670244.2013.769099; Pingali P, 2015, FOOD SECUR, V7, P583, DOI 10.1007/s12571-015-0461-x; Powell B, 2015, FOOD SECUR, V7, P535, DOI 10.1007/s12571-015-0466-5; Reardon T, 2003, AM J AGR ECON, V85, P1140, DOI 10.1111/j.0092-5853.2003.00520.x; Remans R, 2015, P NATL ACAD SCI USA, V112, pE6082, DOI 10.1073/pnas.1518531112; Remans R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021235; Republique du Benin, 2014, AN GLOB VULN SEC AL; Richards E, 2013, SOC SCI MED, V95, P24, DOI 10.1016/j.socscimed.2012.06.015; Ruel MT, 2003, J NUTR, V133, p3911S, DOI 10.1093/jn/133.11.3911S; Savy M, 2005, EUR J CLIN NUTR, V59, P703, DOI 10.1038/sj.ejcn.1602135; Setimela P, 2005, EUPHYTICA, V145, P123, DOI 10.1007/s10681-005-0625-4; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, pE5657, DOI 10.1073/pnas.1517209112; Sibhatu KT, 2015, P NATL ACAD SCI USA, V112, P10657, DOI 10.1073/pnas.1510982112; Singh L. S., 1986, AGR HOUSEHOLD MODELS; Slack A., 1996, FOOD INSECURITY NUTR; Torheim LE, 2004, EUR J CLIN NUTR, V58, P594, DOI 10.1038/sj.ejcn.1601853; Torheim LE, 2013, DIET QUALITY, P105, DOI [10.1007/978-1-4614-7339-8_9, DOI 10.1007/978-1-4614-7339-8_9]; Windmeijer FAG, 1997, J APPL ECONOMET, V12, P281	68	72	72	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162535	10.1371/journal.pone.0162535	http://dx.doi.org/10.1371/journal.pone.0162535			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27606782	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600060
J	Fitzpatrick, BR; Lamb, DW; Mengersen, K				Fitzpatrick, Benjamin R.; Lamb, David W.; Mengersen, Kerrie			Ultrahigh Dimensional Variable Selection for Interpolation of Point Referenced Spatial Data: A Digital Soil Mapping Case Study	PLOS ONE			English	Article							ORGANIC-CARBON; TERRAIN ATTRIBUTES; ELECTRICAL-CONDUCTIVITY; MODEL SELECTION; PREDICTION; CLIMATE; REGRESSION; LASSO; PLAIN; MAP	Modern soil mapping is characterised by the need to interpolate point referenced (geostatistical) observations and the availability of large numbers of environmental characteristics for consideration as covariates to aid this interpolation. Modelling tasks of this nature also occur in other fields such as biogeography and environmental science. This analysis employs the Least Angle Regression (LAR) algorithm for fitting Least Absolute Shrinkage and Selection Operator (LASSO) penalized Multiple Linear Regressions models. This analysis demonstrates the efficiency of the LAR algorithm at selecting covariates to aid the interpolation of geostatistical soil carbon observations. Where an exhaustive search of the models that could be constructed from 800 potential covariate terms and 60 observations would be prohibitively demanding, LASSO variable selection is accomplished with trivial computational investment.	[Fitzpatrick, Benjamin R.; Mengersen, Kerrie] Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia; [Fitzpatrick, Benjamin R.; Lamb, David W.; Mengersen, Kerrie] CRCSI, Carlton, Vic 3053, Australia; [Fitzpatrick, Benjamin R.; Mengersen, Kerrie] Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia; [Lamb, David W.] Univ New England, Precis Agr Res Grp, Armidale, NSW 2351, Australia; [Mengersen, Kerrie] Queensland Univ Technol, ARC Ctr Excellence Math & Stat Frontiers, Brisbane, Qld 4001, Australia	Queensland University of Technology (QUT); Queensland University of Technology (QUT); University of New England; Queensland University of Technology (QUT)	Fitzpatrick, BR (corresponding author), Queensland Univ Technol, Sch Math Sci, Brisbane, Qld 4001, Australia.; Fitzpatrick, BR (corresponding author), CRCSI, Carlton, Vic 3053, Australia.; Fitzpatrick, BR (corresponding author), Queensland Univ Technol, Inst Future Environm, Brisbane, Qld 4001, Australia.	b1.fitzpatrick@qut.edu.au	Mengersen, Kerrie/AHC-4096-2022	Mengersen, Kerrie/0000-0001-8625-9168; Fitzpatrick, Benjamin R./0000-0003-1916-0939; Lamb, David/0000-0002-2917-2231	CRC for Spatial Information (CRCSI); Australian Government Cooperative Research Centres Programme	CRC for Spatial Information (CRCSI)(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme); Australian Government Cooperative Research Centres Programme(Australian GovernmentDepartment of Industry, Innovation and ScienceCooperative Research Centres (CRC) Programme)	This work was funded by the CRC for Spatial Information (CRCSI), established and supported under the Australian Government Cooperative Research Centres Programme. One of the authors (BRF) wishes to acknowledge the receipt of a Postgraduate Scholarship from the CRCSI (http://www.crcsi.com.au/).	Adhikari K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0105519; Ahmed SE, 2014, PENALTY SHRINKAGE PR, P5; Ahmed SE., 2014, PENALTY SHRINKAGE PR; Banerjee S., 2004, HIERARCHICAL MODELIN; Banerjee S, 2004, HIERARCHICAL MODELIN, P22; Banerjee S, 2004, HIERARCHICAL MODELIN, P175; Barnes EM, 2003, PHOTOGRAMM ENG REM S, V69, P619, DOI 10.14358/PERS.69.6.619; Betts RA, 2007, AGR FOREST METEOROL, V142, P216, DOI 10.1016/j.agrformet.2006.08.021; Bondell HD, 2010, BIOMETRICS, V66, P1069, DOI 10.1111/j.1541-0420.2010.01391.x; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Brenning A., 2008, HAMBURGER BEITRAEGE, V19, P23; Chen F, 2008, SOIL SCI SOC AM J, V72, P186, DOI 10.2136/sssaj2007.0028; Chipman HA, 1998, J AM STAT ASSOC, V93, P935, DOI 10.2307/2669832; Chipman HA, 2002, MACH LEARN, V48, P299, DOI 10.1023/A:1013916107446; Conrad O, 2015, GEOSCI MODEL DEV, V8, P1991, DOI 10.5194/gmd-8-1991-2015; Dlugoss V, 2010, SOIL SCI SOC AM J, V74, P922, DOI 10.2136/sssaj2009.0325; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Eisfelder C, 2012, INT J REMOTE SENS, V33, P2937, DOI 10.1080/01431161.2011.620034; Engelmann JC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040634; Fan JQ, 2001, J AM STAT ASSOC, V96, P1348, DOI 10.1198/016214501753382273; Florinsky IV, 2002, ENVIRON MODELL SOFTW, V17, P295, DOI 10.1016/S1364-8152(01)00067-6; Franklin J, 2009, MAPPING SPECIES DIST; Friedman JH, 2002, COMPUT STAT DATA AN, V38, P367, DOI 10.1016/S0167-9473(01)00065-2; Gotway CA, 2002, J AM STAT ASSOC, V97, P632, DOI 10.1198/016214502760047140; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed.; Hbirkou C, 2012, GEODERMA, V175, P21, DOI 10.1016/j.geoderma.2012.01.017; Hijmans RJ, 2015, RASTER GEOGRAPHIC AN; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Ibrahim JG, 2011, BIOMETRICS, V67, P495, DOI 10.1111/j.1541-0420.2010.01463.x; Johnson CK, 2001, SOIL SCI SOC AM J, V65, P1829, DOI 10.2136/sssaj2001.1829; Kheir RB, 2010, J ENVIRON MANAGE, V91, P1150, DOI 10.1016/j.jenvman.2010.01.001; Kursa MB, 2010, J STAT SOFTW, V36, P1, DOI 10.18637/jss.v036.i11; Lacoste M, 2014, GEODERMA, V213, P296, DOI 10.1016/j.geoderma.2013.07.002; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Lal R., 2009, SOIL CARBON SEQUESTR, V2nd; Lu DS, 2016, INT J DIGIT EARTH, V9, P63, DOI 10.1080/17538947.2014.990526; Lumley T., 2009, LEAPS REGRESSION SUB; Mao DH, 2015, BIOGEOSCIENCES, V12, P1635, DOI 10.5194/bg-12-1635-2015; Meersmans J, 2012, AGRON SUSTAIN DEV, V32, P873, DOI 10.1007/s13593-012-0085-x; Miklos M, 2010, AUST J SOIL RES, V48, P248, DOI 10.1071/SR09111; Millar A, 2002, SUBSET SELECTION REG, P52; Minasny B, 2014, PROGR SOIL SCI, P45, DOI 10.1007/978-3-319-04084-4_5; Minasny B, 2013, ADV AGRON, V118, P1, DOI 10.1016/B978-0-12-405942-9.00001-3; MOORE ID, 1993, SOIL SCI SOC AM J, V57, P443, DOI 10.2136/sssaj1993.03615995005700020026x; Muller S, 2013, STAT SCI, V28, P135, DOI 10.1214/12-STS410; Mueller TG, 2003, SOIL SCI SOC AM J, V67, P258, DOI 10.2136/sssaj2003.0258; Nychka D, 2015, FIELDS TOOLS SPATIAL; Park T, 2008, J AM STAT ASSOC, V103, P681, DOI 10.1198/016214508000000337; Peng H, 2012, J MULTIVARIATE ANAL, V109, P109, DOI 10.1016/j.jmva.2012.02.005; Quinlan J. R., 1992, Proceedings of the 5th Australian Joint Conference on Artificial Intelligence. AI '92, P343; R Core Team, 2021, R LANGUAGE ENV STAT; Rossel RAV, 2014, GLOBAL CHANGE BIOL, V20, P2953, DOI 10.1111/gcb.12569; SCHLESINGER WH, 1977, ANNU REV ECOL SYST, V8, P51, DOI 10.1146/annurev.es.08.110177.000411; Simbahan GC, 2006, GEODERMA, V132, P471, DOI 10.1016/j.geoderma.2005.07.001; Sudipto Banerjee, 2004, HIERARCHICAL MODELIN, P1; Terra JA, 2004, SOIL SCI, V169, P819, DOI 10.1097/00010694-200412000-00001; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Usai M Graziano, 2012, BMC Proc, V6 Suppl 2, pS9, DOI 10.1186/1753-6561-6-S2-S9; Usai MG, 2009, GENET RES, V91, P427, DOI 10.1017/S0016672309990334; Valdman C, 2012, EUR SIGNAL PR CONF, P2104; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wiesmeier M, 2013, AGR ECOSYST ENVIRON, V176, P39, DOI 10.1016/j.agee.2013.05.012; Wiesmeier M, 2011, PLANT SOIL, V340, P7, DOI 10.1007/s11104-010-0425-z; Xiong X, 2014, ENVIRON MODELL SOFTW, V57, P202, DOI 10.1016/j.envsoft.2014.03.004; Zhang CH, 2010, ANN STAT, V38, P894, DOI 10.1214/09-AOS729; Zou H, 2006, J AM STAT ASSOC, V101, P1418, DOI 10.1198/016214506000000735; Zuur Alain F., 2009, P1	68	6	6	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162489	10.1371/journal.pone.0162489	http://dx.doi.org/10.1371/journal.pone.0162489			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603135	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200070
J	French, AS; Zadoks, RN; Skuce, PJ; Mitchell, G; Gordon-Gibbs, DK; Craine, A; Shaw, D; Gibb, SW; Taggart, MA				French, Andrew S.; Zadoks, Ruth N.; Skuce, Philip J.; Mitchell, Gillian; Gordon-Gibbs, Danielle K.; Craine, Alexandra; Shaw, David; Gibb, Stuart W.; Taggart, Mark A.			Prevalence of Liver Fluke (Fasciola hepatica) in Wild Red Deer (Cervus elaphus): Coproantigen ELISA Is a Practicable Alternative to Faecal Egg Counting for Surveillance in Remote Populations	PLOS ONE			English	Article							RUMEN FLUKE; SPATIAL-DISTRIBUTION; DAIRY HERDS; CATTLE; SHEEP; ANTIBODIES; SAMPLES; RUMINANTS; INFECTION; AGREEMENT	Red deer (Cervus elaphus) are hosts of liver fluke (Fasciola hepatica); yet, prevalence is rarely quantified in wild populations. Testing fresh samples from remote regions by faecal examination (FE) can be logistically challenging; hence, we appraise frozen storage and the use of a coproantigen ELISA (cELISA) for F. hepatica surveillance. We also present cELISA surveillance data for red deer from the Highlands of Scotland. Diagnoses in faecal samples (207 frozen, 146 fresh) were compared using a cELISA and by FE. For each storage method (frozen or fresh), agreement between the two diagnostics was estimated at individual and population levels, where population prevalence was stratified into cohorts (e.g., by sampling location). To approximate sensitivity and specificity, 65 post-slaughter whole liver examinations were used as a reference. At the individual level, FE and cELISA diagnoses agreed moderately (k(frozen) = 0.46; k(fresh) = 0.51), a likely reflection of their underlying principles. At the population level, FE and cELISA cohort prevalence correlated strongly (Pearson's R = 0.89, p < 0.0001), reflecting good agreement on relative differences between cohort prevalence. In frozen samples, prevalence by cELISA exceeded FE overall (42.8% vs. 25.8%) and in 9/12 cohorts, alluding to differences in sensitivity; though, in fresh samples, no significant difference was found. In 959 deer tested by cELISA across the Scottish Highlands, infection prevalence ranged from 9.6% to 53% by sampling location. We highlight two key advantages of cELISA over FE: i) the ability to store samples long term (frozen) without apparent loss in diagnostic power; and ii) reduced labour and the ability to process large batches. Further evaluation of cELISA sensitivity in red deer, where a range of fluke burdens can be obtained, is desirable. In the interim, the cELISA is a practicable diagnostic for F. hepatica surveillance in red deer, and its application here has revealed considerable geographic, temporal, sex and age related differences in F. hepatica prevalence in wild Scottish Highland red deer.	[French, Andrew S.; Craine, Alexandra; Gibb, Stuart W.; Taggart, Mark A.] Univ Highlands & Islands, Environm Res Inst, North Highland Coll, Castle St, Thurso KW14 7JD, Scotland; [Zadoks, Ruth N.; Skuce, Philip J.; Mitchell, Gillian; Gordon-Gibbs, Danielle K.] Moredun Res Inst, Pentlands Sci Pk, Penicuik EH26 0PZ, Midlothian, Scotland; [Zadoks, Ruth N.] Univ Glasgow, Inst Biodivers Anim Hlth & Comparat Med, Coll Med Vet & Life Sci, Glasgow G61 1QH, Lanark, Scotland; [Shaw, David] Univ Highlands & Islands, UHI Rural Studies Ctr, North Highland Coll, Dale Farm KW12 6UW, Halkirk, Scotland	UHI Millennium Institute; Moredun Research Institute; University of Glasgow; UHI Millennium Institute	French, AS (corresponding author), Univ Highlands & Islands, Environm Res Inst, North Highland Coll, Castle St, Thurso KW14 7JD, Scotland.	Andrew.French@uhi.ac.uk	French, Andrew/Q-8012-2016	French, Andrew/0000-0001-6662-4113; Taggart, Mark/0000-0002-0649-8490; Gibb, Stuart/0000-0003-3882-338X; Zadoks, Ruth/0000-0002-1164-8000	Highlands and Islands Scotland European Social Fund programme; Scottish Government's Rural and Environment Science and Analytical Services Division; BBSRC [BB/K015346/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/K015346/1] Funding Source: researchfish	Highlands and Islands Scotland European Social Fund programme; Scottish Government's Rural and Environment Science and Analytical Services Division; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	ASF's studentship was funded by the Highlands and Islands Scotland European Social Fund 2007-2013 programme. Funding for contributions by GM, PJS and RNZ was obtained from the Scottish Government's Rural and Environment Science and Analytical Services Division. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Valero MA, 2009, VET PARASITOL, V159, P77, DOI 10.1016/j.vetpar.2008.10.014; Alasaad S, 2007, PARASITOL RES, V101, P1245, DOI 10.1007/s00436-007-0628-2; Arias MS, 2013, RES VET SCI, V95, P1031, DOI 10.1016/j.rvsc.2013.07.027; BARTH D, 1973, Zeitschrift fuer Jagdwissenschaft, V19, P183, DOI 10.1007/BF01904174; Bennema SC, 2011, INT J PARASITOL, V41, P225, DOI 10.1016/j.ijpara.2010.09.003; Bohm M, 2006, VET J, V171, P287, DOI 10.1016/j.tvjl.2004.10.020; Branscum AJ, 2005, PREV VET MED, V68, P145, DOI 10.1016/j.prevetmed.2004.12.005; Brockwell YM, 2013, VET PARASITOL, V196, P417, DOI 10.1016/j.vetpar.2013.04.012; BYRT T, 1993, J CLIN EPIDEMIOL, V46, P423, DOI 10.1016/0895-4356(93)90018-V; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; DURBIN C. G., 1952, PROC HELMINTHOL SOC WASHINGTON, V19, P120; Flanagan AM, 2011, VET PARASITOL, V176, P34, DOI 10.1016/j.vetpar.2010.10.037; FOREYT WJ, 1986, J AM VET MED ASSOC, V189, P1065; Fox NJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016126; Gordon DK, 2013, VET PARASITOL, V195, P65, DOI 10.1016/j.vetpar.2013.01.014; Gordon DK, 2012, VET PARASITOL, V187, P436, DOI 10.1016/j.vetpar.2012.02.009; Gordon-Gibbs D, 2014, THESIS; Hoby S, 2006, VET PARASITOL, V138, P337, DOI 10.1016/j.vetpar.2006.01.028; Hothorn T, 2008, BIOMETRICAL J, V50, P346, DOI 10.1002/bimj.200810425; HUI SL, 1980, BIOMETRICS, V36, P167, DOI 10.2307/2530508; Issia L, 2009, VET PARASITOL, V165, P341, DOI 10.1016/j.vetpar.2009.07.011; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LEIPER J. W. G., 1938, JOUR HELMINTHOL, V16, P173, DOI 10.1017/S0022149X00018551; McCann CM, 2010, VET REC, V166, P612, DOI 10.1136/vr.b4836; McCann CM, 2010, INT J PARASITOL, V40, P1021, DOI 10.1016/j.ijpara.2010.02.009; Menard A, 2001, VET RES, V32, P499, DOI 10.1051/vetres:2001141; Mezo M, 2004, J PARASITOL, V90, P845, DOI 10.1645/GE-192R; Mezo M, 2010, PARASITOL INT, V59, P610, DOI 10.1016/j.parint.2010.09.001; Mezo M, 2007, J PARASITOL, V93, P65, DOI 10.1645/GE-925R.1; Mezo M, 2013, VET PARASITOL, V198, P274, DOI 10.1016/j.vetpar.2013.09.009; MITCHELL B, 1986, BIOL CONSERV, V37, P237, DOI 10.1016/0006-3207(86)90084-4; O'Toole A, 2014, PARASITOL RES, V113, P4097, DOI 10.1007/s00436-014-4078-3; Palmer DG, 2014, AUST VET J, V92, P357, DOI 10.1111/avj.12224; R Core Team, 2013, R LANG ENV STAT COMP; R Studio Team, 2016, RSTUDIO INT DEV ENV; Rinaldi L, 2011, VET PARASITOL, V177, P345, DOI 10.1016/j.vetpar.2010.12.010; Rondelaud D, 2001, PARASITOL RES, V87, P475, DOI 10.1007/s004360100385; ROSS JG, 1968, VET REC, V82, P587; Shimalov VV, 2000, PARASITOL RES, V86, P342, DOI 10.1007/s004360050056; Arias MS, 2012, J PARASITOL, V98, P754, DOI 10.1645/GE-2804.1; Toolan DP, 2015, VET PARASITOL, V212, P168, DOI 10.1016/j.vetpar.2015.07.040; Ubeira FM, 2009, AM J TROP MED HYG, V81, P156, DOI 10.4269/ajtmh.2009.81.156; van Dijk J, 2010, ANIMAL, V4, P377, DOI 10.1017/S1751731109990991; van Wyk JA, 2002, ONDERSTEPOORT J VET, V69, P299; Walker SM, 2011, VET PARASITOL, V177, P179, DOI 10.1016/j.vetpar.2010.11.043	46	20	20	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162420	10.1371/journal.pone.0162420	http://dx.doi.org/10.1371/journal.pone.0162420			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598003	Green Published, Green Accepted, gold, Green Submitted			2022-12-26	WOS:000383254800065
J	Abfalter, CM; Schonauer, E; Ponnuraj, K; Huemer, M; Gadermaier, G; Regl, C; Briza, P; Ferreira, F; Huber, CG; Brandstetter, H; Posselt, G; Wessler, S				Abfalter, Carmen M.; Schoenauer, Esther; Ponnuraj, Karthe; Huemer, Markus; Gadermaier, Gabriele; Regl, Christof; Briza, Peter; Ferreira, Fatima; Huber, Christian G.; Brandstetter, Hans; Posselt, Gernot; Wessler, Silja			Cloning, Purification and Characterization of the Collagenase ColA Expressed by Bacillus cereus ATCC 14579	PLOS ONE			English	Article							CLOSTRIDIUM-HISTOLYTICUM; COLLAGENOLYTIC ACTIVITY; NUCLEOTIDE-SEQUENCE; VIBRIO-VULNIFICUS; PHOSPHOLIPASE-C; IDENTIFICATION; REVEALS; GENE; ACTIVATION; SECRETION	Bacterial collagenases differ considerably in their structure and functions. The collagenases ColH and ColG from Clostridium histolyticum and ColA expressed by Clostridium perfringens are well-characterized collagenases that cleave triple-helical collagen, which were therefore termed as 'true' collagenases. ColA from Bacillus cereus (B. cereus) has been added to the collection of true collagenases. However, the molecular characteristics of B. cereus ColA are less understood. In this study, we identified ColA as a secreted true collagenase from B. cereus ATCC 14579, which is transcriptionally controlled by the regulon phospholipase C regulator (PlcR). B. cereus ATCC 14579 ColA was cloned to express recombinant wildtype ColA (ColA(wt)) and mutated to a proteolytically inactive (ColA(E501A)) version. Recombinant ColAwt was tested for gelatinolytic and collagenolytic activities and ColA(E501A) was used for the production of a polyclonal anti-ColA antibody. Comparison of ColAwt activity with homologous proteases in additional strains of B. cereus sensu lato (B. cereus s.l.) and related clostridial collagenases revealed that B. cereus ATCC 14579 ColA is a highly active peptidolytic and collagenolytic protease. These findings could lead to a deeper insight into the function and mechanism of bacterial collagenases which are used in medical and biotechnological applications.	[Abfalter, Carmen M.; Huemer, Markus; Posselt, Gernot; Wessler, Silja] Paris Lodron Univ Salzburg, Dept Mol Biol, Div Microbiol, Salzburg, Austria; [Schoenauer, Esther; Brandstetter, Hans] Paris Lodron Univ Salzburg, Dept Mol Biol, Div Struct Biol, Salzburg, Austria; [Ponnuraj, Karthe] Univ Madras, Ctr Adv Study Crystallog & Biophys, Guindy Campus, Chennai, Tamil Nadu, India; [Gadermaier, Gabriele; Briza, Peter; Ferreira, Fatima] Paris Lodron Univ Salzburg, Dept Mol Biol, Div Allergy & Immunol, Salzburg, Austria; [Regl, Christof; Huber, Christian G.] Paris Lodron Univ Salzburg, Dept Mol Biol, Div Chem & Bioanalyt, Salzburg, Austria	Salzburg University; Salzburg University; University of Madras; Salzburg University; Salzburg University	Wessler, S (corresponding author), Paris Lodron Univ Salzburg, Dept Mol Biol, Div Microbiol, Salzburg, Austria.	silja.wessler@sbg.ac.at	Brandstetter, Hans/E-6754-2011; Huber, Christian G./E-5445-2011; Ferreira, Fatima/AAB-4321-2019; Ferreira, Fatima/E-4889-2011; Posselt, Gernot/K-1747-2015; Wessler, Silja/C-6309-2015; Briza, Peter/D-7309-2012; Gadermaier, Gabriele/L-5997-2015	Brandstetter, Hans/0000-0002-6089-3045; Huber, Christian G./0000-0001-8358-1880; Ferreira, Fatima/0000-0003-0989-2335; Ferreira, Fatima/0000-0003-0989-2335; Posselt, Gernot/0000-0002-0593-6620; Wessler, Silja/0000-0001-7011-6162; Briza, Peter/0000-0002-4941-6782; Gadermaier, Gabriele/0000-0002-4886-417X; Schonauer, Esther/0000-0002-2625-9446; Huemer, Markus/0000-0002-4308-1619	University of Salzburg	University of Salzburg	We thank Michel Gohar, Didier Lereclus and Nalini Ramarao for providing bacterial strains and are grateful to Isabel J. Hoppe for providing ColG protein. This work was supported by the publication funds of the University of Salzburg.	Abfalter Carmen M, 2015, Br Microbiol Res J, V7, P62, DOI 10.9734/BMRJ/2015/16402; Agaisse H, 1999, MOL MICROBIOL, V32, P1043, DOI 10.1046/j.1365-2958.1999.01419.x; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apte SS, 2015, MATRIX BIOL, V44-46, P1, DOI 10.1016/j.matbio.2015.04.005; Arnesen LPS, 2008, FEMS MICROBIOL REV, V32, P579, DOI 10.1111/j.1574-6976.2008.00112.x; BARRIE D, 1992, J INFECTION, V25, P291, DOI 10.1016/0163-4453(92)91579-Z; Beecher DJ, 2000, INFECT IMMUN, V68, P5269, DOI 10.1128/IAI.68.9.5269-5276.2000; Bottone EJ, 2010, CLIN MICROBIOL REV, V23, P382, DOI 10.1128/CMR.00073-09; Chang SC, 1997, BIOCHEM J, V321, P29, DOI 10.1042/bj3210029; CHANG SC, 1994, J BIOL CHEM, V269, P3548; Darbar A, 2005, J ORTHOP TRAUMA, V19, P353; DROBNIEWSKI FA, 1993, CLIN MICROBIOL REV, V6, P324, DOI 10.1128/CMR.6.4.324-338.1993; Eckhard U, 2008, ACTA CRYSTALLOGR F, V64, P419, DOI 10.1107/S1744309108010476; Eckhard U, 2014, J PROTEOMICS, V100, P102, DOI 10.1016/j.jprot.2013.10.004; Eckhard U, 2013, J BIOL CHEM, V288, P20184, DOI 10.1074/jbc.M112.448548; Eckhard U, 2011, NAT STRUCT MOL BIOL, V18, P1109, DOI 10.1038/nsmb.2127; Eckhard U, 2009, BIOL CHEM, V390, P11, DOI 10.1515/BC.2009.004; Frankard J, 2004, EUR J CLIN MICROBIOL, V23, P725, DOI 10.1007/s10096-004-1180-y; Frees Dorte, 2013, Subcell Biochem, V66, P161, DOI 10.1007/978-94-007-5940-4_7; Gilois N, 2007, PROTEOMICS, V7, P1719, DOI 10.1002/pmic.200600502; Gohar M, 2002, PROTEOMICS, V2, P784, DOI 10.1002/1615-9861(200206)2:6<784::AID-PROT784>3.0.CO;2-R; Gohar M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002793; GRANT GA, 1987, J BIOL CHEM, V262, P5886; Guinebretiere MH, 2013, INT J SYST EVOL MICR, V63, P31, DOI 10.1099/ijs.0.030627-0; Harrington DJ, 1996, INFECT IMMUN, V64, P1885, DOI 10.1128/IAI.64.6.1885-1891.1996; Ingmer H, 2009, RES MICROBIOL, V160, P704, DOI 10.1016/j.resmic.2009.08.017; Jung CM, 1999, J BACTERIOL, V181, P2816, DOI 10.1128/JB.181.9.2816-2822.1999; Katsuya H, 2009, J INFECT CHEMOTHER, V15, P39, DOI 10.1007/s10156-008-0654-8; Kavermann H, 2003, J EXP MED, V197, P813, DOI 10.1084/jem.20021531; Kopel AC, 2008, OPHTHAL SURG LAS IM, V39, P153, DOI 10.3928/15428877-20080301-10; Kotiranta A, 2000, MICROBES INFECT, V2, P189, DOI 10.1016/S1286-4579(00)00269-0; Krause A, 1996, J TRAUMA, V41, P546, DOI 10.1097/00005373-199609000-00030; Lereclus D, 1996, J BACTERIOL, V178, P2749, DOI 10.1128/jb.178.10.2749-2756.1996; Letunic I, 2015, NUCLEIC ACIDS RES, V43, P9; LOESCHE WJ, 1974, INFECT IMMUN, V9, P329, DOI 10.1128/IAI.9.2.329-336.1974; Lower M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003510; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Lu PF, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005058; Lund T, 1999, FEMS MICROBIOL LETT, V178, P355, DOI 10.1016/S0378-1097(99)00382-1; Magklara A, 2003, BIOCHEM BIOPH RES CO, V307, P948, DOI 10.1016/S0006-291X(03)01271-3; MAKINEN KK, 1987, J BIOL CHEM, V262, P12488; Marshman LAG, 2000, BRIT J NEUROSURG, V14, P580; MATSUSHITA O, 1994, J BACTERIOL, V176, P149, DOI 10.1128/JB.176.1.149-156.1994; Matsushita O, 1999, J BACTERIOL, V181, P923, DOI 10.1128/JB.181.3.923-933.1999; Matsushita O, 2001, TOXICON, V39, P1769, DOI 10.1016/S0041-0101(01)00163-5; Miller JJ, 2008, AM J OPHTHALMOL, V145, P883, DOI 10.1016/j.ajo.2007.12.026; MIYOSHI N, 1987, MICROBIOL IMMUNOL, V31, P13, DOI 10.1111/j.1348-0421.1987.tb03064.x; Peak TC, 2015, BIOL-TARGETS THER, V9, P107, DOI 10.2147/BTT.S65619; PEIMER CA, 2015, THE JOURNAL OF HAND, V40, P141, DOI DOI 10.1177/1753193414528843; Petersen TN, 2011, NAT METHODS, V8, P785, DOI 10.1038/nmeth.1701; Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharma V, 2015, BIOCHEM J, V465, P163, DOI 10.1042/BJ20140809; SMITH GC, 1982, INFECT IMMUN, V35, P1155, DOI 10.1128/IAI.35.3.1155-1156.1982; Theocharis AD, 2016, ADV DRUG DELIVER REV, V97, P4, DOI 10.1016/j.addr.2015.11.001; VANWART HE, 1981, ANAL BIOCHEM, V113, P356, DOI 10.1016/0003-2697(81)90089-0; WANDERSMAN C, 1989, MOL MICROBIOL, V3, P1825, DOI 10.1111/j.1365-2958.1989.tb00169.x; Watanabe K, 2004, APPL MICROBIOL BIOT, V63, P520, DOI 10.1007/s00253-003-1442-0; YOSHIHARA K, 1994, J BACTERIOL, V176, P6489, DOI 10.1128/JB.176.21.6489-6496.1994; Zigha A, 2006, ARCH MICROBIOL, V185, P222, DOI 10.1007/s00203-006-0090-z	60	18	21	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162433	10.1371/journal.pone.0162433	http://dx.doi.org/10.1371/journal.pone.0162433			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588686	gold, Green Submitted, Green Published			2022-12-26	WOS:000382877800062
J	Klein, S; Hinuber, C; Hittatiya, K; Schierwagen, R; Uschner, FE; Strassburg, CP; Fischer, HP; Spengler, U; Trebicka, J				Klein, Sabine; Hinueber, Christian; Hittatiya, Kanishka; Schierwagen, Robert; Uschner, Frank Erhard; Strassburg, Christian P.; Fischer, Hans-Peter; Spengler, Ulrich; Trebicka, Jonel			Novel Rat Model of Repetitive Portal Venous Embolization Mimicking Human Non-Cirrhotic Idiopathic Portal Hypertension	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; SECONDARY BILIARY-CIRRHOSIS; DUCT-LIGATED RATS; RHO-KINASE; ACTIVATION; FIBROSIS; RECEPTOR; DEFICIENCY; MANAGEMENT; PRESSURE	Background Non-cirrhotic idiopathic portal hypertension (NCIPH) is characterized by splenomegaly, anemia and portal hypertension, while liver function is preserved. However, no animal models have been established yet. This study assessed a rat model of NCIPH and characterized the hemodynamics, and compared it to human NCIPH. Methods Portal pressure (PP) was measured invasively and coloured microspheres were injected in the ileocecal vein in rats. This procedure was performed weekly for 3 weeks (weekly embolization). Rats without and with single embolization served as controls. After four weeks (one week after last embolization), hemodynamics were investigated, hepatic fibrosis and accumulation of myofibroblasts were analysed. General characteristics, laboratory analyses and liver histology were collected in patients with NCIPH. Results Weekly embolization induced a hyperdynamic circulation, with increased PP. The mesenteric flow and hepatic hydroxyproline content was significantly higher in weekly embolized compared to single embolized rats (mesenteric flow +54.1%, hydroxyproline +41.7%). Mesenteric blood flow and shunt volumes increased, whereas splanchnic vascular resistance was decreased in the weekly embolization group. Fibrotic markers alpha SMA and Desmin were upregulated in weekly embolized rats. Discussion This study establishes a model using repetitive embolization via portal veins, comparable with human NCIPH and may serve to test new therapies.	[Klein, Sabine; Hinueber, Christian; Schierwagen, Robert; Uschner, Frank Erhard; Strassburg, Christian P.; Spengler, Ulrich; Trebicka, Jonel] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Hittatiya, Kanishka; Fischer, Hans-Peter] Univ Bonn, Inst Pathol, Bonn, Germany; [Trebicka, Jonel] Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark	University of Bonn; University of Bonn; University of Southern Denmark	Trebicka, J (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.; Trebicka, J (corresponding author), Univ Southern Denmark, Fac Hlth Sci, Odense, Denmark.	jonel.trebicka@ukb.uni-bonn.de	Klein, Sabine/U-1098-2018; Schierwagen, Robert/AAE-6305-2019	Klein, Sabine/0000-0001-6691-2895; Schierwagen, Robert/0000-0002-2195-3666; Uschner, Frank Erhard/0000-0002-3760-2887	Deutsche Forschungsgemeinschaft [SFB TRR57 18]; H. J. & W. Hector Foundation [M60.2]; Ernst-Bertha-Grimke [6/15]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H. J. & W. Hector Foundation; Ernst-Bertha-Grimke	The study was supported by grants from the Deutsche Forschungsgemeinschaft (SFB TRR57 project 18), H. J. & W. Hector Foundation (M60.2), Ernst-Bertha-Grimke (6/15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bayan K, 2009, J THROMB THROMBOLYS, V28, P57, DOI 10.1007/s11239-008-0244-8; Biecker E, 2008, LIVER INT, V28, P331, DOI 10.1111/j.1478-3231.2008.01664.x; Flecknell PA, 1999, VET REC, V144, P65, DOI 10.1136/vr.144.3.65; GERAGHTY JG, 1989, AM J PHYSIOL, V257, pG52, DOI 10.1152/ajpgi.1989.257.1.G52; Grace JA, 2013, GASTROENTEROLOGY, V145, P874, DOI 10.1053/j.gastro.2013.06.036; Granzow M, 2014, HEPATOLOGY, V60, P334, DOI 10.1002/hep.27117; HAKKINEN JP, 1995, CARDIOVASC RES, V29, P74, DOI 10.1016/S0008-6363(96)88549-X; Heller J, 2005, LIVER INT, V25, P657, DOI 10.1111/j.1478-3231.2005.01053.x; Hennenberg M, 2008, GUT, V57, P1300, DOI 10.1136/gut.2007.144584; Hennenberg M, 2009, BRIT J PHARMACOL, V157, P258, DOI 10.1111/j.1476-5381.2009.00158.x; Hennenberg M, 2009, LIVER INT, V29, P933, DOI 10.1111/j.1478-3231.2009.02010.x; Hillaire S, 2002, GUT, V51, P275, DOI 10.1136/gut.51.2.275; Horai Y, 2010, INTERNAL MED, V49, P2013, DOI 10.2169/internalmedicine.49.3834; Khanna R, 2014, J HEPATOL, V60, P421, DOI 10.1016/j.jhep.2013.08.013; Moleda L, 2011, GUT, V60, P1122, DOI 10.1136/gut.2010.226407; Sarin SK, 2002, J GASTROEN HEPATOL, V17, P526, DOI 10.1046/j.1440-1746.2002.02764.x; Sawada S, 2007, J GASTROEN HEPATOL, V22, P204, DOI 10.1111/j.1440-1746.2006.04492.x; Schouten JNL, 2012, ALIMENT PHARM THER, V35, P1424, DOI 10.1111/j.1365-2036.2012.05112.x; Schouten JNL, 2011, HEPATOLOGY, V54, P1071, DOI 10.1002/hep.24422; Siramolpiwat S, 2014, HEPATOLOGY, V59, P2276, DOI 10.1002/hep.26904; Tanaka T, 2013, INTRACTABLE RARE DIS, V2, P94, DOI 10.5582/irdr.2013.v2.3.94; Trebicka J, 2008, HEPATOLOGY, V47, P1264, DOI 10.1002/hep.22170; Trebicka J, 2007, HEPATOLOGY, V46, P242, DOI 10.1002/hep.21673; Trebicka J, 2010, J HEPATOL, V53, P702, DOI 10.1016/j.jhep.2010.04.025; Trebicka J, 2009, HEPATOLOGY, V50, P1924, DOI 10.1002/hep.23222	25	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162144	10.1371/journal.pone.0162144	http://dx.doi.org/10.1371/journal.pone.0162144			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589391	Green Published, gold, Green Submitted			2022-12-26	WOS:000382877800032
J	Steca, P; D'Addario, M; Magrin, ME; Miglioretti, M; Monzani, D; Pancani, L; Sarini, M; Scrignaro, M; Vecchio, L; Fattirolli, F; Giannattasio, C; Cesana, F; Riccobono, SP; Greco, A				Steca, Patrizia; D'Addario, Marco; Magrin, Maria Elena; Miglioretti, Massimo; Monzani, Dario; Pancani, Luca; Sarini, Marcello; Scrignaro, Marta; Vecchio, Luca; Fattirolli, Francesco; Giannattasio, Cristina; Cesana, Francesca; Riccobono, Salvatore Pio; Greco, Andrea			A Type A and Type D Combined Personality Typology in Essential Hypertension and Acute Coronary Syndrome Patients: Associations with Demographic, Psychological, Clinical, and Lifestyle Indicators	PLOS ONE			English	Article							QUALITY-OF-LIFE; ISCHEMIC-HEART-DISEASE; IMPAIRED HEALTH-STATUS; BEHAVIOR PATTERN; ILLNESS PERCEPTION; CARDIOVASCULAR-DISEASE; PSYCHOSOCIAL FACTORS; SELF-EFFICACY; MYOCARDIAL-INFARCTION; CLUSTER-ANALYSIS	Many studies have focused on Type A and Type D personality types in the context of cardiovascular diseases (CVDs), but nothing is known about how these personality types combine to create new profiles. The present study aimed to develop a typology of Type A and Type D personality in two groups of patients affected by and at risk for coronary disease. The study involved 711 patients: 51.6% with acute coronary syndrome, 48.4% with essential hypertension (mean age = 56.4 years; SD = 9.7 years; 70.7% men). Cluster analysis was applied. External variables, such as socio-demographic, psychological, lifestyle, and clinical parameters, were assessed. Six groups, each with its own unique combined personality profile scores, were identified: Type D, Type A-Negatively Affected, Not Type A-Negatively Affected, Socially Inhibited-Positively Affected, Not Socially Inhibited, and Not Type A-Not Type D. The Type A-Negatively Affected cluster and, to a lesser extent, the Type D cluster, displayed the worst profile: namely higher total cardiovascular risk index, physical inactivity, higher anxiety and depression, and lower self-esteem, optimism, and health status. Identifying combined personality profiles is important in clinical research and practice in cardiovascular diseases. Practical implications are discussed.	[Steca, Patrizia; D'Addario, Marco; Magrin, Maria Elena; Miglioretti, Massimo; Monzani, Dario; Pancani, Luca; Sarini, Marcello; Scrignaro, Marta; Vecchio, Luca; Greco, Andrea] Univ Milano Bicocca, Dept Psychol, Milan, Italy; [Fattirolli, Francesco] Univ Florence, Cardiac Rehabil Unit, Dept Med & Surg Crit Care, Florence, Italy; [Fattirolli, Francesco] Azienda Osped Univ Careggi, Florence, Italy; [Giannattasio, Cristina; Cesana, Francesca] Univ Milano Bicocca, Dept Hlth Sci, Milan, Italy; [Giannattasio, Cristina; Cesana, Francesca; Riccobono, Salvatore Pio] Osped Niguarda Ca Granda, Cardiovasc A De Gasperis Dept, Cardiol 4, Milan, Italy	University of Milano-Bicocca; University of Florence; University of Florence; Azienda Ospedaliero Universitaria Careggi; University of Milano-Bicocca; IRCCS Ca Granda Ospedale Maggiore Policlinico; Ospedale Niguarda Ca' Granda	Greco, A (corresponding author), Univ Milano Bicocca, Dept Psychol, Milan, Italy.	andrea.greco@unimib.it	Pancani, Luca/L-9475-2019; Monzani, Dario/AAR-2609-2021; D'Addario, Marco/AAY-6426-2021; Vecchio, Luca/C-1670-2013; Greco, Andrea/I-7266-2016; Monzani, Dario/AAP-4501-2020	Pancani, Luca/0000-0002-7834-3826; Vecchio, Luca/0000-0001-6784-2817; Greco, Andrea/0000-0002-8086-2801; D'ADDARIO, MARCO/0000-0002-7659-885X	Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca" [RBFR08YVUL]	Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca"	This work was supported by the Italian Ministry of Instruction, University and Research - FIRB "Futuro in ricerca" [grant number RBFR08YVUL]; Principal Investigator: PS, http://futuroinricerca.miur.it/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Asadi J. N., 2010, Eastern Mediterranean Health Journal, V16, P740; Al-Lami FH, 1997, RISK FACTORS ANAL MY; Al-Ruzzeh S, 2005, HEART, V91, P1557, DOI 10.1136/hrt.2004.047068; Aldenderfer MS., 1984, CLUSTER ANAL; Andridge RR, 2010, INT STAT REV, V78, P40, DOI 10.1111/j.1751-5823.2010.00103.x; Aquarius AE, 2005, AM J CARDIOL, V96, P996, DOI 10.1016/j.amjcard.2005.05.059; Asendorpf JB, 2001, EUR J PERSONALITY, V15, P169, DOI 10.1002/per.408; BAKER FB, 1975, J AM STAT ASSOC, V70, P31, DOI 10.2307/2285371; BAREFOOT JC, 1983, PSYCHOSOM MED, V45, P59, DOI 10.1097/00006842-198303000-00008; Barefoot JC, 2011, ARCH INTERN MED, V171, P929, DOI 10.1001/archinternmed.2011.41; Barth J, 2015, HEALTH QUAL LIFE OUT, V3, P15; Barth J, 2010, PSYCHOSOM MED, V72, P229, DOI 10.1097/PSY.0b013e3181d01611; Bean D, 2007, PSYCHOL HEALTH, V22, P787, DOI 10.1080/14768320600976240; Bergman LR, 2001, EUR PSYCHOL, V6, P177, DOI 10.1027//1016-9040.6.3.177; Bergman LR, 2003, SERIES PATHS LIFE, V4; Bergman LR, 2002, SPLEINER STAT PACKAG; Bergman LR, 1998, INDIVIDUAL FOCUS DEV; Bertolotti G, 2012, ACT NERV SUPER REDIV, V54, P21; BLUMENTHAL JA, 1978, CIRCULATION, V58, P634, DOI 10.1161/01.CIR.58.4.634; BRACKETT CD, 1988, AM J CARDIOL, V61, P979, DOI 10.1016/0002-9149(88)90110-5; Breckenridge JN, 2000, MULTIVAR BEHAV RES, V35, P261, DOI 10.1207/S15327906MBR3502_5; Breckernridge JN, 1989, APPL PSYCH MEAS, V16, P119; Broadbent E, 2006, J PSYCHOSOM RES, V60, P631, DOI 10.1016/j.jpsychores.2005.10.020; BUCHMAN BP, 1991, J PSYCHOSOM RES, V35, P197, DOI 10.1016/0022-3999(91)90074-X; Carlson ED, 2005, RES NURS HEALTH, V28, P306, DOI 10.1002/nur.20084; CASE RB, 1985, NEW ENGL J MED, V312, P737, DOI 10.1056/NEJM198503213121201; Chauvet-Gelinier JC, DIABETES METABOLISM; CHESNEY M A, 1981, Journal of Behavioral Medicine, V4, P217, DOI 10.1007/BF00844272; Clatworthy J, 2007, PSYCHOL HEALTH, V22, P123, DOI 10.1080/14768320600774496; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Cohen J.E., 1988, STAT POWER ANAL BEHA; Cohen L, 1997, PSYCHOL HEALTH, V12, P619, DOI 10.1080/08870449708407410; Comrey A, 1992, 1 COURSE FACTOR ANAL, V2nd, P2; Conraads VM, 2006, INT J CARDIOL, V113, P34, DOI 10.1016/j.ijcard.2005.10.013; Cosci F, 2012, ADV PSYCHOSOM MED, V32, P133, DOI 10.1159/000330014; Costantini M, 1999, SUPPORT CARE CANCER, V7, P121, DOI 10.1007/s005200050241; Coyne JC, 2012, J PSYCHOSOM RES, V73, P401, DOI 10.1016/j.jpsychores.2012.09.016; Coyne JC, 2011, PSYCHOSOM MED, V73, P557, DOI 10.1097/PSY.0b013e318227ac75; Cronbach LJ, 1951, PSYCHOMETRIKA, V16, P297; Dembroski T M, 1978, J Behav Med, V1, P159, DOI 10.1007/BF00846637; DEMBROSKI TM, 1985, PSYCHOSOM MED, V47, P219, DOI 10.1097/00006842-198505000-00001; DEMBROSKI TM, 1989, PSYCHOSOM MED, V51, P514, DOI 10.1097/00006842-198909000-00003; DENOLLET J, 1995, PSYCHOSOM MED, V57, P582, DOI 10.1097/00006842-199511000-00011; Denollet J, 2000, CIRCULATION, V102, P630, DOI 10.1161/01.CIR.102.6.630; Denollet J, 2006, EUR HEART J, V27, P171, DOI 10.1093/eurheartj/ehi616; Denollet J, 2005, PSYCHOSOM MED, V67, P89, DOI 10.1097/01.psy.0000149256.81953.49; Denollet J, 2000, J PSYCHOSOM RES, V49, P255, DOI 10.1016/S0022-3999(00)00177-X; Denollet J, 1998, CIRCULATION, V97, P167, DOI 10.1161/01.CIR.97.2.167; Denollet J, 1996, LANCET, V347, P417, DOI 10.1016/S0140-6736(96)90007-0; DIAMOND EL, 1982, PSYCHOL BULL, V92, P410, DOI 10.1037/0033-2909.92.2.410; DIMSDALE JE, 1978, AM J CARDIOL, V42, P583, DOI 10.1016/0002-9149(78)90627-6; DIMSDALE JE, 1981, AM J CARDIOL, V47, P73, DOI 10.1016/0002-9149(81)90292-7; Ford ES, 2007, NEW ENGL J MED, V356, P2388, DOI 10.1056/NEJMsa053935; Frasure-Smith N, 2008, ARCH GEN PSYCHIAT, V65, P62, DOI 10.1001/archgenpsychiatry.2007.4; FRIEDMAN HS, 1987, AM PSYCHOL, V42, P539, DOI 10.1037/0003-066X.42.6.539; FRIEDMAN M, 1959, JAMA-J AM MED ASSOC, V169, P1286, DOI 10.1001/jama.1959.03000290012005; FRIEDMAN M, 1977, B NEW YORK ACAD MED, V53, P593; Gallacher JEJ, 2003, PSYCHOSOM MED, V65, P339, DOI 10.1097/01.PSY.0000041608.55974.A8; Gallagher J, 2015, CURR CARDIOL REP, V17, DOI 10.1007/s11886-015-0667-8; GIOVANNUCCI E, 1991, AM J EPIDEMIOL, V133, P810; Goldston K, 2008, CLIN PSYCHOL REV, V28, P288, DOI 10.1016/j.cpr.2007.05.005; Gore SW., 2000, ENHANCING STUDENTS E; Graham I, 2007, EUR HEART J, V28, P2375, DOI 10.1093/eurheartj/ehm316; Grande G, 2012, ANN BEHAV MED, V43, P299, DOI 10.1007/s12160-011-9339-0; Grande G, 2011, PSYCHOSOM MED, V73, P548, DOI 10.1097/PSY.0b013e318227a9bc; Greco A, 2014, INT J BEHAV MED, V21, P221, DOI 10.1007/s12529-013-9290-5; Greco A, 2015, BEHAV MED, V41, P9, DOI 10.1080/08964289.2013.855159; Gremigni P., 2005, PSICOTER COGN COMPOR, V11, P7, DOI DOI 10.13140/2.1.2918.9765; Gulliksson M, 2011, ARCH INTERN MED, V171, P134, DOI 10.1001/archinternmed.2010.510; HAYNES SG, 1978, AM J EPIDEMIOL, V107, P362, DOI 10.1093/oxfordjournals.aje.a112556; HAYNES SG, 1980, AM J EPIDEMIOL, V111, P37, DOI 10.1093/oxfordjournals.aje.a112873; Hemingway H, 1999, BMJ-BRIT MED J, V318, P1460, DOI 10.1136/bmj.318.7196.1460; HIGUCHI S, 1994, ALCOHOL CLIN EXP RES, V18, P305, DOI 10.1111/j.1530-0277.1994.tb00018.x; HOWARD JH, 1976, J HUM STRESS, V2, P24, DOI 10.1080/0097840X.1976.9937486; Hu J, 2008, MENTAL HLTH NURSING, V29, P895, DOI DOI 10.1080/01612840802182938; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; HUBERT LJ, 1976, PSYCHOL BULL, V83, P1072, DOI 10.1037/0033-2909.83.6.1072; IRVINE J, 1991, HYPERTENSION, V18, P72, DOI 10.1161/01.HYP.18.1.72; Jamil G, 2013, AM J CARDIOVASC DIS, V3, P163; JOHNSTON DW, 1993, J ROY SOC MED, V86, P406; JULKUNEN J, 1993, J PSYCHOSOM RES, V37, P11, DOI 10.1016/0022-3999(93)90119-Z; Keltikangas-Jarvinen L, 1999, ARTERIOSCL THROM VAS, V19, P1998, DOI 10.1161/01.ATV.19.8.1998; KIRKCALDY BD, 1993, PERS INDIV DIFFER, V15, P69, DOI 10.1016/0191-8869(93)90042-2; KORNITZER M, 1981, PSYCHOSOM MED, V43, P133, DOI 10.1097/00006842-198104000-00005; Kuper Hannah, 2002, Semin Vasc Med, V2, P267, DOI 10.1055/s-2002-35401; Kupper N, 2013, INT J CARDIOL, V166, P327, DOI 10.1016/j.ijcard.2011.10.084; Leach LS, 2008, SOC PSYCH PSYCH EPID, V43, P983, DOI 10.1007/s00127-008-0388-z; Lenzen MJ, 2007, HEART, V93, P339, DOI 10.1136/hrt.2005.086868; Leventhal H., 1984, HDB PSYCHOL HLTH, P219, DOI DOI 10.1201/9781003044307-9; Logan JG, 2008, J CLIN NURS, V17, P201, DOI 10.1111/j.1365-2702.2008.02347.x; Madden T. E, 2000, GENDER EMOTION SOCIA, P277, DOI DOI 10.1017/CBO9780511628191; Maes S, 2005, APPL PSYCHOL-INT REV, V54, P267, DOI 10.1111/j.1464-0597.2005.00210.x; Magnusson D, 1998, METHODS AND MODELS FOR STUDYING THE INDIVIDUAL, P33; MAGNUSSON D, 1992, EUR J PERSONALITY, V6, P119, DOI 10.1002/per.2410060205; Mancia G, 2013, J HYPERTENS, V31, P1281, DOI 10.1097/01.hjh.0000431740.32696.cc; Martens EJ, 2010, J CLIN PSYCHIAT, V71, P778, DOI 10.4088/JCP.08m04765blu; Maruta T., 2000, MAYO CLIN P, V75, P318, DOI DOI 10.4065/75.2.140; Matthews G, 2003, EUR J PERSONALITY, V17, P157, DOI 10.1002/per.476; MATTHEWS KA, 1988, PSYCHOL BULL, V104, P373, DOI 10.1037/0033-2909.104.3.373; MATTHEWS KA, 1977, J CHRON DIS, V30, P489, DOI 10.1016/0021-9681(77)90071-6; MILLIGAN GW, 1981, PSYCHOMETRIKA, V46, P187, DOI 10.1007/BF02293899; Mols F, 2012, J PSYCHOSOM RES, V73, P232, DOI 10.1016/j.jpsychores.2012.07.004; Mommersteeg PMC, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-714; Monzani D, 2014, J ADOLESCENCE, V37, P97, DOI 10.1016/j.adolescence.2013.11.006; Muthen L. K., 2017, MPLUS USERS GUIDE, DOI DOI 10.1111/J.1600-0447.2011.01711.X; Myrtek M, 2001, INT J CARDIOL, V79, P245, DOI 10.1016/S0167-5273(01)00441-7; MYRTEK M, 1995, PERS INDIV DIFFER, V18, P491, DOI 10.1016/0191-8869(94)00197-Z; Nadkarni S, 2011, ARTERIOSCL THROM VAS, V31, P2749, DOI 10.1161/ATVBAHA.111.235176; Oginska-Bulik N., 2014, POLISH J APPL PSYCHO, V12, P29; Orth-Gomer K, 2009, CIRC-CARDIOVASC QUAL, V2, P25, DOI 10.1161/CIRCOUTCOMES.108.812859; Pain D, 2006, PSICOLOGIA SALUTE, V1, P81, DOI DOI 10.1400/91143; Pedersen SS, 2004, J PSYCHOSOM RES, V57, P265, DOI 10.1016/S0022-3999(03)00614-7; Pedersen SS, 2007, INT J CARDIOL, V114, P358, DOI 10.1016/j.ijcard.2005.12.018; Pedersen SS, 2006, J PSYCHOSOM RES, V61, P783, DOI 10.1016/j.jpsychores.2006.06.009; Perbandt K, 2006, PSYCHOTHER PSYCH MED, V56, P310, DOI 10.1055/s-2006-932663; Perk Joep, 2012, Int J Behav Med, V19, P403, DOI [10.1016/j.atherosclerosis.2012.05.007, 10.1093/eurheartj/ehs092, 10.1007/s12529-012-9242-5]; Piepoli MF, 2010, EUR J CARDIOV PREV R, V17, P1, DOI 10.1097/HJR.0b013e3283313592; Raibhoge CM, 2015, INT J ADV HLTH SCI, V5, P86; Ritzel RM, 2013, HORM BEHAV, V63, P238, DOI 10.1016/j.yhbeh.2012.04.007; ROHLFS J, 1974, BELL J ECON, V5, P16, DOI 10.2307/3003090; Rosenberg M., 1965, SOC ADOLESCENT SELF, DOI 10.1515/9781400876136; ROSENMAN RH, 1964, JAMA-J AM MED ASSOC, V189, P15; ROSENMAN RH, 1975, JAMA-J AM MED ASSOC, V233, P872, DOI 10.1001/jama.233.8.872; ROSENMAN RH, 1961, CIRCULATION, V24, P1173, DOI 10.1161/01.CIR.24.5.1173; ROTH PL, 1994, PERS PSYCHOL, V47, P537, DOI 10.1111/j.1744-6570.1994.tb01736.x; Rozanski A, 2005, J AM COLL CARDIOL, V45, P637, DOI 10.1016/j.jacc.2004.12.005; Rumsfeld JS, 1999, JAMA-J AM MED ASSOC, V281, P1298, DOI 10.1001/jama.281.14.1298; SCHEIER MF, 1994, J PERS SOC PSYCHOL, V67, P1063, DOI 10.1037/0022-3514.67.6.1063; Schiffer AA, 2008, EUR J HEART FAIL, V10, P802, DOI 10.1016/j.ejheart.2008.06.012; Schiffer AA, 2007, HEART, V93, P814, DOI 10.1136/hrt.2006.102822; Scholte RHJ, 2005, MERRILL PALMER QUART, V51, P258, DOI 10.1353/mpq.2005.0019; Schroeder KE, 2000, HYPERTENSION, V36, P830, DOI 10.1161/01.HYP.36.5.830; SCHWARZER R, 1994, PSYCHOL HEALTH, V9, P161, DOI 10.1080/08870449408407475; SEEMAN TE, 1987, PSYCHOSOM MED, V49, P341, DOI 10.1097/00006842-198707000-00003; Sharma A., 2012, ADV ASIAN SOCIAL SCI, V3, P751; Sharma Jogendra, 2012, Nurs J India, V103, P245; Shek DTL, 1997, SOC BEHAV PERSONAL, V25, P277, DOI 10.2224/sbp.1997.25.3.277; SHEKELLE RB, 1976, J CHRON DIS, V29, P381, DOI 10.1016/0021-9681(76)90059-X; SHEKELLE RB, 1983, PSYCHOSOM MED, V45, P109, DOI 10.1097/00006842-198305000-00003; Shin Jinho, 2014, Hanyang Medical Reviews, V34, P72, DOI 10.7599/hmr.2014.34.2.72; Sirri L, 2007, J PERS ASSESS, V89, P216, DOI 10.1080/00223890701629649; Smith DF, 1996, SCAND J PSYCHOL, V37, P249, DOI 10.1111/j.1467-9450.1996.tb00657.x; Smith GCS, 2006, PEDIATRICS, V117, P60, DOI 10.1542/peds.2004-2828; Soto GE, 2004, CIRCULATION, V110, P546, DOI 10.1161/01.CIR.0000136991.85540.A9; Spertus JA, 2002, CIRCULATION, V106, P43, DOI 10.1161/01.CIR.0000020688.24874.90; Staniute M, 2015, HEALTH QUAL LIFE OUT, V13, DOI 10.1186/s12955-014-0204-2; Steca P, 2013, PSYCHOL HEALTH, V28, P765, DOI 10.1080/08870446.2012.759223; Steca P, 2014, ASSESSMENT, V22, P1; Steca P, 2015, APPL PSYCHOL HLTH WE; Svansdottir E, 2012, J BEHAV MED, V35, P155, DOI 10.1007/s10865-011-9337-5; Tan PN, 2006, INTRO DATA MINING, p[227, 276, 633]; Thomas F, 2001, HYPERTENSION, V37, P1256, DOI 10.1161/01.HYP.37.5.1256; Tinsley HEA, 2000, HDB APPL MULTIVARIAT, DOI [10.1016/B978-012691360-6/50002-1, DOI 10.1016/B978-012691360-6/50002-1, 10.1016/b978-012691360-6/50002-1]; Topolski Tari D, 2006, Prev Chronic Dis, V3, pA118; Trichopoulou A, 2003, NEW ENGL J MED, V348, P2599, DOI 10.1056/NEJMoa025039; Trovato GM, 2012, CLIN TER, V163, P281; VOGT TM, 1992, J CLIN EPIDEMIOL, V45, P659, DOI 10.1016/0895-4356(92)90138-D; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; WATSON D, 1988, J ABNORM PSYCHOL, V97, P346, DOI 10.1037/0021-843X.97.3.346; Weatherall M, 2010, EUR RESPIR J, V36, P472, DOI 10.1183/09031936.00035210; Welin C, 2000, J INTERN MED, V247, P629, DOI 10.1046/j.1365-2796.2000.00694.x; Whalley B, 2014, INT J BEHAV MED, V21, P109, DOI 10.1007/s12529-012-9282-x; Williams L, 2012, J PSYCHOSOM RES, V72, P422, DOI 10.1016/j.jpsychores.2012.02.007; Williams L, 2011, J PSYCHOSOM RES, V70, P141, DOI 10.1016/j.jpsychores.2010.07.015; Williams PG, 2002, PERS SOC PSYCHOL B, V28, P1015, DOI 10.1177/01461672022811001; Wilsnack RW, 2009, ADDICTION, V104, P1487, DOI 10.1111/j.1360-0443.2009.02696.x; WILSON IB, 1995, JAMA-J AM MED ASSOC, V273, P59, DOI 10.1001/jama.273.1.59; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zotti AM., 2000, LINEE GUIDA SCREENIN	170	14	15	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161840	10.1371/journal.pone.0161840	http://dx.doi.org/10.1371/journal.pone.0161840			28	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589065	Green Published, gold			2022-12-26	WOS:000382877800020
J	Medeiros, CR; Hepp, LU; Patricio, J; Molozzi, J				Medeiros, Carlinda Railly; Hepp, Luiz Ubiratan; Patricio, Joana; Molozzi, Joseline			Tropical Estuarine Macrobenthic Communities Are Structured by Turnover Rather than Nestedness	PLOS ONE			English	Article							STREAM MACROINVERTEBRATE COMMUNITIES; BETA-DIVERSITY; SPECIES-DIVERSITY; SALINITY; ORGANIZATION; LANDSCAPES; SIMILARITY; FRAMEWORK; SEDIMENTS; RICHNESS	Turnover (i.e., species substitution) and nestedness (i.e., subsets of species from more diverse locations), the two main mechanisms used to explain the beta diversity of biological communities, have different implications for biodiversity conservation. To better understand how these mechanisms contribute to beta diversity, we tested the following hypotheses: (i) greater dissimilarity in community composition occurs between estuarine zones than other hierarchical level studied; (ii) beta diversity in these communities develops by turnover in estuaries with a lower degree of anthropogenic impact, but by nestedness in estuaries with a greater degree of anthropogenic impact; and (iii) the structuring mechanism is independent of season. We studied two tropical estuaries (dry and wet seasons) that vary in terms of land-use of the drainage basins. Subtidal benthic macroinvertebrates were sampled along the estuarine gradient in each of the two estuaries. The additive partitioning approach to species diversity was used to determine the hierarchical scale with the greatest dissimilarity in community composition. General beta diversity was measured using the Sorensen dissimilarity index, partitioning the turnover and nestedness components. The greatest dissimilarity in the composition of the communities occurred between the zones along the estuarine gradient in both seasons (dry = 58.6%; wet = 46.3%). In the estuary with a lower degree of anthropogenic influence, benthic macroinvertebrate diversity was generated by turnover regardless of the season. In the estuary with a greater degree of anthropogenic impact, beta diversity was structured by turnover during the dry season and a combination of both mechanisms during the wet season. We conclude that turnover is the principal mechanism responsible for beta diversity in benthic macroinvertebrate communities in tropical estuaries.	[Medeiros, Carlinda Railly] State Univ Paraiba, Postgrad Program Ecol & Conservat, Campina Grande, Paraiba, Brazil; [Hepp, Luiz Ubiratan] Integrated Reg Univ Alto Uruguai & Missoes, Dept Biol Sci, Erechim, RS, Brazil; [Patricio, Joana] Univ Coimbra, Sch Sci & Technol, MARE Ctr Marine & Environm Sci, Coimbra, Portugal; [Molozzi, Joseline] State Univ Paraiba, Dept Biol Sci, Campina Grande, Paraiba, Brazil	Universidade Estadual da Paraiba; Universidade Regional Integrada do Alto Uruguai e das Missoes (URI); Universidade de Coimbra; Universidade Estadual da Paraiba	Medeiros, CR (corresponding author), State Univ Paraiba, Postgrad Program Ecol & Conservat, Campina Grande, Paraiba, Brazil.	carlindarailly@gmail.com	Medeiros, Carlinda Raílly/AAW-2991-2021; Molozzi, Joseline/M-3951-2014; Hepp, Luiz Ubiratan/H-9133-2012	Medeiros, Carlinda Raílly/0000-0002-7332-2399; Molozzi, Joseline/0000-0002-8256-5739; Hepp, Luiz Ubiratan/0000-0002-8499-9549	"What lessons can we draw from the ecological functioning of estuarine systems in Paraiba? Analyses of the effects of natural and anthropogenic disturbances", under the Brazilian program Science Without Borders (Special Visiting Researcher) [173/2012]; Conselho Nacional de Pesquisa e Desenvolvimento (CNPq) [471272/2012-8]	"What lessons can we draw from the ecological functioning of estuarine systems in Paraiba? Analyses of the effects of natural and anthropogenic disturbances", under the Brazilian program Science Without Borders (Special Visiting Researcher); Conselho Nacional de Pesquisa e Desenvolvimento (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ))	This study was funded by Project No. 173/2012 "What lessons can we draw from the ecological functioning of estuarine systems in Paraiba? Analyses of the effects of natural and anthropogenic disturbances", under the Brazilian program Science Without Borders (Special Visiting Researcher). LUH received financial support from Conselho Nacional de Pesquisa e Desenvolvimento (CNPq proc. # 471272/2012-8). We are grateful to the Universidade Estadual da Paraiba, Laboratorio de Ecologia de Bentos and Laboratorio de Ecologia Aquatica for technical support, and to Dr. Paulo Lana for his help in identifying the polychaetes. Dr. A. Leyva helped with English editing of the manuscript.	AESA-Agencia executiva de gestao das aguas do estado da paraiba, 2014, CHUV AC AN MUN RIO T; Alves AS, 2013, ECOL INDIC, V24, P462, DOI 10.1016/j.ecolind.2012.07.013; Alves RRD, 2003, INTERCIENCIA, V28, P36; Amaral A.C., 1996, ANNELIDA POLYCHAETA; Amaral A. Cecilia Z., 1998, Revista Brasileira de Biologia, V58, P307; Anderson MJ, 2011, ECOL LETT, V14, P19, DOI 10.1111/j.1461-0248.2010.01552.x; Angeler DG, 2013, DIVERS DISTRIB, V19, P772, DOI 10.1111/ddi.12029; Attrill MJ, 2002, J ANIM ECOL, V71, P262, DOI 10.1046/j.1365-2656.2002.00593.x; Barros F, 2014, ESTUAR COAST SHELF S, V149, P223, DOI 10.1016/j.ecss.2014.08.025; Baselga A, 2007, ECOGRAPHY, V30, P838, DOI 10.1111/j.2007.0906-7590.05191.x; Baselga A, 2012, METHODS ECOL EVOL, V3, P808, DOI 10.1111/j.2041-210X.2012.00224.x; Baselga A, 2010, GLOBAL ECOL BIOGEOGR, V19, P134, DOI 10.1111/j.1466-8238.2009.00490.x; Blanchet H, 2014, J SEA RES, V90, P95, DOI 10.1016/j.seares.2014.02.014; Bleich S, 2011, MAR ECOL PROG SER, V436, P101, DOI 10.3354/meps09219; Boyero L, 2001, HYDROBIOLOGIA, V464, P219, DOI 10.1023/A:1013922307096; Cartier V., 2011, Journal of Experimental Marine Biology and Ecology, V405, P93, DOI 10.1016/j.jembe.2011.05.019; Costa RS, 2015, MARINE FRESHWATER RE, V1, P1; Cottenie K, 2005, ECOL LETT, V8, P1175, DOI 10.1111/j.1461-0248.2005.00820.x; Crist TO, 2003, AM NAT, V162, P734, DOI 10.1086/378901; Diaz-Jaramillo M, 2013, SCI TOTAL ENVIRON, V442, P198, DOI 10.1016/j.scitotenv.2012.10.039; Elliott M, 2007, MAR POLLUT BULL, V54, P640, DOI 10.1016/j.marpolbul.2007.02.003; Guedes L., 2011, AN 15 S BRAS SENS RE, P3538; Gutierrez-Canovas C, 2013, GLOBAL ECOL BIOGEOGR, V22, P796, DOI 10.1111/geb.12060; HARRISON S, 1992, J ANIM ECOL, V61, P151, DOI 10.2307/5518; Heino J, 2007, ECOGRAPHY, V30, P217, DOI 10.1111/j.2007.0906-7590.04894.x; Heino J, 2015, ECOL EVOL, V5, P1235, DOI 10.1002/ece3.1439; Heino J, 2015, FRESHWATER BIOL, V60, P223, DOI 10.1111/fwb.12502; Heino J, 2014, CURR OPIN INSECT SCI, V2, P7, DOI 10.1016/j.cois.2014.06.002; Hepp LU, 2013, HYDROBIOLOGIA, V703, P239, DOI 10.1007/s10750-012-1367-7; Hewitt JE, 2005, ECOLOGY, V86, P1619, DOI 10.1890/04-1099; Josefson AB, 2004, GLOBAL ECOL BIOGEOGR, V13, P273, DOI 10.1111/j.1466-822X.2004.00091.x; Josefson AB, 2013, J BIOGEOGR, V40, P1000, DOI 10.1111/jbi.12047; Koppen W., 1930, HDB KLIMATOLOGIE; Kraft NJB, 2015, FUNCT ECOL, V29, P592, DOI 10.1111/1365-2435.12345; Lamouroux N, 2004, J N AM BENTHOL SOC, V23, P449, DOI 10.1899/0887-3593(2004)023<0449:BTOSMC>2.0.CO;2; Lande R, 1996, OIKOS, V76, P5, DOI 10.2307/3545743; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; Marcelino RL, 2005, TROPICAL OCEANOGRAPH, V33, P183; Mikkelsen PM, 2008, SEASHELLS SO FLORIDA; Mil-Homens M, 2014, MAR POLLUT BULL, V84, P135, DOI 10.1016/j.marpolbul.2014.05.026; Oksanen J., 2015, VEGAN COMMUNITY ECOL, V22-1, P1; Poff NL, 1997, J N AM BENTHOL SOC, V16, P391, DOI 10.2307/1468026; Puente A, 2008, ECOL INDIC, V8, P373, DOI 10.1016/j.ecolind.2007.04.002; R Core Team, 2013, R LANG ENV STAT COMP; Remane A., 1934, Verhandlungen der Deutschen Zoologischen Gesellschaft Leipzig, V37, P34; RIOS E.C., 1985, SEASHELLS BRAZIL; Rundle S. D., 1998, Aquatic Ecology, V32, P211, DOI 10.1023/A:1009934828611; Si X, 2015, PLOS ONE, V10, P1, DOI DOI 10.1371/J0URNAL.P0NE.0132708; Sousa R, 2008, AQUAT CONSERV, V18, P1063, DOI 10.1002/aqc.871; Trivinho-Strixino S., 2011, LARVAS CHIRONOMIDAE, P1; TUNNELL JR J.W., 2010, ENCY TEXAS SEASHELLS; Van De Meutter F, 2007, ECOLOGY, V88, P1687, DOI 10.1890/06-0333.1; Veech JA, 2009, PARTITION SOFTWARE H; Vellend M, 2010, Q REV BIOL, V85, P183, DOI 10.1086/652373; WHITTAKER R H, 1972, Taxon, V21, P213, DOI 10.2307/1218190; WHITTAKER ROBERT H., 1960, ECOL MONOGR, V30, P279, DOI 10.2307/1943563; Wiens JA, 2002, FRESHWATER BIOL, V47, P501, DOI 10.1046/j.1365-2427.2002.00887.x; WRIGHT DH, 1992, OECOLOGIA, V92, P416, DOI 10.1007/BF00317469; Zonta R, 2007, MAR POLLUT BULL, V55, P403, DOI 10.1016/j.marpolbul.2007.09.003	60	23	24	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161082	10.1371/journal.pone.0161082	http://dx.doi.org/10.1371/journal.pone.0161082			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584726	Green Published, gold, Green Submitted			2022-12-26	WOS:000382855600013
J	Subramani, J; Kundumani-Sridharan, V; Hilgers, RHP; Owens, C; Das, KC				Subramani, Jaganathan; Kundumani-Sridharan, Venkatesh; Hilgers, Rob H. P.; Owens, Cade; Das, Kumuda C.			Thioredoxin Uses a GSH-independent Route to Deglutathionylate Endothelial Nitric-oxide Synthase and Protect against Myocardial Infarction	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						endothelial dysfunction; glutathionylation; heart failure; ischemia; myocardial infarction; nitric-oxide synthase; thioredoxin; thioredoxin reductase; reperfusion	OXIDATIVE STRESS; ISCHEMIA/REPERFUSION INJURY; S-GLUTATHIONYLATION; VASCULAR-DISEASE; CARDIOVASCULAR-DISEASES; ENDOGENOUS THIOREDOXIN; SUPEROXIDE-DISMUTASE; REPERFUSION INJURY; GENE-EXPRESSION; NO SYNTHASE	Reversible glutathionylation plays a critical role in protecting protein function under conditions of oxidative stress generally and for endothelial nitric-oxide synthase (eNOS) specifically. Glutathione-dependent glutaredoxin-mediated deglutathionylation of eNOS has been shown to confer protection in a model of heart damage termed ischemia-reperfusion injury, motivating further study of eNOS deglutathionylation in general. In this report, we present evidence for an alternative mechanism of deglutathionylation. In this pathway thioredoxin (Trx), a small cellular redox protein, is shown to rescue eNOS from glutathionylation during ischemia-reperfusion in a GSH-independent manner. By comparing mice with global overexpression of Trx and mice with cardiomyocyte-specific overexpression of Trx, we demonstrate that vascular Trx-mediated deglutathionylation of eNOS protects against ischemia-reperfusion-mediated myocardial infarction. Trx deficiency in endothelial cells promoted eNOS glutathionylation and reduced its enzymatic activity, whereas increased levels of Trx led to deglutathionylated eNOS. Thioredoxin-mediated deglutathionylation of eNOS in the coronary artery in vivo protected against reperfusion injury, even in the presence of normal levels of GSH. We further show that Trx directly interacts with eNOS, and we confirmed that Cys-691 and Cys-910 are the glutathionylated sites, as mutation of these cysteines partially rescued the decrease in eNOS activity, whereas mutation of a distal site, Cys-384, did not. Collectively, this study shows for the first time that Trx is a potent deglutathionylating protein in vivo and in vitro that can deglutathionylate proteins in the presence of high levels of GSSG in conditions of oxidative stress.	[Subramani, Jaganathan; Kundumani-Sridharan, Venkatesh; Hilgers, Rob H. P.; Owens, Cade; Das, Kumuda C.] Texas Tech Univ, Dept Anesthesiol, Hlth Sci Ctr, 3601 4th St,STOP 6598, Lubbock, TX 79430 USA	Texas Tech University System; Texas Tech University; Texas Tech University Health Science Center	Das, KC (corresponding author), Texas Tech Univ, Dept Anesthesiol, Hlth Sci Ctr, 3601 4th St,STOP 6598, Lubbock, TX 79430 USA.	kumuda.das@ttuhsc.edu	Kundumani-Sridharan, Venkatesh/AAB-4535-2020; Kundumani-Sridharan, Venkatesh/ABD-9613-2021	Kundumani-Sridharan, Venkatesh/0000-0002-6134-4371; Subramani, Jaganathan/0000-0002-5707-8621	National Institutes of Health [HL 1R01HL107885, 1R01HL109397]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL107885, R01HL109397] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health Grants HL 1R01HL107885 and 1R01HL109397 (to K. C. D.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bohl S, 2009, AM J PHYSIOL-HEART C, V297, pH2054, DOI 10.1152/ajpheart.00836.2009; Brunner F, 2001, CIRCULATION, V104, P3097, DOI 10.1161/hc5001.101966; Cai H, 2000, CIRC RES, V87, P840, DOI 10.1161/01.RES.87.10.840; Chen CA, 2013, BIOCHEMISTRY-US, V52, P6712, DOI 10.1021/bi400404s; Chen CA, 2010, NATURE, V468, P1115, DOI 10.1038/nature09599; Chrestensen CA, 2000, J BIOL CHEM, V275, P26556, DOI 10.1074/jbc.M004097200; Das KC, 2000, BIOCHEM BIOPH RES CO, V277, P443, DOI 10.1006/bbrc.2000.3689; Das KC, 1999, AM J PHYSIOL-LUNG C, V276, pL530, DOI 10.1152/ajplung.1999.276.3.L530; Das KC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073358; De Pascali F, 2014, BIOCHEMISTRY-US, V53, P3679, DOI 10.1021/bi500076r; Duncan MC, 2001, NAT CELL BIOL, V3, P687, DOI 10.1038/35083087; Fernandes AP, 2004, ANTIOXID REDOX SIGN, V6, P63, DOI 10.1089/152308604771978354; Forstermann U, 2008, NAT CLIN PRACT CARD, V5, P338, DOI 10.1038/ncpcardio1211; Gallogly MM, 2007, CURR OPIN PHARMACOL, V7, P381, DOI 10.1016/j.coph.2007.06.003; Godecke A, 2001, J PHYSIOL-LONDON, V532, P195, DOI 10.1111/j.1469-7793.2001.0195g.x; Hilgers RHP, 2015, HYPERTENSION, V65, P130, DOI 10.1161/HYPERTENSIONAHA.114.04473; Ho YS, 2007, FREE RADICAL BIO MED, V43, P1299, DOI 10.1016/j.freeradbiomed.2007.07.025; HOLMGREN A, 1985, ANNU REV BIOCHEM, V54, P237, DOI 10.1146/annurev.bi.54.070185.001321; HOLMGREN A, 1995, METHOD ENZYMOL, V252, P199; Holmgren Arne, 2000, Biofactors, V11, P63; Holmgren A, 2000, ANTIOXID REDOX SIGN, V2, P811, DOI 10.1089/ars.2000.2.4-811; Hsieh PCH, 2006, ANNU REV PHYSIOL, V68, P51, DOI 10.1146/annurev.physiol.68.040104.124629; Jin YX, 2012, METHODS MOL BIOL, V843, P147, DOI 10.1007/978-1-61779-523-7_14; Kanno S, 2000, CIRCULATION, V101, P2742, DOI 10.1161/01.CIR.101.23.2742; Karbach S, 2014, CURR PHARM DESIGN, V20, P3579, DOI 10.2174/13816128113196660748; Kasuno K, 2003, KIDNEY INT, V64, P1273, DOI 10.1046/j.1523-1755.2003.00224.x; Kundumani-Sridharan V, 2015, J BIOL CHEM, V290, P17505, DOI 10.1074/jbc.M115.660365; Kuramochi Y, 2004, J BIOL CHEM, V279, P51141, DOI 10.1074/jbc.M408662200; LAURENT TC, 1964, J BIOL CHEM, V239, P3436; Lee MCI, 2014, BIOCHEMISTRY-US, V53, P6615, DOI 10.1021/bi500582r; LEFER AM, 1991, FASEB J, V5, P2029, DOI 10.1096/fasebj.5.7.2010056; Li HG, 2013, CURR OPIN PHARMACOL, V13, P161, DOI 10.1016/j.coph.2013.01.006; Louch WE, 2011, J MOL CELL CARDIOL, V51, P288, DOI 10.1016/j.yjmcc.2011.06.012; Muniyappa H, 2009, J BIOL CHEM, V284, P17069, DOI 10.1074/jbc.M109.008557; O'Connell Timothy D, 2007, Methods Mol Biol, V357, P271; Otani H, 2009, ANTIOXID REDOX SIGN, V11, P1913, DOI [10.1089/ars.2009.2453, 10.1089/ARS.2009.2453]; Petroff MGV, 2001, NAT CELL BIOL, V3, P867, DOI 10.1038/ncb1001-867; Pinto AR, 2016, CIRC RES, V118, P400, DOI 10.1161/CIRCRESAHA.115.307778; Qian J, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00347; Ravi D, 2005, J BIOL CHEM, V280, P40084, DOI 10.1074/jbc.M507192200; Sadek HA, 2003, ARCH BIOCHEM BIOPHYS, V420, P201, DOI 10.1016/j.abb.2003.09.029; Schiffrin EL, 2008, HYPERTENSION, V51, P31, DOI 10.1161/HYPERTENSIONAHA.107.103226; Schulz R, 2004, CARDIOVASC RES, V61, P402, DOI 10.1016/j.cardiores.2003.09.019; Shelton MD, 2005, ANTIOXID REDOX SIGN, V7, P348, DOI 10.1089/ars.2005.7.348; Sowa G, 1999, J BIOL CHEM, V274, P22524, DOI 10.1074/jbc.274.32.22524; Thomas SR, 2008, ANTIOXID REDOX SIGN, V10, P1713, DOI 10.1089/ars.2008.2027; Vanhoutte PM, 2009, ACTA PHYSIOL, V196, P193, DOI 10.1111/j.1748-1716.2009.01964.x; Yamamoto M, 2003, J CLIN INVEST, V112, P1395, DOI 10.1172/JCI200317700; Zhao YY, 1998, J BIOL CHEM, V273, P10261, DOI 10.1074/jbc.273.17.10261; Zweier JL, 2011, ANTIOXID REDOX SIGN, V14, P1769, DOI 10.1089/ars.2011.3904	50	27	27	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23374	23389		10.1074/jbc.M116.745034	http://dx.doi.org/10.1074/jbc.M116.745034			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27587398	Green Published, hybrid			2022-12-26	WOS:000387884400002
J	Wylezinski, LS; Hawiger, J				Wylezinski, Lukasz S.; Hawiger, Jacek			Interleukin 2 Activates Brain Microvascular Endothelial Cells Resulting in Destabilization of Adherens Junctions	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NF-KAPPA-B; VE-CADHERIN; TYROSINE PHOSPHORYLATION; VASCULAR-PERMEABILITY; RECEPTOR COMPLEX; BARRIER FUNCTION; UP-REGULATION; BETA-CATENIN; IN-VIVO; P120-CATENIN	The pleiotropic cytokine interleukin 2 (IL2) disrupts the blood-brain barrier and alters brain microcirculation, underlying vascular leak syndrome that complicates cancer immunotherapy with IL2. The microvascular effects of IL2 also play a role in the development of multiple sclerosis and other chronic neurological disorders. The mechanism of IL2-induced disruption of brain microcirculation has not been determined previously. We found that both human and murine brain microvascular endothelial cells express constituents of the IL2 receptor complex. Then we established that signaling through this receptor complex leads to activation of the transcription factor, nuclear factor kappa B, resulting in expression of proinflammatory interleukin 6 and monocyte chemoattractant protein 1. We also discovered that IL2 induces disruption of adherens junctions, concomitant with cytoskeletal reorganization, ultimately leading to increased endothelial cell permeability. IL2-induced phosphorylation of vascular endothelial cadherin (VE-cadherin), a constituent of adherens junctions, leads to dissociation of its stabilizing adaptor partners, p120-catenin and beta-catenin. Increased phosphorylation of VE-cadherin was also accompanied by a reduction of Src homology 2 domain-containing protein-tyrosine phosphatase 2, known to maintain vascular barrier function. These results unravel the mechanism of deleterious effects induced by IL2 on brain microvascular endothelial cells and may inform the development of new measures to improve IL2 cancer immunotherapy, as well as treatments for autoimmune diseases affecting the central nervous system.	[Wylezinski, Lukasz S.; Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Mol Physiol & Biophys, Div Allergy Pulm & Crit Care Med,Sch Med, Nashville, TN 37232 USA; [Hawiger, Jacek] Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med,Sch Med, 1161 21st Ave South,T1218 MCN, Nashville, TN 37232 USA; [Hawiger, Jacek] Tennessee Valley Healthcare Syst, Dept Vet Affairs, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Hawiger, J (corresponding author), Vanderbilt Univ, Med Ctr, Dept Med, Div Allergy Pulm & Crit Care Med,Sch Med, 1161 21st Ave South,T1218 MCN, Nashville, TN 37232 USA.	jacek.hawiger@vanderbilt.edu		Wylezinski, Lukasz/0000-0001-6481-8379	National Institutes of Health [CA68485, DK20593, DK58404, DK59637, EY08126]; Vanderbilt Ingram Cancer Center (National Institutes of Health) [P30 CA68485]; Vanderbilt Digestive Disease Research Center (National Institutes of Health) [DK058404]; NATIONAL CANCER INSTITUTE [P30CA068485] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000445] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [P30EY008126] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL069765, R01HL069452, R01HL085833] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK020593, P60DK020593, P30DK058404, U24DK059637] Funding Source: NIH RePORTER; Veterans Affairs [I01BX002750] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Ingram Cancer Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Vanderbilt Digestive Disease Research Center (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Veterans Affairs(US Department of Veterans Affairs)	We thank Professor Babette Weksler (Weil-Cornell Medical College, New York, NY) and Professor Pierre-Olivier Couraud and Dr. Nacho Romero (Institute Cochin, INSERM, Paris, France) for generously providing human BMEC line hCMEC/D3 and for helpful comments concerning the manuscript. We also thank Alyssa Hasty, Roger Colbran, David G. Harrison, Luc Van Kaer, and Ruth Ann Veach for valuable and constructive comments during the course of this study. Additionally, we thank Jozef Zienkiewicz for insightful discussions and suggestions throughout the course of experimentation and preparation of this manuscript. Fluorescence microscopy and analysis were performed in part through the use of the Vanderbilt University Medical Center Cell Imaging Shared Resource (supported by National Institutes of Health Grants CA68485, DK20593, DK58404, DK59637, and EY08126). Flow cytometry experiments were performed in the Vanderbilt Medical Center (VMC) Flow Cytometry Shared Resource. The VMC Flow Cytometry Shared Resource is supported by the Vanderbilt Ingram Cancer Center (National Institutes of Health Grant P30 CA68485) and the Vanderbilt Digestive Disease Research Center (National Institutes of Health Grant DK058404).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abu Taha A, 2014, CELL ADHES MIGR, V8, P125, DOI 10.4161/cam.28243; Adam AP, 2010, J BIOL CHEM, V285, P7045, DOI 10.1074/jbc.M109.079277; ARIMA N, 1992, J IMMUNOL, V149, P83; Brasier AR, 2010, CARDIOVASC RES, V86, P211, DOI 10.1093/cvr/cvq076; Chang SF, 2014, P NATL ACAD SCI USA, V111, P1855, DOI 10.1073/pnas.1323761111; Cooper JT, 1996, J BIOL CHEM, V271, P18068, DOI 10.1074/jbc.271.30.18068; CORDLE SR, 1993, J BIOL CHEM, V268, P11803; DENICOFF KD, 1987, ANN INTERN MED, V107, P293, DOI 10.7326/0003-4819-107-2-293; Desai TR, 2002, J SURG RES, V104, P118, DOI 10.1006/jsre.2002.6415; Dignat-George F, 2000, EUR J HAEMATOL, V65, P215, DOI 10.1034/j.1600-0609.2000.065004215.x; DONALD R, 1995, J BIOL CHEM, V270, P9, DOI 10.1074/jbc.270.1.9; Gallo P, 1992, Ital J Neurol Sci, V13, P65; Greenwood J, 2011, NEUROPATH APPL NEURO, V37, P24, DOI 10.1111/j.1365-2990.2010.01140.x; Grinnell KL, 2010, AM J PHYSIOL-LUNG C, V298, pL361, DOI 10.1152/ajplung.00374.2009; Hatanaka K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037600; Hawiger J, 2015, J THROMB HAEMOST, V13, P1743, DOI 10.1111/jth.13061; Ichinose K, 2015, CLIN IMMUNOL, V157, P114, DOI 10.1016/j.clim.2015.01.010; Jee Y, 2002, J NEUROIMMUNOL, V128, P49, DOI 10.1016/S0165-5728(02)00147-9; Kempe S, 2005, NUCLEIC ACIDS RES, V33, P5308, DOI 10.1093/nar/gki836; Kim DW, 2014, J TRANSL MED, V12, DOI 10.1186/1479-5876-12-113; Krieg C, 2010, P NATL ACAD SCI USA, V107, P11906, DOI 10.1073/pnas.1002569107; Lampugnani MG, 2007, THROMB RES, V120, pS1, DOI 10.1016/S0049-3848(07)70124-X; LIBERMANN TA, 1990, MOL CELL BIOL, V10, P2327, DOI 10.1128/MCB.10.5.2327; Lippmann ES, 2012, NAT BIOTECHNOL, V30, P783, DOI 10.1038/nbt.2247; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Martins TB, 2011, AM J CLIN PATHOL, V136, P696, DOI 10.1309/AJCP7UBK8IBVMVNR; Middleton J, 2005, J PATHOL, V206, P260, DOI 10.1002/path.1788; MINAMI Y, 1993, ANNU REV IMMUNOL, V11, P245, DOI 10.1146/annurev.immunol.11.1.245; MONTESANO R, 1990, CELL, V62, P435, DOI 10.1016/0092-8674(90)90009-4; Orsenigo F, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms2199; Potter MD, 2005, J BIOL CHEM, V280, P31906, DOI 10.1074/jbc.M505568200; Qiao H, 2014, J BIOL CHEM, V289, P21973, DOI 10.1074/jbc.M114.588723; Rajput C, 2013, J BIOL CHEM, V288, P4241, DOI 10.1074/jbc.M112.440396; Ridder DA, 2011, J EXP MED, V208, P2615, DOI 10.1084/jem.20110398; Rosenberg SA, 2014, J IMMUNOL, V192, P5451, DOI 10.4049/jimmunol.1490019; Ruiz-Medina BE, 2015, J BIOL CHEM, V290, P20972, DOI 10.1074/jbc.M115.660654; SARIS SC, 1989, J NEUROSURG, V71, P169, DOI 10.3171/jns.1989.71.2.0169; Sheibani N, 1998, MOL BIOL CELL, V9, P701, DOI 10.1091/mbc.9.4.701; Stamatovic SM, 2003, J CELL SCI, V116, P4615, DOI 10.1242/jcs.00755; Stone KP, 2011, CELL PHYSIOL BIOCHEM, V28, P115, DOI 10.1159/000331720; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Tieu BC, 2009, J CLIN INVEST, V119, P3637, DOI 10.1172/JCI38308; Ukropec JA, 2000, J BIOL CHEM, V275, P5983, DOI 10.1074/jbc.275.8.5983; Wang D, 2000, J BIOL CHEM, V275, P32592, DOI 10.1074/jbc.M001358200; Weksler BB, 2005, FASEB J, V19, P1872, DOI 10.1096/fj.04-3458fje; Wessel F, 2014, NAT IMMUNOL, V15, P223, DOI 10.1038/ni.2824; WESTLIN WF, 1993, AM J PATHOL, V142, P117; Xiao KY, 2005, MOL BIOL CELL, V16, P5141, DOI 10.1091/mbc.E05-05-0440	49	20	22	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 28	2016	291	44					22913	22923		10.1074/jbc.M116.729038	http://dx.doi.org/10.1074/jbc.M116.729038			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EB2XB	27601468	Green Published, hybrid			2022-12-26	WOS:000387224800005
J	Miller, BR; Drake, EJ; Shi, C; Aldrich, CC; Gulick, AM				Miller, Bradley R.; Drake, Eric J.; Shi, Ce; Aldrich, Courtney C.; Gulick, Andrew M.			Structures of a Nonribosomal Peptide Synthetase Module Bound to MbtH-like Proteins Support a Highly Dynamic Domain Architecture	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						acyl carrier protein (ACP); bacterial metabolism; enzyme mechanism; enzyme mutation; multifunctional protein; natural product biosynthesis; siderophore; structural biology	CONDENSATION DOMAIN; ADENYLATION DOMAIN; CRYSTAL-STRUCTURE; BIOSYNTHESIS; ENZYMES; ENTB; CRYSTALLIZATION; IDENTIFICATION; ACTIVATION; BIOLOGY	Nonribosomal peptide synthetases (NRPSs) produce a wide variety of peptide natural products. During synthesis, the multidomain NRPSs act as an assembly line, passing the growing product from one module to the next. Each module generally consists of an integrated peptidyl carrier protein, an amino acid-loading adenylation domain, and a condensation domain that catalyzes peptide bond formation. Some adenylation domains interact with small partner proteins called MbtH-like proteins (MLPs) that enhance solubility or activity. A structure of an MLP bound to an adenylation domain has been previously reported using a truncated adenylation domain, precluding any insight that might be derived from understanding the influence of the MLP on the intact adenylation domain or on the dynamics of the entire NRPS module. Here, we present the structures of the full-length NRPS EntF bound to the MLPs from Escherichia coli and Pseudomonas aeruginosa. These new structures, along with biochemical and bioinformatics support, further elaborate the residues that define the MLP-adenylation domain interface. Additionally, the structures highlight the dynamic behavior of NRPS modules, including the module core formed by the adenylation and condensation domains as well as the orientation of the mobile thioesterase domain.	[Miller, Bradley R.; Drake, Eric J.; Gulick, Andrew M.] Hauptman Woodward Med Res Inst, Buffalo, NY 14203 USA; [Miller, Bradley R.; Drake, Eric J.; Gulick, Andrew M.] SUNY Buffalo, Dept Biol Struct, Buffalo, NY 14203 USA; [Shi, Ce; Aldrich, Courtney C.] Univ Minnesota, Ctr Drug Design, Minneapolis, MN 55455 USA; [Shi, Ce; Aldrich, Courtney C.; Gulick, Andrew M.] Univ Minnesota, Dept Med Chem, Minneapolis, MN 55455 USA	Hauptman Woodward Medical Research Institute; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Gulick, AM (corresponding author), Hauptman Woodward Inst, 700 Ellicott St, Buffalo, NY 14203 USA.	gulick@hwi.buffalo.edu		Gulick, Andrew/0000-0003-4238-7453	National Cancer Institute [ACB-12002]; National Institute of General Medical Sciences [AGM-12006]; DOE Office of Science [DE-AC02-06CH11357]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-76SF00515]; DOE Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences, [P41GM103393]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393, R01GM116957] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); DOE Office of Science(United States Department of Energy (DOE)); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); DOE Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences,(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Alyssa Aldridge for technical assistance with the NikP1 rnutagenesis experiments. We also thank Professors Christopher Walsh and Michael Thomas for generously providing bacterial strains. The General Medical Sciences and Cancer Institutes Structural Biology Facility at the Advanced Photon Source (GM/CA@APS) has been funded in whole or in part with federal funds from the National Cancer Institute (Grant ACB-12002) and the National Institute of General Medical Sciences (Grant AGM-12006). This research used resources of the Advanced Photon Source, a United States Department of Energy (DOE) Office of Science User Facility operated for the DOE Office of Science by Argonne National Laboratory under Contract DE-AC02-06CH11357. Use of the Stanford Synchrotron Radiation Light source (SSRL) is supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences under Contract DE-AC02-76SF00515. The SSRL Structural Molecular Biology Program is supported by the DOE Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences, including Grant P41GM103393.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Al-Mestarihi AH, 2015, CHEMBIOCHEM, V16, P1307, DOI 10.1002/cbic.201402711; Baltz RH, 2011, J IND MICROBIOL BIOT, V38, P1747, DOI 10.1007/s10295-011-1022-8; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bloudoff K, 2013, J MOL BIOL, V425, P3137, DOI 10.1016/j.jmb.2013.06.003; Boll B, 2011, J BIOL CHEM, V286, P36281, DOI 10.1074/jbc.M111.288092; Bruner SD, 2002, STRUCTURE, V10, P301, DOI 10.1016/S0969-2126(02)00716-5; Buchko GW, 2010, TUBERCULOSIS, V90, P245, DOI 10.1016/j.tube.2010.04.002; Chen H, 2002, CHEM BIOL, V9, P103, DOI 10.1016/S1074-5521(02)00090-X; Chen WH, 2016, ACS CHEM BIOL, V11, P2293, DOI 10.1021/acschembio.6b00332; Drake EJ, 2006, CHEM BIOL, V13, P409, DOI 10.1016/j.chembiol.2006.02.005; Drake EJ, 2007, J BIOL CHEM, V282, P20425, DOI 10.1074/jbc.M611833200; Drake EJ, 2016, NATURE, V529, P235, DOI 10.1038/nature16163; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Felnagle EA, 2010, BIOCHEMISTRY-US, V49, P8815, DOI 10.1021/bi1012854; Frueh DP, 2008, NATURE, V454, P903, DOI 10.1038/nature07162; Gehring AM, 1997, BIOCHEMISTRY-US, V36, P8495, DOI 10.1021/bi970453p; Gehring AM, 1998, BIOCHEMISTRY-US, V37, P2648, DOI 10.1021/bi9726584; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; Heemstra JR, 2009, J AM CHEM SOC, V131, P15317, DOI 10.1021/ja9056008; Herbst DA, 2013, J BIOL CHEM, V288, P1991, DOI 10.1074/jbc.M112.420182; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Labby KJ, 2015, NAT PROD REP, V32, P641, DOI 10.1039/c4np00120f; Liu Y, 2011, CHEM BIOL, V18, P1482, DOI 10.1016/j.chembiol.2011.09.018; Luft JR, 1999, ACTA CRYSTALLOGR D, V55, P988, DOI 10.1107/S0907444999002085; Luft JR, 2003, J STRUCT BIOL, V142, P170, DOI 10.1016/S1047-8477(03)00048-0; Marahiel MA, 1997, CHEM REV, V97, P2651, DOI 10.1021/cr960029e; Miller BR, 2016, METHODS MOL BIOL, V1401, P3, DOI 10.1007/978-1-4939-3375-4_1; Miller BR, 2014, PROTEINS, V82, P2691, DOI 10.1002/prot.24635; Mitchell CA, 2012, BIOCHEMISTRY-US, V51, P3252, DOI 10.1021/bi300112e; Mossialos D, 2002, MOL MICROBIOL, V45, P1673, DOI 10.1046/j.1365-2958.2002.03120.x; Quadri LEN, 1998, CHEM BIOL, V5, P631, DOI 10.1016/S1074-5521(98)90291-5; Reimer JM, 2016, NATURE, V529, P239, DOI 10.1038/nature16503; Roche ED, 2003, BIOCHEMISTRY-US, V42, P1334, DOI 10.1021/BI026867m; RUSNAK F, 1989, BIOCHEMISTRY-US, V28, P6827, DOI 10.1021/bi00443a008; Samel SA, 2008, MOL BIOSYST, V4, P387, DOI 10.1039/b717538h; Sundlov JA, 2013, ACTA CRYSTALLOGR D, V69, P1482, DOI 10.1107/S0907444913009372; Sundlov JA, 2012, CHEM BIOL, V19, P188, DOI 10.1016/j.chembiol.2011.11.013; Tanovic A, 2008, SCIENCE, V321, P659, DOI 10.1126/science.1159850; Walsh CT, 2016, NAT PROD REP, V33, P127, DOI 10.1039/c5np00035a; Walsh CT, 2001, CURR OPIN CHEM BIOL, V5, P525, DOI 10.1016/S1367-5931(00)00235-0; Weissman KJ, 2015, NAT CHEM BIOL, V11, P660, DOI [10.1038/NCHEMBIO.1883, 10.1038/nchembio.1883]; Zhang WJ, 2010, BIOCHEMISTRY-US, V49, P9946, DOI 10.1021/bi101539b; Zolova OE, 2012, MEDCHEMCOMM, V3, P950, DOI 10.1039/c2md20131c	45	65	66	3	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22559	22571		10.1074/jbc.M116.746297	http://dx.doi.org/10.1074/jbc.M116.746297			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27597544	hybrid, Green Published			2022-12-26	WOS:000386760600017
J	Sano, R; Nakajima, T; Takahashi, Y; Kubo, R; Kobayashi, M; Takahashi, K; Takeshita, H; Ogasawara, K; Kominato, Y				Sano, Rie; Nakajima, Tamiko; Takahashi, Yoichiro; Kubo, Rieko; Kobayashi, Momoko; Takahashi, Keiko; Takeshita, Haruo; Ogasawara, Kenichi; Kominato, Yoshihiko			Epithelial Expression of Human ABO Blood Group Genes Is Dependent upon a Downstream Regulatory Element Functioning through an Epithelial Cell-specific Transcription Factor, Elf5	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CRISPR; Cas; epithelial cell; ETS transcription factor family; gene regulation; tissue-specific transcription factor; transcription enhancer; ABO; Elf5	MAMMARY-GLAND DEVELOPMENT; DNA METHYLATION; GATA SITE; CBF/NF-Y; B GENE; PROMOTER; GENOME; REGION; SUBFAMILY; MUTATION	The human ABO blood group system is of great importance in blood transfusion and organ transplantation. The ABO system is composed of complex carbohydrate structures that are biosynthesized by A- and B-transferases encoded by the ABO gene. However, the mechanisms regulating ABO gene expression in epithelial cells remain obscure. On the basis of DNase I-hypersensitive sites in and around ABO in epithelial cells, we prepared reporter plasmid constructs including these sites. Subsequent luciferase assays and histone modifications indicated a novel positive regulatory element, designated the +22.6-kb site, downstream from ABO, and this was shown to enhance ABO promoter activity in an epithelial cell-specific manner. Expression of ABO and B-antigen was reduced in gastric cancer KATOIII cells by biallelic deletion of the +22.6-kb site using the CRISPR/Cas9 system. Electrophoretic mobility shift assay and chromatin immunoprecipitation assay demonstrated that the site bound to an epithelial cell-specific transcription factor, Elf5. Mutation of the Ets binding motifs to abrogate binding of this factor reduced the regulatory activity of the +22.6-kb site. Furthermore, ELF5 knockdown with shRNA reduced both endogenous transcription from ABO and B-antigen expression in KATOIII cells. Thus, Elf5 appeared to be involved in the enhancer potential of the +22.6-kb site. These results support the contention that ABO expression is dependent upon a downstream positive regulatory element functioning through a tissue-restricted transcription factor, Elf5, in epithelial cells.	[Sano, Rie; Nakajima, Tamiko; Takahashi, Yoichiro; Kubo, Rieko; Kobayashi, Momoko; Takahashi, Keiko; Kominato, Yoshihiko] Gunma Univ, Dept Legal Med, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan; [Takeshita, Haruo] Shimane Univ, Sch Med, Dept Legal Med, Izumo, Shimane, Japan; [Ogasawara, Kenichi] Japanese Red Cross Cent Blood Inst, Tokyo, Japan	Gunma University; Shimane University	Sano, R (corresponding author), Gunma Univ, Dept Legal Med, Grad Sch Med, 3-39-22 Showa Machi, Maebashi, Gunma 3718511, Japan.	takagirie@gunma-u.ac.jp			Japan Society for the Promotion of Science [25460861, 25860486, 26293161]; Grants-in-Aid for Scientific Research [16K19293, 26293161] Funding Source: KAKEN	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by a Grants-in-Aid 25460861 (to T. N.), 25860486 (to Y. T.), and 26293161 (to Y. K.) from the Japan Society for the Promotion of Science. The authors declare that they have no conflicts of interest with the contents of this article.	Andreoli JM, 1997, NUCLEIC ACIDS RES, V25, P4287, DOI 10.1093/nar/25.21.4287; Bochert MA, 1998, BIOCHEM BIOPH RES CO, V246, P176, DOI 10.1006/bbrc.1998.8560; Bolger AM, 2014, BIOINFORMATICS, V30, P2114, DOI 10.1093/bioinformatics/btu170; Chakrabarti R, 2012, NAT CELL BIOL, V14, P1212, DOI 10.1038/ncb2607; Choi YS, 2009, DEV BIOL, V329, P227, DOI 10.1016/j.ydbio.2009.02.032; Creyghton MP, 2010, P NATL ACAD SCI USA, V107, P21931, DOI 10.1073/pnas.1016071107; Daniels G., 2013, HUMAN BLOOD GROUPS, V3; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Ernst J, 2011, NATURE, V473, P43, DOI 10.1038/nature09906; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Escamilla-Hernandez R, 2010, BMC MOL BIOL, V11, DOI 10.1186/1471-2199-11-68; Gao S, 2004, INT J CANCER, V109, P230, DOI 10.1002/ijc.11592; Hata Y, 2002, VOX SANG, V82, P39, DOI 10.1046/j.0042-9007.2001.00134.x; Hay ED, 1995, ACTA ANAT, V154, P8; Ichikawa D, 1997, CANCER RES, V57, P3092; Iwamoto S, 1999, GLYCOCONJUGATE J, V16, P659, DOI 10.1023/A:1007085202379; Kas K, 2000, J BIOL CHEM, V275, P2986, DOI 10.1074/jbc.275.4.2986; Kominato Y, 1997, J BIOL CHEM, V272, P25890, DOI 10.1074/jbc.272.41.25890; Kominato Y, 1999, J BIOL CHEM, V274, P37240, DOI 10.1074/jbc.274.52.37240; Kominato Y, 2002, J BIOL CHEM, V277, P37936, DOI 10.1074/jbc.M204238200; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/NMETH.1923, 10.1038/nmeth.1923]; Lapinskas EJ, 2004, HISTOCHEM CELL BIOL, V122, P521, DOI 10.1007/s00418-004-0713-x; LEE JS, 1991, NEW ENGL J MED, V324, P1084, DOI 10.1056/NEJM199104183241603; Levine M, 2014, CELL, V157, P13, DOI 10.1016/j.cell.2014.02.009; MATSUMOTO H, 1993, CANCER-AM CANCER SOC, V72, P75, DOI 10.1002/1097-0142(19930701)72:1<75::AID-CNCR2820720116>3.0.CO;2-Z; Nakajima T, 2013, TRANSFUSION, V53, P2917, DOI 10.1111/trf.12181; Ng AYN, 2002, GASTROENTEROLOGY, V122, P1455, DOI 10.1053/gast.2002.32990; Oda A, 2015, VOX SANG, V108, P425, DOI 10.1111/vox.12229; Orlow I, 1998, INT J CANCER, V75, P819, DOI 10.1002/(SICI)1097-0215(19980316)75:6<819::AID-IJC1>3.0.CO;2-Y; Ran FA, 2013, NAT PROTOC, V8, P2281, DOI 10.1038/nprot.2013.143; Rao SSP, 2014, CELL, V159, P1665, DOI 10.1016/j.cell.2014.11.021; Robinson MD, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r25; Sano R, 2015, VOX SANG, V108, P310, DOI 10.1111/vox.12216; Sano R, 2015, VOX SANG, V108, P302, DOI 10.1111/vox.12220; Sano R, 2012, BLOOD, V119, P5301, DOI 10.1182/blood-2011-10-387167; Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076; Silverman ES, 2002, AM J RESP CELL MOL, V27, P697, DOI 10.1165/rcmb.2002-0011OC; Takahashi Y, 2014, VOX SANG, V106, P167, DOI 10.1111/vox.12077; Thiery JP, 2002, NAT REV CANCER, V2, P442, DOI 10.1038/nrc822; Thuresson B, 2013, VOX SANG, V105, P44; Tymms MJ, 1997, ONCOGENE, V15, P2449, DOI 10.1038/sj.onc.1201427; Vernimmen D, 2014, PLOS GENET, V10, DOI 10.1371/journal.pgen.1004668; Yamamoto F, 2000, VOX SANG, V78, P91; Yamamoto F, 2012, TRANSFUS MED REV, V26, P103, DOI 10.1016/j.tmrv.2011.08.002; Zhou J, 2005, EMBO J, V24, P635, DOI 10.1038/sj.emboj.7600538; Zhou J, 1998, ONCOGENE, V17, P2719, DOI 10.1038/sj.onc.1202198; Zhou S, 2014, WORLD J CARDIOL, V6, P985, DOI 10.4330/wjc.v6.i9.985; Zhu Y, 2013, NUCLEIC ACIDS RES, V41, P10032, DOI 10.1093/nar/gkt826	48	10	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22594	22606		10.1074/jbc.M116.730655	http://dx.doi.org/10.1074/jbc.M116.730655			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587399	Green Published, hybrid			2022-12-26	WOS:000386760600020
J	Song, ZW; Fusco, J; Zimmerman, R; Fischbach, S; Chen, CD; Ricks, DM; Prasadan, K; Shiota, C; Xiao, XW; Gittes, GK				Song, Zewen; Fusco, Joseph; Zimmerman, Ray; Fischbach, Shane; Chen, Congde; Ricks, David Matthew; Prasadan, Krishna; Shiota, Chiyo; Xiao, Xiangwei; Gittes, George K.			Epidermal Growth Factor Receptor Signaling Regulates Cell Proliferation in Adult Mice	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						beta cell ( cell); cell proliferation; cyclin D1; diabetes; epidermal growth factor receptor (EGFR)	PANCREATIC BETA-CELL; PRIMARY MECHANISM; ISLET CELLS; MASS; REPLICATION; ACTIVATION; DIFFERENTIATION; REGENERATION; MACROPHAGES; PROGENITORS	A thorough understanding of the signaling pathways involved in the regulation of cell proliferation is an important initial step in restoring cell mass in the diabetic patient. Here, we show that epidermal growth factor receptor 1 (EGFR) was significantly up-regulated in the islets of C57BL/6 mice after 50% partial pancreatectomy (PPx), a model for workload-induced cell proliferation. Specific deletion of EGFR in the cells of adult mice impaired cell proliferation at baseline and after 50% PPx, suggesting that the EGFR signaling pathway plays an essential role in adult cell proliferation. Further analyses showed that cell-specific depletion of EGFR resulted in impaired expression of cyclin D1 and impaired suppression of p27 after PPx, both of which enhance cell proliferation. These data highlight the importance of EGFR signaling and its downstream signaling cascade in postnatal cell growth.	[Song, Zewen; Fusco, Joseph; Zimmerman, Ray; Fischbach, Shane; Chen, Congde; Ricks, David Matthew; Prasadan, Krishna; Shiota, Chiyo; Xiao, Xiangwei; Gittes, George K.] Univ Pittsburgh, Childrens Hosp Pittsburgh, Div Pediat Surg, Dept Surg,Sch Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA; [Song, Zewen] Cent S Univ, Xiangya Hosp 3, Dept Oncol, 138 Tongzipo Rd, Changsha 410013, Hunan, Peoples R China; [Chen, Congde] Wenzhou Med Univ, Affiliated Hosp 2, Dept Pediat Surg, Wenzhou 325000, Peoples R China; [Chen, Congde] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou 325000, Peoples R China	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Central South University; Wenzhou Medical University; Wenzhou Medical University	Xiao, XW; Gittes, GK (corresponding author), Univ Pittsburgh, Childrens Hosp Pittsburgh, Div Pediat Surg, Dept Surg,Sch Med, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	Xiangwei.xiao@chp.edu; gittesgk@upmc.edu	Song, Zewen/ABA-2788-2020	Xiao, Xiangwei/0000-0003-0890-9203; song, zewen/0000-0002-9685-0725	National Institutes of Health [R01 DK098196]; Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK098196] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Hospital of Pittsburgh; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health (to G. K. G, Grant R01 DK098196) and the Children's Hospital of Pittsburgh. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Brouwers B, 2014, CELL METAB, V20, P979, DOI 10.1016/j.cmet.2014.11.004; Brown ML, 2010, TRENDS ENDOCRIN MET, V21, P441, DOI 10.1016/j.tem.2010.02.008; Buteau J, 2003, DIABETES, V52, P124, DOI 10.2337/diabetes.52.1.124; Dai C, 2012, DIABETOLOGIA, V55, P707, DOI 10.1007/s00125-011-2369-0; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; El-Gohary Y, 2014, DIABETES, V63, P224, DOI 10.2337/db13-0432; Georgia S, 2004, J CLIN INVEST, V114, P963, DOI 10.1172/JCI200422098; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Gunasekaran U, 2012, CELL CYCLE, V11, P2431, DOI 10.4161/cc.20545; Gunasekaran U, 2011, AGING-US, V3, P565, DOI 10.18632/aging.100350; Hakonen E, 2011, DIABETOLOGIA, V54, P1735, DOI 10.1007/s00125-011-2153-1; Hakonen E, 2014, DIABETOLOGIA, V57, P970, DOI 10.1007/s00125-014-3175-2; He LM, 2009, MOL ENDOCRINOL, V23, P1865, DOI 10.1210/me.2009-0057; Herbst RS, 2004, INT J RADIAT ONCOL, V59, P21, DOI 10.1016/j.ijrobp.2003.11.041; Huotari MA, 2002, ENDOCRINOLOGY, V143, P4437, DOI 10.1210/en.2002-220382; Kulkarni RN, 2012, DIABETES, V61, P2205, DOI 10.2337/db12-0018; Lee TC, 2009, GENESIS, V47, P85, DOI 10.1002/dvg.20464; Li DS, 2009, NAT PROTOC, V4, P1649, DOI 10.1038/nprot.2009.150; Magnuson MA, 2013, CELL METAB, V18, P9, DOI 10.1016/j.cmet.2013.06.011; Meier JJ, 2008, DIABETES, V57, P1584, DOI 10.2337/db07-1369; Miettinen PJ, 2006, DIABETES, V55, P3299, DOI 10.2337/db06-0413; MIETTINEN PJ, 1995, NATURE, V376, P337, DOI 10.1038/376337a0; Miettinen PJ, 2000, DEVELOPMENT, V127, P2617; Narita Y, 2002, CANCER RES, V62, P6764; Oh YS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023894; Rieck S, 2009, MOL ENDOCRINOL, V23, P1702, DOI 10.1210/me.2009-0144; Rooman I, 2004, DIABETOLOGIA, V47, P259, DOI 10.1007/s00125-003-1287-1; Saunders D, 2016, J AUTOIMMUN, V71, P59, DOI 10.1016/j.jaut.2016.03.014; Stewart AF, 2015, DIABETES, V64, P1872, DOI 10.2337/db14-1843; Suarez-Pinzon WL, 2005, DIABETES, V54, P2596, DOI 10.2337/diabetes.54.9.2596; Tao YG, 2005, EXP CELL RES, V303, P240, DOI 10.1016/j.yexcr.2004.09.030; Teta M, 2007, DEV CELL, V12, P817, DOI 10.1016/j.devcel.2007.04.011; Xiao XW, 2016, ENDOCRINOLOGY, V157, P1348, DOI 10.1210/en.2015-1986; Xiao XW, 2015, STEM CELL TRANSL MED, V4, P655, DOI 10.5966/sctm.2014-0248; Xiao XW, 2014, DIABETOLOGIA, V57, P991, DOI 10.1007/s00125-014-3179-y; Xiao XW, 2014, P NATL ACAD SCI USA, V111, pE1211, DOI 10.1073/pnas.1321347111; Xiao XW, 2013, J BIOL CHEM, V288, P25297, DOI 10.1074/jbc.M113.484022; Xiao XW, 2013, J CLIN INVEST, V123, P2207, DOI 10.1172/JCI66323; Xiao XW, 2013, J BIOL CHEM, V288, P8636, DOI 10.1074/jbc.M112.422949; Xiao XW, 2013, DIABETES, V62, P1217, DOI 10.2337/db12-1428; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zarrouki B, 2014, DIABETES, V63, P982, DOI 10.2337/db13-0425	42	20	23	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22630	22637		10.1074/jbc.M116.747840	http://dx.doi.org/10.1074/jbc.M116.747840			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27587395	Green Published, hybrid			2022-12-26	WOS:000386760600023
J	Liu, LJ; Yao, FJ; Lu, GH; Xu, CG; Xu, Z; Tang, K; Cheng, YJ; Gao, XR; Wu, SH				Liu, Li-Juan; Yao, Feng-Juan; Lu, Gui-Hua; Xu, Cheng-Gui; Xu, Zhe; Tang, Kai; Cheng, Yun-Jiu; Gao, Xiu-Ren; Wu, Su-Hua			The Role of the Rho/ROCK Pathway in Ang II and TGF-beta 1-Induced Atrial Remodeling	PLOS ONE			English	Article							TISSUE GROWTH-FACTOR; INDUCED CARDIAC-HYPERTROPHY; RHO-KINASE; TGF-BETA; MYOCARDIAL-INFARCTION; FACTOR EXPRESSION; RAT MODEL; FIBROSIS; FIBRILLATION; FIBROBLASTS	Objectives To study the role of the Rho/ROCK pathway in Ang II and TGF-beta 1-induced atrial remodeling. Methods and Results A canine atrial fibrillation (AF) model was established by rapid atrial pacing (RAP) of the left atrium. The roles of TGF-beta 1, the RhoA/ROCK signaling pathway and connective tissue growth factor (CTGF) in atrial remodeling were studied via both in vitro and in vivo experiments. Each of the dogs that received RAP developed persistent AF within 4 weeks. The mRNA expression levels of TGF-beta 1 (1.32 +/- 0.38), Collagen-I(1.33 +/- 0.91), CTGF(5.83 +/- 3.71), RhoA(1.23 +/- 0.57) and ROCK-1 (1.02 +/- 0.27) in the left atriumwere significantly increased following 4 weeks of RAP. Angiotensin II (Ang II) induced the proliferation of atrial fibroblasts and up-regulated the expression of both CTGF and ROCK-1 in a dose-dependent manner. Simvastatin and Y27632 reversed Ang II-induced CFs proliferation, as well as ROCK-1(0.89 +/- 0.05 and 1.27 +/- 0.03, respectively) and CTGF (0.87 +/- 0.04 and 0.91 +/- 0.02, respectively) expression. The expression mRNA of ROCK-1(1.74 +/- 0.13) and CTGF (2.28 +/- 0.11) can upregulated by TGF-beta 1, and down-regulated by Simvastatin (1.22 +/- 0.03 vs 2.27 +/- 0.11), Y27632 (1.01 +/- 0.04 vs 1.64 +/- 0.03), Los (1.04 +/- 0.11 vs 1.26 +/- 0.05), respectively. Losartan and Simvastatin attenuated the effects of TGF-beta 1, inhibited RhoA activity as opposed to RhoA protein expression. Y27632 had no effect on either the expression or the activity of RhoA. Conclusions The increased expression of profibrotic factors (CTGF, ROCK1 and Smad2/3) played an important role in our RAP-induced AF model. Increased atrial profibrotic factors involve the activation of either the TGF-beta 1/RhoA/ROCK-1 or the TGF-beta 1/Smad2/3 signaling pathway.	[Liu, Li-Juan; Lu, Gui-Hua; Xu, Cheng-Gui; Xu, Zhe; Tang, Kai; Cheng, Yun-Jiu; Gao, Xiu-Ren; Wu, Su-Hua] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China; [Yao, Feng-Juan] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Ultrasonog, Guangzhou, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Gao, XR; Wu, SH (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou, Guangdong, Peoples R China.	xiurengao@163.com; wusuhua@hotmail.com		Liu, Li-juan/0000-0001-8068-8498; Xu, Chenggui/0000-0001-5993-5263	National Natural Science Foundation of China [81370285, 81370284]; Guangdong Province Science and Technology Program [2012B031800091]; Guangzhou City Science and Technology Program [201508020057]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Province Science and Technology Program; Guangzhou City Science and Technology Program	This work was supported by National Natural Science Foundation of China (No. 81370285), Guangdong Province Science and Technology Program (No. 2012B031800091), Guangzhou City Science and Technology Program (No. 201508020057) to Dr. Wu; National Natural Science Foundation of China (No. 81370284) to Dr. Gao. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu JG, 2002, NAT CELL BIOL, V4, P599, DOI 10.1038/ncb826; Amano M, 1997, SCIENCE, V275, P1308, DOI 10.1126/science.275.5304.1308; Ames A, 2006, CIRCULATION, V113, pE666, DOI 10.1161/CIRCULATIONAHA.105.613083; BENJAMIN EJ, 1994, JAMA-J AM MED ASSOC, V271, P840, DOI 10.1001/jama.271.11.840; Bourgier C, 2005, GUT, V54, P336, DOI 10.1136/gut.2004.051169; Chen MM, 2000, J MOL CELL CARDIOL, V32, P1805, DOI 10.1006/jmcc.2000.1215; CORY AH, 1991, CANCER COMMUN, V3, P207, DOI 10.3727/095535491820873191; Cui B, 2011, AUTON NEUROSCI-BASIC, V161, P87, DOI 10.1016/j.autneu.2011.01.004; Cui YK, 2015, EXP THER MED, V9, P631, DOI 10.3892/etm.2014.2143; Dean RG, 2005, J HISTOCHEM CYTOCHEM, V53, P1245, DOI 10.1369/jhc.4A6560.2005; Frustaci A, 1997, CIRCULATION, V96, P1180, DOI 10.1161/01.CIR.96.4.1180; Gao XR, 2009, EUR J PHARMACOL, V606, P115, DOI 10.1016/j.ejphar.2008.12.049; Gervaz P, 2009, CURR MOL MED, V9, P273, DOI 10.2174/156652409787847164; Haissaguerre M, 1998, NEW ENGL J MED, V339, P659, DOI 10.1056/NEJM199809033391003; He XY, 2011, CIRC RES, V108, P164, DOI 10.1161/CIRCRESAHA.110.234369; Heusinger-Ribeiro J, 2001, J AM SOC NEPHROL, V12, P1853, DOI 10.1681/ASN.V1291853; Huang ZH, 2006, AM J PHYSIOL-LUNG C, V290, pL1291, DOI 10.1152/ajplung.00443.2005; Iqbal MB, 2005, BMJ-BRIT MED J, V330, P238, DOI 10.1136/bmj.330.7485.238; Ko WC, 2011, CIRC J, V75, P1592, DOI 10.1253/circj.CJ-10-0892; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; Lee SJ, 2013, BIOCHEM J, V456, P109, DOI 10.1042/BJ20130744; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mun JH, 2014, WOUND REPAIR REGEN, V22, P125, DOI 10.1111/wrr.12136; Nakajima H, 2000, CIRC RES, V86, P571, DOI 10.1161/01.RES.86.5.571; Ohnishi H, 1998, J MOL CELL CARDIOL, V30, P2411, DOI 10.1006/jmcc.1998.0799; Porter KE, 2004, CARDIOVASC RES, V61, P745, DOI 10.1016/j.cardiores.2003.11.032; Rikitake Y, 2005, CIRCULATION, V112, P2959, DOI 10.1161/CIRCULATIONAHA.105.584623; Sah VP, 1999, J CLIN INVEST, V103, P1627, DOI 10.1172/JCI6842; SANFILIPPO AJ, 1990, CIRCULATION, V82, P792, DOI 10.1161/01.CIR.82.3.792; SHULL MM, 1992, NATURE, V359, P693, DOI 10.1038/359693a0; Spach MS, 1997, PACE, V20, P397, DOI 10.1111/j.1540-8159.1997.tb06199.x; Wang YX, 2005, EUR J PHARMACOL, V512, P215, DOI 10.1016/j.ejphar.2005.02.024; Washida N, 2011, NEPHROL DIAL TRANSPL, V26, P2770, DOI 10.1093/ndt/gfr012; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Yang J, 2013, INT J BIOCHEM CELL B, V45, P657, DOI 10.1016/j.biocel.2012.12.016; Yeh YH, 2015, J MOL CELL CARDIOL, V82, P84, DOI 10.1016/j.yjmcc.2015.03.004; Zhai YS, 2008, EUR J PHARMACOL, V587, P196, DOI 10.1016/j.ejphar.2008.03.006; Zhang YM, 2006, FASEB J, V20, P916, DOI 10.1096/fj.05-5129com; Zhou H, 2011, ACTA PHARMACOL SIN, V32, P999, DOI 10.1038/aps.2011.54	39	21	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161625	10.1371/journal.pone.0161625	http://dx.doi.org/10.1371/journal.pone.0161625			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611832	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900024
J	Thompson, SM; Callstrom, MR; Jondal, DE; Butters, KA; Knudsen, BE; Anderson, JL; Lien, KR; Sutor, SL; Lee, JS; Thorgeirsson, SS; Grande, JP; Roberts, LR; Woodrum, DA				Thompson, Scott M.; Callstrom, Matthew R.; Jondal, Danielle E.; Butters, Kim A.; Knudsen, Bruce E.; Anderson, Jill L.; Lien, Karen R.; Sutor, Shari L.; Lee, Ju-Seog; Thorgeirsson, Snorri S.; Grande, Joseph P.; Roberts, Lewis R.; Woodrum, David A.			Heat Stress-Induced PI3K/mTORC2-Dependent AKT Signaling Is a Central Mediator of Hepatocellular Carcinoma Survival to Thermal Ablation Induced Heat Stress	PLOS ONE			English	Article							RADIOFREQUENCY ABLATION; IN-VITRO; DISEASE RECURRENCE; RAPID PROGRESSION; TUMOR PROGRESSION; POOR-PROGNOSIS; RISK-FACTORS; CELL-LINES; PHOSPHORYLATION; GROWTH	Thermal ablative therapies are important treatment options in the multidisciplinary care of patients with hepatocellular carcinoma (HCC), but lesions larger than 2-3 cm are plagued with high local recurrence rates and overall survival of these patients remains poor. Currently no adjuvant therapies exist to prevent local HCC recurrence in patients undergoing thermal ablation. The molecular mechanisms mediating HCC resistance to thermal ablation induced heat stress and local recurrence remain unclear. Here we demonstrate that the HCC cells with a poor prognostic hepatic stem cell subtype (Subtype HS) are more resistant to heat stress than HCC cells with a better prognostic hepatocyte subtype (Subtype HC). Moreover, sublethal heat stress rapidly induces phosphoinositide 3-kinase (PI3K)/mammalian target of rapamycin (mTOR) dependent-protein kinase B (AKT) survival signaling in HCC cells in vitro and at the tumor ablation margin in vivo. Conversely, inhibition of PI3K/mTOR complex 2 (mTORC2)-dependent AKT phosphorylation or direct inhibition of AKT function both enhance HCC cell killing and decrease HCC cell survival to sublethal heat stress in both poor and better prognostic HCC subtypes while mTOR complex 1 (mTORC1)-inhibition has no impact. Finally, we showed that AKT isoforms 1, 2 and 3 are differentially upregulated in primaryhuman HCCs and that overexpression of AKT correlates with worse tumor biology and pathologic features (AKT3) and prognosis (AKT1). Together these findings define a novel molecular mechanism whereby heat stress induces PI3K/mTORC2-dependent AKT survival signaling in HCC cells and provide a mechanistic rationale for adjuvant AKT inhibition in combination with thermal ablation as a strategy to enhance HCC cell killing and prevent local recurrence, particularly at the ablation margin.	[Thompson, Scott M.; Callstrom, Matthew R.; Jondal, Danielle E.; Butters, Kim A.; Anderson, Jill L.; Woodrum, David A.] Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55902 USA; [Knudsen, Bruce E.; Lien, Karen R.; Grande, Joseph P.] Mayo Clin, Coll Med, Dept Lab Med & Pathol, Rochester, MN USA; [Sutor, Shari L.] Mayo Clin, Coll Med, Genom Res Ctr, Rochester, MN USA; [Lee, Ju-Seog] Univ Texas MD Anderson Canc Ctr, Div Canc Med, Houston, TX 77030 USA; [Thorgeirsson, Snorri S.] NCI, Ctr Canc Res, Bethesda, MD 20892 USA; [Roberts, Lewis R.] Mayo Clin, Coll Med, Div Gastroenterol & Hepatol, Rochester, MN USA	Mayo Clinic; Mayo Clinic; Mayo Clinic; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Mayo Clinic	Thompson, SM; Woodrum, DA (corresponding author), Mayo Clin, Coll Med, Dept Radiol, Rochester, MN 55902 USA.	thompson.scott@mayo.edu; woodrum.david@mayo.edu	Grande, Joseph P./AAG-2128-2020; Lee, Ju-Seog/X-1786-2018	Grande, Joseph P./0000-0001-5674-1682; Lee, Ju-Seog/0000-0002-5666-9753; Roberts, Lewis/0000-0001-7885-8574	National Institutes of Health (NIH) [NIH C06 RR018898]; Society of Interventional Radiology (SIR) Foundation Allied Scientist Training Grant; Mayo Clinic Center for Clinical and Translational Science (CCaTS) through National Center for Research Resources (NCRR), a component of the NIH [UL1 RR024150]; NIH from the National Cancer Institute (NCI) [R01 CA177686]; Mayo Clinic Center for Clinical and Translational Science (CCaTS) MD/PhD in Clinical and Translational Science [TL1 RR024152, TL1 TR000137]	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Society of Interventional Radiology (SIR) Foundation Allied Scientist Training Grant; Mayo Clinic Center for Clinical and Translational Science (CCaTS) through National Center for Research Resources (NCRR), a component of the NIH; NIH from the National Cancer Institute (NCI); Mayo Clinic Center for Clinical and Translational Science (CCaTS) MD/PhD in Clinical and Translational Science	Infrastructure support provided by National Institutes of Health (NIH; https://www.nih.gov/) construction grant NIH C06 RR018898. Research support provided in part by the Society of Interventional Radiology (SIR) Foundation (http://www.sirfoundation.org/) Allied Scientist Training Grant (SMT), Mayo Clinic Center for Clinical and Translational Science (CCaTS; http://www.mayo.edu/ctsa) through grant number UL1 RR024150 from the National Center for Research Resources (NCRR), a component of the NIH (LRR, DAW) and NIH grant number R01 CA177686 from the National Cancer Institute (NCI) (DAW). The funding sources did not play any role in the study design, data collection or analysis, decision to publish or preparation of the manuscript. Dr. Thompson's MD, PhD training was supported by Mayo Clinic Center for Clinical and Translational Science (CCaTS) MD/PhD in Clinical and Translational Science TL1 RR024152 and TL1 TR000137. The contents herein are solely the responsibility of the authors and do not necessarily represent the official views of the NIH.	Ahmed M, 2011, SURG ONCOL CLIN N AM, V20, P237, DOI 10.1016/j.soc.2010.11.011; Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085; Angonese C, 2006, GUT, V55, P435; Breuhahn K, 2006, ONCOGENE, V25, P3787, DOI 10.1038/sj.onc.1209556; Bruix J, 2014, GUT, V63, P844, DOI 10.1136/gutjnl-2013-306627; Cho YK, 2009, HEPATOLOGY, V49, P453, DOI 10.1002/hep.22648; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dhanasekaran R, 2016, J HEPATOL, V64, P736, DOI 10.1016/j.jhep.2015.09.008; Dumont FJ, 1995, LIFE SCI, V58, P373, DOI 10.1016/0024-3205(95)02233-3; Everhart JE, 2009, GASTROENTEROLOGY, V136, P1134, DOI 10.1053/j.gastro.2009.02.038; Ferlay J, 2015, INT J CANCER, V136, pE359, DOI 10.1002/ijc.29210; FIELD S B, 1983, Radiotherapy and Oncology, V1, P179, DOI 10.1016/S0167-8140(83)80020-6; Gedaly R, 2012, ANTICANCER RES, V32, P2531; Gonzalez E, 2009, CELL CYCLE, V8, P2502, DOI 10.4161/cc.8.16.9335; Hara S, 2008, BIOCHEM BIOPH RES CO, V370, P123, DOI 10.1016/j.bbrc.2008.03.042; Harrison LE, 2003, J AM COLL SURGEONS, V197, P759, DOI 10.1016/S1072-7515(03)00750-6; Hildebrandt B, 2002, CRIT REV ONCOL HEMAT, V43, P33, DOI 10.1016/S1040-8428(01)00179-2; Hirai H, 2010, MOL CANCER THER, V9, P1956, DOI 10.1158/1535-7163.MCT-09-1012; Hoshida Y, 2010, SEMIN LIVER DIS, V30, P35, DOI 10.1055/s-0030-1247131; Huynh H, 2007, MOL CANCER THER, V6, P138, DOI 10.1158/1535-7163.MCT-06-0436; Joshi CN, 2004, BRAIN RES PROTOC, V13, P11, DOI 10.1016/j.brainresprot.2003.12.001; Kang TW, 2015, RADIOLOGY; Kao WY, 2011, EUR J GASTROEN HEPAT, V23, P528, DOI 10.1097/MEG.0b013e328346d529; Kei SK, 2008, AM J ROENTGENOL, V190, P1544, DOI 10.2214/AJR.07.2798; Klippel A, 1997, MOL CELL BIOL, V17, P338, DOI 10.1128/MCB.17.1.338; Koseoglu S, 2007, CANCER BIOL THER, V6, P755, DOI 10.4161/cbt.6.5.3995; Kuger S, 2013, TRANSL ONCOL, V6, P169, DOI 10.1593/tlo.12364; Lai JP, 2008, HEPATOLOGY, V47, P1211, DOI 10.1002/hep.22202; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee JS, 2006, NAT MED, V12, P410, DOI 10.1038/nm1377; Lee JS, 2004, NAT GENET, V36, P1306, DOI 10.1038/ng1481; Lee JS, 2004, HEPATOLOGY, V40, P667, DOI 10.1002/hep.20375; Liu CH, 2010, EUR RADIOL, V20, P877, DOI 10.1007/s00330-009-1610-4; Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mertyna P, 2008, INT J HYPERTHER, V24, P550, DOI 10.1080/02656730802035662; Mertyna P, 2007, J VASC INTERV RADIOL, V18, P647, DOI 10.1016/j.jvir.2007.02.033; Minko T, 1999, J CONTROL RELEASE, V59, P133, DOI 10.1016/S0168-3659(98)00186-2; Nakanishi K, 2005, CANCER-AM CANCER SOC, V103, P307, DOI 10.1002/cncr.20774; Ng KK, 2008, J GASTROINTEST SURG, V12, P183, DOI 10.1007/s11605-007-0276-y; Park HG, 2005, CELL MOL LIFE SCI, V62, P10, DOI 10.1007/s00018-004-4208-7; Portolani N, 2003, HEPATO-GASTROENTEROL, V50, P2179; Roberts LR, 2005, SEMIN LIVER DIS, V25, P212, DOI 10.1055/s-2005-871200; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Roberts PJ, 2012, CLIN CANCER RES, V18, P5290, DOI 10.1158/1078-0432.CCR-12-0563; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Ruzzenente A, 2004, WORLD J GASTROENTERO, V10, P1137; SAPARETO SA, 1984, INT J RADIAT ONCOL, V10, P787, DOI 10.1016/0360-3016(84)90379-1; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Sasaki T, 2010, BIOCHEM BIOPH RES CO, V399, P79, DOI 10.1016/j.bbrc.2010.07.045; SCHAMHART DHJ, 1984, CANCER RES, V44, P4507; Schmitz KJ, 2008, J HEPATOL, V48, P83, DOI 10.1016/j.jhep.2007.08.018; Seki T, 2001, EUR J GASTROEN HEPAT, V13, P291, DOI 10.1097/00042737-200103000-00014; Semba S, 2002, CLIN CANCER RES, V8, P1957; Shaw M, 1998, BIOCHEM J, V336, P241, DOI 10.1042/bj3360241; Shiozawa K, 2009, HEPATO-GASTROENTEROL, V56, P1689; Thompson SM, 2014, CARDIOVASC INTER RAD, V37, P1343, DOI 10.1007/s00270-013-0828-3; Thompson SM, 2014, LASER SURG MED, V46, P290, DOI 10.1002/lsm.22231; Thompson SM, 2013, INVEST RADIOL, V48, P413, DOI 10.1097/RLI.0b013e31827a4a3f; Thompson SM, 2013, CARDIOVASC INTER RAD, V36, P198, DOI 10.1007/s00270-012-0466-1; Thompson SM, 2012, J VASC INTERV RADIOL, V23, P385, DOI 10.1016/j.jvir.2011.11.018; Tiong L, 2011, BRIT J SURG, V98, P1210, DOI 10.1002/bjs.7669; Wang JH, 2012, J HEPATOL, V56, P412, DOI 10.1016/j.jhep.2011.05.020; Whittaker S, 2010, ONCOGENE, V29, P4989, DOI 10.1038/onc.2010.236; Yang BW, 2011, EUR J RADIOL, V79, P196, DOI 10.1016/j.ejrad.2010.02.010; Yang F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059879; Yang JD, 2012, MAYO CLIN PROC, V87, P9, DOI 10.1016/j.mayocp.2011.07.001; Yang JD, 2010, NAT REV GASTRO HEPAT, V7, P448, DOI 10.1038/nrgastro.2010.100; Yang SJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026343; Yin XY, 2009, CANCER-AM CANCER SOC, V115, P1914, DOI 10.1002/cncr.24196; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429; Zhang YQ, 2011, CANCER BIOL THER, V12, P253, DOI 10.4161/cbt.12.4.15954; Zheng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049581; Zhou Q, 2011, FUTURE ONCOL, V7, P1149, DOI [10.2217/FON.11.95, 10.2217/fon.11.95]	75	19	20	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162634	10.1371/journal.pone.0162634	http://dx.doi.org/10.1371/journal.pone.0162634			29	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611696	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900140
J	Vann, NC; Pham, FD; Hayes, JA; Kottick, A; Del Negro, CA				Vann, Nikolas C.; Pham, Francis D.; Hayes, John A.; Kottick, Andrew; Del Negro, Christopher A.			Transient Suppression of Dbx1 PreBotzinger Interneurons Disrupts Breathing in Adult Mice	PLOS ONE			English	Article							RESPIRATORY RHYTHM-GENERATOR; PRE-BOTZINGER COMPLEX; SPINAL-CORD; IN-VIVO; NEURONS; MOTOR; SOMATOSTATIN; ACTIVATION; DIVERSITY; PATTERN	Interneurons derived from Dbx1-expressing precursors located in the brainstem preBotzinger complex (preBotC) putatively form the core oscillator for inspiratory breathing movements. We tested this Dbx1 core hypothesis by expressing archaerhodopsin in Dbx1-derived interneurons and then transiently hyperpolarizing these neurons while measuring respiratory rhythm in vitro or breathing in vagus-intact adult mice. Transient illumination of the preBotC interrupted inspiratory rhythm in both slice preparations and sedated mice. In awake mice, light application reduced breathing frequency and prolonged the inspiratory duration. Support for the Dbx1 core hypothesis previously came from embryonic and perinatal mouse experiments, but these data suggest that Dbx1-derived preBotC interneurons are rhythmogenic in adult mice too. The neural origins of breathing behavior can be attributed to a localized and genetically well-defined interneuron population.	[Vann, Nikolas C.; Pham, Francis D.; Hayes, John A.; Kottick, Andrew; Del Negro, Christopher A.] Coll William & Mary, Dept Appl Sci, Williamsburg, VA 23185 USA	William & Mary	Del Negro, CA (corresponding author), Coll William & Mary, Dept Appl Sci, Williamsburg, VA 23185 USA.	cadeln@wm.edu	Del Negro, Christopher A./AAB-4565-2020	Del Negro, Christopher A./0000-0002-7848-8224; Pham, Francis/0000-0003-1082-8533	National Institutes of Health [R01 HL104127]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL104127] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	National Institutes of Health grant R01 HL104127 (PI: CDN) supported this work.	Abbott SBG, 2013, J NEUROSCI, V33, P3164, DOI 10.1523/JNEUROSCI.1046-12.2013; Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; Bikoff JB, 2016, CELL, V165, P207, DOI 10.1016/j.cell.2016.01.027; Bouvier J, 2010, NAT NEUROSCI, V13, P1066, DOI 10.1038/nn.2622; Cui Y, 2016, NEURON, V91, P602, DOI 10.1016/j.neuron.2016.07.003; Deschenes M, 2016, NEURON, V90, P374, DOI 10.1016/j.neuron.2016.03.007; ERHARDT W, 1984, RES EXP MED, V184, P159, DOI 10.1007/BF01852390; Feldman JL, 2013, ANNU REV PHYSIOL, V75, P423, DOI 10.1146/annurev-physiol-040510-130049; Flecknell P, 2015, LAB ANIMAL ANAESTHES; Franklin K.B.J., 2013, PAXINOS FRANKLINS MO; FUNK GD, 1993, J NEUROPHYSIOL, V70, P1497, DOI 10.1152/jn.1993.70.4.1497; Funk GD, 2013, RESP PHYSIOL NEUROBI, V186, P236, DOI 10.1016/j.resp.2013.01.011; Gabitto MI, 2016, CELL, V165, P220, DOI 10.1016/j.cell.2016.01.026; Gray PA, 2001, NAT NEUROSCI, V4, P927, DOI 10.1038/nn0901-927; Gray PA, 1999, SCIENCE, V286, P1566, DOI 10.1126/science.286.5444.1566; Gray PA, 2010, J NEUROSCI, V30, P14883, DOI 10.1523/JNEUROSCI.4031-10.2010; GREEN CJ, 1981, LAB ANIM, V15, P163, DOI 10.1258/002367781780959107; GREER JJ, 1991, J PHYSIOL-LONDON, V437, P727, DOI 10.1113/jphysiol.1991.sp018622; Guyenet PG, 2016, J PHYSIOL-LONDON, V594, P1529, DOI 10.1113/JP271480; Guyenet PG, 2013, AM J PHYSIOL-REG I, V305, pR187, DOI 10.1152/ajpregu.00054.2013; Guyenet PG, 2002, J NEUROSCI, V22, P3806; Hilaire G, 2004, RESP PHYSIOL NEUROBI, V143, P187, DOI 10.1016/j.resp.2004.04.016; Hirata T, 2009, NAT NEUROSCI, V12, P141, DOI 10.1038/nn.2241; Holloway BB, 2013, J NEUROSCI, V33, P18792, DOI 10.1523/JNEUROSCI.2916-13.2013; KLEINMAN LI, 1964, J APPL PHYSIOL, V19, P360, DOI 10.1152/jappl.1964.19.2.360; Koizumi H, 2008, J NEUROSCI, V28, P2353, DOI 10.1523/JNEUROSCI.3553-07.2008; Llona I, 2005, BIOL RES, V38, P347, DOI 10.4067/S0716-97602005000400006; Madisen L, 2012, NAT NEUROSCI, V15, P793, DOI 10.1038/nn.3078; Marchenko V, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0011-16.2016; McKay LC, 2005, NAT NEUROSCI, V8, P1142, DOI 10.1038/nn1517; Moore JD, 2013, NATURE, V497, P205, DOI 10.1038/nature12076; Picardo MCD, 2013, J PHYSIOL-LONDON, V591, P2687, DOI 10.1113/jphysiol.2012.250118; Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4; Ptak K, 2009, J NEUROSCI, V29, P3720, DOI 10.1523/JNEUROSCI.5271-08.2009; Revill AL, 2015, ELIFE, V4, DOI 10.7554/eLife.12301; Ruangkittisakul A., 2014, PHYSL REP, V2, P2; Ruangkittisakul A, 2006, J NEUROSCI, V26, P11870, DOI 10.1523/JNEUROSCI.3357-06.2006; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Schulz H, 2002, ACTA PHYSIOL SCAND, V174, P367, DOI 10.1046/j.1365-201x.2002.00955.x; SMITH JC, 1991, SCIENCE, V254, P726, DOI 10.1126/science.1683005; SMITH JC, 1990, J NEUROPHYSIOL, V64, P1149, DOI 10.1152/jn.1990.64.4.1149; Song H, J NEUROSCI  IN PRESS; Song NN, 2015, RESP PHYSIOL NEUROBI, V219, P25, DOI 10.1016/j.resp.2015.07.015; STAHL WR, 1967, J APPL PHYSIOL, V22, P453, DOI 10.1152/jappl.1967.22.3.453; Stornetta RL, 2002, J COMP NEUROL, V444, P207, DOI 10.1002/cne.10142; Stornetta RL, 2003, J COMP NEUROL, V455, P499, DOI 10.1002/cne.10504; Tan WB, 2008, NAT NEUROSCI, V11, P538, DOI 10.1038/nn.2104; Viemari JC, 2003, EUR J NEUROSCI, V17, P1233, DOI 10.1046/j.1460-9568.2003.02561.x; Wallen-Mackenzie A, 2006, J NEUROSCI, V26, P12294, DOI 10.1523/JNEUROSCI.3855-06.2006; Wang H, 2001, J COMP NEUROL, V434, P128, DOI 10.1002/cne.1169; Wang XY, 2014, ELIFE, V3, DOI 10.7554/eLife.03427; Yizhar O, 2011, NEURON, V71, P9, DOI 10.1016/j.neuron.2011.06.004	52	25	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162418	10.1371/journal.pone.0162418	http://dx.doi.org/10.1371/journal.pone.0162418			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611210	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900096
J	Gao, L; Cui, WN; Zhang, PY; Jang, A; Zhu, WQ; Zhang, JY				Gao, Ling; Cui, Weina; Zhang, Pengyuan; Jang, Albert; Zhu, Wuqiang; Zhang, Jianyi			P-31 NMR 2D Mapping of Creatine Kinase Forward Flux Rate in Hearts with Postinfarction Left Ventricular Remodeling in Response to Cell Therapy	PLOS ONE			English	Article							INDUCED PLURIPOTENT STEM; FUNCTIONAL CONSEQUENCES; PORCINE MODEL; IN-VIVO; MYOCARDIAL-INFARCTION; PROGENITOR CELLS; WALL STRESS; DIFFERENTIATION; HYPERTROPHY; CONTRIBUTES	Utilizing a fast P-31 magnetic resonance spectroscopy (MRS) 2-dimensional chemical shift imaging (2D-CSI) method, this study examined the heterogeneity of creatine kinase (CK) forward flux rate of hearts with postinfarction left ventricular (LV) remodeling. Immunosuppressed Yorkshire pigs were assigned to 4 groups: 1) A sham-operated normal group (SHAM, n = 6); 2) A 60 minutes distal left anterior descending coronary artery ligation and reperfusion (MI, n = 6); 3) Open patch group; ligation injury plus open fibrin patch over the site of injury (Patch, n = 6); and 4) Cell group, hiPSCs-cardiomyocytes,-endothelial cells, and-smooth muscle cells (2 million, each) were injected into the injured myocardium pass through a fibrin patch (Cell+Patch, n = 5). At 4 weeks, the creatine phosphate (PCr)/ATP ratio, CK forward flux rate (Flux (PCr -> ATP)), and k constant of CK forward flux rate (k(PCr -> ATP)) were severely decreased at border zone myocardium (BZ) adjacent to MI. Cell treatment results in significantly increase of PCr/ATP ratio and improve the value of k(PCr -> ATP) and Flux (PCr -> ATP) in BZ myocardium. Moreover, the BZ myocardial CK total activity and protein expression of CK mitochondria isozyme and CK myocardial isozyme were significantly reduced, but recovered in response to cell treatment. Thus, cell therapy results in improvement of BZ bioenergetic abnormality in hearts with postinfarction LV remodeling, which is accompanied by significantly improvements in BZ CK activity and CK isozyme expression. The fast 2D P-31 MR CSI mapping can reliably measure the heterogeneity of bioenergetics in hearts with post infarction LV remodeling.	[Gao, Ling; Zhu, Wuqiang; Zhang, Jianyi] Univ Alabama Birmingham, Sch Med, Dept Biomed Engn, Birmingham, AL 35233 USA; [Gao, Ling; Zhu, Wuqiang; Zhang, Jianyi] Univ Alabama Birmingham, Sch Engn, Birmingham, AL 35233 USA; [Cui, Weina; Zhang, Pengyuan; Jang, Albert] Univ Minnesota Twin Cities, Dept Med, Div Cardiol, Minneapolis, MN 55455 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Minnesota System; University of Minnesota Twin Cities	Zhang, JY (corresponding author), Univ Alabama Birmingham, Sch Med, Dept Biomed Engn, Birmingham, AL 35233 USA.; Zhang, JY (corresponding author), Univ Alabama Birmingham, Sch Engn, Birmingham, AL 35233 USA.	jayzhang@uab.edu			National Institutes of Health [RO1 HL67828, RO1 HL95077, RO1 HL114120, UO1 HL100407]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100407, U01HL134764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health RO1 HL67828; National Institutes of Health RO1 HL95077; National Institutes of Health RO1 HL114120; and National Institutes of Health UO1 HL100407.	Bao XP, 2015, STEM CELL RES, V15, P122, DOI 10.1016/j.scr.2015.05.004; Bolli R, 2015, J AM COLL CARDIOL, V66, P2000, DOI 10.1016/j.jacc.2015.09.002; Bottomley PA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007328; Feygin J, 2008, AM J PHYSIOL-HEART C, V294, pH2313, DOI 10.1152/ajpheart.01288.2007; Gao L, 2014, J MOL CELL CARDIOL, V77, P102, DOI 10.1016/j.yjmcc.2014.10.004; Gao L, 2014, AM J PHYSIOL-HEART C, V306, pH1569, DOI 10.1152/ajpheart.00772.2013; Gupta A, 2012, J CLIN INVEST, V122, P291, DOI 10.1172/JCI57426; Guzun R, 2011, AMINO ACIDS, V40, P1333, DOI 10.1007/s00726-011-0854-x; Ilic D, 2015, BRIT MED BULL, V116, P19, DOI 10.1093/bmb/ldv045; Ingwall JS, 2009, CARDIOVASC RES, V81, P412, DOI 10.1093/cvr/cvn301; Karantalis V, 2015, J AM COLL CARDIOL, V66, P1990, DOI 10.1016/j.jacc.2015.08.879; Katz Arnold M., 1998, Cardiology Clinics, V16, P633, DOI 10.1016/S0733-8651(05)70040-0; Lian XJ, 2013, NAT PROTOC, V8, P162, DOI 10.1038/nprot.2012.150; Makkar RR, 2012, LANCET, V379, P895, DOI 10.1016/S0140-6736(12)60195-0; Marchand M, 2014, STEM CELL TRANSL MED, V3, P91, DOI 10.5966/sctm.2013-0124; Matsa E, 2014, CIRC RES, V114, P21, DOI 10.1161/CIRCRESAHA.113.302895; MORIARTY TF, 1980, CIRC RES, V46, P321, DOI 10.1161/01.RES.46.3.321; ROBITAILLE PML, 1993, MAGNET RESON MED, V30, P4; Tohyama S, 2013, CELL STEM CELL, V12, P127, DOI 10.1016/j.stem.2012.09.013; Wallimann T, 2011, AMINO ACIDS, V40, P1271, DOI 10.1007/s00726-011-0877-3; Wang XH, 2009, CIRCULATION, V120, pS238, DOI 10.1161/CIRCULATIONAHA.109.885236; Weiss RG, 2005, P NATL ACAD SCI USA, V102, P808, DOI 10.1073/pnas.0408962102; Xiong Q, 2015, AM J PHYSIOL-HEART C, V309, pH450, DOI 10.1152/ajpheart.00072.2015; Xiong Q, 2013, CIRCULATION, V127, P997, DOI 10.1161/CIRCULATIONAHA.112.000641; Xiong Q, 2012, CIRC RES, V111, P455, DOI 10.1161/CIRCRESAHA.112.269894; Xiong QA, 2011, CIRC RES, V108, P653, DOI 10.1161/CIRCRESAHA.110.231456; Xiong QA, 2011, STEM CELLS, V29, P367, DOI 10.1002/stem.580; Xiong Q, 2009, AM J PHYSIOL-HEART C, V297, pH1010, DOI 10.1152/ajpheart.01195.2008; Yang LB, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147155; Ye L, 2014, CELL STEM CELL, V15, P750, DOI 10.1016/j.stem.2014.11.009; Ye Y, 2001, CIRCULATION, V103, P1570; Zeng LP, 2007, CIRCULATION, V115, P1866, DOI 10.1161/CIRCULATIONAHA.106.659730; Zhang S, 2014, BIOMATERIALS, V35, P3786, DOI 10.1016/j.biomaterials.2014.01.037	33	3	3	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162149	10.1371/journal.pone.0162149	http://dx.doi.org/10.1371/journal.pone.0162149			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606901	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600022
J	Hackett, JL; Wang, XF; Smith, BR; Macdonald, SJ				Hackett, Jennifer L.; Wang, Xiaofei; Smith, Brittny R.; Macdonald, Stuart J.			Mapping QTL Contributing to Variation in Posterior Lobe Morphology between Strains of Drosophila melanogaster	PLOS ONE			English	Article							QUANTITATIVE TRAIT LOCI; ADVANCED INTERCROSS LINES; SYNTHETIC POPULATION RESOURCE; GENETIC REFERENCE PANEL; CRYPTIC FEMALE CHOICE; GENITAL MORPHOLOGY; COMPLEX TRAITS; RECOMBINANT POPULATIONS; MISSING HERITABILITY; NATURAL-POPULATIONS	Closely-related, and otherwise morphologically similar insect species frequently show striking divergence in the shape and/or size of male genital structures, a phenomenon thought to be driven by sexual selection. Comparative interspecific studies can help elucidate the evolutionary forces acting on genital structures to drive this rapid differentiation. However, genetic dissection of sexual trait divergence between species is frequently hampered by the difficulty generating interspecific recombinants. Intraspecific variation can be leveraged to investigate the genetics of rapidly-evolving sexual traits, and here we carry out a genetic analysis of variation in the posterior lobe within D. melanogaster. The lobe is a male-specific process emerging from the genital arch of D. melanogaster and three closely-related species, is essential for copulation, and shows radical divergence in form across species. There is also abundant variation within species in the shape and size of the lobe, and while this variation is considerably more subtle than that seen among species, it nonetheless provides the raw material for QTL mapping. We created an advanced intercross population from a pair of phenotypically-different inbred strains, and after phenotyping and genotyping-by-sequencing the recombinants, mapped several QTL contributing to various measures of lobe morphology. The additional generations of crossing over in our mapping population led to QTL intervals that are smaller than is typical for an F-2 mapping design. The intervals we map overlap with a pair of lobe QTL we previously identified in an independent mapping cross, potentially suggesting a level of shared genetic control of trait variation. Our QTL additionally implicate a suite of genes that have been shown to contribute to the development of the posterior lobe. These loci are strong candidates to harbor naturally-segregating sites contributing to phenotypic variation within D. melanogaster, and may also be those contributing to divergence in lobe morphology between species.	[Hackett, Jennifer L.; Wang, Xiaofei; Smith, Brittny R.; Macdonald, Stuart J.] Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA; [Macdonald, Stuart J.] Univ Kansas, Ctr Computat Biol, 2030 Becker Dr, Lawrence, KS 66047 USA	University of Kansas; University of Kansas	Macdonald, SJ (corresponding author), Univ Kansas, Dept Mol Biosci, 1200 Sunnyside Ave, Lawrence, KS 66045 USA.; Macdonald, SJ (corresponding author), Univ Kansas, Ctr Computat Biol, 2030 Becker Dr, Lawrence, KS 66047 USA.	sjmac@ku.edu		Macdonald, Stuart/0000-0002-9421-002X	NIH [R01 GM085260, P20 GM103638, P20 GM103418]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103418, R01GM085260, P20GM103638] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by NIH R01 GM085260 to SJM. The KU Genome Sequencing Core is supported by NIH P20 GM103638, and the KINBRE Bioinformatics Core is supported by NIH P20 GM103418. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Andolfatto P, 2011, GENOME RES, V21, P610, DOI 10.1101/gr.115402.110; Attrill H, 2016, NUCLEIC ACIDS RES, V44, pD786, DOI 10.1093/nar/gkv1046; Barbash DA, 2010, GENETICS, V186, P1, DOI 10.1534/genetics.110.121459; Barton NH, 2002, NAT REV GENET, V3, P11, DOI 10.1038/nrg700; BARTON NH, 1989, ANNU REV GENET, V23, P337, DOI 10.1146/annurev.ge.23.120189.002005; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Broman KW, 2006, GENETICS, V174, P2151, DOI 10.1534/genetics.106.061176; Broman KW, 2012, G3-GENES GENOM GENET, V2, P199, DOI 10.1534/g3.111.001818; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Chatterjee SS, 2011, DEVELOPMENT, V138, P1099, DOI 10.1242/dev.055731; Cheng RY, 2010, GENETICS, V185, P1033, DOI 10.1534/genetics.110.116863; CHURCHILL GA, 1994, GENETICS, V138, P963; COYNE JA, 1983, EVOLUTION, V37, P1101, DOI 10.1111/j.1558-5646.1983.tb00225.x; COYNE JA, 1986, EVOLUTION, V40, P673, DOI 10.1111/j.1558-5646.1986.tb00530.x; DARVASI A, 1995, GENETICS, V141, P1199; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Eberhard W.G., 1985, SEXUAL SELECTION ANI; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; FERSON S, 1985, SYST ZOOL, V34, P59, DOI 10.2307/2413345; Flint J, 2009, GENOME RES, V19, P723, DOI 10.1101/gr.086660.108; Frazee SR, 2015, ECOL EVOL, V5, P4437, DOI 10.1002/ece3.1721; Glassford WJ, 2015, DEV CELL, V34, P520, DOI 10.1016/j.devcel.2015.08.005; Holeski LM, 2014, G3-GENES GENOM GENET, V4, P813, DOI 10.1534/g3.113.010124; Hosken DJ, 2004, TRENDS ECOL EVOL, V19, P87, DOI 10.1016/j.tree.2003.11.012; Huang W, 2014, GENOME RES, V24, P1193, DOI 10.1101/gr.171546.113; Jagadeeshan S, 2006, J EVOLUTION BIOL, V19, P1058, DOI 10.1111/j.1420-9101.2006.01099.x; King EG, 2012, GENOME RES, V22, P1558, DOI 10.1101/gr.134031.111; KUHL FP, 1982, COMPUT VISION GRAPH, V18, P236, DOI 10.1016/0146-664X(82)90034-X; LACHAISE D, 1988, EVOL BIOL, V22, P159; Laurie CC, 1997, GENETICS, V145, P339; LeVasseur-Viens H, 2015, EVOLUTION, V69, P1797, DOI 10.1111/evo.12685; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liu J, 1996, GENETICS, V142, P1129; Liu SC, 1996, GENETICS, V142, P247; Long AD, 1996, GENETICS, V144, P1497; Long AD, 1998, GENETICS, V149, P999; Long AD, 2014, TRENDS GENET, V30, P488, DOI 10.1016/j.tig.2014.07.009; Macdonald SJ, 1999, GENETICS, V153, P1683; Macdonald SJ, 2007, GENETICS, V176, P1261, DOI 10.1534/genetics.106.069641; Mackay TFC, 2012, NATURE, V482, P173, DOI 10.1038/nature10811; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Masly JP, 2014, EVOLUTION, V68, P2401, DOI 10.1111/evo.12436; Masly JP, 2011, GENETICS, V189, P357, DOI 10.1534/genetics.111.130815; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; McNeil CL, 2011, G3-GENES GENOM GENET, V1, P343, DOI 10.1534/g3.111.000661; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Parker CC, 2014, GENETICS, V198, P103, DOI 10.1534/genetics.114.167056; Rockman MV, 2008, GENETICS, V179, P1069, DOI 10.1534/genetics.107.083873; Schielzeth H, 2014, ANN NY ACAD SCI, V1320, P35, DOI 10.1111/nyas.12397; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Sen S, 2001, GENETICS, V159, P371; Shingleton AW, 2009, P ROY SOC B-BIOL SCI, V276, P2625, DOI 10.1098/rspb.2008.1796; Stern DL, 2014, TRENDS GENET, V30, P547, DOI 10.1016/j.tig.2014.09.006; Takahara B, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132846; Tanaka KM, 2015, GENETICS, V200, P357, DOI 10.1534/genetics.114.174045; Turner TL, 2014, MOL ECOL, V23, P2377, DOI 10.1111/mec.12719; Valdar W, 2006, NAT GENET, V38, P879, DOI 10.1038/ng1840; Wittkopp PJ, 2009, SCIENCE, V326, P540, DOI 10.1126/science.1176980; Zeng ZB, 2000, GENETICS, V154, P299	60	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162573	10.1371/journal.pone.0162573	http://dx.doi.org/10.1371/journal.pone.0162573			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606594	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600067
J	Yang, L; Guo, S; Chen, QW; Chen, FJ; Yuan, LX; Mi, GH				Yang, Lan; Guo, Song; Chen, Qinwu; Chen, Fanjun; Yuan, Lixing; Mi, Guohua			Use of the Stable Nitrogen Isotope to Reveal the Source-Sink Regulation of Nitrogen Uptake and Remobilization during Grain Filling Phase in Maize	PLOS ONE			English	Article							USE EFFICIENCY; LEAF SENESCENCE; EAR REMOVAL; ROOT-GROWTH; DRY-MATTER; STAY-GREEN; HYBRIDS; YIELD; N-15; CARBON	Although the remobilization of vegetative nitrogen (N) and post-silking N both contribute to grain N in maize (Zea mays L.), their regulation by grain sink strength is poorly understood. Here we use N-15 labeling to analyze the dynamic behaviors of both pre- and post-silking N in relation to source and sink manipulation in maize plants. The results showed that the remobilization of pre-silking N started immediately after silking and the remobilized pre-silking N had a greater contribution to grain N during early grain filling, with post-silking N importance increasing during the later filling stage. The amount of post-silking N uptake was largely driven by post-silking dry matter accumulation in both grain as well as vegetative organs. Prevention of pollination during silking had less effect on post-silking N uptake, as a consequence of compensatory growth of stems, husk + cob and roots. Also, leaves continuously export N even though grain sink was removed. The remobilization efficiency of N in the leaf and stem increased with increasing grain yield (hence N requirement). It is suggested that the remobilization of N in the leaf is controlled by sink strength but not the leaf per se. Enhancing post-silking N uptake rather than N remobilization is more likely to increase grain N accumulation.	[Yang, Lan; Guo, Song; Chen, Qinwu; Chen, Fanjun; Yuan, Lixing; Mi, Guohua] China Agr Univ, Coll Resources & Environm Sci, Ctr Resources Environm & Food Secur, Beijing, Peoples R China; [Guo, Song] Sichuan Acad Agr Sci, Soil & Fertilizer Res Inst, Chengdu, Peoples R China	China Agricultural University; Sichuan Academy of Agricultural Sciences (SAAS)	Mi, GH (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Ctr Resources Environm & Food Secur, Beijing, Peoples R China.	miguohua@cau.edu.cn	Yuan, Lixing/I-2727-2012	Yuan, Lixing/0000-0003-0233-6184; Chen, Qinwu/0000-0002-4134-6185; Chen, Fanjun/0000-0001-8105-1683	National Science Foundation of China [31272233, 31421092]; National Basic Research Program of China [2015CB150402]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	Financial support was provided by the National Science Foundation of China (grant nos. 31272233 and 31421092) and the National Basic Research Program of China (2015CB150402). GHM received the funding.	Antonietta M, 2014, FIELD CROP RES, V155, P111, DOI 10.1016/j.fcr.2013.09.016; Chen XC, 2013, GLOBAL CHANGE BIOL, V19, P923, DOI 10.1111/gcb.12093; Chen YL, 2015, EUR J AGRON, V62, P79, DOI 10.1016/j.eja.2014.09.008; Chen YL, 2014, FIELD CROP RES, V159, P1, DOI 10.1016/j.fcr.2014.01.002; CHRISTENSEN LE, 1981, PLANT PHYSIOL, V68, P1180, DOI 10.1104/pp.68.5.1180; Ciampitti IA, 2013, CROP SCI, V53, P366, DOI 10.2135/cropsci2012.07.0439; CLIQUET JB, 1990, PLANT PHYSIOL, V92, P79, DOI 10.1104/pp.92.1.79; CLIQUET JB, 1990, PLANT PHYSIOL, V94, P1547, DOI 10.1104/pp.94.4.1547; CRAFTSBRANDNER SJ, 1984, PLANT PHYSIOL, V74, P360, DOI 10.1104/pp.74.2.360; Duvick DN, 1999, CROP SCI, V39, P1622, DOI 10.2135/cropsci1999.3961622x; Gallais A, 2007, CROP SCI, V47, P685, DOI 10.2135/cropsci2006.08.0523; Gallais A, 2006, NEW PHYTOL, V172, P696, DOI 10.1111/j.1469-8137.2006.01890.x; Hirel B, 2006, NEW PHYTOL, V169, P445, DOI 10.1111/j.1469-8137.2006.01641.x; Hirel B, 2007, J EXP BOT, V58, P2369, DOI 10.1093/jxb/erm097; Jones DL, 2009, PLANT SOIL, V321, P5, DOI 10.1007/s11104-009-9925-0; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; Kant S, 2011, J EXP BOT, V62, P1499, DOI 10.1093/jxb/erq297; Ma BL, 1998, PLANT SOIL, V199, P283, DOI 10.1023/A:1004397219723; Ma BL, 1998, COMMUN SOIL SCI PLAN, V29, P2459, DOI 10.1080/00103629809370124; Masclaux-Daubresse C, 2008, PLANT BIOLOGY, V10, P23, DOI 10.1111/j.1438-8677.2008.00097.x; Mi GH, 2003, J PLANT NUTR, V26, P237, DOI 10.1081/PLN-120016507; Mu XH, 2015, EUR J AGRON, V63, P55, DOI 10.1016/j.eja.2014.11.009; Mueller ND, 2012, NATURE, V490, P254, DOI 10.1038/nature11420; Niu JF, 2010, J PLANT NUTR SOIL SC, V173, P306, DOI 10.1002/jpln.200800316; PAN WL, 1986, PLANT PHYSIOL, V82, P247, DOI 10.1104/pp.82.1.247; PAN WL, 1995, CROP SCI, V35, P836, DOI 10.2135/cropsci1995.0011183X003500030034x; Pommel B, 2006, EUR J AGRON, V24, P203, DOI 10.1016/j.eja.2005.10.001; Rajcan I, 1999, FIELD CROP RES, V60, P255, DOI 10.1016/S0378-4290(98)00143-9; Raun WR, 1999, AGRON J, V91, P357, DOI 10.2134/agronj1999.00021962009100030001x; REED AJ, 1988, CROP SCI, V28, P819, DOI 10.2135/cropsci1988.0011183X002800050020x; Seebauer JR, 2010, J EXP BOT, V61, P511, DOI 10.1093/jxb/erp324; Subedi KD, 2005, CROP SCI, V45, P740, DOI 10.2135/cropsci2005.0740; TA CT, 1991, PLANT PHYSIOL, V97, P1375, DOI 10.1104/pp.97.4.1375; TA CT, 1992, CROP SCI, V32, P443, DOI 10.2135/cropsci1992.0011183X003200020032x; Tran Thi Sen, 1998, Canadian Journal of Soil Science, V78, P597; UHART SA, 1995, CROP SCI, V35, P1376, DOI [10.2135/cropsci1995.0011183X003500050020x, 10.2135/cropsci1995.0011183X003500010034x, 10.2135/cropsci1995.0011183X003500050021x]; Valentinuz OR, 2004, CROP SCI, V44, P827, DOI 10.2135/cropsci2004.0827; WEILAND RT, 1992, AUST J PLANT PHYSIOL, V19, P77, DOI 10.1071/PP9920077; Yan HF, 2011, CROP SCI, V51, P265, DOI 10.2135/cropsci2010.03.0180	39	18	25	6	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162201	10.1371/journal.pone.0162201	http://dx.doi.org/10.1371/journal.pone.0162201			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606628	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255600028
J	Figueroa, A; McKelvy, AD; Grismer, LL; Bell, CD; Lailvaux, SP				Figueroa, Alex; McKelvy, Alexander D.; Grismer, L. Lee; Bell, Charles D.; Lailvaux, Simon P.			A Species-Level Phylogeny of Extant Snakes with Description of a New Colubrid Subfamily and Genus	PLOS ONE			English	Article							MOLECULAR PHYLOGENY; MISSING DATA; EVOLUTIONARY HISTORY; LARGE-SCALE; REVISED CLASSIFICATION; SERPENTES COLUBRIDAE; MAXIMUM-LIKELIHOOD; TAXONOMIC REVISION; RAPID RADIATION; 4 NUCLEAR	Background With over 3,500 species encompassing a diverse range of morphologies and ecologies, snakes make up 36% of squamate diversity. Despite several attempts at estimating higher-level snake relationships and numerous assessments of generic- or species-level phylogenies, a large-scale species-level phylogeny solely focusing on snakes has not been completed. Here, we provide the largest-yet estimate of the snake tree of life using maximum likelihood on a supermatrix of 1745 taxa (1652 snake species + 7 outgroup taxa) and 9,523 base pairs from 10 loci (5 nuclear, 5 mitochondrial), including previously unsequenced genera (2) and species Results Increased taxon sampling resulted in a phylogeny with a new higher-level topology and corroborate many lower-level relationships, strengthened by high nodal support values (> 85%) down to the species level (73.69% of nodes). Although the majority of families and subfamilies were strongly supported as monophyletic with > 88% support values, some families and numerous genera were paraphyletic, primarily due to limited taxon and loci sampling leading to a sparse supermatrix and minimal sequence overlap between some closely-related taxa. With all rogue taxa and incertae sedis species eliminated, higher-level relationships and support values remained relatively unchanged, except in five problematic clades. Conclusion Our analyses resulted in new topologies at higher- and lower-levels; resolved several previous topological issues; established novel paraphyletic affiliations; designated a new subfamily, Ahaetuliinae, for the genera Ahaetulla, Chrysopelea, Dendrelaphis, and Dryophiops; and appointed Hemerophis (Coluber) zebrinus to a new genus, Mopanveldophis. Although we provide insight into some distinguished problematic nodes, at the deeper phylogenetic scale, resolution of these nodes may require sampling of more slowly-evolving nuclear genes.	[Figueroa, Alex; Bell, Charles D.; Lailvaux, Simon P.] Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA; [McKelvy, Alexander D.] CUNY, Grad Sch & Ctr, Dept Biol, New York, NY 10021 USA; [McKelvy, Alexander D.] CUNY Coll Staten Isl, Dept Biol, 6S-143,2800 Victory Blvd, Staten Isl, NY USA; [Grismer, L. Lee] La Sierra Univ, Dept Biol, 4500 Riverwalk Pkwy, Riverside, CA USA	University of Louisiana System; University of New Orleans; City University of New York (CUNY) System; City University of New York (CUNY) System; College of Staten Island (CUNY)	Figueroa, A (corresponding author), Univ New Orleans, Dept Biol Sci, New Orleans, LA 70148 USA.	afigueroa21@gmail.com	Figueroa, Alex/AAN-3626-2020; Lailvaux, Simon/C-3121-2008	Figueroa, Alex/0000-0002-5083-9993; 	National Science Foundation East Asia & Pacific Summer Institute [OISE-1107819]; University of New Orleans College of Sciences Graduate Student Research Grant; University of New Orleans Department of Biological Science Dissertation Enhancement Award; University of New Orleans Dissertation Improvement Grant; University of New Orleans Latin American Studies Abroad Program Award; NSF [DEB-9200779, DEB-9505518]; Museum of Vertebrate Zoology (MVZ); Peabody Museum of Natural History Yale University (YPM)	National Science Foundation East Asia & Pacific Summer Institute; University of New Orleans College of Sciences Graduate Student Research Grant; University of New Orleans Department of Biological Science Dissertation Enhancement Award; University of New Orleans Dissertation Improvement Grant; University of New Orleans Latin American Studies Abroad Program Award; NSF(National Science Foundation (NSF)); Museum of Vertebrate Zoology (MVZ); Peabody Museum of Natural History Yale University (YPM)	This work was supported by National Science Foundation East Asia & Pacific Summer Institute (OISE-1107819); University of New Orleans College of Sciences Graduate Student Research Grant; University of New Orleans Department of Biological Science Dissertation Enhancement Award; University of New Orleans Dissertation Improvement Grant; and University of New Orleans Latin American Studies Abroad Program Award. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We are indebted to the many researchers who donated tissue samples to museum collections and uploaded their sequences on GenBank. For supporting this research in the way of loaning tissue samples, we would like to acknowledge curators and staff at the Ambrose Monell Cryo Collection (AMCC) at the American Museum of Natural History, New York (AMNH), the California Academy of Sciences (CAS), the Field Museum of Natural History (FMNH), the Natural History Museum & Biodiversity Research Center at the University of Kansas (KU), and the LSU Museum of Natural Science Collection of Genetic Resources (LSUMNS) and L.J. Vitt and his NSF grants DEB-9200779 and DEB-9505518, the Museum of Vertebrate Zoology (MVZ), and the Peabody Museum of Natural History Yale University (YPM).	Aberer AJ, 2013, SYST BIOL, V62, P162, DOI 10.1093/sysbio/sys078; Alfaro ME, 2001, MOL PHYLOGENET EVOL, V21, P408, DOI 10.1006/mpev.2001.1024; Alfaro ME, 2008, MOL PHYLOGENET EVOL, V46, P576, DOI 10.1016/j.ympev.2007.10.024; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Bauer Aaron M., 2001, Herpetozoa, V14, P75; Bohme W, 2011, SALAMANDRA, V47, P120; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; Boulenger G.A., 1896, CATALOGUE SNAKES BRI, V3; Broadley Donald G., 1997, Madoqua, V19, P171; Brongersma L. D., 1938, Zoologische Mededeelingen Leiden, VXX, P240; Burbrink FT, 2007, MOL PHYLOGENET EVOL, V43, P173, DOI 10.1016/j.ympev.2006.09.009; Burbrink FT, 2011, REPROD BIOL PHYLOGEN, V9, P19; Burleigh JG, 2015, MOL PHYLOGENET EVOL, V84, P53, DOI 10.1016/j.ympev.2014.12.003; Cadle J. E., 1988, U CALIFORNIA PUBL ZO, V119, P1; Carranza S, 2006, MOL PHYLOGENET EVOL, V40, P532, DOI 10.1016/j.ympev.2006.03.028; Castoe TA, 2006, MOL PHYLOGENET EVOL, V39, P91, DOI 10.1016/j.ympev.2005.12.014; Chen X, 2014, ZOOTAXA, V3881, P532, DOI 10.11646/zootaxa.3881.6.3; Chen X, 2013, MOL PHYLOGENET EVOL, V66, P254, DOI 10.1016/j.ympev.2012.09.032; de Queiroz A, 2007, TRENDS ECOL EVOL, V22, P34, DOI 10.1016/j.tree.2006.10.002; Dowling HG, 1996, J ZOOL, V240, P1, DOI 10.1111/j.1469-7998.1996.tb05482.x; Driskell AC, 2004, SCIENCE, V306, P1172, DOI 10.1126/science.1102036; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards SV, 2009, EVOLUTION, V63, P1, DOI 10.1111/j.1558-5646.2008.00549.x; Fenwick AM, 2009, ZOOL J LINN SOC-LOND, V156, P617, DOI 10.1111/j.1096-3642.2008.00495.x; Gatesy J, 2014, MOL PHYLOGENET EVOL, V80, P231, DOI 10.1016/j.ympev.2014.08.013; Gower DJ, 2005, J ZOOL SYST EVOL RES, V43, P315, DOI 10.1111/j.1439-0469.2005.00315.x; Grazziotin FG, 2012, CLADISTICS, V28, P437, DOI 10.1111/j.1096-0031.2012.00393.x; Grismer LL, 2014, ZOOTAXA, V3815, P51, DOI 10.11646/zootaxa.3815.1.3; Guo P, 2014, ZOOTAXA, V3873, P425, DOI 10.11646/zootaxa.3873.4.5; Harvey P. H., 1991, COMP METHOD EVOLUTIO, V239; Hedges S. Blair, 2014, Caribbean Herpetology, V49; Hedges SB, 2009, ZOOTAXA, P1; Hedtke SM, 2006, SYST BIOL, V55, P522, DOI 10.1080/10635150600697358; HEISE PJ, 1995, MOL BIOL EVOL, V12, P259; Herrmann HW, 2013, J ARID ENVIRON, V93, P94, DOI 10.1016/j.jaridenv.2012.05.003; Hsiang AY, 2015, BMC EVOL BIOL, V15, DOI 10.1186/s12862-015-0358-5; Huelsenbeck JP, 1997, SCIENCE, V276, P227, DOI 10.1126/science.276.5310.227; Kearse M, 2012, BIOINFORMATICS, V28, P1647, DOI 10.1093/bioinformatics/bts199; Kelly CMR, 2008, MOL PHYLOGENET EVOL, V47, P1045, DOI 10.1016/j.ympev.2008.03.025; Kelly CMR, 2009, CLADISTICS, V25, P38, DOI 10.1111/j.1096-0031.2008.00237.x; Kelly CMR, 2003, SYST BIOL, V52, P439, DOI 10.1080/10635150390218132; Kluge AG, 1993, REC AUS MUS S19, V77; Kornilios P, 2013, MOL PHYLOGENET EVOL, V68, P35, DOI 10.1016/j.ympev.2013.03.009; Lambert SM, 2015, MOL PHYLOGENET EVOL, V82, P146, DOI 10.1016/j.ympev.2014.10.004; Lawson R, 2005, MOL PHYLOGENET EVOL, V37, P581, DOI 10.1016/j.ympev.2005.07.016; Lawson R, 2004, J ZOOL, V263, P285, DOI 10.1017/S0952836904005278; Lemmon AR, 2009, SYST BIOL, V58, P130, DOI 10.1093/sysbio/syp017; Lemmon EM, 2013, ANNU REV ECOL EVOL S, V44, P99, DOI 10.1146/annurev-ecolsys-110512-135822; Lenk P, 2001, AMPHIBIA-REPTILIA, V22, P329, DOI 10.1163/156853801317050124; Lenk P, 2001, MOL PHYLOGENET EVOL, V19, P94, DOI 10.1006/mpev.2001.0912; Link HF, 1807, BESCHREIBUNG NATURAL, V2; Malhotra A, 2004, MOL PHYLOGENET EVOL, V32, P83, DOI 10.1016/j.ympev.2004.02.008; Malhotra A, 2010, MOL PHYLOGENET EVOL, V54, P172, DOI 10.1016/j.ympev.2009.09.007; McCormack JE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054848; McMahon MM, 2006, SYST BIOL, V55, P818, DOI 10.1080/10635150600999150; McVay JD, 2015, BIOL J LINN SOC, V116, P1, DOI 10.1111/bij.12558; Miller M.A., 2010, P GAT COMP ENV WORKS; Mullin S.J., 2009, SNAKES ECOLOGY CONSE, V1st; Murphy JC, 2011, MOL PHYLOGENET EVOL, V61, P953, DOI 10.1016/j.ympev.2011.08.013; Nabhan AR, 2012, BRIEF BIOINFORM, V13, P122, DOI 10.1093/bib/bbr014; Nagy ZT, 2004, J ZOOL SYST EVOL RES, V42, P223, DOI 10.1111/j.1439-0469.2004.00249.x; Nagy ZT, 2003, P ROY SOC B-BIOL SCI, V270, P2613, DOI 10.1098/rspb.2003.2547; Noonan BP, 2006, MOL PHYLOGENET EVOL, V40, P347, DOI 10.1016/j.ympev.2006.03.010; Pagel M, 1999, NATURE, V401, P877, DOI 10.1038/44766; Peng LF, 2014, ASIAN HERPETOL RES, V5, P228, DOI 10.3724/SP.J.1245.2014.00228; Philippe H, 2004, MOL BIOL EVOL, V21, P1740, DOI 10.1093/molbev/msh182; Piwczynski M, 2014, SYST ENTOMOL, V39, P783, DOI 10.1111/syen.12086; Pyron RA, 2014, MOL PHYLOGENET EVOL, V81, P221, DOI 10.1016/j.ympev.2014.08.023; Pyron RA, 2014, ZOOTAXA, V3846, P249, DOI 10.11646/zootaxa.3846.2.5; Pyron RA, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-93; Pyron RA, 2013, MOL PHYLOGENET EVOL, V66, P969, DOI 10.1016/j.ympev.2012.12.004; Pyron RA, 2012, EVOLUTION, V66, P163, DOI 10.1111/j.1558-5646.2011.01437.x; Pyron RA, 2011, MOL PHYLOGENET EVOL, V58, P329, DOI 10.1016/j.ympev.2010.11.006; Pyron RA, 2011, MOL PHYLOGENET EVOL, V61, P543, DOI 10.1016/j.ympev.2011.06.012; Pyron RA, 2014, ZOOTAXA, V3829, P1, DOI 10.11646/zootaxa.3829.1.1; Rabosky DL, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2958; Rawlings LH, 2008, BIOL J LINN SOC, V93, P603, DOI 10.1111/j.1095-8312.2007.00904.x; Reeder TW, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118199; Reynolds RG, 2014, MOL PHYLOGENET EVOL, V71, P201, DOI 10.1016/j.ympev.2013.11.011; RIEPPEL O, 1988, EVOL BIOL, V22, P37; Roure B, 2013, MOL BIOL EVOL, V30, P197, DOI 10.1093/molbev/mss208; Sanders KL, 2008, J EVOLUTION BIOL, V21, P682, DOI 10.1111/j.1420-9101.2008.01525.x; Sanders KL, 2013, MOL PHYLOGENET EVOL, V66, P575, DOI 10.1016/j.ympev.2012.09.021; Sanders KL, 2010, MOL PHYLOGENET EVOL, V56, P857, DOI 10.1016/j.ympev.2010.04.031; Sanderson MJ, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-155; Sanderson MJ, 2002, ANNU REV ECOL SYST, V33, P49, DOI 10.1146/annurev.ecolsys.33.010802.150509; Savage J. M., 1956, Bulletin of Zoological Nomenclature, V12, P147; Scanlon JD, 2011, REPROD BIOL PHYLOGEN, V9, P55; Schatti B, 2008, REV SUISSE ZOOL, V115, P595, DOI 10.5962/bhl.part.80448; Schulz KD, 1995, MONOGRAPH COLUBRID S; Seigel R.A., 1993, SNAKES ECOLOGY BEHAV; Seigel RA., 1987, SNAKES ECOLOGY EVOLU; Slowinski JB, 2002, MOL PHYLOGENET EVOL, V24, P194, DOI 10.1016/S1055-7903(02)00239-7; Smid J, 2015, ZOOTAXA, V4033, P380, DOI 10.11646/zootaxa.4033.3.4; Socha JJ, 2011, INTEGR COMP BIOL, V51, P969, DOI 10.1093/icb/icr092; Soltis DE, 2013, AM J BOT, V100, P916, DOI 10.3732/ajb.1300044; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Teynie A, 2015, ZOOTAXA, V3926, P523, DOI 10.11646/zootaxa.3926.4.4; Thomson RC, 2009, SYST BIOL, V59, P42, DOI DOI 10.1093/SYSBI0/; Townsend TM, 2004, SYST BIOL, V53, P735, DOI 10.1080/10635150490522340; Uetz P., REPTILE DATABASE; Underwood G., 1967, CONTRIBUTION CLASSIF; Utiger Urs, 2002, Russian Journal of Herpetology, V9, P105; Vidal N, 2002, CR BIOL, V325, P987, DOI 10.1016/S1631-0691(02)01509-3; Vidal N, 2002, CR BIOL, V325, P977, DOI 10.1016/S1631-0691(02)01510-X; Vidal N, 2007, CR BIOL, V330, P182, DOI 10.1016/j.crvi.2006.10.001; Vidal N, 2010, BIOL LETTERS, V6, P558, DOI 10.1098/rsbl.2010.0220; Vidal N, 2010, CR BIOL, V333, P48, DOI 10.1016/j.crvi.2009.11.003; Vidal N, 2008, ZOOTAXA, P51, DOI 10.11646/zootaxa.1945.1.3; Vidal Nicolas, 2009, P390; Wallach V., 2014, SNAKES WORLD CATALOG; Walls G. L., 1942, P1; Wang XH, 2014, ASIAN HERPETOL RES, V5, P137, DOI 10.3724/SP.J.1245.2014.00137; Weinstein SA, 2011, ELSEV INSIGHT, P1; Whelan S, 2001, TRENDS GENET, V17, P262, DOI 10.1016/S0168-9525(01)02272-7; Wiens JJ, 2008, SYST BIOL, V57, P420, DOI 10.1080/10635150802166053; Wiens JJ, 2008, J SYST EVOL, V46, P307, DOI 10.3724/SP.J.1002.2008.08040; Wiens JJ, 2012, BIOL LETTERS, V8, P1043, DOI 10.1098/rsbl.2012.0703; Wiens JJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042925; Wiens JJ, 2011, SYST BIOL, V60, P719, DOI 10.1093/sysbio/syr025; Wilkinson M, 1996, MOL BIOL EVOL, V13, P437, DOI 10.1093/oxfordjournals.molbev.a025604; You CW, 2015, ZOOL SCR, V44, P349, DOI 10.1111/zsc.12111; Zaher Hussam, 2009, Pap. Avulsos Zool., V49, P115; Zhang BL, 2013, ASIAN HERPETOL RES, V4, P155, DOI 10.3724/SP.J.1245.2013.00155; Zheng YC, 2016, MOL PHYLOGENET EVOL, V94, P537, DOI 10.1016/j.ympev.2015.10.009	126	217	242	5	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161070	10.1371/journal.pone.0161070	http://dx.doi.org/10.1371/journal.pone.0161070			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603205	gold, Green Published			2022-12-26	WOS:000383255200011
J	Weaver, SR; Bohrer, JC; Prichard, AS; Perez, PK; Streckenbach, LJ; Olson, JM; Cook, ME; Hernandez, LL				Weaver, Samantha R.; Bohrer, Justin C.; Prichard, Allan S.; Perez, Paola K.; Streckenbach, Liana J.; Olson, Jake M.; Cook, Mark E.; Hernandez, Laura L.			Serotonin Deficiency Rescues Lactation on Day 1 in Mice Fed a High Fat Diet	PLOS ONE			English	Article							MAMMARY-GLAND INVOLUTION; MATERNAL OBESITY; TRYPTOPHAN-HYDROXYLASE; PERIPHERAL SEROTONIN; ADIPOSE-TISSUE; DELAYED-ONSET; NITRIC-OXIDE; PREGNANCY; INFLAMMATION; WEIGHT	Obesity is an inflammatory state associated with delayed lactogenesis stage II and altered mammary gland morphology. Serotonin mediates inflammation and mammary gland involution. The objective of this study was to determine if a genetic deficiency of tryptophan hydroxylase 1, the rate-limiting enzyme in peripheral serotonin synthesis, would result in an improved ability to lactate in dams fed a high fat diet. Twenty-six female mice were fed a high (HFD) or low fat (LFD) diet throughout pregnancy and lactation. Fourteen mice were genetically deficient for Tph1 (Tph1(-/-)), and twelve were wild type. Milk yield, pup mortality, and dam weights were recorded and milk samples were collected. On day 10 of lactation, dams were sacrificed and mammary glands were harvested for RT-PCR and histological evaluation. HFD dams weighed more than LFD dams at the onset of lactation. WT HFD dams were unable to lactate on day 1 of lactation and exhibited increased pup mortality relative to all other treatments, including Tph1(-/-) HFD dams. mRNA expression of immune markers C-X-C motif chemokine 5 and tumor necrosis factor alpha were elevated in WT HFD mammary glands. Mammary gland histology showed a reduced number of alveoli in WT compared to Tph1(-/-) dams, regardless of diet, and the alveoli of HFD dams were smaller than those of LFD dams. Finally, fatty acid profile in milk was dynamic in both early and peak lactation, with reduced de novo synthesis of fatty acids on day 10 of lactation in the HFD groups. Administration of a HFD to C57BL/6 dams produced an obese phenotype in the mammary gland, which was alleviated by a genetic deficiency of Tph1. Serotonin may modulate the effects of obesity on the mammary gland, potentially contributing to the delayed onset of lactogenesis seen in obese women.	[Weaver, Samantha R.; Prichard, Allan S.; Perez, Paola K.; Streckenbach, Liana J.] Univ Wisconsin, Dept Dairy Sci, Madison, WI 53706 USA; [Bohrer, Justin C.] Univ Wisconsin, Dept Obstet & Gynecol, Madison, WI 53706 USA; [Olson, Jake M.; Cook, Mark E.; Hernandez, Laura L.] Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Hernandez, LL (corresponding author), Univ Wisconsin, Dept Anim Sci, Madison, WI 53706 USA.	llhernandez@wisc.edu		Hernandez, Laura/0000-0001-7591-5203				Ashino NG, 2012, J NUTR BIOCHEM, V23, P341, DOI 10.1016/j.jnutbio.2010.12.011; Bautista CJ, 2016, BRIT J NUTR, V115, P538, DOI 10.1017/S0007114515004547; Brown RE, 1999, PHYSIOL BEHAV, V67, P599, DOI 10.1016/S0031-9384(99)00109-2; Burke LK, 2015, J NEUROENDOCRINOL, V27, P389, DOI 10.1111/jne.12287; CHRISTIE WW, 1982, J LIPID RES, V23, P1072; Clancy RM, 1998, ARTHRITIS RHEUM-US, V41, P1141, DOI 10.1002/1529-0131(199807)41:7<1141::AID-ART2>3.0.CO;2-S; Crane JD, 2015, NAT MED, V21, P166, DOI 10.1038/nm.3766; Das UN, 2001, NUTRITION, V17, P953, DOI 10.1016/S0899-9007(01)00672-4; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; Flint DJ, 2005, DOMEST ANIM ENDOCRIN, V29, P274, DOI 10.1016/j.domaniend.2005.02.021; Flint DJ, 2005, AM J PHYSIOL-ENDOC M, V288, pE1179, DOI 10.1152/ajpendo.00433.2004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Freeman DJ, 2010, SEMIN FETAL NEONAT M, V15, P113, DOI 10.1016/j.siny.2009.09.001; Hernandez LL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032598; Hilson JA, 1997, AM J CLIN NUTR, V66, P1371, DOI 10.1093/ajcn/66.6.1371; Horseman ND, 2014, ANNU REV ANIM BIOSCI, V2, P353, DOI 10.1146/annurev-animal-022513-114227; Huebner SM, 2010, J NUTR, V140, P1454, DOI 10.3945/jn.109.120527; Kamikawa A, 2009, DEV DYNAM, V238, P1092, DOI 10.1002/dvdy.21947; Kierson JA, 2006, ACTA PAEDIATR, V95, P991, DOI 10.1080/08035250600669769; King JC, 2006, ANNU REV NUTR, V26, P271, DOI 10.1146/annurev.nutr.24.012003.132249; Laporta J, 2013, DOMEST ANIM ENDOCRIN, V44, P176, DOI 10.1016/j.domaniend.2013.01.005; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Matsuda M, 2004, DEV CELL, V6, P193, DOI 10.1016/S1534-5807(04)00022-X; Miranda RA, CROSS FOSTERING REDU; Mishra AC, 2010, J PSYCHOPHARMACOL, V24, P1089, DOI 10.1177/0269881108100775; Mozes S, 2014, EUR J NUTR, V53, P1273, DOI 10.1007/s00394-013-0630-7; Murney R, 2015, J DAIRY SCI, V98, P5422, DOI 10.3168/jds.2015-9425; Neuenschwander S, 1996, J CLIN INVEST, V97, P2225, DOI 10.1172/JCI118663; Nommsen-Rivers LA, 2010, AM J CLIN NUTR, V92, P574, DOI 10.3945/ajcn.2010.29192; Nowak R, 2000, REV REPROD, V5, P153, DOI 10.1530/ror.0.0050153; Nunemaker CS, 2014, J ENDOCRINOL, V222, P267, DOI 10.1530/JOE-14-0126; Oddy WH, 2006, J PEDIATR-US, V149, P185, DOI 10.1016/j.jpeds.2006.04.005; Pai VP, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/364746; Park JH, 2016, LAB ANIM-UK, V50, P94, DOI 10.1177/0023677215590526; Payolla TB, 2016, MOL CELL ENDOCRINOL, V422, P192, DOI 10.1016/j.mce.2015.12.004; Politz Mark, 2013, Bio Protoc, V3; Rasmussen KM, 2001, J NUTR, V131, p3009S, DOI 10.1093/jn/131.11.3009S; Rasmussen KM, 2004, PEDIATRICS, V113, pE465, DOI 10.1542/peds.113.5.e465; Ritze Y, 2016, NEUROGASTROENT MOTIL, V28, P806, DOI 10.1111/nmo.12773; ROLLS BA, 1986, PHYSIOL BEHAV, V38, P185, DOI 10.1016/0031-9384(86)90153-8; Saben JL, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098066; Schack-Nielsen L, 2006, CURR OPIN CLIN NUTR, V9, P289, DOI 10.1097/01.mco.0000222114.84159.79; Section on Breastfeeding, 2012, Pediatrics, V129, pe827, DOI 10.1542/peds.2011-3552; Shajib MS, 2015, ACTA PHYSIOL, V213, P561, DOI 10.1111/apha.12430; Stein T, 2007, J MAMMARY GLAND BIOL, V12, P25, DOI 10.1007/s10911-007-9035-7; Stull MA, 2007, P NATL ACAD SCI USA, V104, P16708, DOI 10.1073/pnas.0708136104; Subbaramaiah K, 2011, CANCER PREV RES, V4, P329, DOI 10.1158/1940-6207.CAPR-10-0381; Sutherland KD, 2007, J MAMMARY GLAND BIOL, V12, P15, DOI 10.1007/s10911-007-9034-8; Vanhouten JN, 2003, ENDOCRINOLOGY, V144, P5521, DOI 10.1210/en.2003-0892; Wahlig JL, 2012, OBESITY, V20, P65, DOI 10.1038/oby.2011.196; Walker M, 2008, J PERINAT NEONAT NUR, V22, P267, DOI 10.1097/01.JPN.0000341356.45446.23; Walther DJ, 2003, BIOCHEM PHARMACOL, V66, P1673, DOI 10.1016/S0006-2952(03)00556-2; Wang L, 2002, BIOCHEMISTRY-US, V41, P12569, DOI 10.1021/bi026561f; Watanabe H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0147143; Watson CJ, 2011, INT J DEV BIOL, V55, P757, DOI 10.1387/ijdb.113414cw; White CL, 2009, AM J PHYSIOL-REG I, V296, pR1464, DOI 10.1152/ajpregu.91015.2008; Wojcicki JM, 2011, J WOMENS HEALTH, V20, P341, DOI 10.1089/jwh.2010.2248; Zaragoza R, 2010, BIOCHEM J, V428, P451, DOI 10.1042/BJ20091091	58	11	12	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162432	10.1371/journal.pone.0162432	http://dx.doi.org/10.1371/journal.pone.0162432			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603698	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200065
J	Choi, SH; Park, SJ; Kim, NR				Choi, Seong Hye; Park, Sang Jun; Kim, Na Rae			Macular Ganglion Cell -Inner Plexiform Layer Thickness Is Associated with Clinical Progression in Mild Cognitive Impairment and Alzheimers Disease	PLOS ONE			English	Article							OPTICAL COHERENCE TOMOGRAPHY; NERVE-FIBER LAYER; DIAGNOSTIC GUIDELINES; NATIONAL INSTITUTE; RETINAL PATHOLOGY; MOUSE MODEL; RECOMMENDATIONS; DEMENTIA; DEGENERATION; WORKGROUPS	Purpose We investigated the association of the macular ganglion cell-inner plexiform layer (GCIPL) and peripapillary retinal nerve fiber layer (RNFL) thicknesses with disease progression in mild cognitive impairment (MCI) and Alzheimer's disease (AD). Methods We recruited 42 patients with AD, 26 with MCI, and 66 normal elderly controls. The thicknesses of the RNFL and GCIPL were measured via spectral-domain optic coherent tomography in all participants at baseline. The patients with MCI or AD underwent clinical and neuropsychological tests at baseline and once every year thereafter for 2 years. Results The Clinical Dementia Rating scale-Sum of Boxes (CDR-SB) score exhibited significant negative relationships with the average GCIPL thickness (beta = -0.15, p < 0.05) and the GCIPL thickness in the superotemporal, superonasal, and inferonasal sectors. The composite memory score exhibited significant positive associations with the average GCIPL thickness and the GCIPL thickness in the superotemporal, inferonasal, and inferotemporal sectors. The temporal RNFL thickness, the average and minimum GCIPL thicknesses, and the GCIPL thickness in the inferonasal, inferior, and inferotemporal sectors at baseline were significantly reduced in MCI patients who were converted to AD compared to stable MCI patients. The change of CDR-SB from baseline to 2 years exhibited significant negative associations with the average (beta = -0.150, p = 0.006) and minimum GCIPL thicknesses as well as GCIPL thickness in the superotemporal, superior, superonasal, and inferonasal sectors at baseline. Conclusions Our data suggest that macular GCIPL thickness represents a promising biomarker for monitoring the progression of MCI and AD.	[Choi, Seong Hye] Inha Univ, Dept Neurol, Sch Med, Inchon, South Korea; [Park, Sang Jun; Kim, Na Rae] Inha Univ, Sch Med, Dept Ophthalmol, Inchon, South Korea; [Park, Sang Jun; Kim, Na Rae] Inha Univ, Sch Med, Inha Vis Sci Lab, Inchon, South Korea	Inha University; Inha University; Inha University	Kim, NR (corresponding author), Inha Univ, Sch Med, Dept Ophthalmol, Inchon, South Korea.; Kim, NR (corresponding author), Inha Univ, Sch Med, Inha Vis Sci Lab, Inchon, South Korea.	nrkim@inha.ac.kr		Kim, Na Rae/0000-0003-4224-5447	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning [2016R1A1A1A05005484]; Original Technology Research Program for Brain Science through NRF - Korean government (MSIP) [2014M3C7A1064752]	Basic Science Research Program through National Research Foundation of Korea (NRF) - Ministry of Science, ICT, and Future Planning; Original Technology Research Program for Brain Science through NRF - Korean government (MSIP)	This work was supported by the Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT, and Future Planning (No. 2016R1A1A1A05005484) and by the Original Technology Research Program for Brain Science through the NRF funded by the Korean government (MSIP) (No. 2014M3C7A1064752). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn HJ, 2010, J KOREAN MED SCI, V25, P1071, DOI 10.3346/jkms.2010.25.7.1071; Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; American Psychiatric Association, 1994, DIAGN STAT MAN MENT; Bayhan HA, 2015, CLIN EXP OPHTHALMOL, V43, P145, DOI 10.1111/ceo.12386; Belleville S, 2014, J ALZHEIMERS DIS, V42, pS375, DOI 10.3233/JAD-141470; Berisha F, 2007, INVEST OPHTH VIS SCI, V48, P2285, DOI 10.1167/iovs.06-1029; BLANKS JC, 1989, BRAIN RES, V501, P364, DOI 10.1016/0006-8993(89)90653-7; Blanks JC, 1996, NEUROBIOL AGING, V17, P377, DOI 10.1016/0197-4580(96)00010-3; Blanks JC, 1996, NEUROBIOL AGING, V17, P385, DOI 10.1016/0197-4580(96)00009-7; Cheung CYL, 2015, J ALZHEIMERS DIS, V45, P45, DOI 10.3233/JAD-141659; Choi SH, 2012, NEUROL SCI, V33, P839, DOI 10.1007/s10072-011-0845-4; Choi SH, 2003, ALZ DIS ASSOC DIS, V17, P98, DOI 10.1097/00002093-200304000-00008; Christensen K. J., 1991, PSYCHOL ASSESSMENT J, V3, P168, DOI [10.1037/1040-3590.3.2.168, DOI 10.1037/1040-3590.3.2.168]; Clark CM, 2012, LANCET NEUROL, V11, P669, DOI 10.1016/S1474-4422(12)70142-4; Coppola G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134750; CURCIO CA, 1990, J COMP NEUROL, V300, P5, DOI 10.1002/cne.903000103; Dubois B, 2007, LANCET NEUROL, V6, P734, DOI 10.1016/S1474-4422(07)70178-3; Gao LY, 2015, ARCH GERONTOL GERIAT, V60, P162, DOI 10.1016/j.archger.2014.10.011; Garcia-Martin ES, 2014, OPHTHALMOLOGY, V121, P1149, DOI 10.1016/j.ophtha.2013.12.023; Gasparini L, 2011, NEUROBIOL AGING, V32, P419, DOI 10.1016/j.neurobiolaging.2009.03.002; Han C, 2008, ARCH GERONTOL GERIAT, V47, P302, DOI 10.1016/j.archger.2007.08.012; HINTON DR, 1986, NEW ENGL J MED, V315, P485, DOI 10.1056/NEJM198608213150804; Iseri PK, 2006, J NEURO-OPHTHALMOL, V26, P18, DOI 10.1097/01.wno.0000204645.56873.26; Kim HJ, 2015, J ALZHEIMERS DIS, V48, P1043, DOI 10.3233/JAD-143018; Kirby E, 2010, J ALZHEIMERS DIS, V21, P15, DOI 10.3233/JAD-2010-080785; La Morgia C, 2016, ANN NEUROL, V79, P90, DOI 10.1002/ana.24548; Liu M, 2011, EXP EYE RES, V92, P244, DOI 10.1016/j.exer.2011.01.014; Marziani E, 2013, INVEST OPHTH VIS SCI, V54, P5953, DOI 10.1167/iovs.13-12046; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mwanza JC, 2012, OPHTHALMOLOGY, V119, P1151, DOI 10.1016/j.ophtha.2011.12.014; Ning A, 2008, INVEST OPHTH VIS SCI, V49, P5136, DOI 10.1167/iovs.08-1849; Paquet C, 2007, NEUROSCI LETT, V420, P97, DOI 10.1016/j.neulet.2007.02.090; Parnell Miles, 2012, Int J Alzheimers Dis, V2012, P786494, DOI 10.1155/2012/786494; Petersen RC, 2001, ARCH NEUROL-CHICAGO, V58, P1985, DOI 10.1001/archneur.58.12.1985; Querfurth HW, 2010, NEW ENGL J MED, V362, P329, DOI 10.1056/NEJMra0909142; SADUN AA, 1990, OPHTHALMOLOGY, V97, P9; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Williams PA, 2013, NEUROBIOL AGING, V34, P1799, DOI 10.1016/j.neurobiolaging.2013.01.006	38	51	53	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162202	10.1371/journal.pone.0162202	http://dx.doi.org/10.1371/journal.pone.0162202			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598262	gold, Green Published, Green Submitted			2022-12-26	WOS:000383254800046
J	Dai, M; Liou, B; Swope, B; Wang, XH; Zhang, WJ; Inskeep, V; Grabowski, GA; Sun, Y; Pan, D				Dai, Mei; Liou, Benjamin; Swope, Brittany; Wang, Xiaohong; Zhang, Wujuan; Inskeep, Venette; Grabowski, Gregory A.; Sun, Ying; Pan, Dao			Progression of Behavioral and CNS Deficits in a Viable Murine Model of Chronic Neuronopathic Gaucher Disease	PLOS ONE			English	Article							MUCOPOLYSACCHARIDOSIS TYPE IIIA; LYSOSOMAL STORAGE DISEASES; CHRONIC RESTRAINT STRESS; BLOOD-BRAIN-BARRIER; OF-THE-LITERATURE; ALPHA-SYNUCLEIN; PARKINSONS-DISEASE; GLUCOCEREBROSIDASE MUTATIONS; HURLER-SYNDROME; SEX-DIFFERENCES	To study the neuronal deficits in neuronopathic Gaucher Disease (nGD), the chronological behavioral profiles and the age of onset of brain abnormalities were characterized in a chronic nGD mouse model (9V/null). Progressive accumulation of glucosylceramide (GC) and glucosylsphingosine (GS) in the brain of 9V/null mice were observed at as early as 6 and 3 months of age for GC and GS, respectively. Abnormal accumulation of a-synuclein was present in the 9V/null brain as detected by immunofluorescence and Western blot analysis. In a repeated open-field test, the 9V/null mice (9 months and older) displayed significantly less environmental habituation and spent more time exploring the open-field than age-matched WT group, indicating the onset of short-term spatial memory deficits. In the marble burying test, the 9V/null group had a shorter latency to initiate burying activity at 3 months of age, whereas the latency increased significantly at >= 12 months of age; 9V/null females buried significantly more marbles to completion than the WT group, suggesting an abnormal response to the instinctive behavior and an abnormal activity in non-associative anxiety-like behavior. In the conditional fear test, only the 9V/null males exhibited a significant decrease in response to contextual fear, but both genders showed less response to auditory-cued fear compared to age-and gender-matched WT at 12 months of age. These results indicate hippocampus-related emotional memory defects. Abnormal gait emerged in 9V/null mice with wider front-paw and hind-paw widths, as well as longer stride in a gender-dependent manner with different ages of onset. Significantly higher liver-and spleen-to-body weight ratios were detected in 9V/null mice with different ages of onsets. These data provide temporal evaluation of neurobehavioral dysfunctions and brain pathology in 9V/null mice that can be used for experimental designs to evaluate novel therapies for nGD.	[Dai, Mei; Swope, Brittany; Wang, Xiaohong; Pan, Dao] Cincinnati Childrens Hosp Med Ctr, Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA; [Liou, Benjamin; Inskeep, Venette; Grabowski, Gregory A.; Sun, Ying] Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA; [Swope, Brittany; Sun, Ying; Pan, Dao] Univ Cincinnati, Sch Med, Dept Pediat, Cincinnati, OH USA; [Zhang, Wujuan] Cincinnati Childrens Hosp Med Ctr, Div Pathol, Cincinnati, OH 45229 USA	Cincinnati Children's Hospital Medical Center; Cincinnati Children's Hospital Medical Center; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Pan, D (corresponding author), Cincinnati Childrens Hosp Med Ctr, Expt Hematol & Canc Biol, Cincinnati, OH 45229 USA.; Sun, Y (corresponding author), Cincinnati Childrens Hosp Med Ctr, Div Human Genet, Cincinnati, OH 45229 USA.; Sun, Y; Pan, D (corresponding author), Univ Cincinnati, Sch Med, Dept Pediat, Cincinnati, OH USA.	ying.sun@cchmc.org; Dao.pan@cchmc.org			NIH [R01 NS086134, R01 DK36729, R01 NS064330]; Cincinnati Children's Hospital Medical Center RIP awards; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS064330, R01NS086134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cincinnati Children's Hospital Medical Center RIP awards; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by NIH grants (R01 NS086134, R01 DK36729, and R01 NS064330) and Cincinnati Children's Hospital Medical Center RIP awards (to D.P. and to Y.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmari SE, 2016, NEUROSCIENCE, V321, P121, DOI 10.1016/j.neuroscience.2015.11.009; Alcalay RN, 2012, NEUROLOGY, V78, P1434, DOI 10.1212/WNL.0b013e318253d54b; Anheim M, 2012, NEUROLOGY, V78, P417, DOI 10.1212/WNL.0b013e318245f476; [Anonymous], 2013, ADV DIFFER EQU, DOI DOI 10.1371/J0URNAL.P0NE.0057560; Ausseil J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002296; Barnes S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0116023; Beavan M, 2015, JAMA NEUROL, V72, P201, DOI 10.1001/jamaneurol.2014.2950; Biegstraaten M, 2008, J INHERIT METAB DIS, V31, P337, DOI 10.1007/s10545-008-0832-y; Bowman RE, 2003, HORM BEHAV, V43, P48, DOI 10.1016/S0018-506X(02)00022-3; Bultron G, 2010, J INHERIT METAB DIS, V33, P167, DOI 10.1007/s10545-010-9055-0; Burrow TA, 2007, CURR OPIN PEDIATR, V19, P628, DOI 10.1097/MOP.0b013e3282f161f2; Burrow TA, 2015, MOL GENET METAB, V114, P233, DOI 10.1016/j.ymgme.2014.08.011; Cabrera-Salazar MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043310; Carter R.J., 2001, CURRENT PROTOCOLS NE; Case LK, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0591-7; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; Cheng JS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115765; Cherin P, 2010, J INHERIT METAB DIS, V33, P331, DOI 10.1007/s10545-010-9095-5; Choi JH, 2011, MOL GENET METAB, V104, P185, DOI 10.1016/j.ymgme.2011.06.008; Cleeter MWJ, 2013, NEUROCHEM INT, V62, P1, DOI 10.1016/j.neuint.2012.10.010; Clinton LK, 2010, J NEUROSCI, V30, P7281, DOI 10.1523/JNEUROSCI.0490-10.2010; Cox TM, 2015, AM J HEMATOL, V90, pS25, DOI 10.1002/ajh.24057; Crawley AC, 2006, BRAIN RES, V1104, P1, DOI 10.1016/j.brainres.2006.05.079; Cullen V, 2011, ANN NEUROL, V69, P940, DOI 10.1002/ana.22400; Dasgupta N, 2015, HUM MOL GENET, V24, P7031, DOI 10.1093/hmg/ddv404; DePaolo J, 2009, MOVEMENT DISORD, V24, P1571, DOI 10.1002/mds.22538; El-Amouri SS, 2014, MOL THER, V22, P2028, DOI 10.1038/mt.2014.152; Fanselow MS, 2010, NEURON, V65, P7, DOI 10.1016/j.neuron.2009.11.031; Fishbein I, 2014, BRAIN, V137, P3235, DOI 10.1093/brain/awu291; Fleming SM, 2004, J NEUROSCI, V24, P9434, DOI 10.1523/JNEUROSCI.3080-04.2004; Galea LAM, 1997, NEUROSCIENCE, V81, P689, DOI 10.1016/S0306-4522(97)00233-9; Geldenhuys WJ, 2015, PEERJ, V3, DOI 10.7717/peerj.1175; German DC, 2002, NEUROSCIENCE, V109, P437, DOI 10.1016/S0306-4522(01)00517-6; Giasson BI, 2003, SCIENCE, V300, P636, DOI 10.1126/science.1082324; Ginns EI, 2014, MOL GENET METAB, V111, P152, DOI 10.1016/j.ymgme.2013.12.003; Goker-Alpan O, 2008, ARCH NEUROL-CHICAGO, V65, P1353, DOI 10.1001/archneur.65.10.1353; Grabowski GA, 2010, THE ONLINE METABOLIC; Grabowski Gregory A, 2006, Expert Opin Drug Deliv, V3, P771, DOI 10.1517/17425247.3.6.771; Grabowski GA, 2015, AM J HEMATOL, V90, pS12, DOI 10.1002/ajh.24063; Hayashi E, 2010, PHARMACOLOGY, V86, P293, DOI 10.1159/000321190; Hemsley KM, 2005, BEHAV BRAIN RES, V158, P191, DOI 10.1016/j.bbr.2004.08.019; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Hess B, 1996, P NATL ACAD SCI USA, V93, P14821, DOI 10.1073/pnas.93.25.14821; Howerton CL, 2013, P NATL ACAD SCI USA, V110, P5169, DOI 10.1073/pnas.1300065110; Hruska KS, 2008, HUM MUTAT, V29, P567, DOI 10.1002/humu.20676; Johansen JP, 2011, CELL, V147, P509, DOI 10.1016/j.cell.2011.10.009; Koprivica V, 2000, AM J HUM GENET, V66, P1777, DOI 10.1086/302925; Korkotian E, 1999, J BIOL CHEM, V274, P21673, DOI 10.1074/jbc.274.31.21673; Kotzbauer PT, 2004, EXP NEUROL, V187, P279, DOI 10.1016/j.expneurol.2004.01.007; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lesage S, 2011, HUM MOL GENET, V20, P202, DOI 10.1093/hmg/ddq454; Lloyd-Evans E, 2003, J BIOL CHEM, V278, P23594, DOI 10.1074/jbc.M300212200; Luine V, 2002, STRESS, V5, P205, DOI 10.1080/1025389021000010549; Marshall J, 2010, J INHERIT METAB DIS, V33, P281, DOI 10.1007/s10545-010-9072-z; Matsuda J, 2001, HUM MOL GENET, V10, P1191, DOI 10.1093/hmg/10.11.1191; Mazzulli JR, 2011, CELL, V146, P37, DOI 10.1016/j.cell.2011.06.001; McNeill A, 2012, J NEUROL NEUROSUR PS, V83, P853, DOI 10.1136/jnnp-2012-302402; Mehta A, 2006, EUR J INTERN MED, V17, pS2, DOI 10.1016/j.ejim.2006.07.005; Michelakakis H, 2002, BLOOD CELL MOL DIS, V28, P1, DOI 10.1006/bcmd.2001.0477; Mignot C, 2006, BRAIN DEV-JPN, V28, P39, DOI 10.1016/j.braindev.2005.04.005; Mitra R, 2005, NEUROSCI LETT, V383, P278, DOI 10.1016/j.neulet.2005.04.037; Moussaud S, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-43; Nichols WC, 2009, NEUROLOGY, V72, P310, DOI 10.1212/01.wnl.0000327823.81237.d1; NILSSON O, 1982, CLIN GENET, V22, P274; Noelker C, 2015, J NEUROL SCI, V356, P129, DOI 10.1016/j.jns.2015.06.030; Orvisky E, 2002, MOL GENET METAB, V76, P262, DOI 10.1016/S1096-7192(02)00117-8; Orvisky E, 2000, PEDIATR RES, V48, P233, DOI 10.1203/00006450-200008000-00018; Osellame LD, 2013, AUTOPHAGY, V9, P1633, DOI 10.4161/auto.25878; Osellame LD, 2013, CELL METAB, V17, P941, DOI 10.1016/j.cmet.2013.04.014; Pan D, 2008, BRAIN RES, V1188, P241, DOI 10.1016/j.brainres.2007.10.036; Park JK, 2003, PEDIATR RES, V53, P387, DOI 10.1203/01.PDR.0000049515.79882.94; Pelled D, 2005, NEUROBIOL DIS, V18, P83, DOI 10.1016/j.nbd.2004.09.004; Quirk GJ, 2010, NATURE, V463, P36, DOI 10.1038/463036a; Sanders A, 2013, BLOOD CELL MOL DIS, V51, P109, DOI 10.1016/j.bcmd.2013.03.006; Sardi SP, 2011, P NATL ACAD SCI USA, V108, P12101, DOI 10.1073/pnas.1108197108; Schondorf DC, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5028; Schueler UH, 2003, NEUROBIOL DIS, V14, P595, DOI 10.1016/j.nbd.2003.08.016; Sengupta U, 2015, BIOL PSYCHIAT, V78, P672, DOI 10.1016/j.biopsych.2014.12.019; Shayman JA, 2014, J LIPID RES, V55, P993, DOI 10.1194/jlr.E049817; Shulman Lisa M, 2006, Expert Rev Neurother, V6, P407; Sidransky E, 2009, NEW ENGL J MED, V361, P1651, DOI 10.1056/NEJMoa0901281; Sidransky E, 2012, LANCET NEUROL, V11, P986, DOI 10.1016/S1474-4422(12)70190-4; Sidransky E, 2009, NEUROLOGY, V73, P1424, DOI 10.1212/WNL.0b013e3181b28601; Skelton MR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016187; Sorrentino NC, 2013, EMBO MOL MED, V5, P675, DOI 10.1002/emmm.201202083; Sugimoto H, 2014, BEHAV BRAIN RES, V272, P100, DOI 10.1016/j.bbr.2014.06.048; Sun Y, 2013, HUM MOL GENET, V22, P2435, DOI 10.1093/hmg/ddt096; Sun Y, 2010, HUM MOL GENET, V19, P1088, DOI 10.1093/hmg/ddp580; Tayebi N, 1998, PEDIATR RES, V43, P571, DOI 10.1203/00006450-199805000-00003; Vegeto E, 2003, P NATL ACAD SCI USA, V100, P9614, DOI 10.1073/pnas.1531957100; Wang DR, 2013, P NATL ACAD SCI USA, V110, P2999, DOI 10.1073/pnas.1222742110; Wang DR, 2009, P NATL ACAD SCI USA, V106, P19958, DOI 10.1073/pnas.0908528106; Wong KD, 2004, MOL GENET METAB, V82, P192, DOI 10.1016/j.ymgme.2004.04.011; Xu YH, 2011, MOL GENET METAB, V102, P436, DOI 10.1016/j.ymgme.2010.12.014; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Xu YH, 2008, MOL GENET METAB, V94, P190, DOI 10.1016/j.ymgme.2008.01.013; Xu YH, 2014, HUM MOL GENET, V23, P3943, DOI 10.1093/hmg/ddu105; Xu YH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010750; Yap TL, 2013, MOL GENET METAB, V108, P56, DOI 10.1016/j.ymgme.2012.11.010	99	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162367	10.1371/journal.pone.0162367	http://dx.doi.org/10.1371/journal.pone.0162367			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598339	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800058
J	Hadrup, N; Svingen, T; Mandrup, K; Skov, K; Pedersen, M; Frederiksen, H; Frandsen, HL; Vinggaard, AM				Hadrup, Niels; Svingen, Terje; Mandrup, Karen; Skov, Kasper; Pedersen, Mikael; Frederiksen, Hanne; Frandsen, Henrik Lauritz; Vinggaard, Anne Marie			Juvenile Male Rats Exposed to a Low-Dose Mixture of Twenty-Seven Environmental Chemicals Display Adverse Health Effects	PLOS ONE			English	Article							BISPHENOL-A; PHTHALATE METABOLITES; DISRUPTING CHEMICALS; DIETARY EXPOSURE; DANISH CHILDREN; UNITED-STATES; PLASMA; TCDD; ORGANOCHLORINE; CONTAMINANTS	Humans are exposed to a large number of environmental chemicals in their daily life, many of which are readily detectable in blood or urine. It remains uncertain if these chemicals can cause adverse health effects when present together at low doses. In this study we have tested whether a mixture of 27 chemicals administered orally to juvenile male rats for three months could leave a pathophysiological footprint. The mixture contained metals, perfluorinated compounds, PCB, dioxins, pesticides, heterocyclic amines, phthalate, PAHs and others, with a combined dose of 0.16 (Low dose), 0.47 (Mid dose) or 1.6 (High dose) mg/kg bw/day. The lowest dose was designed with the aim of obtaining plasma or urine concentrations in rats at levels approaching those observed in humans. Some single congeners were administered at doses representative of combined doses for chemical groups. With this baseline, we found effects on weight, histology and gene expression in the liver, as well as changes to the blood plasma metabolome in all exposure groups, including low-dose. Additional adverse effects were observed in the higher dosed groups, including enlarged kidneys and alterations to the metabolome. No significant effects on reproductive parameters were observed.	[Hadrup, Niels; Svingen, Terje; Mandrup, Karen; Vinggaard, Anne Marie] Tech Univ Denmark, Natl Food Inst, Div Diet Dis Prevent & Toxicol, DK-2400 Soborg, Denmark; [Skov, Kasper; Pedersen, Mikael; Frandsen, Henrik Lauritz] Tech Univ Denmark, Natl Food Inst, Div Food Chem, DK-2400 Soborg, Denmark; [Frederiksen, Hanne] Copenhagen Univ Hosp, Rigshosp, Dept Growth & Reprod, DK-2100 Copenhagen, Denmark	Technical University of Denmark; Technical University of Denmark; Rigshospitalet; University of Copenhagen	Hadrup, N (corresponding author), Tech Univ Denmark, Natl Food Inst, Div Diet Dis Prevent & Toxicol, DK-2400 Soborg, Denmark.	niels.hadrup@gmail.com	Svingen, Terje/A-5283-2010; Frederiksen, Hanne/N-8632-2013	Svingen, Terje/0000-0003-4650-7651; Frederiksen, Hanne/0000-0002-3180-9879; Hadrup, Niels/0000-0002-1188-445X; Vinggaard, Anne Marie/0000-0002-6822-3572; Pedersen, Mikael/0000-0001-6540-4805	Ministry of Food, Agriculture and Fisheries of Denmark; Danish Veterinary and Food Administration; EDMaRC - International Center for Research and Research Training in Endocrine Disrupting Effects on Male Reproduction and Child Health	Ministry of Food, Agriculture and Fisheries of Denmark; Danish Veterinary and Food Administration; EDMaRC - International Center for Research and Research Training in Endocrine Disrupting Effects on Male Reproduction and Child Health	This work was supported by The Ministry of Food, Agriculture and Fisheries of Denmark and the Danish Veterinary and Food Administration and EDMaRC - International Center for Research and Research Training in Endocrine Disrupting Effects on Male Reproduction and Child Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Androutsopoulos VP, 2013, TOXICOLOGY, V307, P89, DOI 10.1016/j.tox.2012.09.011; [Anonymous], [No title captured]; Bakker M, 2003, INDICATOR PCBS FOODS; Bashir S, 2006, TOXICOLOGY, V217, P63, DOI 10.1016/j.tox.2005.08.023; Browning JD, 2004, HEPATOLOGY, V40, P1387, DOI 10.1002/hep.20466; Chen HL, 2010, BIRTH DEFECTS RES C, V90, P272, DOI 10.1002/bdrc.20192; Christiansen S, 2014, REPRODUCTION, V147, P477, DOI 10.1530/REP-13-0377; Chu I, 1996, J APPL TOXICOL, V16, P121, DOI 10.1002/(SICI)1099-1263(199603)16:2<121::AID-JAT320>3.0.CO;2-G; Crofton KM, 2005, ENVIRON HEALTH PERSP, V113, P1549, DOI 10.1289/ehp.8195; Demur C, 2013, TOXICOLOGY, V308, P74, DOI 10.1016/j.tox.2013.03.004; DEVITO MJ, 1995, ENVIRON HEALTH PERSP, V103, P820, DOI 10.2307/3432395; EXTON JH, 1994, BBA-LIPID LIPID MET, V1212, P26, DOI 10.1016/0005-2760(94)90186-4; Frederiksen H, 2013, INT J HYG ENVIR HEAL, V216, P710, DOI 10.1016/j.ijheh.2013.01.007; Frederiksen H, 2011, ENVIRON RES, V111, P656, DOI 10.1016/j.envres.2011.03.005; Frederiksen H, 2010, J ANAL TOXICOL, V34, P400, DOI 10.1093/jat/34.7.400; GUSTAFSSON J, 1985, J CLIN INVEST, V75, P604, DOI 10.1172/JCI111737; Hadrup N, 2015, ARCH TOXICOL; HERA, 2004, HERA RISK ASS AHTN 6; Karami-Mohajeri S, 2011, HUM EXP TOXICOL, V30, P1119, DOI 10.1177/0960327110388959; KOCIBA RJ, 1976, TOXICOL APPL PHARM, V35, P553, DOI 10.1016/0041-008X(76)90078-8; Kortenkamp A, 2014, REPRODUCTION, V147, P515, DOI 10.1530/REP-13-0440; Krueger SK, 2005, PHARMACOL THERAPEUT, V106, P357, DOI 10.1016/j.pharmthera.2005.01.001; Lee KY, 2004, TOXICOLOGY, V203, P221, DOI 10.1016/j.tox.2004.06.013; Maranghi F, 2013, FOOD CHEM TOXICOL, V56, P443, DOI 10.1016/j.fct.2013.02.056; Merhi M, 2010, TOXICOLOGY, V267, P80, DOI 10.1016/j.tox.2009.10.024; Nukaya M, 2009, P NATL ACAD SCI USA, V106, P4923, DOI 10.1073/pnas.0809613106; R Core Team, 2012, R LANG ENV STAT COMP; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Rey RA, 2014, ANN ENDOCRINOL-PARIS, V75, P58, DOI 10.1016/j.ando.2014.03.001; Ronn M, 2013, TOXICOLOGY, V303, P125, DOI 10.1016/j.tox.2012.09.013; Ruhl CE, 2015, ALIMENT PHARM THER, V41, P65, DOI 10.1111/apt.13012; Rui LY, 2014, COMPR PHYSIOL, V4, P177, DOI 10.1002/cphy.c130024; Shintyapina AB, 2014, B EXP BIOL MED+, V157, P473, DOI 10.1007/s10517-014-2594-x; Skov K, 2015, J CHROMATOGR B, V978, P83, DOI 10.1016/j.jchromb.2014.11.033; Stanko JP, 2010, REPROD TOXICOL, V30, P540, DOI 10.1016/j.reprotox.2010.07.006; Sun H, 2013, ONCOGENE, V32, P234, DOI 10.1038/onc.2012.34; Svingen T, 2016, J EPIDEMIOL COMMUN H, V70, P322, DOI 10.1136/jech-2015-206268; Svingen T, 2015, PEERJ, V3, DOI 10.7717/peerj.855; Svingen T, 2013, GENE DEV, V27, P2409, DOI 10.1101/gad.228080.113; Veeravalli S, 2014, BIOCHEM PHARMACOL, V90, P88, DOI 10.1016/j.bcp.2014.04.007; Wade MG, 2002, TOXICOL SCI, V67, P131, DOI 10.1093/toxsci/67.1.131; WAKABAYASHI K, 1993, ENVIRON HEALTH PERSP, V99, P129, DOI 10.2307/3431468; Wan HT, 2013, J HAZARD MATER, V261, P763, DOI 10.1016/j.jhazmat.2013.01.034; Wishart DS, 2013, NUCLEIC ACIDS RES, V41, pD801, DOI 10.1093/nar/gks1065; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xia W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090443; Xu DM, 2014, ENVIRON TOXICOL PHAR, V37, P1212, DOI 10.1016/j.etap.2014.04.022	47	12	12	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162027	10.1371/journal.pone.0162027	http://dx.doi.org/10.1371/journal.pone.0162027			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598887	Green Submitted, gold, Green Published			2022-12-26	WOS:000383254800033
J	Loiseau, C; Augenstreich, J; Marchand, A; Harte, E; Garcia, M; Verdon, J; Mesnil, M; Lecomte, S; Berjeaud, JM				Loiseau, Clemence; Augenstreich, Jacques; Marchand, Adrienne; Harte, Etienne; Garcia, Martine; Verdon, Julien; Mesnil, Marc; Lecomte, Sophie; Berjeaud, Jean-Marc			Specific Anti-Leukemic Activity of the Peptide Warnericin RK and Analogues and Visualization of Their Effect on Cancer Cells by Chemical Raman Imaging	PLOS ONE			English	Article							ANTI-LEGIONELLA PEPTIDE; STAPHYLOCOCCUS-EPIDERMIDIS; ANTIMICROBIAL PEPTIDES; LASSO PEPTIDE; SINGLE; SPECTROSCOPY; DEFENSINS; STRAIN; LINES; PLANTARICIN	Antimicrobial peptides can be used as therapeutic agents against cancer cells. Warnericin RK and derivatives (WarnG20D and WarnF14V) were tested on various, solid tumor or leukemia, cancer cells. These peptides appeared to be cytotoxic on all the cell types tested, cancerous as well healthy, but very interestingly displayed no deleterious effect on healthy mononuclear cells. The mode of action of the peptide was proposed to be membranolytic, using chemical Raman imaging. Addition of peptide induced a large disorganization of the membrane leading to the loss of the content of inner compartments of Jurkat cell, whereas no effect was observed on the healthy mononuclear cells. The less hemolytic peptides WarnG20D and WarnF14V could be good candidates for the leukemia treatment.	[Loiseau, Clemence; Augenstreich, Jacques; Marchand, Adrienne; Verdon, Julien; Berjeaud, Jean-Marc] Univ Poitiers, Equipe Microbiol Eau, Lab Ecol & Biol Interact, UMR CNRS 7267, Poitiers, France; [Augenstreich, Jacques; Harte, Etienne; Lecomte, Sophie] Univ Bordeaux, Inst Chim Biol Membranes & Nanoobjets, CNRS, UMR 5248, Pessac, France; [Garcia, Martine] Lab Inflammat Tissus Epitheliaux & Cytokines EA 4, Poitiers, France; [Mesnil, Marc] CNRS ERL 7368, Signalisat & Transports Ioniques Membranaires, Poitiers, France	Centre National de la Recherche Scientifique (CNRS); Universite de Poitiers; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; Universite de Bordeaux; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB)	Berjeaud, JM (corresponding author), Univ Poitiers, Equipe Microbiol Eau, Lab Ecol & Biol Interact, UMR CNRS 7267, Poitiers, France.	jean-marc.berjeaud@univ-poitiers.fr	Berjeaud, Jean-Marc/ABF-9966-2021; Berjeaud, Jean-Marc/GOP-0237-2022; harté, étienne/D-2721-2013	Berjeaud, Jean-Marc/0000-0001-9013-8430; harté, étienne/0000-0002-5642-887X; Mesnil, Marc/0000-0003-4922-0365; Verdon, Julien/0000-0002-9722-8719; Augenstreich, Jacques/0000-0003-2147-2675				Al-Benna S, 2012, ARCH GYNECOL OBSTET, V285, P1153, DOI 10.1007/s00404-011-2018-3; Anderssen EL, 1998, APPL ENVIRON MICROB, V64, P2269; BAKER MA, 1993, CANCER RES, V53, P3052; Benevides JM, 2005, J RAMAN SPECTROSC, V36, P279, DOI 10.1002/jrs.1324; Brun M, 2015, FOOD RES INT, V67, P366, DOI 10.1016/j.foodres.2014.11.044; Chen HM, 1997, BBA-GEN SUBJECTS, V1336, P171, DOI 10.1016/S0304-4165(97)00024-X; Clede S, 2013, ANALYST, V138, P5627, DOI 10.1039/c3an00807j; CRUCIANI RA, 1991, P NATL ACAD SCI USA, V88, P3792, DOI 10.1073/pnas.88.9.3792; Dieing T., 2011, CONFOCAL RAMAN MICRO; Dinges MM, 2000, CLIN MICROBIOL REV, V13, P16, DOI 10.1128/CMR.13.1.16-34.2000; Droin N, 2009, J PROTEOMICS, V72, P918, DOI 10.1016/j.jprot.2009.01.002; Elsard SS, 2015, J ORG CHEM, V80, P10252, DOI 10.1021/acs.joc.5b01878; Fitzmaurice C, 2015, JAMA ONCOL, V1, P505, DOI 10.1001/jamaoncol.2015.0735; Gajski G, 2013, ENVIRON TOXICOL PHAR, V36, P697, DOI 10.1016/j.etap.2013.06.009; Gaspar D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00294; Harris V, 2011, CLIN ONCOL-UK, V23, P706, DOI 10.1016/j.clon.2011.04.014; Hechard Y, 2005, FEMS MICROBIOL LETT, V252, P19, DOI 10.1016/j.femsle.2005.03.046; Hetz C, 2002, P NATL ACAD SCI USA, V99, P2696, DOI 10.1073/pnas.052709699; Hoskin DW, 2008, BBA-BIOMEMBRANES, V1778, P357, DOI 10.1016/j.bbamem.2007.11.008; Iwasaki T, 2009, PEPTIDES, V30, P660, DOI 10.1016/j.peptides.2008.12.019; Kalyanaraman B, 2002, MOL CELL BIOCHEM, V234, P119, DOI 10.1023/A:1015976430790; Kamarajan P, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131008; Kann B, 2015, ADV DRUG DELIVER REV, V89, P71, DOI 10.1016/j.addr.2015.02.006; Lee DG, 2005, CANCER CELL INT, V5, DOI 10.1186/1475-2867-5-21; LICHTENSTEIN A, 1986, BLOOD, V68, P1407; Marchand A, 2011, PEPTIDES, V32, P845, DOI 10.1016/j.peptides.2011.01.025; Marchand A, 2015, MOL CELL BIOCHEM, V405, P159, DOI 10.1007/s11010-015-2407-1; Mehlin C, 1999, J EXP MED, V189, P907, DOI 10.1084/jem.189.6.907; Movasaghi Z, 2007, APPL SPECTROSC REV, V42, P493, DOI 10.1080/05704920701551530; NAUS CCG, 1992, CANCER RES, V52, P4208; Nicchia GP, 2005, FASEB J, V19, P1674, DOI 10.1096/fj.04-3281fje; Niggemann J, 2014, CHEMBIOCHEM, V15, P1021, DOI 10.1002/cbic.201300778; Papo N, 2005, CELL MOL LIFE SCI, V62, P784, DOI 10.1007/s00018-005-4560-2; Perez-Tomas R, 2006, CURR MED CHEM, V13, P1859, DOI 10.2174/092986706777585077; PETICOLAS WL, 1987, BIOL APPLICATIONS RA, V1, P81; PUPPELS GJ, 1990, NATURE, V347, P301, DOI 10.1038/347301a0; Qiao J, 2011, ANALYST, V136, P2077, DOI 10.1039/c1an15067g; Reddy KVR, 2004, INT J ANTIMICROB AG, V24, P536, DOI 10.1016/j.ijantimicag.2004.09.005; Sand SL, 2007, J MEMBRANE BIOL, V216, P61, DOI 10.1007/s00232-007-9030-3; Schie IW, 2014, ANALYST, V139, P2726, DOI 10.1039/c4an00250d; Schweizer F, 2009, EUR J PHARMACOL, V625, P190, DOI 10.1016/j.ejphar.2009.08.043; Tareq FS, 2014, MAR DRUGS, V12, P871, DOI 10.3390/md12020871; Um S, 2013, J NAT PROD, V76, P873, DOI 10.1021/np300902g; Verdon J, 2008, PEPTIDES, V29, P978, DOI 10.1016/j.peptides.2008.01.017; Verdon J, 2011, BBA-BIOMEMBRANES, V1808, P1146, DOI 10.1016/j.bbamem.2010.12.011; Verdon J, 2009, BIOPHYS J, V97, P1933, DOI 10.1016/j.bpj.2009.06.053; Verdon J, 2009, PEPTIDES, V30, P817, DOI 10.1016/j.peptides.2008.12.017; Vuong C, 2002, MICROBES INFECT, V4, P481, DOI 10.1016/S1286-4579(02)01563-0; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wilderman PJ, 2002, J BACTERIOL, V184, P4792, DOI 10.1128/JB.184.17.4792-4799.2002; Wu WKK, 2010, INT J CANCER, V127, P1741, DOI 10.1002/ijc.25489; Yao YF, 2005, J INFECT DIS, V191, P289, DOI 10.1086/426945	52	2	2	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162007	10.1371/journal.pone.0162007	http://dx.doi.org/10.1371/journal.pone.0162007			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598770	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800032
J	Tan, L; Moriel, DG; Totsika, M; Beatson, SA; Schembri, MA				Tan, Lendl; Moriel, Danilo G.; Totsika, Makrina; Beatson, Scott A.; Schembri, Mark A.			Differential Regulation of the Surface-Exposed and Secreted SslE Lipoprotein in Extraintestinal Pathogenic Escherichia coli	PLOS ONE			English	Article							URINARY-TRACT-INFECTIONS; DEPENDENT TRANSCRIPTION TERMINATION; PROTEIN H-NS; BIOFILM FORMATION; RNA-POLYMERASE; NUSA PROTEIN; MOLECULAR CHARACTERIZATION; AUTOTRANSPORTER PROTEINS; ANTIBIOTIC-RESISTANCE; GLOBAL DISSEMINATION	Extra-intestinal pathogenic Escherichia coli (ExPEC) are responsible for diverse infections including meningitis, sepsis and urinary tract infections. The alarming rise in anti-microbial resistance amongst ExPEC complicates treatment and has highlighted the need for alternative preventive measures. SslE is a lipoprotein secreted by a dedicated type II secretion system in E. coli that was first identified as a potential vaccine candidate using reverse genetics. Although the function and protective efficacy of SslE has been studied, the molecular mechanisms that regulate SslE expression remain to be fully elucidated. Here, we show that while the expression of SslE can be detected in E. coli culture supernatants, different strains express and secrete different amounts of SslE when grown under the same conditions. While the histone-like transcriptional regulator H-NS strongly represses sslE at ambient temperatures, the variation in SslE expression at human physiological temperature suggested a more complex mode of regulation. Using a genetic screen to identify novel regulators of sslE in the high SslE-expressing strain UTI89, we defined a new role for the nucleoid-associated regulator Fis and the ribosome-binding GTPase TypA as positive regulators of sslE transcription. We also showed that Fis-mediated enhancement of sslE transcription is dependent on a putative Fis-binding sequence located upstream of the -35 sequence in the core promoter element, and provide evidence to suggest that Fis may work in complex with H-NS to control SslE expression. Overall, this study has defined a new mechanism for sslE regulation and increases our understanding of this broadly conserved E. coli vaccine antigen.	[Tan, Lendl; Moriel, Danilo G.; Beatson, Scott A.; Schembri, Mark A.] Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Totsika, Makrina] Queensland Univ Technol, Sch Biomed Sci, Inst Hlth & Biomed Innovat, Brisbane, Qld 4059, Australia	University of Queensland; Queensland University of Technology (QUT)	Schembri, MA (corresponding author), Univ Queensland, Australian Infect Dis Res Ctr, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	m.schembri@uq.edu.au	Schembri, Mark A/C-7262-2009; Beatson, Scott/B-6985-2013; Tan, Lendl/Y-2149-2018; Totsika, Makrina/A-8993-2011	Schembri, Mark A/0000-0003-4863-9260; Beatson, Scott/0000-0002-1806-3283; Tan, Lendl/0000-0002-9955-2440; Totsika, Makrina/0000-0003-2468-0293	Australian National Health and Medical Research Council (NHMRC) [GNT1042651, GNT1067455]; NHMRC Senior Research Fellowship [GNT1106930]; ARC Discovery Early Career Researcher Award [DE130101169]; NHMRC Career Development Fellowship [GNT1090456]	Australian National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NHMRC Senior Research Fellowship(National Health and Medical Research Council (NHMRC) of Australia); ARC Discovery Early Career Researcher Award(Australian Research Council); NHMRC Career Development Fellowship(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported by grants from the Australian National Health and Medical Research Council (NHMRC; GNT1042651 and GNT1067455). MAS is supported by an NHMRC Senior Research Fellowship (GNT1106930), MT is supported by an ARC Discovery Early Career Researcher Award (DE130101169) and SAB is supported by an NHMRC Career Development Fellowship (GNT1090456). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ACHTMAN M, 1983, INFECT IMMUN, V39, P315, DOI 10.1128/IAI.39.1.315-335.1983; Afflerbach H, 1999, J MOL BIOL, V286, P339, DOI 10.1006/jmbi.1998.2494; Allsopp LP, 2012, J BACTERIOL, V194, P5769, DOI 10.1128/JB.01264-12; Allsopp LP, 2012, INFECT IMMUN, V80, P321, DOI 10.1128/IAI.05322-11; Allsopp LP, 2010, INFECT IMMUN, V78, P1659, DOI 10.1128/IAI.01010-09; [Anonymous], 2005, Nat Methods, V2, P629; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; BACHMANN BJ, 1972, BACTERIOL REV, V36, P525, DOI 10.1128/MMBR.36.4.525-557.1972; Baldi DL, 2012, INFECT IMMUN, V80, P2042, DOI 10.1128/IAI.06160-11; BALL CA, 1992, J BACTERIOL, V174, P8043, DOI 10.1128/JB.174.24.8043-8056.1992; Barker HC, 2000, MOL MICROBIOL, V35, P1518, DOI 10.1046/j.1365-2958.2000.01820.x; Bauer HW, 2005, EUR UROL, V47, P542, DOI 10.1016/j.eururo.2004.12.009; Bauer HW, 2002, INT J ANTIMICROB AG, V19, P451, DOI 10.1016/S0924-8579(02)00106-1; Beach MB, 1998, J BACTERIOL, V180, P5932, DOI 10.1128/JB.180.22.5932-5946.1998; Bishop AC, 2002, J BIOL CHEM, V277, P25090, DOI 10.1074/jbc.M203208200; Blattner FR, 1997, SCIENCE, V277, P1453, DOI 10.1126/science.277.5331.1453; BOSCH L, 1990, BIOCHIM BIOPHYS ACTA, V1050, P293, DOI 10.1016/0167-4781(90)90184-4; Bouffartigues E, 2007, NAT STRUCT MOL BIOL, V14, P441, DOI 10.1038/nsmb1233; Bradley MD, 2007, MICROBIOL-SGM, V153, P2922, DOI 10.1099/mic.0.2007/008565-0; Browning DF, 2000, MOL MICROBIOL, V37, P1258, DOI 10.1046/j.1365-2958.2000.02087.x; Brumbaugh AR, 2013, INFECT IMMUN, V81, P3309, DOI 10.1128/IAI.00470-13; Brumbaugh AR, 2012, EXPERT REV VACCINES, V11, P663, DOI [10.1586/erv.12.36, 10.1586/ERV.12.36]; Brzuszkiewicz E, 2006, P NATL ACAD SCI USA, V103, P12879, DOI 10.1073/pnas.0603038103; Chen SL, 2006, P NATL ACAD SCI USA, V103, P5977, DOI 10.1073/pnas.0600938103; CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A; Choudhury P, 2015, J BACTERIOL, V197, P1819, DOI 10.1128/JB.00023-15; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; DeCanio MS, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-130; deLivron MA, 2009, BIOCHEMISTRY-US, V48, P10533, DOI 10.1021/bi901026z; Dorman CJ, 2009, ADV APPL MICROBIOL, V67, P47, DOI 10.1016/S0065-2164(08)01002-2; Dunstan RA, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003117; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Falconi M, 1998, EMBO J, V17, P7033, DOI 10.1093/emboj/17.23.7033; Falconi M, 1996, MOL MICROBIOL, V19, P965, DOI 10.1046/j.1365-2958.1996.436961.x; Falconi M, 2001, MOL MICROBIOL, V42, P439, DOI 10.1046/j.1365-2958.2001.02646.x; Fan H, 2015, J BIOL CHEM, DOI [10.1074/, DOI 10.1074/101]; Fang FC, 2008, CURR OPIN MICROBIOL, V11, P113, DOI 10.1016/j.mib.2008.02.011; FARINHA MA, 1990, J BACTERIOL, V172, P3496, DOI 10.1128/jb.172.6.3496-3499.1990; Farris M, 1998, MOL MICROBIOL, V28, P265, DOI 10.1046/j.1365-2958.1998.00793.x; FILLOUX A, 1990, EMBO J, V9, P4323, DOI 10.1002/j.1460-2075.1990.tb07881.x; FILUTOWICZ M, 1992, J BACTERIOL, V174, P398, DOI 10.1128/jb.174.2.398-407.1992; Forde BM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104400; Foxman B, 2002, AM J MED, V113, p5S; Foxman B, 2000, ANN EPIDEMIOL, V10, P509, DOI 10.1016/S1047-2797(00)00072-7; FRIEDMAN DI, 1974, VIROLOGY, V58, P141, DOI 10.1016/0042-6822(74)90149-4; Gerganova V, 2015, J BIOL CHEM, V290, P8095, DOI 10.1074/jbc.M114.628131; Goldberg MD, 2001, MOL MICROBIOL, V41, P549, DOI 10.1046/j.1365-2958.2001.02526.x; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; Grant AJ, 2003, MOL MICROBIOL, V48, P507, DOI 10.1046/j.1365-2958.2003.t01-1-03447.x; GREENBLATT J, 1980, P NATL ACAD SCI-BIOL, V77, P1991, DOI 10.1073/pnas.77.4.1991; Gupta K, 2002, AM J MED, V113, p29S; HACKER J, 1983, J BACTERIOL, V154, P1145, DOI 10.1128/JB.154.3.1145-1152.1983; Hashimoto M, 2005, MOL MICROBIOL, V55, P137, DOI 10.1111/j.1365-2958.2004.04386.x; Hernandes RT, 2013, INFECT IMMUN, V81, P3793, DOI 10.1128/IAI.00620-13; Horstman AL, 2002, J BIOL CHEM, V277, P32538, DOI 10.1074/jbc.M203740200; Iwobi A, 2003, INFECT IMMUN, V71, P1872, DOI 10.1128/IAI.71.4.1872-1879.2003; Kahlmeter G, 2003, J ANTIMICROB CHEMOTH, V51, P69, DOI 10.1093/jac/dkg028; Kainz M, 1998, J MOL BIOL, V284, P1379, DOI 10.1006/jmbi.1998.2272; Kang YS, 2004, J BACTERIOL, V186, P4921, DOI 10.1128/JB.186.15.4921-4930.2004; Kotlajich MV, 2015, ELIFE, V4, DOI 10.7554/eLife.04970; KUNG HF, 1975, J BIOL CHEM, V250, P1556; Langermann S, 2000, J INFECT DIS, V181, P774, DOI 10.1086/315258; Langermann S, 1997, SCIENCE, V276, P607, DOI 10.1126/science.276.5312.607; Lau SH, 2008, J ANTIMICROB CHEMOTH, V62, P1241, DOI 10.1093/jac/dkn380; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luo QW, 2015, PLOS NEGLECT TROP D, V9, DOI 10.1371/journal.pntd.0003446; Luo QW, 2014, INFECT IMMUN, V82, P509, DOI 10.1128/IAI.01106-13; Madrid C, 2002, J BACTERIOL, V184, P5058, DOI 10.1128/JB.184.18.5058-5066.2002; Manges AR, 2001, NEW ENGL J MED, V345, P1007, DOI 10.1056/NEJMoa011265; MARTINEZ E, 1988, GENE, V68, P159, DOI 10.1016/0378-1119(88)90608-7; Miller JH, 1992, SHORT COURSE BACTERI, DOI DOI 10.1006/JMBI.1998.2272; Moriel DG, 2013, CURR PHARM BIOTECHNO, V14, P967; Moriel DG, 2010, P NATL ACAD SCI USA, V107, P9072, DOI 10.1073/pnas.0915077107; Muller CM, 2006, J BACTERIOL, V188, P5428, DOI 10.1128/JB.01956-05; Mulvey MA, 2001, INFECT IMMUN, V69, P4572, DOI 10.1128/IAI.69.7.4572-4579.2001; Nafissi M, 2012, J BACTERIOL, V194, P2458, DOI 10.1128/JB.00053-12; NAKAMURA Y, 1983, MOL GEN GENET, V190, P196, DOI 10.1007/BF00330640; NAKAMURA Y, 1986, J MOL BIOL, V189, P103, DOI 10.1016/0022-2836(86)90384-0; Nakjang S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030287; Navarre WW, 2006, SCIENCE, V313, P236, DOI 10.1126/science.1128794; Neidig A, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-77; Nesta B, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004124; Nichols KB, 2016, J BACTERIOL, V198, P1487, DOI 10.1128/JB.00791-15; NINNEMANN O, 1992, EMBO J, V11, P1075, DOI 10.1002/j.1460-2075.1992.tb05146.x; Nowak-Lovato K, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002881; O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x; Peirano G, 2011, ANTIMICROB AGENTS CH, V55, P2986, DOI 10.1128/AAC.01763-10; Petty NK, 2014, P NATL ACAD SCI USA, V111, P5694, DOI 10.1073/pnas.1322678111; Pfennig PL, 2001, MOL GENET GENOMICS, V266, P313, DOI 10.1007/s004380100559; Ronald A, 2002, AM J MED, V113, p14S; Rossiter AE, 2011, MOL MICROBIOL, V81, P179, DOI 10.1111/j.1365-2958.2011.07685.x; Rowe S, 2000, J BACTERIOL, V182, P2741, DOI 10.1128/JB.182.10.2741-2745.2000; Roy K, 2010, INFECT IMMUN, V78, P3027, DOI 10.1128/IAI.00264-10; Russo TA, 2000, J INFECT DIS, V181, P1753, DOI 10.1086/315418; Russo TA, 2003, INFECT IMMUN, V71, P7164, DOI 10.1128/IAI.71.12.7164-7169.2003; Sandkvist M, 1997, J BACTERIOL, V179, P6994, DOI 10.1128/jb.179.22.6994-7003.1997; Saxena S, 2011, J BACTERIOL, V193, P3832, DOI 10.1128/JB.00220-11; SCHAUER AT, 1987, J MOL BIOL, V194, P679, DOI 10.1016/0022-2836(87)90245-2; SCHMIDT MC, 1987, J MOL BIOL, V195, P809, DOI 10.1016/0022-2836(87)90486-4; Scott K, 2003, BRIT J BIOMED SCI, V60, P168, DOI 10.1080/09674845.2003.11978047; Shao YP, 2008, J MOL BIOL, V376, P771, DOI 10.1016/j.jmb.2007.11.101; Spurio R, 1997, EMBO J, V16, P1795, DOI 10.1093/emboj/16.7.1795; Tangden T, 2015, J INTERN MED, V277, P501, DOI 10.1111/joim.12342; TIPPNER D, 1994, MOL MICROBIOL, V11, P589, DOI 10.1111/j.1365-2958.1994.tb00339.x; Totsika M, 2012, APPL ENVIRON MICROB, V78, P2179, DOI 10.1128/AEM.06680-11; Totsika M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026578; Ulett GC, 2006, MICROBIOL-SGM, V152, P2101, DOI 10.1099/mic.0.28607-0; Valeri M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117486; Vogel U, 1997, J BIOL CHEM, V272, P12265, DOI 10.1074/jbc.272.19.12265; Wurpel DJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093177; Xing F, 2002, RNA, V8, P370, DOI 10.1017/S1355838202029825; Yakhnin AV, 2002, P NATL ACAD SCI USA, V99, P11067, DOI 10.1073/pnas.162373299; YAMADA H, 1991, MOL GEN GENET, V230, P332, DOI 10.1007/BF00290685; Yang J, 2007, J BACTERIOL, V189, P142, DOI 10.1128/JB.01115-06; Yang X, 2009, EMBO REP, V10, P997, DOI 10.1038/embor.2009.155; Zalewska-Piatek B, 2008, J BACTERIOL, V190, P5044, DOI 10.1128/JB.00224-08; ZHENG CH, 1994, P NATL ACAD SCI USA, V91, P7543, DOI 10.1073/pnas.91.16.7543; Zhou J, 2011, MOL CELL, V44, P635, DOI 10.1016/j.molcel.2011.09.018	118	8	8	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162391	10.1371/journal.pone.0162391	http://dx.doi.org/10.1371/journal.pone.0162391			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598999	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800064
J	Zielinski, BL; Allen, AE; Carpenter, EJ; Coles, VJ; Crump, BC; Doherty, M; Foster, RA; Goes, JI; Gomes, HR; Hood, RR; McCrow, JP; Montoya, JP; Moustafa, A; Satinsky, BM; Sharma, S; Smith, CB; Yager, PL; Paul, JH				Zielinski, Brian L.; Allen, Andrew E.; Carpenter, Edward J.; Coles, Victoria J.; Crump, Byron C.; Doherty, Mary; Foster, Rachel A.; Goes, Joaquim I.; Gomes, Helga R.; Hood, Raleigh R.; McCrow, John P.; Montoya, Joseph P.; Moustafa, Ahmed; Satinsky, Brandon M.; Sharma, Shalabh; Smith, Christa B.; Yager, Patricia L.; Paul, John H.			Patterns of Transcript Abundance of Eukaryotic Biogeochemically-Relevant Genes in the Amazon River Plume	PLOS ONE			English	Article							MAXIMUM-LIKELIHOOD; CYLINDROTHECA-FUSIFORMIS; EXPRESSION ANALYSIS; NITROGEN-FIXATION; PHYTOPLANKTON; RNA; SEQUENCES; EVOLUTION; TRANSPORTERS; PRODUCTIVITY	The Amazon River has the largest discharge of all rivers on Earth, and its complex plume system fuels a wide array of biogeochemical processes, across a large area of the western tropical North Atlantic. The plume thus stimulates microbial processes affecting carbon sequestration and nutrient cycles at a global scale. Chromosomal gene expression patterns of the 2.0 to 156 mu m size-fraction eukaryotic microbial community were investigated in the Amazon River Plume, generating a robust dataset (more than 100 million mRNA sequences) that depicts the metabolic capabilities and interactions among the eukaryotic microbes. Combining classical oceanographic field measurements with metatranscriptomics yielded characterization of the hydrographic conditions simultaneous with a quantification of transcriptional activity and identity of the community. We highlight the patterns of eukaryotic gene expression for 31 biogeochemically significant gene targets hypothesized to be valuable within forecasting models. An advantage to this targeted approach is that the database of reference sequences used to identify the target genes was selectively constructed and highly curated optimizing taxonomic coverage, throughput, and the accuracy of annotations. A coastal diatom bloom highly expressed nitrate transporters and carbonic anhydrase presumably to support high growth rates and enhance uptake of low levels of dissolved nitrate and CO2. Diatom-diazotroph association (DDA: diatoms with nitrogen fixing symbionts) blooms were common when surface salinity was mesohaline and dissolved nitrate concentrations were below detection, and hence did not show evidence of nitrate utilization, suggesting they relied on ammonium transporters to aquire recently fixed nitrogen. These DDA blooms in the outer plume had rapid turnover of the photosystem D1 protein presumably caused by photodegradation under increased light penetration in clearer waters, and increased expression of silicon transporters as silicon became limiting. Expression of these genes, including carbonic anhydrase and transporters for nitrate and phosphate, were found to reflect the physiological status and biogeochemistry of river plume environments. These relatively stable patterns of eukaryotic transcript abundance occurred over modest spatiotemporal scales, with similarity observed in sample duplicates collected up to 2.45 km in space and 120 minutes in time. These results confirm the use of metatranscriptomics as a valuable tool to understand and predict microbial community function.	[Zielinski, Brian L.; Paul, John H.] Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA; [Allen, Andrew E.; McCrow, John P.] J Craig Venter Inst, Dept Microbial & Environm Genom, San Diego, CA USA; [Carpenter, Edward J.] San Francisco State Univ, Romberg Tiburon Ctr, Tiburon, CA USA; [Coles, Victoria J.; Hood, Raleigh R.] Univ Maryland, Horn Point Lab, Ctr Environm Sci, Cambridge, MD USA; [Crump, Byron C.] Oregon State Univ, Coll Earth Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Doherty, Mary] Rhodes Coll, Memphis, TN 38112 USA; [Foster, Rachel A.] Univ Calif Santa Cruz, Ocean Sci, Santa Cruz, CA 95064 USA; [Goes, Joaquim I.; Gomes, Helga R.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY USA; [Montoya, Joseph P.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA; [Moustafa, Ahmed] Amer Univ Cairo, Dept Biol, New Cairo, Egypt; [Moustafa, Ahmed] Amer Univ Cairo, Biotechnol Grad Program, New Cairo, Egypt; [Satinsky, Brandon M.] MIT, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA; [Sharma, Shalabh; Smith, Christa B.; Yager, Patricia L.] Univ Georgia, Dept Marine Sci, Athens, GA 30602 USA; [Foster, Rachel A.] Stockholm Univ, Dept Ecol Environm & Plant Sci, Stockholm, Sweden	State University System of Florida; University of South Florida; J. Craig Venter Institute; California State University System; San Francisco State University; University System of Maryland; University of Maryland Center for Environmental Science; Oregon State University; University of California System; University of California Santa Cruz; Columbia University; University System of Georgia; Georgia Institute of Technology; Egyptian Knowledge Bank (EKB); American University Cairo; Egyptian Knowledge Bank (EKB); American University Cairo; Massachusetts Institute of Technology (MIT); University System of Georgia; University of Georgia; Stockholm University	Paul, JH (corresponding author), Univ S Florida, Coll Marine Sci, St Petersburg, FL 33701 USA.	jpaul@usf.edu	Coles, Victoria/AAB-3331-2022; Montoya, Joseph/C-3115-2013; Moustafa, Ahmed/AAZ-3991-2020; Hood, Raleigh/AGW-0453-2022; Allen, Andrew E/C-4896-2012; Crump, Byron/ABF-3711-2020; Yager, Patricia L/K-8020-2014; Moustafa, Ahmed/C-5234-2009	Montoya, Joseph/0000-0001-7197-4660; Moustafa, Ahmed/0000-0002-0111-3555; Allen, Andrew E/0000-0001-5911-6081; Yager, Patricia L/0000-0002-8462-6427; Moustafa, Ahmed/0000-0002-0111-3555; McCrow, John/0000-0002-7014-5040; Coles, Victoria/0000-0002-7247-0007; Crump, Byron/0000-0001-7062-1273; Hood, Raleigh/0000-0002-7248-3481; Foster, Rachel/0000-0002-8696-1835	Gordon and Betty Moore Foundation [2293, 2928, 3828]; National Science Foundation (NSF) [NSF-OCE 0934095, NSF-OCE 0929015, OCE-1136477]	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); National Science Foundation (NSF)(National Science Foundation (NSF))	Funding was provided by the Gordon and Betty Moore Foundation as part of the River Ocean Continuum of the Amazon (ROCA) project (Grants GBMF #2293 and #2928). This funded BLZ EJC VJC BCC MD RAF JIG RG RRH J.P. Montoya BMS SS CBS PLY and JHP. This agency contributed to the study design and the data analysis only. They encourage publication of the data. Gordon and Betty Moore Foundation funded AEA, J.P. McCrow and AM (Grant #3828). This agency contributed to the study design and the data analysis only. They encourage publication of the data. The National Science Foundation (NSF) funded the cruise and all the supporting data (Grant NSF-OCE 0934095). This funded BLZ EJC VJC BCC MD RAF JIG HRG RRH J.P. Montoya BMS SS CBS PLY and JHP. This agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Science Foundation (NSF) funded RAF (Grant NSF-OCE 0929015). This agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The National Science Foundation (NSF) funded AEA J.P. McCrow and AM (OCE-1136477). This agency had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by the Gordon and Betty Moore Foundation as part of the River Ocean Continuum of the Amazon (ROCA) project (Grants GBMF #2293 and #2928). The National Science Foundation (NSF) funded the cruise and all the supporting data (Grant NSF-OCE 0934095; RAF is funded by NSF-OCE 0929015); JPMcCrow, AEA and AM were funded by the Gordon and Betty Moore Foundation (Grant GBMF #3828) and the NSF (Grant OCE-1136477). We thank the captain and crew of the RV Knorr for excellent at-sea support. The authors declare no competing interests.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Bombar D, 2011, MAR ECOL PROG SER, V424, P39, DOI 10.3354/meps08976; Bouchard JN, 2006, PHOTOCHEM PHOTOBIOL, V82, P936, DOI 10.1562/2005-08-31-IR-666; Carpenter EJ, 2004, DEEP-SEA RES PT I, V51, P173, DOI 10.1016/j.dsr.2003.10.006; Chakraborty S, 2015, MAR ECOL PROG SER, V521, P31, DOI 10.3354/meps11107; Chew LL, 2011, HYDROBIOLOGIA, V666, P127, DOI 10.1007/s10750-010-0092-3; Coles VJ, 2013, J GEOPHYS RES-OCEANS, V118, P6894, DOI 10.1002/2013JC008981; DAGG MJ, 1991, CONT SHELF RES, V11, P1409, DOI 10.1016/0278-4343(91)90043-6; Del Vecchio R, 2004, J GEOPHYS RES-OCEANS, V109, DOI [10.1029/2004JC002503, 10.1029/2004jc002503]; DORTCH Q, 1990, MAR ECOL PROG SER, V61, P183, DOI 10.3354/meps061183; DORTCH Q, 1992, CONT SHELF RES, V12, P1293, DOI 10.1016/0278-4343(92)90065-R; Durkin CA, 2009, EUKARYOT CELL, V8, P1038, DOI 10.1128/EC.00079-09; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186; Falgueras J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-38; Foster RA, 2011, ISME J, V5, P1484, DOI 10.1038/ismej.2011.26; Foster RA, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1197, DOI 10.1016/B978-0-12-372522-6.00027-X; Foster RA, 2009, ENVIRON MICROBIOL, V11, P741, DOI 10.1111/j.1462-2920.2008.01796.x; Gifford SM, 2011, ISME J, V5, P461, DOI 10.1038/ismej.2010.141; Goes JI, 2014, PROG OCEANOGR, V120, P29, DOI 10.1016/j.pocean.2013.07.010; Hayes R, 1999, TRENDS BIOCHEM SCI, V24, P199, DOI 10.1016/S0968-0004(99)01388-2; Hickey BM, 2010, J GEOPHYS RES OCEANS, V115; Hildebrand M, 2005, J PHYCOL, V41, P105, DOI 10.1111/j.1529-8817.2005.04108.x; Hildebrand M, 1998, MOL GEN GENET, V260, P480, DOI 10.1007/s004380050920; Hilton JA, 2015, ISME J, V9, P1557, DOI 10.1038/ismej.2014.240; Hilton JA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2748; Hooley P, 2008, TRENDS BIOCHEM SCI, V33, P577, DOI 10.1016/j.tibs.2008.09.007; Huang LM, 2004, MAR POLLUT BULL, V49, P588, DOI 10.1016/j.marpolbul.2004.03.015; John DE, 2007, ISME J, V1, P517, DOI 10.1038/ismej.2007.70; Katoh K, 2013, MOL BIOL EVOL, V30, P772, DOI 10.1093/molbev/mst010; MAGUE TH, 1974, MAR BIOL, V24, P109, DOI 10.1007/BF00389344; Matsen FA, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-538; MCLACHLA.J, 1965, CAN J BOTANY, V43, P707, DOI 10.1139/b65-079; McLACHLAN J., 1966, P511; Medeiros PM, 2015, GLOBAL BIOGEOCHEM CY; Molleri GSF, 2010, CONT SHELF RES, V30, P342, DOI 10.1016/j.csr.2009.11.015; Moroney JV, 2001, PLANT CELL ENVIRON, V24, P141, DOI 10.1111/j.1365-3040.2001.00669.x; Muchhal US, 1996, P NATL ACAD SCI USA, V93, P10519, DOI 10.1073/pnas.93.19.10519; Nawrocki EP, 2013, BIOINFORMATICS, V29, P2933, DOI 10.1093/bioinformatics/btt509; Pattengale ND, 2010, J COMPUT BIOL, V17, P337, DOI 10.1089/cmb.2009.0179; PICK U, 1991, PLANT PHYSIOL, V97, P1234, DOI 10.1104/pp.97.3.1234; Poretsky RS, 2005, APPL ENVIRON MICROB, V71, P4121, DOI 10.1128/AEM.71.7.4121-4126.2005; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Quast C, 2013, NUCLEIC ACIDS RES, V41, pD590, DOI 10.1093/nar/gks1219; Rapaport F, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-9-r95; Rivers AR, 2013, ISME J, V7, P2315, DOI 10.1038/ismej.2013.129; Roberts K, 2007, PHOTOSYNTH RES, V93, P79, DOI 10.1007/s11120-007-9172-2; Round F. E., 1990, DIATOMS BIOL MORPHOL; Salisbury J, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006989; Satinsky BM, 2014, P NATL ACAD SCI USA; Satinsky BM, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-17; Schaeffer BA, 2012, MAR POLLUT BULL, V64, P1705, DOI 10.1016/j.marpolbul.2012.03.017; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith WO, 1996, CONT SHELF RES, V16, P291, DOI 10.1016/0278-4343(95)00007-N; Stamatakis A, 2014, BIOINFORMATICS, V30, P1312, DOI 10.1093/bioinformatics/btu033; Stukel M, 2013, BIOGEOSCIENCES DISCU, V10; Stukel MR, 2014, BIOGEOSCIENCES, V11, P3259, DOI 10.5194/bg-11-3259-2014; Subramaniam A, 2008, P NATL ACAD SCI USA, V105, P10460, DOI 10.1073/pnas.0710279105; Tabita FR, 2008, J EXP BOT, V59, P1515, DOI 10.1093/jxb/erm361; Toseland A, 2013, NAT CLIM CHANGE, V3, P979, DOI 10.1038/NCLIMATE1989; Villareal TA, 2003, MICROB ECOL, V45, P1, DOI 10.1007/s00248-002-1012-5; Ward B, 2013, MARINE NIGROGEN CYCL, V368; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Whelan S, 2001, MOL BIOL EVOL, V18, P691, DOI 10.1093/oxfordjournals.molbev.a003851; Yeung LY, 2012, GEOPHYS RES LETT, V39, DOI 10.1029/2012GL053356; Zhu F, 2005, FEMS MICROBIOL ECOL, V52, P79, DOI 10.1016/j.femsec.2004.10.006	68	10	10	2	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0160929	10.1371/journal.pone.0160929	http://dx.doi.org/10.1371/journal.pone.0160929			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598790	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800003
J	Cheung, YC; Juan, YH; Lin, YC; Lo, YF; Tsai, HP; Ueng, SH; Chen, SC				Cheung, Yun-Chung; Juan, Yu-Hsiang; Lin, Yu-Ching; Lo, Yung-Feng; Tsai, Hsiu-Pei; Ueng, Shir-Hwa; Chen, Shin-Cheh			Dual-Energy Contrast-Enhanced Spectral Mammography: Enhancement Analysis on BI-RADS 4 Non-Mass Microcalcifications in Screened Women	PLOS ONE			English	Article							DIGITAL BREAST TOMOSYNTHESIS; DIAGNOSTIC PERFORMANCE; BIOPSY; DESCRIPTORS; MULTICENTER; MALIGNANCY; CARCINOMA; TRIAL; RISK; MRI	Background Mammography screening is a cost-efficient modality with high sensitivity for detecting impalpable cancer with microcalcifications, and results in reduced mortality rates. However, the probability of finding microcalcifications without associated cancerous masses varies. We retrospectively evaluated the diagnosis and cancer probability of the non-mass screened microcalcifications by dual-energy contrast-enhanced spectral mammography (DE-CESM). Patients and Methods With ethical approval from our hospital, we enrolled the cases of DE-CESM for analysis under the following inclusion criteria: (1) referrals due to screened BI-RADS 4 microcalcifications; (2) having DE-CESM prior to stereotactic biopsy; (3) no associated mass found by sonography and physical examination; and (4) pathology-based diagnosis using stereotactic vacuum-assisted breast biopsy. We analyzed the added value of post-contrast enhancement on DE-CESM. Results A total of 94 biopsed lesions were available for analysis in our 87 women, yielding 27 cancers [19 ductal carcinoma in situ (DCIS), and 8 invasive ductal carcinoma (IDC)], 32 premalignant and 35 benign lesions. Of these 94 lesions, 33 showed associated enhancement in DE-CESM while the other 61 did not. All 8 IDC (100%) and 16 of 19 DCIS (84.21%) showed enhancement, but the other 3 DCIS (15.79%) did not. Overall sensitivity, specificity, positive predictive value, negative predictive value and accuracy were 88.89%, 86.56%, 72.72%, 95.08% and 87.24%, respectively. The performances of DE-CESM on both amorphous and pleomorphic microcalcifications were satisfactory (AUC 0.8 and 0.92, respectively). The pleomorphous microcalcifications with enhancement showed higher positive predictive value (90.00% vs 46.15%, p = 0.013) and higher cancer probability than the amorphous microcalcifications (46.3% VS 15.1%). The Odds Ratio was 4.85 (95% CI: 1.84-12.82). Conclusion DE-CESM might provide added value in assessing the non-mass screened breast microcalcification, with enhancement favorable to the diagnosis of cancers or lack of enhancement virtually diagnostic for non-malignant lesions or noninvasive subgroup cancers.	[Cheung, Yun-Chung; Juan, Yu-Hsiang; Lin, Yu-Ching] Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan; [Lo, Yung-Feng; Tsai, Hsiu-Pei; Chen, Shin-Cheh] Chang Gung Mem Hosp Linkou, Dept Surg, Taoyuan, Taiwan; [Ueng, Shir-Hwa] Chang Gung Mem Hosp Linkou, Dept Pathol, Taoyuan, Taiwan; [Cheung, Yun-Chung; Juan, Yu-Hsiang; Lin, Yu-Ching; Lo, Yung-Feng; Tsai, Hsiu-Pei; Ueng, Shir-Hwa; Chen, Shin-Cheh] Chang Gung Univ, Coll Med, 5 Fuxing St, Taoyuan, Taoyuan County, Taiwan	Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung Memorial Hospital; Chang Gung University	Cheung, YC (corresponding author), Chang Gung Mem Hosp Linkou, Dept Med Imaging & Intervent, Taoyuan, Taiwan.; Cheung, YC (corresponding author), Chang Gung Univ, Coll Med, 5 Fuxing St, Taoyuan, Taoyuan County, Taiwan.	alex2143@cgmh.org.tw						Bazzocchi M, 2006, AM J ROENTGENOL, V186, P1723, DOI 10.2214/AJR.04.1898; Bent CK, 2010, AM J ROENTGENOL, V194, P1378, DOI 10.2214/AJR.09.3423; Berg WA, 2003, AM J ROENTGENOL, V180, P1225, DOI 10.2214/ajr.180.5.1801225; Burnside ES, 2007, RADIOLOGY, V242, P388, DOI 10.1148/radiol.2422052130; Cheung YC, 2002, J CLIN ULTRASOUND, V30, P323, DOI 10.1002/jcu.10074; Cheung YC, 2016, EUR RADIOL, V26, P1082, DOI 10.1007/s00330-015-3904-z; Cheung YC, 2014, EUR RADIOL, V24, P2394, DOI 10.1007/s00330-014-3271-1; Dromain C, 2012, BREAST CANCER RES, V14, DOI 10.1186/bcr3210; Dromain C, 2011, EUR RADIOL, V21, P565, DOI 10.1007/s00330-010-1944-y; HOLLAND R, 1982, CANCER, V49, P2527, DOI 10.1002/1097-0142(19820615)49:12<2527::AID-CNCR2820491220>3.0.CO;2-E; Jochelson MS, 2013, RADIOLOGY, V266, P743, DOI 10.1148/radiol.12121084; Jorgensen KJ, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-12; Kettritz U, 2004, CANCER-AM CANCER SOC, V100, P245, DOI 10.1002/cncr.11887; Liberman L, 1998, AM J ROENTGENOL, V171, P35, DOI 10.2214/ajr.171.1.9648759; Lobbes MBI, 2014, EUR RADIOL, V24, P1668, DOI 10.1007/s00330-014-3154-5; Michell MJ, 2012, CLIN RADIOL, V67, P976, DOI 10.1016/j.crad.2012.03.009; Morris EA, 2003, AM J ROENTGENOL, V181, P619, DOI 10.2214/ajr.181.3.1810619; Orel SG, 1999, RADIOLOGY, V211, P845, DOI 10.1148/radiology.211.3.r99jn31845; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Soo MS, 2003, AM J ROENTGENOL, V180, P941, DOI 10.2214/ajr.180.4.1800941; Spangler ML, 2011, AM J ROENTGENOL, V196, P320, DOI 10.2214/AJR.10.4656; Wallis MG, 2012, RADIOLOGY, V262, P788, DOI 10.1148/radiol.11103514	22	31	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162740	10.1371/journal.pone.0162740	http://dx.doi.org/10.1371/journal.pone.0162740			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611215	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900161
J	Lavoie, BR; Okoniewski, M; Fear, EC				Lavoie, Benjamin R.; Okoniewski, Michal; Fear, Elise C.			Estimating the Effective Permittivity for Reconstructing Accurate Microwave-Radar Images	PLOS ONE			English	Article							BREAST-CANCER DETECTION; POLYNOMIAL CHAOS; SENSITIVITY; SYSTEM	We present preliminary results from a method for estimating the optimal effective permittivity for reconstructing microwave-radar images. Using knowledge of how microwave-radar images are formed, we identify characteristics that are typical of good images, and define a fitness function to measure the relative image quality. We build a polynomial interpolant of the fitness function in order to identify the most likely permittivity values of the tissue. To make the estimation process more efficient, the polynomial interpolant is constructed using a locally and dimensionally adaptive sampling method that is a novel combination of stochastic collocation and polynomial chaos. Examples, using a series of simulated, experimental and patient data collected using the Tissue Sensing Adaptive Radar system, which is under development at the University of Calgary, are presented. These examples show how, using our method, accurate images can be reconstructed starting with only a broad estimate of the permittivity range.	[Lavoie, Benjamin R.; Okoniewski, Michal; Fear, Elise C.] Univ Calgary, Schulich Sch Engn, Dept Elect & Comp Engn, Calgary, AB T2N 1N4, Canada	University of Calgary	Lavoie, BR (corresponding author), Univ Calgary, Schulich Sch Engn, Dept Elect & Comp Engn, Calgary, AB T2N 1N4, Canada.	brlavoie@ucalgary.ca		Lavoie, Benjamin/0000-0002-5476-0561; Fear, Elise/0000-0002-9984-8188	Alberta Innovates Health Solutions; Alvin Libin/Alberta Ingenuity Chair in Biomedical Engineering; Alberta Innovates Technology Futures iCORE Strategic Chair in Multi-modality Imaging and Sensing	Alberta Innovates Health Solutions; Alvin Libin/Alberta Ingenuity Chair in Biomedical Engineering; Alberta Innovates Technology Futures iCORE Strategic Chair in Multi-modality Imaging and Sensing	ECF is supported by the Alberta Innovates Technology Futures iCORE Strategic Chair in Multi-modality Imaging and Sensing (http://www.albertatechfutures.ca/Research/BasicResearch/StrategicChairProgram.aspx), and by Alberta Innovates Health Solutions. MO is supported by the Alvin Libin/Alberta Ingenuity Chair in Biomedical Engineering. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; M. Okoniewski is supported by the Alvin Libin/Alberta Ingenuity Chair in Biomedical Engineering, and E. Fear is supported by the Alberta Innovates Technology Futures iCORE Strategic Chair in Multi-modality Imaging and Sensing. The authors would like to thank Charlotte Curtis, Jeremie Bourqui and Doug Kurrant for their contributions.	Agarwal N, 2009, J COMPUT PHYS, V228, P7662, DOI 10.1016/j.jcp.2009.07.014; Bourqui J, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/851234; Bourqui J, 2014, PROC EUR CONF ANTENN, P77, DOI 10.1109/EuCAP.2014.6901696; Bourqui J, 2010, IEEE T ANTENN PROPAG, V58, P2318, DOI 10.1109/TAP.2010.2048844; Byrne D, 2015, IEEE T ANTENN PROPAG, V63, P1725, DOI 10.1109/TAP.2015.2398125; Crestaux T, 2009, RELIAB ENG SYST SAFE, V94, P1161, DOI 10.1016/j.ress.2008.10.008; Curtis C, 2014, PROC EUR CONF ANTENN, P72, DOI 10.1109/EuCAP.2014.6901695; Curtis C, 2013, PROC EUR CONF ANTENN, P628; Curtis C, 2012, INT J BIOMED IMAGING, V2012, DOI 10.1155/2012/235380; Curtis CF, 2015, USNC-URSI RADIO SCI, P306; Curtis CF, 2013, USNC-URSI RADIO SCI, P179, DOI 10.1109/USNC-URSI.2013.6715485; Deprez J.-F, 2012, Progress In Electromagnetics Research B, V42, P381; Elahi MA, 2015, USNC-URSI RADIO SCI, P307; Eldred M., 2009, AIAA J, P376; Fear EC, 2013, IEEE T MICROW THEORY, V61, P2119, DOI 10.1109/TMTT.2013.2255884; Fear EC, 2002, IEEE T BIO-MED ENG, V49, P812, DOI 10.1109/TBME.2002.800759; Garrett J, 2015, IEEE T ANTENN PROPAG, V63, P1693, DOI 10.1109/TAP.2015.2393854; Gerstner T, 1998, NUMER ALGORITHMS, V18, P209, DOI 10.1023/A:1019129717644; Guo L, 2015, IEEE T ANTENN PROPAG, V63, P3531, DOI 10.1109/TAP.2015.2434394; Kurrant D, 2015, IEEE T ANTENN PROPAG, V63, P4910, DOI 10.1109/TAP.2015.2476415; Kurrant D, 2013, IEEE T MICROW THEORY, V61, P2137, DOI 10.1109/TMTT.2013.2250993; Lazebnik M, 2007, PHYS MED BIOL, V52, P6093, DOI 10.1088/0031-9155/52/20/002; Ma X, 2009, J COMPUT PHYS, V228, P3084, DOI 10.1016/j.jcp.2009.01.006; Maklad B., 2012, Progress In Electromagnetics Research B, V39, P115, DOI 10.2528/PIERB11122208; Mobashsher AT, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152351; Nikolova NK, 2011, IEEE MICROW MAG, V12, P78, DOI 10.1109/MMM.2011.942702; Perko Z, 2014, J COMPUT PHYS, V260, P54, DOI 10.1016/j.jcp.2013.12.025; Porter E, 2013, IEEE ANTENN WIREL PR, V12, P229, DOI 10.1109/LAWP.2013.2247374; Santamaria Lancia Adran A., 2015, 29th European Photovoltaic Solar Energy Conference and Exhibition (EU PVSEC 2014); Sarafianou M, 2013, PROC EUR CONF ANTENN, P839; Sill JM, 2005, IEEE T MICROW THEORY, V53, P3312, DOI 10.1109/TMTT.2005.857330; Sobol IM, 2001, MATH COMPUT SIMULAT, V55, P271, DOI 10.1016/S0378-4754(00)00270-6; Sudret B, 2008, RELIAB ENG SYST SAFE, V93, P964, DOI 10.1016/j.ress.2007.04.002; Wiggett WS, 2012, S AFR J SURG, V50, P75, DOI 10.7196/SAJS.1103; Xiu DB, 2002, SIAM J SCI COMPUT, V24, P619, DOI 10.1137/S1064827501387826	35	22	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160849	10.1371/journal.pone.0160849	http://dx.doi.org/10.1371/journal.pone.0160849			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611785	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900011
J	Soffan, A; Antony, B; Abdelazim, M; Shukla, P; Witjaksono, W; Aldosari, SA; Aldawood, AS				Soffan, Alan; Antony, Binu; Abdelazim, Mahmoud; Shukla, Paraj; Witjaksono, Witjaksono; Aldosari, Saleh A.; Aldawood, Abdulrahman S.			Silencing the Olfactory Co-Receptor RferOrco Reduces the Response to Pheromones in the Red Palm Weevil, Rhynchophorus ferrugineus	PLOS ONE			English	Article							RNA INTERFERENCE; ODORANT RECEPTORS; CHEMOSENSORY RECEPTOR; DATE PALM; IDENTIFICATION; COLEOPTERA; ORCO; GENE; CURCULIONIDAE; KNOCKDOWN	The red palm weevil (RPW, Rhynchophorus ferrugineus), one of the most widespread of all invasive insect pest species, is a major cause of severe damage to economically important palm trees. RPW exhibits behaviors very similar to those of its sympatric species, the Asian palm weevil (R. vulneratus), which is restricted geographically to the southern part of Southeast Asia. Although efficient and sustainable control of these pests remains challenging, olfactory-system disruption has been proposed as a promising approach for controlling palm weevils. Here, we report the cloning and sequencing of an olfactory co-receptor (Orco) from R. ferrugineus (RferOrco) and R. vulneratus (RvulOrco) and examine the effects of RferOrco silencing (RNAi) on odorant detection. RferOrco and RvulOrco encoding 482 amino acids showing 99.58% identity. The injection of double-stranded RNA (dsRNA) from RferOrco into R. ferrugineus pupae significantly reduced RferOrco gene expression and led to the failure of odor-stimulus detection, as confirmed through olfactometer and electroantennography (EAG) assays. These results suggest that olfactory-system disruption leading to reduced pheromone detection holds great potential for RPW pest-control strategies.	[Soffan, Alan; Antony, Binu; Abdelazim, Mahmoud; Shukla, Paraj; Aldosari, Saleh A.] King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Chair Date Palm Res, Riyadh 11451, Saudi Arabia; [Aldawood, Abdulrahman S.] King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Riyadh 11451, Saudi Arabia; [Witjaksono, Witjaksono] Gadjah Mada Univ, Dept Plant Protect, Coll Agr, Yogyakarta 55281, Indonesia	King Saud University; King Saud University; Gadjah Mada University	Antony, B (corresponding author), King Saud Univ, Dept Plant Protect, Coll Food & Agr Sci, Chair Date Palm Res, Riyadh 11451, Saudi Arabia.	bantony@ksu.edu.sa	Witjaksono, Witjaksono/GOV-4618-2022; Antony, Binu/M-8562-2015; Soffan, Alan/AAG-2533-2020; Aldawood, Abdulrahman Saad/M-3657-2019	Antony, Binu/0000-0002-6292-620X; Soffan, Alan/0000-0003-3680-6295; Aldawood, Abdulrahman Saad/0000-0003-0721-6632	National Plan for Science, Technology and Innovation (MAARIFAH) of King Abdul Aziz City for Science and Technology (KACST), Kingdom of Saudi Arabia [KACST-NSTIP 12-AGR2854-02];  [12-AGR2854-02];  [12-AGR2554-02]	National Plan for Science, Technology and Innovation (MAARIFAH) of King Abdul Aziz City for Science and Technology (KACST), Kingdom of Saudi Arabia; ; 	BA and SAA are thankful for funds (grant no. KACST-NSTIP 12-AGR2854-02) provided by the National Plan for Science, Technology and Innovation (MAARIFAH) of King Abdul Aziz City for Science and Technology (KACST), Kingdom of Saudi Arabia. AS is thankful to the researcher stipend obtained from 12-AGR2854-02 and 12-AGR2554-02 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Funding for this research (awarded to BA, KACST-NSTIP 12-AGR2854-02) was provided by the National Plan for Science, Technology and Innovation (MAARIFAH) of King Abdul Aziz City for Science and Technology (KACST), Kingdom of Saudi Arabia. We thank the King Saud University-Deanship of Scientific Research, Research Chair program, Saudi Arabia. AS thankful to the researcher stipend obtained from 12-AGR2854-02 and 12-AGR2554-02 projects.	Abdel-Azim M. M., 2012, Journal of Agricultural Science and Technology A, V2, P520; Abraham V. A., 1998, Sultan Qaboos University Journal for Scientific Research - Agricultural Sciences, V3, P77; Antony B, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2362-6; Baum JA, 2007, NAT BIOTECHNOL, V25, P1322, DOI 10.1038/nbt1359; Bengtsson JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031620; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Bettencourt R, 2002, INSECT MOL BIOL, V11, P267, DOI 10.1046/j.1365-2583.2002.00334.x; Chakravarthy AK, 2014, J ENVIRON BIOL, V35, P479; DeGennaro M, 2013, NATURE, V498, P487, DOI 10.1038/nature12206; Dong XL, 2013, J INSECT PHYSIOL, V59, P26, DOI 10.1016/j.jinsphys.2012.11.004; Duxbury MS, 2004, J SURG RES, V117, P339, DOI 10.1016/j.jss.2003.09.010; El-Mergawy RAAM, 2011, INT J AGRIC BIOL, V13, P227; Faleiro J. R., 2006, International Journal of Tropical Insect Science, V26, P135, DOI 10.1079/IJT2006113; Faleiro JR, 2014, FLA ENTOMOL, V97, P1529, DOI 10.1653/024.097.0427; Faleiro JR., 2006, FUND AGROALIMED, V06, P35; Fjose A, 2001, Biotechnol Annu Rev, V7, P31, DOI 10.1016/S1387-2656(01)07032-6; Franco TA, 2016, INSECT BIOCHEM MOLEC, V69, P82, DOI 10.1016/j.ibmb.2015.02.012; Gong LA, 2011, PEST MANAG SCI, V67, P514, DOI 10.1002/ps.2086; Gries R, 2009, CAN ENTOMOL, V141, P145, DOI 10.4039/n09-010; Gunawardena NE, 1998, J CHEM ECOL, V24, P425, DOI 10.1023/A:1022304601123; Gunawardena Neelakanthi E., 1995, Journal of the National Science Council of Sri Lanka, V23, P71; Ha TS, 2008, CELL, V133, P761, DOI 10.1016/j.cell.2008.05.007; Hallett RH, 2004, J NAT HIST, V38, P2863, DOI 10.1080/00222930310001657874; HALLETT RH, 1993, NATURWISSENSCHAFTEN, V80, P328, DOI 10.1007/BF01141908; Hansen IA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113692; Howlett N, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-211; Hull JJ, 2012, ARCH INSECT BIOCHEM, V81, P179, DOI 10.1002/arch.21042; Huvenne H, 2010, J INSECT PHYSIOL, V56, P227, DOI 10.1016/j.jinsphys.2009.10.004; JAFFE K, 1993, J CHEM ECOL, V19, P1703, DOI 10.1007/BF00982302; Jones WD, 2005, CURR BIOL, V15, pR119, DOI 10.1016/j.cub.2005.02.007; Kurreck J, 2009, ANGEW CHEM INT EDIT, V48, P1378, DOI 10.1002/anie.200802092; Larsson MC, 2004, NEURON, V43, P703, DOI 10.1016/j.neuron.2004.08.019; Leal WS, 2013, ANNU REV ENTOMOL, V58, P373, DOI 10.1146/annurev-ento-120811-153635; Li H, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065931; Li KM, 2012, J CHEM ECOL, V38, P287, DOI 10.1007/s10886-012-0085-y; Lin W, 2015, INT J BIOL SCI, V11, P772, DOI 10.7150/ijbs.11898; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Meier LR, 2014, THESIS; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Melo ACA, 2004, CHEM SENSES, V29, P403, DOI 10.1093/chemse/bjh041; Mignone F, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-3-reviews0004; Missbach C, 2014, ELIFE, V3, DOI 10.7554/eLife.02115; Murphy ST, 1999, BIOCONTROL NEWS INF, V20, P35; Pellegrino M, 2009, J EXP BIOL, V212, P1973, DOI 10.1242/jeb.023036; Perez AL, 1996, J CHEM ECOL, V22, P357, DOI 10.1007/BF02055104; Pitts RJ, 2004, P NATL ACAD SCI USA, V101, P5058, DOI 10.1073/pnas.0308146101; Price DRG, 2008, TRENDS BIOTECHNOL, V26, P393, DOI 10.1016/j.tibtech.2008.04.004; Qiao Q, 2010, AGR SCI CHINA, V9, P1001, DOI 10.1016/S1671-2927(09)60183-8; Reichle C, 2013, ANIM BEHAV, V85, P225, DOI 10.1016/j.anbehav.2012.10.029; Roda A., 2011, Bulletin OEPP, V41, P116, DOI 10.1111/j.1365-2338.2011.02446.x; Rugman-Jones PF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078379; Rutzler M, 2005, J COMP PHYSIOL A, V191, P777, DOI 10.1007/s00359-005-0044-y; Said I, 2011, CHEM CENT J, V5, DOI 10.1186/1752-153X-5-14; Sakurai T, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002115; SAS Institute, 2008, SAS STAT 9 2 US GUID; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Stelinski L, 2013, JOVE-J VIS EXP, DOI 10.3791/50229; Stengl M, 2013, J COMP PHYSIOL A, V199, P897, DOI 10.1007/s00359-013-0837-3; Tamura K, 2013, MOL BIOL EVOL, V30, P2725, DOI [10.1093/molbev/mst197, 10.1093/molbev/msr121]; Terenius O, 2011, J INSECT PHYSIOL, V57, P231, DOI 10.1016/j.jinsphys.2010.11.006; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tian HG, 2009, PLOS ONE, V4, DOI [10.1371/journal.pone.0006225, 10.1371/journal.pone.0005157]; Tsitoura P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015428; Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191; Vosshall Leslie B., 2003, P567, DOI 10.1016/B978-012107151-6/50021-9; Wattanapongsiri A, 1965, THESIS; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; Yang Y, 2012, INT J BIOL SCI, V8, P159, DOI 10.7150/ijbs.8.159; Zhao YY, 2011, INSECT MOL BIOL, V20, P97, DOI 10.1111/j.1365-2583.2010.01049.x; Zhou YL, 2014, J INSECT PHYSIOL, V60, P31, DOI 10.1016/j.jinsphys.2013.10.006; Zhu F, 2013, INSECT BIOCHEM MOLEC, V43, P916, DOI 10.1016/j.ibmb.2013.07.008	71	19	19	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162203	10.1371/journal.pone.0162203	http://dx.doi.org/10.1371/journal.pone.0162203			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606688	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255600029
J	Varela, R; Santos, F; Gomez-Gesteira, M; Alvarez, I; Costoya, X; Dias, JM				Varela, R.; Santos, F.; Gomez-Gesteira, M.; Alvarez, I.; Costoya, X.; Dias, J. M.			Influence of Coastal Upwelling on SST Trends along the South Coast of Java	PLOS ONE			English	Article							SEA-SURFACE TEMPERATURE; DATA ASSIMILATION ANALYSIS; TROPICAL INDIAN-OCEAN; INTERANNUAL VARIABILITY; WORLD OCEAN; SUMATRA	The south coast of Java has warmed at a much lower rate than adjacent ocean locations over the last three decades (1982-2015). This behavior can be observed during the upwelling season (July-October) and it is especially patent in August and September when upwelling attains the highest values. Although different warming rates (ocean-coast) had been previously observed in other areas around the world, this behavior was always linked to situations where upwelling increased or remained unchanged. South Java warming is observed at ocean locations and cooling near shore but under a scenario of decreasing upwelling (similar to 30% in some cases). The origin of coastal cooling is due to changes in the vertical structure of the water column. A vein of subsurface water, which has cooled at a rate higher than 0.3 degrees C per decade, is observed to enter from the northwestern part of the study area following the South Java Current. This water only manifests at surface near coast, where it is pumped up by coastal upwelling.	[Varela, R.; Santos, F.; Gomez-Gesteira, M.; Alvarez, I.; Costoya, X.] Univ Vigo, Fac Ciencias, Environm Phys Lab, Ephyslab, Orense 32004, Spain; [Santos, F.; Alvarez, I.; Dias, J. M.] Univ Aveiro, Dept Fis, CESAM, P-3810193 Aveiro, Portugal	Universidade de Vigo; Universidade de Aveiro	Varela, R (corresponding author), Univ Vigo, Fac Ciencias, Environm Phys Lab, Ephyslab, Orense 32004, Spain.	ruvarela@uvigo.es	Gesteira, Moncho Gomez/R-9431-2019; Varela, Ruben/AAB-7411-2022; Dias, João Miguel/F-3292-2010	Gesteira, Moncho Gomez/0000-0002-0661-9731; Dias, João Miguel/0000-0002-7613-6241; Costoya, Xurxo/0000-0001-8050-760X; Santos, Fran/0000-0002-4576-3744; Varela, Ruben/0000-0001-9676-2349	Xunta de Galicia - European Regional Development Fund (FEDER) [GRC-2013-001]; Portuguese Science Foundation (FCT) [SFRH/BPD/97320/2013, C/MAR/LA0017/2013]	Xunta de Galicia - European Regional Development Fund (FEDER); Portuguese Science Foundation (FCT)(Portuguese Foundation for Science and Technology)	This research was also partially supported by Xunta de Galicia under projects GRC-2013-001 "Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Grupos de Referencia Competitiva)" co-funded by European Regional Development Fund (FEDER). The Portuguese Science Foundation (FCT) partially supported this research through a Post-doctoral grant (SFRH/BPD/97320/2013) of the second author and through the project Pest (C/MAR/LA0017/2013). CFSR data was obtained from Environmental Modeling Center/National Centers for Environmental Prediction/National Weather Service/NOAA/U.S. NCEP Climate Forecast System Reanalysis (CFSR) Monthly Products. Research Data Archive at the National Center for Atmospheric Research, Computational and Information Systems Laboratory (http://rda.ucar.edu/datasets/ds093.2/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was also partially supported by Xunta de Galicia under projects GRC-2013-001 "Programa de Consolidacion e Estructuracion de Unidades de Investigacion Competitivas (Grupos de Referencia Competitiva)" co-funded by European Regional Development Fund (FEDER). The Portuguese Science Foundation (FCT) partially supported this research through a Post-doctoral grant (SFRH/BPD/97320/2013) of the second author and through the project Pest (C/MAR/LA0017/2013). CFSR data was obtained from Environmental Modeling Center/National Centers for Environmental Prediction/National Weather Service/NOAA/U.S. NCEP Climate Forecast System Reanalysis (CFSR) Monthly Products. Research Data Archive at the National Center for Atmospheric Research, Computational and Information Systems Laboratory. http://rda.ucar.edu/datasets/ds093.2/.	Barton ED, 2013, PROG OCEANOGR, V116, P167, DOI 10.1016/j.pocean.2013.07.007; Barton ED, 1998, PROG OCEANOGR, V41, P455, DOI 10.1016/S0079-6611(98)00023-8; Carton JA, 2000, J PHYS OCEANOGR, V30, P294, DOI 10.1175/1520-0485(2000)030<0294:ASODAA>2.0.CO;2; Carton JA, 2000, J PHYS OCEANOGR, V30, P311, DOI [10.1175/1520-0485(2000)030<0311:ASODAA>2.0.CO;2, 10.1175/1520-0485(2000)030<0294:ASODAA>2.0.CO;2]; Cropper TE, 2014, DEEP-SEA RES PT I, V86, P94, DOI 10.1016/j.dsr.2014.01.007; Du Y, 2008, J CLIMATE, V21, P2451, DOI 10.1175/2007JCLI1753.1; Gomez-Gesteira M, 2008, ANN NY ACAD SCI, V1146, P320, DOI 10.1196/annals.1446.004; Gordon A L, 2005, OCEANOGRAPHY, V18, P13; Harrison DE, 2007, J PHYS OCEANOGR, V37, P174, DOI 10.1175/JPO3005.1; Iskandar I, 2010, OCEAN DYNAM, V60, P731, DOI 10.1007/s10236-010-0290-6; Kuswardani RTD, 2014, CHINESE SCI BULL, V59, P4516, DOI 10.1007/s11434-014-0549-2; Lemos RT, 2006, J GEOPHYS RES-OCEANS, V111, DOI 10.1029/2005JC003051; Lengaigne M., 2013, BIOGEOSCIENCES, V10, P5841, DOI DOI 10.5194/BGD-10-5841-2013; Levitus S, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021592; Lima FP, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1713; Ma JF, 2015, J GEOPHYS RES-OCEANS, V120, P7015, DOI 10.1002/2015JC010862; Narayan N, 2010, OCEAN SCI, V6, P815, DOI 10.5194/os-6-815-2010; NYKJAER L, 1994, J GEOPHYS RES-OCEANS, V99, P14197, DOI 10.1029/94JC00814; Pardo PC, 2011, CLIM RES, V48, P231, DOI 10.3354/cr00989; Patti B, 2010, ESTUAR COAST SHELF S, V88, P45, DOI 10.1016/j.ecss.2010.03.004; Purba M, 2007, TORANI JURNAL ILMU K, V2, P140; Qu T., 2005, OCEANOGRAPHY, V18, P50, DOI [DOI 10.5670/OCEANOG.2005.05, 10.5670/oceanog.2005.05]; Rao SA, 2002, DEEP-SEA RES PT II, V49, P1549, DOI 10.1016/S0967-0645(01)00158-8; Reynolds R. W., 2009, WHATS NEW VERSION 2; Reynolds RW, 2010, J CLIMATE, V23, P3545, DOI 10.1175/2010JCLI3294.1; Saha S, 2010, B AM METEOROL SOC, V91, P1015, DOI 10.1175/2010BAMS3001.1; Saji NH, 1999, NATURE, V401, P360, DOI 10.1038/43855; Santos F, 2012, CONT SHELF RES, V47, P1, DOI 10.1016/j.csr.2012.07.023; Santos F, 2011, CONT SHELF RES, V31, P2012, DOI 10.1016/j.csr.2011.10.005; Santos F, 2012, CONT SHELF RES, V34, P79, DOI 10.1016/j.csr.2011.12.004; Santos F, INFLUENCE U IN PRESS; Santos J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037090; Siswanto, 2008, INT J REMOTE SENS EA, V5, P46; Sprintall J, 2010, DYNAM ATMOS OCEANS, V50, P140, DOI 10.1016/j.dynatmoce.2010.02.006; Susanto R.D., 2005, OCEANOGRAPHY, V18, P124, DOI [10.5670/oceanog.2005.13, DOI 10.5670/OCEANOG.2005.13]; Susanto RD, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001009; Susanto RD, 2001, GEOPHYS RES LETT, V28, P1599, DOI 10.1029/2000GL011844; Sydeman WJ, 2014, SCIENCE, V345, P77, DOI [10.1126/science.1251635, 10.1126/science.1250830]; Varela R, 2015, SCI REP-UK, V5, DOI 10.1038/srep10016; Webster PJ, 1999, NATURE, V401, P356, DOI 10.1038/43848; Xue L, 2016, J MARINE SYST, V153, P10, DOI 10.1016/j.jmarsys.2015.08.003	41	14	15	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162122	10.1371/journal.pone.0162122	http://dx.doi.org/10.1371/journal.pone.0162122			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606676	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600019
J	Ebenezer, PJ; Wilson, CB; Wilson, LD; Nair, AR; Francis, J				Ebenezer, Philip J.; Wilson, C. Brad; Wilson, Leslie D.; Nair, Anand R.; Francis, J.			The Anti-Inflammatory Effects of Blueberries in an Animal Model of Post-Traumatic Stress Disorder (PTSD)	PLOS ONE			English	Article							OXIDATIVE STRESS; PROTECTIVE ROLE; BRAIN-INJURY; INFLAMMATION; MICE; ACTIVATION; ANXIETY; ACID; HIPPOCAMPUS; VACCINATION	Post-traumatic stress disorder (PTSD) is a trauma and stressor-related disorder that results in a prolonged stress response. It is associated with increased oxidative stress and inflammation in the prefrontal cortex (PFC) and hippocampus (HC). The only approved therapy for PTSD is selective serotonin re-uptake inhibitors (SSRIs), but their efficacy ismarginal. Recently, we demonstrated that over-production of norepinephrine (NE) as the possible reason for the lack of efficacy of SSRIs. Hence, there is a need for novel therapeutic approaches for the treatment of PTSD. In this study, we investigated the anti-inflammatory role of blueberries in modulating inflammatory markers and neurotransmitter levels in PTSD. Rats were fed either a blueberry enriched (2%) or a control diet. Rats were exposed to cats for one hour on days 1 and 11 of a 31-day schedule to simulate traumatic conditions. The rats were also subjected to psychosocial stress via daily cage cohort changes. At the end of the study, the rats were euthanized and the PFC and HC were isolated. Monoamines were measured by high-performance liquid chromatography. Reactive oxygen species (ROS), gene and protein expression levels of inflammatory cytokines were alsomeasured. In our PTSD-model, NE levels were increased and 5-HT levels were decreased when compared to control. In contrast, a blueberry enriched diet increased 5-HT without affecting NE levels. The rate limiting enzymes tyrosine hydroxylase and tryptophan hydroxylase were also studied and they confirmed our findings. The enhanced levels free radicals, gene and protein expression of inflammatory cytokines seen in the PTSD group were normalized with a blueberry enriched diet. Decreased anxiety in this group was shown by improved performance on the elevated plus-maze. These findings indicate blueberries can attenuate oxidative stress and inflammation and restore neurotransmitter imbalances in a ratmodel of PTSD.	[Ebenezer, Philip J.; Wilson, C. Brad; Nair, Anand R.; Francis, J.] Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA; [Wilson, Leslie D.] Louisiana State Univ, Sch Vet Med, Pathobiol Sci, Baton Rouge, LA 70803 USA	Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University; Louisiana State University School of Veterinary Medicine; Louisiana State University System; Louisiana State University	Francis, J (corresponding author), Louisiana State Univ, Sch Vet Med, Comparat Biomed Sci, Baton Rouge, LA 70803 USA.	jfrancis@lsu.edu			Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program [W81XWH-15-1-0061]; United States Highbush Blueberry Council	Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program; United States Highbush Blueberry Council	This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Research Program 2014 under Award No. W81XWH-15-1-0061 and United States Highbush Blueberry Council for JF. The opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the Department of Defense or United States Highbush Blueberry Council. There was no additional external funding received for this study.	Acosta SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081585; Alam Q., 2015, CURR PHARM DES; Baker DG, 2001, NEUROIMMUNOMODULAT, V9, P209, DOI 10.1159/000049028; Bollinger JL, 2016, BRAIN BEHAV IMMUN, V52, P88, DOI 10.1016/j.bbi.2015.10.003; Brewin CR, 2000, J TRAUMA STRESS, V13, P499, DOI 10.1023/A:1007741526169; Chaki S, 2003, EUR J PHARMACOL, V464, P49, DOI 10.1016/S0014-2999(03)01368-2; Chaki S, 2003, J PHARMACOL EXP THER, V304, P818, DOI 10.1124/jpet.102.044826; Chang CH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011971; Chuang CY, 2014, FREE RADICAL RES, V48, P970, DOI 10.3109/10715762.2014.920087; Cusack K, 2016, CLIN PSYCHOL REV, V43, P128, DOI 10.1016/j.cpr.2015.10.003; Denev P, 2014, FOOD CHEM, V157, P37, DOI 10.1016/j.foodchem.2014.02.022; Diamond DM, 2016, J NEUROSCI RES, V94, P437, DOI 10.1002/jnr.23684; Diamond David M., 2007, Neural Plasticity, V2007, P1, DOI 10.1155/2007/60803; Elks CM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024028; Eyre H, 2012, BRAIN BEHAV IMMUN, V26, P251, DOI 10.1016/j.bbi.2011.09.015; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Garate I, 2013, BIOL PSYCHIAT, V73, P32, DOI 10.1016/j.biopsych.2012.07.005; Hohne C, 2013, BRAIN, V136, P1746, DOI 10.1093/brain/awt064; Hoogland ICM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0332-6; Huang M, 2012, J ETHNOPHARMACOL, V143, P228, DOI 10.1016/j.jep.2012.06.028; Jesudason EP, 2007, MOL CELL BIOCHEM, V298, P69, DOI 10.1007/s11010-006-9353-x; Jesudason EP, 2005, BRAIN RES BULL, V65, P361, DOI 10.1016/j.brainresbull.2005.01.010; Jiang W, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0152371; Johnson SA, 2015, J ACAD NUTR DIET, V115, P369, DOI 10.1016/j.jand.2014.11.001; Joseph SV, 2014, J AGR FOOD CHEM, V62, P3886, DOI 10.1021/jf4044056; Lemieux A, 2008, BRAIN BEHAV IMMUN, V22, P994, DOI 10.1016/j.bbi.2008.02.005; Liu YN, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127813; Loganovsky KN, 2013, CNS SPECTRUMS, V18, P95, DOI 10.1017/S109285291200096X; Maddox SA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054463; Masilamoni JG, 2005, BBA-MOL BASIS DIS, V1740, P411, DOI 10.1016/j.bbadis.2004.11.002; McEwen BS, 2000, BRAIN RES, V886, P172, DOI 10.1016/S0006-8993(00)02950-4; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Nair AR, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0111976; Nair AR, 2014, FREE RADICAL BIO MED, V71, P16, DOI 10.1016/j.freeradbiomed.2014.03.012; Naviaux RK, 2014, MITOCHONDRION, V16, P7, DOI 10.1016/j.mito.2013.08.006; Nawaz MI, 2015, J RECEPT SIG TRANSD, V35, P340, DOI 10.3109/10799893.2014.984309; Nie H, 2014, PROG NEURO-PSYCHOPH, V51, P16, DOI 10.1016/j.pnpbp.2014.01.002; Oosthuizen Frasia, 2005, Neuropsychiatr Dis Treat, V1, P109, DOI 10.2147/nedt.1.2.109.61049; Potter KA, 2014, ACTA BIOMATER, V10, P2209, DOI 10.1016/j.actbio.2014.01.018; Poulose SM, 2014, BRAIN RES, V1593, P9, DOI 10.1016/j.brainres.2014.10.028; Redlich S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-71; Sasaki T, 2016, EXP NEUROL, V275, P220, DOI 10.1016/j.expneurol.2015.11.003; Schneider BL, 2016, J NEUROTRAUM, V33, P1614, DOI 10.1089/neu.2015.4190; Shukitt-Hale B, 2012, GERONTOLOGY, V58, P518, DOI 10.1159/000341101; Tataranno ML, 2015, CLIN PERINATOL, V42, P529, DOI 10.1016/j.clp.2015.04.011; Taverniti V, 2014, J AGR FOOD CHEM, V62, P8346, DOI 10.1021/jf502180j; Varman DR, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127945; Vida C, 2014, CURR PHARM DESIGN, V20, P4656; Viggiano Davide, 2004, Neural Plasticity, V11, P97, DOI 10.1155/NP.2004.97; Weston CSE, 2014, FRONT PSYCHIATRY, V5, DOI 10.3389/fpsyt.2014.00037; Wilson CB, 2014, FRONT BEHAV NEUROSCI, V8, DOI 10.3389/fnbeh.2014.00256; Wilson CB, 2014, BEHAV BRAIN RES, V268, P72, DOI 10.1016/j.bbr.2014.03.029; Wilson CB, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089104; Wilson CB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076146; Wolf EG, 2015, UNDERSEA HYPERBAR M, V42, P313; Zhao MY, 2015, J FOOD SCI, V80, pH869, DOI 10.1111/1750-3841.12815; Zoladz PR, 2012, PSYCHONEUROENDOCRINO, V37, P1531, DOI 10.1016/j.psyneuen.2012.02.007; Zoladz PR, 2013, NEUROSCI BIOBEHAV R, V37, P860, DOI 10.1016/j.neubiorev.2013.03.024	58	36	37	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0160923	10.1371/journal.pone.0160923	http://dx.doi.org/10.1371/journal.pone.0160923			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603014	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200009
J	Xin, S; Tao, CC; Li, HB				Xin, Shan; Tao, Chengcheng; Li, Hongbin			Cloning and Functional Analysis of the Promoter of an Ascorbate Oxidase Gene from Gossypium hirsutum	PLOS ONE			English	Article							FRUIT-DEVELOPMENT; TOBACCO PLANTS; REDOX STATE; EXPRESSION; PUMPKIN; AUXIN; CDNA; BIOSYNTHESIS; PEROXIDASE; ELONGATION	Apoplastic ascorbate oxidase (AO) plays significant roles in plant cell growth. However, the mechanism of underlying the transcriptional regulation of AO in Gossypium hirsutum remains unclear. Here, we obtained a 1,920-bp promoter sequence from the Gossypium hirsutum ascorbate oxidase (GhAO1) gene, and this GhAO1 promoter included a number of known cis-elements. Promoter activity analysis in overexpressing pGhAO1::GFP-GUS tobacco (Nicotiana benthamiana) showed that the GhAO1 promoter exhibited high activity, driving strong reporter gene expression in tobacco trichomes, leaves and roots. Promoter 5'-deletion analysis demonstrated that truncated GhAO1 promoters with serial 5'-end deletions had different GUS activities. A 360-bp fragment was sufficient to activate GUS expression. The P-1040 region had less GUS activity than the P-720 region, suggesting that the 320-bp region from nucleotide -720 to -1040 might include a cis-element acting as a silencer. Interestingly, an auxin-responsive cis-acting element (TGA-element) was uncovered in the promoter. To analyze the function of the TGA-element, tobacco leaves transformed with promoters with different 5' truncations were treated with indole-3-acetic acid (IAA). Tobacco leaves transformed with the promoter regions containing the TGA-element showed significantly increased GUS activity after IAA treatment, implying that the fragment spanning nucleotides -1760 to -1600 (which includes the TGA-element) might be a key component for IAA responsiveness. Analyses of the AO promoter region and AO expression pattern in Gossypium arboreum (Ga, diploid cotton with an AA genome), Gossypium raimondii (Gr, diploid cotton with a DD genome) and Gossypium hirsutum (Gh, tetraploid cotton with an AADD genome) indicated that AO promoter activation and AO transcription were detected together only in D genome/sub-genome (Gr and Gh) cotton. Taken together, these results suggest that the 1,920-bp GhAO1 promoter is a functional sequence with a potential effect on fiber cell development, mediated by TGA-element containing sequences, via the auxin-signaling pathway.	[Xin, Shan; Tao, Chengcheng; Li, Hongbin] Shihezi Univ, Coll Life Sci, Key Lab Agrobiotechnol, Shihezi, Xinjiang, Peoples R China	Shihezi University	Li, HB (corresponding author), Shihezi Univ, Coll Life Sci, Key Lab Agrobiotechnol, Shihezi, Xinjiang, Peoples R China.	lihb@shzu.edu.cn		Li, Hongbin/0000-0001-5350-7540	National Natural Science Foundation of China [31260339]; Germplasm resource innovation project of Bingtuan [2012BB050]; Distinguished Youth innovation foundation of Bingtuan [2014CD003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Germplasm resource innovation project of Bingtuan; Distinguished Youth innovation foundation of Bingtuan	This work was supported by National Natural Science Foundation of China (Grant number 31260339), Germplasm resource innovation project of Bingtuan (Grant number 2012BB050), and Distinguished Youth innovation foundation of Bingtuan (Grant number 2014CD003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARRIERBRYGOO H, 1989, P NATL ACAD SCI USA, V86, P891, DOI 10.1073/pnas.86.3.891; Cervera M, 2005, METH MOL B, V286, P203; CHEN JY, 2015, PLOS GENET, V11, DOI DOI 10.1371/JOURNAL.PONE.0129870; De Tullio MC, 2013, PLANT SIGNAL BEHAV, V8, DOI 10.4161/psb.23213; Diallinas G, 1997, PLANT MOL BIOL, V34, P759, DOI 10.1023/A:1005851527227; Ding MQ, 2014, GENE, V535, P273, DOI 10.1016/j.gene.2013.11.017; ESAKA M, 1990, EUR J BIOCHEM, V191, P537, DOI 10.1111/j.1432-1033.1990.tb19154.x; ESAKA M, 1992, PLANT PHYSIOL, V100, P231, DOI 10.1104/pp.100.1.231; ESAKA M, 1988, PLANT PHYSIOL, V88, P656, DOI 10.1104/pp.88.3.656; Fotopoulos V, 2006, J EXP BOT, V57, P3933, DOI 10.1093/jxb/erl147; Fotopoulos V, 2013, PLANT PHYSIOL BIOCH, V73, P154, DOI 10.1016/j.plaphy.2013.09.002; Gong WF, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112966; Green MA, 2005, NATURE, V433, P83, DOI 10.1038/nature03172; Ioannidi E, 2009, J EXP BOT, V60, P663, DOI 10.1093/jxb/ern322; John ME, 1996, P NATL ACAD SCI USA, V93, P12768, DOI 10.1073/pnas.93.23.12768; Joo JH, 2001, PLANT PHYSIOL, V126, P1055, DOI 10.1104/pp.126.3.1055; Kato N, 1996, PLANT MOL BIOL, V30, P833, DOI 10.1007/BF00019015; Kim HJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0125046; Kisu Y, 1997, PLANT CELL PHYSIOL, V38, P631, DOI 10.1093/oxfordjournals.pcp.a029214; Lee JJ, 2007, ANN BOT-LONDON, V100, P1391, DOI 10.1093/aob/mcm232; Li HB, 2007, NEW PHYTOL, V175, P462, DOI 10.1111/j.1469-8137.2007.02120.x; Li XB, 2002, PLANT PHYSIOL, V130, P666, DOI 10.1104/pp.005538; Liu YG, 2007, BIOTECHNIQUES, V43, P649, DOI 10.2144/000112601; OHKAWA J, 1989, P NATL ACAD SCI USA, V86, P1239, DOI 10.1073/pnas.86.4.1239; OHKAWA J, 1994, PLANT CELL REP, V13, P481, DOI 10.1007/BF00232941; Pignocchi C, 2003, PLANT PHYSIOL, V132, P1631, DOI 10.1104/pp.103.022798; Pignocchi C, 2003, CURR OPIN PLANT BIOL, V6, P379, DOI 10.1016/S1369-5266(03)00069-4; Pignocchi C, 2006, PLANT PHYSIOL, V141, P423, DOI 10.1104/pp.106.078469; Qin YM, 2011, CURR OPIN PLANT BIOL, V14, P106, DOI 10.1016/j.pbi.2010.09.010; Qin YM, 2008, PLANT SIGNAL BEHAV, V3, P194, DOI 10.4161/psb.3.3.5208; Schopfer P, 2002, PLANTA, V214, P821, DOI 10.1007/s00425-001-0699-8; Sparkes IA, 2006, NAT PROTOC, V1, P2019, DOI 10.1038/nprot.2006.286; Stomp AM, 1992, METHOD MOL BIOL, P103, DOI [10.1385/0-89603-191-8:103, DOI 10.1385/0-89603-191-8:103]; Tang WX, 2014, PLANT MOL BIOL, V85, P613, DOI 10.1007/s11103-014-0208-7; Wang J, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-961; Zhang M, 2011, NAT BIOTECHNOL, V29, P453, DOI 10.1038/nbt.1843; Zhu YX, 2013, J INTEGR PLANT BIOL, V55, P570, DOI 10.1111/jipb.12076	37	18	21	3	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161695	10.1371/journal.pone.0161695	http://dx.doi.org/10.1371/journal.pone.0161695			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27597995	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800015
J	Yuki, T; Tobiishi, M; Kusaka-Kikushima, A; Ota, Y; Tokura, Y				Yuki, Takuo; Tobiishi, Megumi; Kusaka-Kikushima, Ayumi; Ota, Yukiko; Tokura, Yoshiki			Impaired Tight Junctions in Atopic Dermatitis Skin and in a Skin-Equivalent Model Treated with Interleukin-17	PLOS ONE			English	Article							STRATUM-CORNEUM BARRIER; CLAUDIN-1-DEFICIENT MICE; EPIDERMAL BARRIER; FILAGGRIN; KERATINOCYTES; EXPRESSION; PROTEINS; OCCLUDIN; PSORIASIS; DISEASE	Tight junction (TJ) dysfunction in the stratum granulosum leads to aberrant barrier function of the stratum corneum (SC) in the epidermis. However, it is unclear whether TJs are perturbed in atopic dermatitis (AD), a representative aberrant SC-related skin disease, and whether some factors related to AD pathogenesis induce TJ dysfunction. To address these issues, we investigated the alterations of TJs in AD skin and the effects of Th2 and Th17 cytokines on TJs in a skin-equivalent model. The levels of TJ proteins were determined in the epidermis of nonlesional and lesional skin sites of AD. Western blot and immunohisto-chemical analyses revealed that the levels of zonula occludens 1 were decreased in the nonlesional sites of AD, and the levels of zonula occludens 1 and claudin-1 were decreased in the lesional sites relative to the levels in skin from healthy subjects. Next, we examined the effects of interleukin (IL)-4, tumor necrosis factor-a, IL-17, and IL-22 on the TJ barrier in a skin-equivalent model. Only IL-17 impaired the TJ barrier. Furthermore, we observed a defect in filaggrin monomer degradation in the IL-17-treated skin model. Thus, TJs are dysfunctional in AD, at least partly, due to the effect of IL-17, which may result in an aberrant SC barrier.	[Yuki, Takuo; Tobiishi, Megumi; Kusaka-Kikushima, Ayumi; Ota, Yukiko] Kao Corp, Biol Sci Res, Odawara, Kanagawa, Japan; [Tokura, Yoshiki] Hamamatsu Univ, Sch Med, Dept Dermatol, Hamamatsu, Shizuoka, Japan	KAO Corporation; Hamamatsu University School of Medicine	Yuki, T (corresponding author), Kao Corp, Biol Sci Res, Odawara, Kanagawa, Japan.	yuki.takuo@kao.co.jp			Kao Corporation	Kao Corporation	Kao Corporation provided support in the form of salaries for authors Takuo Yuki, Megumi Tobiishi, Ayumi Kusaka, and Yukiko Ota, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Brandner JM, 2002, EUR J CELL BIOL, V81, P253, DOI 10.1078/0171-9335-00244; Brown SJ, 2012, J INVEST DERMATOL, V132, P751, DOI 10.1038/jid.2011.393; De Benedetto A, 2011, J ALLERGY CLIN IMMUN, V127, P773, DOI 10.1016/j.jaci.2010.10.018; del Giudice MM, 2006, ALLERGY ASTHMA PROC, V27, P451, DOI 10.2500/aap.2006.27.2887; Donetti E, 2014, CYTOKINE, V68, P1, DOI 10.1016/j.cyto.2014.03.003; Eichenfield LF, 2004, ALLERGY, V59, P86, DOI 10.1111/j.1398-9995.2004.00569.x; Eyerich K, 2013, ALLERGY, V68, P974, DOI 10.1111/all.12184; Fuchs E, 2007, NATURE, V445, P834, DOI 10.1038/nature05659; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Furuse M, 2010, CSH PERSPECT BIOL, V2, DOI 10.1101/cshperspect.a002907; Gutowska-Owsiak D, 2012, EXP DERMATOL, V21, P104, DOI 10.1111/j.1600-0625.2011.01412.x; Hadj-Rabia S, 2004, GASTROENTEROLOGY, V127, P1386, DOI 10.1053/j.gastro.2004.07.022; Howell MD, 2007, J ALLERGY CLIN IMMUN, V120, P150, DOI 10.1016/j.jaci.2007.04.031; Kabashima-Kubo R, 2012, J DERMATOL SCI, V67, P37, DOI 10.1016/j.jdermsci.2012.04.004; Kawasaki H, 2012, J ALLERGY CLIN IMMUN, V129, P1538, DOI 10.1016/j.jaci.2012.01.068; Kirschner N, 2013, J INVEST DERMATOL, V133, P1161, DOI 10.1038/jid.2012.507; Kirschner N, 2009, AM J PATHOL, V175, P1095, DOI 10.2353/ajpath.2009.080973; Koga C, 2008, J INVEST DERMATOL, V128, P2625, DOI 10.1038/jid.2008.111; Kubo A, 2009, J EXP MED, V206, P2937, DOI 10.1084/jem.20091527; Kuo IH, 2013, J INVEST DERMATOL, V133, P988, DOI 10.1038/jid.2012.437; Morita K, 2004, BRIT J DERMATOL, V151, P328, DOI 10.1111/j.1365-2133.2004.06029.x; Morita K, 2002, J INVEST DERMATOL, V118, P1073, DOI 10.1046/j.1523-1747.2002.01774.x; Nakagawa N, 2004, J INVEST DERMATOL, V122, P755, DOI 10.1111/j.0022-202X.2004.22317.x; Ouchi T, 2011, J EXP MED, V208, P2607, DOI 10.1084/jem.20111718; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Peltonen S, 2007, BRIT J DERMATOL, V156, P466, DOI 10.1111/j.1365-2133.2006.07642.x; Raiko L, 2009, DERMATOL REP, V1, P1, DOI 10.4081/dr.2009.e1; Saitou M, 1997, EUR J CELL BIOL, V73, P222; Sandilands A, 2009, J CELL SCI, V122, P1285, DOI 10.1242/jcs.033969; Sonoda N, 1999, J CELL BIOL, V147, P195, DOI 10.1083/jcb.147.1.195; Suarez-Farinas M, 2013, J ALLERGY CLIN IMMUN, V132, P361, DOI 10.1016/j.jaci.2013.04.046; Sugawara T, 2013, J DERMATOL SCI, V70, P12, DOI 10.1016/j.jdermsci.2013.01.002; Tsukita S, 2001, NAT REV MOL CELL BIO, V2, P285, DOI 10.1038/35067088; Yoshida Y, 2001, ARCH DERMATOL RES, V293, P239, DOI 10.1007/s004030100221; Yuki T, 2007, EXP DERMATOL, V16, P324, DOI 10.1111/j.1600-0625.2006.00539.x; Yuki T, 2013, J DERMATOL SCI, V69, P148, DOI 10.1016/j.jdermsci.2012.11.595; Yuki T, 2011, J IMMUNOL, V187, P3230, DOI 10.4049/jimmunol.1100058; Yuki T, 2011, J INVEST DERMATOL, V131, P744, DOI 10.1038/jid.2010.385	38	76	85	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161759	10.1371/journal.pone.0161759	http://dx.doi.org/10.1371/journal.pone.0161759			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588419	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800016
J	Eldeeb, MA; Fahlman, RP				Eldeeb, Mohamed A.; Fahlman, Richard P.			Phosphorylation Impacts N-end Rule Degradation of the Proteolytically Activated Form of BMX Kinase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						apoptosis; phosphorylation; protein degradation; tyrosine-protein kinase (tyrosine kinase); ubiquitin ligase; BMX; Etk; N-end Rule	PROSTATE-CANCER CELLS; ETK/BMX TYROSINE KINASE; PROTEIN-FRAGMENTS; INDUCED APOPTOSIS; UBIQUITIN LIGASE; TEC FAMILY; PH-DOMAIN; PATHWAY; DEATH; DOCETAXEL	Cellular signaling leading to the initiation of apoptosis typically results in the activation of caspases, which in turn leads to the proteolytic generation of protein fragments with new or altered cellular functions. Increasing numbers of reports are demonstrating that the activity of many of these proteolytically activated protein fragments can be attenuated by their selective degradation by the N-end rule pathway. Here we report the first evidence that selective degradation of a caspase product by the N-end rule pathway can be modulated by phosphorylation. We demonstrate that the pro-apoptotic fragment of the bone marrow kinase on chromosome X (BMX) generated by caspase cleavage in the prostate cancer-derived PC3 cell line is metabolically unstable in cells because its N-terminal tryptophan targets it for proteasomal degradation via the N-end rule pathway. In addition, we have demonstrated that phosphorylation of tyrosine 566 relatively inhibits degradation of the C-terminal BMX catalytic fragment, and this phosphorylation is crucial for its pro-apoptotic function. Overall, our results demonstrate that cleaved BMX is a novel N-end rule substrate, and its degradation exhibits a novel interplay between substrate phosphorylation and N-end rule degradation, revealing an increasing complex regulatory network of apoptotic proteolytic signaling cascades.	[Eldeeb, Mohamed A.; Fahlman, Richard P.] Univ Alberta, Dept Biochem, Edmonton, AB T6J 2H7, Canada; [Fahlman, Richard P.] Univ Alberta, Dept Oncol, Edmonton, AB T6J 2H7, Canada	University of Alberta; University of Alberta	Fahlman, RP (corresponding author), Univ Alberta, Fac Med & Dent, Dept Biochem, 474 Med Sci Bldg, Edmonton, AB T6J 2H7, Canada.	rfahlman@ualberta.ca	Eldeeb, Mohamed/H-5437-2019	A. Eldeeb, Mohamed/0000-0001-9671-9340	Natural Sciences and Engineering Research Council (NSERC) of Canada [341453-12]; Alberta Innovates Technology Futures Graduate Student Scholarship	Natural Sciences and Engineering Research Council (NSERC) of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)); Alberta Innovates Technology Futures Graduate Student Scholarship	This work was supported by Natural Sciences and Engineering Research Council (NSERC) of Canada Discovery Grant 341453-12 (to R. P. F.). The authors declare that they have no conflicts of interest with the contents of this article.r Supported by an Alberta Innovates Technology Futures Graduate Student Scholarship.	An JY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037414; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; Bagheri-Yarmand R, 2001, J BIOL CHEM, V276, P29403, DOI 10.1074/jbc.M103129200; Chen RY, 2001, NAT CELL BIOL, V3, P439, DOI 10.1038/35074500; Chen XY, 2004, ONCOGENE, V23, P1854, DOI 10.1038/sj.onc.1207308; Crawford ED, 2011, ANNU REV BIOCHEM, V80, P1055, DOI 10.1146/annurev-biochem-061809-121639; Dix MM, 2012, CELL, V150, P426, DOI 10.1016/j.cell.2012.05.040; Ekman N, 2000, ONCOGENE, V19, P4151, DOI 10.1038/sj.onc.1203763; Eldeeb M, 2016, PROTEIN PEPTIDE LETT, V23, P343, DOI 10.2174/0929866523666160108115809; Eldeeb MA, 2014, ONCOTARGET, V5, P2714, DOI 10.18632/oncotarget.1931; Fabbri F, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-6; Fox JL, 2015, CANCER RES, V75, P1345, DOI 10.1158/0008-5472.CAN-14-1340; Gan L, 2011, PROSTATE, V71, P1158, DOI 10.1002/pros.21331; Gao G, 2000, J CELL BIOCHEM, V80, P53; Gibbs DJ, 2014, TRENDS CELL BIOL, V24, P603, DOI 10.1016/j.tcb.2014.05.001; GORDON JA, 1991, METHOD ENZYMOL, V201, P477; Gottar-Guillier M, 2011, J IMMUNOL, V186, P6014, DOI 10.4049/jimmunol.1002813; Guryanova OA, 2011, CANCER CELL, V19, P498, DOI 10.1016/j.ccr.2011.03.004; Hunter T, 2007, MOL CELL, V28, P730, DOI 10.1016/j.molcel.2007.11.019; Ichimura T, 2005, J BIOL CHEM, V280, P13187, DOI 10.1074/jbc.M412884200; Jiang SY, 2014, MOL CELL BIOL, V34, P3928, DOI 10.1128/MCB.00745-14; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Kim JW, 2000, ONCOGENE, V19, P4491, DOI 10.1038/sj.onc.1203796; Kwon YT, 2003, MOL CELL BIOL, V23, P8255, DOI 10.1128/MCB.23.22.8255-8271.2003; Lewis CM, 2001, CURR OPIN IMMUNOL, V13, P317, DOI 10.1016/S0952-7915(00)00221-1; Lin Y, 1999, GENE DEV, V13, P2514, DOI 10.1101/gad.13.19.2514; Liu YJ, 2016, J BIOL CHEM, V291, P7426, DOI 10.1074/jbc.M116.714964; Mediavilla-Varela M, 2009, MOL CANCER, V8, DOI 10.1186/1476-4598-8-68; Nore BF, 2003, BBA-PROTEINS PROTEOM, V1645, P123, DOI 10.1016/S1570-9639(02)00524-1; Piatkov KI, 2014, P NATL ACAD SCI USA, V111, pE817, DOI 10.1073/pnas.1401639111; Piatkov KI, 2012, P NATL ACAD SCI USA, V109, pE1839, DOI 10.1073/pnas.1207786109; Polverino AJ, 1997, J BIOL CHEM, V272, P7013, DOI 10.1074/jbc.272.11.7013; Potter DS, 2014, NEOPLASIA, V16, P147, DOI 10.1593/neo.131376; Qiu Y, 1998, P NATL ACAD SCI USA, V95, P3644, DOI 10.1073/pnas.95.7.3644; Qiu Y, 2000, ONCOGENE, V19, P5651, DOI 10.1038/sj.onc.1203958; Robinson D, 1996, P NATL ACAD SCI USA, V93, P5958, DOI 10.1073/pnas.93.12.5958; Roman-Hernandez G, 2009, P NATL ACAD SCI USA, V106, P8888, DOI 10.1073/pnas.0903614106; Sheng J, 2002, EMBO J, V21, P6061, DOI 10.1093/emboj/cdf626; Smith CIE, 2001, BIOESSAYS, V23, P436, DOI 10.1002/bies.1062; Sriram S, 2013, J MED CHEM, V56, P2540, DOI 10.1021/jm400046q; Tasaki T, 2012, ANNU REV BIOCHEM, V81, P261, DOI 10.1146/annurev-biochem-051710-093308; Tsai YT, 2000, MOL CELL BIOL, V20, P2043, DOI 10.1128/MCB.20.6.2043-2054.2000; Varshavsky A, 2011, PROTEIN SCI, V20, P1298, DOI 10.1002/pro.666; Wu YM, 2001, J BIOL CHEM, V276, P17672, DOI 10.1074/jbc.M010964200; Xu ZZ, 2012, J BIOL CHEM, V287, P7495, DOI 10.1074/jbc.M111.301002; Xue LY, 1999, ONCOGENE, V18, P3391, DOI 10.1038/sj.onc.1202687; Zhang ZH, 2011, CANCER BIOL THER, V11, P690, DOI 10.4161/cbt.11.7.15060	47	19	19	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22757	22768		10.1074/jbc.M116.737387	http://dx.doi.org/10.1074/jbc.M116.737387			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601470	Green Published, hybrid			2022-12-26	WOS:000386760600033
J	Akiyama, T; Oishi, K; Wullaert, A				Akiyama, Takuya; Oishi, Kenji; Wullaert, Andy			Bifidobacteria Prevent Tunicamycin-Induced Endoplasmic Reticulum Stress and Subsequent Barrier Disruption in Human Intestinal Epithelial Caco-2 Monolayers	PLOS ONE			English	Article							UNFOLDED PROTEIN RESPONSE; CELL-DEATH; HOMOLOGOUS PROTEIN; COLITIS; PROBIOTICS; NECROSIS; TISSUE	Endoplasmic reticulum (ER) stress is caused by accumulation of unfolded and misfolded proteins in the ER, thereby compromising its vital cellular functions in protein production and secretion. Genome wide association studies in humans as well as experimental animal models linked ER stress in intestinal epithelial cells (IECs) with intestinal disorders including inflammatory bowel diseases. However, the mechanisms linking the outcomes of ER stress in IECs to intestinal disease have not been clarified. In this study, we investigated the impact of ER stress on intestinal epithelial barrier function using human colon carcinoma-derived Caco-2 monolayers. Tunicamycin-induced ER stress decreased the trans-epithelial electrical resistance of Caco-2 monolayers, concomitant with loss of cellular plasma membrane integrity. Epithelial barrier disruption in Caco-2 cells after ER stress was not caused by caspase- or RIPK1-dependent cell death but was accompanied by lysosomal rupture and up-regulation of the ER stress markers Grp78, sXBP1 and Chop. Interestingly, several bifidobacteria species inhibited tunicamycin-induced ER stress and thereby diminished barrier disruption in Caco-2 monolayers. Together, these results showed that ER stress compromises the epithelial barrier function of Caco-2 monolayers and demonstrate beneficial impacts of bifidobacteria on ER stress in IECs. Our results identify epithelial barrier loss as a potential link between ER stress and intestinal disease development, and suggest that bifidobacteria could exert beneficial effects on this phenomenon.	[Akiyama, Takuya; Oishi, Kenji; Wullaert, Andy] Yakult Honsha European Res Ctr Microbiol ESV, Ghent, Belgium; [Oishi, Kenji] Yakult Cent Inst, Tokyo, Japan; [Wullaert, Andy] VIB, Inflammat Res Ctr, Ghent, Belgium; [Wullaert, Andy] Univ Ghent, Dept Internal Med, Ghent, Belgium	Yakult Honsha Company, Limited; Yakult Honsha Company, Limited; Flanders Institute for Biotechnology (VIB); Ghent University	Akiyama, T; Wullaert, A (corresponding author), Yakult Honsha European Res Ctr Microbiol ESV, Ghent, Belgium.; Wullaert, A (corresponding author), VIB, Inflammat Res Ctr, Ghent, Belgium.; Wullaert, A (corresponding author), Univ Ghent, Dept Internal Med, Ghent, Belgium.	takuya.akiyama@yher.be; andy.wullaert@ugent.be	Wullaert, Andy/R-1924-2019; Wullaert, Andy/D-2975-2018	Wullaert, Andy/0000-0001-5012-654X; Wullaert, Andy/0000-0001-5012-654X	Research Foundation-Flanders (FWO); FWO [G.0C49.13N]	Research Foundation-Flanders (FWO)(FWO); FWO(FWO)	AW holds a postdoctoral fellowship from the Research Foundation-Flanders (FWO, http://www.fwo.be/en/) and is supported by the FWO Odysseus return grant number G.0C49.13N. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; AW holds a postdoctoral fellowship from the Research Foundation-Flanders (FWO) and is supported by the FWO Odysseus return grant number G.0C49.13N.	Aits S, 2013, J CELL SCI, V126, P1905, DOI 10.1242/jcs.091181; Bailly-Maitre B, 2010, J BIOL CHEM, V285, P6198, DOI 10.1074/jbc.M109.056648; Bertolotti A, 2001, J CLIN INVEST, V107, P585, DOI 10.1172/JCI11476; Bischoff SC, 2014, BMC GASTROENTEROL, V14, DOI 10.1186/s12876-014-0189-7; Cao SS, 2013, GASTROENTEROLOGY, V144, P989, DOI 10.1053/j.gastro.2013.01.023; Chakrabarti A, 2011, BIOTECHNOL BIOENG, V108, P2777, DOI 10.1002/bit.23282; Claudio N, 2013, EMBO J, V32, P1214, DOI 10.1038/emboj.2013.80; Degterev A, 2005, NAT CHEM BIOL, V1, P112, DOI 10.1038/nchembio711; Didari T, 2015, WORLD J GASTROENTERO, V21, P3072, DOI 10.3748/wjg.v21.i10.3072; Ghouri YA, 2014, CLIN EXP GASTROENTER, V7, P473, DOI 10.2147/CEG.S27530; Halpern MD, 2015, TISSUE BARRIERS, V3, DOI 10.1080/21688370.2014.1000707; Heazlewood CK, 2008, PLOS MED, V5, P440, DOI 10.1371/journal.pmed.0050054; Hino K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0088048; Hiramatsu N, 2015, AM J PATHOL, V185, P1800, DOI 10.1016/j.ajpath.2015.03.009; Hosomi S, 2015, CURR OPIN GASTROEN, V31, P81, DOI 10.1097/MOG.0000000000000144; Huang WC, 2009, J PHARMACOL EXP THER, V329, P524, DOI 10.1124/jpet.108.148122; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Laukens D, 2014, LAB INVEST, V94, P1419, DOI 10.1038/labinvest.2014.117; Lu P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078491; Malhotra JD, 2008, P NATL ACAD SCI USA, V105, P18525, DOI 10.1073/pnas.0809677105; Mena S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044524; Namba T, 2009, AM J PATHOL, V174, P1786, DOI 10.2353/ajpath.2009.080864; Ono K, 2003, MOL CELL BIOL, V23, P665, DOI 10.1128/MCB.23.2.665-676.2003; Radons J, 2016, CELL STRESS CHAPERON, V21, P379, DOI 10.1007/s12192-016-0676-6; Saveljeva S, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2014.548; Shkoda A, 2007, GASTROENTEROLOGY, V132, P190, DOI 10.1053/j.gastro.2006.10.030; Treton X, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101669; Treton X, 2011, GASTROENTEROLOGY, V141, P1024, DOI 10.1053/j.gastro.2011.05.033; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Waldschmitt N, 2014, MUCOSAL IMMUNOL, V7, P1452, DOI 10.1038/mi.2014.34	30	11	11	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162448	10.1371/journal.pone.0162448	http://dx.doi.org/10.1371/journal.pone.0162448			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611782	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900101
J	Lee, J; Ahn, E; Park, WK; Park, S				Lee, Joomin; Ahn, Eunsook; Park, Wyun Kon; Park, Seyeon			Phosphoproteome Profiling of SH-SY5y Neuroblastoma Cells Treated with Anesthetics: Sevoflurane and Isoflurane Affect the Phosphorylation of Proteins Involved in Cytoskeletal Regulation	PLOS ONE			English	Article							RHO-GTPASES; MECHANISMS; GABA(A); REORGANIZATION; DYNAMICS; INCREASE; POTENCY; KINASE; GROWTH; PAK1	Inhalation anesthetics are used to decrease the spinal cord transmission of painful stimuli. However, the molecular or biochemical processes within cells that regulate anesthetic-induced responses at the cellular level are largely unknown. Here, we report the phospho-proteome profile of SH-SY5y human neuroblastoma cells treated with sevoflurane, a clinically used anesthetic. Phosphoproteins were isolated from cell lysates and analyzed using two-dimensional gel electrophoresis. The phosphorylation of putative anesthetic-responsive marker proteins was validated using western blot analysis in cells treated with both sevoflurane and isoflurane. A total of 25 phosphoproteins were identified as differentially phosphorylated proteins. These included key regulators that signal cytoskeletal remodeling steps in pathways related to vesicle trafficking, axonal growth, and cell migration. These proteins included the Rho GTPase, Ras-GAP SH3 binding protein, Rho GTPase activating protein, actin-related protein, and actin. Sevoflurane and isoflurane also resulted in the dissolution of F-actin fibers in SH-SY5y cells. Our results show that anesthetics affect the phosphorylation of proteins involved in cytoskeletal remodeling pathways.	[Lee, Joomin] Chosun Univ, Dept Food & Nutr, Gwangju 61452, South Korea; [Ahn, Eunsook; Park, Seyeon] Dongduk Womens Univ, Dept Appl Chem, Seoul 02748, South Korea; [Park, Wyun Kon] Yonsei Univ, Dept Anesthesia & Pain, Coll Med, Seoul 03722, South Korea	Chosun University; Dongduk Women's University; Yonsei University; Yonsei University Health System	Park, S (corresponding author), Dongduk Womens Univ, Dept Appl Chem, Seoul 02748, South Korea.	sypark21@dongduk.ac.kr			National Research foundation of Korea (NRF) - Korean Government (Program for Basic Science) [NRF-2014R1A1A2053384]	National Research foundation of Korea (NRF) - Korean Government (Program for Basic Science)	This research was supported by a National Research foundation of Korea (NRF) grant funded by the Korean Government (Program for Basic Science: NRF-2014R1A1A2053384).	Alkire MT, 2000, CONSCIOUS COGN, V9, P370, DOI 10.1006/ccog.1999.0423; Alkire MT, 1997, ANESTHESIOLOGY, V86, P549, DOI 10.1097/00000542-199703000-00006; ANTOGNINI JF, 1993, ANESTHESIOLOGY, V79, P1244, DOI 10.1097/00000542-199312000-00015; Auer M, 2011, ANN ANAT, V193, P259, DOI 10.1016/j.aanat.2011.02.015; Campagna JA, 2003, NEW ENGL J MED, V348, P2110, DOI 10.1056/NEJMra021261; Cheng G, 2000, ANESTHESIOLOGY, V93, P1075, DOI 10.1097/00000542-200010000-00032; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; Daniels RH, 1999, TRENDS BIOCHEM SCI, V24, P350, DOI 10.1016/S0968-0004(99)01442-5; Delom F, 2006, PROTEOME SCI, V4, DOI 10.1186/1477-5956-4-15; Dharmawardhane S, 1997, J CELL BIOL, V138, P1265, DOI 10.1083/jcb.138.6.1265; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; FRANKS NP, 1994, NATURE, V367, P607, DOI 10.1038/367607a0; Franks NP, 1996, ANESTHESIOLOGY, V84, P716, DOI 10.1097/00000542-199603000-00027; Ginisty H, 1999, J CELL SCI, V112, P761; Grasshoff C, 2005, CURR OPIN ANESTHESIO, V18, P386, DOI 10.1097/01.aco.0000174961.90135.dc; Hall A, 1998, SCIENCE, V279, P509, DOI 10.1126/science.279.5350.509; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Hentschke H, 2005, EUR J NEUROSCI, V21, P93, DOI 10.1111/j.1460-9568.2004.03843.x; Honkura N, 2008, NEURON, V57, P719, DOI 10.1016/j.neuron.2008.01.013; HUNTER T, 1995, CELL, V80, P225, DOI 10.1016/0092-8674(95)90405-0; Kapitein LC, 2011, J NEUROSCI, V31, P8194, DOI 10.1523/JNEUROSCI.6215-10.2011; Keck T, 2008, NAT NEUROSCI, V11, P1162, DOI 10.1038/nn.2181; Lee TM, 2000, NEURON, V25, P307, DOI 10.1016/S0896-6273(00)80896-X; Lorenzetto E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064350; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; MACDONALD RL, 1994, ANNU REV NEUROSCI, V17, P569, DOI 10.1146/annurev.neuro.17.1.569; Martinez-Contreras R, 2007, ADV EXP MED BIOL, V623, P123, DOI 10.1007/978-0-387-77374-2_8; Martino A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00062; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311; Papakonstanti EA, 1998, J CELL BIOCHEM, V70, P60, DOI 10.1002/(SICI)1097-4644(19980701)70:1<60::AID-JCB7>3.0.CO;2-1; Papakonstanti EA, 2002, MOL BIOL CELL, V13, P2946, DOI 10.1091/mbc.02-01-0599; Park S, 2011, J CELL BIOCHEM, V112, P633, DOI 10.1002/jcb.22960; RAMPIL IJ, 1993, ANESTHESIOLOGY, V78, P707, DOI 10.1097/00000542-199304000-00014; Rottner K, 1999, NAT CELL BIOL, V1, P321, DOI 10.1038/13040; Schwarz K, 2012, OPEN J HEMATOL, V6, P1; Squatrito M, 2004, ONCOGENE, V23, P4454, DOI 10.1038/sj.onc.1207579; Tocque B, 1997, CELL SIGNAL, V9, P153, DOI 10.1016/S0898-6568(96)00135-0; Torri G, 2010, MINERVA ANESTESIOL, V76, P215; Tsodyks M, 1998, NEURAL COMPUT, V10, P821, DOI 10.1162/089976698300017502; Valencia CA, 2007, BIOCHEM BIOPH RES CO, V361, P281, DOI 10.1016/j.bbrc.2007.06.156; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Wang SA, 2011, J BIOL CHEM, V286, P43816, DOI 10.1074/jbc.M111.310979; Ye XF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052887; Zolnierowicz Stanislaw, 2000, EMBO (European Molecular Biology Organization) Journal, V19, P483, DOI 10.1093/emboj/19.4.483	46	6	6	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162214	10.1371/journal.pone.0162214	http://dx.doi.org/10.1371/journal.pone.0162214			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611435	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900059
J	Vargas, J; Junco, M; Gomez, C; Lajud, N				Vargas, Javier; Junco, Mariana; Gomez, Carlos; Lajud, Naima			Early Life Stress Increases Metabolic Risk, HPA Axis Reactivity, and Depressive-Like Behavior When Combined with Postweaning Social Isolation in Rats	PLOS ONE			English	Article							MATERNAL SEPARATION; NEUROPEPTIDE-Y; GLUCOSE-HOMEOSTASIS; CUMULATIVE STRESS; NEUROENDOCRINE; CHILDHOOD; FEMALE; ADOLESCENT; EXPRESSION; ANXIETY	Early-life stress is associated with depression and metabolic abnormalities that increase the risk of cardiovascular disease and diabetes. Such associations could be due to increased glucocorticoid levels. Periodic maternal separation in the neonate and rearing in social isolation are potent stressors that increase hypothalamus-pituitary-adrenal axis activity. Moreover, social isolation promotes feed intake and body weight gain in rats subjected to periodic maternal separation; however, its effects on metabolic risks have not been described. In the present study, we evaluated whether periodic maternal separation, social isolation rearing, and a combination of these two stressors (periodic maternal separation + social isolation rearing) impair glucose homeostasis and its relation to the hypothalamus-pituitary-adrenalaxis and depressive-like behavior. Periodic maternal separation increased basal corticosterone levels, induced a passive coping strategy in the forced swimming test, and was associated with a mild (24%) increase in fasting glucose, insulin resistance, and dyslipidemia. Rearing in social isolation increased stress reactivity in comparison to both controls and in combination with periodic maternal separation, without affecting the coping strategy associated with the forced swimming test. However, social isolation also increased body weight gain, fasting glucose (120%), and insulin levels in rats subjected to periodic maternal separation. Correlation analyses showed that stress-induced effects on coping strategy on the forced swimming test (but not on metabolic risk markers) are associated with basal corticosterone levels. These findings suggest that maternal separation and post-weaning social isolation affect stress and metabolic vulnerability differentially and that early-life stress-related effects on metabolism are not directly dependent on glucocorticoid levels. In conclusion, our study supports the cumulative stress hypothesis, which suggests that metabolic risk markers arise when vulnerable individuals are exposed to social challenges later in life.	[Vargas, Javier; Junco, Mariana; Gomez, Carlos; Lajud, Naima] Inst Mexicano Seguro Social, Ctr Invest Biomed Michoacan, Div Neurociencias, Morelia, Michoacan, Mexico	Instituto Mexicano del Seguro Social	Lajud, N (corresponding author), Inst Mexicano Seguro Social, Ctr Invest Biomed Michoacan, Div Neurociencias, Morelia, Michoacan, Mexico.	naimalajud@yahoo.com.mx	Lajud, Naima/B-4605-2018	Lajud, Naima/0000-0003-3905-798X	Fondo de Investigacion en Salud - IMSS [FIS/IMSS/PROT/G11/976, FIS/IMSS/PROT/G13/1223]	Fondo de Investigacion en Salud - IMSS	The present work was supported by grant FIS/IMSS/PROT/G11/976 and FIS/IMSS/PROT/G13/1223 to NL from Fondo de Investigacion en Salud - IMSS. Funding source had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; or in the decision to submit the article for publication.	Agardh E, 2011, INT J EPIDEMIOL, V40, P804, DOI 10.1093/ije/dyr029; Aisa B, 2007, PSYCHONEUROENDOCRINO, V32, P256, DOI 10.1016/j.psyneuen.2006.12.013; Alastalo H, 2009, ANN MED, V41, P66, DOI 10.1080/07853890802301983; Asghar S., 2012, INT J CLIN MED, V3, P7, DOI [10.4236/ijcm.2012.37104, DOI 10.4236/IJCM.2012.37104]; Berge LI, 2015, INT J ENDOCRINOL, V2015, DOI 10.1155/2015/164760; Bernardi JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062031; Bick J, 2015, DEV PSYCHOBIOL, V57, P131, DOI 10.1002/dev.21265; Biggio F, 2014, EUR NEUROPSYCHOPHARM, V24, P1152, DOI 10.1016/j.euroneuro.2014.03.009; Bjorntorp P, 2001, Obes Rev, V2, P73, DOI 10.1046/j.1467-789x.2001.00027.x; Bowe JE, 2014, J ENDOCRINOL, V222, pG13, DOI 10.1530/JOE-14-0182; Brietzke E, 2012, REV BRAS PSIQUIATR, V34, P480, DOI 10.1016/j.rbp.2012.04.009; Charmandari E, 2003, HORM RES, V59, P161, DOI 10.1159/000069325; Colaianna M, 2013, ANTIOXID REDOX SIGN, V18, P1385, DOI 10.1089/ars.2012.4569; Cotella EM, 2013, STRESS, V16, P477, DOI 10.3109/10253890.2013.775241; D'mello AP, 2006, PSYCHONEUROENDOCRINO, V31, P395, DOI 10.1016/j.psyneuen.2005.10.003; Dallman MF, 2007, CURR ALZHEIMER RES, V4, P199, DOI 10.2174/156720507780362236; Dandekar MP, 2009, NEUROPSYCHOPHARMACOL, V34, P1288, DOI 10.1038/npp.2008.201; Danese A, 2014, MOL PSYCHIATR, V19, P544, DOI 10.1038/mp.2013.54; Daskalakis NP, 2014, PSYCHONEUROENDOCRINO, V39, P39, DOI 10.1016/j.psyneuen.2013.09.021; Daskalakis NP, 2012, PHYSIOL BEHAV, V106, P707, DOI 10.1016/j.physbeh.2012.01.015; Daskalakis NP, 2011, HORM BEHAV, V60, P165, DOI 10.1016/j.yhbeh.2011.04.003; Dimatelis JJ, 2016, METAB BRAIN DIS, V31, P109, DOI 10.1007/s11011-015-9723-8; Doom JR, 2014, J AM ACAD CHILD PSY, V53, P1206, DOI 10.1016/j.jaac.2014.08.006; Ebner K, 2005, HORM BEHAV, V47, P14, DOI 10.1016/j.yhbeh.2004.08.002; Ellenbroek BA, 2000, NEUROPSYCHOPHARMACOL, V23, P99, DOI 10.1016/S0893-133X(00)00088-9; Filipovic D, 2012, J NEURAL TRANSM, V119, P1275, DOI 10.1007/s00702-012-0776-0; Fish EW, 2004, ANN NY ACAD SCI, V1036, P167, DOI 10.1196/annals.1330.011; Fone KCF, 2008, NEUROSCI BIOBEHAV R, V32, P1087, DOI 10.1016/j.neubiorev.2008.03.003; Gabory A, 2011, AM J CLIN NUTR, V94, p1943S, DOI 10.3945/ajcn.110.000927; Gilman SE, 2002, INT J EPIDEMIOL, V31, P359, DOI 10.1093/ije/31.2.359; Haley S, 2013, EARLY HUM DEV, V89, P387, DOI 10.1016/j.earlhumdev.2012.12.005; Hall FS, 1998, CRIT REV NEUROBIOL, V12, P129, DOI 10.1615/CritRevNeurobiol.v12.i1-2.50; Heim C, 2008, PSYCHONEUROENDOCRINO, V33, P693, DOI 10.1016/j.psyneuen.2008.03.008; Hensleigh E, 2015, BEHAV BRAIN RES, V295, P3, DOI 10.1016/j.bbr.2014.12.008; Hong SZ, 2012, PHYSIOL BEHAV, V105, P269, DOI 10.1016/j.physbeh.2011.08.036; Hulshof HJ, 2011, BEHAV BRAIN RES, V216, P552, DOI 10.1016/j.bbr.2010.08.038; Jahng JW, 2012, INT J DEV NEUROSCI, V30, P47, DOI 10.1016/j.ijdevneu.2011.10.001; Jahng JW, 2011, HORM BEHAV, V59, P213, DOI 10.1016/j.yhbeh.2010.11.010; Jimenez-Vasquez PA, 2001, DEV BRAIN RES, V131, P149, DOI 10.1016/S0165-3806(01)00264-4; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Konno J, 2008, NEUROSCI RES, V60, P259, DOI 10.1016/j.neures.2007.11.005; Krolow R, 2013, METABOLISM, V62, P1268, DOI 10.1016/j.metabol.2013.04.009; Krugel U, 2014, ARCH TOXICOL, V88, P853, DOI 10.1007/s00204-014-1203-0; Ladd CO, 2000, PROG BRAIN RES, V122, P81; Lajud N, 2012, PSYCHONEUROENDOCRINO, V37, P410, DOI 10.1016/j.psyneuen.2011.07.011; Lee JH, 2014, ENDOCRINOL METAB, V29, P169, DOI 10.3803/EnM.2014.29.2.169; Lehmann J, 2000, REV NEUROSCIENCE, V11, P383; Maccari S, 2014, J NEUROENDOCRINOL, V26, P707, DOI 10.1111/jne.12175; Mallei A, 2015, INT J NEUROPSYCHOPH, V18, DOI 10.1093/ijnp/pyu067; Maniam J, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00073; Martinac M, 2014, ACTA CLIN CROAT, V53, P55; McIntyre RS, 2012, INT J PSYCHIAT MED, V43, P165, DOI 10.2190/PM.43.2.e; McIntyre RS, 2009, CURR DIABETES REP, V9, P51, DOI 10.1007/s11892-009-0010-0; Miki T, 2013, BIOCHEM BIOPH RES CO, V442, P68, DOI 10.1016/j.bbrc.2013.11.005; Mirescu C, 2004, NAT NEUROSCI, V7, P841, DOI 10.1038/nn1290; Miyazaki T, 2012, J CLIN INVEST, V122, P2690, DOI 10.1172/JCI63060; Morris MJ, 2015, NEUROSCI BIOBEHAV R, V58, P36, DOI 10.1016/j.neubiorev.2014.12.002; Morton NM, 2001, J BIOL CHEM, V276, P41293, DOI 10.1074/jbc.M103676200; Nederhof E, 2012, PHYSIOL BEHAV, V106, P691, DOI 10.1016/j.physbeh.2011.12.008; Neumann ID, 1998, J PHYSIOL-LONDON, V508, P289, DOI 10.1111/j.1469-7793.1998.289br.x; Paternain L, 2013, STRESS, V16, P220, DOI 10.3109/10253890.2012.707708; Paternain L, 2012, NEUROENDOCRINOLOGY, V96, P249, DOI 10.1159/000341684; Paternain L, 2012, DIS MODEL MECH, V5, P691, DOI 10.1242/dmm.009043; Pesonen AK, 2007, AM J EPIDEMIOL, V166, P1126, DOI 10.1093/aje/kwm254; Rana S, 2015, NEUROSCI LETT, V584, P146, DOI 10.1016/j.neulet.2014.10.011; Reis FMCV, 2012, STRESS, V15, P318, DOI 10.3109/10253890.2011.623740; Rotella F, 2013, J CLIN PSYCHIAT, V74, P32, DOI 10.4088/JCP.12r07922; Ryu V, 2008, INT J OBESITY, V32, P1355, DOI 10.1038/ijo.2008.108; Ryu V, 2009, BRAIN RES, V1295, P127, DOI 10.1016/j.brainres.2009.08.006; Scherrer JF, 2011, TWIN RES HUM GENET, V14, P169, DOI 10.1375/twin.14.2.169; Shimizu H, 2008, ENDOCRINOLOGY, V149, P4544, DOI 10.1210/en.2008-0229; Shin JA, 2013, J DIABETES INVEST, V4, P334, DOI 10.1111/jdi.12075; Solas M, 2010, NEUROPSYCHOPHARMACOL, V35, P1664, DOI 10.1038/npp.2010.13; Sominsky L, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00434; Thamer S, 2014, J CHEM BIO PHY SCI, V4, P3232; Thorsell A, 2006, PHARMACOL BIOCHEM BE, V83, P28, DOI 10.1016/j.pbb.2005.12.005; Turecki G, 2016, BIOL PSYCHIAT, V79, P87, DOI 10.1016/j.biopsych.2014.11.022; van Zyl PJ, 2016, METAB BRAIN DIS, V31, P121, DOI 10.1007/s11011-015-9757-y; Weiss IC, 2001, PHARMACOL BIOCHEM BE, V70, P397, DOI 10.1016/S0091-3057(01)00626-8; Weiss IC, 2004, BEHAV BRAIN RES, V152, P279, DOI 10.1016/j.bbr.2003.10.015; Yamada C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140094; Zimmerberg Betty, 2011, Front Psychiatry, V2, P39, DOI 10.3389/fpsyt.2011.00039; Zlatkovic J, 2012, NEUROSCIENCE, V223, P238, DOI 10.1016/j.neuroscience.2012.08.005; Zlatkovic J, 2014, MOL CELL BIOCHEM, V393, P43, DOI 10.1007/s11010-014-2045-z	84	63	64	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162665	10.1371/journal.pone.0162665	http://dx.doi.org/10.1371/journal.pone.0162665			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611197	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900148
J	Zhang, ZY; Zhang, J; Yang, CJ; Lian, HY; Yu, H; Huang, XM; Cai, P				Zhang, Zi-Yan; Zhang, Jing; Yang, Chuan-Jun; Lian, Hui-Yong; Yu, Hui; Huang, Xiao-Mei; Cai, Peng			Coupling Mechanism of Electromagnetic Field and Thermal Stress on Drosophila melanogaster	PLOS ONE			English	Article							ALTERNATING MAGNETIC-FIELD; HEAT-SHOCK; OXIDATIVE STRESS; HIGH-TEMPERATURE; GENE-EXPRESSION; LIFE-SPAN; CAENORHABDITIS-ELEGANS; HSP70 EXPRESSION; DNA-DAMAGE; EXPOSURE	Temperature is an important factor in research on the biological effects of extremely low-frequency electromagnetic field (ELF-EMF), but interactions between ELF-EMF and temperature remain unknown. The effects of ELF-EMF (50 Hz, 3 mT) on the lifespan, locomotion, heat shock response (HSR), and oxidative stress (OS) of Canton-Special (CS) and mutant w1118 flies were investigated at 25 degrees C and 35 degrees C (thermal stress). Results showed that thermal stress accelerated the death rates of CS and w1118 flies, shortened their lifespan, and influenced their locomotion rhythm and activity. The upregulated expression levels of heat shock protein (HSP) 22, HSP26, and HSP70 indicated that HSR was enhanced. Thermal stress-induced OS response increased malondialdehyde content, enhanced superoxide dismutase activity, and decreased reactive oxygen species level. The effects of thermal stress on the death rates, lifespan, locomotion, and HSP gene expression of flies, especially w1118 line, were also enhanced by ELF-EMF. In conclusion, thermal stress weakened the physiological function and promoted the HSR and OS of flies. ELF-EMF aggravated damages and enhanced thermal stress-induced HSP and OS response. Therefore, thermal stress and ELF-EMF elicited a synergistic effect.	[Zhang, Zi-Yan; Yang, Chuan-Jun; Lian, Hui-Yong; Yu, Hui; Cai, Peng] Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China; [Zhang, Zi-Yan; Zhang, Jing; Huang, Xiao-Mei] Univ Chinese Acad Sci, Beijing, Peoples R China; [Zhang, Jing] Xiamen Univ, Xiamen, Peoples R China	Chinese Academy of Sciences; Institute of Urban Environment, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Xiamen University	Cai, P (corresponding author), Chinese Acad Sci, Inst Urban Environm, Key Lab Urban Environm & Hlth, Xiamen, Peoples R China.	pcai@iue.ac.cn	CAS, KLUEH/T-5743-2019	?, ??/0000-0003-0168-9201	Scientific Equipment Development Project of Chinese Academy of Sciences (CAS) [YZ201104]; Xiamen Science and Technology Plans Project [3502Z20126012]; National Natural Science Foundation of China [31270888]	Scientific Equipment Development Project of Chinese Academy of Sciences (CAS); Xiamen Science and Technology Plans Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by YZ201104, http://www.cas.cn/, Scientific Equipment Development Project of Chinese Academy of Sciences (CAS), Peng Cai; 3502Z20126012, http://www.xminfo.net.cn/, Xiamen Science and Technology Plans Project, Peng Cai; and 31270888, National Natural Science Foundation of China, Hui-Yong Lian. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Akhras MA, 2008, ELECTROMAGN BIOL MED, V27, P155, DOI 10.1080/15368370802072125; Alfieri RR, 2006, RADIAT RES, V165, P95, DOI 10.1667/RR3487.1; Heredia-Rojas JA, 2010, IN VITRO CELL DEV-AN, V46, P758, DOI 10.1007/s11626-010-9342-y; Baker MK, 2014, J PHYS CHEM B, V118, P13590, DOI 10.1021/jp507027t; Bernardini C, 2007, BIOELECTROMAGNETICS, V28, P231, DOI 10.1002/bem.20299; Buldak RJ, 2012, BIOELECTROMAGNETICS, V33, P641, DOI 10.1002/bem.21732; Chatelain EH, 2011, J EXP ZOOL PART B, V316B, P188, DOI 10.1002/jez.b.21389; Chen CH, 2010, BREAST CANCER RES TR, V123, P569, DOI 10.1007/s10549-010-0782-6; Council EaS, 2015, UNECE ITU SMART SUST; FROHLICH H, 1982, BIOELECTROMAGNETICS, V3, P45, DOI 10.1002/bem.2250030109; Grover N, 2007, JNMA J Nepal Med Assoc, V46, P62; Guxens M, 2014, OCCUPATIONAL ENV S1, V71, pA50, DOI [10.1136/, 10. 1136/oemed- 2014- 102362.156 PMID: 25018385., DOI 10.1136/0EMED-2014-102362.156]; Hercus MJ, 2003, BIOGERONTOLOGY, V4, P149, DOI 10.1023/A:1024197806855; Hofling F, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2901170; Jammes Y, 2009, J INTERN MED, V266, P196, DOI 10.1111/j.1365-2796.2009.02079.x; Junkersdorf B, 2000, BIOELECTROMAGNETICS, V21, P100, DOI 10.1002/(SICI)1521-186X(200002)21:2<100::AID-BEM4>3.0.CO;2-U; Kim BM, 2014, COMP BIOCHEM PHYS C, V166, P65, DOI 10.1016/j.cbpc.2014.07.005; Krebs RA, 1997, J EXP BIOL, V200, P2007; Lawrence A F, 1982, Neurol Res, V4, P115; Le Bourg E, 2001, BIOGERONTOLOGY, V2, P155, DOI 10.1023/A:1011561107055; Li SS, 2013, MUTAT RES-GEN TOX EN, V758, P95, DOI 10.1016/j.mrgentox.2013.10.004; Liao PC, 2008, BIOCHEM BIOPH RES CO, V376, P637, DOI 10.1016/j.bbrc.2008.08.161; Liu Yun, 2002, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V20, P263; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malagoli D, 2004, COMP BIOCHEM PHYS C, V137, P75, DOI 10.1016/j.cca.2003.11.007; Morono Y, 2015, ENV MICROBIOL REP, V7, P243, DOI 10.1111/1758-2229.12238; Morrow G, 2004, FASEB J, V18, P598, DOI 10.1096/fj.03-0860fje; MUTERO A, 1994, MOL GEN GENET, V243, P699, DOI 10.1007/BF00279580; Naito M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051902; Panagopoulos DJ, 2013, CELL BIOCHEM BIOPHYS, V67, P703, DOI 10.1007/s12013-013-9560-5; Pandey A, 2014, AGE, V36, P1139, DOI 10.1007/s11357-014-9628-1; Podda MV, 2014, EUR J NEUROSCI, V39, P893, DOI 10.1111/ejn.12465; Qin SY, 2016, NAT MATER, V15, P217, DOI [10.1038/NMAT4484, 10.1038/nmat4484]; Reale M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104973; Roosli M, 2007, NEUROEPIDEMIOLOGY, V28, P197, DOI 10.1159/000108111; Rolandi C, 2014, J EXP BIOL, V217, P4414, DOI 10.1242/jeb.109298; Sharma S, 2012, CHRONOBIOL INT, V29, P157, DOI 10.3109/07420528.2011.644875; Shi ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep08471; Sorensen JG, 2013, J EXP BIOL, V216, P809, DOI 10.1242/jeb.076356; Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1; Sullivan W., 2000, DROSOPHILA PROTOCOLS; Tipping DR, 1999, BIOELECTROMAGNETICS, V20, P129, DOI 10.1002/(SICI)1521-186X(1999)20:2<129::AID-BEM8>3.0.CO;2-Q; Tower J, 2014, J GERONTOL A-BIOL, V69, P253, DOI 10.1093/gerona/glt078; Villarini M, 2013, INT J RADIAT BIOL, V89, P562, DOI 10.3109/09553002.2013.782449; WALTER MF, 1990, DEV GENET, V11, P270, DOI 10.1002/dvg.1020110405; Ward BK, 2015, ANN NY ACAD SCI, V1343, P69, DOI 10.1111/nyas.12702; Wen J, 2009, BIOELECTROMAGNETICS, V30, P163, DOI 10.1002/bem.20461; WERTHEIMER N, 1979, AM J EPIDEMIOL, V109, P273, DOI 10.1093/oxfordjournals.aje.a112681; Williams KD, 2003, MOL ECOL, V12, P1165, DOI 10.1046/j.1365-294X.2003.01771.x; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054; Yoshii T, 2008, J COMP NEUROL, V508, P952, DOI 10.1002/cne.21702; [张晶 Zhang Jing], 2014, [军事医学, Military Medical Sciences], V38, P321; Zhang SZ, 2015, J INSECT PHYSIOL, V73, P47, DOI 10.1016/j.jinsphys.2015.01.004; Zhao G, 2014, EUR J GYNAECOL ONCOL, V35, P264	54	8	10	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162675	10.1371/journal.pone.0162675	http://dx.doi.org/10.1371/journal.pone.0162675			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611438	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900150
J	Cho, JH; Ryu, HM; Oh, EJ; Yook, JM; Ahn, JS; Jung, HY; Choi, JY; Park, SH; Kim, YL; Kwak, IS; Kim, CD				Cho, Jang-Hee; Ryu, Hye-Myung; Oh, Eun-Joo; Yook, Ju-Min; Ahn, Ji-Sun; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Yong-Lim; Kwak, Ihm Soo; Kim, Chan-Duck			Alpha1-Antitrypsin Attenuates Renal Fibrosis by Inhibiting TGF-beta 1-Induced Epithelial Mesenchymal Transition	PLOS ONE			English	Article							CHRONIC KIDNEY-DISEASE; TGF-BETA; INTERSTITIAL FIBROSIS; ALPHA-1-ANTITRYPSIN DEFICIENCY; OBSTRUCTIVE NEPHROPATHY; URETERAL OBSTRUCTION; FIBROBLASTS; MECHANISMS; MICE; TNF	Alpha1-antitrypsin (AAT) exerts its anti-inflammatory effect through regulating the activity of serine proteinases. This study evaluated the inhibitory effects of AAT against the transforming growth factor (TGF)-beta 1 induced epithelial-to-mesenchymal transition (EMT) in unilateral ureter obstruction (UUO) mice and Madin-Darby canine kidney (MDCK) cells. C57BL/6 mice with induced UUO were injected intraperitoneally with AAT (80 mg/Kg) or vehicle for 7 days. MDCK cells were treated with TGF-beta 1 (2 ng/mL) for 48 hours to induce EMT, and co-treated with AAT (10 mg/mL) to inhibit the EMT. Masson's trichrome and Sirius red staining was used to estimate the extent of renal fibrosis in UUO mice. The expression of alpha-smooth muscle actin (alpha-SMA), vimentin, fibronectin, collagen I, and E-cadherin in MDCK cells and kidney tissue were evaluated. Masson's and Sirius red staining revealed that the area of renal fibrosis was significantly smaller in AAT treated UUO group compared with that of UUO and vehicle treated UUO groups. AAT treatment attenuated upregulation of Smad2/3 phosphorylation in UUO mouse model. Co-treatment of MDCK cells with TGF-beta 1 and AAT significantly attenuated the changes in the expression of alpha-SMA, vimentin, fibronectin, collagen I, and E-cadherin. AAT also decreased the phosphorylated Smad3 expression and the phosphorylated Smad3/Smad3 ratio in MDCK cells. AAT treatment inhibited EMT induced by TGF-beta 1 in MDCK cells and attenuated renal fibrosis in the UUO mouse model. The results of this work suggest that AAT could inhibit the process of EMT through the suppression of TGF-beta/Smad3 signaling.	[Cho, Jang-Hee; Ryu, Hye-Myung; Oh, Eun-Joo; Yook, Ju-Min; Ahn, Ji-Sun; Jung, Hee-Yeon; Choi, Ji-Young; Park, Sun-Hee; Kim, Yong-Lim; Kim, Chan-Duck] Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea; [Kwak, Ihm Soo] Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea	Kyungpook National University; Pusan National University; Pusan National University Hospital	Kim, CD (corresponding author), Kyungpook Natl Univ, Dept Internal Med, Sch Med, Daegu, South Korea.; Kwak, IS (corresponding author), Pusan Natl Univ Hosp, Dept Internal Med, Busan, South Korea.	iskwak@pusan.ac.kr; drcdkim@knu.ac.kr	Cho, Jang-hee/ABD-3534-2020; Park, Sun/GSD-9620-2022	Cho, Jang-hee/0000-0002-7031-5214; Jung, Hee-Yeon/0000-0003-0232-7202	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea [HI15C0001]; Korean Society of Nephrology; Baxter Healthcare for Aralast(R)	Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI) - Ministry of Health & Welfare, Republic of Korea; Korean Society of Nephrology; Baxter Healthcare for Aralast(R)	This research was supported by a grant from the Korea Health Technology R&D Project through the Korea Health Industry Development Institute (KHIDI), which is funded by the Ministry of Health & Welfare, Republic of Korea (HI15C0001); by a grant from the Korean Society of Nephrology in 2015. Supported by Baxter Healthcare for Aralast (R). The commercial funder of the present study had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; Supported by Baxter Healthcare for Aralast (R).	Ai J, 2015, J AM SOC NEPHROL, V26, P1827, DOI 10.1681/ASN.2014040363; Barnes JL, 2011, CONTRIB NEPHROL, V169, P73, DOI 10.1159/000313946; BLANK CA, 1994, ANN ALLERGY, V72, P105; BUCURENCI N, 1992, FEBS LETT, V300, P21, DOI 10.1016/0014-5793(92)80156-B; Carrell RW, 2002, NEW ENGL J MED, V346, P45, DOI 10.1056/NEJMra010772; Chevalier RL, 2009, KIDNEY INT, V75, P1145, DOI 10.1038/ki.2009.86; Fan JM, 1999, KIDNEY INT, V56, P1455, DOI 10.1046/j.1523-1755.1999.00656.x; Garcia-Sanchez O, 2010, KIDNEY INT, V77, P950, DOI 10.1038/ki.2010.88; Guo GJ, 2001, AM J PHYSIOL-RENAL, V280, pF777, DOI 10.1152/ajprenal.2001.280.5.F777; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; JOHNSON D, 1979, J BIOL CHEM, V254, P4022; Kriz W, 2011, J CLIN INVEST, V121, P468, DOI 10.1172/JCI44595; LeBleu VS, 2013, NAT MED, V19, P1047, DOI 10.1038/nm.3218; Lewis EC, 2012, MOL MED, V18, P957, DOI 10.2119/molmed.2011.00196; Libert C, 1996, J IMMUNOL, V157, P5126; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Liu YH, 2010, J AM SOC NEPHROL, V21, P212, DOI 10.1681/ASN.2008121226; Lopez-Hernandez FJ, 2012, CELL TISSUE RES, V347, P141, DOI 10.1007/s00441-011-1275-6; Meldrum KK, 2007, AM J PHYSIOL-REG I, V292, pR1456, DOI 10.1152/ajpregu.00620.2005; Misseri Rosalia, 2005, Curr Urol Rep, V6, P140, DOI 10.1007/s11934-005-0083-5; Park SH, 2007, J AM SOC NEPHROL, V18, P1497, DOI 10.1681/ASN.2005080866; POTEMPA J, 1994, J BIOL CHEM, V269, P15957; Ralston DR, 1997, J CLIN INVEST, V100, P1416, DOI 10.1172/JCI119662; Segel GB, 2011, J LEUKOCYTE BIOL, V89, P359, DOI 10.1189/jlb.0910538; Stockley RA, 2002, AM J RESP CRIT CARE, V165, P1494, DOI 10.1164/rccm.2109013; Stockley RA, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.04.25; TRAVIS J, 1988, Tokai Journal of Experimental and Clinical Medicine, V13, P313; VanMolle W, 1997, J IMMUNOL, V159, P3555; Wynn TA, 2012, NAT MED, V18, P1028, DOI 10.1038/nm.2807; Yaghmaei M, 2009, DIABETES RES CLIN PR, V84, P201, DOI 10.1016/j.diabres.2009.03.003; Yang JW, 2002, J AM SOC NEPHROL, V13, P96, DOI 10.1681/ASN.V13196; Yuan WH, 2001, J BIOL CHEM, V276, P38502, DOI 10.1074/jbc.M107081200; Zeisberg EM, 2008, J AM SOC NEPHROL, V19, P2282, DOI 10.1681/ASN.2008050513; Zeisberg M, 2003, NAT MED, V9, P964, DOI 10.1038/nm888	35	20	21	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162186	10.1371/journal.pone.0162186	http://dx.doi.org/10.1371/journal.pone.0162186			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607429	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255600025
J	Zhuang, L; Su, JB; Zhang, XL; Huang, HY; Zhao, LH; Xu, F; Chen, T; Wang, XQ; Wu, G; Wang, XH				Zhuang, Lei; Su, Jian-bin; Zhang, Xiu-lin; Huang, Hai-yan; Zhao, Li-hua; Xu, Feng; Chen, Tong; Wang, Xue-qin; Wu, Gang; Wang, Xiao-hua			Serum Amylase Levels in Relation to Islet beta Cell Function in Patients with Early Type 2 Diabetes	PLOS ONE			English	Article							EXOCRINE PANCREATIC INSUFFICIENCY; GLUCOSE-TOLERANCE; METABOLIC SYNDROME; INSULIN-RESISTANCE; LIPASE; SECRETION; MECHANISM; RAT; SENSITIVITY; MELLITUS	Objective The insulin-pancreatic acinar axis may play a major role in pancreatic function. Amylase is an exocrine enzyme that is produced by pancreatic acinar cells, and low serum amylase levels may be associated with endocrine diseases, such as metabolic syndrome and diabetes. We hypothesized that low serum amylase levels may be associated with impaired islet beta cell function in type 2 diabetes. Therefore, we investigated the relationship between the serum amylase levels and islet beta cell function in patients with early type 2 diabetes. Methods The cross-sectional study recruited 2327 patients with a mean of 1.71 +/- 1.62 years since their diagnosis of type 2 diabetes, and all participants were treated with lifestyle intervention alone. Serum amylase levels, the 75-g oral glucose tolerance test (OGTT) and metabolic risk factors were examined in all participants. The insulin sensitivity index (Matsuda index, ISIMatsuda) and insulin secretion index (ratio of total area-under-the-insulin-curve to glucose-curve, AUC(ins/glu)) were derived from the OGTT. Integrated islet beta cell function was assessed by the Insulin Secretion-Sensitivity Index-2 (ISSI-2) (ISIMatsuda multiplied by AUC(ins/glu)). Results Serum amylase levels in the normal range were significantly correlated with ISIMatsuda, AUC(ins/glu) and ISSI-2 (r = 0.203, 0.246 and 0.413, respectively, p<0.001). The association of the serum amylase levels with ISSI-2 (adjusted r = 0.363, p<0.001) was closer than the association with ISIMatsuda (adjusted r = 0.191, p<0.001) and AUC(ins/glu) (adjusted r = 0.174, p<0.001) after adjusting for the anthropometric indices, time since the diagnosis of diabetes,lipid profiles, uric acid levels, estimated glomerular filtration rate, HbA1c levels, smoking and drinking using the partial correlation test. After adjusting for these metabolic risk factors in the multivariate regression analysis with the amylase levels as the dependent variable, ISSI-2 was the major independent contributor to the serum amylase levels (beta = 0.416, t = 21.72, p<0.001). Meanwhile, in a comparison of the groups with the highest and lowest quartiles of serum amylase levels, the mean difference in logISSI-2 was 0.902 (95% CI 0.823 to 0.982), and after adjusting for metabolic risk factors, the mean difference in logISSI-2 was 0.610 (0.537 to 0.683). Conclusions Serum amylase levels in the normal range are positively associated with integrated islet beta cell function in patients with early type 2 diabetes, as assessed by ISSI-2.	[Zhuang, Lei] Second Peoples Hosp Nantong City, Dept Endocrinol, 43 Xinglong St, Gangzha Dist 226002, Nantong, Peoples R China; [Su, Jian-bin; Huang, Hai-yan; Zhao, Li-hua; Xu, Feng; Wang, Xue-qin; Wu, Gang; Wang, Xiao-hua] Nantong Univ, Affiliated Hosp 2, Dept Endocrinol, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China; [Zhang, Xiu-lin; Chen, Tong] Nantong Univ, Affiliated Hosp 2, Dept Clin Lab, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China	Nantong University; Nantong University	Su, JB (corresponding author), Nantong Univ, Affiliated Hosp 2, Dept Endocrinol, 6 North Hai Er Xiang Rd, Nantong 226001, Peoples R China.	sujbzjx@163.com	Su, Jian-bin/R-9181-2017	Su, Jian-bin/0000-0002-2138-0263	Scientific Research Program of Nantong [HS2012028]; Scientific Research Program of Health and Planning Commission of Jiangsu [H201553]	Scientific Research Program of Nantong; Scientific Research Program of Health and Planning Commission of Jiangsu	The study was funded by the Scientific Research Program of Nantong (HS2012028) and the Scientific Research Program of Health and Planning Commission of Jiangsu (H201553).	Abdul-Ghani MA, 2006, DIABETES CARE, V29, P1130, DOI 10.2337/dc05-2179; Abdul-Ghani MA, 2007, DIABETES CARE, V30, P1544, DOI 10.2337/dc06-1331; Amer Diabet Assoc, 2012, DIABETES CARE, V35, pS64, DOI [10.2337/dc12-S064, 10.2337/dc09-S062, 10.2337/dc11-S011]; Aughsteen AA, 2002, SAUDI MED J, V23, P838; Barreto SG, 2010, AM J PHYSIOL-GASTR L, V299, pG10, DOI 10.1152/ajpgi.00077.2010; Eleftheriou Phaedra, 2014, Hell J Nucl Med, V17 Suppl 1, P35; Gupta V, 2005, POSTGRAD MED J, V81, P491, DOI 10.1136/pgmj.2003.009761; Jiang Chaw-Fung, 2002, Zhonghua Yi Xue Za Zhi (Taipei), V65, P49; Lee JG, 2011, CLIN CHIM ACTA, V412, P1848, DOI 10.1016/j.cca.2011.06.023; LEE KY, 1995, PANCREAS, V11, P190, DOI 10.1097/00006676-199508000-00013; LEE KY, 1994, AM J PHYSIOL, V267, pG207, DOI 10.1152/ajpgi.1994.267.2.G207; Levey AS, 2006, ANN INTERN MED, V145, P247, DOI 10.7326/0003-4819-145-4-200608150-00004; Makela A, 1997, EUR J SURG, V163, P915; Matsuda M, 1999, DIABETES CARE, V22, P1462, DOI 10.2337/diacare.22.9.1462; Muneyuki T, 2012, CARDIOVASC DIABETOL, V11, DOI 10.1186/1475-2840-11-80; Nakajima Kei, 2011, BMC Res Notes, V4, P419, DOI 10.1186/1756-0500-4-419; Nakajima K, 2011, CARDIOVASC DIABETOL, V10, DOI 10.1186/1475-2840-10-34; Nathan DM, 2007, DIABETOLOGIA, V50, P2239, DOI 10.1007/s00125-007-0803-0; Patel R, 2004, MOL CELL BIOCHEM, V261, P83, DOI 10.1023/B:MCBI.0000028741.85353.c6; Patel R, 2006, ANN NY ACAD SCI, V1084, P71, DOI 10.1196/annals.1372.038; Patel R, 2006, ANN NY ACAD SCI, V1084, P58, DOI 10.1196/annals.1372.027; Quiros JA, 2008, PEDIATR CRIT CARE ME, V9, P418, DOI 10.1097/PCC.0b013e318172e99b; Retnakaran R, 2009, DIABETIC MED, V26, P1198, DOI 10.1111/j.1464-5491.2009.02841.x; Retnakaran R, 2008, OBESITY, V16, P1901, DOI 10.1038/oby.2008.307; Rizvi AA, 2003, DIABETES CARE, V26, P3193, DOI 10.2337/diacare.26.11.3193; SENO T, 1995, AM J GASTROENTEROL, V90, P2002; Swislocki A, 2005, HORM METAB RES, V37, P326, DOI 10.1055/s-2005-861478; Wang YM, 2015, DIABETOL METAB SYNDR, V7, DOI 10.1186/s13098-015-0077-5; Yadav D, 2002, AM J GASTROENTEROL, V97, P1309, DOI 10.1016/S0002-9270(02)04122-9; Yao JM, 2014, LIPIDS HEALTH DIS, V13, DOI 10.1186/1476-511X-13-185; Yeh HC, 2010, ANN INTERN MED, V152, P10, DOI 10.7326/0003-4819-152-1-201001050-00005; Zhao Y, 2014, SCAND J CLIN LAB INV, V74, P235, DOI 10.3109/00365513.2013.878469; Zini E, 2010, RES VET SCI, V89, P20, DOI 10.1016/j.rvsc.2010.01.006	33	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162204	10.1371/journal.pone.0162204	http://dx.doi.org/10.1371/journal.pone.0162204			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606813	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600030
J	Chen, TL; Zheng, XJ; Ma, XJ; Bao, YQ; Ni, Y; Hu, C; Rajani, C; Huang, FJ; Zhao, AH; Jia, WP; Jia, W				Chen, Tianlu; Zheng, Xiaojiao; Ma, Xiaojing; Bao, Yuqian; Ni, Yan; Hu, Cheng; Rajani, Cynthia; Huang, Fengjie; Zhao, Aihua; Jia, Weiping; Jia, Wei			Tryptophan Predicts the Risk for Future Type 2 Diabetes	PLOS ONE			English	Article							CHAIN AMINO-ACIDS; INSULIN SENSITIVITY; GUT MICROBIOTA; METABOLITE PROFILES; GLUCOSE; SECRETION; RESISTANCE; MELLITUS; POPULATION; MECHANISMS	Recently, 5 amino acids were identified and verified as important metabolites highly associated with type 2 diabetes (T2D) development. This report aims to assess the association of tryptophan with the development of T2D and to evaluate its performance with existing amino acid markers. A total of 213 participants selected from a ten-year longitudinal Shanghai Diabetes Study (SHDS) were examined in two ways: 1) 51 subjects who developed diabetes and 162 individuals who remained metabolically healthy in 10 years; 2) the same 51 future diabetes and 23 strictly matched ones selected from the 162 healthy individuals. Baseline fasting serum tryptophan concentrations were quantitatively measured using ultra-performance liquid chromatography triple quadruple mass spectrometry. First, serum tryptophan level was found significantly higher in future T2D and was positively and independently associated with diabetes onset risk. Patients with higher tryptophan level tended to present higher degree of insulin resistance and secretion, triglyceride and blood pressure. Second, the prediction potential of tryptophan is non-inferior to the 5 existing amino acids. The predictive performance of the combined score improved after taking tryptophan into account. Our findings unveiled the potential of tryptophan as a new marker associated with diabetes risk in Chinese populations. The addition of tryptophan provided complementary value to the existing amino acid predictors.	[Chen, Tianlu; Zheng, Xiaojiao; Huang, Fengjie; Zhao, Aihua; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China; [Chen, Tianlu; Zheng, Xiaojiao; Huang, Fengjie; Zhao, Aihua; Jia, Weiping; Jia, Wei] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai, Peoples R China; [Ma, Xiaojing; Bao, Yuqian; Hu, Cheng; Jia, Weiping] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai Diabet Inst, Shanghai, Peoples R China; [Ni, Yan; Rajani, Cynthia; Jia, Wei] Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA	Shanghai Jiao Tong University; Shanghai Jiao Tong University; Shanghai Jiao Tong University; Cancer Research Center of Hawaii; University of Hawaii System	Jia, WP; Jia, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Shanghai Key Lab Diabet Mellitus, Shanghai, Peoples R China.; Jia, WP; Jia, W (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Ctr Translat Med, Shanghai, Peoples R China.; Jia, WP (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Endocrinol & Metab, Shanghai Diabet Inst, Shanghai, Peoples R China.; Jia, W (corresponding author), Univ Hawaii, Ctr Canc, Honolulu, HI 96822 USA.	wpjia@sjtu.edu.cn; wjia@cc.hawaii.edu	Hu, Cheng/C-3346-2008; Jia, Wei/AAN-5102-2020	Hu, Cheng/0000-0003-4314-2386; Jia, Wei/0000-0002-3739-8994	International Science & Technology Cooperation Program of China [2014DFA31870]; Major State Basic Research Development Program [2011CB504001]	International Science & Technology Cooperation Program of China; Major State Basic Research Development Program(National Basic Research Program of China)	This work was supported by International Science & Technology Cooperation Program of China (2014DFA31870, http://www.most.gov.cn/kjjh/xmsb/) and Major State Basic Research Development Program (2011CB504001, http://www.most.gov.cn/eng/programmes1/200610/t20061009_36223.htm).	Allin KH, 2015, EUR J ENDOCRINOL, V172, pR167, DOI 10.1530/EJE-14-0874; Bain JR, 2009, DIABETES, V58, P2429, DOI 10.2337/db09-0580; Bao YQ, 2009, J PROTEOME RES, V8, P1623, DOI 10.1021/pr800643w; Batch BC, 2013, METABOLISM, V62, P961, DOI 10.1016/j.metabol.2013.01.007; Bennet H, 2015, PEPTIDES, V71, P113, DOI 10.1016/j.peptides.2015.07.008; Cani PD, 2012, GUT MICROBES, V3, P279, DOI 10.4161/gmic.19625; Chen T, 2016, SCI REP; Cho YS, 2012, NAT GENET, V44, P67, DOI 10.1038/ng.1019; Fernstrom JD, 2013, AMINO ACIDS, V45, P419, DOI 10.1007/s00726-012-1330-y; Gu YJ, 2013, J PROTEOME RES, V12, P5801, DOI 10.1021/pr4008199; Han JL, 2014, WORLD J GASTROENTERO, V20, P17737, DOI 10.3748/wjg.v20.i47.17737; Herrera R, 2003, PEDIATR NEUROL, V28, P20, DOI 10.1016/S0887-8994(02)00462-9; Holman RR, 1998, DIABETES RES CLIN PR, V40, pS21; Iida H, 2015, J MOL ENDOCRINOL, V55, P41, DOI 10.1530/JME-14-0299; Inubushi T, 2012, J NUTR SCI VITAMINOL, V58, P415, DOI 10.3177/jnsv.58.415; Isbell JM, 2010, DIABETES CARE, V33, P1438, DOI 10.2337/dc09-2107; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Karlsson FH, 2013, NATURE, V498, P99, DOI 10.1038/nature12198; Katz A, 2000, J CLIN ENDOCR METAB, V85, P2402, DOI 10.1210/jc.85.7.2402; Kim K, 2015, ENDOCRINOLOGY, V156, P444, DOI 10.1210/en.2014-1687; Larsen N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009085; Le Chatelier E, 2013, NATURE, V500, P541, DOI 10.1038/nature12506; Le Floc'h N, 2011, AMINO ACIDS, V41, P1195, DOI 10.1007/s00726-010-0752-7; Lin ZW, 2015, ENDOCRINE, V48, P179, DOI 10.1007/s12020-014-0244-8; Ma RCW, 2013, ANN NY ACAD SCI, V1281, P64, DOI 10.1111/nyas.12098; Mahendran Y, 2013, DIABETES CARE, V36, P3732, DOI 10.2337/dc13-0800; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Menni C, 2013, DIABETES, V62, P4270, DOI 10.2337/db13-0570; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Oxenkrug Gregory, 2015, Integr Mol Med, V2, P365; Oxenkrug G, 2013, MOL NEUROBIOL, V48, P294, DOI 10.1007/s12035-013-8497-4; Oxenkrug GF, 2015, MOL NEUROBIOL, V52, P805, DOI 10.1007/s12035-015-9232-0; Pedersen ER, 2015, ARTERIOSCL THROM VAS, V35, P455, DOI 10.1161/ATVBAHA.114.304674; Piccolo BD, 2016, AM J PHYSIOL-ENDOC M, V310, pE958, DOI 10.1152/ajpendo.00052.2016; Qin JJ, 2012, NATURE, V490, P55, DOI 10.1038/nature11450; Reginaldo C, 2015, FASEB J S, V29; Samuel VT, 2012, CELL, V148, P852, DOI 10.1016/j.cell.2012.02.017; Stumvoll M, 2001, DIABETES CARE, V24, P796, DOI 10.2337/diacare.24.4.796; Tillin T, 2015, DIABETOLOGIA, V58, P968, DOI 10.1007/s00125-015-3517-8; Tsavkelova E, 2012, FUNGAL GENET BIOL, V49, P48, DOI 10.1016/j.fgb.2011.10.005; Wang TJ, 2011, NAT MED, V17, P448, DOI 10.1038/nm.2307; Whiting DR, 2011, DIABETES RES CLIN PR, V94, P311, DOI 10.1016/j.diabres.2011.10.029; World Health Organization DoNDSG, 1999, DONDSG DEF DIAGN CLA; Wurtz P, 2013, DIABETES CARE, V36, P648, DOI 10.2337/dc12-0895; Wurtz P, 2012, DIABETES CARE, V35, P1749, DOI 10.2337/dc11-1838; Xie GX, 2014, J PROTEOME RES, V13, P4062, DOI 10.1021/pr500434s; Yu H, 2015, J CLIN ENDOCR METAB; Yu HY, 2015, SURG OBES RELAT DIS, V11, P6, DOI 10.1016/j.soard.2014.06.019; Zhang M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126082	49	43	43	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162192	10.1371/journal.pone.0162192	http://dx.doi.org/10.1371/journal.pone.0162192			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598004	Green Submitted, Green Published, gold			2022-12-26	WOS:000383254800045
J	Katsuyama, N; Usui, N; Taira, M				Katsuyama, Narumi; Usui, Nobuo; Taira, Masato			Activation of the Human MT Complex by Motion in Depth Induced by a Moving Cast Shadow	PLOS ONE			English	Article							SUPERIOR TEMPORAL SULCUS; VISUAL CORTICAL AREAS; HUMAN BRAIN; 3-DIMENSIONAL MOTION; STEREOSCOPIC DEPTH; MOVEMENT VISION; MACAQUE MONKEY; PLUS COMPLEX; PERCEPTION; CORTEX	A moving cast shadow is a powerful monocular depth cue for motion perception in depth. For example, when a cast shadow moves away from or toward an object in a two-dimensional plane, the object appears to move toward or away from the observer in depth, respectively, whereas the size and position of the object are constant. Although the cortical mechanisms underlying motion perception in depth by cast shadow are unknown, the human MT complex (hMT+) is likely involved in the process, as it is sensitive to motion in depth represented by binocular depth cues. In the present study, we examined this possibility by using a functional magnetic resonance imaging (fMRI) technique. First, we identified the cortical regions sensitive to the motion of a square in depth represented via binocular disparity. Consistent with previous studies, we observed significant activation in the bilateral hMT+, and defined functional regions of interest (ROIs) there. We then investigated the activity of the ROIs during observation of the following stimuli: 1) a central square that appeared to move back and forth via a moving cast shadow (mCS); 2) a segmented and scrambled cast shadow presented beside the square (sCS); and 3) no cast shadow (nCS). Participants perceived motion of the square in depth in the mCS condition only. The activity of the hMT+ was significantly higher in the mCS compared with the sCS and nCS conditions. Moreover, the hMT+ was activated equally in both hemispheres in the mCS condition, despite presentation of the cast shadow in the bottom-right quadrant of the stimulus. Perception of the square moving in depth across visual hemifields may be reflected in the bilateral activation of the hMT+. We concluded that the hMT+ is involved in motion perception in depth induced by moving cast shadow and by binocular disparity.	[Katsuyama, Narumi; Usui, Nobuo; Taira, Masato] Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cognit Neurobiol, Bunkyo Ku, Tokyo, Japan; [Katsuyama, Narumi; Usui, Nobuo; Taira, Masato] Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo, Japan	Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Katsuyama, N (corresponding author), Tokyo Med & Dent Univ, Grad Sch Med & Dent Sci, Dept Cognit Neurobiol, Bunkyo Ku, Tokyo, Japan.; Katsuyama, N (corresponding author), Tokyo Med & Dent Univ, Ctr Brain Integrat Res, Bunkyo Ku, Tokyo, Japan.	katz.cnb@tmd.ac.jp			Ministry of Education, Culture, Sports, Science and Technology of Japan [17022038]	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This research was supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#17022038 to MT), http://www.mext.go.jp/a_menu/shinkou/hojyo/main5_a5.htm (in Japanese), http://www.mext.go.jp/english/ (the home of website for the Ministry of Education, Culture, Sports, Science and Technology of Japan in English). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; The authors wish to thank Solidray Co., Ltd. for their technical support with 3D graphics. This research was supported by Grants-in-Aid for Scientific Research on Priority Areas from the Ministry of Education, Culture, Sports, Science and Technology of Japan (#17022038 to MT).	Ajina S, 2015, ELIFE, V4, DOI 10.7554/eLife.08935; Akin B, 2014, J VISION, V14, DOI 10.1167/14.12.30; ALBRIGHT TD, 1984, J NEUROPHYSIOL, V51, P16, DOI 10.1152/jn.1984.51.1.16; Amano K, 2009, J NEUROPHYSIOL, V102, P2704, DOI 10.1152/jn.00102.2009; Backus BT, 2001, J NEUROPHYSIOL, V86, P2054, DOI 10.1152/jn.2001.86.4.2054; Brett M., 2002, 8 INT C FUNCT MAPP H, DOI DOI 10.1016/S1053-8119(02)90010-8; Czuba TB, 2014, J NEUROSCI, V34, P15522, DOI 10.1523/JNEUROSCI.1081-14.2014; DESIMONE R, 1986, J COMP NEUROL, V248, P164, DOI 10.1002/cne.902480203; DeYoe EA, 1996, P NATL ACAD SCI USA, V93, P2382, DOI 10.1073/pnas.93.6.2382; Dukelow SP, 2001, J NEUROPHYSIOL, V86, P1991, DOI 10.1152/jn.2001.86.4.1991; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Eifuku S, 1999, J NEUROPHYSIOL, V82, P2462, DOI 10.1152/jn.1999.82.5.2462; Eifuku S, 1998, J NEUROPHYSIOL, V80, P282, DOI 10.1152/jn.1998.80.1.282; Ffytche DH, 2000, EUR J NEUROSCI, V12, P3015, DOI 10.1046/j.1460-9568.2000.00177.x; Fortin A, 2002, NEUROREPORT, V13, P895, DOI 10.1097/00001756-200205070-00032; Hervais-Adelman A, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00051; Howard IP, 2012, PERCEIVING IN DEPTH, V3; Huk AC, 2002, J NEUROSCI, V22, P7195; Kersten D, 1996, NATURE, V379, P31, DOI 10.1038/379031a0; Kersten D, 1997, PERCEPTION, V26, P171, DOI 10.1068/p260171; Khuu SK, 2014, J VISION, V14, DOI 10.1167/14.3.25; Kolster H, 2010, J NEUROSCI, V30, P9801, DOI 10.1523/JNEUROSCI.2069-10.2010; Lacadie CM, 2008, NEUROIMAGE, V42, P717, DOI 10.1016/j.neuroimage.2008.04.240; Likova LT, 2007, NEUROIMAGE, V38, P293, DOI 10.1016/j.neuroimage.2007.06.039; Liu ZM, 2009, NEUROIMAGE, V46, P989, DOI 10.1016/j.neuroimage.2009.03.028; Mamassian P, 1998, TRENDS COGN SCI, V2, P288, DOI 10.1016/S1364-6613(98)01204-2; MAUNSELL JHR, 1983, J NEUROPHYSIOL, V49, P1127, DOI 10.1152/jn.1983.49.5.1127; Mizutani S, 2015, BEHAV BRAIN RES, V288, P63, DOI 10.1016/j.bbr.2015.04.005; Morrone MC, 2000, NAT NEUROSCI, V3, P1322, DOI 10.1038/81860; Neri P, 2004, J NEUROPHYSIOL, V92, P1880, DOI 10.1152/jn.01042.2003; Orban GA, 1999, NEURON, V24, P929, DOI 10.1016/S0896-6273(00)81040-5; Peuskens H, 2001, J NEUROSCI, V21, P2451, DOI 10.1523/JNEUROSCI.21-07-02451.2001; Ptito M, 2003, NEUROIMAGE, V19, P246, DOI 10.1016/S1053-8119(03)00082-X; Ptito M, 2001, NEUROIMAGE, V14, P1409, DOI 10.1006/nimg.2001.0947; Rokers B, 2009, NAT NEUROSCI, V12, P1050, DOI 10.1038/nn.2343; Sanada TM, 2014, J NEUROSCI, V34, P15508, DOI 10.1523/JNEUROSCI.1072-14.2014; Smith AT, 2008, J VISION, V8, DOI 10.1167/8.10.1; Sunaert S, 1999, EXP BRAIN RES, V127, P355, DOI 10.1007/s002210050804; Talairach J., 1988, COPLANAR STEREOTAXIC; Tamietto M, 2016, CURR BIOL, V26, pR70, DOI 10.1016/j.cub.2015.11.026; TOOTELL RBH, 1995, J NEUROSCI, V15, P3215; Wilms M, 2005, ANAT EMBRYOL, V210, P485, DOI 10.1007/s00429-005-0064-y; Wunderlich G, 2002, NEUROSCIENCE, V112, P535, DOI 10.1016/S0306-4522(02)00110-0; ZEKI S, 1991, J NEUROSCI, V11, P641; ZEKI SM, 1974, J PHYSIOL-LONDON, V236, P549, DOI 10.1113/jphysiol.1974.sp010452; ZIHL J, 1983, BRAIN, V106, P313, DOI 10.1093/brain/106.2.313; ZIHL J, 1991, BRAIN, V114, P2235, DOI 10.1093/brain/114.5.2235; Zihr J, 2015, FRONT INTEGR NEUROSC, V9, DOI 10.3389/fnint.2015.00006	48	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162555	10.1371/journal.pone.0162555	http://dx.doi.org/10.1371/journal.pone.0162555			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27597999	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800075
J	Deng, Y; Cheng, J; Fu, B; Liu, W; Chen, G; Zhang, Q; Yang, Y				Deng, Y.; Cheng, J.; Fu, B.; Liu, W.; Chen, G.; Zhang, Q.; Yang, Y.			Hepatic carcinoma-associated fibroblasts enhance immune suppression by facilitating the generation of myeloid-derived suppressor cells	ONCOGENE			English	Article							CANCER-ASSOCIATED FIBROBLASTS; TUMOR MICROENVIRONMENT; PERIPHERAL-BLOOD; T-CELLS; INFLAMMATION; MECHANISM; PROMOTE; MODULATION; EXPANSION; MELANOMA	A major barrier to effective cancer immunotherapy is immune suppression in favor of tumor progression. Additionally, the accumulation of myeloid-derived suppressor cells (MDSCs) has recently been recognized as a major mechanism of the promotion of immune suppression. However, how MDSCs are induced and the cells from which they arise remains unknown. Although studies have demonstrated that tumor-derived cytokines promote MDSC accumulation and activation, little is known regarding the role of the tumor stroma in MDSC accumulation and activation. In this study, we identified a novel mechanism of MDSC differentiation. Tumor-associated fibroblasts (TAFs) attracted monocytes by the stromal cell-derived factor (SDF)-1a/CXCR4 pathway and induced their differentiation into MDSCs through interleukin (IL)-6-mediated STAT3 activation. TAF-treated monocytes (T-MDSCs) then impaired T-cell proliferation and altered the phenotype and/or function of T-cells in an STAT3-dependent manner. CD11b(+) myeloid cells, which resembled T-MDSCs both phenotypically and functionally, were primarily in the peritumoral stroma and a positive association with TAFs in vivo. Additionally, a negative association between CD11b(+) myeloid cell densities and overall survival was observed. An increased number of stromal CD11b(+) myeloid cells was correlated with Hepatocellular Carcinoma (HCC) progression. Together, our results are the first to show that TAF-derived cytokines, such as IL-6 and SDF-1a, can induce MDSC generation and activation and then impair human anti-tumor immune responses, which create favorable conditions for HCC progression. These data also suggest an important role for STAT3 activation in TAF-mediated MDSC generation and MDSC-mediated immune suppression. Consequently, methods in which immunotherapy is combined with IL-6, SDF-1a or STAT3 inhibition may offer an improved option to eliminate suppressive CD11b(+) myeloid cells in HCC patients.	[Deng, Y.; Cheng, J.; Fu, B.; Chen, G.; Yang, Y.] Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China; [Deng, Y.; Cheng, J.; Liu, W.; Chen, G.; Zhang, Q.; Yang, Y.] Guangdong Prov Key Lab Liver Dis Res, Guangzhou, Guangdong, Peoples R China; [Zhang, Q.] Sun Yat Sen Univ, Affiliated Hosp 3, Cell Gene Therapy Translat Med Res Ctr, Guangzhou 510630, Guangdong, Peoples R China	Sun Yat Sen University; Sun Yat Sen University	Yang, Y (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Dept Hepat Surg, 600 Tianhe Rd, Guangzhou 510630, Guangdong, Peoples R China.; Zhang, Q (corresponding author), Sun Yat Sen Univ, Affiliated Hosp 3, Cell Gene Therapy Translat Med Res Ctr, Guangzhou 510630, Guangdong, Peoples R China.	kee_kee@126.com; yysysu@163.com	yang, yang/HGT-7999-2022; Lang, Ming/HIK-0758-2022; yang, yang/GVT-5210-2022	Zhang, Qi/0000-0001-9916-8919	National Natural Science Foundation of China [81372243, 81172036, 81170451, 81370575, 81370555]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by: National Natural Science Foundation of China (81372243, 81172036, 81170451, 81370575, 81370555).	Almand B, 2001, J IMMUNOL, V166, P678, DOI 10.4049/jimmunol.166.1.678; Balsamo M, 2009, P NATL ACAD SCI USA, V106, P20847, DOI 10.1073/pnas.0906481106; Barclay WW, 2008, STEM CELLS, V26, P600, DOI 10.1634/stemcells.2007-0309; Barnas JL, 2010, J IMMUNOL, V185, P2681, DOI 10.4049/jimmunol.1000896; Bayne LJ, 2012, CANCER CELL, V21, P822, DOI 10.1016/j.ccr.2012.04.025; Berking C, 2001, CANCER RES, V61, P8306; Byzova TV, 2000, MOL CELL, V6, P851, DOI 10.1016/S1097-2765(05)00076-6; Condamine T, 2011, TRENDS IMMUNOL, V32, P19, DOI 10.1016/j.it.2010.10.002; Corzo CA, 2009, J IMMUNOL, V182, P5693, DOI 10.4049/jimmunol.0900092; Diaz-Montero CM, 2009, CANCER IMMUNOL IMMUN, V58, P49, DOI 10.1007/s00262-008-0523-4; Erez N, 2010, CANCER CELL, V17, P135, DOI 10.1016/j.ccr.2009.12.041; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Fortin CF, 2007, BIOGERONTOLOGY, V8, P173, DOI 10.1007/s10522-006-9067-1; Fukumura D, 1998, CELL, V94, P715, DOI 10.1016/S0092-8674(00)81731-6; Gabrilovich DI, 2012, NAT REV IMMUNOL, V12, P253, DOI 10.1038/nri3175; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; Gaggioli C, 2007, NAT CELL BIOL, V9, P1392, DOI 10.1038/ncb1658; Goh PP, 2007, CURR CANCER DRUG TAR, V7, P743, DOI 10.2174/156800907783220462; Greten TF, 2011, INT IMMUNOPHARMACOL, V11, P802, DOI 10.1016/j.intimp.2011.01.003; Highfill SL, 2010, BLOOD, V116, P5738, DOI 10.1182/blood-2010-06-287839; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hoechst B, 2008, GASTROENTEROLOGY, V135, P234, DOI 10.1053/j.gastro.2008.03.020; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jia CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063243; Kuang DM, 2008, J IMMUNOL, V181, P3089, DOI 10.4049/jimmunol.181.5.3089; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Kusmartsev S, 2008, CLIN CANCER RES, V14, P8270, DOI 10.1158/1078-0432.CCR-08-0165; Lechner MG, 2010, J IMMUNOL, V185, P2273, DOI 10.4049/jimmunol.1000901; Li TJ, 2012, CANCER LETT, V318, P154, DOI 10.1016/j.canlet.2011.12.020; Liao D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007965; Mandruzzato S, 2009, J IMMUNOL, V182, P6562, DOI 10.4049/jimmunol.0803831; Marigo I, 2010, IMMUNITY, V32, P790, DOI 10.1016/j.immuni.2010.05.010; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Ohishi W, 2014, INT J CANCER, V134, P154, DOI 10.1002/ijc.28337; Ostrand-Rosenberg S, 2012, SEMIN CANCER BIOL, V22, P275, DOI 10.1016/j.semcancer.2012.01.011; Ostrand-Rosenberg S, 2009, J IMMUNOL, V182, P4499, DOI 10.4049/jimmunol.0802740; Pavlides S, 2010, CELL CYCLE, V9, P2201, DOI 10.4161/cc.9.11.11848; Raychaudhuri B, 2011, NEURO-ONCOLOGY, V13, P591, DOI 10.1093/neuonc/nor042; Rodriguez PC, 2009, CANCER RES, V69, P1553, DOI 10.1158/0008-5472.CAN-08-1921; Serafini P, 2006, SEMIN CANCER BIOL, V16, P53, DOI 10.1016/j.semcancer.2005.07.005; Servais C, 2013, J PATHOL, V229, P198, DOI 10.1002/path.4103; Solito S, 2011, BLOOD, V118, P2254, DOI 10.1182/blood-2010-12-325753; Su XM, 2010, J IMMUNOL, V184, P1630, DOI 10.4049/jimmunol.0902813; Vered M, 2010, INT J CANCER, V127, P1356, DOI 10.1002/ijc.25358; Vuk-Pavlovic S, 2010, PROSTATE, V70, P443, DOI 10.1002/pros.21078; Xing F, 2010, FRONT BIOSCI-LANDMRK, V15, P166, DOI 10.2741/3613; Yan DH, 2013, EUR J IMMUNOL, V43, P2943, DOI 10.1002/eji.201343472; Zea AH, 2005, CANCER RES, V65, P3044, DOI 10.1158/0008-5472.CAN-04-4505	48	86	98	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	FEB 23	2017	36	8					1090	1101		10.1038/onc.2016.273	http://dx.doi.org/10.1038/onc.2016.273			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	EM5SA	27593937				2022-12-26	WOS:000395371500007
J	Ambang, T; Tan, JS; Ong, S; Wong, KT; Goh, KJ				Ambang, Tomica; Tan, Joo-San; Ong, Sheila; Wong, Kum-Thong; Goh, Khean-Jin			Clinicopathological Features of Telbivudine-Associated Myopathy	PLOS ONE			English	Article							CHRONIC HEPATITIS-B; DISEASE; ANALOGS	Telbivudine, a thymidine nucleoside analog, is a common therapeutic option for chronic hepatitis B infection. While raised serum creatine kinase is common, myopathy associated with telbivudine is rare. Reports on its myopathological features are few and immunohistochemical analyses of inflammatory cell infiltrates have not been previously described. We describe the clinical, myopathological and immunohistochemical features of four patients who developed myopathy after telbivudine therapy for chronic hepatitis B infection. All four patients presented with progressive proximal muscle weakness, elevation of serum creatine kinase and myopathic changes on electromyography. Muscle biopsies showed myofiber degeneration/necrosis, regeneration, and fibers with cytoplasmic bodies and cytochrome c oxidase deficiency. There was minimal inflammation associated with strong sarcolemmal overexpression of class I major histocompatibility complex (MHC class I). Upon withdrawal of telbivudine, muscle weakness improved in all patients and eventually completely resolved in three. In our series, telbivudine-associated myopathy is characterized by necrotizingmyopathy which improved on drug withdrawal. Although the occasional loss of cytochrome c oxidase is consistent with mitochondrial toxicity, the overexpression of MHC class I in all patients could suggest an underlying immune-mediated mechanism which may warrant further investigation.	[Ambang, Tomica; Tan, Joo-San; Goh, Khean-Jin] Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia; [Ambang, Tomica; Tan, Joo-San; Wong, Kum-Thong] Univ Malaya, Fac Med, Dept Pathol, Kuala Lumpur, Malaysia; [Ong, Sheila] Queen Elizabeth Hosp, Dept Med, Kota Kinabalu, Sabah, Malaysia	Universiti Malaya; Universiti Malaya	Goh, KJ (corresponding author), Univ Malaya, Fac Med, Dept Med, Div Neurol, Kuala Lumpur, Malaysia.	gohkj@ummc.edu.my	Wong, Kum Thong/B-2788-2010; Goh, Khean Jin/D-1990-2010	Goh, Khean Jin/0000-0001-5416-9627	UM/MoHE High Impact Research Grant [H-20001-E00031]; Ministry of Higher Education, Malaysia	UM/MoHE High Impact Research Grant; Ministry of Higher Education, Malaysia(Ministry of Education, Malaysia)	This study was supported by the UM/MoHE/08 High Impact Research Grant H-20001-E00031, Ministry of Higher Education, Malaysia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baharin Janudin, 2014, Electron Physician, V6, P863, DOI 10.14661/2014.863-867; Bryant ML, 2001, ANTIMICROB AGENTS CH, V45, P229, DOI 10.1128/AAC.45.1.229-235.2001; DALAKAS MC, 1990, NEW ENGL J MED, V322, P1098, DOI 10.1056/NEJM199004193221602; Departmentof Health U.S. and Human Services National Institute of Health National Cancer Institute, 2009, COMM TERM CRIT ADV E; Dong Y, 2012, HEPATOL INT, V6, P120; ENGEL AG, 2004, MYOLOGY, P681; Finsterer J, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-323; Fleischer RD, 2009, J HEPATOL, V51, P787, DOI 10.1016/j.jhep.2009.06.011; Fung J, 2014, J GASTROEN HEPATOL, V29, P428, DOI 10.1111/jgh.12499; Fung J, 2011, J ANTIMICROB CHEMOTH, V66, P2715, DOI 10.1093/jac/dkr388; Jin JL, 2013, WORLD J GASTROENTERO, V19, P5575, DOI 10.3748/wjg.v19.i33.5575; Jung M, 2011, HEPATOL INT, V5, P117; Kim EH, 2013, CLIN MOL HEPATOL, V19, P82, DOI 10.3350/cmh.2013.19.1.82; Lavanchy D, 2004, J VIRAL HEPATITIS, V11, P97, DOI 10.1046/j.1365-2893.2003.00487.x; Lee SW, 2013, INTERN MED J, V43, P1048, DOI 10.1111/imj.12237; Liaw YF, 2009, GASTROENTEROLOGY, V136, P486, DOI 10.1053/j.gastro.2008.10.026; Lok ASF, 2007, HEPATOLOGY, V45, P507, DOI 10.1002/hep.21513; MULLERHOCKER J, 1990, J NEUROL SCI, V100, P14, DOI 10.1016/0022-510x(90)90006-9; Preusse C, 2012, AM J PATHOL, V181, P2161, DOI 10.1016/j.ajpath.2012.08.033; Sarin SK, 2016, HEPATOL INT, V10, P1, DOI 10.1007/s12072-015-9675-4; Seok JI, 2009, HEPATOLOGY, V49, P2080, DOI 10.1002/hep.22959; Wang M, 2012, INT J CLIN PHARM-NET, V34, P422, DOI 10.1007/s11096-012-9633-3; Xu HL, 2014, J CLIN PATHOL, V67, P999, DOI 10.1136/jclinpath-2013-202069; Zou XJ, 2011, J VIRAL HEPATITIS, V18, P892, DOI 10.1111/j.1365-2893.2010.01412.x	24	11	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162760	10.1371/journal.pone.0162760	http://dx.doi.org/10.1371/journal.pone.0162760			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611456	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900163
J	Davison, M; Treangen, TJ; Koren, S; Pop, M; Bhaya, D				Davison, Michelle; Treangen, Todd J.; Koren, Sergey; Pop, Mihai; Bhaya, Devaki			Diversity in a Polymicrobial Community Revealed by Analysis of Viromes, Endolysins and CRISPR Spacers	PLOS ONE			English	Article							MULTIPLE SEQUENCE ALIGNMENT; THERMOPHILIC CYANOBACTERIA; PHYLOGENETIC ANALYSIS; COMPARATIVE GENOMICS; HUMAN MICROBIOME; VIRAL DIVERSITY; RESISTANCE; EXPRESSION; BIOFILMS; PHOTOSYNTHESIS	The polymicrobial biofilm communities in Mushroom and Octopus Spring in Yellowstone National Park (YNP) are well characterized, yet little is known about the phage populations. Dominant species, Synechococcus sp. JA-2-3B'a(2-13), Synechococcus sp. JA-3-3Ab, Chloroflexus sp. Y-400-fl, and Roseiflexus sp. RS-1, contain multiple CRISPR-Cas arrays, suggesting complex interactions with phage predators. To analyze phage populations from Octopus Spring biofilms, we sequenced a viral enriched fraction. To assemble and analyze phage metagenomic data, we developed a custom module, VIRITAS, implemented within the MetAMOS framework. This module bins contigs into groups based on tetranucleotide frequencies and CRISPR spacer-protospacer matching and ORF calling. Using this pipeline we were able to assemble phage sequences into contigs and bin them into three clusters that corroborated with their potential host range. The virome contained 52,348 predicted ORFs; some were clearly phage-like; 9319 ORFs had a recognizable Pfam domain while the rest were hypothetical. Of the recognized domains with CRISPR spacer matches, was the phage endolysin used by lytic phage to disrupt cells. Analysis of the endolysins present in the thermophilic cyanophage contigs revealed a subset of characterized endolysins as well as a Glyco_hydro_108 (PF05838) domain not previously associated with sequenced cyanophages. A search for CRISPR spacer matches to all identified phage endolysins demonstrated that a majority of endolysin domains were targets. This strategy provides a general way to link host and phage as endolysins are known to be widely distributed in bacteriophage. Endolysins can also provide information about host cell wall composition and have the additional potential to be used as targets for novel therapeutics.	[Davison, Michelle; Bhaya, Devaki] Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA; [Treangen, Todd J.; Koren, Sergey; Pop, Mihai] Ctr Bioinformat & Computat Biol, Biomol Sci Bldg, College Pk, MD 20742 USA; [Davison, Michelle; Bhaya, Devaki] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Pop, Mihai] Univ Maryland, Dept Comp Sci, College Pk, MD 20742 USA; [Treangen, Todd J.] Natl Biodef Anal & Countermeasures Ctr, Ft Detrick, MD 21702 USA; [Koren, Sergey] NHGRI, Genome Informat Sect, Computat & Stat Genom Branch, NIH, Bethesda, MD 20892 USA	Carnegie Institution for Science; Stanford University; University System of Maryland; University of Maryland College Park; National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI)	Davison, M; Bhaya, D (corresponding author), Carnegie Inst Sci, Dept Plant Biol, 290 Panama St, Stanford, CA 94305 USA.; Davison, M; Bhaya, D (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	mdavison@carnegiescience.edu; dbhaya@carnegiescience.edu	Koren, Sergey/AAE-8314-2019; Pop, Mihai/A-7987-2013; Davison, Michelle/AAE-2573-2021	Pop, Mihai/0000-0001-9617-5304; Davison, Michelle/0000-0002-0748-949X; Koren, Sergey/0000-0002-1472-8962	National Institutes of Health [R01HG004885]; National Science Foundation [IIS-0812111]; National Science Foundation Division of Molecular and Cellular Biosciences [1024755, 1331151]; Carnegie Institution for Science; Stanford Department of Biology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004885] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); National Science Foundation Division of Molecular and Cellular Biosciences(National Science Foundation (NSF)); Carnegie Institution for Science; Stanford Department of Biology; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	Mihai Pop would like to acknowledge funding from National Institutes of Health grant # R01HG004885 and National Science Foundation grant # IIS-0812111. Devaki Bhaya would like to acknowledge funding from National Science Foundation Division of Molecular and Cellular Biosciences # 1024755 and National Science Foundation Division of Molecular and Cellular Biosciences # 1331151 and the Carnegie Institution for Science. Michelle Davison would like to acknowledge funding from the Stanford Department of Biology, as a portion of this work was done during her PhD.	Adriaenssens EM, 2014, APPL ENVIRON MICROB, V80, P4470, DOI 10.1128/AEM.00878-14; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Bankevich A, 2012, J COMPUT BIOL, V19, P455, DOI 10.1089/cmb.2012.0021; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bhaya D, 2007, ISME J, V1, P703, DOI 10.1038/ismej.2007.46; Bhaya D, 2011, ANNU REV GENET, V45, P273, DOI 10.1146/annurev-genet-110410-132430; Boomer SM, 2009, APPL ENVIRON MICROB, V75, P2464, DOI 10.1128/AEM.01802-08; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Briers Y, 2014, MBIO, V5, DOI 10.1128/mBio.01379-14; Buckley DH, 1998, APPL ENVIRON MICROB, V64, P4333; Cho I, 2012, NAT REV GENET, V13, P260, DOI 10.1038/nrg3182; Clokie Martha Rj, 2011, Bacteriophage, V1, P31, DOI 10.4161/bact.1.1.14942; Dereeper A, 2008, NUCLEIC ACIDS RES, V36, pW465, DOI 10.1093/nar/gkn180; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Dick GJ, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-8-r85; Dutilh BE, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5498; Eddy SR, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002195; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Edwards RA, 2005, NAT REV MICROBIOL, V3, P504, DOI 10.1038/nrmicro1163; Emerson D, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00254; Emerson JB, 2013, APPL ENVIRON MICROB, V79, P6755, DOI 10.1128/AEM.01946-13; Frank DN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007811; Gervasi T, 2014, APPL MICROBIOL BIOT, V98, P2495, DOI 10.1007/s00253-013-5128-y; Gomez-Garcia MR, 2011, ISME J, V5, P141, DOI 10.1038/ismej.2010.96; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Grissa I, 2007, NUCLEIC ACIDS RES, V35, pW52, DOI 10.1093/nar/gkm360; Heidelberg JF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004169; Held NL, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012988; Howe AC, 2014, P NATL ACAD SCI USA, V111, P4904, DOI 10.1073/pnas.1402564111; Hua ZS, 2015, ISME J, V9, P1280, DOI 10.1038/ismej.2014.212; Hurwitz BL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057355; Jensen SI, 2011, ISME J, V5, P317, DOI 10.1038/ismej.2010.131; Johnson M, 2008, NUCLEIC ACIDS RES, V36, pW5, DOI 10.1093/nar/gkn201; Jones DS, 2012, ISME J, V6, P158, DOI 10.1038/ismej.2011.75; Kimura S, 2013, APPL ENVIRON MICROBI; Klatt CG, 2007, ENVIRON MICROBIOL, V9, P2067, DOI 10.1111/j.1462-2920.2007.01323.x; Klatt CG, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00106; Labrie SJ, 2010, NAT REV MICROBIOL, V8, P317, DOI 10.1038/nrmicro2315; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Loman NJ, 2012, NAT REV MICROBIOL, V10, P599, DOI 10.1038/nrmicro2850; Lopes A, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-1027; Mao JZ, 2013, FEMS MICROBIOL LETT, V342, P30, DOI 10.1111/1574-6968.12104; Markowitz VM, 2014, NUCLEIC ACIDS RES, V42, pD568, DOI 10.1093/nar/gkt919; Mayer MJ, 2012, APPL ENVIRON MICROB, V78, P3685, DOI 10.1128/AEM.07884-11; Mazumdar V, 2013, METABOLIC PROXIMITY, V8, DOI [10.1371/journal.pone.0077617, DOI 10.1371/JOURNAL.PONE.0077617]; Mizuno CM, 2013, APPL ENVIRON MICROB, V79, P688, DOI 10.1128/AEM.02742-12; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; Milferstedt K, 2013, DISTURBANCE FREQUENC, V8, DOI [10.1371/journal.pone.0080692, DOI 10.1371/JOURNAL.PONE.0080692]; Miyake K, 2014, BIOTECHNOL BIOFUELS, V7, DOI 10.1186/1754-6834-7-56; Namiki T, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks678; Ogilvie LA, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3420; Oh J, 2014, NATURE, V514, P59, DOI 10.1038/nature13786; Ohsumi T, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116647; Oliveira H, 2013, J VIROL, V87, P4558, DOI 10.1128/JVI.03277-12; Paez-Espino D, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2440; Parks DH, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-328; Peleg AY, 2010, NEW ENGL J MED, V362, P1804, DOI 10.1056/NEJMra0904124; Peters BM, 2012, CLIN MICROBIOL REV, V25, P193, DOI 10.1128/CMR.00013-11; Peterson BW, 2015, FEMS MICROBIOL REV, V39, P234, DOI 10.1093/femsre/fuu008; Peterson J, 2009, GENOME RES, V19, P2317, DOI 10.1101/gr.096651.109; Pope PB, 2011, ISME J, V5, P341, DOI 10.1038/ismej.2010.116; Pride DT, 2012, ISME J, V6, P915, DOI 10.1038/ismej.2011.169; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rodriguez-Rubio L, 2016, CRIT REV BIOTECHNOL, V36, P542, DOI 10.3109/07388551.2014.993587; Rombel IT, 2002, GENE, V282, P33, DOI 10.1016/S0378-1119(01)00819-8; Rosen MJ, 2015, SCIENCE, V348, P1019, DOI 10.1126/science.aaa4456; Roux S, 2015, ELIFE, V4, DOI 10.7554/eLife.08490; Sakowski EG, 2014, P NATL ACAD SCI USA, V111, P15786, DOI 10.1073/pnas.1401322111; Schleper C, 2005, NAT REV MICROBIOL, V3, P479, DOI 10.1038/nrmicro1159; Schmelcher M, 2012, FUTURE MICROBIOL, V7, P1147, DOI [10.2217/fmb.12.97, 10.2217/FMB.12.97]; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; Schuster-Bockler B, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-7; Semenyuk EG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087757; Shade A, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00417; Simpson JT, 2015, ANNU REV GENOM HUM G, V16, P153, DOI 10.1146/annurev-genom-090314-050032; Skennerton CT, 2013, NUCLEIC ACIDS RES, P183; Steunou AS, 2006, P NATL ACAD SCI USA, V103, P2398, DOI 10.1073/pnas.0507513103; Strous M, 2012, FRONT MICROBIOL, V3, DOI 10.3389/fmicb.2012.00410; Sullivan MB, 2015, J VIROL, V89, P2459, DOI 10.1128/JVI.03289-14; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sundararajan A, 2007, BE J THEOR ECON, V7, DOI 10.1186/1471-2180-7-108; Teeling H, 2012, CURRENT OPPORTUNITIE; Teschler JK, 2015, NAT REV MICROBIOL, V13, P255, DOI 10.1038/nrmicro3433; Thompson LR, 2011, P NATL ACAD SCI USA, V108, pE757, DOI 10.1073/pnas.1102164108; Treangen TJ, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-1-r2; Ultsch A, 2005, ESOM MAPS TOOLS FOR; Ursell T, 2013, MOTILITY ENHANCEMENT, V9, DOI [10.1371/journal.pcbi.1003205, DOI 10.1371/JOURNAL.PCBI.1003205]; Waterhouse AM, 2009, BIOINFORMATICS, V25, P1189, DOI 10.1093/bioinformatics/btp033; Williamson KS, 2012, J BACTERIOL, V194, P2062, DOI 10.1128/JB.00022-12; Wilmes P, 2008, ISME J, V2, P853, DOI 10.1038/ismej.2008.38; Wu S, 2014, CARBOHYD METABOL, V9, DOI [10.1371/journal.pone.0099204, DOI 10.1371/JOURNAL.PONE.0099204]; Yilmaz S, 2010, NAT METHODS, V7, P943, DOI 10.1038/nmeth1210-943; Young R, 2014, J MICROBIOL, V52, P243, DOI 10.1007/s12275-014-4087-z; Zago CE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0123206; Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847	96	14	14	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160574	10.1371/journal.pone.0160574	http://dx.doi.org/10.1371/journal.pone.0160574			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611571	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900008
J	Molbak, K; Hansen, ND; Valentiner-Branth, P				Molbak, Kare; Hansen, Niels Dalum; Valentiner-Branth, Palle			Pre-Vaccination Care-Seeking in Females Reporting Severe Adverse Reactions to HPV Vaccine. A Registry Based Case-Control Study	PLOS ONE			English	Article							HUMAN-PAPILLOMAVIRUS VACCINE; ADOLESCENT GIRLS; IMMUNIZATION; SYMPTOMS; RISK	Background Since 2013 the number of suspected adverse reactions to the quadrivalent human papillomavirus (HPV) vaccine reported to the Danish Medicines Agency (DMA) has increased. Due to the resulting public concerns about vaccine safety, the coverage of HPV vaccinations in the childhood vaccination programme has declined. The aim of the present study was to determine health care-seeking prior to the first HPV vaccination among females who suspected adverse reactions to HPV vaccine. Methods In this registry-based case-control study, we included as cases vaccinated females with reports to the DMA of suspected severe adverse reactions. We selected controls without reports of adverse reactions from the Danish vaccination registry and matched by year of vaccination, age of vaccination, and municipality, and obtained from the Danish National Patient Registry and The National Health Insurance Service Register the history of health care usage two years prior to the first vaccine. We analysed the data by logistic regression while adjusting for the matching variables. Results The study included 316 cases who received first HPV vaccine between 2006 and 2014. Age range of cases was 11 to 52 years, with a peak at 12 years, corresponding to the recommended age at vaccination, and another peak at 19 to 28 years, corresponding to a catch-up programme targeting young women. Compared with 163,910 controls, cases had increased care-seeking in the two years before receiving the first HPV vaccine. A multivariable model showed higher use of telephone/email consultations (OR 1.9; 95% CI 1.2-3.2), physiotherapy (OR 2.1; 95% CI 1.6-2.8) and psychologist/psychiatrist (OR 1.9; 95% CI 1.3-2.7). Cases were more likely to have a diagnosis in the ICD-10 chapters of diseases of the digestive system (OR 1.6; 95% CI 1.0-2.4), of the musculoskeletal system (OR 1.6; 95% CI 1.1-2.2), symptoms or signs not classified elsewhere (OR 1.8; 95% CI 1.3-2.5) as well as injuries (OR 1.5; 95% CI 1.2-1.9). Conclusion Before receiving the first HPV vaccination, females who suspected adverse reactions has symptoms and a health care-seeking pattern that is different from the matched population. Pre-vaccination morbidity should be taken into account in the evaluation of vaccine safety signals.	[Molbak, Kare; Valentiner-Branth, Palle] Statens Serum Inst, Dept Infect Dis Epidemiol, Copenhagen, Denmark; [Hansen, Niels Dalum] Univ Copenhagen, Dept Comp Sci, Copenhagen, Denmark; [Hansen, Niels Dalum] IBM Denmark, Holte, Denmark	Statens Serum Institut; University of Copenhagen	Molbak, K (corresponding author), Statens Serum Inst, Dept Infect Dis Epidemiol, Copenhagen, Denmark.	krm@ssi.dk		Molbak, Kare/0000-0002-3100-4990	Innovation Fund Denmark; IBM Denmark	Innovation Fund Denmark; IBM Denmark(International Business Machines (IBM))	The study was in part supported by a grant from Innovation Fund Denmark and IBM Denmark (PhD grant to Niels Dalum Hansen). Niels Dalum Hansen is partly employed by IBM Denmark. IBM Denmark provided support in the form of a part of the salary for author Niels Dalum Hansen, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific role of this author is articulated in the 'author contributions' section.	[Anonymous], 2016, DECLINE UPTAKE HPV V; Arnheim-Dahlstom L, 2013, BMJ-BRIT MED J, V347, DOI 10.1136/bmj.f5906; Brinth L, 2015, INT J VACCINES VACCI, V1, DOI [DOI 10.15406/ijvv.2015.01.00003, 10.15406/ijvv.2015.01.00003]; Brinth L, 2015, DAN MED J, V62; Callreus T, 2009, VACCINE, V27, P2954, DOI 10.1016/j.vaccine.2009.02.106; Cameron RL, 2016, INTERN MED J; Donegan K, 2013, VACCINE, V31, P4961, DOI 10.1016/j.vaccine.2013.08.024; Fonteneau L, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2575-7; Global Advisory Committee on Vaccine Safety, 2015, WEEKLY EPID REC, V91, P21; Hanley SJB, 2015, LANCET, V386, P248, DOI 10.1016/S0140-6736(15)61280-6; Kinoshita T, 2014, INTERNAL MED, V53, P2185, DOI 10.2169/internalmedicine.53.3133; Klein NP, 2012, ARCH PEDIAT ADOL MED, V166, P1140, DOI 10.1001/archpediatrics.2012.1451; KRAUSE TG, 2012, EURO SURVEILL, V17; Peveler R, 1997, J PSYCHOSOM RES, V42, P245, DOI 10.1016/S0022-3999(96)00292-9; Reid S, 2001, BRIT MED J, V322, P767, DOI 10.1136/bmj.322.7289.767; Scheller NM, 2015, JAMA-J AM MED ASSOC, V313, P54, DOI 10.1001/jama.2014.16946; The Danish Health Authority the Danish Medicines Authority and Statens Serum Institut, ANN REP DAN CHILDH V	17	32	32	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162520	10.1371/journal.pone.0162520	http://dx.doi.org/10.1371/journal.pone.0162520			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611088	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900121
J	Narmadha, G; Yenugu, S				Narmadha, Ganapathy; Yenugu, Suresh			In Silico and Biochemical Characterization of Lysozyme-Like Proteins in the Rat	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; OXIDATIVE STRESS; SPERM-BINDING; HE-2 FAMILY; EPIDIDYMIS; SPERMATOZOA; CAPACITATION; RECOGNITION; FERTILITY; RECEPTOR	Background Spermatogenesis and sperm maturation in the male reproductive tract is dictated by a variety of proteins secreted in the testis and epididymis. Though the proteome of these tissues is known, the functional role of many of these proteins remains uncharacterized. In this study, we characterize the rat Lysozyme-like (Lyzl) genes and proteins. Methods In silico tools were used to predict the primary, secondary and tertiary structures. Reverse transcription PCR, immunofluorescence and immunoblotting were used to determine the expression pattern. Lysozyme like enzyme activity was assessed by standard assays. Results Six rat Lyzl genes namely Lyzl1, Lyzl3, Lyzl4, Lyzl5, Lyzl6 and Lyzl7 were found to be highly conserved among the vertebrates with higher homology to mouse counterparts than with human counterparts. All the LYZL proteins contained the characteristic 4 disulfide bridges similar to c-type lysozyme. Only LYZL 1 and 6, conserved the active site amino acids of the lysozyme. Molecular modeling studies indicated that LYZL proteins exhibit strikingly similar three-dimensional structures among themselves. The secondary structure analysis of the recombinant LYZL proteins indicated the presence of alpha-helix, beta-sheet and random coil with a-helix being the majority. Docking studies indicated the peptidoglycan binding nature of LYZL proteins. All the rat Lyzl mRNA transcripts (Lyzl1, Lyzl3, Lyzl4, Lyzl5, Lyzl6 and Lyzl7) are predominantly expressed in testes though some of them are expressed in tissues other than reproductive tract. Their expression was androgen independent. The rat LYZL proteins are localized in the germinal epithelium and on the spermatozoa. Recombinant LYZL1 and 6 possessed muramidase, isopeptidase and antibacterial activities. The mechanism of antibacterial action of LYZL1 and LYZL6 involved bacterial membrane damage and leakage of cellular contents. Only LYZL1 and 6 possess peptidoglycan binding ability, whereas LYZL3, LYZL4 and LYZL5 possess hyaluronan binding ability suggesting a possible functional divergence of these proteins. LYZL3, LYZL4 and LYZL7 possessed free radical scavenging property, suggesting that they may act as antioxidants. Conclusion The divergent properties of LYZL proteins indicate that they may have a role in sperm function, innate immunity and other physiological process as well.	[Narmadha, Ganapathy; Yenugu, Suresh] Univ Hyderabad, Dept Anim Biol, Hyderabad 500046, Andhra Pradesh, India	University of Hyderabad	Yenugu, S (corresponding author), Univ Hyderabad, Dept Anim Biol, Hyderabad 500046, Andhra Pradesh, India.	ysnaidu@yahoo.com	Yenugu, Suresh/Y-7661-2019	Yenugu, Suresh/0000-0002-5431-2267				Aitken RJ, 2008, ADV EXP MED BIOL, V636, P154, DOI 10.1007/978-0-387-09597-4_9; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Ashrafzadeh A, 2013, INT J MED SCI, V10, P1649, DOI 10.7150/ijms.6395; Cornwall GA, 2009, HUM REPROD UPDATE, V15, P213, DOI 10.1093/humupd/dmn055; Dacheux JL, 2014, REPRODUCTION, V147, pR27, DOI 10.1530/REP-13-0420; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Geourjon C, 1995, COMPUT APPL BIOSCI, V11, P681; Ghosh I, 2007, J REPROD FERTIL S, V63, P539; Guo CY, 2009, J BIOTECHNOL, V139, P33, DOI 10.1016/j.jbiotec.2008.10.003; Guyonnet B, 2012, ISOLATION PROTEOMIC, P1; Hall SH, 2007, ASIAN J ANDROL, V9, P453, DOI 10.1111/j.1745-7262.2007.00298.x; Hallgren O, 2008, ADV EXP MED BIOL, V606, P217, DOI 10.1007/978-0-387-74087-4_8; Handwaskar RUC, 2007, HYALURONIDASE AND CO, V32, P755; HARRIS ME, 1981, EXPERIENTIA, V37, P426, DOI 10.1007/BF01959901; Herrero MB, 2005, DEV BIOL, V284, P126, DOI 10.1016/j.ydbio.2005.05.008; Ibrahim HR, 2001, J BIOL CHEM, V276, P43767, DOI 10.1074/jbc.M106317200; Irwin DM, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-166; Jean-Louis D, 2016, ANIM REPROD SCI, V169, P76, DOI 10.1016/j.anireprosci.2016.02.034; Jiborn T, 2004, J ANDROL, V25, P564; Jin YZ, 1997, MOL REPROD DEV, V47, P490, DOI 10.1002/(SICI)1098-2795(199708)47:4&lt;490::AID-MRD16&gt;3.0.CO;2-#; JONES G, 1995, J MOL BIOL, V245, P43, DOI 10.1016/S0022-2836(95)80037-9; Kirby AJ, 2001, NAT STRUCT BIOL, V8, P737, DOI 10.1038/nsb0901-737; Kirchhoff C, 1998, REV REPROD, V3, P86; Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148; Li J, 2011, MOL CELLULAR PROTEOM, V3, P1; Louis-Jeune C, 2012, PROTEINS, V80, P374, DOI 10.1002/prot.23188; Ma WX, 2014, NAT PROTOC, V9, P1428, DOI 10.1038/nprot.2014.083; Malm J, 2000, INFECT IMMUN, V68, P4297, DOI 10.1128/IAI.68.7.4297-4302.2000; Mandal A, 2003, BIOL REPROD, V68, P1525, DOI 10.1095/biolreprod.102.010108; Markart P, 2004, BIOCHEM J, V380, P385, DOI 10.1042/BJ20031810; Memarpoor-Yazdi M, 2012, J FUNCT FOODS, V4, P278, DOI 10.1016/j.jff.2011.12.004; Mendeluk GR, 1997, ARCH ANDROLOGY, V38, P7, DOI 10.3109/01485019708988526; Mihajlovic M, 2012, BBA-BIOMEMBRANES, V1818, P1274, DOI 10.1016/j.bbamem.2012.01.016; Narmadha G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027659; Novo DJ, 2000, ANTIMICROB AGENTS CH, V44, P827, DOI 10.1128/AAC.44.4.827-834.2000; OHNO N, 1989, J BIOL CHEM, V264, P4434; Rajesh A, 2015, J REPROD IMMUNOL, V110, P117, DOI 10.1016/j.jri.2015.02.009; Rajesh A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032633; RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6; Rodriguez CM, 2001, REPRODUCTION, V122, P41, DOI 10.1530/reprod/122.1.41; Sachdev M, 2012, DEV BIOL, V363, P40, DOI 10.1016/j.ydbio.2011.12.021; Sreerama N, 2004, METHOD ENZYMOL, V2, P1; Sun RL, 2011, ACTA BIOCH BIOPH SIN, V43, P346, DOI 10.1093/abbs/gmr017; Syntin P, 1999, BIOL REPROD, V60, P1542, DOI 10.1095/biolreprod60.6.1542; Takeshita K, 2003, CELL MOL LIFE SCI, V60, P1944, DOI 10.1007/s00018-003-3082-z; Turner TT, 2008, J ANDROL, V29, P488, DOI 10.2164/jandrol.108.005132; WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127; Wang SH, 2011, J BIOL CHEM, V286, P22653, DOI 10.1074/jbc.M111.247635; Wang Z-q, 2013, NOVEL LIPOPOLYSACCHA; Wei J, 2013, ASIAN J ANDROL, V14, P834; Whelly S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036394; Wiwanitkit Viroj, 2010, J Hum Reprod Sci, V3, P146, DOI 10.4103/0974-1208.74158; Yenugu S, 2003, BIOCHEM J, V372, P473, DOI 10.1042/BJ20020225; Yenugu S, 2006, REPROD BIOL ENDOCRIN, V4, DOI 10.1186/1477-7827-4-23; Yenugu Suresh, 2004, Reprod Biol Endocrinol, V2, P61, DOI 10.1186/1477-7827-2-61; Yenugu S, 2010, J PEPT SCI, V16, P337, DOI 10.1002/psc.1246; You SJ, 2010, FOOD RES INT, V43, P848, DOI 10.1016/j.foodres.2009.12.004; Yudin AI, 2003, BIOL REPROD, V69, P1118, DOI 10.1095/biolreprod.103.016105; Zhang KX, 2005, BIOL REPROD, V73, P1064, DOI 10.1095/biolreprod.105.041889; Zhou YC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004106	60	11	11	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161909	10.1371/journal.pone.0161909	http://dx.doi.org/10.1371/journal.pone.0161909			32	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611690	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900036
J	Naseri, NN; Bonica, J; Xu, H; Park, LC; Arjomand, J; Chen, ZM; Gibson, GE				Naseri, Nima N.; Bonica, Joseph; Xu, Hui; Park, Larry C.; Arjomand, Jamshid; Chen, Zhengming; Gibson, Gary E.			Novel Metabolic Abnormalities in the Tricarboxylic Acid Cycle in Peripheral Cells From Huntington's Disease Patients	PLOS ONE			English	Article							KETOGLUTARATE DEHYDROGENASE COMPLEX; PYRUVATE-DEHYDROGENASE; ALPHA-KETOGLUTARATE; PATHOLOGICAL LENGTH; TRANSGENIC MOUSE; ALZHEIMER BRAIN; MITOCHONDRIAL; PROTEIN; MODELS; DAMAGE	Metabolic dysfunction is well-documented in Huntington's disease (HD). However, the link between the mutant huntingtin (mHTT) gene and the pathology is unknown. The tricarboxylic acid (TCA) cycle is the main metabolic pathway for the production of NADH for conversion to ATP via the electron transport chain (ETC). The objective of this study was to test for differences in enzyme activities, mRNAs and protein levels related to the TCA cycle between lymphoblasts from healthy subjects and from patients with HD. The experiments utilize the advantages of lymphoblasts to reveal new insights about HD. The large quantity of homogeneous cell populations permits multiple dynamic measures to be made on exactly comparable tissues. The activities of nine enzymes related to the TCA cycle and the expression of twenty-nine mRNAs encoding for these enzymes and enzyme complexes were measured. Cells were studied under baseline conditions and during metabolic stress. The results support our recent findings that the activities of the pyruvate dehydrogenase complex (PDHC) and succinate dehydrogenase (SDH) are elevated in HD. The data also show a large unexpected depression in MDH activities. Furthermore, message levels for isocitrate dehydrogenase 1 (IDH1) were markedly increased in in HD lymphoblasts and were responsive to treatments. The use of lymphoblasts allowed us to clarify that the reported decrease in aconitase activity in HD autopsy brains is likely due to secondary hypoxic effects. These results demonstrate the mRNA and enzymes of the TCA cycle are critical therapeutic targets that have been understudied in HD.	[Naseri, Nima N.; Bonica, Joseph; Xu, Hui; Gibson, Gary E.] Weill Cornell Med Coll, Brain & Mind Res Inst, Burke Med Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA; [Chen, Zhengming] Weill Cornell Med Coll, Dept Healthcare Policy & Res, Div Biostat & Epidemiol, 425 East 61st St, New York, NY 10065 USA; [Park, Larry C.; Arjomand, Jamshid] CHDI Management CHDI Fdn Inc, 6080 Ctr Dr Suite 100, Los Angeles, CA 90045 USA	Cornell University; Cornell University	Gibson, GE (corresponding author), Weill Cornell Med Coll, Brain & Mind Res Inst, Burke Med Res Inst, 785 Mamaroneck Ave, White Plains, NY 10605 USA.	ggibson@med.cornell.edu			CHDI; NIH [PP-AG14930]; Burke Medical Research Institute; NATIONAL INSTITUTE ON AGING [P01AG014930] Funding Source: NIH RePORTER	CHDI; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burke Medical Research Institute; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding was provided by CHDI, NIH PP-AG14930 and the Burke Medical Research Institute. CHDI Foundation is also the employer of two authors (LCP and JA). Beyond their intellectual contributions to the design of the study and preparation of the manuscript, CHDI foundation staff did not play a role in primary figures, data collection and analysis or the decision to publish this manuscript. The rest of funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreassen OA, 2001, ANN NEUROL, V50, P112, DOI 10.1002/ana.1085; Bates TE, 1996, NEUROREPORT, V7, P1397, DOI 10.1097/00001756-199605310-00014; BEAL MF, 1993, J NEUROCHEM, V61, P1147, DOI 10.1111/j.1471-4159.1993.tb03633.x; Beal MF, NEUROCHEMICAL HISTOL; Benchoua A, 2006, MOL BIOL CELL, V17, P1652, DOI 10.1091/mbc.E05-07-0607; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BROUILLET E, 1995, P NATL ACAD SCI USA, V92, P7105, DOI 10.1073/pnas.92.15.7105; Browne SE, 1997, ANN NEUROL, V41, P646, DOI 10.1002/ana.410410514; Bubber P, 2005, ANN NEUROL, V57, P695, DOI 10.1002/ana.20474; Bubber P, 2004, NEUROCHEM INT, V45, P1021, DOI 10.1016/j.neuint.2004.05.007; BUTTERWORTH J, 1985, J NEUROL SCI, V67, P161, DOI 10.1016/0022-510X(85)90112-1; Chang DTW, 2006, NEUROBIOL DIS, V22, P388, DOI 10.1016/j.nbd.2005.12.007; Cooper AJL, 1997, P NATL ACAD SCI USA, V94, P12604, DOI 10.1073/pnas.94.23.12604; Cooper AJL, 1998, AGE, V21, P25, DOI 10.1007/s11357-998-0004-x; Costa V, 2010, EMBO MOL MED, V2, P490, DOI 10.1002/emmm.201000102; DEAN RB, 1951, ANAL CHEM, V23, P636, DOI 10.1021/ac60052a025; Fu WJJ, 2006, COMPUT BIOL CHEM, V30, P21, DOI 10.1016/j.compbiolchem.2005.10.005; Gibson GE, 2000, NEUROCHEM INT, V36, P97, DOI 10.1016/S0197-0186(99)00114-X; Gu M, 1996, ANN NEUROL, V39, P385, DOI 10.1002/ana.410390317; Hazeki N, 1999, BIOCHEM BIOPH RES CO, V256, P361, DOI 10.1006/bbrc.1999.0337; Holness MJ, REGULATION PYRUVATE; Jenkins BG, EVIDENCE IMPAIRMENT; Kim J, MITOCHONDRIAL LOSS D, P1460; Klivenyi P, 2004, J NEUROCHEM, V88, P1352, DOI 10.1046/j.1471-4159.2003.02263.x; Kuhl De Fau-Markham CH, 1985, LOCAL CEREBRAL GLUCO, P199; Kuhl De Fau-Metter EJ, 1984, ANN NEUROL, P119; Kuhl De Fau-Phelps ME, 1982, ANN NEUROL, P425; MACDONALD ME, 1993, CELL, V72, P971, DOI 10.1016/0092-8674(93)90585-E; Naseri NN, 2015, J NEUROPATH EXP NEUR, V74, P527, DOI 10.1097/NEN.0000000000000197; Orth M, 2011, J NEUROL NEUROSUR PS, V82, P1409, DOI 10.1136/jnnp.2010.209668; PRINCE J, 1994, J NEURAL TRANSM-PARK, V8, P171, DOI 10.1007/BF02260938; Pringsheim T, 2012, MOVEMENT DISORD, V27, P1083, DOI 10.1002/mds.25075; Sawa A, 1999, NAT MED, V5, P1194, DOI 10.1038/13518; Shirendeb U, 2011, HUM MOL GENET, V20, P1438, DOI 10.1093/hmg/ddr024; Shirendeb UP, 2012, HUM MOL GENET, V21, P406, DOI 10.1093/hmg/ddr475; SORBI S, 1983, ANN NEUROL, V13, P72, DOI 10.1002/ana.410130116; Tabrizi SJ, 2000, ANN NEUROL, V47, P80; Tabrizi SJ, 1999, ANN NEUROL, V45, P25, DOI 10.1002/1531-8249(199901)45:1<25::AID-ART6>3.0.CO;2-E; TROTTIER Y, 1995, NAT GENET, V10, P104, DOI 10.1038/ng0595-104; Vogel R, 1999, NEUROSCI LETT, V275, P97, DOI 10.1016/S0304-3940(99)00748-X; Yang LC, 2009, NEUROBIOL DIS, V36, P320, DOI 10.1016/j.nbd.2009.07.023; 1996, MOVEMENT DISORD, V11, P136, DOI DOI 10.1002/MDS.870110204	42	19	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0160384	10.1371/journal.pone.0160384	http://dx.doi.org/10.1371/journal.pone.0160384			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611087	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255900004
J	Samimi-Rad, K; Rahimnia, R; Sadeghi, M; Malekpour, SA; Marzban, M; Keshvari, M; Kiani, SJ; Alavian, SM				Samimi-Rad, Katayoun; Rahimnia, Ramin; Sadeghi, Mahdi; Malekpour, Seyed Amir; Marzban, Mona; Keshvari, Maryam; Kiani, Seyed Jalal; Alavian, Seyed-Moayed			Epidemic History of Hepatitis C Virus among Patients with Inherited Bleeding Disorders in Iran	PLOS ONE			English	Article							DRUG-USERS; MOLECULAR EPIDEMIOLOGY; GENETIC HISTORY; RISK-FACTORS; INFECTION; PREVALENCE; PHYLOGENIES; JMODELTEST; PRISONERS; INJECTION	The high rate of hepatitis C virus (HCV) infection among transfusion related risk groups such as patients with inherited bleeding disorders highlighting the investigation on prevalent subtypes and their epidemic history among this group. In this study, 166 new HCV NS5B sequences isolated from patients with inherited bleeding disorders together with 29 sequences related to hemophiliacs obtained from a previous study on diversity of HCV in Iran were analyzed. The most prevalent subtype was 1a (65%), followed by 3a (18.7%), 1b (14.5%), 4(1.2%) and 2k (0.6%). Subtypes 1a and 3a showed exponential expansion during the 20th century. Whereas expansion of 3a started around 20 years earlier than 1a among the study patients, the epidemic growth of 1a revealed a delay of about 10 years compared with that found for this subtype in developed countries. Our results supported the view that the spread of 3a reached the plateau 10 years prior to the screening of blood donors for HCV. Rather, 1a reached the plateau when screening program was implemented. The differences observed in the epidemic behavior of HCV-1a and 3a may be associated with different transmission routes of two subtypes. Indeed, expansion of 1a was more commonly linked to blood transfusion, while 3a was more strongly associated to drug use and specially IDU after 1960. Our findings also showed HCV transmission through blood products has effectively been controlled from late 1990s. In conclusion, the implementation of strategies such as standard surveillance programs and subsiding antiviral treatments seems to be essential to both prevent new HCV infections and to decline the current and future HCV disease among Iranian patients with inherited bleeding disorders.	[Samimi-Rad, Katayoun; Marzban, Mona; Kiani, Seyed Jalal] Tehran Univ Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran; [Rahimnia, Ramin] Tehran Univ Med Sci, Sch Adv Technol Med, Dept Nano Med, Tehran, Iran; [Sadeghi, Mahdi] Natl Inst Genet Engn & Biotechnol, Tehran, Iran; [Malekpour, Seyed Amir] Univ Tehran, Coll Sci, Sch Math Stat & Comp Sci, Tehran, Iran; [Keshvari, Maryam] High Inst Res & Educ Transfus Med, Blood Transfus Res Ctr, Tehran, Iran; [Alavian, Seyed-Moayed] Baqiatallah Univ Med Sci, Res Ctr Gastroenterol & Liver Dis, Tehran, Iran	Tehran University of Medical Sciences; Tehran University of Medical Sciences; University of Tehran; Baqiyatallah University of Medical Sciences (BMSU)	Samimi-Rad, K (corresponding author), Tehran Univ Med Sci, Sch Publ Hlth, Dept Virol, Tehran, Iran.	Ksamimirad@sina.tums.ac.ir	Kiani, Seyed Jalal/L-7731-2018; Keshvari, Maryam/C-6678-2017	Kiani, Seyed Jalal/0000-0002-5499-8924; 				Abolghasemi H, 2009, IRAN J PUBLIC HEALTH, V38, P82; Ahmadi J, 2007, AM J DRUG ALCOHOL AB, V33, P483, DOI 10.1080/00952990701301293; Alizadeh AHM, 2005, WORLD J GASTROENTERO, V11, P4085, DOI 10.3748/wjg.v11.i26.4085; Amiri Z. Mohtasham, 2007, Eastern Mediterranean Health Journal, V13, P250; Azizi MH, 2015, ARCH IRAN MED, V18, P393, DOI 015186/AIM.0016; Culasso ACA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044757; DALVAND S, 1984, DRUG ALCOHOL DEPEN, V14, P87, DOI 10.1016/0376-8716(84)90023-1; Darriba D, 2012, NAT METHODS, V9, P772, DOI 10.1038/nmeth.2109; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Farhadi Langeroodi M, 1998, PRINCIPLES BLOOD TRA, P27; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hagan H, 2005, AIDS, V19, pS199, DOI 10.1097/01.aids.0000192090.61753.d4; Keshvari M, 2010, IRAN RED CRESCENT ME, V12, P608; Lu L, 2005, J MED VIROL, V75, P538, DOI 10.1002/jmv.20307; Malekinejad M, 2015, INT J INFECT DIS, V40, P116, DOI 10.1016/j.ijid.2015.09.022; Nakano T, 2006, J GEN VIROL, V87, P73, DOI 10.1099/vir.0.81360-0; Oliveira AB, 2014, VIROL J, V11, DOI 10.1186/1743-422X-11-38; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Pybus OG, 2003, MOL BIOL EVOL, V20, P381, DOI 10.1093/molbev/msg043; Pybus OG, 2001, SCIENCE, V292, P2323, DOI 10.1126/science.1058321; Pybus OG, 2009, J VIROL, V83, P1071, DOI 10.1128/JVI.01501-08; Quaglio G, 2003, CLIN INFECT DIS, V37, P33, DOI 10.1086/375566; Reid G, 2002, REVISITING HIDDEN EP, P100; Rezvan H, 2007, TRANSFUSION MED, V17, P425, DOI 10.1111/j.1365-3148.2007.00794.x; Samimi-Rad K, 2007, HAEMOPHILIA, V13, P156, DOI 10.1111/j.1365-2516.2006.01415.x; Samimi-Rad K, 2004, J MED VIROL, V74, P246, DOI 10.1002/jmv.20170; Samimi-Rad K., 2012, Eastern Mediterranean Health Journal, V18, P227; Samimi-Rad K, 2013, HEPAT MON, V13, DOI [10.5812/hepatmon.7699, 10.5812/hepatmon.76]; Samimi-Rad K, 2012, ARCH VIROL, V157, P1959, DOI 10.1007/s00705-012-1369-9; Somi Mohammad H, 2008, Saudi J Kidney Dis Transpl, V19, P461; Wada K, 1999, ADDICTION, V94, P1063, DOI 10.1046/j.1360-0443.1999.947106311.x; Yuan MQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064698	34	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162492	10.1371/journal.pone.0162492	http://dx.doi.org/10.1371/journal.pone.0162492			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611688	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900114
J	Skare, JT; Shaw, DK; Trzeciakowski, JP; Hyde, JA				Skare, Jonathan T.; Shaw, Dana K.; Trzeciakowski, Jerome P.; Hyde, Jenny A.			In Vivo Imaging Demonstrates That Borrelia burgdorferi ospC Is Uniquely Expressed Temporally and Spatially throughout Experimental Infection	PLOS ONE			English	Article							OUTER-SURFACE PROTEIN; RESPONSE REGULATOR RRP2; LYME-DISEASE SPIROCHETE; GENE-EXPRESSION; BINDING-PROTEIN; CRYSTAL-STRUCTURE; VIRULENCE FACTOR; SENSU-STRICTO; RPOS; STRAINS	Borrelia burgdorferiis a spirochetal bacterium transmitted by the Ixodes tick that causes Lyme disease in humans due to its ability to evade the host immune response and disseminate to multiple immunoprotective tissues. The pathogen undergoes dynamic genetic alterations important for adaptation from the tick vector to the mammalian host, but little is known regarding the changes at the transcriptional level within the distal tissues they colonize. In this study, B. burgdorferiinfection and gene expression of the essential virulence determinant ospC was quantitatively monitored in a spatial and temporal manner utilizing reporter bioluminescent borrelial strains with in vivo and ex vivo imaging. Although expressed from a shuttle vector, the PospC-luc construct exhibited a similar expression pattern relative to native ospC. Bacterial burden in skin, inguinal lymph node, heart, bladder and tibiotarsal joint varied between tissues and fluctuated over the course of infection possibly in response to unique cues of each microenvironment. Expression of ospC, when normalized for changes in bacterial load, presented unique profiles in murine tissues at different time points. The inguinal lymph node was infected with a significant B. burgdorferi burden, but showed minimal ospC expression. B. burgdorferi infected skin and heart induced expression of ospC early during infection while the bladder and tibiotarsal joint continued to display P-ospC driven luminescence throughout the 21 day time course. Localized skin borrelial burden increased dramatically in the first 96 hours following inoculation, which was not paralleled with an increase in ospC expression, despite the requirement of ospC for dermal colonization. Quantitation of bioluminescence representing ospC expression in individual tissues was validated by qRT-PCR of the native ospC transcript. Taken together, the temporal regulation of ospC expression in distal tissues suggests a role for this virulence determinant beyond early infection.	[Skare, Jonathan T.; Shaw, Dana K.; Hyde, Jenny A.] Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Coll Med, Bryan College Stn, TX 77807 USA; [Trzeciakowski, Jerome P.] Texas A&M Hlth Sci Ctr, Coll Med, Dept Med Physiol, Bryan College Stn, TX USA; [Shaw, Dana K.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; Texas A&M University System; Texas A&M University College Station; Texas A&M Health Science Center; University System of Maryland; University of Maryland Baltimore	Hyde, JA (corresponding author), Texas A&M Hlth Sci Ctr, Dept Microbial Pathogenesis & Immunol, Coll Med, Bryan College Stn, TX 77807 USA.	jshyde@medicine.tamhsc.edu			 [AI101740A]		This work was supported by AI101740A, https://www.niaid.nih.gov/Pages/default.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akins DR, 1998, J CLIN INVEST, V101, P2240, DOI 10.1172/JCI2325; Anguita J, 2002, IMMUNITY, V16, P849, DOI 10.1016/S1074-7613(02)00325-4; Antonara S, 2007, MOL MICROBIOL, V66, P262, DOI 10.1111/j.1365-2958.2007.05924.x; Antonara S, 2010, INFECT IMMUN, V78, P4723, DOI 10.1128/IAI.00464-10; Bacconi M, 2016, APPL MICROBIOL BIOT, V100, P3197, DOI 10.1007/s00253-015-7229-2; BARTHOLD SW, 1990, J INFECT DIS, V162, P133, DOI 10.1093/infdis/162.1.133; Blevins JS, 2007, APPL ENVIRON MICROB, V73, P1501, DOI 10.1128/AEM.02454-06; Blevins JS, 2009, J BACTERIOL, V191, P2902, DOI 10.1128/JB.01721-08; Boardman BK, 2008, INFECT IMMUN, V76, P3844, DOI 10.1128/IAI.00467-08; Bockenstedt LK, 1997, INFECT IMMUN, V65, P4661, DOI 10.1128/IAI.65.11.4661-4667.1997; Bontemps-Gallo S, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005791; Burns S M, 2001, Contrib Microbiol, V9, P71; Burtnick MN, 2007, MOL MICROBIOL, V65, P277, DOI 10.1111/j.1365-2958.2007.05813.x; Caimano MJ, 2005, J BACTERIOL, V187, P7845, DOI 10.1128/JB.187.22.7845-7852.2005; Calmano MJ, 2007, MOL MICROBIOL, V65, P1193, DOI 10.1111/j.1365-2958.2007.05860.x; Carrasco SE, 2015, INFECT IMMUN, V83, P4848, DOI 10.1128/IAI.01215-15; Carroll JA, 2000, INFECT IMMUN, V68, P6677, DOI 10.1128/IAI.68.12.6677-6684.2000; Carroll JA, 1999, INFECT IMMUN, V67, P3181, DOI 10.1128/IAI.67.7.3181-3187.1999; Chan KF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129532; Chang MH, 2011, JOVE-J VIS EXP, DOI 10.3791/2547; Contag CH, 1995, MOL MICROBIOL, V18, P593, DOI 10.1111/j.1365-2958.1995.mmi_18040593.x; Drecktrah D, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068799; Dunham-Ems SM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002532; Earnhart CG, 2014, PATHOG DIS, V70, P176, DOI 10.1111/2049-632X.12119; Earnhart CG, 2011, CLIN VACCINE IMMUNOL, V18, P901, DOI 10.1128/CVI.05004-11; Earnhart CG, 2010, MOL MICROBIOL, V76, P393, DOI 10.1111/j.1365-2958.2010.07103.x; Eggers CH, 2004, J BACTERIOL, V186, P7390, DOI 10.1128/JB.186.21.7390-7402.2004; Eicken C, 2001, J BIOL CHEM, V276, P10010, DOI 10.1074/jbc.M010062200; Fisher MA, 2005, P NATL ACAD SCI USA, V102, P5162, DOI 10.1073/pnas.0408536102; Francis KP, 2000, INFECT IMMUN, V68, P3594, DOI 10.1128/IAI.68.6.3594-3600.2000; Francis KP, 2001, INFECT IMMUN, V69, P3350, DOI 10.1128/IAI.69.5.3350-3358.2001; Gherardini F., 2010, BORRELIA MOL BIOL HO, P103; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Groshong AM, 2012, J BACTERIOL, V194, P3336, DOI 10.1128/JB.00253-12; Hodzic E, 2003, INFECT IMMUN, V71, P5042, DOI 10.1128/IAI.71.9.5042-5055.2003; Hubner A, 2001, P NATL ACAD SCI USA, V98, P12724, DOI 10.1073/pnas.231442498; Hyde JA, 2007, J BACTERIOL, V189, P437, DOI 10.1128/JB.01109-06; Hyde Jenny A, 2011, Curr Protoc Microbiol, VChapter 12, DOI 10.1002/9780471729259.mc12c04s20; Hyde JA, 2011, MOL MICROBIOL, V82, P99, DOI 10.1111/j.1365-2958.2011.07801.x; Hyde JA, 2010, INFECT IMMUN, V78, P265, DOI 10.1128/IAI.01018-09; Hyde JA, 2009, MOL MICROBIOL, V74, P1344, DOI 10.1111/j.1365-2958.2009.06951.x; Iyer R, 2015, MOL MICROBIOL, V95, P509, DOI 10.1111/mmi.12882; Kenedy MR, 2012, FEMS IMMUNOL MED MIC, V66, P1, DOI 10.1111/j.1574-695X.2012.00980.x; Kong Y, 2011, CURR PROTOC MICROBIO, V2; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; La Rosa SL, 2013, APPL ENVIRON MICROB, V79, P3986, DOI 10.1128/AEM.00831-13; Labandeira-Rey M, 2001, INFECT IMMUN, V69, P446, DOI 10.1128/IAI.69.1.446-455.2001; Labandeira-Rey M, INFECT IMMUN; Lagal V, 2003, J CLIN MICROBIOL, V41, P5059, DOI 10.1128/JCM.41.11.5059-5065.2003; Lagal V, 2006, MICROBES INFECT, V8, P645, DOI 10.1016/j.micinf.2005.08.017; Liang FT, 2004, INFECT IMMUN, V72, P5759, DOI 10.1128/IAI.72.10.5759-5767.2004; Lin YP, 2015, CELL MICROBIOL, V17, P860, DOI 10.1111/cmi.12407; Lin YP, 2014, PLOS PATHOG, V10, DOI 10.1371/journal.ppat.1004238; Liveris D, 2002, J CLIN MICROBIOL, V40, P1249, DOI 10.1128/JCM.40.4.1249-1253.2002; Lybecker MC, 2007, MOL MICROBIOL, V64, P1075, DOI 10.1111/j.1365-2958.2007.05716.x; Massey S, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00174; Mead PS, 2015, INFECT DIS CLIN N AM, V29, P187, DOI 10.1016/j.idc.2015.02.010; Mendez J, 2013, ENV MICROBIOL REP, V5, P179, DOI 10.1111/1758-2229.12030; Obonyo M, 1999, J CLIN MICROBIOL, V37, P2137, DOI 10.1128/JCM.37.7.2137-2141.1999; Onder O, 2012, J BIOL CHEM, V287, P16860, DOI 10.1074/jbc.M111.290775; Ohnishi J, 2001, P NATL ACAD SCI USA, V98, P670, DOI 10.1073/pnas.98.2.670; Ojaimi C, 2003, INFECT IMMUN, V71, P1689, DOI 10.1128/IAI.71.4.1689-1705.2003; Ouyang ZM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096917; Ouyang ZM, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-44; Ouyang ZM, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001272; Ouyang ZM, 2010, J BACTERIOL, V192, P1965, DOI 10.1128/JB.01616-09; Ouyang ZM, 2009, MOL MICROBIOL, V74, P1331, DOI 10.1111/j.1365-2958.2009.06945.x; Pal U, 2004, J CLIN INVEST, V113, P220, DOI 10.1172/JCI200419894; Purser JE, 2003, MOL MICROBIOL, V48, P753, DOI 10.1046/j.1365-2958.2003.03452.x; Radolf JD, 2012, NAT REV MICROBIOL, V10, P87, DOI 10.1038/nrmicro2714; Ramamoorthy R, 2001, INFECT IMMUN, V69, P2739, DOI 10.1128/IAI.69.4.2739-2742.2001; Rego ROM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101009; Rhee KJ, 2011, GUT MICROBES, V2, P34, DOI 10.4161/gmic.2.1.14882; Samuels DS, 2011, ANNU REV MICROBIOL, V65, P479, DOI 10.1146/annurev.micro.112408.134040; Samuels DS, 1995, ELECTROTRANSFORMATIO; SCHWAN TG, 1995, P NATL ACAD SCI USA, V92, P2909, DOI 10.1073/pnas.92.7.2909; Seemanapalli SV, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015830; Seinost G, 1999, ARCH DERMATOL, V135, P1329, DOI 10.1001/archderm.135.11.1329; Seshu J, 2006, MOL MICROBIOL, V59, P1591, DOI 10.1111/j.1365-2958.2005.05042.x; Seshu J, 2004, INFECT IMMUN, V72, P1580, DOI 10.1128/IAI.72.3.1580-1586.2004; Shapiro ED, 2014, NEW ENGL J MED, V370, P1724, DOI [10.1056/NEJMcp1314325, 10.1056/NEJMc1407264]; Shaw DK, 2012, MOL MICROBIOL, V83, P319, DOI 10.1111/j.1365-2958.2011.07932.x; Shi YL, 2008, INFECT IMMUN, V76, P1239, DOI 10.1128/IAI.00897-07; Smith AH, 2007, J BACTERIOL, V189, P2139, DOI 10.1128/JB.01653-06; Stanek G, 2012, LANCET, V379, P461, DOI 10.1016/S0140-6736(11)60103-7; Steere AC, 2004, J CLIN INVEST, V113, P1093, DOI [10.1172/JCI200421681, 10.1172/JCI21681]; Stewart PE, 2006, INFECT IMMUN, V74, P3547, DOI 10.1128/IAI.00158-06; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Tilly K, 2013, MOL MICROBIOL, V89, P216, DOI 10.1111/mmi.12271; Tilly K, 2009, INFECT IMMUN, V77, P2672, DOI 10.1128/IAI.01193-08; Troxell B, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00079; Troy EB, 2013, INFECT IMMUN, V81, P2347, DOI 10.1128/IAI.00266-13; Weening EH, 2008, INFECT IMMUN, V76, P5694, DOI 10.1128/IAI.00690-08; Wu J, 2011, INFECT IMMUN, V79, P1338, DOI 10.1128/IAI.01188-10; Xu QL, 2007, MOL MICROBIOL, V64, P220, DOI 10.1111/j.1365-2958.2007.05636.x; Xu QL, 2006, INFECT IMMUN, V74, P5177, DOI 10.1128/IAI.00713-06; Yang XF, 2000, MOL MICROBIOL, V37, P1470, DOI 10.1046/j.1365-2958.2000.02104.x; Yang XFF, 2005, J BACTERIOL, V187, P4822, DOI 10.1128/JB.187.14.4822-4829.2005; Yang XFF, 2003, P NATL ACAD SCI USA, V100, P11001, DOI 10.1073/pnas.1834315100; Yin YP, 2016, J BACTERIOL, V198, P1543, DOI 10.1128/JB.01010-15; Zhiming OY, 2008, MICROBIOL-SGM, V154, P2641, DOI 10.1099/mic.0.2008/019992-0	102	19	19	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162501	10.1371/journal.pone.0162501	http://dx.doi.org/10.1371/journal.pone.0162501			27	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611840	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900116
J	Yadav, A; Dhole, K; Sinha, H				Yadav, Anupama; Dhole, Kaustubh; Sinha, Himanshu			Genetic Regulation of Phenotypic Plasticity and Canalisation in Yeast Growth	PLOS ONE			English	Article							LIFE-HISTORY TRAITS; ENVIRONMENT; EVOLUTION; ASSIMILATION; POPULATIONS; ADAPTATION; MECHANISMS; CROSS	The ability of a genotype to show diverse phenotypes in different environments is called phenotypic plasticity. Phenotypic plasticity helps populations to evade extinctions in novel environments, facilitates adaptation and fuels evolution. However, most studies focus on understanding the genetic basis of phenotypic regulation in specific environments. As a result, while it's evolutionary relevance is well established, genetic mechanisms regulating phenotypic plasticity and their overlap with the environment specific regulators is not well understood. Saccharomyces cerevisiae is highly sensitive to the environment, which acts as not just external stimulus but also as signalling cue for this unicellular, sessile organism. We used a previously published dataset of a biparental yeast population grown in 34 diverse environments and mapped genetic loci regulating variation in phenotypic plasticity, plasticity QTL, and compared them with environment-specific QTL. Plasticity QTL is one whose one allele exhibits high plasticity whereas the other shows a relatively canalised behaviour. We mapped phenotypic plasticity using two parameters-environmental variance, an environmental order-independent parameter and reaction norm(slope), an environmental order-dependent parameter. Our results show a partial overlap between pleiotropic QTL and plasticity QTL such that while some plasticity QTL are also pleiotropic, others have a significant effect on phenotypic plasticity without being significant in any environment independently. Furthermore, while some plasticity QTL are revealed only in specific environmental orders, we identify large effect plasticity QTL, which are order-independent such that whatever the order of the environments, one allele is always plastic and the other is canalised. Finally, we show that the environments can be divided into two categories based on the phenotypic diversity of the population within them and the two categories have differential regulators of phenotypic plasticity. Our results highlight the importance of identifying genetic regulators of phenotypic plasticity to comprehensively understand the genotype-phenotype map.	[Yadav, Anupama; Dhole, Kaustubh; Sinha, Himanshu] Tata Inst Fundamental Res, Dept Biol Sci, Bombay, Maharashtra, India; [Sinha, Himanshu] Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras, Tamil Nadu, India; [Sinha, Himanshu] Indian Inst Technol Madras, Initiat Biol Syst Engn, Madras, Tamil Nadu, India	Tata Institute of Fundamental Research (TIFR); Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras; Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Madras	Yadav, A; Sinha, H (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Bombay, Maharashtra, India.; Sinha, H (corresponding author), Indian Inst Technol Madras, Bhupat & Jyoti Mehta Sch Biosci, Dept Biotechnol, Madras, Tamil Nadu, India.; Sinha, H (corresponding author), Indian Inst Technol Madras, Initiat Biol Syst Engn, Madras, Tamil Nadu, India.	anupamayadav1990@gmail.com; sinha@iitm.ac.in	Sinha, Himanshu/AAT-7853-2021	Sinha, Himanshu/0000-0001-7031-0491; Yadav, Anupama/0000-0001-5338-0455	Tata Institute of Fundamental Research [12P-0120]	Tata Institute of Fundamental Research(Tata Institute of Fundamental Research (TIFR))	The authors were supported by an intramural grant (12P-0120) from Tata Institute of Fundamental Research to HS. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agrawal AA, 2001, SCIENCE, V294, P321, DOI 10.1126/science.1060701; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; Bhatia A, 2014, G3-GENES GENOM GENET, V4, P769, DOI 10.1534/g3.113.009142; Bloom JS, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9712; Bloom JS, 2013, NATURE, V494, P234, DOI 10.1038/nature11867; Broman KW, 2009, STAT BIOL HEALTH, P1, DOI 10.1007/978-0-387-92125-9_1; Broman KW, 2003, BIOINFORMATICS, V19, P889, DOI 10.1093/bioinformatics/btg112; Cooper TF, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-11; Crispo E, 2008, J EVOLUTION BIOL, V21, P1460, DOI 10.1111/j.1420-9101.2008.01592.x; Crispo E, 2007, EVOLUTION, V61, P2469, DOI 10.1111/j.1558-5646.2007.00203.x; Cubillos FA, 2011, MOL ECOL, V20, P1401, DOI 10.1111/j.1365-294X.2011.05005.x; Debat V, 2001, TRENDS ECOL EVOL, V16, P555, DOI 10.1016/S0169-5347(01)02266-2; Flatt T, 2005, Q REV BIOL, V80, P287, DOI 10.1086/432265; Forsman A, 2015, HEREDITY, V115, P276, DOI 10.1038/hdy.2014.92; Gutteling EW, 2007, HEREDITY, V98, P28, DOI 10.1038/sj.hdy.6800894; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Korte A, 2013, PLANT METHODS, V9, DOI 10.1186/1746-4811-9-29; Kwan EX, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002250; Lacaze X, 2009, HEREDITY, V102, P163, DOI 10.1038/hdy.2008.76; Lande R, 2009, J EVOLUTION BIOL, V22, P1435, DOI 10.1111/j.1420-9101.2009.01754.x; Li ZH, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000213; Monaghan P, 2008, PHILOS T R SOC B, V363, P1635, DOI 10.1098/rstb.2007.0011; Nussey DH, 2005, SCIENCE, V310, P304, DOI 10.1126/science.1117004; Perlstein EO, 2007, NAT GENET, V39, P496, DOI 10.1038/ng1991; Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001; Sangster TA, 2005, CURR OPIN PLANT BIOL, V8, P86, DOI 10.1016/j.pbi.2004.11.012; Schlichting CD, 2008, ANN NY ACAD SCI, V1133, P187, DOI 10.1196/annals.1438.010; Smith EN, 2008, PLOS BIOL, V6, P810, DOI 10.1371/journal.pbio.0060083; STEARNS SC, 1994, EVOLUTION, V48, P1438, DOI 10.1111/j.1558-5646.1994.tb02186.x; Swynghedauw B, 2006, J EXP BIOL, V209, P2320, DOI 10.1242/jeb.02084; Taylor MB, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11669; Vedder O, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001605; Wu RL, 1998, EVOLUTION, V52, P967, DOI [10.2307/2411229, 10.1111/j.1558-5646.1998.tb01826.x]; Yadav A, 2016, 033621 BIORXIV, DOI [10.1101/033621, DOI 10.1101/033621]; Yadav A, 2015, G3-GENES GENOM GENET, V5, P699, DOI 10.1534/g3.115.017020	35	13	13	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162326	10.1371/journal.pone.0162326	http://dx.doi.org/10.1371/journal.pone.0162326			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611930	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255900077
J	Zeng, DY; Luo, JT; Li, ZL; Chen, G; Zhang, LQ; Ning, SZ; Yuan, ZW; Zheng, YL; Hao, M; Liu, DC				Zeng, Deying; Luo, Jiangtao; Li, Zenglin; Chen, Gang; Zhang, Lianquan; Ning, Shunzong; Yuan, Zhongwei; Zheng, Youliang; Hao, Ming; Liu, Dengcai			High Transferability of Homoeolog-Specific Markers between Bread Wheat and Newly Synthesized Hexaploid Wheat Lines	PLOS ONE			English	Article							ALLOHEXAPLOID WHEAT; AEGILOPS-TAUSCHII; DRAFT GENOME; IMPROVEMENT; ANEUPLOIDY; SEQUENCES; INSIGHTS	Bread wheat (Triticum aestivum, 2n = 6x = 42, AABBDD) has a complex allohexaploid genome, which makes it difficult to differentiate between the homoeologous sequences and assign them to the chromosome A, B, or D subgenomes. The chromosome-based draft genome sequence of the 'Chinese Spring' common wheat cultivar enables the large-scale development of polymerase chain reaction (PCR)-based markers specific for homoeologs. Based on high-confidence 'Chinese Spring' genes with known functions, we developed 183 putative homoeolog- specific markers for chromosomes 4B and 7B. These markers were used in PCR assays for the 4B and 7B nullisomes and their euploid synthetic hexaploid wheat (SHW) line that was newly generated from a hybridization between Triticum turgidum (AABB) and the wild diploid species Aegilops tauschii (DD). Up to 64% of the markers for chromosomes 4B or 7B in the SHW background were confirmedto be homoeolog-specific. Thus, these markers were highly transferable between the 'Chinese Spring' bread wheat and SHW lines. Homoeolog-specific markers designed using genes with known functions may be useful for genetic investigations involving homoeologous chromosome tracking and homoeolog expression and interaction analyses.	[Zeng, Deying; Li, Zenglin; Chen, Gang; Zhang, Lianquan; Ning, Shunzong; Yuan, Zhongwei; Zheng, Youliang; Hao, Ming; Liu, Dengcai] Sichuan Agr Univ Chengdu, Triticeae Res Inst, Wenjiang 611130, Sichuan, Peoples R China; [Luo, Jiangtao] Sichuan Acad Agr Sci, Crop Res Inst, Chengdu 610066, Sichuan, Peoples R China	Sichuan Academy of Agricultural Sciences (SAAS)	Hao, M; Liu, DC (corresponding author), Sichuan Agr Univ Chengdu, Triticeae Res Inst, Wenjiang 611130, Sichuan, Peoples R China.	haomingluo@foxmail.com; dcliu7@yahoo.com	Hao, Ming/GXI-0243-2022; Hao, Ming/K-3216-2019	Liu, Dengcai/0000-0001-5508-1125	National key research and development program [2016YFD0102002]; National Natural Science Foundation of China (NSFC) [31271723]; Key Projects of Sichuan Provincial Department of Education [16ZA0028]; Youth Fund of the Sichuan Academy of Agricultural Sciences [2016QNJJ-008]	National key research and development program; National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); Key Projects of Sichuan Provincial Department of Education; Youth Fund of the Sichuan Academy of Agricultural Sciences	This study was supported in part by National key research and development program (2016YFD0102002), National Natural Science Foundation of China (NSFC) (http://www.nsfc.gov.cn/publish/portal1/) (31271723 to DL), The Key Projects of Sichuan Provincial Department of Education (16ZA0028 to MH), and The Youth Fund of the Sichuan Academy of Agricultural Sciences (2016QNJJ-008 to JL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank Professors Long Mao and Aili Li from the Chinese Academy of Agricultural Sciences for their help with the bioinformatics analysis. This study was supported in part by National key research and development program (2016YFD0102002), National Natural Science Foundation of China (NSFC) (31271723), The Key Projects of Sichuan Provincial Department of Education (16ZA0028), and The Youth Fund of the Sichuan Academy of Agricultural Sciences (2016QNJJ-008).	Allen AM, 2011, PLANT BIOTECHNOL J, V9, P1086, DOI 10.1111/j.1467-7652.2011.00628.x; Barker GLA, 2009, PLANT BIOTECHNOL J, V7, P318, DOI 10.1111/j.1467-7652.2009.00412.x; Hao M, 2014, G3-GENES GENOM GENET, V4, P1943, DOI 10.1534/g3.114.013078; Hawkesford MJ, 2013, FOOD ENERGY SECUR, V2, P34, DOI 10.1002/fes3.15; Huang S, 2002, P NATL ACAD SCI USA, V99, P8133, DOI 10.1073/pnas.072223799; Jia JZ, 2013, NATURE, V496, P91, DOI 10.1038/nature12028; Kihara H, 1944, AGR HORTIC, V19, P889; Komuro S, 2013, GENOME, V56, P131, DOI 10.1139/gen-2013-0003; Li AL, 2015, MOL PLANT, V8, P847, DOI 10.1016/j.molp.2015.02.016; Li AL, 2014, PLANT CELL, V26, P1878, DOI 10.1105/tpc.114.124388; Ling HQ, 2013, NATURE, V496, P87, DOI 10.1038/nature11997; Liu D, 2016, POLYPLOIDY HYBRIDIZA, P27; Marcussen T, 2014, SCIENCE, V345, DOI 10.1126/science.1250092; Mayer KFX, 2014, SCIENCE, V345, DOI 10.1126/science.1251788; McFadden E.S., 1944, REC GENET SOC AM, V13, P26; Mestiri I, 2010, NEW PHYTOL, V186, P86, DOI 10.1111/j.1469-8137.2010.03186.x; MujeebKazi A, 1996, GENET RESOUR CROP EV, V43, P129, DOI 10.1007/BF00126756; Ogbonnaya FC, 2013, PL BRED RE, V37, P35; Poole R, 2007, FUNCT INTEGR GENOMIC, V7, P207, DOI 10.1007/s10142-007-0046-7; Tang ZX, 2014, J APPL GENET, V55, P313, DOI 10.1007/s13353-014-0215-z; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Wang Y, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1852-2; Yang WY, 2009, J GENET GENOMICS, V36, P539, DOI 10.1016/S1673-8527(08)60145-9; Zhang HK, 2013, P NATL ACAD SCI USA, V110, P3447, DOI 10.1073/pnas.1300153110; Zhang LQ, 2010, EUPHYTICA, V172, P285, DOI 10.1007/s10681-009-0081-7; Zhang LQ, 2008, J GENET GENOMICS, V35, P617, DOI 10.1016/S1673-8527(08)60082-X	26	9	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162847	10.1371/journal.pone.0162847	http://dx.doi.org/10.1371/journal.pone.0162847			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611704	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900179
J	Deconinck, H; Pesonen, A; Hallarou, M; Gerard, JC; Briend, A; Donnen, P; Macq, J				Deconinck, Hedwig; Pesonen, Anais; Hallarou, Mahaman; Gerard, Jean-Christophe; Briend, Andre; Donnen, Philippe; Macq, Jean			Challenges of Estimating the Annual Caseload of Severe Acute Malnutrition: The Case of Niger	PLOS ONE			English	Article							DURATION; CHILDREN; DISEASE; BURDEN	Introduction Reliable prospective estimates of annual severe acute malnutrition (SAM) caseloads for treatment are needed for policy decisions and planning of quality services in the context of competing public health priorities and limited resources. This paper compares the reliability of SAM caseloads of children 6-59 months of age in Niger estimated from prevalence at the start of the year and counted from incidence at the end of the year. Methods Secondary data from two health districts for 2012 and the country overall for 2013 were used to calculate annual caseload of SAM. Prevalence and coverage were extracted from survey reports, and incidence from weekly surveillance systems. Results The prospective caseload estimate derived from prevalence and duration of illness underestimated the true burden. Similar incidence was derived from two weekly surveillance systems, but differed from that obtained from the monthly system. Incidence conversion factors were two to five times higher than recommended. Discussion Obtaining reliable prospective caseloads was challenging because prevalence is unsuitable for estimating incidence of SAM. Different SAM indicators identified different SAM populations, and duration of illness, expected contact coverage and population figures were inaccurate. The quality of primary data measurement, recording and reporting affected incidence numbers from surveillance. Coverage estimated in population surveys was rarely available, and coverage obtained by comparing admissions with prospective caseload estimates was unrealistic or impractical. Conclusions Caseload estimates derived from prevalence are unreliable and should be used with caution. Policy and service decisions that depend on these numbers may weaken performance of service delivery. Niger may improve SAM surveillance by simplifying and improving primary data collection and methods using innovative information technologies for single data entry at the first contact with the health system. Lessons may be relevant for countries with a high burden of SAM, including for targeted emergency responses.	[Deconinck, Hedwig; Macq, Jean] Catholic Univ Louvain, Inst Rech Sante & Soc, Brussels, Belgium; [Pesonen, Anais] Catholic Univ Louvain, Ecole Med, Brussels, Belgium; [Hallarou, Mahaman; Donnen, Philippe] Catholic Univ Louvain, Ecole Sante Publ, Brussels, Belgium; [Gerard, Jean-Christophe] Save Children, Niamey, Niger; [Briend, Andre] Univ Tampere, Tampere Ctr Child Hlth Res, Tampere, Finland; [Briend, Andre] Tampere Univ Hosp, Tampere, Finland; [Briend, Andre] Univ Copenhagen, Dept Nutr Exercise & Sports, Fac Sci, Frederiksberg, Denmark	Universite Catholique Louvain; Universite Catholique Louvain; Universite Catholique Louvain; Save the Children; Tampere University; Tampere University; Tampere University Hospital; University of Copenhagen	Deconinck, H (corresponding author), Catholic Univ Louvain, Inst Rech Sante & Soc, Brussels, Belgium.	hedwig.deconinck@gmail.com	Laivuori, Hannele/F-2953-2011	Laivuori, Hannele/0000-0003-3212-7826; Mahaman, Hallarou/0000-0003-0940-2105				Adam T, 2012, HEALTH POLICY PLANN, V27, P1, DOI 10.1093/heapol/czs084; Agyepong I, 2015, LANCET, V385, P1377, DOI 10.1016/S0140-6736(15)60024-1; Black RE, 2013, LANCET, V382, P427, DOI 10.1016/S0140-6736(13)60937-X; Crowe S, 2014, PEERJ, V2, DOI 10.7717/peerj.380; Deconinck H, 2014, REV INTEGRATED MANAG; Deconinck H, 2015, REPORT LIT REV; Deconinck H, 2016, HEALTH POLICY PLANN, V31, P1364, DOI [10.1093/heapol/czw073, 10.109]; Department of Maternal and Child Health and Community Health Ministry of Health PRC, 2009, CHILD GROWTH STAND I; Emergency Nutrition Network, 2012, C GOV EXP COMM BAS M; Garenne M, 2009, PUBLIC HEALTH NUTR, V12, P1974, DOI 10.1017/S1368980009004972; Grellety E, 2015, PUBLIC HEALTH NUTR, V18, P2575, DOI 10.1017/S1368980015000737; Isanaka S, 2016, GETTING BETTER NUMBE; Isanaka S, 2011, AM J EPIDEMIOL, V173, P932, DOI 10.1093/aje/kwq436; Myatt M, 2012, COVERAGE TRAINING CO; Myatt M, 2012, SEMIQUANTITATIVE EVA; Pawson R, 2004, ENCY EVALUATION; Republique du Niger Institut national de la statistique, 2013, RAPP ENQ NUTR SURV E; Republique du Niger Institut national de la statistique, 2012, RAPP ENQ NUTR SURV E; Republique du Niger Ministere de la sante publique Direction des statistiques, 2014, SYST NAT INF SAN ANN; Republique du Niger Ministere de la sante publique Direction des statistiques, 2012, SCAL PRIS CHARG INT; Republique du Niger Ministere de la sante publique Direction des statistiques, 2012, MAL DECL OBL BAS DON; Republique du Niger Ministere de la sante publique Direction des statistiques, 2012, REPP MENS PRIS CHARG; Ribesse N, 2017, GLOB HEALTH PROMOT, V24, P43, DOI 10.1177/1757975915591684; Rogers E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128666; Save the Children Niger, 2012, RAPP ENQ NUTR SURV E; Save the Children Niger, 2010, EV SEM ACC COUV DIST; Save the Children Niger, 2012, EV SEM ACC COUV DIST; Standardized Monitoring Assessment of Relief Transitions (SMART), 2006, MEAS MORT NUTR STAT; The Sphere Project, 2011, HUM CHART MIN STAND; The World Bank, WOLD BANK DAT BAS; United Nations Children's Fund, 2014, NUTRIDASH GLOB REP N; United Nations Children's Fund, 2015, MAN SEV AC MALN CHIL; United Nations Children's Fund World Health Organization, 2009, WHO CHILD GROWTH STA; United Nations Children's Fund  World Health Organization & World Bank, 2015, LEV TRENDS CHILD MAL; WHO, 2013, GUID UPD MAN SEV AC; Wurthwein R, 2001, INT J EPIDEMIOL, V30, P501, DOI 10.1093/ije/30.3.501	36	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162534	10.1371/journal.pone.0162534	http://dx.doi.org/10.1371/journal.pone.0162534			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606677	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600059
J	Eckhard, LH; Houri-Haddad, Y; Sol, A; Zeharia, R; Shai, Y; Beyth, S; Domb, AJ; Bachrach, G; Beyth, N				Eckhard, Lea H.; Houri-Haddad, Yael; Sol, Asaf; Zeharia, Rotem; Shai, Yechiel; Beyth, Shaul; Domb, Abraham J.; Bachrach, Gilad; Beyth, Nurit			Sustained Release of Antibacterial Lipopeptides from Biodegradable Polymers against Oral Pathogens	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDES; IN-VITRO; RICINOLEIC ACID; BIOCOMPATIBILITY; FLUORESCAMINE; DAPTOMYCIN; PACLITAXEL; BACTERIA; MAGAININ; CARRIER	The development of antibacterial drugs to overcome various pathogenic species, which inhabit the oral cavity, faces several challenges, such as salivary flow and enzymatic activity that restrict dosage retention. Owing to their amphipathic nature, antimicrobial peptides (AMPs) serve as the first line of defense of the innate immune system. The ability to synthesize different types of AMPs enables exploitation of their advantages as alternatives to antibiotics. Sustained release of AMPs incorporated in biodegradable polymers can be advantageous in maintaining high levels of the peptides. In this study, four potent ultra-short lipopeptides, conjugated to an aliphatic acid chain (16C) were incorporated in two different biodegradable polymers: poly (lactic acid co castor oil) (PLACO) and ricinoleic acid-based poly (ester-anhydride) (P(SA-RA)) for sustained release. The lipopeptide and polymer formulations were tested for antibacterial activity during one week, by turbidometric measurements of bacterial outgrowth, anti-biofilm activity by live/dead staining, biocompatibility by hemolysis and XTT colorimetric assays, mode of action by fluorescence-activated cell sorting (FACS) and release profile by a fluorometric assay. The results show that an antibacterial and anti-biofilm effect, as well as membrane disruption, can be achieved by the use of a formulation of lipopeptide incorporated in biodegradable polymer.	[Eckhard, Lea H.; Houri-Haddad, Yael; Zeharia, Rotem; Beyth, Nurit] Hebrew Univ Jerusalem, Fac Med Dent, Dept Prosthodont, Jerusalem, Israel; [Sol, Asaf; Bachrach, Gilad] Hebrew Univ Jerusalem, Fac Med Dent, Inst Dent Sci, Jerusalem, Israel; [Shai, Yechiel] Weizmann Inst Sci, Dept Biol Chem, Rehovot, Israel; [Beyth, Shaul] Hadassah Med Ctr, Dept Orthoped Surg, Jerusalem, Israel; [Domb, Abraham J.] Hebrew Univ Jerusalem, Fac Med, Inst Drug Res, Sch Pharmacol, Jerusalem, Israel	Hebrew University of Jerusalem; Hebrew University of Jerusalem; Weizmann Institute of Science; Hebrew University of Jerusalem; Hadassah University Medical Center; Hebrew University of Jerusalem	Beyth, N (corresponding author), Hebrew Univ Jerusalem, Fac Med Dent, Dept Prosthodont, Jerusalem, Israel.	nuritb@ekmd.huji.ac.il		Sol, Asaf/0000-0002-8731-2490; Domb, Abraham J./0000-0002-2241-7726; Bachrach, Gilad/0000-0003-1350-2280	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation [1764/11]	Legacy Heritage Clinical Research Initiative of the Israel Science Foundation	This work was supported by the Legacy Heritage Clinical Research Initiative of the Israel Science Foundation (Grant No. 1764/11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by The Legacy Heritage Clinical Research Initiative of the Israel Science Foundation (Grant No. 1764/11). The authors would like to thank Ester Abtew for her help in preparing the polymers.	Al-Tahami Khaled, 2007, Recent Pat Drug Deliv Formul, V1, P65, DOI 10.2174/187221107779814113; ANDERSON JM, 1984, BIOMATERIALS, V5, P5, DOI 10.1016/0142-9612(84)90060-7; Avrahami D, 2002, BIOCHEMISTRY-US, V41, P2254, DOI 10.1021/bi011549t; BESSALLE R, 1992, ANTIMICROB AGENTS CH, V36, P313, DOI 10.1128/AAC.36.2.313; Beyth N, 2010, P NATL ACAD SCI USA, V107, P22038, DOI 10.1073/pnas.1010341107; Blondelle SE, 1996, ANTIMICROB AGENTS CH, V40, P1067, DOI 10.1128/AAC.40.5.1067; Boman HG, 2003, J INTERN MED, V254, P197, DOI 10.1046/j.1365-2796.2003.01228.x; Bowdish DME, 2005, ANTIMICROB AGENTS CH, V49, P1727, DOI 10.1128/AAC.49.5.1727-1732.2005; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Carmona-Ribeiro AM, 2014, INT J MOL SCI, V15, P18040, DOI 10.3390/ijms151018040; Cully M, 2015, NAT REV DRUG DISCOV, V14, P750, DOI 10.1038/nrd4766; Davis RR, 2007, J BIOMED MATER RES B, V83B, P505, DOI 10.1002/jbm.b.30823; DE BERNARDO S, 1974, ARCH BIOCHEM BIOPHYS, V163, P390, DOI 10.1016/0003-9861(74)90490-1; Eckhard LH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109413; Heil TL, 2002, J ORAL REHABIL, V29, P401, DOI 10.1046/j.1365-2842.2002.00893.x; Horn JN, 2013, BIOCHEMISTRY-US, V52, P5604, DOI 10.1021/bi400773q; Jain JP, 2008, POLYM REV, V48, P156, DOI 10.1080/15583720701834232; Krasko MY, 2003, J POLYM SCI POL CHEM, V41, P1059, DOI 10.1002/pola.10651; Krishna OD, 2010, BIOPOLYMERS, V94, P32, DOI 10.1002/bip.21333; Makovitzki A, 2008, BIOCHEMISTRY-US, V47, P10630, DOI 10.1021/bi8011675; Makovitzki A, 2006, P NATL ACAD SCI USA, V103, P15997, DOI 10.1073/pnas.0606129103; Mangoni ML, 2011, CELL MOL LIFE SCI, V68, P2267, DOI 10.1007/s00018-011-0718-2; Mitragotri S, 2014, NAT REV DRUG DISCOV, V13, P655, DOI 10.1038/nrd4363; Nakatsuji T, 2012, J INVEST DERMATOL, V132, P887, DOI 10.1038/jid.2011.387; Nguyen LT, 2011, TRENDS BIOTECHNOL, V29, P464, DOI 10.1016/j.tibtech.2011.05.001; Nikaido H, 1996, J BACTERIOL, V178, P5853, DOI 10.1128/jb.178.20.5853-5859.1996; Oren Z, 1997, BIOCHEMISTRY-US, V36, P1826, DOI 10.1021/bi962507l; Papo N, 2002, J BIOL CHEM, V277, P33913, DOI 10.1074/jbc.M204928200; Peschel A, 1999, J BIOL CHEM, V274, P8405, DOI 10.1074/jbc.274.13.8405; Phoenix D.A., 2013, ANTIMICROB PEPT, V8, P1, DOI [10.1002/9783527652853.ch1, DOI 10.1002/9783527652853.CH1]; ROEHM NW, 1991, J IMMUNOL METHODS, V142, P257, DOI 10.1016/0022-1759(91)90114-U; Rosier BT, 2014, FRONT CELL INFECT MI, V4, DOI 10.3389/fcimb.2014.00092; Sampaio-Maia Benedita, 2014, Dent Res J (Isfahan), V11, P291; Shelton CL, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002360; Shikanov A, 2006, BIOMACROMOLECULES, V7, P288, DOI 10.1021/bm050648+; Shikanov A, 2005, J CONTROL RELEASE, V105, P52, DOI 10.1016/j.jconrel.2005.02.018; Shikanov A, 2004, J BIOMED MATER RES A, V69A, P47, DOI 10.1002/jbm.a.20101; SOREN L, 1995, J ANTIMICROB CHEMOTH, V35, P669, DOI 10.1093/jac/35.5.669; Spengler G, 2009, IN VIVO, V23, P81; Steenbergen JN, 2005, J ANTIMICROB CHEMOTH, V55, P283, DOI 10.1093/jac/dkh546; Steinberg D, 1999, CRIT REV THER DRUG, V16, P425; Straus SK, 2006, BBA-BIOMEMBRANES, V1758, P1215, DOI 10.1016/j.bbamem.2006.02.009; Struzycka I, 2014, POL J MICROBIOL, V63, P127; UDENFRIEND S, 1972, SCIENCE, V178, P871, DOI 10.1126/science.178.4063.871; Vaisman B, 2010, J BIOMED MATER RES A, V92A, P419, DOI 10.1002/jbm.a.32342	45	8	10	1	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162537	10.1371/journal.pone.0162537	http://dx.doi.org/10.1371/journal.pone.0162537			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606830	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255600061
J	Nickson, D; Timming, AR; Re, D; Perrett, DI				Nickson, Dennis; Timming, Andrew R.; Re, Daniel; Perrett, David I.			Subtle Increases in BMI within a Healthy Weight Range Still Reduce Womens Employment Chances in the Service Sector	PLOS ONE			English	Article							AESTHETIC LABOR; RETAIL; DISCRIMINATION; APPLICANTS; OBESITY; BIAS	Using mixed design analysis of variance (ANOVA), this paper investigates the effects of a subtle simulated increase in adiposity on women's employment chances in the service sector. Employing a unique simulation of altering individuals' BMIs and the literature on "aesthetic labour", the study suggests that, especially for women, being heavier, but still within a healthy BMI, deleteriously impacts on hireability ratings. The paper explores the gendered dimension of this prejudice by asking whether female employees at the upper end of a healthy BMI range are likely to be viewed more negatively than their overtly overweight male counterparts. The paper concludes by considering the implications of these findings.	[Nickson, Dennis] Univ Strathclyde, Strathclyde Business Sch, Dept Human Resource Management, Glasgow, Lanark, Scotland; [Timming, Andrew R.] Univ St Andrews, Sch Management, St Andrews, Fife, Scotland; [Re, Daniel] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Perrett, David I.] Univ St Andrews, Sch Psychol & Neurosci, St Andrews, Fife, Scotland	University of Strathclyde; University of St Andrews; University of Toronto; University of St Andrews	Nickson, D (corresponding author), Univ Strathclyde, Strathclyde Business Sch, Dept Human Resource Management, Glasgow, Lanark, Scotland.	d.p.nickson@strath.ac.uk	Nickson, Dennis/I-2886-2019	Nickson, Dennis/0000-0002-3328-0729; Timming, Andrew R/0000-0001-8773-8873; Perrett, David/0000-0002-6025-0939				Agerstrom J, 2011, J APPL PSYCHOL, V96, P790, DOI 10.1037/a0021594; BERNSTEN V, 1975, J APPL PSYCHOL, V60, P266, DOI 10.1037/h0076544; CRANDALL CS, 1994, J PERS SOC PSYCHOL, V66, P882, DOI 10.1037/0022-3514.66.5.882; Cummins ER, 2015, GENDER SOC, V29, P623, DOI 10.1177/0891243215591949; Czerniawski AM, 2012, J CONTEMP ETHNOGR, V41, P127, DOI 10.1177/0891241611413579; Dipboye R., 1990, INT REV IND ORG PSYC, V5, P1; Falk A, 2009, SCIENCE, V326, P535, DOI 10.1126/science.1168244; Finkelstein LM, 2007, HUM RESOUR MANAGE-US, V46, P203, DOI 10.1002/hrm.20157; Flint SW, 2014, INT J DISCRIM LAW, V14, P183, DOI 10.1177/1358229114534550; Frey H., 2015, WIDENER LAW REV, V21, P95; Gatta Mary, 2011, RETAIL WORK, P49, DOI [DOI 10.1007/978-0-230-34488-4, 10.1007/978-0-230-34488-4]; Goffman Erving, 1959, MISE SCENE VIE QUOTI; Gosling SD, 2004, AM PSYCHOL, V59, P93, DOI 10.1037/0003-066X.59.2.93; Gruys K, 2012, SOC PROBL, V59, P481, DOI 10.1525/sp.2012.59.4.481; Harris C, 2014, HOSPITALITY SOC, V3, P111; Hay O, 2003, INT J DISCRIMINATION, V6, P69; Haynes K, 2012, GENDER WORK ORGAN, V19, P489, DOI 10.1111/j.1468-0432.2011.00583.x; Hilpern K, 2005, OVERWEIGHT UNDERPAID, P4; Human Resource Management International Digest, 2006, SURVIVAL FITTEST, V14, P26; Huzell H, 2012, ECON IND DEMOCRACY, V33, P103, DOI 10.1177/0143831X11427590; Jeffery R., 2014, PEOPLE MANAGEMENT, P16; KLESGES RC, 1990, INT J OBESITY, V14, P527; LARKIN JC, 1979, SOCIOL WORK OCCUP, V6, P312, DOI 10.1177/073088847900600303; Link BG, 2001, ANNU REV SOCIOL, V27, P363, DOI 10.1146/annurev.soc.27.1.363; MacDonald CL, 2009, SERVICE WORK CRITICA, P113; MCCLELLAND GH, 1993, PSYCHOL BULL, V114, P376, DOI 10.1037/0033-2909.114.2.376; McDowell Linda., 2009, WORKING BODIES INTER; Nickson Dennis., 2001, CUSTOMER SERVICE EMP, P170, DOI DOI 10.1108/03090560610681069; Ogden CL, 2014, JAMA-J AM MED ASSOC, V311, P806, DOI 10.1001/jama.2014.732; Paus? Cat., 2014, FAT STUDIES, V3, DOI [10.1080/21604851.2014.889487, DOI 10.1080/21604851.2014.889487]; Perrett DI, 1998, NATURE, V394, P884, DOI 10.1038/29772; Pettinger Lynne., 2004, CONSUMP MARK CULT, V7, P165, DOI [DOI 10.1080/1025386042000246214, 10.1080/1025386042000246214]; PINGITORE R, 1994, J APPL PSYCHOL, V79, P909, DOI 10.1037/0021-9010.79.6.909; Re D. E., 2014, Q J EXPT PSYCHOL, V67, P1; Rooth DO, 2009, J HUM RESOUR, V44, P710, DOI 10.1353/jhr.2009.0027; ROWLAND DA, 1995, IEEE COMPUT GRAPH, V15, P70, DOI 10.1109/38.403830; Rudolph CW, 2009, J VOCAT BEHAV, V74, P1, DOI 10.1016/j.jvb.2008.09.008; Ruggs EN, 2015, J APPL PSYCHOL, V100, P1483, DOI 10.1037/apl0000017; Silvester J, 1996, INT J SELECT ASSESS, V4, P63, DOI 10.1111/j.1468-2389.1996.tb00060.x; Smith NA, 2016, CORNELL HOSP Q, V57, P314, DOI 10.1177/1938965515622564; Tiddeman B, 2001, IEEE COMPUT GRAPH, V21, P42, DOI 10.1109/38.946630; Timming AR, 2017, HUM RESOUR MANAGE-US, V56, P133, DOI 10.1002/hrm.21770; Timming AR, 2015, WORK EMPLOY SOC, V29, P60, DOI 10.1177/0950017014528402; Trethewey A, 1999, ORGAN STUD, V20, P423, DOI 10.1177/0170840699203003; Walpole SC, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-439; WARHURST C., 2012, INT J WORK ORG EMOTI, V5, P72; Warhurst C, 2007, WORK EMPLOY SOC, V21, P103, DOI 10.1177/0950017007073622; Williams CL, 2010, WORK OCCUPATION, V37, P349, DOI 10.1177/0730888410373744; Zebrowitz LA, 2007, SOC COGNITION, V25, P306, DOI 10.1521/soco.2007.25.2.306	49	14	14	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0159659	10.1371/journal.pone.0159659	http://dx.doi.org/10.1371/journal.pone.0159659			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603519	Green Published, Green Accepted, gold			2022-12-26	WOS:000383255200003
J	Moroni, S; Moscatelli, G; Bournissen, FG; Gonzalez, N; Ballering, G; Freilij, H; Salgueiro, F; Altcheh, J				Moroni, Samanta; Moscatelli, Guillermo; Garcia Bournissen, Facundo; Gonzalez, Nicolas; Ballering, Griselda; Freilij, Hector; Salgueiro, Fabian; Altcheh, Jaime			Abdominal Cystic Echinococcosis Treated with Albendazole. A Pediatric Cohort Study	PLOS ONE			English	Article							ADVERSE DRUG-REACTIONS; HYDATID-DISEASE	Introduction Cystic echinococcosis is endemic in Argentina. The standard pharmacological treatment for the disease is albendazole, but surgery is a common alternative. Even though primary infection occurs mainly in the pediatric population, the optimal therapeutic option in pediatrics is not clearly defined and few pediatric cohorts with cystic echinococcosis treated with albendazole have been described to date. Objective To describe therapeutic response to albendazole in a cohort of pediatric patients with abdominal cystic echinococcosis. Population and Methods Patients (0-18 years old) with abdominal cystic echinococcosis who were treated with albendazole between January 1998 and August 2013. Diagnosis of abdominal cystic echinococcosis was made by ultrasound. All patients received albendazole, 10-15 mg/kg/day. Epidemiological data, symptoms, number, location and outcome of the cysts, serology and treatment received were analyzed. The parameter used to assess treatment response was cyst changes evaluated by ultrasound follow up using the WHO-IWGE classification. Results A total of 28 patients (with 46 abdominal cysts) were included in the cohort. Mean age at enrolment was 9.4 years and mean duration of follow-up, 23.8 months. All patients resided in rural areas and had had contact with dogs. The asymptomatic form of the disease was the most common presentation. All patients received albendazole (mean duration: 142.5 days), with low incidence of adverse events. Albendazole had a positive effect on most of the cysts. Surgery was performed in 13 patients. Conclusion Treatment with albendazole for uncomplicated cystic echinococcosis cysts is safe and effective, and can potentially reduce the need for surgical intervention.	[Moroni, Samanta; Moscatelli, Guillermo; Garcia Bournissen, Facundo; Gonzalez, Nicolas; Ballering, Griselda; Freilij, Hector; Altcheh, Jaime] Buenos Aires Children Hosp Ricardo Gutierrez, Parasitol & Chagas Serv, Buenos Aires, DF, Argentina; [Salgueiro, Fabian] Buenos Aires Children Hosp Ricardo Gutierrez, Dept Surg, Buenos Aires, DF, Argentina	Hospital de Ninos Doctor Ricardo Gutierrez; Hospital de Ninos Doctor Ricardo Gutierrez	Moroni, S (corresponding author), Buenos Aires Children Hosp Ricardo Gutierrez, Parasitol & Chagas Serv, Buenos Aires, DF, Argentina.	samantamoroni@yahoo.com.ar	GARCIA-BOURNISSEN, FACUNDO/E-8286-2015	GARCIA-BOURNISSEN, FACUNDO/0000-0002-8732-247X; Altcheh, jaime/0000-0002-5865-7991				Altcheh J, 2009, 23 C MUND HID COL SA; Altcheh J, 2008, 6 C ARG INF PED BUEN; [Anonymous], 2012, HID DIAGN HID GUIA E; Brunetti E, 2010, EXPERT CONSENSUS DIA; Brunetti E, 2009, CURR OPIN INFECT DIS, V22, P497, DOI 10.1097/QCO.0b013e328330331c; DEROSA F, 1990, ANN TROP MED PARASIT, V84, P467, DOI 10.1080/00034983.1990.11812496; Edwards IR, 2000, LANCET, V356, P1255, DOI 10.1016/S0140-6736(00)02799-9; Freilij H, 2005, PARASITOL LATINOAM, V60, P236; GHARBI HA, 1981, RADIOLOGY, V139, P459, DOI 10.1148/radiology.139.2.7220891; GILGRANDE LA, 1993, LANCET, V342, P1269, DOI 10.1016/0140-6736(93)92361-V; Guillermo Moscatelli, 2011, HIDATIDOSIS ECHINOCO, P770; Hosch W, 2008, NMR BIOMED, V21, P734, DOI 10.1002/nbm.1252; Larrieu E, 2011, ACTA TROP, V117, P1, DOI 10.1016/j.actatropica.2010.08.006; Liu YH, 2003, FUND CLIN PHARM, V17, P205; Meyboom RHB, 1997, DRUG SAFETY, V17, P374, DOI 10.2165/00002018-199717060-00004; NARANJO CA, 1981, CLIN PHARMACOL THER, V30, P239, DOI 10.1038/clpt.1981.154; STEIGER U, 1990, CLIN PHARMACOL THER, V47, P347, DOI 10.1038/clpt.1990.38; Stojkovic M, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000524; Todorov T, 2000, ANN TROP MED PARASIT, V94, P135, DOI 10.1080/00034980057473; WILSON JF, 1987, AM J TROP MED HYG, V37, P162, DOI 10.4269/ajtmh.1987.37.162	20	6	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0160472	10.1371/journal.pone.0160472	http://dx.doi.org/10.1371/journal.pone.0160472			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589236	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800003
J	Kirkby, NS; Tesfai, A; Ahmetaj-Shala, B; Gashaw, HH; Sampaio, W; Etelvino, G; Leao, NM; Santos, RA; Mitchell, JA				Kirkby, Nicholas S.; Tesfai, Abel; Ahmetaj-Shala, Blerina; Gashaw, Hime H.; Sampaio, Walkyria; Etelvino, Gisele; Leao, Nadia Miriceia; Santos, Robson A.; Mitchell, Jane A.			Ibuprofen arginate retains eNOS substrate activity and reverses endothelial dysfunction: implications for the COX-2/ADMA axis	FASEB JOURNAL			English	Article						aspirin; methylarginines; nitric oxide; prostacyclin; Vioxx	NONSTEROIDAL ANTIINFLAMMATORY DRUGS; INCREASED ASYMMETRIC DIMETHYLARGININE; NITRIC-OXIDE SYNTHASE; L-ARGININE; RELAXING FACTOR; LINKS LOSS; IN-VITRO; KAPPA-B; CYCLOOXYGENASE-2; CELLS	Nonsteroidal antiinflammatory drugs, including ibuprofen, are among the most commonly used medications and produce their antiinflammatory effects by blocking cyclooxygenase (COX)-2. Their use is associated with increased risk of heart attacks caused by blocking COX-2 in the vasculature and/or kidney, with our recent work implicating the endogenous NOS inhibitor asymmetric dimethylarginine (ADMA), a cardiotoxic hormone whose effects can be prevented by L-arginine. The ibuprofen salt ibuprofen arginate (Spididol) was created to increase solubility but we suggest that it could also augment the NO pathway through codelivery of arginine. Here we investigated the idea that ibuprofen arginate can act to simultaneously inhibit COX-2 and preserve the NO pathway. Ibuprofen arginate functioned similarly to ibuprofen sodium for inhibition of mouse/human COX-2, but only ibuprofen arginate served as a substrate for NOS. Ibuprofen arginate but not ibuprofen sodium also reversed the inhibitory effects of ADMA and N-G-nitro-L-arginine methyl ester on inducible NOS(macrophages) and endothelial NOS in vitro (aorta) and in vivo (blood pressure). These observations show that ibuprofen arginate provides, in one preparation, a COX-2 inhibitor and NOS substrate that could act to negate the harmful cardiovascular consequences mediated by blocking renal COX-2 and increased ADMA. While remarkably simple, our findings are potentially game-changing in the nonsteroidal antiinflammatory drug arena.	[Kirkby, Nicholas S.; Tesfai, Abel; Ahmetaj-Shala, Blerina; Gashaw, Hime H.; Mitchell, Jane A.] Imperial Coll London, Natl Heart & Lung Inst, Vasc Biol Sect, London SW3 6LY, England; [Sampaio, Walkyria; Etelvino, Gisele; Leao, Nadia Miriceia; Santos, Robson A.] Univ Fed Minas Gerais, Dept Physiol & Biophys, Natl Inst Sci & Technol Nanobiopharmaceut, Belo Horizonte, MG, Brazil	Imperial College London; Universidade Federal de Minas Gerais	Kirkby, NS; Mitchell, JA (corresponding author), Imperial Coll London, Natl Heart & Lung Inst, Vasc Biol Sect, London SW3 6LY, England.	n.kirkby@imperial.ac.uk; j.a.mitchell@ic.ac.uk	Santos, Robson A S/C-9336-2011; Tesfai, Abel/Z-2699-2019	Santos, Robson A S/0000-0001-8738-5852; Kirkby, Nicholas/0000-0003-3509-8549; Tesfai, Abel/0000-0003-2209-5808	Wellcome Trust [0852551Z108/Z]; Imperial College (Wellcome Trust) [PS2124]; Medical Research Council [1416296] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Imperial College (Wellcome Trust); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Wellcome Trust program grant (0852551Z108/Z, to J.A.M.) and an Imperial College (Wellcome Trust) Junior Research Fellowship (PS2124, to N.S.K.).	Ahmetaj-Shala B, 2015, CIRCULATION, V132, pE213, DOI 10.1161/CIRCULATIONAHA.115.017260; Ahmetaj-Shala B, 2015, CIRCULATION, V131, P633, DOI 10.1161/CIRCULATIONAHA.114.011591; Antman EM, 2007, CIRCULATION, V115, P1634, DOI 10.1161/CIRCULATIONAHA.106.181424; Bhala N, 2013, LANCET, V382, P769, DOI 10.1016/S0140-6736(13)60900-9; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Bouras G, 2013, CURR TOP MED CHEM, V13, P180, DOI 10.2174/1568026611313020007; Cheng Y, 2006, J CLIN INVEST, V116, P1391, DOI 10.1172/JCI27540; De Palma C, 2009, PHARMACOL RES, V60, P221, DOI 10.1016/j.phrs.2009.06.002; FURCHGOTT RF, 1980, NATURE, V288, P373, DOI 10.1038/288373a0; Garcia Rodriguez Luis A, 2013, Recent Results Cancer Res, V191, P67, DOI 10.1007/978-3-642-30331-9_4; GEISSLINGER G, 1989, INT J CLIN PHARM TH, V27, P324; Harrington LS, 2007, AM J PHYSIOL-HEART C, V293, pH1682, DOI 10.1152/ajpheart.00389.2007; Harris RC, 2006, CLIN J AM SOC NEPHRO, V1, P236, DOI 10.2215/CJN.00890805; HIBBS JB, 1987, SCIENCE, V235, P473, DOI 10.1126/science.2432665; Kirkby NS, 2016, P NATL ACAD SCI USA, V113, P434, DOI 10.1073/pnas.1517642113; Kirkby NS, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098165; Kirkby NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069524; Kittel A, 2014, CURR PHARM DESIGN, V20, P3530, DOI 10.2174/13816128113196660750; Leiper J, 2011, NAT REV DRUG DISCOV, V10, P277, DOI 10.1038/nrd3358; Luneburg N, 2011, J NUTR, V141, P2186, DOI 10.3945/jn.111.148197; MCCALL TB, 1991, BRIT J PHARMACOL, V102, P234, DOI 10.1111/j.1476-5381.1991.tb12159.x; Mehlisch DR, 2002, J CLIN PHARMACOL, V42, P904, DOI 10.1177/009127002401102821; Mitchell JA, 1997, MOL PHARMACOL, V51, P907, DOI 10.1124/mol.51.6.907; Mitchell JA, 2006, NAT REV DRUG DISCOV, V5, P75, DOI 10.1038/nrd1929; MITCHELL JA, 1994, BRIT J PHARMACOL, V113, P1008, DOI 10.1111/j.1476-5381.1994.tb17093.x; MITCHELL JA, 1993, P NATL ACAD SCI USA, V90, P11693, DOI 10.1073/pnas.90.24.11693; MITCHELL JA, 1990, EUR J PHARMACOL, V182, P573, DOI 10.1016/0014-2999(90)90058-E; Mitchell JA, 2006, FASEB J, V20, P2468, DOI 10.1096/fj.06-6615com; Pahlavani N., 2014, F100 RES, V306, P2, DOI DOI 10.12688/f1000research.5877.1; PALMER RMJ, 1988, BIOCHEM BIOPH RES CO, V153, P1251, DOI 10.1016/S0006-291X(88)81362-7; Patrono C, 2016, CURR CARDIOL REP, V18, DOI 10.1007/s11886-016-0702-4; POLLOCK JS, 1991, P NATL ACAD SCI USA, V88, P10480, DOI 10.1073/pnas.88.23.10480; REES DD, 1990, BRIT J PHARMACOL, V101, P746, DOI 10.1111/j.1476-5381.1990.tb14151.x; REES DD, 1989, BRIT J PHARMACOL, V96, P418, DOI 10.1111/j.1476-5381.1989.tb11833.x; Scarpignato C, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0285-8; SESSA WC, 1990, P NATL ACAD SCI USA, V87, P8607, DOI 10.1073/pnas.87.21.8607; Surdacki A, 2007, ARTHRITIS RHEUM-US, V56, P809, DOI 10.1002/art.22424; SWIERKOSZ TA, 1990, BIOCHEM BIOPH RES CO, V172, P143, DOI 10.1016/S0006-291X(05)80184-6; Wallace JL, 1998, GASTROENTEROLOGY, V115, P101, DOI 10.1016/S0016-5085(98)70370-1; Warner TD, 1999, P NATL ACAD SCI USA, V96, P7563, DOI 10.1073/pnas.96.13.7563; Warner TD, 2008, LANCET, V371, P270, DOI 10.1016/S0140-6736(08)60137-3; Yu Y, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003787	42	9	9	0	17	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4172	4179		10.1096/fj.201600647R	http://dx.doi.org/10.1096/fj.201600647R			8	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27601438	Green Submitted, Green Published, hybrid			2022-12-26	WOS:000388201500023
J	Wiedemann, A; Mijouin, L; Ayoub, MA; Barilleau, E; Canepa, S; Teixeira-Gomes, AP; Le Vern, Y; Rosselin, M; Reiter, E; Velge, P				Wiedemann, Agnes; Mijouin, Lily; Ayoub, Mohammed Akli; Barilleau, Emilie; Canepa, Sylvie; Teixeira-Gomes, Ana Paula; Le Vern, Yves; Rosselin, Manon; Reiter, Eric; Velge, Philippe			Identification of the epidermal growth factor receptor as the receptor for Salmonella Rck-dependent invasion	FASEB JOURNAL			English	Article						bacterial internalization; membrane receptor; cell signaling	TIME-RESOLVED FRET; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; PROTEIN; ACTIVATION; ENTERITIDIS; BINDING; FAMILY; EGFR; TRANSACTIVATION	The Salmonella Rck outer membrane protein binds to the cell surface, which leads to bacterial internalization via a Zipper mechanism. This invasion process requires induction of cellular signals, including phosphorylation of tyrosine proteins, and activation of c-Src and PI3K, which arises as a result of an interaction with a host cell surface receptor. In this study, epidermal growth factor receptor (EGFR) was identified as the cell signaling receptor required for Rck-mediated adhesion and internalization. First, Rck-mediated adhesion and internalization were shown to be altered when EGFR expression and activity were modulated. Then, immunoprecipitations were performed to demonstrate the Rck-EGFR interaction. Furthermore, surface plasmon resonance biosensor and homogeneous time-resolved fluorescence technologies were used to demonstrate the direct interaction of Rck with the extracellular domain of human EGFR. Finally, our study strongly suggests a noncompetitive binding of Rck and EGF to EGFR. Overall, these results demonstrate that Rck is able to bind to EGFR and thereby establish a tight adherence to provide a signaling cascade, which leads to internalization of Rck-expressing bacteria.	[Wiedemann, Agnes; Mijouin, Lily; Barilleau, Emilie; Teixeira-Gomes, Ana Paula; Le Vern, Yves; Rosselin, Manon; Velge, Philippe] INRA, Unite Mixtes Rech 1282, Infectiol & Sante Publ, F-37380 Nouzilly, France; [Wiedemann, Agnes; Mijouin, Lily; Barilleau, Emilie; Teixeira-Gomes, Ana Paula; Le Vern, Yves; Rosselin, Manon; Velge, Philippe] Univ Francois Rabelais Tours, Unite Mixtes Rech 1282, Infectiol & Sante Publ, Tours, France; [Ayoub, Mohammed Akli; Reiter, Eric] INRA, Unite Mixtes Rech 85, Unite Physiol Reprod & Comportements, Nouzilly, France; [Ayoub, Mohammed Akli; Canepa, Sylvie; Reiter, Eric] CNRS, Unite Mixtes Rech 7247, Nouzilly, France; [Ayoub, Mohammed Akli; Canepa, Sylvie; Reiter, Eric] Inst Francais Cheval & Equitat, Nouzilly, France; [Ayoub, Mohammed Akli] Le Studium Loire Valley Inst Adv Studies, Orleans, France; [Canepa, Sylvie; Teixeira-Gomes, Ana Paula; Le Vern, Yves] INRA, Unite Mixtes Rech 85, Plate Forme Anal Integrat Biomol, Nouzilly, France; [Mijouin, Lily] Ctr Biophys Mol, UPR 4301, Orleans, France; [Rosselin, Manon] Univ Geneva, Dept Physiol Cellulaire & Metab, Geneva, Switzerland	INRAE; Centre National de la Recherche Scientifique (CNRS); Universite de Tours; INRAE; Centre National de la Recherche Scientifique (CNRS); INRAE; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); University of Geneva	Wiedemann, A (corresponding author), INRA, Unite Mixtes Rech 1282, Infectiol & Sante Publ, F-37380 Nouzilly, France.	agnes.wiedemann@tours.inra.fr	velge, philippe/AAK-4165-2021	Wiedemann, Agnes/0000-0001-8237-3545; AYOUB, Mohammed Akli/0000-0003-0022-578X				Abed N, 2014, MOL MICROBIOL, V94, P254, DOI 10.1111/mmi.12738; Alonso A, 2004, INT MICROBIOL, V7, P181; Ayoub MA, 2010, FASEB J, V24, P3522, DOI 10.1096/fj.10-154997; BLISKA JB, 1993, CELL, V73, P903, DOI 10.1016/0092-8674(93)90270-Z; Chan G, 2009, P NATL ACAD SCI USA, V106, P22369, DOI 10.1073/pnas.0908787106; COURTNEIDGE SA, 1993, DEVELOPMENT, P57; Dyszel JL, 2010, J BACTERIOL, V192, P29, DOI 10.1128/JB.01139-09; Eierhoff T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001099; FRANCIS CL, 1993, NATURE, V364, P639, DOI 10.1038/364639a0; GALAN JE, 1992, NATURE, V357, P588, DOI 10.1038/357588a0; GUSTERSON B, 1984, CELL BIOL INT REP, V8, P649, DOI 10.1016/0309-1651(84)90045-6; Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413; Haraga A, 2008, NAT REV MICROBIOL, V6, P53, DOI 10.1038/nrmicro1788; Hayes N, 2004, CANCER LETT, V206, P129, DOI 10.1016/j.canlet.2003.08.030; HEFFERNAN EJ, 1994, INFECT IMMUN, V62, P5183, DOI 10.1128/IAI.62.11.5183-5186.1994; HONEGGER AM, 1990, J CELL BIOL, V110, P1541, DOI 10.1083/jcb.110.5.1541; JONES BD, 1993, P NATL ACAD SCI USA, V90, P10390, DOI 10.1073/pnas.90.21.10390; Jones JT, 1999, FEBS LETT, V447, P227, DOI 10.1016/S0014-5793(99)00283-5; Jorissen RN, 2003, EXP CELL RES, V284, P31, DOI 10.1016/S0014-4827(02)00098-8; Keller B, 2015, CELL MICROBIOL, V17, P1179, DOI 10.1111/cmi.12429; Lahti JL, 2011, FEBS LETT, V585, P1135, DOI 10.1016/j.febslet.2011.03.044; Leyris JP, 2011, ANAL BIOCHEM, V408, P253, DOI 10.1016/j.ab.2010.09.030; LOPEZ JG, 1992, INVEST OPHTH VIS SCI, V33, P2053; Maurel D, 2008, NAT METHODS, V5, P561, DOI [10.1038/nmeth.1213, 10.1038/NMETH.1213]; Mijouin L, 2012, FASEB J, V26, P1569, DOI 10.1096/fj.11-189647; Molleken K, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003325; MOUNIER J, 1992, INFECT IMMUN, V60, P237, DOI 10.1128/IAI.60.1.237-248.1992; Muller KM, 1998, ANAL BIOCHEM, V261, P149, DOI 10.1006/abio.1998.2725; Oueslati N, 2015, METHODS MOL BIOL, V1272, P23, DOI 10.1007/978-1-4939-2336-6_2; PACE J, 1993, CELL, V72, P505, DOI 10.1016/0092-8674(93)90070-7; Prenzel N, 2001, ENDOCR-RELAT CANCER, V8, P11, DOI 10.1677/erc.0.0080011; Riese DJ, 1998, BIOESSAYS, V20, P41, DOI 10.1002/(SICI)1521-1878(199801)20:1<41::AID-BIES7>3.0.CO;2-V; Rosselin M, 2010, CELL RES, V20, P647, DOI 10.1038/cr.2010.45; Singh B, 2014, ANNU REV PHYSIOL, V76, P275, DOI 10.1146/annurev-physiol-021113-170406; Slanina H, 2014, INFECT IMMUN, V82, P1243, DOI 10.1128/IAI.01346-13; Smith JN, 2003, J BACTERIOL, V185, P1357, DOI 10.1128/JB.185.4.1357-1366.2003; Sorkin A, 2001, BIOCHEM SOC T, V29, P480, DOI 10.1042/BST0290480; Sorkin A, 2009, EXP CELL RES, V315, P683, DOI [10.1016/j.yexcr.2008.07.029, 10.1016/j.yexcr.2008.08.013]; Swanson KV, 2011, CELL MICROBIOL, V13, P1078, DOI 10.1111/j.1462-5822.2011.01603.x; Tzahar E, 1996, MOL CELL BIOL, V16, P5276; Velge P, 2012, MICROBIOLOGYOPEN, V1, P243, DOI 10.1002/mbo3.28; Wiedemann A, 2012, J BIOL CHEM, V287, P31148, DOI 10.1074/jbc.M112.392134; Wilson KJ, 2009, PHARMACOL THERAPEUT, V122, P1, DOI 10.1016/j.pharmthera.2008.11.008; Yan F, 2009, GASTROENTEROLOGY, V136, P1297, DOI 10.1053/j.gastro.2008.12.059; Zhang J, 2004, INVEST OPHTH VIS SCI, V45, P2569, DOI 10.1167/iovs.03-1323; Zhang YG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058606; Zwier JM, 2010, J BIOMOL SCREEN, V15, P1248, DOI 10.1177/1087057110384611	47	26	30	1	13	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4180	4191		10.1096/fj.201600701R	http://dx.doi.org/10.1096/fj.201600701R			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27609774				2022-12-26	WOS:000388201500024
J	Fan, Y; He, JJ				Fan, Yan; He, Johnny J.			HIV-1 Tat Promotes Lysosomal Exocytosis in Astrocytes and Contributes to Astrocyte-mediated Tat Neurotoxicity	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						astrocyte; cathepsin B (CTSB); exocytosis; glial cell; human immunodeficiency virus (HIV); neuron	HUMAN-IMMUNODEFICIENCY-VIRUS; FIBRILLARY ACIDIC PROTEIN; MONOCYTE CHEMOATTRACTANT PROTEIN-1; TERMINAL REPEAT PROMOTER; CATHEPSIN-B INHIBITOR; NEURONAL CELL-DEATH; IN-VITRO; ALPHA PRODUCTION; TRANSGENIC MICE; AIDS DEMENTIA	Tat interaction with astrocytes has been shown to be important for Tat neurotoxicity and HIV/neuroAIDS. We have recently shown that Tat expression leads to increased glial fibrillary acidic protein (GFAP) expression and aggregation and activation of unfolded protein response/endoplasmic reticulum (ER) stress in astrocytes and causes neurotoxicity. However, the exact molecular mechanism of astrocyte-mediated Tat neurotoxicity is not defined. In this study, we showed that neurotoxic factors other than Tat protein itself were present in the supernatant of Tat-expressing astrocytes. Two-dimensional gel electrophoresis and mass spectrometry revealed significantly elevated lysosomal hydrolytic enzymes and plasma membrane-associated proteins in the supernatant of Tat-expressing astrocytes. We confirmed that Tat expression and infection of pseudotyped HIV.GFP led to increased lysosomal exocytosis from mouse astrocytes and human astrocytes. We found that Tat-induced lysosomal exocytosis was tightly coupled to astrocyte-mediated Tat neurotoxicity. In addition, we demonstrated that Tat-induced lysosomal exocytosis was astrocyte-specific and required GFAP expression and was mediated by ER stress. Taken together, these results show for the first time that Tat promotes lysosomal exocytosis in astrocytes and causes neurotoxicity through GFAP activation and ER stress induction in astrocytes and suggest a common cascade through which aberrant astrocytosis/GFAP up-regulation potentiates neurotoxicity and contributes to neurodegenerative diseases.	[Fan, Yan; He, Johnny J.] Univ North Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA	University of North Texas System; University of North Texas Denton; University of North Texas Health Science Center	He, JJ (corresponding author), Univ North Texas, Hlth Sci Ctr, Grad Sch Biomed Sci, Dept Cell Biol & Immunol, 3500 Camp Bowie Blvd, Ft Worth, TX 76107 USA.	johnny.he@unthsc.edu	Fan, Yan/F-5107-2018		NINDS, National Institutes of Health [R01NS065785, R01094108, R01MH092673]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH092673] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS094108, R01NS065785] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA043162] Funding Source: NIH RePORTER	NINDS, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by NINDS, National Institutes of Health Grants R01NS065785, R01094108, and R01MH092673 (to J. J. H.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Akopova I, 2012, PURINERG SIGNAL, V8, P59, DOI 10.1007/s11302-011-9259-2; Amritraj A, 2013, J BIOL CHEM, V288, P3136, DOI 10.1074/jbc.M112.412460; An SF, 1999, J NEUROPATH EXP NEUR, V58, P1156, DOI 10.1097/00005072-199911000-00005; ATWOOD WJ, 1993, ANN NY ACAD SCI, V693, P324, DOI 10.1111/j.1749-6632.1993.tb26298.x; Banks WA, 2005, EXP NEUROL, V193, P218, DOI 10.1016/j.expneurol.2004.11.019; Bastow ER, 2012, BIOL OPEN, V1, P318, DOI 10.1242/bio.2012547; Benelli R, 2000, J INFECT DIS, V182, P1643, DOI 10.1086/317597; BOJE KM, 1992, BRAIN RES, V587, P250, DOI 10.1016/0006-8993(92)91004-X; Brack-Werner R, 1999, AIDS, V13, P1, DOI 10.1097/00002030-199901140-00003; BUMA P, 1983, CELL TISSUE RES, V233, P143; Cantres-Rosario Y, 2013, AIDS, V27, P347, DOI 10.1097/QAD.0b013e32835b3e47; Cerny J, 2004, EMBO REP, V5, P883, DOI 10.1038/sj.embor.7400243; Chauhan A, 2003, J BIOL CHEM, V278, P13512, DOI 10.1074/jbc.M209381200; Chen PQ, 1997, J BIOL CHEM, V272, P22385, DOI 10.1074/jbc.272.36.22385; Cohen RA, 2009, NEUROLOGY, V73, P338, DOI 10.1212/WNL.0b013e3181b1220d; Conant K, 1998, P NATL ACAD SCI USA, V95, P3117, DOI 10.1073/pnas.95.6.3117; Del Valle L, 2006, FRONT BIOSCI-LANDMRK, V11, P718, DOI 10.2741/1830; El-Hage N, 2005, GLIA, V50, P91, DOI 10.1002/glia.20148; Ellis RJ, 1997, ARCH NEUROL-CHICAGO, V54, P416, DOI 10.1001/archneur.1997.00550160054016; Ellis R, 2007, NAT REV NEUROSCI, V8, P33, DOI 10.1038/nrn2040; ENSOLI B, 1993, J VIROL, V67, P277, DOI 10.1128/JVI.67.1.277-287.1993; Fan Y, 2016, J BIOL CHEM, V291, P22819, DOI 10.1074/jbc.M116.731828; Fan Y, 2015, CURR HIV RES, V13, P55, DOI 10.2174/1570162X13666150121115804; Fan Y, 2011, J NEUROIMMUNE PHARM, V6, P121, DOI 10.1007/s11481-010-9217-8; Ferri KF, 2001, NAT CELL BIOL, V3, pE255, DOI 10.1038/ncb1101-e255; Fine SM, 1996, J BIOL CHEM, V271, P15303, DOI 10.1074/jbc.271.26.15303; Fitting S, 2013, BIOL PSYCHIAT, V73, P443, DOI 10.1016/j.biopsych.2012.09.026; Gan L, 2004, J BIOL CHEM, V279, P5565, DOI 10.1074/jbc.M306183200; Hammadi M, 2013, FASEB J, V27, P1600, DOI 10.1096/fj.12-218875; Harding HP, 1999, NATURE, V397, P271, DOI 10.1038/16729; Haughey NJ, 2002, JAIDS-J ACQ IMM DEF, V31, pS55, DOI 10.1097/00126334-200210012-00005; Houseweart MK, 2003, J NEUROBIOL, V56, P315, DOI 10.1002/neu.10253; Hoyer-Hansen M, 2007, CELL DEATH DIFFER, V14, P1576, DOI 10.1038/sj.cdd.4402200; Hudson L, 2000, J NEUROVIROL, V6, P145, DOI 10.3109/13550280009013158; Hui L, 2012, ASN NEURO, V4, P243, DOI 10.1042/AN20120017; Jeeninga RE, 2000, J VIROL, V74, P3740, DOI 10.1128/JVI.74.8.3740-3751.2000; Jin JJ, 2012, AM J TRANSL RES, V4, P302; Johnson TP, 2013, P NATL ACAD SCI USA, V110, P13588, DOI 10.1073/pnas.1308673110; Jones M, 1998, J NEUROPATH EXP NEUR, V57, P563, DOI 10.1097/00005072-199806000-00004; Jung J, 2016, NEUROSCIENCE, V313, P10, DOI 10.1016/j.neuroscience.2015.11.028; Kim BO, 2003, AM J PATHOL, V162, P1693, DOI 10.1016/S0002-9440(10)64304-0; KLAVER B, 1994, J VIROL, V68, P3830, DOI 10.1128/JVI.68.6.3830-3840.1994; Koike M, 2000, J NEUROSCI, V20, P6898, DOI 10.1523/JNEUROSCI.20-18-06898.2000; KOLSON DL, 1993, AIDS RES HUM RETROV, V9, P677, DOI 10.1089/aid.1993.9.677; Lafrenie RM, 1996, J IMMUNOL, V157, P974; Lawrence CP, 2006, J IMMUNOL, V177, P3827, DOI 10.4049/jimmunol.177.6.3827; LEE SC, 1993, ANN NY ACAD SCI, V693, P314, DOI 10.1111/j.1749-6632.1993.tb26295.x; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Leist M, 2001, CELL DEATH DIFFER, V8, P324, DOI 10.1038/sj.cdd.4400859; Liang QL, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-37; Lieuallen K, 2001, HUM MOL GENET, V10, P1867, DOI 10.1093/hmg/10.18.1867; Liu Y, 2002, J BIOL CHEM, V277, P23854, DOI 10.1074/jbc.M200773200; Liu ZQ, 2014, J NEUROVIROL, V20, P278, DOI 10.1007/s13365-014-0245-7; Los M, 1999, IMMUNITY, V10, P629, DOI 10.1016/S1074-7613(00)80062-X; MAGNUSON DSK, 1995, ANN NEUROL, V37, P373, DOI 10.1002/ana.410370314; Mayne M, 2000, J IMMUNOL, V164, P6538, DOI 10.4049/jimmunol.164.12.6538; McCall MA, 1996, P NATL ACAD SCI USA, V93, P6361, DOI 10.1073/pnas.93.13.6361; Nath A, 1996, J VIROL, V70, P1475, DOI 10.1128/JVI.70.3.1475-1480.1996; PAPAGAPIOU MP, 1990, J CEREBR BLOOD F MET, V10, P270, DOI 10.1038/jcbfm.1990.44; Park IW, 2001, BLOOD, V97, P352, DOI 10.1182/blood.V97.2.352; Parks A, 2015, PEERJ, V3, DOI 10.7717/peerj.1314; PRICE RW, 1988, J INFECT DIS, V158, P1079, DOI 10.1093/infdis/158.5.1079; Qi X, 2004, MOL PHARMACOL, V66, P899, DOI 10.1124/mol.104.001339; RANKI A, 1995, AIDS, V9, P1001, DOI 10.1097/00002030-199509000-00004; Raraty M, 2000, P NATL ACAD SCI USA, V97, P13126, DOI 10.1073/pnas.97.24.13126; REMPEL SA, 1994, CANCER RES, V54, P6027; Rivera LE, 2014, CURR HIV RES, V12, P111, DOI 10.2174/1570162X12666140526120249; Rodriguez A, 1997, J CELL BIOL, V137, P93, DOI 10.1083/jcb.137.1.93; Rodriguez-Franco EJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036571; SABATIER JM, 1991, J VIROL, V65, P961, DOI 10.1128/JVI.65.2.961-967.1991; Saito A, 2007, ANTIOXID REDOX SIGN, V9, P563, DOI 10.1089/ars.2006.1520; SAITO Y, 1994, NEUROLOGY, V44, P474, DOI 10.1212/WNL.44.3_Part_1.474; Schotte P, 2001, J BIOL CHEM, V276, P21153, DOI 10.1074/jbc.M102239200; Shute AA, 2005, NEUROSCIENCE, V131, P349, DOI 10.1016/j.neuroscience.2004.11.025; Sudhof TC, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011353; Sun L, 2010, BIOCHEM BIOPH RES CO, V399, P391, DOI 10.1016/j.bbrc.2010.07.084; Tsuchiya K, 1999, EXP NEUROL, V155, P187, DOI 10.1006/exnr.1998.6988; Turchan-Cholewo J, 2009, J NEUROCHEM, V108, P202, DOI 10.1111/j.1471-4159.2008.05756.x; Williams R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005709; Zhang ZJ, 2007, NAT CELL BIOL, V9, P945, DOI 10.1038/ncb1620; Zhou BY, 2004, MOL CELL NEUROSCI, V27, P296, DOI 10.1016/j.mcn.2004.07.003; Zhou BY, 2004, NEUROSCI LETT, V359, P155, DOI 10.1016/j.neulet.2004.02.012; Zou W, 2007, AM J PATHOL, V171, P1923, DOI 10.2353/ajpath.2007.070333; Zou W, 2010, GLIA, V58, P1640, DOI 10.1002/glia.21038	84	24	24	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22830	22840		10.1074/jbc.M116.731836	http://dx.doi.org/10.1074/jbc.M116.731836			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609518	hybrid, Green Published			2022-12-26	WOS:000386760600039
J	Makita, N; Sato, T; Yajima-Shoji, Y; Sato, J; Manaka, K; Eda-Hashimoto, M; Ootaki, M; Matsumoto, N; Nangaku, M; Iiri, T				Makita, Noriko; Sato, Tomohiko; Yajima-Shoji, Yuki; Sato, Junichiro; Manaka, Katsunori; Eda-Hashimoto, Makiko; Ootaki, Masanori; Matsumoto, Naoki; Nangaku, Masaomi; Iiri, Taroh			Analysis of the V2 Vasopressin Receptor (V2R) Mutations Causing Partial Nephrogenic Diabetes Insipidus Highlights a Sustainable Signaling by a Non-peptide V2R Agonist	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						G protein-coupled receptor (GPCR); membrane trafficking; molecular chaperone; receptor regulation; signal transduction	FUNCTIONAL-CHARACTERIZATION; PHARMACOLOGICAL CHAPERONES; BIASED AGONISM; MUTANT; ACTIVATION; G(S-ALPHA); RESCUE; IDENTIFICATION; DEFECT	Disease-causing mutations in G protein-coupled receptor (GPCR) genes, including the V2 vasopressin receptor (V2R) gene, often cause misfolded receptors, leading to a defect in plasma membrane trafficking. A novel V2R mutation, T273M, identified in a boy with partial nephrogenic diabetes insipidus (NDI), shows intracellular localization and partial defects similar to the two mutants we described previously (10). Although non-peptide V2R antagonists have been shown to rescue the membrane localization of V2R mutants, their level of functional rescue is weak. Interestingly, it has been reported that a non-peptide agonist, OPC51803, activates misfolded V2R mutants intracellularly without degradation, thus potentially serving as a therapeutic agent against NDI (14). In our current experiments, however, a peptide antagonist blocked arginine vasopressin (AVP)- or OPC51803-stimulated cAMP accumulation both in COS-7 and MDCK cells, suggesting that OPC51803 mainly stimulates cell surface V2R mutants. In addition, our analyses revealed that OPC51803 works not only as a non-peptide agonist that causes activation/-arrestin-dependent desensitization of V2R mutants expressed at the plasma membrane but also as a pharmacochaperone that promotes the endoplasmic reticulum-retained mutant maturation and trafficking to the plasma membrane. The ratio of the pharmacochaperone effect to the desensitization effect likely correlates negatively with the residual function of the tested mutants, suggesting that OPC5 has a more favorable effect on the V2R mutants with a less residual function. We speculated that the canceling of the desensitization effect of OPC51803 by the pharmacochaperone effect after long-term treatment may produce sustainable signaling, and thus pharmacochaperone agonists such as OPC51803 may serve as promising therapeutics for NDI caused by misfolded V2R mutants.	[Makita, Noriko; Yajima-Shoji, Yuki; Sato, Junichiro; Manaka, Katsunori; Eda-Hashimoto, Makiko; Nangaku, Masaomi; Iiri, Taroh] Univ Tokyo, Dept Endocrinol & Nephrol, Tokyo 1138655, Japan; [Sato, Tomohiko] Hirosaki Univ, Grad Sch Med, Dept Pediat, Hirosaki, Aomori 0368562, Japan; [Ootaki, Masanori; Matsumoto, Naoki; Iiri, Taroh] St Marianna Univ, Dept Pharmacol, Sch Med, Kawasaki, Kanagawa 2168511, Japan	University of Tokyo; Hirosaki University; Saint Marianna University	Makita, N (corresponding author), 7-3-1 Hongo,Bunkyo Ku, Tokyo 1138655, Japan.; Iiri, T (corresponding author), 2-16-1 Sugao, Kawasaki, Kanagawa 2168511, Japan.	norimaki-tky@umin.ac.jp; tiiri-tky@umin.ac.jp	Makita, Noriko/GQY-8175-2022		Ministry of Education, Science, Sports, and Culture, Japan	Ministry of Education, Science, Sports, and Culture, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant-in-aid for scientific research from the Ministry of Education, Science, Sports, and Culture, Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Ala Y, 1998, J AM SOC NEPHROL, V9, P1861; Bernier V, 2004, MOL ENDOCRINOL, V18, P2074, DOI 10.1210/me.2004-0080; Bernier V, 2006, J AM SOC NEPHROL, V17, P232, DOI 10.1681/ASN.2005080854; Bichet DG, 2016, BEST PRACT RES CL EN, V30, P263, DOI 10.1016/j.beem.2016.02.010; Bichet DG, 2006, ADV CHRONIC KIDNEY D, V13, P96, DOI 10.1053/j.ackd.2006.01.006; Bockenhauer D, 2015, NAT REV NEPHROL, V11, P576, DOI 10.1038/nrneph.2015.89; Bockenhauer D, 2010, NEPHRON PHYSIOL, V114, P1, DOI 10.1159/000245059; Chen CH, 2002, J HUM GENET, V47, P66, DOI 10.1007/s100380200002; Faerch M, 2008, CLIN ENDOCRINOL, V68, P395, DOI 10.1111/j.1365-2265.2007.03054.x; Faerch M, 2009, AM J PHYSIOL-RENAL, V297, pF1518, DOI 10.1152/ajprenal.00331.2009; Hill SJ, 2006, BRIT J PHARMACOL, V147, pS27, DOI 10.1038/sj.bjp.0706455; Huang CY, 2016, ACTA CRYSTALLOGR D, V72, P93, DOI 10.1107/S2059798315021683; Iiri T, 1997, P NATL ACAD SCI USA, V94, P5656, DOI 10.1073/pnas.94.11.5656; Iiri T, 1999, P NATL ACAD SCI USA, V96, P499, DOI 10.1073/pnas.96.2.499; IIRI T, 1994, NATURE, V371, P164, DOI 10.1038/371164a0; Inaba S, 2001, J CLIN ENDOCR METAB, V86, P381, DOI 10.1210/jc.86.1.381; Jean-Alphonse F, 2009, J AM SOC NEPHROL, V20, P2190, DOI 10.1681/ASN.2008121289; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Macion-Dazard R, 2006, J PHARMACOL EXP THER, V316, P564, DOI 10.1124/jpet.105.095554; Makita N, 2007, P NATL ACAD SCI USA, V104, P17424, DOI 10.1073/pnas.0708561104; Makita N, 2007, P NATL ACAD SCI USA, V104, P5443, DOI 10.1073/pnas.0701290104; Makita N, 2014, ENDOCR J, V61, P303, DOI 10.1507/endocrj.EJ13-0453; Makita N, 2013, CIRC RES, V112, P327, DOI 10.1161/CIRCRESAHA.112.277665; McDonald PH, 2000, SCIENCE, V290, P1574, DOI 10.1126/science.290.5496.1574; Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688; Neocleous V, 2012, METABOLISM, V61, P922, DOI 10.1016/j.metabol.2012.01.005; Oishi A, 2012, J BIOL CHEM, V287, P38705, DOI 10.1074/jbc.M112.401547; Pasel K, 2000, J CLIN ENDOCR METAB, V85, P1703, DOI 10.1210/jc.85.4.1703; Robben JH, 2007, AM J PHYSIOL-RENAL, V292, pF253, DOI 10.1152/ajprenal.00247.2006; Robben JH, 2006, AM J PHYSIOL-RENAL, V291, pF257, DOI 10.1152/ajprenal.00491.2005; Robben JH, 2009, P NATL ACAD SCI USA, V106, P12195, DOI 10.1073/pnas.0900130106; Sadeghi H, 1997, MOL ENDOCRINOL, V11, P1806, DOI 10.1210/me.11.12.1806; Sahakitrungruang T, 2010, HORM RES PAEDIAT, V73, P349, DOI 10.1159/000308167; Takahashi K, 2012, J BIOL CHEM, V287, P2099, DOI 10.1074/jbc.M111.268797; Webb B., 2014, CURR PROTOC BIOINFOR, V5.6, P32, DOI [10.1002/0471250953.bi0506s47, DOI 10.1002/0471250953.BI0506S47]	35	12	12	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22460	22471		10.1074/jbc.M116.733220	http://dx.doi.org/10.1074/jbc.M116.733220			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601473	Green Published, hybrid			2022-12-26	WOS:000386760600009
J	Oho, M; Nakano, R; Nakayama, R; Sakurai, W; Miyamoto, A; Masuhiro, Y; Hanazawa, S				Oho, Michitaka; Nakano, Risa; Nakayama, Ryutarou; Sakurai, Wataru; Miyamoto, Azusa; Masuhiro, Yoshikazu; Hanazawa, Shigemasa			TIPE2 (Tumor Necrosis Factor -induced Protein 8-like 2) Is a Novel Negative Regulator of TAK1 Signal	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						cell-penetrating peptide (CPP); immunology; inflammation; signal transduction; tumor necrosis factor (TNF)	NF-KAPPA-B; CELL-CYCLE PROGRESSION; KINASE KINASE KINASE; MAP KINASE; TRANSCRIPTIONAL ACTIVITY; TNFAIP8 FAMILY; ACTIVATION; TRAF6; BETA; IL-1	TIPE2 (TNF--induced protein 8-like 2) is a novel death effector domain protein and is a negative regulator of the innate and adaptive immune response. Although it has been demonstrated that caspase-8 contributes to the negative regulation of TIPE2, the negative regulatory mechanism is not entirely understood. Here, we demonstrate that TIPE2 interacts with TGF--activated kinase 1 (TAK1), a crucial regulatory molecule of inflammatory and immune signals, and consequently acts as a powerful negative regulator of TAK1. The interaction between endogenous TIPE2 and TAK1 was observed in RAW264.7 macrophage-like cells and mouse primary cells derived from spleen and thymus. The TIPE2 amino acid 101-140 region interacted with TAK1 by binding to the amino acid 200-291 region of the internal kinase domain of TAK1. TIPE2 interfered with the formation of the TAK1-TAB1-TAB2 complex and subsequently inhibited activation of TAK1 and its downstream molecules. Importantly, silencing TIPE2 through RNA interference attenuated the inhibitory action of TIPE2 on LPS- and TNF--stimulated TAK1 activity. Exogenous TIPE2 101-140, the region that interacts with TAK1, also inhibited LPS- and TNF--stimulated NF-B reporter activity. Interestingly, cell-permeable TIPE2 protein maintained its binding ability with TAK1 and exhibited the same inhibitory action of native TIPE2 on TLR4 signaling in vitro. Thus, cell-permeable TIPE2 protein is a potential candidate for intracellular protein therapy for TAK1-related diseases. The present study demonstrates that TIPE2 acts as a novel negative regulator of inflammatory and immune responses through TAK1 signaling.	[Oho, Michitaka; Nakano, Risa; Nakayama, Ryutarou; Sakurai, Wataru; Miyamoto, Azusa; Masuhiro, Yoshikazu; Hanazawa, Shigemasa] Nihon Univ, Dept Appl Biol Sci, Coll Bioresource Sci, Fujisawa, Kanagawa 2520880, Japan	Nihon University	Hanazawa, S (corresponding author), Nihon Univ, Dept Appl Biol Sci, Coll Bioresource Sci, Lab Mol & Cell Physiol, 1866 Kameino, Fujisawa, Kanagawa 2520880, Japan.	hanazawa@brs.nihon-u.ac.jp			ministry of Education, Culture, Sports, Science and Technology of Japan	ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid for science research from the ministry of Education, Culture, Sports, Science and Technology of Japan. The authors declare that they have no conflicts of interest with the contents of this article.	Blonska M, 2007, IMMUNITY, V26, P55, DOI 10.1016/j.immuni.2006.11.008; Cao XL, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-149; Choi JM, 2010, P NATL ACAD SCI USA, V107, P18575, DOI 10.1073/pnas.1000400107; Delaney JR, 2006, CELL CYCLE, V5, P2852, DOI 10.4161/cc.5.24.3558; Fan YH, 2012, CELL SIGNAL, V24, P1381, DOI 10.1016/j.cellsig.2012.02.017; Goswami M, 2001, DEV BIOL, V236, P259, DOI 10.1006/dbio.2001.0338; Gus-Brautbar Y, 2012, MOL CELL, V45, P610, DOI 10.1016/j.molcel.2012.01.006; Ha JY, 2014, J NEUROCHEM, V129, P527, DOI [10.1111/jnc.12643, 10.1111/j.1471-4159.2013.12643.x]; Ishida H, 2005, J BIOL CHEM, V280, P24642, DOI 10.1074/jbc.M500189200; Ishitani T, 2003, EMBO J, V22, P6277, DOI 10.1093/emboj/cdg605; Jo D, 2005, NAT MED, V11, P892, DOI 10.1038/nm1269; Kim SY, 2014, MOL CELL BIOL, V34, P510, DOI 10.1128/MCB.01225-13; Kishimoto K, 2000, J BIOL CHEM, V275, P7359, DOI 10.1074/jbc.275.10.7359; Kurahashi T, 2005, MOL BIOL CELL, V16, P4705, DOI 10.1091/mbc.E05-05-0470; Kwak JH, 2008, J BIOL CHEM, V283, P19816, DOI 10.1074/jbc.M802285200; Lou YW, 2013, J IMMUNOL, V191, P4849, DOI 10.4049/jimmunol.1300053; Lou YW, 2011, MOL IMMUNOL, V49, P4, DOI 10.1016/j.molimm.2011.08.006; Mahmud SA, 2014, NAT IMMUNOL, V15, P473, DOI 10.1038/ni.2849; Masuhiro Y, 2008, J BIOL CHEM, V283, P31575, DOI 10.1074/jbc.M800328200; Mochida Y, 2000, J BIOL CHEM, V275, P32747, DOI 10.1074/jbc.M003042200; Munoz-Sanjuan I, 2002, DEVELOPMENT, V129, P5529, DOI 10.1242/dev.00097; Ninomiya-Tsuji J, 1999, NATURE, V398, P252, DOI 10.1038/18465; Pathak S, 2012, EMBO J, V31, P1394, DOI 10.1038/emboj.2012.8; Ray DM, 2010, BIOCHEM CELL BIOL, V88, P947, DOI 10.1139/O10-148; Sakurai H, 2000, FEBS LETT, V474, P141, DOI 10.1016/S0014-5793(00)01588-X; Sakurai H, 2012, TRENDS PHARMACOL SCI, V33, P522, DOI 10.1016/j.tips.2012.06.007; Schuman J, 2009, BLOOD, V113, P4566, DOI 10.1182/blood-2008-08-176057; Shi TY, 2013, CARCINOGENESIS, V34, P770, DOI 10.1093/carcin/bgt001; Shibuya H, 1996, SCIENCE, V272, P1179, DOI 10.1126/science.272.5265.1179; Shim JH, 2009, EMBO J, V28, P2028, DOI 10.1038/emboj.2009.162; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Shinohara H, 2009, IMMUNOL REV, V232, P300, DOI 10.1111/j.1600-065X.2009.00836.x; Shuto T, 2001, P NATL ACAD SCI USA, V98, P8774, DOI 10.1073/pnas.151236098; Sorrentino A, 2008, NAT CELL BIOL, V10, P1199, DOI 10.1038/ncb1780; Sun HH, 2008, CELL, V133, P415, DOI 10.1016/j.cell.2008.03.026; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Takaesu G, 2000, MOL CELL, V5, P649, DOI 10.1016/S1097-2765(00)80244-0; Walsh MC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004064; Woodward MJ, 2010, CELL DEATH DIFFER, V17, P316, DOI 10.1038/cdd.2009.125; Zhang SY, 2010, BBA-MOL BASIS DIS, V1802, P1078, DOI 10.1016/j.bbadis.2010.08.003; Zhang Y, 2012, J BIOL CHEM, V287, P32546, DOI 10.1074/jbc.M112.348755; Zhang Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037846; Zhou HY, 2009, CELL STEM CELL, V4, P381, DOI 10.1016/j.stem.2009.04.005	43	23	29	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22650	22660		10.1074/jbc.M116.733451	http://dx.doi.org/10.1074/jbc.M116.733451			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27601471	Green Published, hybrid			2022-12-26	WOS:000386760600025
J	Smith, CA; Nossoni, Z; Toth, M; Stewart, NK; Frase, H; Vakulenko, SB				Smith, Clyde A.; Nossoni, Zahra; Toth, Marta; Stewart, Nichole K.; Frase, Hilary; Vakulenko, Sergei B.			Role of the Conserved Disulfide Bridge in Class A Carbapenemases	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antibiotic resistance; crystal structure; disulfide; enzyme kinetics; hydrogen bond; carbapenemase; enzyme stability	BETA-LACTAMASES; ESCHERICHIA-COLI; STRUCTURAL BASIS; ACTIVE-SITE; CRYSTALLOGRAPHY; RESISTANCE; CEPHALOSPORINASE; REQUIREMENTS; HYDROLYSIS; RESOLUTION	Some members of the class A -lactamase family are capable of conferring resistance to the last resort antibiotics, carbapenems. A unique structural feature of these clinically important enzymes, collectively referred to as class A carbapenemases, is a disulfide bridge between invariant Cys(69) and Cys(238) residues. It was proposed that this conserved disulfide bridge is responsible for their carbapenemase activity, but this has not yet been validated. Here we show that disruption of the disulfide bridge in the GES-5 carbapenemase by the C69G substitution results in only minor decreases in the conferred levels of resistance to the carbapenem imipenem and other -lactams. Kinetic and circular dichroism experiments with C69G-GES-5 demonstrate that this small drop in antibiotic resistance is due to a decline in the enzyme activity caused by a marginal loss of its thermal stability. The atomic resolution crystal structure of C69G-GES-5 shows that two domains of this disulfide bridge-deficient enzyme are held together by an intensive hydrogen-bonding network. As a result, the protein architecture and imipenem binding mode remain unchanged. In contrast, the corresponding hydrogen-bonding networks in NMCA, SFC-1, and SME-1 carbapenemases are less intensive, and as a consequence, disruption of the disulfide bridge in these enzymes destabilizes them, which causes arrest of bacterial growth. Our results demonstrate that the disulfide bridge is essential for stability but does not play a direct role in the carbapenemase activity of the GES family of -lactamases. This would likely apply to all other class A carbapenemases given the high degree of their structural similarity.	[Smith, Clyde A.] Stanford Univ, Stanford Synchrotron Radiat Lightsource, Menlo Pk, CA 94025 USA; [Nossoni, Zahra; Toth, Marta; Stewart, Nichole K.; Frase, Hilary; Vakulenko, Sergei B.] Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA	Stanford University; University of Notre Dame	Vakulenko, SB (corresponding author), Univ Notre Dame, Dept Chem & Biochem, 417 Nieuwland Sci Hall, Notre Dame, IN 46556 USA.; Smith, CA (corresponding author), Stanford Synchrotron Radiat Lightsource, 2575 Sand Hill Rd, Menlo Pk, CA 94025 USA.	csmith@slac.stanford.edu; svakulen@nd.edu			National Institutes of Health [R01AI089726]; Department of Energy Office of Biological and Environmental Research; National Institutes of Health, National Institute of General Medical Sciences [P41GM103393]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI089726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P41GM103393] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Energy Office of Biological and Environmental Research(United States Department of Energy (DOE)); National Institutes of Health, National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by National Institutes of Health Grant R01AI089726 (to S. B. V.). The SSRL Structural Molecular Biology Program is supported by the Department of Energy Office of Biological and Environmental Research and by the National Institutes of Health, National Institute of General Medical Sciences (including Grant P41GM103393). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	ABAGYAN R, 1994, J MOL BIOL, V235, P983, DOI 10.1006/jmbi.1994.1052; Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; AMBLER RP, 1980, PHILOS T R SOC B, V289, P321, DOI 10.1098/rstb.1980.0049; AMBLER RP, 1991, BIOCHEM J, V276, P269, DOI 10.1042/bj2760269; An JH, 2005, MOL CELL PROTEOMICS, V4, P752, DOI 10.1074/mcp.M400159-MCP200; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Bush K, 2013, ANN NY ACAD SCI, V1277, P84, DOI 10.1111/nyas.12023; Cohen AE, 2002, J APPL CRYSTALLOGR, V35, P720, DOI 10.1107/S0021889802016709; Copeland R. A., 2004, ENZYMES PRACTICAL IN; DELAIRE M, 1992, J BIOL CHEM, V267, P20600; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans PR, 2013, ACTA CRYSTALLOGR D, V69, P1204, DOI 10.1107/S0907444913000061; Fonseca F, 2012, J AM CHEM SOC, V134, P18275, DOI 10.1021/ja304460j; Frase H, 2009, J BIOL CHEM, V284, P29509, DOI 10.1074/jbc.M109.011262; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Greenfield NJ, 2006, NAT PROTOC, V1, P2527, DOI 10.1038/nprot.2006.204; Helfand MS, 2002, J BIOL CHEM, V277, P47719, DOI 10.1074/jbc.M207271200; JAURIN B, 1981, P NATL ACAD SCI-BIOL, V78, P4897, DOI 10.1073/pnas.78.8.4897; JELSCH C, 1992, FEBS LETT, V299, P135, DOI 10.1016/0014-5793(92)80232-6; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Majiduddin FK, 2003, ANTIMICROB AGENTS CH, V47, P1062, DOI 10.1128/AAC.47.3.1062-1067.2003; Maveyraud L, 1998, J AM CHEM SOC, V120, P9748, DOI 10.1021/ja9818001; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nordmann P, 2012, TRENDS MOL MED, V18, P263, DOI 10.1016/j.molmed.2012.03.003; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; OUELLETTE M, 1987, P NATL ACAD SCI USA, V84, P7378, DOI 10.1073/pnas.84.21.7378; Patel G, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00048; Paterson DL, 2005, CLIN MICROBIOL REV, V18, P657, DOI 10.1128/CMR.18.4.657-686.2005; Raquet X, 1997, PROTEINS, V27, P47, DOI 10.1002/(SICI)1097-0134(199701)27:1<47::AID-PROT6>3.0.CO;2-K; Russi S, 2016, J APPL CRYSTALLOGR, V49, P622, DOI 10.1107/S1600576716000649; Smith CA, 2007, ACTA CRYSTALLOGR D, V63, P982, DOI 10.1107/S0907444907036955; Smith CA, 2012, J AM CHEM SOC, V134, P19512, DOI 10.1021/ja308197j; Smith Clyde A, 2008, JALA Charlottesv Va, V13, P335, DOI 10.1016/j.jala.2008.08.008; Soltis SM, 2008, ACTA CRYSTALLOGR D, V64, P1210, DOI 10.1107/S0907444908030564; Sougakoff W, 2002, ACTA CRYSTALLOGR D, V58, P267, DOI 10.1107/S0907444901019606; Stewart NK, 2015, BIOCHEMISTRY-US, V54, P588, DOI 10.1021/bi501052t; Swaren P, 1998, J BIOL CHEM, V273, P26714, DOI 10.1074/jbc.273.41.26714; Tondi D, 2016, CURR DRUG TARGETS, V17, P983, DOI 10.2174/1389450116666151001104448; Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766; Walther-Rasmussen J, 2007, J ANTIMICROB CHEMOTH, V60, P470, DOI 10.1093/jac/dkm226; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749	42	19	19	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22196	22206		10.1074/jbc.M116.749648	http://dx.doi.org/10.1074/jbc.M116.749648			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27590339	Green Published, hybrid			2022-12-26	WOS:000386332600031
J	Hovorakova, M; Lochovska, K; Zahradnicek, O; Tibenska, KD; Dornhoferova, M; Horakova-Smrckova, L; Bodorikova, S				Hovorakova, Maria; Lochovska, Katerina; Zahradnicek, Oldrich; Domonkosova Tibenska, Kristina; Dornhoferova, Michaela; Horakova-Smrckova, Lucie; Bodorikova, Silvia			One OdontogenicCell-Population Contributes to the Development of the Mouse Incisors and of the Oral Vestibule	PLOS ONE			English	Article							DECIDUOUS DENTITION; TOOTH DEVELOPMENT; HUMAN EMBRYOS; STEM-CELLS; EXPRESSION; SOX2; ODONTOMA; MARKER; ADULT; CRE	The area of the oral vestibule is often a place where pathologies appear (e.g., peripheral odontomas). The origin of these pathologies is not fully understood. In the present study, we traced a cell population expressing Sonic hedgehog (Shh) from the beginning of tooth development using Cre-LoxP system in the lower jaw of wild-type (WT) mice. We focused on Shh expression in the area of the early appearing rudimentaryincisor germs located anteriorly to the prospective incisors. The localization of the labelled cells in the incisor germs and also in the inner epithelial layer of the vestibular anlage showed that the first very early developmental events in the lower incisor area are common to the vestibulum oris and the prospective incisor primordia in mice. Scanning electron microscopic analysis of human historical tooth-like structures found in the vestibular area of jaws confirmedtheir relation to teeth and thus the capability of the vestibular tissue to form teeth. The location of labelled cells descendant of the early appearing Shh expression domain related to the rudimentary incisor anlage not only in the rudimentary and functional incisor germs but also in the externally located anlage of the oral vestibule documented the odontogenic potential of the vestibular epithelium. This potential can be awakened under pathological conditions and become a source of pathologies in the vestibular area.	[Hovorakova, Maria; Lochovska, Katerina; Zahradnicek, Oldrich; Horakova-Smrckova, Lucie] Acad Sci Czech Republic, Inst Expt Med, Dept Teratol, Prague 14220 4, Czech Republic; [Lochovska, Katerina] Charles Univ Prague, Fac Sci, Dept Anthropol & Human Genet, Prague, Czech Republic; [Domonkosova Tibenska, Kristina; Dornhoferova, Michaela; Bodorikova, Silvia] Comenius Univ, Fac Nat Sci, Dept Anthropol, Bratislava, Slovakia; [Horakova-Smrckova, Lucie] Charles Univ Prague, Fac Sci, Dept Cell Biol, Prague, Czech Republic	Czech Academy of Sciences; Institute of Experimental Medicine of the Czech Academy of Sciences; Charles University Prague; Comenius University Bratislava; Charles University Prague	Hovorakova, M (corresponding author), Acad Sci Czech Republic, Inst Expt Med, Dept Teratol, Prague 14220 4, Czech Republic.	marhor@biomed.cas.cz	Hovořáková, Mária/AAD-5403-2022; Lochovska, Katerina/H-3831-2018	Hovořáková, Mária/0000-0002-6346-6671; Lochovska, Katerina/0000-0003-4142-4531; Bodorikova, Silvia/0000-0001-5090-8066; Dornhoferova, Michaela/0000-0002-5058-1021	Grant Agency of the Czech Republic [P305/12/1766]; Ministry of Education, Science, Research and Sport of the Slovak Republic [VEGA 1/0442/13]	Grant Agency of the Czech Republic(Grant Agency of the Czech Republic); Ministry of Education, Science, Research and Sport of the Slovak Republic	Funded by MH: Grant Agency of the Czech Republic (P305/12/1766) and SB: Ministry of Education, Science, Research and Sport of the Slovak Republic (VEGA 1/0442/13).; The authors would like to thank Martina Gregorovicova, Ivana Koppova, Zdenka Lisa and Dr. Simona Vojtechova for their technical assistance, and to Petr Velensky for the egg of a mangrove monitor lizard. The research was supported by Grant Agency of the Czech Republic (P305/12/1766), and Ministry of Education, Science, Research and Sport of the Slovak Republic (VEGA 1/0442/13). The authors declare that they have no competing interests.	Bernardes VDF., 2008, BRAZ J ORAL SCI, V7, P1624, DOI DOI 10.20396/BJ0S.V7I26.8642760; Bolk L., 1924, DEUT MONATSSCHR ZAHN, V7, P129; Ellis P, 2004, DEV NEUROSCI-BASEL, V26, P148, DOI 10.1159/000082134; Fukumoto S, 2004, J CELL BIOL, V167, P973, DOI 10.1083/jcb.200409077; GIUNTA JL, 1990, ORAL SURG ORAL MED O, V69, P406, DOI 10.1016/0030-4220(90)90312-G; Hanemann JAC, 2013, HEAD FACE MED, V9, DOI 10.1186/1746-160X-9-15; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hattab F N, 1998, J Clin Pediatr Dent, V22, P159; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hovorakova M, 2005, ANAT EMBRYOL, V209, P303, DOI 10.1007/s00429-004-0441-y; Hovorakova M, 2007, EUR J ORAL SCI, V115, P280, DOI 10.1111/j.1600-0722.2007.00464.x; Hovorakova M, 2013, J EXP ZOOL PART B, V320, P455, DOI 10.1002/jez.b.22522; Hovorakova M, 2011, J EXP ZOOL PART B, V316B, P347, DOI 10.1002/jez.b.21408; Ide F, 2000, J PERIODONTOL, V71, P830, DOI 10.1902/jop.2000.71.5.830; Ide F, 2008, ORAL SURG ORAL MED O, V106, pE14, DOI 10.1016/j.tripleo.2008.05.064; Juuri E, 2013, EUR J ORAL SCI, V121, P509, DOI 10.1111/eos.12095; Juuri E, 2012, DEV CELL, V23, P317, DOI 10.1016/j.devcel.2012.05.012; LedesmaMontes C, 1996, INT J ORAL MAX SURG, V25, P296, DOI 10.1016/S0901-5027(06)80061-5; Peterka M, 2002, CONNECT TISSUE RES, V43, P186, DOI 10.1080/03008200290000673; PETERKOVA R, 1985, J CRAN GENET DEV BIO, V5, P89; ROSE C, 1895, OSTERREICHISCH UNGAR, V2, P45; Schour I, 1929, J DENT RES, V9, P699, DOI [10.1177/00220345290090050801, DOI 10.1177/00220345290090050801]; Silva ARS, 2009, MED ORAL PATOL ORAL, V14, pE612, DOI 10.4317/medoral.14.e612; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tonkova M., 2010, ANTROPOLOGICKA ANALY; Tucker AS, 2010, FRONT ORAL BIOL, V14, P21, DOI 10.1159/000313705; Zhang L, 2012, GENE EXPR PATTERNS, V12, P273, DOI 10.1016/j.gep.2012.07.001	27	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162523	10.1371/journal.pone.0162523	http://dx.doi.org/10.1371/journal.pone.0162523			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611193	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900122
J	Mayadevi, M; Lakshmi, K; Priya, SDS; John, S; Omkumar, RV				Mayadevi, Madhavan; Lakshmi, Kesavan; Priya, Sudarsana Devi Suma; John, Sebastian; Omkumar, Ramakrishnapillai V.			Protection of alpha-CaMKII from Dephosphorylation by GluN2B Subunit of NMDA Receptor Is Abolished by Mutation of Glu(96) or His(282) of alpha-CaMKII	PLOS ONE			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; D-ASPARTATE RECEPTOR; POSTSYNAPTIC DENSITY; AUTOINHIBITORY DOMAIN; SYNAPTIC PLASTICITY; INHIBITOR-ALPHA; MEMORY SWITCH; NR2B SUBUNIT; FEAR MEMORY	Interaction of CaMKII and the GluN2B subunit of NMDA receptor is essential for synaptic plasticity events such as LTP. Synaptic targeting of CaMKII and regulation of its biochemical functions result from this interaction. GluN2B binding to the T-site of CaMKII leads to changes in substrate binding and catalytic parameters and inhibition of its own dephosphorylation. We find that CaMKIIN alpha, a natural inhibitor that binds to the T-site of CaMKII, also causes inhibition of dephosphorylation of CaMKII similar to GluN2B. Two residues on alpha-CaMKII, Glu(96) and His(282), are involved in the inhibition of CaMKII dephosphorylation exerted by binding of GluN2B. E96A-alpha-CaMKII is known to be defective in GluN2B-induced catalytic modulation. Data presented here show that, in both E96A and H282A mutants of alpha-CaMKII, GluN2B-induced inhibition of dephosphorylation is impaired.	[Mayadevi, Madhavan; Lakshmi, Kesavan; Priya, Sudarsana Devi Suma; John, Sebastian; Omkumar, Ramakrishnapillai V.] Rajiv Gandhi Ctr Biotechnol, Mol Neurobiol Div, Thiruvananthapuram 695014, Kerala, India; [Priya, Sudarsana Devi Suma] Yale Univ, Sch Med, Dept Pharmacol, New Haven, CT 06510 USA	Department of Biotechnology (DBT) India; Rajiv Gandhi Centre for Biotechnology (RGCB); Yale University	Omkumar, RV (corresponding author), Rajiv Gandhi Ctr Biotechnol, Mol Neurobiol Div, Thiruvananthapuram 695014, Kerala, India.	omkumar@rgcb.res.in		John, Sebastian/0000-0002-4488-1300	Council of Scientific and Industrial research, Government of India [18-12/2011(ii)EU-V]; UGC Award [F.2-56/2002/(II)EU-II]; Rajiv Gandhi Centre for Biotechnology, Intramural Funding; University Grants Commission, Government of India	Council of Scientific and Industrial research, Government of India(Council of Scientific & Industrial Research (CSIR) - India); UGC Award; Rajiv Gandhi Centre for Biotechnology, Intramural Funding; University Grants Commission, Government of India(University Grants Commission, India)	This work was supported by Council of Scientific and Industrial research, Government of India (http://www.csir.res.in/), Ref. No: 18-12/2011(ii)EU-V, KL; University Grants Commission, Government of India (http://www.ugc.ac.in/), UGC Award Letter No. F.2-56/2002/(II)EU-II, SDSP; and Rajiv Gandhi Centre for Biotechnology (www.rgcb.res.in), Intramural Funding, RVO, MM, SJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barcomb K, 2016, J BIOL CHEM, V291, P16082, DOI 10.1074/jbc.M116.734822; Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034; Bayer KU, 2006, J NEUROSCI, V26, P1164, DOI 10.1523/JNEUROSCI.3116-05.2006; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bradshaw JM, 2003, P NATL ACAD SCI USA, V100, P10512, DOI 10.1073/pnas.1932759100; BRICKEY DA, 1994, J BIOL CHEM, V269, P29047; Chang BH, 1998, P NATL ACAD SCI USA, V95, P10890, DOI 10.1073/pnas.95.18.10890; Chao LH, 2010, NAT STRUCT MOL BIOL, V17, P264, DOI 10.1038/nsmb.1751; Cheriyan J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016495; Coultrap SJ, 2014, CELL REP, V6, P431, DOI 10.1016/j.celrep.2014.01.005; DOSEMECI A, 1993, J NEUROCHEM, V61, P550; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; Gouet C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049293; Gustin RM, 2011, MOL CELL NEUROSCI, V47, P286, DOI 10.1016/j.mcn.2011.05.006; Halt AR, 2012, EMBO J, V31, P1203, DOI 10.1038/emboj.2011.482; Hudmon A, 2002, ANNU REV BIOCHEM, V71, P473, DOI 10.1146/annurev.biochem.71.110601.135410; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Leonard AS, 1999, P NATL ACAD SCI USA, V96, P3239, DOI 10.1073/pnas.96.6.3239; Lepicard EM, 2006, EUR J NEUROSCI, V23, P3063, DOI 10.1111/j.1460-9568.2006.04830.x; LISMAN JE, 1985, P NATL ACAD SCI USA, V82, P3055, DOI 10.1073/pnas.82.9.3055; Lisman JE, 2001, NEURON, V31, P191, DOI 10.1016/S0896-6273(01)00364-6; Lisman J, 2015, BRAIN RES, V1621, P51, DOI 10.1016/j.brainres.2014.12.010; Lisman J, 2012, NAT REV NEUROSCI, V13, P169, DOI 10.1038/nrn3192; Lucchesi W, 2011, BRAIN RES BULL, V85, P2, DOI 10.1016/j.brainresbull.2010.10.009; MALINOW R, 1989, SCIENCE, V245, P862, DOI 10.1126/science.2549638; Miller P, 2005, PLOS BIOL, V3, P705, DOI 10.1371/journal.pbio.0030107; MILLER SG, 1986, CELL, V44, P861, DOI 10.1016/0092-8674(86)90008-5; Mullasseril P, 2007, J NEUROCHEM, V103, P357, DOI 10.1111/j.1471-4159.2007.04744.x; O'Leary H, 2011, J BIOL CHEM, V286, P31272, DOI 10.1074/jbc.M111.233668; Otmakhov N, 1997, J NEUROSCI, V17, P5357; Pradeep KK, 2009, BIOCHEM J, V419, P123, DOI 10.1042/BJ20081707; Praseeda M, 2004, BIOCHEM J, V378, P391, DOI 10.1042/BJ20030741; Radwanska K, 2010, GENES BRAIN BEHAV, V9, P648, DOI 10.1111/j.1601-183X.2010.00595.x; Raveendran R, 2009, J NEUROCHEM, V110, P92, DOI 10.1111/j.1471-4159.2009.06108.x; Rellos P, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000426; Rosenberg OS, 2005, CELL, V123, P849, DOI 10.1016/j.cell.2005.10.029; Saha S, 2007, BRAIN RES, V1148, P38, DOI 10.1016/j.brainres.2007.02.018; Saha S, 2006, BIOCHEM BIOPH RES CO, V350, P444, DOI 10.1016/j.bbrc.2006.09.066; Sanhueza M, 2007, J NEUROSCI, V27, P5190, DOI 10.1523/JNEUROSCI.5049-06.2007; Sanhueza M, 2013, MOL BRAIN, V6, DOI 10.1186/1756-6606-6-10; Sanhueza M, 2011, J NEUROSCI, V31, P9170, DOI 10.1523/JNEUROSCI.1250-11.2011; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; SHIELDS SM, 1985, J NEUROSCI, V5, P3414; SILVA AJ, 1992, SCIENCE, V257, P201, DOI 10.1126/science.1378648; SMITH MK, 1992, J BIOL CHEM, V267, P1761; SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7; Strack S, 1997, J NEUROCHEM, V68, P2119; Strack S, 1998, J BIOL CHEM, V273, P20689, DOI 10.1074/jbc.273.33.20689; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Urakubo H, 2014, BIOPHYS J, V106, P1414, DOI 10.1016/j.bpj.2014.01.026; Vest RS, 2007, MOL BIOL CELL, V18, P5024, DOI 10.1091/mbc.E07-02-0185; Zhou Y, 2007, J NEUROSCI, V27, P13843, DOI 10.1523/JNEUROSCI.4486-07.2007	52	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162011	10.1371/journal.pone.0162011	http://dx.doi.org/10.1371/journal.pone.0162011			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610621	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900042
J	Yan, F; Pang, JX; Peng, Y; Molina, JR; Yang, P; Liu, SJ				Yan, Fei; Pang, Jiuxia; Peng, Yong; Molina, Julian R.; Yang, Ping; Liu, Shujun			Elevated Cellular PD1/PD-L1 Expression Confers Acquired Resistance to Cisplatin in Small Cell Lung Cancer Cells	PLOS ONE			English	Article							TUMOR IMMUNE MICROENVIRONMENT; 2ND-LINE THERAPY; PD-1; ACTIVATION; MECHANISM; P53; EPIDEMIOLOGY; CHEMOTHERAPY; CHECKPOINTS; TOPOTECAN	Although small cell lung cancer (SCLC) is highly responsive to chemotherapies (e.g., cisplatin-etoposide doublet), virtually almost all responsive SCLC patients experience disease recurrence characterized by drug resistance. The mechanisms underlying cisplatin resistance remain elusive. Here we report that cell-intrinsic expression of PD1 and PD-L1, two immune checkpoints, is required for sustained expansion of SCLC cells under cisplatin selection. Indeed, PD1 and PD-L1 were expressed at a higher level in lung cancer cell lines, tumor tissues, and importantly, in SCLC cells resistant to cisplatin (H69R, H82R), when compared to respective controls. Genetic abrogation of PD1 and PD-L1 in H69R and H82R cells decreased their proliferation rate, and restored their sensitivity to cisplatin. Mechanistically, PD-L1 upregulation in H69R and H82R cells was attributed to the overexpression of DNA methyltransferase 1 (DNMT1) or receptor tyrosine kinase KIT, as knockdown of DNMT1 or KIT in H69R and H82R cells led to PD-L1 downregulation. Consequently, combined knockdown of PD-L1 with KIT or DNMT1 resulted in more pronounced inhibition of H69R and H82R cell growth. Thus, cell intrinsic PD1/PD-L1 signaling may be a predictor for poor efficacy of cisplatin treatment, and targeting the cellular PD1/PD-L1 axis may improve chemosensitization of aggressive SCLC.	[Yan, Fei; Pang, Jiuxia; Liu, Shujun] Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA; [Peng, Yong] Sichuan Univ, West China Hosp, Collaborat Innovat Ctr Biotherapy, Dept Thorac Surg,State Key Lab Biotherapy, Chengdu 610041, Peoples R China; [Molina, Julian R.] Mayo Clin, Dept Med Oncol, 200 1st St SW, Rochester, MN 55905 USA; [Yang, Ping] Mayo Clin, Div Epidemiol, 200 1st St SW, Rochester, MN 55905 USA	University of Minnesota System; Sichuan University; Mayo Clinic; Mayo Clinic	Liu, SJ (corresponding author), Univ Minnesota, Hormel Inst, 801 16th Ave NE, Austin, MN 55912 USA.	sliu@hi.umn.edu	Yan, Fei/G-4941-2016	Yan, Fei/0000-0003-4750-1200	National Cancer Institute (Bethesda, MD) [R01CA149623, R21CA155915]; Hormel Institute Foundation [4592336]	National Cancer Institute (Bethesda, MD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Hormel Institute Foundation	This work was supported in part by National Cancer Institute (Bethesda, MD) grants R01CA149623 (SL), R21CA155915 (SL) and Hormel Institute Foundation 4592336 (SL). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basu A, 2010, J NUCLEIC ACIDS, V2010, DOI 10.4061/2010/201367; Bauer JA, 2005, MOL CANCER THER, V4, P1096, DOI 10.1158/1535-7163.MCT-05-0081; Biswas SK, 2004, MOL CANCER THER, V3, P327; Bragado P, 2007, APOPTOSIS, V12, P1733, DOI 10.1007/s10495-007-0082-8; Chan BA, 2013, J THORAC DIS, V5, pS565, DOI 10.3978/j.issn.2072-1439.2013.07.43; Crivellari G, 2007, ONCOLOGIST, V12, P79, DOI 10.1634/theoncologist.12-1-79; D'Incecco A, 2015, BRIT J CANCER, V112, P95, DOI 10.1038/bjc.2014.555; Dong HD, 2002, NAT MED, V8, P793, DOI 10.1038/nm730; Eckardt JR, 2007, J CLIN ONCOL, V25, P2086, DOI 10.1200/JCO.2006.08.3998; Galluzzi L, 2012, ONCOGENE, V31, P1869, DOI 10.1038/onc.2011.384; Gao XN, 2015, LEUKEMIA, V29, P1730, DOI 10.1038/leu.2015.56; Giaccone G, 1998, J CLIN ONCOL, V16, P2133, DOI 10.1200/JCO.1998.16.6.2133; Govindan R, 2006, J CLIN ONCOL, V24, P4539, DOI 10.1200/JCO.2005.04.4859; Hagmann R, 2015, J CANCER, V6, P1148, DOI 10.7150/jca.13080; He JB, 2015, SCI REP-UK, V5, DOI 10.1038/srep13110; Herbst RS, 2014, NATURE, V515, P563, DOI 10.1038/nature14011; Itamochi H, 2014, INT J GYNECOL CANCER, V24, P61, DOI 10.1097/IGC.0000000000000014; Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167; Kleffel S, 2015, CELL, V162, P1242, DOI 10.1016/j.cell.2015.08.052; Knoechel B, 2014, NAT GENET, V46, P364, DOI 10.1038/ng.2913; Konishi J, 2004, CLIN CANCER RES, V10, P5094, DOI 10.1158/1078-0432.CCR-04-0428; Li W, 2012, ONCOGENE, V31, P2412, DOI 10.1038/onc.2011.426; Liu LZ, 2007, CANCER RES, V67, P6325, DOI 10.1158/0008-5472.CAN-06-4261; Marzec M, 2008, P NATL ACAD SCI USA, V105, P20852, DOI 10.1073/pnas.0810958105; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Mu CY, 2011, MED ONCOL, V28, P682, DOI 10.1007/s12032-010-9515-2; O'Byrne Kenneth J, 2011, Cancers (Basel), V3, P1426, DOI 10.3390/cancers3011426; Pabla N, 2008, J BIOL CHEM, V283, P6572, DOI 10.1074/jbc.M707568200; Pardoll DM, 2012, NAT REV CANCER, V12, P252, DOI 10.1038/nrc3239; Pietanza MC, 2016, J CLIN ONCOL, V34, P1027, DOI 10.1200/JCO.2015.65.6462; Puglisi M, 2010, BRIT J CANCER, V102, P629, DOI 10.1038/sj.bjc.6605527; Rizvi NA, 2015, SCIENCE, V348, P124, DOI 10.1126/science.aaa1348; Santarpia M, 2015, CANCER BIOL MED, V12, P74, DOI 10.7497/j.issn.2095-3941.2015.0022; Sharma SV, 2010, CELL, V141, P69, DOI 10.1016/j.cell.2010.02.027; Shen DW, 2012, PHARMACOL REV, V64, P706, DOI 10.1124/pr.111.005637; Shen N, 2014, ONCOTARGET, V5, P5494, DOI 10.18632/oncotarget.2131; Tang CH, 2011, CANCER CHEMOTH PHARM, V67, P1389, DOI 10.1007/s00280-010-1435-5; Topalian SL, 2012, CURR OPIN IMMUNOL, V24, P207, DOI 10.1016/j.coi.2011.12.009; Voron T, 2015, J EXP MED, V212, P139, DOI 10.1084/jem.20140559; Wang M, 2013, J CHEMOTHERAPY, V25, P162, DOI 10.1179/1973947812Y.0000000056; Wohlkoenig C, 2011, CANCER LETT, V308, P134, DOI 10.1016/j.canlet.2011.03.014; Wu W, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-49; Yan F, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.380; Yan F, 2015, J BIOL CHEM, V290, P18480, DOI 10.1074/jbc.M114.633693; Yu W, 2012, J NANOMATER, V2012, DOI 10.1155/2012/435873; Zeller C, 2012, ONCOGENE, V31, P4567, DOI 10.1038/onc.2011.611	46	24	29	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162925	10.1371/journal.pone.0162925	http://dx.doi.org/10.1371/journal.pone.0162925			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610620	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900185
J	Inostroza, L; Palme, M; de la Barrera, F				Inostroza, Luis; Palme, Massimo; de la Barrera, Francisco			A Heat Vulnerability Index: Spatial Patterns of Exposure, Sensitivity and Adaptive Capacity for Santiago de Chile	PLOS ONE			English	Article							SOCIAL VULNERABILITY; METROPOLITAN REGION; AIR-POLLUTION; URBAN; ISLAND; TEMPERATURE; CLIMATE; SURFACE; INDICATORS; SUSTAINABILITY	Climate change will worsen the high levels of urban vulnerability in Latin American cities due to specific environmental stressors. Some impacts of climate change, such as high temperatures in urban environments, have not yet been addressed through adaptation strategies, which are based on poorly supported data. These impacts remain outside the scope of urban planning. New spatially explicit approaches that identify highly vulnerable urban areas and include specific adaptation requirements are needed in current urban planning practices to cope with heat hazards. In this paper, a heat vulnerability index is proposed for Santiago, Chile. The index was created using a GIS-based spatial information system and was constructed from spatially explicit indexes for exposure, sensitivity and adaptive capacity levels derived from remote sensing data and socio-economic information assessed via principal component analysis (PCA). The objective of this study is to determine the levels of heat vulnerability at local scales by providing insights into these indexes at the intra city scale. The results reveal a spatial pattern of heat vulnerability with strong variations among individual spatial indexes. While exposure and adaptive capacities depict a clear spatial pattern, sensitivity follows a complex spatial distribution. These conditions change when examining PCA results, showing that sensitivity is more robust than exposure and adaptive capacity. These indexes can be used both for urban planning purposes and for proposing specific policies and measures that can help minimize heat hazards in highly dynamic urban areas. The proposed methodology can be applied to other Latin American cities to support policy making.	[Inostroza, Luis] Tech Univ Dresden, Inst Photogrammetry & Remote Sensing, D-01062 Dresden, Germany; [Inostroza, Luis] Univ Autonoma Chile, Temuco, Chile; [Palme, Massimo] Univ Catolica Norte, Escuela Arquitectura, Angamos 610, Antofagasta, Chile; [Palme, Massimo] Inst Nacl Eficiencia Energet & Energia Renovable, Inaquito & Serrano, Quito, Ecuador; [de la Barrera, Francisco] Pontificia Univ Catolica Chile, Inst Geog, Vicuna Mackenna 4860, Macul, Santiago De Chi, Chile; [de la Barrera, Francisco] Pontificia Univ Catolica Chile, Ctr Desarrollo Urbano Sustentable, Vicuna Mackenna 4860, Macul, Santiago De Chi, Chile	Technische Universitat Dresden; Universidad Autonoma de Chile; Universidad Catolica del Norte; Pontificia Universidad Catolica de Chile; Pontificia Universidad Catolica de Chile	Inostroza, L (corresponding author), Tech Univ Dresden, Inst Photogrammetry & Remote Sensing, D-01062 Dresden, Germany.; Inostroza, L (corresponding author), Univ Autonoma Chile, Temuco, Chile.	inostroza@technotope.org	Palme, Massimo/H-5322-2011; Inostroza, Luis/N-1524-2014	Palme, Massimo/0000-0003-1166-2926; Inostroza, Luis/0000-0002-6303-4529; de la Barrera, Francisco/0000-0002-6854-3197	Lincoln Institute [ULI091112]; Fondecyt [111458, 3150403]; CONICYT-FONDECYT [3150403]	Lincoln Institute; Fondecyt(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT); CONICYT-FONDECYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)CONICYT FONDECYT)	LI was recipient of the Lincoln Institute research project: ULI091112 to develop the methodology of this research. MS counted with the financial support of the Fondecyt Projects 111458 and 3150403. FB counted with the financial support of the CONICYT-FONDECYT 3150403 project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharya, 2011, VULNERABILITY ADAPTA; Adger WN, 2003, ECON GEOGR, V79, P387; Angel S., 2005, DYNAMICS GLOBAL URBA; ANIELLO C, 1995, COMPUT GEOSCI-UK, V21, P965, DOI 10.1016/0098-3004(95)00033-5; [Anonymous], 1992, FUNDAMENTALS REMOTE; [Anonymous], 2009, RES MONOGR; ANSELIN L, 1995, GEOGR ANAL, V27, P93, DOI 10.1111/j.1538-4632.1995.tb00338.x; Arnfield AJ, 2003, INT J CLIMATOL, V23, P1, DOI 10.1002/joc.859; Baklanov A, 2016, ATMOS ENVIRON, V126, P235, DOI 10.1016/j.atmosenv.2015.11.059; Banzhaf E, 2014, ECOL INDIC, V45, P664, DOI 10.1016/j.ecolind.2014.06.002; Bao JZ, 2015, INT J ENV RES PUB HE, V12, P7220, DOI 10.3390/ijerph120707220; Basu R, 2002, EPIDEMIOL REV, V24, P190, DOI 10.1093/epirev/mxf007; Blakely EJ, 2007, LINCOLN I LAND POLIC, P1; Brain L, 1987, LANDSAT MSS TM POSTC; Bulkeley H, 2013, LOCAL ENVIRON, V18, P646, DOI 10.1080/13549839.2013.788479; Chow WTL, 2012, B AM METEOROL SOC, V93, P517, DOI 10.1175/BAMS-D-11-00011.1; Cutter SL, 2003, SOC SCI QUART, V84, P242, DOI 10.1111/1540-6237.8402002; de la Barrera F, 2016, ECOL INDIC, V62, P212, DOI 10.1016/j.ecolind.2015.10.027; Dong WH, 2014, SUSTAINABILITY-BASEL, V6, P7334, DOI 10.3390/su6107334; Folberth GA, 2015, ENVIRON POLLUT, V203, P235, DOI 10.1016/j.envpol.2014.09.004; Gorsuch R., 1983, FACTOR ANAL; Hoppe P, 1999, INT J BIOMETEOROL, V43, P71, DOI 10.1007/s004840050118; Icaza LE, 2016, SUSTAINABILITY-BASEL, V8, DOI 10.3390/su8040320; Inostroza L, REGIONAL ENV CHANGE, P1; Inostroza L., 2014, MEASURING CLIMATE CH; Inostroza L, 2014, J LAND USE MOBI 0518; Inostroza L., 2016, LANDSCAPE U IN PRESS, DOI 10.1016/j.landurbplan.2016.03.021; Inostroza L, 2016, CAMBIO CLIMATICO LEC, P391; Inostroza L, 2013, J ENVIRON MANAGE, V115, P87, DOI 10.1016/j.jenvman.2012.11.007; Instituto Nacional de Estadistica (INE Chile), 2012, CENS POBL VIV 2012; IPCC, 2012, MANAGING RISKS EXTRE; Johnson DP, 2009, INT J HEALTH GEOGR, V8, DOI 10.1186/1476-072X-8-57; Kosatsky Tom, 2005, Euro Surveill, V10, P148; Krellenberg K, 2013, APPL GEOGR, V38, P86, DOI 10.1016/j.apgeog.2012.11.017; Lindley S., 2011, CLIMATE CHANGE JUSTI; Matthews T., 2011, CLIMATE CHANGE ADAPT; McGeehin MA, 2001, ENVIRON HEALTH PERSP, V109, P185, DOI 10.2307/3435008; Palme M, 2014, SUSTAINABILITY-BASEL, V6, P3321, DOI 10.3390/su6063321; Palme M, 2013, SUSTAINABILITY-BASEL, V5, P2840, DOI 10.3390/su5072840; Pena MA, 2008, INT J REMOTE SENS, V29, P4385, DOI 10.1080/01431160801908137; Prihodko L, 1997, REMOTE SENS ENVIRON, V60, P335, DOI 10.1016/S0034-4257(96)00216-7; Revich B. A., 2011, KOLOGIYA CHELOVEKA, P3; Rizwan AM, 2008, J ENVIRON SCI, V20, P120, DOI 10.1016/S1001-0742(08)60019-4; Robine JM, 2008, CR BIOL, V331, P171, DOI 10.1016/j.crvi.2007.12.001; Romero H, 1999, ATMOS ENVIRON, V33, P4039, DOI 10.1016/S1352-2310(99)00145-4; Romero Hugo, 2010, Revista INVI, V25, P151; Romero-Lankao P, 2013, SOC SCI MED, V83, P110, DOI 10.1016/j.socscimed.2013.01.009; Sabatini F, 2009, URBAN SEGREGATION AND GOVERNANCE IN THE AMERICAS, P121; Espinoza PS, 2014, REV GEOGR NORTE GD, P123; Schmidtlein MC, 2008, RISK ANAL, V28, P1099, DOI 10.1111/j.1539-6924.2008.01072.x; Schwarz N, 2012, ECOL INDIC, V18, P693, DOI 10.1016/j.ecolind.2012.01.001; Stafoggia M, 2006, EPIDEMIOLOGY, P17; Sun QQ, 2010, ENVIRON EARTH SCI, V59, P1047, DOI 10.1007/s12665-009-0096-3; Thurstone LL, 1947, MULTIPLE FACTOR ANAL; Tibbetts J, 2002, ENVIRON HEALTH PERSP, V110, pA674, DOI 10.1289/ehp.110-a674; Tomlinson CJ, 2011, INT J HEALTH GEOGR, V10, DOI 10.1186/1476-072X-10-42; Turner BL, 2003, P NATL ACAD SCI USA, V100, P8074, DOI 10.1073/pnas.1231335100; Welz J, 2016, EURE, V42, P251, DOI 10.4067/S0250-71612016000100011; Wilhelmi O.V., 2004, NAT HAZARDS REV, V5, P147, DOI [10.1061/(ASCE)1527-6988(2004)5:3(147)., DOI 10.1061/(ASCE)1527-6988(2004)5:3(147)]; Wilhelmi OV, 2010, ENVIRON RES LETT, V5, DOI 10.1088/1748-9326/5/1/014021; Wolf J, 2010, GLOBAL ENVIRON CHANG, V20, P44, DOI 10.1016/j.gloenvcha.2009.09.004; Wolf T, 2013, WEATHER CLIM EXTREME, V1, P59, DOI 10.1016/j.wace.2013.07.004; Wong NH, 2005, HABITAT INT, V29, P547, DOI 10.1016/j.habitatint.2004.04.008; Xiao R, 2008, PHOTOGRAMMETRIC ENG, P74; Yuan F, 2007, REMOTE SENS ENVIRON, V106, P375, DOI 10.1016/j.rse.2006.09.003	65	83	90	8	71	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162464	10.1371/journal.pone.0162464	http://dx.doi.org/10.1371/journal.pone.0162464			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27606592	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255600047
J	Ohbuchi, K; Mori, Y; Ogawa, K; Warabi, E; Yamamoto, M; Hirokawa, T				Ohbuchi, Katsuya; Mori, Yoshikazu; Ogawa, Kazuo; Warabi, Eiji; Yamamoto, Masahiro; Hirokawa, Takatsugu			Detailed Analysis of the Binding Mode of Vanilloids to Transient Receptor Potential Vanilloid Type I (TRPV1) by a Mutational and Computational Study	PLOS ONE			English	Article							ION-CHANNEL; CAPSAICIN RECEPTOR; MOLECULAR-BASIS; ACTIVATION; RESINIFERATOXIN; SENSITIVITY; MECHANISMS; RESIDUES; INSIGHTS	Transient receptor potential vanilloid type 1 (TRPV1) is a non-selective cation channel and a multimodal sensor protein. Since the precise structure of TRPV1 was obtained by electron cryo-microscopy, the binding mode of representative agonists such as capsaicin and resiniferatoxin (RTX) has been extensively characterized; however, detailed information on the binding mode of other vanilloids remains lacking. In this study, mutational analysis of human TRPV1 was performed, and four agonists (capsaicin, RTX, [6]-shogaol and [6]-gingerol) were used to identify amino acid residues involved in ligand binding and/or modulation of proton sensitivity. The detailed binding mode of each ligand was then simulated by computational analysis. As a result, three amino acids (L518, F591 and L670) were newly identified as being involved in ligand binding and/or modulation of proton sensitivity. In addition, in silico docking simulation and a subsequent mutational study suggested that [6]-gingerol might bind to and activate TRPV1 in a unique manner. These results provide novel insights into the binding mode of various vanilloids to the channel and will be helpful in developing a TRPV1 modulator.	[Ohbuchi, Katsuya; Ogawa, Kazuo; Yamamoto, Masahiro] Tsumura & Co, Tsumura Res Labs, Ibaraki, Japan; [Mori, Yoshikazu] Tsumura & Co, Analyt & Pharmaceut Technol Res Ctr, Ibaraki, Japan; [Warabi, Eiji] Univ Tsukuba, Environm Mol Biol Lab, Fac Med, Tsukuba, Ibaraki 305, Japan; [Hirokawa, Takatsugu] AIST, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo, Japan; [Hirokawa, Takatsugu] Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki 305, Japan	Tsumura & Company; Tsumura & Company; University of Tsukuba; National Institute of Advanced Industrial Science & Technology (AIST); University of Tsukuba	Ohbuchi, K (corresponding author), Tsumura & Co, Tsumura Res Labs, Ibaraki, Japan.; Hirokawa, T (corresponding author), AIST, Mol Profiling Res Ctr Drug Discovery, Koto Ku, Tokyo, Japan.; Hirokawa, T (corresponding author), Univ Tsukuba, Div Biomed Sci, Fac Med, Tsukuba, Ibaraki 305, Japan.	oobuchi_katsuya@mail.tsumura.co.jp; t-hirokawa@aist.go.jp		Ohbuchi, Katsuya/0000-0001-6756-3260	Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and development (AMED); Tsumura Co.	Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Agency for Medical Research and development (AMED)(Japan Agency for Medical Research and Development (AMED)); Tsumura Co.(Tsumura & Company)	This research was partially supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and development (AMED). Tsumura & Co., provided support in the form of salaries for authors KOhbuchi, YM, KOgawa and MY. The specific roles of these authors are articulated in the 'author contributions' section. This study was funded by Tsumura & Co. Tsumura & Co. was responsible for the study design, and the collection, analysis and interpretation of data.; This research is partially supported by the Platform Project for Supporting in Drug Discovery and Life Science Research (Platform for Drug Discovery, Informatics and Structural Life Science) from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) and Japan Agency for Medical Research and development (AMED).	Aneiros E, 2011, EMBO J, V30, P994, DOI 10.1038/emboj.2011.19; Anjana R, 2012, BIOINFORMATION, V8, P1220, DOI 10.6026/97320630081220; Bishnoi M, 2011, CURR PHARM BIOTECHNO, V12, P102, DOI 10.2174/138920111793937907; Boukalova S, 2010, J BIOL CHEM, V285, P41455, DOI 10.1074/jbc.M110.145466; Cao EH, 2013, NATURE, V504, P113, DOI 10.1038/nature12823; Caterina MJ, 1997, NATURE, V389, P816, DOI 10.1038/39807; Chou MZ, 2004, BIOCHEMISTRY-US, V43, P2501, DOI 10.1021/bi035981h; Elokely K, 2016, P NATL ACAD SCI USA, V113, pE137, DOI 10.1073/pnas.1517288113; Fernandes ES, 2012, BRIT J PHARMACOL, V166, P510, DOI 10.1111/j.1476-5381.2012.01851.x; Gao Y, 2016, NATURE, V534, P347, DOI 10.1038/nature17964; Garami A, 2010, J NEUROSCI, V30, P1435, DOI 10.1523/JNEUROSCI.5150-09.2010; Gavva NR, 2004, J BIOL CHEM, V279, P20283, DOI 10.1074/jbc.M312577200; Johnson DM, 2006, MOL PHARMACOL, V70, P1005, DOI 10.1124/mol.106.023945; Jordt SE, 2002, CELL, V108, P421, DOI 10.1016/S0092-8674(02)00637-2; Lee JH, 2011, J COMPUT AID MOL DES, V25, P317, DOI 10.1007/s10822-011-9421-5; Liao MF, 2013, NATURE, V504, P107, DOI 10.1038/nature12822; Meents JE, 2010, TRENDS MOL MED, V16, P153, DOI 10.1016/j.molmed.2010.02.004; Morita A, 2007, BIOSCI BIOTECH BIOCH, V71, P2304, DOI 10.1271/bbb.70187; Salazar H, 2008, NAT NEUROSCI, V11, P255, DOI 10.1038/nn2056; Szallasi A, 2007, NAT REV DRUG DISCOV, V6, P357, DOI 10.1038/nrd2280; Szolcsanyi J, 2012, TRENDS PHARMACOL SCI, V33, P646, DOI 10.1016/j.tips.2012.09.002; Vriens J, 2009, MOL PHARMACOL, V75, P1262, DOI 10.1124/mol.109.055624; Winter Z, 2013, MOL PAIN, V9, DOI 10.1186/1744-8069-9-30; Yang F, 2015, NAT CHEM BIOL, V12, P1, DOI DOI 10.1038/NCHEMBI0.1835	24	19	20	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162543	10.1371/journal.pone.0162543	http://dx.doi.org/10.1371/journal.pone.0162543			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606946	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255600062
J	Yashima, K; Sasaki, A				Yashima, Kenta; Sasaki, Akira			Spotting Epidemic Keystones by R-0 Sensitivity Analysis: High-Risk Stations in the Tokyo Metropolitan Area	PLOS ONE			English	Article							PANDEMIC INFLUENZA; IMMUNIZATION; STRATEGIES; NETWORKS; SPREAD; POPULATIONS; OUTBREAKS; MOVEMENT; MODEL	How can we identify the epidemiologically high-risk communities in a metapopulation network? The network centrality measure, which quantifies the relative importance of each location, is commonly utilized for this purpose. As the disease invasion condition is given from the basic reproductive ratio R-0, we have introduced a novel centrality measure based on the sensitivity analysis of this R-0 and shown its capability of revealing the characteristics that has been overlooked by the conventional centrality measures. The epidemic dynamics over the commute network of the Tokyo metropolitan area is theoretically analyzed by using this centrality measure. We found that, the impact of countermeasures at the largest station is more than 1,000 times stronger compare to that at the second largest station, even though the population sizes are only around 1.5 times larger. Furthermore, the effect of countermeasures at every station is strongly dependent on the existence and the number of commuters to this largest station. It is well known that the hubs are the most influential nodes, however, our analysis shows that only the largest among the network plays an extraordinary role. Lastly, we also found that, the location that is important for the prevention of disease invasion does not necessarily match the location that is important for reducing the number of infected.	[Yashima, Kenta; Sasaki, Akira] Grad Univ Adv Studies SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan; [Yashima, Kenta] Meiji Univ, Meiji Inst Adv Study Math Sci, Nakano Ku, Tokyo, Japan; [Sasaki, Akira] Int Inst Appl Syst Anal, Evolut & Ecol Program, Laxenburg, Austria	Graduate University for Advanced Studies - Japan; International Institute for Applied Systems Analysis (IIASA)	Yashima, K (corresponding author), Grad Univ Adv Studies SOKENDAI, Dept Evolutionary Studies Biosyst, Hayama, Kanagawa, Japan.; Yashima, K (corresponding author), Meiji Univ, Meiji Inst Adv Study Math Sci, Nakano Ku, Tokyo, Japan.	yashima_kenta@soken.ac.jp			MEXT [24115001]	MEXT(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This study was funded by the MEXT Grant-in-Aid for Scientific Research on Innovative Areas 24115001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSON R M, 1991; [Anonymous], 2007, 10 URBAN TRANSPORTAT; Balcan D, 2012, J THEOR BIOL, V293, P87, DOI 10.1016/j.jtbi.2011.10.010; Balcan D, 2011, NAT PHYS, V7, P581, DOI 10.1038/NPHYS1944; Belik V, 2011, PHYS REV X, V1, DOI 10.1103/PhysRevX.1.011001; Britton N, 2005, SPRINGER UNDERGRADUA; Caswell, 2000, MATRIX POPULATION MO; Chowell G, 2003, PHYS REV E, V68, DOI 10.1103/PhysRevE.68.066102; Cohen R, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.247901; Colizza V, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.148701; Colizza V, 2008, J THEOR BIOL, V251, P450, DOI 10.1016/j.jtbi.2007.11.028; Cooley P, 2011, J URBAN HEALTH, V88, P982, DOI 10.1007/s11524-011-9603-4; Cui FQ, 2011, J EPIDEMIOL, V21, P271, DOI 10.2188/jea.JE20100119; Daley DJ, 1999, EPIDEMIC MODELING; DIEKMANN O, 1990, J MATH BIOL, V28, P365; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; ELLNER S. P., 2011, DYNAMIC MODELS BIOL; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; Holme Petter, 2002, Phys Rev E Stat Nonlin Soft Matter Phys, V65, P066109; Keeling MJ, 2010, P NATL ACAD SCI USA, V107, P8866, DOI 10.1073/pnas.1000416107; Keeling MJ., 2007, MODELING INFECT DIS, VIllustrated edition; Kitsak M, 2010, NAT PHYS, V6, P888, DOI [10.1038/nphys1746, 10.1038/NPHYS1746]; Klemm K, 2012, SCI REP-UK, V2, DOI 10.1038/srep00292; Kuramitsu M, 2005, EPIDEMIOL INFECT, V133, P1131, DOI 10.1017/S0950268805004139; Lloyd AL, 2001, SCIENCE, V292, P1316, DOI 10.1126/science.1061076; Longini IM, 2004, AM J EPIDEMIOL, V159, P623, DOI 10.1093/aje/kwh092; Longini IM, 2005, SCIENCE, V309, P1083, DOI 10.1126/science.1115717; Madar N, 2004, EUR PHYS J B, V38, P269, DOI 10.1140/epjb/e2004-00119-8; Matthews JE, 2012, EPIDEMIOL INFECT, V140, P1161, DOI 10.1017/S0950268812000234; May RM, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.066112; Mohr O, 2012, EUROSURVEILLANCE, V17, P12; Moreno Y, 2002, EUR PHYS J B, V26, P521, DOI 10.1140/epjb/e20020122; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Murray J. D., 2002, MATH BIOL; Newman M., 2010, NETWORKS INTRO, DOI [10.1162/artl_r_00062, 10.1093/acprof:oso/9780199206650.001.0001, DOI 10.1093/ACPROF:OSO/9780199206650.001.0001]; Ohkusa Yasushi, 2007, Journal of Infection and Chemotherapy, V13, P380, DOI 10.1007/s10156-007-0556-1; Ohkusa Y, 2009, JPN J INFECT DIS, V62, P98; Pastor-Satorras R, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.036104; Pastor-Satorras R, 2001, PHYS REV E, V63, DOI 10.1103/PhysRevE.63.066117; Pastor-Satorras R, 2001, PHYS REV LETT, V86, P3200, DOI 10.1103/PhysRevLett.86.3200; Saito MM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072866; Schneider CM, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.061911; Tanaka G, 2014, SCI REP-UK, V4, DOI 10.1038/srep05522; Yashima K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098518; Yasuda H, 2009, EUROSURVEILLANCE, V14, P12; Yasuda H, 2008, J URBAN HEALTH, V85, P619, DOI 10.1007/s11524-008-9264-0	48	4	4	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162406	10.1371/journal.pone.0162406	http://dx.doi.org/10.1371/journal.pone.0162406			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607239	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000383255600044
J	Alimardani, M; Nishio, S; Ishiguro, H				Alimardani, Maryam; Nishio, Shuichi; Ishiguro, Hiroshi			The Importance of Visual Feedback Design in BCIs; from Embodiment to Motor Imagery Learning	PLOS ONE			English	Article							BRAIN-COMPUTER INTERFACE; MIRROR-NEURON SYSTEM; MU-RHYTHM; HUMANOID ROBOT; SSVEP BCI; EEG; CLASSIFICATION; PROSTHESIS; OWNERSHIP; MOVEMENT	Brain computer interfaces (BCIs) have been developed and implemented in many areas as a new communication channel between the human brain and external devices. Despite their rapid growth and broad popularity, the inaccurate performance and cost of user-training are yet the main issues that prevent their application out of the research and clinical environment. We previously introduced a BCI system for the control of a very humanlike android that could raise a sense of embodiment and agency in the operators only by imagining a movement (motor imagery) and watching the robot perform it. Also using the same setup, we further discovered that the positive bias of subjects' performance both increased their sensation of embodiment and improved their motor imagery skills in a short period. In this work, we studied the shared mechanism between the experience of embodiment and motor imagery. We compared the trend of motor imagery learning when two groups of subjects BCI-operated different looking robots, a very humanlike android's hands and a pair of metallic gripper. Although our experiments did not show a significant change of learning between the two groups immediately during one session, the android group revealed better motor imagery skills in the follow up session when both groups repeated the task using the non-humanlike gripper. This result shows that motor imagery skills learnt during the BCI-operation of humanlike hands are more robust to time and visual feedback changes. We discuss the role of embodiment and mirror neuron system in such outcome and propose the application of androids for efficient BCI training.	[Alimardani, Maryam] Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan; [Nishio, Shuichi; Ishiguro, Hiroshi] Adv Telecommun Res Inst Int ATR, Kyoto, Japan; [Ishiguro, Hiroshi] Osaka Univ, Grad Sch Engn Sci, Dept Syst Innovat, Osaka, Japan	University of Tokyo; Advanced Telecommunications Research Institute International; Osaka University	Alimardani, M (corresponding author), Univ Tokyo, Grad Sch Arts & Sci, Dept Gen Syst Studies, Tokyo, Japan.	maryam@ardbeg.c.u-tokyo.ac.jp			KAKENHI [25220004, 26540109, 15F15046]; ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan)	This research was supported by KAKENHI (https://www.jsps.go.jp/english/e-grants/) (Grant-in-Aid for Scientific Research) grant number 25220004 to HI, 26540109 to SN and 15F15046 to MA. This research was also supported by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan) to SN. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This research was supported by Grants-in-Aid for Scientific Research 25220004, 26540109 and 15F15046 and also by ImPACT Program of Council for Science, Technology and Innovation (Cabinet Office, Government of Japan).	Abbott A, 2006, NATURE, V442, P125, DOI 10.1038/442125a; Adams JA, 1975, P HUM FACT ERG SOC A, V19, P162; Alimardani M, 2013, FRONTIERS SYSTEMS NE, V8, P52; Alimardani M, 2014, BIOM ROB BIOM 2014 5, P403; Alimardani M, 2013, SCI REPORTS, P3; Anatole L, 2008, COMPUTER, V1, P66; ANNETT J, 1995, NEUROPSYCHOLOGIA, V33, P1395, DOI 10.1016/0028-3932(95)00072-B; Barbero A, 2010, J NEUROENG REHABIL, V7, DOI 10.1186/1743-0003-7-34; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Cecotti H, 2011, J PHYSIOL-PARIS, V105, P106, DOI 10.1016/j.jphysparis.2011.08.003; Cohen O, 2014, PRESENCE-TELEOP VIRT, V23, P229, DOI 10.1162/PRES_a_00191; Cohen O, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/3/035006; Curran EA, 2003, BRAIN COGNITION, P51; Dal Seno Bernardo, 2010, Comput Intell Neurosci, P307254, DOI 10.1155/2010/307254; de Vries S, 2007, J REHABIL MED, V39, P5, DOI 10.2340/16501977-0020; Decety J, 1996, BEHAV BRAIN RES, V77, P45, DOI 10.1016/0166-4328(95)00225-1; Ehrsson HH, 2003, J NEUROPHYSIOL, P90; Evans N, 2013, NEUROIMAGE, V64, P216, DOI 10.1016/j.neuroimage.2012.09.027; Fabiani GE, 2004, IEEE T NEUR SYS REH, V12, P331, DOI 10.1109/TNSRE.2004.834627; FLEISHMAN EA, 1963, J EXP PSYCHOL, V66, P6, DOI 10.1037/h0046677; Fukumura K, 2007, INT J NEUROSCI, V117, P1039, DOI 10.1080/00207450600936841; Gazzola V, 2007, NEUROIMAGE, V35, P1674, DOI 10.1016/j.neuroimage.2007.02.003; Gomez-Rodriguez M, 2011, J NEURAL ENG, V8, DOI 10.1088/1741-2560/8/3/036005; Gonzalez-Franco M, 2011, IEEE ENG MED BIO, P6323, DOI 10.1109/IEMBS.2011.6091560; Guger C, 2000, IEEE T REHABIL ENG, V8, P447, DOI 10.1109/86.895947; Guger C., 1999, P AAATE 5 EUR C ADV, P3; Guger C, 2009, NEUROSCI LETT, V462, P94, DOI 10.1016/j.neulet.2009.06.045; Horki P, 2011, MED BIOL ENG COMPUT, V49, P567, DOI 10.1007/s11517-011-0750-2; Jackson A, 2006, IEEE T NEUR SYS REH, V14, P187, DOI 10.1109/TNSRE.2006.875547; Jeannerod M, 1995, CURR OPIN NEUROBIOL, V5, P727, DOI 10.1016/0959-4388(95)80099-9; JEANNEROD M, 1995, NEUROPSYCHOLOGIA, V33, P1419, DOI 10.1016/0028-3932(95)00073-C; Jin J, 2015, INT J NEURAL SYST, V25, DOI 10.1142/S0129065715500112; Kaiser V, 2011, FRONT NEUROSCI-SWITZ, V5, DOI [10.3389/fnins.2011.00086, 10.3389/fninf.2011.00030]; Kauhanen L., 2006, P 3 INT BRAIN COMP I; Kishore S, 2014, PRESENCE-TELEOP VIRT, V23, P242, DOI 10.1162/PRES_a_00192; Lacourse MG, 2004, J REHABIL RES DEV, V41, P505, DOI 10.1682/JRRD.2004.04.0505; Leeb R., 2007, COMPUTATIONAL INTELL; Leonardis D, 2014, PRESENCE-TELEOP VIRT, V23, P253, DOI 10.1162/PRES_a_00190; Lorey B, 2009, EXP BRAIN RES, V194, P233, DOI 10.1007/s00221-008-1693-1; Lotte F, FLAWS CURRENT HUMAN; Lotte F., 2012, PRACTICAL BRAIN COMP, P197, DOI [10.1007/978-3-642-29746-5, DOI 10.1007/978-3-642-29746-5]; Lotze M, 1999, J COGNITIVE NEUROSCI, V11, P491, DOI 10.1162/089892999563553; Mercier C, 2008, CEREB CORTEX, V18, P272, DOI 10.1093/cercor/bhm052; Miller KJ, 2010, P NATL ACAD SCI USA, V107, P4430, DOI 10.1073/pnas.0913697107; Muller-Putz GR, 2008, IEEE T BIO-MED ENG, V55, P361, DOI 10.1109/TBME.2007.897815; Munzert J, 2009, BRAIN RES REV, V60, P306, DOI 10.1016/j.brainresrev.2008.12.024; Muthukumaraswamy SD, 2004, COGNITIVE BRAIN RES, V19, P195, DOI 10.1016/j.cogbrainres.2003.12.001; Muthukumaraswamy SD, 2004, PSYCHOPHYSIOLOGY, V41, P152, DOI 10.1046/j.1469-8986.2003.00129.x; Neumann N, 2003, IEEE T NEUR SYS REH, V11, P169, DOI 10.1109/TNSRE.2003.814431; Neuper C, 1999, J CLIN NEUROPHYSIOL, V16, P373, DOI 10.1097/00004691-199907000-00010; Neuper C, 2005, COGNITIVE BRAIN RES, V25, P668, DOI 10.1016/j.cogbrainres.2005.08.014; Neuper C, 2006, PROG BRAIN RES, V159, P393, DOI 10.1016/S0079-6123(06)59025-9; Neuper C, 2009, CLIN NEUROPHYSIOL, V120, P239, DOI 10.1016/j.clinph.2008.11.015; Oberman LM, 2007, NEUROCOMPUTING, V70, P2194, DOI 10.1016/j.neucom.2006.02.024; Ortner R, 2011, IEEE T NEUR SYS REH, V19, P1, DOI 10.1109/TNSRE.2010.2076364; Perez-Marcos D, 2009, NEUROREPORT, V20, P589, DOI 10.1097/WNR.0b013e32832a0a2a; Petit D, 2015, IEEE INT CONF ROBOT, P2882, DOI 10.1109/ICRA.2015.7139592; Pfurtscheller G, 2006, BRAIN RES, V1071, P145, DOI 10.1016/j.brainres.2005.11.083; Pfurtscheller G, 2006, NEUROIMAGE, V31, P153, DOI 10.1016/j.neuroimage.2005.12.003; Pfurtscheller G, 2001, P IEEE, V89, P1123, DOI 10.1109/5.939829; Pfurtscheller G, 2006, PROG BRAIN RES, V159, P433, DOI 10.1016/S0079-6123(06)59028-4; Rizzolatti G, 2004, ANNU REV NEUROSCI, V27, P169, DOI 10.1146/annurev.neuro.27.070203.144230; Schuster C, 2011, BMC MED, V9, DOI 10.1186/1741-7015-9-75; Spence C, 2015, CLIN SYSTEMS NEUROSC, P151, DOI 10.1007/978-4-431-55037-2_9; Thobbi A, 2010, INT J ARITF INTELL M, V10, P41; Townsend G, 2004, IEEE T NEUR SYS REH, V12, P258, DOI 10.1109/TNSRE.2004.827220; Tsakiris M, 2010, EXP BRAIN RES, V204, P343, DOI 10.1007/s00221-009-2039-3; Yin EW, 2015, IEEE T BIO-MED ENG, V62, P1447, DOI 10.1109/TBME.2014.2320948; Yin EW, 2013, J NEURAL ENG, V10, DOI 10.1088/1741-2560/10/2/026012	69	28	31	2	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161945	10.1371/journal.pone.0161945	http://dx.doi.org/10.1371/journal.pone.0161945			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598310	Green Submitted, gold, Green Published			2022-12-26	WOS:000383254800027
J	Hayat, T; Awais, M; Imtiaz, A				Hayat, Tasawar; Awais, Muhammad; Imtiaz, Amna			Heat Source/Sink in a Magneto-Hydrodynamic Non-Newtonian Fluid Flow in a Porous Medium: Dual Solutions	PLOS ONE			English	Article							3RD GRADE FLUID; MHD; CHANNEL; NANOFLUID	This communication deals with the properties of heat source/sink in a magneto-hydrodynamic flow of a non-Newtonian fluid immersed in a porous medium. Shrinking phenomenon along with the permeability of the wall is considered. Mathematical modelling is performed to convert the considered physical process into set of coupled nonlinear mathematical equations. Suitable transformations are invoked to convert the set of partial differential equations into nonlinear ordinary differential equations which are tackled numerically for the solution computations. It is noted that dual solutions for various physical parameters exist which are analyzed in detail.	[Hayat, Tasawar; Imtiaz, Amna] Quaid I Azam Univ, Dept Math, Islamabad, Pakistan; [Awais, Muhammad] COMSATS Inst Informat Technol, Dept Math, Attock, Pakistan	Quaid I Azam University; COMSATS University Islamabad (CUI)	Awais, M (corresponding author), COMSATS Inst Informat Technol, Dept Math, Attock, Pakistan.	awais_mm@yahoo.com	Awais, Muhammad/AAZ-3455-2020; Hayat, Tasawar/Y-2524-2019; Awais, Muhammad/HCI-3725-2022					Adesanya SO, 2015, ALEX ENG J, V54, P615, DOI 10.1016/j.aej.2015.05.014; Awais M, 2015, BRAZ J CHEM ENG, V32, P555, DOI 10.1590/0104-6632.20150322s00001918; Ellahi R, 2013, APPL MATH MODEL, V37, P1451, DOI 10.1016/j.apm.2012.04.004; Ellahi R, 2010, INT J NUMER METH FL, V63, P847, DOI 10.1002/fld.2105; Fetecau C, 2013, Z NATURFORSCH A, V68, P659, DOI 10.5560/ZNA.2013-0041; Freidoonimehr N, 2015, INT J THERM SCI, V87, P136, DOI 10.1016/j.ijthermalsci.2014.08.009; Iqbal Z, 2016, J AEROSPACE ENG, V29, DOI 10.1061/(ASCE)AS.1943-5525.0000546; Mehmood OU, 2015, APPL BIONICS BIOMECH, V2015, P1, DOI 10.1155/2015/283892; Rashidi MM, 2014, ADV MECH ENG, DOI 10.1155/2014/735939; Rashidi MM, 2012, J APPL MATH, DOI 10.1155/2012/780415; Rashidi MM, 2014, AIN SHAMS ENG J, V5, P901, DOI 10.1016/j.asej.2014.02.007; Raza J, 2016, J MOL LIQ, V219, P703, DOI 10.1016/j.molliq.2016.04.003; Sheikholeslami M, 2014, J MOL LIQ, V194, P30, DOI 10.1016/j.molliq.2014.01.005; Sheikholeslami M, 2014, COMM NUMER ANAL, V2014; Turkyilmazoglu M, 2012, COMPUT FLUIDS, V70, P53, DOI 10.1016/j.compfluid.2012.01.009	15	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162205	10.1371/journal.pone.0162205	http://dx.doi.org/10.1371/journal.pone.0162205			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598314	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800047
J	Berman, J; Sheng, YM; Gomez, LG; Veiga, T; Ni, XZ; Farre, G; Capell, T; Guitian, J; Guitian, P; Sandmann, G; Christou, P; Zhu, CF				Berman, Judit; Sheng, Yanmin; Gomez Gomez, Lourdes; Veiga, Tania; Ni, Xiuzhen; Farre, Gemma; Capell, Teresa; Guitian, Javier; Guitian, Pablo; Sandmann, Gerhard; Christou, Paul; Zhu, Changfu			Red Anthocyanins and Yellow Carotenoids Form the Color of Orange-Flower Gentian (Gentiana lutea L. var. aurantiaca)	PLOS ONE			English	Article							DIHYDROFLAVONOL 4-REDUCTASE; GENE-EXPRESSION; FLAVONOID BIOSYNTHESIS; SUBSTRATE-SPECIFICITY; PETUNIA-HYBRIDA; CDNA CLONING; TRIFLORA; IDENTIFICATION; BIOCHEMISTRY; EVOLUTION	Flower color is an important characteristic that determines the commercial value of ornamental plants. Gentian flowers occur in a limited range of colors because this species is not widely cultivated as a cut flower. Gentiana lutea L. var. aurantiaca (abbr, aurantiaca) is characterized by its orange flowers, but the specific pigments responsible for this coloration are unknown. We therefore investigated the carotenoid and flavonoid composition of petals during flower development in the orange-flowered gentian variety of aurantiaca and the yellow-flowered variety of G. lutea L. var. lutea (abbr, lutea). We observed minor varietal differences in the concentration of carotenoids at the early and final stages, but only aurantiaca petals accumulated pelargonidin glycosides, whereas these compounds were not found in lutea petals. We cloned and sequenced the anthocyanin biosynthetic gene fragments from petals, and analyzed the expression of these genes in the petals of both varieties to determine the molecular mechanisms responsible for the differences in petal color. Comparisons of deduced amino acid sequences encoded by the isolated anthocyanin cDNA fragments indicated that chalcone synthase (CHS), chalcone isomerase (CHI), anthocyanidin synthase 1 (ANS1) and ANS2 are identical in both aurantiaca and lutea varieties whereas minor amino acid differences of the deduced flavonone 3-hydroxylase (F3H) and dihydroflavonol 4-reductase (DFR) between both varieties were observed. The aurantiaca petals expressed substantially higher levels of transcripts representing CHS, F3H, DFR, ANS and UDP-glucose: flavonoid-3-O-glucosyltransferase genes, compared to lutea petals. Pelargonidin glycoside synthesis in aurantiaca petals therefore appears to reflect the higher steady-state levels of pelargonidin synthesis transcripts. Moreover, possible changes in the substrate specificity of DFR enzymes may represent additional mechanisms for producing red pelargonidin glycosides in petals of aurantiaca. Our report describing the exclusive accumulation of pelargonidin glycosides in aurantiaca petals may facilitate the modification of gentian flower color by the production of red anthocyanins.	[Berman, Judit; Farre, Gemma; Capell, Teresa; Christou, Paul; Zhu, Changfu] Univ Lleida, Agrotecnio Ctr, Dept Prod Vegetal & Ciencia Forestal, Lleida, Spain; [Sheng, Yanmin; Ni, Xiuzhen; Zhu, Changfu] Changchun Normal Univ, Sch Life Sci, Changchun, Peoples R China; [Gomez Gomez, Lourdes] Univ Castilla La Mancha, Fac Farm, Inst Bot, Dept Ciencia & Tecnol Agroforestal & Genet, Albacete, Spain; [Veiga, Tania; Guitian, Javier; Guitian, Pablo] Univ Santiago de Compostela, Dept Bot, Galicia, Spain; [Sandmann, Gerhard] Goethe Univ Frankfurt, Biosynth Grp, Mol Biosci, Frankfurt, Germany; [Christou, Paul] Catalan Inst Res & Adv Studies, ICREA, Barcelona, Spain	Universitat de Lleida; Changchun Normal University; Universidad de Castilla-La Mancha; Universidade de Santiago de Compostela; Goethe University Frankfurt; ICREA	Zhu, CF (corresponding author), Univ Lleida, Agrotecnio Ctr, Dept Prod Vegetal & Ciencia Forestal, Lleida, Spain.; Zhu, CF (corresponding author), Changchun Normal Univ, Sch Life Sci, Changchun, Peoples R China.	zhu@pvcf.udl.cat	Guitian, Javier/O-5744-2019; Capell, Teresa/AAD-8609-2022; Gomez-Gomez, Lourdes/AAF-2371-2020; Capell, Teresa/B-2757-2011; Zhu, Changfu/C-8446-2011	Guitian, Javier/0000-0003-0799-0476; Gomez-Gomez, Lourdes/0000-0003-2586-4457; Capell, Teresa/0000-0002-6436-4538; Berman, Judit/0000-0002-0972-8941; Zhu, Changfu/0000-0003-2834-2742	MICINN, Spain [BIO2014-54441-P, BIO2014-54426-P, BIO2013-44239-R, BIO2011-23324, BIO2011-22525, PIM2010PKB-00746]; National Natural Science Foundation of China [31270344]; Plan Nacional de I + D + I; IBERCAROT network [112RT0445]; PROGRAMA ESTATAL DE INVESTIGACION CIENTIFICA Y TECNICA DE EXCELENCIA, Spain [BIO2015-71703-REDT]; COSTaction (EUROCAROTEN) [OC-2015-1-19780]; European Union Framework 7 European Research Council IDEAS Advanced Grant; Program-BIOFORCE; ERC Proof of Concept Grant; Catalan Government Agricultural Biotechnology Research Group [2014 SGR 1296]; Plan Galego de Investigacion e Crecemento (Plan I2C), Conselleria de Cultura, Educacion e Ordenacion Universitaria; ICREA Funding Source: Custom	MICINN, Spain(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Plan Nacional de I + D + I; IBERCAROT network; PROGRAMA ESTATAL DE INVESTIGACION CIENTIFICA Y TECNICA DE EXCELENCIA, Spain; COSTaction (EUROCAROTEN); European Union Framework 7 European Research Council IDEAS Advanced Grant; Program-BIOFORCE; ERC Proof of Concept Grant; Catalan Government Agricultural Biotechnology Research Group; Plan Galego de Investigacion e Crecemento (Plan I2C), Conselleria de Cultura, Educacion e Ordenacion Universitaria; ICREA(ICREA)	This work was supported by MICINN, Spain (BIO2014-54441-P, BIO2014-54426-P, BIO2013-44239-R, BIO2011-23324, BIO2011-22525, PIM2010PKB-00746); the National Natural Science Foundation of China (31270344); the Plan Nacional de I + D + I (2008-2011); the IBERCAROT network (112RT0445); PROGRAMA ESTATAL DE INVESTIGACION CIENTIFICA Y TECNICA DE EXCELENCIA, Spain (BIO2015-71703-REDT); COSTaction (EUROCAROTEN, OC-2015-1-19780); European Union Framework 7 European Research Council IDEAS Advanced Grant (to P.C.) Program-BIOFORCE; and ERC Proof of Concept Grant (to P.C), Catalan Government 2014 SGR 1296 Agricultural Biotechnology Research Group. T.V. was supported by a Ph.D. grant from the Plan Galego de Investigacion e Crecemento 2011/2015 (Plan I2C), Conselleria de Cultura, Educacion e Ordenacion Universitaria. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; T.V. was supported by a PhD grant from the Plan Galego de Investigacion e Crecemento 2011/2015 (Plan I2C), Conselleria de Cultura, Educacion e Ordenacion Universitaria.	Broun P, 2005, CURR OPIN PLANT BIOL, V8, P272, DOI 10.1016/j.pbi.2005.03.006; FORKMANN G, 1987, Z NATURFORSCH C, V42, P1146; Fujiwara H, 1998, PLANT J, V16, P421, DOI 10.1046/j.1365-313x.1998.00312.x; Fukuchi-Mizutani M, 2003, PLANT PHYSIOL, V132, P1652, DOI 10.1104/pp.102.018242; GOFF SA, 1992, GENE DEV, V6, P864, DOI 10.1101/gad.6.5.864; Gonzalez-Lopez O, 2014, INT J MOL SCI, V15, P10052, DOI 10.3390/ijms150610052; Goodwin TW, 1998, PLANT PIGMENTS, P62; Grotewold E, 2000, P NATL ACAD SCI USA, V97, P13579, DOI 10.1073/pnas.250379897; Grotewold E, 2006, ANNU REV PLANT BIOL, V57, P761, DOI 10.1146/annurev.arplant.57.032905.105248; Hichri I, 2011, J EXP BOT, V62, P2465, DOI 10.1093/jxb/erq442; HOLTON TA, 1995, PLANT CELL, V7, P1071, DOI 10.1105/tpc.7.7.1071; HOSOKAWA K, 1995, PHYTOCHEMISTRY, V40, P941, DOI 10.1016/0031-9422(95)00242-Y; Jensen SR, 2002, GENTIANACEAE SYSTEMA, P573, DOI DOI 10.1017/CBO9780511541865.007; Johnson ET, 1999, PLANT J, V19, P81, DOI 10.1046/j.1365-313X.1999.00502.x; Johnson ET, 2001, PLANT J, V25, P325, DOI 10.1046/j.1365-313x.2001.00962.x; Kishimoto S, 2007, J JPN SOC HORTIC SCI, V76, P250, DOI 10.2503/jjshs.76.250; Kobayashi H, 1998, PLANT SCI, V131, P173, DOI 10.1016/S0168-9452(97)00236-7; Kohlein F, 1991, GENTIANS, P9; Miosic S, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112707; Moehs CP, 2001, PLANT MOL BIOL, V45, P281, DOI 10.1023/A:1006417009203; Mol J, 1998, TRENDS PLANT SCI, V3, P212, DOI 10.1016/S1360-1385(98)01242-4; Nakatsuka T, 2006, MOL GENET GENOMICS, V275, P231, DOI 10.1007/s00438-005-0083-7; Nakatsuka T, 2005, PLANT SCI, V169, P949, DOI 10.1016/j.plantsci.2005.06.013; Nakatsuka T, 2005, PLANT SCI, V168, P1309, DOI 10.1016/j.plantsci.2005.01.009; Nakatsuka T, 2008, PLANT CELL PHYSIOL, V49, P1818, DOI 10.1093/pcp/pcn163; Nishihara M, 2008, FLORICULTURAL ORNAME, P57; Ramsay NA, 2005, TRENDS PLANT SCI, V10, P63, DOI 10.1016/j.tplants.2004.12.011; Renobales SG, 2012, FLORA; Renobales SG, 2002, ANALES JARDIN BOT MA, V60, P461; Sandmann G, 2002, CHEMBIOCHEM, V3, P629, DOI 10.1002/1439-7633(20020703)3:7<629::AID-CBIC629>3.0.CO;2-5; Sobral M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132522; Strain HH, 1938, J BIOL CHEM, V123, P425; Streisfeld MA, 2009, MOL BIOL EVOL, V26, P433, DOI 10.1093/molbev/msn268; Tanaka T, 2013, PHIL T R SOC LOND BI, V368; Tanaka Y, 1996, PLANT CELL PHYSIOL, V37, P711, DOI 10.1093/oxfordjournals.pcp.a029004; Tanaka Yoshikazu, 2006, Phytochemistry Reviews, V5, P283, DOI 10.1007/s11101-006-9003-7; Zhu CF, 2002, PLANT MOL BIOL, V48, P277, DOI 10.1023/A:1013383120392; Zhua CF, 2003, BBA-GENE STRUCT EXPR, V1625, P305, DOI 10.1016/S0167-4781(03)00017-4	39	14	16	2	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162410	10.1371/journal.pone.0162410	http://dx.doi.org/10.1371/journal.pone.0162410			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589396	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800059
J	Goto, S; Yoshioka, T; Ohta, S; Kita, M; Hamada, H; Shimizu, T				Goto, Shingo; Yoshioka, Terutaka; Ohta, Satoshi; Kita, Masayuki; Hamada, Hiroko; Shimizu, Tokurou			Segregation and Heritability of Male Sterility in Populations Derived from Progeny of Satsuma Mandarin	PLOS ONE			English	Article							MOLECULAR CHARACTERIZATION; ENVIRONMENTAL VARIATIONS; GENETIC-DIFFERENCES; ABORTED ANTHERS; CYBRID PLANTS; CITRUS; IDENTIFICATION; SEEDLESSNESS; CULTIVARS; SELECTION	Male sterility derived from Satsuma mandarin (Citrus unshiu) has been used in Japanese citrus breeding programs to obtain seedless cultivars, which is a desirable trait for consumers. Male sterility has often been evaluated by anther development or pollen fertility; however, the inheritance and heritability of male sterility derived from Satsuma is poorly understood. In this study, we investigated the mode of inheritance and broad-sense heritability of male sterility derived from Satsuma. Initially, we evaluated the total number of pollen grains per anther and apparent pollen fertility, as indicated by lactophenol blue staining, in 15 citrus cultivars and selections to understand the male sterility of Satsuma. The results indicated that male sterility was primarily caused by decreased number of pollen grains per anther in progeny of Satsuma. We also evaluated these traits in three F-1 populations (hyuganatsu x 'Okitsu No. 56', 'Okitsu No. 46' x 'Okitsu No. 56' and 'Okitsu No. 46' x 'Kara'), of which the parents are derived from Satsuma. Individuals in these populations showed strong segregation for number of pollen grains per anther. The apparent fertility of pollen also showed segregation but was almost constant at 70%-90%. The estimated broad-sense heritability for the number of pollen grains per anther was as high as 0.898 in the 'Okitsu No. 46' x 'Okitsu No. 56' and 'Okitsu No. 46' x 'Kara' populations. These results indicated that the number of pollen grains per anther primarily determined male sterility among progeny of Satsuma, and this trait was inherited by the progeny. Development of DNA markers closely linked to male sterility using the F1 populations of 'Okitsu No. 46' x 'Okitsu No. 56' and 'Okitsu No. 46' x 'Kara' is expected to contribute to the breeding of novel seedless citrus cultivars.	[Goto, Shingo; Yoshioka, Terutaka; Ohta, Satoshi; Kita, Masayuki; Hamada, Hiroko; Shimizu, Tokurou] NARO, Inst Fruit Tree & Tea Sci, Div Citrus Res, Shizuoka, Japan; [Kita, Masayuki] NARO, Western Reg Agr Res Ctr, Div Hillside Hort Res, Zentsuji, Kagawa, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Shimizu, T (corresponding author), NARO, Inst Fruit Tree & Tea Sci, Div Citrus Res, Shizuoka, Japan.	tshimizu@affrc.go.jp	Goto, Shingo/AAU-4777-2021	Goto, Shingo/0000-0002-2298-7016	Institute of Fruit Tree and Tea Science, NARO, Japan; Grants-in-Aid for Scientific Research [15K18643] Funding Source: KAKEN	Institute of Fruit Tree and Tea Science, NARO, Japan; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported by the basic research fund of the Institute of Fruit Tree and Tea Science, NARO, Japan.	Cai XD, 2007, PLANT CELL TISS ORG, V90, P275, DOI 10.1007/s11240-007-9266-8; Campbell R. C., 1974, STAT BIOL, V2nd; Chen LT, 2014, ANNU REV PLANT BIOL, V65, P579, DOI 10.1146/annurev-arplant-050213-040119; 채치원, 2011, [Journal of Life Science, 생명과학회지], V21, P1659; Goto S, 2016, ACTA HORTIC, V1135, P103, DOI 10.17660/ActaHortic.2016.1135.12; Guo WW, 2013, SCI HORTIC-AMSTERDAM, V163, P20, DOI 10.1016/j.scienta.2013.07.018; Guo WW, 2004, PLANT CELL REP, V22, P752, DOI 10.1007/s00299-003-0747-x; Hasegawa Y, 2013, J JPN SOC FOOD SCI, V60, P609; IWAMASA M., 1966, Bulletin of the Horticultural Research Station, P1; IWASAKI T., 1966, Bulletin of the Horticultural Research Station, P83; Kaminuma E, 2013, NUCLEIC ACIDS RES, V41, pD880, DOI 10.1093/nar/gks1216; Kaul, 1988, MALE STERILITY HIGHE; Kunihisa M, 2014, BREEDING SCI, V64, P240, DOI 10.1270/jsbbs.64.240; Nakano M, 2001, J JPN SOC HORTIC SCI, V70, P539, DOI 10.2503/jjshs.70.539; Nishio S, 2014, HORTSCIENCE, V49, P696, DOI 10.21273/HORTSCI.49.6.696; Nishio S, 2011, HORTSCIENCE, V46, P1540, DOI 10.21273/HORTSCI.46.11.1540; Nishiura M., 1983, B FRUIT TREE RES STN, V10, P1; Nonaka K, 2012, J AM SOC HORTIC SCI, V137, P243, DOI 10.21273/JASHS.137.4.243; Siviero A, 2006, J APPL GENET, V47, P23, DOI 10.1007/BF03194595; Vardi A, 2008, J AM SOC HORTIC SCI, V133, P117, DOI 10.21273/JASHS.133.1.117; Visscher PM, 2008, NAT REV GENET, V9, P255, DOI 10.1038/nrg2322; Xiao SX, 2014, PLANT CELL TISS ORG, V116, P81, DOI 10.1007/s11240-013-0384-1; Yamada M, 2002, HORTSCIENCE, V37, P164, DOI 10.21273/HORTSCI.37.1.164; YAMADA M, 1993, HORTSCIENCE, V28, P838, DOI 10.21273/HORTSCI.28.8.838; Yamamoto M, 1997, SCI HORTIC-AMSTERDAM, V70, P9, DOI 10.1016/S0304-4238(97)00017-4; YAMAMOTO M, 1992, J JPN SOC HORTIC SCI, V60, P791, DOI 10.2503/jjshs.60.791; YAMAMOTO M, 1995, J JPN SOC HORTIC SCI, V64, P23, DOI 10.2503/jjshs.64.23; Yamamoto M, 1996, J JPN SOC HORTIC SCI, V65, P291, DOI 10.2503/jjshs.65.291; Yoshida Toshio, 2005, Bulletin of the National Institute of Fruit Tree Science, P37; Zheng BB, 2014, J PROTEOME RES, V13, P2998, DOI 10.1021/pr500126g; Zheng BB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043758	31	12	12	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162408	10.1371/journal.pone.0162408	http://dx.doi.org/10.1371/journal.pone.0162408			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589237	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800057
J	Matsushika, A; Negi, K; Suzuki, T; Goshima, T; Hoshino, T				Matsushika, Akinori; Negi, Kanako; Suzuki, Toshihiro; Goshima, Tetsuya; Hoshino, Tamotsu			Identification and Characterization of a Novel Issatchenkia orientalis GPI-Anchored Protein, IoGas1, Required for Resistance to Low pH and Salt Stress	PLOS ONE			English	Article							ENGINEERED SACCHAROMYCES-CEREVISIAE; MULTIPLE SEQUENCE ALIGNMENT; GLUCAN-REMODELING ENZYMES; ETHANOL-PRODUCTION; CANDIDA-ALBICANS; GLUCANOSYLTRANSFERASE GAS1; BIOETHANOL PRODUCTION; REGULATED GENE; CROSS-LINKING; LACTIC-ACID	The use of yeasts tolerant to acid (low pH) and salt stress is of industrial importance for several bioproduction processes. To identify new candidate genes having potential roles in low-pH tolerance, we screened an expression genomic DNA library of a multiple-stress-tolerant yeast, Issatchenkia orientalis (Pichia kudriavzevii), for clones that allowed Saccharomyces cerevisiae cells to grow under highly acidic conditions (pH 2.0). A genomic DNA clone containing two putative open reading frames was obtained, of which the putative protein-coding gene comprising 1629 bp was retransformed into the host. This transformant grew significantly at pH 2.0, and at pH 2.5 in the presence of 7.5% Na2SO4. The predicted amino acid sequence of this new gene, named I. orientalis GAS1 (IoGAS1), was 60% identical to the S. cerevisiae Gas1 protein, a glycosylphosphatidylinositol-anchored protein essential for maintaining cell wall integrity, and 58-59% identical to Candida albicans Phr1 and Phr2, pH-responsive proteins implicated in cell wall assembly and virulence. Northern hybridization analyses indicated that, as for the C. albicans homologs, IoGAS1 expression was pH-dependent, with expression increasing with decreasing pH (from 4.0 to 2.0) of the medium. These results suggest that IoGAS1 represents a novel pH-regulated system required for the adaptation of I. orientalis to environments of diverse pH. Heterologous expression of IoGAS1 complemented the growth and morphological defects of a S. cerevisiae gas1 Delta mutant, demonstrating that IoGAS1 and the corresponding S. cerevisiae gene play similar roles in cell wall biosynthesis. Site-directed mutagenesis experiments revealed that two conserved glutamate residues (E161 and E262) in the IoGas1 protein play a crucial role in yeast morphogenesis and tolerance to low pH and salt stress. Furthermore, overexpression of IoGAS1 in S. cerevisiae remarkably improved the ethanol fermentation ability at pH 2.5, and at pH 2.0 in the presence of salt (5% Na2SO4), compared to that of a reference strain. Our results strongly suggest that constitutive expression of the IoGAS1 gene in S. cerevisiae could be advantageous for several fermentation processes under these stress conditions.	[Matsushika, Akinori; Negi, Kanako; Suzuki, Toshihiro; Hoshino, Tamotsu] Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem ISC, Hiroshima, Japan; [Matsushika, Akinori; Hoshino, Tamotsu] Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima, Japan; [Goshima, Tetsuya] Natl Res Inst Brewing, Hiroshima, Japan	National Institute of Advanced Industrial Science & Technology (AIST); Hiroshima University	Matsushika, A (corresponding author), Natl Inst Adv Ind Sci & Technol, Res Inst Sustainable Chem ISC, Hiroshima, Japan.; Matsushika, A (corresponding author), Hiroshima Univ, Grad Sch Adv Sci Matter, Hiroshima, Japan.	a-matsushika@aist.go.jp	Matsushika, Akinori/B-8721-2018; HOSHINO, Tamotsu/R-2959-2019; Hoshino, Tamotsu/F-3357-2017	Matsushika, Akinori/0000-0002-5283-2875; Hoshino, Tamotsu/0000-0001-5211-6425	New Energy and Industrial Technology Development Organization (NEDO), Japan	New Energy and Industrial Technology Development Organization (NEDO), Japan(New Energy and Industrial Technology Development Organization (NEDO))	This study was funded by the New Energy and Industrial Technology Development Organization (NEDO), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Auesukaree C, 2009, J APPL GENET, V50, P301, DOI 10.1007/BF03195688; Balat M, 2008, PROG ENERG COMBUST, V34, P551, DOI 10.1016/j.pecs.2007.11.001; Benjaphokee S, 2012, NEW BIOTECHNOL, V29, P379, DOI 10.1016/j.nbt.2011.07.002; Carotti C, 2004, EUR J BIOCHEM, V271, P3635, DOI 10.1111/j.1432-1033.2004.04297.x; Casey E, 2013, BIOTECHNOL BIOFUELS, V6, DOI 10.1186/1754-6834-6-83; Dandi ND, 2013, ANTON LEEUW INT J G, V103, P723, DOI 10.1007/s10482-012-9854-4; Dogan A, 2014, APPL BIOCHEM BIOTECH, V174, P28, DOI [10.100, 10.1007/s12010-014-1006-z]; Edgardo A, 2008, ENZYME MICROB TECH, V43, P120, DOI 10.1016/j.enzmictec.2007.08.006; Eustice M, 2014, GENETICS, V196, P1029, DOI 10.1534/genetics.113.158824; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Fonzi WA, 1999, J BACTERIOL, V181, P7070, DOI 10.1128/JB.181.22.7070-7079.1999; Fuchs BB, 2009, EUKARYOT CELL, V8, P1616, DOI 10.1128/EC.00193-09; Galbe M, 2007, ADV BIOCHEM ENG BIOT, V108, P41, DOI 10.1007/10_2007_070; Garcia MJ, 1997, MICROBIOL-UK, V143, P1125, DOI 10.1099/00221287-143-4-1125; Gastebois A, 2010, EUKARYOT CELL, V9, P1294, DOI 10.1128/EC.00107-10; GATTI E, 1994, J BIOL CHEM, V269, P19695; Gibney PA, 2013, P NATL ACAD SCI USA, V110, pE4393, DOI 10.1073/pnas.1318100110; GIETZ D, 1992, NUCLEIC ACIDS RES, V20, P1425, DOI 10.1093/nar/20.6.1425; Guglielmi B, 2002, J BIOL CHEM, V277, P35712, DOI 10.1074/jbc.M205526200; Ha CW, 2014, NUCLEIC ACIDS RES, V42, P8486, DOI 10.1093/nar/gku570; Hahn-Hagerdal B, 2006, TRENDS BIOTECHNOL, V24, P549, DOI 10.1016/j.tibtech.2006.10.004; Hasunuma T, 2013, BIORESOURCE TECHNOL, V135, P513, DOI 10.1016/j.biortech.2012.10.047; Hirokawa T, 1998, BIOINFORMATICS, V14, P378, DOI 10.1093/bioinformatics/14.4.378; Hisamatsu M., 2006, J APPL GLYCOSCI, V53, P111, DOI DOI 10.5458/JAG.53.111; Hurtado-Guerrero R, 2009, J BIOL CHEM, V284, P8461, DOI 10.1074/jbc.M807990200; Ishida N, 2005, APPL ENVIRON MICROB, V71, P1964, DOI 10.1128/AEM.71.4.1964-1970.2005; Isono N, 2012, J BIOSCI BIOENG, V113, P76, DOI 10.1016/j.jbiosc.2011.09.004; Jeanmougin F, 1998, TRENDS BIOCHEM SCI, V23, P403, DOI 10.1016/S0968-0004(98)01285-7; KANG YS, 1990, MOL CELL BIOL, V10, P2582, DOI 10.1128/MCB.10.6.2582; Kapteyn JC, 1997, J BACTERIOL, V179, P6279, DOI 10.1128/JB.179.20.6279-6284.1997; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kitagawa T, 2010, APPL MICROBIOL BIOT, V87, P1841, DOI 10.1007/s00253-010-2629-9; Klinke HB, 2004, APPL MICROBIOL BIOT, V66, P10, DOI 10.1007/s00253-004-1642-2; Koch MR, 2009, P NATL ACAD SCI USA, V106, P11224, DOI 10.1073/pnas.0900809106; Kovacova K, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fou011; Kwon YJ, 2011, BIORESOURCE TECHNOL, V102, P8099, DOI 10.1016/j.biortech.2011.06.035; Lesage G, 2004, GENETICS, V167, P35, DOI 10.1534/genetics.167.1.35; Limayem A, 2012, PROG ENERG COMBUST, V38, P449, DOI 10.1016/j.pecs.2012.03.002; Lin J, 2004, GENE DEV, V18, P387, DOI 10.1101/gad.1171804; Ma MG, 2010, APPL MICROBIOL BIOT, V87, P829, DOI 10.1007/s00253-010-2594-3; MAIORELLA BL, 1984, BIOTECHNOL BIOENG, V26, P1155, DOI 10.1002/bit.260261004; Marx H, 2006, FEMS MICROBIOL LETT, V264, P40, DOI 10.1111/j.1574-6968.2006.00427.x; Matsushika A, 2008, APPL MICROBIOL BIOT, V81, P243, DOI 10.1007/s00253-008-1649-1; Matsushika A, 2012, APPL BIOCHEM BIOTECH, V168, P2094, DOI 10.1007/s12010-012-9920-4; Matsushika A, 2012, ENZYME MICROB TECH, V51, P16, DOI 10.1016/j.enzmictec.2012.03.008; Matsushika A, 2010, J BIOSCI BIOENG, V110, P102, DOI 10.1016/j.jbiosc.2010.01.002; Matsushika A, 2009, APPL MICROBIOL BIOT, V84, P37, DOI 10.1007/s00253-009-2101-x; Mazan M, 2011, BIOCHEM J, V438, P275, DOI 10.1042/BJ20110405; Meroth CB, 2003, APPL ENVIRON MICROB, V69, P7453, DOI 10.1128/AEM.69.12.7453-7461.2003; Mira NP, 2010, OMICS, V14, P525, DOI 10.1089/omi.2010.0072; Modig T, 2007, APPL MICROBIOL BIOT, V75, P289, DOI 10.1007/s00253-006-0821-8; Mouyna I, 2000, J BIOL CHEM, V275, P14882, DOI 10.1074/jbc.275.20.14882; Mouyna I, 2000, BIOCHEM J, V347, P741, DOI 10.1042/0264-6021:3470741; Muhlschlegel FA, 1997, MOL CELL BIOL, V17, P5960; Nevoigt E, 2008, MICROBIOL MOL BIOL R, V72, P379, DOI 10.1128/MMBR.00025-07; Nilvebrant NO, 2003, APPL BIOCHEM BIOTECH, V105, P615; Oberoi HS, 2012, J IND MICROBIOL BIOT, V39, P557, DOI 10.1007/s10295-011-1060-2; Octave S, 2009, BIOCHIMIE, V91, P659, DOI 10.1016/j.biochi.2009.03.015; Olofsson K, 2008, BIOTECHNOL BIOFUELS, V1, DOI 10.1186/1754-6834-1-7; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Palmqvist E, 2000, BIORESOURCE TECHNOL, V74, P25, DOI 10.1016/S0960-8524(99)00161-3; Papaleo E, 2006, J MOL MODEL, V12, P237, DOI 10.1007/s00894-005-0025-7; Passolunghi S, 2010, MICROB CELL FACT, V9, DOI 10.1186/1475-2859-9-7; Popolo L, 1999, BBA-GEN SUBJECTS, V1426, P385, DOI 10.1016/S0304-4165(98)00138-X; POPOLO L, 1993, J BACTERIOL, V175, P1879, DOI 10.1128/JB.175.7.1879-1885.1993; Popolo L, 1997, J BACTERIOL, V179, P463, DOI 10.1128/jb.179.2.463-469.1997; Prista C, 1997, APPL ENVIRON MICROB, V63, P4005, DOI 10.1128/AEM.63.10.4005-4009.1997; Radecka D, 2015, FEMS YEAST RES, V15, DOI 10.1093/femsyr/fov053; Ragni E, 2007, YEAST, V24, P297, DOI 10.1002/yea.1473; Ragni E, 2007, EUKARYOT CELL, V6, P302, DOI 10.1128/EC.00321-06; Ram AFJ, 1998, J BACTERIOL, V180, P1418, DOI 10.1128/JB.180.6.1418-1424.1998; RAM AFJ, 1994, YEAST, V10, P1019, DOI 10.1002/yea.320100804; Rolli E, 2011, MOL BIOL CELL, V22, P1585, DOI 10.1091/mbc.E10-03-0268; Ruyters S, 2015, J IND MICROBIOL BIOT, V42, P39, DOI 10.1007/s10295-014-1544-y; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; SAPORITOIRWIN SM, 1995, MOL CELL BIOL, V15, P601; Sillo F, 2013, FUNGAL GENET BIOL, V53, P10, DOI 10.1016/j.fgb.2013.01.010; Skrzypek M, 1997, J BACTERIOL, V179, P1513, DOI 10.1128/jb.179.5.1513-1520.1997; Solomon BD, 2007, BIOMASS BIOENERG, V31, P416, DOI 10.1016/j.biombioe.2007.01.023; Stanley D, 2010, J APPL MICROBIOL, V109, P13, DOI 10.1111/j.1365-2672.2009.04657.x; Suzuki T, 2013, J BIOSCI BIOENG, V115, P467, DOI 10.1016/j.jbiosc.2012.11.014; Tao F, 2005, PROCESS BIOCHEM, V40, P183, DOI 10.1016/j.procbio.2003.11.054; Thalagala T. A. T. P., 2009, Journal of Applied Glycoscience, V56, P7; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Turchini A, 2000, J BACTERIOL, V182, P1167, DOI 10.1128/JB.182.4.1167-1171.2000; Vai M, 1996, YEAST, V12, P361, DOI 10.1002/(SICI)1097-0061(19960330)12:4<361::AID-YEA920>3.0.CO;2-T; VAI M, 1991, J BIOL CHEM, V266, P12242; Watanabe I, 2008, J IND MICROBIOL BIOT, V35, P1117, DOI 10.1007/s10295-008-0390-1; WEI CJ, 1982, APPL ENVIRON MICROB, V43, P757, DOI 10.1128/AEM.43.4.757-763.1982; Zhou XZ, 2001, CELL, V107, P347, DOI 10.1016/S0092-8674(01)00538-4	90	16	17	2	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0161888	10.1371/journal.pone.0161888	http://dx.doi.org/10.1371/journal.pone.0161888			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589271	gold, Green Published, Green Submitted			2022-12-26	WOS:000382877800022
J	Paras-Bravo, P; Paz-Zulueta, M; Sarabia-Lavin, R; Amo-Setien, FJ; Herrero-Montes, M; Olavarria-Beivide, E; Rodriguez-Rodriguez, M; Torres-Manrique, B; Rodriguez-de la Vega, C; Caso-Alvarez, V; Gonzalez-Parralo, L; Antolin-Juarez, FM				Paras-Bravo, Paula; Paz-Zulueta, Maria; Sarabia-Lavin, Raquel; Jose Amo-Setien, Francisco; Herrero-Montes, Manuel; Olavarria-Beivide, Encarnacion; Rodriguez-Rodriguez, Mercedes; Torres-Manrique, Blanca; Rodriguez-de la Vega, Carlos; Caso-Alvarez, Vanesa; Gonzalez-Parralo, Laura; Manuel Antolin-Juarez, Francisco			Complications of Peripherally Inserted Central Venous Catheters: A Retrospective Cohort Study	PLOS ONE			English	Article							BLOOD-STREAM INFECTION; CHEMOTHERAPY PATIENTS; VEIN-THROMBOSIS; CARE; MANAGEMENT; PLACEMENT; ADULTS; LINES; RISK	Background and Aim The use of venous catheters is a widespread practice, especially in oncological and oncohematological units. The objective of this study was to evaluate the complications associated with peripherally inserted central catheters (PICCs) in a cohort of patients. Materials and Methods In this retrospective cohort study, we included all patient carrying PICCs (n = 603) inserted at our institute between October 2010 and December 2013. The main variables collected were medical diagnosis, catheter care, location, duration of catheterization, reasons for catheter removal, complications, and nursing care. Complications were classified as infection, thrombosis, phlebitis, migration, edema, and/or ecchymosis. Results All patients were treated according to the same "nursing care" protocol. The incidence rate of complications was two cases per 1000 days of catheter duration. The most relevant complications were infection and thrombosis, both with an incidence of 0.17 cases per 1000 days of the total catheterization period. The total average duration of catheterization was 170 days [SD 6.06]. Additionally to "end of treatment" (48.42%) and "exitus", (22.53%) the most frequent cause of removal was migration (displacement towards the exterior) of the catheter (5.80%). Conclusions PICCs are safe devices that allow the administration of long-term treatment and preserve the integrity of the venous system of the patient. Proper care of the catheter is very important to improve the quality life of patients with oncologic and hematologic conditions. Therefore, correct training of professionals and patients as well as following the latest scientific recommendations are particularly relevant.	[Paras-Bravo, Paula; Paz-Zulueta, Maria; Sarabia-Lavin, Raquel; Jose Amo-Setien, Francisco] Univ Cantabria, Dept Enfermeria, Santander, Cantabria, Spain; [Herrero-Montes, Manuel; Olavarria-Beivide, Encarnacion; Rodriguez-Rodriguez, Mercedes; Torres-Manrique, Blanca; Rodriguez-de la Vega, Carlos; Caso-Alvarez, Vanesa; Gonzalez-Parralo, Laura; Manuel Antolin-Juarez, Francisco] Serv Cantabro Salud, Santander, Cantabria, Spain	Universidad de Cantabria	Paras-Bravo, P (corresponding author), Univ Cantabria, Dept Enfermeria, Santander, Cantabria, Spain.	paula.paras@unican.es	Parás-Bravo, Paula/AAC-7250-2020; Herrero-Montes, Manuel/AAV-1583-2020	Parás-Bravo, Paula/0000-0001-7745-3006; Herrero-Montes, Manuel/0000-0002-5732-8344; Sarabia-Lavin, Raquel/0000-0003-3679-4327				Adams S, 2007, CENTRAL VENOUS ACCES; Aw A, 2012, THROMB RES, V130, P323, DOI 10.1016/j.thromres.2012.02.048; Baxi SM, 2013, INFECT CONT HOSP EP, V34, P785, DOI 10.1086/671266; Camp-Sorrell Dawn, 2010, Semin Oncol Nurs, V26, P80, DOI 10.1016/j.soncn.2010.02.001; Chan RJ, 2012, CANCER NURS, V35, pE35, DOI 10.1097/NCC.0b013e3182352916; Chernecky Cynthia, 2010, Semin Oncol Nurs, V26, P79, DOI 10.1016/j.soncn.2010.02.005; Chopra V, 2013, INFECT CONT HOSP EP, V34, P908, DOI 10.1086/671737; de Naurois J1, MANAGEMENT FEBRILE N; Dudeck MA, 2013, AM J INFECT CONTROL, V41, P1148, DOI 10.1016/j.ajic.2013.09.002; Fernandez-de-Maya J, 2013, EUR J ONCOL NURS, V17, P835, DOI 10.1016/j.ejon.2013.06.008; Gallieni M, 2008, CA-CANCER J CLIN, V58, P323, DOI 10.3322/CA.2008.0015; Galvez R., 2010, MANUAL MED INTENSIVA, P27; Grant JD, 2012, THROMB HAEMOSTASIS, V108, P1097, DOI 10.1160/TH12-05-0352; Moraza-Dulanto MI, 2012, ENFERM CLIN, V22, P135, DOI 10.1016/j.enfcli.2012.04.002; Leroyer C, 2013, MED MALADIES INFECT, V43, P350, DOI 10.1016/j.medmal.2013.06.013; Leung TK, 2011, CANCER NURS, V34, pE25, DOI 10.1097/NCC.0b013e3181f1ad6f; Li J, 2014, EUR J ONCOL NURS, V18, P94, DOI 10.1016/j.ejon.2013.08.003; Manasek V, 2012, Klin Onkol, V25, P9; Marsh N, 2015, J EVAL CLIN PRACT, V21, P893, DOI 10.1111/jep.12396; Mollee P, 2011, J HOSP INFECT, V78, P26, DOI 10.1016/j.jhin.2011.01.018; O'Grady NP, 2011, AM J INFECT CONTROL, V39, pS1, DOI 10.1016/j.ajic.2011.01.003; Registered Nurses Association of Ontario, 2005, CAR MAINT RED VASC A; Registered Nurses Association of Ontario, 2004, ASS DEV SEL VASC ACC; Santolim Thais Queiroz, 2012, Br J Nurs, V21, pS30; Santolim TQ, 2012, BR J NURS, V21, pS30; Schiffer CA, 2013, J CLIN ONCOL, V31, P1357, DOI 10.1200/JCO.2012.45.5733; Seckold T, 2015, J VASC ACCESS, V16, P167, DOI 10.5301/jva.5000330; The Joanna Briggs Institute, BEST PRACT MAN PER I; The RCN IV Therapy Forum, 2010, STAND INF THER; Wilson TJ, 2013, CLIN NEUROL NEUROSUR, V115, P879, DOI 10.1016/j.clineuro.2012.08.025; Wolf J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135904	31	16	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162479	10.1371/journal.pone.0162479	http://dx.doi.org/10.1371/journal.pone.0162479			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588946	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800064
J	Renfroe, JB; Bradley, MM; Sege, CT; Bowers, D				Renfroe, Jenna B.; Bradley, Margaret M.; Sege, Christopher T.; Bowers, Dawn			Emotional Modulation of the Late Positive Potential during Picture Free Viewing in Older and Young Adults	PLOS ONE			English	Article							EVENT-RELATED POTENTIALS; BRAIN POTENTIALS; NEGATIVITY BIAS; EVALUATIVE CATEGORIZATION; MOTIVATED ATTENTION; AROUSAL; MEMORY; AGE; PERCEPTION; RESPONSES	Hedonic bias during free viewing of novel emotional and neutral scenes was investigated in older adults and college students. A neurophysiological index of emotional picture processing-the amplitude of the centroparietal late positive potential (LPP)-was recorded from the scalp using a dense sensor array while participants (29 older adults; 21 college students) viewed emotionally engaging or mundane natural scenes that varied in specific content. Both students and older adults showed LPP enhancement when viewing affective, compared to neutral, scenes, and there was no difference in LPP amplitude between older individuals and college students when viewing neutral everyday scenes. However, compared to the college students, older individuals showed attenuated LPP amplitude when viewing emotional scenes, regardless of hedonic valence or specific content. Age related differences could be mediated by a reduction in reactive emotional arousal with age, possible mediated by repeated life exposure to emotional stimuli.	[Renfroe, Jenna B.; Bradley, Margaret M.; Sege, Christopher T.; Bowers, Dawn] Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA	State University System of Florida; University of Florida	Renfroe, JB (corresponding author), Univ Florida, Dept Clin & Hlth Psychol, Gainesville, FL 32611 USA.	jenna.renfroe.phd@gmail.com			NRSA by the NIH National Institute of Neurological Disorders and Stroke (NINDS) [F31 NS 073331-01]	NRSA by the NIH National Institute of Neurological Disorders and Stroke (NINDS)	This work was supported by an NRSA awarded to the first author (JR) by the NIH National Institute of Neurological Disorders and Stroke (NINDS) (F31 NS 073331-01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck A.T., 1996, PSYCHOL ASSESS, V2, DOI DOI 10.1037/T00742-000; Bradley MM, 2007, PSYCHOPHYSIOLOGY, V44, P364, DOI 10.1111/j.1469-8986.2007.00520.x; BRADLEY MM, 1994, J BEHAV THER EXP PSY, V25, P49, DOI 10.1016/0005-7916(94)90063-9; Cacioppo JT, 1999, ANNU REV PSYCHOL, V50, P191, DOI 10.1146/annurev.psych.50.1.191; Carstensen LL, 2000, J PERS SOC PSYCHOL, V79, P644, DOI 10.1037//0022-3514.79.4.644; CARSTENSEN LL, 1992, PSYCHOL AGING, V7, P331, DOI 10.1037/0882-7974.7.3.331; Codispoti M, 2007, J COGNITIVE NEUROSCI, V19, P577, DOI 10.1162/jocn.2007.19.4.577; Comblain C, 2005, EXP AGING RES, V31, P173, DOI 10.1080/03610730590915010; Cuthbert BN, 2000, BIOL PSYCHOL, V52, P95, DOI 10.1016/S0301-0511(99)00044-7; Diedrich O, 1997, J PSYCHOPHYSIOL, V11, P71; Dufey M, 2011, SOC NEUROSCI-UK, V6, P48, DOI 10.1080/17470911003691402; Ferrari V, 2008, J COGNITIVE NEUROSCI, V20, P1753, DOI 10.1162/jocn.2008.20121; Ferrari V, 2011, PSYCHOPHYSIOLOGY, V48, P515, DOI 10.1111/j.1469-8986.2010.01083.x; Foster SM, 2013, PSYCHOL AGING, V28, P179, DOI 10.1037/a0030928; Foti D, 2009, PSYCHOPHYSIOLOGY, V46, P521, DOI 10.1111/j.1469-8986.2009.00796.x; Gavazzeni J, 2008, PSYCHOPHYSIOLOGY, V45, P148, DOI 10.1111/j.1469-8986.2007.00596.x; Ito TA, 1998, J PERS SOC PSYCHOL, V75, P887, DOI 10.1037/0022-3514.75.4.887; Junghofer M, 2000, PSYCHOPHYSIOLOGY, V37, P523, DOI 10.1111/1469-8986.3740523; Keil A, 2009, PSYCHOL AGING, V24, P668, DOI 10.1037/a0016969; Kisley MA, 2007, PSYCHOL SCI, V18, P838, DOI 10.1111/j.1467-9280.2007.01988.x; Lang P.J., 2008, A8 U FLOR; Lang P.J., 1968, RES PSYCHOTHER, P90, DOI [10.1037/10546-004, DOI 10.1037/10546-004]; Langeslag SJE, 2009, EMOTION, V9, P369, DOI 10.1037/a0015356; Leite J, 2012, INT J PSYCHOPHYSIOL, V83, P375, DOI 10.1016/j.ijpsycho.2011.12.005; LEVENSON RW, 1991, PSYCHOL AGING, V6, P28, DOI 10.1037/0882-7974.6.1.28; Mather M, 2005, TRENDS COGN SCI, V9, P496, DOI 10.1016/j.tics.2005.08.005; Mathieu NG, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099523; McTeague LM, 2012, PSYCHOPHYSIOLOGY, P336; Moser JS, 2006, PSYCHOPHYSIOLOGY, V43, P292, DOI 10.1111/j.1469-8986.2006.00402.x; Palomba D, 1997, INT J PSYCHOPHYSIOL, V27, P55, DOI 10.1016/S0167-8760(97)00751-4; Peyk P, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/861705; Rehmert AE, 2013, EMOTION, V13, P949, DOI 10.1037/a0032771; Reynolds GD, 2005, DEV PSYCHOL, V41, P598, DOI 10.1037/0012-1649.41.4.598; Schlogl A, 2007, CLIN NEUROPHYSIOL, V118, P98, DOI 10.1016/j.clinph.2006.09.003; Schupp HT, 2004, COGNITION EMOTION, V18, P593, DOI 10.1080/02699930341000239; Simola J, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00041; Spielberger C. D., 1999, USE PSYCHOL TESTING, P993; STARKSTEIN SE, 1992, J NEUROPSYCH CLIN N, V4, P134; Weinberg A, 2012, INT J PSYCHOPHYSIOL, V84, P149, DOI 10.1016/j.ijpsycho.2012.01.023; Weinberg A, 2010, EMOTION, V10, P767, DOI 10.1037/a0020242; Wiens S, 2011, BIOL PSYCHOL, V86, P83, DOI 10.1016/j.biopsycho.2010.11.001; Wood S, 2006, PSYCHOL AGING, V21, P815, DOI 10.1037/0882-7974.21.4.815	42	15	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162323	10.1371/journal.pone.0162323	http://dx.doi.org/10.1371/journal.pone.0162323			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589393	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800050
J	Yano, N; Muramoto, K; Shimada, A; Takemura, S; Baba, J; Fujisawa, H; Mochizuki, M; Shinzawa-Itoh, K; Yamashita, E; Tsukihara, T; Yoshikawa, S				Yano, Naomine; Muramoto, Kazumasa; Shimada, Atsuhiro; Takemura, Shuhei; Baba, Junpei; Fujisawa, Hidenori; Mochizuki, Masao; Shinzawa-Itoh, Kyoko; Yamashita, Eiki; Tsukihara, Tomitake; Yoshikawa, Shinya			The Mg2+-containing Water Cluster of Mammalian Cytochrome c Oxidase Collects Four Pumping Proton Equivalents in Each Catalytic Cycle	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						bioenergetics; copper; cytochrome c oxidase (Complex IV); heme; membrane protein; mitochondrial membrane potential; proton pump; x-ray crystallography	O-2 REDUCTION; MECHANISM; REFINEMENT; RESOLUTION; MUTATIONS; MOLECULES; PATHWAY; ROLES; HEME; IONS	Bovine heart cytochrome c oxidase (CcO) pumps four proton equivalents per catalytic cycle through the H-pathway, a proton-conducting pathway, which includes a hydrogen bond network and a water channel operating in tandem. Protons are transferred by H3O+ through the water channel from the N-side into the hydrogen bond network, where they are pumped to the P-side by electrostatic repulsion between protons and net positive charges created at heme a as a result of electron donation to O-2 bound to heme a(3). To block backward proton movement, the water channel remains closed after O-2 binding until the sequential four-proton pumping process is complete. Thus, the hydrogen bond network must collect four proton equivalents before O-2 binding. However, a region with the capacity to accept four proton equivalents was not discernable in the x-ray structures of the hydrogen bond network. The present x-ray structures of oxidized/reduced bovine CcO are improved from 1.8/1.9 to 1.5/1.6 angstrom resolution, increasing the structural information by 1.7/1.6 times and revealing that a large water cluster, which includes a Mg2+ ion, is linked to the H-pathway. The cluster contains enough proton acceptor groups to retain four proton equivalents. The redox-coupled x-ray structural changes in Glu(198), which bridges the Mg2+ and Cu-A (the initial electron acceptor from cytochrome c) sites, suggest that the Cu-A-Glu(198)-Mg2+ system drives redox-coupled transfer of protons pooled in the water cluster to the H-pathway. Thus, these x-ray structures indicate that the Mg2+-containing water cluster is the crucial structural element providing the effective proton pumping in bovine CcO.	[Yano, Naomine; Shimada, Atsuhiro; Takemura, Shuhei; Baba, Junpei; Fujisawa, Hidenori; Mochizuki, Masao; Shinzawa-Itoh, Kyoko; Tsukihara, Tomitake; Yoshikawa, Shinya] Univ Hyogo, Picobiol Inst, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan; [Muramoto, Kazumasa] Univ Hyogo, Dept Life Sci, Grad Sch Life Sci, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan; [Yamashita, Eiki; Tsukihara, Tomitake] Osaka Univ, Inst Prot Res, 3-2 Yamadaoka, Suita, Osaka 5650871, Japan; [Tsukihara, Tomitake] CREST, JSJT, 4-1-8 Honcho, Kawaguchi, Saitama 3320012, Japan	University of Hyogo; University of Hyogo; Osaka University; Japan Science & Technology Agency (JST)	Yoshikawa, S (corresponding author), Univ Hyogo, Picobiol Inst, 3-2-1 Koto, Akoh, Hyogo 6781297, Japan.	yoshi@sci.u-hyogo.ac.jp	Yamashita, Eiki/V-6758-2019	Yamashita, Eiki/0000-0002-4278-0039	Academia Sinica; National Synchrotron Radiation Research Center; Grants-in-Aid for Scientific Research [26291033] Funding Source: KAKEN	Academia Sinica(Academia Sinica - Taiwan); National Synchrotron Radiation Research Center; Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We sincerely thank Prof. Masaru Tateno (University of Hyogo) and Dr. Minoru Kubo for important comments and advice regarding the mechanism of CcO. We thank Kazunori Maeda and Wataru Ido for preliminary x-ray diffraction experiments and structural analyses. Diffraction data were collected in the SPring-8 facility at BL44XU under the proposals 2006B6500, 2008A6500, 2008B6500, 2009A6500, 2009B6500, and 2010A6500 and at BL41XU 2008B1001, 2008B1015, 2009A1012, 2009A1013, 2009B1001, and 2009B1031. Use of the MX225HE CCD detector was financially supported by Academia Sinica and the National Synchrotron Radiation Research Center.	Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106; Belevich I, 2007, P NATL ACAD SCI USA, V104, P2685, DOI 10.1073/pnas.0608794104; Braden BC, 1995, J MOL RECOGNIT, V8, P317, DOI 10.1002/jmr.300080505; BRICOGNE G, 1974, ACTA CRYSTALLOGR A, VA 30, P395, DOI 10.1107/S0567739474010722; BRICOGNE G, 1976, ACTA CRYSTALLOGR A, V32, P832, DOI 10.1107/S0567739476001691; BRUNGER AT, 1987, SCIENCE, V235, P458, DOI 10.1126/science.235.4787.458; Chan SI, 2010, P NATL ACAD SCI USA, V107, P8505, DOI 10.1073/pnas.1004050107; Cowtan K., 1994, JOINT CCP4 ESF EACBM, V31, P34; Egawa T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063669; Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921; FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114; Goyal P, 2015, CHEM SCI, V6, P826, DOI 10.1039/c4sc01674b; Hirata K, 2014, NAT METHODS, V11, P734, DOI [10.1038/nmeth.2962, 10.1038/NMETH.2962]; Isaacs N. S., 1995, PHYS ORGANIC CHEM, P235; Kamiya K, 2007, J AM CHEM SOC, V129, P9663, DOI 10.1021/ja070464y; Katz AK, 1998, J PHYS CHEM B, V102, P6342, DOI 10.1021/jp9815412; Konstantinov AA, 1997, P NATL ACAD SCI USA, V94, P9085, DOI 10.1073/pnas.94.17.9085; Lee HM, 2000, BIOCHEMISTRY-US, V39, P2989, DOI 10.1021/bi9924821; Mochizuki M, 1999, J BIOL CHEM, V274, P33403, DOI 10.1074/jbc.274.47.33403; Muramoto K, 2010, P NATL ACAD SCI USA, V107, P7740, DOI 10.1073/pnas.0910410107; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rich PR, 2013, J R SOC INTERFACE, V10, DOI 10.1098/rsif.2013.0183; ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067; Sharma V, 2015, P NATL ACAD SCI USA, V112, P2040, DOI 10.1073/pnas.1409543112; Shimokata K, 2007, P NATL ACAD SCI USA, V104, P4200, DOI 10.1073/pnas.0611627104; Shinzawa-Itoh K, 2007, EMBO J, V26, P1713, DOI 10.1038/sj.emboj.7601618; Tomizaki T, 1999, ACTA CRYSTALLOGR D, V55, P31, DOI 10.1107/S0907444998006362; Tsukihara T, 2003, P NATL ACAD SCI USA, V100, P15304, DOI 10.1073/pnas.2635097100; von Ballmoos C, 2011, P NATL ACAD SCI USA, V108, P11057, DOI 10.1073/pnas.1104103108; WANG BC, 1985, METHOD ENZYMOL, V115, P90; Weiss MS, 2001, J APPL CRYSTALLOGR, V34, P130, DOI 10.1107/S0021889800018227; WILLIAMS RJP, 1995, NATURE, V376, P643, DOI 10.1038/376643a0; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yoshikawa S, 2015, CHEM REV, V115, P1936, DOI 10.1021/cr500266a; Yoshikawa S, 2011, ANNU REV BIOPHYS, V40, P205, DOI 10.1146/annurev-biophys-042910-155341	35	55	56	0	12	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 11	2016	291	46					23882	23894		10.1074/jbc.M115.711770	http://dx.doi.org/10.1074/jbc.M115.711770			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC9XR	27605664	Green Published, hybrid			2022-12-26	WOS:000388498100004
J	Welinder, KG; Hansen, R; Overgaard, MT; Brohus, M; Sonderkaer, M; von Bergen, M; Rolle-Kampczyk, U; Otto, W; Lindahl, TL; Arinell, K; Evans, AL; Swenson, JE; Revsbech, IG; Frobert, O				Welinder, Karen Gjesing; Hansen, Rasmus; Overgaard, Michael Toft; Brohus, Malene; Sonderkaer, Mads; von Bergen, Martin; Rolle-Kampczyk, Ulrike; Otto, Wolfgang; Lindahl, Tomas L.; Arinell, Karin; Evans, Alina L.; Swenson, Jon E.; Revsbech, Inge G.; Frobert, Ole			Biochemical Foundations of Health and Energy Conservation in Hibernating Free-ranging Subadult Brown Bear Ursus arctos	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						coagulation factor; complement system; metabolomics; protein turnover; proteomics; antimicrobial proteins; blood constituents; hibernation physiology; sex hormone-binding globulin (SHBG)	HORMONE-BINDING GLOBULIN; BLACK BEARS; BODY-TEMPERATURE; PROTEIN-SYNTHESIS; GENE-EXPRESSION; AMERICANUS; PLASMA; TESTOSTERONE; GENOMICS; HAPTOGLOBIN	Brown bears (Ursus arctos) hibernate for 5-7 months without eating, drinking, urinating, and defecating at a metabolic rate of only 25% of the summer activity rate. Nonetheless, they emerge healthy and alert in spring. We quantified the biochemical adaptations for hibernation by comparing the proteome, metabolome, and hematological features of blood from hibernating and active free-ranging subadult brown bears with a focus on conservation of health and energy. We found that total plasma protein concentration increased during hibernation, even though the concentrations of most individual plasma proteins decreased, as did the white blood cell types. Strikingly, antimicrobial defense proteins increased in concentration. Central functions in hibernation involving the coagulation response and protease inhibition, as well as lipid transport and metabolism, were upheld by increased levels of very few key or broad specificity proteins. The changes in coagulation factor levels matched the changes in activity measurements. A dramatic 45-fold increase in sex hormone-binding globulin levels during hibernation draws, for the first time, attention to its significant but unknown role in maintaining hibernation physiology. We propose that energy for the costly protein synthesis is reduced by three mechanisms as follows: (i) dehydration, which increases protein concentration without de novo synthesis; (ii) reduced protein degradation rates due to a 6 degrees C reduction in body temperature and decreased protease activity; and (iii) a marked redistribution of energy resources only increasing de novo synthesis of a few key proteins. The comprehensive global data identified novel biochemical strategies for bear adaptations to the extreme condition of hibernation and have implications for our understanding of physiology in general.	[Welinder, Karen Gjesing; Hansen, Rasmus; Overgaard, Michael Toft; Brohus, Malene; Sonderkaer, Mads; von Bergen, Martin] Aalborg Univ, Sect Biotechnol, Dept Chem & Biosci, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark; [von Bergen, Martin; Rolle-Kampczyk, Ulrike] UFZ Helmholtz Ctr Environm Res, Dept Metabol, Permoserstr 15, D-04318 Leipzig, Germany; [von Bergen, Martin; Otto, Wolfgang] UFZ Helmholtz Ctr Environm Res, Dept Prote, Permoserstr 15, D-04318 Leipzig, Germany; [Lindahl, Tomas L.] Linkoping Univ, Dept Clin & Expt Med, S-58185 Linkoping, Sweden; [Arinell, Karin; Frobert, Ole] Univ Orebro, Fac Hlth, Dept Cardiol, S-70185 Orebro, Sweden; [Evans, Alina L.] Hedmark Univ Coll, Dept Forestry & Wildlife Management, Campus Evenstrand, N-2411 Elverum, Norway; [Swenson, Jon E.] Norwegian Univ Life Sci, Dept Ecol & Nat Resource Management, Postbox 5014, N-1432 As, Norway; [Swenson, Jon E.] Norwegian Inst Nat Res, Tungasletta 2, N-7485 Trondheim, Norway; [Revsbech, Inge G.] Aarhus Univ, Zoophysiol, Dept Biosci, CF Mollers Alle 3, DK-8000 Aarhus C, Denmark; [Hansen, Rasmus] Wellspring Biosci LLC, 11119 N Torrey Pines Rd,Ste 125, La Jolla, CA 92037 USA	Aalborg University; Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Helmholtz Association; Helmholtz Center for Environmental Research (UFZ); Linkoping University; Orebro University; Inland Norway University of Applied Sciences; Norwegian University of Life Sciences; Norwegian Institute Nature Research; Aarhus University	Welinder, KG (corresponding author), Aalborg Univ, Dept Chem & Biosci, Fredrik Bajers Vej 7H, DK-9220 Aalborg, Denmark.	kgw@bio.aau.dk	Overgaard, Michael Toft/E-1354-2011; Lindahl, Tomas L/H-5150-2012; von Bergen, Martin/D-7960-2011; Swenson, Jon/AAE-2890-2019; Rolle-Kampczyk, Ulrike E./D-4786-2015; Evans, Alina/AAH-8881-2019	Overgaard, Michael Toft/0000-0002-1423-2481; Lindahl, Tomas L/0000-0003-0174-8152; von Bergen, Martin/0000-0003-2732-2977; Rolle-Kampczyk, Ulrike E./0000-0002-7728-6284; Welinder, Karen Gjesing/0000-0002-5409-0131; Sonderkaer, Mads/0000-0002-9309-7459; Frobert, Ole/0000-0002-5846-345X	Lundbech Foundation [R126-2012-12408]; Aalborg University; Lundbeck Foundation [R194-2015-1108, R126-2012-12408] Funding Source: researchfish	Lundbech Foundation; Aalborg University; Lundbeck Foundation(Lundbeckfonden)	This work was supported by Grant R126-2012-12408 from the Lundbech Foundation (to F. O. and M. T. O.) and by Aalborg University (to K. G. W. and R. H.). The authors declare that they have no conflicts of interest with the contents of this article.	Arinell K, 2012, CTS-CLIN TRANSL SCI, V5, P269, DOI 10.1111/j.1752-8062.2011.00370.x; Banerjee S, 2012, FREE RADICAL BIO MED, V53, P1317, DOI 10.1016/j.freeradbiomed.2012.07.023; Blumenthal S, 2011, AM J PHYSIOL-ENDOC M, V301, pE628, DOI 10.1152/ajpendo.00082.2011; BOCCHINFUSO WP, 1992, ENDOCRINOLOGY, V131, P2331, DOI 10.1210/en.131.5.2331; Cahill JA, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003345; Canoy D, 2014, EUR J ENDOCRINOL, V170, P863, DOI 10.1530/EJE-13-1046; Carey HV, 2003, PHYSIOL REV, V83, P1153, DOI 10.1152/physrev.00008.2003; Chauhan V, 2002, BIOCHIMIE, V84, P1031, DOI 10.1016/S0300-9084(02)00006-8; Chow BA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066119; Croft D, 2011, NUCLEIC ACIDS RES, V39, pD691, DOI 10.1093/nar/gkq1018; Evans AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040520; Fedorov VB, 2014, MOL ECOL, V23, P5524, DOI 10.1111/mec.12963; Fedorov VB, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-171; Friebe A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101410; Fuster G, 2007, CLIN NUTR, V26, P658, DOI 10.1016/j.clnu.2007.07.003; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2013, CURR BIOL, V23, pR188, DOI 10.1016/j.cub.2013.01.062; Graesli AR, 2015, BMC VET RES, V11, DOI 10.1186/s12917-015-0615-2; GUSTAFSON AW, 1985, BIOL REPROD, V33, P1126, DOI 10.1095/biolreprod33.5.1126; Harlow HJ, 2002, J MAMMAL, V83, P1020, DOI 10.1644/1545-1542(2002)083&lt;1020:BMALCB&gt;2.0.CO;2; Hortin GL, 2008, CLIN CHEM, V54, P1608, DOI 10.1373/clinchem.2008.108175; Iaizzo PA, 2012, INTEGR ZOOL, V7, P48, DOI [10.1111/j.1749-4877.2012.00275.x, 10.1111/j.1749-4877.2011.00280.x]; Jorgensen PG, 2014, CARDIOVASC ULTRASOUN, V12, DOI 10.1186/1476-7120-12-36; Li GW, 2014, CELL, V157, P624, DOI 10.1016/j.cell.2014.02.033; Li RQ, 2010, NATURE, V463, P311, DOI 10.1038/nature08696; Liu SP, 2014, CELL, V157, P785, DOI 10.1016/j.cell.2014.03.054; Lohuis TD, 2007, COMP BIOCHEM PHYS B, V147, P20, DOI 10.1016/j.cbpb.2006.12.020; Villanueva-Canas JL, 2014, INTEGR COMP BIOL, V54, P452, DOI 10.1093/icb/icu048; MCMILLIN JM, 1976, BIOL REPROD, V15, P163, DOI 10.1095/biolreprod15.2.163; Mominoki K, 2005, COMP BIOCHEM PHYS A, V142, P472, DOI 10.1016/j.cbpa.2005.09.017; Nelson OL, 2010, J COMP PHYSIOL B, V180, P465, DOI 10.1007/s00360-009-0421-x; PALMER SS, 1988, BIOL REPROD, V38, P1044, DOI 10.1095/biolreprod38.5.1044; PANNEVIS MC, 1992, J COMP PHYSIOL B, V162, P393; RCoreTeam, 2014, R LANG ENV STAT COMP; Revsbech IG, 2013, AM J PHYSIOL-REG I, V304, pR43, DOI 10.1152/ajpregu.00440.2012; Ritchie RF, 2004, J CLIN LAB ANAL, V18, P139, DOI 10.1002/jcla.20012; Rosner W, 2010, MOL CELL ENDOCRINOL, V316, P79, DOI 10.1016/j.mce.2009.08.009; SABOUREAU M, 1982, GEN COMP ENDOCR, V47, P59, DOI 10.1016/0016-6480(82)90084-3; Sahdo B, 2013, INT J MED SCI, V10, P508, DOI 10.7150/ijms.4476; Schwanhausser B, 2011, NATURE, V473, P337, DOI 10.1038/nature10098; Sheikh AM, 2003, BIOCHIMIE, V85, P1027, DOI 10.1016/S0300-9084(03)00133-0; Sleep D, 2013, BBA-GEN SUBJECTS, V1830, P5526, DOI 10.1016/j.bbagen.2013.04.023; Sommer F, 2016, CELL REP, V14, P1655, DOI 10.1016/j.celrep.2016.01.026; Stenvinkel P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072934; Toien O, 2011, SCIENCE, V331, P906, DOI 10.1126/science.1199435; Tomasi TE, 1998, GEN COMP ENDOCR, V109, P192, DOI 10.1006/gcen.1997.7018; Vestergaard P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021483; Vizcaino JA, 2016, NUCLEIC ACIDS RES, V44, pD447, DOI 10.1093/nar/gkv1145; Vos MJ, 2014, J CLIN ENDOCR METAB, V99, pE1798, DOI 10.1210/jc.2014-2055; Wallace IR, 2013, CLIN ENDOCRINOL, V78, P321, DOI 10.1111/cen.12086; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]; Zedrosser A, 2007, J ANIM ECOL, V76, P368, DOI 10.1111/j.1365-2656.2006.01203.x; Zhao S, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-201	54	24	24	1	29	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 21	2016	291	43					22509	22523		10.1074/jbc.M116.742916	http://dx.doi.org/10.1074/jbc.M116.742916			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA6SZ	27609515	Green Published, Green Submitted, hybrid			2022-12-26	WOS:000386760600013
J	Desfougeres, Y; Gerasimaite, R; Jessen, HJ; Mayer, A				Desfougeres, Yann; Gerasimaite, Ruta; Jessen, Henning Jacob; Mayer, Andreas			Vtc5, a Novel Subunit of the Vacuolar Transporter Chaperone Complex, Regulates Polyphosphate Synthesis and Phosphate Homeostasis in Yeast	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						homeostasis; inositol phosphate; plant physiology; vacuole; yeast; polyphosphate; acidocalcisome; phosphate homeostasis	CYCLIN-CDK COMPLEX; SACCHAROMYCES-CEREVISIAE; INORGANIC POLYPHOSPHATE; V-ATPASE; SOLUBLE EXOPOLYPHOSPHATASE; TRYPANOSOMA-CRUZI; MEMBRANE-FUSION; AMINO-ACID; PROTEIN; GENE	SPX domains control phosphate homeostasis in eukaryotes. Ten genes in yeast encode SPX-containing proteins, among which YDR089W is the only one of unknown function. Here, we show that YDR089W encodes a novel subunit of the vacuole transporter chaperone (VTC) complex that produces inorganic polyphosphate (polyP). The polyP synthesis transfers inorganic phosphate (P-i) from the cytosol into the acidocalcisome- and lysosome-related vacuoles of yeast, where it can be released again. It was therefore proposed for buffer changes in cytosolic P-i concentration (Thomas, M. R., and O'Shea, E. K. (2005) Proc. Natl. Acad. Sci. U.S.A. 102, 9565-9570). Vtc5 physically interacts with the VTC complex and accelerates the accumulation of polyP synthesized by it. Deletion of VTC5 reduces polyP accumulation in vivo and in vitro. Its overexpression hyperactivates polyP production and triggers the phosphate starvation response via the PHO pathway. Because this Vtc5-induced starvation response can be reverted by shutting down polyP synthesis genetically or pharmacologically, we propose that polyP synthesis rather than Vtc5 itself is a regulator of the PHO pathway. Our observations suggest that polyP synthesis not only serves to establish a buffer for transient drops in cytosolic P-i levels but that it can actively decrease or increase the steady state of cytosolic P-i.	[Desfougeres, Yann; Gerasimaite, Ruta; Mayer, Andreas] Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland; [Jessen, Henning Jacob] Univ Freiburg, Inst Organ Chem, D-79104 Freiburg, Germany; [Desfougeres, Yann] UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of Lausanne; University of Freiburg; University of London; University College London	Mayer, A (corresponding author), Univ Lausanne, Dept Biochem, Chemin Boveresses 155, CH-1066 Epalinges, Switzerland.	andreas.mayer@unil.ch	Gerasimaitė, Rūta/GLV-5402-2022; Mayer, Andreas/AAE-4315-2020; Desfougères, Yann/AAC-9244-2019; Jessen, Henning/O-1157-2019; Jessen, Henning/F-5108-2014	Mayer, Andreas/0000-0001-6131-313X; Desfougères, Yann/0000-0002-6450-5863; Jessen, Henning/0000-0002-1025-9484; Jessen, Henning/0000-0002-1025-9484	European Research Council [233458]; Schweizerischer Nationalfonds zur Forderung der Wissenschaften [144258, 163477/1, PP00P2-157607]	European Research Council(European Research Council (ERC)European Commission); Schweizerischer Nationalfonds zur Forderung der Wissenschaften	This work was supported by European Research Council Grant 233458 and Schweizerischer Nationalfonds zur Forderung der Wissenschaften Grants 144258 and 163477/1 (to A. M.) and PP00P2-157607 (to H. J. J.). The authors declare that they have no conflicts of interest with the contents of this article.	Auesukaree C, 2005, J BIOL CHEM, V280, P25127, DOI 10.1074/jbc.M414579200; Auesukaree C, 2004, J BIOL CHEM, V279, P17289, DOI 10.1074/jbc.M312202200; Baars TL, 2007, MOL BIOL CELL, V18, P3873, DOI 10.1091/mbc.E07-03-0205; Bru S, 2016, MOL MICROBIOL, V101, P367, DOI 10.1111/mmi.13396; BunYa M, 1996, CURR GENET, V29, P344, DOI 10.1007/s002940050055; Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885; Desfougeres Y, 2016, J CELL SCI, V129, P2817, DOI 10.1242/jcs.184382; DURR M, 1979, ARCH MICROBIOL, V121, P169, DOI 10.1007/BF00689982; Fang JM, 2007, J BIOL CHEM, V282, P32501, DOI 10.1074/jbc.M704841200; Fisher E, 2005, J BIOL CHEM, V280, P36110, DOI 10.1074/jbc.M507051200; Gerasimaite R, 2014, J CELL SCI, V127, P5093, DOI 10.1242/jcs.159772; Giots F, 2003, MOL MICROBIOL, V47, P1163, DOI 10.1046/j.1365-2958.2003.03365.x; Giovannini D, 2013, CELL REP, V3, P1866, DOI 10.1016/j.celrep.2013.05.035; HAAS A, 1994, J CELL BIOL, V126, P87, DOI 10.1083/jcb.126.1.87; Han BK, 2005, GENE DEV, V19, P2606, DOI 10.1101/gad.1361505; Holt LJ, 2009, SCIENCE, V325, P1682, DOI 10.1126/science.1172867; Hothorn M, 2009, SCIENCE, V324, P513, DOI 10.1126/science.1168120; Hurlimann BC, 2007, MOL BIOL CELL, V18, P4438, DOI 10.1091/mbc.E07-05-0457; Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142; JONES EW, 1982, GENETICS, V102, P665; KAFFMAN A, 1994, SCIENCE, V263, P1153, DOI 10.1126/science.8108735; Kornberg A, 1999, ANNU REV BIOCHEM, V68, P89, DOI 10.1146/annurev.biochem.68.1.89; Kulak NA, 2014, NAT METHODS, V11, P319, DOI [10.1038/NMETH.2834, 10.1038/nmeth.2834]; Kumble KD, 1996, J BIOL CHEM, V271, P27146, DOI 10.1074/jbc.271.43.27146; Lau WTW, 2000, P NATL ACAD SCI USA, V97, P1107, DOI 10.1073/pnas.97.3.1107; Lee YS, 2007, SCIENCE, V316, P109, DOI 10.1126/science.1139080; Li ZH, 2011, J BIOL CHEM, V286, P43959, DOI 10.1074/jbc.M111.311530; Liu C, 2000, J BIOL CHEM, V275, P31972, DOI 10.1074/jbc.M003055200; Ljungdahl PO, 2012, GENETICS, V190, P885, DOI 10.1534/genetics.111.133306; Lonetti A, 2011, J BIOL CHEM, V286, P31966, DOI 10.1074/jbc.M111.266320; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Michaillat L, 2012, MOL BIOL CELL, V23, P881, DOI 10.1091/mbc.E11-08-0703; Muller O, 2003, J CELL SCI, V116, P1107, DOI 10.1242/jcs.00328; Muller O, 2002, EMBO J, V21, P259, DOI 10.1093/emboj/21.3.259; Muller O, 2001, EMBO J, V20, P5657, DOI 10.1093/emboj/20.20.5657; Ogawa N, 2000, MOL BIOL CELL, V11, P4309, DOI 10.1091/mbc.11.12.4309; ONeill EM, 1996, SCIENCE, V271, P209, DOI 10.1126/science.271.5246.209; Peters C, 2004, CELL, V119, P667, DOI 10.1016/j.cell.2004.11.023; Pieren M, 2010, NAT STRUCT MOL BIOL, V17, P710, DOI 10.1038/nsmb.1809; Pinson B, 2004, J BIOL CHEM, V279, P35273, DOI 10.1074/jbc.M405398200; Reese C, 2005, NATURE, V436, P410, DOI 10.1038/nature03722; SCHNEIDER KR, 1994, SCIENCE, V266, P122, DOI 10.1126/science.7939631; Secco D, 2012, FEBS LETT, V586, P289, DOI 10.1016/j.febslet.2012.01.036; Sethuraman A, 2001, P NATL ACAD SCI USA, V98, P8542, DOI 10.1073/pnas.151269398; Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130; Shirahama K, 1996, PLANT CELL PHYSIOL, V37, P1090, DOI 10.1093/oxfordjournals.pcp.a029058; Smith SA, 2007, ELECTROPHORESIS, V28, P3461, DOI 10.1002/elps.200700041; SPAIN BH, 1995, J BIOL CHEM, V270, P25435, DOI 10.1074/jbc.270.43.25435; Springer M, 2003, PLOS BIOL, V1, P261, DOI 10.1371/journal.pbio.0000028; Thomas MR, 2005, P NATL ACAD SCI USA, V102, P9565, DOI 10.1073/pnas.0501122102; TOHE A, 1973, J BACTERIOL, V113, P727, DOI 10.1128/JB.113.2.727-738.1973; UEDA Y, 1975, J BACTERIOL, V122, P911, DOI 10.1128/JB.122.3.911-922.1975; Uttenweiler A, 2007, MOL BIOL CELL, V18, P166, DOI 10.1091/mbc.E06-08-0664; Vardi N, 2014, CELL REP, V9, P1122, DOI 10.1016/j.celrep.2014.10.002; Vardi N, 2013, CURR BIOL, V23, P2051, DOI 10.1016/j.cub.2013.08.043; Vaughan AE, 2012, J VIROL, V86, P1661, DOI 10.1128/JVI.06073-11; Werner TP, 2005, ARCH MICROBIOL, V184, P129, DOI 10.1007/s00203-005-0031-2; WIEMKEN A, 1970, Archiv fuer Mikrobiologie, V70, P89, DOI 10.1007/BF00412200; Wild R, 2016, SCIENCE, V352, P986, DOI 10.1126/science.aad9858; WURST H, 1994, J BIOL CHEM, V269, P10996; Wykoff DD, 2001, GENETICS, V159, P1491	61	45	45	2	40	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22262	22275		10.1074/jbc.M116.746784	http://dx.doi.org/10.1074/jbc.M116.746784			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27587415	Green Published, hybrid			2022-12-26	WOS:000386332600037
J	Asou, Y; Iwata, M; Ochi, H; Ailixiding, M; Aibibula, Z; Piao, JY; Jin, GW; Hara, Y; Okawa, A				Asou, Yoshinori; Iwata, Munetaka; Ochi, Hiroki; Ailixiding, Maierhaba; Aibibula, Zulipiya; Piao, Jinying; Jin, Guangwen; Hara, Yasushi; Okawa, Atsushi			Pleiotropic Functions of High Fat Diet in the Etiology of Osteoarthritis	PLOS ONE			English	Article							BONE-RESORPTION; INDUCED OBESITY; KNEE-JOINT; DEGRADATION; PAD; CHONDROCYTES; INFLAMMATION; OVERWEIGHT; APOPTOSIS; MOUSE	Obesity is a risk factor for osteoarthritis(OA). To investigate the roles of increased mechanical loading in the onset of obesity-induced OA, knee joints were histologically analyzed after applying a tail suspension (TS) model to a high-fat diet (HFD)-induced OA model. Mice were divided into four groups: normal diet (ND) with normal loading (NL) group; HFD with NL group; ND with TS group; and HFD with TS group. Whole knee joints were evaluated by immunohistological analysis. The infrapatellar fat pad (IPFP) was excised and mRNA expression profiles were compared by qPCR analysis. After twelve weeks of the diet, body weight was increased by HFD in both the NL group and TS group. Upon histological analysis, the irregularity of the surface layer of articular cartilage was observed only in the NL+HFD group. Osteophyte area increased as a result of HFD in both the NL and TS groups, although osteophyte area in the TS+HFD group was smaller than that of the NL+HFD group. In the evaluation of the IPFP by qPCR, adipokines and inflammatory cytokines also increased as a result of HFD. While TGF-beta increased as a result of HFD, the trend was slightly lower in the TS group, in parallel with osteophyte area. To detect apoptosis of articular chondrocytes, TUNEL staining was employed. TUNEL-positive cells were abundantly observed in the articular cartilage in the HFD mice regardless of mechanical loading. IPFP inflammation, enhanced chondrocyte apoptosis, and osteophyte formation were seen even in the TS group as a result of a HFD. In all, these data demonstrate that HFD contributed to osteophyte formation through mechanical loading dependent and independent mechanisms.	[Asou, Yoshinori; Aibibula, Zulipiya; Piao, Jinying; Jin, Guangwen; Okawa, Atsushi] Tokyo Med & Dent Univ, Dept Orthoped Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan; [Iwata, Munetaka; Hara, Yasushi] Nippon Vet & Life Sci Univ, Div Vet Surg, 1-7-1 Sakaiminamicho, Musashino, Tokyo 1808602, Japan; [Ochi, Hiroki] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan; [Ailixiding, Maierhaba] Tokyo Med & Dent Univ, Grad Sch, Dept Rehabil Med, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan	Tokyo Medical & Dental University (TMDU); Nippon Veterinary & Life Science University; Tokyo Medical & Dental University (TMDU); Tokyo Medical & Dental University (TMDU)	Asou, Y (corresponding author), Tokyo Med & Dent Univ, Dept Orthoped Surg, Bunkyo Ku, 1-5-45 Yushima, Tokyo 1138519, Japan.	aso.orth@tmd.ac.jp		Iwata, Munetaka/0000-0002-5561-4996	Ministry of Education, Culture, Sports, Science, and Technology, Japan	Ministry of Education, Culture, Sports, Science, and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a grant from the Ministry of Education, Culture, Sports, Science, and Technology, Japan. The supporter had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors have declared that no competing interests exist.	ANDERSON JJ, 1988, AM J EPIDEMIOL, V128, P179, DOI 10.1093/oxfordjournals.aje.a114939; Andriacchi TP, 2004, PATHOMECHANICS OSTEO, P447; Bastiaansen-Jenniskens YM, 2012, ANN RHEUM DIS, V71, P288, DOI 10.1136/ard.2011.153858; Blanco FJ, 1998, ARTHRITIS RHEUM, V41, P284, DOI 10.1002/1529-0131(199802)41:2<284::AID-ART12>3.0.CO;2-T; CARMAN WJ, 1994, AM J EPIDEMIOL, V139, P119, DOI 10.1093/oxfordjournals.aje.a116974; Clockaerts S, 2010, OSTEOARTHR CARTILAGE, V18, P876, DOI 10.1016/j.joca.2010.03.014; Dahaghin S, 2007, ANN RHEUM DIS, V66, P916, DOI 10.1136/ard.2005.045724; Davidson ENB, 2007, ARTHRITIS RHEUM, V56, P4065, DOI 10.1002/art.23034; Distel E, 2009, ARTHRITIS RHEUM-US, V60, P3374, DOI 10.1002/art.24881; Doi T, 2002, OSTEOARTHR CARTILAGE, V10, P270, DOI 10.1053/joca.2001.0503; Dumond H, 2003, ARTHRITIS RHEUM, V48, P3118, DOI 10.1002/art.11303; Gabay O, 2008, JOINT BONE SPINE, V75, P675, DOI 10.1016/j.jbspin.2008.07.011; Glasson SS, 2010, OSTEOARTHR CARTILAGE, V18, pS17, DOI 10.1016/j.joca.2010.05.025; Gosset M, 2008, ARTHRITIS RHEUM-US, V58, P1399, DOI 10.1002/art.23431; Grano M, 2002, CALCIFIED TISSUE INT, V70, P176, DOI 10.1007/s00223-001-2034-6; Griffin TM, 2012, ARTHRITIS RHEUM-US, V64, P443, DOI 10.1002/art.33332; Griffin TM, 2010, ARTHRITIS RES THER, V12, DOI 10.1186/ar3068; Hashimoto S, 1998, ARTHRITIS RHEUM-US, V41, P1632, DOI 10.1002/1529-0131(199809)41:9<1632::AID-ART14>3.0.CO;2-A; Hirose T, 2008, J APPL PHYSIOL, V104, P170, DOI 10.1152/japplphysiol.00463.2006; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Iwata M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060706; Kamekura S, 2005, OSTEOARTHR CARTILAGE, V13, P632, DOI 10.1016/j.joca.2005.03.004; Kamiya T, 2010, J BIOMED MATER RES A, V92A, P801, DOI 10.1002/jbm.a.32295; Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395; Klein-Wieringa IR, 2011, ANN RHEUM DIS, V70, P851, DOI 10.1136/ard.2010.140046; Kwon OS, 2015, AM J PHYSIOL-ENDOC M, V309, pE11, DOI 10.1152/ajpendo.00124.2015; Li Y, 2011, J BONE MINER RES, V26, P2656, DOI 10.1002/jbmr.480; Magliano Malgorzata, 2008, Menopause Int, V14, P149, DOI 10.1258/mi.2008.008018; Saamanen AMK, 2000, OSTEOARTHR CARTILAGE, V8, P248, DOI 10.1053/joca.2000.0298; Scharstuhl A, 2002, J IMMUNOL, V169, P507, DOI 10.4049/jimmunol.169.1.507; SILBERBERG M, 1952, Exp Med Surg, V10, P76; SOKOLOFF L, 1960, AM J PHYSIOL, V198, P765, DOI 10.1152/ajplegacy.1960.198.4.765; Tomiya M, 2009, BONE, V44, P295, DOI 10.1016/j.bone.2008.10.038; Tozuka Y, 2009, FASEB J, V23, P1920, DOI 10.1096/fj.08-124784; WALTON M, 1979, J PATHOL, V127, P165, DOI 10.1002/path.1711270402; WILHELMI G, 1976, PHARMACOLOGY, V14, P289, DOI 10.1159/000136607; Won Y, 2016, ANN RHEUM DIS, V75, P2045, DOI 10.1136/annrheumdis-2015-208406; Yang S, 2015, ANN RHEUM DIS, V74, P595, DOI 10.1136/annrheumdis-2013-204355	38	14	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162794	10.1371/journal.pone.0162794	http://dx.doi.org/10.1371/journal.pone.0162794			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611831	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255900167
J	Galindo-Romero, C; Harun-Or-Rashid, M; Jimenez-Lopez, M; Vidal-Sanz, M; Agudo-Barriuso, M; Hallbook, F				Galindo-Romero, Caridad; Harun-Or-Rashid, Mohammad; Jimenez-Lopez, Manuel; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta; Hallbook, Finn			Neuroprotection by alpha 2-Adrenergic Receptor Stimulation after Excitotoxic Retinal Injury: A Study of the Total Population of Retinal Ganglion Cells and Their Distribution in the Chicken Retina	PLOS ONE			English	Article							CHRONIC OCULAR HYPERTENSION; QUANTITATIVE-ANALYSIS; SPATIAL-DISTRIBUTION; GROWTH-FACTOR; MULLER CELLS; COMPUTERIZED ANALYSIS; EMBRYONIC-DEVELOPMENT; EXPERIMENTAL GLAUCOMA; TRANSIENT ISCHEMIA; AMACRINE CELLS	We have studied the effect of alpha 2-adrenergic receptor stimulation on the total excitotoxically injured chicken retinal ganglion cell population. N-methyl-D-aspartate (NMDA) was intraocularly injected at embryonic day 18 and Brn3a positive retinal ganglion cells (Brn3a+ RGCs) were counted in flat-mounted retinas using automated routines. The number and distribution of the Brn3a+ RGCs were analyzed in series of normal retinas from embryonic day 8 to post-hatch day 11 retinas and in retinas 7 or 14 days post NMDA lesion. The total number of Brn3a+ RGCs in the post-hatch retina was approximately 1.9x10(6) with a density of approximately 9.2x10(3) cells/mm(2). The isodensity maps of normal retina showed that the density decreased with age as the retinal size increased. In contrast to previous studies, we did not find any specific region with increased RGC density, rather the Brn3a+ RGCs were homogeneously distributed over the central retina with decreasing density in the periphery and in the region of the pecten oculli. Injection of 5-10 mu g NMDA caused 30-50% loss of Brn3a+ cells and the loss was more severe in the dorsal than in the ventral retina. Pretreatment with brimonidine reduced the loss of Brn3a+ cells both 7 and 14 days post lesion and the protective effect was higher in the dorsal than in the ventral retina. We conclude that alpha 2-adrenergic receptor stimulation reduced the impact of the excitotoxic injury in chicken similarly to what has been shown in mammals. Furthermore, the data show that the RGCs are evenly distributed over in the retina, which challenges previous results that indicate the presence of specific high RGC-density regions of the chicken retina.	[Galindo-Romero, Caridad; Harun-Or-Rashid, Mohammad; Hallbook, Finn] Uppsala Univ, Dept Neurosci, Box 593, S-75124 Uppsala, Sweden; [Galindo-Romero, Caridad; Jimenez-Lopez, Manuel; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta] Univ Murcia, Inst Murciano Invest Biosanitaria, Hosp Virgen de la Arrixaca IMIB Virgen de la Arri, Murcia, Spain; [Galindo-Romero, Caridad; Jimenez-Lopez, Manuel; Vidal-Sanz, Manuel; Agudo-Barriuso, Marta] Univ Murcia, Fac Med, Dept Oftalmol, Murcia, Spain	Uppsala University; University of Murcia; University of Murcia	Hallbook, F (corresponding author), Uppsala Univ, Dept Neurosci, Box 593, S-75124 Uppsala, Sweden.	Finn.hallbook@neuro.uu.se	GALINDO-ROMERO, CARIDAD/AAF-8324-2021; Agudo-Barriuso, Marta/B-7100-2016	GALINDO-ROMERO, CARIDAD/0000-0001-9469-9868; Agudo-Barriuso, Marta/0000-0002-8566-9277; Hallbook, Finn/0000-0001-7552-187X	Spanish Ministry of Economy and Competitiveness [SAF-2012-38328]; ISCIII-FEDER "Una manera de hacer Europa'' [PI13/00643, PI13/01266]; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS) [RD12/0034/0014, RD12/0034/0010]; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for Synskadade; Swedish Research Council [MH521.2013.3346]	Spanish Ministry of Economy and Competitiveness(Spanish Government); ISCIII-FEDER "Una manera de hacer Europa''; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS)(European Commission); Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for Synskadade; Swedish Research Council(Swedish Research CouncilEuropean Commission)	Supported by grants from the Spanish Ministry of Economy and Competitiveness: SAF-2012-38328, MVS; ISCIII-FEDER "Una manera de hacer Europa'' PI13/00643 and PI13/01266; Red Tem'atica de Investigaci'on Cooperativa en Salud (RETICS): RD12/0034/0014 and RD12/0034/0010; Stiftelsen Kronprinsessan Margaretas Arbetsnamnd for Synskadade 34:2015, FH; and Swedish Research Council MH521.2013.3346, FH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aviles-Trigueros M, 2003, EXP NEUROL, V184, P767, DOI 10.1016/S0014-4886(03)00298-X; BARRINGTON M, 1989, CURR EYE RES, V8, P781, DOI 10.3109/02713688909000868; Boije H, 2013, DIFFERENTIATION, V85, P11, DOI 10.1016/j.diff.2012.12.002; Boije H, 2013, J MOL NEUROSCI, V51, P615, DOI 10.1007/s12031-013-0034-4; Bruhn SL, 1996, J NEUROSCI, V16, P1430; Chen Y, 2004, ANAT HISTOL EMBRYOL, V33, P161, DOI 10.1111/j.1439-0264.2004.00528.x; Chen YX, 1999, BRAIN BEHAV EVOLUT, V53, P75, DOI 10.1159/000006584; Doh ST, 2010, BMC DEV BIOL, V10, DOI 10.1186/1471-213X-10-8; Dong CJ, 2008, INVEST OPHTH VIS SCI, V49, P4515, DOI 10.1167/iovs.08-2078; Dong CJ, 2010, INVEST OPHTH VIS SCI, V51, P4174, DOI 10.1167/iovs.09-4613; Erkman L, 1996, NATURE, V381, P603, DOI 10.1038/381603a0; Fischer AJ, 2001, NAT NEUROSCI, V4, P247, DOI 10.1038/85090; Fischer AJ, 1998, J COMP NEUROL, V393, P1; Fischer AJ, 2009, GLIA, V57, P166, DOI 10.1002/glia.20743; Galindo-Romero C, 2013, EXP EYE RES, V108, P84, DOI 10.1016/j.exer.2012.12.010; Galindo-Romero C, 2011, EXP EYE RES, V92, P377, DOI 10.1016/j.exer.2011.02.008; GALVEZ JMG, 1977, EXP NEUROL, V56, P151, DOI 10.1016/0014-4886(77)90145-5; Greenfield DS, 1997, J GLAUCOMA, V6, P250; Harun-Or-Rashid M, 2015, INVEST OPHTH VIS SCI, V56, P5933, DOI 10.1167/iovs.15-16816; Harun-Or-Rashid M, 2014, INVEST OPHTH VIS SCI, V55, P3385, DOI 10.1167/iovs.13-13823; Heidinger V, 1999, GLIA, V25, P229, DOI 10.1002/(SICI)1098-1136(19990201)25:3<229::AID-GLIA3>3.0.CO;2-C; Jung KI, 2015, EUR J PHARMACOL, V765, P274, DOI 10.1016/j.ejphar.2015.08.035; Karlsson M, 2001, DEVELOPMENT, V128, P471; Lafuente MP, 2002, EXP EYE RES, V74, P181, DOI 10.1006/exer.2001.1122; Lafuente MP, 2001, INVEST OPHTH VIS SCI, V42, P2074; LAYER PG, 1982, NEUROSCI LETT, V31, P99, DOI 10.1016/0304-3940(82)90099-4; Li XD, 2008, DEV DYNAM, V237, P3210, DOI 10.1002/dvdy.21744; Liu W, 2000, DEVELOPMENT, V127, P3237; Lonngren U, 2006, BRAIN RES BULL, V71, P208, DOI 10.1016/j.brainresbull.2006.09.005; Mayor-Torroglosa S, 2005, INVEST OPHTH VIS SCI, V46, P3825, DOI 10.1167/iovs.05-0392; Mayordomo R, 2003, EUR J NEUROSCI, V18, P1744, DOI 10.1046/j.1460-9568.2003.02891.x; Nadal-Nicolas FM, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00099; Nadal-Nicolas FM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049830; Nadal-Nicolas FM, 2009, INVEST OPHTH VIS SCI, V50, P3860, DOI 10.1167/iovs.08-3267; Naito Jumpei, 2004, Anatomical Science International, V79, P213, DOI 10.1111/j.1447-073x.2004.00084.x; Ortin-Martinez A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113798; RAGER G, 1978, EXP BRAIN RES, V33, P65, DOI 10.1007/BF00238795; Salinas-Navarro M, 2009, VISION RES, V49, P637, DOI 10.1016/j.visres.2009.01.010; Salinas-Navarro M, 2009, VISION RES, V49, P115, DOI 10.1016/j.visres.2008.09.029; Seki M, 2005, NEUROCHEM RES, V30, P1163, DOI 10.1007/s11064-005-7936-7; SHIRAZI F, 2013, PLOS ONE, V0008; Stanke JJ, 2010, INVEST OPHTH VIS SCI, V51, P2208, DOI 10.1167/iovs.09-4447; Thangaraj G, 2012, J COMP NEUROL, V520, P3181, DOI 10.1002/cne.23083; TUNG NN, 1990, VISUAL NEUROSCI, V4, P217, DOI 10.1017/S0952523800003369; Vidal-Sanz M, 2015, PROG BRAIN RES, V220, P1, DOI 10.1016/bs.pbr.2015.04.008; Vidal-Sanz M, 2012, PROG RETIN EYE RES, V31, P1, DOI 10.1016/j.preteyeres.2011.08.001; Wan J, 2012, DEV CELL, V22, P334, DOI 10.1016/j.devcel.2011.11.020; Wen R, 1996, J NEUROSCI, V16, P5986; WILDSOET CF, 1988, INVEST OPHTH VIS SCI, V29, P311; WoldeMussie E, 2001, INVEST OPHTH VIS SCI, V42, P2849; XIANG MQ, 1995, J NEUROSCI, V15, P4762; Yoles E, 1999, INVEST OPHTH VIS SCI, V40, P65; ZEEVALK GD, 1989, J NEUROCHEM, V53, P1610, DOI 10.1111/j.1471-4159.1989.tb08559.x; Zelinka CP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044477	54	5	5	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161862	10.1371/journal.pone.0161862	http://dx.doi.org/10.1371/journal.pone.0161862			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611432	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900033
J	Hou, WC; Zhang, W; Chen, GD; Luo, YP				Hou, Wencheng; Zhang, Wei; Chen, Guode; Luo, Yanping			Optimization of Extraction Conditions for Maximal Phenolic, Flavonoid and Antioxidant Activity from Melaleuca bracteata Leaves Using the Response Surface Methodology	PLOS ONE			English	Article							CHEMICAL-COMPOSITION; OCIMUM-GRATISSIMUM; ESSENTIAL OILS; L.; COMMON; CAPACITY; STRESS; FRUIT; SKIN	Melaleuca bracteata is a yellow-leaved tree belonging to the Melaleuca genus. Species from this genus are known to be good sources of natural antioxidants, for example, the "tea tree oil" derived from M. alternifolia is used in food processing to extend the shelf life of products. In order to determine whether M. bracteata contains novel natural antioxidants, the components of M. bracteata ethanol extracts were analyzed by gas chromatography-mass spectrometry. Total phenolic and flavonoid contents were extracted and the antioxidant activities of the extracts evaluated. Single-factor experiments, central composite rotatable design (CCRD) and response surface methodology (RSM) were used to optimize the extraction conditions for total phenolic content (TPC) and total flavonoid content (TFC). Ferric reducing power (FRP) and 1,1-Diphenyl-2-picrylhydrazyl radical (DPPH.) scavenging capacity were used as the evaluation indices of antioxidant activity. The results showed that the main components of M. bracteata ethanol extracts are methyl eugenol (86.86%) and trans-cinnamic acid methyl ester (6.41%). The single-factor experiments revealed that the ethanol concentration is the key factor determining the TPC, TFC, FRP and DPPH.scavenging capacity. RSM results indicated that the optimal condition of all four evaluation indices was achieved by extracting for 3.65 days at 53.26 degrees C in 34.81% ethanol. Under these conditions, the TPC, TFC, FRP and DPPH.scavenging capacity reached values of 88.6 +/- 1.3 mg GAE/g DW, 19.4 +/- 0.2 mg RE/g DW, 2.37 +/- 0.01 mMFe(2+)/g DW and 86.0 +/- 0.3%, respectively, which were higher than those of the positive control, methyl eugenol (FRP 0.97 +/- 0.02 mM, DPPH.scavenging capacity 58.6 +/- 0.7%) at comparable concentrations. Therefore, the extracts of M. bracteata leaves have higher antioxidant activity, which did not only attributed to the methyl eugenol. Further research could lead to the development of a potent new natural antioxidant.	[Hou, Wencheng; Luo, Yanping] Hainan Univ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Minist Educ, Haikou 570228, Hainan, Peoples R China; [Hou, Wencheng; Luo, Yanping] Hainan Univ, Coll Environm & Plant Protect, Haikou 570228, Hainan, Peoples R China; [Zhang, Wei; Chen, Guode] Hainan Prov Forestry Sci Inst, Tongshen Branch Off, Wuzhishan 572200, Hainan, Peoples R China	Hainan University; Hainan University	Luo, YP (corresponding author), Hainan Univ, Key Lab Protect & Dev Utilizat Trop Crop Germplas, Minist Educ, Haikou 570228, Hainan, Peoples R China.; Luo, YP (corresponding author), Hainan Univ, Coll Environm & Plant Protect, Haikou 570228, Hainan, Peoples R China.	yanpluo@126.com			National Natural Science Foundation of China [21162007, 21402059]; Opening Project of Shanghai Key Laboratory of Chemical Biology	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Opening Project of Shanghai Key Laboratory of Chemical Biology	We are grateful for financial support from the National Natural Science Foundation of China (No. 21162007, 21402059) and the Opening Project of Shanghai Key Laboratory of Chemical Biology (2015).	Ai XingMei, 2014, Journal of West China Forestry Science, V43, P29; Asoodeh A, 2012, J PEPT SCI, V18, P10, DOI 10.1002/psc.1409; Bouaziz M, 2009, FOOD CHEM TOXICOL, V47, P2755, DOI 10.1016/j.fct.2009.08.005; Budhiraja SS, 1999, J MANIP PHYSIOL THER, V22, P447, DOI 10.1016/S0161-4754(99)70033-3; Chamani J, 2006, J COLLOID INTERF SCI, V293, P52, DOI 10.1016/j.jcis.2005.06.015; Chang CC, 2002, J FOOD DRUG ANAL, V10, P178; COSGROVE D. J., 1948, BULL IMPERIAL INST [GR BRIT], V46, P46; Du B., 2014, BIOACTIVE CARBOHYDRA, V3, P11, DOI [10.1016/j.bcdf.2013.12.001, DOI 10.1016/J.BCDF.2013.12.001]; Garcia-Salas P, 2010, MOLECULES, V15, P8813, DOI 10.3390/molecules15128813; Gliwa J, 2011, J AGR FOOD CHEM, V59, P11473, DOI 10.1021/jf2023353; Gulluce M, 2007, FOOD CHEM, V103, P1449, DOI 10.1016/j.foodchem.2006.10.061; Halake K, 2016, J IND ENG CHEM, V35, P1, DOI 10.1016/j.jiec.2016.01.003; Han QX, 2003, PLANT PROTECTION, V30, P60; Hefnawy H. T. M., 2013, Asian Pacific Journal of Tropical Disease, V3, P277; Holetzi FB, 2003, ACTA PROTOZOOL, V42, P269; Hou Shuting, 2014, ACTA BOTANICA BOREALI-OCCIDENTALIA SINICA, V34, P2491, DOI 10.7606/j.issn.1000-4025.2014.12.2491; Ibrahim MM, 2015, SAUDI J BIOL SCI, V22, P168, DOI 10.1016/j.sjbs.2014.11.019; Juergens UR, 2003, RESP MED, V97, P250, DOI 10.1053/rmed.2003.1432; Kim SG, 2009, COLLOID SURFACE A, V348, P289, DOI 10.1016/j.colsurfa.2009.07.043; Kim SC, 2016, J IND ENG CHEM, V38, P93, DOI 10.1016/j.jiec.2016.04.010; Kumarappan CT, 2012, SAUDI J BIOL SCI, V19, DOI 10.1016/j.sjbs.2012.04.004; Kuppusamy S, 2016, PROCESS SAF ENVIRON, V100, P173, DOI 10.1016/j.psep.2016.01.009; Kuppusamy S, 2016, IND CROP PROD, V83, P630, DOI 10.1016/j.indcrop.2015.12.060; Lee LS, 2016, J CEREAL SCI, V68, P181, DOI 10.1016/j.jcs.2015.07.005; Lemos JD, 2005, MEM I OSWALDO CRUZ, V100, P55, DOI 10.1590/S0074-02762005000100011; [林晓红 Lin Xiaohong], 2015, [热带作物学报, Chinese Journal of Tropical Crops], V36, P991; Liu GL, 2010, J ANHUI AGR SCI, V38, P12062; Martins N, 2016, TRENDS FOOD SCI TECH, V48, P1, DOI 10.1016/j.tifs.2015.11.008; Mokrani A, 2016, SEP PURIF TECHNOL, V162, P68, DOI 10.1016/j.seppur.2016.01.043; Naczk M, 2006, J PHARMACEUT BIOMED, V41, P1523, DOI 10.1016/j.jpba.2006.04.002; Padalia RC, 2015, IND CROP PROD, V63, P264, DOI 10.1016/j.indcrop.2014.09.039; Qian ZJ, 2008, BIORESOURCE TECHNOL, V99, P1690, DOI 10.1016/j.biortech.2007.04.005; Qu FX, 2011, NO HORTICULTURE, V8, P152; Saurav K, 2012, SAUDI J BIOL SCI, V19, P81, DOI 10.1016/j.sjbs.2011.07.003; Shim JY, 2010, TOXICOL APPL PHARM, V242, P318, DOI 10.1016/j.taap.2009.11.005; Silva CJ, 2010, QUIM NOVA, V33, P104, DOI 10.1590/S0100-40422010000100019; Silva EM, 2007, SEP PURIF TECHNOL, V55, P381, DOI 10.1016/j.seppur.2007.01.008; Singh M, 2014, EUR J MED CHEM, V84, P206, DOI 10.1016/j.ejmech.2014.07.013; Sokmen M, 2004, J AGR FOOD CHEM, V52, P3309, DOI 10.1021/jf049859g; Tang JC, 2016, APPL ENERG, V169, P696, DOI 10.1016/j.apenergy.2016.02.042; Tao Yan-Yan, 2004, Zhong Xi Yi Jie He Xue Bao, V2, P145, DOI 10.3736/jcim20040223; Tchabo W, 2015, IND CROP PROD, V63, P214, DOI 10.1016/j.indcrop.2014.09.053; Wang LF, 2016, FOOD CHEM, V196, P509, DOI 10.1016/j.foodchem.2015.09.083; Wojtunik-Kulesza KA, 2016, BIOMED PHARMACOTHER, V78, P39, DOI 10.1016/j.biopha.2015.12.024; [吴丽君 Wu Lijun], 2010, [福建林学院学报, Journal of Fujian College of Forestry], V30, P314; Xu GH, 2007, J AGR FOOD CHEM, V55, P330, DOI 10.1021/jf062517l; Yang LiQiong, 2014, Guizhou Agricultural Sciences, V42, P150; [叶征美 Ye Zhengmei], 2014, [热带作物学报, Chinese Journal of Tropical Crops], V35, P992; Yoshimura M, 2008, PHYTOCHEMISTRY, V69, P3062, DOI 10.1016/j.phytochem.2008.04.004; ZHONG CY, 2009, FLAVOUR FRAGRANCE CO, V6, P8	50	27	28	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162139	10.1371/journal.pone.0162139	http://dx.doi.org/10.1371/journal.pone.0162139			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611576	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900047
J	Kopylov, PK; Platonov, ME; Ablamunits, VG; Kombarova, TI; Ivanov, SA; Kadnikova, LA; Somov, AN; Dentovskaya, SV; Uversky, VN; Anisimov, AP				Kopylov, Pavel Kh.; Platonov, Mikhail E.; Ablamunits, Vitaly G.; Kombarova, Tat'yana I.; Ivanov, Sergey A.; Kadnikova, Lidiya A.; Somov, Aleksey N.; Dentovskaya, Svetlana V.; Uversky, Vladimir N.; Anisimov, Andrey P.			Yersinia pestis Caf1 Protein: Effect of Sequence Polymorphism on Intrinsic Disorder Propensity, Serological Cross-Reactivity and Cross-Protectivity of Isoforms	PLOS ONE			English	Article							MOLECULAR RECOGNITION FEATURES; UNSTRUCTURED PROTEINS; PLAGUE VACCINES; F1 ANTIGEN; WEB SERVER; B-CELL; BINDING; PREDICTION; REGIONS; PHAGOCYTOSIS	Yersinia pestis Caf1 is a multifunctional protein responsible for antiphagocytic activity and is a key protective antigen. It is generally conserved between globally distributed Y. pestis strains, but Y. pestis subsp. microtus biovar caucasica strains circulating within populations of common voles in Georgia and Armenia were reported to carry a single substitution of alanine to serine. We investigated polymorphism of the Caf1 sequences among other Y. pestis subsp. microtus strains, which have a limited virulence in guinea pigs and in humans. Sequencing of caf1 genes from 119 Y. pestis strains belonging to different biovars within subsp. microtus showed that the Caf1 proteins exist in three isoforms, the global type Caf1(NT1) (Ala48 Phe117), type Caf1(NT2) (Ser48 Phe117) found in Transcaucasian-highland and Pre-Araks natural plague foci #4-7, and a novel Caf1(NT3) type (Ala48 Val117) endemic in Dagestan-highland natural plague focus #39. Both minor types are the progenies of the global isoform. In this report, Caf1 polymorphism was analyzed by comparing predicted intrinsic disorder propensities and potential protein-protein interactivities of the three Caf1 isoforms. The analysis revealed that these properties of Caf1 protein are minimally affected by its polymorphism. All protein isoforms could be equally detected by an immunochromatography test for plague at the lowest protein concentration tested (1.0 ng/mL), which is the detection limit. When compared to the classic Caf1(NT1) isoform, the endemic Caf1(NT2) or Caf1(NT3) had lower immunoreactivity in ELISA and lower indices of self-and cross-protection. Despite a visible reduction in cross-protection between all Caf1 isoforms, our data suggest that polymorphism in the caf1 gene may not allow the carriers of Caf1(NT2) or Caf1(NT3) variants escaping from the Caf1(NT1)-mediated immunity to plague in the case of a low-dose flea-borne infection.	[Kopylov, Pavel Kh.; Platonov, Mikhail E.; Kombarova, Tat'yana I.; Ivanov, Sergey A.; Kadnikova, Lidiya A.; Somov, Aleksey N.; Dentovskaya, Svetlana V.; Anisimov, Andrey P.] State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia; [Ablamunits, Vitaly G.] St Petersburg Med Pediat Univ, St Petersburg, Russia; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL 33620 USA; [Uversky, Vladimir N.] Russian Acad Sci, Inst Biol Instrumentat, Lab New Methods Biol, Pushchino, Moscow Region, Russia	State University System of Florida; University of South Florida; State University System of Florida; University of South Florida; Russian Academy of Sciences	Anisimov, AP (corresponding author), State Res Ctr Appl Microbiol & Biotechnol, Obolensk, Moscow Region, Russia.; Uversky, VN (corresponding author), Univ S Florida, Morsani Coll Med, Dept Mol Med, Tampa, FL 33620 USA.; Uversky, VN (corresponding author), Univ S Florida, Morsani Coll Med, Byrd Alzheimers Res Inst, Tampa, FL 33620 USA.; Uversky, VN (corresponding author), Russian Acad Sci, Inst Biol Instrumentat, Lab New Methods Biol, Pushchino, Moscow Region, Russia.	vuversky@health.usf.edu; a-p-anisimov@yandex.ru	Anisimov, Andrey P/D-2217-2009; Platonov, Mikhail E/S-1209-2016; Dentovskaya, Svetlana/F-4623-2017; Ivanov, Sergey/GSD-3061-2022; Michael, Platonov/GZG-8615-2022; Somov, Alexey N/Q-1577-2017; Anisimov, Andrey P./H-5257-2012; Uversky, Vladimir N./F-4515-2011	Anisimov, Andrey P/0000-0002-5499-7999; Dentovskaya, Svetlana/0000-0002-1996-8949; Anisimov, Andrey P./0000-0002-5499-7999; Uversky, Vladimir N./0000-0002-4037-5857; Platonov, Mihail/0000-0003-3946-1755	Russian Science Foundation (Ru) [14-15-00599]; Russian Science Foundation [14-15-00599] Funding Source: Russian Science Foundation	Russian Science Foundation (Ru)(Russian Science Foundation (RSF)); Russian Science Foundation(Russian Science Foundation (RSF))	This research and PKK MEP TIK SAI LAK SVD APA were supported by the Russian Science Foundation (Ru) (grant 14-15-00599; http://www.rscf.ru/en/).	Anisimov AP, 2004, CLIN MICROBIOL REV, V17, P434, DOI 10.1128/CMR.17.2.434-464.2004; CAVANAUGH DC, 1959, J IMMUNOL, V83, P348; Cheng YG, 2007, BIOCHEMISTRY-US, V46, P13468, DOI 10.1021/bi7012273; Cui YJ, 2013, P NATL ACAD SCI USA, V110, P577, DOI 10.1073/pnas.1205750110; Daughdrill GW, 2005, HDB PROTEIN FOLDING, P271; Dennis DT, 1999, WKLY EPIDEMIOL REC, V74, P447; Dentovskaya SV, 2013, MOL GENET MICROBIOL+, V28, P87, DOI 10.3103/S089141681303004X; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dosztanyi Z, 2009, BIOINFORMATICS, V25, P2745, DOI 10.1093/bioinformatics/btp518; DROZDOV IG, 1995, J MED MICROBIOL, V42, P264, DOI 10.1099/00222615-42-4-264; Du YD, 2002, INFECT IMMUN, V70, P1453, DOI 10.1128/IAI.70.3.1453-1460.2002; Dunker AK, 2008, NAT CHEM BIOL, V4, P229, DOI 10.1038/nchembio0408-229; Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002; Dunker AK, 2002, ADV PROTEIN CHEM, V62, P25; Dunker AK, 2002, BIOCHEMISTRY-US, V41, P6573, DOI 10.1021/bi012159+; Dunker AK, 2001, J MOL GRAPH MODEL, V19, P26, DOI 10.1016/S1093-3263(00)00138-8; Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589; Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0; Fan X, 2014, J BIOMOL STRUCT DYN, V32, P448, DOI 10.1080/07391102.2013.775969; Feodorova VA, 2012, EMERG MICROBES INFEC, V1, DOI 10.1038/emi.2012.34; FINNEY D. J., 1978, STAT METHOD BIOL ASS; Galen JE, 2015, INFECT IMMUN, V83, P161, DOI 10.1128/IAI.02443-14; GALYOV EE, 1990, FEBS LETT, V277, P230, DOI 10.1016/0014-5793(90)80852-A; Garcia E, 2007, ADV EXP MED BIOL, V603, P17; Golubov A, 2004, INFECT IMMUN, V72, P5613, DOI 10.1128/IAI.72.10.5613-5621.2004; Gupta G, 2010, SCAND J IMMUNOL, V71, P186, DOI 10.1111/j.1365-3083.2009.02365.x; Huang SS, 2014, INT J NANOMED, V9, P813, DOI 10.2147/IJN.S56260; Joosten SA, 2008, HUM IMMUNOL, V69, P760, DOI 10.1016/j.humimm.2008.07.017; Kiefer D, 2012, VECTOR-BORNE ZOONOT, V12, P183, DOI 10.1089/vbz.2011.0748; Lorange EA, 2005, J INFECT DIS, V191, P1907, DOI 10.1086/429931; Meszaros B, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000376; Mohan A, 2006, J MOL BIOL, V362, P1043, DOI 10.1016/j.jmb.2006.07.087; Morelli G, 2010, NAT GENET, V42, P1140, DOI 10.1038/ng.705; Musson JA, 2006, J BIOL CHEM, V281, P26129, DOI 10.1074/jbc.M605482200; Neubauer H., 1998, MEDISCHE MICROBIOLOG, V6, pS10; Oldfield CJ, 2005, BIOCHEMISTRY-US, V44, P12454, DOI 10.1021/bi050736e; Peng K, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-208; Peng Kang, 2005, Journal of Bioinformatics and Computational Biology, V3, P35, DOI 10.1142/S0219720005000886; Peng ZL, 2012, CURR PROTEIN PEPT SC, V13, P6, DOI 10.2174/138920312799277938; Platonov ME, 2013, MOL GENET MICROBIOL+, V28, P41, DOI 10.3103/S0891416813020067; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Quenee LE, 2008, INFECT IMMUN, V76, P2025, DOI 10.1128/IAI.00105-08; Quenee LE, 2009, HUM VACCINES, V5, P817, DOI 10.4161/hv.9866; Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045; Revazishvili T, 2008, CLIN MICROBIOL INFEC, V14, P429, DOI 10.1111/j.1469-0691.2008.01953.x; Riehm JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030624; Romero P, 2001, PROTEINS, V42, P38, DOI 10.1002/1097-0134(20010101)42:1<38::AID-PROT50>3.0.CO;2-3; Russell P, 1997, BRIT J BIOMED SCI, V54, P231; Sauer FG, 2004, BBA-MOL CELL RES, V1694, P259, DOI 10.1016/j.bbamcr.2004.02.010; Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Uversky VN, 2013, BBA-PROTEINS PROTEOM, V1834, P932, DOI 10.1016/j.bbapap.2012.12.008; Uversky VN, 2012, J MOL BIOL, V418, P267, DOI 10.1016/j.jmb.2012.02.034; Uversky VN, 2011, CHEM SOC REV, V40, P1623, DOI 10.1039/c0cs00057d; Uversky VN, 2010, BBA-PROTEINS PROTEOM, V1804, P1231, DOI 10.1016/j.bbapap.2010.01.017; Uversky VN, 2000, PROTEINS, V41, P415, DOI 10.1002/1097-0134(20001115)41:3<415::AID-PROT130>3.3.CO;2-Z; Uversky VN, 2005, J MOL RECOGNIT, V18, P343, DOI 10.1002/jmr.747; Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411; WILLIAMS RC, 1972, J INFECT DIS, V126, P235, DOI 10.1093/infdis/126.3.235; Wright PE, 1999, J MOL BIOL, V293, P321, DOI 10.1006/jmbi.1999.3110; Xue B, 2010, BBA-PROTEINS PROTEOM, V1804, P996, DOI 10.1016/j.bbapap.2010.01.011; Yersin Alexandre, 1894, ANN I PASTEUR PARIS, V8, P662; ZAVYALOV V, 1995, IMMUNOL LETT, V45, P19, DOI 10.1016/0165-2478(94)00194-V; Zhang X, 2014, SCAND J IMMUNOL, V79, P157, DOI 10.1111/sji.12146	64	4	4	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162308	10.1371/journal.pone.0162308	http://dx.doi.org/10.1371/journal.pone.0162308			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606595	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255600037
J	Rath, D; Schaeffeler, E; Winter, S; Hewer, J; MuLler, K; Droppa, M; Stimpfle, F; Gawaz, M; Schwab, M; Geisler, T				Rath, Dominik; Schaeffeler, Elke; Winter, Stefan; Hewer, Jens; MueLler, Karin; Droppa, Michal; Stimpfle, Fabian; Gawaz, Meinrad; Schwab, Matthias; Geisler, Tobias			SDF1 Polymorphisms Influence Outcome in Patients with Symptomatic Cardiovascular Disease	PLOS ONE			English	Article							ACUTE CORONARY SYNDROME; MESENCHYMAL STEM-CELLS; I RECEPTORS CXCR4; CIRCULATING PLATELETS; HEART-DISEASE; EXPRESSION; GENE; ASSOCIATION; RECRUITMENT; GENOTYPE	Background SDF1 and its cognate receptors CXCR4 and CXCR7 are involved in myocardial repair and are associated with outcome in cardiovascular patients. Hence, we aimed to investigate clinically significant SDF1 SNPs for their prognostic impact in patients with cardiovascular disease. Methods and Results Genotyping for selected SDF1 variants (rs1065297, rs2839693, rs1801157, rs266087, rs266085 and rs266089 was performed in patients (n = 872) who underwent percutaneous coronary intervention. Carriers of variant rs2839693 and rs266089 showed significantly higher cumulative event-free survival compared with non-carriers. All other polymorphisms had no relevant influence on outcome. Multivariate Cox regression analysis showed a significant correlation of these SNPs with cardiovascular outcome after inclusion of clinical and prognostic relevant variables (hazard ratio (HR) 0.51 (95% CI 0.30-0.88), p = 0.015 and [ HR 0.51 (95% CI 0.30-0.88), p = 0.016, respectively). In addition, multivariate Cox regression with SDF1 haplotypes revealed a significantly reduced risk for the haplotype carrying the minor alleles of rs2839693 and rs266089 (HR 0.47 (95% CI 0.27-0.84), p = 0.011). Conclusion Distinct SDF1 polymorphisms are associated with improved cardiovascular prognosis in CAD patients. Further studies are warranted to validate these results and to better describe the endogenous regeneration potential in carriers of these SNPs. Targeted, genotype guided therapeutic approaches to foster myocardial regeneration and thus cardiovascular prognosis should be evaluated in future.	[Rath, Dominik; Hewer, Jens; MueLler, Karin; Droppa, Michal; Stimpfle, Fabian; Gawaz, Meinrad; Geisler, Tobias] Univ Hosp Tuebingen, Dept Cardiol, Otfried Mueller Str 10, Tubingen, Germany; [Schaeffeler, Elke; Winter, Stefan; Schwab, Matthias] Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, Stuttgart, Germany; [Schwab, Matthias] Univ Hosp Tuebingen, Dept Clin Pharmacol, Morgenstelle 8, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Geisler, T (corresponding author), Univ Hosp Tuebingen, Dept Cardiol, Otfried Mueller Str 10, Tubingen, Germany.	tobias.geisler@med.uni-tuebingen.de	Schwab, Matthias/ABH-7449-2020; Geisler, Tobias/AAO-4472-2020	Droppa, Michal/0000-0001-5807-7615	German Ministry of Education and Research; Deutsche Forschungsgemeinschaft [BO 3786/1-1]; Robert Bosch Stiftung Stuttgart; University of Tuebingen; Klinische Forschergruppe [KFO274, 2133-0-0, SCHW858/1-1/2]	German Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Robert Bosch Stiftung Stuttgart; University of Tuebingen; Klinische Forschergruppe	This work was supported in part by the German Ministry of Education and Research, the Deutsche Forschungsgemeinschaft (Grant Number: BO 3786/1-1), the Robert Bosch Stiftung Stuttgart, the Open Access Publishing Fund of the University of Tuebingen and the Klinische Forschergruppe KFO274 (Grant number 2133-0-0; SCHW858/1-1/2) 'Platelets-Basic Mechanisms and Translational Implications'. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported in part by the German Ministry of Education and Research, the Deutsche Forschungsgemeinschaft (Grant Number: BO 3786/1-1), the Robert Bosch Stiftung Stuttgart, the Open Access Publishing Fund of the University of Tuebingen and the Klinische Forschergruppe KFO274 (Grant number 2133-0-0; SCHW858/1-1/2) 'Platelets-Basic Mechanisms and Translational Implications'. We gratefully acknowledge Monika Elbl, Andrea Jarmuth, and Heidi Kohler for excellent technical assistance. Furthermore we would like to thank L. Laptev, E. Tavlaki, D. Lombardi, A. Hoffmann, A. Valera, D. Eppler, D. Tschernow, J. Metzger, J. P. Schwille, K. Hey, M. Schmid, M. Haas, S. Breuning, C. Eick, and Christina Flaum for the excellent support in data collection.	Abbott JD, 2004, CIRCULATION, V110, P3300, DOI 10.1161/01.CIR.0000147780.30124.CF; [Anonymous], 1997, Cardiovasc Res, V35, P2; [Anonymous], 2002, Med Etika Bioet, V9, P12; Feng L, 2014, INT J MOL SCI, V15, P11054, DOI 10.3390/ijms150611054; Geisler T, 2012, EUR J RADIOL, V81, pE486, DOI 10.1016/j.ejrad.2011.06.019; GENSINI GG, 1983, AM J CARDIOL, V51, P606, DOI 10.1016/S0002-9149(83)80105-2; GEORGE JN, 1986, J CLIN INVEST, V78, P340, DOI 10.1172/JCI112582; Gerli G, 2005, CLIN CHEM, V51, P2411, DOI 10.1373/clinchem.2005.057802; Gillette JM, 2009, NAT CELL BIOL, V11, P303, DOI 10.1038/ncb1838; Gu XL, 2014, BIOCHEM BIOPH RES CO, V443, P932, DOI 10.1016/j.bbrc.2013.12.065; Hayakawa Jun, 2009, Journal of Nippon Medical School, V76, P198; Hu XF, 2007, CIRCULATION, V116, P654, DOI 10.1161/CIRCULATIONAHA.106.672451; ICH Harmonised Tripartite Guideline, 2001, J POSTGRAD MED, V47, P45; Janowski M, 2009, CELL ADHES MIGR, V3, P243, DOI 10.4161/cam.3.3.8260; Kathiresan S, 2009, NAT GENET, V41, P334, DOI 10.1038/ng.327; Kimura R, 2005, HUM MOL GENET, V14, P1579, DOI 10.1093/hmg/ddi166; Ku FC, 2013, EUR J HAEMATOL, V90, P25, DOI 10.1111/ejh.12025; Kyriakou C, 2008, HAEMATOL-HEMATOL J, V93, P1457, DOI 10.3324/haematol.12553; Liu HB, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034608, 10.1371/journal.pone.0050785]; Mazzinghi B, 2008, J EXP MED, V205, P479, DOI 10.1084/jem.20071903; Pirmohamed M, 2013, NEW ENGL J MED, V369, P2294, DOI 10.1056/NEJMoa1311386; Rath D, 2015, J THROMB HAEMOST, V13, P719, DOI 10.1111/jth.12870; Rath D, 2014, EUR HEART J, V35, P386, DOI 10.1093/eurheartj/eht448; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Schesny MK, 2014, BIOMATERIALS, V35, P7180, DOI 10.1016/j.biomaterials.2014.04.116; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Secchiero P, 2000, ANAT REC, V260, P141, DOI 10.1002/1097-0185(20001001)260:2<141::AID-AR40>3.0.CO;2-I; Soriano A, 2002, J INFECT DIS, V186, P922, DOI 10.1086/343741; Stellos K, 2008, CIRCULATION, V117, P206, DOI 10.1161/CIRCULATIONAHA.107.714691; Stellos K, 2011, ATHEROSCLEROSIS, V219, P913, DOI 10.1016/j.atherosclerosis.2011.09.022; Stellos K, 2009, EUR HEART J, V30, P584, DOI 10.1093/eurheartj/ehn566; Verschuren JJW, 2012, EUR HEART J, V33, P165, DOI 10.1093/eurheartj/ehr239; Winkler C, 1998, SCIENCE, V279, P389, DOI 10.1126/science.279.5349.389; Wright LM, 2005, BONE, V36, P840, DOI 10.1016/j.bone.2005.01.021; Wu N, 2015, SCI REP-UK, V5, DOI 10.1038/srep11803; Xiao QZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004061; Zaruba MM, 2009, CELL STEM CELL, V4, P313, DOI 10.1016/j.stem.2009.02.013; Zhang DS, 2008, J MOL CELL CARDIOL, V44, P281, DOI 10.1016/j.yjmcc.2007.11.010; Ziegler M, 2012, CIRCULATION, V125, P685, DOI 10.1161/CIRCULATIONAHA.111.070508	39	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161933	10.1371/journal.pone.0161933	http://dx.doi.org/10.1371/journal.pone.0161933			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607427	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255600015
J	Young, A; Dandekar, U; Pan, C; Sader, A; Zheng, JJ; Lewis, RA; Farber, DB				Young, Alejandra; Dandekar, Uma; Pan, Calvin; Sader, Avery; Zheng, Jie J.; Lewis, Richard A.; Farber, Debora B.			GNAI3: Another Candidate Gene to Screen in Persons with Ocular Albinism	PLOS ONE			English	Article							HETEROTRIMERIC G-PROTEIN; RNA-BINDING PROTEINS; MISSENSE MUTATION; OA1 GENE; TYPE-1; CELLS; SEQUENCE; ELEMENTS; REVEALS; REGIONS	Ocular albinism type 1 (OA), caused by mutations in the OA1 gene, encodes a G-protein coupled receptor, OA1, localized in melanosomal membranes of the retinal pigment epithelium (RPE). This disorder is characterized by both RPE macro-melanosomes and abnormal decussation of ganglion cell axons at the brain's optic chiasm. We demonstrated previously that Oa1 specifically activates G alpha i3, which also signals in the Oa1 transduction pathway that regulates melanosomal biogenesis. In this study, we screened the human G alpha i3 gene, GNAI3, in DNA samples from 26 patients who had all clinical characteristics of OA but in whom a specific mutation in the OA1 gene had not been found, and in 6 normal control individuals. Using the Agilent HaloPlex Target Enrichment System and next-generation sequencing (NGS) on the Illumina MiSeq platform, we identified 518 variants after rigorous filtering. Many of these variants were corroborated by Sanger sequencing. Overall, 98.8% coverage of the GNAI3 gene was obtained by the HaloPlex amplicons. Of all variants, 6 non-synonymous and 3 synonymous were in exons, 41 in a non-coding exon embedded in the 3' untranslated region (UTR), 6 in the 5' UTR, and 462 in introns. These variants included novel SNVs, insertions, deletions, and a frameshift mutation. All were found in at least one patient but none in control samples. Using computational methods, we modeled the GNAI3 protein and its non-synonymous exonic mutations and determined that several of these may be the cause of disease in the patients studied. Thus, we have identified GNAI3 as a second gene possibly responsible for X-linked ocular albinism.	[Young, Alejandra; Sader, Avery; Zheng, Jie J.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA; [Young, Alejandra; Sader, Avery; Zheng, Jie J.; Farber, Debora B.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Young, Alejandra; Farber, Debora B.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA; [Farber, Debora B.] Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA; [Dandekar, Uma; Pan, Calvin] Univ Calif Los Angeles, UCLA GenoSeq Core, Los Angeles, CA USA; [Lewis, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine	Farber, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Stein Eye Inst, Los Angeles, CA 90095 USA.; Farber, DB (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA.; Farber, DB (corresponding author), Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90024 USA.; Farber, DB (corresponding author), Univ Calif Los Angeles, Brain Res Inst, Los Angeles, CA 90024 USA.	farber@jsei.ucla.edu		Young, Alejandra/0000-0002-1855-0559; Farber, Debora/0000-0002-3207-697X; Zheng, Jie/0000-0001-6524-6800; Lewis, Richard/0000-0002-6644-6385	Vision of Children Foundation; NIH Core center [EY000331]; Research to Prevent Blindness; Genetic Resource Association of Texas (GReAT); NATIONAL EYE INSTITUTE [P30EY002520, P30EY000331, T32EY007026] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM100909] Funding Source: NIH RePORTER	Vision of Children Foundation; NIH Core center; Research to Prevent Blindness(Research to Prevent Blindness (RPB)); Genetic Resource Association of Texas (GReAT); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was funded by The Vision of Children Foundation, http://www.visionofchildren.org/(AY). Stein Eye Institute core facilities used (available to DBF) were supported by an NIH Core center grant (EY000331) and by a grant from Research to Prevent Blindness. RAL received partial support from the Genetic Resource Association of Texas (GReAT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABKEVICH VI, 1995, J MOL BIOL, V252, P460, DOI 10.1006/jmbi.1995.0511; Bahar I, 1997, J MOL BIOL, V266, P195, DOI 10.1006/jmbi.1996.0758; Baou M, 2011, BLOOD, V118, P5732, DOI 10.1182/blood-2011-07-347237; Barrett LW, 2012, CELL MOL LIFE SCI, V69, P3613, DOI 10.1007/s00018-012-0990-9; BASSI MT, 1995, NAT GENET, V10, P13, DOI 10.1038/ng0595-13; Bassi MT, 2001, HUM GENET, V108, P51, DOI 10.1007/s004390000440; Bicknell AA, 2012, BIOESSAYS, V34, P1025, DOI 10.1002/bies.201200073; Cenik C, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001366; Chatterjee S, 2009, BIOL CELL, V101, P251, DOI 10.1042/BC20080104; Cortese K, 2005, INVEST OPHTH VIS SCI, V46, P4358, DOI 10.1167/iovs.05-0834; Dainer E, 2008, HEMOGLOBIN, V32, P596, DOI 10.1080/03630260802507915; Eidinger O, 2015, MOL VIS, V21, P1295; Emmrich S, 2016, ONCOGENE, V35, P1822, DOI 10.1038/onc.2015.247; ERCOLANI L, 1990, P NATL ACAD SCI USA, V87, P4635, DOI 10.1073/pnas.87.12.4635; Garcia TY, 2015, INVEST OPHTH VIS SCI, V56, P7480, DOI 10.1167/iovs.15-17251; Glaser F, 2003, BIOINFORMATICS, V19, P163, DOI 10.1093/bioinformatics/19.1.163; Gregory TR, 2005, NAT REV GENET, V6, P699, DOI 10.1038/nrg1674; Grzybowska EA, 2001, BIOCHEM BIOPH RES CO, V288, P291, DOI 10.1006/bbrc.2001.5738; Hallsson JH, 2007, PIGM CELL RES, V20, P185, DOI 10.1111/j.1600-0749.2007.00373.x; HAUBENWALLNER S, 1993, GENOMICS, V18, P392, DOI 10.1006/geno.1993.1481; HERMANS MMP, 1993, BIOCHEM J, V289, P687, DOI 10.1042/bj2890687; Huang HY, 2006, NUCLEIC ACIDS RES, V34, pW429, DOI 10.1093/nar/gkl333; Huber RG, 2014, J CHEM INF MODEL, V54, P1371, DOI 10.1021/ci500183u; Hulme EC, 2013, TRENDS PHARMACOL SCI, V34, P67, DOI 10.1016/j.tips.2012.11.002; Incerti B, 2000, HUM MOL GENET, V9, P2781, DOI 10.1093/hmg/9.19.2781; Innamorati G, 2006, PIGM CELL RES, V19, P125, DOI 10.1111/j.1600-0749.2006.00292.x; Karolina DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022839; Khabar KSA, 2010, CELL MOL LIFE SCI, V67, P2937, DOI 10.1007/s00018-010-0383-x; Kimple AJ, 2009, J BIOL CHEM, V284, P19402, DOI 10.1074/jbc.M109.024711; Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370; LAZZARINO DA, 1988, J BIOL CHEM, V263, P10118; Lee EC, 2007, J PHYS CHEM A, V111, P3446, DOI 10.1021/jp068635t; LEYTE A, 1992, EMBO J, V11, P4795, DOI 10.1002/j.1460-2075.1992.tb05585.x; Li CY, 2009, NUCLEIC ACIDS RES, V37, pD251, DOI 10.1093/nar/gkn568; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Liang TM, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/679563; Liao SM, 2013, CHEM CENT J, V7, DOI 10.1186/1752-153X-7-44; MARTINIUK F, 1991, DNA CELL BIOL, V10, P681, DOI 10.1089/dna.1991.10.681; Mattick JS, 2005, HUM MOL GENET, V14, pR121, DOI 10.1093/hmg/ddi101; Mirny LA, 1996, J MOL BIOL, V264, P1164, DOI 10.1006/jmbi.1996.0704; Mishra PJ, 2009, PHARMACOGENOMICS, V10, P399, DOI 10.2217/14622416.10.3.399; Newton JM, 1996, GENOMICS, V37, P219, DOI 10.1006/geno.1996.0545; Owens CD, 2010, J VASC SURG, V52, P205, DOI 10.1016/j.jvs.2010.01.097; Pras E, 2002, AM J HUM GENET, V70, P1363, DOI 10.1086/340318; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Raghunath A, 2015, OPHTHALMIC RES, V53, P169, DOI 10.1159/000371853; Sampath P, 2003, MOL CELL BIOL, V23, P1509, DOI 10.1128/MCB.23.5.1509-1519.2003; Scheper GC, 2007, NAT REV GENET, V8, P711, DOI 10.1038/nrg2142; Schiaffino MV, 1999, NAT GENET, V23, P108, DOI 10.1038/12715; SCHIAFFINO MV, 1995, HUM MOL GENET, V4, P2319, DOI 10.1093/hmg/4.12.2319; Schnur RE, 1998, AM J HUM GENET, V62, P800, DOI 10.1086/301776; Shalom-Feuerstein R, 2012, STEM CELLS, V30, P898, DOI 10.1002/stem.1068; Sivasakthi V, 2013, CELL BIOCHEM BIOPHYS, V67, P853, DOI 10.1007/s12013-013-9573-0; Soundararajan M, 2008, P NATL ACAD SCI USA, V105, P6457, DOI 10.1073/pnas.0801508105; Sprang SR, 1997, ANNU REV BIOCHEM, V66, P639, DOI 10.1146/annurev.biochem.66.1.639; STOW JL, 1991, J CELL BIOL, V114, P1113, DOI 10.1083/jcb.114.6.1113; TAMAOKA A, 1994, J BIOL CHEM, V269, P32721; Tsao H, 2012, GENE DEV, V26, P1131, DOI 10.1101/gad.191999.112; Tsiatis AC, 2010, J MOL DIAGN, V12, P425, DOI 10.2353/jmoldx.2010.090188; Vetrini F, 2006, HUM MUTAT, V27, P420, DOI 10.1002/humu.20303; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Wang LJ, 2006, BIOCHEMISTRY-US, V45, P13750, DOI 10.1021/bi0615689; Wilm A, 2012, NUCLEIC ACIDS RES, V40, P11189, DOI 10.1093/nar/gks918; Young A, 2008, INVEST OPHTH VIS SCI, V49, P3245, DOI 10.1167/iovs.08-1806; Young A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076240; Young A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024376	66	1	1	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162273	10.1371/journal.pone.0162273	http://dx.doi.org/10.1371/journal.pone.0162273			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27607449	Green Published, gold			2022-12-26	WOS:000383255600035
J	Bondarenko, VS; Gelfand, MS				Bondarenko, Vladyslav S.; Gelfand, Mikhail S.			Evolution of the Exon-Intron Structure in Ciliate Genomes	PLOS ONE			English	Article							MESSENGER-RNA; DNA-SEQUENCES; GENES; DEFINITION; SELECTION; ORIGIN	A typical eukaryotic gene is comprised of alternating stretches of regions, exons and introns, retained in and spliced out a mature mRNA, respectively. Although the length of introns may vary substantially among organisms, a large fraction of genes contains short introns in many species. Notably, some Ciliates (Paramecium and Nyctotherus) possess only ultra-short introns, around 25 bp long. In Paramecium, ultra-short introns with length divisible by three (3n) are under strong evolutionary pressure and have a high frequency of in-frame stop codons, which, in the case of intron retention, cause premature termination of mRNA translation and consequent degradation of the mis-spliced mRNA by the nonsense-mediated decay mechanism. Here, we analyzed introns in five genera of Ciliates, Paramecium, Tetrahymena, Ichthyophthirius, Oxytricha, and Stylonychia. Introns can be classified into two length classes in Tetrahymena and Ichthyophthirius (with means 48 bp, 69 bp, and 55 bp, 64 bp, respectively), but, surprisingly, comprise three distinct length classes in Oxytricha and Stylonychia (with means 33-35 bp, 47-51 bp, and 78-80 bp). In most ranges of the intron lengths, 3n introns are underrepresented and have a high frequency of in-frame stop codons in all studied species. Introns of Paramecium, Tetrahymena, and Ichthyophthirius are preferentially located at the 5' and 3' ends of genes, whereas introns of Oxytricha and Stylonychia are strongly skewed towards the 5' end. Analysis of evolutionary conservation shows that, in each studied genome, a significant fraction of intron positions is conserved between the orthologs, but intron lengths are not correlated between the species. In summary, our study provides a detailed characterization of introns in several genera of Ciliates and highlights some of their distinctive properties, which, together, indicate that splicing spellchecking is a universal and evolutionarily conserved process in the biogenesis of short introns in various representatives of Ciliates.	[Bondarenko, Vladyslav S.] NASU, Inst Mol Biol & Genet, Zabolotnogo Str 150, UA-03680 Kiev, Ukraine; [Gelfand, Mikhail S.] RAS, AA Kharkevich Inst Informat Transmiss Problems, Bolshoy Karetny Per 19, Moscow 127994, Russia; [Gelfand, Mikhail S.] Skolkovo Inst Sci & Technol, Moscow 143026, Russia; [Gelfand, Mikhail S.] Moscow MV Lomonosov State Univ, Dept Bioengn & Bioinformat, Vorobievy Gory 1-73,GSP 1, Moscow 119234, Russia	National Academy of Sciences Ukraine; Institute of Molecular Biology & Genetics of NASU; Kharkevich Institute for Information Transmission Problems of the RAS; Russian Academy of Sciences; Skolkovo Institute of Science & Technology; Lomonosov Moscow State University	Bondarenko, VS (corresponding author), NASU, Inst Mol Biol & Genet, Zabolotnogo Str 150, UA-03680 Kiev, Ukraine.	vladyslav.bon@gmail.com	Gelfand, Mikhail S/F-3425-2012	Bondarenko, Vladyslav/0000-0003-3388-2743; Gelfand, Mikhail/0000-0003-4181-0846	Russian Science Foundation [14-24-00155]	Russian Science Foundation(Russian Science Foundation (RSF))	This study was supported by the Russian Science Foundation (grant 14-24-00155).; This study was supported by the Russian Science Foundation (grant 14-24-00155). It was initiated at the Winter School "Modern Biology-Future Biotech-2013".	Aeschlimann SH, 2014, GENOME BIOL EVOL, V6, P1707, DOI 10.1093/gbe/evu139; Arnaiz O, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002984; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Belshaw R, 2006, HEREDITY, V96, P208, DOI 10.1038/sj.hdy.6800791; Benaglia T, 2009, J STAT SOFTW, V32, P1; BREATHNACH R, 1978, P NATL ACAD SCI USA, V75, P4853, DOI 10.1073/pnas.75.10.4853; Cavalier-Smith T, 2006, P NATL ACAD SCI USA, V103, P9379, DOI 10.1073/pnas.0603505103; Chang WJ, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-6; Chang WJ, 2005, P NATL ACAD SCI USA, V102, P15149, DOI 10.1073/pnas.0507682102; Chen X, 2015, GENOME BIOL EVOL, V7, P2859, DOI 10.1093/gbe/evv172; Coyne RS, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-10-r100; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Csuros M, 2008, MOL BIOL EVOL, V25, P903, DOI 10.1093/molbev/msn039; De Conti L, 2013, WIRES RNA, V4, P49, DOI 10.1002/wrna.1140; Derr LK, 1998, GENETICS, V148, P937; Dewey CN, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-311; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; FINK GR, 1987, CELL, V49, P5, DOI 10.1016/0092-8674(87)90746-X; Hurst LD, 1996, NAT GENET, V12, P234, DOI 10.1038/ng0396-234; Jaillon O, 2008, NATURE, V451, P359, DOI 10.1038/nature06495; Katinka MD, 2001, NATURE, V414, P450, DOI 10.1038/35106579; Kristensen DM, 2010, BIOINFORMATICS, V26, P1481, DOI 10.1093/bioinformatics/btq229; Lim LP, 2001, P NATL ACAD SCI USA, V98, P11193, DOI 10.1073/pnas.201407298; Lin K, 2005, NUCLEIC ACIDS RES, V33, P6522, DOI 10.1093/nar/gki970; Mourier T, 2003, SCIENCE, V300, P1393, DOI 10.1126/science.1080559; Niu DK, 2005, MOL BIOL EVOL, V22, P1475, DOI 10.1093/molbev/msi138; Nowacki M, 2008, NATURE, V451, P153, DOI 10.1038/nature06452; Prescott DM, 2000, NAT REV GENET, V1, P191, DOI 10.1038/35042057; Prescott DM, 1999, ANN NY ACAD SCI, V870, P301, DOI 10.1111/j.1749-6632.1999.tb08892.x; Prescott DM, 2002, PROTIST, V153, P71, DOI 10.1078/1434-4610-00084; PRESCOTT DM, 1992, BIOESSAYS, V14, P317, DOI 10.1002/bies.950140505; PRESCOTT DM, 1994, MICROBIOL REV, V58, P233, DOI 10.1128/MMBR.58.2.233-267.1994; ROBBERSON BL, 1990, MOL CELL BIOL, V10, P84, DOI 10.1128/MCB.10.1.84; Seoighe C, 2005, PLOS GENET, V1, P154, DOI 10.1371/journal.pgen.0010013; Slamovits CH, 2009, MOL BIOL EVOL, V26, P1699, DOI 10.1093/molbev/msp081; Swart EC, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001473; TALERICO M, 1994, MOL CELL BIOL, V14, P3434, DOI 10.1128/MCB.14.5.3434; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Urrutia AO, 2003, GENOME RES, V13, P2260, DOI 10.1101/gr.641103; Vinogradov D V, 2012, Mol Biol (Mosk), V46, P361; Yu J, 2002, GENOME RES, V12, P1185, DOI 10.1101/gr.224602	42	12	13	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161476	10.1371/journal.pone.0161476	http://dx.doi.org/10.1371/journal.pone.0161476			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603699	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200015
J	Sola-Carmona, JJ; Lopez-Liria, R; Padilla-Gongora, D; Daza, MT; Aguilar-Parra, JM; Salido-Campos, MA				Jesus Sola-Carmona, Juan; Lopez-Liria, Remedios; Padilla-Gongora, David; Teresa Daza, Maria; Manuel Aguilar-Parra, Jose; Angeles Salido-Campos, Maria			Factors Associated with the Anxiety, Subjective Psychological Well-Being and Self-Esteem of Parents of Blind Children	PLOS ONE			English	Article							INTELLECTUAL DISABILITIES; YOUNG-CHILDREN; BEHAVIOR PROBLEMS; HEALTH; FAMILIES; MOTHERS; STRESS; IMPACT; PERCEPTIONS; ADJUSTMENT	The objective was to examine the connection of the personal, social and family context, educational variables with the levels of anxiety, subjective psychological well-being and self-esteem in a sample of 61 parents of blind children. Results suggest that parents present less anxiety when they have only one child, possess a technical degree, receive remuneration for their work, their child's visual impairment is not progressive, their knowledge about their child's disability is appropriate, and their leisure and labour possibilities have not been affected. Their psychological well-being is higher when they are married in first nuptials and perceive that their health is good. Their well-being is negatively related to reduced leisure, and self-esteem is lower when labour possibilities have been affected. In order for these families to achieve a more pleasant life, with greater psychological well-being, lower anxiety and higher self-esteem, professionals should be aware of the aspects with a negative impact.	[Jesus Sola-Carmona, Juan] Natl Org Spanish Blind ONCE, Almeria, Spain; [Lopez-Liria, Remedios] Univ Almeria, Dept Nursing Sci Physiotherapy & Med, Fac Hlth Sci, Almeria, Spain; [Padilla-Gongora, David; Teresa Daza, Maria; Manuel Aguilar-Parra, Jose] Univ Almeria, Fac Psychol, Dept Psychol, Almeria, Spain; [Angeles Salido-Campos, Maria] Complejo Hosp Torrecardenas Junta de Andalucia, Almeria, Spain; [Lopez-Liria, Remedios; Padilla-Gongora, David; Teresa Daza, Maria; Manuel Aguilar-Parra, Jose] Univ Almeria, Carretera Sacramento S-N, La Canada De San Urbano, Almeria, Spain	Universidad de Almeria; Universidad de Almeria; Universidad de Almeria	Lopez-Liria, R (corresponding author), Univ Almeria, Dept Nursing Sci Physiotherapy & Med, Fac Hlth Sci, Almeria, Spain.	rll040@ual.es	Daza, María Teresa/A-2670-2015; López-Liria, Remedios/V-3851-2019; PARRA, JOSE MANUEL AGUILAR/AAD-6978-2019	Daza, María Teresa/0000-0002-6561-8982; López-Liria, Remedios/0000-0002-3416-2791; PARRA, JOSE MANUEL AGUILAR/0000-0002-6703-0680				Argyle M., 1989, RECENT ADV SOCIAL PS, p189?247, DOI DOI 10.1111/J.1758-0854.20.10.01032.X; Badia M, 2002, SIGLO CERO, V33, P5; Banos RM, 2000, PSYCHOL REP, V87, P269, DOI 10.2466/pr0.2000.87.1.269; BECKMAN PJ, 1991, AM J MENT RETARD, V95, P585; Benn R, 2012, DEV PSYCHOL, V48, P1476, DOI 10.1037/a0027537; Benzies KM, 2009, J PEDIATR PSYCHOL, V36, P506, DOI [10.1093/jpepsy/jsq081, DOI 10.1093/JPEPSY/JSQ081]; Bingham A, 2000, INTERV SCH CLIN, V35, P294, DOI [DOI 10.1177/105345120003500507, 10.1177/105345120003500507]; Brehaut JC, 2009, AM J PUBLIC HEALTH, V99, P1254, DOI 10.2105/AJPH.2007.129817; Bumbalo J, 2005, MATERN CHILD HLTH J, V9, pS3, DOI 10.1007/s10995-005-4350-3; BYRNE EA, 1985, J CHILD PSYCHOL PSYC, V26, P847, DOI 10.1111/j.1469-7610.1985.tb00602.x; Calvo C., 2004, PSICOLOG A CEGUERA M, P243; Checa J, 2004, PSYCHOL BLINDNESS MA; Cordoba L., 2003, SIGLO CERO, V34, P19; Cordoba L, 2006, ROMPIENDO INERCIAS A, P443; CUMMINGS ST, 1976, AM J ORTHOPSYCHIAT, V46, P246, DOI 10.1111/j.1939-0025.1976.tb00925.x; Dempsey I, 2004, J INTELLECT DEV DIS, V29, P40, DOI 10.1080/13668250410001662874; Dempsey I, 2008, TOP EARLY CHILD SPEC, V28, P42, DOI 10.1177/0271121408316699; Dempsey I, 2009, RES DEV DISABIL, V30, P558, DOI 10.1016/j.ridd.2008.08.005; Dunst C. J., 2007, INT J DISABIL DEV ED, V54, P305, DOI [DOI 10.1080/10349120701488772, 10.1080/10349120701488772]; Dunst CJ, 1999, TOP EARLY CHILD SPEC, V19, P141, DOI 10.1177/027112149901900302; DUNST CJ, 1986, AM J MENT DEF, V90, P403; Dunst CJ, 2002, J SPEC EDUC, V36, P139; Dykens EM, 2005, MENT RETARD, V43, P360; Eisenhower AS, 2009, SOC SCI MED, V68, P89, DOI 10.1016/j.socscimed.2008.09.033; Emerson E, 2008, AM J MENT RETARD, V113, P143, DOI 10.1352/0895-8017(2008)113[143:SWOWAM]2.0.CO;2; Femenias M., 2003, SIGLO CERO, V34, P19; Feniger-Schaal R, 2013, RES DEV DISABIL, V34, P306, DOI 10.1016/j.ridd.2012.08.007; Fierro Alfredo, 2006, Clínica y Salud, V17, P297; FRIEDRICH WN, 1981, AM J MENT DEF, V85, P551; Goudie A, 2014, FAM SYST HEALTH, V32, P280, DOI 10.1037/fsh0000027; Guillen-Riquelme A, 2011, PSICOTHEMA, V23, P510; Guralnick MJ, 1998, AM J MENT RETARD, V102, P319; Hatton C, 2010, J APPL RES INTELLECT, V23, P63, DOI 10.1111/j.1468-3148.2009.00544.x; Hinojosa MS, 2012, J PEDIATR NURS, V27, P500, DOI 10.1016/j.pedn.2011.06.013; HOLROYD J, 1976, AM J MENT DEF, V80, P431; Holroyd J, 1975, AM J COMMUN PSYCHOL, V3, P26; Hutchinson KC, 2009, PSYCHO-ONCOLOGY, V18, P515, DOI 10.1002/pon.1421; Sola-Carmona JJ, 2013, RES DEV DISABIL, V34, P1886, DOI 10.1016/j.ridd.2013.03.002; Jimenez A., 2010, POLITICA SOC, V47, P165; KAZAK AE, 1987, J ABNORM CHILD PSYCH, V15, P137, DOI 10.1007/BF00916471; Keen D., 2007, INT J DISABIL DEV ED, V54, P339, DOI [10.1080/10349120701488855, DOI 10.1080/10349120701488855]; King G, 2003, CHILD HEALTH CARE, V32, P191, DOI 10.1207/S15326888CHC3203_2; King G, 1999, J PEDIATR PSYCHOL, V24, P41, DOI 10.1093/jpepsy/24.1.41; KRAUSS MW, 1993, AM J MENT RETARD, V97, P393; Kuhlthau K, 2010, MATERN CHILD HLTH J, V14, P155, DOI 10.1007/s10995-008-0434-1; Lafuente M. A., 2000, ATENCION TEMPRANA NI; Leyser Y, 2001, 2 INT C PAR DIS THEI; Gras RML, 2007, AN PSICOL, V23, P201; Lloyd T, 2008, J INTELL DISABIL RES, V52, P37, DOI 10.1111/j.1365-2788.2007.00974.x; MacDonald EE, 2010, J APPL RES INTELLECT, V23, P27, DOI 10.1111/j.1468-3148.2009.00546.x; Mahoney G, 1998, TOP EARLY CHILD SPEC, V18, P83, DOI 10.1177/027112149801800204; Martin-Albo J, 2007, SPAN J PSYCHOL, V10, P458, DOI 10.1017/S1138741600006727; Martorell A, 2011, RES DEV DISABIL, V32, P2847, DOI 10.1016/j.ridd.2011.05.021; Mayo ME, 2006, 4 C VIRT INTEREDVISU; Mayo ME, 2007, CUADERNOS TERAPIA FA, V21, P231; Mayo ME, 2011, FAMILY FACE CHILDS V; Naseef R, 2002, EYE CONTACT AUTUMN, P39; Navarro J, 2004, ENFERMEDAD FAMILIA M; O'Neil ME, 2001, PHYS THER, V81, P1412, DOI 10.1093/ptj/81.8.1412; Pallero R, 2008, INTEGRACION, V55, P34; Papadopoulos K, 2011, RES DEV DISABIL, V32, P1086, DOI 10.1016/j.ridd.2011.01.021; Piazza VE, 2014, AJIDD-AM J INTELLECT, V119, P186, DOI 10.1352/1944-7558-119.2.186; Ponce A, 2008, DE PADRES A PADRES; Puga Dolores, 2005, Rev. Esp. Salud Publica, V79, P327, DOI 10.1590/s1135-57272005000300001; Reich S, 2004, J EMOT BEHAV DISORD, V12, P99, DOI 10.1177/10634266040120020401; Rodger S, 2008, J APPL RES INTELLECT, V21, P174, DOI 10.1111/j.1468-3148.2007.00393.x; Rosa F, 2001, INTEGRACION, V36, P40; Rosenberg M., 1965, MEASUREMENT SELF EST, DOI [10.1515/9781400876136, DOI 10.1515/9781400876136]; Sanchez-Canovas J, 2007, ESCALA BIENESTAR PSI; SERRADAS FONSECA Marian, 2003, Rev. Ped, V24, P447; Singer GH, 1990, CRITICAL ISSUES LIVE, P271; Smith AM, 2014, FAM SYST HEALTH, V32, P303, DOI 10.1037/fsh0000049; Spielberger C.D., 1983, MANUAL STATE TRAIT A; Spielberger CD., 1982, STAI CUESTIONARIO AN; Troster H, 2001, J VISUAL IMPAIR BLIN, V95, P623, DOI 10.1177/0145482X0109501005; Van Riper M, 1999, RES NURS HEALTH, V22, P357, DOI 10.1002/(SICI)1098-240X(199910)22:5<357::AID-NUR2>3.0.CO;2-Q; van Schie PEM, 2004, CHILD CARE HLTH DEV, V30, P529, DOI 10.1111/j.1365-2214.2004.00451.x; WALLANDER JL, 1988, J CLIN CHILD PSYCHOL, V17, P336, DOI 10.1207/s15374424jccp1704_7	78	9	9	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162294	10.1371/journal.pone.0162294	http://dx.doi.org/10.1371/journal.pone.0162294			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9IX	27603670	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200054
J	Kar, A; Beam, H; Borror, MB; Luckow, M; Gao, XL; Rea, SL				Kar, Adwitiya; Beam, Haley; Borror, Megan B.; Luckow, Michael; Gao, Xiaoli; Rea, Shane L.			CLD1 Reverses the Ubiquinone Insufficiency of Mutant cat5/coq7 in a Saccharomyces cerevisiae Model System	PLOS ONE			English	Article							COENZYME-Q BIOSYNTHESIS; PARA-AMINOBENZOIC ACID; CAENORHABDITIS-ELEGANS; LIFE-SPAN; MITOCHONDRIAL-FUNCTION; CEREBELLAR-ATAXIA; Q(6) BIOSYNTHESIS; BARTH-SYNDROME; ENZYME CLK-1; MIT MUTANTS	Ubiquinone (Q(n)) functions as a mobile electron carrier in mitochondria. In humans, Q biosynthetic pathway mutations lead to Q(10) deficiency, a life threatening disorder. We have used a Saccharomyces cerevisiae model of Q(6) deficiency to screen for new modulators of ubiquinone biosynthesis. We generated several hypomorphic alleles of coq7/cat5 (clk-1 in Caenorhabditis elegans) encoding the penultimate enzyme in Q biosynthesis which converts 5-demethoxy Q(6) (DMQ(6)) to 5-demethyl Q(6), and screened for genes that, when overexpressed, suppressed their inability to grow on non-fermentable ethanol-implying recovery of lost mitochondrial function. Through this approach we identified Cardiolipin-specific Deacylase 1 (CLD1), a gene encoding a phospholipase A(2) required for cardiolipin acyl remodeling. Interestingly, not all coq7 mutants were suppressed by Cld1p overexpression, and molecular modeling of the mutant Coq7p proteins that were suppressed showed they all contained disruptions in a hydrophobic alpha-helix that is predicted to mediate membrane-binding. CLD1 overexpression in the suppressible coq7 mutants restored the ratio of DMQ(6) to Q(6) toward wild type levels, suggesting recovery of lost Coq7p function. Identification of a spontaneous Cld1p loss-of-function mutation illustrated that Cld1p activity was required for coq7 suppression. This observation was further supported by HPLC-ESI-MS/MS profiling of monolysocardiolipin, the product of Cld1p. In summary, our results present a novel example of a lipid remodeling enzyme reversing a mitochondrial ubiquinone insufficiency by facilitating recovery of hypomorphic enzymatic function.	[Kar, Adwitiya; Beam, Haley; Borror, Megan B.; Rea, Shane L.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA; [Kar, Adwitiya; Beam, Haley; Borror, Megan B.; Rea, Shane L.] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA; [Luckow, Michael] Univ Colorado, Inst Behav Genet, Boulder, CO 80309 USA; [Gao, Xiaoli] Univ Texas Hlth Sci Ctr San Antonio, Dept Biochem, San Antonio, TX 78229 USA; [Kar, Adwitiya] Univ Colorado, Dept Endocrinol, Sch Med, Anschutz Med Campus, Aurora, CO USA; [Luckow, Michael] Univ Colorado, Sch Med, Anschutz Med Campus, Aurora, CO USA	University of Texas System; University of Texas Health San Antonio; University of Texas System; University of Texas Health San Antonio; University of Colorado System; University of Colorado Boulder; University of Texas System; University of Texas Health San Antonio; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus	Rea, SL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, San Antonio, TX 78229 USA.; Rea, SL (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, San Antonio, TX 78229 USA.	reas3@uthscsa.edu			NIH [1S10RR031586-01]; Ellison Medical Foundation [AG-NS-051908]; National Institute on Aging [AG-025207, AG-047561]; National Institute for General Medical Sciences [K12-GM111726]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR031586] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [K12GM111726] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R21AG025207, R21AG047561] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institute for General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Mass spectrometry analyses were conducted in the Metabolomics Core Facility of the Mass Spectrometry Laboratory at the University of Texas Health Science Center at San Antonio, with instrumentation funded in part by NIH Grant 1S10RR031586-01. Additional financial support was provided by the Ellison Medical Foundation (http://www.ellisonfoundation.org/; AG-NS-051908; S.L.R.), the National Institute on Aging (https://www.nia.nih.gov/; AG-025207, AG-047561; S.L.R.), and the National Institute for General Medical Sciences (https://www.nigms.nih.gov,; K12-GM111726; M.B.B.).	Adamian L, 2011, BBA-BIOMEMBRANES, V1808, P1092, DOI 10.1016/j.bbamem.2010.12.008; Baile MG, 2013, MOL BIOL CELL, V24, P2008, DOI 10.1091/mbc.E13-03-0121; Bazan S, 2013, J BIOL CHEM, V288, P401, DOI 10.1074/jbc.M112.425876; Behan RK, 2010, BIOCHEMISTRY-US, V49, P9679, DOI 10.1021/bi101475z; Beranek A, 2009, J BIOL CHEM, V284, P11572, DOI 10.1074/jbc.M805511200; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Busso C, 2015, BIOCHIMIE, V119, P92, DOI 10.1016/j.biochi.2015.10.016; Butler JA, 2013, AGING CELL, V12, P130, DOI 10.1111/acel.12029; Butler JA, 2010, FASEB J, V24, P4977, DOI 10.1096/fj.10-162941; Cristina D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000450; de Kroon AIPM, 2013, PROG LIPID RES, V52, P374, DOI 10.1016/j.plipres.2013.04.006; DiMauro S, 2007, J CLIN INVEST, V117, P587, DOI 10.1172/JCI31423; Dimitrov LN, 2009, GENETICS, V183, P365, DOI 10.1534/genetics.109.104497; Doimo M, 2014, BBA-MOL BASIS DIS, V1842, P1, DOI 10.1016/j.bbadis.2013.10.007; Ewbank JJ, 1997, SCIENCE, V275, P980, DOI 10.1126/science.275.5302.980; Freyer C, 2015, J MED GENET, V52, P779, DOI 10.1136/jmedgenet-2015-102986; Gille C, 2001, BIOINFORMATICS, V17, P377, DOI 10.1093/bioinformatics/17.4.377; Gironi M, 2004, NEUROLOGY, V62, P818, DOI 10.1212/01.WNL.0000113719.67643.B7; Gonzalez-Mariscal I, 2014, MOL SYNDROMOL, V5, P107, DOI 10.1159/000362897; Hotelier T, 2004, NUCLEIC ACIDS RES, V32, pD145, DOI 10.1093/nar/gkh141; Hsieh EJ, 2007, ARCH BIOCHEM BIOPHYS, V463, P19, DOI 10.1016/j.abb.2007.02.016; Jiang N, 2001, J BIOL CHEM, V276, P29218, DOI 10.1074/jbc.M103686200; Jonassen T, 1998, J BIOL CHEM, V273, P3351, DOI 10.1074/jbc.273.6.3351; Kayser EB, 2004, J BIOL CHEM, V279, P54479, DOI 10.1074/jbc.M403066200; Killian JA, 1998, BBA-REV BIOMEMBRANES, V1376, P401, DOI 10.1016/S0304-4157(98)00017-3; Larsen PL, 2002, SCIENCE, V295, P120, DOI 10.1126/science.1064653; Lee AG, 2004, BBA-BIOMEMBRANES, V1666, P62, DOI 10.1016/j.bbamem.2004.05.012; Licitra F, 2014, MOL SYNDROMOL, V5, P180, DOI 10.1159/000362942; Lohman DC, 2014, P NATL ACAD SCI USA, V111, pE4697, DOI 10.1073/pnas.1413128111; Lu TT, 2013, BIOCHEMISTRY-US, V52, P2236, DOI 10.1021/bi301674p; Marbois B, 2010, J BIOL CHEM, V285, P27827, DOI 10.1074/jbc.M110.151894; Marbois B, 2009, BBA-MOL CELL BIOL L, V1791, P69, DOI 10.1016/j.bbalip.2008.10.006; Marbois BN, 1996, J BIOL CHEM, V271, P2995, DOI 10.1074/jbc.271.6.2995; Martin-Montalvo A, 2011, BIOCHEM J, V440, P107, DOI 10.1042/BJ20101422; METZLER DE, 1977, BIOCHEMISTRY CHEM RE; Mollet J, 2008, AM J HUM GENET, V82, P623, DOI 10.1016/j.ajhg.2007.12.022; Monaghan RM, 2015, NAT CELL BIOL, V17, P782, DOI 10.1038/ncb3170; Mowbray SL, 2006, PROTEIN SCI, V15, P1628, DOI 10.1110/ps.051792106; Nielsen M, 2010, NUCLEIC ACIDS RES, V38, pW576, DOI 10.1093/nar/gkq535; Ozeir M, 2011, CHEM BIOL, V18, P1134, DOI 10.1016/j.chembiol.2011.07.008; Padilla S, 2004, J BIOL CHEM, V279, P25995, DOI 10.1074/jbc.M400001200; Padilla S, 2009, CELL MOL LIFE SCI, V66, P173, DOI 10.1007/s00018-008-8547-7; Paradies G, 2014, ANTIOXID REDOX SIGN, V20, P1925, DOI 10.1089/ars.2013.5280; Pierrel F, 2010, CHEM BIOL, V17, P449, DOI 10.1016/j.chembiol.2010.03.014; Poon WW, 1997, MOL ASPECTS MED, V18, pS121; Quinzii CM, 2007, MITOCHONDRION, V7, pS122, DOI 10.1016/j.mito.2007.03.004; Rea S, 2001, FEBS LETT, V509, P389, DOI 10.1016/S0014-5793(01)03099-X; SCHLAME M, 1990, BIOCHEM J, V265, P79, DOI 10.1042/bj2650079; Schultz JR, 1996, BIOCHEMISTRY-US, V35, P6595, DOI 10.1021/bi960245h; SIRUMCONNOLLY K, 1993, SCIENCE, V262, P1886, DOI 10.1126/science.8266080; Steffen Kristan K, 2009, J Vis Exp, DOI 10.3791/1209; STRUHL K, 1985, P NATL ACAD SCI USA, V82, P8419, DOI 10.1073/pnas.82.24.8419; Tran UC, 2007, MITOCHONDRION, V7, pS62, DOI 10.1016/j.mito.2007.03.007; Tran UC, 2006, J BIOL CHEM, V281, P16401, DOI 10.1074/jbc.M513267200; Turunen M, 2004, BBA-BIOMEMBRANES, V1660, P171, DOI 10.1016/j.bbamem.2003.11.012; TZAGOLOFF A, 1990, MICROBIOL REV, V54, P211, DOI 10.1128/MMBR.54.3.211-225.1990; Vaden DL, 2005, ANAL BIOCHEM, V338, P162, DOI 10.1016/j.ab.2004.11.020; Wang Y, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7393; Wasko BM, 2014, BIOL CHEM, V14, P148, DOI [10.1111/1567-1364.12104, DOI 10.1074/JBC.M113.474494]; Wasko BM, 2014, FEMS YEAST RES, V14, P148, DOI 10.1111/1567-1364.12104; WONG A, 1995, GENETICS, V139, P1247; Xie LTX, 2011, BBA-MOL CELL BIOL L, V1811, P348, DOI 10.1016/j.bbalip.2011.01.009; Ye CQ, 2014, J BIOL CHEM, V289, P3114, DOI 10.1074/jbc.M113.529487	64	2	2	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162165	10.1371/journal.pone.0162165	http://dx.doi.org/10.1371/journal.pone.0162165			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603010	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255200049
J	Barardi, A; Garcia-Ojalvo, J; Mazzoni, A				Barardi, Alessandro; Garcia-Ojalvo, Jordi; Mazzoni, Alberto			Transition between Functional Regimes in an Integrate-And-Fire Network Model of the Thalamus	PLOS ONE			English	Article							DEEP BRAIN-STIMULATION; ELECTROPHYSIOLOGICAL PROPERTIES; SOMATOSENSORY CORTEX; RETICULAR NUCLEUS; DYNAMICS; INFORMATION; NEURONS; OSCILLATIONS; INHIBITION; FREQUENCY	The thalamus is a key brain element in the processing of sensory information. During the sleep and awake states, this brain area is characterized by the presence of two distinct dynamical regimes: in the sleep state activity is dominated by spindle oscillations (7 - 15 Hz) weakly affected by external stimuli, while in the awake state the activity is primarily driven by external stimuli. Here we develop a simple and computationally efficient model of the thalamus that exhibits two dynamical regimes with different information-processing capabilities, and study the transition between them. The network model includes glutamatergic thalamocortical (TC) relay neurons and GABAergic reticular (RE) neurons described by adaptive integrate-and-fire models in which spikes are induced by either depolarization or hyperpolarization rebound. We found a range of connectivity conditions under which the thalamic network composed by these neurons displays the two aforementioned dynamical regimes. Our results show that TC-RE loops generate spindle-like oscillations and that a minimum level of clustering (i.e. local connectivity density) in the RE-RE connections is necessary for the coexistence of the two regimes. We also observe that the transition between the two regimes occurs when the external excitatory input on TC neurons (mimicking sensory stimulation) is large enough to cause a significant fraction of them to switch from hyper-polarization-rebound-driven firing to depolarization-driven firing. Overall, our model gives a novel and clear description of the role that the two types of neurons and their connectivity play in the dynamical regimes observed in the thalamus, and in the transition between them. These results pave the way for the development of efficient models of the transmission of sensory information from periphery to cortex.	[Barardi, Alessandro; Garcia-Ojalvo, Jordi] Univ Pompeu Fabra, Dept Expt & Hlth Sci, Dr Aiguader 88, Barcelona 08003, Spain; [Barardi, Alessandro] Univ Politecn Cataluna, Dept Fis & Engn Nucl, Rambla St Nebridi 22, Terrassa 08222, Spain; [Mazzoni, Alberto] Scuola Super Sant Anna, BioRobot Inst, I-56026 Pontedera, Italy	Pompeu Fabra University; Universitat Politecnica de Catalunya; Scuola Superiore Sant'Anna	Garcia-Ojalvo, J (corresponding author), Univ Pompeu Fabra, Dept Expt & Hlth Sci, Dr Aiguader 88, Barcelona 08003, Spain.; Mazzoni, A (corresponding author), Scuola Super Sant Anna, BioRobot Inst, I-56026 Pontedera, Italy.	jordi.g.ojalvo@upf.edu; a.mazzoni@sssup.it	Mazzoni, Alberto/AGO-5998-2022; Mazzoni, Alberto/A-5433-2018; Garcia-Ojalvo, Jordi/A-4574-2009; Mazzoni, Alberto/N-6960-2016	Mazzoni, Alberto/0000-0002-9632-1831; Mazzoni, Alberto/0000-0002-9632-1831; Garcia-Ojalvo, Jordi/0000-0002-3716-7520; Mazzoni, Alberto/0000-0002-9632-1831	European Commission under ITN project NETT (FP7) [289146]; Spanish Ministry of Economy and Competitiveness and FEDER [FIS2015-66503-C3-1-P1]; Generalitat de Catalunya [2014SGR0947]; NEBIAS European project [EUFP7-ICT-611687]; PRIN/HandBot Italian project [B81J12002680008, 20102YF2RY]; Italian Ministry of Foreign Affairs and International Cooperation, Directorate General for Country Promotion (Economy, Culture and Science) Unit for Scientific and Technological Cooperation, via the Italy-Sweden bilateral research project on; ICREA Academia programme; "Maria de Maeztu" Programme for Units of Excellence in R&D (Spanish Ministry of Economy and Competitiveness) [MDM-2014-0370]	European Commission under ITN project NETT (FP7); Spanish Ministry of Economy and Competitiveness and FEDER(Spanish Government); Generalitat de Catalunya(Generalitat de Catalunya); NEBIAS European project; PRIN/HandBot Italian project; Italian Ministry of Foreign Affairs and International Cooperation, Directorate General for Country Promotion (Economy, Culture and Science) Unit for Scientific and Technological Cooperation, via the Italy-Sweden bilateral research project on; ICREA Academia programme(ICREA); "Maria de Maeztu" Programme for Units of Excellence in R&D (Spanish Ministry of Economy and Competitiveness)	This work was supported by the European Commission under ITN project NETT (FP7 contract 289146), by the Spanish Ministry of Economy and Competitiveness and FEDER (project FIS2015-66503-C3-1-P1), and by the Generalitat de Catalunya (project 2014SGR0947). A.M. was supported by the NEBIAS European project (EUFP7-ICT-611687), by the PRIN/HandBot Italian project (CUP: B81J12002680008; prot.: 20102YF2RY), and by the Italian Ministry of Foreign Affairs and International Cooperation, Directorate General for Country Promotion (Economy, Culture and Science) Unit for Scientific and Technological Cooperation, via the Italy-Sweden bilateral research project on "Brain network mechanisms for integration of natural tactile input patterns". J.G.O. also acknowledges support from the ICREA Academia programme and from the "Maria de Maeztu" Programme for Units of Excellence in R&D (Spanish Ministry of Economy and Competitiveness, MDM-2014-0370). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We thank two anonymous reviewers for their constructive comments. This work was supported by the European Commission under ITN project NETT (FP7 contract 289146), by the Spanish Ministry of Economy and Competitiveness and FEDER (project FIS2015-66503-C3-1-P), and by the Generalitat de Catalunya (project 2014SGR0947). A.M. was supported by the NEBIAS European project (EUFP7-ICT-611687), by the PRIN/HandBot Italian project (CUP: B81J12002680008; prot.: 20102YF2RY), and by the Italian Ministry of Foreign Affairs and International Cooperation, Directorate General for Country Promotion (Economy, Culture and Science) Unit for Scientific and Technological Cooperation, via the Italy-Sweden bilateral research project on "Brain network mechanisms for integration of natural tactile input patterns". J.G.O. also acknowledges support from the ICREA Academia programme and from the "Maria de Maeztu" Programme for Units of Excellence in R&D (Spanish Ministry of Economy and Competitiveness, MDM-2014-0370).	ANDERSEN P, 1962, NATURE, V196, P645, DOI 10.1038/196645a0; Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0; Barardi A, 2014, PLOS COMPUT BIOL, V10, DOI 10.1371/journal.pcbi.1003723; Barbieri F, 2014, J NEUROSCI, V34, P14589, DOI 10.1523/JNEUROSCI.5365-13.2014; Battaglia D, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002176; Bazhenov M, 1999, NAT NEUROSCI, V2, P168, DOI 10.1038/5729; Brette R, 2005, J NEUROPHYSIOL, V94, P3637, DOI 10.1152/jn.00686.2005; Brunel N, 2003, J NEUROPHYSIOL, V90, P415, DOI 10.1152/jn.01095.2002; Brunel N, 2000, J COMPUT NEUROSCI, V8, P183, DOI 10.1023/A:1008925309027; Butts DA, 2007, NATURE, V449, P92, DOI [10.1038/nature06105, 10.1038/natureO6105]; CONTRERAS D, 1993, J PHYSIOL-LONDON, V470, P273, DOI 10.1113/jphysiol.1993.sp019858; CRICK F, 1984, P NATL ACAD SCI-BIOL, V81, P4586, DOI 10.1073/pnas.81.14.4586; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; DESTEXHE A, 1993, BIOPHYS J, V65, P2473, DOI 10.1016/S0006-3495(93)81297-9; Destexhe A, 1999, J NEUROPHYSIOL, V81, P1531, DOI 10.1152/jn.1999.81.4.1531; Destexhe A, 1994, J Comput Neurosci, V1, P195, DOI 10.1007/BF00961734; Destexhe A, 2003, PHYSIOL REV, V83, P1401, DOI 10.1152/physrev.00012.2003; DESTEXHE A, 1994, J NEUROPHYSIOL, V72, P803, DOI 10.1152/jn.1994.72.2.803; Destexhe A, 2000, J PHYSIOLOGY-PARIS, V94, P391, DOI 10.1016/S0928-4257(00)01093-7; Destexhe A, 2009, J COMPUT NEUROSCI, V27, P493, DOI 10.1007/s10827-009-0164-4; DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262; Einevoll GT, 2013, NAT REV NEUROSCI, V14, P770, DOI 10.1038/nrn3599; El Boustani S, 2007, J PHYSIOL-PARIS, V101, P99, DOI 10.1016/j.jphysparis.2007.10.001; Fitzgibbon T, 1995, J COMP NEUROL, V363, P489, DOI 10.1002/cne.903630311; Fourcaud-Trocme N, 2003, J NEUROSCI, V23, P11628; GILBERT CD, 1992, NATURE, V356, P150, DOI 10.1038/356150a0; Golomb D, 1996, J NEUROPHYSIOL, V75, P750, DOI 10.1152/jn.1996.75.2.750; Guillery RW, 1998, TRENDS NEUROSCI, V21, P28, DOI 10.1016/S0166-2236(97)01157-0; Halassa MM, 2014, CELL, V158, P808, DOI 10.1016/j.cell.2014.06.025; Ince RAA, 2010, FRONT NEUROSCI-SWITZ, V4, DOI 10.3389/neuro.01.011.2010; Izhikevich EM, 2004, IEEE T NEURAL NETWOR, V15, P1063, DOI 10.1109/TNN.2004.832719; Izhikevich EM, 2008, P NATL ACAD SCI USA, V105, P3593, DOI 10.1073/pnas.0712231105; JAHNSEN H, 1984, J PHYSIOL-LONDON, V349, P205, DOI 10.1113/jphysiol.1984.sp015153; Kim U, 1997, SCIENCE, V278, P130, DOI 10.1126/science.278.5335.130; Klinshov VV, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094292; Kumar A, 2008, NEURAL COMPUT, V20, P1, DOI 10.1162/neco.2008.20.1.1; Ladenbauer J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002478; LAND PW, 1995, SOMATOSENS MOT RES, V12, P127, DOI 10.3109/08990229509101504; Lewis LD, 2015, ELIFE, V4, DOI 10.7554/eLife.08760; Linden H., 2014, FRONT NEUROINFORM, V7, P41, DOI DOI 10.3389/fninf.2013.00041; Litwin-Kumar A, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms6319; Litwin-Kumar A, 2012, NAT NEUROSCI, V15, P1498, DOI 10.1038/nn.3220; LIVINGSTONE MS, 1981, NATURE, V291, P554, DOI 10.1038/291554a0; LLINAS R, 1982, NATURE, V297, P406, DOI 10.1038/297406a0; LLINAS RR, 1991, NEUROSCIENCE, V44, P521, DOI 10.1016/0306-4522(91)90075-Y; Magri C, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-81; Mazzoni A, 2015, PLOS COMPUT BIOL, V11, DOI 10.1371/journal.pcbi.1004584; Mazzoni A, 2010, NEUROIMAGE, V52, P956, DOI 10.1016/j.neuroimage.2009.12.040; Mazzoni A, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000239; McAlonan K, 2008, NATURE, V456, P391, DOI 10.1038/nature07382; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; MCCORMICK DA, 1992, PROG NEUROBIOL, V39, P337, DOI 10.1016/0301-0082(92)90012-4; McIntyre CC, 2004, J NEUROPHYSIOL, V91, P1457, DOI 10.1152/jn.00989.2003; MINDERHOUD JM, 1971, EXP BRAIN RES, V12, P435; Muller L, 2012, J PHYSIOL-PARIS, V106, P222, DOI 10.1016/j.jphysparis.2012.06.005; Naud R, 2008, BIOL CYBERN, V99, P335, DOI 10.1007/s00422-008-0264-7; Pais-Vieira M, 2015, J NEUROPHYSIOL, V114, P1652, DOI 10.1152/jn.00108.2015; Panzeri S, 1996, NETWORK-COMP NEURAL, V7, P87, DOI [10.1088/0954-898X/7/1/006, 10.1080/0954898X.1996.11978656]; Potjans TC, 2014, CEREB CORTEX, V24, P785, DOI 10.1093/cercor/bhs358; Reinhold K, 2015, NAT NEUROSCI, V18, P1789, DOI 10.1038/nn.4153; Schwartz A, 2015, SCIENCE, V350, P11, DOI 10.1126/science.aad5010; Servello D, 2008, J NEUROL NEUROSUR PS, V79, P136, DOI 10.1136/jnnp.2006.104067; Sherman SM, 2002, PHILOS T R SOC B, V357, P1695, DOI 10.1098/rstb.2002.1161; Sherman SM, 2001, TRENDS NEUROSCI, V24, P122, DOI 10.1016/S0166-2236(00)01714-8; STERIADE M, 1993, SCIENCE, V262, P679, DOI 10.1126/science.8235588; Steriade M., 2003, NEURONAL SUBSTRATES; Steriade M. M., 2005, BRAIN CONTROL WAKEFU; Tasker RR, 1998, SURG NEUROL, V49, P145, DOI 10.1016/S0090-3019(97)00459-X; Touboul J, 2008, BIOL CYBERN, V99, P319, DOI 10.1007/s00422-008-0267-4; Victor Jonathan D, 2006, Biol Theory, V1, P302, DOI 10.1162/biot.2006.1.3.302; Willis AM, 2015, J NEUROPHYSIOL, V114, P2353, DOI 10.1152/jn.00926.2014; Wimmer K, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms7177; Womelsdorf T, 2007, SCIENCE, V316, P1609, DOI [10.1126/science.1139597, 10.1126/science.1139178]	73	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161934	10.1371/journal.pone.0161934	http://dx.doi.org/10.1371/journal.pone.0161934			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598260	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800026
J	Watanabe, M; Zemack, H; Johansson, H; Hagbard, L; Jorns, C; Li, M; Ellis, E				Watanabe, Masaaki; Zemack, Helen; Johansson, Helene; Hagbard, Louise; Jorns, Carl; Li, Meng; Ellis, Ewa			Maintenance of Hepatic Functions in Primary Human Hepatocytes Cultured on Xeno-Free and Chemical Defined Human Recombinant Laminins	PLOS ONE			English	Article							EXTRACELLULAR-MATRIX; EXPRESSION; CELLS; ADHESION; ANOIKIS; CHAIN	Refined methods for maintaining specific functions of isolated hepatocytes under xeno-free and chemical defined conditions is of great importance for the development of hepatocyte research and regenerative therapy. Laminins, a large family of heterotrimeric basement membrane adhesion proteins, are highly cell and tissue type specific components of the extracellular matrix and strongly influence the behavior and function of associated cells and/or tissues. However, detailed biological functions of many laminin isoforms are still to be evaluated. In this study, we determined the distribution of laminin isoforms in human liver tissue and isolated primary human hepatocytes by western blot analysis, and investigated the efficacy of different human recombinant laminin isoforms on hepatic functions during culture. Protein expressions of laminin-chain alpha 2, alpha 3, alpha 4, beta 1, beta 3, gamma 1, and gamma 2 were detected in both isolated human hepatocytes and liver tissue. No alpha 1 and alpha 5 expression could be detected in liver tissue or hepatocytes. Hepatocytes were isolated from five different individual livers, and cultured on human recombinant laminin isoforms -111, -211, -221, -332, -411, -421, -511, and -521 (Biolamina AB), matrigel (extracted from Engelbreth-Holm-Swarm sarcoma), or collagen type IV (Collagen). Hepatocytes cultured on laminin showed characteristic hexagonal shape in a flat cell monolayer. Viability, double stranded DNA concentration, and Ki67 expression for hepatocytes cultured for six days on laminin were comparable to those cultured on EHS and Collagen. Hepatocytes cultured on laminin also displayed production of human albumin, alpha-1-antitrypsin, bile acids, and gene expression of liver-enriched factors, such as hepatocyte nuclear factor 4 alpha, glucose-6-phosphate, cytochrome P450 3A4, and multidrug resistance-associated protein 2. We conclude that all forms of human recombinant laminin tested maintain cell viability and liver-specific functions of primary human hepatocytes, and that recombinant laminin is a promising xeno-free and chemical defined strategy for preservation of hepatocyte specific function in vitro.	[Watanabe, Masaaki; Zemack, Helen; Johansson, Helene; Jorns, Carl; Li, Meng; Ellis, Ewa] Karolinska Inst, Div Transplantat Surg, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden; [Hagbard, Louise] BioLamina AB, Stockholm, Sweden	Karolinska Institutet	Watanabe, M (corresponding author), Karolinska Inst, Div Transplantat Surg, Dept Clin Sci Intervent & Technol CLINTEC, Stockholm, Sweden.	masaaki@w8.dion.ne.jp	Johansson, Helene/AGR-5090-2022; Jorns, Carl/AAE-6925-2021; Watanabe, Masaaki/AAV-7033-2020; Ellis, Ewa C S/D-5370-2014	Jorns, Carl/0000-0001-7727-8113; Ellis, Ewa C S/0000-0002-3057-5337; Johansson, Helene/0000-0001-5519-0401	BioLamina AB	BioLamina AB	The funder BioLamina AB provided support in the form of salaries for author LH, but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. This does not alter our adherence to PLOS ONE policies on sharing data and materials. The specific role of the author is articulated in the 'author contributions' section.	Aumailley M, 2005, MATRIX BIOL, V24, P326, DOI 10.1016/j.matbio.2005.05.006; Cheng N, 2008, TISSUE ENG PT A, V14, P1, DOI 10.1089/ten.a.2007.0131; Chia SM, 2000, TISSUE ENG, V6, P481, DOI 10.1089/107632700750022134; Crestani M, 1998, J LIPID RES, V39, P2192; Domogatskaya A, 2012, ANNU REV CELL DEV BI, V28, P523, DOI 10.1146/annurev-cellbio-101011-155750; Durbeej M, 2010, CELL TISSUE RES, V339, P259, DOI 10.1007/s00441-009-0838-2; Elkayam T, 2006, TISSUE ENG, V12, P1357, DOI 10.1089/ten.2006.12.1357; Ellis E, 1998, HEPATOLOGY, V27, P615, DOI 10.1002/hep.510270241; EMONARD H, 1987, J CELL PHYSIOL, V133, P95, DOI 10.1002/jcp.1041330112; Fisher RA, 2004, CELL TRANSPLANT, V13, P677, DOI 10.3727/000000004783983576; Fu T, 2001, CELL TRANSPLANT, V10, P59; Gramignoli R, 2012, CELL TRANSPLANT, V21, P1245, DOI 10.3727/096368911X600939; Gubler MC, 2008, NAT CLIN PRACT NEPHR, V4, P24, DOI 10.1038/ncpneph0671; Hongisto H, 2012, STEM CELL RES, V8, P97, DOI 10.1016/j.scr.2011.08.005; Jimenez-Mallebrera C, 2005, CELL MOL LIFE SCI, V62, P809, DOI 10.1007/s00018-004-4510-4; Jorns C, 2014, CELL TRANSPLANT, V23, P1009, DOI 10.3727/096368913X667484; Kikkawa Y, 2005, EXP CELL RES, V305, P99, DOI 10.1016/j.yexcr.2005.01.005; Kikkawa Y, 2008, EXP CELL RES, V314, P2579, DOI 10.1016/j.yexcr.2008.05.021; Kikkawa Y, 2009, BIOMATERIALS, V30, P6888, DOI 10.1016/j.biomaterials.2009.09.011; Miner JH, 2004, ANNU REV CELL DEV BI, V20, P255, DOI 10.1146/annurev.cellbio.20.010403.094555; Miranda JP, 2010, TISSUE ENG PART C-ME, V16, P1223, DOI [10.1089/ten.tec.2009.0784, 10.1089/ten.TEC.2009.0784]; Ohashi K, 2004, TRANSPL P, V36, P2469, DOI 10.1016/j.transproceed.2004.07.072; Rodin S, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4195; Sainz B, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-103; Smets FN, 2002, MOL GENET METAB, V75, P344, DOI 10.1016/S1096-7192(02)00004-5; Spencer VA, 2010, J MAMMARY GLAND BIOL, V15, P65, DOI 10.1007/s10911-010-9163-3; Takayama K, 2013, STEM CELL REP, V1, P322, DOI 10.1016/j.stemcr.2013.08.006; Thomas FT, 1999, SURGERY, V126, P299, DOI 10.1067/msy.1999.99164; Yurchenco PD, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004911	29	10	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161383	10.1371/journal.pone.0161383	http://dx.doi.org/10.1371/journal.pone.0161383			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598296	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800007
J	Li, B; Schmidt, NW				Li, Bing; Schmidt, Nathan W.			Epidermal Fatty Acid Binding Protein (E-FABP) Is Not Required for the Generation or Maintenance of Effector and Memory T Cells following Infection with Listeria monocytogenes	PLOS ONE			English	Article							METABOLISM; IMMUNITY; DIFFERENTIATION; CARBOXYLASE; EXPRESSION; AQP9	Following activation of naive T cells there are dynamic changes in the metabolic pathways used by T cells to support both the energetic needs of the cell and the macromolecules required for growth and proliferation. Among other changes, lipid metabolism undergoes dynamic transitions between fatty acid oxidation and fatty acid synthesis as cells progress from naive to effector and effector to memory T cells. The hydrophobic nature of lipids requires that they be bound to protein chaperones within a cell. Fatty acid binding proteins (FABPs) represent a large class of lipid chaperones, with epidermal FABP (E-FABP) expressed in T cells. The objective of this study was to determine the contribution of E-FABP in antigen-specific T cell responses. Following infection with Listeria monocytogenes, we observed similar clonal expansion, contraction and formation of memory CD8 T cells in WT and E-FABP-/- mice, which also exhibited similar phenotypic and functional characteristics. Analysis of Listeria-specific CD4 T cells also revealed no defect in the expansion, contraction, and formation of memory CD4 T cells in E-FABP-/- mice. These data demonstrate that E-FABP is dispensable for antigen-specific T cell responses following a bacterial infection.	[Li, Bing; Schmidt, Nathan W.] Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA	University of Louisville	Schmidt, NW (corresponding author), Univ Louisville, Dept Microbiol & Immunol, Louisville, KY 40202 USA.	nathan.schmidt@louisville.edu			National Institutes of Health [1R21AI113386, CA18098601A1, CA17767901A1]; American Cancer Society [RSG-14-057-01-MPC]; NATIONAL CANCER INSTITUTE [R01CA180986] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI113386] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society(American Cancer Society); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by grants from the National Institutes of Health (1R21AI113386) and the American Cancer Society (Research Scholar Grant, RSG-14-057-01-MPC) to NWS, and the National Institutes of Health (CA18098601A1, CA17767901A1) to BL. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bar JJ, 2008, IMMUNITY, V28, P859, DOI 10.1016/j.immuni.2008.04.010; Berod L, 2014, NAT MED, V20, P1327, DOI 10.1038/nm.3704; Brownsey RW, 2006, BIOCHEM SOC T, V34, P223, DOI 10.1042/BST0340223; Buck MD, 2015, J EXP MED, V212, P1345, DOI 10.1084/jem.20151159; Carbrey JM, 2003, P NATL ACAD SCI USA, V100, P2945, DOI 10.1073/pnas.0437994100; Chang CH, 2013, CELL, V153, P1239, DOI 10.1016/j.cell.2013.05.016; Chmurzynska A, 2006, J APPL GENET, V47, P39, DOI 10.1007/BF03194597; Cui GL, 2015, CELL, V161, P750, DOI 10.1016/j.cell.2015.03.021; Furuhashi M, 2008, NAT REV DRUG DISCOV, V7, P489, DOI 10.1038/nrd2589; Harty JT, 2008, NAT REV IMMUNOL, V8, P107, DOI 10.1038/nri2251; Joshi NS, 2007, IMMUNITY, V27, P281, DOI 10.1016/j.immuni.2007.07.010; Kidani Y, 2013, NAT IMMUNOL, V14, P489, DOI 10.1038/ni.2570; Lee JE, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137776; Lee J, 2014, J IMMUNOL, V192, P3190, DOI 10.4049/jimmunol.1302985; Li B, 2009, J IMMUNOL, V182, P7625, DOI 10.4049/jimmunol.0804192; Maeda K, 2003, DIABETES, V52, P300, DOI 10.2337/diabetes.52.2.300; Moon JJ, 2007, IMMUNITY, V27, P203, DOI 10.1016/j.immuni.2007.07.007; Nolz JC, 2014, J CLIN INVEST, V124, P1013, DOI 10.1172/JCI72039; Nolz JC, 2012, P NATL ACAD SCI USA, V109, P6199, DOI 10.1073/pnas.1118868109; O'Sullivan D, 2014, IMMUNITY, V41, P75, DOI 10.1016/j.immuni.2014.06.005; Park BV, 2015, MOL IMMUNOL, V68, P497, DOI 10.1016/j.molimm.2015.07.027; Pearce EL, 2009, NATURE, V460, P103, DOI 10.1038/nature08097; Pepper M, 2010, NAT IMMUNOL, V11, P83, DOI 10.1038/ni.1826; Rojek AM, 2007, P NATL ACAD SCI USA, V104, P3609, DOI 10.1073/pnas.0610894104; Tvinnereim AR, 2002, INFECT IMMUN, V70, P153, DOI 10.1128/IAI.70.1.153-162.2002; Zhang YW, 2014, CANCER RES, V74, P2986, DOI 10.1158/0008-5472.CAN-13-2689	26	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162427	10.1371/journal.pone.0162427	http://dx.doi.org/10.1371/journal.pone.0162427			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588422	Green Published, Green Submitted, gold			2022-12-26	WOS:000382877800061
J	Li, ZY; Xiong, CL; Mo, S; Tian, HY; Yu, MQ; Mao, TT; Chen, Q; Luo, HT; Li, QZ; Lu, JX; Zhao, Y; Li, W				Li, Ziyang; Xiong, Chaoliang; Mo, Suo; Tian, Haiying; Yu, Mengqian; Mao, Tingting; Chen, Qian; Luo, Haitao; Li, Quanzhen; Lu, Jianxin; Zhao, Yi; Li, Wei			Comprehensive Transcriptome Analyses of the Fructose-Fed Syrian Golden Hamster Liver Provides Novel Insights into Lipid Metabolism	PLOS ONE			English	Article							TRIGLYCERIDE TRANSFER PROTEIN; LOW-DENSITY LIPOPROTEINS; LONG NONCODING RNAS; INSULIN-RESISTANCE; EFFECTOR C; SECRETION; GENE; MECHANISMS; OVERPRODUCTION; OVEREXPRESSION	Dyslipidemia has been widely proven to contribute to cardiovascular diseases and other metabolic disorders, especially in insulin resistance and type 2 diabetes. The overproduction of VLDL is a significant characteristic of dyslipidemia, indicating the dysfunction of hepatic lipid metabolism, from triglyceride synthesis to transport. The fructose-fed Syrian golden hamster is an established animal model for the study of VLDL assembly with insulin resistance, however, it remains unknown how VLDL production is regulated at the transcriptional level due to the absence of a complete hamster genome. Here, we performed deep sequencing and constructed an mRNA-miRNA-lncRNA interaction network of Syrian golden hamster liver in order to reveal the global transcription profile and find potential RNA molecular regulation of VLDL production. We identified 4,450 novel multi-exon hamster lncRNAs and 755 miRNAs expressed in liver. Additionally, 146 differentially expressed coding genes, 27 differentially expressed lncRNA genes, as well as 16 differentially expressed miRNAs were identified. We then constructed an mRNA-miRNA-lncRNA interaction network that may potentially regulate VLDL production, and interestingly found several micro-RNA-centered regulatory networks. In order to verify our interpretation, miR-486 was selected for further experiments. Overexpression or down-regulation of miR-486 in fructose-fed hamsters resulted in altered hepatic expression of proteins involved in VLDL production, and in modulated levels of circulating VLDL. Our findings implicated that miR-486 is a potential regulator of circulating VLDL levels. These results provide new insights and a valuable resource for further study of the molecular mechanisms of VLDL secretion.	[Li, Ziyang; Xiong, Chaoliang; Mo, Suo; Tian, Haiying; Yu, Mengqian; Mao, Tingting; Chen, Qian; Lu, Jianxin; Zhao, Yi; Li, Wei] Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ China, Wenzhou 325035, Peoples R China; [Lu, Jianxin; Li, Wei] Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Wenzhou 325035, Peoples R China; [Luo, Haitao; Zhao, Yi] Chinese Acad Sci, Adv Comp Res Ctr, Inst Comp Technol, Key Lab Intelligent Informat Proc,State Key Lab C, Beijing 100190, Peoples R China; [Li, Quanzhen] Univ Texas Southwestern Med Ctr Dallas, Dept Immunol, Dallas, TX 75390 USA; [Li, Quanzhen] Univ Texas Southwestern Med Ctr Dallas, Microarray Core Facil, Dallas, TX 75390 USA	Ministry of Education, China; Wenzhou Medical University; Wenzhou Medical University; Chinese Academy of Sciences; Institute of Computing Technology, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Lu, JX; Zhao, Y; Li, W (corresponding author), Wenzhou Med Univ, Sch Lab Med & Life Sci, Key Lab Lab Med, Minist Educ China, Wenzhou 325035, Peoples R China.; Lu, JX; Li, W (corresponding author), Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Wenzhou 325035, Peoples R China.; Zhao, Y (corresponding author), Chinese Acad Sci, Adv Comp Res Ctr, Inst Comp Technol, Key Lab Intelligent Informat Proc,State Key Lab C, Beijing 100190, Peoples R China.	jxlu313@163.com; biozy@ict.ac.cn; liweiwzmc@163.com	Zhao, Yi/A-2962-2011	Zhao, Yi/0000-0001-6046-8420; Xiong, Chaoliang/0000-0003-0124-2530	National Natural Science Foundation of China [81170749, 31370795]; Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Provincial Top Key Discipline in Clinical Medicine (Laboratory Medicine)	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents; Zhejiang Provincial Top Key Discipline in Clinical Medicine (Laboratory Medicine)	This work was supported by National Natural Science Foundation of China (81170749 and 31370795), Zhejiang Provincial Program for the Cultivation of High-level Innovative Health Talents (Wei Li), and Zhejiang Provincial Top Key Discipline in Clinical Medicine (Laboratory Medicine).	Adeli K, 2011, AM J PHYSIOL-ENDOC M, V301, pE1051, DOI 10.1152/ajpendo.00399.2011; Adiels M, 2006, CURR OPIN LIPIDOL, V17, P238, DOI 10.1097/01.mol.0000226115.97436.c0; ARBEENY CM, 1992, J LIPID RES, V33, P843; BARTOLOMEI MS, 1991, NATURE, V351, P153, DOI 10.1038/351153a0; Basaranoglu M, 2013, WORLD J GASTROENTERO, V19, P1158, DOI 10.3748/wjg.v19.i8.1158; Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; BORSANI G, 1991, NATURE, V351, P325, DOI 10.1038/351325a0; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Cai ZW, 2015, BMC GENOMICS, V16, DOI 10.1186/s12864-015-1283-0; Fu SX, 2012, CELL PHYSIOL BIOCHEM, V30, P1005, DOI 10.1159/000341477; Grahn THM, 2013, BIOCHEM BIOPH RES CO, V432, P296, DOI 10.1016/j.bbrc.2013.01.113; Hung T, 2011, NAT GENET, V43, P621, DOI 10.1038/ng.848; Imamura M, 2002, AM J PHYSIOL-ENDOC M, V283, pE775, DOI 10.1152/ajpendo.00040.2002; Jeon TI, 2013, CELL METAB, V18, P51, DOI 10.1016/j.cmet.2013.06.010; Ji J, 2015, SCI REPORTS, P5; Jiang Y, 2014, SCI REPORTS, P4; Kamagate A, 2008, CELL CYCLE, V7, P3162, DOI 10.4161/cc.7.20.6882; Kung JTY, 2013, GENETICS, V193, P651, DOI 10.1534/genetics.112.146704; Larigauderie G, 2004, ARTERIOSCL THROM VAS, V24, P504, DOI 10.1161/01.ATV.0000115638.27381.97; Lee JT, 2009, GENE DEV, V23, P1831, DOI 10.1101/gad.1811209; Li P, 2015, CELL METAB, V21, P455, DOI 10.1016/j.cmet.2015.02.004; Loewer S, 2010, NAT GENET, V42, P1113, DOI 10.1038/ng.710; Luo HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070835; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; Matsusue K, 2008, CELL METAB, V7, P302, DOI 10.1016/j.cmet.2008.03.003; Matsusue K, 2010, BIOL PHARM BULL, V33, P346, DOI 10.1248/bpb.33.346; Orom UA, 2010, CELL, V143, P46, DOI 10.1016/j.cell.2010.09.001; Penny GD, 1996, NATURE, V379, P131, DOI 10.1038/379131a0; Qiu W, 2004, DIABETES, V53, P3057, DOI 10.2337/diabetes.53.12.3057; Qiu W, 2008, HEPATOLOGY, V48, P1799, DOI 10.1002/hep.22565; Rayner KJ, 2010, SCIENCE, V328, P1570, DOI 10.1126/science.1189862; Rinn JL, 2007, CELL, V129, P1311, DOI 10.1016/j.cell.2007.05.022; Rutledge AC, 2010, BIOCHEM CELL BIOL, V88, P251, DOI [10.1139/O09-168, 10.1139/o09-168]; Saito R, 2012, NAT METHODS, V9, P1069, DOI [10.1038/nmeth.2212, 10.1038/NMETH.2212]; Schmucki R, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-237; Shelness GS, 2001, CURR OPIN LIPIDOL, V12, P151, DOI 10.1097/00041433-200104000-00008; Small EM, 2010, P NATL ACAD SCI USA, V107, P4218, DOI 10.1073/pnas.1000300107; Sparks JD, 2012, ARTERIOSCL THROM VAS, V32, P2104, DOI 10.1161/ATVBAHA.111.241463; Stillemark P, 2000, J BIOL CHEM, V275, P10506, DOI 10.1074/jbc.275.14.10506; SWIFT LL, 1995, J LIPID RES, V36, P395; Taghibiglou C, 2000, J BIOL CHEM, V275, P8416, DOI 10.1074/jbc.275.12.8416; Taghibiglou C, 2000, J LIPID RES, V41, P499; Taghibiglou C, 2002, J BIOL CHEM, V277, P793, DOI 10.1074/jbc.M106737200; Tchitchek N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112617; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Wang J, 2013, MOL BIOL REP, V40, P6765, DOI 10.1007/s11033-013-2793-y; Wang KC, 2011, NATURE, V472, P120, DOI 10.1038/nature09819; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Xu L, 2012, ARTERIOSCL THROM VAS, V32, P1094, DOI 10.1161/ATVBAHA.111.241489; Ye J, 2009, CELL METAB, V9, P177, DOI 10.1016/j.cmet.2008.12.013; Zhao Y, 2016, NUCLEIC ACIDS RES, V44, pD203, DOI 10.1093/nar/gkv1252	51	6	6	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162402	10.1371/journal.pone.0162402	http://dx.doi.org/10.1371/journal.pone.0162402			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589064	gold, Green Submitted, Green Published			2022-12-26	WOS:000382877800056
J	Marrachelli, VG; Rentero, P; Mansego, ML; Morales, JM; Galan, I; Pardo-Tendero, M; Martinez, F; Martin-Escudero, JC; Briongos, L; Chaves, FJ; Redon, J; Monleon, D				Marrachelli, Vannina G.; Rentero, Pilar; Mansego, Maria L.; Manuel Morales, Jose; Galan, Inma; Pardo-Tendero, Mercedes; Martinez, Fernando; Carlos Martin-Escudero, Juan; Briongos, Laisa; Javier Chaves, Felipe; Redon, Josep; Monleon, Daniel			Genomic and Metabolomic Profile Associated to Clustering of Cardio-Metabolic Risk Factors	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; INSULIN-RESISTANCE; PATHWAYS; DISEASE; HEALTH; IDENTIFICATION; HYPERTENSION; POPULATION; PREVALENCE; BIOMARKERS	Background To identify metabolomic and genomic markers associated with the presence of clustering of cardiometabolic risk factors (CMRFs) from a general population. Methods and Findings One thousand five hundred and two subjects, Caucasian, > 18 years, representative of the general population, were included. Blood pressure measurement, anthropometric parameters and metabolic markers were measured. Subjects were grouped according the number of CMRFs (Group 1: <2; Group 2: 2; Group 3: 3 or more CMRFs). Using SNPlex, 1251 SNPs potentially associated to clustering of three or more CMRFs were analyzed. Serum metabolomic profile was assessed by H-1 NMR spectra using a Brucker Advance DRX 600 spectrometer. From the total population, 1217 (mean age 54 +/- 19, 50.6% men) with high genotyping call rate were analysed. A differential metabolomic profile, which included products from mitochondrial metabolism, extra mitochondrial metabolism, branched amino acids and fatty acid signals were observed among the three groups. The comparison of metabolomic patterns between subjects of Groups 1 to 3 for each of the genotypes associated to those subjects with three or more CMRFs revealed two SNPs, the rs174577_AA of FADS2 gene and the rs3803_TT of GATA2 transcription factor gene, with minimal or no statistically significant differences. Subjects with and without three or more CMRFs who shared the same genotype and metabolomic profile differed in the pattern of CMRFS cluster. Subjects of Group 3 and the AA genotype of the rs174577 had a lower prevalence of hypertension compared to the CC and CT genotype. In contrast, subjects of Group 3 and the TT genotype of the rs3803 polymorphism had a lower prevalence of T2DM, although they were predominantly males and had higher values of plasma creatinine. Conclusions The results of the present study add information to the metabolomics profile and to the potential impact of genetic factors on the variants of clustering of cardiometabolic risk factors.	[Marrachelli, Vannina G.; Manuel Morales, Jose; Pardo-Tendero, Mercedes] INCLIVA, Hlth Res Inst, Metabol & Mol Image Lab, Valencia, Spain; [Rentero, Pilar; Galan, Inma; Javier Chaves, Felipe] INCLIVA, Hlth Res Inst, Genotyping & Genet Diag Unit, Valencia, Spain; [Mansego, Maria L.] Univ Navarra, Dept Nutr Food Sci & Physiol, Pamplona, Spain; [Martinez, Fernando; Briongos, Laisa; Redon, Josep] Univ Valencia, INCLIVA Res Inst, Valencia, Spain; [Carlos Martin-Escudero, Juan] Hosp Rio Hortega, Internal Med, Valladolid, Spain; [Javier Chaves, Felipe] Hlth Inst Carlos III, CIBERDem, Madrid, Spain; [Redon, Josep] Hlth Inst Carlos III, CIBERObn, Madrid, Spain	University of Navarra; University of Valencia; Hospital del Rio Hortega; CIBER - Centro de Investigacion Biomedica en Red; CIBERDEM; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN	Redon, J (corresponding author), Univ Valencia, INCLIVA Res Inst, Valencia, Spain.; Redon, J (corresponding author), Hlth Inst Carlos III, CIBERObn, Madrid, Spain.	josep.redon@uv.es	MartÃnez, Fernando/AAO-5879-2021; Rentero-Garrido, Pilar/AAC-1788-2019; Monleon, Daniel/A-5078-2010; Pardo-Tendero, María Mercedes/AAV-3301-2021; Chaves-Martinez, Felipe Javier/ABC-3294-2021; tatay, jose manuel morales/L-7972-2014; Monleon, Daniel/GNP-4083-2022; REDON, JOSEP/E-1719-2019; marrachelli, vannina G/L-6041-2014; Redon, Josep/L-5997-2019	MartÃnez, Fernando/0000-0001-8562-4477; Monleon, Daniel/0000-0002-4803-1573; Pardo-Tendero, María Mercedes/0000-0001-8878-8311; Chaves-Martinez, Felipe Javier/0000-0001-8009-3689; tatay, jose manuel morales/0000-0002-4404-6735; Monleon, Daniel/0000-0002-4803-1573; marrachelli, vannina G/0000-0002-4097-3312; Redon, Josep/0000-0001-8777-6773; Rentero-Garrido, Pilar/0000-0002-6158-0104; Martin-Escudero, Juan Carlos/0000-0002-6209-6509	Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH European Commission, 7th Framework Programme [2011.2.4.2-2]; FEDER; EU;  [PS09/02014];  [SAF2011-23029];  [PI 12/02615]	Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH European Commission, 7th Framework Programme; FEDER(European Commission); EU(European Commission); ; ; 	The study has been funded by the Ingenious Hypercare Network of Excellence, Life sciences, genomics and biotechnology for health, 6th Framework Programme; EU-MASCARA HEALTH, 2011.2.4.2-2 European Commission, 7th Framework Programme; and the grants PS09/02014, SAF2011-23029, PI 12/02615 and Research Funds from FEDER, EU.	Alegria E, 2005, REV ESP CARDIOL, V58, P797, DOI 10.1157/13077231; BRADY PS, 1982, J BIOL CHEM, V257, P9290; Chang YC, 2001, ELS; Duarte IF, 2014, J PHARMACEUT BIOMED, V93, P17, DOI 10.1016/j.jpba.2013.09.025; Fernandez-Berges D, 2011, GAC SANIT, V25, P519, DOI 10.1016/j.gaceta.2011.05.009; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Guallar-Castillon P, 2014, REV ESP CARDIOL, V67, P367, DOI [10.1016/j.rec.2013.08.014, 10.1016/j.recesp.2013.08.014]; Holmes E, 2012, CELL METAB, V16, P559, DOI 10.1016/j.cmet.2012.10.007; Huang Y, 2011, CARDIOVASC RES, V90, P220, DOI 10.1093/cvr/cvr070; IWASAKI Y, 1980, GASTROENTEROLOGY, V78, P677; Kaur J, 2014, CARDIOL RES PRACT, V2014, DOI 10.1155/2014/943162; Kim OY, 2011, NUTR METAB, V8, DOI 10.1186/1743-7075-8-24; Kordalewska M, 2015, J PHARMACEUT BIOMED, V113, P121, DOI 10.1016/j.jpba.2015.04.021; Kraja AT, 2014, MOL GENET METAB, V112, P317, DOI 10.1016/j.ymgme.2014.04.007; Lattka E, 2010, CLIN NUTR, V29, P277, DOI 10.1016/j.clnu.2009.11.005; Lattka E, 2010, CURR OPIN LIPIDOL, V21, P64, DOI 10.1097/MOL.0b013e3283327ca8; Lin Z, 2014, ANAL CHIM ACTA, V827, P22, DOI [10.1016/j.aca.2014.04.008, 10.1016/j.aca.2014.04.039]; Medina S, 2014, CURR MED CHEM, V21, P823, DOI 10.2174/0929867320666131119124056; Mena-Martin FJ, 2003, J HYPERTENS, V21, P1283, DOI 10.1097/00004872-200307000-00015; Nakayama K, 2010, HUM GENET, V127, P685, DOI 10.1007/s00439-010-0815-6; Newgard CB, 2012, CELL METAB, V15, P606, DOI 10.1016/j.cmet.2012.01.024; Ooga T, 2011, MOL BIOSYST, V7, P1217, DOI 10.1039/c0mb00141d; Poulsen P, 2001, DIABETOLOGIA, V44, P537, DOI 10.1007/s001250051659; Shearer J, 2008, DIABETES OBES METAB, V10, P950, DOI 10.1111/j.1463-1326.2007.00837.x; Stern MP, 2004, DIABETES CARE, V27, P2676, DOI 10.2337/diacare.27.11.2676; Stoffel W, 2014, EMBO REP, V15, P110, DOI 10.1002/embr.201338041; Tong Q, 2005, MOL CELL BIOL, V25, P706, DOI 10.1128/MCB.25.2.706-715.2005; Tong Q, 2003, DRUG NEWS PERSPECT, V16, P585, DOI 10.1358/dnp.2003.16.9.829340; Ueland PM, 2011, J INHERIT METAB DIS, V34, P3, DOI 10.1007/s10545-010-9088-4; Walsh MC, 2014, BRIT J NUTR, V111, P424, DOI 10.1017/S0007114513002602; Wiklund PK, 2014, DIABETOL METAB SYNDR, V6, DOI 10.1186/1758-5996-6-40; Yu ZR, 2014, J HUAZHONG U SCI-MED, V34, P276, DOI 10.1007/s11596-014-1271-7; Zhang AH, 2014, CLIN CHIM ACTA, V429, P106, DOI 10.1016/j.cca.2013.11.037; Zhang AH, 2012, ANALYST, V137, P4200, DOI 10.1039/c2an35780a; Zhong L, 2014, EUR REV MED PHARMACO, V18, P3673	35	10	10	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0160656	10.1371/journal.pone.0160656	http://dx.doi.org/10.1371/journal.pone.0160656			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589269	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800004
J	Ding, N; Wang, X; Weisskopf, MG; Sparrow, D; Schwartz, J; Hu, H; Park, SK				Ding, Ning; Wang, Xin; Weisskopf, Marc G.; Sparrow, David; Schwartz, Joel; Hu, Howard; Park, Sung Kyun			Lead-Related Genetic Loci, Cumulative Lead Exposure and Incident Coronary Heart Disease: The Normative Aging Study	PLOS ONE			English	Article							BONE-MINERAL DENSITY; ACID DEHYDRATASE GENOTYPE; X-RAY-FLUORESCENCE; OXIDATIVE STRESS; BLOOD LEAD; VITAMIN-D; PULSE PRESSURE; APOE GENOTYPE; NITRIC-OXIDE; POLYMORPHISM	Background Cumulative exposure to lead is associated with cardiovascular outcomes. Polymorphisms in the delta-aminolevulinic acid dehydratase (ALAD), hemochromatosis (HFE), heme oxygenase-1 (HMOX1), vitamin D receptor (VDR), glutathione S-transferase (GST) supergene family (GSTP1, GSTT1, GSTM1), apolipoprotein E (APOE), angiotensin II receptor-1 (AGTR1) and angiotensinogen (AGT) genes, are believed to alter toxicokinetics and/or toxi-codynamics of lead. Objectives We assessed possible effect modification by genetic polymorphisms in ALAD, HFE, HMOX1, VDR, GSTP1, GSTT1, GSTM1, APOE, AGTR1 and AGT individually and as the genetic risk score (GRS) on the association between cumulative lead exposure and incident coronary heart disease (CHD) events. Methods We used K-shell-X-ray fluorescence to measure bone lead levels. GRS was calculated on the basis of 22 lead-related loci. We constructed Cox proportional hazard models to compute adjusted hazard ratios (HRs) and 95% confidence intervals (CIs) for incident CHD. We applied inverse probability weighting to account for potential selection bias due to recruitment into the bone lead sub-study. Results Significant effect modification was found by VDR, HMOX1, GSTP1, APOE, and AGT genetic polymorphisms when evaluated individually. Further, the bone lead-CHD associations became larger as GRS increases. After adjusting for potential confounders, a HR of CHD was 2.27 (95%CI: 1.50-3.42) with 2-fold increase in patella lead levels, among participants in the top tertile of GRS. We also detected an increasing trend in HRs across tertiles of GRS (p-trend = 0.0063). Conclusions Our findings suggest that lead-related loci as a whole may play an important role in susceptibility to lead-related CHD risk. These findings need to be validated in a separate cohort containing bone lead, lead-related genetic loci and incident CHD data.	[Ding, Ning; Wang, Xin; Park, Sung Kyun] Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA; [Weisskopf, Marc G.; Schwartz, Joel] Harvard TH Chan Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Sparrow, David] Vet Affairs Boston Healthcare Syst, Vet Affairs Normat Aging Study, Boston, MA USA; [Sparrow, David] Boston Univ, Sch Med, Dept Med, Boston, MA 02118 USA; [Hu, Howard] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Hu, Howard; Park, Sung Kyun] Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; Harvard University; Harvard T.H. Chan School of Public Health; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; University of Toronto; University of Michigan System; University of Michigan	Park, SK (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Epidemiol, Ann Arbor, MI 48109 USA.; Park, SK (corresponding author), Univ Michigan, Sch Publ Hlth, Dept Environm Hlth Sci, Ann Arbor, MI 48109 USA.	sungkyun@umich.edu	Ding, Ning/AAQ-2262-2020; Hu, Howard/AAV-5360-2021	Ding, Ning/0000-0001-5244-2909; Wang, Xin/0000-0002-0851-6605; Hu, Howard/0000-0002-3676-2707; Park, Sung Kyun/0000-0001-9981-6250	National Institute of Environmental Health Sciences (NIEHS) [R01-ES005257, K01-ES016587, P30-ES017885]; Center for Disease Control and Prevention (CDC)/National Institute for Occupational Safety and Health (NIOSH) [T42-OH008455]; VA Research Career Scientist Award; Cooperative Studies Program/Epidemiology Research and Information Centers of the U.S. Department of Veterans Affairs; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH [T42OH008455] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK092926, P30DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [K01ES016587, P30ES017885, R01ES005257] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences (NIEHS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Center for Disease Control and Prevention (CDC)/National Institute for Occupational Safety and Health (NIOSH); VA Research Career Scientist Award; Cooperative Studies Program/Epidemiology Research and Information Centers of the U.S. Department of Veterans Affairs; NATIONAL INSTITUTE FOR OCCUPATIONAL SAFETY AND HEALTH(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USANational Institute for Occupational Safety & Health (NIOSH)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by grants from the National Institute of Environmental Health Sciences (NIEHS) R01-ES005257, K01-ES016587 and P30-ES017885, and by the Center for Disease Control and Prevention (CDC)/National Institute for Occupational Safety and Health (NIOSH) grant T42-OH008455. Dr. David Sparrow was supported by a VA Research Career Scientist Award. The VA Normative Aging Study is supported by the Cooperative Studies Program/Epidemiology Research and Information Centers of the U.S. Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by grants from the National Institute of Environmental Health Sciences (NIEHS) R01-ES005257, K01-ES016587 and P30-ES017885, and by the Center for Disease Control and Prevention (CDC)/National Institute for Occupational Safety and Health (NIOSH) grant T42-OH008455. Dr. David Sparrow was supported by a VA Research Career Scientist Award. The VA Normative Aging Study is supported by the Cooperative Studies Program/Epidemiology Research and Information Centers of the U.S. Department of Veterans Affairs and is a component of the Massachusetts Veterans Epidemiology Research and Information Center, Boston, Massachusetts.	Alexander BH, 1998, ENVIRON HEALTH PERSP, V106, P213, DOI 10.2307/3433966; ARO ACA, 1994, PHYS MED BIOL, V39, P2263, DOI 10.1088/0031-9155/39/12/009; Ashrafunnisa Begum AV, 2014, INT J SCI RES, V3, P318; Ballatori N, 1994, Adv Pharmacol, V27, P271, DOI 10.1016/S1054-3589(08)61036-4; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bergdahl IA, 1997, PHARMACOL TOXICOL, V81, P153, DOI 10.1111/j.1600-0773.1997.tb02061.x; Billionnet C, 2012, ANN EPIDEMIOL, V22, P126, DOI 10.1016/j.annepidem.2011.11.004; Birdsall RE, 2010, J PROTEOME RES, V9, P4443, DOI 10.1021/pr100204g; Calafat AM, 2012, INT J HYG ENVIR HEAL, V215, P99, DOI 10.1016/j.ijheh.2011.08.014; CAMPBELL BC, 1985, TOXICOL LETT, V25, P25, DOI 10.1016/0378-4274(85)90096-7; Choi SH, 2009, CLIN ENDOCRINOL, V71, P644, DOI 10.1111/j.1365-2265.2009.03535.x; Colton CA, 2002, NEUROBIOL AGING, V23, P777, DOI 10.1016/S0197-4580(02)00016-7; Cooper GS, 1996, J BONE MINER RES, V11, P1841; COUDERC R, 1993, STROKE, V24, P661, DOI 10.1161/01.STR.24.5.661; Dietze EC, 1996, BIOCHEMISTRY-US, V35, P11938, DOI 10.1021/bi961073r; Ekong EB, 2006, KIDNEY INT, V70, P2074, DOI 10.1038/sj.ki.5001809; Ercal N, 1996, TOXICOLOGY, V108, P57, DOI 10.1016/S0300-483X(95)03273-I; Ercal Nuran, 2001, Current Topics in Medicinal Chemistry, V1, P529, DOI 10.2174/1568026013394831; Feder JN, 1998, P NATL ACAD SCI USA, V95, P1472, DOI 10.1073/pnas.95.4.1472; Guggenbuhl P, 2005, OSTEOPOROSIS INT, V16, P1809, DOI 10.1007/s00198-005-1934-0; Gunnar F N, 2014, HDB TOXICOLOGY METAL, Vfourth; HAYES JD, 1995, FREE RADICAL RES, V22, P193, DOI 10.3109/10715769509147539; Haynes EN, 2003, ENVIRON HEALTH PERSP, V111, P1665, DOI 10.1289/ehp.6167; Hu H, 2001, ENVIRON HEALTH PERSP, V109, P827, DOI 10.2307/3454826; HU H, 1995, ENVIRON HEALTH PERSP, V103, P105, DOI 10.2307/3432024; Hurwitz S, 1996, CRIT REV BIOCHEM MOL, V31, P41, DOI 10.3109/10409239609110575; Jhun MA, 2015, ENVIRON HEALTH-GLOB, V14, DOI 10.1186/1476-069X-14-5; Jofre-Monseny L, 2008, MOL NUTR FOOD RES, V52, P131, DOI 10.1002/mnfr.200700322; Kim HK, 2014, J RENIN ANGIOTENSIN; Li HM, 2014, ANGIOLOGY, V65, P614, DOI 10.1177/0003319713491309; Li YC, 2004, J STEROID BIOCHEM, V89-90, P387, DOI 10.1016/j.jsbmb.2004.03.004; Mannila MN, 2013, ARTERIOSCL THROM VAS, V33, P1063, DOI 10.1161/ATVBAHA.112.300353; Coral-Vazquez RM, 2013, CLIN BIOCHEM, V46, P627, DOI 10.1016/j.clinbiochem.2012.12.016; Menke A, 2006, CIRCULATION, V114, P1388, DOI 10.1161/CIRCULATIONAHA.106.628321; Miyaki K, 2009, INT J ENV RES PUB HE, V6, P999, DOI 10.3390/ijerph6030999; Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55; Park SK, 2009, ENVIRON HEALTH PERSP, V117, P80, DOI 10.1289/ehp.11559; Pawlas N, 2012, NEUROTOXICOLOGY, V33, P37, DOI 10.1016/j.neuro.2011.10.012; Pilbrow AP, 2007, HYPERTENSION, V49, P322, DOI 10.1161/01.HYP.0000253061.30170.68; POUNDS JG, 1984, NEUROTOXICOLOGY, V5, P295; Program NT, 2012, NTP MON, pi; Rezende VB, 2008, ARCH TOXICOL, V82, P29, DOI 10.1007/s00204-007-0231-4; Rodriguez-Iturbe B, 2005, ANTIOXID REDOX SIGN, V7, P1269, DOI 10.1089/ars.2005.7.1269; Rudic RD, 1998, J CLIN INVEST, V101, P731, DOI 10.1172/JCI1699; Schisterman EF, 2009, EPIDEMIOLOGY, V20, P488, DOI 10.1097/EDE.0b013e3181a819a1; SCHWARTZ BS, 1995, AM J EPIDEMIOL, V142, P738, DOI 10.1093/oxfordjournals.aje.a117705; Sharifi AM, 2004, TOXICOL LETT, V153, P233, DOI 10.1016/j.toxlet.2004.04.013; Sheng-jie Nie TW, 2009, CLIN BIOCHEM, V43, P253, DOI [10.1016/j.clinbiochem, DOI 10.1016/J.CLINBIOCHEM]; Sirivarasai J, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/474963; Stewart WF, 2002, ENVIRON HEALTH PERSP, V110, P501, DOI 10.1289/ehp.02110501; Tanaka G, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-117; Theppeang K, 2008, ENVIRON HEALTH PERSP, V116, P784, DOI 10.1289/ehp.10977; Tolonen S, 2011, BONE, V48, P1058, DOI 10.1016/j.bone.2011.01.013; Vaziri ND, 2000, HYPERTENSION, V36, P142, DOI 10.1161/01.HYP.36.1.142; Waheed A, 1997, P NATL ACAD SCI USA, V94, P12384, DOI 10.1073/pnas.94.23.12384; Warrell DA, 2010, OXFORD TXB MED; WASSERMAN RH, 1995, J NUTR, V125, pS1971, DOI 10.1093/jn/125.suppl_7.1971S; Weisskopf MG, 2015, ENVIRON HEALTH PERSP, V123, P1113, DOI 10.1289/ehp.1408888; WETMUR JG, 1994, ENVIRON HEALTH PERSP, V102, P215, DOI 10.2307/3431789; Wilker E, 2011, J OCCUP ENVIRON MED, V53, P850, DOI 10.1097/JOM.0b013e31822589a9; Willerson JT, 2015, CARDIOVASC MED-LOND, P461, DOI 10.1007/978-1-4471-2828-1_18; Wright RO, 2004, ENVIRON HEALTH PERSP, V112, P746, DOI 10.1289/ehp.6581; Yamada N, 2000, AM J HUM GENET, V66, P187, DOI 10.1086/302729; Zhang AM, 2010, ENVIRON HEALTH PERSP, V118, P1261, DOI 10.1289/ehp.1002251	64	26	27	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161472	10.1371/journal.pone.0161472	http://dx.doi.org/10.1371/journal.pone.0161472			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584680	Green Published, Green Submitted, gold			2022-12-26	WOS:000382855600032
J	Garcia-Barros, M; Coant, N; Kawamori, T; Wada, M; Snider, AJ; Truman, JP; Wu, BX; Furuya, H; Clarke, CJ; Bialkowska, AB; Ghaleb, A; Yang, VW; Obeid, LM; Hannun, YA				Garcia-Barros, Monica; Coant, Nicolas; Kawamori, Toshihiko; Wada, Masayuki; Snider, Ashley J.; Truman, Jean-Philip; Wu, Bill X.; Furuya, Hideki; Clarke, Christopher J.; Bialkowska, Agnieszka B.; Ghaleb, Amr; Yang, Vincent W.; Obeid, Lina M.; Hannun, Yusuf A.			Role of neutral ceramidase in colon cancer	FASEB JOURNAL			English	Article						sphingolipids ceramide; aberrant crypt foci; azoxymethane; apoptosis	RENAL MESANGIAL CELLS; NECROSIS-FACTOR-ALPHA; SPHINGOSINE KINASE 1; BETA-CATENIN; COLORECTAL-CANCER; IN-VIVO; INTESTINAL TUMORIGENESIS; TUMOR-GROWTH; CRYPT FOCI; CF1 MICE	Alterations in sphingolipid metabolism, especially ceramide and sphingosine 1-phosphate, have been linked to colon cancer, suggesting that enzymes of sphingolipid metabolism may emerge as novel regulators and targets in colon cancer. Neutral ceramidase (nCDase), a key enzyme in sphingolipid metabolism that hydrolyzes ceramide into sphingosine, is highly expressed in the intestine; however, its role in colon cancer has not been defined. Here we show that molecular and pharmacological inhibition of nCDase in colon cancer cells increases ceramide, and this is accompanied by decreased cell survival and increased apoptosis and autophagy, with minimal effects on noncancerous cells. Inhibition of nCDase resulted in loss of beta-catenin and inhibition of ERK, components of pathways relevant for colon cancer development. Furthermore, inhibition of nCDase in a xenograft model delayed tumor growth and increased ceramide while decreasing proliferation. It is noteworthy that mice lacking nCDase treated with azoxymethane were protected from tumor formation. Taken together, these studies show that nCDase is pivotal for regulating initiation and development of colon cancer, and these data suggest that this enzyme is a suitable and novel target for colon cancer therapy.	[Garcia-Barros, Monica; Coant, Nicolas; Wada, Masayuki; Snider, Ashley J.; Truman, Jean-Philip; Clarke, Christopher J.; Bialkowska, Agnieszka B.; Ghaleb, Amr; Yang, Vincent W.; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Biochem, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Pharmacol, Stony Brook, NY 11794 USA; [Hannun, Yusuf A.] SUNY Stony Brook, Dept Pathol, Stony Brook, NY 11794 USA; [Garcia-Barros, Monica; Coant, Nicolas; Wada, Masayuki; Snider, Ashley J.; Truman, Jean-Philip; Clarke, Christopher J.; Obeid, Lina M.; Hannun, Yusuf A.] SUNY Stony Brook, Stony Brook Canc Ctr, Stony Brook, NY 11794 USA; [Kawamori, Toshihiko; Furuya, Hideki] Univ Hawaii, Ctr Canc, Canc Biol Program, Honolulu, HI 96822 USA; [Kawamori, Toshihiko] Tokyo Leon Clin, Res Inst Canc Prevent & Pathol Diag, Nagoya, Aichi, Japan; [Snider, Ashley J.; Obeid, Lina M.] Northport Vet Affairs Med Ctr, Northport, NY USA; [Wu, Bill X.] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC USA	State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; Cancer Research Center of Hawaii; University of Hawaii System; Medical University of South Carolina	Hannun, YA (corresponding author), Dept Biochem, 101 Nicolls Rd,T15,023, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), Dept Pharmacol, 101 Nicolls Rd,T15,023, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), Dept Pathol, 101 Nicolls Rd,T15,023, Stony Brook, NY 11794 USA.; Hannun, YA (corresponding author), Dept Med, 101 Nicolls Rd,T15,023, Stony Brook, NY 11794 USA.	yusuf.hannun@stonybrookmedicine.edu	Furuya, Hideki/AAH-5719-2021	Furuya, Hideki/0000-0002-9536-8662; COANT, Nicolas/0000-0001-9237-2132	U.S. National Institutes of Health, National Cancer Institute [R01-CA172517, P01-CA97132, R01-CA172113]; ONO Co.; NATIONAL CANCER INSTITUTE [P01CA097132, R01CA172113, R01CA172517] Funding Source: NIH RePORTER	U.S. National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ONO Co.; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by U.S. National Institutes of Health, National Cancer Institute Grants R01-CA172517 (to Y.A.H.), P01-CA97132 (to L.M.O.), and R01-CA172113 (to V.W.Y.). The authors thank the Lipidomics Core facility at the State University of New York at Stony Brook for lipid analysis, the Lipidomic Facility at the Medical University of South Carolina for providing the nCDase inhibitor, the Flow Cytometry Core facility for assistance with cell cycle analysis, the Research Core Histology Laboratory at Stony Brook University for technical assistance, and Dr. Takuji Tanaka (certified pathologist and toxicologist; Gifu Municipal Hospital, Gifu, Japan) for assistance with AOM-induced tumors diagnosis. The laboratory of Dr. Y.A.H. has research support from ONO Co., for a distinct project.	Arnold CN, 2005, CANCER-AM CANCER SOC, V104, P2035, DOI 10.1002/cncr.21462; Begagne E, 2014, J CLIN INVEST, V124, P5368, DOI 10.1172/JCI74188; Bielawski J, 2010, ADV EXP MED BIOL, V688, P46; BIRD RP, 1987, CANCER LETT, V37, P147, DOI 10.1016/0304-3835(87)90157-1; BLAY J, 1985, BIOCHEM J, V225, P85, DOI 10.1042/bj2250085; Brabletz T, 2000, AM J PATHOL, V156, P865, DOI 10.1016/S0002-9440(10)64955-3; Castro ME, 2008, CARCINOGENESIS, V29, P491, DOI 10.1093/carcin/bgm246; Chen Y, 2015, MOL CANCER THER, V14, P259, DOI 10.1158/1535-7163.MCT-14-0468-T; Dahm F, 2008, BRIT J CANCER, V98, P98, DOI 10.1038/sj.bjc.6604099; DILLEHAY DL, 1994, J NUTR, V124, P615, DOI 10.1093/jn/124.5.615; El Alwani M, 2006, PHARMACOL THERAPEUT, V112, P171, DOI 10.1016/j.pharmthera.2006.04.004; El Bawab S, 1999, J BIOL CHEM, V274, P27948, DOI 10.1074/jbc.274.39.27948; Franzen R, 2002, J BIOL CHEM, V277, P46184, DOI 10.1074/jbc.M204034200; Franzen R, 2001, J BIOL CHEM, V276, P35382, DOI 10.1074/jbc.M102153200; Gandy KAO, 2013, BIOCHEM J, V449, P661, DOI 10.1042/BJ20120213; Garcia-Barros M, 2014, BBA-MOL CELL BIOL L, V1841, P773, DOI 10.1016/j.bbalip.2013.09.007; Garzotto M, 1998, CANCER RES, V58, P2260; Green DW, 2001, J SURG RES, V101, P16, DOI 10.1006/jsre.2001.6241; Hannun YA, 1996, SCIENCE, V274, P1855, DOI 10.1126/science.274.5294.1855; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hannun YA, 2011, J BIOL CHEM, V286, P27855, DOI 10.1074/jbc.R111.254359; Hernandez-Corbacho MJ, 2015, J BIOL CHEM, V290, P25356, DOI 10.1074/jbc.M115.658658; Hertervig E, 1997, CANCER, V79, P448, DOI 10.1002/(SICI)1097-0142(19970201)79:3<448::AID-CNCR4>3.0.CO;2-E; Huwiler A, 1999, J BIOL CHEM, V274, P7190, DOI 10.1074/jbc.274.11.7190; Ito M, 2014, BBA-MOL CELL BIOL L, V1841, P682, DOI 10.1016/j.bbalip.2013.09.008; Johnson RL, 2013, CANCER METAST REV, V32, P39, DOI 10.1007/s10555-012-9404-6; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; KIM JH, 1986, CANCER RES, V46, P1120; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Kono M, 2006, J BIOL CHEM, V281, P7324, DOI 10.1074/jbc.M508382200; Kraveka JM, 2003, ARCH BIOCHEM BIOPHYS, V419, P110, DOI 10.1016/j.abb.2003.08.034; Krutovskikh V A, 1994, IARC Sci Publ, P195; Kung CP, 2011, CRIT REV EUKAR GENE, V21, P71, DOI 10.1615/CritRevEukarGeneExpr.v21.i1.50; Liang J, 2013, CANCER CELL, V23, P107, DOI 10.1016/j.ccr.2012.11.013; Marchesini N, 2007, BBA-MOL CELL BIOL L, V1771, P1418, DOI 10.1016/j.bbalip.2007.10.003; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Morad SAF, 2013, NAT REV CANCER, V13, P51, DOI 10.1038/nrc3398; Nikolova-Karakashian MN, 2010, ADV EXP MED BIOL, V688, P86; Novgorodov SA, 2011, J BIOL CHEM, V286, P25352, DOI 10.1074/jbc.M110.214866; Osawa Y, 2005, J BIOL CHEM, V280, P27879, DOI 10.1074/jbc.M503002200; Oskouian B, 2007, CELL CYCLE, V6, P522, DOI 10.4161/cc.6.5.3903; Pattingre S, 2009, AUTOPHAGY, V5, P558, DOI 10.4161/auto.5.4.8390; Pretlow TP, 2005, BBA-REV CANCER, V1756, P83, DOI 10.1016/j.bbcan.2005.06.002; Roh H, 2001, CANCER RES, V61, P6563; Rosenberg DW, 2009, CARCINOGENESIS, V30, P183, DOI 10.1093/carcin/bgn267; Schmelz EM, 1996, CANCER RES, V56, P4936; Schmelz EM, 2001, CANCER RES, V61, P6723; Selzner M, 2001, CANCER RES, V61, P1233; Stancevic B, 2010, FEBS LETT, V584, P1728, DOI 10.1016/j.febslet.2010.02.026; Symolon H, 2011, MOL CANCER THER, V10, P648, DOI 10.1158/1535-7163.MCT-10-0754; Tai CJ, 2012, POL J PATHOL, V63, P93; Tan SSL, 2014, CLIN TRANSL GASTROEN, V5, DOI 10.1038/ctg.2013.21; Tanaka K, 2012, J BIOCHEM, V151, P611, DOI 10.1093/jb/mvs033; Uchida Y, 2010, J INVEST DERMATOL, V130, P2472, DOI 10.1038/jid.2010.153; Usta J, 2001, BIOCHEMISTRY-US, V40, P9657, DOI 10.1021/bi010535k; Venable ME, 2009, CELL BIOCHEM FUNCT, V27, P547, DOI 10.1002/cbf.1605; Venable ME, 1995, J BIOL CHEM, V270, P30701, DOI 10.1074/jbc.270.51.30701; Verma UN, 2003, CLIN CANCER RES, V9, P1291; Voelkel-Johnson C, 2005, MOL CANCER THER, V4, P1320, DOI 10.1158/1535-7163.MCT-05-0086; VOGELSTEIN B, 1988, NEW ENGL J MED, V319, P525, DOI 10.1056/NEJM198809013190901; Wargovich Michael J, 2010, Cancers (Basel), V2, P1705, DOI 10.3390/cancers2031705; White-Gilbertson S, 2009, ONCOGENE, V28, P1132, DOI 10.1038/onc.2008.468; Wu BX, 2009, BBA-MOL CELL BIOL L, V1791, P730, DOI 10.1016/j.bbalip.2009.03.012	64	36	38	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	DEC	2016	30	12					4159	4171		10.1096/fj.201600611R	http://dx.doi.org/10.1096/fj.201600611R			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	EC5UG	27609772	Green Published			2022-12-26	WOS:000388201500022
J	Bian, YQ; Deng, C; Li, WZ; Lei, ZJ; Li, YJ; Li, XY				Bian, Yongqian; Deng, Chen; Li, Wangzhou; Lei, Zhanjun; Li, Yuejun; Li, Xueyong			A Comparative Study on the Biological Characteristics of Human Adipose-Derived Stem Cells from Lipectomy and Liposuction	PLOS ONE			English	Article							LOCAL-ANESTHETICS; REGENERATIVE MEDICINE; TISSUE; APOPTOSIS; DIFFERENTIATION; RECONSTRUCTION; CYTOTOXICITY; TOXICITY	Purposes To compare the biological behaviors of human adipose-derived stem cells (ADSCs) isolated from adipose tissue by lipectomy and liposuction, with the purpose of providing the basis for clinical application. Methods The proliferation and apoptosis of ADSCs were analyzed by CCK-8 assay and flow cytometry. Cell migration was measured by a wound healing assay. An ELISA assay was used to evaluate paracrine functions. SOD and MDA were tested by xanthine oxidase and thiobarbituric acid reactions, respectively. In addition, we used a CCK-8, LDH assay and flow cytometry to analyze the proliferation and apoptosis of ADSCs treated with lidocaine or adrenaline. Results The viable ADSCs yield from liposuction was significantly lower than that from lipectomy, while the apoptosis of cells from liposuction was significantly higher than from lipectomy. The paracrine secretion of the two sources of ADSCs was highest when treated with 10(-7) mol/L insulin and 10 ng/mL TGF-alpha, but there were no significant differences in VEGF, IL-6, IL-8 or HGF levels. The ADSCs from lipectomy migrated faster than those from liposuction, and SOD in the lipectomy group was higher than in the liposuction group, whereas MDA of the lipectomy group was lower than that of the liposuction group. The proliferation ADSCs treated with lidocaine or adrenaline was greatly decreased, while apoptosis was significantly increased, and cytotoxicity of lidocaine or adrenaline to ADSCs was dose-dependent. Conclusions Compared with ADSCs from liposuction, the ADSCs from lipectomy have better biological characteristics. Lidocaine and adrenaline decreased the viability of ADSCs, and their cytotoxicity to ADSCs was dose-dependent.	[Bian, Yongqian; Deng, Chen; Li, Wangzhou; Lei, Zhanjun; Li, Yuejun; Li, Xueyong] Fourth Mil Med Univ, Tangdu Hosp, Dept Burn & Plast Surg, Xian, Shannxi, Peoples R China	Air Force Military Medical University	Li, YJ; Li, XY (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Burn & Plast Surg, Xian, Shannxi, Peoples R China.	liyj@fmmu.edu.cn; yuyong@fmmu.edu.cn			National High Technology Research and Development Program of China [2015AA020313]; National Natural Foundation of China [81302377]; Military Medical Science and Technology for Youth Development Project [13QNP133]	National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Foundation of China(National Natural Science Foundation of China (NSFC)); Military Medical Science and Technology for Youth Development Project	This study was funded by National High Technology Research and Development Program of China (No. 2015AA020313, http://www.most.gov.cn, Xueyong Li received the funding), National Natural Foundation of China (No. 81302377, http://www.nsfc.gov.cn, Yongqian Bian received the funding), and Military Medical Science and Technology for Youth Development Project (No. 13QNP133, Yongqian Bian received the funding). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander RW, 2010, AUTOLOGOUS FAT TRANSFER: ART, SCIENCE, AND CLINICAL PRACTICE, P445, DOI 10.1007/978-3-642-00473-5_58; Bhang SH, 2009, STEM CELLS, V27, P1976, DOI 10.1002/stem.115; Chang YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089563; Chung MT, 2013, STEM CELL TRANSL MED, V2, P808, DOI 10.5966/sctm.2012-0183; Gause TM, 2014, ADIPOCYTE, V3, P273, DOI 10.4161/21623945.2014.957987; Gimble JM, 2007, CIRC RES, V100, P1249, DOI 10.1161/01.RES.0000265074.83288.09; Gir P, 2012, PLAST RECONSTR SURG, V129, P1277, DOI 10.1097/PRS.0b013e31824ecae6; Lei H, 2014, ANN PLAS SURG, V73, P225, DOI 10.1097/SAP.0b013e318271005f; Li KH, 2015, J MOL NEUROSCI, V56, P122, DOI 10.1007/s12031-014-0473-6; Livaoglu M, 2012, J CRANIOFAC SURG, V23, P1015, DOI 10.1097/SCS.0b013e31824e7302; Lopatina T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017899; Serra-Renom JM, 2010, PLAST RECONSTR SURG, V125, P12, DOI 10.1097/PRS.0b013e3181c49458; Milena R, 2014, ACTA VET, V64, P281, DOI [10.2478/acve-2014-0027, DOI 10.2478/ACVE-2014-0027]; Naderi N, 2014, J PLAST RECONSTR AES, V67, P1726, DOI 10.1016/j.bjps.2014.08.013; Nagata H, 2016, STEM CELL TRANSL MED, V5, P141, DOI 10.5966/sctm.2015-0083; Perez-Castro R, 2009, ANESTH ANALG, V108, P997, DOI 10.1213/ane.0b013e31819385e1; Rahnama R, 2013, J BONE JOINT SURG AM, V95A, P132, DOI 10.2106/JBJS.K.01291; Reilly GC, 2010, J BIOMECH, V43, P55, DOI 10.1016/j.jbiomech.2009.09.009; Rigotti G, 2007, PLAST RECONSTR SURG, V119, P1409, DOI 10.1097/01.prs.0000256047.47909.71; Rubin JP, 2013, LANCET, V382, P1077, DOI 10.1016/S0140-6736(13)61744-4; Schreml S, 2009, CYTOTHERAPY, V11, P947, DOI 10.3109/14653240903204322; Stosich MS, 2007, PLAST RECONSTR SURG, V119, P71, DOI 10.1097/01.prs.0000244840.80661.e7; Tran AN, 2014, J DRUGS DERMATOL, V13, P1118; Uysal AC, 2009, PLAST RECONSTR SURG, V124, P804, DOI 10.1097/PRS.0b013e3181b17bb4; Walker SM, 2012, ANESTH ANALG, V115, P450, DOI 10.1213/ANE.0b013e3182501a09; Werdehausen R, 2009, BRIT J ANAESTH, V103, P711, DOI 10.1093/bja/aep236; Wu W, 2013, PLAST RECONSTR SURG, V131, P27, DOI 10.1097/PRS.0b013e3182729cfc; Zuk PA, 2002, MOL BIOL CELL, V13, P4279, DOI 10.1091/mbc.E02-02-0105	28	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162343	10.1371/journal.pone.0162343	http://dx.doi.org/10.1371/journal.pone.0162343			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27610618	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255900081
J	Esteban, C; Arostegui, I; Aburto, M; Moraza, J; Quintana, JM; Garcia-Loizaga, A; Basualdo, LV; Aramburu, A; Aizpiri, S; Uranga, A; Capelastegui, A				Esteban, Cristobal; Arostegui, Inmaculada; Aburto, Myriam; Moraza, Javier; Quintana, Jose M.; Garcia-Loizaga, Amaia; Basualdo, Luis V.; Aramburu, Amaia; Aizpiri, Susana; Uranga, Ane; Capelastegui, Alberto			Chronic Obstructive Pulmonary Disease Subtypes. Transitions over Time	PLOS ONE			English	Article							PHYSICAL-ACTIVITY; CLINICAL PHENOTYPES; COPD; MORTALITY; IDENTIFICATION; COMORBIDITIES; RELIABILITY; STRENGTH; CLUSTERS; DYSPNEA	Background Although subtypes of chronic obstructive pulmonary disease are recognized, it is unknown what happens to these subtypes over time. Our objectives were to assess the stability of cluster-based subtypes in patients with stable disease and explore changes in clusters over 1 year. Methods Multiple correspondence and cluster analysis were used to evaluate data collected from 543 stable patients included consecutively from 5 respiratory outpatient clinics. Results Four subtypes were identified. Three of them, A, B, and C, had marked respiratory profiles with a continuum in severity of several variables, while the fourth, subtype D, had a more systemic profile with intermediate respiratory disease severity. Subtype A was associated with less dyspnea, better health-related quality of life and lower Charlson comorbidity scores, and subtype C with the most severe dyspnea, and poorer pulmonary function and quality of life, while subtype B was between subtypes A and C. Subtype D had higher rates of hospitalization the previous year, and comorbidities. After 1 year, all clusters remained stable. Generally, patients continued in the same subtype but 28% migrated to another cluster. Together with movement across clusters, patients showed changes in certain characteristics (especially exercise capacity, some variables of pulmonary function and physical activity) and changes in outcomes (quality of life, hospitalization and mortality) depending on the new cluster they belonged to. Conclusions Chronic obstructive pulmonary disease clusters remained stable over 1 year. Most patients stayed in their initial subtype cluster, but some moved to another subtype and accordingly had different outcomes.	[Esteban, Cristobal; Aburto, Myriam; Moraza, Javier; Garcia-Loizaga, Amaia; Basualdo, Luis V.; Aramburu, Amaia; Aizpiri, Susana; Uranga, Ane; Capelastegui, Alberto] Hosp Galdakao Usansolo, Resp Dept, Galdakao, Bizkaia, Spain; [Esteban, Cristobal; Arostegui, Inmaculada; Quintana, Jose M.] Hlth Serv Res Chron Patients Network REDISSEC, Galdakao, Bizkaia, Spain; [Arostegui, Inmaculada] Univ Basque Country UPV EHU, Dept Appl Math Stat & Operat Res, Leioa, Bizkaia, Spain; [Arostegui, Inmaculada] Basque Ctr Appl Math BCAM, Leioa, Bizkaia, Spain; [Quintana, Jose M.] Hosp Galdakao Usansolo, Res Unit, Galdakao, Bizkaia, Spain	Galdakao Hospital; University of Basque Country; Basque Center for Applied Mathematics (BCAM); Galdakao Hospital	Esteban, C (corresponding author), Hosp Galdakao Usansolo, Resp Dept, Galdakao, Bizkaia, Spain.; Esteban, C (corresponding author), Hlth Serv Res Chron Patients Network REDISSEC, Galdakao, Bizkaia, Spain.	cristobal.est@gmail.com	; AROSTEGUI, INMACULADA/G-5941-2014	Aburto, Myriam/0000-0001-8644-1015; AROSTEGUI, INMACULADA/0000-0002-6848-2240; Quintana, Jose M./0000-0003-2170-7876; ESTEBAN, CRISTOBAL/0000-0001-9878-7806	Fondo de Investigacion Sanitaria [PI020510]; Departamento de Sanidad del Gobierno Vasco Ministerio de Economia y Competitividad del Gobierno de Espana [200111002, MTM2013-40941-P]; Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco [IT620-13]	Fondo de Investigacion Sanitaria(Instituto de Salud Carlos III); Departamento de Sanidad del Gobierno Vasco Ministerio de Economia y Competitividad del Gobierno de Espana; Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco	This work was supported by Fondo de Investigacion Sanitaria [grant number PI020510], and by Departamento de Sanidad del Gobierno Vasco [grant number 200111002] Ministerio de Economia y Competitividad del Gobierno de Espana (MTM2013-40941-P), Departamento de Educacion, Politica Linguistica y Cultura del Gobierno Vasco (IT620-13).	Agusti A, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-122; Almagro P, 2012, CHEST, V142, P1126, DOI 10.1378/chest.11-2413; [Anonymous], 2010, R LANG ENV STAT COMP; [Anonymous], 2004, MANUAL SEPAR PROCEDI; Arostegui I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0098580; Bafadhel M, 2011, AM J RESP CRIT CARE, V184, P662, DOI 10.1164/rccm.201104-0597OC; Benzecri J. P., 1969, Proceedings of the international conference on methodologies of pattern recognition, P35; Bohannon RW, 2009, ISOKINET EXERC SCI, V17, P169, DOI 10.3233/IES-2009-0349; Burgel PR, 2010, EUR RESPIR J, V36, P531, DOI 10.1183/09031936.00175109; Burgel PR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051048; Casanova C, 2011, AM J RESP CRIT CARE, V184, P1015, DOI 10.1164/rccm.201105-0831OC; Celli BR, 2004, NEW ENGL J MED, V350, P1005, DOI 10.1056/NEJMoa021322; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Crapo RO, 2002, AM J RESP CRIT CARE, V166, P111, DOI 10.1164/rccm.166/1/111; Divo M, 2012, AM J RESP CRIT CARE, V186, P155, DOI 10.1164/rccm.201201-0034OC; DORNHORST AC, 1955, LANCET, V1, P1185; Esteban C, 2010, EUR RESPIR J, V36, P292, DOI 10.1183/09031936.00021409; Esteban C, 2014, RESPIROLOGY, V19, P330, DOI 10.1111/resp.12239; Ferrer M, 1996, EUR RESPIR J, V9, P1160, DOI 10.1183/09031936.96.09061160; Garcia-Aymerich J, 2006, THORAX, V61, P772, DOI 10.1136/thx.2006.060145; Garcia-Aymerich J, 2011, THORAX, V66, P430, DOI 10.1136/thx.2010.154484; Greenacre M, 1992, Stat Methods Med Res, V1, P97, DOI 10.1177/096228029200100106; Haldar P, 2008, AM J RESP CRIT CARE, V178, P218, DOI 10.1164/rccm.200711-1754OC; Jambu M, 1978, CLASSIFICATION AUTOM, V1; JONES PW, 1991, RESP MED, V85, P25, DOI 10.1016/S0954-6111(06)80166-6; Lange P, 2012, AM J RESP CRIT CARE, V186, P975, DOI 10.1164/rccm.201207-1299OC; Mahler DA, 2009, CHEST, V136, P1473, DOI 10.1378/chest.09-0934; Mannino DM, 2008, EUR RESPIR J, V32, P962, DOI 10.1183/09031936.00012408; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; Miravitiles M, 2013, EUR RESPIR J, V41, P1252, DOI 10.1183/09031936.00118912; Pinto-Plata VM, 2004, EUR RESPIR J, V23, P28, DOI 10.1183/09031936.03.00034603; QUANJER PH, 1993, EUR RESPIR J, V6, P5, DOI 10.1183/09041950.005s1693; Rennard SI, 2015, ANN AM THORAC SOC, V12, P303, DOI 10.1513/AnnalsATS.201403-125OC; Schnohr P, 2003, AM J EPIDEMIOL, V158, P639, DOI 10.1093/aje/kwg207; Swallow EB, 2007, THORAX, V62, P115, DOI 10.1136/thx.2006.062026; Vanfleteren LEGW, 2013, AM J RESP CRIT CARE, V187, P728, DOI 10.1164/rccm.201209-1665OC; Vestbo J, 2013, AM J RESP CRIT CARE, V187, P347, DOI 10.1164/rccm.201204-0596PP; WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967; Weatherall M, 2009, EUR RESPIR J, V34, P812, DOI 10.1183/09031936.00174408	39	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161710	10.1371/journal.pone.0161710	http://dx.doi.org/10.1371/journal.pone.0161710			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611911	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900025
J	Ollberding, NJ; Volgyi, E; Macaluso, M; Kumar, R; Morrow, C; Tylavsky, FA; Piyathilake, CJ				Ollberding, Nicholas J.; Volgyi, Eszter; Macaluso, Maurizio; Kumar, Ranjit; Morrow, Casey; Tylavsky, Frances A.; Piyathilake, Chandrika J.			Urinary Microbiota Associated with Preterm Birth: Results from the Conditions Affecting Neurocognitive Development and Learning in Early Childhood (CANDLE) Study	PLOS ONE			English	Article							TRACT-INFECTION; SERRATIA-MARCESCENS; BACTERIAL VAGINOSIS; VAGINAL MICROBIOME; AMNIOTIC-FLUID; PREGNANT-WOMEN; 16S RDNA; DIVERSITY; SEQUENCES; FLORA	Preterm birth (PTB) is the leading cause of infant morbidity and mortality. Genitourinary infection is implicated in the initiation of spontaneous PTB; however, examination of the urinary microbiota in relation to preterm delivery using next-generation sequencing technologies is lacking. In a case-control study nested within the Conditions Affecting Neurocognitive Development and Learning in Early Childhood (CANDLE) study, we examined associations between the urinary microbiota and PTB. A total of 49 cases (delivery < 37 weeks gestation) and 48 controls (delivery >= 37 weeks gestation) balanced on health insurance type were included in the present analysis. Illumina sequencing of the 16S rRNA gene V4 region was performed on urine samples collected during the second trimester. We observed no difference in taxa richness, evenness, or community composition between cases and controls or for gestational age modeled as a continuous variable. Operational taxonomic units (OTUs) classified to Prevotella, Sutterella, L. iners, Blautia, Kocuria, Lachnospiraceae, and S. marcescens were enriched among cases (FDR corrected p <= 0.05). A urinary microbiota clustering partition dominated by S. marcescens was also associated with PTB (OR = 3.97, 95% CI: 1.19-13.24). These data suggest a limited role for the urinary microbiota in PTB when measured during the second trimester by 16S rRNA gene sequencing. The enrichment among cases in several organisms previously reported to be associated with genitourinary pathology requires confirmation in future studies to rule out the potential for false positive findings.	[Ollberding, Nicholas J.; Macaluso, Maurizio] Cincinnati Childrens Hosp Med Ctr, Div Biostat & Epidemiol, Cincinnati, OH 45229 USA; [Volgyi, Eszter] Univ Tennessee, Hlth Sci Ctr, Dept Pediat, Memphis, TN USA; [Volgyi, Eszter; Tylavsky, Frances A.] Univ Tennessee, Hlth Sci Ctr, Dept Prevent Med, Memphis, TN USA; [Kumar, Ranjit] Univ Alabama Birmingham, Ctr Clin & Translat Sci, Birmingham, AL USA; [Morrow, Casey] Univ Alabama Birmingham, Dept Cell Dev & Integrat Biol, Birmingham, AL USA; [Piyathilake, Chandrika J.] Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL USA	Cincinnati Children's Hospital Medical Center; University of Tennessee System; University of Tennessee Health Science Center; University of Tennessee System; University of Tennessee Health Science Center; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Piyathilake, CJ (corresponding author), Univ Alabama Birmingham, Dept Nutr Sci, Birmingham, AL USA.	piyathic@uab.edu			Urban Child Institute; Urban Child Institute, Memphis, TN; Microbiome Resource at the University of Alabama at Birmingham: School of Medicine, Comprehensive Cancer Center [P30AR050948]; Center for AIDS Research [5P30AI027767]; Center for Clinical Translational Science [UL1TR000165]; Heflin Center	Urban Child Institute; Urban Child Institute, Memphis, TN; Microbiome Resource at the University of Alabama at Birmingham: School of Medicine, Comprehensive Cancer Center; Center for AIDS Research; Center for Clinical Translational Science; Heflin Center	This project was supported by The Urban Child Institute (F.T.). The funding sources had no role in the design, implementation and interpretation or in the preparation of the manuscript. The CANDLE study (Director F.T.) was funded by the Urban Child Institute, Memphis, TN. The following are acknowledged for their support of the Microbiome Resource at the University of Alabama at Birmingham: School of Medicine, Comprehensive Cancer Center (P30AR050948), Center for AIDS Research (5P30AI027767), and Center for Clinical Translational Science (UL1TR000165) and Heflin Center.	Aagaard K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3008599; Anahtar MN, 2015, IMMUNITY, V42, P965, DOI 10.1016/j.immuni.2015.04.019; Andrews S., 2010, FASTQC QUALITY CONTR; Austin MN, 2005, J CLIN MICROBIOL, V43, P4492, DOI 10.1128/JCM.43.9.4492-4497.2005; AVERBUCH B, 1995, EUR J OBSTET GYN R B, V62, P25, DOI 10.1016/0301-2115(95)02176-8; Blencowe H, 2013, REPROD HEALTH, V10, DOI 10.1186/1742-4755-10-S1-S2; Bokulich NA, 2013, NAT METHODS, V10, P57, DOI [10.1038/nmeth.2276, 10.1038/NMETH.2276]; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brocklehurst P, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000262.pub4; Brook I, 2004, INT J UROL, V11, P133, DOI 10.1111/j.1442-2042.2003.00756.x; Brubaker L, 2015, AM J OBSTET GYNECOL, V213, P644, DOI 10.1016/j.ajog.2015.05.032; Caporaso JG, 2011, P NATL ACAD SCI USA, V108, P4516, DOI 10.1073/pnas.1000080107; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Caporaso JG, 2010, BIOINFORMATICS, V26, P266, DOI 10.1093/bioinformatics/btp636; DiGiulio DB, 2015, P NATL ACAD SCI USA, V112, P11060, DOI 10.1073/pnas.1502875112; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; El Aila NA, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-167; Eren AM, 2015, ISME J, V9, P968, DOI 10.1038/ismej.2014.195; Fardini Y, 2010, INFECT IMMUN, V78, P1789, DOI 10.1128/IAI.01395-09; Fouts DE, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-174; Hamilton BE, 2013, PEDIATRICS, V131, P548, DOI 10.1542/peds.2012-3769; Han YPW, 2006, J CLIN MICROBIOL, V44, P1475, DOI 10.1128/JCM.44.4.1475-1483.2006; Hay PE, 2002, POLYMICROBIAL DIS; Hejazi A, 1997, J MED MICROBIOL, V46, P903, DOI 10.1099/00222615-46-11-903; Hertle R, 2005, CURR PROTEIN PEPT SC, V6, P313, DOI 10.2174/1389203054546370; Hilt EE, 2014, J CLIN MICROBIOL, V52, P871, DOI 10.1128/JCM.02876-13; Holmes I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030126; Honaker J, 2011, J STAT SOFTW, V45, P1; HORN HS, 1966, AM NAT, V100, P419, DOI 10.1086/282436; Hyman RW, 2014, REPROD SCI, V21, P32, DOI 10.1177/1933719113488838; Jacobsson B, 2003, ACTA OBSTET GYN SCAN, V82, P120, DOI 10.1080/j.1600-0412.2003.00047.x; Kacerovsky M, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0126884; Kawecki D, 2011, TRANSPL P, V43, P2991, DOI 10.1016/j.transproceed.2011.09.002; Langille MGI, 2013, NAT BIOTECHNOL, V31, P814, DOI 10.1038/nbt.2676; Lawn JE, 2010, SEMIN PERINATOL, V34, P371, DOI 10.1053/j.semperi.2010.09.011; Leitich H, 2007, BEST PRACT RES CL OB, V21, P375, DOI 10.1016/j.bpobgyn.2006.12.005; Lewis DA, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00041; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Liu L, 2012, LANCET, V379, P2151, DOI 10.1016/S0140-6736(12)60560-1; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Mahlen SD, 2011, CLIN MICROBIOL REV, V24, P755, DOI 10.1128/CMR.00017-11; Mazor-Dray E, 2009, J MATERN-FETAL NEO M, V22, P124, DOI 10.1080/14767050802488246; McDonald D, 2012, ISME J, V6, P610, DOI 10.1038/ismej.2011.139; McMurdie PJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061217; Mysorekar IU, 2014, SEMIN REPROD MED, V32, P50, DOI 10.1055/s-0033-1361830; Nelson DB, 2016, AM J PERINAT, V33, P887, DOI 10.1055/s-0036-1581057; Oksanen J., 2019, R PACKAGE VERSION; Payne MS, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00595; Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995; Petricevic L, 2012, EUR J OBSTET GYN R B, V160, P93, DOI 10.1016/j.ejogrb.2011.10.002; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Proctor LM, 2014, CELL HOST MICROBE, V16, P276, DOI 10.1016/j.chom.2014.08.014; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Romero R, 2006, BJOG-INT J OBSTET GY, V113, P17, DOI 10.1111/j.1471-0528.2006.01120.x; Romero R, 2014, MICROBIOME, V2, DOI 10.1186/2049-2618-2-18; SCHIEVE LA, 1994, AM J PUBLIC HEALTH, V84, P405, DOI 10.2105/AJPH.84.3.405; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Shanks RMQ, 2007, J BACTERIOL, V189, P7262, DOI 10.1128/JB.00859-07; Shannon CE, 1997, M D COMPUT, V14, P306; Siddiqui H, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-244; Simcox R, 2007, AUST NZ J OBSTET GYN, V47, P368, DOI 10.1111/j.1479-828X.2007.00759.x; Stock I, 2003, INT J ANTIMICROB AG, V22, P35, DOI 10.1016/S0924-8579(02)00163-2; Ulett GC, 2010, J INFECT DIS, V201, P866, DOI 10.1086/650696; Volgyi E, 2013, NUTRIENTS, V5, P1511, DOI 10.3390/nu5051511; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Wolfe AJ, 2012, J CLIN MICROBIOL, V50, P1376, DOI 10.1128/JCM.05852-11	70	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162302	10.1371/journal.pone.0162302	http://dx.doi.org/10.1371/journal.pone.0162302			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611781	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900075
J	Yin, ZY; Chen, DY; Li, BF				Yin Zongyi; Chen Dongying; Li Baifeng			Global Regulatory T-Cell Research from 2000 to 2015: A Bibliometric Analysis	PLOS ONE			English	Article							IMMUNOLOGICAL SELF-TOLERANCE; KNOWLEDGE DOMAIN; EMERGING TRENDS; GRANZYME-B; SUPPRESSION; TH17; DIFFERENTIATION; AUTOIMMUNITY; MECHANISMS; GENERATION	We aimed to analyze the global scientific output of regulatoryT-cell (Treg) research and built a model to qualitatively and quantitatively evaluate publications from 2000 to 2015. Data were obtained from the Web of Science Core Collection (WoSCC) of Thomson Reuters on January 1, 2016. The bibliometric method and Citespace III were used to analyze authors, journals, publication outputs, institutions, countries, research areas, research hotspots, and trends. In total, we identified 35,741 publications on Treg research from 2000 to 2015, and observed that the annual publication rate increased with time. The Journal of Immunology published the highest number of articles, the leading country was the USA, and the leading institute was Harvard University. Sakaguchi, Hori, Fontenot, and Wang were the top authors in Treg research. Immunology accounted for the highest number of publications, followed by oncology, experimental medicine, cell biology, and hematology. Keyword analysis indicated that autoimmunity, inflammation, cytokine, gene expression, foxp3, and immunotherapy were the research hotspots, whereas autoimmune inflammation, gene therapy, granzyme B, ROR gamma t, and th17 were the frontiers of Treg research. This bibliometric analysis revealed that Treg-related studies are still research hotspots, and that Treg-related clinical therapies are the research frontiers; however, further study and collaborations are needed worldwide. Overall, our findings provide valuable information for the editors of immunology journals to identify new perspectives and shape future research directions.	[Yin Zongyi; Li Baifeng] China Med Univ, Hosp 1, Dept Hepatobiliary Surg & Organ Transplantat, Shenyang, Peoples R China; [Chen Dongying] China Med Univ, Hosp 1, Dept Anesthesiol, Shenyang, Peoples R China	China Medical University; China Medical University	Li, BF (corresponding author), China Med Univ, Hosp 1, Dept Hepatobiliary Surg & Organ Transplantat, Shenyang, Peoples R China.	bfli@cmu.edu.cn			National Natural Science Foundation of China [81370882]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Natural Science Foundation of China (81370882), Li Baifeng, http://www.nsfc.gov.cn/nsfc/cen/zc/09.htm.	Anz D, 2015, CANCER RES, V75, P4483, DOI 10.1158/0008-5472.CAN-14-3499; Asseman C, 2000, AM J RESP CRIT CARE, V162, pS185, DOI 10.1164/ajrccm.162.supplement_3.15tac9; Barbi J, 2014, IMMUNOL REV, V259, P115, DOI 10.1111/imr.12172; Bettelli E, 2006, NATURE, V441, P235, DOI 10.1038/nature04753; Bettelli E, 2007, CURR OPIN IMMUNOL, V19, P652, DOI 10.1016/j.coi.2007.07.020; Bettelli E, 2007, NAT IMMUNOL, V8, P345, DOI 10.1038/ni0407-345; Bhela S, 2015, J IMMUNOL, V194, P2180, DOI 10.4049/jimmunol.1303257; Bouvy AP, 2014, NEPHROL DIAL TRANSPL, V29, P1587, DOI 10.1093/ndt/gfu079; Bradford S. C., 1934, ENGINEERING, P85; Carter CRD, 2013, J CLIN PATHOL, V66, P146, DOI 10.1136/jclinpath-2012-201046; Chen CM, 2014, EXPERT OPIN BIOL TH, V14, P1295, DOI 10.1517/14712598.2014.920813; Chen CM, 2006, J AM SOC INF SCI TEC, V57, P359, DOI 10.1002/asi.20317; Chen CM, 2004, P NATL ACAD SCI USA, V101, P5303, DOI 10.1073/pnas.0307513100; Cheng X, 2008, CLIN IMMUNOL, V127, P89, DOI 10.1016/j.clim.2008.01.009; Coombes JL, 2007, J EXP MED, V204, P1757, DOI 10.1084/jem.20070590; Curiel TJ, 2004, NAT MED, V10, P942, DOI 10.1038/nm1093; Dong C, 2006, NAT REV IMMUNOL, V6, P329, DOI 10.1038/nri1807; Golovina TN, 2010, CANCER J, V16, P342, DOI 10.1097/PPO.0b013e3181eb336d; Gregori S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00593; Hashizume H, 2016, J DERMATOL SCI, V81, P131, DOI 10.1016/j.jdermsci.2015.11.002; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Huang CP, 2009, J CHIN MED ASSOC, V72, P6; Huang YF, 2015, J IMMUNOL, V195, P5572, DOI 10.4049/jimmunol.1501604; Issa F, 2010, EXPERT REV CLIN IMMU, V6, P155, DOI 10.1586/ECI.09.64; Jarosz-Biej M, 2015, ARCH IMMUNOL THER EX, V63, P451, DOI 10.1007/s00005-015-0337-y; Josefowicz SZ, 2012, ANNU REV IMMUNOL, V30, P531, DOI 10.1146/annurev.immunol.25.022106.141623; Kanwar B, 2010, CURR OPIN HIV AIDS, V5, P151, DOI 10.1097/COH.0b013e328335c0c1; Kendal AR, 2011, J EXP MED, V208, P2043, DOI 10.1084/jem.20110767; Khattri R, 2003, NAT IMMUNOL, V4, P337, DOI 10.1038/ni909; Kim JM, 2007, NAT IMMUNOL, V8, P191, DOI 10.1038/ni1428; Kim MG, 2014, KIDNEY INT, V85, P62, DOI 10.1038/ki.2013.277; Kimura A, 2010, EUR J IMMUNOL, V40, P1830, DOI 10.1002/eji.201040391; Klabusay M., 2015, KLIN ONKOL, V28, P23; Kurose K, 2015, CLIN CANCER RES, V21, P4327, DOI 10.1158/1078-0432.CCR-15-0357; Lahl K, 2007, J EXP MED, V204, P57, DOI 10.1084/jem.20061852; Leceta J, 2007, NEUROIMMUNOMODULAT, V14, P134, DOI 10.1159/000110636; Lee YC, 2016, APPL SCI-BASEL, V6, DOI 10.3390/app6010011; Li H, 2015, CYTOTHERAPY, V17, P1560, DOI 10.1016/j.jcyt.2015.07.018; Li JF, 2009, CROAT CHEM ACTA, V82, P695; Liao JY, 2016, CLIN IMMUNOL, V162, P74, DOI 10.1016/j.clim.2015.11.006; Lin KL, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00473; Liu ZG, 2015, SCIENTOMETRICS, V103, P135, DOI 10.1007/s11192-014-1517-y; Lv Hong, 2014, Zhonghua Gan Zang Bing Za Zhi, V22, P493, DOI 10.3760/cma.j.issn.1007-3418.2014.07.004; Mangodt TC, 2015, PEDIATR RES, V78, P483, DOI 10.1038/pr.2015.143; Matino D, 2015, J CLIN INVEST, V125, P3766, DOI 10.1172/JCI81859; Merigo JM, 2010, J SYSTEMS ENG ELECT, V21, P10; Mittag D, 2010, J IMMUNOL, V184, P4708, DOI 10.4049/jimmunol.0901036; Montane J, 2015, CELL TRANSPLANT, V24, P2143, DOI 10.3727/096368914X685249; Nguyen MTJP, 2016, TRANSPLANTATION, V100, P314, DOI 10.1097/TP.0000000000000942; Nishikawa H, 2010, INT J CANCER, V127, P759, DOI 10.1002/ijc.25429; Omenetti S, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00639; Powrie F, 1996, J EXP MED, V183, P2669, DOI 10.1084/jem.183.6.2669; Ray A, 2010, MUCOSAL IMMUNOL, V3, P216, DOI 10.1038/mi.2010.4; Read S, 2000, J EXP MED, V192, P295, DOI 10.1084/jem.192.2.295; Richards DM, 2015, PROG MOL BIOL TRANSL, V136, P175, DOI 10.1016/bs.pmbts.2015.07.014; Rolland JM, 2010, CURR OPIN ALLERGY CL, V10, P559, DOI 10.1097/ACI.0b013e32833ff2b2; Rothstein DM, 2015, CURR OPIN ORGAN TRAN, V20, P376, DOI 10.1097/MOT.0000000000000212; Sakaguchi S, 2004, ANNU REV IMMUNOL, V22, P531, DOI 10.1146/annurev.immunol.21.120601.141122; SAKAGUCHI S, 1995, J IMMUNOL, V155, P1151; Sakaguchi S, 2010, NAT REV IMMUNOL, V10, P490, DOI 10.1038/nri2785; Salvalaggio PRO, 2006, J IMMUNOL, V176, P2292, DOI 10.4049/jimmunol.176.4.2292; Serr I, 2014, BIODRUGS, V28, P7, DOI 10.1007/s40259-013-0060-3; Shimizu J, 2002, NAT IMMUNOL, V3, P135, DOI 10.1038/ni759; Spence A, 2015, CURR OPIN IMMUNOL, V37, P11, DOI 10.1016/j.coi.2015.09.002; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tang QZ, 2014, CURR OPIN ORGAN TRAN, V19, P616, DOI 10.1097/MOT.0000000000000132; Tang QZ, 2013, CSH PERSPECT MED, V3, DOI 10.1101/cshperspect.a015552; von Boehmer H, 2013, NAT REV DRUG DISCOV, V12, P51, DOI 10.1038/nrd3683; Wang Q. Y Y, 2014, SCI TOTAL ENVIRON, P473; Wei F., 2015, PROF GEOGR, V67, P1; Wei Y, 2015, EVID-BASED COMPL ALT, V2015, DOI 10.1155/2015/340126; Whelan MC, 2010, CANCER GENE THER, V17, P501, DOI 10.1038/cgt.2010.8; White HD, 2003, J AM SOC INF SCI TEC, V54, P423, DOI 10.1002/asi.10228; Zhou XD, 2015, SCIENTOMETRICS, V105, P231, DOI 10.1007/s11192-015-1659-6; Zhou XY, 2009, NAT IMMUNOL, V10, P1000, DOI 10.1038/ni.1774; Zou WP, 2006, NAT REV IMMUNOL, V6, P295, DOI 10.1038/nri1806	76	19	19	2	109	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162099	10.1371/journal.pone.0162099	http://dx.doi.org/10.1371/journal.pone.0162099			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JE	27611317	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900045
J	Gannon, MA; Knapp, AA; Adams, TG; Long, SM; Parks, NA				Gannon, Matthew A.; Knapp, Ashley A.; Adams, Thomas G.; Long, Stephanie M.; Parks, Nathan A.			Spatial Scaling of the Profile of Selective Attention in the Visual Field	PLOS ONE			English	Article							PERCEPTUAL LOAD; NORMALIZATION MODEL; EVOKED-POTENTIALS; NEURAL MECHANISMS; FOCAL ATTENTION; CORTEX; OBJECTS; COMPETITION; RESPONSES; SUPPRESSION	Neural mechanisms of selective attention must be capable of adapting to variation in the absolute size of an attended stimulus in the ever-changing visual environment. To date, little is known regarding how attentional selection interacts with fluctuations in the spatial expanse of an attended object. Here, we use event-related potentials (ERPs) to investigate the scaling of attentional enhancement and suppression across the visual field. We measured ERPs while participants performed a task at fixation that varied in its attentional demands (attentional load) and visual angle (1.0 degrees or 2.5 degrees). Observers were presented with a stream of task-relevant stimuli while foveal, parafoveal, and peripheral visual locations were probed by irrelevant distractor stimuli. We found two important effects in the N1 component of visual ERPs. First, N1 modulations to task-relevant stimuli indexed attentional selection of stimuli during the load task and further correlated with task performance. Second, with increased task size, attentional modulation of the N1 to distractor stimuli showed a differential pattern that was consistent with a scaling of attentional selection. Together, these results demonstrate that the size of an attended stimulus scales the profile of attentional selection across the visual field and provides insights into the attentional mechanisms associated with such spatial scaling.	[Gannon, Matthew A.; Knapp, Ashley A.; Long, Stephanie M.; Parks, Nathan A.] Univ Arkansas, Dept Psychol Sci, Fayetteville, AR 72701 USA; [Adams, Thomas G.] Yale Univ, Dept Psychiat, New Haven, CT 06520 USA	University of Arkansas System; University of Arkansas Fayetteville; Yale University	Gannon, MA (corresponding author), Univ Arkansas, Dept Psychol Sci, Fayetteville, AR 72701 USA.	magannon@uark.edu	Knapp, Ashley/Q-4136-2019	Knapp, Ashley/0000-0002-0073-1466	Arkansas Biosciences Institute [000482-00001]; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH062994] Funding Source: NIH RePORTER	Arkansas Biosciences Institute; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	This work was supported by a grant (to NAP) from the Arkansas Biosciences Institute, http://arbiosciences.org/, grant number 000482-00001. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck DM, 2009, VISION RES, V49, P1154, DOI 10.1016/j.visres.2008.07.012; Boehler CN, 2009, CEREB CORTEX, V19, P982, DOI 10.1093/cercor/bhn139; Carrasco M, 1997, VISION RES, V37, P63, DOI 10.1016/S0042-6989(96)00102-2; Carrasco M, 2011, VISION RES, V51, P1484, DOI 10.1016/j.visres.2011.04.012; CASTIELLO U, 1992, J EXP PSYCHOL HUMAN, V18, P837, DOI 10.1037/0096-1523.18.3.837; Davis G, 2000, VISION RES, V40, P1323, DOI 10.1016/S0042-6989(99)00189-3; DESIMONE R, 1995, ANNU REV NEUROSCI, V18, P193, DOI 10.1146/annurev.ne.18.030195.001205; Di Russo F, 2003, CEREB CORTEX, V13, P486, DOI 10.1093/cercor/13.5.486; Ding YL, 2014, HUM BRAIN MAPP, V35, P3008, DOI 10.1002/hbm.22381; ERIKSEN CW, 1985, J EXP PSYCHOL HUMAN, V11, P583, DOI 10.1037/0096-1523.11.5.583; ERIKSEN CW, 1986, PERCEPT PSYCHOPHYS, V40, P225, DOI 10.3758/BF03211502; GRATTON G, 1983, ELECTROEN CLIN NEURO, V55, P468, DOI 10.1016/0013-4694(83)90135-9; He X, 2004, J COGNITIVE NEUROSCI, V16, P1085, DOI 10.1162/0898929041502689; Heinemann L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005560; Hillyard SA, 1998, P NATL ACAD SCI USA, V95, P781, DOI 10.1073/pnas.95.3.781; Hopf JM, 2006, P NATL ACAD SCI USA, V103, P1053, DOI 10.1073/pnas.0507746103; Itier RJ, 2004, CEREB CORTEX, V14, P132, DOI 10.1093/cercor/bhg111; Jacoby O, 2012, NEUROIMAGE, V61, P1050, DOI 10.1016/j.neuroimage.2012.03.040; Kastner S, 2000, ANNU REV NEUROSCI, V23, P315, DOI 10.1146/annurev.neuro.23.1.315; Lavie N, 2005, TRENDS COGN SCI, V9, P75, DOI 10.1016/j.tics.2004.12.004; LAVIE N, 1994, PERCEPT PSYCHOPHYS, V56, P183, DOI 10.3758/BF03213897; LAVIE N, 1995, J EXP PSYCHOL HUMAN, V21, P451, DOI 10.1037/0096-1523.21.3.451; Lavie N, 2004, J EXP PSYCHOL GEN, V133, P339, DOI 10.1037/0096-3445.133.3.339; Lavie N, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0205; Lee J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004651; MANGUN GR, 1995, PSYCHOPHYSIOLOGY, V32, P4, DOI 10.1111/j.1469-8986.1995.tb03400.x; Martinez A, 2006, J COGNITIVE NEUROSCI, V18, P298, DOI 10.1162/089892906775783642; Martinez A, 2007, J NEUROSCI, V27, P7963, DOI 10.1523/JNEUROSCI.0031-07.2007; Muller MM, 2002, PSYCHOL SCI, V13, P119, DOI 10.1111/1467-9280.00422; Muller NG, 2005, VISION RES, V45, P1129, DOI 10.1016/j.visres.2004.11.003; O'Connor DH, 2002, NAT NEUROSCI, V5, P1203, DOI 10.1038/nn957; Parks NA, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00050; Parks NA, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00275; Parks NA, 2011, J COGNITIVE NEUROSCI, V23, P1113, DOI 10.1162/jocn.2010.21460; Pinsk MA, 2004, J NEUROPHYSIOL, V92, P622, DOI 10.1152/jn.00974.2003; Plainis S, 2001, PERCEPTION, V30, P1203, DOI 10.1068/p3117; Rauss K, 2012, HUM BRAIN MAPP, V33, P63, DOI 10.1002/hbm.21193; Rauss KS, 2009, HUM BRAIN MAPP, V30, P1723, DOI 10.1002/hbm.20636; Reynolds JH, 2009, NEURON, V61, P168, DOI 10.1016/j.neuron.2009.01.002; Rorden C, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.004.2008; Schwartz S, 2005, CEREB CORTEX, V15, P770, DOI 10.1093/cercor/bhh178; TREISMAN AM, 1980, COGNITIVE PSYCHOL, V12, P97, DOI 10.1016/0010-0285(80)90005-5; Weber TA, 1997, BIOL PSYCHOL, V45, P159, DOI 10.1016/S0301-0511(96)05227-1	43	3	3	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0162190	10.1371/journal.pone.0162190	http://dx.doi.org/10.1371/journal.pone.0162190			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV9JB	27606426	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255600026
J	Nowak, M; Castellini, C				Nowak, Markus; Castellini, Claudio			The LET Procedure for Prosthetic Myocontrol: Towards Multi-DOF Control Using Single-DOF Activations	PLOS ONE			English	Article							MYOELECTRIC CONTROL; SURFACE EMG	Simultaneous and proportional myocontrol of dexterous hand prostheses is to a large extent still an open problem. With the advent of commercially and clinically available multi-fingered hand prostheses there are now more independent degrees of freedom (DOFs) in prostheses than can be effectively controlled using surface electromyography (sEMG), the current standard human-machine interface for hand amputees. In particular, it is uncertain, whether several DOFs can be controlled simultaneously and proportionally by exclusively calibrating the intended activation of single DOFs. The problem is currently solved by training on all required combinations. However, as the number of available DOFs grows, this approach becomes overly long and poses a high cognitive burden on the subject. In this paper we present a novel approach to overcome this problem. Multi-DOF activations are artificially modelled from single-DOF ones using a simple linear combination of sEMG signals, which are then added to the training set. This procedure, which we named LET (Linearly Enhanced Training), provides an augmented data set to any machine-learning-based intent detection system. In two experiments involving intact subjects, one offline and one online, we trained a standard machine learning approach using the full data set containing single-and multi-DOF activations as well as using the LET-augmented data set in order to evaluate the performance of the LET procedure. The results indicate that the machine trained on the latter data set obtains worse results in the offline experiment compared to the full data set. However, the online implementation enables the user to perform multi-DOF tasks with almost the same precision as single-DOF tasks without the need of explicitly training multi-DOF activations. Moreover, the parameters involved in the system are statistically uniform across subjects.	[Nowak, Markus; Castellini, Claudio] DLR German Aerosp Ctr, Robot & Mechatron Ctr, Wessling, Germany	Helmholtz Association; German Aerospace Centre (DLR)	Nowak, M (corresponding author), DLR German Aerosp Ctr, Robot & Mechatron Ctr, Wessling, Germany.	markus.nowak@dlr.de	Castellini, Claudio/M-8555-2017	Castellini, Claudio/0000-0002-7346-2180	German Aerospace Center (DLR)	German Aerospace Center (DLR)(Helmholtz AssociationGerman Aerospace Centre (DLR))	The authors were funded by the basic funding of the German Aerospace Center (DLR). The funding provider had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsuss S., 2014, P MEC MYOEL CONTR S, P2; [Anonymous], 2013, TXB ES; Aszmann OC, 2015, LANCET, V385, P2183, DOI 10.1016/S0140-6736(14)61776-1; Boser B. E., 1992, Proceedings of the Fifth Annual ACM Workshop on Computational Learning Theory, P144, DOI 10.1145/130385.130401; Castellini C., 2014, P MEC MYOEL CONTR S, P45; Castellini C, 2014, FRONT NEUROROBOTICS, V8, P1, DOI 10.3389/fnbot.2014.00022; Christensen R, 2001, ADV LINEAR MODELING; Diers M, 2010, PAIN, V149, P296, DOI 10.1016/j.pain.2010.02.020; Farina D, 2014, IEEE T NEUR SYS REH, V22, P797, DOI 10.1109/TNSRE.2014.2305111; Fougner A, 2012, IEEE T NEUR SYS REH, V20, P663, DOI 10.1109/TNSRE.2012.2196711; FUGLEVAND AJ, 1993, J NEUROPHYSIOL, V70, P2470, DOI 10.1152/jn.1993.70.6.2470; Gijsberts A, 2014, FRONT NEUROROBOTICS, V8, P1, DOI 10.3389/fnbot.2014.00008; HOERL AE, 1970, TECHNOMETRICS, V12, P55, DOI 10.1080/00401706.1970.10488634; Hogg RV., 1987, ENG STAT; Ison M, 2014, J NEURAL ENG, V11, DOI 10.1088/1741-2560/11/5/051001; Jiang N, 2014, IEEE T NEUR SYS REH, V22, P549, DOI 10.1109/TNSRE.2013.2287383; Jiang N, 2012, IEEE SIGNAL PROC MAG, V29, P147, DOI 10.1109/MSP.2012.2203480; Jiang N, 2009, IEEE T BIO-MED ENG, V56, P1070, DOI 10.1109/TBME.2008.2007967; Koiva R, 2012, IEEE ENG MED BIO, P531, DOI 10.1109/EMBC.2012.6345985; Kuiken TA, 2009, JAMA-J AM MED ASSOC, V301, P619, DOI 10.1001/jama.2009.116; Kutner M. H., 2004, APPL LINEAR REGRESSI; Li ZM, 1998, EXP BRAIN RES, V119, P276, DOI 10.1007/s002210050343; Micera Silvestro, 2010, IEEE Rev Biomed Eng, V3, P48, DOI 10.1109/RBME.2010.2085429; Nagata K, 2011, IEEE ENG MED BIO, P7865, DOI 10.1109/IEMBS.2011.6091938; Peerdeman B, 2011, J REHABIL RES DEV, V48, P719, DOI 10.1682/JRRD.2010.08.0161; Rahimi A., 2007, ADV NEURAL INFORM PR, V20, P1177, DOI DOI 10.5555/2981562.2981710; Rifkin R, 2003, NATO SCI SERIES 3, V190, P131, DOI DOI 10.1016/S0072-9752(06)80038-2; Rudolf M, 2008, BIOSTATISTIK EINFUHR; Yatsenko D, 2007, P ANN INT IEEE EMBS, P6134	30	14	14	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 8	2016	11	9							e0161678	10.1371/journal.pone.0161678	http://dx.doi.org/10.1371/journal.pone.0161678			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JB	27606674	Green Published, gold, Green Submitted, Green Accepted			2022-12-26	WOS:000383255600009
J	Chan, S; Jantama, SS; Kanchanatawee, S; Jantama, K				Chan, Sitha; Jantama, Sirima Suvarnakuta; Kanchanatawee, Sunthorn; Jantama, Kaemwich			Process Optimization on Micro-Aeration Supply for High Production Yield of 2,3-Butanediol from Maltodextrin by Metabolically-Engineered Klebsiella oxytoca	PLOS ONE			English	Article							ESCHERICHIA-COLI; FERMENTATION; PNEUMONIAE; LACTATE; ACID; DEHYDROGENASE; 1,3-PROPANEDIOL; EXPRESSION; GLYCEROL; GENES	An optimization process with a cheap and abundant substrate is considered one of the factors affecting the price of the production of economical 2,3-Butanediol (2,3-BD). A combination of the conventional method and response surface methodology (RSM) was applied in this study. The optimized levels of pH, aeration rate, agitation speed, and substrate concentration (maltodextrin) were investigated to determine the cost-effectiveness of fermentative 2,3-BD production by metabolically-engineered Klebsiella oxytoca KMS005. Results revealed that pH, aeration rate, agitation speed, and maltodextrin concentration at levels of 6.0, 0.8 vvm, 400 rpm, and 150 g/L respectively were the optimal conditions. RSM also indicated that the agitation speed was the most influential parameter when either agitation and aeration interaction or agitation and substrate concentration interaction played important roles for 2,3-BD production by the strain from maltodextrin. Under interim fed-batch fermentation, 2,3-BD concentration, yield, and productivity were obtained at 88.1 +/- 0.2 g/L, 0.412 +/- 0.001 g/g, and 1.13 +/- 0.01 g/L/h respectively within 78 h.	[Chan, Sitha; Kanchanatawee, Sunthorn; Jantama, Kaemwich] Suranaree Univ Technol, Sch Biotechnol, Inst Agr Technol, Metab Engn Res Unit, 111 Univ Ave, Muang Dist 30000, Nakhon Ratchasi, Thailand; [Jantama, Sirima Suvarnakuta] Ubon Ratchathani Univ, Fac Pharmaceut Sci, Div Biopharm, Warinchamrap 34190, Ubon Ratchathan, Thailand	Suranaree University of Technology; Ubon Ratchathani University	Jantama, K (corresponding author), Suranaree Univ Technol, Sch Biotechnol, Inst Agr Technol, Metab Engn Res Unit, 111 Univ Ave, Muang Dist 30000, Nakhon Ratchasi, Thailand.	kaemwich@sut.ac.th	jantama, kaemwich/K-6880-2017	jantama, kaemwich/0000-0002-5405-6304	National Research Council of Thailand (NRCT) [PK/2555-138]	National Research Council of Thailand (NRCT)(National Research Council of Thailand (NRCT))	This work was financially supported by National Research Council of Thailand (NRCT) under the contract number PK/2555-138 to KJ. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was financially supported by National Research Council of Thailand (NRCT) under the contract number PK/2555-138 to KJ. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Thanks also to Bob Tremayne, Ubon Ratchathani University Division of International Relations, for assistance with English.	[Anonymous], 1985, COMPREHENSIVE BIOTEC; AXLEY MJ, 1990, J BIOL CHEM, V265, P18213; Banks GT, 1979, TOP ENZYME FERMENT B, V3, P170; BENDER H, 1990, CARBOHYD RES, V206, P257, DOI 10.1016/0008-6215(90)80065-B; Biebl H, 1998, APPL MICROBIOL BIOT, V50, P24, DOI 10.1007/s002530051251; BLOMQVIST K, 1993, J BACTERIOL, V175, P1392, DOI 10.1128/JB.175.5.1392-1404.1993; Celinska E, 2009, BIOTECHNOL ADV, V27, P715, DOI 10.1016/j.biotechadv.2009.05.002; Cheng KK, 2010, PROCESS BIOCHEM, V45, P613, DOI 10.1016/j.procbio.2009.12.009; Cho JH, 2012, BIOPROC BIOSYST ENG, V35, P1081, DOI 10.1007/s00449-012-0691-7; Cho S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0138109; FAOSTAT, 2011, PROD CROPS CASS 2010; FERENCI T, 1986, BIOCHIM BIOPHYS ACTA, V860, P44, DOI 10.1016/0005-2736(86)90496-7; Formanek J, 1997, APPL ENVIRON MICROB, V63, P2306, DOI 10.1128/AEM.63.6.2306-2310.1997; Ge L., 2011, J BIOMATER NANOBIOTE, V2, P335, DOI DOI 10.4236/JBNB.2011.23041; GOTTSCHALK G, 1986, BACTERIAL METABOLISM, P237; Han SH, 2013, NEW BIOTECHNOL, V30, P166, DOI 10.1016/j.nbt.2012.09.004; Jantama K, 2015, METAB ENG, V30, P16, DOI 10.1016/j.ymben.2015.04.004; Ji XJ, 2011, APPL MICROBIOL BIOT, V89, P1119, DOI 10.1007/s00253-010-2940-5; Ji XJ, 2010, APPL MICROBIOL BIOT, V85, P1751, DOI 10.1007/s00253-009-2222-2; Ji XJ, 2009, BIORESOURCE TECHNOL, V100, P5214, DOI 10.1016/j.biortech.2009.05.036; Jiang LQ, 2012, BIORESOURCE TECHNOL, V107, P405, DOI 10.1016/j.biortech.2011.12.083; Kamm B, 2004, APPL MICROBIOL BIOT, V64, P137, DOI 10.1007/s00253-003-1537-7; Kearsley MW, 1995, HDB STARCH HYDROLYSI, P230; KHURI AI, 1988, TECHNOMETRICS, V30, P95, DOI 10.2307/1270325; Klein-Marcuschamer D, 2012, BIOTECHNOL BIOENG, V109, P1083, DOI 10.1002/bit.24370; Lee SM, 2013, BIOTECHNOL BIOPROC E, V18, P1210, DOI 10.1007/s12257-013-0396-z; Ma CQ, 2009, APPL MICROBIOL BIOT, V82, P49, DOI 10.1007/s00253-008-1732-7; Martinez A, 2007, BIOTECHNOL LETT, V29, P397, DOI 10.1007/s10529-006-9252-y; MAYER D, 1995, J BACTERIOL, V177, P5261, DOI 10.1128/jb.177.18.5261-5269.1995; Nie ZK, 2011, APPL BIOCHEM BIOTECH, V163, P946, DOI 10.1007/s12010-010-9098-6; Pajatsch M, 1998, J BACTERIOL, V180, P2630, DOI 10.1128/JB.180.10.2630-2635.1998; Park JM, 2013, MICROB CELL FACT, V12, DOI 10.1186/1475-2859-12-20; PARK SJ, 1995, J BACTERIOL, V177, P6652, DOI 10.1128/jb.177.22.6652-6656.1995; PEDERSEN PL, 1987, TRENDS BIOCHEM SCI, V12, P146, DOI 10.1016/0968-0004(87)90071-5; Ragauskas AJ, 2006, SCIENCE, V311, P484, DOI 10.1126/science.1114736; Reed JL, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r54; Roehr M., 1996, BIOTECHNOLOGY, V6, P269; Sangproo M, 2012, BIORESOURCE TECHNOL, V119, P191, DOI 10.1016/j.biortech.2012.05.114; Shalel-Levanon S, 2005, METAB ENG, V7, P364, DOI 10.1016/j.ymben.2005.07.001; Song H, 2006, ENZYME MICROB TECH, V39, P352, DOI 10.1016/j.enzmictec.2005.11.043; Stanbury PF, 1995, PRINCIPLES FERMENTAT; STORMER F C, 1968, Febs Letters, V2, P36, DOI 10.1016/0014-5793(68)80094-8; THAUER RK, 1977, BACTERIOL REV, V41, P100, DOI 10.1128/MMBR.41.1.100-180.1977; THOMAS D, 1992, J GEN MICROBIOL, V138, P2021, DOI 10.1099/00221287-138-10-2021; Wang AL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040442; Wong CL, 2014, BIORESOURCE TECHNOL, V152, P169, DOI 10.1016/j.biortech.2013.10.101; YU EKC, 1983, APPL ENVIRON MICROB, V46, P630, DOI 10.1128/AEM.46.3.630-635.1983; Zeng AP, 2011, CURR OPIN BIOTECH, V22, P749, DOI 10.1016/j.copbio.2011.05.005; Zhuge B, 2010, APPL MICROBIOL BIOT, V87, P2177, DOI 10.1007/s00253-010-2678-0	49	13	15	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161503	10.1371/journal.pone.0161503	http://dx.doi.org/10.1371/journal.pone.0161503			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603922	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200017
J	Chen, CJ; He, WC; Nassirou, TY; Zhou, W; Yin, YL; Dong, XL; Rao, QQ; Shi, H; Zhao, WB; Efisue, A; Jin, DM				Chen, Caijin; He, Wenchuang; Nassirou, Tondi Yacouba; Zhou, Wei; Yin, Yilong; Dong, Xilong; Rao, Quanqin; Shi, Han; Zhao, Wubin; Efisue, Andrew; Jin, Deming			Genetic Diversity and Phenotypic Variation in an Introgression Line Population Derived from an Interspecific Cross between Oryza glaberrima and Oryza sativa	PLOS ONE			English	Article							GRAIN QUALITY TRAITS; LINKAGE DISEQUILIBRIUM; BACKCROSS POPULATION; CULTIVATED RICE; MAJOR QTL; AFLP; L.; TOLERANCE; IDENTIFICATION; RESISTANCE	The introduction of closely related species genomic fragments is an effective way to enrich genetic diversity and creates new germplasms in crops. Here, we studied the genetic diversity of an introgression line (IL) population composed of 106 ILs derived from an interspecific tetra cross between O. glaberrima and O. sativa (RAM3/Jin23B//Jin23B///YuetaiB). The proportion of O. glaberrima genome (PGG) in the ILs ranged from 0.3% to 36.7%, with an average value of 12.32% which is close to the theoretically expected proportion. A total of 250 polymorphic alleles were amplified by 21 AFLP primer combinations with an average of 12 alleles per primer. Population structure analysis revealed that the IL population can be divided into four genetically distinct subpopulations. Both principal component analysis and neighbor-joining tree analysis showed that ILs with a higher PGG displayed greater genetic diversity. Canonical discriminant analysis identified six phenotypic traits (plant height, yield per plant, filled grain percentage, panicle length, panicle number and days to flowering) as the main discriminatory traits among the ILs and between the subpopulations and showed significant phenotypic distances between subpopulations. The effects of PGG on phenotypic traits in the ILs were estimated using a linear admixed model, which showed a significant positive effect on grain yield per plant (0.286 +/- 0.117), plant height (0.418 +/- 0.132), panicle length (0.663 +/- 0.107), and spikelet number per panicle (0.339 +/- 0.128), and a significant negative effect on filled grain percentage (-0.267 +/- 0.123) and days to flowering (-0.324 +/- 0.075). We found that an intermediate range (10% - 20%) of PGG was more effective for producing ILs with favorable integrated agronomic traits. Our results confirm that construction of IL population carrying O. glaberrima genomic fragments could be an effective approach to increase the genetic diversity of O. sativa genome and an appropriate level of PGG could facilitate pyramiding more favorable genes for developing more adaptive and productive rice.	[Chen, Caijin; He, Wenchuang; Nassirou, Tondi Yacouba; Zhou, Wei; Yin, Yilong; Dong, Xilong; Rao, Quanqin; Shi, Han; Zhao, Wubin; Jin, Deming] Huazhong Agr Univ, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Coll Plant Sci & Technol, Wuhan, Peoples R China; [Efisue, Andrew] Univ Port Harcourt, Dept Crop & Soil Sci, Port Harcourt, Nigeria	Huazhong Agricultural University; University of Port Harcourt	Jin, DM (corresponding author), Huazhong Agr Univ, MOA Key Lab Crop Ecophysiol & Farming Syst Middle, Coll Plant Sci & Technol, Wuhan, Peoples R China.	djin@mail.hzau.edu.cn		He, Wenchuang/0000-0001-5568-7215	Fundamental Research Funds for the Central Universities [2013PY134]; Development Programme (863 Programme) of China [2012AA101101]; Specialized Research Fund for the Doctoral Program of Higher Education [20130146110026]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Development Programme (863 Programme) of China; Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This study was funded by the Fundamental Research Funds for the Central Universities with program no. 2013PY134 (DJ), Development Programme (863 Programme) of China with grant no. 2012AA101101 (www.863.gov.cn, DJ), Specialized Research Fund for the Doctoral Program of Higher Education with grant no. 20130146110026 (www.cutech.edu.cn, DJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adedze YMN, 2016, J AGR SCI-CAMBRIDGE, V154, P367, DOI 10.1017/S002185961500026X; Ali ML, 2011, CROP SCI, V51, P2021, DOI 10.2135/cropsci2010.11.0641; Aluko G, 2004, THEOR APPL GENET, V109, P630, DOI 10.1007/s00122-004-1668-y; Bimpong IK, 2011, J PLANT BIOL, V54, P237, DOI 10.1007/s12374-011-9161-z; Bocco R, 2012, PLANT SCI, V183, P65, DOI 10.1016/j.plantsci.2011.09.010; Deng XJ, 2012, J INTEGR AGR, V11, P1059, DOI 10.1016/S2095-3119(12)60098-7; Deng XJ, 2012, J ANHUI AGR SCI, V40, P1336; Doi K, 1998, BREEDING SCI, V48, P395; Doi K., 1999, RICE GENET NEWSL, V16, P65; Efisue AA, 2009, J CROP IMPROV, V23, P383, DOI 10.1080/15427520902976471; Eric F, 2015, PEERJ PREPRINTS; Felix DT, 2014, CONSERV GENET, V15, P1315, DOI 10.1007/s10592-014-0619-7; Fujita D, 2010, BREEDING SCI, V60, P336, DOI 10.1270/jsbbs.60.336; Gonzalo GA, 2010, BMC PLANT BIOL, V10, P1; Gouy M, 2015, FIELD CROP RES, V171, P99, DOI 10.1016/j.fcr.2014.11.002; Guei RG., 2005, AGRON AFR, V5, P17; Guo SB, 2013, RICE SCI, V20, P95, DOI 10.1016/S1672-6308(13)60111-0; He YX, 2010, PLANT BREEDING, V129, P167, DOI 10.1111/j.1439-0523.2009.01683.x; Hu FY, 2006, EUPHYTICA, V151, P273, DOI 10.1007/s10681-006-9146-z; Huang F, 2013, CROP SCI, V53, P132, DOI 10.2135/cropsci2012.07.0444; Johnson DE, 1998, WEED RES, V38, P207, DOI 10.1046/j.1365-3180.1998.00092.x; Jones MP, 1997, EUPHYTICA, V94, P237, DOI 10.1023/A:1002969932224; Kaya HB, 2014, PLANT SYST EVOL, V300, P1337, DOI 10.1007/s00606-013-0965-9; Koide Y, 2008, NEW PHYTOL, V179, P888, DOI 10.1111/j.1469-8137.2008.02490.x; Lai Yong, 2012, Acta Agronomica Sinica, V38, P1640; Lamine M, 2015, APPL BIOCHEM BIOTECH, V175, P2996, DOI 10.1007/s12010-015-1477-6; Li F, 2011, PLANT BREEDING, V130, P165, DOI 10.1111/j.1439-0523.2010.01845.x; Li JM, 2004, GENOME, V47, P697, DOI [10.1139/g04-029, 10.1139/G04-029]; Linares OF, 2002, P NATL ACAD SCI USA, V99, P16360, DOI 10.1073/pnas.252604599; Maduakor H. O., 1989, Journal of Root Crops, V15, P115; MAJI T, 2001, ORYZA, V38, P17; Meudt HM, 2007, TRENDS PLANT SCI, V12, P106, DOI 10.1016/j.tplants.2007.02.001; Ndjiondjop MN, 2012, CROP SCI, V52, P524, DOI 10.2135/cropsci2011.05.0287; Ndjiondjop MN, 2010, PLANT SCI, V179, P364, DOI 10.1016/j.plantsci.2010.06.006; Nie XH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141064; Pariasca-Tanaka J, 2014, THEOR APPL GENET, V127, P1387, DOI 10.1007/s00122-014-2306-y; Plowright RA, 1999, NEMATOLOGY, V1, P745, DOI 10.1163/156854199508775; Powell W, 1996, MOL BREEDING, V2, P225, DOI 10.1007/BF00564200; Pritchard JK, 2000, GENETICS, V155, P945; Roy S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129607; Saikumar S, 2014, FIELD CROP RES, V163, P119, DOI 10.1016/j.fcr.2014.03.011; Saito K, 2010, CROP SCI, V50, P227, DOI 10.2135/cropsci2009.06.0284; SANO Y, 1983, J HERED, V74, P435, DOI 10.1093/oxfordjournals.jhered.a109832; Sarla N, 2005, CURR SCI INDIA, V89, P955; SAUPHANOR B, 1985, INSECT SCI APPL, V6, P429, DOI 10.1017/S1742758400004756; Semon M, 2005, GENETICS, V169, P1639, DOI 10.1534/genetics.104.033175; Stich B, 2005, THEOR APPL GENET, V111, P723, DOI 10.1007/s00122-005-2057-x; Suh JungPil, 2005, Korean Journal of Breeding, V37, P214; Sweeney M, 2007, ANN BOT-LONDON, V100, P951, DOI 10.1093/aob/mcm128; Vaylay R, 2002, CROP SCI, V42, P534, DOI 10.2135/cropsci2002.0534; VOS P, 1995, NUCLEIC ACIDS RES, V23, P4407, DOI 10.1093/nar/23.21.4407; Wang MH, 2014, NAT GENET, V46, P982, DOI 10.1038/ng.3044; Wasano K, 1986, B FACULTY AGR, V60, P45; Watanabe H, 2006, PLANT PROD SCI, V9, P287, DOI 10.1626/pps.9.287; Wiredu A. N., 2014, Journal of Sustainable Development, V7, P167; Xiao JH, 1998, GENETICS, V150, P899; Yao DARA, 2015, GENET RESOUR CROP EV, V62, P863, DOI 10.1007/s10722-014-0197-z	57	6	6	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161746	10.1371/journal.pone.0161746	http://dx.doi.org/10.1371/journal.pone.0161746			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603678	gold, Green Published, Green Submitted			2022-12-26	WOS:000383255200024
J	Li, YQ; Poroyko, V; Yan, ZL; Pan, LY; Feng, Y; Zhao, PH; Xie, ZLL; Hong, L				Li, Yuqing; Poroyko, Valeriy; Yan, Zhilong; Pan, Liya; Feng, Yi; Zhao, Peihua; Xie, Zhoulonglong; Hong, Li			Characterization of Intestinal Microbiomes of Hirschsprung's Disease Patients with or without Enterocolitis Using Illumina-MiSeq High-Throughput Sequencing	PLOS ONE			English	Article							INFLAMMATORY BOWEL DISEASES; CLOSTRIDIUM-DIFFICILE; PATHOGENESIS; COMMUNITIES; FUTURE; TRIAL	Hirschsprung-associated enterocolitis (HAEC) is a life-threatening complication of Hirschsprung's disease (HD). Although the pathological mechanisms are still unclear, studies have shown that HAEC has a close relationship with the disturbance of intestinal microbiota. This study aimed to investigate the characteristics of the intestinal microbiome of HD patients with or without enterocolitis. During routine or emergency surgery, we collected 35 intestinal content samples from five patients with HAEC and eight HD patients, including three HD patients with a history of enterocolitis who were in a HAEC remission (HAEC-R) phase. Using Illumina-MiSeq high-throughput sequencing, we sequenced the V4 region of bacterial 16S rRNA, and operational taxonomic units (OTUs) were defined by 97% sequence similarity. Principal coordinate analysis (PCoA) of weighted UniFrac distances was performed to evaluate the diversity of each intestinal microbiome sample. The microbiota differed significantly between the HD patients (characterized by the prevalence of Bacteroidetes) and HAEC patients (characterized by the prevalence of Proteobacteria), while the microbiota of the HAEC-R patients was more similar to that of the HAEC patients. We also observed that the specimens from different intestinal sites of each HD patient differed significantly, while the specimens from different intestinal sites of each HAEC and HAEC-R patient were more similar. In conclusion, the microbiome pattern of the HAEC-R patients was more similar to that of the HAEC patients than to that of the HD patients. The HD patients had a relatively distinct, more stable community than the HAEC and HAEC-R patients, suggesting that enterocolitis may either be caused by or result in a disruption of the patient's uniquely adapted intestinal flora. The intestinal microbiota associated with enterocolitis may persist following symptom resolution and can be implicated in the symptom recurrence.	[Li, Yuqing; Pan, Liya; Feng, Yi; Hong, Li] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Clin Nutr, Shanghai, Peoples R China; [Poroyko, Valeriy] City Hope Natl Med Ctr, Dept Med Oncol & Therapeut Res, Duarte, CA USA; [Yan, Zhilong; Xie, Zhoulonglong] Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Surg, Shanghai, Peoples R China; [Zhao, Peihua] East China Normal Univ, Inst Mol Ecol & Evolut, SKLEC, Shanghai, Peoples R China; [Zhao, Peihua] East China Normal Univ, IECR, Shanghai, Peoples R China	Shanghai Jiao Tong University; City of Hope; Shanghai Jiao Tong University; East China Normal University; East China Normal University	Hong, L (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Shanghai Childrens Med Ctr, Dept Clin Nutr, Shanghai, Peoples R China.	lihongscmc@aliyun.com			Shanghai Science & Technology Commission Project [13ZR1426300]; Project HOPE "The Abbott Fund Institute of Nutrition Science" [AFINS-HOPE-2013-18]	Shanghai Science & Technology Commission Project; Project HOPE "The Abbott Fund Institute of Nutrition Science"	This study is supported by a grant from Shanghai Science & Technology Commission Project (No. 13ZR1426300, to HONG L) and Project HOPE "The Abbott Fund Institute of Nutrition Science (AFINS-HOPE-2013-18, to HONG L)". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Austin KM, 2012, SEMIN PEDIATR SURG, V21, P319, DOI 10.1053/j.sempedsurg.2012.07.006; Burkardt DD, 2014, CLIN PEDIATR, V53, P71, DOI 10.1177/0009922813500846; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Dave M, 2012, TRANSL RES, V160, P246, DOI 10.1016/j.trsl.2012.05.003; De Filippo C, 2010, PEDIATR SURG INT, V26, P465, DOI 10.1007/s00383-010-2586-5; El-Sawaf M, 2013, J PEDIATR SURG, V48, P111, DOI 10.1016/j.jpedsurg.2012.10.028; ELHALABY EA, 1995, J PEDIATR SURG, V30, P76, DOI 10.1016/0022-3468(95)90615-0; Frykman PK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124172; Kostic AD, 2014, GASTROENTEROLOGY, V146, P1489, DOI 10.1053/j.gastro.2014.02.009; Langer JC, 2013, CURR OPIN PEDIATR, V25, P368, DOI 10.1097/MOP.0b013e328360c2a0; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Menezes M, 2006, PEDIATR SURG INT, V22, P316, DOI 10.1007/s00383-006-1639-2; Moore SW, 2008, J PEDIATR SURG, V43, P1439, DOI 10.1016/j.jpedsurg.2007.12.057; Morowitz MJ, 2011, ANN SURG, V253, P1094, DOI 10.1097/SLA.0b013e31821175d7; Parsons SJ, 2005, J PAEDIATR CHILD H, V41, P689, DOI 10.1111/j.1440-1754.2005.00762.x; Pastor AC, 2009, J PEDIATR SURG, V44, P251, DOI 10.1016/j.jpedsurg.2008.10.052; Polytarchou C, 2014, CURR OPIN GASTROEN, V30, P339, DOI 10.1097/MOG.0000000000000081; Reding R, 1997, J PEDIATR SURG, V32, P1221, DOI 10.1016/S0022-3468(97)90686-2; RIETRA PJG, 1978, LANCET, V2, P319; Schaubeck M, 2015, CURR OPIN GASTROEN, V31, P464, DOI 10.1097/MOG.0000000000000216; Snoek SA, 2010, EXPERT REV GASTROENT, V4, P637, DOI [10.1586/egh.10.51, 10.1586/EGH.10.51]; TEITELBAUM DH, 1989, J PEDIATR SURG, V24, P1271, DOI 10.1016/S0022-3468(89)80566-4; THOMAS DFM, 1982, LANCET, V1, P78; THOMAS DFM, 1986, J PEDIATR SURG, V21, P22, DOI 10.1016/S0022-3468(86)80644-3; Vieten Daniela, 2004, Semin Pediatr Surg, V13, P263, DOI 10.1053/j.sempedsurg.2004.10.014; Wang JS, 2004, PEDIATR SURG INT, V20, P525, DOI 10.1007/s00383-004-1213-8; Wang XL, 2015, INT J COLORECTAL DIS, V30, P105, DOI 10.1007/s00384-014-2054-0; WILSON-STOREY D, 1988, Journal of the Royal College of Surgeons of Edinburgh, V33, P185; WILSONSTOREY D, 1989, J PEDIATR SURG, V24, P462, DOI 10.1016/S0022-3468(89)80402-6; WILSONSTOREY D, 1990, ARCH DIS CHILD, V65, P1338, DOI 10.1136/adc.65.12.1338; Yan ZL, 2014, BIOCHEM BIOPH RES CO, V445, P269, DOI 10.1016/j.bbrc.2014.01.104	32	26	29	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162079	10.1371/journal.pone.0162079	http://dx.doi.org/10.1371/journal.pone.0162079			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603009	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255200039
J	Albers, T; Maniak, M; Beitz, E; von Bulow, J				Albers, Tineke; Maniak, Markus; Beitz, Eric; von Buelow, Julia			The C Isoform of Dictyostelium Tetraspanins Localizes to the Contractile Vacuole and Contributes to Resistance against Osmotic Stress	PLOS ONE			English	Article							DISCOIDEUM AMEBAS; CELL-ADHESION; PROTEINS; PALMITOYLATION; ORGANIZATION; MICRODOMAINS; EVOLUTION; MOTILITY; DOMAINS; SYSTEM	Tetraspanins (Tsps) are membrane proteins that are widely expressed in eukaryotic organisms. Only recently, Tsps have started to acquire relevance as potential new drug targets as they contribute, via protein-protein interactions, to numerous pathophysiological processes including infectious diseases and cancer. However, due to a high number of iso-forms and functional redundancy, knowledge on specific functions of most Tsps is still scarce. We set out to characterize five previously annotated Tsps, TspA-E, from Dictyostelium discoideum, a model for studying proteins that have human orthologues. Using reverse transcriptase PCRs, we found mRNAs for TspA-E in the multicellular slug stage, whereas vegetative cells expressed only TspA, TspC and, to a lesser extent, TspD. We raised antibodies against TspA, TspC and TspD and detected endogenous TspA, as well as heterologously expressed TspA and TspC by Western blot. N-deglycosylation assays and mutational analyses showed glycosylation of TspA and TspC in vivo. GFP-tagged Tsps colocalized with the proton pump on the contractile vacuole network. Deletion strains of TspC and TspD exibited unaltered growth, adhesion, random motility and development. Yet, tspC(-) cells showed a defect in coping with hypo-osmotic stress, due to accumulation of contractile vacuoles, but heterologous expression of TspC rescued their phenotype. In conclusion, our data fill a gap in Dictyostelium research and open up the possibility that Tsps in contractile vacuoles of e.g. Trypanosoma may one day constitute a valuable drug target for treating sleeping sickness, one of the most threatening tropical diseases.	[Albers, Tineke; Beitz, Eric; von Buelow, Julia] Univ Kiel, Dept Med & Pharmaceut Chem, Kiel, Germany; [Maniak, Markus] Univ Kassel, Dept Cell Biol, Kassel, Germany	University of Kiel; Universitat Kassel	von Bulow, J (corresponding author), Univ Kiel, Dept Med & Pharmaceut Chem, Kiel, Germany.	jbuelow@pharmazie.uni-kiel.de		Maniak, Markus/0000-0001-6442-5372				Ageberg M, 2003, CLIN LAB HAEMATOL, V25, P297, DOI 10.1046/j.1365-2257.2003.00541.x; ASHWORTH JM, 1970, BIOCHEM J, V119, P175, DOI 10.1042/bj1190175; AUBRY L, 1993, J CELL SCI, V105, P861; Becker M, 1999, EMBO J, V18, P3305, DOI 10.1093/emboj/18.12.3305; Beitz E, 2000, BIOINFORMATICS, V16, P135, DOI 10.1093/bioinformatics/16.2.135; Berditchevski F, 2002, J BIOL CHEM, V277, P36991, DOI 10.1074/jbc.M205265200; Berditchevski F., 2013, TETRASPANINS; Berditchevski F, 2007, TRAFFIC, V8, P89, DOI 10.1111/j.1600-0854.2006.00515.x; Boavida LC, 2013, PLANT PHYSIOL, V163, P696, DOI 10.1104/pp.113.216598; Boucheix C, 2001, CELL MOL LIFE SCI, V58, P1189, DOI 10.1007/PL00000933; Bozzaro Salvatore, 2013, Methods Mol Biol, V983, P17, DOI 10.1007/978-1-62703-302-2_2; Charrin S, 2002, FEBS LETT, V516, P139, DOI 10.1016/S0014-5793(02)02522-X; Charrin S, 2014, J CELL SCI, V127, P3641, DOI 10.1242/jcs.154906; Charrin S, 2009, BIOCHEM J, V420, P133, DOI 10.1042/BJ20082422; Delos Santos RC, 2015, CELL SIGNAL, V27, P1963, DOI 10.1016/j.cellsig.2015.07.004; Du F, 2008, EMBO J, V27, P2064, DOI 10.1038/emboj.2008.131; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Escola JM, 1998, J BIOL CHEM, V273, P20121, DOI 10.1074/jbc.273.32.20121; Essid M, 2012, MOL BIOL CELL, V23, P1267, DOI 10.1091/mbc.E11-06-0576; Faix J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh136; Garcia R, 2013, CYTOSKELETON, V70, P269, DOI 10.1002/cm.21107; Gerald NJ, 2002, TRAFFIC, V3, P50, DOI 10.1034/j.1600-0854.2002.30107.x; Gerisch G, 2002, CELL BIOL INT, V26, P845, DOI 10.1006/cbir.2002.0938; Heijnen HFG, 1998, BLOOD, V91, P2313, DOI 10.1182/blood.V91.7.2313.2313_2313_2325; Hemler ME, 2008, NAT REV DRUG DISCOV, V7, P747, DOI 10.1038/nrd2659; Hemler ME, 2014, NAT REV CANCER, V14, P49, DOI 10.1038/nrc3640; Hemler ME, 2005, NAT REV MOL CELL BIO, V6, P801, DOI 10.1038/nrm1736; Hemler ME, 2003, ANNU REV CELL DEV BI, V19, P397, DOI 10.1146/annurev.cellbio.19.111301.153609; HEUSER J, 1993, J CELL BIOL, V121, P1311, DOI 10.1083/jcb.121.6.1311; Huang SF, 2005, GENOMICS, V86, P674, DOI 10.1016/j.ygeno.2005.08.004; Humbel BM, SCANNING MICROSC, V6, P817; Jenne N, 1998, J CELL SCI, V111, P61; Jung G, 2009, J CELL BIOL, V186, P555, DOI 10.1083/jcb.200810147; Kitadokoro K, 2001, EMBO J, V20, P12, DOI 10.1093/emboj/20.1.12; Kovalenko OV, 2005, BMC STRUCT BIOL, V5, DOI 10.1186/1472-6807-5-11; Levi S, 2000, PLASMID, V44, P231, DOI 10.1006/plas.2000.1487; Malchow D, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-31; Monk Peter N., 2012, Infectious Disorders - Drug Targets, V12, P4; Monnat J, 1997, FEBS LETT, V418, P357, DOI 10.1016/S0014-5793(97)01415-4; Muller-Taubenberger A, 2013, EUR J CELL BIOL, V92, P45, DOI 10.1016/j.ejcb.2012.10.003; Neuhaus EM, 1998, J STRUCT BIOL, V121, P326, DOI 10.1006/jsbi.1998.3971; Nichols SA, 2006, P NATL ACAD SCI USA, V103, P12451, DOI 10.1073/pnas.0604065103; NOLTA KV, 1994, J BIOL CHEM, V269, P2225; Ono M, 2000, BIOCHEM BIOPH RES CO, V279, P744, DOI 10.1006/bbrc.2000.4030; OREN R, 1990, MOL CELL BIOL, V10, P4007, DOI 10.1128/MCB.10.8.4007; Parikh A, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-r35; Rai A, 2011, CELL MOL LIFE SCI, V68, P2751, DOI 10.1007/s00018-010-0590-5; Raposo G, 2007, CURR OPIN CELL BIOL, V19, P394, DOI 10.1016/j.ceb.2007.05.001; Sesaki H, 1997, J CELL BIOL, V138, P939, DOI 10.1083/jcb.138.4.939; Sriskanthadevan S, 2013, FEBS J, V280, P1795, DOI 10.1111/febs.12203; Sriskanthadevan S, 2009, J BIOL CHEM, V284, P36377, DOI 10.1074/jbc.M109.057257; Stipp CS, 2003, TRENDS BIOCHEM SCI, V28, P106, DOI 10.1016/S0968-0004(02)00014-2; Veltman DM, 2009, PLASMID, V61, P110, DOI 10.1016/j.plasmid.2008.11.003; von Bulow J, 2015, BIOL BULL-US, V229, P38, DOI 10.1086/BBLv229n1p38; von Bulow J, 2015, BIOL CELL, V107, P78, DOI 10.1111/boc.201400070; von Bulow J, 2012, J BIOL CHEM, V287, P7487, DOI 10.1074/jbc.M111.329102; Yanez-Mo M, 2009, TRENDS CELL BIOL, V19, P434, DOI 10.1016/j.tcb.2009.06.004; Yang XW, 2002, MOL BIOL CELL, V13, P767, DOI 10.1091/mbc.01-05-0275; Zhou FF, 2006, BIOINFORMATICS, V22, P894, DOI 10.1093/bioinformatics/btl013	59	2	2	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162065	10.1371/journal.pone.0162065	http://dx.doi.org/10.1371/journal.pone.0162065			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27597994	gold, Green Submitted, Green Published			2022-12-26	WOS:000383254800035
J	Nishikawa, S; Aoyama, H; Kamiya, M; Higuchi, J; Kato, A; Soga, M; Kawai, T; Yoshimura, K; Kumazawa, S; Tsuda, T				Nishikawa, Sho; Aoyama, Hiroki; Kamiya, Misa; Higuchi, Jun; Kato, Aiko; Soga, Minoru; Kawai, Taeko; Yoshimura, Kazuki; Kumazawa, Shigenori; Tsuda, Takanori			Artepillin C, a Typical Brazilian Propolis-Derived Component, Induces Brown-Like Adipocyte Formation in C3H10T1/2 Cells, Primary Inguinal White Adipose Tissue-Derived Adipocytes, and Mice	PLOS ONE			English	Article							ANTIOXIDANT ACTIVITY; GENE-EXPRESSION; PROTEIN-KINASE; INSULIN ACTION; FAT; PRDM16; CONSTITUENTS; ACTIVATION; MUSCLE	Induction of brown-like adipocytes (beige/brite cells) in white adipose tissue (WAT) suggests a new approach for preventing and treating obesity via induction of thermogenesis associated with uncoupling protein 1 (UCP1). However, whether diet-derived factors can directly induce browning of white adipocytes has not been well established. In addition, the underlying mechanism of induction of brown-like adipocytes by diet-derived factors has been unclear. Here, we demonstrate that artepillin C (ArtC), which is a typical Brazilian propolis-derived component, significantly induces brown-like adipocytes in murine C3H10T1/2 cells and primary inguinal WAT (iWAT)-derived adipocytes. This significant induction is due to activation of peroxisome proliferator-activated receptor. and stabilization of PRD1-BF-1-RIZ1 homologous domain-containing protein-16 (PRDM16). Furthermore, the oral administration of ArtC (10 mg/kg) for 4 weeks significantly induced brown-like adipocytes accompanied by significant expression of UCP1 and PRDM16 proteins in iWAT of mice, and was independent of the beta 3-adrenergic signaling pathway via the sympathetic nervous system. These findings may provide insight into browning of white adipocytes including the molecular mechanism mediated by dietary factors and demonstrate that ArtC has a novel biological function with regard to increasing energy expenditure by browning of white adipocytes.	[Nishikawa, Sho; Aoyama, Hiroki; Kamiya, Misa; Higuchi, Jun; Kato, Aiko; Soga, Minoru; Kawai, Taeko; Tsuda, Takanori] Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan; [Yoshimura, Kazuki; Kumazawa, Shigenori] Univ Shizuoka, Dept Food & Nutr Sci, Suruga Ku, Shizuoka, Shizuoka 4228526, Japan	Chubu University; University of Shizuoka	Tsuda, T (corresponding author), Chubu Univ, Coll Biosci & Biotechnol, Kasugai, Aichi 4878501, Japan.	tsudat@isc.chubu.ac.jp	Kumazawa, Shigenori/A-2067-2013	NISHIKAWA, SHO/0000-0001-8219-6825	Japan Society for Promotion of Science [26450168]; Yamada Research Grant	Japan Society for Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Yamada Research Grant	This work was supported by Grants-in-Aid for Scientific Research (No. 26450168) from the Japan Society for Promotion of Science and Yamada Research Grant. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadian M, 2013, NAT MED, V19, P557, DOI 10.1038/nm.3159; Ahn MR, 2009, MOL NUTR FOOD RES, V53, P643, DOI 10.1002/mnfr.200800021; Aune UL, 2013, JOVE-J VIS EXP, DOI 10.3791/50191; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; Cohen P, 2014, CELL, V156, P304, DOI 10.1016/j.cell.2013.12.021; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Frontini A, 2010, CELL METAB, V11, P253, DOI 10.1016/j.cmet.2010.03.004; Giralt M, 2013, ENDOCRINOLOGY, V154, P2992, DOI 10.1210/en.2013-1403; Ikeda R, 2011, BBA-GEN SUBJECTS, V1810, P695, DOI 10.1016/j.bbagen.2011.04.007; Kim M, 2015, SCI REP-UK, V5, DOI 10.1038/srep18013; Kumazawa S, 2004, FOOD CHEM, V84, P329, DOI 10.1016/S0308-8146(03)00216-4; Kumazawa S, 2003, CHEM PHARM BULL, V51, P740, DOI 10.1248/cpb.51.740; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lau P, 2015, AM J PHYSIOL-ENDOC M, V308, pE159, DOI 10.1152/ajpendo.00056.2014; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Mahadev K, 2001, J BIOL CHEM, V276, P21938, DOI 10.1074/jbc.C100109200; Nagase I, 1996, J CLIN INVEST, V97, P2898, DOI 10.1172/JCI118748; Nakajima Y, 2009, PHYTOTHER RES, V23, P1431, DOI 10.1002/ptr.2797; Nedergaard J, 2010, CELL METAB, V11, P268, DOI 10.1016/j.cmet.2010.03.007; Ohno H, 2012, CELL METAB, V15, P395, DOI 10.1016/j.cmet.2012.01.019; Petrovic N, 2010, J BIOL CHEM, V285, P7153, DOI 10.1074/jbc.M109.053942; REZNIKOFF CA, 1973, CANCER RES, V33, P3239; Saito M, 2009, DIABETES, V58, P1526, DOI 10.2337/db09-0530; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Seale P, 2011, J CLIN INVEST, V121, P96, DOI 10.1172/JCI44271; SLAVIN BG, 1978, ANAT REC, V191, P377, DOI 10.1002/ar.1091910310; Takikawa M, 2013, MOL NUTR FOOD RES, V57, P1794, DOI 10.1002/mnfr.201300041; Tani H, 2010, BIOORGAN MED CHEM, V18, P151, DOI 10.1016/j.bmc.2009.11.007; Tazawa S, 1998, CHEM PHARM BULL, V46, P1477, DOI 10.1248/cpb.46.1477; TRAYHURN P, 1987, P NUTR SOC, V46, P135, DOI 10.1079/PNS19870017; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; Weyer C, 1998, DIABETES, V47, P1555, DOI 10.2337/diabetes.47.10.1555; Yang XY, 2015, FRONT ENDOCRINOL, V6, DOI 10.3389/fendo.2015.00149; Yoneshiro T, 2011, OBESITY, V19, P13, DOI 10.1038/oby.2010.105; Zhang GQ, 2016, FRONT PHYSIOL, V7, DOI 10.3389/fphys.2016.00029	36	28	29	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0162512	10.1371/journal.pone.0162512	http://dx.doi.org/10.1371/journal.pone.0162512			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598888	Green Published, gold, Green Submitted			2022-12-26	WOS:000383254800073
J	Yagdiran, Y; Tallkvist, J; Artursson, K; Oskarsson, A				Yagdiran, Yagmur; Tallkvist, Jonas; Artursson, Karin; Oskarsson, Agneta			Staphylococcus aureus and Lipopolysaccharide Modulate Gene Expressions of Drug Transporters in Mouse Mammary Epithelial Cells Correlation to Inflammatory Biomarkers	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; P-GLYCOPROTEIN EXPRESSION; BETA-CASEIN GENE; MULTIDRUG-RESISTANCE; DECREASED EXPRESSION; MEMBRANE-VESICLES; ABC TRANSPORTERS; INDUCED MASTITIS; UP-REGULATION; HEALTHY COWS	Inflammation in the mammary gland (mastitis) is the most common disease in dairy herds worldwide, often caused by the pathogens Staphylococcus aureus (S. aureus) and Escherichia coli (E. coli). Little is known about the effects of mastitis on drug transporters and the impact on transporter-mediated excretion of drugs into milk. We used murine mammary epithelial HC11 cells, after lactogenic differentiation into a secreting phenotype, and studied gene expressions of ABC- and SLC- transporters after treatment of cells with S. aureus and lipopolysaccharide, an endotoxin secreted by E. coli. The studied transporters were Bcrp, Mdr1, Mrp1, Oatp1a5, Octn1 and Oct1. In addition, Csn2, the gene encoding beta-casein, was analyzed. As biomarkers of the inflammatory response, gene expressions of the cytokines Il6 and Tnf alpha and the chemokine Cxcl2 were determined. Our results show that S. aureus and LPS treatment of cells, at non-cytotoxic concentrations, induced an up-regulation of Mdr1 and of the inflammatory biomarkers, except that Tnf alpha was not affected by lipopolysac-charide. By simple regression analysis we could demonstrate statistically significant positive correlations between each of the transporters with each of the inflammatory biomarkers in cells treated with S. aureus. The coefficients of determination (R-2) were 0.7-0.9 for all but one correlation. After treatment of cells with lipopolysaccharide, statistically significant correlations were only found between Mdr1 and the two parameters Cxcl2 and Il6. The expression of Csn2 was up-regulated in cells treated with S. aureus, indicating that the secretory function of the cells was not impaired. The strong correlation in gene expressions between transporters and inflammatory biomarkers may suggest a co-regulation and that the transporters have a role in the transport of cytokines and chemokines. Our results demonstrate that transporters in mammary cells can be affected by infection, which may have an impact on transport of essential compounds and contaminants into milk.	[Yagdiran, Yagmur; Tallkvist, Jonas; Oskarsson, Agneta] Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden; [Artursson, Karin] Natl Vet Inst, Uppsala, Sweden	Swedish University of Agricultural Sciences; National Veterinary Institute SVA	Oskarsson, A (corresponding author), Swedish Univ Agr Sci, Dept Biomed Sci & Vet Publ Hlth, Uppsala, Sweden.	agneta.oskarsson@slu.se		Oskarsson, Agneta/0000-0002-3134-7811	TvarLivs; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas); Sweden's Innovation Agency (Vinnova); Swedish Farmer's Foundation for Agricultural Research; Swedish Food Federation; Swedish Food Retailer's Federation [2011-281]	TvarLivs; Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas)(Swedish Research Council Formas); Sweden's Innovation Agency (Vinnova)(Vinnova); Swedish Farmer's Foundation for Agricultural Research; Swedish Food Federation; Swedish Food Retailer's Federation	This research project was funded by a grant from the research program TvarLivs, which is co-sponsored by the Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning (Formas), Sweden's Innovation Agency (Vinnova), Swedish Farmer's Foundation for Agricultural Research, the Swedish Food Federation and the Swedish Food Retailer's Federation (grant number 2011-281).	Al-Bataineh MM, 2010, BIOPHARM DRUG DISPOS, V31, P506, DOI 10.1002/bdd.731; Alvarez AI, 2008, J PHARM SCI-US, V97, P3483, DOI 10.1002/jps.21233; BALL RK, 1988, EMBO J, V7, P2089, DOI 10.1002/j.1460-2075.1988.tb03048.x; Barkema HW, 2006, J DAIRY SCI, V89, P1877, DOI 10.3168/jds.S0022-0302(06)72256-1; Bauer B, 2007, MOL PHARMACOL, V71, P667, DOI 10.1124/mol.106.029512; Bradley AJ, 2002, VET J, V164, P116, DOI 10.1053/tvjl.2002.0724; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; Chen QX, 2014, DRUG METAB PHARMACOK, V29, P223, DOI 10.2133/dmpk.DMPK-13-SH-068; Chen ZL, 2016, CANCER LETT, V370, P153, DOI 10.1016/j.canlet.2015.10.010; Cressman AM, 2014, DRUG METAB DISPOS, V42, P603, DOI 10.1124/dmd.113.053983; Cressman AM, 2012, EXPERT REV CLIN PHAR, V5, P69, DOI [10.1586/ecp.11.66, 10.1586/ECP.11.66]; Desrivieres S, 2003, MOL CELL PROTEOMICS, V2, P1039, DOI 10.1074/mcp.M300032-MCP200; Drach J, 1996, BLOOD, V88, P1747, DOI 10.1182/blood.V88.5.1747.bloodjournal8851747; Eriksson H, 2009, VET MICROBIOL, V137, P98, DOI 10.1016/j.vetmic.2008.12.016; Fu YH, 2013, VET IMMUNOL IMMUNOP, V155, P245, DOI 10.1016/j.vetimm.2013.08.003; Gandhi A, 2012, CURR DRUG METAB, V13, P1327, DOI 10.2174/138920012803341302; Gilchrist SE, 2010, FUND CLIN PHARMACOL, V24, P205, DOI 10.1111/j.1472-8206.2009.00760.x; Gips M, 1999, J VET PHARMACOL THER, V22, P202, DOI 10.1046/j.1365-2885.1999.00210.x; Griesbeck-Zilch B, 2008, J DAIRY SCI, V91, P2215, DOI 10.3168/jds.2007-0752; Gunther J, 2011, INFECT IMMUN, V79, P695, DOI 10.1128/IAI.01071-10; Han LQ, 2010, GENET MOL RES, V9, P449, DOI 10.4238/vol9-1gmr724; Hartmann G, 2002, J PHARMACOL EXP THER, V303, P273, DOI 10.1124/jpet.102.039404; Heemskerk S, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/525180; HYNES NE, 1990, MOL CELL BIOL, V10, P4027, DOI 10.1128/MCB.10.8.4027; Ingman WV, 2014, J MAMMARY GLAND BIOL, V19, P161, DOI 10.1007/s10911-014-9325-9; Ito S, 2003, ADV DRUG DELIVER REV, V55, P653, DOI 10.1016/S0169-409X(03)00031-0; Jaeger A, 2015, VET RES, V46, DOI 10.1186/s13567-015-0178-z; Jonker JW, 2005, NAT MED, V11, P127, DOI 10.1038/nm1186; Kissell LW, 2015, JAVMA-J AM VET MED A, V246, P118, DOI 10.2460/javma.246.1.118; Klaassen CD, 2010, PHARMACOL REV, V62, P1, DOI 10.1124/pr.109.002014; Kulp A, 2010, ANNU REV MICROBIOL, V64, P163, DOI 10.1146/annurev.micro.091208.073413; Lamhonwah AM, 2011, BIOCHEM BIOPH RES CO, V404, P1010, DOI 10.1016/j.bbrc.2010.12.100; Leslie EM, 2005, TOXICOL APPL PHARM, V204, P216, DOI 10.1016/j.taap.2004.10.012; Li Y, 2009, BIOCHIMIE, V91, P58, DOI 10.1016/j.biochi.2008.04.014; Liptrott NJ, 2009, BRIT J PHARMACOL, V156, P497, DOI 10.1111/j.1476-5381.2008.00050.x; Liptrott NJ, 2011, EXPERT OPIN DRUG MET, V7, P341, DOI 10.1517/17425255.2011.553600; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Loe DW, 1996, J BIOL CHEM, V271, P9675, DOI 10.1074/jbc.271.16.9675; LOHUIS JACM, 1991, J VET PHARMACOL THER, V14, P219, DOI 10.1111/j.1365-2885.1991.tb00830.x; Lucas MF, 2010, J VET PHARMACOL THER, V33, P132, DOI 10.1111/j.1365-2885.2009.01128.x; Mahnke H, 2016, DRUG METAB DISPOS, V44, P700, DOI 10.1124/dmd.115.068940; MARTE BM, 1994, CELL GROWTH DIFFER, V5, P239; Martinez M, 2008, J VET PHARMACOL THER, V31, P285, DOI 10.1111/j.1365-2885.2008.00964.x; Mealey KL, 2012, J VET PHARMACOL THER, V35, P105, DOI 10.1111/j.1365-2885.2011.01313.x; Merino G, 2006, DRUG METAB DISPOS, V34, P690, DOI 10.1124/dmd.105.008219; Morgan ET, 2008, DRUG METAB DISPOS, V36, P205, DOI 10.1124/dmd.107.018747; Mosaffa F, 2009, INFLAMM RES, V58, P669, DOI 10.1007/s00011-009-0034-6; Pawlik A, 2005, J PHARM PHARMACOL, V57, P1421, DOI 10.1211/jpp.57.11.0007; Petrovic V, 2007, MOL INTERV, V7, P99, DOI 10.1124/mi.7.2.10; Piquette-Miller M, 1998, PHARMACEUT RES, V15, P706, DOI 10.1023/A:1011962818051; Rantala M, 2002, J VET PHARMACOL THER, V25, P251, DOI 10.1046/j.1365-2885.2002.00411.x; Royster E, 2015, VET CLIN N AM-FOOD A, V31, P17, DOI 10.1016/j.cvfa.2014.11.010; Sai Y, 2004, DRUG DISCOV TODAY, V9, P712, DOI 10.1016/S1359-6446(04)03198-8; Schrickx JA, 2008, EUR J PHARMACOL, V585, P510, DOI 10.1016/j.ejphar.2008.03.014; Schuetz JD, 2014, DRUG METAB DISPOS, V42, P541, DOI 10.1124/dmd.114.057539; Schukken YH, 2011, VET IMMUNOL IMMUNOP, V144, P270, DOI 10.1016/j.vetimm.2011.08.022; Sigal N, 2015, INFECT IMMUN, V83, P2358, DOI 10.1128/IAI.00380-15; Stein U, 1997, JNCI-J NATL CANCER I, V89, P807, DOI 10.1093/jnci/89.11.807; Sukhai M, 2001, INFLAMM RES, V50, P362, DOI 10.1007/PL00000257; Tallkvist J, 2015, CELL BIOL TOXICOL, V31, P111, DOI 10.1007/s10565-015-9298-5; Teng S, 2008, MOL PHARMACEUT, V5, P67, DOI 10.1021/mp700102q; Theron D, 2003, BIOCHEM PHARMACOL, V66, P579, DOI 10.1016/S0006-2952(03)00340-X; van de Ven R, 2009, J LEUKOCYTE BIOL, V86, P1075, DOI 10.1189/jlb.0309147; Vos TA, 1998, HEPATOLOGY, V28, P1637, DOI 10.1002/hep.510280625; Yagdiran Y, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0151904; Zheng JM, 2006, INFECT IMMUN, V74, P1907, DOI 10.1128/IAI.74.3.1907-1915.2006	66	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 1	2016	11	9							e0161346	10.1371/journal.pone.0161346	http://dx.doi.org/10.1371/journal.pone.0161346			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV3WN	27584666	Green Submitted, gold, Green Published			2022-12-26	WOS:000382855600022
J	Benoit, SL; Maier, RJ				Benoit, Stephane L.; Maier, Robert J.			Helicobacter Catalase Devoid of Catalytic Activity Protects the Bacterium against Oxidative Stress	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						antioxidant; bacterial metabolism; bacterial pathogenesis; infectious disease; microbiology; multifunctional enzyme; oxidative stress	METHIONINE SULFOXIDE REDUCTASE; PYLORI-CATALASE; IN-VIVO; PROTEINS; GASTRITIS; RESIDUES; STRAINS; ENZYMES; ACID; KAPA	Catalase, a conserved and abundant enzyme found in all domains of life, dissipates the oxidant hydrogen peroxide (H2O2). The gastric pathogen Helicobacter pylori undergoes host-mediated oxidant stress exposure, and its catalase contains oxidizable methionine (Met) residues. We hypothesized catalase may play a large stress-combating role independent of its classical catalytic one, namely quenching harmful oxidants through its recyclable Met residues, resulting in oxidant protection to the bacterium. Two Helicobacter mutant strains (katA(H56A) and katA(Y339A)) containing catalase without enzyme activity but that retain all Met residues were created. These strains were much more resistant to oxidants than a catalase-deletion mutant strain. The quenching ability of the altered versions was shown, whereby oxidant-stressed (HOCl-exposed) Helicobacter retained viability even upon extracellular addition of the inactive versions of catalase, in contrast to cells receiving HOCl alone. The importance of the methionine-mediated quenching to the pathogen residing in the oxidant-rich gastric mucus was studied. In contrast to a catalase-null strain, both site-change mutants proficiently colonized the murine gastric mucosa, suggesting that the amino acid composition-dependent oxidant-quenching role of catalase is more important than the well described H2O2-dissipating catalytic role. Over 100 years after the discovery of catalase, these findings reveal a new non-enzymatic protective mechanism of action for the ubiquitous enzyme.	[Benoit, Stephane L.; Maier, Robert J.] Univ Georgia, Dept Microbiol, 807 Biological Sci Bldg,100 Cedar St, Athens, GA 30602 USA	University System of Georgia; University of Georgia	Maier, RJ (corresponding author), Univ Georgia, Dept Microbiol, 807 Biological Sci Bldg,100 Cedar St, Athens, GA 30602 USA.	rmaier@uga.edu		Benoit, Stephane/0000-0002-9314-8586	National Institutes of Health [1R21AI121181]; University of Georgia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI121181] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); University of Georgia Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health Grant 1R21AI121181 and by the University of Georgia Foundation. The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Achilli C, 2015, BIOFACTORS, V41, P135, DOI 10.1002/biof.1214; Akada JK, 2003, MICROBIOL-SGM, V149, P1901, DOI 10.1099/mic.0.26129-0; Alamuri P, 2006, J BACTERIOL, V188, P5839, DOI 10.1128/JB.00430-06; Alfonso-Prieto M, 2012, ARCH BIOCHEM BIOPHYS, V525, P121, DOI 10.1016/j.abb.2012.04.004; ARUOMA OI, 1987, BIOCHEM J, V248, P973, DOI 10.1042/bj2480973; Bagchi D, 1996, FREE RADICAL RES, V24, P439, DOI 10.3109/10715769609088043; Benoit SL, 2007, MICROBIOL-SGM, V153, P1474, DOI 10.1099/mic.0.2006/003228-0; Benoit SL, 2014, MBIO, V5, DOI 10.1128/mBio.01016-13; Benoit SL, 2013, J BACTERIOL, V195, P5396, DOI 10.1128/JB.01001-13; BLASER MJ, 1995, ALIMENT PHARM THERAP, V9, P27; Booniakuakul JK, 2004, J INFECT DIS, V190, P946, DOI 10.1086/423142; Copass M, 1997, INFECT IMMUN, V65, P1949, DOI 10.1128/IAI.65.5.1949-1952.1997; DAVIES GR, 1994, GUT, V35, P179, DOI 10.1136/gut.35.2.179; Handa O, 2010, INFLAMM RES, V59, P997, DOI 10.1007/s00011-010-0245-x; Harris AG, 2003, FEMS MICROBIOL LETT, V229, P283, DOI 10.1016/S0378-1097(03)00850-4; Harris AG, 2003, MICROBIOL-SGM, V149, P665, DOI 10.1099/mic.0.26012-0; Hawkins CL, 2003, AMINO ACIDS, V25, P259, DOI 10.1007/s00726-003-0016-x; HAZELL SL, 1991, J GEN MICROBIOL, V137, P57, DOI 10.1099/00221287-137-1-57; Johnson William M, 2015, Ther Targets Neurol Dis, V2; Kim G, 2014, BBA-GEN SUBJECTS, V1840, P901, DOI 10.1016/j.bbagen.2013.04.038; Kleanthous H, 2001, VACCINE, V19, P4883, DOI 10.1016/S0264-410X(01)00248-1; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Levine RL, 1999, MECH AGEING DEV, V107, P323, DOI 10.1016/S0047-6374(98)00152-3; Loew O, 1900, SCIENCE, V11, P701, DOI 10.1126/science.11.279.701; Loewen PC, 2004, BIOCHEMISTRY-US, V43, P3089, DOI 10.1021/bi035663i; Mahawar M, 2011, J BIOL CHEM, V286, P19159, DOI 10.1074/jbc.M111.223677; MASTERS C, 1995, PEROXISOME VITAL ORG; Miyashita M, 2002, VACCINE, V20, P2336, DOI 10.1016/S0264-410X(02)00104-4; Radcliff FJ, 1997, INFECT IMMUN, V65, P4668, DOI 10.1128/IAI.65.11.4668-4674.1997; Ramarao N, 2000, MOL MICROBIOL, V38, P103, DOI 10.1046/j.1365-2958.2000.02114.x; Sipponen P, 1998, ALIMENT PHARM THER, V12, P61, DOI 10.1111/j.1365-2036.1998.00005.x; Smith TG, 2007, PROTEOMICS, V7, P2240, DOI 10.1002/pmic.200600875; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wang G, 2004, J BIOL CHEM, V279, P51908, DOI 10.1074/jbc.M408450200; WEISS SJ, 1989, NEW ENGL J MED, V320, P365	36	23	23	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	NOV 4	2016	291	45					23366	23373		10.1074/jbc.M116.747881	http://dx.doi.org/10.1074/jbc.M116.747881			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EC1RH	27605666	Green Published, hybrid			2022-12-26	WOS:000387884400001
J	Jadhav, S; Russo, S; Cottier, S; Schneiter, R; Cowart, A; Greenberg, ML				Jadhav, Shyamalagauri; Russo, Sarah; Cottier, Stephanie; Schneiter, Roger; Cowart, Ashley; Greenberg, Miriam L.			Valproate Induces the Unfolded Protein Response by Increasing Ceramide Levels	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ceramide; fatty acid metabolism; lipid metabolism; sphingolipid; unfolded protein response (UPR); inositol	ENDOPLASMIC-RETICULUM MEMBRANE; SACCHAROMYCES-CEREVISIAE; BIPOLAR DISORDER; INOSITOL-BIOSYNTHESIS; STRESS-RESPONSE; SPHINGOLIPID HOMEOSTASIS; PHOSPHATASE SAC1P; GENE-EXPRESSION; FUMONISIN B-1; YEAST	Bipolar disorder (BD), which is characterized by depression and mania, affects 1-2% of the world population. Current treatments are effective in only 40-60% of cases and cause severe side effects. Valproate (VPA) is one of the most widely used drugs for the treatment of BD, but the therapeutic mechanism of action of this drug is not understood. This knowledge gap has hampered the development of effective treatments. To identify candidate pathways affected by VPA, we performed a genome-wide expression analysis in yeast cells grown in the presence or absence of the drug. VPA caused up-regulation of FEN1 and SUR4, encoding fatty acid elongases that catalyze the synthesis of very long chain fatty acids (C24 to C26) required for ceramide synthesis. Interestingly, fen1 and sur4 mutants exhibited VPA sensitivity. In agreement with increased fatty acid elongase gene expression, VPA increased levels of phytoceramide, especially those containing C24-C26 fatty acids. Consistent with an increase in ceramide, VPA decreased the expression of amino acid transporters, increased the expression of ER chaperones, and activated the unfolded protein response element (UPRE), suggesting that VPA induces the UPR pathway. These effects were rescued by supplementation of inositol and similarly observed in inositol-starved ino1 cells. Starvation of ino1 cells increased expression of FEN1 and SUR4, increased ceramide levels, decreased expression of nutrient transporters, and induced the UPR. These findings suggest that VPA-mediated inositol depletion induces the UPR by increasing the de novo synthesis of ceramide.	[Jadhav, Shyamalagauri; Greenberg, Miriam L.] Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA; [Russo, Sarah; Cowart, Ashley] Med Univ South Carolina, Dept Biochem & Mol Biol, Charleston, SC 29425 USA; [Russo, Sarah; Cowart, Ashley] Ralph H Johnson Vet Affairs Med Ctr, Charleston, SC 29401 USA; [Cottier, Stephanie; Schneiter, Roger] Univ Fribourg, Dept Biol, CH-1700 Fribourg, Switzerland	Wayne State University; Medical University of South Carolina; US Department of Veterans Affairs; Veterans Health Administration (VHA); Ralph H Johnson VA Medical Center; University of Fribourg	Greenberg, ML (corresponding author), Wayne State Univ, Dept Biol Sci, Detroit, MI 48202 USA.	mgreenberg@wayne.edu		Schneiter, Roger/0000-0002-9102-8396; Jadhav, Shyamalagauri/0000-0003-4302-6713	National Institutes of Health [DK081367]; Swiss National Science Foundation; Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL117233] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK081367] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Graduate School of Wayne State University; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by National Institutes of Health Grant DK081367 (to M. L. G.), the Swiss National Science Foundation (to R. S.), and the Graduate School of Wayne State University (to S. J.). The authors declare that they have no conflicts of interest with the contents of this article. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alvarez-Vasquez F, 2005, NATURE, V433, P425, DOI 10.1038/nature03232; Balla T, 2013, PHYSIOL REV, V93, P1019, DOI 10.1152/physrev.00028.2012; Belmaker RH, 2004, NEW ENGL J MED, V351, P476, DOI 10.1056/NEJMra035354; BERRIDGE MJ, 1989, PROC R SOC SER B-BIO, V238, P235, DOI 10.1098/rspb.1989.0079; Bostwick JM, 2000, AM J PSYCHIAT, V157, P1925, DOI 10.1176/appi.ajp.157.12.1925; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Chang HJ, 2004, GENETICS, V168, P1899, DOI 10.1534/genetics.104.032961; Chang HJ, 2002, GENETICS, V162, P29; Chapman R, 1998, ANNU REV CELL DEV BI, V14, P459, DOI 10.1146/annurev.cellbio.14.1.459; Cheng RSY, 2005, MED SCI LAW, V45, P317, DOI 10.1258/rsmmsl.45.4.317; Cox JS, 1997, MOL BIOL CELL, V8, P1805, DOI 10.1091/mbc.8.9.1805; Deranieh RM, 2013, J BIOL CHEM, V288, P26822, DOI 10.1074/jbc.M113.479121; Deranieh RM, 2009, BIOCHEM SOC T, V37, P1099, DOI 10.1042/BST0371099; Epstein S, 2012, J LIPID RES, V53, P412, DOI 10.1194/jlr.M022186; Fagone P, 2009, J LIPID RES, V50, pS311, DOI 10.1194/jlr.R800049-JLR200; Fu Yu, 2006, Methods Mol Biol, V313, P257; Gaspar ML, 2006, J BIOL CHEM, V281, P22773, DOI 10.1074/jbc.M603548200; Goodwin GM, 2007, EVID-BASED MENT HEAL, V10, P82, DOI 10.1136/ebmh.10.3.82; Gould TD, 2004, MOL PSYCHIATR, V9, P734, DOI 10.1038/sj.mp.4001518; Guenther GG, 2008, P NATL ACAD SCI USA, V105, P17402, DOI 10.1073/pnas.0802781105; Gururaj C, 2013, J BIOL CHEM, V288, P20453, DOI 10.1074/jbc.M113.472860; HALLCHER LM, 1980, J BIOL CHEM, V255, P896; Han SM, 2010, P NATL ACAD SCI USA, V107, P5851, DOI 10.1073/pnas.0911617107; Hayashi A, 2009, INT J NEUROPSYCHOPH, V12, P33, DOI 10.1017/S1461145708009358; He QR, 2006, TOXICOL SCI, V94, P388, DOI 10.1093/toxsci/kfl102; Henry CA, 2003, J CHILD ADOL PSYCHOP, V13, P523, DOI 10.1089/104454603322724913; Henry SA, 2014, CHEM PHYS LIPIDS, V180, P23, DOI 10.1016/j.chemphyslip.2013.12.013; Jesch SA, 2005, J BIOL CHEM, V280, P9106, DOI 10.1074/jbc.M411770200; Jesch SA, 2006, J BIOL CHEM, V281, P24070, DOI 10.1074/jbc.M604541200; Jesch SA, 2010, J BIOL CHEM, V285, P41947, DOI 10.1074/jbc.M110.188607; Johnson SS, 2010, J BIOL CHEM, V285, P35792, DOI 10.1074/jbc.M110.162883; Ju SL, 2004, J BIOL CHEM, V279, P21759, DOI 10.1074/jbc.M312078200; Ju SL, 2003, MOL MICROBIOL, V49, P1595, DOI 10.1046/j.1365-2958.2003.03641.x; Kakiuchi C, 2003, NAT GENET, V35, P171, DOI 10.1038/ng1235; Kihara A, 2002, J BIOL CHEM, V277, P30048, DOI 10.1074/jbc.M203385200; Knodler A, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-16; KOHRER K, 1991, METHOD ENZYMOL, V194, P398; Mayinger P, 2009, SEMIN CELL DEV BIOL, V20, P793, DOI 10.1016/j.semcdb.2009.03.016; Mori K, 2000, P NATL ACAD SCI USA, V97, P4660, DOI 10.1073/pnas.050010197; Mousley CJ, 2008, MOL BIOL CELL, V19, P4785, DOI 10.1091/mbc.E08-04-0426; Oh CS, 1997, J BIOL CHEM, V272, P17376, DOI 10.1074/jbc.272.28.17376; Pahl HL, 1999, PHYSIOL REV, V79, P683, DOI 10.1152/physrev.1999.79.3.683; Parthasarathy RN, 2013, MOL CELL BIOCHEM, V378, P83, DOI 10.1007/s11010-013-1597-7; Payet LA, 2013, TRAFFIC, V14, P1257, DOI 10.1111/tra.12117; Promlek T, 2011, MOL BIOL CELL, V22, P3520, DOI 10.1091/mbc.E11-04-0295; Santiago TC, 2003, J BIOL CHEM, V278, P38723, DOI 10.1074/jbc.M303008200; Sawai H, 2000, J BIOL CHEM, V275, P39793, DOI 10.1074/jbc.M007721200; Shaltiel G, 2004, BIOL PSYCHIAT, V56, P868, DOI 10.1016/j.biopsych.2004.08.027; So J, 2007, BIOL PSYCHIAT, V62, P141, DOI 10.1016/j.biopsych.2006.10.014; Vaden DL, 2001, J BIOL CHEM, V276, P15466, DOI 10.1074/jbc.M004179200; Villa-Garcia MJ, 2011, MOL GENET GENOMICS, V285, P125, DOI 10.1007/s00438-010-0592-x; Williams RSB, 2002, NATURE, V417, P292, DOI 10.1038/417292a; WU WI, 1995, J BIOL CHEM, V270, P13171, DOI 10.1074/jbc.270.22.13171; Ye CQ, 2015, J NEUROCHEM, V133, P273, DOI 10.1111/jnc.12978	55	16	18	1	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	OCT 14	2016	291	42					22253	22261		10.1074/jbc.M116.752634	http://dx.doi.org/10.1074/jbc.M116.752634			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EA1DL	27590340	Green Submitted, hybrid, Green Published			2022-12-26	WOS:000386332600036
J	Muroya, S; Shibata, M; Hayashi, M; Oe, M; Ojima, K				Muroya, Susumu; Shibata, Masahiro; Hayashi, Masayuki; Oe, Mika; Ojima, Koichi			Differences in Circulating microRNAs between Grazing and Grain-Fed Wagyu Cattle Are Associated with Altered Expression of Intramuscular microRNA, the Potential Target PTEN, and Lipogenic Genes	PLOS ONE			English	Article							MUSCLE-FIBER CHARACTERISTICS; SKELETAL-MUSCLE; ADIPOSE-TISSUE; JAPANESE-BLACK; IDENTIFICATION; ADIPOGENESIS; BIOGENESIS; HOLSTEIN; ISOFORMS; PROFILIN	We aimed to understand the roles of miRNAs in the muscle tissue maturation and those of circulating microRNAs (c-miRNAs) in beef production of Japanese Black (JB) cattle (Wagyu), a breed with genetically background of superior intermuscular fat depot, by comparing different feeding conditions (indoor grain-feeding vs. grazing on pasture). The cattle at 18 months old were assigned to pasture feeding or conventional indoor grain feeding conditions for 5 months. Microarray analysis of c-miRNAs from the plasma extracellular vesicles led to the detection of a total of 202 bovine miRNAs in the plasma, including 15 miRNAs that differed between the feeding conditions. Validation of the microarray results by qPCR showed that the circulating miR-10b level in the grazing cattle was upregulated compared to that of the grain-fed cattle. In contrast, the levels of miR-17-5p, miR-19b, miR-29b, miR-30b-5p, miR-98, miR-142-5p, miR-301a, miR-374b, miR-425-5p, and miR-652 were lower in the grazing cattle than in the grain-fed cattle. Bioinformatic analysis indicated that the predicted target genes of those c-miRNAs were enriched in gene ontology terms associated with blood vessel morphogenesis, plasma membrane, focal adhesion, endocytosis, collagen, ECM-receptor interaction, and phosphorylation. In the grazing cattle, the elevation of miR-10b expression in the plasma was coincident with its elevation in the longissimus lumborum (LL) muscle. Expression of bovine-specific miR-2478, the most plasma-enriched miRNA, tended to be also upregulated in the muscle but not in the plasma. Furthermore, grazing caused the downregulated mRNA expression of predicted miR-10b and/or miR-2478 target genes, such as DNAJB2, PTEN, and SCD1. Thus, the feeding system used for JB cattle affected the c-miRNAs that could be indicators of grain feeding. Among these, miR-10b expression was especially associated with feeding-induced changes and with the expression of the potential target genes responsible for glucose homeo-stasis and intramuscular fat depot in the LL muscle of JB cattle.	[Muroya, Susumu; Oe, Mika; Ojima, Koichi] NARO Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki, Japan; [Shibata, Masahiro] NARO Western Reg Agr Ctr, Livestock Prod & Wildlife Management Res Div, Ohda, Shimane, Japan; [Hayashi, Masayuki] NARO Inst Livestock & Grassland Sci, Anim Physiol & Nutr Res Div, Tsukuba, Ibaraki, Japan	National Agriculture & Food Research Organization - Japan; National Agriculture & Food Research Organization - Japan	Muroya, S (corresponding author), NARO Inst Livestock & Grassland Sci, Anim Prod Res Div, Tsukuba, Ibaraki, Japan.	muros@affrc.go.jp	MUROYA, Susumu/H-9604-2019	MUROYA, Susumu/0000-0002-2376-9352; Ojima, Koichi/0000-0002-5973-1073	Japan Society for the Promotion of Science [JP15K07775, JP15K14849]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported by the Japan Society for the Promotion of Science (https://www.jsps.go.jp/; JSPS KAKENHI JP15K07775 to SM and JP15K14849 to MH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. There was no additional external funding received for this study.	Agarwal V, 2015, ELIFE, V4, DOI 10.7554/eLife.05005; Bai WL, 2014, EXP MOL PATHOL, V96, P426, DOI 10.1016/j.yexmp.2014.04.011; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Chartoumpekis DV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034872; Choi YM, 2009, LIVEST SCI, V122, P105, DOI 10.1016/j.livsci.2008.08.015; Chung KY, 2007, J ANIM SCI, V85, P380, DOI 10.2527/jas.2006-087; Claeys KG, 2010, AM J PATHOL, V176, P2901, DOI 10.2353/ajpath.2010.090663; Das T, 2009, J CELL PHYSIOL, V218, P436, DOI 10.1002/jcp.21618; Endo K, 2013, BIOMED RES-TOKYO, V34, P289, DOI 10.2220/biomedres.34.289; Farrell D, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134310; Horikawa A, 2015, ANIMAL SCI IN PRESS; Hu ZY, 2010, DIABETES, V59, P1312, DOI 10.2337/db09-1155; Huang DW, 2009, NUCLEIC ACIDS RES, V37, P1, DOI 10.1093/nar/gkn923; Ioannidis J, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2529-1; Jeng SF, 2009, J NEUROTRAUM, V26, P2345, DOI 10.1089/neu.2009.0960; Kim JM, 2015, ANIM GENET, V46, P73, DOI 10.1111/age.12255; Kosaka N, 2013, J BIOL CHEM, V288, P10849, DOI 10.1074/jbc.M112.446831; LAMBRECHTS A, 1995, EUR J BIOCHEM, V230, P281, DOI 10.1111/j.1432-1033.1995.0281i.x; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Li HY, 2012, ANIM GENET, V43, P704, DOI 10.1111/j.1365-2052.2012.02332.x; Liu JY, 2014, BIOL REPROD, V91, DOI 10.1095/biolreprod.114.122788; Liu YK, 2013, BMC MOL BIOL, V14, DOI 10.1186/1471-2199-14-7; Mahoney DJ, 2008, AM J PHYSIOL-REG I, V294, pR1901, DOI 10.1152/ajpregu.00847.2007; Mandl A, 2007, MOL CELL BIOL, V27, P8098, DOI 10.1128/MCB.00756-07; Meale SJ, 2014, J ANIM SCI, V92, P3328, DOI 10.2527/jas.2014-7710; Moisa SJ, 2014, GENE REGUL SYST BIO, V8, P17, DOI 10.4137/GRSB.S11782; Muroya S, 2013, J ANIM SCI, V91, P90, DOI 10.2527/jas.2012-5371; Muroya S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136475; Muroya S, 2014, MEAT SCI, V98, P726, DOI 10.1016/j.meatsci.2014.07.018; Mussnich P, 2013, MOL ONCOL, V7, P531, DOI 10.1016/j.molonc.2013.01.002; Nakashima N, 2000, J BIOL CHEM, V275, P12889, DOI 10.1074/jbc.275.17.12889; Ortega FJ, 2015, J NUTR BIOCHEM, V26, P1095, DOI 10.1016/j.jnutbio.2015.05.001; Parra P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013005; Pernier J, 2016, DEV CELL, V36, P201, DOI 10.1016/j.devcel.2015.12.024; Ponsuksili S, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-533; Romao JM, 2014, BMC GENOMICS, V15, DOI 10.1186/1471-2164-15-137; Romao JM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040605; Ryu YC, 2005, MEAT SCI, V71, P351, DOI 10.1016/j.meatsci.2005.04.015; Sharples AP, 2013, GROWTH HORM IGF RES, V23, P53, DOI 10.1016/j.ghir.2013.03.004; Shen LY, 2016, MEAT SCI, V116, P201, DOI 10.1016/j.meatsci.2016.02.023; Shibata M., 2014, Open Journal of Animal Sciences, V4, P297; Shibata M, 2009, J ANIM SCI, V87, P2700, DOI 10.2527/jas.2008-1486; Shibata M, 2016, ANIM SCI J, V87, P929, DOI 10.1111/asj.12519; Shibata M, 2011, MEAT SCI, V89, P451, DOI 10.1016/j.meatsci.2011.05.006; Sun JC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099299; Takanabe R, 2008, BIOCHEM BIOPH RES CO, V376, P728, DOI 10.1016/j.bbrc.2008.09.050; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; van Rooij E, 2009, DEV CELL, V17, P662, DOI 10.1016/j.devcel.2009.10.013; Waters SM, 2009, J ANIM SCI, V87, P244, DOI 10.2527/jas.2008-1005; Wijesekara N, 2005, MOL CELL BIOL, V25, P1135, DOI 10.1128/MCB.25.3.1135-1145.2005; Yamada T, 2012, MEAT SCI, V90, P807, DOI 10.1016/j.meatsci.2011.11.019; ZEMBAYASHI M, 1995, MEAT SCI, V40, P211, DOI 10.1016/0309-1740(94)00046-A; Zheng Y, 2014, CELL STRESS CHAPERON, V19, P973, DOI 10.1007/s12192-014-0521-8	53	15	16	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162496	10.1371/journal.pone.0162496	http://dx.doi.org/10.1371/journal.pone.0162496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611783	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900115
J	Qiu, K; Qin, CF; Luo, M; Zhang, X; Sun, WJ; Jiao, N; Li, DF; Yin, JD				Qiu, Kai; Qin, Chun Fu.; Luo, Min; Zhang, Xin; Sun, Wen Juan; Jiao, Ning; Li, De Fa; Yin, Jing Dong			Protein Restriction with Amino Acid-Balanced Diets Shrinks Circulating Pool Size of Amino Acid by Decreasing Expression of Specific Transporters in the Small Intestine	PLOS ONE			English	Article							PEPTIDE TRANSPORTERS; CARCASS COMPOSITION; NITROGEN-EXCRETION; MESSENGER-RNA; PIGS; PERFORMANCE; METABOLISM; GROWTH; SUPPLEMENTATION; ARGININE	Dietary protein restriction is not only beneficial to health and longevity in humans, but also protects against air pollution and minimizes feeding cost in livestock production. However, its impact on amino acid (AA) absorption and metabolism is not quite understood. Therefore, the study aimed to explore the effect of protein restriction on nitrogen balance, circulating AA pool size, and AA absorption using a pig model. In Exp. 1, 72 gilts weighting 29.9 +/- 1.5 kg were allocated to 1 of the 3 diets containing 14, 16, or 18% CP for a 28-d trial. Growth (n = 24), nitrogen balance (n = 6), and the expression of small intestinal AA and peptide transporters (n = 6) were evaluated. In Exp. 2, 12 barrows weighting 22.7 +/- 1.3 kg were surgically fitted with catheters in the portal and jejunal veins as well as the carotid artery and assigned to a diet containing 14 or 18% CP. A series of blood samples were collected before and after feeding for determining the pool size of circulating AA and AA absorption in the portal vein, respectively. Protein restriction did not sacrifice body weight gain and protein retention, since nitrogen digestibility was increased as dietary protein content reduced. However, the pool size of circulating AA except for lysine and threonine, and most AA flux through the portal vein were reduced in pigs fed the low protein diet. Meanwhile, the expression of peptide transporter 1 (PepT-1) was stimulated, but the expression of the neutral and cationic AA transporter systems was depressed. These results evidenced that protein restriction with essential AA-balanced diets, decreased AA absorption and reduced circulating AA pool size. Increased expression of small intestinal peptide transporter PepT-1 could not compensate for the depressed expression of jejunal AA transporters for AA absorption.	[Qiu, Kai; Qin, Chun Fu.; Zhang, Xin; Sun, Wen Juan; Jiao, Ning; Li, De Fa; Yin, Jing Dong] China Agr Univ, State Key Lab Anim Nutr, Beijing 100193, Peoples R China; [Qiu, Kai; Qin, Chun Fu.; Zhang, Xin; Sun, Wen Juan; Jiao, Ning; Li, De Fa; Yin, Jing Dong] China Agr Univ, Minist Agr, Feed Ind Ctr, Coll Anim Sci & Technol, Beijing 100193, Peoples R China; [Luo, Min] Chongqing Acad Anim Sci, Chongqing 450023, Peoples R China	China Agricultural University; China Agricultural University; Ministry of Agriculture & Rural Affairs	Yin, JD (corresponding author), China Agr Univ, State Key Lab Anim Nutr, Beijing 100193, Peoples R China.; Yin, JD (corresponding author), China Agr Univ, Minist Agr, Feed Ind Ctr, Coll Anim Sci & Technol, Beijing 100193, Peoples R China.	yinjd@cau.edu.cn		Yin, Jingdong/0000-0003-4623-0568; Qiu, Kai/0000-0002-6575-5346	National Key Basic Research Program of China [2013CB127302, 2012CB124703]; National Natural Science Foundation of China [31272452]	National Key Basic Research Program of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by National Key Basic Research Program of China (2013CB127302) received by JY; National Key Basic Research Program of China (2012CB124703) received by DL; and National Natural Science Foundation of China (31272452) received by JY. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AOAC, 2003, OFFICIAL METHODS ANA, V17th; Bauchart-Thevret C, 2011, J ANIM SCI, V89, P4093, DOI 10.2527/jas.2011-3944; Bergen WG, 2009, J NUTR, V139, P821, DOI 10.3945/jn.109.104497; BOYD CAR, 1981, BIOSCIENCE REP, V1, P851, DOI 10.1007/BF01114818; Broer S, 2008, PHYSIOL REV, V88, P249, DOI 10.1152/physrev.00018.2006; Bunger L, 2015, ANIM PROD SCI, V55, P461, DOI 10.1071/AN13051; Burrin D. G., 2001, P75, DOI 10.1079/9780851995175.0075; Canh TT, 1998, LIVEST PROD SCI, V56, P181, DOI 10.1016/S0301-6226(98)00156-0; Chen LX, 2009, AMINO ACIDS, V37, P143, DOI 10.1007/s00726-009-0268-1; Daniel H, 2004, ANNU REV PHYSIOL, V66, P361, DOI 10.1146/annurev.physiol.66.032102.144149; Deng D, 2009, J NUTR BIOCHEM, V20, P544, DOI 10.1016/j.jnutbio.2008.05.014; Gallinetti J, 2013, BIOCHEM J, V449, P1, DOI 10.1042/BJ20121098; Garcia-Launay F, 2014, LIVEST SCI, V161, P158, DOI 10.1016/j.livsci.2013.11.027; Garcia-Villalobos H, 2012, ARCH ANIM NUTR, V66, P257, DOI 10.1080/1745039X.2012.697351; GATEL F, 1992, LIVEST PROD SCI, V31, P109, DOI 10.1016/0301-6226(92)90059-D; Gloaguen M, 2014, J ANIM SCI, V92, P637, DOI 10.2527/jas.2013-6514; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Harputlugil E, 2014, CELL REP, V8, P1160, DOI 10.1016/j.celrep.2014.07.018; HARVEY RB, 1962, ANN NY ACAD SCI, V102, P46, DOI 10.1111/j.1749-6632.1962.tb13624.x; Hatzoglou M, 2004, ANNU REV NUTR, V24, P377, DOI 10.1146/annurev.nutr.23.011702.073120; Hietakangas V, 2009, ANNU REV GENET, V43, P389, DOI 10.1146/annurev-genet-102108-134815; Ihara T, 2000, DIGESTION, V61, P59, DOI 10.1159/000007736; Kanai Y, 2013, MOL ASPECTS MED, V34, P108, DOI 10.1016/j.mam.2013.01.001; Kim SG, 2013, MOL CELLS, V35, P463, DOI 10.1007/s10059-013-0138-2; LeBoucher J, 1997, CLIN CHEM, V43, P1421; Lebret B, 2008, ANIMAL, V2, P1548, DOI 10.1017/S1751731108002796; Leibach FH, 1996, ANNU REV NUTR, V16, P99, DOI 10.1146/annurev.nu.16.070196.000531; Li FN, 2011, AMINO ACIDS, V41, P1185, DOI 10.1007/s00726-011-0983-2; Li W, 2015, J ZHEJIANG UNIV-SC B, V16, P496, DOI [10.1631/jzus.B1400259, DOI 10.1631/JZUS.B1400259]; Liu LY, 2014, J ANIM PHYSIOL AN N, V98, P310, DOI 10.1111/jpn.12081; Liu XD, 2012, AMINO ACIDS, V42, P2111, DOI 10.1007/s00726-011-0948-5; Madara J.L., 1991, COMPR PHYSIOL, P83, DOI [10.1002/cphy.cp060403, DOI 10.1002/CPHY.CP060403]; Majumder M, 2009, MOL CELL BIOL, V29, P2899, DOI 10.1128/MCB.01774-08; Morales A, 2015, J ANIM SCI, V93, P2154, DOI 10.2527/jas.2014-8834; MOUGHAN PJ, 1994, EAAP PUBLIC, P389; National Research Council (NRC), 2012, NUTR REQ SWIN, V11, DOI [10.17226/13298, DOI 10.17226/13298]; Qin CF, 2015, J ANIM SCI BIOTECHNO, V6, DOI 10.1186/s40104-015-0052-x; RERAT A, 1992, BRIT J NUTR, V68, P111, DOI 10.1079/BJN19920071; Sanayama Y, 2014, SCI REP-UK, V4, DOI 10.1038/srep06941; Schaart MW, 2005, J NUTR, V135, P765, DOI 10.1093/jn/135.4.765; Schiavon S, 2012, ANIM FEED SCI TECH, V174, P96, DOI 10.1016/j.anifeedsci.2012.02.011; SILK DBA, 1985, P NUTR SOC, V44, P63, DOI 10.1079/PNS19850011; Sirtori F, 2014, ANIMAL, V8, P1987, DOI 10.1017/S1751731114002006; Stoll B, 1998, J NUTR, V128, P606, DOI 10.1093/jn/128.3.606; Tan B, 2012, AMINO ACIDS, V43, P2481, DOI 10.1007/s00726-012-1328-5; Taylor PM, 2014, AM J CLIN NUTR, V99, p223S, DOI 10.3945/ajcn.113.070086; Troncone C, 2015, FARMECONOMIA, V16, P45, DOI 10.7175/fe.v16i2.1176; Wang WW, 2009, AMINO ACIDS, V37, P105, DOI 10.1007/s00726-008-0152-4; Whang KY, 2003, J ANIM SCI, V81, P705; Wood JD, 2013, MEAT SCI, V95, P123, DOI 10.1016/j.meatsci.2013.03.001; Wu GY, 2009, AMINO ACIDS, V37, P1, DOI 10.1007/s00726-009-0269-0; Wu GY, 2010, DYNAMICS IN ANIMAL NUTRITION, P69; Wu GY, 1996, AM J PHYSIOL-GASTR L, V271, pG913, DOI 10.1152/ajpgi.1996.271.5.G913; WU GY, 1995, AM J PHYSIOL-REG I, V268, pR334; Wu GY, 1997, AM J PHYSIOL-GASTR L, V272, pG1382, DOI 10.1152/ajpgi.1997.272.6.G1382; Wu GY, 1998, J NUTR, V128, P1249, DOI 10.1093/jn/128.8.1249; Ye JB, 2015, GENE DEV, V29, P2331, DOI 10.1101/gad.269324.115; Yen JT, 2004, J ANIM SCI, V82, P1079; YEN JT, 1987, J ANIM SCI, V64, P923, DOI 10.2527/jas1987.643923x; Yin J, 2014, AMINO ACIDS, V46, P883, DOI 10.1007/s00726-013-1643-5; Yin YL, 2010, AMINO ACIDS, V39, P1581, DOI 10.1007/s00726-010-0577-4; Yin YL, 2010, AMINO ACIDS, V39, P1477, DOI 10.1007/s00726-010-0612-5; Yue LY, 2008, LIVEST SCI, V115, P144, DOI 10.1016/j.livsci.2007.06.018; Zhang SH, 2013, AMINO ACIDS, V45, P1191, DOI 10.1007/s00726-013-1577-y	64	22	24	4	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162475	10.1371/journal.pone.0162475	http://dx.doi.org/10.1371/journal.pone.0162475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611307	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900110
J	Zelenay, V; Arzt, ME; Bibow, S; Schwab, ME; Riek, R				Zelenay, Viviane; Arzt, Michael E.; Bibow, Stefan; Schwab, Martin E.; Riek, Roland			The Neurite Outgrowth Inhibitory Nogo-A-Delta 20 Region Is an Intrinsically Disordered Segment Harbouring Three Stretches with Helical Propensity	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; ISOTOPICALLY ENRICHED PROTEINS; RECEPTOR FAMILY-MEMBER; NOGO-A; NMR-SPECTROSCOPY; UNSTRUCTURED PROTEINS; SYNAPTIC PLASTICITY; AXONAL REGENERATION; BACKBONE DYNAMICS; SIGNALING COMPLEX	Functional recovery from central neurotrauma, such as spinal cord injury, is limited by myelin-associated inhibitory proteins. The most prominent example, Nogo-A, imposes an inhibitory cue for nerve fibre growth via two independent domains: Nogo-A-Delta 20 (residues 544725 of the rat Nogo-A sequence) and Nogo-66 (residues 1026-1091). Inhibitory signalling from these domains causes a collapse of the neuronal growth cone via individual receptor complexes, centred around sphingosine 1-phosphate receptor 2 (S1PR2) for Nogo-A-Delta 20 and Nogo receptor 1 (NgR1) for Nogo-66. Whereas the helical conformation of Nogo-66 has been studied extensively, only little structural information is available for the Nogo-A-Delta 20 region. We used nuclear magnetic resonance (NMR) spectroscopy to assess potential residual structural propensities of the intrinsically disordered Nogo-A-Delta 20. Using triple resonance experiments, we were able to assign 94% of the non-proline backbone residues. While secondary structure analysis and relaxation measurements highlighted the intrinsically disordered character of Nogo-A-Delta 20, three stretches comprising residues (561)EAI-QESL(567), (639)EAMNVALKALGT(650), and (693)SNYSEIAK(700) formtransient a-helical structures. Interestingly, (561)EAIQESL(567) is situated directly adjacent to one of the most conserved regions of Nogo-A-Delta 20 that contains a binding motif for beta 1-integrin. Likewise, 639EAMNVALKALGT650 partially overlaps with the epitope recognized by 11C7, a Nogo-A-neutralizing antibody that promotes functional recovery from spinal cord injury. Diffusion measurements by pulse-field gradient NMR spectroscopy suggest concentration-and oxidation state-dependent dimerisation of Nogo-A-Delta 20. Surprisingly, NMR and isothermal titration calorimetry (ITC) data could not validate previously shown binding of extracellular loops of S1PR2 to Nogo-A-Delta 20.	[Zelenay, Viviane; Bibow, Stefan; Riek, Roland] Swiss Fed Inst Technol, Dept Phys Chem, Zurich, Switzerland; [Arzt, Michael E.; Schwab, Martin E.] Univ Zurich, Brain Res Inst, Zurich, Switzerland; [Arzt, Michael E.] Swiss Fed Inst Technol, Dept Biol, Zurich, Switzerland; [Schwab, Martin E.] Swiss Fed Inst Technol, Dept Hlth Sci & Technol, Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich; Swiss Federal Institutes of Technology Domain; ETH Zurich	Riek, R (corresponding author), Swiss Fed Inst Technol, Dept Phys Chem, Zurich, Switzerland.	roland.riek@phys.chem.ethz.ch			Swiss National Science Foundation grant [31003A_149315]; ERC advanced grant 'Nogorise' [294115]	Swiss National Science Foundation grant(Swiss National Science Foundation (SNSF)); ERC advanced grant 'Nogorise'	This work was supported by the Swiss National Science Foundation grant 31003A_149315 and the ERC advanced grant 294115 'Nogorise' to MES. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berlow RB, 2015, FEBS LETT, V589, P2433, DOI 10.1016/j.febslet.2015.06.003; Chen MS, 2000, NATURE, V403, P434, DOI 10.1038/35000219; Chou JJ, 2004, J BIOMOL NMR, V29, P299, DOI 10.1023/B:JNMR.0000032560.43738.6a; CLORE GM, 1990, BIOCHEMISTRY-US, V29, P7387, DOI 10.1021/bi00484a006; DAVID S, 1981, SCIENCE, V214, P931, DOI 10.1126/science.6171034; Dodd DA, 2005, J BIOL CHEM, V280, P12494, DOI 10.1074/jbc.M411827200; Dunker AK, 2015, SEMIN CELL DEV BIOL, V37, P44, DOI 10.1016/j.semcdb.2014.09.025; Eliezer D, 1998, NAT STRUCT BIOL, V5, P148; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; Fournier AE, 2001, NATURE, V409, P341, DOI 10.1038/35053072; Freund P, 2006, NAT MED, V12, P790, DOI 10.1038/nm1436; Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017; Gal M, 2011, J BIOMOL NMR, V51, P497, DOI 10.1007/s10858-011-9580-7; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; GRZESIEK S, 1992, J MAGN RESON, V99, P201, DOI 10.1016/0022-2364(92)90169-8; Hu FH, 2008, J NEUROSCI, V28, P1262, DOI 10.1523/JNEUROSCI.1068-07.2008; Jerabek-Willemsen M, 2011, ASSAY DRUG DEV TECHN, V9, P342, DOI 10.1089/adt.2011.0380; Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091; Kamentsky L, 2011, BIOINFORMATICS, V27, P1179, DOI 10.1093/bioinformatics/btr095; KAY LE, 1990, J MAGN RESON, V89, P496, DOI 10.1016/0022-2364(90)90333-5; Kempf A, 2014, PLOS BIOL, V12, DOI 10.1371/journal.pbio.1001763; Kempf A, 2013, PHYSIOLOGY, V28, P151, DOI 10.1152/physiol.00052.2012; Kjaergaard M, 2011, J BIOMOL NMR, V50, P157, DOI 10.1007/s10858-011-9508-2; Lam SL, 2003, BIOPOLYMERS, V69, P270, DOI 10.1002/bip.10354; Li MF, 2004, EUR J BIOCHEM, V271, P3512, DOI 10.1111/j.0014-2956.2004.04286.x; Li MF, 2007, PROTEINS, V68, P100, DOI 10.1002/prot.21385; Liebscher T, 2005, ANN NEUROL, V58, P706, DOI 10.1002/ana.20627; Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306; Mi S, 2004, NAT NEUROSCI, V7, P221, DOI 10.1038/nn1188; MILLS R, 1973, J PHYS CHEM-US, V77, P685, DOI 10.1021/j100624a025; Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009; Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034; Novacek J, 2014, J MAGN RESON, V241, P41, DOI 10.1016/j.jmr.2013.12.008; Oertle T, 2003, J NEUROSCI, V23, P5393; Oldfield CJ, 2014, ANNU REV BIOCHEM, V83, P553, DOI 10.1146/annurev-biochem-072711-164947; Panchal SC, 2001, J BIOMOL NMR, V20, P135, DOI 10.1023/A:1011239023422; Park JB, 2005, NEURON, V45, P345, DOI 10.1016/j.neuron.2004.12.040; Permi P, 2000, J BIOMOL NMR, V16, P29, DOI 10.1023/A:1008343926502; Plaxco KW, 1997, J BIOMOL NMR, V10, P221, DOI 10.1023/A:1018340217891; Prinjha R, 2000, NATURE, V403, P383, DOI 10.1038/35000287; Qin HN, 2008, BIOCHEMISTRY-US, V47, P13647, DOI 10.1021/bi8017976; Rezaei-Ghaleh N, 2012, CHEMBIOCHEM, V13, P930, DOI 10.1002/cbic.201200093; Schmandke A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078212; Schwab ME, 2014, CURR OPIN NEUROBIOL, V27, P53, DOI 10.1016/j.conb.2014.02.011; Schwab ME, 2010, NAT REV NEUROSCI, V11, P799, DOI 10.1038/nrn2936; SCHWAB ME, 1988, J NEUROSCI, V8, P2381; SCHWAB ME, 1985, J NEUROSCI, V5, P2415; Shao ZH, 2005, NEURON, V45, P353, DOI 10.1016/j.neuron.2004.12.050; Shypitsyna A, 2011, MOL BIOL EVOL, V28, P1363, DOI 10.1093/molbev/msq313; Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105; Sumiyoshi K, 2010, NEUROPATHOLOGY, V30, P7, DOI 10.1111/j.1440-1789.2009.01035.x; Tews B, 2013, P NATL ACAD SCI USA, V110, P6583, DOI 10.1073/pnas.1217665110; Thiede-Stan NK, 2015, J CELL SCI, V128, P3583, DOI 10.1242/jcs.167981; Tompa P, 2005, TRENDS BIOCHEM SCI, V30, P484, DOI 10.1016/j.tibs.2005.07.008; Tompa P, 2003, J MOL STRUC-THEOCHEM, V666, P361, DOI 10.1016/j.theochem.2003.08.047; Tompa P, 2005, FEBS LETT, V579, P3346, DOI 10.1016/j.febslet.2005.03.072; Tsai CJ, 2001, PROTEINS, V44, P418, DOI 10.1002/prot.1107; Uversky VN, 2013, CURR PHARM DESIGN, V19, P4191, DOI 10.2174/1381612811319230005; Vasudevan SV, 2010, P NATL ACAD SCI USA, V107, P6847, DOI 10.1073/pnas.0911817107; Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047; Vranken WF, 2005, PROTEINS, V59, P687, DOI 10.1002/prot.20449; Wang KC, 2002, NATURE, V420, P74, DOI 10.1038/nature01176; Williamson MP, 2013, PROG NUCL MAG RES SP, V73, P1, DOI 10.1016/j.pnmrs.2013.02.001; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Zander H, 2007, FEBS J, V274, P2603, DOI 10.1111/j.1742-4658.2007.05796.x; Zar J. H., 1999, BIOSTATISTICAL ANALY; Zhang WH, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002353; Zheng G, 2008, J MAGN RESON, V191, P159, DOI 10.1016/j.jmr.2007.12.001	68	2	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0161813	10.1371/journal.pone.0161813	http://dx.doi.org/10.1371/journal.pone.0161813			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611089	Green Published, Green Submitted, Green Accepted, gold			2022-12-26	WOS:000383255900030
J	Broggini, T; Piffko, A; Hoffmann, CJ; Harms, C; Vajkoczy, P; Czabanka, M				Broggini, Thomas; Piffko, Andras; Hoffmann, Christian J.; Harms, Christoph; Vajkoczy, Peter; Czabanka, Marcus			Passive Entrapment of Tumor Cells Determines Metastatic Dissemination to Spinal Bone and Other Osseous Tissues	PLOS ONE			English	Article							IN-VITRO; COLONIZATION; MIGRATION; ORGAN; GROWTH; BRAIN; MICE	During the metastatic process tumor cells circulate in the blood stream and are carried to various organs. In order to spread to different organs tumor cell-endothelial cell interactions are crucial for extravasation mechanisms. It remains unclear if tumor cell dissemination to the spinal bone occurs by passive entrapment of circulating tumor cells or by active cellular mechanisms mediated by cell surface molecules or secreted factors. We investigated the seeding of three different tumor cell lines (melanoma, lung and prostate carcinoma) to the microvasculature of different organs. Their dissemination was compared to biologically passive microbeads. The spine and other organs were resected three hours after intraarterial injection of tumor cells or microbeads. Ex vivo homogenization and fluorescence analysis allowed quantification of tumor cells or microbeads in different organs. Interestingly, tumor cell distribution to the spinal bone was comparable to dissemination of microbeads independent of the tumor cell type (melanoma: 5.646% +/- 7.614%, lung: 6.007% +/- 1.785%, prostate: 3.469% +/- 0.602%, 7 mu m beads: 9.884% +/- 7.379%, 16 mu m beads: 7.23% +/- 1.488%). Tumor cell seeding differed significantly between tumor cells and microbeads in all soft tissue organs. Moreover, there were significant differences between the different tumor cell lines in their dissemination behaviour to soft tissue organs only. These findings demonstrate that metastatic dissemination of tumor cells to spinal bone and other osseous organs is mediated by passive entrapment of tumor cells similar to passive plugging of microvasculature observed after intraarterial microbeads injection.	[Broggini, Thomas; Piffko, Andras; Vajkoczy, Peter; Czabanka, Marcus] Charite, Dept Neurosurg, Berlin, Germany; [Hoffmann, Christian J.; Harms, Christoph] Charite, Dept Expt Neurol, Berlin, Germany; [Broggini, Thomas] Univ Calif San Diego, Dept Phys, 9500 Gilman Dr, La Jolla, CA 92093 USA	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of California System; University of California San Diego	Vajkoczy, P; Czabanka, M (corresponding author), Charite, Dept Neurosurg, Berlin, Germany.	peter.vajkoczy@charite.de; marcus.czabanka@charite.de	Harms, Christoph/HIK-2989-2022; Harms, Christoph/AAD-7895-2021	Harms, Christoph/0000-0002-2063-2860; Hoffmann, Christian Johannes/0000-0003-0861-2418; Vajkoczy, Peter/0000-0003-4350-392X; Piffko, Andras/0000-0001-5300-6594	German research foundation (DFG GEPRIS) [267716524]; Swiss National Science Foundation; 'Berliner Krebsgesellschaft e.V.' as a doctoral student of the Medical Neuroscience Charite PhD Program; Volkswagen Foundation; Charite Foundation	German research foundation (DFG GEPRIS)(German Research Foundation (DFG)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); 'Berliner Krebsgesellschaft e.V.' as a doctoral student of the Medical Neuroscience Charite PhD Program; Volkswagen Foundation(Volkswagen); Charite Foundation	This work was supported by the German research foundation (DFG GEPRIS: 267716524) T.B. received the Early Postdoc.Mobility fellowship from the Swiss National Science Foundation and the Ernst von Leyden fellowship from the 'Berliner Krebsgesellschaft e.V.' as a doctoral student of the Medical Neuroscience Charite PhD Program. M.C. was part of the Friedrich C. Luft Clinical Scientist Pilot Program funded by the Volkswagen Foundation and the Charite Foundation. The funding sources had no involvement in study design; in the collection, analysis and interpretation of data; in the writing of the report; and in the decision to submit the article for publication.	[Anonymous], 2000, ECONOMETRIC FDN PACK; Aoudjit F, 1998, J IMMUNOL, V161, P2333; ARGUELLO F, 1988, CANCER RES, V48, P6876; BADENOCHJONES P, 1984, INVAS METAST, V4, P98; Broggini T, 2015, EUR SPINE J, V24, P2173, DOI 10.1007/s00586-015-3811-7; Campbell J. P., 2012, JOVE-J VIS EXP, V67, pe4260, DOI DOI 10.3791/4260; FARHOOD A, 1995, J LEUKOCYTE BIOL, V57, P368, DOI 10.1002/jlb.57.3.368; FIDLER IJ, 1977, SCIENCE, V197, P893, DOI 10.1126/science.887927; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; FOGELQUIST S, 1991, INVAS METAST, V11, P261; Heroult M, 2010, MOL CANCER RES, V8, P1297, DOI 10.1158/1541-7786.MCR-09-0453; Hoshino A, 2015, NATURE, V527, P329, DOI 10.1038/nature15756; Jeevan DS, 2016, ANTICANCER RES, V36, P523; Lamprecht MR, 2007, BIOTECHNIQUES, V42, P71, DOI 10.2144/000112257; Langley RR, 2011, INT J CANCER, V128, P2527, DOI 10.1002/ijc.26031; LAPIS K, 1988, CLIN EXP METASTAS, V6, P73, DOI 10.1007/BF01580408; Li Shuling, 2012, Clin Epidemiol, V4, P87, DOI 10.2147/CLEP.S28339; Liang CC, 2007, NAT PROTOC, V2, P329, DOI 10.1038/nprot.2007.30; Mina LA, 2011, NAT REV CLIN ONCOL, V8, P325, DOI 10.1038/nrclinonc.2011.59; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; SanchezSweatman OH, 1997, EUR J CANCER, V33, P918, DOI 10.1016/S0959-8049(97)00513-3; SARIN SK, 1990, AM J PHYSIOL, V258, pG365, DOI 10.1152/ajpgi.1990.258.3.G365; SCHACKERT G, 1988, CANCER RES, V48, P3478; Seiler AEM, 2011, NAT PROTOC, V6, P961, DOI 10.1038/nprot.2011.348; Sturge J, 2011, NAT REV CLIN ONCOL, V8, P357, DOI 10.1038/nrclinonc.2011.67; Tavassoli M, 1981, Prog Clin Biol Res, V59B, P249; VALLE EF, 1992, CLIN EXP METASTAS, V10, P419, DOI 10.1007/BF00133471; Wibmer C, 2011, SPINE, V36, P1977, DOI 10.1097/BRS.0b013e3182011f84; YOUNG MR, 1985, CANCER RES, V45, P3918	29	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162540	10.1371/journal.pone.0162540	http://dx.doi.org/10.1371/journal.pone.0162540			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603673	Green Published, Green Submitted, gold			2022-12-26	WOS:000383255200074
J	Kuriakose, M; Skotak, M; Misistia, A; Kahali, S; Sundaramurthy, A; Chandra, N				Kuriakose, Matthew; Skotak, Maciej; Misistia, Anthony; Kahali, Sudeepto; Sundaramurthy, Aravind; Chandra, Namas			Tailoring the Blast Exposure Conditions in the Shock Tube for Generating Pure, Primary Shock Waves: The End Plate Facilitates Elimination of Secondary Loading of the Specimen	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; INDUCED NEUROTRAUMA; NERVOUS-SYSTEM; PRESSURE; IMPACT; MODEL; RAT	The end plate mounted at the mouth of the shock tube is a versatile and effective implement to control and mitigate the end effects. We have performed a series of measurements of incident shock wave velocities and overpressures followed by quantification of impulse values (integral of pressure in time domain) for four different end plate configurations (0.625, 2, 4 inches, and an open end). Shock wave characteristics were monitored by high response rate pressure sensors allocated in six positions along the length of 6 meters long 229 mm square cross section shock tube. Tests were performed at three shock wave intensities, which was controlled by varying the Mylar membrane thickness (0.02, 0.04 and 0.06 inch). The end reflector plate installed at the exit of the shock tube allows precise control over the intensity of reflected waves penetrating into the shock tube. At the optimized distance of the tube to end plate gap the secondary waves were entirely eliminated from the test section, which was confirmed by pressure sensor at T4 location. This is pronounced finding for implementation of pure primary blast wave animal model. These data also suggest only deep in the shock tube experimental conditions allow exposure to a single shock wave free of artifacts. Our results provide detailed insight into spatiotemporal dynamics of shock waves with Friedlander waveform generated using helium as a driver gas and propagating in the air inside medium sized tube. Diffusion of driver gas (helium) inside the shock tube was responsible for velocity increase of reflected shock waves. Numerical simulations combined with experimental data suggest the shock wave attenuation mechanism is simply the expansion of the internal pressure. In the absence of any other postulated shock wave decay mechanisms, which were not implemented in the model the agreement between theory and experimental data is excellent.	[Kuriakose, Matthew; Skotak, Maciej; Misistia, Anthony; Kahali, Sudeepto; Sundaramurthy, Aravind; Chandra, Namas] New Jersey Inst Technol, Ctr Injury Biomech Mat & Med CIBM3, Dept Biomed Engn, Newark, NJ 07102 USA	New Jersey Institute of Technology	Chandra, N (corresponding author), New Jersey Inst Technol, Ctr Injury Biomech Mat & Med CIBM3, Dept Biomed Engn, Newark, NJ 07102 USA.	namas.chandra@njit.edu	Skotak, Maciej/H-4769-2019; Sundaramurthy, Aravind/O-2047-2019; Kahali, Sudeepto/G-9413-2018	Skotak, Maciej/0000-0003-2584-7294; Kahali, Sudeepto/0000-0001-8675-7466; Sundaramurthy, Aravind/0000-0002-0359-8680	U.S. Army Medical Research and Materiel Command [14059001]	U.S. Army Medical Research and Materiel Command(United States Department of DefenseUnited States ArmyU.S. Army Medical Research & Materiel Command (USAMRMC))	This work was supported by grant no. 14059001 entitled "Primary Blast Injury Criteria for Animal/Human TBI Models using Field Validated Shock Tubes" received from the U.S. Army Medical Research and Materiel Command.	BECKER H, 1965, J APPL POLYM SCI, V9, P911, DOI 10.1002/app.1965.070090309; Bell RS, 2009, J TRAUMA, V66, pS104, DOI 10.1097/TA.0b013e31819d88c8; Bolander R, 2011, ANN BIOMED ENG, V39, P2550, DOI 10.1007/s10439-011-0343-0; Burnside R, 1965, J AUSTRALIAN MATH SO, V5, P258; Cernak I, 2000, J NEUROTRAUM, V17, P53, DOI 10.1089/neu.2000.17.53; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak I., 2015, FRONTIERS NEUROENGIN; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Chavko M, 2011, J NEUROSCI METH, V195, P61, DOI 10.1016/j.jneumeth.2010.11.019; Cullis I G, 2001, J R Army Med Corps, V147, P16; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; DRYER M, 1967, J GEOPHYS RES, V72, P2955, DOI 10.1029/JZ072i011p02955; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; EMRICH RJ, 1953, J APPL PHYS, V24, P360, DOI 10.1063/1.1721279; GLASS II, 1955, J AERONAUT SCI, V22, P73, DOI 10.2514/8.3282; Gould KE, 1981, DTIC DOCUMENT; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; HOOKER WJ, 1963, J CHEM PHYS, V38, P214, DOI 10.1063/1.1733464; Hyde D., 2004, CONWEP 2 1 0 8; KIEFER JH, 1985, J PHYS CHEM-US, V89, P2013, DOI 10.1021/j100256a043; Knudsen SK, 2003, NEUROSCI RES, V46, P377, DOI 10.1016/S0168-0102(03)00101-9; MIURA H, 1990, FLUID DYN RES, V6, P251, DOI 10.1016/0169-5983(90)90015-Q; Moore DF, 2008, FUTUR NEUROL, V3, P243, DOI 10.2217/14796708.3.3.243; Needham C. E., 2010, BLAST WAVE PROPAGATI; Needham CE, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00072; Newman AJ, 2010, J FLUID ENG-T ASME, V132, DOI 10.1115/1.4002183; PARK C, 1973, COMBUST FLAME, V20, P369, DOI 10.1016/0010-2180(73)90029-1; Rafaels KA, 2010, BLAST BRAIN INJURY R; Reneer DV, 2011, J NEUROTRAUM, V28, P95, DOI 10.1089/neu.2010.1513; Saljo A, 2009, J NEUROTRAUM, V26, P1345, DOI [10.1089/neu.2008.0856, 10.1089/neu.2008-0856]; Saljo A, 2008, J NEUROTRAUM, V25, P1397, DOI 10.1089/neu.2008.0602; SLEPICKA F, 1966, PHYS FLUIDS, V9, P1865, DOI 10.1063/1.1761946; SOMMERFELD M, 1985, EXP FLUIDS, V3, P197; Stuhmiller J. H., 1991, CONVENTIONAL WARFARE, P241; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Svetlov SI, 2010, J TRAUMA, V69, P795, DOI 10.1097/TA.0b013e3181bbd885; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vieille P., 1899, CR HEBD ACAD SCI, V129, P1228; Yattoo Gh, 2008, J Trauma Manag Outcomes, V2, P5, DOI 10.1186/1752-2897-2-5; Zel'dovlch YB, 1965, PHYS SHOCK WAVES HIG, P1966	44	31	31	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161597	10.1371/journal.pone.0161597	http://dx.doi.org/10.1371/journal.pone.0161597			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603017	gold, Green Submitted, Green Published			2022-12-26	WOS:000383255200019
J	Xu, WS; Luo, PY; Sun, L; Lin, N				Xu, W. S.; Luo, P. Y.; Sun, L.; Lin, N.			A Prediction Model of the Capillary Pressure J-Function	PLOS ONE			English	Article							HYDRAULIC CONDUCTIVITY	The capillary pressure J-function is a dimensionless measure of the capillary pressure of a fluid in a porous medium. The function was derived based on a capillary bundle model. However, the dependence of the J-function on the saturation S-w is not well understood. A prediction model for it is presented based on capillary pressure model, and the J-function prediction model is a power function instead of an exponential or polynomial function. Relative permeability is calculated with the J-function prediction model, resulting in an easier calculation and results that are more representative.	[Xu, W. S.; Luo, P. Y.; Sun, L.] Southwest Petr Univ, State Key Oil & Gas Reservoir Geol & Exploitat, Chengdu 610500, Sichuan, Peoples R China; [Xu, W. S.; Lin, N.] PetroChina, Tarim Oilfield Co, Korla 841000, Xinjiang, Peoples R China	Southwest Petroleum University; China National Petroleum Corporation	Xu, WS (corresponding author), Southwest Petr Univ, State Key Oil & Gas Reservoir Geol & Exploitat, Chengdu 610500, Sichuan, Peoples R China.; Xu, WS (corresponding author), PetroChina, Tarim Oilfield Co, Korla 841000, Xinjiang, Peoples R China.	shujia2012@163.com			Tarim Oilfield Company	Tarim Oilfield Company	The funding organization (Tarim Oilfield Company) did not play a role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript and only provided financial support in the form of authors' salaries. I have reviewed the statements relating to the author contributions. The funder provided support in the form of salaries for authors [Employee ID No. 00699778], but did not have any additional role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript. The specific roles of these authors are articulated in the 'author contributions' section.	Bakke S, 1997, SPE J, V2, P136, DOI 10.2118/35479-PA; Bartley JT, 1999, TRANSPORT POROUS MED, V36, P161, DOI 10.1023/A:1006575231732; Brooks R. H., 1964, HYDROLOGY PAPERS COL, P72; Brown H. W., 1951, PETROL T AIME, V192, P67; BURDINE NT, 1953, T AM I MIN MET ENG, V198, P71; Donaldson EC, 1991, J PETROL SCI ENG, V6, P249, DOI 10.1016/0920-4105(91)90017-H; Dong MZ, 2005, TRANSPORT POROUS MED, V59, P1, DOI 10.1007/s11242-004-0763-5; Dullien FLA, 1992, POROUS MEDIA FLUID T; Gao HJ, 2014, INT J HEAT MASS TRAN, V69, P26, DOI 10.1016/j.ijheatmasstransfer.2013.10.006; Gerhard J. I., 2003, WATER RESOUR RES, V39, P1; Guo ZL, 2009, PHYS REV B, V80, DOI 10.1103/PhysRevB.80.195310; He G.S., 2011, PETROPHYSICS; Kevin G. M., 2011, VADOSE ZONE J, V10, P1162; Leverett M. C., 1941, PETROLEUM T AIME, V27, P152; Li KW, 2010, J PETROL SCI ENG, V73, P20, DOI 10.1016/j.petrol.2010.05.002; MCCUEN RH, 1981, WATER RESOUR RES, V17, P1005, DOI 10.1029/WR017i004p01005; MUALEM Y, 1976, WATER RESOUR RES, V12, P513, DOI 10.1029/WR012i003p00513; Oren PE, 1998, SPE J, V3, P324, DOI 10.2118/52052-PA; Oren PE, 2002, TRANSPORT POROUS MED, V46, P311, DOI 10.1023/A:1015031122338; Osisanya S. O., 2014, J CANADIAN PETROLEUM, V40, P30; Purcell W. R., 1949, PETROLEUM T AIME, V2, P39; Rose W., 1949, PETROLEUM T AIME, V5, P127; Thomeer J. H. M., 1960, J PETROL TECHNOL, V3, P73; Tiab D., PETROPHYSICS; Touati M., 2009, 2009 SPE SAUD AR SEC; VANGENUCHTEN MT, 1980, SOIL SCI SOC AM J, V44, P892, DOI 10.2136/sssaj1980.03615995004400050002x; Wo SC, 2001, COLLOID SURFACE A, V187, P449, DOI 10.1016/S0927-7757(01)00613-6; Wu T.-R., 2004, THESIS CORNELL U USA; ZuwaOmoregle S., 1986, SPE J, V3, P146, DOI [10.2118/15384-pa, DOI 10.2118/15384-PA]	29	11	11	2	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0162123	10.1371/journal.pone.0162123	http://dx.doi.org/10.1371/journal.pone.0162123			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603701	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200045
J	Ye, WX; Ren, WB; Kong, LQ; Zhang, WJ; Wang, T				Ye, Wenxing; Ren, Weibo; Kong, Lingqi; Zhang, Wanjun; Wang, Tao			Transcriptomic Profiling Analysis of Arabidopsis thaliana Treated with Exogenous Myo-Inositol	PLOS ONE			English	Article							GLUCOSE 6-PHOSPHATE/PHOSPHATE TRANSLOCATOR; CELL-WALL POLYSACCHARIDE; GENOME-WIDE ANALYSIS; DEFENSE RESPONSES; DROUGHT TOLERANCE; OXYGENASE GENE; HISTONE H2A; RNA-SEQ; INOSITOL; METABOLISM	Myo-insositol (MI) is a crucial substance in the growth and developmental processes in plants. It is commonly added to the culture medium to promote adventitious shoot development. In our previous work, MI was found in influencing Agrobacterium-mediated transformation. In this report, a high-throughput RNA sequencing technique (RNA-Seq) was used to investigate differently expressed genes in one-month-old Arabidopsis seedling grown on MI free or MI supplemented culture medium. The results showed that 21,288 and 21,299 genes were detected with and without MI treatment, respectively. The detected genes included 184 new genes that were not annotated in the Arabidopsis thaliana reference genome. Additionally, 183 differentially expressed genes were identified (DEGs, FDR <= 0.05, log(2) FC >= 1), including 93 up-regulated genes and 90 down-regulated genes. The DEGs were involved in multiple pathways, such as cell wall biosynthesis, biotic and abiotic stress response, chromosome modification, and substrate transportation. Some significantly differently expressed genes provided us with valuable information for exploring the functions of exogenous MI. RNA-Seq results showed that exogenous MI could alter gene expression and signaling transduction in plant cells. These results provided a systematic understanding of the functions of exogenous MI in detail and provided a foundation for future studies.	[Ye, Wenxing; Zhang, Wanjun] China Agr Univ, Dept Grassland Sci, Beijing, Peoples R China; [Wang, Tao] China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China; [Ye, Wenxing; Zhang, Wanjun; Wang, Tao] China Agr Univ, Beijing Key Lab Grassland Sci, Beijing, Peoples R China; [Ren, Weibo; Kong, Lingqi] Chinese Acad Agr Sci, Inst Grassland Res, Hohhot, Inner Mongolia, Peoples R China	China Agricultural University; China Agricultural University; China Agricultural University; Chinese Academy of Agricultural Sciences; Institute of Grassland Research, CAAS	Zhang, WJ (corresponding author), China Agr Univ, Dept Grassland Sci, Beijing, Peoples R China.; Wang, T (corresponding author), China Agr Univ, State Key Lab Agrobiotechnol, Beijing, Peoples R China.; Zhang, WJ; Wang, T (corresponding author), China Agr Univ, Beijing Key Lab Grassland Sci, Beijing, Peoples R China.	wjzhang@cau.edu.cn; wangt@cau.edu.cn	Kong, Lingxue/D-8216-2011	Kong, Lingxue/0000-0001-6219-3897	DaBeiNong young scholars funding [1041-2415002]; Co construction project of Beijing Municipal Education commission [25016056]	DaBeiNong young scholars funding; Co construction project of Beijing Municipal Education commission	This research was funded by DaBeiNong young scholars funding (grant no. 1041-2415002) and Co construction project of Beijing Municipal Education commission (grant no. 25016056). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar-Roman AR, 2008, CHROMOSOMA, V117, P1, DOI 10.1007/s00412-007-0126-4; Alford SR, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00069; Ayadi A, 2015, PLANT PHYSIOL, V167, P1511, DOI 10.1104/pp.114.252338; BECK E, 1989, ANNU REV PLANT PHYS, V40, P95, DOI 10.1146/annurev.pp.40.060189.000523; Berridge MJ, 2007, BIOCHEM SOC SYMP, V74, P1, DOI 10.1002/9780470514696.ch1; Bleeker PM, 2011, PLANT MOL BIOL, V77, P323, DOI 10.1007/s11103-011-9813-x; Bluthgen Nils, 2005, Genome Inform, V16, P106; Boss Wendy E., 2006, V39, P181; Casas-Mollano JA, 2006, J EXP BOT, V57, P3301, DOI 10.1093/jxb/erl093; Celeste A, 2002, SCIENCE, V296, P922, DOI 10.1126/science.1069398; Chaouch S, 2010, NEW PHYTOL, V188, P711, DOI 10.1111/j.1469-8137.2010.03453.x; Chatterjee J, 2010, PROTOPLASMA, V245, P165, DOI 10.1007/s00709-010-0170-4; Chen MQ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035904; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Conesa A., 2008, INT J PLANT GENOMICS; Dastidar KG, 2006, PLANT PHYSIOL, V140, P1279, DOI 10.1104/pp.105.075150; de Jong F, 2014, PLANT PHYSIOL, V164, P308, DOI 10.1104/pp.113.230599; Donahue JL, 2010, PLANT CELL, V22, P888, DOI 10.1105/tpc.109.071779; Duan JZ, 2012, PLANT SCI, V196, P143, DOI 10.1016/j.plantsci.2012.08.003; Duroux M, 2004, PLANT J, V40, P660, DOI 10.1111/j.1365-313X.2004.02242.x; Dyson BC, 2014, ANN BOT-LONDON, V113, P643, DOI 10.1093/aob/mct298; Ebbs ML, 2006, PLANT CELL, V18, P1166, DOI 10.1105/tpc.106.041400; Fellenberg C, 2009, PHYTOCHEMISTRY, V70, P1392, DOI 10.1016/j.phytochem.2009.08.010; Fode B, 2008, PLANT CELL, V20, P3122, DOI 10.1105/tpc.108.058974; GAMBORG OL, 1968, EXP CELL RES, V50, P151, DOI 10.1016/0014-4827(68)90403-5; Gan SS, 1997, PLANT PHYSIOL, V113, P313, DOI 10.1104/pp.113.2.313; Gaspar YM, 2004, PLANT PHYSIOL, V135, P2162, DOI 10.1104/pp.104.045542; Gelvin SB, 2010, ANNU REV PHYTOPATHOL, V48, P45, DOI 10.1146/annurev-phyto-080508-081852; Gelvin SB, 2010, CURR OPIN MICROBIOL, V13, P53, DOI 10.1016/j.mib.2009.11.003; Gelvin SB, 2006, METH MOL B, V343, P105; Gillaspy GE, 2011, NEW PHYTOL, V192, P823, DOI 10.1111/j.1469-8137.2011.03939.x; Goujon T, 2003, PLANT J, V33, P677, DOI 10.1046/j.1365-313X.2003.01654.x; Gutierrez L, 2008, PLANT BIOTECHNOL J, V6, P609, DOI 10.1111/j.1467-7652.2008.00346.x; Hosmani PS, 2013, P NATL ACAD SCI USA, V110, P14498, DOI 10.1073/pnas.1308412110; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Kanter U, 2005, PLANTA, V221, P243, DOI 10.1007/s00425-004-1441-0; Kim CY, 2008, NEW PHYTOL, V180, P57, DOI 10.1111/j.1469-8137.2008.02557.x; Klinghammer M, 2007, J EXP BOT, V58, P3609, DOI 10.1093/jxb/erm209; Ko JH, 2006, PLANT J, V47, P343, DOI 10.1111/j.1365-313X.2006.02782.x; Kunz HH, 2010, PLANT BIOLOGY, V12, P115, DOI 10.1111/j.1438-8677.2010.00349.x; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; LOEWUS FA, 1990, PLANT BIOL, V9, P1; LOEWUS FA, 1983, ANNU REV PLANT PHYS, V34, P137, DOI 10.1146/annurev.pp.34.060183.001033; Loewus Frank A., 2006, V39, P21; Lorence A, 2004, PLANT PHYSIOL, V134, P1200, DOI 10.1104/pp.103.033936; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Ma JK, 2011, NEW PHYTOL, V191, P733, DOI 10.1111/j.1469-8137.2011.03735.x; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Meng PH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007364; Monserrate JP, 2010, CURR OPIN CELL BIOL, V22, P365, DOI 10.1016/j.ceb.2010.03.006; Mosblech A, 2008, MOL PLANT, V1, P249, DOI 10.1093/mp/ssm028; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; Mysore KS, 2000, P NATL ACAD SCI USA, V97, P948, DOI 10.1073/pnas.97.2.948; Naumann K, 2005, EMBO J, V24, P1418, DOI 10.1038/sj.emboj.7600604; Nelson DE, 1998, PLANT CELL, V10, P753; Niewiadomski P, 2005, PLANT CELL, V17, P760, DOI 10.1105/tpc.104.029124; Pendaries C, 2005, ADV ENZYME REGUL, V45, P201, DOI 10.1016/j.advenzreg.2005.02.006; Rautengarten C, 2011, PLANT CELL, V23, P1373, DOI 10.1105/tpc.111.083931; Sancenon V, 2003, PLANT MOL BIOL, V51, P577, DOI 10.1023/A:1022345507112; Sanchez-Calderon L, 2005, PLANT CELL PHYSIOL, V46, P174, DOI 10.1093/pcp/pci011; SCHENK RU, 1972, CAN J BOTANY, V50, P199, DOI 10.1139/b72-026; Sengupta S, 2012, J PLANT BIOCHEM BIOT, V21, pS15, DOI 10.1007/s13562-012-0132-3; Sharples SC, 2007, PLANT J, V52, P252, DOI 10.1111/j.1365-313X.2007.03225.x; Shen XY, 2014, PLANT MOL BIOL, V86, P303, DOI 10.1007/s11103-014-0230-9; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tzfira T, 2004, TRENDS GENET, V20, P375, DOI 10.1016/j.tig.2004.06.004; Valluru R, 2011, PLANT SCI, V181, P387, DOI 10.1016/j.plantsci.2011.07.009; Wang H, 1996, PLANT CELL, V8, P375, DOI 10.1105/tpc.8.3.375; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wirsing L, 2011, ANAL BIOCHEM, V408, P220, DOI 10.1016/j.ab.2010.09.029; Wyatt HR, 2003, GENETICS, V164, P47; Xu H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030646; Yadav V, 2014, PLANT CELL, V26, P3569, DOI 10.1105/tpc.114.129049; Zhang WJ, 2013, PLANT MOL BIOL, V81, P273, DOI 10.1007/s11103-012-9997-8; Zhao GR, 2002, BBA-GENE STRUCT EXPR, V1574, P370, DOI 10.1016/S0167-4781(01)00311-6	78	6	6	3	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2016	11	9							e0161949	10.1371/journal.pone.0161949	http://dx.doi.org/10.1371/journal.pone.0161949			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IX	27603208	Green Submitted, Green Published, gold			2022-12-26	WOS:000383255200031
J	Van Acker, N; Rage, M; Vermeirsch, H; Schrijvers, D; Nuydens, R; Byttebier, G; Timmers, M; De Schepper, S; Streffer, J; Andries, L; Plaghki, L; Cras, P; Meert, T				Van Acker, Nathalie; Rage, Michael; Vermeirsch, Hilde; Schrijvers, Dorien; Nuydens, Rony; Byttebier, Geert; Timmers, Maarten; De Schepper, Stefanie; Streffer, Johannes; Andries, Luc; Plaghki, Leon; Cras, Patrick; Meert, Theo			NRP-1 Receptor Expression Mismatch in Skin of Subjects with Experimental and Diabetic Small Fiber Neuropathy	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; TOPICAL CAPSAICIN; VESSEL DEVELOPMENT; ATOPIC-DERMATITIS; SEMAPHORIN 3A; AXON GUIDANCE; NERVE; REGENERATION; NEUROPILIN-1; MECHANISMS	The in vivo cutaneous nerve regeneration model using capsaicin is applied extensively to study the regenerative mechanisms and therapeutic efficacy of disease modifying molecules for small fiber neuropathy (SFN). Since mismatches between functional and morphological nerve fiber recovery are described for this model, we aimed at determining the capability of the capsaicin model to truly mimic the morphological manifestations of SFN in diabetes. As nerve and blood vessel growth and regenerative capacities are defective in diabetes, we focused on studying the key regulator of these processes, the neuropilin-1 (NRP-1)/semaphorin pathway. This led us to the evaluation of NRP-1 receptor expression in epidermis and dermis of subjects presenting experimentally induced small fiber neuropathy, diabetic polyneuropathy and of diabetic subjects without clinical signs of small fiber neuropathy. The NRP-1 receptor was co-stained with CD31 vessel-marker using immunofluorescence and analyzed with Definiens (R) technology. This study indicates that capsaicin application results in significant loss of epidermal NRP-1 receptor expression, whereas diabetic subjects presenting small fiber neuropathy show full epidermal NRP-1 expression in contrast to the basal expression pattern seen in healthy controls. Capsaicin induced a decrease in dermal non-vascular NRP-1 receptor expression which did not appear in diabetic polyneuropathy. We can conclude that the capsaicin model does not mimic diabetic neuropathy related changes for cutaneous NRP-1 receptor expression. In addition, our data suggest that NRP-1 might play an important role in epidermal nerve fiber loss and/or defective regeneration and that NRP-1 receptor could change the epidermal environment to a nerve fiber repellant bed possibly through Sem3A in diabetes.	[Van Acker, Nathalie; Cras, Patrick] Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium; [Van Acker, Nathalie; Vermeirsch, Hilde; Schrijvers, Dorien; De Schepper, Stefanie; Andries, Luc] HistoGeneX NV, Antwerp, Belgium; [Rage, Michael; Plaghki, Leon] Catholic Univ Louvain, Inst Neurosci, Brussels, Belgium; [Nuydens, Rony; Byttebier, Geert; Timmers, Maarten; Streffer, Johannes; Meert, Theo] Janssen Pharmaceut NV, Janssen Res & Dev, Beerse, Belgium; [Timmers, Maarten; Streffer, Johannes] Univ Antwerp, Inst Born Bunge, Reference Ctr Biol Markers Dementia BIODEM, Antwerp, Belgium; [Cras, Patrick] Univ Antwerp, Univ Antwerp Hosp, Born Bunge Inst, Dept Neurol, Antwerp, Belgium	University of Antwerp; Universite Catholique Louvain; Johnson & Johnson; Janssen Pharmaceuticals; University of Antwerp; University of Antwerp	Van Acker, N (corresponding author), Univ Antwerp, Fac Med & Hlth Sci, Antwerp, Belgium.; Van Acker, N (corresponding author), HistoGeneX NV, Antwerp, Belgium.	nathalie.vanacker@student.uantwerpen.be		Rolf Streffer, Johannes/0000-0002-9387-5951	Janssen Research and Development, a division of Janssen Pharmaceutica NV; HistoGeneX NV	Janssen Research and Development, a division of Janssen Pharmaceutica NV; HistoGeneX NV	RN, JS, MT and TM are employees of Janssen Pharmaceutica NV. NVA, HV, LA, DS and SDS are employees of HistoGeneX NV. The study was supported by Janssen Research and Development, a division of Janssen Pharmaceutica NV and HistoGeneX NV. The study was designed and conducted by LP and MR in collaboration with TM through MT. NVA coordinated the experiments and digitized the images which were analyzed by HV, LA and SDS. Statistical analysis was supported by LA and GB. PC, RN, DS and JS provided scientific support. HistoGeneX NV participated in study design, data collection and analysis. Both Janssen Research and Development and HistoGeneX NV participated in preparation of the manuscript.	Alik RAAM, 2010, DIABETIC NEUROPATHIE, V33, DOI [10.2337/dc10-1303, DOI 10.2337/DC10-1303]; Anand P, 2011, BRIT J ANAESTH, V107, P490, DOI 10.1093/bja/aer260; Aslam A., 2014, PAIN RES TREAT, V2014, DOI DOI 10.1155/2014/412041; Bagi Z, 2008, TISSUE SPECIFIC REGU, V73, P1405, DOI [10.1124/mol.107.043323, DOI 10.1124/MOL.107.043323]; Botusan IR, 2008, P NATL ACAD SCI USA, V105, P19426, DOI 10.1073/pnas.0805230105; Cao Y, 2010, J BIOL CHEM, V285, P31840, DOI 10.1074/jbc.M110.151696; Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875; Carmeliet P, 2013, CELL MOL LIFE SCI, V70, P1763, DOI 10.1007/s00018-013-1283-7; Carmeliet P, 2009, NAT REV CLIN ONCOL, V6, P315, DOI 10.1038/nrclinonc.2009.64; Cashman CR, 2015, NEUROSCI LETT, V596, P33, DOI 10.1016/j.neulet.2015.01.048; Chanda S, 2008, DRUG METAB DISPOS, V36, P670, DOI 10.1124/dmd.107.019240; Chao CYL, 2009, DIABETES-METAB RES, V25, P604, DOI 10.1002/dmrr.1004; De Almodovar CR, 2009, PHYSIOL REV, V89, P607, DOI 10.1152/physrev.00031.2008; De Smet F, 2009, ARTERIOSCL THROM VAS, V29, P639, DOI 10.1161/ATVBAHA.109.185165; Divisova S, 2012, J PERIPHER NERV SYST, V17, P341, DOI 10.1111/j.1529-8027.2012.00420.x; Dux M, 2003, CAPSAICIN SENSITIVE, P859, DOI [10.1113/jphysiol.2003.050633, DOI 10.1113/JPHYSIOL.2003.050633]; Ebenezer GJ, 2011, BRAIN, V134, P1853, DOI 10.1093/brain/awr086; Gibbons CH, 2010, ANN NEUROL, V68, P888, DOI 10.1002/ana.22126; Goshima Y, 2000, JPN J PHARMACOL, V82, P273, DOI 10.1254/jjp.82.273; Han P, 2007, BIOCHEM PHARMACOL, V73, P1635, DOI 10.1016/j.bcp.2006.12.035; Hartemann A, 2011, DIABETES METAB, V37, P377, DOI 10.1016/j.diabet.2011.06.003; Kaku M, 2015, CURR DIABETES REP, V15, DOI 10.1007/s11892-015-0609-2; Klagsbrun M, 2005, CYTOKINE GROWTH F R, V16, P535, DOI 10.1016/j.cytogfr.2005.05.002; Kou KZ, 2012, ACTA DERM-VENEREOL, V92, P521, DOI 10.2340/00015555-1350; Krishnan STM, 2007, DIABETES CARE, V30, P3058, DOI 10.2337/dc07-1421; Kubanov AA, 2015, B EXP BIOL MED+, V159, P318, DOI 10.1007/s10517-015-2951-4; Kurschat P, 2006, J BIOL CHEM, V281, P2721, DOI 10.1074/jbc.M507860200; Lauria G, 2005, EUR J NEUROL, V12, P747, DOI 10.1111/j.1468-1331.2005.01260.x; Light AR, 2004, J NEUROPHYSIOL, V91, P2401, DOI 10.1152/jn.00090.2004; Mahdy RA, 2010, EYE, V24, P1576, DOI 10.1038/eye.2010.86; Man XY, 2006, MOL MED, V12, P127, DOI 10.2119/2006-00024.Man; Marfella R, 2012, EXP DIABETES RES, DOI 10.1155/2012/892706; Mason L, 2004, BMJ-BRIT MED J, V328, P991, DOI 10.1136/bmj.38042.506748.EE; Masuda T, 2005, NEUROSCI RES, V51, P337, DOI 10.1016/j.neures.2005.01.007; Matthies AM, 2002, AM J PATHOL, V160, P289, DOI 10.1016/S0002-9440(10)64372-6; Mukouyama YS, 2005, DEVELOPMENT, V132, P941, DOI 10.1242/dev.01675; Nabavi Nouri M, 2012, PLOS ONE, V7, DOI [10. 1371/ journal. pone. 0034807, DOI 10.1371/J0URNAL.P0NE.0034807]; Narayanaswamy H, 2012, J CLIN NEUROSCI, V19, P1490, DOI 10.1016/j.jocn.2011.12.026; Neufeld G, 2002, TRENDS CARDIOVAS MED, V12, P13, DOI 10.1016/S1050-1738(01)00140-2; Nolano M, 1999, PAIN, V81, P135, DOI 10.1016/S0304-3959(99)00007-X; Oyenihi AB, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/515042; Pasterkamp RJ, 1998, J NEUROSCI, V18, P9962; Pellet-Many C, 2011, BIOCHEM J, V435, P609, DOI 10.1042/BJ20100580; Polydefkis M, 2006, NEUROLOGY, V66, P259, DOI 10.1212/01.wnl.0000194209.37604.57; Polydefkis M, 2004, BRAIN, V127, P1606, DOI 10.1093/brain/awh175; Polydefkis M, 2007, CONTEMP DIABETES, P293, DOI 10.1007/978-1-59745-311-0_17; Quattrini C, 2008, DIABETES CARE, V31, P140, DOI 10.2337/dc07-1556; Quattrini C, 2007, DIABETES, V56, P2148, DOI 10.2337/db07-0285; Rage M, 2011, J NEUROL, V258, P1852, DOI 10.1007/s00415-011-6031-z; Rage M, 2010, CLIN NEUROPHYSIOL, V121, P1256, DOI 10.1016/j.clinph.2010.02.159; Raimondi C, 2016, PROG RETIN EYE RES, V52, P64, DOI 10.1016/j.preteyeres.2016.02.003; Riese A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050944; Rosenzweig S, 2010, GRAEF ARCH CLIN EXP, V248, P1423, DOI 10.1007/s00417-010-1377-y; Shahrabi-Farahani S, 2014, LAB INVEST, V94, P752, DOI 10.1038/labinvest.2014.66; Shun CT, 2004, BRAIN, V127, P1593, DOI 10.1093/brain/awh180; Tavee J, 2009, CLEV CLIN J MED, V76, P297, DOI 10.3949/ccjm.76a.08070; Tesfaye S, 2004, ADV STUD MED, V4, P1014; Thangarajah H, 2009, P NATL ACAD SCI USA, V106, P13505, DOI 10.1073/pnas.0906670106; Tolofari SK, 2010, EXPRESSION SEMAPHORI, P1; Tominaga M, 2008, BRIT J DERMATOL, V158, P842, DOI 10.1111/j.1365-2133.2007.08410.x; Tominaga M, 2009, J DERMATOL SCI, V55, P40, DOI 10.1016/j.jdermsci.2009.03.007; Umapathi T, 2007, MUSCLE NERVE, V35, P591, DOI 10.1002/mus.20732; Vas PRJ, 2012, DIABETOLOGIA, V55, P795, DOI 10.1007/s00125-011-2417-9; Verheyen A, 2013, NEUROSCIENCE, V244, P77, DOI 10.1016/j.neuroscience.2013.03.050; Verkhratsky A, 2014, CELL CALCIUM, V56, P362, DOI 10.1016/j.ceca.2014.07.005; Vinik AI, 2004, MED CLIN N AM, V88, P947, DOI [10.1016/j.mcna.2004.04.009, 10.1212/01.CON.0000455884.29545.d2]; Vinik AI, 2001, DIABETES CARE, V24, P1468, DOI 10.2337/diacare.24.8.1468; Vlckova-Moravcova E, 2008, DIABETIC MED, V25, P692, DOI 10.1111/j.1464-5491.2008.02446.x; Xiao HJ, 2013, INT J MED SCI, V10, P1412, DOI 10.7150/ijms.5630; Yamaguchi J, 2008, J INVEST DERMATOL, V128, P2842, DOI 10.1038/jid.2008.150; Yuan L, 2002, DEVELOPMENT, V129, P4797; Yusof MI, 2008, SINGAP MED J, V49, P100	72	3	3	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 6	2016	11	9							e0161441	10.1371/journal.pone.0161441	http://dx.doi.org/10.1371/journal.pone.0161441			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9IT	27598321	Green Published, Green Submitted, gold			2022-12-26	WOS:000383254800008
J	Kim, S; So, WY; Kim, J; Sung, DJ				Kim, SoJung; So, Wi-Young; Kim, Jooyoung; Sung, Dong Jun			Relationship between Bone-Specific Physical Activity Scores and Measures for Body Composition and Bone Mineral Density in Healthy Young College Women	PLOS ONE			English	Article							BIOELECTRICAL-IMPEDANCE ANALYSIS; LEAN MASS; FAT; CHILDREN; OSTEOPOROSIS; ASSOCIATION; MUSCLE; BPAQ	Objective The purpose of this cross-sectional study was to investigate the relationship between bone-specific physical activity (BPAQ) scores, body composition, and bone mineral density (BMD) in healthy young college women. Methods Seventy-three college women (21.7 +/- 1.8 years; 162.1 +/- 4.6 cm; 53.9 +/- 5.8 kg) between the ages of 19 and 26 years were recruited from the universities in Seoul and Gyeonggi province, South Korea. We used dual energy X-ray absorptiometry to measure the lumbar spine (L2-L4) and proximal femur BMD (left side; total hip, femoral neck). The BPAQ scores (past, pBPAQ; current, cBPAQ; total, tBPAQ) were used to obtain a comprehensive account of lifetime physical activity related to bone health. We used X-scan plus II instrumentation to measure height (cm), weight (kg), fat free mass (FFM, kg), percent body fat (%), and body mass index (BMI). Participants were asked to record their 24-hour food intake in a questionnaire. Results There were positive correlations between BPAQ scores and total hip (pBPAQ r = 0.308, p = 0.008; tBPAQ, r = 0.286, p = 0.014) and FN BMD (pBPAQ r = 0.309, p = 0.008; tBPAQ, r = 0.311, p = 0.007), while no significant relationships were found in cBPAQ (p > 0.05). When FFM, Vitamin D intake, cBPAQ, pBPAQ, and tBPAQ were included in a stepwise multiple linear regression analysis, FFM and pBPAQ were predictors of total hip, accounting for 16% (p = 0.024), while FFM and tBPAQ predicted 14% of the variance in FN (p = 0.015). Only FFM predicted 15% of the variance in L2-L4 (p = 0.004). There was a positive correlation between Vitamin D intake and L2-L4 (p = 0.025), but other dietary intakes variables were not significant (p > 0.05). Conclusions BPAQ-derived physical activity scores and FFM were positively associated with total hip and FN BMD in healthy young college women. Our study suggests that osteoporosis awareness and effective bone healthy behaviors for college women are required to prevent serious bone diseases later in life.	[Kim, SoJung] Univ Massachusetts, Coll Hlth Sci, Dept Phys Therapy, Lowell, MA 01854 USA; [So, Wi-Young] Korea Natl Univ Transportat, Sports & Hlth Care Major, Coll Humanities & Arts, Chungju Si 27469, South Korea; [Kim, Jooyoung] Kookmin Univ, Hlth & Rehabil Major, Seoul 02707, South Korea; [Sung, Dong Jun] Konkuk Univ, Coll Sci & Technol, Div Sport Sci, Chungju Si 27478, South Korea	University of Massachusetts System; University of Massachusetts Lowell; Korea National University of Transportation; Kookmin University; Konkuk University	Sung, DJ (corresponding author), Konkuk Univ, Coll Sci & Technol, Div Sport Sci, Chungju Si 27478, South Korea.	sls98@kku.ac.kr			National Research Foundation of Korea Grant - Korean Government [NRF-2013S1A5B5A07046267]	National Research Foundation of Korea Grant - Korean Government	This work was supported by the National Research Foundation of Korea Grant funded by the Korean Government (NRF-2013S1A5B5A07046267).	Alghadir AH, 2015, J PHYS THER SCI, V27, P2261, DOI 10.1589/jpts.27.2261; [Anonymous], 1994, World Health Organ Tech Rep Ser, V843, P1; Ashok K, 2016, J OBSTET GYNECOL IND, V66, P52, DOI 10.1007/s13224-014-0629-x; BASSEY EJ, 1994, OSTEOPOROSIS INT, V4, P72, DOI 10.1007/BF01623226; Bolam KA, 2014, OSTEOPOROSIS INT, V25, P2663, DOI 10.1007/s00198-014-2797-z; Borer KT, 2005, SPORTS MED, V35, P779, DOI 10.2165/00007256-200535090-00004; Byeon YS, 2006, KOREAN J ADULT NURS, V18, P790; Cardadeiro G, 2014, OSTEOPOROSIS INT, V25, P2035, DOI 10.1007/s00198-014-2729-y; Chon Mi-Young, 2012, [Korean J Women Health Nurs, 여성건강간호학회지], V18, P190; Dolan SH, 2006, MED SCI SPORT EXER, V38, P1121, DOI 10.1249/01.mss.0000222841.96885.a8; Eun-nam Lee, 2009, [The Journal of Muscle and Joint Health, 근관절건강학회지], V16, P105; Farr JN, 2011, MED SCI SPORT EXER, V43, P476, DOI 10.1249/MSS.0b013e3181eeb2f2; Going S, 2006, Int J Body Compos Res, V4, P161; Heron N, 2014, BRIT J SPORT MED, V48, P1558, DOI 10.1136/bjsports-2012-091581; Ho-Pham LT, 2014, J CLIN ENDOCR METAB, V99, P30, DOI 10.1210/jc.2013-3190; Huang TH, 2016, ANN NY ACAD SCI, V1363, P26, DOI 10.1111/nyas.13004; Jho Kwang Hyun, 2014, [Journal of THE KOREAN DIETETIC ASSOCIATION, 대한영양사협회 학술지], V20, P110, DOI 10.14373/JKDA.2014.20.2.110; Kelley S, 2014, RES Q EXERCISE SPORT, V85, P245, DOI 10.1080/02701367.2014.897680; Kim W, 2014, J BONE MINER METAB, V32, P709, DOI 10.1007/s00774-013-0545-7; Kindler JM, 2015, INT J SPORT NUTR EXE, V25, P136, DOI 10.1123/ijsnem.2013-0258; Kohrt WM, 2009, MED SCI SPORT EXER, V41, P2050, DOI 10.1249/MSS.0b013e3181a8c717; Kohrt WM, 2004, MED SCI SPORT EXER, V36, P1985, DOI 10.1249/01.MSS.0000142662.21767.58; Lee SM, 2012, J INT ACAD PHYS THER, V3, P345; Lewiecki E Michael, 2004, Clin Mol Allergy, V2, P9, DOI 10.1186/1476-7961-2-9; Li YC, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0073186, 10.1371/journal.pone.0058272]; Liu Jian-Min, 2004, Osteoporos Int, V15, P238, DOI 10.1007/s00198-003-1536-7; Liu PY, 2014, INT J PREVENTIVE MED, V5, P1452; Na-Mi Chun，, 2015, [Korean J Women Health Nurs, 여성건강간호학회지], V21, P43; Park JH, 2012, BONE, V50, P1006, DOI 10.1016/j.bone.2012.01.015; Park KH, 2015, J BONE MINER METAB; Park YJ, 2014, J KOREAN ACAD NURS, V44, P504, DOI 10.4040/jkan.2014.44.5.504; Rantalainen T, 2015, BONE, V72, P101, DOI 10.1016/j.bone.2014.11.015; Ross AC, 2011, J CLIN ENDOCR METAB, V96, P53, DOI 10.1210/jc.2010-2704; Sayed-Hassan R, 2013, ARCH OSTEOPOROS, V8, DOI 10.1007/s11657-013-0149-9; Weeks BK, 2008, OSTEOPOROSIS INT, V19, P1567, DOI 10.1007/s00198-008-0606-2; Weeks BK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039133; Weeks BK, 2016, EUR J SPORT SCI, P1; Williams Bethan, 2002, Health Care Women Int, V23, P344, DOI 10.1080/0739933029008919; Winters-Stone KM, 2006, BONE, V39, P1203, DOI 10.1016/j.bone.2006.06.005; Wu CS, 2015, NUTR J, V14, DOI 10.1186/s12937-015-0041-0; WU YT, 1993, PHYS THER, V73, P320, DOI 10.1093/ptj/73.5.320	42	7	7	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162127	10.1371/journal.pone.0162127	http://dx.doi.org/10.1371/journal.pone.0162127			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589270	Green Submitted, Green Published, gold			2022-12-26	WOS:000382877800031
J	Ma, YY; Sun, L; Chen, XJ; Wang, N; Yi, PF; Song, M; Zhang, B; Wang, YZ; Liang, QH				Ma, Yun-Yun; Sun, Lin; Chen, Xiu-Juan; Wang, Na; Yi, Peng-Fei; Song, Min; Zhang, Bo; Wang, Yu-Zhong; Liang, Qiu-Hua			Vinpocetine Attenuates the Osteoblastic Differentiation of Vascular Smooth Muscle Cells	PLOS ONE			English	Article							CEREBROVASCULAR DISEASES; OXIDATIVE STRESS; IN-VIVO; CALCIFICATION; EXPRESSION; MECHANISMS; MICE	Vascular calcification is an active process of osteoblastic differentiation of vascular smooth muscle cells; however, its definite mechanism remains unknown. Vinpocetine, a derivative of the alkaloid vincamine, has been demonstrated to inhibit the high glucose-induced proliferation of vascular smooth muscle cells; however, it remains unknown whether vinpocetine can affect the osteoblastic differentiation of vascular smooth muscle cells. We hereby investigated the effect of vinpocetine on vascular calcification using a beta-glycerophosphate-induced cell model. Our results showed that vinpocetine significantly reduced the osteoblast-like phenotypes of vascular smooth muscle cells including ALP activity, osteocalcin, collagen type I, Runx2 and BMP-2 expression as well as the formation of mineralized nodule. Vinpocetine, binding to translocation protein, induced phosphorylation of extracellular signal-related kinase and Akt and thus inhibited the translocation of nuclear factor-kappa B into the nucleus. Silencing of translocator protein significantly attenuated the inhibitory effect of vinpocetine on osteoblastic differentiation of vascular smooth muscle cells. Taken together, vinpocetine may be a promising candidate for the clinical therapy of vascular calcification.	[Ma, Yun-Yun; Sun, Lin; Wang, Na; Yi, Peng-Fei; Song, Min; Zhang, Bo; Liang, Qiu-Hua] Jining Med Univ, Affiliated Hosp, Dept Endocrinol, Jining, Shandong, Peoples R China; [Ma, Yun-Yun; Chen, Xiu-Juan] Jining Med Univ, Jining, Shandong, Peoples R China; [Wang, Yu-Zhong] Jining Med Univ, Affiliated Hosp, Dept Neurol, Jining, Shandong, Peoples R China; [Wang, Yu-Zhong] Jining Med Univ, Affiliated Hosp, Cent Lab, Jining, Shandong, Peoples R China	Jining Medical University; Jining Medical University; Jining Medical University; Jining Medical University	Liang, QH (corresponding author), Jining Med Univ, Affiliated Hosp, Dept Endocrinol, Jining, Shandong, Peoples R China.	huaqiuliang@sohu.com			National Natural Science Foundation of China [81400860]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National Natural Science Foundation of China (81400860).	Bagoly Edit, 2007, Orvosi Hetilap, V148, P1353, DOI 10.1556/OH.2007.28115; Batarseh A, 2010, MOL CELL ENDOCRINOL, V327, P1, DOI 10.1016/j.mce.2010.06.013; Cai YJ, 2012, J PHARMACOL EXP THER, V343, P479, DOI 10.1124/jpet.112.195446; Deshmukh R, 2009, EUR J PHARMACOL, V620, P49, DOI 10.1016/j.ejphar.2009.08.027; Grainger DJ, 1998, J CELL SCI, V111, P2977; Jayalath RW, 2005, EUR J VASC ENDOVASC, V30, P476, DOI 10.1016/j.ejvs.2005.04.030; Johnson RC, 2006, CIRC RES, V99, P1044, DOI 10.1161/01.RES.0000249379.55535.21; Lanzer P, 2014, EUR HEART J, V35, P1515, DOI 10.1093/eurheartj/ehu163; Liang QH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033126; Liu GY, 2014, ENDOCRINOLOGY, V155, P558, DOI 10.1210/en.2013-1298; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Patyar S, 2011, PHARMACOL REP, V63, P618, DOI 10.1016/S1734-1140(11)70574-6; Ruiz-Miyazawa KW, 2015, CHEM-BIOL INTERACT, V237, P9, DOI 10.1016/j.cbi.2015.05.007; Steitz SA, 2001, CIRC RES, V89, P1147, DOI 10.1161/hh2401.101070; Wang K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096894; Wu MT, 2013, CALCIFIED TISSUE INT, V93, P365, DOI 10.1007/s00223-013-9712-z; Yang SY, 2003, J BONE MINER RES, V18, P705, DOI 10.1359/jbmr.2003.18.4.705; Zhao Yan-Yin, 2011, Neuron Glia Biol, V7, P187, DOI 10.1017/S1740925X12000129	18	6	6	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162295	10.1371/journal.pone.0162295	http://dx.doi.org/10.1371/journal.pone.0162295			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27589055	gold, Green Published			2022-12-26	WOS:000382877800047
J	Oremus, M; Xie, F; Gaebel, K				Oremus, Mark; Xie, Feng; Gaebel, Kathryn			Development of Clinical Vignettes to Describe Alzheimer's Disease Health States: A Qualitative Study	PLOS ONE			English	Article							OF-LIFE; DEMENTIA; RATINGS; RECOMMENDATIONS; ASSOCIATION; PREDICTORS; CRITERIA; PEOPLE; STIGMA	Aims To develop clinical descriptions (vignettes) of life with Alzheimer's disease (AD), we conducted focus groups of persons with AD (n = 14), family caregivers of persons with AD (n = 20), and clinicians who see persons with AD in their practices (n = 5). Methods Group participants read existing descriptions of AD and commented on the realism and comprehensibility of the descriptions. We used thematic framework analysis to code the comments into themes and develop three new vignettes to describe mild, moderate, and severe AD. Results Themes included the types of symptoms to mention in the new vignettes, plus the manner in which the vignettes should be written. Since the vignette descriptions were based on focus group participants' first-hand knowledge of AD, the descriptions can be said to demonstrate content validity. Conclusion Members of the general public can read the vignettes and estimate their health-related quality-of-life (HRQoL) as if they had AD based on the vignette descriptions. This is especially important for economic evaluations of new AD medications, which require HRQoL to be assessed in a manner that persons with AD often find difficult to undertake. The vignettes will allow the general public to serve as a proxy and provide HRQoL estimates in place of persons with AD.	[Oremus, Mark] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada; [Xie, Feng] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Xie, Feng] Program Hlth Econ & Outcome Measures PHENOM, Hamilton, ON, Canada; [Xie, Feng; Gaebel, Kathryn] St Josephs Healthcare Hamilton, Ctr Evaluat Med, Hamilton, ON, Canada	University of Waterloo; McMaster University; McMaster University	Oremus, M (corresponding author), Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON, Canada.	moremus@uwaterloo.ca			Canadian Institutes of Health Research [IAO - 126567, IAO-126567]	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the Canadian Institutes of Health Research (grant number IAO - 126567): http://www.cihr-irsc.gc.ca/e/193.html. The Co-principal investigators are: MO, FX. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by the Canadian Institutes of Health Research (grant number IAO-126567).	Aguinis H, 2014, ORGAN RES METHODS, V17, P351, DOI 10.1177/1094428114547952; ALEXANDER CS, 1978, PUBLIC OPIN QUART, V42, P93, DOI 10.1086/268432; American psychiatric association, 2013, DIAGNOSTIC STAT MANU, DOI 10.1176/appi.books.9780890425596; Arons AMM, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-110; Au N, 2014, QUAL LIFE RES, V23, P1721, DOI 10.1007/s11136-013-0615-2; Sousa MFB, 2013, INT PSYCHOGERIATR, V25, P1097, DOI 10.1017/S1041610213000410; Bernard H. R., 2016, ANAL QUALITATIVE DAT; Black BS, 2012, QUAL LIFE RES, V21, P1379, DOI 10.1007/s11136-011-0044-z; Blay SL, 2008, ALZ DIS ASSOC DIS, V22, P79, DOI 10.1097/WAD.0b013e31815ccd47; Bosboom PR, 2013, ALZ DIS ASSOC DIS, V27, P363, DOI 10.1097/WAD.0b013e318293b5f8; Bruni RA, 2008, CAN MED ASSOC J, V179, P15, DOI 10.1503/cmaj.071656; Burgener SC, 2015, DEMENTIA-LONDON, V14, P609, DOI 10.1177/1471301213504202; Carlsen B, 2011, BMC MED RES METHODOL, V11, DOI 10.1186/1471-2288-11-26; Conde-Sala JL, 2013, J GERIATR PSYCH NEUR, V26, P86, DOI 10.1177/0891988713481266; Crespo M, 2013, INT PSYCHOGERIATR, V25, P1687, DOI 10.1017/S1041610213000823; Foster NL, 2014, ALZHEIMERS DEMENT, V10, P503, DOI 10.1016/j.jalz.2014.05.003; Gove D, 2016, AGING MENT HEALTH, V20, P391, DOI 10.1080/13607863.2015.1015962; Hebert K., 2003, CLIN GERONTOLOGIST, V26, P17, DOI [10.1300/J018v26n01_03, DOI 10.1300/J018V26N01_03, DOI 10.1300/J018v26n01_03]; Herdman M, 2011, QUAL LIFE RES, V20, P1727, DOI 10.1007/s11136-011-9903-x; Johnson R, 2015, SOC SCI MED, V143, P117, DOI 10.1016/j.socscimed.2015.08.031; Keeley T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0085287; Magasi S, 2012, QUAL LIFE RES, V21, P739, DOI 10.1007/s11136-011-9990-8; Mansell Ian, 2004, Nurse Res, V11, P79; McDowell I, 2000, NEUROLOGY, V55, P66; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Morse JM, 2015, QUAL HEALTH RES, V25, P1212, DOI 10.1177/1049732315588501; Naglie G, 2011, AM J GERIAT PSYCHIAT, V19, P881, DOI 10.1097/JGP.0b013e3182006a67; Naglie G, 2011, AM J GERIAT PSYCHIAT, V19, P891, DOI 10.1097/JGP.0b013e3182006a7f; Onwuegbuzie A.J., 2009, INT J QUALITATIVE ME, V8, P1, DOI [10.1177/160940690900800301, DOI 10.1177/160940690900800301]; Oremus M, 2016, BMC GERIATR, V16, DOI 10.1186/s12877-016-0207-4; Oremus M, 2015, DEMENTIA-LONDON, V14, P63, DOI 10.1177/1471301213490709; Oremus M, 2009, BMC HEALTH SERV RES, V9, DOI 10.1186/1472-6963-9-246; Quail JM, 2007, EUR J AGEING, V4, P45, DOI 10.1007/s10433-007-0042-8; Randhawa H, 2015, BMC MED INFORM DECIS, V15, DOI 10.1186/s12911-015-0179-x; Ready Rebecca E, 2007, Am J Alzheimers Dis Other Demen, V22, P528, DOI 10.1177/1533317507307032; REISBERG B, 1988, PSYCHOPHARMACOL BULL, V24, P653; Reitz C, 2014, BIOCHEM PHARMACOL, V88, P640, DOI 10.1016/j.bcp.2013.12.024; Rice N, 2011, EUR J HEALTH ECON, V12, P141, DOI 10.1007/s10198-010-0235-5; Schaller S, 2015, INT J GERIATR PSYCH, V30, P111, DOI 10.1002/gps.4198; Schulz R, 2013, AM J GERIAT PSYCHIAT, V21, P14, DOI 10.1016/j.jagp.2012.10.002; Szkultecka-Debek M, 2015, CURR ISS PHARM MED S, V28, P8, DOI 10.1515/cipms-2015-0032; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Werner P, 2004, INT J GERIATR PSYCH, V19, P391, DOI 10.1002/gps.1107; Woods RT, 2014, HEALTH QUAL LIFE OUT, V12, DOI 10.1186/1477-7525-12-94; Xie F, 2012, QUAL LIFE RES, V21, P593, DOI 10.1007/s11136-011-9966-8	45	4	5	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162422	10.1371/journal.pone.0162422	http://dx.doi.org/10.1371/journal.pone.0162422			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27589604	gold, Green Submitted, Green Published			2022-12-26	WOS:000382877800060
J	Padalino, B; Raidal, SL; Hall, E; Knight, P; Celi, P; Jeffcott, L; Muscatello, G				Padalino, Barbara; Raidal, Sharanne L.; Hall, Evelyn; Knight, Peter; Celi, Pietro; Jeffcott, Leo; Muscatello, Gary			A Survey on Transport Management Practices Associated with Injuries and Health Problems in Horses	PLOS ONE			English	Article							LONG-HAUL TRANSPORT; RISK-FACTORS; EQUINE INFLUENZA; BEHAVIOR; WELFARE; STRESS; TRAILER; BALANCE	An online survey was conducted to determine associations between transport management and transport-related injuries and diseases in horses in Australia. The survey was composed of three sections: respondents' demographic information, transport management strategies or procedures (before, during and after transportation) and transport diseases experienced in the previous two year period. Univariate and multivariate modelling was performed exploring associations between variables (respondents' details and transport management strategies) and the following transport-related diseases as outcomes: traumatic injuries, diarrhoea, heat stroke, muscular problems, laminitis, transport pneumonia and colic. The survey generated 797 responses. Traumatic injuries were the most common transport-related problem, with a reported incidence of 45.0%. Younger respondents (<40 years old) caring for large numbers of horses (>30 in a week) were more likely to report transport-related injuries. Injury risk was also linked to the use of protections and tranquilizers prior to transport, and checking horses after the journey. Diarrhoea (20.0%) and heat stroke (10.5%) were reported more by amateur than professional horse carers. Increased risk of heat stroke was linked to the restriction of hay and water prior to transportation. Muscular problems (13.0%) appeared to be exacerbated when horse health was not assessed before journey; whilst the risk of laminitis (2.9%) was around three fold greater when post transport recovery strategies were not applied. Associations were made between transport pneumonia (9.2%) and duration of journey, and with activity (horses involved in racing at greater risk). No associations were seen between the incidence of colic (10.3%) and the variables examined. Study findings should be interpreted with caution as they represent participant perceptions and recall. Nevertheless, results support many current recommendations for safe transportation of horses. They also highlight the need to further investigate many of identified management factors to refine existing policies and practices in equine transportation.	[Padalino, Barbara; Hall, Evelyn; Celi, Pietro; Jeffcott, Leo; Muscatello, Gary] Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Camden, NSW, Australia; [Padalino, Barbara] Univ Bari, Dept Vet Med, Bari, Italy; [Padalino, Barbara; Raidal, Sharanne L.] Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia; [Knight, Peter] Univ Sydney, Sydney Med Sch, Sch Med Sci, Discipline Biomed Sci, Sydney, NSW, Australia; [Celi, Pietro] DSM Nutr Prod Anim Nutr & Hlth, Columbia, MD USA; [Celi, Pietro] Univ Melbourne, Fac Vet & Agr Sci, Parkville, Vic, Australia	University of Sydney; Universita degli Studi di Bari Aldo Moro; Charles Sturt University; University of Sydney; DSM NV; University of Melbourne	Padalino, B (corresponding author), Univ Sydney, Fac Vet Sci, Sch Life & Environm Sci, Camden, NSW, Australia.; Padalino, B (corresponding author), Univ Bari, Dept Vet Med, Bari, Italy.; Padalino, B (corresponding author), Charles Sturt Univ, Sch Anim & Vet Sci, Wagga Wagga, NSW, Australia.	barbara.padalino@sydney.edu.au	Muscatello, Gary/AAG-1047-2021; Knight, Peter/A-9555-2011; Padalino, Barbara/AAJ-7498-2020; Celi, Pietro/D-6567-2014; Jeffcott, Leo/S-8887-2017	Knight, Peter/0000-0002-1076-5379; Celi, Pietro/0000-0002-7933-3160; Jeffcott, Leo/0000-0002-2855-6946; Raidal, Sharanne/0000-0001-5558-3133; PADALINO, BARBARA/0000-0002-7630-8285	University of Sydney International Postgraduate Research Scholarship (IPRS) -	University of Sydney International Postgraduate Research Scholarship (IPRS) -	This study was funded by the University of Sydney International Postgraduate Research Scholarship (IPRS).	[Anonymous], 2014, PRACTICAL GUIDELINES, P36; Anzai Toru, 2001, Journal of Equine Science, V12, P135, DOI 10.1294/jes.12.135; AUSTIN SM, 1995, J AM VET MED ASSOC, V207, P325; Boden LA, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-188; Christley RM, 2016, EQUINE VET J, V48, P138, DOI 10.1111/evj.12552; CLARK DK, 1993, APPL ANIM BEHAV SCI, V38, P179, DOI 10.1016/0168-1591(93)90018-K; Codazza D., 1974, Journal of the South African Veterinary Association., V45, P331; Cohen ND, 2005, JAVMA-J AM VET MED A, V226, P404, DOI 10.2460/javma.2005.226.404; Copas V, 2011, IN PRACTICE, V33, P155, DOI 10.1136/inp.d1811; Cregier S. E., 1984, Proceedings of the International Congress on Applied Ethology in Farm Animals, Kiel 1984, P175; Cregier SE, 2015, NONCOMMERCIAL HORSE; Cullinane A, 2014, EQUINE VET EDUC, V26, P456, DOI 10.1111/eve.12215; Darth AC, 2014, IDENTIFYING CAUSES P; Dean RS, 2015, EQUINE VET J, V47, P379, DOI 10.1111/evj.12429; DeAraugo J, 2016, ANIMALS, V6, DOI 10.3390/ani6020012; Giovagnoli G, 2002, LIVEST PROD SCI, V73, P247, DOI 10.1016/S0301-6226(01)00253-6; Gonzalez LA, 2012, J ANIM SCI, V90, P3640, DOI 10.2527/jas.2011-4796; Hillyer MH, 2002, EQUINE VET J, V34, P455, DOI 10.2746/042516402776117746; Hockenhull J, 2014, APPL ANIM BEHAV SCI, V155, P49, DOI 10.1016/j.applanim.2014.02.014; Houpt KA, 2014, LIVESTOCK HANDLING AND TRANSPORT, 4TH EDITION, P315, DOI 10.1079/9781780643212.0315; Jones WE, 2003, J EQUINE VET SCI, V23, P543, DOI 10.1016/j.jevs.2003.11.014; Kohn CW, 2000, GUIDELINES HORSE TRA; LEADON D, 1989, J EQUINE VET SCI, V9, P200, DOI 10.1016/S0737-0806(89)80051-6; Leadon D.P., 2014, ATHLETIC HORSE PRINC, V2nd ed., P155, DOI DOI 10.1016/B978-0-7216-0075-8.00019-8; Leadon Des, 2008, Vet Ital, V44, P149; Lee J, 2001, J EQUINE VET SCI, V21, P237, DOI 10.1016/S0737-0806(01)70042-1; MANSMANN RA, 1995, J EQUINE VET SCI, V15, P141, DOI 10.1016/S0737-0806(06)81843-5; Marahrens M, 2011, PREV VET MED, V102, P157, DOI 10.1016/j.prevetmed.2011.04.010; Marlin DJ, 2004, TRANSPORT HORSES EQU, P1239; MCCLINTOCK SA, 1990, AUST VET J, V67, P265, DOI 10.1111/j.1751-0813.1990.tb07785.x; McGreevy PD, 2007, VET J, V174, P492, DOI 10.1016/j.tvjl.2006.09.008; MCGREEVY PD, 1995, EQUINE VET J, V27, P86, DOI 10.1111/j.2042-3306.1995.tb03041.x; Moberg GP, 2000, BIOLOGY OF ANIMAL STRESS, P1, DOI 10.1079/9780851993591.0001; Noble B, 2013, INT LARGE ANIMAL RES, P10; Oikawa Masa-aki, 2004, Journal of Equine Science, V15, P99, DOI 10.1294/jes.15.99; Padalino B, 2016, AUST VET J, V94, P349, DOI 10.1111/avj.12486; Padalino B, 2015, ANIMALS, V5, P1296, DOI 10.3390/ani5040412; Padalino B, 2015, J VET BEHAV, V10, P272, DOI 10.1016/j.jveb.2015.02.002; Padalino B, 2012, J VET BEHAV, V7, P135, DOI 10.1016/j.jveb.2011.09.003; Pagan JD, 2004, IPPOLOGIA, V15, P5; Purswell JL, 2006, T ASABE, V49, P193, DOI 10.13031/2013.20238; Purswell JL, 2010, T ASABE, V53, P1885; RAIDAL SL, 1995, AUST VET J, V72, P45, DOI 10.1111/j.1751-0813.1995.tb15328.x; Reed SM, 2003, EQUINE INTERNAL MED, P1; Schemann K, 2011, PREV VET MED, V102, P304, DOI 10.1016/j.prevetmed.2011.08.002; Smyth GB, 2015, AUST VET J, V93, P433, DOI 10.1111/avj.12390; Tateo A, 2012, J VET BEHAV, V7, P33, DOI 10.1016/j.jveb.2011.04.007; Tinker MK, 1997, EQUINE VET J, V29, P454, DOI 10.1111/j.2042-3306.1997.tb03158.x; Waran N., 2007, WELFARE HORSES, P125; Waran NK, 1996, VET REC, V139, P7, DOI 10.1136/vr.139.1.7; Weeks CA, 2012, EQUINE VET EDUC, V24, P423, DOI 10.1111/j.2042-3292.2011.00293.x	51	19	19	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0162371	10.1371/journal.pone.0162371	http://dx.doi.org/10.1371/journal.pone.0162371			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV4EJ	27588689	Green Published, gold			2022-12-26	WOS:000382877800053
J	Piantadosi, S; Aslin, R				Piantadosi, Steven; Aslin, Richard			Compositional Reasoning in Early Childhood	PLOS ONE			English	Article							PROTOTYPE THEORY; INFANTS; ACQUISITION; MODEL	Compositional "language of thought" models have recently been proposed to account for a wide range of children's conceptual and linguistic learning. The present work aims to evaluate one of the most basic assumptions of these models: children should have an ability to represent and compose functions. We show that 3.5-4.5 year olds are able to predictively compose two novel functions at significantly above chance levels, even without any explicit training or feedback on the composition itself. We take this as evidence that children at this age possess some capacity for compositionality, consistent with models that make this ability explicit, and providing an empirical challenge to those that do not.	[Piantadosi, Steven; Aslin, Richard] Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA	University of Rochester	Piantadosi, S (corresponding author), Univ Rochester, Dept Brain & Cognit Sci, Rochester, NY 14627 USA.	spiantado@gmail.com			Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health [F32HD070544]; NIH research grant [HD-037082]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD037082, F32HD070544] Funding Source: NIH RePORTER	Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health; NIH research grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute of Child Health & Human Development of the National Institutes of Health under Award Number F32HD070544 and an NIH research grant to R. Aslin and E. Newport (HD-037082). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.; This work benefited greatly from discussions with Roman Feiman, Celeste Kidd, Noah Goodman, and members of AKlab. Children were run with the help of Holly Palmeri and the Rochester Babylab RAs. Research reported in this publication was supported by the Eunice Kennedy Shriver National Institute Of Child Health & Human Development of the National Institutes of Health under Award Number F32HD070544 and an NIH research grant to R. Aslin and E. Newport (HD-037082). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Baillargeon R., 1994, 10 MONTH OLD I UNPUB; Barner D, 2008, CHILD DEV, V79, P594, DOI 10.1111/j.1467-8624.2008.01145.x; Boole G., 1854, INVESTIGATION LAWS T; Church A, 1936, AM J MATH, V58, P345, DOI 10.2307/2371045; Feigenson L, 2005, COGNITION, V97, P295, DOI 10.1016/j.cognition.2004.09.010; Feldman J, 2000, NATURE, V407, P630, DOI 10.1038/35036586; Fernald A, 2010, COGNITIVE PSYCHOL, V60, P190, DOI 10.1016/j.cogpsych.2009.12.002; Fodor J, 1996, COGNITION, V58, P253, DOI 10.1016/0010-0277(95)00694-X; Fodor J. A., 1975, LANGUAGE THOUGHT; Frege G, 1892, WITTGENSTEIN STUDIEN, V1; Gelman A., 2007, DATA ANAL USING REGR; Goodman ND, 2009, P 31 ANN C COGN SCI, P2188; Goodman ND, 2008, COGNITIVE SCI, V32, P108, DOI 10.1080/03640210701802071; Hindley J, 1986, INTRO COMBINATORS LA; KAMP H, 1995, COGNITION, V57, P129, DOI 10.1016/0010-0277(94)00659-9; Katz Y., 2008, P 30 ANN M COGN SCI; Kemp C, 2008, ADV NEURAL INFORM PR, V20, P753; Margolis E., 1999, CONCEPTS CORE READIN; MATTHEI EH, 1982, COGNITION, V11, P301, DOI 10.1016/0010-0277(82)90018-X; MEDIN DL, 1978, PSYCHOL REV, V85, P207, DOI 10.1037/0033-295X.85.3.207; Moher M, 2012, J EXP CHILD PSYCHOL, V112, P361, DOI 10.1016/j.jecp.2012.03.007; OSHERSON DN, 1981, COGNITION, V9, P35, DOI 10.1016/0010-0277(81)90013-5; Piantadosi ST, 2012, KELPY FREE LIB CHILD; Piantadosi ST, 2012, COGNITION, V123, P199, DOI 10.1016/j.cognition.2011.11.005; ROSCH E, 1975, COGNITIVE PSYCHOL, V7, P573, DOI 10.1016/0010-0285(75)90024-9; Rumelhart D., 1986, PARALLEL DISTRIBUTED; Schonfinkel M, 1967, FREGE GODEL SOURCE B, P355; Siskind JM, 1996, COGNITION, V61, P39, DOI 10.1016/S0010-0277(96)00728-7; SMITH EE, 1988, COGNITIVE SCI, V12, P485, DOI 10.1207/s15516709cog1204_1; SMITH EE, 1984, COGNITIVE SCI, V8, P337, DOI 10.1016/S0364-0213(84)80006-3; Smith EE, 2002, EXEMPLAR VIEW FDN CO, P277; Smullyan RM, 1985, MOCK MOCKINGBIRD OTH; Syrett K, 2010, LANG LEARN DEV, V6, P258, DOI 10.1080/15475440903507905; Ullman TD, 2010, P 32 ANN M COGN SCI; WIMMER H, 1983, COGNITION, V13, P103, DOI 10.1016/0010-0277(83)90004-5; WYNN K, 1992, NATURE, V358, P749, DOI 10.1038/358749a0	37	4	4	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 2	2016	11	9							e0147734	10.1371/journal.pone.0147734	http://dx.doi.org/10.1371/journal.pone.0147734			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DV4EJ	27588944	Green Submitted, gold, Green Published			2022-12-26	WOS:000382877800001
J	Zhang, C; Chen, M; Wang, GZ; Fang, W; Ye, C; Hu, HH; Fa, ZZ; Yi, J; Liao, WQ				Zhang, Chao; Chen, Mei; Wang, Guizhen; Fang, Wei; Ye, Chen; Hu, Hanhua; Fa, Zhenzong; Yi, Jiu; Liao, Wan-qing			Pd@Ag Nanosheets in Combination with Amphotericin B Exert a Potent Anti-Cryptococcal Fungicidal Effect	PLOS ONE			English	Article							SILVER NANOPARTICLES; ANTIFUNGAL ACTIVITY; ESCHERICHIA-COLI; ANTIBACTERIAL; FLUCONAZOLE; RESISTANCE; MENINGITIS; EPIDEMIOLOGY; NEOFORMANS; AGENTS	Silver nanoparticles have received considerable interest as new "nanoantibiotics" with the potential to kill drug-resistant microorganisms. Recently, a class of new core-shell nanostructures, Pd@Ag nanosheets (Pd@Ag NSs), were created using deposition techniques and demonstrated excellent inhibitory effects on various bacteria in vitro. In this study, we evaluated the antifungal activity of Pd@Ag NSs against common invasive fungal pathogens. Among these organisms, Cryptococcus neoformans complex species was most susceptible to Pd@Ag NSs, which exhibited potent antifungal activity against various molecular types or sources of cryptococcal strains including fluconazole-resistant isolates. The anticryptococcal activity of Pd@Ag NSs was significantly greater than fluconazole and similar to that of amphotericin B (AmB). At relatively high concentrations, Pd@Ag NSs exhibited fungicidal activity against Cryptococcus spp., which can likely be attributed to the disruption of cell integrity, intracellular protein synthesis, and energy metabolism. Intriguingly, Pd@Ag NSs also exhibited strong synergistic anti-cryptococcal fungicidal effects at low concentrations in combination with AmB but exhibitedmuch better safety in erythrocytes than AmB, even at the minimal fungicidal concentration. Therefore, Pd@Ag NSs may be a promising adjunctive agent for treating cryptococcosis, and further investigation for clinical applications is required.	[Zhang, Chao; Yi, Jiu; Liao, Wan-qing] Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China; [Zhang, Chao; Fang, Wei; Fa, Zhenzong] Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China; [Chen, Mei] Xiamen Univ, Coll Chem & Chem Engn, Collaborat Innovat Ctr Chem Energy Mat, State Key Lab Phys Chem Solid Surfaces, Xiamen, Peoples R China; [Chen, Mei] Xiamen Univ, Dept Chem, Coll Chem & Chem Engn, Xiamen 361005, Peoples R China; [Wang, Guizhen] Urumuqi Army Gen Hosp, ICU Dept, Urumqi, Xinjiang, Peoples R China; [Ye, Chen] Second Mil Med Univ, Changhai Hosp, Dept Urol, Shanghai, Peoples R China; [Hu, Hanhua] Xinjiang Med Univ, UEM Dept, Urumqi, Xinjiang, Peoples R China	Naval Medical University; Naval Medical University; Xiamen University; Xiamen University; Naval Medical University; Xinjiang Medical University	Liao, WQ (corresponding author), Second Mil Med Univ, Shanghai Inst Med Mycol, Shanghai Key Lab Mol Med Mycol, Shanghai, Peoples R China.; Fang, W (corresponding author), Changzheng Hosp, Dept Dermatol & Venereol, PLA Key Lab Mycosis, Shanghai, Peoples R China.	weifang081782@163.com; liaowanqing@sohu.com	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	National Key Basic Research Programs of China [2013CB531601]; National Natural Science Foundation of China [81401651, 81471926, 31170139]; Shanghai Municipal Natural Science Foundation [12JC1411000, 12ZR1454400, 14495800500]; Shanghai Key Laboratory of Molecular Medical Mycology [14DZ2272900]; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	National Key Basic Research Programs of China(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Municipal Natural Science Foundation; Shanghai Key Laboratory of Molecular Medical Mycology; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This study was supported by the National Key Basic Research Programs of China (2013CB531601), the National Natural Science Foundation of China (81401651, 81471926, and 31170139), the Shanghai Municipal Natural Science Foundation (12JC1411000, 12ZR1454400, and 14495800500), and the Shanghai Key Laboratory of Molecular Medical Mycology (14DZ2272900).	AbuSalah KM, 1996, BRIT J BIOMED SCI, V53, P122; Ajesh K, 2013, J APPL MICROBIOL, V115, P1287, DOI 10.1111/jam.12324; BARTNICK.S, 1968, ANNU REV MICROBIOL, V22, P87, DOI 10.1146/annurev.mi.22.100168.000511; Bicanic T, 2006, CLIN INFECT DIS, V43, P1069, DOI 10.1086/507895; Bratton EW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043582; Brouwer AE, 2004, LANCET, V363, P1764, DOI 10.1016/S0140-6736(04)16301-0; Chowdhary A, 2011, J MED MICROBIOL, V60, P961, DOI 10.1099/jmm.0.029025-0; Chwalibog A, 2010, INT J NANOMED, V5, P1085, DOI 10.2147/IJN.S13532; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; CLSI, 2008, M27A3 CLSI; Despax B, 2011, NANOTECHNOLOGY, V22, DOI 10.1088/0957-4484/22/17/175101; Fang W, 2015, FUNGAL GENET BIOL, V78, P7, DOI 10.1016/j.fgb.2014.10.017; Fang WJ, 2012, SMALL, V8, P3816, DOI 10.1002/smll.201200962; Fang WJ, 2012, ADV FUNCT MATER, V22, P842, DOI 10.1002/adfm.201101960; Feng QL, 2000, J BIOMED MATER RES, V52, P662, DOI 10.1002/1097-4636(20001215)52:4<662::AID-JBM10>3.0.CO;2-3; Fortun J, 2011, ENFERM INFEC MICR CL, V29, P38, DOI 10.1016/S0213-005X(11)70042-8; Friese G, 2001, AIDS, V15, P2344, DOI 10.1097/00002030-200111230-00026; Georgopapadakou NH, 1998, CURR OPIN MICROBIOL, V1, P547, DOI 10.1016/S1369-5274(98)80087-8; Groll AH, 1998, ADV PHARMACOL, V44, P343, DOI 10.1016/S1054-3589(08)60129-5; Heitman J, 2011, CRYPTOCOCCUS: FROM HUMAN PATHOGEN TO MODEL YEAST, P1; HSUCHEN CC, 1973, ANTIMICROB AGENTS CH, V4, P316, DOI 10.1128/AAC.4.3.316; Huang XQ, 2011, ADV MATER, V23, P3420, DOI 10.1002/adma.201100905; Huang XQ, 2011, NAT NANOTECHNOL, V6, P28, DOI 10.1038/NNANO.2010.235; Huh AJ, 2011, J CONTROL RELEASE, V156, P128, DOI 10.1016/j.jconrel.2011.07.002; Hwang ET, 2008, SMALL, V4, P746, DOI 10.1002/smll.200700954; Ishida K, 2014, MEM I OSWALDO CRUZ, V109, P220, DOI 10.1590/0074-0276130269; Ivask A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102108; Jebali A, 2014, MED MYCOL, V52, P65, DOI 10.3109/13693786.2013.822996; Kalishwaralal K, 2010, COLLOID SURFACE B, V79, P340, DOI 10.1016/j.colsurfb.2010.04.014; Kanafani ZA, 2008, CLIN INFECT DIS, V46, P120, DOI 10.1086/524071; Kim KJ, 2008, J MICROBIOL BIOTECHN, V18, P1482; Kim KJ, 2009, BIOMETALS, V22, P235, DOI 10.1007/s10534-008-9159-2; Kong H, 2008, LANGMUIR, V24, P2051, DOI 10.1021/la703085e; Liu W, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0103442; Lortholary O, 2007, CLIN INFECT DIS, V45, P81, DOI 10.1086/518583; Manfredi R, 2006, AIDS PATIENT CARE ST, V20, P227, DOI 10.1089/apc.2006.20.227; Mares D, 1998, MED MYCOL, V36, P379, DOI 10.1080/02681219880000601; Mdodo R, 2010, East Afr Med J, V87, P481; Mo SG, 2015, J MATER CHEM B, V3, P6255, DOI 10.1039/c5tb00830a; Monteiro DR, 2011, BIOFOULING, V27, P711, DOI 10.1080/08927014.2011.599101; Morones JR, 2005, NANOTECHNOLOGY, V16, P2346, DOI 10.1088/0957-4484/16/10/059; Niazi JH, 2011, APPL BIOCHEM BIOTECH, V164, P1278, DOI 10.1007/s12010-011-9212-4; Odds FC, 2003, TRENDS MICROBIOL, V11, P272, DOI 10.1016/S0966-842X(03)00117-3; Odds FC, 2003, J ANTIMICROB CHEMOTH, V52, P1, DOI 10.1093/jac/dkg301; Ostrosky-Zeichner L, 2010, NAT REV DRUG DISCOV, V9, P719, DOI 10.1038/nrd3074; Osumi M, 1998, MICRON, V29, P207; Panacek A, 2009, BIOMATERIALS, V30, P6333, DOI 10.1016/j.biomaterials.2009.07.065; Park BJ, 2009, AIDS, V23, P525, DOI 10.1097/QAD.0b013e328322ffac; Park HJ, 2009, WATER RES, V43, P1027, DOI 10.1016/j.watres.2008.12.002; Perfect JR, 2010, CLIN INFECT DIS, V50, P291, DOI 10.1086/649858; Pfaller MA, 2009, J CLIN MICROBIOL, V47, P117, DOI 10.1128/JCM.01747-08; Pfaller MA, 2012, AM J MED, V125, pS3, DOI 10.1016/j.amjmed.2011.11.001; Prucek R, 2011, BIOMATERIALS, V32, P4704, DOI 10.1016/j.biomaterials.2011.03.039; Pukkila-Worley R, 2008, EXPERT OPIN PHARMACO, V9, P551, DOI 10.1517/14656566.9.4.551; Rai M, 2009, BIOTECHNOL ADV, V27, P76, DOI 10.1016/j.biotechadv.2008.09.002; Richardson M, 2008, CLIN MICROBIOL INFEC, V14, P5, DOI 10.1111/j.1469-0691.2008.01978.x; Roling EE, 2002, DIAGN MICR INFEC DIS, V43, P13, DOI 10.1016/S0732-8893(02)00361-9; Sar B, 2004, J ANTIMICROB CHEMOTH, V54, P563, DOI 10.1093/jac/dkh361; Selvaraj M, 2014, APPL BIOCHEM BIOTECH, V173, P55, DOI 10.1007/s12010-014-0782-9; Shrivastava S, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/22/225103; Sifuentes-Osornio J, 2012, CURR FUNGAL INFECT R, V6, P23, DOI 10.1007/s12281-011-0081-7; Sondi I, 2004, J COLLOID INTERF SCI, V275, P177, DOI 10.1016/j.jcis.2004.02.012; Tang SH, 2014, SMALL, V10, P3139, DOI 10.1002/smll.201303631; Vazquez-Munoz R, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0108876; Xu Y, 2013, J OCUL PHARMACOL TH, V29, P270, DOI 10.1089/jop.2012.0155; Yamanaka M, 2005, APPL ENVIRON MICROB, V71, P7589, DOI 10.1128/AEM.71.11.7589-7593.2005; Zhang L, 2008, CLIN PHARMACOL THER, V83, P761, DOI 10.1038/sj.clpt.6100400; Zhao ZX, 2014, NANOTECHNOLOGY, V25, DOI 10.1088/0957-4484/25/28/285701	69	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 7	2016	11	6							e0157000	10.1371/journal.pone.0157000	http://dx.doi.org/10.1371/journal.pone.0157000			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DO1TC	27611217	Green Submitted, Green Published, gold			2022-12-26	WOS:000377561000058
J	Zhang, N; Becares, L; Chandola, T				Zhang, Nan; Becares, Laia; Chandola, Tarani			Patterns and Determinants of Double-Burden of Malnutrition among Rural Children: Evidence from China	PLOS ONE			English	Article							LEFT-BEHIND CHILDREN; DEVELOPING-COUNTRIES; NUTRITIONAL-STATUS; RISK-FACTORS; PARENTAL MIGRATION; PHYSICAL-ACTIVITY; GROWTH STANDARDS; OLDER CHILDREN; HEALTH-STATUS; LIFE-COURSE	Chinese children are facing dual burden of malnutrition-coexistence of under-and overnutrition. Little systematic evidence exists for explaining the simultaneous presence of under-and over-nutrition. This study aims to explore underlying mechanisms of under-and over-nutrition among children in rural China. This study used a nationwide longitudinal data-set of children (N = 5,017) from 9 provinces across China, with four exclusively categories of nutritional outcomes including under-nutrition (stunting and underweight), over-nutrition (overweight only including obesity), paradox (stunted overweight), with normal nutrition as reference. Multinomial logit models (Level-1: occasions; Level-2: children; Level-3: villages) were fitted which corrected for non-independence of observations due to geographic clustering and repeated observations of individuals. A mixture of risk factors at the individual, household and neighbourhood levels predicted under-and over-nutrition among children in rural China. Improved socioeconomic status and living in more urbanised villages reduced the risk of stunted overweight among rural children in China. Young girls appeared to have higher risk of under-nutrition, and the risk decreased with age more markedly than for boys up to age 5. From age 5 onwards, boys tended to have higher risk of under-nutrition than girls. Girls aged around 12 and older were less likely to suffer from under-nutrition, while boys' higher risk of under-nutrition persisted throughout adolescence. Children were less likely to suffer from over-nutrition compared to normal nutrition. Boys tended to have an even lower risk of over-nutrition than girls and the gender difference widened with age until adolescence. Our results have important policy implications that improving household economic status, in particular, maternal education and health insurance for children, and living environment are important to enhance rural children's nutritional status in China. Investments in early years of childhood can be effective to reduce gender inequality in nutritional health in rural China.	[Zhang, Nan; Becares, Laia; Chandola, Tarani] Univ Manchester, Sch Social Sci, Cathie Marsh Inst Social Res CMIST, Manchester M13 9PL, Lancs, England; [Becares, Laia] Univ Manchester, Ctr Dynam Ethn CoDE, Sch Social Sci, Manchester M13 9PL, Lancs, England	University of Manchester; University of Manchester	Zhang, N (corresponding author), Univ Manchester, Sch Social Sci, Cathie Marsh Inst Social Res CMIST, Manchester M13 9PL, Lancs, England.	nancytju@gmail.com	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	ESRC; National Institute of Nutrition and Food Safety; China Centre for Disease Control and Prevention; Carolina Population Centre [5 R24 HD050924]; University of North Carolina at Chapel Hill; NIH [R01-HD30880, DK056350, R24 HD050924, R01-HD38700]; Fogarty International Centre, NIH; China-Japan Friendship Hospital, Ministry of Health; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); National Institute of Nutrition and Food Safety; China Centre for Disease Control and Prevention; Carolina Population Centre; University of North Carolina at Chapel Hill; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Centre, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); China-Japan Friendship Hospital, Ministry of Health; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	This work was supporting by an ESRC postgraduate scholarship to NZ. We thank the National Institute of Nutrition and Food Safety, China Centre for Disease Control and Prevention, Carolina Population Centre (5 R24 HD050924), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the Fogarty International Centre, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; This work was supported by an ESRC postgraduate scholarship to NZ. We use data from China Health and Nutrition Survey (CHNS), which is available for public use from http://www.cpc.unc.edu/projects/china/data. We thank the National Institute of Nutrition and Food Safety, China Centre for Disease Control and Prevention, Carolina Population Centre (5 R24 HD050924), the University of North Carolina at Chapel Hill, the NIH (R01-HD30880, DK056350, R24 HD050924, and R01-HD38700) and the Fogarty International Centre, NIH for financial support for the CHNS data collection and analysis files from 1989 to 2011 and future surveys, and the China-Japan Friendship Hospital, Ministry of Health for support for CHNS 2009.	All-China Women's Federation, 2013, RES REP RUR LEFT CHI; [Anonymous], 2000, MODERNISATION SON PR; ASTRUP A, 1994, AM J PHYSIOL, V266, pE592, DOI 10.1152/ajpendo.1994.266.4.E592; Barker DJP, 2002, INT J EPIDEMIOL, V31, P1235, DOI 10.1093/ije/31.6.1235; Barker DJP, 1998, MOTHERS BABIES HLTH; Berk LE., 2013, CHILD DEV; Black RE, 2003, LANCET, V361, P2226, DOI 10.1016/S0140-6736(03)13779-8; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bosy-Westphal A, 2009, BRIT J NUTR, V102, P453, DOI 10.1017/S0007114508190304; Bredenkamp C, 2006, INCOME CHILD NUTR ST; Brown J, 2007, NUTR LIFE CYCLE; Browne W.J., 2015, MCMC ESTIMATION MLWI; Chang S, 2000, Wei Sheng Yan Jiu, V29, P270; Chang Suying, 2006, Wei Sheng Yan Jiu, V35, P768; Chen CM, 2011, BIOMED ENVIRON SCI, V24, P321, DOI 10.3967/0895-3988.2011.04.001; Dang SN, 2014, J CHILD HEALTH CARE, V18, P358, DOI 10.1177/1367493513496669; Dearth-Wesley T, 2008, EUR J CLIN NUTR, V62, P1302, DOI 10.1038/sj.ejcn.1602853; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Du SF, 2014, OBES REV, V15, P8, DOI 10.1111/obr.12122; Du SF, 2004, SOC SCI MED, V59, P1505, DOI 10.1016/j.socscimed.2004.01.021; Duncan C, 1998, SOC SCI MED, V46, P97, DOI 10.1016/S0277-9536(97)00148-2; Egger G, 1997, BRIT MED J, V315, P477, DOI 10.1136/bmj.315.7106.477; Evans GW, 2002, ANNU REV PUBL HEALTH, V23, P303, DOI 10.1146/annurev.publhealth.23.112001.112349; Gao Y, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-56; Ge XJ, 2001, SOC PSYCHOL QUART, V64, P363, DOI 10.2307/3090160; Glewwe P, 1999, J HUM RESOUR, V34, P124, DOI 10.2307/146305; Gong P, 2012, LANCET, V379, P843, DOI 10.1016/S0140-6736(11)61878-3; Gracey M, 2002, ACTA PAEDIATR, V91, P1, DOI 10.1080/080352502753457842; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Harris NS, 2001, NEW ENGL J MED, V344, P341, DOI 10.1056/NEJM200102013440504; He W, 2014, AM J PUBLIC HEALTH, V104, pE14, DOI 10.2105/AJPH.2013.301669; Hoffman DJ, 2000, AM J CLIN NUTR, V72, P702; Hui L, 2003, HEALTH PLACE, V9, P371, DOI 10.1016/S1353-8292(03)00049-2; Jia X-y, 2012, CHINESE J PUBLIC HLT, V1; Jiang JX, 2007, APPETITE, V48, P377, DOI 10.1016/j.appet.2006.10.004; Jiang Y, 2015, CHILD CARE HLTH DEV, V41, P45, DOI 10.1111/cch.12148; Jimenez-Pavon D, 2010, INT J PEDIATR OBES, V5, P3, DOI 10.3109/17477160903067601; Jones-Smith JC, 2010, SOC SCI MED, V71, P1436, DOI 10.1016/j.socscimed.2010.07.027; Kristjansdottir G, 2001, ACTA PAEDIATR, V90, P429, DOI 10.1111/j.1651-2227.2001.tb00445.x; Li Li-ming, 2005, Zhonghua Liu Xing Bing Xue Za Zhi, V26, P478; Li YP, 2009, BIOMED ENVIRON SCI, V22, P130, DOI 10.1016/S0895-3988(09)60035-0; Liu Y, 2007, ECON BULL, V15; Luo JY, 2008, PUBLIC HEALTH REP, V123, P382; Lynch J, 2005, ANNU REV PUBL HEALTH, V26, P1, DOI 10.1146/annurev.publhealth.26.021304.144505; Mamabolo RL, 2005, PUBLIC HEALTH NUTR, V8, P501, DOI 10.1079/PHN2005786; Marmot M, 2007, LANCET, V370, P1153, DOI 10.1016/S0140-6736(07)61385-3; McDonald CM, 2013, AM J CLIN NUTR, V97, P896, DOI 10.3945/ajcn.112.047639; Monda KL, 2007, SOC SCI MED, V64, P858, DOI 10.1016/j.socscimed.2006.10.019; Morgan SL, 2000, CHINA J, V44, P1, DOI 10.2307/2667475; Mu R, 2015, J POPUL ECON, V28, P631, DOI 10.1007/s00148-015-0550-3; Na Zhang, 2015, 2015 Visual Communications and Image Processing (VCIP), P1, DOI 10.1109/VCIP.2015.7457813; Ning MX, 2013, AGR ECON-CZECH, V59, P467, DOI 10.17221/19/2013-AGRICECON; Pei LL, 2014, BMC PUBLIC HEALTH, V14, DOI 10.1186/1471-2458-14-121; Piernas C, 2015, EUROPEAN J CLIN NUTR; Popkin B. M., 2003, Development Policy Review, V21, P581, DOI 10.1111/j.1467-8659.2003.00225.x; Popkin BM, 2010, INT J EPIDEMIOL, V39, P1435, DOI 10.1093/ije/dyp322; Popkin BM, 1996, J NUTR, V126, P3009, DOI 10.1093/jn/126.12.3009; Popkin BM, 1999, WORLD DEV, V27, P1905, DOI 10.1016/S0305-750X(99)00094-7; Popkin BM, 2001, J NUTR, V131, p871S, DOI 10.1093/jn/131.3.871S; Poskitt EME, 2009, ANN TROP PAEDIATR, V29, P1, DOI 10.1179/146532809X401971; Rasbash J, 2013, MLWIN VERSION 2 28; Reilly JJ, 2003, ARCH DIS CHILD, V88, P748, DOI 10.1136/adc.88.9.748; Ren WW, 2014, CHINA ECON REV, V31, P145, DOI 10.1016/j.chieco.2014.09.001; RODRIGUEZ G, 1995, J ROY STAT SOC A STA, V158, P73, DOI 10.2307/2983404; Shan XY, 2010, INT J PEDIATR OBES, V5, P383, DOI 10.3109/17477160903572001; Shen TF, 1996, NEW ENGL J MED, V335, P400, DOI 10.1056/NEJM199608083350606; Shetty P, 2013, INDIAN J PEDIATR, V80, pS21, DOI 10.1007/s12098-013-0971-5; Shi ZM, 2005, J ADOLESCENT HEALTH, V37, P313, DOI 10.1016/j.jadohealth.2004.10.013; Stevens GA, 2012, LANCET, V380, P824, DOI 10.1016/S0140-6736(12)60647-3; Strauss J, 1998, J ECON LIT, V36, P766; Strong WB, 2005, J PEDIATR-US, V146, P732, DOI 10.1016/j.jpeds.2005.01.055; Tan C, 2010, PUBLIC HEALTH NUTR, V13, P1663, DOI 10.1017/S1368980010000078; Tassoni P., 2007, CHILD DEV 6 16 YEARS; United Nations Children's Fund, 1998, STAT WORLDS CHILDR 1; United Nations Children's Fund, 1990, STRAT IMPR NUTR STAT; Van de Poel E, 2009, ECON HUM BIOL, V7, P200, DOI 10.1016/j.ehb.2009.05.004; Walker SP, 2007, LANCET, V369, P145, DOI 10.1016/S0140-6736(07)60076-2; Wang XL, 2009, PUBLIC HEALTH NUTR, V12, P1991, DOI 10.1017/S1368980009990796; Wang Y, 1998, EUR J CLIN NUTR, V52, P908, DOI 10.1038/sj.ejcn.1600664; Wang Y., 2012, HDB ANTHROPOMETRY PH, V1, P29, DOI DOI 10.1007/978-1-4419-1788-1_2; Wang YF, 2003, PUBLIC HEALTH NUTR, V6, P549, DOI 10.1079/PHN2003470; Wang YF, 2002, AM J CLIN NUTR, V75, P971, DOI 10.1093/ajcn/75.6.971; Wei SG, 2011, AUSTRALAS MED J, V4, P123, DOI 10.4066/AMJ.2011.584; Zhang J, 2011, ASIA PAC J CLIN NUTR, V20, P584; Zhang N, 2016, PARENTAL MIGRATION I; Zhang N, 2015, APPETITE, V95, P484, DOI 10.1016/j.appet.2015.08.024; Zhang N, 2015, BMC PUBLIC HEALTH, V15, DOI 10.1186/s12889-015-2296-y; Zhang YX, 2014, INT J CARDIOL, V176, P1212, DOI 10.1016/j.ijcard.2014.07.222; Zong XN, 2014, B WORLD HEALTH ORGAN, V92, P555, DOI 10.2471/BLT.13.126243; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569; ZURLO F, 1990, AM J PHYSIOL, V259, pE650	91	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 8	2016	11	7							e0158119	10.1371/journal.pone.0158119	http://dx.doi.org/10.1371/journal.pone.0158119			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	DR6IK	27611217	Green Accepted, Green Published, Green Submitted, gold			2022-12-26	WOS:000380005400031
J	Zhang, MH; Xin, M				Zhang, Miaohui; Xin, Ming			Human Detection Using Random Color Similarity Feature and Random Ferns Classifier	PLOS ONE			English	Article								We explore a novel approach for human detection based on random color similarity feature (RCS) and random ferns classifier which is also known as semi-naive Bayesian classifier. In contrast to other existing features employed by human detection, color-based features are rarely used in vision-based human detection because of large intra-class variations. In this paper, we propose a novel color-based feature, RCS feature, which is yielded by simple color similarity computation between image cells randomly picked in still images, and can effectively characterize human appearances. In addition, a histogram of oriented gradient based local binary feature (HOG-LBF) is also introduced to enrich the human descriptor set. Furthermore, random ferns classifier is used in the proposed approach because of its faster speed in training and testing than traditional classifiers such as SupportVector Machine (SVM) classifier, without a loss in performance. Finally, the proposed method is conducted in public datasets and achieves competitive detection results.	[Zhang, Miaohui] Henan Univ, Inst Image Proc & Pattern Recognit, Kaifeng, Peoples R China; [Xin, Ming] Beihang Univ, Sch Comp Sci & Engn, Beijing Key Lab Digital Media, Beijing, Peoples R China	Henan University; Beihang University	Zhang, MH (corresponding author), Henan Univ, Inst Image Proc & Pattern Recognit, Kaifeng, Peoples R China.	zhmh@henu.edu.cn	Chandola, Tarani/I-3192-2013; Becares, Laia/J-6027-2015	Chandola, Tarani/0000-0002-1864-3413; ZHANG, NAN/0000-0002-8032-275X; Becares, Laia/0000-0002-4207-074X; Xin, Ming/0000-0002-9379-3710	National Natural Science Foundation of China [61305042, 61503250, 61503173]; Science and Technology Research Key Project of Education Department of Henan Province [152102210057]; Postdoctoral Science Fund of China [2015M582182]; Henan University Fund [2012YBZR005]; ESRC [ES/J019119/1, ES/K001582/1] Funding Source: UKRI	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Science and Technology Research Key Project of Education Department of Henan Province; Postdoctoral Science Fund of China(China Postdoctoral Science Foundation); Henan University Fund; ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The work was supported by the National Natural Science Foundation of China (No. 61305042, No. 61503250, No. 61503173), the Science and Technology Research Key Project of Education Department of Henan Province (No. 152102210057), the Postdoctoral Science Fund of China (No. 2015M582182), Henan University Fund (2012YBZR005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amit Y, 1997, NEURAL COMPUT, V9, P1545, DOI 10.1162/neco.1997.9.7.1545; Bosch A, 2007, IEEE I CONF COMP VIS, P1863; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Cheng WC, 2013, ENG APPL ARTIF INTEL, V26, P1016, DOI 10.1016/j.engappai.2012.08.013; Dalal N, 2005, PROC CVPR IEEE, P886, DOI 10.1109/cvpr.2005.177; Dalal N, 2006, LECT NOTES COMPUT SC, V3952, P428, DOI 10.1007/11744047_33; Everingham P. M., 2009, P INT C COMP VIS KYO; Kalal Z., 2010, P COMP VIS PATT REC; Kong KK, 2015, PATTERN RECOGN LETT, V68, P63, DOI 10.1016/j.patrec.2015.07.043; Laptev I, 2006, BMVC, V3, P949; Liu CH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142820; Luo P, 2014, IEEE C CVPR; Maji S, 2008, PROC CVPR IEEE, P2245; Mikolajczyk K, 2004, LECT NOTES COMPUT SC, V3021, P69; Mohan A, 2001, IEEE T PATTERN ANAL, V23, P349, DOI 10.1109/34.917571; Ozuysal M, 2010, IEEE T PATTERN ANAL, V32, P448, DOI 10.1109/TPAMI.2009.23; Ojala T, 2002, IEEE T PATTERN ANAL, V24, P971, DOI 10.1109/TPAMI.2002.1017623; Schwartz W.R., 2009, P INT C COMP VIS KYO; Tuzel O., 2007, CVPR, V1; Villamizar M., 2010, CVPR; WALK S, 2010, PROC CVPR IEEE, P1030, DOI DOI 10.1109/CVPR.2010.5540102; Wen XZ, 2015, INFORM SCIENCES, V295, P395, DOI 10.1016/j.ins.2014.10.040; Winn J., 2006, CVPR; Wu B, 2005, IEEE I CONF COMP VIS, P90; Wu B., 2008, P IEEE COMP SOC C CO; Yao SH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134242; Zhang M., 2011, OPTICAL ENG, V9; Zhang S, 2015, J OPHTHALMOL, V2015, DOI 10.1155/2015/275435; Zhao Y, 2013, IEEE INTELLIGENT TRA, V7, P459	30	82	85	1	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 9	2016	11	9							e0162830	10.1371/journal.pone.0162830	http://dx.doi.org/10.1371/journal.pone.0162830			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DV9JE	27611217	Green Published, gold, Green Submitted			2022-12-26	WOS:000383255900174
J	Yang, FX; Mao, DQ; Zhou, H; Luo, Y				Yang, Fengxia; Mao, Daqing; Zhou, Hao; Luo, Yi			Prevalence and Fate of Carbapenemase Genes in a Wastewater Treatment Plant in Northern China	PLOS ONE			English	Article							SPECTRUM-BETA-LACTAMASE; KLEBSIELLA-PNEUMONIAE ISOLATE; ANTIBIOTIC-RESISTANCE GENES; HYDROLYZING ENZYME KPC-2; ESCHERICHIA-COLI; PSEUDOMONAS-AERUGINOSA; PLASMIDS; ENTEROBACTERIACEAE; DISSEMINATION; VIRULENCE	Carbapenemase-producing strains of bacteria, which were primarily found in the medical field, have increasingly been found in the environment, thus posing potential risks to public health. One possible way for carbapenemase genes to enter the environment is via wastewater. Therefore, the goal of this study was to determine the occurrence and fate of five high-risk carbapenemase genes in a wastewater treatment plant (WWTP) in northern China using real-time qPCR. Results showed that the bla(KPC-2), bla(GES-1), and bla(IMP-1) genes prevailed throughout all processing stages (even in the chlorination disinfection unit) in the WWTP, whereas the bla(VIM-2) and bla(OXA-48) genes were not detected in all samples. Worryingly, considerable amounts of carbapenemase genes ((1.54 +/- 0.61) x 10(3) copies/mL to (2.14 +/- 0.41) x 10(5) copies/mL) were detected in WWTP effluent samples, while the majority of the carbapenemase genes were transported to the dewatered sludge with concentrations from (6.51 +/- 0.14) x 10(9) copies/g to (6.18 +/- 0.63) x 10(10) copies/g dry weight. Furthermore, a total of 97 KPC-2-producing strains, belonging to 8 bacterial genera, were isolated from the WWTP. Sequencing of 16S rRNA revealed that most of KPC-2 producing isolates were opportunistic pathogens, including Klebsiella spp. (10.3%), Enterococcus spp. (11.3%), Acinetobacter spp. (19.6%), Escherichia spp. (12.4%), Shigella spp. (17.5%), Stenotrophomonas spp. (10.3%) and Wautersiella spp. (9.3%). Moreover, bla(KPC-2) genes were identified for the first time in Paenibacillus spp. isolates (an indigenous bacteria), indicating an increased risk of horizontal transfer between clinical pathogens and environmental bacteria. Indeed, a conjugation experiment demonstrated transfer of the bla(KPC-2) gene to an E. coli J53 strain from a Klebsiella strain isolated from the WWTP. To our knowledge, this is the first study to obtain Paenibacillus spp. isolates carrying the carbapenemase gene and to quantify the abundance of carbapenemase genes in the environment.	[Yang, Fengxia; Mao, Daqing] Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China; [Yang, Fengxia; Zhou, Hao; Luo, Yi] Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China	Tianjin University; Nankai University	Mao, DQ (corresponding author), Tianjin Univ, Sch Environm Sci & Engn, Tianjin 300072, Peoples R China.; Luo, Y (corresponding author), Nankai Univ, Coll Environm Sci & Engn, Minist Educ, Key Lab Pollut Proc & Environm Criteria, Tianjin 300071, Peoples R China.	mao@tju.edu.cn; luoy@nankai.edu.cn	Luo, Yi/C-2451-2018; Zhou, Hao/AFQ-5956-2022; Zhou, Hao/Q-2401-2018	Zhou, Hao/0000-0001-7131-3758; Zhou, Hao/0000-0001-7131-3758	National Natural Science Foundation of China [31470440, 21277075]; State Environmental Protection Commonweal Project [201309031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); State Environmental Protection Commonweal Project	This study was supported by the National Natural Science Foundation of China (31470440, 21277075), and the State Environmental Protection Commonweal Project (201309031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpaka PE, 2009, J CLIN MICROBIOL, V47, P2670, DOI 10.1128/JCM.00362-09; Amos GCA, 2014, VET MICROBIOL, V171, P441, DOI 10.1016/j.vetmic.2014.02.017; Baughman Robert P, 2009, J Intensive Care Med, V24, P230, DOI 10.1177/0885066609335660; Berendonk TU, 2015, NAT REV MICROBIOL, V13, P310, DOI 10.1038/nrmicro3439; Boyd EF, 1996, GENETICS, V143, P1091; Cabezon E, 1997, MOL GEN GENET, V254, P400, DOI 10.1007/s004380050432; CALISTO F, 2011, BMC PROCEEDINGS, V5, P132, DOI DOI 10.1186/1753-6561-5-S6-P132; Canton R, 2012, CLIN MICROBIOL INFEC, V18, P413, DOI 10.1111/j.1469-0691.2012.03821.x; Carattoli A, 2005, J MICROBIOL METH, V63, P219, DOI 10.1016/j.mimet.2005.03.018; Carattoli A, 2001, EMERG INFECT DIS, V7, P444, DOI 10.3201/eid0703.017314; Carrer A, 2008, ANTIMICROB AGENTS CH, V52, P2950, DOI 10.1128/AAC.01672-07; CAVALLI LL, 1953, J GEN MICROBIOL, V8, P89, DOI 10.1099/00221287-8-1-89; Chen ZW, 2015, J QUANT SPECTROSC RA, V167, P1, DOI 10.1016/j.jqsrt.2015.07.018; CLSI, 2012, M100S22 CLSI; Coque TM, 2008, EMERG INFECT DIS, V14, P195, DOI 10.3201/eid1402.070350; Cuzon G, 2008, ANTIMICROB AGENTS CH, V52, P796, DOI 10.1128/AAC.01180-07; Dallal MMS, 2008, INFECT DIS CLIN PRAC, V16, P41, DOI [10.1097/ipc.0b013e31815f6586, DOI 10.1097/IPC.0B013E31815F6586]; Desai P J, 2001, Indian J Med Microbiol, V19, P132; DEVRIESE LA, 1993, J APPL BACTERIOL, V75, P399, DOI 10.1111/j.1365-2672.1993.tb02794.x; Diallo AA, 2013, WATER RES, V47, P4719, DOI 10.1016/j.watres.2013.04.047; Fleurbaaij F, 2014, ANAL CHEM, V86, P9154, DOI 10.1021/ac502049p; Galler H, 2014, CLIN MICROBIOL INFEC, V20, pO132, DOI 10.1111/1469-0691.12336; Garcia-Fernandez A, 2010, ANTIMICROB AGENTS CH, V54, P4178, DOI 10.1128/AAC.01301-09; Gonullu N, 2008, J CLIN MICROBIOL, V46, P1110, DOI 10.1128/JCM.01974-07; Hays C, 2012, INT J ANTIMICROB AG, V39, P545, DOI 10.1016/j.ijantimicag.2012.03.002; Hopkins KL, 2006, ANTIMICROB AGENTS CH, V50, P3203, DOI 10.1128/AAC.00149-06; Hossain A, 2004, ANTIMICROB AGENTS CH, V48, P4438, DOI 10.1128/AAC.48.11.4438-4440.2004; Huang JJ, 2011, WATER RES, V45, P2775, DOI 10.1016/j.watres.2011.02.026; Insa R, 2007, J ANTIMICROB CHEMOTH, V59, P583, DOI 10.1093/jac/dkl496; Johnson TJ, 2009, MICROBIOL MOL BIOL R, V73, P750, DOI 10.1128/MMBR.00015-09; Kim Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024621; Kumarasamy K, 2012, J ANTIMICROB CHEMOTH, V67, P243, DOI 10.1093/jac/dkr431; Lane D.J., 1991, NUCL ACID TECH BACT, P115, DOI DOI 10.1007/S00227-012-2133-0; Lartigue MF, 2006, ANTIMICROB AGENTS CH, V50, P1282, DOI 10.1128/AAC.50.4.1282-1286.2006; Lawley TD, 2003, FEMS MICROBIOL LETT, V224, P1, DOI 10.1016/S0378-1097(03)00430-0; Lu SY, 2010, APPL ENVIRON MICROB, V76, P5972, DOI 10.1128/AEM.00711-10; Luo Y, 2014, ENVIRON SCI TECH LET, V1, P26, DOI 10.1021/ez400152e; Luo Y, 2010, ENVIRON SCI TECHNOL, V44, P7220, DOI 10.1021/es100233w; Manenzhe RI, 2015, J ANTIMICROB CHEMOTH, V53, P3396; Mao DQ, 2015, WATER RES, V85, P458, DOI 10.1016/j.watres.2015.09.010; Marcade G, 2009, J ANTIMICROB CHEMOTH, V63, P67, DOI 10.1093/jac/dkn428; Mavroidi A, 2012, INT J ANTIMICROB AG, V39, P247, DOI 10.1016/j.ijantimicag.2011.11.003; Montezzi LF, 2015, INT J ANTIMICROB AG, V45, P174, DOI 10.1016/j.ijantimicag.2014.10.016; Munir M, 2011, WATER RES, V45, P681, DOI 10.1016/j.watres.2010.08.033; Naas T, 2011, ANTIMICROB AGENTS CH, V55, P4933, DOI 10.1128/AAC.00719-11; Navon-Venezia S, 2006, ANTIMICROB AGENTS CH, V50, P3098, DOI 10.1128/AAC.00438-06; Nicolau DP, 2008, EXPERT OPIN PHARMACO, V9, P23, DOI 10.1517/14656566.9.1.23; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Nordmann P, 2009, LANCET INFECT DIS, V9, P228, DOI 10.1016/S1473-3099(09)70054-4; Oelschlaeger P, 2010, J MED CHEM, V53, P3013, DOI 10.1021/jm9012938; Ojer-Usoz E, 2014, WATER RES, V56, P37, DOI 10.1016/j.watres.2014.02.041; Pan XH, 2014, BIOCHEMISTRY-US, V53, P5414, DOI 10.1021/bi401609h; Papp-Wallace KM, 2011, ANTIMICROB AGENTS CH, V55, P4943, DOI 10.1128/AAC.00296-11; Poirel L, 2000, ANTIMICROB AGENTS CH, V44, P622, DOI 10.1128/AAC.44.3.622-632.2000; Poirel L, 2012, ANTIMICROB AGENTS CH, V56, P1662, DOI 10.1128/AAC.05850-11; Poirel L, 2011, DIAGN MICR INFEC DIS, V70, P119, DOI 10.1016/j.diagmicrobio.2010.12.002; Poirel L, 2010, ANTIMICROB AGENTS CH, V54, P3072, DOI 10.1128/AAC.00513-10; Potron A, 2011, FEMS MICROBIOL LETT, V324, P111, DOI 10.1111/j.1574-6968.2011.02392.x; Queenan AM, 2007, CLIN MICROBIOL REV, V20, P440, DOI 10.1128/CMR.00001-07; Robledo IE, 2010, ANTIMICROB AGENTS CH, V54, P1354, DOI 10.1128/AAC.00899-09; Rumbo C, 2011, ANTIMICROB AGENTS CH, V55, P3084, DOI 10.1128/AAC.00929-10; Shi P, 2013, WATER RES, V47, P111, DOI 10.1016/j.watres.2012.09.046; Siu LK, 2012, MICROB DRUG RESIST, V18, P380, DOI 10.1089/mdr.2011.0241; Stewart NK, 2015, BIOCHEMISTRY-US, V54, P588, DOI 10.1021/bi501052t; Suzuki MT, 2000, APPL ENVIRON MICROB, V66, P4605, DOI 10.1128/AEM.66.11.4605-4614.2000; Szczepanowski R, 2005, MICROBIOL-SGM, V151, P1095, DOI 10.1099/mic.0.27773-0; Tumbarello M, 2012, CLIN INFECT DIS, V55, P943, DOI 10.1093/cid/cis588; Villa L, 2010, J ANTIMICROB CHEMOTH, V65, P2518, DOI 10.1093/jac/dkq347; Villegas MV, 2007, ANTIMICROB AGENTS CH, V51, P1553, DOI 10.1128/AAC.01405-06; Virgincar N, 2011, J HOSP INFECT, V78, P293, DOI 10.1016/j.jhin.2011.03.016; Walsh TR, 2005, CLIN MICROBIOL REV, V18, P306, DOI 10.1128/CMR.18.2.306-325.2005; Wang XJ, 2014, MICROB DRUG RESIST, V20, P144, DOI 10.1089/mdr.2013.0100; Xi CW, 2009, APPL ENVIRON MICROB, V75, P5714, DOI 10.1128/AEM.00382-09; Yigit H, 2001, ANTIMICROB AGENTS CH, V45, P1151, DOI 10.1128/AAC.45.4.1151-1161.2001; Zhang R, 2007, J ANTIMICROB CHEMOTH, V59, P574, DOI 10.1093/jac/dkl541; Zurfluh K, 2013, APPL ENVIRON MICROB, V79, P3021, DOI 10.1128/AEM.00054-13	77	44	44	3	61	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 26	2016	11	5							e0156383	10.1371/journal.pone.0156383	http://dx.doi.org/10.1371/journal.pone.0156383			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	DN2GQ	27607467	Green Published, gold, Green Submitted			2022-12-26	WOS:000376882500127
